<?xml version="1.0" encoding="UTF-8"?>
<FEDREG xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="FRMergedXML.xsd">
  <VOL>68</VOL>
  <NO>158</NO>
  <DATE>Friday, August 15, 2003</DATE>
  <UNITNAME>Contents</UNITNAME>
  <CNTNTS>
    <AGCY>
      <EAR>Agricultural</EAR>
      <PRTPAGE P="iii"/>
      <HD>Agricultural Marketing Service</HD>
      <CAT>
        <HD>RULES</HD>
        <SJ>Milk marketing orders:</SJ>
        <SJDENT>
          <SJDOC>Central, </SJDOC>
          <PGS>48770-48771</PGS>
          <FRDOCBP D="2" T="15AUR1.sgm">03-20817</FRDOCBP>
        </SJDENT>
        <SJ>Nectarines and peaches grown in—</SJ>
        <SJDENT>
          <SJDOC>California, </SJDOC>
          <PGS>48767-48770</PGS>
          <FRDOCBP D="4" T="15AUR1.sgm">03-20875</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Agricultural</EAR>
      <HD>Agricultural Research Service</HD>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Patent licenses; non-exclusive, exclusive, or partially exclusive:</SJ>
        <SJDENT>
          <SJDOC>Fiorini Ranch, </SJDOC>
          <PGS>48876</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20876</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR/>
      <HD>Agriculture Department</HD>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Agricultural Marketing Service</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Agricultural Research Service</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Forest Service</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> National Agricultural Statistics Service</P>
      </SEE>
    </AGCY>
    <AGCY>
      <EAR>Air Force</EAR>
      <HD>Air Force Department</HD>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Meetings:</SJ>
        <SJDENT>
          <SJDOC>Scientific Advisory Board, </SJDOC>
          <PGS>48889-48890</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20815</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Alcohol</EAR>
      <HD>Alcohol and Tobacco Tax and Trade Bureau</HD>
      <CAT>
        <HD>PROPOSED RULES</HD>
        <SJ>Alcohol; viticultural area designations:</SJ>
        <SJDENT>
          <SJDOC>Dundee Hills, OR, </SJDOC>
          <PGS>48839-48843</PGS>
          <FRDOCBP D="5" T="15AUP1.sgm">03-20914</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Antitrust</EAR>
      <HD>Antitrust Division</HD>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>National cooperative research notifications:</SJ>
        <SJDENT>
          <SJDOC>Digital Subscriber Line Forum, </SJDOC>
          <PGS>48940-48941</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20825</FRDOCBP>
        </SJDENT>
        <SJDENT>
          <SJDOC>Multiservice Switching Forum, </SJDOC>
          <PGS>48941</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20826</FRDOCBP>
        </SJDENT>
        <SJDENT>
          <SJDOC>National Center for Manufacturing Sciences, Inc., </SJDOC>
          <PGS>48941-48942</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20824</FRDOCBP>
        </SJDENT>
        <SJDENT>
          <SJDOC>Petrotechnical Open Standards Consortium, Inc., </SJDOC>
          <PGS>48942</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20823</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Army</EAR>
      <HD>Army Department</HD>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Engineers Corps</P>
      </SEE>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Meetings:</SJ>
        <SJDENT>
          <SJDOC>Armed Forces Epidemiological Board, </SJDOC>
          <PGS>48890</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20910</FRDOCBP>
        </SJDENT>
        <SJ>Patent licenses; non-exclusive, exclusive, or partially exclusive:</SJ>
        <SJDENT>
          <SJDOC>Compositions and methods for enhancing bioassay performance through nanomanipulation, </SJDOC>
          <PGS>48890</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20911</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Blind</EAR>
      <HD>Blind or Severely Disabled, Committee for Purchase From  People Who Are</HD>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Committee for Purchase From People Who Are Blind or Severely Disabled</P>
      </SEE>
    </AGCY>
    <AGCY>
      <EAR>Centers</EAR>
      <HD>Centers for Medicare &amp; Medicaid Services</HD>
      <CAT>
        <HD>RULES</HD>
        <SJ>Medicare:</SJ>
        <SJDENT>
          <SJDOC>Claims; electronic submission, </SJDOC>
          <PGS>48805-48813</PGS>
          <FRDOCBP D="9" T="15AUR1.sgm">03-20955</FRDOCBP>
        </SJDENT>
      </CAT>
      <CAT>
        <HD>PROPOSED RULES</HD>
        <SJ>Medicare:</SJ>
        <SJDENT>
          <SJDOC>Physician fee schedule (2004 CY); payment policies and relative value unit adjustments, </SJDOC>
          <PGS>49029-49300</PGS>
          <FRDOCBP D="272" T="15AUP3.sgm">03-20662</FRDOCBP>
        </SJDENT>
      </CAT>
      <CAT>
        <HD>NOTICES</HD>
        <DOCENT>
          <DOC>Agency information collection activities; proposals, submissions, and approvals, </DOC>
          <PGS>48922</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20816</FRDOCBP>
        </DOCENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Children</EAR>
      <HD>Children and Families Administration</HD>
      <CAT>
        <HD>NOTICES</HD>
        <DOCENT>
          <DOC>Agency information collection activities; proposals, submissions, and approvals, </DOC>
          <PGS>48922-48923</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20884</FRDOCBP>
        </DOCENT>
        <SJ>Grants and cooperative agreements; availability, etc.:</SJ>
        <SUBSJ>Developmental disabilities programs—</SUBSJ>
        <SSJDENT>
          <SUBSJDOC>Help America Vote Training and Technical Assistance Projects; correction, </SUBSJDOC>
          <PGS>48923</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20885</FRDOCBP>
        </SSJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Coast Guard</EAR>
      <HD>Coast Guard</HD>
      <CAT>
        <HD>RULES</HD>
        <SJ>Ports and waterways safety:</SJ>
        <SJDENT>
          <SJDOC>Long Island Sound Marine Inspection and Captain of Port Zone; regulated navigation areas and safety and security zones, </SJDOC>
          <PGS>48798-48803</PGS>
          <FRDOCBP D="6" T="15AUR1.sgm">03-20929</FRDOCBP>
        </SJDENT>
      </CAT>
      <CAT>
        <HD>PROPOSED RULES</HD>
        <SJ>Regattas and marine parades:</SJ>
        <SJDENT>
          <SJDOC>Sunset Lake Hydrofest, Wildwood Crest, NJ, </SJDOC>
          <PGS>48846-48848</PGS>
          <FRDOCBP D="3" T="15AUP1.sgm">03-20928</FRDOCBP>
        </SJDENT>
      </CAT>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Environmental statements; availability, etc.:</SJ>
        <SJDENT>
          <SJDOC>Ketchikan Gateway Borough, AK; Gravina Access Project, </SJDOC>
          <PGS>48924-48925</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20822</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Commerce</EAR>
      <HD>Commerce Department</HD>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> International Trade Administration</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> National Institute of Standards and Technology</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> National Oceanic and Atmospheric Administration</P>
      </SEE>
    </AGCY>
    <AGCY>
      <EAR>Committee for Purchase</EAR>
      <HD>Committee for Purchase From People Who Are Blind or Severely Disabled</HD>
      <CAT>
        <HD>NOTICES</HD>
        <DOCENT>
          <DOC>Procurement list; additions and deletions, </DOC>
          <PGS>48878-48880</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20880</FRDOCBP>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20881</FRDOCBP>
        </DOCENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Comptroller</EAR>
      <HD>Comptroller of the Currency</HD>
      <CAT>
        <HD>RULES</HD>
        <DOCENT>
          <DOC>Community and economic development entities, community development projects, and other public welfare investments, </DOC>
          <PGS>48771-48783</PGS>
          <FRDOCBP D="13" T="15AUR1.sgm">03-20801</FRDOCBP>
        </DOCENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Defense</EAR>
      <HD>Defense Department</HD>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Air Force Department</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Army Department</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Engineers Corps</P>
      </SEE>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Committees; establishment, renewal, termination, etc.:</SJ>
        <SJDENT>
          <SJDOC>Employer Support of the Guard and Reserve Advisory Board, </SJDOC>
          <PGS>48886</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20868</FRDOCBP>
        </SJDENT>
        <DOCENT>
          <DOC>Courts-Martial Manual; amendments, </DOC>
          <PGS>48886-48888</PGS>
          <FRDOCBP D="3" T="15AUN1.sgm">03-20870</FRDOCBP>
        </DOCENT>
        <SJ>Grants and cooperative agreements; availability, etc.:</SJ>
        <SJDENT>
          <SJDOC>Institutions of higher education ineligible for Federal funds; list, </SJDOC>
          <PGS>48888</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20865</FRDOCBP>
        </SJDENT>
        <SJ>Meetings:</SJ>
        <SJDENT>
          <SJDOC>Historical Records Declassification Advisory Panel, </SJDOC>
          <PGS>48889</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20867</FRDOCBP>
        </SJDENT>
        <SJDENT>
          <SJDOC>Threat  Reduction Advisory Committee, </SJDOC>
          <PGS>48889</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20866</FRDOCBP>
        </SJDENT>
        <SJDENT>
          <SJDOC>Women in Services Advisory Committee, </SJDOC>
          <PGS>48889</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20869</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Drug</EAR>
      <PRTPAGE P="iv"/>
      <HD>Drug Enforcement Administration</HD>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>
          <E T="03">Applications, hearings, determinations, etc.:</E>
        </SJ>
        <SJDENT>
          <SJDOC>Clark, Cordell M., M.D., </SJDOC>
          <PGS>48942-48943</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20805</FRDOCBP>
        </SJDENT>
        <SJDENT>
          <SJDOC>Serai, Kanwaljit S., M.D., </SJDOC>
          <PGS>48943-48944</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20806</FRDOCBP>
        </SJDENT>
        <SJDENT>
          <SJDOC>Smiley, Karen Joe, M.D., </SJDOC>
          <PGS>48944-48945</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20807</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Education</EAR>
      <HD>Education Department</HD>
      <CAT>
        <HD>NOTICES</HD>
        <DOCENT>
          <DOC>Agency information collection activities; proposals, submissions, and approvals, </DOC>
          <PGS>48892-48893</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20913</FRDOCBP>
        </DOCENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Employee</EAR>
      <HD>Employee Benefits Security Administration</HD>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Employee benefit plans; prohibited transaction exemptions:</SJ>
        <SJDENT>
          <SJDOC>Liberty Media 401(k) Savings Plan, </SJDOC>
          <PGS>49301-49321</PGS>
          <FRDOCBP D="21" T="15AUN2.sgm">03-20766</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Employment</EAR>
      <HD>Employment Standards Administration</HD>
      <CAT>
        <HD>NOTICES</HD>
        <DOCENT>
          <DOC>Minimum wages for Federal and federally-assisted construction; general wage determination decisions, </DOC>
          <PGS>48946-48947</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20538</FRDOCBP>
        </DOCENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Energy</EAR>
      <HD>Energy Department</HD>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Federal Energy Regulatory Commission</P>
      </SEE>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Environmental statements; notice of intent:</SJ>
        <SJDENT>
          <SJDOC>Next-Generation Circulating Fluidized Bed Coal Generating Unit Demonstration Plant Project, Fountain, CO, </SJDOC>
          <PGS>48893-48896</PGS>
          <FRDOCBP D="4" T="15AUN1.sgm">03-20862</FRDOCBP>
        </SJDENT>
        <SJ>Grants and cooperative agreements; availability, etc.:</SJ>
        <SJDENT>
          <SJDOC>Fusion Science Centers, </SJDOC>
          <PGS>48896-48898</PGS>
          <FRDOCBP D="3" T="15AUN1.sgm">03-20863</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Engineers</EAR>
      <HD>Engineers Corps</HD>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Environmental statements; availability, etc.:</SJ>
        <SJDENT>
          <SJDOC>Milton, Cabell County, WV; Lower Mud River Watershed Project, </SJDOC>
          <PGS>48890-48891</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20912</FRDOCBP>
        </SJDENT>
        <SJ>Meetings:</SJ>
        <SJDENT>
          <SJDOC>Multimedia Environmental Modeling Federal Interagency Steering Committee, </SJDOC>
          <PGS>48891-48892</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20909</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>EPA</EAR>
      <HD>Environmental Protection Agency</HD>
      <CAT>
        <HD>RULES</HD>
        <SJ>Air quality implementation plans; approval and promulgation; various States:</SJ>
        <SJDENT>
          <SJDOC>Pennsylvania, </SJDOC>
          <PGS>48803-48805</PGS>
          <FRDOCBP D="3" T="15AUR1.sgm">03-20895</FRDOCBP>
        </SJDENT>
      </CAT>
      <CAT>
        <HD>PROPOSED RULES</HD>
        <SJ>Air quality planning purposes; designation of areas:</SJ>
        <SJDENT>
          <SJDOC>California, </SJDOC>
          <PGS>48848-48851</PGS>
          <FRDOCBP D="4" T="15AUP1.sgm">03-20894</FRDOCBP>
        </SJDENT>
      </CAT>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Environmental statements; availability, etc.:</SJ>
        <SUBSJ>Agency statements—</SUBSJ>
        <SSJDENT>
          <SUBSJDOC>Comment availability, </SUBSJDOC>
          <PGS>48900-48901</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20901</FRDOCBP>
        </SSJDENT>
        <SSJDENT>
          <SUBSJDOC>Weekly receipts, </SUBSJDOC>
          <PGS>48901-48902</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20902</FRDOCBP>
        </SSJDENT>
        <SJ>Grants and cooperative agreements; availability, etc.:</SJ>
        <SJDENT>
          <SJDOC>Lead-based paint programs, </SJDOC>
          <PGS>48902-48908</PGS>
          <FRDOCBP D="7" T="15AUN1.sgm">03-20898</FRDOCBP>
        </SJDENT>
        <SJ>Pesticide, food, and feed additive petitions:</SJ>
        <SJDENT>
          <SJDOC>Bayer CropScience, </SJDOC>
          <PGS>48908-48913</PGS>
          <FRDOCBP D="6" T="15AUN1.sgm">03-20897</FRDOCBP>
        </SJDENT>
        <SJ>Toxic and hazardous substances control:</SJ>
        <SUBSJ>New chemicals—</SUBSJ>
        <SSJDENT>
          <SUBSJDOC>Receipt and status information, </SUBSJDOC>
          <PGS>48913-48919</PGS>
          <FRDOCBP D="7" T="15AUN1.sgm">03-20900</FRDOCBP>
        </SSJDENT>
        <SJ>Water pollution control:</SJ>
        <SUBSJ>Clean Water Act—</SUBSJ>
        <SSJDENT>
          <SUBSJDOC>Class II administrative penalty assessments, </SUBSJDOC>
          <PGS>48919</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20896</FRDOCBP>
        </SSJDENT>
        <SJ>Water supply:</SJ>
        <SUBSJ>Public water supply supervision program—</SUBSJ>
        <SSJDENT>
          <SUBSJDOC>Colorado, </SUBSJDOC>
          <PGS>48919-48920</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20891</FRDOCBP>
        </SSJDENT>
        <SSJDENT>
          <SUBSJDOC>North Dakota, </SUBSJDOC>
          <PGS>48921-48922</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20893</FRDOCBP>
        </SSJDENT>
        <SSJDENT>
          <SUBSJDOC>South Dakota, </SUBSJDOC>
          <PGS>48920-48921</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20892</FRDOCBP>
        </SSJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Executive</EAR>
      <HD>Executive Office of the President</HD>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Management and Budget Office</P>
      </SEE>
    </AGCY>
    <AGCY>
      <EAR>FAA</EAR>
      <HD>Federal Aviation Administration</HD>
      <CAT>
        <HD>RULES</HD>
        <SJ>Airworthiness directives:</SJ>
        <SJDENT>
          <SJDOC>Bombardier; correction, </SJDOC>
          <PGS>48783-48784</PGS>
          <FRDOCBP D="2" T="15AUR1.sgm">03-20834</FRDOCBP>
        </SJDENT>
        <DOCENT>
          <DOC>Class E airspace; correction, </DOC>
          <PGS>48994</PGS>
          <FRDOCBP D="1" T="15AUCX.sgm">C3-17766</FRDOCBP>
        </DOCENT>
      </CAT>
      <CAT>
        <HD>PROPOSED RULES</HD>
        <SJ>Airworthiness directives:</SJ>
        <SJDENT>
          <SJDOC>Boeing, </SJDOC>
          <PGS>48833-48835</PGS>
          <FRDOCBP D="3" T="15AUP1.sgm">03-20836</FRDOCBP>
        </SJDENT>
        <SJDENT>
          <SJDOC>McDonnell Douglas, </SJDOC>
          <PGS>48835-48837</PGS>
          <FRDOCBP D="3" T="15AUP1.sgm">03-20835</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Federal Emergency</EAR>
      <HD>Federal Emergency Management Agency</HD>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Disaster and emergency areas:</SJ>
        <SJDENT>
          <SJDOC>Florida, </SJDOC>
          <PGS>48925</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20846</FRDOCBP>
        </SJDENT>
        <SJDENT>
          <SJDOC>Indiana, </SJDOC>
          <PGS>48925</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20840</FRDOCBP>
        </SJDENT>
        <SJDENT>
          <SJDOC>Nebraska, </SJDOC>
          <PGS>48925-48926</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20847</FRDOCBP>
        </SJDENT>
        <SJDENT>
          <SJDOC>North Dakota, </SJDOC>
          <PGS>48926</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20851</FRDOCBP>
        </SJDENT>
        <SJDENT>
          <SJDOC>Ohio, </SJDOC>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20842</FRDOCBP>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20843</FRDOCBP>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20850</FRDOCBP>
          <PGS>48926-48928</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20854</FRDOCBP>
        </SJDENT>
        <SJDENT>
          <SJDOC>Tennessee, </SJDOC>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20848</FRDOCBP>
          <PGS>48928</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20849</FRDOCBP>
        </SJDENT>
        <SJDENT>
          <SJDOC>Texas, </SJDOC>
          <PGS>48928-48929</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20844</FRDOCBP>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20845</FRDOCBP>
        </SJDENT>
        <SJDENT>
          <SJDOC>West Virginia, </SJDOC>
          <PGS>48929</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20841</FRDOCBP>
        </SJDENT>
        <SJ>Grants and cooperative agreements; availability, etc.:</SJ>
        <SJDENT>
          <SJDOC>Community Emergency Response Team Training Program, </SJDOC>
          <PGS>48929-48931</PGS>
          <FRDOCBP D="3" T="15AUN1.sgm">03-20855</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Federal Energy</EAR>
      <HD>Federal Energy Regulatory Commission</HD>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Electric rate and corporate regulation filings:</SJ>
        <SJDENT>
          <SJDOC>Allegheny Energy Supply Co., LLC, et al., </SJDOC>
          <PGS>48898-48899</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20852</FRDOCBP>
        </SJDENT>
        <SJDENT>
          <SJDOC>New York Independent System Operator, Inc., et al., </SJDOC>
          <PGS>48899-48900</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20853</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Federal Highway</EAR>
      <HD>Federal Highway Administration</HD>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Environmental statements; availability, etc.:</SJ>
        <SJDENT>
          <SJDOC>Ketchikan Gateway Borough, AK; Gravina Access Project, </SJDOC>
          <PGS>48924-48925</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20822</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Federal Motor</EAR>
      <HD>Federal Motor Carrier Safety Administration</HD>
      <CAT>
        <HD>PROPOSED RULES</HD>
        <SJ>Motor carrier safety standards:</SJ>
        <SUBSJ>Special training requirements—</SUBSJ>
        <SSJDENT>
          <SUBSJDOC>Entry-level commercial motor vehicle operators; minimum training requirements, </SUBSJDOC>
          <PGS>48863-48875</PGS>
          <FRDOCBP D="13" T="15AUP1.sgm">03-20888</FRDOCBP>
        </SSJDENT>
      </CAT>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Motor carrier safety standards:</SJ>
        <SUBSJ>Driver qualifications—</SUBSJ>
        <SSJDENT>
          <SUBSJDOC>Adams, Gene E., et al.; vision requirement, </SUBSJDOC>
          <PGS>48989-48991</PGS>
          <FRDOCBP D="3" T="15AUN1.sgm">03-20889</FRDOCBP>
        </SSJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Federal Railroad</EAR>
      <HD>Federal Railroad Administration</HD>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Meetings:</SJ>
        <SJDENT>
          <SJDOC>Railroad Safety Advisory Committee, </SJDOC>
          <PGS>48991-48992</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20922</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Fish</EAR>
      <HD>Fish and Wildlife Service</HD>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Endangered and threatened species:</SJ>
        <SUBSJ>Recovery plans—</SUBSJ>
        <SSJDENT>
          <SUBSJDOC>Higgins’ eye pearlymussel, </SUBSJDOC>
          <PGS>48933-48934</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20830</FRDOCBP>
        </SSJDENT>
        <DOCENT>
          <DOC>Endangered and threatened species permit applications, </DOC>
          <PGS>48931-48933</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20802</FRDOCBP>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20803</FRDOCBP>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20828</FRDOCBP>
        </DOCENT>
        <PRTPAGE P="v"/>
        <SJ>Grants and cooperative agreements; availability, etc.:</SJ>
        <SJDENT>
          <SJDOC>Landowner Incentive Program (non-tribal portion) for States, territories, and District of Columbia, </SJDOC>
          <PGS>48934</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20717</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Food</EAR>
      <HD>Food and Drug Administration</HD>
      <CAT>
        <HD>RULES</HD>
        <SJ>Animal drugs, feeds, and related products:</SJ>
        <SJDENT>
          <SJDOC>Trenbolone and estradiol; implant or injectable dosage, </SJDOC>
          <PGS>48784-48785</PGS>
          <FRDOCBP D="2" T="15AUR1.sgm">03-20797</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Forest</EAR>
      <HD>Forest Service</HD>
      <CAT>
        <HD>NOTICES</HD>
        <DOCENT>
          <DOC>Agency information collection activities; proposals, submissions, and approvals, </DOC>
          <PGS>48876-48877</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20798</FRDOCBP>
        </DOCENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Health</EAR>
      <HD>Health and Human Services Department</HD>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Centers for Medicare &amp; Medicaid Services</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Children and Families Administration</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Food and Drug Administration</P>
      </SEE>
    </AGCY>
    <AGCY>
      <EAR>Homeland</EAR>
      <HD>Homeland Security Department</HD>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Coast Guard</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Federal Emergency Management Agency</P>
      </SEE>
    </AGCY>
    <AGCY>
      <EAR>Housing</EAR>
      <HD>Housing and Urban Development Department</HD>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Grants and cooperative agreements; availability, etc.:</SJ>
        <SUBSJ>Facilities to assist homeless—</SUBSJ>
        <SSJDENT>
          <SUBSJDOC>Excess and surplus Federal property, </SUBSJDOC>
          <PGS>48931</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20487</FRDOCBP>
        </SSJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Indian</EAR>
      <HD>Indian Affairs Bureau</HD>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Land acquisitions into trust:</SJ>
        <SJDENT>
          <SJDOC>Little Traverse Bay Bands of Odawa Indians of Michigan, </SJDOC>
          <PGS>48934-48935</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20935</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Interior</EAR>
      <HD>Interior Department</HD>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Fish and Wildlife Service</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Indian Affairs Bureau</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Land Management Bureau</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Reclamation Bureau</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Surface Mining Reclamation and Enforcement Office</P>
      </SEE>
    </AGCY>
    <AGCY>
      <EAR>IRS</EAR>
      <HD>Internal Revenue Service</HD>
      <CAT>
        <HD>RULES</HD>
        <SJ>Procedure and administration:</SJ>
        <SJDENT>
          <SJDOC>User fees; compromise offers processing, </SJDOC>
          <PGS>48785-48787</PGS>
          <FRDOCBP D="3" T="15AUR1.sgm">03-20933</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>International</EAR>
      <HD>International Trade Administration</HD>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Antidumping:</SJ>
        <SUBSJ>Steel concrete reinforcing bars from—</SUBSJ>
        <SSJDENT>
          <SUBSJDOC>Latvia, </SUBSJDOC>
          <PGS>48880-48884</PGS>
          <FRDOCBP D="5" T="15AUN1.sgm">03-21058</FRDOCBP>
        </SSJDENT>
        <SJ>
          <E T="03">Applications, hearings, determinations, etc.:</E>
        </SJ>
        <SJDENT>
          <SJDOC>Research Foundation of State University of New York, </SJDOC>
          <PGS>48884-48885</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20934</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>International</EAR>
      <HD>International Trade Commission</HD>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Import investigations:</SJ>
        <SUBSJ>Brake drums and rotors from—</SUBSJ>
        <SSJDENT>
          <SUBSJDOC>China, </SUBSJDOC>
          <PGS>48938</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20813</FRDOCBP>
        </SSJDENT>
        <SUBSJ>Tetrahydrofurfuryl alcohol from—</SUBSJ>
        <SSJDENT>
          <SUBSJDOC>China, </SUBSJDOC>
          <PGS>48938-48939</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20814</FRDOCBP>
        </SSJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Justice</EAR>
      <HD>Justice Department</HD>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Antitrust Division</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Drug Enforcement Administration</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Justice Programs Office</P>
      </SEE>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Americans with Disabilities Act:</SJ>
        <SJDENT>
          <SJDOC>Maryland Accessibility Code; certification determination; hearings, </SJDOC>
          <PGS>48939-48940</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20795</FRDOCBP>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20796</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Justice</EAR>
      <HD>Justice Programs Office</HD>
      <CAT>
        <HD>NOTICES</HD>
        <DOCENT>
          <DOC>Agency information collection activities; proposals, submissions, and approvals, </DOC>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20882</FRDOCBP>
          <PGS>48945-48946</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20883</FRDOCBP>
        </DOCENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Labor</EAR>
      <HD>Labor Department</HD>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Employee Benefits Security Administration</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Employment Standards Administration</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Occupational Safety and Health Administration</P>
      </SEE>
      <CAT>
        <HD>PROPOSED RULES</HD>
        <DOCENT>
          <DOC>Acquisition regulations; revision, </DOC>
          <PGS>48995-49027</PGS>
          <FRDOCBP D="33" T="15AUP2.sgm">03-20095</FRDOCBP>
        </DOCENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Land</EAR>
      <HD>Land Management Bureau</HD>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Environmental statements; availability, etc.:</SJ>
        <SJDENT>
          <SJDOC>Upper Siuslaw River Late-Successional Reserve Restoration Plan, OR, </SJDOC>
          <PGS>48935-48936</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-19255</FRDOCBP>
        </SJDENT>
        <SJ>Meetings:</SJ>
        <SJDENT>
          <SJDOC>Pittsburg and Midway Coal Exchange, WY; public hearing, </SJDOC>
          <PGS>48936</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20829</FRDOCBP>
        </SJDENT>
        <SJ>Resource management plans, etc.:</SJ>
        <SJDENT>
          <SJDOC>Las Cienegas National Conservation Area et al., AZ, </SJDOC>
          <PGS>48936-48937</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-21073</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Local</EAR>
      <HD>Local Television Loan Guarantee Board</HD>
      <CAT>
        <HD>PROPOSED RULES</HD>
        <DOCENT>
          <DOC>LOCAL Television Loan Guarantee Program, </DOC>
          <PGS>48814-48833</PGS>
          <FRDOCBP D="20" T="15AUP1.sgm">03-20786</FRDOCBP>
        </DOCENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Management</EAR>
      <HD>Management and Budget Office</HD>
      <CAT>
        <HD>NOTICES</HD>
        <DOCENT>
          <DOC>Agency information collection activities; proposals, submissions, and approvals, </DOC>
          <PGS>48960-48961</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20919</FRDOCBP>
        </DOCENT>
        <SJ>Commercial activities performance (Circular A-76):</SJ>
        <SJDENT>
          <SJDOC>Revision; correction, </SJDOC>
          <PGS>48961-48962</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20939</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>NASA</EAR>
      <HD>National Aeronautics and Space Administration</HD>
      <CAT>
        <HD>PROPOSED RULES</HD>
        <SJ>Grant and Cooperative Agreement Handbook:</SJ>
        <SJDENT>
          <SJDOC>NASA Center, facility, computer system, or technical information access; investigative requirements, </SJDOC>
          <PGS>48838</PGS>
          <FRDOCBP D="1" T="15AUP1.sgm">03-20921</FRDOCBP>
        </SJDENT>
        <SJDENT>
          <SJDOC>Photographs and illustrations in reports or publications; public acknowledgements, </SJDOC>
          <PGS>48837-48838</PGS>
          <FRDOCBP D="2" T="15AUP1.sgm">03-20920</FRDOCBP>
        </SJDENT>
      </CAT>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Reports and guidance documents; availability, etc.:</SJ>
        <SJDENT>
          <SJDOC>National origin discrimination as it affects limited English proficient persons; prohibition; policy guidance to Federal financial assistance recipients, </SJDOC>
          <PGS>48947-48956</PGS>
          <FRDOCBP D="10" T="15AUN1.sgm">03-20804</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>National Agricultural</EAR>
      <HD>National Agricultural Statistics Service</HD>
      <CAT>
        <HD>NOTICES</HD>
        <DOCENT>
          <DOC>Agency information collection activities; proposals, submissions, and approvals, </DOC>
          <PGS>48877-48878</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20877</FRDOCBP>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20878</FRDOCBP>
        </DOCENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>National Archives</EAR>
      <HD>National Archives and Records Administration</HD>
      <CAT>
        <HD>NOTICES</HD>
        <DOCENT>
          <DOC>Agency records schedules; availability, </DOC>
          <PGS>48956-48958</PGS>
          <FRDOCBP D="3" T="15AUN1.sgm">03-20858</FRDOCBP>
        </DOCENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>National Credit</EAR>
      <HD>National Credit Union Administration</HD>
      <CAT>
        <HD>NOTICES</HD>
        <DOCENT>
          <DOC>Agency information collection activities; proposals, submissions, and approvals, </DOC>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20809</FRDOCBP>
          <PGS>48958-48959</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20810</FRDOCBP>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20811</FRDOCBP>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20812</FRDOCBP>
        </DOCENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>National Highway</EAR>
      <PRTPAGE P="vi"/>
      <HD>National Highway Traffic Safety Administration</HD>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Motor vehicle safety standards; exemption petitions, etc.:</SJ>
        <SJDENT>
          <SJDOC>General Motors of North America, Inc., </SJDOC>
          <PGS>48992</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20924</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>National Institute</EAR>
      <HD>National Institute of Standards and Technology</HD>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Meetings:</SJ>
        <SJDENT>
          <SJDOC>Advanced Technology Visiting Committee, </SJDOC>
          <PGS>48885</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20859</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>NOAA</EAR>
      <HD>National Oceanic and Atmospheric Administration</HD>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Meetings:</SJ>
        <SJDENT>
          <SJDOC>North Pacific Fishery Management Council, </SJDOC>
          <PGS>48885-48886</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20918</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Nuclear</EAR>
      <HD>Nuclear Regulatory Commission</HD>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Environmental statements; availability, etc.:</SJ>
        <SJDENT>
          <SJDOC>Omaha Public Power District, </SJDOC>
          <PGS>48959-48960</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20838</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Occupational</EAR>
      <HD>Occupational Safety and Health Administration</HD>
      <CAT>
        <HD>PROPOSED RULES</HD>
        <SJ>Construction safety and health standards:</SJ>
        <SUBSJ>Crane and Derrick Negotiated Rulemaking Advisory Committee—</SUBSJ>
        <SSJDENT>
          <SUBSJDOC>Meetings, </SUBSJDOC>
          <PGS>48843-48844</PGS>
          <FRDOCBP D="2" T="15AUP1.sgm">03-20856</FRDOCBP>
        </SSJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Office</EAR>
      <HD>Office of Management and Budget</HD>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Management and Budget Office</P>
      </SEE>
    </AGCY>
    <AGCY>
      <EAR>Pension</EAR>
      <HD>Pension Benefit Guaranty Corporation</HD>
      <CAT>
        <HD>RULES</HD>
        <SJ>Single-employer plans:</SJ>
        <SUBSJ>Allocation of assets—</SUBSJ>
        <SSJDENT>
          <SUBSJDOC>Interest assumptions for valuing and paying benefits, </SUBSJDOC>
          <PGS>48787-48789</PGS>
          <FRDOCBP D="3" T="15AUR1.sgm">03-20860</FRDOCBP>
        </SSJDENT>
      </CAT>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Multiemployer plans:</SJ>
        <SJDENT>
          <SJDOC>Interest rates and assumptions, </SJDOC>
          <PGS>48962</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20861</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Personnel</EAR>
      <HD>Personnel Management Office</HD>
      <CAT>
        <HD>PROPOSED RULES</HD>
        <SJ>Acquisition regulations:</SJ>
        <SUBSJ>Federal Employees Health Benefits Program—</SUBSJ>
        <SSJDENT>
          <SUBSJDOC>Large provider agreements, subcontracts, and miscellaneous changes, </SUBSJDOC>
          <PGS>48851-48863</PGS>
          <FRDOCBP D="13" T="15AUP1.sgm">03-20857</FRDOCBP>
        </SSJDENT>
      </CAT>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Meetings:</SJ>
        <SJDENT>
          <SJDOC>Federal Salary Council, </SJDOC>
          <PGS>48962-48963</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-21041</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Postal</EAR>
      <HD>Postal Rate Commission</HD>
      <CAT>
        <HD>NOTICES</HD>
        <DOCENT>
          <DOC>Meetings; Sunshine Act, </DOC>
          <PGS>48963</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20993</FRDOCBP>
        </DOCENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Postal</EAR>
      <HD>Postal Service</HD>
      <CAT>
        <HD>NOTICES</HD>
        <DOCENT>
          <DOC>Meetings; Sunshine Act, </DOC>
          <PGS>48963</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-21042</FRDOCBP>
        </DOCENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Railroad</EAR>
      <HD>Railroad Retirement Board</HD>
      <CAT>
        <HD>NOTICES</HD>
        <DOCENT>
          <DOC>Agency information collection activities; proposals, submissions, and approvals, </DOC>
          <PGS>48963</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20886</FRDOCBP>
        </DOCENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Reclamation</EAR>
      <HD>Reclamation Bureau</HD>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Committees; establishment, renewal, termination, etc.:</SJ>
        <SJDENT>
          <SJDOC>California Bay-Delta Public Advisory Committee, </SJDOC>
          <PGS>48937</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20800</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>SEC</EAR>
      <HD>Securities and Exchange Commission</HD>
      <CAT>
        <HD>NOTICES</HD>
        <DOCENT>
          <DOC>Agency information collection activities; proposals, submissions, and approvals, </DOC>
          <PGS>48963-48964</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20818</FRDOCBP>
        </DOCENT>
        <SJ>Self-regulatory organizations; proposed rule changes:</SJ>
        <SJDENT>
          <SJDOC>American Stock Exchange LLC, </SJDOC>
          <PGS>48969-48974</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20905</FRDOCBP>
          <FRDOCBP D="5" T="15AUN1.sgm">03-20906</FRDOCBP>
        </SJDENT>
        <SJDENT>
          <SJDOC>Chicago Board Options Exchange, Inc., </SJDOC>
          <PGS>48974-48975</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20908</FRDOCBP>
        </SJDENT>
        <SJDENT>
          <SJDOC>National Association of Securities Dealers, Inc., </SJDOC>
          <PGS>48975-48977</PGS>
          <FRDOCBP D="3" T="15AUN1.sgm">03-20907</FRDOCBP>
        </SJDENT>
        <SJDENT>
          <SJDOC>New York Stock Exchange, Inc., </SJDOC>
          <PGS>48977-48978</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20820</FRDOCBP>
        </SJDENT>
        <SJDENT>
          <SJDOC>Philadelphia Stock Exchange, Inc., </SJDOC>
          <PGS>48978-48980</PGS>
          <FRDOCBP D="3" T="15AUN1.sgm">03-20819</FRDOCBP>
        </SJDENT>
        <SJ>
          <E T="03">Applications, hearings, determinations, etc.:</E>
        </SJ>
        <SJDENT>
          <SJDOC>Nations Fund Trust et al., </SJDOC>
          <PGS>48964-48969</PGS>
          <FRDOCBP D="6" T="15AUN1.sgm">03-20904</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>SBA</EAR>
      <HD>Small Business Administration</HD>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Disaster loan areas:</SJ>
        <SJDENT>
          <SJDOC>Indiana, </SJDOC>
          <PGS>48980-48981</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20890</FRDOCBP>
        </SJDENT>
        <SJ>
          <E T="03">Applications, hearings, determinations, etc.:</E>
        </SJ>
        <SJDENT>
          <SJDOC>Meridian Venture Partners II, L.P., </SJDOC>
          <PGS>48980</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20837</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Social</EAR>
      <HD>Social Security Administration</HD>
      <CAT>
        <HD>NOTICES</HD>
        <DOCENT>
          <DOC>Agency information collection activities; proposals, submissions, and approvals, </DOC>
          <PGS>48981-48984</PGS>
          <FRDOCBP D="4" T="15AUN1.sgm">03-20730</FRDOCBP>
        </DOCENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>State</EAR>
      <HD>State Department</HD>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Art objects; importation for exhibition:</SJ>
        <SJDENT>
          <SJDOC>Picasso:  The Cubist Portraits of Fernando Olivier, </SJDOC>
          <PGS>48984</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-21052</FRDOCBP>
        </SJDENT>
        <SJ>Foreign terrorists and terrorist organizations; determinations:</SJ>
        <SJDENT>
          <SJDOC>Mujahedin-e Khalq, </SJDOC>
          <PGS>48984</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20923</FRDOCBP>
        </SJDENT>
        <SJ>Grants and cooperative agreements; availability, etc.:</SJ>
        <SJDENT>
          <SJDOC>Human rights and democratization initiatives in Sub-Saharan Africa, </SJDOC>
          <PGS>48984-48987</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20936</FRDOCBP>
          <FRDOCBP D="3" T="15AUN1.sgm">03-20937</FRDOCBP>
        </SJDENT>
        <SJ>Migration and refugee assistance; qualified countries:</SJ>
        <SJDENT>
          <SJDOC>Liberia, </SJDOC>
          <PGS>48987</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20938</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Statistical</EAR>
      <HD>Statistical Reporting Service</HD>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> National Agricultural Statistics Service</P>
      </SEE>
    </AGCY>
    <AGCY>
      <EAR>Surface</EAR>
      <HD>Surface Mining Reclamation and Enforcement Office</HD>
      <CAT>
        <HD>RULES</HD>
        <SJ>Permanent program and abandoned mine land reclamation plan submissions:</SJ>
        <SJDENT>
          <SJDOC>Pennsylvania, </SJDOC>
          <PGS>48789-48798</PGS>
          <FRDOCBP D="10" T="15AUR1.sgm">03-20916</FRDOCBP>
        </SJDENT>
      </CAT>
      <CAT>
        <HD>PROPOSED RULES</HD>
        <SJ>Permanent program and abandoned mine land reclamation plan submissions:</SJ>
        <SJDENT>
          <SJDOC>Texas, </SJDOC>
          <PGS>48844-48846</PGS>
          <FRDOCBP D="3" T="15AUP1.sgm">03-20915</FRDOCBP>
        </SJDENT>
      </CAT>
      <CAT>
        <HD>NOTICES</HD>
        <DOCENT>
          <DOC>Agency information collection activities; proposals, submissions, and approvals, </DOC>
          <PGS>48937-48938</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20917</FRDOCBP>
        </DOCENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Transportation</EAR>
      <HD>Transportation Department</HD>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Federal Aviation Administration</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Federal Highway Administration</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Federal Motor Carrier Safety Administration</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Federal Railroad Administration</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> National Highway Traffic Safety Administration</P>
      </SEE>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Aviation proceedings:</SJ>
        <SJDENT>
          <SJDOC>Agreements filed, weekly receipts, </SJDOC>
          <PGS>48987</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20931</FRDOCBP>
        </SJDENT>
        <SJDENT>
          <SJDOC>Certificates of public convenience and necessity and foreign air carrier permits; weekly applications, </SJDOC>
          <PGS>48987</PGS>
          <FRDOCBP D="1" T="15AUN1.sgm">03-20930</FRDOCBP>
        </SJDENT>
        <PRTPAGE P="vii"/>
        <SJ>Reports and guidance documents; availability, etc.:</SJ>
        <SJDENT>
          <SJDOC>Motor carrier financial information; exemption from reporting requiremenets; comment request, </SJDOC>
          <PGS>48987-48989</PGS>
          <FRDOCBP D="3" T="15AUN1.sgm">03-20932</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <AGCY>
      <EAR>Treasury</EAR>
      <HD>Treasury Department</HD>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Alcohol and Tobacco Tax and Trade Bureau</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Comptroller of the Currency</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> Internal Revenue Service</P>
      </SEE>
      <SEE>
        <HD SOURCE="HED">See</HD>
        <P> United States Mint</P>
      </SEE>
    </AGCY>
    <AGCY>
      <EAR>MISSING FOR: United States Mint</EAR>
      <HD>United States Mint</HD>
      <CAT>
        <HD>NOTICES</HD>
        <SJ>Committees; establishment, renewal, termination, etc.:</SJ>
        <SJDENT>
          <SJDOC>Citizens Coinage Advisory Committee, </SJDOC>
          <PGS>48992-48993</PGS>
          <FRDOCBP D="2" T="15AUN1.sgm">03-20799</FRDOCBP>
        </SJDENT>
      </CAT>
    </AGCY>
    <PTS>
      <HD SOURCE="HED">Separate Parts In This Issue</HD>
      <HD>Part II</HD>
      <DOCENT>
        <DOC>Labor Department, </DOC>
        <PGS>48995-49027</PGS>
        <FRDOCBP D="33" T="15AUP2.sgm">03-20095</FRDOCBP>
      </DOCENT>
      <HD>Part III</HD>
      <DOCENT>
        <DOC>Health and Human Services Department, Centers for Medicare &amp; Medicaid Services, </DOC>
        <PGS>49029-49300</PGS>
        <FRDOCBP D="272" T="15AUP3.sgm">03-20662</FRDOCBP>
      </DOCENT>
      <HD>Part IV</HD>
      <DOCENT>
        <DOC>Labor Department, Employee Benefits Security Administration, </DOC>
        <PGS>49301-49321</PGS>
        <FRDOCBP D="21" T="15AUN2.sgm">03-20766</FRDOCBP>
      </DOCENT>
    </PTS>
    <AIDS>
      <HD SOURCE="HED">Reader Aids</HD>
      <P>Consult the Reader Aids section at the end of this issue for phone numbers, online resources, finding aids, reminders, and notice of recently enacted public laws.</P>
      <P>To subscribe to the Federal Register Table of Contents LISTSERV electronic mailing list, go to http://listserv.access.gpo.gov and select Online mailing list archives, FEDREGTOC-L, Join or leave the list (or change settings); then follow the instructions.</P>
    </AIDS>
  </CNTNTS>
  <VOL>68</VOL>
  <NO>158</NO>
  <DATE>Friday, August 15, 2003</DATE>
  <UNITNAME>Rules and Regulations</UNITNAME>
  <RULES>
    <RULE>
      <PREAMB>
        <PRTPAGE P="48767"/>
        <AGENCY TYPE="F">DEPARTMENT OF AGRICULTURE </AGENCY>
        <SUBAGY>Agricultural Marketing Service </SUBAGY>
        <CFR>7 CFR Parts 916 and 917 </CFR>
        <DEPDOC>[Docket No. FV03-916-4 IFR] </DEPDOC>
        <SUBJECT>Nectarines and Peaches Grown in California; Increased Assessment Rates </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Agricultural Marketing Service, USDA. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Interim final rule with request for comments. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This rule increases the assessment rates established for the Nectarine Administrative Committee and the Peach Commodity Committee (committees) for the 2003-04 and subsequent fiscal periods from $0.19 to $0.20 per 25-pound container or container equivalent of nectarines and peaches handled. The committees locally administer the marketing orders which regulate the handling of nectarines and peaches grown in California. Authorization to assess nectarine and peach handlers enables the committees to incur expenses that are reasonable and necessary to administer the programs. The fiscal periods run from March 1 through the last day of February. The assessment rates will remain in effect indefinitely unless modified, suspended, or terminated. </P>
        </SUM>
        <EFFDATE>
          <HD SOURCE="HED">DATES:</HD>
          <P>Effective August 16, 2003. Comments must be received by October 14, 2003. </P>
        </EFFDATE>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>

          <P>Interested persons are invited to submit written comments concerning this rule. Comments must be sent to the Docket Clerk, Marketing Order Administration Branch, Fruit and Vegetable Programs, AMS, USDA, 1400 Independence Avenue SW., STOP 0237, Washington, DC 20250-0237; Fax: (202) 720-8938, or E-mail: <E T="03">moab.docketclerk@usda.gov</E>. Comments should reference the docket number and the date and page number of this issue of the <E T="04">Federal Register</E> and will be available for public inspection in the Office of the Docket Clerk during regular business hours, or can be viewed at: <E T="03">http://www.ams.usda.gov/fv/moab.html</E>. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Toni Sasselli, Marketing Assistant, California Marketing Field Office, Fruit and Vegetable Programs, AMS, USDA, 2202 Monterey Street, suite 102B, Fresno, California 93721, (559) 487-5901, Fax: (559) 487-5906; or George Kelhart, Technical Advisor, Marketing Order Administration Branch, Fruit and Vegetable Programs, AMS, USDA, 1400 Independence Avenue SW., STOP 0237, Washington, DC 20250-0237; telephone: (202) 720-2491, Fax: (202) 720-8938. </P>

          <P>Small businesses may request information on complying with this regulation by contacting Jay Guerber, Marketing Order Administration Branch, Fruit and Vegetable Programs, AMS, USDA, 1400 Independence Avenue SW., STOP 0237, Washington, DC 20250-0237; telephone: (202) 720-2491, Fax: (202) 720-8938, or E-mail: <E T="03">Jay.Guerber@usda.gov</E>. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>This rule is issued under Marketing Agreement Nos. 85 and 124 and Order Nos. 916 and 917, both as amended (7 CFR parts 916 and 917), regulating the handling of nectarines and peaches grown in California, respectively, hereinafter referred to as the “orders.” The marketing agreements and orders are effective under the Agricultural Marketing Agreement Act of 1937, as amended (7 U.S.C. 601-674), hereinafter referred to as the “Act.” </P>
        <P>The Department of Agriculture (USDA) is issuing this rule in conformance with Executive Order 12866. </P>
        <P>This rule has been reviewed under Executive Order 12988, Civil Justice Reform. Under the marketing orders now in effect, California nectarine and peach handlers are subject to assessments. Funds to administer the orders are derived from such assessments. It is intended that the assessment rates as issued herein will be applicable to all assessable nectarines and peaches beginning on March 1, 2003, and continue until amended, suspended, or terminated. This rule will not preempt any State or local laws, regulations, or policies, unless they present an irreconcilable conflict with this rule. </P>
        <P>The Act provides that administrative proceedings must be exhausted before parties may file suit in court. Under section 608c(15)(A) of the Act, any handler subject to an order may file with USDA a petition stating that the order, any provision of the order, or any obligation imposed in connection with the order is not in accordance with law and request a modification of the order or to be exempted therefrom. Such handler is afforded the opportunity for a hearing on the petition. After the hearing USDA would rule on the petition. The Act provides that the district court of the United States in any district in which the handler is an inhabitant, or has his or her principal place of business, has jurisdiction to review USDA's ruling on the petition, provided an action is filed not later than 20 days after the date of the entry of the ruling. </P>
        <P>This rule increases the assessment rates established for the committees for the 2003-04 and subsequent fiscal periods from $0.19 to $0.20 per 25-pound container or container equivalent of nectarines and peaches. </P>
        <P>The nectarine and peach marketing orders provide authority for the committees, with the approval of USDA, to formulate an annual budget of expenses and collect assessments from handlers to administer the programs. The members of the Nectarine Administrative Committee (NAC) and Peach Commodity Committee (PCC) are producers of California nectarines and peaches, respectively. They are familiar with the committees' needs, and with the costs for goods and services in their local area and are, thus, in a position to formulate appropriate budgets and assessment rates. The assessment rates are formulated and discussed in public meetings. Thus, all directly affected persons have an opportunity to participate and provide input. </P>
        <HD SOURCE="HD1">NAC Assessment and Expenses </HD>

        <P>The NAC recommended, for the 2002-03 fiscal period, and USDA approved, an assessment rate of $0.19 that would continue in effect from fiscal period to fiscal period unless modified, suspended, or terminated by USDA upon recommendation and information submitted by the committee or other information available to USDA. <PRTPAGE P="48768"/>
        </P>
        <P>The NAC met on May 1, 2003, and recommended 2003-04 expenditures of $4,173,438 and an assessment rate of $0.20 per 25-pound container or container equivalent of nectarines on a 7 to 1 vote. In comparison, last year's budgeted expenditures were $4,671,342. The assessment rate of $0.20 is $0.01 higher than the rate currently in effect. </P>
        <P>The dissenting voter stated that the growers he represented did not support increasing the assessment rate. However, later in the meeting, following a discussion about the development of a nectarine fruit beverage, the dissenter indicated he no longer opposed the assessment increase because the CTFA intended to fund beverage development. He further stated that funds used to create more outlets for nectarines will provide a service to the industry. </P>
        <P>The rate increase was recommended to ensure that the NAC could meet its 2003-04 anticipated expenses and carry over a financial reserve that will provide adequate funds at the beginning of the 2004 season before assessment collections begin. A financial reserve carryover of about $400,000 is desirable because major expense outlays for seasonal promotions and other activities occur before assessments are received. Increasing the assessment rate from $0.19 to $0.20 per 25-pound container is expected to provide about $220,400 in additional assessment revenue, and will allow the NAC to start the 2004 season with about $438,374. </P>
        <P>The major expenditures recommended by the NAC for the 2003-04 fiscal period include $226,121 for salaries and benefits, $142,612 for general expenses and industry activities, $1,210,220 for inspection, $138,929 for research, and $2,263,061 for domestic and international promotion. Budgeted expenses for these items in 2002-03 were $505,000 for salaries and benefits, $309,039 for general expenses and industry activities, $1,050,000 for inspection, $138,018 for research, and $2,574,160 for domestic and international promotion. </P>
        <P>The 2002-03 and 2003-04 budgeted expenses differ somewhat because the NAC reorganized some expense categories for 2003-2004. NAC's total expenses are significantly lower this fiscal year compared to last fiscal year. </P>
        <P>The 2003-04 NAC assessment rate was derived after considering the total NAC expenses of $4,173,438; the estimated assessable nectarines of 22,004,000 25-pound containers or container equivalents; the estimated income from other sources, such as interest; and the need for an adequate financial reserve to carry the NAC into the 2004 season. The committee decided that a financial reserve of $400,000 is necessary to meet its obligations in the early part of each season, before handler assessments are billed and received. To meet these goals, the NAC recommended an assessment rate of $0.20 per 25-pound containers or container equivalent. According to the committee, that assessment rate will result in an adequate financial reserve, yet one well within the maximum permitted by the order (one year's expenses; § 916.42). </P>
        <HD SOURCE="HD1">PCC Assessment and Expenses </HD>
        <P>The PCC recommended, for the 1996-97 fiscal period, and USDA approved, an assessment rate of $0.19 that would continue in effect from fiscal period to fiscal period unless modified, suspended, or terminated by USDA upon recommendation and information submitted by the committee or other information available to USDA. </P>
        <P>The PCC also met on May 1, 2003, and recommended 2003-04 expenditures of $4,086,316 and an assessment rate of $0.20 per 25-pound container or container equivalent of peaches on a vote of 12 to 1. In comparison, last year's budgeted expenditures were $4,678,883. The assessment rate of $0.20 is $0.01 higher than the rate currently in effect. </P>
        <P>The dissenting voter stated that the growers he represented did not support increasing the assessment rate, and he, therefore, could not support the increase. </P>
        <P>The rate increase was recommended to ensure that the PCC could meet its 2003-04 anticipated expenses and carry over a financial reserve for the PCC which will provide adequate funds at the beginning of the 2004 season before assessment collections begin. A financial reserve carryover of $500,000 is desirable because major expense outlays for seasonal promotions and other activities occur before assessments are received. Increasing the assessment rate from $0.19 to $0.20 per 25-pound container is expected to provide about $213,360 in additional assessment revenue, and will allow the PCC to start the 2004 season with about $530,586. </P>
        <P>The major expenditures recommended by the PCC for the 2003-04 fiscal period include $226,121 for salaries and benefits, $144,743 for general expenses and industry activities, $1,206,414 for inspection, $138,930 for research, and $2,211,346 for domestic and international promotion. Budgeted expenses for these items in 2002-03 were $505,000 for salaries and benefits, $206,747 for general expenses, $1,100,000 for inspection, $142,186 for research, and $2,529,036 for domestic and international promotion. </P>
        <P>The 2002-03 and 2003-04 budgeted expenses differ somewhat because the PCC reorganized some expense categories for 2003-2004. PCC's total expenses are significantly lower this fiscal year compared to last fiscal year. </P>
        <P>The 2003-04 PCC assessment rate was derived after considering the total PCC expenses of $4,086,316; the estimated assessable peaches of 21,336,000 25-pound containers or container equivalents; the estimated income from other sources, such as interest; and the need for an adequate reserve to carry the PCC into the 2004 season. The committee decided that a financial reserve of $500,000 is necessary to meet its obligations in the early part of each season, before handler assessments are billed and received. To meet these goals, the PCC recommended an assessment rate of $0.20 per 25-pound container or container equivalent. According to the committee, that assessment rate will result in an adequate financial reserve, yet one well within the maximum permitted by the order (one year's expenses; § 917.38). </P>
        <HD SOURCE="HD1">Continuance of Assessment Rates </HD>
        <P>The assessment rates established in this rule will continue in effect indefinitely unless modified, suspended, or terminated by USDA upon recommendation and information submitted by the committees or other available information. </P>
        <P>Although these assessment rates will be in effect for an indefinite period, the committees will continue to meet prior to or during each fiscal period to recommend a budget of expenses and consider recommendations for modification of the assessment rates. The dates and times of committee meetings are available from the committees' website or USDA. Committee meetings are open to the public and interested persons may express their views at these meetings. USDA will evaluate the committees' recommendations and other available information to determine whether modification of the assessment rate for each committee is needed. Further rulemaking will be undertaken as necessary. The committee's 2003-04 budget and those for subsequent fiscal periods will be reviewed and, as appropriate, approved by USDA. </P>
        <HD SOURCE="HD1">Initial Regulatory Flexibility Analysis </HD>

        <P>Pursuant to requirements set forth in the Regulatory Flexibility Act (RFA), the Agricultural Marketing Service (AMS) has considered the economic impact of this rule on small entities. Accordingly, <PRTPAGE P="48769"/>AMS has prepared this initial regulatory flexibility analysis. </P>
        <P>The purpose of the RFA is to fit regulatory actions to the scale of business subject to such actions in order that small businesses will not be unduly or disproportionately burdened. Marketing orders issued pursuant to the Act, and the rules issued thereunder, are unique in that they are brought about through group action of essentially small entities acting on their own behalf. Thus, both statutes have small entity orientation and compatibility. </P>
        <P>There are approximately 300 California nectarine and peach handlers subject to regulation under the orders covering nectarines and peaches grown in California, and about 1,800 producers of these fruits in California. Small agricultural service firms, which include handlers, are defined by the Small Business Administration [13 CFR 121.201] as those whose annual receipts are less than $5,000,000. Small agricultural producers are defined by the Small Business Administration as those having annual receipts of less than $750,000. A majority of these handlers and producers may be classified as small entities. </P>
        <P>The committees' staff has estimated that there are less than 20 handlers in the industry who could be defined as other than small entities. For the 2002 season, the committees' staff estimated that the average handler price received was $9.00 per container or container equivalent of nectarines or peaches. A handler would have to ship at least 556,000 containers to have annual receipts of $5,000,000. Given data on shipments maintained by the committees' staff and the average handler price received during the 2002 season, the committees' staff estimates that small handlers represent approximately 94 percent of all the handlers within the industry. </P>
        <P>The committees' staff has also estimated that less than 20 percent of the producers in the industry could be defined as other than small entities. For the 2002 season, the committees' estimated the average producer price received was $4.00 per container or container equivalent for nectarines and peaches. A producer would have to produce at least 187,500 containers of nectarines and peaches to have annual receipts of $750,000. </P>
        <P>With data maintained by the committees' staff and the average producer price received during the 2002 season, the committees' staff estimates that small producers represent more than 80 percent of the producers within the industry. With an average producer price of $4.00 per container or container equivalent, and a combined packout of nectarines and peaches of 43,340,000 containers, the value of the 2002 packout level is estimated to be $173,360,000. Dividing this total estimated grower revenue figure by the estimated number of producers (1,800) yields an estimate of average revenue per producer of about $96,311 from the sales of peaches and nectarines. </P>
        <P>This rule will increase the assessment rates established for the committees and collected from handlers for the 2003-04 and subsequent fiscal periods from $0.19 to $0.20 per 25-pound container or container equivalent of nectarines and peaches. The committees recommended 2003-04 expenditures of $4,173,438 for nectarines and expenditures of $4,086,316 for peaches and an assessment rate of $0.20 per 25-pound container or container equivalent of nectarines and peaches. The assessment rate of $0.20 is $0.01 higher than the current rate. </P>
        <HD SOURCE="HD1">Analysis of NAC Budget </HD>
        <P>The quantity of assessable nectarines for the 2003-04 fiscal year is estimated at 22,004,000 25-pound container or container equivalents. Thus, the $0.20 rate should provide $4,400,800 in assessment income. Income derived from handler assessments will be adequate to cover budgeted expenses and permit an adequate reserve. </P>
        <P>The major expenditures recommended by the NAC for the 2003-04 year include $226,121 for salaries and benefits, $142,612 for general expenses and industry activities, $1,210,220 for inspection, $138,929 for research, and $2,263,061 for domestic and international promotion. </P>
        <P>Budgeted expenses for these items in 2002-03 were $505,000 for salaries and benefits, $309,039 for general expenses and industry activities, $1,050,000 for inspection, $138,018 for research, and $2,574,160 for domestic and international promotion. </P>
        <P>The NAC recommended an increase in the assessment rate to meet anticipated 2003-04 expenses and preserve an acceptable financial reserve. A reserve of $400,000 is needed to fund expenses for the following year until assessments for that year are received. The NAC reviewed and recommended 2003-04 expenditures of $4,173,438 and the increased assessment rate. </P>
        <HD SOURCE="HD1">Analysis of PCC Budget </HD>
        <P>The quantity of assessable peaches for the 2003-04 fiscal year is estimated at 21,336,000 25-pound container or container equivalents. Thus, the $0.20 rate should provide $4,267,200 in assessment income. Income derived from handler assessments will be adequate to cover budgeted expenses and permit a small increase in reserves. </P>
        <P>The major expenditures recommended by the PCC for the 2003-04 year include $226,121 for salaries and benefits, $144,743 for general expenses and industry activities, $1,206,414 for inspection, $138,930 for research, and $2,211,346 for domestic and international promotion. </P>
        <P>Budgeted expenses for these items in 2002-03 were $505,000 for salaries and benefits, $206,747 for general expenses, $1,100,000 for inspection, $142,186 for research, and $2,529,036 for domestic and international promotion. </P>
        <P>The PCC recommended an increase in the assessment rate to meet anticipated 2003-04 expenses and preserve an acceptable financial reserve. A reserve of $500,000 to $550,000 is needed to fund expenses for the following year until assessments for that year are received. The PCC reviewed and recommended 2003-04 expenditures of $4,086,316 and the increased assessment rate. </P>
        <HD SOURCE="HD1">Considerations in Determining Expenses and Assessment Rates </HD>
        <P>Prior to arriving at these budgets, the committees considered information and recommendations from various sources, including, but not limited to: The Executive Committee, the Research Subcommittee, the International Programs Subcommittee, the Grade and Size Subcommittee, and the Domestic Promotion Subcommittee. </P>
        <P>Each of the committees then reviewed the proposed expenses; the total estimated assessable 25-pound containers or container equivalents; and the estimated income from other sources, such as interest income, prior to recommending a final assessment rate. The NAC decided that an assessment rate of $0.20 per 25-pound container or container equivalent will allow it to meet its 2003-04 expenses and carry over an operating reserve of about $438,374, which is in line with the committee's financial needs. The PCC decided that an assessment rate of $0.20 per 25-pound container or container equivalent will allow it to meet its 2003-04 expenses and carry over an operating reserve of $530,586, which is in line with the committee's financial needs. The committees then recommended this rate to USDA with one dissenting vote from each committee. </P>

        <P>A review of historical and preliminary information pertaining to the upcoming fiscal period indicates that the grower price for the 2003-04 seasons could range between $4.00 and $6.00 per 25-<PRTPAGE P="48770"/>pound container or container equivalent. Therefore, the estimated assessment revenue for the 2003-04 fiscal period as a percentage of total grower revenue could range between 3.33 and 5.0 percent. </P>
        <P>This action increases the assessment obligation imposed on handlers. While assessments impose some additional costs on handlers, the costs are minimal and uniform on all handlers. Some of the additional costs may be passed on to producers. However, these costs would be offset by the benefits derived from the operation of the marketing orders. In addition, the committees' meetings were widely publicized throughout the California nectarine and peach industries and all interested persons were invited to attend the meetings and participate in the committees' deliberations on all issues. Like all committee meetings, the May 1, 2003, meetings were public meetings and all entities of all sizes were able to express views on this issue. Finally, interested persons are invited to submit information on the regulatory and informational impacts of this action on small businesses. </P>
        <P>This rule will impose no additional reporting or recordkeeping requirements on either small or large handlers. As with all Federal marketing order programs, reports and forms are periodically reviewed to reduce information requirements and duplication by industry and public sector agencies. </P>
        <P>USDA has not identified any relevant Federal rules that duplicate, overlap, or conflict with this rule. </P>

        <P>A small business guide on complying with fruit, vegetable, and specialty crop marketing agreements and orders may be viewed at: <E T="03">http://www.ams.usda.gov/fv/moab.html.</E> Any questions about the compliance guide should be sent to Jay Guerber at the previously mentioned address in the <E T="02">FOR FURTHER INFORMATION CONTACT</E> section. </P>
        <P>A 60-day comment period is provided to allow interested persons to respond to this rule. All written comments received will be considered before a final decision is made on this matter. </P>
        <P>After consideration of all relevant material presented, including the Committees' recommendations, and other information, it is found that this interim final rule, as hereinafter set forth, will tend to effectuate the declared policy of the Act. </P>

        <P>Pursuant to 5 U.S.C. 553, it is also found and determined upon good cause that it is impracticable, unnecessary and contrary to the public interest to give preliminary notice prior to putting this rule into effect and that good cause exists for not postponing the effective date of this rule until 30 days after publication in the <E T="04">Federal Register</E> because: (1) The 2003-04 fiscal periods began on March 1, 2003, and the marketing orders require that the rates of assessment for each fiscal period apply to all assessable nectarines and peaches handled during such fiscal period; (2) the committees need to have sufficient funds to pay their expenses which are incurred on a continuous basis; and (3) handlers are aware of this action which was recommended by the committees at public meetings and is similar to other assessment rate actions issued in past years; (4) this interim final rule provides a 60-day comment period, and all comments timely received will be considered prior to finalization of this rule. </P>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects </HD>
          <CFR>7 CFR Part 916 </CFR>
          <P>Marketing agreements, Nectarines, Reporting and recordkeeping requirements. </P>
          <CFR>7 CFR Part 917 </CFR>
          <P>Marketing agreements, Peaches, Pears, Reporting and recordkeeping requirements.</P>
        </LSTSUB>
        
        <REGTEXT PART="916" TITLE="7">
          <AMDPAR>For the reasons set forth in the preamble, 7 CFR parts 916 and 917 are amended as follows: </AMDPAR>
          <AMDPAR>1. The authority citation for 7 CFR parts 916 and 917 continues to read as follows: </AMDPAR>
          <AUTH>
            <HD SOURCE="HED">Authority:</HD>
            <P>7 U.S.C. 601-674. </P>
          </AUTH>
        </REGTEXT>
        <REGTEXT PART="916" TITLE="7">
          <PART>
            <HD SOURCE="HED">PART 916—NECTARINES GROWN IN CALIFORNIA </HD>
          </PART>
          <AMDPAR>2. Section 916.234 is revised to read as follows: </AMDPAR>
          <SECTION>
            <SECTNO>§ 916.234 </SECTNO>
            <SUBJECT>Assessment rate. </SUBJECT>
            <P>On and after March 1, 2003, an assessment rate of $0.20 per 25-pound container or container equivalent of nectarines is established for California nectarines. </P>
          </SECTION>
        </REGTEXT>
        <REGTEXT PART="916" TITLE="7">
          <PART>
            <HD SOURCE="HED">PART 917—PEACHES GROWN IN CALIFORNIA </HD>
          </PART>
          <AMDPAR>3. Section 917.258 is revised to read as follows: </AMDPAR>
          <SECTION>
            <SECTNO>§ 917.258 </SECTNO>
            <SUBJECT>Assessment rate. </SUBJECT>
            <P>On and after March 1, 2003, an assessment rate of $0.20 per 25-pound container or container equivalent of peaches is established for California peaches. </P>
          </SECTION>
        </REGTEXT>
        <SIG>
          <DATED>Dated: August 11, 2003. </DATED>
          <NAME>A.J. Yates, </NAME>
          <TITLE>Administrator, Agricultural Marketing Service. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20875 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 3410-02-U </BILCOD>
    </RULE>
    <RULE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF AGRICULTURE </AGENCY>
        <SUBAGY>Agricultural Marketing Service </SUBAGY>
        <CFR>7 CFR Parts 1000 and 1032 </CFR>
        <DEPDOC>[Docket # DA-03-09; AO-313-A45] </DEPDOC>
        <SUBJECT>Milk in the Central Marketing Area </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Agricultural Marketing Service, USDA. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Final rule; technical amendment. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>In a final rule published in the <E T="04">Federal Register</E> on December 17, 1999 (64 FR 70868) the Agricultural Marketing Service (AMS) consolidated Federal milk marketing orders. This document adds “Broomfield” to the Adjusted Class I differentials table. </P>
        </SUM>
        <EFFDATE>
          <HD SOURCE="HED">EFFECTIVE DATE:</HD>
          <P>August 16, 2003. </P>
        </EFFDATE>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>

          <P>Jack Rower, Marketing Specialist, Order Formulation and Enforcement Branch, USDA/AMS/Dairy Programs, Stop 0231-Room 2971, 1400 Independence Avenue, SW., Washington, DC 20250-0231, (202) 720-9363, e-mail: <E T="03">jack.rower@usda.gov</E>. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION: </HD>
        <HD SOURCE="HD1">Background </HD>
        <P>On December 17, 1999, the Agricultural Marketing Service published a final rule consolidating the Federal milk marketing orders and changing the Class I differentials contained therein. Subsequent to adoption of this final regulation, on November 15, 2001, Broomfield became Colorado's 64th county as a result of an amendment to the Colorado State constitution. </P>
        <P>This document amends the regulations by adding the county of Broomfield, CO, to both parts 1000 and 1032 in the General Provisions of Federal milk marketing orders and the Central marketing area, respectively. </P>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects in 7 CFR Parts 1000 and 1032 </HD>
          <P>Milk marketing orders.</P>
        </LSTSUB>
        
        <AMDPAR>Accordingly we are amending 7 CFR parts 1000 and 1032 as follows:</AMDPAR>
        <REGTEXT PART="1000" TITLE="7">
          <AMDPAR>1. The authority citation for 7 CFR parts 1000 and 1032 continues to read as follows: </AMDPAR>
          <AUTH>
            <HD SOURCE="HED">Authority:</HD>
            <P>7 U.S.C. 601-674.</P>
          </AUTH>
        </REGTEXT>
        <REGTEXT PART="1000" TITLE="7">
          <PART>
            <PRTPAGE P="48771"/>
            <HD SOURCE="HED">PART 1000—[AMENDED] </HD>
          </PART>
          <AMDPAR>2. Section 1000.52 is amended by adding “Broomfield, CO” immediately following “Boulder, CO” in the table to read as follows: </AMDPAR>
          <SECTION>
            <SECTNO>§ 1000.52</SECTNO>
            <SUBJECT>Adjusted Class I differentials. </SUBJECT>
            <STARS/>
            <GPOTABLE CDEF="s100,r50,12,12" COLS="4" OPTS="L1,tp0,i1">
              <TTITLE/>
              <BOXHD>
                <CHED H="1">County/parish/city </CHED>
                <CHED H="1">State </CHED>
                <CHED H="1">FIPS code </CHED>
                <CHED H="1">Class I <LI>differential </LI>
                  <LI>adjusted for </LI>
                  <LI>location </LI>
                </CHED>
              </BOXHD>
              <ROW>
                <ENT I="22">  </ENT>
              </ROW>
              <ROW>
                <ENT I="28">*         *         *         *         *         *         * </ENT>
              </ROW>
              <ROW>
                <ENT I="01">BROOMFIELD</ENT>
                <ENT>CO </ENT>
                <ENT>08014 </ENT>
                <ENT>2.45 </ENT>
              </ROW>
              <ROW>
                <ENT I="22"/>
              </ROW>
              <ROW>
                <ENT I="28">*         *         *         *         *         *         * </ENT>
              </ROW>
            </GPOTABLE>
          </SECTION>
        </REGTEXT>
        <REGTEXT PART="1032" TITLE="7">
          <PART>
            <HD SOURCE="HED">PART 1032—[AMENDED] </HD>
          </PART>
          <AMDPAR>3. In § 1032.2, the county “Broomfield” is added immediately following “Boulder”. </AMDPAR>
        </REGTEXT>
        <SIG>
          <DATED>Dated: August 11, 2003. </DATED>
          <NAME>A.J. Yates, </NAME>
          <TITLE>Administrator, Agricultural Marketing Service. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20817 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 3410-02-U</BILCOD>
    </RULE>
    <RULE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF THE TREASURY </AGENCY>
        <SUBAGY>Office of the Comptroller of the Currency </SUBAGY>
        <CFR>12 CFR Part 24 </CFR>
        <DEPDOC>[Docket No. 03-20] </DEPDOC>
        <RIN>RIN 1557-AC09 </RIN>
        <SUBJECT>Community and Economic Development Entities, Community Development Projects, and Other Public Welfare Investments </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Office of the Comptroller of the Currency, Treasury. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Final rule. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The Office of the Comptroller of the Currency (OCC) is amending 12 CFR part 24, the regulation governing national bank investments that are designed primarily to promote the public welfare. This final rule updates the regulation to reflect the additional types of public welfare investment structures that have become more common in recent years and that are permissible under the governing statute. It also clarifies the statutory standard that applies to the activities of those entities; simplifies the standards for making public welfare investments; clarifies how a national bank calculates the value of its public welfare investments for purposes of complying with the rule's investment limits; simplifies the regulation's investment self-certification and prior approval processes; and expands the list of examples of qualifying public welfare investments that satisfy the rule's requirements. The final rule also appends the form national banks may use to inform the OCC about an investment made under part 24. These changes are intended to encourage additional public welfare investments by national banks by simplifying the regulation and further reducing unnecessary burden associated with part 24 investments. </P>
        </SUM>
        <EFFDATE>
          <HD SOURCE="HED">EFFECTIVE DATE:</HD>
          <P>September 15, 2003. </P>
        </EFFDATE>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Michele Meyer, Counsel, Legislative and Regulatory Activities Division, (202) 874-5090; Stephen Van Meter, Assistant Director, Community and Consumer Law Division, (202) 874-5750; or Barry Wides, Director, or Karen Bellesi, Investments Manager, Community Development Division, (202) 874-4930. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P/>
        <HD SOURCE="HD1">The Proposal </HD>
        <P>On January 10, 2003, the OCC published a notice of proposed rulemaking (NPRM) to amend 12 CFR part 24.<SU>1</SU>
          <FTREF/> Part 24 implements 12 U.S.C. 24 (Eleventh), which authorizes national banks to make investments designed primarily to promote the public welfare, including the welfare of low- and moderate-income communities and families, subject to certain percentage-of-capital limitations. The NPRM sought to eliminate unnecessary regulatory requirements associated with these investments and thus make it easier for national banks to use the public welfare investment authority that the statute and regulation provide, consistent with statutory requirements and safety and soundness considerations. </P>
        <FTNT>
          <P>
            <SU>1</SU> 68 FR 1394 (January 10, 2003).</P>
        </FTNT>
        <HD SOURCE="HD1">Description of Comments Received and Final Rule </HD>
        <P>The NPRM comment period closed March 11, 2003, and we received 10 comments. Commenters included banks, a banking trade association, community groups, and individuals. The majority of the commenters supported the proposed changes. A summary of the comments and a description of the final rule follows. </P>
        <HD SOURCE="HD2">Definitions (§ 24.2) </HD>
        <P>The NPRM proposed adding a new definition of “community and economic development entity” to replace the current definition of “community development corporation.” A community development corporation was defined in the former regulation as a corporation established by one or more insured financial institutions (with or without other investors) “to make one or more investments that meet the requirements of § 24.3.” <SU>2</SU>
          <FTREF/> The proposal defined a community and economic development entity (CDE) as an entity—such as a national bank community development subsidiary, community development financial institution, limited liability company, or limited partnership—that makes investments or conducts activities that primarily benefit low- and moderate-income individuals or areas or other areas targeted for redevelopment. In our view, this proposed definition better reflected the scope of the statute and its legislative history, neither of which restricts the entities in which a national bank may invest to a particular form of organization, provided the bank is not exposed to unlimited liability. </P>
        <FTNT>
          <P>
            <SU>2</SU> The prior rule set forth the criteria for a public welfare investment, including that the investment primarily benefits low- and moderate-income individuals or areas or other areas targeted for redevelopment, and that the bank demonstrates non-bank community support for the investment.</P>
        </FTNT>

        <P>None of the commenters objected to the substance of this proposed definition. Several, however, pointed out that the abbreviation “CDE” could cause confusion because that term is used in the context of the New Markets Tax Credit to refer to an entity that may have similar activities but must meet additional qualifications. To avoid this <PRTPAGE P="48772"/>confusion, the final rule abbreviates the term “community and economic development entity” as “CEDE.” </P>

        <P>In addition, the final rule modifies the definition of “CEDE” to reflect a change to § 24.3. As explained below, the final rule modifies § 24.3 to permit a national bank to make an investment that either primarily benefits low- and moderate-income individuals or areas or other areas targeted for redevelopment or would receive consideration as a “qualified investment” under the CRA regulations. The final rule accordingly defines a CEDE as an entity that makes investments or conducts activities that primarily benefit low- and moderate-income individuals, low- and moderate-income areas, or other areas targeted by a governmental entity for redevelopment <E T="03">or</E> that would receive consideration as “qualified investments” under the CRA. </P>

        <P>Finally, because an investment in a small farm may receive CRA consideration under certain circumstances, the final rule modifies the definition of “small business” to include a reference to small farms. Thus, under the final rule, a “small business” is “a business, <E T="03">including a small farm</E> or minority-owned business, that meets the qualifications for Small Business Administration Development Company or Small Business Investment Company programs in 13 CFR 121.301.” </P>
        <HD SOURCE="HD2">Public Welfare Investments (§ 24.3) </HD>
        <P>Section 24 (Eleventh) authorizes national banks to make investments “designed primarily to promote the public welfare, including the welfare of low- and moderate-income communities or families (such as through the provision of housing, services, or jobs).” Section 24.3 of the prior rule implemented this authority by providing that a national bank may make an investment under part 24 if two conditions were met. The first, set forth in the former rule at § 24.3(a), was that the investment primarily benefit low- and moderate-income individuals, low- and moderate-income areas, or other areas targeted for redevelopment by providing or supporting one or more of four enumerated public welfare activities.<SU>3</SU>
          <FTREF/> The second condition, set forth in the former rule at § 24.3(b), was that the bank demonstrate non-bank community support for, or participation in, the investment.<SU>4</SU>
          <FTREF/> The NPRM proposed simplifying the text of § 24.3(a) and deleting § 24.3(b). </P>
        <FTNT>
          <P>
            <SU>3</SU> Under the prior rule, these included affordable housing, equity or debt financing for small businesses, area revitalization or stabilization, and “other activities, services, or facilities that primarily promote the public welfare.”</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>4</SU> Under the prior rule, a bank could demonstrate community support in a variety of ways, including: having non-bank community representatives as members of the board of directors of a CEDE or on a separate advisory board for the bank's community development activities; formation of formal business relationships between the bank and a community organization; contractual agreements with community partners to provide services in connection with the proposed investment; joint ventures with local small businesses; and financing for the proposed investment from the public sector or community development organizations or the receipt of Federal low-income housing tax credits by the project in which the investment is made.</P>
        </FTNT>
        <P>
          <E T="03">1. Simplifying former § 24.3(a).</E> Proposed § 24.3 would have permitted a national bank to make a part 24 investment if the investment primarily benefited low- and moderate-income individuals or areas or government-targeted redevelopment areas. The proposal deleted the four enumerated public welfare activities set forth in former § 24.3(a)(1)-(4) because they were merely illustrative of the types of investments a national bank may make under this part. In fact, the last is a catch-all provision that would cover all part 24 investments not covered by the first three. As we explained in the preamble to the proposal, the list is unnecessary in light of § 24.6, which sets forth examples of public welfare investments a national bank may make under part 24. </P>
        <P>Several commenters proposed further revisions to § 24.3. These commenters suggested that we either eliminate the requirement that an investment primarily benefit low- and moderate-income individuals or areas, or change the regulation so that these individuals or areas need not be the only, or even the primary, beneficiaries of such investments. These commenters note that the “primary benefit” test is not required by statute and that many investment activities that do not meet this test nonetheless promote the public welfare. Several bank commenters also noted that some investments that would receive consideration under the CRA as “qualified investments” do not necessarily satisfy the requirements of part 24. This comment was made, in particular, with respect to small business investments that do not meet part 24's “primary benefit” test. </P>
        <P>We believe that the elimination of the “primary benefit” test in its entirety is inappropriate. First, the primary benefit test provides an objective criterion—the benefit to low- and moderate-income individuals or areas or targeted redevelopment areas—for determining whether an investment “primarily promotes the public welfare” under the statute. Eliminating this objective test would create significant uncertainty concerning what types of investments are permitted under part 24. Second, removal of the primary benefit test may dilute the public welfare purpose of the statute by weakening the incentive for national banks to identify investments that are sound and profitable but not widely perceived as such.<SU>5</SU>
          <FTREF/>
        </P>
        <FTNT>
          <P>

            <SU>5</SU> For examples of the diverse and creative investments national banks have made under part 24, <E T="03">see</E> “National Bank Community Development Investments, 2001 Directory.”</P>
        </FTNT>
        <P>However, we believe that many of the benefits of the commenters' suggestions can be achieved by including, as an alternative to investments that satisfy the primary benefit test, investments that would receive consideration as “qualified investments” under the CRA regulations. The CRA regulations provide their own set of objective criteria. Under the CRA regulations, a qualified investment must have as its primary purpose community development, which is defined to include affordable housing; community services targeted to low- or moderate-income individuals; activities that promote economic development by financing small businesses or farms; or activities that stabilize low or moderate-income geographies.<SU>6</SU>

          <FTREF/> The final rule incorporates these standards by modifying § 24.3 to permit a bank to make a part 24 investment if the investment primarily benefits low- and moderate-income individuals or areas or government-targeted redevelopment areas <E T="03">or would receive consideration as a “qualified investment” under the CRA regulations.</E>
          <SU>7</SU>
          <FTREF/> Examples of such investments are included in new § 24.6. </P>
        <FTNT>
          <P>
            <SU>6</SU> 12 CFR 25.12(h) and (s).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>7</SU> It is important to note that an investment that is permitted under part 24 will not always receive positive consideration under the CRA regulations. Under the CRA regulations, a national bank will receive consideration for qualified investments that benefit its assessment areas or a broader statewide or regional area that includes the bank's assessment areas. 12 CFR 25.23(a). For example, a retail national bank located only in California would be permitted under part 24 to invest in an entity that provides affordable housing for low- or moderate-income individuals in New York. The California bank would not receive positive consideration for this investment under the CRA regulations, however, because New York is outside its California assessment area and the broader statewide or regional area that includes its assessment area.</P>
        </FTNT>
        <P>2. <E T="03">Eliminating former § 24.3(b) (the community support requirement).</E>
        </P>
        <P>The NPRM proposed deleting the community support requirement because it is not required by statute or the comparable rules that apply to other financial institutions that have Federal statutory investment authority similar to section 24 (Eleventh) <SU>8</SU>
          <FTREF/>, and the OCC's <PRTPAGE P="48773"/>experience in implementing part 24 suggests that investments that otherwise meet the requirements of part 24 will receive the support of the communities benefitted. </P>
        <FTNT>
          <P>
            <SU>8</SU> The Federal Reserve Board's community development regulation (12 CFR 208.22) implements statutory authority (12 U.S.C. 338a) that <PRTPAGE/>is identical in all material respects to 24 (Eleventh) and does not require the demonstration of community support for an investment.</P>
        </FTNT>
        <P>The OCC received several comments from banks in support of the proposed deletion of this requirement. These commenters echoed our statement in the preamble to the NPRM that most investments that otherwise meet the requirements of part 24 will receive the support of the communities benefited. In addition, the supporting commenters said that mandating community involvement may limit management's ability to realize its own business strategy. </P>
        <P>The OCC received no comments voicing opposition to the proposed deletion of the community support requirement either banks or community groups. The final rule therefore deletes the community support requirement. </P>
        <HD SOURCE="HD2">Investment Limits (§ 24.4) </HD>
        <P>Section 24.4 of the rule implements the investment limits imposed by 12 U.S.C. 24 (Eleventh). Under both the regulation and the statute, a national bank's aggregate public welfare investments may not exceed 5 percent of its capital and surplus, unless the bank is at least adequately capitalized and the OCC determines that a higher amount will pose no significant risk to the deposit insurance fund. In no case, however, may a bank's aggregate outstanding part 24 investments exceed 10 percent of its capital and surplus.<SU>9</SU>
          <FTREF/>
        </P>
        <FTNT>
          <P>
            <SU>9</SU> As explained in § 24.1(d), national banks that make loans or investments that are designed primarily to promote the public welfare and that are authorized under provisions other than section 24 (Eleventh) may do so without regard to the provisions—including the capital limitations—of 24 (Eleventh) or part 24.</P>
        </FTNT>
        <P>The OCC proposed amending § 24.4 to clarify that a bank should follow generally accepted accounting principles (GAAP) when calculating the aggregate amount of its part 24 investments, unless otherwise directed or permitted in writing by the OCC for prudential or safety and soundness reasons. We received two comments on this proposal seeking a further explanation of this clarification. </P>
        <P>National banks prepare statements and reports required to be filed with the OCC using accounting standards that are consistent with GAAP. Under GAAP, the valuation method applied to an investment in an entity depends on the nature of the investment <SU>10</SU>
          <FTREF/> and the degree of the investor's control reflected by the percentage that the investment represents in the entity. Generally, investments over 50 percent are fully consolidated; investments between 20 and 50 percent are valued according to the equity method; and investments under 20 percent may be valued at cost, unless the asset becomes permanently impaired. There are certain circumstances, however, when the application of a particular GAAP valuation method to a part 24 investment may lead to unintended results. </P>
        <FTNT>
          <P>

            <SU>10</SU> For example, Statement of Financial Accounting Standards Board No. 115, <E T="03">Accounting for Certain Investments in Debt and Equity Securities,</E> identifies the categories among which national banks must divide their securities holdings as held-to-maturity, trading, and available-for-sale, and provides a different accounting treatment for each category.</P>
        </FTNT>
        <P>For example, if the equity method of GAAP is applied to a part 24 investment, the value of a bank's part 24 investment carried on the bank's books would be originally recorded at cost but subsequently adjusted periodically to reflect the bank's proportionate share of the investment's earnings or losses, and decreased by any cash dividends or similar distributions from the investment. The use of the equity method would mean that the valuation of the bank's part 24 investment would fluctuate with the profits and losses of the investment. As the investment's profits increase under the equity method, the carrying value of the bank's investment would also increase. Consequently, even if the bank's investment was within the part 24 investment limits when made, this increase in the carrying value under the equity method could cause the investment to later exceed the investment limits. </P>
        <P>Conversely, if the part 24 investment incurred losses, the value of the bank's investment would decrease, which would permit the bank to make additional investments without exceeding the investment limit. Thus, although the equity method may better reflect the current value of the bank's investment, its application could limit the investment capacity of banks with the most profitable part 24 investment programs while, contrary to safety and soundness, increasing the investment capacity of banks that make unprofitable part 24 investments. </P>
        <P>In such circumstances, it may be appropriate for a bank to use a different method to calculate the aggregate amount of its part 24 investments. For example, under the cost method, the actual cost of a bank's part 24 investment would be used in determining compliance with the statutory investment limit. No further adjustments would be required. As a result, as long as the part 24 investment was within the investment limits when made (and assuming there has been no change in the bank's capital and surplus), a bank's compliance with these limits would be unaffected by profits or losses on the investment. </P>
        <P>In order to provide flexibility where the application of a specific GAAP valuation method would be inappropriate, the final rule follows the proposal and amends § 24.4 to provide that a bank should follow GAAP when calculating the aggregate amount of its part 24 investments, unless otherwise directed or permitted in writing by the OCC for prudential or safety and soundness reasons. </P>
        <HD SOURCE="HD2">Public Welfare Self-Certification and Prior Approval Procedures (§ 24.5) </HD>
        <P>An eligible national bank may make qualifying public welfare investments without prior notification to, or approval by, the OCC by submitting a self-certification letter to the OCC within 10 working days after it makes the investment. For all other investments under part 24, a national bank must submit an investment proposal application to the OCC for prior approval. Unless otherwise notified in writing by the OCC, the proposed investment is deemed approved 30 calendar days from the date on which the OCC receives the proposal application.<SU>11</SU>
          <FTREF/>
        </P>
        <FTNT>
          <P>
            <SU>11</SU> <E T="03">See</E> 12 CFR 24.5 and 24.6.</P>
        </FTNT>
        <P>To emphasize that eligible national banks are not required to seek prior approval of eligible public welfare investments, the NRPM proposed changing the title of § 24.5 to “Public welfare investment after-the-fact notice and prior approval procedures,” and changed references in the section from “self-certification” to “after-the-fact notice.” The OCC further proposed to simplify the part 24 investment notification processes and make them more consistent with the notification processes established under 12 CFR part 5 for certain equity investments. Under those provisions of part 5, a national bank's written after-the-fact notice of certain equity investments must set forth simply “a description, and the amount, of the bank's investment.”<SU>12</SU>
          <FTREF/>
        </P>
        <FTNT>
          <P>
            <SU>12</SU> <E T="03">See</E> 12 CFR 5.36(d)(2).</P>
        </FTNT>

        <P>The NPRM proposed revising § 24.5 to make it more consistent with the part 5 equity investment notification procedures and to remove unnecessary administrative impediments to national bank public welfare investments. Thus, the proposal provided that a national <PRTPAGE P="48774"/>bank may make an investment without prior notification to the OCC if the bank submits an after-the-fact notice to the OCC that includes: a description of the bank's investment; the amount of the investment; the percentage of the bank's capital and surplus represented by the current investment being self-certified and by the bank's aggregate outstanding part 24 investments, including the investment being self-certified; and a certification that the investment complies with the requirements of §§ 24.3 and 24.4. </P>
        <P>The NPRM also proposed applying these modified requirements to the investment prior approval process described in § 24.5(b). As a result, the after-the-fact notices and the investment proposals submitted in accordance with these modified requirements would be significantly less burdensome to prepare than are the materials submitted under the current rule while still providing the OCC with sufficient information to determine whether an investment is consistent with safe and sound practices.<SU>13</SU>
          <FTREF/>
        </P>
        <FTNT>
          <P>
            <SU>13</SU> Neither the proposal nor the final rule changes the triggers for the prior approval process. Thus, a bank that is not an “eligible bank” under our rules must seek prior approval of its investments. 12 CFR 24.5(b)(1). So must an eligible bank that seeks to exceed the five percent investment limit or to invest in other real estate owned or make some other investment determined by the OCC to be ineligible for the after-the-fact notice process. 12 CFR 24.4 and 24.5(a)(5).</P>
        </FTNT>
        <P>The OCC received no comments opposed to these streamlined procedures and several comments in favor of them. Several commenters suggested, however, that we further streamline the self-certification process. One commenter proposed eliminating the required inclusion in the self-certification letter of the percentage of the bank's capital and surplus represented by the current investment and by the bank's aggregate outstanding investments. This commenter noted that neither part 5 nor the FRB's rule requires this information. On the other hand, this information is necessary to enable the OCC to ascertain whether a bank is complying with the statutory investment limit, and requiring its inclusion poses minimal additional burden because the bank itself must calculate the percentage of its capital and surplus represented by the current investment and by its aggregate outstanding investments in order to determine whether it is in compliance with the rule's investment limits. The final rule thus retains this requirement. </P>
        <P>A bank commenter also suggested that we eliminate two other differences between the part 24 procedures and the procedures set forth in the FRB's rule. First, the bank suggested that the OCC change the requirement that a bank must notify the OCC within 10 days of making an investment to be consistent with the 30-day period permitted by the FRB. Second, the bank proposed that we eliminate the requirement that a bank must be well-capitalized in order to submit after-the-fact notices because the FRB only requires that a bank be adequately capitalized. We decline to adopt in part 24 the timing and capitalization requirements applied by the FRB in its community development investment regulation. The requirements in part 24 are consistent with requirements applied in connection with certain equity investments under part 5 and achieve the twin objectives of minimizing burden while providing adequate safeguards. The OCC believes that changing these requirements in the context of part 24 may have the unintended consequence of increasing burden on banks by imposing a new and different set of rules applicable to a subset of investments that national banks may make. For these reasons, we have retained the current requirements. </P>

        <P>The OCC has revised the sample form (OCC form CD-1) for investment notification and prior approval to reflect the streamlined requirements set forth in this final rule. This sample form is added to the final rule as Appendix 1, is available for downloading on the OCC's Web site at <E T="03">http://www.occ.treas.gov/cdd/pt24toppage.htm</E>, and will be available through the OCC's Community Development Division.<SU>14</SU>
          <FTREF/>
        </P>
        <FTNT>
          <P>
            <SU>14</SU> The Community Development Division may be contacted at (202) 874-4930.</P>
        </FTNT>
        <HD SOURCE="HD2">Examples of Qualifying Public Welfare Investments (§ 24.6) </HD>
        <P>The NPRM proposed revising § 24.6 to provide additional examples of the types of investments that meet the requirements of § 24.3. For ease of reference, this list is organized by type of activity (such as affordable housing, economic development and job creation, and investments in community and economic development entities). As we explained in the preamble to the NPRM, this list is merely illustrative of the types of investments a bank may make under this part, and national banks are not limited to the listed investments in creating or expanding their public welfare investment programs. The expanded list of eligible investments would help to streamline the notice and application processes, however, by making clear the scope of investments that are eligible and reducing the need for staff to do case-by-case reviews of the permissibility of such investments. </P>
        <P>Two commenters suggested additions to this list of examples consistent with the view that we should eliminate or reduce the emphasis in § 24.3 on whether an investment primarily benefits low- and moderate-income persons or areas. Because the final rule amends § 24.3 to permit banks to make investments that would receive consideration as “qualified investments” under the CRA regulations, the final rule includes an additional example in § 24.6 of such an investment. </P>
        <P>This example, set forth at § 24.6(b)(2), is of an investment that finances small businesses or small farms that, although not located in low- and moderate-income areas, create a significant number of permanent jobs for low- or moderate-income individuals. As explained in the Interagency Questions and Answers Regarding Community Reinvestments,<SU>15</SU>
          <FTREF/> a national bank would receive positive CRA consideration for such an investment,<SU>16</SU>
          <FTREF/> but would not have been permitted to make it under former § 24.3 because the small businesses or small farms are not located in a low- or moderate-income area or redevelopment area and a majority of the permanent jobs created are not for low- and moderate-income individuals. </P>
        <FTNT>
          <P>
            <SU>15</SU> 66 FR 36620 (July 12, 2001).</P>
        </FTNT>
        <FTNT>
          <P>

            <SU>16</SU> Interagency Questions and Answers Regarding Community Reinvestments, Q &amp; A ___ .12(h)(3)-1, 66 FR at 36625. A national bank would be permitted to make this investment under the Small Business Investment Act (SBIA), 15 U.S.C. 661 <E T="03">et seq.</E> The SBIA authorizes the Small Business Administration to charter private Small Business Investment Companies (SBICs), and authorizes banks to invest in those SBICs. Under the final rule, a national bank could make a similar investment using, for example, a CEDE rather than an SBIC.</P>
        </FTNT>
        <HD SOURCE="HD2">Examination, Records, and Remedial Action (§ 24.7) </HD>

        <P>As explained above, this rulemaking expands the investment opportunities available to national banks under part 24 by modifying § 24.3 to permit a bank to make a part 24 investment if the investment primarily benefits low- and moderate-income individuals or areas or government-targeted redevelopment areas or would receive consideration as a “qualified investment” under the CRA regulations. With the expanded examples of qualifying investments, it becomes increasingly important that the bank be able to readily demonstrate that the investment meets the criteria for an eligible investment under part 24. Where a bank relies on an investment being a “qualified investment” under the CRA regulations in order to be <PRTPAGE P="48775"/>eligible under part 24, this means that the bank's records of its part 24 investment must clearly support the investment as a “qualified investment” under the standards of the CRA regulations. The final rule therefore amends § 24.7(b) to emphasize that a national bank “maintain in its files information adequate to demonstrate that its investments meet the standards set out in § 24.3 and that the bank is otherwise in compliance with the requirements of this part.” </P>
        <HD SOURCE="HD2">Conforming Amendments </HD>
        <P>As we have explained, the proposal changes the definition of “community development corporation” to “community and economic development entity” to better reflect the range of investment vehicles that may be used for making part 24 investments. The final rule revises the title of part 24 to reflect this change. Thus, the title of the final rule is “Community and Economic Development Entities, Community Development Projects, and Other Public Welfare Investments.” </P>
        <P>The final rule also revises the authority statement of the rule (§ 24.1) to refer to “community and economic development entities” rather than “community development corporations.” </P>
        <HD SOURCE="HD1">Regulatory Flexibility Act Analysis </HD>

        <P>Pursuant to section 605(b) of the Regulatory Flexibility Act, 5 U.S.C. 605(b) (RFA), the regulatory flexibility analysis otherwise required under section 604 of the RFA is not required if the agency certifies that the rule will not have a significant economic impact on a substantial number of small entities and publishes its certification and a short, explanatory statement in the <E T="04">Federal Register</E> along with its rule. </P>
        <P>Pursuant to section 605(b) of the RFA, the OCC hereby certifies that this rulemaking will not have a significant economic impact on a substantial number of small entities. The OCC has reviewed the impact this final rule will have on small national banks. For purposes of this Regulatory Flexibility Analysis and final rule, the OCC defines “small national banks” to be those banks with less than $150 million in total assets. Based on that review, the OCC certifies that the final rule will not have a significant economic impact on a substantial number of small entities. The final rule would reduce regulatory burden on all national banks by simplifying the requirements and procedures applicable to part 24 investments. The economic impact of this final rule on national banks, regardless of size, is not expected to be significant, though some national banks may benefit from a modest reduction in compliance costs. Accordingly, a regulatory flexibility analysis is not needed. </P>
        <HD SOURCE="HD1">Executive Order 12866</HD>
        <P>The OCC has determined that this final rule is not a significant regulatory action under Executive Order 12866.</P>
        <HD SOURCE="HD1">Unfunded Mandates Reform Act of 1995</HD>
        <P>Section 202 of the Unfunded Mandates Reform Act of 1995, Pub. L. 104-4 (2 U.S.C. 1532) (Unfunded Mandates Act), requires that an agency prepare a budgetary impact statement before promulgating any rule likely to result in a federal mandate that may result in the expenditure by state, local, and tribal governments, in the aggregate, or by the private sector of $100 million or more in any one year. If a budgetary impact statement is required, section 205 of the Unfunded Mandates Act also requires an agency to identify and consider a reasonable number of regulatory alternatives before promulgating a rule. The OCC has determined that the final rule will not result in expenditures by state, local, and tribal governments, or by the private sector, of $100 million or more in any one year. Accordingly, this rulemaking requires no further analysis under the Unfunded Mandates Act.</P>
        <HD SOURCE="HD1">Paperwork Reduction Act</HD>
        <P>In accordance with the requirements of the Paperwork Reduction Act of 1995, the OCC may not conduct or sponsor, and a respondent is not required to respond to, an information collection unless it displays a currently valid Office of Management and Budget (OMB) control number.</P>
        <P>The information collection requirements contained in the notice of proposed rulemaking (68 FR 1394, January 10, 2003) were submitted to OMB for review and approved by OMB under OMB Control Number 1557-0194.</P>
        <P>The OCC solicited comments for 60 days on the information collection requirements contained notice of proposed rulemaking. The OCC received no comments.</P>
        <P>The revisions of the information collections contained in the final rule are unchanged from the proposed rule and are expected to reduce annual paperwork burden for respondents because it eliminates certain application and notification requirements. The information collection requirements in this final rule are contained in §§ 24.5(a) and 24.5(b). Section 24.5(a) requires a national bank to submit an after-the-fact notice of public welfare investments to the OCC. The time per response to complete an after-the-fact notice is estimated to be 1.5 hours and the number of respondents is estimated to be 195 national banks. Section 24.5(b) requires a national bank to submit an investment proposal to the OCC if the bank does not meet the requirements for after-the-fact notification. The time per response to complete an investment proposal is estimated to be 1.5 hours and the number of respondents is estimated to be 22.</P>
        <P>Section 24.5(a)(4) contains an existing requirement for certain national banks to submit a letter requesting authority to submit after-the-fact notices of their investments. The time per response is approximately 30 minutes and the number of respondents is estimated to be four.</P>
        <P>The likely respondents are national banks.</P>
        <P>
          <E T="03">Estimated number of respondents:</E> 221 hours.</P>
        <P>
          <E T="03">Estimated number of responses:</E> 221 responses.</P>
        <P>
          <E T="03">Estimated total burden hours:</E> 327.5 hours.</P>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects in 12 CFR Part 24</HD>
          <P>Community development, Credit, Investments, National banks, Reporting and recordkeeping requirements.</P>
        </LSTSUB>
        <REGTEXT PART="24" TITLE="12">
          <HD SOURCE="HD1">Authority and Issuance</HD>
          <AMDPAR>For the reasons set forth in the preamble, the OCC amends part 24 of chapter I of title 12 of the Code of Federal Regulations as follows:</AMDPAR>
          <AMDPAR>1. Revise the part heading of part 24 to read as follows:</AMDPAR>
          <PART>
            <HD SOURCE="HED">PART 24—COMMUNITY AND ECONOMIC DEVELOPMENT ENTITIES, COMMUNITY DEVELOPMENT PROJECTS, AND OTHER PUBLIC WELFARE INVESTMENTS</HD>
          </PART>
        </REGTEXT>
        <REGTEXT PART="24" TITLE="12">
          <AMDPAR>2. The authority citation for part 24 continues to read as follows:</AMDPAR>
          <AUTH>
            <HD SOURCE="HED">Authority:</HD>
            <P>12 U.S.C. 24 (Eleventh), 93a, 481 and 1818.</P>
          </AUTH>
          
        </REGTEXT>
        <REGTEXT PART="24" TITLE="12">
          <AMDPAR>3. In part 24, revise all references to “community development corporation” and “CDC” to read “community and economic development entity” and “CEDE,” respectively.</AMDPAR>
        </REGTEXT>
        <REGTEXT PART="24" TITLE="12">
          <AMDPAR>4. In § 24.2, revise paragraphs (c) and (h) to read as follows:</AMDPAR>
          <SECTION>
            <SECTNO>§ 24.2 </SECTNO>
            <SUBJECT>Definitions.</SUBJECT>
            <STARS/>
            <P>(c) <E T="03">Community and economic development entity</E> (CEDE) means an entity that makes investments or conducts activities that primarily <PRTPAGE P="48776"/>benefit low- and moderate-income individuals, low- and moderate-income areas, or other areas targeted by a governmental entity for redevelopment, or would receive consideration as “qualified investments” under 12 CFR 25.23. The following is a non-exclusive list of examples of the types of entities that may be CEDEs:</P>
            <P>(1) National bank community development corporation subsidiaries;</P>
            <P>(2) Private or nonbank community development corporations;</P>
            <P>(3) CDFI Fund-certified Community Development Financial Institutions or Community Development Entities;</P>
            <P>(4) Limited liability companies or limited partnerships;</P>
            <P>(5) Community development loan funds or lending consortia;</P>
            <P>(6) Community development real estate investment trusts;</P>
            <P>(7) Business development companies;</P>
            <P>(8) Community development closed-end mutual funds;</P>
            <P>(9) Non-diversified closed-end investment companies; and</P>
            <P>(10) Community development venture or equity capital funds.</P>
            <STARS/>
            <P>(h) <E T="03">Small business</E> means a business, including a small farm or minority-owned small business, that meets the qualifications for Small Business Administration Development Company or Small Business Investment Company loan programs in 13 CFR 121.301.</P>
          </SECTION>
        </REGTEXT>
        <REGTEXT PART="24" TITLE="12">
          <AMDPAR>5. Revise § 24.3 to read as follows:</AMDPAR>
          <SECTION>
            <SECTNO>§ 24.3 </SECTNO>
            <SUBJECT>Public welfare investments.</SUBJECT>
            <P>A national bank may make an investment under this part if the investment primarily benefits low- and moderate-income individuals, low- and moderate-income areas, or other areas targeted by a governmental entity for redevelopment, or the investment would receive consideration under 12 CFR 25.23 as a “qualified investment.”</P>
          </SECTION>
        </REGTEXT>
        <REGTEXT PART="24" TITLE="12">
          <AMDPAR>6. In § 24.4, revise paragraph (a) to read as follows:</AMDPAR>
          <SECTION>
            <SECTNO>§ 24.4</SECTNO>
            <SUBJECT>Investment limits.</SUBJECT>
            <P>(a) <E T="03">Limits on aggregate outstanding investments.</E> A national bank's aggregate outstanding investments under this part may not exceed 5 percent of its capital and surplus, unless the bank is at least adequately capitalized and the OCC determines, by written approval of the bank's proposed investment pursuant to § 24.5(b), that a higher amount will pose no significant risk to the deposit insurance fund. In no case may a bank's aggregate outstanding investments under this part exceed 10 percent of its capital and surplus. When calculating the aggregate amount of its aggregate outstanding investments under this part, a national bank should follow generally accepted accounting principles, unless otherwise directed or permitted in writing by the OCC for prudential or safety and soundness reasons.</P>
            <STARS/>
          </SECTION>
        </REGTEXT>
        <REGTEXT PART="24" TITLE="12">
          <AMDPAR>7. In § 24.5:</AMDPAR>
          <AMDPAR>a. Revise the section heading;</AMDPAR>
          <AMDPAR>b. Revise paragraph (a) and;</AMDPAR>
          <AMDPAR>c. Revise paragraphs (b)(1) and (b)(2) to read as follows:</AMDPAR>
          <SECTION>
            <SECTNO>§ 24.5 </SECTNO>
            <SUBJECT>Public welfare investment after-the-fact notice and prior approval procedures.</SUBJECT>
            <P>(a) <E T="03">After-the-fact notice of public welfare investments.</E> (1) Subject to § 24.4(a), an eligible bank may make an investment authorized by 12 U.S.C. 24 (Eleventh) and this part without prior notification to, or approval by, the OCC if the bank follows the after-the-fact notice procedures described in this section.</P>
            <P>(2) An eligible bank shall provide an after-the-fact notification of an investment, within 10 working days after it makes the investment, to the Director, Community Development Division, Office of the Comptroller of the Currency, Washington, DC 20219.</P>
            <P>(3) The bank's after-the-fact-notice must include:</P>
            <P>(i) A description of the bank's investment;</P>
            <P>(ii) The amount of the investment;</P>
            <P>(iii) The percentage of the bank's capital and surplus represented by the investment that is the subject of the notice and by the bank's aggregate outstanding public welfare investments and commitments, including the investment that is the subject of the notice; and</P>
            <P>(iv) A statement certifying that the investment complies with the requirements of §§ 24.3 and 24.4.</P>
            <P>(4) A bank may satisfy the notice requirements of paragraph (3) of this section by completing form CD-1, attached as Appendix 1 to this part.</P>
            <P>(5) A national bank that is not an eligible bank but that is at least adequately capitalized, and has a composite rating of at least 3 with improving trends under the Uniform Financial Institutions Rating System, may submit a letter to the Community Development Division requesting authority to submit after-the-fact notices of its investments. The Community Development Division considers these requests on a case-by-case basis.</P>
            <P>(6) Notwithstanding the provisions of this section, a bank may not submit an after-the-fact notice of an investment if:</P>
            <P>(i) The investment involves properties carried on the bank's books as “other real estate owned”; or</P>
            <P>(ii) The OCC determines, in published guidance, that the investment is inappropriate for after-the-fact notice.</P>
            <P>(b) <E T="03">Investments requiring prior approval.</E> (1) If a national bank does not meet the requirements for after-the-fact investment notification set forth in this part, the bank must submit an investment proposal to the Director, Community Development Division, Office of the Comptroller of the Currency, Washington, DC 20219. The bank may use form CD-1, attached to this part as Appendix 1, to satisfy this requirement.</P>
            <P>(2) The bank's investment proposal must include:</P>
            <P>(i) A description of the bank's investment;</P>
            <P>(ii) The amount of the investment;</P>
            <P>(iii) The percentage of the bank's capital and surplus represented by the proposed investment and by the bank's aggregate outstanding public welfare investments and commitments, including the proposed investment; and</P>
            <P>(iv) A statement certifying that the investment complies with the requirements of §§ 24.3 and 24.4.</P>
          </SECTION>
        </REGTEXT>
        <REGTEXT PART="24" TITLE="12">
          <STARS/>
          <AMDPAR>8. Revise § 24.6 to read as follows:</AMDPAR>
          <SECTION>
            <SECTNO>§ 24.6</SECTNO>
            <SUBJECT>Examples of qualifying public welfare investments.</SUBJECT>
            <P>Investments that primarily support the following types of activities are examples of investments that meet the requirements of § 24.3: </P>
            <P>(a) Affordable housing activities, including: </P>
            <P>(1) Investments in an entity that finances, acquires, develops, rehabilitates, manages, sells, or rents housing primarily for low- and moderate-income individuals; </P>
            <P>(2) Investments in a project that develops or operates transitional housing for the homeless; </P>
            <P>(3) Investments in a project that develops or operates special needs housing for disabled or elderly low- and moderate-income individuals; and </P>
            <P>(4) Investments in a project that qualifies for the Federal low-income housing tax credit; </P>
            <P>(b) Economic development and job creation investments, including: </P>
            <P>(1) Investments that finance small businesses (including equity or debt financing and investments in an entity that provides loan guarantees) that are located in low- and moderate-income areas or other targeted redevelopment areas or that produce or retain permanent jobs, the majority of which are held by low- and moderate-income individuals; </P>

            <P>(2) Investments that finance small businesses or small farms that, although <PRTPAGE P="48777"/>not located in low- and moderate-income areas or targeted redevelopment areas, create a significant number of permanent jobs for low- or moderate-income individuals; </P>
            <P>(3) Investments in an entity that acquires, develops, rehabilitates, manages, sells, or rents commercial or industrial property that is located in a low- and moderate-income area or targeted redevelopment area and occupied primarily by small businesses, or that is occupied primarily by small businesses that produce or retain permanent jobs, the majority of which are held by low- and moderate-income individuals; and </P>
            <P>(4) Investments in low- and moderate-income areas or targeted redevelopment areas that produce or retain permanent jobs, the majority of which are held by low- and moderate-income individuals; </P>
            <P>(c) Investments in CEDEs, including: </P>
            <P>(1) Investments in a national bank that has been approved by the OCC as a national bank with a community development focus; </P>
            <P>(2) Investments in a community development financial institution, as defined in 12 U.S.C. 4742(5); </P>
            <P>(3) Investments in a CEDE that is eligible to receive New Markets tax credits under 26 U.S.C. 45D; and </P>
            <P>(d) Other public welfare investments, including: </P>
            <P>(1) Investments that provide credit counseling, job training, community development research, and similar technical assistance services for non-profit community development organizations, low- and moderate-income individuals or areas or targeted redevelopment areas, or small businesses located in low- and moderate-income areas or that produce or retain permanent jobs, the majority of which are held by low- and moderate-income individuals; </P>
            <P>(2) Investments of a type approved by the Federal Reserve Board under 12 CFR 208.22 for state member banks that are consistent with the requirements of § 24.3; and </P>
            <P>(3) Investments of a type previously determined by the OCC to be permissible under this part.</P>
          </SECTION>
        </REGTEXT>
        <REGTEXT PART="24" TITLE="12">
          <AMDPAR>9. In § 24.7, revise paragraph (b) to read as follows: </AMDPAR>
          <SECTION>
            <SECTNO>§ 24.7 </SECTNO>
            <SUBJECT>Examination, records, and remedial action. </SUBJECT>
            <P>(a) * * * </P>
            <P>(b) <E T="03">Records.</E> Each national bank shall maintain in its files information adequate to demonstrate that its investments meet the standards set out in § 24.3 of this part, including, where applicable, the criteria of 12 C.F.R. 25.23, and that the bank is otherwise in compliance with the requirements of this part. </P>
            <STARS/>
          </SECTION>
        </REGTEXT>
        <REGTEXT PART="24" TITLE="12">
          <AMDPAR>10. Appendix 1 is added to read as follows: </AMDPAR>
          <BILCOD>BILLING CODE 4810-33-P</BILCOD>
          
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="48778"/>
            <GID>ER15AU03.060</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="48779"/>
            <GID>ER15AU03.061</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="48780"/>
            <GID>ER15AU03.062</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="48781"/>
            <GID>ER15AU03.063</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="48782"/>
            <GID>ER15AU03.064</GID>
          </GPH>
        </REGTEXT>
        <SIG>
          <PRTPAGE P="48783"/>
          <DATED>Dated: July 10, 2003. </DATED>
          <NAME>John D. Hawke, Jr., </NAME>
          <TITLE>Comptroller of the Currency. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20801 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4810-33-C</BILCOD>
    </RULE>
    <RULE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF TRANSPORTATION </AGENCY>
        <SUBAGY>Federal Aviation Administration </SUBAGY>
        <CFR>14 CFR Part 39 </CFR>
        <DEPDOC>[Docket No. 2001-NM-322-AD; Amendment 39-13221; AD 2003-14-02 R1] </DEPDOC>
        <RIN>RIN 2120-AA64 </RIN>
        <SUBJECT>Airworthiness Directives; Bombardier Model CL-600-2B19 (Regional Jet Series 100 &amp; 440) Airplanes </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Federal Aviation Administration, DOT. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Final rule; correction. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This document corrects information in an existing airworthiness directive (AD) that applies to certain Bombardier Model CL-600-2B19 (Regional Jet series 100 &amp; 440) airplanes. That AD currently requires a one-time inspection of the aft edge of the left and right main windshields to determine whether a certain placard is installed, and corrective actions if necessary. This document corrects several incorrect references to the affected airplane models. This correction is necessary to ensure that model designations are specified as published in the most recent type certificate data sheet for the affected models. </P>
        </SUM>
        <EFFDATE>
          <HD SOURCE="HED">DATES:</HD>
          <P>Effective August 14, 2003. </P>
          <P>The incorporation by reference of Bombardier Service Bulletin 601R-56-004, dated August 16, 2001, as listed in the regulations, was approved previously by the Director of the Federal Register as of August 14, 2003 (68 FR 41059, July 10, 2003). </P>
        </EFFDATE>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Serge Napoleon, Aerospace Engineer, Airframe and Propulsion Branch, ANE-171, FAA, New York Aircraft Certification Office, 10 Fifth Street, Third Floor, Valley Stream, New York 11581; telephone (516) 256-7512; fax (516) 568-2716. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>On July 1, 2003, the Federal Aviation Administration (FAA) issued airworthiness directive (AD) 2003-14-02, amendment 39-13221 (68 FR 41059, July 10, 2003), which applies to certain Bombardier Model CL-600-2B19 (Regional Jet series 100 &amp; 440) airplanes. That AD requires a one-time inspection of the aft edge of the left and right main windshields to determine whether a certain placard is installed, and corrective actions if necessary. That AD was prompted by a significant number of cracking incidents that occurred in the inner and middle panes of the main windshields during taxi, takeoff, climb, cruise, and descent of the airplane. The actions required by that AD are intended to prevent stress-related cracking of the windshields, and subsequent excessive frequency of abnormal procedures specified in the airplane flight manual and/or an emergency descent be accomplished, which poses an increased risk to passengers and crew members. </P>
        <HD SOURCE="HD1">Need for the Correction </HD>
        <P>As published, that AD contains several incorrect references to the affected airplane models. As discussed in the preamble of that AD, we intended to revise the applicability of the final rule to identify model designations as published in the most recent type certificate data sheet. However, Regional Jet series “400,” which does not exist, was inadvertently indicated in several references instead of the correct model designation Regional Jet series “440.” The correct model designation (Bombardier Model CL-600-2B19 (Regional Jet Series 100 &amp; 440) airplanes) was listed in the title of the AD. </P>
        <P>The FAA has determined that a correction to AD 2003-14-02 is necessary. The correction will properly specify model designations as published in the most recent type certificate data sheet for the affected models. </P>
        <HD SOURCE="HD1">Correction of Publication </HD>
        <P>This document corrects the error and correctly adds the AD as an amendment to section 39.13 of the Federal Aviation Regulations (14 CFR 39.13). </P>
        <P>The AD is reprinted in its entirety with the changes incorporated for the convenience of affected operators. The effective date of the AD remains August 14, 2003. </P>
        <P>Since this action only specifies model designations as published in the most recent type certificate data sheet for the affected models, it has no adverse economic impact and imposes no additional burden on any person. Therefore, the FAA has determined that notice and public procedures are unnecessary. </P>
        <HD SOURCE="HD1">Restatement of Supplemental Information Section of AD 2003-14-02 </HD>

        <P>A proposal to amend part 39 of the Federal Aviation Regulations (14 CFR part 39) to include an AD that is applicable to certain Bombardier Model CL-600-2B19 series airplanes was published in the <E T="04">Federal Register</E> on May 20, 2002 (67 FR 35461). That action proposed to require a one-time inspection of the aft edge of the left and right main windshields to determine whether a certain placard is installed, and corrective actions if necessary. </P>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects in 14 CFR Part 39 </HD>
          <P>Air transportation, Aircraft, Aviation safety, Incorporation by reference, Safety.</P>
        </LSTSUB>
        <REGTEXT PART="39" TITLE="14">
          <HD SOURCE="HD1">Adoption of the Correction </HD>
          <AMDPAR>Accordingly, pursuant to the authority delegated to me by the Administrator, the Federal Aviation Administration amends part 39 of the Federal Aviation Regulations (14 CFR part 39) as follows: </AMDPAR>
          <PART>
            <HD SOURCE="HED">PART 39—AIRWORTHINESS DIRECTIVES </HD>
          </PART>
          <AMDPAR>1. The authority citation for part 39 continues to read as follows: </AMDPAR>
          <AUTH>
            <HD SOURCE="HED">Authority:</HD>
            <P>49 U.S.C. 106(g), 40113, 44701. </P>
          </AUTH>
          
          <SECTION>
            <SECTNO>§ 39.13 </SECTNO>
            <SUBJECT>[Corrected] </SUBJECT>
          </SECTION>
        </REGTEXT>
        <REGTEXT PART="39" TITLE="14">
          <AMDPAR>2. Section 39.13 is amended by correctly adding the following airworthiness directive (AD): </AMDPAR>
          
          <EXTRACT>
            <FP SOURCE="FP-2">
              <E T="04">AD 2003-14-02 R1 Bombardier, Inc.</E> (Formerly Canadair): Amendment 39-13221. Docket 2001-NM-322-AD. </FP>
            
            <P>
              <E T="03">Applicability:</E> Model CL-600-2B19 (Regional Jet series 100 &amp; 440) airplanes; certificated in any category; serial numbers 7003 and subsequent; equipped with main windshield units, part numbers 601R33033-1, -2, -5, -6, -9, or -10. </P>
            <P>Compliance: Required as indicated, unless accomplished previously. </P>
            <NOTE>
              <HD SOURCE="HED">Note 1:</HD>
              <P>This AD applies to each airplane identified in the preceding applicability provision, regardless of whether it has been modified, altered, or repaired in the area subject to the requirements of this AD. For airplanes that have been modified, altered, or repaired so that the performance of the requirements of this AD is affected, the owner/operator must request approval for an alternative method of compliance in accordance with paragraph (b) of this AD. The request should include an assessment of the effect of the modification, alteration, or repair on the unsafe condition addressed by this AD; and, if the unsafe condition has not been eliminated, the request should include specific proposed actions to address it. </P>
            </NOTE>
            <P>
              <E T="03">Compliance:</E> Required as indicated, unless accomplished previously. </P>

            <P>To prevent stress-related cracking of the windshields, and subsequent excessive frequency of abnormal procedures specified in the airplane flight manual and/or an emergency descent be accomplished, which poses an increased risk to passengers and crew members; accomplish the following: <PRTPAGE P="48784"/>
            </P>
            <HD SOURCE="HD1">Inspection and Corrective Action </HD>
            <P>(a) For airplanes equipped with windshield units that have accumulated fewer than 2,500 total flight cycles as of the effective date of this AD: Within 6 months after 3 the effective date of this AD, accomplish a one-time general visual inspection of the aft edges of the left and right main windshields to determine whether a placard having part number (P/N) CSB-NP-139321-002-1 is installed, per the Accomplishment Instructions of Bombardier Service Bulletin 601R-56-004, dated August 16, 2001. </P>
            <P>(1) If a placard having P/N CSB-NP-139321-002-1 is installed, no further action is required by this AD. </P>
            <P>(2) If a placard having a P/N other than CSB-NP-139321-002-1 is installed, before further flight, accomplish the corrective actions (including modifying the main windshields by replacing nine of the hi-lok pins installed in the lower forward corner of the windshields with hi-lok pins having a reduced diameter shank, installing a placard having the correct P/N on the inner retainer near the part identification placard located along the aft edge of the window, and replacing any torn or deformed gasket), per the Accomplishment Instructions of the service bulletin. </P>
            <NOTE>
              <HD SOURCE="HED">Note 2:</HD>
              <P>For the purposes of this AD, a general visual inspection is defined as: “A visual examination of an interior or exterior area, installation, or assembly to detect obvious damage, failure, or irregularity. This level of inspection is made from within touching distance unless otherwise specified. A mirror may be necessary to enhance visual access to all exposed surfaces in the inspection area. This level of inspection is made under normally available lighting conditions such as daylight, hangar lighting, flashlight, or droplight and may require removal or opening of access panels or doors. Stands, ladders, or platforms may be required to gain proximity to the area being checked.” </P>
            </NOTE>
            <NOTE>
              <HD SOURCE="HED">Note 3:</HD>
              <P>Bombardier Service Bulletin 601R-56-004, dated August 16, 2001, references PPG Industries, Inc., Service Bulletin CSB-NP-139321-002, Revision C, dated July 31, 2001, as an additional source of service information for accomplishment of the modification of the left and right main windshields. </P>
            </NOTE>4 <HD SOURCE="HD1">Alternative Methods of Compliance </HD>
            <P>(b) An alternative method of compliance or adjustment of the compliance time that provides an acceptable level of safety may be used if approved by the Manager, New York Aircraft Certification Office (ACO), FAA. Operators shall submit their requests through an appropriate FAA Principal Maintenance Inspector, who may add comments and then send it to the Manager, New York ACO. </P>
            <NOTE>
              <HD SOURCE="HED">Note 4:</HD>
              <P>Information concerning the existence of approved alternative methods of compliance with this AD, if any, may be obtained from the New York ACO. </P>
            </NOTE>
            <HD SOURCE="HD1">Special Flight Permit </HD>
            <P>(c) Special flight permits may be issued in accordance with sections 21.197 and 21.199 of the Federal Aviation Regulations (14 CFR 21.197 and 21.199) to operate the airplane to a location where the requirements of this AD can be accomplished. </P>
            <HD SOURCE="HD1">Incorporation by Reference </HD>

            <P>(d) The actions shall be done in accordance with Bombardier Service Bulletin 601R-56-004, dated August 16, 2001. The incorporation by reference of that document was approved previously by the Director of the Federal Register as of August 14, 2003 (68 FR 41059, July 10, 2003). Copies may be obtained from Bombardier, Inc., Canadair, Aerospace Group, PO Box 6087, Station Centre-ville, Montreal, Quebec H3C 3G9, Canada. Copies may be inspected at the FAA, Transport Airplane Directorate, 1601 Lind Avenue, SW., Renton, Washington; or at the FAA, New York Aircraft Certification Office, 10 Fifth Street, Third Floor, Valley Stream, New York; or at the <E T="03">Office of the Federal Register</E>, 800 North Capitol Street, NW., suite 700, Washington, DC. </P>
            <NOTE>
              <HD SOURCE="HED">Note 5:</HD>
              <P>The subject of this AD is addressed in Canadian airworthiness directive CF-2001-35R1, dated September 27, 2001.</P>
            </NOTE>
            <HD SOURCE="HD1">Effective Date </HD>
            <P>(e) The effective date of this amendment remains August 11, 2003. </P>
          </EXTRACT>
        </REGTEXT>
        <SIG>
          <DATED>Issued in Renton, Washington, on August 11, 2003. </DATED>
          <NAME>Neil D. Schalekamp, </NAME>
          <TITLE>Acting Manager, Transport Airplane Directorate, Aircraft Certification Service. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20834 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4910-13-P</BILCOD>
    </RULE>
    <RULE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF HEALTH AND HUMAN SERVICES</AGENCY>
        <SUBAGY>Food and Drug Administration</SUBAGY>
        <CFR>21 CFR Part 522</CFR>
        <SUBJECT>Implantation or Injectable Dosage Form New Animal Drugs; Trenbolone and Estradiol</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Food and Drug Administration, HHS.</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Final rule.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental abbreviated new animal drug application (ANADA) filed by Ivy Laboratories, Division of Ivy Animal Health, Inc.  The supplemental ANADA provides for an additional dose of trenbolone acetate and estradiol implant for use in feedlot steers for increased rate of weight gain and improved feed efficiency.</P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>This rule is effective August 15, 2003.</P>
        </DATES>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>

          <P>Lonnie W. Luther, Center for Veterinary Medicine (HFV-104), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 301-827-8549, e-mail: <E T="03">lluther@cvm.fda.gov</E>.</P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>Ivy Laboratories, Division of Ivy Animal Health, Inc., 8857 Bond St., Overland Park, KS 66214, filed a supplement to ANADA 200-346.  The supplemental ANADA provides for the use of COMPONENT TE-200 (trenbolone acetate and estradiol), a subcutaneous implant containing 200 milligrams (mg) trenbolone acetate and 20 mg estradiol in steers fed in confinement for slaughter for increased rate of weight gain and improved feed efficiency.  Ivy Laboratories' COMPONENT TE-200 is approved as a generic copy of Intervet, Inc.'s REVALOR-200, approved under NADA 140-992.  The application is approved as of April 21, 2003, and the regulations are amended in 21 CFR 522.2477 to reflect the approval.  The basis of approval is discussed in the freedom of information summary.</P>
        <P>In accordance with the freedom of information provisions of 21 CFR part 20 and 21 CFR 514.11(e)(2)(ii), a summary of safety and effectiveness data and information submitted to support approval of this application may be seen in the Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852, between 9 a.m. and 4 p.m., Monday through Friday.</P>
        <P>The agency has determined under 21 CFR 25.33(a)(1) that this action is of a type that does not individually or cumulatively have a significant effect on the human environment.  Therefore, neither an environmental assessment nor an environmental impact statement is required.</P>
        <P>This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.”  Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.</P>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects in 21 CFR Part 522</HD>
          <P>Animal drugs.</P>
        </LSTSUB>
        <REGTEXT PART="522" TITLE="21">
          <AMDPAR>Therefore, under the Federal Food, Drug, and Cosmetic Act and under the authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 522 is amended as follows:</AMDPAR>
          <PART>
            <HD SOURCE="HED">PART 522—IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS</HD>
          </PART>
        </REGTEXT>
        <REGTEXT PART="522" TITLE="21">
          <AMDPAR>1.  The authority citation for 21 CFR part 522 continues to read as follows:</AMDPAR>
          <AUTH>
            <HD SOURCE="HED">Authority:</HD>
            <P>21 U.S.C. 360b.</P>
          </AUTH>
          <SECTION>
            <PRTPAGE P="48785"/>
            <SECTNO>§ 522.2477</SECTNO>
            <SUBJECT>[Amended]</SUBJECT>
          </SECTION>
          <AMDPAR>2.  Section 522.2477 <E T="03">Trenbolone acetate and estradiol</E> is amended in paragraph (b)(1) by adding “(d)(1)(i)(C),” after “(d)(1)(i)(B),”.</AMDPAR>
        </REGTEXT>
        <SIG>
          <DATED>Dated: August 1, 2003.</DATED>
          <NAME>Stephen F. Sundlof,</NAME>
          <TITLE>Director, Center for Veterinary Medicine.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20797 Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 4160-01-S</BILCOD>
    </RULE>
    <RULE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF THE TREASURY </AGENCY>
        <SUBAGY>Internal Revenue Service </SUBAGY>
        <CFR>26 CFR Part 300 </CFR>
        <DEPDOC>[TD 9086] </DEPDOC>
        <RIN>RIN 1545-BA54 </RIN>
        <SUBJECT>User Fees for Processing Offers To Compromise </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Internal Revenue Service (IRS), Treasury. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Final regulations. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This document contains amendments to the regulations relating to user fees to provide for the imposition of user fees for the processing of offers to compromise. The charging of user fees implements the Independent Offices Appropriations Act. </P>
        </SUM>
        <EFFDATE>
          <HD SOURCE="HED">EFFECTIVE DATE:</HD>
          <P>November 1, 2003. </P>
        </EFFDATE>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Concerning cost methodology, Eva Williams, 301-492-5395; concerning the regulations, G. William Beard, 202-622-3620 (not toll free numbers). </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P/>
        <HD SOURCE="HD1">Background </HD>

        <P>This document amends the regulations relating to user fees to provide for the imposition of user fees for the processing of offers to compromise. The charging of user fees implements the Independent Offices Appropriations Act (IOAA), which is codified at 31 U.S.C. 9701. On November 6, 2002, a notice of proposed rulemaking (REG-103777-02) was published in the <E T="04">Federal Register</E>. Approximately 149 comments were received. A public hearing on the regulations was held on February 13, 2003. The final regulations adopt the rules of the proposed regulations. </P>
        <HD SOURCE="HD1">Offers To Compromise </HD>
        <P>Section 7122 of the Internal Revenue Code (Code) gives the IRS the authority to compromise any civil or criminal case arising under the internal revenue laws, prior to the referral of that case to the Department of Justice. Section 7122 also directs the IRS to prescribe guidelines for officers and employees of the IRS to determine whether an offer to compromise is adequate and should be accepted. Guidelines are contained in § 301.7122-1. Pursuant to § 301.7122-1(b), an offer may be accepted if there is doubt as to liability, if there is doubt as to collectibility, or if acceptance will promote effective tax administration. Pursuant to § 301.7122-1(b)(3), offers may be accepted to promote effective tax administration if either: (1) The IRS determines that, although collection in full could be achieved, collection of the full liability would cause the taxpayer economic hardship within the meaning of § 301.6343-1, or (2) there are no other grounds for compromise and there are compelling public policy or equity considerations. </P>
        <P>When an offer to compromise is received, an initial determination is made as to whether the offer is processable. Currently, an offer is returned as nonprocessable if the taxpayer is in bankruptcy, has not filed required tax returns, or has not submitted the offer to compromise on the proper form. Absent these conditions, the offer is accepted for processing and cannot be rejected without an independent administrative review of the decision to reject and, if the taxpayer chooses to appeal the rejection, independent review by the Office of Appeals. Even though an offer accepted for processing may later be returned to the taxpayer if the taxpayer fails to provide requested information or the IRS determines that the offer was submitted solely to delay collection, such an offer may not be returned before a managerial review of the proposed return is completed pursuant to § 301.7122-1(f)(5)(ii). </P>
        <HD SOURCE="HD1">Explanation of Provisions </HD>
        <P>The final regulations establish a $150 user fee for the processing of certain offers to compromise tax liabilities pursuant to § 301.7122-1. The user fee will not apply to offers based solely on doubt as to liability and offers made by low income taxpayers whose incomes are at or below the poverty guidelines set by the Department of Health and Human Services (DHHS), or such other measure the IRS may adopt. </P>
        <P>Offers based on doubt as to liability are excepted from the user fee based on the inequity of the IRS charging a fee to compromise an uncertain liability when a compromise is based upon a redetermination or reevaluation of the taxpayer's liability for a tax (and the agreed upon amount may, in fact, provide for the full payment of the amount actually owed). </P>
        <P>Offers from low income taxpayers are excepted from the fee in light of section 7122(c)(3)(A), which prohibits the IRS from rejecting an offer from a low income taxpayer solely on the basis of the amount offered. Section 7122(c)(3)(A) literally applies to the rejection of an offer, rather than the return of an offer for failure to pay a user fee. Requiring payment of a user fee from a low income taxpayer would undermine section 7122(c)(3)(A) in cases where the taxpayer does not have the ability to pay the fee. Offers from low income taxpayers are therefore excepted. </P>
        <P>Taxpayers with offers that do not fall within the doubt as to liability or low income exceptions will submit the user fee along with the offer to compromise. If the offer is accepted to promote effective tax administration or is accepted based on doubt as to collectibility and a determination that collecting more than the amount offered would create economic hardship within the meaning of §§ 301.6343-1, the fee will be applied to the amount of the offer or, if the taxpayer requests, refunded to the taxpayer. In other cases, the payment of the fee will be taken into account in determining the acceptable amount of the offer and therefore the taxpayer in total will pay no more than the taxpayer would have paid without the fee. While the fee will not be refunded if an offer is withdrawn, rejected, or returned as nonprocessable after acceptance for processing, no additional fee will be charged if a taxpayer resubmits an offer the IRS determines to have been rejected or returned in error. </P>
        <HD SOURCE="HD1">Comments on the Proposed Regulation </HD>
        <P>Most of the comments on the proposed regulations did not favor the fee. The comments focused on three concerns: The fee would create an additional financial hardship on taxpayers who are already experiencing hardship; the income level for the low income exception to the fee was too low; and the fee should not be imposed until the offer to compromise is administered more effectively and efficiently. For the following reasons, these final regulations follow the proposed regulations without change. </P>

        <P>The most frequent concern in the comments was that the fee would cause additional financial hardship for taxpayers who are already experiencing financial hardship. The exception for low income taxpayers, however, excludes those taxpayers most likely to be disadvantaged by the user fee. <PRTPAGE P="48786"/>Further, the imposition of the fee on other taxpayers will not change the net amount paid by the taxpayer to reach a compromise; the fee will be taken into account when considering whether the amount offered is acceptable. Although taxpayers who must pay the fee will not receive a refund if the offer is withdrawn, rejected, or returned after being accepted for processing, the IRS will work closely with taxpayers to perfect incomplete or inadequate offers before returning or rejecting them. </P>
        <P>A number of commentators were concerned that the DHHS poverty guidelines used for purposes of the low income exception are too low and recommended that the exception for low income taxpayers should be extended to 250% of the DHHS guidelines. The 250% level corresponds to one of the criteria used for funding low income taxpayer clinics: In order to receive funding pursuant to section 7526 of the Code, 90% of a clinic's clients must fall below 250% of the DHHS poverty level. The commentators pointed to the relationship between section 7526 and offers to compromise. Section 7526 was enacted contemporaneously with section 7122(c)(3), which prohibits the IRS from rejecting an offer from a low income taxpayer based on the amount of the offer. Commentators argued that imposing a user fee on taxpayers whose incomes are within 250% of the poverty level thwarts the objective of section 7526 to assist such taxpayers. </P>
        <P>The DHHS poverty guidelines are retained as the measure of the exception for the low income taxpayer. The 250% criteria in section 7526 only applies for purposes of that section; it does not extend to offers to compromise under section 7122. Had Congress intended to extend the 250% criteria to offers in compromise under section 7122, it could have done so. The DHHS poverty guidelines are a reasonable standard for offers to compromise in light of the fact that the amount of the fee will be reflected in the amount of the offer. Although some taxpayers may not be able to pay the fee because the fee exceeds their collectible assets and income, the DHHS standard will generally cover such taxpayers. Further, the IRS retains the authority under the final regulations to adjust the definition of low income taxpayer. The IRS could, therefore, change the low income standard if, in practice, there are a significant number of taxpayers with incomes above the DHHS standard who are experiencing hardship as a result of the fee. </P>
        <P>A number of commentators urged that the fee should not be imposed until inefficiencies and errors in the processing of offers to compromise are eliminated. In the past year, however, the IRS made substantial improvements to its offer in compromise program and is now able to process offers to compromise much more accurately, effectively and efficiently. The IRS acknowledges that further improvements are needed and is taking steps to achieve greater accuracy and efficiency, but the user fee is an integral part of that effort. The user fee should help reduce the number of frivolous offers and the number of offers that are either withdrawn, returned, or rejected because the offeror would not provide adequate information for the IRS to process the offer or would not offer an amount that reflects the taxpayer's ability to pay. Limiting the number of offers that will be withdrawn, returned, or rejected will enable the IRS to direct its resources towards the timely and efficient processing of acceptable offers. In addition, the final regulation was amended to make clear that no additional fee will be charged if a taxpayer resubmits an offer the IRS determines to have been rejected or returned in error after acceptance for processing. </P>
        <HD SOURCE="HD1">Authority </HD>
        <P>The IOAA authorizes agencies to prescribe regulations that establish charges for services provided by the agency (user fees). The charges must be fair and be based on the costs to the Government, the value of the service to the recipient, the public policy or interest served, and other relevant facts. The IOAA provides that regulations implementing user fees are subject to policies prescribed by the President, which are currently set forth in OMB Circular A-25, 58 FR 38142 (July 15, 1993). </P>
        <P>The OMB Circular encourages user fees for Government-provided services that confer benefits on identifiable recipients over and above those benefits received by the general public. Under the OMB Circular, an agency that seeks to impose a user fee for Government-provided services must calculate its full cost of providing those services. In general, the amount of a user fee should recover the cost of providing the special service, unless the Office of Management and Budget grants an exception. Pursuant to the guidelines in the OMB Circular, the IRS calculated its cost of providing services under the offer in compromise program. The IRS determined that the full cost of investigating doubt as to collectibility and effective tax administration offers averages $471 when streamlined procedures are used to investigate the financial condition of the taxpayer, and $3,983 when more detailed investigations are used. The IRS estimates that 70% of offers are processed under streamlined procedures. OMB granted an exception to the “full cost” requirement of the OMB Circular. </P>
        <P>The Treasury, Postal Service, and General Government Appropriations Act of 1995, Public Law 103-329 (108 Stat. 2382) (the 1995 Appropriations Act) provides that the Secretary may establish new fees for services provided by the IRS where such fees are authorized by another law, such as the IOAA. </P>
        <P>The user fees are implemented under the authority of the IOAA, the OMB Circular, and the 1995 Appropriations Act. </P>
        <HD SOURCE="HD1">Special Analysis </HD>
        <P>It has been determined that this Treasury decision is not a significant regulatory action as defined in Executive Order 12866. Therefore, a regulatory assessment is not required. It is hereby certified that these regulations will not have a significant economic impact on a substantial number of small entities. Accordingly, a regulatory flexibility analysis is not required. This certification is based on the information that follows. The economic impact of these regulations on any small entity will result from the entity being required to pay a fee prescribed by these regulations in order to obtain a particular service. The dollar amount of the fee is not, however, substantial enough to have a significant economic impact on any entity subject to the fee. Pursuant to section 7805(f) of the Code, the preceding notice of proposed rulemaking was submitted to the Chief Counsel for Advocacy of the Small Business Administration for comment on its impact on small business. </P>
        <HD SOURCE="HD1">Drafting Information </HD>
        <P>The principal author of these regulations is G. William Beard, Office of Associate Chief Counsel (Procedure and Administration), Collection, Bankruptcy and Summonses Division. </P>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects in 26 CFR Part 300</HD>
          <P>Estate taxes, Excise taxes, Gift taxes, Income taxes, Reporting and recordkeeping requirements, User fees. </P>
        </LSTSUB>
        <HD SOURCE="HD1">Adoption of Amendments to the Regulations </HD>
        <REGTEXT PART="300" TITLE="26">
          <AMDPAR>Accordingly, 26 CFR part 300 is amended as follows: </AMDPAR>
          <PART>
            <PRTPAGE P="48787"/>
            <HD SOURCE="HED">PART 300—USER FEES </HD>
          </PART>
          <AMDPAR>
            <E T="04">Paragraph 1.</E> The authority citation for part 300 continues to read as follows: </AMDPAR>
          <AUTH>
            <HD SOURCE="HED">Authority:</HD>
            <P>31 U.S.C. 9701.   </P>
          </AUTH>
          
          <AMDPAR>
            <E T="04">Par. 2.</E> Section 300.0 is amended as follows: </AMDPAR>
          <AMDPAR>1. Paragraph (b)(3) is added.</AMDPAR>
          <AMDPAR>2. Paragraph (c) is revised. </AMDPAR>
          <P>The addition and revision read as follows:</P>
          <SECTION>
            <SECTNO>§ 300.0</SECTNO>
            <SUBJECT>User fees; in general. </SUBJECT>
            <STARS/>
            <P>(b) * * * </P>
            <P>(3) Processing an offer to compromise. </P>
            <P>(c) <E T="03">Effective Date.</E> This part 300 is applicable March 16, 1995, except that the user fee for processing offers to compromise is applicable November 1, 2003.</P>
          </SECTION>
        </REGTEXT>
        <REGTEXT PART="300" TITLE="26">
          <AMDPAR>
            <E T="04">Par. 3.</E> Section 300.3 is added to read as follows:</AMDPAR>
          <SECTION>
            <SECTNO>§ 300.3</SECTNO>
            <SUBJECT>Offer to compromise fee. </SUBJECT>
            <P>(a) <E T="03">Applicability.</E> This section applies to the processing of offers to compromise tax liabilities pursuant to § 301.7122-1 of this chapter. Except as provided in this section, this fee applies to all offers to compromise accepted for processing. </P>
            <P>(b) <E T="03">Fee.</E> (1) The fee for processing an offer to compromise is $150.00, except that no fee will be charged if an offer is— </P>
            <P>(i) Based solely on doubt as to liability as defined in § 301.7122-1(b)(1) of this chapter; or </P>

            <P>(ii) Made by a low income taxpayer, that is, an individual who falls at or below the dollar criteria established by the poverty guidelines updated annually in the <E T="04">Federal Register</E> by the U.S. Department of Health and Human Services under authority of section 673(2) of the Omnibus Budget Reconciliation Act of 1981 (95 Stat. 357, 511) or such other measure that is adopted by the Secretary. </P>
            <P>(2) The fee will be applied against the amount of the offer, unless the taxpayer requests that it be refunded, if the offer is— </P>
            <P>(i) Accepted to promote effective tax administration pursuant to § 301.7122-1(b)(3) of this chapter; or </P>
            <P>(ii) Accepted based on doubt as to collectibility and a determination that collection of an amount greater than the amount offered would create economic hardship within the meaning of § 301.6343-1 of this chapter. </P>
            <P>(3) Except as otherwise provided in this paragraph (b), the fee will not be refunded to the taxpayer if the offer is accepted, rejected, withdrawn, or returned as nonprocessable after acceptance for processing. </P>
            <P>(4) No additional fee will be charged if a taxpayer resubmits an offer the Secretary determines to have been rejected in error or returned in error after acceptance for processing. </P>
            <P>(c) <E T="03">Person liable for the fee.</E> The person liable for the processing fee is the taxpayer whose tax liabilities are the subject of the offer.</P>
          </SECTION>
        </REGTEXT>
        <SIG>
          <NAME>Robert E. Wenzel,</NAME>
          <TITLE>Deputy Commissioner for Services and Enforcement.</TITLE>
          <DATED/>
          <APPR>Approved: July 17, 2003. </APPR>
          <NAME>Pamela F. Olsen,</NAME>
          <TITLE>Assistant Secretary of the Treasury (Tax Policy).</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20933 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4830-01-P</BILCOD>
    </RULE>
    <RULE>
      <PREAMB>
        <AGENCY TYPE="N">PENSION BENEFIT GUARANTY CORPORATION</AGENCY>
        <CFR>29 CFR Parts 4022 and 4044</CFR>
        <SUBJECT>Benefits Payable in Terminated Single-Employer Plans; Allocation of Assets in Single-Employer Plans; Interest Assumptions for Valuing and Paying Benefits</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Pension Benefit Guaranty Corporation.</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Final rule.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>

          <P>The Pension Benefit Guaranty Corporation's regulations on Benefits Payable in Terminated Single-Employer Plans and Allocation of Assets in Single-Employer Plans prescribe interest assumptions for valuing and paying benefits under terminating single-employer plans. This final rule amends the regulations to adopt interest assumptions for plans with valuation dates in September 2003. Interest assumptions are also published on the PBGC's Web site (<E T="03">http://www.pbgc.gov</E>).</P>
        </SUM>
        <EFFDATE>
          <HD SOURCE="HED">EFFECTIVE DATE:</HD>
          <P>September 1, 2003.</P>
        </EFFDATE>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Harold J. Ashner, Assistant General Counsel, Office of the General Counsel, Pension Benefit Guaranty Corporation, 1200 K Street NW., Washington, DC 20005, 202-326-4024. (TTY/TDD users may call the Federal relay service toll-free at 1-800-877-8339 and ask to be connected to 202-326-4024.)</P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>The PBGC's regulations prescribe actuarial assumptions—including interest assumptions—for valuing and paying plan benefits of terminating single-employer plans covered by title IV of the Employee Retirement Income Security Act of 1974. The interest assumptions are intended to reflect current conditions in the financial and annuity markets.</P>
        <P>Three sets of interest assumptions are prescribed: (1) A set for the valuation of benefits for allocation purposes under section 4044 (found in appendix B to part 4044), (2) a set for the PBGC to use to determine whether a benefit is payable as a lump sum and to determine lump-sum amounts to be paid by the PBGC (found in appendix B to part 4022), and (3) a set for private-sector pension practitioners to refer to if they wish to use lump-sum interest rates determined using the PBGC's historical methodology (found in appendix C to part 4022).</P>
        <P>Accordingly, this amendment (1) adds to appendix B to part 4044 the interest assumptions for valuing benefits for allocation purposes in plans with valuation dates during September 2003, (2) adds to appendix B to part 4022 the interest assumptions for the PBGC to use for its own lump-sum payments in plans with valuation dates during September 2003, and (3) adds to appendix C to part 4022 the interest assumptions for private-sector pension practitioners to refer to if they wish to use lump-sum interest rates determined using the PBGC's historical methodology for valuation dates during September 2003. </P>
        <P>For valuation of benefits for allocation purposes, the interest assumptions that the PBGC will use (set forth in appendix B to part 4044) will be 4.90 percent for the first 20 years following the valuation date and 5.25 percent thereafter. These interest assumptions represent an increase (from those in effect for August 2003) of 0.50 percent for the first 20 years following the valuation date and are otherwise unchanged.</P>
        <P>The interest assumptions that the PBGC will use for its own lump-sum payments (set forth in appendix B to part 4022) will be 3.50 percent for the period during which a benefit is in pay status and 4.00 percent during any years preceding the benefit's placement in pay status. These interest assumptions represent an increase (from those in effect for August 2003) of 0.50 percent for the period during which a benefit is in pay status and are otherwise unchanged.</P>
        <P>For private-sector payments, the interest assumptions (set forth in appendix C to part 4022) will be the same as those used by the PBGC for determining and paying lump sums (set forth in appendix B to part 4022).</P>

        <P>The PBGC has determined that notice and public comment on this amendment are impracticable and contrary to the public interest. This finding is based on the need to determine and issue new <PRTPAGE P="48788"/>interest assumptions promptly so that the assumptions can reflect, as accurately as possible, current market conditions.</P>
        <P>Because of the need to provide immediate guidance for the valuation and payment of benefits in plans with valuation dates during September 2003, the PBGC finds that good cause exists for making the assumptions set forth in this amendment effective less than 30 days after publication.</P>
        <P>The PBGC has determined that this action is not a “significant regulatory action” under the criteria set forth in Executive Order 12866.</P>
        <P>Because no general notice of proposed rulemaking is required for this amendment, the Regulatory Flexibility Act of 1980 does not apply. See 5 U.S.C. 601(2).</P>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects</HD>
          <CFR>29 CFR Part 4022</CFR>
          <P>Employee benefit plans, Pension insurance, Pensions, Reporting and recordkeeping requirements.</P>
          <CFR>29 CFR Part 4044</CFR>
          <P>Employee benefit plans, Pension insurance, Pensions.</P>
        </LSTSUB>
        
        <REGTEXT PART="4022" TITLE="29">
          <AMDPAR>In consideration of the foregoing, 29 CFR parts 4022 and 4044 are amended as follows:</AMDPAR>
          <PART>
            <HD SOURCE="HED">PART 4022—BENEFITS PAYABLE IN TERMINATED SINGLE-EMPLOYER PLANS</HD>
          </PART>
          <AMDPAR>1. The authority citation for part 4022 continues to read as follows:</AMDPAR>
          <AUTH>
            <HD SOURCE="HED">Authority:</HD>
            <P>29 U.S.C. 1302, 1322, 1322b, 1341(c)(3)(D), and 1344.</P>
          </AUTH>
        </REGTEXT>
        
        <REGTEXT PART="4022" TITLE="29">
          <AMDPAR>2. In appendix B to part 4022, Rate Set 119, as set forth below, is added to the table. (The introductory text of the table is omitted.)</AMDPAR>
          <HD SOURCE="HD1">Appendix B to Part 4022—Lump Sum Interest Rates For PBGC Payments</HD>
          <STARS/>
          <GPOTABLE CDEF="10C,10C,10C,10C,10C,10C,10C,10C,10C" COLS="9" OPTS="L1,tp0,i1">
            <TTITLE>  </TTITLE>
            <BOXHD>
              <CHED H="1">Rate set </CHED>
              <CHED H="1">For plans with a valuation date </CHED>
              <CHED H="2">On or after </CHED>
              <CHED H="2">Before </CHED>
              <CHED H="1">Immediate annuity rate <LI>(percent) </LI>
              </CHED>
              <CHED H="1">Deferred annuities <LI>(percent) </LI>
              </CHED>
              <CHED H="2">
                <E T="03">i</E>
                <E T="54">1</E>
              </CHED>
              <CHED H="2">
                <E T="03">i</E>
                <E T="54">2</E>
              </CHED>
              <CHED H="2">
                <E T="03">i</E>
                <E T="54">3</E>
              </CHED>
              <CHED H="2">
                <E T="03">n</E>
                <E T="54">1</E>
              </CHED>
              <CHED H="2">
                <E T="03">n</E>
                <E T="54">2</E>
              </CHED>
            </BOXHD>
            <ROW>
              <ENT I="22">  </ENT>
            </ROW>
            <ROW>
              <ENT I="28">*         *         *         *         *         *         * </ENT>
            </ROW>
            <ROW>
              <ENT I="01">119</ENT>
              <ENT>9-1-03</ENT>
              <ENT>10-1-03</ENT>
              <ENT>3.50</ENT>
              <ENT>4.00</ENT>
              <ENT>4.00</ENT>
              <ENT>4.00</ENT>
              <ENT>7</ENT>
              <ENT>8 </ENT>
            </ROW>
          </GPOTABLE>
          <AMDPAR>3. In appendix C to part 4022, Rate Set 119, as set forth below, is added to the table. (The introductory text of the table is omitted.)</AMDPAR>
          <HD SOURCE="HD1">Appendix C to Part 4022—Lump Sum Interest Rates For Private-Sector Payments</HD>
          <STARS/>
          <GPOTABLE CDEF="10C,10C,10C,10C,10C,10C,10C,10C,10C" COLS="9" OPTS="L1,tp0,i1">
            <TTITLE>  </TTITLE>
            <BOXHD>
              <CHED H="1">Rate set </CHED>
              <CHED H="1">For plans with a valuation date </CHED>
              <CHED H="2">On or after </CHED>
              <CHED H="2">Before </CHED>
              <CHED H="1">Immediate annuity rate (percent) </CHED>
              <CHED H="1">Deferred annuities (percent) </CHED>
              <CHED H="2">
                <E T="03">i</E>
                <E T="54">1</E>
              </CHED>
              <CHED H="2">
                <E T="03">i</E>
                <E T="54">2</E>
              </CHED>
              <CHED H="2">
                <E T="03">i</E>
                <E T="54">3</E>
              </CHED>
              <CHED H="2">
                <E T="03">n</E>
                <E T="54">1</E>
              </CHED>
              <CHED H="2">
                <E T="03">n</E>
                <E T="54">2</E>
              </CHED>
            </BOXHD>
            <ROW>
              <ENT I="22">  </ENT>
            </ROW>
            <ROW>
              <ENT I="28">*         *         *         *         *         *         * </ENT>
            </ROW>
            <ROW>
              <ENT I="01">119</ENT>
              <ENT>9-1-03</ENT>
              <ENT>10-1-03</ENT>
              <ENT>3.50</ENT>
              <ENT>4.00</ENT>
              <ENT>4.00</ENT>
              <ENT>4.00</ENT>
              <ENT>7</ENT>
              <ENT>8 </ENT>
            </ROW>
          </GPOTABLE>
        </REGTEXT>
        <REGTEXT PART="4044" TITLE="29">
          <PART>
            <HD SOURCE="HED">PART 4044—ALLOCATION OF ASSETS IN SINGLE-EMPLOYER PLANS</HD>
          </PART>
          <AMDPAR>4. The authority citation for part 4044 continues to read as follows:</AMDPAR>
          <AUTH>
            <HD SOURCE="HED">Authority:</HD>
            <P>29 U.S.C. 1301(a), 1302(b)(3), 1341, 1344, 1362.</P>
          </AUTH>
        </REGTEXT>
        
        <REGTEXT PART="4044" TITLE="29">
          <AMDPAR>5. In appendix B to part 4044, a new entry, as set forth below, is added to the table. (The introductory text of the table is omitted.)</AMDPAR>
          <HD SOURCE="HD1">Appendix B to Part 4044—Interest Rates Used to Value Benefits</HD>
          <STARS/>
          <GPOTABLE CDEF="s25,10C,10C,10C,10C,xls40,xls40" COLS="7" OPTS="L1,tp0,i1">
            <TTITLE>  </TTITLE>
            <BOXHD>
              <CHED H="1">For valuation dates occurring in the month— </CHED>
              <CHED H="1">The values of i<E T="54">t</E> are: </CHED>
              <CHED H="2">
                <E T="03">i</E>
                <E T="54">t</E>
              </CHED>
              <CHED H="2">for <E T="03">t =</E>
              </CHED>
              <CHED H="2">
                <E T="03">i</E>
                <E T="54">t</E>
              </CHED>
              <CHED H="2">for <E T="03">t =</E>
              </CHED>
              <CHED H="2">
                <E T="03">i</E>
                <E T="54">t</E>
              </CHED>
              <CHED H="2">for <E T="03">t =</E>
              </CHED>
            </BOXHD>
            <ROW>
              <ENT I="22">  </ENT>
            </ROW>
            <ROW>
              <ENT I="28">*         *         *         *         *         *         * </ENT>
            </ROW>
            <ROW>
              <ENT I="01">September 2003</ENT>
              <ENT>.0490</ENT>
              <ENT>1-20</ENT>
              <ENT>.0525</ENT>
              <ENT>&gt;20</ENT>
              <ENT>N/A</ENT>
              <ENT>N/A </ENT>
            </ROW>
          </GPOTABLE>
        </REGTEXT>
        <SIG>
          <PRTPAGE P="48789"/>
          <DATED>Issued in Washington, DC on this 7th day of August 2003.</DATED>
          <NAME>Joseph H. Grant,</NAME>
          <TITLE>Deputy Executive Director and Chief Operating Officer, Pension Benefit Guaranty Corporation.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20860 Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 7708-01-P</BILCOD>
    </RULE>
    <RULE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF THE INTERIOR </AGENCY>
        <SUBAGY>Office of Surface Mining Reclamation and Enforcement </SUBAGY>
        <CFR>30 CFR Part 938 </CFR>
        <DEPDOC>[PA-137-FOR] </DEPDOC>
        <SUBJECT>Pennsylvania Regulatory Program </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Office of Surface Mining Reclamation and Enforcement (OSM), Interior. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Final rule; approval of amendment. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>We are approving an amendment to the Pennsylvania permanent regulatory program (the “Pennsylvania program”) under the Surface Mining Control and Reclamation Act of 1977 (SMCRA or the Act). Pennsylvania proposed to revise its regulations regarding licensing of blasters and the storage, handling and use of explosives. Pennsylvania intends to reorganize and clarify its blasting regulations to reflect the advances in technology and research associated with blasting. </P>
        </SUM>
        <EFFDATE>
          <HD SOURCE="HED">EFFECTIVE DATE:</HD>
          <P>August 15, 2003. </P>
        </EFFDATE>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>

          <P>George Rieger, Acting Field Office Director, Harrisburg Field Office, Telephone: (717) 782-4036, e-mail: <E T="03">grieger@osmre.gov.</E>
          </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        
        <EXTRACT>
          <FP SOURCE="FP-1">I. Background on the Pennsylvania Program </FP>
          <FP SOURCE="FP-1">II. Submission of the Proposed Amendment </FP>
          <FP SOURCE="FP-1">III. OSM's Findings </FP>
          <FP SOURCE="FP-1">IV. Summary and Disposition of Comments </FP>
          <FP SOURCE="FP-1">V. OSM's Decision </FP>
          <FP SOURCE="FP-1">VI. Procedural Determinations </FP>
        </EXTRACT>
        <HD SOURCE="HD1">I. Background on the Pennsylvania Program </HD>

        <P>Section 503(a) of the Act permits a State to assume primacy for the regulation of surface coal mining and reclamation operations on non-Federal and non-Indian lands within its borders by demonstrating that its State program includes, among other things, “* * * a State law which provides for the regulation of surface coal mining and reclamation operations in accordance with the requirements of the Act * * *; and rules and regulations consistent with regulations issued by the Secretary pursuant to the Act.” <E T="03">See</E> 30 U.S.C. 1253(a)(1) and (7). On the basis of these criteria, the Secretary of the Interior conditionally approved the Pennsylvania program on July 30, 1982. You can find background information on the Pennsylvania program, including the Secretary's findings, the disposition of comments, and conditions of approval in the July 30, 1982, <E T="04">Federal Register</E> (47 FR 33050). You can also find later actions concerning Pennsylvania's program and program amendments at 30 CFR 938.11, 938.12, 938.15 and 938.16. </P>
        <HD SOURCE="HD1">II. Submission of the Amendment </HD>

        <P>By letter dated February 25, 2002, Pennsylvania sent us an amendment to its program (Administrative Record No. PA 878.02) under SMCRA (30 U.S.C. 1201 <E T="03">et seq.</E>). The amendment includes changes to Title 25, Part I, Subpart D, Article IV, Chapters 210 Blaster's License, and 211 Storage, Handling and Use of Explosives. We announced receipt of the proposed amendment in the April 30, 2002, <E T="04">Federal Register</E> (67 FR 21187). In the same document, we opened the public comment period and provided an opportunity for a public hearing or meeting on the amendment's adequacy. We did not hold a public hearing, as one was not requested. The public comment period ended on May 30, 2002. We received comments from two Federal agencies and from one State agency. The Federal agencies were the U.S. Department of Labor, Mine Safety and Health Administration's (MSHA) New Stanton Office and the U.S. Environmental Protection Agency (EPA), Region III. The State agency was the Pennsylvania Historical and Museum Commission (PHMC). </P>
        <HD SOURCE="HD1">III. OSM's Findings</HD>
        <P>Following are the findings we made concerning the amendment under SMCRA and the Federal regulations at 30 CFR 732.15 and 732.17.  We are approving the amendment as described below.  Any revisions that we do not specifically discuss below concern nonsubstantive wording or editorial changes and are approved here without discussion. </P>
        <HD SOURCE="HD2">A. Minor Revisions to Pennsylvania's Rules </HD>
        <P>Pennsylvania proposed minor wording and recodification changes to the following previously approved rules: </P>
        <GPOTABLE CDEF="s100,r100,r100" COLS="3" OPTS="L2,tp0,i1">
          <TTITLE>  </TTITLE>
          <BOXHD>
            <CHED H="1">Previously approved section </CHED>
            <CHED H="1">Recodified section (These sections may include minor wording changes from the original language.) </CHED>
            <CHED H="1">Subject </CHED>
          </BOXHD>
          <ROW>
            <ENT I="01">210.1(a)</ENT>
            <ENT>210.16(a)</ENT>
            <ENT>Examinations for Blaster's License. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">210.1(b)</ENT>
            <ENT>210.16(b)</ENT>
            <ENT>Frequency of Examinations. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">210.1(e)</ENT>
            <ENT>210.15(b)</ENT>
            <ENT>License Application. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">210.2(d)</ENT>
            <ENT>210.14(a)(4)</ENT>
            <ENT>Requirement to Pass Examination. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">210.2(e)</ENT>
            <ENT>210.13(c)</ENT>
            <ENT>Exhibiting License. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">210.2(g)</ENT>
            <ENT>210.16(c) and (d)</ENT>
            <ENT>Forfeiture of Fees. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">210.3(b)</ENT>
            <ENT>210.17(f)</ENT>
            <ENT>Lapsed Licenses. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">210.5(a)</ENT>
            <ENT>210.13(a) and 211.154(a)</ENT>
            <ENT>Blaster in Charge. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">210.5(b)</ENT>
            <ENT>211.154(c)</ENT>
            <ENT>Another person present during blast. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">210.5(c)</ENT>
            <ENT>211.102(a)</ENT>
            <ENT>Scope. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.2(2)</ENT>
            <ENT>211.101</ENT>
            <ENT>Definition—Magazine. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.2(4)</ENT>
            <ENT>211.101</ENT>
            <ENT>Definition—Primer. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.2(5)</ENT>
            <ENT>211.101</ENT>
            <ENT>Definition—Stemming. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.2(6)</ENT>
            <ENT>211.101</ENT>
            <ENT>Definition—Building. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.2(12)</ENT>
            <ENT>211.101</ENT>
            <ENT>Definition—Person. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.2(18)</ENT>
            <ENT>211.101</ENT>
            <ENT>Definition—Charge Weight. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.2(20)</ENT>
            <ENT>211.101</ENT>
            <ENT>Definition—Delay Interval. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.32(1)</ENT>
            <ENT>211.112(a)</ENT>
            <ENT>Location of magazine. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.36(1)</ENT>
            <ENT>211.121(a)</ENT>
            <ENT>Records of Disposition of explosives. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.36(2)</ENT>
            <ENT>211.101</ENT>
            <ENT>Definitions of “purchase,” and “sale or sell”. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.36(6), (7)</ENT>
            <ENT>211.122(b), (c) and 211.123(b), (c)</ENT>
            <ENT>Permits to sell/purchase explosives. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.42(1), (3)-(12), and (15)-17)</ENT>
            <ENT>211.141</ENT>
            <ENT>Transportation of Explosives. </ENT>
          </ROW>
          <ROW>
            <PRTPAGE P="48790"/>
            <ENT I="01">211.46(1)-(15), (20)</ENT>
            <ENT>211.133(a)(1), (2)-(14), (16)-(20), (22)</ENT>
            <ENT>Blast reports. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(3)</ENT>
            <ENT>210.13(a) and 211.153(f)</ENT>
            <ENT>General/General requirements for handling explosives. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(6)</ENT>
            <ENT>211.154(e) and 211.154(b)</ENT>
            <ENT>Preparing the blast. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(9)</ENT>
            <ENT>211.159(j)</ENT>
            <ENT>Electric detonation. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(11)</ENT>
            <ENT>211.162(c)</ENT>
            <ENT>Safety fuse. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(14)</ENT>
            <ENT>211.154(n) and 211.161(b)</ENT>
            <ENT>Preparing the blast/Detonating cords. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(16)</ENT>
            <ENT>211.156(b) and 211.157(b)</ENT>
            <ENT>Detonating the blast/Postblast measures. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(19)</ENT>
            <ENT>211.154(h)</ENT>
            <ENT>Preparing the blast. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(20)</ENT>
            <ENT>211.153(d)</ENT>
            <ENT>General requirements for handling explosives. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(22)</ENT>
            <ENT>211.161(1)</ENT>
            <ENT>Detonating cords. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(23)</ENT>
            <ENT>211.154(k)</ENT>
            <ENT>Preparing the blast. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(24)</ENT>
            <ENT>211.154(l)</ENT>
            <ENT>Preparing the blast. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(25)</ENT>
            <ENT>211.154(f)(4)</ENT>
            <ENT>Preparing the blast. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(26)</ENT>
            <ENT>211.159(a)</ENT>
            <ENT>Electric detonation. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(28)</ENT>
            <ENT>211.159(c)</ENT>
            <ENT>Electric detonation. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(29)</ENT>
            <ENT>211.154(i)</ENT>
            <ENT>Preparing the blast. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(30)</ENT>
            <ENT>211.159(d)</ENT>
            <ENT>Electric detonation. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(31) and (32)</ENT>
            <ENT>211.159(e)</ENT>
            <ENT>Electric detonation. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(34)</ENT>
            <ENT>211.159(g)</ENT>
            <ENT>Electric detonation. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(35)</ENT>
            <ENT>211.158</ENT>
            <ENT>Mudcapping. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(36)</ENT>
            <ENT>211.154(j)(2)</ENT>
            <ENT>Preparing the blast. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(37)</ENT>
            <ENT>211.54(f)(5)</ENT>
            <ENT>Preparing the blast. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(38)</ENT>
            <ENT>211.157(a)</ENT>
            <ENT>Postblast measures. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(41)</ENT>
            <ENT>211.154(j)(1)</ENT>
            <ENT>Preparing the blast. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.52</ENT>
            <ENT>211.181</ENT>
            <ENT>Blasting activities near utility line. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.52(2)</ENT>
            <ENT>211.182(a) and (b)</ENT>
            <ENT>General provisions—Blasting activities near utility line. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.61(4)</ENT>
            <ENT>211.115</ENT>
            <ENT>Standards for classifying and storing explosives and constructing, maintaining and siting magazines. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.65(7)</ENT>
            <ENT>211.154(f)(3)</ENT>
            <ENT>Preparing the blast. </ENT>
          </ROW>
        </GPOTABLE>
        <P>Because these changes are minor and do not affect the meaning or the application of the previously approved rules, we find that they will not make Pennsylvania's rules less effective than the corresponding Federal regulations.</P>
        <HD SOURCE="HD2">B. Previously Approved Pennsylvania Rules That Have Been Eliminated in This Amendment</HD>
        <P>The following rules that we previously approved as part of the Pennsylvania program have been eliminated in this rulemaking.</P>
        <GPOTABLE CDEF="s100,r100" COLS="2" OPTS="L2,tp0,i1">
          <TTITLE>  </TTITLE>
          <BOXHD>
            <CHED H="1">Previously approved section </CHED>
            <CHED H="1">Subject </CHED>
          </BOXHD>
          <ROW>
            <ENT I="01">210.1(c)</ENT>
            <ENT>Sealed examinations for the blaster's license test. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">210.1(f)</ENT>
            <ENT>Notification of blaster's license examination. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">210.2(h)</ENT>
            <ENT>Issuance and status of licenses—fees. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">210.5(d)</ENT>
            <ENT>Use of explosives in waters of the Commonwealth. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.1</ENT>
            <ENT>Safety devices for machinery. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.2; the definitions for the following terms were eliminated: “establishment,” “explosive plant,” “factory building,” “railroad,” “highway,” “barricade,” “Department,” “Board,” “Secretary,” “approved,” “vehicle,” and “actual distance.”</ENT>
            <ENT>Definitions. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.36(10)</ENT>
            <ENT>Inventory records for explosives and blasting caps. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.37</ENT>
            <ENT>Regulations for magazines used for storing explosives. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(5)</ENT>
            <ENT>Firing horizontal holes. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(8)</ENT>
            <ENT>Use of blasting machines. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(12)</ENT>
            <ENT>Clearing black powder or dynamite from around holes. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(18)</ENT>
            <ENT>Counting explosions. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(21)</ENT>
            <ENT>Back primed holes. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(33)</ENT>
            <ENT>Explosives in underground mines. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(39)</ENT>
            <ENT>Returning remaining explosives after loading. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.51(40)</ENT>
            <ENT>Stemming holes when loose dynamite is used. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.52(1)</ENT>
            <ENT>Showing utility lines on plans. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.61(3), (5)</ENT>
            <ENT>Storage of ammonium nitrates. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.62</ENT>
            <ENT>Blasting prohibited. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.63</ENT>
            <ENT>Building, Operation and Storage Requirement. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.64</ENT>
            <ENT>Mobile Equipment for mixing prohibited. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.71</ENT>
            <ENT>Special precautions for storage and use of propellants. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.72</ENT>
            <ENT>Storehouses—Distances—limitations. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.73</ENT>
            <ENT>Protection from Fire. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.74</ENT>
            <ENT>Storehouses. </ENT>
          </ROW>
          <ROW>
            <PRTPAGE P="48791"/>
            <ENT I="01">211.75</ENT>
            <ENT>Transporting of Propellants in vehicles. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.76</ENT>
            <ENT>Smoking prohibited. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.77</ENT>
            <ENT>Tools for opening containers. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">211.78</ENT>
            <ENT>Permit to sell. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">Appendix A</ENT>
            <ENT>Radio Transmitters. </ENT>
          </ROW>
        </GPOTABLE>
        <P>There are no Federal counterparts to the rules listed in the above table.  Our review found that elimination of these sections does not make the Pennsylvania program less effective than the Federal regulations.  We are approving their elimination.</P>
        <P>In addition to the above sections, Pennsylvania also eliminated section 210.5(e) that we had also previously approved. This section provides that blasting operations near streams are prohibited when the effect of the blasting is liable to change the course or channel of any stream unless a permit is obtained from the Pennsylvania Department of Environmental Protection (PADEP). The Federal counterpart to this section is found in 30 CFR 816/817.67(a), which provides that blasting must be conducted to prevent, among other things, a change in the course, channel, or availability of surface water outside the permit area. Pennsylvania's approved program at 25 Pennsylvania Code (Pa. Code) 87.127(g) provides that blasting shall be prohibited in cases when the effect of the blasting is liable to change the course or channel of a stream. Because Pennsylvania's program still provides protection to streams from the effects of blasting that is no less effective than the Federal regulations, we find that elimination of section 210.5(e) is not inconsistent with the Federal regulations. </P>
        <HD SOURCE="HD2">C. Revisions to Pennsylvania's Rules That Have the Same Meaning as the Corresponding Provisions of the Federal Regulations </HD>
        <P>Pennsylvania added a definition for the term “blaster” in section 210.11. Both the State and Federal definition of “blaster” as defined in 30 CFR 850.5 include in the term that the person must have a blaster's license/certification and must be responsible for the blasting. Since this definition means the same as the term “blaster” in the Federal rules, we find it no less effective and we are approving this definition. </P>
        <P>Pennsylvania also added definitions for terms in Chapter 211 that are not specifically defined in Federal regulations, but the use of the terms in the Federal regulations indicate they mean the same as Pennsylvania's definitions. In section 211.101, Pennsylvania added a definition for the term “air blast” which means, “An airborne shock wave resulting from an explosion, also known as air overpressure, which may or may not be audible.” The Federal regulations at 30 CFR 816/817.67(b) provide specific limits for monitoring and controlling air blast including a chart indicating the maximum limit, in decibels, for air blast. This limitation indicates that air blast is air overpressure as defined by Pennsylvania. As a result, we find this definition consistent with the Federal rules and we are approving it. </P>
        <P>Pennsylvania also added a definition for the term, “blaster,” to section 211.101. The term was defined to be, “An individual who is licensed by the Department under Chapter 210 (relating to blasters' licenses) to detonate explosives and supervise blasting activities.” As discussed above with the definition found at Chapter 210, this definition is no less effective than the definition of blaster in the Federal regulations at 30 CFR 850.5. We are approving it. </P>
        <P>Pennsylvania added a definition for the term, “flyrock,” to section 211.101. Pennsylvania defined flyrock as overburden, stone, clay, or other material ejected from the blast area by the force of the blast. There is no Federal definition for “flyrock.” The definition is consistent with the way we use the term in 30 CFR 816/817.67(c) which indicates that flyrock traveling in the air or along the ground shall not be cast from the blasting site. Pennsylvania's definition of “flyrock” serves to clarify its use in Chapter 211 and in 25 Pa. Code 87.127(f)(5). We are approving this addition. </P>
        <P>Pennsylvania added a definition for the term, “peak particle velocity,” to section 211.101. Pennsylvania defined the term to mean, “A measure of the intensity of ground vibration, specifically the time rate of change of the amplitude of ground vibration.” This definition is consistent with the way we use the term peak particle velocity in 30 CFR 816/817.67 where we indicate ground vibration cannot exceed maximum peak particle velocities. Pennsylvania's definition clarifies the use of the term in Chapter 211 and we are approving it. </P>
        <P>Pennsylvania added a definition for the term, “utility lines,” to section 211.101. Pennsylvania defined the term as, “An electric cable, fiber optic line, pipeline or other type of conduit used to transport or transmit electricity, gases, liquids and other media including information.” The term is used in Chapter 211, Subchapter H to provide additional protections to utility lines from blasting. The use of this term is not inconsistent with the Federal regulations at 30 CFR 816/817.180 which regulate the effects of surface coal mining operations on utilities. We are approving this definition. </P>
        <P>Pennsylvania also changed its definition of “scaled distance” that was formerly found in section 211.2(21). The definition is now found in section 211.101. The revised definition defines the actual distance portion of the scaled distance equation as the distance in feet measured in a horizontal line from the blast site to the nearest building or structure, neither owned or leased by the blasting activity permittee or customer. The former definition did not define what structures were to be included in the actual distance measurement. The revised definition is no less effective than the Federal definition at 30 CFR 816/817.67(d)(3). </P>
        <P>Former section 211.41(24) provided that blasting must not be done in such a manner as to eject debris into the air or to constitute a hazard or danger or do harm or damage to persons or property in the area of the blasting. There is no equivalent section in the current blasting regulations in Chapter 210 or 211 for this provision. However, we previously approved 25 Pa. Code 87.127(f)(6) which contains substantively the same language as former section 211.41(24). For this reason, we are approving its deletion. </P>
        <P>Former section 211.45 provided the requirements for monitoring blasts. Some of the information was incorporated into current section 211.171. Additionally, Pennsylvania has incorporated monitoring requirements into 25 Pa. Code 87.127 that we previously approved. We have found that the requirements of section 211.171, when coupled with the requirements of section 87.127, are no less effective than the monitoring requirements of 30 CFR 816/817.67. </P>

        <P>Section 211.151(a) was added by this amendment. This section provides that <PRTPAGE P="48792"/>blasting may not damage real property except for real property under the control of the permittee. Pennsylvania has an additional provision dealing with damage at 25 Pa. Code 87.127(g) which provides that blasting shall be conducted to prevent, among other things, damage to public or private property outside the permit area. We previously approved this section. Taken together these sections provide the same level of protection to property as found in the Federal regulations at 30 CFR 816/817.67(a). As a result, we are approving this section. </P>
        <P>Section 211.151(b) was added by this amendment. This section provides that blasting may not cause flyrock. Pennsylvania has an additional provision regarding flyrock at 25 Pa. Code 87.127(f)(5) that we previously approved. Section 87.127(f)(5) provides specific limits from which flyrock cannot be cast. These limits are the same as the Federal regulations at 30 CFR 816/817.67(c). For these reasons, we are approving this section. </P>
        <P>Section 211.151(c) was added by this amendment. This section provides limitations on blasting using either a scaled distance of 90 or a maximum allowable peak particle velocity as indicated in a chart designated as Figure 1. The scaled distance and maximum allowable peak particle velocity do not apply at a building or other structure owned or leased by the permittee or its customer. Pennsylvania has additional provisions regarding limitations on blasting at 25 Pa. Code 87.127(h) and (p) that we previously approved. The Federal regulations at 816/817.67(e) also allow for ground vibrations to exceed the established velocity. However, the Federal rules go on to state that the ground vibration standards of 816/817.67(d) shall not apply at structures owned by the permittee and leased to another person if a written waiver by the lessee is submitted to the regulatory authority before blasting. Section 211.151(c) does not provide for written waiver by the lessee. Nonetheless, Pennsylvania has provided protections for people leasing structures from a permittee in its approved regulations at 25 Pa. Code 87.127(i) which requires a waiver from the lessee before a blast is fired that exceeds the vibrations limitations. In a July 23, 2003, conversation (Administrative Record No. PA 878.10), the Chief of the Explosives and Safety Section of PADEP clarified that the ground vibration limits cannot be lessened if the people leasing the structure from the operator do not waive the limitations. This would apply regardless of whether the operator was using scaled distance for prediction of ground vibration or whether a seismograph was used to measure ground vibration. For these reasons, we find that this section is no less effective than the comparable regulations at 30 CFR 816/817.67(d) and (e) are we are approving it. </P>
        <P>Section 211.151(d) was added by this amendment. This section provides that blasts must be designed and conducted to control airblast so that it does not exceed the noise levels specified in an included table at a building or other structure designated by Pennsylvania unless the building is owned or leased by the permittee. The Federal regulations at 816/817.67(b) provide an identical table listing the noise levels. However, this section provides that the airblast cannot exceed the maximum limits at the location of any dwelling, public building, school, church, or community or institutional building outside the permit area. Pennsylvania's regulations are more inclusive because they are applied at any building or structure and not limited to the structures noted in the Federal regulations. While this section does not provide for a waiver of the airblast levels by a person leasing a structure from a permittee, the regulations at 25 Pa. Code 87.127(e) do provide for such a waiver. As a result, we have found that this provision is no less effective than the Federal regulations. </P>
        <P>Section 211.151(e) was added by this amendment. This section provides that Pennsylvania may establish an alternative peak particle velocity or airblast level if it determines that an alternative standard is appropriate because of density of population, land use, age or type of structure, geology or hydrology of the area, frequency of blasts or other factors. The Federal regulations at 30 CFR 816/817.67(d)(5) provides that the maximum allowable ground vibration shall be reduced if determined to be necessary to provide damage protection. Similarly 30 CFR 816/817.67(b)(1)(ii) provides that the maximum airblast levels shall be reduced if necessary to prevent damage. Pennsylvania's approved program at 25 Pa. Code 87.127(e)(2) provides that Pennsylvania will specify lower airblast levels if necessary to prevent damage. Pennsylvania's approved program at 25 Pa. Code 87.127(h) provides that it may reduce the maximum peak particle velocity allowed if it determines that a lower standard is required. Taken together we have found that Pennsylvania's regulations are no less effective than the Federal regulations in requiring alternative airblast and peak particle velocity levels when necessary to prevent damage. </P>
        <P>Section 211.156(a) provides that a blast may only be detonated between sunrise and sunset unless Pennsylvania authorized a blast at another time of day. This is similar to Pennsylvania's approved program at 25 Pa. Code 87.127(a) which provides that blasting shall be conducted between sunrise and sunset, at times announced in the blasting schedule. The Federal regulations at 30 CFR 816.64(a)(2) and 817.64(c) provide that all blasting shall be conducted between sunrise and sunset, except that nighttime blasting can be approved under certain circumstances. The Pennsylvania regulations are no less effective than the Federal regulations in restricting the times for blasting and therefore, we are approving them. </P>
        <P>Section 211.157(c) provides the signal to be given after a blast has been detonated. This section indicates that the signal must be of sufficient power to be heard 1,000 feet from the blast site. Pennsylvania's regulations on surface mining at 25 Pa. Code 87.127(c) indicate the all-clear signal must be capable of being heard <FR>1/2</FR> mile from the point of the blast. We previously approved 25 Pa. Code 87.127(c) which is similar to the Federal regulation at 30 CFR 816/817.66(b). We are approving section 211.157(c) even though the all-clear signal may not have to be audible from as great an area, because of the provision of 25 Pa. Code 211.102(b). Section 211.102(b) provides that a person will not be relieved from compliance with other applicable laws or regulations even if they are in compliance with Chapter 211. Therefore, the more strict limitation of 25 Pa. Code 87.127(c) will be in effect for blasting on surface mining operations. </P>
        <HD SOURCE="HD2">D. Revisions to Pennsylvania's Rules That Are Not the Same as the Corresponding Provisions of the Federal Regulations </HD>

        <P>Section 210.4 formerly required that a blaster's license could not be transferred and any attempt to transfer the license will automatically cancel the license. This section was previously approved by OSM on July 30, 1982 (47 FR 33050). In the current amendment, section 210.4 was recodified to section 210.13(d). Section 210.13(d) states that a blaster's license is not transferable. The recodified section does not contain the provision regarding attempts to transfer the license resulting in cancellation of the license. However, section 210.19 provides that Pennsylvania may suspend, modify or revoke a blaster's license for violations of chapter 210. The deletion of the provision regarding <PRTPAGE P="48793"/>attempts to transfer the license does not make this section less effective than the Federal regulations because of section 210.19. An attempt to transfer the license would constitute a violation of Chapter 210 and would give Pennsylvania the authority to take action on the license. Taken together these two sections are no less effective than 30 CFR 850.15(e)(2) in preventing the transfer of blaster's licenses. </P>
        <P>Section 210.14(a)(2) of the current regulations provides that a person must have at least one year of experience as a blaster learner in preparing blasts to be eligible for a blaster's license. The Federal regulations at 30 CFR 850.14(a)(2) require the regulatory authority to ensure that candidates for blaster certification have practical field experience. The Federal requirement does not specify how much experience is needed before someone can apply for certification. Less than a year of experience could suffice under the Federal rules. Therefore, we find that Pennsylvania's regulation is no less effective than the Federal regulation and we are approving it. </P>
        <P>Section 210.14(a)(3) provides that a person must take Pennsylvania's class on explosives to be eligible for a blaster's license. Section 30 CFR 850.13(b) of the Federal regulations requires the regulatory authority to ensure that courses are available to train persons responsible for the use of explosives in surface coal mining operations. In a rulemaking dated April 4, 1985 (50 FR 13315), we noted that Pennsylvania submitted a Blaster Training Course Outline, and Assorted Blasting Training Course Materials (among other documents) in consideration for approval of its blaster certification program. We approved the submission of these documents noting that the materials submitted were no less effective than the Federal blaster training and examination requirements at 30 CFR 850.13 and 850.14. In an e-mail dated July 15, 2003 (Administrative Record No. PA 878.08), Pennsylvania confirmed that these materials were still used in its blaster certification program. Accordingly, based on Pennsylvania's July 15 response, we find that this section is no less effective than the Federal regulations and we are approving it. </P>

        <P>Section 210.19 of the current regulations provides that Pennsylvania may suspend, modify, or revoke a blaster's license for violations of Chapter 210 and 211. Former section 210.2(f) contained similar provisions, but it did not provide for modification of the blaster's license, only for suspension or revocation of the license. Additionally, former section 210.2(f) provided that an appeal of a revocation of a blaster's license may be made to the Environmental Hearing Board and only allowed a suspension for due cause. The right to appeal was not stated in 210.19. The Federal regulations at 30 CFR 850.15(b) provide for suspension <E T="03">or</E> revocation of a blaster's certification, but it also notes that the regulatory authority can take other necessary actions with regard to the certification. While the term “other necessary actions” was not defined in the Federal regulations, it is not unreasonable to interpret this phrase as allowing a modification of a blaster's license. The Federal rules at 30 CFR 850.15(b) require written notice and a hearing whenever a blaster's certification is suspended, revoked or other adverse action is taken. While the right to appeal a revocation, suspension, or modification was not stated in section 210.19, Pennsylvania in an e-mail dated July 15, 2003 (Administrative Record No. PA 878.08), confirmed, through copies of Notice of Suspension of Blaster's License it submitted to us, that blasters served with suspension or revocation notices are provided the right of appeal to the Environmental Hearing Board. Additionally, Pennsylvania law at 2 Pa. Consolidated Statutes (C.S.) 504 and 35 Pennsylvania Statute (P.S.) 7514, requires an opportunity for a hearing before the Environmental Hearing Board of all orders, permits, licenses or decisions of the Pennsylvania Department of Environmental Resources (now known as PADEP, pursuant 71 P.S. 1340.101). Thus, Pennsylvania provides the same level of hearing requirements as the Federal regulations. For these reasons, we are approving this provision as being no less effective than the Federal counterpart. </P>
        <P>Section 211.133(a) provides that blasting records must be made available to Pennsylvania upon request. The section also lists the items that must be noted on the blasting report. The Federal regulations at 30 CFR 816/817.68 require that the records be made available to the public as well as the regulatory authority. Pennsylvania's approved program at 25 Pa. Code 87.129 requires that the blasting records be made available to the public. The items to be noted on blast reports are the same as in the approved program at 25 Pa. Code 87.129 except that it includes two additional items: the blasting activity permit or mining permit number and a description of the nearest building location not owned or leased by the permittee based upon local landmarks. Taken together these two sections are no less effective than the requirements at 30 CFR 816/817.68. As a result, we are approving this section.</P>
        <P>Section 211.155 lists the duties a blaster-in-charge must perform prior to detonating a blast. There is no Federal counterpart for the duties listed in subsections (1) through (4). These duties apply to safety in and around the blast area. The duties listed in subsections (5) and (6) apply to protecting the public on public roads and to sounding a warning signal prior to detonating a blast. These sections are similar to the Federal regulations at 30 CFR 816/817.66(b) which provide for warning signals and 30 CFR 816/817.67(a) which provides for prevention of injury to persons and property damage outside the permit area. These provisions, when taken with the provisions from 25 Pa. Code 87.127, such as subsection (c) that we already approved, are no less effective than the corresponding Federal requirements.</P>
        <HD SOURCE="HD2">E. Revisions to Pennsylvania's Rules With No Corresponding Federal Regulation</HD>
        <P>Several sections of Pennsylvania's program that we previously approved and that have no Federal counterparts were modified by this amendment. Each of these sections is described below.</P>
        <P>Former section 210.1(d) regarding examinations for a blaster's license requires a notarized application form to be mailed to Pennsylvania with a check or money order for $10.00. This section was recodified as section 210.15(a). Section 210.15(a) dropped the requirement for the application to be notarized and increased the fee to $50.00. This section also requires the application to be submitted at least two weeks prior to the examination. There are no corresponding Federal regulations to this section and we have found that the modification does not make Pennsylvania's program less effective than the Federal regulations.</P>

        <P>Former section 210.2(a) regarding the issuance and status of licenses required the applicant to be at least nineteen years of age in order to apply for a blaster's license. This section was recodified as section 210.14(a)(1). Section 210.14(a)(1) increased the age requirement to twenty-one. There is no Federal counterpart to the age requirement, however this section is consistent with the Federal regulations at 30 CFR 850.14 that requires the regulatory authority to verify that applicants for blaster certification are competent and have practical field experience. This requirement is also similar to the age requirement for blaster certification in Federal program States <PRTPAGE P="48794"/>as found in 30 CFR 955.11(a). As a result, we are approving the change.</P>
        <P>Former sections 210.2(b) and (c) provide the different types of blasting categories for which blasters will be examined and provide that each category requires an examination. New sections 210.17(a) and (b) slightly modified these requirements. These new sections describe the classifications for which a blaster's license is issued and allows people to amend the classifications if they meet the requirements of section 210.14. There is no direct Federal counterpart to this section, but we find that it does not make the Pennsylvania program inconsistent with the Federal regulations and we are approving it.</P>
        <P>Former section 210.3(a) provides the procedures for the annual renewal of blaster's licenses. This section was recodified as section 210.17(e). Subsection (e) changes the term for renewal from one year to three years and the application fee was increased from $3.50 to $30.00. Former section 210.3(a) also provided that the renewal may be refused for due cause after notification to the applicant and a hearing. This provision was dropped from the recodified section 210.17. However, section 210.19 provides that Pennsylvania may issue orders suspending, modifying or revoking a blaster's license. This section gives Pennsylvania the authority to take action regarding the license at any time, which makes it more effective than the provision of former section 210.13(a) that provides for refusal to renew a license application. As stated earlier, we found section 210.19 to be no less effective than the Federal regulations. There is no Federal counterpart to section 210.17 and the changes do not make this less effective than the Federal regulations.</P>
        <P>Former section 210.5(c) provides that use of explosives must be in accordance with all rules and regulations for storage, handling and use of explosives. Portions of this provision are now found in current section 211.102(a). Section 211.102(a) provides that Chapter 211 applies to persons engaging in blasting activities. However, it also exempts persons using and storing explosives at underground mines from the requirements of the chapter. The Federal regulation at 30 CFR 817.61(a) states that the performance standards of 817.61 through 817.68 apply to surface blasting activities incident to underground coal mining. We asked the Chief of the Explosives and Safety Section of PADEP if this section exempts blasting activities incident to underground mining. In an e-mail dated June 17, 2003 (Administrative Record No. PA 878.09), he replied that this section pertains to blasting or storage within the underground mine not blasting incident to underground mining. He further replied that blasting incident to underground mining is regulated by Chapter 87. Since PADEP confirmed that this section does not apply to surface blasting activities incident to underground coal mining, we find that there is no corresponding Federal regulation to this section and it does not render the Pennsylvania program inconsistent with the Federal regulations. Therefore, we are approving it.</P>
        <P>Former section 210.6 provides that conditions under which blaster learners may work with a licensed blaster. Portions of this provision are now found in current sections 210.11, 211.101, and 211.154(e). There is no direct Federal counterpart to these provisions; however, they are consistent with the Federal regulations at 30 CFR 850.13(a) that requires the regulatory authority to establish procedures for persons who are not certified blasters to receive direction and on-the-job training from a certified blaster.</P>
        <P>Former section 211.2(3) provided a definition for the term, “explosives.” The definition for the term was modified in current section 211.101. There is no Federal counterpart for the definition of the term, “explosive,” however we find that Pennsylvania's definition of the term is not inconsistent with the Federal regulations and we are approving it.</P>
        <P>Former section 211.31 provided for licensing and fees for storage magazines. This section was recodified as section 211.112(a) and (d), and 211.114. The recodified sections increase the fees and modify the locations at which the license must be displayed. There is no Federal counterpart to these sections and we have found that the changes do not make Pennsylvania's program less effective than the Federal regulations.</P>
        <P>Former section 211.32(2) provides specifications for the location of, and storage of materials in, magazines. Some of these requirements were placed in current section 211.115. There are no Federal counterparts to this section and we have found that these requirements are not inconsistent with the Federal regulations.</P>
        <P>Former section 211.33 provided construction specifications for magazines for storing explosives. Former sections 211.35 and 211.43 provided for the handling, housekeeping and storage of explosives around magazines. These sections were recodified as section 211.115. Section 211.115 shortened the provisions of former sections 211.33, 211.35, and 211.43 and incorporated Federal standards at 27 CFR Part 55, Subpart K by reference. There were no Federal counterparts to the former sections and there are no Federal counterparts in Title 30 of the Federal regulations for section 211.15. We have found that the changes do not make Pennsylvania's program inconsistent with the Federal regulations.</P>
        <P>Former section 211.34 gives the requirements for plans for locating storage magazines on sites. Some of these requirements were placed in current section 211.115. There are no Federal counterparts to either section and we have found that these changes are not inconsistent with the Federal regulations.</P>
        <P>Former section 211.36(3) provides requirements for selling explosives including a permit to sell. Some of these requirements were placed in current sections 211.121(a) and 211.122(a) and (d). There are no Federal counterparts to the former section or its requirements that were placed in sections 211.121 or 211.122. We have found that the changes are not inconsistent with the Federal regulations.</P>
        <P>Former section 211.36(4) provides requirements for selling explosives including a permit to sell them. Some of these requirements were placed in current section 211.123(a). There are no Federal counterparts to the former section or its requirements that were placed in section 211.123. We have found that the changes are not inconsistent with the Federal regulations.</P>

        <P>Former section 211.36(8) provides the circumstances under which permits for the manufacture, storage, handling, use or sale of explosives can be suspended or revoked. The permit can be suspended for due cause and may be revoked after written notice to the permit holder and a hearing before the Environmental Hearing Board. The revised regulation at section 211.103(a) provides that Pennsylvania can issue orders to modify or revoke a permit but it doesn't indicate that a permit can be suspended for due cause nor does it provide appeal of a permit revocation to the Environmental Hearing Board. Federal regulations do not require specific permits for blasting activities. Instead, there must be a permit to conduct surface coal mining operations which also includes blasting activities. Pennsylvania does require a permit for surface coal mining operations. See 25 Pa. Code 86.11 <E T="03">et seq.</E> Additionally, surface coal mining operations must contain a blasting plan as noted in the <PRTPAGE P="48795"/>requirements at 30 CFR 780.13. Pennsylvania's regulations at 25 Pa. Code 87.64 also require a blasting plan for surface coal mines. As a result, we have found that the changes to this section are not inconsistent with the Federal regulations.</P>
        <P>Former section 211.36(9) provides additional requirements for selling explosives. Some of these requirements were placed in current section 211.131. There are no Federal counterparts to this former section or its requirements that were placed in section 211.131. We have found that these changes are not inconsistent with the Federal regulations.</P>
        <P>Former section 211.38 provided specifications for transporting blasting caps. This section was recodified as section 211.141(9). The construction specifics for the containers for transporting blasting caps were dropped and now the section requires containers to conform to the current version of Institute of Makers of Explosives Safety Library Publication # 22. There are no Federal counterparts to these provisions and we have found that the changes do not make Pennsylvania's program less effective than the Federal regulations.</P>
        <P>Former section 211.41 provides safety precautions for physically handling explosives. Some of these requirements were placed in current section 211.153. There are no Federal counterparts to the former section or its requirements that were placed in section 211.153. We have found that these changes are not inconsistent with the Federal regulations.</P>
        <P>Former section 211.44 provides specification for instruments to monitor explosives. The requirements were modified in current section 211.172. There are no Federal counterparts to the former section or the new section. We have found that these changes are not inconsistent with the Federal regulations.</P>
        <P>Former section 211.51(1) provides limitations for the use of open fire and smoking around explosives. Some of these requirements were placed in current section 211.153(b). There are no Federal counterparts to the former section or its requirements that were placed in section 211.153(b). We have found that these changes are not inconsistent with the Federal regulations.</P>
        <P>Former section 211.51(2) provides the types of tools that can be used to open containers of explosives and blasting implements. The types of tools that can be used to open containers of explosives have been modified in current section 211.153(a). There are no Federal counterparts to the former section or the new section. We have found that these changes are not inconsistent with the Federal regulations.</P>
        <P>Former section 211.51(4) provides for the use of wooden tamping sticks. This section was recodified to section 211.154(f) and was changed to provide for the use of non-ferrous tamping sticks. There are no Federal counterparts to the former section or the new section. We have found that these changes are not inconsistent with the Federal regulations.</P>
        <P>Former section 211.51(7) provides the means by which explosives are to be fired. These provisions were modified in current section 211.159(h) and (k). There are no Federal counterparts to the former section or the new section. We have found that these changes are not inconsistent with the Federal regulations.</P>
        <P>Former section 211.51(17) provides for procedures to be used in the event of a misfired hole. Some of these provisions have been placed in current sections 211.157(d) and (e). There are no Federal counterparts to the former section or the new section. We have found that these changes are not inconsistent with the Federal regulations.</P>
        <P>Former section 211.52(3) provides specifications for blasting in the vicinity of utility lines. This section was recodified in Subchapter H. Blasting Activities Near Utility Lines. New sections 211.181 and 211.182 now contain the requirements for conducting blasting near utility lines. These sections contain information concerning the design of the blast, the type of explosives to be used, the size of holes, and the specifics of excavation for blasts. There is no direct Federal counterpart for former section or the proposed section, however our review found it to be consistent with 30 CFR 816/817.180 regarding how surface mining operations are to be conducted to minimize damage, destruction, or disruption to utilities. We are approving these changes.</P>
        <P>Former sections 211.61(1) and (2) regarding handling and storing of ammonium nitrate were incorporated into new section 211.115. Section 211.115 provides regulations for classifying and storing explosives. There are no Federal counterparts for these regulations, however our review found that these regulations do not make Pennsylvania's program inconsistent with the Federal regulations. We are approving the change.</P>
        <P>Pennsylvania also added definitions and new sections to its regulations. These additions are discussed below.</P>
        <P>Pennsylvania added definitions of terms that have no Federal counterpart to Chapters 210 and 211. In section 210.11, Pennsylvania added definitions for the terms, “blaster learner,” “blaster license,” “demolition and demolition blasting,” and “person.” These definitions are used to clarify various sections of Pennsylvania's blaster license program. There are no Federal counterparts, however, these definitions do not make Pennsylvania's program inconsistent with the Federal regulations.</P>
        <P>In section 211.101, Pennsylvania added definitions for the terms, “blast area,” “blast site,” “blaster-in-charge,” “blasting activity,” “detonator,” “misfire,” “purchase,” “sale or sell,” and “structure.” These definitions are used to clarify various sections of Pennsylvania's rules on the storage, handling and use of explosives. There are no Federal counterparts to the definitions. However, these definitions do not make Pennsylvania's program inconsistent with the Federal regulations.</P>
        <P>Section 210.13(b) was added by this amendment. This section of the regulations provides that Pennsylvania may exempt individuals from a blaster's license if the person is detonating extremely small amounts of explosives for industrial or research purposes. The Federal regulations do not provide an exemption for quantity. It was unclear if surface coal mining operations were included in this provision. We asked Pennsylvania if individuals conducting blasting on surface coal mining operations could be exempt. In an e-mail dated July 15, 2003 (Administrative Record No. PA 878.08), the Chief of the Explosives and Safety Section of PADEP indicated that this exemption does not pertain to mining. It pertains to non-excavation activities such as industrial applications or research. We find this provision is not inconsistent with the Federal regulations and we are approving it with the understanding that Pennsylvania will not exempt blasters on surface coal mining operations from the licensing requirements. </P>

        <P>Section 210.14(b) was added by this amendment. This section of the regulations provides that Pennsylvania will not issue or renew a license if the applicant has or had violations or demonstrated a lack of ability or intention to comply with the blasting regulations. There is no direct Federal counterpart. However, this provision is consistent with the Federal rules at 30 CFR 850.14(a)(2) which require that the blaster candidate “exhibit a pattern of conduct consistent with the acceptance <PRTPAGE P="48796"/>of responsibility for blasting operations' and 30 CFR 850.15 which requires the suspension and revocation of blaster certification for specified violations. </P>
        <P>Section 210.17(d) was added by this amendment. This section provides that a blaster's license is renewable if the blaster can demonstrate that he has had 8 hours of continuing education in Department-approved courses related to blasting and safety within the 3 year period. There is no direct Federal counterpart to this section, but it is consistent with the goals of the Federal regulations at 30 CFR 850.13 regarding continuing blaster competency. We find that this requirement does not make the Pennsylvania program inconsistent with the Federal regulations and we are approving it. </P>
        <P>Section 210.17(g) was added by this amendment. This section provides for demolition blasting. There is no Federal counterpart for this definition, as we do not regulate demolition blasting. We are approving this definition. </P>
        <P>Section 210.18 was added by this amendment. This section provides for recognition of out-of-state blaster's licenses. Pennsylvania may license a person who holds a blaster's license in another State if Pennsylvania determines that State has an equivalent licensing and training program. There is no counterpart to this provision in 30 CFR Subchapter M, Part 850 of the Federal regulations. However, there is nothing in Part 850 that prevents Pennsylvania from accepting a certification from another State. We are approving this provision with the understanding that blasters from other States seeking a license in Pennsylvania must be certified or licensed under that State's equivalent to 30 CFR Part 850 of the Federal regulations. </P>
        <P>Section 211.103(b) was added by this amendment. This section provides that before Pennsylvania issues an order modifying peak particle velocity or airblast limits in a blasting activity permit, it will provide the permittee an opportunity to meet and discuss the modifications. There is no direct Federal counterpart to this provision, however 30 CFR 816/817.67(b)(1)(ii) and (d)(5) give the State regulatory authority discretion to specify lower levels for airblast and ground vibrations than set forth in the regulations. We have found that that the opportunity to discuss required revisions with the permittee does not make this provision less effective than the Federal regulations requiring the regulatory authority to specify lowered levels if necessary to prevent damage. Therefore, we have found that this provision is not inconsistent with the Federal regulations. </P>
        <P>Section 211.111 was added by this amendment. This section defines the scope of Subchapter B. Storage and Classification of Explosives. There is no Federal counterpart to this provision. We are approving it because it is not inconsistent with the Federal regulations. </P>
        <P>Section 211.113 was added by this amendment. This section requires a magazine license and the contents of such a magazine license application. There is no Federal counterpart to this provision. We are approving it because it is not inconsistent with the Federal regulations. </P>
        <P>Section 211.121(c) was added by this amendment. This section provides an exception to subsection (d), which requires a blasting activity permit to conduct blasting activities. The exception provided by subsection (c) is that blasting activities authorized under a permit issued under Pennsylvania's coal mining program serves to act as a blasting activity permit. There is no provision in the Federal regulations requiring a blasting activity permit separate from that required as part of a permit for mining activities. As a result, we are approving this section because it does not make Pennsylvania's program inconsistent with the Federal regulations. Accordingly, we are also approving subsections (d) and (e) as not inconsistent with the Federal rules as these sections are intended to apply to blasting activities other than those conducted on surface coal mining operations and therefore, there is no Federal counterpart. </P>
        <P>Section 211.152 was added by this amendment. This section provides for control of gases generated by blasts. There is no Federal counterpart to this provision. We are approving this section because it is not inconsistent with the Federal regulations. </P>
        <P>Section 211.157(g) was added by this amendment. This section requires a blaster-in-charge to notify Pennsylvania of the occurrence of a misfire within 24 hours. There is no Federal counterpart to this provision. We are approving this section because it is not inconsistent with the Federal regulations. </P>
        <P>Sections 211.162(a) and (b) were added by this amendment. These sections provide for the use of safety fuses in blasting. There is no Federal counterpart to this provision. We are approving this section because it is not inconsistent with the Federal regulations. </P>
        <P>Section 211.173(a) was added by this amendment. This section provides that, “Anyone using a monitoring instrument shall be trained on the proper use of that instrument by a representative of the manufacturer or distributor, or other competent individual. A record of that training is to be maintained and available for review by the Department.” There is no Federal counterpart to this provision. We are approving this section because it is not inconsistent with the Federal regulations. </P>
        <HD SOURCE="HD1">IV. Summary and Disposition of Comments </HD>
        <HD SOURCE="HD2">Public Comments </HD>
        <P>We asked for public comments on the amendment (Administrative Record No. PA 878.03), but did not receive any. </P>
        <HD SOURCE="HD2">Federal Agency Comments </HD>
        <P>Under 30 CFR 732.17(h)(11)(i) and section 503(b) of SMCRA, we requested comments on the amendment from various Federal agencies with an actual or potential interest in the Pennsylvania program (Administrative Record No. PA 878.03). In a letter dated April 5, 2002 (Administrative Record No. PA 878.06), the United States Department of Labor, Mining Safety and Health Administration's District 2 New Stanton Office found the changes were not in conflict with 30 CFR, Part 77, Subpart N-Explosives and Blasting. </P>
        <HD SOURCE="HD2">Environmental Protection Agency (EPA) Concurrence and Comments </HD>
        <P>Under 30 CFR 732.17(h)(11)(i), we requested comments on the amendment from EPA (Administrative Record No. PA 878.03). EPA responded on March 26, 2002, that there were no apparent inconsistencies with the Clean Water Act or other statutes under its jurisdiction (Administrative Record No. PA 878.04). </P>
        <HD SOURCE="HD2">State Historic Preservation Officer (SHPO) and the Advisory Council on Historic Preservation (ACHP) </HD>
        <P>Under 30 CFR 732.17(h)(4), we are required to request comments from the SHPO and ACHP on amendments that may have an effect on historic properties. On March 1, 2002, we requested comments on Pennsylvania's amendment (Administrative Record No. PA 878.03) from the Pennsylvania Historical and Museum Commission (PHMC). The PHMC responded on March 26, 2002 (Administrative Record No. PA 878.05) that it had no comment on the amendment. </P>
        <HD SOURCE="HD1">V. OSM's Decision </HD>

        <P>Based on the above findings, we approve the amendment Pennsylvania sent to us on February 25, 2002, as clarified on July 15, 2003, and July 23, 2003. <PRTPAGE P="48797"/>
        </P>
        <P>To implement this decision, we are amending the Federal regulations at 30 CFR part 938, which codify decisions concerning the Pennsylvania program. We find that good cause exists under 5 U.S.C. 553(d)(3) to make this final rule effective immediately. Section 503(a) of SMCRA requires that the State's program demonstrate that the State has the capability of carrying out the provisions of the Act and meeting its purposes. Making this regulation effective immediately will expedite that process. SMCRA requires consistency of State and Federal standards. </P>
        <HD SOURCE="HD1">VI. Procedural Determinations </HD>
        <HD SOURCE="HD2">Executive Order 12630—Takings </HD>
        <P>This rule does not have takings implications. This determination is based on the analysis performed for the counterpart Federal regulation. Similarly there are no takings implications for the portions of the amendment that have no Federal counterpart because the provisions are administrative and procedural in nature and are not expected to have an economical or substantive effect on the regulated industry. The amendment concerns only the regulation of blasting operations and does not imply the taking of private property by the Federal government. </P>
        <HD SOURCE="HD2">Executive Order 12866—Regulatory Planning and Review </HD>
        <P>This rule is exempted from review by the Office of Management and Budget under Executive Order 12866. </P>
        <HD SOURCE="HD2">Executive Order 12988—Civil Justice Reform </HD>
        <P>The Department of the Interior has conducted the reviews required by section 3 of Executive Order 12988 and has determined that this rule meets the applicable standards of subsections (a) and (b) of that section. However, these standards are not applicable to the actual language of State regulatory programs and program amendments because each program is drafted and promulgated by a specific State, not by OSM. Under sections 503 and 505 of SMCRA (30 U.S.C. 1253 and 1255) and the Federal regulations at 30 CFR 730.11, 732.15, and 732.17(h)(10), decisions on proposed State regulatory programs and program amendments submitted by the States must be based solely on a determination of whether the submittal is consistent with SMCRA and its implementing Federal regulations and whether the other requirements of 30 CFR parts 730, 731, and 732 have been met. </P>
        <HD SOURCE="HD2">Executive Order 13132—Federalism </HD>
        <P>This rule does not have Federalism implications. SMCRA delineates the roles of the Federal and State governments with regard to the regulation of surface coal mining and reclamation operations. One of the purposes of SMCRA is to “establish a nationwide program to protect society and the environment from the adverse effects of surface coal mining operations.” Section 503(a)(1) of SMCRA requires that State laws regulating surface coal mining and reclamation operations be “in accordance with” the requirements of SMCRA, and section 503(a)(7) requires that State programs contain rules and regulations “consistent with” regulations issued by the Secretary pursuant to SMCRA. </P>
        <HD SOURCE="HD2">Executive Order 13175—Consultation and Coordination With Indian Tribal Governments </HD>
        <P>In accordance with Executive Order 13175, we have evaluated the potential effects of this rule on Federally-recognized Indian tribes and have determined that the rule does not have substantial direct effects on one or more Indian tribes, on the relationship between the Federal Government and Indian tribes, or on the distribution of power and responsibilities between the Federal Government and Indian Tribes. Pennsylvania does not regulate any Native Tribal lands. </P>
        <HD SOURCE="HD2">Executive Order 13211—Regulations That Significantly Affect the Supply, Distribution, or Use of Energy </HD>
        <P>On May 18, 2001, the President issued Executive Order 13211 which requires agencies to prepare a Statement of Energy Effects for a rule that is (1) considered significant under Executive Order 12866, and (2) likely to have a significant adverse effect on the supply, distribution, or use of energy. Because this rule is exempt from review under Executive Order 12866 and is not expected to have a significant adverse effect on the supply, distribution, or use of energy, a Statement of Energy Effects is not required. </P>
        <HD SOURCE="HD2">National Environmental Policy Act </HD>
        <P>This rule does not require an environmental impact statement because section 702(d) of SMCRA (30 U.S.C. 1292(d)) provides that agency decisions on proposed State regulatory program provisions do not constitute major Federal actions within the meaning of section 102(2)(C) of the National Environmental Policy Act (42 U.S.C. 4332(2)(C)). </P>
        <HD SOURCE="HD2">Paperwork Reduction Act </HD>

        <P>This rule does not contain information collection requirements that require approval by OMB under the Paperwork Reduction Act (44 U.S.C. 3507 <E T="03">et seq.</E>). </P>
        <HD SOURCE="HD2">Regulatory Flexibility Act </HD>

        <P>The Department of the Interior certifies that this rule will not have a significant economic impact on a substantial number of small entities under the Regulatory Flexibility Act (5 U.S.C. 601 <E T="03">et seq.</E>). This determination is based on the fact that the deletions, revisions, and additions by the Pennsylvania Department of Environmental Protection listed in Chapters 210 and 211 are administrative and procedural in nature and are not expected to have an economical or substantive effect on the regulated industry. </P>
        <HD SOURCE="HD2">Small Business Regulatory Enforcement Fairness Act </HD>
        <P>This rule is not a major rule under 5 U.S.C. 804(2), the Small Business Regulatory Enforcement Fairness Act. This rule: (a) Does not have an annual effect on the economy of $100 million; (b) Will not cause a major increase in costs or prices for consumers, individual industries, Federal, State, or local government agencies, or geographic regions; and (c) Does not have significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete with foreign-based enterprises. This determination is based on the fact that the deletions, revisions, and additions by the Pennsylvania Department of Environmental Protection listed in Chapters 210 and 211 are administrative and procedural in nature and are not expected to have an economical or substantive effect on the regulated industry. </P>
        <HD SOURCE="HD2">Unfunded Mandates </HD>
        <P>This rule will not impose an unfunded mandate on State, local, or tribal governments or the private sector of $100 million or more in any given year. This determination is based on the fact that the deletions, revisions, and additions by the Pennsylvania Department of Environmental Protection listed in Chapters 210 and 211 are administrative and procedural in nature and are not expected to have an economical or substantive effect on the regulated industry. </P>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects in 30 CFR Part 938 </HD>
          <P>Intergovernmental relations, Surface mining, Underground mining.</P>
        </LSTSUB>
        <SIG>
          <PRTPAGE P="48798"/>
          <DATED>Dated: July 24, 2003. </DATED>
          <NAME>Brent Wahlquist, </NAME>
          <TITLE>Regional Director, Appalachian Regional Coordinating Center. </TITLE>
        </SIG>
        <REGTEXT PART="938" TITLE="30">
          <AMDPAR>For the reasons set out in the preamble, 30 CFR part 938 is amended as set forth below: </AMDPAR>
          <PART>
            <HD SOURCE="HED">PART 938—PENNSYLVANIA </HD>
          </PART>
          <AMDPAR>1. The authority citation for part 938 continues to read as follows: </AMDPAR>
          <AUTH>
            <HD SOURCE="HED">Authority:</HD>
            <P>30 U.S.C. 1201 <E T="03">et seq.</E>
            </P>
          </AUTH>
        </REGTEXT>
        
        <REGTEXT PART="938" TITLE="30">

          <AMDPAR>2. Section 938.15 is amended in the table by adding a new entry in chronological order by “<E T="03">Date of final publication</E>” to read as follows: </AMDPAR>
          <SECTION>
            <SECTNO>§ 938.15 </SECTNO>
            <SUBJECT>Approval of Pennsylvania regulatory program amendments. </SUBJECT>
            <STARS/>
            <GPOTABLE CDEF="s75,r75,r100" COLS="3" OPTS="L1,tp0,i1">
              <TTITLE>  </TTITLE>
              <BOXHD>
                <CHED H="1">Original amendment submission date </CHED>
                <CHED H="1">Date of final publication </CHED>
                <CHED H="1">Citation/description </CHED>
              </BOXHD>
              <ROW>
                <ENT I="22">  </ENT>
              </ROW>
              <ROW>
                <ENT I="28">*         *         *         *         *         *         * </ENT>
              </ROW>
              <ROW>
                <ENT I="01">February 25, 2002 </ENT>
                <ENT>August 15, 2003 </ENT>
                <ENT>25 Pa. Code 210.11; 210.13—210.19; 211.101-211.103; 211.111-211.115; 211.121-211.125; 211.131-211.133; 211.141; 211.151-211.162; 211.171-211.173; 211.181-211.182 </ENT>
              </ROW>
            </GPOTABLE>
          </SECTION>
        </REGTEXT>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20916 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4310-05-P</BILCOD>
    </RULE>
    <RULE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF HOMELAND SECURITY </AGENCY>
        <SUBAGY>Coast Guard </SUBAGY>
        <CFR>33 CFR Part 165 </CFR>
        <DEPDOC>[CGD01-02-104] </DEPDOC>
        <RIN>RIN 1625-AA00, AA11 </RIN>
        <SUBJECT>Regulated Navigation Areas, Safety and Security Zones; Long Island Sound Marine Inspection and Captain of the Port Zone </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Coast Guard, DHS. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Final rule. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The Coast Guard is establishing a regulated navigation area (RNA) and two safety and security zones. The rule regulates the circumstances under which certain vessels may enter, transit or operate within the RNA and excludes all vessels from operating within the prescribed safety and security zones without first obtaining authorization from the Captain of the Port. This action is necessary to ensure public safety and prevent sabotage or other subversive acts. </P>
        </SUM>
        <EFFDATE>
          <HD SOURCE="HED">DATES:</HD>
          <P>This rule is effective August 16, 2003. </P>
        </EFFDATE>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Comments and material received from the public, as well as documents indicated in this preamble as being available in the docket, are part of docket CGD01-02-104, and are available for inspection or copying at Group/MSO Long Island Sound, New Haven, CT, between 9 a.m. and 3 p.m., Monday through Friday, except Federal holidays </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Lieutenant A. Logman, Waterways Management Officer, Coast Guard Group/Marine Safety Office Long Island Sound at (203) 468-4429. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P/>
        <HD SOURCE="HD1">Regulatory Information </HD>

        <P>On March 20, 2003, we published a notice of proposed rulemaking (NPRM) entitled “Regulated Navigation Areas, Safety and Security Zones; Long Island Sound Marine Inspection and Captain of the Port Zone” in the <E T="04">Federal Register</E> (68 FR 13643). We received two (2) letters commenting on the proposed rule. No public hearing was requested, and none was held. </P>

        <P>Good cause exists for making this regulation effective on August 16, 2003, in less than 30 days after <E T="04">Federal Register</E> publication. Delaying publication is unnecessary for the following reasons: Several of the permanent regulations described herein have been in effect as temporary regulations since December 10, 2001 with no adverse impact; the public has had significant and adequate advanced knowledge of the intent to implement these as permanent regulations through the notice and comment rulemaking process, as well as through outreach to the maritime community by the Captain of the Port (COTP) Long Island Sound; and the NPRM stated this regulation was designed to replace temporary security measures expiring on August 15, 2003. Thus the public has had significant advanced knowledge of these regulations and that it was necessary that they be effective by August 16, 2003. Any delay encountered in this regulation's effective date would also be contrary to public interest. As discussed in the <E T="03">Background and Purpose</E> section below, these regulations are necessary to address potential terrorist threats in the Long Island Sound Marine Inspection and Captain of the Port Zone on a permanent basis. If the temporary regulations were to expire on August 15, 2003 without permanent regulations being implemented, vessels, waterfront facilities, the maritime community, public infrastructure, and the public in general in the Long Island Sound Marine Inspection and Captain of the Port Zone would be left vulnerable to possible sabotage or other subversive acts, accidents or other causes of a similar nature. </P>
        <HD SOURCE="HD1">Background and Purpose </HD>
        <P>On September 11, 2001, two commercial aircraft were hijacked from Logan Airport in Boston, Massachusetts and flown into the World Trade Center in New York, NY inflicting catastrophic human casualties and property damage. A similar attack was conducted on the Pentagon with a plane launched from Newark, NJ on the same day. National security and intelligence officials warn that future terrorist attacks are likely. </P>

        <P>Vessels operating within the Long Island Sound Marine Inspection and Captain of the Port (COTP) Zone present potential targets of terrorist attack or platforms from which terrorist attacks may be launched upon other vessels, waterfront facilities and adjacent population centers. Following the September 11 attacks, we published a temporary rule (67 FR 517-520, January 4, 2002), which was effective December 10, 2001, that established a temporary regulated navigation area (RNA) and safety and security zones in the Long Island Sound Marine Inspection and COTP Zone. We revised the temporary rule three times (67 FR 40859-40861, June 14, 2002, 67 FR 69132, November 15, 2002, and 68 FR 12304, March 14, 2003) to extend its effective period to August 15, 2003. These temporary measures were taken to safeguard human life, vessels and waterfront facilities from sabotage or terrorist acts while we assessed the security environment within the area and determined the need for and <PRTPAGE P="48799"/>advisability of permanent security measures. </P>
        <P>The Coast Guard is now establishing a permanent RNA and two permanent safety and security zones within Long Island Sound as part of a comprehensive, port security regime designed to safeguard human life, vessels and waterfront facilities from sabotage or terrorist acts. This permanent RNA incorporates the provisions of the temporary RNA that have been in place since December 10, 2001, and expands the operating requirements for vessels within the RNA. This rule also establishes two permanent safety and security zones. The zones have been tailored to fit the needs of security, while minimizing the impact on the maritime community. </P>
        <HD SOURCE="HD1">Discussion of Comments and Changes </HD>
        <P>We received two (2) letters commenting on the notice of proposed rulemaking. The first comment letter recommended that proposed regulation 33 Code of Federal Regulations (CFR) 165.153(d)(3) be amended to include not only towing vessels engaged in towing tank barges carrying petroleum oil in bulk as cargo, but rather to include all primary towing vessels engaged in towing. The section has been revised to include all towing vessels engaged in towing. In addition, we have included a provision in the rule that exempts towing vessels engaged in coastwise trade. This revision reflects the intention of the proposed rulemaking, which was, in part, to facilitate trade in the COTP Long Island Sound Zone consistent with the needs of safety and security. This exemption permits coastwise tug and barge units to move freely within United States waters. </P>
        <P>In addition, the comment indicated to us that combining the inspection and advanced authorization requirements into one regulation in proposed section 165.153(d)(3) may have been confusing with respect to the two distinct requirements imposed. To clarify these requirements, section 165.153(d)(3) has been revised into two separate regulations for inspection and authorization, located in the final rule in sections 165.153(d)(3) and 165.153(d)(4), respectively. Subsequent paragraphs (4) through (8) in the proposed regulation 165.153(d) have been renumbered as paragraphs (5) through (9), respectively. </P>
        <P>The second letter contained 12 distinct comments and/or recommendations regarding the proposed regulations. Each of these comments, and the response taken to each in the final regulations, are addressed below: </P>
        <P>The first comment questioned the need for defining “public vessels” both in sections 165.153(b) and (c)(3). We agree that this is unnecessary repetition of the definition of “public vessels;” as such, the definition of “public vessels” has been removed from the final rule in section 165.153(b). </P>
        <P>The second comment asked for clarification regarding the definition of “commercial vessel.” Specifically, the comment asked whether a commercial vessel is a vessel in commercial service or a vessel engaged in commerce. The proposed regulation used the term “commercial vessel” as the title of section 165.153(d)(6). While the content of this section is clear in its applicability of the vessel operating requirements to those vessels in commercial service, the use of the term “commercial vessel” in this section is potentially confusing. This regulation was intended to apply to those vessels engaged in commercial service, as that term is defined in section 165.153(c)(1). For clarification, the title of the final rule section 165.153(d)(7) has been changed to “vessels engaged in commercial service.” In addition, the text of the regulation has been revised to prohibit vessels from entering within a 100-yard radius of any vessel “engaged in commercial service,” vice the proposed regulation language of “vessel in commercial service.” </P>
        <P>The third comment asked whether “engaged in commerce” used in the definition of public vessel in proposed section 165.153(c)(3) differs from the definition of “commercial service” in proposed section 165.153(c)(1). The definitions were intended to be the same in the proposed regulation. The use of “engaged in commerce” in the proposed regulation has been revised to read “engaged in commercial service”; this reflects the intention of the original proposed regulation, and is consistent with the derivation of the definition of “public vessel,” which is found in title 46 United States Code, sections 2101(24)(A) and (B). </P>
        <P>The fourth comment asked whether the tonnage threshold in proposed section 165.153(d)(2) applies to individual vessels or whether these apply to the combined tonnage of towing vessels and their tows. As proposed, and as implemented here, the tonnage limitation applies to individual vessels. The standard industry practice is for the tugboat operator to issue the security call for both manned and unmanned barges. It was not the intention of the proposed regulation to require vessels under tow to make their own securité call in addition to that made by the tugboat. In addition, this section was only intended to address vessels engaged in towing of barges, and was not intended to encompass recreational vessels or commercial assistance towing. The final regulation located in section 165.153(d)(2) has been revised as a result of this comment to include all vessels engaged in towing barges. </P>
        <P>The fifth comment recommended applying an exemption for vessels in innocent passage to proposed regulation 165.153(d)(4), since one was applied in proposed section 165.153(d)(3). Innocent passage, as defined under Articles 18 and 19 of the 1982 United Nations Convention on the Law of the Sea (UNCLOS II), involves “navigation through the territorial sea for the purpose of (a) traversing that sea without entering internal waters or calling at a roadstead or port facility outside internal waters; or (b) proceeding to or from internal waters or a call at such roadstead or port facility.” Proposed section 165.153(d)(4) (now section 165.153(d)(5)) requires vessels over 1600 gross tons operating within three nautical miles from the territorial sea baseline to receive COTP authorization prior to vessel movements. As the internationally recognized rights of “innocent passage” could potentially be impacted in this proposed section as well as proposed section 165.153(d)(3), we addressed this comment in regards to both proposed sections and made appropriate changes in the regulation. </P>

        <P>The inspection and authorization requirements in proposed section 165.153(d)(3) (now final sections 165.153(d)(3) and (d)(4)) were intended to require all vessels bound for a port or place in the United States, and not otherwise exempted, to be inspected and/or obtain COTP authorization prior to entering within three nautical miles of the territorial sea baseline. It contained a complete exemption for vessels in innocent passage. The intention of the requirements in proposed section 165.153(d)(4) (now section 165.153(d)(5)) was for vessels over 1600 gross tons, operating within three nautical miles of the territorial sea baseline or within internal waters, to be required to receive authorization prior to any intentional vessel movements. As originally proposed, these two sections, 165.153(d)(3) and (d)(4) were intended to protect against vessels entering within or operating within three nautical miles of the territorial sea baseline and in the internal waters of the United States. These vessels present potential security concerns which these regulations were designed to protect against.<PRTPAGE P="48800"/>
        </P>
        <P>A complete exception for vessels in “innocent passage”, as proposed in section 165.153(d)(3) and sought by the comment in section 165.153(d)(4) would permit any vessel bound for a port or place in the United States to transit within three nautical miles of the territorial sea baseline without invoking the regulation's inspection and authorization requirements. This would negate the operation and purpose of these protective measures. As a result, proposed sections 165.153 (d)(3) and (d)(4) were rewritten, and references to “innocent passage” were changed as described herein to allow certain exceptions as allowable or required by Treaty and Law, while still allowing for effective regulation. </P>
        <P>Innocent passage rights will and must be impacted in certain situations in final sections 165.153(d)(3), (d)(4), and (d)(5), to maintain the purpose and effectiveness of this regulation. For example, any vessel transiting to a port in Unites States internal waters, by definition, is considered in “innocent passage” while still in the territorial sea (which includes the area within three nautical miles of the territorial sea baseline) during its transit. Final sections 165.153(d)(3), (d)(4), and (d)(5) impact the right of “innocent passage” because they impose requirements which vessels must meet before entering within three nautical miles of the territorial sea baseline when they are bound for ports or places in United States. </P>
        <P>Even when within three nautical miles of the territorial sea baseline, these vessels are in “innocent passage” if they are en route to a United States port in United States internal waters because they are still within United States territorial waters and “proceeding to or from internal waters” as per Article 18 of UNCLOS II. Yet, if the COTP were not permitted to impose requirements on vessels in these situations, sections 165.153(d)(3), (d)(4), and (d)(5) of this regulation would be meaningless, and potentially dangerous vessels claiming “innocent passage” bound for United States internal ports could transit up to the territorial sea baseline without being investigated by the COTP. </P>
        <P>Thus, with regards to innocent passage, only those vessels which are not bound for a port or place in the United States will be exempted from the requirements of sections 165.153(d)(3), (d)(4), and (d)(5). These vessels are of minimal security interest to the COTP. Additionally, under 33 U.S.C. 1223(d) such vessels are statutorily exempted from the requirements herein (33 U.S.C. 1223(d) falls under the Port and Waterways Safety Act, which is one of the authorities under which this regulation is promulgated). </P>
        <P>Vessels “bound for a port or place located in the United States or that must transit the internal waters of the United States” as dictated in final sections 165.153(d)(3), (d)(4), and (d)(5) will be subject to these regulations, even if in “innocent passage” by definition under Article 18 1. (b) of the UNCLOS II. Such vessels are not exempted from the Port and Waterways Safety Act under 33 U.S.C. 1223(d). In addition, imposing certain conditions on vessels in “innocent passage” is supported by Article 21 under UNCLOS II, which states that coastal nations may adopt laws and regulations relating to innocent passage through the territorial sea with respect to, among other items, “the safety of navigation and the regulation of maritime traffic * * *, * * * the protection of navigational aids and facilities and other facilities or installations * * * and * * * the prevention of infringement of the customs, fiscal, immigration or sanitary laws and regulations of the coastal State.” </P>
        <P>The sixth comment addressed the appropriateness of proposed section 165.153(d)(3)'s applicability to all tonnages and recreational vessels, as many of the vessels impacted by this section are not required to carry radios, making it impossible for them to obtain authorization. Proposed section 165.153(d)(3) specifically exempted recreational vessels from these requirements, as well as other vessels. The intention of this section was to be able to monitor those vessels not engaged in commercial service arriving into the United States from a foreign port and ensure compliance with appropriate customs and immigration requirements. As such, this exemption has been narrowed and we have revised final rule sections 165.153(d)(3) and (d)(4) to exempt only those vessels not engaged in commercial service whose last port of call was in the United States. Vessels to which the regulation applies may obtain authorization from the Captain of the Port, Long Island Sound, in several ways, including via marine radio, telephone, facsimile, or letter. Final rule sections 165.153(d)(3) and (d)(4) have been revised to include these options for contacting the COTP. </P>
        <P>The seventh comment raised concern with excluding primary towing vessels engaged in towing tank barges carrying petroleum oil in bulk as cargo from the inspection and authorization requirements of proposed regulation 165.153(d)(3). Specifically, it questioned why this requirement was not applicable to tank barges carrying petroleum, and questions why these vessels are considered less of a safety and security threat. As discussed above, this section is being expanded to include all towing vessels engaged in towing in coastwise trade. This exemption permits coastwise tug and barge units to move freely within United States waters. </P>
        <P>The eighth and ninth comments raised concern with the ability of vessels to contact commercial vessels which are moored or anchored to request permission to enter the restricted navigation area imposed by proposed section 165.153(d)(6). This comment recommended that anchored or moored commercial vessels be required to maintain a continuous radio watch, and also recommended that the regulation provide for delegation of the authority to authorize entry into the zone by the licensed master or operator of the vessel to subordinates. As discussed above in paragraph 3, the scope of the requirement in the final rule has been clarified to include vessels engaged in commercial service, vice all commercial vessels, which significantly limits the scope of this regulation. For example, this requirement would not apply to a small passenger vessel moored at a marina which is not engaged in carrying passengers or goods. The master of a vessel is responsible for ensuring compliance with this regulation, however, nothing in this regulation prohibits the master from developing procedures/orders for the crew to ensure its operation is in compliance with the laws and/or regulations herein. As such, it is unnecessary to specifically address the delegation of this authority in the regulatory text. Vessels seeking permission to enter within 100-yards of a vessel engaged in commercial service should use all means available to communicate with the vessel; if unable to contact the vessel to obtain permission, vessels are not permitted to enter within this 100-yard zone. No changes have been made to the final rule based on this comment. </P>
        <P>The tenth comment raised questioned whether section 165.153(d)(6) created a “no authorized entry zone” around commercial vessels of any size. There is no size limitation within this regulation; the prohibition on entry within 100-yards of a vessel engaged in commercial service applies to all vessels engaged in commercial service, irrespective of size. No changes have been made to the final rule based on this comment. </P>

        <P>The eleventh comment questions whether safety and security zones can be implemented around anchored Coast <PRTPAGE P="48801"/>Guard vessels in proposed regulation section 165.154(a)(2), because proposed section 165.153(b) excludes “public vessels” from the applicability of the regulations. The public vessel exclusion in section 165.153 only applies to that section. It does not apply to those regulations in section 165.154. Even if this exclusion was applicable to section 165.154, it would not exclude creation of safety and security zones around Coast Guard vessels: the applicability section addresses who the regulation may be enforced against, not what regulations may be imposed. No changes have been made to the final rule based on this comment. </P>
        <P>The twelfth and final comment of this letter recommended allowing other federal, state and municipal agencies to assist the Coast Guard in enforcement of proposed sections 165.153(d)(5)-(7), as is provided in section 165.153(d)(1). Section 165.153(d)(1) provides that the U.S. Navy and other Federal, State and municipal agencies may assist the U.S. Coast Guard in the enforcement of the speed restrictions imposed in the vicinity of Naval Submarine Base New London. Title 33 CFR 6.04-11 provides that the Captain of the Port may enlist the aid of Federal, State, municipal and private agencies to assist in the enforcement of regulations. It is not necessary to restate this authority in the regulatory text. No changes have been made to the regulatory text of the final rule based on this comment. </P>
        <P>Lastly, a definition of “territorial sea baseline” has been included as section 165.153(c)(4). This definition adopts the definition of “territorial sea baseline” as found in 33 CFR subchapter A, and aids in clarity of the requirements imposed by section 165.153. </P>
        <HD SOURCE="HD1">Regulatory Evaluation </HD>
        <P>This rule is not a “significant regulatory action” under section 3(f) of Executive Order 12866, Regulatory Planning and Review, and does not require an assessment of potential costs and benefits under section 6(a)(3) of that Order. The Office of Management and Budget has not reviewed it under that Order. It is not “significant” under the regulatory policies and procedures of the Department of Homeland Security (DHS). </P>
        <P>The Coast Guard expects the economic impact of this final rule to be so minimal that a full Regulatory Evaluation under the regulatory policies and procedures of DHS is unnecessary. This regulation may have some impact on the public, but these potential impacts will be minimized for the following reasons: there is ample room for vessels to navigate around each of the safety and security zones; it is contemplated that vessels will be able to operate elsewhere within the RNA once the Captain of the Port has determined that the vessels do not pose a threat to individuals, other vessels or waterfront facilities; to the extent that the rule tracks the provisions of temporary rules that have been in place since December 10, 2001, our experience demonstrates that it not burdensome on the maritime public; and the local maritime community will be informed of the zones via marine information broadcasts. While recognizing the potential for some minimal impact from the rule, the Coast Guard considers it de minimus in comparison to the compelling national interest in protecting the public, vessels, and vessel crews from the further devastating consequences of the aforementioned acts of terrorism, and from potential future sabotage or other subversive acts, accidents, or other causes of a similar nature.</P>
        <HD SOURCE="HD1">Small Entities </HD>
        <P>Under the Regulatory Flexibility Act (5 U.S.C. 601-612), we have considered whether this rule would have a significant economic impact on a substantial number of small entities. The term “small entities” comprises small businesses, not-for-profit organizations that are independently owned and operated and are not dominant in their fields, and governmental jurisdictions with populations of less than 50,000. </P>
        <P>The Coast Guard certifies under 5 U.S.C. 605(b) that this rule will not have a significant economic impact on a substantial number of small entities. This rule may affect the following entities, some of which may be small entities: the owners or operators of vessels intending to transit or anchor in those portions of Long Island Sound and the Thames River covered by the RNA and/or safety and security zones. </P>
        <P>This rule will not have a significant impact on a substantial number of small entities because the safety and security zones are limited in size, leaving ample room for vessels to navigate around the zones. The zones will not significantly impact commuter and passenger vessel traffic patterns, and mariners will be notified of the zones via local notice to mariners and marine broadcasts. Also, the Captain of the Port will make broad allowances for individuals to enter the zones during periods when the potential threats to the area are deemed to be low. The regulations imposed under the RNA will impact a minimal number of commercial and recreational vessels, as several of the regulations only apply to large commercial vessels. The regulated areas around ferry vessels and vessels engaged in commercial service will minimally impact those vessels to whom these regulations apply while waiting for authorization to enter the regulated area from the licensed operator, licensed master, or the designated COTP on-scene patrol. Moreover, the ferry vessel regulated navigation area only applies to vessels of 300 gross tons or greater; the 100-yard regulated navigation area around commercial vessels leaves ample room for vessels to navigate outside of this area. To the extent that this rule tracks the provisions of temporary rules that have been in place since December 10, 2001 our experience demonstrates that it has not been burdensome on the maritime public. </P>
        <HD SOURCE="HD1">Assistance for Small Entities </HD>
        <P>Under subsection 213(a) of the Small Business Regulatory Enforcement Fairness Act of 1996 (Pub. L. 104-121), the Coast Guard wants to assist small entities in understanding this rule so that they can better evaluate its effects on them and participate in the rulemaking. If the rule would affect your small business, organization, or governmental jurisdiction and you have questions concerning its provisions or options for compliance, please call Lieutenant A. Logman, Waterways Management Officer, Group/Marine Safety Office Long Island Sound, at (203) 468-4429. </P>
        <P>Small businesses may send comments on the actions of Federal employees who enforce, or otherwise determine compliance with, Federal regulations to the Small Business and Agriculture Regulatory Enforcement Ombudsman and the Regional Small Business Regulatory Fairness Boards. The Ombudsman evaluates these actions annually and rates each agency's responsiveness to small business. If you wish to comment on actions by employees of the Coast Guard, call 1-888-REG-FAIR (1-888-734-3247). </P>
        <HD SOURCE="HD1">Collection of Information </HD>
        <P>This rule calls for no new collection of information under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501-3520). </P>
        <HD SOURCE="HD1">Federalism </HD>

        <P>A rule has implications for federalism under Executive Order 13132, Federalism, if it has a substantial direct effect on State or local governments and would either preempt State law or imposes a substantial direct cost of compliance on them. We have analyzed this rule under that Order and have <PRTPAGE P="48802"/>determined that it does not have implications for federalism. </P>
        <HD SOURCE="HD1">Unfunded Mandates Reform Act </HD>
        <P>The Unfunded Mandates Reform Act of 1995 (2 U.S.C. 1531-1538) requires Federal agencies to assess the effects of their discretionary regulatory actions. In particular, the Act addresses actions that may result in the expenditure by a State, local, or tribal government, in the aggregate, or by the private sector of $100,000,000 or more in any one year. Though this rule will not result in such an expenditure, we do discuss the effects of this rule elsewhere in this preamble. </P>
        <HD SOURCE="HD1">Taking of Private Property </HD>
        <P>This rule will not effect a taking of private property or otherwise have taking implications under Executive Order 12630, Governmental Actions and Interference with Constitutionally Protected Property Rights. </P>
        <HD SOURCE="HD1">Civil Justice Reform </HD>
        <P>This rule meets applicable standards in sections 3(a) and 3(b)(2) of Executive Order 12988, Civil Justice Reform, to minimize litigation, eliminate ambiguity, and reduce burden. </P>
        <HD SOURCE="HD1">Protection of Children </HD>
        <P>We have analyzed this rule under Executive Order 13045, Protection of Children from Environmental Health Risks and Safety Risks. This rule is not an economically significant rule and would not concern an environmental risk to health or risk to safety that may disproportionately affect children. </P>
        <HD SOURCE="HD1">Indian Tribal Governments </HD>
        <P>This rule does not have tribal implications under Executive Order 13175, Consultation and Coordination with Indian Tribal Governments, because it would not have a substantial direct effect on one or more Indian tribes, on the relationship between the Federal Government and Indian tribes, or on the distribution of power and responsibilities between the Federal Government and Indian tribes. </P>
        <HD SOURCE="HD1">Energy Effects </HD>
        <P>We have analyzed this rule under Executive Order 13211, Actions Concerning Regulations That Significantly Affect Energy Supply, Distribution, or Use. We have determined that it is not a “significant energy action” under that Order because it is not a “significant regulatory action” under Executive Order 12866 and is not likely to have a significant adverse effect on the supply, distribution, or use of energy. It has not been designated by the Administrator of the Office of Information and Regulatory Affairs as a significant energy action. Therefore, it does not require a Statement of Energy Effects under Executive Order 13211. </P>
        <HD SOURCE="HD1">Environment </HD>

        <P>The Coast Guard considered the environmental impact of this rule and concluded that, under figure 2-1, paragraph 34(g), of Commandant Instruction M16475.1D, this rule is categorically excluded from further environmental documentation. A “Categorical Exclusion Determination” is available in the docket where indicated under <E T="02">ADDRESSES.</E>
        </P>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects in 33 CFR Part 165 </HD>
          <P>Harbors, Marine safety, Navigation (water), Reporting and recordkeeping requirements, Security measures, Waterways.</P>
        </LSTSUB>
        
        <REGTEXT PART="165" TITLE="33">
          <AMDPAR>For the reasons discussed in the preamble, the Coast Guard amends 33 CFR part 165 as follows: </AMDPAR>
          <PART>
            <HD SOURCE="HED">PART 165—REGULATED NAVIGATION AREAS AND LIMITED ACCESS AREAS </HD>
          </PART>
          <AMDPAR>1. The authority citation for part 165 continues to read as follows: </AMDPAR>
          <AUTH>
            <HD SOURCE="HED">Authority:</HD>
            <P>33 U.S.C. 1226, 1231; 46 U.S.C. Chapter 701; 50 U.S.C. 191, 195; 33 CFR 1.05-1(g), 6.04-1, 6.04-6, and 160.5; Department of Homeland Security Delegation No. 0170. </P>
          </AUTH>
        </REGTEXT>
        
        <REGTEXT PART="165" TITLE="33">
          <AMDPAR>2. Add § 165.153 to read as follows: </AMDPAR>
          <SECTION>
            <SECTNO>§ 165.153 </SECTNO>
            <SUBJECT>Regulated Navigation Area: Long Island Sound Marine Inspection and Captain of the Port Zone. </SUBJECT>
            <P>(a) <E T="03">Regulated Navigation Area location.</E> All waters of the Long Island Sound Marine Inspection and Captain of the Port (COTP) Zone, as delineated in 33 CFR 3.05-35, extending seaward 12 nautical miles from the territorial sea baseline, are established as a regulated navigation area (RNA). </P>
            <P>(b) <E T="03">Applicability.</E> This section applies to all vessels operating within the RNA excluding public vessels. </P>
            <P>(c) <E T="03">Definitions.</E> The following definitions apply to this section: </P>
            <P>
              <E T="03">Commercial service</E> means any type of trade or business involving the transportation of goods or individuals, except service performed by a combatant vessel. </P>
            <P>
              <E T="03">Ferry</E> means a vessel that: </P>
            <P>(1) Operates in other than ocean or coastwise service; </P>
            <P>(2) Has provisions only for deck passengers or vehicles, or both; </P>
            <P>(3) Operates on a short run on a frequent schedule between two points over the most direct water route; and </P>
            <P>(4) Offers a public service of a type normally attributed to a bridge or tunnel. </P>
            <P>
              <E T="03">Public vessels</E> means vessels owned or bareboat chartered and operated by the United States, or by a State or political subdivision thereof, or by a foreign nation, except when such vessel is engaged in commercial service. </P>
            <P>
              <E T="03">Territorial sea baseline</E> means the line defining the shoreward extent of the territorial sea of the United States drawn according to the principles, as recognized by the United States, of the Convention on the Territorial Sea and the Contiguous Zone, 15 U.S.T. 1606, and the 1982 United Nations Convention on the Law of the Sea (UNCLOS), 21 I.L.M. 1261. Normally, the territorial sea baseline is the mean low water line along the coast of the United States. </P>
            <P>(d) <E T="03">Regulations.</E> (1) Speed restrictions in the vicinity of Naval Submarine Base New London and Lower Thames River. Unless authorized by the Captain of the Port (COTP), vessels of 300 gross tons or more may not proceed at a speed in excess of eight knots in the Thames River from New London Harbor channel buoys 7 and 8 (Light List numbers 21875 and 21880 respectively) north through the upper limit of the Naval Submarine Base New London Restricted Area, as that area is specified in 33 CFR 334.75(a). The U.S. Navy and other Federal, State and municipal agencies may assist the U.S. Coast Guard in the enforcement of this rule. </P>
            <P>(2) <E T="03">Enhanced communications.</E> Vessels of 300 gross tons or more and all vessels engaged in towing barges must issue securité calls on marine band or Very High Frequency (VHF) radio channel 16 upon approach to the following locations: </P>
            <P>(i) Inbound approach to Cerberus Shoal; and </P>
            <P>(ii) Outbound approach to Race Rock Light (USCG Light List No. 19815). </P>

            <P>(3) All vessels operating within the RNA that are bound for a port or place located in the United States or that must transit the internal waters of the United States, must be inspected to the satisfaction of the U. S. Coast Guard, before entering waters within three nautical miles from the territorial sea baseline. Vessels awaiting inspection will be required to anchor in the manner directed by the COTP. This section does not apply to vessels operating exclusively within the Long Island Sound Marine Inspection and COTP Zone, vessels on a single voyage which depart from and return to the same port or place within the RNA, all towing vessels engaged in coastwise trade, vessels in innocent passage not bound <PRTPAGE P="48803"/>for a port or place subject to the jurisdiction of the United States, and all vessels not engaged in commercial service whose last port of call was in the United States. Vessels requiring inspection by the COTP may contact the COTP via marine band or Very High Frequency (VHF) channel 16, telephone at (203) 468-4401, facsimile at (203) 468-4418, or letter addressed to Captain of the Port, Long Island Sound, 120 Woodward Ave., New Haven, CT 06512. </P>
            <P>(4) All vessels operating within the RNA that are bound for a port or place located in the United States or that must transit the internal waters of the United States, must obtain authorization from the Captain of the Port (COTP) before entering waters within three nautical miles from the territorial sea baseline. Vessels awaiting COTP authorization to enter waters within three nautical miles from the territorial sea baseline will be required to anchor in the manner directed by the COTP. This section does not apply to vessels operating exclusively within the Long Island Sound Marine Inspection and COTP Zone, vessels on a single voyage which depart from and return to the same port or place within the RNA, all towing vessels engaged in coastwise trade, vessels in innocent passage not bound for a port or place subject to the jurisdiction of the United States, and all vessels not engaged in commercial service whose last port of call was in the United States. Vessels may request authorization from the COTP by contacting the COTP via marine band or Very High Frequency (VHF) channel 16, telephone at (203) 468-4401, facsimile at (203) 468-4418, or letter addressed to Captain of the Port, Long Island Sound, 120 Woodward Ave., New Haven, CT 06512. </P>
            <P>(5) Vessels over 1,600 gross tons operating in the RNA within three nautical miles from the territorial sea baseline that are bound for a port or place located in the United States or that must transit the internal waters of the United States must receive authorization from the COTP prior to transiting or any intentional vessel movements, including, but not limited to, shifting berths, departing anchorage, or getting underway from a mooring. This section does not apply to vessels in innocent passage not bound for a port or place subject to the jurisdiction of the United States. </P>
            <P>(6) <E T="03">Ferry vessels.</E> Vessels of 300 gross tons or more are prohibited from entering all waters within a 1200-yard radius of any ferry vessel transiting in any portion of the Long Island Sound Marine Inspection and COTP Zone without first obtaining the express prior authorization of the ferry vessel licensed operator, licensed master, COTP, or the designated COTP on-scene patrol. </P>
            <P>(7) <E T="03">Vessels engaged in commercial service.</E> No vessel may enter within a 100-yard radius of any vessel engaged in commercial service while that vessel is transiting, moored, or berthed in any portion of the Long Island Sound Marine Inspection and COTP zone, without the express prior authorization of the vessel's licensed operator, master, COTP, or the designated COTP on-scene representative. </P>
            <P>(8) <E T="03">Bridge foundations.</E> Any vessel operating beneath a bridge must make a direct, immediate and expeditious passage beneath the bridge while remaining within the navigable channel. No vessel may stop, moor, anchor or loiter beneath a bridge at any time. No vessel may approach within a 25-yard radius of any bridge foundation, support, stanchion, pier or abutment except as required for the direct, immediate and expeditious transit beneath a bridge. </P>
            <P>(9) This section does not relieve any vessel from compliance with applicable navigation rules. </P>
          </SECTION>
        </REGTEXT>
        <REGTEXT PART="165" TITLE="33">
          <AMDPAR>3. Add § 165.154 to read as follows: </AMDPAR>
          <SECTION>
            <SECTNO>§ 165.154 </SECTNO>
            <SUBJECT>Safety and Security Zones: Long Island Sound Marine Inspection Zone and Captain of the Port Zone. </SUBJECT>
            <P>(a) <E T="03">Safety and security zones.</E> The following areas are safety and security zones: </P>
            <P>(1) <E T="03">Dominion Millstone Nuclear Power Plant Safety and Security Zones.</E> (i) All waters north and north east of a line running from Bay Point, at approximate position 41-18.57 N, 072-10.41 W, to Millstone Point at approximate position 41-18.25 N, 072-09.96 W. </P>
            <P>(ii) All waters west of a line starting at 41-18.700 N, 072-09.650 W, running south to the eastern most point of Fox Island at approximate position 41-18.400 N, 072-09.660 W. All coordinates are North American Datum 1983. </P>
            <P>(2) <E T="03">Coast Guard Vessels Safety and Security Zones.</E> All waters within a 100-yard radius of any anchored Coast Guard vessel. For the purposes of this section, Coast Guard vessels includes any commissioned vessel or small boat in the service of the regular Coast Guard and does not include Coast Guard Auxiliary vessels. </P>
            <P>(b) <E T="03">Regulations.</E> (1) The general regulations contained in § 165.23 and § 165.33 of this part apply. </P>
            <P>(2) In accordance with the general regulations in § 165.23 and § 165.33 of this part, entry into or movement within this zone is prohibited unless authorized by the Captain of the Port Long, Island Sound. </P>
            <P>(3) All persons and vessels shall comply with the instructions of the Coast Guard Captain of the Port or on-scene patrol personnel. These personnel comprise commissioned, warrant, and petty officers of the Coast Guard. Upon being hailed by a U. S. Coast Guard vessel by siren, radio, flashing light, or other means, the operator of a vessel shall proceed as directed. </P>
          </SECTION>
        </REGTEXT>
        <SIG>
          <DATED>Dated: August 8, 2003. </DATED>
          <NAME>Vivien S. Crea, </NAME>
          <TITLE>Rear Admiral, U.S. Coast Guard, Commander, First Coast Guard District. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20929 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4910-15-P</BILCOD>
    </RULE>
    <RULE>
      <PREAMB>
        <AGENCY TYPE="N">ENVIRONMENTAL PROTECTION AGENCY </AGENCY>
        <CFR>40 CFR Part 52 </CFR>
        <DEPDOC>[PA 207-4213; FRL-7544-7] </DEPDOC>
        <SUBJECT>Approval and Promulgation of Air Quality Implementation Plans; Pennsylvania; Motor Vehicle Inspection and Maintenance Program—Revised Final Standards for the Acceleration Simulation Mode Exhaust Emissions Test </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Environmental Protection Agency (EPA). </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Final rule.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>EPA is approving a State Implementation Plan (SIP) revision submitted by the Commonwealth of Pennsylvania. This revision amends Pennsylvania's SIP-approved Enhanced Vehicle Inspection and Maintenance Program (or I/M program) to implement final tailpipe test standards for the Acceleration Simulation Mode (ASM) tailpipe emissions test. This is being done through the substitution of revised ASM test standards in place of the previously adopted and SIP-approved final ASM test standards. Under Pennsylvania's SIP-approved I/M program, ASM testing is conducted only in the Philadelphia I/M program area comprised of Bucks, Chester, Delaware, Montgomery, and Philadelphia Counties. Therefore, this action affects only motorists in those counties subject to the ASM test as part of the I/M program for the Philadelphia area. The intended effect of this action is to approve Pennsylvania's SIP revision request. This action is being taken under authority of the Clean Air Act. </P>
        </SUM>
        <EFFDATE>
          <HD SOURCE="HED">EFFECTIVE DATE:</HD>
          <P>This final rule is effective on September 15, 2003. </P>
        </EFFDATE>
        <ADD>
          <PRTPAGE P="48804"/>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Copies of the documents relevant to this action are available for public inspection during normal business hours at the Air Protection Division, U.S. Environmental Protection Agency, Region III, 1650 Arch Street, Philadelphia, Pennsylvania 19103; and at the Air and Radiation Docket and Information Center, U.S. Environmental Protection Agency, 1301 Constitution Avenue, NW., Room B108, Washington, DC 20460. Copies are also available for public inspection at the Pennsylvania Department of Environmental Protection, Bureau of Air Quality, PO Box 8468, 400 Market Street, Harrisburg, Pennsylvania 17105. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Brian Rehn, (215) 814-2176, or by e-mail at <E T="03">rehn.brian@epa.gov.</E>
          </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <HD SOURCE="HD1">I. Background </HD>
        <P>On June 27, 2003 (68 FR 38266), EPA published a notice of proposed rulemaking (NPR) for the Commonwealth of Pennsylvania. EPA's NPR proposed to approve a revision to Pennsylvania's SIP-approved enhanced I/M program SIP to revise final exhaust emission standards for Pennsylvania's ASM exhaust emissions test. The Commonwealth submitted a request for parallel processing of the state-proposed version of this SIP revision on June 5, 2003. Parallel processing is a means by which EPA proposes rulemaking action concurrently with the state's procedures for adoption of regulations. Upon completion of the state adoption process, EPA can then take final rulemaking action. Pennsylvania formally submitted its final, adopted SIP revision (amending the final test cutpoints for the ASM test) to EPA on July 23, 2003. </P>
        <HD SOURCE="HD1">II. Summary of SIP Revision </HD>
        <P>The Commonwealth's SIP revision substitutes a set of revised final ASM test cutpoints (recently released by EPA as a compliance alternative) for the cutpoints previously approved in Pennsylvania's I/M program SIP. </P>
        <P>The ASM test is a test method used to measure tailpipe emissions from cars. In Pennsylvania, the test is performed on a portion of the I/M-subject fleet in five counties in the Philadelphia severe ozone nonattainment area (Bucks, Chester, Delaware, Montgomery, and Philadelphia counties). The ASM tailpipe emissions test employs tailpipe emissions sensing equipment that measures emissions while the vehicle is driven, under load, at a steady speed on a chassis dynamometer. This SIP revision serves to substitute a different set of final test cutpoints than was previously SIP-approved—that utilize a different methodology and which are expressed in different units of measurement, and which are different than the prior approved phase-in or final ASM cutpoints. Since the Commonwealth is utilizing a set of alternative final ASM cutpoints that were developed by EPA for the purpose of providing a compliance alternative in implementing an ASM-based I/M program, EPA proposed approval of the Commonwealth's proposed SIP revision. </P>
        <P>A more detailed explanation of the Commonwealth's SIP revision or the rationale for EPA's proposed action are explained in the NPR and will not be restated here. No public comments were received on the NPR. </P>
        <HD SOURCE="HD1">III. Final Action </HD>
        <P>EPA is approving Pennsylvania's July 23, 2003 formal SIP revision to substitute an alternative set of final ASM test cutpoints to the I/M program as a revision to the Pennsylvania SIP. </P>
        <HD SOURCE="HD1">IV. Statutory and Executive Order Reviews </HD>
        <HD SOURCE="HD2">A. General Requirements </HD>

        <P>Under Executive Order 12866 (58 FR 51735, October 4, 1993), this action is not a “significant regulatory action” and therefore is not subject to review by the Office of Management and Budget. For this reason, this action is also not subject to Executive Order 13211, “Actions Concerning Regulations That Significantly Affect Energy Supply, Distribution, or Use” (66 FR 28355, May 22, 2001). This action merely approves state law as meeting Federal requirements and imposes no additional requirements beyond those imposed by state law. Accordingly, the Administrator certifies that this rule will not have a significant economic impact on a substantial number of small entities under the Regulatory Flexibility Act (5 U.S.C. 601 <E T="03">et seq.</E>). Because this rule approves pre-existing requirements under state law and does not impose any additional enforceable duty beyond that required by state law, it does not contain any unfunded mandate or significantly or uniquely affect small governments, as described in the Unfunded Mandates Reform Act of 1995 (Pub. L. 104-4). This rule also does not have tribal implications because it will not have a substantial direct effect on one or more Indian tribes, on the relationship between the Federal Government and Indian tribes, or on the distribution of power and responsibilities between the Federal Government and Indian tribes, as specified by Executive Order 13175 (65 FR 67249, November 9, 2000). This action also does not have Federalism implications because it does not have substantial direct effects on the States, on the relationship between the national government and the States, or on the distribution of power and responsibilities among the various levels of government, as specified in Executive Order 13132 (64 FR 43255, August 10, 1999). This action merely approves a state rule implementing a Federal standard, and does not alter the relationship or the distribution of power and responsibilities established in the Clean Air Act. This rule also is not subject to Executive Order 13045 “Protection of Children from Environmental Health Risks and Safety Risks” (62 FR 19885, April 23, 1997), because it is not economically significant. </P>

        <P>In reviewing SIP submissions, EPA's role is to approve state choices, provided that they meet the criteria of the Clean Air Act. In this context, in the absence of a prior existing requirement for the State to use voluntary consensus standards (VCS), EPA has no authority to disapprove a SIP submission for failure to use VCS. It would thus be inconsistent with applicable law for EPA, when it reviews a SIP submission, to use VCS in place of a SIP submission that otherwise satisfies the provisions of the Clean Air Act. Thus, the requirements of section 12(d) of the National Technology Transfer and Advancement Act of 1995 (15 U.S.C. 272 note) do not apply. This rule does not impose an information collection burden under the provisions of the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 <E T="03">et seq.</E>). </P>
        <HD SOURCE="HD2">B. Submission to Congress and the Comptroller General </HD>
        <P>The Congressional Review Act, 5 U.S.C. 801 <E T="03">et seq.</E>, as added by the Small Business Regulatory Enforcement Fairness Act of 1996, generally provides that before a rule may take effect, the agency promulgating the rule must submit a rule report, which includes a copy of the rule, to each House of the Congress and to the Comptroller General of the United States. EPA will submit a report containing this rule and other required information to the U.S. Senate, the U.S. House of Representatives, and the Comptroller General of the United States prior to publication of the rule in the <E T="04">Federal Register</E>. This rule is not a “major rule” as defined by 5 U.S.C. 804(2). <PRTPAGE P="48805"/>
        </P>
        <HD SOURCE="HD2">C. Petitions for Judicial Review </HD>
        <P>Under section 307(b)(1) of the Clean Air Act, petitions for judicial review of this approval of an alternative set of final ASM test cutpoints to Pennsylvania's I/M program SIP must be filed in the United States Court of Appeals for the appropriate circuit by October 14, 2003. Filing a petition for reconsideration by the Administrator of this final rule does not affect the finality of this rule for the purposes of judicial review nor does it extend the time within which a petition for judicial review may be filed, and shall not postpone the effectiveness of such rule or action. This action may not be challenged later in proceedings to enforce its requirements. (See section 307(b)(2).) </P>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects in 40 CFR Part 52 </HD>
          <P>Environmental protection, Air pollution control, Carbon monoxide, Incorporation by reference, Intergovernmental relations, Ozone, Reporting and recordkeeping requirements, Volatile organic compounds.</P>
        </LSTSUB>
        <SIG>
          <DATED>Dated: August 6, 2003.</DATED>
          <NAME>Donald S. Welsh, </NAME>
          <TITLE>Regional Administrator, Region III. </TITLE>
        </SIG>
        
        <REGTEXT PART="52" TITLE="40">
          <AMDPAR>40 CFR part 52 is amended as follows: </AMDPAR>
          <PART>
            <HD SOURCE="HED">PART 52—[AMENDED] </HD>
          </PART>
          <AMDPAR>1. The authority citation for part 52 continues to read as follows: </AMDPAR>
          <AUTH>
            <HD SOURCE="HED">Authority:</HD>
            <P>42 U.S.C. 7401 <E T="03">et seq.</E>
            </P>
          </AUTH>
        </REGTEXT>
        <REGTEXT PART="52" TITLE="40">
          <SUBPART>
            <HD SOURCE="HED">Subpart NN—Pennsylvania </HD>
          </SUBPART>
          <AMDPAR>2. Section 52.2020 is amended by adding paragraph (c)(211) to read as follows: </AMDPAR>
          <SECTION>
            <SECTNO>§ 52.2020 </SECTNO>
            <SUBJECT>Identification of plan. </SUBJECT>
            <STARS/>
            <P>(c) * * *</P>
            <P>(211) Revisions to the Pennsylvania Emission Inspection Program Regulations to adopt revised alternative final ASM test cutpoints submitted on July 23, 2003 by the Department of Environmental Protection: </P>
            <P>(i) Incorporation by reference. </P>
            <P>(A) Letter of July 23, 2003 from the Secretary of the Department of Environmental Protection transmitting a regulatory amendment to the motor vehicle emissions testing program to adopt an alternative set of final ASM test cutpoints developed by EPA. </P>
            <P>(B) Revisions to Chapter 177, Appendix A, Section 1 of the Pennsylvania motor vehicle emission inspection program regulations (codified in the Pennsylvania Code at Title 67, Part I, Subpart A, Article VII), effective on May 24, 2003. </P>
            <P>(ii) Additional Material.—Remainder of the State submittal pertaining to the revisions listed in paragraph (c)(211)(i) of this section.</P>
          </SECTION>
        </REGTEXT>
        
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20895 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 6560-50-P</BILCOD>
    </RULE>
    <RULE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF HEALTH AND HUMAN SERVICES </AGENCY>
        <SUBAGY>Centers for Medicare &amp; Medicaid Services </SUBAGY>
        <CFR>42 CFR Part 424 </CFR>
        <DEPDOC>[CMS-0008-IFC] </DEPDOC>
        <RIN>RIN 0938-AM22 </RIN>
        <SUBJECT>Medicare Program; Electronic Submission of Medicare Claims </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Centers for Medicare &amp; Medicaid Services (CMS), HHS. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Interim final rule with comment period. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This interim final rule with comment period implements the statutory requirement that claims for reimbursement under the Medicare Program be submitted electronically as of October 16, 2003,except where waived. This rule identifies those circumstances for which mandatory submission of electronic claims to the Medicare Program is waived. </P>
        </SUM>
        <EFFDATE>
          <HD SOURCE="HED">DATES:</HD>
          <P>
            <E T="03">Effective date:</E> October 16, 2003. These regulations are applicable for Medicare claims submitted on or after October 16, 2003. </P>
          <P>
            <E T="03">Comment date:</E> Comments will be considered if we receive them at the appropriate address, as provided below, no later than 5 p.m. on October 14, 2003. </P>
        </EFFDATE>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>In commenting, please refer to file code CMS-0008-IFC. Because of staff and resource limitations, we cannot accept comments by facsimile (FAX) transmission or e-mail. Mail written comments (one original and three copies) to the following address ONLY: Centers for Medicare &amp; Medicaid Services, Department of Health and Human Services, Attention: CMS-0008-IFC, P.O. Box 8010, Baltimore, MD 21244-8010. </P>
          <P>Please allow sufficient time for mailed comments to be timely received in the event of delivery delays. If you prefer, you may deliver (by hand or courier) your written comments (one original and three copies) to one of the following addresses: Room 445-G, Hubert H. Humphrey (HHH) Building, 200 Independence Avenue, SW., Washington, DC 20201, or Room C5-14-03, 7500 Security Boulevard, Baltimore, MD 21244-8010. </P>
          <P>(Because access to the interior of the HHH Building is not readily available to persons without Federal Government identification, commenters are encouraged to leave their comments in the CMS drop slots located in the main lobby of the building. A stamp-in clock is available for commenters wishing to retain a proof of filing by stamping in and retaining an extra copy of the comments being filed.) </P>
          <P>Comments mailed to the addresses indicated as appropriate for hand or courier delivery may be delayed, and could be considered untimely. </P>

          <P>For information on viewing public comments, see the beginning of the <E T="02">SUPPLEMENTARY INFORMATION</E> section. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Kathleen Simmons, (410) 786-6157. Stewart Streimer, (410) 786-9318. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P/>
        <P SOURCE="NPAR">
          <E T="03">Inspection of Public Comments:</E> Comments received timely will be available for public inspection as they are received, generally beginning approximately 3 weeks after publication of a document, at the headquarters of the Centers for Medicare &amp; Medicaid Services, 7500 Security Boulevard, Baltimore, Maryland 21244, Monday through Friday of each week from 8:30 a.m. to 4 p.m. To schedule an appointment to view public comments, contact Sharon Jones (410) 786-9994. </P>
        <P>
          <E T="03">Copies:</E> Additional copies of the <E T="04">Federal Register</E> containing this interim final rule with comment period can be made at most libraries designated as Federal Depository Libraries and at many other public and academic libraries throughout the country that receive the <E T="04">Federal Register</E>. </P>
        <P>This <E T="04">Federal Register</E> document is also available from the <E T="04">Federal Register</E> online database through <E T="03">GPO Access,</E> a service of the U.S. Government Printing Office. The Web site address is: <E T="03">http://www.access.gpo.gov/nara/index.html.</E>
        </P>
        <HD SOURCE="HD1">I. Background </HD>

        <P>Section 3 of the Administrative Simplification Compliance Act (ASCA), Pub. L. 107-105, was enacted by the Congress to improve the administration of the Medicare Program by facilitating program efficiencies gained through the electronic submission of Medicare claims. Section 3 of ASCA amends subsection (a) of section 1862 of the Social Security Act (the Act) (42 U.S.C. 1395y(a)) and adds a new subsection (h) to section 1862 (42 U.S.C. 1395y). The amendment to subsection (a) requires <PRTPAGE P="48806"/>the Medicare Program, subject to subsection (h), to deny payment under Part A or Part B for services “for which a claim is submitted other than in an electronic form specified by the Secretary.” Subsection (h) provides that the Secretary shall waive such denial in two types of cases and may also waive such denial “in such unusual cases as the Secretary finds appropriate.” </P>
        <P>Section 3 of ASCA operates in the context of the Administrative Simplification provisions of the Health Insurance Portability and Accountability Act of 1996 (HIPAA), Pub. L. 104-191. Those provisions require the Secretary to adopt, among other standards, standards for financial and administrative transactions for the health care industry, including the health care claim transaction (see section 1173(a) of the Act). In 2000, the Secretary of Health and Human Services (HHS) adopted standards for eight electronic transactions, including the Health Care Claim or Equivalent Encounter Information transaction, 65 FR 50312 (August 17, 2000). These rules, which are codified at 45 CFR part 162, subparts A and I through R, are generally known as the Transactions Rule. </P>
        <P>The HIPAA standards apply to health plans, health care clearinghouses, and certain health care providers; collectively, these entities are known as “covered entities.” Covered entities are required to comply not only with the Transactions Rule, but also with the other HIPAA Administrative Simplification rules—the Privacy Rule, the Employer Identifier Rule, and the Security Rule—when the respective applicable compliance dates for those rules occur. </P>
        <P>Compliance with the standards for the electronic transactions covered by the Transactions Rule was required for all covered entities other than small health plans by October 16, 2002; compliance by small health plans is required by October 16, 2003. However, section 2 of ASCA extended the October 16, 2002 compliance deadline to October 16, 2003 for covered entities that submitted a compliance plan by October 15, 2002. Covered entities that were not small health plans and that did not timely submit a compliance plan under ASCA were required to comply with the Transactions Rule by October 16, 2002. Regardless, no later than October 16, 2003, all covered entities must be in compliance with the Transactions Rule. </P>
        <P>By statute, the Medicare Program is a health plan under HIPAA (see section 1171(5)(D) of the Act). It is, therefore, a covered entity. Health care providers are covered entities if they transmit health information in electronic form in connection with a transaction for which the Secretary has adopted a standard (covered transaction) (see 45 CFR 160.102). Under the Transactions Rule, if a covered entity electronically conducts a covered transaction with another covered entity, it must conduct it as a standard transaction (see 45 CFR 162.923(a)). </P>
        <P>Approximately 86.1 percent of claims submitted to the Medicare Program are submitted electronically, which means that approximately 139 million claims are submitted on paper per year (fiscal year (FY) 2002). Section 3 of ASCA requires Medicare providers to submit claims electronically by October 16, 2003, unless one of the specified grounds for waiver applies. Section 3 of ASCA, thus, in general has the effect of requiring Medicare providers that are not already covered entities to conduct a covered transaction (the health care claim transaction) electronically and, thereby, become covered entities. In submitting claims electronically, the providers will be required to comply with the applicable HIPAA standard for the health care claim transaction, by virtue of the Transactions Rule. Thus, section 3 of ASCA promotes the submission of standard transactions and will further the goal of improved health care delivery by reducing the administrative burden and paperwork associated with Medicare claims submission. </P>
        <P>Although 86.1 percent of Medicare claims are submitted electronically, the volume of Medicare claims submitted in paper form is substantial, and moving from paper to electronic submission has the potential for significant savings and efficiencies for Medicare physicians, practitioners, facilities, suppliers, and other health care providers, as well as for the Medicare program itself. Although these Medicare physicians, practitioners, facilities, suppliers, and other health care providers would incur a cost to comply with the mandatory electronic billing requirement, we believe their savings will offset the cost. Further, the use of the HIPAA electronic claim standard could result in additional savings should these entities begin electronically billing other payers. However, the statute recognizes that certain circumstances may preclude or make less attractive converting from a paper to an electronic environment. ASCA, thus, identifies exceptions to the mandatory submission of electronic Medicare claims. These exceptions are interpreted and provided for by this interim final rule with comment period. </P>
        <P>We considered whether the amendment to section 1862(a) in section 3 of ASCA could be interpreted to apply to payments made by Medicare + Choice (M+C) organizations to providers for services provided to Medicare beneficiaries. The question was raised by the provision in section 4 of ASCA which expressly adds Medicare Part C, found in Part C of Title XVIII, to the definition of Medicare “health plans” found in section 1171(5)(D). </P>
        <P>The plain language of section 1862(a), however, provides that “payment may not be made under Part A or Part B” for a number of activities. The Congress could have amended this provision, just as it amended section 1171(5), if it had wanted to prohibit M+C organizations from paying for claims for services given to M+C enrollees by the M+C organization's participating providers. The fact that it did not so amend this provision indicates that it did not intend to apply the ASCA payment prohibition to the M+C organizations. The Congress's intent to apply the broader definition of “health plan” in section 4 of ASCA solely to the Administrative Simplifications provisions of HIPAA and not to the electronic submission requirement for Medicare claims is further suggested by in the title of section 4 of ASCA: “Clarification with Respect to Applicability of Administrative Simplification Requirement to M+C Organizations.” </P>
        <P>The M+C organizations, as health plans for the purposes of HIPAA Administrative Simplification, are required to come into compliance with the requirements of the HIPAA Transactions Rule no later than October 16, 2003. We understand that all M+C organizations properly filed ASCA compliance plans prior to October 16, 2002. They, therefore, obtained extensions and have a compliance date of October 16, 2003. </P>

        <P>An M+C organization that pays a non-compliant electronic claim after October 16, 2003, would accordingly be out of compliance with the HIPAA Transactions Rule requirements, but would not violate the provisions of section 1862(a)(22) or the requirements of this regulation. This regulation applies only to providers, practitioners and suppliers who submit claims under Part A or Part B of Medicare. It does not apply to the submission of claims by providers to M+C organizations. Moreover, the waiver provisions for small providers, practitioners and suppliers established by section 3 of ASCA and this regulation do not extend to claims submitted by such providers to any health plans other than Medicare. <PRTPAGE P="48807"/>
        </P>
        <HD SOURCE="HD1">II. Provisions of the Interim Final Rule With Comment Period </HD>
        <P>Section 3 of ASCA established the requirements and exceptions under the Medicare Program for the mandatory submission of claims submitted in electronic form. 45 CFR 162.1101(a) defines a health care claim as the transmission of “A request to obtain payment, and the necessary accompanying information from a health care provider to a health plan, for health care.” 45 CFR 160.103 defines electronic media as—</P>
        
        <EXTRACT>
          <P>(1) Electronic storage media including memory devices in computers (hard drives) and any such removable/transportable digital memory medium, such as magnetic tape or disk, optical disk, or digital memory card; or (2) Transmission media used to exchange information already in electronic storage media. Transmission media include, for example, the internet (wide-open), extranet (using internet technology to l ink a business with information accessible only to collaborating parties), leased lines, dial-up lines, private networks, and the physical movement of removable/transportable electronic storage media. Certain transmissions, including of paper, via facsimile, and of voice, via telephone, are not considered to be transmissions via electronic media, because the information being exchanged did not exist in electronic form before the transmission.</P>
        </EXTRACT>
        
        <P>In this interim final Rule with comment period, we integrate the definitions of “electronic media” and “claims submitted in electronic form” into the newly defined term, “electronic claim.” Furthermore, for brevity, and to reflect common use, the term “electronic claim(s)” is considered to be synonymous with and is being used in lieu of the term “claims submitted in electronic form” in this Rule. </P>
        <HD SOURCE="HD2">A. Definitions Used for Electronic Claim Submission </HD>
        <P>In § 424.32(d)(1), we are adding a definition section to define terms used in paragraph (d). We define the following terms: claim; electronic claim; direct data entry; electronic media; initial Medicare claim; physician, practitioner, facility or supplier; provider of services; and small provider or small supplier. We define “claim” to mean the transaction defined at 45 CFR 162.1101(a), which is the regulatory definition of “ health care claim” in the Transactions Rule. We specify the definition of “electronic claim” to mean a claim that is submitted via electronic media. We specify that the definitions of “direct data entry” and “electronic media” are defined as those terms are defined in 45 CFR 162.103, and 160.103, respectively. </P>

        <P>In § 424.32(d)(1)(iv), we define an “initial Medicare claim” as a claim submitted to Medicare for payment under Part A or Part B of the Medicare Program for the first time for processing, including claims sent to Medicare for the first time for secondary payment purposes. <E T="03">Initial Medicare claim</E> excludes any adjustment or appeal of a previously submitted claim. </P>

        <P>We specify in § 424.32(d)(1)(vi) that a “Physician, practitioner, facility, or supplier” is a Medicare provider other than a <E T="03">provider of services.</E> In § 424.32(d)(1)(vii), we define a “Provider of services” as a provider of services as defined in section 1861(u) of the Act. We define in § 424.32(d)(1)(viii), a “Small provider or small supplier” as a provider of services with fewer than 25 full-time equivalent employees; or a physician, practitioner, facility, or supplier (other than provider of services) with fewer than 10 full-time equivalent employees. </P>
        <HD SOURCE="HD2">B. Submission of Electronic Claims Required </HD>
        <P>Electronic submission of Medicare claims is required for <E T="03">initial</E> Medicare claims, including initial claims with paper attachments, submitted for processing by the Medicare fiscal intermediary (FI) or carrier that serves the physician, practitioner, facility, supplier, or other health care provider. No other transactions, including changes, adjustments, or appeals to the initial claim, are required to be submitted electronically. </P>
        <P>In § 424.32(d)(2), we specify that except for claims to which § 424.32(d)(3) applies, an initial Medicare claim under Part A and/or Part B may be paid only if submitted as an electronic claim for processing by the Medicare FI or carrier that serves the physician, practitioner, facility, supplier, or provider of services. This requirement does not apply to any other transactions, including adjustment or appeal of the initial Medicare claim. </P>
        <HD SOURCE="HD2">C. Exceptions to Requirement To Submit Electronic Claims </HD>

        <P>The regulation set forth at 45 CFR 162.923 states that “Except as otherwise provided in this part, if a covered entity conducts with another covered entity (or within the same covered entity), using electronic media, a transaction for which the Secretary has adopted a standard under this part, the covered entity must conduct the transaction as a standard transaction.” HIPAA does not require that a health care plan be able to accept claims via every type of electronic media, only that claims received via such media comply with the standard format and content requirements of HIPAA <E T="03">(www.wpc-edi.com/HIPAA)</E>. Only electronic media accepted by Medicare, and as defined in the Medicare Carrier and Intermediary Manuals and Program Memoranda issued by CMS, are affected by this requirement of ASCA. At present, Medicare does not accept claims via the internet, an extranet or, in many cases, via removable/transportable storage media. This rule does not change this Medicare policy. Advance notice of any future plans for expansion or contraction in the electronic media accepted for submission of Medicare claims would be published in Medicare program instructions and via routine contractor notification and instructional media. </P>
        <P>Claims submitted via a direct data entry screen maintained for Medicare, and as permitted by 45 CFR 162.923, are considered to be electronic claims for purposes of this requirement. Claims transmitted to a Medicare contractor using the free or low cost claims software issued by Medicare fee-for-service plans are also electronic claims for purposes of this requirement. </P>

        <P>The ASCA provides for exceptions to the mandatory electronic submission of Medicare claims. Under the ASCA, the Secretary of Health and Human Services will waive the application of the electronic claim requirement for specific cases. This interim final rule with comment period provides more explicit requirements to implement the statutory mandate that we specify in the regulations at § 424.32(d). Specifically, in § 424.32(d)(3), we specify the exceptions when electronic submission of initial Medicare claims can be waived. In § 424.32(d)(3)(i), we specify that electronic submission will be waived when: (a) there is no method available for the submission of an electronic claim. We cannot reasonably expect Medicare beneficiaries to submit electronic claims. (Even though, the statute requires, with very few exceptions, that providers of health care bill Medicare on behalf of a beneficiary (sections 1814(a) and 1848(g)(4) of the Act) some beneficiaries will still submit claims to Medicare. However, those relatively few beneficiaries who submit claims are not likely to possess the capability to submit a HIPAA compliant claim). Further, there is no method available in those situations in which the standard adopted by the Secretary at 45 CFR 162.1102 does not support all of the information necessary for payment of the claim. At this time, we have identified three situations which fall into this category, in addition to beneficiary claims: (1) Roster billing of <PRTPAGE P="48808"/>vaccinations covered by the Medicare Program (In order to promote an increase in the flu vaccinations for Medicare beneficiaries, since 1993 Medicare allowed mass immunizers to bill the program using a single claim form with an attached list of beneficiaries to which a flu vaccine was administered. Generally, mass immunizers bill electronically, but in a non-standard format. This roster billing simplified provider billing but is not available in electronic form under the HIPAA Transaction Rule); (2) claims for payment under Medicare demonstration projects (Medicare demonstration projects often allow for unusual situations not normally handled by the standard transactions.); and (3) claims where more than one plan is responsible for payment prior to Medicare. The standard electronic formats do not currently have a clear method for the reporting of per service payments made by more than one primary payer. Efforts are being made to resolve this deficiency. These claims can continue to be submitted to Medicare on paper, but once a solution is reached we will notify the public, and providers will then be required to submit these claims electronically. Specific program guidance will be issued to Medicare providers concerning submission of these claims on paper effective October 16, 2003. We will also issue specific guidance or regulations, as necessary, informing covered entities if this or another exception no longer applies. (b) In 424.32(d)(3)(ii), we provide that electronic submission will be waived when the entity submitting the claim is a small provider or small supplier. The statute is quite specific as to the size requirements and the rule simply incorporates the statutory requirements. </P>
        <HD SOURCE="HD2">D. Unusual Circumstances </HD>
        <P>The Secretary may waive the electronic submission requirement in certain situations as the Secretary finds appropriate. In § 424.32(d)(4), we specify three circumstances that will provide for an exception to exist in the following situations: (1) The submission of dental claims (This exception is being included because, under HIPAA, dentists are required to submit electronic transactions to other payers in a format different from that generally used in the Medicare Program. Since Medicare does not generally cover dental services, this exception is added to minimize the burden on dentists who may, at times, need to bill the Program.); (2) A service interruption in the mode of submitting the electronic claim that is outside of the control of the entity submitting the claim, for the period of the interruption (This exception will apply only if the physician, practitioner, facility, supplier, or other health care provider has no telephone or other communication service. If telephone service exists but is unavailable for a period of time (for example, because of inclement whether or due to telephone company technical breakdowns), paper claims will be accepted during the period of disrupted telephone service.); and (3) On demonstration, satisfactory to the Secretary, of other extraordinary circumstances precluding submission of electronic claims. </P>
        <P>Entities will not generally need to make a special request to determine whether an exception applies that would make them eligible for a mandatory waiver under § 424.32(d)(3) or a discretionary waiver under § 424.32(d)(4). A special request must be submitted to a Medicare FI or carrier when an entity does not meet the mandated or discretionary waiver criteria being established but believes there are other extraordinary circumstances that preclude their submission of electronic claims. We will issue program guidance to Medicare FIs and carriers to enable them to handle, on a case-by-case basis, requests for relief in extraordinary circumstances. </P>
        <HD SOURCE="HD2">E. Enforcement </HD>
        <P>ASCA's amendment to section 1862(a) of the Act prescribes that “no payment may be made under Part A or Part B of the Medicare Program for any expenses incurred for items or services” for which a claim is submitted in a non-electronic form. Consequently, absent an applicable exception, paper claims submitted to Medicare will not be paid. </P>
        <P>The Secretary may audit entities that bill Medicare non-electronically. Entities determined to be in violation of the statute or this rule may be subject to claim denials, overpayment recoveries, and applicable interest on overpayments. </P>
        <HD SOURCE="HD2">F. Effective Date </HD>
        <P>In § 424.32(d)(6), we specify the effective date for these amendments will be for claims submitted on or after October 16, 2003. This effective date is specified in section 3(b) of ASCA. </P>
        <HD SOURCE="HD1">III. Response to Comments </HD>

        <P>Because of the large number of items of correspondence we normally receive on <E T="04">Federal Register</E> documents published for comment, we are not able to acknowledge or respond to them individually. We will consider all comments we receive by the date and time specified in the <E T="02">DATES</E> section of this preamble, and, if we revise this final rule, we will respond to the major comments in the preamble to that document. </P>
        <HD SOURCE="HD1">IV. Waiver of Proposed Rulemaking </HD>

        <P>We ordinarily publish a notice of proposed rulemaking in the <E T="04">Federal Register</E> and invite public comment on the proposed rule. The notice of proposed rulemaking includes a reference to the legal authority, under which the rule is proposed, and the terms and substances of the proposed rule or a description of the subjects and issues involved. This procedure can be waived, however, if an agency finds good cause that a notice-and-comment procedure is impracticable, unnecessary, or contrary to the public interest and incorporates a statement of the finding and its reasons in the rule issued. </P>

        <P>We find that it would be contrary to the public interest to undertake prior notice and comment procedures before implementing this interim final rule with comment period. The ASCA evidences the Congress' intent to increase electronic claims submission to the Medicare Program through mandatory electronic billing requirements and to tie the mandatory Medicare electronic billing requirement's October 16, 2003 effective date to the compliance date for national implementation of the electronic transactions standards required under the Administrative Simplification provisions of HIPAA (<E T="03">see</E> 45 CFR parts 160 and 162). However, the ASCA also provides that not all Medicare health care providers must engage in electronic billing and identifies, in general terms, those circumstances under which health care providers will be exempt from the requirements. </P>

        <P>The implementation of the HIPAA standards by health care providers requires detailed planning, budgeting, implementation, and testing in order for those covered entities to be ready to submit HIPAA transactions by the October 16, 2003 compliance date. Since section 3 of ASCA mandates electronic billing for Medicare providers, these entities must come into compliance with the HIPAA requirements on the same date and, in turn, they must plan appropriately like those covered entities that were already planning to be electronic billers. It is imperative that the affected Medicare billers have sufficient time to ascertain whether they must transition to electronic billing as a result of section 3 of ASCA and, if so, begin the implementation process for the HIPAA transaction standards. This interim final rule with comment period allows those <PRTPAGE P="48809"/>Medicare paper billers to fully understand their obligations under ASCA and, in turn, begin preparing for HIPAA implementation, if required to do so. We believe any delay in implementing this rule, effective October 16, 2003, would hinder Medicare providers' ability to meet the October 16, 2003 HIPAA compliance date or determine that they did not have to file electronically with Medicare and so incur unnecessary costs. </P>
        <P>Thus, we find, for good cause, that providing notice and opportunity to comment under 5 U.S.C. 553(b) would be impracticable and contrary to the public interest. We are providing a 60-day public comment period. </P>
        <P>This rule is effective October 16, 2003, as required by section 3(b) of the ASCA. </P>
        <HD SOURCE="HD1">V. Collection of Information Requirements </HD>

        <P>Under the Paperwork Reduction Act (PRA) of 1995, we are required to provide 60-day notice in the <E T="04">Federal Register</E> and solicit public comment before a collection of information requirement is submitted to the Office of Management and Budget (OMB) for review and approval. In order to fairly evaluate whether an information collection should be approved by OMB, section 3506(c)(2)(A) of the PRA of 1995 requires that we solicit comment on the following issues: </P>
        <P>• The need for the information collection and its usefulness in carrying out the proper functions of our agency. </P>
        <P>• The accuracy of our estimate of the information collection burden. </P>
        <P>• The quality, utility, and clarity of the information to be collected. </P>
        <P>• Recommendations to minimize the information collection burden on the affected public, including automated collection techniques. </P>
        <P>Therefore, we are soliciting public comments on each of these issues for the information collection requirements discussed below. </P>
        <P>The information collection requirements and associated burdens in § 424.32 are subject to the PRA. The burden of submitting the information required is addressed under OMB approval number:</P>
        
        <P>0938-0866, HIPAA Standards for Coding Electronic Transactions, with a one-time burden of 34,000,000 hours. The current approval expires 5/31/05. </P>
        <P>0938-0279, Medicare Uniform Institutional Provider Bill, with an annual burden of 1,666,208 (form CMS-1450). The current approval expires 12/31/05. </P>
        <P>0938-0042, Request for Medicare Payment—Ambulance, with an annual burden of 390,418 hours (form CMS-1491). The current approval expires 3/31/04. </P>
        <P>0938-0008, Common Claim form, instructions, and supporting regulations at §§ 414.40, 424.32, and 414.40, with an annual burden of 44,189,007 (form CMS-1500). The current approval expires 3/31/06. </P>
        <P>Approximately 205,409 providers and suppliers will be affected by this rule and will have to change the format for the claims they submit (the information collected does not change). They will incur some costs, either that of switching to clearinghouses, which will not affect the time it takes to submit the information for a claim, but will cost them $.30 per claim, or that of purchasing computer equipment, which we estimate at $500 to $1,000. </P>
        <P>For our rule published to implement the electronic transactions in general, we estimated that it would take an average of ten hours per entity to switch over to the mandated standard transaction. (The switch could be from paper to electronic or from another electronic format to the standard format.) </P>
        <P>For purposes of this discussion, we are estimating that 37.5 percent of the affected providers and suppliers (that is, those not meeting one of the exceptions) already own computers and will not incur capital costs. We are also estimating that 50 percent of the affected providers and suppliers will start using a clearinghouse or billing service, which will not impose any capital costs subject to the PRA. The remaining 12.5 percent (25,676) will buy computers at an average of $750, for a total capital cost of $19.3 million. </P>
        <P>On the other hand, the providers and suppliers who own or who will buy a computer will require less time to submit claims. Form CMS-1450 takes approximately 9 minutes to submit in hard copy and .5 minutes to submit electronically; form CMS-1500 takes 15 minutes and 1 minute, respectively; form CMS-1491 takes 10 minutes and 1 minute, respectively. </P>
        <P>If the 50 percent of the entities that will bill us directly are responsible for 25 percent of the paper bills (we assume that half of the bills are submitted by entities that will be excepted from the requirements, and that 25 percent will be submitted through an intermediate party), they will save 7,651,089 million hours for form 1500, 58,850 hours for form 1491, and 129,196 hours for form 1450. Mailing costs will be reduced by approximately $.40 per claim on average and the cost of the forms by $.03 for the form 1450 and form 1500 (the third form is furnished by CMS). We welcome comments on this aspect of the collection. </P>
        <P>We are submitting a copy of the revision to § 424.32 to OMB for its review of the information collection requirements. The revision is not effective until OMB has approved it. If you comment on any of these information collection and record keeping requirements, please mail copies directly to the following: Office of Strategic Operations and Regulatory Affairs, Centers for Medicare and Medicaid Services, 7500 Security Boulevard, Attn: PRA Reports Clearance Officer, Baltimore, MD 21244, Attn: Julie Brown, CMS-0008-IFC, and Office of Information and Regulatory Affairs, Office of Management and Budget, Room 10235, New Executive Office Building, Washington, DC 20503, Attn: Brenda Aguilar, Desk Officer, CMS-0008-IFC. </P>
        <HD SOURCE="HD1">VI. Regulatory Impact Analysis </HD>
        <HD SOURCE="HD2">A. Overall Impact </HD>
        <P>We have examined the impacts of this rule as required by Executive Order 12866 (September 1993, Regulatory Planning and Review), the Regulatory Flexibility Act (RFA) (September 16, 1980, Pub. L. 96-354), section 1102(b) of the Social Security Act, the Unfunded Mandates Reform Act of 1995 (Pub. L. 104-4), and Executive Order 13132. </P>
        <P>For the purpose of this analysis, CMS uses a pre-statute baseline; therefore, all costs and benefits identified in this impact analysis are attributed to this rulemaking. Nevertheless, the ASCA mandates most aspects of this rulemaking. In particular, the ASCA requires Medicare providers to submit claims electronically and stipulates exceptions that will and may be granted. However, CMS did have discretion in setting the conditions for exceptions, and believes that these exceptions reduce the burden relative to the burden that may have been imposed by ASCA without this enabling regulation. </P>

        <P>Executive Order 12866 directs agencies to assess all costs and benefits of available regulatory alternatives and, if regulation is necessary, to select regulatory approaches that maximize net benefits (including potential economic, environmental, public health and safety effects, distributive impacts, and equity). A regulatory impact analysis (RIA) must be prepared for major rules with economically significant effects ($100 million or more in any 1 year). This is not a major rule. While additional costs will be imposed on those entities that do not meet any of the exception requirements and which must purchase the capability to <PRTPAGE P="48810"/>bill Medicare electronically, we estimate the impact to be less than $100 million. Our estimates of the cost impact are based on the following analysis. (<E T="04">Note:</E> The primary sources of data contained herein are the Medicare Program's “Contractor Reporting of Operational Workload Data” (CROWD), the “2002 CMS Statistics” Handbook), and the Year 2000 “Statistics of U.S. Business” issued by the U.S. Census Bureau.</P>
        <P>The Administrative Simplification provisions under HIPAA establish the standards for electronic data transmission when transactions are conducted electronically, but they do not require physicians, practitioners, facilities, suppliers, and other health care providers to transmit claims and other transactions electronically. ASCA, however, does require Medicare physicians, practitioners, facilities, suppliers, and other health care providers (except those for which this rule provides for an exception) to submit claims electronically to Medicare. Consequently, Medicare claims must be submitted in the HIPAA-prescribed electronic format. Thus, this rule will only have an impact on that group of entities that now submit paper claims to the Medicare Program and who do not fall into one of the excepted groups. </P>
        <P>Approximately 139 million paper claims were submitted to Medicare in FY 2002. This represents about 13.9 percent of all claims processed. Broken down between paper claims submitted to FIs and carriers, the number of paper claims in FY 2002 was 3.4 million and 136 million, respectively (source of data is CROWD). </P>
        <P>Over the past 4 years, Medicare's electronic media claims rate (EMC) has slowly grown at an average of 0.3 percent per year for FIs and 0.9 percent per year for carriers (source of data is CROWD). We do not expect a change in this trend for the immediate future. Therefore, we assume that similar changes will continue for, at least, FY 2003 and FY 2004, the first year of implementation of mandatory Medicare EMC. Using workload growth projections from the CMS FY 2004 budget submission to the Congress, we estimate the FY 2004 volume of paper claims impacted by the ASCA, factoring out Medicare's continuing trend of higher EMC rates, will be 2.5 million for Medicare FIs and 133.7 million for carriers. Please note that these volumes could be even smaller in FY 2004 due to the simultaneous implementation of HIPAA. However, the impact of HIPAA, coupled with Medicare's EMC trends, cannot be quantified, though the impact would only further reduce the cost/savings impact of ASCA and further support that a RIA is not needed. </P>
        <P>We do not know at this time how many providers will be excepted from the ASCA requirements, but projections have been made based upon the percentage of health care providers reported in the Census Bureau's “Year 2000 Statistics of U.S. Businesses,” which includes data on the number of health care providers by type with fewer than 20 employees and the numbers of physician, practitioner, and supplier entities with fewer than 10 employees. The Census figures do not differentiate between part-time and full-time employees, and would be expected to result in inflated numbers on the whole when applied to Medicare, but that is acceptable for impact assessment purposes. The Census did not have a category for fewer than 25 employees; fewer than 20 employees was their closest statistic. Overall, the Census data would still be reliable indicators of the anticipated worse case scenario of the maximum number of Medicare providers, physicians, practitioners, and suppliers likely to be impacted by this regulation. The percentages of small providers, physicians, practitioners, and suppliers based on employment numbers for the universe of all U.S. providers, physicians, practitioners, and suppliers should be comparable to the percentage of the subset of those providers that bill the Medicare program. </P>
        <P>The Census figures did not include each of the same provider, physician, practitioner, and supplier breakouts as tracked by Medicare's statistics, but the Census figures did include the largest provider, physician, practitioner, and supplier types. The Census figures included 90 percent of all Medicare providers, physicians, practitioners, and suppliers by type. The provider types track differently by CMS and the Census Bureau include regional referral centers, Christian Science Sanitoria, rural health clinics, critical access facilities, and hospices. The “2002 CMS Statistics” directory and the 2000 Census data health care establishment totals reported the following: </P>
        <GPOTABLE CDEF="s100,12,12,12" COLS="4" OPTS="L2(,,0),ns,tp0,i1">
          <TTITLE>  </TTITLE>
          <BOXHD>
            <CHED H="1">Provider type </CHED>
            <CHED H="1">Number of providers </CHED>
            <CHED H="1">Percentage of providers with less than 20 employees </CHED>
            <CHED H="1">Likely number excepted </CHED>
          </BOXHD>
          <ROW>
            <ENT I="01">Hospitals </ENT>
            <ENT>6,031 </ENT>
            <ENT>10.6 </ENT>
            <ENT>639 </ENT>
          </ROW>
          <ROW>
            <ENT I="01">Home Health Agencies </ENT>
            <ENT>7,099 </ENT>
            <ENT>69.2 </ENT>
            <ENT>4,913 </ENT>
          </ROW>
          <ROW>
            <ENT I="01">ESRD Facilities </ENT>
            <ENT>3,991 </ENT>
            <ENT>16.6 </ENT>
            <ENT>663 </ENT>
          </ROW>
          <ROW RUL="n,s">
            <ENT I="01">Skilled Nursing Facilities </ENT>
            <ENT>14,841 </ENT>
            <ENT>25.7 </ENT>
            <ENT>3,814 </ENT>
          </ROW>
          <ROW>
            <ENT I="03">Totals </ENT>
            <ENT>31,962 </ENT>
            <ENT>31.4 </ENT>
            <ENT>10,029 </ENT>
          </ROW>
        </GPOTABLE>
        
        <GPOTABLE CDEF="s100,12,12,12" COLS="4" OPTS="L2,tp0,i1">
          <TTITLE>  </TTITLE>
          <BOXHD>
            <CHED H="1">Type of physician, practitioner or supplier </CHED>
            <CHED H="1">Number of providers </CHED>
            <CHED H="1">Percentage of providers with less than 10 employees </CHED>
            <CHED H="1">Likely number excepted </CHED>
          </BOXHD>
          <ROW>
            <ENT I="01">Clinical Labs </ENT>
            <ENT>168,333 </ENT>
            <ENT>41.4 </ENT>
            <ENT>69,690 </ENT>
          </ROW>
          <ROW>
            <ENT I="01">Ambulatory Surgical Centers </ENT>
            <ENT>3,147 </ENT>
            <ENT>34.9 </ENT>
            <ENT>1,098 </ENT>
          </ROW>
          <ROW>
            <ENT I="01">Physicians </ENT>
            <ENT>567,412 </ENT>
            <ENT>70.6 </ENT>
            <ENT>400,593 </ENT>
          </ROW>
          <ROW RUL="n,s">
            <ENT I="01">All Other Practitioners </ENT>
            <ENT>297,967 </ENT>
            <ENT>71.8 </ENT>
            <ENT>213,940 </ENT>
          </ROW>
          <ROW>
            <ENT I="03">Totals </ENT>
            <ENT>1,036,859 </ENT>
            <ENT>66.1 </ENT>
            <ENT>685,321 </ENT>
          </ROW>
        </GPOTABLE>

        <P>As there was a 10 percent difference between the Census provider, physician, practitioner, and supplier types and the Medicare provider types, dues to differences in type collection, the numbers impacted would need to be increased by 10 percent to account for the difference. Increased by 10 percent, approximately 11,032 (31.4 percent) of <PRTPAGE P="48811"/>all Medicare providers, and 753,853 (66.1 percent) of all Medicare physicians, practitioners and suppliers could qualify for an exception of the electronic claim filing requirement based on provider size, leaving approximately 24,126 providers and 386,692 physicians, practitioners, and suppliers (a total of 410,818 potentially affected by the ASCA Medicare requirement nationally). </P>
        <P>Approximately 98 percent of providers, and 83 percent or physicians, practitioners, and suppliers already submit claims to Medicare electronically though, and are expected to continue doing so, so the total impacted must be further reduced to determine the approximate number of current paper claim submitters that would likely be affected. It is reasonable to assume that the majority of the paper claims received by Medicare are submitted by smaller providers, physicians, practitioners, and suppliers. As a result, it would not be accurate to reduce the number of affected providers by the full 98 percent of 83 percent. In the absence of reliable statistics to project the current source of all paper claims however, the number of providers potentially affected by the mandatory Medicare electronic claim requirement will be conservatively estimated at a maximum of 50 percent of the entities that would not qualify for a waiver. This leaves 12,063 providers and 193,346 physicians, practitioners, and suppliers (a total of 205,409) that would need to begin submitting claims to Medicare electronically. </P>
        <P>Statistics collected for PRA clearance of the Medicare paper claim forms and referenced in the “Collection of Information Requirements” section of this preamble indicate that in the absence of a mandatory electronic claim requirement effective for FY 2004, 2.5 million paper claims are expected to be sent to Medicare intermediaries and 133.7 million paper claims are to be sent to Medicare carriers. </P>
        <P>Today, many Medicare providers use billing agents or clearinghouses to bill the Medicare program. Many providers, physicians, practitioners, and suppliers that currently submit paper claims have indicated anecdotally that they use paper as they would rather avoid the “hassle” of dealing with the multiple electronic claim formats currently required by payers, and the need to have staff keep abreast of the updates to those formats. HIPAA will largely eliminate format differences among payers, but there will continue to be differences concerning use of certain “situational” segments and data elements in the formats. It is reasonable to assume that up to half (205,409 × 50 percent = 102,704) of those entities that do not submit claims to Medicare electronically today would prefer to contract with third party to deal with such differences on their behalf. </P>
        <P>A small sampling of Medicare contractors indicated an average cost of $0.30 per claim for billing agent and clearinghouse services. The total cost to physicians, practitioners, facilities, suppliers, and other health care providers to use a billing agent or clearinghouse should not be more than $7,055,895 (that is, $.30 × {the sum of 2.5 million paper claims sent to intermediaries as estimated previously for FY 2004 multiplied by the 68.6 percent of providers that would not meet the exception criteria plus 133.7 million paper claims estimated to be sent to carriers multiplied by the 33.9 percent of physicians, practitioners, and suppliers that would not meet the exception criteria}, reduced by 50 percent to account for the assumption that 50 percent of the firms will contract with the third party claims processors). </P>
        <P>Finally, in regard to the balance of 102,704 (205,409 × 50 percent) providers, physicians, practitioners, and suppliers that would not be expected to meet the criteria to submit paper claims, we conservatively estimate that approximately 75 percent of these already own personal computers that are used to prepare the paper claim forms they currently submitted to Medicare. Very few hand-written or manually typed claims are submitted to Medicare. Although many paper claim submitters have not used personal computers for electronic billing, they have used them for claim preparation, patient scheduling and other aspects of their practice. </P>
        <P>We estimate that at a maximum, the remaining total of 25,676 (25 percent of 102,704) providers, physicians, practitioners, and suppliers will obtain personal computers to allow them to submit their claims directly to Medicare electronically. A recent review of ads in Sunday newspapers indicated that personal computers sufficient to meet the mandatory electronic claim requirement could be obtained for between $500 to $1,000 for hardware (personal computer, monitor, printer, and modem). Billing software is available free or at low cost (less than $25 for shipping and handling) from Medicare. At the average rate of $750, it would cost $19.3 million to purchase 25,676 personal computer systems. More expensive equipment and peripherals could be used, but would not be necessary for basic compliance. Therefore, the total maximum cost should be no higher than $26.4 million ($7.1 million for users of clearinghouses or billing services, and $19.3 million for those that obtain personal computers). </P>
        <P>Following the HIPAA savings calculation used in the Transaction Rule, but projected to FY 2004 to account for inflation, a savings of $615 per provider could result in a total provider savings of approximately $15.8 million (that is, 25,676 times $615). </P>
        <P>We note that pages 50353 through 50359 of the August 17, 2000 transaction final rule for HIPAA used a 10-year time frame to capture the full extent of costs and savings that could be attributed to the use of the transactions adopted under HIPAA. Data from the 2000 edition of Faulkner and Gray's “Health Data Directory,” from a Workgroup for Electronic Data Interchange study report, and from the Department of Labor was used in those calculations to determine total claims in the health care industry, costs to use the transactions electronically, savings expected to be realized, the historical growth rate for claims overall as well as electronic claims, the percentage of electronic health care claims nationally in 2000, and the anticipated inflation rate for the 10-year period. </P>

        <P>The RFA requires agencies to analyze options for regulatory relief of small businesses. For purposes of the RFA, small entities include small businesses, nonprofit organizations, and government agencies. According to the Small Business Administration's (SBA's) data, approximately 95 percent of offices of physicians are considered small businesses (see the Small Business Administration's final rule titled “Small Business Size Standards, Health Care,” published in the <E T="04">Federal Register</E> on November 17, 2000, 65 FR 69432). Most practitioners, facilities, suppliers, and other providers are small entities either because of nonprofit status or because of having revenues of $6 million to $29 million or less in any 1 year. For purposes of the RFA, all physicians, practitioners, facilities, suppliers, and other health care providers that serve Medicare beneficiaries are considered to be small entities. However, as stated earlier, this rule in and of itself does not impose a regulatory burden. The ASCA mandates most aspects of this rule, in particular, the ASCA requires Medicare providers to submit claims electronically and stipulates exceptions that will and may be granted. We did have discretion; however, in setting conditions for exceptions, and believe these exceptions reduce the burden relative to the burden that may have been imposed by ASCA without this enabling regulation. <PRTPAGE P="48812"/>Individuals and States are not considered small entities. Therefore, no regulatory relief options are considered. A rule has a significant economic impact if it exceeds 3-5 percent of its total costs or revenues according to criterion set by the SBA. The statute exempts many small firms from this rulemaking, affording considerable relief to small entities. At most, small firms that are not exempt will incur an average of either $69 per firm ($7.1 million/102,704 firms) to contract out their claims filing, or purchase computer equipment at an average net cost of $135 per firm ($750 cost−$615 savings.) Therefore, we expect the impact of this rulemaking to fall well below the SBA threshold. </P>
        <P>In addition, section 1102(b) of the Act requires us to prepare a regulatory impact analysis if a rule may have a significant impact on the operations of a substantial number of small rural hospitals. This analysis must conform to the provisions of section 604 of the RFA. For purposes of section 1102(b) of the Act, we define a small rural hospital as a hospital that is located outside of a Metropolitan Statistical Area and has fewer than 100 beds. As indicated above, this rule could have an impact on those small rural hospitals that bill Medicare and that do not meet one of the exceptions. However, we do not believe the impact is significant since the cost of compliance is relatively small ($500 to $1,000) and small rural hospitals may be able to qualify for the small provider exception. Therefore, no regulatory impact analysis is required as the impact on small rural hospitals is not significant. </P>
        <P>Section 202 of the Unfunded Mandates Reform Act of 1995 also requires that agencies assess anticipated costs and benefits before issuing any rule that may result in an expenditure in any 1 year by State, local, or tribal governments, in the aggregate, or by the private sector, of $110 million. This interim final rule with comment period will not have an impact on State, local, or tribal governments or on the private sector. Instead, the primary impact on State, local, or tribal governments, or the private sector will be that entities that must begin billing Medicare electronically as a result of the ASCA are likely to use that capability to also bill other payers (such as State, local, or tribal governments and the private sector). </P>
        <P>Executive Order 13132 establishes certain requirements that an agency must meet when it promulgates a final rule that imposes substantial direct requirement costs on State and local governments, preempts State law, or otherwise has federalism implications. This interim final rule with comment period will not have a substantial effect on State or local governments for the reasons noted above. </P>
        <HD SOURCE="HD2">B. Anticipated Effects </HD>
        <HD SOURCE="HD3">1. Effects on Beneficiaries, Physicians, Practitioners, Facilities, Suppliers, and Other Health Care Providers </HD>
        <P>The anticipated effects on Medicare's beneficiaries will be that additional attention and services may be provided by their health care physician because, for example, electronic billing should reduce administrative paperwork. (This assertion has been made by the medical community in numerous forums over the years, though documentation to this effect is not available.) </P>
        <P>The anticipated effects on the entities required to bill electronically will reduce or eliminate paper in their administrative operations, realizing increased efficiencies and indeterminable savings. These savings may be increased by the fact that the Administrative Simplification provisions of HIPAA mandate a standard transaction for electronic claim submissions, and this will facilitate electronic claims submissions to all health care payers. At this time, we do not have additional data to estimate those savings to Medicare physicians, practitioners, facilities, suppliers, and other healthcare providers. As previously stated, there will be a cost incurred by those entities that cannot satisfy one of the exceptions and would be required to bill Medicare in electronic form. </P>
        <HD SOURCE="HD3">2. Effects on the Medicare and Medicaid Programs </HD>

        <P>Implementation of this interim final rule with comment period will result in a savings to the Medicare program. If the FY 2004 projected paper claims submissions of 136.2 million (HHS FY 2004 Budget submission to the Congress and estimated electronic media claims rate), are reduced by half and we assume a savings of $1.40 per claim as a result, the program could realize administrative savings of over $95 million per year. (<E T="04">Note:</E> The $1.40 per claim savings is the CMS estimate of savings based upon a 1990 Industrial Engineering Study, contracted by CMS (then HCFA). The study documented that FI paper claims cost about $3.30 more to process than electronic claims and, similarly, carrier paper claims cost about $1.00 more to process than electronic claims. Weighing these differences by the 2004 workloads and combining them yields the $1.40 estimated per claim savings.) </P>
        <P>We might expect similar types of savings for the States, which administer the Medicaid Program. That is, Medicare providers who become electronic billers due to ASCA may decide to begin billing Medicaid electronically as well. However, this would depend on which of the affected Medicare physicians, practitioners, facilities, suppliers, and other healthcare providers also bill Medicaid. Again, the fact that the Administrative Simplification provisions of HIPAA mandate a standard transaction for electronic claim submissions will facilitate electronic claims submissions to all health care payers. </P>
        <HD SOURCE="HD2">C. Alternatives Considered </HD>
        <P>Section 3 of ASCA requires electronic claims submission by those who bill Medicare. There is little room for us to consider alternatives, though we expect that public comment may focus upon further definition regarding the mandatory waivers or regarding those “unusual cases” for which the Secretary may waive the mandatory electronic claims submission requirement. </P>
        <HD SOURCE="HD2">D. Conclusion </HD>
        <P>As described above, this interim final rule with comment period establishes the requirements for implementing the statutory provisions under section 3 of the ASCA. The law requires, with few exceptions, that physicians, practitioners, facilities, suppliers, and other health care providers that bill Medicare must do so electronically. Coupled with the electronic standard transaction requirements under HIPAA, this rule facilitates greater administrative efficiencies for the Medicare program as well as for those that bill Medicare. There will be a cost incurred for those entities that are unable to meet one of the statutory exceptions, but we expect these initial costs to be offset by increased efficiencies and ongoing lower costs attributable to Medicare claims processing. </P>
        <P>In accordance with the provisions of Executive Order 12866, the Office of Management and Budget reviewed this regulation. </P>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects in 42 CFR Part 424 </HD>
          <P>Emergency medical services, Health facilities, Health professions, Medicare, Reporting and recordkeeping requirements.</P>
        </LSTSUB>
        <REGTEXT PART="424" TITLE="42">
          <AMDPAR>For the reasons set forth in the preamble, CMS proposes to amend 42 CFR chapter VI part 424 as set forth below: </AMDPAR>
          <PART>
            <PRTPAGE P="48813"/>
            <HD SOURCE="HED">PART 424—CONDITIONS FOR MEDICARE PAYMENT </HD>
          </PART>
          <AMDPAR>1. The authority citation for part 424 continues to read as follows: </AMDPAR>
          <AUTH>
            <HD SOURCE="HED">Authority:</HD>
            <P>Secs. 1102 and 1871 of the Social Security Act (42 U.S.C. 1302 and 1395hh). </P>
          </AUTH>
        </REGTEXT>
        
        <REGTEXT PART="424" TITLE="42">
          <AMDPAR>2. In § 424.32, add a new paragraph (d) to read as follows: </AMDPAR>
          <SECTION>
            <SECTNO>§ 424.32 </SECTNO>
            <SUBJECT>Basic requirements for all claims. </SUBJECT>
            <STARS/>
            <P>(d) <E T="03">Submission of electronic claims.</E>
            </P>
            <P>(1) <E T="03">Definitions.</E> For purposes of this paragraph, the following terms have the following meanings: </P>
            <P>(i) <E T="03">Claim</E> means a transaction defined at 45 CFR 162.1101(a). </P>
            <P>(ii) <E T="03">Electronic claim</E> means a claim that is submitted via electronic media. A claim submitted via direct data entry is considered to be an electronic claim. </P>
            <P>(iii) <E T="03">Direct data entry</E> is defined at 45 CFR 162.103. </P>
            <P>(iv) <E T="03">Electronic media</E> is defined at 45 CFR 160.103. </P>
            <P>(v) <E T="03">Initial Medicare claim</E> means a claim submitted to Medicare for payment under Part A or Part B of the Medicare Program under title XVIII of the Act for the first time for processing, including claims sent to Medicare for the first time for secondary payment purposes. <E T="03">Initial Medicare claim</E> excludes any adjustment or appeal of a previously submitted claim, and claims submitted for payment under Part C of the Medicare program under Title XVIII of the Act. </P>
            <P>(vi) <E T="03">Physician, practitioner, facility, or supplier</E> is a Medicare provider other than a <E T="03">provider of services.</E>
            </P>
            <P>(vii) <E T="03">Provider of services</E> means a provider of services as defined in section 1861(u) of the Act. </P>
            <P>(viii) <E T="03">Small provider of services or small supplier</E> means—</P>
            <P>(A) A provider of services with fewer than 25 full-time equivalent employees; or </P>
            <P>(B) A physician, practitioner, facility, or supplier with fewer than 10 full-time equivalent employees. </P>
            <P>(2) <E T="03">Submission of electronic claims required.</E> Except for claims to which paragraph (d)(3) or (d)(4) of this section applies, an initial Medicare claim may be paid only if submitted as an electronic claim for processing by the Medicare fiscal intermediary or carrier that serves the physician, practitioner, facility, supplier, or provider of services. This requirement does not apply to any other transactions, including adjustment or appeal of the initial Medicare claim. </P>
            <P>(3) <E T="03">Exceptions to requirement to submit electronic claims.</E> The requirement of paragraph (d)(2) of this section is waived for any initial Medicare claim when—</P>
            <P>(i) There is no method available for the submission of an electronic claim. This exception includes claims submitted by Medicare beneficiaries and situations in which the standard adopted by the Secretary at 45 FR 162.1102 does not support all of the information necessary for payment of the claim. The Secretary may identify situations coming within this exception in guidance. </P>
            <P>(ii) The entity submitting the claim is a small provider or small supplier. </P>
            <P>(4) <E T="03">Unusual circumstances.</E> The Secretary may waive the requirement of paragraph (d)(2) of this section in such unusual circumstances as the Secretary finds appropriate. Unusual circumstances are deemed to exist in the following situations: </P>
            <P>(i) The submission of dental claims. </P>
            <P>(ii) There is a service interruption in the mode of submitting the electronic claim that is outside the control of the entity submitting the claim, for the period of the interruption. </P>
            <P>(iii) On demonstration, satisfactory to the Secretary, of other extraordinary circumstances precluding submission of electronic claims. </P>
            <P>(5) <E T="03">Effective date.</E> This paragraph (d) is effective October 16, 2003, and applies to claims submitted on or after October 16, 2003. </P>
            
            <EXTRACT>
              <FP>(Catalog of Federal Domestic Assistance Program No. 93.774, Medicare—Supplementary Medical Insurance Program)   </FP>
            </EXTRACT>
          </SECTION>
        </REGTEXT>
        <SIG>
          <DATED>Dated: April 22, 2003. </DATED>
          <NAME>Thomas A. Scully, </NAME>
          <TITLE>Administrator, Centers for Medicare &amp; Medicaid Services. </TITLE>
          <DATED>Approved: August 12, 2003. </DATED>
          <NAME>Tommy G. Thompson, </NAME>
          <TITLE>Secretary.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20955 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4120-01-P</BILCOD>
    </RULE>
  </RULES>
  <VOL>68</VOL>
  <NO>158</NO>
  <DATE>Friday, August 15, 2003</DATE>
  <UNITNAME>Proposed Rules</UNITNAME>
  <PRORULES>
    <PRORULE>
      <PREAMB>
        <PRTPAGE P="48814"/>
        <AGENCY TYPE="F">LOCAL TELEVISION LOAN GUARANTEE BOARD </AGENCY>
        <CFR>7 CFR Parts 2200 and 2201 </CFR>
        <RIN>RIN 0572-AB82 </RIN>
        <SUBJECT>LOCAL Television Loan Guarantee Program </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>LOCAL Television Loan Guarantee Board. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Proposed rule. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The LOCAL Television Loan Guarantee Board (Board) is proposing regulations to implement the LOCAL Television Loan Guarantee Program (Program or LOCAL TV Program) as authorized by the Launching Our Communities' Access to Local Television Act of 2000 (the Act). Section 1002 of the Act sets forth the primary purpose of the Act to facilitate access, on a technologically neutral basis to signals of local television stations for households located in Nonserved Areas and Underserved Areas. The Act establishes a LOCAL Television Loan Guarantee Board (the Board) to approve Guarantees made under the Act. The Board is comprised of the Secretary of the Treasury, the Chairman of the Board of Governors of the Federal Reserve System, the Secretary of Agriculture, and the Secretary of Commerce, or their designees. </P>
          <P>This rule proposes to establish eligibility and Guarantee requirements, the application and approval process, as well as the administration of Guarantees made by the Board. Additionally, this rule proposes the process through which the Board will consider applications under the priority considerations required in the Act. </P>
        </SUM>
        <EFFDATE>
          <HD SOURCE="HED">DATES:</HD>
          <P>Written comments must by received by the LOCAL Television Loan Guarantee Board, or bear a postmark or equivalent, no later than September 15, 2003. Comments regarding the information and recordkeeping requirements must be received by October 14, 2003.</P>
        </EFFDATE>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>

          <P>Written comments should be addressed to Jacqueline G. Rosier, Secretary, LOCAL Television Loan Guarantee Board, 1400 Independence Avenue, SW., STOP 1575, Room 2919-S, Washington, DC 20250-1575. Telephone (202) 720-0530; Facsimile (202) 720-2734; e-mail <E T="03">localtv@rus.usda.gov.</E>
          </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>

          <P>Jacqueline G. Rosier, Secretary, LOCAL Television Loan Guarantee Board, 1400 Independence Avenue, SW., STOP 1575, Room 2919-S, Washington, DC 20250-1575. Telephone (202) 720-0530; Facsimile (202) 720-2734; E-mail <E T="03">localtv@rus.usda.gov.</E>
          </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <HD SOURCE="HD1">Executive Order 12866 </HD>
        <P>This proposed rule has been determined to be significant for purposes of Executive Order 12866, and therefore has been reviewed by the Office of Management and Budget (OMB). In accordance with Executive Order 12866, an Economic Impact Analysis was completed, outlining the costs and benefits of implementing this program. The complete analysis is available from the Board upon request. </P>
        <HD SOURCE="HD1">Executive Order 12988 </HD>
        <P>This rule has been reviewed under Executive Order 12988, Civil Justice Reform. The Board has determined that this rule meets the applicable standards provided in section 3 of the Executive Order, to minimize litigation, eliminate ambiguity, and reduce burden. </P>
        <HD SOURCE="HD1">Administrative Procedure Act </HD>

        <P>Pursuant to authority at 5 U.S.C. 553 (a)(2), this rule related to loans is exempt from the rulemaking requirements of the Administrative Procedure Act, 5 U.S.C. 551 <E T="03">et seq.</E>, including the requirement to provide prior notice and an opportunity for public comment. </P>
        <HD SOURCE="HD1">Regulatory Flexibility Act </HD>

        <P>Because this rule is not subject to a requirement to provide prior notice and an opportunity for public comment pursuant to 5 U.S.C. 553, or any other law, the analytical requirements of the Regulatory Flexibility Act, 5 U.S.C. 601 <E T="03">et seq.</E> are inapplicable. </P>
        <HD SOURCE="HD1">Information Collection and Recordkeeping Requirements </HD>
        <P>In accordance with the Paperwork Reduction Act of 1995 (44 U.S.C. chapter 35), the Board invites comments on this information collection for which the Board intends to request approval from the Office of Management and Budget (OMB). </P>
        <P>Comments on the information collection and recordkeeping requirements in this proposed rule must be received by October 14, 2003. </P>
        <P>Comments are invited on (a) whether the collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) the accuracy of the agency's estimate of burden including the validity of the methodology and assumptions used; (c) ways to enhance the quality, utility and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. </P>
        <P>Comments on the information collection and recordkeeping requirements in this proposed rule may be sent to F. Lamont Heppe, Jr., Director, Program Development and Regulatory Analysis, Rural Utilities Service, U.S. Department of Agriculture, 1400 Independence Ave. SW., Stop 1522, Room 4034 South Building, Washington, DC 20250-1522. </P>
        <P>
          <E T="03">Title:</E> LOCAL Television Loan Guarantee Program. </P>
        <P>
          <E T="03">Type of Request:</E> New collection. </P>
        <P>
          <E T="03">Estimate of Burden:</E> Public reporting burden for this collection of information is estimated to average 9 hours per response. </P>
        <P>
          <E T="03">Respondents:</E> Public bodies, commercial companies, cooperatives, nonprofits, Indian tribes, and limited dividend or mutual associations and must be incorporated or a limited liability company. </P>
        <P>
          <E T="03">Estimated Number of Respondents:</E> 10. </P>
        <P>
          <E T="03">Estimated Number of Responses per Respondent:</E> 19.4 </P>
        <P>
          <E T="03">Estimated Total Annual Burden on Respondents:</E> 1,830 hours. </P>

        <P>Copies of this information collection can be obtained from Michele Brooks, <PRTPAGE P="48815"/>Program Development and Regulatory Analysis, at (202) 690-1078. </P>
        <P>All responses to this information collection and recordkeeping notice will be summarized and included in the request for OMB approval. All comments will also become a matter of public record. </P>
        <HD SOURCE="HD1">Catalog of Federal Domestic Assistance </HD>
        <P>The Program described by this rule is listed in the Catalog of Federal Domestic Assistance Programs under No. 10.853, LOCAL Television Loan Guarantee Program. This catalog is available on a subscription basis from the Superintendent of Documents, the United States Government Printing Office, Washington, DC 20402. Telephone: (202) 512-1800. </P>
        <HD SOURCE="HD1">Executive Order 12372 </HD>
        <P>No intergovernmental consultation with State and local officials is required because this rule is not subject to the provisions of Executive Order 12372, Intergovernmental Consultation. </P>
        <HD SOURCE="HD1">Unfunded Mandates </HD>
        <P>This rule contains no Federal mandates (under the regulatory provision of Title II of the Unfunded Mandates Reform Act of 1995) for State, local, and tribal governments or the private sector. Thus, this rule is not subject to the requirements of sections 202 and 205 of the Unfunded Mandates Reform Act of 1995. </P>
        <HD SOURCE="HD1">National Environmental Policy Act </HD>

        <P>It has been determined that this rule does not constitute a major Federal action significantly affecting the quality of the human environment, and in accordance with the National Environmental Policy Act of 1969 [42 U.S.C. 4321 <E T="03">et seq.</E>] (NEPA), an Environmental Impact Statement is not required. If necessary, Loans sought to be guaranteed under this Program will be assessed individually to determine appropriate compliance with NEPA. </P>
        <HD SOURCE="HD1">Government Paperwork Elimination Act </HD>
        <P>The Board is committed to compliance with the Government Paperwork Elimination Act, which requires Government agencies to provide the public the option of submitting information or transacting business electronically to the maximum extent possible. </P>
        <HD SOURCE="HD1">Civil Rights </HD>
        <P>The LOCAL TV Board is an equal opportunity lender. Applicants are required to comply with regulations on nondiscrimination and equal employment opportunity. </P>
        <HD SOURCE="HD1">Executive Order 12630 </HD>
        <P>This rule does not contain policies that have takings implications. </P>
        <HD SOURCE="HD1">Executive Order 13132 </HD>
        <P>This rule does not contain policies having federalism implications requiring preparation of a Federalism Summary Impact Statement. </P>
        <HD SOURCE="HD1">Background </HD>

        <P>On December 21, 2000, the President signed Public Law 106-553, the Federal Funding Act for Fiscal Year 2001. Title X of Pub. L. 106-553, entitled the “Launching our Communities” Access to Local Television Act of 2000” established the LOCAL Television Loan Guarantee Board and authorized the Board to guarantee Loans to facilitate access, on a technologically neutral basis, to signals of local television stations for households located in Nonserved Areas or Underserved Areas. The Board is comprised of the Secretaries of Agriculture, Treasury, and Commerce, and the Chair of the Board of Governors of the Federal Reserve System, or their designees. Individuals have been designated as Board members for each of the agencies represented on the Board. The LOCAL Television Act does not, however, designate a chair of the Board. Pursuant to procedural regulations previously published in the <E T="04">Federal Register</E> on December 11, 2002 (67 FR 76105), the Board has chosen the designee of the Secretary of the Treasury as Chair. The Board is authorized to approve Guarantees up to 80 percent of the principal amount of up to $1.25 billion in Loans. The Board's authority to guarantee Loans under the Program expires on the earlier of the date the Secretary of Agriculture determines that at least 75 percent of Designated Market Areas, other than the top 40 Designated Market Areas, have access to Local Television Broadcast Signals for virtually all households or December 31, 2006. </P>
        <P>The Act requires the issuance of regulations to implement its provisions. Specifically, the Act requires that these regulations set forth: (1) The form of any application to be submitted to the Board; (2) the time periods for the review and consideration by the Board of applications submitted to the Board, as well as any other actions to be taken by the Board with respect to such applications; (3) appropriate safeguards against evasions of the Act; (4) circumstances in which an Applicant, together with any Affiliate of an Applicant, shall be treated as an Applicant for a Guarantee; (5) requirements that appropriate parties submit to the Board any documents and assurances that are required for the administration of the Act's provisions; (6) requirements governing defaults on Loans guaranteed under the Act, including the administration of the payment of guaranteed amounts upon Default; and (7) other provisions consistent with the Act's purposes as the Board considers appropriate. </P>

        <P>On March 14, 2001, the Rural Utilities Service (RUS), U.S. Department of Agriculture, published in the <E T="04">Federal Register</E> a request for public comment and a notice of public discussion meetings on implementing the provisions of the Act (66 FR 14880). This notice requested comments and encouraged participation in informal meetings regarding the implementation of the Act. RUS requested information regarding all aspects of the Program, including any financial and technological implications, as well as analyses of any provisions of the Act that may present issues or problems in implementing the Program. On April 30, 2002, RUS issued a Notice of Inquiry (NOI) in the <E T="04">Federal Register</E> (67 FR 21216) seeking additional public comment on the implementation of the Act. Specifically, the NOI was issued to assess the interest of eligible entities in pursuing application for funding under the Act taking into account: (1) The recent commercial and regulatory developments, including pending industry mergers; (2) the impacts of new technology capable of providing local TV signals; (3) the effects of the Satellite Home Viewer Improvement Act; and (4) the ability to accomplish the Act's objectives utilizing current appropriations. </P>
        <HD SOURCE="HD1">Comments and Responses </HD>
        <P>RUS received nine written comments in response to its March 14, 2001, request for public comment and notice of public discussion meetings. Five of the nine commenters participated in public discussion meetings with RUS and other Board staff. </P>
        <P>RUS received three written comments in response to its April 30, 2002, NOI. </P>
        <P>The twelve respondents included: satellite and internet services providers, cable, telecommunications &amp; television trade associations, the interest of rural utilities companies and cooperatives, TV station owners and operators, a rural financial lender, a financial consultant and a terrestrial system local TV provider. </P>

        <P>RUS submitted the comments to the Board and the Board considered the oral and written comments as it formulated <PRTPAGE P="48816"/>these regulations implementing the Program. </P>

        <P>The comments received in response to both notices are available on the RUS Web site at: <E T="03">http://www.usda.gov/rus/telecom/initiatives/index_initiatives.htm#comment.</E>
        </P>
        <HD SOURCE="HD1">Description of Proposed Rule </HD>
        <P>The LOCAL TV Act is intended to help spread local television into Nonserved Areas and Underserved Areas. The Act defines these terms in relation to the ability to receive the Local Television Broadcast Signals serving a particular Designated Market Area. What comprises these Local Television Broadcast Signals is not defined. This proposed rule would define Local Television Broadcast Signals to create a reasonable, meaningful, and administratively workable distinction between Nonserved Areas and Underserved Areas, so that priority is given to Projects that provide signals to areas without access to local signals. </P>
        <P>The Act refers to signals (plural). As such, receiving a single local television signal does not constitute access. The various technologies used to provide a multichannel system (typically a cable television system or a Direct Broadcast Satellite) do not inherently dictate the number of local signals provided. Therefore, Local Television Broadcast Signals must be defined on a different basis. </P>
        <P>As of August 15, 2003, the Federal Communications Commission (FCC) recognizes four major national television broadcast networks in its rulings. In addition, the Board determined that it is reasonable to define a practical set of “Local Television Broadcast Signals” as a set most likely to provide the local news, weather, sports and other programming of local interest that are the reason people need access to local signals. As such, the Board proposes a technologically neutral definition of “Local Television Broadcast Signals” so that Nonserved Areas and Underserved Areas are determined by whether that area has access to the local signals of the major national television broadcast networks. Further, the Act defines “Nonserved Area” to mean any area that is outside the grade B contour (as determined using standards employed by the FCC) of the Local Television Broadcast Signals serving a particular Designated Market Area and does not have access to such signals by any commercial, for profit, multichannel video provider. “Underserved Area” is defined in the Act to mean any area that is outside the grade A contour (as determined using standards employed by the FCC) of the Local Television Broadcast Signals serving a particular Designated Market Area and has access to Local Television Broadcast Signals from not more than one commercial, for-profit multichannel video provider. </P>
        <P>The definitions of nonserved area and underserved area contained in this proposed rule are directly from the Act. We interpret these statutory definitions as follows. An area outside of the grade A contour, but within the grade B contour, can never be considered a nonserved area. Areas outside of the grade B contour, which by definition are always not included in the grade A contour, may be considered either a nonserved area or an underserved area. However, any one geographic area outside of the grade B contour can never be both nonserved and underserved. An area outside of the grade B contour would be nonserved if it does not have access to local television broadcast signals from any commercial, for profit, or multichannel video provider. An area outside of the grade B contour would be underserved if it has access to local television broadcast signals from only one commercial, for profit, multichannel video provider. </P>

        <P>The LOCAL TV Act requires the Board to develop and utilize underwriting criteria to determine which loans may be eligible for a loan guarantee under the Act. The underwriting criteria have been embodied within these proposed rules. The underwriting criteria will be posted on the LOCAL TV Web site at <E T="03">http://www.usda.gov/rus/localtvboard.</E>
        </P>
        <P>In Section 2201.11(g)(2) of the proposed rule, the Board proposes that an Applicant applying for a guarantee for a loan greater than some minimum amount be required to submit a preliminary credit rating opinion letter prepared by a nationally recognized statistical rating organization. The proposed rule provides for a minimum amount of $5 million. The Board Is interested in receiving comment on where this minimum should be set within the range of $5 million to $25 million. Comments must include relevant information in support of their positions. </P>
        <P>These proposed rules implement the requirements of the Act and provide a procedure to administer the Program. </P>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects in 7 CFR Parts 2200 and 2201 </HD>
          <P>Loan programs—Communications, Rural areas, Telecommunications, Reporting and recordkeeping requirements.</P>
        </LSTSUB>
        <P>For the reasons set forth in the preamble, chapter XX of title 7 of the Code of Federal Regulations is proposed to be amended as follows:</P>
        <PART>
          <HD SOURCE="HED">PART 2200—ACCESS TO LOCAL TELEVISION SIGNALS GUARANTEED LOAN PROGRAM; GENERAL POLICIES AND PROCEDURES</HD>
          <P>1. The authority citation for part 2200 continues to read as follows:</P>
          <AUTH>
            <HD SOURCE="HED">Authority:</HD>
            <P>47 U.S.C. 1101 <E T="03">et seq.</E>; Pub. L. 106—553; Pub. L. 107-171.</P>
          </AUTH>
          
          <P>2. The title of part 2200 is proposed to be revised to read as set out above.</P>
          <P>3. Section 2200.1 is proposed to be amended by adding a new paragraph (d) to read as follows:</P>
          <SECTION>
            <SECTNO>§ 2200.1 </SECTNO>
            <SUBJECT>Definitions.</SUBJECT>
            <STARS/>
            <P>(d) <E T="03">Person</E> means any individual, corporation, cooperative, partnership, joint venture, association, joint-stock company, limited liability company or partnership, trust, unincorporated organization, government entity, agency or instrumentality or any subdivision thereof.</P>
            <P>4. Part 2200 is proposed to be amended by adding sections 2200.10 through 2200.12 to read as follows:</P>
          </SECTION>
          <SECTION>
            <SECTNO>§ 2200.10 </SECTNO>
            <SUBJECT>Restrictions on lobbying.</SUBJECT>
            <P>(a) No funds received through a Loan guaranteed under the Program in this chapter may be expended by the recipient of a Federal contract, grant, loan, loan guarantee, or cooperative agreement to pay any person for influencing or attempting to influence an officer or employee of any agency, a Member of Congress, an officer or employee of Congress, or an employee of a Member of Congress in connection with any of the following covered Federal actions: the awarding of any Federal contract, the making of any Federal grant, the making of any Federal loan or loan Guarantee, the entering into of any cooperative agreement, and the extension, continuation, renewal, amendment, or modification of any Federal contract, grant, loan, loan Guarantee, or cooperative agreement.</P>

            <P>(b) Each person who requests or receives from an agency a commitment providing for the United States to insure or guarantee a loan shall file with that agency a statement, set forth in the application form, whether that person has made or has agreed to make any payment to influence or attempt to influence an officer or employee of any agency, a Member of Congress, an officer or employee of Congress, or an employee of a Member of Congress in <PRTPAGE P="48817"/>connection with that loan insurance or Guarantee.</P>
            <P>(c) Each person who requests or receives from an agency a commitment providing for the United States to insure or guarantee a loan shall file with that agency a Standard Form—LLL if that person has made or has agreed to make any payment to influence or attempt to influence an officer or employee of any agency, a Member of Congress, an officer or employee of Congress, or an employee of a Member of Congress in connection with that loan insurance or Guarantee.</P>
            <P>(d) Each person shall file a certification, contained in the application form, and a disclosure form (Standard Form—LLL), if required, with each submission that initiates agency consideration of such person for:</P>
            <P>(1) Award of a Federal contract, grant, or cooperative agreement exceeding $100,000; or</P>
            <P>(2) An award of a Federal loan or a commitment providing for the United States to insure or guarantee a loan exceeding $150,000.</P>
            <P>(e) Each person shall file a certification, and a disclosure form, if required, upon receipt by such person of:</P>
            <P>(1) A Federal contract, grant, or cooperative agreement exceeding $100,000; or</P>
            <P>(2) A Federal loan or a commitment providing for the United States to insure or guarantee a loan exceeding $150,000, unless such person previously filed a certification, and a disclosure form, if required, under paragraph (c) of this section.</P>
            <P>(f) Each person shall file a disclosure form at the end of each calendar quarter in which there occurs any event that requires disclosure or that materially affects the accuracy of the information contained in any disclosure form previously filed by such person under paragraphs (d) or (e) of this section. An event that materially affects the accuracy of the information reported includes:</P>
            <P>(1) A cumulative increase of $25,000 or more in the amount paid or expected to be paid for influencing or attempting to influence a covered Federal action; or</P>
            <P>(2) A change in the person(s) or individual(s) influencing or attempting to influence a covered Federal action; or</P>
            <P>(3) A change in the officer(s), employee(s), or Member(s) contacted to influence or attempt to influence a covered Federal action.</P>
          </SECTION>
          <SECTION>
            <SECTNO>§ 2200.11 </SECTNO>
            <SUBJECT>Government-wide debarment and suspension (nonprocurement).</SUBJECT>
            <P>(a) Executive Order (E.O.) 12549 provides that, to the extent permitted by law, Executive departments and agencies shall participate in a governmentwide system for nonprocurement debarment and suspension. A person who is debarred or suspended shall be excluded from Federal financial and nonfinancial assistance and benefits under Federal programs and activities. Debarment or suspension of a participant in a program by one agency shall have governmentwide effect. The Board shall review the List of Debarred entities prior to making final loan Guarantee decisions. Suspension or debarment may be a basis for denying a loan Guarantee.</P>
            <P>(b) This section applies to all persons who have participated, are currently participating or may reasonably be expected to participate in transactions under Federal nonprocurement programs. For purposes of this section such transactions will be referred to as “covered transactions.”</P>
            <P>(1) <E T="03">Covered transaction.</E> For purposes of this section, a covered transaction is a primary covered transaction or a lower tier covered transaction. Covered transactions at any tier need not involve the transfer of Federal funds.</P>
            <P>(i) <E T="03">Primary covered transaction.</E> Except as noted in paragraph (b)(2) of this section, a primary covered transaction is any nonprocurement transaction between an agency and a person, regardless of type, including: grants, cooperative agreements, scholarships, fellowships, contracts of assistance, loans, loan guarantees, subsidies, insurance, payments for specified use, donation agreements and any other nonprocurement transactions between a Federal agency and a person.</P>
            <P>(ii) <E T="03">Lower tier covered transaction.</E> A lower tier covered transaction is:</P>
            <P>(A) Any transaction between a participant and a person other than a procurement contract for goods or services, regardless of type, under a primary covered transaction;</P>
            <P>(B) Any procurement contract for goods or services between a participant and a person, regardless of type, expected to equal or exceed the Federal procurement small purchase threshold fixed at 10 U.S.C. 2304(g) and 41 U.S.C. 253(g) (currently $100,000) under a primary covered transaction;</P>
            <P>(C) Any procurement contract for goods or services between a participant and a person under a covered transaction, regardless of amount, under which that person will have a critical influence on or substantive control over that covered transaction. Such persons may include loan officers or chief executive officers acting as principal investigators and providers of federally required audit services.</P>
            <P>(2) <E T="03">Exceptions.</E> The following transactions are not covered:</P>
            <P>(i) Statutory entitlements or mandatory awards (but not subtier awards thereunder which are not themselves mandatory), including deposited funds insured by the Federal Government;</P>
            <P>(ii) Direct awards to foreign governments or public international organizations, or transactions with foreign governments or foreign governmental entities, public international organizations, foreign government owned (in whole or in part) or controlled entities, entities consisting wholly or partially of foreign governments or foreign governmental entities;</P>
            <P>(iii) Benefits to an individual as a personal entitlement without regard to the individual's present responsibility (but benefits received in an individual's business capacity are not accepted);</P>
            <P>(iv) Federal employment; </P>
            <P>(v) Transactions pursuant to national or agency-recognized emergencies or disasters; </P>
            <P>(vi) Incidental benefits derived from ordinary governmental operations; and </P>
            <P>(vii) Other transactions where the application of this section would be prohibited by law. </P>
            <P>(3) <E T="03">Board covered transactions.</E> This section applies to the Board's Loan Guarantees, subcontracts and transactions at any tier that are charges as direct or indirect costs, regardless of type. </P>
            <P>(c) <E T="03">Primary covered transactions.</E> Except to the extent prohibited by law, persons who are debarred or suspended shall be excluded from primary covered transactions as either participants or principals throughout the Executive Branch of the Federal Government for the period of their debarment, suspension, or the period they are proposed for debarment under 48 CFR part 9, subpart 9.4. Accordingly, no agency shall enter into primary covered transactions with such excluded persons during such period, except as permitted pursuant to paragraph (l) of this section. </P>
            <P>(d) <E T="03">Lower tier covered transactions.</E> Except to the extent prohibited by law, persons who have been proposed for debarment under 48 CFR part 9, subpart 9.4, debarred or suspended shall be excluded from participating as either participants or principals in all lower tier covered transactions (see paragraph (b)(1)(ii) of this section for the period of their exclusion. <PRTPAGE P="48818"/>
            </P>
            <P>(e) <E T="03">Exceptions.</E> Debarment or suspension does not affect a person's eligibility for: </P>
            <P>(1) Statutory entitlements or mandatory awards (but not subtier awards thereunder which are not themselves mandatory), including deposited funds insured by the Federal Government; </P>
            <P>(2) Direct awards to foreign governments or public international organizations, or transactions with foreign governments or foreign governmental entities, public international organizations, foreign government owned (in whole or in part) or controlled entities, and entities consisting wholly or partially of foreign governments or foreign governmental entities; </P>
            <P>(3) Benefits to an individual as a personal entitlement without regard to the individual's present responsibility (but benefits received in an individual's business capacity are not accepted); </P>
            <P>(4) Federal employment; </P>
            <P>(5) Transactions pursuant to national or agency-recognized emergencies or disasters; </P>
            <P>(6) Incidental benefits derived from ordinary governmental operations; and </P>
            <P>(7) Other transactions where the application of this section would be prohibited by law. </P>
            <P>(f) Persons who are ineligible are excluded in accordance with the applicable statutory, executive order, or regulatory authority. </P>
            <P>(g) Persons who accept voluntary exclusions are excluded in accordance with the terms of their settlements. The Board shall, and participants may, contact the original action agency to ascertain the extent of the exclusion. </P>
            <P>(h) The Board may grant an exception permitting a debarred, suspended, or voluntarily excluded person, or a person proposed for debarment under 48 CFR part 9, subpart 9.4, to participate in a particular covered transaction upon a written determination by the agency head or an authorized designee stating the reason(s) for deviating from the Presidential policy established by Executive Order 12549. However, in accordance with the President's stated intention in the Executive Order, exceptions shall be granted only infrequently. Exceptions shall be reported in accordance with the Executive Order. </P>
            <P>(i) Notwithstanding the debarment, suspension, proposed debarment under 48 CFR part 9, subpart 9.4, determination of ineligibility, or voluntary exclusion of any person by an agency, agencies and participants may continue covered transactions in existence at the time the person was debarred, suspended, proposed for debarment under 48 CFR part 9, subpart 9.4, declared ineligible, or voluntarily excluded. A decision as to the type of termination action, if any, to be taken should be made only after thorough review to ensure the propriety of the proposed action. </P>
            <P>(j) Agencies and participants shall not renew or extend covered transactions (other than no-cost time extensions) with any person who is debarred, suspended, proposed for debarment under 48 CFR part 9, subpart 9.4, ineligible or voluntary excluded, except as provided in paragraph (h) of this section. </P>
            <P>(k) Except as permitted under paragraphs (h) or (i) of this section, a participant shall not knowingly do business under a covered transaction with a person who is: </P>
            <P>(1) Debarred or suspended; </P>
            <P>(2) Proposed for debarment under 48 CFR part 9, subpart 9.4; or </P>
            <P>(3) Ineligible for or voluntarily excluded from the covered transaction. </P>
            <P>(l) Violation of the restriction under paragraph (k) of this section may result in disallowance of costs, annulment or termination of award, issuance of a stop work order, debarment or suspension, or other remedies as appropriate. </P>
            <P>(m) A participant may rely upon the certification of a prospective participant in a lower tier covered transaction that it and its principals are not debarred, suspended, proposed for debarment under 48 CFR part 9, subpart 9.4, ineligible, or voluntarily excluded from the covered transaction, unless it knows that the certification is erroneous. An agency has the burden of proof that a participant did knowingly do business with a person that filed an erroneous certification. </P>
          </SECTION>
          <SECTION>
            <SECTNO>§ 2200.12 </SECTNO>
            <SUBJECT>Freedom of Information Act. </SUBJECT>
            <P>(a) <E T="03">Definitions.</E> All terms used in this section, which are defined in 5 U.S.C. 551 or 5 U.S.C. 552 shall have the same meaning in this section. In addition the following definitions apply to this section: </P>
            <P>(1) <E T="03">FOIA</E>, as used in this section, means the “Freedom of Information Act,” as amended, 5 U.S.C. 552. </P>
            <P>(2) <E T="03">Commercial use request</E> means a request from or on behalf of one who seeks information for a use or purpose that furthers the commercial, trade, or profit interests of the requester or the person on whose behalf the request is made. </P>
            <P>(3) <E T="03">Direct costs</E> mean those expenditures that the Board actually incurs in searching for, reviewing, and duplicating documents in response to a request made under paragraph (c) of this section. Direct costs include, for example, the labor costs of the employee performing the work (the basic rate of pay for the employee, plus 16 percent of that rate to cover benefits). Not included in direct costs are overhead expenses such as the costs of space and heating or lighting of the facility in which the records are kept. </P>
            <P>(4) <E T="03">Duplication</E> means the process of making a copy of a document in response to a request for disclosure of records or for inspection of original records that contain exempt material or that otherwise cannot be inspected directly. Among others, such copies may take the form of paper, microfilm, audiovisual materials, or machine-readable documentation (<E T="03">e.g.</E>, magnetic tape or disk). </P>
            <P>(5) <E T="03">Educational institution</E> means a preschool, a public or private elementary or secondary school, or an institution of undergraduate higher education, graduate higher education, professional education, or an institution of vocational education that operates a program of scholarly research. </P>
            <P>(6) <E T="03">Noncommercial scientific institution</E> refers to an institution that is not operated on a “commercial” basis (as that term is used in this section) and which is operated solely for the purpose of conducting scientific research, the results of which are not intended to promote any particular product or industry. </P>
            <P>(7) <E T="03">News</E> means information about current events or that would be of current interest to the public. Examples of news media entities include, but are not limited to, television or radio stations broadcasting to the public at large, and publishers of newspapers and other periodicals (but only in those instances when they can qualify as disseminators of “news”) who make their products available for purchase or subscription by the general public. “Freelance” journalists may be regarded as working for a news organization if they can demonstrate a solid basis for expecting publication through that organization, even though not actually employed by it. </P>
            <P>(8) <E T="03">Representative of the news media</E> means any person actively gathering news for an entity that is organized and operated to publish or broadcast news to the general public. </P>
            <P>(9) <E T="03">Review</E> means the process of examining documents, located in response to a request for access, to determine whether any portion of a document is exempt information. It includes doing all that is necessary to excise the documents and otherwise to prepare them for release. Review does not include time spent resolving general <PRTPAGE P="48819"/>legal or policy issues regarding the application of exemptions. </P>
            <P>(10) <E T="03">Search</E> means the process of looking for material that is responsive to a request, including page-by-page or line-by-line identification within documents. Searches may be done manually or by computer. </P>
            <P>(b) <E T="03">Records available for public inspection and copying.</E> (1) <E T="03">Types of records made available.</E> The information in this section is furnished for the guidance of the public and in compliance with the requirements of the FOIA. This section sets forth the procedures the Board follows to make publicly available the materials specified in 5 U.S.C. 552(a)(2). These materials shall be made available for inspection and copying at the Board's offices pursuant to 5 U.S.C. 552(a)(2). Information routinely provided to the public as part of a regular Board activity (for example, press releases) may be provided to the public without following this section. </P>
            <P>(2) <E T="03">Reading room procedures.</E> Information available under this section is available for inspection and copying, from 9 a.m. to 5 p.m. weekdays, at 1400 Independence Avenue, SW., Washington, DC. </P>
            <P>(3) <E T="03">Electronic records.</E> Information available under this section shall also be available on the Board's Web site found at <E T="03">www.usda.gov/rus/localtvboard.</E>
            </P>
            <P>(c) <E T="03">Records available to the public on request.</E> (1) <E T="03">Types of records made available.</E> All records of the Board that are not available under paragraph (b) of this section shall be made available upon request, pursuant to the procedures in this section and the exceptions set forth in the FOIA. </P>
            <P>(2) <E T="03">Procedures for requesting records.</E> A request for records shall reasonably describe the records in a way that enables the Board's staff to identify and produce the records with reasonable effort and without unduly burdening or significantly interfering with any of the Board's operations. The request shall be submitted in writing to the Secretary of the Board at LOCAL Television Loan Guarantee Board, 1400 Independence Avenue, SW., STOP 1575, Room 2919-S, Washington, DC 20250-1575, or sent by facsimile to the Secretary of the Board at (202) 720-2734. The request shall be clearly marked <E T="03">FREEDOM OF INFORMATION ACT REQUEST.</E>
            </P>
            <P>(3) <E T="03">Contents of request.</E> The request shall contain the following information: </P>
            <P>(i) The name and address of the requester, and the telephone number at which the requester can be reached during normal business hours; </P>
            <P>(ii) Whether the requested information is intended for commercial use, or whether the requester represents an educational or noncommercial scientific institution, or news media; </P>
            <P>(iii) A statement agreeing to pay the applicable fees, or a statement identifying any fee limitation desired, or a request for a waiver or reduction of fees that satisfies paragraph (f) of this section. </P>
            <P>(d) <E T="03">Processing requests.</E> (1) <E T="03">Priority of responses.</E> The date of receipt for any request, including one that is addressed incorrectly or that is referred to the Board by another agency, is the date the Secretary of the Board actually receives the request. The Secretary of the Board shall normally process requests in the order they are received. However, in the Secretary of the Board's discretion, the Board may use two or more processing tracks by distinguishing between simple and more complex requests based on the number of pages involved, or some other measure of the amount of work and/or time needed to process the request, and whether the request qualifies for expedited processing as described in paragraph (d)(2) of this section. When using multitrack processing, the Secretary of the Board may provide requesters in the slower track(s) with an opportunity to limit the scope of their requests in order to qualify for faster processing. The Secretary of the Board shall contact the requester by telephone or by letter, whichever is most efficient in each case. </P>
            <P>(2) <E T="03">Expedited processing.</E> (i) A person may request expedited access to records by submitting a statement, certified to be true and correct to the best of that person's knowledge and belief, that demonstrates a compelling need for the records, as defined in 5 U.S.C. 552(a)(6)(E)(v). </P>
            <P>(ii) The Secretary of the Board shall notify a requester of the determination whether to grant or deny a request for expedited processing within ten working days of receipt of the request. If the Secretary of the Board grants the request for expedited processing, the Board shall process the request for access to information as soon as practicable. If the Secretary of the Board denies a request for expedited processing, the requester may file an appeal pursuant to the procedures set forth in paragraph (e) of this section, and the Board shall respond to the appeal within twenty days after the appeal was received by the Board. </P>
            <P>(3) <E T="03">Time limits.</E> The time for response to requests shall be 20 working days, except: </P>
            <P>(i) In the case of expedited treatment under paragraph (d)(2) of this section; </P>
            <P>(ii) Where the running of such time is suspended for payment of fees pursuant to paragraph (f)(2)(ii) of this section; </P>
            <P>(iii) Where the estimated charge is less than $250, and the requester does not guarantee payment pursuant to paragraph (f)(2)(i) of this section; or </P>
            <P>(iv) In unusual circumstances, as defined in 5 U.S.C. 552(a)(6)(B)(iii), the time limit may be extended for a period of time not to exceed 10 working days as provided by written notice to the requester, setting forth the reasons for the extension and the date on which a determination is expected to be dispatched; or such alternative time period as mutually agreed to by the Secretary of the Board and the requester when the Secretary of the Board notifies the requester that the request cannot be processed in the specified time limit. </P>
            <P>(4) <E T="03">Response to request.</E> In response to a request that satisfies paragraph (c) of this section, an appropriate search shall be conducted of records in the custody and control of the Board on the date of receipt of the request, and a review made of any responsive information located. The Secretary of the Board shall notify the requester of: </P>
            <P>(i) The Secretary of the Board's determination of the request and the reasons therefor; </P>
            <P>(ii) The information withheld, and the basis for withholding; and </P>
            <P>(iii) The right to appeal any denial or partial denial, pursuant to paragraph (e) of this section. </P>
            <P>(5) <E T="03">Referral to another agency.</E> To the extent a request covers documents that were created by, obtained from, classified by, or is in the primary interest of another agency, the Secretary of the Board may refer the request to that agency for a direct response by that agency and inform the requester promptly of the referral. The Secretary of the Board shall consult with another Federal agency before responding to a requester if the Board receives a request for a record in which: </P>
            <P>(i) Another Federal agency subject to the FOIA has a significant interest, but not the primary interest; or </P>
            <P>(ii) Another Federal agency not subject to the FOIA has the primary interest or a significant interest. Ordinarily, the agency that originated a record will be presumed to have the primary interest in it. </P>
            <P>(6) <E T="03">Providing responsive records.</E> (i) A copy of records or portions of records responsive to the request shall be sent to the requester by regular U.S. mail to the address indicated in the request, unless the requester elects to take delivery of the documents at the Board's Freedom of Information Office or makes other acceptable arrangements, or the <PRTPAGE P="48820"/>Secretary of the Board deems it appropriate to send the documents by another means. The Secretary of the Board shall provide a copy of the record in any form or format requested if the record is readily reproducible in that form or format, but the Secretary of the Board need not provide more than one copy of any record to a requester. </P>
            <P>(ii) The Secretary of the Board shall provide any reasonably segregable portion of a record that is responsive to the request after deleting those portions that are exempt under the FOIA or this section. </P>
            <P>(iii) Except where disclosure is expressly prohibited by statute, regulation, or order, the Secretary of the Board may authorize the release of records that are exempt from mandatory disclosure whenever the Board or designated Board members determine that there would be no foreseeable harm in such disclosure. </P>
            <P>(iv) The Board is not required in response to the request to create records or otherwise to prepare new records. </P>
            <P>(7) <E T="03">Prohibition against disclosure.</E> Except as provided in this part, no officer, employee, or agent of the Board shall disclose or permit the disclosure of any unpublished information of the Board to any person (other than Board officers, employees, or agents properly entitled to such information for the performance of official duties), unless required by law. </P>
            <P>(e) <E T="03">Appeals.</E> (1) Any person denied access to Board records requested under paragraph (c) of this section, denied expedited processing under paragraph (d) of this section, or denied a waiver of fees under paragraph (f) of this section may file a written appeal within 30 calendar days after the date of such denial with the Board. The written appeal shall prominently display the phrase <E T="03">FREEDOM OF INFORMATION ACT APPEAL</E> on the first page, and shall be addressed to Chairman of the Board, LOCAL Television Loan Guarantee Board, 1400 Independence Avenue, SW., STOP 1575, Room 2919-S, Washington, DC 20250-1575, or sent by facsimile to (202) 720-2734. The appeal shall include a copy of the original request, the initial denial, if any, and a statement of the reasons why the requested records should be made available and why the initial denial was in error. </P>
            <P>(2) The Chairman of the Board shall make a determination regarding any appeal within 20 working days of actual receipt of the appeal, and the determination letter shall notify the appealing party of the right to seek judicial review in the event of denial. </P>
            <P>(f) <E T="03">Fee schedules and waiver of fees.</E>
            </P>
            <P>(1) <E T="03">Fee schedule.</E> The fees applicable to a request for records pursuant to paragraph (c) of this section are set forth in the uniform fee schedule at the end of this paragraph (f). </P>
            <P>(i) <E T="03">Search.</E> (A) Search fees shall be charged for all requests other than requests made by educational institutions, noncommercial scientific institutions, or representatives of the news media, subject to the limitations of paragraph (f)(1)(iv) of this section. The Secretary of the Board shall charge for time spent searching even if no responsive record is located or if the Secretary of the Board withholds the record(s) located as entirely exempt from disclosure. </P>
            <P>Search fees shall be the direct costs of conducting the search by the involved employees. </P>
            <P>(B) For computer searches of records, requesters will be charged the direct costs of conducting the search, although certain requesters (as provided in paragraph (f)(3) of this section) will be charged no search fee and certain other requesters (as provided in paragraph (f)(3)) are entitled to the cost equivalent of two hours of manual search time without charge. These direct costs include the costs, attributable to the search, of operating a central processing unit and operator/programmer salary. </P>
            <P>(ii) <E T="03">Duplication.</E> Duplication fees will be charged to all requesters, subject to the limitations of paragraph (f)(1)(iv) of this section. For a paper photocopy of a record (no more than one copy of which need be supplied), the fee shall be 15 cents per page. For copies produced by computer, such as tapes or printouts, the Secretary of the Board shall charge the direct costs, including operator time, of producing the copy. For other forms of duplication, the Secretary of the Board will charge the direct costs of that duplication. </P>
            <P>(iii) <E T="03">Review.</E> Review fees shall be charged to requesters who make a commercial use request. Review fees shall be charged only for the initial record review—the review done when the Secretary of the Board determines whether an exemption applies to a particular record at the initial request level. No charge will be made for review at the administrative appeal level for an exemption already applied. However, records withheld under an exemption that is subsequently determined not to apply may be reviewed again to determine whether any other exemption not previously considered applies, and the costs of that review are chargeable. Review fees shall be the direct costs of conducting the review by the involved employees. </P>
            <P>(iv) <E T="03">Limitations on charging fees.</E> (A) No search fee will be charged for requests by educational institutions, noncommercial scientific institutions, or representatives of the news media. </P>
            <P>(B) No search fee or review fee will be charged for a quarter-hour period unless more than half of that period is required for search or review. </P>
            <P>(C) Whenever a total fee calculated under this paragraph is $25 or less for any request, no fee will be charged. </P>
            <P>(D) For requesters other than those seeking records for a commercial use, no fee will be charged unless the cost of search in excess of two hours plus the cost of duplication in excess of 100 pages totals more than $25. </P>
            <P>(2) <E T="03">Payment procedures.</E> All persons requesting records pursuant to paragraph (c) of this section shall pay the applicable fees before the Secretary of the Board sends copies of the requested records, unless a fee waiver has been granted pursuant to paragraph (f)(6) of this section. Requesters must pay fees by check or money order made payable to the Treasury of the United States. </P>
            <P>(i) <E T="03">Advance notification of fees.</E> If the estimated charges are likely to exceed $25, the Secretary of the Board shall notify the requester of the estimated amount, unless the requester has indicated a willingness to pay fees as high as those anticipated. Upon receipt of such notice, the requester may confer with the Secretary of the Board to reformulate the request to lower the costs. The processing of the request shall be suspended until the requester provides the Secretary of the Board with a written guarantee that payment will be made upon completion of the processing. </P>
            <P>(ii) <E T="03">Advance payment.</E> The Secretary of the Board shall require advance payment of any fee estimated to exceed $250. The Secretary of the Board shall also require full payment in advance where a requester has previously failed to pay a fee in a timely fashion. If an advance payment of an estimated fee exceeds the actual total fee by $1 or more, the difference shall be refunded to the requester. The time period for responding to requests under paragraph (d)(4) of this section, and the processing of the request shall be suspended until the Secretary of the Board receives the required payment. </P>
            <P>(iii) <E T="03">Late charges.</E> The Secretary of the Board may assess interest charges when fee payment is not made within 30 days of the date on which the billing was sent. Assessment of such interest will commence on the 31st day following the day on which the billing was sent. <PRTPAGE P="48821"/>Interest is at the rate prescribed in 31 U.S.C. 3717. </P>
            <P>(3) <E T="03">Categories of uses.</E> The fees assessed depend upon the fee category. In determining which category is appropriate, the Secretary of the Board shall look to the identity of the requester and the intended use set forth in the request for records. Where a requester's description of the use is insufficient to make a determination, the Secretary of the Board may seek additional clarification before categorizing the request. </P>
            <P>(i) <E T="03">Commercial use requester.</E> The fees for search, duplication, and review apply when records are requested for commercial use. </P>
            <P>(ii) <E T="03">Educational, non-commercial scientific institutions, or representatives of the news media requesters.</E> The fees for duplication apply when records are not sought for commercial use, and the requester is a representative of the news media or an educational or noncommercial scientific institution, whose purpose is scholarly or scientific research. The first 100 pages of duplication, however, will be provided free. </P>
            <P>(iii) <E T="03">All other requesters.</E> For all other requests, the fees for search and duplication apply. The first two hours of search time and the first 100 pages of duplication, however, will be provided free. </P>
            <P>(4) <E T="03">Nonproductive search.</E> Fees for search may be charged even if no responsive documents are found. Fees for search and review may be charged even if the request is denied. </P>
            <P>(5) <E T="03">Aggregated requests.</E> A requester may not file multiple requests at the same time, solely in order to avoid payment of fees. If the Secretary of the Board reasonably believes that a requester is separating a request into a series of requests for the purpose of evading the assessment of fees or that several requesters appear to be acting together to submit multiple requests solely in order to avoid payment of fees, the Secretary of the Board may aggregate such requests and charge accordingly. It is considered reasonable for the Secretary of the Board to presume that multiple requests by one requester on the same topic made within a 30-day period have been made to avoid fees. </P>
            <P>(6) <E T="03">Waiver or reduction of fees.</E> A request for a waiver or reduction of the fees, and the justification for the waiver, shall be included with the request for records to which it pertains. If a waiver is requested and the requester has not indicated in writing an agreement to pay the applicable fees if the waiver request is denied, the time for response to the request for documents, as set forth in under paragraph (d)(4) of this section, shall not begin until a determination has been made on the request for a waiver or reduction of fees. </P>
            <P>(i) <E T="03">Standards for determining waiver or reduction.</E> The Secretary of the Board may grant a waiver or reduction of fees where it is determined both that disclosure of the information is in the public interest because it is likely to contribute significantly to public understanding of the operation or activities of the government, and that the disclosure of information is not primarily in the commercial interest of the requester. In making this determination, the following factors shall be considered: </P>
            <P>(A) Whether the subject of the records concerns the operations or activities of the government; </P>
            <P>(B) Whether disclosure of the information is likely to contribute significantly to public understanding of government operations or activities; </P>
            <P>(C) Whether the requester has the intention and ability to disseminate the information to the public; </P>
            <P>(D) Whether the information is already in the public domain; </P>
            <P>(E) Whether the requester has a commercial interest that would be furthered by the disclosure; and, if so, </P>
            <P>(F) Whether the magnitude of the identified commercial interest of the requester is sufficiently large, in comparison with the public interest in disclosure, that disclosure is primarily in the commercial interest of the requester. </P>
            <P>(ii) <E T="03">Contents of request for waiver.</E> A request for a waiver or reduction of fees shall include a clear statement of how the request satisfies the criteria set forth in paragraph (f)(6)(i) of this section. </P>
            <P>(iii) <E T="03">Burden of proof.</E> The burden shall be on the requester to present evidence or information in support of a request for a waiver or reduction of fees. </P>
            <P>(iv) <E T="03">Determination by Secretary of the Board.</E> The Secretary of the Board shall make a determination on the request for a waiver or reduction of fees and shall notify the requester accordingly. A denial may be appealed to the Board in accordance with paragraph (e) of this section. </P>
            <P>(7) Uniform fee schedule. </P>
            <GPOTABLE CDEF="s50,r50" COLS="2" OPTS="L2,tp0,i1">
              <TTITLE>  </TTITLE>
              <BOXHD>
                <CHED H="1">Service </CHED>
                <CHED H="1">Rate </CHED>
              </BOXHD>
              <ROW>
                <ENT I="01">(i) Manual search</ENT>
                <ENT>Actual salary rate of employee involved, plus 16 percent of salary rate. </ENT>
              </ROW>
              <ROW>
                <ENT I="01">(ii) Computerized search</ENT>
                <ENT>Actual direct cost, including operator time. </ENT>
              </ROW>
              <ROW>
                <ENT I="01" O="xl">(iii) Duplication of records: </ENT>
              </ROW>
              <ROW>
                <ENT I="02">(A) Paper copy reproduction</ENT>
                <ENT>$.15 per page. </ENT>
              </ROW>
              <ROW>
                <ENT I="02">(B) Other reproduction (<E T="03">e.g.</E>, computer disk or printout, microfilm, microfiche, or microform)</ENT>
                <ENT>Actual direct cost, including operator time. </ENT>
              </ROW>
              <ROW>
                <ENT I="01">(iv) Review of records (includes employee preparation for release, <E T="03">i.e.</E> excising) </ENT>
                <ENT>Actual salary rate of conducting review, plus 16 percent of salary rate. </ENT>
              </ROW>
            </GPOTABLE>
            <P>(g) <E T="03">Request for confidential treatment of business information.</E> (1) <E T="03">Submission of request.</E> Any submitter of information to the Board who desires confidential treatment of business information pursuant to 5 U.S.C. 552(b)(4) shall file a request for confidential treatment with the Board at the time the information is submitted or a reasonable time after submission. </P>
            <P>(2) <E T="03">Form of request.</E> Each request for confidential treatment of business information shall state in reasonable detail the facts supporting the commercial or financial nature of the business information and the legal justification under which the business information should be protected. Conclusory statements that release of the information would cause competitive harm generally will not be considered sufficient to justify confidential treatment. </P>
            <P>(3) <E T="03">Designation and separation of confidential material.</E> All information considered confidential by a submitter shall be clearly designated “<E T="03">PROPRIETARY</E>” or “<E T="03">BUSINESS CONFIDENTIAL</E>” in the submission and separated from information for which confidential treatment is not requested. Failure to segregate confidential commercial or financial information from other material may result in release of the nonsegregated material to the public without notice to the submitter.</P>
            <P>(h) <E T="03">Request for access to confidential commercial or financial information.</E> (1) <E T="03">Request for confidential commercial or financial information.</E> A request by a submitter for confidential treatment of any business information shall be considered in connection with a request for access to that information.</P>
            <P>(2) <E T="03">Notice to the submitter.</E> (i) The Secretary of the Board shall notify a submitter who requested confidential treatment of information pursuant to 5 U.S.C. 552(b)(4), of the request for access.</P>

            <P>(ii) Absent a request for confidential treatment, the Secretary of the Board may notify a submitter of a request for access to submitter's business information if the Secretary of the Board <PRTPAGE P="48822"/>reasonably believes that disclosure of the information may cause substantial competitive harm to the submitter. </P>
            <P>(iii) The notice given to the submitter by mail, return receipt requested, shall be given as soon as practicable after receipt of the request for access, and shall describe the request and provide the submitter seven working days from the date of notice, to submit written objections to disclosure of the information. Such statement shall specify all grounds for withholding any of the information and shall demonstrate why the information which is considered to be commercial or financial information, and that the information is a trade secret, is privileged or confidential, or that its disclosure is likely to cause substantial competitive harm to the submitter. If the submitter fails to respond to the notice within the time specified, the submitter will be considered to have no objection to the release of the information. Information a submitter provides under this paragraph may itself be subject to disclosure under the FOIA. </P>
            <P>(3) <E T="03">Exceptions to notice to submitter.</E> Notice to the submitter need not be given if: </P>
            <P>(i) The Secretary of the Board determines that the request for access should be denied; </P>
            <P>(ii) The requested information lawfully has been made available to the public; </P>
            <P>(iii) Disclosure of the information is required by law (other than 5 U.S.C. 552); or </P>
            <P>(iv) The submitter's claim of confidentiality under 5 U.S.C. 552(b)(4) appears obviously frivolous or has already been denied by the Secretary of the Board, except that in this last instance the Secretary of the Board shall give the submitter written notice of the determination to disclose the information at least seven working days prior to disclosure. </P>
            <P>(4) <E T="03">Notice to requester.</E> At the same time the Secretary of the Board notifies the submitter, the Secretary of the Board also shall notify the requester that the request is subject to the provisions of this section.</P>
            <P>(5) <E T="03">Determination by Secretary of the Board.</E> The Secretary of the Board's determination whether or not to disclose any information for which confidential treatment has been requested pursuant to this section shall be communicated to the submitter and the requester immediately. If the Secretary of the Board determines to disclose the business information over the objection of a submitter, the Secretary of the Board shall give the submitter written notice via mail, return receipt requested, or similar means, which shall include: </P>
            <P>(i) A statement of reason(s) why the submitter's objections to disclosure were not sustained; </P>
            <P>(ii) A description of the business information to be disclosed; and </P>
            <P>(iii) A statement that the component intends to disclose the information seven working days from the date the submitter receives the notice. </P>
            <P>(6) <E T="03">Notice of lawsuit.</E> The Secretary of the Board shall promptly notify any submitter of information covered by this section of the filing of any suit against the Board to compel disclosure of such information, and shall promptly notify a requester of any suit filed against the Board to enjoin the disclosure of requested documents.</P>
            <P>5. Part 2201 is proposed to be added to read as follows: </P>
          </SECTION>
        </PART>
        <PART>
          <HD SOURCE="HED">PART 2201—LOCAL TELEVISION LOAN GUARANTEE PROGRAM—PROGRAM REGULATIONS </HD>
          <CONTENTS>
            <SUBPART>
              <HD SOURCE="HED">Subpart A—General </HD>
              <SECHD>Sec. </SECHD>
              <SECTNO>2201.1 </SECTNO>
              <SUBJECT>Definitions. </SUBJECT>
              <SECTNO>2201.2-2201.9 </SECTNO>
              <SUBJECT>[Reserved] </SUBJECT>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart B—Loan Guarantees </HD>
              <SECTNO>2201.10 </SECTNO>
              <SUBJECT>Loan amount and Guarantee percentage. </SUBJECT>
              <SECTNO>2201.11 </SECTNO>
              <SUBJECT>Application requirements. </SUBJECT>
              <SECTNO>2201.12 </SECTNO>
              <SUBJECT>Applicant. </SUBJECT>
              <SECTNO>2201.13 </SECTNO>
              <SUBJECT>Lender. </SUBJECT>
              <SECTNO>2201.14 </SECTNO>
              <SUBJECT>Eligible Loan purposes. </SUBJECT>
              <SECTNO>2201.15 </SECTNO>
              <SUBJECT>Ineligible Loan purposes. </SUBJECT>
              <SECTNO>2201.16 </SECTNO>
              <SUBJECT>Environmental requirements. </SUBJECT>
              <SECTNO>2201.17 </SECTNO>
              <SUBJECT>Submission of applications. </SUBJECT>
              <SECTNO>2201.18 </SECTNO>
              <SUBJECT>Application selection. </SUBJECT>
              <SECTNO>2201.19 </SECTNO>
              <SUBJECT>Loan terms. </SUBJECT>
              <SECTNO>2201.20 </SECTNO>
              <SUBJECT>Collateral. </SUBJECT>
              <SECTNO>2201.21 </SECTNO>
              <SUBJECT>Fees. </SUBJECT>
              <SECTNO>2201.22 </SECTNO>
              <SUBJECT>Issuance of Guarantees. </SUBJECT>
              <SECTNO>2201.23 </SECTNO>
              <SUBJECT>Funding for the Program. </SUBJECT>
              <SECTNO>2201.24 </SECTNO>
              <SUBJECT>Insurance. </SUBJECT>
              <SECTNO>2201.25 </SECTNO>
              <SUBJECT>Performance Agreement. </SUBJECT>
              <SECTNO>2201.26 </SECTNO>
              <SUBJECT>Lender standard of care. </SUBJECT>
              <SECTNO>2201.27 </SECTNO>
              <SUBJECT>Assignment or transfer of Loans. </SUBJECT>
              <SECTNO>2201.28 </SECTNO>
              <SUBJECT>Participation in guaranteed Loans. </SUBJECT>
              <SECTNO>2201.29 </SECTNO>
              <SUBJECT>Supplemental guarantees. </SUBJECT>
              <SECTNO>2201.30 </SECTNO>
              <SUBJECT>Adjustments. </SUBJECT>
              <SECTNO>2201.31 </SECTNO>
              <SUBJECT>Indemnification. </SUBJECT>
              <SECTNO>2201.32 </SECTNO>
              <SUBJECT>Termination of obligations. </SUBJECT>
              <SECTNO>2201.33 </SECTNO>
              <SUBJECT>Defaults </SUBJECT>
              <SECTNO>2201.34 </SECTNO>
              <SUBJECT>OMB Control Number </SUBJECT>
            </SUBPART>
          </CONTENTS>
          <AUTH>
            <HD SOURCE="HED">Authority:</HD>
            <P>47 U.S.C. 1101 <E T="03">et seq.;</E> Pub. L. 106-553; Pub. L. 107-171. </P>
          </AUTH>
          <SUBPART>
            <HD SOURCE="HED">Subpart A—General </HD>
            <SECTION>
              <SECTNO>§ 2201.1 </SECTNO>
              <SUBJECT>Definitions. </SUBJECT>
              <P>
                <E T="03">Act</E> means Title X of Public Law 106-553, entitled the Launching our Communities' Access to Local Television (LOCAL TV) Act of 2000, as amended. </P>
              <P>
                <E T="03">Administrator</E> means the Administrator of the Rural Utilities Service, U.S. Department of Agriculture, acting pursuant to the Act and on behalf of the Board. </P>
              <P>
                <E T="03">Affiliate</E> means any person or entity that controls, or is controlled by, or is under common control with, another person or entity; and may include any individual who is a director or senior management officer of an Affiliate, a shareholder controlling more than 25 percent of the voting securities of an Affiliate, or more than 25 percent of the ownership interest in an Affiliate not organized in stock form.</P>
              <P>
                <E T="03">Agent</E> means that Lender authorized to take such actions, exercise such powers, and perform such duties on behalf and in representation of all Lenders party to a Guarantee of a single Loan, as is required by, or necessarily incidental to, the terms and conditions of the Guarantee. </P>
              <P>
                <E T="03">Applicant</E> means any party that is seeking financing under the Act in order to provide access to Local Television Broadcast Signals for households in Nonserved Areas and Underserved Areas. </P>
              <P>
                <E T="03">Asset</E> means anything owned by the Applicant that has commercial or exchange value including, but not limited to, cash flows and rights thereto. </P>
              <P>
                <E T="03">Banking Institution</E> means a bank or bank holding company. </P>
              <P>
                <E T="03">Board</E> means the LOCAL Television Loan Guarantee Board authorized by the Act to approve Guarantees to facilitate access, on a technologically neutral basis, to Local Television Broadcast Signals for households located in Nonserved Areas and Underserved Areas.</P>
              <P>
                <E T="03">Borrower</E> means the entity liable for the payment of principal and interest on any Loan guaranteed under the Act, where such entity shall be a corporation, partnership, joint venture trustee or government entity, agency or instrumentality. An individual cannot be a Borrower. </P>
              <P>
                <E T="03">Collateral</E> means all Assets economically pledged by the Applicant, any Affiliate of the Applicant, or both that is required under the provisions of the Act or the Loan Documents to secure the repayment of the indebtedness of the Borrower under the Loan Documents. </P>
              <P>
                <E T="03">Default</E> means a failure by a Borrower, other than a Payment Default, on its obligations under the Loan Documents which has not been cured by the Borrower or duly waived by the Lender within any applicable cure period. </P>
              <P>
                <E T="03">Designated Market Area (DMA)</E> means an area designated as such by Nielsen Media Research and published in the most recent Nielsen Station Index Directory and Nielsen Station Index <PRTPAGE P="48823"/>United States Television Household Estimates. </P>
              <P>
                <E T="03">Generally Accepted Accounting Principles (GAAP)</E> means a common set of accounting standards and procedures that are either promulgated by an authoritative accounting rulemaking body or accepted as appropriate due to wide-spread application in the United States. </P>
              <P>
                <E T="03">Guarantee</E> means the written agreement, including all terms and conditions and all exhibits thereto, guaranteeing repayment of a specified percentage of the principal of a Loan pursuant to the Act.</P>
              <P>
                <E T="03">Guaranteed Portion</E> means the portion of the principal of a loan that is subject to the Guarantee.</P>
              <P>
                <E T="03">High-Speed Internet</E> means a data connection to the Internet providing an information rate exceeding 200 kilobits per second (kbps) in the consumer's connection to the network in at least one direction, either from the provider to the consumer (downstream) or from the consumer to the provider (upstream). </P>
              <P>
                <E T="03">Lender</E> means an entity that has committed to make a Loan to an Applicant, where such entity shall be: </P>
              <P>(1) An entity currently engaged in commercial lending in the normal course of its business; or </P>
              <P>(2) A nonprofit corporation, including the National Rural Utilities Cooperative Finance Corporation, engaged primarily in commercial lending, but does not include any governmental entity or any Affiliate thereof, the Federal Agricultural Mortgage Corporation, any institution supervised by the Office of Federal Housing Enterprise Oversight, the Federal Housing Finance Board, or any Affiliate of such entities. </P>
              <P>
                <E T="03">Loan</E> means a Loan guaranteed pursuant to the Act and includes the funds made available to the Borrower by the Lender.</P>
              <P>
                <E T="03">Loan Agreement</E> means the contract between the Lender and the Borrower, approved by the Board, setting forth the terms applicable to the Loan. </P>
              <P>
                <E T="03">Loan Documents</E> means the Loan Agreement, Guarantee and all other instruments, and all documentation between or among the Lender, the Borrower, and the Board or Administrator, evidencing the making, disbursing, securing, collecting, or otherwise administering of the Loan.</P>
              <P>
                <E T="03">Local Television Broadcast Signals</E> means the television signals that carry the local network broadcasts of the four major national television broadcast networks as recognized by the Federal Communications Commission (as of August 15, 2003 these networks are ABC, CBS, Fox, and NBC). When a particular national television broadcast network is carried by more than one broadcaster in a DMA, the signal of any one of these local broadcasters will qualify as the Local Television Broadcast Signal of the network at that location. In a DMA where one or more of these networks do not have a local affiliate, the set of Local Television Broadcast Signals only includes the local affiliates of the aforementioned networks that are present in that DMA. In areas not included in a DMA but under the jurisdiction of the FCC, an appropriate set of Local Television Broadcast Signals will be determined on a case-by-case basis, subject to the approval of the Board. </P>
              <P>
                <E T="03">Net equity</E> means the value of the total Assets of an entity, less the total liabilities of that entity, as recorded under Generally Accepted Accounting Principles for the fiscal quarter ended immediately prior to the date on which the subject Loan is approved.</P>
              <P>
                <E T="03">Net Worth Ratio</E> means the book value of equity over total Assets.</P>
              <P>
                <E T="03">Nonserved Area</E> means any area that is outside the grade B contour (as determined using standards employed by the Federal Communications Commission (FCC)) of the Local Television Broadcast Signals serving a particular Designated Market Area and does not have access to such signals by any commercial, for profit, multichannel video provider. </P>
              <P>
                <E T="03">Offer of Guarantee</E> means the Board's decision to approve an application for, and extend a Guarantee under, the LOCAL TV Act.</P>
              <P>
                <E T="03">Payment Default</E> means any failure of a Borrower to pay any amount of principal or interest on the Loan when and as due under the Loan Agreement (including, without limitation, following any acceleration thereunder) which has not been cured within any applicable cure period.</P>
              <P>
                <E T="03">Payment Demand</E> means a request, by the Lender or Agent, following a Payment Default, in writing to the Board, for payment under the Guarantee in respect of the defaulted principal.</P>
              <P>
                <E T="03">Performance Agreement</E> means the written agreement between the Administrator and the Borrower (and Lender, if applicable), pursuant to which the Borrower provides stipulated performance schedules with respect to Local Television Broadcast Signals provided through the Project. </P>
              <P>
                <E T="03">Program</E> means the LOCAL Television Loan Guarantee Program (LOCAL TV Program) established under the Act. </P>
              <P>
                <E T="03">Project</E> means a proposal for the acquisition, improvement, enhancement, construction, deployment, launch, or rehabilitation of the means to deliver Local Television Broadcast Signals to a Nonserved Area or Underserved Area. </P>
              <P>
                <E T="03">Regulatory Capital Ratio</E> means tier 1 and total capital ratios as shown on a Banking Institution's balance sheet. </P>
              <P>
                <E T="03">Security</E> means all Collateral required by the provisions of the Act or the Loan Documents to secure repayment of any indebtedness of the Borrower under the Loan Documents. </P>
              <P>
                <E T="03">Separate Tier of Local Television Broadcast Signals</E> means a category or package of services provided by the applicant, to include the Local Television Broadcast Signals and all over-the-air television broadcast signals carried pursuant to the must-carry requirement of the Communications Act of 1934, as amended, offered as a distinct and separate service choice to the applicant's subscribers at a specified lower rate when compared to other program service choices. </P>
              <P>
                <E T="03">Term Sheet</E> means an executed agreement between the Applicant and the Lender or Agent that sets forth the key business terms and conditions of the proposed Loan. Execution of this agreement represents evidence of the commitment between the Applicant and Lender or Agent. </P>
              <P>
                <E T="03">Underserved Area</E> means any area that is outside the grade A contour (as determined using standards employed by the Federal Communications Commission) of the Local Television Broadcast Signals serving a particular Designated Market Area and has access to such signals from not more than one commercial, for profit, multichannel video provider. </P>
              <P>
                <E T="03">Unguaranteed Portion</E> means the portion of the principal of a Loan that is not covered by the Guarantee. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§§ 2201.2—2201.9 </SECTNO>
              <SUBJECT>[Reserved] </SUBJECT>
            </SECTION>
          </SUBPART>
          <SUBPART>
            <HD SOURCE="HED">Subpart B—Loan Guarantees </HD>
            <SECTION>
              <SECTNO>§ 2201.10 </SECTNO>
              <SUBJECT>Loan amount and Guarantee percentage. </SUBJECT>
              <P>(a) <E T="03">Aggregate value of loans.</E> The aggregate value of all Loans for which Guarantees are issued under the Program, including the Unguaranteed Portions of such Loans, may not exceed $1,250,000,000. </P>
              <P>(b) <E T="03">Guarantee percentage.</E> (1) A Guarantee approved by the Board may not exceed an amount equal to 80 percent of the principal amount of a Loan made to finance the acquisition, improvement, enhancement, construction, deployment, launch, or rehabilitation of the means by which Local Television Broadcast Signals are delivered to a Nonserved Area or Underserved Area; <PRTPAGE P="48824"/>
              </P>
              <P>(2) If only a portion of a Loan is meant to achieve the purposes described in paragraph (b)(1) of this section, the Board shall determine that portion of the Loan meant to achieve such purpose and may approve a Guarantee in an amount not exceeding 80 percent of that portion of the Loan. </P>
              <P>(c) <E T="03">Minimum loan amount.</E> The Board will not approve a Guarantee for a Loan in an amount less than $1,000,000 (inclusive of both the Guaranteed and Unguaranteed Portions of the Loan). </P>
              <P>(d) <E T="03">Form of Guarantee.</E> The Board shall adopt a form of Guarantee to be used under the Program, and shall publish the Guarantee on its website. Modifications to the provisions of the form of Guarantee must be approved and adopted by the Board. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 2201.11 </SECTNO>
              <SUBJECT>Application requirements. </SUBJECT>
              <P>A completed application consists of the following information:</P>
              <P>(a) <E T="03">An executive summary of the Project.</E> The Applicant must provide the Board with a general Project overview that addresses each of the following six categories: </P>
              <P>(1) A general overview of the system to be developed and description of the Project including the types of equipment, technologies, and facilities to be used; </P>
              <P>(2) An explanation of how the Applicant will provide Local Television Broadcast Signals to Nonserved Areas and Underserved Areas; </P>
              <P>(3) A short description of the Applicant including a written narrative describing its demonstrated capability and experience in providing access to Local Television Broadcast Signals for households; </P>
              <P>(4) An explanation of the total Project cost including a breakdown of the Loan required and the source of funding for the remainder of the Project, if a portion of the Project is to be paid with non-Loan funds; </P>
              <P>(5) The name of the Lender or Agent (including a listing of other participating Lenders, if applicable) and a description of the financing structure of the proposed Loan; and </P>
              <P>(6) A general description of the geographic area to be served. </P>
              <P>(b) <E T="03">Background information.</E> General information concerning the Applicant, its Affiliates, and its Lender or Agent, including a description of any financial and contractual arrangements among the parties. Specific information required of all Applicants is as follows: </P>
              <P>(1) <E T="03">Evidence of legal authority and existence of the applicant.</E> The Applicant must provide evidence of its legal existence and authority to execute the Loan Documents under the proposed Loan and perform the activities proposed under the Project. Such evidence must include Articles of Incorporation and bylaws for incorporated Applicants; other types of Applicants should submit appropriate documentation for their forms of organization. If the Applicant is a special purpose entity (SPE) formed for the purpose of the Project, then the Applicant must provide a copy of the Deed of Partnership or Articles of Organization for the SPE. </P>
              <P>(2) <E T="03">Affiliates descriptions.</E> A listing of all Affiliates of the Applicant including a description of the nature of the Applicants relationship to each Affiliate. Any existing or proposed contractual arrangements with each Affiliate should be described. </P>
              <P>(3) <E T="03">Legal name.</E> The legal name and form of organization of the proposed Lender or Agent. </P>
              <P>(4) <E T="03">Cover Form.</E> A signed copy of Standard Form 424. </P>
              <P>(c) <E T="03">A business plan.</E> A plan, satisfactory to the Board, presenting in detail the fundamentals of the business and providing sufficient financial data to indicate that the business will be economically sustainable. The business plan should include, at a minimum: </P>
              <P>(1) <E T="03">Risk assessments.</E> An assessment of the risks related to construction, performance, demand, and financing structure, including a narrative statement detailing planned risks mitigation strategies; </P>
              <P>(2) <E T="03">Plans.</E> A comprehensive operations and maintenance plan; </P>
              <P>(3) <E T="03">Economic and financial analysis.</E> A review of economic and financial factors affecting the business in general and the Project in particular, including: </P>
              <P>(i) The adequacy and stability of the business' customer base; </P>
              <P>(ii) The demand for services; </P>
              <P>(iii) The sensitivity of the business to economic cycles; </P>
              <P>(iv) Future capital needs; </P>
              <P>(v) The adequacy, competitiveness and affordability of service fees; and </P>
              <P>(vi) An overview of the prevailing economic and demographic trends in the target service area. </P>
              <P>(4) <E T="03">Project Market Analysis.</E> A breakdown of the key elements of the Project, including: </P>
              <P>(i) All proposed services to be offered, including High-speed Internet Service, and whether a Separate Tier of Local Television Broadcast Signals will be provided; </P>
              <P>(ii) The total number of households, by DMA, and by Nonserved and Underserved Area, which will have access to Local Television Broadcast Signals under the Project; </P>
              <P>(iii) The total number of households, by DMA, and by Nonserved and Underserved Area, which will have access under the Project to any other services as described pursuant to paragraph (c)(4)(i) of this section, including an explanation if this number is greater than the total identified in paragraph (c)(4)(ii); </P>
              <P>(iv) Estimates of the number of households identified in paragraphs (c)(4)(ii) and (c)(4)(iii) which will subscribe to each of the services identified in paragraph (c)(4)(i) of this section by DMA, including a breakdown of Nonserved and Underserved households; </P>
              <P>(v) A breakdown of the Applicant's proposed pricing coupled with an evaluation of any competitor's services offerings and pricings. </P>
              <P>(vi) A service deployment plan and a deployment performance schedule, by DMA, for the services to access the Local Television Broadcast Signals. </P>
              <P>(d) <E T="03">Financial forecast and information.</E> The Applicant must demonstrate its financial ability to complete and maintain the Project and repay its obligations. The financial data must include the following: </P>
              <P>(1) <E T="03">Audited financial statements.</E> Income statements, balance sheets, and cash flow statements for at least the last three years or from the date of inception if less than three years. If the Applicant is an SPE, then the Applicant must provide at least the last three years of audited financial statements of the shareholders or partners of the SPE. If an Affiliate has been designated by the Applicant as a source of credit support, then at least three years audited financial statements for the Affiliate must be submitted as well; </P>
              <P>(2) <E T="03">Plan of finance.</E> An identification and explanation of all sources and uses of funds throughout the proposed loan period, including, but not limited to, any payments to Affiliates or shareholders of the Applicant, estimated Project costs, and proposed terms. </P>
              <P>(3) <E T="03">A Pro-forma financial forecast</E> covering the life of the proposed loan, including balance sheets, income statements and cash flow statements, with an explanation of assumptions. These Projections must be prepared in accordance with Generally Accepted Accounting Principles and should discuss such issues as the effects of inflation, competition, ongoing repair and replacement needs, technological obsolescence, working capital requirements, and other factors that may affect the Applicant's ability to meet its debt service obligations. </P>
              <P>(4) <E T="03">Project budget.</E> A detailed cost breakdown of all facilities to be constructed as part of the Project. This breakdown should be on a per unit <PRTPAGE P="48825"/>basis. It should also clearly show what will be financed with guaranteed loan funds and what will be financed with other funds, consistent with the plan of finance in paragraph (d)(2) of this section. </P>
              <P>(5) <E T="03">Commitments.</E> The Applicant must disclose all reasonably foreseeable financial obligations, contingent liabilities, or other commitments that could affect its financial health over the proposed financing term. At the Board's request, the Applicant must take all reasonable measures to insulate the Project and the Loan from external factors that could affect timely payment of principal and interest. The Board may ask for additional detailed information on commitments where it is deemed necessary. </P>
              <P>(6) <E T="03">Credit enhancement.</E> In cases where an Affiliate provides credit enhancement, the Applicant must provide documentation demonstrating the Affiliate is sufficiently capitalized and evidencing the strength, extent, limitations, and priority of the credit enhancement relative to the other obligations of the Affiliate. </P>
              <P>(e) <E T="03">A certified system plan, technical analysis, and design.</E> Prepared by qualified personnel on the Applicant's staff or by a licensed consulting engineer, consisting of the following: </P>
              <P>(1) A detailed description of the proposed service area including maps of the service area; </P>

              <P>(2) A TV Signals Coverage Diagram and detailed description of all existing and proposed facilities. The diagram must include proposed route miles of cable plant, if applicable, the estimated area served, types of facilities to be deployed (terrestrial microwave or satellite microwave, wireless, translator, fiber optic cable or coaxial cable, electronic equipment, <E T="03">etc.</E>), the capacity of the facilities (number of fibers, size of the cables, and intended number of channels, frequencies used, bandwidth capacity, <E T="03">etc.</E>), and the serving area of the proposed facilities; </P>
              <P>(3) The intended capabilities of the Project's facilities, including bandwidth, proposed television signal topology, standards, and television signal transmission protocols. In addition, the Applicant must explain the manner in which the transmission facilities will deliver the proposed Local Television Broadcast Signals, including any equipment necessary to receive the signals which will be located at the subscribers premise, and/or, near or/on the subscribers' television set; </P>
              <P>(4) A listing of all regulatory approvals required to operate facilities, including licenses, permits, and franchises and the status of any required approvals not obtained at the time of the application. For any approvals not yet received, the Applicant should provide details on the nature of the needed approval, the justification for expecting such an approval, the track-record of the Applicant in obtaining such approvals, and the contingency plan in the event the approval is delayed; </P>
              <P>(5) A description of the television signal sources (including, but not limited to local, regional and national television signal broadcasters, other television signal providers, content providers, cable television operators and providers, enhanced service providers, providers of satellite services, and the anticipated role of such providers in the proposed Project); </P>
              <P>(6) The results of discussions, if any, with local television broadcasters serving the Project area; </P>
              <P>(7) An identification of all Local Television Broadcast Signals that will be carried by the Project; </P>
              <P>(8) An identification of the digital signal quality and capacity in megabits per second (Mb/s) that will be required to digitally broadcast all Local Television Broadcast Signals to be provided by the Project; </P>
              <P>(9) An identification of the net usable bandwidth, in Mb/s, that are surplus to the provision of the Local Television Broadcast Signals to be provided by the Project and that will be used to provide High Speed Internet Service; and </P>
              <P>(10) A description of the extent to which the Project will enable the delivery of Local Television Broadcast Signals by a means reasonably compatible with existing systems or devices predominantly in use for the reception of television signals. </P>
              <P>(f) <E T="03">Lender information.</E> (1) <E T="03">Lender.</E> The Application shall include the information described in § 2201.13(b), (c) and (d) of this part concerning the Lender or Lenders. </P>
              <P>(2) <E T="03">Term Sheet.</E> The Application shall include a signed Term Sheet. </P>
              <P>(3) <E T="03">Lender's analysis.</E> The Applicant shall submit the Lender's detailed analysis of the creditworthiness of the transaction at the time of application and any supporting due diligence documentation, including a complete underwriting analysis of the Project (assessing Applicant creditworthiness and Project feasibility) exercising the Lender's standard of care as set forth at § 2201.26(a). </P>
              <P>(4) <E T="03">Certification.</E> The Lender must certify that the information provided pursuant to paragraphs (f)(1), (2) and (3) of this section is true and accurate. </P>
              <P>(5) <E T="03">Additional Information.</E> The Board will request any other information the Board deems material to its assessment of the Lender. </P>
              <P>(g) <E T="03">Other Financial Information.</E> (1) <E T="03">Collateral.</E> The Applicant shall provide a detailed description and valuation of all Collateral to be used to secure the Loan. This valuation shall be supported by an independent, third party appraisal for existing Assets, and/or adequate cost substantiation for Assets to be constructed for purposes of the Project, and in all cases shall be acceptable to the Board. Such a valuation should address, at a minimum, pledged Assets of the Applicant, any designated Affiliate of the Applicant, or both as identified in the Loan Documents, including primary Assets to be used in the delivery of the service for which the Loan sought would be guaranteed. The Applicant also must provide a depreciation schedule (as classified under and in accordance with GAAP) for the major Assets in order for the Board to determine the economically useful life of the primary Assets to be used in delivery of the signals concerned. Appraisals of real property must be prepared by State licensed or certified appraisers, and be consistent with the “Uniform Standards of Professional Appraisal Practice,” promulgated by the Appraisal Standards Board of the Appraisal Foundation. </P>
              <P>(2) <E T="03">Credit Opinion.</E> With respect to applications for a Loan of $5 million or more, the Applicant is required to obtain and submit to the Board a preliminary credit rating opinion letter on the proposed transaction at the time of application, prepared by a nationally recognized statistical rating organization (rating agency) approved by the Board. This preliminary credit rating opinion shall be based on the financing structure proposed by the Applicant for the Project absent the Federal Guarantee. The Board will utilize this preliminary credit assessment to assist in evaluating the creditworthiness of the proposed transaction and determining whether it provides a reasonable assurance of repayment. In addition, applicants for loans less than $5 million that have a credit rating shall provide that credit rating to the Board. The Board will utilize this preliminary credit assessment (for loans over $5 million) or an existing credit rating (for loans less than $5 million) to assist in evaluating the creditworthiness of the proposed transaction and determining whether it provides a reasonable assurance of repayment. The Board may approve a Guarantee over $5 million only if it receives a final credit rating opinion letter from the rating agency on the Loan that is in form and substance acceptable to the Board. <PRTPAGE P="48826"/>
              </P>
              <P>(3) <E T="03">Evidence of lack of credit elsewhere.</E> The Applicant shall provide the information required pursuant to § 2201.12(b)(2)(v) of this part. </P>
              <P>(h) <E T="03">Compliance with other Federal statutes, regulations and Executive Orders.</E> The Applicant must certify compliance with other applicable Federal statutes, regulations, and Executive Orders. </P>
              <P>(i) <E T="03">Environmental impact.</E> The Applicant must provide an environmental assessment that details of the Project's impact on the environment as required pursuant to § 2201.16 of this part. </P>
              <P>(j) <E T="03">Federal debt certification.</E> The Applicant must provide a certification that it is not delinquent on any obligation owed to the government (7 CFR parts 3016 and 3019). No Guarantee will be made if either the Applicant or Lender has an outstanding, delinquent Federal debt until: </P>
              <P>(1) The delinquent account has been paid in full; </P>
              <P>(2) A negotiated repayment schedule is established and at least one payment has been received; or </P>
              <P>(3) Other arrangements, satisfactory to the agency responsible for collecting the debt, are made. </P>
              <P>(k) <E T="03">Supplemental information.</E> The Applicant should provide any additional information it considers relevant to the Project and likely to be helpful in determining the extent to which the Project would further the purposes of the Act. </P>
              <P>(l) <E T="03">Additional information required by the Board.</E> The Applicant must provide any additional information the Board determines is necessary to adequately evaluate the application. </P>
              <P>(m) <E T="03">Application fee.</E> For an application to be considered complete, the Applicant must submit a check payable to the United States Treasury in the amount of the application fee as set forth in § 2201.21(a) of this part. </P>
              <P>(n) <E T="03">Incomplete application.</E> An incomplete application, including any fee submitted therewith, will be returned to the Applicant without action. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 2201.12 </SECTNO>
              <SUBJECT>Applicant. </SUBJECT>
              <P>(a) <E T="03">Eligibility.</E> (1) The Board will make a determination of eligibility of an Applicant to be a Borrower under the Program based upon the Applicant's ability to directly provide, as a result of financing received under the Program, Local Television Broadcast Signals to households in Nonserved Areas and/or Underserved Areas and the information provided pursuant to paragraph (b) of this section. </P>
              <P>(2) A determination that an Applicant is eligible does not assure that the Board will approve a Guarantee sought, or otherwise preclude the Board from declining to approve a Guarantee. </P>
              <P>(b) <E T="03">Documentation for Eligibility Determination.</E> (1) An Applicant must provide a Term Sheet evidencing a commitment of that Lender or Agent, and the Lenders it represents, to make a Loan to the Applicant upon an Offer of Guarantee by the Board, subject to the requirements of the Act and the regulations set forth in this part. </P>
              <P>(2) An Applicant must provide documentation demonstrating that: </P>
              <P>(i) The Assets, facilities, or equipment covered by the Loan will be utilized economically and efficiently; </P>
              <P>(ii) The terms, conditions, security, and schedule and amount of repayments of principal and the payment of interest with respect to the Loan protect the financial interests of the United States and are reasonable; </P>
              <P>(iii) Appropriate and adequate Collateral secures the Loan sought to be guaranteed; </P>
              <P>(iv) All necessary and required regulatory and other approvals, spectrum licenses, and delivery permissions have been received for the Loan and the Project under the Loan; </P>
              <P>(v) The Loan would not be available on reasonable terms and conditions without a Guarantee under this Program. To satisfy this requirement, an Applicant must provide, with its application, documentation from at least one lending institution other than the Lender to which the Applicant has applied for financial assistance dated within six months of submission of the application, indicating that the Applicant was unable to obtain substantially the same Loan it is applying for on reasonable terms and conditions; and </P>
              <P>(vi) Repayment of the Loan can reasonably be expected. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 2201.13 </SECTNO>
              <SUBJECT>Lender. </SUBJECT>
              <P>(a) <E T="03">Eligibility.</E> (1) The Board will make a determination of eligibility of a Lender to make a Loan to be guaranteed under the Program based upon the criteria set forth in paragraphs (b) and (c) of this section. </P>
              <P>(2) A determination that a Lender is eligible does not assure that the Board will approve a Guarantee sought, or otherwise preclude the Board from declining to approve a Guarantee. </P>
              <P>(b) <E T="03">Qualifications.</E> In addition to evaluating an application pursuant to § 2201.18, in making a determination to approve a Guarantee to a Lender, the Board will assess: </P>
              <P>(1) The Lender's Regulatory Capital Ratios, in the case of Banking Institutions, or Net Worth Ratios, in the case of other institutions; </P>
              <P>(2) Whether the Lender possesses the ability to administer the Loan, including its experience with loans to telecommunications companies; </P>
              <P>(3) The scope, volume and duration of the Lender's activity in administering loans, including federally guaranteed loans; </P>
              <P>(4) The performance of the Lender's loan portfolio, including its current delinquency rate; </P>
              <P>(5) The Lender's charge-off rate, expressed as a percentage of outstanding loans for its current fiscal year; </P>
              <P>(6) If the Lender intends to sell participation interests in the Loan, the plan of syndication; and </P>
              <P>(7) Any other matter the Board deems material to its assessment of the Lender. </P>
              <P>(c) A Loan will not be guaranteed unless: </P>
              <P>(1) If the Lender is not a nonprofit corporation and is subject to loan-to-one-borrower and Affiliate transaction restrictions under applicable law, the Loan is made in accordance with such restrictions; </P>
              <P>(2) If the Lender is not a nonprofit corporation and is not subject to the restrictions described in paragraph (c)(1) of this section, the Loan is made to a Borrower that is not an Affiliate of the Lender and the amount of the Loan, and all outstanding loans by the Lender to the Borrower and any of its Affiliates, does not exceed 10 percent of the Net Equity of the Lender; </P>
              <P>(3) If the Lender is a nonprofit corporation, the Board determines that: </P>
              <P>(i) Such nonprofit corporation has one or more issues of outstanding long-term debt that is rated within the highest 3 rating categories of a nationally recognized statistical rating organization, as evidenced by written confirmation from the nationally recognized statistical rating organization, subject to updating upon request of the Board; and </P>
              <P>(ii) The making of the Loan would not cause a decline in the rating of such Lender's long-term debt below the highest 3 rating categories of a nationally recognized statistical rating organization, as evidenced by written confirmation from the nationally recognized statistical rating organization, subject to updating upon request of the Board. </P>
              <P>(d) <E T="03">Agent.</E> (1) An application for a Guarantee of a single Loan that includes participation of more than one Lender must identify one of the Lenders participating in such Loan to act as Agent for all Lenders. This Agent is <PRTPAGE P="48827"/>responsible for administering the Loan and shall have those duties and responsibilities required of an Agent, as set forth in the Guarantee. </P>
              <P>(2) If more than one Lender is seeking a Guarantee of a single Loan, each one of the Lenders on the application must meet the qualifications set forth in paragraphs (b) and (c) of this section. However, only the Agent must meet the qualifications set forth in paragraph (b)(2) and (3) of this section. </P>
              <P>(3) Each Lender, irrespective of any indemnities or other agreements between the Lenders and the Agent, shall be bound by all actions, and/or failures to act, of the Agent. The Board and the Administrator shall be entitled to rely upon such actions and/or failures to act of the Agent as binding all Lenders. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 2201.14 </SECTNO>
              <SUBJECT>Eligible Loan purposes. </SUBJECT>
              <P>To be guaranteed under the Program, a Loan must be made for the purpose of financing the acquisition, improvement, enhancement, construction, deployment, launch, or rehabilitation of the means by which Local Television Broadcast Signals will be delivered to a Nonserved Area or Underserved Area. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 2201.15 </SECTNO>
              <SUBJECT>Ineligible Loan purposes. </SUBJECT>
              <P>(a) The proceeds of the Loan shall not be used for operating, advertising, or promotion expenses, or for the acquisition of licenses for the use of spectrum in any competitive bidding. </P>
              <P>(b) The Applicant shall not transfer proceeds of the Loan to any Affiliate(s). </P>
              <P>(c) A Loan shall not be guaranteed unless the proposed Project, as determined by the Board in consultation with the National Telecommunications and Information Administration, is not likely to have a substantial adverse impact on competition that outweighs the benefits of improving access to Local Television Broadcast Signals in a Nonserved Area or Underserved Area and is commercially viable. </P>
              <P>(d) The Board will not fund a Project that is designed primarily to serve one or more of the top 40 Designated Market Areas. </P>
              <P>(e) The Board will not fund a Project that would alter or remove National Weather Service warnings from Local Television Broadcast Signals. </P>
              <P>(f) No Guarantee may be granted or used to provide funds to a Project that extends, upgrades, or enhances the services provided over any cable system to an area that, as of the enactment of the Act, is covered by a cable franchise agreement that expressly obligates a cable operator to serve such area. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 2201.16 </SECTNO>
              <SUBJECT>Environmental requirements. </SUBJECT>
              <P>(a) <E T="03">General.</E> (1) Environmental assessments of the Board's actions will be conducted in accordance with applicable statutes, regulations, and Executive Orders. Therefore, each application for a Guarantee under the Program must be accompanied by information necessary for the Board to meet the requirements of applicable law. </P>
              <P>(2) <E T="03">Actions requiring compliance with NEPA.</E> (i) The types of actions classified as “major Federal actions” subject to NEPA procedures are discussed in 40 CFR parts 1500 through 1508. </P>
              <P>(ii) With respect to this Program, these actions typically include: </P>
              <P>(A) Any Project, permanent or temporary, that will involve construction and/or installations; </P>
              <P>(B) Any Project, permanent or temporary, that will involve ground disturbing activities; and </P>
              <P>(C) Any Project supporting renovation, other than interior remodeling. </P>
              <P>(3) <E T="03">Environmental information required from the Applicant.</E> (i) Environmental data or documentation concerning the use of the proceeds of any Loan guaranteed under this Program must be provided by the Applicant to the Board to assist the Board in meeting its legal responsibilities. </P>
              <P>(ii) Such information includes: </P>
              <P>(A) Documentation for an environmental threshold review from qualified data sources, such as a Federal, State or local agency with expertise and experience in environmental protection, or other sources, qualified to provide reliable environmental information; </P>
              <P>(B) Any previously prepared environmental reports or data relevant to the Loan at issue; </P>
              <P>(C) Any environmental review prepared by Federal, State, or local agencies relevant to the Loan at issue; and </P>
              <P>(D) Any other information that can be used by the Board to ensure compliance with environmental laws. </P>
              <P>(iii) All information supplied by the Applicant is subject to verification by the Board. </P>
              <P>(b) The regulations of the Council on Environmental Quality implementing NEPA require the Board to provide public notice of the availability of Project specific environmental documents such as environmental impact statements, environmental assessments, findings of no significant impact, records of decision, etc., to the affected public. See 40 CFR 1506.6(b). Environmental information concerning specific Projects can be obtained from the Board by contacting: Secretary, LOCAL Television Loan Guarantee Board, 1400 Independence Ave., SW., Room 2919-S, Stop 1575; Washington, DC 20250-1575. </P>
              <P>(c) <E T="03">National Environmental Policy Act.</E> (1) <E T="03">Purpose.</E> The purpose of this paragraph (c) is to adopt procedures for compliance with the National Environmental Policy Act, 42 U.S.C. 4321 <E T="03">et seq.</E>, by the Board. This paragraph supplements regulations at 40 CFR Chapter V. </P>
              <P>(2) <E T="03">Definitions.</E> For purposes of this section, the following definitions apply: </P>
              <P>
                <E T="03">Categorical exclusion</E> means a category of actions which do not individually or cumulatively have a significant effect on the human environment and for which neither an environmental assessment nor an environmental impact statement is required. </P>
              <P>
                <E T="03">Environmental assessment</E> means a document that briefly discusses the environmental consequences of a proposed action and alternatives prepared for the purposes set forth in 40 CFR 1508.9. </P>
              <P>
                <E T="03">EIS</E> means an environmental impact statement prepared pursuant to section 102(2)(C) of NEPA. </P>
              <P>
                <E T="03">FONSI</E> means a finding of no significant impact on the quality of human environment after the completion of an environmental assessment. </P>
              <P>
                <E T="03">NEPA</E> means the National Environmental Policy Act, 42 U.S.C. 4321, <E T="03">et seq.</E>
              </P>
              <P>
                <E T="03">Working capital loan</E> means money used by an ongoing business concern to fund its existing operations. </P>
              <P>(3) <E T="03">Delegations to the Secretary of the Board.</E> (i) All incoming correspondence from Council on Environmental Quality (CEQ) and other agencies concerning matters related to NEPA, including draft and final EIS, shall be brought to the attention of the Secretary of the Board. The Secretary of the Board will prepare or, at his or her discretion, coordinated replies to such correspondence. </P>
              <P>(ii) With respect to actions of the Board, the Board will: </P>
              <P>(A) Ensure preparation of all necessary environmental assessments and EISs; </P>
              <P>(B) Maintain a list of actions for which environmental assessments are being prepared; </P>
              <P>(C) Revise this list at regular intervals, and send the revisions to the Environmental Protection Agency; </P>
              <P>(D) Make the list available for public inspection; </P>
              <P>(E) Maintain a list of EISs; and </P>
              <P>(F) Maintain a file of draft and final EISs. <PRTPAGE P="48828"/>
              </P>
              <P>(4) <E T="03">Categorical exclusions.</E> (i) This paragraph describes various classes of Board actions that normally do not have a significant impact on the human environment and are categorically excluded. The word “normally” is stressed; there may be individual cases in which specific factors require contrary action. </P>
              <P>(ii) Subject to the limitations in paragraph (c)(4)(iii) of this section, the actions described in this paragraph have been determined not to have a significant impact on the quality of the human environment. They are categorically excluded from the need to prepare an environmental assessment or an EIS under NEPA. </P>
              <P>(A) Guarantees of working capital loans; and </P>
              <P>(B) Guarantees of loans for the refinancing of outstanding indebtedness of the Applicant, regardless of the purpose for which the original indebtedness was incurred. </P>
              <P>(iii) Actions listed in paragraph (c)(4)(ii) of this section that otherwise are categorically excluded from NEPA review are not necessarily excluded from review if they would be located within, or in other cases, potentially affect: </P>
              <P>(A) A floodplain; </P>
              <P>(B) A wetland; </P>
              <P>(C) Important farmlands, or prime forestlands or rangelands; </P>
              <P>(D) A listed species or critical habitat for an endangered species; </P>
              <P>(E) A property that is listed on or may be eligible for listing on the National Register of Historic Places; </P>
              <P>(F) An area within an approved State Coastal Zone Management Program; </P>
              <P>(G) A coastal barrier or a portion of a barrier within the Coastal Barrier Resources System; </P>
              <P>(H) A river or portion of a river included in, or designated for, potential addition to the Wild and Scenic Rivers System; </P>
              <P>(I) A sole source aquifer recharge area; </P>
              <P>(J) A State water quality standard (including designated and/or existing beneficial uses and anti-degradation requirements); or </P>
              <P>(K) The release or disposal of regulated substances above the levels set forth in a permit or license issued by an appropriate regulatory authority. </P>
              <P>(5) <E T="03">Responsibilities and procedures for preparation of an environmental assessment.</E> (i) The Board will request that the Lender and Applicant prepare an environmental assessment that provides information concerning all potentially significant environmental impacts of the Applicant's proposed Project. The Board, consulting at its discretion with CEQ, will review the information provided by the Lender and Applicant. Though no specific format for an environmental assessment is prescribed, it shall be a separate document, suitable for public review and should include the following in conformance with 40 CFR 1508.9: </P>
              <P>(A) <E T="03">Description of the environment.</E> The existing environmental conditions relevant to the Board's analysis determining the environmental impacts of the proposed Project should be described. The no action alternative also should be discussed; </P>
              <P>(B) <E T="03">Documentation.</E> Citations to information used to describe the existing environment and to assess environmental impacts should be clearly referenced and documented. These sources should include, as appropriate, but not be limited to, local, tribal, regional, State, and Federal agencies, as well as, public and private organizations and institutions; </P>
              <P>(C) <E T="03">Evaluating environmental consequences of proposed actions.</E> A brief discussion should be included of the need for the proposal, of alternatives as required by 42 U.S.C. 4332(2)(E) and their environmental impacts. The discussion of the environmental impacts should include measures to mitigate adverse impacts and any irreversible or irretrievable commitments of resources to the proposed Project. </P>
              <P>(ii) An environmental assessment, may: </P>
              <P>(A) Tier upon the information contained in a previous EIS, as described in 40 CFR 1502.20; </P>
              <P>(B) Incorporate by reference reasonably available material, as described in 40 CFR 1502.21; and/or </P>
              <P>(C) Adopt a previously completed EIS reasonably related to the Project for which the proceeds of the Loan sought to be guaranteed under the Program will be used, as described in 40 CFR 1506.3. </P>
              <P>(iii) If, on the basis of the environmental assessment, the Board determines that an EIS is not required, a FONSI, as described in 40 CFR 1508.13 will be prepared. The FONSI will include the environmental assessment or a summary of it and be available to the public from the Board. The Board shall maintain a record of these decisions, making them available to interested parties upon request. Requests should be directed to LOCAL Television Loan Guarantee Board, 1400 Independence Ave., SW., Room 2919-S, Stop 1575; Washington, DC 20250-1575. Prior to a final Guarantee decision, a copy of the NEPA documentation shall be sent to the Board for consideration. </P>
              <P>(6) <E T="03">Responsibilities and procedures for preparation of an environmental impact statement.</E> (i) If after the environmental assessment has been completed, the Board determines that an EIS is necessary, it and other related documentation will be prepared by the Board in accordance with section 102(2)(c) of NEPA, this section, and 40 CFR parts 1500 through 1508. The Board may seek additional information from the Applicant in preparing the EIS. Once the document is prepared, the Board will transmit the document to the Environmental Protection Agency. </P>
              <P>(ii) <E T="03">EIS.</E> (A) The following procedures, as discussed in 40 CFR parts 1500 through 1508, will be followed in preparing an EIS: </P>
              <P>(<E T="03">1</E>) The format and contents of the draft and final EIS shall be as discussed in 40 CFR part 1502. </P>
              <P>(<E T="03">2</E>) The requirements of 40 CFR 1506.9 for filing of documents with the Environmental Protection Agency shall be followed. </P>
              <P>(<E T="03">3</E>) The Board, consulting at its discretion with CEQ, shall examine carefully the basis on which supportive studies have been conducted to assure that such studies are objective and comprehensive in scope and in depth. </P>
              <P>(<E T="03">4</E>) NEPA requires that the decision making “utilize a systematic, interdisciplinary approach that will ensure the integrated use of the natural and social sciences and the environmental design arts.” 42 U.S.C. 4332(A). If such disciplines are not present on the Board staff, appropriate use should be made of personnel of Federal, State, and local agencies, universities, non-profit organizations, or private industry. </P>
              <P>(B) Until the Board issues a record of decision as provided in 40 CFR 1502.2 no action concerning the proposal shall be taken which would: </P>
              <P>(<E T="03">1</E>) Have an adverse environmental impact; or </P>
              <P>(<E T="03">2</E>) Limit the choice of reasonable alternatives. </P>
              <P>(<E T="03">3</E>) 40 CFR 1506.10 places certain limitations on the timing of Board decisions on taking “major Federal actions.” A Guarantee shall not be made before the times set forth in 40 CFR 1506.10. </P>
              <P>(iii) A public record of decision stating what the decision was; identifying alternatives that were considered, including the environmentally preferable one(s); discussing any national considerations that entered into the decision; and summarizing a monitoring and enforcement program if applicable for mitigating the environmental effects of a proposal will be prepared. This record of decision will be prepared at the time the decision is made. </P>
            </SECTION>
            <SECTION>
              <PRTPAGE P="48829"/>
              <SECTNO>§ 2201.17 </SECTNO>
              <SUBJECT>Submission of applications. </SUBJECT>
              <P>(a) Applications should be submitted as follows: </P>
              <P>(1) Applications for Guarantees shall be submitted to the LOCAL Television Loan Guarantee Board, 1400 Independence Avenue, SW., Stop 1575, Room 2919-S, Washington, DC 20250-1575. Applications should be marked Attention: Secretary, LOCAL Television Loan Guarantee Board. </P>
              <P>(2) Applications must be submitted postmarked not later than the application filing deadline established by the Board if the applications are to be considered during the period for which the application was submitted. </P>
              <P>(3) All Applicants must submit an original and two copies of a completed application. </P>
              <P>(b) <E T="03">Application deadline.</E> One or more application windows will be announced. The duration of each application window for submission of applications will be approximately 120 days. Notice of an application window will be published in the <E T="04">Federal Register</E>. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 2201.18 </SECTNO>
              <SUBJECT>Application selection. </SUBJECT>
              <P>(a) <E T="03">Application priority.</E> When evaluating applications to determine which Project or combinations of Projects will best facilitate access to Local Television Broadcast Signals, the Board shall give priority in the approval of Guarantees to the following categories: </P>
              <P>(1) First, to applications for Projects that will serve households in Nonserved Areas. </P>
              <P>(2) Second, to applications for Projects that will serve households in Underserved Areas. </P>
              <P>(3) Within each category, the Board shall balance applications for Projects that will serve the largest number of households with applications for Projects that will serve remote, isolated communities (including noncontiguous States) in areas that are unlikely to be served through market mechanisms. The Board shall consider the Project's estimated cost per household and shall give priority to those applications for Projects that provide the highest quality service at the lowest cost per household. </P>
              <P>(b) <E T="03">Additional considerations.</E> (1) The Board shall give higher consideration to applications for Projects that, in addition to providing Local Television Broadcast Signals, also provide High-speed Internet service. </P>
              <P>(2) The Board shall consider other factors, which shall include applications for Projects that: </P>
              <P>(i) Offer a separate tier of Local Television Broadcast Signals at a lower cost to consumers, except where prohibited by applicable Federal, State, or local laws or regulations; </P>
              <P>(ii) Enable the delivery of Local Television Broadcast Signals consistent with the purpose of the Act by means reasonably compatible with existing systems or devices predominantly in use. </P>
              <P>(c) <E T="03">Other considerations.</E> All other evaluation factors and priority considerations being equal, the Board will give a preference in approving Guarantees to those applications for Projects that provide greater amounts and higher quality Collateral. </P>
              <P>(d) <E T="03">Protection of United States financial interests.</E> The Board may not approve the Guarantee of a Loan unless: </P>
              <P>(1) The Board has been given documentation, assurances, and access to information, persons, and entities necessary, as determined by the Board, to address issues relevant to review of the Loan by the Board for purposes of the Act; and </P>
              <P>(2) The Board makes a determination in writing that: </P>
              <P>(i) To the best of its knowledge upon due inquiry, the Assets, facilities, or equipment covered by the Loan will be utilized economically and efficiently; </P>
              <P>(ii) The terms, conditions, security, and schedule and amount of repayments of principal and the payment of interest with respect to the Loan protect the financial interests of the United States and are reasonable; </P>
              <P>(iii) The value of Collateral provided by an Applicant is at least equal to the unpaid balance of the Loan amount; and if the value of Collateral provided by an Applicant is less than the Loan amount, the additional required Collateral is provided by the Applicant or an Affiliate designated by the Applicant and acceptable to the Board; </P>
              <P>(iv) All necessary and required regulatory and other approvals, spectrum licenses, and delivery permissions have been received for the Loan and the Project under the Loan; </P>
              <P>(v) The Loan would not be available on reasonable terms and conditions without a Guarantee under the Act; and </P>
              <P>(vi) Repayment of the Loan can be reasonably expected. </P>
              <P>(e) <E T="03">Non approvals.</E> A Guarantee will not be approved if it is determined that: </P>
              <P>(1) The Applicant's proposal does not indicate financial feasibility, or the Collateral is determined to not adequately secure the Loan; </P>
              <P>(2) The Applicant's proposal indicates technical flaws, which, in the opinion of the Board, would prevent successful implementation, or operation of the Project; </P>
              <P>(3) Any other aspect of the Applicant's proposal fails to adequately address any requirements of the Act or the regulations in this part or contains inadequacies which would, in the opinion of the Board, undermine the ability of the Project to meet the general purpose of the Act or comply with requirements of the regulations in this part; or </P>
              <P>(4) Proceeds for the Loan will be used for any of the ineligible purposes set forth in § 2201.15. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 2201.19 </SECTNO>
              <SUBJECT>Loan terms. </SUBJECT>
              <P>(a) All Loans guaranteed under the Program shall be due and payable in full no later than the earlier of 25 years from date of the closing of the Loan or the economically useful life of the primary Assets to be used in delivery of the signals concerned, as determined by the Board. </P>
              <P>(b) Loans guaranteed under the Program must: </P>
              <P>(1) Bear a rate of interest determined by the Board to protect the financial interests of the United States and to be reasonable. This determination will be based on the Board's comparison of the: </P>
              <P>(i) Difference, or interest rate spread, between the interest rate on the Loan sought to be guaranteed and the current average yield on outstanding marketable obligations of the United States of comparable maturity; and </P>
              <P>(ii) The interest rate spread between the rates on recently issued and similarly rated and structured obligations and the current yields on outstanding marketable obligations of the United States of comparable maturity.; and </P>
              <P>(2) Have terms that, in the judgment of the Board, are consistent in material respects with the terms of similar obligations in the private capital market. </P>
              <P>(c) So long as any principal and interest is due and payable on a Loan guaranteed under the Act, a Borrower shall: </P>
              <P>(1) Maintain Assets, equipment, facilities, and operations on a continuing basis; </P>
              <P>(2) Not make any discretionary dividend payments that impair its ability to repay obligations guaranteed under the Act; </P>
              <P>(3) Remain sufficiently capitalized; and </P>
              <P>(4) Submit to and cooperate fully with any audit or Collateral review required by the Board. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 2201.20 </SECTNO>
              <SUBJECT>Collateral. </SUBJECT>
              <P>(a) <E T="03">Existence of adequate Collateral.</E> An Applicant shall provide the Board such documentation as is necessary, in the judgment of the Board, to provide satisfactory evidence that appropriate and adequate Collateral secures a Loan <PRTPAGE P="48830"/>guaranteed under the Program. Prior to approving a Guarantee, the Board shall require that the value of the Collateral pledged to be at least equal to the unpaid balance of the Loan Amount. </P>
              <P>(b) <E T="03">Form of Collateral.</E> Collateral required by paragraph (a) of this section shall consist solely of Assets of the Applicant, any Affiliate of the Applicant, or both, as identified in the Loan Documents, including primary Assets to be used in the delivery of the service for which the Loan is guaranteed. Such Assets may include, but are not limited to, the following: </P>
              <P>(1) Tangible Assets, including current Assets (such as cash, accounts receivable, and inventory), reserve funds, land, buildings, machinery, fixtures, and equipment; </P>
              <P>(2) Assignments of all relevant contractual agreements, including contractual rights to certain cash flows, marketing arrangements, third-party guarantees, insurance policies, contractors' bonds, and other agreements or rights that may be of value; </P>
              <P>(3) All permits, governmental approvals, franchises and licenses, necessary to carry out and operate the required equipment or service; and </P>
              <P>(4) Other Assets, which, in the judgment of the Board, possess Collateral value suitable for securing the Loan, including a pledge of all or part of the Applicant's ownership interest in the Project or company, and any after-acquired property. </P>
              <P>(c) <E T="03">Applicant's compliance findings.</E> An Applicant's compliance with paragraphs (a) and (b) of this section does not assure a finding of reasonable assurance of repayment, or assure the Board's Guarantee of the Loan. </P>
              <P>(d) <E T="03">Collateral for entire loan.</E> The same Collateral shall secure the entire Loan, including both the Guaranteed Portion and the Unguaranteed Portion. </P>
              <P>(e) <E T="03">Review of valuation.</E> The value of Collateral securing a Loan is subject to review and approval by the Board, and may be adjusted downward by the Board if the Board reasonably believes such adjustment is appropriate. The Board's evaluation of the proposed Collateral for the Loan will be based on several factors, including but not limited to: </P>
              <P>(1) The expected value of the pledged Collateral in the event of defaults with specific consideration given to the residual value of Project Assets to third-parties and the liquidity of such Assets; </P>
              <P>(2) The cash flow characteristics of the Project; </P>
              <P>(3) The contractual characteristics of the Project to the extent Project-related agreements underpin the Project's estimated cash flows; </P>
              <P>(4) The competitiveness of the Project's economics and the associated certainty of cash flows in the future; and </P>
              <P>(5) The creditworthiness of any designated Affiliates(s) that provides services to the Applicant or provides any credit support. </P>
              <P>(f) <E T="03">Ongoing Collateral assessment.</E> The Board shall require that the value of the Collateral shall be at all times at least equal to the unpaid balance of the Loan Amount. To ensure that the ongoing value of the Collateral is properly maintained, the Board may require the borrower to have an ongoing third-party inspection and valuation of the Collateral that is acceptable to the Board. If the Collateral value at the measurement date is less than the unpaid balance of the Loan Amount, the Borrower or its designated Affiliates(s) will be required to pledge additional acceptable Collateral to cover any deficit. </P>
              <P>(g) <E T="03">Lien on Collateral.</E> (1) Upon the Board's approval of a Guarantee, the Administrator shall have liens on Collateral securing the Loan, which shall be superior to all other liens on such Collateral. The value of the Collateral (based on a determination satisfactory to the Board) shall be at least equal to the unpaid balance of the Loan amount, giving significant consideration to the expected value of the Collateral in the event of defaults with specific consideration given to the residual value of the Project Assets to third-parties and the liquidity of such Assets. </P>
              <P>(2) Both the Administrator and the Lender or Agent shall have a perfected security interest in the Collateral fully sufficient to protect the financial interests of the United States and the Lenders. However, the security interest perfected by the Administrator shall ensure that the Administrator has first priority in such Collateral. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 2201.21 </SECTNO>
              <SUBJECT>Fees. </SUBJECT>
              <P>(a) <E T="03">Application fee.</E> The Board shall charge each Applicant for a Guarantee under the Program a non-refundable fee, payable to the United States Treasury, to cover the costs of making necessary determinations and findings with respect to an application for a Guarantee under the Program. The amount of the fee is $10,000 for Loans of $1 million up to $50 million, $15,000 for Loans of $50 million up to $100 million, $30,000 for Loans of $100 million up to $500 million, and $40,000 for Loans of $500 million or greater. </P>
              <P>(b) <E T="03">Guarantee Origination Fee.</E> The Board shall charge and collect from a Borrower, at the closing of the Loan, a Guarantee Origination Fee to cover the administrative costs of Board related to such Loan. The amount of such fee shall be the lesser of two percent of the Loan amount or $500,000. </P>
              <P>(c) <E T="03">Lender fees.</E> A Lender or Agent may assess and collect from the Borrower such fees and costs associated with the application and origination of the Loan as are reasonable and customary, taking into consideration the amount and complexity of the credit. The Board may take such fees and costs into consideration when determining whether to offer a Guarantee. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 2201.22 </SECTNO>
              <SUBJECT>Issuance of Guarantees. </SUBJECT>
              <P>(a) The Board's decisions to approve an application and extend an Offer of Guarantee under the Program is conditioned upon: </P>
              <P>(1) The Lender or Agent and Applicant obtaining any required regulatory or judicial approvals; </P>
              <P>(2) The Lender or Agent and Applicant being legally authorized to enter into the Loan under the terms and conditions submitted to the Board in the application; </P>
              <P>(3) The Board's receipt of the Loan Documents and any related instruments, in form and substance satisfactory to the Board all properly executed by the Lender or Agent, Applicant, and any other required party other than the Board; </P>
              <P>(4) No material adverse change in the Applicant's ability to repay the Loan between the date of the Board's approval and the date the Guarantee is to be issued; </P>
              <P>(5) Entering into the Guarantee violates no Loan covenants or existing contractual obligations of the Borrower; and </P>
              <P>(6) Such other conditions as determined by the Board. </P>
              <P>(b) The Board may withdraw its approval of an application and rescind its Offer of Guarantee if the Board determines that the Lender or Agent or the Applicant cannot, or is unwilling to, provide adequate documentation and proof of compliance with paragraph (a) of this section within the time provided for in the Offer of Guarantee. </P>
              <P>(c) Only after receipt of all the documentation required by this section will the Administrator sign and deliver the Guarantee. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 2201.23 </SECTNO>
              <SUBJECT>Funding for the Program. </SUBJECT>
              <P>(a) <E T="03">Costs incurred by the Government.</E> The Act provides funding for the costs incurred by the Government as a result of granting Guarantees under the Program. While pursuing the goals of the Act, it is the intent of the Board to <PRTPAGE P="48831"/>minimize the cost of the Program to the Government. The Board will estimate the risk posed by the guaranteed Loans to the funds appropriated for the costs of the Guarantees under the Program and operate the Program accordingly. </P>
              <P>(b) <E T="03">Credit risk premium.</E> (1) <E T="03">Establishment and approval.</E> The Board may establish and approve the acceptance of credit risk premiums with respect to a Guarantee under this Act in order to offset the cost, as defined in section 502(5) of the Federal Credit Reform Act of 1990, of the Guarantee. To the extent that appropriations of budget authority are insufficient to cover the cost, as so determined, of a Guarantee, and the Board approves such a Guarantee, credit risk premiums shall be accepted from a non-Federal source on behalf of a Borrower. </P>
              <P>(2) <E T="03">Credit risk premium amount.</E> (i) <E T="03">General.</E> The Board shall determine the amount of any credit risk premium to be accepted with respect to a Guarantee on the basis of: </P>
              <P>(A) The financial and economic circumstances of the Borrower, including the amount of Collateral offered; </P>
              <P>(B) The proposed schedule of Loan disbursements; </P>
              <P>(C) The business plans of the Borrower; </P>
              <P>(D) Any financial commitment from a broadcast signal provider; and </P>
              <P>(E) The concurrence of the Director of the Office of Management and Budget as to the amount of the credit risk premium. </P>
              <P>(ii) <E T="03">Proportionality.</E> To the extent that appropriations of budget authority are sufficient to cover the cost, as determined under section 502(5) of the Federal Credit Reform Act of 1990, of Guarantees, the credit risk premium with respect to each Guarantee shall be reduced proportionately. </P>
              <P>(iii) <E T="03">Payment of premiums.</E> Credit risk premiums under this paragraph shall be paid to an escrow account established in the Treasury, which shall accrue interest. Such interest shall be retained by the escrow account, subject to paragraph (b)(2)(iv) of this section. </P>
              <P>(iv) <E T="03">Deductions from escrow account.</E> If a liquidation of the Collateral occurs pursuant to § 2201.33(h), any shortfall between the proceeds of the liquidation net of costs and expenses relating to the liquidation, and the guarantee amount paid shall be deducted from funds in the escrow account and credited to the Administrator for payment of such shortfall. At such time as all Loans guaranteed under this Program have been repaid or otherwise satisfied in accordance with the Act and the regulations in this part, remaining funds in the escrow account, if any, shall be refunded, on a pro rata basis, to Borrowers whose Loans guaranteed under the Program were not in Payment Default or Default, or where any Payment Default or Default was cured in accordance with the terms of the Loan Documents. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 2201.24 </SECTNO>
              <SUBJECT>Insurance. </SUBJECT>
              <P>The Borrower of a Loan guaranteed under the Program shall obtain, at its expense, insurance sufficient to protect the financial interests of the United States, as determined by the Board. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 2201.25 </SECTNO>
              <SUBJECT>Performance Agreement. </SUBJECT>
              <P>(a) The Borrower of a Loan guaranteed under the Program shall enter into a Performance Agreement with the Administrator with respect to the Local Television Broadcast Signals to be provided through the Project. </P>
              <P>(b) The Administrator may assess against and collect from a Borrower a penalty not to exceed 3 times the interest accrued on the Loan during the period of noncompliance if the Borrower fails to meet its stipulated Performance Agreement entered into under paragraph (a) of this section. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 2201.26 </SECTNO>
              <SUBJECT>Lender standard of care. </SUBJECT>
              <P>(a) The Lender or Agent shall exercise due care and diligence in analyzing and administering the Loan as would be exercised by a responsible and prudent Banking Institution when analyzing and administering a secured loan of such Banking Institution's own funds without a Guarantee. Such standards shall also apply to any and all underwriting analysis, approvals, determinations, permissions, acceptances, requirements, or opinion made, given, imposed or reached by Lender. </P>
              <P>(b) The Lender or Agent shall have such other obligations and duties to the Board and the Administrator as are set forth in the Act or Loan Documents. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 2201.27 </SECTNO>
              <SUBJECT>Assignment or transfer of Loans. </SUBJECT>
              <P>(a) <E T="03">Modifications.</E> The Loan Documents may not be modified, in whole or in part, without the prior written approval of the Board. </P>
              <P>(b) <E T="03">Requirements.</E> (1) Subject to the provisions of paragraphs (c) and (d) of this section and other provisions of this part, a Lender or Agent may assign or transfer the Loan including the Loan Documents to another Lender that meets the eligibility requirements of § 2201.13 of this part. </P>
              <P>(2) Any assignment or transfer of a Loan, or any pledge or other use of a Loan as security, including but not limited to any derivatives transaction, will require the prior written approval of the Board. </P>
              <P>(c) The provisions of paragraph (b) of this section shall not apply to transfers which occur by operation of law. </P>
              <P>(d) The Agent must hold an interest in a Loan guaranteed under the Program equal to at least the lesser of $25 million or fifteen percent of the aggregate amount of the Loan. Of this amount, the Agent must hold an interest in the Unguaranteed Portion of the Loan equal to at least the minimum amount of the Loan required to be held by the Agent under the preceding sentence multiplied by the percentage of the entire Loan that is not guaranteed. A non-Agent Lender must hold an interest in the Unguaranteed Portion of the Loan representing no less than five percent of such Lender's total interest in the Loan; provided, that a non-Agent Lender may transfer its interest in the Unguaranteed Portion after payment of the Guaranteed Portion has been made under the Guarantee. </P>
              <P>(e) The Guarantee shall have no force or effect if any part of the Guaranteed Portion of the Loan is transferred separate and apart from the Unguaranteed Portion of the Loan. At least five percent of any assignment or transfer interest in a Loan must be unguaranteed to ensure that no part of the Guaranteed Portion of the Loan is transferred separate and apart from the Unguaranteed Portion of the Loan. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 2201.28 </SECTNO>
              <SUBJECT>Participation in guaranteed Loans. </SUBJECT>
              <P>(a) Subject to paragraphs (b), (c) and (d) of this section, a Lender may distribute the risk of a portion of a Loan guaranteed under the Program by sale of participations therein if: </P>
              <P>(1) Neither the Loan note nor the Guarantee is assigned, conveyed, sold, or transferred in whole or in part as a result of the sale of such participations; </P>
              <P>(2) The Lender remains solely responsible for the administration of the Loan as an Agent; and </P>
              <P>(3) The Board's ability to assert any and all defenses available to it under the law and under the Loan Documents is not adversely affected. </P>
              <P>(b) The following categories of entities may purchase participation interests in Loans guaranteed under the Program: </P>
              <P>(1) Lenders that meet the eligibility requirements of § 2201.13 of this part; </P>

              <P>(2) Qualified institutional buyers as defined in 17 CFR 230.144A (a), known as Rule 144A (a) of the Securities and Exchange Commission and issued under the Securities Act of 1933 (15 U.S.C. 77a <E T="03">et seq.</E>); or </P>

              <P>(3) Any other entity approved by the Board on a case-by-case basis. <PRTPAGE P="48832"/>
              </P>
              <P>(c) An Agent may not grant participations in that portion of its interest in a Loan that may not be assigned or transferred under § 2201.27(d) of this part. A Lender, other than the Agent, may not grant participations in that portion of its interest in a Loan that may not be assigned or transferred under § 2201.27(d) of this part. </P>
              <P>(d) At least five percent of any participation interest in a Loan must be unguaranteed. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 2201.29 </SECTNO>
              <SUBJECT>Supplemental guarantees. </SUBJECT>
              <P>The Board will allow the structure of a guaranteed Loan to include one or more supplemental guarantees only from a State or local governmental or tribal entity that cover the Unguaranteed Portion of the Loan, provided that: </P>
              <P>(a) There shall be no supplemental guarantee with respect to the Unguaranteed Portion required to be held by the Agent or sole Lender pursuant to § 2201.27(d) of this part; </P>
              <P>(b) The Loan Documents relating to any supplemental guarantee shall be acceptable in form and substance to the Board; and </P>
              <P>(c) In approving the issuance of a Guarantee, the Board may impose any conditions with respect to supplemental guarantee(s) relating to the Loan that it considers appropriate. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 2201.30 </SECTNO>
              <SUBJECT>Adjustments. </SUBJECT>
              <P>(a) The Board must approve the adjustment of any term or condition of the Loan Documents under this Program, including the rate of interest, time of payment of principal or interest, or Collateral requirements. Adjustments may be approved by the Board only if: </P>
              <P>(1) The adjustment is consistent with the financial interests of the United States; </P>
              <P>(2) Consent has been obtained from the parties to the Loan Agreement; </P>
              <P>(3) The adjustment is consistent with the underwriting criteria developed for the Program; </P>
              <P>(4) The adjustment does not adversely affect the interest of the Federal Government in the Assets or Collateral of the Borrower; </P>
              <P>(5) The adjustment does not adversely affect the ability of the Borrower to repay the Loan; and </P>
              <P>(6) The National Telecommunications and Information Administration of the Department of Commerce has been consulted by the Board regarding the adjustment. </P>
              <P>(b) A Lender's decision to forego remedial action in the event of a breach of financial covenants required under the Loan Agreement will not constitute an adjustment under this section. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 2201.31 </SECTNO>
              <SUBJECT>Indemnification. </SUBJECT>
              <P>(a) The United States shall be indemnified by any Affiliate of a Borrower designated in the Loan Documents for any losses that the United States incurs as a result of: </P>
              <P>(1) A judgment against the Borrower or any of its Affiliates; </P>
              <P>(2) Any breach by the Borrower or any of its Affiliates of their obligations under the Loan Documents; </P>
              <P>(3) Any violation of the provisions of the Act, or the regulations in this part, by the Borrower or any of its Affiliates; </P>
              <P>(4) Any penalties incurred by the Borrower or any of its Affiliates for any reason, including violation of a performance schedule stipulated in a Performance Agreement; and </P>
              <P>(5) Any other circumstances that the Board considers appropriate. </P>
              <P>(b) The Board may require more than one Affiliate of a Borrower to make the indemnifications referred to in paragraph (a) of this section. </P>
              <P>(c) The indemnifications referred to in paragraph (a) of this section shall be included in the Loan Documents. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 2201.32 </SECTNO>
              <SUBJECT>Termination of obligations. </SUBJECT>
              <P>The Board shall have such rights to terminate the Guarantee as are set forth in the Act and Loan Documents. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 2201.33 </SECTNO>
              <SUBJECT>Defaults. </SUBJECT>
              <P>(a) In determining, following any Payment Default or Default, whether to accelerate the maturity of any amounts outstanding under the Loan Documents or otherwise to declare such amounts to be immediately due and payable, or pursue other remedial actions available under the Loan Documents, the Agent or Lender, as the case may be, shall act at all times in accordance with the standard of care and diligence required under § 2201.26(a) of this part. </P>
              <P>(b) Following any Payment Default, the Agent or Lender shall promptly notify the Board and be entitled to make a Payment Demand. Any Payment Demand shall: </P>
              <P>(1) Identify the amount and due date of the defaulted payment of principal and the outstanding amounts of principal and interest under the Loan; </P>
              <P>(2) Describe briefly the circumstances leading to the Payment Default, including, without limitation, the nature of any precipitating Default, whether an acceleration has occurred, and whether a bankruptcy proceeding has been instituted or threatened; and </P>
              <P>(3) Be accompanied by a copy of each of the Loan Documents and all notices and other correspondence with the Borrower or other Lender relating to the Payment Default and any precipitating Default. </P>
              <P>(c) Following any Payment Demand being made, the Agent or Lender shall furnish to the Board promptly upon request from the Board and, in any event, not later than ninety (90) days from the date of such request, each of the following: </P>
              <P>(1) A written, detailed and reasonable plan for the partial or complete foreclosure on and liquidation of the Collateral, including, without limitation, detailed estimates by the Agent or Lender of the time and reasonable costs of collection anticipated to be necessary in order to carry out such plan; and </P>
              <P>(2) A written, detailed and reasonable work-out plan, if such a plan is feasible, for the continued operation of the Borrower calculated, in the Agent's or Lender's judgment, to assure the best prospect for repayment of principal and interest under the Loan without partial or complete foreclosure and liquidation of the Collateral, including, without limitation, detailed estimates of the time and expense required for such work-out and an assessment of the risks to the Agent or Lender and the Board associated therewith relative to such risks associated with complete foreclosure and liquidation; and, if any partial foreclosure and liquidation is a part of such proposed work-out plan, a detailed estimate of the time and reasonable costs of collection anticipated by the Agent or Lender to be required to effect such partial liquidation. </P>
              <P>(d) By making a Payment Demand, the Agent or Lender shall be conclusively deemed to have certified, with full knowledge of the provisions of 18 U.S.C. 1001 and 31 U.S.C. 3729 including, without limitation, the provisions thereof for penalties and damages, to the Board that it has fully and timely complied with all material provisions and obligations under the Guarantee and the Loan Documents, that the amount demanded is past due and owed by the Borrower under the Loan Agreement, and that the demand is properly made and required to be satisfied by the Board under the terms of the Guarantee. </P>
              <P>(e) Following receipt of any Payment Demand, the Board or, on its behalf, any duly authorized representative or designee, may conduct an audit and investigation of compliance with all material provisions and obligations under the Guarantee. The Agent and/or Lender shall cooperate fully and diligently with any such audit and investigation. </P>

              <P>(f) Within a reasonable period of time from receipt by the Board of a Payment Demand, the Board shall approve <PRTPAGE P="48833"/>payment of the amount to be paid in respect of the unpaid principal amount under the Loan to which the Payment Demand relates. The Board may withhold such payment if any audit or investigation is pending or if information remains to be furnished by the Agent or Lender. Further, payment shall not be made to the extent it is determined by the Board, whether as the result of an audit, investigation or otherwise, that the Board's payment obligation has terminated. Payment shall be made by wire transfer in immediately available funds to the bank and account designated by the Agent or Lender for such purpose. </P>
              <P>(g) The Board may take, or direct to be taken any action in liquidating the Collateral that the Board determines to be necessary or proper, consistent with Federal law and regulations. </P>
              <P>(h) Pursuant to the Guarantee, upon Payment Demand by the Agent or Lender, and whether the Board has approved any payment under the Guarantee or any payment has been made under the Guarantee, the Board, through the Administrator, shall have the right to liquidate, or cause to be liquidated, the Collateral. The Board, at its sole discretion, shall have the right to require that the Agent or Lender, solely or with the Administrator, conduct to completion any liquidation of any of the Collateral. Such liquidation shall be conducted by the Agent or Lender in accordance with the standards of care specified in § 2201.26(a) of this part. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 2201.34 </SECTNO>
              <SUBJECT>OMB Control Number. </SUBJECT>
              <P>The information collection requirements in this part are approved by the Office of Management and Budget and assigned OMB control number 0572-XXXX. </P>
            </SECTION>
          </SUBPART>
          <SIG>
            <DATED>Dated: August 11, 2003. </DATED>
            <NAME>Jacqueline G. Rosier, </NAME>
            <TITLE>Secretary,  LOCAL Television Loan Guarantee Board. </TITLE>
          </SIG>
        </PART>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20786 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 3410-15-P </BILCOD>
    </PRORULE>
    <PRORULE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF TRANSPORTATION </AGENCY>
        <SUBAGY>Federal Aviation Administration </SUBAGY>
        <CFR>14 CFR Part 39 </CFR>
        <DEPDOC>[Docket No. 2001-NM-296-AD] </DEPDOC>
        <RIN>RIN 2120-AA64 </RIN>
        <SUBJECT>Airworthiness Directives; Boeing Model 777-200 and -300 Series Airplanes </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Federal Aviation Administration, DOT. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of proposed rulemaking (NPRM). </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This document proposes the adoption of a new airworthiness directive (AD) that is applicable to certain Boeing Model 777-200 and -300 series airplanes. This proposal would require replacing existing ceiling and sidewall light connectors in the passenger cabin with new connectors, and follow-on actions. This action is necessary to prevent overheating of the light connectors, which could result in smoke and a possible fire in the passenger cabin. This action is intended to address the identified unsafe condition. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Comments must be received by September 29, 2003. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>

          <P>Submit comments in triplicate to the Federal Aviation Administration (FAA), Transport Airplane Directorate, ANM-114, Attention: Rules Docket No. 2001-NM-296-AD, 1601 Lind Avenue, SW., Renton, Washington 98055-4056. Comments may be inspected at this location between 9 a.m. and 3 p.m., Monday through Friday, except Federal holidays. Comments may be submitted via fax to (425) 227-1232. Comments may also be sent via the Internet using the following address: <E T="03">9-anm-nprmcomment@faa.gov.</E> Comments sent via fax or the Internet must contain “Docket No. 2001-NM-296-AD” in the subject line and need not be submitted in triplicate. Comments sent via the Internet as attached electronic files must be formatted in Microsoft Word 97 or 2000 or ASCII text. </P>
          <P>The service information referenced in the proposed rule may be obtained from Boeing Commercial Airplane Group, PO Box 3707, Seattle, Washington 98124-2207. This information may be examined at the FAA, Transport Airplane Directorate, 1601 Lind Avenue, SW., Renton, Washington. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Binh V. Tran, Aerospace Engineer, Systems and Equipment Branch, ANM-130S, FAA, Seattle Aircraft Certification Office, 1601 Lind Avenue, SW., Renton, Washington 98055-4056; telephone (425) 917-6485; fax (425) 917-6590. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <HD SOURCE="HD1">Comments Invited </HD>
        <P>Interested persons are invited to participate in the making of the proposed rule by submitting such written data, views, or arguments as they may desire. Communications shall identify the Rules Docket number and be submitted in triplicate to the address specified above. All communications received on or before the closing date for comments, specified above, will be considered before taking action on the proposed rule. The proposals contained in this action may be changed in light of the comments received.</P>
        <P>Submit comments using the following format: </P>
        <P>• Organize comments issue-by-issue. For example, discuss a request to change the compliance time and a request to change the service bulletin reference as two separate issues. </P>
        <P>• For each issue, state what specific change to the proposed AD is being requested. </P>
        <P>• Include justification (<E T="03">e.g.</E>, reasons or data) for each request. </P>
        <P>Comments are specifically invited on the overall regulatory, economic, environmental, and energy aspects of the proposed rule. All comments submitted will be available, both before and after the closing date for comments, in the Rules Docket for examination by interested persons. A report summarizing each FAA-public contact concerned with the substance of this proposal will be filed in the Rules Docket. </P>
        <P>Commenters wishing the FAA to acknowledge receipt of their comments submitted in response to this action must submit a self-addressed, stamped postcard on which the following statement is made: “Comments to Docket Number 2001-NM-296-AD.” The postcard will be date stamped and returned to the commenter. </P>
        <HD SOURCE="HD1">Availability of NPRMs </HD>
        <P>Any person may obtain a copy of this NPRM by submitting a request to the FAA, Transport Airplane Directorate, ANM-114, Attention: Rules Docket No. 2001-NM-296-AD, 1601 Lind Avenue, SW., Renton, Washington 98055-4056. </P>
        <HD SOURCE="HD1">Discussion </HD>

        <P>The FAA has received several reports that ceiling and sidewall light connectors have overheated on several Boeing Model 777-200 and -300 series airplanes. Investigation following failure <PRTPAGE P="48834"/>of ceiling and sidewall lights and, in two cases, tripped circuit breakers, revealed burned and charred light connectors. This damage has been attributed to moisture contamination within light connectors in which 115-volt power is present, which caused arcing within the connectors, and consequent melting, burning, and charring of the connectors. This condition, if not corrected, could result in smoke and a possible fire in the passenger cabin. </P>
        <HD SOURCE="HD1">Explanation of Relevant Service Information </HD>
        <P>The FAA has reviewed and approved Boeing Special Attention Service Bulletin 777-33-0019, dated July 19, 2001, which describes procedures for replacing existing ceiling and sidewall light connectors with new connectors in the forward, middle, and aft passenger cabin. The procedures in the service bulletin include replacing ceiling and sidewall light assemblies with improved assemblies, replacing jumper bundles on ceiling lights (if installed) with new bundles, replacing connectors on certain wire bundles with new improved connectors, and performing functional tests. Accomplishment of the applicable actions specified in the service bulletin is intended to adequately address the identified unsafe condition. </P>
        <P>Boeing Special Attention Service Bulletin 777-33-0019 refers to Diehl Service Bulletin 3352-33-01, dated June 20, 2001, as an additional source of service information for accomplishment of the connector replacements. </P>
        <HD SOURCE="HD1">Explanation of Requirements of Proposed Rule </HD>
        <P>Since an unsafe condition has been identified that is likely to exist or develop on other products of this same type design, the proposed AD would require accomplishment of the actions specified in the Boeing service bulletin described previously. </P>
        <P>In developing an appropriate compliance time for this AD, we considered the manufacturer's recommendation, the degree of urgency associated with the subject unsafe condition, the average utilization of the affected fleet, and the time necessary to perform the proposed actions. In light of all of these factors, we find that an 18-month compliance time represents an appropriate interval of time for affected airplanes to continue to operate without compromising safety. </P>
        <HD SOURCE="HD1">Changes to 14 CFR Part 39/Effect on the Proposed AD </HD>
        <P>On July 10, 2002, we issued a new version of 14 CFR part 39 (67 FR 47997, July 22, 2002), which governs the FAA's airworthiness directives system. The regulation now includes material that relates to altered products, special flight permits, and alternative methods of compliance (AMOCs). Because we have now included this material in part 39, only the office authorized to approve AMOCs is identified in each individual AD. </P>
        <HD SOURCE="HD1">Change to Labor Rate Estimate </HD>
        <P>We have reviewed the figures we have used over the past several years to calculate AD costs to operators. To account for various inflationary costs in the airline industry, we find it necessary to increase the labor rate used in these calculations from $60 per work hour to $65 per work hour. The cost impact information, below, has been revised to reflect this increase in the specified hourly labor rate. </P>
        <HD SOURCE="HD1">Cost Impact </HD>
        <P>There are approximately 341 airplanes of the affected design in the worldwide fleet. The FAA estimates that 108 airplanes of U.S. registry, 22 Model 777-200 series airplanes and 86 Model 777-300 series airplanes, would be affected by this proposed AD. </P>
        <P>For those Model 777-200 series airplanes, it would take approximately 72 work hours per airplane to accomplish the proposed actions, at an average labor rate of $65 per work hour. Required parts would cost approximately $4,631 per airplane. Based on these figures, the cost impact of the proposed AD on U.S. operators of Model 777-200 series airplanes is estimated to be $204,842, or $9,311 per airplane. </P>
        <P>For those Model 777-300 series airplanes, it would take approximately 82 work hours per airplane to accomplish the proposed actions, at an average labor rate of $65 per work hour. Required parts would cost approximately $5,488 per airplane. Based on these figures, the cost impact of the proposed AD on U.S. operators of Model 777-300 series airplanes is estimated to be $930,348, or $10,818 per airplane. </P>
        <P>The cost impact figures discussed above are based on assumptions that no operator has yet accomplished any of the proposed requirements of this AD action, and that no operator would accomplish those actions in the future if this proposed AD were not adopted. The cost impact figures discussed in AD rulemaking actions represent only the time necessary to perform the specific actions actually required by the AD. These figures typically do not include incidental costs, such as the time required to gain access and close up, planning time, or time necessitated by other administrative actions. </P>
        <HD SOURCE="HD1">Regulatory Impact </HD>
        <P>The regulations proposed herein would not have a substantial direct effect on the States, on the relationship between the national Government and the States, or on the distribution of power and responsibilities among the various levels of government. Therefore, it is determined that this proposal would not have federalism implications under Executive Order 13132. </P>

        <P>For the reasons discussed above, I certify that this proposed regulation (1) is not a “significant regulatory action” under Executive Order 12866; (2) is not a “significant rule” under the DOT Regulatory Policies and Procedures (44 FR 11034, February 26, 1979); and (3) if promulgated, will not have a significant economic impact, positive or negative, on a substantial number of small entities under the criteria of the Regulatory Flexibility Act. A copy of the draft regulatory evaluation prepared for this action is contained in the Rules Docket. A copy of it may be obtained by contacting the Rules Docket at the location provided under the caption <E T="02">ADDRESSES.</E>
        </P>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects in 14 CFR Part 39 </HD>
          <P>Air transportation, Aircraft, Aviation safety, Safety.</P>
        </LSTSUB>
        <HD SOURCE="HD1">The Proposed Amendment </HD>
        <P>Accordingly, pursuant to the authority delegated to me by the Administrator, the Federal Aviation Administration proposes to amend part 39 of the Federal Aviation Regulations (14 CFR part 39) as follows: </P>
        <PART>
          <HD SOURCE="HED">PART 39—AIRWORTHINESS DIRECTIVES </HD>
          <P>1. The authority citation for part 39 continues to read as follows: </P>
          
          <AUTH>
            <HD SOURCE="HED">Authority:</HD>
            <P>49 U.S.C. 106(g), 40113, 44701. </P>
          </AUTH>
          <SECTION>
            <SECTNO>§ 39.13 </SECTNO>
            <SUBJECT>[Amended] </SUBJECT>
            <P>2. Section 39.13 is amended by adding the following new airworthiness directive: </P>
            
            <EXTRACT>
              <FP SOURCE="FP-2">
                <E T="04">Boeing:</E> Docket 2001-NM-296-AD. </FP>
              
              <P>
                <E T="03">Applicability:</E> Model 777-200 and -300 series airplanes, certificated in any category, line numbers 001 through 341 inclusive. </P>
              <P>
                <E T="03">Compliance:</E> Required as indicated, unless accomplished previously. </P>

              <P>To prevent overheating of ceiling and sidewall light connectors, which could result in smoke and a possible fire in the passenger cabin, accomplish the following: <PRTPAGE P="48835"/>
              </P>
              <HD SOURCE="HD1">Service Bulletin References </HD>
              <P>(a) The following information pertains to the service bulletin referenced in this AD: </P>
              <P>(1) The term “service bulletin,” as used in this AD, means the Accomplishment Instructions of Boeing Special Attention Service Bulletin 777-33-0019, dated July 19, 2001. </P>
              <P>(2) Although the service bulletin referenced in this AD specifies to submit information to the manufacturer, this AD does not include such a requirement. </P>
              <HD SOURCE="HD1">Replacement of Light Connectors </HD>
              <P>(b) Within 18 months after the effective date of this AD: Replace, with improved parts, the existing ceiling and sidewall light connectors and wire bundle connectors in the areas specified in the service bulletin; by accomplishing all actions in steps A. through S. in Work Packages 1, 2, and 3, of the Accomplishment Instructions of the service bulletin. </P>
              <NOTE>
                <HD SOURCE="HED">Note:</HD>
                <P>Boeing Special Attention Service Bulletin 777-33-0019 refers to Diehl Service Bulletin 3352-33-01, dated June 20, 2001, as an additional source of service information for accomplishment of the connector replacements. </P>
              </NOTE>
              <HD SOURCE="HD1">Alternative Methods of Compliance </HD>
              <P>(c) In accordance with 14 CFR 39.19, the Manager, Seattle Aircraft Certification Office, FAA, is authorized to approve alternative methods of compliance for this AD. </P>
            </EXTRACT>
            
          </SECTION>
          <SIG>
            <DATED>Issued in Renton, Washington, on August 11, 2003. </DATED>
            <NAME>Neil D. Schalekamp, </NAME>
            <TITLE>Acting Manager, Transport Airplane Directorate, Aircraft Certification Service. </TITLE>
          </SIG>
        </PART>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20836 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4910-13-P</BILCOD>
    </PRORULE>
    <PRORULE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF TRANSPORTATION </AGENCY>
        <SUBAGY>Federal Aviation Administration </SUBAGY>
        <CFR>14 CFR Part 39 </CFR>
        <DEPDOC>[Docket No. 2003-NM-70-AD] </DEPDOC>
        <RIN>RIN 2120-AA64 </RIN>
        <SUBJECT>Airworthiness Directives; McDonnell Douglas Model MD-11 and -11F Airplanes </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Federal Aviation Administration, DOT. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of proposed rulemaking (NPRM).</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This document proposes the supersedure of an existing airworthiness directive (AD), applicable to certain McDonnell Douglas Model MD-11 series airplanes, that currently requires performing a general visual inspection to detect chafing or damage of the parallel power feeder cables of the number 2 integrated drive generator (IDG); repairing any chafed cable and damaged structure; and repositioning the parallel power feeder cables of the number 2 IDG. This action would revise the applicability of the existing AD by adding certain airplanes and removing certain other airplanes. The actions specified by the proposed AD are intended to prevent chafing and arcing of the parallel feeder cables of the number 2 IDG, which could result in smoke and/or fire in the right aft galley area. This action is intended to address the identified unsafe condition.</P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Comments must be received by September 29, 2003. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>

          <P>Submit comments in triplicate to the Federal Aviation Administration (FAA), Transport Airplane Directorate, ANM-114, Attention: Rules Docket No. 2003-NM-70-AD, 1601 Lind Avenue, SW., Renton, Washington 98055-4056. Comments may be inspected at this location between 9 a.m. and 3 p.m., Monday through Friday, except Federal holidays. Comments may be submitted via fax to (425) 227-1232. Comments may also be sent via the Internet using the following address: <E T="03">9-anm-nprmcomment@faa.gov.</E> Comments sent via fax or the Internet must contain “Docket No. 2003-NM-70-AD” in the subject line and need not be submitted in triplicate. Comments sent via the Internet as attached electronic files must be formatted in Microsoft Word 97 or 2000 or ASCII text. </P>
          <P>The service information referenced in the proposed rule may be obtained from Boeing Commercial Aircraft Group, Long Beach Division, 3855 Lakewood Boulevard, Long Beach, California 90846, Attention: Data and Service Management, Dept. C1-L5A (D800-0024). This information may be examined at the FAA, Transport Airplane Directorate, 1601 Lind Avenue, SW., Renton, Washington; or at the FAA, Los Angeles Aircraft Certification Office, 3960 Paramount Boulevard, Lakewood, California. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Brett Portwood, Aerospace Engineer, Systems and Equipment Branch, ANM-130L, FAA, Los Angeles Aircraft Certification Office, 3960 Paramount Boulevard, Lakewood, California 90712-4137; telephone (562) 627-5350; fax (562) 627-5210. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <HD SOURCE="HD1">Comments Invited</HD>
        <P>Interested persons are invited to participate in the making of the proposed rule by submitting such written data, views, or arguments as they may desire. Communications shall identify the Rules Docket number and be submitted in triplicate to the address specified above. All communications received on or before the closing date for comments, specified above, will be considered before taking action on the proposed rule. The proposals contained in this action may be changed in light of the comments received.</P>
        <P>Submit comments using the following format:</P>
        <P>• Organize comments issue-by-issue. For example, discuss a request to change the compliance time and a request to change the service bulletin reference as two separate issues. </P>
        <P>• For each issue, state what specific change to the proposed AD is being requested. </P>
        <P>• Include justification (<E T="03">e.g.</E>, reasons or data) for each request. </P>
        <P>Comments are specifically invited on the overall regulatory, economic, environmental, and energy aspects of the proposed rule. All comments submitted will be available, both before and after the closing date for comments, in the Rules Docket for examination by interested persons. A report summarizing each FAA-public contact concerned with the substance of this proposal will be filed in the Rules Docket. </P>
        <P>Commenters wishing the FAA to acknowledge receipt of their comments submitted in response to this action must submit a self-addressed, stamped postcard on which the following statement is made: “Comments to Docket Number 2003-NM-70-AD.” The postcard will be date stamped and returned to the commenter. </P>
        <HD SOURCE="HD1">Availability of NPRMs </HD>
        <P>Any person may obtain a copy of this NPRM by submitting a request to the FAA, Transport Airplane Directorate, ANM-114, Attention: Rules Docket No. 2003-NM-70-AD, 1601 Lind Avenue, SW., Renton, Washington 98055-4056.</P>
        <HD SOURCE="HD1">Discussion </HD>

        <P>On August 14, 2001, the FAA issued AD 2001-17-08, amendment 39-12399 (66 FR 44043, August 22, 2001), applicable to certain McDonnell Douglas Model MD-11 series airplanes, to require performing a general visual inspection to detect chafing or damage of the parallel power feeder cables of the number 2 integrated drive generator (IDG); repairing any chafed cable and damaged structure; and repositioning the parallel power feeder cables of the number 2 IDG. That action was prompted by an incident in which smoke permeated the right aft galley area and an electrical power generator system fault alert occurred on a McDonnell Douglas Model MD-11 <PRTPAGE P="48836"/>airplane. The requirements of that AD are intended to prevent chafing and arcing of the parallel feeder cables of the number 2 IDG, which could result in smoke and/or fire in the right aft galley area. </P>
        <HD SOURCE="HD1">Actions Since Issuance of Previous Rule </HD>
        <P>Since the issuance of that AD, the airplane manufacturer has informed the FAA that it inadvertently omitted 43 airplanes from the effectivity listing of McDonnell Douglas Alert Service Bulletin MD11-24A157, dated August 10, 2000 (which was referenced in AD 2001-17-08 an appropriate source of service information for accomplishing the required actions) that are subject to the identified unsafe condition and included 24 other airplanes that are not subject to the identified unsafe condition. </P>
        <HD SOURCE="HD1">Explanation of Relevant Service Information </HD>
        <P>We have reviewed and approved Boeing Alert Service Bulletin MD11-24A157, Revision 01, dated March 11, 2003, which revises the effectivity of the initial release of the service bulletin by adding 43 additional airplanes and removing 24 other airplanes. The inspection, repositioning, and corrective actions if necessary specified in Revision 01 are essentially identical to those described in initial release of the service bulletin. No more work is necessary on airplanes changed per the initial release of this service bulletin. Accomplishment of the actions specified in the service bulletin is intended to adequately address the identified unsafe condition.</P>
        <HD SOURCE="HD1">Explanation of Requirements of Proposed Rule </HD>
        <P>Since an unsafe condition has been identified that is likely to exist or develop on other products of this same type design, the proposed AD would supersede AD 2001-17-08 to require performing a general visual inspection to detect chafing or damage of the parallel power feeder cables of the number 2 IDG; repairing any chafed cable and damaged structure; and repositioning the parallel power feeder cables of the number 2 IDG. The proposed AD also would revise the applicability of the existing AD by adding certain airplanes and removing certain other airplanes. The actions would be required to be accomplished in accordance with the applicable service bulletin revision described previously. </P>
        <HD SOURCE="HD1">Explanation of Change to Applicability </HD>

        <P>The applicability of AD 2001-17-08 identified the affected airplanes as “Model MD-11 series airplanes, as listed in McDonnell Douglas Alert Service Bulletin MD11-24A157, dated August 10, 2000.” Although Model MD-11F airplanes are not specifically identified by model name in the applicability of that AD, those airplanes are identified by the manufacturer's fuselage numbers in the referenced service bulletin. This proposed AD would identify those model designations as published in the most recent type certificate data sheet for the affected models (<E T="03">i.e.</E>, Model MD-11 and -11F airplanes). </P>
        <HD SOURCE="HD1">Changes to 14 CFR Part 39/Effect on the AD </HD>
        <P>On July 10, 2002, we issued a new version of 14 CFR part 39 (67 FR 47997, July 22, 2002), which governs our AD system. The regulation now includes material that relates to altered products, special flight permits, and alternative methods of compliance (AMOCs). Because we have now included this material in part 39, for purposes of this proposed AD, it is only necessary to identify the office authorized to approve AMOCs and previously approved AMOCs that are acceptable for compliance with the applicable requirements of this proposed AD. Therefore, Note 1 and paragraph (c) of AD 2001-17-08 are not included in this proposed AD, and paragraph (b) of AD 2001-17-08 has been revised in this proposed AD. </P>
        <HD SOURCE="HD1">Change to Labor Rate Estimate </HD>
        <P>We have reviewed the figures we have used over the past several years to calculate AD costs to operators. To account for various inflationary costs in the airline industry, we find it necessary to increase the labor rate used in these calculations from $60 per work hour to $65 per work hour. The cost impact information, below, reflects this increase in the specified hourly labor rate. </P>
        <HD SOURCE="HD1">Cost Impact </HD>
        <P>There are approximately 85 airplanes of the affected design in the worldwide fleet. The FAA estimates that 15 airplanes of U.S. registry would be affected by this proposed AD. </P>
        <P>For Group 1 airplanes listed in Boeing Alert Service Bulletin MD11-24A157, Revision 01, dated March 11, 2003: The actions that are currently required by AD 2001-17-08 take approximately 4 work hours per airplane to accomplish, at an average labor rate of $65 per work hour. Based on these figures, the cost impact of the currently required actions on these U.S. operators is estimated to be $260 per airplane. </P>
        <P>For Group 2 airplanes listed in Boeing Alert Service Bulletin MD11-24A157, Revision 01, dated March 11, 2003: The new actions that are proposed in this AD action would take approximately 5 work hours per airplane to accomplish, at an average labor rate of $65 per work hour. Required parts would cost approximately $673 per airplane. Based on these figures, the cost impact of the proposed requirements of this AD on these U.S. operators is estimated to be $998 per airplane. </P>
        <P>The cost impact figures discussed above are based on assumptions that no operator has yet accomplished any of the current or proposed requirements of this AD action, and that no operator would accomplish those actions in the future if this AD were not adopted. The cost impact figures discussed in AD rulemaking actions represent only the time necessary to perform the specific actions actually required by the AD. These figures typically do not include incidental costs, such as the time required to gain access and close up, planning time, or time necessitated by other administrative actions. The manufacturer may cover the cost of replacement parts associated with this proposed AD, subject to warranty conditions. Manufacturer warranty remedies may also be available for labor costs associated with this proposed AD. As a result, the costs attributable to the proposed AD may be less than stated above. </P>
        <HD SOURCE="HD1">Regulatory Impact </HD>
        <P>The regulations proposed herein would not have a substantial direct effect on the States, on the relationship between the national Government and the States, or on the distribution of power and responsibilities among the various levels of government. Therefore, it is determined that this proposal would not have federalism implications under Executive Order 13132. </P>

        <P>For the reasons discussed above, I certify that this proposed regulation (1) is not a “significant regulatory action” under Executive Order 12866; (2) is not a “significant rule” under the DOT Regulatory Policies and Procedures (44 FR 11034, February 26, 1979); and (3) if promulgated, will not have a significant economic impact, positive or negative, on a substantial number of small entities under the criteria of the Regulatory Flexibility Act. A copy of the draft regulatory evaluation prepared for this action is contained in the Rules Docket. A copy of it may be obtained by contacting the Rules Docket at the <PRTPAGE P="48837"/>location provided under the caption <E T="02">ADDRESSES.</E>
        </P>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects in 14 CFR Part 39 </HD>
          <P>Air transportation, Aircraft, Aviation safety, Safety.</P>
        </LSTSUB>
        <HD SOURCE="HD1">The Proposed Amendment </HD>
        <P>Accordingly, pursuant to the authority delegated to me by the Administrator, the Federal Aviation Administration proposes to amend part 39 of the Federal Aviation Regulations (14 CFR part 39) as follows: </P>
        <PART>
          <HD SOURCE="HED">PART 39—AIRWORTHINESS DIRECTIVES </HD>
          <P>1. The authority citation for part 39 continues to read as follows: </P>
          <AUTH>
            <HD SOURCE="HED">Authority:</HD>
            <P>49 U.S.C. 106(g), 40113, 44701. </P>
          </AUTH>
          <SECTION>
            <SECTNO>§ 39.13 </SECTNO>
            <SUBJECT>[Amended] </SUBJECT>
            <P>2. Section 39.13 is amended by removing amendment 39-12399 (66 FR 44043, August 22, 2001), and by adding a new airworthiness directive (AD), to read as follows: </P>
            
            <EXTRACT>
              <FP SOURCE="FP-2">
                <E T="04">McDonnell Douglas:</E> Docket 2003-NM-70-AD. Supersedes AD 2001-17-08, Amendment 39-12399. </FP>
              
              <P>
                <E T="03">Applicability:</E> Model MD-11 and -11F airplanes, as listed in Boeing Alert Service Bulletin MD11-24A157, Revision 01, dated March 11, 2003; certificated in any category. </P>
              <P>
                <E T="03">Compliance:</E> Required as indicated, unless accomplished previously. </P>
              <P>To prevent chafing and arcing of the parallel feeder cables of the number 2 integrated drive generator (IDG), which could result in smoke and/or fire in the right aft galley area, accomplish the following: </P>
              <HD SOURCE="HD1">Inspection </HD>
              <P>(a) Do a general visual inspection to detect chafing or damage of the parallel power feeder cables of the number 2 IDG at the applicable time and per the applicable service bulletin specified in Table 1 of this AD. Table 1 is as follows: </P>
              <GPOTABLE CDEF="s75,r75,r75" COLS="3" OPTS="L2,i1">
                <TTITLE>Table 1.—Compliance Time/Service Bulletin </TTITLE>
                <BOXHD>
                  <CHED H="1">Airplanes </CHED>
                  <CHED H="1">Compliance Time </CHED>
                  <CHED H="1">Service Bulletin </CHED>
                </BOXHD>
                <ROW>
                  <ENT I="01">For Group 1 airplanes listed in Boeing Alert Service Bulletin MD11-24A157, Revision 01, dated March 11, 2003</ENT>
                  <ENT>Within 6 months after September 26, 2001 (the effective date of AD 2001-17-08, amendment 39-12399)</ENT>
                  <ENT>McDonnell Douglas Alert Service Bulletin MD11-24A157, dated August 10, 2000. </ENT>
                </ROW>
                <ROW>
                  <ENT I="01">For Group 2 airplanes listed in Boeing Alert Service Bulletin MD11-24A157, Revision 01, dated March 11, 2003</ENT>
                  <ENT>Within 6 months after the effective date of this AD</ENT>
                  <ENT>Boeing Alert Service Bulletin MD11-24A157, Revision 01, dated March 11, 2003. </ENT>
                </ROW>
              </GPOTABLE>
              <NOTE>
                <HD SOURCE="HED">Note 1:</HD>
                <P>For the purposes of this AD, a general visual inspection is defined as “A visual examination of an interior or exterior area, installation, or assembly to detect obvious damage, failure, or irregularity. This level of inspection is made under normally available lighting conditions such as daylight, hangar lighting, flashlight, or drop-light, and may require removal or opening of access panels or doors. Stands, ladders, or platforms may be required to gain proximity to the area being checked.” </P>
              </NOTE>
              <HD SOURCE="HD1">Condition 1 (No Chafing and No Structure Damage) </HD>
              <P>(1) If no chafing and damage is detected, before further flight, reposition the parallel power feeder cables of the number 2 IDG, per the applicable service bulletin. </P>
              <HD SOURCE="HD1">Condition 2 (Chafing or Structure Damage) </HD>
              <P>(2) If any chafing or damage is detected, before further flight, repair the chafed cable and damaged structure, as applicable, and reposition the parallel power feeder cables of the number 2 IDG, per the applicable service bulletin. </P>
              <HD SOURCE="HD1">Alternative Methods of Compliance </HD>
              <P>(b)(1) In accordance with 14 CFR 39.19, the Manager, Los Angeles Aircraft Certification Office, FAA, is authorized to approve alternative methods of compliance for this AD. </P>
              <P>(2) Alternative methods of compliance, approved previously per AD 2001-17-08, amendment 39-12399, are approved as alternative methods of compliance with the requirements of this AD. </P>
            </EXTRACT>
            
          </SECTION>
          <SIG>
            <DATED>Issued in Renton, Washington, on August 11, 2003. </DATED>
            <NAME>Neil D. Schalekamp, </NAME>
            <TITLE>Acting Manager, Transport Airplane Directorate, Aircraft Certification Service. </TITLE>
          </SIG>
        </PART>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20835 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4910-13-P</BILCOD>
    </PRORULE>
    <PRORULE>
      <PREAMB>
        <AGENCY TYPE="N">NATIONAL AERONAUTICS AND SPACE ADMINISTRATION </AGENCY>
        <CFR>14 CFR Part 1260 </CFR>
        <RIN>RIN 2700-AC75 </RIN>
        <SUBJECT>NASA Grant and Cooperative Agreement Handbook—Public Acknowledgements </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>National Aeronautics and Space Administration. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Proposed rule. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This proposed rule would amend the NASA Grant and Cooperative Agreement Handbook to include public acknowledgement of NASA's photographs and illustrations in reports or publications spawned by NASA's award of grants or cooperative agreements. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Interested parties should submit comments in writing on or before October 14, 2003 to be considered in formulation of a final rule. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>

          <P>Submit written comments to Paul Brundage, NASA Headquarters, Office of Procurement, Code HK, Washington, DC 20546. Comments may also be submitted by via the Internet to <E T="03">paul.d.brundage@nasa.gov</E>. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Paul Brundage, Code HK, (202) 358-0481, e-mail: <E T="03">paul.d.brundage@nasa.gov</E>. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <HD SOURCE="HD1">A. Background </HD>
        <P>In publications spawned from NASA's award of grants and cooperative agreements, principal investigators sometimes fail to acknowledge NASA's photographs and illustrations. This proposed change sets forth NASA's desire for acknowledgement in 14 CFR 1260.22. </P>
        <HD SOURCE="HD1">B. Regulatory Flexibility Act </HD>

        <P>NASA certifies that this proposed rule will not have a significant economic impact on a substantial number of small entities within the meaning of the Regulatory Flexibility Act, 5 U.S.C. 601 <E T="03">et seq.</E>, because (a) few grants and cooperative agreements under 14 CFR part 1260 are awarded to small businesses, (b) it will only affect the few recipients of awards that make use of NASA photographs and illustrations in their publications, and (c) this proposed rule has no economic impact on award recipients since it only requests acknowledgment of the source of photographs and illustrations in the recipients' publications. </P>
        <HD SOURCE="HD1">C. Paperwork Reduction Act </HD>

        <P>The Paperwork Reduction Act does not apply because this proposed rule <PRTPAGE P="48838"/>does not impose any new recordkeeping or information collection requirements, or collection of information from offerors, contractors, or members of the public that require the approval of the Office of Management (OMB) and Budget under 44 U.S.C. 3501, <E T="03">et. seq</E>. </P>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects in CFR Part 1260 </HD>
          <P>Grant Programs—Science and Technology.</P>
        </LSTSUB>
        <SIG>
          <NAME>Tom Luedtke,</NAME>
          <TITLE>Assistant Administrator for Procurement. </TITLE>
        </SIG>
        <P>Accordingly, 14 CFR part 1260 is proposed to be amended as follows:</P>
        <P>1. The authority citation for 14 CFR part 1260 continues to read as follows: </P>
        <AUTH>
          <HD SOURCE="HED">Authority:</HD>

          <P>42 U.S.C. 2473(c)(1), Pub. L. 97-258, and 96 Stat. 1003 (31 U.S.C. 6301, <E T="03">et seq.</E>). </P>
        </AUTH>
        <PART>
          <HD SOURCE="HED">PART 1260—GRANTS AND COOPERATIVE AGREEMENTS </HD>
          <P>2. Amend the provision at § 1260.22 by revising the date of the provision and adding paragraph (a)(3) to read as follows: </P>
          <SECTION>
            <SECTNO>§ 1260.22</SECTNO>
            <SUBJECT>Technical publications and reports. </SUBJECT>
            <HD SOURCE="HD1">Technical Publications and Reports </HD>
            <HD SOURCE="HD2">(Month/Year) </HD>
            <P>(a) * * * </P>
            <P>(3) As a courtesy, any release of a NASA photograph or illustration should list NASA first on the credit line followed by the name of the Principal Investigator's Institution. An example follows: </P>
            <P>“Photograph &lt;or illustration, figure, etc.&gt; courtesy of NASA &lt;or NASA Center managing the mission or program&gt; and the &lt;Principal Investigator's institution&gt;.” </P>
            <STARS/>
          </SECTION>
        </PART>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20920 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 7510-01-P</BILCOD>
    </PRORULE>
    <PRORULE>
      <PREAMB>
        <AGENCY TYPE="S">NATIONAL AERONAUTICS AND SPACE ADMINISTRATION </AGENCY>
        <CFR>14 CFR Part 1260 </CFR>
        <RIN>RIN 2700-AC74 </RIN>
        <SUBJECT>NASA Grant and Cooperative Agreement Handbook—Investigative Requirements </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>National Aeronautics and Space Administration. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Proposed rule. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This rule proposes to amend the existing “Investigative Requirements” provision of the NASA Grant and Cooperative Agreement Handbook to require recipients of grants and cooperative agreements to ensure that individuals needing access to a NASA Center, facility, or computer system, or to NASA technical information, provide the personal background and biographical information requested by NASA. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Comments should be submitted on or before October 14, 2003. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Interested parties should submit written comments to Paul Brundage, NASA Headquarters, Office of Procurement, Contract Management Division (Code HK), Washington DC 20546. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Paul Brundage, (202) 358-0481, e-mail: <E T="03">Paul.D.Brundage@nasa.gov.</E>
          </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P/>
        <HD SOURCE="HD1">A. Background </HD>
        <P>NASA sometimes, albeit infrequently, requires information for investigations of individuals working on grants and cooperative agreements in order to determine whether to permit, deny, or restrict access to a NASA Center, facility, or computer system, or to NASA technical information. The provision at 1260.35, Investigative Requirements, is inserted in all grants and cooperative agreements to ensure recipients provide the information requested by NASA for any required investigation. This proposed change is needed because recipients of grants and cooperative agreements, especially educational institutions, often do not maintain or have access to the types of information required by the provision at 1260.35 about their staff, faculty, and students because of policy and legal restrictions. Instead of requiring the recipients to obtain and submit personal information, this proposed rule makes it clear that the individuals needing access may provide the requisite information directly to NASA. This proposed rule also clarifies that access is to NASA Centers, facilities, computer systems, and NASA technical information. </P>
        <HD SOURCE="HD1">B. Regulatory Flexibility Act </HD>

        <P>NASA certifies that this proposed rule will not have a significant economic impact on a substantial number of small entities within the meaning of the Regulatory Flexibility Act, 5 U.S.C. 601 <E T="03">et seq,</E> because there are few grants and cooperative agreements that require access to NASA Centers, facilities, and computer systems, or to NASA technical information. Furthermore, only a small portion of NASA's grants and cooperative agreements are awarded to small entities as defined in the statute. </P>
        <HD SOURCE="HD1">C. Paperwork Reduction Act </HD>

        <P>The Paperwork Reduction Act does not apply because this proposed rule does not impose any new recordkeeping or information collection requirements, or collection of information from offerors, contractors, or members of the public that require the approval of the Office of Management and Budget under 44 U.S.C. 3501, <E T="03">et. seq.</E>
        </P>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects in CFR Part 1260 </HD>
          <P>Grant Programs—Science and Technology.</P>
        </LSTSUB>
        <SIG>
          <NAME>Tom Luedtke, </NAME>
          <TITLE>Assistant Administrator for Procurement. </TITLE>
        </SIG>
        
        <P>Accordingly, 14 CFR part 1260 is proposed to be amended as follows:</P>
        <P>1. The authority citation for 14 CFR 1260 continues to read as follows: </P>
        <AUTH>
          <HD SOURCE="HED">Authority:</HD>

          <P>42 U.S.C. 2473(c)(1), Pub. L. 97-258, and 96 Stat. 1003 (31 U.S.C. 6301, <E T="03">et seq.</E>) </P>
        </AUTH>
        <PART>
          <HD SOURCE="HED">PART 1260—GRANTS AND COOPERATIVE AGREEMENTS </HD>
          <P>2. Section 1260.35 is revised to read as follows: </P>
          <SECTION>
            <SECTNO>§ 1260.35</SECTNO>
            <SUBJECT>Investigative requirements. </SUBJECT>
            <HD SOURCE="HD1">Investigative Requirements </HD>
            <HD SOURCE="HD2">(XX/XX) </HD>
            <P>(a) NASA reserves the right to perform security checks and to deny or restrict access to a NASA Center, facility, or computer system, or to NASA technical information, as NASA deems appropriate. To the extent the Recipient needs such access for performance of the work, the Recipient shall ensure that individuals needing such access provide the personal background and biographical information requested by NASA. Individuals failing to provide the requested information will be denied such access. </P>
            <P>(b) All requests to visit a NASA Center or facility must be submitted in a timely manner in accordance with instructions provided by that Center or facility. </P>
            
          </SECTION>
        </PART>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20921 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 7510-01-P</BILCOD>
    </PRORULE>
    <PRORULE>
      <PREAMB>
        <PRTPAGE P="48839"/>
        <AGENCY TYPE="N">DEPARTMENT OF THE TREASURY</AGENCY>
        <SUBAGY>Alcohol and Tobacco Tax and Trade Bureau</SUBAGY>
        <CFR>27 CFR Part 9</CFR>
        <RIN>RIN: 1513-AA50</RIN>
        <DEPDOC>[Notice No. 14]</DEPDOC>
        <SUBJECT>Proposed Dundee Hills Viticultural Area (2002R-218P)</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Alcohol and Tobacco Tax and Trade Bureau (TTB), Treasury.</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of proposed rulemaking.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The Alcohol and Tobacco Tax and Trade Bureau proposes to establish the Dundee Hills viticultural area in Yamhill County, Oregon. Located entirely within the established Willamette Valley viticultural area, the proposed Dundee Hills area covers 6,490 acres, of which 1,264 are planted to grapes. We invite comments on this proposal.</P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>We must receive written comments on or before October 14, 2003.</P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>You may send comments to any of the following addresses:</P>
          <P>• Chief, Regulations and Procedures Division, Alcohol and Tobacco Tax and Trade Bureau, PO Box 50221, Washington, DC 20091-0221 (Attn: Notice No. 14);</P>
          <P>• (202) 927-8525 (facsimile);</P>
          <P>• <E T="03">nprm@ttb.gov</E> (e-mail); or</P>
          <P>• <E T="03">http://www.ttb.gov</E> (An online comment form is posted with this notice on our Web site.)</P>

          <P>You may view copies of this notice and any comments received at <E T="03">http://www.ttb.gov/alcohol/rules/</E> or by appointment at the ATF Reference Library, 650 Massachusetts Avenue, NW., Washington, DC 20226; phone (202) 927-7890.</P>
          <P>
            <E T="03">See</E> the “Public Participation” section of this notice for specific instructions and requirements, and for information on how to request a public hearing.</P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>N. A. Sutton, Specialist, Regulations and Procedures Division (Oregon), TTB, 946 NW Circle Blvd., #286, Corvallis, OR 97330; telephone (415) 271-1254.</P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <HD SOURCE="HD1">Background on Viticultural Areas</HD>
        <HD SOURCE="HD2">TTB Authority</HD>
        <P>The Federal Alcohol Administration Act (FAA Act) at 27 U.S.C. 205(e) requires that alcohol beverage labels provide the consumer with adequate information regarding a product's identity, while prohibiting the use of deceptive information on such labels. The FAA Act also authorizes the Secretary of the Treasury to issue regulations to carry out the Act's provisions. The Secretary has delegated this authority to the Alcohol and Tobacco Tax and Trade Bureau (TTB).</P>
        <P>Regulations in 27 CFR part 4, Labeling and Advertising of Wine, allow the establishment of definitive viticultural areas and the use of their names as appellations of origin on wine labels and in wine advertisements. Title 27 CFR part 9, American Viticultural Areas, contains the list of approved viticultural areas.</P>
        <HD SOURCE="HD2">Definition</HD>
        <P>Title 27 CFR 4.25a(e)(1) defines an American viticultural area as a delimited grape-growing region distinguishable by geographic features whose boundaries have been delineated in subpart C of part 9. The establishment of viticultural areas allows the identification of regions where a given quality, reputation, or other characteristics of the wine is essentially attributable to its geographic origin. We believe that the establishment of viticultural areas allows wineries to describe more accurately the origin of their wines to consumers and helps consumers identify the wines they purchase. Establishment of a viticultural area is neither an approval nor endorsement by TTB of the wine produced there.</P>
        <HD SOURCE="HD2">Requirements</HD>
        <P>Section 4.25a(e)(2) outlines the procedure for proposing an American viticultural area. Anyone interested may petition TTB to establish a grape-growing region as a viticultural area. The petition must include—</P>
        <P>• Evidence that the proposed viticultural area is locally and/or nationally known by the name specified in the petition;</P>
        <P>• Historical or current evidence that the boundaries of the proposed viticultural area are as specified in the petition;</P>

        <P>• Evidence that the proposed area's growing conditions, such as climate, soils, elevation, physical features, <E T="03">etc.,</E> distinguish it from surrounding areas;</P>
        <P>• A description of the proposed viticultural area's specific boundaries, based on features found on maps approved by the United States Geological Survey (USGS); and</P>
        <P>• A copy of the appropriate USGS-approved map(s) with the boundaries prominently marked.</P>
        <HD SOURCE="HD2">Impact on Current Wine Labels</HD>
        <P>If this proposed viticultural area is established, bottlers who use brand names like the name of the viticultural area may be affected. Such bottlers must ensure that their existing products are eligible to use the name of the viticultural area as an appellation of origin. For a wine to be eligible, at least 85 percent of the grapes in the wine must have been grown within the viticultural area and must meet the other conditions listed in 27 CFR 4.25a(e)(3).</P>

        <P>If the wine is not eligible to use the appellation, the bottler must change the brand name of that wine and obtain approval of a new label. Different rules apply to a wine in this category bearing a brand name traceable to a label approved before July 7, 1986. <E T="03">See</E> 27 CFR 4.39(i) for details. In addition, if you use the viticultural area name on a wine label in a context other than an appellation of origin, the general prohibitions against misleading representation in 27 CFR part 4 apply.</P>
        <HD SOURCE="HD1">Dundee Hills Petition</HD>
        <P>TTB has received a petition from Mr. Alex Sokol Blosser, secretary of the North Willamette Valley AVA Group, proposing the establishment of a new viticultural area to be called “Dundee Hills” in Yamhill County, Oregon. The petition states that within the 6,490-acre proposed viticultural area, 1,264 acres are currently planted to grapes with another 800 acres available for future vineyard use.</P>
        <P>This proposed area is entirely within the northern portion of the established Willamette Valley viticultural area in northwestern Oregon. It is located about 28 miles southwest of Portland, Oregon, and about 40 miles inland from the Pacific Ocean near the town of Newberg. The township of Dundee straddles the proposed area's eastern border, the Yamhill River runs near its southern boundary, Millican Creek and the Trappist Abbey of Our Lady of Guadalupe anchor its west side, and the Chehalem Valley lies beyond its northern boundary.</P>
        <P>The Dundee Hills rise above the low, flat floors of the surrounding Willamette and Chehalem Valleys. These hills have peaks generally above 700 feet in elevation, with the highest rising to 1,067 feet. The petition states that in addition to their higher elevation, the hills have warmer nighttime temperatures and less low-elevation fog and frost than the surrounding valleys.</P>

        <P>The North Willamette Valley AVA Group originally proposed the name “Red Hills,” but upon learning of other <PRTPAGE P="48840"/>petitioners proposing the same (or a similar) name for other viticultural areas, the Group amended its petitioned name to “Red Hills of Dundee.” After continuing concern, the Group again renamed petitioned area “Dundee Hills” to avoid confusion with other domestic and international “Red Hill” or “Red Hills” viticultural areas.</P>
        <HD SOURCE="HD2">Name Evidence </HD>
        <P>The revised petition states that local residents, vintners, and others know the proposed viticultural area as the “Dundee Hills.” Noting that several area businesses use the Dundee Hills name, the petition includes references to the October 2002 Yamhill County, Oregon, Verizon Super Pages telephone book, which lists “Dundee Hills Estate,” and the “Shop Newberg” Web site, which lists “Dundee Hills Farm.” </P>
        <P>The updated petition also includes over 30 other examples of the proposed name's use from academic journals, magazines, newspapers, and Web sites. These include Ellen C. McCornack's March 1912 Oregon Historical Society Quarterly article, “A Glimpse into Prehistoric Oregon.” The Willamette Valley was, she noted, a large, prehistoric body of water, and that “[a]cross a narrow straight from Chehalem was the island of the Dundee Hills * * *.” </P>
        <P>An article in the fall/winter 1998 issue of Wine Press Northwest, “In with the New World,” lists several pioneer Oregon wine growers, including David Lett, who arrived in 1965 with:</P>
        
        <EXTRACT>
          <FP>a degree in viticulture from the University of California-Davis and a plan to find a cool climate suitable for planting pinot noir and other varieties from Burgundy. Lett decided on the Dundee Hills in the Willamette Valley * * *. Another early pioneer is Dick Erath of Erath Vineyards, also still producing great wine in the Dundee Hills near Newberg. </FP>
        </EXTRACT>
        
        <FP>Fred Delkin, in a 2002 Oregon Magazine article, “Papa Pinot Still Preaching Gospel That Created an Industry,” also notes that, in 1966, Lett planted “Pinot Noir and its cousin, Pinot Gris, in the Dundee hills area.” A November 14, 2002, Seattle Times article, “Wine Is the Main Course this Thanksgiving Celebration,” adds, “Erath Vineyards, high in the Dundee hills, is one of the Willamette Valley's pioneer wineries.” </FP>
        <P>The 1989 Parker's Wine Buyer's Guide (page 814) explains that “Pinot Noir from the Dundee Hills, a subregion of the Willamette Valley, has a more herbaceous, bing-cherry fruitiness.” In Marne Coggan's Vineyards and Winery Management article, “Vineyard Land Values Part 2: What's Happening Beyond the North Coast” (Vol. 27, No. 4, 2001), states: </P>
        
        <EXTRACT>
          <P>The premier Oregon wine growing area is called the Dundee Hills * * * Vacant land values in the Dundee Hills have climbed from $8,000-$10,000 to $10,000-$15,000 per acre. But those prices drop dramatically as you head south toward Salem and the Polk County area, where values are probably half of the Dundee Hills levels. </P>
        </EXTRACT>
        
        <P>In addition, the revised petition contains an October 2001 Oregon Wine Magazine article (page 20) that describes a French-owned gravity-fed winery, Domaine Drouhin, which “clings to the heights of the Dundee Hills.” The revised petition's remaining name evidence contains similar references to Dundee Hills. </P>
        <HD SOURCE="HD2">Boundary Evidence </HD>
        <P>According to the petition, the proposed Dundee Hills viticultural area's boundaries are based on a combination of geographical features, including elevation, terrain, climate, and soil, as well as the modern viticultural history of the area. </P>
        <P>The proposed area consists of a single, continuous uplifted landmass that rises above the surrounding valley floors. The petition states that the level lands along the Willamette River and its tributary, the Yamhill River, define the Dundee Hills to the east and south. Millican Creek, a southward flowing tributary of the Yamhill River, and a smaller drainage flowing north into Chehalem Creek, which empties into the Willamette River, border the hills to the west. The petition notes that the Chehalem Valley defines the hills' northern limits. </P>
        <P>The area's proposed boundary line is an irregular circle encompassing the Dundee Hills. The 200-foot contour line constitutes most of the proposed area's boundary line, which, the petition states, divides the base of the hills' slopes from the surrounding valley floors. On much of its western side, a roadway that varies between 200 and 300 feet in elevation is used in lieu of the 200-foot elevation line, which, the petition notes, meanders far from the logical perimeter of the proposed viticultural area. </P>
        <P>Wine grapes planted in 1969 at Erath Vineyards produced 216 cases of Pinot noir in 1972, and, in 1971, five acres of Pinot noir grapes were planted at the Sokol Blosser vineyard, according to the petition. Statistics from the petition show the viticultural growth of the proposed Dundee Hills area: </P>
        <GPOTABLE CDEF="s50,11,11,11,11" COLS="5" OPTS="L2,i1">
          <TTITLE>Viticulture Growth in Dundee Hills Area </TTITLE>
          <BOXHD>
            <CHED H="1">  </CHED>
            <CHED H="1">Decade ending 1980 </CHED>
            <CHED H="1">Decade ending 1990 </CHED>
            <CHED H="1">Decade ending 2000 </CHED>
            <CHED H="1">As of 2002 </CHED>
          </BOXHD>
          <ROW>
            <ENT I="01">Acreage </ENT>
            <ENT>299 </ENT>
            <ENT>577 </ENT>
            <ENT>1,161 </ENT>
            <ENT>1,264 </ENT>
          </ROW>
          <ROW>
            <ENT I="01">Vineyards </ENT>
            <ENT>13 </ENT>
            <ENT>22 </ENT>
            <ENT>38 </ENT>
            <ENT>44 </ENT>
          </ROW>
        </GPOTABLE>
        <HD SOURCE="HD2">Growing Conditions </HD>
        <P>A combination of elevation, terrain, climate, and soil factors that contrast with the surrounding valley floors define the proposed viticultural area, according to the petition. As noted earlier, the 200-foot contour line defines most of the boundary between the proposed Dundee Hills viticultural area and the surrounding, flatter valley floors. The petition proposes to use a roadway to mark much of the area's western boundary. </P>
        <HD SOURCE="HD3">Elevation and Terrain </HD>
        <P>The proposed area's elevation rises from the 200-foot contour line to the highest hill's peak of 1,067 feet. These heights contrast with the Chehalem and Willamette Valleys, which flank the north, east, and south sides of the proposed area. The petition states that the western boundary line, along Abbey and Kuehne Roads, is marked by a natural depression with drainage south to the Yamhill River via Millican Creek, while a smaller, unnamed drainage flows north into the Chehalem Valley. </P>
        <P>The proposed Dundee Hills viticultural area's topography consists of a north-south spine with ridges and small valleys on the east, south and west sides. This hilly area is above the Willamette and Chehalem Valleys' flood plains. Numerous small streams originate in the hills' higher elevations, according to the petitioner, and the proposed area is dotted with small reservoirs. Light-duty and unimproved dirt roads service the proposed area. </P>

        <P>The petition cites the 5th edition of the “Geology of Oregon” by Elizabeth <PRTPAGE P="48841"/>and William Orr to explain that the geological history of the Dundee Hills area dates back 66 million years with the uplifting of the North American tectonic plate, which formed the Coast Range of mountains and the inland ridges and valleys. Lava flows, dating back 15 million years, pushed into the area from northeast Oregon, depositing Columbia River basalts and restructuring the landscape with hills and broken ridges, according to the petition. </P>
        <P>To the west, the Coast Range, a huge uplifted landmass paralleling the Pacific Ocean coastline, provides a rain shadow for the Dundee Hills proposed viticultural area, according to the petition. The Yamhill-Carlton area is between the petitioned area and the Coast Range, to the immediate northwest and west of the Dundee Hills area. The petition notes that the Yamhill-Carlton area has small uplifted slopes that drain entirely into the Yamhill River system, while only the west side of the Dundee Hills area drains into this watershed. </P>
        <P>To the north, the petition states that the Chehalem Mountains, with an east to west orientation, have a large footprint covering more land surface area than the proposed viticultural area. Taller than the Dundee Hills, these mountains provide some protection to the petitioned area from climatic extremes created by the Columbia River Gorge to the north. </P>
        <P>The petition also explains that to the east and immediate south of the proposed area, the lower-elevation Willamette Valley floor has different growing conditions and is subject to standing water in the winter and spring. </P>
        <P>The petitioner adds that the Eola Hills, 20 miles south of the proposed Dundee Hills viticultural area, have a north-south orientation, a large footprint, and a strong marine climate. The Van Duzer Corridor, a mountain gap in the Coast Range, pushes the cooling marine summer breezes inland toward the Eola Hills area and Salem, Oregon. </P>
        <HD SOURCE="HD3">Climate </HD>
        <P>The petition also examines the differences in climate between the proposed Dundee Hills viticultural area and the surrounding regions. The petition states that the Dundee Hills is a foothill area protected from great climatic variations, with warmer nights and less frost than the adjacent valley floors. The mountain ranges to the west and north lessen the climatic effect of the strong Pacific Ocean winds and storms. These mountain ranges also lessen the influence of the Columbia River Gorge effect. </P>
        <P>In examining these climatic differences, the petition notes, for example, that the proposed Dundee Hills viticultural area lies in the rain shadow of the Coast Range. The proposed viticultural area receives 30 to 45 inches of rain annually, while the Coast Range annually receives 90 to 135 inches, about three times as much rain as the proposed area. The Coast Range is also cooler in the summer and warmer in the winter, the petition comments, based on its proximity to the Pacific Ocean's marine influence. It also states that this mountain range buffers the proposed area from the Pacific Ocean's heavy rainfall pattern, windy storms, and temperature-moderating marine influence. </P>
        <P>The Yamhill-Carlton area is located between the Coast Range and the Dundee Hills proposed viticultural area. This district averages 60 inches of annual precipitation, has 150 fewer degree-growing days, and receives a stronger marine influence, with more wind and rainfall, than the proposed Dundee Hills viticultural area, according to the petitioner. </P>
        <P>The petition also explains that the Columbia River Gorge funnels cold air in the winter, and warm air in the summer, into the Willamette Valley area from the interior of northern Oregon. With the Chehalem Mountains standing between the Columbia River Gorge and the proposed Dundee Hills viticultural area, the petition notes that these large mountains protect the petitioned area from the climatic influences of the Columbia River Gorge weather effect. </P>
        <P>In addition, the petitioner states that the Willamette Valley floor, to the east and south of the Dundee Hills area, has seasonal fog and frost. Cool night air drains from the higher elevation hillsides onto the valley floor, creating fall and spring fog and frost. </P>
        <P>The petition also explains that the Eola Hills, 20 miles to the south, receive a strong cooling marine influence that pushes inland from the Pacific Ocean through the Van Duzer Corridor, an opening in the Coast Range. This marine effect loses most of its cooling benefit before reaching north to the proposed Dundee Hills area, according to the petition. </P>
        <HD SOURCE="HD3">Soils </HD>
        <P>The petition relies on the “Soil Survey of the Yamhill Area, Oregon,” issued by the U.S. Department of Agriculture's Soil Conservation Service in January 1974 for its evidence regarding the proposed viticultural area's soils. The petition states that the reddish color in the proposed area's soil is derived from the Columbia River basalt lavas, including the Jory soil series that covers approximately 80 percent of the proposed area. These lava-based soils decompose quickly with the high rain levels of the northwest Oregon area and produce the Jory series reddish silt, clay, and loam soils. This soil series, found predominantly on the Dundee Hills's eastern side, is moderately fertile and well-drained, with slight to moderate erosion levels, according to the petition. </P>
        <P>The petition adds that the west side of the proposed viticultural area, with its steeper slopes, is primarily covered by the sedimentary-derived Willakenzie soil series. This series is categorized as well drained with moderate to high erosion levels. A smaller amount of the Jory series exists on the area's western side where the Columbia River lava flows cover the sedimentary formations, the petition notes. </P>
        <P>The petition states that, outside the petitioned area's boundaries, the soils of the Coast Range, the Yamhill-Carlton area, the Chehalem Mountains, the Willamette Valley floor, and the Eola Hills contrast with the soils found within the proposed Dundee Hills viticultural area. The petition explains that the Coast Range to the west has marine volcanic and sediment soils, with high water holding capacity silts and basalt layers sandwiched between marine sediments. The Yamhill-Carlton area, to the west and northwest, has soils derived from marine sediments and ocean floor volcanic basalt with high water holding capacity. The Chehalem Mountains, to the north and northeast, have the Columbia River basalt, ocean sedimentation, and wind-blown loess derivation soil types. The Willamette Valley floor, to the east and south, has deep, alluvial soils with high water holding capacity. The Eola Hills area, to the south, has predominantly Gelderman and Ritner basalt soil series that are characterized by their low water holding capacity, slow permeability, and moderate erosion level. </P>
        <HD SOURCE="HD2">Boundary Description </HD>

        <P>The proposed Dundee Hills viticultural area covers 6,490 acres, of which 1,264 acres are planted to wine grapes. It is located entirely within the established Willamette Valley viticultural area and Yamhill County, Oregon. The area is west of the town of Newberg, approximately 28 miles southwest of Portland and 40 miles east and inland from the Pacific Ocean coastline. Portions of the townships of Dundee and Lafayette are included within the proposed area where the 200-<PRTPAGE P="48842"/>foot contour line crosses their boundaries of incorporation. </P>
        <P>Oregon State Route 99W, a heavy-duty road to the east and south, and State Route 240, a medium-duty road to the north, are generally outside the proposed boundary line, but occasionally cross into the proposed Dundee Hills viticultural area. See the narrative boundary description in the proposed regulation below. </P>
        <HD SOURCE="HD2">Maps </HD>
        <P>The USGS maps required for determining the boundary of the proposed Dundee Hills viticultural area are: (1) Dundee Quadrangle, Oregon, 7.5 Minute Series, 1956, revised 1993; (2) Newberg Quadrangle, Oregon, 7.5 Minute Series, 1961, photorevised 1985; and (3) Dayton Quadrangle, Oregon, 7.5 Minute Series, 1957, revised 1992. The petitioner submitted the required maps, and we list them in the proposed regulation below. </P>
        <HD SOURCE="HD1">Public Participation </HD>
        <HD SOURCE="HD2">Comments Sought </HD>
        <P>We request comments from anyone interested. Please support your comments with specific information about the proposed area's name, growing conditions, or boundaries. All comments must include your name and mailing address, reference this notice number, and be legible and written in language acceptable for public disclosure. </P>
        <P>Although we do not acknowledge receipt, we will consider your comments if we receive them on or before the closing date. We will consider comments received after the closing date if we can. We regard all comments as originals. </P>
        <HD SOURCE="HD2">Confidentiality </HD>
        <P>We do not recognize any submitted material as confidential. All comments are part of the public record and subject to disclosure. Do not enclose in your comments any material you consider confidential or inappropriate for disclosure. </P>
        <HD SOURCE="HD2">Submitting Comments </HD>
        <P>You may submit comments in any of four ways:</P>
        <P>• <E T="03">By mail:</E> You may send written comments to TTB at the address listed in the <E T="02">ADDRESSES</E> section. </P>
        <P>• <E T="03">By facsimile:</E> You may submit comments by facsimile transmission to 202-927-8525. Faxed comments must—</P>
        <P>(1) Be on 8.5- by 11-inch paper; </P>
        <P>(2) Contain a legible, written signature; and </P>
        <P>(3) Be five or less pages long. This limitation assures electronic access to our equipment. We will not accept faxed comments that exceed five pages. </P>
        <P>• <E T="03">By e-mail:</E> You may e-mail comments to <E T="03">nprm@ttb.gov.</E> Comments transmitted by electronic-mail must—</P>
        <P>(1) Contain your e-mail address; </P>
        <P>(2) Reference this notice number on the subject line; and </P>
        <P>(3) Be legible when printed on 8.5- by 11-inch paper. </P>
        <P>• <E T="03">By online form:</E> We provide a comment form with the online copy of this notice on our Web site at <E T="03">http://www.ttb.gov/alcohol/rules/.</E> Select “Send comments via e-mail” under this notice number. </P>
        <P>You may also write to the Administrator before the comment closing date to ask for a public hearing. The Administrator reserves the right to determine, in light of all circumstances, whether a public hearing will be held. </P>
        <HD SOURCE="HD2">Disclosure </HD>
        <P>You may view copies of the petition, the proposed regulation, the appropriate maps, and any comments received by appointment at the ATF Reference Library, 650 Massachusetts Avenue, NW., Washington, DC 20226. You may also obtain copies at 20 cents per 8.5-x 11-inch page. Contact the ATF Librarian at the above address or telephone 202-927-7890 to schedule an appointment or to request copies of comments. </P>

        <P>For your convenience, we will post this notice and the comments received on the TTB Web site. All posted comments will show the names of commenters but not street addresses, telephone numbers, or e-mail addresses. We may also omit voluminous attachments or material that we consider unsuitable for posting. In all cases, the full comment will be available in the TTB Reference Library. To access the online copy of this notice, visit <E T="03">http://www.ttb.gov/alcohol/rules/</E> and select the “View Comments” link under this notice number to view the posted comments. </P>
        <HD SOURCE="HD1">Regulatory Analyses and Notices </HD>
        <HD SOURCE="HD2">Paperwork Reduction Act </HD>
        <P>We propose no requirement to collect information. Therefore, the provisions of the Paperwork Reduction Act of 1995, 44 U.S.C. 3507, and its implementing regulations, 5 CFR part 1320, do not apply. </P>
        <HD SOURCE="HD2">Regulatory Flexibility Act </HD>
        <P>We certify that this proposed regulation, if adopted, will not have a significant economic impact on a substantial number of small entities. This proposed regulation imposes no new reporting, recordkeeping, or other administrative requirement. Any benefit derived from the use of a viticultural area name would be the result of a proprietor's efforts and consumer acceptance of wines from that area. Therefore, no regulatory flexibility analysis is required. </P>
        <HD SOURCE="HD2">Executive Order 12866 </HD>
        <P>This proposed rule is not a significant regulatory action as defined by Executive Order 12866, 58 FR 51735. Therefore, it requires no regulatory assessment. </P>
        <HD SOURCE="HD1">Drafting Information </HD>
        <P>The principal author of this document is N.A. Sutton (Oregon), Regulations and Procedures Division, Alcohol and Tobacco Tax and Trade Bureau. </P>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects in 27 CFR Part 9 </HD>
          <P>Wine.</P>
        </LSTSUB>
        <HD SOURCE="HD1">Authority and Issuance </HD>
        <P>For the reasons discussed in the preamble, we propose to amend Title 27, Code of Federal Regulations, Part 9, American Viticultural Areas, as follows: </P>
        <PART>
          <HD SOURCE="HED">PART 9—AMERICAN VITICULTURAL AREAS </HD>
          <P>1. The authority citation for part 9 continues to read as follows: </P>
          <AUTH>
            <HD SOURCE="HED">Authority:</HD>
            <P>27 U.S.C. 205. </P>
          </AUTH>
          
          <P>2. Subpart C is amended by adding § 9.____ to read as follows: </P>
          <SUBPART>
            <HD SOURCE="HED">Subpart C—Approved American Viticultural Areas </HD>
            <SECTION>
              <SECTNO>§ 9.____ </SECTNO>
              <SUBJECT>Dundee Hills. </SUBJECT>
              <P>(a) The name of the viticultural area described in this section is “Dundee Hills”. </P>
              <P>(b) <E T="03">Approved maps.</E> The appropriate maps for determining the boundaries of the Dundee Hills viticultural area are three 1:24,000 Scale U.S.G.S. topography maps. They are titled: </P>
              <P>(1) Dundee Quadrangle, Oregon, 1956, revised 1993; </P>
              <P>(2) Newberg Quadrangle, Oregon, 1961, photorevised 1985; </P>
              <P>(3) Dayton Quadrangle, Oregon, 1957, revised 1992. </P>
              <P>(c) <E T="03">Boundaries.</E> The Dundee Hills viticultural area is located entirely within the Willamette Valley viticultural area and Yamhill County, Oregon, near the town of Newberg. </P>

              <P>(1) Beginning on the Dundee Quadrangle map at the intersection of the 200-foot contour line with Kuehne Road at the common boundary line of Section 47 and 48, T3S, R3W, proceed east, followed by south, along the <PRTPAGE P="48843"/>meandering 200-foot contour line, crossing over to and back off the Newberg Quadrangle map, and then cutting diagonally southwest through Dundee township to Hess Creek, Section 34, T3S, R3W (Dundee Quadrangle); then </P>
              <P>(2) Proceed south, followed by west and then northeast, along the meandering 200-foot contour line, twice crossing over to and back off the Dayton Quadrangle map, to its intersection with Abbey Road after the 200-foot contour line passes a quarry and crosses the two forks of Millican Creek in Section 52, T3S, R3W (Dundee Quadrangle); then </P>
              <P>(3) Proceed generally north on Abbey Road to Kuehne Road and follow Kuehne Road northeast, returning to the point of beginning. </P>
            </SECTION>
          </SUBPART>
          <SIG>
            <DATED>Signed: August 5, 2003. </DATED>
            <NAME>Arthur J. Libertucci, </NAME>
            <TITLE>Administrator. </TITLE>
          </SIG>
        </PART>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20914 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4810-31-P</BILCOD>
    </PRORULE>
    <PRORULE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF LABOR </AGENCY>
        <SUBAGY>Occupational Safety and Health Administration </SUBAGY>
        <CFR>29 CFR Part 1926 </CFR>
        <DEPDOC>[Docket No. S-030] </DEPDOC>
        <RIN>RIN 1218-AC01 </RIN>
        <SUBJECT>Safety Standards for Cranes and Derricks </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Occupational Safety and Health Administration (OSHA), U.S. Department of Labor. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of the second meeting of the Negotiated Rulemaking Committee. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The Occupational Safety and Health Administration (OSHA) announces the second meeting of the Crane and Derrick Negotiated Rulemaking Advisory Committee (C-DAC). The Committee will review summary notes of the first meeting, adopt ground rules (including a definition of consensus) and continue to address substantive issues. The meeting will be open to the public. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>The meeting will be on September 3, 4, 5, 2003. It will begin each day at 8:30 a.m. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>The meeting will be held at the U.S. Department of Labor, 200 Constitution Avenue, NW., Washington, DC 20210. The September 3rd session will be in conference room C5310-1A/B. The September 4th and 5th sessions will be in conference room N3437 A, B and C. </P>
          <P>Written comments to the Committee may be submitted in any of three ways: by mail, by fax, or by e-mail. Please include “Docket No. S-030” on all submissions. </P>
          <P>By mail, submit three (3) copies to: OSHA Docket Office, Docket No. S-030, U.S. Department of Labor, 200 Constitution Avenue, NW., Room N-2625, Washington, DC 20210, telephone (202) 693-2350. Note that receipt of comments submitted by mail may be delayed by several weeks. </P>
          <P>By fax, written comments that are 10 pages or fewer may be transmitted to the OSHA Docket Office at fax number (202) 693-1648. </P>

          <P>Electronically, comments may be submitted through OSHA's Web page at <E T="03">http://ecomments.osha.gov</E>. Please note that you may not attach materials such as studies or journal articles to your electronic comments. If you wish to include such materials, you must submit three copies to the OSHA Docket Office at the address listed above. When submitting such materials to the OSHA Docket Office, clearly identify your electronic comments by name, date, subject, and Docket Number, so that we can attach the materials to your electronic comments. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Michael Buchet, Office of Construction Standards and Guidance, Occupational Safety and Health Administration, U.S. Department of Labor, Room N-3468, 200 Constitution Avenue, NW., Washington, DC 20210; Telephone: (202) 693-2345. </P>
          <EXTRACT>
            <HD SOURCE="HD1">Table of Contents </HD>
            <FP SOURCE="FP-2">I. Background </FP>
            <FP SOURCE="FP-2">II. Agenda </FP>
            <FP SOURCE="FP-2">III. Anticipated Key Issues for Negotiation </FP>
            <FP SOURCE="FP-2">IV. Public Participation </FP>
          </EXTRACT>
          <HD SOURCE="HD1">I. Background </HD>

          <P>On July 16, 2002, OSHA published a notice of intent to establish a negotiated rulemaking committee, requesting comments and nominations for membership (Volume 67 of the <E T="04">Federal Register</E>, page 46612). In subsequent notices the Department of Labor announced the establishment of the Committee (Volume 68 of the <E T="04">Federal Register</E>, page 35172, June 12, 2003), requested comments on a list of proposed members (68 FR 9036, February 27, 2003), published a final membership list (68 FR 39877, July 3, 2003), and announced the first meeting, (68 FR 39880, July 3, 2003), which was held July 30-August 1, 2003. </P>
          <HD SOURCE="HD1">II. Agenda </HD>
          <P>The Committee will address the schedule for future meetings, adopt ground rules, review draft text prepared by the Agency on issues discussed at the first meeting, and address additional issues. </P>
          <HD SOURCE="HD1">III. Anticipated Key Issues for Negotiation </HD>
          <P>OSHA anticipates that key issues to be addressed will include: </P>
          <P>1. The identification/description of what constitutes “cranes and derricks” for purposes of determining the equipment that will be covered by the proposed rule. </P>
          <P>2. Qualifications of individuals who operate, maintain, repair, assemble, and disassemble cranes and derricks. </P>
          <P>3. Work zone control. </P>
          <P>4. Crane operations near electric power lines. </P>
          <P>5.Qualifications of signal-persons and communication systems and requirements. </P>
          <P>6. Load capacity and control procedures. </P>
          <P>7. Wire rope criteria. </P>
          <P>8. Crane inspection/certification records. </P>
          <P>9. Rigging procedures. </P>
          <P>10. Requirements for fail-safe, warning, and other safety-related devices/technologies. </P>
          <P>11. Verification criteria for the structural adequacy of crane components. </P>
          <P>12. Stability testing requirements. </P>
          <P>13. Blind pick procedures. </P>
          <HD SOURCE="HD1">IV. Public Participation </HD>
          <P>All interested parties are invited to attend this public meeting at the time and place indicated above. Note, however, that a government issued photo ID card (State or Federal) is required for entry into the Department of Labor building. No advanced registration is required. The public must enter the Department of Labor for this meeting through the 3rd and C Street, NW entrance. Seating will be available to the public on a first-come, first-served basis. Individuals with disabilities wishing to attend should contact Luz DelaCruz by telephone at 202-693-2020 or by fax at 202-693-1689 to obtain appropriate accommodations no later than Wednesday, August 20, 2003. The C-DAC meeting is expected to last two and a half days. </P>

          <P>In addition, members of the general public may request an opportunity to make oral presentations to the Committee. The Facilitator has the authority to decide to what extent oral presentations by members of the public may be permitted at the meeting. Oral presentations will be limited to statements of fact and views, and shall not include any questioning of the <PRTPAGE P="48844"/>committee members or other participants. </P>
          <P>Minutes of the meetings and materials prepared for the Committee will be available for public inspection at the OSHA Docket Office, N-2625, 200 Constitution Ave., NW., Washington, DC 20210; Telephone (202) 693-2350. </P>
          <P>The Facilitator, Susan Podziba, can be reached at Susan Podziba and Associates, 21 Orchard Road, Brookline, MA 02445; telephone (617) 738-5320, fax (617) 738-6911. </P>
          <SIG>
            <DATED>Signed at Washington, DC, this 8th day of August, 2003. </DATED>
            <NAME>John L. Henshaw, </NAME>
            <TITLE>Assistant Secretary of Labor for Occupational Safety and Health. </TITLE>
          </SIG>
        </FURINF>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20856 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4510-26-U</BILCOD>
    </PRORULE>
    <PRORULE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF THE INTERIOR </AGENCY>
        <SUBAGY>Office of Surface Mining Reclamation and Enforcement </SUBAGY>
        <CFR>30 CFR Part 943 </CFR>
        <DEPDOC>[TX-050-FOR] </DEPDOC>
        <SUBJECT>Texas Regulatory Program </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Office of Surface Mining Reclamation and Enforcement, Interior. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Proposed rule; public comment period and opportunity for public hearing on proposed amendment. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>We, the Office of Surface Mining Reclamation and Enforcement (OSM), are announcing receipt of a proposed amendment to the Texas regulatory program (Texas program) under the Surface Mining Control and Reclamation Act of 1977 (SMCRA or the Act). Texas proposes revisions to its regulations regarding annual permit fees. Texas intends to revise its program to improve operational efficiency. </P>
          <P>This document gives the times and locations that the Texas program and proposed amendment to that program are available for your inspection, the comment period during which you may submit written comments on the amendment, and the procedures that we will follow for the public hearing, if one is requested. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>We will accept written comments on this amendment until 4 p.m., c.d.t., September 15, 2003. If requested, we will hold a public hearing on the amendment on September 9, 2003. We will accept requests to speak at a hearing until 4 p.m., c.d.t. on September 2, 2003. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>You should mail or hand deliver written comments and requests to speak at the hearing to Michael C. Wolfrom, Director, Tulsa Field Office, at the address listed below. </P>
          <P>You may review copies of the Texas program, this amendment, a listing of any scheduled public hearings, and all written comments received in response to this document at the addresses listed below during normal business hours, Monday through Friday, excluding holidays. You may receive one free copy of the amendment by contacting OSM's Tulsa Field Office. </P>
          

          <FP SOURCE="FP-1">Michael C. Wolfrom, Director, Tulsa Field Office, Office of Surface Mining Reclamation and Enforcement, 5100 East Skelly Drive, Suite 470, Tulsa, Oklahoma 74135-6547, Telephone: (918) 581-6430, Internet address: <E T="03">mwolfrom@osmre.gov</E>
          </FP>
          <FP SOURCE="FP-1">Surface Mining and Reclamation Division, Railroad Commission of Texas, 1701 North Congress Avenue, Capitol Station, P.O. Box 12967, Austin, Texas 78711-2967, Telephone: (512) 463-6900 </FP>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>

          <P>Michael C. Wolfrom, Director, Tulsa Field Office. Telephone: (918) 581-6430. Internet address: <E T="03">mwolfrom@osmre.gov.</E>
          </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        
        <EXTRACT>
          <FP SOURCE="FP-2">I. Background on the Texas Program </FP>
          <FP SOURCE="FP-2">II. Description of the Proposed Amendment </FP>
          <FP SOURCE="FP-2">III. Public Comment Procedures </FP>
          <FP SOURCE="FP-2">IV. Procedural Determinations </FP>
        </EXTRACT>
        <HD SOURCE="HD1">I. Background on the Texas Program </HD>

        <P>Section 503(a) of the Act permits a State to assume primacy for the regulation of surface coal mining and reclamation operations on non-Federal and non-Indian lands within its borders by demonstrating that its program includes, among other things, “a State law which provides for the regulation of surface coal mining and reclamation operations in accordance with the requirements of this Act * * *; and rules and regulations consistent with regulations issued by the Secretary pursuant to this Act.” See 30 U.S.C. 1253(a)(1) and (7). On the basis of these criteria, the Secretary of the Interior conditionally approved the Texas program effective February 16, 1980. You can find background information on the Texas program, including the Secretary's findings, the disposition of comments, and the conditions of approval of the Texas program in the February 27, 1980, <E T="04">Federal Register</E> (45 FR 12998). You can also find later actions concerning the Texas program and program amendments at 30 CFR 943.10, 943.15 and 943.16. </P>
        <HD SOURCE="HD1">II. Description of the Proposed Amendment </HD>

        <P>By letter dated July 10, 2003 (Administrative Record No. TX-655), Texas sent us an amendment to its program under SMCRA (30 U.S.C. 1201 <E T="03">et seq.</E>). Texas sent the amendment at its own initiative. Below is the full text of the proposed revised regulation. </P>
        <SECTION>
          <SECTNO>§ 12.108 </SECTNO>
          <SUBJECT>Permit Fees. </SUBJECT>
          <EXTRACT>
            <P>(a) Each application for a surface coal mining and reclamation permit or renewal or revision of a permit shall be accompanied by a fee. The initial application fee and the application fee for renewal of a permit may be paid in equal annual installments during the term of the permit. The fee schedule is as follows: </P>
            <P>(1) application for a permit”—$5,000.00 </P>
            <P>(2) application for revision of a permit—$500.00 </P>
            <P>(3) application for renewal of a permit—$3,000.00 </P>
            <P>(b) In addition to application fees required by this section, each permittee shall pay to the Commission an annual fee in the amount of $300 for each acre of land within the permit area on which the permittee actually conducted operations for the removal of coal and lignite during the calendar year. The total amount of this fee is due and payable not later than March 15th of the year following the year of removal operations. For calendar year 2003 only, the annual fee shall be calculated as follows: for each acre of land on which the permittee actually conducted operations for the removal of coal and lignite during the period January 1, 2003 through August 31, 2003, the permittee shall pay to the Commission an annual fee of $120 per acre. For each acre of land on which the permittee actually conducted operations for the removal of coal and lignite during the period September 1, 2003, through December 31, 2003, the permittee shall pay to the Commission an annual fee of $300 per acre. </P>
            <P>(c) Fees paid to the Commission under this section shall be deposited in the State treasury and credited to the general revenue fund. </P>
          </EXTRACT>
          <HD SOURCE="HD1">III. Public Comment Procedures </HD>
          <P>Under the provisions of 30 CFR 732.17(h), we are seeking your comments on whether the amendment satisfies the applicable program approval criteria of 30 CFR 732.15. If we approve the amendment, it will become part of the State program. </P>
          <HD SOURCE="HD2">Written Comments </HD>

          <P>Send your written or electronic comments to OSM at the address given above. Your written comments should be specific, pertain only to the issues proposed in this rulemaking, and include explanations in support of your recommendations. We will not consider or respond to your comments when developing the final rule if they are received after the close of the comment period (<E T="03">see</E>
            <E T="02">DATES</E>). We will make every <PRTPAGE P="48845"/>attempt to log all comments into the administrative record, but comments delivered to an address other than the Tulsa Field Office may not be logged in. </P>
          <HD SOURCE="HD2">Electronic Comments </HD>
          <P>Please submit Internet comments as an ASCII or Word file avoiding the use of special characters and any form of encryption. Please also include “Attn: TX-050-FOR” and your name and return address in your Internet message. If you do not receive a confirmation that we have received your Internet message, contact the Tulsa Field Office at (918) 581-6430. </P>
          <HD SOURCE="HD2">Availability of Comments </HD>
          <P>We will make comments, including names and addresses of respondents, available for public review during normal business hours. We will not consider anonymous comments. If individual respondents request confidentiality, we will honor their request to the extent allowable by law. Individual respondents who wish to withhold their name or address from public review, except for the city or town, must state this prominently at the beginning of their comments. We will make all submissions from organizations or businesses, and from individuals identifying themselves as representatives or officials of organizations or businesses, available for public review in their entirety. </P>
          <HD SOURCE="HD2">Public Hearing </HD>

          <P>If you wish to speak at the public hearing, contact the person listed under <E T="02">FOR FURTHER INFORMATION CONTACT</E> by 4 p.m., c.d.t. on September 2, 2003. If you are disabled and need special accommodations to attend a public hearing, contact the person listed under <E T="02">FOR FURTHER INFORMATION CONTACT.</E> We will arrange the location and time of the hearing with those persons requesting the hearing. If no one requests an opportunity to speak, we will not hold a hearing. </P>
          <P>To assist the transcriber and ensure an accurate record, we request, if possible, that each person who speaks at the public hearing provide us with a written copy of his or her comments. The public hearing will continue on the specified date until everyone scheduled to speak has been given an opportunity to be heard. If you are in the audience and have not been scheduled to speak and wish to do so, you will be allowed to speak after those who have been scheduled. We will end the hearing after everyone scheduled to speak and others present in the audience who wish to speak, have been heard. </P>
          <HD SOURCE="HD2">Public Meeting </HD>

          <P>If only one person requests an opportunity to speak, we may hold a public meeting rather than a public hearing. If you wish to meet with us to discuss the amendment, please request a meeting by contacting the person listed under <E T="02">FOR FURTHER INFORMATION CONTACT.</E> All such meetings are open to the public and, if possible, we will post notices of meetings at the locations listed under <E T="02">ADDRESSES.</E> We will make a written summary of each meeting a part of the administrative record. </P>
          <HD SOURCE="HD1">IV. Procedural Determinations </HD>
          <HD SOURCE="HD2">Executive Order 12630—Takings </HD>
          <P>This rule does not have takings implications. This determination is based on the analysis performed for the counterpart Federal regulation. </P>
          <HD SOURCE="HD2">Executive Order 12866—Regulatory Planning and Review </HD>
          <P>This rule is exempted from review by the Office of Management and Budget (OMB) under Executive Order 12866. </P>
          <HD SOURCE="HD2">Executive Order 12988—Civil Justice Reform </HD>
          <P>The Department of the Interior has conducted the reviews required by section 3 of Executive Order 12988 and has determined that this rule meets the applicable standards of subsections (a) and (b) of that section. However, these standards are not applicable to the actual language of State regulatory programs and program amendments because each program is drafted and promulgated by a specific State, not by OSM. Under sections 503 and 505 of SMCRA (30 U.S.C. 1253 and 1255) and the Federal regulations at 30 CFR 730.11, 732.15, and 732.17(h)(10), decisions on proposed State regulatory programs and program amendments submitted by the States must be based solely on a determination of whether the submittal is consistent with SMCRA and its implementing Federal regulations and whether the other requirements of 30 CFR Parts 730, 731, and 732 have been met. </P>
          <HD SOURCE="HD2">Executive Order 13132—Federalism </HD>
          <P>This rule does not have Federalism implications. SMCRA delineates the roles of the Federal and State governments with regard to the regulation of surface coal mining and reclamation operations. One of the purposes of SMCRA is to “establish a nationwide program to protect society and the environment from the adverse effects of surface coal mining operations.” Section 503(a)(1) of SMCRA requires that State laws regulating surface coal mining and reclamation operations be “in accordance with” the requirements of SMCRA, and section 503(a)(7) requires that State programs contain rules and regulations “consistent with” regulations issued by the Secretary pursuant to SMCRA. </P>
          <HD SOURCE="HD2">Executive Order 13175—Consultation and Coordination With Indian Tribal Governments </HD>
          <P>In accordance with Executive Order 13175, we have evaluated the potential effects of this rule on Federally-recognized Indian tribes and have determined that the rule does not have substantial direct effects on one or more Indian tribes, on the relationship between the Federal Government and Indian tribes, or on the distribution of power and responsibilities between the Federal Government and Indian tribes. This determination is based on the fact that the Texas program does not regulate coal exploration and surface coal mining and reclamation operations on Indian lands. Therefore, the Texas program has no effect on Federally-recognized Indian tribes. </P>
          <HD SOURCE="HD2">Executive Order 13211—Regulations That Significantly Affect The Supply, Distribution, or Use of Energy </HD>
          <P>On May 18, 2001, the President issued Executive Order 13211 which requires agencies to prepare a Statement of Energy Effects for a rule that is (1) considered significant under Executive Order 12866, and (2) likely to have a significant adverse effect on the supply, distribution, or use of energy. Because this rule is exempt from review under Executive Order 12866 and is not expected to have a significant adverse effect on the supply, distribution, or use of energy, a Statement of Energy Effects is not required. </P>
          <HD SOURCE="HD2">National Environmental Policy Act </HD>
          <P>This rule does not require an environmental impact statement because section 702(d) of SMCRA (30 U.S.C. 1292(d)) provides that agency decisions on proposed State regulatory program provisions do not constitute major Federal actions within the meaning of section 102(2)(C) of the National Environmental Policy Act (42 U.S.C. 4332(2)(C)). </P>
          <HD SOURCE="HD2">Paperwork Reduction Act </HD>

          <P>This rule does not contain information collection requirements that require approval by OMB under the Paperwork Reduction Act (44 U.S.C. 3507 <E T="03">et seq.</E>). <PRTPAGE P="48846"/>
          </P>
          <HD SOURCE="HD2">Regulatory Flexibility Act </HD>

          <P>The Department of the Interior certifies that this rule will not have a significant economic impact on a substantial number of small entities under the Regulatory Flexibility Act (5 U.S.C. 601 <E T="03">et seq.</E>). The State submittal, which is the subject of this rule, is based upon counterpart Federal regulations for which an economic analysis was prepared and certification made that such regulations would not have a significant economic effect upon a substantial number of small entities. In making the determination as to whether this rule would have a significant economic impact, the Department relied upon the data and assumptions for the counterpart Federal regulations. </P>
          <HD SOURCE="HD2">Small Business Regulatory Enforcement Fairness Act </HD>
          <P>This rule is not a major rule under 5 U.S.C. 804(2), the Small Business Regulatory Enforcement Fairness Act. This rule: (a) Does not have an annual effect on the economy of $100 million; (b) Will not cause a major increase in costs or prices for consumers, individual industries, Federal, State, or local government agencies, or geographic regions; and (c) Does not have significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete with foreign-based enterprises. This determination is based upon the fact that the State submittal, which is the subject of this rule, is based upon counterpart Federal regulations for which an analysis was prepared and a determination made that the Federal regulation was not considered a major rule. </P>
          <HD SOURCE="HD2">Unfunded Mandates </HD>
          <P>This rule will not impose an unfunded mandate on State, local, or tribal governments or the private sector of $100 million or more in any given year. This determination is based upon the fact that the State submittal, which is the subject of this rule, is based upon counterpart Federal regulations for which an analysis was prepared and a determination made that the Federal regulation did not impose an unfunded mandate. </P>
        </SECTION>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects in 30 CFR Part 943 </HD>
          <P>Intergovernmental relations, Surface mining, Underground mining.</P>
        </LSTSUB>
        <SIG>
          <DATED>Dated: July 25, 2003. </DATED>
          <NAME>Nancy L. Shaw, </NAME>
          <TITLE>Acting Regional Director, Mid-Continent Regional Coordinating Center. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20915 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4310-05-P</BILCOD>
    </PRORULE>
    <PRORULE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF HOMELAND SECURITY </AGENCY>
        <SUBAGY>Coast Guard </SUBAGY>
        <CFR>33 CFR Part 100 </CFR>
        <DEPDOC>[CGD05-03-109] </DEPDOC>
        <RIN>RIN 1625-AA08 </RIN>
        <SUBJECT>Special Local Regulations for Marine Events; Sunset Lake, Wildwood Crest, NJ </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Coast Guard, DHS. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of proposed rulemaking. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The Coast Guard proposes to establish temporary special local regulations during the “Sunset Lake Hydrofest”, a marine event to be held September 27 and 28, 2003, on the waters of Sunset Lake, Wildwood Crest, New Jersey. These special local regulations are necessary to provide for the safety of life on navigable waters during the event. This action is intended to restrict vessel traffic in portions of Sunset Lake during the events. </P>
        </SUM>
        <EFFDATE>
          <HD SOURCE="HED">DATES:</HD>
          <P>Comments and related material must reach the Coast Guard on or before September 15, 2003. </P>
        </EFFDATE>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>You may mail comments and related material to Commander (oax), Fifth Coast Guard District, 431 Crawford Street, Portsmouth, Virginia 23704-5004, hand-deliver them to Room 119 at the same address between 9 a.m. and 2 p.m., Monday through Friday, except Federal holidays, or fax them to (757) 398-6203. The Auxiliary and Recreational Boating Safety Branch, Fifth Coast Guard District, maintains the public docket for this rulemaking. Comments and material received from the public, as well as documents indicated in this preamble as being available in the docket, will become part of this docket and will be available for inspection or copying at the above address between 9 a.m. and 2 p.m., Monday through Friday, except Federal holidays. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>S. L. Phillips, Project Manager, Auxiliary and Recreational Boating Safety Branch, at (757) 398-6204. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <HD SOURCE="HD1">Request for Comments </HD>
        <P>We encourage you to participate in this rulemaking by submitting comments and related material. If you do so, please include your name and address, identify the docket number for this rulemaking (CGD05-03-109), indicate the specific section of this document to which each comment applies, and give the reason for each comment. Please submit all comments and related material in an unbound format, no larger than 8<FR>1/2</FR> by 11 inches, suitable for copying. If you would like to know they reached us, please enclose a stamped, self-addressed postcard or envelope. We will consider all comments and material received during the comment period. We may change this proposed rule in view of them. </P>

        <P>In order to provide notice and an opportunity to comment before issuing an effective rule, we are providing a shorter than normal comment period. A 30-day comment period is sufficient to allow those who might be affected by this rulemaking to submit their comments because the regulations have a narrow, local application, and there will be local notifications in addition to the <E T="04">Federal Register</E> publication such as press releases, marine information broadcasts, and the Local Notice to Mariners. </P>
        <HD SOURCE="HD1">Public Meeting </HD>

        <P>We do not now plan to hold a public meeting. But you may submit a request for a meeting by writing to the address listed under <E T="02">ADDRESSES</E> explaining why one would be beneficial. If we determine that one would aid this rulemaking, we will hold one at a time and place announced by a later notice in the <E T="04">Federal Register</E>. </P>
        <HD SOURCE="HD1">Background and Purpose </HD>
        <P>On September 27 and 28, 2003, the Sunset Lake Hydrofest Association will sponsor the “Sunset Lake Hydrofest”, on the waters of Sunset Lake near Wildwood Crest, New Jersey. The event will consist of approximately 80 inboard hydroplanes, Jersey Speed Skiffs and flat-bottom Ski boats racing in heats counter-clockwise around an oval racecourse. A fleet of approximately 100 spectator vessels is expected to gather nearby to view the competition. Due to the need for vessel control during the event, vessel traffic will be temporarily restricted to provide for the safety of participants, spectators and transiting vessels. </P>
        <HD SOURCE="HD1">Discussion of Proposed Rule </HD>

        <P>The Coast Guard proposes to establish temporary special local regulations on specified waters of Sunset Lake. The <PRTPAGE P="48847"/>temporary regulations would be enforced from 7:30 a.m. to 2:30 p.m. on September 27 and 28, 2003, and would restrict general navigation in the regulated area during the event. Except for participants and vessels authorized by the Coast Guard Patrol Commander, no person or vessel would be allowed to enter or remain in the regulated area. These regulations are needed to control vessel traffic during the event to enhance the safety of participants, spectators and transiting vessels. </P>
        <HD SOURCE="HD1">Regulatory Evaluation </HD>
        <P>This proposed rule is not a “significant regulatory action” under section 3(f) of Executive Order 12866, Regulatory Planning and Review, and does not require an assessment of potential costs and benefits under section 6(a)(3) of that Order. The Office of Management and Budget has not reviewed it under that Order. It is not “significant” under the regulatory policies and procedures of the Department of Homeland Security (DHS). </P>
        <P>We expect the economic impact of this proposed rule to be so minimal that a full Regulatory Evaluation under the regulatory policies and procedures of DHS is unnecessary. </P>
        <P>Although this proposed regulation would prevent traffic from transiting a portion of Sunset Lake during the event, the effect of this proposed regulation would not be significant due to the limited duration that the regulated area will be in effect and the extensive advance notifications that will be made to the maritime community via the Local Notice to Mariners, marine information broadcasts, and area newspapers, so mariners can adjust their plans accordingly. Additionally, the proposed regulated area has been narrowly tailored to impose the least impact on general navigation yet provide the level of safety deemed necessary. Vessel traffic would be able to transit Sunset Lake by navigating around the regulated area. </P>
        <HD SOURCE="HD1">Small Entities </HD>
        <P>Under the Regulatory Flexibility Act (5 U.S.C. 601-612), we have considered whether this proposed rule would have a significant economic impact on a substantial number of small entities. The term “small entities” comprises small businesses, not-for-profit organizations that are independently owned and operated and are not dominant in their fields, and governmental jurisdictions with populations of less than 50,000. </P>
        <P>The Coast Guard certifies under 5 U.S.C. 605(b) that this proposed rule would not have a significant economic impact on a substantial number of small entities. This proposed rule would affect the following entities, some of which might be small entities: the owners or operators of vessels intending to transit or anchor in a portion of Sunset Lake during the event. </P>
        <P>This proposed rule would not have a significant economic impact on a substantial number of small entities for the following reasons. This proposed rule would be in effect for only a limited period. Vessel traffic could pass safely around the regulated area. Before the enforcement period, we would issue maritime advisories so mariners can adjust their plans accordingly. </P>

        <P>If you think that your business, organization, or governmental jurisdiction qualifies as a small entity and that this proposed rule would have a significant economic impact on it, please submit a comment (see <E T="02">ADDRESSES</E>) explaining why you think it qualifies and how and to what degree this proposed rule would economically affect it. </P>
        <HD SOURCE="HD1">Assistance for Small Entities </HD>

        <P>Under section 213(a) of the Small Business Regulatory Enforcement Fairness Act of 1996 (Public Law 104-121), we want to assist small entities in understanding this proposed rule so that they can better evaluate its effects on them and participate in the rulemaking. If the rule would affect your small business, organization, or governmental jurisdiction and you have questions concerning its provisions or options for compliance, please contact the address listed under <E T="02">ADDRESSES.</E>
        </P>
        <HD SOURCE="HD1">Collection of Information </HD>
        <P>This proposed rule would call for no new collection of information under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501-3520). </P>
        <HD SOURCE="HD1">Federalism </HD>
        <P>A rule has implications for federalism under Executive Order 13132, Federalism, if it has a substantial direct effect on State or local governments and would either preempt State law or impose a substantial direct cost of compliance on them. We have analyzed this proposed rule under that Order and have determined that it does not have implications for federalism. </P>
        <HD SOURCE="HD1">Unfunded Mandates Reform Act </HD>
        <P>The Unfunded Mandates Reform Act of 1995 (2 U.S.C. 1531-1538) requires Federal agencies to assess the effects of their discretionary regulatory actions. In particular, the Act addresses actions that may result in the expenditure by a State, local, or tribal government, in the aggregate, or by the private sector of $100,000,000 or more in any one year. Though this proposed rule would not result in such an expenditure, we do discuss the effects of this rule elsewhere in this preamble. </P>
        <HD SOURCE="HD1">Taking of Private Property </HD>
        <P>This proposed rule would not effect a taking of private property or otherwise have taking implications under Executive Order 12630, Governmental Actions and Interference with Constitutionally Protected Property Rights. </P>
        <HD SOURCE="HD1">Civil Justice Reform </HD>
        <P>This proposed rule meets applicable standards in sections 3(a) and 3(b)(2) of Executive Order 12988, Civil Justice Reform, to minimize litigation, eliminate ambiguity, and reduce burden. </P>
        <HD SOURCE="HD1">Protection of Children </HD>
        <P>We have analyzed this proposed rule under Executive Order 13045, Protection of Children from Environmental Health Risks and Safety Risks. This rule is not an economically significant rule and would not create an environmental risk to health or risk to safety that might disproportionately affect children. </P>
        <HD SOURCE="HD1">Indian Tribal Governments </HD>
        <P>This proposed rule does not have tribal implications under Executive Order 13175, Consultation and Coordination with Indian Tribal Governments, because it would not have a substantial direct effect on one or more Indian tribes, on the relationship between the Federal Government and Indian tribes, or on the distribution of power and responsibilities between the Federal Government and Indian tribes. </P>
        <HD SOURCE="HD1">Energy Effects </HD>

        <P>We have analyzed this proposed rule under Executive Order 13211, Actions Concerning Regulations That Significantly Affect Energy Supply, Distribution, or Use. We have determined that it is not a “significant energy action” under that order because it is not a “significant regulatory action” under Executive Order 12866 and is not likely to have a significant adverse effect on the supply, distribution, or use of energy. The Administrator of the Office of Information and Regulatory Affairs has not designated it as a significant energy action. Therefore, it does not require a Statement of Energy Effects under Executive Order 13211. <PRTPAGE P="48848"/>
        </P>
        <HD SOURCE="HD1">Environment </HD>
        <P>We have analyzed this proposed rule under Commandant Instruction M16475.1D, which guides the Coast Guard in complying with the National Environmental Policy Act of 1969 (NEPA)(42 U.S.C. 4321-4370f), and have concluded that there are no factors in this case that would limit the use of a categorical exclusion under section 2.B.2 of the Instruction. Therefore, this rule is categorically excluded, under figure 2-1, paragraph (34)(h), of the Instruction, from further environmental documentation. Special local regulations issued in conjunction with a regatta or marine parade permit are specifically excluded from further analysis and documentation under that section. </P>
        <P>Under figure 2-1, paragraph (34)(h), of the Instruction, an “Environmental Analysis Check List” and a “Categorical Exclusion Determination” are not required for this rule. Comments on this section will be considered before we make the final decision on whether to categorically exclude this rule from further environmental review. </P>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects in 33 CFR Part 100 </HD>
          <P>Marine safety, Navigation (water), Reporting and recordkeeping requirements, Waterways.</P>
        </LSTSUB>
        
        <P>For the reasons discussed in the preamble, the Coast Guard proposes to amend 33 CFR part 100 as follows: </P>
        <PART>
          <HD SOURCE="HED">PART 100—SAFETY OF LIFE ON NAVIGABLE WATERS </HD>
          <P>1. The authority citation for part 100 continues to read as follows: </P>
          
          <AUTH>
            <HD SOURCE="HED">Authority:</HD>
            <P>33 U.S.C. 1233 through 1236; Department of Homeland Security Delegation No. 0170.1, 33 CFR 100.35.</P>
          </AUTH>
          
          <P>2. Add a temporary § 100.35-T05-109 to read as follows: </P>
          <SECTION>
            <SECTNO>§ 100.35-T05-109 </SECTNO>
            <SUBJECT>Sunset Lake, Wildwood Crest, NJ </SUBJECT>
            <P>(a) <E T="03">Definitions</E>—(1) <E T="03">Coast Guard Patrol Commander</E> means a commissioned, warrant, or petty officer of the Coast Guard who has been designated by the Commander, Coast Guard Group Atlantic City. </P>
            <P>(2) <E T="03">Official Patrol</E> means any vessel assigned or approved by Commander, Coast Guard Group Atlantic City with a commissioned, warrant, or petty officer on board and displaying a Coast Guard ensign. </P>
            <P>(3) <E T="03">Participant</E> includes all vessels participating in the Sunset Lake Hydrofest under the auspices of the Marine Event Permit issued to the event sponsor and approved by Commander, Coast Guard Group Atlantic City. </P>
            <P>(4) <E T="03">Regulated area</E> includes all waters of Sunset Lake, New Jersey, from shoreline to shoreline, south of latitude 38° 58′32″ N. All coordinates reference Datum: NAD 1983. </P>
            <P>(b) <E T="03">Special local regulations.</E> (1) Except for event participants and persons or vessels authorized by the Coast Guard Patrol Commander, no person or vessel may enter or remain in the regulated area. </P>
            <P>(2) The operator of any vessel in the regulated area shall: </P>
            <P>(i) Stop the vessel immediately when directed to do so by any Official Patrol. </P>
            <P>(ii) Proceed as directed by any Official Patrol. </P>
            <P>(iii) Unless otherwise directed by the Official Patrol, operate at a minimum wake speed not to exceed six (6) knots. </P>
            <P>(c) <E T="03">Enforcement period.</E> This section will be enforced from 7:30 a.m. to 2:30 p.m. on September 27 and 28, 2003. </P>
          </SECTION>
          <SIG>
            <DATED>Dated: August 5, 2003. </DATED>
            <NAME>Sally Brice-O'Hara, </NAME>
            <TITLE>Rear Admiral, Coast Guard, Commander, Fifth Coast Guard District. </TITLE>
          </SIG>
        </PART>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20928 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4910-15-P</BILCOD>
    </PRORULE>
    <PRORULE>
      <PREAMB>
        <AGENCY TYPE="N">ENVIRONMENTAL PROTECTION AGENCY </AGENCY>
        <CFR>40 CFR Part 81 </CFR>
        <DEPDOC>[CA087-DESIG; FRL-7544-8] </DEPDOC>
        <SUBJECT>Clean Air Act Area Designations; California </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Environmental Protection Agency (EPA). </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Proposed rule. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>

          <P>EPA is proposing to make minor changes in the boundaries between areas in Southern California established under the Clean Air Act for purposes of addressing the national ambient air quality standards (NAAQS) for 1-hour ozone, particulate matter (PM-10), carbon monoxide (CO), nitrogen dioxide (NO<E T="52">2</E>), and sulfur dioxide (SO<E T="52">2</E>), and the prior NAAQS for total suspended particulate matter (TSP). </P>
          <P>We are taking comments on this proposal and plan to follow with a final action. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Any comments must arrive by September 15, 2003. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>

          <P>Please address your comments to: Dave Jesson, Air Planning Office (AIR-2), Air Division, EPA, Region IX, 75 Hawthorne Street, San Francisco, CA 94105-3901, or to <E T="03">jesson.david@epa.gov</E>. </P>
          <P>A copy of the State's submittal is available for public inspection during normal business hours at EPA's Region IX office. Please contact Dave Jesson if you wish to schedule a visit. A copy of the submittal is also available at the following location: California Air Resources Board, 1001 “I” Street, Sacramento, CA 95812. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Dave Jesson, EPA Region IX, at (415) 972-3957, or <E T="03">jesson.david@epa.gov</E>. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>Throughout this document, “we,” “us,” and “our” refer to EPA. </P>
        <HD SOURCE="HD1">I. Background </HD>
        <HD SOURCE="HD2">A. Current Area Boundaries, Designations, and Classifications </HD>
        <P>Areas of the country were originally designated as attainment, nonattainment, or unclassifiable following enactment of 1977 Amendments to the Clean Air Act (“CAA” or “the Act”). 43 FR 8962 (March 3, 1978). These designations were generally based on monitored air quality values compared to the applicable NAAQS. </P>
        <P>On November 15, 1990, the date of enactment of the 1990 CAA Amendments, each ozone and CO area designated nonattainment, attainment, or unclassifiable immediately before enactment of the Amendments was designated, by operation of law, as a nonattainment, attainment, or unclassifiable area, respectively. CAA section 107(d)(1)(C). The specific boundaries of the areas were determined subsequently based on requests by each state and final determinations by EPA. 56 FR 56694 (November 6, 1991). Ozone and CO nonattainment areas were also given classifications according to the design values prescribed in the 1990 Amendments. CAA sections 181(a)(1) and 186(a)(1), respectively.</P>

        <P>PM-10 areas meeting the requirements of either (i) or (ii) of CAA section 107(d)(4)(B) were designated nonattainment for PM-10 by operation of law and classified “moderate” at the time of enactment of the 1990 CAA Amendments. EPA later designated additional PM-10 nonattainment areas (<E T="03">see,</E> for example, 58 FR 67335, December 21, 1993) and amended the initial classifications in accordance with CAA section 188(b). </P>
        <P>SO<E T="52">2</E> and NO<E T="52">2</E> areas designated as nonattainment or attainment/unclassified before enactment of the 1990 CAA Amendments retained those designations by operation of law. CAA section 107(d)(1)(C)(i) and (ii), respectively. </P>

        <P>Area boundaries and (for ozone, CO, and PM-10) area classifications have been amended over the years under the <PRTPAGE P="48849"/>applicable CAA provisions, either by request of each state, by operation of law, or by EPA initiative. For the State of California, the current area designations and classifications are codified at 40 CFR 81.305. For historical reference, this regulatory section also includes designations for TSP, a NAAQS which was replaced in 1987 when we promulgated the PM-10 NAAQS. </P>
        <HD SOURCE="HD2">B. California's Request for Area Changes </HD>
        <P>Under CAA section 107(d)(3)(D), the Governor of any state, on the Governor's own motion, is authorized to submit to the Administrator a revised designation of any nonattainment area or portions thereof within the State.<SU>1</SU>
          <FTREF/> On November 18, 2002, the California Air Resources Board (CARB) submitted to EPA a request under CAA section 107(d)(3)(D) to revise the boundaries of the Los-Angeles-South Coast Air Basin Area (“South Coast Air Basin”) and the Southeast Desert Air Basin.<SU>2</SU>
          <FTREF/> The purposes of CARB's request are to: </P>
        <FTNT>
          <P>

            <SU>1</SU> Boundary changes are an inherent part of a designation or redesignation of an area under the CAA. <E T="03">See</E> CAA section 107(d)(1)(B)(ii).</P>
        </FTNT>
        <FTNT>
          <P>

            <SU>2</SU> The Los Angeles-South Coast Air Basin Area includes all of Orange County and the more populated portions of Los Angeles, San Bernardino, and Riverside Counties. The Southeast Desert Air Basin includes portions of Los Angeles, San Bernardino, and Riverside Counties. For a description of the current boundaries of the basins and subareas, <E T="03">see</E> 40 CFR 81.305.</P>
        </FTNT>
        <P>(1) Enlarge the South Coast Air Basin to include the Banning Pass area, thereby excluding the area from the Southeast Desert; </P>
        <P>(2) harmonize the PM-10 and ozone boundaries of the Coachella Valley area <SU>3</SU>
          <FTREF/> by changing the ozone area boundaries to match the PM-10 area boundaries; and </P>
        <FTNT>
          <P>
            <SU>3</SU> The Coachella Valley area is part of the Southeast Desert nonattainment area for ozone and is its own PM-10 nonattainment area.</P>
        </FTNT>
        <P>(3) correct the eastern boundary of the South Coast Air Basin with respect to CO. </P>
        <HD SOURCE="HD1">II. EPA Review of the State's Request </HD>
        <HD SOURCE="HD2">A. Applicable Criteria </HD>
        <P>In determining whether to approve or deny a state's request for a revision to the designation of an area under section 107(d)(3)(D), we use the same factors Congress directed us to consider when we initiate a revision to a designation of an area on our own motion under section 107(d)(3)(A). These factors include “air quality data, planning and control considerations, or any other air quality-related considerations the Administrator deems appropriate.” </P>
        <HD SOURCE="HD2">B. Expansion of the South Coast Air Basin to Include the Banning Pass </HD>

        <P>The Banning Pass area in Riverside County is also known as the San Gorgonio Pass area. The area is a mountain saddle about 15 miles long by 5 miles wide in northwestern Riverside County. There are only 4 communities in this area: Banning, Beaumont, Cabazon, and Cherry Valley. This area is currently part of the Southeast Desert severe-17 ozone nonattainment area and the Coachella Valley serious PM-10 nonattainment area, and the area has been designated as attainment or unclassifiable with respect to CO, NO<E T="52">2</E>, SO<E T="52">2</E>, and TSP.<SU>4</SU>
          <FTREF/> The populated portion of the Southeast Desert-Coachella Valley area is primarily low desert. Palm Springs is the largest community, and tourism and agriculture are the major industries in the Coachella Valley. </P>
        <FTNT>
          <P>
            <SU>4</SU> CAA sections 181(a)(1) and (2) establish an ozone classification scheme based on 1-hour ozone design values, and set attainment deadlines for each classification. CAA section 182 then provides progressively more stringent requirements for the State Implementation Plans (SIPs) depending upon an area's classification. The 1-hour ozone classifications are marginal, moderate, serious, severe, and extreme, and the severe classification is divided into those areas with attainment deadlines 15 years after enactment of the 1990 CAA Amendments and those areas with deadlines 17 years after enactment. Similarly, the CAA sets moderate and serious classifications for CO (in section 186(a)(1)) and for PM-10 (in sections 188(a) and (b)).</P>
        </FTNT>
        <P>The South Coast Air Quality Management District (SCAQMD) has local jurisdiction over the South Coast Air Basin, the Banning Pass area, and the Coachella Valley portion of the Southeast Desert. Both CARB and SCAQMD conclude that the Banning Pass area is more similar to the South Coast Air Basin in climate and topography and measured air quality, and that air pollution levels within the Banning Pass area are far more heavily influenced by emissions originating in the South Coast Air Basin than in the Southeast Desert-Coachella Valley. </P>
        <P>The climate of the Banning Pass area closely resembles the “steppe” (semi-arid) climate of the South Coast Air Basin in terms of rainfall and temperature. Precipitation levels recorded in the Banning Pass are much higher than those of the Coachella Valley, which has a “desert” (arid) climate classification. For example, the annual average rainfall is 17 inches in Beaumont, and only 5.2 inches in Palm Springs. On average, summer temperatures in the Coachella Valley are 10-15 degrees F warmer than those recorded at the Banning Pass and in the central South Coast Air Basin. The mean temperature in Palm Springs for July is 92 degrees F, compared to 77 degrees F in Beaumont. </P>

        <P>Pollution from western and central portions of the South Coast Air Basin is typically transported eastward by prevailing ocean breezes. This results in high ozone concentrations measured in mountain sites at the eastern boundary of the basin, including Banning (elevation 2300 feet), which recorded a total of 25 exceedances with a design value of 0.143 parts per million (ppm) during the period 1999 to 2001. During this same period, Palm Springs (elevation 200 feet) recorded only 7 exceedances, with a design value of 0.128 ppm. Similarly, the Banning Pass is much more closely linked to the South Coast Air Basin than to the Southeast Desert with respect to emissions and ambient concentrations for the other pollutants, such as NO<E T="52">2</E> and SO<E T="52">2</E>. </P>
        <P>In terms of ozone generation, the South Coast Air Basin has far greater emissions than the Southeast Desert generally and the Coachella Valley specifically, and the easterly direction of the prevailing winds also ensures that elevated pollution levels in Banning Pass are a consequence of the air mass shared with the western and central portions of the South Coast Air Basin, and are not associated with the Coachella Valley or other portions of the Southeast Desert. </P>
        <P>For these reasons, the Banning Pass area was moved to the South Coast Air Basin under State law in 1996. CARB and SCAQMD therefore request that the Federal boundaries be adjusted to match the boundaries used for State air quality purposes, by moving the Banning Pass area from the Southeast Desert-Coachella Valley area to the South Coast Air Basin. </P>

        <P>The table below labeled “Banning Pass Area” shows the current federal designations and classifications of this area, and the changes that would result from approval of the State's proposed revision. <PRTPAGE P="48850"/>
        </P>
        <GPOTABLE CDEF="xs48,r40,r40,r40,r40,r40,r40,r40,r40" COLS="9" OPTS="L2,p7,7/8,i1">
          <TTITLE>Banning Pass Area </TTITLE>
          <BOXHD>
            <CHED H="1">  </CHED>
            <CHED H="1">Ozone </CHED>
            <CHED H="2">Designation </CHED>
            <CHED H="2">Classification </CHED>
            <CHED H="1">CO </CHED>
            <CHED H="2">Designation </CHED>
            <CHED H="2">Classification </CHED>
            <CHED H="1">PM-10 </CHED>
            <CHED H="2">Designation </CHED>
            <CHED H="2">Classification </CHED>
            <CHED H="1">NO<E T="52">2</E>
            </CHED>
            <CHED H="2">Designation </CHED>
            <CHED H="1">SO<E T="52">2</E>
            </CHED>
            <CHED H="2">Designation </CHED>
          </BOXHD>
          <ROW>
            <ENT I="01">Current</ENT>
            <ENT>Non-attainment (area is part of SE Desert Modified AQMA Area)</ENT>
            <ENT>Severe 17</ENT>
            <ENT>Unclassifiable/Attainment (part of SE Desert Air Basin, Riverside County, AQMA portion)</ENT>
            <ENT>N/A</ENT>
            <ENT>Non-attainment (part of Riverside County, Coachella Valley planning area)</ENT>
            <ENT>Serious</ENT>
            <ENT>Cannot be classified or better than national standards (part of Riverside County, non-AQMA portion)</ENT>
            <ENT>Cannot be classified (part of SE Desert Air Basin, excluding Imperial County). </ENT>
          </ROW>
          <ROW>
            <ENT I="01">Proposed</ENT>
            <ENT>Non-attainment (area becomes part of South Coast Air Basin)</ENT>
            <ENT>Extreme</ENT>
            <ENT>Non-attainment (area becomes part of South Coast Air Basin)</ENT>
            <ENT>Serious</ENT>
            <ENT>Non-attainment (area becomes part of South Coast Air Basin)</ENT>
            <ENT>Serious</ENT>
            <ENT>Cannot be classified or better than national standards (area becomes part of South Coast Air Basin)</ENT>
            <ENT>Cannot be classified (area becomes part of South Coast Air Basin). </ENT>
          </ROW>
        </GPOTABLE>
        <P>We believe that Banning is more similar to the South Coast than the Coachella area, and that it would support efficient planning and control to move the federal boundary of the South Coast Air Basin eastward to encompass the Banning Pass area. </P>
        <HD SOURCE="HD2">C. Revision to the Southeast Desert Ozone Nonattainment Boundary to Align It's Eastern Border With the Coachella Valley PM-10 Nonattainment Boundary </HD>
        <P>At present, the boundary of the Coachella Valley portion of the Southeast Desert ozone nonattainment area is different from the boundary of the Coachella Valley nonattainment area for PM-10. The existing ozone nonattainment area boundary differs from the Riverside portion of the Southeast Desert Air Basin boundary by: (1) Excluding a sparsely populated, 550 square mile portion of the Coachella Valley area, and (2) including a tiny portion of the Southeast Desert Air Basin. The State has proposed to align the Coachella Valley nonattainment area boundaries by using for all pollutants the boundary of the Coachella Valley nonattainment area for PM-10. This boundary tracks the mountain ridge line that separates the air basins and thus reflects air quality considerations. The change will simplify and make more consistent the planning activities for ozone and PM-10, and will reconcile boundaries for Federal and State planning purposes. As a result of the change, a sparsely-populated mountainous area above the Coachella Valley would shift from an ozone attainment area to a nonattainment area, with a severe-17 classification. </P>
        <P>We agree with the State's argument that it is appropriate to align the federal boundaries of the Coachella Valley portion of the Southeast Desert Air Basin ozone nonattainment area to match the Coachella Valley PM-10 nonattainment area. </P>
        <HD SOURCE="HD2">D. Typographical Correction to the Boundaries of the South Coast Air Basin for Carbon Monoxide </HD>
        <P>The CO boundaries of the South Coast Air Basin in 40 CFR 81.305 are incorrect because they mistakenly incorporate the following phrase: “and that portion of San Bernardino County which lies south and west of a line described as follows: 3. latitude 35 degrees, 10 minutes north and longitude 115 degrees, 45 minutes west.” Neither EPA nor CARB intended the South Coast CO nonattainment area to include this portion of San Bernardino County, which was inadvertently incorporated in the designations promulgated on November 6, 1991 (56 FR 56724). California requests that we correct this typographical mistake in the original designation by deleting the portion of the boundary description quoted above. Correction of this error will result in the CO boundaries conforming to the 1-hour ozone boundaries for the South Coast Air Basin. We agree that this correction is appropriate. </P>
        <HD SOURCE="HD1">III. Summary of Proposed Action and Request for Comment </HD>
        <P>EPA is proposing to take the following actions: </P>
        <P>(1) Approve the State's request to revise the boundary of the South Coast Air Basin to incorporate the Banning Pass; </P>
        <P>(2) Approve the State's request to amend the 1-hour ozone boundary of the Coachella Valley area (Riverside County portion of the Southeast Desert Air Basin to correspond to the PM-10 boundary; and </P>
        <P>(3) Approve the State's request to make a typographical correction to the boundary of the South Coast Air Basin with respect to CO. </P>
        <P>Because EPA believes the proposed boundary revisions, reorganizations, and corrections are consistent with relevant requirements, we are proposing to fully approve them under CAA section 107(d)(3)(D). We will accept comments from the public on this proposal for the next 30 days. Unless we receive convincing new information during the comment period, we intend to publish a final approval of the designation changes. </P>
        <HD SOURCE="HD1">IV. Administrative Requirements </HD>

        <P>Under Executive Order 12866 (58 FR 51735, October 4, 1993), this proposed action is not a “significant regulatory action” and therefore is not subject to review by the Office of Management and Budget. For this reason, this action is also not subject to Executive Order 13211, “Actions Concerning Regulations That Significantly Affect Energy Supply, Distribution, or Use” (66 FR 28355, May 22, 2001). This proposed action merely proposes to approve state law as meeting Federal requirements and imposes no additional requirements beyond those imposed by state law. Accordingly, the Administrator certifies that this proposed rule will not have a significant economic impact on a substantial number of small entities under the Regulatory Flexibility Act (5 U.S.C. 601 <E T="03">et seq</E>.). Because this rule proposes to approve pre-existing requirements under state law and does not impose any additional enforceable duty beyond that required by state law, it does not contain any unfunded mandate or significantly or uniquely affect small governments, as described in the Unfunded Mandates Reform Act of 1995 (Pub. L. 104-4). </P>

        <P>This proposed rule also does not have tribal implications because it will not <PRTPAGE P="48851"/>have a substantial direct effect on one or more Indian tribes, on the relationship between the Federal Government and Indian tribes, or on the distribution of power and responsibilities between the Federal Government and Indian tribes, as specified by Executive Order 13175 (65 FR 67249, November 9, 2000). This action also does not have Federalism implications because it does not have substantial direct effects on the States, on the relationship between the national government and the States, or on the distribution of power and responsibilities among the various levels of government, as specified in Executive Order 13132 (64 FR 43255, August 10, 1999). This action merely proposes to approve a state rule implementing a Federal standard, and does not alter the relationship or the distribution of power and responsibilities established in the Clean Air Act. This proposed rule also is not subject to Executive Order 13045 “Protection of Children from Environmental Health Risks and Safety Risks” (62 FR 19885, April 23, 1997), because it is not economically significant. </P>

        <P>In reviewing SIP submissions, EPA's role is to approve state choices, provided that they meet the criteria of the Clean Air Act. In this context, in the absence of a prior existing requirement for the State to use voluntary consensus standards (VCS), EPA has no authority to disapprove a SIP submission for failure to use VCS. It would thus be inconsistent with applicable law for EPA, when it reviews a SIP submission, to use VCS in place of a SIP submission that otherwise satisfies the provisions of the Clean Air Act. Thus, the requirements of section 12(d) of the National Technology Transfer and Advancement Act of 1995 (15 U.S.C. 272 note) do not apply. This proposed rule does not impose an information collection burden under the provisions of the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 <E T="03">et seq.</E>). </P>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects in 40 CFR Part 81 </HD>
          <P>Environmental protection, Air pollution control, National parks, Wilderness areas.</P>
        </LSTSUB>
        <SIG>
          <DATED>Dated: August 6, 2003. </DATED>
          <NAME>Deborah Jordan, </NAME>
          <TITLE>Acting Regional Administrator, Region IX. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20894 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 6560-50-U</BILCOD>
    </PRORULE>
    <PRORULE>
      <PREAMB>
        <AGENCY TYPE="N">OFFICE OF PERSONNEL MANAGEMENT </AGENCY>
        <CFR>48 CFR Parts 1601, 1602, 1604, 1615, 1631, 1632, 1644, and 1652 </CFR>
        <RIN>RIN 3206-AJ20 </RIN>
        <SUBJECT>Federal Employees Health Benefits; Acquisition Regulation: Large Provider Agreements, Subcontracts, and Miscellaneous Changes </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Office of Personnel Management. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Proposed regulation. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The Office of Personnel Management (OPM) is issuing a proposed regulation to amend the Federal Employees Health Benefits Acquisition Regulation (FEHBAR). We are proposing a new policy that establishes notification and information requirements, including audit, for Federal Employees Health Benefits (FEHB) Program experience rated carriers' large provider agreements. The proposed regulation also modifies the threshold for review of carrier subcontracts; revises the definitions of Cost or Pricing Data and Experience Rate to reflect mental health parity requirements effective with the 2001 contract year; updates the records retention period, updates the FEHB Program Clause Matrix, and conforms various subpart and paragraph references in the Federal Acquisition Regulation (FAR) revisions made since we last updated the FEHBAR. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Comments must be received on or before October 14, 2003. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Send written comments to Abby L. Block, Deputy Associate Director, Employee and Family Services, Strategic Human Resources Policy Division, Office of Personnel Management, Washington, DC 20415-3601; or deliver to OPM, Room 3425, 1900 E Street NW., Washington, DC; or FAX to (202) 606-0633. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Michael W. Kaszynski, (202) 606-0004; or send email to <E T="03">mwkaszyn@opm.gov.</E>
          </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>The primary purpose of this rulemaking is to provide for additional OPM oversight of the FEHB Program carriers' contract costs that are charged to the Government. Since the beginning of the Program, we have maintained oversight of FEHB carriers' costs, including their subcontractor costs. We have specified standard contracting requirements for review and audit of those costs and have routinely updated our requirements as necessary. Historically, we did not consider providers of medical services or supplies to be subcontractors as the term is defined in the Federal Acquisition Regulation (FAR) because hundreds of thousands of such agreements between carriers and providers are in place, and until recently, the dollar value of each individual agreement was relatively small. However, the healthcare delivery system has changed over the years and new large healthcare delivery entities now play a significant role in the healthcare industry. FEHB carriers contract with those types of entities for the delivery of services that represent a significant portion of individual carriers total costs charged to the FEHB Program, and in the aggregate represent a sizeable portion of overall Program costs. Because of the impact of these costs on the FEHB Program, we are expanding our oversight in this area. Even though large providers of medical services or supplies are not defined as subcontractors under the FEHB Program, the proposed regulatory changes would bring them under the umbrella of the FEHBAR and subject them to audit requirements currently applicable to carriers and their subcontractors. Some but not all FEHB carriers' large provider agreements already provide for a limited right to audit. We believe the provision should be in regulation rather than in individual contracts to make the context clear, explicit and consistent for all experience-rated carriers by mirroring the regulatory requirements for subcontracting arrangements that are already in place. As is currently the case with audit findings in subcontract arrangements, any audit findings regarding large providers would be referred to the FEHB carriers holding the provider contract. </P>
        <P>For FAR audit purposes, we define a <E T="03">large provider agreement</E> as an agreement between (1) an FEHB carrier, at least 25 percent of whose total contracts are comprised of FEHB enrollee contracts, and (2) a provider, where the total costs charged to the FEHB carrier for a contract term for FEHB members, including benefits and services, are reasonably expected to exceed 5 percent of the carrier's total FEHB benefits costs, or 5 percent of the carrier's total FEHB administrative costs (where the provider is not responsible for benefits costs under the agreement). We will use the FEHB Program Annual Accounting Statement for the prior contract year to determine the 5 percent threshold. </P>

        <P>The proposed regulation requires experience rated carriers to meet minimum notification and information requirements with respect to any new <PRTPAGE P="48852"/>procurement, renewal, significant modification, or option relating to such a provider agreement. Examples of information to be provided are a description of the supplies or services required, basis for reimbursement, reason the proposed provider was selected, method of contracting and competition obtained, methodology used to compute profit, and provider risk provisions. This new oversight initiative reflects OPM's need to be informed of the types of carrier large provider agreements and their terms and conditions, because of the value and cost of such agreements to the FEHB Program. </P>
        <P>The proposed regulation authorizes the contracting officer to request additional information after he or she receives the carrier's notification and required information and prior to award of a large provider agreement, and any time during the performance of the agreement. The contracting officer will give the carrier either written comments on the agreement, or will give written notice that there will be no comments. If the contracting officer provides comments, the carrier must tell the contracting officer how it intends to address the contracting officer's concerns. </P>
        <P>In the event the carrier awards the large provider agreement without providing notification and addressing each of the contracting officer's written concerns, the contracting officer may disallow the carrier's costs incurred under the agreement. </P>
        <P>Under the proposed regulation, large providers must retain and make available for Government inspection all records applicable to the carrier's provider contractual agreement. The Government will have audit rights with respect to large provider contractual agreements that are the same as for carriers. The contract clause at 1652.204-74, Large provider agreements, contains a flow-down provision that requires the carrier to insert the clause in all large provider agreements. </P>
        <P>We are updating our policy for FEHB Program subcontracting consent which currently requires advance approval of carrier subcontracts or modifications that exceed $100,000. The proposed regulation increases the threshold so that subcontracts and modifications will require advance approval only if they equal or exceed $550,000. The regulation also clarifies the cost components the carrier must consider in determining the $550,000 threshold. Under the Competition in Subcontracting Clause (FAR 52.244-5), however carriers must still comply with the competition requirements even when the subcontract does not require OPM approval. </P>
        <P>We have added a new section in part 1631, Contract Cost Principles and Procedures, concerning the inferred reasonableness of a subcontract's costs. If the carrier follows the notification and consent requirements of 1652.244-70, Subcontracts, and later obtains the contracting officer's consent or ratification of the subcontract's costs, then the reasonableness of the subcontract's costs will be inferred. </P>
        <P>The modified definitions of Cost or Pricing Data and Experience Rate incorporate mental health benefits capitation rates to reflect the new mental health parity requirements in the FEHB Program effective as of the 2001 contract year. Specifically, we are clarifying that mental health capitation rates are considered to be cost or pricing data and are included as actual paid claims and administrative expenses in experience rating. </P>
        <P>We are also updating the contractor records retention requirement for carrier rate submissions, patient claims, large provider agreements, and subcontracts to 6 years. Earlier in the history of the Program when virtually all records were maintained in paper format, we established a requirement for carriers to retain claims records for three years and financial records for five years. Since electronic data storage significantly reduces the maintenance burden and the Program can benefit from having records available for a slightly longer period, we are modifying and standardizing the records retention requirement. All carriers' records are subject to The Health Insurance Portability and Accountability Act (HIPAA) standards for privacy of individually identifiable health information. </P>
        <P>To conform with the current FAR sections, we have redesignated and/or retitled certain sections and references in FEHBAR parts 1615, 1632, and 1652. No material changes were made to these three Parts. Old FEHBAR 1615.1, General Requirements for Negotiation, is retitled “Source Selection Processes and Techniques.” Old FEHBAR 1615.170, Negotiation authority, is now section 1615.070. Old FEHBAR 1615.4, Solicitations and Receipt of Proposals and Quotations, is now 1615.2, Solicitations and Receipt of Proposals and Information. Old 1615.401, Applicability, is now 1615.270. Old FEHBAR 1615.6, Source Selection, is now 1615.3. Old FEHBAR 1615.602, Applicability, is now 1615.370. We moved the provisions in old FEHBAR Subparts 1615.8, Price Negotiation, and 1615.9, Profit, to Subpart 1615.4, Contract Pricing, to correspond with the FAR. We removed and reserved sections 1615.8 and 1615.9 because there are no longer corresponding references in the FAR. Old Section 1615.802, Policy, is now 1615.402, Pricing policy. Old paragraph 1615.804-70, Certificate of accurate cost or pricing data for community rated carriers, is now 1615.406-2, Certificate of accurate cost or pricing data for community rated carriers. Old paragraph 1615.804-72, Rate reduction for defective pricing or defective cost or pricing data, is now 1615.407-1. Old paragraph 1615.805-70, Carrier investment of FEHB funds, is now 1615.470. Old paragraph 1615.805-71, Investment income clause, is now 1615.470-1. Old Section 1615.902, Policy, is now 1615.404-4, Profit, and old Section 1615.905, Profit analysis factors, is now 1615.404-70. </P>
        <P>In 1632.170, Recurring premium payments to carriers, we removed paragraph (c) relating to the 3-Year DoD Demonstration Project (10 U.S.C. 1108) because the term of the demonstration project expired December 31, 2002. </P>
        <P>In 1632.771, Non-commingling of FEHB Program funds, and 1632.772, Contract clause, we removed the incorrect reference to paragraph 1652.232-70 and replaced it with the reference 1652.232-72. </P>
        <P>We removed the reference to “1615.804-72” in the introductory text of “1652.215-70, Rate reduction for defective pricing or defective cost or pricing data,” and replaced it with “1615.407-1.” In the same section, we removed the reference to “15.804-2(a)(1)” and replaced it with “15.403-4(a)(1).” We also replaced the clause date with “2003.” In paragraph (a) of the clause, we replaced “1615.804-70 “with “1615.406-2.” Finally, we removed paragraph (d) relating to the 3-Year DoD Demonstration Project (10 U.S.C. 1108) because the term of the demonstration project expired December 31, 2002. </P>
        <P>In the introductory text of 1652.215-71, Investment income, we replaced “1615.805-71” with “1615.470-1.” </P>
        <P>In 1652.216-70, Accounting and price adjustment, we changed the clause date to “2003” and removed paragraph (c) because the term of the 3-Year DoD Demonstration Project (10 U.S.C. 1108) expired December 31, 2002. </P>
        <P>In 1652.216-71, Accounting and allowable cost, we changed the clause date to “2003” and removed paragraph (d) because the term of the 3-Year DoD Demonstration Project (10 U.S.C. 1108) expired December 31, 2002. </P>

        <P>In 1652.222-70, Notice of significant events, we revised paragraph (d) of the clause to increase the threshold for <PRTPAGE P="48853"/>inserting the clause in the carrier's subcontracts and subcontract modifications.</P>
        <P>In 1652.232-70, Payments—Community-rated contracts, we changed the clause date to “2003” and removed paragraph (f) because the term of the 3-Year DoD Demonstration Project (10 U.S.C. 1108) expired December 31, 2002.</P>
        <P>In 1652.232-71, Payments—Experience-rated contracts, we changed the clause date to “2003” and removed paragraph (f) because the term of the 3-Year DoD Demonstration Project (10 U.S.C. 1108) expired December 31, 2002.</P>
        <P>We have also updated the FEHB Clause Matrix by removing clauses that relate to the Cost Accounting Standards.</P>
        <HD SOURCE="HD1">Collection of Information Requirement</HD>

        <P>This rulemaking imposes additional oversight and audit requirements on individual Federal contractors. The requirements do not represent routine information collection. Carriers are required to provide the information on an individual case by case basis only when they are initiating a new large provider contract or renewing an existing contract. It does not impose information collection and recordkeeping requirements that meet the definition of the Paperwork Reduction Act of 1995's term “collection of information” which means obtaining, causing to be obtained, soliciting, or requiring the disclosure to third parties or the public, of facts or opinions by or for an agency, regardless of form or format, calling for either answers to identical questions posed to, or identical reporting or recordkeeping requirements imposed on, ten or more persons, other than agencies, instrumentalities, or employees of the United States; or answers to questions posed to agencies, instrumentalities, or employees of the United States which are to be used for general statistical purposes * * * Consequently, it need not be reviewed by the Office of Management and Budget under the authority of the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 <E T="03">et seq.</E>).</P>
        <HD SOURCE="HD1">Regulatory Flexibility Act</HD>
        <P>The RFA requires agencies to analyze options for regulatory relief of small businesses. For purposes of the RFA, small entities include small businesses, nonprofit organizations, and government agencies with revenues of $11.5 million or less in any 1 year. This rulemaking primarily affects FEHB Program experience rated carriers and their large provider contractual arrangements which exceed that dollar threshold. Therefore, I certify that this regulation will not have a significant economic impact on a substantial number of small entities.</P>
        <HD SOURCE="HD1">Regulatory Impact Analysis</HD>
        <P>We have examined the impacts of this final rule as required by Executive Order 12866 (September 1993, Regulatory Planning and Review), the Regulatory Flexibility Act (RFA) (September 16, 1980, Pub. L. 96-354), section 1102(b) of the Social Security Act (the Act), the Unfunded Mandates Reform Act of 1995 (UMRA), (Pub. L. 104-4), and Executive Order 13132. Executive Order 12866 (as amended by Executive Order 13258, which merely assigns responsibility of duties) directs agencies to assess all costs and benefits of available regulatory alternatives and, if regulation is necessary, to select regulatory approaches that maximize net benefits (including potential economic, environmental, public health and safety effects, distributive impacts, and equity). A regulatory impact analysis (RIA) must be prepared for major rules with economically significant effects ($100 million or more in any 1 year). This proposed rule is not considered a major rule, as defined in Title 5, United States Code, section 804(2), because we estimate its impact will only affect FEHB carriers and their large provider agreements and would mirror current FEHB Program practice with regard to carriers' subcontract arrangements. Any economic impact resulting from oversight or audit efforts would not be expected to exceed the dollar threshold.</P>
        <HD SOURCE="HD1">Executive Order 12866, Regulatory Review</HD>
        <P>This rule has been reviewed by the Office of Management and Budget in accordance with Executive Order 12866.</P>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects in 48 CFR Parts 1601, 1602, 1604, 1615, 1631, 1632, 1644, and 1652</HD>
          <P>Government employees, Government procurement, Health insurance, Reporting &amp; recordkeeping requirements.</P>
        </LSTSUB>
        <SIG>
          <FP>Office of Personnel Management.</FP>
          <NAME>Kay Coles James,</NAME>
          <TITLE>Director.</TITLE>
        </SIG>
        <P>Accordingly, OPM proposes to amend chapter 16 of title 48, CFR as follows:</P>
        <CHAPTER>
          <HD SOURCE="HED">CHAPTER 16—OFFICE OF PERSONNEL MANAGEMENT FEDERAL EMPLOYEES HEALTH BENEFITS ACQUISITION REGULATION</HD>
        </CHAPTER>
        <P>1. The authority citation for 48 CFR parts 1601, 1602, 1604, 1615, 1631, 1632, 1644, and 1652 continues to read as follows:</P>
        <AUTH>
          <HD SOURCE="HED">Authority:</HD>
          <P>5 U.S.C. 8913; 40 U.S.C. 486(c); 48 CFR 1.301.</P>
        </AUTH>
        <HD SOURCE="HD1">SUBCHAPTER A—GENERAL</HD>
        <PART>
          <HD SOURCE="HED">PART 1601—FEDERAL ACQUISITION REGULATIONS SYSTEM</HD>
          <SUBPART>
            <HD SOURCE="HED">Subpart 1601.1—Purpose, Authority, Issuance.</HD>
          </SUBPART>
          <P>2. Section 1601.105 is redesignated as 1601.106.</P>
        </PART>
        <PART>
          <HD SOURCE="HED">PART 1602—DEFINITIONS OF WORDS AND TERMS</HD>
          <SUBPART>
            <HD SOURCE="HED">Subpart 1602.1—Definitions of FEHB Program Terms</HD>
          </SUBPART>
          <P>3. In 1602.170-5, paragraph (a) is revised to read as follows:</P>
          <SECTION>
            <SECTNO>1602.170-5 </SECTNO>
            <SUBJECT>Cost or pricing data.</SUBJECT>
            <P>(a) <E T="03">Experience rated carriers.</E> Cost or pricing data for experience rated carriers includes:</P>
            <P>(1) Information such as claims data;</P>
            <P>(2) Actual or negotiated benefits payments made to providers of medical services for the provision of healthcare, such as capitation not adjusted for specific groups, including mental health benefits capitation rates, per diems, and Diagnostic Related Group (DRG) payments;</P>
            <P>(3) Cost data;</P>
            <P>(4) Utilization data; and</P>
            <P>(5) Administrative expenses and retentions, including capitated administrative expenses and retentions.</P>
            <STARS/>
            <P>4. Section 1602.170-7 is revised to read as follows:</P>
          </SECTION>
          <SECTION>
            <SECTNO>1602.170-7 </SECTNO>
            <SUBJECT>Experience rate.</SUBJECT>
            <P>
              <E T="03">Experience rate</E> means a rate for a given group that is the result of that group's actual paid claims, administrative expenses (including capitated administrative expenses), retentions, and estimated claims incurred but not reported, adjusted for benefit modifications, utilization trends, and economic trends. Actual paid claims include any actual or negotiated benefits payments made to providers of medical services for the provision of healthcare such as capitation not adjusted for specific groups, including mental health benefits capitation rates, per diems, and Diagnostic Related Group (DRG) payments.</P>
            <P>5. Section 1602.170-15 is added to read as follows:</P>
          </SECTION>
          <SECTION>
            <SECTNO>1602.170-15 </SECTNO>
            <SUBJECT>Large provider agreement.</SUBJECT>
            <P>(a) <E T="03">Large provider agreement</E> means an agreement between—<PRTPAGE P="48854"/>
            </P>
            <P>(1) An FEHB carrier, at least 25 percent of whose total contracts are comprised of FEHB enrollee contracts, and</P>
            <P>(2) A provider of services or supplies (including organizations that own or contract with direct providers, or organizations that process claims or manage patient care),</P>
            <P>(i) Where the total costs charged to the FEHB carrier for a contract term for FEHB members, including benefits and services, are reasonably expected to exceed 5 percent of the carrier's total FEHB benefits costs, or</P>
            <P>(ii) Where the total administrative costs charged to the FEHB carrier for the contract term for FEHB members are reasonably expected to exceed 5 percent of the carrier's total FEHB administrative costs (applicable to agreements where the provider is not responsible for FEHB benefits costs).</P>
            <P>(b) The FEHB Program Annual Accounting Statement for the prior contract year will be used to determine the 5 percent threshold under large provider agreements.</P>
            <P>(c) Large provider agreements are subject to the audit provisions of FAR 52.215-2, “Audit and Records-Negotiation.”</P>
          </SECTION>
        </PART>
        <PART>
          <HD SOURCE="HED">PART 1604—ADMINISTRATIVE MATTERS</HD>
          <P>6. Subpart 1604.72 is added to read as follows:</P>
          <CONTENTS>
            <SUBPART>
              <HD SOURCE="HED">Subpart 1604.72—Large Provider Agreements</HD>
              <SECHD>Sec.</SECHD>
              <SECTNO>1604.7201 </SECTNO>
              <SUBJECT>FEHB Program large provider agreements.</SUBJECT>
              <SECTNO>1604.7202 </SECTNO>
              <SUBJECT>Large provider agreement clause.</SUBJECT>
            </SUBPART>
          </CONTENTS>
          <AUTH>
            <HD SOURCE="HED">Authority:</HD>
            <P>5 U.S.C. 8913; 40 U.S.C. 486(c); 48 CFR 1.301.</P>
          </AUTH>
          <SUBPART>
            <HD SOURCE="HED">Subpart 1604.72—Large Provider Agreements </HD>
            <SECTION>
              <SECTNO>1604.7201 </SECTNO>
              <SUBJECT>FEHB Program large provider agreements.</SUBJECT>
              <P>The following provisions apply to all experience rated carriers participating in the FEHB Program:</P>
              <P>(a) <E T="03">Notification and information requirements.</E> (1) All experience rated carriers must provide notice to the contracting officer of its intent to enter into or to make a significant modification of a large provider agreement:</P>
              <P>(i) Not less than 60 days before entering into any large provider agreement; and</P>
              <P>(ii) Not less than 60 days before exercising renewals or other options, or making a significant modification.</P>
              <P>(2) The carrier's notification to the contracting officer must be in writing and must, at a minimum:</P>
              <P>(i) Describe the supplies and/or services the proposed provider agreement will require;</P>
              <P>(ii) Identify the proposed basis for reimbursement;</P>
              <P>(iii) Identify the proposed provider agreement, explain why the carrier selected the proposed provider, and what contracting method it used, where applicable, including the kind of competition obtained;</P>
              <P>(iv) Describe the methodology the carrier used to compute the provider's profit; and,</P>
              <P>(v) Describe provider risk provisions.</P>
              <P>(3) The contracting officer may request from the carrier any additional information on a proposed provider agreement and its terms and conditions prior to a provider award and during the performance of the agreement.</P>
              <P>(4) Within 30 days of receiving the carrier's notification, the contracting officer will either give the carrier written comments or written notice that there will be no comments. If the contracting officer comments, the carrier must respond in writing within 10 calendar days and explain how it intends to address any concerns.</P>
              <P>(5) The contracting officer may inform the carrier that if it awards the provider agreement before addressing OPM's concerns, it may not charge costs incurred under the agreement to the contract.</P>
              <P>(6) When computing the carrier's annual service charge, the contracting officer will consider how well the carrier complies with the provisions of this section, including the advance notification requirements, as an aspect of the carrier's performance factor.</P>
              <P>(7) The contracting officer's review of any provider agreement, option, renewal, or modification shall not constitute a determination of the acceptability of terms or conditions of any provider agreement or the allowability of any costs under the carrier's contract, nor shall it relieve the carrier of any responsibility for performing the contract.</P>
              <P>(b) <E T="03">Records and Inspection.</E> The carrier must insert in all large provider agreements the requirement that the provider will retain and make available to the Government all records relating to the agreement as follows:</P>
              <P>(1) Records that support the annual statement of operations—Retain for 6 years after the agreement term ends.</P>
              <P>(2) Enrollee records, if applicable—Retain for 6 years after the agreement term ends.</P>
              <P>(c) <E T="03">Audit.</E> The provisions of FAR 52.215-2, Audit and Records—Negotiation, apply to all experience rated carriers' large provider agreements.</P>
            </SECTION>
            <SECTION>
              <SECTNO>1604.7202 </SECTNO>
              <SUBJECT>Large provider agreement clause.</SUBJECT>
              <P>The Contracting Officer shall insert the clause set forth at section 1652.204-74 in all experience rated FEHB Program contracts.</P>
              <HD SOURCE="HD1">SUBCHAPTER C—CONTRACTING METHODS AND CONTRACT TYPES</HD>
            </SECTION>
          </SUBPART>
        </PART>
        <PART>
          <HD SOURCE="HED">PART 1615—CONTRACTING BY NEGOTIATION</HD>
          <P>7. A new § 1615.070 is added to read as follows:</P>
          <SECTION>
            <SECTNO>1615.070 </SECTNO>
            <SUBJECT>Negotiation authority.</SUBJECT>
            <P>The authority to negotiate FEHB contracts is conferred by 5 U.S.C. 8902.</P>
            <P>8. Subpart 1615.1 is revised to read as follows:</P>
            <CONTENTS>
              <SUBPART>
                <HD SOURCE="HED">Subpart 1615.1—Source Selection Processes and Techniques.</HD>
                <SECHD>Sec.</SECHD>
                <SECTNO>1615.170 </SECTNO>
                <SUBJECT>Applicability.</SUBJECT>
              </SUBPART>
            </CONTENTS>
            <AUTH>
              <HD SOURCE="HED">Authority:</HD>
              <P>5 U.S.C. 8913; 40 U.S.C. 486(c); 48 CFR 1.301.</P>
            </AUTH>
          </SECTION>
          <SECTION>
            <SECTNO>1615.170 </SECTNO>
            <SUBJECT>Applicability.</SUBJECT>
            <P>FAR subpart 15.1 has no practical application to the FEHB Program because prospective contractors (carriers) are considered for inclusion in the FEHB Program according to criteria in 5 U.S.C. chapter 89 and 5 CFR part 890 rather than by competition between prospective carriers.</P>
            <P>9. Subpart 1615.2 is added to read as follows:</P>
            <CONTENTS>
              <SUBPART>
                <HD SOURCE="HED">Subpart 1615.2—Solicitation and Receipt of Proposals and Information</HD>
                <SECHD>Sec.</SECHD>
                <SECTNO>1615.270 </SECTNO>
                <SUBJECT>Applicability.</SUBJECT>
              </SUBPART>
            </CONTENTS>
            <AUTH>
              <HD SOURCE="HED">Authority:</HD>
              <P>5 U.S.C. 8913; 40 U.S.C. 486(c); 48 CFR 1.301.</P>
            </AUTH>
          </SECTION>
          <SECTION>
            <SECTNO>1615.270 </SECTNO>
            <SUBJECT>Applicability.</SUBJECT>

            <P>FAR subpart 15.2 has no practical application to the FEHB Program because OPM does not issue formal procurement solicitations to health benefits carriers. Eligible contractors (<E T="03">i.e.,</E> qualified health benefits carriers) are identified in accordance with 5 U.S.C. 8903. Offerors voluntarily come forth in accordance with procedures provided in 5 CFR part 890.</P>
          </SECTION>
          <SUBPART>
            <HD SOURCE="HED">Subpart 1615.6—[Amended]</HD>
          </SUBPART>

          <P>10. Subpart 1615.6 is redesignated as 1615.3 and Section 1615.602 is redesignated as 1615.370. In newly redesignated 1615.370 remove “15.6” and add in its place “15.3”.<PRTPAGE P="48855"/>
          </P>
          <P>11. Subpart 1615.4 is revised to read as follows:</P>
          <CONTENTS>
            <SUBPART>
              <HD SOURCE="HED">Subpart 1615.4—Contract Pricing</HD>
              <SECHD>Sec.</SECHD>
              <SECTNO>1615.402 </SECTNO>
              <SUBJECT>Pricing policy.</SUBJECT>
              <SECTNO>1615.404-4 </SECTNO>
              <SUBJECT>Profit.</SUBJECT>
              <SECTNO>1615.404-70 </SECTNO>
              <SUBJECT>Profit analysis factors.</SUBJECT>
              <SECTNO>1615.406-2 </SECTNO>
              <SUBJECT>Certificate of accurate cost or pricing data for community rated carriers.</SUBJECT>
              <SECTNO>1615.407-1 </SECTNO>
              <SUBJECT>Rate reduction for defective pricing or defective cost or pricing data.</SUBJECT>
              <SECTNO>1615.470 </SECTNO>
              <SUBJECT>Carrier investment of FEHB funds.</SUBJECT>
              <SECTNO>1615.470-1 </SECTNO>
              <SUBJECT>Investment income clause.</SUBJECT>
            </SUBPART>
          </CONTENTS>
          <AUTH>
            <HD SOURCE="HED">Authority:</HD>
            <P>5 U.S.C. 8913; 40 U.S.C. 486(c); 48 CFR 1.301.</P>
          </AUTH>
        </PART>
        <PART>
          <HD SOURCE="HED">Subpart 1615.4—Contract Pricing</HD>
          <SECTION>
            <SECTNO>1615.402</SECTNO>
            <SUBJECT>Pricing policy. </SUBJECT>
            <P>Pricing of FEHB contracts is governed by 5 U.S.C. 8902(i), 5 U.S.C. 8906, and other applicable law. FAR subpart 15.4 shall be implemented by applying its policies and procedures—to the extent practicable—as follows: </P>
            <P>(a) For both experience rated and community rated contracts for which the FEHB Program premiums for the contract term will be less than the threshold at FAR 15.403-4(a)(1), OPM shall not require the carrier to provide cost or pricing data in the rate proposal for the following contract term. </P>
            <P>(b) Cost analysis shall be used for contracts where premiums and subscription income are determined on the basis of experience rating. </P>
            <P>(c)(1) A combination of cost and price analysis shall be used for contracts where premiums and subscription income are based on community rates. For contracts for which the FEHB Program premiums for the contract term will be less than the threshold at FAR 15.403-4(a)(1), OPM shall not require the carrier to provide cost or pricing data. The carrier is required to submit only a rate proposal and abbreviated utilization data for the applicable contract year. OPM will evaluate the proposed rates by performing a basic reasonableness test on the information submitted. Rates failing this test will be subject to further review. </P>
            <P>(2) For contracts with fewer than 1,500 enrollee contracts for which the FEHB Program premiums for the contract term will be at or above the threshold at FAR 15.403-4(a)(1), OPM shall require the carrier to submit its rate proposal, utilization data, and the certificate of accurate cost or pricing data required in 1615.406-2. In addition, OPM shall require the carrier to complete the proposed rates form containing cost and pricing data, and the Community Rate Questionnaire, but shall not require the carrier to send these documents to OPM. The carrier shall keep the documents on file for periodic auditor and actuarial review in accordance with 1652.204-70. OPM shall perform a basic reasonableness test on the data submitted. Rates that do not pass this test shall be subject to further OPM review. </P>
            <P>(3) For contracts with 1,500 or more enrollee contracts for which the FEHB Program premiums for the contract term will be at or above the threshold at FAR 15.403-4(a)(1), OPM shall require the carrier to provide the data and methodology used to determine the FEHB Program rates. OPM shall also require the data and methodology used to determine the rates for the carrier's similarly sized subscriber groups. The carrier shall provide cost or pricing data required by OPM in its rate instructions for the applicable contract period. OPM shall evaluate the data to ensure that the rate is reasonable and consistent with the requirements in this chapter. If necessary, OPM may require the carrier to provide additional documentation. </P>
            <P>(4) Contracts shall be subject to a downward price adjustment if OPM determines that the Federal group was charged more than it would have been charged using a methodology consistent with that used for the SSSGs. Such adjustments shall be based on the lower of the two rates determined by using the methodology (including discounts) the Carrier used for the two SSSGs. </P>
            <P>(5) FEHB Program community rated carriers shall comply with SSSG criteria provided by OPM in the rate instructions for the applicable contract period. </P>
            <P>(d) The application of FAR 15.402(b)(2) should not be construed to prohibit the consideration of preceding year surpluses or deficits in carrier-held reserves in the rate adjustments for subsequent year renewals of contracts based, in whole or in part, on cost analysis. </P>
          </SECTION>
          <SECTION>
            <SECTNO>1615.404-4 </SECTNO>
            <SUBJECT>Profit. </SUBJECT>
            <P>(a) When the pricing of FEHB Program contracts is determined by cost analysis, OPM will determine the profit or fee prenegotiation objective (service charge) portion of the contracts by use of a weighted guidelines structured approach. The service charge so determined shall be the total service charge that may be negotiated for the contract and shall encompass any service charge (whether entitled service charge, profit, fee, contribution to reserves or surpluses, or any other title) that may have been negotiated by the prime contractor with any subcontractor or underwriter. </P>
            <P>(b) OPM will not guarantee a minimum service charge. </P>
          </SECTION>
          <SECTION>
            <SECTNO>1615.404-70</SECTNO>
            <SUBJECT>Profit analysis factors. </SUBJECT>
            <P>(a) OPM contracting officers will apply a weighted guidelines method in developing the service charge prenegotiation objective for FEHB Program contracts. The following factors, as defined in FAR 15.404-4(d), will be applied to projected incurred claims and allowable administrative expenses: </P>
            <P>(1) <E T="03">Contractor performance.</E> OPM will consider such elements as the accurate and timely processing of benefit claims and the volume and validity of disputed claims as measures of economical and efficient contract performance. This factor will be judged apart from the contractor's basic responsibility for contract performance and will be a measure of the extent and nature of the contractor's contribution to the FEHB Program through the application of managerial expertise and effort. Evidence of effective contract performance will receive a plus weight, and poor performance or failure to comply with contract terms and conditions a negative weight. Innovations of benefit to the FEHB Program will generally result in a positive weight; documented inattention or indifference to cost control will generally result in a negative weight. </P>
            <P>(2) <E T="03">Contract cost risk.</E> In assessing the degree of cost responsibility and associated risk assumed by the contractor as a factor to be considered in negotiating profit, OPM will consider such underwriting elements as the availability of margins, group size, enrollment demographics and fluctuation, and the probability of conversion and adverse selection, as well as the extent of financial assistance the carrier renders to the contract. However, the “loss carry forward basis” of experience rated group insurance practices, which mitigates contract risk, will likely serve to diminish this profit analysis factor in an overall determination of profit. This factor is intended to provide profit opportunities commensurate with the contractor's share of cost risks only, taking into account elements such as the adequacy and reliability of data for estimating costs. </P>
            <P>(3) <E T="03">Federal socioeconomic programs.</E> OPM will consider documented evidence of successful, contractor-initiated efforts to support Federal socioeconomic programs such as drug and substance abuse deterrents and concerns of the type enumerated in FAR 15.404-4(d)(iii), as a factor in negotiating profit. This factor will be <PRTPAGE P="48856"/>assessed by considering the quality of the contractor's policies and procedures and the extent of unusual effort or achievement demonstrated. Evidence of effective support of Federal socioeconomic programs will receive a positive weight; poor support will receive a negative weight. </P>
            <P>(4) <E T="03">Capital investments.</E> This factor is generally not applicable to FEHB Program contracts because facilities capital cost of money may be an allowable administrative expense. Generally, this factor shall be given a weight of zero. However, special purpose facilities or investment costs of direct benefit to the FEHB Program that are not recoverable as allowable or allocable administrative expenses may be taken into account in assigning a positive weight.</P>
            <P>(5) <E T="03">Cost control.</E> OPM will consider contractor-initiated efforts such as improved benefit design, cost-sharing features, innovative peer review, or other professional cost containment efforts as a factor in negotiating profit. OPM shall use this factor to reward contractors with additional profit opportunities for self-initiated efforts to control contract costs. </P>
            <P>(6) <E T="03">Independent development.</E> OPM will consider any profit opportunities that may be directly related to relevant independent efforts such as the development of a unique and enhanced customer support system that is of demonstrated value to the FEHB Program and for which developmental costs have not been recovered directly or indirectly through allowable administrative expenses. OPM will use this factor to provide additional profit opportunities based upon an assessment of the contractor's investment and risk in developing techniques, methods, and practices having viability to the program at large. OPM will not consider improvements and innovations recognized and rewarded under any of the other profit factors. </P>
            <P>(b) The weight ranges for each factor to be used in the weighted guidelines approach are set forth as follows:</P>
            <GPOTABLE CDEF="s50,r75" COLS="2" OPTS="L2,tp0,i1">
              <TTITLE>  </TTITLE>
              <BOXHD>
                <CHED H="1">Profit factor </CHED>
                <CHED H="1">Weight ranges <LI>(percent) </LI>
                </CHED>
              </BOXHD>
              <ROW>
                <ENT I="01">1. Contractor performance </ENT>
                <ENT>−.2 to + .45 </ENT>
              </ROW>
              <ROW>
                <ENT I="01">2. Contract cost risk* </ENT>
                <ENT>+.02 to + .2 </ENT>
              </ROW>
              <ROW>
                <ENT I="01">3. Federal socioeconomic programs </ENT>
                <ENT>−.05 to + .05 </ENT>
              </ROW>
              <ROW>
                <ENT I="01">4. Capital investments </ENT>
                <ENT>0 to +.02 </ENT>
              </ROW>
              <ROW>
                <ENT I="01">5. Cost control </ENT>
                <ENT>0 to +.35 </ENT>
              </ROW>
              <ROW>
                <ENT I="01">6. Independent development </ENT>
                <ENT>0 to +.03 </ENT>
              </ROW>
              <TNOTE>*The contract cost risk factor is subdivided into two parts: group size (.02 to .10) and other risk elements (0 to .10). With respect to the group size element, subweights should be assigned as follows: </TNOTE>
            </GPOTABLE>
            <GPOTABLE CDEF="s50,r75" COLS="2" OPTS="L2,tp0,i1">
              <TTITLE>  </TTITLE>
              <BOXHD>
                <CHED H="1">Enrollment </CHED>
                <CHED H="1">Weight (percent) </CHED>
              </BOXHD>
              <ROW>
                <ENT I="01">10,000 or less </ENT>
                <ENT>.06 to .10 </ENT>
              </ROW>
              <ROW>
                <ENT I="01">10,001-50,000 </ENT>
                <ENT>.05 to .09 </ENT>
              </ROW>
              <ROW>
                <ENT I="01">50,001-200,000 </ENT>
                <ENT>.04 to .07 </ENT>
              </ROW>
              <ROW>
                <ENT I="01">200,001-500,000 </ENT>
                <ENT>.03 to .06 </ENT>
              </ROW>
              <ROW>
                <ENT I="01">500,001 and over </ENT>
                <ENT>.02 to .04 </ENT>
              </ROW>
            </GPOTABLE>
          </SECTION>
          <SECTION>
            <SECTNO>1615.406-2</SECTNO>
            <SUBJECT>Certificate of accurate cost or pricing data for community rated carriers. </SUBJECT>
            <P>The contracting officer shall require a carrier with a contract meeting the requirements in 1615.402(c)(2) or 1615.402(c)(3) to execute the Certificate of Accurate Cost or Pricing Data contained in this section. A carrier with a contract meeting the requirements in 1615.402(c)(2) shall complete the Certificate and keep it on file at the carrier's place of business in accordance with 1652.204-70. A carrier with a contract meeting the requirements in 1615.402(c)(3) shall submit the Certificate to OPM along with its rate reconciliation, which is submitted during the first quarter of the applicable contract year.</P>
            <EXTRACT>
              <HD SOURCE="HD1">Certificate of Accurate Cost or Pricing Data for Community Rated Carriers </HD>
              <P>This is to certify that, to the best of my knowledge and belief: (1) The cost or pricing data submitted (or, if not submitted, maintained and identified by the carrier as supporting documentation) to the Contracting Officer or the Contracting Officer's representative or designee, in support of the ____* FEHB Program rates were developed in accordance with the requirements of 48 CFR Chapter 16 and the FEHB Program contract and are accurate, complete, and current as of the date this certificate is executed; and (2) the methodology used to determine the FEHB Program rates is consistent with the methodology used to determine the rates for the carrier's Similarly Sized Subscriber Groups.</P>
              <FP>Firm:______</FP>
              <FP>Name: ______</FP>
              <FP>Signature: ______</FP>
              <FP>Date of Execution: ______</FP>
              
              <FP>*Insert the year for which the rates apply. Normally, this will be the year for which the rates are being reconciled. </FP>
              <FP>(End of Certificate) </FP>
            </EXTRACT>
          </SECTION>
          <SECTION>
            <SECTNO>1615.407-1 </SECTNO>
            <SUBJECT>Rate reduction for defective pricing or defective cost or pricing data. </SUBJECT>
            <P>The clause set forth in section 1652.215-70 shall be inserted in FEHB Program contracts, at or above the threshold in FAR 15.403-4(a)(1), that are based on a combination of cost and price analysis (community rated). </P>
          </SECTION>
          <SECTION>
            <SECTNO>1615.470 </SECTNO>
            <SUBJECT>Carrier investment of FEHB funds. </SUBJECT>
            <P>(a) Except for contracts based on a combination of cost and price analysis (community rated), the carrier is required to invest and reinvest all funds on hand, including any attributable to the special reserve or the reserve for incurred but unpaid claims, exceeding the funds needed to discharge promptly the obligations incurred under the contract. </P>
            <P>(b) The carrier is required to credit income earned from its investment of FEHB funds to the special reserve on behalf of the FEHB Program. If a carrier, for any reason, fails to invest excess FEHB funds or to credit any income due to the contract, it shall return or credit any investment income lost to OPM or the special reserve. </P>
            <P>(c) Investment income. Investment income is the net amount earned by the carrier after deducting investment expenses. </P>
          </SECTION>
          <SECTION>
            <SECTNO>1615.470-1 </SECTNO>
            <SUBJECT>Investment income clause. </SUBJECT>
            <P>The clause set forth in 1652.215-71 shall be inserted in all FEHB contracts based on cost analysis. </P>
          </SECTION>
          <SUBPART>
            <HD SOURCE="HED">Subpart 1615.8 [Reserved] </HD>
          </SUBPART>
          <P>12. Subpart 1615.8 is removed and reserved. </P>
          <SUBPART>
            <HD SOURCE="HED">Subpart 1615.9 [Reserved] </HD>
          </SUBPART>
          <P>13. Subpart 1615.9 is removed and reserved. </P>
          <SUBPART>
            <HD SOURCE="HED">Subpart 1615.70—Audit and Records—Negotiation </HD>
          </SUBPART>
          <P>14. Section 1615.7001 is added to read as follows: </P>
          <SECTION>
            <SECTNO>1615.7001 </SECTNO>
            <SUBJECT>Audit and records. </SUBJECT>
            <P>The Contracting Officer shall modify 52.215-2 in all FEHB Program experience rated contracts by amending paragraph (g) of that section to replace the words “exceed the simplified acquisition threshold” with “equals or exceeds $550,000.” </P>
            <HD SOURCE="HD1">SUBCHAPTER E—GENERAL CONTRACTING REQUIREMENTS </HD>
          </SECTION>
        </PART>
        <PART>
          <HD SOURCE="HED">PART 1631—CONTRACT COST PRINCIPLES AND PROCEDURES </HD>
          <SUBPART>
            <HD SOURCE="HED">Subpart 1631.2—Contracts With Commercial Organizations </HD>
          </SUBPART>
          <P>15. A new 1631.205-81, is added to read as follows: </P>
          <SECTION>
            <PRTPAGE P="48857"/>
            <SECTNO>1631.205-81 </SECTNO>
            <SUBJECT>Inferred Reasonableness. </SUBJECT>
            <P>If the Carrier follows the notification and consent requirements of paragraphs (a), (b) and (c) of 1652.244-70, and subsequently obtains the Contracting Officer's consent or ratification, then the reasonableness of the subcontract's costs will be inferred. </P>
          </SECTION>
        </PART>
        <PART>
          <HD SOURCE="HED">PART 1632—CONTRACT FINANCING </HD>
          <SUBPART>
            <HD SOURCE="HED">Subpart 1632.1—General </HD>
            <SECTION>
              <SECTNO>1632.170 </SECTNO>
              <SUBJECT>[Amended] </SUBJECT>
              <P>16. In 1632.170, remove paragraph (c). </P>
            </SECTION>
          </SUBPART>
          <SUBPART>
            <HD SOURCE="HED">Subpart 1632.7—Contract Funding </HD>
            <SECTION>
              <SECTNO>1632.771 </SECTNO>
              <SUBJECT>[Amended]</SUBJECT>
              <P>17. In 1632.771 paragraph (d), remove “1652.232-70” and add in its place “1652.232-72.” </P>
            </SECTION>
            <SECTION>
              <SECTNO>1632.772 </SECTNO>
              <SUBJECT>[Amended] </SUBJECT>
              <P>18. In 1632.772, remove “1652.232-70” and add in its place “1652.232-72.” </P>
              <HD SOURCE="HD1">SUBCHAPTER G—CONTRACT MANAGEMENT </HD>
            </SECTION>
          </SUBPART>
        </PART>
        <PART>
          <HD SOURCE="HED">PART 1644—SUBCONTRACTING POLICIES AND PROCEDURES </HD>
          <SUBPART>
            <HD SOURCE="HED">Subpart 1644.1—General </HD>
          </SUBPART>
          <P>19. Section 1644.170 is revised to read as follows: </P>
          <SECTION>
            <SECTNO>1644.170 </SECTNO>
            <SUBJECT>Policy for FEHB Program subcontracting consent. </SUBJECT>
            <P>For all experience rated contracts, the Carriers shall notify the Contracting Officer in writing at least 60 days in advance of entering into any subcontract or subcontract modification, or as otherwise specified by the contract, if the amount of the subcontract or modification charged to the FEHB Program equals or exceeds $550,000. Failure to provide advance notice may result in the Contracting Officer's disallowance of the costs. In determining whether the amount chargeable to the FEHB Program contract for a given subcontract or modification equals or exceeds the $550,000 threshold, the following rules apply: </P>
            <P>(a) For initial advance notification, the Carrier shall add the total price for the base year and all options, including quantity or service options and option periods, and </P>
            <P>(b) The Carrier shall give advance notification of modifications not accounted for in paragraph (a) of this section that cause the total price to equal or exceed the threshold. Carriers shall follow appropriate procurement procedures that comply with the Federal Acquisition Regulation's (FAR) policies and procedures relating to competition and contract pricing for the acquisition of both commercial and non-commercial items. All subcontracts or subcontract modifications that equal or exceed the threshold are subject to audit under FAR 52.215-2 Audit and Records—Negotiation. </P>
            <HD SOURCE="HD1">SUBCHAPTER H—CLAUSES AND FORMS </HD>
          </SECTION>
        </PART>
        <PART>
          <HD SOURCE="HED">PART 1652—CONTRACT CLAUSES </HD>
          <SUBPART>
            <HD SOURCE="HED">Subpart 1652.2—Texts of FEHB Program Clauses </HD>
          </SUBPART>
          <P>20. Section 1652.204-70 is revised to read as follows: </P>
          <SECTION>
            <SECTNO>1652.204-70 </SECTNO>
            <SUBJECT>Contractor Records Retention. </SUBJECT>
            <P>As prescribed in 1604.705 the following clause shall be inserted in all FEHB Program contracts. </P>
            
            <EXTRACT>
              <HD SOURCE="HD1">Contractor Records Retention (Jan 2003) </HD>
              <P>Notwithstanding the provisions of Section 5.7 (FAR 52.215-2(f)) Audit and Records—Negotiation, the Carrier shall retain and make available all records applicable to a contract term that support the annual statement of operations and, for contracts that equal or exceed the threshold at FAR 15.403-4(a)(1), the rate submission for that contract term for a period of 6 years after the end of the contract term to which the records relate. This includes all records of large provider agreements and subcontracts that equal or exceed the threshold requirements. In addition, individual enrollee and/or patient claim records shall be maintained for 6 years after the end of the contract term to which the claim records relate. </P>
              <FP>(End Clause) </FP>
            </EXTRACT>
            
            <P>21. Section 1652.204-74 is added to read as follows: </P>
          </SECTION>
          <SECTION>
            <SECTNO>1652.204-74 </SECTNO>
            <SUBJECT>Large provider agreements. </SUBJECT>
            <P>As prescribed by 1604.7202, the contracting officer shall insert the following clause in all FEHB Program contracts based on cost analysis (experience rated): </P>
            <EXTRACT>
              <HD SOURCE="HD1">Large Provider Agreements (JAN 2003) </HD>
              <P>(a) <E T="03">Notification and Information Requirements.</E> (1) The experience rated Carrier must provide notice to the contracting officer of its intent to enter into or to make a significant modification of a large provider agreement: </P>
              <P>(i) Not less than 60 days before entering into any large provider agreement; and </P>
              <P>(ii) Not less than 60 days before exercising a renewal or other option, or significant modification to a large provider agreement. </P>
              <P>(2) The Carrier's notification to the contracting officer must be in writing and must, at a minimum: </P>
              <P>(i) Describe the supplies and/or services the proposed provider agreement will require; </P>
              <P>(ii) Identify the proposed basis for reimbursement; </P>
              <P>(iii) Identify the proposed provider agreement, explain why the Carrier selected the proposed provider, and what contracting method it used, where applicable, including the kind of competition obtained; </P>
              <P>(iv) Describe the methodology the carrier used to compute the provider's profit; and, </P>
              <P>(v) Describe provider risk provisions. </P>
              <P>(3) The Contracting Officer may request from the Carrier any additional information on a proposed provider agreement and its terms and conditions prior to a provider award and during the performance of the agreement. </P>
              <P>(4) Within 30 days of receiving the Carrier's notification, the Contracting Officer will give the Carrier either written comments or written notice that there will be no comments. If the Contracting Officer comments, the Carrier must respond in writing within 10 calendar days, and explain how it intends to address any concerns. </P>
              <P>(5) The Contracting Officer may inform the Carrier that if it awards the provider agreement before addressing OPM's concerns, it may not charge costs incurred under the agreement to the contract. </P>
              <P>(6) When computing the carrier's service charge, the Contracting Officer will consider how well the Carrier complies with the provisions of this section, including the advance notification requirements, as an aspect of the Carrier's performance factor. </P>
              <P>(7) The Contracting Officer's review of any provider agreement, option, renewal, or modification shall not constitute a determination of the acceptability of the terms and conditions of any provider agreement or of the allowability of any costs under the Carrier's contract, nor shall it relieve the Carrier of any responsibility for performing the contract. </P>
              <P>(b) <E T="03">Records and Inspection.</E> The Carrier must insert in all large provider agreements the requirement that the provider will retain and make available to the Government all records relating to the agreement that support the annual statement of operations and enrollee records—Retain for 6 years after the agreement term ends. </P>
              <P>(c) <E T="03">Audit.</E> The provisions of FAR 52.215-2, Audit and Records—Negotiation, apply to all experience rated Carriers' large provider agreements. The Carrier shall insert the clause, 52.215-2, in all large provider agreements and shall substitute </P>
              <P>(1) The term “provider” for the term “Contractor” throughout the clause, and </P>
              <P>(2) The term “large provider contracts” for the term “Subcontracts” in paragraph (g) of FAR 52.215-2. The term “Contracting Officer” shall mean the FEHB Program Contracting Officer at OPM. The Carrier shall be responsible for ensuring the large provider complies with the provisions set forth in the clause. </P>
              <P>(d) <E T="03">Prohibited Agreements.</E> No provider agreement made under this contract shall provide for payment on a cost-plus-a-percentage-of-cost basis. </P>
              <P>(e) The Carrier shall insert this clause, 1652.204-74, in all large provider agreements. </P>
              <FP>(End of Clause)</FP>
            </EXTRACT>
          </SECTION>
          <SECTION>
            <PRTPAGE P="48858"/>
            <SECTNO>1652.215-70 </SECTNO>
            <SUBJECT>(Amended) </SUBJECT>
            <P>22. In the introductory text of section 1652.215-70, remove “1615.804.72” and add in its place “1615.407-1,” remove “15.804-2(a)(1)” and add in its place “15.403-4(a)(1),” in the clause title, remove “JAN 2000” and add in its place “JAN 2003,” in paragraph (a)(1) of the clause remove “1615.804.70” and add in its place “1615.406-2,” and remove paragraph (d). </P>
          </SECTION>
          <SECTION>
            <SECTNO>1652.215-71 </SECTNO>
            <SUBJECT>[Amended] </SUBJECT>
            <P>23. In the introductory text of section 1652.215-71, remove “1615.805-71” and add in its place “1615.470-1.” </P>
          </SECTION>
          <SECTION>
            <SECTNO>1652.216-70 </SECTNO>
            <SUBJECT>[Amended] </SUBJECT>
            <P>24. In 1652.216-70, remove “JAN 2000” in the clause title and add in its place “JAN 2003,” and remove paragraph (c) of the clause. </P>
          </SECTION>
          <SECTION>
            <SECTNO>1652.216-71 </SECTNO>
            <SUBJECT>[Amended] </SUBJECT>
            <P>25. In 1652.216-71, remove “JAN 2000” in the clause title and add in its place “JAN 2003,” and remove paragraph (d) of the clause. </P>
            <P>26. In 1652.222-70, paragraph (d) of the clause is revised to read as follows: </P>
          </SECTION>
          <SECTION>
            <SECTNO>1652.222-70 </SECTNO>
            <SUBJECT>Notice of Significant Events. </SUBJECT>
            <STARS/>
            <EXTRACT>
              <HD SOURCE="HD1">Notice of Significant Events (Jan 2001) </HD>
              <STARS/>
              <P>(d) The Carrier shall insert this clause in any subcontract or subcontract modification if the amount of the subcontract or modification charged to the FEHB Program (or in the case of a community rated carrier, applicable to the FEHB Program) equals or exceeds $550,000. </P>
              <FP>(End of Clause)</FP>
            </EXTRACT>
            
            <P>27. Section 1652.244-70, is revised to read as follows: </P>
          </SECTION>
          <SECTION>
            <SECTNO>1652.244-70 </SECTNO>
            <SUBJECT>Subcontracts. </SUBJECT>
            <P>As prescribed in section 1644.270, the following clause shall be inserted in all FEHB Program contracts based on cost analysis (experience rated): </P>
            <EXTRACT>
              <HD SOURCE="HD3">Subcontracts (Jan 2003) </HD>
              <P>(a) The Carrier shall notify the Contracting Officer in writing at least 60 days in advance of entering into any subcontract or subcontract modification, or as otherwise specified by this contract, if the amount of the subcontract or modification charged to the FEHB Program equals or exceeds $550,000. Failure to provide advance notice may result in the Contracting Officer's disallowance of the costs. In determining whether the amount chargeable to the FEHB Program contract for a given subcontract or modification equals or exceeds the $550,000 threshold, the following rules apply: </P>
              <P>(1) For initial advance notification, the Carrier shall add the total price for the base year and all options, including quantity or service options and option periods, and </P>
              <P>(2) The Carrier shall give advance notification of modifications not accounted for in paragraph (a) of this clause, if they cause the total price to equal or exceed the threshold. The Carrier shall follow appropriate procurement procedures that comply with the Federal Acquisition Regulation's (FAR) policies and procedures relating to competition and contract pricing for the acquisition of both commercial and non-commercial items. All subcontracts or subcontract modifications that equal or exceed the threshold are subject to audit under FAR 52.215-2 Audit and Records-Negotiations. </P>
              <P>(b) The advance notification required by paragraph (a) of this clause shall include the information specified below: </P>
              <P>(1) A description of the supplies or services to be subcontracted; </P>
              <P>(2) Identification of the type of subcontract to be used; </P>
              <P>(3) Identification of the proposed subcontractor and an explanation of why and how the proposed subcontractor was selected, including the competition obtained; </P>
              <P>(4) The proposed subcontract price and the Carrier's cost or price analysis; </P>
              <P>(5) An explanation of why the subcontract has been categorized as a subcontract for a commercial item as defined in 48 CFR 2.101. If the subcontract is not for a commercial item, then the subcontractor's current, complete, and accurate cost or pricing data and a Certificate of Current Cost or Pricing Data must be submitted to the Contracting Officer. </P>
              <P>(6) (Reserved) </P>
              <P>(7) A negotiation memorandum reflecting— </P>
              <P>(i) The principal elements of the subcontract price negotiations; </P>
              <P>(ii) The most significant consideration controlling establishment of initial or revised prices; </P>
              <P>(iii) An explanation of the reason cost or pricing data are not required, if the item is not a commercial item but the carrier believes that cost or pricing data are not required.</P>
              <P>(iv) The extent, if any, to which the Carrier did not rely on the subcontractor's cost or pricing data in determining the price objective and in negotiating the final price; </P>
              <P>(v) The extent, if any, to which it was recognized in the negotiation that the subcontractor's cost or pricing data were not accurate, complete, or current; the action taken by the Carrier and the subcontractor; and the effect of any such defective data on the total price negotiated; </P>
              <P>(vi) The reasons for any significant difference between the Carrier's price objective and the price negotiated; and </P>
              <P>(vii) A complete explanation of the incentive fee or profit plan, when incentives are used. The explanation shall identify each critical performance element, management decisions used to quantify each incentive element, reasons for the incentives, and a summary of all trade-off possibilities considered. </P>
              <P>(c) The Carrier shall obtain the Contracting Officer's written consent before placing any subcontract for which advance notification is required under paragraph (a) of this clause. However, the Contracting Officer may ratify in writing any such subcontract for which written consent was not obtained. Ratification shall constitute the consent of the Contracting Officer. </P>
              <P>(d) The Contracting Officer may waive the requirement for advance notification and consent required by paragraphs (a), (b) and (c) of this clause where the Carrier and subcontractor submit an application or renewal as a contractor team arrangement as defined in FAR Subpart 9.6 and— </P>
              <P>(1) The Contracting Officer evaluated the arrangement during negotiation of the contract or contract renewal; and </P>
              <P>(2) The subcontractor's price and/or costs were included in the Plan's rates that were reviewed and approved by the Contracting Officer during negotiation of the contract or contract renewal. </P>
              <P>(e) If the Carrier follows the notification and consent requirements of paragraphs (a), (b) and (c) of this clause and subsequently obtains the Contracting Officer's consent or ratification, then the reasonableness of the subcontract's costs will be inferred as provided for in 1631.205-81. However, consent or ratification by the Contracting Officer will not constitute a determination </P>
              <P>(1) Of the acceptability of any subcontract terms or conditions; </P>
              <P>(2) Of the allowability of any cost under this contract; or </P>
              <P>(3) That the Carrier should be relieved of any responsibility for performing this contract. </P>
              <P>(f) No subcontract placed under this contract shall provide for payment on a cost-plus-a-percentage-of-cost basis. Any fee payable under cost reimbursement type subcontracts shall not exceed the fee limitations in FAR 15.404-4(c)(4)(i). Any profit or fee payable under a subcontract shall be in accordance with the provision of Section 3.7, Service Charge. </P>
              <P>(g) The Carrier shall give the Contracting Officer immediate written notice of any action or suit filed and prompt notice of any claim made against the Carrier by any subcontractor or vendor that, in the opinion of the Carrier, may result in litigation related in any way to this contract with respect to which the Carrier may be entitled to reimbursement from the Government. </P>
              <FP>(End of Clause) </FP>
            </EXTRACT>
          </SECTION>
          <SUBPART>
            <HD SOURCE="HED">Subpart 1652.3-FEHB Program Clause Matrix </HD>
          </SUBPART>
          <P>28. In section 1652.370, the FEHB Program Clause Matrix, is revised to read as follows: </P>
          <SECTION>
            <SECTNO>1652.370 </SECTNO>
            <SUBJECT>Use of the Matrix. </SUBJECT>
            <STARS/>
            <BILCOD>BILLING CODE 6325-50-P</BILCOD>
            <GPH DEEP="640" SPAN="3">
              <PRTPAGE P="48859"/>
              <GID>EP15AU03.065</GID>
            </GPH>
            <GPH DEEP="640" SPAN="3">
              <PRTPAGE P="48860"/>
              <GID>EP15AU03.066</GID>
            </GPH>
            <GPH DEEP="640" SPAN="3">
              <PRTPAGE P="48861"/>
              <GID>EP15AU03.067</GID>
            </GPH>
            <GPH DEEP="640" SPAN="3">
              <PRTPAGE P="48862"/>
              <GID>EP15AU03.068</GID>
            </GPH>
            <PRTPAGE P="48863"/>
          </SECTION>
        </PART>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20857 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 6325-50-C</BILCOD>
    </PRORULE>
    <PRORULE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF TRANSPORTATION </AGENCY>
        <SUBAGY>Federal Motor Carrier Safety Administration </SUBAGY>
        <CFR>49 CFR Part 380 </CFR>
        <DEPDOC>[Docket No. FMCSA-97-2199] </DEPDOC>
        <RIN>RIN 2126-AA09 </RIN>
        <SUBJECT>Minimum Training Requirements for Entry-Level Commercial Motor Vehicle Operators </SUBJECT>
        <DATE>August 4, 2003. </DATE>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Federal Motor Carrier Safety Administration, DOT. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of proposed rulemaking (NPRM); request for comments. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The Federal Motor Carrier Safety Administration (FMCSA) is proposing standards for mandatory training requirements for entry-level operators of commercial motor vehicles (CMVs) who are required to hold or obtain a commercial driver's license (CDL). This action responds to a study mandated by the Intermodal Surface Transportation Efficiency Act of 1991 that found the training of entry-level drivers in the heavy truck, motorcoach, and school bus industries was not adequate. The purpose of this proposal is to enhance the safety of CMV operations on our nation's highways. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Submit comments on or before October 14, 2003. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>You may submit comments identified by DOT DMS Docket Number FMCSA-1997-2199 by any of the following methods: </P>
          <P>• <E T="03">Web Site: http://dms.dot.gov.</E> Follow the instructions for submitting comments on the DOT electronic docket site. </P>
          <P>• <E T="03">Fax:</E> 1-202-493-2251. </P>
          <P>• <E T="03">Mail:</E> Docket Management Facility; U.S. Department of Transportation, 400 Seventh Street, SW., Nassif Building, Room PL-401, Washington, DC 20590-0001. </P>
          <P>• <E T="03">Hand Delivery:</E> Room PL-401 on the plaza level of the Nassif Building, 400 Seventh Street SW., Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday, except Federal holidays. </P>
          <P>• <E T="03">Federal eRulemaking Portal:</E> Go to <E T="03">http://www.regulations.gov.</E> Follow the online instructions for submitting comments. </P>
          <P>
            <E T="03">Instructions:</E> All submissions must include the agency name and docket number or Regulatory Identification Number (RIN) for this rulemaking. Note that all comments received will be posted without change to <E T="03">http://dms.dot.gov,</E> including any personal information provided. Please see the Privacy Act heading for further information. </P>
          <P>
            <E T="03">Docket:</E> For access to the docket to read background documents or comments received, go to <E T="03">http://dms.dot.gov</E> at any time or to Room PL-401 on the plaza level of the Nassif Building, 400 Seventh Street SW., Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday, except Federal holidays. </P>
          <P>
            <E T="03">Privacy Act:</E> Anyone is able to search the electronic form of all comments received into any of our dockets by the name of the individual submitting the comment (or signing the comment, if submitted on behalf of an association, business, labor union, <E T="03">etc.</E>). You may review DOT's complete Privacy Act Statement in the <E T="04">Federal Register</E> published on April 11, 2000 (Volume 65, Number 70; Pages 19477-78) or you may visit <E T="03">http://dms.dot.gov.</E>
          </P>
          <P>Comments received after the comment closing date will be included in the docket and we will consider late comments to the extent practicable. The FMCSA may, however, issue a final rule at any time after the close of the comment period. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Mr. Ronald Finn, Office of Safety Programs, (202) 366-0647, Federal Motor Carrier Safety Administration, 400 Seventh Street SW., Washington, DC 20590. Office hours are from 7:45 a.m. to 4:15 p.m. e.t., Monday through Friday, except Federal holidays. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P/>
        <HD SOURCE="HD1">Background </HD>
        <HD SOURCE="HD2">Training Curricula </HD>
        <P>In the early 1980's, the agency determined that there was a need for technical guidance in the area of truck driver training. Research showed that few driver training institutions offered a structured curriculum or a standardized training program for any type of CMV. </P>
        <P>In 1984, the agency developed the “Proposed Minimum Standards for Training Tractor-Trailer Drivers” as a curriculum standard based upon research conducted by the agency. The proposed minimum curriculum standards were used by the agency to produce a curriculum for the heavy truck industry. This Model Curriculum contains standardized minimum core curriculum requirements and training materials as well as guidelines pertaining to vehicles, facilities, instructor hiring practices, graduation requirements, and student placement. Curriculum content addresses the following areas: basic operation, safe operating practices, vehicle maintenance, and non-vehicle activities. In 1995, the agency created a similar curriculum, the “Model Curriculum for Training Motorcoach Drivers,” that can be used to train motorcoach drivers. </P>
        <P>In 1986, the motor carrier, truck driver training school, and insurance industries created the Professional Truck Driver Institute (PTDI) to certify training programs offered by training institutions. The PTDI used the truck driver Model Curriculum as the basis for its training institute certification criteria and has recently made major revisions to its curriculum. As of December 2002, 71 training schools were PTDI certified. </P>
        <HD SOURCE="HD2">The Commercial Motor Vehicle Safety Act of 1986 and the CDL Program </HD>

        <P>The Commercial Motor Vehicle Safety Act of 1986 (CMVSA) (49 U.S.C. 31301 <E T="03">et seq.</E>) established national minimum testing and licensing standards for operators of CMVs. The goal was to ensure that drivers of large trucks and buses possess the knowledge and skill necessary to safely operate on public highways. The CMVSA established the CDL program and directed the agency to establish minimum Federal standards that States must meet when licensing CMV drivers. The CMVSA applies to anyone who operates a CMV in interstate or intrastate commerce, including employees of Federal, State, and local governments. As defined by the implementing regulation in 49 CFR 383.5, a CMV is a motor vehicle or combination of motor vehicles used in commerce to transport passengers or property if the vehicle:</P>
        <P>(a) Has a gross combination weight rating (GCWR) of 11,794 or more kilograms (26,001 or more pounds) inclusive of a towed unit with a gross vehicle weight rating (GVWR) of more than 4,536 kilograms (10,000 pounds); or </P>
        <P>(b) Has a GVWR of 11,794 or more kilograms (26,001 or more pounds); or </P>
        <P>(c) Is designed to transport 16 or more passengers, including the driver; or </P>
        <P>(d) Is of any size and is used in the transportation of <E T="03">hazardous materials</E> as defined in this section. </P>
        <P>
          <E T="03">See</E> the FMCSA's recently published interim final rule entitled “Limitations on the Issuance of Commercial Driver's Licenses with a Hazardous Materials Endorsement” (68 FR 23844, 23849; May 5, 2003) implementing certain requirements in section 1012 of the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (USA PATRIOT Act) [Pub. L. <PRTPAGE P="48864"/>107-56, October 26, 2001, 115 Stat. 272]. The definition of the term “hazardous of materials” was changed to include any material listed as a select agent or toxin by the Centers for Disease Control and Prevention (CDC) in 42 CFR part 73. </P>
        <P>In accordance with the CMVSA, all drivers of CMVs must possess a valid CDL in order to be properly qualified to operate the vehicle(s) they drive. In addition to passing the CDL knowledge and skill tests required for the basic vehicle group, all persons who operate or anticipate operating the following vehicles, which have special handling characteristics, must obtain endorsements under § 383.93: </P>
        <P>(a) Double/triple trailers; </P>
        <P>(b) Passenger vehicles; </P>
        <P>(c) Tank vehicles; or </P>
        <P>(d) Vehicles required to be placarded for hazardous materials. </P>
        <P>The driver is required to pass a knowledge test for all endorsements. The driver must also pass a skill test to obtain a passenger vehicle endorsement. </P>
        <P>The CDL requirements address driver testing and licensing. The CMVSA does not contain any provisions specifically addressing driver training. Accordingly, there are no prerequisite Federal training requirements to obtain a CDL. Generally, drivers individually prepare for the CDL tests by studying such areas as vehicle inspection procedures, off-road vehicle maneuvers and operating a CMV in traffic. </P>
        <P>The agency here is proposing required training in the following four additional areas: driver qualifications, hours of service of drivers, driver wellness, and whistle blower protection. The CDL tests do not cover these subject areas and the agency believes that a driver's knowledge of these areas is vital to large truck and bus safety. </P>
        <P>This proposal is part of an overall FMCSA effort to improve the CDL program, which also involves improvements to the CDL tests, and a graduated licensing study. Section 4019 of the Transportation Equity Act for the 21st Century (Pub.L. 105-178; June 9, 1998) required the agency to determine if the current system of CDL testing is an accurate measure of an applicant's knowledge and skill needed to operate a CMV. As a result, the questions used in the CDL knowledge tests are currently being revised to insure that test questions and answers adequately cover the required knowledge the driver needs to operate a CMV. </P>

        <P>The agency is examining the various skill test components to determine whether testing modifications are necessary. If testing modifications are needed, the agency may develop a future rulemaking, which modifies the testing procedures. Section 4019 also required the agency to identify the costs and benefits of a graduated licensing system. The agency published a notice in the <E T="04">Federal Register</E> on February 25, 2003, asking for public comment on whether a graduated licensing system for CMV operators is a workable concept (68 FR 8798). The agency plans to use this information to help determine the costs and benefits of the graduated CDL. </P>
        <HD SOURCE="HD2">Advance Notice of Proposed Rulemaking </HD>

        <P>Pursuant to Section 4007(a)(2) of the Intermodal Surface Transportation Efficiency Act of 1991 (ISTEA), the agency began a rulemaking proceeding on the need to require training of all entry-level CMV drivers. On June 21, 1993, the agency published in the <E T="04">Federal Register</E> an advance notice of proposed rulemaking (ANPRM) entitled “Commercial Motor Vehicles: Training for All Entry Level Drivers” (58 FR 33874). The agency asked 13 questions, which addressed training adequacy standards, curriculum requirements, the CDL, the definition of “entry-level driver;” and training, pass rates and costs. There was no consensus on the issue of mandated entry-level driver training. The heavy truck and bus industries were against mandated training; the International Brotherhood of Teamsters was in favor. </P>
        <P>The agency received a total of 104 comments. When the agency published a notice on April 25, 1996, reopening the docket (61 FR 18355), it received 48 additional comments on an adequacy study, and cost-benefit analysis, both of which are discussed below. On November 13, 1996, the agency held a public meeting at the Department of Transportation headquarters in Washington, DC, to discuss mandatory training for entry-level CMV drivers. There were 26 persons who participated at the public meeting. </P>
        <P>A detailed analysis of the questions and comments appears later in this document under the heading, “Information from the ANPRM and the Public Meeting.” </P>
        <HD SOURCE="HD2">Training Adequacy Study </HD>
        <P>Concurrent with the development of the ANPRM, the agency conducted a study, as required by Section 4007(a)(1) of the ISTEA, on the effectiveness of private sector efforts to train entry-level drivers in the heavy truck, motorcoach, and school bus industries. The first step of the study involved development of a baseline training standard for both the cargo and passenger-transporting segments of the CMV industry. The next step involved collecting information on training currently being offered by the cargo and passenger-transporting segments of the CMV industry. A comparison of current training to the baseline standards was then made to determine if employer-provided training was adequate. In the final step of the study, driver and employer surveys were performed to determine what percentage of drivers were adequately trained by employers. Drivers were also asked what percentage of drivers were adequately trained by training schools. </P>
        <P>The agency assembled two groups of experts: one from the trucking sector and the other from the motorcoach and school bus sectors. The experts identified driver training baselines. The truck experts selected the Model Curriculum as a baseline. The bus experts selected a combination of the Model Curriculum and the National Highway Traffic Safety Administration (NHTSA) “School Bus Driver Instructional Program,” developed in 1974 and currently being updated. The experts reached a consensus on minimum requirements for the numbers of class and practice driving hours, student/teacher ratios, and course topics. They then developed an algorithm to quantitatively compare existing driver training with the baselines. An overall negative score demonstrated that the program was judged to be less effective than the baseline. An overall positive score showed that the program was judged to be more effective. Based on this analysis, the percentage of employers that provide entry-level drivers with adequate training was: heavy truck employers (8 percent), motorcoach employers (19 percent), and school bus operators (24 percent). </P>
        <P>One-hundred ninety-two (192) drivers were surveyed to determine the adequacy of training provided by training schools in the opinion of the drivers. Based on this survey, the percentage of drivers adequately trained by heavy truck training schools was 31 percent. The survey found that no heavy truck training school adequately trained drivers to operate school buses, and that the motor coach industry had no training school for motor coach drivers. According to the survey, the percentage of heavy truck training schools providing adequate training was 50 percent. </P>

        <P>The agency also surveyed a total of 641 employers. The percentage of employers who train drivers, according to the employer survey, was as follows: heavy truck 39 percent, motor coach 37.4 percent, and school bus 93.5 percent. <PRTPAGE P="48865"/>
        </P>
        <P>The conclusion of both the training analysis and the driver survey, using this methodology, was that neither the heavy truck, motorcoach, nor school bus segments of the CMV industry were providing adequate entry-level driver training. At the same time, the adequacy study found that the only research-based evidence on the relationship between training and accident reduction indicated that drivers with formal training are somewhat more likely to have accidents. However, the researchers concluded that the lack of uniform training standards may have masked the real effects of good training. </P>
        <P>The adequacy study found few studies within the motor carrier industry that had examined the relationship between training and accident reduction. However, Builder's Transport, Inc., a motor carrier, did a study of 2,600 trained drivers in 1994, that showed a two percent reduction in accidents per million miles driven in contrast to drivers who had no training. Schneider National, Inc., a motor carrier, also performed a study involving its training on hazard-driving conditions, and found a 40 percent reduction in accidents. In both of these studies, drivers with training had fewer accidents. </P>
        <HD SOURCE="HD2">Adequacy Study Cost-Benefit Analysis </HD>
        <P>As part of the adequacy study, the agency performed a cost-benefit analysis of training in the heavy truck industry. The analysis was limited to heavy trucks due to a scarcity of available cost data among motorcoach and school bus training programs. However, the agency believes that the findings are generally applicable to the other industries, because motor coaches and most school buses are over 11,794 kilograms (26,001 pounds), and the drivers of all three have similar responsibilities. The cost benefit analysis applied the definition of CMV contained in the CMVSA, but did not include placarded hazardous material vehicles with a GVWR less than 11,794 kilograms (26,001 pounds). The results of this earlier analysis showed a much higher cost than today's proposal, because it was based on 65.8 hours of required training. This NPRM, however, does not specify a minimum number of hours. The regulatory evaluation for this proposal is based on a total of 10<FR>1/2</FR> hours of training for heavy truck and motorcoach drivers, and 4.5 hours for school bus drivers, as discussed later in this proposal. </P>
        <HD SOURCE="HD2">Report to Congress </HD>
        <P>The Secretary of Transportation submitted the adequacy study entitled, Assessing the Adequacy of Commercial Motor Vehicle Driver Training: Final Report and the first Cost-Benefit analysis to the U.S. Congress on February 5, 1996, as required by the ISTEA. </P>
        <HD SOURCE="HD2">Information from the ANPRM and the Public Meeting </HD>
        <P>The agency received a total of 154 comments to the ANPRM and the public meeting. Some commenters responded more than once, and some commenters provided more than one answer to a particular question. </P>
        <HD SOURCE="HD3">Question 1: How Can the Adequacy of Training Be Defined? What Mechanisms Exist to Measure Adequacy? </HD>
        <P>A total of forty-seven comments were received regarding Question 1. </P>
        <P>
          <E T="03">Defining Adequacy:</E> Sixteen commenters, including the PTDI, stated that adequacy was defined either by the PTDI tractor-trailer curriculum or the Model Curriculum referenced above. Fourteen commenters, including the National Private Truck Council, stated that either the CDL in general, or the CDL tests in particular, define adequate training. The remaining comments included statements that training adequacy is defined by a job skills analysis, or that it is defined by the Model Curriculum modified for straight trucks. </P>
        <P>
          <E T="03">Measuring Adequacy:</E> Seven commenters, including the ATA, stated that the PTDI Model Curriculum is a measurement of training adequacy. Nine commenters, including the California Department of Motor Vehicles, stated that training adequacy is measured by the CDL tests. The remaining comments included statements that training adequacy is determined by comparing accident rates of trained versus untrained drivers, or that it is determined by gaining employment as a CDL driver. </P>
        <P>The agency believes that the Model Curriculum represents the basis for training adequacy. It is based on minimum training standards that were adopted by the agency after an analysis of heavy truck driver training being provided by the industry in the 1980's. Likewise, both the PTDI curriculum and the Model Curriculum for Training Motorcoach Drivers are adequate because they are based on the Model Curriculum. Finally, the agency believes that the NHTSA School Bus Driver Instructional Program is adequate. It was developed by school bus driver employers in conjunction with NHTSA. The school bus driver employers and NHTSA periodically meet to review the instructional program and make any necessary revisions. Moreover, all of the above curricula were selected as training program baselines by experts in the adequacy study. They were also developed based on the regulations and technology current at the time of development. However, the agency disagrees with commenters indicating that the knowledge to pass the CDL test is sufficient to determine training adequacy. </P>
        <P>Finally, the agency believes employers that wish to train entry-level drivers should ensure that the curriculum is suitable for the type of vehicle the driver intends to operate. For example, a modified Model Curriculum could be used to train drivers who operate straight trucks exclusively. </P>
        <HD SOURCE="HD3">Question 2: What Standards Exist to Ensure That Training Provided by Schools and Employers Is Adequate for Entry-Level Truck Driver Training? </HD>
        <P>A total of forty-three commenters responded to this question. Thirteen commenters, including the Owner-Operator Independent Drivers Association, cited either the PTDI organization or the PTDI certification process, as a standard to ensure that training provided by schools is adequate. Again, eight commenters, including the American Bus Association, cited the CDL tests. The remaining comments cited the Model Curriculum as an adequate training standard, or stated that no standard exists. </P>
        <P>The discussion to Question 1 also contains relevant information on the adequacy of driver training. In addition, the agency agrees with commenters that although the CDL requirements are a licensing standard and not a training standard, the driver must study to pass the CDL tests. </P>

        <HD SOURCE="HD3">Question 3: What Should an Adequate Truck Driver Training Program Include (<E T="03">e.g.</E> Night Driving, Behind-the-Wheel Training, and Classroom Instruction)? What Is the Minimum Amount of Time or Number of Hours That Should Be Devoted to Each of These Components? </HD>
        <P>A total of seventy-one commenters addressed this question. </P>

        <P>Eight commenters, including the ATA, stated that the training should be the PTDI curriculum for both course content and length. Three commenters, including the American Bakers Association, cited the Model Curriculum as the standard for both course content and length. The remaining comments recommend specific topics for classroom, off-road maneuvers, or on-road driving, which included down hill speed control for <PRTPAGE P="48866"/>automatic transmission-equipped vehicles, railroad grade crossing safety, and work zone safety. </P>
        <P>The ATA and the American Bakers Association stated that both the PTDI curriculum and Model Curriculum have acceptable course content and length for heavy truck drivers. The agency agrees that both curricula are acceptable because experts use the agency's Model Curriculum as a training standard in the adequacy study. </P>
        <P>In addition, all drivers who wish to obtain a CDL are required to pass specified knowledge tests. The agency and the American Association of Motor Vehicle Administrators (AAMVA) have developed a Commercial Driver's Manual to assist drivers in passing these tests. The manual instructs drivers to shift to a lower gear before starting down a steep grade in order to maintain a safe speed. The manual also has a section for railroad highway grade crossing safety, as well as work zones where the work can create a distraction for drivers and the workers may not see the driver. </P>
        <HD SOURCE="HD3">Question 4: Can Government or Private Standards That Guide the Training of Entry-Level Drivers Be Used To Determine the Adequacy of Entry-level Driver Training? Why Are These Standards Appropriate? </HD>
        <P>A total of forty-five commenters responded to this question. </P>
        <P>Eight commenters, including the ATA, mentioned either the PTDI organization or the PTDI certification process as standards for determining the adequacy of entry-level driver training. Two commenters, including the Michigan Truck Safety Commission, cited the Model Curriculum, and again, six commenters, including the American Bus Association, cited the CDL test as a standard for determining the adequacy of entry-level driver training. One employer, ITC, stated that a motor carrier approves of a training institution by hiring its students. The remaining commenters stated that the agency should establish minimum entry-level training standards and that no standard exists. </P>
        <P>As discussed above, the agency agrees with commenters that the PTDI curriculum and Model Curriculum are both voluntary government-industry developed standards that can be used to determine the adequacy of entry-level driver training. </P>
        <HD SOURCE="HD3">Question 5: To Obtain a CDL, a CMV Driver Must Demonstrate Knowledge and Skill Needed To Operate a CMV. Are These Tests Sufficiently Comprehensive To Accurately Measure a Driver's Performance? Please Explain Why or Why Not. Provide Information of Specific Deficiencies. </HD>
        <P>A total of eighty-one commenters responded to this question. Forty-two commenters, including the ATA, stated that the CDL accurately measures a driver's performance. Thirty-nine commenters, including the International Brotherhood of Teamsters, stated that the CDL does not accurately measure a driver's performance. The Teamsters stated further that mere possession of a CDL does not guarantee that the driver has the necessary experience and skill. </P>
        <P>The agency believes that the CDL gives the novice driver the basic knowledge and skill necessary to operate a CMV. However, the employer may have to provide additional safety training, or allow the driver to gain CMV-operating experience before permitting the driver to drive, for example, in hazardous weather conditions. Because of the differences in operating practices among various CMV industries, the employer should be responsible for ensuring that the driver receives the appropriate training. </P>
        <HD SOURCE="HD3">Question 6: Should Training Requirements for Entry-Level CMV Drivers be Federally Mandated? </HD>
        <P>A total of one hundred and fifty-one commenters responded to this question. Fifty-one commenters, including the Fox Valley Technical College, stated that training should be mandated. The Fox Valley Technical College stated that if training were not federally mandated, many companies would not comply. Sysco Food Services stated that training should only be mandated for companies with 50 or more new drivers. Ninety-two commenters, including the National Private Truck Council, stated that training should not be federally mandated. The National Private Truck Council stated that because the CDL is a performance based standard, training should not be mandated. Citizens Gas and Coke Utility stated that training should only be required for combination vehicles. </P>
        <P>The agency believes that mandating training only for groups of 50 or more new drivers is not consistent with the need to train all entry-level drivers. A large majority of motor carriers have six or fewer power units, and would therefore be excluded from a 50 or more driver mandate. Moreover, larger employers could limit the number of drivers hired at one time to less than 50 to avoid being subject to mandatory entry-level training requirements. The adequacy study found that neither the heavy truck, motorcoach, nor the school bus industries provided adequate entry-level driver training. As the study surveyed drivers and employers that use both single and combination vehicles, its findings lead the agency to conclude that training should be mandatory for all entry-level drivers, irrespective of the kind of vehicle they drive or the size of the employing carrier. </P>
        <HD SOURCE="HD3">Question 7: What Is an Entry-Level Driver? </HD>
        <P>A total of forty-four commenters responded to this question. Eighteen commenters, including the PTDI, stated that an entry-level driver is one who has never driven a CMV. The adequacy study found that entry-level training is training received in the first three years of driving. However, the Truckload Carriers Association and ATA indicated three years was too long. A representative of the Truckload Carriers Association stated during the public meeting that the term “entry level” is limited to the driver's first six months of driving. A representative of the ATA indicated during the public meeting that an “entry-level driver” is a person who has “a couple of years of experience.” In written comments, the ATA stated that the definition of an entry-level driver should include a driver who moves to a higher class of CMV. </P>
        <P>The agency agrees with the ATA and the Truckload Carriers Association that the three-year experience requirement cited in the adequacy study is too long, because operating experience helps CMV drivers reduce accidents caused by driver error. This rule proposes to define entry-level driver as a driver with less than two years experience operating a CMV with a CDL. </P>
        <HD SOURCE="HD3">Question 8: What Industry-Wide Initiatives or Policies, If Any, Assure That the Majority of All Entry-Level Drivers Are Trained? </HD>
        <P>A total of thirty-five commenters responded to this question. </P>

        <P>Twelve commenters, including the Distribution LTL Association, cited the PTDI curriculum, the Model Curriculum or both. Fifteen commenters, including Schneider National, cited the CDL license. Three commenters, including the Washington Department of Licensing, stated that no such initiatives or policies exist. Five commenters, including the ATA, cited insurance companies, which promote training programs for entry-level drivers.<PRTPAGE P="48867"/>
        </P>
        <HD SOURCE="HD3">Question 9: How Many Truck Driver Training Schools and Motor Carrier Programs Train Entry-Level Drivers? What Percentage of Those Enrolled, Successfully Complete Such Training? </HD>
        <P>A total of thirty commenters responded to this question. </P>
        <P>The Association of Publicly Funded Truck Driving Schools stated that there are approximately 85 such schools in the country, and that 88 to 92 percent of students successfully complete training. The ATA stated that there are 150 to 300 training schools nationwide, and that 60 to 70 percent of students successfully complete training. Mike Byrnes and Associates stated that there are approximately 375 training schools and motor carrier training programs in the United States. A representative of Robert Forman Associates stated at the public meeting that there were no motorcoach training schools in the country. </P>
        <HD SOURCE="HD3">Question 10: Is the Successful Completion of an Entry-Level CMV Driver Training Program (Either Before or After Hiring) a Requirement for the Drivers Employed by Your Company? </HD>
        <P>A total of thirty commenters responded to this question. </P>
        <P>The ATA stated that company policies generally require that new drivers receive additional training relating to the motor carrier's specific equipment and type of operation. Federal Express requires its entry-level drivers to complete a 3-week training program. Eleven commenters cited the PTDI standard. Eight commenters stated that motor carriers trained drivers to motor carrier's own standards. One commenter stated that its insurance company set training standards. </P>
        <HD SOURCE="HD3">Question 11: Describe the Training Opportunities Available for Drivers of Smaller Trucking Companies/Owner-Operators. What Percentage of Those Enrolled Successfully Completes Such Training? </HD>
        <P>A total of twenty commenters responded to this question. </P>
        <P>The National Solid Waste Management Association stated that small companies rely primarily on supervised on-the-job training to qualify new drivers. Mike Byrnes and Associates stated that some trucking schools offer weekend training for drivers of small trucking companies. The ATA believes that the percentage of truck drivers employed by small employers, who complete training, is 60 to 70 percent; the same percentage as for large employers. </P>
        <HD SOURCE="HD3">Question 12: Describe the Expected Benefits and Estimated Dollar Costs for the Following Types of Training: Residential Training at Public and Private Truck Driver Training School (e.g. Trade, Vocational, and Community College Program); a Combination of a Home Study Course and Behind-the-Wheel Training; Formal School Training; and Externships (i.e. Combination Truck Driver Training School and Motor Carrier Operation)? </HD>
        <P>A total of twenty-eight persons responded to this question. </P>
        <P>The Michigan Truck Safety Commission stated that it did not endorse home study training. The International Trucking School stated that an externship, involving both a truck driver school and a motor carrier, is the best form of training available to the student. The Association of Publicly Funded Truck Driving Schools agreed with this comment. The PTDI stated that the cost of both private schools and motor carrier training ranges from $1,500 to $6,000. The ATA stated that the costs of motor carrier-run training programs range from $3,000 to $5,000; externships cost between $3,000 and $6,000. The other cost comments were similar. At the public meeting, Northeast Career Schools stated that longer entry-level training courses involve better equipment and more qualified instructors. </P>
        <HD SOURCE="HD3">Question 13: Although the Primary Purpose of This ANPRM Is to Gather Information on Entry-Level Truck Driver Training, the Agency Would Like To Collect Some Information on the Training Experienced Drivers Receive. Please Describe the Type and Frequency of Training, If Any, That You Offer or Financially Support for the More Experienced CMV Drivers of Your Company: Is This Training Required at Certain Specific Intervals or Provided Only on an “as Needed” Basis? </HD>
        <P>A total of 18 comments responded to this question. </P>
        <P>The Association of Publicly Funded Truck Driving Schools stated that their members teach defensive driving courses, advanced driving techniques, and specialized training. Schneider National offers training in preparing logs, backing, defensive driving, injury prevention, trip planning, and efficient driving. CRST, Inc. requires all experienced drivers to be trained in a 2-day program. The ATA stated that the training for experienced drivers varies significantly from fleet to fleet. Fox Valley Technical College stated that the industry generally provides no formal training for its experienced truck drivers. The Advocates for Highway and Auto Safety stated training should be given every five years. The ATA and J.B. Hunt stated that training should be given either after accident involvement or to correct hours of service problems. </P>
        <HD SOURCE="HD2">Other Issues Raised By Commenters </HD>
        <P>The Advocates for Highway and Auto Safety stated that the adequacy study should not have excluded transit buses. </P>
        <P>Transportation performed by the Federal government, a State, or any political subdivision of a State, or an agency established under a compact between States that has been approved by the Congress of the United States, is exempt from parts 350 through 399 of the Federal Motor Carrier Safety Regulations. Transit bus operators are subject to the jurisdiction of the Federal Transit Administration (FTA) and are generally local government employees. Transit systems utilize training materials developed by the FTA. These materials cover basic vehicle controls and vehicle maneuvers in traffic. Transit systems report total bus mileage to FTA as a condition for receiving Federal grants. These grantees operated CMVs approximately 1.8 billion miles in calendar year 2000 according to the FTA's Transit Safety &amp; Security Statistics &amp; Analysis 2000 Annual Report. The report also states that there were 90 total fatalities for transit buses in calendar year 2000. Therefore, the fatal accident frequency per million miles for calendar year 2000 is approximately .048, which is very low. The agency believes that the FTA can effectively monitor transit bus system training. For these reasons, the agency is not including transit bus drivers in the proposed rule. </P>
        <P>The ATA also provided comments on the adequacy study-cost benefit analysis referenced above. ATA stated that the cost of providing adequate entry-level training exceeded the 450 million dollar per year estimate cited in that analysis. </P>
        <HD SOURCE="HD1">Summary of NPRM Provisions </HD>
        <P>This proposal is in response to a Congressional mandate in ISTEA, which directed the Secretary of Transportation to promulgate safety regulations for entry-level training of heavy truck, motorcoach, and school bus drivers. Congress was specifically concerned about the number of heavy truck crashes caused by inadequate driver training, and believed that better training would reduce these types of crashes. In addition, an agency study found that training for entry-level drivers in these industries was inadequate. </P>

        <P>Both the Model Curriculum and the Model Curriculum for Training <PRTPAGE P="48868"/>Motorcoach Drivers instruct drivers on the basic operational skills, such as vehicle inspection, vehicle backing, hazard perception, proper communications procedures, and speed and space management, which are necessary to operate CMVs on the public road, plus the specialized knowledge and skill a driver needs to obtain the passenger, double/triple, tank vehicle, and hazardous materials endorsements. These curricula also contain instruction in vehicle inspection procedures, off-road skill test maneuvers, and operating CMVs in vehicular traffic. The CDL tests examine CMV drivers on the knowledge and skill the drivers learn in these curricula. </P>
        <P>The agency is not requiring entry-level drivers to receive training in areas that are covered in the CDL test. Such training would be redundant. Instead, the required training would address: (1) driver qualifications—medical, and drug and alcohol testing, (2) driver hours of service limitations, (3) driver wellness, and (4) whistle blower protection. These are training areas that are not covered in the current CDL test. The agency is only requiring drivers to be trained in the areas appropriate to their driving occupation as entry-level drivers. Each of these areas focuses on the commercial motor vehicle driver, who the agency believes is key to promoting motor carrier safety on our nation's highways. The agency believes that training in these four areas would serve to set a minimum floor of safety for entry-level CMV drivers, and at the same time not be overly burdensome for drivers or motor carriers to implement. Although the proposal does not specify a required number of hours for the training, the agency estimates that it would require approximately 10.5 hours for heavy truck and motorcoach drivers, and 4.5 hours for school bus drivers. The Texas Department of Public Safety stated in comments to the ANPRM that the State of Texas currently requires a school bus driver to receive twenty hours of initial training and 8 hours of refresher training every three years. The Michigan Department of Education requires a school bus driver to pass an initial training course and a road test. The State also requires the school bus driver to receive 6 hours of refresher training every two years. The NHTSA has developed the “School Bus Driver Instructional Program” as a voluntary training standard. However, the NHTSA training standard does not cover either driver wellness or whistle blower protection. In addition, the agency's review of school bus driver training data indicates that school districts do not include instruction in driver wellness and whistle blower protection. The agency estimates that driver wellness and whistle blower training would mean an additional 4.5 hours of training for school bus drivers. </P>
        <P>The agency requests comments on whether entry-level training in other areas, such as fire extinguisher training, should be required. </P>
        <HD SOURCE="HD1">Driver Qualification </HD>
        <P>Examples of topics that could be covered are minimum vision and hearing standards, the recommended hypertension standard, the recommended monitoring practices for mild hypertension, and standards for other health-related problems. Emphasis could be placed on medical disqualification caused by illegal drug use, alcoholism, or epilepsy. </P>
        <HD SOURCE="HD1">Hours of Service </HD>
        <P>There is evidence that many crashes occur as a result of CMV driver error, and that driver error is often the result of inattention. Inattention can often be the result of fatigue, which may be related to sleep deprivation. Sleep deprivation can often be related to working conditions. </P>
        <P>Examples of possible topics for hours of service would include awareness of the causes of fatigue, its effect on driving safety, sleep disorders, fatigue-prevention strategies (including good sleep hygiene), the procedures used to complete a driver's daily log including the use of quarter-hour increments to indicate time, the different types of duty statuses, the hours of service rules, and the importance of keeping up-to-date and accurate logs.</P>
        <HD SOURCE="HD1">Driver Wellness </HD>

        <P>According to Roberts and York, “Design, Development and Evaluation of Truck and Bus Driver Wellness Programs,” FMCSA, No. DOT-MC-00-200, June 2000, obesity, high blood pressure, alcohol and drug abuse, and stress are major health issues, among truck and bus drivers. The Roberts and York report cited a study by Stoohs, Guilleminault, and Dement, “Sleep Apnea and Hypertension in Commercial Truck Drivers,” Sleep, Vol. 16 No. 8 (1993) that 71 percent of the 125 drivers in the Stoohs, Guilleminault, and Dement study were obese because they had a body mass/fat index greater than 28. In addition, the Roberts and York report cited data from “Heart and Stroke Facts, 1996 Statistical Supplement,” American Heart Association, that nationally 26.3 percent of men and 25.0 percent of woman have blood pressures greater than 140 over 90 millimeters of mercury (mm Hg). Hypertension is defined as blood pressure greater than or equal to 140 over 90 mm Hg. Additionally, the Roberts and York report cited data from “Accident Facts:” 1996 edition that indicates that alcohol is a factor in 41 percent of all traffic fatalities. Finally, the Roberts and York report cited data from Orris, <E T="03">et. al.</E>, “Stress Among Package Truck Drivers,” American Journal of Industrial Medicine, Vol. 31, (1997), that indicates that the drivers in that study had higher stress levels than 91 percent of the U.S. population. </P>
        <P>In light of these data, examples of topics that could be covered in driver wellness training include information on how to maintain healthy blood cholesterol, blood pressure, and weight, as well as the importance of periodic health monitoring and testing, diet, and exercise. </P>
        <HD SOURCE="HD1">Whistleblower </HD>
        <P>Topics that the agency anticipates would be covered include: the right of a driver to refuse to drive if there is an unsafe vehicle condition, the requirement for an employer to provide the driver a safe place to work, the prohibition against the motor carrier to pressure the driver to violate the hours-of-service requirements, and the complaint process of the U.S. Department of Labor if a driver feels that he or she has been discriminated against for filing a safety-related complaint. </P>
        <P>Under the proposal, employers would have to ensure that new entry-level drivers receive the required training before driving. The agency solicits comments on whether a 90-day period or some other time period would be more appropriate for new entry-level drivers. Commenters are requested to provide supporting rationale. </P>
        <P>Drivers with up to one year of driving experience would have 90 days to complete the training. Drivers having between one to two years of experience who do not qualify for grandfathering would also have 90 days to complete the required training. The agency solicits comments on whether the 90-day time period is appropriate for these two groups of drivers, and specifically whether a lesser period of time should be required. Commenters are requested to provide supporting rationale. </P>

        <P>The motor carrier, a training school, or a class conducted by a consortium or association of motor carriers could provide the training. Examples include a classroom setting and a professional instructor, a one-on-one office meeting between the entry-level driver and a representative of his or her employer working from a prepared outline, or <PRTPAGE P="48869"/>exposure of the entry-level driver to a professionally prepared video covering the required topics. In all cases, the motor carrier would have to maintain some evidence of the content of the instruction for a Safety Investigator seeking to verify that the requirements of the training have been met. Informal, unverifiable, or undocumented communication between the entry-level driver and his or her employer would not be acceptable. Evidence that a driver has received the training would be maintained in the driver's personnel file. An entry-level driver would be one with less than two years of experience operating a CMV with a CDL. However, drivers with one year of experience operating a CMV with a CDL, who have a good driving record, would be grandfathered and therefore would not have to take the proposed training. </P>
        <P>The FMCSA believes that for many entry-level drivers, the combination of a good driving record and at least one year of experience operating a CMV with a CDL is an appropriate indication that the individual has the minimum knowledge and driving skills to operate such a vehicle. Accordingly, the FMCSA would allow certain drivers to substitute a good driving record and experience for the completion of the proposed driver-training requirements. The FMCSA believes grandfathering such drivers would not diminish public safety or overall safe operation of CMVs. </P>
        <P>The FMCSA is proposing that a motor carrier issue a Certificate of Grandfathering to those drivers whose experience and driving record qualify them to be grandfathered under this proposal. A copy of the certificate would be filed in the driver's personnel file. Grandfathered drivers would not be subject to the training requirements of this new subpart. This action is consistent with that taken when the agency grandfathered certain drivers from the CDL skills tests contained in part 383. Qualified drivers, who want to obtain a Certificate of Grandfathering, must do so within one year of the effective date of the final rule. After the one-year period, only those drivers who present an employer with a Certificate of Grandfathering would be exempted from entry-level driver training requirements. </P>

        <P>The agency recognizes that, in order to develop the training curriculum required by this proposal, a phase-in period would be necessary. The agency believes that a 2-month phase-in period is adequate and would provide sufficient time for motor carriers and training schools to develop the required training material. The effective date of the rule would be 2 months after its publication in the <E T="04">Federal Register</E>. </P>
        <P>The FMCSA solicits comments on all aspects of this proposal. </P>
        <HD SOURCE="HD1">Rulemaking Analyses and Notices </HD>
        <HD SOURCE="HD2">Executive Order 12866 (Regulatory Planning and Review) and DOT Regulatory Policies and Procedures </HD>
        <P>The FMCSA has determined that this action is a significant regulatory action within the meaning of E.O. 12866, and is significant within the meaning of the Department of Transportation's regulatory policies and procedures (DOT Order 2100.5 dated May 22, 1980; 44 FR 11034, February 26, 1979) because of significant public interest in the issues relating to CMV safety and training of certain CMV drivers. This proposed rule has been reviewed by the Office of Management and Budget under E.O 12866. </P>
        <HD SOURCE="HD1">Summary of Benefit-Cost Analysis for this Proposal </HD>
        <HD SOURCE="HD2">Background </HD>
        <P>This proposed rule is required by the Intermodal Surface Transportation Efficiency Act of 1991. The FMCSA is proposing that entry-level commercial drivers receive mandatory training in the following content areas: driver qualifications, hours of service of drivers, driver wellness, and whistle blower rights. This NPRM would require an applicant to complete entry-level driver training that includes these four content areas and furnish a copy of the training certificate to the employer in cases where someone other than the employer provides the training. An employer could not allow a new entry-level driver to operate a CMV on the public road unless the driver has received the required training and documentation of training is in the employer's possession. </P>
        <P>The agency seeks to ensure high standards of safety among more experienced drivers without imposing an undue burden on these drivers by imposing an immediate training requirement. Such a requirement could mean an interruption of the driver's work schedule and a substantial loss in wages. In order to eliminate an overly burdensome approach to training, the NPRM proposes that drivers with up to one year of driving experience would have 90 days to complete the training. Drivers having between one to two years of experience who do not qualify for grandfathering would also have 90 days to complete the required training. The agency solicits comments on the economic impact of requiring training within the 90-day time period for these two groups of experienced drivers as well as the costs associated with a lesser period of time. Commenters are requested to provide supporting rationale. </P>

        <P>The FMCSA has conducted a regulatory evaluation of this proposed rule in accordance with Executive Order 12866, “Regulatory Planning and Review.” This rule is estimated to cost $25.1 million in the first year of implementation and $22.7 million annually thereafter (undiscounted). The higher costs in the first year are the result of this rule's effect on some existing drivers (<E T="03">i.e.</E>, those with less than two years of experience), where a certain percentage would be required to undertake the required training within the first 90 days of the rule's implementation. Total discounted costs of this rule are $173.3 million over the 10-year period. </P>

        <P>Our analysis of this proposed rule indicates that it would have to prevent 315 truck-related crashes (<E T="03">i.e.</E>, combined fatal, injury-related, and property-damage-only crashes) in the first year to be cost-beneficial (<E T="03">i.e.</E>, to offset the $25.1 million in first-year costs). The rule would have to prevent 285 crashes in each year thereafter to be cost-beneficial. The 285-315 truck-related crashes to be avoided represent less than seven one-hundredths of one percent (or 0.07 percent) of the average total number of truck-related crashes reported annually (estimated at 445,000 in 1999 and 2000). This 0.07-percent reduction in truck-related crashes is obviously much less than the size of crash reductions experienced in studies cited earlier in this NPRM, where case studies revealed crash reductions of 2 and 40 percent from implementation of new driver training programs and is also well below the 15-percent reduction in crashes used in the regulatory evaluation prepared in 1995 for the ANPRM (which involved a more comprehensive training program than proposed here). A summary of costs is provided in the next section. For a complete discussion of the assumptions made, data used, and analysis performed in this regulatory evaluation, the reader is referred to the docket, where a copy of the full regulatory evaluation is contained. </P>
        <HD SOURCE="HD2">Costs </HD>

        <P>The largest cost component of this rule is the cost of providing training to entry-level operators of heavy trucks, school buses, and motor coaches. Training costs include both the direct cost to train drivers and the (opportunity) cost of drivers' time. The two key factors in estimating the <PRTPAGE P="48870"/>training costs are the number of drivers who will need training and the hours of training they will have to undertake. </P>
        <P>The FMCSA estimates that the proposed rule would require 10.5 hours of training of the entry-level drivers of heavy trucks in the proposed four subject areas. The two content areas of driver qualifications and hours of service together would require about 6 hours of training. The driver wellness training would also require about 4 hours, while training on whistle blower protection is estimated at 30 minutes. However, the FMCSA believes that the entry-level drivers of school buses would only require 4.5 hours of training, comprised of 4 hours of driver wellness instruction and 30 minutes of whistle blower protection training (given that the Federal driver qualifications and hours-of-service content would not apply). The FMCSA also estimates that the proposed rule would require 10.5 hours of training of the entry-level drivers of motorcoaches. The training hours estimate for heavy truck drivers was based on information provided in the instructor's guide for the Professional Truck Drivers Institute's (PTDI) accredited training courses and discussions held with FMCSA CDL Program staff. The training hours estimate for motor coach drivers was estimated using the instructor's guide for the Model Curriculum for motor coach drivers and discussions with FMCSA CDL Program staff. </P>
        <P>Using data from the Bureau of Labor Statistics, the total number of entry-level truck drivers is estimated at 58,600 per year for the next 10 years, while the entry-level drivers required for growth and replacement for the school bus and motorcoach industry are estimated at 17,800 and 2,100 per year, respectively, also over the next 10 years. </P>

        <P>In this analysis, we assumed that 30 percent of the entry-level heavy truck drivers, or 17,580, would not need any additional training, as they are assumed to attend a PTDI or similar accredited training program (<E T="03">i.e.</E>, PTDI accredited courses already include these content areas in their curriculum). This assumption is based on information obtained regarding the number of accredited programs as a percent of total driver training programs. For the remaining 70 percent (or 41,020, entry-level drivers), we assumed that they either receive training from a non-accredited training program or they receive informal training from their employer. Therefore, this 70 percent of entry-level drivers would require 10.5 hours of training per driver on the four subject areas mentioned above. Therefore, the total hours of training required by the proposed rule for the entry-level heavy truck drivers is estimated at 430,710 hours per year. For those drivers who already receive some type of formal (yet non-accredited) employer-or third-party training, it is quite possible that employers (or third-party training providers) might reduce the amount of training time spent on other, non-required subject matter, so that the net increase in training per truck driver would be less than 10.5 hours. However, in the absence of specific information on the types of subject matter than might be omitted from these driver training programs to offset the new training costs, we assumed a net increase of 10.5 hours for estimating the costs of this rule. </P>
        <P>Regarding school bus driver training, neither the Federal driver qualifications nor the Federal Hours of Service rules are applicable to these drivers. Therefore, this entry-level training rulemaking will result in only 4.5 hours of additional training for each entry-level driver, since these training programs would include primarily driver wellness (4 hours) as well as whistle blower protection (0.5 hours). States have long required school bus drivers to take written exams designated to test an entry-level driver's knowledge of state laws and regulations affecting school transportation. Additionally, behind-the-wheel road tests are used to evaluate an applicant's driving skills. For example, as a comment to the ANPRM, the Texas Department of Public Safety stated that Texas requires classroom and behind-the-wheel training totaling 20 hours. In our review of the school bus driver training information, we concluded that no districts were providing instruction in driver wellness and whistle blower protection, since the NHTSA voluntary training standard, known as the School Bus Driver Training Program, did not include such content. Therefore, FMCSA estimates that all 17,800 entry-level school bus drivers would need an additional 4.5 hours of training for a total of 80,100 hours of training per year. </P>
        <P>FMCSA assumes that the additional hours of training for an entry-level motorcoach driver would be 10.5 hours. The instructor's guide to the model curriculum for training motor coach drivers includes 5 hours of logbook training but only about an hour on safety and wellness issues (including topics such as the correct lifting of heavy objects and identifying prohibited cargo). The FMCSA does not have information on the proportion of entry-level motorcoach drivers following training as per the model curriculum. Therefore, the FMCSA estimates that 2,100 entry-level drivers of motorcoaches would require 10.5 hours of training on driver qualifications, hours of service for drivers, driver wellness and whistle blower protection for a total of 22,050 hours of training per year. </P>

        <P>To be conservative, a figure of $25 per hour of training was used in this analysis to calculate the direct costs of training (calculated via an average cost of $4,000 per training course divided by 4 weeks divided by 40 hours per week). This translates into $262.50 of direct training costs for a 10.5-hour course and $112.50 for 4.5-hour course. The agency believes that this was a reasonable estimate of the total hourly cost to train drivers (whether or not the training is provided by the employer or a third party) because it falls well within the range of training cost estimates provided in comments to the ANPRM. In reality, employer-based training could very well be less than $25/hour in certain cases (<E T="03">i.e.</E>, assuming new physical space is not leased by the employer to conduct the training, or the training is self-directed by the driver), but to be conservative the agency used the same figure whether the training was employer-or third party-based so as to ensure not underestimating employer and/or driver costs. </P>
        <P>To arrive at a truck driver's wage rate, we use a figure of $14.75 per hour, which is an average from three recent national wage/employment surveys (including the Current Population Survey). We added 31 percent to cover the cost of fringe benefits, an estimate developed in the Hours of Service regulatory evaluation. (It is a weighted average of the fringe benefits for private and for-hire carriers, based on data from the ATA and the BLS.) The 31 percent increase brings total compensation to $19.32. </P>
        <P>Regarding a school bus driver's wage, we use a figure of $7.67 per hour obtained from the BLS 2001 National Occupational Employment and Wage survey. This figure represents the 25th percentile wage estimate for an entry-level school bus driver and we used it because entry-level drivers generally earn at the low range of the industry wage standards. Again, 31 percent is added to cover the cost of fringe benefits, resulting in a total hourly wage estimate of $10.05 per hour. </P>

        <P>Regarding a motorcoach driver's wage, we use a figure of $9.98 per hour obtained from the BLS 2001 National Occupational Employment and Wage survey. This figure represents the 25th percentile wage estimate for an entry-level motorcoach driver and we used it <PRTPAGE P="48871"/>because entry-level drivers generally earn at the low range of the industry wage standards. Again, 31 percent is added to cover the cost of fringe benefits, resulting in a total hourly wage estimate of $13.07 per hour. </P>
        <P>To get the total unit cost of training per hour (<E T="03">i.e.</E>, including both direct training costs and the drivers' cost of time), the relevant estimate of the driver's wage rate for truck, school bus, and motor coach drivers was added to the average hourly cost of training discussed earlier. For example, for an entry-level truck driver, the unit cost of training is $44.32 an hour ($19.32 of foregone driver wages plus $25 in actual training costs). For entry-level school bus drivers, the total training cost is estimated at $35.05 per hour ($10.05 of foregone driver wages plus $25 in actual training costs), and for entry-level motor coach drivers, it is $38.07 per hour ($13.07 of foregone driver wages plus $25 in actual training costs. </P>
        <P>Taking these hourly training costs for each type of entry-level driver (based on median wage rates and an average hourly cost of training) and applying them to the hours of required training for each type of driver (discussed earlier) and the number of entry-level drivers in each category, we can develop an estimate of total annual costs of this rule. </P>
        <P>To do so, we multiplied the hours of training required for each type of driver by the total number of drivers in that driver group per year by the applicable hourly wage rate to drivers in each group (including direct wage and costs of training). The result is a total first-year cost of $25.1 million and $22.7 million (undiscounted) annually in each subsequent year of the rule. Using the 7 percent discount rate recommended by the OMB, the present value of training costs of the proposed rule is calculated as $173.3 million over 10 years, or a discounted average of $17.3 million per year for next 10 years. </P>

        <P>The reason first year costs are higher than the annual costs in subsequent years is that within the first year (90 days to be exact), some portion of the entry level drivers who received training between 12-24 months prior to implementation of this rule (<E T="03">i.e.</E>, those effectively with chargeable crashes) would be required to undertake training in these four content areas. Our analysis indicates that almost 6,000 drivers who received training between 12-24 months prior to the rule's implementation would have to undertake the training required under this rule. As such, first-year costs increase because a larger pool of drivers must initially undertake the required training. Full details of these costs are provided in the stand-alone regulatory evaluation contained in the docket. </P>
        <HD SOURCE="HD2">Benefits </HD>

        <P>The total number of accidents potentially avoided by the proposed rule is difficult to quantify largely because of the variability in study results on the impact of training on the truck crash reduction. This variability is most likely due to the wide variation in quality of driver training programs and the difficulty associated with estimating (statistically speaking) the relationship between a single input (training) and an output (safety) when working with very large data sets. However, several case studies, including two cited earlier in this NPRM, reveal that driver training programs reduced crashes by two to 40 percent. Because of the relatively modest costs (estimated at $22.7 million to $25.1 million annually (undiscounted)), this proposed rule would have to deter between 285 and 315 truck-related crashes (fatal, injury-related, and property-damage-only crashes combined) each year in order to be cost beneficial (<E T="03">i.e.</E>, where the rule's benefits exceed its costs). </P>

        <P>To develop the above estimate of the number of truck- and bus-related crashes that must be avoided each year for the rule to be cost beneficial, the researchers used crash cost estimates from a recent study by Zaloshnja, <E T="03">et al.</E>, which estimated the average cost of a crash involving a large truck (<E T="03">i.e.</E>, those &gt; 10,000 lbs GVW) at almost $80,000 (in 2001 dollars). Dividing the annual costs of the rule ($22.7 million to $25.1 million) by this average cost per truck-related crash ($80,000) allows us to arrive at the cost-beneficial threshold of 285-315 annual crashes. This range (285-315 avoided crashes) represents less than seven one-hundredths of one percent (or 0.07 percent) of the total average number of truck-related crashes annually (estimated at 445,000 using 1999-2000 data). This 0.07-percent reduction is obviously much smaller than the size of crash reductions experienced in studies cited earlier in this NPRM, where case studies revealed crash reductions of 2 and 40 percent from implementation of new driver training programs and is also well below the 15-percent reduction in crashes used in the regulatory evaluation prepared in 1995 for the ANPRM (which involved a more comprehensive training program than proposed here). Therefore, we believe the rule would be cost-beneficial upon implementation.</P>

        <P>A complete copy of the preliminary regulatory evaluation is in the public docket described above under <E T="02">ADDRESSES.</E>
        </P>
        <HD SOURCE="HD1">Regulatory Flexibility Act </HD>
        <P>In compliance with the Regulatory Flexibility Act (5 U.S.C. 601-612), the agency has evaluated the effects of this rulemaking on small entities. In addition, DOT policy requires an analysis of the impact of all regulations (or proposals) on small entities, and mandates that agencies strive to lessen any adverse effects on these businesses. The Interim Regulatory Flexibility Analysis must cover the following topics. </P>
        <P>(1) A description of the reasons why the action by the agency is being considered. </P>
        <P>(2) A succinct statement of the objectives of, and legal basis for, the proposed rule. </P>
        <P>(3) A description, and where feasible, an estimate of the number of small entities to which the proposed rule would apply. </P>
        <P>(4) A description of the projected reporting, record-keeping, and other compliance requirements of the proposed rule, including an estimate of the classes of small entities that will be subject to the requirement and the types of professional skills necessary for preparation of the report or record. </P>
        <P>(5) An identification, to the extent practicable, of all relevant federal rules that may duplicate, overlap, or conflict with the proposed rule. </P>
        <HD SOURCE="HD2">Reason the Action Is Being Considered </HD>
        <P>This action is required by Congressional direction. Specifically, section 4007 of the Intermodal Surface Transportation Efficiency Act of 1991 directed the Secretary of Transportation to promulgate regulations requiring training for entry-level heavy truck, school bus, and motorcoach drivers. </P>
        <HD SOURCE="HD2">Objective and Legal Basis for This Action </HD>
        <P>The objective for this action is to reduce the number of crashes caused by entry-level drivers of heavy trucks, school buses, and motorcoaches. Congress was specifically concerned about the number of heavy truck crashes caused by inadequate driver training, and believes that better training will reduce these types of crashes. As noted above, the legal basis for this rule is section 4007 of the Intermodal Surface Transportation Efficiency Act of 1991. </P>
        <HD SOURCE="HD2">Number of Small Entities to Which the Action Would Apply </HD>

        <P>This action would apply to all small entities regulated by the FMCSA. The FMCSA is currently conducting <PRTPAGE P="48872"/>research to specify the size of the small motor carrier population. Presently we consider motor carriers with 6 or fewer drivers to be small entities. Using this number of drivers as a proxy for size, the majority of carriers can reasonably be described as small. As of April of 2002, there were 610,000 motor carriers on the FMCSA's Motor Carrier Management Information System (MCMIS) census file. Among the 500,000 of these motor carriers for which the agency has driver data, 435,000 (87 percent) have 6 or fewer drivers. Assuming that 87 percent of the 110,000 motor carriers with no driver information are also small, the total number of motor carriers with six or fewer drivers would exceed half a million. </P>
        <HD SOURCE="HD2">Reporting, Recordkeeping, and Other Compliance Requirements of the Proposed Rule </HD>
        <P>This action would impose a very modest burden on small entities, since it largely proscribes the actions of drivers rather than motor carriers. Nonetheless, this action does impose some reporting and recordkeeping requirements on motor carriers. The primary motor carrier requirement would be to verify drivers' eligibility before allowing them to operate a CMV. In addition, motor carriers must maintain a copy of the required driver's training certificate in each personnel file. Motor carriers are currently required to maintain a driver qualification file for each driver, as outlined in Part 391 of the FMCSRs. No special skill is required to verify eligibility to operate a CMV or to place a driver's training certificate in a personnel file. </P>
        <HD SOURCE="HD2">Duplicative, Overlapping, or Conflicting Federal Rules </HD>
        <P>The FMCSA is not aware of any other rules that duplicate State, local, or tribal governments, in the aggregate, or overlap, or conflict with the proposed action. </P>
        <P>Accordingly, the FMCSA hereby certifies that the proposed action discussed in this document will not have a significant economic impact on a substantial number of small entities. </P>
        <HD SOURCE="HD1">Unfunded Mandates Reform Act of 1995</HD>
        <P>The Unfunded Mandates Reform Act of 1995 (the Act) requires each agency to assess the effects of its regulatory actions on State, local, tribal governments, and the private sector. This proposed rule does not impose an unfunded Federal mandate resulting in the expenditure by State, local, or tribal governments, in the aggregate, or the private sector, of $100 million, adjusted for inflation, or more in any one year. (2 U.S.C. 1531 et. seq.). </P>
        <HD SOURCE="HD1">Executive Order 13132 (Federalism) </HD>
        <P>This action has been analyzed in accordance with the principles and criteria contained in Executive Order 13132. It has been determined that this rulemaking does not have a substantial direct effect on States, nor would it limit the policy-making discretion of the States. Nothing in this document preempts any State law or regulation. </P>
        <HD SOURCE="HD1">Paperwork Reduction Act </HD>

        <P>Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501 <E T="03">et seq.</E>), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct, sponsor, or require through regulations. An analysis of this proposal was made by the FMCSA, and it has been determined that the final rule, when promulgated, would create a new collection of information requiring OMB's approval. This PRA section addresses the information collection burden for activities associated with training certification forms and grandfathering eligible drivers. </P>
        <P>The FMCSA estimates that operators of heavy trucks, operators of motor coaches, and operators of school buses will require additional training due to requirements contained in this proposed rule. The agency further estimates 58,600 new drivers will be needed annually in the heavy truck industry, 2,100 new drivers in the motor coach industry, and 17,800 new drivers in the school bus industry. However, it is estimated that for the heavy truck industry 30 percent of the entry level drivers already receive training through an accredited program and will not require additional training. The remaining 70 percent, or 41,020 drivers, would require additional training. </P>
        <P>There would be an annual burden to the motor carrier or other training entity to complete, photocopy, and file the certification form. FMCSA estimates this will take 10 minutes, resulting in an additional annual burden of 10,153 hours [60,920 (41,020 + 2,100 + 17,800) drivers × 10 minutes per motor carrier/training entity, divided by 60 minutes = 10,153]. </P>
        <P>For the first year after the rule becomes effective, there would also be burdens associated with the estimated 121,840 drivers currently employed with less than 2 years experience who have not already received accredited training [41,020 (heavy truck) + 2,100 (motor coach) + 17,800 (school bus) = 60,920 × 2 years = 121,840 drivers]. Based on eligibility criteria previously described in this proposed rule, the FMCSA estimates that 75 percent of these 121,840 drivers would be eligible to be grandfathered and 25 percent would not be eligible. </P>
        <P>Using these estimates, there would be an additional 21,560 drivers in the heavy truck and motor coach industries [(41,020 × 2 = 82,040) + (2,100 × 2 = 4,200) = 86,240 × 25 percent = 21,560] that would need additional training, because they would be ineligible to be grandfathered. Using the same percentage as above (25 percent), the school bus industry would have 8,900 drivers (17,800 × 2 years × 25 percent) who would be ineligible for grandfathering and would thus require additional training. Each of these 30,460 (21,560 + 8,900) drivers would need to be issued certificates following their training. At 10 minutes per certificate, that burden is estimated to be 5,077 hours (30,460 drivers × 10 minutes, divided by 60 minutes). </P>
        <P>For grandfathering the estimated 91,380 remaining drivers (75 percent of 121,840 drivers eligible for grandfathering during the first year), there would be a one-time burden, since drivers could only be grandfathered during the first year after the rule becomes effective. There are two parts to the burden for these 91,380 drivers: (1) the burden for the driver to collect and provide the information to the motor carrier, and (2) the burden for the motor carrier to review the documents, complete, duplicate, and file the certification form. FMCSA estimates that it would take approximately 10 minutes for a driver to collect the necessary information and provide the document to the motor carrier, and 10 minutes for the motor carrier to review the information, complete the certification, and duplicate and file the document. Therefore, the one time burden associated with grandfathering the 91,380 drivers would be 30,460 hours [(91,380 × 10 minutes per driver / 60 minutes = 15,230) + (91,380 × 10 minutes per motor carrier / 60 minutes = 15,230) = 30,460]. This 30,460-hour estimate represents the first-year only burden associated with certifying drivers who are grandfathered. </P>
        <P>Accordingly, the burden associated with the 121,840 current drivers is 35,537 burden hours [5,077 hours (for current entry level drivers not eligible for grandfathering) + 30,460 hours (for certifying drivers who are eligible to be grandfathered)]. </P>

        <P>Thus, the total first-year burden is estimated to be 45,690 hours [10,153 <PRTPAGE P="48873"/>(annual burden) + 35,537 (first year burden of 5,077 + 30,460)]. </P>
        <GPOTABLE CDEF="s50,10" COLS="2">
          <TTITLE>  </TTITLE>
          <BOXHD>
            <CHED H="1">Activity </CHED>
            <CHED H="1">Burden Hours </CHED>
          </BOXHD>
          <ROW>
            <ENT I="01">Annual Certification form for new entry level drivers </ENT>
            <ENT>10,153 </ENT>
          </ROW>
          <ROW>
            <ENT I="01">Certification form for drivers <E T="03">not</E> eligible to be grandfathered (following training) (first year only) </ENT>
            <ENT>5,077 </ENT>
          </ROW>
          <ROW>
            <ENT I="01">Grandfathering certificate for those eligible (first year only) </ENT>
            <ENT>30,460 </ENT>
          </ROW>
          <ROW>
            <ENT I="03">Total </ENT>
            <ENT>45,690 </ENT>
          </ROW>
        </GPOTABLE>
        <P>The information collection burden for subsequent years would drop to 10,153 hours [45,690 −35,537 (first year only burden hours)]. </P>
        <P>Interested parties are invited to send comments regarding any aspect of these information collection requirements, including, but not limited to: (1) Whether the collection of information is necessary for the performance of the functions of the FMCSA, including whether the information has practical utility, (2) the accuracy of the estimated burden, (3) ways to enhance the quality, utility, and clarity of the collected information, and (4) ways to minimize the collection burden without reducing the quality of the information collected. </P>
        <P>You may submit comments on this <E T="03">information collection burden</E> directly to OMB. The OMB must receive your comments by October 14, 2003. You must mail or hand deliver your comments to: Attention: Desk Officer for the Department of Transportation, Docket Library, Office of Information and Regulatory Affairs, Office of Management and Budget, Room 10102, 725 17th Street, NW., Washington, DC 20503. </P>
        <HD SOURCE="HD1">Executive Order 12898 (Federal Actions to Address Environmental Justice in Minority Populations and Low Income Populations) </HD>
        <P>The agency evaluated the environmental effects of the proposed action and alternatives in accordance with Executive Order 12898 and determined that there were no environmental justice issues associated with this proposed rule. Environmental justice issues would be raised if there were a “disproportionate” and “high and adverse impact” on minority or low-income populations. The agency determined that there were no high and adverse impacts associated with the proposal. In addition, the agency analyzed the demographic makeup of the trucking industry, potentially affected, and determined that there was no disproportionate impact on minority or low-income populations. This is based on the finding that low-income and minority populations are generally underrepresented in the trucking occupation. </P>
        <HD SOURCE="HD1">Executive Order 13045 (Protection of Children) </HD>
        <P>Executive Order 13045, “Protection of Children from Environmental Health Risks and Safety Risks” (April 23, 1997, 62 FR 19885), requires that agencies issuing “economically significant” rules that also concern an environmental health or safety risk, or that an agency has reason to believe may disproportionately affect children, must include an evaluation of these effects on children. Section 5 of Executive Order 13045 directs an agency to submit for a “covered regulatory action” an evaluation of its environmental health or safety effects on children. </P>
        <P>The agency evaluated the possible effects of the proposed action and determined that they would not create disproportionate environmental health risks or safety risks to children. </P>
        <HD SOURCE="HD1">Executive Order 12988 (Civil Justice Reform) </HD>
        <P>This action meets applicable standards in sections 3(a) and 3(b)(2) of Executive Order 12988, Civil Justice Reform, to minimize litigation, eliminate ambiguity, and reduce burden. </P>
        <HD SOURCE="HD1">Executive Order 12630 (Taking of Private Property) </HD>
        <P>This rule will not effect a taking of private property or otherwise have taking implications under E. O. 12630, Governmental Actions and Interference with Constitutionally Protected Property Rights. </P>
        <HD SOURCE="HD1">Executive Order 12372 (Intergovernmental Review) </HD>
        <P>Catalog of Federal Domestic Assistance Program Number of 20.217, Motor Carrier Safety. The regulations implementing Executive Order 12372 regarding intergovernmental consultation on Federal programs and activities do not apply to this program. </P>
        <HD SOURCE="HD1">National Environmental Policy Act </HD>

        <P>The agency has analyzed this rulemaking for the purpose of the National Environmental Policy Act of 1969 (42 U.S.C. 4321 <E T="03">et seq.</E>) and has determined that this action would not have an adverse effect on the quality of the environment. </P>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects in 49 CFR Part 380 </HD>
          <P>Driver Training, instructor requirements.</P>
        </LSTSUB>
        
        <P>In consideration of the foregoing, the FMCSA hereby proposes to amend title 49, Code of Federal Regulations, chapter III, subchapter B, part 380 as set forth below: </P>
        <P>1. The authority citation for this part continues to read as follows: </P>
        <AUTH>
          <HD SOURCE="HED">Authority:</HD>
          <P>49 U.S.C. 31136, 31307, and 31502; and Sec. 4007(b) of Pub. L. 102-240 (105 Stat. 2152); and 49 CFR 1.73. </P>
        </AUTH>
        
        <P>2. Part 380 is revised by adding a new subpart E to read as follows. </P>
        <PART>
          <HD SOURCE="HED">PART 380—SPECIAL TRAINING REQUIREMENTS </HD>
          <CONTENTS>
            <SUBPART>
              <HD SOURCE="HED">Subpart E—Entry-Level Driver Training Requirements </HD>
              <SECHD>Sec. </SECHD>
              <SECTNO>380.501 </SECTNO>
              <SUBJECT>Applicability. </SUBJECT>
              <SECTNO>380.502 </SECTNO>
              <SUBJECT>Definitions. </SUBJECT>
              <SECTNO>380.503 </SECTNO>
              <SUBJECT>Entry-level driver training requirements. </SUBJECT>
              <SECTNO>380.505 </SECTNO>
              <SUBJECT>Substitute for driver training. </SUBJECT>
              <SECTNO>380.507 </SECTNO>
              <SUBJECT>Proof of training. </SUBJECT>
              <SECTNO>380.509 </SECTNO>
              <SUBJECT>Driver responsibilities. </SUBJECT>
              <SECTNO>380.511 </SECTNO>
              <SUBJECT>Employer responsibilities. </SUBJECT>
              <SECTNO>380.513 </SECTNO>
              <SUBJECT>Employer recordkeeping responsibilities. </SUBJECT>
              <SECTNO>380.515 </SECTNO>
              <SUBJECT>Required information on the training certificate. </SUBJECT>
            </SUBPART>
          </CONTENTS>
          <SUBPART>
            <HD SOURCE="HED">Subpart E—Entry-Level Driver Training Requirements </HD>
            <SECTION>
              <SECTNO>§ 380.501 </SECTNO>
              <SUBJECT>Applicability. </SUBJECT>
              <P>All entry-level drivers who drive in interstate commerce and are subject to the CDL requirements of part 383 of this subchapter must comply with the rules of this subpart, except drivers who are subject to the jurisdiction of the Federal Transit Administration. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 380.502 </SECTNO>
              <SUBJECT>Definitions. </SUBJECT>
              <P>(a) The definitions in part 383 of this subchapter apply to this part, except where otherwise specifically noted. </P>
              <P>(b) As used in this subpart: </P>
              <P>
                <E T="03">Entry-level driver</E> is a driver with less than 2 years experience operating a CMV with a CDL. </P>
              <P>
                <E T="03">Entry-level driver training</E> is training the CDL driver receives in driver qualification requirements, hours of service of drivers, driver wellness, and whistle blower protection as appropriate to the entry-level driver's current position in addition to passing the CDL test. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 380.503 </SECTNO>
              <SUBJECT>Entry-level driver training requirements. </SUBJECT>
              <P>Entry-level driver training must include instruction addressing the following four areas: </P>

              <P>(1) Driver qualification requirements: The federal rules on medical <PRTPAGE P="48874"/>certification, medical examination procedures (49 CFR part 391, subparts B and E), and drug and alcohol testing (49 CFR part 382). </P>
              <P>(2) Hours of service of drivers: The limitations on driving hours and the requirement to be off-duty for certain periods of time (49 CFR part 395). </P>
              <P>(3) Driver wellness: Basic health maintenance including diet and exercise. The importance of avoiding alcohol and drug abuse. Fatigue countermeasures as a means to avoid accidents. </P>
              <P>(4) Whistleblower protection: The right of an employee to question the safety practices of an employer without the employee's risk of losing a job or being subject to reprisals simply for stating a safety concern (29 CFR part 1978). </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 380.505 </SECTNO>
              <SUBJECT>Substitute for Driver Training. </SUBJECT>
              <P>(a) <E T="03">Grandfather clause.</E> The driver training requirements specified in subpart E of this part do not apply to an individual who meets the conditions set forth in paragraphs (b), (c), and (d) of this section. A motor carrier must ensure that an individual claiming eligibility to operate a CMV on the basis of this section meets these conditions before allowing him/her to operate a CMV. </P>
              <P>(b) An individual must certify that, during the 1-year period immediately preceding the date of application for a Certificate of Grandfathering, he/she had: </P>
              <P>(1) A valid CDL; </P>
              <P>(2) No more than one driver's license; </P>
              <P>(3) No suspension, revocation, or cancellation of his/her CDL; </P>
              <P>(4) No convictions for a major offense while operating a CMV as defined in § 383.51(b) of this subchapter; </P>
              <P>(5) No convictions for a railroad-highway grade crossing offense while operating a CMV as stated in § 383.51(d) of this subchapter; </P>
              <P>(6) No convictions for violating an out-of-service order as defined in § 383.51(e) of this subchapter; </P>
              <P>(7) No more than one conviction for a serious traffic violation, as defined in § 383.5 of this subchapter, while operating a CMV; </P>
              <P>(8) No convictions for a violation of State or local law relating to motor vehicle traffic control arising in connection with any traffic accident while operating a CMV; and </P>
              <P>(9) No accident in which he/she was found to be at fault, while operating a CMV. </P>
              <P>(c) An individual must certify and provide evidence that he/she: </P>
              <P>(1) Is regularly employed in a job requiring the operation of a CMV that requires a CDL; and </P>
              <P>(2) Has operated a CMV for at least 1 year immediately preceding the date of application for a Certificate of Grandfathering. </P>
              <P>(d) An employer must issue a Certificate of Grandfathering, which is substantially in accordance with the form below, to an individual that meets the requirements of this section and maintain a copy of the certificate in his/her personnel file. </P>

              <P>(e) The grandfather provisions of this section are available to eligible drivers for a limited period of one year after [<E T="03">The effective date of the final rule.</E>]. </P>
              <GPH DEEP="246" SPAN="3">
                <GID>EP15AU03.069</GID>
              </GPH>
            </SECTION>
            <SECTION>
              <SECTNO>§ 380.507 </SECTNO>
              <SUBJECT>Proof of training. </SUBJECT>
              <P>(a) An entry-level driver who receives the required training must receive an original training certificate containing all the information contained in § 380.515 from the training provider. </P>
              <P>(b) The entry-level driver must also receive a copy of the training certificate if the training provider is not the driver's employer or potential employer. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 380.509 </SECTNO>
              <SUBJECT>Driver responsibilities. </SUBJECT>
              <P>The driver must present a training certificate, containing the information specified in § 380.515, to the employer or potential employee that the driver received training as specified in § 380.503, if the employer or potential employer is not the training provider. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 380.511 </SECTNO>
              <SUBJECT>Employer responsibilities. </SUBJECT>

              <P>(a) Employers must ensure that all new entry-level drivers receive the required training on or after [<E T="03">Insert the effective date of the final rule</E>]. </P>

              <P>(b) Employers must ensure that entry-level drivers, who do not qualify for grandfathering, receive the required training no later than 90 days after [<E T="03">The effective date of the final rule</E>]. </P>
              <P>(c) The employer must place evidence of training completion or a Certificate of Grandfathering, as appropriate, in the driver's qualification file. </P>
            </SECTION>
            <SECTION>
              <PRTPAGE P="48875"/>
              <SECTNO>§ 380.513 </SECTNO>
              <SUBJECT>Employer recordkeeping responsibilities. </SUBJECT>
              <P>The employer must keep the records specified in § 380.511 for as long as the driver is employed by the employer and for three years thereafter. </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 380.515 </SECTNO>
              <SUBJECT>Required information on the training certificate. </SUBJECT>
              <P>(a) The training provider must provide a training certificate to the entry-level driver, which contains the following six items of information. </P>
              <P>(1) Name of training institution; </P>
              <P>(2) Mailing address of training institution; </P>
              <P>(3) Name of driver; </P>
              <P>(4) A statement that the driver has completed driver qualification requirements, hours of service of drivers, driver wellness, and whistle blower protection; </P>
              <P>(5) The printed name of the person attesting that the driver has received the required training. </P>
              <P>(6) The signature of the person attesting that the driver has received the required training. </P>
              <P>(b) The training provider must issue a Driver Training Certificate that is substantially in accordance with the following form. </P>
              <P>(1) Driver-Certification </P>
              <P>I certify that  ________ has completed training requirements set forth in the Federal Motor Carrier Safety Regulations (49 CFR 380.503) for entry-level driver training. </P>
              
            </SECTION>
          </SUBPART>
        </PART>
        <FP SOURCE="FP-DASH"/>
        <FP>Full name of training entity </FP>
        
        <FP SOURCE="FP-DASH"/>
        <FP>Business address (Street Address, City, State and Zip code)</FP>
        
        <FP SOURCE="FP-DASH"/>
        <FP>Telephone number: </FP>
        <FP SOURCE="FP-DASH"/>
        <FP>Name of training certifying official </FP>
        
        <FP SOURCE="FP-DASH"/>
        <FP>Signature of training certifying official </FP>
        <SIG>
          <DATED>Issued on: August 12, 2003. </DATED>
          <NAME>Warren E. Hoemann, </NAME>
          <TITLE>Deputy Administrator. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20888 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4910-EX-P</BILCOD>
    </PRORULE>
  </PRORULES>
  <VOL>68</VOL>
  <NO>158</NO>
  <DATE>Friday, August 15, 2003</DATE>
  <UNITNAME>Notices</UNITNAME>
  <NOTICES>
    <NOTICE>
      <PREAMB>
        <PRTPAGE P="48876"/>
        <AGENCY TYPE="F">DEPARTMENT OF AGRICULTURE </AGENCY>
        <SUBAGY>Agricultural Research Service </SUBAGY>
        <SUBJECT>Notice of Federal Invention Available for Licensing and Intent To Grant Exclusive License </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Agricultural Research Service, USDA. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of availability and intent. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>Notice is hereby given that the federally owned invention disclosed in U.S. Patent Application No. 09/774,810 “Intermediate-Moisture Formed Food Products Made From Partially Dehydrated Fruit and/or Vegetables and Novel Methods of Packaging Thereof”, filed January 30, 2001, is available for licensing and that the U.S. Department of Agriculture, Agricultural Research Service, intends to grant to Fiorini Ranch of Turlock, California, an exclusive license to this invention. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>

          <P>Comments must be received within ninety (90) calendar days of the date of publication of this notice in the <E T="04">Federal Register</E>. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Send comments to: USDA, ARS, Office of Technology Transfer, 5601 Sunnyside Avenue, Room 4-1174, Beltsville, Maryland 20705-5131. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>June Blalock of the Office of Technology Transfer at the Beltsville address given above; telephone: 301-504-5989. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>The Federal Government's patent rights to this invention are assigned to the United States of America, as represented by the Secretary of Agriculture. It is in the public interest to so license this invention as Fiorini Ranch of Turlock, California has submitted a complete and sufficient application for a license. The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within ninety (90) days from the date of this published notice, the Agricultural Research Service receives written evidence and argument which establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. </P>
        <SIG>
          <NAME>Michael D. Ruff, </NAME>
          <TITLE>Assistant Administrator.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20876 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 3410-03-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF AGRICULTURE </AGENCY>
        <SUBAGY>Forest Service </SUBAGY>
        <SUBJECT>Information Collection; Application for the Senior Community Service Employment Program </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Forest Service, USDA. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice; Request for comments. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>In accordance with the Paperwork Reduction Act of 1995, the U.S. Department of Agriculture, Forest Service is seeking comments from all interested individuals and organizations on the extension of a currently approved information collection for application to the Senior Community Service Program. The Forest Service surveys senior applicants for enrollment into the Senior Community Service Employment Program (SCSEP). Questions asked are personal information such as: Name, age, income residency, gender, education, ethnic group, English speaking ability, veteran, and disability status. This information is used to qualify individuals for enrollment into the SCSEP and assist with subsidized placement for the agency's special use program. The collected information will help the Forest Service determine eligibility for enrollment in the Senior Community Service Employment Program. Information will be collected from prospective applicants and enrollees age 55 years or older. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Comments must be received in writing on or before October 14, 2003. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>

          <P>All comments should be addressed to Director, Senior, Youth, &amp; Volunteer Programs Staff, (MAIL STOP 1136), Forest Service, USDA, 1400 Independence Avenue, SW., Washington, DC 20090-1136. Comments also may be submitted via facsimile to (703) 605-5115 or by e-mail to: <E T="03">syvp/wo@fs.fed.us</E>. The public may inspect comments received at 1621 N. Kent Street, Room 1010, Rosslyn, VA 22209. Visitors are encouraged to call ahead to (703) 605-4853. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Priscella McCray, Senior, Youth, &amp; Volunteer Programs Staff, at (703) 605-4853. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <HD SOURCE="HD1">Background </HD>

        <P>The Senior Community Service Employment Program (SCSEP) is designed to provide part-time employment opportunities and training to low-income and disadvantaged persons age 55 or above. To establish the eligibility of each individual for enrollment into the program, it is necessary to collect income information and age data. The application document is the tool needed to collect this pertinent data and other relevant information required by the Department of Labor. The Department of Labor is the grantor for the SCSEP and provides guidelines for the program's operation. The authority for data collection is contained in the <E T="04">Federal Register</E> Rules and Regulations, section 641.100, prepared by the Department of Labor, Employment and Training Administration. The application is used by Forest Service Staffs to collect information required to determine eligibility for enrollment in the SCSEP. Information attesting that the applicant meets the current income guidelines and age requirements to participate and benefit from the SCSEP, is documented on the application, signed by the applicant, and the Forest Service staff. The application also becomes a part of the participant's official personnel folder and is maintained with other personnel documents related to the employment and work history of the individual. </P>
        <HD SOURCE="HD1">Description of Information Collection </HD>
        <P>The following describes the information collection to be extended: </P>
        <P>
          <E T="03">Title:</E> Application for the Senior Community Service Employment Program. </P>
        <P>
          <E T="03">OMB Number:</E> 0596-0099. </P>
        <P>
          <E T="03">Expiration Date of Approval:</E> December 31, 2003. </P>
        <P>
          <E T="03">Type of Request:</E> Extension of a previously approved information collection. </P>
        <P>
          <E T="03">Abstract:</E> Sections I and II are completed by the applicant or a Forest <PRTPAGE P="48877"/>Service official on behalf of the applicant, to determine eligibility for the program or continued participation in the program. The remaining sections, III, IV, and V are completed by a Forest Service official with responsibility for determining eligibility for participation in the program. The statistical data in these sections are collected and used for a Quarterly Progress Report (QPR) prepared by the Forest Service and transmitted to the Department of Labor. The QPR is a requirement of the current program regulations. The data collected from the Forest Service is used by the Department of Labor to prepare a composite activity report highlighting the program's accomplishments and demographic efforts over the program year and is transmitted annually to Congress. </P>
        <P>Data gathered in this information collection are not available from other sources. </P>
        <P>
          <E T="03">Estimate of Annual Burden:</E> 12 minutes. </P>
        <P>
          <E T="03">Type of Respondents:</E> Economically disadvantaged individuals, including legal aliens, age 55 or older. </P>
        <P>
          <E T="03">Estimated Annual Number of Respondents:</E> 6,500. </P>
        <P>
          <E T="03">Estimated Annual Number of Responses per Respondent:</E> 1. </P>
        <P>
          <E T="03">Estimated Total Annual Burden on Respondents:</E> 1,300 hours. </P>
        <HD SOURCE="HD1">Request for Comments </HD>
        <P>The agency invites comments on the following: (a) The necessity of the proposed information collection for the proper performance of agency functions, including the practical utility of the information; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) the enhancements of the quality, utility, and clarity of the information to be collected; and (d) the minimization of the burden of collection of information on respondents, including the use of automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. </P>
        <HD SOURCE="HD1">Use of Comments </HD>
        <P>All comments received in response to this notice, including names and addresses when provided, will become a matter of public record. Comments will be summarized and included in the request for Office of Management and Budget approval. </P>
        <SIG>
          <DATED>Dated: July 30, 2003. </DATED>
          <NAME>Irving W. Thomas, </NAME>
          <TITLE>Acting Deputy Chief, Business Operations. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20798 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 3410-11-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF AGRICULTURE </AGENCY>
        <SUBAGY>National Agricultural Statistics Service </SUBAGY>
        <SUBJECT>Notice of Intent To Seek Approval To Revise a Currently Approved Information Collection </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>National Agricultural Statistics Service, (USDA). </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice and request for comments. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>

          <P>In accordance with the Paperwork Reduction Act of 1995 44 U.S.C. 3501 <E T="03">et seq.</E> and Office of Management and Budget regulations at 5 CFR part 1320 (60 FR 44978, August 29, 1995), this notice announces the intent of the National Agricultural Statistics Service (NASS) to request revision to a currently approved information collection, (OMB No. 0535-0244) the Nursery Production Survey and Nursery and Floriculture Chemical Use Survey. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Comments on this notice must be received by October 20, 2003, to be assured of consideration. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>

          <P>Comments may be sent to Ginny McBride, NASS OMB Clearance Officer, USDA, Room 5336 South Building, 1400 Independence Avenue SW., Washington, DC 20250 or to <E T="03">gmcbride@nass.usda.gov.</E>
          </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Carol House, Associate Administrator, NASS, USDA, (202) 720-4333. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P SOURCE="NPAR">
          <E T="03">Title:</E> Nursery Production Survey and Nursery and Floriculture Chemical Use Survey. </P>
        <P>
          <E T="03">OMB Control Number:</E> 0535-0244. </P>
        <P>
          <E T="03">Expiration Date of Approval:</E> January 31, 2004. </P>
        <P>
          <E T="03">Type of Request:</E> Intent to Seek Approval to Revise a Currently Approved Information Collection. </P>
        <P>
          <E T="03">Abstract:</E> This NASS information collection will again measure production and value of key nursery products as well as chemical use in nursery and floriculture operations. The first Nursery Production Survey, covering the year 2000, revealed that gross value of sales for 9 categories of nursery products totaled $3.32 billion in seventeen selected States. Although nursery production continues to be the fastest growing segment of American agriculture, the USDA has not previously made regular estimates of nursery production. The Nursery Production Survey will update the production and economic contribution of the nursery industry to U.S. agriculture every 2 years by conducting a census of nursery and greenhouse operations with sales over $10,000 in the 17 major producing States. These operations will receive the production mail questionnaire with some telephone and personal interview follow-up for non-response. </P>
        <P>The first Nursery and Floriculture Chemical Use Survey measured chemical use, covering the year 2000, related to the production of nursery and floriculture crops in the six major producing States. The resulting publication, part of the NASS series on Agricultural Chemical Usage, summarized rates of application, total amount of active ingredients applied, and use of pest management practices. NASS collects on-farm chemical use data to enhance the quality of information used in the evaluation of issues related to agricultural chemicals, including pesticide registrations. Pest management data are used to measure integrated pest management (IPM) adoption levels and evaluate the impact of alternative pesticide regulations, policies, and practices. A sample of nursery and floriculture operations with sales over $10,000 in the major States will be personally interviewed, since chemical use data are not accurately collected by telephone or mail. Data collection for both surveys is scheduled to coincide with the annual Commercial Floriculture Survey (of production, OMB docket #0535-0093) in January—March 2004. These data will be collected under the authority of 7 U.S.C. 2204(a). Individually identifiable data collected under this authority are governed by Section 1770 of the Food Security Act of 1985, 7 U.S.C. 2276, which requires USDA to afford strict confidentiality to non-aggregated data provided by respondents. </P>
        <P>
          <E T="03">Estimate of Burden:</E> Based on data collected on the 2000 Nursery Production Survey, the nursery production questionnaire is expected to average 35 minutes per respondent. Based on the 2000 Nursery and Floriculture Chemical Use Survey, it is estimated that the chemical use questionnaire will average 60 minutes per respondent. </P>
        <P>
          <E T="03">Respondents:</E> Producers of nursery, greenhouse, and floriculture products. </P>
        <P>
          <E T="03">Estimated Number of Respondents:</E> 8,800. </P>
        <P>
          <E T="03">Estimated Total Annual Burden on Respondents:</E> 6,000 hours. <PRTPAGE P="48878"/>
        </P>
        <P>Copies of this information collection and related instructions can be obtained without charge from Ginny McBride, NASS OMB Clearance Officer, at (202) 720-5778. </P>
        <P>
          <E T="03">Comments:</E> Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information including the validity of the methodology and assumptions used; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. </P>
        <P>All responses to this notice will become a matter of public record and be included in the request for OMB approval. </P>
        <SIG>
          <DATED>Signed at Washington, DC, July 14, 2003. </DATED>
          <NAME>Carol House, </NAME>
          <TITLE>Associate Administrator. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20877 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 3410-20-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF AGRICULTURE </AGENCY>
        <SUBAGY>National Agricultural Statistics Service </SUBAGY>
        <SUBJECT>Notice of Intent To Request a Revision to a Currently Approved Information Collection </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>National Agricultural Statistics Service, (USDA). </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice and request for comments. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>

          <P>In accordance with the Paperwork Reduction Act of 1995 44 U.S.C.301 <E T="03">et seq.</E> and Office of Management and Budget regulations at 5 CFR part 1320 (60 FR 44978, August 29, 1995), this notice announces the intent of the National Agricultural Statistics Service (NASS) to request a revision to a currently approved information collection, (OMB No. 0535-0220) the Cotton Ginning Survey. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Comments on this notice must be received by October 20, 2003, to be assured of consideration. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>

          <P>Comments may be sent to Ginny McBride, NASS OMB Clearance Officer, U.S. Department of Agriculture, Room 5336 South Building, 1400 Independence Avenue SW., Washington, DC 20250 or to <E T="03">gmcbride@nass.usda.gov.</E>
          </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Carol House, Associate Administrator, NASS, USDA, (202) 720-4333. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P SOURCE="NPAR">
          <E T="03">Title:</E> Cotton Ginning Survey. </P>
        <P>
          <E T="03">OMB Control Number:</E> 0535-0220. </P>
        <P>
          <E T="03">Expiration Date of Approval:</E> March 31, 2004. </P>
        <P>
          <E T="03">Type of Request:</E> To Revise a Currently Approved Information Collection. </P>
        <P>
          <E T="03">Abstract:</E> The primary objective of the NASS is to prepare and issue state and national estimates of crop and livestock production. The Cotton Ginning Survey provides statistics concerning cotton ginning for specific dates and geographic regions and aids in forecasting cotton production. </P>
        <P>
          <E T="03">Estimate of Burden:</E> Public reporting burden for this collection of information is estimated to average 6 minutes per response. </P>
        <P>
          <E T="03">Respondents:</E> Cotton Ginners. </P>
        <P>
          <E T="03">Estimated Number of Respondents:</E> 10,000. </P>
        <P>
          <E T="03">Estimated Total Annual Burden on Respondents:</E> 1,000 hours. </P>
        <P>Copies of this information collection and related instructions can be obtained without charge from Ginny McBride, NASS OMB Clearance Officer, at (202) 720-5778. </P>
        <P>
          <E T="03">Comments:</E> Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information including the validity of the methodology and assumptions used; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. Comments may be sent to: Ginny McBride, Agency OMB Clearance Officer, USDA, 1400 Independence Avenue SW., Room 5336 South Building, Washington, DC 20250-2009. All responses to this notice will become a matter of public record and be summarized in the request for OMB approval. </P>
        <SIG>
          <DATED>Signed at Washington, DC, July 14, 2000. </DATED>
          <NAME>Carol House, </NAME>
          <TITLE>Associate Administrator. </TITLE>
        </SIG>
        <NOTE>
          <HD SOURCE="HED">[Editorial note:</HD>
          <P>This document was received at the Office of the Federal Register on August 12, 2003.]</P>
        </NOTE>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20878 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 3410-20-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">COMMITTEE FOR PURCHASE FROM PEOPLE WHO ARE BLIND OR SEVERELY DISABLED </AGENCY>
        <SUBJECT>Procurement List Proposed Additions and Deletions </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Committee for Purchase From People Who Are Blind or Severely Disabled. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Proposed additions to and deletions from procurement list. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The Committee is proposing to add to the Procurement List services to be furnished by nonprofit agencies employing persons who are blind or have other severe disabilities, and to delete products and services previously furnished by such agencies. Comments must be received on or before: September 14, 2003. </P>
        </SUM>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Committee for Purchase From People Who Are Blind or Severely Disabled, Jefferson Plaza 2, Suite 10800, 1421 Jefferson Davis Highway, Arlington, Virginia 22202-3259. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Sheryl D. Kennerly, (703) 603-7740. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>This notice is published pursuant to 41 U.S.C 47(a)(2) and 41 CFR 51-2.3. Its purpose is to provide interested persons an opportunity to submit comments on the proposed actions. </P>
        <HD SOURCE="HD1">Additions </HD>
        <P>If the Committee approves the proposed additions, the entities of the Federal Government identified in this notice for each product or service will be required to procure the services listed below from nonprofit agencies employing persons who are blind or have other severe disabilities. </P>
        <HD SOURCE="HD2">Regulatory Flexibility Act Certification </HD>
        <P>I certify that the following action will not have a significant impact on a substantial number of small entities. The major factors considered for this certification were: </P>

        <P>1. If approved, the action will not result in any additional reporting, recordkeeping or other compliance requirements for small entities other than the small organizations that will furnish the services to the Government. <PRTPAGE P="48879"/>
        </P>
        <P>2. If approved, the action will result in authorizing small entities to furnish the services to the Government. </P>
        <P>3. There are no known regulatory alternatives which would accomplish the objectives of the Javits-Wagner-O'Day Act (41 U.S.C. 46-48c) in connection with the services proposed for addition to the Procurement List. Comments on this certification are invited. Commenters should identify the statement(s) underlying the certification on which they are providing additional information.</P>
        
        <FP>
          <E T="03">(End of Certification)</E>
        </FP>
        
        <P>The following services are proposed for addition to the Procurement List for production by the nonprofit agencies listed: </P>
        
        <EXTRACT>
          <HD SOURCE="HD2">Services </HD>
          <FP SOURCE="FP-2">
            <E T="03">Service Type/Location:</E> Custodial Services, FAA, New Air Traffic Control Tower &amp; Administrative Office Space, Located on 3rd &amp; 4th floor of the Old ATCT, Cleveland, Ohio. </FP>
          <FP SOURCE="FP-2">
            <E T="03">NPA:</E> Murray Ridge Production Center, Inc., Elyria, Ohio. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Contract Activity:</E> Federal Aviation Administration, North Olmsted, Ohio. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Service Type/Location:</E> Janitorial/Custodial, USDA, Forest Service, Shasta Trinity National Forest, Redding, California. </FP>
          <FP SOURCE="FP-2">
            <E T="03">NPA:</E> Shasta County Opportunity Center, Redding, California. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Contract Activity:</E> USDA, Northern Province Operations, Redding, California. </FP>
        </EXTRACT>
        
        <HD SOURCE="HD1">Deletions </HD>
        <HD SOURCE="HD2">Regulatory Flexibility Act Certification </HD>
        <P>I certify that the following action will not have a significant impact on a substantial number of small entities. The major factors considered for this certification were: </P>
        <P>1. If approved, the action will not result in any additional reporting, recordkeeping or other compliance requirements for small entities. </P>
        <P>2. If approved, the action may result in authorizing small entities to furnish the products and services to the Government. </P>
        <P>3. There are no known regulatory alternatives which would accomplish the objectives of the Javits-Wagner-O'Day Act (41 U.S.C. 46-48c) in connection with the products and services proposed for deletion from the Procurement List.</P>
        
        <FP>
          <E T="03">(End of Certification)</E>
        </FP>
        
        <P>The following products and services are proposed for deletion from the Procurement List: </P>
        
        <EXTRACT>
          <HD SOURCE="HD1">Products</HD>
          <FP SOURCE="FP-2">
            <E T="03">Product/NSN:</E> Bag, Vacuum Cleaner, Disposable, M.R. 1001, M.R. 1002, M.R. 1003, M.R. 1004, M.R. 1005, M.R. 1006, M.R. 1007, M.R. 1008. </FP>
          <FP SOURCE="FP-2">
            <E T="03">NPA:</E> New York City Industries for the Blind, Inc., Brooklyn, New York. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Contract Activity:</E> Defense Commissary Agency, Fort Lee, Virginia. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Product/NSN:</E> Broom, Whisk, M.R. 909. </FP>
          <FP SOURCE="FP-2">
            <E T="03">NPA:</E> None currently authorized. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Contract Activity:</E> Defense Commissary Agency (DeCA), Ft. Lee, Virginia. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Product/NSN:</E> Dustpan, M.R. 995. </FP>
          <FP SOURCE="FP-2">
            <E T="03">NPA:</E> None currently authorized. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Contract Activity:</E> Defense Commissary Agency (DeCA), Ft. Lee, Virginia. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Product/NSN:</E> Egg Slicer, M.R. 843. </FP>
          <FP SOURCE="FP-2">
            <E T="03">NPA:</E> Alabama Industries for the Blind, Talladega, Alabama. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Contract Activity:</E> Defense Commissary Agency (DeCA), Ft. Lee, Virginia. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Product/NSN:</E> Fabric Softener Sheets, Reusable, M.R. 520.</FP>
          <FP SOURCE="FP-2">
            <E T="03">NPA:</E> Industries of the Blind, Inc., Greensboro, North Carolina. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Contract Activity:</E> Defense Commissary Agency (DeCA), Ft. Lee, Virginia. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Product/NSN:</E> Kitchen, Utensils, M.R. 821. </FP>
          <FP SOURCE="FP-2">
            <E T="03">NPA:</E> Cincinnati Association for the Blind, Cincinnati, Ohio. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Contract Activity:</E> Defense Commissary Agency (DeCA), Ft. Lee, Virginia. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Product/NSN:</E> Nylon &amp; Plastic Kitchen Utensils, M.R. 839, M.R. 840. </FP>
          <FP SOURCE="FP-2">
            <E T="03">NPA:</E> The Lighthouse for the Blind, Inc. (Seattle Lighthouse), Seattle, Washington. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Contract Activity:</E> Defense Commissary Agency (DeCA), Ft. Lee, Virginia. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Product/NSN:</E> Pencil, Mechanical, Dual Action, M.R. 052. </FP>
          <FP SOURCE="FP-2">
            <E T="03">NPA:</E> San Antonio Lighthouse, San Antonio, Texas. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Contract Activity:</E> Defense Commissary Agency (DeCA), Ft. Lee, Virginia. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Product/NSN:</E> Pens and Markers, M.R. 062, M.R. 063, M.R. 064, M.R. 065, M.R. 066, M.R. 067. </FP>
          <FP SOURCE="FP-2">
            <E T="03">NPA:</E> West Texas Lighthouse for the Blind, San Angelo, Texas. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Contract Activity:</E> Defense Commissary Agency (DeCA), Ft. Lee, Virginia. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Product/NSN:</E> Potpourri, M.R. 400, M.R. 401, M.R. 403. </FP>
          <FP SOURCE="FP-2">
            <E T="03">NPA:</E> Envision, Inc., Wichita, Kansas. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Contract Activity:</E> Defense Commissary Agency (DeCA), Ft. Lee, Virginia. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Product/NSN:</E> PVA Mop, M.R. 1027. </FP>
          <FP SOURCE="FP-2">
            <E T="03">NPA:</E> The Lighthouse for the Blind, Inc. (Seattle Lighthouse), Seattle, Washington. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Contract Activity:</E> Defense Commissary Agency (DeCA), Ft. Lee, Virginia. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Product/NSN:</E> Scrubber, M.R. 543. </FP>
          <FP SOURCE="FP-2">
            <E T="03">NPA:</E> Beacon Lighthouse, Inc., Wichita Falls, Texas. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Contract Activity:</E> Defense Commissary Agency (DeCA), Ft. Lee, Virginia. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Product/NSN:</E> Scrubber, Sponge, M.R. 548. </FP>
          <FP SOURCE="FP-2">
            <E T="03">NPA:</E> Mississippi Industries for the Blind, Jackson, Mississippi. </FP>
          <FP SOURCE="FP-2">
            <E T="03">NPA:</E> New York City Industries for the Blind, Inc., Brooklyn, New York. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Contract Activity:</E> Defense Commissary Agency (DeCA), Ft. Lee, Virginia. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Product/NSN:</E> Towels, Seasonal, M.R. 1009. </FP>
          <FP SOURCE="FP-2">
            <E T="03">NPA:</E> Chester County Branch of the PAB, Coatesville, Pennsylvania. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Contract Activity:</E> Defense Commissary Agency, Fort Lee, Virginia. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Product/NSN:</E> Wipes, Scrubber, M.R. 588. </FP>
          <FP SOURCE="FP-2">
            <E T="03">NPA:</E> Mississippi Industries for the Blind, Jackson, Mississippi. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Contract Activity:</E> Defense Commissary Agency (DeCA), Ft. Lee, Virginia. </FP>
          <HD SOURCE="HD1">Services </HD>
          <FP SOURCE="FP-2">
            <E T="03">Service Type/Location:</E> Food Service Attendant, Charleston Naval Weapons Station, Building 306, Charleston, South Carolina. </FP>
          <FP SOURCE="FP-2">
            <E T="03">NPA:</E> Goodwill Industries of Lower South Carolina, Inc., North Charleston, South Carolina. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Contract Activity:</E> Department of the Navy. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Service Type/Location:</E> Food Service Attendant, Charleston Naval Weapon Station, Building NS-43, Charleston, South Carolina. </FP>
          <FP SOURCE="FP-2">
            <E T="03">NPA:</E> Goodwill Industries of Lower South Carolina, Inc., North Charleston, South Carolina. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Contract Activity:</E> Department of the Navy. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Service Type/Location:</E> Food Service Attendant, Orlando Naval Training Center, Orlando, Florida. </FP>
          <FP SOURCE="FP-2">
            <E T="03">NPA:</E> Goodwill Industries of Central Florida, Orlando, Florida. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Contract Activity:</E> Department of the Navy. </FP>
          <FP SOURCE="FP-2">
            <E T="03">Service Type/Location:</E> Janitorial/Custodial, U.S. Army Reserve Center, Memphis, Tennessee. </FP>
          <FP SOURCE="FP-2">
            <E T="03">NPA:</E> Shelby Residential and Vocational Services, Inc., Memphis, Tennessee.</FP>
          <FP SOURCE="FP-2">
            <E T="03">Contract Activity:</E> Department of the Army.</FP>
        </EXTRACT>
        
        <SIG>
          <NAME>Sheryl D. Kennerly, </NAME>
          <TITLE>Director, Information Management.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20880 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 6353-01-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">COMMITTEE FOR PURCHASE FROM PEOPLE WHO ARE BLIND OR SEVERELY DISABLED </AGENCY>
        <SUBJECT>Procurement List; Additions </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Committee for Purchase From People Who Are Blind or Severely Disabled. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Additions to procurement list. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This action adds to the Procurement List products and services to be furnished by nonprofit agencies employing persons who are blind or have other severe disabilities. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">EFFECTIVE DATE:</HD>
          <P>The effective date for addition of the service CD-Rom Replication, Government Printing Office, Program 5455-S, Chicago, Illinois will be March 1, 2004. The addition for all other products and services in this notice will be effective September 14, 2003. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Committee for Purchase From People Who Are Blind or Severely Disabled, Jefferson Plaza 2, Suite 10800, 1421 Jefferson Davis Highway, Arlington, Virginia, 22202-3259. </P>
        </ADD>
        <FURINF>
          <PRTPAGE P="48880"/>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Sheryl D. Kennerly, (703) 603-7740. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>On February 7, May 2, June 6, and June 13, 2003, the Committee for Purchase From People Who Are Blind or Severely Disabled published notice (68 FR 6403, 23441, 33908, and 35380) of proposed additions to the Procurement List. After consideration of the material presented to it concerning capability of qualified nonprofit agencies to provide the products and services and impact of the additions on the current or most recent contractors, the Committee has determined that the products and services listed below are suitable for procurement by the Federal Government under 41 U.S.C. 46-48c and 41 CFR 51-2.4. </P>
        <HD SOURCE="HD1">Regulatory Flexibility Act Certification </HD>
        <P>I certify that the following action will not have a significant impact on a substantial number of small entities. The major factors considered for this certification were: </P>
        <P>1. The action will not result in any additional reporting, recordkeeping or other compliance requirements for small entities other than the small organizations that will furnish the products and services to the Government. </P>
        <P>2. The action will result in authorizing small entities to furnish the products and services to the Government. </P>
        <P>3. There are no known regulatory alternatives which would accomplish the objectives of the Javits-Wagner-O'Day Act (41 U.S.C. 46-48c) in connection with the products and services proposed for addition to the Procurement List.</P>
        
        <FP>
          <E T="03">(End of Certification)</E>
        </FP>
        
        <P>Accordingly, the following products and services are added to the Procurement List: </P>
        <HD SOURCE="HD1">Products </HD>
        <FP SOURCE="FP-1">
          <E T="03">Product/NSN:</E> Candle</FP>
        
        <FP SOURCE="FP-2">3″ x 3″ Pillar, Gardenia/M.R. 481. </FP>
        <FP SOURCE="FP-2">3″ x 3″ Pillar, Vanilla/M.R. 480. </FP>
        <FP SOURCE="FP-2">6″ x 3″ Pillar, Gardenia/M.R. 483. </FP>
        <FP SOURCE="FP-2">6″ x 3″ Pillar, Vanilla/M.R. 482. </FP>
        <FP SOURCE="FP-2">Jar, Lavender/M.R. 485. </FP>
        <FP SOURCE="FP-2">Jar, Vanilla/M.R. 484. </FP>
        
        <FP SOURCE="FP-1">
          <E T="03">NPA:</E> South Texas Lighthouse for the Blind, Corpus Christi, Texas. </FP>
        <FP SOURCE="FP-1">
          <E T="03">Contract Activity:</E> Defense Commissary Agency (DeCA), Ft. Lee, Virginia. </FP>
        
        <FP SOURCE="FP-1">
          <E T="03">Product/NSN:</E> Pen, Gel Ink, Aristocrat. </FP>
        
        <FP SOURCE="FP-2">7520-00-NIB-1461 </FP>
        <FP SOURCE="FP-2">7520-00-NIB-1481</FP>
        
        <FP SOURCE="FP-1">
          <E T="03">NPA:</E> Industries of the Blind, Inc., Greensboro, North Carolina. </FP>
        <FP SOURCE="FP-1">
          <E T="03">Contract Activity:</E> Office Supplies &amp; Paper Products Acquisition Center, New York, New York. </FP>
        <FP SOURCE="FP-1">
          <E T="03">Product/NSN:</E> Pen, Gel, Executive.</FP>
        
        <FP SOURCE="FP-2">7520-00-NIB-1491</FP>
        
        <FP SOURCE="FP-1">
          <E T="03">NPA:</E> West Texas Lighthouse for the Blind, San Angelo, Texas. </FP>
        <FP SOURCE="FP-1">
          <E T="03">Contract Activity:</E> Office Supplies &amp; Paper Products Acquisition Center, New York, New York. </FP>
        <HD SOURCE="HD1">Services </HD>
        <FP SOURCE="FP-1">
          <E T="03">Service Type/Location:</E> CD-ROM Replication, Government Printing Office, Program 5455-S, Chicago, Illinois. </FP>
        <FP SOURCE="FP-1">
          <E T="03">NPA:</E> Assoc for the Blind &amp; Visually Impaired &amp; Goodwill Industries of Greater Rochester, Rochester, New York. </FP>
        <FP SOURCE="FP-1">
          <E T="03">Contract Activity:</E> Government Printing Office, Chicago, Illinois.</FP>
        
        <FP SOURCE="FP-1">
          <E T="03">Service Type/Location:</E> Custodial Services. Army Corps of Engineers, Jadwin Building, Galveston, Texas. </FP>
        <FP SOURCE="FP-1">
          <E T="03">NPA:</E> Training, Rehabilitation, &amp; Development Institute, Inc., San Antonio, Texas. </FP>
        <FP SOURCE="FP-1">
          <E T="03">Contract Activity:</E> U.S. Army Corps of Engineers, Galveston, Texas.</FP>
        
        <FP SOURCE="FP-1">
          <E T="03">Service Type/Location:</E> Food Service, U.S. Property and Fiscal Officer, Wisconsin Military Academy, Fort McCoy, Wisconsin. </FP>
        <FP SOURCE="FP-1">
          <E T="03">NPA:</E> Challenge Unlimited, Inc., Alton, Illinois. </FP>
        <FP SOURCE="FP-1">
          <E T="03">Contract Activity:</E> U.S. Property and Fiscal Officer for Wisconsin, Camp Douglas, Wisconsin. </FP>
        
        <FP SOURCE="FP-1">
          <E T="03">Service Type/Location:</E> Janitorial/Custodial, The Dalles Dam, The Dalles, Oregon. </FP>
        <FP SOURCE="FP-1">
          <E T="03">NPA:</E> Hood River Sheltered Workshop, Hood River, Oregon. </FP>
        <FP SOURCE="FP-1">
          <E T="03">Contract Activity:</E> Army Corps of Engineers, Portland, Oregon.</FP>
        
        <P>This action does not affect current contracts awarded prior to the effective date of this addition or options that may be exercised under those contracts. </P>
        <SIG>
          <NAME>Sheryl D. Kennerly,</NAME>
          <TITLE>Director, Information Management.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20881 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 6353-01-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF COMMERCE</AGENCY>
        <SUBAGY>International Trade Administration</SUBAGY>
        <DEPDOC>[A-449-804]</DEPDOC>
        <SUBJECT>Notice of Preliminary Results of Antidumping Duty Administrative Review:  Steel Concrete Reinforcing Bars from Latvia</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Import Administration, International Trade Administration, Department of Commerce.</P>
        </AGY>
        <EFFDATE>
          <HD SOURCE="HED">EFFECTIVE DATE:</HD>
          <P>August 15, 2003..</P>
        </EFFDATE>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Jim Kemp or Daniel O'Brien, at (202) 482-5346 or (202) 482-1376, respectively; AD/CVD Enforcement Office 5, Group II, Import Administration, International Trade Administration, U.S. Department of Commerce, 14th Street &amp; Constitution Avenue, NW, Washington, DC 20230.</P>
        </FURINF>
        <SUM>
          <HD SOURCE="HED">Summary:</HD>
          <P>The Department of Commerce is conducting an administrative review of the antidumping duty order on steel concrete reinforcing bar (rebar) from Latvia.  We preliminarily determine that sales of subject merchandise by Joint Stock Company Liepajas Metalurgs (Liepajas Metalurgs) have been made below normal value (NV).  If these preliminary results are adopted in our final results, we will instruct the U.S. Bureau of Customs and Border Protection (BCBP) <SU>1</SU>
            <FTREF/> to assess antidumping duties on appropriate entries based on the difference between the export price (EP) and the NV.</P>
          <FTNT>
            <P>
              <SU>1</SU> Formerly the U.S. Customs Service.</P>
          </FTNT>
          <P>Interested parties are invited to comment on these preliminary results.  Parties that submit arguments are requested to submit with each argument:  (1) a statement of the issue and (2) a brief summary of the argument.  Further, we ask that parties submitting comments provide the Department of Commerce (the Department) with an additional copy of the public version of any such comments on diskette.</P>
        </SUM>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <HD SOURCE="HD1">Background</HD>

        <P>On September 7, 2001, the Department issued an antidumping duty order on rebar from Latvia. <E T="03">See Antidumping Duty Orders:  Steel Concrete Reinforcing Bars From Belarus, Indonesia, Latvia, Moldova, People's Republic of China, Poland, Republic of Korea and Ukraine</E>, 66 FR 46777 (September 7, 2001).  On September 3, 2002, the Department issued a notice of opportunity to request the first administrative review of this order. <E T="03">See Antidumping or Countervailing Duty <PRTPAGE P="48881"/>Order, Finding, or Suspended Investigation;  Opportunity to Request Administrative Review</E>, 67 FR 56267 (September 3, 2002).On September 3, 2003, in accordance with 19 CFR 351.213(b), Liepajas Metalurgs requested an administrative review.  On October 24, 2002, the Department published the notice of initiation of this antidumping duty administrative review, covering the period January 30, 2001, through August 31, 2002 (the POR). <E T="03">See Initiation of Antidumping and Countervailing Duty Administrative Reviews</E>, 67 FR 65336 (October 24, 2002).</P>
        <P>On October 25, 2002, the Department issued its antidumping questionnaire to Liepajas Metalurgs, specifying that the responses to Section A and Sections B-D would be due on November 15, and December 2, 2003, respectively.<FTREF/>
          <SU>2</SU> We received timely responses to Sections A-C of the initial antidumping questionnaire and associated supplemental questionnaires.  Based on a timely allegation filed by the petitioners<FTREF/>
          <SU>3</SU> on January 6, 2003, we initiated a cost of production (COP) investigation of Liepajas Metalurgs.  The company submitted timely responses to Section D of the antidumping questionnaire, as well as to supplemental questionnaires.</P>
        <FTNT>
          <P>
            <SU>2</SU> Section A of the questionnaire requests general information concerning a company's corporate structure and business practices, the merchandise under review that it sells, and the manner in which it sells that merchandise in all of its markets.  Section B requests a complete listing of all home market sales, or, if the home market is not viable, of sales in the most appropriate third-country market (this section is not applicable to respondents in non-market economy cases).  Section C requests a complete listing of U.S. sales.  Section D requests information on the cost of production of the foreign like product and the constructed value of the merchandise under review.  Section E requests information on further manufacturing.</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>3</SU> The petitioners in this case are the Rebar Trade Action Coalition (“RTAC”) and its individual members.</P>
        </FTNT>
        <HD SOURCE="HD1">Scope of the Order</HD>

        <P>For purposes of this review, the product covered by this order is all steel concrete reinforcing bars sold in straight lengths, currently classifiable in the Harmonized Tariff Schedule of the United States (HTSUS) under item number 7214.20.00 or any other tariff item number. Specifically excluded are plain rounds (<E T="03">i.e.</E>, non-deformed or smooth bars) and rebar that has been further processed through bending or coating.  HTSUS subheadings are provided for convenience and customs purposes. The written description of the scope of this proceeding is dispositive.</P>
        <HD SOURCE="HD1">Verification</HD>

        <P>As provided in section 782(i)(3) of the Tariff Act of 1930, as amended (the Act), we verified information provided by Liepajas Metalurgs.  We used standard verification procedures, including on-site inspection of Liepajas Metalurgs' facilities and examination of relevant sales and financial records. <E T="03">See</E> Memorandum from Daniel O'Brien and Jim Kemp, International Trade Compliance Analysts, to Gary Taverman, Director, Office 5, Re:  Verification of the Sales and Cost Responses of Joint Stock Company Liepaja Metalurgs in the First Administrative Review of Steel Concrete Reinforcing Bars from Latvia, dated July 30, 2003 (the Verification Report).</P>
        <HD SOURCE="HD1">Facts Available</HD>
        <P>When responding to the questionnaire, Liepajas Metalurgs did not report all of the product characteristics for certain home market sales made by its affiliated reseller, Armaturas Servisa Centrs (ASC).  Additionally, Liepajas Metalurgs did not report certain sales of merchandise that Liepajas Metalurgs produced but which was commingled at ASC's warehouse with incoming rebar produced by other companies and sold by ASC.  Finally, we found that Liepajas Metalurgs' calculation of home market freight expense was unreliable for rebar shipments from the plant to the warehouse and shipments from Liepajas Metalurgs' Riga sales office (RSO) to the customer.  We examined these issues closely at verification and found that Liepajas Metalurgs, in the normal course of business, did not maintain the necessary records to report the data as requested by the Department.</P>

        <P>With regard to sales of merchandise commingled with different manufacturers' products, we found that ASC developed a system to identify the producer based on the customer, grade and size of the rebar, and location of the merchandise in inventory.  However, ASC could not provide documentation to support its segregation of rebar and acknowledged that even by this method, the company was unable to identify the manufacturer for every sale.  Concerning sales of merchandise with incomplete matching characteristics, we found that ASC only recorded all of the product characteristics (<E T="03">i.e.</E> type of steel, yield strength, and size) of its merchandise when a customer ordered a specific grade of rebar.  Therefore, ASC was unable to the report yield strength, and sometimes size, for sales where no such request was made by its customers.  Finally, for the freight calculations in question, Liepajas Metalurgs could not properly document the type of merchandise shipped (i.e. rebar or other products) and the quantity relating to the freight invoices.  For a further discussion of these issues, <E T="03">see</E> the Verification Report.</P>
        <P>Section 776(a)(2) of the Act provides that, if an interested party or any other person (A) withholds information that has been requested by the administering authority;  (B) fails to provide such information by the deadlines for the submission of the information or in the form and manner requested, subject to subsections (c)(1) and (e) of section 782 of the Act;  (C) significantly impedes a proceeding under this title;  or (D) provides such information but the information cannot be verified as provided in section 782(i) of the Act, the Department shall, subject to section 782(d) of the Act, use the facts otherwise available in reaching the applicable determination under this title.</P>

        <P>In applying facts otherwise available, section 776(b) of the Act provides that the Department may use an inference adverse to the interests of a party that has failed to cooperate by not acting to the best of its ability to comply with the Department's requests for information. <E T="03">See, e.g., Notice of Final Determination of Sales at Less Than Fair Value and Final Negative Critical Circumstances:  Carbon and Certain Alloy Steel Wire Rod from Brazil</E>, 67 FR 55792, 55794-96 (August 30, 2002).  Adverse inferences are appropriate “to ensure that the party does not obtain a more favorable result by failing to cooperate than if it had cooperated fully.” <E T="03">See</E> Statement of Administrative Action accompanying the Uruguay Round Agreements Act, H.R. Rep. No. 103-316, (1994) (SAA) at 870.  Furthermore, “{a}ffirmative evidence of bad faith on the part of a respondent is not required before the Department may make an adverse inference.” <E T="03">See Antidumping Countervailing Duties:  Final Rule</E>, 62 FR 27296, 27340 (May 19, 1997).</P>

        <P>In this case, we have found that an adverse inference is not appropriate for Liepajas Metalurgs because the company acted to the best of its ability to report the data requested by the Department.  In its December 16, 2002, Section B response, Liepajas Metalurgs explained that ASC had some sales for which it did not track the necessary product information.  Thereafter, the company answered all the Department's supplemental questions on this issue.  At verification, we confirmed the information contained in Liepajas Metalurgs' responses regarding the sales with incomplete product information. <PRTPAGE P="48882"/> Likewise, Liepajas Metalurgs attempted to the best of its ability to identify the manufacturer of all of ASC's sales.  The company developed a method to accomplish this task, but, as we found at verification, due to ASC's manner of conducting business, it had no means to document its segregation of rebar by producer.   ASC opened in May 2002 and was only in business and had sales for approximately four months during the POR.  During this time frame, ASC was still in the process of developing a record keeping system and establishing routine procedures for the sales process.  At verification, we confirmed that ASC conducted business and tracked sales in a manner that did not provide for the proper reporting of all the information requested by the Department, in spite of ASC's best efforts to do so.</P>
        <P>Therefore, we preliminarily determine that Liepajas Metalurgs (and its affiliate, ASC) acted to the best of their ability and no adverse inference is warranted.  Moreover, we expect that in future reviews ASC will have had sufficient time to establish its record keeping procedures in full awareness of the Department's reporting requirements.  Thus, the Department will expect the company to properly report the source and matching characteristics for all of its home market sales and failure to do so may result in an adverse inference in the application of facts available.</P>

        <P>Instead of an adverse inference, we have applied neutral facts available in response to Liepajas Metalurgs' inability to provide all the requested information.  For purposes of the margin calculation, we were able to find an identical match at the same level of trade for the vast majority of Liepajas Metalurgs' U.S. sales (ASC's sales are at a distinct (more advanced) level of trade than Liepajas Metalurgs' direct home market and EP sales). <E T="03">See</E> the <E T="03">Level of Trade Adjustment</E> section below.  Since we do not have all the information pertaining to ASC's sales, we cannot determine whether we may have found “most similar” matches among ASC's sales, if the company had correctly reported all of the information.  Therefore, rather than attempting to match to similar home market sales, we applied neutral facts available pursuant to section 776(a)(2)(D) of the Act and compared the U.S. sales with no identical match to constructed value (CV), as described in the <E T="03">Calculation of Normal Value Based on Constructed Value</E> section of this notice.</P>

        <P>We have also applied a neutral facts available adjustment to Liepajas Metalurgs' home market freight expense calculated on shipments from the plant to the warehouse.  In its calculation, Liepajas Metalurgs combined the cost for train and truck shipments into one expense allocated over all sales through the RSO or ASC warehouse.  At verification, we found that the component of the expense based on truck shipments was unreliable.  We found that in spite of Liepajas Metalurgs' best effort to properly calculate the expense, the documentation available to Liepajas Metalurgs did not provide the necessary information to do so. <E T="03">See</E> the Verification Report at 17.  Therefore, we have applied neutral facts available pursuant to section 776(a)(2)(D) of the Act and relied on the portion of the expense based on train freight for all shipments to the RSO or ASC warehouses.</P>
        <P>While we found similar deficiencies with the calculation of freight expense for shipments from the RSO to the customer, we concluded that the expense calculated by the RSO was reasonable when compared to other verified and properly reported freight expenses incurred by Liepajas Metalurgs to the same or similar destinations.  Therefore, we made no adjustment to the freight expense for shipments from the RSO to the customer.</P>
        <HD SOURCE="HD1">Fair Value Comparisons</HD>
        <P>We compared the EP to the NV, as described in the <E T="03">Export Price</E> and <E T="03">Normal Value</E> sections of this notice.  We first attempted to compare contemporaneous sales of products sold in the United States and comparison markets that are identical with respect to the matching characteristics.  Pursuant to section 771(16) of the Act, all products produced by the respondent that fit the definition of the scope of the order and were sold in the comparison market during the POR fall within the definition of the foreign like product.  We have relied on three criteria to match U.S. sales of subject merchandise to comparison market sales of the foreign like product:  type of steel, yield strength, and size.  Where there were no sales of identical merchandise in the comparison market, we compared U.S. sales to sales of the next most similar foreign like product on the basis of the characteristics listed above.</P>
        <HD SOURCE="HD1">Export Price</HD>
        <P>We calculated an EP for all of Liepajas Metalurgs' sales because the merchandise was sold directly by Liepajas Metalurgs to the first unaffiliated purchaser for delivery to the United States, and constructed export price (CEP) was not otherwise warranted based on the facts of record.  We made deductions from the starting price for movement expenses in accordance with section 772(c)(2)(A) of the Act.  These included inland freight and domestic brokerage and handling expenses.</P>
        <HD SOURCE="HD1">Normal Value</HD>
        <HD SOURCE="HD1">A.  Selection of Comparison Markets</HD>
        <P>Section 773(a)(1) of the Act directs that NV be based on the price at which the foreign like product is sold in the home market, provided that the merchandise is sold in sufficient quantities (or value, if quantity is inappropriate), that the time of the sales reasonably corresponds</P>
        <P>to the time of the sale used to determine EP, and that there is no particular market situation that prevents a proper comparison with the EP.  The statute contemplates that quantities (or value) will normally be considered insufficient if they are less than five percent of the aggregate quantity (or value) of sales of the subject merchandise to the United States.</P>
        <P>We found that Liepajas Metalurgs had a viable home market for rebar.  As such, Liepajas Metalurgs submitted home market sales data for purposes of the calculation of NV.</P>
        <P>In deriving NV, we made adjustments as detailed in the <E T="03">Calculation of Normal Value Based on Home Market Prices</E> section below.</P>
        <HD SOURCE="HD1">B.  Cost of Production Analysis</HD>

        <P>Based on a timely allegation filed by the petitioners, we initiated a COP investigation of Liepajas Metalurgs to determine whether sales were made at prices below COP. <E T="03">See</E> Memorandum From Daniel O'Brien, International Trade Compliance Analyst, to Gary Taverman, Director, Office 5, Re: Petitioners' Allegation of Sales Below the Cost of Production for Liepajas Metalurgs, dated January 29, 2003.</P>
        <HD SOURCE="HD2">1.  Calculation of Cost of Production</HD>
        <P>In accordance with section 773(b)(3) of the Act, we calculated the weighted-average COP, by model, based on the sum of materials, fabrication, and general and administrative (G&amp;A) expenses.  We relied on Liepajas Metalurgs' submitted COP except in the specific instances noted below, where the submitted costs were not appropriately quantified or valued.  See Memorandum from Daniel O'Brien and Jim Kemp, International Trade Compliance Analysts, to Constance Handley, Program Manager, Re: Analysis Memorandum for Joint Stock Company Liepajas Metalurgs, dated August 4, 2003 (the Analysis Memorandum).</P>
        <PRTPAGE P="48883"/>
        <P>a.   We revised the G&amp;A and interest expense factor by removing packing expenses from the denominator of Liepajas Metalurgs' original calculation.  Additionally, we removed net exchange rate gains and losses from G&amp;A and included them in the calculation of the financial expense factor.</P>
        <P>b.   We recalculated ASC's reported expense for cutting rebar.</P>
        <HD SOURCE="HD2">2.  Test of Comparison Market Sales Prices</HD>

        <P>We compared the adjusted weighted-average COP for Liepajas Metalurgs to its home-market sales prices of the foreign like product, as required under section 773(b) of the Act, to determine whether these sales had been made at prices below the COP within an extended period of time (<E T="03">i.e.</E>, a period of one year) in substantial quantities and whether such prices were sufficient to permit the recovery of all costs within a reasonable period of time.</P>
        <P>On a model-specific basis, we compared the revised COP to the home market prices, less any applicable movement charges, discounts, rebates, and direct and indirect selling expenses.</P>
        <HD SOURCE="HD2">3.  Results of the COP Test</HD>
        <P>We disregarded below-cost sales where (1) 20 percent or more of Liepajas Metalurgs' sales of a given product were made at prices below the COP and such sales were made within an extended period of time in substantial quantities in accordance with sections 773(b)(2)(B) and (C) of the Act, and (2) based on comparisons of price to weighted-average COPs for the POR, we determined that the below-cost sales of the product were at prices which would not permit recovery of all costs within a reasonable time period, in accordance with section 773(b)(2)(D) of the Act.  We found that Liepajas Metalurgs made sales below cost and we disregarded such sales where appropriate.</P>
        <HD SOURCE="HD1">C.  Calculation of Normal Value Based on Comparison-Market Prices</HD>

        <P>We determined NV for Liepajas Metalurgs as follows.  We made adjustments for any differences in packing and deducted home market movement expenses pursuant to sections 773(a)(6)(A) and 773(a)(6)(B)(ii) of the Act.  In addition, we made adjustments for differences in circumstances of sale (COS) pursuant to section 773(a)(6)(C)(iii) of the Act.  We made COS adjustments for Liepajas Metalurgs's EP transactions by deducting direct selling expenses incurred for home market sales (credit expenses) and adding U.S. direct selling expenses (credit expenses).  We made the following additional adjustment to the calculation of normal value. <E T="03">See</E> the Analysis Memorandum.</P>
        <P>We recalculated Liepajas Metalurgs' and ASC's indirect selling expense calculation to incorporate certain expenses found at verification.</P>

        <P>As reported in its  December 16, 2002, Section B Questionnaire Response (Section B), Liepajas Metalurgs made sales of “non-commercial length” rebar during the POR.  Liepajas Metalurgs considers the merchandise corresponding to these sales to be a “by-product from production of commercial length” rebar. <E T="03">See</E> Section B at B-6.  Accordingly, Liepajas Metalurgs sold the non-commercial length products at “salvage value” in the home market.  Therefore, we have designated the non-commercial length rebar as non-prime in our calculation of Liepajas Metalurgs' antidumping duty margin.  We confirmed at verification that Liepajas Metalurgs sold no such merchandise in the U.S. market.</P>

        <P>In addition to these adjustments, we have made modifications to the calculation of normal value based on the facts otherwise available, as discussed in the <E T="03">Facts Available</E> section of this notice.</P>
        <HD SOURCE="HD1">D.   Calculation of Normal Value Based on Constructed Value</HD>

        <P>For those comparisons with no identical matches, we compared EP to CV, as a neutral facts available adjustment, because of ASC's inability to report all of the sales data requested by the Department. <E T="03">See</E> the <E T="03">Facts Available</E> section above.  Section 773(e) of the Act provides that CV shall be based on the sum of the cost of materials and fabrication for the foreign like product, plus amounts for selling, G&amp;A expenses, profit, and U.S. packing.</P>
        <P>We calculated CV based on the methodology described in the COP section, above.  In accordance with section 773(e)(2)(A) of the Act, we used the actual amounts incurred and realized by Liepajas Metalurgs in connection with the production and sale of the foreign like product, in the ordinary course of trade, for consumption in the comparison market to calculate selling expenses and profit.  For price-to-CV comparisons, we made adjustments to CV for COS differences, pursuant to section 773(a)(8) of the Act.  Specifically, we made COS adjustments by deducting direct selling expenses incurred for home market sales (credit expenses) and adding U.S. direct selling expenses (credit expenses).</P>
        <HD SOURCE="HD1">E.   Level of Trade Adjustment</HD>
        <P>In accordance with section 773(a)(1)(B) of the Act, to the extent practicable, we determine NV based on sales in the comparison market at the same level of trade as the EP transaction.  The NV level of trade is that of the starting-price sales in the comparison market.  For EP sales, the U.S. level of trade is also the level of the starting-price sale, which is usually from exporter to importer.</P>
        <P>To determine whether NV sales are at a different level of trade than EP transactions, we examine stages in the marketing process and selling functions along the chain of distribution between the producer and the unaffiliated customer.  If the comparison-market sales are at a different level of trade and the difference affects price comparability, as manifested in a pattern of consistent price differences between the sales on which NV is based and comparison-market sales at the level of trade of the export transaction, we make a level-of-trade adjustment under section 773(a)(7)(A) of the Act.</P>
        <P>In implementing these principles in this administrative review, we obtained information from Liepajas Metalurgs about the marketing stages involved in the reported U.S. and home market sales, including a description of the selling activities performed by the respondent for each channel of distribution.  In identifying levels of trade for EP and home market sales we considered the selling functions reflected in the starting price before any adjustments.</P>
        <P>In conducting our level-of-trade analysis for Liepajas Metalurgs, we examined the specific types of customers, the channels of distribution, and the selling practices of the respondent.  Generally, if the reported levels of trade are the same, the functions and activities of the seller should be similar.  Conversely, if a party reports levels of trade that are different for different categories of sales, the functions and activities may be dissimilar.  We found the following.</P>

        <P>Liepajas Metalurgs reported three channels of distribution in the home market:  1) direct sales by Liepajas Metalurgs;  2) sales by Liepajas Metalurgs' RSO;  and 3) sales by ASC.  In the U.S. market, Liepajas Metalurgs reported one channel of distribution:  direct sales by Liepajas Metalurgs.  The company reported three customer categories in the home market:  1) traders;  2) end users;  and 3) service centers.  We found that the selling functions performed by  Liepajas Metalurgs differed significantly for <PRTPAGE P="48884"/>home market customers depending on the channel of distribution.  The activities performed by ASC and the RSO were in greater number and more advanced than those provided by Liepajas Metalurgs on direct sales.  ASC and RSO both provided selling functions such as customer negotiation, warehousing, sorting, repacking, and freight delivery, while Liepajas Metalurgs only negotiated with customers and arranged delivery of the product.  Therefore, we have preliminarily determined that sales through ASC and RSO are at the same level of trade and Liepajas Metalurgs' direct sales are at a different level of trade in the home market.</P>
        <P>Liepajas Metalurgs has reported one customer category in the U.S. market:  traders.  In comparing EP sales to the direct sales in the home market sales, we found that the selling functions performed by Liepajas Metalurgs for its direct customers and channels of distribution were very similar in the U.S. and Latvian markets.  For U.S. sales, Liepajas Metalurgs conducts negotiations with the traders and arranges delivery to the port.  Therefore, we concluded that the EP and home market direct sales were made at the same level of trade.  Since Liepajas Metalurgs' direct home market and U.S. sales are at the same level of trade, and RSO's and ASC's home market sales are at a more advanced level of trade and a consistent pattern of price differences exist, we have preliminarily determined that a level of trade adjustment is warranted.</P>
        <HD SOURCE="HD1">Currency Conversion</HD>
        <P>We made currency conversions into U.S. dollars in accordance with section 773A of the Act, based on exchange rates in effect on the date of the U.S. sale, as certified by the Federal Reserve Bank.</P>
        <HD SOURCE="HD1">Preliminary Results of Review</HD>
        <P>As a result of this review, we preliminarily determine that the following weighted-average margin exists for the period January 30, 2001, through August 31, 2002:</P>
        <GPOTABLE CDEF="s50,50" COLS="2" OPTS="L2,i1">
          <BOXHD>
            <CHED H="1">Producer</CHED>
            <CHED H="1">Weighted-Average Margin (Percentage)</CHED>
          </BOXHD>
          <ROW>
            <ENT I="01">Joint Stock Company Liepajas Metalurgs</ENT>
            <ENT>0.87</ENT>
          </ROW>
        </GPOTABLE>

        <P>The Department will disclose calculations performed in accordance with 19 CFR 351.224(b).  An interested party may request a hearing within 30 days of publication of these preliminary results. <E T="03">See</E> 19 CFR 351.310(c).  Any hearing, if requested, will be held 44 days after the date of publication, or the first working day thereafter.  Interested parties may submit case briefs and/or written comments no later than 30 days after the date of publication of these preliminary results.  Rebuttal briefs and rebuttals to written comments, limited to issues raised in such briefs or comments, may be filed no later than 37 days after the date of publication.  Parties who submit arguments are requested to submit with the argument (1) a statement of the issue,</P>
        <P>(2) a brief summary of the argument, and (3) a table of authorities.  Further, the parties submitting written comments should provide the Department with an additional copy of the public version of any such comments on diskette.  The Department will issue the final results of this administrative review, which will include the results of its analysis of issues raised in any such comments, within 120 days of publication of these preliminary results.</P>
        <HD SOURCE="HD1">Assessment</HD>

        <P>Upon completion of this administrative review, pursuant to 19 CFR 351.212(b), the Department will calculate an assessment rate on all appropriate entries.  We will calculate importer-specific duty assessment rates on the basis of the ratio of the total amount of antidumping duties calculated for the examined sales to the total entered value of the examined sales for that importer.  Since the delivery terms for all of Liepajas Metalurgs' U.S. sales were FOB Latvian seaport, we will calculate entered value using the gross unit price reported in the U.S. sales database.  Where the assessment rate is above <E T="03">de minimis</E>, we will instruct the BCBP to assess duties on all entries of subject merchandise by that importer.</P>
        <HD SOURCE="HD1">Cash Deposit Requirements</HD>

        <P>The following deposit rates will be effective upon publication of the final results of this administrative review for all shipments of rebar from Latvia entered, or withdrawn from warehouse, for consumption on or after the publication date, as provided by section 751(a)(1) of the Act:  (1) the cash deposit rate listed above for Liepajas Metalurgs will be the rate established in the final results of this review, except if a rate is less than 0.5 percent, and therefore <E T="03">de minimis</E>, the cash deposit will be zero;  (2) for previously reviewed or investigated companies not listed above, the cash deposit rate will continue to be the company-specific rate published for the most recent period;  (3) if the exporter is not a firm covered in this review, a prior review, or the less-than-fair-value (LTFV) investigation, but the manufacturer is, the cash deposit rate will be the rate established for the most recent period for the manufacturer of the merchandise;  and (4) if neither the exporter nor the manufacturer is a firm covered in this or any previous review conducted by the Department, the cash deposit rate will be 17.21 percent, the “All Others” rate established in the LTFV investigation.  These cash deposit requirements, when imposed, shall remain in effect until publication of the final results of the next administrative review.</P>
        <P>This notice serves as a preliminary reminder to importers of their responsibility under 19 CFR 351.402(f) to file a certificate regarding the reimbursement of antidumping duties prior to liquidation of the relevant entities during this review period.  Failure to comply with this requirement could result in the Secretary's presumption that reimbursement of antidumping duties occurred and the subsequent assessment of double antidumping duties.</P>
        <P>This determination is issued and published in accordance with sections 751(a)(1) and 777(i)(1) of the Act.</P>
        <SIG>
          <DATED>Dated:  August 4, 2003.</DATED>
          <NAME>Joseph A. Spetrini,</NAME>
          <TITLE>Acting Assistant Secretary for Grant Aldonas, Under Secretary.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-21058 Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 3510-DS-S</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF COMMERCE </AGENCY>
        <SUBAGY>International Trade Administration </SUBAGY>
        <SUBJECT>The Research Foundation of the State University of New York; Notice of Decision on Application for Duty-Free Entry of Scientific Instrument </SUBJECT>

        <P>This decision is made pursuant to Section 6(c) of the Educational, Scientific, and Cultural Materials Importation Act of 1966 (Pub. L. 89-651, 80 Stat. 897; 15 CFR part 301). Related records can be viewed between 8:30 a.m. and 5 p.m. in Suite 4100W, U.S. Department of Commerce, Franklin <PRTPAGE P="48885"/>Court Building, 1099 14th Street, NW., Washington, DC. </P>
        <P>
          <E T="03">Docket Number:</E> 03-030. </P>
        <P>
          <E T="03">Applicant:</E> The Research Foundation of the State University of New York, Buffalo, NY 14260. </P>
        <P>
          <E T="03">Instrument:</E> Scanning Near-field Optical Microscope, Model Alpha<E T="03">SNOM</E>. </P>
        <P>
          <E T="03">Manufacturer:</E> Wissenschaftliche Instrumente und Technologie GmbH, Germany. </P>
        <P>
          <E T="03">Intended Use: See</E> notice at 68 FR 42007, July 16, 2003. </P>
        <P>
          <E T="03">Comments:</E> None received. <E T="03">Decision:</E> Approved. No instrument of equivalent scientific value to the foreign instrument, for such purposes as it is intended to be used, is being manufactured in the United States. </P>
        <P>
          <E T="03">Reasons:</E> The foreign instrument provides: (1) Easy switching between 3 types of microscopy (scanning near-field optical, confocal and atomic force) without moving the sample, (2) 50 nm resolution and (3) optimal flexibility for operation in a multi-user environment. The National Institutes of Health advised in its memorandum of July 21, 2003 that (1) these capabilities are pertinent to the applicant's intended purpose and (2) it knows of no domestic instrument or apparatus of equivalent scientific value to the foreign instrument for the applicant's intended use. </P>
        <P>We know of no other instrument or apparatus of equivalent scientific value to the foreign instrument which is being manufactured in the United States. </P>
        <SIG>
          <NAME>Gerald A. Zerdy, </NAME>
          <TITLE>Program Manager, Statutory Import Programs Staff. </TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20934 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 3510-DS-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF COMMERCE </AGENCY>
        <SUBAGY>National Institute of Standards and Technology </SUBAGY>
        <SUBJECT>Visiting Committee on Advanced Technology </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>National Institute of Standards and Technology, Department of Commerce. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of partially closed meeting. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>

          <P>Pursuant to the Federal Advisory Committee Act, 5 U.S.C. app. 2, notice is hereby given that the Visiting Committee on Advanced Technology, National Institute of Standards and Technology (NIST), will meet Tuesday, September 9, 2003, from 8:25 a.m. to 5:30 p.m. and Wednesday, September 10, 2003, from 8:15 a.m. to Noon. The Visiting Committee on Advanced Technology is composed of thirteen members appointed by the Director of NIST; who are eminent in such fields as business, research, new product development, engineering, labor, education, management consulting, environment, and international relations. The purpose of this meeting is to review and make recommendations regarding general policy for the Institute, its organization, its budget, and its programs within the framework of applicable national policies as set forth by the President and the Congress. The agenda will include a NIST Update, Remarks by the Acting Deputy Director and Acting Chief of Staff on Goals and Priorities, a Boulder Update, The New Office of the CIO, an Overview of NRC Board on Assessment FY 2002 Evaluation of NIST Labs, laboratory tours, Time and Frequency Measurements and Standards and Quantum Measurements and Standards. Discussions scheduled to begin at 8:25 a.m. and to end at 9 a.m., on September 9, and to begin at 8:15 a.m. and to end at 9 a.m. and to begin at 9:45 a.m. and to end at noon on September 10, 2003, on the NIST budget, planning information and feedback sessions will be closed. Agenda may change to accommodate Committee business. Final agenda will be posted on Web site. All visitors to the National Institute of Standards and Technology site will have to pre-register to be admitted. Please submit your name, time of arrival, e-mail address and phone number to Carolyn Peters no later than Thursday, September 4, 2003, and she will provide you with instructions for admittance. Ms. Peter's e-mail address is <E T="03">carolyn.peters@nist.gov</E> and her phone number is (301) 975-5607. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>The meeting will convene September 9, 2003 at 8:25 a.m. and will adjourn at Noon on September 10, 2003. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>

          <P>The meeting will be held in the Radio Building, Room 1107 (seating capacity 60, includes 35 participants), at NIST, Boulder, Colorado. Please note admittance instructions under <E T="02">SUMMARY</E> paragraph. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Carolyn J. Peters, Visiting Committee on Advanced Technology, National Institute of Standards and Technology, Gaithersburg, Maryland 20899-1004, telephone number (301) 975-5607. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>The Assistant Secretary for Administration, with the concurrence of the General Counsel, formally determined on February 25, 2003, that portions of the meeting of the Visiting Committee on Advanced Technology which deal with discussion of sensitive budget and planning information that would cause harm to third parties if publicly shared be closed in accordance with Section 10(d) of the Federal Advisory Committee Act, 5 U.S.C. app. 2. </P>
        <SIG>
          <DATED>Dated: August 8, 2003. </DATED>
          <NAME>Arden L. Bement, Jr., </NAME>
          <TITLE>Director. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20859 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 3510-13-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF COMMERCE</AGENCY>
        <SUBAGY>National Oceanic and Atmospheric Administration</SUBAGY>
        <DEPDOC>[I.D. 080803B]</DEPDOC>
        <SUBJECT>North Pacific Fishery Management Council; Public Meetings</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>National Marine Fisheries Service (NMFS), National Oceanic and Atmospheric Administration (NOAA), Commerce.</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of public meetings.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The North Pacific Fishery Management Council's (Council) Gulf of Alaska (GOA) and Bering Sea/Aleutian Islands (BS/AI) groundfish plan teams will meet in Seattle, WA.</P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>The meetings will be held on September 8-11, 2003.</P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>The meetings will be held at the Alaska Fisheries Science Center, 7600 Sand Point Way N.E., Bldg. 4, Room 2076 (BS/AI Plan Team) and Room 2039 (GOA Plan Team), Seattle, WA.</P>
          <P>
            <E T="03">Council address</E>:   North Pacific Fishery Management Council, 605 W. 4th Ave., Suite 306, Anchorage, AK  99501-2252.</P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Jane DiCosimo, North Pacific Fishery Management Council; telephone:   907-271-2809.</P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>The meetings will begin at 1 p.m. on Monday, September 8, and continue through Thursday September 11.  The plan teams will review available stock assessments and catch statistics for Gulf of Alaska and Bering Sea/Aleutian Islands groundfish fisheries, review methodology for and adopt overfishing level and available biological catch projections for preliminary 2004 groundfish fisheries, review draft ecosystem chapter, review draft ecosystem assessment chapter, and review other potential Council actions on management on non-target groundfish and the total allowable catch setting process.</P>
        <PRTPAGE P="48886"/>
        <P>Although non-emergency issues not contained in this agenda may come before this group for discussion, those issues may not be the subject of formal action during this meeting.  Action will be restricted to those issues specifically identified in this notice and any issues arising after publication of this notice that require emergency action under section 305(c) of the Magnuson-Stevens Fishery Conservation and Management Act, provided the public has been notified of the Council's intent to take final action to address the emergency.</P>
        <HD SOURCE="HD1">Special Accommodations</HD>
        <P>These meetings are physically accessible to people with disabilities.  Requests for sign language interpretation or other auxiliary aids should be directed to Gail Benidxen, 907-271-2809, at least 5 working days prior to the meeting date.</P>
        <SIG>
          <DATED>Dated: August 8, 2003.</DATED>
          <NAME>Richard W. Surdi,</NAME>
          <TITLE>Acting Director, Office of Sustainable Fisheries, National Marine Fisheries Service.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20918 Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 3510-22-S</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF DEFENSE</AGENCY>
        <SUBAGY>Office of the Secretary of Defense</SUBAGY>
        <SUBJECT>Establishment of the Defense Advisory Board for Employer Support of the Guard and Reserve</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Department of Defense.</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of establishment.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The Defense Advisory Board for Employer Support of the Guard and Reserve (ESGR) is being established in consonance with the public interest and in accordance with the provisions of Pub. L. 92-463, the “Federal Advisory Committee Act,” title 5 U.S.C., Appendix 2. The ESGR will provide advice to the Secretary of Defense about issues concerning Reservists and their civilian employers, to include recommending policies and priorities for employer support actions and programs.</P>
          <P>The board will be composed of a national cross-section of industry, public and private sector leaders whose understanding of employer issues, as they are affected by employee membership in the guard and reserve, will serve as a foundation for providing input and recommendations to the Secretary of Defense on guard and reserve employment issues of public and private employers.</P>
        </SUM>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Contact Mr. Michael E. Naylon, 703-696-1386.</P>
          <SIG>
            <DATED>Dated: August 11, 2003.</DATED>
            <NAME>Patricia Toppings,</NAME>
            <TITLE>Alternate OSD Federal Register Liaison Officer, Department of Defense.</TITLE>
          </SIG>
        </FURINF>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20868  Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 5001-08-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF DEFENSE </AGENCY>
        <SUBAGY>Office of the Secretary </SUBAGY>
        <SUBJECT>Manual for Courts-Martial; Proposed Amendments </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Joint Service Committee on Military Justice (JSC). </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of Proposed Amendments to the Manual for Courts-Martial, United States (2002 ed.) and Notice of Public Meeting. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>

          <P>The Department of Defense is considering recommending changes to the <E T="03">Manual for Courts-Martial, United States</E> (2002 ed.) (MCM). The proposed changes constitute the 2003 annual review required by the MCM and DoD Directive 5500.17, “Role and Responsibilities of the Joint Service Committee (JSC) on Military Justice,” May 3, 2003. The proposed changes concern the rules of procedure and evidence and the punitive articles applicable in trials by courts-martial. These proposed changes have not been coordinated within the Department of Defense under DoD Directive 5500.1, “Preparation and Processing of Legislation, Executive Orders, Proclamations, and Reports and Comments Thereon,” May 21, 1964, and do not constitute the official position of the Department of Defense, the Military Departments, or any other Government agency. </P>
          <P>This notice also sets forth the date, time and location for the public meeting of the JSC to discuss the proposed changes. </P>
          <P>This notice is provided in accordance with DoD Directive 5500.17, “Role and Responsibilities of the Joint Service Committee (JSC) on Military Justice,” May 3, 2003. This notice is intended only to improve the internal management of the Federal Government. It is not intended to create any right or benefit, substantive or procedural, enforceable at law by any party against the United States, its agencies, its officers, or any person. </P>
          <P>In accordance with paragraph III.B.4 of the Internal Organization and Operating Procedures of the JSC, the committee also invites members of the public to suggest changes to the Manual for Courts-Martial in accordance with the described format. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Comments on the proposed changes must be received no later than October 31, 2003 to be assured consideration by the JSC. A public meeting will be held on October 1, 2003 at 11 a.m. in Room 808, 1501 Wilson Boulevard, Rosslyn, VA 22209-2403. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Comments on the proposed changes should be sent to Lieutenant Commander James Carsten, Office of the Judge Advocate General, 716 Sicard St. SE., Suite 1000, Washington, DC 20374-5047. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Lieutenant Commander James Carsten, Executive Secretary, Joint Service Committee on Military Justice, Office of the Judge Advocate General, 716 Sicard St. SE., Suite 1000, Washington, DC 20374-5047, (202) 685-7298, (202) 685-7687 fax. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>The proposed amendments to the MCM are as follows: </P>
        <P>Amend the Discussion section of Part I (Preamble) by twice replacing the word “Transportation” with the words “Homeland Security.” </P>
        <P>Amend Discussion section following R.C.M. 103(19), Definition for 10 U.S.C. 801(1) by replacing the phrase “the General Counsel of the Department of Transportation” with the phrase “an official designated to serve as Judge Advocate General of the Coast Guard by the Secretary of Homeland Security. </P>
        
        <EXTRACT>
          <FP>[<E T="04">Note:</E> The Secretary of Homeland Security has designated the Chief Counsel, U.S. Coast Guard, to serve as the Judge Advocate General of the Coast Guard.]”</FP>
        </EXTRACT>
        
        <P>Amend R.C.M. 201(e)(2)(B) by adding the word “general” before “courts-martial” and inserting the following at the end thereof: </P>
        
        <FP>“assigned or attached to a combatant command or joint command.” </FP>
        
        <P>Amend R.C.M. 201(e)(2)(C), inserting the phrase “assigned or attached to a joint command or joint task force,” immediately before the words “under regulations which the superior command may prescribe.” </P>
        <P>Amend the Analysis accompanying R.C.M. 201(e)(2) by inserting the following paragraph: </P>
        <P>“<E T="03">200_Amendment:</E> Subsections (e)(2)(B) and (C) were revised to clarify that the reciprocal jurisdiction authority of joint commanders designated in either subsections (A), (B), or (C), is limited. This limitation is intended to preclude a joint commander from convening courts upon members who are not assigned or attached to a joint command.” <PRTPAGE P="48887"/>
        </P>
        <P>Amend R.C.M. 201(e)(3) by inserting the following immediately after the words “armed force”:</P>
        
        <FP>“using the implementing regulations and procedures prescribed by the Secretary concerned of the military service of the accused,”</FP>
        
        <P>Amend the Analysis accompanying R.C.M. 201(e)(3) by inserting the following paragraph: </P>
        <P>“<E T="03">200_Amendment:</E> This rule clarifies that when a service member is tried by a court-martial convened by a combatant or joint commander, the implementing regulations and procedures of the service to which the accused is a member shall apply.” </P>
        <P>Amend R.C.M. 201(e)(4) by adding the words “member, or counsel” after the words “military judge.” </P>
        <P>Amend the Analysis accompanying R.C.M. 201(e)(4) by inserting the following paragraph: </P>
        <P>“<E T="03">200_Amendment:</E> Subsection (e)(4) was amended to clarify that members and counsel from different services may be detailed to a court-martial convened by a combatant or joint commander.”</P>
        <P>Amend the Discussion following R.C.M. 201(e)(7)(B) by adding this sentence to the beginning of the Discussion: </P>
        <P>“As to the authority to convene courts-martial, see R.C.M. 504.” </P>
        <P>Amend R.C.M. 503(a)(3) by inserting an “s” to the word “court” of the term “court-martial.” </P>
        <P>Amend R.C.M. 503(b)(3) by inserting “, a combatant command or joint command” after the words “A military judge from one armed force may be detailed to a court-martial convened in a different armed force”. </P>
        <P>Amend the Analysis accompanying R.C.M. 503(b)(3) by inserting the following paragraph: </P>
        <P>“<E T="03">200_Amendment:</E> Subsection (b)(3) was amended to clarify that a military judge from any service may be detailed to a court-martial convened by a combatant or joint commander.” </P>
        <P>Amend R.C.M. 503(c)(3) by inserting the phrase “, a combatant command or joint command” after the words “A person from one armed force may be detailed to serve as counsel in a court-martial in a different armed force”. </P>
        <P>Amend the Analysis accompanying R.C.M. 503(c)(3) by inserting the following: </P>
        <P>“<E T="03">200_Amendment:</E> Subsection (c)(3) was amended to clarify that counsel from any service may be detailed to a court-martial convened by a combatant or joint commander.” </P>
        <P>Amend R.C.M. 504(b)(2)(A) by inserting the following at the end thereof: </P>
        <P>“A subordinate joint command or joint task force is ordinarily considered to be ‘separate or detached.’ ” </P>
        <P>Amend R.C.M. 504(b)(2)(B) by inserting the following as a third element thereof: </P>
        <P>“(iii) In a combatant command or joint command, by the officer exercising general court-martial jurisdiction over the command.” </P>
        <P>Amend the Analysis accompanying R.C.M. 504(b)(2)(B) by inserting the following paragraph: </P>
        <P>“<E T="03">200_Amendment:</E> Subsection (b)(2)(B) was amended to clarify those authorized to determine when a unit is ‘separate or detached.’ ”</P>
        <P>Amend R.C.M. 912(f)(4) by deleting the entirety of the fifth sentence and inserting the following words immediately after the words “When a challenge for cause has been denied” in the fourth sentence:</P>
        
        <FP>“the successful use of a peremptory challenge by either party, excusing the challenged member from further participation in the court-martial, shall preclude further consideration of the challenge of that excused member upon later review. Further,”</FP>
        
        <P>Amend the Analysis to R.C.M. 912(f)(4) by inserting the following paragraph: </P>
        <P>“<E T="03">200_Amendment:</E> This rule change is intended to conform military practice to federal practice and limit appellate litigation when the challenged panel member could have been peremptorily challenged or actually did not participate in the trial due to a peremptory challenge by either party. This amendment is consistent with the President's lawful authority to promulgate a rule that would result in placing before the accused the hard choice faced by defendants in federal district courts—to let the challenged juror sit on the case and challenge the ruling on appeal or to use a peremptory challenge to remove the juror and ensure an impartial jury. <E T="03">See United States</E> v. <E T="03">Miles,</E> 58 M.J. 192 (C.A.A.F. 2003); <E T="03">United States</E> v. <E T="03">Wiesen,</E> 56 M.J. 172 (C.A.A.F. 2001), petition for reconsideration denied, 57 M.J. 48 (C.A.A.F. 2002); <E T="03">United States</E> v. <E T="03">Armstrong,</E> 54 M.J. 51 (C.A.A.F. 2000). </P>
        <P>Amend R.C.M. 1004(c)(10) by deleting the words “death is authorized under the law of war for the offense” and replacing with the words “the violation constitutes a grave breach of the law of war.” </P>
        <P>Insert the following Discussion to accompany R.C.M. 1004(c)(10): </P>
        <P>“Grave breaches of the laws and customs of war are defined by the 1949 Geneva Conventions and customary international law. For the definition of what may constitute a grave breach see The First Geneva Convention, Aug. 12, 1949, art. 50, 6 U.S.T. 3114, T.I.A.S. 3362; The Second Geneva Convention, Aug. 12, 1949, art. 51, 6 U.S.T. 3217, T.I.A.S. 3363; The Third Geneva Convention, Aug. 12, 1949, art. 130, 6 U.S.T. 3316, T.I.A.S. 3364; and The Fourth Geneva Convention, Aug. 12, 1949, art. 147, 6 U.S.T. 3516, T.I.A.S. 3365.” </P>
        <P>Amend the Analysis accompanying R.C.M. 1004(c)(10) by inserting the following paragraph: </P>
        <P>“<E T="03">200_Amendment:</E> Subsection (c)(10) was amended to clarify which law of war violations may subject the accused to capital punishment.” </P>
        <P>Amend R.C.M. 1301(a) by inserting the following after the second sentence: </P>
        <P>“Summary courts-martial shall be conducted in accordance with the regulations of the military service to which the accused belongs.” </P>
        <P>Amend the Analysis accompanying R.C.M. 1301(a) by inserting the following paragraph: </P>
        <P>“<E T="03">200_Amendment:</E> Subsection (a) was amended to clarify that summary courts-martial convened by a combatant or joint commander are to be conducted in accordance with the implementing regulations and procedures of the service to which the accused is a member.” </P>
        <P>Amend M.R.E. 317(b) replacing the word “Transportation” with the words “Homeland Security.” </P>
        <P>Amend the Analysis to M.R.E. 317(b) by replacing the word “Transportation” with the words “Homeland Security.” </P>
        <P>Amend the Analysis to M.R.E. 801(d)(1)(B) by substituting the following therefor: </P>
        <P>“Rule 801(d)(1)(B) makes admissible on the merits a statement consistent with the in-court testimony of the witness and ‘offered to rebut an express or implied charge against the declarant of recent fabrication or improper influence or motive.’ Unlike Rule 801(d)(1)(A), which addresses prior inconsistent statements given under oath, the earlier consistent statement need not have been made under oath or at any type of proceeding. </P>

        <P>Rule 801(d)(1)(B) provides in pertinent part that a statement is not hearsay if the declarant testifies at the trial or hearing and is subject to cross-examination concerning the statement, and the statement is consistent with the declarant's testimony and is offered to rebut an express or implied charge against the declarant of recent fabrication or improper influence or motive. The court has interpreted the rule to require that a prior statement, <PRTPAGE P="48888"/>admitted as substantive evidence, precede any motive to fabricate or improper influence that it is offered to rebut. <E T="03">United States</E> v. <E T="03">Allison,</E> 49 M.J. 54 (C.A.A.F. 1998). Where multiple motives to fabricate or multiple improper influences are asserted, the statement need not precede all such motives or inferences, but only the one it is offered to rebut. <E T="03">United States</E> v. <E T="03">Faison,</E> 49 M.J. 59 (C.A.A.F. 1998). This interpretation of the rule is consistent with the Supreme Court's decision in <E T="03">Tome</E> v. <E T="03">United States,</E> 513 U.S. 150 (1995).” </P>
        <P>Delete the Analysis to M.R.E. 803(24). </P>
        <P>Delete the Analysis to M.R.E. 804(b)(5). </P>
        <P>Insert the following Analysis for M.R.E. 807:</P>
        <P>“MRE 807 was adopted on 30 May 1998 without change from the Federal Rule and represents the residual exception to the hearsay rule formerly contained in MRE 803(24) and MRE 804(b)(5). </P>

        <P>“The Rule strikes a balance between the general policy behind the Rules of Evidence of permitting admission of probative and reliable evidence and the congressional intent that ‘that the residual hearsay exceptions will be used very rarely, and only in exceptional circumstances.’ S. Rep. No. 1277, 93d Cong., 2d Sess., reprinted in 1974 U.S. Code Cong. &amp; Admin. News 7051, 7066. MRE 807 represents the acceptance of the so-called ‘catch-all’ or ‘residual’ exception to the hearsay rule. Because of the Constitutional concerns associated with hearsay statements, the courts have placed specific foundational requirements in order for residual hearsay to be admitted. <E T="03">See United States</E> v. <E T="03">Haner,</E> 49 M.J. 72 (C.A.A.F. 1998). These requirements are: necessity, materiality, reliability, and notice.</P>

        <P>“The necessity prong ’essentially creates a “best evidence” requirement.' <E T="03">United States</E> v. <E T="03">Kelley,</E> 45 M.J. 275 (C.A.A.F. 1996) (citing <E T="03">Larez</E> v. <E T="03">City of Los Angeles</E>, 946 F.2d 630, 644 (9th Cir. 1991)). Coupled with the rule's materiality requirement, necessity represents an important fact that is more than marginal or inconsequential and is in furtherance of the interests of justice and the general purposes of the rules of evidence. <E T="03">See United States</E> v. <E T="03">Gonzalez,</E> 2003 CCA Lexis 57 (A.F.Ct.Crim.App. 2003). </P>

        <P>“In order to fulfill the reliability condition, the proponent of the statement must demonstrate that the statement has particularized guarantees of trustworthiness as shown from the totality of the circumstances. <E T="03">Idaho</E> v. <E T="03">Wright,</E> 497 U.S. 805 (1990). The factors surrounding the taking of the statement and corroboration by other evidence should be examined to test the statement for trustworthiness. The Court of Appeals for the Armed Forces has held that the Supreme Court's prohibition against bolstering the indicia of reliability under a Sixth Amendment analysis does not apply to a residual hearsay analysis. Therefor, in addition to evidence of the circumstances surrounding the taking of the statement, extrinsic evidence can be considered. <E T="03">United States</E> v. <E T="03">McGrath,</E> 39 M.J. 158 (C.M.A. 1994).” </P>
        <P>Amend Part IV, Punitive Articles, para. 16(c)(1)(a) by replacing the word “Transportation” with the words “Homeland Security.” </P>
        <P>Amend Part V, Nonjudicial Punishment Procedure, paragraph 1(h), by renaming existing paragraph 1(h) to 1(i) and inserting the following new paragraph 1(h): </P>
        <P>(h) “Applicable standards. Unless otherwise provided, the service regulations and procedures of the servicemember shall apply.” </P>
        <P>Amend the Analysis section of Part V, Nonjudicial Punishment Procedure, paragraph 1(h), by renaming it paragraph 1(i) and inserting the following as paragraph 1(h): </P>
        <P>“<E T="03">200</E>_<E T="03">Amendment:</E> Subsection (h) is new. This subsection was added to clarify that nonjudicial punishment proceedings conducted in a combatant or joint command are to be conducted in accordance with the implementing regulations and procedures of the service to which the accused is a member.” </P>
        <P>Amend Part V, Nonjudicial Punishment Procedure, paragraph 2(a) by deleting “Unless otherwise” and replacing with “As.” </P>
        <P>Amend Part V, Nonjudicial Punishment Procedure, paragraph 2(a) by inserting the following after the second sentence: </P>
        <P>“Commander includes a commander of a joint command.” </P>
        <P>Amend Part V, Nonjudicial Punishment Procedure, paragraph 2(a) by inserting the phrase “of a commander” in the third sentence after the words “the authority.” </P>
        <P>Amend the Analysis accompanying Part V, Nonjudicial Punishment Procedure, paragraph 2 by inserting the following paragraph: </P>
        <P>“<E T="03">200_Amendment:</E> Subsection (2) was amended to clarify the authority of the commander of a joint command to impose nonjudicial punishment upon service members of the joint command.” </P>
        <P>Amend Part V, Nonjudicial Punishment Procedures, paragraph 7(e), by replacing the word “Transportation” with the words “Homeland Security.” </P>
        <P>Delete Appendix 3.1. </P>
        <P>Amend Appendix 21, Introduction, paragraph b (Supplementary Materials) by replacing the word “Transportation” with the words “Homeland Security.” </P>
        <P>Amend the Introduction to Appendix 22 by inserting the following at the end of the first sentence: </P>
        
        <P>“(the department under which the Coast Guard was operating at that time.)” </P>
        <P>Amend the Introduction to Appendix 22 by replacing the word “Transportation” located at the second paragraph with the words “Homeland Security.” </P>
        <SIG>
          <DATED>Dated: August 11, 2003. </DATED>
          <NAME>Patricia L. Toppings, </NAME>
          <TITLE>Alternate OSD <E T="03">Federal Register</E> Liaison Officer,  Department of Defense. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20870 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 5001-08-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF DEFENSE</AGENCY>
        <SUBAGY>Office of the Secretary</SUBAGY>
        <SUBJECT>List of Institutions of Higher Education Ineligible for Federal Funds</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Department of Defense.</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This document is published to identify institutions of higher education that are ineligible for contracts and grants by reason of a determination by the Secretary of Defense that the institution prohibits or in effect prevents military recruiter access to the campus, students on campus, or student directory information. It also implements the requirements set forth in section 983 of title 10, United States Code, and 32 CFR part 216. The institution of higher education so identified is: William Mitchell College of Law, St. Paul, Minnesota.</P>
        </SUM>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Director for Accession Policy, Office of the Under Secretary of Defense for Personnel and Readiness, 4000 Defense Pentagon, Washington, DC 20301-4000.</P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Major Brenda K. Leong, (703) 695-5529.</P>
          <SIG>
            <DATED>Dated: August 11, 2003.</DATED>
            <NAME>Patricia L. Toppings,</NAME>
            <TITLE>Alternate OSD Federal Register Liaison Officer, Department of Defense.</TITLE>
          </SIG>
        </FURINF>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20865 Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 5001-08-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <PRTPAGE P="48889"/>
        <AGENCY TYPE="S">DEPARTMENT OF DEFENSE</AGENCY>
        <SUBAGY>Office of the Secretary</SUBAGY>
        <SUBJECT>Meeting of the Secretary of Defense's Historical Records Declassification Advisory Panel</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Department of Defense.</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of open meeting.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>Notice is hereby given of the forthcoming meeting of the Historical Records Declassification Advisory Panel (HRDAP). THe purpose of this meeting is to discuss and form recommendations to the Secretary of Defense on issues involving the declassification and management of DoD classified historical documents. This is the first meeting held in 2003. The OSD Historian will chair this meeting.</P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Friday, September 12, 2003. The meeting is scheduled from 9 a.m. to 3 p.m.</P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>National Archives and Records Administration, Room 503, 700 Pennsylvania Avenue, Washington, DC 20408.</P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Ms. Chris Bromwell, Office of the Deputy Under Secretary of Defense (Counterintelligence and Security), Office of the Under Secretary of Defense (Intelligence), 5000 Defense Pentagon, Washington, DC 20302-5000, telephone (703) 697-1988.</P>
          <SIG>
            <DATED>Dated: August 11, 2003.</DATED>
            <NAME>Patricia L. Toppings,</NAME>
            <TITLE>Alternate OSD Federal Register Liaison Officer, Department of Defense.</TITLE>
          </SIG>
        </FURINF>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20867  Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 5001-08-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF DEFENSE</AGENCY>
        <SUBAGY>Office of the Secretary</SUBAGY>
        <SUBJECT>Threat Reduction Advisory Committee</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Department of Defense, Office of the Under Secretary of Defense (Acquisition, Technology and Logistics).</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of Advisory Committee Meeting.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The Threat Reduction Advisory Committee will meet in closed session on Thursday, October 9, 2003, at the Institute for Defense Analyses (IDA), and on Friday, October 10, 2003 in the Pentagon, Washington, DC.</P>
          <P>The mission of the Committee is to advise the Under Secretary of Defense (Acquisition, Technology and Logistics) on counterproliferation, chemical and biological defense, transformation of the nuclear weapons stockpile, and other matters related to the Defense Threat Reduction Agency's mission.</P>
          <P>In accordance with Section 10(d) of the Federal Advisory Committee Act, Pub. L. 92-463, as amended (5 U.S.C. Appendix II), it has been determined that this Committee meeting concerns matters listed in 5 U.S.C. 552b(c)(1), and that accordingly the meeting will be closed to the public.</P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Thursday, October 9, 2003, (8 a.m. to 4 p.m.) and Friday, October 10, 2003, (8 a.m. to 9:30 a.m.).</P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Institute for Defense Analyses, (boardroom), 4850 Mark Center Drive, Alexandria, Virginia and the USD (AT&amp;L) Conference Room (3D1019), the Pentagon, Washington, DC.</P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Contact Lieutenant Colonel Don Culp, USAF, Defense Threat Reduction Agency/AST, 8725 John J. Kingman Road MS 6201, Fort Belvoir, VA 22060-6201. Phone: (703) 767-5717.</P>
          <SIG>
            <DATED>August 11, 2003.</DATED>
            <NAME>Patricia L. Toppings,</NAME>
            <TITLE>Alternate OSD Federal Register Liaison Officer, Department of Defense.</TITLE>
          </SIG>
        </FURINF>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20866 Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 5001-08-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF DEFENSE</AGENCY>
        <SUBAGY>Office of the Secretary</SUBAGY>
        <SUBJECT>Meeting of the Defense Department Advisory Committee on Women in the Services</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Department of Defense.</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>Pursuant to Section 10(a), Pub. L. 92-463, as amended, notice is hereby given of a forthcoming meeting of the Defense Department Advisory Committee on Women in the Services (DACOWITS). The purpose of the Committee meeting is to provide further briefings on various topics to Committee members. The meeting is open to the public, subject to the availability of space.</P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>4 September 2003, 8:30 a.m.-6:30 p.m.</P>
          <P>5 September 2003, 8:30 a.m.-5 p.m.</P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Double Tree Hotel, 300 Army Navy Drive, Arlington, VA 22202.</P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Lieutenant Commander Shannon Thaeler, USN, DACOWITS, 4000 Defense Pentagon, Room 3D769, Washington, DC 20301-4000. Telephone (703) 697-2122.</P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>Meeting agenda:</P>
        <HD SOURCE="HD1">Thursday, September 4, 2003</HD>
        <FP SOURCE="FP-1">Welcome &amp; Administrative Remarks.</FP>
        <FP SOURCE="FP-1">Caliber Associates Question and Answer Period.</FP>
        <FP SOURCE="FP-1">Committee Time.</FP>
        <FP SOURCE="FP-1">Lunch (by invitation only).</FP>
        <FP SOURCE="FP-1">Committee Time.</FP>
        <FP SOURCE="FP-1">Senior Defense Official (tentative).</FP>
        <FP SOURCE="FP-1">Committee Time.</FP>
        <FP SOURCE="FP-1">Review of Caliber Reports.</FP>
        <FP SOURCE="FP-1">Wrap-up.</FP>
        <HD SOURCE="HD1">Friday, September 5, 2003</HD>
        <FP SOURCE="FP-1">Renewal Paperwork.</FP>
        <FP SOURCE="FP-1">Committee Time.</FP>
        <FP SOURCE="FP-1">Conclusions/Recommendations—Vote.</FP>
        <FP SOURCE="FP-1">Lunch (by invitation only).</FP>
        <FP SOURCE="FP-1">Committee Time.</FP>
        <FP SOURCE="FP-1">Public Forum.</FP>
        
        <P>Interested persons may submit a written statement for consideration by the Committee and make an oral presentation of such. Persons desiring to make an oral presentation or submit a written statement to the Committee must notify the point of contact listed above no later than noon, August 29, 2003. Oral presentations by Members of the public will be permitted only on Friday, September 5, 2003, from 4:45 p.m. to 5:00 p.m. before the full Committee. Presentations will be limited to two minutes. Number of oral presentations to be made will depend on the number of requests received from members of the public. Each person desiring to make an oral presentation must provide the point of contact listed above with only one (1) Copy of the presentation by noon, September 4, 2003 and bring 35 copies of any material that is intended for distribution at the meeting. Persons submitting a written statement only must submit one (1) Copy of the statement to the DACOWITS staff by the close of the meeting on September 5, 2003.</P>
        <SIG>
          <DATED>Dated: August 11, 2003.</DATED>
          <NAME>Patricia L. Toppings,</NAME>
          <TITLE>Alternate OSD Federal Register Liaison Officer, Department of Defense.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20869  Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 5001-08-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF DEFENSE </AGENCY>
        <SUBAGY>Department of the Air Force </SUBAGY>
        <SUBJECT>HQ USAF Scientific Advisory Board </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Department of the Air Force, DoD. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of meeting. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>

          <P>Pursuant to Pub. L. 92-463, notice is hereby given of the forthcoming meeting of the Technology for Machine-to-Machine (MTM) <PRTPAGE P="48890"/>Integration. The purpose of the meeting is to allow the SAB leadership to brief the Chief of Staff of the Air Force on the outcome of the Technology for Machine-to-Machine Integration. Because classified and contractor-proprietary information will be discussed, this meeting will be closed to the public. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>September 2, 2003. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Pentagon. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>The Air Force Scientific Advisory Board Secretariat, 1180 Air Force Pentagon, Room 5D982, Washington DC 20330-1180, (703) 697-4811. </P>
          <SIG>
            <NAME>Pamela D. Fitzgerald, </NAME>
            <TITLE>Air Force Federal Register Liaison Officer. </TITLE>
          </SIG>
        </FURINF>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20815 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 5001-5-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF DEFENSE</AGENCY>
        <SUBAGY>Department of the Army</SUBAGY>
        <SUBJECT>Armed Forces Epidemiological Board; Meeting</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Department of the Army; DoD.</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of open meeting.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>In accordance with section 10(a)(2) of Public Law 92-463, The Federal Advisory Committee Act, announcement is made of the following meeting:</P>
          <P>
            <E T="03">Name of Committee:</E> Armed Forces Epidemiological Board (AFEB).</P>
          <P>
            <E T="03">Dates:</E> September 16-17, 2003.</P>
          <P>
            <E T="03">Times:</E> 7:30 a.m.-6:30 p.m. (September 16, 2003). 7:30 a.m.-5 p.m. (September 17, 2003).</P>
          <P>
            <E T="03">Location:</E> Conference Room on the 2nd Deck of the Submarine Force Museum.</P>
          <P>
            <E T="03">Agenda:</E> The purpose of the meeting is to address pending and new Board issues, provide briefings for Board members on topics related to ongoing and new Board issues, conduct subcommittee meetings, and conduct an executive working session. </P>
        </SUM>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Colonel James R. Riddle, Executive Secretary, Armed Forces Epidemiological Board, Skyline Six, 5109 Leesburg Pike, Room 682, Falls Church, VA 22041-3258.</P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>This meeting will be open to the public, but limited by space accommodations. Any interested person may attend, appear before or file statements with the committee at the time and in the manner permitted by the committee.</P>
        <SIG>
          <NAME>Luz D. Ortiz,</NAME>
          <TITLE>Army Federal Register Liaison Officer.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20910 Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 3710-08-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF DEFENSE</AGENCY>
        <SUBAGY>Department of the Army</SUBAGY>
        <SUBJECT>Intent To Grant an Exclusive or Partially Exclusive License to ANP Technologies, Inc.</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Department of the Army, DoD.</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of intent to license.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>In compliance with 37 CFR 404 <E T="03">et seq.,</E> the Department of the Army hereby gives notice of its intent to grant to ANP Technologies, Inc., of 1201 Technology Drive Aberdeen, MD 21001, an exclusive license relative to a U.S. Army Research Laboratory patent application entitled “Compositions and Methods for Enhancing Bioassay Performance Through Nanomanipulation”, Yin, <E T="03">et al.,</E> filed on August 27, 2001. Anyone wishing to object to the granting of this license has 15 days to file written objections along with supporting evidence, if any.</P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>File written objections by September 2, 2003.</P>
        </DATES>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Michael D. Rausa, U.S. Army Research Laboratory, Office of Research and Technology Applications, ATTN: AMSRL-DP-T/Bldg. 459, Aberdeen Proving Ground, MD 21005-5425, telephone: (410) 278-5028.</P>
          <SIG>
            <NAME>Luz D. Ortiz,</NAME>
            <TITLE>Army Federal Register Liaison Officer.</TITLE>
          </SIG>
        </FURINF>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20911 Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 3710-08-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF DEFENSE</AGENCY>
        <SUBAGY>Department of the Army; Corps of Engineers</SUBAGY>
        <SUBJECT>Draft Environmental Impact Statement—Supplement 1.0 for Lower Mud River at Milton, West Virginia, Milton Local Protection Project</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Department of the Army, U.S. Army Corps of Engineers, DoD.</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of availability.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>

          <P>In accordance with the requirements of the National Environmental Policy Act (NEPA), the U.S. Army Corps of Engineers (USACE), Huntington District has prepared this Limited Reevaluation Report and Environmental Impact Statement—Supplement 1.0 (LRR/SEIS) in response to Section 580 of the Water Resources Development Act of 1996 (WRDA) which authorizes the USACE to “* * * conduct a limited reevaluation of the watershed plan and environmental impact statement prepared for the Lower Mud River, Milton, W.V., by the Natural Resources Conservation Service, pursuant to the Watershed Protection and Flood Prevention Act (16 U.S.C. 1001 <E T="03">et seq.</E>) and may carry out the project,” and Section 340 of the WRDA of 2000, which reads: “Modifies Lower Mud River project at Milton authority (Section 580 of WRDA of 1996) to direct the COE to construct the project as selected in the COE reevaluation report.” This report focuses on providing flood protection for the City of Milton, Cabell County, WV against flooding such as occurred in December 1978, March 1997, and February 2003. In accordance with the requirements of NEPA, the potential impacts to the natural, physical, and human environment associated with proposed flood damage reduction measures for the City of Milton (Milton Local Protection Project) are evaluated.</P>
          <P>The flood of record for the City of Milton occurred in March 1997. The flood had an estimated return frequency of 3.7% chance (27-year) flood event, causing over $23 million dollars in damage (1997 price level). The need for local flood protection at Milton is well documented as flooding has played a significant role in the town's history. Milton lies approximately 19 miles upstream from the confluence of the Mud River with the Guyandotte River. Within the town, approximately 736 structures (both residential and nonresidential) stand within the 100-year floodplain and potential annual damages for this reach of the Mud River are estimated to be $3.58 million (2003 dollars).</P>

          <P>In addition to evaluating the flood damage reduction measures for Milton and the surrounding area, the natural resources that will be impacted by these measures have been examined. Potential significant impacts from the final levee alternatives include those to aesthetics, aquatic and terrestrial resources, and socioeconomic resources. Social impacts associated with construction of a project include principally traffic and noise impacts, economic gains and losses, impacts to community cohesion due to acquisition of residences and businesses to construct a project, and aesthetic impacts from the visual prominence of the levee in the community. The document includes a detailed description of the existing <PRTPAGE P="48891"/>environment and describes impacts anticipated from the final flood damage reduction alternatives considered, including the no action alternative.</P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Comments should be submitted by September 30, 2003.</P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>

          <P>Submit comments by letter to: Mr. S. Michael Worley, Chief, Planning Branch, Planning Programs and Project Management Division, U.S. Army Corps of Engineers, Huntington District, 502 Eighth Street, Huntington, WV 25701-2070; FAX: 304-529-5136; or e-mail: <E T="03">Michaelw@Lrh.usace.army.mil.</E>
          </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>

          <P>For additional information about the proposed project, contact Mr. Louis Aspey, Project Manager, PM-P, U.S. Army Corps of Engineers, Huntington District, 502 Eighth Street, Huntington, WV, 25701-2070, telephone: 304-528-7446, or e-mail: <E T="03">Louisa@Lrh.usace.army.mil.</E>
          </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P> </P>
        <HD SOURCE="HD1">1. Background</HD>
        <P>Under authority of the Watershed Protection and Flood Prevention Act (Pub. L. 83-566), the Natural Resources Conservation Service (NRCS), formerly Soil Conservation Service, began an investigation of land and water resource problems, including flooding, in the Lower Mud River watershed in 1972. This early investigation culminated with completion of the Lower Mud River Watershed Plan and Environmental Impact Statement in May 1993, in which a channel modification project of the Mud River in the vicinity of Milton was recommended. Section 580 of WRDA 1996 and Section 340 of WRDA 2000 provided the USACE authority to re-evaluate that study and construct a project.</P>
        <P>A notice of intent to prepare a SEIS was published in the <E T="04">Federal Register</E> on August 14, 2002 (67 FR 52959). The USACE invited full public participation to promote open communication and better decision-making. Persons and organizations interested in the Mud River flooding problems as they affect the community of Milton, WV and the affected environment were urged to participate in this public environmental analysis process. To keep the Milton community informed throughout the study process, a citizen's action group consisting of community members in the vicinity of Milton was formed and the first meeting held in November 2002, with the USACE as an invited guest. They have continued meeting on the fourth Thursday of each month at 9:30 a.m. in the Milton City Hall. Members include the City Council, West Virginia Conservation Agency, Cabell County Floodplain Coordinator, and concerned citizens. Meetings are informal and open to the public. Assistance will continue to be provided upon request to anyone having difficulty with learning how to participate.</P>
        <P>As stated in the notice of intent, public comments are welcomed anytime throughout the NEPA process. Formal opportunities for public participation include: (1) Public meetings held near the community of Milton; (2) Anytime during the NEPA process via mail, telephone or e-mail; (3) During review and comment on the draft LRR/SEIS—approximately August 11 through September 30, 2003; and (4) Review of the final LRR/SEIS—winter 2003-2004. Schedules and locations for public meetings will be announced in local news media. Interested parties may also request to be included on the mailing list for public distribution of meeting announcements and documents.</P>
        <P>To ensure that all issues related to the proposed project are addressed, the USACE has conducted an open process to define the scope of the LRR/SEIS. Recommendations from interested agencies, local and regional stakeholders and the general public were encouraged to provide input in identifying areas of concern, issues and impacts to be addressed in the LRR/SEIS, and the alternatives that would be analyzed.</P>
        <HD SOURCE="HD1">2. Alternatives Considered</HD>
        <P>Detailed project studies have included consideration of a number of local flood damage reduction alternatives including tributary impoundments, floodwall/levee combinations, channel modification and various nonstructural measures. As part of the study, various alternatives considered were found effective for protecting Milton from flooding, including a floodwall, levees, floodproofing, and floodplain evacuation options. More detailed evaluations determined that none of the alternatives were economically feasible except a protective levee on the north bank of the Mud River (Plan B) and a protective levee with relocation of a segment of the Mud River channel (Plan D). These two alternatives along with the No Action alternative have been evaluated in detail and the results documented in the LRR/SEIS.</P>
        <P>The primary planning objective was to develop the most economically feasible plan and the most environmentally acceptable plan to reduce flood damages at Milton. Plan B provides a high level of protection, but includes modification to the Mud River channel. Plan B has the greatest net benefits and is the National Economic Development (NED) plan. Plan D provides a lower level of protection, to approximately that of the 1997 flood; however, the project first cost is about 30 percent less than Plan B. Although Plan D affects several businesses and residences, the impacts on the natural environment are minor; therefore it is the environmentally preferred plan. Because Plan B provides the highest level of flood protection, has the greatest net benefits, and all significant environmental impacts can be mitigated by special project features, Plan B is the selected plan.</P>
        <HD SOURCE="HD1">3. Availability of the Draft LRR/SEIS</HD>
        <P>USACE has distributed copies of the draft LRR/SEIS to appropriate Members of Congress, State and local government official in West Virginia, Federal agencies, and other interested parties. Copies of the document may be obtained by contacting USACE Huntington District Office of the Corps of Engineers at 304-529-5712. Comments pertaining to the documents should be sent to the address above. Copies of the draft LRR/SEIS are also available for inspection at the locations identified below:</P>
        <P>(1) Cabell County Library, 455 Ninth Street Plaza, Huntington, WV 25701.</P>
        <P>(2) Milton Public Library, 11401 Smith Street, Milton, WV 25541.</P>
        <P>(3) Barboursville Public Library, 728 Main Street, Barboursville, WV 25504.</P>
        <P>(4) <E T="03">http://www.lrh.usace.army.mil/.</E>
        </P>
        <P>After the public comment period ends (<E T="03">see</E>
          <E T="02">DATES</E>), USACE will consider all comments received, revise the draft SEIS as appropriate, and issue a final LRR/SEIS.</P>
        <SIG>
          <NAME>Luz D. Ortiz,</NAME>
          <TITLE>Army Federal Register Liaison Officer.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20912  Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 3710-6M-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF DEFENSE</AGENCY>
        <SUBAGY>Department of the Army; Corps of Engineers</SUBAGY>
        <SUBJECT>Federal Interagency Steering Committee on Multimedia Environmental Modeling</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Department of the Army, U.S. Army Corps of Engineers, DoD.</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of open meeting.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>

          <P>The annual public meeting of the Federal Interagency Steering Committee on Multimedia Environmental Modeling (ISCMEM) will convene to review progress by the <PRTPAGE P="48892"/>working groups and to discuss initiatives for FY 2004.</P>
          <P>
            <E T="03">Date of Meeting:</E> September 24, 2003.</P>
          <P>
            <E T="03">Place:</E> U.S. Nuclear Regulatory Commission Headquarters Auditorium, 11545 Rockville Pike, Rockville, MD, 20852.</P>
          <P>
            <E T="03">Time:</E> 9:30 a.m. to 4 p.m.</P>
        </SUM>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Inquiries and notice of intent to attend the meeting may be addressed to Dr. Mark S. Dortch, ISCMEM Chair, Environmental Laboratory, U.S. Army Engineer Research and Development Center, 3909 Halls Ferry Road, Vicksburg, MS 39180-6199, or phone 601-634-3517.</P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P SOURCE="NPAR">
          <E T="03">Background:</E> On July 5, 2001, six Federal agencies entered into a Memorandum of Understanding (MOU) on research and development of multimedia environmental modeling (for a copy of the MOU with addendums, and details of the activities please see <E T="03">http://www.ISCMEM.Org).</E> In 2002 and 2003, two additional Federal Agencies joined the interagency cooperative project. The MOU establishes a framework for facilitating cooperation and coordination among the following agencies (the specific research organization within the agency is in parenthesis): U.S. Army Corps of Engineers (Engineer Research and Development Center); U.S. Department of Agriculture (Agricultural Research Service); U.S. Department of Agriculture (Natural Resources Conservation Service); U.S. Department of Energy (Office of Research and Development); U.S. Geological Survey; U.S. National Oceanographic and Atmospheric Administration; and U.S. Nuclear Regulatory Commission (Office of Nuclear Regulatory Research). These agencies are cooperating and coordinating in research and development (R&amp;D) of multimedia environmental models, software and related databases, including development, enhancements, applications and assessments of site-specific, generic, and process-oriented multimedia environmental models as they pertain to human and environmental health risk assessment. Specifically, the MOU supports collaboration and the exchange of technical information in support of multimedia environmental modeling focusing on environmental risk assessments, including development/enhancements of models and model frameworks or infrastructure and advancement of related technical activities, such as considering uncertainty and model application procedures.</P>
        <P>
          <E T="03">Purpose of the Public Meeting:</E> The annual public meeting provides an opportunity for the scientific community, other Federal and State agencies, and the public to be briefed on the progress of the MOU working groups and their initiatives for the upcoming year, and to discuss technological advancements in multimedia environmental modeling.</P>
        <P>
          <E T="03">Proposed Agenda:</E> The ISCMEM Chair will report on new participating Federal agencies. The four MOU working groups, Software System Design and Implementation, Uncertainty and Parameter Estimation, Modeling Reactive Transport, and Watershed Modeling, will report on their progress during the year. A series of technical presentations will focus on: progress on the Geospatial Library for Environmental Modeling (GEOLEM) project as related to integration of modeling frameworks and GIS; results of the <E T="03">International Workshop on Uncertainty, Sensitivity and Parameter;</E> and activities towards conceptualized model development for subsurface reactive transport modeling of inorganic contaminants, radionuclides, and nutrients. Participation with this MOU of similar coordinating groups and consortia outside the U.S. will be discussed. A detailed agenda with presentation titles and speakers will be posted on the MOU public Web site: <E T="03">http://ww.ISCMEM.Org.</E>
        </P>
        <P>
          <E T="03">Meeting Access:</E> The U.S. Nuclear Regulatory Commission (NRC) Headquarters Auditorium is located in Two White Flint North Building at 11545 Rockville Pike, Rockville, Maryland. To access the NRC Auditorium, please use the Two White Flint North building entrance to proceed through security. The most convenient transportation to the meeting venue is via Metro. Please take Metro to the White Flint Metro stop on the Red Line. NRC is directly across the street from the White Flint Metro exit on Marinelli Road. Please inform the security personnel that you are attending the public meeting on multimedia environmental modeling in the NRC Auditorium.</P>
        <SIG>
          <NAME>Mark S. Dortch,</NAME>
          <TITLE>Chair, Federal Interagency Steering Committee on Multimedia Environmental Modeling.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20909  Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 3710-61-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF EDUCATION </AGENCY>
        <SUBJECT>Notice of Proposed Information Collection Requests </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Department of Education. </P>
        </AGY>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The Leader, Regulatory Information Management Group, Office of the Chief Information Officer, invites comments on the proposed information collection requests as required by the Paperwork Reduction Act of 1995. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Interested persons are invited to submit comments on or before October 14, 2003. </P>
        </DATES>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>

        <P>Section 3506 of the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35) requires that the Office of Management and Budget (OMB) provide interested Federal agencies and the public an early opportunity to comment on information collection requests. OMB may amend or waive the requirement for public consultation to the extent that public participation in the approval process would defeat the purpose of the information collection, violate State or Federal law, or substantially interfere with any agency's ability to perform its statutory obligations. The Leader, Regulatory Information Management Group, Office of the Chief Information Officer, publishes that notice containing proposed information collection requests prior to submission of these requests to OMB. Each proposed information collection, grouped by office, contains the following: (1) Type of review requested, <E T="03">e.g.</E> new, revision, extension, existing or reinstatement; (2) Title; (3) Summary of the collection; (4) Description of the need for, and proposed use of, the information; (5) Respondents and frequency of collection; and (6) Reporting and/or Recordkeeping burden. OMB invites public comment. The Department of Education is especially interested in public comment addressing the following issues: (1) Is this collection necessary to the proper functions of the Department; (2) will this information be processed and used in a timely manner; (3) is the estimate of burden accurate; (4) how might the Department enhance the quality, utility, and clarity of the information to be collected; and (5) how might the Department minimize the burden of this collection on the respondents, including through the use of information technology. </P>
        <SIG>
          <DATED>Dated: August 12, 2003. </DATED>
          <NAME>Angela C. Arrington, </NAME>
          <TITLE>Leader, Regulatory Information Management Group, Office of the Chief Information Officer. </TITLE>
        </SIG>
        <HD SOURCE="HD1">Office of Postsecondary Education </HD>
        <P>
          <E T="03">Type of Review:</E> Revision. <PRTPAGE P="48893"/>
        </P>
        <P>
          <E T="03">Title:</E> Comprehensive Program Annual Performance Report. </P>
        <P>
          <E T="03">Frequency:</E> One time. </P>
        <P>
          <E T="03">Affected Public:</E> Not-for-profit institutions. </P>
        <P>
          <E T="03">Reporting and Recordkeeping Hour Burden:</E>
        </P>
        
        <P> Responses: 140. </P>
        <P> Burden Hours: 2,800. </P>
        
        <P>
          <E T="03">Abstract:</E> The Comprehensive Program is a discretionary grant program that makes competitive awards to support reform and innovations through projects that improve educational practice at the postsecondary level. Grantees annually submit a performance report to demonstrate that substantial progress is being made toward meeting the objectives of their projects. Reporting requirements are currently based on broad criteria from the Education Department General Administrative Regulations (EDGAR). This request is to use a reporting format that elicits needed information on program-specific outcomes within the annual report without posing additional burden to the grantee. </P>

        <P>Requests for copies of the proposed information collection request may be accessed from <E T="03">http://edicsweb.ed.gov</E>, by selecting the “Browse Pending Collections” link and by clicking on link number 2319. When you access the information collection, click on “Download Attachments” to view. Written requests for information should be addressed to Vivian Reese, Department of Education, 400 Maryland Avenue, SW., Room 4050, Regional Office Building 3, Washington, DC 20202-4651 or to the e-mail address <E T="03">vivian_reese@ed.gov</E>. Requests may also be electronically mailed to the Internet address <E T="03">OCIO_RIMG@ed.gov</E> or faxed to 202-708-9346. Please specify the complete title of the information collection when making your request. </P>

        <P>Comments regarding burden and/or the collection activity requirements should be directed to Joseph Schubart at his e-mail address <E T="03">Joe.Schubart@ed.gov</E>. Individuals who use a telecommunications device for the deaf (TDD) may call the Federal Information Relay Service (FIRS) at 1-800-877-8339. </P>
        
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20913 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4000-01-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF ENERGY </AGENCY>
        <SUBJECT>Notice of Intent To Prepare an Environmental Impact Statement for the Colorado Springs Utilities Next-Generation CFB Coal Generating Unit, Fountain, CO </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Department of Energy. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of intent. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The U.S. Department of Energy (DOE) announces its intent to prepare an Environmental Impact Statement (EIS) pursuant to the National Environmental Policy Act (NEPA), the Council on Environmental Quality (CEQ) NEPA regulations (40 Code of Federal Regulations [CFR] parts 1500-1508), and the DOE NEPA regulations (10 CFR part 1021) to assess the potential environmental impacts of a project proposed by Colorado Springs Utilities to design, construct, and operate a Next-Generation Circulating Fluidized Bed (CFB) Coal Generating Unit demonstration plant near Fountain, El Paso County, Colorado. The plant is proposed for a site adjacent to the existing 227 megawatt (MW) Ray D. Nixon Power Plant on the Clear Springs Ranch, a 5,000-acre Colorado Springs Utilities-owned property located approximately 17 miles south of Colorado Springs. </P>
          <P>The proposed project, selected under the Clean Coal Power Initiative solicitation, would demonstrate advanced technologies to produce electricity using a variety of fuels, including subbituminous coal from the Powder River Basin (PRB) in Wyoming, which would provide the primary fuel for long-term operation of the plant, bituminous coals from Illinois and Pennsylvania, and blends of PRB coal with waste coal and wood waste. Colorado Springs Utilities would also consider combusting several other fuels, including waste tires and processed municipal solid waste sludge, in blends with the PRB coal. Technologies to be integrated into the proposed plant would include a circulating fluid-bed combustion system to achieve low emissions of sulfur oxides, an advanced staged-combustion process to achieve low nitrogen oxide levels, an advanced selective non-catalytic reduction system to further reduce nitrogen oxide emissions, and a low-cost, integrated trace metal control system having potential to remove virtually all acid gases and up to 90% of mercury from the combustion gas. Upon completing a successful demonstration of the advanced technologies, the new CFB unit would be operated as a commercial power plant to supply approximately 150 MW of electricity to the Colorado Springs Utilities power grid. </P>
          <P>The EIS will help DOE decide whether to provide 10% (approximately $30 million in financial assistance) of the total estimated cost of $301 million for the proposed project. The purpose of this Notice of Intent is to inform the public about the proposed project; invite public participation in the EIS process; announce the plans for a public scoping meeting and explain the EIS scoping process; and solicit public comments for consideration in establishing the proposed scope and content of the EIS. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>

          <P>To ensure that all of the issues related to this proposal are addressed, DOE invites comments on the proposed scope and content of the EIS from all interested parties. Comments must be received by September 19, 2003, to ensure consideration. Late comments will be considered to the extent practicable. In addition to receiving comments in writing and by telephone, (<E T="03">See</E>
            <E T="02">ADDRESSES</E> below), DOE will conduct a public scoping meeting in which agencies, organizations, and the general public are invited to present oral comments or suggestions with regard to the range of actions, alternatives, analysis methods, and environmental issues to be considered in the EIS. The scoping meeting will be held at the Fountain Middle School, 515 North Santa Fe Avenue, Fountain, CO, on September 3, 2003, beginning at 7 pm (<E T="03">See</E> “Public Scoping Process”). The public is invited to an informal session at this location beginning at 5 pm to learn more about the proposed action.</P>
          <P>Displays and other forms of information about the proposed agency action and the demonstration plant will be available, and DOE personnel will be present at the informal session to discuss the proposed project and the EIS process. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Written comments on the proposed EIS scope and requests to participate in the public scoping meeting should be addressed to the NEPA Document Manager for the CFB Generating Unit project (hereafter termed the “Project”): Mr. Lloyd Lorenzi, National Energy Technology Laboratory, U.S. Department of Energy, P.O. Box 10940, Pittsburgh, PA 15236-0940. </P>

          <P>Individuals who would like to otherwise participate in the public scoping process should contact Mr. Lloyd Lorenzi directly by telephone: 412-386-6159; toll free number for recording messages: 1-800-276-9851; fax: 412-386-4604; or electronic mail: <E T="03">lorenzi@netl.doe.gov.</E>
          </P>
        </ADD>
        <FURINF>
          <PRTPAGE P="48894"/>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>For information regarding the Project or to receive a copy of the draft EIS for review when it is issued, contact Mr. Lloyd Lorenzi as described above. Those seeking general information on the DOE NEPA process, contact: Ms. Carol M. Borgstrom, Director, Office of NEPA Policy and Compliance (EH-42), U.S. Department of Energy, 1000 Independence Avenue, SW., Washington, DC 20585-0119, Telephone: (202) 586-4600, Facsimile: (202) 586-7031, or leave a toll-free message at 1-800-472-2756.</P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <HD SOURCE="HD1">Background and Need for Agency Action </HD>
        <P>Since the early 1970s, DOE and its predecessor agencies have supported research and development programs for a wide variety of innovative coal technologies through the proof-of-concept stage. However, the availability of a technology at the proof-of-concept stage is not sufficient to ensure continued development and subsequent commercialization. Before any technology can be considered seriously for commercialization, it must be demonstrated. The financial risk associated with technology demonstration is, in general, too high for the private sector to assume in the absence of strong incentives. The Clean Coal Power Initiative (CCPI) was established in 2002 as a government/industry partnership to implement the President's National Energy Policy recommendation to increase investment in clean coal technology. That recommendation addresses a national challenge of ensuring the reliability of electric supply while simultaneously protecting the environment. </P>
        <P>The goal of the CCPI program is to accelerate commercial deployment of advanced coal technologies that provide the United States with clean, reliable, and affordable energy. Through cooperative agreements established pursuant to the CCPI program, DOE would accelerate deployment of innovative technologies to meet near-term energy and environmental goals; to reduce technological risk to the business community to an acceptable level; and to provide private sector incentives required for continued activity in innovative research and development directed at providing solutions to long-range energy supply problems. </P>
        <HD SOURCE="HD1">Proposed Action </HD>
        <P>The proposed action is for DOE to provide, through a cooperative agreement with Colorado Springs Utilities, financial assistance for the proposed Project. The CFB Generating Unit to be constructed under the Project would be designed for long-term commercial operation following completion of an approximately 12-month period of operation to demonstrate performance of advanced technologies under the cooperative agreement with DOE. The cost of the Project is approximately $301 million; DOE's share would be approximately $30 million (10%). </P>
        <P>The CFB Generating Unit would produce approximately 150 MW of electricity, at extremely high environmental performance levels, for export to the local grid. The primary fuel for the plant would be subbituminous coal from the Powder River Basin (PRB) in Wyoming. During the demonstration phase of operation for DOE, other fuels would be tested, including bituminous coals from Illinois and Pennsylvania and blends of PRB coal with waste coal and forest biomass (non-commercial timber removed during forest thinning and fire risk reduction activities on National Forest lands). Colorado Springs Utilities would also consider combustion of PRB coal in blends with other fuels, including pelletized or shredded rubber from waste tires and processed sludge from wastewater treatment activities of Colorado Springs Utilities, to demonstrate the range of environmental performance capabilities of the advanced CFB generating unit. </P>
        <P>The CFB generating unit would be constructed on an approximately 10-acre site adjacent to the existing 151-acre Ray D. Nixon Power Plant, which has been operating since 1980. The existing power plant features a 227 MW pulverized coal-fired boiler using PRB coal, two 35 MW combustion turbines, a coal storage area, and coal handling facilities. All facilities for the new CFB Unit would be located on the 5,000-acre Clear Springs Ranch property that Colorado Springs Utilities owns and uses for power generation, ash disposal, wastewater treatment, and land application sludge disposal. Site preparation would require grading, clearing of vegetation, and the addition of infrastructure improvements, such as roads, fencing, and drainage. Construction preparations would include installation of foundations for the plant equipment and structures. </P>
        <P>The CFB Generating Unit would feature an advanced staged-combustion process that can achieve low nitrogen oxide levels, and an advanced selective non-catalytic reduction system that can further reduce nitrogen oxide emissions. Limestone would be added to the combustion furnace for sulfur removal. The CFB Generating Unit would also include a three-stage system for sulfur oxide control to achieve up to 98 percent sulfur removal. Requirements for limestone, which would be the only reagent added to the combustion furnace for sulfur control, would be reduced to less than half the amount required by conventional CFB systems. </P>
        <P>In addition to the advanced sulfur oxide and nitrogen oxide control technologies, the low emission combustion system would feature an integrated trace metal control system with potential to remove virtually all acid gas emissions and up to 90 percent of mercury from the combustion gas. The CFB generating unit would include an advanced system for solids separation, whereby solids separators would be integrated into the traditional furnace structure to reduce cost and improve reliability. This design would allow reduced size of the overall combustion system and eliminate hot expansion joints, thus potentially achieving improved operational performance and reduced maintenance costs. </P>
        <P>The primary feed material for the new CFB Unit would be up to approximately 2,200 tons-per-day of subbituminous coal that would be delivered to the site using the existing rail loop and coal handling facilities. Coal would be stored in the same coal storage area that is currently serving the Nixon Power Plant, though a separate conveyor would be constructed to service the CFB Unit. </P>
        <P>Construction of the proposed plant would take approximately 36 months. Plant start-up, system and feedstock testing, and long-term performance and reliability demonstration under the cooperative agreement with DOE would require approximately 12 months, after which the plant could continue in commercial operation. </P>
        <HD SOURCE="HD1">Alternatives </HD>
        <P>NEPA requires that agencies evaluate the reasonable alternatives to the proposed action in an EIS. The purpose for agency action determines the range of reasonable alternatives. </P>

        <P>The Clean Coal Power Initiative (CCPI) was established to help implement the President's National Energy Policy (NEP) recommendation to increase investment in clean coal technology by addressing national challenges of ensuring the reliability of domestic electric and energy supplies while simultaneously protecting the environment. The CCPI program was structured to achieve NEP goals by promoting private sector initiatives to invest in demonstrations of advanced <PRTPAGE P="48895"/>technologies that could be widely deployed commercially to ensure that the United States has clean, reliable, and affordable energy. Private sector investments and deployment of energy systems in the United States places DOE in a more limited role than if the Federal government were the owner and operator of the energy systems. In the latter situation, DOE would be responsible for a comprehensive review of reasonable alternatives for siting the system. However, in dealing with applicants under the CCPI solicitation, the scope of alternatives is necessarily more restrictive, because DOE must give substantial consideration to the applicant's needs, as reflected in its CCPI application, in establishing a project's reasonable alternatives. </P>
        <P>The range of reasonable alternatives to be considered in the EIS for the Project is determined in accordance with the overall NEPA strategy. Because of DOE's limited role of providing cost-shared funding for the Project, DOE currently plans to give primary emphasis to the proposed action and the no-action alternative. Under the proposed action, Project activities would include equipment design and fabrication, process engineering, plant permitting and construction, and testing and demonstration of the technology. Under the no-action alternative, DOE would not provide partial funding for the design, construction, and operation of the plant. </P>
        <P>In the absence of DOE funding, the new CFB Unit may be constructed, but likely would not include demonstration of operation with the range of fuel sources that has been proposed. In the absence of DOE funding, Colorado Springs Utilities could also consider building a natural gas combustion turbine plant at the Clear Spring Ranch Site. This alternative will be examined in the EIS. DOE will consider other reasonable alternatives that may be suggested during the public scoping period. </P>
        <P>DOE plans to complete the EIS within 15 months following publication of this Notice of Intent, and to issue a Record of Decision no sooner than 30 days following completion of the Final EIS. Upon completing the demonstration effort for DOE, Colorado Springs Utilities could continue commercial operation of the new CFB Unit constructed under the Project. </P>
        <HD SOURCE="HD1">Preliminary Identification of Environmental Issues </HD>
        <P>The following environmental issues have been tentatively identified for analysis in the EIS. This list is presented to facilitate public comment on the planned scope of the EIS, and is not intended to be a pre-determined set of potential impacts. Additions to or deletions from this list may occur as a result of the public scoping process. The environmental issues include: </P>
        <P>(1) Atmospheric resources: Potential air quality effects resulting from emissions during construction and operation of the proposed CFB Unit; </P>
        <P>(2) Water resources: Potential effects on surface water and groundwater resources, including effects of water usage, wastewater management, and storm water management; </P>
        <P>(3) Aesthetic and scenic resources: Visual effects associated with plant structures and operations; </P>
        <P>(4) Ecological resources: Potential on-site and off-site impacts to vegetation, terrestrial wildlife, threatened and endangered species, and ecologically sensitive habitats, including the Fountain Creek riparian corridor and the Clear Springs Ranch Wildlife Management area; </P>
        <P>(5) Land use requirements and compatibility for disposal of power plant ash; </P>
        <P>(6) Noise: Potential effects resulting from construction and operation of the proposed plant and from transportation of feed materials and plant products; </P>
        <P>(7) Health and safety impacts, including construction-related safety and process-related safety associated with handling and management of chemical materials; </P>
        <P>(8) Socioeconomic effects resulting from influx of construction laborers and plant operating staff; </P>
        <P>(9) Soils and geology compatibility for plant construction and ash disposal; </P>
        <P>(10) Utility and transportation infrastructure requirements for delivery of fuels and chemicals to the power plant; </P>
        <P>(11) Resource utilization; </P>
        <P>(12) Cumulative effects that result from the incremental impacts of the proposed plant when added to the other past, present, and reasonably foreseeable future activities, including the adjacent Nixon Power Plant and the nearby recently-completed Front Range Power Plant; </P>
        <P>(13) Connected actions associated with recovery of other fuels, including wood waste, and feed materials for the plant; and </P>
        <P>(14) Regulatory compliance and environmental monitoring. </P>
        <HD SOURCE="HD1">Public Scoping Process </HD>

        <P>To ensure that all issues related to this proposal are addressed, DOE will conduct an open process to define the scope of the EIS. The public scoping period will end on September 19, 2003. Interested agencies, organizations, and the general public are encouraged to submit comments or suggestions concerning the content of the EIS, issues and potential impacts to be addressed in the EIS, and alternatives that should be considered. Scoping comments should identify specific issues or topics that the EIS should address in order to assist DOE in identifying significant issues for analysis. Written, e-mailed, or faxed comments should be communicated by September 19, 2003 (<E T="03">See</E>
          <E T="02">ADDRESSES</E>). </P>
        <P>DOE will conduct a public scoping meeting at the Fountain Middle School, 515 North Santa Fe Avenue, Fountain, CO, on September 3, 2003, at 7 pm. In addition, the public is invited to an informal session beginning at 5 pm, to learn more about the proposed action. Displays and other information about the proposed agency action and the demonstration plant will be available, and DOE personnel will be present to discuss the proposed action and the NEPA process. </P>

        <P>The formal scoping meeting will begin on September 3, 2003, at 7 pm. DOE requests that members of the public who wish to speak at this public scoping meeting contact Mr. Lloyd Lorenzi, either by phone, fax, computer, or in writing (<E T="03">See</E>
          <E T="02">ADDRESSES</E> in this Notice). </P>
        <P>Members of the public who do not arrange in advance to speak may register at the meeting (preferably at the beginning of the meeting) and will be provided opportunities to speak following previously scheduled speakers. Speakers who need more than five minutes should indicate the length of time desired in their request. Depending on the number of speakers, DOE may need to limit speakers to five minutes initially but will provide additional opportunities as time permits. Speakers may also provide written materials to supplement their presentations. Oral and written comments will be given equal consideration. </P>
        <P>DOE will begin the meeting with an overview of the proposed Project. The meeting will not be conducted as an evidentiary hearing, and speakers will not be cross-examined. However, speakers may be asked questions to help ensure that DOE fully understands their comments or suggestions. A presiding officer will establish the order of speakers and provide any additional procedures necessary to conduct the meeting. </P>
        <SIG>
          <PRTPAGE P="48896"/>
          <DATED>Issued in Washington, DC, on this 11th day of August, 2003. </DATED>
          <NAME>Beverly A. Cook, </NAME>
          <TITLE>Assistant Secretary, Environment, Safety and Health. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20862 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 6450-01-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF ENERGY </AGENCY>
        <SUBJECT>Office of Science Financial Assistance Program Notice DE-FG01-03ER03-26; Fusion Science Centers </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>U.S. Department of Energy. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice inviting grant applications. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The Office of Fusion Energy Sciences (OFES) of the Office of Science (SC), U.S. Department of Energy (DOE), announces its interest in receiving grant applications for Fusion Science Centers with a research focus in fusion plasma science. The duration of the Center grant will be five years, with the possibility of a one time renewal for five more years. All institutions or groups planning to submit applications for funding a new center in Fiscal Year 2004 should submit in response to this Notice. Applicants are not being asked, in any way, to fund or establish a Federally Funded Research and Development Center (FFRDC). </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>To permit timely consideration for awards in Fiscal Year 2004, applicants are required to submit a Preliminary Application by November 14, 2003. Following a review of the Preliminary Application, applicants may be invited to submit a Full Application in response to this notice which must be received by DOE no later than 4:30 p.m., March 1, 2004. Electronic submission of formal applications in PDF format is required. </P>

          <P>Applicants are requested to submit a letter-of-intent by October 15, 2003. Letters-of-Intent should be sent by e-mail to the following e-mail address: <E T="03">john.sauter@science.doe.gov</E> and the subject line should state: Letter-of-Intent regarding Program Notice DE-FG01-03ER03-26. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>

          <P>A copy of the Preliminary Application should be sent by e-mail to: <E T="03">john.sauter@science.doe.gov</E> with a subject line titled Preliminary Application Regarding Program Notice DE-FG01-03ER03-26. In addition, you must provide two CDs, with one PDF file copy of the Preliminary Application on each, to be sent Federal Express to: John Sauter, SC-55, Office of Fusion Energy Sciences, Germantown Building, U.S. Department of Energy, 19901 Germantown Road, Germantown, MD 20874-1290. Full Applications in response to this solicitation Number DE-FG01-03ER03-26 are to be electronically submitted by an authorized institutional business official through DOE's Industry Interactive Procurement System (IIPS) at: <E T="03">http://e-center.doe.gov/.</E> IIPS provides for the posting of solicitations and receipt of applications in a paperless environment via the Internet. In order to submit applications through IIPS, your business official will need to register at the IIPS Web site. It is suggested that this registration be completed several days prior to the date on which you plan to submit the formal application. The Office of Science will include attachments as part of this notice that provide the appropriate forms in PDF fillable format that are to be submitted through IIPS. <E T="03">IIPS offers the option of submitting multiple files—please limit submissions to only one file within the volume if possible, with a maximum of no more than four files.</E> Questions regarding the operation of IIPS may be e-mailed to the IIPS Help Desk at: <E T="03">helpdesk@pr.doe.gov,</E> or you may call the help desk at: (800) 683-0751. Further information on the use of IIPS by the Office of Science is available at: <E T="03">http://www.sc.doe.gov/production/grants/grants.html.</E>
          </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>

          <P>Dr. Michael D. Crisp, Research Division, SC-55, Office of Fusion Energy Sciences, Germantown Building, U.S. Department of Energy, 1000 Independence Avenue, SW., Washington, DC 20585-1290. Telephone: (301) 903-4883, or by e-mail address: <E T="03">michael.crisp@science.doe.gov.</E>
          </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>

        <P>General information about development and submission of applications, eligibility, limitations, evaluations and selection processes, and other policies and procedures may be found in the Application Guide for the Office of Science Financial Assistance Program and 10 CFR part 605. Electronic access to SC's Financial Assistance Guide and required forms is possible via the Internet using the following Web site address: <E T="03">http://www.sc.doe.gov/production/grants/grants.html.</E> DOE is under no obligation to pay for any costs associated with the preparation or submission of an application if an award is not made. </P>
        <HD SOURCE="HD1">Program Objectives </HD>
        <P>The development of new investigative techniques and research tools presents a window of opportunity for fundamental advances in the understanding of fusion plasma science. Many of the issues in plasma science are sufficiently complex that significant progress requires closely interacting, critical-mass groups of scientists with a broad mix of skills and backgrounds. There is also a need to strengthen the connection between the fusion research community and the broader scientific community. The objective of this initiative is to establish one or two university-based Fusion Science Centers (FSC), which will focus on fundamental issues in plasma science. The FSC will be supported to perform fusion plasma science research in areas of such wide scope and complexity that it would not be feasible for individual investigators or small groups to make progress. For example, understanding the dynamics of plasma turbulence and transport requires the development of appropriate physical models, computational algorithms for treating disparate space and times scales, as well as complex magnetic geometries, efficient programming on massively parallel computing platforms, and an understanding of nonlinear physics. A well coordinated collaboration of a team of scientists is more likely to have the breadth of knowledge and skills required to tackle such large and complex problems successfully. The research team that will be assembled for the FSC should also promote connectivity with the broader scientific community. </P>
        <HD SOURCE="HD1">Areas of Focus </HD>
        <P>The FSC will be a university-based center of excellence that will emphasize scientific issues that are of fundamental importance to fusion plasma science. Examples of topics that could serve as a focus of a FSC include, but are not limited to: turbulence and transport, chaos and self-organization, energetic particle dynamics, and high energy density plasma physics. </P>
        <HD SOURCE="HD1">Educational Component </HD>
        <P>Since future manpower requirements of the fusion energy sciences program are an important concern, proposals should discuss effective ways in which education and training are integrated within their research programs. Centers should be expected to sponsor multidisciplinary workshops and summer schools that will bring together students and researchers from various fields and institutions to focus on basic plasma science. The workshops should also serve to communicate the advances and challenges of fusion science to the broader scientific community. </P>
        <HD SOURCE="HD1">Eligibility Information </HD>

        <P>Applications are sought from academic institutions and groups, <PRTPAGE P="48897"/>within the United States, which have research and educational programs in plasma science. The Center is expected, and encouraged, to participate in collaborations with other research institutions. The FSC is envisioned to combine the expertise and approaches of national laboratories and universities. However, since the thrust of this initiative is for university-based institutions, any participation of a (FFRDC), including a Department of Energy National Laboratory, should be limited to no more than 20 percent of the Center funding. </P>
        <HD SOURCE="HD1">Cost Sharing </HD>
        <P>The host institution is required to provide at least 15 percent matching funds for the Center. </P>
        <HD SOURCE="HD1">Application Process </HD>
        <P>Applicants are requested to submit a letter-of-intent as stated above. Applicants will be required to submit a detailed Preliminary Application that will be reviewed by a panel of experts. Following the review of the Preliminary Application, applicants may be invited to submit a Full Application. The Full Application will receive an extensive review which may include oral presentations by the Principal Investigator and his collaborators. </P>
        <HD SOURCE="HD1">Letter-of-Intent </HD>
        <P>Letters-of-intent must include the title of the application, the name of the Principal Investigator(s), the requested funding and a one-page abstract. These letters-of-intent will be used to organize and expedite review processes. Failure to submit a letter-of-intent will not negatively prejudice a responsive formal application submitted in a timely fashion. </P>
        <HD SOURCE="HD1">Preliminary Application </HD>
        <P>The Preliminary Application should consist of a description of the research proposed to be undertaken by the Fusion Science Center including a clear explanation of its importance to the advancement of fusion plasma science. The Preliminary Application should be limited to a maximum of 30 pages (including text and figures) of technical information. It should briefly describe the institutional setting of the FSC, its proposed scope and organization, activities in research and education and their integration, development of human resources and shared experimental facilities, links with related major research centers, on campus or off campus, and a management plan. The application should emphasize the synergy of collaborations that will be facilitated by the Center. A clear case should be made that the Center's research program will contribute more to the advancement of fusion plasma science than would be expected from the independent efforts of its individual investigators. Also included should be a description of educational activities that will be an integral part of the Center's research program and other information necessary for a concise overview of the FSC activities. The FSC application should describe proposed efforts to communicate concepts, methods, tools, and results to the wider world of science in order to raise awareness of the fusion science community's scientific accomplishments. </P>
        <HD SOURCE="HD1">Full Application </HD>
        <P>The Department of Energy will accept Full Applications for a Fusion Science Center by invitation only, based upon the results of an evaluation of the Preliminary Application. The Full Application should consist of a more detailed description of the material contained in the Preliminary Application. The Full Application may be modified in response to the reviewers' comments concerning the Preliminary Application. The review process for the Full Application may also include oral presentations, made to a review panel, by the proposed Center's key people. </P>
        <HD SOURCE="HD1">Program Funding </HD>
        <P>It is anticipated that about $2,000,000 of Fiscal Year 2004 funding will be available to fund one or two new Fusion Science Centers from applications received in response to this Notice. Because future year funding is not anticipated to increase, applications should propose constant effort in future years (allowing for inflation). Future year funding will depend upon suitable progress and the availability of funds. The cost-effectiveness of the application will be considered when comparing applications with differing funding requirements. </P>
        <HD SOURCE="HD1">Merit Review </HD>
        <P>Applications will be subjected to formal merit review and will be evaluated against the following criteria, which are listed in descending order of importance as set forth in 10 CFR part 605. </P>
        <P>1. Scientific and/or technical merit of the project, </P>
        <P>2. Appropriateness of the proposed method or approach, </P>
        <P>3. Competency of the applicant's personnel and adequacy of the proposed resources, </P>
        <P>4. Reasonableness and appropriateness of the proposed budget. </P>
        <P>The Office of Fusion Energy Sciences will also consider, as part of the evaluation, other available advice or information as well as program policy factors, such as ensuring an appropriate balance among and within the program areas, ensuring support for major computational efforts, ensuring support for experiments, and quality of previous performance. </P>
        <HD SOURCE="HD1">Additional Review Criteria </HD>
        <P>In order to encourage innovation and originality in the application, preconceived specifications are being kept to a minimum in this announcement. A proposal for a center should have a plan to identify, pose, and answer scientific questions of widely recognized importance. In all cases, however, a Center's application should demonstrate that the whole of the Center's effort will be substantially greater than the sum of its parts. Attention will be paid to the management plan, which should include a description of how the FSC will operate. The plan should also describe proposed activities that will be undertaken to enhance connectivity between the Center and the broad scientific community. </P>

        <P>In addition to the information required by 10 CFR part 605 each application should contain the following items: (1) A succinct statement of the goal of the research, (2) a detailed research plan, (3) the specific results expected at the end of the project period, (4) an analysis of the adequacy of the budget, (5) a discussion of the impact of the proposed research on other fields of science, and (6) for projects requiring significant computational resources (<E T="03">e.g.</E>, at the National Energy Research Scientific Computing Center), an estimate and justification of the resources that will be required. </P>
        <P>With respect to the enhanced productivity that one would expect from the synergy of a Center, additional review criteria are: </P>
        <P>(1) Clear evidence of collaborative work. </P>
        <P>(2) The extent to which the group addresses difficult problems requiring a team effort. </P>
        <P>(3) Clear evidence of scientific leadership. </P>
        <P>(4) The extent to which the management will evaluate the relevance and scientific impact of the group's work. </P>

        <P>Selection of applications for award will be based upon the findings of the technical evaluations, the importance and relevance of the proposed research <PRTPAGE P="48898"/>to the Office of Fusion Energy Sciences' mission, and funding availability. </P>
        <P>The Catalog of Federal Domestic Assistance Number for this program is 81.049, and the solicitation control number is ERFAP 10 CFR part 605. </P>
        <SIG>
          <DATED>Issued in Washington, DC on: August 7, 2003. </DATED>
          <NAME>John Rodney Clark, </NAME>
          <TITLE>Associate Director of Science for Resource Management. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20863 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 6450-01-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF ENERGY </AGENCY>
        <SUBAGY>Federal Energy Regulatory Commission </SUBAGY>
        <DEPDOC>[Docket No. EC03-118-000, et al.] </DEPDOC>
        <SUBJECT>Allegheny Energy Supply Company, LLC, et al., Electric Rate and Corporate Filings </SUBJECT>
        <DATE>August 6, 2003. </DATE>
        <P>The following filings have been made with the Commission. The filings are listed in ascending order within each docket classification. </P>
        <HD SOURCE="HD1">1. Allegheny Energy Supply Company, LLC, Allegheny Trading Finance Company, J. Aron &amp; Company, Power Receivable Finance, LLC </HD>
        <DEPDOC>[Docket No. EC03-118-000] </DEPDOC>
        <P>Take notice that on July 31, 2003, Allegheny Energy Supply Company, LLC, (AESC), Allegheny Trading Finance Company, (ATF), J. Aron &amp; Company (J.Aron) and Power Receivable Finance, LLC (PRF) (together, the Applicants) filed with the Federal Energy Regulatory Commission a joint application pursuant to Section 203 of the Federal Power Act for authorization of a disposition of jurisdictional facilities whereby AESC and ATF will sell and transfer to J.Aron and PRF contracts for the wholesale sale of power. The Applicants have requested Commission action on an expedited basis to permit the transaction to close on or about September 1, 2003. </P>
        <P>
          <E T="03">Comment Date:</E> August 19, 2003. </P>
        <HD SOURCE="HD1">2. Florida Power &amp; Light Company </HD>
        <DEPDOC>[Docket No. ER02-766-005] </DEPDOC>
        <P>Take notice that on August 1, 2003, Florida Power &amp; Light Company filed with the Federal Energy Regulatory Commission a refund compliance filing in the above captioned proceeding. </P>
        <P>FPL states that a copy of this filing has been served on DeSoto County Generating Company, L.L.C., parties to Docket No. ER02-766, and the Florida Public Service Commission. </P>
        <P>
          <E T="03">Comment Date:</E> August 22, 2003. </P>
        <HD SOURCE="HD1">3. Public Service Company of Colorado</HD>
        <DEPDOC>[Docket No. ER03-971-001] </DEPDOC>
        <P>Take notice that on August 1, 2003, Public Service Company of Colorado (PS Colorado) tendered for filing a supplement to its general rate case filing, made in Docket ER03-971-000 on June 19, 2003 (June 19 Filing). PS Colorado states that this filing corrects a tax calculation error in the cost of service underlying the rates proposed in the June 19 Filing. </P>
        <P>
          <E T="03">Comment Date:</E> August 22, 2003. </P>
        <HD SOURCE="HD1">4. PJM Interconnection, L.L.C. </HD>
        <DEPDOC>[Docket No. ER03-1145-000] </DEPDOC>
        <P>Take notice that on July 31, 2003, PJM Interconnection, L.L.C. (PJM), submitted for filing amendments to the Amended and Restated Operating Agreement of PJM Interconnection, L.L.C., the Reliability Assurance Agreement Among Load Serving Entities in the MAAC Control Zone, and the PJM West Reliability Assurance Agreement Among Load Serving Entities in the PJM West Region to revise the PJM stakeholder committee structure and to make other changes to facilitate the stakeholder process in PJM. </P>
        <P>PJM states that copies of this filing have been served on all PJM members, and each state electric utility regulatory commission in the PJM region. </P>
        <P>
          <E T="03">Comment Date:</E> August 21, 2003. </P>
        <HD SOURCE="HD1">5. Power Receivable Finance, LLC </HD>
        <DEPDOC>[Docket No. ER03-1151-000] </DEPDOC>
        <P>Take notice that on August 1, 2003, Power Receivable Finance, LLC (PRF) petitioned the Federal Energy Regulatory Commission for an order: (1) Accepting for filing PRF's Rate Schedule FERC No. 1; (2) granting waiver of certain requirements of the Commission's regulations; and (3) granting the blanket approvals normally accorded to sellers permitted to sell at market-based rates. PRF also requests that the Commission grant waiver of the 60-day prior notice requirement. </P>
        <P>
          <E T="03">Comment Date:</E> August 22, 2003. </P>
        <HD SOURCE="HD1">6. Michigan Electric Transmission Company, LLC </HD>
        <DEPDOC>[Docket No. ER03-1154-000] </DEPDOC>
        <P>Take notice that on August 1, 2003, Michigan Electric Transmission Company, LLC (METC) filed an executed Wholesale Distribution Service Agreement (Agreement) with Consumers Energy Company (Consumers). METC seeks an effective date of September 1, 2003. </P>
        <P>METC states that a copy of this filing has been served on Consumers and the Midwest ISO. </P>
        <P>
          <E T="03">Comment Date:</E> August 22, 2003. </P>
        <HD SOURCE="HD1">7. California Independent System Operator Corporation </HD>
        <DEPDOC>[Docket No. ER03-1155-000] </DEPDOC>
        <P>Take notice that on August 1, 2003, the California Independent System Operator Corporation (ISO) tendered for filing Amendment No. 1 to the Interconnected Control Area Operating Agreement (ICAOA) between the ISO and Sacramento Municipal Utility District (SMUD). The ISO requests that the agreement be made effective as of July 7, 2003. ISO states that the purpose of Amendment No. 1 is to revise Service Schedule 6 (Real-Time Operating Limits) to update certain rating information for the Hurley Interconnection and for the Elverta Interconnection. </P>
        <P>The ISO states that this filing has been served on SMUD and the Public Utilities Commission of the State of California. </P>
        <P>
          <E T="03">Comment Date:</E> August 22, 2003. </P>
        <HD SOURCE="HD1">8. Soyland Power Cooperative, Inc. </HD>
        <DEPDOC>[Docket No. ES03-47-000] </DEPDOC>
        <P>Take notice that on August 1, 2003, Soyland Power Cooperative, Inc. (Soyland), filed an application for authorization to issue and pledge up to and including $18,000,000 of debt securities under Section 204 of the Federal Power Act, and a request for waiver of the competitive bidding requirements and negotiated placement requirements of 18 CFR 34.2(a). Soyland requests expedited treatment of its application. </P>
        <P>
          <E T="03">Comment Date:</E> August 27, 2003. </P>
        <HD SOURCE="HD1">9. Soyland Power Cooperative, Inc. </HD>
        <DEPDOC>[Docket No. ES03-48-000] </DEPDOC>
        <P>Take notice that on August 1, 2003, Soyland Power Cooperative, Inc. (Soyland), filed an application for authorization to issue and pledge up to and including $2,858,000 of debt securities under Section 204 of the Federal Power Act, and a request for waiver of the competitive bidding requirements and negotiated placement requirements of 18 CFR 34.2(a). Soyland requests expedited treatment of its application. </P>
        <P>
          <E T="03">Comment Date:</E> August 27, 2003. </P>
        <HD SOURCE="HD1">10. Soyland Power Cooperative, Inc. </HD>
        <DEPDOC>[Docket No. ES03-49-000] </DEPDOC>

        <P>Take notice that on August 1, 2003, Soyland Power Cooperative, Inc. (Soyland), filed an application for authorization to issue and pledge up to and including $20,000,000 of debt securities under Section 204 of the Federal Power Act, and a request for <PRTPAGE P="48899"/>waiver of the competitive bidding requirements and negotiated placement requirements of 18 CFR 34.2(a). Soyland requests expedited treatment of its application. </P>
        <P>
          <E T="03">Comment Date:</E> August 27, 2003. </P>
        <HD SOURCE="HD1">Standard Paragraph</HD>

        <P>Any person desiring to intervene or to protest this filing should file with the Federal Energy Regulatory Commission, 888 First Street, NE., Washington, DC 20426, in accordance with Rules 211 and 214 of the Commission's Rules of Practice and Procedure (18 CFR 385.211 and 385.214). Protests will be considered by the Commission in determining the appropriate action to be taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a party must file a motion to intervene. All such motions or protests should be filed on or before the comment date, and, to the extent applicable, must be served on the applicant and on any other person designated on the official service list. This filing is available for review at the Commission or may be viewed on the Commission's Web site at <E T="03">http://www.ferc.gov</E> , using the “FERRIS” link. Enter the docket number excluding the last three digits in the docket number field to access the document. For assistance, contact FERC Online Support at <E T="03">FERCOnlineSupport@ferc.gov</E> or toll-free at (866)208-3676, or for TTY, contact (202)502-8659. Protests and interventions may be filed electronically via the Internet in lieu of paper; <E T="03">see</E> 18 CFR 385.2001(a)(1)(iii) and the instructions on the Commission's Web site under the “e-Filing” link. The Commission strongly encourages electronic filings. </P>
        <SIG>
          <NAME>Magalie R. Salas, </NAME>
          <TITLE>Secretary. </TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20852 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 6717-01-P </BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF ENERGY </AGENCY>
        <SUBAGY>Federal Energy Regulatory Commission </SUBAGY>
        <DEPDOC>[Docket No. ER01-3155-005, et al.] </DEPDOC>
        <SUBJECT>New York Independent System Operator, Inc., et al., Electric Rate and Corporate Filings </SUBJECT>
        <DATE>August 6, 2003. </DATE>
        <P>The following filings have been made with the Commission. The filings are listed in ascending order within each docket classification. </P>
        <HD SOURCE="HD1">1. New York Independent System Operator, Inc. </HD>
        <DEPDOC>[Docket Nos. ER01-3155-005, ER01-1385-014 and EL01-45-013] </DEPDOC>
        <P>Take notice that on July 11, 2003, New York Independent System Operator, Inc. (NYISO) tendered for filing with the Federal Energy Regulatory Commission (Commission) its response to the Commission's Order on Requests for Rehearing and Motion dated June 5, 2003 in Docket Nos. ER01-3155-003, ER01-1285-012 and EL01-45-011. </P>
        <P>
          <E T="03">Comment Date:</E> August 20, 2003. </P>
        <HD SOURCE="HD1">2. Portland General Electric Company </HD>
        <DEPDOC>[Docket No. ER03-1019-001] </DEPDOC>
        <P>Take notice that on August 1, 2003, Portland General Electric Company (PGE) tendered for filing Amended Revised Tariff Sheets to the Second Revised Volume No. 8 of PGE's FERC Electric Tariff. PGE states that the revisions are intended to broaden the application of Energy Imbalance Service Schedule 4 pursuant to PGE's Open Access Transmission Tariff (OATT), effective April 2, 2001. </P>
        <P>PGE requests a waiver of the Commission's 60-day notice requirement and an effective date of June 1, 2003. PGE states that a copy of the filing was served upon the Oregon Public Utility Commission. </P>
        <P>
          <E T="03">Comment Date:</E> August 22, 2003. </P>
        <HD SOURCE="HD1">3. Ameren Services Company </HD>
        <DEPDOC>[Docket No. ER03-1146-000] </DEPDOC>
        <P>Take notice that on August 1, 2003, Ameren Services Company (ASC) tendered for filing Service Agreements for Network Integration Transmission Service and a Network Operating Agreement between ASC and the City of Jackson, Missouri (Customer). ASC states that the purpose of the Agreement is to permit ASC to provide transmission service to Customer pursuant to Ameren=s Open Access Transmission Tariff. </P>
        <P>
          <E T="03">Comment Date:</E> August 22, 2003. </P>
        <HD SOURCE="HD1">4. Ameren Services Company </HD>
        <DEPDOC>[Docket No. ER03-1147-000] </DEPDOC>
        <P>Take notice that on August 1, 2003, Ameren Services Company (ASC) tendered for filing Service Agreements for Network Integration Transmission Service and a Network Operating Agreement between ASC and Ameren Energy Marketing Company as agent for Caterpillar (Customer). ASC asserts that the purpose of the Agreement is to permit ASC to provide transmission service to Customer pursuant to Ameren's Open Access Transmission Tariff. </P>
        <P>
          <E T="03">Comment Date:</E> August 22, 2003. </P>
        <HD SOURCE="HD1">5. New England Power Pool </HD>
        <DEPDOC>[Docket No. ER03-1148-000] </DEPDOC>
        <P>Take notice that on August 1, 2003, the New England Power Pool (NEPOOL) Participants Committee filed for acceptance materials to permit NEPOOL to expand its membership to include Powerex Corp. (Powerex), and to terminate the membership of SmartEnergy, Inc. (SmartEnergy). The Participants Committee requests a August 1, 2003 effective date for commencement of participation in NEPOOL by Powerex and a July 1, 2003 effective date for the termination of SmartEnergy. </P>
        <P>The Participants Committee states that copies of these materials were sent to the New England state governors and regulatory commissions and the Participants in NEPOOL. </P>
        <P>
          <E T="03">Comment Date:</E> August 22, 2003. </P>
        <HD SOURCE="HD1">6. Reliant Energy Services, Inc., as agent for Reliant Energy Hunterstown, LLC </HD>
        <DEPDOC>[Docket No. ER03-1164-000] </DEPDOC>
        <P>Take notice that on August 1, 2003, Reliant Energy Services, Inc., as agent for Reliant Energy Hunterstown, LLC (Hunterstown, LLC) tendered for filing, pursuant to Section 205 of the Federal Power Act (16 U.S.C.824d), and part 35 of the Federal Energy Regulatory Commission's Rules of Practice and Procedure, a rate schedule for reactive power to be provided to the PJM Interconnection, LLC transmission grid. Hunterstown, LLC requests an effective date of September 1, 2003. </P>
        <P>
          <E T="03">Comment Date:</E> August 22, 2003. </P>
        <HD SOURCE="HD1">7. Texas-New Mexico Power Company </HD>
        <DEPDOC>[Docket No. ES03-45-000] </DEPDOC>
        <P>Take notice that on July 31, 2003, Texas-New Mexico Power Company (Texas-New Mexico) submitted an application pursuant to section 204 of the Federal Power Act seeking authorization to issue long-term, unsecured debt in an amount not to exceed $250 million. </P>
        <P>Texas-New Mexico also requests a waiver from the Commission's competitive bidding and negotiated placement requirements at 18 CFR 34.2. </P>
        <P>
          <E T="03">Comment Date:</E> August 27, 2003. </P>
        <HD SOURCE="HD1">8. Florida Keys Electric Cooperative Association, Inc. </HD>
        <DEPDOC>[Docket No. ES03-46-000] </DEPDOC>

        <P>Take notice that on August 1, 2003, Florida Keys Electric Cooperative Association, Inc. (Florida Keys) submitted an application pursuant to section 204 of the Federal Power Act <PRTPAGE P="48900"/>seeking authorization to issue long-term, mortgage notes in an amount equal to $11.2 million. Florida Keys also requests a waiver from the Commission's competitive bidding and negotiated placement requirements at 18 CFR 34.2. </P>
        <P>
          <E T="03">Comment Date:</E> August 27, 2003. </P>
        <HD SOURCE="HD1">Standard Paragraph</HD>

        <P>Any person desiring to intervene or to protest this filing should file with the Federal Energy Regulatory Commission, 888 First Street, NE., Washington, DC 20426, in accordance with Rules 211 and 214 of the Commission's Rules of Practice and Procedure (18 CFR 385.211 and 385.214). Protests will be considered by the Commission in determining the appropriate action to be taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a party must file a motion to intervene. All such motions or protests should be filed on or before the comment date, and, to the extent applicable, must be served on the applicant and on any other person designated on the official service list. This filing is available for review at the Commission or may be viewed on the Commission's Web site at <E T="03">http://www.ferc.gov</E> , using the “FERRIS” link. Enter the docket number excluding the last three digits in the docket number field to access the document. For assistance, please contact FERC Online Support at <E T="03">FERCOnlineSupport@ferc.gov</E> or toll-free at (866)208-3676, or for TTY, contact (202)502-8659. Protests and interventions may be filed electronically via the Internet in lieu of paper; <E T="03">see</E> 18 CFR 385.2001(a)(1)(iii) and the instructions on the Commission's Web site under the “e-Filing” link. The Commission strongly encourages electronic filings. </P>
        <SIG>
          <NAME>Magalie R. Salas, </NAME>
          <TITLE>Secretary.</TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20853 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 6717-01-P </BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">ENVIRONMENTAL PROTECTION AGENCY </AGENCY>
        <DEPDOC>[ER-FRL-6642-9] </DEPDOC>
        <SUBJECT>Environmental Impact Statements and Regulations; Availability of EPA Comments</SUBJECT>
        <P>Availability of EPA comments prepared pursuant to the Environmental Review Process (ERP), under Section 309 of the Clean Air Act and Section 102(2)(c) of the National Environmental Policy Act as amended. Requests for copies of EPA comments can be directed to the Office of Federal Activities at (202) 564-7167. An explanation of the ratings assigned to draft environmental impact statements (EISs) was published in FR dated April 4, 2003 (68 FR 16511).</P>
        <HD SOURCE="HD1">Draft EISs</HD>
        <P>
          <E T="03">ERP No. D-AFS-E65061-SC Rating EC2,</E> Sumter National Forest Revised Land and Resource Management Plan, Implementation, Oconee, Chester, Fairfield, Laurens, Newberry, Union-Abbeville, Edgefield, Greenwood, McCormick and Saluda Counties, SC. </P>
        <P>
          <E T="03">Summary:</E> EPA has environmental concerns related primarily to water quality improvement goals and objectives for the National Forest. EPA recommends inclusion of several forest-wide goals, objectives and standards to improve water quality and identified several individual, watershed-specific, management prescriptions for implementation.</P>
        <P>
          <E T="03">ERP No. D-AFS-E65062-TN Rating EC2,</E> Cherokee National Forest Revised Land and Resource Management Plan, Implementation, Carter, Cocke, Greene, Johnson, McMinn, Monroe, Polk, Sullivan and Unicoil, TN.</P>
        <P>
          <E T="03">Summary:</E> EPA has environmental concerns related primarily to water quality improvement goals and objectives for the National Forest. EPA recommends inclusion of several forest-wide goals, objectives and standards to improve water quality and identified several individual, watershed-specific, management prescriptions for implementation.</P>
        <P>
          <E T="03">ERP No. D-AFS-E65063-GA Rating EC2,</E> Chattahoochee-Oconee National Forests Revised Land and Resource Management Plan, Implementation, several Counties, GA. </P>
        <P>
          <E T="03">Summary:</E> EPA has environmental concerns related primarily to water quality improvement goals and objectives for the National Forest. EPA recommends inclusion of several forest-wide goals, objectives and standards to improve water quality and identified several individual, watershed-specific, management prescriptions for implementation.</P>
        <P>
          <E T="03">ERP No. D-AFS-E65064-AL Rating EC2,</E> Alabama National Forests Revised Land and Resource Management Plan, Implementation, Bankhead National Forest, Lawrence, Winston and Franklin Counties, AL.</P>
        <P>
          <E T="03">Summary:</E> EPA has environmental concerns related primarily to water quality improvement goals and objectives for the National Forest. EPA recommends inclusion of several forest-wide goals, objectives and standards to improve water quality and identified several, watershed-specific, management prescriptions for implementation.</P>
        <P>
          <E T="03">ERP No. D-AFS-J65382-SD Rating EC2,</E> Elk Bugs and Fuels Project, Vegetation Management to Reduce the Spread of Mountain Pine Beetles and the Threat and Severity of Potential Wildfires, Black Hills National Forest Land and Resource Management Plan, Implementation, Northern Hills Ranger District, Black Hills National Forest, Lawrence and Meade Counties, SD. </P>
        <P>
          <E T="03">Summary:</E> EPA expressed environmental concerns about adverse impacts of erosion on water quality and riparian habitat, sedimentation of streams and water-storage reservoirs, fish and wildlife impacts to sensitive species; and noxious weeds. EPA recommended focusing fire reducing treatments to wildland-private land interface, allowing large, fire-resistant trees to remain for wildlife habitat in the back country, and maximizing use of existing roads and reducing new roads near private lands. </P>
        <P>
          <E T="03">ERP No. D-BLM-J01080-WY Rating EC2,</E> West Hay Creek Coal Lease Application, Federal Coal Leasing, Buckskin Mine, Powder River Basin, Campbell County, WY. </P>
        <P>
          <E T="03">Summary:</E> EPA expressed environmental concerns with potential impacts to air quality in the Powder River Basin, nitrogen oxides from blasting and wetlands loss. </P>
        <P>
          <E T="03">ERP No. D-DOD-A09832-00 Rating LO,</E> Mercury Management Project, Site Selection and Implementation of a Long-Term (<E T="03">i.e.</E>, 40 Years) Management Plan for the Defense Stockpile of Elemental Mercury, Hawthore, NV; New Haven, IN; Oak Ridge, TN; Romulus, NY; Somerville, NJ; Tooele, UT and Warren, OH. </P>
        <P>
          <E T="03">Summary:</E> EPA had no objection to the proposed action. </P>
        <P>
          <E T="03">ERP No. D-DOD-A10075-00 Rating LO,</E> Programmatic EIS—Chemical and Biological Defense Program, Protection of our Soldiers, Sailors, Marines and Airmen on the Battlefield, United States and other Countries. </P>
        <P>
          <E T="03">Summary:</E> EPA had no objection to the proposed action. </P>
        <P>
          <E T="03">ERP No. D-DOE-C22003-NY Rating LO,</E> West Valley Demonstration Project, Waste Management, Onsite Management and Offsite Transportation of Radioactive Waste, West Valley, Cattaraugus County, NY. </P>
        <P>
          <E T="03">Summary:</E> EPA has no objections to the implementation of the proposed project. </P>
        <P>
          <E T="03">ERP No. D-DOE-L91018-OR Rating LO,</E> Northeast Oregon Hatchery Program, Grande Ronde—Imnaha Spring Chinook Hatchery Modification <PRTPAGE P="48901"/>and Modernization of Two Existing Hatchery Facilities and Construction of Three New Auxiliary Hatchery Facilities, Wallowa County, OR. </P>
        <P>
          <E T="03">Summary:</E> EPA requested additional information in the final EIS to support the need for the hatchery facilities. EPA also requested clarification on: cumulative impacts collection, maintenance and operation criteria; future facility plans and consultation with Native American Tribes. </P>
        <P>
          <E T="03">ERP No. D-FHW-F40412-OH Rating EC1,</E> OH-161/37 Improvement, from OH-161 (New Albany Bypass) to west of OH-161/37 Interchange with OH-16, Funding, Franklin and Licking Counties, OH. </P>
        <P>
          <E T="03">Summary:</E> EPA has environmental concerns with the preferred alternative, specifically with impacts to wetlands, floodplains/streams, and groundwater resources. EPA recommends that the FEIS include specific mitigation measures to minimize these impacts. </P>
        <P>
          <E T="03">ERP No. D-FTA-E54012-FL Rating EC1,</E> MIC/Earlington Heights Connector Study, Earlington Heights Metrorail Station to the Miami-Dade Intermodal Center (MIC) Transit Improvements, Funding and NPDES, U.S. Army COE Section 10 and U.S. Coast Guard Bridge Permits Issuance, Miami-Dade County, FL. </P>
        <P>
          <E T="03">Summary:</E> EPA has environmental concerns with the proposed project regarding potential impacts to floodplains, aquatic resources, and wildlife and aquatic habitat as well as concerns regarding visual and noise impacts. </P>
        <P>
          <E T="03">ERP No. D-NRC-E05101-SC Rating EC1,</E> H.B. Robinson Steam Electric Plant, Unit No. 2 (RNP), Application for Operating License Renewal of Nuclear Plants for 20-Years, Supplement 13, located on the Shore of Lake Robinson, Darlington and Chesterfield Counties, SC. </P>
        <P>
          <E T="03">Summary:</E> EPA notes that radiological monitoring of all plant effluents, and appropriate storage and disposition of radioactive waste, will be necessary during the license renewal period. </P>
        <P>
          <E T="03">ERP No. D-USA-C11021-NY Rating LO,</E> Thomas Jefferson Hall and Other Construction Activities in the Cadet Zone of the United States Military Academy, Implementation, West Point, Hudson River Valley, Orange and Putnam Counties, NY. </P>
        <P>
          <E T="03">Summary:</E> EPA has no objections to the implementation of the proposed project. </P>
        <P>
          <E T="03">ERP No. DC-NOA-B91017-00 Rating LO,</E> Atlantic Sea Scallop Fishery Management Plan (FMP), Amendment 10, Introduction of Spatial Management of Adult Scallops, Essential Fish Habitat (EFH), from the Gulf of Maine and Georges Banks to Cape Hatteras, NC. </P>
        <P>
          <E T="03">Summary:</E> While EPA has no objection to the proposed action, it was suggested that public comments and additional data on protected species be included in the final document. </P>
        <P>
          <E T="03">ERP No. DS-DOE-A06178-00 Rating LO,</E> Programmatic EIS—Stockpile and Management for a Modern Pit Facility (MPF) Construction and Operation, Site Location: Savannah River Site, SC; Los Alamos Site, NM; Nevada Test Site; Carlsbad Site, NM; and Pantex Site, TX, and Plutonium Pit Manufacturing Capabilities Upgrading at Los Alamos National Laboratory (LANL), NM. </P>
        <P>
          <E T="03">Summary:</E> EPA does not object to the proposed action, but requests that the final EIS address several technical comments. </P>
        <HD SOURCE="HD1">Final EISs </HD>
        <P>
          <E T="03">ERP No. F-AFS-H65014-MO,</E> Pineknot Woodland Restoration Project, Open Shortleaf Pine Woodland Restoration, Implementation, Doniphan/Eleven Point Ranger District, Mark Twain National Forest, Carter County, MO. </P>
        <P>
          <E T="03">Summary:</E> EPA's concerns regarding old growth designations, water quality and soil protection, and a smoke/fire management plan have been adequately addressed. </P>
        <P>
          <E T="03">ERP No. F-COE-G39034-TX,</E> Bayport Channel Container/Cruise Terminal Project, Marine Terminal Complex Construction and Operation, Bayport Ship Channel, U.S. Army COE Section 10 and 404 Permits Issuance, Harris County, TX. </P>
        <P>
          <E T="03">Summary:</E> EPA expressed environmental concern that impacts to wetlands should be fully mitigated and that a mitigation plan be incorporated in the Record of Decision and be made a condition to the Section 10/404 Corps of Engineers permit. </P>
        <P>
          <E T="03">ERP No. F-FHW-E50293-00,</E> Louisville-Southern Indiana Ohio River Bridges Project, Cross-River Mobility Improvement between Jefferson County, KY and Clark County, ID, Coast Guard Bridge and U.S. Army COE Section 10 and 404 Permits Issuance, Jefferson County, KY and Clark County, IN. </P>
        <P>
          <E T="03">Summary:</E> EPA has environmental concerns with the proposed project regarding traffic noise, environmental justice issues, surface water quality, upland forest losses, and loss of agricultural lands. Air quality conformity is a particular area of concern. EPA recommends that all reasonable and feasible mitigation measures be identified in the Record of Decision. </P>
        <P>
          <E T="03">ERP No. F-FRC-J03015-00,</E> Grasslands Pipeline Project, Interstate Natural Gas Pipeline System Construction and Operation, Docket No. CP02-037-000, WY, ND and MT. </P>
        <P>
          <E T="03">Summary:</E> FERC and the project proponent made some revisions in response to EPA's comments, to reduce wetland and aquatic impacts. The project proponent agreed to directionally drill its Sandstone Creek crossing, to eliminate water quality impacts to that sensitive, perennial stream. EPA requested that a plan be developed to prevent and monitor noxious weed introduction and spread before project construction begins. EPA expressed concerns that cumulative environmental impacts from related gas production projects were not addressed in the EIS. </P>
        <P>
          <E T="03">ERP No. F-NOA-E91010-00,</E> Amendment 13 to the Fishery Management Plan for Summer Flounder, Scup, and Black Sea Bass, Implementation, in the Western Atlantic Ocean, from Cape Harteras, NC, northward to the US-Canadian Border. </P>
        <P>
          <E T="03">Summary:</E> While EPA has no objection to the proposed action, EPA did request some clarification information regarding wet storage of fishing pots/traps and the tag program. </P>
        <P>
          <E T="03">ERP No. FS-COE-E67003-FL,</E> PCS Phosphate—White Springs Mine Continuation Mining Operations, Proposal to Discharge Dredged/ Fill Material into 1,858 Acres of Jurisdictional Wetlands, Applications of “Life of Mine” Permits, Hamilton County, FL. </P>
        <P>
          <E T="03">Summary:</E> EPA noted that although most of its requests for technical data were provided, there were some environmental concerns that some data was not readily available in the Final EIS and had to be obtained from a project Web site. </P>
        <SIG>
          <DATED>Dated: August 12, 2003. </DATED>
          <NAME>Joseph C. Montgomery, </NAME>
          <TITLE>Director, NEPA Compliance Division, Office of Federal Activities. </TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20901 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 6560-50-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">ENVIRONMENTAL PROTECTION AGENCY </AGENCY>
        <DEPDOC>[ER-FRL-6642-8] </DEPDOC>
        <SUBJECT>Environmental Impact Statements; Notice of Availability</SUBJECT>
        <P>
          <E T="03">Responsible Agency:</E> Office of Federal Activities, General Information (202) 564-7167 or <E T="03">http://www.epa.gov/compliance/nepa/.</E>
        </P>
        
        <PRTPAGE P="48902"/>
        <FP SOURCE="FP-1">Weekly receipt of Environmental Impact Statements </FP>
        <FP SOURCE="FP-1">Filed August 4, 2003 Through August 8, 2003 </FP>
        <FP SOURCE="FP-1">Pursuant to 40 CFR 1506.9.</FP>
        
        <FP SOURCE="FP-1">
          <E T="03">EIS No. 030365, Final EIS, NPS, PA,</E> Living With The River: Schuylkill River Valley National Area Management Plan, Implementation, Schuylkill, Chester, Philadelphia, Belks, and Montgomery Counties, PA, Wait Period Ends: September 8, 2003, Contact: Peter Samuel (215) 597-1848. </FP>
        <P>The above NPS EIS should have appeared in the 8/8/2003 <E T="04">Federal Register</E>. The 30-day Wait Period is Calculated from 8/8/2003.</P>
        <FP SOURCE="FP-1">
          <E T="03">EIS No. 030366, Final EIS, NPS, NC,</E> Carl Sandburg Home National Historic Site, General Management Plan, Implementation, Located in the Village of Flat Rock, Henderson County, NC, Wait Period Ends: September 15, 2003, Contact: Connie Hudson-Bucklund (828) 693-4179. </FP>
        <FP SOURCE="FP-1">
          <E T="03">EIS No. 030367, Draft EIS, IBR, CA,</E> Freeport Regional Water Project, To Construct and Operate a Water Supply Project to Meet Regional Water Supply Needs, Sacramento County Water Agency  (SCWA) and the East Bay Municipal Utility District (EBMUD), Alameda, Contra Costa, San Joaquin, Sacramento Counties, CA, Comment Period Ends: September 29, 2003, Contact: Rod Schroeder (916) 989-7274.</FP>
        <FP SOURCE="FP-1">
          <E T="03">EIS No. 030368, Draft EIS, NPS, AZ,</E> Coronado National Memorial General Management Plan, Implementation, Cochise County, AZ, Comment Period Ends: October 14, 2003, Contact: John Paige (303) 969-2356.</FP>
        <FP SOURCE="FP-1">
          <E T="03">EIS No. 230369, Draft EIS, BLM, OR,</E> Timbered Rock Fire Salvage and Elk Creek Watershed Restoration Project, Implementation, Northwest Forest Plan, Butte Falls Resource Area, Medford District, Douglas, Jackson and Josephine Counties, OR, Comment Period Ends: October 14, 2003, Contact: Jean Williams (541) 944-6620. This document is available on the Internet at: <E T="03">http://www.or.blm.gov/Medford/TimbrockEIS.</E>
        </FP>
        <FP SOURCE="FP-1">
          <E T="03">EIS No. 030370, Draft EIS, BLM, OR,</E> Upper Siuslaw Late-Successional Reserve Restoration Plan, To Protect and Enhance Late-Successional and Old-Growth Forest Ecosystems, Eugene District Resource Management Plan, Northwest Forest Plan, Coast Range Mountains, Lane and Douglas Counties, OR, Comment Period Ends: October 15, 2003, Contact: Rick Colvin (541) 683-6600.</FP>
        <FP SOURCE="FP-1">
          <E T="03">EIS No. 030371, Final EIS, FRC, CA,</E> El Dorado Hydroelectric Project, Application for a New License, South Fork of the American River Basin and Truckee River Basin (FERC NO. 184-065), El Dorado National Forest, Lake Tahoe Basin Management Unit, Alpine, Amador and El Dorado Counties, CA, Wait Period Ends: September 15, 2003, Contact: Susan O'Brien (202) 502-8449. This document is available on the Internet at: <E T="03"> http://www.ferc.gov.</E>
        </FP>
        <FP SOURCE="FP-1">
          <E T="03">EIS No. 030372, Draft Supplement, COE, WV,</E> Lower Mud River at Milton Project, Updated Information on the Milton Local Protection Project, Proposed Flood Damage Reduction Measure, City of Milton, Cabell County, WV, Comment Period Ends: September 29, 2003, Contact: S. Michael Worley (304) 529-5636.</FP>
        <FP SOURCE="FP-1">
          <E T="03">EIS No. 030373, Final Supplement, AFS, CA,</E> Herger-Feinstein Quincy Library Group Forest Act Pilot Project, Proposal to Analyze Options for Maintaining Defensible Fuel Profile Zones (DFPZs), Lassen, Plumas and Tahoe National Forests, Shasta, Lassen, Tehama, Yuba, Plumas and Battle Counties, CA, Wait Period Ends: September 15, 2003, Contact: Linda Kanski (530) 283-7821.</FP>
        <FP SOURCE="FP-1">
          <E T="03">EIS No. 030374, Draft EIS, AFS, CA,</E> South Tahoe Public Utility District (STPUD) B-Line Phase III Wastewater Export Pipeline Replacement Project, Luther Pass Pump Station to U.S. Forest Service Luther Pass Overflow Campground Access Road, Special Use Permit, U.S. Army COE Section 404 and US Fish and Wildlife Service Permits Issuance and EPA Grant, El Dorado and Alpine Counties, CA, Comment Period Ends: September 29, 2003, Contact: Gary Weigel (530) 543-2665.</FP>
        <FP SOURCE="FP-1">
          <E T="03">EIS No. 030375, Final EIS, TVA, TN, NC, VA, Adoption</E>—Patriot Project, Construction and Operation of Mainline Expansion and Patriot Extension in order to Transport 510,000 dekatherms per day (dth/day) of Natural Gas, TN, VA and NC, Contact: Harold M. Draper (865) 632-6889. Tennessee Valley Authority's has adopted the Federal Regulatory Commission's Final EIS, #020401 filed 09-20-2002. TVA was a Cooperating Agency for the above final EIS. Recirculation of the document is not necessary under Section 1506.3(c) of the Council on Environmental Quality Regulations. </FP>
        <SIG>
          <DATED>Dated: August 12, 2003. </DATED>
          <NAME>Joseph C. Montgomery, </NAME>
          <TITLE>Director, NEPA Compliance Division, Office of Federal Activities. </TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20902 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 6560-50-U</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">ENVIRONMENTAL PROTECTION AGENCY</AGENCY>
        <DEPDOC>[OPPT-2003-0033; FRL-7315-3]</DEPDOC>
        <SUBJECT>Solicitation of Applications for Lead-Based Paint Program Grants; Notice of Availability of Funds</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Environmental Protection Agency (EPA). </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This notice announces EPA's intent to enter into cooperative agreements with States, Territories, Indian Tribes, Intertribal Consortia, and the District of Columbia to provide financial assistance for purposes of developing and carrying out EPA-authorized lead-based paint programs.  These programs and this financial assistance are authorized by section 404 of the Toxic Substances Control Act (TSCA).  In order for Indian Tribes and Intertribal Consortia to be eligible for financial assistance under this program, the Indian Tribes must demonstrate that they meet the criteria for treatment as a State.   The total amount of fiscal year (FY) 2003 funding to be awarded to States, Territories, Indian Tribes, Intertribal Consortia, and the District of Columbia for development and implementation of EPA-authorized lead-based paint programs, and for EPA's direct implementation of such programs for those States, Territories, the District of Columbia, and Indian Tribes that do not have EPA-authorized programs is $12.5 million.  For FY2003, the Agency is allocating up to $1.0 million of these funds for the Indian Tribes and Intertribal Consortia.</P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Applications submitted by States, Territories, and the District of Columbia for financial assistance, identified by docket ID number OPPT-2003-0033, must be received by EPA Regional staff on or before September 15, 2003.  Applications submitted by Indian Tribes and Intertribal Consortia for financial assistance, identified by docket ID  number OPPT-2003-0033, must be received by EPA Regional staff on or before September 29, 2003.</P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>

          <P>Applications may be submitted by mail, or in some instances electronically.  Please follow the detailed instructions provided in Unit I. of the <E T="02">SUPPLEMENTARY INFORMATION</E>. To ensure <PRTPAGE P="48903"/>proper receipt by EPA, it is imperative that you identify docket ID number OPPT-2003-0033 in the subject line on the first page of your response. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>
            <E T="03">For general information contact</E>: Barbara Cunningham, Director, Environmental Assistance Division (7408M), Office of Pollution Prevention and Toxics, Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460; telephone number: (202) 554-1404; e-mail address: <E T="03">TSCA-Hotline@epa.gov</E>.</P>
          <P>
            <E T="03">For technical information contact</E>: The appropriate Regional Lead Coordinator listed in Unit I.C. of the <E T="02">SUPPLEMENTARY INFORMATION</E>. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <HD SOURCE="HD1">I.  General Information</HD>
        <HD SOURCE="HD2">A.  Does This Action Apply to Me?</HD>

        <P>This action is directed to States, Territories, eligible Indian Tribes, and Intertribal Consortia, and the District of Columbia to develop and carry out authorized lead-based paint programs under TSCA section 404.  In order for Indian Tribes and Intertribal Consortia to be eligible for financial assistance under this program, the Tribes or Intertribal Consortia must demonstrate that they meet the criteria at 40 CFR 35.693 for treatment as a State. In order for Intertribal Consortia to be eligible for financial assistance under TSCA section 404(g) they must also meet the requirements at 40 CFR 35.504.  If you have any questions regarding the applicability of this action to a particular entity, consult the technical person listed under <E T="02">FOR FURTHER INFORMATION CONTACT</E>.</P>
        <HD SOURCE="HD2">B.  How Can I Get Additional Information, Including Copies of This Document or Other Related Documents?</HD>
        <P>1. <E T="03">Docket</E>.  EPA has established an official public docket for this action under docket identification (ID) number OPPT-2003-0033.  The official public docket consists of the documents specifically referenced in this action.  The official public docket is the collection of materials that is available for public viewing at the EPA Docket Center, Rm. B102-Reading Room, EPA West, 1301 Constitution Ave., NW., Washington, DC.  The EPA Docket Center is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal holidays. The EPA Docket Center Reading Room telephone number is (202) 566-1744 and the telephone number for the OPPT Docket, which is located in EPA Docket Center, is (202) 566-0280.</P>
        <P>2. <E T="03">Electronic access</E>.  You may access this <E T="04">Federal Register</E> document electronically through the EPA Internet under the “<E T="04">Federal Register</E>” listings at <E T="03">http://www.epa.gov/fedrgstr/</E>.</P>

        <P>You may also access this document on the Home Page for the Office of Pollution Prevention and Toxics at <E T="03">http://www.epa.gov/lead</E>.  Select “What's New.”  Hard copies of this document are available from the appropriate Regional Primary Lead person listed in Unit I.C. </P>

        <P>An electronic version of the public docket is available through EPA's electronic public docket and comment system, EPA Dockets.  You may use EPA Dockets at <E T="03">http://www.epa.gov/edocket/</E> to submit or view public comments, access the index listing of the contents of the official public docket, and to access those documents in the public docket that are available electronically. Although not all docket materials may be available electronically, you may still access any of the publicly available docket materials through the docket facility identified in Unit I.B.1.  Once in the system, select “search,” then key in the appropriate docket ID number. </P>
        <HD SOURCE="HD2">C.  How and to Whom Do I Submit an Application?</HD>
        <P>You may submit an application through the mail, or in some instances electronically, to the Regional Lead Coordinator in the appropriate EPA Regional Office. The mailing addresses and contact telephone numbers for these offices are listed below.  To ensure proper receipt by EPA, it is imperative that you identify docket ID number OPPT-2003-0033 in the subject line on the first page of your response.</P>

        <P>Region I:  (Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, and Vermont), Regional Contact--James Bryson, USEPA Region I, One Congress St., Suite 1100 (CPT), Boston, MA 02114-0203; telephone number: (617) 918-1524; e-mail address: <E T="03">bryson.jamesm@epa.gov</E>.</P>

        <P>Region II:  (New Jersey, New York, Puerto Rico, and the Virgin Islands), Regional Contact--Lou Bevilacqua, USEPA Region II, MS-225, 2890 Woodbridge Ave., Edison, NJ 08837; telephone number: (732) 321-6671; e-mail address: <E T="03">bevilacqua.lou@epa.gov</E>.</P>

        <P>Region III:  (Delaware, Maryland, Pennsylvania, Virginia, West Virginia, and the District of Columbia), Regional Contact--Demian Ellis, USEPA Region III, (3WC33), 1650 Arch Street, Philadelphia, PA 19103-2029; telephone number: (215) 814-3114; e-mail address: <E T="03">ellis.demian@epa.gov</E>.</P>

        <P>Region IV:  (Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, and Tennessee), Regional Contact--Keith Bates, USEPA Region IV, 61 Forsyth Street, S.W.,  Atlanta, GA 30303; telephone number: (404) 562-8992; e-mail address: <E T="03">bates.keith@epa.gov</E>.</P>

        <P>Region V:  (Illinois, Indiana, Michigan, Minnesota, Ohio, and Wisconsin), Regional Contact--David Turpin, USEPA Region V (DT-8J), 77 W. Jackson Blvd., Chicago, IL 60604; telephone number: (312) 886-7836; e-mail address: <E T="03">turpin.david@epa.gov</E>.</P>

        <P>Region VI:  (Arkansas, Louisiana, New Mexico, Oklahoma, and Texas), Regional Contact--Eva Steele, USEPA Region VI, 1445 Ross Ave., 12th Floor, Dallas, TX 75202; telephone number: (214) 665-7211; e-mail address: <E T="03">steele.eva@epa.gov</E>.</P>

        <P>Region VII:  (Iowa, Kansas, Missouri, and Nebraska), Regional Contact--Randall Whipple, USEPA Region VII, ARTD/RALI, 901 North 5th, Kansas City, KS 66101; telephone number: (913) 551-7093; e-mail address: <E T="03">whipple.randall@epa.gov</E>.</P>

        <P>Region VIII:  (Colorado, Montana, North Dakota, South Dakota, Utah, and Wyoming), Regional Contact--David Combs, USEPA Region VIII, 999 18th St., Suite 300, Denver, CO 80202; telephone number: (303) 312-6021; e-mail address: <E T="03">combs.dave@epa.gov</E>.</P>

        <P>Region IX:  (Arizona, California, Hawaii, Nevada, American Samoa, and Guam), Regional Contact--Mary Aycock, USEPA Region IX, (CMD-4-2), 75 Hawthorne St., San Francisco, CA 94105; telephone number: (415) 947-4169; e-mail address: <E T="03">aycock.mary@epa.gov</E>.</P>

        <P>Region X:  (Alaska, Idaho, Oregon, and Washington), Regional Contact--Barbara Ross, USEPA Region X, Solid Waste and Toxics Unit (WCM-128), 1200 Sixth Ave., Seattle, WA 98101; telephone number: (206) 553-1985; e-mail address: <E T="03">ross.barbara@epa.gov</E>.</P>
        <HD SOURCE="HD2">D.  What Should I Consider as I Prepare My Application for EPA?</HD>
        <P>1. <E T="03">Purpose and scope</E>.  EPA awards non-matching cooperative agreements under TSCA section 404(g) to States, Territories, eligible Indian Tribes and Intertribal Consortia, and the District of Columbia to develop and carry out authorized lead-based paint programs.  The term “Territory” includes the Commonwealth of Puerto Rico, the Virgin Islands, Guam, American Samoa, the Northern Mariana Islands, and any other Territory or possession of the United States.  Also, hereinafter, the term “States” includes the “District of Columbia.”  In the past, recipients of the grants have used the funds to assist in program development and prepare for <PRTPAGE P="48904"/>program authorization.  EPA intends to continue to support the development and authorization of these programs as well as implementation of authorized programs as budget constraints allow.  This Notice has been developed based on the knowledge that some States, Tribes, and Territories have received authorization and that several States and Indian Tribes are continuing to develop their programs.  This Notice addresses the criteria EPA will consider when evaluating the grant proposals submitted to the Agency.</P>
        <P>Under TSCA section 404, EPA authorizes States, Territories, and eligible Indian Tribes and Intertribal Consortia to administer lead-based paint programs in lieu of the corresponding Federal program.  These lead-based paint programs are intended to reduce the incidence of childhood lead poisoning by ensuring that individuals conducting lead-based paint activities are properly trained and certified and that renovation contractors provide lead-hazard information to building owners and residents.   EPA issued regulations to establish these lead-based paint programs under the authority of TSCA sections 402 and 406.</P>
        <P>In 40 CFR part 745, subpart L, EPA promulgated regulations pursuant to TSCA section 402 that cover the training and certification of individuals engaged in lead-based paint activities.  In 40 CFR part 745, subpart E, EPA issued regulations pursuant to TSCA section 406.  The regulation requires persons performing renovation in residential housing to provide a lead hazard information pamphlet to the owner and occupant of the housing prior to renovation.  The procedures for authorizing States, Territories, and eligible Indian Tribes and Intertribal Consortia to implement these lead-based paint programs are found at 40 CFR part 745, subpart Q.</P>
        <P>2. <E T="03">Goal and objectives</E>.  Pursuant to Title IV of TSCA, EPA encourages States, Territories, Indian Tribes, and Intertribal Consortia to seek authorization of their own lead-based paint programs.  EPA's goal is to have authorized programs in all States and a large number of Territories, and on a large number of Indian Tribal lands.  EPA therefore recommends that parties seek funding through the TSCA Title IV section 404(g) assistance program, which is being implemented to assist with development and implementation of lead-based paint programs.</P>

        <P>Since 1994, EPA has been offering financial assistance under TSCA section 404(g) in the form of cooperative agreements without matching-fund requirements.  In the upcoming funding cycle, the Agency will continue to work with eligible applicants to develop cooperative agreements consistent with the objectives critical to the ultimate success of implementation of a national lead program, with the emphasis on State, Territorial, Indian Tribal, and Intertribal Consortium programs.  Although EPA's goal is to have authorized programs in all States and a large number of Territories, and on a large number of Indian Tribal lands, the Agency and Congress anticipated that there would be a number of States, Territories, and Indian Tribes that would not seek program authorization.  Consistent with authority granted in the Agency's FY 1998 Appropriation Act (Ref. 1), and the provisions contained within, EPA is authorized to use section 404(g) funds to implement a Federal lead-based paint program for non-authorized States, Territories, and Indian Tribes.  See 40 CFR 35.116 and 40 CFR 35.516.  [<E T="03">Note</E>: Where the Agency has direct implementation responsibilities, EPA cannot provide financial assistance under this grant program to non-authorized States, Indian Tribes, or Intertribal Consortia, or Territories to assist the Agency in implementing and enforcing a Federal program under TSCA section 404(h).]</P>
        <P>The cooperative agreements must be used to develop and implement authorized programs.  States, Territories, Indian Tribes, and Intertribal Consortia that do not have authorized programs may receive cooperative agreement funding, but only for the continued development of lead-based paint programs which will meet the requirements of TSCA Title IV.  To receive continued funding, States, Territories, Indian Tribes, and Intertribal Consortia without an authorized program must be making progress toward an authorized program.  Therefore, the Regional Offices, as part of their grant oversight responsibilities, will work with the grantees to determine the appropriate amount of continued funding based upon the amount of developmental work to be completed as the grantee makes progress toward authorization.  Eligible parties may utilize this grant support in a way that complements and does not duplicate activities for which they already receive or could receive financial assistance from other Federal sources (e.g., Center for Disease Control (CDC) and U.S. Department of Housing and Urban Development (HUD)).</P>

        <P>This section 404(g) Notice is one of two Notices that announce the availability of funds for Indian Tribes and Intertribal Consortia conducting various lead-based paint activities.  A separate <E T="04">Federal Register</E> notice titled <E T="03">Educational Outreach and Baseline Assessment of Existing Exposure and Risks of Exposure to Lead Poisoning of Tribal American Children</E>, also called Title X Tribal Lead Grant Program,   will be published at a later date.  As stated in this unit, Indian Tribes and Intertribal Consortium, as well as all grantees, will not be awarded grants to fund the same activities from more than one source.  Although a Tribe may apply to receive grant funding from both Notices, they each have very distinct objectives.  The grant program opportunities described in the other Notice may serve as precursors to, but not as equivalents or supplements to, the section 404(g) lead-based paint grant program described in this Notice.  Grant funds will not be awarded to Tribes who apply for both grant programs during the same time. The section 404(g) lead-based paint grant program, for which funding is provided in this Notice, involves infrastructure development for the anticipated implementation of a lead program and does not include activities (testing for lead in blood, paint, dust, or soil samples, or general outreach and education activities) listed in the other Notice. </P>
        <P>Under TSCA, authorized lead-based paint training and certification programs are required to collect fees to cover certain costs incurred by the program.  These fees are considered “program income,” which is defined as “gross income received by a grantee or subgrantee directly generated by a grant supported activity, or earned only as a result of the grant agreement during the grant period.”  See 40 CFR 31.25(b).  It includes income from fees for services performed by the recipient.  Program income generated by activities supported under TSCA section 404(g) grants may include fees that a State, Territory, Indian Tribe, or Intertribal Consortium charges for training, accreditation, certification, licensing or other services performed by the lead training and certification programs, as well as fees that are collected which provide for enforcement of standards and regulations.  Consequently, States, Indian Tribes, Intertribal Consortia, and Territories must comply with the rules governing “program income,” found at 40 CFR 31.25, and use the funds generated by grant supported activities to assist with program operation costs. </P>
        <P>3. <E T="03">Eligibility</E>.     States, Territories, Indian Tribes, and Intertribal Consortia are eligible to apply for financial assistance under this program if they are either implementing an EPA-authorized lead-based paint program pursuant to 40 CFR part 745, subpart Q or developing <PRTPAGE P="48905"/>a lead-based paint program that may be authorized in the future.  However, funds will be awarded based upon the progress made by the applicant in developing an acceptable program, including implementing regulations.  Failure to make satisfactory progress toward program authorization will result in a State, Territory, Indian Tribe, or Intertribal Consortium not receiving funding.  The EPA Regional Offices, as part of their grant oversight responsibilities, will have discretion with respect to determining whether sufficient progress is being made by a given State, Territory, Indian Tribe, and/or Intertribal Consortium toward the development and implementation of a program under TSCA Title IV.</P>
        <P>States, Territories, eligible Indian Tribes and Intertribal Consortia may choose to combine section 404(g) grant funds with other environmental program grants as part of a performance partnership grant (PPG) if the requirements in 40 CFR 35.130 through 35.138 (which apply to States) and 40 CFR 35.530 through 35.538 (which apply to Indian Tribes and Intertribal Consortia) are adhered to by the grantee.</P>
        <P>4. <E T="03">Authority</E>.  The TSCA Title IV lead-based paint program is a cooperative agreement program administered by EPA under the authority of section 404(g) of TSCA.  Regulations governing these cooperative agreements are found at 40 CFR part 31 (Uniform Administrative Requirements for Grants and Cooperative Agreements to State and Local Governments).  Regulations which supplement the EPA general assistance regulations found in 40 CFR part 31 are found at 40 CFR part 35, subpart A and subpart B.  Contained within 40 CFR part 35 are specific sections which govern grants and cooperative agreements for the lead-based paint program under section 404(g); 40 CFR 35.270 through 35.273 (applicable to States, Territories, and the District of Columbia), and 40 CFR 35.690 through 35.693 (applicable to Indian Tribes and Intertribal Consortia).  The EPA Regional Offices administer the section 404(g) cooperative agreements pursuant to a delegation of authority which permits the 10 EPA Regional Administrators to enter into cooperative agreements with eligible States, Territories, Indian Tribes, and Intertribal Consortia. </P>
        <P>5. <E T="03">Activities to be funded</E>. This Notice was developed by EPA's Office of Pollution Prevention and Toxics (OPPT) in cooperation with the Agency's 10 Regional Offices, to describe in more detail the required elements of grant agreements  funded under TSCA section 404(g), to describe the eligible activities that will be considered for funding, and to facilitate and support Regional administration of this program.  EPA's list of eligible grant activities includes activities that are outlined as required elements of authorized lead-based paint programs, including development of enabling legislation and regulations, enforcement components, as well as other items associated with performance reporting.  The elements are specified in 40 CFR 745.325 through 745.327, and are repeated in this unit to assist with the development of applicant work plans.</P>
        <P>More recently, EPA promulgated its final TSCA section 403 lead hazard standards.  The hazard standards were published on December 22, 2000, and can be found at 40 CFR part 745, subpart D.  The final TSCA section 403 standards also amended the work practice standards for lead-based paint activities found at 40 CFR 745.227.  These amendments establish clearance standards for dust, limit reuse of abated soil, add a requirement for interpreting composite dust clearance samples, and change risk assessment and clearance sampling requirements to ensure compatibility between sampling results and the TSCA section 403 hazard standards and section 402 clearance standards.  In order to maintain their authorization, authorized State, Territory, Indian Tribe, and Intertribal Consortium lead-based paint activities programs must develop lead hazard and clearance standards that are as protective of human health and the environment as the Federal standards (40 CFR 745.324).   TSCA section 404(g) funds can be utilized by authorized States, Territories, Indian Tribes, and Intertribal Consortia to develop and/or adopt lead hazard standards and clearance standards for lead in soil, dust, and paint.</P>

        <P>Another potential regulatory change should be considered by applicants.  Pursuant to TSCA section 402(c)(3), EPA is developing a program that will integrate both regulatory and voluntary components, to the extent that each is feasible, to govern the conduct of renovation and remodeling activities that create lead-based paint hazards.  As with existing EPA lead-based paint regulations, States, Territories, Indian Tribes, and Intertribal Consortia will be given the opportunity to seek program authorization.  While it may be some time before this program is in place, States, Territories, Indian Tribes, and Intertribal Consortia are encouraged to begin considering the need for such a program in their jurisdiction.  TSCA section 404(g) funds can be utilized to assist in the regulatory component of this program.  In the interim, EPA has developed a model renovators training curriculum titled “Minimizing Lead-Based Paint Hazards During Renovation, Remodeling, and Repainting.”  EPA has made this course available, and is encouraging its use voluntarily until the renovation and remodeling rule is effective.  The course is available on the internet at <E T="03">http://www.epa.gov/lead/rrmodel.htm</E>, and a limited number of printed copies are available from the National Lead Information Center at 1-800-424-LEAD. </P>
        <P>Although the list is not exhaustive, the following activities are eligible for funding under section 404(g) if they are conducted in support of developing and implementing lead-based paint programs authorized pursuant to 40 CFR part 745, subpart Q.  In addition, the Agency will consider for funding other activities which focus on the development and implementation of authorized programs, such as:</P>
        <P>a. Develop and/or adopt lead hazard standards and clearance standards for lead in soil, dust, and paint.</P>
        <P>b. Develop and/or enact enabling legislation.</P>
        <P>c. Adopt implementing regulations.</P>
        <P>d. Develop a system to document certification of inspectors, risk assessors, supervisors, workers and project designers.</P>
        <P>e. Adjust or enhance the appropriate infrastructure to accommodate additional program responsibilities.</P>
        <P>f. Maintain, improve and/or develop the appropriate infrastructure to successfully administer and enforce a program to ensure that individuals engaged in lead-based paint activities are properly trained, that training programs are accredited, and that contractors and firms engaged in such activities are certified.</P>
        <P>g. Maintain, improve and/or develop the appropriate infrastructure to successfully administer and enforce a program to ensure that renovation contractors provide lead-hazard information to building owners and residents.</P>
        <P>h. Oversee the conduct of certified contractors engaged in lead-based paint activities to ensure that they are conducting their activities according to all applicable regulations, including monitoring inspection, risk assessment, and abatement activities per the authorized program.</P>
        <P>i. Oversee accredited training programs per the authorized program.</P>

        <P>j. Develop and/or revise as needed, work practice standards for the conduct of lead-based paint activities associated with inspections, risk assessments, and abatement.<PRTPAGE P="48906"/>
        </P>
        <P>k. Monitor compliance with work practice standards or regulations for the conduct of abatement per the authorized program.</P>
        <P>l. Implement the timely training of enforcement inspectors.</P>
        <P>m. Implement lead-based paint compliance assistance programs.</P>
        <P>n. Implement compliance and enforcement inspection sampling techniques.</P>
        <P>o. Adopt or develop specific lead-based paint hazard values or standards.</P>
        <P>p. Maintain, improve, and/or develop specific procedures and supporting documentation to carry out the enforcement program as described in an authorized program.  Typical activities could include development of administrative or civil action procedures and the associated warning letters, notices of noncompliance, or the equivalent.</P>
        <P>q. Maintain, improve, and/or develop specific procedures and supporting documentation to carry out the tracking of tips and complaints as described in the authorized program.  Typical activities could include development of methods of recording the receipt of complaints, referring lead-based paint complaints to appropriate State or local agencies, tracking the follow-up investigation, tracking any enforcement action associated with the complaint, and notifying citizens of the disposition of their complaints.</P>
        <P>r. Prepare a report per 40 CFR 745.327(d) and/or 40 CFR part 31 grant reporting requirements on the applicant's program progress and performance.</P>
        <P>s. Develop and/or revise as needed, the lead-based paint programs, including regulations or procedures for decertification, suspension, revocation or modification of approvals and certificates.</P>
        <P>t. Develop and/or revise as needed, requirements for the administration of a third-party certification exam.</P>
        <P>u. Develop and/or revise as needed, lead-based paint programs' authority to enter, for purposes of inspection, and other relevant enforcement authorities.</P>
        <P>v. Develop and/or revise as needed, enforcement remedies, procedures, etc.</P>
        <P>w. Maintain, improve and/or develop techniques for targeting lead-based paint activities' inspections.</P>
        <P>x. Improve the timeliness of the processing and follow-up of inspection reports and other information generated through enforcement-related activities associated with a lead-based paint program.</P>
        <P>y. Enhance the capacity to improve compliance with Lead Program laws, and effectively develop and issue enforcement remedies/responses to violations.</P>
        <P>z. Foster activities that would increase the efficiency of an applicant's program to ensure that individuals engaged in lead-based paint activities are properly trained; that training programs are accredited; and that contractors engaged in such activities are certified.  These activities could include initiatives to develop local capacity in low-income and rural areas, to promote increased competition in the regulated community through agreements which permit entities recognized by an outside jurisdiction to operate in the grantees jurisdiction (referred to as “reciprocity”), and similar efforts.</P>
        <P>6. <E T="03">Award and distribution of funds</E>. EPA currently expects that up to $12.5 million of FY2003 appropriated funds will be available during the FY2003 funding cycle for financial assistance under TSCA section 404(g) for awards to States, Territories, Indian Tribes, and Intertribal Consortia for development and implementation of EPA-authorized lead-based paint programs, and for EPA's direct implementation of programs in States, Territories, and Indian Tribes that do not have EPA authorized programs.  Additional TSCA section 404(g) carry-over funds from previous years may also be available from some Regions.  For FY2003 funding, the Agency is setting-aside $1 million of the $12.5 million for eligible Indian Tribes and Intertribal Consortia.  The remaining $11.5 million plus any available carry-over dollars will be used to fund State, Territorial, and Federal lead-based paint programs.</P>
        <P>a. <E T="03">Financial assistance to Indian Tribes and Intertribal Consortia</E>.  Each Indian Tribe and Intertribal Consortium that submits a qualifying proposal and is making sufficient progress toward the development and/or implementation of an acceptable lead-based paint program, as determined by the EPA Regional Offices, may receive base funding of $50,000.  Though Indian Tribes and Intertribal Consortia may submit qualifying proposals, the award of funds will be based upon the applicant's progress in developing an acceptable program, including implementing regulations and seeking program authorization from EPA.  Failure to make satisfactory progress toward program authorization may result in the Indian Tribe or Intertribal Consortium receiving reduced or no funding.  The Regional Offices will have the discretion, as part of their grant oversight responsibilities, to determine if the progress being made toward program authorization is sufficient to warrant funding.  Further distribution of the Indian Tribal and Intertribal Consortia set-aside funds will be dependent upon the number of applicants, the progress that the grantee is making in developing a program, the status of expenditures of previously awarded funds, population, and the relative strength of the proposal.  After the closing date for submittal of Indian Tribe and Intertribal Consortium applications specified in this Notice, EPA Headquarters and Regional Offices will consider each of the proposals, and make decisions about the level of funding to be awarded to each of the applicants.  Following those decisions, EPA Headquarters will transfer the funds to the Regional Offices for award to the Tribes and Intertribal Consortia.   Indian Tribal and Intertribal Consortia set-aside funds are not included in the formula funds pool for States and Territories discussed in Unit I.D.6.b.</P>
        <P>b. <E T="03">Financial assistance to States and Territories</E>.  The process used by EPA for determining award funding levels for States and Territories involves two steps.  EPA Headquarters first determines, based on various factors discussed below, the funding level that will be made available to each of the EPA Regional Offices for grantee awards in the respective regions.  Following distribution of the funds to the EPA Regional Offices, the Regional Offices then make decisions on the actual funding level to be received by each of the grantees.</P>
        <P>The Agency currently uses a three-tiered system to implement step one: The process for deciding the amount of FY2003 cooperative agreement funds that will be distributed to the EPA Regional Offices.  This system is designed to provide a base funding level for each qualified applicant and to provide funding for EPA Headquarters and Regional Offices to address direct program implementation responsibilities, while providing funds targeted to areas with the greatest potential lead burden.  The system accomplishes this first by providing a discretionary funding set-aside that is used to fund special needs among the grantees; second by providing a base funding set-aside for every State and Territorial applicant; and third by providing funding based on a formula that considers the relative lead burden estimated to exist within a State or Territory.</P>

        <P>The discretionary funding set-aside involves setting aside $200,000 of funds for each of the 10 EPA Regional Offices (total $2.0 million) for discretionary funding of grantee activities as well as the Regional direct implementation activities.  These funds are primarily <PRTPAGE P="48907"/>intended to provide each Region with the means of awarding funds to States and Territories based upon the progress that the grantee is making in developing a program, the overall quality of the program, and/or identified needs.  The EPA Regional Offices will also have the discretion to use these dollars to help support the Federal lead-based paint programs in non-authorized States, Territories, and Tribal lands within the Region.</P>
        <P>The base funding set-aside provides a base level of funds for every State and Territorial applicant.  Each State that submits a qualifying proposal and is making sufficient progress toward development and implementation of an authorized lead-based paint program may receive a base funding allotment of $100,000.   Each Territory that submits a qualifying proposal and is making sufficient progress toward implementation of an acceptable program may receive a $50,000 base.  However, base level funding for non-authorized States and Territories may be reduced by the Regional Offices depending on progress made toward the development and/or implementation of acceptable programs.  Funds are also set aside and are apportioned to EPA Regional and EPA Headquarters Offices based upon direct implementation funding needs.  These funds are intended to ensure that EPA has adequate funds to directly implement the lead-based paint program in non-authorized States, Territories, and Indian Tribes.</P>
        <P>Once base and discretionary funding set-asides are accounted for, the remaining State and Territorial funds are allocated through the third tier of the process, which involves allocating funds for every State and Territorial applicant based on a formula that considers the relative lead burden estimated to exist within States and Territories.  States and Territories whose funding requests exceed their base allotments can be given additional funds (“formula funds”) based upon their relative lead burden, and for this exercise, all 50 States, the District of Columbia, and the Territories are used to calculate the formula distribution.</P>
        <P>In calculating the lead burden for the formula rankings, EPA uses readily available data derived from the 2000 Census and the 2001 National Survey of Lead and Allergens in Housing prepared by the U.S. Department of Housing and Urban Development.  The formula uses four factors to generate an estimate of the potential lead problem, or “lead burden,” in each State and Territory.  Two of these factors, the number of housing units with lead-based paint and the number of children under age 6, express the potential magnitude of the lead problem.  The remaining two factors, the percentage of young children in poverty and the number of low-income housing units with lead-based paint, express the potential severity of the problem.</P>
        <P>In determining formula rankings, each State and Territory is scored independently for each factor, and the four individual factor scores for each of the States and Territories are then summed to obtain an overall score for that applicant (a combined factor score).  The combined factor scores of all States and Territories applying for formula funds are then summed, and the percentage of the total sum represented by the individual State's or Territory's score is then identified.  The applicant's formula allotment is determined by multiplying the total formula funding by the percentage scores of the individual State or Territory.</P>
        <P>After funding levels (base, discretionary, and formula set-asides) are determined for each State and Territory, the funds will be pooled for each Region and transferred in bulk to the respective Regional accounts.</P>
        <P>Following distribution of the funds to the Regional Office accounts, then the second step in the distribution process occurs; Regional Offices determining the actual funding level to be received by each of the grantees.  Funding levels per grantee will be determined by the Regional Offices based on the application submitted and may be decreased or increased based on performance and/or by fiscal need, which may include an evaluation of the progress that the grantee is making in developing a program, an evaluation of  the performance of the grantee in implementing a program, an evaluation of expenditures of previously awarded funds, and/or an evaluation of future funding needs.</P>
        <P>7. <E T="03">Submission requirements</E>.   Applicants are directed to 40 CFR part 35, subpart A and subpart B for details on the submission requirements for grant applications.  To be considered for funding, each application must include the following components listed in 40 CFR part 35.104 (applicable to States and Territories) or 40 CFR part 35.505 (applicable to Indian Tribes and Intertribal Consortia): </P>
        <P>i.  Meet the requirements in 40 CFR part 31, subpart B.</P>
        <P>ii. Include a proposed work plan that meets the requirements in 40 CFR 35.107 (for States and Territories) or 40 CFR 35.507 (for Indian Tribes or Intertribal Consortia).</P>
        <P>iii.  Specify the environmental program and the amount of funds requested.</P>
        <P>For TSCA Title IV section 404(g) funding for Indian Tribes, EPA is soliciting pre-application grant proposals prior to the submittal of the forms and certifications listed in this unit.  This pre-application procedure entails the applicants initially submitting only a work plan and a budget.  The Agency will use the applicants' work plans and budgets to select programs to be funded under this grant program.  After EPA conducts a review of all submitted pre-applications, successful applicants will be contacted and requested to submit the other required documents listed in this unit, such as the “Application for Federal Assistance” form (Standard Form 424 or SF424), and the “Budget Information: Non-Construction Programs” form (SF424A).  In addition, as part of the pre-application, Indian Tribes and/or Intertribal Consortia must include all appropriate information to demonstrate that they meet the criteria at 40 CFR 35.693 for treatment as a State.  In order for Intertribal Consortia to be eligible for financial assistance under section 404(g), they must include all appropriate information to demonstrate that they meet the requirements at 40 CFR 35.504 concerning eligibility. </P>
        <P>The following forms and certifications, which are contained in EPA's “Application Kit for Assistance,” must be included in all applications:</P>
        <P>a. Standard Form 424 (Application for Federal Assistance).</P>
        <P>b. Standard Form 424A (Budget Information: Non-Construction Programs).</P>
        <P>c. Standard Form 424B (Assurances: Non-Construction Programs).</P>
        <P>d. Standard Form LLL (Disclosure of Lobbying Activities).</P>
        <P>e. Certification Regarding Debarment and Suspension.</P>
        <P>f.  EPA Form 4700-4 (Compliance Review Report Form).</P>
        <P>g. Quality Assurance Statement. </P>
        <FP>Application Kits for Assistance are available from any of EPA's 10 Regional Offices.</FP>

        <P>The following regulations may also be helpful to the applicants as they prepare their financial assistance applications: 40 CFR part 7 (Nondiscrimination in Programs Receiving Federal Assistance from the EPA); 40 CFR part 12 (Nondiscrimination on the Basis of Handicap in Programs or Activities Conducted by the EPA); 40 CFR part 32 (Government Wide Debarment and Suspension and Government Wide Requirements for Drug-Free Workplace); and 40 CFR part 29 (Intergovernmental <PRTPAGE P="48908"/>Review of EPA Programs and Activities).</P>
        <P>Where a single State or Territorial agency has been designated as responsible for coordinating lead activities, EPA encourages that agency to apply for funding under TSCA section 404(g).  Coordination of Federally funded lead activities by a single agency is viewed as conducive to achieving integration of lead activities.  Early consultations are recommended between prospective applicants and their EPA Regional Offices.  Because TSCA grants will be administered at the Regional level, these consultations can be critical to the success of a project or program, and can also contribute substantially to efficient program operations.  As part of the work plan, EPA Regional Offices may ask for additional information that will be useful in evaluating the program such as the status of enabling legislation, a detailed line-item budget with sufficient information to clearly justify costs, a list of work products or deliverables, a schedule for their completion and application for program authorization under TSCA, and a description of any financial assistance received from other Federal sources concerning the lead program.  Applicants must also include all appropriate information on program income in accordance with 40 CFR 31.25.</P>
        <P>Work plans are to be negotiated between applicants and their Regional Offices to ensure that both EPA and State, Territorial, or Tribal priorities are addressed.  Any application from a State, Territory, Indian Tribe, or Intertribal Consortium that is not making sufficient progress toward implementation of an acceptable program will not be funded.  Also, any applicant proposing the collection of environmental or health related measurements or data generation must adequately address the requirements of 40 CFR 31.45 relating to quality assurance/quality control.  EPA issued final guidance that provides details about EPA's requirements for the preparation of “quality management plans.”  The finalized document is titled “EPA Requirements for Quality Management Plans” (EPA QA/R-2, March 2001), and is available from each Regional Office.</P>
        <P>8. <E T="03">Application procedures</E>.  Applications must be submitted to the appropriate EPA Regional Office in duplicate; one copy to the Regional lead program branch and the other to the Regional grants management branch.  In the case of electronic applications, if allowed by a particular EPA Regional Office, the applicant should follow the procedures required by the Regional Office for submission of electronic applications.  After the formula funding calculations are determined and the funds are transferred to the appropriate EPA Regional account, the Regional Office lead contact person will contact the applicant and discuss the final award allotment.  EPA Regional Offices may request the applicant to modify its proposed work plan and cooperative agreement based upon the final cooperative agreement allotment.  For Tribal applicants, final negotiations for the award of the grants, including the completion of a final work plan and budget, will be completed after the determination of successful applicants.</P>
        <P>9. <E T="03">Reporting</E>.  Pursuant to 40 CFR 31.40, grantees shall, at a minimum, submit annual performance reports to the appropriate EPA Regional Office.  These requirements were approved by the Office of Management and Budget (OMB) under OMB Control Number 2030-0020 (General Administrative Requirement for Assistance Programs).  The individual Regional Offices may require that these reports be submitted on a quarterly or semiannual basis, but not more frequently than quarterly.  The specific information contained within the report will include, at a minimum, a comparison of actual accomplishments to the objectives established for the period.   Regional Offices may ask for the inclusion of specific data (e.g., providing to EPA  specific address information associated with the abatement notifications that are received by the grantee) as part of the annual performance report from the grantees which may be useful for Agency reporting under the Government Performance and Results Act.  It is assumed that any data that is requested to be submitted by the grantee will already have been collected pursuant to the grantee's work plan. </P>
        <HD SOURCE="HD1">II.  What Action is the Agency Taking?</HD>
        <P>EPA is soliciting applications from States, Territories, Indian Tribes, Intertribal Consortia, and the District of Columbia for financial assistance for purposes of developing and carrying out EPA-authorized lead-based paint programs.  Approximately $12.5 million is available to fund cooperative agreements with States, Indian Tribes, Intertribal Consortia, Territories, and the District of Columbia for development and implementation of EPA-authorized lead-based paint programs.</P>
        <HD SOURCE="HD1">III. Statutory Authority and Regulations</HD>
        <P>EPA is authorized under TSCA section 404(g) to make grants to develop and carry out authorized lead-based paint programs.  Regulations governing these cooperative agreements are found at 40 CFR part 31 and part 35.</P>
        <HD SOURCE="HD1">IV.  Submission to Congress and the Comptroller General</HD>

        <P>Grant solicitations such as this are considered rules for the purpose of the Congressional Review Act (CRA).  The CRA, 5 U.S.C. 801 <E T="03">et seq.</E>, as added by the Small Business Regulatory Enforcement Fairness Act of 1996 (SBREFA), generally provides that, before a rule may take effect, the agency promulgating the rule must submit a rule report, which includes a copy of the rule, to each House of the Congress and to the Comptroller General of the United States. EPA will submit a report containing this rule and other required information to the U.S. Senate, the U.S. House of Representatives, and the Comptroller General of the United States prior to publication of the rule in the <E T="04">Federal Register</E>.  This rule is not a “major rule” as defined by 5 U.S.C. 804(2). </P>
        <HD SOURCE="HD1">V.  Reference</HD>
        <P>1. Departments of Veterans Affairs and Housing and Urban Development, and Independent Agencies Appropriations Act, Public Law 105-65, 111 Stat. 1374. </P>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects</HD>
          <P>Environmental protection, Grants, Lead, Training and accreditation.</P>
        </LSTSUB>
        
        <SIG>
          <DATED>Dated:  August 8, 2003.</DATED>
          <NAME>Susan B. Hazen, </NAME>
          <TITLE>Acting Assistant Administrator, Office of Prevention, Pesticides and Toxic Substances.</TITLE>
        </SIG>
        
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20898 Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 6560-50-S </BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">ENVIRONMENTAL PROTECTION AGENCY</AGENCY>
        <DEPDOC>[OPP-2003-0274; FRL-7322-9]</DEPDOC>
        <SUBJECT>Glufosinate-Ammonium; Notice of Filing a Pesticide Petition to Establish a Tolerance for a Certain Pesticide Chemical in or on Food</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Environmental Protection Agency (EPA).</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This notice announces the initial filing of a pesticide petition proposing the establishment of regulations for residues of a certain pesticide chemical in or on various food commodities. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>

          <P>Comments, identified by docket ID number OPP-2003-0274, must be <PRTPAGE P="48909"/>received on or before September 15, 2003. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>

          <P>Comments may be submitted electronically, by mail, or through hand delivery/courier.  Follow the detailed instructions as provided in Unit I. of the <E T="02">SUPPLEMENTARY INFORMATION</E>.</P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>

          <P>Joanne I. Miller, Registration Division (7505C), Office of Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone number: (703) 305-6224; e-mail address: <E T="03">miller.joanne@epa.gov</E>.</P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION: </HD>
        <HD SOURCE="HD1">I. General Information </HD>
        <HD SOURCE="HD2">A. Does This Action Apply to Me? </HD>
        <P>You may be potentially affected by this action if you are an agricultural producer, food manufacturer, or pesticide manufacturer. Potentially affected entities may include, but are not limited to:</P>
        <P>• Crop production (NAICS 111)</P>
        <P>• Animal production (NAICS 112)</P>
        <P>• Food manufacturing (NAICS 311)</P>
        <P>• Pesticide manufacturing (NAICS 32532)</P>

        <P>This listing is not intended to be exhaustive, but rather provides a guide for readers regarding entities likely to be affected by this action.  Other types of entities not listed in this unit could also be affected.  The North American Industrial Classification System (NAICS) codes have been provided to assist you and others in determining whether this action might apply to certain entities.  If you have any questions regarding the applicability of this action to a particular entity, consult the person listed under <E T="02">FOR FURTHER INFORMATION CONTACT</E>.</P>
        <HD SOURCE="HD2">B. How Can I Get Copies of This Document and Other Related Information? </HD>
        <P>1. <E T="03">Docket</E>.  EPA has established an official public docket for this action under docket identification (ID) number OPP-2003-0274.  The official public docket consists of the documents specifically referenced in this action, any public comments received, and other information related to this action.  Although a part of the official docket, the public docket does not include Confidential Business Information (CBI) or other information whose disclosure is restricted by statute.  The official public docket is the collection of materials that is available for public viewing at the Public Information and Records Integrity Branch (PIRIB), Rm. 119, Crystal Mall #2, 1921 Jefferson Davis Hwy., Arlington, VA.  This docket facility is open from 8:30 a.m. to 4 p.m., Monday through Friday, excluding legal holidays.  The docket telephone number is (703) 305-5805.</P>
        <P>2. <E T="03">Electronic access</E>.  You may access this <E T="04">Federal Register</E> document electronically through the EPA Internet under the “<E T="04">Federal Register</E>” listings at <E T="03">http://www.epa.gov/fedrgstr/.</E>
        </P>

        <P>An electronic version of the public docket is available through EPA's electronic public docket and comment system, EPA Dockets.  You may use EPA Dockets at <E T="03">http://www.epa.gov/edocket/</E> to submit or view public comments, access the index listing of the contents of the official public docket, and to access those documents in the public docket that are available electronically.  Although not all docket materials may be available electronically, you may still access any of the publicly available docket materials through the docket facility identified in Unit I.B.1.  Once in the system, select “search,” then key in the appropriate docket ID number. </P>
        <P>Certain types of information will not be placed in the EPA Dockets.  Information claimed as CBI and other information whose disclosure is restricted by statute, which is not included in the official public docket, will not be available for public viewing in EPA's electronic public docket.  EPA's policy is that copyrighted material will not be placed in EPA's electronic public docket but will be available only in printed, paper form in the official public docket.  To the extent feasible, publicly available docket materials will be made available in EPA's electronic public docket.  When a document is selected from the index list in EPA Dockets, the system will identify whether the document is available for viewing in EPA's electronic public docket. Although not all docket materials may be available electronically, you may still access any of the publicly available docket materials through the docket facility identified in Unit I.B.  EPA intends to work towards providing electronic access to all of the publicly available docket materials through EPA's electronic public docket.</P>
        <P>For public commenters, it is important to note that EPA's policy is that public comments, whether submitted electronically or in paper, will be made available for public viewing in EPA's electronic public docket as EPA receives them and without change, unless the comment contains copyrighted material, CBI, or other information whose disclosure is restricted by statute.  When EPA identifies a comment containing copyrighted material, EPA will provide a reference to that material in the version of the comment that is placed in EPA's electronic public docket.  The entire printed comment, including the copyrighted material, will be available in the public docket. </P>
        <P>Public comments submitted on computer disks that are mailed or delivered to the docket will be transferred to EPA's electronic public docket.  Public comments that are mailed or delivered to the docket will be scanned and placed in EPA's electronic public docket.  Where practical, physical objects will be photographed, and the photograph will be placed in EPA's electronic public docket along with a brief description written by the docket staff.</P>
        <HD SOURCE="HD2">C.  How and To Whom Do I Submit Comments?</HD>
        <P>You may submit comments electronically, by mail, or through hand delivery/courier.  To ensure proper receipt by EPA, identify the appropriate docket ID number in the subject line on the first page of your comment.  Please ensure that your comments are submitted within the specified comment period.  Comments received after the close of the comment period will be marked “late.”  EPA is not required to consider these late comments. If you wish to submit CBI or information that is otherwise protected by statute, please follow the instructions in Unit I.D.   Do not use EPA Dockets or e-mail to submit CBI or information protected by statute.</P>
        <P>1. <E T="03">Electronically</E>.  If you submit an electronic comment as prescribed in this unit, EPA recommends that you include your name, mailing address, and an e-mail address or other contact information in the body of your comment.  Also include this contact information on the outside of any disk or CD ROM you submit, and in any cover letter accompanying the disk or CD ROM.  This ensures that you can be identified as the submitter of the comment and allows EPA to contact you in case EPA cannot read your comment due to technical difficulties or needs further information on the substance of your comment.  EPA's policy is that EPA will not edit your comment, and any identifying or contact information provided in the body of a comment will be included as part of the comment that is placed in the official public docket, and made available in EPA's electronic public docket.  If EPA cannot read your comment due to technical difficulties and cannot contact you for clarification, EPA may not be able to consider your comment. <PRTPAGE P="48910"/>
        </P>
        <P>i. <E T="03">EPA Dockets</E>.  Your use of EPA's electronic public docket to submit comments to EPA electronically is EPA's preferred method for receiving comments.  Go directly to EPA Dockets at <E T="03">http://www.epa.gov/edocket</E>, and follow the online instructions for submitting comments.  Once in the system, select “search,” and then key in docket ID number OPP-2003-0274. The system is an “anonymous access” system, which means EPA will not know your identity, e-mail address, or other contact information unless you provide it in the body of your comment. </P>
        <P>ii. <E T="03">E-mail</E>.  Comments may be sent by e-mail to <E T="03">opp-docket@epa.gov</E>, Attention: Docket ID Number OPP-2003-0274.  In contrast to EPA's electronic public docket, EPA's e-mail system is not an “anonymous access” system.  If you send an e-mail comment directly to the docket without going through EPA's electronic public docket, EPA's e-mail system automatically captures your e-mail address.  E-mail addresses that are automatically captured by EPA's e-mail system are included as part of the comment that is placed in the official public docket, and made available in EPA's electronic public docket. </P>
        <P>iii. <E T="03">Disk or CD ROM</E>.  You may submit comments on a disk or CD ROM that you mail to the mailing address identified in Unit I.C.2.  These electronic submissions will be accepted in WordPerfect or ASCII file format.  Avoid the use of special characters and any form of encryption.</P>
        <P>2. <E T="03">By mail</E>.  Send your comments to:  Public Information and Records Integrity Branch (PIRIB) (7502C), Office of Pesticide Programs (OPP), Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-0001, Attention: Docket ID Number OPP-2003-0274.</P>
        <P>3. <E T="03">By hand delivery or courier</E>.  Deliver your comments to: Public Information and Records Integrity Branch (PIRIB), Office of Pesticide Programs (OPP), Environmental Protection Agency, Rm. 119, Crystal Mall #2, 1921 Jefferson Davis Hwy., Arlington, VA, Attention: Docket ID Number OPP-2003-0274.  Such deliveries are only accepted during the docket's normal hours of operation as identified in Unit I.B.1.</P>
        <HD SOURCE="HD2">D.  How Should I Submit CBI to the Agency?</HD>
        <P>Do not submit information that you consider to be CBI electronically through EPA's electronic public docket or by e-mail.  You may claim information that you submit to EPA as CBI by marking any part or all of that information as CBI (if you submit CBI on disk or CD ROM, mark the outside of the disk or CD ROM as CBI and then identify electronically within the disk or CD ROM the specific information that is CBI).  Information so marked will not be disclosed except in accordance with procedures set forth in 40 CFR part 2.</P>

        <P>In addition to one complete version of the comment that includes any information claimed as CBI, a copy of the comment that does not contain the information claimed as CBI must be submitted for inclusion in the public docket and EPA's electronic public docket.  If you submit the copy that does not contain CBI on disk or CD ROM, mark the outside of the disk or CD ROM clearly that it does not contain CBI.  Information not marked as CBI will be included in the public docket and EPA's electronic public docket without prior notice.  If you have any questions about CBI or the procedures for claiming CBI, please consult the person listed under <E T="02">FOR FURTHER INFORMATION CONTACT</E>.</P>
        <HD SOURCE="HD2">E. What Should I Consider as I Prepare My Comments for EPA? </HD>
        <P>You may find the following suggestions helpful for preparing your comments: </P>
        <P>1. Explain your views as clearly as possible.</P>
        <P>2. Describe any assumptions that you used.</P>
        <P>3. Provide copies of any technical information and/or data you used that support your views.</P>
        <P>4. If you estimate potential burden or costs, explain how you arrived at the estimate that you provide.</P>
        <P>5. Provide specific examples to illustrate your concerns.</P>
        <P>6. Make sure to submit your comments by the deadline in this notice.</P>

        <P>7. To ensure proper receipt by EPA, be sure to identify the docket ID number assigned to this action in the subject line on the first page of your response. You may also provide the name, date, and <E T="04">Federal Register</E> citation. </P>
        <HD SOURCE="HD1">II. What Action is the Agency Taking? </HD>
        <P>EPA has received a pesticide petition as follows proposing the establishment and/or amendment of regulations for residues of a certain pesticide chemical in or on various food commodities under section 408 of the Federal Food, Drug, and Cosmetic Act (FFDCA), 21 U.S.C. 346a. EPA has determined that this petition contains data or information regarding the elements set forth in FFDCA section 408(d)(2); however, EPA has not fully evaluated the sufficiency of the submitted data at this time or whether the data support granting of the petition.  Additional data may be needed before EPA rules on the petition. </P>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects </HD>
          <P>Environmental protection, Agricultural commodities, Feed additives, Food additives, Pesticides and pests, Reporting and recordkeeping requirements.</P>
        </LSTSUB>
        <SIG>
          <DATED>Dated: August 11, 2003.</DATED>
          <NAME>Peter Caulkins,</NAME>
          <TITLE>Acting Director, Registration Division, Office of Pesticide Programs.</TITLE>
        </SIG>
        <HD SOURCE="HD1">Summary of Petition </HD>
        <P>The petitioner summary of the pesticide petition is printed below as required by FFDCA section 408(d)(3). The summary of the petition was prepared by the petitioner and represents the view of the petitioner. The petition summary announces the availability of a description of the analytical methods available to EPA for the detection and measurement of the pesticide chemical residues or an explanation of why no such method is needed. </P>
        <HD SOURCE="HD1">Bayer CropScience</HD>
        <HD SOURCE="HD2">PP 0F06140 and PP 0F06210</HD>

        <P>EPA has received pesticide petitions (PP 0F06140 and 0F06210) from Bayer CropScience, 2 T.W. Alexander Drive, Research Triangle Park, NC 27709 proposing, pursuant to section 408(d) of the Federal Food, Drug, and Cosmetic Act (FFDCA), 21 U.S.C. 346a(d), to amend 40 CFR 180.473 by establishing a tolerance for residues of the herbicide glufosinate-ammonium (butanoic acid, 2-amino-4-(hydroxymethylphosphinyl)-, monoammonium salt) and its metabolite, 3-methylphosphinicopropionic acid expressed as 2-amino-4-(hydroxymethylphosphinyl)butanoic acid equivalents in or on the raw agricultural commodities: Cotton, undelinted seed at 4.0 parts per million (ppm); cotton gin byproducts at 15 ppm; cattle, fat at 0.4 ppm; cattle, meat at 0.15 ppm; cattle meat byproducts at 6.0 ppm; goat, fat at 0.4 ppm; goat, meat at 0.15 ppm; goat meat byproducts at 6.0 ppm; hog, fat at 0.4 ppm; hog, meat at 0.15 ppm; hog meat byproducts at 6.0 ppm; horse, fat at 0.4 ppm; horse, meat at 0.15 ppm; horse meat byproducts at 6.0 ppm; sheep, fat at 0.4 ppm; sheep, meat at 0.15 ppm; sheep meat byproducts at 6.0 ppm; egg at 0.15 ppm; milk at 0.15 ppm; poultry, fat at 0.15 ppm; poultry, meat at 0.15 ppm; and poultry meat byproducts at 0.6 ppm.  Bayer CropScience also proposes establishing a tolerance for residues of the herbicide glufosinate-ammonium (butanoic acid, <PRTPAGE P="48911"/>2-amino-4-(hydroxymethylphosphinyl)-, monoammonium salt) and its metabolites, 3-methylphosphinicopropionic acid, and 2-acetamido-4-methylphosphinico-butanoic acid expressed as 2-amino-4-(hydroxymethylphosphinyl)butanoic acid equivalents in or on the raw agricultural commodities derived from transgenic cotton and rice tolerant to glufosinate-ammonium: Rice, grain at 1.0 ppm; rice, straw at 2.0 ppm; rice, hull at 2.0 ppm; cotton, undelinted seed at 4.0 ppm; and cotton, gin byproducts at 15.0 ppm.</P>
        <P>EPA has determined that the petition contains data or information regarding the elements set forth in section 408(d)(2) of the FFDCA; however, EPA has not fully evaluated the sufficiency of the submitted data at this time or whether the data supports granting of the petition.  Additional data may be needed before EPA rules on the petition.</P>
        <HD SOURCE="HD2">A. Residue Chemistry </HD>
        <P>1. <E T="03">Plant metabolism</E>. Metabolism studies have been conducted on crops tolerant to glufosinate-ammonium using radiolabeled parent.  As a result, the nature of residues found in cotton, rice, and other transgenic crops tolerant to glufosinate ammonium is well understood.  The principal residue in raw agricultural commodities at harvest was 3-methylphosphinicopropionic acid (Hoe 061517).  Other relevant residues are <E T="03">N</E>-acetyl-<E T="03">L</E>-glufosinate (2-acetamido-4-methylphosphinico-butanoic acid, Hoe 099730) and lesser amounts of the parent compound.</P>
        <P>2. <E T="03">Analytical method</E>. The enforcement analytical method utilizes gas chromatography for detecting and measuring levels of glufosinate-ammonium and metabolites with a general limit of quantification of 0.05 ppm.  This method allows detection of residues at or above the proposed tolerances.</P>
        <P>3. <E T="03">Magnitude of residues</E>. Field residue trials were conducted across the major regions of rice and cotton production in the United States.    The treatment regime was selected to represent the use pattern that is the most likely to result in the highest residues.  When sampled at 70 days or more after the last application glufosinate-ammonium derived residues did not exceed 0.74 ppm in rice grain and 1.48 ppm in rice straw; whereas, in cotton seed and gin by products the highest mean residue level was 3.2 ppm and 10.58 ppm, respectively.  No concentration of the residues occurred when rice whole grain was processed into polished grain and bran, whereas a concentration factor of approximately 2.3 was found for rice hulls.  After ginning, the cotton  seed was processed into meal, hulls, and refined oil.  No concentration of the residues upon processing of the cotton seed was observed.</P>
        <HD SOURCE="HD2">B. Toxicological Profile</HD>
        <P>1. <E T="03">Acute toxicity</E>.  Glufosinate-ammonium has been classified as toxicity category III for acute oral, dermal, and inhalation toxicity; and for eye irritation.  Glufosinate-ammonium is not a dermal irritant (toxicity category IV) nor is it a dermal sensitizer.  The oral LD<E T="52">50</E> is 2,000 milligrams/kilogram (mg/kg) in male rats and 1,620 mg/kg in female rats. </P>
        <P>2. <E T="03">Genotoxicity</E>. Based on results of a complete genotoxicity data base, there is no evidence of mutagenic activity in a battery of studies, including: <E T="03">Salmonella spp</E>., <E T="03">E. coli</E>, <E T="03">in vitro</E> mammalian cell gene mutation assays, mammalian cell chromosome aberration assays, <E T="03">in vivo</E> mouse bone marrow micronucleus assays, and unscheduled DNA synthesis assays.</P>
        <P>3. <E T="03">Reproductive and developmental toxicity</E>.  In a developmental toxicity study, groups of 20 pregnant female Wistar rats were administered glufosinate-ammonium by gavage at doses of 0, 0.5, 2.24 10, 50,  and 250 mg/kg/day from days 7 to 16 of pregnancy.  The no observed adverse effect level (NOAEL) for maternal toxicity is 10 mg/kg/day; the lowest observed adverse effect level (LOAEL) is 50 mg/kg/day based on vaginal bleeding and hyperactivity in dams.  In the fetus, the NOAEL is 50 mg/kg/day, based on dilated renal pelvis observations at the LOAEL of 250 mg/kg/day.  In a developmental toxicity study, groups of 15 pregnant female Himalayan rabbits were administered glufosinate-ammonium by gavage at doses of 0, 2.0, 6.3, or 20.0 mg/kg/day from days 7 to 19 of pregnancy.  In maternal animals, decreases in food consumption and body weight gain were observed at the 20 mg/kg/day dose level.  The NOAEL for maternal toxicity was 6.3 mg/kg/day and that for developmental toxicity was 20 mg/kg/day.</P>
        <P>In a multi-generation reproduction study, glufosinate-ammonium was administered to groups of 30 male and 30 female Wistar/Han rats in the diet at concentrations of 0, 40, 120, or 360 ppm.  The LOAEL for systemic toxicity is 120 ppm based on increased kidney weights in both sexes and generations. The systemic toxicity NOAEL is 40 ppm.  The LOAEL for reproductive/developmental toxicity is 360 ppm based on decreased numbers of viable pups in all generations.  The NOAEL is 120 ppm.</P>
        <P>4. <E T="03">Subchronic toxicity.</E>In a subchronic oral toxicity study, glufosinate-ammonium was administered to 10 NMRI mice/sex/ dose in the diet at levels of 0, 80, 320, or 1,280 ppm (equivalent to 0, 12, 48, or 192 millgrams/kilogram/day (mg/kg/day)) for 13 weeks.  Significant (p<E T="62">&lt;</E> 0.05) increases were observed in serum aspartate aminotransferase and in alkaline phosphatase in high-dose (192 mg/kg/day) males.  Also observed were increases in absolute and relative liver weights in mid-(48 mg/kg/day) and high-dose males.  The NOAEL is 12 mg/kg/day, the LOAEL is 48 mg/kg/day based on the changes in clinical biochemistry and liver weights.</P>
        <P>5. <E T="03">Chronic toxicity</E>. In a combined chronic toxicity/oncogenicity study, glufosinate-ammonium was administered to 50 Wistar rats/sex/dose in the diet for 130 weeks at dose levels of 0, 40, 140, or 500 ppm (mean compound intake in males was 0, 1.9, 6.8, and 24.4 mg/kg/day and for females was 0, 2.4, 8.2, and 28.7 mg/kg/day, respectively).  A dose-related increase in mortality was noted in females at 140 and 500 ppm, whereas in males increased absolute and relative kidney weights were noted at 140 ppm and 500 ppm.  The NOAEL was considered to be 40 ppm. No treatment-related oncogenic response was noted.</P>
        <P>In an oncogenicity study, glufosinate-ammonium was administered to 50 NMRI mice/sex/dose in the diet at dose levels of 0, 80, 160 (males only) or 320 (females only) ppm for 104 weeks.  The NOAEL for systemic toxicity is 80 ppm (10.82/16.19 mg/kg/day in males/females (M/F)), and the LOAEL is 160/320 ppm (22.60/63.96 mg/kg/day in M/F), based on increased mortality in males, increased glucose levels in males and females, and changes in glutathione levels in males.  No increase in tumor incidence was found in any treatment group.</P>
        <P>In a chronic feeding study, technical glufosinate-ammonium was fed to male and female beagle dogs for 12 months in the diet at levels of 2.0, 5.0, or 8.5 mg/kg/day.  The NOAEL is 5.0 mg/kg/day based on clinical signs of toxicity, reduced weight gain and mortality 8.5 mg/kg/day.</P>

        <P>In a rat oncogenicity study, glufosinate-ammonium was administered to Wistar rats (60/sex/group) for up to 24 months at 0, 1,000, 5,000, or 10,000 ppm (equivalent to 0, 45.4, 228.9, or 466.3 mg/kg/day in males and 0, 57.1, 281.5, or 579.3 mg/kg/day in females).  The LOAEL for chronic toxicity is 5,000 ppm (equivalent to <PRTPAGE P="48912"/>228.9 mg/kg/day for male rats and 281.5 mg/kg/day for females), based on increased incidences of retinal atrophy.  The chronic NOAEL is 1,000 ppm.  Under the conditions of this study, there was no evidence of carcinogenic potential.  Dosing was considered adequate based on the increased incidence of retinal atrophy.</P>
        <P>6. <E T="03">Animal metabolism</E>.  Studies conducted in rats using <E T="51">14</E>C- glufosinate-ammonium have shown that the compound is poorly absorbed (5-10%) after oral administration and is rapidly eliminated primarily as the parent compound.  The highest residue levels were found in liver and kidney tissues. </P>

        <P>The metabolic profile and the quantitative distribution of metabolites were very similar in both goat and hen.  The vast majority of the dose was excreted, primarily as parent compound.  The very limited residues found in edible tissues, milk and eggs were comprised principally of glufosinate and 3-methylphosphinico-propionic acid (Hoe 061517), with lesser amounts of <E T="03">N</E>-acetyl-<E T="03">L</E>-glufosinate (Hoe 099730) and 2-methylohosphinico-acetic acid (Hoe 064619).</P>
        <P>7. <E T="03">Metabolite toxicology</E>. Additional testing has been conducted with the major metabolites, 3-methylphosphinico-propionic acid, and <E T="03">N</E>-acetyl-<E T="03">L</E>-glufosinate.  Based on subchronic and developmental toxicity study results, a profile of similar or less toxicity was observed for the metabolites as compared to the parent compound, glufosinate-ammonium.</P>
        <P>8. <E T="03">Endocrine disruption.</E> No special studies have been conducted to investigate the potential of glufosinate-ammonium to induce estrogenic or other endocrine effects.  However, no evidence of estrogenic or other endocrine effects have been noted in any of the toxicology studies that have been conducted with this product and there is no reason to suspect that any such effects would be likely.</P>
        <HD SOURCE="HD2">C. Aggregate Exposure</HD>
        <P>1. <E T="03">Dietary exposure</E>. Tolerances have been established (40 CFR  180.473) for the combined residues of glufosinate-ammonium and metabolites in or on a variety of raw agricultural commodities.  No appropriate toxicological endpoint attributable to a single exposure was identified in the available toxicity studies.  EPA has, therefore, not established an acute reference dose (RfD) for the general population including infants and children.  An acute population adjusted dose (aPAD - 95th percentile) of 0.021 mg/kg/day was established, however, for the females 13+ subgroup based on the results of the developmental toxicity study in rabbits with an uncertainty factor of 300. Therefore, an acute dietary analysis was conducted for this sub-population; whereas, chronic dietary analysis was conducted for the usual populations.  A chronic population adjusted dose (cPAD) of 0.007 mg/kg/day (based on the 2-year chronic study in rats and an uncertainty factor of 300) was used to perform the chronic dietary analysis.</P>
        <P>i. <E T="03">Food</E>.  An acute dietary analysis was conducted using the Dietary Exposure Evaluation Model (DEEM<E T="51">TM</E>) software version 7.6 and the 1994-1998 Continuing Survey of Food Intake by Individuals (CSFII) consumption data base.  The Tier I acute dietary assessment was modified by incorporating percent crop treated (PCT) values for blended items only.  Thus, the following PCT values were used: Soybean, 6%; canola, 11%; cotton, 15%, rice, 2%; sugar beet, 1%; and sugar beet molasses, 1%.  Tolerance values of blended feed items in the animal diets were also multiplied by PCT.  Dietary burdens were then multiplied by the maximum tissue to feed ratios observed in the animal feeding studies.  This Tier I analysis resulted in an exposure of 0.002746 mg/kg bw/day (95th percentile) for the female 13+ sub-population (the only population of concern) representing 13% utilization of the aPAD.</P>

        <P>Chronic dietary analysis was conducted to estimate exposure to potential glufosinate-ammonium residues in or on registered and proposed commodities.  The DEEM<E T="51">TM</E> software (version 7.6) and the 1994-1998 USDA food consumption data were used.  Tolerance level residues were assumed for all commodities.  Percent crop treated values generated by EPA/BEAD and Bayer CropScience were incorporated as follows: Tree nuts, 1%; apples, 1%; field corn, 3%; grapes, 1%; soybeans, 6%; potatoes, 1%; canola, 11%; and sugar beet, 1%.  Bayer CropScience estimates that an upper bound value for cotton at market maturity is 15% and that for rice is 2%.  All other crops are included at 100% of crop treated.  For the chronic dietary risk assessment, secondary residues that could occur as a result of residues of glufosinate-ammonium and metabolites in the diet of ruminants and poultry were adjusted for percent of the crop treated as indicated above.  Chronic dietary exposure estimates from residues of glufosinate-ammonium for the U.S. population represented approximately 3.2% of the chronic PAD; whereas that for children 1-2, the sub-population with the highest exposure, represented approximately 12% of the chronic PAD.  The approach used is very conservative, yet still indicates that dietary exposures for all segments of the population are well within the chronic reference doses.  This analysis was based on highly conservative assumptions.  The Agency has no concerns with PAD utilization up to 100%.</P>
        <P>ii. <E T="03">Drinking water</E>. U.S. EPA's Standard Operating Procedure (SOP) for Drinking Water Exposure and Risk Assessments was used to perform the drinking water assessment.  The models Screening Concentrations in Ground Water (SCI-GROW) and EPA's Pesticide Root Zone Model/Exposure Analysis Modeling System (PRZM/EXAMS) were used to estimate the concentration of glufosinate-ammonium that might occur in water.  The acute drinking water level of comparison (DWLOC) for females 13+ is 548 parts per billion (ppb).  In comparison, the acute estimated drinking water concentrations (EDWC) calculated by PRZM/EXAMS is 67 ppb.</P>
        <P>The chronic DWLOC calculated for adults is 237 ppb and that for children/toddlers is 62 ppb.  The chronic EDWC calculated using a worst case scenario is 17 ppb PRZM/EXAMS.  The DWLOCs are based on highly conservative dietary (food) exposures and are expected to be much higher in real world situations reducing further the percent utilization of the DWLOC. </P>
        <P>2. <E T="03">Non-dietary exposure</E>.  U.S. EPA's SOP for Drinking Water Exposure and Risk Assessments was used to perform the drinking water assessment.  The models SCI-GROW and PRZM/EXAMS were used to estimate the concentration of glufosinate-ammonium that might occur in water. The acute DWLOC for females 13+ is 548 ppb. In comparison, the acute EDWC calculated by PRZM/EXAMS is 67 ppb.</P>
        <P>The chronic DWLOC calculated for adults is 237 ppb and that for children/toddlers is 62 ppb.  The chronic EDWC calculated using a worst case scenario is 17 ppb PRZM/EXAMS.  The DWLOCs are based on highly conservative dietary (food) exposures and are expected to be much higher in real world situations reducing further the percent utilization of the DWLOC.</P>
        <HD SOURCE="HD2">D. Cumulative Effects</HD>

        <P>Section 408(b)(2)(D)(v) requires that, when considering whether to establish, modify, or revoke a tolerance, the Agency consider “available information” concerning the cumulative effects of a particular pesticide's residues and “other substances that have a common mechanism of toxicity.”  EPA has indicated that, at this time, the Agency does not have available data to determine whether glufosinate-<PRTPAGE P="48913"/>ammonium has a common mechanism of toxicity with other substances or how to include this pesticide in a cumulative risk assessment.  Unlike other pesticides for which EPA has followed a cumulative risk approach based on a common mechanism of toxicity, glufosinate-ammonium does not appear to produce a toxic metabolite produced by other substances.  For the purposes of this tolerance petition, therefore, it has not been assumed that glufosinate-ammonium has a common mechanism of toxicity with other substances.</P>
        <HD SOURCE="HD2">E. Safety Determination</HD>
        <P>1. <E T="03">U.S. population</E>. Using the conservative assumptions described above and based on the completeness and reliability of the toxicity data, it is concluded that chronic dietary exposure to the registered and proposed uses of glufosinate-ammonium will utilize at most 3.2% of the chronic population adjusted dose for the U.S. population.  The actual exposure is likely to be significantly less than predicted by this analysis as data and models that are more realistic are developed.  Exposures below 100% of the PAD are generally assumed to be of no concern because the PAD represents the level at or below which daily aggregate exposure over a lifetime will not pose appreciable risk to human health.</P>
        <P>The acute population of concern, female 13+ utilizes 13% of the aPAD.  This is a Tier I highly conservative assessment and actual exposure is likely to be far less.  DWLOCs based on dietary exposures are greater than the conservative estimated levels, and would be expected to be well below the 100% level of the reference dose, if they occur at all.</P>
        <P>EPA has concluded that it is not appropriate to aggregate non-dietary exposures with dietary exposures in a risk assessment because the toxicity end-points are different.</P>
        <P>Therefore, there is a reasonable certainty that no harm will occur to the U.S. population from aggregate exposure (food, drinking water and nonresidential) to residues of glufosinate-ammonium and metabolites.</P>
        <P>2. <E T="03">Infants and children</E>. The toxicological data base is sufficient for evaluating prenatal and postnatal toxicity for glufosinate-ammonium.  There are no prenatal or postnatal susceptibility concerns for infants and children, based on the results of the rat and rabbit developmental toxicity studies and the 2-generation reproduction study.  Based on clinical signs of neurological toxicity in short and intermediate dermal toxicity studies with rats, EPA has determined that an added FQPA safety factor of 3x is appropriate of assessing the risk of glufosinate-ammonium derived residues in crop commodities.</P>
        <P>Using the conservative assumptions described in the exposure section above, the percent of the chronic population adjusted dose that will be used for exposure to residues of glufosinate-ammonium in food for children 1-2 (the most highly exposed sub-group) is 12%.  Infants utilize 11.6% of the chronic PAD.  As in the adult situation, DWLOCs are higher than the worst case EDWC and are expected to use well below 100% of the PAD, if they occur at all.</P>
        <P>Therefore, there is a reasonable certainty that no harm will occur to infants and children from aggregate exposure to residues of glufosinate-ammonium.</P>
        <HD SOURCE="HD2">F. International Tolerances</HD>
        <P>Maximum residue limits for glufosinate-ammonium and metabolites in or on rice commodities have not been established by the Codex Alimentarius Commission.</P>
        
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20897 Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 6560-50-S</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">ENVIRONMENTAL PROTECTION AGENCY</AGENCY>
        <DEPDOC>[OPPT-2003-0050; FRL-7323-6]</DEPDOC>
        <SUBJECT>Certain New Chemicals; Receipt and Status Information</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Environmental Protection Agency (EPA).</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>Section 5 of the Toxic Substances Control Act (TSCA) requires any person who intends to manufacture (defined by statute to include import) a new chemical (i.e., a chemical not on the TSCA Inventory) to notify EPA and comply with the statutory provisions pertaining to the manufacture of new chemicals.  Under sections 5(d)(2) and 5(d)(3) of TSCA, EPA is required to publish a notice of receipt of a premanufacture notice (PMN) or an application for a test marketing exemption (TME), and to publish periodic status reports on the chemicals under review and the receipt of notices of commencement to manufacture those chemicals.  This status report, which covers the period from July 14, 2003 to July 31, 2003, consists of the PMNs and TME, both pending or expired, and the notices of commencement to manufacture a new chemical that the Agency has received under TSCA section 5 during this time period.</P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Comments identified by the docket ID number OPPT-2003-0050 and the specific PMN number or TME number, must be received on or before September 15, 2003.</P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>

          <P>Comments may be submitted electronically, by mail, or through hand delivery/courier.  Follow the detailed instructions as provided in Unit I. of the <E T="02">SUPPLEMENTARY INFORMATION</E>.</P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Barbara Cunningham, Director, Environmental Assistance Division, Office of Pollution Prevention and Toxics (7408M), Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC  20460-0001; telephone number: (202) 554-1404; e-mail address: TSCA-Hotline@epa.gov.</P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <HD SOURCE="HD1">I.  General Information</HD>
        <HD SOURCE="HD2">A.  Does this Action Apply to Me?</HD>

        <P>This action is directed to the public in general.  As such, the Agency has not attempted to describe the specific entities that this action may apply to.  Although others may be affected, this action applies directly to the submitter of the premanufacture notices addressed in the action.  If you have any questions regarding the applicability of this action to a particular entity, consult the person listed under <E T="02">FOR FURTHER INFORMATION CONTACT</E>.</P>
        <HD SOURCE="HD2">B. How Can I Get Copies of This Document and Other Related Information?</HD>
        <P>1. <E T="03">Docket.</E> EPA has established an official public docket for this action under docket identification (ID) number OPPT-2003-0050. The official public docket consists of the documents specifically referenced in this action, any public comments received, and other information related to this action.  Although a part of the official docket, the public docket does not include Confidential Business Information (CBI) or other information whose disclosure is restricted by statute.  The official public docket is the collection of materials that is available for public viewing at the EPA Docket Center, Rm. B102-Reading Room, EPA West, 1301 Constitution Ave., NW., Washington, DC.  The EPA Docket Center is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal holidays. The EPA Docket Center Reading Room telephone number is (202) 566-1744 and the telephone number for the OPPT Docket, which is located in EPA Docket Center, is (202) 566-0280.<PRTPAGE P="48914"/>
        </P>
        <P>2. <E T="03">Electronic access</E>.  You may access this <E T="04">Federal Register</E> document electronically through the EPA Internet under the “<E T="04">Federal Register</E>” listings at <E T="03">http://www.epa.gov/fedrgstr/</E>.</P>

        <P>An electronic version of the public docket is available through EPA's electronic public docket and comment system, EPA Dockets.  You may use EPA Dockets at <E T="03">http://www.epa.gov/edocket/</E> to submit or view public comments, access the index listing of the contents of the official public docket, and to access those documents in the public docket that are available electronically. Although not all docket materials may be available electronically, you may still access any of the publicly available docket materials through the docket facility identified in Unit I.B.1. Once in the system, select “search,” then key in the appropriate docket ID number.</P>
        <P>Certain types of information will not be placed in the EPA Dockets.  Information claimed as CBI and other information whose disclosure is restricted by statute, which is not included in the official public docket, will not be available for public viewing in EPA's electronic public docket.  EPA's policy is that copyrighted material will not be placed in EPA's electronic public docket but will be available only in printed, paper form in the official public docket.  To the extent feasible, publicly available docket materials will be made available in EPA's electronic public docket.  When a document is selected from the index list in EPA Dockets, the system will identify whether the document is available for viewing in EPA's electronic public docket. Although not all docket materials may be available electronically, you may still access any of the publicly available docket materials through the docket facility identified in Unit I.B.1. EPA intends to work towards providing electronic access to all of the publicly available docket materials through EPA's electronic public docket.</P>
        <P>For public commenters, it is important to note that EPA's policy is that public comments, whether submitted electronically or in paper, will be made available for public viewing in EPA's electronic public docket as EPA receives them and without change, unless the comment contains copyrighted material, CBI, or other information whose disclosure is restricted by statute.  When EPA identifies a comment containing copyrighted material, EPA will provide a reference to that material in the version of the comment that is placed in EPA's electronic public docket.  The entire printed comment, including the copyrighted material, will be available in the public docket.</P>
        <P>Public comments submitted on computer disks that are mailed or delivered to the docket will be transferred to EPA's electronic public docket.  Public comments that are mailed or delivered to the docket will be scanned and placed in EPA's electronic public docket.  Where practical, physical objects will be photographed, and the photograph will be placed in EPA's electronic public docket along with a brief description written by the docket staff.</P>
        <HD SOURCE="HD2">C.  How and To Whom Do I Submit Comments?</HD>
        <P>You may submit comments electronically, by mail, or through hand delivery/courier.  To ensure proper receipt by EPA, identify the appropriate docket ID number and specific PMN number or TME number in the subject line on the first page of your comment.  Please ensure that your comments are submitted within the specified comment period.  Comments received after the close of the comment period will be marked “late.”  EPA is not required to consider these late comments. If you wish to submit CBI or information that is otherwise protected by statute, please follow the instructions in Unit I.D.   Do not use EPA Dockets or e-mail to submit CBI or information protected by statute.</P>
        <P>1. <E T="03">Electronically</E>.  If you submit an electronic comment as prescribed in this unit, EPA recommends that you include your name, mailing address, and an e-mail address or other contact information in the body of your comment.  Also include this contact information on the outside of any disk or CD ROM you submit, and in any cover letter accompanying the disk or CD ROM.  This ensures that you can be identified as the submitter of the comment and allows EPA to contact you in case EPA cannot read your comment due to technical difficulties or needs further information on the substance of your comment.  EPA's policy is that EPA will not edit your comment, and any identifying or contact information provided in the body of a comment will be included as part of the comment that is placed in the official public docket, and made available in EPA's electronic public docket.  If EPA cannot read your comment due to technical difficulties and cannot contact you for clarification, EPA may not be able to consider your comment.</P>
        <P>i. <E T="03">EPA Dockets</E>.  Your use of EPA's electronic public docket to submit comments to EPA electronically is EPA's preferred method for receiving comments.  Go directly to EPA Dockets at <E T="03">http://www.epa.gov/edocket</E>, and follow the online instructions for submitting comments.  Once in the system, select “search,” and then key in docket ID number OPPT-2003-0050.  The system is an “anonymous access” system, which means EPA will not know your identity, e-mail address, or other contact information unless you provide it in the body of your comment.</P>
        <P>ii. <E T="03">E-mail</E>.  Comments may be sent by e-mail to <E T="03">oppt.ncic@epa.gov</E>, Attention: Docket ID Number OPPT-2003-0050 and PMN Number or TME Number.  In contrast to EPA's electronic public docket, EPA's e-mail system is not an “anonymous access” system.  If you send an e-mail comment directly to the docket without going through EPA's electronic public docket, EPA's e-mail system automatically captures your e-mail address.  E-mail addresses that are automatically captured by EPA's e-mail system are included as part of the comment that is placed in the official public docket, and made available in EPA's electronic public docket.</P>
        <P>iii. <E T="03">Disk or CD ROM</E>.  You may submit comments on a disk or CD ROM that you mail to the mailing address identified in Unit I.C.2.  These electronic submissions will be accepted in WordPerfect or ASCII file format.  Avoid the use of special characters and any form of encryption.</P>
        <P>2. <E T="03">By mail</E>.  Send your comments to: Document Control Office (7407M), Office of Pollution Prevention and Toxics (OPPT), Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-0001.</P>
        <P>3. <E T="03">By hand delivery or courier</E>.  Deliver your comments to: OPPT Document Control Office (DCO) in EPA East Building Rm. 6428, 1201 Constitution Ave., NW., Washington, DC. Attention: Docket ID Number OPPT-2003-0050 and PMN Number or TME Number.  The DCO is open from 8 a.m. to 4 p.m., Monday through Friday, excluding legal holidays. The telephone number for the DCO is (202) 564-8930.</P>
        <HD SOURCE="HD2">D.  How Should I Submit CBI To the Agency?</HD>

        <P>Do not submit information that you consider to be CBI electronically through EPA's electronic public docket or by e-mail.  You may claim information that you submit to EPA as CBI by marking any part or all of that information as CBI (if you submit CBI on disk or CD ROM, mark the outside of the disk or CD ROM as CBI and then identify electronically within the disk or CD ROM the specific information that is CBI).  Information so marked will not be <PRTPAGE P="48915"/>disclosed except in accordance with procedures set forth in 40 CFR part 2.</P>

        <P>In addition to one complete version of the comment that includes any information claimed as CBI, a copy of the comment that does not contain the information claimed as CBI must be submitted for inclusion in the public docket and EPA's electronic public docket.  If you submit the copy that does not contain CBI on disk or CD ROM, mark the outside of the disk or CD ROM clearly that it does not contain CBI.  Information not marked as CBI will be included in the public docket and EPA's electronic public docket without prior notice.  If you have any questions about CBI or the procedures for claiming CBI, please consult the technical person listed under <E T="02">FOR FURTHER INFORMATION CONTACT</E>.</P>
        <HD SOURCE="HD2">E.  What Should I Consider as I Prepare My Comments for EPA?</HD>
        <P>You may find the following suggestions helpful for preparing your comments:</P>
        <P>1. Explain your views as clearly as possible.</P>
        <P>2. Describe any assumptions that you used.</P>
        <P>3. Provide copies of any technical information and/or data you used that support your views.</P>
        <P>4. If you estimate potential burden or costs, explain how you arrived at the estimate that you provide.</P>
        <P>5. Provide specific examples to illustrate your concerns.</P>
        <P>6. Offer alternative ways to improve the notice or collection activity.</P>
        <P>7. Make sure to submit your comments by the deadline in this document.</P>

        <P>8. To ensure proper receipt by EPA, be sure to identify the docket ID number assigned to this action and the specific PMN number you are commenting on in the subject line on the first page of your response. You  may also provide the name, date, and <E T="04">Federal Register</E> citation.</P>
        <HD SOURCE="HD1">II.  Why is EPA Taking this Action?</HD>
        <P>Section 5 of TSCA requires any person who intends to manufacture (defined by statute to include import) a new chemical (i.e., a chemical not on the TSCA Inventory to notify EPA and comply with the statutory provisions pertaining to the manufacture of new chemicals.  Under sections 5(d)(2) and 5(d)(3) of TSCA, EPA is required to publish a notice of receipt of a PMN or an application for a TME and to publish periodic status reports on the chemicals under review and the receipt of notices of commencement to manufacture those chemicals.  This status report, which covers the period from July 14, 2003 to July 31, 2003, consists of the PMNs and TME, both pending or expired, and the notices of commencement to manufacture a new chemical that the Agency has received under TSCA section 5 during this time period.</P>
        <HD SOURCE="HD1">III.  Receipt and Status Report for PMNs and TME</HD>
        <P>This status report identifies the PMNs and TME, both pending or expired, and the notices of commencement to manufacture a new chemical that the Agency has received under TSCA section 5 during this time period.  If you are interested in information that is not included in the following tables, you may contact EPA as described in Unit II. to access additional non-CBI information that may be available.</P>
        <P>In Table I of this unit, EPA provides the following information (to the extent that such information is not claimed as CBI) on the PMNs received by EPA during this period: The EPA case number assigned to the PMN; the date the PMN was received by EPA; the projected end date for EPA's review of the PMN; the submitting manufacturer; the potential uses identified by the manufacturer in the PMN; and the chemical identity.</P>
        <GPOTABLE CDEF="s25,r20,r20,r45,r75,r75" COLS="6" OPTS="L2,i1">
          <TTITLE>
            <E T="04">I.  61 Premanufacture Notices Received From: 07/14/03 to 07/31/03</E>
          </TTITLE>
          <BOXHD>
            <CHED H="1">Case No.</CHED>
            <CHED H="1">Received Date</CHED>
            <CHED H="1">Projected Notice End Date</CHED>
            <CHED H="1">Manufacturer/Importer</CHED>
            <CHED H="1">Use</CHED>
            <CHED H="1">Chemical</CHED>
          </BOXHD>
          <ROW>
            <ENT I="01" O="xl">P-03-0686</ENT>
            <ENT O="xl">07/15/03 </ENT>
            <ENT O="xl">10/12/03 </ENT>
            <ENT O="xl">Lynx Chemical Group, LLC</ENT>
            <ENT O="xl">(S) Scale and corrosion inhibitor for downhole oilfield applications</ENT>
            <ENT O="xl">(G) Ammonium salt of phosphonomethylated diamine</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0687</ENT>
            <ENT O="xl">07/15/03 </ENT>
            <ENT O="xl">10/12/03 </ENT>
            <ENT O="xl">Lynx Chemical Group, LLC</ENT>
            <ENT O="xl">(S) Scale and corrosion inhibitor for downhole oilfield applications</ENT>
            <ENT O="xl">(G) Potassium salt of phosphonomethylated diamine</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0688</ENT>
            <ENT O="xl">07/15/03 </ENT>
            <ENT O="xl">10/12/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Pigment dispersant</ENT>
            <ENT O="xl">(G) Phosphated polyalkoxylate</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0689</ENT>
            <ENT O="xl">07/15/03 </ENT>
            <ENT O="xl">10/12/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Open, non-dispersive use </ENT>
            <ENT O="xl">(G) Blocked isocyanate</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0690</ENT>
            <ENT O="xl">07/16/03 </ENT>
            <ENT O="xl">10/13/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(S) The pmn substances function as binders in lithographic and publication gravure printing inks, as follows: Heatset web offset printing inks; sheetfed quickset printing inks; publication gravure printing inks</ENT>
            <ENT O="xl">(G) Rosin, polymer with a monocarboxylic acid, a phenol, maleic anhydride, formaldehyde and pentaerythritol</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0691</ENT>
            <ENT O="xl">07/16/03 </ENT>
            <ENT O="xl">10/13/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(S) The pmn substances function as binders in lithographic and publication gravure printing inks, as follows: Heatset web offset printing inks; sheetfed quickset printing inks; publication gravure printing inks</ENT>
            <ENT O="xl">(G) Rosin, polymer with a monocarboxylic acid, a phenol, formaldehyde and pentaerythritol</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0692</ENT>
            <ENT O="xl">07/16/03 </ENT>
            <ENT O="xl">10/13/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(S) The pmn substances function as binders in lithographic and publication gravure printing inks, as follows: Heatset web offset printing inks; sheetfed quickset printing inks; publication gravure printing inks</ENT>
            <ENT O="xl">(G) Rosin, polymer with a monocarboxylic acid, phenols, maleic anhydride, formaldehyde and pentaerythritol</ENT>
          </ROW>
          <ROW>
            <PRTPAGE P="48916"/>
            <ENT I="01" O="xl">P-03-0693</ENT>
            <ENT O="xl">07/16/03 </ENT>
            <ENT O="xl">10/13/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(S) The pmn substances function as binders in lithographic and publication gravure printing inks, as follows: Heatset web offset printing inks; sheetfed quickset printing inks; publication gravure printing inks</ENT>
            <ENT O="xl">(G) Rosin, polymer with a monocarboxylic acid, phenols, formaldehyde and pentaerythritol</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0694</ENT>
            <ENT O="xl">07/16/03 </ENT>
            <ENT O="xl">10/13/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(S) The pmn substances function as binders in lithographic and publication gravure printing inks, as follows: Heatset web offset printing inks; sheetfed quickset printing inks; publication gravure printing inks</ENT>
            <ENT O="xl">(G) Rosin, polymer with a monocarboxylic acid, a phenol, maleic anhydride, formaldehyde and pentaerythritol, metal salts.</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0695</ENT>
            <ENT O="xl">07/16/03 </ENT>
            <ENT O="xl">10/13/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(S) The pmn substances function as binders in lithographic and publication gravure printing inks, as follows: Heatset web offset printing inks; sheetfed quickset printing inks; publication gravure printing inks</ENT>
            <ENT O="xl">(G) Rosin, polymer with a monocarboxylic acid, phenols, formaldehyde, maleic anhydride and pentaerythritol</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0696</ENT>
            <ENT O="xl">07/16/03 </ENT>
            <ENT O="xl">10/13/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(S) The pmn substances function as binders in lithographic and publication gravure printing inks, as follows: Heatset web offset printing inks; sheetfed quickset printing inks; publication gravure printing inks</ENT>
            <ENT O="xl">(G) Rosin, polymer with a monocarboxylic acid, phenols, formaldehyde and pentaerythritol</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0697</ENT>
            <ENT O="xl">07/16/03 </ENT>
            <ENT O="xl">10/13/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(S) The pmn substances function as binders in lithographic and publication gravure printing inks, as follows: Heatset web offset printing inks; sheetfed quickset printing inks; publication gravure printing inks</ENT>
            <ENT O="xl">(G) Rosin, polymer with a monocarboxylic acid, alkylphenol, formaldehyde, maleic anhydride and pentaerythritol</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0698</ENT>
            <ENT O="xl">07/16/03 </ENT>
            <ENT O="xl">10/13/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(S) The pmn substances function as binders in lithographic and publication gravure printing inks, as follows: Heatset web offset printing inks; sheetfed quickset printing inks; publication gravure printing inks</ENT>
            <ENT O="xl">(G) Rosin, polymer with a monocarboxylic acid, alkylphenols, formaldehyde, maleic anhydride and pentaerythritol</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0699</ENT>
            <ENT O="xl">07/16/03 </ENT>
            <ENT O="xl">10/13/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(S) The pmn substances function as binders in lithographic and publication gravure printing inks, as follows: Heatset web offset printing inks; sheetfed quickset printing inks; publication gravure printing inks</ENT>
            <ENT O="xl">(G) Rosin, polymer with a monocarboxylic acid, alkylphenol, formaldehyde, maleic anhydride and pentaerythritol</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0700</ENT>
            <ENT O="xl">07/16/03 </ENT>
            <ENT O="xl">10/13/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(S) The pmn substances function as binders in lithographic and publication gravure printing inks, as follows: Heatset web offset printing inks; sheetfed quickset printing inks; publication gravure printing inks</ENT>
            <ENT O="xl">(G) Rosin, polymer with a monocarboxylic acid, a phenol, maleic anhydride, formaldehyde and glycerine</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0701</ENT>
            <ENT O="xl">07/16/03 </ENT>
            <ENT O="xl">10/13/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Ingredients for use in consumer products: Highly dispersive</ENT>
            <ENT O="xl">(G) Methylene bicycloalkane</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0702</ENT>
            <ENT O="xl">07/16/03 </ENT>
            <ENT O="xl">10/13/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Ingredients for use in consumer products: Highly dispersive</ENT>
            <ENT O="xl">(G) Trialkyl oxathiane</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0703</ENT>
            <ENT O="xl">07/16/03 </ENT>
            <ENT O="xl">10/13/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Redispersible powder</ENT>
            <ENT O="xl">(G) Water redispersible actionic acrylic copolymer</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0704</ENT>
            <ENT O="xl">07/16/03 </ENT>
            <ENT O="xl">10/13/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Commercial and consumer use in an article</ENT>
            <ENT O="xl">(G) Pyrazolotriazol derivative</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0705</ENT>
            <ENT O="xl">07/17/03 </ENT>
            <ENT O="xl">10/14/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Polymeric add mixture for cements </ENT>
            <ENT O="xl">(G) Polycarboxylate polymer with alkenyloxyalkylol modified poly(oxyalkylenediyl), calcium potassium salt</ENT>
          </ROW>
          <ROW>
            <PRTPAGE P="48917"/>
            <ENT I="01" O="xl">P-03-0706</ENT>
            <ENT O="xl">07/17/03 </ENT>
            <ENT O="xl">10/14/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Polymeric add mixture for cements </ENT>
            <ENT O="xl">(G) Alkylcarboxyalkenyl dihydroxyalkylate, polymer with carboxyalkenyl and alkylalkenyl sodium sulfonate, calcium salt</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0707</ENT>
            <ENT O="xl">07/17/03 </ENT>
            <ENT O="xl">10/14/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Polymeric add mixture for cements </ENT>
            <ENT O="xl">(G) Alkylcarboxyalkenyl polymer with carboxyalkenyl dihydroxyalkylate and alkylalkenyl sulfonate sodium salt</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0714</ENT>
            <ENT O="xl">07/18/03 </ENT>
            <ENT O="xl">10/15/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Solution additive</ENT>
            <ENT O="xl">(G) Aluminum alkoxide complex</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0715</ENT>
            <ENT O="xl">07/21/03 </ENT>
            <ENT O="xl">10/18/03 </ENT>
            <ENT O="xl">Lonza Inc.</ENT>
            <ENT O="xl">(S) Metal treating Chemical; corrossion inhibitor in process equipment; surfactant in hard cleaning applications</ENT>
            <ENT O="xl">(G) Dialkyl dimethyl ammonium carbonate (1:1)</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0716</ENT>
            <ENT O="xl">07/21/03 </ENT>
            <ENT O="xl">10/18/03 </ENT>
            <ENT O="xl">Lonza Inc.</ENT>
            <ENT O="xl">(S) Metal treating Chemical; corrossion inhibitor in process equipment; surfactant in hard cleaning applications</ENT>
            <ENT O="xl">(G) Dialkyl dimethyl ammonium carbonate (2:1)</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0717</ENT>
            <ENT O="xl">07/22/03 </ENT>
            <ENT O="xl">10/19/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Industrial crosslinker </ENT>
            <ENT O="xl">(G) Alcohol blocked polymeric isocyanate</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0718</ENT>
            <ENT O="xl">07/22/03 </ENT>
            <ENT O="xl">10/19/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Surfactant/dispersant</ENT>
            <ENT O="xl">(G) Aminated polypropylene glycol formate</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0719</ENT>
            <ENT O="xl">07/22/03 </ENT>
            <ENT O="xl">10/19/03 </ENT>
            <ENT O="xl">Forbo Adhesives, LLC </ENT>
            <ENT O="xl">(G) Hot melt polyurethane adhesive</ENT>
            <ENT O="xl">(G) Isocyanate functional polyester polyether urethane polymer</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0720</ENT>
            <ENT O="xl">07/22/03 </ENT>
            <ENT O="xl">10/19/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Open, non-dispersive (resin) </ENT>
            <ENT O="xl">(G) Aromatic polyisocyanate</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0721</ENT>
            <ENT O="xl">07/22/03 </ENT>
            <ENT O="xl">10/19/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Industrial coatings binder</ENT>
            <ENT O="xl">(G) Aminated epoxy formates</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0722</ENT>
            <ENT O="xl">07/23/03 </ENT>
            <ENT O="xl">10/20/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Thermal transfer ink ribbon</ENT>
            <ENT O="xl">(G) Pyrazolone derivative</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0723</ENT>
            <ENT O="xl">07/23/03 </ENT>
            <ENT O="xl">10/20/03 </ENT>
            <ENT O="xl">Ciba Specialty Chemicals Corporation, Textile Effects </ENT>
            <ENT O="xl">(S) Exhaust dyeing of polyester fibers </ENT>
            <ENT O="xl">(G) Substituted alkylamino phenyl azo substitute isoindole</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0724</ENT>
            <ENT O="xl">07/23/03 </ENT>
            <ENT O="xl">10/20/03 </ENT>
            <ENT O="xl">The Dow Chemical Company</ENT>
            <ENT O="xl">(S) Surfactant for waterbourne epoxy dispersions</ENT>
            <ENT O="xl">(G) Polyetherester diepoxide</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0725</ENT>
            <ENT O="xl">07/23/03 </ENT>
            <ENT O="xl">10/08/03 </ENT>
            <ENT O="xl">The Dow Chemical Company</ENT>
            <ENT O="xl">(S) Surfactant for waterbourne epoxy dispersions</ENT>
            <ENT O="xl">(G) Polyetherester diepoxide</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0726</ENT>
            <ENT O="xl">07/23/03 </ENT>
            <ENT O="xl">10/08/03 </ENT>
            <ENT O="xl">The Dow Chemical Company</ENT>
            <ENT O="xl">(S) Surfactant for waterbourne epoxy dispersions</ENT>
            <ENT O="xl">(G) Polyetherester diepoxide</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0727</ENT>
            <ENT O="xl">07/23/03 </ENT>
            <ENT O="xl">10/08/03 </ENT>
            <ENT O="xl">The Dow Chemical Company</ENT>
            <ENT O="xl">(S) Surfactant for waterbourne epoxy dispersions</ENT>
            <ENT O="xl">(G) Polyetherester diepoxide</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0728</ENT>
            <ENT O="xl">07/23/03 </ENT>
            <ENT O="xl">10/20/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Polyol component in polyester resin synthesis - destructive use </ENT>
            <ENT O="xl">(G) Polyester polyol</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0729</ENT>
            <ENT O="xl">07/24/03 </ENT>
            <ENT O="xl">10/21/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Component of batteries </ENT>
            <ENT O="xl">(G) Alkyleneoxide derivatives</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0730</ENT>
            <ENT O="xl">07/24/03 </ENT>
            <ENT O="xl">10/21/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Ingredients for use in consumer products: Highly dispersive</ENT>
            <ENT O="xl">(G) Tert- cycloalkanol</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0731</ENT>
            <ENT O="xl">07/24/03 </ENT>
            <ENT O="xl">10/21/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Sealant component</ENT>
            <ENT O="xl">(G) Polypropylene glycol, polymer with a carbomonocyclic diisocyanate, substituted-trialkoxysilane-blocked</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0732</ENT>
            <ENT O="xl">07/25/03 </ENT>
            <ENT O="xl">10/22/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(S) Industrial coating for plastic, metal, wood </ENT>
            <ENT O="xl">(G) Copolymer based on methacrylic acid esters</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0733</ENT>
            <ENT O="xl">07/25/03 </ENT>
            <ENT O="xl">10/22/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Open, non-dispersive (resin used in coatings applications) </ENT>
            <ENT O="xl">(G) Aspartic ester</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0734</ENT>
            <ENT O="xl">07/25/03 </ENT>
            <ENT O="xl">10/22/03 </ENT>
            <ENT O="xl">Scotia Ventures, L.L.C. </ENT>
            <ENT O="xl">(S) Paper coating additive; wet-end paper additive </ENT>
            <ENT O="xl">(G) Cationic polyvinyl alcohol</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0735</ENT>
            <ENT O="xl">07/25/03 </ENT>
            <ENT O="xl">10/22/03 </ENT>
            <ENT O="xl">Scotia Ventures, L.L.C. </ENT>
            <ENT O="xl">(S) Paper coating additive; wet-end paper additive </ENT>
            <ENT O="xl">(G) Cationic polyvinyl alcohol</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0736</ENT>
            <ENT O="xl">07/25/03 </ENT>
            <ENT O="xl">10/22/03 </ENT>
            <ENT O="xl">Scotia Ventures, L.L.C. </ENT>
            <ENT O="xl">(S) Paper coating additive; wet-end paper additive </ENT>
            <ENT O="xl">(G) Cationic polyvinyl alcohol</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0737</ENT>
            <ENT O="xl">07/25/03 </ENT>
            <ENT O="xl">10/22/03 </ENT>
            <ENT O="xl">Scotia Ventures, L.L.C. </ENT>
            <ENT O="xl">(S) Paper coating additive; wet-end paper additive </ENT>
            <ENT O="xl">(G) Cationic polyvinyl alcohol</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0739</ENT>
            <ENT O="xl">07/28/03 </ENT>
            <ENT O="xl">10/25/03 </ENT>
            <ENT O="xl">Dow Corning Corporation </ENT>
            <ENT O="xl">(G) Epoxy molding compound for encapsulation of semiconductor devices</ENT>
            <ENT O="xl">(G) Epoxy functional silsesquioxane</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0740</ENT>
            <ENT O="xl">07/24/03</ENT>
            <ENT O="xl">10/21/03</ENT>
            <ENT O="xl">The Goodyear Tire and Rubber Company</ENT>
            <ENT O="xl">(S) Monomer</ENT>
            <ENT O="xl">(G) Pyrrolidene, Functionzed Styrene</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0741</ENT>
            <ENT O="xl">07/28/03 </ENT>
            <ENT O="xl">10/25/03 </ENT>
            <ENT O="xl">BASF Corporation</ENT>
            <ENT O="xl">(G) Intermediate in the production of pigments</ENT>
            <ENT O="xl">(G) Diol distillation bottoms.</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0742</ENT>
            <ENT O="xl">07/28/03 </ENT>
            <ENT O="xl">10/25/03 </ENT>
            <ENT O="xl">BASF Corporation</ENT>
            <ENT O="xl">(G) Intermediate in the production of pigments</ENT>
            <ENT O="xl">(G) Diol distillation bottoms.</ENT>
          </ROW>
          <ROW>
            <PRTPAGE P="48918"/>
            <ENT I="01" O="xl">P-03-0743</ENT>
            <ENT O="xl">07/28/03 </ENT>
            <ENT O="xl">10/25/03 </ENT>
            <ENT O="xl">BASF Corporation</ENT>
            <ENT O="xl">(G) Intermediate in the production of pigments</ENT>
            <ENT O="xl">(G) Diol distillation bottoms.</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0744</ENT>
            <ENT O="xl">07/28/03 </ENT>
            <ENT O="xl">10/25/03 </ENT>
            <ENT O="xl">Dupont Company </ENT>
            <ENT O="xl">(G) Molded and extruded rubber parts</ENT>
            <ENT O="xl">(G) Modified ethylene/acrylate polymer</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0745</ENT>
            <ENT O="xl">07/28/03 </ENT>
            <ENT O="xl">10/25/03 </ENT>
            <ENT O="xl">Dupont Company </ENT>
            <ENT O="xl">(G) Molded and extruded rubber parts</ENT>
            <ENT O="xl">(G) Modified ethylene/acrylate polymer</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0746</ENT>
            <ENT O="xl">07/29/03 </ENT>
            <ENT O="xl">10/26/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Polymeric colorant</ENT>
            <ENT O="xl">(G) Polymeric aromatic amine colorant</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0747</ENT>
            <ENT O="xl">07/30/03 </ENT>
            <ENT O="xl">10/27/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Automotive coatings </ENT>
            <ENT O="xl">(G) Polyacrylic resin</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0748</ENT>
            <ENT O="xl">07/30/03 </ENT>
            <ENT O="xl">10/27/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Automotive coatings </ENT>
            <ENT O="xl">(G) Polyacrylic resin</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0749</ENT>
            <ENT O="xl">07/30/03 </ENT>
            <ENT O="xl">10/27/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Automotive coatings </ENT>
            <ENT O="xl">(G) Polyacrylic resin</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0750</ENT>
            <ENT O="xl">07/30/03 </ENT>
            <ENT O="xl">10/27/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Automotive coatings </ENT>
            <ENT O="xl">(G) Polyacrylic resin</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0751</ENT>
            <ENT O="xl">07/30/03 </ENT>
            <ENT O="xl">10/27/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Automotive coatings </ENT>
            <ENT O="xl">(G) Polyacrylic resin</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0752</ENT>
            <ENT O="xl">07/30/03 </ENT>
            <ENT O="xl">10/27/03 </ENT>
            <ENT O="xl">CBI</ENT>
            <ENT O="xl">(G) Automotive coatings </ENT>
            <ENT O="xl">(G) Polyacrylic resin</ENT>
          </ROW>
        </GPOTABLE>
        <P>In Table II of this unit, EPA provides the following information (to the extent that such information is not claimed as CBI) on the TMEs received:</P>
        <GPOTABLE CDEF="s25,r20,r20,r45,r75,r75" COLS="6" OPTS="L2,i1">
          <TTITLE>
            <E T="04">II.  1 Test Marketing Exemption Notices Received From: 07/14/03 to 07/31/03</E>
          </TTITLE>
          <BOXHD>
            <CHED H="1">Case No.</CHED>
            <CHED H="1">Received Date</CHED>
            <CHED H="1">Projected Notice End Date</CHED>
            <CHED H="1">Manufacturer/Importer</CHED>
            <CHED H="1">Use</CHED>
            <CHED H="1">Chemical</CHED>
          </BOXHD>
          <ROW>
            <ENT I="01" O="xl">T-03-0005</ENT>
            <ENT O="xl">07/31/03 </ENT>
            <ENT O="xl">09/13/03 </ENT>
            <ENT O="xl">Gardere Wynne Sewell LLP</ENT>
            <ENT O="xl">(S) For use as a cleaning solvent and insecticide carrier</ENT>
            <ENT O="xl">(S) Alkanes, C<E T="62">8</E>-C<E T="62">12</E>, branched</ENT>
          </ROW>
        </GPOTABLE>
        <P>In Table III of this unit, EPA provides the following information (to the extent that such information is not claimed as CBI) on the Notices of Commencement to manufacture received:</P>
        <GPOTABLE CDEF="s25,r20,r20,r95" COLS="4" OPTS="L2,i1">
          <TTITLE>
            <E T="04">III.  26 Notices of Commencement From:  07/14/03 to 07/31/03</E>
          </TTITLE>
          <BOXHD>
            <CHED H="1"> Case No.</CHED>
            <CHED H="1"> Received Date</CHED>
            <CHED H="1"> Commencement/Import Date</CHED>
            <CHED H="1"> Chemical</CHED>
          </BOXHD>
          <ROW>
            <ENT I="01" O="xl">P-01-0452</ENT>
            <ENT O="xl">07/17/03 </ENT>
            <ENT O="xl">04/21/03 </ENT>
            <ENT O="xl">(S) Silicon sodium strontium titanium hydroxide oxide</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-01-0769</ENT>
            <ENT O="xl">07/29/03 </ENT>
            <ENT O="xl">07/22/03 </ENT>
            <ENT O="xl">(G) Alkylated phenothiazine/diphenylamine mixture</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-01-0770</ENT>
            <ENT O="xl">07/29/03 </ENT>
            <ENT O="xl">07/22/03 </ENT>
            <ENT O="xl">(G) Alkylated phenothiazine/diphenylamine mixture</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-01-0771</ENT>
            <ENT O="xl">07/29/03 </ENT>
            <ENT O="xl">07/22/03 </ENT>
            <ENT O="xl">(G) Alkylated phenothiazine/diphenylamine mixture</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-01-0772</ENT>
            <ENT O="xl">07/29/03 </ENT>
            <ENT O="xl">07/22/03 </ENT>
            <ENT O="xl">(G) Alkylated phenothiazine/diphenylamine mixture</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-02-0651</ENT>
            <ENT O="xl">07/23/03 </ENT>
            <ENT O="xl">06/25/03 </ENT>
            <ENT O="xl">(G) Bis(phenol), 3,3-bis(3,4-dihydro-3phenyl-2h-1,3-benzoxazin-6-yl) derivative</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0032</ENT>
            <ENT O="xl">07/22/03 </ENT>
            <ENT O="xl">07/14/03 </ENT>
            <ENT O="xl">(G) Blocked fluoroChemical urethane</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0033</ENT>
            <ENT O="xl">07/22/03 </ENT>
            <ENT O="xl">07/09/03 </ENT>
            <ENT O="xl">(G) FluoroChemical alcohol</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0039</ENT>
            <ENT O="xl">07/29/03 </ENT>
            <ENT O="xl">07/22/03 </ENT>
            <ENT O="xl">(G) Amine stabilizer</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0133</ENT>
            <ENT O="xl">07/24/03 </ENT>
            <ENT O="xl">06/17/03 </ENT>
            <ENT O="xl">(G) Polysilazane</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0215</ENT>
            <ENT O="xl">07/15/03 </ENT>
            <ENT O="xl">06/26/03</ENT>
            <ENT O="xl">(S) 4h-1,3,2-benzodioxabismin-4-one, 2-hydroxy-</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0282</ENT>
            <ENT O="xl">07/25/03 </ENT>
            <ENT O="xl">06/30/03 </ENT>
            <ENT O="xl">(G) Amino-substituted carbopolycycle</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0283</ENT>
            <ENT O="xl">07/23/03 </ENT>
            <ENT O="xl">06/26/03 </ENT>
            <ENT O="xl">(S) Adenosine, n-benzoyl-5′-o-[bis(4-methoxyphenyl)phenylmethyl]-2′-deoxy-</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0296</ENT>
            <ENT O="xl">07/23/03 </ENT>
            <ENT O="xl">06/26/03 </ENT>
            <ENT O="xl">(S) Cytidene, n-benzoyl-5′-o-[bis(4-methoxyphenyl)phenylmethyl]-2′-deoxy-</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0298</ENT>
            <ENT O="xl">07/23/03 </ENT>
            <ENT O="xl">06/26/03 </ENT>
            <ENT O="xl">(S) Guanosine, 5′-o-[bis(4-methoxyphenyl)phenylmethyl]-2′-deoxy-n-(2-methyl-1-oxopropyl)-</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0302</ENT>
            <ENT O="xl">07/15/03 </ENT>
            <ENT O="xl">06/20/03 </ENT>
            <ENT O="xl">(G) Acrylic copolymer</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0315</ENT>
            <ENT O="xl">07/16/03 </ENT>
            <ENT O="xl">06/24/03 </ENT>
            <ENT O="xl">(G) Substituted polymethacrylic esters, hydrolyzed, sodium salt</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0331</ENT>
            <ENT O="xl">07/23/03 </ENT>
            <ENT O="xl">06/26/03 </ENT>
            <ENT O="xl">(S) Thymidine, 5′-o-[bis(4-methoxyphenyl)phenylmethyl]-</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0361</ENT>
            <ENT O="xl">07/21/03 </ENT>
            <ENT O="xl">07/10/03 </ENT>
            <ENT O="xl">(S) 2-propenoic acid, 2-methyl-, 2-hydroxyethyl ester, polymer  with n-[3-(dimethylamino)propyl]-2-methyl-2-propenamide and 1-ethenylhexahydro-2h-azepin-2-one, 2,2′-azobis[2-methylbutanenitrile]-initiated</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0392</ENT>
            <ENT O="xl">07/21/03 </ENT>
            <ENT O="xl">06/19/03 </ENT>
            <ENT O="xl">(G) Anthranilic acid derivative</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0400</ENT>
            <ENT O="xl">07/14/03 </ENT>
            <ENT O="xl">06/10/03 </ENT>
            <ENT O="xl">(G) Substituted anthracene ester</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0430</ENT>
            <ENT O="xl">07/28/03 </ENT>
            <ENT O="xl">07/02/03 </ENT>
            <ENT O="xl">(G) Polymer of methylene diphenyl diisocyanate, polyether polyol and a polyester polyol</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0442</ENT>
            <ENT O="xl">07/24/03 </ENT>
            <ENT O="xl">06/26/03 </ENT>
            <ENT O="xl">(G) Polysiloxazane</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-03-0459</ENT>
            <ENT O="xl">07/18/03 </ENT>
            <ENT O="xl">07/10/03 </ENT>
            <ENT O="xl">(G) Carboxylated modified poly(oxyalkylenediyl), calcium salt</ENT>
          </ROW>
          <ROW>
            <ENT I="01" O="xl">P-92-0830</ENT>
            <ENT O="xl">07/24/03 </ENT>
            <ENT O="xl">07/16/03 </ENT>
            <ENT O="xl">(S) 4-isobutyl benzaldehyde</ENT>
          </ROW>
          <ROW>
            <PRTPAGE P="48919"/>
            <ENT I="01" O="xl">P-93-0563</ENT>
            <ENT O="xl">07/22/03 </ENT>
            <ENT O="xl">04/13/98 </ENT>
            <ENT O="xl">(G) Alkoxylated alkyl phenol</ENT>
          </ROW>
        </GPOTABLE>
        <LSTSUB>
          <HD SOURCE="HED">List of Subjects</HD>
          <P>Environmental protection, Chemicals, Premanufacturer notices.</P>
        </LSTSUB>
        <SIG>
          <DATED>Dated:  August 12, 2003.</DATED>
          <NAME>Sandra R. Wilkins,</NAME>
          <TITLE>Acting Director, Information Management Division, Office of Pollution Prevention and Toxics.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20900 Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 6560-50-S</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">ENVIRONMENTAL PROTECTION AGENCY </AGENCY>
        <DEPDOC>[FRL-7544-2] </DEPDOC>
        <SUBJECT>Mission Foods Corporation—Administrative Consent Agreement and Final Order; Notice of Proposed Administrative Consent Agreement and Final Order Pursuant to Section 311(B)(6) of the Clean Water Act </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Environmental Protection Agency. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice, request for public comments. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>

          <P>In accordance with section 311(b)(6)(C) of the Clean Water Act, (“CWA”), 33 U.S.C. 1321(b)(6)(C), notice is hereby given of a proposed Consent Agreement and Final Order (“CA/FO,” Region 9 Docket No. OPA 9-2003-0003), which resolves penalties for alleged violations of sections 311(b)(3) and 311(j) of the CWA. The respondent to the CA/FO is the Mission Foods Corporation, a California corporation. Through the proposed CA/FO, the Mission Foods Corporation will pay $60,000 to the Oil Spill Liability Trust Fund as a penalty for alleged violations involving the discharge of oil into waters of the United States, and the failure to prepare and maintain Spill Prevention, Control and Countermeasure plans. The penalty included in this CA/FO was calculated in accordance with the Agency's guidance document, <E T="03">Civil Penalty Policy for Section</E> 311(b)(3) <E T="03">and Section</E> 311(j) <E T="03">of the Clean Water Act</E>, dated August 21, 1998. For thirty (30) days following the date of publication of this Notice, the Agency will receive written comments relating to the proposed CA/FO. Any person who comments on the proposed CA/FO shall be given notice of any hearing held and a reasonable opportunity to be heard and to present evidence. If no hearing is held regarding comments received, any person commenting on this proposed CA/FO may, within 30 days after the issuance of the final order, petition the Agency to set aside the CA/FO, as provided by section 311(b)(6)(C)(iii) of the CWA, 33 U.S.C. 1321(b)(6)(C)(iii). </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Comments must be submitted on or before September 15, 2003. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>The proposed CA/FO may be obtained from Laurie Williams, telephone (415) 972-3867. Comments regarding the proposed CA/FO should be addressed to Danielle Carr (ORC-1) at 75 Hawthorne Street, San Francisco, California 94105, and should reference the Mission Foods Corporation and Region 9 Docket No. OPA 9-2003-0003. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Laurie Williams (ORC-3), Office of Regional Counsel, U.S. Environmental Protection Agency, Region 9, 75 Hawthorne Street, San Francisco, CA 94105, (415) 972-3867. </P>
          <SIG>
            <DATED>Dated: August 6, 2003. </DATED>
            <NAME>Daniel Meer, </NAME>
            <TITLE>Acting Director, Superfund Division, Region 9. </TITLE>
          </SIG>
        </FURINF>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20896 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 6560-50-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">ENVIRONMENTAL PROTECTION AGENCY</AGENCY>
        <DEPDOC>[FRL-7544-9]</DEPDOC>
        <SUBJECT>Public Water System Supervision Program Revision for the State of Colorado</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Environmental Protection Agency (EPA).</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The State of Colorado has revised its Public Water System Supervision (PWSS) primacy program by adopting regulations for the Interim Enhanced Surface Water Treatment Rule (IESWTR), Disinfectants/Disinfection Byproducts Rule (D/DBPR), Radionuclides Rule, revisions to the Variances and Exemptions Rule, Administrative Penalty Authority, Definition of “Public Water System,” and the Public Notification Rule (PNR). Having determined that these revisions meet all pertinent requirements in the Safe Drinking Water Act (SDWA), and EPA's implementing regulations, the EPA approves them.</P>

          <P>Today's approval action does not extend to public water systems in Indian country. Please see <E T="02">SUPPLEMENTARY INFORMATION</E>, Item B.</P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>

          <P>Any member of the public is invited to submit written comments and/or request a public hearing on this determination by September 15, 2003. Please see <E T="02">SUPPLEMENTARY INFORMATION</E>, Item C, for information on submitting comments and requesting a hearing. If no hearing is requested or granted, then this action shall become effective September 15, 2003. If a public hearing is requested and granted, then this determination shall not become effective until such time following the hearing as the Regional Administrator (RA) issues an order affirming or rescinding this action.</P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Written comments and requests for a public hearing should be addressed to: Robert E. Roberts, Regional Administrator, c/o Qian Zhang (8P-W-MS), U.S. EPA, Region 8, 999 18th Street, Suite 300, Denver, CO 80202-2466.</P>
          <P>All documents relating to this determination are available for inspection at the following locations: (1) U.S. EPA, Region 8, Municipal Systems Unit, 999 18th Street (4th Floor), Denver, CO 80202-2466; (2) Colorado Department of Public Health and Environment (CDPHE), Drinking Water Section, 4300 Cherry Creek Drive South, Denver, CO.</P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Qian Zhang, Municipal Systems Unit, EPA, Region 8 (8P-W-MS), 999 18th Street, Suite 300, Denver, CO 80202-2466, 303-312-6267.</P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>

        <P>EPA approved Colorado's application for assuming primary enforcement authority for the PWSS program, pursuant to section 1413 of SDWA, 42 U.S.C. 300g-2, and 40 CFR part 142. CDPHE administers Colorado's PWSS program. The State of Colorado has revised its PWSS primacy program by adopting regulations for the IESWTR (December 16, 1998, 63 FR 69478-69521), D/DBPR (December 16, 1998, 63 FR 69390-69476), Radionuclides Rule (December 7, 2000, 65 FR 76708), revisions to the Variances and <PRTPAGE P="48920"/>Exemptions Rule (August 14, 1998, 63 FR 43833-43851), Administrative Penalty Authority (April 28, 1998, 62 FR 23362), Definition of “Public Water System” (April 28, 1998, 63 FR 23362), and the PNR (May 4, 2000, 65 FR 25981-26049), that correspond to the National Primary Drinking Water Regulations (NPDWRs) in 40 CFR part 141.</P>
        <HD SOURCE="HD1">A. Why Are Revisions to State Programs Necessary?</HD>
        <P>States with primary PWSS enforcement authority must comply with the requirements of 40 CFR part 142 for maintaining primacy. They must adopt regulations that are at least as stringent as NPDWRs at 40 CFR part 141 (40 CFR 142.10(a)). Changes to state programs may be necessary as federal primacy requirements change, as states must adopt all new and revised NPDWRs in order to retain primacy (40 CFR 142.12(a)).</P>
        <HD SOURCE="HD1">B. How Does Today's Action Affect Indian Country (18 U.S.C. 1151) in Colorado?</HD>
        <P>Colorado is not authorized to carry out its PWSS program in Indian country. This includes, but is not limited to, land within formal Indian reservations located within or abutting the State of Colorado, including the Southern Ute Indian Reservation and the Ute Mountain Ute Indian Reservation, any land held in trust by the United States for an Indian tribe, and any other areas which are “Indian country” within the meaning of 18 U.S.C. 1151.</P>
        <HD SOURCE="HD1">C. Requesting a Hearing and Submitting Written Comments.</HD>
        <P>Any request for a public hearing shall include the following: (1) The name, address, and telephone number of the individual, organization, or other entity requesting a hearing; (2) a brief statement of the requesting person's interest in the RA's determination and of information that the requesting person intends to submit at such hearing; and (3) the signature of the individual making the request, or, if the request is made on behalf of an organization or other entity, the signature of the responsible official of the organization or other entity.</P>

        <P>Notice of any hearing shall be given not less than fifteen (15) days prior to the time scheduled for the hearing. Such notice will be made by the RA in the <E T="04">Federal Register</E> and in newspapers of general circulation in the State of Colorado. A notice will also be sent to the person(s) requesting the hearing as well as to the State of Colorado. The hearing notice will include a statement of purpose, information regarding time and location, and the address and telephone number where interested persons may obtain further information. A final determination will be made upon review of the hearing record.</P>
        <P>Frivolous or insubstantial requests for a hearing may be denied by the RA. However, if a substantial request is made within thirty (30) days after this notice, a public hearing will be held.</P>
        <P>Please bring this notice to the attention of any persons known by you to have an interest in this determination.</P>
        <SIG>
          <DATED>Dated: August 6, 2003.</DATED>
          <NAME>Robert E. Roberts,</NAME>
          <TITLE>Regional Administrator, Region 8.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20891 Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 6560-50-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">ENVIRONMENTAL PROTECTION AGENCY</AGENCY>
        <DEPDOC>[FRL-7545-1]</DEPDOC>
        <SUBJECT>Public Water System Supervision Program Revision for the State of South Dakota</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Environmental Protection Agency (EPA).</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>In accordance with the provisions of section 1413 of the Safe Drinking Water Act (SDWA), 42 U.S.C. 300g-2, and 40 CFR 142.13, public notice is hereby given that the State of South Dakota has revised its Public Water System Supervision (PWSS) Primacy Program by developing regulations for the Lead and Copper Rule Minor Revisions (LCRMR), the Public Notification Rule (PNR), the Disinfectants/ Disinfection Byproducts Rule (D/DBPR), and the Interim Enhanced Surface Water Treatment Rule (IESWTR) that correspond to 40 CFR parts 141 and 142. The EPA has completed its review of South Dakota's primacy revisions in accordance with the SDWA, and EPA's implementing regulations at 40 CFR parts 141 and 142, and proposes to approve South Dakota's primacy revisions for the LCRMR, PNR, D/DBPR and conditionally approves the IESWTR.</P>

          <P>Today's approval action does not extend to public water systems in Indian country, as that term is defined in 18 U.S.C. 1151. Please see <E T="02">SUPPLEMENTARY INFORMATION</E>, Item B.</P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>

          <P>Any member of the public is invited to submit written comments and/or request a public hearing on this determination by September 15, 2003. Please see <E T="02">SUPPLEMENTARY INFORMATION</E>, Item C, for information on submitting comments and requesting a hearing. Should no timely and appropriate request for a hearing be received, and the Regional Administrator (RA) does not elect to hold a hearing on his own motion, this determination shall become effective September 15, 2003. If a hearing is requested or granted, then this determination shall not become effective until such time following the hearing as the RA issues an order affirming or rescinding this action.</P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Written comments and a request for a public hearing should be addressed to: Robert E. Roberts, Regional Administrator, c/o Bruce Suchomel (8P-W-MS), U.S. Environmental Protection Agency, Region 8, 999 18th St., Suite 300, Denver, CO 80202-2466.</P>
          <P>
            <E T="03">Reviewing Documents:</E> All documents relating to this determination are available for inspection at the following locations: (1) U.S. EPA, Region 8, Municipal Systems Unit, 999 18th St. (4th Floor), Denver, CO 80202-2466; (2) South Dakota Department of Environment and Natural Resources, Drinking Water Program, 523 E. Capitol Ave., Pierre, SD 57501-3181.</P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Bruce Suchomel, Municipal Systems Unit, U.S. EPA, Region 8 (8P-W-MS), 999 18th St., Suite 300, Denver, CO 80202-2466; telephone 303-312-6001.</P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>

        <P>Effective January 9, 1984, EPA approved South Dakota's application for assuming primary enforcement authority for the PWSS program, pursuant to section 1413 of SDWA, 42 U.S.C. 300g-2, and 40 CFR part 142 (<E T="03">see</E> 48 FR 55173). The South Dakota Department of Environment and Natural Resources (DENR) administers South Dakota's PWSS program.</P>
        <HD SOURCE="HD1">A. Why Are Revisions to State Programs Necessary?</HD>

        <P>States with primary PWSS enforcement authority must comply with the requirements of 40 CFR part 142 for maintaining primacy. They must adopt regulations that are at least as stringent as the National Primary Drinking Water Regulations (NPDWRs) at 40 CFR parts 141 and 142. As new NPDWRs become final, states must adopt all new and revised NPDWRs in order to retain primacy. (40 CFR 142.12(a)).<PRTPAGE P="48921"/>
        </P>
        <HD SOURCE="HD1">B. How Does Today's Action Affect Indian Country (18 U.S.C. 1151) in South Dakota?</HD>
        <P>South Dakota is not authorized to carry out its PWSS program in Indian Country, as defined in 18 U.S.C. 1151. This includes:</P>
        <P>1. Lands within the exterior boundaries of the following Indian reservations located within or abutting the State of South Dakota.</P>
        <P>a. Cheyenne River Indian Reservation;</P>
        <P>b. Crow Creek Indian Reservation;</P>
        <P>c. Flandreau Indian Reservation;</P>
        <P>d. Lower Brule Indian Reservation;</P>
        <P>e. Pine Ridge Indian Reservation;</P>
        <P>f. Rosebud Indian Reservation;</P>
        <P>g. Standing Rock Indian Reservation; and</P>
        <P>h. Yankton Indian Reservation.</P>
        <P>2. Any land held in trust by the United States for an Indian tribe, and</P>
        <P>3. Any other areas which are “Indian country” within the meaning of 18 U.S.C. 1151.</P>
        <HD SOURCE="HD1">C. Requesting a Hearing and Submitting Written Comments.</HD>
        <P>Any request for a public hearing shall include the following: (1) The name, address, and telephone number of the individual, organization, or other entity requesting ; (2) a brief statement of the requesting person's interest in the RA's determination and of information that the requesting person intends to submit at such hearing; and (3) the signature of the individual making the request, or, if the request is made on behalf of an organization or other entity, the signature of the responsible official of the organization or other entity.</P>

        <P>Notice of any hearing shall be given not less than fifteen (15) days prior to the time scheduled for the hearing. Such notice will be made by the RA in the <E T="04">Federal Register</E> and in newspapers of general circulation in the State of South Dakota. A notice will also be sent to the person(s) requesting the hearing as well as to the State of South Dakota. The hearing notice will include a statement of purpose, information regarding time and location, and the address and telephone number where interested persons may obtain further information. The RA will issue the final determination upon review of the hearing record.</P>
        <P>Frivolous or insubstantial requests for a hearing may be denied by the RA. However, if a substantial request is made within thirty (30) days after this notice, a public hearing will be held.</P>
        <P>Please bring this notice to the attention of any persons known by you to have an interest in this determination.</P>
        <SIG>
          <DATED>Dated: August 1, 2003.</DATED>
          <NAME>Robert E. Roberts,</NAME>
          <TITLE>Regional Administrator, Region 8.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20892 Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 6560-50-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">ENVIRONMENTAL PROTECTION AGENCY </AGENCY>
        <DEPDOC>[FRL-7545-2] </DEPDOC>
        <SUBJECT>Public Water System Supervision Program Revision for the State of North Dakota </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Environmental Protection Agency (EPA). </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The State of North Dakota has revised its Public Water System Supervision (PWSS) primacy program by adopting regulations for the Public Water System Definition Rule, Administrative Penalty Authority Rule, Consumer Confidence Report Rule (CCR), Variances and Exemptions Rule, Interim Enhanced Surface Water Treatment Rule (IESWTR), and Disinfectants/Disinfection Byproducts Rule (D/DBPR). Having determined that these revisions meet all pertinent requirements in the Safe Drinking Water Act (SDWA), and EPA's implementing regulations, the EPA approves them. </P>

          <P>Today's approval action does not extend to public water systems in Indian Country. Please see <E T="02">SUPPLEMENTARY INFORMATION,</E> Item B. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>

          <P>Any member of the public is invited to submit written comments and/or request a public hearing on this determination by September 15, 2003. Please see <E T="02">SUPPLEMENTARY INFORMATION,</E> Item C, for information on submitting comments and requesting a hearing. If no hearing is requested or granted, then this action shall become effective September 15, 2003. If a public hearing is requested and granted, then this determination shall not become effective until such time following the hearing as the Regional Administrator (RA) issues an order affirming or rescinding this action. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Written comments and requests for a public hearing should be addressed to: Robert E. Roberts, Regional Administrator, c/o Anthony Q. DeLoach (8P-W-MS), U.S. EPA, Region 8, 999 18th Street, Suite 300, Denver, CO 80202-2466. </P>
          <P>All documents relating to this determination are available for inspection at the following locations: (1) U.S. EPA, Region 8, Municipal Systems Unit, 999 18th Street (4th Floor), Denver, CO 80202-2466; (2) North Dakota Department of Health, Environmental Health Section, P.O. Box 5520 Bismarck, ND 58506-5520. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Anthony Q. DeLoach, Municipal Systems Unit, EPA, Region 8 (8P-W-MS), 999 18th Street, Suite 300, Denver, CO 80202-2466, 303-312-6070. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>EPA approved North Dakota's application for assuming primary enforcement authority for the PWSS program, pursuant to section 1413 of SDWA, 42 U.S.C. 300g-2, and 40 CFR part 142. NDDH administers North Dakota's PWSS program. The State of North Dakota has revised its PWSS primacy program by adopting regulations for the Public Water System Definition Rule, Administrative Penalty Authority Rule, CCR, Variances and Exemptions Rule, IESWTR, and D/DBPR that correspond to regulations for 40 CFR part 141, subpart O. </P>
        <HD SOURCE="HD1">A. Why Are Revisions to State Programs Necessary? </HD>
        <P>States with primary PWSS enforcement authority (see 40 CFR 142.10(a)) must comply with the requirements of 40 CFR part 142 for maintaining primacy. They must adopt regulations that are at least as stringent as NPDWRs at 40 CFR part 141. Changes to state programs may be necessary as federal primacy requirements change, as states must adopt all new and revised NPDWRs in order to retain primacy. </P>
        <HD SOURCE="HD1">B. How Does Today's Action Affect Indian Country (18 U.S.C. 115) in North Dakota? </HD>
        <P>North Dakota is not authorized to carry out its primacy program in Indian country, as defined in 18 U.S.C. 1151. This includes: </P>
        <P>1. Lands within the exterior boundaries of the following Indian Reservations located within or abutting the State of North Dakota: </P>
        <P>a. Fort Totten Indian Reservation; </P>
        <P>b. Fort Berthold Indian Reservation; </P>
        <P>c. Standing Rock Indian Reservation; </P>
        <P>d. Turtle Mountain Indian Reservation; </P>
        <P>2. Any land held in trust by the U.S. for an Indian tribe, and </P>
        <P>3. Any other land, whether on or off a reservation that qualifies as Indian country. </P>
        <P>Therefore, this action has no effect in Indian country where EPA will continue to implement and administer the Drinking Water program in these lands. </P>
        <HD SOURCE="HD1">C. Requesting a Hearing and Submitting Written Comments. </HD>

        <P>Any request for a public hearing shall include the following: (1) The name, <PRTPAGE P="48922"/>address, and telephone number of the individual, organization, or other entity requesting a hearing; (2) A brief statement of the requesting person's interest in the RA's determination and of information that the requesting person intends to submit at such hearing; and (3) the signature of the individual making the request, or, if the request is made on behalf of an organization or other entity, the signature of the responsible official of the organization or other entity. </P>

        <P>Notice of any hearing shall be given not less than fifteen (15) days prior to the time scheduled for the hearing. Such notice will be made by the RA in the <E T="04">Federal Register</E> and in newspapers of general circulation in the State of North Dakota. A notice will also be sent to the person(s) requesting the hearing as well as to the State of North Dakota. The hearing notice will include a statement of purpose, information regarding time and location, and the address and telephone number where interested persons may obtain further information. A final determination will be made upon review of the hearing record. </P>
        <P>Frivolous or insubstantial requests for a hearing may be denied by the RA. However, if a substantial request is made within thirty (30) days after this notice, a public hearing will be held. </P>
        <P>Please bring this notice to the attention of any persons known by you to have an interest in this determination. </P>
        <SIG>
          <DATED>Dated: July 30, 2003. </DATED>
          <NAME>Robert E. Roberts, </NAME>
          <TITLE>Regional Administrator, Region 8. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20893 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 6560-50-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF HEALTH AND HUMAN SERVICES </AGENCY>
        <SUBAGY>Centers for Medicare and Medicaid Services </SUBAGY>
        <DEPDOC>[Document Identifier: CMS-10095] </DEPDOC>
        <SUBJECT>Agency Information Collection Activities: Proposed Collection; Comment Request </SUBJECT>
        <P>
          <E T="03">Agency:</E> Centers for Medicare and Medicaid Services. </P>
        <P>In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare and Medicaid Services (CMS) (formerly known as the Health Care Financing Administration (CMS)), Department of Health and Human Services, is publishing the following summary of proposed collections for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency's functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. </P>
        <P>1. <E T="03">Type of Information Collection Request:</E> New Collection; <E T="03">Title of Information Collection:</E> “Detailed Explanation of Non-Coverage” 42 CFR 422.626(e)(1), and “Important Message of Non-Coverage” 42 CFR 625(b)(1); <E T="03">Form No.:</E> CMS-10095 (OMB# 0938-NEW); <E T="03">Use:</E> Pursuant of 42 CFR 422.624(b)(1), providers in skilled nursing facilities, home health agencies, and comprehensive outpatient rehabilitation facilities must deliver to M+C enrollees a 2-day advance notice of termination of services. Per requirements at 42 CFR 422.626(e)(1), M+C organizations must deliver detailed notices to the QIO and enrollees upon request for appeal of the termination of services. These notices fulfill the regulatory requirement; <E T="03">Frequency:</E> Other: distribution; <E T="03">Affected Public:</E> Business or other-for-profit, Not-for-profit institutions, Federal Government, and Individuals or Households.; <E T="03">Number of Respondents:</E> 155; <E T="03">Total Annual Responses:</E> 12,000; <E T="03">Total Annual Hours:</E> 18,000. </P>

        <P>To obtain copies of the supporting statement and any related forms for the proposed paperwork collections referenced above, access CMS's Web Site address at <E T="03">http://cms.hhs.gov/regulations/pra/default.asp,</E> or e-mail your request, including your address, phone number, OMB number, and CMS document identifier, to <E T="03">Paperwork@cms.hhs.gov,</E> or call the Reports Clearance Office on (410) 786-1326. Written comments and recommendations for the proposed information collections must be mailed within 60 days of this notice directly to the CMS Paperwork Clearance Officer designated at the following address: CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development and Issuances, Attention: Dawn Willinghan, Room: C5-14-03, 7500 Security Boulevard, Baltimore, Maryland 21244-1850. </P>
        <SIG>
          <DATED>Dated: August 7, 2003. </DATED>
          <NAME>Dawn Willinghan, </NAME>
          <TITLE>Acting CMS Reports Clearance Officer, Division of Regulations Development and Issuances, Office of Strategic Operations and Strategic Affairs. </TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20816 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4120-03-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF HEALTH AND HUMAN SERVICES</AGENCY>
        <SUBAGY>Administration for Children and Families </SUBAGY>
        <SUBJECT>Proposed Information Collection Activity; Comment Request</SUBJECT>
        <HD SOURCE="HD1">Proposed Projects</HD>
        <P>
          <E T="03">Title:</E> HHS/ACF Rural Welfare-to-Work Strategies Demonstration Evaluation Project 30-Month Survey</P>
        <P>
          <E T="03">OMB No.:</E> New collection</P>
        <P>
          <E T="03">Description:</E> The Rural Welfare-to-Work Strategies Demonstration Evaluation Project, which was developed and funded by the Administration for Children and Families (ACF) of the U.S. Department of Health and Human Services (HHS), is a national evaluation to determine the benefits and cost-effectiveness of methods designed to aid current or former Temporary Assistance for Needy Families (TANF) recipients or other low-income families as the transition from welfare to the employment arena. This evaluation addresses four research questions:</P>
        <P>• What are the issues and challenges associated with operating the new welfare-to-work services and policy approaches being studied?</P>
        <P>• How effective are the welfare-to-work programs under the project in increasing employment and earnings and in improving other measures?</P>
        <P>• What are the net costs of the welfare-to-work programs, and do the programs' benefits outweigh the costs?</P>
        <P>• What approaches should policymakers and program managers consider in designing strategies to improve the efficacy of welfare-to-work strategies for families in rural areas?</P>

        <P>The evaluation employs a multi-pronged approach to answer the research questions. These approaches include: (1) an impact study, which will examine the differences between control and intervention groups with respect to factors such as employment rates, earnings, and welfare receipt; (2) a cost-benefit analysis, which will calculate estimates of net program cost-effectiveness; and (3) an in-depth process study, which will identify implemetation issues and challenges, <PRTPAGE P="48923"/>examine program costs, and provide details on how programs achieve observed results. The data collected during the conduct of this study will be used for the following purposes:</P>
        <P>• To study rural welfare-to-work programs' effects on factors such as employment, earnings, educational attainment and family composition;</P>
        <P>• To collect data on a wider range of outcome measures—such as job acquisition, retention and advancement, job quality, educational attainment, and employment barriers—than is available through welfare or unemployment insurance records, in order to understand how individuals are being affected by the demonstrated programs;</P>
        <P>• To support research on the implementation of welfare-to-work programs across sites;</P>
        <P>• To obtain program participation and service use information important to the evaluation's cost-benefit component; and</P>
        <P>• To obtain contact information for a future follow-up survey that will be important to achieving high response rates for that survey.</P>
        <P>
          <E T="03">Respondents:</E> The respondents of the 30-month follow-up survey are current and former TANF recipients, or individuals in families at risk of needing TANF benefits (working poor, hard-to-employ) from the three states participating in the evaluation (Illinois, Nebraska, and Tennessee). The survey will be administered to both intervention and control groups in each participating site. The estimated sample size for the survey is 3,400 individuals, including projected samples of 2,200 in Tennessee, and 600 each in Illinois and Nebraska. The survey will be conducted primarily by telephone, with field interviews conducted with those individuals who cannot be interviewed by telephone. OMB already approved the process evaluation component and 18-month follow-up survey for this study.</P>
        <GPOTABLE CDEF="s100,12C,12C,xls90,12C" COLS="5" OPTS="L2,i1">
          <TTITLE>Annual Burden Estimates </TTITLE>
          <BOXHD>
            <CHED H="1">Instrument </CHED>
            <CHED H="1">Number of respondents </CHED>
            <CHED H="1">Number of responses per respondent </CHED>
            <CHED H="1">Average burden hours per response </CHED>
            <CHED H="1">Total burden hours </CHED>
          </BOXHD>
          <ROW>
            <ENT I="01">30-month follow-up survey</ENT>
            <ENT>686</ENT>
            <ENT>1</ENT>
            <ENT>30 minutes or .5 hours</ENT>
            <ENT>343 </ENT>
          </ROW>
        </GPOTABLE>
        <P>Estimated Total Annual Burden Hours: 343</P>

        <P>In compliance with the requirements of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Administration for Children and Families is soliciting public comment on the specific aspects of the information collection described above. Copies of the proposed collection of information can be obtained and comments may be forwarded by writing to the Administration for Children and Families, Office of Administration, Office of Information Services, 370 L'Enfant Promenade, SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. E-mail address: <E T="03">rsargis@acf.hhs.gov.</E> All requests should be identified by the title of the information collection.</P>
        <P>The Department specifically requests comments on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information; (c) the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Consideration will be given to comments and suggestions submitted within 60 days of this publication.</P>
        <SIG>
          <DATED>Dated: August 11, 2003.</DATED>
          <NAME>Robert Sargis,</NAME>
          <TITLE>Reports Clearance Officer.</TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20884 Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 4184-01-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF HEALTH AND HUMAN SERVICES </AGENCY>
        <SUBAGY>Administration for Children and Families </SUBAGY>
        <DEPDOC>[ACF-ADD-07-11-2003] </DEPDOC>
        <SUBJECT>Developmental Disabilities: Notice of Availability of Financial Assistance and Request for Applications To Fund Training and Technical Assistance To Improve Voting Access for Individuals With Disabilities </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Administration on Developmental Disabilities (ADD), ACF, DHHS.</P>
        </AGY>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The purpose of this notice is to correct errors that were printed in notice 68 FR 46189 on August 5, 2003. The notice contained an incorrect page limit for application submissions and incorrectly lettered requirements within the Instructions for the Development and Submission of Application section. The purpose of this program is to fund training and technical assistance grants that establish and improve voting access for individuals with the full range of disabilities. </P>
        </SUM>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>

          <P>Administration for Children and Families, Carla R. Brown, Management Analyst, 370 L'Enfant Promenade, SW., Washington, DC 20447, (202) 690-8332, <E T="03">crbrown@acf.hhs.gov</E>; or Lois Hodge, Grants Officer, 370 L'Enfant Promenade SW., Washington, DC 20447, (202) 401-2344, <E T="03">lhodge@acf.hhs.gov</E>. Copies of this program announcement and many of the required forms may be obtained electronically at the ADD World Wide Web page: <E T="03">http://www.acf.dhhs.gov/programs/add/</E>. </P>
          <P>
            <E T="03">Correction:</E> In the <E T="04">Federal Register</E> on August 5, 2003, in FR DOC 68-46197, in the third full paragraph please change the 25-page limit to a 50-page limit so that the first sentence of the paragraph reads, “The length of the application, including the application forms and all attachments, should not exceed 50 pages.” Also within this paragraph please change the fourth sentence to read, “These materials, if submitted, will not be included in the review process if they exceed the 50-page limit.” </P>
          <P>Also in the <E T="04">Federal Register</E> on August 5, 2003 in FR DOC 68-46198, please change the lettering for “E. Checklist for a Complete Application, F. Application Package, and G. Paperwork Reduction Act of 1995” to “C. Checklist for a Complete Application, D. Application Package, and E. Paperwork Reduction Act of 1995.” The doc had incorrectly lettered these sections. </P>
          <SIG>
            <DATED>Dated: August 12, 2003. </DATED>
            <NAME>Patricia Morrissey, </NAME>
            <TITLE>Commissioner, Administration on Developmental Disabilities. </TITLE>
          </SIG>
        </FURINF>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20885 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4184-01-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <PRTPAGE P="48924"/>
        <AGENCY TYPE="N">DEPARTMENT OF TRANSPORTATION</AGENCY>
        <SUBAGY>Federal Highway Administration</SUBAGY>
        <AGENCY TYPE="O">DEPARTMENT OF HOMELAND SECURITY</AGENCY>
        <SUBAGY>Coast Guard</SUBAGY>
        <SUBJECT>Gravina Access Project, Tongass Narrows, Ketchikan Gateway Borough, AK</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Federal Highway Administration. U.S. Coast Guard.</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of public hearing; Request for comments. Notice of availability of draft environmental impact statement (EIS).</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>the Federal Highway Administration (FHWA), together with U.S. Coast Guard and the Alaska Department of Transportation and Public Facilities, has issued a Gravina Access Project Draft Environmental Impact Statement (EIS) on August 6, 2003. The agencies will jointly hold two public hearings to receive information concerning the environmental impacts on the project, including marine navigation impacts.</P>
          <P>The project would construct a bridge or new ferry across Tongass Narrows in southern Southeast Alaska. The cities of Ketchikan and Saxman, along with surrounding developed areas within the Ketchikan Gateway Borough on Revillagigedo Island, are separated by Tongass Narrows from Ketchikan International Airport and developable land within the borough on Gravina Island. Ferry service currently connects Ketchikan to the airport terminal, but there is no connection to other lands on Gravina Island. The project proposes to improve transportation across Tongass Narrows by enhanced ferry or by bridge. Nine alternatives, plus No Action Alternative, are under consideration. All share in common a spine road around the airport to provide access to the airport and to other developable lands around the airport. Other developable lands include airport reserve lands, State of Alaska Mental Health Trust lands, University of Alaska lands, and private lands. The Ketchikan Gateway Borough is within Tongass National Forest.</P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>The public hearings will start at 7 p.m. on Wednesday, September 17, and Thursday, September 18, 2003. On Tuesday September 16, from 3 p.m. to 8 p.m., a public information open house will be held to enable interested parties to learn more about the project and ask questions. Display materials will be available during the open house and beginning at 5 p.m., September 17 and 18, prior to the public hearings. Comments must be received by October 6, 2003.</P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>The public hearings and associated open house will be held at the West Coast Cape Fox Lodge, 800 Venetia Way, Ketchikan, AK 99901. Comments on the Draft Environmental Impact Statement should be sent to Mr. Reuben Yost, Special Projects Manager, Alaska Department of Transportation and Public Facilities—Southeast Region, 6860 Glacier Highway, Juneau, AK 99801-7999. Please submit all comments in an unbound format no larger than 8<FR>1/2</FR> x 11 inches and suitable for copying.</P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Mr. Tim A. Haugh, Environment and Right-of-Way Programs Manager, Alaska Division FHWA, P.O. Box 21648, Juneau, Alaska 99802, Telephone (907) 586-7418; Mr. James Helfinstine, Chief, Bridge Administration Program, Commander (OAN), Seventeenth Coast Guard District, P.O. Box 25517, Juneau, AK 99802-5517, Telephone (907) 463-2268; Mr. Reuben Yost, P.E., Special Projects Manager, DOT&amp;PF Southeast Region, 6860 Glacier Highway, Juneau, Alaska 99801-7999, Telephone (907) 465-1828</P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <HD SOURCE="HD1">Background</HD>
        <P>The Gravina Access Project is one of 17 high-priority infrastructure projects in the State of Alaska to be funded under the Federal Transportation Equity  Act for the 21st Century (TEA-21), enacted in 1998. The Draft EIS examines a range of alternatives: Four bridge alternatives that cross Tongass Narrows near the airport, two bridge alternatives that cross Pennock Island southeast of the airport, and three ferry alternatives that would supplement the existing airport ferry service with a second ferry at different locations. All nine build alternatives tie into Tongass Avenue, which parallels the coast of Revillagigedo Island. All nine include a spine road around the western side and southern end of the airport, providing access to the airport terminal and other developable lands.</P>
        <P>The road associated with each alternative would consist of two lanes. The length of the road varies from 16,670 fee to 42,100 feet, depending on alternative. The ferry alternatives each include docks, terminal buildings, parking areas, and a ferry vessel. The location of the terminals and crossings vary. The bridge alternatives are either 120 feet high (to pass Alaska Marine Highway vessels) or 200 feet high (to pass the largest cruise ships sailing in Southeast Alaska). Two bridge alternatives cross Pennock Island, which divides Tongass Narrows. </P>
        <P>These alternatives require bridges over both the east and west channels. Alternative F1, a Pennock Island option that has a West Channel bridge 120 feet high and an East Channel bridge 200 feet high, is the agency-preferred alternative.</P>
        <P>The FHWA is the lead Federal agency for the environmental documentation. The Alaska Department of Transportation and Public Facilities has written the environmental documentation on behalf of FHWA. The U.S. Army Corps of Engineers, U.S. Coast Guard, Ketchikan Gateway Borough, City of Ketchikan, and City of Saxman are cooperating agencies for the project.</P>

        <P>The public hearings will provide a public forum that affords a full opportunity for presenting views on the social, economic, and environmental effects of the alternatives including impacts on navigation and marine transportation. Comments are invited from all interested parties and should be directed by October 6, 2003 to Mr. Reuben Yost at the address provided above. Information on the project and the Draft EIS are available electronically at <E T="03">http://www.gravina-access.com.</E>
        </P>
        <HD SOURCE="HD1">Procedural</HD>

        <P>Individuals and representatives of organizations that wish to speak at the public hearings may sign in as they arrive at the WestCoast Cape Fox Lodge. Individuals will have 3 minutes to speak and organizations 5 minutes. Each person or organization will be afforded one opportunity to speak only. Speakers will be called in the order they signed in. Those who wish to be placed on the project mailing list may submit a request to Mr. Reuben Yost, listed above under <E T="02">addresses</E>.</P>
        <HD SOURCE="HD1">Information on Services for Individuals With Disabilities</HD>

        <P>Appropriate aids and services for qualified individuals with disabilities or non-English-speaking persons will be provided upon request. Please make requests for these services in writing; by telephone or via e-mail to Mr. Reuben Yost at the contacts listed under <E T="02">addresses</E> above, or via teletype 1-907-465-4647; or via e-mail at <E T="03">Reuben _Yost@dot.state.ak.us.</E> Any requests for an oral or sign language interpreter must be received by September 9, 2003.</P>
        <SIG>
          <PRTPAGE P="48925"/>
          <DATED>Dated: July 31, 2003.</DATED>
          <NAME>J. A. Schott,</NAME>
          <TITLE>Captain, U.S. Coast Guard, Commander, 17th Coast Guard District, Acting.</TITLE>
          <NAME>David C. Miller,</NAME>
          <TITLE>Division Administrator, Federal Highway Administration.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20822  Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 4910-22-M; 4910-15-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF HOMELAND SECURITY </AGENCY>
        <SUBAGY>Federal Emergency Management Agency </SUBAGY>
        <DEPDOC>[FEMA-1481-DR] </DEPDOC>
        <SUBJECT>Florida; Major Disaster and Related Determinations </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Federal Emergency Management Agency, Emergency Preparedness and Response Directorate, Department of Homeland Security. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This is a notice of the Presidential declaration of a major disaster for the State of Florida (FEMA-1481-DR), dated July 29, 2003, and related determinations. </P>
        </SUM>
        <EFFDATE>
          <HD SOURCE="HED">EFFECTIVE DATE:</HD>
          <P>July 29, 2003. </P>
        </EFFDATE>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Magda Ruiz, Recovery Division, Federal Emergency Management Agency, Washington, DC 20472, (202) 646-2705. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>Notice is hereby given that, in a letter dated July 29, 2003, the President declared a major disaster under the authority of the Robert T. Stafford Disaster Relief and Emergency Assistance Act, 42 U.S.C. 5121-5206 (the Stafford Act), as follows: </P>
        
        <EXTRACT>
          <P>I have determined that the damage in certain areas of the State of Florida, resulting from severe storms and flooding on June 13, 2003, and continuing is of sufficient severity and magnitude to warrant a major disaster declaration under the Robert T. Stafford Disaster Relief and Emergency Assistance Act, 42 U.S.C. 5121-5206 (the Stafford Act). I, therefore, declare that such a major disaster exists in the State of Florida. </P>
          <P>In order to provide Federal assistance, you are hereby authorized to allocate from funds available for these purposes, such amounts as you find necessary for Federal disaster assistance and administrative expenses. </P>
          <P>You are authorized to provide Public Assistance in the designated areas, Hazard Mitigation throughout the State, and any other forms of assistance under the Stafford Act you may deem appropriate. Consistent with the requirement that Federal assistance be supplemental, any Federal funds provided under the Stafford Act for Public Assistance and Hazard Mitigation will be limited to 75 percent of the total eligible costs. If Other Needs Assistance under Section 408 of the Stafford Act is later requested and warranted, Federal funding under that program will also be limited to 75 percent of the total eligible costs. </P>
          <P>Further, you are authorized to make changes to this declaration to the extent allowable under the Stafford Act. </P>
        </EXTRACT>
        
        <P>The Federal Emergency Management Agency (FEMA) hereby gives notice that pursuant to the authority vested in the Under Secretary for Emergency Preparedness and Response, Department of Homeland Security, under Executive Order 12148, as amended, Peter Martinasco, of FEMA is appointed to act as the Federal Coordinating Officer for this declared disaster. </P>
        <P>I do hereby determine the following areas of the State of Florida to have been affected adversely by this declared major disaster: </P>
        
        <EXTRACT>
          <P>Charlotte, Citrus, DeSota, Hardee, Levy, Manatee, and Sarasota Counties for Public Assistance. </P>
        </EXTRACT>
        
        <P>All counties within the State of Florida are eligible to apply for assistance under the Hazard Mitigation Grant Program. </P>
        <SIG>
          <FP>(The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 83.537, Community Disaster Loans; 83.538, Cora Brown Fund Program; 83.539, Crisis Counseling; 83.540, Disaster Legal Services Program; 83.541, Disaster Unemployment Assistance (DUA); 83.556, Fire Management Assistance; 83.558, Individual and Household Housing; 83.559, Individual and Household Disaster Housing Operations; 83.560, Individual and Household Program-Other Needs; 83.544, Public Assistance Grants; 83.548, Hazard Mitigation Grant Program.) </FP>
          <NAME>Michael D. Brown, </NAME>
          <TITLE>Under Secretary, Emergency Preparedness and Response. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20846 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 6718-02-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF HOMELAND SECURITY </AGENCY>
        <SUBAGY>Federal Emergency Management Agency </SUBAGY>
        <DEPDOC>[FEMA-1476-DR] </DEPDOC>
        <SUBJECT>Indiana; Amendment No. 4 to Notice of a Major Disaster Declaration </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Federal Emergency Management Agency, Emergency Preparedness and Response Directorate, Department of Homeland Security. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This notice amends the notice of a major disaster declaration for the State of Indiana (FEMA-1476-DR), dated July 11, 2003, and related determinations. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">EFFECTIVE DATE:</HD>
          <P>July 30, 2003. </P>
        </DATES>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Magda Ruiz, Recovery Division, Federal Emergency Management Agency, Washington, DC 20472, (202) 646-2705. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>The notice of a major disaster declaration for the State of Indiana is hereby amended to include the following areas among those areas determined to have been adversely affected by the catastrophe declared a major disaster by the President in his declaration of July 11, 2003: </P>
        
        <EXTRACT>
          <FP SOURCE="FP-2">Union County for Public Assistance. </FP>
          <FP SOURCE="FP-2">Cass, Clay, Jay, and Tipton Counties for Public Assistance (already designated for Individual Assistance.) </FP>
        </EXTRACT>
        <SIG>
          <FP>(The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 83.537, Community Disaster Loans; 83.538, Cora Brown Fund Program; 83.539, Crisis Counseling; 83.540, Disaster Legal Services Program; 83.541, Disaster Unemployment Assistance (DUA); 83.556, Fire Management Assistance; 83.558, Individual and Household Housing; 83.559, Individual and Household Disaster Housing Operations; 83.560 Individual and Household Program—Other Needs, 83.544, Public Assistance Grants; 83.548, Hazard Mitigation Grant Program.) </FP>
          <NAME>Michael D. Brown, </NAME>
          <TITLE>Under Secretary, Emergency Preparedness and Response. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20840 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 6718-02-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF HOMELAND SECURITY </AGENCY>
        <SUBAGY>Federal Emergency Management Agency </SUBAGY>
        <DEPDOC>[FEMA-1480-DR] </DEPDOC>
        <SUBJECT>Nebraska; Amendment No. 1 to Notice of a Major Disaster Declaration </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Federal Emergency Management Agency, Emergency Preparedness and Response Directorate, Department of Homeland Security. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This notice amends the notice of a major disaster declaration for the State of Nebraska (FEMA-1480-DR), dated July 21, 2003, and related determinations. </P>
        </SUM>
        <EFFDATE>
          <HD SOURCE="HED">EFFECTIVE DATE:</HD>
          <P>August 4, 2003. </P>
        </EFFDATE>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Magda Ruiz, Recovery Division, Federal Emergency Management Agency, Washington, DC 20472, (202) 646-2705. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>The notice of a major disaster declaration for the <PRTPAGE P="48926"/>State of Nebraska is hereby amended to include the following areas among those areas determined to have been adversely affected by the catastrophe declared a major disaster by the President in his declaration of July 21, 2003: </P>
        
        <EXTRACT>
          <P>Butler, Cuming, Deuel, Dixon, Holt, Knox, Pierce, and Polk Counties for Public Assistance. </P>
        </EXTRACT>
        
        <SIG>
          <FP>(The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 83.537, Community Disaster Loans; 83.538, Cora Brown Fund Program; 83.539, Crisis Counseling; 83.540, Disaster Legal Services Program; 83.541, Disaster Unemployment Assistance (DUA); 83.556, Fire Management Assistance; 83.558, Individual and Household Housing; 83.559, Individual and Household Disaster Housing Operations; 83.560, Individual and Household Program-Other Needs; 83.544, Public Assistance Grants; 83.548, Hazard Mitigation Grant Program.) </FP>
          <NAME>Michael D. Brown, </NAME>
          <TITLE>Under Secretary, Emergency Preparedness and Response. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20847 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 6718-02-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF HOMELAND SECURITY </AGENCY>
        <SUBAGY>Federal Emergency Management Agency </SUBAGY>
        <DEPDOC>[FEMA-1483-DR] </DEPDOC>
        <SUBJECT>North Dakota; Major Disaster and Related Determinations </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Federal Emergency Management Agency, Emergency Preparedness and Response Directorate, Department of Homeland Security. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This is a notice of the Presidential declaration of a major disaster for the State of North Dakota (FEMA-1483-DR), dated August 1, 2003, and related determinations. </P>
        </SUM>
        <EFFDATE>
          <HD SOURCE="HED">EFFECTIVE DATE:</HD>
          <P>August 1, 2003. </P>
        </EFFDATE>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Magda Ruiz, Recovery Division, Federal Emergency Management Agency, Washington, DC 20472, (202) 646-2705. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>Notice is hereby given that, in a letter dated August 1, 2003, the President declared a major disaster under the authority of the Robert T. Stafford Disaster Relief and Emergency Assistance Act, 42 U.S.C. 5121-5206 (the Stafford Act), as follows: </P>
        
        <EXTRACT>
          <P>I have determined that the damage in certain areas of the State of North Dakota, resulting from severe storms and high winds on June 24-25, 2003, is of sufficient severity and magnitude to warrant a major disaster declaration under the Robert T. Stafford Disaster Relief and Emergency Assistance Act, 42 U.S.C. §§ 5121-5206 (the Stafford Act). I, therefore, declare that such a major disaster exists in the State of North Dakota. </P>
          <P>In order to provide Federal assistance, you are hereby authorized to allocate from funds available for these purposes, such amounts as you find necessary for Federal disaster assistance and administrative expenses. </P>
          <P>You are authorized to provide Public Assistance in the designated areas, and Hazard Mitigation throughout the State, and any other forms of assistance under the Stafford Act you may deem appropriate. Consistent with the requirement that Federal assistance be supplemental, any Federal funds provided under the Stafford Act for Public Assistance and Hazard Mitigation will be limited to 75 percent of the total eligible costs. If Other Needs Assistance under Section 408 of the Stafford Act is later requested and warranted, Federal funding under that program will also be limited to 75 percent of the total eligible costs. </P>
          <P>The North Dakota Division of Emergency Management (DEM) will manage the Public Assistance operation, including project eligibility reviews, process control, and resource allocation. The Federal Emergency Management Agency (FEMA) will retain obligation authority, the final approval of environmental and historic preservation reviews, and will assist the North Dakota DEM to the extent that such assistance is necessary and requested by DEM. </P>
          <P>Further, you are authorized to make changes to this declaration to the extent allowable under the Stafford Act. </P>
        </EXTRACT>
        
        <P>The Federal Emergency Management Agency (FEMA) hereby gives notice that pursuant to the authority vested in the Under Secretary for Emergency Preparedness and Response, Department of Homeland Security, under Executive Order 12148, as amended, James N. Russo, of FEMA is appointed to act as the Federal Coordinating Officer for this declared disaster. </P>
        <P>I do hereby determine the following area of the State of North Dakota to have been affected adversely by this declared major disaster: </P>
        
        <EXTRACT>
          <P>Barnes County for Public Assistance. </P>
        </EXTRACT>
        
        <P>All counties within the State of North Dakota are eligible to apply for assistance under the Hazard Mitigation Grant Program. </P>
        
        <EXTRACT>
          <FP>(The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 83.537, Community Disaster Loans; 83.538, Cora Brown Fund Program; 83.539, Crisis Counseling; 83.540, Disaster Legal Services Program; 83.541, Disaster Unemployment Assistance (DUA); 83.556, Fire Management Assistance; 83.558, Individual and Household Housing; 83.559, Individual and Household Disaster Housing Operations; 83.560, Individual and Household Program-Other Needs; 83.544, Public Assistance Grants; 83.548, Hazard Mitigation Grant Program.) </FP>
        </EXTRACT>
        <SIG>
          <NAME>Michael D. Brown, </NAME>
          <TITLE>Under Secretary, Emergency Preparedness and Response. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20851 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 6718-02-P </BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF HOMELAND SECURITY </AGENCY>
        <SUBAGY>Federal Emergency Management Agency </SUBAGY>
        <DEPDOC>[FEMA-1478-DR] </DEPDOC>
        <SUBJECT>Ohio; Amendment No. 3 to Notice of a Major Disaster Declaration </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Federal Emergency Management Agency, Emergency Preparedness and Response Directorate, Department of Homeland Security. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This notice amends the notice of a major disaster declaration for the State of Ohio (FEMA-1478-DR), dated July 15, 2003, and related determinations. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">EFFECTIVE DATE:</HD>
          <P>August 4, 2003. </P>
        </DATES>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Magda Ruiz, Recovery Division, Federal Emergency Management Agency, Washington, DC 20472, (202) 646-2705. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>The notice of a major disaster declaration for the State of Ohio is hereby amended to include the following areas among those areas determined to have been adversely affected by the catastrophe declared a major disaster by the President in his declaration of July 15, 2003: </P>
        
        <EXTRACT>
          <FP SOURCE="FP-2">Columbiana and Mahoning Counties for Individual Assistance. </FP>
        </EXTRACT>
        <SIG>
          <FP>(The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 83.537, Community Disaster Loans; 83.538, Cora Brown Fund Program; 83.539, Crisis Counseling; 83.540, Disaster Legal Services Program; 83.541, Disaster Unemployment Assistance (DUA); 83.556, Fire Management Assistance; 83.558, Individual and Household Housing; 83.559, Individual and Household Disaster Housing Operations; 83.560 Individual and Household Program—Other Needs, 83.544, Public Assistance Grants; 83.548, Hazard Mitigation Grant Program.) </FP>
          <NAME>Michael D. Brown, </NAME>
          <TITLE>Under Secretary, Emergency Preparedness and Response. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20842 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 6718-02-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <PRTPAGE P="48927"/>
        <AGENCY TYPE="S">DEPARTMENT OF HOMELAND SECURITY</AGENCY>
        <SUBAGY>Federal Emergency Management Agency</SUBAGY>
        <DEPDOC>[FEMA-1478-DR]</DEPDOC>
        <SUBJECT>Ohio; Amendment No. 2 to Notice of a Major Disaster Declaration</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Federal Emergency Management Agency, Emergency Preparedness and Response Directorate, Department of Homeland Security.</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This notice amends the notice of a major disaster declaration for the State of Ohio (FEMA-1478-DR), dated July 15, 2003, and related determinations.</P>
        </SUM>
        <EFFDATE>
          <HD SOURCE="HED">EFFECTIVE DATE:</HD>
          <P>July 29, 2003.</P>
        </EFFDATE>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Magda Ruiz, Recovery Division, Federal Emergency Management Agency, Washington, DC 20472, (202) 646-2705.</P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>The notice of a major disaster declaration for the State of Ohio is hereby amended to include the following areas among those areas determined to have been adversely affected by the catastrophe declared a major disaster by the President in his declaration of July 15, 2003:</P>
        
        <EXTRACT>
          <FP SOURCE="FP-2">Crawford and Pike Counties for Individual Assistance.</FP>
        </EXTRACT>
        <SIG>
          <FP>(The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 83.537, Community Disaster Loans; 83.538, Cora Brown Fund Program; 83.539, Crisis Counseling; 83.540, Disaster Legal Services Program; 83.541, Disaster Unemployment Assistance (DUA); 83.556, Fire Management Assistance; 83.558, Individual and Household Housing; 83.559, Individual and Household Disaster Housing Operations; 83.560 Individual and Household Program-Other Needs, 83.544, Public Assistance Grants; 83.548, Hazard Mitigation Grant Program.)</FP>
          <NAME>Michael D. Brown,</NAME>
          <TITLE>Under Secretary, Emergency Preparedness and Response.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20843 Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 6718-02-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF HOMELAND SECURITY </AGENCY>
        <SUBAGY>Federal Emergency Management Agency </SUBAGY>
        <DEPDOC>[FEMA-1484-DR] </DEPDOC>
        <SUBJECT>Ohio; Major Disaster and Related Determinations </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Federal Emergency Management Agency, Emergency Preparedness and Response Directorate, Department of Homeland Security. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This is a notice of the Presidential declaration of a major disaster for the State of Ohio (FEMA-1484-DR), dated August 1, 2003, and related determinations. </P>
        </SUM>
        <EFFDATE>
          <HD SOURCE="HED">EFFECTIVE DATE:</HD>
          <P>August 1, 2003. </P>
        </EFFDATE>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Magda Ruiz, Recovery Division, Federal Emergency Management Agency, Washington, DC 20472, (202) 646-2705. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>Notice is hereby given that, in a letter dated August 1, 2003, the President declared a major disaster under the authority of the Robert T. Stafford Disaster Relief and Emergency Assistance Act, 42 U.S.C. 5121-5206 (the Stafford Act), as follows: </P>
        
        <EXTRACT>
          <P>I have determined that the damage in certain areas of the State of Ohio, resulting from tornadoes, flooding, severe storms, and high winds, on July 21, 2003, and continuing, is of sufficient severity and magnitude to warrant a major disaster declaration under the Robert T. Stafford Disaster Relief and Emergency Assistance Act, 42 U.S.C. 5121-5206 (the Stafford Act). I, therefore, declare that such a major disaster exists in the State of Ohio. </P>
          <P>In order to provide Federal assistance, you are hereby authorized to allocate from funds available for these purposes, such amounts as you find necessary for Federal disaster assistance and administrative expenses. </P>
          <P>You are authorized to provide Individual Assistance in the designated areas, and Hazard Mitigation throughout the State, and any other forms of assistance under the Stafford Act you may deem appropriate. Consistent with the requirement that Federal assistance be supplemental, any Federal funds provided under the Stafford Act for Hazard Mitigation, and the Other Needs Assistance under Section 408 of the Stafford Act will be limited to 75 percent of the total eligible costs. If Public Assistance is later requested and warranted, Federal funds provided under that program will also be limited to 75 percent of the total eligible costs. </P>
          <P>Further, you are authorized to make changes to this declaration to the extent allowable under the Stafford Act. </P>
        </EXTRACT>
        
        <P>The time period prescribed for the implementation of section 310(a), Priority to Certain Applications for Public Facility and Public Housing Assistance, 42 U.S.C. 5153, shall be for a period not to exceed six months after the date of this declaration. </P>
        <P>The Federal Emergency Management Agency (FEMA) hereby gives notice that pursuant to the authority vested in the Under Secretary for Emergency Preparedness and Response, Department of Homeland Security, under Executive Order 12148, as amended, Ron Sherman, of FEMA is appointed to act as the Federal Coordinating Officer for this declared disaster. </P>
        <P>I do hereby determine the following areas of the State of Ohio to have been affected adversely by this declared major disaster: </P>
        
        <EXTRACT>
          <P>Mahoning, Medina, Portage, Summit, and Trumbull Counties for Individual Assistance. </P>
        </EXTRACT>
        
        <P>All counties within the State of Ohio are eligible to apply for assistance under the Hazard Mitigation Grant Program. </P>
        <SIG>
          <FP>(The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 83.537, Community Disaster Loans; 83.538, Cora Brown Fund Program; 83.539, Crisis Counseling; 83.540, Disaster Legal Services Program; 83.541, Disaster Unemployment Assistance (DUA); 83.556, Fire Management Assistance; 83.558, Individual and Household Housing; 83.559, Individual and Household Disaster Housing Operations; 83.560, Individual and Household Program-Other Needs; 83.544, Public Assistance Grants; 83.548, Hazard Mitigation Grant Program.) </FP>
          <NAME>Michael D. Brown, </NAME>
          <TITLE>Under Secretary, Emergency Preparedness and Response. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20850 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 6718-02-P </BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF HOMELAND SECURITY </AGENCY>
        <SUBAGY>Federal Emergency Management Agency </SUBAGY>
        <DEPDOC>[FEMA-1484-DR] </DEPDOC>
        <SUBJECT>Ohio; Amendment No. 1 to Notice of a Major Disaster Declaration </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Federal Emergency Management Agency, Emergency Preparedness and Response Directorate, Department of Homeland Security. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This notice amends the notice of a major disaster declaration for the State of Ohio (FEMA-1484-DR), dated August 1, 2003, and related determinations. </P>
        </SUM>
        <EFFDATE>
          <HD SOURCE="HED">EFFECTIVE DATE:</HD>
          <P>August 5, 2003. </P>
        </EFFDATE>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Magda Ruiz, Recovery Division, Federal Emergency Management Agency, Washington, DC 20472, (202) 646-2705. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>The notice of a major disaster declaration for the State of Ohio is hereby amended to include the following areas among those areas determined to have been adversely affected by the catastrophe declared a major disaster by the President in his declaration of August 1, 2003: </P>
        
        <EXTRACT>
          <FP SOURCE="FP-2">Carroll, Columbiana, Cuyahoga, and Stark <PRTPAGE P="48928"/>Counties for Individual Assistance. </FP>
        </EXTRACT>
        <SIG>
          <FP>(The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 83.537, Community Disaster Loans; 83.538, Cora Brown Fund Program; 83.539, Crisis Counseling; 83.540, Disaster Legal Services Program; 83.541, Disaster Unemployment Assistance (DUA); 83.556, Fire Management Assistance; 83.558, Individual and Household Housing; 83.559, Individual and Household Disaster Housing Operations; 83.560, Individual and Household Program-Other Needs; 83.544, Public Assistance Grants; 83.548, Hazard Mitigation Grant Program.) </FP>
          <NAME>Michael D. Brown, </NAME>
          <TITLE>Under Secretary, Emergency Preparedness and Response. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20854 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 6718-02-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF HOMELAND SECURITY </AGENCY>
        <SUBAGY>Federal Emergency Management Agency </SUBAGY>
        <DEPDOC>[FEMA-1482-DR] </DEPDOC>
        <SUBJECT>Tennessee; Amendment No. 1 to Notice of a Major Disaster Declaration </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Federal Emergency Management Agency, Emergency Preparedness and Response Directorate, Department of Homeland Security. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This notice amends the notice of a major disaster declaration for the State of Tennessee (FEMA-1482-DR), dated July 29, 2003, and related determinations. </P>
        </SUM>
        <EFFDATE>
          <HD SOURCE="HED">EFFECTIVE DATE:</HD>
          <P>August 6, 2003. </P>
        </EFFDATE>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Magda Ruiz, Recovery Division, Federal Emergency Management Agency, Washington, DC 20472, (202) 646-2705. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>The notice of a major disaster declaration for the State of Tennessee is hereby amended to include the following area among those areas determined to have been adversely affected by the catastrophe declared a major disaster by the President in his declaration of July 29, 2003: </P>
        
        <EXTRACT>
          <P>Fayette County for Individual Assistance (already designated for Public Assistance.) </P>
        </EXTRACT>
        <SIG>
          <FP>(The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 83.537, Community Disaster Loans; 83.538, Cora Brown Fund Program; 83.539, Crisis Counseling; 83.540, Disaster Legal Services Program; 83.541, Disaster Unemployment Assistance (DUA); 83.556, Fire Management Assistance; 83.558, Individual and Household Housing; 83.559, Individual and Household Disaster Housing Operations; 83.560 Individual and Household Program—Other Needs, 83.544, Public Assistance Grants; 83.548, Hazard Mitigation Grant Program.) </FP>
          <NAME>Michael D. Brown, </NAME>
          <TITLE>Under Secretary, Emergency Preparedness and Response. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20848 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 6718-02-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF HOMELAND SECURITY </AGENCY>
        <SUBAGY>Federal Emergency Management Agency </SUBAGY>
        <DEPDOC>[FEMA-1482-DR] </DEPDOC>
        <SUBJECT>Tennessee; Major Disaster and Related Determinations </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Federal Emergency Management Agency, Emergency Preparedness and Response Directorate, Department of Homeland Security. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This is a notice of the Presidential declaration of a major disaster for the State of Tennessee (FEMA-1482-DR), dated July 29, 2003, and related determinations. </P>
        </SUM>
        <EFFDATE>
          <HD SOURCE="HED">EFFECTIVE DATE:</HD>
          <P>July 29, 2003. </P>
        </EFFDATE>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Magda Ruiz, Recovery Division, Federal Emergency Management Agency, Washington, DC 20472, (202) 646-2705. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>Notice is hereby given that, in a letter dated July 29, 2003, the President declared a major disaster under the authority of the Robert T. Stafford Disaster Relief and Emergency Assistance Act, 42 U.S.C. 5121-5206 (the Stafford Act), as follows: </P>
        
        <EXTRACT>
          <P>I have determined that the damage in certain areas of the State of Tennessee, resulting from severe storms, high winds, and heavy rain on July 21-22, 2003, is of sufficient severity and magnitude to warrant a major disaster declaration under the Robert T. Stafford Disaster Relief and Emergency Assistance Act, 42 U.S.C. 5121-5206 (the Stafford Act). I, therefore, declare that such a major disaster exists in the State of Tennessee. </P>
          <P>In order to provide Federal assistance, you are hereby authorized to allocate from funds available for these purposes, such amounts as you find necessary for Federal disaster assistance and administrative expenses. </P>
          <P>You are authorized to provide Individual Assistance and Public Assistance in the designated areas, and Hazard Mitigation throughout the State. Consistent with the requirement that Federal assistance be supplemental, any Federal funds provided under the Stafford Act for Public Assistance, Hazard Mitigation, and the Other Needs Assistance under Section 408 of the Stafford Act will be limited to 75 percent of the total eligible costs. </P>
          <P>Further, you are authorized to make changes to this declaration to the extent allowable under the Stafford Act. </P>
        </EXTRACT>
        
        <P>The time period prescribed for the implementation of section 310(a), Priority to Certain Applications for Public Facility and Public Housing Assistance, 42 U.S.C. 5153, shall be for a period not to exceed six months after the date of this declaration. </P>
        <P>The Federal Emergency Management Agency (FEMA) hereby gives notice that pursuant to the authority vested in the Under Secretary for Emergency Preparedness and Response, Department of Homeland Security, under Executive Order 12148, as amended, Charles M. Butler, of FEMA is appointed to act as the Federal Coordinating Officer for this declared disaster. </P>
        <P>I do hereby determine the following areas of the State of Tennessee to have been affected adversely by this declared major disaster: </P>
        
        <EXTRACT>
          <P>Shelby County for Individual Assistance and Public Assistance. </P>
          <P>Fayette County for Public Assistance. </P>
        </EXTRACT>
        
        <P>All counties within the State of Tennessee are eligible to apply for assistance under the Hazard Mitigation Grant Program. </P>
        <SIG>
          <FP>(The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 83.537, Community Disaster Loans; 83.538, Cora Brown Fund Program; 83.539, Crisis Counseling; 83.540, Disaster Legal Services Program; 83.541, Disaster Unemployment Assistance (DUA); 83.556, Fire Management Assistance; 83.558, Individual and Household Housing; 83.559, Individual and Household Disaster Housing Operations; 83.560, Individual and Household Program-Other Needs; 83.544, Public Assistance Grants; 83.548, Hazard Mitigation Grant Program.) </FP>
          <NAME>Michael D. Brown, </NAME>
          <TITLE>Under Secretary, Emergency Preparedness and Response. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20849 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 6718-02-P </BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF HOMELAND SECURITY</AGENCY>
        <SUBAGY>Federal Emergency Management Agency</SUBAGY>
        <DEPDOC>[FEMA-1479-DR]</DEPDOC>
        <SUBJECT>Texas; Amendment No. 5 to Notice of a Major Disaster Declaration</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Federal Emergency Management Agency, Emergency Preparedness and Response Directorate, Department of Homeland Security.</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice.</P>
        </ACT>
        <SUM>
          <PRTPAGE P="48929"/>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This notice amends the notice of a major disaster declaration for the State of Texas (FEMA-1479-DR), dated July 17, 2003, and related determinations.</P>
        </SUM>
        <EFFDATE>
          <HD SOURCE="HED">EFFECTIVE DATE:</HD>
          <P>August 5, 2003.</P>
        </EFFDATE>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Magda Ruiz, Recovery Division, Federal Emergency Management Agency, Washington, DC 20472, (202) 646-2705.</P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>The notice of a major disaster declaration for the State of Texas is hereby amended to include the following area among those areas determined to have been adversely affected by the catastrophe declared a major disaster by the President in his declaration of July 17, 2003:</P>
        
        <FP SOURCE="FP-2">Aransas County for Individual Assistance.</FP>
        <SIG>
          <FP>(The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 83.537, Community Disaster Loans; 83.538, Cora Brown Fund Program; 83.539, Crisis Counseling; 83.540, Disaster Legal Services Program; 83.541, Disaster Unemployment Assistance (DUA); 83.556, Fire Management Assistance; 83.558, Individual and Household Housing; 83.559, Individual and Household Disaster Housing Operations; 83.560 Individual and Household Program-Other Needs, 83.544, Public Assistance Grants; 83.548, Hazard Mitigation Grant Program.)</FP>
          <NAME>Michael D. Brown,</NAME>
          <TITLE>Under Secretary, Emergency Preparedness and Response.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20844 Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 6718-02-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF HOMELAND SECURITY </AGENCY>
        <SUBAGY>Federal Emergency Management Agency </SUBAGY>
        <DEPDOC>[FEMA-1479-DR] </DEPDOC>
        <SUBJECT>Texas; Amendment No. 4 to Notice of a Major Disaster Declaration </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Federal Emergency Management Agency, Emergency Preparedness and Response Directorate, Department of Homeland Security. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This notice amends the notice of a major disaster declaration for the State of Texas (FEMA-1479-DR), dated July 17, 2003, and related determinations. </P>
        </SUM>
        <EFFDATE>
          <HD SOURCE="HED">EFFECTIVE DATE:</HD>
          <P>August 1, 2003. </P>
        </EFFDATE>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Magda Ruiz, Recovery Division, Federal Emergency Management Agency, Washington, DC 20472, (202) 646-2705. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>The notice of a major disaster declaration for the State of Texas is hereby amended to include the following areas among those areas determined to have been adversely affected by the catastrophe declared a major disaster by the President in his declaration of July 17, 2003: </P>
        
        <EXTRACT>
          <P>Atascosa and McMullen Counties for Individual Assistance (already designated for Public Assistance.) </P>
          <P>Zavala County for Individual Assistance and Public Assistance. </P>
        </EXTRACT>
        <SIG>
          <FP>(The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 83.537, Community Disaster Loans; 83.538, Cora Brown Fund Program; 83.539, Crisis Counseling; 83.540, Disaster Legal Services Program; 83.541, Disaster Unemployment Assistance (DUA); 83.556, Fire Management Assistance; 83.558, Individual and Household Housing; 83.559, Individual and Household Disaster Housing Operations; 83.560 Individual and Household Program—Other Needs, 83.544, Public Assistance Grants; 83.548, Hazard Mitigation Grant Program.) </FP>
          <NAME>Michael D. Brown, </NAME>
          <TITLE>Under Secretary, Emergency Preparedness and Response.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20845 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 6718-02-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF HOMELAND SECURITY</AGENCY>
        <SUBAGY>Federal Emergency Management Agency</SUBAGY>
        <DEPDOC>[FEMA-1474-DR]</DEPDOC>
        <SUBJECT>West Virginia; Amendment No. 9 to Notice of a Major Disaster Declaration</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Federal Emergency Management Agency, Emergency Preparedness and Response Directorate, Department of Homeland Security.</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This notice amends the notice of a major disaster declaration for the State of West Virginia (FEMA-1474-DR), dated June 21, 2003, and related determinations.</P>
        </SUM>
        <EFFDATE>
          <HD SOURCE="HED">EFFECTIVE DATE:</HD>
          <P>July 30, 2003.</P>
        </EFFDATE>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Magda Ruiz, Recovery Division, Federal Emergency Management Agency, Washington, DC 20472, (202) 646-2705.</P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>The notice of a major disaster declaration for the State of West Virginia is hereby amended to include the following area among those areas determined to have been adversely affected by the catastrophe declared a major disaster by the President in his declaration of June 21, 2003:</P>
        <FP SOURCE="FP-2">Marion County for Individual Assistance.</FP>
        <SIG>
          <FP>(The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 83.537, Community Disaster Loans; 83.538, Cora Brown Fund Program; 83.539, Crisis Counseling; 83.540, Disaster Legal Services Program; 83.541, Disaster Unemployment Assistance (DUA); 83.556, Fire Management Assistance; 83.558, Individual and Household Housing; 83.559, Individual and Household Disaster Housing Operations; 83.560 Individual and Household Program-Other Needs, 83.544, Public Assistance Grants; 83.548, Hazard Mitigation Grant Program.)</FP>
          <NAME>Michael D. Brown,</NAME>
          <TITLE>Under Secretary, Emergency Preparedness and Response.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20841 Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 6718-02-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF HOMELAND SECURITY </AGENCY>
        <SUBAGY>Federal Emergency Management Agency </SUBAGY>
        <SUBJECT>Grants to States for Community Emergency Response Teams </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>U.S. Fire Administration (USFA), Federal Emergency Management Agency, Emergency Preparedness and Response Directorate, Department of Homeland Security. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of funds availability. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>FEMA gives notice of the availability of grant funding in the amount of $18.8 million for fiscal year (FY) 2003 for the development or improvement of Community Emergency Response Teams (CERTs). </P>
        </SUM>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>

          <P>Sam Isenberger, National Emergency Training Center, Training Division, 16825 S. Seton Avenue, Emmitsburg, MD 21727. Telephone No. (301) 447-1071 or e-mail: <E T="03">sam.isenberger@dhs.gov</E>. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>The CERT concept was developed and implemented by the Los Angeles City Fire Department in 1985. When emergencies occur, CERT members can give critical support to first responders, provide immediate assistance to victims, and organize spontaneous volunteers at a disaster site. CERT members can also help with non-emergency projects that help improve the safety of the community. </P>

        <P>The CERT training program, made available nationally by FEMA in 1993, is a 20-hour course typically delivered over a seven-week period. Training sessions cover disaster preparedness, disaster fire suppression, basic disaster <PRTPAGE P="48930"/>medical operations, light search and rescue, and team operations. </P>
        <P>The FY 2003 grant funding is in addition to $17 million distributed under the FY 2002 emergency supplemental appropriation. In the FY 2003 program, FEMA intends to continue, maintain, and expand existing State and local CERT programs while supporting new CERT Train-The-Trainer courses and extending the CERT program into new jurisdictions nationwide. </P>
        <HD SOURCE="HD1">Authority </HD>
        <P>Robert T. Stafford Disaster Relief and Emergency Assistance Act (Stafford Act), 42 U.S.C. 5121-5206. </P>
        <HD SOURCE="HD1">Appropriations </HD>
        <P>The Consolidated Appropriations Resolution, 2003, Pub. L. 108-7, provides $20 million for CERTs of which FEMA is using $18.8 million for grants and $1.2 million for FEMA activities essential for the development and maintenance of the CERT training program. </P>
        <HD SOURCE="HD1">Applicant Eligibility </HD>
        <P>States are eligible to apply for the assistance described in this notice. The term “State” as used in this notice and consistent with the Stafford Act, 42 U.S.C. 5122(4), means any State of the United States, the District of Columbia, Puerto Rico, the Virgin Islands, Guam, American Samoa, and the Commonwealth of the Northern Mariana Islands. </P>
        <P>Local governments may receive assistance as subgrantees of the States in which they are located. The term “Local government” as used in this notice shall have the meaning set forth in the Stafford Act, 42 U.S.C. 5122(6). </P>
        <HD SOURCE="HD1">Target Funding Allocations </HD>
        <P>Funds are allocated on the basis of population with minimums, or base amounts, derived using the percentages prescribed in Section 1014 of the USA Patriot Act. Each of the fifty States, the District of Columbia, and Puerto Rico will be allocated a base amount of 0.75 percent of the total funding available. The insular areas of the Virgin Islands, American Samoa, Guam, and the Commonwealth of the Northern Mariana Islands will be allocated a base amount of 0.25 percent of the total funding available. The remainder of the funding available will be allocated on the basis of the most recent official population estimates. </P>
        <HD SOURCE="HD1">Cost-Share and Pass-Through Requirements </HD>
        <P>There is no cost-share, or matching, requirement associated with funding under this program. Grantees must pass through at least 75 percent of the funding received to local governments, also with no matching requirement. </P>
        <HD SOURCE="HD1">Activities To Be Funded </HD>
        <P>• Grantees conduct CERT Train-The-Trainer courses to prepare program managers and instructional teams who will initiate or expand the CERT training program. </P>
        <P>• Local governments initiate, organize, train, and maintain CERTs and use these teams as an emergency management resource and as a volunteer pool to perform special projects that improve a community's preparedness. This may include the purchase of CERT equipment including hard hats, safety vests, goggles, and gloves that will remain the property of the State or local jurisdiction. </P>
        <P>• Communities with established CERT programs continue, maintain, and expand these programs. </P>
        <HD SOURCE="HD1">Grant Application Process </HD>
        <P>The grant application for CERT funding must include: </P>
        <P>• Application for Federal Assistance, Standard Form 424; </P>
        <P>• Budget Information—Non-Construction Program, FEMA Form 20-20; </P>
        <P>• Budget Narrative; </P>
        <P>• Summary Sheet for Assurances and Certification, FEMA Form 20-16; </P>
        <P>• Assurances—Non-Construction Program, FEMA Form 20-16A; </P>
        <P>• Certification Regarding Lobbying; Debarment, Suspension and Other Responsibility Matters; and Drug-Free Workplace Requirements, FEMA Form 20-16C; </P>
        <P>• Disclosure of Lobbying Activities, Standard Form LLL; and </P>
        <P>• Program Narrative identifying the activities for which funding is requested. </P>
        <P>The Program Narrative should include the following:</P>
        <P>• A timeline for conducting CERT Train-The-Trainer (TTT) courses for the State's jurisdictions; </P>
        <P>• A process for soliciting, evaluating, and awarding subgrants to local governments that will establish or continue CERT programs as part of their community preparedness efforts; </P>
        <P>• Criteria for awarding subgrants; and </P>
        <P>• Description of the procedure the State will use to meet the reporting requirements to the FEMA Regional office. </P>
        <P>Applications should be submitted to the FEMA Regional Offices no later than four weeks after receipt of request for applications from the FEMA Regional offices. The FEMA Regional addresses are found at the end of this notice. FEMA Regional offices will work directly with State points of contact, as needed, on the development of applications. Applications will be reviewed to determine that: </P>
        <P>• A time line has been identified for distributing funds to localities. </P>
        <P>• A time line has been identified, if applicable, for conducting CERT Train-The-Trainer courses. </P>
        <P>• The State has explained how it will solicit, evaluate, and award subgrants to local governments. </P>
        <P>• The State has identified the sponsorship for State's and localities' Emergency Management Institute CERT programs: public sector emergency management, response agency, or local Citizen Corps Council. </P>
        <P>• The State has given a proposed number of trained CERT instructors. </P>
        <P>• The State has given a proposed number of people who will be trained using the CERT program. </P>
        <P>• The State provides information on its plans for maintaining CERT members including how they can be used to supplement emergency management activities in disaster and non-disaster situations. </P>
        <P>• The State will require as part of the subgrant to local governments that they will list their programs in the Directory of CERT Programs by State on the CERT Internet Web site. </P>
        <P>State points of contact will be notified of all relevant time requirements for submission of applications. </P>
        <HD SOURCE="HD1">Performance Periods </HD>
        <P>The performance period for grants to support CERT activities is 12 months from the date of the grant award. </P>
        <HD SOURCE="HD1">Reporting Requirements </HD>
        <P>The States are required to submit quarterly financial and performance reports 30 days after the end of each quarter, per 44 CFR 13.40 and 41. Reporting dates are: January 30, April 30, July 30, and October 30. The performance reports will provide a comparison of actual accomplishments to the objectives approved for the period. Grantee and subgrantee activities should be reported for the reporting period and for the cumulative period from the grant award date. Program performance reports shall include the following information: </P>
        <P>• Total amount of grant funds used to date and for what activities; </P>

        <P>• Number of CERT trainers and members trained, by location; <PRTPAGE P="48931"/>
        </P>
        <P>• Concerns regarding a jurisdiction using its grant allocation or meeting its training targets (Include any suggested remedies); and </P>
        <P>• Examples of emergency and non-emergency use of CERT in the community. </P>
        <P>When the Department of Health and Human Services (HHS) Payment Management System (SMARTLINK) is used for advanced or reimbursement payments, the grantee is required to submit a copy of Federal Cash Transaction Report (HHS/PMS 272) to FEMA when it is submitted to HHS. In addition, final financial and performance reports are required 90 days after the close of the grant, per 44 CFR 13.50. </P>
        <P>
          <E T="03">Addresses:</E> FEMA Regional Offices: </P>
        <P>FEMA Region I—<E T="03">Serving the States of Maine, New Hampshire, Vermont, Rhode Island, Connecticut, and Massachusetts:</E> 442 J.W. McCormack POCH, Boston, MA 02109-4595. </P>
        <P>FEMA Region II—<E T="03">Serving the States of New York and New Jersey, the Commonwealth of Puerto Rico and the Territory of the U.S. Virgin Islands:</E> 26 Federal Plaza, Rm. 1337, New York, NY 10278-0002. </P>
        <P>FEMA Region III—<E T="03">Serving the District of Columbia and the States of Delaware, Maryland, Pennsylvania, Virginia, and West Virginia:</E> 1 Independence Mall, 6th Floor, 615 Chestnut Street, Philadelphia, PA 19106-4404. </P>
        <P>FEMA Region IV—<E T="03">Serving the States of Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina and Tennessee:</E> 3003 Chamblee Tucker Road, Atlanta, GA 30341. </P>
        <P>FEMA Region V—<E T="03">Serving the States of Illinois, Indiana, Michigan, Minnesota, Ohio and Wisconsin:</E> 536 S. Clark Street, 6th Floor, Chicago, IL 60605. </P>
        <P>FEMA Region VI—<E T="03">Serving the States of Arkansas, Louisiana, New Mexico, Oklahoma and Texas:</E> FRC 800 North Loop 288, Denton, TX 76201-3698. </P>
        <P>FEMA Region VII—<E T="03">Serving the States of Iowa, Kansas, Missouri, and Nebraska:</E> 2323 Grand Blvd., Suite 900, Kansas City, MO 64108. </P>
        <P>FEMA Region VIII—<E T="03">Serving the States of Colorado, Montana, North Dakota, South Dakota, Utah, and Wyoming:</E> Denver Federal Center, Building 710, Box 25267, Denver, CO 80225-0267. </P>
        <P>FEMA Region IX—<E T="03">Serving the States of Arizona, California, Hawaii and Nevada; the Territories of American Samoa and Guam, and the Commonwealth of the Northern Mariana Islands:</E> 1111 Broadway, Suite 1200, Oakland, CA 94607-4052. </P>
        <P>FEMA Region X—<E T="03">Serving the States of Alaska, Idaho, Oregon and Washington:</E> Federal Regional Center, 130 228th Street, SW., Bothell, WA 98021-9709. </P>
        <SIG>
          <NAME>Michael D. Brown,</NAME>
          <TITLE>Under Secretary, Emergency Preparedness and Response Directorate. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20855 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 6718-04-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT</AGENCY>
        <DEPDOC>[Docket No. FR-4809-N-33]</DEPDOC>
        <SUBJECT>Federal Property Suitable as Facilities to Assist the Homeless</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Office of the Assistant Secretary for Community Planning and Development, HUD.</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This Notice identifies unutilized, underutilized, excess, and surplus Federal property reviewed by HUD for suitability for possible use to assist the homeless.</P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">EFFECTIVE DATE:</HD>
          <P>August 15, 2003.</P>
        </DATES>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Mark Johnston, Department of Housing and Urban Development, Room 7262, 451 Seventh Street, SW., Washington, DC 20410; telephone (202) 708-1234; TTY number for the hearing- and speech-impaired (202) 708-2565, (these telephone numbers are not toll-free), or call the toll-free Title V information line at 1-800-927-7588.</P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>In accordance with the December 12, 1988 court order in <E T="03">National Coalition for the Homeless</E> v. <E T="03">Veterans Administration,</E> No. 88-2503-OG (D.D.C.), HUD publishes a Notice, on a weekly basis, identifying unutilized, underutilized, excess and surplus Federal buildings and real property that HUD has reviewed for suitability for use to assist the homeless.  Today's Notice is for the purpose of announcing that no additional properties have been determined suitable or unsuitable this week.</P>
        <SIG>
          <DATED>Dated: August 7, 2003.</DATED>
          <NAME>John D. Garrity,</NAME>
          <TITLE>Director, Office of Special Needs Assistance Programs.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20487  Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 4210-29-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF THE INTERIOR </AGENCY>
        <SUBAGY>Fish and Wildlife Service </SUBAGY>
        <SUBJECT>Issuance of Permits </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Fish and Wildlife Service, Interior. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of issuance of permits for endangered species. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The following permits were issued. </P>
        </SUM>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Documents and other information submitted with these applications are available for review, subject to the requirements of the Privacy Act and Freedom of Information Act, by any party who submits a written request for a copy of such documents to: U.S. Fish and Wildlife Service, Division of Management Authority, 4401 North Fairfax Drive, Room 700, Arlington, Virginia 22203; fax 703/358-2281. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Division of Management Authority, telephone 703/358-2104. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>

        <P>Notice is hereby given that on the dates below, as authorized by the provisions of the Endangered Species Act of 1973, <E T="03">as amended</E> (16 U.S.C. 1531, <E T="03">et seq.</E>), the Fish and Wildlife Service issued the requested permits subject to certain conditions set forth therein. For each permit for an endangered species, the Service found that (1) the application was filed in good faith, (2) the granted permit would not operate to the disadvantage of the endangered species, and (3) the granted permit would be consistent with the purposes and policy set forth in section 2 of the Endangered Species Act of 1973, as amended. </P>
        <HD SOURCE="HD1">Endangered Species </HD>
        <GPOTABLE CDEF="xs60,r50,r50,xs68" COLS="4" OPTS="L2,tp0,i1">
          <TTITLE>  </TTITLE>
          <BOXHD>
            <CHED H="1">Permit No. </CHED>
            <CHED H="1">Applicant </CHED>
            <CHED H="1">Receipt of application <E T="02">Federal Register</E> notice </CHED>
            <CHED H="1">Permit issuance date </CHED>
          </BOXHD>
          <ROW>
            <ENT I="01">067101 </ENT>
            <ENT>Albuquerque Biological Park </ENT>
            <ENT>68 FR 25620; May 13, 2003.</ENT>
            <ENT>July 14, 2003. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">067587 </ENT>
            <ENT>Patricia Szczys</ENT>
            <ENT>68 FR 33734; June 5, 2003 </ENT>
            <ENT>July 23, 2003. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">071450 </ENT>
            <ENT>William E. Rypkema</ENT>
            <ENT>68 FR 33179; June 3, 2003 </ENT>
            <ENT>July 14, 2003. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">072073 </ENT>
            <ENT>James H. Zindl</ENT>
            <ENT>68 FR 33734; June 5, 2003 </ENT>
            <ENT>July 14, 2003. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">072106 </ENT>
            <ENT>William R. Myers</ENT>
            <ENT>68 FR 33734; June 5, 2003 </ENT>
            <ENT>July 14, 2003. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">072379 </ENT>
            <ENT>Lynn C. Thompson</ENT>
            <ENT>68 FR 33734; June 5, 2003 </ENT>
            <ENT>July 14, 2003. </ENT>
          </ROW>
        </GPOTABLE>
        <SIG>
          <PRTPAGE P="48932"/>
          <DATED>Dated: August 1, 2003. </DATED>
          <NAME>Michael S. Moore, </NAME>
          <TITLE>Senior Permit Biologist, Branch of Permits, Division of Management Authority. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20802 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4310-55-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF THE INTERIOR </AGENCY>
        <SUBAGY>Fish and Wildlife Service </SUBAGY>
        <SUBJECT>Receipt of Applications for Permit </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Fish and Wildlife Service, Interior. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of receipt of applications for permit. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The public is invited to comment on the following applications to conduct certain activities with endangered species and/or marine mammals. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Written data, comments or requests must be received by September 15, 2003. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Documents and other information submitted with these applications are available for review, subject to the requirements of the Privacy Act and Freedom of Information Act, by any party who submits a written request for a copy of such documents within 30 days of the date of publication of this notice to: U.S. Fish and Wildlife Service, Division of Management Authority, 4401 North Fairfax Drive, Room 700, Arlington, Virginia 22203; fax 703/358-2281. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Division of Management Authority, telephone 703/358-2104. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <HD SOURCE="HD1">Endangered Species </HD>

        <P>The public is invited to comment on the following application(s) for a permit to conduct certain activities with endangered species. This notice is provided pursuant to Section 10(c) of the Endangered Species Act of 1973, <E T="03">as amended</E> (16 U.S.C. 1531, <E T="03">et seq.</E>). Written data, comments, or requests for copies of these complete applications should be submitted to the Director (address above). </P>
        <HD SOURCE="HD1">PRT-075020</HD>
        <FP SOURCE="FP-1">
          <E T="03">Applicant:</E> David R. Curl, Carrollton, TX. </FP>
        

        <P>The applicant requests a permit to import the sport-hunted trophy of one male bontebok (<E T="03">Damaliscus pygargus dorcas</E>) culled from a captive herd maintained under the management program of the Republic of South Africa, for the purpose of enhancement of the survival of the species.</P>
        <HD SOURCE="HD1">PRT-075282</HD>
        <FP SOURCE="FP-1">
          <E T="03">Applicant:</E> James G. Kehler, III, Woodbury, NJ.</FP>
        

        <P>The applicant requests a permit to import the sport-hunted trophy of one male bontebok (<E T="03">Damaliscus pygargus dorcas</E>) culled from a captive herd maintained under the management program of the Republic of South Africa, for the purpose of enhancement of the survival of the species. </P>
        <HD SOURCE="HD1">Endangered Marine Mammals and Marine Mammals </HD>

        <P>The public is invited to comment on the following application for a permit to conduct certain activities with endangered marine mammals and/or marine mammals. The application was submitted to satisfy requirements of the Endangered Species Act of 1973, <E T="03">as amended</E> (16 U.S.C. 1531, <E T="03">et seq.</E>) and/or the Marine Mammal Protection Act of 1972, <E T="03">as amended</E> (16 U.S.C. 1361 <E T="03">et seq.</E>), and the regulations governing endangered species (50 CFR Part 17) and/or marine mammals (50 CFR Part 18). Written data, comments, or requests for copies of the complete applications or requests for a public hearing on these applications should be submitted to the Director (address above). Anyone requesting a hearing should give specific reasons why a hearing would be appropriate. The holding of such a hearing is at the discretion of the Director. </P>
        <HD SOURCE="HD1">PRT-075190</HD>
        <FP SOURCE="FP-1">
          <E T="03">Applicant:</E> Byron H. Christie, San Angelo, TX.</FP>
        
        <P>The applicant requests a permit to import a polar bear (<E T="03">Ursus maritimus</E>) sport hunted from the Viscount Melville Sound polar bear population in Canada for personal use. </P>
        <P>The U.S. Fish and Wildlife Service has information collection approval from OMB through March 31, 2004, OMB Control Number 1018-0093. Federal agencies may not conduct or sponsor and a person is not required to respond to a collection of information unless it displays a current valid OMB control number. </P>
        <SIG>
          <DATED>Dated: August 1, 2003. </DATED>
          <NAME>Michael S. Moore, </NAME>
          <TITLE>Senior Permit Biologist, Branch of Permits, Division of Management Authority.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20803 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4310-55-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF THE INTERIOR </AGENCY>
        <SUBAGY>Fish and Wildlife Service </SUBAGY>
        <SUBJECT>Endangered Species; Permit </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Fish and Wildlife Service, Interior. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of Finding of No Significant Impact (FONSI) and issuance of permit for Incidental Take of Endangered Species. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>On June 4, 2003, a FONSI determination was made for the action as described in the final Environmental Assessment. As authorized by the provisions of the Endangered Species Act (Act), as amended, the Service issued an Incidental Take Permit to the Long Point Homeowner's Association subject to certain conditions set forth therein. </P>
        </SUM>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Mr. Peter Fasbender, Regional Permits Coordinator, 1 Federal Drive, Fort Snelling, Minnesota 55111-4056. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>

          <P>Additional information on this permit may be requested by contacting Mr. Peter Fasbender, at (612) 713-5343, or <E T="03">peter_fasbender@fws.gov.</E> The final Environmental Assessment and final Habitat Conservation Plan can be viewed on the Service's Regional Web site at: <E T="03">http://midwest.fws.gov/NEPA.</E>
          </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>On March 17, 2003, a notice was published in the <E T="04">Federal Register</E> (68 FR 12711) announcing that a draft Environmental Assessment and Habitat Conservation Plan and that a permit application had been filed with the U.S. Fish and Wildlife Service by the Long Point Homeowner's Association, Kellys Island, Erie County, Ohio. The permit was to incidentally take, pursuant to section 10(a)(1)(B) of the Act, Lake Erie water snake (<E T="03">Nerodia sipedon insularum</E>) within the Long Point Subdivision pursuant to the terms of the Habitat Conservation Plan. </P>
        <P>Notice is hereby given that on June 4, 2003, the Proposed Action (Alternative 3) was selected and a FONSI determination was made for the action as described in the final Environmental Assessment. As authorized by the provisions of the Act, the Service issued a permit (TE-072436) to the above-named party subject to certain conditions set forth therein. The permit was granted only after the Service determined it was applied for in good faith, that granting the permit would not be to the disadvantage of the endangered species, and that granting the permit was consistent with the purposes and policy set forth in the Act. </P>
        <SIG>
          <PRTPAGE P="48933"/>
          <DATED>Dated: July 24, 2003. </DATED>
          <NAME>TJ Miller, </NAME>
          <TITLE>Acting Assistant Regional Director, Ecological Services, Region 3, Fort Snelling, Minnesota. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20828 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4310-55-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF THE INTERIOR </AGENCY>
        <SUBAGY>Fish and Wildlife Service </SUBAGY>

        <SUBJECT>Notice of Availability of the Higgins' Eye Pearlymussel (<E T="0742">Lampsilis higginsii</E>) Draft Revised Recovery Plan for Review and Comment </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Fish and Wildlife Service, Interior. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of document availability. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>

          <P>The U.S. Fish and Wildlife Service (Service) announces availability for public review of the draft revised recovery plan for the Higgins' eye pearlymussel (<E T="03">Lampsilis higginsii</E>), a species that is federally listed as endangered under the Endangered Species Act of 1973 (Act). The purpose of this plan is to recover this species so that it can be removed from the list of Threatened and Endangered Species. This species occurs in the Mississippi River and tributaries to the Mississippi River in Illinois, Iowa, Minnesota, Missouri, and Wisconsin. The Service solicits review and comment from the public on this draft plan. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Comments on the draft recovery plan must be received on or before October 14, 2003. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>

          <P>Persons wishing to review the draft recovery plan may obtain a copy by contacting the Field Supervisor, U.S. Fish and Wildlife Service, Ecological Services Field Office, 4101 E. 80th St., Bloomington, MN 55425 (telephone (612) 725-3548) or by accessing the following Web site: <E T="03">http://midwest.fws.gov/Endangered</E>. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Mr. Phil Delphey at the above address, or telephone at (612) 725-3548 ext. 206. TTY users may contact Mr. Delphey through the Federal Relay Service at (800) 877-8339. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <HD SOURCE="HD1">Background </HD>
        <P>Restoring an endangered or threatened animal or plant to the point where it is again a secure self-sustaining member of its ecosystem is a primary goal of the Service's endangered species program. To help guide the recovery effort, the Service is working to prepare recovery plans for most of the federally listed threatened and endangered species native to the United States. Recovery plans describe actions considered necessary for conservation of the species, establish criteria for reclassification and delisting, and provide estimates of the time and costs for implementing the recovery measures needed. </P>
        <P>The Act requires the development of recovery plans for listed species unless such a plan would not promote the conservation of a particular species. Section 4(f) of the Act, as amended in 1988, requires public notice and opportunity for public review and comment be provided during recovery plan development. The Service will consider all information presented during a public comment period before approval of each new or revised recovery plan. The Service and other Federal agencies will also take these comments into consideration in the course of implementing approved recovery plans. </P>

        <P>Higgins' eye pearlymussel is currently listed as endangered. Studies before 1993 indicated healthy populations of Higgins' eye in the Upper Mississippi River drainage, with no apparent significant declines in its distribution or abundance. In fact, new information since completion of the first recovery plan in 1983 extended its known range by 180 river-miles. There was concern, however, that a major flood in 1993 and the infestation of the Mississippi River by the non-native zebra mussel (<E T="03">Dreissena polymorpha</E>) may have posed serious threats to the continued existence of Higgins' eye. In response to these threats and information, the Service convened a recovery team to review the status of the species and to revise the initial recovery plan, if necessary. The team commissioned a review of all research conducted on the species since 1980 and a survey of all sites designated as Essential Habitat Areas in the 1983 recovery plan. During the development of this revised recovery plan, new information came forward that suggested a significant impact of zebra mussels on Higgins' eye, and the team believes there is now a significant risk that the distribution and abundance of this species will be severely compromised. </P>
        <P>The initial Higgins' Eye Pearlymussel Recovery Plan listed seven locations as primary habitats (called Essential Habitat Areas in this document) and nine locations as potential secondary habitats. This revised plan includes 10 Essential Habitat Areas—6 in the Mississippi River between river-miles 489 and 656, 1 in the Wisconsin River, and 3 in the St. Croix River, which empties into the Mississippi River at river-mile 811. Higgins' eye also occurs elsewhere in the Mississippi River. This revised plan recommends that surveys be conducted in several specific areas to better describe other potentially important habitats and also outlines specific criteria for evaluating additional areas as essential habitat. The plan recommends the development of a uniform protocol for collecting information on populations of Higgins' eye. Use of this protocol will allow for ongoing evaluation of the list of Essential Habitat Areas and progress towards recovery. </P>
        <P>The removal of zebra mussels in a manner and scale necessary to benefit Higgins' eye is not currently feasible. Therefore, the plan focuses on developing methods to prevent new infestations, monitoring zebra mussels at Essential Habitat Areas, and developing and implementing contingency plans to alleviate impacts to infested populations. Based on recent activities, the latter may consist largely of removing Higgins' eye from areas where zebra mussels pose an imminent threat and releasing them into suitable habitats within their historical range where zebra mussels are not an imminent threat. Cleaning fouled adults in situ and artificial propagation and release are also currently being implemented in an attempt to alleviate the effects of zebra mussels on the conservation of Higgins' eye. </P>
        <P>Although zebra mussels are currently the most important threat to Higgins' eye, construction activities and environmental contaminants may also pose significant threats. Therefore, the U.S. Army Corps of Engineers and other agencies must continue to assess and limit the potential impacts of their actions on Higgins' eye. The plan also outlines tasks needed to improve our understanding of the potential importance that contaminants play in the conservation of Higgins' eye and calls on the U.S. Coast Guard, Environmental Protection Agency, and other agencies to take actions to minimize the potential impacts of toxic spills. </P>

        <P>The goal of this plan is to provide a framework for the recovery of the Higgins' eye pearlymussel so that protection by the Act is no longer necessary and the species can be considered for removal from the list of Endangered and Threatened Wildlife and Plants (50 CFR part 17). Higgins' eye may be considered for reclassification from endangered to threatened when at least five identified Essential Habitat Areas contain reproducing, self-sustaining populations of Higgins' eye that are not threatened by zebra mussels. Delisting Higgins' eye <PRTPAGE P="48934"/>requires that populations of Higgins' eye in at least five Essential Habitat Areas are reproducing, self-sustaining, not threatened by zebra mussels, and are sufficiently secure to assure long-term viability of the species. </P>
        <HD SOURCE="HD1">Public Comments Solicited </HD>

        <P>The Service solicits written comments on the recovery plan described. All comments received by the date specified will be considered prior to approval of the plan. Written comments and materials regarding the plan should be sent to the Field Supervisor, Ecological Services Field Office (see <E T="02">ADDRESSES</E> section). Comments received will be available for public inspection by appointment during normal business hours. </P>
        <AUTH>
          <HD SOURCE="HED">Authority:</HD>
          <P>The authority for this action is section 4(f) of the Endangered Species Act, 16 U.S.C. 1533(f). </P>
        </AUTH>
        <SIG>
          <DATED>Dated: July 31, 2003. </DATED>
          <NAME>Charles M. Wooley, </NAME>
          <TITLE>Assistant Regional Director, Ecological Services, Region 3. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20830 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4310-55-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF THE INTERIOR</AGENCY>
        <SUBAGY>Fish and Wildlife Service</SUBAGY>
        <SUBJECT>Fiscal Year (FY) 2004 Landowner Incentive Program (Non Tribal Portion) for States, Territories, and the District of Columbia; Notice of Request for Proposals</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Fish and Wildlife Service, Interior.</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice; Request for proposals.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>

          <P>The Service is requesting proposals at this time under the Landowner Incentive Program pending a Department of the Interior and Related Agencies Appropriations Act 2004 allocation of funds for conservation grants to States, the District of Columbia, Puerto Rico, Guam, the United States Virgin Islands, the Northern Mariana Islands, and American Samoa (hereafter referred to collectively as States), and Tribes. The Service will address the Tribal component of LIP under a separate <E T="04">Federal Register</E> notice.</P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>The Service must receive your grant proposal no later than October 14, 2003. We will not accept facsimile grant proposals, but States are encouraged to submit their proposals in electronic format (Word, Word Perfect or PDF files). All parts of the grant proposal must be received prior to the deadline.</P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Grant proposals must be submitted to the Service's Division of Federal Assistance at the following locations:</P>
          
          <FP SOURCE="FP-1">
            <E T="03">Region 1.</E> Hawaii, Idaho, Oregon, Washington, California, Nevada, American Samoa, Guam, and Commonwealth of the Northern Mariana Islands.</FP>
          

          <P>Regional Director, Division of Federal Assistance, U.S. Fish and Wildlife Service, 911 NE., 11th Avenue, Portland, Oregon 97232-4181, LIP Contact: Verlyn Ebert, (503) 231-6128; <E T="03">verlyn_ebert@r1.fws.gov.</E>
          </P>
          
          <FP SOURCE="FP-1">
            <E T="03">Region 2.</E> Arizona, New Mexico, Oklahoma, and Texas.</FP>
          

          <P>Regional Director, Division of Federal Assistance, U.S. Fish and Wildlife Service, P.O. Box 1306, 500 Gold Avenue SW., Room 4012, Albuquerque, New Mexico 87102, LIP Contact: Bob Anderson, (505) 248-7459; <E T="03">bob_anderson@fws.gov.</E>
          </P>
          
          <FP SOURCE="FP-1">
            <E T="03">Region 3.</E> Illinois, Indiana, Iowa, Michigan, Minnesota, Missouri, Ohio, and Wisconsin.</FP>
          

          <P>Regional Director, Division of Federal Assistance, U.S. Fish and Wildlife Service, Bishop Henry Whipple Federal Building, One Federal Drive, Fort Snelling, Minnesota 55111-4056, LIP Contact: Lucinda Corcoran, (612) 713-5135; <E T="03">lucinda_corcoran@fws.gov.</E>
          </P>
          
          <FP SOURCE="FP-1">
            <E T="03">Region 4.</E> Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, Mississippi, North Carolina, South Carolina, Tennessee, Puerto Rico, and the U.S. Virgin Islands.</FP>
          

          <P>Regional Director, Division of Federal Assistance, U.S. Fish and Wildlife Service, 1875 Century Boulevard, Suite 200, Atlanta, Georgia 30345, LIP Contact: Mike Piccirilli, (404) 679-4154; <E T="03">mike_piccirilli@fws.gov.</E>
          </P>
          
          <FP SOURCE="FP-1">
            <E T="03">Region 5.</E> Connecticut, Delaware, District of Columbia, Maine, Maryland, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont, Virginia, and West Virginia.</FP>
          

          <P>Regional Director, Division of Federal Assistance, U.S. Fish and Wildlife Service, 300 Westgate Center Drive, Hadley, MA 01035-9589, LIP Contact: Colleen Sculley, (413) 253-8509; <E T="03">colleen_sculley@fws.gov.</E>
          </P>
          
          <FP SOURCE="FP-1">
            <E T="03">Region 6.</E> Colorado, Kansas, Montana, Nebraska, North Dakota, South Dakota, Utah, and Wyoming. </FP>
          

          <P>Regional Director, Division of Federal Assistance, U.S. Fish and Wildlife Service, P.O. Box 25486, Denver Federal Center, Denver, Colorado 80225-0486, LIP Contact: Jacque Richy, (303) 236-8155 ext. 236; <E T="03">jacque_richy@fws.gov.</E>
          </P>
          
          <FP SOURCE="FP-1">
            <E T="03">Region 7.</E> Alaska.</FP>
          

          <P>Regional Director, Division of Federal Assistance, U.S. Fish and Wildlife Service, 1011 East Tudor Road, Anchorage, Alaska 99503-6199, LIP Contact: Al Havens (907) 786-3435; <E T="03">al_havens@fws.gov.</E>
          </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>

          <P>Kim Galvan, Policy Analyst, U.S. Fish and Wildlife Service, Division of Federal Assistance, 4401 North Fairfax Drive—Mailstop MBSP 4020, Arlington, VA 22203-1610; telephone 703-358-2420; e-mail <E T="03"> kim_galvan@fws.gov,</E> or any of the individuals identified previously in the Regional Offices.</P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>

        <P>The Service will award grants on a competitive basis to State fish and wildlife agency programs that enhance, protect, or restore habitats that benefit federally listed, proposed, or candidate species, or other at-risk species on private lands. A copy of the FY 2004 LIP Guidelines can be obtained at <E T="03">http://federalaid.fws.gov/index.html</E> or from the Regional Offices described in the <E T="02">ADDRESSES</E> section above.</P>
        <P>The Service will distribute any LIP funds made available in the FY 2004 budget in the same manner described in these Guidelines. The Service requests that the States number the pages in their proposals, and limit their proposals to no more than 50 pages, inclusive of attachments.</P>
        <SIG>
          <DATED>Dated: July 22, 2003.</DATED>
          <NAME>Paul R. Schmidt,</NAME>
          <TITLE>Assistant Director, Migratory Birds and State Programs.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20717 Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 4310-55-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF THE INTERIOR </AGENCY>
        <SUBAGY>Bureau of Indian Affairs </SUBAGY>
        <SUBJECT>Land Acquisitions; Little Traverse Bay Bands of Odawa Indians of Michigan </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Bureau of Indian Affairs, Interior. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of final agency determination to take land into trust under 25 CFR part 151. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>

          <P>The Assistant Secretary—Indian Affairs made a final agency determination to acquire approximately 96 acres, more or less, of land into trust for the Little Traverse Bay Bands of Odawa Indians of Michigan on July 18, 2003. This notice is published in the exercise of authority delegated by the Secretary of the Interior to the Assistant Secretary—Indian Affairs by 209 Departmental Manual 8.1. <PRTPAGE P="48935"/>
          </P>
        </SUM>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>This notice is published to comply with the requirement of 25 CFR part 151.12(b) that notice be given to the public of the Secretary's decision to acquire land in trust at least 30 days prior to signatory acceptance of the land into trust. The purpose of the 30-day waiting period in 25 CFR part 151.12(b) is to afford interested parties the opportunity to seek judicial review of final administrative decisions to take land in trust for Indian tribes and individual Indians before transfer of title to the property occurs. On July 18, 2003, the Assistant Secretary—Indian Affairs decided to accept approximately 96 acres, more or less, of land into trust for the Little Traverse Bay Bands of Odawa Indians of Michigan under the authority of the Little Traverse Bay Bands of Odawa Indians Act, 25 U.S.C. 1300k-1300k-7 (1994), which also restored Federal recognition to the Little Traverse Bay Bands of Odawa Indians and the Little River Band of Ottawa Indians. In a memorandum dated November 12, 1997, the Associate Solicitor, Division of Indian Affairs, determined that the Little Traverse Bay Bands is a restored tribe within the meaning of Section 20 of the Indian Gaming Regulatory Act (IGRA), 25 U.S.C. 2719 and that the trust acquisition of the parcel known as the “Mackinaw City Tract” qualified as restored lands. The Mackinaw Tract is within Emmet County. On August 5, 1999, the Associate Solicitor, Division of Indian Affairs further concluded that the site of the temporary Victories casino qualified as “restored” land within the meaning of section 20 of IGRA, because it is within Emmet County and is exempt from the general prohibition against gaming on land acquired in trust after October 17, 1988. On March 24, 2003, the Field Solicitor, Twin Cities concluded that pursuant to 25 U.S.C. 1300k-4(a) the acquisition of land located in Emmet County, Michigan for the Little Traverse Bay Bands is a mandatory acquisition for purposes of 25 CFR 151.10 and is considered “restored” land for purposes of 25 U.S.C. 2719(b)(1)(B)(iii) of IGRA. </P>
        <P>The land referred to in Commitment No. 60016179, situated in the Township of Resort, County of Emmet, State of Michigan is described as follows: </P>
        
        <EXTRACT>

          <P>The Northeast <FR>1/4</FR> of the Southeast <FR>1/4</FR> and the South one-half of the Northwest <FR>1/4</FR> of the Southeast <FR>1/4</FR>, all in Section 12, Township 34 North, Range 6 West, <E T="03">except</E>: Commencing at the East <FR>1/4</FR> corner of Section 12, Township 34 North, Range 6 West; Resort Township, Emmet County, Michigan; thence South along the East line of said Section 12, for a distance of 427.29 feet; thence West 33.00 feet to a concrete monument on the West edge of Greenwood Cemetery Road, which is the point of beginning; thence West 217.00 feet to a concrete monument, thence South 160.00 feet to a concrete monument; thence East 217.00 feet to a concrete monument on the West edge of Greenwood Cemetery Road; thence North 160.00 feet to the point of beginning. </P>
        </EXTRACT>
        
        <P>The land referred to in Commitment No. 60016178, situated in the Township of Resort, County of Emmet, State of Michigan is described as follows: </P>
        
        <EXTRACT>
          <P>The Southeast <FR>1/4</FR> of the Southeast <FR>1/4</FR> of Section 12, Township 34 North, Range 6 West. </P>
        </EXTRACT>
        
        <P>The property consists of approximately 96 acres located in Emmet County, Michigan. </P>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>George Skibine, Office of Indian Gaming Management, Bureau of Indian Affairs, MS-4543 MIB, 1849 C Street, NW., Washington, DC 20240; Telephone (202) 219-4066. </P>
          <SIG>
            <DATED>Dated: July 18, 2003. </DATED>
            <NAME>Aurene M. Martin, </NAME>
            <TITLE>Assistant Secretary—Indian Affairs. </TITLE>
          </SIG>
        </FURINF>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20935 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4310-4N-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF THE INTERIOR </AGENCY>
        <SUBAGY>Bureau of Land Management </SUBAGY>
        <DEPDOC>[OR-090-5900, HAG03-0062] </DEPDOC>
        <SUBJECT>Notice of Availability of the Draft Environmental Impact Statement for the Upper Siuslaw River Late-Successional Reserve Restoration Plan </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Bureau of Land Management, Interior. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of Availability (NOA) of the Draft Environmental Impact Statement (DEIS) for the Upper Siuslaw River Late-Successional Reserve (LSR) Restoration Plan. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>Pursuant to section 102(2)(C) of the National Environmental Policy Act (NEPA) of 1969, a DEIS has been prepared by the Bureau of Land Management (BLM), Eugene District, with the U.S. Fish and Wildlife Service as a cooperating agency, for the Upper Siuslaw River Late-Successional Reserve (LSR) Restoration Plan. The DEIS was prepared to analyze the impacts of a long-term management approach and specific actions needed to achieve the LSR goals and Aquatic Conservation Strategy objectives set out in the Northwest Forest Plan. The Upper Siuslaw LSR Restoration Plan will address management of approximately 25,000 acres of BLM-managed lands within LSR 267 in the upper portion of the Siuslaw River fifth-field watershed. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>

          <P>Written comments on the DEIS must be postmarked or otherwise delivered by 4:15 p.m., 60 days following the date the Environmental Protection Agency (EPA) publishes the NOA and filing of the DEIS in the <E T="04">Federal Register</E>. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>

          <P>Written comments on the document should be addressed to: Rick Colvin, P.O. Box 10226, Eugene, OR, 97440; or e-mail to: <E T="03">or090mb@or.blm.gov</E> Attn: Rick Colvin. Written comments may also be hand-delivered to the Eugene District Office, 2890 Chad Drive, Eugene, OR. Comments, including names and street addresses of respondents, will be available for public review at the Eugene District office during regular hours (7:45 a.m. to 4:15 p.m.), Monday through Friday, except holidays, and may be published as part of the environmental analysis or other related documents. Individual respondents may request confidentiality. If you wish to withhold your name or address from public review or from disclosure under the Freedom of Information Act, you must state this prominently at the beginning of your written comment. Such requests will be honored to the extent allowed by law. All submissions from organizations or businesses, and from individuals identifying themselves as representatives or officials of organization or businesses, will be made available for public inspection in their entirety. </P>

          <P>Copies of the DEIS will be mailed to individuals, agencies, or companies who previously requested copies. A limited number of copies of the document will be available at the Eugene District Office. The DEIS is also available online from the Eugene District Internet Web site at <E T="03">http://www.edo.or.blm.gov</E>. All public meetings will be announced through the local news media, newsletters, and the Eugene District Internet Web site (<E T="03">http://www.edo.or.blm.gov</E>) at least 15 days prior to the event. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Rick Colvin at (541) 683-6600 or 1-888-442-3061. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>

        <P>The DEIS addresses alternatives for forest and aquatic restoration within a Late-Successional Reserve in the Coast Range Mountains west of Eugene, Oregon. The purpose of the action is to protect and enhance late-successional and old-growth forest ecosystems; foster the development of late-successional forest structure and composition in <PRTPAGE P="48936"/>plantations and young forests; and reconnect streams and reconnect stream channel to their riparian areas and upslope areas. </P>
        <P>The DEIS analyzes in detail the following six alternatives:</P>
        
        <FP SOURCE="FP-1">Alternative A—no active management (No Action);</FP>
        <FP SOURCE="FP-1">Alternative B—restoration limited to forest plantations and road management with no commercial timber harvest;</FP>
        <FP SOURCE="FP-1">Alternative C—continuation of the current management approach; </FP>
        <FP SOURCE="FP-1">Alternative D—restoration focused on recovery of threatened and endangered species;</FP>
        <FP SOURCE="FP-1">Alternative E—restoration that would reduce forest stand densities as quickly as possible; and </FP>
        <FP SOURCE="FP-1">Alternative F—restoration based on multi-entry and multi-trajectory thinning. </FP>
        

        <P>All alternatives analyzed in the DEIS would be in conformance with the 1995 Eugene District Resource Management Plan (RMP) and would not require any amendment or revision of the RMP. The Preferred Alternative is <E T="03">Alternative D</E>. </P>
        <P>The DEIS analyzes the following issues: </P>
        
        <FP SOURCE="FP-1">—How would thinning affect development of late-successional forest habitat characteristics? </FP>
        <FP SOURCE="FP-1">—What are the effects of restoration activities on the northern spotted owl, marbled murrelet, and coho salmon habitat? </FP>
        <FP SOURCE="FP-1">—What level of risk to existing late-successional forest would result from restoration activities? </FP>
        <FP SOURCE="FP-1">—How would actions meet the objectives of the Aquatic Conservation Strategy? </FP>
        <FP SOURCE="FP-1">—How much new road construction would be needed to implement restoration actions? </FP>
        <FP SOURCE="FP-1">—How would road decommissioning and road management actions alter public access to BLM lands? </FP>
        <FP SOURCE="FP-1">—How would restoration actions affect the presence and spread of noxious weeds? </FP>
        <FP SOURCE="FP-1">—What would be the economic effects of restoration activities? </FP>
        <FP SOURCE="FP-1">—What would the restoration program cost? </FP>
        <SIG>
          <NAME>Steven Calish, </NAME>
          <TITLE>Field Manager. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-19255 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4310-AG-P </BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF THE INTERIOR </AGENCY>
        <SUBAGY>Bureau of Land Management </SUBAGY>
        <DEPDOC>[WY-920-1430-FM, WYW 148816] </DEPDOC>
        <SUBJECT>Notice of Public Interest Hearing </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Bureau of Land Management, Interior and Forest Service, Agriculture.</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of a public interest determination hearing on the proposed Pittsburg &amp; Midway Coal exchange. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>

          <P>A public hearing as required under regulations at 43 CFR 2203.3, is scheduled to accept oral and written testimony and comments on the public interest factors associated with the proposed Pittsburg and Midway (P&amp;M) Coal Exchange. Pertinent information regarding the proposed exchange is contained in a Final Environmental Impact Statement (FEIS) which documents and discloses the results of an environmental analysis of the proposed P&amp;M Coal Exchange. The FEIS may be viewed and downloaded from the BLM Wyoming Web site <E T="03">http://www.wy.blm.gov.</E>
          </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>The public hearing will be held from 7-9 p.m. m.d.t., September 17, 2003, at Sheridan College, 3059 Coffeen Avenue, Whitney Building, Room W-136, Sheridan, Wyoming 82801. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Copies of the FEIS are also available for public inspection at the following BLM Offices: Wyoming State Office, 5353 Yellowstone Road, Cheyenne, WY 82009; Buffalo Field Office, 1425 Fort Street, Buffalo, WY 82834; Rawlins Field Office, 1300 N. Third Street, Rawlins, WY 82301; Casper Field Office, 2987 Prospector Drive, Casper, WY 82604; and the Pinedale Field Office, 432 E. Mill Street, Pinedale, WY 82941. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>For more information contact Nancy Doelger at 307-261-7627, Mel Schlagel at 307-775-6257, or Tamara Gertsch at 307-775-6115. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>After completion of the FEIS and prior to making a public interest determination and issuing a notice of decision, the BLM is required to hold a public hearing to receive public comments on the public interest factors on the proposed exchange. BLM will provide an attendance register at the door to record names of the parties attending the meeting. BLM will also provide a register for those desiring to express their views during the formal hearing procedure. The time allotted to each person wishing to make a statement will be determined by the number of attendees wishing to speak. </P>
        <P>The hearing will consist of two distinct phases: (1) an informal phase where the BLM and the USFS will explain the exchange proposal in general terms and will respond to any questions about the exchange proposal, and (2) a formal phase where it will be explained that the hearing is afforded to provide an opportunity to receive comments regarding the public interest factors associated with the proposed exchange. BLM will ask each party who registered at the door to proceed to the microphone and provide their comments. Each party will be asked for their name, business affiliation (if any), and a written copy of their comments if one is available. BLM will not respond to any questions during the formal phase of the hearing. A transcript of both the written and verbal comments will be recorded and will become part of the official transcript for the hearing. The complete transcript of the formal phase of the hearing will be forwarded to the Department of Justice for their review, prior to a Record of Decision being issued for the proposed land exchange. Any comments received will be considered in the final decision issued for this exchange. </P>
        <SIG>
          <DATED>Dated: August 12, 2003. </DATED>
          <NAME>Melvin Schlagel, </NAME>
          <TITLE>Realty Officer. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20829 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4310-22-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF THE INTERIOR </AGENCY>
        <SUBAGY>Bureau of Land Management </SUBAGY>
        <DEPDOC>[AZ-068-03-1610-DR-241E] </DEPDOC>
        <SUBJECT>Notice of Availability of Approved Resource Management Plan/Record of Decision </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Bureau of Land Management, Interior. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of availability. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>Notice is hereby given that the Bureau of Land Management (BLM) has prepared an Approved Resource Management Plan/Record of Decision (RMP/ROD) for the Las Cienegas National Conservation Area (NCA) and Sonoita Valley Acquisition Planning District (SVAPD) located in Pima and Santa Cruz Counties, Arizona. The RMP/ROD will be signed by the Arizona State Director and become effective upon publication of this notice. </P>

          <P>The RMP/ROD has been prepared pursuant to the National Environmental Policy Act (NEPA), the Federal Land Policy and Management Act (FLPMA), the act establishing the Las Cienegas <PRTPAGE P="48937"/>National Conservation Area (H.R. 2941), and BLM management policies. </P>
          <P>The RMP/ROD was developed with broad public participation through a six-year collaborative planning process. The RMP/ROD addresses management on approximately 49,000 acres of public land within the NCA and SVAPD. The RMP/ROD is designed to achieve or maintain desired future conditions developed through the Sonoita Valley Planning Partnership process. The RMP/ROD also includes a series of management actions to meet the desired resource conditions for upland and riparian vegetation, wildlife habitats, and cultural and visual resources as well as livestock grazing and recreation. </P>
        </SUM>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>

          <P>Copies of the RMP/ROD are available upon request from the Field Manager, Tucson Field Office, Bureau of Land Management, 12661 East Broadway Boulevard, Tucson, Arizona 85748-7208 or via the Internet at <E T="03">www.az.blm.gov.</E>
          </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Karen Simms, Ecosystem Planner, Tucson Field Office, Bureau of Land Management, 12661 East Broadway Boulevard, Tucson, Arizona 85748-7208; telephone number (520) 258-7210. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>The approved Resource Management Plan is essentially the same as Alternative 2 in the Proposed Las Cienegas RMP/Final Environmental Impact Statement (PRMP/FEIS) that was published in June 2002. BLM received only one protest to the PRMP/FEIS. No inconsistencies with State or local plans, policies, or programs were identified during the Governor consistency review of the PRMP/FEIS. As a result, only minor editorial modifications were made in preparing the RMP/ROD. These modifications corrected errors that were noted during review of Alternative 2 of the PRMP/FEIS and provide further clarification for some of the decisions. An errata sheet is included with the RMP/ROD that identifies the location of the corrections in the PRMP/FEIS.</P>
        <SIG>
          <NAME>Elaine Y. Zielinski,</NAME>
          <TITLE>State Director.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-21073 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4810-32-P </BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF THE INTERIOR</AGENCY>
        <SUBAGY>Bureau of Reclamation</SUBAGY>
        <SUBJECT>California Bay-Delta Public Advisory Committee Charter Renewal</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Bureau of Reclamation, Interior.</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of charter renewal.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>This notice is published in accordance with Section 9(a)(2) of the Federal Advisory Committee Act of 1972 (Pub. L. 92-463). Following consultation with the General Services Administration, notice is hereby given that the Secretary of the Interior is renewing the charter for the California Bay-Delta Public Advisory Committee.  The purpose of the Committee is to provide recommendations to the Secretary of the Interior, the Governor of California, the California Bay-Delta Authority, and other participating Federal agencies on implementation of the CALFED Bay-Delta Program (Program) as described in the Programmatic Record of Decision which outlines the long-term comprehensive solution for addressing the problems affecting the San Francisco Bay/Sacramento-San Joaquin Delta Estuary.  The Committee will provide recommendations on implementation of each element of the Program through the completion of Stage 1 (first 7 years). Specific responsibilities of the Committee include: (1) Making recommendations on annual priorities and coordination of Program actions to achieve balanced implementation of the Program elements; (2) providing recommendations on effective integration of Program elements to provide continuous, balanced improvement of each of the Program objectives (ecosystem restoration, water quality, levee system integrity, and water supply reliability); (3) evaluating implementation of Program actions in Stage 1, including assessment of Program area performance; (4) reviewing and making recommendations on Program Plans and Annual Reports describing implementation of Program elements as set forth in the Programmatic Record of Decision to the Secretary, the Governor, the Congress, the California Legislature, the Authority, and other interested parties; (5) recommending Program actions taking into account recommendations from the Committee's subcommittees; and (6) liaison between the Committee's subcommittee, the State and Federal agencies, the Secretary and the Governor. </P>
          <P>The Committee consists of 20 to 30 members who are appointed by the Secretary in consultation with the Governor.</P>
        </SUM>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Diane Buzard, CALFED Program Manager, 2800 Cottage Way, Sacramento, California 95821-1898, telephone (916) 978-5525.</P>
          <P>The certification of Charter renewal is published below: </P>
          <HD SOURCE="HD1">Certification</HD>
          <P>I hereby certify that Charter renewal of the California Bay-Delta Public Advisory Committee is in the public interest in connection with the performance of duties imposed on the Department of the Interior.</P>
          <SIG>
            <NAME>Gale A. Norton, </NAME>
            <TITLE>Secretary of the Interior.</TITLE>
          </SIG>
        </FURINF>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20800  Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 4310-MN-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF THE INTERIOR</AGENCY>
        <SUBAGY>Office of Surface Mining Reclamation and Enforcement</SUBAGY>
        <SUBJECT>Notice of Proposed Information Collection for 1029-0103</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Office of Surface Mining Reclamation and Enforcement.</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice and request for comments.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>In compliance with the Paperwork Reduction Act of 1995, the Office of Surface Mining Reclamation and Enforcement (OSM) is announcing that the information collection request regarding noncoal reclamation, found at 30 CFR part 875, has been forwarded to the Office of Management and Budget (OMB) for renewal authority. The information collection request describes the nature of the information collection and the expected burden and cost.</P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>OMB has up to 60 days to approve or disapprove the information collection but may respond after 30 days. Therefore, public comments should be submitted to OMB by September 15, 2003, in order to be assured of consideration.</P>
        </DATES>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>

          <P>To request a copy of the information collection request, explanatory information and related form, contact John A. Trelease at (202) 208-2783, or electronically at <E T="03">jtreleas@osmre.gov.</E>
          </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>

        <P>The Office of Management and Budget (OMB) regulations at 5 CFR 1320, which implement provisions of the Paperwork Reduction Act of 1995 (Pub. L. 104-13), require that interested members of the public and affected agencies have an opportunity to comment on information collection and recordkeeping activities (see 5 CFR 1320.8 (d)). OSM has submitted a request to OMB to renew its approval of the collection of information for noncoal reclamation, found at 30 CFR part 875. OSM is requesting a 3-<PRTPAGE P="48938"/>year term of approval for this information collection activity.</P>
        <P>An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. The OMB control number for this collection of information is listed in 30 CFR part 875, which is 1029-0103. </P>
        <P>As required under 5 CFR 1320.8(dl), a <E T="04">Federal Register</E> notice soliciting comments on these collections of information was published on May 2, 2003 (68 FR 23496). No comments were received. This notice provides the public with an additional 30 days in which to comment on the following information collection activity:</P>
        <P>
          <E T="03">Title:</E> Noncoal reclamation, 30 CFR part 875. </P>
        <P>
          <E T="03">OMB Control Number:</E> 1029-0103.</P>
        <P>
          <E T="03">Summary:</E> This part establishes procedures and requirements for State and Indian tribes to conduct noncoal reclamation using abandoned mine land funding. The information is needed to assure compliance with the Surface Mining Control and Reclamation Act of 1977.</P>
        <P>
          <E T="03">Bureau Form Numbers:</E> OSM-47, OSM-51.</P>
        <P>
          <E T="03">Frequency of collection:</E> Once.</P>
        <P>
          <E T="03">Description of Respondents:</E> State governments and Indian Tribes.</P>
        <P>
          <E T="03">Total Annual Responses:</E> 10.</P>
        <P>
          <E T="03">Total Annual Burden Hours:</E> 189.</P>
        <P>Send comments on the need for the collection of information for the performance of the functions of the agency; the accuracy of the agency's burden estimates; ways to enhance the quality, utility and clarity of the information collection; and ways to minimize the information collection burden on respondents, such as use of automated means of collection of the information, to the following address. Please refer to the appropriate OMB control number in all correspondence.</P>
        <SUPLHD>
          <HD SOURCE="HED">ADDRESSES:</HD>

          <P>Submit comments to the Office of Information and Regulatory Affairs, Office of Management and Budget, Attention: Department of Interior Desk Officer, by telefax at (202) 395-5806 or via e-mail to <E T="03">Ruth_Solomon@omb.eop.gov.</E> Also, please send a copy of your comments to John A. Trelease, Office of Surface Mining Reclamation and Enforcement, 1951 Constitution Ave, NW., Room 210-SIB, Washington, DC 20240; or electronically to <E T="03">jtreleas@osmre.gov.</E>
          </P>
        </SUPLHD>
        <SIG>
          <DATED>Dated: July 1, 2003.</DATED>
          <NAME>Richard G. Bryson, </NAME>
          <TITLE>Chief, Division of Regulatory Support.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20917  Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 4310-05-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">INTERNATIONAL TRADE COMMISSION </AGENCY>
        <DEPDOC>[Investigation No. TA-421-3] </DEPDOC>
        <SUBJECT>Certain Brake Drums and Rotors From China </SUBJECT>
        <HD SOURCE="HD1">Determination </HD>
        <P>On the basis of information developed in the subject investigation, the United States International Trade Commission determines, pursuant to section 421(b)(1) of the Trade Act of 1974,<SU>1</SU>
          <FTREF/> that certain brake drums and rotors <SU>2</SU>
          <FTREF/> from the People's Republic of China are not being imported into the United States in such increased quantities or under such conditions as to cause or threaten to cause market disruption to the domestic producers of like or directly competitive products. </P>
        <FTNT>
          <P>
            <SU>1</SU> 19 U.S.C. 2451(b)(1).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>2</SU> For purposes of this investigation, aftermarket brake drums and aftermarket brake rotors are defined as certain brake drums and certain brake rotors made of gray cast iron, whether finished, semifinished, or unfinished, ranging in diameter from 8 to 16 inches (20.32 to 40.64 centimeters) and in weight from 8 to 45 pounds (3.63 to 20.41 kilograms). The size parameters (weight and dimension) of the brake drums and brake rotors limit their use to the following types of motor vehicles: automobiles, all-terrain vehicles, vans and recreational vehicles under “one ton and a half,” and light trucks designated as “one ton and a half.” </P>
          <P>Finished aftermarket brake drums and finished aftermarket brake rotors are those that are ready for sale and installation without any further operations. Semifinished aftermarket brake drums and semifinished aftermarket brake rotors are those on which the surface is not entirely smooth, and has undergone some drilling. Unfinished aftermarket brake drums and unfinished aftermarket brake rotors are those which have undergone some grinding or turning. </P>
          <P>The brake drums and brake rotors are for motor vehicles, and do not contain in the casting a logo of an original equipment manufacturer which produces vehicles sold in the United States (e.g., General Motors, Ford, DaimlerChrysler, Honda, Toyota, Volvo). Brake drums and brake rotors covered in this investigation are not certified by OEM producers of vehicles sold in the United States. The scope also includes composite brake drums and composite brake rotors that are made of gray cast iron, which contain a steel plate, but otherwise meet the above criteria. </P>

          <P>The imported products are provided for in subheading 8708.39.50 of the HTS at a general duty rate of 2.5 percent <E T="03">ad valorem.</E> Although the HTS category is provided for convenience and Customs purposes, the written description of the merchandise under investigation is dispositive. </P>
        </FTNT>
        <HD SOURCE="HD1">Background </HD>
        <P>Following receipt of a petition, as amended, filed on June 6, 2003, on behalf of the Coalition for the Preservation of American Brake Drum and Rotor Aftermarket Manufacturers, the Commission instituted investigation No. TA-421-3, Certain Brake Drums and Rotors from China, under section 421 of the Trade Act of 1974 to determine whether certain brake drums and rotors from China are being imported into the United States in such increased quantities or under such conditions as to cause or threaten to cause market disruption to the domestic producers of like or directly competitive products. </P>

        <P>Notice of the institution of the Commission's investigation and of the scheduling of a public hearing to be held in connection therewith was given by posting a copy of the notice on the Commission's Web site (<E T="03">http://www.usitc.gov</E>) and by publishing the notice in the <E T="04">Federal Register</E> of June 16, 2003 (68 FR 35702). The hearing was held on July 18, 2003 in Washington, DC; all persons who requested the opportunity were permitted to appear in person or by counsel. </P>
        <P>The views of the Commission are contained in USITC Publication 3622 (August 2003), entitled Certain Brake Drums and Rotors from China: Investigation No. TA-421-3. </P>
        <SIG>
          <P>By order of the Commission. </P>
          
          <DATED>Issued: August 5, 2003. </DATED>
          <NAME>Marilyn R. Abbott, </NAME>
          <TITLE>Secretary to the Commission. </TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20813 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 7020-02-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">INTERNATIONAL TRADE COMMISSION </AGENCY>
        <DEPDOC>[Investigation No. 731-TA-1046 (Preliminary)] </DEPDOC>
        <SUBJECT>Tetrahydrofurfuryl Alcohol From China </SUBJECT>
        <HD SOURCE="HD1">Determination </HD>
        <P>On the basis of the record <SU>1</SU>
          <FTREF/> developed in the subject investigation, the United States International Trade Commission (Commission) determines, pursuant to section 733(a) of the Tariff Act of 1930 (19 U.S.C. 1673b(a)) (the Act), that there is a reasonable indication that an industry in the United States is materially injured by reason of imports from China of tetrahydrofurfuryl alcohol, provided for in subheading 2932.13.00 of the Harmonized Tariff Schedule of the United States, that are alleged to be sold in the United States at less than fair value (LTFV). </P>
        <FTNT>
          <P>
            <SU>1</SU> The record is defined in sec. 207.2(f) of the Commission's Rules of Practice and Procedure (19 CFR 207.2(f)).</P>
        </FTNT>
        <HD SOURCE="HD1">Commencement of Final Phase Investigation </HD>

        <P>Pursuant to section 207.18 of the Commission's rules, the Commission also gives notice of the commencement of the final phase of its investigation. The Commission will issue a final phase <PRTPAGE P="48939"/>notice of scheduling, which will be published in the <E T="04">Federal Register</E> as provided in section 207.21 of the Commission's rules, upon notice from the Department of Commerce (Commerce) of an affirmative preliminary determination in the investigation under section 733(b) of the Act, or, if the preliminary determination is negative, upon notice of an affirmative final determination in that investigation under section 735(a) of the Act. Parties that filed entries of appearance in the preliminary phase of the investigation need not enter a separate appearance for the final phase of the investigation. Industrial users, and, if the merchandise under investigation is sold at the retail level, representative consumer organizations have the right to appear as parties in Commission antidumping and countervailing duty investigations. The Secretary will prepare a public service list containing the names and addresses of all persons, or their representatives, who are parties to the investigation. </P>
        <HD SOURCE="HD1">Background </HD>
        <P>On June 23, 2003, a petition was filed with the Commission and Commerce by Penn Specialty Chemicals, Inc., Plymouth Meeting, PA, alleging that an industry in the United States is materially injured or threatened with material injury by reason of LTFV imports of tetrahydrofurfuryl alcohol from China. Accordingly, effective June 23, 2003, the Commission instituted antidumping duty investigation No. 731-TA-1046 (Preliminary). </P>

        <P>Notice of the institution of the Commission's investigation and of a public conference to be held in connection therewith was given by posting copies of the notice in the Office of the Secretary, U.S. International Trade Commission, Washington, DC, and by publishing the notice in the <E T="04">Federal Register</E> of June 30, 2003 (69 FR 38721). The conference was held in Washington, DC, on July 14, 2003, and all persons who requested the opportunity were permitted to appear in person or by counsel. </P>

        <P>The Commission transmitted its determination in this investigation to the Secretary of Commerce on August 7, 2003. The views of the Commission are contained in USITC Publication 3620 (August 2003), entitled <E T="03">Tetrahydrofurfuryl Alcohol from China: Investigation No. 1046 (Preliminary)</E>. </P>
        <SIG>
          <P>By order of the Commission. </P>
          
          <DATED>Issued: August 11, 2003. </DATED>
          <NAME>Marilyn R. Abbott, </NAME>
          <TITLE>Secretary to the Commission. </TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20814 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 7020-02-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF JUSTICE</AGENCY>
        <SUBJECT>Office of the Assistant Attorney General for Civil Rights; Certification of the Maryland Accessibility Code Under the Americans With Disabilities Act</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Department of Justice.</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of preliminary determination of equivalency, the period for submitting public comments and the hearing in Maryland on the proposed determination of equivalency.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>

          <P>The Department of Justice (Department) has determined that the Maryland Accessibility Code, under .05.02.02 of the Code of Maryland Regulations (COMAR), as adopted pursuant to Article 83B, section 6-102 of the Annotated Code of Maryland (together, the Maryland law), meets or exceeds the new construction and alterations requirements of title III of the Americans with Disabilities Act of 1990 (ADA). The Department proposes to issue a final certification, pursuant to 42 U.S.C. 12188(b)(1)(A)(ii) and 28 CFR 36.601 <E T="03">et seq</E>., which would constitute rebuttable evidence, in any enforcement proceeding, that a building constructed or altered in accordance with the Maryland law meets or exceeds the requirements of the ADA. The Department invites public comment on the proposed certification determination and will hold an informal hearing on the proposed determination in Ellicott City, Maryland.</P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>To be assured of consideration, comments must be in writing and must be received on or before October 14, 2003. The hearing in Ellicott City, Maryland is scheduled for Thursday, September 4, 2003, at 1 p.m., Eastern Time. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Comments on the preliminary determination of equivalency and on the proposal to issue final certification of equivalency of the Maryland law should be sent to: John L. Wodatch, Chief, Disability Rights Section, Civil Rights Division, U.S. Department of Justice, 950 Pennsylvania Avenue, NW., 1425 NYA Building, Washington, DC 20530.</P>
          <P>The hearing in Maryland will be held at the office of the Maryland Department of Community Development located at: The Banneker Room, George Howard Building/Howard County Office Complex, Ellicott City, MD 21043.</P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>John L. Wodatch, Chief, Disability Rights Section, Civil Rights Division, U.S. Department of Justice, 950 Pennsylvania Avenue, NW., 1425 NYA Building, Washington, DC 20530. Telephone number (800) 514-0301 (Voice) or (800) 514-0383 (TTY).</P>

          <P>Copies of this notice are available in formats accessible to individuals with vision impairments and may be obtained by calling (800) 514-0301 (Voice) or (800) 514-0383 (TTY). Copies of the Maryland law and supporting materials may be inspected by appointment at 1425 New York Avenue, NW., Suite 4039, Washington, DC by calling Linda Garrett at (202) 353-0423 TTY, or by e-mail at <E T="03">Linda.Garrett@usdoj.gov</E>.</P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P/>
        <P SOURCE="NPAR">
          <E T="03">Background:</E> The ADA authorizes the Department of Justice, upon application by a State or local government, to certify that a State or local law that establishes accessibility requirements meets or exceeds the minimum requirements of title III of the ADA for new construction and alterations. 42 U.S.C. 12188(b)(1)(A)(ii); 28 CFR 36.601 <E T="03">et seq.</E> Final certification constitutes rebuttable evidence, in any ADA enforcement action, that a building constructed or altered in accordance with the certified code complies with the new construction and alterations requirements of title III of the ADA.</P>
        <P>The Maryland Department of Housing and Community Development requested that the Department of Justice (Department) certify that the Maryland Accessibility Code, under .05.02.02 of the Code of Maryland Regulations (COMAR), as adopted pursuant to Article 83B, section 6-102 of the Annotated Code of Maryland (together, the Maryland law), meets or exceeds the new construction and alterations requirements of title III of the ADA. </P>
        <P>The Department has analyzed the Maryland law and has preliminarily determined that it meets or exceeds the new construction and alterations requirements of title III of the ADA. By letter dated May 29, 2003, the Department notified the Maryland Department of Housing and Community Development of its preliminary determination of equivalency.</P>
        <P>
          <E T="03">Effect of Certification:</E> The certification determination will be limited to the version of the Maryland law that has been submitted to the Department. The certification will not apply to amendments or interpretations <PRTPAGE P="48940"/>that have not been submitted and reviewed by the Department.</P>
        <P>Certification will not apply to buildings constructed by or for State or local government entities, which are subject to title II of the ADA. Nor does certification apply to accessibility requirements that are addressed by the Maryland law that are not addressed by the ADA Standards for Accessible Design.</P>
        <P>Finally, certification does not apply to variances or waivers granted under the Maryland law. Therefore, if a builder receives a variance, waiver, modification, or other exemption from the requirements of the Maryland law for any element of construction or alterations, the certification determination will not constitute evidence of ADA compliance with respect to that element.</P>
        <P>
          <E T="03">Procedure:</E> The Department will review comments received from the public regarding the proposed determination and, during the 60-day comment period, will hold an informal hearing in Maryland to provide an opportunity for interested persons, including individuals with disabilities, to express their views with respect to the preliminary determination of equivalency of the Maryland law. Interested parties who wish to testify at the hearing should contact Linda Garrett at (202) 353-0423 TTY or by e-mail at <E T="03">Linda.Garrett@usdoj.gov.</E>
        </P>

        <P>The hearing site will be accessible to individuals with disabilities. Individuals who require sign language interpreters or other auxiliary aids should contact Linda Garrett at (202) 353-0423 TTY, or by e-mail at <E T="03">Linda.Garrett@usdoj.gov.</E> A notice of at least four days before the hearing date would be greatly appreciated if individuals require sign language interpreters or other auxiliary aids.</P>
        <SIG>
          <DATED>Dated: August 8, 2003.</DATED>
          <NAME>J. Michael Wiggins,</NAME>
          <TITLE>Acting Assistant Attorney General for Civil Rights.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20795  Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 4410-13-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF JUSTICE</AGENCY>
        <SUBJECT>Office of the Assistant Attorney General for Civil Rights; Certification of the Maryland Accessibility Code Under the Americans With Disabilities Act</SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Department of Justice.</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of hearing.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The Department of Justice will hold an informal hearing in Washington, DC on the proposed certification that the Maryland Accessibility Code, under .05.02.02 of the Code of Maryland Regulations (COMAR), as adopted pursuant to Article 83B, section 6-102 of the Annotated Code of Maryland (together, the Maryland law), meets or exceeds the new construction and alterations requirements of title III of the Americans With Disabilities Act (ADA).</P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>The hearing in Washington, DC is scheduled for Wednesday, October 22, 2003, at 2 p.m. Eastern Time.</P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>The hearing will be held at: Disability  Rights Section, 1425 New York Avenue, NW, Suite 4039, Washington, DC.</P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>John L. Wodatch, Chief, Disability Rights Section, Civil Rights Division, U.S. Department of Justice, 950 Pennsylvania Avenue, NW, 1425 NYA Building, Washington, DC 20530. Telephone number (800) 514-0301 (Voice) or (800) 514-0383 (TTY).</P>
          <P>Copies of this notice are available in formats accessible to individuals with vision impairments and may be obtained by calling (800) 514-0301 (Voice) or (800) 514-0383 (TTY).</P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P SOURCE="NPAR">
          <E T="03">Background:</E> Elsewhere in this issue of the <E T="04">Federal Register</E>, the Department of Justice (Department) is publishing a notice in the <E T="04">Federal Register</E> announcing that it had preliminarily determined that the Maryland Accessibility Code, under .05.02.02 of the Code of Maryland Regulations (COMAR), as adopted pursuant to Article 83B, section 6-102 of the Annotated Code of Maryland (together, the Maryland law), meets or exceeds the new construction and alterations requirements of title III of the ADA. The Department noted that it intended to issue final certification of the Maryland law and requested written comments on the preliminary determination and the proposed final certification. The Department also noted that it intended to hold an informal hearing in Ellicott City, Maryland, during the 60-day comment  period on the preliminary determination.</P>
        <P>
          <E T="03">Procedure:</E> In addition to the informal hearing in Ellicott City, Maryland, the Department will hold an informal hearing in Washington, DC, after the close of the 60-day comment period to provide an opportunity for interested persons, including individuals with disabilities, to express their views with respect to the issuance of a final determination of equivalency of the Maryland Law. Interested parties who wish to testify at the hearing should contact Linda Garrett at (202) 353-0423 TTY, or by e-mail at <E T="03">Linda.Garrett@usdoj.gov.</E>
        </P>

        <P>The meeting site will be accessible to individuals with disabilities. Individuals who require sign language interpreters or other auxiliary aids should contact Linda Garrett at (202) 353-0423 TTY, or by e-mail at <E T="03">Linda.Garrett@usdoj.gov.</E> A notice of at least four days before the hearing date would be greatly appreciated if individuals require sign language interpreters or other auxiliary aids.</P>
        <SIG>
          <DATED>Dated: August 8, 2003.</DATED>
          <NAME>J. Michael Wiggins,</NAME>
          <TITLE>Acting Assistant Attorney General for Civil Rights.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20796  Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 4410-13-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF JUSTICE</AGENCY>
        <SUBAGY>Antitrust Division</SUBAGY>
        <SUBJECT>Notice Pursuant to the National Cooperative Research and Production Act of 1993—The Digital Subscriber Line Forum</SUBJECT>

        <P>Notice is hereby given that, on July 16, 2003, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 <E T="03">et seq.</E> (“the Act”), The Digital Subscriber Line Forum (“DSL”) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership status. The notifications were filed for the purpose of extending the Act's  provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, ASTRI, Tsimshatsui, Kowloon, Hong Kong-China; Bridgewater Systems, Kanata, Ontario, Canada; Celite Systems, Austin, TX; Cidco Communications Corporation, Morgan Hill, CA; DrayTek Corp., Hsinchu, Taiwan; E &amp; E Magnetic Products, Hong Kong, Hong Kong-China; eCommerce Innovation Centre, Cardiff, Wales, United Kingdom; Efficient Networks, Dallas, TX; Entrisphere, Santa Clara, CA; Gemtek Technology Co., Hokou, Hsinchu, Taiwan; Georgia Tech Broadband Institute, Atlanta, GA; Incognito Software, Vancouver, British Columbia, Canada; Infratel Communications, Huntingdon Valley, PA; ITI Limited, Bangalore, Karatka, India; Juniper Networks, Westford, MA; Lite-On Technology, Chung-Ho, Taipei, Hsien, Taiwan; Netgear, Santa Clara, CA; Pine-net, Broken Bow, OK; Point Topic, <PRTPAGE P="48941"/>London, United Kingdom; Real Communications, Milpitas, CA; Redback Networks, San Jose, CA; Sparnex, Laguna Hills, CA; Stanford University, Stanford, CA; Telenor, Fornebu, Norway; Xignal Technologies, Unterhaching, Germany; and Xilinx, San Jose, CA, have been added as parties to this venture. The following companies have cancelled their memberships: 3Com, San Diego, CA; Acterna Eningen GmbH, Salem, VA; Admit Design Systems, Dalgety Bay, Fife, United Kingdom; Advanced TelCom Group, Santa Rosa, CA; Agilent Technologies, San Jose, CA; Allied Data Technologies, Spijkenisse, The Netherlands; Angeles Design Systems, Inc., Los Angeles, CA: Aspex Technology, Hygh Wycombe, United Kingdom; Atech Technology Co., Taipei, Taiwan; Avail Networks, Ann Arbor, MI; Best Data Products, Chatsworth, CA; BRECIS Communications, San Jose, CA; Broadframe Corporation, Alta Loma, CA; C-DOT, Bangalore, Karataka, India; Calix Networks, Petaluma, CA; Carrier Access Corporation, Boulder, CO; Castlenet Technology, Wu-Ku Hsiang, Taipei Hsien, Taiwan; Celsian Technologies, Tustin, CA; Chaos Telecom, San Diego, CA; CoEv, Inc., Watertown, SD; Communications Standards Review, Palo Alto, CA; Conklin Corporation, Duluth, GA; Corecess, Seoul, Republic of Korea; Croatian Telecom, Zagreb, Croatia; Data Connection, Chester, United Kingdom; DSLB it Hantro Oy, Oulu, Finland; DTI, Newport, South Wales, United Kingdom; Eicon Networks, Montreal, Quebec, Canada; Exigen Group, Saint John, New Brunswick, Canada; FutureSoft, San Jose, CA; Garnet Systems Co., Seoul, Republic of Korea; General Bandwidth, Austin, TX; Hewlett Packard, Piscataway, NJ; Hyundai Electronics, Seoul, Republic of Korea; Integrated Telecom Express, Inc., San Jose, CA; Inventel, Paris, France; Ishoni Networks, Santa Clara, CA; ITRI, Chutung, Hsinchu, Taiwan; Jetstream Communications, San Jose, CA; Kinpo Electronics, Taipei Hsien, Taiwan; KYE Systems, Taipei, Taiwan; Lake Communications, Dublin, Ireland; Marconi Communications, Genoa, Italy; Maxxio Technologies, Vienna, Austria; MDS Gateways, Dublin, Ireland; Metro-OptiX, Allen, TX; Mitel Networks, Kanata, Ontario, Canada; MMG-North America, Patterson, NJ; MTnet, Skopje, Macedonia, Greece; Netergy Networks, Marlow, United Kingdom; NHC Communications, Mount-Royal, Quebec, Canada; OKI Electric Industry, Naples, FL; Optimal Communications LTD, Gerrards Cross, United Kingdom; Partner Voxtream, Vojens, Denmark; Polycom Inc., Milpitas, CA; Prestolite Wire/Krone, Garland, TX; Pulsent Corporation, Milpitas, CA; QSC, Cologne, Germany; RIT Technologies, Tel Aviv, Israel; Santera Systems, Plano, TX; Sasken Communication Technologies, Bangalore, Karataka, India; SercoNet, Ra'anana, Israel; Silicom, Kfar-Sava, Israel; Telcordia Technologies, Red Bank, NJ; Telebyte, Greenlawn, NY; TeleChoice, Mansfield Center, CT; TeliaSonera AB, Farsta, Sweden; Telrad, Rosh Ha'ayin, Israel; Tenovis GmbH &amp; Co. KG, Frankfurt, Germany; Turnstone Systems, Santa Clara, CA; Tut Systems, Pleasanton, CA: Uniden America, Fort Worth, TX; URMET Suds S.p.A., Torino, Italy; VideoTele.com, Lake Oswego, OR; Virtual Access, Foxboro, MA; Vitria Technology, Sunnyvale, CA; VoicePump, Schaumberg, IL; Voyan Technology, Santa Clara, CA; Wind River Systems, Alameda, CA; Wipro, Bangalore, Karataka, India; Yokogawa Electric Corporation, Tokyo, Japan; and Zhone Technologies, Oakland, CA.</P>
        <P>Panasonic Semiconductor is now Panasonic Communications, Tokyo, Japan; Pacific Century Cyperworks is now PCCW Limited, Hong Kong, Hong Kong-China; Professional Multimedia Networks is now Sphairon, Bautzen, Germany; and CSI Suttle/Apparatus is now Suttle, Eden Prairie, MN.</P>
        <P>No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and DSL intends to file additional written notifications disclosing all changes in membership.</P>

        <P>On May 15, 1995, DSL filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the <E T="04">Federal Register</E> pursuant to Section 6(b) of the Act on July 25, 1995 (60 FR 38058).</P>

        <P>The last notification was filed with the Department on October 16, 2002. A notice was published in the <E T="04">Federal Register</E> pursuant to Section 6(b) of the Act on December 20, 2002 (67 FR 78014).</P>
        <SIG>
          <NAME>Dorothy B. Fountain,</NAME>
          <TITLE>Deputy Director of Operations, Antitrust Division.</TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20825  Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 4410-11-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF JUSTICE</AGENCY>
        <SUBAGY>Antitrust Division</SUBAGY>
        <SUBJECT>Notice Pursuant to the National Cooperative Research and Production Act of 1993—Multiservice Switching Forum</SUBJECT>

        <P>Notice is hereby given that, on July 28, 2003, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 <E T="03">et seq.</E> (“the Act”), Multiservice Switching Forum (“MSF”) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership status. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Operax AB, Lulea, Sweden, has been added as a party to this venture.</P>
        <P>No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and MSF intends to file additional written notifications disclosing all changes in membership.</P>

        <P>On January 22, 1999, MSF filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the <E T="04">Federal Register</E> pursuant to Section 6(b) of the Act on May 26, 1999 (64 FR 28519).</P>

        <P>The last notification was filed with the Department on May 6, 2003. A notice was published in the <E T="04">Federal Register</E> pursuant to Section 6(b) of the Act on June 30, 2003 (68 FR 38722).</P>
        <SIG>
          <NAME>Dorothy B. Fountain,</NAME>
          <TITLE>Deputy Director of Operations, Antitrust Division.</TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20826 Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 4410-11-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF JUSTICE</AGENCY>
        <SUBAGY>Antitrust Division</SUBAGY>
        <SUBJECT>Notice Pursuant to the National Cooperative Research and Production Act of 1993—The National Center for Manufacturing Sciences, Inc.</SUBJECT>

        <P>Notice is hereby given that, on July 22, 2003, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 <E T="03">et seq.</E> (“the Act”), The National Center for Manufacturing Sciences, Inc. has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its <PRTPAGE P="48942"/>membership status. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Acer America Corporation, Newbury Port, MA; Foster-Miller, Inc., Waltham, MA; Gage Products Company, Ferndale, MI; Leszynski Group Inc., Bellevue, WA; Intel Corporation, Santa Clara, CA; Precon Machining Optimization Technologies, Gross Pointe Park, MI; Rolls Royce Corporation, Indianapolis, IN; and Unigraphics Solutions, Inc., Plymouth Meeting, PA have been added as parties to this venture.</P>
        <P>No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and The National Center for Manufacturing Sciences, Inc. intends to file additional written notification disclosing all changes in membership.</P>

        <P>On February 20, 1987, The National Center for Manufacturing Sciences, Inc. filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the <E T="04">Federal Register</E> pursuant to Section 6(b) of the Act on March 17, 1987 (52 FR 8375).</P>

        <P>The last notification was filed with the Department on April 7, 2003. A notice was published in the <E T="04">Federal Register</E> pursuant to Section 6(b) of the Act on May 14, 2003 (68 FR 25906-01).</P>
        <SIG>
          <NAME>Dorothy B. Fountain,</NAME>
          <TITLE>Deputy Director of Operations, Antitrust Division.</TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20824  Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 4410-11-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF JUSTICE</AGENCY>
        <SUBAGY>Antitrust Division</SUBAGY>
        <SUBJECT>Notice Pursuant to the National Cooperative Research and Production Act of 1993—Petrotechnical Open Standards Consortium, Inc. (“POSC”)</SUBJECT>

        <P>Notice is hereby given that, on July 17, 2003, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 <E T="03">et seq.</E> (“the Act”), Petrotechnical Open Standards Consortium, Inc. (“POSC”) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership status. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, ETL Solutions Limited, Blaenau Ffestiniog, Gwynedd, United Kingdom; and Trust Technical Services, Abu Dhabi, United Arab Emirates, have been added as parties to this venture.</P>
        <P>No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and Petrotechnical Open Standards Consortium, Inc. (“POSC”) intends to file additional written notification disclosing all changes in membership.</P>

        <P>On January 14, 1991, Petrotechnical Open Standards Consortium, Inc. (“POSC”) filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the <E T="04">Federal Register</E> pursuant to Section 6(b) of the Act on February 7, 1991 (56 FR 5021). </P>

        <P>The last notification was filed with the Department on October 17, 2002. A notice was published in the <E T="04">Federal Register</E> pursuant to Section 6(b) of the Act on January 22, 2003 (68 FR 3037).</P>
        <SIG>
          <NAME>Constance K. Robinson,</NAME>
          <TITLE>Director of Operations, Antitrust Division.</TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20823  Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 4410-11-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF JUSTICE</AGENCY>
        <SUBAGY>Drug Enforcement Administration</SUBAGY>
        <SUBJECT>Cordell Clark, M.D., Revocation of Registration</SUBJECT>
        <P>On July 26, 2002, the then-Deputy Administrator of the Drug Enforcement Administration (DEA), issued an Order to Show Cause and Notice of Immediate Suspension of Registration to Cordell Clark, M.D. (Dr. Clark). Dr. Clark was notified of an opportunity to show cause as to why DEA should not revoke his DEA Certificate of Registration, AC1074892, pursuant to 21 U.S.C. 824(a)(1), (3) and (4), and deny any pending applications for renewal or modification as a practitioner pursuant to 21 U.S.C. 823(f). The Order to Show Cause—Notice of Immediate Suspension further notified Dr. Clark that his DEA registration was immediately suspended as an imminent danger to the public health and safety pursuant to 21 U.S.C. 824(d). Dr. Clark was also notified that should no request for a hearing be filed within 30 days, his hearing right would be deemed waived.</P>
        <P>On July 31, 2002, three DEA Diversion Investigators attempted to serve the Order to Show Cause-Notice of Suspension upon Dr. Clark at his registered address in Dallas, Texas. The investigators also attempted delivery at a second business address in Dallas. Dr. Clark was at neither location, and both appeared to have been vacated. On August 1, 2002, two DEA Diversion Investigators along with a DEA Special Agent hand carried the Order to Show Cause—Notice of Immediate Suspension to Dr. Clark's residence in Cedar Hill, Texas. Dr. Clark again was not present, however, a person identifying himself as Christopher Clark (later determined to be Dr. Clark's twenty-year old son) was present at the location. After displaying credentials and identifying themselves as representatives of DEA, the investigators inquired as to the whereabouts of Dr. Clark. Christopher Clark informed DEA personnel that his father was “at work” but would not divulge Dr. Clark's location or telephonically contact him so that DEA personnel could speak with him. As a result, DEA personnel left the Order to Show Cause—Notice of Suspension (along with a business card from a Diversion Investigator) with Christopher Clark with instructions that he deliver the same to Dr. Clark. DEA has not received a request for hearing or any other reply from Dr. Clark or anyone purporting to represent him in this matter.</P>
        <P>Therefore, the Acting Administrator, finding that (1) 30 days have passed since the receipt of the Order to Show Cause, and (2) no request for a hearing having been received, concludes that Dr. Clark is deemed to have waived his hearing right. After considering material from the investigative file in this matter, the Acting Administrator now enters his final order without a hearing pursuant to 21 CFR 1301.43 (d) and (e) and 1301.46.</P>
        <P>The Acting Administrator finds that Dr. Clark currently possesses DEA Certificate of Registration AC1974892. While Dr. Clark's DEA registration reflects an expiration date of August 31, 2001, that registration remains valid based upon his timely submission of a DEA renewal application dated August 16, 2001.</P>

        <P>The Acting Administrator finds that on September 25, 2000, the Texas State Board of Medical Examiners (Board) issued an order suspending Dr. Clark's license to practice medicine. The Board's order was based in part upon Dr. Clark's failure to evaluate a patent prior to ordering physical therapy and his failure to comply with terms and conditions of a prior Agreed Order that Dr. Clark had entered into with the Board. On September 7, 2001, the Board issued an Order denying Dr. Clark's petition to terminate the suspension of his medical license.<PRTPAGE P="48943"/>
        </P>
        <P>On September 26, 2001, the Texas Department of Public Safety (DPS) notified Dr. Clark of the cancellation of his state Controlled Substances Registration Certificate number Y0042101. The action by DPS was initiated based upon Dr. Clark's failure to meet a necessary precondition for a Texas controlled substance registration—a medical license with the Board that was current and in good standing.</P>
        <P>The above referenced Order to Show Cause—Notice of Immediate Suspension further alleged, and a review of information in the investigative file suggests, that Dr. Clark materially falsified his August 16, 2001 application for renewal of his DEA registration by failing to disclose information regarding the suspension of his Texas medical license. The investigative file also reveals that Dr. Clark continued issuing prescriptions for controlled substances despite the lack of state authorization to practice medicine or handle controlled substances, and being advised by DEA personnel on August 30, 2001, to cease writing such prescriptions.</P>
        <P>There is no evidence in the record that the Board has lifted the suspension of Dr. Clark's medical license or that his Texas State Controlled Substances Certificate has been reinstated. Therefore, the Acting Administrator finds that Dr. Clark is not currently authorized to handle controlled substances in that state.</P>

        <P>DEA does not have statutory authority under the Controlled Substances Act to issue or maintain a registration if the applicant or registrant is without state authority to handle controlled substances in the state in which he conducts business. <E T="03">See</E> 21 U.S.C. 802(21), 823(f) and 824(a)(3). This prerequisite has been consistently upheld. <E T="03">See Joseph Thomas Allevi, M.D.,</E> 67 FR 35581 (2002); <E T="03">Dominick A. Ricci, M.D.,</E> 58 FR 51104 (1993); <E T="03">Bobby Watts, M.D.,</E> 53 FR 11919 (1988).</P>

        <P>Here, it is clear that Dr. Clark is not licensed to handle controlled substances in Texas, where he is registered with DEA. Therefore, he is not entitled to maintain that registration. Because Dr. Clark is not entitled to a DEA registration in Texas due to his lack of state authorization to handle controlled substances, the Acting Administrator concludes that it is unnecessary to address whether Dr. Clark's registration should be revoked based upon the other grounds asserted in the Order to Show Cause—Notice of Immediate Suspension. <E T="03">See Fereida Walker-Graham, M.D.,</E> 68 FR 24761 (2003); <E T="03">Nathaniel-Aikens-Afful, M.D.,</E> 62 FR 16871 (1997); <E T="03">San F. Moore, D.V.M.,</E> 58 FR 14428 (1993).</P>
        <P>Accordingly, the Acting Administrator of the Drug Enforcement Administration, pursuant to the authority vested in him by 21 U.S.C. 823 and 824 and 28 CFR 0.100(b) and 0.104, hereby orders that DEA Certificate of Registration, AC1074892, issued to Cordell Clark, M.D., be, and it hereby is, revoked. The Acting Administrator further orders that any pending application for renewal or modification of such registration be, and they hereby are, denied. This order is effective September 15, 2003.</P>
        <SIG>
          <DATED>Dated: July 28, 2003.</DATED>
          <NAME>William B. Simpkins,</NAME>
          <TITLE>Acting Administrator.</TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20805  Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 4410-09-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF JUSTICE</AGENCY>
        <SUBAGY>Drug Enforcement Administration</SUBAGY>
        <DEPDOC>[Docket No. 02-50]</DEPDOC>
        <SUBJECT>Kanwaljit S. Serai, M.D.; Revocation of Registration</SUBJECT>
        <P>On June 28, 2002, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to Kanwaljit S. Serai, M.D. (Respondent). The Order to Show Cause notified the Respondent of an opportunity to show cause as to why DEA should not revoke his DEA Certificate of Registration, AS1852715, and deny any pending applications for renewal or modification of that registration. The Order to Show alleged in relevant part that the Respondent is not authorized to handle controlled substances in the State of Florida pursuant to 21 U.S.C. 824(a)(3), and his continued registration would be inconsistent with the public interest as that term is used in 21 U.S.C. 824(a)(4) based, in part, upon allegations that the Respondent inappropriately treated five patients, and that on April 17, 2001, he was arrested and charged with six counts of delivery of a controlled substance.</P>
        <P>By letter dated July 17, 2002, the Respondent, through counsel, requested a hearing in this matter. On July 30, 2002, the presiding Administrative Law Judge Mary Ellen Bittner (Judge Bittner) issued an Order for Prehearing Statements. However, in lieu of filing a prehearing statement, the Government filed Government's Motion for  Summary Judgement and Stay of Proceedings, arguing that the Respondent is without authorization to handle controlled substances in the State of Florida, and as a result,  further proceedings in the matter were not required. Attached to the Government's motion was an Order of Emergency Suspension of License dated August 27, 2001, whereby the State Florida Department of Health (Department of Health) ordered the immediate suspension of the Respondent's license to practice medicine in that state.</P>
        <P>On August 15, 2002, Judge Bittner issued a Memorandum to Counsel staying the filing of prehearing statements and afforded the Respondent until September 4, 2002, to respond to the Government's Motion. The Respondent did not file a response.</P>
        <P>On September 18, 2002, Judge Bittner issued her Opinion and Recommended Decision  of the Administrative Law Judge (Opinion and Recommended Decision). As part of her recommended ruling, Judge Bittner granted the Government's Motion for Summary Disposition and found that the Respondent lacked authorization to handle controlled substances in the State of Florida, the jurisdiction in which he is registered with DEA.</P>
        <P>In granting the Government's motion, Judge Bittner also recommended that the Respondent's DEA registration be revoked and any pending applications for modification or renewal be denied. Neither party filed exceptions to her Opinion and Recommended Decision, and on October 28, 2002, Judge Bittner transmitted the record of these proceedings to the Office of the DEA Deputy Administrator.</P>
        <P>The Acting Administrator has considered the record in its entirety, and pursuant to 21 CFR 1316.67, hereby issues his final order based upon findings of fact and conclusions of law as hereinafter set forth. The Acting Administrator adopts, in full, the Opinion and Recommended Decision of the Administrative Law Judge.</P>
        <P>The Acting Administrator finds that the Respondent currently possesses DEA Certificate of Registration AS1852715, and is registered at an address in Tallahassee, Florida. That registration remains valid until February 28, 2004.</P>

        <P>The Acting Administrator further finds that on August 27, 2001, the Department of Health issued an Order of Emergency Suspension of License suspending the Respondent's license to practice medicine. The Acting Administrator's review of the Department of Health's suspension order reveals that in or around January 2000, the Respondent was found to have delivered controlled substances to <PRTPAGE P="48944"/>several patients as well as to an undercover law enforcement agent without medical justification. In further support of its suspension action, the Department of Health also found that the Respondent engaged in sexual misconduct with respect to his treatment of a patient.</P>
        <P>There is no evidence before the Acting Administrator that the suspension of the Respondent's medical license has been stayed or lifted. Therefore, the Acting Administrator finds that the Respondent is currently suspended from the practice of medicine in the State of Florida and as a result, it is reasonable to infer that he is also without authorization to handle controlled substances in that state.</P>

        <P>Pursuant to 21 U.S.C. 824(a), the Acting Administrator may revoke a DEA Certificate of Registration if he finds that the registrant has had his state license revoked and is no longer authorized to dispense controlled substances or has committed such acts  as would render his registration contrary to the public interest as determined by factors listed in 21 U.S.C. 823(f). <E T="03">Thomas B. Pelkowski, D.D.S.,</E> 57 FR 28538 (1992). Nevertheless, despite the findings of the Florida Department of Health related to the Respondent's inappropriate handling of controlled substances, his sexual misconduct with a patient, as well as other public interest factors for the revocation of his DEA registration asserted herein, the more relevant consideration here is the present status of the Respondent's state authorization to handle controlled substances.</P>

        <P>DEA does not have statutory authority under the Controlled Substances Act to issue or maintain a registration if the applicant or registrant is without state authority to  handle controlled substances in the state in which he conducts business. <E T="03">See,</E> 21 U.S.C. 802(21), 823(f) and 824(a)(3). This prerequisite has been consistently upheld. <E T="03">See Joseph  Thomas Allevi, MD.,</E> 67 FR 35581 (2002); <E T="03">Dominick A. Ricci, MD.,</E> 58 FR 51104 (1993); <E T="03">Bobby Watts, MD.,</E> 53 FR 11919 (1988).</P>

        <P>Here, it is clear that the Respondent is not licensed to handle controlled substances in Florida, the state where he currently possesses a DEA registration. Therefore, the Respondent is not entitled to maintain that registration. Because the Respondent lacks state authorization to handle controlled substances, the Acting Administrator concludes that it is unnecessary to address whether the Respondent's DEA registration should be revoked based upon the public interest grounds asserted in the Order to Show Cause. <E T="03">See Samual Silas Jackson,</E> 67 FR 65145 (2002); <E T="03">Nathaniel-Aikens-Afful, MD.,</E> 62 FR 16871 (1997); <E T="03">Sam F. Moore, D.V.M.,</E> 58 FR 14428 (1993).</P>
        <P>Accordingly, the Acting Administrator of the Drug Enforcement Administration, pursuant to the authority vested in him by 21 U.S.C. 823 and 824 and 28 CFR 0.100(b) and 0.104, hereby orders that DEA Certificate of Registration, AS1852715, issued to Kanwaljit S. Serai, M.D., be, and it hereby is, revoked. The Acting Administrator further orders that any pending applications for renewal or modification of such registration be, and they hereby are, denied. This order is effective September 5, 2003.</P>
        <SIG>
          <DATED>Dated: July 28, 2003.</DATED>
          <NAME>William B. Simpkins,</NAME>
          <TITLE>Acting Administrator.</TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20806  Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 4410-09-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF JUSTICE</AGENCY>
        <SUBAGY>Drug Enforcement Administration</SUBAGY>
        <SUBJECT>Karen Joe Smiley, M.D.; Revocation of Registration</SUBJECT>
        <P>On September 13, 2002, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to Karen J. Smiley (Dr. Smiley), notifying her of an opportunity to show cause as to why DEA should not revoke her DEA Certificate of Registration, BS5832868 under 21 U.S.C. 824(a)(3), and deny any pending applications for that registration, pursuant to 21 U.S.C. 823(f). As a basis for revocation, the Order to Show Cause alleged that Dr. Smiley was not currently authorized to practice medicine or handle controlled substances in Tennessee, the State in which she practices. The order also notified Dr. Smiley that should no request for a hearing be filed within 30 days, her hearing right would be deemed waived.</P>
        <P>The Order to Show Cause was sent by certified mail to Dr. Smiley at her registered location in Lexington, Tennessee. The show cause order was subsequently returned to DEA unclaimed with a post office notation “Returned to Sender—Not Deliverable as Addressed” stamped to the mailing envelope. According to the investigative file, DEA has made diligent attempts to locate Dr. Smiley and serve her with the Order to Show Cause, but such attempts have not met with success. Her current whereabouts are unknown. DEA has not received a request for hearing or any other reply from Dr. Smiley or anyone purporting to represent her in this matter.</P>

        <P>Therefore, the Acting Administrator of DEA, finding that (1) thirty days having passed since the attempted delivery of the Order to Show Cause at Dr. Smiley's registered address, (2) the Order to Show Cause having been returned and DEA's unsuccessful attempts at redelivery of the same, and (3) no request for hearing having been received, concludes that Dr. Smiley is deemed to have waived her hearing right. <E T="03">See David W. Linder,</E> 67 FR 12579 (2002). After considering material from the investigative file in this matter, the Acting Administrator now enters his final order without a hearing pursuant to 21 CFR 1301.43(d) and (e) and 1301.46.</P>
        <P>The Acting Administrator finds that Dr. Smiley currently possesses DEA Certificate of Registration BS5832868, and that registration remains valid until February 29, 2004. A review of the investigative reveals that on September 19, 2001, a majority of a quorum of the Tennessee Board of Medical Examiners (Board) approved an Order of Permanent Revocation of the medical license of Dr. Smiley in that state. The matter involving the disposition of Dr. Smiley's Tennessee medical license came before the Board pursuant to an earlier Notice of Charges and Memorandum of Assessment of Civil (Notice of Charges) with respect to Dr. Smiley's medical license. In the Notice of Charges, it was alleged, and the Board subsequently found that Dr. Smiley was “guilty of gross malpractice, or a pattern of continued or repeated malpractice, ignorance, negligence or incompetence in the course of medical practice.” Specifically, the Board found, among other things, that Dr. Smiley violated the Board's statutes governing the dispensing and/or prescribing of controlled substances.</P>
        <P>The investigative file contains no evidence that the Board's Order of Permanent Revocation has been stayed or that Dr. Smiley's medical license has been reinstated. Therefore, the Acting Administrator finds that Dr. Smiley is not currently authorized to practice medicine in the State of Tennessee. As a result, it is reasonable to infer that she is also without authorization to handle controlled substances in that state.</P>

        <P>DEA does not have statutory authority under the Controlled Substances Act to issue or maintain a registration if the applicant or registrant is without state authority to handle controlled substances in the state in which he conducts business. <E T="03">See</E> 21 U.S.C. 802(21), 823(f) and 824(a)(3). This prerequisite has been consistently <PRTPAGE P="48945"/>upheld. <E T="03">See Muttaiya Darmarajeh, M.D.,</E> 66 FR 52936 (2001); <E T="03">Dominick A. Ricci, M.D.,</E> 58 FR 51104 (1993); <E T="03">Bobby Watts, M.D.,</E> 53 FR 11919 (1988).</P>
        <P>Here, it is clear that Dr. Smiley's medical license has been revoked and she is not licensed to handle controlled substances in the State of Tennessee, where she is registered with DEA. Therefore, Dr. Smiley is not entitled to a DEA registration in that state.</P>
        <P>Accordingly, the Acting Administrator of the Drug Enforcement Administration, pursuant to the authority vested in him by 21 U.S.C. 823 and 824 and 28 CFR 0.100(b) and 0.104, hereby orders that DEA Certificate of Registration BS5832868, issued to Karen Joe Smiley, M.D. be, and it hereby is, revoked. The Acting Administrator further orders that any pending applications for renewal or modification of such registration be, and they hereby are, denied. This order is effective September 15, 2003.</P>
        <SIG>
          <DATED>Dated: July 28, 2003.</DATED>
          <NAME>William B. Simpkins,</NAME>
          <TITLE>Acting Administrator.</TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20807  Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 4410-09-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF JUSTICE </AGENCY>
        <SUBAGY>Office of Justice Programs </SUBAGY>
        <SUBJECT>Agency Information Collection Activities: Proposed Collection; Comment Request </SUBJECT>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>30-Day notice of information collection under review: Denial of Federal benefits for drug offenders.</P>
        </ACT>

        <P>The Department of Justice, Office of Justice Programs (OJP), Bureau of Justice Assistance (BJA), has submitted the following information collection request for review and clearance in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the <E T="04">Federal Register</E>, Volume 67, Number 228, page 70758, on November 26, 2002, allowing for a 60 day comment period. </P>
        <P>The purpose of this notice is to allow for an additional 30 days for public comment until September 15, 2003. This process is conducted in accordance with 5 CFR 1320.10. </P>
        <P>Written comments, or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention: Department of Justice Desk Officer, Washington, DC 20530. Additionally, comments may be submitted to OMB via facsimile at (202) 395-7285. </P>
        <P>Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: </P>
        <P>(1) Evaluate whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility. </P>
        <P>(2) Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used. </P>
        <P>(3) Enhance the quality, utility, and clarity of the information to be collected. </P>

        <P>(4) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, <E T="03">e.g.</E>, permitting electronic submission of responses. </P>
        <P>Overview of this information:</P>
        <P>(1) <E T="03">Type of information collection:</E> Reinstatement, without change, of a previously approved collection for which approval has expired. </P>
        <P>(2) <E T="03">The title of the form/collection:</E> Denial of Federal Benefits for Drug Offenders. </P>
        <P>(3) <E T="03">The agency form number, if any, and the applicable component of the Department sponsoring the collection:</E> Form Number: OJP FORM 3500/2, Office of Justice Programs, Department of Justice. </P>
        <P>(4) <E T="03">Affected public who will be asked or required to respond, as well as a brief abstract.</E> Primary: State, local, or Tribal Governments. Other: None. Abstract: The Denial of Federal Benefits (DFB) Program provides courts with the ability to deny all or selected federal benefits to individuals who are convicted of drug trafficking or drug possession. When denial of benefits is part of a sentence, the sentencing court notifies the BJA DFB Clearinghouse via the approved information collection form. The names of individuals who are denied benefits appear on the U.S. General Service Administration's Excluded Parties Listing System. </P>
        <P>(5) <E T="03">An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond/reply:</E> There are approximately 7 respondents who will respond approximately 36 times each throughout the year, for a total of 252 responses. Each response will require approximately 5 minutes to complete. </P>
        <P>(6) <E T="03">An estimate of the total public burden (in hours) associated with the collection:</E> The total annual public burden hours for this information collection is estimated to be 21 hours. </P>
        <P>If additional information is required, contact: Ms. Brenda E. Dyer, Deputy Clearance Officer, U.S. Department of Justice, Planning and Policy Staff, Justice Management Division, 601 D Street, NW., Washington, DC 20004, or via facsimile at (202) 514-1590. </P>
        <SIG>
          <DATED>Dated: August 8, 2003. </DATED>
          <NAME>Brenda E. Dyer, </NAME>
          <TITLE>Deputy Clearance Officer, Department of Justice. </TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20882 Filed 8-15-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4410-18-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF JUSTICE </AGENCY>
        <SUBAGY>Office of Justice Programs </SUBAGY>
        <SUBJECT>Agency Information Collection Activities: Proposed Collection; Comment Request </SUBJECT>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>30-Day notice of information collection under review: Edward Byrne Memorial State and Local Law Enforcement Assistance Program.</P>
        </ACT>

        <P>The Department of Justice, Office of Justice Programs (OJP), Bureau of Justice Assistance (BJA), has submitted the following information collection request for review and clearance in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the <E T="04">Federal Register</E>, Volume 68, Number 66, page 16831, on April 7, 2003, allowing for a 60 day comment period. </P>
        <P>The purpose of this notice is to allow for an additional 30 days for public comment until September 15, 2003. This process is conducted in accordance with 5 CFR 1320.10. </P>

        <P>Written comments, or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention: Department of Justice Desk Officer, Washington, DC 20530. <PRTPAGE P="48946"/>Additionally, comments may be submitted to OMB via facsimile at (202) 395-7285. </P>
        <P>Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: </P>
        <P>(1) Evaluate whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility. </P>
        <P>(2) Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used. </P>
        <P>(3) Enhance the quality, utility, and clarity of the information to be collected. </P>

        <P>(4) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, <E T="03">e.g.</E>, permitting electronic submission of responses. </P>
        <P>Overview of this information:</P>
        <P>(1) <E T="03">Type of information collection:</E> Reinstatement, with change, of a previously approved collection for which approval has expired. </P>
        <P>(2) <E T="03">The title of the form/collection:</E> Edward Byrne Memorial State and Local Law Enforcement Assistance Program. </P>
        <P>(3) <E T="03">The agency form number, if any, and the applicable component of the Department sponsoring the collection:</E> Form Number: OJP FORM 4061/6, Office of Justice Programs, Department of Justice. </P>
        <P>(4) <E T="03">Affected public who will be asked or required to respond, as well as a brief abstract.</E> Primary: State, local, or Tribal Governments. Other: None. Abstract: This request covers application requirements to receive formula grant funds under the Edward Byrne Memorial State and Local Law Enforcement Assistance Program. There are 56 eligible states and territories. The goal of the program is to create safer communities. BJA relies on the information collected in the application package to make an affirmative finding that the state applicant will carry out programs or projects consistent the direction of Congress. </P>
        <P>(5) <E T="03">An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond/reply:</E> There are approximately 56 respondents who will respond 1 time per year, for a total of 56 responses. Each response will require approximately 24 hours to complete. </P>
        <P>(6) <E T="03">An estimate of the total public burden (in hours) associated with the collection:</E> The total annual public burden hours for this information collection is estimated to be 1344 hours. </P>
        <P>If additional information is required, contact: Ms. Brenda E. Dyer, Deputy Clearance Officer, U.S. Department of Justice, Planning and Policy Staff, Justice Management Division, 601 D Street, NW., Washington, DC 20004, or via facsimile at (202) 514-1590. </P>
        <SIG>
          <DATED>Dated: August 8, 2003. </DATED>
          <NAME>Brenda E. Dyer, </NAME>
          <TITLE>Deputy Clearance Officer, Department of Justice. </TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20883 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4410-18-P </BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF LABOR</AGENCY>
        <SUBAGY>Employment Standards Administration; Wage and Hour Division</SUBAGY>
        <SUBJECT>Minimum Wages for Federal and Federally Assisted Construction; General Wage Determination Decisions</SUBJECT>
        <P>General wage determination decisions of the Secretary of Labor are issued in accordance with applicable law and are based on the information obtained by the Department of Labor from its study of local wage conditions and data made available from other sources. They specify the basic hourly wage rates and fringe benefits which are determined to be prevailing for the described classes of laborers and mechanics employed on construction projects of a similar character and in the localities specified therein.</P>
        <P>The determinations in these decisions of prevailing rates and fringe benefits have been made in accordance with 29 CFR part 1, by authority of the Secretary of Labor pursuant to the provisions of the Davis-Bacon Act of March 3, 1931, as amended (46 Stat. 1494, as amended, 40 U.S.C. 276a) and of other Federal statutes referred to in 29 CFR part 1, Appendix, as well as such additional statutes as may from time to time be enacted containing provisions for the payment of wages determined to be prevailing by the Secretary of Labor in accordance with the Davis-Bacon Act. The prevailing rates and fringe benefits determined in these decisions shall, in accordance with the provisions of the foregoing statutes, constitute the minimum wages payable on Federal and federally assisted construction projects to laborers and mechanics of the specified classes engaged on contract work of the character and in the localities described therein.</P>
        <P>Good cause is hereby found for not utilizing notice and public comment procedures thereon prior to the issuance of these determinations as prescribed in 5 U.S.C. 553 and not providing for delay in the effective date as prescribed in that section, because the necessity to issue construction industry wage determinations frequently and in large volume causes procedures to be impractical and contrary to the public interest.</P>

        <P>General  wage determination decisions, and modifications and supersedes decisions thereto, contain no expiration dates and are effective from their date of notice in the <E T="04">Federal Register</E>, or on the date written notice is received by the agency, whichever is earlier. These decisions are to be used in accordance with the provisions of 29 CFR parts 1 and 5. Accordingly, the applicable decision, together with any modifications issued, must be made a part of every contract for performance of the described work within the geographic area indicated as required by an applicable Federal prevailing wage law and 29 CFR part 5. The wage rates and fringe benefits, notice of which is published herein, and which are contained in the Government Printing Office (GPO) document entitled   “General Wage Determinations Issued Under the Davis-Bacon And Related Acts,” shall be the minimum paid by contractors and subcontractors to laborers and mechanics.</P>
        <P>Any person, organization, or governmental agency having an interest in the rates determined as prevailing is encouraged to submit wage rate and fringe benefit information for consideration by the Department.</P>
        <P>Further information and self-explanatory forms for the purpose of submitting this data may be obtained by writing to the U.S. Department of Labor, Employment Standards Administration, Wage and Hour Division, Division of Wage Determinations, 200 Constitution Avenue, NW., Room S-3014, Washington, DC, 20210.</P>
        <HD SOURCE="HD1">Modification to General Wage Determination Decisions</HD>

        <P>The number of the decisions listed to the Government Printing Office document entitled “General Wage Determinations Issued Under the Davis-Bacon and related Acts” being modified are listed by Volume and State. Dates of publication in the <E T="04">Federal Register</E> are in parentheses following the decision being modified.<PRTPAGE P="48947"/>
        </P>
        <HD SOURCE="HD2">Volume I</HD>
        <FP SOURCE="FP-2">Rhode Island </FP>
        <FP SOURCE="FP1-2">RI030001 (Jun. 13, 2003)</FP>
        <HD SOURCE="HD2">Volume II</HD>
        <FP SOURCE="FP-2">None</FP>
        <HD SOURCE="HD2">Volume III</HD>
        <FP SOURCE="FP-2">None</FP>
        <HD SOURCE="HD2">Volume IV</HD>
        <FP SOURCE="FP-2">None</FP>
        <HD SOURCE="HD2">Volume V</HD>
        <FP SOURCE="FP-2">None</FP>
        <HD SOURCE="HD2">Volume VI</HD>
        <FP SOURCE="FP-2">Colorado</FP>
        <FP SOURCE="FP1-2">CO030001 (Jun. 13, 2003)</FP>
        <FP SOURCE="FP1-2">CO030002 (Jun. 13, 2003)</FP>
        <FP SOURCE="FP1-2">CO030003 (Jun. 13, 2003)</FP>
        <FP SOURCE="FP1-2">CO030004 (Jun. 13, 2003)</FP>
        <FP SOURCE="FP1-2">CO030005 (Jun. 13, 2003)</FP>
        <FP SOURCE="FP1-2">CO030006 (Jun. 13, 2003)</FP>
        <FP SOURCE="FP1-2">CO030007 (Jun. 13, 2003)</FP>
        <FP SOURCE="FP1-2">CO030008 (Jun. 13, 2003)</FP>
        <FP SOURCE="FP1-2">CO030009 (Jun. 13, 2003)</FP>
        <FP SOURCE="FP1-2">CO030010 (Jun. 13, 2003)</FP>
        <FP SOURCE="FP1-2">CO030011 (Jun. 13, 2003)</FP>
        <FP SOURCE="FP1-2">CO030012 (Jun. 13, 2003)</FP>
        <FP SOURCE="FP1-2">CO030013 (Jun. 13, 2003)</FP>
        <FP SOURCE="FP1-2">CO030014 (Jun. 13, 2003)</FP>
        <FP SOURCE="FP1-2">CO030015 (Jun. 13, 2003)</FP>
        <FP SOURCE="FP1-2">CO030016 (Jun. 13, 2003)</FP>
        <HD SOURCE="HD2">Volume VII</HD>
        <FP SOURCE="FP-2">None</FP>
        <HD SOURCE="HD1">General Wage Determination Publication</HD>
        <P>General wage determinations issued under the Davis-Bacon and related Acts, including those noted above, may be found in the Government Printing Office (GPO) document entitled “General Wage determinations Issued Under the Davis-Bacon and Related Acts”. This publication is available at each of the 50 Regional Government Depository Libraries and many of the 1,400 Government Depository Libraries across the country.</P>

        <P>General wage determinations issued under the Davis-Bacon and related Acts are available electronically at not cost on the Government Printing Office site at <E T="03">http://www.access.gpo.gov/davisbacon.</E> They are also available electronically by subscription to the Davis-Bacon Online Service (<E T="03">http://davisbacon.fedworld.gov</E>) of the National Technical Information Service (NTIS) of the U.S. Department of Commerce at 1-800-363-2068. This subscription offers value-added features such as electronic delivery of modified wage decisions directly to the user's desktop, the ability to access prior wage decisions issued during the year, extensive Help desk Support, etc.</P>
        <P>Hard-copy subscriptions may be purchased from: Superintendent of Documents, U.S. Government Printing Office, Washington, DC 20402, (202) 512-1800.</P>
        <P>When ordering hard-copy subscription(s), be sure to specify the State(s) of interest, since subscriptions may be ordered for any or all of the six separate Volumes, arranged by State. Subscriptions include an annual edition (issued in January or February) which includes all current general wage determinations for the States covered by each volume. Throughout the remainder of the year, regular weekly updates will be distributed to subscribers.</P>
        <SIG>
          <DATED>Signed at Washington, DC, this 7 day of August, 2003.</DATED>
          <NAME>Carl J. Poleskey,</NAME>
          <TITLE>Chief, Branch of Construction Wage Determinations.</TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20538  Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 4510-27-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">NATIONAL AERONAUTICS AND SPACE ADMINISTRATION </AGENCY>
        <DEPDOC>[Notice: 03-094] </DEPDOC>
        <SUBJECT>Title VI of the Civil Rights Act of 1964, as Amended: Policy Guidance on the Prohibition Against National Origin Discrimination as It Affects Persons With Limited English Proficiency </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>National Aeronautics and Space Administration (NASA). </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of revised policy guidance with request for comments. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>Title VI of the Civil Rights Act of 1964, 42 U.S.C. 2000d-2000d-42, as amended, and NASA's implementing regulation at 14 CFR part 1250 provide that no person shall be subjected to discrimination on the basis of race, color, or national origin under any program or activity that receives Federal financial assistance. NASA is republishing for additional public comment revised policy guidance on Title VI's prohibition against national origin discrimination as it affects Limited English Proficient (LEP) persons. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>

          <P>Comments must be submitted on or before September 15, 2003. NASA will review all comments and will determine what modifications to the policy guidance, if any, are necessary before issuing final guidance through publication in the <E T="04">Federal Register</E>. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Interested persons should submit written comments to Dr. Dorothy Hayden-Watkins, Assistant Administrator for Equal Opportunity Programs, Code E, NASA Headquarters, 300 E Street, SW., Room 4W31, Washington, DC 20546. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Mr. Miguel A. Torres, (202) 358-0937, or TDD: (202) 358-3748. Arrangements to receive the policy in an alternative format may be made by contacting Mr. Miguel A. Torres. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>The purpose of this revised policy guidance is to further clarify the responsibilities of institutions and/or entities that receive financial assistance from NASA, and assist them in fulfilling their responsibilities to LEP persons pursuant to Title VI of the Civil Rights Act of 1964. The revised policy guidance emphasizes that in order to avoid discrimination against LEP persons on grounds of national origin, recipients of NASA financial assistance must take adequate steps to ensure that people who are not proficient in English can effectively participate in and benefit from the recipient's programs and activities. Therefore, LEP persons should expect to receive the language assistance necessary to afford them meaningful access to the recipients' programs and activities, free of charge. </P>

        <P>This document was originally published as policy guidance for public comment on March 15, 2001. <E T="03">See</E> 66 FR 15141. The document was based on the policy guidance issued by the Department of Justice entitled “Enforcement of Title VI of the Civil Rights Act of 1964—National Origin Discrimination Against Persons with Limited English Proficiency.” 65 FR 50213 (August 16, 2000). </P>

        <P>On October 26, 2001, and January 11, 2002, the Assistant Attorney General for Civil Rights issued to Federal departments and agencies guidance memoranda, which reaffirmed the Department of Justice's commitment to ensuring that federally assisted programs and activities fulfill their LEP responsibilities and which clarified and answered certain questions raised regarding the August 16th publication. In addition, on March 14, 2002, the Office of Management and Budget (OMB) issued a Report to Congress titled “Assessment of the Total Benefits and Costs of Implementing Executive Order No. 13166: Improving Access to Services for Persons with Limited English Proficiency.” Among other things, the Report recommended the adoption of uniform guidance across all Federal agencies, with flexibility to permit tailoring to each agency's specific recipients. Consistent with this OMB recommendation, DOJ published LEP Guidance for DOJ recipients that <PRTPAGE P="48948"/>was drafted and organized to also function as a model for similar guidance documents by other Federal grant agencies. <E T="03">See</E> 67 FR 41455 (June 18, 2002). NASA has reviewed its March 15, 2001, publication in light of these clarifications, to determine whether there is a need to clarify or modify the March 15th policy guidance. The LEP Guidance is consistent with the goals set forth in Executive Order (E.O.) 13166, and with the DOJ policy guidance documents dated August 16, 2000, and June 18, 2002. </P>
        <P>In furtherance of those memoranda, NASA is republishing revised policy guidance for the purpose of obtaining additional public comment. Because this guidance must adhere to the federal-wide compliance standards and framework detailed in the model DOJ LEP Guidance, NASA specifically solicits comments on the nature, scope and appropriateness of the NASA-specific examples set out in this guidance explaining and/or highlighting how those consistent Federal-wide compliance standards are applicable to recipients of Federal financial assistance through NASA. </P>
        <P>It has been determined that this Guidance, which supplants existing Guidance on the same subject previously published at 66 FR 15141 (March 15, 2001), does not constitute a regulation subject to the rulemaking requirements of the Administrative Procedure Act, 5 U.S.C. 553. It has also been determined that this guidance is not subject to Executive Order 12866. </P>
        <HD SOURCE="HD1">I. Introduction </HD>
        <P>Most individuals living in the United States read, write, speak and understand English. There are many individuals, however, for whom English is not their primary language. For instance, based on the 2000 census, over 26 million individuals speak Spanish and almost 7 million individuals speak an Asian or Pacific Island language at home. If these individuals have a limited ability to read, write, speak, or understand English, they are limited English proficient, or LEP. While detailed data from the 2000 census has not yet been released, 26% of all Spanish-speakers, 29.9% of all Chinese-speakers, and 28.2% of all Vietnamese-speakers reported that they spoke English not well or not at all in response to the 1990 census. </P>
        <P>Language for LEP individuals can be a barrier to accessing important benefits or services, understanding and exercising important rights, complying with applicable responsibilities, or understanding other information provided by federally funded programs and activities. The Federal Government funds an array of services that can be made accessible to otherwise eligible LEP persons. The Federal Government is committed to improving the accessibility of these programs and activities to eligible LEP persons, a goal that reinforces its equally important commitment to promoting programs and activities designed to help individuals learn English. Recipients should not overlook the long-term positive impacts of incorporating or offering English as a Second Language (ESL) programs in parallel with language assistance services. ESL courses can serve as an important adjunct to a proper Language Assistance Plan (LAP). However, the fact that ESL classes are made available does not obviate the statutory and regulatory requirement to provide meaningful access for those who are not yet English proficient. Recipients of federal financial assistance have an obligation to reduce language barriers that can preclude meaningful access by LEP persons to important government services.<SU>1</SU>
          <FTREF/>
        </P>
        <FTNT>
          <P>
            <SU>1</SU> NASA recognizes that many recipients had language assistance programs in place prior to the issuance of Executive Order 13166. This policy guidance provides a uniform framework for a recipient to integrate, formalize, and assess the continued vitality of these existing and possibly additional reasonable efforts based on the nature of its program or activity, the current needs of the LEP populations it encounters, and its prior experience in providing language services in the community it serves.</P>
        </FTNT>
        <P>In certain circumstances, failure to ensure that LEP persons can effectively participate in or benefit from federally assisted programs and activities may violate the prohibition under Title VI of the Civil Rights Act of 1964, 42 U.S.C. 2000d and Title VI regulations against national origin discrimination. The purpose of this policy guidance is to assist recipients in fulfilling their responsibilities to provide meaningful access to LEP persons under existing law. This policy guidance clarifies existing legal requirements for LEP persons by providing a description of the factors recipients should consider in fulfilling their responsibilities to LEP persons.<SU>2</SU>
          <FTREF/> These are the same criteria DOJ will use in evaluating whether recipients are in compliance with Title VI and Title VI regulations. </P>
        <FTNT>
          <P>
            <SU>2</SU> The policy guidance is not a regulation but rather a guide. Title VI and its implementing regulations require that recipients take responsible steps to ensure meaningful access by LEP persons. This guidance provides an analytical framework that recipients may use to determine how best to comply with statutory and regulatory obligations to provide meaningful access to the benefits, services, information, and other important portions of their programs and activities for individuals who are limited English proficient.</P>
        </FTNT>

        <P>There are many productive steps that NASA can take to help recipients reduce the costs of language services without sacrificing meaningful access for LEP persons. Without these steps, certain smaller grantees may well choose not to participate in federally assisted programs, threatening the critical functions that the programs strive to provide. To that end, NASA plans to continue to provide assistance and guidance in this important area. In addition, NASA plans to work with its recipients, and LEP persons to identify and share model plans, examples of best practices, and cost-saving approaches. Moreover, NASA intends to explore how language assistance measures, resources and cost-containment approaches developed with respect to its own federally conducted programs and activities can be effectively shared or otherwise made available to recipients, particularly small businesses, and small non-profits. An interagency working group on LEP has developed a Web site, <E T="03">http://www.lep.gov</E>, to assist in disseminating this information to recipients, Federal agencies, and the communities being served. </P>

        <P>Many commentators, responding to the proposed DOJ LEP Policy Guidance, have noted that some have interpreted the case of <E T="03">Alexander</E> v. <E T="03">Sandoval</E>, 532 U.S. 275 (2001), as impliedly striking down the regulations promulgated under Title VI that form the basis for the part of Executive Order 13166 that applies to federally assisted programs and activities. The Department of Justice has taken the position that this is not the case, and NASA agrees with that position. Accordingly, NASA will strive to ensure that federally assisted programs and activities work in a way that is effective for all eligible beneficiaries, including those with limited English proficiency. </P>
        <HD SOURCE="HD1">II. Legal Authority </HD>
        <P>Section 601 of Title VI of the Civil Rights Act of 1964, 42 U.S.C. 2000d, provides that no person shall on the grounds of race, color, or national origin, be excluded from participation in, be denied the benefits of, or be subjected to discrimination under any program or activity receiving Federal financial assistance. Section 602 authorizes and directs federal agencies that are empowered to extend federal financial assistance to any program or activity to effectuate the provisions of [Section 601] by issuing rules, regulations, or orders of general applicability. 42 U.S.C. 2000d-1.</P>

        <P>NASA regulations promulgated pursuant to Section 602 forbid <PRTPAGE P="48949"/>recipients from utilizing criteria or methods of administration which have the effect of subjecting individuals to discrimination because of their race, color, or national origin, or have the effect of defeating or substantially impairing accomplishment of the objectives of the program as to individuals of a particular race, color, or national origin. 14 CFR 1250.103-2. </P>
        <P>The Supreme Court, in <E T="03">Lau</E> v. <E T="03">Nichols</E>, 414 U.S. 563 (1974), interpreted regulations promulgated by the former Department of Health, Education, and Welfare, including a regulation similar to that of NASA, 45 CFR 80.3(b)(2), to hold that Title VI prohibits conduct that has a disproportionate effect on LEP persons because such conduct constitutes national-origin discrimination. In <E T="03">Lau</E>, a San Francisco school district that had a significant number of non-English speaking students of Chinese origin was required to take reasonable steps to provide them with a meaningful opportunity to participate in federally funded educational programs. </P>
        <P>On August 11, 2000, Executive Order 13166 was issued. Improving Access to Services for Persons with Limited English Proficiency, 65 FR 50121 (August 16, 2000). Under that Order, every Federal agency that provides financial assistance to non-Federal entities must publish guidance on how their recipients can provide meaningful access to LEP persons and thus comply with Title VI regulations forbidding funding recipients from restricting an individual in any way in the enjoyment of any advantage or privilege enjoyed by others receiving any service, financial aid, or other benefit under the program. Title VI regulations also prohibit utilizing criteria or methods of administration which have the effect of subjecting individuals to discrimination because of their race, color, or national origin, or have the effect of defeating or substantially impairing accomplishment of the objectives of the program as respects individuals of a particular race, color, or national origin. </P>
        <P>On that same day, DOJ issued a general guidance document addressed to Executive Agency Civil Rights Officers setting forth general principles for agencies to apply in developing guidance documents for recipients pursuant to the Executive Order. Enforcement of Title VI of the Civil Rights Act of 1964 National Origin Discrimination Against Persons With Limited English Proficiency, 65 FR 50123 (August 16, 2000) (DOJ LEP Guidance). The DOJ role under Executive Order 13188 (the Executive Order) is unique. The Executive Order charges DOJ with responsibility for providing LEP Guidance to other Federal agencies and for ensuring consistency among each agency-specific guidance. Consistency among Departments of the Federal Government is particularly important. Inconsistency or contradictory guidance could confuse recipients of Federal funds and needlessly increase costs without rendering the meaningful access for LEP persons that this Guidance is designed to address. </P>

        <P>Subsequently, Federal agencies raised questions regarding the requirements of the Executive Order, especially in light of the Supreme Court's decision in <E T="03">Alexander</E> v. <E T="03">Sandoval</E>, 532 U.S. 275 (2001). On October 26, 2001, Ralph F. Boyd, Jr., Assistant Attorney General for the Civil Rights Division, issued a memorandum for Heads of Departments and Agencies, General Counsels and Civil Rights Directors. This memorandum clarified and reaffirmed the DOJ LEP Guidance in light of <E T="03">Sandoval.</E>
          <SU>3</SU>
          <FTREF/> The Assistant Attorney General stated that because <E T="03">Sandoval</E> did not invalidate any Title VI regulations that proscribe conduct that has a disparate impact on covered groups—the types of regulations that form the legal basis for the part of Executive Order 13166 that applies to federally assisted programs and activities—the Executive Order remains in force. </P>
        <FTNT>
          <P>

            <SU>3</SU> The memorandum noted that some commentators have interpreted <E T="03">Sandoval</E> as impliedly striking down the disparate-impact regulations promulgated under Title VI that form the basis for the part of Executive Order 13166 that applies to federally assisted programs and activities. <E T="03">See, e.g., Sandoval,</E> 532 U.S. at 286, 286 n.6 ([W]e assume for purposes of this decision that section 602 confers the authority to promulgate disparate-impact regulations; * * * We cannot help observing, however, how strange it is to say that disparate-impact regulations are ‘inspired by, at the service of, and inseparably intertwined with’ Sec. 601 when Sec. 601 permits the very behavior that the regulations forbid.) The memorandum, however, made clear that DOJ disagreed with the commentator's interpretation. <E T="03">Sandoval</E> holds principally that there is no private right of action to enforce Title VI disparate-impact regulations. It did not address the validity of those regulations or Executive Order 13166 or otherwise limit the authority and responsibility of Federal grant agencies to enforce their own implementing regulations.</P>
        </FTNT>

        <P>Pursuant to Executive Order 13166, DOJ developed its own guidance document for recipients and initially issued it on January 16, 2001. Guidance to Federal Financial Assistance Recipients Regarding Title VI Prohibition Against National Origin Discrimination Affecting Limited English Proficient Persons, 66 FR 3834 (January 16, 2001) (LEP Guidance for DOJ Recipients). NASA published in the <E T="04">Federal Register</E> (66 FR 15141) its own LEP Guidance. NASA did not receive comments from the public. </P>
        <P>This guidance document is thus published pursuant to Executive Order 13166 and supplants the January 16, 2001, publication in light of the public comment received and Assistant Attorney General Boyd's October 26, 2001 clarifying memorandum. </P>
        <HD SOURCE="HD1">Guidance </HD>
        <HD SOURCE="HD1">III. Who Is Covered? </HD>
        <P>NASA regulations, 14 CFR part 1250, require all recipients of Federal financial assistance from NASA to provide meaningful access to LEP persons.<SU>4</SU>
          <FTREF/> Federal financial assistance includes grants, training, use of equipment, donations of surplus property, and other assistance. Recipients of NASA assistance include, for example: </P>
        <FTNT>
          <P>
            <SU>4</SU> Pursuant to Executive Order 13166, the meaningful access requirement of Title VI regulations and the four-factor analysis set forth in the DOJ LEP Guidance are to additionally apply to the programs and activities of Federal agencies, including NASA.</P>
        </FTNT>
        <P>• State or local agencies </P>
        <P>• Non-profit institutions or organizations </P>
        <P>• Educational Institutions </P>
        <P>• Any public or private individual to whom Federal assistance is extended, directly or through another recipient, including any successor, assignee, or transferee thereof. </P>

        <P>Sub-recipients likewise are covered when Federal funds are passed through from one recipient to a sub-recipient. Coverage extends to a recipient's entire program or activity, <E T="03">i.e.</E>, to all parts of a recipient's operations. This is true even if only one part of the recipient receives the Federal assistance.<SU>5</SU>
          <FTREF/>
        </P>
        <FTNT>
          <P>
            <SU>5</SU> However, if a Federal agency were to decide to terminate Federal funds based on noncompliance with Title VI or its regulations, only funds directed to the particular program or activity that is out of compliance would be terminated. 42 U.S.C. 2000d-1.</P>
        </FTNT>
        <P>Example: NASA provides assistance to a state department of education for curriculum enhancement in science and mathematics in its public schools. All of the operations of the entire state department of education—not just the schools—are covered. </P>

        <P>Finally, some recipients operate in jurisdictions in which English has been declared the official language. Nonetheless, these recipients continue to be subject to Federal non-discrimination requirements, including those applicable to the provision of federally assisted services to persons with limited English proficiency. <PRTPAGE P="48950"/>
        </P>
        <HD SOURCE="HD1">IV. Who Is a Limited English Proficient Individual? </HD>
        <P>Individuals who do not speak English as their primary language and who have a limited ability to read, write, speak, or understand English can be limited English proficient, or LEP, entitled to language assistance with respect to a particular type of service, benefit, or encounter. </P>
        <P>Examples of populations likely to include LEP persons who are encountered and/or served by NASA recipients and should be considered when planning language services include, but are not limited to: </P>
        <P>• Students enrolled in NASA-funded science, mathematics, and technology enrichment activities. </P>
        <P>• Parents or family members of the above. </P>
        <P>• Individuals participating in NASA program orientations and visiting exhibits at NASA Visitor centers where the programs and activities are funded and conducted by a NASA financial assistance recipient. </P>
        <HD SOURCE="HD1">V. How Does a Recipient Determine the Extent of Its Obligation To Provide LEP Services? </HD>
        <P>Recipients are required to take reasonable steps to ensure meaningful access to their programs and activities by LEP persons. While designed to be a flexible and fact-dependent standard, the starting point is an individualized assessment that balances the following four factors: (1) The number or proportion of LEP persons eligible to be served or likely to be encountered by the program or grantee; (2) the frequency with which LEP individuals come in contact with the program; (3) the nature and importance of the program, activity, or service provided by the program to people's lives; and (4) the resources available to the grantee/recipient and costs. As indicated above, the intent of this guidance is to suggest a balance that ensures meaningful access by LEP persons to critical services while not imposing undue burdens on small business, small local governments, or small nonprofits. </P>
        <P>After applying the above four-factor analysis, a recipient may conclude that different language assistance measures are sufficient for the different types of programs or activities in which it engages. For instance, some of a recipient's activities will be more important than others and/or have greater impact on or contact with LEP persons, and thus may require more in the way of language assistance. The flexibility that recipients have in addressing the needs of the LEP populations they serve does not diminish, and should not be used to minimize, the obligation that those needs be addressed. NASA recipients should apply the following four factors to the various kinds of contacts that they have with the public to assess language needs and decide what reasonable steps they should take to ensure meaningful access for LEP persons. </P>
        <HD SOURCE="HD2">(1) The Number or Proportion of LEP Persons Served or Encountered in the Eligible Service Population </HD>
        <P>One factor in determining what language services recipients should provide is the number or proportion of LEP persons from a particular language group served or encountered in the eligible service population. The greater the number or proportion of these LEP persons, the more likely language services are needed. Ordinarily, persons eligible to be served, or likely to be directly affected, by a recipient's program or activity are those who are served or encountered in the eligible service population. This population will be program-specific, and includes persons who are in the geographic area that has been approved by a Federal grant agency as the recipient's service area. However, where, for instance, a school district receiving NASA financial assistance serves a large LEP population, the appropriate service area is most likely the school district, and not the entire State. Where no service area has previously been approved, the relevant service area may be that which is approved by State or local authorities or designated by the recipient, provided that these designations do not themselves discriminatorily exclude certain populations. When considering the number or proportion of LEP individuals in a service area, recipients should consider LEP parent(s) when their English-proficient or LEP minor children and dependents are potential or actual participants or beneficiaries of NASA-funded programs and activities. </P>
        <P>Recipients should first examine their prior experiences with LEP encounters and determine the breadth and scope of language services that were needed. In conducting this analysis, it is important to include language minority populations that are eligible for their programs or activities but may be underserved because of existing language barriers. Other data should be consulted to refine or validate a recipient's prior experience, including the latest census data for the area served, data from school systems and from community organizations, and data from state and local governments.<SU>6</SU>
          <FTREF/> Community agencies, school systems, and others can often assist in identifying populations for whom outreach is needed and who would benefit from the recipients' programs and activities were language services provided. </P>
        <FTNT>
          <P>
            <SU>6</SU> The focus of the analysis is on lack of English proficiency, not the ability to speak more than one language. Note that demographic data may indicate the more frequently spoken language other than English and the percentage of people who speak that language or understand English less than well. Some of the most commonly spoken languages other than English may be spoken by people who are also overwhelming proficient in English. Thus, they may not be languages spoken more frequently by limited English proficient individuals. When using demographics data, it is important to focus in on the languages spoken by those who are not proficient in English.</P>
        </FTNT>
        <HD SOURCE="HD2">(2) The Frequency With Which LEP Individuals Come in Contact With the Program </HD>

        <P>Recipients should assess, as accurately as possible, the frequency with which they have or should have contact with an LEP individual from different language groups seeking assistance. The more frequent the contact with a particular language group, the more likely that enhanced language services in that language are needed. The steps that are reasonable for a recipient that serves an LEP person on a one-time basis will be very different than those expected from a recipient that serves LEP persons daily. It is also advisable to consider the frequency of different types of language contacts. For example, frequent contacts with Spanish-speaking people who are LEP may require certain assistance in Spanish. Less frequent contact with different language groups may suggest a different and less intensified solution. If an LEP individual accesses a program or service on a daily basis, a recipient has greater duties than if the same individual's program or activity contact is unpredictable or infrequent. But even recipients that serve LEP persons on an unpredictable or infrequent basis should use this balancing analysis to determine what to do if an LEP individual seeks services under the program in question. This plan need not be intricate. It may be as simple as being prepared to use one of the commercially-available telephonic interpretation services to obtain immediate interpreter services. In applying this standard, recipients should take care to consider whether appropriate outreach to LEP persons could increase the frequency of contact with LEP language groups. <PRTPAGE P="48951"/>
        </P>
        <HD SOURCE="HD2">(3) The Nature and Importance of the Program, Activity, or Service Provided by the Program </HD>
        <P>The more important the activity, information, service, or program, or the greater the possible consequences of the contact to the LEP individuals, the more likely language services are needed. The obligations to communicate information on short and long-term weather patterns to rural communities via satellite pictures and computer modeling differ, for example, from those to provide curriculum enhancement in science and mathematics to middle school students. A recipient needs to determine whether denial or delay of access to services or information could have serious or even life-threatening implications for the LEP individual. Decisions by NASA recipients to make an activity compulsory, such as instruction on safety and security requirements before touring a NASA facility, can serve as strong evidence of the program's importance. </P>
        <HD SOURCE="HD2">(4) The Resources Available to the Recipient and Costs </HD>
        <P>A recipient's level of resources and the costs that would be imposed on it may have an impact on the nature of the steps it should take. Smaller recipients with more limited budgets are not expected to provide the same level of language services as larger recipients with larger budgets. In addition, reasonable steps may cease to be reasonable where the costs imposed substantially exceed the benefits. </P>
        <P>Resource and cost issues, however, can often be reduced by technological advances; the sharing of language assistance materials and services among and between recipients, advocacy groups, and Federal grant agencies; and reasonable business practices. Where appropriate, training bilingual staff to act as interpreters and translators, information sharing through industry groups, telephonic and video conferencing interpretation services, pooling resources and standardizing documents to reduce translation needs, using qualified translators and interpreters to ensure that documents need not be fixed later and that inaccurate interpretations do not cause delay or other costs, centralizing interpreter and translator services to achieve economies of scale, or the formalized use of qualified community volunteers, for example, may help reduce costs.<SU>7</SU>
          <FTREF/> Recipients should carefully explore the most cost-effective means of delivering competent and accurate language services before limiting services due to resource concerns. Large entities and those entities serving a significant number or proportion of LEP persons should ensure that their resource limitations are well-substantiated before using this factor as a reason to limit language assistance. Such recipients may find it useful to be able to articulate, through documentation or in some other reasonable manner, their process for determining that language services would be limited based on resources or costs. </P>
        <FTNT>
          <P>
            <SU>7</SU>Small recipients with limited resources may find that entering into a bulk telephonic interpretation service will prove cost effective.</P>
        </FTNT>
        <P>This four-factor analysis necessarily implicates the mix of LEP services required. Recipients have two main ways to provide language services: Oral interpretation either in person or via telephone interpretation service (hereinafter interpretation) and written translation (hereinafter translation). Oral interpretation can range from on-site interpreters for critical services provided to a high volume of LEP persons to access through commercially-available telephonic interpretation services. Written translation, likewise, can range from translation of an entire document to translation of a short description of the document. In some cases, language services should be made available on an expedited basis while in others the LEP individual may be referred to another office of the recipient for language assistance. </P>
        <P>The correct mix should be based on what is both necessary and reasonable in light of the four-factor analysis. For instance, a visit by the NASA Administrator to a largely Hispanic neighborhood may need immediate oral interpreters available. (Of course, many community organizations may have already made such arrangements.) In contrast, there may be circumstances where the importance and nature of the activity and number or proportion and frequency of contact with LEP persons may be low and the costs and resources needed to provide language services may be high, such as in the case of a voluntary general public tour of a NASA program site in which pre-arranged language services for the particular service may not be necessary. Regardless of the type of language service provided, quality and accuracy of those services can be critical in order to avoid serious consequences to the LEP person and to the recipient. Recipients have substantial flexibility in determining the appropriate mix. </P>
        <HD SOURCE="HD1">VI. Selecting Language Assistance Services </HD>
        <P>Recipients have two main ways to provide language services: oral and written language services. Quality and accuracy of the language service is critical in order to avoid serious consequences to the LEP person and to the recipient. </P>
        <HD SOURCE="HD2">A. Oral Language Services (Interpretation) </HD>
        <P>Interpretation is the act of listening to something in one language (source language) and orally translating it into another language (target language). Where interpretation is needed and is reasonable, recipients should consider some or all of the following options for providing competent interpreters in a timely manner: </P>
        <P>Competence of Interpreters. When providing oral assistance, recipients should ensure competency of the language service provider, no matter which of the strategies outlined below are used. Competency requires more than self-identification as bilingual. Some bilingual staff and community volunteers, for instance, may be able to communicate effectively in a different language when communicating information directly in that language, but not be competent to interpret in and out of English. Likewise, they may not be able to do written translations. </P>
        <P>Competency to interpret, however, does not necessarily mean formal certification as an interpreter, although certification is helpful. When using interpreters, recipients should ensure that they: </P>

        <P>Demonstrate proficiency in and ability to communicate information accurately in both English and in the other language and identify and employ the appropriate mode of interpreting (<E T="03">e.g.</E>, consecutive, simultaneous, summarization, or sight translation); Have knowledge in both languages of any specialized terms or concepts peculiar to the entity's program or activity and of any particularized vocabulary and phraseology used by the LEP person,<SU>8</SU>

          <FTREF/> and understand and follow confidentiality and impartiality rules to the same extent the recipient employee <PRTPAGE P="48952"/>for whom they are interpreting and/or to the extent their position requires. </P>
        <FTNT>
          <P>
            <SU>8</SU> Many languages have regionalisms, or differences in usage. For instance, a word that may be understood to mean something in Spanish for someone from Cuba may not be so understood by someone from Mexico. In addition, because there may be languages that do not have an appropriate direct interpretation of some technical terms, the interpreter should be so aware of the issue. The interpreter and recipient can then work to develop a consistent and appropriate set of descriptions of these terms in that language so that they can be used again, when appropriate.</P>
        </FTNT>
        <P>Understand and adhere to their role as interpreters without deviating into a role as counselor, legal advisor, or other roles. </P>
        <P>Some recipients, such as technical or scientific recipients, may have additional self-imposed requirements for interpreters. Where the technical integrity of the information depends on precise, complete, and accurate interpretation or translations, particularly in the context of communicating technology innovations to the public, the use of certified interpreters is strongly encouraged.<SU>9</SU>
          <FTREF/> Where such activities are lengthy, the interpreter will likely need breaks and team interpreting may be appropriate. </P>
        <FTNT>
          <P>
            <SU>9</SU> For those languages for which no formal accreditation or certification currently exists, NASA recipients should consider a formal process for establishing the credentials of the interpreter.</P>
        </FTNT>
        <P>The quality and accuracy of language services is part of the appropriate mix of LEP services required. The quality and accuracy of language services during a safety and security briefing, for example, must be extraordinarily high, while the quality and accuracy of language services in responding to telephonic inquiries for general information need not meet the same exacting standards. </P>
        <P>Finally, when interpretation is needed and is reasonable, it should be provided in a timely manner. To be meaningfully effective, language assistance should be timely. While there is no single definition for timely applicable to all types of interactions at all times by all types of recipients, one clear guide is that the language assistance should be provided at a time and place that avoids the effective denial of the service, benefit, or right at issue or the imposition of an undue burden on or delay in important rights, benefits, or services to the LEP person. For example, when the timeliness of services is important, such as with certain activities of NASA recipients which involve the provision of enrollment information to parents of potential student participants in NASA-funded enrichment activities in science, mathematics, and/or technology, a recipient would likely not be providing meaningful access if it had one bilingual member of the staff available one day a week to provide the service. Such conduct would likely result in delays for LEP persons that would be significantly greater than those for English proficient persons. Conversely, where access to or exercise of a service, benefit, or right is not effectively precluded by a reasonable delay, language assistance can likely be delayed for a reasonable period. </P>
        <P>
          <E T="03">Hiring Bilingual Staff</E>. When particular languages are encountered often, hiring bilingual staff offers one of the best, and often most economical, options. Recipients can, for example, fill public contact positions, such as public information specialists, guards, or program directors, with staff that are bilingual and competent to communicate directly with LEP persons in their language. If bilingual staff is also used to interpret between English speakers and LEP persons, or to orally interpret written documents from English into another language, they should be competent in the skill of interpreting. Being bilingual does not necessarily mean that a person has the ability to interpret. In addition, there may be times when the role of the bilingual employee may conflict with the role of an interpreter (for instance, a bilingual security guard would probably not be able to perform effectively the role of a planetary science interpreter and security guard at the same time, even if the security guard were a qualified interpreter). Effective management strategies, including any appropriate adjustments in assignments and protocols for using bilingual staff, can ensure that bilingual staff is fully and appropriately utilized. When bilingual staff cannot meet all of the language service obligations of the recipient, the recipient should turn to other options. </P>
        <P>
          <E T="03">Hiring Staff Interpreters.</E> Hiring interpreters may be most helpful where there is a frequent need for interpreting services in one or more languages. Depending on the facts, sometimes it may be necessary and reasonable to provide on-site interpreters to provide accurate and meaningful communication with an LEP person. </P>
        <P>
          <E T="03">Contracting for Interpreters</E>. Contract interpreters may be a cost-effective option when there is no regular need for a particular language skill. In addition to commercial and other private providers, many community-based organizations and mutual assistance associations provide interpretation services for particular languages. Contracting with and providing training regarding the recipient's programs and processes to these organizations can be a cost-effective option for providing language services to LEP persons from those language groups. </P>
        <P>
          <E T="03">Using Telephone Interpreter Lines</E>. Telephone interpreter service lines often offer speedy interpreting assistance in many different languages. They may be particularly appropriate where the mode of communicating with an English proficient person would also be over the phone. Although telephonic interpretation services are useful in many situations, it is important to ensure that, when using such services, the interpreters used are competent to interpret any technical or legal terms specific to a particular program that may be important parts of the conversation. Nuances in language and non-verbal communication can often assist an interpreter and cannot be recognized over the phone. Video teleconferencing may sometimes help to resolve this issue where necessary. In addition, where documents are being discussed, it is important to give telephonic interpreters adequate opportunity to review the document prior to the discussion and any logistical problems should be addressed. </P>
        <P>
          <E T="03">Using Community Volunteers</E>. In addition to consideration of bilingual staff, staff interpreters, or contract interpreters (either in-person or by telephone) as options to ensure meaningful access by LEP persons, use of recipient-coordinated community volunteers, working with, for instance, community-based organizations may provide a cost-effective supplemental language assistance strategy under appropriate circumstances. They may be particularly useful in providing language access for a recipient's less critical programs and activities. To the extent the recipient relies on community volunteers, it is often best to use volunteers who are trained in the information or services of the program and can communicate directly with LEP persons in their language. Just as with all interpreters, community volunteers used to interpret between English speakers and LEP persons, or to orally translate documents, should be competent in the skill of interpreting and knowledgeable about applicable confidentiality and impartiality rules. Recipients should consider formal arrangements with community-based organizations that provide volunteers to address these concerns and to help ensure that services are available more regularly. </P>
        <P>
          <E T="03">Use of Family Members or Friends as Interpreters</E>. Although recipients should not plan to rely on an LEP person's family members, friends, or other informal interpreters to provide meaningful access to important programs and activities, where LEP persons so desire, they should be permitted to use, at their own expense, an interpreter of their own choosing (whether a professional interpreter, family member, or friend) in place of or as a supplement to the free language <PRTPAGE P="48953"/>services expressly offered by the recipient. LEP persons may feel more comfortable when a trusted family member, or friend, acts as an interpreter. In addition, in exigent circumstances that are not reasonably foreseeable, temporary use of interpreters not provided by the recipient may be necessary. However, with proper planning and implementation, recipients should be able to avoid most such situations. </P>

        <P>Recipients, however, should take special care to ensure that family, legal guardians, caretakers, and other informal interpreters are appropriate in light of the circumstances and subject matter of the program, service or activity, including protection of the recipient's own administrative or enforcement interest in accurate interpretation. In many circumstances, family members (especially children), or friends, are not competent to provide quality and accurate interpretations. Issues of confidentiality, privacy, or conflict of interest may also arise. LEP individuals may feel uncomfortable revealing or describing sensitive, confidential, or potentially embarrassing medical, law enforcement (<E T="03">e.g.</E>, sexual or violent assaults), family, or financial information to a family member, friend, or member of the local community.<SU>10</SU>
          <FTREF/> In addition, such informal interpreters may have a personal connection to the LEP person or an undisclosed conflict of interest, such as the desire to protect themselves or another person in certain matters. For these reasons, when oral language services are necessary, recipients should generally offer competent interpreter services free of cost to the LEP person. For NASA recipient programs and activities, this is particularly true in situations in which health, safety, or security is at stake, or when credibility and accuracy are important to protect an individual's rights and access to important services. </P>
        <FTNT>
          <P>
            <SU>10</SU> For example, special circumstances may raise additional serious concerns regarding the voluntary nature, conflicts of interest, and privacy issues surrounding the use of persons other than qualified interpreters, particularly where technical information, an important right, benefit, service, or access to personal or enforcement information is at stake. In some situations, individuals could potentially misuse information they obtained in interpreting for other persons. In addition to ensuring competency and accuracy of the interpretation, recipients should take these special circumstances into account when determining whether a person makes a knowing and voluntary choice to use another person to interpret, instead of an interpreter provided by the recipient.</P>
        </FTNT>
        <P>An example of such a case is when security guards respond to an illegal entry call. In such a case, use of family members or neighbors to interpret for the alleged perpetrator or witnesses may raise serious issues of competency, confidentiality, and conflict of interest and is thus inappropriate. While issues of competency, confidentiality, and conflict of interest in the use of family members (especially children), or friends, often make their use inappropriate, the use of these individuals as interpreters may be an appropriate option where proper application of the four factors would lead to a conclusion that recipient-provided services are not necessary. An example of this is a voluntary, unescorted tour of artwork in a NASA facility open to the general public. There, the importance and nature of the activity may be relatively low and unlikely to implicate issues of confidentiality, conflict of interest, or the need for accuracy. In addition, the resources needed and costs of providing language services may be high. In such a setting, an LEP person's use of family members, friends, or others may be appropriate. </P>
        <P>If the LEP person voluntarily chooses to provide his or her own interpreter, a recipient should consider whether a record of that choice and of the recipient's offer of assistance is appropriate. Where precise, complete, and accurate interpretations or translations of information are critical, or where the competency of the LEP person's interpreter is not established, a recipient might decide to provide its own, independent interpreter, even if an LEP person wants to use his or her own interpreter as well. Extra caution should be exercised when the LEP person chooses to use a minor as the interpreter. While the LEP person's decision should be respected, there may be additional issues of competency, confidentiality, or conflict of interest when the choice involves using children as interpreters. The recipient should take care to ensure that the LEP person's choice is voluntary, that the LEP person is aware of the possible problems if the preferred interpreter is a minor child, and that the LEP person knows that a competent interpreter could be provided by the recipient at no cost. </P>
        <HD SOURCE="HD2">B. Written Language Services (Translation) </HD>
        <P>Translation is the replacement of a written text from one language (source language) into an equivalent written text in another language (target language). </P>
        <P>
          <E T="03">What Documents Should Be Translated?</E> After applying the four-factor analysis, a recipient may determine that an effective LAP plan for its particular program or activity includes the translation of vital written materials into the language of each frequently-encountered LEP group eligible to be served and/or likely to be affected by the recipient's program. </P>
        <P>Such written materials could include, for example:</P>
        <P>• Consent and complaint forms </P>
        <P>• Written notices of rights, or discontinuation of programs and/or activities </P>
        <P>• Notices advising LEP persons of free language assistance </P>
        <P>• Security or safety brochures for visitors to NASA facilities </P>
        <P>• Applications to participate in a recipient's program or activity or to receive recipient benefits or services. </P>
        <P>Whether or not a document (or the information it solicits) is vital may depend upon the importance of the program, information, encounter, or service involved, and the consequence to the LEP person if the information in question is not provided accurately or in a timely manner. For instance, applications for participation in an after-school science and mathematics enrichment program could be considered vital. Where appropriate, recipients are encouraged to create a plan for consistently determining, over time and across its various activities, what documents are vital to the meaningful access of the LEP populations they serve. </P>
        <P>Classifying a document as vital or non-vital is sometimes difficult, especially in the case of outreach materials like brochures or other information on rights and services. Awareness of rights or services is an important part of meaningful access. Lack of awareness that a particular program, right, or service exists may effectively deny LEP individuals meaningful access. Thus, where a recipient is engaged in community outreach activities in furtherance of its activities, it should regularly assess the needs of the populations frequently encountered or affected by the program or activity to determine whether certain critical outreach materials should be translated. Community organizations may be helpful in determining what outreach materials may be most helpful to translate. In addition, the recipient should consider whether translations of outreach material may be made more effective when done in tandem with other outreach methods, including utilizing the ethnic media, schools, religious, and community organizations to spread a message. </P>

        <P>Sometimes a document includes both vital and non-vital information. This may be the case when the document is very large. It may also be the case when the title and a phone number for obtaining more information on the <PRTPAGE P="48954"/>contents of the document in frequently-encountered languages other than English is critical, but the document is sent out to the general public and cannot reasonably be translated into many languages. Thus, vital information may include, for instance, the provision of information in appropriate languages other than English regarding where a LEP person might obtain an interpretation or translation of the document. </P>
        <P>
          <E T="03">Into What Languages Should Documents Be Translated?</E> The languages spoken by the LEP individuals with whom the recipient has contact determine the languages into which vital documents should be translated. A distinction should be made, however, between languages that are frequently encountered by a recipient and less commonly-encountered languages. Many recipients serve communities in large cities or across the country. They may serve LEP persons who speak many different languages. To translate all written materials into all of those languages is unrealistic. Although recent technological advances have made it easier for recipients to store and share translated documents, such an undertaking would incur substantial costs and require substantial resources. Nevertheless, well-substantiated claims of lack of resources to translate all vital documents into dozens of languages do not necessarily relieve the recipient of the obligation to translate those documents into at least several of the more frequently-encountered languages and to set benchmarks for continued translations into the remaining languages over time. As a result, the extent of the recipient's obligation to provide written translations of documents should be determined by the recipient on a case-by-case basis, looking at the totality of the circumstances in light of the four-factor analysis. Because translation is a one-time expense, consideration should be given to whether the upfront cost of translating a document (as opposed to oral interpretation) should be amortized over the likely lifespan of the document when applying this four-factor analysis. </P>
        <P>
          <E T="03">Safe Harbor.</E> Many recipients would like to ensure with greater certainty that they comply with their obligations to provide written translations in languages other than English. Paragraphs (a) and (b) outline the circumstances that can provide a safe harbor for recipients regarding the requirements for translation of written materials. A safe harbor means that if a recipient provides written translations under these circumstances, such action will be considered strong evidence of compliance with the recipient's written-translation obligations. </P>
        <P>The failure to provide written translations under the circumstances outlined in paragraphs (a) and (b) does not mean there is non-compliance. Rather, they provide a common starting point for recipients to consider whether and at what point the importance of the service, benefit, or activity involved; the nature of the information sought; and the number or proportion of LEP persons served call for written translations of commonly-used forms into frequently-encountered languages other than English. Thus, these paragraphs merely provide a guide for recipients that would like greater certainty of compliance than can be provided by a fact-intensive, four-factor analysis. </P>
        <P>Example: Even if the safe harbors are not used, if written translation of a certain document(s) would be so burdensome as to defeat the legitimate objectives of its program, the translation of the written materials is not necessary. Other ways of providing meaningful access, such as effective oral interpretation of certain vital documents, might be acceptable under such circumstances. </P>
        <P>
          <E T="03">Safe Harbor.</E> The following actions will be considered strong evidence of compliance with the recipient's written-translation obligations: </P>
        <P>(a) The NASA recipient provides written translations of vital documents for each eligible LEP language group that constitutes five percent or 1,000, whichever is less, of the population of persons eligible to be served or likely to be affected or encountered. Translation of other documents, if needed, can be provided orally; or </P>
        <P>(b) If there are fewer than 50 persons in a language group that reaches the five percent trigger in (a), the recipient does not translate vital written materials but provides written notice in the primary language of the LEP language group of the right to receive competent oral interpretation of those written materials, free of cost. </P>
        <P>These safe harbor provisions apply to the translation of written documents only. They do not affect the requirement to provide meaningful access to LEP individuals through competent oral interpreters where oral language services are needed and are reasonable. For example, NASA-funded educational enrichment programs should, where appropriate, ensure that NASA safety and security rules have been explained to LEP participants, at orientation, for instance, prior to taking a tour of any NASA facility. </P>
        <P>
          <E T="03">Competence of Translators.</E> As with oral interpreters, translators of written documents should be competent. Many of the same considerations apply. However, the skill of translating is very different from the skill of interpreting, and a person who is a competent interpreter may or may not be competent to translate. </P>
        <P>Particularly where scientific and other technical documents are being translated, competence can often be achieved by use of certified translators. Certification or accreditation may not always be possible or necessary.<SU>11</SU>
          <FTREF/> Competence can often be ensured by having a second, independent translator check the work of the primary translator. Alternatively, one translator can translate the document, and a second, independent translator could translate it back into English to check that the appropriate meaning has been conveyed. This is called Aback translation. </P>
        <FTNT>
          <P>
            <SU>11</SU> For those languages in which no formal accreditation currently exists, a particular level of membership in a professional translation association can provide some indicator of professionalism.</P>
        </FTNT>
        <P>Translators should understand the expected reading level of the audience and, where appropriate, have fundamental knowledge about the target language group's vocabulary and phraseology. Sometimes direct translation of materials results in a translation that is written at a much more difficult level than the English language version or has no relevant equivalent meaning.<SU>12</SU>
          <FTREF/> Community organizations may be able to help consider whether a document is written at a good level for the audience. Likewise, consistency in the words and phrases used to translate terms of art, legal, or other technical concepts helps avoid confusion by LEP individuals and may reduce costs. Creating or using already-created glossaries of commonly used terms may be useful for LEP persons and translators, and cost effective for the recipient. Providing translators with examples of previous accurate translations of similar material by the recipient, other recipients, of federal agencies may be helpful. </P>
        <FTNT>
          <P>
            <SU>12</SU> For instance, there may be languages which do not have an appropriate direct translation of some technical terms and the translator should be able to provide an appropriate translation. The translator should likely also make the recipient award of this. Recipients can then work with translators to develop a consistent and appropriate set of descriptions of these terms in that language that can be used again, when appropriate. Recipients will find it more effective and less costly if they try to maintain consistency in the words and phrases used to translate terms of art and legal or other technical concepts.</P>
        </FTNT>
        <PRTPAGE P="48955"/>

        <P>While quality and accuracy of translation services is critical, the quality and accuracy of translation services is nonetheless part of the appropriate mix of LEP services required. For instance, documents that are simple for LEP persons who rely on them may use translators that are less skilled than important documents upon which reliance has important consequences (including, <E T="03">e.g.</E>, information or documents of NASA recipients regarding certain security, health, and safety requirements). The permanent nature of written translations, however, imposes additional responsibility on the recipient to ensure that the quality and accuracy permit meaningful access by LEP persons. </P>
        <HD SOURCE="HD1">VII. Elements of Effective Plan on Language Assistance for LEP Persons </HD>
        <P>After completing the four-factor analysis and deciding what language assistance services are appropriate, a recipient should develop an implementation plan to address the identified needs of the LEP populations they serve. Recipients have considerable flexibility in developing this plan. The development and maintenance of a periodically-updated written Language Assistance Plan (LAP) for LEP persons for use by recipient employees serving the public will likely be the most appropriate and cost-effective means of documenting compliance and providing a framework for the provision of timely and reasonable language assistance. Moreover, such written plans would likely provide additional benefits to a recipient's managers in the areas of training, administration, planning, and budgeting. These benefits should lead most recipients to document in a written LAP, their language assistance services, and how staff and LEP persons can access those services. Despite these benefits, certain NASA recipients, such as recipients serving very few LEP persons and recipients with very limited resources, may choose not to develop a written LAP. However, the absence of a written LAP does not obviate the underlying obligation to ensure meaningful access by LEP persons to a recipient's program or activities. Accordingly, in the event that a recipient elects not to develop a written plan, it should consider alternative ways to articulate in some other reasonable manner a plan for providing meaningful access. Entities having significant contact with LEP persons, such as schools, religious organizations, community groups, and groups working with new immigrants can be very helpful in providing important input into this planning process from the beginning. </P>
        <P>The following five steps may be helpful in designing a LAP and are typically part of effective implementation plans. </P>
        <HD SOURCE="HD3">(1) Identifying LEP Individuals Who Need Language Assistance </HD>
        <P>The first two factors in the four-factor analysis require an assessment of the number or proportion of LEP individuals eligible to be served or encountered and the frequency of encounters. This requires recipients to identify LEP persons with whom it has contact. </P>

        <P>One way to determine the language of communication is to use language identification cards (or “I speak cards”), which invite LEP persons to identify their language needs to staff. Such cards, for instance, might say “I speak Spanish” in both Spanish and English, “I speak Vietnamese” in both English and Vietnamese, <E T="03">etc.</E> To reduce costs of compliance, the Federal Government has made a set of these cards available on the Internet. The Census Bureau “I speak card” can be found and downloaded at <E T="03">http://www.usdoj.gov/crt/cor/13166.htm.</E> When records are normally kept of past interactions with members of the public, the language of the LEP person can be included as part of the record. In addition to helping employees identify the language of LEP persons they encounter, this process will help in future applications of the first two factors of the four-factor analysis. In addition, posting notices in commonly encountered languages notifying LEP persons of language assistance will encourage them to self-identify. </P>
        <HD SOURCE="HD3">(2) Language Assistance Measures</HD>
        <P>An effective LAP would likely include information about the ways in which language assistance will be provided. For instance, recipients may want to include information on at least the following:</P>
        <P>• Types of language services available.</P>
        <P>• How staff can obtain those services.</P>
        <P>• How to respond to LEP callers.</P>
        <P>• How to respond to written communications from LEP persons.</P>
        <P>• How to respond to LEP individuals who have in-person contact with recipient staff.</P>
        <P>• How to ensure competency of interpreters and translation services.</P>
        <HD SOURCE="HD3">(3) Training Staff</HD>
        <P>Staff should know their obligations to provide meaningful access to information and services for LEP persons. An effective LAP plan would likely include training to ensure that:</P>
        <P>• Staff know about LEP policies and procedures.</P>
        <P>• Staff having contact with the public (or those in a recipient's custody) are trained to work effectively with in-person and telephone interpreters.</P>
        <P>Recipients may want to include this training as part of the orientation for new employees. It is important to ensure that all employees in public contact positions are properly trained. Recipients have flexibility in deciding the manner in which the training is provided. The more frequent the contact with LEP persons, the greater the need will be for in-depth training. Staff with little or no contact with LEP persons may only have to be aware of a LAP. However, management staff, even if they do not interact regularly with LEP persons, should be fully aware of and understand the plan so they can reinforce its importance and ensure its implementation by staff.</P>
        <HD SOURCE="HD3">(4) Providing Notice to LEP Persons</HD>
        <P>Once a recipient has decided, based on the four factors, that it will provide language services, it is important for the recipient to let LEP persons know that those services are available and that they are free of charge. Recipients should provide this notice in a language LEP persons will understand. Examples of notification that recipients should consider include:</P>
        <P>• Posting signs in intake areas and other entry points. When language assistance is needed to ensure meaningful access to information and services, it is important to provide notice in appropriate languages in intake areas or initial points of contact so that LEP persons can learn how to access those language services. This is particularly true in areas with high volumes of LEP persons seeking access to certain NASA programs, activities and or facilities run by NASA recipients. For instance, signs in entry areas could state that free language assistance is available. The signs should be translated into the most common languages encountered. They should explain how to get the language help.</P>
        <P>• Stating in outreach documents that language services are available from the NASA recipient. Announcements could be in, for instance, brochures, booklets, and in outreach and recruitment information. These statements should be translated into the most common languages and could be placed on the front of common documents.</P>

        <P>• Working with community-based organizations and other stakeholders to inform LEP individuals of the <PRTPAGE P="48956"/>recipients' services, including the availability of language assistance services.</P>
        <P>• Using a telephone voice mail menu. The menu could be in the most common languages encountered. It should provide information about available language assistance services and how to get them.</P>
        <P>• Including notices in local newspapers in languages other than English.</P>
        <P>• Providing notices on non-English-language radio and television stations about the available language assistance services and how to get them.</P>
        <P>• Presentations and/or notices at schools and religious organizations.</P>
        <HD SOURCE="HD3">(5) Monitoring and Updating the LAP</HD>
        <P>Recipients should, where appropriate, have a process for determining, on an ongoing basis, whether new documents, programs, services, and activities need to be made accessible for LEP individuals, and they may want to provide notice of any changes in services to the LEP public and to employees. In addition, recipients should consider whether changes in demographics, types of services, or other needs require annual re-evaluation of their LAP. Less frequent re-evaluation may be more appropriate where demographics, services, and needs are more static. One good way to evaluate the LAP is to seek feedback from the community.</P>
        <P>In their reviews, recipients may want to consider assessing changes in:</P>
        <P>• Current LEP populations in service area or population affected or encountered.</P>
        <P>• Frequency of encounters with LEP language groups.</P>
        <P>• Nature and importance of activities to LEP persons.</P>
        <P>• Availability of resources, including technological advances and sources of additional resources, and the costs imposed.</P>
        <P>• Whether existing assistance is meeting the needs of LEP persons.</P>
        <P>• Whether staff knows and understands the LAP and how to implement it.</P>
        <P>• Whether identified sources for assistance are still available and viable.</P>
        <P>In addition to these five elements, effective plans set clear goals, management accountability, and opportunities for community input and planning throughout the process.</P>
        <HD SOURCE="HD1">VIII. Voluntary Compliance Effort</HD>
        <P>The goal for Title VI and Title VI regulatory enforcement is to achieve voluntary compliance. The requirement to provide meaningful access to LEP persons is enforced and implemented by NASA through the procedures identified in the Title VI regulations. These procedures include complaint investigations, compliance reviews, efforts to secure voluntary compliance, and technical assistance.</P>
        <P>The Title VI regulations provide that NASA will investigate whenever it receives a complaint, report, or other information that alleges or indicates possible noncompliance with Title VI or NASA regulations.<SU>13</SU>
          <FTREF/> If an investigation results in a finding of noncompliance, NASA will inform the recipient in writing of this determination, including the basis for the determination. NASA uses voluntary mediation to resolve most complaints. However, if a case is fully investigated and results in a finding of noncompliance, NASA must inform the recipient of the noncompliance through a Letter of Findings that sets out the areas of noncompliance and the steps that must be taken to correct the noncompliance. It must attempt to secure voluntary compliance through informal means. If the matter cannot be resolved informally, NASA must secure compliance through the termination of federal assistance after the NASA recipient has been given an opportunity for an administrative hearing and/or by referring the matter to the DOJ to seek injunctive relief or pursue other enforcement proceedings. NASA engages in voluntary compliance efforts and provides technical assistance to recipients at all stages of an investigation. During these efforts, NASA proposes reasonable timetables for achieving compliance and consults with and assists recipients in exploring cost-effective ways of coming into compliance. In determining a recipient's compliance with the Title VI regulations, NASA's primary concern is to ensure that the recipient's policies and procedures provide meaningful access for LEP persons to the recipient's programs and activities.</P>
        <FTNT>
          <P>
            <SU>13</SU> At educational institutions, investigations will be conducted by the U.S. Department of Education under a Memorandum of Understanding (MOV) between NASA and the U.S. Department of Education.</P>
        </FTNT>
        <P>While all recipients must work toward building systems that will ensure access for LEP individuals, NASA acknowledges that the implementation of a comprehensive system to serve LEP individuals is a process and that a system will evolve over time as it is implemented and periodically reevaluated. As recipients take reasonable steps to provide meaningful access to federally assisted programs and activities for LEP persons, NASA will look favorably on intermediate steps recipients take that are consistent with this Guidance, and that, as part of a broader implementation plan or schedule, move their service delivery system toward providing full access to LEP persons. This does not excuse noncompliance but instead recognizes that full compliance in all areas of a recipient's activities and for all potential language minority groups may reasonably require a series of implementing actions over a period of time. However, in developing any phased implementation schedule, NASA recipients should ensure that the provision of appropriate assistance for significant LEP populations or with respect to activities having a significant impact on beneficiaries is addressed first. Recipients are encouraged to document their efforts to provide LEP persons with meaningful access to federally assisted programs and activities.</P>
        <SIG>
          <NAME>Dr. Dorothy Hayden-Watkins,</NAME>
          <TITLE>Assistant Administrator of Equal Opportunity Programs.</TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20804 Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 7510-01-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">NATIONAL ARCHIVES AND RECORDS ADMINISTRATION </AGENCY>
        <SUBJECT>Records Schedules; Availability and Request for Comments </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>National Archives and Records Administration (NARA). </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of availability of proposed records schedules; request for comments. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The National Archives and Records Administration (NARA) publishes notice at least once monthly of certain Federal agency requests for records disposition authority (records schedules). Once approved by NARA, records schedules provide mandatory instructions on what happens to records when no longer needed for current Government business. They authorize the preservation of records of continuing value in the National Archives of the United States and the destruction, after a specified period, of records lacking administrative, legal, research, or other value. Notice is published for records schedules in which agencies propose to destroy records not previously authorized for disposal or reduce the retention period of records already authorized for disposal. NARA invites public comments on such records schedules, as required by 44 U.S.C. 3303a(a). </P>
        </SUM>
        <DATES>
          <PRTPAGE P="48957"/>
          <HD SOURCE="HED">DATES:</HD>
          <P>Requests for copies must be received in writing on or before September 29, 2003. Once the appraisal of the records is completed, NARA will send a copy of the schedule. NARA staff usually prepare appraisal memorandums that contain additional information concerning the records covered by a proposed schedule. These, too, may be requested and will be provided once the appraisal is completed. Requesters will be given 30 days to submit comments. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>

          <P>To request a copy of any records schedule identified in this notice, write to the Life Cycle Management Division (NWML), National Archives and Records Administration (NARA), 8601 Adelphi Road, College Park, MD 20740-6001. Requests also may be transmitted by FAX to 301-837-3698 or by e-mail to <E T="03">records.mgt@nara.gov.</E> Requesters must cite the control number, which appears in parentheses after the name of the agency which submitted the schedule, and must provide a mailing address. Those who desire appraisal reports should so indicate in their request. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>

          <P>Paul M. Wester, Jr., Director, Life Cycle Management Division (NWML), National Archives and Records Administration, 8601 Adelphi Road, College Park, MD 20740-6001. Telephone: (301) 837-3120. E-mail: <E T="03">records.mgt@nara.gov.</E>
          </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>Each year Federal agencies create billions of records on paper, film, magnetic tape, and other media. To control this accumulation, agency records managers prepare schedules proposing retention periods for records and submit these schedules for NARA's approval, using the Standard Form (SF) 115, Request for Records Disposition Authority. These schedules provide for the timely transfer into the National Archives of historically valuable records and authorize the disposal of all other records after the agency no longer needs them to conduct its business. Some schedules are comprehensive and cover all the records of an agency or one of its major subdivisions. Most schedules, however, cover records of only one office or program or a few series of records. Many of these update previously approved schedules, and some include records proposed as permanent. </P>
        <P>No Federal records are authorized for destruction without the approval of the Archivist of the United States. This approval is granted only after a thorough consideration of their administrative use by the agency of origin, the rights of the Government and of private persons directly affected by the Government's activities, and whether or not they have historical or other value. </P>
        <P>Besides identifying the Federal agencies and any subdivisions requesting disposition authority, this public notice lists the organizational unit(s) accumulating the records or indicates agency-wide applicability in the case of schedules that cover records that may be accumulated throughout an agency. This notice provides the control number assigned to each schedule, the total number of schedule items, and the number of temporary items (the records proposed for destruction). It also includes a brief description of the temporary records. The records schedule itself contains a full description of the records at the file unit level as well as their disposition. If NARA staff has prepared an appraisal memorandum for the schedule, it too includes information about the records. Further information about the disposition process is available on request. </P>
        <HD SOURCE="HD1">Schedules Pending </HD>
        <P>1. Department of the Army, Agency-wide (N1-AU-03-9, 2 items, 2 temporary items). Records relating to the Global Freight Management System, an electronic recordkeeping system which contains information relating to the procurement of commercial freight transportation services. Included are proposals, master reference files, freight tenders, domestic route order requests, bills of lading shipment information, carrier costing and performance data, and discrepancy reports. This schedule authorizes the agency to apply the proposed disposition instructions to any recordkeeping medium. </P>
        <P>2. Department of Health and Human Services, Food and Drug Administration (N1-88-03-4, 12 items, 11 temporary items). Export program files, including such records as applications, notifications, requests, certificates, background documentation concerning exporting firms, procedures and instructions for export processing, and a related tracking system. Also included are electronic copies of records created using electronic mail and word processing. Proposed for permanent retention are recordkeeping copies of final policy documents, which include decision-making memorandums, final working group reports, and action items. </P>
        <P>3. Department of Justice, Drug Enforcement Administration (N1-170-03-6, 1 item, 1 temporary item). Agency internal web site pages, which include copies of such materials as publications, policies and procedures, articles relating to law enforcement, reference material relating to trends in drug trafficking, high level briefings, frequently asked questions, staff telephone numbers, and information about occupational hazards. </P>
        <P>4. Department of Justice, Federal Bureau of Investigation (N1-65-03-3, 2 items, 2 temporary items). Forfeiture administrative documentation and work papers accumulated by the Forfeiture and Seized Property Unit in connection with civil and criminal forfeiture proceedings. Also included are electronic copies of documents created using word processing and electronic mail. </P>
        <P>5. Department of the Navy, Agency-wide, (N1-NU-03-2, 10 items, 10 temporary items). Records relating to law enforcement and physical security. Included are such records as security journals, weapons registrations, inventory control files, and ammunition stock records. Also included are electronic copies of records created using electronic mail and word processing. </P>
        <P>6. Department of the Navy, Agency-wide, (N1-NU-03-3, 4 items, 4 temporary items). Records relating to nuclear submarine reactors. Included are logs, reports, and similar records. Also included are electronic copies of records created using electronic mail and word processing. </P>
        <P>7. Department of the Treasury, United States Mint (N1-104-03-5, 9 items, 8 temporary items). Management studies relating to the acquisition of contracted commercial services and special procurement studies and files. Also included are electronic copies of records created using electronic mail and word processing. Proposed for permanent retention are recordkeeping copies of agreements relating to the purchase of gold and other metals for coin production. </P>
        <P>8. Department of the Treasury, United States Mint (N1-104-03-6, 8 items, 8 temporary items). Documentation relating to permit applications, hazardous substance transfer files, and reports concerning environmental matters. Also included are electronic copies of documents created using electronic mail and word processing. </P>

        <P>9. Department of the Treasury, United States Mint (N1-104-03-9, 5 items, 5 temporary items). Master files and system documentation associated with the agency's Computerized Maintenance Management System. The system is used to manage maintenance and repair operations and inventories. Also included are electronic copies of records created using electronic mail and word processing. <PRTPAGE P="48958"/>
        </P>
        <P>10. Department of the Treasury, Financial Management Service (N1-425-03-4, 30 items, 30 temporary items). Files of the Business and Agency Liaison Division, including such records as electronic mail reading files, the director's subject files, agency portfolios, Treasury reports on receivables, inputs, outputs, system documentation, and master files of the Debt Management Information System, business continuity planning files, and human capital management records. Also included are electronic copies of records created using electronic mail and word processing. </P>
        <P>11. Department of the Treasury, Financial Management Service (N1-425-03-5, 3 items, 3 temporary items). Records relating to collecting payments and servicing mortgages from the sale of Government property. Included are correspondence, loan activity reports, disbursement information, mortgage amortization schedules, and mortgage payment distribution reports. Also included are electronic copies of documents created using electronic mail and word processing. </P>
        <P>12. National Archives and Records Administration, Government-wide (N1-GRS-03-2, 4 items, 4 temporary items). Addition to General Records Schedule 1, Civilian Personnel Records, consisting of general files and case files relating to agency alternative dispute resolution programs. Also included are electronic copies of records created using electronic mail and word processing. </P>
        <P>13. U.S. Maritime Administration, Associate Administrator for Administration (N1-357-03-1, 3 items, 3 temporary items). Operational differential subsidy bulk and linear files, which include contract agreements, expense audits, wage audits, paid vouchers, directives, and correspondence from subsidized companies. Also included are electronic copies of documents created using electronic mail and word processing. </P>
        <SIG>
          <DATED>Dated: August 11, 2003. </DATED>
          <NAME>Michael J. Kurtz, </NAME>
          <TITLE>Assistant Archivist for Record Services—Washington, DC. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20858 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 7515-01-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">NATIONAL CREDIT UNION ADMINISTRATION </AGENCY>
        <SUBJECT>Agency Information Collection Activities: Submission to OMB for Review; Comment Request </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>National Credit Union Administration (NCUA). </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Request for comment. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The NCUA is submitting the following reinstatement, without change, of a previously approved collection for which approval has expired, to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 (Pub. L. 104-13, 44 U.S.C. chapter 35). This information collection is published to obtain comments from the public. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Comments will be accepted until October 14, 2003. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Interested parties are invited to submit written comments to NCUA Clearance Officer or OMB Reviewer listed below: </P>
          <P>
            <E T="03">Clearance Officer:</E> Mr. Neil McNamara, (703) 518-6447, National Credit Union Administration, 1775 Duke Street, Alexandria, Virginia 22314-3428, Fax No. (703) 518-6669, E-mail: <E T="03">mcnamara@ncua.gov.</E>
          </P>
          <P>
            <E T="03">OMB Reviewer:</E> Mr. Joseph F. Lackey, (202) 395-4741, Office of Management and Budget, Room 10226, New Executive Office Building, Washington, DC 20503. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>

          <P>Copies of this information collection request, with applicable supporting documentation, may be obtained by calling the NCUA Clearance Officer, Neil McNamara, (703) 518-6447. It is also available on the following Web site: <E T="03">http://www.NCUA.gov.</E>
          </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>Proposal for the following collection of information: </P>
        <P>
          <E T="03">OMB Number:</E> 3133-0139. </P>
        <P>
          <E T="03">Form Number:</E> N/A. </P>
        <P>
          <E T="03">Type of Review:</E> Reinstatement, without change, of a previously approved collection for which approval has expired. </P>
        <P>
          <E T="03">Title:</E> Organization and Operation of Federal Credit Unions. </P>
        <P>
          <E T="03">Description:</E> Federal Credit Unions wishing to pay lending-related incentives to employees must establish written policies. </P>
        <P>
          <E T="03">Respondents:</E> Certain Federal Credit Unions. </P>
        <P>
          <E T="03">Estimated No. of Respondents/Recordkeepers:</E> 1,000. </P>
        <P>
          <E T="03">Estimated Burden Hours Per Response:</E> One. </P>
        <P>
          <E T="03">Frequency of Response:</E> On Occasion. </P>
        <P>
          <E T="03">Estimated Total Annual Burden Hours:</E> 1,000. </P>
        <P>
          <E T="03">Estimated Total Annual Cost:</E> $25,000. </P>
        <SIG>
          <DATED>By the National Credit Union Administration Board on August 8, 2003. </DATED>
          <NAME>James J. Engel,</NAME>
          <TITLE>Acting Secretary of the Board. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20809 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 7535-01-U</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">NATIONAL CREDIT UNION ADMINISTRATION </AGENCY>
        <SUBJECT>Agency Information Collection Activities: Submission to OMB for Revision to a Currently Approved Information Collection; Comment Request </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>National Credit Union Administration (NCUA). </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Request for comment. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The NCUA intends to submit the following information collection to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 (Pub. L. 104-13, 44 U.S.C. chapter 35). This information collection is published to obtain comments from the public. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Comments will be accepted until October 14, 2003. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Interested parties are invited to submit written comments to NCUA Clearance Officer or OMB Reviewer listed below: </P>
          <P>
            <E T="03">Clearance Officer:</E> Mr. Neil McNamara, (703) 518-6447, National Credit Union Administration, 1775 Duke Street, Alexandria, Virginia 22314-3428, Fax No. (703) 518-6669, E-mail: <E T="03">mcnamara@ncua.gov.</E>
          </P>
          <P>
            <E T="03">OMB Reviewer:</E> Mr. Joseph F. Lackey, (202) 395-4741, Office of Management and Budget, Room 10226, New Executive Office Building, Washington, DC 20503. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>

          <P>Copies of the information collection requests, with applicable supporting documentation, may be obtained by calling the NCUA Clearance Officer, Neil McNamara, (703) 518-6447. It is also available on the following Web site: <E T="03">http://www.NCUA.gov.</E>
          </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>Proposal for the following collection of information: </P>
        <P>
          <E T="03">OMB Number:</E> 3133-0135. </P>
        <P>
          <E T="03">Form Number:</E> N/A. </P>
        <P>
          <E T="03">Type of Review:</E> Reinstatement, with change, of a previously approved collection for which approval has expired. </P>
        <P>
          <E T="03">Title:</E> National Credit Union Administration Agreement for Electronic Funds Transfer Payments. </P>
        <P>
          <E T="03">Description:</E> NCUA needs this information to comply with the Debt Collection Improvement Act which has <PRTPAGE P="48959"/>a provision concerning the use of EFT payments. </P>
        <P>
          <E T="03">Respondents:</E> All Federally Insured Credit Unions. </P>
        <P>
          <E T="03">Estimated No. of Respondents/Recordkeepers:</E> 250. </P>
        <P>
          <E T="03">Estimated Burden Hours Per Response:</E> 15 minutes, (15/60 hr). </P>
        <P>
          <E T="03">Frequency of Response:</E> Annually. </P>
        <P>
          <E T="03">Estimated Total Annual Burden Hours:</E> 62.5 hours. </P>
        <P>
          <E T="03">Estimated Total Annual Cost:</E> $1,350. </P>
        <SIG>
          <DATED>By the National Credit Union Administration Board on August 7, 2003. </DATED>
          <NAME>Hattie Ulan,</NAME>
          <TITLE>Acting Secretary of the Board. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20810 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 7535-01-U</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">NATIONAL CREDIT UNION ADMINISTRATION </AGENCY>
        <SUBJECT>Agency Information Collection Activities: Submission to OMB for an Extension of a Currently Approved Collection; Comment Request </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>National Credit Union Administration (NCUA). </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Request for comment.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The NCUA intends to submit the following information collection to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 (Pub. L. 104-13, 44 U.S.C. chapter 35). This information collection is published to obtain comments from the public. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Comments will be accepted until September 15, 2003. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Interested parties are invited to submit written comments to NCUA Clearance Officer or OMB Reviewer listed below: </P>
          <P>
            <E T="03">Clearance Officer:</E> Mr. Neil McNamara, (703) 518-6447, National Credit Union Administration, 1775 Duke Street,  Alexandria, Virginia 22314-3428, Fax No. 703-518-6489,  E-mail: <E T="03">mcnamara@ncua.gov.</E>
          </P>
          <P>
            <E T="03">OMB Reviewer:</E> Mr. Joseph F. Lackey, (202) 395-4741, Office of Management and Budget,  Room 10226, New Executive Office Building, Washington, DC 20503. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION:</HD>
          <P>Copies of the information collection requests, with applicable supporting documentation, may be obtained by calling the NCUA Clearance Officer, Neil McNamara, (703) 518-6447. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>Proposal for the following collection of information:</P>
        <P>
          <E T="03">OMB Number:</E> 3133-0163.</P>
        <P>
          <E T="03">Form Number:</E> N/A.</P>
        <P>
          <E T="03">Type of Review:</E> Extension of a currently approved collection. </P>
        <P>
          <E T="03">Title:</E> Privacy of Consumer Financial Information, 12 CFR part 716 and Requirements for Insurance, 12 CFR part 741.</P>
        <P>
          <E T="03">Description:</E> The regulations direct newly chartered and troubled credit unions to provide NCUA with 30 days notice before making a management change. 12 CFR parts 701.14 and 741.205.</P>
        <P>
          <E T="03">Estimated No. of Respondents/Recordkeepers:</E> 10,627.</P>
        <P>
          <E T="03">Estimated Burden Hours Per Response:</E> 45 hours.</P>
        <P>
          <E T="03">Frequency of Response:</E> Recordkeeping and third party disclosure.</P>
        <P>
          <E T="03">Estimated Total Annual Burden Hours:</E> 478,215.</P>
        <P>
          <E T="03">Estimated Total Annual Cost:</E> $0.</P>
        <SIG>
          <DATED>By the National Credit Union Administration Board on August 7, 2003.</DATED>
          <NAME>Hattie Ulan, </NAME>
          <TITLE>Acting Secretary of the Board. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20811 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 7535-01-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">NATIONAL CREDIT UNION ADMINISTRATION </AGENCY>
        <SUBJECT>Agency Information Collection Activities: Submission to OMB for Revision to a Currently Approved Information Collection; Comment Request </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>National Credit Union Administration (NCUA). </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Request for comment.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The NCUA intends to submit the following information collection to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 (Pub. L. 104-13, 44 U.S.C. chapter 35). This information collection is published to obtain comments from the public. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Comments will be accepted until October 14, 2003. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Interested parties are invited to submit written comments to NCUA Clearance Officer or OMB Reviewer listed below: </P>
          <P>
            <E T="03">Clearance Officer:</E> Mr. Neil McNamara, (703) 518-6447, National Credit Union Administration,  1775 Duke Street,  Alexandria, Virginia 22314-3428,  Fax No. 703-518-6669,  E-mail: <E T="03">mcnamara@ncua.gov.</E>
          </P>
          <P>
            <E T="03">OMB Reviewer:</E> Mr. Joseph F. Lackey, (202) 395-4741, Office of Management and Budget,  Room 10226, New Executive Office Building, Washington, DC 20503. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Copies of the information collection requests, with applicable supporting documentation, may be obtained by calling the NCUA Clearance Officer, Neil McNamara, (703) 518-6447. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>Proposal for the following collection of information: </P>
        <P>
          <E T="03">OMB Number:</E> 3133-0108. </P>
        <P>
          <E T="03">Form Number:</E> N/A. </P>
        <P>
          <E T="03">Type of Review:</E> Reinstatement, without change, of a previously approved collection for which approval has expired. </P>
        <P>
          <E T="03">Title:</E> 12 CFR 748.2 Monitoring Bank Secrecy Act Compliance. </P>
        <P>
          <E T="03">Description:</E> The collection is needed to allow NCUA to determine whether credit unions have established a program reasonably designed to assure and monitor their compliance with currency recordkeeping and reporting requirements established by Federal statute and Department of Treasury Regulations. </P>
        <P>
          <E T="03">Respondents:</E> Federally Insured Credit Unions. </P>
        <P>
          <E T="03">Estimated No. of Respondents/Recordkeepers:</E> 11,127. </P>
        <P>
          <E T="03">Estimated Burden Hours Per Response:</E> 3 hours. </P>
        <P>
          <E T="03">Frequency of Response:</E> Recordkeeping. </P>
        <P>
          <E T="03">Estimated Total Annual Burden Hours:</E> 33,477. </P>
        <P>
          <E T="03">Estimated Total Annual Cost:</E> Not applicable. </P>
        <SIG>
          <DATED>By the National Credit Union Administration Board on August 7, 2003. </DATED>
          <NAME>Hattie Ulan,</NAME>
          <TITLE>Acting Secretary of the Board. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20812 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 7535-01-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">NUCLEAR REGULATORY COMMISSION </AGENCY>
        <DEPDOC>[Docket No. 50-285] </DEPDOC>
        <SUBJECT>Omaha Public Power District, Fort Calhoun Station, Unit 1; Notice of Availability of the Final Supplement 12 to the Generic Environmental Impact Statement Regarding License Renewal for the Fort Calhoun Station, Unit 1 </SUBJECT>

        <P>Notice is hereby given that the U.S. Nuclear Regulatory Commission (the Commission) has published a final plant-specific supplement to the “Generic Environmental Impact Statement (GEIS)”, NUREG-1437, regarding the renewal of operating license DPR-40 for Fort Calhoun Station, Unit 1, for an additional 20 years of operation. The Fort Calhoun Station, Unit 1, is owned by the Omaha <PRTPAGE P="48960"/>Public Power District (OPPD). The Fort Calhoun Station, Unit 1, is located in Washington County, Nebraska. Possible alternatives to the proposed action (license renewal) include no action and reasonable alternative methods of power generation. </P>
        <P>It is stated in Section 9.3 of the report:</P>
        <P>Based on (1) the analysis and findings in the GEIS (NRC 1996; 1999); (2) the ER [Environmental Report] submitted by the OPPD (OPPD 2002); (3) consultation with Federal, State, and local agencies; (4) the staff's own independent review; and (5) the staff's consideration of the public comments received, the recommendation of the staff is that the Commission determine that the adverse environmental impacts of license renewal for Fort Calhoun Station Unit 1 are not so great that preserving the option of license renewal for energy-planning decision makers would be unreasonable. </P>

        <P>The final Supplement 12 to the GEIS is available for public inspection in the NRC Public Document Room (PDR) located at One White Flint North, 11555 Rockville Pike (first floor), Rockville, Maryland, or from the Publicly Available Records (PARS) component of NRC's Agencywide Documents Access and Management System (ADAMS). ADAMS is accessible from the NRC Web site at <E T="03">http://www.nrc.gov</E> (the Public Electronic Reading Room). Persons who do not have access to ADAMS, or who encounter problems in accessing the documents located in ADAMS, should contact the PDR reference staff at 1-800-397-4209, 301-415-4737, or by e-mail to <E T="03">pdr@nrc.gov.</E>
        </P>
        <P>
          <E T="03">For Further Information Contact:</E> Mr. Jack Cushing, License Renewal and Environmental Impacts Program, Division of Regulatory Improvement Programs, U.S. Nuclear Regulatory Commission, Washington, DC 20555. Mr. Cushing may be contacted at (301) 415-1424 or by writing to Jack Cushing, U.S. Nuclear Regulatory Commission, Mail Stop O-11-F1. </P>
        <SIG>
          <DATED>Dated at Rockville, Maryland, this 11th day of August, 2003. </DATED>
          
          <P>For the Nuclear Regulatory Commission. </P>
          <NAME>John Tappert,</NAME>
          <TITLE>Acting Program Director, License Renewal and Environmental Impacts Program, Division of Regulatory Improvement Programs, Office of Nuclear Reactor Regulation. </TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20838 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 7590-01-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">OFFICE OF MANAGEMENT AND BUDGET </AGENCY>
        <SUBJECT>Information Collection; Request for Public Comments </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Office of Management and Budget, Executive Office of the President. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice and request for comments.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>

          <P>In compliance with the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 <E T="03">et seq.</E>), the Office of Management and Budget (OMB) invites the general public and Federal agencies to comment on renewal and changes to two information collection requests from two types of entities: (1) the reports of auditors to auditees concerning audit results, audit findings, and questioned costs, and (2) reports from auditees to the Federal Government providing information about the auditees, the awards they administer, and the audit results. These collection efforts are required by the Single Audit Act Amendments of 1996 (31 U.S.C. 7501 <E T="03">et seq.</E>) and OMB Circular A-133, “Audits of States, Local Governments, and Non-Profit Organizations.” </P>
          <P>Included as part of this information collection is the Data Collection Form (SF-SAC). The changes being proposed are to modify the data elements collected on the SF-SAC. The current Form SF-SAC is being used for audit periods ending in 2001, 2002, and 2003. A revised Form SF-SAC will be used for audit periods ending in 2004, 2005, and 2006. </P>

          <P>Additionally, OMB is interested in receiving comments on ways to streamline the submission of the Data Collection Form (SF-SAC) and the single audit reporting packages (<E T="03">e.g.</E>, electronic submission) to more fully comply with the Government Paperwork Elimination Act (Pub. L. 105-277). </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Submit comments on or before October 14, 2003. Late comments will be considered to the extent practicable. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>Due to potential delays in OMB's receipt and processing of mail sent through the U.S. Postal Service, we encourage respondents to submit comments electronically to ensure timely receipt. We cannot guarantee that comments mailed will be received before the comment closing date. </P>
          <P>Electronic mail comments may be submitted to: <E T="03">tramsey@omb.eop.gov</E>. Please include “Form SF-SAC Comments” in the subject line and the full body of your comments in the text of the electronic message and not as an attachment. Please include your name, title, organization, postal address, telephone number, and E-mail address in the text of the message. Comments may also be submitted via facsimile to (202) 395-4915. </P>
          <P>Comments may be mailed to Terrill W. Ramsey, Office of Federal Financial Management, Office of Management and Budget, Room 6025, New Executive Office Building, Washington, DC 20503. </P>
          <P>
            <E T="03">Comments:</E> All responses will be summarized and included in the request for OMB approval. All comments will also be a matter of public record. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>

          <P>Terrill W. Ramsey, Office of Federal Financial Management, Office of Management and Budget, (202) 395-3812. The proposed revisions to the Information Collection Form, Form SF-SAC can be obtained by contacting the Office of Federal Financial Management as indicated above or by download from the OMB Grants Management home page on the Internet at <E T="03">http://www.whitehouse.gov/OMB/grants/grants_docs.html</E>. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P SOURCE="NPAR">
          <E T="03">OMB Control No.:</E> 0348-0057. </P>
        <P>
          <E T="03">Title:</E> Data Collection Form. </P>
        <P>
          <E T="03">Form No:</E> SF-SAC. </P>
        <P>
          <E T="03">Type of Review:</E> Revision of a currently approved collection. </P>
        <P>
          <E T="03">Respondents:</E> States, local governments, non-profit organizations (Non-Federal entities) and their auditors. </P>
        <P>
          <E T="03">Estimated Number of Respondents:</E> 62,400. </P>
        <P>
          <E T="03">Estimated Time per Respondent:</E> 59 hours for each of 400 large respondents and 17 hours for each of 62,000 small respondents for estimated annual burden hours of 1,077,600. </P>
        <P>
          <E T="03">Estimated Number of Responses per Respondent:</E> 1. </P>
        <P>
          <E T="03">Frequency of Response:</E> Annually. </P>
        <P>
          <E T="03">Needs and Uses:</E> Reports from auditors to auditees and reports from auditees to the Federal government are used by non-Federal entities, pass-through entities, and Federal agencies to ensure that Federal awards are expended in accordance with applicable laws and regulations. The Federal Audit Clearinghouse (FAC) (maintained by the U.S. Bureau of the Census) uses the information on the SF-SAC to ensure proper distribution of audit reports to Federal agencies and identify non-Federal entities who have not filed the required reports. The FAC also uses the information on the SF-SAC to create a government-wide database which contains information on audit results. This database is publicly accessible on the Internet at <E T="03">http://<PRTPAGE P="48961"/>harvester.census.gov/sac/.</E> It is used by Federal agencies, pass-through entities, non-Federal entities, auditors, the General Accounting Office, OMB, and the general public for management of and information about Federal awards and the results of audits. Comments are invited on: (a) Whether the proposed information collection is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the estimate of the burden of the collection of the information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on those who respond, including through the use of automated collection techniques or other forms of information technology. </P>
        <SIG>
          <NAME>Joseph L. Kull, </NAME>
          <TITLE>Deputy Controller. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20919 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 3110-01-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">OFFICE OF MANAGEMENT AND BUDGET </AGENCY>
        <SUBJECT>Performance of Commercial Activities </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Office of Management and Budget, Executive Office of the President. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Technical correction to Office of Management and Budget Circular No. A-76, “Performance of Commercial Activities.” </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The Office of Management and Budget (OMB) is making a technical correction to the coverage in Attachment A of Circular No. A-76 addressing the submission of a challenge to an agency's inventory of its commercial and inherently governmental activities. The technical correction is intended to clarify that an interested party may challenge the inclusion or exclusion of an activity in an inventory, including the classification or reclassification of an activity. This action makes no other changes to the revised Circular. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Effective Date: This technical correction to Circular A-76 is effective August 15, 2003. </P>
        </DATES>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Mathew Blum, Office of Federal Procurement Policy, NEOB Room 9013, Office of Management and Budget, 725 17th Street, NW., Washington, DC 20503 (tel: (202) 395-4953). </P>
          <P>
            <E T="03">Availability:</E> Copies of OMB Circular A-76, as revised by this notice, may be obtained at the OMB home page at <E T="03">http://www.whitehouse.gov/OMB/circulars/index.html#numerical.</E> Paper copies of the Circular may be obtained by calling OFPP (tel: (202) 395-7579). </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>The Federal Activities Inventory Reform (FAIR) Act of 1998, Public Law 105-270 (31 U.S.C. 501 note) requires executive agencies to prepare annual inventories of activities performed by their employees that, in the judgment of the head of the agency, are not inherently governmental. Under section 3 of the FAIR Act, an interested party may submit to an executive agency a challenge of an omission of a particular activity from, or an inclusion of a particular activity on, an agency's inventory. Consistent with section 3, the version of Circular A-76 that was in effect prior to May 29, 2003 authorized an interested party to submit a challenge to the inclusion or exclusion of an activity from the agency's inventory. </P>

        <P>On May 29, 2003, OMB issued revisions to Circular No. A-76. See 68 FR 32134 (preamble); <E T="03">http://www.whitehouse.gov/omb/circulars/a076/a76 rev2003.pdf</E> (text of Circular). Attachment A to the Circular provides guidance regarding agencies' responsibility to prepare annual inventories that categorize all activities performed by their government personnel as either commercial or inherently governmental. Paragraph D describes the processes that agencies must make available to interested parties for challenging agency inventories of commercial or inherently governmental activities. Paragraph D.2. of the May 29th revision states, among other things, that an inventory challenge shall be limited to “(a) the reclassification of an activity as inherently governmental or commercial, or (b) the application of reason codes.” </P>
        <P>As OMB explained in the <E T="04">Federal Register</E> notice announcing the revisions to the Circular, the purpose of this change was to authorize challenges (that had not previously been permitted) to an agency's application of reason codes to commercial activities performed by the government. 68 FR 32134, 32137-38 (May 29, 2003). OMB did not intend to restrict the availability of challenges to an agency's classification of an activity as inherently governmental or commercial. </P>

        <P>The use of the term “reclassification” in clause (a) of paragraph D.2. has created confusion in that it suggests that an interested party may not challenge an agency's determination that an activity is commercial or inherently governmental unless the determination has changed from prior years. Notwithstanding the wording of clause (a), OMB did not intend to impose such a limitation. Instead, OMB intended to continue to provide that interested parties may submit challenges to an activity's classification as commercial or as inherently governmental, and such challenges would include the reasons for the interested party's belief that an activity which the agency classified as “commercial” should be reclassified as inherently governmental or that an activity which the agency classified as “inherently governmental” should be reclassified as commercial (<E T="03">see</E> 64 FR 33927, 33930 (Appendix 2, Paragraph G.3) (June 24, 1999). </P>
        <P>By this notice, OMB is issuing a technical correction to clause (a) of Paragraph D.2. to avoid confusion and ensure the Circular's intent is clear regarding the ability of interested parties to file challenges to any classification of an activity as inherently governmental or commercial. This technical correction is intended to make clear that interested parties may challenge the inclusion or exclusion of an activity on the inventory, regardless of whether the activity's classification as commercial or inherently governmental has changed from the prior year or has remained the same. </P>
        <P>OMB believes that any confusion that may have been caused by clause (a) of paragraph D.2, as published on May 29th, should have no impact on interested parties in light of this correction. The time period for interested parties to file challenges to the 2002 inventories expired prior to the issuance of the May 29th revision and the time period for filing challenges to the 2003 inventories has not yet commenced (as the draft 2003 inventories have only been recently submitted to OMB for review). </P>
        <P>This technical correction notice makes no other changes to Paragraph D.2 (or any other part of the Circular). Accordingly, interested parties may challenge the application of reason codes, as provided by the May 29th revision to the Circular, but they may not challenge the application of function codes. </P>
        <SIG>
          <NAME>Joshua B. Bolten, </NAME>
          <TITLE>Director. </TITLE>
        </SIG>
        <HD SOURCE="HD1">Memorandum for the Heads of Executive Departments and Agencies </HD>
        <FP SOURCE="FP-2">
          <E T="03">From:</E> Joshua B. Bolten, Director. </FP>
        <FP SOURCE="FP-2">
          <E T="03">Subject:</E> Technical Correction to OMB Circular No. A-76, “Performance of Commercial Activities.” </FP>
        

        <P>This memorandum is intended to advise you of a technical correction to paragraph D.2. of Attachment A of <PRTPAGE P="48962"/>Office of Management and Budget (OMB) Circular No. A-76. This provision addresses the submission of challenges by interested parties to inventories of the commercial and inherently governmental activities performed by agency personnel. </P>
        <P>Paragraph D.2. of Attachment A states, among other things, that an inventory challenge shall be limited to “(a) the reclassification of an activity as inherently governmental or commercial, or (b) the application of reason codes.” With respect to clause (a), OMB intends to permit interested parties to challenge the inclusion of an activity on, or exclusion of an activity from, an agency inventory, regardless of whether the activity's classification as commercial or inherently governmental has changed from the prior year or has remained the same. Accordingly, as was the case under the Circular in effect prior to the May 29th revisions, challenges may address classifications or reclassifications of activities as either commercial or inherently governmental. </P>
        <P>The attached technical correction to Paragraph D.2. is meant to avoid confusion and ensure OMB's intent is clear regarding the ability of an interested party to challenge the inclusion or exclusion of an activity. No other changes are made to Paragraph D.2 by this memorandum. </P>
        <P>Questions regarding this technical clarification may be addressed to Mathew Blum of the Office of Federal Procurement Policy at (202) 395-4953. </P>
        <HD SOURCE="HD1">Technical Correction to OMB Circular No. A-76 (Revised, May 29, 2003) </HD>
        <P>1. Paragraph D.2. of Attachment A to Circular No. A-76 is revised to read as follows:</P>
        
        <EXTRACT>
          <P>2. Submission of an Inventory Challenge. After publication of OMB's Federal Register notice stating that an agency's inventories are available, an interested party shall have 30 working days to submit a written inventory challenge. The inventory challenge shall be limited to (a) the classification of an activity as inherently governmental or commercial, or (b) the application of reason codes. Function codes shall not be subject to the inventory challenge process. A written inventory challenge shall be submitted to agency inventory challenge authorities and shall specify the agency, agency component, agency organization, function(s), and location(s) for the activities being challenged.</P>
        </EXTRACT>
        
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20939 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 3110-01-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">PENSION BENEFIT GUARANTY CORPORATION </AGENCY>
        <SUBJECT>Required Interest Rate Assumption for Determining Variable-Rate Premium; Interest Assumptions for Multiemployer Plan Valuations Following Mass Withdrawal </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Pension Benefit Guaranty Corporation. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of interest rates and assumptions. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>

          <P>This notice informs the public of the interest rates and assumptions to be used under certain Pension Benefit Guaranty Corporation regulations. These rates and assumptions are published elsewhere (or can be derived from rates published elsewhere), but are collected and published in this notice for the convenience of the public. Interest rates are also published on the PBGC's Web site (<E T="03">http://www.pbgc.gov</E>). </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>The required interest rate for determining the variable-rate premium under part 4006 applies to premium payment years beginning in August 2003. The interest assumptions for performing multiemployer plan valuations following mass withdrawal under part 4281 apply to valuation dates occurring in September 2003. </P>
        </DATES>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Harold J. Ashner, Assistant General Counsel, Office of the General Counsel, Pension Benefit Guaranty Corporation, 1200 K Street, NW., Washington, DC 20005, (202) 326-4024. TTY/TDD users may call the Federal relay service toll-free at 1-800-877-8339 and ask to be connected to (202) 326-4024. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <HD SOURCE="HD1">Variable-Rate Premiums </HD>
        <P>Section 4006(a)(3)(E)(iii)(II) of the Employee Retirement Income Security Act of 1974 (ERISA) and § 4006.4(b)(1) of the PBGC's regulation on Premium Rates (29 CFR part 4006) prescribe use of an assumed interest rate (the “required interest rate”) in determining a single-employer plan's variable-rate premium. The required interest rate is the “applicable percentage” (currently 100 percent) of the annual yield on 30-year Treasury securities for the month preceding the beginning of the plan year for which premiums are being paid (the “premium payment year”). (Although the Treasury Department has ceased issuing 30-year securities, the Internal Revenue Service announces a surrogate yield figure each month—based on the 30-year Treasury bond maturing in February 2031—which the PBGC uses to determine the required interest rate.) </P>
        <P>The required interest rate to be used in determining variable-rate premiums for premium payment years beginning in August 2003 is 4.93 percent. </P>
        <P>The following table lists the required interest rates to be used in determining variable-rate premiums for premium payment years beginning between September 2002 and August 2003. </P>
        <GPOTABLE CDEF="s30,12" COLS="2" OPTS="L1,tp0,i1">
          <TTITLE>  </TTITLE>
          <BOXHD>
            <CHED H="1" O="L">For premium payment years beginning in: </CHED>
            <CHED H="1" O="L">The required interest rate is: </CHED>
          </BOXHD>
          <ROW>
            <ENT I="01">September 2002 </ENT>
            <ENT>5.08 </ENT>
          </ROW>
          <ROW>
            <ENT I="01">October 2002 </ENT>
            <ENT>4.76 </ENT>
          </ROW>
          <ROW>
            <ENT I="01">November 2002 </ENT>
            <ENT>4.93 </ENT>
          </ROW>
          <ROW>
            <ENT I="01">December 2002 </ENT>
            <ENT>4.96 </ENT>
          </ROW>
          <ROW>
            <ENT I="01">January 2003 </ENT>
            <ENT>4.92 </ENT>
          </ROW>
          <ROW>
            <ENT I="01">February 2003 </ENT>
            <ENT>4.94 </ENT>
          </ROW>
          <ROW>
            <ENT I="01">March 2003 </ENT>
            <ENT>4.81 </ENT>
          </ROW>
          <ROW>
            <ENT I="01">April 2003 </ENT>
            <ENT>4.80 </ENT>
          </ROW>
          <ROW>
            <ENT I="01">May 2003 </ENT>
            <ENT>4.90 </ENT>
          </ROW>
          <ROW>
            <ENT I="01">June 2003 </ENT>
            <ENT>4.53 </ENT>
          </ROW>
          <ROW>
            <ENT I="01">July 2003 </ENT>
            <ENT>4.37 </ENT>
          </ROW>
          <ROW>
            <ENT I="01">August 2003 </ENT>
            <ENT>4.93 </ENT>
          </ROW>
        </GPOTABLE>
        <HD SOURCE="HD1">Multiemployer Plan Valuations Following Mass Withdrawal </HD>

        <P>The PBGC's regulation on Duties of Plan Sponsor Following Mass Withdrawal (29 CFR part 4281) prescribes the use of interest assumptions under the PBGC's regulation on Allocation of Assets in Single-Employer Plans (29 CFR part 4044). The interest assumptions applicable to valuation dates in September 2003 under part 4044 are contained in an amendment to part 4044 published September 2003 under part 4044 are contained in an amendment to part 4004 published elsewhere in today's <E T="04">Federal Register</E>. Tables showing the assumptions applicable to prior periods are codified in appendix B to 29 CFR part 4044. </P>
        <SIG>
          <DATED>Issued in Washington, DC, on this 7th day of August 2003. </DATED>
          <NAME>Joseph H. Grant, </NAME>
          <TITLE>Deputy Executive Director and Chief Operating Officer, Pension Benefit Guaranty Corporation. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20861 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 7708-01-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">OFFICE OF PERSONNEL MANAGEMENT </AGENCY>
        <SUBJECT>Federal Salary Council </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Office of Personnel Management. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of meeting. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>

          <P>The Federal Salary Council will meet at the time and location shown below. The Council is an advisory body composed of representatives of Federal employee <PRTPAGE P="48963"/>organizations and experts in the fields of labor relations or pay policy. The Council makes recommendations to the President's Pay Agent (the Secretary of Labor and the Directors of the Office of Management and Budget and the Office of Personnel Management) about the locality pay program for General Schedule employees under section 5304 of title 5, United States Code. The Council's recommendations cover the establishment or modification of locality pay areas, the coverage of salary surveys, the process of comparing Federal and non-Federal rates of pay, and the level of comparability payments that should be paid. </P>
          <P>At this meeting, the Council will consider whether any changes should be recommended in locality pay area boundaries and may also consider which geographic locations should be surveyed for locality pay purposes and other aspects of the locality pay program. The Council will review the new metropolitan statistical areas announced by the Office of Management and Budget in June 2003, new commuting pattern data, and other information related to establishing or modifying locality pay area boundaries. The Council will meet again later this fall to continue this review and formulate its recommendations for locality pay areas, methodology, and rates for 2005. The meeting is open to the public. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>September 3, 2003, at 1 p.m. </P>
          <P>
            <E T="03">Location:</E> Office of Personnel Management, 1900 E Street NW., Room 5303 (Pendleton Room), Washington, DC. </P>
        </DATES>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>

          <P>Donald J. Winstead, Deputy Associate Director for Pay and Performance Policy, Office of Personnel Management, 1900 E Street NW., Room 7H31, Washington, DC 20415-8200. Phone (202) 606-2838; FAX (202) 606-0824; or e-mail at <E T="03">pay-performance-policy@opm.gov.</E>
          </P>
          <SIG>
            <P>For the President's Pay Agent </P>
            <NAME>Kay Coles James,</NAME>
            <TITLE>Director. </TITLE>
          </SIG>
        </FURINF>
      </PREAMB>
      <FRDOC>[FR Doc. 03-21041 Filed 8-13-03; 2:02 pm] </FRDOC>
      <BILCOD>BILLING CODE 6325-39-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">POSTAL RATE COMMISSION</AGENCY>
        <SUBJECT>Sunshine Act Meeting</SUBJECT>
        <PREAMHD>
          <HD SOURCE="HED">Name of Agency:</HD>
          <P>Postal Rate Commission.</P>
        </PREAMHD>
        <PREAMHD>
          <HD SOURCE="HED">Time and Date:</HD>
          <P>Wednesday, August 20, 2003, at 10:30 a.m.</P>
        </PREAMHD>
        <PREAMHD>
          <HD SOURCE="HED">Place:</HD>
          <P>Commission conference room, 1333 H Street, NW., Suite 300, Washington, DC 20268-0001.</P>
        </PREAMHD>
        <PREAMHD>
          <HD SOURCE="HED">Status:</HD>
          <P>Closed.</P>
        </PREAMHD>
        <PREAMHD>
          <HD SOURCE="HED">Matters to be Considered:</HD>
          <P>Decision in Docket No. MC2003-2, Experimental Parcel Return Services.</P>
        </PREAMHD>
        <PREAMHD>
          <HD SOURCE="HED">For Further Information Contact:</HD>
          <P>Stephen L. Sharfman, General Counsel, Postal Rate Commission, Suite 300, 1333 H Street, NW., Washington, DC 20268-0001, 202-789-6820.</P>
        </PREAMHD>
        <SIG>
          <DATED>Dated: August 12, 2003.</DATED>
          <NAME>Steven W. Williams,</NAME>
          <TITLE>Secretary.</TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20993  Filed 8-13-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 7710-FW-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">POSTAL SERVICE </AGENCY>
        <SUBJECT>Sunshine Act Meeting</SUBJECT>
        <HD SOURCE="HD1">Governors Vote To Close August 11, 2003, Meeting</HD>
        <P>By telephone vote on August 11, 2003, a majority of the Governors contacted and voting, the Governors voted to close to public observation a meeting held via teleconference. The Governors determined that prior public notice was not possible.</P>
        <PREAMHD>
          <HD SOURCE="HED">Item Considered:</HD>
          <P SOURCE="NPAR">1. Personnel Matters and Compensation Issues.</P>
        </PREAMHD>
        <PREAMHD>
          <HD SOURCE="HED">General Counsel Certification:</HD>
          <P SOURCE="NPAR">The General Counsel of the United States Postal Service has certified that the meeting was properly closed under the Government in the Sunshine Act.</P>
        </PREAMHD>
        <PREAMHD>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Requests for information about the meeting should be addressed to the Secretary of the Board, William T. Johnstone, at (202) 268-4800.</P>
        </PREAMHD>
        <SIG>
          <NAME>William T. Johnstone,</NAME>
          <TITLE>Secretary.</TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-21042  Filed 8-13-03; 2:14 pm]</FRDOC>
      <BILCOD>BILLING CODE 7710-12-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">RAILROAD RETIREMENT BOARD</AGENCY>
        <SUBJECT>Agency Forms Submitted for OMB Review</SUBJECT>
        <P>
          <E T="03">Summary:</E> In accordance with the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35), the Railroad Retirement Board (RRB) has submitted the following proposal(s) for the collection of information of the Office of Management and Budget for review and approval.</P>
        <P>
          <E T="03">Summary of Proposal(s):</E> (1) <E T="03">Collection title:</E> Application for Spouse Annuity Under the Railroad Retirement Act.</P>
        <P>(2) <E T="03">Form(s) submitted:</E> AA-3, AA-3cert.</P>
        <P>(3) <E T="03">OMB Number:</E> 3220-0042.</P>
        <P>(4) <E T="03">Expiration date of current OMB clearance:</E> 10/31/2003.</P>
        <P>(5) <E T="03">Type of request:</E> Extension of a currently approved collection.</P>
        <P>(6) <E T="03">Respondents:</E> Individuals or households.</P>
        <P>(7) <E T="03">Estimated annual number of respondents:</E> 8,500.</P>
        <P>(8) <E T="03">Total annual responses:</E> 8,500.</P>
        <P>(9) <E T="03">Total annual reporting hours:</E> 4,297.</P>
        <P>(10) <E T="03">Collection description:</E> The Railroad Retirement Act provides for the payment of annuities to spouses of railroad retirement annuitants who meet the requirements under the Act. The application obtains information supporting the claim for benefits based on being a spouse of an annuitant. The information is used for determining entitlement to and amount of the annuity applied for.</P>
        <P>
          <E T="03">Additional Information or Comments:</E> Copies of the forms and supporting documents can be obtained from Chuck Mierzwa, the agency clearance officer (312-751-3363).</P>
        <P>Comments regarding the information collection should be addressed to Ronald J. Hodapp, Railroad Retirement Board, 844 North Rush Street, Chicago, Illinois, 60611-2092 and to the OMB Desk Officer for the RRB, at the Office of Management and Budget, Room 10230, New Executive Office Building, Washington, DC 20503.</P>
        <SIG>
          <NAME>Chuck Mierzwa,</NAME>
          <TITLE>Clearance Officer.</TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20886  Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 7905-01-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">SECURITIES AND EXCHANGE COMMISSION </AGENCY>
        <SUBJECT>Submission for OMB Review; Comment Request </SUBJECT>
        <FP SOURCE="FP-1">Upon Written Request, Copies Available From: Securities and Exchange Commission, Office of Filings and Information Services, Washington, DC 20549. </FP>
        
        <EXTRACT>
          <FP SOURCE="FP-2">
            <E T="03">Extension:</E>
          </FP>
          <FP SOURCE="FP1-2">Form F-3; OMB Control No. 3235-0256; SEC File No. 270-251 </FP>
          <FP SOURCE="FP1-2">Form F-7; OMB Control No. 3235-0383; SEC File No. 270-331 </FP>
          <FP SOURCE="FP1-2">Form F-8; OMB Control No. 3235-0378; SEC File No. 270-332 </FP>
          <FP SOURCE="FP1-2">Schedule 14D-1F; OMB Control No. 3235-0376; SEC File No. 270-338 </FP>
          <FP SOURCE="FP1-2">Schedule 14D-9F; OMB Control No. 3235-0382; SEC File No. 270-339 </FP>
        </EXTRACT>
        
        <PRTPAGE P="48964"/>

        <P>Notice is hereby given that pursuant to the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 <E T="03">et seq.</E>) the Securities and Exchange Commission (“Commission”) has submitted to the Office of Management and Budget requests for extension of the previously approved collections of information discussed below. </P>
        <P>Form F-3 is used by foreign issuers to register securities pursuant to the Securities Act of 1933. The information collected is intended to ensure that the information required to be filed by the Commission permits verification of compliance with securities law requirements and assures the public availability of such information. The information provided is mandatory and all information is made available to the public upon request. Form F-3 it takes approximately 166 hours per response and is filed by approximately 120 respondents for a total burden of 19,920 hours. It is estimated that 25% of the total burden hours (4,980 reporting burden hours) is prepared by the issuer. </P>
        <P>Form F-7 may be used to register under the Securities Act securities offered for cash upon exercise of rights that are granted to its existing shareholders of the registrant to purchase or subscribe such securities. The information collected is intended to ensure that the information required to be filed by the Commission permits verification of compliance with securities law requirements and assures the public availability of such information. The information provided is mandatory and all information is made available to the public upon request. Approximately 5 respondents file Form F-7 and it takes approximately 4 hours per response for a total burden of 20 hours. It is estimated that 25% of the total burden hours (5 reporting burden hours) is prepared by the company. </P>
        <P>Form F-8 may be used to register under the Securities Act securities of certain Canadian issuers to be used in exchange offers or business combinations. The information collected is intended to ensure that the information required to be filed by the Commission permits verification of compliance with securities law requirements and assures the public availability of such information. The information provided is mandatory and all information is made available to the public upon request. Approximately 10 respondents file Form F-8 and it takes approximately 1 hour per response for a total burden of 10 hours. It is estimated that 25% of the total burden hours (2.5 reporting burden hours) is prepared by the company. </P>
        <P>Schedule 14D-1F may be used by any person making a cash tender or exchange offer (the “bidder”) for securities of any issuer incorporated or organized under the laws of Canada or any Canadian province or territory that is a foreign private issuer, where less than 40% of the outstanding class of such issuer's securities that is the subject of the offer is held by U.S. holders. Schedule 14D-1F is designed to facilitate cross-border transactions in securities of Canadian issuers. The information required to be filed with the Commission is intended to permit verification of compliance with the securities law requirements and assures the public availability of such information. The information provided is mandatory and all information is made available to the public upon request. Approximately 5 respondents file Schedule 14D-1F and it takes approximately 2 hours per response for total burden of 10 hours. </P>
        <P>Schedule 14D-9F is used by any issuer incorporated or organized under the laws of Canada or any Canadian province or territory that is foreign private issuer (the “subject company”), or by any director or officer of such issuer, where the issuer's is the subject of a cash tender or exchange offer for a class of securities filed on Schedule 14D-1F. The information required to be filed with the Commission is intended to permit verification of compliance with the securities law requirements and assures the public availability of such information. The information provided is mandatory and all information is made available to the public upon request. Approximately 5 respondents file Schedule 14D-9F and it takes approximately 2 hours per response for total burden of 10 hours. </P>
        <P>An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid control number. </P>
        <P>Written comments regarding the above information should be directed to the following persons: (i) Desk Officer for the Securities and Exchange Commission, Office of Information and Regulatory Affairs, Office of Management and Budget, Room 10102, New Executive Office Building, Washington, D.C. 20503; and (ii) Kenneth A. Fogash, Acting Associate Executive Director/CIO, Office of Information Technology, Securities and Exchange Commission, 450 Fifth Street, NW., Washington, DC 20549. Comments must be submitted to OMB within 30 days of this notice. </P>
        <SIG>
          <DATED>Dated: August 8, 2003. </DATED>
          <NAME>Margaret H. McFarland, </NAME>
          <TITLE>Deputy Secretary. </TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20818 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 8010-01-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">SECURITIES AND EXCHANGE COMMISSION </AGENCY>
        <DEPDOC>[Investment Company Act Release No. 26146; 812-12784] </DEPDOC>
        <SUBJECT>Nations Fund Trust, et al.; Notice of Application </SUBJECT>
        <DATE>August 11, 2003. </DATE>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Securities and Exchange Commission (“Commission”). </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of application for an order under the Investment Company Act of 1940 (the “Act”) under (i) section 6(c) of the Act granting an exemption from sections 18(f) and 21(b) of the Act; (ii) section 12(d)(1)(J) of the Act granting an exemption from section 12(d)(1) of the Act; (iii) sections 6(c) and 17(b) of the Act granting an exemption from sections 17(a)(1) and 17(a)(3) of the Act; and (iv) section 17(d) of the Act and rule 17d-1 under the Act to permit certain joint transactions. </P>
        </ACT>
        <PREAMHD>
          <HD SOURCE="HED">SUMMARY OF APPLICATION:</HD>
          <P>Applicants request an order that would permit certain registered investment companies to participate in a joint lending and borrowing facility. </P>
        </PREAMHD>
        <PREAMHD>
          <HD SOURCE="HED">APPLICANTS:</HD>
          <P>Nations Funds Trust, Nations Separate Account Trust, Nations Master Investment Trust (collectively, the “Trusts”), and Banc of America Capital Management, LLC (“BACAP”). </P>
        </PREAMHD>
        <PREAMHD>
          <HD SOURCE="HED">FILING DATES:</HD>
          <P>The application was filed on February 26, 2002, and amended on August 4, 2003. </P>
        </PREAMHD>
        <PREAMHD>
          <HD SOURCE="HED">HEARING OR NOTIFICATION OF HEARING:</HD>
          <P>An order granting the application will be issued unless the Commission orders a hearing. Interested persons may request a hearing by writing to the Commission's Secretary and serving applicants with a copy of the request, personally or by mail. Hearing requests should be received by the Commission by 5:30 p.m. on September 4, 2003 and should be accompanied by proof of service on the applicants, in the form of an affidavit or, for lawyers, a certificate of service. Hearing requests should state the nature of the writer's interest, the reason for the request, and the issues contested. Persons who wish to be notified of a hearing may request notification by writing to the Commission's Secretary. </P>
        </PREAMHD>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>

          <P>Secretary, Commission, 450 Fifth Street, NW., Washington, DC <PRTPAGE P="48965"/>20549-0609; Applicants, c/o Marco Adelfio, Esq., Morrison &amp; Foerster LLP, 2000 Pennsylvania Avenue, NW., Suite 5500, Washington, DC 20006. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>John L. Sullivan, Senior Counsel, at (202) 942-0681 or Todd F. Kuehl, Branch Chief, at (202) 942-0564 (Division of Investment Management, Office of Investment Company Regulation). </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>The following is a summary of the application. The complete application may be obtained for a fee at the Commission's Public Reference Branch, 450 Fifth Street, NW., Washington, DC 20549-0102 (tel. (202) 942-8090). </P>
        <HD SOURCE="HD1">Applicants' Representations </HD>
        <P>1. Each Trust is organized as a Delaware statutory trust and registered under the Act as an open-end management investment company.<SU>1</SU>
          <FTREF/> Responsibility for the overall management of the Trusts rests with each Trust's respective board of trustees (each, a “Board”). </P>
        <FTNT>
          <P>
            <SU>1</SU> Applicants ask that the requested relief apply to (i) The Trusts and their existing and future investment portfolios (“Funds”), (ii) BACAP and any successor entity to BACAP, and (iii) any other registered management investment company and its series advised by BACAP or a person controlling, controlled by or under common control with, BACAP in the future (included in the term “Funds”). The term “successor” is limited to entities that result from a reorganization into another jurisdiction or a change in the type of business organization or other type of restructuring within the group of entities controlled by Bank of America Corporation. All existing investment companies that currently intend to rely on the requested relief are named as applicants. Any other existing or future investment companies that subsequently rely on the requested order will comply with the terms and conditions in the application. Applicants represent that any registered open-end Fund (an “Open-End Fund”) may participate in the proposed credit facility (“Proposed Credit Facility”) as either a borrower or lender. Applicants further represent that any registered closed-end Fund (“Closed-End Fund”) that participates in the Proposed Credit Facility would only participate as a lender (the Closed-End Funds together with the Open-End Funds are referred to as the “Funds”).</P>
        </FTNT>
        <P>2. BACAP is registered as an investment adviser under the Investment Advisers Act of 1940. BACAP serves as investment adviser to each Fund. BACAP is a wholly owned subsidiary of Bank of America, N.A., which in turn is a wholly owned subsidiary of Bank of America Corporation, a bank holding company organized as a Delaware corporation. </P>
        <P>3. Some Funds may lend money to banks or other entities by entering into repurchase agreements or purchasing other short-term instruments. Other Funds may need to borrow money from the same or similar banks or other entities for temporary purposes to satisfy redemption requests, to cover unanticipated cash shortfalls such as a trade “fail” in which cash payment for a security sold by a Fund has been delayed, or for other temporary purposes. Currently, the Funds have an uncommitted line of credit and overdraft protection with their custodian, which is designed to cover reasonably anticipated borrowing needs. </P>
        <P>4. If the Funds were to borrow money under this line of credit, the Funds would pay interest on the borrowed cash at a rate that would be higher than the rate that would be earned by them on repurchase agreements and other short-term instruments of the same maturity as the bank loan. </P>
        <P>5. Applicants request an order that would permit the Funds to enter into a master interfund lending agreement (“Interfund Lending Agreements”) that would permit each Fund to lend money directly to, and each Open-End Fund to borrow directly from, other Funds for temporary purposes (an “Interfund Loan”). Applicants believe that the Proposed Credit Facility would substantially reduce the Funds' potential borrowing costs and enhance their ability to earn higher rates of interest on short-term lendings. Although the Proposed Credit Facility would substantially reduce the Funds' need to borrow from banks, it would not necessarily eliminate the need to maintain lines of credit or other borrowing arrangements with banks. The Funds also would continue to maintain their existing uncommitted line of credit and overdraft protection. </P>
        <P>6. Applicants anticipate that the Proposed Credit Facility will provide a borrowing Fund with significant cost savings when the cash position of the Fund is insufficient to meet temporary cash requirements. This situation could arise when redemptions exceed anticipated volumes and the Fund has insufficient cash on hand to satisfy such redemptions. When a Fund liquidates portfolio securities to meet redemption requests, it often does not receive payment in settlement for up to three days (or longer for certain foreign transactions). The Proposed Credit Facility would provide a source of immediate, short-term liquidity pending settlement of the sale of portfolio securities. </P>
        <P>7. Applicants also propose using the Proposed Credit Facility when a sale of portfolio securities fails due to circumstances beyond the Fund's control, such as a delay in the delivery of cash to the Fund's custodian or improper delivery instructions by the broker effecting the transaction. Sales fails may present a cash shortfall if the Fund has undertaken to purchase a security with the proceeds from securities sold. When the Fund experiences a cash shortfall due to a sales fail, the custodian typically extends temporary credit to cover the shortfall and the Fund incurs overdraft charges. Alternatively, the Fund could fail on its intended purchase due to lack of funds from the previous sale, resulting in additional costs to the Fund, or sell a security on a same day settlement basis, earning a lower return on the investment. Use of the Proposed Credit Facility under these circumstances would enable the Fund to have access to immediate short-term liquidity without incurring custodian overdraft, line of credit or other costs.</P>
        <P>8. While bank borrowings could generally supply needed cash to cover unanticipated redemptions and sales fails, under the Proposed Credit Facility, a borrowing Fund would pay lower interest rates than would be payable under the Fund's line of credit arrangements or the overdraft provisions of the custody contract. In addition, Funds making loans to other Funds would earn interest at a rate higher than they otherwise could obtain from investing their cash in repurchase agreements or other short-term investments. Thus, applicants believe that the Proposed Credit Facility would benefit both borrowing and lending Funds. </P>

        <P>9. The interest rate charged to the Funds on any loan under the Proposed Credit Facility (the “Interfund Rate”) would be determined daily and would be the average of the Repo Rate and the Bank Loan Rate, both as defined below. The Repo Rate on any day would be the highest current rate available to the Funds from investments in overnight repurchase agreements. The Bank Loan Rate would be calculated by the Cash Management Group (as defined below) on each day an Interfund Loan is made according to a formula approved by the Boards intended to approximate the lowest interest rate at which short-term bank loans would be available to the Funds. The formula would be based upon a publicly available rate (<E T="03">e.g.</E>, Federal funds plus 25 basis points) and would vary with this rate so as to reflect changing bank loan rates. Each Board periodically would review the continuing appropriateness of using the formula to determine the Bank Loan Rate, as well as the relationship between the Bank Loan Rate and current bank loan rates that would be available to the Funds. The initial formula and any subsequent modifications to the formula would be subject to the approval of each Fund's Board. <PRTPAGE P="48966"/>
        </P>
        <P>10. The Proposed Credit Facility would be administered by investment professionals and administrative personnel from BACAP, including a portfolio manager of the Nations Money Market Funds (“Cash Management Group”).<SU>2</SU>
          <FTREF/> Under the Proposed Credit Facility, the portfolio managers for each Fund could provide standing instructions to participate as a borrower or lender. The Cash Management Group would collect data on the uninvested cash and borrowing requirements of all participating Funds from the Funds' custodians. The Cash Management Group will determine the aggregate amount of cash available for loans and borrowing demand at least once and possibly twice a day. Then, the Cash Management Group will allocate loans among borrowing Funds without any further communication from portfolio managers (other than the Nations Money Market Funds portfolio manager acting in his or her capacity as a member of the Cash Management Group). It is expected that there typically will be far more available uninvested cash each day than borrowing demand. All allocations will require approval of at least one member of the Cash Management Group who is not a portfolio manager of a Nations Money Market Fund. After allocating cash for Interfund Loans, the Cash Management Group will invest any remaining cash in accordance with the standing instructions of the relevant portfolio managers or return remaining amounts for investment directly by such portfolio managers. </P>
        <FTNT>
          <P>
            <SU>2</SU> For purposes of the requested order, “Nations Money Market Funds” refers to money market Funds, each of which operates under rule 2a-7 under the Act.</P>
        </FTNT>
        <P>11. The Cash Management Group would allocate borrowing demand and cash available for lending among participating Funds on what the Cash Management Group believes to be an equitable basis, subject to certain administrative procedures applicable to all Funds, such as the time of filing requests to participate; minimum, maximum or preferable loan sizes; and efforts to minimize the number of transactions and associated administrative costs. To reduce administrative and custody costs, each loan normally would be allocated in a manner intended to minimize the number of participants necessary to complete the loan transaction. The method of allocation and related administrative procedures would be approved by each Board, including a majority of trustees who are not “interested persons,” as defined in section 2(a)(19) of the Act (“Independent Trustees”), to ensure that both borrowing and lending Funds participate on an equitable basis. </P>
        <P>12. The Cash Management Group would (a) Monitor the interest rates charged and the other terms and conditions of the loans, (b) limit the borrowings and loans entered into by each Fund to ensure that they comply with the Fund's investment policies and limitations, (c) ensure equitable treatment of each Fund, and (d) make quarterly reports to the Boards concerning any transactions by the Funds under the Proposed Credit Facility and the interest rates charged. </P>
        <P>13. BACAP, through the members of the Cash Management Group, would administer the Proposed Credit Facility under its existing investment advisory agreement with each Fund and would receive no additional fees as compensation for these services. BACAP could, however, collect reimbursement for record keeping, book keeping, accounting, administrative and transactions fees or charges incurred in connection with any credit facilities. Fees for these services would be no higher than those applicable for comparable bank loan transactions. </P>
        <P>14. No Fund will participate in the Proposed Credit Facility except to the extent such participation is consistent with its organizational documents and its investment policies and limitations. Also, no Fund will participate in the Proposed Credit Facility unless it has disclosed in its prospectus or statement of additional information (“SAI”) all material facts about its intended participation. </P>
        <P>15. In connection with the Proposed Credit Facility, applicants request an order under (a) section 6(c) of the Act granting relief from sections 18(f) and 21(b) of the Act; (b) section 12(d)(1)(J) of the Act granting relief from section 12(d)(1) of the Act; (c) sections 6(c) and 17(b) of the Act granting relief from sections 17(a)(1) and 17(a)(3) of the Act; and (d) section 17(d) of the Act and rule 17d-1 under the Act to permit certain joint arrangements. </P>
        <HD SOURCE="HD1">Applicants' Legal Analysis </HD>
        <P>1. Section 17(a)(3) of the Act generally prohibits any affiliated person, or affiliated person of an affiliated person, from borrowing money or other property from a registered investment company. Section 21(b) of the Act generally prohibits any registered management investment company from lending money or other property to any person if that person controls or is under common control with the company. Section 2(a)(3)(C) of the Act defines “affiliated person” of another person, in part, to be any person directly or indirectly controlling, controlled by, or under common control with, such other person. Applicants state that the Funds may be under common control by virtue of having BACAP as their common investment adviser, and/or by virtue of having common officers and trustees. </P>
        <P>2. Section 6(c) of the Act provides that an exemptive order may be granted where an exemption is necessary or appropriate in the public interest and consistent with the protection of investors and the purposes fairly intended by the policy and provisions of the Act. Section 17(b) authorizes the Commission to exempt a proposed transaction from section 17(a) of the Act provided that the terms of the transaction, including the consideration to be paid or received, are fair and reasonable and do not involve overreaching on the part of any person concerned, and the transaction is consistent with the policy of the investment company as recited in its registration statement and with the general purposes of the Act. Applicants believe that the proposed arrangements satisfy these standards for the reasons discussed below. </P>

        <P>3. Applicants submit that sections 17(a)(3) and 21(b) were intended to prevent a person with strong potential adverse interests to, and some influence over the investment decisions of, a registered investment company from causing or inducing the investment company to engage in lending transactions that unfairly inure to the benefit of that person and that are detrimental to the best interests of the investment company and its shareholders. Applicants assert that the Proposed Credit Facility transactions do not raise these concerns because (a) BACAP would administer the program as a disinterested fiduciary; (b) all Interfund Loans would consist only of uninvested cash reserves that the Fund otherwise would invest in short-term repurchase agreements or other short-term instruments; (c) the Interfund Loans would not involve a greater risk than such other investments; (d) the lending Fund would receive interest at a rate higher than it could obtain through such other investments; and (e) the borrowing Fund would pay interest at a rate lower than otherwise available to it under its bank loan agreements, and any charges incurred would be no higher than those associated with comparable bank loan arrangements. Moreover, applicants believe that the other conditions in the application would effectively preclude the possibility of any Fund obtaining an undue advantage over any other Fund. <PRTPAGE P="48967"/>
        </P>
        <P>4. Section 17(a)(1) of the Act generally prohibits an affiliated person of a registered investment company, or an affiliated person of an affiliated person, from selling any securities or other property to the company. Section 12(d)(1) of the Act generally makes it unlawful for a registered investment company to purchase or otherwise acquire any security issued by any other investment company except in accordance with the limitations set forth in that section. Applicants state that the obligation of a borrowing Fund to repay a credit facility loan may constitute a security under sections 17(a)(1) and 12(d)(1). Section 12(d)(1)(J) provides that an exemptive order may be granted by the Commission from any provision of section 12(d)(1) if and to the extent such exemption is consistent with the public interest and the protection of investors. Applicants contend that the standards under sections 6(c), 17(b) and 12(d)(1)(J) are satisfied for all the reasons set forth above in support of their request for relief from sections 17(a)(3) and 21(b) and for the reasons discussed below. </P>
        <P>5. Applicants state that section 12(d)(1) was intended to prevent the pyramiding of investment companies in order to avoid duplicative costs and fees attendant upon multiple layers of investment companies. Applicants submit that the Proposed Credit Facility does not involve these abuses. Applicants note that there would be no duplicative costs or fees to the Funds or shareholders, and that BACAP would administer the Proposed Credit Facility under its existing advisory agreements with the Funds, and other than the administrative and transactional charges described above, BACAP would receive no additional compensation for its services. Applicants also note that the purpose of Proposed Credit Facility is to provide economic benefits for all the participating Funds. </P>
        <P>6. Section 18(f)(1) of the Act prohibits open-end investment companies from issuing any senior security except that a company is permitted to borrow from any bank; provided that, immediately after the borrowing, there is an asset coverage of at least 300 per centum for all borrowings of the company. Under section 18(g) of the Act, the term “senior security” includes any bond, debenture, note, or similar obligation or instrument constituting a security and evidencing indebtedness. Applicants request exemptive relief from section 18(f)(1) to the limited extent necessary to implement the credit facility (because the lending Funds are not banks). </P>
        <P>7. Applicants believe that granting the relief under section 6(c) is appropriate because the Funds would remain subject to the requirement of section 18(f)(1) that all borrowings of the Fund, including combined interfund and bank borrowings, have at least 300% asset coverage. Based on the conditions and safeguards described in the application, applicants also submit that to allow the Funds to borrow from other Funds pursuant to the Proposed Credit Facility is consistent with the purposes and policies of section 18(f)(1). </P>
        <P>8. Section 17(d) of the Act and rule 17d-1 thereunder generally prohibit any affiliated person of a registered investment company, or affiliated persons of an affiliated person, when acting as principal, from effecting any transaction in which the company is a joint or a joint and several participant unless permitted by Commission order upon application. Rule 17d-1(b) under the Act provides that in passing upon applications for exemptive relief, the Commission will consider whether the participation of a registered investment company in a joint enterprise on the basis proposed is consistent with the provisions, policies and purposes of the Act and the extent to which the company's participation is on a basis different from or less advantageous than that of other participants. </P>
        <P>9. Applicants submit that the purpose of section 17(d) is to avoid overreaching by and unfair advantage to investment company insiders. Applicants believe that the Proposed Credit Facility is consistent with the provisions, policies and purposes of the Act in that it offers both reduced borrowing costs and enhanced returns on loaned funds to all participating Funds and their shareholders. Applicants note that each Fund would have an equal opportunity to borrow and lend on equal terms consistent with its investment policies and fundamental investment limitations. Applicants therefore believe that each Fund's participation in the Proposed Credit Facility would be on terms which are no different from or less advantageous than that of other participating Funds. </P>
        <HD SOURCE="HD1">Applicants' Conditions </HD>
        <P>Applicants agree that any order of the Commission granting the requested relief will be subject to the following conditions: </P>
        <P>1. The interest rates to be charged to the Funds under the Proposed Credit Facility will be the average of the Repo Rate and the Bank Loan Rate. </P>
        <P>2. On each business day, the Cash Management Group will compare the Bank Loan Rate with the Repo Rate and will make cash available for Interfund Loans only if the Interfund Rate is (a) More favorable to the lending Fund than the Repo Rate and (b) more favorable to the borrowing Fund than the Bank Loan Rate. </P>
        <P>3. If a Fund has outstanding borrowings, any Interfund Loans to the Fund (a) Will be at an interest rate equal to or lower than any outstanding bank loan; (b) will be secured at least on an equal priority basis with at least an equivalent percentage of collateral to loan value as any outstanding bank loan that requires collateral; (c) will have a maturity no longer than any outstanding bank loan (and in any event not over seven days); and (d) will provide that, if an event of default occurs under any agreement evidencing an outstanding bank loan to the Fund, the event of default will automatically (without need for action or notice by the lending Fund) constitute an immediate event of default under the Interfund Lending Agreement entitling the lending Fund to call the Interfund Loan (and exercise all rights with respect to any collateral) and that such call will be made if the lending bank exercises its right to call its loan under its agreement with the borrowing Fund. </P>
        <P>4. A Fund may make an unsecured borrowing through the Proposed Credit Facility if its outstanding borrowings from all sources immediately after the interfund borrowing total 10% or less of its total assets, provided that if the Fund has a secured loan outstanding from any other lender, including but not limited to another Fund, the Fund's interfund borrowing will be secured on at least an equal priority basis with at least an equivalent percentage of collateral to loan value as any outstanding loan that requires collateral. If a Fund's total outstanding borrowings immediately after an interfund borrowing would be greater than 10% of its total assets, the Fund may borrow through the Proposed Credit Facility on a secured basis only. A Fund may not borrow through the Proposed Credit Facility or from any other source if its total outstanding borrowings immediately after such borrowing would be more than 33 <FR>1/3</FR>% of its total assets. </P>

        <P>5. Before any Fund that has outstanding interfund borrowings may, through additional borrowings, cause its outstanding borrowings from all sources to exceed 10% of its total assets, the Fund must first secure each outstanding Interfund Loan by the pledge of segregated collateral with a market value at least equal to 102% of the outstanding principal value of the loan. If the total outstanding borrowings of a Fund with outstanding Interfund Loans exceed 10% of its total assets for any other reason (such as a decline in net <PRTPAGE P="48968"/>asset value or because of shareholder redemptions), the Fund will within one business day thereafter (a) repay all of its outstanding Interfund Loans, (b) reduce its outstanding indebtedness to 10% or less of its total assets, or (c) secure each outstanding Interfund Loan by the pledge of segregated collateral with a market value at least equal to 102% of the outstanding principal value of the loan until the Fund's total outstanding borrowings cease to exceed 10% of its total assets, at which time the collateral called for by this condition 5 shall no longer be required. Until each Interfund Loan that is outstanding at any time that a Fund's total outstanding borrowings exceeds 10% is repaid or the Fund's total outstanding borrowings cease to exceed 10% of its total assets, the Fund will mark the value of collateral to market each day and will pledge such additional collateral as is necessary to maintain the market value of the collateral that secures each outstanding Interfund Loan at least equal to 102% of the outstanding principal value of the Interfund Loan. </P>
        <P>6. No Fund may lend to another Fund through the Proposed Credit Facility if the loan would cause its aggregate outstanding loans through the Proposed Credit Facility to exceed 15% of the lending Fund's current net assets at the time of the loan. </P>
        <P>7. A Fund's Interfund Loans to any one Fund will not exceed 5% of the lending Fund's net assets. </P>
        <P>8. The duration of Interfund Loans will be limited to the time required to receive payment for securities sold, but in no event more than seven days. Loans effected within seven days of each other will be treated as separate loan transactions for purposes of this condition. </P>
        <P>9. A Fund's borrowings through the Proposed Credit Facility, as measured on the day when the most recent loan was made, will not exceed the greater of 125% of the Fund's total net cash redemptions or 102% of sales fails for the preceding seven calendar days. </P>
        <P>10. Each Interfund Loan may be called on one business day's notice by a lending Fund and may be repaid on any day by a borrowing Fund. </P>
        <P>11. A Fund's participation in the Proposed Credit Facility must be consistent with its investment policies and limitations and organizational documents. </P>
        <P>12. The Cash Management Group will calculate total Fund borrowing and lending demand through the Proposed Credit Facility, and allocate loans on an equitable basis among the Funds without the intervention of any portfolio managers of the Funds (other than the Nations Money Market Funds portfolio manager acting in his or her capacity as a member of the Cash Management Group). All allocations will require approval of at least one member of the Cash Management Group who is not a portfolio manager of a Nations Money Market Fund. The Cash Management Group will not solicit cash for the Proposed Credit Facility from any Fund or prospectively publish or disseminate loan demand data to portfolio managers. The Cash Management Group will invest any amounts remaining after satisfaction of borrowing demand in accordance with the standing instructions from portfolio managers or return remaining amounts for investment directly by the portfolio managers. </P>
        <P>13. The Cash Management Group will monitor the interest rates charged and the other terms and conditions of the Interfund Loans and will make a quarterly report to the Boards concerning the participation of the Funds in the Proposed Credit Facility and the terms and other conditions of any extensions of credit under the facility. </P>
        <P>14. The Boards of the Trusts, including a majority of the Independent Trustees, will (a) review no less frequently than quarterly each Fund's participation in the Proposed Credit Facility during the preceding quarter for compliance with the conditions of any order permitting the transactions; (b) establish the Bank Loan Rate formula used to determine the interest rate on Interfund Loans, approve any modifications thereto, and review no less frequently than annually the continuing appropriateness of the Bank Loan Rate formula; and (c) review no less frequently than annually the continuing appropriateness of the Fund's participation in the Proposed Credit Facility. </P>
        <P>15. In the event an Interfund Loan is not paid according to its terms and the default is not cured within two business days from maturity or from the time the lending Fund makes a demand for payment under the provisions of the Interfund Lending Agreement, the Cash Management Group will promptly refer the loan for arbitration to an independent arbitrator, selected by the Board(s) whose Funds are involved in the loan, who will serve as arbitrator of disputes concerning Interfund Loans.<SU>3</SU>
          <FTREF/> The arbitrator will resolve any problem promptly, and the arbitrator's decision will be binding on both Funds. The arbitrator will submit at least annually a written report to the Board(s) setting forth a description of the nature of any dispute and the actions taken by the Funds to resolve the dispute. </P>
        <FTNT>
          <P>
            <SU>3</SU> If a dispute involves Funds with separate Boards, the respective Boards will agree on an independent arbitrator that is satisfactory to them. </P>
        </FTNT>
        <P>16. Each Fund will maintain and preserve for a period of not less than six years from the end of the fiscal year in which any transaction under the Proposed Credit Facility occurred, the first two years in an easily accessible place, written records of all such transactions, setting forth a description of the terms of the transaction, including the amount, the maturity and the rate of interest on the loan, the rate of interest available at the time on short-term repurchase agreements and bank borrowings, and such other information presented to the Board in connection with the review required by conditions 13 and 14. </P>
        <P>17. The Cash Management Group will prepare and submit to the Boards for review an initial report describing the operations of the Proposed Credit Facility and the procedures to be implemented to ensure that all the Funds are treated fairly. After the commencement of the operations of the Proposed Credit Facility, the Cash Management Group will report on the operations of the Proposed Credit Facility at each Board's quarterly meetings. </P>
        <P>In addition, for two years following the commencement of the Proposed Credit Facility, the independent public accountant for each Trust shall prepare an annual report that evaluates the Cash Management Group's assertion that it has established procedures reasonably designed to achieve compliance with the conditions of the order. The report shall be prepared in accordance with the Statements on Standards for Attestation Engagements No. 3 and it shall be filed pursuant to item 77Q3 of Form N-SAR. In particular, the report shall address procedures designed to achieve the following objectives: (a) That the Interfund Rate will be higher than the Repo Rate but lower than the Bank Loan Rate; (b) compliance with the collateral requirements as set forth in the application; (c) compliance with the percentage limitations on interfund borrowing and lending; (d) allocation of interfund borrowing and lending demand in an equitable manner and in accordance with procedures established by each Board; and (e) that the interest rate on any Interfund Loan does not exceed the interest rate on any third party borrowings of a borrowing Fund at the time of the Interfund Loan. </P>

        <P>After the final report is filed, the independent public accountant for the Trusts in connection with Fund audit <PRTPAGE P="48969"/>examinations, will continue to review the operation of the Proposed Credit Facility for compliance with the conditions of the application and their review will form the basis, in part, of the auditor's report on internal accounting controls in Form N-SAR. </P>
        <P>18. No Fund will participate in the Proposed Credit Facility unless it has fully disclosed in its prospectus or SAI all material facts about its intended participation. </P>
        <SIG>
          <P>For the Commission, by the Division of Investment Management, pursuant to delegated authority. </P>
          <NAME>Margaret H. McFarland, </NAME>
          <TITLE>Deputy Secretary. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20904 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 8010-01-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">SECURITIES AND EXCHANGE COMMISSION </AGENCY>
        <DEPDOC>[Release No. 34-48304; File No. SR-Amex-2003-73] </DEPDOC>
        <SUBJECT>Self-Regulatory Organizations; Notice of Filing and Immediate Effectiveness of Proposed Rule Change by the American Stock Exchange LLC to Extend the Suspension of Transaction Charges for Certain iShares Funds </SUBJECT>
        <DATE>August 8, 2003. </DATE>
        <P>Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (“Act”),<SU>1</SU>
          <FTREF/> and Rule 19b-4 thereunder,<SU>2</SU>
          <FTREF/> notice is hereby given that on August 1, 2003, the American Stock Exchange LLC (“Amex” or “Exchange”) filed with the Securities and Exchange Commission (“SEC” or “Commission”) the proposed rule change as described in Items I, II, and III below, which Items have been prepared by the Exchange. The Commission is publishing this notice to solicit comments on the proposed rule change. </P>
        <FTNT>
          <P>
            <SU>1</SU> 15 U.S.C. 78s(b)(1).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>2</SU> 17 CFR 240.19b-4.</P>
        </FTNT>
        <HD SOURCE="HD1">I. Self-Regulatory Organization's Statement of the Terms of Substance of the Proposed Rule Change </HD>

        <P>The Amex proposes to extend until August 31, 2003 the suspension of Exchange transaction charges for specialist, Registered Trader, and broker-dealer orders for the iShares Lehman 1-3 year Treasury Bond Fund and the iShares Lehman 7-10 year Treasury Bond Fund. Proposed new language is <E T="03">italicized;</E> proposed deletions are in [brackets]. </P>
        <STARS/>
        <GPOTABLE CDEF="xl100,r100" COLS="2" OPTS="L1,p1,8/9,i1">
          <TTITLE>Amex Equity Fee Schedule </TTITLE>
          <BOXHD>
            <CHED H="1">  </CHED>
            <CHED H="1">  </CHED>
          </BOXHD>
          <ROW>
            <ENT I="22">I. Transaction Charges </ENT>
          </ROW>
          <ROW>
            <ENT I="13">No change. </ENT>
          </ROW>
          <ROW>
            <ENT I="22">II. Regulatory Fee </ENT>
          </ROW>
          <ROW>
            <ENT I="13">No Change. </ENT>
          </ROW>
          <ROW>
            <ENT I="22">Notes: </ENT>
          </ROW>
          <ROW>
            <ENT I="13">1. and 2. No change. </ENT>
          </ROW>
          <ROW EXPSTB="01">
            <ENT I="13">3. Customer transaction charges for the following Portfolio Depositary Receipts, Index Fund Shares, and Trust Issued Receipts have been suspended:</ENT>
          </ROW>
          
          <ROW EXPSTB="00">
            <ENT I="01">DIA—DIAMONDS® </ENT>
            <ENT>BHH—B2B Internet HOLDRs<E T="51">TM</E>. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">QQQ—Nasdaq-100® Index Tracking Stock</ENT>
            <ENT>BBH—Biotech HOLDRs. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">SPY—SPDRs®</ENT>
            <ENT>BDH—Broadband HOLDRs. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">IVV—iShares S&amp;P 500</ENT>
            <ENT>EKH—Europe 2001 HOLDRs. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">MDY—MidCap SPDRs</ENT>
            <ENT>IAH—Internet Architecture HOLDRs. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">XLY—Select Sector SPDR-Consumer</ENT>
            <ENT>HHH—Internet HOLDRs </ENT>
          </ROW>
          <ROW>
            <ENT I="01">Discretionary</ENT>
            <ENT>IIH—Internet Infrastructure HOLDRs. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">XLP—Select Sector SPDR-Consumer Staples</ENT>
            <ENT>MKH—Market 2000+ HOLDRs. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">XLE—Select Sector SPDR-Energy</ENT>
            <ENT>OIH—Oil Service HOLDRs. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">XLF—Select Sector SPDR-Financial</ENT>
            <ENT>PPH—Pharmaceutical HOLDRs. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">XLV—Select Sector SPDR-Health Care</ENT>
            <ENT>RKH—Regional Bank HOLDRs. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">XLI—Select Sector SPDR-Industrial</ENT>
            <ENT>RTH—Retail HOLDRs. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">XLB—Select Sector SPDR-Materials</ENT>
            <ENT>SMH—Semiconductor HOLDRs. </ENT>
          </ROW>
          <ROW>
            <ENT I="01">XLK—Select Sector SPDR-Technology</ENT>
            <ENT>SWH—Software HOLDRs </ENT>
          </ROW>
          <ROW>
            <ENT I="01">XLU—Select Sector SPDR-Utilities</ENT>
            <ENT>TTH—Telecom HOLDRs. </ENT>
          </ROW>
          <ROW>
            <ENT I="22"> </ENT>
            <ENT>UTH—Utilities HOLDRs. </ENT>
          </ROW>
          <ROW>
            <ENT I="22"> </ENT>
            <ENT>WMH—Wireless HOLDRs. </ENT>
          </ROW>
          <ROW>
            <ENT I="22"> </ENT>
            <ENT>SHY—iShares Lehman 1-3 Year Treasury Bond Fund. </ENT>
          </ROW>
          <ROW>
            <ENT I="22"> </ENT>
            <ENT>IEF—iShares Lehman 7-10 Year Treasury Bond Fund. </ENT>
          </ROW>
          <ROW>
            <ENT I="22"> </ENT>
            <ENT>TLT—iShares Lehman 20+ Year Treasury Bond Fund. </ENT>
          </ROW>
          <ROW>
            <ENT I="22"> </ENT>
            <ENT>LQD—iShares GS $ InvesTop Corporate Bond Fund. </ENT>
          </ROW>
          
          <ROW EXPSTB="01">
            <ENT I="13">Customer transaction charges for the iShares S&amp;P 100 Index Fund are $.0015 per share ($.15 per 100 shares), capped at $100 per trade. </ENT>
          </ROW>
          <ROW>
            <ENT I="22">Until [July 31] <E T="03">August 31,</E> 2003, transaction charges also have been suspended in SHY and IEF for specialist, Registered Trader and broker dealer orders. </ENT>
          </ROW>
        </GPOTABLE>
        <STARS/>
        <HD SOURCE="HD1">II. Self-Regulatory Organization's Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Change </HD>
        <P>In its filing with the Commission, the Amex included statements concerning the purpose of and basis for the proposed rule change and discussed any comments it received on the proposed rule change. The text of these statements may be examined at the places specified in Item IV below. The Exchange has prepared summaries, set forth in Sections A, B, and C below, of the most significant aspects of such statements. </P>
        <HD SOURCE="HD2">A. Self-Regulatory Organization's Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Change </HD>
        <HD SOURCE="HD1">1. Purpose </HD>

        <P>The Exchange is extending until August 31, 2003 the suspension of transaction charges in iShares Lehman 1-3 year Treasury Bond Fund (Symbol: SHY) and iShares Lehman 7-10 year <PRTPAGE P="48970"/>Treasury Bond Fund (Symbol: IEF) for specialist, Registered Trader and broker-dealer orders. The Exchange previously filed a suspension of such charges until November 30, 2002,<SU>3</SU>
          <FTREF/> December 31, 2002,<SU>4</SU>
          <FTREF/> January 31, 2003,<SU>5</SU>
          <FTREF/> February 28, 2003,<SU>6</SU>
          <FTREF/> March 31, 2003,<SU>7</SU>
          <FTREF/> April 30, 2003,<SU>8</SU>
          <FTREF/> May 31, 2003,<SU>9</SU>
          <FTREF/> June 30, 2003,<SU>10</SU>
          <FTREF/> and July 31, 2003.<SU>11</SU>
          <FTREF/>
        </P>
        <FTNT>
          <P>
            <SU>3</SU> <E T="03">See</E> Securities Exchange Act Release No. 46765 (November 1, 2002), 67 FR 68893 (November 13, 2002) (SR-Amex-2002-91).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>4</SU> <E T="03">See</E> Securities Exchange Act Release No. 46996 (December 13, 2002), 67 FR 78264 (December 23, 2002) (SR-Amex-2002-98).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>5</SU> <E T="03">See</E> Securities Exchange Act Release No. 47141 (January 8, 2003), 68 FR 2090 (January 15, 2003) (SR-Amex-2002-115).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>6</SU> <E T="03">See</E> Securities Exchange Act Release No. 47361 (February 13, 2003), 68 FR 8534 (February 21, 2003) (SR-Amex-2003-04).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>7</SU> <E T="03">See</E> Securities Exchange Act Release No. 47455 (March 6, 2003), 68 FR 12111 (March 13, 2003) (SR-Amex-2003-15).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>8</SU> <E T="03">See</E> Securities Exchange Act Release No. 47668 (April 11, 2003), 68 FR 19241 (April 18, 2003) (SR-Amex-2003-22).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>9</SU> <E T="03">See</E> Securities Exchange Act Release No. 47858 (May 14, 2003), 68 FR 27872 (May 21, 2003) (SR-Amex-2003-40).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>10</SU> <E T="03">See</E> Securities Exchange Act Release No. 47974 (June 4, 2003), 68 FR 35030 (June 11, 2003) (SR-Amex-2003-57).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>11</SU> <E T="03">See</E> Securities Exchange Act Release No. 48240 (July 28, 2003), 68 FR 45866 (August 4, 2003) (SR-Amex-2003-67).</P>
        </FTNT>
        <P>The Exchange believes that a suspension of fees for the SHY and IEF is appropriate to enhance the competitiveness of executions in these securities on the Amex. The Exchange will reassess the fee suspension as appropriate, and will file any modification to the fee suspension with the Commission pursuant to Section 19(b)(3)(A) of the 1934 Act.<SU>12</SU>
          <FTREF/>
        </P>
        <FTNT>
          <P>
            <SU>12</SU> 15 U.S.C. 78s(b)(3)(A).</P>
        </FTNT>
        <HD SOURCE="HD3">2. Statutory Basis </HD>
        <P>The Exchange believes that the proposed rule change is consistent with Section 6(b) of the Act <SU>13</SU>
          <FTREF/> in general, and furthers the objectives of Section 6(b)(4) <SU>14</SU>
          <FTREF/> in particular, in that it provides for the equitable allocation of reasonable dues, fees and other charges among its members and other persons using its facilities. </P>
        <FTNT>
          <P>
            <SU>13</SU> 15 U.S.C. 78f(b).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>14</SU> 15 U.S.C. 78f(b)(4).</P>
        </FTNT>
        <HD SOURCE="HD2">B. Self-Regulatory Organization's Statement on Burden on Competition </HD>
        <P>The Exchange does not believe that the proposed rule change will impose any burden on competition.</P>
        <HD SOURCE="HD2">C. Self-Regulatory Organization's Statement on Comments on the Proposed Rule Change Received From Members, Participants or Others</HD>
        <P>The Exchange has neither solicited nor received comments on the proposed rule change.</P>
        <HD SOURCE="HD1">III. Date of Effectiveness of the Proposed Rule Change and Timing for Commission Action</HD>
        <P>The foregoing rule change has become effective pursuant to Section 19(b)(3)(A) of the Act and Rule 19b-4(f)(6) <SU>15</SU>
          <FTREF/> thereunder because the proposal: (i) Does not significantly affect the protection of investors or the public interest; (ii) does not impose any significant burden on competition; and (iii) does not become operative prior to 30 days after the date of filing or such shorter time as the Commission may designate if consistent with the protection of investors and the public interest; provided that the Exchange has given the Commission notice of its intent to file the proposed rule change, along with a brief description and text of the proposed rule change, at least five business days prior to the date of filing of the proposed rule change, or such shorter time as designated by the Commission. At any time within 60 days of the filing of such proposed rule change, the Commission may summarily abrogate such rule change if it appears to the Commission that such action is necessary or appropriate in the public interest, for the protection of investors or otherwise in furtherance of the purposes of the Act.</P>
        <FTNT>
          <P>
            <SU>15</SU> 17 CFR 240.19b-4(f)(6).</P>
        </FTNT>
        <P>The Amex has requested that the Commission waive the five-day pre-filing notice and the 30-day operative delay. The Commission believes that waiving the five-day pre-filing notice and the 30-day operative delay is consistent with the protection of investors and the public interest. The Commission notes that fee suspensions for the exchange-trade funds that are the subject of this filing have been previously filed with the Commission.<SU>16</SU>
          <FTREF/> Further, extension of the fee suspension for specialist, Registered Trader, and broker-dealer orders will permit the fee suspensions to continue uninterrupted. For these reasons, the Commission designates the proposal to be effective and operative upon filing with the Commission.<SU>17</SU>
          <FTREF/>
        </P>
        <FTNT>
          <P>
            <SU>16</SU> <E T="03">See supra</E> notes 3-10.</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>17</SU> For purposes only of accelerating the operative date of this proposal, the Commission has considered the proposed rule's impact on efficiency, competition, and capital formation. 15 U.S.C. 78c(f).</P>
        </FTNT>
        <HD SOURCE="HD1">IV. Solicitation of Comments</HD>
        <P>Interested persons are invited to submit written data, views, and arguments concerning the foregoing, including whether the proposed rule change is consistent with the Act. Persons making written submissions should file six copies thereof with the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW., Washington, DC 20549-0609. Copies of the submission, all subsequent amendments, all written statements with respect to the proposed rule change that are filed with the Commission, and all written communications relating to the proposed rule change between the Commission and any person, other than those that may be withheld from the public in accordance with the provisions of 5 U.S.C. 552, will be available for inspection and copying at the Commission's Public Reference Room. Copies of such filing will also be available for inspection and copying at the principal office of the Exchange. All submissions should refer to File No. SR-Amex-2003-73 and should be submitted by September 5, 2003.</P>
        <SIG>
          <P>For the Commission, by the Division of Market Regulation, pursuant to delegated authority.<SU>18</SU>
            <FTREF/>
          </P>
          <FTNT>
            <P>
              <SU>18</SU> 17 CFR 200.30-3(a)(12).</P>
          </FTNT>
          <NAME>Margaret H. McFarland,</NAME>
          <TITLE>Deputy Secretary.</TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20905 Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 8010-01-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">SECURITIES AND EXCHANGE COMMISSION </AGENCY>
        <DEPDOC>[Release No. 34-48312; File No. SR-Amex-2003-69] </DEPDOC>
        <SUBJECT>Self-Regulatory Organizations; Notice of Filing and Accelerated Approval of Proposed Rule Change by American Stock Exchange LLC Relating to Trust Certificates Linked to a Basket of Investment Grade Fixed Income Securities </SUBJECT>
        <DATE>August 8, 2003. </DATE>
        <P>Pursuant to section 19(b)(1) of the Securities Exchange Act of 1934 (“Act”),<SU>1</SU>
          <FTREF/> and Rule 19b-4 thereunder,<SU>2</SU>

          <FTREF/> notice is hereby given that on July 17, 2003, the American Stock Exchange LLC (“Amex” or “Exchange”) filed with the Securities and Exchange Commission (“Commission”) the proposed rule change as described in Items I and II below, which Items have been prepared by the Exchange. The Commission is <PRTPAGE P="48971"/>publishing this notice to solicit comments on the proposed rule change from interested persons and is approving the proposal on an accelerated basis.</P>
        <FTNT>
          <P>
            <SU>1</SU> 15 U.S.C. 78s(b)(1).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>2</SU> 17 CFR 240.19b-4.</P>
        </FTNT>
        <HD SOURCE="HD1">I. Self-Regulatory Organization's Statement of the Terms of Substance of the Proposed Rule Change </HD>
        <P>The Exchange proposes to approve for listing and trading under Section 107A of the Amex Company Guide (“Company Guide”), trust certificates linked to a basket of investment grade fixed income debt instruments. </P>
        <HD SOURCE="HD1">II. Self-Regulatory Organization's Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Change </HD>
        <P>In its filing with the Commission, the Amex included statements concerning the purpose of, and basis for, the proposed rule change and discussed any comments it received on the proposed rule change. The text of these statements may be examined at the places specified in Item III below. The Amex prepared summaries, set forth in Sections A, B, and C below, of the most significant aspects of such statements. </P>
        <HD SOURCE="HD2">A. Self-Regulatory Organization's Statement of the Purpose of, and the Statutory Basis for, the Proposed Rule Change </HD>
        <HD SOURCE="HD3">1. Purpose </HD>
        <P>Under Section 107A of the Company Guide, the Exchange may approve for listing and trading securities which cannot be readily categorized under the listing criteria for common and preferred stocks, bonds, debentures, or warrants.<SU>3</SU>
          <FTREF/> The Amex proposes to list for trading under Section 107A of the Company Guide, asset-backed securities (the “ABS Securities”) representing ownership interest in the Select Notes Trust 2003-04 (“Trust”), a special purpose entity to be formed by Structured Obligations Corporation (“SOC”),<SU>4</SU>
          <FTREF/> and the trustee of the Trust pursuant to a trust agreement, which will be entered into on the date that the ABS Securities are issued. The assets of the Trust will consist primarily of a basket or portfolio of up to approximately ten investment-grade fixed-income securities (the “Underlying Corporate Bonds”) <SU>5</SU>
          <FTREF/> and the United States Department of Treasury STRIPS or securities issued by the United States Department of Treasury (the “Treasury Securities”) or government sponsored entity securities (the “GSE Securities”). In the aggregate, component the securities will be referred to as the “Underlying Securities.”</P>
        <FTNT>
          <P>
            <SU>3</SU> <E T="03">See</E> Securities Exchange Act Release No. 27753 (March 1, 1990), 55 FR 8626 (March 8, 1990) (order approving File No. SR-Amex-89-29).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>4</SU> SOC is a wholly-owned special purpose entity of J.P. Morgan Securities Holdings Inc. and the registrant under the Form S-3 Registration Statement (No. 333-671-88) under which the securities will be issued. Telephone Conversation between Jeffrey P. Burns, Assistant General Counsel, Amex, and Hong-Anh Tran, Special Counsel, Division of Market Regulation (“Division”), Commission, on July 30, 2003.</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>5</SU> <E T="03">Id.</E>
          </P>
        </FTNT>
        <P>The ABS Securities will conform to the initial listing guidelines under Section 107A <SU>6</SU>
          <FTREF/> and continued listing guidelines under Sections 1001-1003<SU>7</SU>
          <FTREF/> of the Company Guide. At the time of issuance, the ABS Securities will receive an investment grade rating from a nationally recognized securities rating organization (an “NRSRO”). The issuance of the ABS Securities will be a repackaging of the Underlying Corporate Bonds together with the addition of either Treasury Securities or GSE Securities,<SU>8</SU>
          <FTREF/> with the obligation of the Trust to make distributions to holders of the ABS Securities depending on the amount of distributions received by the Trust on the Underlying Securities. However, due to the pass-through and passive nature of the ABS Securities, the Exchange intends to rely on the assets and stockholder equity of the issuers of the Underlying Corporate Bonds as well as GSE Securities, rather than the Trust to meet the requirement in Section 107A of the Company Guide. The corporate issuers of the Underlying Corporate Bonds and GSE Securities will meet or exceed the requirements of Section 107A of the Company Guide. The distribution and principal amount/aggregate market value requirements found in Sections 107A(b) and (c), respectively, will otherwise be met by the Trust as issuer of the ABS Securities.<SU>9</SU>
          <FTREF/> In addition, the Exchange for purposes of including Treasury Securities will rely on the fact that the issuer is the U.S. Government rather than the asset and stockholder tests found in Section 107A. </P>
        <FTNT>
          <P>
            <SU>6</SU> The initial listing standards for the ABS Securities require: (1) A minimum public distribution of one million units; (2) a minimum of 400 shareholders; (3) a market value of at least $4 million; and (4) a term of at least one year. However, if traded in thousand dollar denominations, then there is no minimum holder requirement. In addition, the listing guidelines provide that the issuer have assets in excess of $100 million, stockholder's equity of at least $10 million, and pre-tax income of at least $750,000 in the last fiscal year or in two of the three prior fiscal years. In the case of an issuer which is unable to satisfy the earning criteria stated in Section 101 of the Company Guide, the Exchange, pursuant to Section 107 of the Company Guide, will require the issuer to have the following: (1) Assets in excess of $200 million and stockholders' equity of at least $10 million; or (2) assets in excess of $100 million and stockholders' equity of at least $20 million.</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>7</SU> The Exchange's continued listing guidelines are set forth in Sections 1001 through 1003 of Part 10 to the Exchange's Company Guide. Section 1002(b) of the Company Guide states that the Exchange will consider removing from listing any security where, in the opinion of the Exchange, it appears that the extent of public distribution or aggregate market value has become so reduced to make further dealings on the Exchange inadvisable. With respect to continued listing guidelines for distribution of the ABS Securities, the Exchange will rely on the guidelines for bonds in Section 1003(b)(iv). Section 1003(b)(iv)(A) provides that the Exchange will normally consider suspending dealings in, or removing from the list, a security if the aggregate market value or the principal amount of bonds publicly held is less than $400,000.</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>8</SU> A GSE Security is a security that is issued by a government-sponsored entity such as Federal National Mortgage Association (Fannie Mae), Federal Home Loan Mortgage Corporation (Freddie Mac), Student Loan Marketing Association (Sallie Mae), the Federal Home Loan Banks and the Federal Farm Credit Banks. All GSE debt is sponsored but not guaranteed by the federal government, whereas government agencies such as Government National Mortgage Association (Ginnie Mae) are divisions of the U.S. government whose securities are backed by the full faith and credit of the U.S.</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>9</SU> Telephone Conversation between Jeffrey P. Burns, Assistant General Counsel, Amex, and Hong-Anh Tran, Special Counsel, Division, Commission, on August 8, 2003.</P>
        </FTNT>
        <P>The basket of Underlying Securities will not be managed and will generally remain static over the term of the ABS Securities. Each of the Underlying Securities provide for the payment of interest on a semi-annual basis, but the ABS Securities will provide for monthly or quarterly distributions of interest. Neither the Treasury Securities or GSE Securities will make periodic payments of interest.<SU>10</SU>
          <FTREF/> The Exchange represents that, to alleviate this cash flow timing issue, the Trust will enter into an interest distribution agreement (the “Interest Distribution Agreement”) as described in the prospectus supplement related to the ABS Securities (the “Prospectus Supplement”).<SU>11</SU>

          <FTREF/> Principal distributions on the ABS Securities are expected to be made on dates that correspond to the maturity dates of the Underlying Securities (<E T="03">i.e.</E>, the Underlying Corporate Bonds and Treasury Securities or GSE Securities). However, some of the Underlying <PRTPAGE P="48972"/>Securities may have redemption provisions and in the event of an early redemption or other liquidation (<E T="03">e.g.</E>, upon an event of default) of the Underlying Securities, the proceeds from such redemption (including any make-whole premium associated with such redemption) or liquidation will be distributed pro rata to the holders of the ABS Securities. Each Underlying Corporate Bond will be issued by a corporate issuer and purchased in the secondary market. In the case of Treasury Securities, the Trust will either purchase the securities directly from primary dealers or in the secondary market which consists of primary dealers, non-primary dealers, customers, financial institutions, non-financial institutions and individuals. Similarly, in the case of GSE Securities, the trust will either purchase the securities directly from the issuer or in the secondary market. </P>
        <FTNT>
          <P>
            <SU>10</SU> A stripped fixed income security, such as a Treasury Security or GSE Security, is a security that is separated into its periodic interest payments and principal repayment. The separate strips are then sold individually as zero coupon securities providing investors with a wide choice of alternative maturities.</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>11</SU> Pursuant to the Interest Distribution Agreement, shortfalls in the amounts available to pay monthly or quarterly interest to holders of the ABS Securities due to the Underlying Securities paying interest semi-annually will be made to the Trust by JP Morgan Chase Bank or one of its affiliates and will be repaid out of future cash flow received by the Trust from the Underlying Securities.</P>
        </FTNT>
        <P>Holders of the ABS Securities generally will receive interest on the face value in an amount to be determined at the time of issuance of the ABS Securities and disclosed to investors. The rate of interest payments will be based upon prevailing interest rates at the time of issuance and interest payments will be made to the extent that coupon payments are received from the Underlying Securities. Distributions of interest will be made monthly or quarterly. Investors will also be entitled to be repaid the principal of their ABS Securities from the proceeds of the principal payments on the Underlying Securities.<SU>12</SU>
          <FTREF/> The payout or return to investors on the ABS Securities will not be leveraged. </P>
        <FTNT>
          <P>

            <SU>12</SU> The Underlying Securities may drop out of the basket upon maturity or upon payment default or acceleration of the maturity date for any default other than payment default. <E T="03">See</E> Prospectus for a schedule of the distribution of interest and of the principal upon maturity of each Underlying Security and for a description of payment default and acceleration of the maturity date.</P>
        </FTNT>
        <P>The ABS Securities will mature on the latest maturity date of the Underlying Securities. Holders of the ABS Securities will have no direct ability to exercise any of the rights of a holder of an Underlying Corporate Bond; however, holders of the ABS Securities as a group will have the right to direct the Trust in its exercise of its rights as holder of the Underlying Securities. </P>
        <P>The proposed ABS Securities are virtually identical to Select Notes Trust 2003-02 and 2003-03 currently listed and traded on the Exchange,<SU>13</SU>
          <FTREF/> with the only difference being the actual Underlying Securities in the basket of investment-grade fixed-income securities. Accordingly, the Exchange proposes to provide for the listing and trading of the ABS Securities where the Underlying Securities meet the Exchange's Bond and Debenture Listing Standards set forth in Section 104 of the Company Guide. The Exchange represents that all of the Underlying Securities in the proposed basket will meet or exceed these listing standards. </P>
        <FTNT>
          <P>
            <SU>13</SU> <E T="03">See</E> Securities Exchange Act Release Nos. 47730 (April 24, 2003), 68 FR 23340 (May 1, 2003) (Amex File No. 2003-25) and 47884 (May 16, 2003), 68 FR 28305 (May 23, 2003) (Amex File No. 2003-37). <E T="03">See also</E> Securities Exchange Act Release Nos. 46835 (November 14, 2002), 67 FR 70271 (November 21, 2002) (Amex File No. 2002-70) and 46923 (November 27, 2002), 67 FR 72247 (December 4, 2002) (Amex File No. 2002-92).</P>
        </FTNT>
        <P>The Exchange's Bond and Debenture Listing Standards in Section 104 of the Company Guide provide for the listing of individual bond or debenture issuances provided the issue has an aggregate market value or principal amount of at least $5 million and any of: (1) The issuer of the debt security has equity securities listed on the Exchange (or on the New York Stock Exchange (“NYSE”) or on the Nasdaq National Market (“Nasdaq”)); (2) an issuer of equity securities listed on the Exchange (or on the NYSE or on Nasdaq) directly or indirectly owns a majority interest in, or is under common control with, the issuer of the debt security; (3) an issuer of equity securities listed on the Exchange (or on the NYSE or on Nasdaq) has guaranteed the debt security; (4) a NRSRO has assigned a current rating to the debt security that is no lower than an S&amp;P Corporation (“S&amp;P”) “B” rating or equivalent rating by another NRSRO; or (5) or if no NRSRO has assigned a rating to the issue, an NRSRO has currently assigned (i) an investment grade rating to an immediately senior issue or (ii) a rating that is no lower than a S&amp;P “B” rating or an equivalent rating by another NRSRO to a pari passu or junior issue. </P>
        <P>In addition to the Exchange's Bond and Debenture Listing Standards, an Underlying Security must also be of investment grade quality as rated by a NRSRO and at least 75% of the underlying basket is required to contain Underlying Securities from issuances of $100 million or more. The maturity of each Underlying Security is expected to match the payment of principal of the ABS Securities with the maturity date of the ABS Securities being the latest maturity date of the Underlying Securities. Amortization of the ABS Securities will be based on: (1) The respective maturities of the Underlying Securities, including Treasury Securities or GSE Securities; (2) principal payout amounts reflecting the pro-rata principal amount of maturing Underlying Securities; and (3) any early redemption or liquidation of the Underlying Securities, including Treasury Securities or GSE Securities. </P>

        <P>Investors will be able to obtain the prices for the Underlying Securities through Bloomberg L.P. or other market vendors, including the broker-dealer through whom the investor purchased the ABS Securities. In addition, The Bond Market Association provides links to price and other bond information sources on its investor web site at <E T="03">www.investinginbonds.com.</E> Transaction prices and volume data for the most actively-traded bonds on the exchanges are also published daily in newspapers and on a variety of financial websites. The National Association of Securities Dealers, Inc. (“NASD”) Trade Reporting and Compliance Engine (“TRACE”) will also help investors obtain transaction information for most corporate debt securities, such as investment grade corporate bonds.<SU>14</SU>
          <FTREF/> For a fee, investors can have access to intra-day bellwether quotes.<SU>15</SU>
          <FTREF/>
        </P>
        <FTNT>
          <P>
            <SU>14</SU> <E T="03">See</E> Securities Exchange Act Release No. 43873 (January 23, 2001), 66 FR 8131 (January 29, 2001) (File No. SR-NASD-99-65). Investors are able to access TRACE information at <E T="03">http://www.nasdbondinfo.com/.</E>
          </P>
        </FTNT>
        <FTNT>
          <P>

            <SU>15</SU> Corporate prices are available at 20-minute intervals from Capital Management Services at <E T="03">http://www.bondvu.com/.</E>
          </P>
        </FTNT>

        <P>Price and transaction information for Treasury Securities and GSE Securities may also be obtained at <E T="03">http://publicdebt.treas.gov</E> and <E T="03">http://www.govpx.com,</E> respectively. Price quotes are also available to investors via proprietary systems such as Bloomberg, Reuters and Dow Jones Telerate. Valuation prices <SU>16</SU>
          <FTREF/> and analytical data may be obtained through vendors such as Bridge Information Systems, Muller Data, Capital Management Sciences, Interactive Data Corporation and Barra.</P>
        <FTNT>
          <P>
            <SU>16</SU> “Valuation Prices” refer to an estimated price that has been determined based on an analytical evaluation of a bond in relation to similar bonds that have traded. Valuation prices are based on bond characteristics, market performance, changes in the level of interest rates, market expectations and other factors that influence a bond's value.</P>
        </FTNT>
        <P>The prices of Underlying Securities generally will be determined by one or more market makers in accordance with applicable law and self-regulatory organization rules. </P>

        <P>The ABS Securities will be listed in $1,000 denominations with the Exchange's existing debt floor trading rules applying to trading. First, pursuant to Amex Rule 411, the Exchange will impose a duty of due diligence on its members and member firms to learn the essential facts relating to every customer <PRTPAGE P="48973"/>prior to trading the ABS Securities.<SU>17</SU>
          <FTREF/> Second, the ABS Securities will be subject to the debt margin rules of the Exchange.<SU>18</SU>
          <FTREF/> Third, the Exchange will, prior to trading the ABS Securities, distribute a circular to the membership providing guidance with regard to member firm compliance responsibilities (including suitability recommendations) when handling transactions in the ABS Securities and highlighting the special risks and characteristics of the ABS Securities. With respect to suitability recommendations and risks, the Exchange will require members, member organizations and employees thereof recommending a transaction in the ABS Securities: (1) To determine that such transaction is suitable for the customer, and (2) to have a reasonable basis for believing that the customer can evaluate the special characteristics of, and is able to bear the financial risks of such transaction. </P>
        <FTNT>
          <P>
            <SU>17</SU> Amex Rule 411 requires that every member, member firm or member corporation use due diligence to learn the essential facts, relative to every customer and to every order or account accepted.</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>18</SU> <E T="03">See</E> Amex Rule 462.</P>
        </FTNT>
        <P>The Exchange represents that its surveillance procedures are adequate to properly monitor the trading of the ABS Securities. Specifically, the Amex will rely on its existing surveillance procedures governing debt, which have been deemed adequate under the Act. In addition, the Exchange also has a general policy which prohibits the distribution of material, non-public information by its employees. </P>
        <HD SOURCE="HD3">2. Statutory Basis </HD>
        <P>The Exchange believes that the proposed rule change is consistent with Section 6 of the Act <SU>19</SU>
          <FTREF/> in general and furthers the objectives of Section 6(b)(5) <SU>20</SU>
          <FTREF/> in particular in that it is designed to prevent fraudulent and manipulative acts and practices, promote just and equitable principles of trade, remove impediments to and perfect the mechanisms of a free and open market and a national market system, and, in general, protect investors and the public interest.</P>
        <FTNT>
          <P>
            <SU>19</SU> 15 U.S.C. 78f(b).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>20</SU> 15 U.S.C. 78f(b)(5).</P>
        </FTNT>
        <HD SOURCE="HD2">B. Self-Regulatory Organization's Statement on Burden on Competition </HD>
        <P>The Exchange does not believe that the proposed rule change will impose any burden on competition. </P>
        <HD SOURCE="HD2">C. Self-Regulatory Organization's Statement on Comments on the Proposed Rule Change Received From Members, Participants or Others</HD>
        <P>The Exchange did not receive any written comments on the proposed rule change.</P>
        <HD SOURCE="HD1">III. Solicitation of Comments</HD>
        <P>Interested persons are invited to submit written data, views and arguments concerning the foregoing, including whether the proposed rule change is consistent with the Act. Persons making written submissions should file six copies thereof with the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW., Washington, DC 20549-0609. Copies of the submission, all subsequent amendments, all written statements with respect to the proposed rule change that are filed with the Commission, and all written communications relating to the proposed rule change between the Commission and any person, other than those that may be withheld from the public in accordance with the provisions of 5 U.S.C. 552, will be available for inspection and copying in the Commission's Public Reference Room. Copies of such filing will also be available for inspection and copying at the principal office of the Amex. All submissions should refer to the File No. SR-Amex-2003-69 and should be submitted by September 5, 2003.</P>
        <HD SOURCE="HD1">IV. Commission's Findings and Order Granting Accelerated Approval of Proposed Rule Change</HD>
        <P>After careful consideration, the Commission finds that the proposed rule change is consistent with the requirements of the Act and the rules and regulations thereunder applicable to a national securities exchange, and, in particular, with the requirements of Section 6(b)(5) of the Act.<SU>21</SU>
          <FTREF/> The Commission finds that this proposal is similar to two separate trust certificates linked to a portfolio of investment grade debt currently trading on the Exchange.<SU>22</SU>
          <FTREF/> Accordingly, the Commission finds that the listing and trading of the ABS Securities is consistent with the Act and will promote just and equitable principles of trade, foster cooperation and coordination with persons engaged in regulating, clearing, settling, processing information with respect to, and facilitating transactions in securities, and, in general, protect investors and the public interest consistent with Section 6(b)(5) of the Act.<SU>23</SU>
          <FTREF/>
        </P>
        <FTNT>
          <P>
            <SU>21</SU> <E T="03">Id.</E>
          </P>
        </FTNT>
        <FTNT>
          <P>
            <SU>22</SU> <E T="03">See supra</E> n. 13.</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>23</SU> 15 U.S.C. 78f(b)(5). In approving this rule, the Commission notes that it has considered the proposed rule's impact on efficiency, competition, and capital formation. 15 U.S.C. 78c(f).</P>
        </FTNT>
        <P>As described more fully above, the ABS Securities are asset-backed securities and represent a repackaging of the Underlying Corporate Bonds together with the addition of either Treasury Securities or GSE Securities, subject to certain distribution of interest obligations of the Trust. The ABS Securities are not leveraged instruments. The ABS Securities are debt instruments whose price will still be derived and based upon the value of the Underlying Securities. The Exchange represents that the value of the Underlying Securities will be determined by one or more market makers, in accordance with Exchange rules. Investors are guaranteed at least the principal amount that they paid for the Underlying Securities. In addition, each of the Underlying Corporate Bonds will pay interest on a semi-annual basis while the ABS Securities themselves will pay interest on a monthly or quarterly basis, pursuant to the Interest Distribution Agreement. Neither the Treasury Securities or GSE Securities will make periodic payments of interest.<SU>24</SU>
          <FTREF/> To alleviate this cash flow timing issue, shortfalls in the amounts available to pay monthly or quarterly interest to holders of the ABS Securities due to the Underlying Securities paying interest semi-annually will be made to the Trust by JP Morgan Chase Bank or one of its affiliates and will be repaid out of future cash flow received by the Trust from the Underlying Securities, pursuant to the Interest Distribution Agreement. In addition, the ABS Securities will mature on the latest maturity date of the Underlying Securities.<SU>25</SU>
          <FTREF/> However, due to the pass-through nature of the ABS Securities, the level of risk involved in the purchase or sale of the ABS Securities is similar to the risk involved in the purchase or sale of traditional common stock.</P>
        <FTNT>
          <P>
            <SU>24</SU> <E T="03">See supra</E> n. 10.</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>25</SU> <E T="03">See supra</E> n. 12.</P>
        </FTNT>

        <P>The Commission notes that the Exchange's rules and procedures that address the special concerns attendant to the trading of hybrid securities will be applicable to the ABS Securities. In particular, by imposing the hybrid listing standards, suitability, disclosure, and compliance requirements noted above, the Commission believes the Exchange has addressed adequately the potential problems that could arise from the hybrid nature of the ABS Securities. <PRTPAGE P="48974"/>Moreover, the Commission notes that the Exchange will distribute a circular to its membership calling attention to the specific risks associated with the ABS Securities.</P>
        <P>The Commission notes that the ABS Securities are dependent upon the individual credit of the issuers of the Underlying Securities. To some extent this credit risk is minimized by the Exchange's listing standards in Section 107A of the Company Guide which provide that only issuers satisfying asset and equity requirements may issue securities such as the ABS Securities. In addition, the Exchange's “Other Securities” listing standards further provide that there is no minimum holder requirement if the securities are traded in thousand dollar denominations.<SU>26</SU>
          <FTREF/> The Commission notes that the Exchange has represented that the ABS Securities will be listed in $1000 denominations with its existing debt floor trading rules applying to the trading. In any event, financial information regarding the issuers of the Underlying Securities will be publicly available.<SU>27</SU>
          <FTREF/>
        </P>
        <FTNT>
          <P>
            <SU>26</SU> <E T="03">See</E> Company Guide Section 107A.</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>27</SU> The ABS Securities will be registered under Section 12 of the Act.</P>
        </FTNT>
        <P>Due to the pass-through and passive nature of the ABS Securities, the Commission does not object to the Exchange's reliance on the assets and stockholder equity of the Underlying Securities rather than the Trust to meet the requirement in Section 107A of the Company Guide. The Commission notes that the distribution and principal amount/aggregate market value requirements found in Sections 107A(b) and (c), respectively, will otherwise be met by the Trust as issuer of the ABS Securities. Thus, the ABS Securities will conform to the initial listing guidelines under Section 107A and continued listing guidelines under Sections 1001-1003 of the Company Guide. At the time of issuance, the Commission also notes that the ABS Securities will receive an investment grade rating from an NRSRO.</P>
        <P>The Commission also believes that the listing and trading of the ABS Securities should not unduly impact the market for the Underlying Securities or raise manipulative concerns. As discussed more fully above, the Exchange represents that, in addition to requiring the issuers of the Underlying Securities meet the Exchange's Section 107A listing requirements (in the case of Treasury securities, the Exchange will rely on the fact that the issuer is the U.S. Government rather than the asset and stockholder tests found in Section 107A), the Underlying Securities will be required to meet or exceed the Exchange's Bond and Debenture Listing Standards pursuant to Section 104 of the Amex's Company Guide, which among other things, requires that underlying debt instrument receive at least an investment grade rating of “B” or equivalent from an NRSRO. Furthermore, at least 75% of the basket is required to contain Underlying Securities from issuances of $100 million or more. The Amex also represents that the basket of Underlying Securities will not be managed and will remain static over the term of the ABS Securities. In addition, the Amex's debt surveillance procedures will serve to deter as well as detect any potential manipulation.</P>

        <P>The Commission notes that the investors may obtain price information on the Underlying Securities through market venders such Bloomberg, L.P., or though Web sites such as <E T="03">www.investinbonds.com</E> (for Underlying Corporate Bonds) and <E T="03">http://publicdebt.treas.gov</E> and <E T="03">http://www.govpx.com</E> (for Treasury Securities and GSE Securities, respectively).</P>

        <P>The Commission finds good cause for approving the proposed rule change prior to the thirtieth day after the date of publication of notice thereof in the <E T="04">Federal Register</E>. The Amex has requested accelerated approval because this product is similar to several other equity-linked instruments currently listed and traded on the Amex.<SU>28</SU>
          <FTREF/> The Commission believes that the ABS Securities will provide investors with an additional investment choice and that accelerated approval of the proposal will allow investors to begin trading the ABS Securities promptly. Additionally, the ABS Securities will be listed pursuant to Amex's existing hybrid security listing standards as described above. Based on the above, the Commission believes that there is good cause, consistent with Sections 6(b)(5) and 19(b)(2) of the Act <SU>29</SU>
          <FTREF/> to approve the proposal, as amended, on an accelerated basis.</P>
        <FTNT>
          <P>
            <SU>28</SU> <E T="03">See supra</E> note 13.</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>29</SU> 15 U.S.C. 78f(b)(5) and 78s(b)(2).</P>
        </FTNT>
        <HD SOURCE="HD1">V. Conclusion</HD>
        <P>
          <E T="03">It is therefore ordered,</E> pursuant to Section 19(b)(2) of the Act,<SU>30</SU>
          <FTREF/> that the proposed rule change (SR-Amex-2003-69) is hereby approved on an accelerated basis.</P>
        <FTNT>
          <P>
            <SU>30</SU> 15 U.S.C. 78<E T="03">o</E>-3(b)(6) and 78s(b)(2).</P>
        </FTNT>
        <SIG>
          <P>For the Commission by the Division of Market Regulation, pursuant to delegated authority.<SU>31</SU>
            <FTREF/>
          </P>
          <FTNT>
            <P>
              <SU>31</SU> 17 CFR 200.30-3(a)(12).</P>
          </FTNT>
          <NAME>Margaret H. McFarland,</NAME>
          <TITLE>Deputy Secretary.</TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20906 Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 8010-01-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">SECURITIES AND EXCHANGE COMMISSION </AGENCY>
        <DEPDOC>[Release No. 34-48306; File No. SR-CBOE-2003-24] </DEPDOC>
        <SUBJECT>Self-Regulatory Organizations; Order Approving a Proposed Rule Change and Amendment No. 1 Thereto by the Chicago Board Options Exchange, Incorporated To Interpret Rules Relating to Margin Requirements for Certain Complex Options Spreads on a Pilot Basis </SUBJECT>
        <DATE>August 8, 2003. </DATE>
        <HD SOURCE="HD1">I. Introduction </HD>
        <P>On June 8, 2003, the Chicago Board Options Exchange, Inc. (“CBOE” or “Exchange”) filed with the Securities and Exchange Commission (“Commission”), pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (“Act”)<SU>1</SU>
          <FTREF/> and Rule 19b-4 thereunder,<SU>2</SU>

          <FTREF/> a proposed rule change to issue a Regulatory Circular to its membership setting forth a clarifying interpretation to CBOE Rule 12.3, Margin Requirements, relating to margin requirements for certain complex option spreads. On June 26, 2003, the Exchange filed Amendment No. 1 to the proposed rule change. The proposed rule change, as amended, was published for public comment in the <E T="04">Federal Register</E> on July 9, 2003.<SU>3</SU>
          <FTREF/> The Commission received one comment letter on the proposal.<SU>4</SU>
          <FTREF/> This order approves the proposed rule change. </P>
        <FTNT>
          <P>
            <SU>1</SU> 15 U.S.C. 78s(b)(1).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>2</SU> 17 CFR 240.19b-4.</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>3</SU> <E T="03">See</E> Securities Exchange Act Release No. 48115 (July 1, 2003), 68 FR 41027.</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>4</SU> <E T="03">See</E> letter from Patrick K. Blackburn, ABN-AMRO Incorporated, to Secretary, Commission, dated July 25, 2003 (“ABN-AMRO Letter”).</P>
        </FTNT>
        <HD SOURCE="HD1">II. Description of the Proposal </HD>

        <P>The Exchange proposes to adopt an interpretation to CBOE Rule 12.3—Margin Requirements—to clarify that margin requirements for certain complex option spreads are provided for under CBOE Rule 12.3. The Exchange proposes to implement this interpretation through a Regulatory Circular that will set forth the margin requirements for such complex spreads. The Exchange believes that the complex <PRTPAGE P="48975"/>spreads in question are simply another way of expressing a collection of two or more basic option spreads (<E T="03">i.e.</E>, the butterfly spread, the box spread, and the time spread) already covered under the margin rules. The proposed Regulatory Circular is intended to be a temporary measure and will operate as a pilot for one year from the date of approval of the Regulatory Circular by the Commission. </P>
        <P>The Regulatory Circular provides that CBOE members may collect a specific amount of margin for each of the seven identified complex spreads. Specifically, the Regulatory Circular will allow CBOE member organizations to require margin for the identified complex spreads, whether they are established outright or through netting, of not less than the sum of the margin required on each basic spread in its corresponding package. </P>
        <HD SOURCE="HD1">III. Summary of Comments </HD>
        <P>As noted above, the Commission received one comment in response to the proposed rule change, which supported the proposal. The commenter believed that the issuance of the Regulatory Circular will resolve ambiguity concerning the appropriate margin treatment for these complex spreads, which will benefit all market participants for whom options are an important part of their investment programs. </P>
        <HD SOURCE="HD1">IV. Discussion </HD>
        <P>After careful review, the Commission finds that the proposed rule change, as amended, is consistent with the requirements of Section 6 of the Act <SU>5</SU>
          <FTREF/> and the rules and regulations thereunder applicable to a national securities exchange.<SU>6</SU>
          <FTREF/> In particular, the Commission finds that the proposed Regulatory Circular is consistent with Section 6(b)(5) of the Act,<SU>7</SU>
          <FTREF/> which requires, among other things, that the Exchange's rules be designed to perfect the mechanisms of a free and open market and, in general, to protect investors and the public interest. The Commission believes that the Regulatory Circular should clarify the margin requirements for the identified complex spreads. </P>
        <FTNT>
          <P>
            <SU>5</SU> 15 U.S.C. 78f(b).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>6</SU> In approving the proposed rule change, the Commission has considered its impact on efficiency, competition, and capital formation. 15 U.S.C. 78c(f).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>7</SU> 15 U.S.C. 78f(b)(5).</P>
        </FTNT>
        <P>The Commission notes that this approval will operate as a one-year pilot from the date of approval of the proposed rule change. The Commission expects that during the pilot period, the CBOE will work to submit a proposed rule change to permanently implement the margin requirements for the subject complex spreads. </P>
        <HD SOURCE="HD1">V. Conclusion </HD>
        <P>
          <E T="03">It is therefore ordered</E>, pursuant to Section 19(b)(2) of the Act,<SU>8</SU>
          <FTREF/> that the proposed rule change, as amended (SR-CBOE-2003-24), is approved until August 7, 2004. </P>
        <FTNT>
          <P>
            <SU>8</SU> 15 U.S.C. 78s(b)(2).</P>
        </FTNT>
        <SIG>
          <P>For the Commission, by the Division of Market Regulation, pursuant to delegated authority.<SU>9</SU>
            <FTREF/>
          </P>
          <FTNT>
            <P>
              <SU>9</SU> 17 CFR 200.30-3(a)(12).</P>
          </FTNT>
          <NAME>Margaret H. McFarland, </NAME>
          <TITLE>Deputy Secretary. </TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20908 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 8010-01-U</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">SECURITIES AND EXCHANGE COMMISSION </AGENCY>
        <DEPDOC>[Release No. 34-48316; File No. SR-NASD-2003-116] </DEPDOC>
        <SUBJECT>Self-Regulatory Organizations; Notice of Filing and Immediate Effectiveness of Proposed Rule Change by the National Association of Securities Dealers, Inc. To Modify the Fees Paid by NNMS Order Entry Firms for Certain Order Executions Through Nasdaq's SuperMontage System </SUBJECT>
        <DATE>August 11, 2003. </DATE>
        <P>Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (“Act”),<SU>1</SU>
          <FTREF/> and Rule 19b-4<SU>2</SU>
          <FTREF/> thereunder, notice is hereby given that on July 31, 2003, the National Association of Securities Dealers, Inc. (“NASD”), through its subsidiary, The Nasdaq Stock Market, Inc. (“Nasdaq”), submitted to the Securities and Exchange Commission (“Commission”) the proposed rule change as described in Items I, II, and III below, which Items have been prepared by Nasdaq. Nasdaq has designated this proposal as one establishing or changing a due, fee or other charge under Section 19(b)(3)(A)(ii) of the Act <SU>3</SU>
          <FTREF/> and Rule 19b-4(f)(2) thereunder.<SU>4</SU>
          <FTREF/> The Commission is publishing this notice to solicit comments on the proposed rule change from interested persons. </P>
        <FTNT>
          <P>
            <SU>1</SU> 15 U.S.C. 78s(b)(1).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>2</SU> 17 CFR 240.19b-4.</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>3</SU> 15 U.S.C. 78s(b)(3)(A)(ii).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>4</SU> 17 CFR 240.19b-4(f)(2).</P>
        </FTNT>
        <HD SOURCE="HD1">I. Self-Regulatory Organization's Statement of the Terms of Substance of the Proposed Rule Change </HD>
        <P>Nasdaq proposes to modify the fees paid by NNMS Order Entry Firms (“OE Firms”) for certain order executions through Nasdaq's SuperMontage system. Nasdaq implemented the rule change on August 1, 2003. </P>
        <P>Below is the text of the proposed rule change. Proposed new language is italicized; proposed deleted language is bracketed. </P>
        <STARS/>
        <HD SOURCE="HD1">7000. CHARGES FOR SERVICES AND EQUIPMENT </HD>
        <HD SOURCE="HD3">7010. System Services </HD>
        <P>(a)-(h) No change. </P>
        <P>(i) Nasdaq National Market Execution System (SuperMontage). </P>
        <P>The following charges shall apply to the use of the Nasdaq National Market Execution System (commonly known as SuperMontage) by members: </P>
        <GPOTABLE CDEF="s100,r100" COLS="2" OPTS="L0,tp0,p0,8/9,g1,t1,i1">
          <TTITLE>  </TTITLE>
          <BOXHD>
            <CHED H="1">  </CHED>
            <CHED H="1">  </CHED>
          </BOXHD>
          <ROW>
            <ENT I="22">
              <E T="04">Order Entry</E>
            </ENT>
          </ROW>
          <ROW>
            <ENT I="01">Non-Directed Orders (excluding Preferenced Orders) </ENT>
            <ENT>No charge </ENT>
          </ROW>
          <ROW>
            <ENT I="22">Preferenced Orders: </ENT>
          </ROW>
          <ROW>
            <ENT I="01">Preferenced Orders that access a Quote/Order of the member that entered the Preferenced Order)</ENT>
            <ENT>No charge </ENT>
          </ROW>
          <ROW>
            <ENT I="01">Other Preferenced Orders </ENT>
            <ENT>$0.02 per order entry </ENT>
          </ROW>
          <ROW>
            <ENT I="01">Directed Orders </ENT>
            <ENT>$0.10 per order entry </ENT>
          </ROW>
          <ROW>
            <ENT I="22">
              <E T="04">Order Execution</E>
            </ENT>
          </ROW>
          <ROW>
            <ENT I="22">Non-Directed or Preferenced Order that accesses the Quote/Order of a market participant that does not charge an access fee to market participants accessing its Quotes/Orders through the NNMS: </ENT>
          </ROW>
          <ROW>
            <ENT I="01">Charge to member entering order</ENT>
            <ENT>$0.003 per share executed (but no more than $120 per trade for trades in securities executed at $1.00 or less per share) </ENT>
          </ROW>
          <ROW>
            <PRTPAGE P="48976"/>
            <ENT I="01">Credit to member providing liquidity </ENT>
            <ENT>$0.002 per share executed (but no more than $80 per trade for trades in securities executed at $1.00 or less per share) </ENT>
          </ROW>
          <ROW>
            <ENT I="01">Non-Directed or Preferenced Order that accesses the Quote/Order of a market participant that charges an access fee to market participants accessing its Quotes/Orders through the NNMS</ENT>
            <ENT>$0.001 per share executed (but no more than $40 per trade for trades in securities executed at $1.00 or less per share) </ENT>
          </ROW>
          <ROW>
            <ENT I="01">Directed Order </ENT>
            <ENT>$0.003 per share executed </ENT>
          </ROW>
          <ROW>
            <ENT I="01">Non-Directed or Preferenced Order entered by a <E T="03">member</E> [Nasdaq Quoting Market Participant] that accesses its own Quote/Order </ENT>
            <ENT>No charge </ENT>
          </ROW>
          <ROW>
            <ENT I="01">[Non-Directed Order entered by an NNMS Order Entry Firm that accesses its own Quote/Order] </ENT>
            <ENT>[$0.001 per share executed (but no more than $40 per trade for trades in securities executed at $1.00 or less per share)] </ENT>
          </ROW>
          <ROW>
            <ENT I="22">
              <E T="04">Order Cancellation</E>
            </ENT>
          </ROW>
          <ROW>
            <ENT I="01">Non-Directed and Preferenced Orders </ENT>
            <ENT>No charge </ENT>
          </ROW>
          <ROW>
            <ENT I="01">Directed Orders </ENT>
            <ENT>$0.10 per order cancelled </ENT>
          </ROW>
        </GPOTABLE>
        <P>(j)-(s) No change. </P>
        <STARS/>
        <HD SOURCE="HD1">II. Self-Regulatory Organization's Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Change </HD>
        <P>In its filing with the Commission, Nasdaq included statements concerning the purpose of and basis for the proposed rule change and discussed any comments it received on the proposed rule change. The text of these statements may be examined at the places specified in Item IV below. Nasdaq has prepared summaries, set forth in Sections A, B, and C below, of the most significant aspects of such statements. </P>
        <HD SOURCE="HD2">A. Self-Regulatory Organization's Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Change </HD>
        <HD SOURCE="HD3">1. Purpose </HD>
        <P>On May 12, 2003, the Commission approved <SU>5</SU>
          <FTREF/> on a permanent basis a proposed rule change to allow OE Firms <SU>6</SU>
          <FTREF/> to enter non-marketable limit orders into SuperMontage using the SIZE Market Participant Identifier (“SIZE”).<SU>7</SU>
          <FTREF/> The program had originally been approved on a 90-day pilot basis, beginning on February 10, 2003.<SU>8</SU>
          <FTREF/>
        </P>
        <FTNT>
          <P>
            <SU>5</SU> <E T="03">See</E> Securities Exchange Act Release No. 47830 (May 12, 2003), 68 FR 27126 (May 19, 2003) (SR-NASD-2003-37) (“May Approval Order”).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>6</SU> As noted in the May Approval Order, Nasdaq interprets the term “NNMS Order Entry Firm” to encompass NNMS Market Makers to the extent that they do not make markets in particular stocks. In SuperMontage, such firms are treated the same as other OE Firms when placing orders into the system for stocks in which they do not make a market.</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>7</SU> SIZE is the anonymous market participant identifier (“MPID”) that represents the aggregate size of all Non-Attributable Quotes and Orders entered by market participants in Nasdaq at a particular price level. Non-Attributable Quotes and Orders are not displayed in the Nasdaq Quotation Montage using the market participant's MPID.</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>8</SU> <E T="03">See</E> Securities Exchange Act Release No. 47301 (January 31, 2003), 68 FR 6236 (February 6, 2003) (SR-NASD-2002-173).</P>
        </FTNT>
        <P>At the beginning of the 90-day pilot period, Nasdaq did not assess a charge (or provide a liquidity provider credit) when a market participant's non-directed or preferenced order executed against its own Quote/Order. Effective April 1, 2003, however, Nasdaq modified its SuperMontage fee schedule to provide that an OE Firm entering a non-directed order that accesses a limit order that the OE Firm itself posted in SIZE would pay $0.001 per share executed (but no more than $40 per trade for trades in securities executed at $1.00 or less per share).<SU>9</SU>
          <FTREF/> In situations where a Quoting Market Participant's order executes against its own Quote/Order, however, the order execution remained free. </P>
        <FTNT>
          <P>
            <SU>9</SU> <E T="03">See</E> Securities Exchange Act Release No. 47530 (March 19, 2003), 68 FR 14730 (March 26, 2003) (SR-NASD-2003-30).</P>
        </FTNT>
        <P>The discount for Quoting Market Participants is based, in part, on an expectation that, in its absence, many Quoting Market Participants would internalize a greater percentage of orders through their own proprietary crossing systems, rather than exposing them to the full market. Based on experience with the program for OE Firms' use of SIZE, however, Nasdaq has concluded that applying the discount to OE Firms' orders may also encourage OE Firms to expose a greater percentage of their orders through SuperMontage, in lieu of internalizing them or routing them to competing market centers. Accordingly, Nasdaq is eliminating the $0.001 fee applicable to order executions in which an OE Firm's non-directed order is matched with the same firm's order in SIZE. </P>
        <HD SOURCE="HD3">2. Statutory Basis </HD>
        <P>Nasdaq believes that the proposed rule change is consistent with the provisions of Section 15A of the Act <SU>10</SU>
          <FTREF/> in general, and with Section 15A(b)(5) of the Act <SU>11</SU>
          <FTREF/> in particular, in that it provides for the equitable allocation of reasonable dues, fees and other charges among members and issuers and other persons using any facility or system which the NASD operates or controls. Nasdaq states that the proposed rule change will result in an elimination of the fees payable by an OE Firm for non-directed orders that execute against orders entered by the OE Firm in SIZE. As a result, Nasdaq believes that the fees assessed on OE Firms and Quoting Market Participants for use of SuperMontage will now be identical in all respects. </P>
        <FTNT>
          <P>
            <SU>10</SU> 15 U.S.C. 78<E T="03">o</E>-3.</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>11</SU> 15 U.S.C. 78<E T="03">o</E>-3(b)(5).</P>
        </FTNT>
        <HD SOURCE="HD2">B. Self-Regulatory Organization's Statement on Burden on Competition </HD>
        <P>Nasdaq does not believe that the proposed rule change will result in any burden on competition that is not necessary and appropriate in furtherance of the purposes of the Act. </P>
        <HD SOURCE="HD2">C. Self-Regulatory Organization's Statement on Comments on the Proposed Rule Change Received From Members, Participants, or Others </HD>
        <P>Written comments were neither solicited nor received. </P>
        <HD SOURCE="HD1">III. Date of Effectiveness of the Proposed Rule Change and Timing for Commission Action </HD>
        <P>The foregoing rule change has become effective upon filing pursuant to Section 19(b)(3)(A)(ii) of the Act <SU>12</SU>
          <FTREF/> and subparagraph (f)(2) of Rule 19b-4 thereunder,<SU>13</SU>
          <FTREF/> because it establishes or changes a due, fee, or other charge imposed by the self-regulatory organization. At any time within 60 days of the filing of the proposed rule change, the Commission may summarily abrogate such rule change if it appears to the Commission that such action is necessary or appropriate in the public interest, for the protection of investors, or otherwise in furtherance of the purposes of the Act. </P>
        <FTNT>
          <P>
            <SU>12</SU> 15 U.S.C. 78s(b)(3)(a)(ii).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>13</SU> 17 CFR 240.19b-4(f)(2).</P>
        </FTNT>
        <HD SOURCE="HD1">IV. Solicitation of Comments </HD>

        <P>Interested persons are invited to submit written data, views and arguments concerning the foregoing, including whether the proposed rule change is consistent with the Act. Persons making written submissions should file six copies thereof with the Secretary, Securities and Exchange <PRTPAGE P="48977"/>Commission, 450 Fifth Street, NW., Washington, DC 20549-0609. Copies of the submission, all subsequent amendments, all written statements with respect to the proposed rule change that are filed with the Commission, and all written communications relating to the proposed rule change between the Commission and any person, other than those that may be withheld from the public in accordance with the provisions of 5 U.S.C. 552, will be available for inspection and copying in the Commission's Public Reference Room. Copies of such filing will also be available for inspection and copying at the principal office of Nasdaq. All submissions should refer to File No. SR-NASD-2003-116 and should be submitted by September 5, 2003. </P>
        <SIG>
          <P>For the Commission, by the Division of Market Regulation, pursuant to delegated authority.<SU>14</SU>
            <FTREF/>
          </P>
          <FTNT>
            <P>
              <SU>14</SU> 17 CFR 200.30-3(a)(12).</P>
          </FTNT>
          <NAME>Margaret H. McFarland,   </NAME>
          <TITLE>Deputy Secretary. </TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20907 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 8010-01-U</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">SECURITIES AND EXCHANGE COMMISSION </AGENCY>
        <DEPDOC>[Release No. 34-48307; File No. SR-NYSE-2002-63] </DEPDOC>
        <SUBJECT>Self-Regulatory Organizations; New York Stock Exchange, Inc.; Order Approving Proposed Rule Change and Notice of Filing and Order Granting Accelerated Approval to Amendment No. 1 Relating to Amendments to Rules 98, 104A.50, 105, and 900 To Permit Single Stock Futures Hedging by Specialists </SUBJECT>
        <DATE>August 8, 2003. </DATE>
        <HD SOURCE="HD1">I. Introduction </HD>
        <P>On November 21, 2002, the New York Stock Exchange (“NYSE” or “Exchange”) filed with the Securities and Exchange Commission (“Commission”), pursuant to section 19(b)(1) of the Securities Exchange Act of 1934 (“Act”) <SU>1</SU>
          <FTREF/> and Rule 19b-4 thereunder,<SU>2</SU>

          <FTREF/> a proposed rule change to amend certain Exchange rules to permit single stock futures hedging by specialists. On January 10, 2003, the rule proposal was published for comment in the <E T="04">Federal Register</E>.<SU>3</SU>
          <FTREF/> On July 23, 2003 the NYSE filed Amendment No. 1 to the proposed rule change.<SU>4</SU>
          <FTREF/> The Commission received no comments on the proposed rule change. This order approves the proposed rule change, as amended, grants accelerated approval of Amendment No. 1 and solicits comments from interested persons on Amendment No. 1. </P>
        <FTNT>
          <P>
            <SU>1</SU> 15 U.S.C. 78s(b)(1).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>2</SU> 17 CFR 240.19b-4.</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>3</SU> <E T="03">See</E> Securities Exchange Act Release No. 47160 (January 10, 2003), 68 FR 02064 (January 17, 2003).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>4</SU> In Amendment No. 1, the Exchange amended the definition of “security future” in Rule 105(b) to conform it to the definition of that term in section 3(a)(55) of the Act for uniformity. The Exchange also made certain technical changes to the proposed rule text and added an example that describes the way a combination of options and single stock futures contracts may be used to hedge a specialty stock position. In addition, the Exchange acknowledged that the prohibition in section 6(h)(1) of the Act on effecting transactions in security futures products that are not listed on a national securities exchange would apply to the transactions permitted under the proposed rule change. The Exchange stated further that it will remind its members of this prohibition when it announces the approval of the proposed rule change.</P>
        </FTNT>
        <HD SOURCE="HD1">II. Description of the Rule Change </HD>
        <P>Under the rule change, the Exchange will permit specialists to use security futures overlying single securities (hereinafter referred to as “single stock futures”) to hedge specialty stock positions. Rule 105 currently permits specialists to use options to hedge their specialty stock positions. Specifically, the Exchange is amending Rules 105, 98, 104A.50, and 900(d)(v). </P>
        <HD SOURCE="HD2">Amendments to Rule 105 </HD>
        <P>The Exchange is amending paragraph (d) of the Guidelines to Rule 105 (the “Guidelines”) to explain the conditions under which single stock futures may be used to hedge an existing specialty stock. Under the rule change, anticipatory hedging is not permitted. As is the case under Rule 105 with options, only existing specialty stock positions may be hedged. </P>
        <P>As amended, Rule 105 will provide three conditions (similar to those applicable to options) that single stock futures transactions must meet: </P>
        <P>(i) The transaction must result in a net futures position on the opposite side of the market from the underlying specialty stock position; </P>
        <P>(ii) The transaction must be effected solely to offset the risk of making a market in the underlying specialty stock; and </P>
        <P>(iii) The resulting net futures position must not exceed the number of shares of the specialty stock position that the specialist is offsetting. </P>
        <P>Any single stock futures transaction that does not meet all three of the above conditions would be deemed to be in violation of Rule 105. </P>
        <P>Under the rule change, a specialist would be able to use one single stock futures contract to hedge each 100 shares of the existing specialty stock position. A hedge that subsequently exceeds the specialty stock position being hedged as a result of 25% or more in the specialist's stock position or which becomes on the same side of the market as the specialty stock position must be liquidated, unless the equivalent share position is 5000 shares or less. </P>
        <P>Similarly, Rule 105 will be amended to specify that, as with options, specialists may also not front-run blocks and must record futures positions in a separate “memo” account. Additionally, specialists must report to the Exchange: (i) accounts in which single stock futures positions are held and (ii) their positions in single stock futures. </P>
        <P>Rule 105 permits an approved person of a specialist to act as a primary market maker or specialist with respect to an option on a specialty stock, provided all the requirements of the Rule 98 exemptive program are met. This provision will be amended to incorporate references to market makers in single stock futures so that an approved person of an equity specialist may act as a primary market maker or specialist with respect to a stock futures contract, provided all the requirements of the Rule 98 exemptive program are met. </P>
        <P>In addition, Rule 105 prohibits an approved person of an equity specialist from acting as a market maker in any equity security in which the associated specialist is registered as such and which underlies an option as to which the approved person acts as an options market maker. Under the rule change, the same prohibition will apply with respect to market makers in single stock futures contracts. </P>
        <P>The Exchange is adding a provision to Rule 105 to explain the combined use of both options and single stock futures to hedge specialty stock positions. Under the rule change, if a specialist chooses to hedge a specialty stock position with positions in both options and single stock futures, the resulting total market position, when established, may not exceed the size of the existing specialty stock position being hedged. Any excess or same side of the market equivalent position must be liquidated in accordance with the provisions of Rule 105. </P>
        <HD SOURCE="HD2">Other Proposed Amendments </HD>

        <P>In addition to the amendments to Rule 105, the Exchange is amending Rules 98, 104A.50, and 900(d)(v) to incorporate appropriate references to single stock futures. <PRTPAGE P="48978"/>
        </P>
        <HD SOURCE="HD1">III. Discussion and Commission Findings </HD>
        <P>After careful review, the Commission finds that the proposed rule change, as amended, is consistent with the requirements of the Act and the rules and regulations thereunder applicable to a national securities exchange.<SU>5</SU>
          <FTREF/> Specifically, the Commission believes the proposed rule change, as amended, is consistent with section 6(b)(5) of the Act,<SU>6</SU>
          <FTREF/> which requires, among other things, that the rules of the Exchange be designed to prevent fraudulent and manipulative acts and practices, to promote just and equitable principles of trade, to remove impediments to perfect the mechanism of a free and open market, and in general to protect investors and the public interest. </P>
        <FTNT>
          <P>
            <SU>5</SU> In approving the proposed rule change, the Commission has considered its impact on efficiency, competition and capital formation. 15 U.S.C. 78c(f).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>6</SU> 15 U.S.C. 78f(b)(5).</P>
        </FTNT>
        <P>The Commission believes that the rule change should provide specialists with greater flexibility in their ability to use hedging transactions to offset market-making risk. By permitting specialists to use single stock futures to hedge their specialty stock positions, the Commission believes that the rule change should enable specialists to add to overall stock market liquidity by taking specialty stock positions they might not otherwise assume or by reducing risks on positions they are required to assume.</P>
        <P>The Commission is accelerating approval of Amendment No. 1 to the proposed rule change. Amendment No. 1 made technical corrections and certain other minor changes to the proposed rule change. The Commission believes that the changes included in Amendment No. 1 should not affect the substance of the rule change. Accordingly, pursuant to Section 19(b)(2) of the Act,<SU>7</SU>

          <FTREF/> the Commission finds good cause to approve Amendment No. 1 prior to the thirtieth day after notice of the Amendment is published in the <E T="04">Federal Register</E>. </P>
        <FTNT>
          <P>
            <SU>7</SU> 15 U.S.C. 78s(b)(2).</P>
        </FTNT>
        <HD SOURCE="HD1">IV. Solicitation of Comments </HD>
        <P>Interested persons are invited to submit written data, views, and arguments concerning Amendment No. 1, including whether Amendment No. 1 is consistent with the Act. Persons making written submissions should file six copies thereof with the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW., Washington, DC 20549-0609. Copies of the submission, all subsequent amendments, all written statements with respect to the proposed rule change that are filed with the Commission, and all written communications relating to the proposed rule change between the Commission and any person, other than those that may be withheld from the public in accordance with the provisions of 5 U.S.C. 552, will be available for inspection and copying in the Commission's Public Reference Room. Copies of such filing also will be available for inspection and copying at the principal office of the NYSE. All submissions should refer to File No. SR-NYSE-2002-63 and should be submitted by September 5, 2003. </P>
        <HD SOURCE="HD1">V. Conclusion </HD>
        <P>
          <E T="03">It is therefore ordered,</E> pursuant to Section 19(b)(2) of the Act,<SU>8</SU>
          <FTREF/> that the proposed rule change (SR-NYSE-2002-63) is approved, and Amendment No. 1 is approved on an accelerated basis. <FTREF/>
        </P>
        <FTNT>
          <P>
            <SU>8</SU> Id.</P>
        </FTNT>
        <SIG>
          <FP>For the Commission, by the Division of Market Regulation, pursuant to delegated authority.<SU>9</SU>
          </FP>
          <FTNT>
            <P>
              <SU>9</SU> 17 CFR 200.30-3(a)(12).</P>
          </FTNT>
          <NAME>Margaret H. McFarland, </NAME>
          <TITLE>Deputy Secretary. </TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20820 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 8010-01-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">SECURITIES AND EXCHANGE COMMISSION </AGENCY>
        <DEPDOC>[Release No. 34-48310; File No. SR-Phlx-2002-85] </DEPDOC>
        <SUBJECT>Self-Regulatory Organizations; Notice of Filing of Proposed Rule Change, and Amendment No. 1 Thereto, by the Philadelphia Stock Exchange, Inc. Relating to the Definition of a Wheel Assignment Area </SUBJECT>
        <DATE>August 8, 2003. </DATE>
        <P>Pursuant to section 19(b)(1) of the Securities Exchange Act of 1934 (“Act”),<SU>1</SU>
          <FTREF/> and Rule 19b-4 thereunder,<SU>2</SU>
          <FTREF/> notice is hereby given that on December 20, 2002, the Philadelphia Stock Exchange, Inc. (“Phlx” or “Exchange”) filed with the Securities and Exchange Commission (“Commission”) the proposed rule change as described in Items I, II, and III below, which Items have been prepared by the Exchange. The Phlx submitted Amendment No. 1 to the proposed rule change on July 28, 2003.<SU>3</SU>
          <FTREF/> The Commission is publishing this notice to solicit comments on the proposed rule change, as amended, from interested persons. </P>
        <FTNT>
          <P>
            <SU>1</SU> 15 U.S.C. 78s(b)(1).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>2</SU> 17 CFR 240.19b-4.</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>3</SU> Letter from Richard S. Rudolph, Director and Counsel, Phlx, to Nancy Sanow, Assistant Director, Division of Market Regulation (“Division”), Commission, dated July 25, 2003 (“Amendment No. 1”). In Amendment No. 1, the Phlx amended the proposed rule change by clarifying the proposed definition of a “Wheel Assignment Area” set forth in paragraph (c)(iii) of OFPA F-24, AUTO-X Contra-Party Participation (The Wheel). The substance of Amendment No. 1 is incorporated into the description of the proposed rule change in Section II.A. below, and the proposed rule text set forth herein reflects the changes made in Amendment No. 1.</P>
        </FTNT>
        <HD SOURCE="HD1">I. Self-Regulatory Organization's Statement of the Terms of Substance of the Proposed Rule Change </HD>
        <P>The Phlx proposes to amend Option Floor Procedure Advice (“OFPA”) F-24, AUTO-X Contra-Party Participation (The Wheel), to redefine a “Wheel Assignment Area,” based on the current configuration of the Exchange Options Floor. The text of the proposed rule change is set forth below. Proposed new language is in italics. Proposed deletions are in brackets. </P>
        <STARS/>
        <HD SOURCE="HD3">F-24 AUTO-X Contra-Party Participation (The Wheel) </HD>
        <P>(a)-(b) No change. </P>
        <P>(c) Participation Requirements and Sign-on/off—Specialists on the Options Floor are required to participate on the Wheel in assigned issues in accordance with paragraph (e) of this Advice. </P>
        <P>(i) <E T="03">An</E> ROT[s] may elect to participate on the Wheel for any or all [issues] <E T="03">options</E> which <E T="03">such ROT</E> [they] maintain<E T="03">s</E> an ROT assignment, as long as <E T="03">such</E> [those listed] <E T="03">options</E> are located <E T="03">within the Wheel Assignment Area (as defined below) for the crowd in which such ROT participates</E>, [within two contiguous quarter turrets of each other] and the ROT is actively making markets in the specific [issues] <E T="03">options traded within such Wheel Assignment Area.</E>
        </P>
        <P>
          <E T="03">(ii)</E> No two associated or dually affiliated ROTs may be on the Wheel for the same option at the same time. Regardless of [an ROT's] <E T="03">the</E> total <E T="03">number of options</E> assigned <E T="03">to an ROT</E> [issues], an ROT may only sign-on the Wheel in one Wheel [a]<E T="03">A</E>ssignment [a]<E T="03">A</E>rea at any given time. </P>
        <P>
          <E T="03">(iii)</E> For [the] purposes of this Advice, a Wheel [a]<E T="03">A</E>ssignment [a]<E T="03">A</E>rea is [each area on the trading floor constituted by two contiguous quarter turrets] <E T="03">a location on the trading floor where an ROT: (1) Is actively making markets by quoting continuous, 2-sided markets in compliance with Advice B-1 and Rule 1014; (2) can hear and ascertain the markets that are being made by the specialist and crowd; (3) is deemed to be quoting the disseminated markets being made by the specialist in accordance <PRTPAGE P="48979"/>with Rule 1080.01(c); and (4) can be heard by the specialist and crowd.</E>[However, t]<E T="03">T</E>he Options Committee may extend <E T="03">the number of options to be included in</E> a Wheel [a]<E T="03">A</E>ssignment [a]<E T="03">A</E>rea on a case-by-case basis, taking into account the activity and trading crowd size in <E T="03">the</E> [those options] <E T="03">Wheel Assignment Area(s) to be extended</E> [as well as the intervening posts, if it is determined that the specialist and all Wheel participants on all Wheels agree that an ROT can be actively making markets in that particular situation and can thus be considered presenting such Wheel issues, until either specialist or any such Wheel participant no longer agree that the circumstances warrant an extension]. </P>
        <P>
          <E T="03">(iv)</E> In order to be placed on the Wheel for an entire trade day, the respective ROT must sign-on, in person on the trading floor for that listed option. Although ROTs may sign-on in individual listed options, a sign-off by an ROT is effective for all options for which the ROT is on the Wheel. Sign-offs shall become effective immediately upon being processed for deletion in the computer system. </P>
        <P>([iii]<E T="03">v</E>) If an ROT who is signed-on the Wheel is away from the Wheel [a]<E T="03">A</E>ssignment [a]<E T="03">A</E>rea for more than a brief interval, a Floor Official shall: </P>
        <P>(A) Remove the ROT from [any]<E T="03">all</E> Wheel participation for the remainder of the trading day; and </P>
        <P>(B) issue a fine pursuant to the fine schedule below. </P>
        <P>If [such] <E T="03">an</E> ROT is assigned a Wheel trade while away from the Wheel [a]<E T="03">A</E>ssignment [a]<E T="03">A</E>rea for more than a brief interval, that ROT is responsible for all [trades]<E T="03">contracts</E> assigned to his/her ROT account until the sign-off is processed. </P>
        
        <GPOTABLE CDEF="s25,r25" COLS="2" OPTS="L0,tp0,p0,8/9,g1,t1,i1">
          <TTITLE>  </TTITLE>
          <BOXHD>
            <CHED H="1">  </CHED>
            <CHED H="1">  </CHED>
          </BOXHD>
          <ROW EXPSTB="01">
            <ENT I="22">Fine Schedule (Implemented on a two-year running calendar basis) </ENT>
          </ROW>
          
          <ROW EXPSTB="00">
            <ENT I="22">F-24 (c) ([iii]<E T="03">v</E>): </ENT>
          </ROW>
          <ROW>
            <ENT I="02">1st Occurrence </ENT>
            <ENT>$250.00 </ENT>
          </ROW>
          <ROW>
            <ENT I="02">2nd Occurrence </ENT>
            <ENT>$500.00 </ENT>
          </ROW>
          <ROW>
            <ENT I="02">3rd Occurrence </ENT>
            <ENT>$1,000.00 </ENT>
          </ROW>
          <ROW>
            <ENT I="02">4th Occurrence and thereafter </ENT>
            <ENT>Sanction is discretionary with Business Conduct Committee </ENT>
          </ROW>
          <ROW EXPSTB="01">
            <ENT I="01" O="xl"> (d)-(f) No change. </ENT>
          </ROW>
          
          <ROW>
            <ENT I="22">Fine Schedule </ENT>
          </ROW>
          
          <ROW>
            <ENT I="22"> F-24 Fine not applicable, except paragraph (c)([iii]<E T="03">v</E>). Matters subject to review by the Business Conduct Committee. </ENT>
          </ROW>
        </GPOTABLE>
        <STARS/>
        <HD SOURCE="HD1">II. Self-Regulatory Organization's Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Change </HD>
        <P>In its filing with the Commission, the Exchange included statements concerning the purpose of and basis for the proposed rule change and discussed any comments it received on the proposed rule change. The text of these statements may be examined at the places specified in Item IV below. The Exchange has prepared summaries, set forth in Sections A, B, and C below, of the most significant aspects of such statements. </P>
        <HD SOURCE="HD2">A. Self-Regulatory Organization's Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Change </HD>
        <HD SOURCE="HD3">1. Purpose </HD>
        <P>The purpose of the proposed rule change is to update the definition of a “Wheel Assignment Area” to be consistent with the current physical configuration of the Options Floor. Due to changes in the physical layout of the Options Floor (as explained below), not only is the “two contiguous quarter turret” standard no longer useful, but the variations in layout and post location on the Options Floor are such that the Exchange believes a standard based on the activities of Registered Options Traders (“ROTs”), rather than a physical description of a “Wheel Assignment Area,” is now more appropriate. </P>
        <P>Currently, OFPA F-24 provides that ROTs may elect to participate on the Wheel <SU>4</SU>
          <FTREF/> for any or all issues in which they maintain an ROT assignment, as long as those listed options are located within two contiguous “quarter turrets” of each other and the ROT is actively making markets in the specific issues. </P>
        <FTNT>
          <P>

            <SU>4</SU> The “Wheel” is a feature of AUTOM that provides an automated mechanism for assigning specialists and ROTs signed on the Wheel for a given listed option, on a rotating basis, as contra-side participants to trades executed via AUTO-X. <E T="03">See</E> Exchange Rule 1080(g). AUTOM is the Exchange's electronic order delivery, routing, execution and reporting system, which provides for the automatic entry and routing of equity option and index option orders to the Exchange trading floor. Orders delivered through AUTOM may be executed manually, or certain orders are eligible for AUTOM's automatic execution feature, AUTO-X. Equity option and index option specialists are required by the Exchange to participate in AUTOM and its features and enhancements. Option orders entered by Exchange members into AUTOM are routed to the appropriate specialist unit on the Exchange trading floor.</P>
        </FTNT>
        <P>The Exchange's Options Floor has undergone many physical changes since the adoption of the current definition of “Wheel assignment area.”<SU>5</SU>
          <FTREF/> Specifically, the Options Floor no longer has any “quarter turrets.” The Options Floor trading posts are now linear, and in some instances extend continuously over the entire length of a given specialist post, encompassing a relatively large number of options in a relatively large physical area. </P>
        <FTNT>
          <P>

            <SU>5</SU> The Exchange previously defined a “Wheel assignment area” as two contiguous quarter turrets. <E T="03">See</E> Securities Exchange Act Release No. 35033 (November 30, 1994), 59 FR 63152 (December 7, 1994) (SR-Phlx-94-32). A quarter turret was one section of a four-sided, diamond-shaped trading post, which no longer exists on the Exchange's Options Floor.</P>
        </FTNT>
        <P>In order to conform the Exchange's rules with the current physical configuration of the Options Floor, the proposed rule change amends the text of OFPA F-24 to include references to the proposed defined term “Wheel Assignment Area” throughout. The proposal defines a “Wheel Assignment Area” as a location on the trading floor where an ROT: (1) Is actively making markets by quoting continuous, 2-sided markets in compliance with Advice B-1 and Rule 1014; (2) can hear and ascertain the markets that are being made by the specialist and crowd; (3) is deemed to be quoting the disseminated markets being made by the specialist in accordance with Rule 1080.01(c); and (4) can be heard by the specialist and crowd.<SU>6</SU>
          <FTREF/>
        </P>
        <FTNT>
          <P>
            <SU>6</SU> <E T="03">See</E> Amendment No. 1, <E T="03">supra</E> n. 3.</P>
        </FTNT>
        <P>As stated above, the proposed definition of “Wheel Assignment Area” is focused on the activities of individual ROTs, and not on the actual physical area in which ROTs are present. The requirements to actively make markets (making continuous two-sided markets in all issues assigned to such ROT), to hear and be heard, and to be deemed by the Exchange to be quoting the disseminated markets being made by the specialist in accordance with Rule 1080.01(c) <SU>7</SU>
          <FTREF/> are central to an ROT's participation in a particular crowd. </P>
        <FTNT>
          <P>
            <SU>7</SU> Phlx Rule 1080.01(c) provides, in relevant part: “[t]he disseminated market  * * * is deemed to represent the quotations of all ROTs in that option unless an ROT has expressly indicated otherwise in a clear and audible manner. * * * ”</P>
        </FTNT>
        <P>The proposal contemplates that issues may be raised on the Options Floor as to whether a particular ROT is eligible to participate in a Wheel Assignment Area based on the above four criteria. In order to account for this, and to address possible disputes, the proposal would continue to provide that the Options Committee <SU>8</SU>

          <FTREF/> may extend the number of options to be included in a Wheel Assignment Area on a case-by-case basis. Under the proposal, the Options Committee could now take into account the activity and trading crowd size in the Wheel Assignment Area(s) to be extended. In such a situation, the Options Committee would have the authority to determine if the Wheel Assignment Area should be extended to <PRTPAGE P="48980"/>include such an ROT. Because the Exchange believes it would be cumbersome and impractical for the Options Committee to meet and vote to approve the extension of a Wheel Assignment Area each time the issue arises on the Options Floor, the Options Committee has delegated its authority to approve such changes to two Exchange Floor Officials, who would indicate their approval by signing the appropriate form and submitting the form to Market Surveillance.<SU>9</SU>
          <FTREF/>
        </P>
        <FTNT>
          <P>

            <SU>8</SU> The Options Committee has general supervision of the dealings of members on the options floor. <E T="03">See</E> Exchange By-Law Article X, Section 10-19.</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>9</SU> Exchange By-Law Article X, Section 10-3(a) provides that each Standing Committee of the Exchange (the Options Committee is a Standing Committee) shall make such regulations for its government as it shall deem proper. By-Law Article X, Section 10-3(b) provides that each Standing Committee may appoint subcommittees as it may deem necessary for the efficient discharge of its duties. Each Options Committee member is a Floor Official, as is each member of the Options Subcommittee on Rules and Rulings. For purposes of efficiency, the Options Committee has delegated authority to these Floor Officials to discharge its on-floor duties of general supervision of the dealings of members on the options floor.</P>
        </FTNT>
        <P>The proposal also includes a provision that would enable a Floor Official to remove an ROT from all Wheel participation for the remainder of the trading day, and issue a fine pursuant to the fine schedule in OFPA F-24, if an ROT who is signed-on the Wheel is away from the Wheel Assignment Area for more than a brief interval. The Exchange believes that this provision substantially reduces the likelihood that an ROT would sign onto the Wheel and then leave the crowd, or even the trading floor, thereby receiving the benefit of participating as contra-side to automatically executed trades, and receiving favorable on-floor margin treatment despite the fact that such an ROT may not even be present in the crowd or on the floor. </P>
        <P>Other technical amendments, included to make the OFPA consistent throughout, are also proposed. </P>
        <HD SOURCE="HD3">2. Statutory Basis </HD>
        <P>For these reasons, the Exchange believes that the proposed rule change is consistent with Section 6(b) of the Act <SU>10</SU>
          <FTREF/> in general, and furthers the objectives of Section 6(b)(5) <SU>11</SU>
          <FTREF/> in particular, in that it is designed to promote just and equitable principles of trade, remove impediments to and perfect the mechanism of a free and open market and protect investors and the public interest by defining “Wheel Assignment Area” to be consistent with the current physical configuration of the Exchange's Options Floor. </P>
        <FTNT>
          <P>
            <SU>10</SU> 15 U.S.C. 78f(b).</P>
        </FTNT>
        <FTNT>
          <P>
            <SU>11</SU> 15 U.S.C. 78f(b)(5).</P>
        </FTNT>
        <HD SOURCE="HD2">B. Self-Regulatory Organization's Statement on Burden on Competition </HD>
        <P>The Exchange does not believe that the proposed rule change will impose any inappropriate burden on competition. </P>
        <HD SOURCE="HD2">C. Self-Regulatory Organization's Statement on Comments on the Proposed Rule Change Received From Members, Participants or Others </HD>
        <P>No written comments were either solicited or received. </P>
        <HD SOURCE="HD1">III. Date of Effectiveness of the Proposed Rule Change and Timing for Commission Action </HD>

        <P>Within 35 days of the date of publication of this notice in the <E T="04">Federal Register</E> or within such longer period (i) as the Commission may designate up to 90 days of such date if it finds such longer period to be appropriate and publishes its reasons for so finding or (ii) as to which the self-regulatory organization consents, the Commission will: </P>
        <P>A. By order approve the proposed rule change, or </P>
        <P>B. Institute proceedings to determine whether the proposed rule change should be disapproved. </P>
        <HD SOURCE="HD1">IV. Solicitation of Comments </HD>
        <P>Interested persons are invited to submit written data, views, and arguments concerning the foregoing, including whether the proposed rule change is consistent with the Act. Persons making written submissions should file six copies thereof with the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW., Washington, DC 20549-0609. Copies of the submission, all subsequent amendments, all written statements with respect to the proposed rule change that are filed with the Commission, and all written communications relating to the proposed rule change between the Commission and any person, other than those that may be withheld from the public in accordance with the provisions of 5 U.S.C. 552, will be available for inspection and copying at the Commission's Public Reference Room. Copies of such filing will also be available for inspection and copying at the principal office of the Exchange. All submissions should refer to File No. SR-Phlx-2002-85 and should be submitted by September 5, 2003. </P>
        <SIG>
          <P>For the Commission, by the Division of Market Regulation, pursuant to delegated authority.<SU>12</SU>
            <FTREF/>
          </P>
          <FTNT>
            <P>
              <SU>12</SU> 17 CFR 200.30-3(a)(12).</P>
          </FTNT>
          <NAME>Margaret H. McFarland, </NAME>
          <TITLE>Deputy Secretary. </TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20819 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 8010-01-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">SMALL BUSINESS ADMINISTRATION </AGENCY>
        <SUBJECT>Meridian Venture Partners II, L.P., License No. 03/73-0220; Notice Seeking Exemption Under Section 312 of the Small Business Investment Act, Conflicts of Interest </SUBJECT>
        <P>Notice is hereby given that Meridian Venture Partners II, L.P., 201 King of Prussia Road, Suite 240, Radnor PA, 19087, a Federal Licensee under the Small Business Investment Act of 1958, as amended (“the Act”), in connection with the financing of a small concern, has sought an exemption under section 312 of the Act and section 107.730, Financings which Constitute Conflicts of Interest of the Small Business Administration (“SBA”) rules and regulations (13 CFR 107.7301(2001)). Meridian Venture Partners II, L.P. proposes to provide equity financing to Woof &amp; Co., 55 Carter Drive, Edison, NJ 08817 (“Woof”). The financing is contemplated for the build out of additional retail stores. </P>
        <P>The financing is brought within the purview of Sec. 107.730(a)(1) of the Regulations because Meridian Venture Partners and MVP Distribution Partners, Associates of Meridian Venture Partners II, L.P., currently own greater than 10 percent of Woof and therefore Woof is considered an Associate of Meridian Venture Partners II, L.P., as defined in Sec. 107.50 of the regulations. </P>
        <P>Notice is hereby given that any interested person may submit written comments on the transaction to the Associate Administrator for Investment, U. S. Small Business Administration, 409 Third Street, SW., Washington, DC 20416. </P>
        <SIG>
          <NAME>Jeffrey D. Pierson, </NAME>
          <TITLE>Associate Administrator for Investment. </TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20837 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 8025-01-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">SMALL BUSINESS ADMINISTRATION </AGENCY>
        <DEPDOC>[Declaration of Disaster #3526] </DEPDOC>
        <SUBJECT>State of Indiana; Amendment #2 </SUBJECT>

        <P>In accordance with the notice received from the Department of <PRTPAGE P="48981"/>Homeland Security—Federal Emergency Management Agency, effective August 6, 2003, the above numbered declaration is hereby amended to establish the incident period for this disaster as beginning on July 4, 2003 and continuing through August 6, 2003. </P>
        <P>All other information remains the same, <E T="03">i.e.</E>, the deadline for filing applications for physical damage is September 9, 2003, and for economic injury the deadline is April 12, 2004. </P>
        <SIG>
          <FP>(Catalog of Federal Domestic Assistance Program Nos. 59002 and 59008)</FP>
          
          <DATED>Dated: August 8, 2003. </DATED>
          <NAME>Cheri L. Cannon, </NAME>
          <TITLE>Acting Associate Administrator for Disaster Assistance. </TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20890 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 8025-01-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">SOCIAL SECURITY ADMINISTRATION </AGENCY>
        <SUBJECT>Agency Information Collection Activities: Proposed Request and Comment Request </SUBJECT>
        <P>The Social Security Administration (SSA) publishes a list of information collection packages that will require clearance by the Office of Management and Budget (OMB) in compliance with Public Law 104-13 effective October 1, 1995, The Paperwork Reduction Act of 1995. The information collection packages that may be included in this notice are for new information collections, revisions to OMB-approved information collections and extensions (no change) of OMB-approved information collections. </P>
        <P>SSA is soliciting comments on the accuracy of the agency's burden estimate; the need for the information; its practical utility; ways to enhance its quality, utility and clarity; and on ways to minimize burden on respondents, including the use of automated collection techniques or other forms of information technology. Written comments and recommendations regarding the information collection(s) should be submitted to the OMB Desk Officer and the SSA Reports Clearance Officer. The information can be mailed and/or faxed to the individuals at the addresses and fax numbers listed below: </P>
        <P>(OMB), Office of Management and Budget, Attn: Desk Officer for SSA, New Executive Office Building, Room 10235, 725 17th St., NW., Washington, DC 20503, Fax: 202-395-6974. </P>
        <P>(SSA), Social Security Administration, DCFAM, Attn: Reports Clearance Officer, 1338 Annex, 6401 Security Blvd., Baltimore, MD 21235, Fax: 410-965-6400. </P>
        <P>I. The information collections listed below are pending at SSA and will be submitted to OMB within 60 days from the date of this notice. Therefore, your comments should be submitted to SSA within 60 days from the date of this publication. You can obtain copies of the collection instruments by calling the SSA Reports Clearance Officer at 410-965-0454, or by writing to the address listed above. </P>
        <P>1. <E T="03">Integrated Registration for Employers and Submitters (IRES)—0960-0626.</E> The IRES authentication system is a free service designed to allow employers to access SSA's electronic wage reporting services, and to replace the use of a handwritten signature with an electronic signature. Employer representatives use an IRES generated PIN and password as their electronic signature. IRES is designed to be more efficient, reducing the costs to both employers and SSA, and will facilitate the filing of wage data electronically. SSA's paramount interest in the development of IRES was to ensure that the new electronic method of identifying wage report submitters provides the same security features as the current paper-based method. Security features include message integrity, originator authentication, non-repudiation and confidentiality. The PIN and password will be issued to an individual designated by the employer after SSA authenticates the company and contact information provided by the individual. SSA uses the IRES in conjunction with SSA's wage reporting processes. It is used as the gateway for electronic wage reporting and the online employee verification service. IRES will also be used when SSA implements additional electronic services such as electronic notices and error information. Also, the PIN will be used in the Annual Wage Reporting diskette process to replace IRS paper form 6559. SSA has received approval from IRS to use an alternative signature. Respondents to IRES will be Employers and Submitters who utilize SSA's electronic wage reporting and online employee verification services. </P>
        <P>
          <E T="03">Type of Request:</E> Revision of an OMB-approved information collection. </P>
        <P>
          <E T="03">Number of Respondents:</E> 250,120. </P>
        <P>
          <E T="03">Number of Responses:</E> 1. </P>
        <P>
          <E T="03">Average Burden Per Response:</E> 2 minutes. </P>
        <P>
          <E T="03">Estimated Annual Burden:</E> 8,337 hours. </P>
        <P>2. <E T="03">Application for Widow's or Widower's Insurance Benefits—20 CFR 404.335-.338—0960-0004.</E> SSA uses the information collected on the Form SSA-10-BK to determine if the applicant meets the statutory and regulatory conditions for entitlement to widow(er)'s benefits. The respondents are applicants for Widow(er)'s benefits. </P>
        <P>
          <E T="03">Type of Request:</E> Extension of an OMB-approved information collection. </P>
        <P>
          <E T="03">Number of Respondents:</E> 288,580. </P>
        <P>
          <E T="03">Frequency of Response:</E> 1. </P>
        <P>
          <E T="03">Average Burden Per Response:</E> 15 minutes. </P>
        <P>
          <E T="03">Estimated Annual Burden:</E> 72,145 hours. </P>
        <P>3. <E T="03">Application of Circuit Court Law—0960-0581.</E> SSA regulations at 20 CFR 404.985 and 416.1485 inform claimants of their right to request that a published Acquiescence Ruling (AR) be applied to a prior determination when we make a determination or decision on a claim between the date of the Circuit Court decision and the date we publish the AR. The regulations also specify that claimants can request that the AR be applied to a prior determination or decision by submitting a statement that demonstrates how the AR could change the prior determination or decision. SSA will use the information provided in the statement to readjudicate the claim if the claimant demonstrates the Ruling could change the prior determination. Claimants may use Form SSA-795, Statement of Claimant or Other Person (0960-0045), to request and support application of a published AR to the prior determination or decision. The respondents are claimants whose determinations or decisions on their claims may be affected by an AR. </P>
        <P>
          <E T="03">Type of Request:</E> Extension of current approved collection. </P>
        <P>
          <E T="03">Number of Respondents:</E> 100,000. </P>
        <P>
          <E T="03">Frequency of Response:</E> 1. </P>
        <P>
          <E T="03">Average Burden Per Response:</E> 17 minutes. </P>
        <P>
          <E T="03">Estimated Annual Burden:</E> 28,333 hours. </P>
        <P>4. <E T="03">Waiver of Right to Appear—20 CFR 404.913-914, 20 CFR 404 916(b)(5), 20 CFR 416.1413-1414 and 1416(b)(5)—0960-0534.</E> The Social Security Administration uses Form-773-U4 to provide claimants with an effective means of requesting a waiver of their right to appear at a disability hearing. The information collected will be used as documentation that claimants understand their rights to appear and the effects of the decision to waive this right. The respondents are claimants under Title II (Old-Age, Survivors and Disability Insurance) and Title XVI (Supplemental Security Income) of the Social Security Act, who wish to waive their right to a disability hearing </P>
        <P>
          <E T="03">Type of Request:</E> Extension of current approved collection. </P>
        <P>
          <E T="03">Number of Respondents:</E> 200. </P>
        <P>
          <E T="03">Frequency of Response:</E> 1. </P>
        <P>
          <E T="03">Average Burden Per Response:</E> 3 minutes. <PRTPAGE P="48982"/>
        </P>
        <P>
          <E T="03">Annual Burden:</E> 10 hours. </P>
        <P>5. <E T="03">Request for Internet Services—Password—0960-0632.</E> SSA uses a personal identification number (PIN)/password process for verifying the identity of individuals who choose to use the Internet and Automated Telephone Response in order to conduct business with the agency. An individual will be requested to provide certain information about himself or herself that SSA can verify in its records in order to obtain a password for use with its electronic services. The information that SSA collects varies depending on individual circumstances. Some examples of the information collected are: Name, social security number, password request code, benefit payment amount, and other shared secret types of information from SSA records. Once the requestor's identity is verified, SSA issues a PIN to the requestor which will allow them to establish a password for use with SSA Internet/telephone transactions. Until now, the services offered have been primarily to beneficiaries receiving benefits under title II of the Social Security Act, including Retirement, Survivors and Disability benefits. In April 2003, SSA began offering the opportunity for certain beneficiaries receiving benefits under title XVI of the Social Security Act, known as Supplemental Security Income (SSI), to report their wages electronically. SSA will initiate a 6-month Proof of Concept project to test the beneficiary acceptance of this technology for reporting wages. Participation in this Proof of Concept is voluntary. Individuals who must report wages include SSI beneficiaries, and, in some cases, the parent or spouse of the SSI beneficiary. In order to use SSA's electronic services, SSA must authenticate the person using its PIN/password process to protect the information in its records from those not authorized to receive it. This technology is expected to be more secure, less burdensome, faster and provide better customer service than other available options. The respondents are individuals who elect to conduct business with the agency in an electronic medium. </P>
        <P>
          <E T="03">Type of Request:</E> Revision of an OMB-approved information collection. </P>
        <P>
          <E T="03">Number of Respondents:</E> 412,267. </P>
        <P>
          <E T="03">Frequency of Response:</E> 1. </P>
        <P>
          <E T="03">Average Burden Per Response:</E> 10 minutes. </P>
        <P>
          <E T="03">Estimated Annual Burden:</E> 68,711 hours. </P>
        <P>6. <E T="03">Student Reporting Form—20 CFR, Subpart B, 404, and 20 CFR, Subparts D &amp; E 422—0960-0088.</E> Form SSA-1383 is used by Social Security student beneficiaries to report events or changes that may affect continuing entitlement to these benefits. We are revising this form in order to solicit information about incarceration in compliance with current law. The respondents are Social Security Student Beneficiaries. </P>
        <P>
          <E T="03">Type of Request:</E> Revision of an OMB-approved information collection. </P>
        <P>
          <E T="03">Number of Respondents:</E> 75,000. </P>
        <P>
          <E T="03">Frequency of Response:</E> 1. </P>
        <P>
          <E T="03">Average Burden Per Response:</E> 6 minutes. </P>
        <P>
          <E T="03">Estimated Annual Burden:</E> 7,500 hours. </P>
        <P>II. The information collection listed below has been submitted to OMB for clearance. Your comments on the information collections would be most useful if received by OMB and SSA within 30 days from the date of this publication. You can obtain a copy of the OMB clearance package by calling the SSA Reports Clearance Officer at 410-965-0454, or by writing to the address listed above. </P>
        <P>1. <E T="03">Disability Hearing Officer's Decision, Title XVI Disabled Child Continuing Disability Review—20 CFR 404 Subpart J and 20 CFR 416 Subpart I&amp;N-OMB No. 0960-0657.</E> Both Federal and state disability hearing officers (DHOs) use the SSA-1209 in preparing the disability determination. The form provides the framework for addressing the crucial elements of the case in a sequential and logical fashion. The completed form will be the official document of the decision. A copy becomes the personalized portion of the notice to the claimant/representative. The respondents are both Federal and state disability hearing officers. </P>
        <P>
          <E T="03">Type of Request:</E> Extension of currently approved collection. </P>
        <P>
          <E T="03">Number of Respondents:</E> 35,000. </P>
        <P>
          <E T="03">Frequency of Response:</E> 1. </P>
        <P>
          <E T="03">Average Burden Per Response:</E> 1 hour 25 minutes. </P>
        <P>
          <E T="03">Estimated Annual Burden:</E> 49,583. </P>
        <P>2. <E T="03">Claimant's Statement About Loan of Food and Shelter, SSA-5062, and Statement About Food or Shelter Provided to Another, SSA-L5063—0960-0529.</E> Forms SSA-5062 and SSA-L5063 are used to obtain statements about food and/or shelter provided to an SSI claimant. SSA uses the information to determine whether food and/or shelter are a bona fide loan or should be counted as income. This determination can affect eligibility for SSI and the amount of SSI that is payable. The respondents are claimants for SSI benefits and individuals who provide (loan) food or shelter to SSI claimants.</P>
        <P>
          <E T="03">Type of Request:</E> Extension of an OMB-approved information collection. </P>
        <P>
          <E T="03">Number of respondents:</E> 65,540. </P>
        <P>
          <E T="03">Frequency of Response:</E> 1. </P>
        <P>
          <E T="03">Average Burden of Response:</E> 10. </P>
        <P>
          <E T="03">Estimated Annual Burden:</E> 10,923. </P>
        <P>3. <E T="03">Medical Consultant's Review of Psychiatric Review Form—20 CFR 404.1520(a), 20 CFR 404.1640, 20 CFR 404.1643, 20 CFR 404.1645, 20 CFR 416.920(a)—0960-NEW.</E> The Social Security Administration measures the performance of State Disability Determination Services (DDS) in the area of quality of documentation and determinations on claims. In mental claims, a Psychiatric Review Technique Form (PRTF) is completed by DDS medical/psychological consultant (MC/PC). Form SSA-3023 is used by the regional review component to facilitate the MC/PC's review of the PRTF. The MC/PC completes an SSA-3023 only when adjudicating component's PRTF is in file. The SSA-3023 is required for each completed PRTF in file. </P>
        <P>
          <E T="03">Type of Request:</E> Request for Approval of Existing Information Collection. </P>
        <P>
          <E T="03">Number of Respondents:</E> 68,000. </P>
        <P>
          <E T="03">Frequency of Response:</E> 1. </P>
        <P>
          <E T="03">Average Burden Per Response:</E> 12 minutes. </P>
        <P>
          <E T="03">Estimated Annual Burden:</E> 13,600. </P>
        <P>4. <E T="03">Collection of SSI Overpayments from Special Benefits for Certain WWII Veterans; 20 CFR, Subpart E, 416.570 &amp; .572—0960-0653.</E> The information collection requirement in 20 CFR 416.570 allows for an individual to request to withhold a title XVI overpayment from Title II/VIII benefits. The information collection requirement in 20 CFR 416.572 allows for an individual to elect a higher or lower rate of withholding for recovery of an SSI overpayment. The information collected will be used to determine the proper rate of withholding of benefits to recover program overpayments. The respondents are Title II or Title VIII beneficiaries who were overpaid title XVI benefits and who request a higher rate of recovery than specified in 20 CFR 416.571. </P>
        <P>
          <E T="03">Type of Request:</E> Extension of an OMB-approved information collection. </P>
        <P>
          <E T="03">Number of Respondents:</E> 2,500. </P>
        <P>
          <E T="03">Frequency of Response:</E> 1. </P>
        <P>
          <E T="03">Average Burden Per Response:</E> 1 hour. </P>
        <P>
          <E T="03">Estimated Annual Burden:</E> 2,500 hours. </P>
        <P>5. <E T="03">Requests for Self-Employment Information, Employee Information, Employer Information—20 CFR, Subpart A, 422.120—0960-0508.</E> SSA uses Forms SSA-L2765, SSA-L3365 and SSA-L4002 to request correct information when an employer, employee or self-employed person reports an individual's earnings without a Social Security Number (SSN) or with an incorrect name or SSN. The <PRTPAGE P="48983"/>respondents are employers, employees or self-employed individuals who are requested to furnish additional identifying information. </P>
        <P>
          <E T="03">Type of Request:</E> Extension of an OMB-approved information collection. </P>
        <P>
          <E T="03">Number of Respondents:</E> 3,000,000. </P>
        <P>
          <E T="03">Frequency of Response:</E> 1. </P>
        <P>
          <E T="03">Average Burden Per Response:</E> 10 minutes. </P>
        <P>
          <E T="03">Estimated Annual Burden:</E> 500,000 hours. </P>
        <P>6. <E T="03">State Mental Institution Policy Review—20 CFR, Subpart U, 404.2001-2065, Subpart F, 416.601-416.665—0960-0110.</E> The Social Security Act provides that the Commissioner of Social Security shall establish a system of accountability monitoring for institutions in each state that serve as a representative payee for recipients of Social Security and SSI benefits. As part of this accountability process, SSA collects information on Form SSA-9584 to determine whether the institutions’ policies and practices conform to SSA's regulations on the use of benefits and whether the institution is performing other duties and responsibilities required of a representative payee. The information also provides a basis for conducting an onsite review of the institution and is used in the preparation of the subsequent report of findings. The respondents are state mental institutions that serve as representative payees. </P>
        <P>
          <E T="03">Type of Request:</E> Extension of an OMB-approved information collection. </P>
        <P>
          <E T="03">Number of Respondents:</E> 125. </P>
        <P>
          <E T="03">Frequency of Response:</E> 1. </P>
        <P>
          <E T="03">Average Burden Per Response:</E> 60 minutes. </P>
        <P>
          <E T="03">Estimated Annual Burden:</E> 125 hours. </P>
        <P>7. <E T="03">Medical or Psychological Consultant's Review of Childhood Disability Evaluation Form—20 CFR, Subpart J, 416.1040, .1043, .1045—0960-NEW.</E> Form SSA-536 is used by SSA medical or psychological consultants to document their review and assessment of the Childhood Disability Evaluation Form, SSA-538, prepared by State DDS employees. A childhood disability evaluation is required in each SSI childhood disability case. Therefore, the consultants must prepare an assessment form SSA-536 for each childhood disability case that is reviewed. The respondents are 256 SSA medical and psychological consultants. </P>
        <P>
          <E T="03">Type of Request:</E> Approval of an existing information collection. </P>
        <P>
          <E T="03">Number of Responses:</E> 17,000. </P>
        <P>
          <E T="03">Frequency of Response:</E> 1. </P>
        <P>
          <E T="03">Average Burden Per Response:</E> 12 minutes. </P>
        <P>
          <E T="03">Estimated Annual Burden:</E> 3,400 hours. </P>
        <P>8. <E T="03">Privacy and Disclosure of Official Records and Information, Availability of Information and Records to the Public—20 CFR 401 and 402—0960-0566.</E> The information collected is needed (a) to identify individuals who request access to their records; (b) designate an individual to receive and review sensitive medical records; (c) correct or amend records; (d) obtain consent from an individual to release his/her records to others; (e) facilitate the release of information under the Freedom of Information Act; and (f) to grant a waiver or reduction of fees for records. The respondents are individuals requesting access to their SSA records, correction of their SSA records and disclosure of SSA records. </P>
        <P>
          <E T="03">Type of Request:</E> Extension of an OMB-approved information collection. The reporting burden is shown below:</P>
        <P>
          <E T="03">(a) Number of Respondents:</E> 10,000. </P>
        <P>
          <E T="03">Frequency of Response:</E> On Occasion. </P>
        <P>
          <E T="03">Average Burden Per Response:</E> 11 minutes. </P>
        <P>
          <E T="03">Estimated Annual Burden:</E> 1,833 hours. </P>
        <P>(b) <E T="03">Number of Respondents:</E> 3,000. </P>
        <P>
          <E T="03">Frequency of Response:</E> On Occasion. </P>
        <P>
          <E T="03">Average Burden Per Response:</E> 2 hours. </P>
        <P>
          <E T="03">Estimated Annual Burden:</E> 6,000 hours. </P>
        <P>(c) <E T="03">Number of Respondents:</E> 100. </P>
        <P>
          <E T="03">Frequency of Response:</E> On Occasion. </P>
        <P>
          <E T="03">Average Burden Per Response:</E> 10 minutes. </P>
        <P>
          <E T="03">Estimated Annual Burden:</E> 17 hours. </P>
        <P>(d) <E T="03">Number of Respondents:</E> 200,000. </P>
        <P>
          <E T="03">Frequency of Response:</E> On Occasion. </P>
        <P>
          <E T="03">Average Burden Per Response:</E> 3 minutes. </P>
        <P>
          <E T="03">Estimated Annual Burden:</E> 10,000 hours. </P>
        <P>(e) <E T="03">Number of Respondents:</E> 15,000. </P>
        <P>
          <E T="03">Frequency of Response:</E> On Occasion. </P>
        <P>
          <E T="03">Average Burden Per Response:</E> 5 minutes. </P>
        <P>
          <E T="03">Estimated Annual Burden:</E> 1,250 hours. </P>
        <P>(f) <E T="03">Number of Respondents:</E> 400. </P>
        <P>
          <E T="03">Frequency of Response:</E> On Occasion. </P>
        <P>
          <E T="03">Average Burden Per Response:</E> 5 minutes. </P>
        <P>
          <E T="03">Estimated Annual Burden:</E> 33 hours. </P>
        <P>9. <E T="03">Social Security Disability Report—20 CFR 404.1512 &amp; 416.912-0960.</E> The Social Security Act requires applicants to furnish medical, work history and other evidence or information to prove they are disabled. The information on the Adult Disability Report, together with other evidence and information, will be used by State Disability Determination Services (DDS) to develop medical evidence, assess the alleged disability, and make a determination on whether or not the applicant is disabled under the Act. DDSs are State agencies that make disability determinations on behalf of SSA. In addition to the traditional paper application, claimants for disability benefits will have the option to complete the Disability Report through the Internet (i3368) or in an interview format with an SSA representative at an SSA field office using the Electronic Disability Collect System (EDCS). Both the i3368 and EDCS formats collect the same information as that contained on the paper SSA-3368, but include enhancements to guide the claimant or interviewer through the application process. For example, the i3368 provides applicants with self-help screens and propagates certain information. Both the i3368 and EDCS applications will, when needed, collect additional information on a claimant's work history. In the paper-based process, however, additional work history information is collected through another form, the SSA-3369, OMB No. 0960-0578. The respondents are applicants for title II and title XVI disability benefits. </P>
        <P>
          <E T="03">Type of Request:</E> Revision of an OMB-approved information collection. </P>
        <GPOTABLE CDEF="s50,12,12,11.1,12" COLS="5" OPTS="L2,tp0,i1">
          <TTITLE>  </TTITLE>
          <BOXHD>
            <CHED H="1">Collection format </CHED>
            <CHED H="1">Number of <LI>respondents </LI>
            </CHED>
            <CHED H="1">Frequency <LI>of </LI>
              <LI>responses </LI>
            </CHED>
            <CHED H="1">Average <LI>burden per </LI>
              <LI>response </LI>
              <LI>(hours) </LI>
            </CHED>
            <CHED H="1">Estimated <LI>annual </LI>
              <LI>burden </LI>
              <LI>(hours) </LI>
            </CHED>
          </BOXHD>
          <ROW>
            <ENT I="01">SSA-3368 (Paper Form) </ENT>
            <ENT>2,040,667 </ENT>
            <ENT>1 </ENT>
            <ENT>1 </ENT>
            <ENT>2,040,667 </ENT>
          </ROW>
          <ROW>
            <ENT I="01">Electronic Disability Collection System (EDCS) </ENT>
            <ENT>10,000 </ENT>
            <ENT>1 </ENT>
            <ENT>1 </ENT>
            <ENT>10,000 </ENT>
          </ROW>
          <ROW>
            <ENT I="01">I3368 (Internet) (Hour burden varies between 1<FR>1/2</FR> hours and 3 hours based on information required) </ENT>
            <ENT>66,000 </ENT>
            <ENT>1 </ENT>
            <ENT>2<FR>.5</FR>
            </ENT>
            <ENT>165,000 </ENT>
          </ROW>
        </GPOTABLE>
        <PRTPAGE P="48984"/>
        <P>
          <E T="03">Total estimated annual burden:</E> 2,215,667.</P>
        <SIG>
          <DATED>Dated: August 8, 2003. </DATED>
          <NAME>Nicholas E. Tagliareni, </NAME>
          <TITLE>Acting Reports Clearance Officer. </TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20730 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4191-02-U</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF STATE </AGENCY>
        <DEPDOC>[Public Notice 4449] </DEPDOC>
        <SUBJECT>Culturally Significant Objects Imported for Exhibition Determinations: “Picasso: The Cubist Portraits of Fernande Olivier” </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Department of State. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>

          <P>Notice is hereby given of the following determinations: Pursuant to the authority vested in me by the Act of October 19, 1965 (79 Stat. 985; 22 U.S.C. 2459), Executive Order 12047 of March 27, 1978, the Foreign Affairs Reform and Restructuring Act of 1998 (112 Stat. 2681, <E T="03">et seq.</E>; 22 U.S.C. 6501 note, <E T="03">et seq.</E>), Delegation of Authority No. 234 of October 1, 1999, Delegation of Authority No. 236 of October 19, 1999, as amended, and Delegation of Authority No. 257 of April 15, 2003, I hereby determine that the objects to be included in the exhibition “Picasso: The Cubist Portraits of Fernande Olivier,” imported from abroad for temporary exhibition within the United States, are of cultural significance. The objects are imported pursuant to loan agreements with the foreign owners. I also determine that the exhibition or display of the exhibit objects at the National Gallery of Art, from on or about October 1, 2003 until on or about January 18, 2004; at the Nasher Sculpture Center in Dallas, Texas from February 15, 2004 to May 9, 2004; and at possible additional venues yet to be determined, is in the national interest. Public Notice of these Determinations is ordered to be published in the <E T="04">Federal Register</E>. </P>
        </SUM>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>For further information, including a list of the exhibit objects, contact Orde F. Kittrie, Attorney-Adviser, Office of the Legal Adviser, U.S. Department of State, (telephone: 202/401-4779). The address is U.S. Department of State, SA-44, 301 4th Street, SW., Room 700, Washington, DC 20547-0001. </P>
          <SIG>
            <DATED>Dated: August 12, 2003. </DATED>
            <NAME>Van S. Wunder, </NAME>
            <TITLE>Deputy Assistant Secretary for Professional and Cultural Exchanges, Acting, Department of State. </TITLE>
          </SIG>
        </FURINF>
      </PREAMB>
      <FRDOC>[FR Doc. 03-21052 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4710-08-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF STATE </AGENCY>
        <DEPDOC>[Public Notice 4447] </DEPDOC>
        <SUBJECT>Determination Pursuant to Section 1(b) of Executive Order 13224 Relating to the Mujahedin-e Khalq (MEK) </SUBJECT>
        <P>Acting under the authority of section 1(b) of Executive Order 13224 of September 23, 2001, as amended by Executive Order 13286 of July 2, 2002, and Executive Order 13284 of January 23, 2003, and in consultation with the Secretary of the Treasury, the Attorney General, and the Secretary of Homeland Security, I hereby determine that the MEK uses or has used as aliases the names “National Council of Resistance” (“NCR”), and “National Council of Resistance of Iran” (“NCRI”). I hereby amend the October 31, 2001, designation of the Mujahedin-e Khalq (MEK and other aliases) to add the following names as aliases of MEK: </P>
        
        <FP SOURCE="FP-1">“National Council of Resistance” (“NCR”) (including its U.S. representative office and all other offices worldwide); and </FP>
        <FP SOURCE="FP-1">“National Council of Resistance of Iran” (“NCRI”) (including its U.S. representative office and all other offices worldwide). </FP>
        
        <P>I also hereby clarify that the October 31, 2001 designation of the People's Mujahedin Organization of Iran, a.k.a. PMOI, as aliases of the MEK includes its U.S. representative office and all other offices worldwide. </P>
        <P>Consistent with the determination in section 10 of Executive Order 13224 that “prior notice to persons determined to be subject to the Order who might have a constitutional presence in the United States would render ineffectual the blocking and other measures authorized in the Order because of the ability to transfer funds instantaneously,” I determine that no prior notice need be provided to any person subject to this determination who might have a constitutional presence in the United States, because to do so would render ineffectual the measures authorized in the Order. </P>
        <P>This notice shall be published in the <E T="04">Federal Register</E>. </P>
        <SIG>
          <DATED>Dated: August 9, 2003. </DATED>
          <NAME>Colin L. Powell, </NAME>
          <TITLE>Secretary of State, Department of State. </TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20923 Filed 8-13-03; 5 pm] </FRDOC>
      <BILCOD>BILLING CODE 4710-10-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF STATE </AGENCY>
        <DEPDOC>[Public Notice 4444] </DEPDOC>
        <SUBJECT>Bureau of Democracy, Human Rights and Labor Request for Grant Proposals: Human Rights and Democratization Initiatives in Sub-Saharan Africa </SUBJECT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The Office for the Promotion of Human Rights and Democracy of the Bureau of Democracy, Human Rights and Labor (DRL/PHD) announces an open competition for assistance awards. Organizations may submit grant proposals that address programs and activities that foster democracy, human rights, press freedoms, and the rule of law in Sub-Saharan Africa. </P>
          <P>Awards are contingent upon the availability of Fiscal Year 2003 funds. The Bureau anticipates awarding between 2-4 grants in amounts of $250,000-$500,000. </P>
          <P>
            <E T="03">Background:</E> The Human Rights and Democracy Fund (HRDF) supports innovative, cutting-edge programs which uphold democratic principles, support and strengthen democratic institutions, promote human rights, and build civil society in countries and regions of the world that are geo-strategically important to the U.S. HRDF funds projects that have an immediate impact but that have potential for continued funding beyond HRDF resources. HRDF projects must not duplicate or simply add to efforts by other entities. </P>
        </SUM>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>The Bureau of Democracy Human Rights and Labor has identified the following issues and countries as priorities. </P>
        <P>1. Support independent media and access to information. Inform population of legal rights and responsibilities. Enhance public awareness of human rights, democratic processes, through print, radio, television and the Internet. Support and advocate freedom of the press, encourage greater social responsibility in reporting, and protect journalists. (Countries: Angola, Burundi, Cote d'Ivoire, Equatorial Guinea, Eritrea, Mozambique, Nigeria, Sudan, Swaziland, Tanzania, and Zimbabwe) </P>

        <P>2. Judicial reform to strengthen rule of law and reinforce mechanisms to ensure accountability for human rights abuses. (Countries: Angola, Cameroon, <PRTPAGE P="48985"/>Equatorial Guinea, Kenya, Mozambique, Nigeria, Rwanda, Sudan, Uganda and Zimbabwe) </P>
        <P>3. Develop and implement long and short-term strategies for ensuring free and fair elections; strengthen political parties, establish and support the work of independent electoral commissions and develop campaign training and overall support for political pluralism. (Countries: Angola, Cameroon, Cote d'Ivoire, Equatorial Guinea, Gabon, Malawi, Nigeria, Tanzania and Uganda) </P>
        <P>4. Support, strengthen and enhance civil society's capacity to advocate, monitor, develop or support human rights rule of law, and the democratic process, good governance or conflict resolution through innovative campaigns (Angola, Burundi, Cameroon, Equatorial Guinea, Eritrea, Ethiopia, Guinea, Mauritania, Mozambique, Nigeria, Rwanda, Sudan, Swaziland, Tanzania and Uganda) </P>
        <P>5. Increase national reconciliation in post-war countries through strengthened civil society and political institutions. (Angola, Burundi, Cote d'Ivoire, Rwanda, Sierra Leone and Sudan) </P>
        <P>6. Sensitize men and women to the destructive and debilitating nature of female genital mutilation. (West Africa) </P>
        <P>
          <E T="03">Project Criteria:</E>
        </P>
        <P>• Project implementation should begin no earlier than March 2004. </P>
        <P>• Projects should not exceed two years in duration. Shorter projects with more immediate outcomes may receive preference. </P>
        <P>• Project activity should take place in Sub-Saharan Africa. U.S-based or exchange projects are strongly discouraged. </P>
        <P>• Projects that have a strong academic or research focus will not be highly considered. DRL will not fund health, technology, environmental, or scientific projects unless they have an explicit democracy, human rights, or rule of law component. Conferences likewise will not be highly considered. </P>
        <P>• Projects should include a follow-on plan that extends beyond the grant period ensuring that Bureau-supported programs are not isolated events. </P>
        <P>In order to avoid the duplication of activities and programs, proposals should also indicate knowledge of similar projects being conducted in the region and how the submitted proposal will complement them. </P>
        <P>
          <E T="03">Applicant/Organization Criteria:</E> Organizations applying for a grant should meet the following criteria: </P>
        <P>• Be a U.S. non-profit organization meeting the provisions described in Internal Revenue Code section 26 U.S.C. 501(c)(3). Applicants must submit proof of its non-profit status in the application at the time of submission. </P>
        <P>• Have demonstrated experience administering successful projects in the region in which it is proposing to administer a project. </P>
        <P>• Have existing, or the capacity to develop, active partnerships with in-country organization(s). </P>
        <NOTE>
          <HD SOURCE="HED">Note:</HD>
          <P>Organizations are welcome to submit more than one proposal, but should know that DRL wishes to reach out to as many different organizations as possible with its limited funds. </P>
        </NOTE>
        
        <P>
          <E T="03">Budget Guidelines:</E> Please refer to the Proposal Submission Instructions (PSI) for complete budget guidelines and formatting instructions. </P>
        <P>
          <E T="03">Deadline for Proposals:</E> All proposals must be received at the Bureau of Democracy, Human Rights and Labor by 5 p.m. Eastern Standard Time (EST) on Tuesday, September 16, 2003. Please refer to the PSI for specific delivery instructions. </P>
        <HD SOURCE="HD1">Review Process </HD>
        <P>The Bureau will acknowledge receipt of all proposals and will review them for eligibility. Proposals will be deemed ineligible if they do not fully adhere to the guidelines stated herein and in the PSI. Eligible proposals will be subject to compliance with Federal and Bureau regulations and guidelines and forwarded to Bureau grant panels for advisory review. Proposals may also be reviewed by the Office of the Legal Adviser or by other Department elements. </P>
        <HD SOURCE="HD1">Review Criteria </HD>
        <P>Eligible applications will be competitively reviewed according to the criteria stated below. Further explanation of these criteria is included in the PSI. These criteria are not rank-ordered and all carry equal weight in the proposal evaluation: quality of the program idea; program planning and ability to achieve program objectives; multiplier effect/impact; institution's record/ability/capacity; cost-effectiveness. </P>
        <P>Some grants may be awarded under the aegis of the Father John Kaiser Memorial Fund which endeavors to advance the work and values of Father John Kaiser with respect to solving ethnic conflict and promoting government accountability and respect for human rights. </P>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>The Office for the Promotion of Human Rights and Democracy of the Bureau of Democracy, Human Rights and Labor (DRL/PHD). Please specify Karen Gilbride 202-647-1458 on all inquiries and correspondence. </P>
          <P>Please read the complete <E T="04">Federal Register</E> announcement before sending inquiries or submitting proposals. Once the RFP deadline has passed, Bureau staff may not discuss this competition with applicants until the proposal review process has been completed. </P>
          <P>
            <E T="03">To Download a Solicitation Package via Internet:</E> The Solicitation Package includes this RFP plus the Proposal Submission Instructions (PSI) which contains detailed award criteria, specific budget instructions, and standard guidelines for proposal preparation. The entire RFP and PSI may be downloaded from the HRDF section on the Bureau's Web site at <E T="03">http://www.state.gov/g/drl/.</E>
          </P>
          <HD SOURCE="HD1">Notice </HD>
          <P>The terms and conditions published in this RFP are binding and may not be modified by any Bureau representative. Explanatory information provided by the Bureau that contradicts published language will not be binding. Issuance of the RFP does not constitute an award commitment on the part of the Government. The Bureau reserves the right to reduce, revise, or increase proposal budgets in accordance with the needs of the program and the availability of funds. Awards made will be subject to periodic reporting and evaluation requirements. Final technical authority for assistance awards resides with the Office of Acquisition Management's Grants Officer. </P>
          <HD SOURCE="HD1">Notification </HD>
          <P>Final awards cannot be made until funds have been appropriated by Congress, allocated and committed through internal Bureau procedures. </P>
          <SIG>
            <DATED>Dated: August 5, 2003. </DATED>
            <NAME>E. Michael Southwick, </NAME>
            <TITLE>Assistant Secretary for Democracy (Acting), Human Rights Labor, Department of State. </TITLE>
          </SIG>
        </FURINF>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20936 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4710-18-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF STATE </AGENCY>
        <DEPDOC>[Public Notice 4445] </DEPDOC>
        <SUBJECT>Bureau of Democracy, Human Rights and Labor Request for Grant Proposals: Human Rights and Democratization Initiatives in the Western Hemisphere </SUBJECT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>

          <P>The Office for the Promotion of Human Rights and Democracy of the Bureau of Democracy, Human Rights and Labor (DRL/PHD) announces an open competition for assistance awards. Organizations may submit grant <PRTPAGE P="48986"/>proposals that address programs and activities that foster democracy, human rights, press freedoms, and the rule of law in the Western Hemisphere. </P>
          <P>Awards are contingent upon the availability of Fiscal Year 2003 funds. The Bureau anticipates awarding between 2-4 grants in amounts of $250,000-$500,000. </P>
          <HD SOURCE="HD1">Background </HD>
          <P>The Human Rights and Democracy Fund (HRDF) supports innovative, cutting-edge programs which uphold democratic principles, support and strengthen democratic institutions, promote human rights, and build civil society in countries and regions of the world that are geo-strategically important to the U.S. HRDF funds projects that have an immediate impact but that have potential for continued funding beyond HRDF resources. HRDF projects must not duplicate or simply add to efforts by other entities. </P>
          <HD SOURCE="HD1">Additional Information </HD>
          <P>The Bureau of Democracy Human Rights and Labor has identified the following issues and countries as priorities. </P>
          <P>1. Support to civil society and democratic institutions, including advocacy groups for human rights and the protection of vulnerable populations. (Priority Countries: Bolivia, Colombia, Cuba, Ecuador, Guatemala, Haiti, Peru, Venezuela) </P>
          <P>2. Promotion of an unrestricted, unbiased and responsible press and protection of freedom of the press, especially in regard to use of threats, intimidation and defamation suits to control the media and stifle investigations into official corruption, incompetence and abuse. Support to enhance public awareness of human rights issues and broaden civic education, including identification of and debate on democratic values and processes through print, radio, television and the Internet. (Priority Countries: Bolivia, Colombia, Cuba, El Salvador, Guatemala, Haiti, Honduras, Nicaragua, Panama, Peru, Venezuela) </P>
          <P>3. Promotion of labor rights and protections, particularly in connection with trade agreements, and especially in non-democratic or transitional regimes and countries suffering from civil conflict. (Priority Countries: Bolivia, Colombia, Cuba, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Nicaragua, Panama, Peru, Venezuela) </P>
          <P>4. Reconciliation, including support for human rights investigations of abuses during military dictatorship and other non-democratic governments. (Priority Countries: Argentina, Guatemala, Paraguay, Peru, Venezuela) </P>
          <P>5. Political party building, including support to democratic institutions and promotion of minority and indigenous population inclusion and representation in political processes. (Priority Countries: Argentina, Bolivia, Colombia, Ecuador, El Salvador, Guatemala, Mexico, Nicaragua, Peru, Venezuela) </P>
          <HD SOURCE="HD1">Project Criteria </HD>
          <P>• Project implementation should begin no earlier than March 2004. </P>
          <P>• Projects should not exceed two years in duration. Shorter projects with more immediate outcomes may receive preference. </P>
          <P>• Project activity should take place abroad. U.S-based or exchange projects are strongly discouraged. </P>
          <P>• Projects that have a strong academic or research focus will not be highly considered. DRL will not fund health, technology, environmental, or scientific projects unless they have an explicit democracy, human rights, or rule of law component. Conferences likewise will not be highly considered. </P>
          <P>• Projects should include a follow-on plan that extends beyond the grant period ensuring that Bureau-supported programs are not isolated events. </P>
          <P>In order to avoid the duplication of activities and programs, proposals should also indicate knowledge of similar projects being conducted in the region and how the submitted proposal will complement them. </P>
          <HD SOURCE="HD1">Applicant/Organization Criteria </HD>
          <P>Organizations applying for a grant should meet the following criteria: </P>
          <P>• Be a U.S. non-profit organization meeting the provisions described in Internal Revenue Code section 26 U.S.C. 501(c)(3). Applicants must submit proof of its non-profit status in the application at the time of submission. </P>
          <P>• Have demonstrated experience administering successful projects in the region in which it is proposing to administer a project. </P>
          <P>• Have existing, or the capacity to develop, active partnerships with in-country organization(s). </P>
        </SUM>
        <NOTE>
          <HD SOURCE="HED">Note:</HD>
          <P>Organizations are welcome to submit more than one proposal, but should know that DRL wishes to reach out to as many different organizations as possible with its limited funds. </P>
        </NOTE>
        <HD SOURCE="HD1">Budget Guidelines </HD>
        <P>Please refer to the Proposal Submission Instructions (PSI) for complete budget guidelines and formatting instructions. </P>
        <HD SOURCE="HD1">Deadline for Proposals </HD>
        <P>All proposals must be received at the Bureau of Democracy, Human Rights and Labor by 5 p.m. Eastern Standard Time (EST) on Wednesday, September 17, 2003. Please refer to the PSI for specific delivery instructions. </P>
        <HD SOURCE="HD1">Review Process </HD>
        <P>The Bureau will acknowledge receipt of all proposals and will review them for eligibility. Proposals will be deemed ineligible if they do not fully adhere to the guidelines stated herein and in the PSI. Eligible proposals will be subject to compliance with Federal and Bureau regulations and guidelines and forwarded to Bureau grant panels for advisory review. Proposals may also be reviewed by the Office of the Legal Adviser or by other Department elements. </P>
        <HD SOURCE="HD1">Review Criteria </HD>
        <P>Eligible applications will be competitively reviewed according to the criteria stated below. Further explanation of these criteria is included in the PSI. These criteria are not rank-ordered and all carry equal weight in the proposal evaluation: quality of the program idea; program planning and ability to achieve program objectives; multiplier effect/impact; institution's record/ability/capacity; cost-effectiveness. </P>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>The Office for the Promotion of Human Rights and Democracy of the Bureau of Democracy, Human Rights and Labor (DRL/PHD). Please specify Cathy Stump (202) 647-3322 on all inquiries and correspondence. </P>
          <P>Please read the complete <E T="04">Federal Register</E> announcement before sending inquiries or submitting proposals. Once the RFP deadline has passed, Bureau staff may not discuss this competition with applicants until the proposal review process has been completed. </P>
          <HD SOURCE="HD1">To Download a Solicitation Package Via Internet </HD>

          <P>The Solicitation Package includes this RFP plus the Proposal Submission Instructions (PSI) which contains detailed award criteria, specific budget instructions, and standard guidelines for proposal preparation. The entire RFP and PSI may be downloaded from the HRDF section on the Bureau's Web site at <E T="03">http://www.state.gov/g/drl/</E>. </P>
          <HD SOURCE="HD1">Notice </HD>

          <P>The terms and conditions published in this RFP are binding and may not be modified by any Bureau representative. Explanatory information provided by <PRTPAGE P="48987"/>the Bureau that contradicts published language will not be binding. Issuance of the RFP does not constitute an award commitment on the part of the Government. The Bureau reserves the right to reduce, revise, or increase proposal budgets in accordance with the needs of the program and the availability of funds. Awards made will be subject to periodic reporting and evaluation requirements. Final technical authority for assistance awards resides with the Office of Acquisition Management's Grants Officer. </P>
          <HD SOURCE="HD1">Notification </HD>
          <P>Final awards cannot be made until funds have been appropriated by Congress, allocated and committed through internal Bureau procedures. </P>
          <SIG>
            <DATED>Dated: August 11, 2003. </DATED>
            <NAME>Lorne W. Craner, </NAME>
            <TITLE>Assistant Secretary for Democracy, Human Rights and Labor, Department of State. </TITLE>
          </SIG>
        </FURINF>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20937 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4710-18-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF STATE</AGENCY>
        <DEPDOC>[Public Notice 4448]</DEPDOC>
        <SUBJECT>Determination Pursuant to Section 2(b)(2) of the Migration and Refugee Assistance Act of 1962, as Amended</SUBJECT>
        <P>Pursuant to section 2(b)(2) of the Migration and Refugee Assistance Act of 1962, as amended, 22 U.S.C. 2601(b)(2), and the functions and authorities delegated to the Secretary of State, or his or her delegate, by Presidential Determination 99-6 of November 30, 1998, and subsequently re-delegated to me by Delegation of Authority of January 5, 1999, I hereby designate refugees and conflict victims in Liberia as qualifying for assistance under Section 2(b)(2) of that Act, and determine that such assistance will contribute to the foreign policy interests of the United States.</P>

        <P>This determination shall be transmitted to the President and published in the <E T="04">Federal Register</E>.</P>
        <SIG>
          <DATED>Dated: August 8, 2003.</DATED>
          <NAME>Arthur E. Dewey,</NAME>
          <TITLE>Assistant Secretary of State, Bureau of Population, Refugees, and Migration.</TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20938  Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 4710-33-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF TRANSPORTATION </AGENCY>
        <SUBAGY>Office of the Secretary </SUBAGY>
        <SUBJECT>Aviation Proceedings, Agreements Filed the Week Ending August 1, 2003 </SUBJECT>
        <P>The following Agreements were filed with the Department of Transportation under the provisions of 49 U.S.C. Sections 412 and 414. Answers may be filed within 21 days after the filing of the application. </P>
        <P>
          <E T="03">Docket Number:</E> OST-2003-15803. </P>
        <P>
          <E T="03">Date Filed:</E> July 29, 2003. </P>
        <P>
          <E T="03">Parties:</E> Members of the International Air Transport Association. </P>
        <P>
          <E T="03">Subject:</E> PTC COMP 1075 dated 29 July 2003 Composite Expedited Resolution 002f r1-r5 Intended effective date: October 1, 2003. </P>
        <SIG>
          <NAME>Andrea M. Jenkins, </NAME>
          <TITLE>Program Manager, Docket Operations, Federal Register Liaison.</TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20931 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4910-62-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF TRANSPORTATION</AGENCY>
        <SUBAGY>Office of the Secretary</SUBAGY>
        <SUBJECT>Notice of Applications for Certificates of Public Convenience and Necessity and Foreign Air Carrier Permits Filed Under Subpart B (Formerly Subpart Q) During the Week Ending August 1, 2003</SUBJECT>

        <P>The following Applications for Certificates of Public Convenience and Necessity and Foreign Air Carrier Permits were filed under subpart B (formerly subpart Q) of the Department of Transportation's Procedural Regulations (<E T="03">See</E> 14 CFR 301.201 <E T="03">et. seq.</E>). The due date for Answers, Conforming Applications, on Motions to Modify Scope are set forth below for each application. Following the Answer period DOT may process the application by expedited procedures. Such procedures may consist of the adoption of a show-cause order, a tentative order, or in appropriate cases a final order without further proceedings.</P>
        
        <P>
          <E T="03">Docket Number</E>: OST-1995-545.</P>
        <P>
          <E T="03">Date Filed:</E> July 30, 2003.</P>
        <P>
          <E T="03">Due Date for Answers, Conforming Applications, or Motion to Modify Scope:</E> August 20, 2003.</P>
        <P>
          <E T="03">Description:</E> Application of Delta Air Lines, Inc., pursuant to 49 U.S.C. Sections 41102, 41108 and subpart B, requesting renewal of its certificate of public convenience and necessity to engage in scheduled foreign air transportation of persons, property, and mail between Atlanta, GA, and Caracas, Venezuela.</P>
        
        <P>
          <E T="03">Docket Number:</E> OST-2003-15821.</P>
        <P>
          <E T="03">Date Filed:</E> July 31, 2003.</P>
        <P>
          <E T="03">Due Date for Answers, Conforming Applications, or Motion to Modify Scope:</E> August 21, 2003.</P>
        <P>
          <E T="03">Description:</E> Application of TransAtlantic Airlines Limited, pursuant to 49 U.S.C. Section 41301, et seq., and subpart B, requesting a foreign air carrier permit authorizing it to engage in scheduled and charter foreign air transportation of persons, property, and mail between Sierra Leone and the United States.</P>
        
        <P>
          <E T="03">Docket Number:</E> OST-1997-3177.</P>
        <P>
          <E T="03">Date Filed:</E> August 1, 2003.</P>
        <P>
          <E T="03">Due Date for Answers, Conforming Applications, or Motion to Modify Scope:</E> August 22, 2003.</P>
        <P>
          <E T="03">Description:</E> Application of Northwest Airlines, Inc., pursuant to 49 U.S.C. section 41101 and subpart B, requesting renewal of Segment 1 of its Route 378 certificate of public convenience and necessity, and to integrate this certificate authority with all of Northwest's existing certificate and exemption authority to the extent consistent with U.S. bilateral agreements and DOT policy.</P>
        <SIG>
          <NAME>Andrea M. Jenkins,</NAME>
          <TITLE>Program Manager, Docket Operations, Federal Register Liaison. </TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20930  Filed 8-14-03; 8:45 am]</FRDOC>
      <BILCOD>BILLING CODE 4910-62-M</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF TRANSPORTATION </AGENCY>
        <SUBAGY>Office of the Secretary </SUBAGY>
        <DEPDOC>[Docket No. OST-2003-15794] </DEPDOC>
        <SUBJECT>Motor Carrier Financial Information Reporting Requirements—Request for Public Comments </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Office of the Secretary (OST), DOT. </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Request for Public Comments. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>DOT has received a petition from the Truckload Carriers Association (TCA), requesting that DOT grant a general exemption to all motor carriers of property that are required to file financial reports with DOT's Bureau of Transportation Statistics (BTS). The petition also requests that DOT docket the petition and request public comments. DOT is seeking public comments on the merits of the TCA petition. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>Comments must be received by October 14, 2003. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>

          <P>You may submit comments (identified by DMS Docket Number OST-2003-15794) through the following methods: <PRTPAGE P="48988"/>
          </P>
          <P>• <E T="03">Web Site: http://dms.dot.gov</E>. Follow the instructions for submitting comments on the DOT electronic docket site. </P>
          <P>• <E T="03">Fax:</E> 1-202-493-2251. </P>
          <P>• <E T="03">Mail:</E> Docket Management Facility; U.S. Department of Transportation, 400 Seventh Street, SW., Nassif Building, Room PL-401, Washington, DC 20590-001. </P>
          <P>• <E T="03">Hand Delivery:</E> Room PL-401 on the plaza level of the Nassif Building, 400 </P>
          <P>• Seventh Street, SW., Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday, except Federal Holidays. </P>
          <P>• <E T="03">Federal Rulemaking Portal:</E> Go to <E T="03">http://www.regulations.gov</E>. Follow the online instructions for submitting comments. </P>
          <P>
            <E T="03">Instructions:</E> All submissions must include the agency name and docket number. Note that all comments received will be posted without change to <E T="03">http://dms.dot.gov</E>, including any personal information provided. You should know that anyone is able to search the electronic form of all comments received into any of our dockets by the name of the individual submitting the comment (or signing the comment, if submitted on behalf of an association, business, labor union, <E T="03">etc.</E>). You may review DOT's complete Privacy Act Statement in the <E T="04">Federal Register</E> published on April 11, 2000 (Volume 65, Number 70; Pages 19477-78) or you may visit <E T="03">http://dms.dot.gov</E>
          </P>
          <P>
            <E T="03">Docket:</E> For access to the docket to read background documents or comments, go to <E T="03">http://dms.dot.gov</E> at any time or to Room PL-401 on the plaza level of the Nassif Building, 400 Seventh Street, SW., Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday, except Federal holidays. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>

          <P>Thomas M. McNamara, Office of Transportation Policy Development, Department of Transportation, 400 Seventh Street, SW., Washington, DC, 20590-0001, (202) 366-4462; <E T="03">thomas.mcnamara@ost.dot.gov</E>. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>

        <P>TCA is a national trade association with approximately 500 motor carrier members providing intercity truck transportation for a variety of commercial, industrial, and consumer products, primarily in full trailer-load quantities. (<E T="03">See</E> TCA Petition, Page 2.) In its petition, which we have included in the docket, TCA requests that DOT use its general exemption authority (<E T="03">see</E> 49 U.S.C. 13541) to exempt all motor carriers of property from the mandatory financial reporting requirements contained in 49 U.S.C. 14123. (<E T="03">See also</E> 49 CFR part 1420.) According to TCA, DOT should grant this regulatory relief because BTS “has made it abundantly clear that it will not exercise its own delegated authority to grant exemptions under subsection 14123(c) from either the filing or the public release of motor carrier reports.” (<E T="03">See</E> TCA Petition, Page 2.) </P>

        <P>The Interstate Commerce Commission (ICC) collected financial data from regulated motor carriers from the 1930s until the end of 1995, when the ICC was abolished and data collection was transferred to DOT. (<E T="03">See</E> 49 U.S.C. 11145 and implementing regulations at 49 CFR part 1420.) Between 1978 and 1994, the ICC reduced the reporting requirements by shortening report forms and easing record retention requirements. These changes followed the shift in the ICC's focus from close economic regulation of the motor carrier industry to broad industry oversight. </P>

        <P>Upon transfer of the program and an additional program review, BTS further reduced the carriers' reporting burden (<E T="03">see</E> 64 FR 13916, 13918; March 23, 1999). Currently, for common and contract motor carriers of property, the BTS regulations create three carrier classes based on revenue: Class I, with annual operating revenues of $10 million or more, file the annual report (Form M) and quarterly reports (Form QFR); Class II, with annual operating revenues of between $3 million and $10 million, file only the annual report (Form M); and Class III, with annual operating revenues of less than $3 million, are exempt from any filing requirements. </P>

        <P>The reporting forms require the motor carriers to provide certain financial information (<E T="03">see</E> 49 U.S.C. 14123(a)(1)): “at a minimum, such reports shall include balance sheets and income statements.” </P>

        <P>Unless a motor carrier requests an exemption from filing or from public release, the information is made publicly available. (<E T="03">See</E> 49 U.S.C. 14123(c)(1) and (2) and the implementing regulations at 49 CFR 1420.8 and 1420.9.) BTS grants an exemption from filing to an individual carrier that shows that “an exemption is required to avoid competitive harm and preserve confidential business information that is not otherwise publicly available.” (<E T="03">See</E> 49 U.S.C. 14123(c)(1).) The carrier must submit a written request containing sufficient supporting documentation, before BTS will consider a proposed exemption. </P>
        <P>BTS grants an exemption from public release upon a showing that the carrier is not a publicly-held corporation or not subject to financial reporting requirements of the Securities and Exchange Commission, and that the exemption is necessary to avoid substantial competitive harm and to avoid the disclosure of information that qualifies as a trade secret or privileged or confidential information under 5 U.S.C. 552(b)(4) (the fourth exemption of the Freedom of Information Act). Again, the carrier must submit a written request containing supporting information. </P>
        <P>The statutory standards for issuing an “exemption from filing” and an “exemption from public release” are very similar. However, the TCA states “BTS disregarded the Congressional intent by making exemptions from reporting or public release available only in theory, while denying them in fact.” (TCA Petition, Page 5.) In addition, the TCA argues, “any benefits of the reporting scheme are far outweighed by its burdens” (TCA Petition, Page 4), and it urges the Department to exempt all motor carriers of property from the requirement to file these financial reports. </P>
        <HD SOURCE="HD1">Request for Public Comments </HD>
        <P>We are issuing this invitation for comments on the TCA petition and views on whether DOT's motor carrier financial reporting requirements should be retained, amended, supplemented, replaced, or removed, including the selected forms and reports involved with the requirement. We are posing a series of questions in the hope that public comments will address several issues in particular: </P>
        <P>(1) Do you use DOT's motor carrier financial information and, if so, how do you use it? </P>
        <P>(2) Should the criteria used to evaluate whether a carrier has demonstrated that it will suffer competitive harm by release of its financial information be changed? (The criteria used by BTS are those in Exemption 4 of the Freedom of Information Act, 5 U.S.C. 552(b)(4): the information is commercial or financial and received from a source outside the Government, and its disclosure would likely lead to significant competitive harm to the supplier of the information or make it harder for the Government to obtain similar information in the future.) </P>

        <P>(3) Should DOT change the reporting thresholds for Class I and II carriers of property and, if so, what level of annual operating revenues should be used? (Raising the reporting thresholds would reduce the number of carriers required to report, while lowering the thresholds would increase the number of carriers.) <PRTPAGE P="48989"/>
        </P>
        <P>(4) Should DOT continue to require Class I carriers of property to submit quarterly reports (Form QFR)? </P>
        <P>(5) Should DOT eliminate or add specific line items in the annual report (Form M) and, if so, which specific line items should be eliminated/added? </P>
        <P>(6) If your company is subject to the current Form M reporting requirements, what is the annual cost for your company to comply with those requirements? Please explain, in detail, how you calculated this total cost. </P>
        <SIG>
          <DATED>Issued in Washington, DC on August 12, 2003. </DATED>
          <NAME>Emil Frankel, </NAME>
          <TITLE>Assistant Secretary for Transportation Policy. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20932 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4910-62-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF TRANSPORTATION </AGENCY>
        <SUBAGY>Federal Motor Carrier Safety Administration </SUBAGY>
        <DEPDOC>[FMCSA Docket No. FMCSA-2003-15268] </DEPDOC>
        <SUBJECT>Qualification of Drivers; Exemption Applications; Vision </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Federal Motor Carrier Safety Administration (FMCSA), DOT.</P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of final disposition. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The FMCSA announces its decision to exempt 35 individuals from the vision requirement in the Federal Motor Carrier Safety Regulations (FMCSRs). The exemptions will enable these individuals to qualify as drivers of commercial motor vehicles (CMVs) in interstate commerce without meeting the vision standard prescribed in 49 CFR 391.41(b)(10). </P>
        </SUM>
        <EFFDATE>
          <HD SOURCE="HED">DATES:</HD>
          <P>August 15, 2003. </P>
        </EFFDATE>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>
          <P>You may submit comments identified by DOT DMS Docket Number FMCSA-2003-15268 by any of the following methods: </P>
          <P>• <E T="03">Web site: http://dms.dot.gov.</E> Follow the instructions for submitting comments on the DOT electronic docket site. </P>
          <P>• <E T="03">Fax:</E> 1-202-493-2251. </P>
          <P>• <E T="03">Mail:</E> Docket Management Facility; U.S. Department of Transportation, 400 Seventh Street, SW., Nassif Building, Room PL-401, Washington, DC 20590-0001. </P>
          <P>• <E T="03">Hand Delivery:</E> Room Pl-401 on the plaza level of the Nassif Building, 400 Seventh Street, SW., Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday, except Federal Holidays. </P>
          <P>• <E T="03">Federal eRulemaking Portal:</E> Go to <E T="03">http://www.regulations.gov.</E> Follow the on-line instructions for submitting comments. </P>
          <P>
            <E T="03">Instructions:</E> All submissions must include the agency name and docket number for this notice. For detailed instructions on submitting comments and additional information on the rulemaking process, see the Public Participation heading of the Supplementary Information section of this document. Note that all comments received will be posted without change to <E T="03">http://dms.dot.gov, </E> including any personal information provided. Please see the Privacy Act heading under Regulatory Notices. </P>
          <P>
            <E T="03">Docket:</E> For access to the docket to read background documents or comments received, go to <E T="03">http://dms.dot.gov</E> at any time or to Room PL-401 on the plaza level of the Nassif Building, 400 Seventh Street, SW., Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday, except Federal Holidays. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>

          <P>Ms. Sandra Zywokarte, Office of Bus and Truck Standards and Operations, (202) 366-2987, FMCSA, Department of Transportation, 400 Seventh Street, SW., Washington, DC 20590-0001. Office hours are from 7:45 a.m. to 4:15 p.m., <E T="03">e.t.,</E> Monday through Friday, except Federal holidays. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P SOURCE="NPAR">
          <E T="03">Public Participation:</E> The DMS is available 24 hours each day, 365 days each year. You can get electronic submission and retrieval help guidelines under the “help” section of the DMS Web site. If you want us to notify you that we received your comments, please include a self-addressed, stamped envelope or postcard or print the acknowledgement page that appears after submitting comments on-line. </P>
        <P>
          <E T="03">Privacy Act:</E> Anyone is able to search the electronic form of all comments received into any of our dockets by the name of the individual submitting the comment (or signing the comment, if submitted on behalf of an association, business, labor union, <E T="03">etc</E>.). You may review the Department of Transportation's complete Privacy Act Statement in the <E T="04">Federal Register</E> published on April 11, 2000 (Volume 65, Number 70; Pages 19477-78) or you may visit <E T="03">http://dms.dot.gov.</E>
        </P>
        <HD SOURCE="HD1">Background </HD>
        <P>On June 23, 2003, the FMCSA published a Notice of its receipt of applications from 36 individuals, and requested comments from the public (68 FR 37197). The 36 individuals petitioned the FMCSA for exemptions from the vision requirement in 49 CFR 391.41(b)(10), which applies to drivers of CMVs in interstate commerce. They are: Gene E. Adams, Morris R. Beebe, William V. Beekler, Jerry W. Branning, Dennis R. Burda, James A. Busbin, Jr., Domenic J. Carassai, Theodore W. Cozat, Todd L. Dewey, John F. Dougherty, Fred W. Duran, Paul J. Edwards, Sr., William R. Evridge, Kenneth J. Fisk, Leslie W. Good, Michael E. Grens, Rodney P. Hains, Bruce E. Hemmer, Steven P. Holden, Russell R. Inlow, Christopher G. Jarvela, Henry Joiner, Darrell D. Kropf, Brad L. Mathna, William G. McClam, Vincent P. Miller, Warren J. Nyland, Dennis M. Prevas, Terry B. Pritchett, Greg L. Riles, Dwayne L. Sandlin, Jon D. Schwengel, Steven R. Smith, Calvin D. Tomlinson, Mona J. van Krieken, and Paul S. Yocum. </P>
        <P>Under 49 U.S.C. 31315 and 31136(e), the FMCSA may grant an exemption for a 2-year period if it finds “such exemption would likely achieve a level of safety that is equivalent to, or greater than, the level that would be achieved absent such exemption.” The statute also allows the agency to renew exemptions at the end of the 2-year period. Accordingly, the FMCSA has evaluated the 36 applications on their merits and made a determination to grant the exemptions to 35 of them. The comment period closed on July 23, 2003. One comment was received, and its contents were carefully considered by the FMCSA in reaching the final decision to grant the exemptions. </P>
        <P>The FMCSA has not made a decision on the application of Dwayne L. Sandlin. Subsequent to the publication of the notice of applications and request for comments, the agency received additional documentation concerning his driving record and is evaluating the information. A decision on this application will be made in the future. </P>
        <HD SOURCE="HD1">Vision and Driving Experience of the Applicants </HD>
        <P>The vision requirement in the FMCSRs provides: </P>
        <P>A person is physically qualified to drive a commercial motor vehicle if that person has distant visual acuity of at least 20/40 (Snellen) in each eye without corrective lenses or visual acuity separately corrected to 20/40 (Snellen) or better with corrective lenses, distant binocular acuity of at least 20/40 (Snellen) in both eyes with or without corrective lenses, field of vision of at least 70° in the horizontal meridian in each eye, and the ability to recognize the colors of traffic signals and devices showing standard red, green, and amber (49 CFR 391.41(b)(10)). </P>

        <P>Since 1992, the agency has undertaken studies to determine if this <PRTPAGE P="48990"/>vision standard should be amended. The final report from our medical panel recommends changing the field of vision standard from 70° to 120°, while leaving the visual acuity standard unchanged. (<E T="03">See</E> Frank C. Berson, M.D., Mark C. Kuperwaser, M.D., Lloyd Paul Aiello, M.D., and James W. Rosenberg, M.D., “Visual Requirements and Commercial Drivers,” October 16, 1998, filed in the docket, FHWA-98-4334.) The panel's conclusion supported the agency's view that the present standard is reasonable and necessary as a general standard to ensure highway safety. The FMCSA also recognizes that some drivers do not meet the vision standard, but have adapted their driving to accommodate their vision limitation and demonstrated their ability to drive safely. </P>
        <P>The 35 applicants fall into this category. They are unable to meet the vision standard in one eye for various reasons, including amblyopia, corneal and macular scars, and loss of an eye due to trauma. In most cases, their eye conditions were not recently developed. All but 14 of the applicants were either born with their vision impairments or have had them since childhood. The 14 individuals who sustained their vision conditions as adults have had them for periods ranging from 4 to 44 years. </P>
        <P>Although each applicant has one eye which does not meet the vision standard in 49 CFR 391.41(b)(10), each has at least 20/40 corrected vision in the other eye, and in a doctor's opinion has sufficient vision to perform all the tasks necessary to operate a CMV. The doctors' opinions are supported by the applicants' possession of valid commercial driver's licenses (CDLs) or non-CDLs to operate CMVs. Before issuing CDLs, States subject drivers to knowledge and performance tests designed to evaluate their qualifications to operate a CMV. All these applicants satisfied the testing standards for their State of residence. By meeting State licensing requirements, the applicants demonstrated their ability to operate a commercial vehicle, with their limited vision, to the satisfaction of the State. </P>
        <P>While possessing a valid CDL or non-CDL, these 35 drivers have been authorized to drive a CMV in intrastate commerce, even though their vision disqualifies them from driving in interstate commerce. They have driven CMVs with their limited vision for careers ranging from 3 to 46 years. In the past 3 years, eight of the drivers have had convictions for traffic violations. Seven of these convictions were for speeding, two for “failure to obey traffic sign,” one for “following too closely,” and one for “impeding traffic.” One driver was involved in an accident but did not receive a citation. </P>
        <P>The qualifications, experience, and medical condition of each applicant were stated and discussed in detail in the June 23, 2003 notice (68 FR 37197). Since there were no docket comments on the specific merits or qualifications of any applicant, we have not repeated the individual profiles here. Our summary analysis of the applicants is supported by the information published at 68 FR 37197. </P>
        <HD SOURCE="HD1">Basis for Exemption Determination </HD>
        <P>Under 49 U.S.C. 31315 and 31136(e), the FMCSA may grant an exemption from the vision standard in 49 CFR 391.41(b)(10) if the exemption is likely to achieve an equivalent or greater level of safety than would be achieved without the exemption. Without the exemption, applicants will continue to be restricted to intrastate driving. With the exemption, applicants can drive in interstate commerce. Thus, our analysis focuses on whether an equal or greater level of safety is likely to be achieved by permitting each of these drivers to drive in interstate commerce as opposed to restricting him or her to driving in intrastate commerce. </P>
        <P>To evaluate the effect of these exemptions on safety, the FMCSA considered not only the medical reports about the applicants' vision, but also their driving records and experience with the vision deficiency. To qualify for an exemption from the vision standard, the FMCSA requires a person to present verifiable evidence that he or she has driven a commercial vehicle safely with the vision deficiency for 3 years. Recent driving performance is especially important in evaluating future safety, according to several research studies designed to correlate past and future driving performance. Results of these studies support the principle that the best predictor of future performance by a driver is his/her past record of accidents and traffic violations. Copies of the studies have been added to the docket. (FHWA-98-3637) </P>

        <P>We believe we can properly apply the principle to monocular drivers, because data from a former FMCSA waiver study program clearly demonstrates that the driving performance of experienced monocular drivers in the program is better than that of all CMV drivers collectively. (<E T="03">See</E> 61 FR 13338, 13345, March 26, 1996.) The fact that experienced monocular drivers with good driving records in the waiver program demonstrated their ability to drive safely supports a conclusion that other monocular drivers, meeting the same qualifying conditions as those required by the waiver program, are also likely to have adapted to their vision deficiency and will continue to operate safely. </P>

        <P>The first major research correlating past and future performance was done in England by Greenwood and Yule in 1920. Subsequent studies, building on that model, concluded that accident rates for the same individual exposed to certain risks for two different time periods vary only slightly. (<E T="03">See</E> Bates and Neyman, University of California Publications in Statistics, April 1952.) Other studies demonstrated theories of predicting accident proneness from accident history coupled with other factors. These factors—such as age, sex, geographic location, mileage driven and conviction history—are used every day by insurance companies and motor vehicle bureaus to predict the probability of an individual experiencing future accidents. (<E T="03">See</E> Weber, Donald C., “Accident Rate Potential: An Application of Multiple Regression Analysis of a Poisson Process,” Journal of American Statistical Association, June 1971.) A 1964 California Driver Record Study prepared by the California Department of Motor Vehicles concluded that the best overall accident predictor for both concurrent and nonconcurrent events is the number of single convictions. This study used 3 consecutive years of data, comparing the experiences of drivers in the first 2 years with their experiences in the final year. </P>
        <P>Applying principles from these studies to the past 3-year record of the 35 applicants receiving an exemption, we note that the applicants have had only 1 accident and 11 traffic violations in the last 3 years. The applicants achieved this record of safety while driving with their vision impairment, demonstrating the likelihood that they have adapted their driving skills to accommodate their condition. As the applicants' ample driving histories with their vision deficiencies are good predictors of future performance, the FMCSA concludes their ability to drive safely can be projected into the future. </P>

        <P>We believe the applicants' intrastate driving experience and history provide an adequate basis for predicting their ability to drive safely in interstate commerce. Intrastate driving, like interstate operations, involves substantial driving on highways on the interstate system and on other roads built to interstate standards. Moreover, driving in congested urban areas exposes the driver to more pedestrian and vehicular traffic than exists on interstate highways. Faster reaction to traffic and traffic signals is generally <PRTPAGE P="48991"/>required because distances are more compact than on highways. These conditions tax visual capacity and driver response just as intensely as interstate driving conditions. The veteran drivers in this proceeding have operated CMVs safely under those conditions for at least 3 years, most for much longer. Their experience and driving records lead us to believe that each applicant is capable of operating in interstate commerce as safely as he or she has been performing in intrastate commerce. Consequently, the FMCSA finds that exempting these applicants from the vision standard in 49 CFR 391.41(b)(10) is likely to achieve a level of safety equal to that existing without the exemption. For this reason, the agency is granting the exemptions for the 2-year period allowed by 49 U.S.C. 31315 and 31136(e) to 35 of the 36 applicants listed in the June notice. </P>
        <P>We recognize that the vision of an applicant may change and affect his/her ability to operate a commercial vehicle as safely as in the past. As a condition of the exemption, therefore, the FMCSA will impose requirements on the 35 individuals consistent with the grandfathering provisions applied to drivers who participated in the agency's vision waiver program. </P>
        <P>Those requirements are found at 49 CFR 391.64(b) and include the following: (1) That each individual be physically examined every year (a) by an ophthalmologist or optometrist who attests that the vision in the better eye continues to meet the standard in 49 CFR 391.41(b)(10), and (b) by a medical examiner who attests that the individual is otherwise physically qualified under 49 CFR 391.41; (2) that each individual provide a copy of the ophthalmologist's or optometrist's report to the medical examiner at the time of the annual medical examination; and (3) that each individual provide a copy of the annual medical certification to the employer for retention in the driver's qualification file, or keep a copy in his/her driver's qualification file if he/she is self-employed. The driver must also have a copy of the certification when driving, for presentation to a duly authorized Federal, State, or local enforcement official. </P>
        <HD SOURCE="HD1">Discussion of Comments </HD>
        <P>The FMCSA received one comment in this proceeding. The comment was considered and is discussed below. </P>
        <P>Advocates for Highway and Auto Safety (Advocates) expresses continued opposition to the FMCSA's policy to grant exemptions from the FMCSRs, including the driver qualification standards. Specifically, Advocates: (1) Objects to the manner in which the FMCSA presents driver information to the public and makes safety determinations; (2) objects to the agency's reliance on conclusions drawn from the vision waiver program; (3) claims the agency has misinterpreted statutory language on the granting of exemptions (49 U.S.C. 31315 and 31136(e)); and finally (4) suggests that a recent Supreme Court decision affects the legal validity of vision exemptions. </P>
        <P>The issues raised by Advocates were addressed at length in 64 FR 51568 (September 23, 1999), 64 FR 66962 (November 30, 1999), 64 FR 69586 (December 13, 1999), 65 FR 159 (January 3, 2000), 65 FR 57230 (September 21, 2000), and 66 FR 13825 (March 7, 2001). We will not address these points again here, but refer interested parties to those earlier discussions. </P>
        <HD SOURCE="HD1">Conclusion </HD>
        <P>After considering the comments to the docket and based upon its evaluation of the 35 exemption applications, the FMCSA exempts Gene E. Adams, Morris R. Beebe, William V. Beekler, Jerry W. Branning, Dennis R. Burda, James A. Busbin, Jr., Domenic J. Carassai, Theodore W. Cozat, Todd L. Dewey, John F. Dougherty, Fred W. Duran, Paul J. Edwards, Sr., William R. Evridge, Kenneth J. Fisk, Leslie W. Good, Michael E. Grens, Rodney P. Hains, Bruce E. Hemmer, Steven P. Holden, Russell R. Inlow, Christopher G. Jarvela, Henry Joiner, Darrell D. Kropf, Brad L. Mathna, William G. McClam, Vincent P. Miller, Warren J. Nyland, Dennis M. Prevas, Terry B. Pritchett, Greg L. Riles, Jon D. Schwengel, Steven R. Smith, Calvin D. Tomlinson, Mona J. van Krieken, and Paul S. Yocum from the vision requirement in 49 CFR 391.41(b)(10), subject to the following conditions: (1) That each individual be physically examined every year (a) by an ophthalmologist or optometrist who attests that the vision in the better eye continues to meet the standard in 49 CFR 391.41(b)(10), and (b) by a medical examiner who attests that the individual is otherwise physically qualified under 49 CFR 391.41; (2) that each individual provide a copy of the ophthalmologist's or optometrist's report to the medical examiner at the time of the annual medical examination; and (3) that each individual provide a copy of the annual medical certification to the employer for retention in the driver's qualification file, or keep a copy in his/her driver's qualification file if he/she is self-employed. The driver must also have a copy of the certification when driving, so it may be presented to a duly authorized Federal, State, or local enforcement official. </P>
        <P>In accordance with 49 U.S.C. 31315 and 31136(e), each exemption will be valid for 2 years unless revoked earlier by the FMCSA. The exemption will be revoked if: (1) The person fails to comply with the terms and conditions of the exemption; (2) the exemption has resulted in a lower level of safety than was maintained before it was granted; or (3) continuation of the exemption would not be consistent with the goals and objectives of 49 U.S.C. 31315 and 31136. If the exemption is still effective at the end of the 2-year period, the person may apply to the FMCSA for a renewal under procedures in effect at that time. </P>
        <SIG>
          <DATED>Issued on: August 11, 2003. </DATED>
          <NAME>Robert F. Proferes, </NAME>
          <TITLE>Acting Associate Administrator for Policy and Program Development. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20889 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4910-EX-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF TRANSPORTATION </AGENCY>
        <SUBAGY>Federal Railroad Administration </SUBAGY>
        <DEPDOC>[Docket No. FRA-2000-7257] </DEPDOC>
        <SUBJECT>Notice No. 31; Railroad Safety Advisory Committee; Notice of Meeting </SUBJECT>
        <AGY>
          <HD SOURCE="HED">AGENCY:</HD>
          <P>Federal Railroad Administration (FRA), Department of Transportation (DOT). </P>
        </AGY>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Notice of Railroad Safety Advisory Committee (“RSAC”) meeting. </P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>FRA announces the next meeting of the RSAC, a Federal Advisory Committee that develops railroad safety regulations through a consensus process. The RSAC meeting topics will include updates on the Safety Reauthorization Bill, the Illinois Department of Transportation Positive Train Control Project, and the Highway-Rail Crossing Action Plan. Status reports will be given on the Event Recorder, Locomotive Crashworthiness, Passenger Safety and other active working groups. The Committee will be briefed on the International Application of Alcohol and Drug Rules, and Medical Standards for Safety Critical Employees. </P>
        </SUM>
        <DATES>
          <HD SOURCE="HED">DATES:</HD>
          <P>The meeting of the RSAC is scheduled to commence at 9:30 a.m. and conclude at 4 p.m. on Thursday, September 18, 2003. </P>
        </DATES>
        <ADD>
          <HD SOURCE="HED">ADDRESSES:</HD>

          <P>The meeting of the RSAC will be held at the Washington Plaza, 10 Thomas Circle, NW., Washington, DC 20005, (202) 842-1300. The meeting is open to the public on a first-come, first-served basis and is accessible to individuals with disabilities. Sign and <PRTPAGE P="48992"/>oral interpretation can be made available if requested 10 calendar days before the meeting. </P>
        </ADD>
        <FURINF>
          <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
          <P>Trish Butera or Lydia Leeds, RSAC Coordinators, FRA, 1120 Vermont Avenue, NW., Stop 25, Washington, DC 20590, (202) 493-6212/6213 or Grady Cothen, Deputy Associate Administrator for Safety Standards and Program Development, FRA, 1120 Vermont Avenue, NW., Mailstop 25, Washington, DC 20590, (202) 493-6302. </P>
        </FURINF>
      </PREAMB>
      <SUPLINF>
        <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
        <P>Pursuant to section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), FRA is giving notice of a meeting of the Railroad Safety Advisory Committee (“RSAC”). The meeting is scheduled to begin at 9:30 a.m. and conclude at 4 p.m. on Thursday, September 18, 2003. The meeting of the RSAC will be held at the Washington Plaza, 10 Thomas Circle, NW., Washington, DC, 20005, (202) 842-1300. All times noted are Daylight Saving Time. </P>
        <P>RSAC was established to provide advice and recommendations to the FRA on railroad safety matters. The Committee consists of 48 individual voting representatives and five associate representatives drawn from among 32 organizations representing various rail industry perspectives, two associate representatives from the agencies with railroad safety regulatory responsibility in Canada and Mexico and other diverse groups. Staffs of the National Transportation Safety Board and Federal Transit Administration also participate in an advisory capacity. </P>
        <P>
          <E T="03">See</E> the RSAC Web site for details on pending tasks at: <E T="03">http://rsac.fra.dot.gov.</E> Please refer to the notice published in the <E T="04">Federal Register</E> on March 11, 1996 (61 FR 9740) for more information about the RSAC. </P>
        <SIG>
          <DATED>Issued in Washington, DC on August 11, 2003. </DATED>
          <NAME>George A. Gavalla, </NAME>
          <TITLE>Associate Administrator for Safety. </TITLE>
        </SIG>
      </SUPLINF>
      <FRDOC>[FR Doc. 03-20922 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4910-06-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="S">DEPARTMENT OF TRANSPORTATION </AGENCY>
        <SUBAGY>National Highway Traffic Safety Administration </SUBAGY>
        <DEPDOC>[Docket No. NHTSA 2003-15690; Notice 1] </DEPDOC>
        <SUBJECT>General Motors North America, Inc., Receipt of Application for Decision of Inconsequential Noncompliance </SUBJECT>
        <P>General Motors North America Inc. (GM), has determined that certain 2001-2003 Oldsmobile Silhouettes and 2003 Pontiac Azteks did not meet requirement S5.2 of Federal Motor Vehicle Safety Standard (FMVSS) 120—“Tire Selection and Rims for Motor Vehicles Other Than Passenger Cars.” </P>
        <P>Pursuant to 49 U.S.C. 30118(d) and 30120(h), GM has petitioned for a determination that this noncompliance is inconsequential to motor vehicle safety and has filed an appropriate report pursuant to 49 CFR part 573, “Defect and Noncompliance Reports.” </P>
        <P>This notice of receipt of an application is published under 49 U.S.C. 30118 and 30120 and does not represent any agency decision or other exercise of judgment concerning the merits of the application. </P>
        <P>GM produced 55,825 model year 2001-2003 Oldsmobile Silhouettes and 15,343 model year 2003 Pontiac Azteks, totaling 71,168 vehicles. These vehicles are classified as multipurpose vehicles (MPVs). According to GM, the rims fitted to the MPVs were originally released for use on passenger cars, and meet all the requirements of FMVSS 110, “Tire Selection and Rims—Passenger Cars”. FMVSS 110 does not require marking the rims with either the designation of the source of the rims' dimensions or the symbol DOT. When the rims were subsequently released for use on the subject MPVs, they were evaluated for the alternative usage with respect to performance requirements, but they inadvertently were not reviewed with respect to the marking requirements of FMVSS 120. These rims meet all rim requirements of FMVSS 120, except the marking requirements of S5.2(a) and S5.2(c), which require the designation of the source of the rims' dimensions, and use of the symbol DOT, respectively. </P>
        <P>GM argues that this noncompliance is inconsequential to motor vehicle safety for the following reason: Apart from S5.2 (a) and S5.2(c), the subject rims meet all requirements of FMVSS 120. The tire and rim of the affected vehicles are properly matched, and are appropriate for the load-carrying characteristics of these vehicles. The missing markings have no effect on safety or the performance of the tire/rim combination. </P>
        <P>Also, the rim markings and vehicle placard, which are used to identify the correct replacement rim, both contain the correct and complete size of rims installed on the Silhouette and Aztek MPVs. </P>

        <P>Interested persons are invited to submit written views, arguments, and data on the application described above. Comments must refer to the docket and notice number cited at the beginning of this notice and be submitted by any of the following methods: Mail: Docket Management Facility; U.S. Department of Transportation, Nassif Building, Room PL-401, 400 Seventh Street, SW., Washington, DC 20590-001. Hand Delivery: Room PL-401 on the plaza level of the Nassif Building, 400 Seventh Street SW., Washington, DC. It is requested, but not required, that two copies of the comments be provided. The Docket Section is open on weekdays from 10 a.m. to 5 p.m. except Federal Holidays. Comments may be submitted electronically by logging onto the Docket Management System Web site at <E T="03">http://dms.dot.gov</E>. Click on “Help” to obtain instructions for filing the document electronically. Comments may be faxed to 1-202-493-2251, or may be submitted to the Federal eRulemaking Portal: Go to <E T="03">http://www.regulations.gov</E>. Follow the online instructions for submitting comments. </P>

        <P>All comments received before the close of business on the closing date indicated below will be considered. The application and supporting materials, and all comments received after the closing date, will also be filed and considered to the extent possible. When the application is granted or denied, the notice is published in the <E T="04">Federal Register</E> pursuant to the authority indicated below. </P>
        <P>Comment closing date: September 15, 2003. </P>
        <AUTH>
          <HD SOURCE="HED">Authority:</HD>
          <P>(49 U.S.C. 301118, 301120; delegations of authority at CFR 1.50 and 501.8). </P>
        </AUTH>
        <SIG>
          <DATED>Issued on: August 7, 2003. </DATED>
          <NAME>Stephen R. Kratzke, </NAME>
          <TITLE>Associate Administrator for Rulemaking. </TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20924 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4910-59-P</BILCOD>
    </NOTICE>
    <NOTICE>
      <PREAMB>
        <AGENCY TYPE="N">DEPARTMENT OF THE TREASURY </AGENCY>
        <SUBJECT>United States Mint </SUBJECT>
        <ACT>
          <HD SOURCE="HED">ACTION:</HD>
          <P>Request for CCAC membership applications.</P>
        </ACT>
        <SUM>
          <HD SOURCE="HED">SUMMARY:</HD>
          <P>The United States Mint is accepting applications for membership to the Citizens Coinage Advisory Committee (CCAC) for three positions—a representative from the general public; an individual specially qualified in numismatics by virtue of his or her education, training, or experience; and an individual specially qualified in American history. Public Law 108-15 established the CCAC to: </P>

          <P>• Advise the Secretary of the Treasury on any theme or design proposals relating to circulating coinage, <PRTPAGE P="48993"/>bullion coinage, Congressional Gold Medals, and other medals produced by the United States Mint. </P>
          <P>• Advise the Secretary of the Treasury with regard to—</P>
          <P>• The events, persons, or places that the Committee recommends to be commemorated by the issuance of commemorative coins in each of the five calendar years succeeding the year in which a commemorative coin designation is made. </P>
          <P>• Making recommendations with respect to the mintage level for any commemorative coin recommended. </P>
          <P>• The proposed designs for commemorative coins. </P>
          <P>Total membership consists of 11 voting members appointed by the Secretary of the Treasury: </P>
          <P>• One person specially qualified by virtue of his or her education, training or experience as nationally or internationally recognized curator in the United States of a numismatic collection; </P>
          <P>• One person specially qualified by virtue of his or her experience in the medallic arts or sculpture; </P>
          <P>• One person specially qualified by virtue of his or her education, training, or experience in American history; </P>
          <P>• One person specially qualified by virtue of his or her education, training, or experience in numismatics; </P>
          <P>• Three persons who can represent the interests of the general public in the coinage of the United States; and </P>
          <P>• Four persons appointed by the Secretary of the Treasury on the basis of the recommendations by the House and Senate leadership; all terms are four years except the terms of the initial appointees. </P>
          <P>The Committee is subject to the direction of the Secretary of the Treasury. Meetings of the CCAC are open to the public. The United States Mint is responsible for providing the necessary support services for the Committee. Committee members are not paid for their time or services, but, consistent with Federal Travel Regulations, members are reimbursed for their travel and lodging expenses to attend up to ten meetings each year. Members may be subject to the Standards of Ethical Conduct for Employees of the Executive Branch (5 CFR part 2653). </P>
          <P>The United States Mint will review all submissions and will forward its recommendations to the Secretary of the Treasury for appointment consideration. Candidates who are specially qualified in numismatics and who can represent the interests of the general public should include their knowledge of history or an understanding of American culture, history and patriotism. Candidates who believe that they are specially qualified to serve by reason of their education, training, or experience in the field of American history should provide support in their applications. Candidates will be called upon to recommend important places, people or events to commemorate our country's history as well as recommend the nation's coin programs to foster future coin collectors. All candidates should include specific skills, abilities, talents, and credentials to support their applications. The United States Mint is also interested in candidates who have demonstrated leadership skills, who have received recognition by their peers in their disciplines or fields of interest, who have records of participation in public service or activities, and who are willing to commit the time and effort to participate in the Committee meetings and related activities. </P>
          <P>
            <E T="03">Application Deadline:</E> September 5, 2003. </P>
          <P>
            <E T="03">Receipt of Applications:</E> Any member of the public wishing to be considered for participation on the committee should submit a resume, or letter describing qualifications for membership, by fax to 202-756-6539 or by mail to the United States Mint, 801 9th Street, NW., Washington, DC, 20001, Attn: CCAC Membership. Submissions must be postmarked no later than September 5, 2003. </P>
        </SUM>
        <SIG>
          <DATED>Dated: August 11, 2003. </DATED>
          <NAME>Henrietta Holsman Fore, </NAME>
          <TITLE>Director, United States Mint. </TITLE>
        </SIG>
      </PREAMB>
      <FRDOC>[FR Doc. 03-20799 Filed 8-14-03; 8:45 am] </FRDOC>
      <BILCOD>BILLING CODE 4810-37-P</BILCOD>
    </NOTICE>
  </NOTICES>
  <VOL>68</VOL>
  <NO>158</NO>
  <DATE>Friday August 15, 2003.</DATE>
  <UNITNAME>CORRECTIONS</UNITNAME>
  <CORRECT>
    <EDITOR>Moja</EDITOR>
    <PREAMB>
      <PRTPAGE P="48994"/>
      <AGENCY TYPE="F">DEPARTMENT OF TRANSPORTATION</AGENCY>
      <SUBAGY>Federal Aviation Administration</SUBAGY>
      <CFR>14 CFR Part 71</CFR>
      <DEPDOC>[Docket No. FAA-2003-15454; Airspace Docket No. 03-ACE-52]</DEPDOC>
      <SUBJECT>Modification of Class E Airspace; Wichita Mid-Continent Airport, KS</SUBJECT>
    </PREAMB>
    <SUPLINF>
      <HD SOURCE="HD2">Correction</HD>
      <P>In the correction to rule document 03-17766 appearing on page 47637 in the issue of Monday, August 11, 2003, paragraph designation 3. should read as set forth below:</P>
      <SECTION>
        <SECTNO>§71.1</SECTNO>
        <SUBJECT>[Corrected]</SUBJECT>

        <P>3. On page 41692, in the second column, in § 71.1, under the heading “<E T="04">ACE KS E5 Wichita Mid-Continent Airport, KS</E>”, in the sixth line “(Lat. 37°37′33″ N.,” should read “(Lat. 37°37′23″ N.,”.</P>
        
      </SECTION>
    </SUPLINF>
    <FRDOC>[FR Doc. C3-17766 Filed 8-14-03; 8:45 am]</FRDOC>
    <BILCOD>BILLING CODE 1505-01-D</BILCOD>
  </CORRECT>
  <VOL>68</VOL>
  <NO>158</NO>
  <DATE>Friday, August 15, 2003</DATE>
  <UNITNAME>Proposed Rules</UNITNAME>
  <NEWPART>
    <PTITLE>
      <PRTPAGE P="48995"/>
      <PARTNO>Part II</PARTNO>
      <AGENCY TYPE="P">Department of Labor</AGENCY>
      <SUBAGY>Office of the Secretary</SUBAGY>
      <HRULE/>
      <CFR>48 CFR Parts 2901 through 2953</CFR>
      <TITLE>Revision to the Department of Labor Acquisition Regulations; Proposed Rule</TITLE>
    </PTITLE>
    <PRORULES>
      <PRORULE>
        <PREAMB>
          <PRTPAGE P="48996"/>
          <AGENCY TYPE="S">DEPARTMENT OF LABOR</AGENCY>
          <SUBAGY>Office of the Secretary</SUBAGY>
          <CFR>48 CFR Parts 2901 through 2953</CFR>
          <RIN>RIN 1291-AA34</RIN>
          <SUBJECT>Revision to the Department of Labor Acquisition Regulations</SUBJECT>
          <AGY>
            <HD SOURCE="HED">AGENCY:</HD>
            <P>Office of the Secretary, Labor.</P>
          </AGY>
          <ACT>
            <HD SOURCE="HED">ACTION:</HD>
            <P>Notice of proposed rulemaking.</P>
          </ACT>
          <SUM>
            <HD SOURCE="HED">SUMMARY:</HD>
            <P>This document sets forth a revised Department of Labor Acquisition Regulation (DOLAR). The Department of Labor Acquisition Regulation implements and supplements the Federal Acquisition Regulation (FAR). The DOLAR was last revised in 1986, and is significantly out-of-date. The regulation has been substantially revised to: Update references to obsolete policies, procedures, and organizations; incorporate electronic links to reference such as revised provisions of the FAR, U.S. Code, and the Code of Federal Regulations; incorporate Office of Federal Procurement Policy Letters, and Executive Orders; and establish revised procedures that follow current established best practices. The DOLAR provides a definition for “Agency Head”, which is inconsistent with the internal Department of Labor Manual Series (DLMS) Chapters 2-800 and 2-900 that establishes DOL procurement operating procedures and policies. Future changes to the DLMS will comport with this definition.</P>
          </SUM>
          <DATES>
            <HD SOURCE="HED">DATES:</HD>
            <P>Interested parties should submit comments on the proposed rule at the address, shown below, on or before October 14, 2003 to be considered in the formulation of the final rule.</P>
          </DATES>
          <ADD>
            <HD SOURCE="HED">ADDRESSES:</HD>
            <P>Comments may be submitted by email to: <E T="03">OASAMRegComments@dol.gov.</E> Otherwise comments may be mailed to Jeffrey Saylor, Director, Division of Acquisition Management Services, 200 Constitution Ave., NW., Room N-5425, Washington, DC 20210-0001.</P>
          </ADD>
          <FURINF>
            <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
            <P>Jeffrey Saylor, Director, Division of Acquisition Management Services, telephone (202) 693-7285.</P>
          </FURINF>
        </PREAMB>
        <SUPLINF>
          <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
          <P>These comprehensive revisions to Parts 2901 through 2954 incorporate changes to the language and structure of the regulations and also update provisions to correspond with the current Federal Acquisition Regulation and Department of Labor policies.</P>
          <HD SOURCE="HD1">Regulatory Flexibility Act </HD>
          <P>The Regulatory Flexibility Act (5 U.S.C. 605(b)) requires that, for each rule with a “significant economic impact on a substantial number of small entities,” an analysis shall be prepared describing the rule's impact on small entities and identifying any significant alternatives to the rule that would minimize the economic impact on small entities. This proposed rule revises and updates existing contracting procedures and does not make any major changes to the DOLAR that would have a significant economic impact on a substantial number of small businesses. </P>
          <HD SOURCE="HD1">Executive Order 12866 </HD>
          <P>This rule is considered by the Department of Labor to be a significant regulatory action under Executive Order 12866, section 3(f), Regulatory Planning and Review. Accordingly, this regulation has been submitted to the Office of Management and Budget for review. </P>
          <HD SOURCE="HD1">Unfunded Reform Mandates Act of 1995 </HD>
          <P>The Unfunded Reform Mandates Act of 1995 (Public Law 104-4) requires agencies to prepare several analytic statements before proposing any rule that may result in annual expenditures of $100 million by State, local, Indian Tribal governments or the private sector. The proposed changes to the DOLAR would not result in expenditures of this magnitude. </P>
          <HD SOURCE="HD1">Paperwork Reduction Act </HD>
          <P>The proposed changes to the DOLAR will not impose additional reporting or record-keeping requirements under the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35). The DOL forms identified in 2953.1 are used for internal review and are not public use documents. </P>
          <HD SOURCE="HD1">Congressional Review of Agency Rulemaking </HD>
          <P>This rule is not a major rule as defined by section 251 of the Small Business Regulatory Enforcement Fairness Act of 1996, (5 U.S.C. 804). This NPRM, if published as a final rule, would not: result in an annual effect on the economy of $100 million or more; result in an increase in cost or prices; or have significant adverse effects on competition, employment, investment, productivity, innovation, or on the ability of United States-based companies to compete with foreign-based companies in domestic and export markets. </P>
          <HD SOURCE="HD1">Executive Order 13132: Federalism </HD>
          <P>The proposed changes to the DOLAR will not have substantial direct effects on the States, on the relationship between the national government and the States, or on the distribution of power and responsibilities among the various levels of government. Therefore, in accordance with section 6 of Executive Order 13132, this rule does not have sufficient federalism implications to warrant the preparation of a federalism summary impact statement. </P>
          <LSTSUB>
            <HD SOURCE="HED">List of Subjects in 48 CFR Parts 2901 through 2953 </HD>
            <P>Government procurement.</P>
          </LSTSUB>
          
          <P>For the reasons stated in the preamble, the Department of Labor proposes to amend 48 CFR Chapter 29 by revising Parts 2901 through 2953, to read as set forth below. </P>
          <SIG>
            <DATED>Signed at Washington, DC this 1st day of August 2003. </DATED>
            <NAME>Elaine L. Chao, </NAME>
            <TITLE>Secretary of Labor. </TITLE>
          </SIG>
          <CONTENTS>
            <SECHD>Sec.</SECHD>
            <HD SOURCE="HD2">
              <E T="42">CHAPTER 29—DEPARTMENT OF LABOR</E>
            </HD>
            <FP SOURCE="FP-2">(Parts 2901 to 2953) </FP>
            <HD SOURCE="HD1">
              <E T="42">SUBCHAPTER A—GENERAL</E>
            </HD>
            <PARTHD>PART 2901—DEPARTMENT OF LABOR ACQUISITION REGULATION SYSTEM </PARTHD>
            <SECTNO>2901.1</SECTNO>
            <SUBJECT>Purpose, Authority, Issuance. </SUBJECT>
            <SECTNO>2901.2</SECTNO>
            <SUBJECT>Administration. </SUBJECT>
            <SECTNO>2901.4</SECTNO>
            <SUBJECT>Deviations From the FAR and DOLAR. </SUBJECT>
            <SECTNO>2901.6</SECTNO>
            <SUBJECT>Career Development, Contracting Authority, and Responsibilities. </SUBJECT>
            <SECTNO>2901.7</SECTNO>
            <SUBJECT>Determinations and Findings.</SUBJECT>
            <PARTHD>PART 2902—DEFINITIONS OF WORDS AND TERMS </PARTHD>
            <SECTNO>2902.1</SECTNO>
            <SUBJECT>Definitions.</SUBJECT>
            <PARTHD>PART 2903—IMPROPER BUSINESS PRACTICES AND PERSONAL CONFLICTS OF INTEREST </PARTHD>
            <SECTNO>2903.1</SECTNO>
            <SUBJECT>Safeguards.</SUBJECT>
            <SECTNO>2903.2</SECTNO>
            <SUBJECT>Contractor Gratuities to Government Personnel. </SUBJECT>
            <SECTNO>2903.6</SECTNO>
            <SUBJECT>Contracts With Government Employees or Organizations Owned or Controlled by Them.</SUBJECT>
            <PARTHD>PART 2904—ADMINISTRATIVE MATTERS </PARTHD>
            <SECTNO>2904.6</SECTNO>
            <SUBJECT>Contract Reporting.</SUBJECT>
            <SECTNO>2904.8</SECTNO>
            <SUBJECT>Government Contract Files.</SUBJECT>
            <HD SOURCE="HD1">
              <E T="42">SUBCHAPTER B—ACQUISITION PLANNING</E>
            </HD>
            <PARTHD>PART 2905—PUBLICIZING CONTRACT ACTIONS </PARTHD>
            <SECTNO>2905.1</SECTNO>
            <SUBJECT>Dissemination of Information.</SUBJECT>
            <SECTNO>2905.2</SECTNO>
            <SUBJECT>Synopsis of Proposed Contract Actions.</SUBJECT>
            <SECTNO>2905.4</SECTNO>
            <SUBJECT>Release of Information.</SUBJECT>
            <SECTNO>2905.5</SECTNO>
            <SUBJECT>Paid Advertisements.<PRTPAGE P="48997"/>
            </SUBJECT>
            <PARTHD>PART 2906—COMPETITION REQUIREMENTS </PARTHD>
            <SECTNO>2906.3</SECTNO>
            <SUBJECT>Other than Full and Open Competition.</SUBJECT>
            <SECTNO>2906.5</SECTNO>
            <SUBJECT>Competition Advocates.</SUBJECT>
            <PARTHD>PART 2907—ACQUISITION PLANNING </PARTHD>
            <SECTNO>2907.1</SECTNO>
            <SUBJECT>Acquisition Plans.</SUBJECT>
            <SECTNO>2907.3</SECTNO>
            <SUBJECT>Contractor Versus Government Performance (A-76 Considerations).</SUBJECT>
            <PARTHD>PART 2908—REQUIRED SOURCES OF SUPPLIES AND SERVICES </PARTHD>
            <SECTNO>2908.4</SECTNO>
            <SUBJECT>Federal Supply Schedules.</SUBJECT>
            <PARTHD>PART 2909—CONTRACTOR QUALIFICATIONS </PARTHD>
            <SECTNO>2909.1</SECTNO>
            <SUBJECT>Responsible Prospective Contractors. </SUBJECT>
            <SECTNO>2909.4</SECTNO>
            <SUBJECT>Debarment, Suspension, And Ineligibility. </SUBJECT>
            <SECTNO>2909.5</SECTNO>
            <SUBJECT>Organizational Conflicts of Interest.</SUBJECT>
            <PARTHD>PART 2910—SPECIFICATIONS, STANDARDS, AND OTHER PURCHASE DESCRIPTIONS </PARTHD>
            <SECTNO>2910.002</SECTNO>
            <SUBJECT>Procedures.</SUBJECT>
            <PARTHD>PART 2911—DESCRIBING AGENCY NEEDS </PARTHD>
            <SECTNO>2911.1</SECTNO>
            <SUBJECT>Selecting And Developing Requirements Documents. </SUBJECT>
            <SECTNO>2911.5</SECTNO>
            <SUBJECT>Liquidated damages.</SUBJECT>
            <PARTHD>PART 2912—ACQUISITION OF COMMERCIAL ITEMS </PARTHD>
            <SECTNO>2912.3</SECTNO>
            <SUBJECT>Solicitation Provisions and Contract Clauses for the Acquisition of Commercial Items.</SUBJECT>
            <PARTHD>PART 2913—SIMPLIFIED ACQUISITION PROCEDURES </PARTHD>
            <SECTNO>2913.1</SECTNO>
            <SUBJECT>Procedures. </SUBJECT>
            <SECTNO>2913.2</SECTNO>
            <SUBJECT>Actions at or Below the Micro-purchase Threshold. </SUBJECT>
            <SECTNO>2913.3</SECTNO>
            <SUBJECT>Simplified Acquisition Methods.</SUBJECT>
            <HD SOURCE="HD1">
              <E T="42">SUBCHAPTER C—CONTRACTING METHODS AND CONTRACT TYPES</E>
            </HD>
            <PARTHD>PART 2914—SEALED BIDDING </PARTHD>
            <SECTNO>2914.4</SECTNO>
            <SUBJECT>Opening of Bids and Award of Contract.</SUBJECT>
            <PARTHD>PART 2915—CONTRACTING BY NEGOTIATION </PARTHD>
            <SECTNO>2915.4</SECTNO>
            <SUBJECT>Contract Pricing. </SUBJECT>
            <SECTNO>2915.5</SECTNO>
            <SUBJECT>Preaward, Award, and Postaward Notifications, Protests, and Mistakes. </SUBJECT>
            <SECTNO>2915.6</SECTNO>
            <SUBJECT>Unsolicited Proposals.</SUBJECT>
            <PARTHD>PART 2916—TYPES OF CONTRACTS </PARTHD>
            <SECTNO>2916.5</SECTNO>
            <SUBJECT>Indefinite-Delivery Contracts. </SUBJECT>
            <SECTNO>2916.6</SECTNO>
            <SUBJECT>Time-and-Materials, Labor-Hour, and Letter Contracts.</SUBJECT>
            <PARTHD>PART 2917—SPECIAL CONTRACTING METHODS </PARTHD>
            <SECTNO>2917.2</SECTNO>
            <SUBJECT>Options. </SUBJECT>
            <SECTNO>2917.5</SECTNO>
            <SUBJECT>Interagency Acquisitions Under The Economy Act.</SUBJECT>
            <HD SOURCE="HD1">
              <E T="42">SUBCHAPTER D—SOCIOECONOMIC PROGRAMS</E>
            </HD>
            <PARTHD>PART 2918 [RESERVED] </PARTHD>
            <SECTNO> </SECTNO>
            <PARTHD>PART 2919—SMALL BUSINESS PROGRAMS </PARTHD>
            <SECTNO>2919.2</SECTNO>
            <SUBJECT>Policies </SUBJECT>
            <SECTNO>2919.5</SECTNO>
            <SUBJECT>Set-Asides for Small Business. </SUBJECT>
            <SECTNO>2919.7</SECTNO>
            <SUBJECT>The Small Business Subcontracting Program. </SUBJECT>
            <SECTNO>2919.8</SECTNO>
            <SUBJECT>Contracting with the Small Business Administration (The 8(a) Program).</SUBJECT>
            <PARTHD>PART 2920-2921 [RESERVED] </PARTHD>
            <SECTNO> </SECTNO>
            <PARTHD>PART 2922—APPLICATION OF LABOR LAWS TO GOVERNMENT ACQUISITIONS</PARTHD>
            <SECTNO>2922.1</SECTNO>
            <SUBJECT>Basic Labor Policies.</SUBJECT>
            <PARTHD>PART 2923—ENVIRONMENT, CONSERVATION, OCCUPATIONAL SAFETY, AND DRUG-FREE WORKPLACE </PARTHD>
            <SECTNO>2923.2</SECTNO>
            <SUBJECT>Energy Conservation.</SUBJECT>
            <PARTHD>PART 2924-2927 [RESERVED] </PARTHD>
            <HD SOURCE="HD1">
              <E T="42">SUBCHAPTER E—GENERAL CONTRACTING REQUIREMENTS</E>
            </HD>
            <PARTHD>PART 2928—BONDS AND INSURANCE </PARTHD>
            <SECTNO>2928.2</SECTNO>
            <SUBJECT>Sureties and Other Security for Bonds. </SUBJECT>
            <SECTNO>2928.3</SECTNO>
            <SUBJECT>Insurance.</SUBJECT>
            <PARTHD>PART 2929—TAXES </PARTHD>
            <SECTNO>2929.1</SECTNO>
            <SUBJECT>General. </SUBJECT>
            <SECTNO>2929.3</SECTNO>
            <SUBJECT>State and Local Taxes.</SUBJECT>
            <PARTHD>PART 2930—COST ACCOUNTING STANDARDS </PARTHD>
            <SECTNO>2930.1</SECTNO>
            <SUBJECT>CAS Program Requirements.</SUBJECT>
            <PARTHD>PART 2931—CONTRACT COST PRINCIPLES AND PROCEDURES </PARTHD>
            <SECTNO>2931.1</SECTNO>
            <SUBJECT>Applicability.</SUBJECT>
            <PARTHD>PART 2932—CONTRACT FINANCING </PARTHD>
            <SECTNO>2932.4</SECTNO>
            <SUBJECT>Advance payments for Non-Commercial Items. </SUBJECT>
            <SECTNO>2932.7</SECTNO>
            <SUBJECT>Contractor Funding.</SUBJECT>
            <PARTHD>PART 2933—PROTESTS, DISPUTES, AND APPEALS </PARTHD>
            <SECTNO>2933.1</SECTNO>
            <SUBJECT>Protests. </SUBJECT>
            <SECTNO>2933.2</SECTNO>
            <SUBJECT>Disputes And Appeals.</SUBJECT>
            <PARTHD>PART 2934-2935 [RESERVED] </PARTHD>
            <SECTNO> </SECTNO>
            <PARTHD>PART 2936—CONSTRUCTION AND ARCHITECT-ENGINEER CONTRACTS </PARTHD>
            <SECTNO>2936.2</SECTNO>
            <SUBJECT>Special Aspects of Contracting for Construction.</SUBJECT>
            <SECTNO>2936.5</SECTNO>
            <SUBJECT>Contract Clauses. </SUBJECT>
            <SECTNO>2936.6</SECTNO>
            <SUBJECT>Architect-Engineer Services.</SUBJECT>
            <PARTHD>PART 2937—SERVICE CONTRACTING </PARTHD>
            <SECTNO>2937.1</SECTNO>
            <SUBJECT>Service Contracts-General. </SUBJECT>
            <SECTNO>2937.6</SECTNO>
            <SUBJECT>Preference for Performance-Based Contracting (PBC).</SUBJECT>
            <PARTHD>PARTS 2938-2941 [RESERVED] </PARTHD>
            <HD SOURCE="HD1">
              <E T="42">SUBCHAPTER G—CONTRACT MANAGEMENT</E>
            </HD>
            <PARTHD>PART 2942—CONTRACT ADMINISTRATION AND AUDIT SERVICES </PARTHD>
            <SECTNO>2942.1</SECTNO>
            <SUBJECT>Contract Audit Services. </SUBJECT>
            <SECTNO>2942.15</SECTNO>
            <SUBJECT>Contractor Performance Information.</SUBJECT>
            <PARTHD>PART 2943—CONTRACT MODIFICATIONS </PARTHD>
            <SECTNO>2943.2</SECTNO>
            <SUBJECT>Change Orders. </SUBJECT>
            <SECTNO>2943.3</SECTNO>
            <SUBJECT>Forms.</SUBJECT>
            <PARTHD>PART 2944—SUBCONTRACTING POLICIES AND PROCEDURES </PARTHD>
            <SECTNO>2944.1</SECTNO>
            <SUBJECT>General. </SUBJECT>
            <SECTNO>2944.2</SECTNO>
            <SUBJECT>Consent To Subcontract. </SUBJECT>
            <SECTNO>2944.3</SECTNO>
            <SUBJECT>Contractors' Purchasing Systems Reviews.</SUBJECT>
            <PARTHD>PART 2945—GOVERNMENT PROPERTY </PARTHD>
            <SECTNO>2945.1</SECTNO>
            <SUBJECT>General. </SUBJECT>
            <SECTNO>2945.3</SECTNO>
            <SUBJECT>Providing Government Property to Contractors. </SUBJECT>
            <SECTNO>2945.4</SECTNO>
            <SUBJECT>Contractor Use and Rental of Government Property. </SUBJECT>
            <PARTHD>PARTS 2946-2951 [RESERVED] </PARTHD>
            <HD SOURCE="HD1">
              <E T="42">SUBCHAPTER H—CLAUSES AND FORMS</E>
            </HD>
            <PARTHD>PART 2952—SOLICITATION PROVISIONS AND CONTRACT CLAUSES </PARTHD>
            <SECTNO>52.2</SECTNO>
            <SUBJECT>Text of Provisions and Clauses.</SUBJECT>
            <PARTHD>PART 2953—FORMS </PARTHD>
            <SECTNO>53.1</SECTNO>
            <SUBJECT>General.</SUBJECT>
            <HD SOURCE="HD1">
              <E T="42">SUBCHAPTER A—GENERAL</E>
            </HD>
            <PARTHD>PART 2901—DEPARTMENT OF LABOR ACQUISITION REGULATION SYSTEM </PARTHD>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2901.0—Scope of Subpart </HD>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2901.1—Purpose, Authority, Issuance </HD>
              <SECHD>Sec. </SECHD>
              <SECTNO>2901.101</SECTNO>
              <SUBJECT>Purpose. </SUBJECT>
              <SECTNO>2901.103</SECTNO>
              <SUBJECT>Authority. </SUBJECT>
              <SECTNO>2901.105-1</SECTNO>
              <SUBJECT>Publication and code arrangement. </SUBJECT>
              <SECTNO>2901.105-2</SECTNO>
              <SUBJECT>Arrangement of regulations. </SUBJECT>
              <SECTNO>2901.105-3</SECTNO>
              <SUBJECT>Copies. </SUBJECT>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2901.2—Administration </HD>
              <SECTNO>2901.201-1</SECTNO>
              <SUBJECT>Maintenance of the FAR. </SUBJECT>
              <SECTNO>2901.302</SECTNO>
              <SUBJECT>Limitations. </SUBJECT>
              <SECTNO>2901.304</SECTNO>
              <SUBJECT>Agency Control and Compliance Procedures. </SUBJECT>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2901.4—Deviations From the FAR and DOLAR </HD>
              <SECTNO>2901.403</SECTNO>
              <SUBJECT>Individual deviations from the FAR. </SUBJECT>
              <SECTNO>2901.404</SECTNO>
              <SUBJECT>Class deviations. </SUBJECT>
              <SECTNO>2901.405</SECTNO>
              <SUBJECT>Deviations pertaining to treaties and executive agreements. </SUBJECT>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2901.5—Agency and Public Participation </HD>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2901.6—Career Development, Contracting Authority, and Responsibilities</HD>
              <SECTNO>2901.601 </SECTNO>
              <SUBJECT>General. </SUBJECT>
              <SECTNO>2901.602 </SECTNO>
              <SUBJECT>Contracting officers. </SUBJECT>
              <SECTNO>2901.602-1 </SECTNO>
              <SUBJECT>Authority. </SUBJECT>
              <SECTNO>2901.602-3 </SECTNO>
              <SUBJECT>Ratification of unauthorized commitments. </SUBJECT>
              <SECTNO>2901.603 </SECTNO>
              <SUBJECT>Selection, appointment, and termination of appointment. </SUBJECT>
              <SECTNO>2901.603-1 </SECTNO>
              <SUBJECT>General. </SUBJECT>
              <SECTNO>2901.603-2 </SECTNO>
              <SUBJECT>Selection. </SUBJECT>
              <SECTNO>2901.603-3 </SECTNO>
              <SUBJECT>Appointment. </SUBJECT>
              <SECTNO>2901.603-4 </SECTNO>
              <SUBJECT>Terminations. </SUBJECT>
              <SECTNO>2901.603-70 </SECTNO>
              <SUBJECT>Responsibility of other Government personnel. </SUBJECT>
              <SECTNO>2901.603-71 </SECTNO>

              <SUBJECT>Contracting officer's technical representatives (COTR). <PRTPAGE P="48998"/>
              </SUBJECT>
              <SECTNO>2901.603-72 </SECTNO>
              <SUBJECT>Administrative procurement reviews. </SUBJECT>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2901.7—Determinations and Findings</HD>
              <SECTNO>2901.707 </SECTNO>
              <SUBJECT>Signatory authority. </SUBJECT>
              <AUTH>
                <HD SOURCE="HED">Authority:</HD>
                <P>5 U.S.C. 301, 40 U.S.C. 486(c). </P>
              </AUTH>
            </SUBPART>
          </CONTENTS>
          <PART>
            <HD SOURCE="HED">PART 2901—DEPARTMENT OF LABOR ACQUISITION REGULATION SYSTEM</HD>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2901.0—Scope of Subpart</HD>
            </SUBPART>
            <P>(a) This chapter may be referred to as the Department of Labor Acquisition Regulation or the DOLAR. This subpart sets forth introductory information about the Department of Labor Acquisition Regulation. This subpart explains the relationship of the DOLAR to the Federal Acquisition Regulation (FAR) and explains the DOLAR's purpose, authority, applicability, exclusions, and issuance. </P>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2901.1—Purpose, Authority, Issuance</HD>
              <SECTION>
                <SECTNO>2901.101 </SECTNO>
                <SUBJECT>Purpose. </SUBJECT>
                <P>(a) Chapter 29, Department of Labor Acquisition Regulation, is established within Title 48 of the Federal Acquisition Regulation System of the Code of Federal Regulations. </P>
                <P>(b) The purpose of the DOLAR is to implement the FAR, and to supplement the FAR when coverage is needed for subject matter not covered in the FAR. The DOLAR is not by itself a complete document, as it must be used in conjunction with the FAR. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2901.103 </SECTNO>
                <SUBJECT>Authority. </SUBJECT>
                <P>The DOLAR is issued pursuant to the authority of the Secretary of Labor under 5 U.S.C. 301 and 40 U.S.C. 486(c). This authority has been delegated to the Assistant Secretary for Administration and Management (ASAM) under Secretary's Order 4-76 in accordance with FAR 1.301(d)(3). </P>
              </SECTION>
              <SECTION>
                <SECTNO>2901.105-2 </SECTNO>
                <SUBJECT>Arrangement of regulations. </SUBJECT>
                <P>(a) <E T="03">Numbering.</E> Where DOLAR implements the FAR, the implementing part, subpart, section or subsection of the DOLAR is numbered and captioned, to the extent feasible, the same as the FAR part, subpart, section or subsection being implemented except that the section or subsection being implemented is preceded with a 29 or a 290 such that there will always be four numbers to the left of the first decimal. For example, the DOLAR implementation of FAR l.105-l is shown as 290l.l05-1 and the DOLAR implementation of FAR Subpart 24.1 is shown as DOLAR Subpart 2924.1. Material which supplements the FAR is assigned the subsection numbers 70 and up. For example, the DOL regulation governing appointment and termination of contracting officers' technical representatives is identified as 2901.603-71. </P>
                <P>(b) References to FAR materials within the DOLAR will include the acronym FAR and the identifying number, for example, FAR l.104-2(c)(2). References to DOLAR materials within the DOLAR simply cite the identifying number, for example, 2901.104-2(c)(2). </P>
              </SECTION>
              <SECTION>
                <SECTNO>2901.105-3 </SECTNO>
                <SUBJECT>Copies. </SUBJECT>
                <P>(a) Copies of the DOLAR published in the <E T="04">Federal Register</E>, CD-ROM, or Code of Federal Regulations may be purchased from the Superintendent of Documents, Government Printing Office, Washington, DC 20402, or from the Government Printing Office Web page, <E T="03">http://www.gpo.gov/.</E> Requests should reference the DOLAR as Chapter 29 of Title 48. The Code of Federal Regulations is printed in paperback edition with updates as needed. Additional information on DOL may be obtained on the Internet at www.dol.gov. Other DOL procurement policy documents referenced within the DOLAR may be available when appropriate by mail from the Division of Acquisition Management Services.</P>
              </SECTION>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2901.2—Administration</HD>
              <SECTION>
                <SECTNO>2901.201-1 </SECTNO>
                <SUBJECT>Maintenance of the FAR. </SUBJECT>
                <P>A member of the Division of Acquisition Management Services (DAMS), an organization within the Office of Acquisition and Management Support Services, the Business Operations Center, Office of the Assistant Secretary for Administration and Management (OASAM), represents the Department of Labor on the Civilian Agency Acquisition Council (CAAC). DAMS will be responsible for coordination with all interested DOL elements regarding proposed FAR revisions, and advocating revisions sought by DOL.</P>
              </SECTION>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2901.3—Agency Acquisition Regulations</HD>
              <SECTION>
                <SECTNO>2901.302 </SECTNO>
                <SUBJECT>Limitations. </SUBJECT>
                <P>DOLAR System issuances are limited to published, codified, Department-wide regulations, which implement or supplement FAR policies and procedures and which affect organizations or individuals seeking to contract with the Department. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2901.304 </SECTNO>
                <SUBJECT>Agency control and compliance procedures. </SUBJECT>
                <P>(a) The DOLAR is under the direct oversight and control of the Department's Procurement Executive. Procedures for review and approval of issuances under the DOLAR System comply with FAR Subparts 1.3 and 1.4. These procedures are contained in Subpart 2901.6. </P>
                <P>(b) DOLAR issuances shall comply with the restrictions in FAR 1.304(b). </P>

                <P>(c) Heads of Contracting Activity (HCAs) must submit all proposed instructions and materials that implement or supplement the DOLAR to the Director, DAMS. In conjunction with the Office of the Solicitor, DAMS will review all issuances whether or not they will be published in the <E T="04">Federal Register</E> as a part of the DOLAR System. In the case of internal procurement policy instructions, the purpose of the review is to ascertain that such instructions are consistent with the FAR and the DOLAR and that they do not contain information which should be issued under the DOLAR. </P>
              </SECTION>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2901.4—Deviations From the FAR and DOLAR </HD>
              <SECTION>
                <SECTNO>2901.403 </SECTNO>
                <SUBJECT>Individual deviations from the FAR. </SUBJECT>

                <P>(a) The Procurement Executive (PE) is authorized to approve deviations from FAR provisions (<E T="03">see</E> FAR 1.403) or DOLAR provisions, which affect only one contracting action, unless FAR 1.405(e) is applicable. Requests for deviations shall be submitted through the Director, DAMS. </P>
                <P>(b) Requests for deviations under paragraph (a) of this section must be submitted by the HCA and include justification as to why the deviation is required.</P>
                <P>(c) A copy of the approved deviation must be included in the contract file. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2901.404 </SECTNO>
                <SUBJECT>Class deviations. </SUBJECT>
                <P>(a) The PE is authorized to approve class deviations from FAR or DOLAR provisions which affect more than one contracting action, unless FAR 1.405(e) is applicable. The request for deviation is submitted through the Director, DAMS. </P>
                <P>(b) Requests for deviations under paragraph (a) of this section, must be submitted by the HCA and include justification as to why the deviation is required and the number of contracting actions which will be affected. </P>
                <P>(c) For a FAR class deviation the Director, DAMS will consult with the Chair of the CAAC, as required in FAR 1.404(a)(1), before authorizing the deviation. </P>
                <P>(d) A copy of the approved class deviation must be included in each contract file. </P>

                <P>(e) Recommended revisions to the FAR and a copy of each approved class <PRTPAGE P="48999"/>FAR deviation will be transmitted to the FAR Secretariat by the Director, DAMS as required in FAR 1.404. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2901.405 </SECTNO>
                <SUBJECT>Deviations pertaining to treaties and executive agreements. </SUBJECT>
                <P>(a) The Director, DAMS is responsible for transmitting to the FAR Secretariat the information required in FAR 1.405(d). </P>
                <P>(b) For deviations not authorized by FAR 1.405(b) or (c), the Director, DAMS will process the request for deviation through the FAR Secretariat. </P>
              </SECTION>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2901.6—Career Development, Contracting Authority, and Responsibilities. </HD>
              <SECTION>
                <SECTNO>2901.601 </SECTNO>
                <SUBJECT>General. </SUBJECT>
                <P>(a) This section deals with contracting authority and responsibilities of the head of the agency as described in 2902.1, FAR Subpart 1.6 and this subpart. </P>
                <P>(1) The authority and responsibility vested in the Secretary to contract for authorized supplies and services is delegated to the Assistant Secretary for Administration and Management (ASAM). </P>
                <P>(2) The ASAM may delegate contracting authority to a bureau or agency within the Department of Labor as he/she delineates in writing. </P>
                <P>(b) The Assistant Secretary for Administration and Management, acting through the Procurement Executive, may delegate additional procurement authority subject to the issuance of warrants by the Procurement Executive, and reserves the right to rescind any acquisition authority, if it is determined that such action is in the best interest of the Government. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2901.602 </SECTNO>
                <SUBJECT>Contracting officers. </SUBJECT>
              </SECTION>
              <SECTION>
                <SECTNO>2901.602-1 </SECTNO>
                <SUBJECT>Authority. </SUBJECT>

                <P>Contracting warrants, at all levels above the micropurchase threshold, must be requested by the HCA in writing and signed by the Procurement Executive. Warrants may be accompanied by letters of appointment that may provide requirements for maintaining the warrant (<E T="03">e.g.</E>, maintaining current documentation for the FAR, DOLAR, and other guidance, and recurrent training). Copies of the appointment shall be maintained in the Division of Acquisition Management Services. Contracting officers must display the original warrant (and its limitations) in their workspace. A listing of current contracting officers may be available for review on the Internet at <E T="03">http://www.dol.gov/oasam/grants/prgms.htm.</E> To modify a contracting officer's authority, the present appointment must be revoked and a new certificate issued. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2901.602-3 </SECTNO>
                <SUBJECT>Ratification of unauthorized commitments. </SUBJECT>
                <P>(a) If the HCA agrees that the commitment appears to be without valid authorization, the Division of Acquisition Management Services must be notified by the HCA in accordance with the procedures outlined in this section. </P>
                <P>(b) <E T="03">Ratifications—thresholds.</E> The Department of Labor may only ratify acquisitions that were intended to fulfill a bona fide need and otherwise were authorized when made. If the action to be ratified is not approved, then the employee who authorized the work may be liable for the entire cost of the action. Requests received by contracting officers for ratification of commitments made by personnel lacking contracting authority must be processed as follows: </P>
                <GPOTABLE CDEF="s100,r100,xs100" COLS="3" OPTS="L2,tp0,i1">
                  <TTITLE>  </TTITLE>
                  <BOXHD>
                    <CHED H="1">Dollar threshold </CHED>
                    <CHED H="1">Must be approved by (ratifying official) </CHED>
                    <CHED H="1">Steps to be followed </CHED>
                  </BOXHD>
                  <ROW>
                    <ENT I="01">Below the micropurchase threshold</ENT>
                    <ENT>Head of the Contracting Office </ENT>
                    <ENT>a through e &amp; g. </ENT>
                  </ROW>
                  <ROW>
                    <ENT I="01">Between the micropurchase threshold and the Simplified Acquisition Threshold </ENT>
                    <ENT>Head of Contracting Activity</ENT>
                    <ENT>a through e &amp; g. </ENT>
                  </ROW>
                  <ROW>
                    <ENT I="01">Above the Simplified Acquisition Threshold </ENT>
                    <ENT>ASAM, after review by the Procurement Review Board </ENT>
                    <ENT>a through g. </ENT>
                  </ROW>
                  <TNOTE>Note: DOL procurement policies require review by the Procurement Review Board of advisory and assistance services acquisitions above $50,000 for competitive acquisitions and at any dollar amount for noncompetitive acquisitions, and waivers for contracts with employees and recently separated employees. Therefore, review by the PRB is required for unauthorized obligations at these lower thresholds. </TNOTE>
                </GPOTABLE>
                <EXTRACT>
                  <HD SOURCE="HD2">Step Instruction </HD>
                  <P>(a) The individual is placed on notice by the contracting officer, in writing, that the purchase may be inappropriate because he did not have a purchasing request, funding, or authority to obligate the Government to make an expenditure of funds. </P>
                  <P>(i) The individual who made the unauthorized contractual commitment shall furnish the contracting officer all records and documents concerning the commitment and a complete written statement of the facts, including, but not limited to a statement as to why the acquisition office was not used, a description of work to be performed or products to be furnished, an estimated or agreed-upon contract price, citation of appropriation available, and a statement as to whether the contractor has commenced performance. </P>
                  <P>(ii) In the absence of such an individual, the head of the applicable office will be responsible for providing such information, including an explanation of why the individual who made the unauthorized commitment is unavailable to provide this information. </P>

                  <P>(b) The individual who made the unauthorized commitment or the head of the applicable office, as appropriate, shall provide a determination and finding (<E T="03">see</E> FAR 1.704) to the contracting officer indicating that: </P>
                  <P>(i) Supplies or services have been provided to and accepted by the Government, or the Government otherwise has obtained or will obtain a benefit resulting from performance of the unauthorized commitment; </P>
                  <P>(ii) A procurement request and/or accompanying documentation including a statement signed by the individual that explains why normal acquisition procedures were not followed, explains why the source was selected, lists other sources considered, describes the work, and estimates or states the agreed upon price. (If the DOL employee who made the unauthorized commitment is no longer available, appropriate program personnel must provide the information described in this paragraph); and </P>
                  <P>(iii) Funds are available and were available at the time of the unauthorized commitment. </P>
                  <P>(c) The contracting officer reviewing the unauthorized commitment shall determine whether the price is fair and reasonable, and if payment is recommended to the ratifying official. (The contracting officer may rely upon written documentation submitted by managing staff above the individual who made the unauthorized commitment, in making his/her determination.) </P>
                  <P>(d) Legal review is required before ratification by the ratifying official. </P>
                  <P>(e) The ratifying official shall make an affirmative determination and finding that: </P>
                  <P>(i) The resulting purchase order or contract would otherwise have been proper if made by an appropriate contracting officer. </P>
                  <P>(ii) The contracting officer reviewing the unauthorized commitment has determined that the price is fair and reasonable, and payment is recommended. </P>
                  <P>(f) For cases over the simplified acquisition threshold, all documentation for steps (a) through (e) must be forwarded to the Director, Division of Acquisition Management Services for submission to the Procurement Review Board. However, the ratifying official is responsible for directing the receipt and acceptance for all products and deliverables received by the Government as a result of an unauthorized commitment. </P>

                  <P>(g) The supervisor of the individual who made the unauthorized commitment shall prepare a corrective action plan to preclude further unauthorized commitments (<E T="03">e.g.</E> ethics, purchase card, or administrative <PRTPAGE P="49000"/>procedures training, or other appropriate action). The ratifying official may approve the corrective action plan. The individual shall report to the ratifying official in writing when the corrective action has been initiated and again after it has been fully implemented. </P>
                </EXTRACT>
              </SECTION>
              <SECTION>
                <SECTNO>2901.603</SECTNO>
                <SUBJECT>Selection, appointment, and termination of appointment. </SUBJECT>
              </SECTION>
              <SECTION>
                <SECTNO>2901.603-1</SECTNO>
                <SUBJECT>General. </SUBJECT>
                <P>(a) The Procurement Executive will develop and manage an acquisition career management program for contracting personnel. Training requirements must conform to Office of Federal Procurement Policy Letters 92-3, 97-01, and the Federal Acquisition Institutes curriculum. These references are available at: </P>
                
                <EXTRACT>
                  <FP>
                    <E T="03">http://www.arnet.gov/Library/OFPP/PolicyLetters/Letters/PL97-01.html, http://www.arnet.gov/Library/OFPP/PolicyLetters/Letters/PL92-3.html,</E> and through the Federal Acquisition Institute (FAI) at: <E T="03">http://www.faionline.com/fai/campus/index4.htm</E>.</FP>
                </EXTRACT>
                
                <P>(b) The program must cover all contracting personnel in the following categories: </P>
                <P>(1) <E T="03">General Schedule (GS-1102) Contracting Series</E> (See also FAR 1.603); </P>
                <P>(2) Contracting officers, regardless of General Schedule Series, with contracting authority above the simplified acquisition threshold; </P>
                <P>(3) Purchasing Series (GS-1105), other individuals performing purchasing duties and individuals with contracting authority between the micro-purchase and simplified acquisition thresholds. </P>
                <P>(4) All Contracting Officer Technical Representatives as identified in 2901.603-71. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2901.603-3</SECTNO>
                <SUBJECT>Appointment. </SUBJECT>
                <P>
                  <E T="03">General.</E> In accordance with FAR 1.603-3 appointments will be made in writing on an SF 1402 for all warrants above the micro-purchase threshold. In addition appointments may be made for specific functions unrelated to dollar threshold, such as indirect cost negotiation, debt management, closeout functions. </P>
                <P>(a) <E T="03">Purchase cards (micropurchase threshold).</E> Purchase cardholders will be appointed in accordance with the DOL Guidelines for Purchase Card Use and the Agency/Office procedures approved by the HCA. Agency/Organization Purchase Card Coordinators requesting issuance of a purchase card must be responsible for ensuring that the purchase cardholder has taken an orientation course before issuance and/or use of the purchase card. A list of purchase cardholders is available at: <E T="03">http://www.dol.gov/oasam/foia/hotfoia/citibank-list.htm</E>. </P>
                <P>(b) <E T="03">Simplified acquisition threshold (currently $100,000).</E> The HCA may request a delegation of procurement authority not to exceed the simplified acquisition threshold based on education, training, and experience, in the acquisition field. Effective October 1, 2003, all new appointments must comply with training requirements listed in “OFPP Policy Letter No. 92-3, Procurement Professionalism Program Policy-Training for Contracting Personnel”, dated June 24, 1992. </P>
                <P>(c) <E T="03">$500,000.</E> The HCA may request a delegation of procurement authority not to exceed $500,000 based on the individual's education, training and experience in contracting. Although primarily reserved for those in the GS 1102 series, the HCA may consider business acumen, education, training, and experience. Effective October 1, 2003, all new appointments must comply with training requirements listed in “OFPP Policy Letter No. 92-3, Procurement Professionalism Program Policy-Training for Contracting Personnel”, dated June 24, 1992. </P>
                <P>(d) <E T="03">Unlimited.</E> The HCA may request a delegation of procurement authority on an unlimited basis for individuals whose education, training, and experience in contracting warrant such authority. Although primarily reserved for those in the GS 1102 series, the HCA may consider length of service, training, and experience. Effective October 1, 2003, all new appointments must comply with training requirements listed in “OFPP Policy Letter No. 92-3, Procurement Professionalism Program Policy-Training for Contracting Personnel”, dated June 24, 1992. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2901.603-4</SECTNO>
                <SUBJECT>Terminations. </SUBJECT>

                <P>Termination of a contracting officer's appointment will be made in writing unless the warrant contains the basis for the termination (<E T="03">i.e.</E>, retirement, reassignment). Terminations may be immediate, but must not operate retroactively. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2901.603-70</SECTNO>
                <SUBJECT>Responsibility of other Government personnel. </SUBJECT>
                <P>(a) Only DOL personnel with contracting authority shall obligate DOL to any type of contractual obligation and only to the extent of their delegated authority. Responsibility for determining how to buy, the conduct of the buying process, and execution of the contract rests with the contracting officer. </P>
                <P>(b) Personnel responsible for determining agency needs should maintain a close and continuous relationship with their contracting officer to ensure that acquisition personnel are made aware of contemplated acquisition actions. This will be mutually beneficial in terms of better planning for acquisition action and more timely, efficient and economical acquisition. </P>
                <P>(c) Personnel not delegated contracting authority or insufficient contracting authority, may not commit the Government, formally or informally, to any type of contractual obligation. However, DOL personnel who must use the contracting process to accomplish their programs, must support the contracting officer to ensure that: </P>
                <P>(1) Requirements are clearly defined and specified without being overly restrictive in accordance with FAR 11.002; </P>
                <P>(2) Competitive sources are solicited, evaluated, and selected as appropriate; </P>

                <P>(3) The FAR and the Competition in Contracting Act requirements for full and open competition are satisfied to the maximum extent practicable. Sole source purchases may only be permitted in accordance with FAR Subpart 6.3 or other applicable provisions of the FAR (<E T="03">e.g.</E> FAR Part 8) or federal law. </P>
                <P>(4) Quality standards are prescribed, and met; </P>
                <P>(5) Performance or delivery is timely; </P>
                <P>(6) Files are documented to substantiate the judgments, decisions, and actions taken, including compliance with paragraphs (c)(2) and (3) of this section. </P>

                <P>(7) Requirements are written in so to encourage competition and to comply with regulations and federal policy for meeting acquisition goals such as performance-based contracting, HUBZone contractors, <E T="03">etc</E>. The contracting officer will identify these programs to the program office. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2901.603-71</SECTNO>
                <SUBJECT>Contracting Officer's Technical Representatives (COTR). </SUBJECT>

                <P>(a) At the time a COTR is to become responsible for a contract, task order, or delivery order, the contracting officer must issue a written letter of delegation informing the individual by name of his or her authority, including a delineation of applicable limitations and responsibilities. This applies to contracts awarded by the Department of Labor and those awarded by other agencies, such as Federal Supply Schedule Contracts or Economy Act transactions. Only the contracting officer cognizant of the contract action may make a COTR delegation. However, a contracting officer at any level above the cognizant contracting officer may sign the delegation letter, following his or her determination of its accuracy, completeness, and sufficiency. <PRTPAGE P="49001"/>
                </P>

                <P>(b) The functions of a COTR typically may include such actions as inspecting, testing, and accepting contract line items, monitoring the contractor's performance, controlling Government-furnished property, reviewing and approving and/or recommending to the contracting officer approval/disapproval of vouchers/invoices, <E T="03">etc</E>. An individual COTR may have only the duties specifically identified in a written delegation to him or her by name (<E T="03">i.e.</E>, COTR duties may not be delegated to a position) and has no authority to exceed them. </P>
                <P>(c) Contracting officers may not delegate to the COTR the following authorities: </P>
                <P>(1) The authority to issue task or delivery orders against a contract or any of the agreements defined under FAR 16.7; </P>
                <P>(2) The authority to change any of the terms and conditions of a contract or any of the agreements defined under FAR 16.7; </P>
                <P>(3) The authority to sign contracts or contract modifications; </P>
                <P>(4) The authority to write letters to the contractor that will affect the cost or schedule of the contract. The authority to otherwise write letters to a contractor must require the COTR to send a copy of the letters to the contracting officer for the contract file; </P>
                <P>(5) The authority to approve contractors' final invoices under cost-reimbursement contracts. However, the COTR must make a final payment recommendation to the contracting officer; or </P>

                <P>(6) The authority to commit the Government to any adjustments to the price or cost of the contract or order (<E T="03">e.g.</E>, the contracting officer must sign all pre-negotiation and price negotiation memoranda including those which may be combined into one document for those adjustments valued at $100,000 or less). </P>
                <P>(d) The contracting officer's delegation must include the admonition that the COTR may be personally liable for unauthorized commitments. Contracting officer authority to sign or authorize contractual instruments must not be delegated through a COTR designation or by any means other than a contracting officer warrant. </P>
                <P>(e) The contractor must be notified of the COTR designation in writing and a copy of the COTR letter of appointment also must be provided to the contractor. The contracting officer must provide the COTR with a copy of the COTR designation notification that was sent to the contractor. </P>
                <P>(f) The letter delegating COTR authority must include the contract number, and must include the following information, at a minimum: </P>
                <P>(1) Contracting officer's and contract specialist's/administrator's name and telephone number; </P>
                <P>(2) COTR's specific authority and responsibilities; </P>
                <P>(3) COTR's specific limitations, including the admonition that the COTR may be personally liable for unauthorized commitments; </P>
                <P>(4) Detailed description of the types of files and the content of the files to be maintained by the COTR; </P>

                <P>(5) Reference to meeting applicable requirements for ethics, procurement integrity, no conflict of interest, and proper standards of conduct, including a copy of FAR Part 3, and other regulations, statutes, or directives governing these topics (<E T="03">e.g.</E>, 5 CFR Part 2635, Standards of Conduct); </P>
                <P>(6) A requirement that the COTR acknowledge receipt and acceptance of the letter and return it to the contracting officer. </P>
                <P>(7) A description of the training required and information on obtaining such training. </P>
                <P>(g) <E T="03">Applicability.</E> The eligibility requirements of this subpart must apply to all individuals who are designated by the contracting officer as COTRs. </P>
                <P>(h) <E T="03">Eligibility standards.</E> To be determined eligible for an appointment as a DOL COTR, the following standards must be met: </P>
                <P>(1) The candidate must attend and successfully complete a minimum of a 16-hour basic COTR course; and </P>
                <P>(2) The candidate must attend a minimum of 1 hour of training specifically in procurement ethics, either through courses offered periodically by the Department of Labor, another federal agency's program, or a commercial vendor. </P>
                <P>(i) <E T="03">Limitations.</E> Effective October 1, 2003, each COTR appointment made by the contracting officer must clearly state that the representative is not an authorized contracting officer and does not have the authority under any circumstances to: </P>
                <P>(1) Award, agree to award, or execute any contract, contract modification, notice of intent, or other form of binding agreement; </P>
                <P>(2) Obligate, in any manner, the payment of money by the Government; </P>
                <P>(3) Make a final decision on any contract matter which is subject to the clause at FAR 52.233-1, Disputes; or </P>
                <P>(4) Terminate, suspend, or otherwise interfere with the contractor's right to proceed, or direct any changes in the contractor's performance that are inconsistent with or materially change the contract specifications. </P>
                <P>(j) <E T="03">Termination.</E> (1) Termination of the COTR's appointment must be made in writing by a contracting officer and must give the effective date of the termination. The contracting officer must promptly modify the contract once a COTR termination notice has been issued. A termination notice is not required when the COTR's appointment terminates upon expiration of the contract. </P>
                <P>(2) COTRs may be terminated for reasons (not an exhaustive listing) such as exceeding their authorities and limitations, conflicts of interest, unethical conduct, failure to perform, reassignment/resignation/retirement, and upon completion of the contract to which assigned. </P>
                <P>(k) <E T="03">Waivers.</E> No individual may serve as a COTR on any contract without the requisite training and signed COTR certificate for the file. In the rare event that there is an urgent requirement for a specific individual to serve as a COTR and the individual has not successfully completed the required training, the HCA may waive the training requirements and authorize the individual to perform the COTR duties. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2901.603-72 </SECTNO>
                <SUBJECT>Administrative procurement reviews. </SUBJECT>
                <P>(a) The Procurement Executive (PE) is responsible for performing administrative procurement reviews for each procurement office in the Department of Labor except the Office of Inspector General (OIG). The purpose of these reviews is to audit internal controls to ensure compliance with established procurement law, regulations, policies, procedures and applicable directives. The reviews are to emphasize the development and improvement of managerial controls and best practices. </P>
                <P>(b) The administrative procurement review system is a three-pronged approach that includes self-assessment, statistical data for validation, and flexible quality reviews and assessment techniques. This system is required to: </P>
                <P>(1) Evaluate the effectiveness and efficiency of office acquisition systems; </P>
                <P>(2) Assess the adequacy of policies, procedures and regulations governing the acquisition process; and </P>
                <P>(3) Identify and implement changes necessary to improve the systems. </P>
                <P>(c) The PE shall establish procurement review procedures, which will focus on: </P>
                <P>(1) Conformance with policies of the FAR, DOLAR and the Department of Labor Manual Series 2-800 and 2-900. </P>

                <P>(2) Conformance with federal reporting requirements for the Department of Labor. <PRTPAGE P="49002"/>
                </P>

                <P>(3) Understanding of new department-wide or government-wide initiatives (<E T="03">e.g.</E>, E-Procurement). </P>
                <P>(4) Government-wide procedures established by the Office of Management and Budget. </P>
                <P>(d) HCAs are responsible for ensuring contracting activity compliance with law and regulations through the review and oversight process.</P>
              </SECTION>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2901.7—Determinations and Findings</HD>
              <SECTION>
                <SECTNO>2901.707 </SECTNO>
                <SUBJECT>Signatory authority.</SUBJECT>
                <P>A class justification for other than full and open competition must be approved in writing by the same approval authority as for individual justifications in accordance with FAR 6.304(a). The approval level must be determined by the estimated total value of the class.</P>
                
              </SECTION>
            </SUBPART>
          </PART>
          <PART>
            <HD SOURCE="HED">PART 2902—DEFINITIONS OF WORDS AND TERMS</HD>
            <CONTENTS>
              <SECHD>Sec.</SECHD>
              <HD SOURCE="HD1">
                <E T="42">2902.1—Definitions</E>
              </HD>
              <SECTNO>2902.101</SECTNO>
              <SUBJECT>Definitions.</SUBJECT>
            </CONTENTS>
            <AUTH>
              <HD SOURCE="HED">Authority:</HD>
              <P>5 U.S.C. 301, 40 U.S.C. 486(c).</P>
            </AUTH>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2.1—Definitions</HD>
              <SECTION>
                <SECTNO>2902.101 </SECTNO>
                <SUBJECT>Definitions.</SUBJECT>
                <P>(a) Commonly used words and terms are defined in FAR Subpart 2.1. This Part 2902 gives DOL-specific meanings for some of these words and terms and defines other words and terms commonly used in the DOL acquisition process.</P>
                <P>(b) The following words and terms are used as defined in this subpart unless the context in which they are used clearly requires a different meaning, or a different definition is prescribed for a particular part or portion of a part:</P>
                <P>
                  <E T="03">Competition Advocate.</E> The Competition Advocate for the Department of Labor is appointed by the ASAM and is defined in FAR 6.5 and 2906.5. If the appointee is recused from a procurement action, the ASAM may designate another official to act in that capacity.</P>
                <P>
                  <E T="03">Contracting activity</E> means an agency or component office within the Department of Labor with specific responsibility for managing contract functions pursuant to one or more warrants signed by the Procurement Executive (or the Office of the Inspector General for its contracting activity).</P>
                <P>
                  <E T="03">Contracting Officer's Technical Representative</E> means the individual appointed by the contracting officer to represent the Department of Labor's programmatic interests on a Department of Labor contract, task order, or delivery order. This individual is responsible to the contracting officer for overseeing receipt and acceptance of goods/services by the Government, reporting on the contractor's performance, and approving/disapproving payment to the Contractor. Authority is otherwise limited to giving technical direction to the Contractor within the framework of the contract (<E T="03">see</E> 2901.603-71). This position may go by other titles, such as: A technical point of contact (TPOC), or Contacting Officer's Representative (COR).</P>
                <P>
                  <E T="03">Head of Agency</E> (also called agency head), for the FAR and DOLAR only, means the Assistant Secretary for Administration and Management; except that, the Secretary of Labor is the head of Agency for acquisition actions which by the terms of a statute or delegation must be performed specifically by the Secretary of Labor; the Inspector General is the Head of Agency in all cases for the Office of the Inspector General. Authority to act as the Head of Agency has been delegated to the Assistant Secretary for Employment and Training and the Assistant Secretary for Mine Safety and Health for their respective agencies. For purposes of the Economy Act, (determinations and interagency agreements under FAR 17.5) only, the Employment Benefits Administration, Employment Standards Administration, Women's Bureau, Office of Solicitor, Bureau of Labor Statistics, Office of Disability Employment, and the Occupational Safety and Health Administration are delegated contracting authority.</P>
                <P>
                  <E T="03">Head of Contracting Activity (HCA)</E> means the official who has overall responsibility for managing the contracting activity, when the contracting activity has more than one person with a warrant issued by the Procurement Executive. In the Department of Labor the following officials are the HCA for their respective organization: </P>
                <P>(i) For the Mine Safety and Health Administration, the Director, Administration and Management, MSHA. </P>
                <P>(ii) For the Employment and Training Administration, the Director, Office of Grants and Contract Management, ETA. </P>
                <P>(iii) For the Office of Inspector General, the Director, Division of Finance and Administration, OIG. </P>
                <P>(iv) For the Bureau of Labor Statistics, the Director, Division of Administrative Services, BLS. </P>
                <P>(v) For the Office of the Assistant Secretary for Administration and Management and all other agencies not listed in this definition, the Director, Business Operations Center, OASAM. </P>
                <P>
                  <E T="03">Procurement Executive</E> means the Director, Business Operations Center, and is synonymous with the term “Senior Procurement Executive” as defined at FAR 2.101. </P>
              </SECTION>
            </SUBPART>
          </PART>
          <PART>
            <HD SOURCE="HED">PART 2903—IMPROPER BUSINESS PRACTICES AND PERSONAL CONFLICTS OF INTEREST </HD>
            <CONTENTS>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2903.1—Safeguards </HD>
                <SECHD>Sec. </SECHD>
                <SECTNO>2903.101 </SECTNO>
                <SUBJECT>Standards of Conduct.</SUBJECT>
                <SECTNO>2903.101-1 </SECTNO>
                <SUBJECT>General. </SUBJECT>
                <SECTNO>2903.104 </SECTNO>
                <SUBJECT>Procurement integrity. </SUBJECT>
                <SECTNO>2903.104-3 </SECTNO>
                <SUBJECT>Definition. </SUBJECT>
                <SECTNO>2903.104-5 </SECTNO>
                <SUBJECT>Disclosure, protection, and marking of contractor bid or proposal information and source selection information. </SUBJECT>
                <SECTNO>2903.104-7 </SECTNO>
                <SUBJECT>Violations or possible violations. </SUBJECT>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2903.2—Contractor Gratuities to Government Personnel</HD>
                <SECTNO>2903.203 </SECTNO>
                <SUBJECT>Reporting suspected violations of the Gratuities clause. </SUBJECT>
                <SECTNO>2903.204 </SECTNO>
                <SUBJECT>Treatment of violations. </SUBJECT>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2903.6—Contracts With Government Employees or Organizations Owned or Controlled by Them </HD>
                <SECTNO>2903.601 </SECTNO>
                <SUBJECT>Policy. </SUBJECT>
                <SECTNO>2903.602 </SECTNO>
                <SUBJECT>Exceptions. </SUBJECT>
              </SUBPART>
            </CONTENTS>
            <AUTH>
              <HD SOURCE="HED">Authority:</HD>
              <P>5 U.S.C. 301, 40 U.S.C. 486(c). </P>
            </AUTH>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2903.1—Safeguards</HD>
              <SECTION>
                <SECTNO>2903.101 </SECTNO>
                <SUBJECT>Standards of conduct. </SUBJECT>
              </SECTION>
              <SECTION>
                <SECTNO>2903.101-1 </SECTNO>
                <SUBJECT>General. </SUBJECT>
                <P>The statutory prohibitions and their application to DOL personnel are discussed in the Standards of Ethical Conduct for Employees of the Executive Branch, 5 CFR Part 2635 and the supplemental DOL standards of conduct, 5 CFR Part 5201. All DOL personnel involved in acquisitions must become familiar with these statutory prohibitions. Any questions concerning them must be referred to an Agency Ethics Official in the Office of the Solicitor. In addition to criminal penalties, the statutes provide that transactions entered into in violation of these prohibitions are voidable (18 U.S.C. 218). Any suspected violations must be reported promptly to the Office of Inspector General. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2903.104 </SECTNO>
                <SUBJECT>Procurement integrity. </SUBJECT>
              </SECTION>
              <SECTION>
                <SECTNO>2903.104-3 </SECTNO>
                <SUBJECT>Definitions. </SUBJECT>
                <P>
                  <E T="03">Agency ethics official</E> means the Solicitor or the Associate Solicitor for Legislation and Legal Counsel (LLC). </P>
              </SECTION>
              <SECTION>
                <PRTPAGE P="49003"/>
                <SECTNO>2903.104-5 </SECTNO>
                <SUBJECT>Disclosure, protection, and marking of contractor bid or proposal information and source selection information. </SUBJECT>
                <P>(a) Government employees serving in the following positions are authorized access to proprietary or source selection information, but only to the extent necessary to perform their official duties: </P>

                <P>(1) Personnel participating in technical evaluation panels (<E T="03">i.e.</E>, source selection board) or personnel evaluating an offeror's or bidder's technical or cost proposal under other competitive procedures, and personnel evaluating protests. </P>
                <P>(2) Personnel assigned to the contracting office. </P>
                <P>(3) The initiator of the procurement request (to include the official having principal technical cognizance over the requirement). </P>
                <P>(4) Small business specialists. </P>
                <P>(5) Personnel assigned to the Office of the Solicitor. </P>
                <P>(6) Personnel assigned to the Department of Labor's Division of Cost Determination and the Defense Contract Audit Agency. </P>
                <P>(7) Personnel assigned to the Division of Acquisition Management Services. </P>
                <P>(8) Members of the Procurement Review Board. </P>
                <P>(9) The Office of Inspector General. </P>
                <P>(10) Other Government employees authorized by the contracting officer. </P>
                <P>(11) Supervisors, at any level, of the personnel listed in this paragraph (a). </P>
                <P>(b) The originator of information that may be source selection information must consult with the contracting officer or the procurement officer, who must determine whether the information is source selection information. DOL personnel responsible for preparing source selection information as defined in FAR 2.101 must assure that the material is marked with the legend in FAR 3.104-4 at the time the material is prepared. </P>

                <P>(c) Unless marked with the legend “SOURCE SELECTION INFORMATION—SEE FAR 3.104-4,” draft specifications, purchase descriptions, and statements of work could erroneously be released during a market survey in order to determine the capabilities of potential competitive sources (<E T="03">see</E> FAR 7.1 and 7.10). </P>
              </SECTION>
              <SECTION>
                <SECTNO>2903.104-7 </SECTNO>
                <SUBJECT>Violations or possible violations of standards of conduct. </SUBJECT>
                <P>(a) The Procurement Executive is the individual designated to receive the contracting officer's report of violations. </P>
                <P>(b) The HCA or designee must refer all information describing an actual or possible violation to the Associate Solicitor for Legislation and Legal Counsel (LLC), the Procurement Executive and Inspector General staff. </P>
              </SECTION>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2903.2—Contractor Gratuities to Government Personnel</HD>
              <SECTION>
                <SECTNO>2903.203 </SECTNO>
                <SUBJECT>Reporting suspected violations of the Gratuities clause. </SUBJECT>
                <P>Contractor gratuities offered to Government personnel are subject to the restriction under the Standards of Ethical Conduct for the Employees of the Executive Branch, 5 CFR Part 2635. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2903.204 </SECTNO>
                <SUBJECT>Treatment of violations. </SUBJECT>

                <P>Any suspected violations of FAR Subpart 3.2 and the clause at<E T="03"> FAR 52.203-3,</E> Gratuities, must be reported to the Office of Inspector General. The authority to determine whether a violation of the Gratuities clause by the contractor, its agent, or another representative, has occurred and the appropriate remedies are delegated to the HCA. </P>
              </SECTION>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2903.6—Contracts With Government Employees or Organizations Owned or Controlled by Them</HD>
              <SECTION>
                <SECTNO>2903.601 </SECTNO>
                <SUBJECT>Policy. </SUBJECT>
                <P>In addition to restrictions placed on current federal government employees, 18 U.S.C. 207 places some restrictions on contracting with former officers, employees, and elected officials of the executive and legislative branches. Under these prohibitions, contracts with former employees are prohibited for a period of one year from the date of severance of duties unless an exception is granted as set forth in 2903.602. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2903.602 </SECTNO>
                <SUBJECT>Exceptions. </SUBJECT>
                <P>(a) In accordance with FAR 3.602, only when there is a most compelling reason to do so, is the ASAM authorized to except a contract from the policy in FAR 3.601, after the Procurement Review Board and the agency ethics official have reviewed and recommended approval of the exception. However, when time does not permit, the ASAM may unilaterally approve an exception. The exception and information supporting the exception must be provided to the contracting officer for their official records. </P>
                <P>(b) When an exception under this subpart is requested, it is submitted through the director of the cognizant program office to the HCA. In the procurement request, the director must describe the basis for the exception from the restrictions of FAR 3.601. </P>
                <P>(c) The Department of Labor may enter into a negotiated contract or an amendment to an existing contract with former employees of DOL within one year of separation (or with firms in which former employees are known to have a substantial interest) only after review and recommendation for approval by the agency ethics official, the Procurement Review Board, and written approval by the ASAM. </P>
                <P>(d) Approval of a decision to grant an exception as provided in the section must be documented by a written findings and determination prepared by the requesting official for signature by the Assistant Secretary for Administration and Management. The determination and findings must document compliance with FAR 3.603, FAR 9.5 and DOLAR 2909.5; specify the compelling reason(s) for award; and be placed in the contract files and the files of the PRB.</P>
              </SECTION>
            </SUBPART>
          </PART>
          <PART>
            <HD SOURCE="HED">PART 2904—ADMINISTRATIVE MATTERS </HD>
            <CONTENTS>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2904.6—Contract Reporting </HD>
                <SECHD>Sec.</SECHD>
                <SECTNO>2904.601 </SECTNO>
                <SUBJECT>Record requirements.</SUBJECT>
                <SECTNO>2904.602 </SECTNO>
                <SUBJECT>Federal Procurement Data System. </SUBJECT>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2904.8—Government Contract Files</HD>
                <SECTNO>2904.800-70 </SECTNO>
                <SUBJECT>Contents of contract files. </SUBJECT>
                <APP>Appendix A to Part 2904 </APP>
              </SUBPART>
            </CONTENTS>
            <AUTH>
              <HD SOURCE="HED">Authority:</HD>
              <P>5 U.S.C. 301, 40 U.S.C. 486(c). </P>
            </AUTH>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2904.6—Contract Reporting</HD>
              <SECTION>
                <SECTNO>2904.601 </SECTNO>
                <SUBJECT>Record requirements. </SUBJECT>
                <P>Appendix A to Part 2904 contains a list of recurring reports requested of the Department of Labor. Unless otherwise noted, procurement offices must submit the information identified to the Division of Acquisition Management Services for consolidation into a single report. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2904.602 </SECTNO>
                <SUBJECT>Federal Procurement Data System. </SUBJECT>
                <P>(a) DOL's data collection point is the Business Operations Center, Division of Acquisition Management Services, U.S. Department of Labor, 200 Constitution Avenue. NW., Washington, DC 20210. </P>
                <P>(b) The SF 279, Individual Contract Action Report (over $25,000), and SF 281, Summary of Contract Actions of $25,000 or less, are due by the tenth day of each month. </P>
              </SECTION>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2904.8—Government Contract Files</HD>
              <SECTION>
                <SECTNO>2904.800-70 </SECTNO>
                <SUBJECT>Contents of contract files. </SUBJECT>
                <P>(a) The reports listed in Appendix A to this part are applicable to the Department of Labor. </P>

                <P>(b) HCAs must be responsible for establishing standard contract files for <PRTPAGE P="49004"/>their contracting activities. The HCA must provide one or more representative contract files to the Director, Division of Acquisition Management Services (DAMS) as requested for comment. </P>
                <APPENDIX>
                  <HD SOURCE="HED">Appendix A to Part 2904 </HD>
                  <GPOTABLE CDEF="s50,r50,r50,r50" COLS="4" OPTS="L2,tp0,i1">
                    <TTITLE>  </TTITLE>
                    <BOXHD>
                      <CHED H="1">Title of report </CHED>
                      <CHED H="1">Reference </CHED>
                      <CHED H="1">Date due </CHED>
                      <CHED H="1">Submitted to</CHED>
                    </BOXHD>
                    <ROW>
                      <ENT I="01">1. Report of Proposed Federal Construction* </ENT>
                      <ENT>29 CFR 1.4 </ENT>
                      <ENT>Annually; 20-Aug </ENT>
                      <ENT>ESA Davis Bacon.</ENT>
                    </ROW>
                    <ROW>
                      <ENT I="01">2. Contractor Report of Government Property* </ENT>
                      <ENT>
                        <E T="03">FAR Chapter 45</E>
                      </ENT>
                      <ENT>Annually; 31-Oct </ENT>
                      <ENT>ASC.</ENT>
                    </ROW>
                    <ROW>
                      <ENT I="01">3. Major Preference Program Goals and Achievements Report* </ENT>
                      <ENT>DLMS 2 1000 </ENT>
                      <ENT>By the 20th of each Month </ENT>
                      <ENT>OSBP.</ENT>
                    </ROW>
                    <ROW>
                      <ENT I="01">4. Semi-annual Labor Enforcement Report </ENT>
                      <ENT>
                        <E T="03">FAR Chapter 22; 29 CFR 5.7(b)</E>
                      </ENT>
                      <ENT>Semi-annually; April 25 and 25-Oct </ENT>
                      <ENT>ESA Service Contract Act.</ENT>
                    </ROW>
                    <ROW>
                      <ENT I="01">5. A-76 &amp; FAIR Act Inventory </ENT>
                      <ENT>
                        <E T="03">FAIR ACT &amp; OMB MEMO</E>
                      </ENT>
                      <ENT>June 30th of each year </ENT>
                      <ENT>OAMS.</ENT>
                    </ROW>
                    <ROW>
                      <ENT I="01">6. SF 281, FPDS Summary Contract Action Report ($25,000 or Less) </ENT>
                      <ENT>
                        <E T="03">FAR Subpart 4.6</E>
                      </ENT>
                      <ENT>Quarterly; January 25, April 25, July 25, and 25-Oct </ENT>
                      <ENT>DAMS.</ENT>
                    </ROW>
                    <ROW>
                      <ENT I="01">7. SF 294, Subcontracting Report for Individual Contracts </ENT>
                      <ENT>
                        <E T="03">FAR Subpart 19.7</E> SF 294 </ENT>
                      <ENT>Semi-annually; April 30; 30-Oct </ENT>
                      <ENT>contracting officer.</ENT>
                    </ROW>
                    <ROW>
                      <ENT I="01">8. SF 295, Summary Subcontract Report </ENT>
                      <ENT>
                        <E T="03">FAR Subpart 19.7</E>
                      </ENT>
                      <ENT>Semi-annually March 30, September 30 </ENT>
                      <ENT>contracting officer.</ENT>
                    </ROW>
                    <ROW>
                      <ENT I="01">9. Value Engineering Report* </ENT>
                      <ENT>OMB Circular A-131 </ENT>
                      <ENT>Annually; 7-Dec </ENT>
                      <ENT>DAMS.</ENT>
                    </ROW>
                    <ROW>
                      <ENT I="01">10. Report on Federal Support to Universities, Colleges, and Nonprofit Institutions </ENT>
                      <ENT>Section 3(a)(7) of the National Science Foundation(NSF) Act </ENT>
                      <ENT>Annually; O/A, 15-May </ENT>
                      <ENT>Upon request, From NSF.</ENT>
                    </ROW>
                    <ROW>
                      <ENT I="01">11. Procurement Forecast, Initial and Update </ENT>
                      <ENT>Pub. L. 100-656 </ENT>
                      <ENT>Sept 15 (Init.) and Apr 15 (Update) </ENT>
                      <ENT>DAMS</ENT>
                    </ROW>
                    <TNOTE>For those reports with an (*), if there was no activity for the period being reported, a negative response for the period must be submitted to the requisitioning office.</TNOTE>
                  </GPOTABLE>
                  <HD SOURCE="HD1">
                    <E T="42">SUBCHAPTER B—ACQUISITION PLANNING</E>
                  </HD>
                  <PARTHD>PART 2905—PUBLICIZING CONTRACT ACTIONS </PARTHD>
                  <CONTENTS>
                    <SUBPART>
                      <HD SOURCE="HED">Subpart 2905.1—Dissemination of Information</HD>
                      <SECHD>Sec. </SECHD>
                      <SECTNO>2905.101 </SECTNO>
                      <SUBJECT>Methods of disseminating information. </SUBJECT>
                    </SUBPART>
                    <SUBPART>
                      <HD SOURCE="HED">Subpart 2905.2—Synopsis of Proposed Contract Actions </HD>
                      <SECTNO>2905.202 </SECTNO>
                      <SUBJECT>Exceptions. </SUBJECT>
                    </SUBPART>
                    <SUBPART>
                      <HD SOURCE="HED">Subpart 2905.4—Release of Information</HD>
                      <SECTNO>2905.402 </SECTNO>
                      <SUBJECT>General public. </SUBJECT>
                      <SECTNO>2905.403 </SECTNO>
                      <SUBJECT>Requests from Members of Congress.</SUBJECT>
                      <SECTNO>2905.404 </SECTNO>
                      <SUBJECT>Release procedures. </SUBJECT>
                    </SUBPART>
                    <SUBPART>
                      <HD SOURCE="HED">Subpart 2905.5—Paid Advertisements</HD>
                      <SECTNO>2905.502 </SECTNO>
                      <SUBJECT>Authority. </SUBJECT>
                      <SECTNO>2905.503 </SECTNO>
                      <SUBJECT>Procedures.</SUBJECT>
                    </SUBPART>
                  </CONTENTS>
                  <AUTH>
                    <HD SOURCE="HED">Authority:</HD>
                    <P>5 U.S.C. 301; 40 U.S.C. 486(c). </P>
                  </AUTH>
                </APPENDIX>
              </SECTION>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2905.1—Dissemination of Information</HD>
              <SECTION>
                <SECTNO>2905.101 </SECTNO>
                <SUBJECT>Methods of disseminating information. </SUBJECT>
                <P>Contracting officers may only use the Government Point of Entry (GPE) for synopsis and dissemination of information concerning procurement actions. The Division of Acquisition Management Services manages the DOL's account. </P>
              </SECTION>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2905.2—Synopsis of Proposed Contract Actions</HD>
              <SECTION>
                <SECTNO>2905.202 </SECTNO>
                <SUBJECT>Exceptions. </SUBJECT>
                <P>The Assistant Secretary for Administration and Management is authorized to make the determination prescribed in FAR 5.202(b). A written determination documenting the reasons why advance notice is not appropriate or reasonable must be submitted by the HCA for appropriate action including communication with the officials listed in FAR 5.202(b). </P>
              </SECTION>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2905.4—Release Of Information</HD>
              <SECTION>
                <SECTNO>2905.402 </SECTNO>
                <SUBJECT>General public. </SUBJECT>
                <P>(a) Unless the HCA determines that disclosure would be prejudicial to the interests of DOL, the bidder's mailing list or solicitation mailing list may be released upon request. </P>
                <P>(b) Any request for release of information is subject to the Freedom of Information Act and FAR 24.2. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2905.403 </SECTNO>
                <SUBJECT>Requests from Members of Congress.</SUBJECT>
                <P>All proposed responses to Congressional inquiries must be prepared and forwarded for coordination with the Office of the Solicitor and the Office of Congressional and Intergovernmental Affairs to determine whether circumstances exist that will allow the release of additional information. In such instances, the Congressional requestor must be furnished an interim reply providing the information that is releasable. The interim reply must describe the problem that precludes release of any requested materials, and describe generally what steps, if any, are being taken to make such information available. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2905.404 </SECTNO>
                <SUBJECT>Release procedures. </SUBJECT>
                <P>Heads of contracting activities are authorized to release long-range acquisition estimates under the conditions in FAR 5.404-1. </P>
              </SECTION>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2905.5—Paid Advertisements </HD>
            </SUBPART>
            <P>This subpart provides policies and procedures for the procurement of paid advertising as covered by 5 U.S.C. 302, 44 U.S.C. 3701, 3702, and 3703. </P>
            <SECTION>
              <SECTNO>2905.502 </SECTNO>
              <SUBJECT>Authority. </SUBJECT>
              <P>When it is deemed necessary to use paid advertisements in newspapers and trade journals, written authority for such publication may be obtained from the HCA or designee. </P>
            </SECTION>
            <SECTION>
              <SECTNO>2905.503 </SECTNO>
              <SUBJECT>Procedures. </SUBJECT>

              <P>(a) Prior to obtaining HCA approval, an agency should seek legal review to determine whether it has appropriate legal authority for advertising. The HCA exercising the authority delegated by 2905.502 must do so in accordance with the procedures set forth in FAR 5.503 and those in this section.<PRTPAGE P="49005"/>
              </P>
              <P>(b) Requests for procurement of advertising must be accompanied by written authority to advertise or publish which sets forth justification and includes the names of newspapers or journals concerned, frequency and dates of proposed advertisements, estimated cost, and other pertinent information.</P>
            </SECTION>
          </PART>
          <PART>
            <HD SOURCE="HED">PART 2906—COMPETITION REQUIREMENTS</HD>
            <CONTENTS>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2906.3—Other Than Full and Open Competition</HD>
                <SECHD>Sec.</SECHD>
                <SECTNO>2906.301 </SECTNO>
                <SUBJECT>Policy.</SUBJECT>
                <SECTNO>2906.303 </SECTNO>
                <SUBJECT>Justifications.</SUBJECT>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2906.5—Competition Advocates</HD>
                <SECTNO>2906.501 </SECTNO>
                <SUBJECT>Requirement.</SUBJECT>
              </SUBPART>
            </CONTENTS>
            <AUTH>
              <HD SOURCE="HED">Authority:</HD>
              <P>5 U.S.C. 301; 40 U.S.C. 486(c).</P>
            </AUTH>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2906.3—Other Than Full and Open Competition</HD>
              <SECTION>
                <SECTNO>2906.301 </SECTNO>
                <SUBJECT>Policy.</SUBJECT>
                <P>(a) Department of Labor acquisitions must comply with the Department of Labor Manual Series (DLMS) 2, Chapter 830 (available for review on the Department of Labor's website or by mail from the Director, Division of Acquisition Management Services, 200 Constitution Ave., NW., Washington, DC 20210-0001). Any proposed noncompetitive acquisition in excess of the simplified acquisition threshold must be fully justified and, if required by the DLMS, submitted to the DOL Procurement Review Board and approved by the Assistant Secretary for Administration and Management and, in the case of research and development contracts, also by the Assistant Secretary for Policy.</P>
                <P>(b) With the exception of contracts for advisory and assistance services or for research and development, the contracting officer has the authority below the simplified acquisition threshold to approve sole source contracts. The contracting officer is responsible for assuring that proposed acquisitions below the simplified acquisition threshold are in compliance with FAR and DOLAR requirements regarding competition.</P>
              </SECTION>
              <SECTION>
                <SECTNO>2906.303 </SECTNO>
                <SUBJECT>Justifications.</SUBJECT>
                <P>The authority of the agency head to determine that only specified make and models of technical equipment will satisfy the agency's need under FAR 6.302-1 is delegated to the HCA.</P>
              </SECTION>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2906.5—Competition Advocate</HD>
              <SECTION>
                <SECTNO>2906.501 </SECTNO>
                <SUBJECT>Requirement.</SUBJECT>
                <P>The Assistant Secretary for Administration and Management must appoint a Competition Advocate for the Department of Labor. The appointment will be predicated on an understanding of the competition requirements in the FAR, and particularly small business programs.</P>
              </SECTION>
            </SUBPART>
          </PART>
          <PART>
            <HD SOURCE="HED">PART 2907—ACQUISITION PLANNING</HD>
            <CONTENTS>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2907.1—Acquisition Plans</HD>
                <SECHD>Sec.</SECHD>
                <SECTNO>2907.105 </SECTNO>
                <SUBJECT>Contents of written acquisition plans.</SUBJECT>
                <SECTNO>2907.107 </SECTNO>
                <SUBJECT>Orders against Federal Supply Schedule contracts, Governmentwide acquisition contracts (GWACs), or other existing indefinite-delivery contracts.</SUBJECT>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2907.3—Contractor Versus Government Performance</HD>
                <SECTNO>2907.300 </SECTNO>
                <SUBJECT>Scope of subpart.</SUBJECT>
              </SUBPART>
            </CONTENTS>
            <AUTH>
              <HD SOURCE="HED">Authority:</HD>
              <P>5 U.S.C. 301; 40 U.S.C. 486(c).</P>
            </AUTH>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2907.1—Acquisition Plans</HD>
              <SECTION>
                <SECTNO>2907.105 </SECTNO>
                <SUBJECT>Contents of written acquisition plans.</SUBJECT>

                <P>The Department of Labor has implemented its acquisition planning system in compliance with FAR 7.1 and internal procedures provided in DLMS 2 Section 834. The annual forecast is available for review from: <E T="03">http://www.apps.dol.gov/contract grant/index.htm.</E>
                </P>
              </SECTION>
              <SECTION>
                <SECTNO>2907.107 </SECTNO>
                <SUBJECT>Additional requirements for acquisitions involving bundling.</SUBJECT>
                <P>The FAR requirements for justification, review, and approval of bundling of contract requirements also apply to an order from a Federal Supply Schedule contract, Governmentwide acquisition contract, or other indefinite-delivery contract if the requirements consolidated under the order meet the definition of “bundling” at FAR 2.101.</P>
              </SECTION>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2907.3—Contractor Versus Government Performance</HD>
              <SECTION>
                <SECTNO>2907.300 </SECTNO>
                <SUBJECT>Scope of subpart.</SUBJECT>

                <P>The Department of Labor's FAIR Act inventory of commercial activities performed by federal employees and inherently governmental functions may be accessed on the Internet at: <E T="03">www.dol.gov</E> under “Doing Business with the Department of Labor.”</P>
              </SECTION>
            </SUBPART>
          </PART>
          <PART>
            <HD SOURCE="HED">PART 2908—REQUIRED SOURCES OF SUPPLIES AND SERVICES</HD>
            <CONTENTS>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2908.4—Federal Supply Schedules </HD>
                <SECHD>Sec.</SECHD>
                <SECTNO>2908.404 </SECTNO>
                <SUBJECT>Using Schedules.</SUBJECT>
              </SUBPART>
            </CONTENTS>
            <AUTH>
              <HD SOURCE="HED">Authority:</HD>
              <P>5 U.S.C. 301; 40 U.S.C. 486(c).</P>
            </AUTH>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2908.4—Federal Supply Schedules </HD>
              <SECTION>
                <SECTNO>2908.404 </SECTNO>
                <SUBJECT>Using Schedules</SUBJECT>

                <P>Small business considerations, procedures regarding both prime and subcontracting and clearances specified in DOLAR 2919 apply to GSA Federal Supply Schedule Orders above the simplified acquisition threshold. Procedures to be followed may be modified by the OSBP as appropriate in order to comply with GSA Federal Supply Schedule procedures (<E T="03">e.g.</E> first tier contracts may be required to report their commercial subcontracting goals to the DOL Office of Small Business Programs).</P>
              </SECTION>
            </SUBPART>
          </PART>
          <PART>
            <HD SOURCE="HED">PART 2909—CONTRACTOR QUALIFICATIONS</HD>
            <CONTENTS>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2909.1—Responsible Prospective Contractors </HD>
                <SECHD>Sec.</SECHD>
                <SECTNO>2909.105 </SECTNO>
                <SUBJECT>Procedures.</SUBJECT>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2909.4—Debarment, Suspension, and Ineligibility</HD>
                <SECTNO>2909.402 </SECTNO>
                <SUBJECT>Policy.</SUBJECT>
                <SECTNO>2909.405 </SECTNO>
                <SUBJECT>Effect of listing.</SUBJECT>
                <SECTNO>2909.405-1 </SECTNO>
                <SUBJECT>Continuation of current contracts.</SUBJECT>
                <SECTNO>2909.406 </SECTNO>
                <SUBJECT>Debarment.</SUBJECT>
                <SECTNO>2909.406-1 </SECTNO>
                <SUBJECT>General.</SUBJECT>
                <SECTNO>2906.407 </SECTNO>
                <SUBJECT>Suspension.</SUBJECT>
                <SECTNO>2909.407-1 </SECTNO>
                <SUBJECT>General.</SUBJECT>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2909.5—Organizational Conflicts of Interest</HD>
                <SECTNO>2909.503 </SECTNO>
                <SUBJECT>Waiver.</SUBJECT>
                <SECTNO>2909.506 </SECTNO>
                <SUBJECT>Procedures.</SUBJECT>
              </SUBPART>
            </CONTENTS>
            <AUTH>
              <HD SOURCE="HED">Authority:</HD>
              <P>5 U.S.C. 301; 40 U.S.C. 486(c).</P>
            </AUTH>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2909.1—Responsible Prospective Contractors </HD>
              <SECTION>
                <SECTNO>2909.105 </SECTNO>
                <SUBJECT>Procedures.</SUBJECT>

                <P>Before awarding a contract, the contracting officer must make a written determination of the otherwise successful bidder's/offeror's responsibility in accordance with FAR 9.105. In addition to past performance information, the contracting officer must insure that the proposed contractor, and any subcontractor representing more than $25,000 in goods or services, does not appear in the “List of Parties Excluded from Federal Procurement” (available on the Internet at <E T="03">www.epls.arnet.gov.</E> In addition, contracting officers should base their determination of contractor responsibility on a review of the company's “Summary or Financial Report” from Dun &amp; Bradstreet (available on the internet for a fee from <E T="03">http://www.dnb.com/</E>).</P>
              </SECTION>
            </SUBPART>
            <SUBPART>
              <PRTPAGE P="49006"/>
              <HD SOURCE="HED">Subpart 2909.4—Debarment, Suspension, and Ineligibility </HD>
              <SECTION>
                <SECTNO>2909.402 </SECTNO>
                <SUBJECT>Policy.</SUBJECT>

                <P>(a) This subpart prescribes DOL policies and procedures governing the debarment and suspension of contractors, the listing of debarred and suspended contractors, contractors declared ineligible (<E T="03">see</E> FAR 9.403) and distribution of the list. This subpart does not apply to Department of Labor debarments or suspensions issued for Davis-Bacon Act and Davis-Bacon Related Act violations, Service Contract Act Violations, Affirmative Action/Equal Employment Opportunity Violations, or violations under other statutes administered by the Department of Labor.</P>
                <P>(b) <E T="03">Contracting activity officials shall have the following responsibilities.</E>
                </P>
                <P>(1) Heads of contracting activity (HCA) shall:</P>

                <P>(i) Provide an effective system to ensure that contracting staffs consult the <E T="03">“List of Parties Excluded from Federal Procurement and Nonprocurement Programs”</E> at <E T="03">http://epls.arnet.gov/</E> before soliciting offers, awarding or extending contracts, or consenting to subcontract.</P>
                <P>(ii) Consider debarment or suspension of a contractor when cause, as defined under FAR 9.406-2 for debarment and FAR 9.407-2 for suspension, is shown. Contracting officers should consult with their appropriate legal counsel before making a decision to initiate debarment or suspension proceedings. If a determination is made that available facts do not justify beginning debarment or suspension proceedings, the file should be documented accordingly. This determination is subject to reconsideration if warranted by new information.</P>
                <P>(iii) When the decision is made to initiate debarment and/or suspension of a contractor, the Procurement Executive must prepare a notice in accordance with FAR 9.406-3(c) or FAR 9.407-3(c). The draft notice, along with the administrative file containing all relevant facts and analysis must be forwarded to the PE, as the debarring and suspending official, following review by the activity's legal counsel. </P>
                <P>(2) The Procurement Executive shall:</P>
                <P>(i) Review the notice and administrative file for sufficiency and provide for review by other DOL officials as considered appropriate;</P>
                <P>(ii) In accordance with FAR 9.406-3(c) or FAR 9.407-3(c), if it is determined that action is warranted, give the contractor prompt notice of the proposed debarment or suspension;</P>
                <P>(iii) Direct additional fact-finding as necessary when material facts are in dispute.</P>
                <P>(iv) Notify the contractor and any affiliates involved of the final decision to debar or suspend, including a decision not to debar or suspend, in accordance with FAR 9.406-3(c) and FAR 9.407-3(c).</P>
                <P>(v) Be responsible for accomplishing the actions required in FAR 9.404(c) within five working days after debarring or suspending a contractor or modifying or rescinding such an action.</P>
                <P>(vi) Maintain Department-wide records of debarred or suspended contractors in accordance with FAR 9.404.</P>
              </SECTION>
              <SECTION>
                <SECTNO>2909.405 </SECTNO>
                <SUBJECT>Effect of listing.</SUBJECT>
                <P>(a) Contractors debarred, suspended, or proposed for debarment are excluded from receiving contracts, and agencies must not solicit offers from, award contracts to, or consent to subcontract with these organizations, unless the HCA determines in writing that there is a compelling reason for such action and the Assistant Secretary for Administration and Management approves such determinations.</P>
                <P>(b) Bids received from any listed contractor in response to an invitation for bids must be entered on the abstract of bids, and rejected unless the HCA determines in writing that there is a compelling reason to consider the bid and the ASAM approves such action.</P>
                <P>(c) Proposals, quotations, or offers received from any listed contractor shall not be evaluated for award or included in the competitive range, nor shall discussions be conducted with a listed offeror during a period of ineligibility, unless the HCA determines in writing that there is a compelling reason to do so and the ASAM approves such action.</P>
              </SECTION>
              <SECTION>
                <SECTNO>2909.405-1 </SECTNO>
                <SUBJECT>Continuation of current contracts.</SUBJECT>
                <P>(a) At the time an option is being exercised, contracting officers must review the List of Parties Excluded from Federal Procurement and Nonprocurement Programs. If a contractor or significant subcontractor is identified in the listing, the contracting officer must make a written determination either to proceed or to terminate the contract, and must explain the rationale for the decision. In accordance with FAR 9.405-1, contracting officers may continue contracts or subcontracts in existence at the time a contractor is suspended or debarred, unless it is determined that termination of the contract is in the best interest of the Government. The contracting officer must make such determination in writing, after consulting with the contracting officer's technical representative and legal counsel. The determination must be approved by the HCA.</P>
                <P>(b) Contracting activities must not renew or otherwise extend the duration of current contracts, or consent to subcontracts, with contractors debarred, suspended, or proposed for debarment, unless the HCA states, in writing, the compelling reasons for renewal or extension and the ASAM approves such action.</P>
              </SECTION>
              <SECTION>
                <SECTNO>2909.406 </SECTNO>
                <SUBJECT>Debarment.</SUBJECT>
              </SECTION>
              <SECTION>
                <SECTNO>2909.406-1 </SECTNO>
                <SUBJECT>General. </SUBJECT>
                <P>(a) The Procurement Executive (PE) is the debarring official for DOL and is authorized to debar a contractor for any of the causes in FAR 9.406-2, using the procedures in 2909.406-3.</P>
                <P>(b) The Procurement Executive is authorized to make an exception, regarding debarment by another agency debarring official in accordance with the conditions in FAR 9.406-1(c).</P>
              </SECTION>
              <SECTION>
                <SECTNO>2909.406-3 </SECTNO>
                <SUBJECT>Procedures.</SUBJECT>
                <P>(a) <E T="03">Investigation and referral.</E> Whenever a DOL employee knows a cause for debarment, as listed in FAR 9.406-2, the appropriate HCA affected must be notified. The contracting officer must consult with the Office of the Solicitor and the Office of the Inspector General, as appropriate, and submit a formal recommendation documenting the cause for debarment to the PE.</P>
                <P>(b) <E T="03">Notice of proposal to debar.</E> Based upon review of the recommendation to debar and consultation with the Office of the Solicitor and Office of the Inspector General, as appropriate, the PE must initiate proposed debarment by taking the actions listed in FAR 9.406-3(c) and advising the contractor of DOL's rules under 2909.4.</P>
                <P>(c) <E T="03">Fact-finding proceedings.</E> For actions listed under FAR 9.406-3(b)(2), the PE must afford the contractor the opportunity to appear at an informal fact-finding proceedings as required by FAR 9.406-3(b)(2)(i). The proceeding must be conducted by the Office of Administrative Law Judges and must be held at a date and location reasonably convenient to the parties concerned. Subject to the provisions of 29 CFR Part 18, entitled “Rules Of Practice And Procedure For Administrative Hearings Before The Office Of Administrative Law Judges”, the contractor and any specifically named affiliates, may be represented by counsel or any duly authorized representative. Either party may call witnesses. The proceedings must be conducted expeditiously and in <PRTPAGE P="49007"/>such a manner that each party will have a full opportunity to present all information considered pertinent to the proposed debarment. A transcript of the proceedings must be made available to the contractor under the conditions in FAR 9.406-3(b)(2)(ii).</P>
                <P>(d) <E T="03">Decision and notice.</E> The PE shall make a decision on imposing debarment in accordance with the procedures in FAR 9.406-3(d), findings of fact of the Administrative Law Judge, and the conditions in FAR 9.406-4 and 9.406-5. Notice of the decision must be provided to the contractor and any affiliates involved in accordance with the procedures in FAR 9.406-3(e).</P>
              </SECTION>
              <SECTION>
                <SECTNO>2909.407 </SECTNO>
                <SUBJECT>Suspension.</SUBJECT>
                <P>(a) The Procurement Executive is the suspending official for DOL and is authorized to suspend a contractor for any of the causes in FAR 9.407-2, using the procedures in 2909.406-3.</P>
                <P>(b) The Procurement Executive is authorized to make an exception, regarding suspension by another agency suspending official, under the conditions in FAR 9.407-1(d).</P>
              </SECTION>
              <SECTION>
                <SECTNO>2909.407-1 </SECTNO>
                <SUBJECT>General.</SUBJECT>
                <P>(a) <E T="03">Investigation and referral.</E> Whenever a DOL employee knows a cause for suspension, as listed in FAR 9.407-2, the appropriate HCA affected must be notified. The HCA must consult with the Office of the Solicitor and the Office of the Inspector General, as appropriate, and submit a formal recommendation documenting the cause for suspension, to the Procurement Executive.</P>
                <P>(b) <E T="03">Notice of suspension.</E> Based upon review of the recommendation to suspend, and consultation with the Office of the Solicitor and the Office of the Inspector General, as required, the PE will initiate suspension by taking the actions listed in FAR 9.407-3(c) and advising the contractor of DOL's rules under this subpart.</P>
                <P>(c) <E T="03">Fact-finding proceedings</E>. For actions listed under FAR 9.407-3(b)(2), the Procurement Executive must afford the contractor the opportunity to appear at informal proceedings, as required by FAR 9.407-3(b)(2)(i). Either party may call witnesses. The proceedings must be conducted expeditiously and in such a manner that each party will have a full opportunity to present all information considered pertinent to the proposed suspension. </P>
                <P>(d) <E T="03">Suspension decisions</E>. The Procurement Executive must make a final decision on suspension as prescribed in FAR 9.407-3(d). Notice of the decision must be provided to the contractor and any affiliates involved, in accordance with the provisions in FAR 9.407-3(d)(4). </P>
              </SECTION>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2909.5—Organizational and Consultant Conflicts of Interest </HD>
              <SECTION>
                <SECTNO>2909.503 </SECTNO>
                <SUBJECT>Waiver.</SUBJECT>
                <P>(a) The PE is delegated authority by the ASAM to waive any general rule or procedure in FAR 9.5 when its application in a particular situation would not be in the Government's best interest. </P>
                <P>(b) Requests for waivers must be made by the HCA to the PE. Each request must include: </P>
                <P>(1) An analysis of the facts involving the potential or actual conflict including benefits and detriments to the Government and prospective contractors; </P>
                <P>(2) A discussion of the factors which preclude avoiding, neutralizing, or mitigating the conflict; and </P>
                <P>(3) Identification of the provision(s) in FAR 9.5 to be waived. </P>
                <P>(c) In making determinations under this subpart the PE must request the opinion of the Office of the Solicitor, Division of Legislation and Legal Counsel. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2909.506 </SECTNO>
                <SUBJECT>Procedures. </SUBJECT>
                <P>(a) If a prospective contractor disagrees with the decision of a contracting officer regarding an organizational conflict of interest and requests higher level review as referred to in FAR 9.506 the matter must be referred to the Office of the Solicitor, Associate Solicitor for Legislative and Legal Counsel, and the Director, Division of Acquisition Management Services. </P>
                <P>(b) Referrals must be made by the head of the contracting agency concerned and include the contracting officer's decision and the position of the prospective contractor. </P>
              </SECTION>
            </SUBPART>
          </PART>
          <PART>
            <HD SOURCE="HED">PART 2910—MARKET RESEARCH</HD>
            <CONTENTS>
              <SECHD>Sec.</SECHD>
              <SECTNO>2910.002 </SECTNO>
              <SUBJECT>Procedures. </SUBJECT>
            </CONTENTS>
            <AUTH>
              <HD SOURCE="HED">Authority:</HD>
              <P>5 U.S.C. 301; 40 U.S.C. 486(c). </P>
            </AUTH>
            <SECTION>
              <SECTNO>2910.002 </SECTNO>
              <SUBJECT>Procedures. </SUBJECT>
              <P>(a) In accordance with FAR 6.302-1(c), purchase descriptions must not specify a product, or specific feature of a product, peculiar to a manufacturer unless they are justified to the contracting officer in writing by the office initiating the purchase request. The justification must state that the product, or specific product feature, is essential to the Government's requirements and other similar products or features will not meet these requirements. This determination must be signed by a representative of the office originating the request and must accompany the purchase requisition submitted to the appropriate contracting office. If such a justification is not made, the contracting officer may assume that another make and model, or a generic product could equally meet the DOL requirement. </P>
              <P>(b) In accordance with FAR 10.002(b), the requisitioning office must submit to the contracting officer information demonstrating that a variety of products from various commercial sources have been considered. This requirement is not necessary for required sources (See FAR 8.001). Orders to be placed against non-mandatory sources, such as the Federal Supply Schedules, or other Governmentwide Acquisition Contracts, should include product information concerning multiple sources based on research from the Government web site or other sources. When documented in this manner, the contracting officer may rely on this information in developing a procurement strategy, or for documenting the comparison of catalogs or pricelists. </P>
            </SECTION>
          </PART>
          <PART>
            <HD SOURCE="HED">PART 2911—DESCRIBING AGENCY NEEDS </HD>
            <CONTENTS>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2911.1—Selecting And Developing Requirements Documents </HD>
                <SECHD>Sec.</SECHD>
                <SECTNO>2911.103 </SECTNO>
                <SUBJECT>Market acceptance. </SUBJECT>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2911.5—Liquidated Damages </HD>
                <SECTNO>2911.501 </SECTNO>
                <SUBJECT>Policy. </SUBJECT>
              </SUBPART>
            </CONTENTS>
            <AUTH>
              <HD SOURCE="HED">Authority:</HD>
              <P>5 U.S.C. 301; 40 U.S.C. 486(c). </P>
            </AUTH>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2911.1—Selecting and Developing Requirements Documents </HD>
              <SECTION>
                <SECTNO>2911.103</SECTNO>
                <SUBJECT>Market acceptance. </SUBJECT>
                <P>The authority of the Head of an Agency under FAR 11.103(a), to require offerors to demonstrate that the items offered have either achieved commercial market acceptance or been satisfactorily supplied to an agency under current or recent contracts for the same or similar requirements, and otherwise meet the item description, specifications, or other criteria prescribed in the public notice and solicitation, is delegated to the HCA. </P>
              </SECTION>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2911.5—Liquidated damages </HD>
              <SECTION>
                <SECTNO>2911.501 </SECTNO>
                <SUBJECT>Policy. </SUBJECT>
                <P>In accordance with FAR 11.501(d), the authority of the Head of Agency to recommend to the Department of Treasury, Commissioner, Financial Management Services, that the amount of a contractor's liquidated damages be waived or reduced in whole or in part, is delegated to the HCA. </P>
              </SECTION>
            </SUBPART>
          </PART>
          <PART>
            <PRTPAGE P="49008"/>
            <HD SOURCE="HED">PART 2912—ACQUISITION OF COMMERCIAL ITEMS </HD>
            <CONTENTS>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2912.3—Solicitation Provisions and Contract Clauses for the Acquisition of Commercial Items </HD>
                <SECHD>Sec. </SECHD>
                <SECTNO>2912.302 </SECTNO>
                <SUBJECT>Tailoring of provisions and clauses for the acquisition of commercial items.</SUBJECT>
              </SUBPART>
            </CONTENTS>
            <AUTH>
              <HD SOURCE="HED">Authority:</HD>
              <P>5 U.S.C. 301; 40 U.S.C. 486(c). </P>
            </AUTH>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2912.3—Solicitation Provisions and Contract Clauses for the Acquisition of Commercial Items </HD>
              <SECTION>
                <SECTNO>2912.302 </SECTNO>
                <SUBJECT>Tailoring of provisions and clauses for the acquisition of commercial items. </SUBJECT>
                <P>In accordance with FAR 12.302(c), a request for waiver to tailor terms inconsistent with customary commercial practice must be documented in a written justification by the contracting officer, and may be approved by the HCA on an individual or class basis. </P>
              </SECTION>
            </SUBPART>
          </PART>
          <PART>
            <HD SOURCE="HED">PART 2913—SIMPLIFIED ACQUISITION PROCEDURES </HD>
            <CONTENTS>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2913.1—Procedures </HD>
                <SECHD>Sec.</SECHD>
                <SECTNO>2913.106-3 </SECTNO>
                <SUBJECT>Soliciting competition, evaluation of quotations or offers, award and documentation. </SUBJECT>
                <HD SOURCE="HD1">
                  <E T="42">2913.2—Actions at or Below the Micropurchase Threshold</E>
                </HD>
                <HD SOURCE="HD1">
                  <E T="42">2913.3—Simplified Acquisition Methods</E>
                </HD>
                <SECTNO>2913.301</SECTNO>
                <SUBJECT>Governmentwide Commercial Purchase Card.</SUBJECT>
                <SECTNO>2913.307</SECTNO>
                <SUBJECT>Forms.</SUBJECT>
              </SUBPART>
            </CONTENTS>
            <AUTH>
              <HD SOURCE="HED">Authority:</HD>
              <P>5 U.S.C. 301; 40 U.S.C. 486(c).</P>
            </AUTH>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2913.1—Procedures</HD>
              <SECTION>
                <SECTNO>2913.106-3 </SECTNO>
                <SUBJECT>Soliciting competition, evaluation of quotations or offers, award and documentation.</SUBJECT>

                <P>(a) In accordance with FAR 13.106-3(b), simplified acquisition files must contain documentation of the factors considered in making an award in excess of the micro-purchase threshold. When other than the lowest responsive quotation from a responsible supplier is used as the basis for a purchase, the contracting officer must identify the basis (<E T="03">i.e.</E> best value) of the award and include in the purchase file documentation of the reasons for rejecting any lower quotation and the name of the individual responsible for making the determination to award to other than the lowest priced quotation. The contracting officer has broad discretion in determining the award of a purchase order, which may be based on the factors listed in FAR 13.106-3. This requirement does not necessitate a separate determination if the procurement file contains preprinted standardized classifications for award.</P>
              </SECTION>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2913.2—Actions at or Below the Micro-Purchase Threshold</HD>
              <SECTION>
                <SECTNO> </SECTNO>
                <SUBJECT> </SUBJECT>
                
                <P>The Government commercial purchase card must be used in preference to other methods of procurement for purchases up to the micropurchase threshold. Other small purchase methods (Blanket Purchase Agreements, third party drafts, and purchase orders) may be used in lieu of the Government purchase card when it is more cost-effective or practicable. </P>
              </SECTION>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2913.3—Simplified Acquisition Methods </HD>
              <SECTION>
                <SECTNO>2913.301 </SECTNO>
                <SUBJECT>Governmentwide Commercial Purchase Card. </SUBJECT>
                <P>(a) The Government purchase card has far fewer requirements for documentation than other methods of purchasing. However, the same legal restrictions apply to credit card purchases that apply to other purchases using appropriated funds. If a purchase cardholder has questions about the lawfulness of a particular purchase, he or she must initially consult their appropriate office purchase card administrator, who will consult the Office of the Solicitor as necessary. </P>
                <P>(b) GAO decisions surrounding the concept of the “availability of appropriations” are often stated in terms of whether appropriated funds are or are not “legally available” for a given expenditure. Restrictions on the purposes for which appropriated funds may be used come from a variety of sources, including the DOL Appropriations Acts, and decisions of the Comptroller General and his predecessor, the Comptroller of the Treasury. </P>
                <P>(c) HCAs, Administrative Officers, and contracting officers are encouraged to review the GAO publication entitled Principles of Federal Appropriations Law. This document must be consulted when developing Office/Agency Purchase/Credit Card Program procedures. A number of the more common restrictions which “accounting officers of the Government” have had frequent occasion to consider and apply include, for example: </P>
                <P>(1) Payment of attorney's fees; </P>
                <P>(2) Purchase of food, entertainment or recreation; </P>
                <P>(3) Payment of personal membership fees; and </P>
                <P>(4) Payment of personal expense items such as gifts for employees, and entry fees for contests. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2913.307 </SECTNO>
                <SUBJECT>Forms. </SUBJECT>
                <P>(a) In accordance with FAR 13.307, Agencies may use order forms other than the Standard Form (SF) 1449 and may print on those forms the clauses considered to be suitable for purchases. Alternate forms should conform with the Standard Form to the maximum extent practicable. </P>
                <P>(b) The SF 30 is to be used to modify a purchase order.</P>
              </SECTION>
            </SUBPART>
          </PART>
          <PART>
            <HD SOURCE="HED">PART 2914—SEALED BIDDING </HD>
            <CONTENTS>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2914.4—Opening of Bids and Award of Contract </HD>
                <SECHD>Sec.</SECHD>
                <SECTNO>2914.404-1 </SECTNO>
                <SUBJECT>Cancellation of invitations after opening. </SUBJECT>
                <SECTNO>2914.407-3 </SECTNO>
                <SUBJECT>Other mistakes disclosed before award. </SUBJECT>
                <SECTNO>2914.408 </SECTNO>
                <SUBJECT>Award.</SUBJECT>
                <SECTNO>2914.408-1 </SECTNO>
                <SUBJECT>General.</SUBJECT>
              </SUBPART>
            </CONTENTS>
            <AUTH>
              <HD SOURCE="HED">Authority:</HD>
              <P>5 U.S.C. 301; 40 U.S.C. 486(c).</P>
            </AUTH>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2914.4—Opening of Bids and Award of Contract </HD>
              <SECTION>
                <SECTNO>2914.404-1 </SECTNO>
                <SUBJECT>Cancellation of invitations after opening. </SUBJECT>
                <P>The authority of the agency head in FAR 14.404-1(c) and (f) to make a written determination to cancel an invitation for bids and reject all bids after opening and to authorize completion of the acquisition through negotiation, is delegated to the HCA. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2914.407-3 </SECTNO>
                <SUBJECT>Other mistakes disclosed before award. </SUBJECT>
                <P>(a) The authority to make determinations, as conferred by FAR 14.407-3 (e) is delegated to the HCA, without power of redelegation, but only after consultation with the Office of the Solicitor. All such determinations shall be documented in the contract file. </P>
                <P>(b) The following procedures must be followed when submitting doubtful cases of mistakes in bids to the Comptroller General for an advance decision, as provided by FAR 14.407-3(i). </P>
                <P>(1) Requests must be made by the HCA after consultation with the Office of Solicitor. </P>
                <P>(2) Requests must be in writing, dated, signed by the requestor, addressed to the Comptroller General of the United States, General Accounting Office, Washington, DC 20548, and contain the following: </P>
                <P>(i) The name and address of the party requesting the decision; and </P>

                <P>(ii) A statement of the question to be decided, a presentation of all relevant <PRTPAGE P="49009"/>facts, a statement of the requesting party's position with respect to the question, and copies of all pertinent records and supporting documentation. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2914.408 </SECTNO>
                <SUBJECT>Award. </SUBJECT>
              </SECTION>
              <SECTION>
                <SECTNO>2914.408-1 </SECTNO>
                <SUBJECT>General. </SUBJECT>
                <P>(a) When only one bid is received in response to an invitation for bids, such bid may be considered and accepted if the contracting officer makes a written determination that: </P>
                <P>(1) The specifications used in the invitation were not unduly restrictive, </P>
                <P>(2) Adequate competition was solicited and it could have been reasonably assumed that more than one bid would have been submitted, </P>
                <P>(3) The price is reasonable, and </P>
                <P>(4) The bid is otherwise in accordance with the invitation for bids. </P>
                <P>(b) Such a determination must be placed in the contract file. </P>
              </SECTION>
            </SUBPART>
          </PART>
          <PART>
            <HD SOURCE="HED">PART 2915—CONTRACTING BY NEGOTIATION </HD>
            <CONTENTS>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2915.4—Contract Pricing </HD>
                <SECHD>Sec.</SECHD>
                <SECTNO>2915.405-70 </SECTNO>
                <SUBJECT>Determining fair and reasonable price. </SUBJECT>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2915.5—Preaward, Award, and Postaward Notifications, Protests, and Mistakes </HD>
                <SECTNO>2915.508 </SECTNO>
                <SUBJECT>Discovery of mistakes. </SUBJECT>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2915.6—Unsolicited Proposals </HD>
                <SECTNO>2915.604 </SECTNO>
                <SUBJECT>Agency points of contact.</SUBJECT>
                <SECTNO>2915.605 </SECTNO>
                <SUBJECT>Content of unsolicited proposals. </SUBJECT>
                <SECTNO>2915.606 </SECTNO>
                <SUBJECT>Agency procedures. </SUBJECT>
              </SUBPART>
            </CONTENTS>
            <AUTH>
              <HD SOURCE="HED">Authority:</HD>
              <P>5 U.S.C. 301; 40 U.S.C. 486(c). </P>
            </AUTH>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2915.4—Contract Pricing </HD>
              <SECTION>
                <SECTNO>2915.405-70 </SECTNO>
                <SUBJECT>Determining fair and reasonable price. </SUBJECT>
                <P>(a) Where the contractor insists on a price or demands a profit or fee that the contracting officer considers unreasonable, and the contracting officer has taken all authorized actions to resolve the matter (see FAR 15.402), the contract action must be referred to the HCA for final resolution. </P>
                <P>(b) Resolution under paragraph (a) of this subsection, must be documented and signed by the HCA, and included in the contract file. </P>
              </SECTION>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2915.5—Preaward, Award, and Postaward Notifications, Protests, and Mistakes </HD>
              <SECTION>
                <SECTNO>2915.508 </SECTNO>
                <SUBJECT>Discovery of mistakes. </SUBJECT>
                <P>(a) The HCA is authorized to make the administrative determinations in FAR 15.508 after consultation with the Office of the Solicitor as required by FAR 14.407-4. This authority may not be redelegated. </P>
                <P>(b) The contracting officer must process a mistake and prepare a case file in accordance with the requirements of FAR 14.407-4(e)(2). The file must be submitted to the HCA for final determination. </P>
              </SECTION>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2915.6—Unsolicited Proposals </HD>
              <SECTION>
                <SECTNO>2915.604 </SECTNO>
                <SUBJECT>Agency points of contact. </SUBJECT>
                <P>(a) HCAs shall be the preliminary contacts for unsolicited proposals. This responsibility may be delegated. </P>
                <P>(b) HCAs must establish within their agencies procedures for handling unsolicited proposals to ensure that unsolicited proposals are controlled, evaluated, safeguarded and disposed of in accordance with FAR 15.6. </P>
                <P>(c) The HCA must not forward for consideration an unsolicited proposal, if the proposal resembles an upcoming solicitation, or a procurement identified in the current annual acquisition plan. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2915.605 </SECTNO>
                <SUBJECT>Content of unsolicited proposals. </SUBJECT>
                <P>In addition to the contents required by FAR 15.605, unsolicited proposals for research should contain a commitment by the offeror to include cost-sharing, or should represent a significant cost savings to the Department of Labor. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2915.606 </SECTNO>
                <SUBJECT>Agency procedures. </SUBJECT>
                <P>When an unsolicited proposal is received by an official of the Department of Labor, the recipient of the proposal must forward it to the HCA. The HCA must address the requirements of FAR 15.604. The HCA must determine if there is an office(s) within the Department of Labor whose mission could be impacted by the proposal. If there is, the HCA must designate a recipient within that office as an “assignee”, and take the following action:</P>
                <P>(a) Within seven (7) working days of receipt, the HCA must forward the proposal to the assignee along with instructions concerning the security, review and disposition of the document. </P>
                <P>(1) Inform the offeror of this transfer in writing (preferably by facsimile or other electronic means). </P>
                <P>(2) Within one (1) month of receipt of the unsolicited proposal by the assignee, the office receiving the proposal must determine the merit of the unsolicited proposal. </P>
                <P>(i) If the office finds insufficient merit to consider the unsolicited proposal further, then a letter will be sent to inform the offeror that their proposal will not be considered further, and is not being retained. </P>
                <P>(ii) If, after a comprehensive evaluation as defined by FAR 15.606-2, the office finds merit in the proposal, it must consult with a DOL contracting officer for direction in complying with FAR 15.607. If not excluded by a condition of FAR 15.607(a), a requisition may be prepared in accordance with FAR 15.607(b). If the requirement exceeds the simplified acquisition threshold inclusive of options then a request must be prepared for the Procurement Review Board in accordance with Department of Labor procedures stated in Department of Labor Manual Series 2-830 (available by mail from the Division of Acquisition Management Services). </P>
                <P>(b) If within one (1) month of receipt (by the HCA) no assignee can be identified, the HCA must notify the offeror that the proposal is not being considered further. </P>
              </SECTION>
            </SUBPART>
          </PART>
          <PART>
            <HD SOURCE="HED">PART 2916—CONTRACT TYPES </HD>
            <CONTENTS>
              <SECHD>Sec. </SECHD>
              <SECTNO>2916.000 </SECTNO>
              <SUBJECT>Scope of part. </SUBJECT>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2916.5—Indefinite-Delivery Contracts </HD>
                <SECTNO>2916.505 </SECTNO>
                <SUBJECT>Ordering. </SUBJECT>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2916.6—Time-and-Materials, Labor-Hour, and Letter Contracts </HD>
                <SECTION>
                  <SECTNO>2916.603-2 </SECTNO>
                  <SUBJECT>Application.</SUBJECT>
                  <AUTH>
                    <HD SOURCE="HED">Authority:</HD>
                    <P>5 U.S.C. 301; 40 U.S.C. 486(c). </P>
                  </AUTH>
                </SECTION>
                <SECTION>
                  <SECTNO>2916.000 </SECTNO>
                  <SUBJECT>Scope of part. </SUBJECT>
                  <P>This part describes types of contracts that may be used in acquisitions. It further prescribes policies and procedures for implementing contracts. </P>
                </SECTION>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2916.5—Indefinite-Delivery Contracts </HD>
                <SECTION>
                  <SECTNO>2916.505 </SECTNO>
                  <SUBJECT>Ordering. </SUBJECT>

                  <P>In accordance with FAR 16.505(b)(5), the Department of Labor Task Order and Delivery Order Ombudsman is the DOL Competition Advocate (<E T="03">see</E> DOLAR Part 2902). </P>
                </SECTION>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2916.6—Time-and-Materials, Labor-Hour, and Letter Contracts </HD>
                <SECTION>
                  <SECTNO> </SECTNO>
                  <SUBJECT> </SUBJECT>
                  
                  <P>Purchase orders for services above $25,000, task orders against DOL contracts, and GSA for orders against GSA or other Governmentwide contracts for services must comply with the provisions of FAR 16.505. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2916.603-2 </SECTNO>
                  <SUBJECT>Application. </SUBJECT>

                  <P>The HCA is authorized to extend the period for definitization of a letter contract required by FAR 16.603-2(c) in extreme cases, where it is determined in writing that such action is in the best interest of the Government. <PRTPAGE P="49010"/>
                  </P>
                </SECTION>
              </SUBPART>
            </CONTENTS>
          </PART>
          <PART>
            <HD SOURCE="HED">PART 2917—SPECIAL CONTRACTING METHODS </HD>
            <CONTENTS>
              <SECHD>Sec.</SECHD>
              <SECTNO>2917.000 </SECTNO>
              <SUBJECT>Scope of part. </SUBJECT>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2917.2—Options </HD>
                <SECTNO>2917.207</SECTNO>
                <SUBJECT>Exercising options. </SUBJECT>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2917.5 —Interagency Acquisitions Under The Economy Act </HD>
                <SECTNO>2917.500 </SECTNO>
                <SUBJECT>Scope of subpart. </SUBJECT>
                <SECTNO>2917.501 </SECTNO>
                <SUBJECT>Definitions. </SUBJECT>
                <SECTNO>2917.502 </SECTNO>
                <SUBJECT>General. </SUBJECT>
                <SECTNO>2917.503 </SECTNO>
                <SUBJECT>Determinations and findings requirements. </SUBJECT>
                <SECTNO>2917.504 </SECTNO>
                <SUBJECT>Ordering procedures. </SUBJECT>
                <SECTNO>2917.504-70 </SECTNO>
                <SUBJECT>Signature authority and Internal Procedures. </SUBJECT>
              </SUBPART>
            </CONTENTS>
            <AUTH>
              <HD SOURCE="HED">Authority:</HD>
              <P>5 U.S.C. 301; 31 U.S.C. 1535; 40 U.S.C. 486(c). </P>
            </AUTH>
            <SECTION>
              <SECTNO>2917.000 </SECTNO>
              <SUBJECT>Scope of part. </SUBJECT>
              <P>This part implements policies and procedures stated in FAR Part 17. </P>
            </SECTION>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2917.2—Options </HD>
              <SECTION>
                <SECTNO> </SECTNO>
                <SUBJECT> </SUBJECT>
                
                <P>The HCA may, in unusual circumstances, approve option quantities in excess of the 50 percent limit prescribed in FAR 17.203(g)(2). The documentation required by FAR 17.205(a) must include a written justification to fully support the need for such action. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2917.207 </SECTNO>
                <SUBJECT>Exercising options. </SUBJECT>
                <P>The contracting officer must use a standardized determination and finding before exercising an option in accordance with FAR 17.207(f). </P>
              </SECTION>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2917.5—Interagency Acquisitions Under the Economy Act </HD>
              <SECTION>
                <SECTNO>2917.500 </SECTNO>
                <SUBJECT>Scope of subpart. </SUBJECT>
                <P>This subpart establishes DOL policy and procedures to assure the appropriate and consistent use of interagency acquisitions under the Economy Act (31 U.S.C. 1535) as prescribed by FAR 17.5. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2917.501 </SECTNO>
                <SUBJECT>Definitions. </SUBJECT>
                <P>
                  <E T="03">Interagency Acquisition</E> means a procedure by which a DOL agency obtains needed supplies or services from, or through, another DOL agency or Federal agency, and appropriated funds are obligated. </P>
                <P>
                  <E T="03">Interagency Agreement</E> means the legal instrument used for an interagency acquisition to exchange funds or property between two DOL organizations, or between a DOL agency and another Federal agency. This instrument is used when the DOL organization meets the definition of either the Requesting Agency or the Servicing Agency. </P>
                <P>
                  <E T="03">Interagency Agreement</E> and <E T="03">Interagency Acquisition</E> does not include:</P>
                <P>(1) Agreements involving supplies and services acquired from or through mandatory sources, as described in FAR Part 8; </P>
                <P>(2) Contracts with the Small Business Administration based upon Section 8(a) of the Small Business Act or a HUBZone small business under the Historically Underutilized Business Zone (HUBZone) Act of 1997; </P>
                <P>(3) Cooperative agreements and grants; or </P>
                <P>(4) Any agreement or acquisition, where a statute authorizes exception. </P>
                <P>
                  <E T="03">Military Interdepartmental Procurement Request (MIPR)</E> means a type of interagency agreement used to place orders for supplies and non-personal services with a military department. </P>
                <P>
                  <E T="03">Requesting Agency</E> means the Federal agency that needs the supplies or services, and is obligating the funds to provide for the costs of performance. </P>
                <P>
                  <E T="03">Servicing Agency</E> means the Federal agency which is providing the supplies, or performing the services, directly or indirectly, and will be receiving the funds to provide for the costs of performance. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2917.502 </SECTNO>
                <SUBJECT>General. </SUBJECT>
                <P>(a) <E T="03">Policy.</E> It is the policy of DOL to require that interagency agreements are written to assure that the obligation of fiscal year funds is valid, that statutory authority exists to obtain or perform the stated requirements, that the stated requirements are consistent with DOL's mission responsibilities, and that each agreement complies with applicable laws and regulations. </P>
                <P>(b) <E T="03">Applicability.</E> The provisions of this subpart apply to interagency acquisitions and agreements under the Economy Act. </P>
                <P>(c) <E T="03">Appropriations principles.</E> The appropriate use of interagency acquisitions embodies several principles of Federal appropriations law. </P>
                <P>(1) In order to record a valid obligation of appropriations, 31 U.S.C. 1501 imposes the requirements that interagency agreements be: </P>

                <P>(i) A binding written agreement for specific goods or services to meet an existing <E T="03">bona fide</E> need; </P>
                <P>(ii) For a purpose authorized by law; and </P>
                <P>(iii) Executed and obligated by the receiving agency before the expiration of available funds. </P>
                <P>(2) The Economy Act authorizes interagency acquisitions, and provides for payment in advance, as well as reimbursement to the appropriation account to which the performance costs have been charged. The Economy Act further authorizes the servicing agency, as an alternative to fulfilling the requirement through internal resources, to obtain the needed supplies or services by contract. </P>
                <P>(3) An agreement entered into under the Economy Act is recorded as an obligation by the requesting agency the same as a contract. However, under the Economy Act, the obligated appropriations must be deobligated upon the date of “expiration” of the appropriation account to the extent that the servicing agency has not incurred obligations through charged costs or under a contract. </P>
                <P>(4) Within DOL, the DOL agencies have a number of statutory authorities available for entering into interagency agreements. Each DOL agency, in consultation with the Office of the Solicitor, must be responsible for determining those authorities, as well as constraints applicable to the use of advance payments and contractors, and set-up procedures. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2917.503 </SECTNO>
                <SUBJECT>Determinations and findings requirements. </SUBJECT>
                <P>
                  <E T="03">Applicability.</E> Before the execution of an interagency agreement under the Economy Act, the contracting officer, or other authorized official, must sign the determination required in FAR 17.503 and 31 U.S.C. 1535. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2917.504 </SECTNO>
                <SUBJECT>Ordering procedures. </SUBJECT>
                <P>(a) Requests for the processing of interagency agreements must be submitted to the procurement office serving the requisitioning office. </P>
                <P>(b) The Procurement Request (PR) must state whether the work is to be performed by a DOL organization, a Federal agency other than DOL, or through one of these entities by a contractor. </P>
                <P>(c) Where the Economy Act is to be used as the authority for an interagency acquisition, the requisitioning office must include the facts which support the conclusion that it is more economical to obtain the required supplies or services through the proposed interagency agreement, rather than by direct contract with a commercial concern. Current market prices or recent procurement prices may be used in this process. </P>
                <P>(d) Orders placed under interagency agreements may take any form that is legally sufficient and reflects the agreement of the parties. </P>

                <P>(e) The contracting officer, or authorized official, must assure compliance with the ordering procedures and payment provisions <PRTPAGE P="49011"/>prescribed in FAR 17.504 and FAR 17.505, and require inclusion of the following provisions in all interagency agreements and/or orders placed against them: </P>
                <P>(1) Legislative authority; </P>
                <P>(2) Period of performance; </P>
                <P>(3) Dollar amount of agreement; </P>
                <P>(4) Billing provisions, including the name and address of the following offices: </P>
                <P>(i) Designated office to receive the required deliverables; and </P>
                <P>(ii) Designated office to receive billings and process payments; </P>
                <P>(5) Modification and termination provisions; and </P>
                <P>(6) Other provisions, as appropriate. </P>
                <P>(f) The Contracting Officer must assure that each interagency agreement or order placed against it includes a reference number assigned by each of the parties. Such numbers must be assigned in accordance with the existing procedures established by the respective organizations. </P>
                <P>(g) Modifications to existing interagency agreements may be accomplished through the use of a SF 30, Amendment of Solicitation/Modification of Contract, or through any other format acceptable to the parties. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2917.504-70</SECTNO>
                <SUBJECT>Signature authority and internal procedures.</SUBJECT>
                <P>(a) A DOL contracting officer, HCA, Agency Head, or another official designated by the ASAM in accordance with FAR 17.503(c), must sign interagency agreements and/or orders placed against them which will result in a procurement action by the requesting or servicing agency. </P>
                <P>(b) Internal procedures (DLMS 3-1700) require DOL Agency Heads to provide notice to the Director, Executive Secretariat of the signing of all new Federal Interagency Agreements and deleting expired agreements. </P>
                <P>(c) Agencies should be aware that, in addition to the requirements of this subpart, there are various other internal Departmental procedures that apply to various types of agreements. Agencies should consult with the Office of the Solicitor and the Office of the Assistant Secretary for Administration and Management, as appropriate.</P>
              </SECTION>
            </SUBPART>
          </PART>
          <PART>
            <RESERVED>PART 2918—RESERVED</RESERVED>
          </PART>
          <PART>
            <HD SOURCE="HED">PART 2919—SMALL BUSINESS AND SMALL DISADVANTAGED BUSINESS CONCERNS </HD>
            <CONTENTS>
              <SECHD>Sec.</SECHD>
              <SECTNO>2919.000 </SECTNO>
              <SUBJECT>Scope of part. </SUBJECT>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2919.2—Policies. </HD>
                <SECTNO>2919.201 </SECTNO>
                <SUBJECT>General policy. </SUBJECT>
                <SECTNO>2919.202 </SECTNO>
                <SUBJECT>Specific policies. </SUBJECT>
                <SECTNO>2919.202-1 </SECTNO>
                <SUBJECT>Encouraging small business participation in acquisitions. </SUBJECT>
                <SECTNO>2919.202-2 </SECTNO>
                <SUBJECT>Locating small Business sources. </SUBJECT>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2919.5—Set-Asides for Small Business. </HD>
                <SECTNO>2919.502 </SECTNO>
                <SUBJECT>Setting Aside Acquisitions. </SUBJECT>
                <SECTNO>2919.505 </SECTNO>
                <SUBJECT>Rejecting Small Business Administration recommendations. </SUBJECT>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2919.7—The Small Business Subcontracting Program. </HD>
                <SECTNO>2919.705-1 </SECTNO>
                <SUBJECT>General Support for the Program. </SUBJECT>
                <SECTNO>2919.705-5 </SECTNO>
                <SUBJECT>Awards involving subcontracting plans. </SUBJECT>
                <SECTNO>2919.705-6 </SECTNO>
                <SUBJECT>Post-award responsibilities of the contracting officer. </SUBJECT>
                <SECTNO>2919.706 </SECTNO>
                <SUBJECT>Responsibilities of the cognizant administrative contracting officer. </SUBJECT>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2919.8—Contracting with the Small Business Administration (The 8(a) Program). </HD>
                <SECTION>
                  <SECTNO>2919.812 </SECTNO>
                  <SUBJECT>Contract Administration. </SUBJECT>
                  <AUTH>
                    <HD SOURCE="HED">Authority:</HD>
                    <P>5 U.S.C. 301; 40 U.S.C. 486(c). </P>
                  </AUTH>
                </SECTION>
                <SECTION>
                  <SECTNO>2919.000 </SECTNO>
                  <SUBJECT>Scope of part. </SUBJECT>
                  <P>This part implements FAR Part 19 and small business programs at the Department of Labor. </P>
                </SECTION>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2919.2—Policies </HD>
                <SECTION>
                  <SECTNO>2919.201 </SECTNO>
                  <SUBJECT>General Policy. </SUBJECT>
                  <P>(a) It is the policy of the Department of Labor to provide maximum practicable opportunities to small businesses in acquisitions. </P>

                  <P>(b) Management responsibilities for small and disadvantaged business utilization are the responsibility of the Director, Office of Small Business Programs (OSBP). This individual is responsible for performing all functions and duties prescribed in FAR 19.2 including appointing, as prescribed in FAR 19.201(d)(8), a small business specialist (SBS) for each contract office. The Department of Labor Manual Series (DLMS), Chapter 2 1000, addresses the implementation of the preference programs in procurement including HUBZone, Subcontracting Plans, Standard Form 294 (Subcontracting Report for Individual Contracts), and the report, Standard Form 295 (Summary Subcontracting Report) submission, <E T="03">et al.</E>
                  </P>
                  <P>(c) All DOL procurements over the simplified acquisition threshold, whether being conducted via open market or by ordering from a pre-existing contract vehicle such as GSA Schedule, must be reviewed and receive a recommendation by the Office of Small Business Programs (OSBP), the Department of Labor's Office of Small Disadvantaged Business Utilization, prior to being advertised. The Acquisition Screening and Review Form DL-1-2004 shall be used for this purpose and the statement of work and market survey documentation shall be submitted to OSBP with the request for review. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2919.202 </SECTNO>
                  <SUBJECT>Specific policies. </SUBJECT>
                  <P>Contracting Officers, administrative officers and program management shall ensure that procurements are structured and conducted to afford small businesses the maximum practicable opportunity to participate in DOL's prime and subcontracts. Administrative officers will review requisitions, which will result in an award of $2 million or more, using available information to certify whether the acquisition would constitute a “bundled contract” under the definition provided in FAR 2.101 in accordance with procedures established by the Office of Small Business Programs. Each certification will be submitted to the Division of Acquisition Management Services, and included with the requisition to the Contracting Officer. Reports will be provided to the Office of Small Business Programs. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2919.202-1 </SECTNO>
                  <SUBJECT>Encouraging small business participation in acquisitions. </SUBJECT>
                  <P>During the performance of a contract, the contracting officer will consider performance against subcontracting plan goals, objectives and planned efforts before exercising an optional period of performance. The Contracting Officer will document the evaluation of the contractor's actual performance using SF-294 data compared to their approved subcontracting plan goals. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2919.202-2 </SECTNO>
                  <SUBJECT>Locating small business sources. </SUBJECT>

                  <P>Any procurement conducted on an unrestricted basis will include solicitations to small businesses of each category with legislatively established government-wide procurement goals (<E T="03">e.g.</E> small, small disadvantaged, women-owned small, HUBZone and service disabled veteran-owned small businesses) to the extent practicable. </P>
                </SECTION>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2919.5—Set-Asides for Small Business </HD>
                <SECTION>
                  <SECTNO>2919.502 </SECTNO>
                  <SUBJECT>Setting Aside Acquisitions. </SUBJECT>

                  <P>Contracting Officers will conduct market surveys specifically to determine whether procurements should be conducted via 8(a) procedures, HUBZone procedures or as small business set-asides. If a reasonable expectation exists that at least two responsible small businesses may submit offers at fair market prices (three responsible small businesses in <PRTPAGE P="49012"/>procurements via GSA Federal Supply Schedule), then the procurement will be set aside for small business. Market surveys will be documented in all procurement actions not reserved for small businesses. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2919.505 </SECTNO>
                  <SUBJECT>Rejecting Small Business Administration recommendations. </SUBJECT>
                  <P>When the SBA Procurement Center Representative appeals a “rejection of an SBA recommendation” as referenced in FAR 19.505(b)&amp;(c), the appeal must be referred to the Assistant Secretary for Administration and Management who is authorized to make a final decision. </P>
                </SECTION>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2919.7—The Small Business Subcontracting Program </HD>
                <SECTION>
                  <SECTNO>2919.704 </SECTNO>
                  <SUBJECT>Subcontracting Plan Requirements </SUBJECT>
                  <P>Contracting Officers will refer subcontracting plans to Office of Small Business Programs for review and recommendation before awarding contracts that require subcontracting plans. Contracting Officers will document the substance of any agreement with the Contractor that permits performance at less than the stated goals recommended by the Office of the Small Business Programs. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2919.705-1 </SECTNO>
                  <SUBJECT>General Support for the Program. </SUBJECT>
                  <P>Contracting Officers will make available a significant number of award points for quality of the subcontracting plan. High rated subcontract plans will incorporate the highest yield of subcontracting to all categories of small businesses when compared to DOL or separately negotiated agency subcontracting goals on a dollar and percentage basis. Conversely, prime small businesses will be compared favorably to large businesses with subcontract goals, but may also be given the maximum score for qualifying under multiple small business categories. Contracting Officers may also make available a significant number of award points for performance against previous subcontracting plan goals and efforts to achieve those goals. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2919.705-5 </SECTNO>
                  <SUBJECT>Awards involving subcontracting plans. </SUBJECT>
                  <P>The Office of Small Business Programs will review subcontracting plans and SF 295 submissions for performance against business goals negotiated between the Department of Labor and the Small Business Administration. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2919.705-6 </SECTNO>
                  <SUBJECT>Post-award responsibilities of the contracting officer. </SUBJECT>
                  <P>(a) Even when a subcontracting plan was submitted to and approved by OSBP before award, the contracting officer upon award, amendment, or significant modification of a contract, must forward to the Director, OSBP, a copy of the subcontracting plan that was incorporated into a contract or contract modification. </P>
                  <P>(b) Each contracting activity must maintain a list of active prime contracts containing subcontracting plans. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2919.706 </SECTNO>
                  <SUBJECT>Responsibilities of the cognizant administrative contracting officer. </SUBJECT>
                  <P>Contracting officers must collect annual and semiannual subcontracting reports from contractors with established subcontracting plans. Copies of the report, Standard Form 294 (Subcontracting Report for Individual Contracts), and the report, Standard Form 295 (Summary Subcontracting Report), must be forwarded to the Director, OSBP, not later than the 30th day of the month following the close of the reporting period. If the contractor has not met the goals for the reporting period, the contracting officer will provide an acknowledgement to the contractor and request corrective action to be taken. If goals are not met in subsequent periods, the Contracting officer must consider factors that would demonstrate a good faith effort, and take appropriate action including assessing liquidated damages in accordance with FAR 52.219-16, and/or not exercising subsequent option periods. </P>
                </SECTION>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2919.8—Contracting With the Small Business Administration (the 8(a) Program) </HD>
                <SECTION>
                  <SECTNO>2919.812 </SECTNO>
                  <SUBJECT>Contract administration. </SUBJECT>
                  <P>(a) Contracting officers, or designees, must conduct periodic evaluations of the performance of an 8(a) contract at various stages of the contract period of performance. Any problems encountered during the performance evaluation, which cannot be resolved, must be referred to OSBP for subsequent review and discussion with the appropriate SBA official. </P>
                  <P>(b) The OSBP and SBA should be notified at least 45 days before initiating final action to terminate an 8(a) contract. </P>
                </SECTION>
              </SUBPART>
            </CONTENTS>
          </PART>
          <PART>
            <RESERVED>PART 2920—2921 [RESERVED] </RESERVED>
          </PART>
          <PART>
            <HD SOURCE="HED">PART 2922—APPLICATION OF LABOR LAWS TO GOVERNMENT ACQUISITIONS </HD>
            <CONTENTS>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2922.1—Basic Labor Policies </HD>
                <SECHD>Sec. </SECHD>
                <SECTNO>2922.101-3 </SECTNO>
                <SUBJECT>Reporting labor disputes. </SUBJECT>
                <SECTNO>2922.101-4 </SECTNO>
                <SUBJECT>Removal of items from contractor's facilities affected by work stoppages. </SUBJECT>
                <SECTNO>2922.103-4 </SECTNO>
                <SUBJECT>Approvals. </SUBJECT>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2922.8—Equal Employment Opportunity </HD>
              </SUBPART>
            </CONTENTS>
            <SECTION>
              <SECTNO>2922.802 </SECTNO>
              <SUBJECT>General. </SUBJECT>
              <AUTH>
                <HD SOURCE="HED">Authority:</HD>
                <P>5 U.S.C. 301; 40 U.S.C. 486(c). </P>
              </AUTH>
            </SECTION>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2922.1—Basic Labor Policies </HD>
              <SECTION>
                <SECTNO>2922.101-3 </SECTNO>
                <SUBJECT>Reporting labor disputes. </SUBJECT>
                <P>Potential or actual labor disputes that may interfere with contract performance must be reported by the contracting activity to the Office of the Solicitor for legal advice or assistance. It may also become necessary to seek advice or assistance from the National Office of the Federal Mediation and Conciliation Service, 2100 K Street, NW, Washington, DC, 20006, or other mediation agencies. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2922.101-4 </SECTNO>
                <SUBJECT>Removal of items from contractor facilities affected by work stoppages. </SUBJECT>
                <P>Before initiating any action under FAR 22.101-4 for removal of items from contractors' facilities, the contracting officer must obtain legal advice from the Office of the Solicitor. </P>
              </SECTION>
              <SECTION>
                <SECTNO>2922.103-4 </SECTNO>
                <SUBJECT>Approvals. </SUBJECT>
                <P>The “agency approving official” as identified in FAR 22.103-4(a) and (b) is a manager, supervisor, or executive responsible for the contracting officer's technical representative (see 2901.603-71). </P>
              </SECTION>
            </SUBPART>
            <SUBPART>
              <HD SOURCE="HED">Subpart 2922.8—Equal Employment Opportunity</HD>
              <SECTION>
                <SECTNO>2922.802 </SECTNO>
                <SUBJECT>General. </SUBJECT>
                <P>Executive Order 11246, as amended, sets forth the Equal Opportunity clause and requires that the Secretary of Labor promote full realization of equal opportunity for all persons regardless of race, color, religion, sex, or national origin. No DOL contracting officer may contract for supplies or services in a manner to avoid applicability of the requirements of E.O. 11246. </P>
                <CONTENTS>
                  <PARTHD>PART 2923—ENVIRONMENT, ENERGY AND WATER EFFICIENCY, RENEWABLE ENERGY TECHNOLOGIES, OCCUPATIONAL SAFETY, AND DRUG-FREE WORKPLACE </PARTHD>
                  <SUBPART>
                    <HD SOURCE="HED">Subpart 2923.2—Energy and Water Efficiency and Renewable Energy </HD>
                  </SUBPART>
                </CONTENTS>
                <AUTH>
                  <HD SOURCE="HED">Authority:</HD>
                  <P>5 U.S.C. 301; 40 U.S.C. 486(c); 42 U.S.C. 8262(g). </P>
                </AUTH>
              </SECTION>
            </SUBPART>
            <SUBPART>
              <PRTPAGE P="49013"/>
              <HD SOURCE="HED">Subpart 2923.2—Energy and Water Efficiency and Renewable Energy </HD>
              <SECTION>
                <SECTNO>2923.271 </SECTNO>
                <SUBJECT>Purchase and use of environmentally sound and energy efficient products and services. </SUBJECT>
                <P>(a) The GSA Federal Supply Schedule Products Guide identifies the recycled and recycled-content items available in the GSA FSS supply system. Copies of the guide may be obtained, without cost, from the GSA, Centralized Mailing List Service, P.O. Box 6477, Fort Worth, Texas 76115, or by calling (817) 334-5215. See also GSA Advantage! </P>

                <P>(b) Executive Order 13123, Greening the Government Through Efficient Energy Management, dated June 8, 1999, requires agencies to select for procurement those energy consuming goods or products which are the most life cycle cost-effective (<E T="03">see</E> FAR 7.101). Green purchasing includes the acquisition of recycled content products, environmentally preferable products and services, biobased products, energy- and water-efficient products, alternate fuel vehicles, and products using renewable energy. </P>
                <P>(1) To the extent practicable, each program official must require vendors of goods or products to provide appropriate data that can be used to assess the life cycle cost of each good or product, including building energy system components, lighting systems, office equipment and other energy using equipment. </P>
                <P>(2) In preparing solicitations and evaluating and selecting offers for award, contracting personnel must consider the life cycle cost data along with other relevant evaluation criteria. If life cycle costing is not used, the contract file must be documented to reflect the rationale for not obtaining and evaluating the data. </P>
                <P>(c) Executive Order 13101, Greening the Government Through Waste Prevention, Recycling, and Federal Acquisition, dated September 14, 1998, requires agencies to comply with executive branch policies for the acquisition and use of environmentally preferable products and services and implement cost-effective procurement preference programs favoring the purchase of these products and services. </P>
                <P>(d) <E T="03">Executive Order 13148 Greening The Government Through Leadership in Environmental Management Systems.</E> This Executive Order assists with developing an environmental management system (EMS). Green acquisition is an integral component of an EMS with energy conservation, recycling, <E T="03">etc.</E> The following sources are provided as references for the subject matter indicated: </P>
                <P>(1) <E T="03">http://www.ofee.gov/gp/gp.htm.</E> The Office of the Federal Environmental Executive provides references to all greening the Government executive orders, web links to other relevant cites, and information on biobased and bioenergy products. </P>
                <P>(2) <E T="03">www.epa.gov/cpg.</E> The Comprehensive Procurement Guidelines program is part of EPA's continued effort to promote the use of materials recovered from solid waste. This listing provides information on products made from recycled materials, such as the carpeting and insulation used in office buildings, or reams of office paper. </P>
                <P>(3) <E T="03">www.energystar.gov.</E> ENERGY STAR is a government-backed program helping businesses and individuals protect the environment through superior energy efficiency. See also <E T="03">http://www.eere.energy.gov/femp/procurement/.</E>
                </P>
                <P>(4) <E T="03">http://www.afdc.doe.gov/.</E> The Alternative Fuels Data Center is a one-stop shop for agency alternative fuel and vehicle information needs. </P>
                <P>(5) <E T="03">www.emall.dla.mil.</E> The Defense Logistics Agency has created an electronic mall for buying environmental preferable products. </P>
              </SECTION>
            </SUBPART>
          </PART>
          <SUBCHAP>
            <HD SOURCE="HED">SUBCHAPTER E—GENERAL CONTRACTING REQUIREMENTS</HD>
            <PART>
              <RESERVED>PART 2924-2927 [RESERVED] </RESERVED>
            </PART>
            <PART>
              <HD SOURCE="HED">PART 2928—BONDS AND INSURANCE </HD>
              <CONTENTS>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2928.2—Sureties and Other Security for Bonds</HD>
                  <SECHD>Sec.</SECHD>
                  <SECTNO>2928.204 </SECTNO>
                  <SUBJECT>Alternatives in lieu of corporate or individual sureties. </SUBJECT>
                </SUBPART>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2928.3—Insurance </HD>
                  <SECTNO>2928.305 </SECTNO>
                  <SUBJECT>Overseas workers' compensation and war hazard insurance. </SUBJECT>
                </SUBPART>
              </CONTENTS>
              <AUTH>
                <HD SOURCE="HED">Authority:</HD>
                <P>5 U.S.C. 301; 40 U.S.C. 486(c). </P>
              </AUTH>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2928.2—Sureties and Other Security for Bonds </HD>
                <SECTION>
                  <SECTNO>2928.204 </SECTNO>
                  <SUBJECT>Alternatives in lieu of corporate or individual sureties. </SUBJECT>

                  <P>Upon receipt of any of the types of securities listed in FAR 28.201 or FAR 28.203, the contracting officer must verify the validity of the security and coordinate the retention of the security with the Chief Financial Officer. Contracting officers may obtain access to Department of Treasury Circular 570 through the Internet at <E T="03">http://www.fms.treas.gov/c570/index.html.</E>
                  </P>
                </SECTION>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2928.3—Insurance </HD>
                <SECTION>
                  <SECTNO>2928.305 </SECTNO>
                  <SUBJECT>Overseas workers' compensation and war hazard insurance. </SUBJECT>

                  <P>The authority of the agency head to recommend to the Secretary of Labor waiver of the applicability of the Defense Base Act (42 U.S.C. 1651 <E T="03">et seq.</E>) to any contract, subcontract, work location, or classification of employees, is delegated to the HCA. </P>
                </SECTION>
              </SUBPART>
            </PART>
            <PART>
              <HD SOURCE="HED">PART 2929—TAXES </HD>
              <CONTENTS>
                <SECHD>Sec.</SECHD>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2929.1—General </HD>
                  <SECTNO>2929.101 </SECTNO>
                  <SUBJECT>Resolving tax problems. </SUBJECT>
                </SUBPART>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2929.3—State and Local Taxes </HD>
                  <SECTNO>2929.303 </SECTNO>
                  <SUBJECT>Application of state and local taxes to Government contractors and subcontractors.</SUBJECT>
                </SUBPART>
              </CONTENTS>
              <AUTH>
                <HD SOURCE="HED">Authority:</HD>
                <P>5 U.S.C. 301; 40 U.S.C. 486(c). </P>
              </AUTH>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2929.1—General </HD>
                <SECTION>
                  <SECTNO>2929.101 </SECTNO>
                  <SUBJECT>Resolving tax problems. </SUBJECT>
                  <P>Contract tax problems or questions must be referred by the contracting officer to the Office of the Solicitor for resolution.</P>
                </SECTION>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2929.3—State and Local Taxes </HD>
                <SECTION>
                  <SECTNO>2929.303 </SECTNO>
                  <SUBJECT>Applications of State and local taxes to Government contractors and subcontractors. </SUBJECT>
                  <P>(a) Contractors may only be treated as agents of the Government for the purposes set forth in FAR 29.303(a) upon the written review and approval of the Assistant Secretary for Administration and Management. </P>
                  <P>(b) Requests for approval under paragraph (a) of this section must be submitted by the HCA through the Office of the Solicitor, to the Division of Acquisition Management Services, for further action. </P>
                </SECTION>
              </SUBPART>
            </PART>
            <PART>
              <HD SOURCE="HED">PART 2930—COST ACCOUNTING STANDARDS ADMINISTRATION </HD>
              <CONTENTS>
                <SECHD>Sec.</SECHD>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2930.2—CAS Program Requirements </HD>
                  <SECTNO>2930.201-5 </SECTNO>
                  <SUBJECT>Waiver. </SUBJECT>
                </SUBPART>
              </CONTENTS>
              <AUTH>
                <HD SOURCE="HED">Authority:</HD>
                <P>5 U.S.C. 301; 40 U.S.C. 486(c). </P>
              </AUTH>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2930.2—CAS Program Requirements </HD>
                <SECTION>
                  <SECTNO>2930.201-5 </SECTNO>
                  <SUBJECT>Waiver. </SUBJECT>
                  <P>(a) The Head of Contracting Activity is authorized to waive CAS requirements as provided in FAR 30.201-5. </P>

                  <P>(b) Requests for waivers under paragraph (a) of this subsection must be prepared by the contracting officer as <PRTPAGE P="49014"/>prescribed in FAR 30.201-5(e) and submitted to the HCA. </P>
                </SECTION>
              </SUBPART>
            </PART>
            <PART>
              <HD SOURCE="HED">PART 2931—CONTRACT COST PRINCIPLES AND PROCEDURES </HD>
              <CONTENTS>
                <SECHD>Sec.</SECHD>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2931.1—Applicability. </HD>
                  <SECTNO>2931.101 </SECTNO>
                  <SUBJECT>Objectives. </SUBJECT>
                </SUBPART>
              </CONTENTS>
              <AUTH>
                <HD SOURCE="HED">Authority:</HD>
                <P>5 U.S.C. 301; 40 U.S.C. 486(c). </P>
              </AUTH>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2931.1—Applicability </HD>
                <SECTION>
                  <SECTNO>2931.101 </SECTNO>
                  <SUBJECT>Objectives. </SUBJECT>
                  <P>Individual and class deviations from cost principles in FAR Part 31 must be processed as prescribed in DOLAR Subpart 2901.4. </P>
                </SECTION>
              </SUBPART>
            </PART>
            <PART>
              <HD SOURCE="HED">PART 2932—CONTRACT FINANCING </HD>
              <CONTENTS>
                <SECHD>Sec.</SECHD>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2932.4—Advance Payments for Non-Commercial Items</HD>
                  <SECTNO>2932.402 </SECTNO>
                  <SUBJECT>General. </SUBJECT>
                  <SECTNO>2932.407 </SECTNO>
                  <SUBJECT>Interest. </SUBJECT>
                </SUBPART>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2932.7—Contract Funding </HD>
                  <SECTNO>2932.703 </SECTNO>
                  <SUBJECT>Contract funding requirements. </SUBJECT>
                </SUBPART>
              </CONTENTS>
              <AUTH>
                <HD SOURCE="HED">Authority:</HD>
                <P>5 U.S.C. 301; 40 U.S.C. 486(c). </P>
              </AUTH>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2932.4—Advance Payments for Non-Commercial Items </HD>
                <SECTION>
                  <SECTNO>2932.402 </SECTNO>
                  <SUBJECT>General. </SUBJECT>
                  <P>The HCA is authorized to approve determinations and findings as well as contract terms for advance payments. The contracting officer must submit a recommendation for approval or disapproval of the contractor's request to the HCA. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2932.407 </SECTNO>
                  <SUBJECT>Interest. </SUBJECT>
                  <P>The HCA may authorize advance payments without interest pursuant to FAR 32.407. </P>
                </SECTION>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2932.7—Contract Funding</HD>
                <SECTION>
                  <SECTNO>2932.703 </SECTNO>
                  <SUBJECT>Contract funding requirements. </SUBJECT>
                  <P>(a) Except in unusual circumstances, the contracting office may not issue solicitations until an approved procurement request (PR), containing a certification that funds are available, has been received. However, the contracting office may take all necessary actions up to the point of contract obligation before receipt of the PR certifying that funds are available when: </P>
                  <P>(1) The Assistant Secretary, Inspector General, Bureau Chief, Deputy Under Secretary, Solicitor of Labor, Commissioner, or Director Women's Bureau certifies that such action is necessary to meet critical program schedules for their program area; </P>
                  <P>(2) The Budget Officer certifies that program authority has been issued and funds to cover the acquisition will be available before the date set for receipt of proposals; </P>
                  <P>(3) The solicitation includes the clause at FAR 52.232-18, Availability of Funds. </P>
                  <P>(b) The contracting office may not open bids/close solicitations until a PR, either planning or final, has been received that contains a certification of fund availability. Only the project or program official with the authority to commit funds from the agency that initiated the PR may make that written certification. </P>
                  <P>(c) The project or program office that initiated the PR is responsible for obtaining required certifications. </P>
                </SECTION>
              </SUBPART>
            </PART>
            <PART>
              <HD SOURCE="HED">PART 2933—PROTESTS, DISPUTES, AND APPEALS </HD>
              <CONTENTS>
                <SECHD>Sec.</SECHD>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2933.1—Protests </HD>
                  <SECTNO>2933.102 </SECTNO>
                  <SUBJECT>General. </SUBJECT>
                  <SECTNO>2933.103 </SECTNO>
                  <SUBJECT>Protests to the agency. </SUBJECT>
                  <SECTNO>2933.104 </SECTNO>
                  <SUBJECT>Protests to GAO. </SUBJECT>
                </SUBPART>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2933.2—Disputes and Appeals </HD>
                  <SECTNO>2933.203 </SECTNO>
                  <SUBJECT>Applicability. </SUBJECT>
                  <SECTNO>2933.209 </SECTNO>
                  <SUBJECT>Suspected fraudulent claims. </SUBJECT>
                  <SECTNO>2933.211 </SECTNO>
                  <SUBJECT>Contracting officer's decision. </SUBJECT>
                  <SECTNO>2933.212 </SECTNO>
                  <SUBJECT>Contracting officer's duties upon appeal. </SUBJECT>
                  <SECTNO>2933.213 </SECTNO>
                  <SUBJECT>Obligation to continue performance. </SUBJECT>
                  <SECTNO>2933.270 </SECTNO>
                  <SUBJECT>Department of Labor Board of Contract Appeals. </SUBJECT>
                </SUBPART>
              </CONTENTS>
              <AUTH>
                <HD SOURCE="HED">Authority:</HD>
                <P>5 U.S.C. 301; 40 U.S.C. 486(c); E.O. 12979,  60 FR 55171, 3 CFR, 1995 Comp., p. 417.</P>
              </AUTH>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2933.1—Protests </HD>
                <SECTION>
                  <SECTNO>2933.102 </SECTNO>
                  <SUBJECT>General. </SUBJECT>
                  <P>(a) The Division of Acquisition Management Services, N-5425, 200 Constitution Ave., NW., Washington DC 20210-0001, telephone (202) 693-7285, facsimile (202) 693-7290 (or the Office acting in that capacity), is responsible for coordinating procurement protests filed with the General Accounting Office. </P>
                  <P>(b) The authority of the Assistant Secretary for Administration and Management under FAR 33.102(b) to determine that a solicitation, proposed award, or award does not comply with the requirements of law or regulation may be delegated to the HCA. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2933.103 </SECTNO>
                  <SUBJECT>Protests to the agency. </SUBJECT>
                  <P>(a) In accordance with Executive Order 12979, the following procedures apply to agency protests: </P>
                  <P>(1) The filing time frames in FAR 33.103(e) apply to agency protests. An agency protest is filed when the protest complaint is received at the location the solicitation designates for serving protests; or if none is designated, when filed with a contracting officer or HCA. </P>
                  <P>(2) An interested party filing an agency protest may request either that the contracting officer or the Agency Protest Official decide the protest. The “Agency Protest Official” is an individual above the level of the contracting officer and designated by the ASAM, such as the Competition Advocate. The deciding official, whether a C.O. or Agency Protest Official, who must work in consultation with the Office of Solicitor to resolve a protest. </P>
                  <P>(3) In addition to the information required by FAR 33.103(d)(2), the protest must: </P>
                  <P>(i) Indicate that it is a protest to the agency. </P>
                  <P>(ii) Be contemporaneously filed with the contracting officer. </P>
                  <P>(iii) State whether the protestor chooses to have the contracting officer or the Agency Protest Official decide the protest. If the protest is silent on this matter, the contracting officer will decide the protest. </P>
                  <P>(b) “Interested Party” means an actual or prospective offeror whose direct economic interest would be affected by the award of a contract or by the failure to award a contract. </P>
                  <P>(c) If the Agency Protest Official is chosen by the protestor to decide the protest, this is an alternative to a decision by the contracting officer, not an appeal. The Agency Protest Official will not consider appeals from a contracting officer's decision on an agency protest. </P>
                  <P>(d) The deciding official should consider conducting a scheduling conference with the protestor within five (5) days after the protest is filed. The scheduling conference will establish deadlines for written arguments in support of the agency protest and for agency officials to present information in response to the protest issues. Alternative Dispute Resolution (ADR) techniques will be considered if determined appropriate by the deciding official. </P>
                  <P>(e) Oral conferences may take place either by telephone or in person. Other parties may attend at the discretion of the deciding official. </P>

                  <P>(f) Apart from its protest document, the protestor will be given only one opportunity to support or explain in writing the substance of its protest. Department of Labor procedures do not provide for any discovery. The deciding official has discretion to request additional information from either the agency or the protestor. However, the deciding official will normally decide protests on the basis of information <PRTPAGE P="49015"/>provided by the protestor and the agency. </P>
                  <P>(g) The preferred practice is to resolve protests through informal oral discussion. </P>
                  <P>(h) An interested party may represent itself or be represented by legal counsel. The Department of Labor will not reimburse the protester for any legal fees or costs related to the agency protest. </P>
                  <P>(i) If an agency protest is received before contract award, the contracting officer may only make award if the HCA makes a determination to proceed under FAR 33.103(f)(1). Similarly, if an agency protest is filed within ten (10) days after award, or within five (5) days of the offered of a debriefing required by FAR 15.505 or 15.506, whichever is later, the contracting officer must suspend performance of the contract unless the HCA makes a determination to proceed under FAR 33.103(f)(3). Any stay of award or suspension of performance remains in effect until the protest is decided, dismissed, or withdrawn. </P>
                  <P>(j) The deciding official must make a best effort to issue a decision on the protest within twenty (20) days after the filing date. The decision may be oral or written, dependent upon advice of legal counsel. </P>
                  <P>(k) The deciding official must send a confirming letter within three (3) days after the decision using a means that provides evidence of receipt. The confirming letter must include the following information: </P>
                  <P>(1) State whether the protest was denied, sustained or dismissed. </P>
                  <P>(2) Indicate the date the decision was provided. </P>
                  <P>(3) If the deciding official sustains the protest, relief may consist of any of the following: </P>
                  <P>(i) Recommendation that the contract be terminated for convenience or cause, or that the solicitation be canceled. </P>
                  <P>(ii) Recompeting the requirement from the beginning of the solicitation or from the last round of negotiations. </P>
                  <P>(iii) Amending the solicitation. </P>
                  <P>(iv) Refraining from exercising contract options. </P>
                  <P>(v) Awarding a contract consistent with statute, regulation, and the terms of the solicitation. </P>
                  <P>(vi) Other action that the deciding official determines is appropriate. </P>
                  <P>(l) If the deciding official sustains a protest, then within 30 days after receiving the official's recommendations for relief, the contracting officer must either: </P>
                  <P>(1) Fully implement the recommended relief; or </P>
                  <P>(2) Notify the deciding official, if the contracting officer was not the deciding official, in writing, if any recommendations have not been implemented and explain why. </P>
                  <P>(m) If the protest is denied, and contract performance has been suspended under paragraph (i) of this section, the contracting officer will not lift such suspension until five (5) days after the protest decision has been issued, to allow the protester to file a protest with the General Accounting Office, unless the HCA makes a new finding under FAR 33.103(f)(3). The contracting officer shall consider allowing such suspension to remain in effect pending the resolution of any GAO proceeding. </P>
                  <P>(n) Proceedings on an agency protest may be dismissed or stayed if a protest on the same or similar basis is filed with a protest forum outside of the Department of Labor. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2933.104 </SECTNO>
                  <SUBJECT>Protests to GAO. </SUBJECT>
                  <P>(a) <E T="03">General procedures.</E> The HCA has the responsibility to prepare and provide to the General Accounting Office (GAO) the agency report with the information required by FAR 33.104(a). The agency report must be coordinated with the Office of the Solicitor before the report is signed and sent to the GAO. </P>
                  <P>(b) <E T="03">Protests before award.</E> The authority of the HCA under FAR 33.104(b) to authorize a contract award when the agency has received notice from the GAO of a protest filed directly with the GAO is nondelegable. The HCA has the responsibility to prepare and provide to the GAO the written finding with the information required by FAR 33.104(b)(1). The written finding must be coordinated with Office of the Solicitor before the HCA affirms its approval by signing the written finding and sending it to the GAO. Copies of the signed written finding and the signed written notice to the GAO must be provided to the PE within two (2) working days after they are sent to the GAO. </P>
                  <P>(c) <E T="03">Protests after award.</E> The authority of the HCA under FAR 33.104(c) to authorize contract performance when the agency has received notice from the GAO of a protest filed directly with the GAO is nondelegable. The HCA has the responsibility to prepare and provide to the GAO the written finding with the information required by FAR 33.104(c)(2). The written finding must be coordinated with the Office of the Solicitor before the notice is signed by the HCA and sent to the GAO. </P>
                  <P>(d) <E T="03">Notice to the GAO.</E> The authority of the HCA under FAR 33.104(g), to report to the GAO the failure to fully implement the GAO recommendations with respect to a solicitation for a contract or an award or a proposed award of a contract within 60 days of receiving the GAO recommendations, is nondelegable. The written notice must be coordinated with the Office of the Solicitor before the notice is signed by the HCA and sent to the GAO. A copy of all notices to the GAO submitted in accordance with FAR 33.104(g) must be provided to the PE within 2 working days after they are sent to the GAO. </P>
                </SECTION>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2933.2—Disputes and Appeals</HD>
                <SECTION>
                  <SECTNO>2933.203</SECTNO>
                  <SUBJECT>Applicability. </SUBJECT>
                  <P>The authority of the agency head to determine that the application of the Contract Disputes Act of 1978 to any contract with a foreign government or agency of that government, or an international organization or a subsidiary body of that organization, would not be in the public interest is delegated to the HCA. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2933.209</SECTNO>
                  <SUBJECT>Suspected fraudulent claims. </SUBJECT>
                  <P>The contracting officer must refer all matters relating to suspected fraudulent claims by a contractor under the conditions in FAR 33.209 to the Office of the Inspector General for further action or investigation. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2933.211</SECTNO>
                  <SUBJECT>Contracting officer's decision. </SUBJECT>
                  <P>The written decision required by FAR 33.211(a)(4) must include, in the paragraph listed under FAR 33.211(a)(4)(v), specific reference to the Department of Labor Board of Contract Appeals (LBCA), 800 K Street, NW., Washington, DC 20001-8002. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2933.212</SECTNO>
                  <SUBJECT>Contracting officer's duties upon appeal. </SUBJECT>
                  <P>(a) When a notice of appeal has been received, the contracting officer must endorse on the appeal the date of mailing (or the date of receipt if the notice was not mailed). The contracting officer must also notify the Solicitor of Labor of the appeal. </P>
                  <P>(b) The contracting officer should prepare and transmit the administrative file for the Office of the Solicitor and assist with the appeal. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2933.213</SECTNO>
                  <SUBJECT>Obligation to continue performance. </SUBJECT>
                  <P>The contracting officer must include the clause at FAR 52.233-1, Disputes (Alternate I), in contracts where continued performance is necessary pending resolution of any claim arising under or relating to the contract. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2933.270</SECTNO>
                  <SUBJECT>Department of Labor Board of Contract Appeals. </SUBJECT>

                  <P>(a) The Department of Labor Board of Contract Appeals (LBCA) is authorized by the Secretary to consider and <PRTPAGE P="49016"/>determine appeals from decisions of contracting officers arising under a contract, or relating to a contract, made by the Department or any other executive agency when such agency or the Administrator of the Office of Federal Procurement Policy has designated the LBCA to decide the appeal. </P>
                  <P>(b) The LBCA rules of procedure are contained in 41 CFR Part 29-60.104, appearing in the July 1, 1983 edition of 41 CFR subtitle A, chapters 19 to 100. </P>
                </SECTION>
              </SUBPART>
            </PART>
            <PART>
              <RESERVED>PART 2934-2935 [RESERVED.] </RESERVED>
            </PART>
            <PART>
              <HD SOURCE="HED">PART 2936—CONSTRUCTION AND ARCHITECT-ENGINEER CONTRACTS </HD>
              <CONTENTS>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2936.2—Special Aspects of Contracting for Construction</HD>
                  <SECHD>Sec.</SECHD>
                  <SECTNO>2936.201</SECTNO>
                  <SUBJECT>Evaluation of contractor performance. </SUBJECT>
                  <SECTNO>2936.209</SECTNO>
                  <SUBJECT>Construction contracts with architect-engineer firms. </SUBJECT>
                </SUBPART>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2936.5—Contract Clauses </HD>
                </SUBPART>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2936.6—Architect-Engineer Services </HD>
                  <SECTNO>2936.602</SECTNO>
                  <SUBJECT>Selection of firms for architect-engineer contracts. </SUBJECT>
                  <SECTNO>2936.602-1</SECTNO>
                  <SUBJECT>Selection criteria. </SUBJECT>
                  <SECTNO>2936.602-2</SECTNO>
                  <SUBJECT>Evaluation boards. </SUBJECT>
                  <SECTNO>2936.602-3</SECTNO>
                  <SUBJECT>Evaluation board functions. </SUBJECT>
                  <SECTNO>2936.602-4</SECTNO>
                  <SUBJECT>Selection authority. </SUBJECT>
                  <SECTNO>2936.602-5</SECTNO>
                  <SUBJECT>Short selection processes for contracts not to exceed $100,000. </SUBJECT>
                  <SECTNO>2936.603</SECTNO>
                  <SUBJECT>Collecting data on and appraising firms' qualifications. </SUBJECT>
                  <SECTNO>2936.604</SECTNO>
                  <SUBJECT>Performance evaluation. </SUBJECT>
                </SUBPART>
              </CONTENTS>
              <AUTH>
                <HD SOURCE="HED">Authority:</HD>
                <P>5 U.S.C. 301; 40 U.S.C. 486(c). </P>
              </AUTH>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2936.2—Special Aspects of Contracting for Construction</HD>
                <SECTION>
                  <SECTNO>2936.201</SECTNO>
                  <SUBJECT>Evaluation of contractor performance. </SUBJECT>
                  <P>The HCA must establish procedures to evaluate construction contractor performance and prepare performance reports as required by FAR 36.201. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2936.209</SECTNO>
                  <SUBJECT>Construction contracts with architect-engineer firms. </SUBJECT>
                  <P>As required by FAR 36.209, no contract for construction of a project may be awarded to the firm that designed the project, or to its subsidiaries or affiliates, without the written approval of the ASAM. Any request for approval must include the reason(s) why award to the design firm is required; an analysis of the facts involving potential or actual organizational conflicts of interest including benefits and detriments to the Government and the prospective contractor; and the measures which are to be taken to avoid, neutralize, or mitigate conflicts of interest. </P>
                </SECTION>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2936.5—Contract Clauses </HD>
                <SECTION>
                  <SECTNO> </SECTNO>
                  <SUBJECT> </SUBJECT>
                  
                  <P>The HCA is authorized to make the determination regarding the impracticability of Government performance of original and final surveys as prescribed in FAR 36.516. </P>
                </SECTION>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2936.6—Architect-Engineer Services</HD>
                <SECTION>
                  <SECTNO>2936.602</SECTNO>
                  <SUBJECT>Selection of firms for architect-engineer contracts. </SUBJECT>
                </SECTION>
                <SECTION>
                  <SECTNO>2936.602-1</SECTNO>
                  <SUBJECT>Selection criteria. </SUBJECT>
                  <P>HCAs are authorized to approve the use of design competition under the conditions in FAR 36.602-1(b). </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2936.602-2</SECTNO>
                  <SUBJECT>Evaluation boards. </SUBJECT>
                  <P>HCAs must establish procedures to provide permanent or ad hoc architect-engineer evaluation boards as prescribed in FAR 36.602-2. Procedures must provide for the appointment of private practitioners of architecture, engineering, or related professions when such action is determined in writing by the HCA to be essential to meeting the Government's minimum needs. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2936.602-3</SECTNO>
                  <SUBJECT>Evaluation board functions. </SUBJECT>
                  <P>The selection report required in FAR 36.602-3(d) must be prepared for the approval of the HCA. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2936.602-4</SECTNO>
                  <SUBJECT>Selection Authority. </SUBJECT>
                  <P>The HCA is authorized to serve as the designated Selection Authority in accordance with FAR 36.602-1. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2936.602-5</SECTNO>
                  <SUBJECT>Short selection processes for contracts not to exceed $100,000. </SUBJECT>
                  <P>The selection process prescribed in FAR 36.602-5(b) must be used for architect-engineer contracts not exceeding the Simplified Acquisition Threshold. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2936.603</SECTNO>
                  <SUBJECT>Collecting data on and appraising firms' qualifications. </SUBJECT>
                  <P>(a) HCAs who acquire architect-engineer services must establish procedures to comply with the requirements of FAR 36.603. </P>
                  <P>(b) Copies of procedures established under paragraph (a) of this section must be submitted to the Division of Acquisition Management Services, for review and recommendation for approval to the HCA when updated. These procedures must include a list of names, addresses, and telephone numbers of offices or boards assigned to maintain architect-engineer qualification data files. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2936.604</SECTNO>
                  <SUBJECT>Performance evaluation. </SUBJECT>
                  <P>(a) The HCA must establish procedures to evaluate architect-engineer contractor performance as required in FAR 36.604. Normally, the performance report must be prepared by the contracting officer's authorized representative or other official who was responsible for monitoring contract performance and who is qualified to evaluate overall performance. DOL Agency/Office procedures must prescribe instructions for review of the report, before distribution, as prescribed in FAR 36.604(b). </P>
                  <P>(b) Performance reports must be made using Standard Form 1421, Performance Evaluation (Architect-Engineer) as prescribed in FAR 36.702(c). Details covering unsatisfactory performance, including Government notification to the contractor and written comments by the contractor, must also be attached to the report. </P>
                </SECTION>
              </SUBPART>
            </PART>
            <PART>
              <HD SOURCE="HED">PART 2937—SERVICE CONTRACTING </HD>
              <CONTENTS>
                <SECHD>Sec.</SECHD>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2937.1—Service Contracts—General</HD>
                  <SECTNO>2937.103 </SECTNO>
                  <SUBJECT>Contracting officer responsibility. </SUBJECT>
                  <SECTNO>2937.103-70</SECTNO>
                  <SUBJECT>Department of Labor checklist to aid analysis and review of requirements for service contracts. </SUBJECT>
                </SUBPART>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2937.2—Advisory and Assistance Services</HD>
                  <SECTNO>2937.203 </SECTNO>
                  <SUBJECT>Policy. </SUBJECT>
                </SUBPART>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2937.6—Preference for Performance-Based Contracting (PBC) </HD>
                  <SECTNO>2937.602</SECTNO>
                  <SUBJECT>Elements of performance-based contracting. </SUBJECT>
                </SUBPART>
              </CONTENTS>
              <AUTH>
                <HD SOURCE="HED">Authority:</HD>
                <P>5 U.S.C. 301, 40 U.S.C. 486(c). </P>
              </AUTH>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2937.1—Service Contracts-General </HD>
                <SECTION>
                  <SECTNO> </SECTNO>
                  <SUBJECT> </SUBJECT>
                  
                  <P>The HCA is responsible for establishing internal review and approval procedures for service contracts in accordance with OFPP Policy Letter 93-1, “Management Oversight of Service Contracting”. As defined by FAR 37.101, contracts for personal services are permitted under the circumstances in 5 U.S.C. 3109. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2937.103-70</SECTNO>
                  <SUBJECT>Department of Labor checklist to aid analysis and review of requirements for service contracts. </SUBJECT>
                  <P>Contracting specialists and contracting officers must work in close collaboration with the beneficiaries of the services being purchased to ensure that contractor performance meets contract requirements and performance standards. </P>
                  <P>(a) <E T="03">General.</E> Following is a checklist to aid analysis and review of requirements for service contracts. </P>

                  <P>(1) Is the statement of work complete, with a clear-cut division of responsibility between the contracting parties? <PRTPAGE P="49017"/>
                  </P>
                  <P>(2) Is the statement of work discussed in terms the market can satisfy? </P>
                  <P>(3) Does the statement of work encompass all commercially available services that can meet the actual functional need (eliminates any nonessential preferences that may thwart full and open competition)? </P>

                  <P>(4) Is the statement of work performance-based to the maximum extent possible (<E T="03">i.e.</E>, is the acquisition structured around the purpose of the work to be performed, as opposed to either the manner by which the work is to be performed or a broad and imprecise statement of work? </P>
                  <P>(b) <E T="03">Cost effectiveness.</E> If the response to any of the following questions is negative, the agency may not have a valid requirement or not be obtaining the requirement in the most cost effective manner. </P>
                  <P>(1) Is the statement of work written so that it supports the need for a specific service? </P>
                  <P>(2) Is the statement of work written so that it permits adequate evaluation of contractor versus in-house cost and performance? </P>
                  <P>(3) Are the choices of contract type, quality assurance plan, competition strategy, or other related acquisition strategies and procedures in the acquisition plan appropriate to ensure good contractor performance to meet the user's needs? </P>
                  <P>(4) If a cost reimbursement contract is contemplated, is the acquisition plan adequate to ensure that the contractor will have the incentive to control costs under the contract? </P>
                  <P>(5) Is the acquisition plan adequate to address the cost effectiveness of using contractor support (either long-term or short-term) versus in-house performance? </P>
                  <P>(6) Is the cost estimate, or other supporting cost information, adequate to enable the contracting office to effectively determine whether costs are reasonable?</P>
                  <P>(7) Is the statement of work adequate to describe the requirement in terms of “what” is to be performed as opposed to “how” the work is to be accomplished?</P>
                  <P>(8) Is the acquisition plan adequate to ensure that there is proper consideration given to “quality” and “best value?”</P>
                  <P>(c) <E T="03">Control.</E> If the response to any of the following questions is negative, there may be a control problem.</P>
                  <P>(1) Are there sufficient resources to evaluate contractor performance when the statement of work requires the contractor to provide advice, analysis and evaluation, opinions, alternatives, or recommendations that could significantly influence agency policy development or decision-making?</P>
                  <P>(2) Does the quality assurance plan provide for adequate monitoring of contractor performance?</P>
                  <P>(3) Is the statement of work written so that it specifies a contract deliverable or requires progress reporting on contractor performance?</P>
                  <P>(4) Is agency expertise adequate to independently evaluate the contractor's approach, methodology, results, options, conclusions or recommendations?</P>
                  <P>(d) <E T="03">Conflicts of interest.</E> If the response to any of the following questions is affirmative, there may be a conflict of interest.</P>
                  <P>(1) Can the potential offeror perform under the contract to devise solutions or make recommendations that would influence the award of future contracts to that contractor?</P>
                  <P>(2) If the requirement is for support services (such as system engineering or technical direction), were any of the potential offerors involved in developing the system design specifications or in the production of the system?</P>
                  <P>(3) Has a potential offeror participated in earlier work involving the same program or activity that is the subject of the present contract wherein the offeror had access to source selection or proprietary information not available to other offerors competing for the contract?</P>
                  <P>(4) Will the contractor be evaluating a competitor's work?</P>
                  <P>(5) Does the contract allow the contractor to accept its own products or activities on behalf of the Government?</P>

                  <P>(6) Will the work under this contract put the contractor in a position to influence government decision-making, <E T="03">e.g.</E>, developing regulations that will affect the contractor's current or future business?</P>
                  <P>(7) Will the work under this contract affect the interests of the contractor's other clients?</P>
                  <P>(8) Are any of the potential offerors, or their personnel who will perform the contract, former agency officials who—while employed by the agency—personally and substantially participated in the development of the requirement for, or the procurement of, these services within the past two years?</P>
                  <P>(e) <E T="03">Competition.</E> If the response to any of the following questions is negative, competition may be unnecessarily limited.</P>
                  <P>(1) Is the statement of work defined so as to avoid overly restrictive specifications or performance standards?</P>
                  <P>(2) Is the contract formulated in such a way as to avoid creating a continuous and dependent arrangement with the same contractor?</P>
                  <P>(3) Is the use of an indefinite quantity or term contract arrangement appropriate to obtain the required services?</P>
                  <P>(4) Will the requirement be obtained through the use of full and open competition?</P>
                </SECTION>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2937.2—Advisory and Assistance Services</HD>
                <SECTION>
                  <SECTNO>2937.203 </SECTNO>
                  <SUBJECT>Policy.</SUBJECT>

                  <P>(a) HCAs having a requirement for certain advisory and assistance services are required by the Department of Labor Manual Series (<E T="03">See</E> DLMS 2 836) to prepare a written justification for such services. Written justification must be submitted to the ASAM for review by the Procurement Review Board, for ASAM approval.</P>
                  <P>(b) Regardless of the type of action planned, the justification in paragraph (a) of this section must include the following:</P>
                  <P>(1) A statement of need, which certifies that the requested services do not unnecessarily duplicate any previously performed work.</P>
                  <P>(2) Nature and scope of the need, and the results expected.</P>
                  <P>(3) Extent to which in-house staff availability was assessed, and the reasons why procurement of outside services is necessary.</P>
                  <P>(4) Any additional information or data that support the requirement for a contract.</P>
                  <P>(5) Name(s) and title(s) of official(s) who will be assigned as project officer(s) to work with the contractor, and who can be contacted for additional information.</P>
                  <P>(6) A statement that the Government policy on advisory and assistance services has been reviewed and complies with FAR 37.203.</P>
                </SECTION>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2937.6—Preference for Performance-Based Contracting (PBC)</HD>
                <SECTION>
                  <SECTNO>2937.602 </SECTNO>
                  <SUBJECT>Elements of performance-based contracting.</SUBJECT>

                  <P>(a) Performance-based contracting is defined in FAR 37.101 and discussed in FAR 37.6. Although FAR Part 37 primarily addresses services contracts, PBC is not limited to these contracts. PBC is the preferred way of contracting for services. (<E T="03">See</E> exceptions listed in FAR 37.102). Generally, when contract performance risk under a PBC specification can be shifted to the contractor to allow for the operation of objective incentives, a contract type with objectively measurable incentives <PRTPAGE P="49018"/>(<E T="03">e.g.</E>, Firm-Fixed-Price, Fixed-Price-Incentive-Fee, or Cost-Plus-Incentive-Fee) is appropriate. However, when contractor performance (<E T="03">e.g.</E>, cost control, schedule, or quality/technical) is best evaluated subjectively using qualitative measures, a Cost-Plus-Award Fee contract may be used.</P>
                  <P>(b) A labor hour level-of-effort contract is not considered a performance-based contract.</P>
                </SECTION>
              </SUBPART>
            </PART>
            <PART>
              <RESERVED>PART 2938—2941 [RESERVED]</RESERVED>
            </PART>
          </SUBCHAP>
          <SUBCHAP>
            <HD SOURCE="HED">SUBCHAPTER G—CONTRACT MANAGEMENT</HD>
            <PART>
              <HD SOURCE="HED">PART 2942—CONTRACT ADMINISTRATION AND AUDIT SERVICES</HD>
              <CONTENTS>
                <SECTNO> </SECTNO>
                <SUBJECT> </SUBJECT>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2942.1—Contract Audit Services </HD>
                  <SECHD>Sec.</SECHD>
                  <SECTNO>2942.101 </SECTNO>
                  <SUBJECT>Policy</SUBJECT>
                </SUBPART>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2942.15—Contractor Performance Information </HD>
                  <SECTNO>2942.1502 </SECTNO>
                  <SUBJECT>Policy.</SUBJECT>
                  <SECTNO>2942.1503 </SECTNO>
                  <SUBJECT>Procedures.</SUBJECT>
                </SUBPART>
              </CONTENTS>
              <AUTH>
                <HD SOURCE="HED">Authority:</HD>
                <P>5 U.S.C. 301, 40 U.S.C. 486(c).</P>
              </AUTH>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2942.1—Contract Audit Services </HD>
                <SECTION>
                  <SECTNO>2942.101 </SECTNO>
                  <SUBJECT>Policy</SUBJECT>
                  <P>The OASAM Division of Cost Determination is responsible for establishing billing rates and indirect cost rates as prescribed in FAR 42.7 for the Department of Labor.</P>
                </SECTION>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2942.15—Contractor Performance Information</HD>
                <SECTION>
                  <SECTNO> </SECTNO>
                  <SUBJECT> </SUBJECT>
                  
                  <P>This subpart provides policies and procedures for evaluating, maintaining, and releasing contractor performance information under DOL contracts.</P>
                </SECTION>
                <SECTION>
                  <SECTNO>2942.1502 </SECTNO>
                  <SUBJECT>Policy.</SUBJECT>
                  <P>DOL contracting officers are required to use or interface with the National Institutes of Health's Contractor Performance System. The HCA is responsible for ensuring that a contractor performance evaluation system is generated to meet the requirements of FAR Subpart 42.15. Contracts, task orders, and delivery orders, exceeding the simplified acquisition threshold, should be formally evaluated in writing. Interim evaluations should be performed on contracts exceeding one year in duration. This will assist contractors with improving marginal performance and identifying any major deficiencies. It will also facilitate performance evaluations at contract completion, as well as determining whether to exercise contract options, if any.</P>
                </SECTION>
                <SECTION>
                  <SECTNO>2942.1503 </SECTNO>
                  <SUBJECT>Procedures.</SUBJECT>
                  <P>(a) In accordance with FAR 42.1502, the contracting officer will prepare an interim evaluation of a contractor's performance at least annually for submission to the Contractor Performance System maintained by the National Institutes of Health.</P>
                  <P>(b) The contracting officer, or designee, must determine who will evaluate a contractor's performance. The contracting officer's technical representative, program manager, contract specialists or administrators, and users are candidates likely to be selected to perform the evaluation.</P>
                  <P>(c) A Contractor's performance evaluation should be obtained from a person who monitored contractor performance, when that individual's assignment of duties or employment terminates before physical completion of the contract. The areas of performance to be selected for evaluation should be tailored to the type of supplies or services normally acquired by the contracting activities and the type of contract. HCAs must ensure uniformity of the evaluation criteria within their contracting activities.</P>
                  <P>(d) <E T="03">Release of contractor performance evaluation information.</E> (1) Requests for performance evaluation information from the public must be processed in accordance with FOIA, as implemented by DOL under 29 CFR Part 70.</P>
                  <P>(2) Release of a contractor's performance evaluation information to other federal agencies is subject to FAR 42.1502. When the performance evaluation information is released to other federal agencies, it should be provided with a written statement that it is nonpublic information that must be processed under FOIA principles if a request for its disclosure is received.</P>
                  <P>(e) Even though the retention period for past performance evaluation information is three years (see FAR 42.1503), the contractor's performance evaluation, any contractor rebuttal, and final decision become a part of the contract file. Therefore, disposal of the contractor's evaluation information must be accomplished in accordance with FAR 4.804.</P>
                </SECTION>
              </SUBPART>
            </PART>
            <PART>
              <HD SOURCE="HED">PART 2943—CONTRACT MODIFICATIONS</HD>
              <CONTENTS>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2943.2—Change Orders </HD>
                  <SECHD>Sec.</SECHD>
                  <SECTNO>2943.205 </SECTNO>
                  <SUBJECT>Contract clauses.</SUBJECT>
                </SUBPART>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2943.3—Forms </HD>
                  <SECTNO>2943.301 </SECTNO>
                  <SUBJECT>Use of forms.</SUBJECT>
                </SUBPART>
              </CONTENTS>
              <AUTH>
                <HD SOURCE="HED">Authority:</HD>
                <P>5 U.S.C. 301; 40 U.S.C. 486(c).</P>
              </AUTH>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2943.2—Change Orders </HD>
                <SECTION>
                  <SECTNO>2943.205 </SECTNO>
                  <SUBJECT>Contract clauses.</SUBJECT>
                  <P>HCAs may establish procedures, or office policies, when appropriate for authorizing the contracting officer to vary the 30-day period for submission of adjustment proposals to the clauses prescribed by FAR 43.205.</P>
                </SECTION>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2943.3—Forms</HD>
                <SECTION>
                  <SECTNO>2943.301 </SECTNO>
                  <SUBJECT>Use of forms.</SUBJECT>
                  <P>(a) FAR 43.301(a)(1)(vi) requires the use of Standard Form 30 (SF-30) to execute any obligation or deobligation of contract funds after award. The SF-30 also must be used to deobligate funds when effecting contract closeout, when obligated funds exceed the final contract costs. In such an instance, the SF-30 may be issued as an administrative modification on a unilateral basis if the contractor's financial release has been separately obtained.</P>
                  <P>(b) The contracting officer must include in any unilateral contract modification issued for contract closeout, a statement that the contractor has signed a release of claims and indicate the date the release of claims was signed by the contractor. The SF-30 must also be used to execute purchase order modifications as specified in FAR 13.302-3(b).</P>
                </SECTION>
              </SUBPART>
            </PART>
            <PART>
              <HD SOURCE="HED">PART 2944—SUBCONTRACTING POLICIES AND PROCEDURES</HD>
              <CONTENTS>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2944.1—General</HD>
                </SUBPART>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2944.2—Consent To Subcontract </HD>
                  <SECHD>Sec.</SECHD>
                  <SECTNO>2944.201-1 </SECTNO>
                  <SUBJECT>Consent requirements. </SUBJECT>
                  <SECTNO>2944.202 </SECTNO>
                  <SUBJECT>Contracting officer's evaluation.</SUBJECT>
                  <SECTNO>2944.202-2 </SECTNO>
                  <SUBJECT>Considerations.</SUBJECT>
                  <SECTNO>2944.203 </SECTNO>
                  <SUBJECT>Consent limitations.</SUBJECT>
                </SUBPART>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2944.3—Contractors' Purchasing Systems Reviews </HD>
                  <SECTNO>2944.302 </SECTNO>
                  <SUBJECT>Requirements.</SUBJECT>
                </SUBPART>
              </CONTENTS>
              <AUTH>
                <HD SOURCE="HED">Authority:</HD>
                <P>5 U.S.C. 301; 40 U.S.C. 486(c).</P>
              </AUTH>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2944.1—General</HD>
                <SECTION>
                  <SECTNO> </SECTNO>
                  <SUBJECT> </SUBJECT>
                  
                  <P>The waiver of consent must be in writing, signed by the contracting officer, and included in the contract file. The waiver must include all supporting facts, including the rationale for waiving the consent to subcontract requirements.</P>
                </SECTION>
              </SUBPART>
              <SUBPART>
                <PRTPAGE P="49019"/>
                <HD SOURCE="HED">Subpart 2944.2—Consent To Subcontract </HD>
                <SECTION>
                  <SECTNO>2944.201-1 </SECTNO>
                  <SUBJECT>Consent requirements</SUBJECT>
                  <P>In accordance with FAR 44.201-1(b) or FAR 44.201-2, advance notification and agreement are required for all cost-reimbursement, time-and-materials, or labor-hour subcontracts exceeding the simplified acquisition threshold.</P>
                </SECTION>
                <SECTION>
                  <SECTNO>2944.202 </SECTNO>
                  <SUBJECT>Contracting officer's evaluation.</SUBJECT>
                </SECTION>
                <SECTION>
                  <SECTNO>2944.202-2 </SECTNO>
                  <SUBJECT>Considerations.</SUBJECT>
                  <P>The review required by FAR 44.202-2(a) must be documented in writing (including supporting facts and rationale), signed by the contracting officer, and included in the contract file.</P>
                </SECTION>
                <SECTION>
                  <SECTNO>2944.203 </SECTNO>
                  <SUBJECT>Consent limitations.</SUBJECT>
                  <P>Any limitations placed on the consent to subcontract must be documented in writing (including supporting facts and rationale), signed by the contracting officer, and included in the contract file.</P>
                </SECTION>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2944.3—Contractors' Purchasing Systems Reviews </HD>
                <SECTION>
                  <SECTNO>2944.302 </SECTNO>
                  <SUBJECT>Requirements.</SUBJECT>
                  <P>The authority of the ASAM under FAR 44.302(a), to raise or lower the $25 million review level for a contractor's purchasing system, may not be delegated. When a CPSR is required by the Contracting Officer, the effort must be coordinated with the Division of Acquisition Management Services, and the Division of Cost Determination.</P>
                </SECTION>
              </SUBPART>
            </PART>
            <PART>
              <HD SOURCE="HED">PART 2945—GOVERNMENT PROPERTY</HD>
              <CONTENTS>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2945.1—General </HD>
                  <SECHD>Sec.</SECHD>
                  <SECTNO>2945.104 </SECTNO>
                  <SUBJECT>Review and correction of contractors' property control systems.</SUBJECT>
                  <SECTNO>2945.105 </SECTNO>
                  <SUBJECT>Records of Government property.</SUBJECT>
                </SUBPART>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2945.3—Providing Government Property to Contractors </HD>
                  <SECTNO>2945.302 </SECTNO>
                  <SUBJECT>Providing facilities.</SUBJECT>
                </SUBPART>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 2945.4—Contractor Use and Rental of Government Property </HD>
                  <SECTNO>2945.403 </SECTNO>
                  <SUBJECT>Rental-use and charges clause.</SUBJECT>
                </SUBPART>
              </CONTENTS>
              <AUTH>
                <HD SOURCE="HED">Authority:</HD>
                <P>5 U.S.C. 301; 40 U.S.C. 486(c).</P>
              </AUTH>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2945.1—General </HD>
                <SECTION>
                  <SECTNO>2945.104 </SECTNO>
                  <SUBJECT>Review and correction of contractors' property control systems.</SUBJECT>
                  <P>When the Government's property administrator determines that review and approval of the contractor's property control system rests with the DOL, the Government's property administrator must review the system to determine whether the contractor will be able to meet the requirements of FAR 45.104. The review must be completed, signed by the appointed property administrator, and retained in the contract file. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2945.105 </SECTNO>
                  <SUBJECT>Records of Government property.</SUBJECT>
                  <P>Contracting officers must maintain a file on any Government property in the possession of the contractors. As a minimum, the file must contain the following:</P>
                  <P>(a) A copy of the applicable portions of the contract that list the Government-furnished property (GFP);</P>
                  <P>(b) Contracting officer's letters assigning the Government property administrator to the contract;</P>
                  <P>(c) Written evidence that the contractor's property control system was reviewed and approved as required by FAR 45.104;</P>
                  <P>(d) If applicable, documentation of the request and approval or denial of the contractor's requests to acquire or fabricate special test equipment in accordance with FAR 45.307 or other property;</P>
                  <P>(e) The contractor's written notice of receipt of the GFP and any reported discrepancies thereto, as required by FAR 45.502-1 and 45.502-2, respectively;</P>
                  <P>(f) Any other documents pertaining to or affecting the status of the Government property in the possession of contractors or subcontractors under the contract;</P>
                  <P>(g) Documentation of the screening and disposal of all Government property as required by FAR 45.6.</P>
                </SECTION>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2945.3—Providing Government Property to Contractors </HD>
                <SECTION>
                  <SECTNO>2945.302 </SECTNO>
                  <SUBJECT>Providing facilities.</SUBJECT>
                  <P>The HCA is authorized to make the determination to provide facilities to a contractor as prescribed in FAR 45.302-1(a)(4).</P>
                </SECTION>
              </SUBPART>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2945.4—Contractor Use and Rental of Government Property </HD>
                <SECTION>
                  <SECTNO>2945.403 </SECTNO>
                  <SUBJECT>Rental-use and charges clause.</SUBJECT>
                  <P>The HCA must make the determination to charge rent on the basis of use under the clause at FAR 52.245-9 when the contracting officer provides access to Government production and research property, as prescribed in FAR 45.403(a).</P>
                </SECTION>
              </SUBPART>
            </PART>
            <PART>
              <HD SOURCE="HED">PARTS 2946-2951 [RESERVED]</HD>
            </PART>
            <PART>
              <HD SOURCE="HED">PART 2952—SOLICITATION PROVISIONS AND CONTRACT CLAUSES</HD>
              <CONTENTS>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 52.2—Text of Provisions and Clauses </HD>
                  <SECHD>Sec.</SECHD>
                  <SECTNO>2952.201-70 </SECTNO>
                  <SUBJECT>Contracting Officer's Technical Representative (COTR).</SUBJECT>
                </SUBPART>
              </CONTENTS>
              <AUTH>
                <HD SOURCE="HED">Authority:</HD>
                <P>5 U.S.C. 301; 40 U.S.C. 486(c).</P>
              </AUTH>
              <SUBPART>
                <HD SOURCE="HED">Subpart 52.2—Text of Provisions and Clauses</HD>
                <SECTION>
                  <SECTNO>2952.201-70 </SECTNO>
                  <SUBJECT>Contracting officer's technical representative (COTR).</SUBJECT>
                  <P>Insert the following clause into contracts requiring COTR representation under 2901.605: </P>
                  
                  <EXTRACT>
                    <P>
                      <E T="03">Contracting officer's technical representative (COTR) [Effective Date of Final Rule]</E>
                    </P>
                    <P>(a) Mr./Ms. (Name) of (Organization) (Room No.), (Building), (Address), (Area Code &amp; Telephone No.), is hereby designated to act as contracting officer's technical representative (COTR) under this contract.</P>
                    <P>(b) The COTR is responsible, as applicable, for: receiving all deliverables, inspecting and accepting the supplies or services provided hereunder in accordance with the terms and conditions of this contract; providing direction to the contractor which clarifies the contract effort, fills in details or otherwise serves to accomplish the contractual Scope of Work; evaluating performance; and certifying all invoices/vouchers for acceptance of the supplies or services furnished for payment.</P>
                    <P>(c) The COTR does not have the authority to alter the contractor's obligations under the contract, and/or modify any of the expressed terms, conditions, specifications, or cost of the agreement. If, as a result of technical discussions, it is desirable to alter/change contractual obligations or the Scope of Work, the contracting officer must issue such changes.</P>
                  </EXTRACT>
                </SECTION>
              </SUBPART>
            </PART>
            <PART>
              <HD SOURCE="HED">PART 2953—FORMS </HD>
              <CONTENTS>
                <SUBPART>
                  <HD SOURCE="HED">Subpart 53.1—General </HD>
                  <SECHD>Sec.</SECHD>
                  <SECTNO>2953.100 </SECTNO>
                  <SUBJECT>Request for review by the Procurement Review Board. </SUBJECT>
                  <SECTNO>2953.101 </SECTNO>
                  <SUBJECT>Simplified Acquisition Checklist DL 1-2001. </SUBJECT>
                  <SECTNO>2953.102 </SECTNO>
                  <SUBJECT>Simplified Acquisition DL 2078. </SUBJECT>
                  <SECTNO>2953.103 </SECTNO>
                  <SUBJECT>Department of Labor Form DL 1-2004, Small Business Procurement Determination. </SUBJECT>
                  <SECTNO>2953.104 </SECTNO>
                  <SUBJECT>Simplified Acquisition Terms And Conditions. </SUBJECT>
                </SUBPART>
              </CONTENTS>
              <AUTH>
                <HD SOURCE="HED">Authority:</HD>
                <P>5 U.S.C. 301; 40 U.S.C. 486(c). </P>
              </AUTH>
              <SUBPART>
                <HD SOURCE="HED">Subpart 2953.1—General </HD>
                <SECTION>
                  <SECTNO>2953.100 </SECTNO>
                  <SUBJECT>Request for review by the Procurement Review Board. </SUBJECT>

                  <P>The following form must be used by the requisitioning office to submit a request for review by the Procurement Review Board as specified in DOLAR parts 2901 and 2943. This form must be submitted through the Assistant Secretary for the program office to the Director, Division of Acquisition Management Services for scheduling before the PRB. In general, the PRB <PRTPAGE P="49020"/>meets on the fourth Tuesday of each month when necessary. The PRB requires five (5) business days to examine the form and attachments before the review. </P>
                </SECTION>
                <SECTION>
                  <SECTNO>2953.101 </SECTNO>
                  <SUBJECT>Simplified Acquisition Checklist. </SUBJECT>
                  <P>The following checklist must be used to document all simplified acquisitions at or below the simplified acquisition threshold. </P>
                  
                  <BILCOD>BILLING CODE 4510-23-P</BILCOD>
                  <GPH DEEP="640" SPAN="3">
                    <PRTPAGE P="49021"/>
                    <GID>EP15AU03.000</GID>
                  </GPH>
                </SECTION>
                <SECTION>
                  <PRTPAGE P="49022"/>
                  <SECTNO>2953.102 </SECTNO>
                  <SUBJECT>Simplified Acquisition DL 2078. </SUBJECT>
                  <P>The following form must be used to document all simplified acquisitions above the micro-purchase threshold and below the simplified acquisition threshold. This form may also be used to document commercial acquisitions on a fixed price basis up to $5 million. </P>
                  <GPH DEEP="640" SPAN="3">
                    <PRTPAGE P="49023"/>
                    <GID>EP15AU03.001</GID>
                  </GPH>
                </SECTION>
                <SECTION>
                  <PRTPAGE P="49024"/>
                  <SECTNO>2953.103 </SECTNO>
                  <SUBJECT>Department of Labor Form DL 1-2004, Small Business Procurement Determination. </SUBJECT>

                  <P>The requiring organization must complete the following form for all acquisitions above the <E T="03">simplified acquisition threshold.</E> This form will then be submitted through the contracting officer to the Office of Small Business Programs for review.</P>
                  <BILCOD>BILLING CODE 4510-23-P</BILCOD>
                  <GPH DEEP="640" SPAN="3">
                    <PRTPAGE P="49025"/>
                    <GID>EP15AU03.002</GID>
                  </GPH>
                </SECTION>
                <SECTION>
                  <SECTNO>2953.104</SECTNO>
                  <SUBJECT>Procurement Review Board DL1-490</SUBJECT>
                  <GPH DEEP="640" SPAN="3">
                    <PRTPAGE P="49026"/>
                    <GID>EP15AU03.003</GID>
                  </GPH>
                  <GPH DEEP="600" SPAN="3">
                    <PRTPAGE P="49027"/>
                    <GID>EP15AU03.004</GID>
                  </GPH>
                </SECTION>
              </SUBPART>
            </PART>
          </SUBCHAP>
        </SUPLINF>
        <FRDOC>[FR Doc. 03-20095 Filed 8-14-03; 8:45 am]</FRDOC>
        <BILCOD>BILLING CODE 4510-23-C</BILCOD>
      </PRORULE>
    </PRORULES>
  </NEWPART>
  <VOL>68</VOL>
  <NO>158</NO>
  <DATE>Friday, August 15, 2003</DATE>
  <UNITNAME>Proposed Rules</UNITNAME>
  <NEWPART>
    <PTITLE>
      <PRTPAGE P="49029"/>
      <PARTNO>Part III</PARTNO>
      <AGENCY TYPE="P">Department of Health and Human Services</AGENCY>
      <SUBAGY>Centers for Medicare &amp; Medicaid Services</SUBAGY>
      <HRULE/>
      <CFR>42 CFR Parts 410 and 414</CFR>
      <TITLE>Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2004; Proposed Rule</TITLE>
    </PTITLE>
    <PRORULES>
      <PRORULE>
        <PREAMB>
          <PRTPAGE P="49030"/>
          <AGENCY TYPE="S">DEPARTMENT OF HEALTH AND HUMAN SERVICES</AGENCY>
          <SUBAGY>Centers for Medicare &amp; Medicaid Services</SUBAGY>
          <CFR>42 CFR Parts 410 and 414</CFR>
          <DEPDOC>[CMS-1476-P]</DEPDOC>
          <RIN>RIN 0938-AL96</RIN>
          <SUBJECT>Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2004</SUBJECT>
          <AGY>
            <HD SOURCE="HED">AGENCY:</HD>
            <P>Centers for Medicare &amp; Medicaid Services (CMS), HHS.</P>
          </AGY>
          <ACT>
            <HD SOURCE="HED">ACTION:</HD>
            <P>Proposed rule.</P>
          </ACT>
          <SUM>
            <HD SOURCE="HED">SUMMARY:</HD>
            <P>This proposed rule would refine the resource-based practice expense relative value units (RVUs) and make other changes to Medicare Part B payment policy. The policy changes concern: Medicare Economic Index, practice expense for professional component services, definition of diabetes for diabetes self-management training, supplemental survey data for practice expense, geographic practice cost indices, and several coding issues.</P>
            <P>We are proposing these changes to ensure that our payment systems are updated to reflect changes in medical practice and the relative value of services. We solicit comments on these proposed policy changes.</P>
            <P>We also discuss the non-physician work-pool, the 5-year review of anesthesia services, and outpatient therapy services performed “incident to” physician services.</P>
          </SUM>
          <DATES>
            <HD SOURCE="HED">DATES:</HD>
            <P>We will consider comments if we receive them at the address, provided below, no later than 5 p.m. on October 7, 2003.</P>
          </DATES>
          <ADD>
            <HD SOURCE="HED">ADDRESSES:</HD>

            <P>In commenting, please refer to file code CMS-1476-P. Because of staff and resource limitations, we cannot accept comments by facsimile (FAX) transmission or e-mail. Mail written comments (one original and two copies) to the following address ONLY: Centers for Medicare &amp; Medicaid Services, Department of Health and Human Services, <E T="03">Attention:</E> CMS-1476-P, P.O. Box 8013, Baltimore, MD 21244-8013. Please allow sufficient time for us to receive mailed comments on time in the event of delivery delays.</P>
            <P>If you prefer, you may deliver (by hand or courier) your written comments (one original and two copies) to one of the following addresses: Room 445-G, Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201, or Room C5-14-03, 7500 Security Boulevard, Baltimore, MD 21244-1850.</P>
            <P>(Because access to the interior of the HHH Building is not readily available to persons without Federal Government identification, commenters are encouraged to leave their comments in the CMS drop slots located in the main lobby of the building. A stamp-in clock is available for persons wishing to retain a proof of filing by stamping in and retaining an extra copy of the comments being filed.)</P>
            <P>Comments mailed to the addresses indicated as appropriate for hand or courier delivery may be delayed and could be considered late.</P>

            <P>For information on viewing public comments, see the beginning of the <E T="02">SUPPLEMENTARY INFORMATION</E> section.</P>
          </ADD>
          <FURINF>
            <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
            <P>Gail Addis (410) 786-4522 (for issues related to repricing of supplies for practice expense inputs.)</P>
            <P>Pam West (410) 786-2302 (for issues related to Practice Expense Advisory Committee (PEAC) recommendations.)</P>
            <P>Jim Menas (410) 786-4507 (for issues related to anesthesia).</P>
            <P>Rick Ensor (410) 786-5617 (for issues related to Geographic Cost Price Index (GPCI)).</P>
            <P>Mary Stojak (410) 786-6939 (for issues related to the definition of diabetes for diabetes self-management training (DSMT)).</P>
            <P>Shannon Martin (410) 786-7939 (for issues related to rebasing of the Medicare Economic Index (MEI)).</P>
            <P>Dorothy Shannon (410) 786-3396 (for issues related to the “Incident To” Therapy Discussion).</P>
            <P>Diane Milstead (410) 786-3355, Latesha Walker (410) 786-1101, or Gaysha Brooks (410) 786-3355 (for all other issues).</P>
          </FURINF>
        </PREAMB>
        <SUPLINF>
          <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
          <P SOURCE="NPAR">
            <E T="03">Inspection of Public Comments:</E> Comments received timely will be available for public inspection as they are processed, generally beginning approximately 3 weeks after publication of a document, at the headquarters of the Centers for Medicare &amp; Medicaid Services, 7500 Security Boulevard, Baltimore, Maryland 21244, Monday through Friday of each week from 8:30 a.m. to 4 p.m. To schedule an appointment to view public comments, phone (410) 786-7197.</P>
          <P>
            <E T="03">Copies:</E> To order copies of the <E T="04">Federal Register</E> containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954. Specify the date of the issue requested and enclose a check or money order payable to the Superintendent of Documents, or enclose your Visa or Master Card number and expiration date. Credit card orders can also be placed by calling the order desk at (202) 512-1800 (or toll-free at 1-888-293-6498) or by faxing to (202) 512-2250. The cost for each copy is $10. As an alternative, you can view and photocopy the <E T="04">Federal Register</E> document at most libraries designated as Federal Depository Libraries and at many other public and academic libraries throughout the country that receive the <E T="04">Federal Register</E>.</P>
          <P>This <E T="04">Federal Register</E> document is also available from the <E T="04">Federal Register</E> online database through <E T="03">GPO Access,</E> a service of the U.S. Government Printing Office. The Web site address is: <E T="03">http://www.access.gpo.gov/nara/index.html.</E>
          </P>
          <P>Information on the physician fee schedule can be found on our homepage. You can access this data by using the following directions:</P>
          <P>1. Go to the CMS homepage (<E T="03">http://www.cms.hhs.gov</E>).</P>
          <P>2. Place your cursor over the word “Professionals” in the blue area near the top of the page. Select “physicians” from the drop-down menu.</P>
          <P>3. Under “Policies/Regulations” select “Physician Fee Schedule.”</P>

          <P>Or, you can go directly to the Physician Fee Schedule page by typing the following: <E T="03">http://www.cms.hhs.gov/physicians/pfs.</E>
          </P>
          <P>To assist readers in referencing sections contained in this preamble, we are providing the following table of contents. Some of the issues discussed in this preamble affect the payment policies but do not require changes to the regulations in the Code of Federal Regulations. Information on the regulation's impact appears throughout the preamble and is not exclusively in section VII.</P>
          
          <EXTRACT>
            <HD SOURCE="HD1">Table of Contents</HD>
            <FP SOURCE="FP-2">I. Background</FP>
            <FP SOURCE="FP1-2">A. Legislative History</FP>
            <FP SOURCE="FP1-2">B. Published Changes to the Fee Schedule</FP>
            <FP SOURCE="FP-2">II. Provisions of the Proposed Regulation</FP>
            <FP SOURCE="FP1-2">A. Resource-Based Practice Expense Relative Value Units</FP>
            <FP SOURCE="FP1-2">1. Resource-Based Practice Expense Legislation</FP>
            <FP SOURCE="FP1-2">2. Current Methodology</FP>
            <FP SOURCE="FP1-2">3. Practice Expense Proposals for Calendar Year 2004</FP>
            <FP SOURCE="FP1-2">B. Geographic Practice Cost Indices (GPCIs)</FP>
            <FP SOURCE="FP1-2">C. Coding Issues</FP>
            <FP SOURCE="FP-2">III. Other Issues</FP>
            <FP SOURCE="FP1-2">A. Rebasing of the Medicare Economic Index (MEI)</FP>
            <FP SOURCE="FP1-2">B. Definition of Diabetes for Diabetes Self-Management Training (DSMT)</FP>
            <FP SOURCE="FP1-2">C. Outpatient Therapy Services Performed “Incident To” Physicians Services</FP>
            <FP SOURCE="FP1-2">D. Status of Anesthesia Work and 5-Year Review</FP>
            <FP SOURCE="FP1-2">E. Payment Policies for Anesthesia Services<PRTPAGE P="49031"/>
            </FP>
            <FP SOURCE="FP1-2">F. Technical Correction</FP>
            <FP SOURCE="FP-2">IV. Collection of Information Requirements</FP>
            <FP SOURCE="FP-2">V. Response to Comments</FP>
            <FP SOURCE="FP-2">VI. Regulatory Impact Analysis</FP>
            <FP SOURCE="FP-2">Addendum A—Explanation and Use of Addendum B</FP>
            <FP SOURCE="FP-2">Addendum B—2004 Relative Value Units and Related Information Used in Determining Medicare Payments for 2004.</FP>
            <FP SOURCE="FP-2">Addendum C—Codes for Which We Received PEAC Recommendations on Practice Expense Direct Cost Inputs.</FP>
            <FP SOURCE="FP-2">Addendum D—Proposed Changes to Practice Expense Supply Description and Pricing.</FP>
          </EXTRACT>
          
          <P>In addition, because of the many organizations and terms to which we refer by acronym in this proposed rule, we are listing these acronyms and their corresponding terms in alphabetical order below:</P>
          
          <FP SOURCE="FP-1">AMA American Medical Association</FP>
          <FP SOURCE="FP-1">BBA Balanced Budget Act of 1997</FP>
          <FP SOURCE="FP-1">BBRA Balanced Budget Refinement Act of 1999</FP>
          <FP SOURCE="FP-1">CF Conversion factor</FP>
          <FP SOURCE="FP-1">CFR Code of Federal Regulations</FP>
          <FP SOURCE="FP-1">CMS Centers for Medicare &amp; Medicaid Services</FP>
          <FP SOURCE="FP-1">CNS Clinical Nurse Specialist</FP>
          <FP SOURCE="FP-1">CPT [Physicians'] Current Procedural Terminology [4th Edition, 2002, copyrighted by the American Medical Association]</FP>
          <FP SOURCE="FP-1">CPEP Clinical Practice Expert Panel</FP>
          <FP SOURCE="FP-1">CRNA Certified Registered Nurse Anesthetist</FP>
          <FP SOURCE="FP-1">E/M Evaluation and management</FP>
          <FP SOURCE="FP-1">FMR Fair market rental</FP>
          <FP SOURCE="FP-1">GAF Geographic adjustment factor</FP>
          <FP SOURCE="FP-1">GPCI Geographic practice cost index</FP>
          <FP SOURCE="FP-1">HCPCS Healthcare Common Procedure Coding System</FP>
          <FP SOURCE="FP-1">HHA Home health agency</FP>
          <FP SOURCE="FP-1">HHS [Department of] Health and Human Services</FP>
          <FP SOURCE="FP-1">IDTFs Independent Diagnostic Testing Facilities</FP>
          <FP SOURCE="FP-1">MCM Medicare Carrier Manual</FP>
          <FP SOURCE="FP-1">MedPAC Medicare Payment Advisory Commission</FP>
          <FP SOURCE="FP-1">MEI Medicare Economic Index</FP>
          <FP SOURCE="FP-1">MGMA Medical Group Management Association</FP>
          <FP SOURCE="FP-1">MPFS Medicare Physician Fee Schedule</FP>
          <FP SOURCE="FP-1">MSA Metropolitan Statistical Area</FP>
          <FP SOURCE="FP-1">NAMCS National Ambulatory Medical Care Survey</FP>
          <FP SOURCE="FP-1">PC Professional component</FP>
          <FP SOURCE="FP-1">PEAC Practice Expense Advisory Committee</FP>
          <FP SOURCE="FP-1">PPS Prospective payment system</FP>
          <FP SOURCE="FP-1">RUC [AMA's Specialty Society] Relative [Value] Update Committee</FP>
          <FP SOURCE="FP-1">RVU Relative value unit</FP>
          <FP SOURCE="FP-1">SGR Sustainable growth rate</FP>
          <FP SOURCE="FP-1">SMS [AMA's] Socioeconomic Monitoring System</FP>
          <FP SOURCE="FP-1">SNF Skilled Nursing Facility</FP>
          <FP SOURCE="FP-1">TC Technical component</FP>
          <HD SOURCE="HD1">I. Background</HD>
          <HD SOURCE="HD2">A. Legislative History </HD>
          <P>Since January 1, 1992, Medicare has paid for physicians' services under section 1848 of the Social Security Act (the Act), “Payment for Physicians' Services.” This section provides for three major elements: (1) A fee schedule for the payment of physicians' services; (2) limits on the amounts that nonparticipating physicians can charge beneficiaries; and (3) a sustainable growth rate for the rates of increase in Medicare expenditures for physicians' services. The Act requires that payments under the fee schedule be based on national uniform relative value units (RVUs) based on the resources used in furnishing a service. Section 1848(c) of the Act requires that national RVUs be established for physician work, practice expense, and malpractice expense. Section 1848(c)(2)(B)(ii)(II) of the Act provides that adjustments in RVUs may not cause total physician fee schedule payments to differ by more than $20 million from what they would have been had the adjustments not been made. If adjustments to RVUs cause expenditures to change by more than $20 million, we must make adjustments to ensure that they do not increase or decrease by more than $20 million. </P>
          <HD SOURCE="HD2">B. Published Changes to the Fee Schedule </HD>
          <P>In the July 2000 proposed rule, (65 FR 44177), we listed all of the final rules published through November 1999. In the August 2001 proposed rule (66 FR 40372) we discussed the November 2000 final rule relating to the updates to the RVUs and revisions to payment policies under the physician fee schedule. </P>
          <P>In the November 2001 final rule with comment period (66 FR 55246), we made revisions to resource-based practice expense RVUs; services and supplies incident to a physician's professional service; anesthesia base unit variations; recognition of CPT tracking codes; and nurse practitioners, physician assistants, and clinical nurse specialists performing screening sigmoidoscopies. We also addressed comments received on the June 8, 2001 proposed notice (66 FR 31028) for the 5-year review of work RVUs and finalized these work RVUs. In addition, we acknowledged comments received in response to a discussion of modifier-62, which is used to report the work of co-surgeons. The November 2001 final rule also updated the list of services that are subject to the physician self-referral prohibitions in order to reflect CPT and Healthcare Common Procedure Coding System (HCPCS) code changes that were effective January 1, 2002. All these revisions ensure that our payment systems are updated to reflect changes in medical practice and the relative value of services. This final rule also conformed our regulations to reflect statutory provisions of Medicare, Medicaid, and State Child Health Insurance Program (SCHIP) Benefits Improvement and Protection Act of 2000 (Pub. L. 106-554) (BIPA) concerning: The mammography screening benefit; biennial screening pelvic examinations for certain beneficiaries; expanded coverage for screening colonoscopies to all beneficiaries; provided for annual glaucoma screenings for high-risk beneficiaries; established coverage for medical nutrition therapy services for certain beneficiaries; expanded payment for telehealth services; required certain Indian Health Service providers to be paid for some services under the physician fee schedule; and revised the payment for certain physician pathology services. </P>
          <P>In the December 31, 2002 final rule with comment period (67 FR 79966), we refined resource-based practice expense RVUs and made other changes to Medicare Part B policy. These included: The pricing of the technical component for positron emission tomography (PET) scans, Medicare qualifications for clinical nurse specialists, a process to add or delete services to the definition of telehealth, the definition for ZZZ global periods, global period for surface radiation, and application of endoscopic reduction rules for certain codes. In addition, this rule: Updated the codes subject to physician self-referral prohibitions, expanded the definition of a screening fecal-occult blood test, and modified our regulations to expand coverage for additional colorectal cancer screening tests through our national coverage determination process. We also made revisions to the sustainable growth rate, the anesthesia conversion factor (CF), and the work values for some gastroenterologic services. We finalized the CY 2002 interim RVUs and assigned interim RVUs for new and revised procedure codes for calendar year CY 2003, clarified the enrollment of therapists in private practice and the policy regarding services and supplies incident to a physician's professional services, and made technical changes to the definition of outpatient rehabilitation services. </P>

          <P>This final rule also revised the regulations at 42 CFR 485.618 to allow registered nurses (RNs) to provide <PRTPAGE P="49032"/>emergency care in certain critical access hospitals (CAHs) in frontier areas (an area with fewer than six residents per square mile) or remote locations (locations designated in a State's rural health plan that we have approved). </P>
          <P>As required by statute this final rule also announced that the physician fee schedule update for CY 2003 was −4.4 percent, the initial estimate of the sustainable growth rate (SGR) for CY 2003 was 7.6 percent, and the CF for CY 2003 was $34.5920, effective March 1, 2003. However, on February 28, 2003 (68 FR 9567), after enactment of the Consolidated Appropriations Resolution of 2003 (Pub. L. 108-7), we published a final rule that revised the estimates used to establish the SGRs for fiscal years 1998 and 1999 and announced a 1.6 percent increase in the CY 2003 physician fee schedule CF for March 1 to December 31, 2003. The CF from March 1 to December 31, 2003 is $36.7856. The anesthesia CF for this period is $17.05. All other provisions of the December 31, 2002 final rule were unchanged by the rule published February 28, 2003. </P>
          <HD SOURCE="HD1">II. Provisions of the Proposed Rule </HD>
          <P>This proposed rule would affect the regulations set forth at Part 410, Supplementary medical insurance (SMI) benefits and part 414, Payment for Part B and other health services. </P>
          <HD SOURCE="HD2">A. Resource-Based Practice Expense Relative Value Units </HD>
          <HD SOURCE="HD3">1. Resource-Based Practice Expense Legislation </HD>
          <P>Section 121 of the Social Security Act Amendments of 1994 (Pub. L. 103-432), enacted on October 31, 1994, required us to develop a methodology for a resource-based system for determining practice expense RVUs for each physician's service beginning in 1998. In developing the methodology, we were to consider the staff, equipment, and supplies used in providing medical and surgical services in various settings. The legislation specifically required that, in implementing the new system of practice expense RVUs, we apply the same budget-neutrality provisions that we apply to other adjustments under the physician fee schedule. </P>
          <P>Section 4505(a) of the Balanced Budget Act of 1997 (BBA) (Pub. L. 105-33), enacted on August 5, 1997, amended section 1848(c)(2)(ii) of the Act and delayed the effective date of the resource-based practice expense RVU system until January 1, 1999. In addition, section 4505(b) of the BBA provided for a 4-year transition period from charge-based practice expense RVUs to resource-based RVUs. </P>
          <P>Further legislation affecting resource-based practice expense RVUs was included in the Medicare, Medicaid and State Child Health Insurance Program (SCHIP) Balanced Budget Refinement Act of 1999 (BBRA) (Pub. L. 106-113) enacted on November 29, 1999. Section 212 of the BBRA amended section 1848(c)(2)(ii) of the Act by directing us to establish a process under which we accept and use, to the maximum extent practicable and consistent with sound data practices, data collected or developed by entities and organizations. These data would supplement the data we normally collect in determining the practice expense component of the physician fee schedule for payments in CY 2001 and CY 2002. (In the 1999 final rule (64 FR 59380), we extended, for an additional 2 years, the period during which we would accept supplementary data.) </P>
          <HD SOURCE="HD3">2. Current Methodology for Computing the Practice Expense Relative Value Unit System </HD>
          <P>Effective with services furnished on or after January 1, 1999, we established a new methodology for computing resource-based practice expense RVUs that used the two significant sources of actual practice expense data we have available—the Clinical Practice Expert Panel (CPEP) data and the American Medical Association's (AMA) Socioeconomic Monitoring System (SMS) data. The methodology was based on an assumption that current aggregate specialty practice costs are a reasonable way to establish initial estimates of relative resource costs for physicians' services across specialties. The methodology allocated these aggregate specialty practice costs to specific procedures and, thus, can be seen as a “top-down” approach. </P>
          <HD SOURCE="HD3">a. Major Steps</HD>
          <P>A brief discussion of the major steps involved in the determination of the practice expense RVUs follows. (Please see the November 1, 2001 final rule (66 FR 55249) for a more detailed explanation of the top-down methodology.)</P>
          <P>• <E T="03">Step 1</E>—Determine the specialty specific practice expense per hour of physician direct patient care. We used the AMA's SMS survey of actual aggregate cost data by specialty to determine the practice expenses per hour for each specialty. We calculated the practice expenses per hour for the specialty by dividing the aggregate practice expenses for the specialty by the total number of hours spent in patient care activities.</P>
          <P>• <E T="03">Step 2</E>—Create a specialty specific practice expense pool of practice expense costs for treating Medicare patients. To calculate the total number of hours spent treating Medicare patients for each specialty, we used the physician time assigned to each procedure code and the Medicare utilization data. We then calculated the specialty specific practice expense pools by multiplying the specialty practice expenses per hour by the total physician hours.</P>
          <P>• <E T="03">Step 3</E>—Allocate the specialty specific practice expense pool to the specific services performed by each specialty. For each specialty, we divided the practice expense pool into two groups based on whether direct or indirect costs were involved and used a different allocation basis for each group. </P>
          <P>(i) Direct costs—For direct costs (which include clinical labor, medical supplies, and medical equipment), we used the procedure specific CPEP data on the staff time, supplies, and equipment as the allocation basis. </P>
          <P>(ii) Indirect costs—To allocate the cost pools for indirect costs, including administrative labor, office expenses, and all other expenses, we used the total direct costs combined with the physician fee schedule work RVUs. We converted the work RVUs to dollars using the Medicare CF (expressed in 1995 dollars for consistency with the SMS survey years). </P>
          <P>• <E T="03">Step 4</E>—For procedures performed by more than one specialty, the final procedure code allocation was a weighted average of allocations for the specialties that perform the procedure, with the weights being the frequency with which each specialty performs the procedure on Medicare patients. </P>
          <HD SOURCE="HD3">b. Other Methodological Issues </HD>
          <HD SOURCE="HD3">(i) Non-Physician Work Pool </HD>
          <P>For services with physician work RVUs equal to zero (including the technical components of radiology services and other diagnostic tests), we created a separate practice expense pool using the average clinical staff time from the CPEP data and the “all physicians” practice expense per hour. </P>

          <P>We then used the adjusted 1998 practice expense RVUs to allocate this pool to each service. We have removed services from the non-physician work pool if the requesting specialty predominates utilization of the service. Also, for all radiology services that are assigned physician work RVUs, we used the adjusted 1998 practice expense RVUs for radiology services as an <PRTPAGE P="49033"/>interim measure to allocate the direct practice expense cost pool for radiology. </P>
          <HD SOURCE="HD3">(ii) Crosswalks for Specialties Without Practice Expense Survey Data </HD>
          <P>Since many specialties identified in our claims data did not correspond exactly to the specialties included in the SMS survey data, it was necessary to crosswalk these specialties to the most appropriate SMS specialty. </P>
          <HD SOURCE="HD3">(iii) Physical Therapy Services</HD>
          <P>Because we believe that most physical therapy services furnished in physicians' offices are performed by physical therapists, we crosswalked all utilization for therapy services in the CPT 97000 series to the physical and occupational therapy practice expense pool.</P>
          <HD SOURCE="HD3">3. Practice Expense Proposals for Calendar Year 2004 </HD>
          <HD SOURCE="HD3">a. Non-Physician Work Pool</HD>
          <P>The non-physician work pool was created as an interim measure until we could further analyze the effect of the top-down methodology on the Medicare payment for services that do not have physician work RVUs (see the November 1998 final rule (63 FR 58841)).</P>
          <P>In the June 28, 2002 proposed rule (67 FR 43849), we discussed alternatives that we have considered to address the non-physician work pool issue, including ideas raised by the Lewin Group as well as recommendations in a 2001 GAO report. While we have not reached a final resolution on how to best address this issue, we are continuing to study the alternatives that are available. We also believe that our proposal extending the deadline for the submission of supplemental survey data (see following discussion) will provide an opportunity for specialties whose services are affected by the non-physician work pool to submit practice expense data that can be used for determining practice expense RVUs under the physician fee schedule. Any modifications to the non-physician work pool would be published in proposed rulemaking. </P>
          <HD SOURCE="HD3">b. Supplemental Practice Expense Survey Data</HD>
          <P>As required by the BBRA, we established criteria to evaluate data collected by organizations to supplement the data normally used in determining the practice expense component of the physician fee schedule. Due to the time constraints imposed by the statute for publication of the physician fee schedule final rule, we have required supplementary survey data to be submitted by August 1 to be considered for computing practice expense RVUs for the following year. We are proposing to change the required submission date to March 1. This would allow us to publish our decisions regarding survey data in the proposed rule and would provide an opportunity for public comment on survey results.</P>
          <P>To continue to ensure the maximum opportunity for specialties to submit supplementary practice expense data, we are again proposing to extend for an additional 2 years the period for accepting survey data that meets the criteria set forth in the November 2000 final rule (as modified in the December 31, 2002 final rule). The deadline for submission of the supplemental data to be considered in CY 2005 and CY 2006 are March 1, 2004 and March 1, 2005, respectively.</P>
          <P>In the December 31, 2002 final rule (67 FR 79979), we responded to comments expressing concern about the impact of making the technical component the difference between the global and professional component practice expense RVUs for services that are not affected by the non-physician work pool calculations. We agreed to a one-year moratorium on implementation of the proposed change for pathology services paid under the physician fee schedule to allow for a supplemental survey of independent laboratories. Consistent with the change to making the survey deadline March 1, we are considering whether to extend the moratorium by one additional year. By extending the moratorium, we can show the impact of the independent laboratory survey in the 2004 proposed rule and allow public comment on its results prior to making changes to the practice expense RVUs on January 1, 2005. We welcome public comment on whether we should adopt the proposed change for 2004 in this year's final rule or extend the moratorium by 1 year. </P>
          <HD SOURCE="HD3">c. Oncology Survey Data</HD>
          <P>In the December 31, 2002 final rule (67 FR 79973), we indicated that the American Society of Clinical Oncology (ASCO) submitted a supplemental practice expense survey. Our contractor, the Lewin Group, raised specific concerns to us about the survey results. Consequently, we did not incorporate the survey into the practice expense methodology but indicated that we would further examine its results with the Lewin Group and confer with ASCO about our concerns. We have discussed the oncology survey together with the Lewin Group and ASCO. These discussions were useful in providing us with more information upon which to make a final decision regarding incorporation of the oncology survey into the practice expense methodology. We expect to make our decision known in a subsequent proposed rule that will address Medicare payment for drugs currently paid based on 95 percent of the average wholesale price. </P>
          <HD SOURCE="HD3">d. Practice Expense for a Professional Component Service </HD>
          <P>Since the inception of the resource-based practice expense methodology, we have assigned all staff equipment and supply costs for services with professional and technical components (PC and TC) to the technical portion of the service. We have done this because we believe that generally all of these direct cost inputs are associated with obtaining the diagnostic information and there would be no direct costs associated with the physician interpretation. However, we now believe that there may be limited exceptions where it is appropriate to assign direct inputs to a PC service. For instance, the Practice Expense Advisory Committee (PEAC) recommended that we include clinical staff time in certain codes that have both a PC and TC component for activities such as scheduling the procedure and educating the patient when the procedure is done in the facility setting. We accepted these recommendations but, because the practice expense methodology currently does not assign direct inputs to PC services and the TC is not paid in the facility setting, these procedures were not credited with the recommended practice expense inputs. </P>
          <P>We propose to modify the practice expense methodology to allow direct inputs to be added to PC services when these inputs are clearly associated with the professional service, including when the PEAC makes such recommendations. We are proposing to add the PEAC recommended staff times to the PC of the following cardiac services: CPT codes 93508, 93510, 93511, 93514, 93524, 93526, 93527, 93528, 93529, 93530, 93531, 93532, 93533 and 93624. The practice expense RVUs for these codes will increase slightly from this change resulting in minor reductions in practice expense RVUs for some other services performed by cardiologists. There will be no impact on the practice expense RVUs for any other specialty. </P>
          <HD SOURCE="HD3">e. Utilization Data </HD>

          <P>We use Medicare utilization data in the development of specialty-specific practice expense RVUs that are then weight averaged to determine a single practice expense RVU per code. Prior to <PRTPAGE P="49034"/>2003, we used the most recent complete year of utilization data to determine the practice expense RVUs. For instance, we determined the 2001 practice expense RVUs using Medicare utilization data from 1999 for most procedure codes. However, if a procedure code was new in 2000, we did not have any 1999 utilization data to determine its 2001 practice expense RVU and could not use specialty-specific data until 2000 utilization data was available to us. In some cases, the new code was clearly related to an older code or codes and we were able to use an estimation of the probable specialty utilization for 2001 until actual specialty-specific utilization was available for 2002. Where we were not able to determine the probable specialty-specific utilization we assigned the “all physician” average practice expenses to the service until we obtained specialty-specific utilization. Thus, in this case, we used the “all physician average” to determine the code's 2001 practice expense RVU and specialty-specific utilization to determine the 2002 practice expense RVU. </P>

          <P>In the December 31, 2002 final rule (67 FR 79982), we adopted a policy of using the 1997 through 2000 Medicare utilization in the practice expense methodology. For new codes created since 2000, there are no Medicare utilization data in the 1997 through 2000 period upon which to determine specialty-specific practice expenses. We are proposing to follow a similar practice to the one described above and use specialty-specific Medicare utilization data for codes created after 2000 at the first opportunity they become available to us. Therefore, we are proposing to use 1997 through 2000 Medicare utilization data for all codes that were in existence at that time. If a code did not exist during the 1997 through 2000 period, we propose using the first available utilization data for the code in order to develop the practice expense RVU. Since we will not have any utilization data at the time we first establish practice expense RVUs for a new code, we propose that we continue, whenever possible, to make an assumption about the specialty that will likely provide the service or to use the “all physician” average when we do not have sufficient information to assign any given specialty. We will make available on the CMS web site (<E T="03">http://cms.hhs.gov</E>) files containing the data that we will use in determining the proposed rule practice expense RVUs. We propose in each year's proposed rule to substitute actual for estimated utilization once the data become available. For instance, in this proposed rule, we will substitute actual 2002 utilization data for estimated 2002 utilization data to determine the 2004 practice expense RVUs for codes that were new in 2002. Practice expense RVUs may change as we make updates to the utilization data that we use in the practice expense methodology. We encourage the AMA's Specialty Society Relative Value Update Committee (RUC) and other interested parties to provide information on the specialties that will likely perform a new service to minimize the potential changes to the practice expense RVUs that will occur when we substitute actual for estimated utilization. </P>
          <P>For the proposed rule, the utilization data from the prior year are 96 percent complete. In the past, we used 100 percent complete data from a prior year in the proposed rule (for example, we used 2000 utilization data to simulate impacts for the June 28, 2002 proposed rule) and did not use the preceding year's utilization data until the final rule (for example, we used 2001 utilization data to simulate impacts for the December 31, 2002 final rule). Beginning with this year's proposed rule, we are using the prior year's utilization data for developing practice expense RVUs and simulating impacts. Because the utilization file that we are using for the proposed rule is only 96 percent complete, there may be minor changes to the payment impacts and practice expense RVUs between the proposed rule and the final rule for which we will use 100 percent complete data from the prior year. </P>
          <HD SOURCE="HD3">f. Practice Expense Advisory Committee (PEAC) </HD>
          <HD SOURCE="HD3">Recommendations on CPEP Inputs for 2004 </HD>
          <P>The PEAC, a subcommittee of the RUC, has, since 1999, been providing us with recommendations for refining the direct practice expense inputs (clinical staff, supplies, and equipment) for existing CPT codes. In the past, our actions on these PEAC recommendations have been incorporated into the physician fee schedule final rule and have been used as interim values for services provided in the following calendar year. We have accepted comments on these refinements and addressed them in rulemaking the following year. This year we are including the PEAC recommendations in the proposed rule, which will enable specialty groups to assess the impact of these changes on their services and make comments on the recommendations before the final rule. </P>
          <P>These PEAC recommendations are the result of meetings held in September of 2002 and January 2003 and account for approximately 772 codes from many specialties. (A list of these codes can be found in Addendum C.) The PEAC has also submitted recommendations on the refinements to the clinical staff time for all 90-day global services (accounting for a further 3,604 CPT codes). </P>
          <P>This massive refinement was possible because the PEAC adopted a standardized approach to the refinement of the clinical staff times for 90-day global codes. The PEAC has recommended that the following standard clinical staff times be applied to all 90-day codes, except for those in which the specialty argued for an exception to the standard: </P>
          <P>• Pre-service time—35 minutes of pre-service clinical staff time in the office and 60 minutes for services performed in the facility setting; </P>
          <P>• Discharge day management time—6 minutes of clinical staff time if the procedure is performed predominantly in the outpatient facility setting and 12 minutes if performed predominantly in the inpatient setting. (This standard is also recommended for all of the 10-day global procedures); and </P>
          <P>• Post-service office visit time—equal to the clinical staff times associated with the evaluation and management visit codes assigned to each service. </P>
          <P>Several specialties, including the neurosurgeons/spine surgeons, thoracic surgeons and colorectal surgeons requested and received increased pre-service times for some of their services. There were also a few services that are usually performed on an emergent basis when the pre-service time was reduced or omitted altogether. We believe that the standards recommended by the PEAC are appropriate and that the exceptions to these standards are also reasonable. Therefore, we are proposing to use the PEAC's recommendations for the clinical staff time for these global codes. </P>

          <P>In addition, the PEAC convened a workgroup to make recommendations on the refinement of all the 116 remaining evaluation and management codes. These are important achievements that have significantly advanced the pace of the refinement process. A total of 5358 codes have been refined; these codes represent 87 percent of physician fee schedule dollars. We greatly appreciate the dedication and hard work of the specialty societies and the AMA that are helping to ensure that this refinement process is successful. <PRTPAGE P="49035"/>
          </P>
          <P>We have reviewed the submitted PEAC recommendations and propose to accept them. The complete PEAC recommendations and the revised CPEP database can be found on our web site. (See the Supplementary Information section of this proposed rule for directions on accessing our web site.) </P>
          <HD SOURCE="HD3">g. Repricing of Clinical Practice Expense Inputs—Supplies </HD>
          <P>We use the practice expense inputs (the clinical staff, supplies, and equipment assigned to each procedure) to allocate the specialty-specific practice expense cost pools to the procedures performed by each specialty. The costs of the original inputs assigned by the CPEP were determined by our contractor, Abt Associates, based primarily on 1994 and 1995 pricing data from supply catalogs. In addition, for many items on the equipment and supply list, the associated costs were based on the recommendations of a CPEP panel member, rather than on actual catalog prices. Subsequent to the CPEP panels, equipment and supply items have also been added to the CPEP data, with the costs of the inputs provided by the relevant specialty society. </P>
          <P>In the August 2, 2001 proposed rule (66 FR 40378), we proposed updates and revisions to the clinical staff salary data which were finalized in the final rule published November 1, 2001 (66 FR 55255). In that final rule, we also indicated that in future rulemaking we would be proposing updates to the supply and equipment inputs that are used in the CPEP database. We, therefore, contracted with a consultant to assist us in obtaining the current price for each supply item in our CPEP database. The consultant has been able to determine the current prices for most of the supply inputs and has submitted documentation for the proposed new pricing from vendor catalogs or websites. Whenever possible, multiple sources were obtained for frequently used supplies so that a typical price could be determined. </P>
          <P>In addition, we asked the consultant to help identify and clarify those supplies for which the original descriptions in the CPEP database are too general to price (for example “laser” or “antigen”) or are otherwise unidentifiable. Our consultant worked closely with the specialty societies to ensure that accurate information was obtained in identifying as many of these supplies as possible. </P>

          <P>Addendum D contains the proposed new unit prices for supply items when current pricing was obtained, as well as new descriptions when needed. A more detailed spreadsheet can be found on our Web site, (<E T="03">http://www.cms.hhs.gov/physicians/pfs</E>), that contains additional information regarding the sources used to price each item. </P>
          <P>There are items that have either not yet been identified or for which pricing information has not yet been found. These supply items are included in Table 1 below. In this table we have identified the supply code (if assigned), the existing item description, unit and price, the procedures or specialties associated with the item, as well as the proposed new description and standardized unit of use. We have also identified items for deletion from the database. We are requesting that commenters, particularly the relevant specialty groups, provide us with the needed pricing information with appropriate documentation. Whenever possible, multiple sources of documentation should be provided so that a typical price can be determined. If we are not able to obtain any verified pricing information for an item, we may eliminate it from the database. </P>
          
          <BILCOD>BILLING CODE 4120-01-P</BILCOD>
          
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49036"/>
            <GID>EP15AU03.005</GID>
          </GPH>
          <GPH DEEP="559" SPAN="3">
            <PRTPAGE P="49037"/>
            <GID>EP15AU03.006</GID>
          </GPH>
          
          <BILCOD>BILLING CODE 4120-01-C</BILCOD>
          
          <PRTPAGE P="49038"/>
          <P>In addition to reviewing and updating the cost information for supplies in the database, our contractor also recommended database revisions to provide uniformity and consistency in the CPEP supply database. All of the following recommendations are noted in Addendum D: </P>
          <P>• <E T="03">Assignment of supply categories.</E> In the original CPEP data, a number was assigned to each supply. The contractor has recommended that each supply item also be assigned a “category” to allow for easier selection and sorting of items. We agree and are proposing that supplies be assigned to one of the following 14 categories: </P>
          <FP SOURCE="FP-1">Accessory, Diagnostics; </FP>
          <FP SOURCE="FP-1">Accessory, Equipment; </FP>
          <FP SOURCE="FP-1">Accessory, Procedure; </FP>
          <FP SOURCE="FP-1">Booklets/Forms; </FP>
          <FP SOURCE="FP-1">Cutters, Closures/Cautery; </FP>
          <FP SOURCE="FP-1">Gown, Drape; </FP>
          <FP SOURCE="FP-1">Hypodermic/IV; </FP>
          <FP SOURCE="FP-1">Infection Control; </FP>
          <FP SOURCE="FP-1">Kit, Pack, Tray; </FP>
          <FP SOURCE="FP-1">Lab; </FP>
          <FP SOURCE="FP-1">Office, Grocery;</FP>
          <FP SOURCE="FP-1">Pharmacy, NonRx; </FP>
          <FP SOURCE="FP-1">Pharmacy, Rx; and </FP>
          <FP SOURCE="FP-1">Wound Care, Dressings. </FP>
          
          <P>These categories could also be used to establish a new numbering system for supplies. We would assign a letter to each supply category and use this in conjunction with a number (000 through 999) to identify each supply. This would enable specialty groups to identify more easily whether a supply has already been included in the CPEP database and would help ensure uniformity in the items used for calculating practice expenses. If we proceed in the final rule with this proposed method for categorizing supplies, we will assign new identifying numbers to each supply input item and these will be available on our website. </P>
          <P>• <E T="03">Consolidation/standardization of item descriptions.</E>
          </P>

          <P>When items appear to be duplicative, we are proposing to combine the items. For example, “Mayo stand cover” and “drape, sterile Mayo” have both been changed to “drape, sterile, for Mayo stand”. We also have attempted to better describe the supply items in a way that will make identification easier, using a key first word when possible. For example, all catheters are described as “catheter, * * *”, all needles are described as “needle * * *.” In addition, references to proprietary or trademark names for multisource items have been included as parenthetical references (for example, “Polibar <E T="51">TM</E>” is renamed barium suspension “(Polibar <E T="51">TM</E> ).” </P>
          <P>• <E T="03">Standardization of unit descriptions.</E>
          </P>
          <P>The current CPEP database contains over 72 unit descriptions associated with supplies (for example, item, gram, and cup). To provide consistency and ensure that inputs in the database accurately reflect the quantity of an item used, we are proposing to standardize the unit description of items. If an item is intended for single use, even if it is not completely used, we propose to identify this by indicating the item size followed by “uou” (unit of use). For example “soap bath” has been renamed “bath soap (one bar uou)” and “bacitracin unit dose pack, 9g” has been renamed “bacitracin oint (0.9 gm uou)”. </P>
          <P>We welcome any comments on the proposed pricing and all other proposed revisions. To help us evaluate the information provided, comments should include documentation such as information from a supply catalog or website or from a current invoice. </P>
          <HD SOURCE="HD3">h. Miscellaneous Practice Expense Issues </HD>
          <HD SOURCE="HD1">Hyperbaric Oxygen Services </HD>

          <P>We have received a request from a freestanding hyperbaric oxygen center to price the service in the office setting, so that those providing this service in a nonfacility can receive an appropriate payment. Therefore, we are proposing to assign on an interim basis the following practice expense inputs to CPT code 99183, <E T="03">Physician attendance and supervision of hyperbaric oxygen therapy, per session:</E>
          </P>
          <P>
            <E T="03">Staff:</E> Respiratory Therapist for 135 minutes (for a 2 hour treatment). </P>
          <P>
            <E T="03">Supplies:</E> Minimum Visit Supply Package, 180 liters of oxygen, 187 cubic feet of air. </P>
          <P>
            <E T="03">Equipment:</E> Hyperbaric chamber. </P>
          <P>We will request that the Practice Expense Advisory Committee review these inputs at a meeting in the near future. </P>
          <HD SOURCE="HD1">Maxillofacial Prosthetics PE/hour </HD>
          <P>In the November 2, 1998 final rule (63 FR 58824), we created a special practice expense pool for maxillofacial prosthetics (CPT codes 21076 through 21087) using the “all physician” practice expense per hour. Because the practice expense survey submitted in 1998 by the American Academy of Maxillofacial Prosthetics (AAMP) differed significantly in format and content from the SMS survey, we were not able to use the submitted data to calculate a practice expense per hour for maxillofacial prosthetics. AAMP has contended that the “all physician” rate underestimates the high costs for the staff, supplies and equipment associated with the provision of maxillofacial prosthetic services. </P>
          <P>We have asked our contractor, The Lewin Group, to analyze the submitted survey data to determine if the data would or would not support a change in the crosswalk for this specialty. The Lewin Group's finding suggests, “the all-physician average may underestimate the practice expense per hour for maxillofacial prosthodontists.” Based on the Lewin Group's finding, we reviewed the Medicare utilization of the maxillofacial prosthetics codes. Oral surgeons (specialty code 19) and maxillofacial surgeons (specialty code 85) overwhelmingly provide these services. We believe the practice expenses for these practitioners are likely to be similar to otolaryngologists since these physicians also provide office procedures affecting the head and face. We are proposing to eliminate the special practice expense pool for procedure codes 21076 through 21087 and use otolaryngology as the crosswalk for oral surgeons and maxillofacial surgeons as a more appropriate approximation of the specialties' practice expense per hour. This proposal will increase payment for the maxillofacial prosthetics and other services that are predominantly billed by oral and maxillofacial surgeons. There will be no impact on payment for services provided by any other specialty from this change. </P>
          <HD SOURCE="HD1">Holter Monitoring Codes </HD>
          <P>A representative of an independent diagnostic testing facility has communicated to us that their review of the practice expense inputs for the holter monitoring codes, CPT 93225, 93226, 93231, and 93232 has revealed the inclusion of items that are not needed to perform these services. The correspondent suggested the following deletions: </P>
          <P>• For CPT codes 93225 and 93231 delete the ECG electrodes and laser paper, as well as the electric bed, computer and holter monitor; and </P>
          <P>• For CPT codes 93226 and 93232 delete the razor, nonsterile gloves, alcohol swab and tape, as well as the electric bed and exam table. </P>

          <P>We agree that these revisions appear reasonable and will make the above deletions on an interim basis until the PEAC can review these codes. It should be noted these codes are currently in the nonphysician work pool and that the CPEP data is not currently used to calculate their practice expense RVUs. Therefore, these changes will not at this time have any effect on the payment for these codes. <PRTPAGE P="49039"/>
          </P>
          <HD SOURCE="HD2">B. Geographic Practice Cost Index Changes </HD>
          <HD SOURCE="HD3">1. Background </HD>
          <P>The Act requires that payments vary among Medicare physician fee schedule (MPFS) areas according to the extent that resource costs vary as measured by the Geographic Practice Cost Indices (GPCIs). In general, the MPFS areas that existed under the prior reasonable charge system were retained under the MPFS from calendar years 1992 through 1996. We implemented a comprehensive revision in MPFS payment areas (localities) in 1997, reducing the number of localities from 210 to 89. Thirty-four states have a single statewide locality. In contrast, under the hospital inpatient prospective payment system (IPPS), costs are adjusted across more than 350 metropolitan statistical areas (MSAs). </P>
          <P>A detailed discussion of the MPFS payment localities can be found in the July 2, 1996 proposed rule (61 FR 34615) and the November 22, 1996 final rule (61 FR 59494). </P>
          <HD SOURCE="HD3">2. Implication of GPCIs for Rural Areas </HD>
          <P>The GPCIs do not affect total national payments under the MPFS, but instead distribute payments among areas according to area cost differences. In general, the data show that urban areas usually have higher costs, while rural areas have generally lower costs. Thus, on average the costs associated with operating a private medical practice, as measured by factors such as wages and rent, are higher in urban areas. Alternatively, the average costs associated with the operation of a private medical practice in a rural area are lower. Since the costs associated with operating a private medical practice are measurably different based upon geographic location, varying payments according to the GPCIs will benefit lower cost areas, usually rural, since the law provides that only one-quarter of the area cost difference in physician work, the largest of the three fee schedule GPCI components, be recognized. We believe this was an attempt by the Congress to shift payments to rural areas. Thus, about 40 percent of MPFS payments (.75 × .52) are by statute not adjusted for area cost differences. Additionally, one component of the practice expense GPCI, supplies, equipment and other, is also, by statute, not adjusted for area cost differences. Supplies, equipment and other represent about 13 percent of total physician resource costs. This means that, effectively, there is a nationwide MPFS for about 53 percent of the average physician payment (40 percent physician work, 13 percent supplies, equipment and other). That is, only about 47 percent of overall physician payment is adjusted for area resource cost differences. In addition, 34 states are statewide payment localities in which all physicians, whether urban or rural, are paid the same. All of these factors shift payments from higher cost, usually urban, areas to lower cost, usually rural areas. </P>
          <HD SOURCE="HD3">3. GPCI Composition </HD>
          <P>Section 1848(e)(1)(C) of the Act requires us to review, and if necessary, adjust the GPCIs at least every 3 years. This section of the Act also requires us to phase in the adjustment over 2 years and implement only one-half of any adjustment if more than 1 year has elapsed since the last GPCI revision. The GPCIs were first implemented in 1992. The first review and revision was implemented in 1995, the second review was implemented in 1998, and the third review was implemented in 2001. The next GPCI review and revision is scheduled for implementation in 2004. However, as will be discussed in more detail, because the work and practice expense GPCIs rely primarily on special tabulations of U.S. Census data not yet available, review and revision of only the malpractice GPCI component will be implemented in 2004. Review and revision of the work and practice expense GPCIs will be implemented in 2005. </P>
          <P>Currently, only one data source is available for the practice expense GPCI (relative cost of office rent space collected by the Department of Housing and Urban Development (HUD)). Since we have not received the primary data upon which practice expense GPCIs are calculated and since the office rent component of the practice expense GPCI has proven not to be very substantial in past GPCI updates (it accounts for approximately 11.0 percent of the total GPCI calculation and is phased in over a two year period), we have decided not to revise the practice expense GPCIs for 2004. The work GPCI relies solely on data collected from the 2000 U.S. Census that is not yet available, so we are not able to propose updates to the work GPCI in this proposed rule. </P>
          <P>Although there are general discussions of both the background and composition of all three GPCI components in this proposed rule, a detailed discussion of only the 2004 revised malpractice GPCI is included in this proposal while a detailed discussion of the revised work and practice expense GPCIs will be included in the 2005 proposed rule. </P>
          <HD SOURCE="HD3">4. Development of the Geographic Practice Cost Indices </HD>
          <P>The GPCIs were developed by a joint effort of the Urban Institute and the Center for Health Economics Research under contract to CMS. The resource inputs and their weights are obtained from the AMA's Socioeconomic Characteristics of Medical Practices Survey. Indices were developed that measured the relative cost differences among areas compared to the national average in a “market basket” of goods. In this case, the market basket consists of the resources involved in operating a private medical practice. The resource inputs are physician work or net income; employee wages; office rents; medical equipment, supplies, other miscellaneous expenses; and malpractice insurance. Employee wages, rents, and miscellaneous expenses are combined to comprise the practice expense component of the GPCI. Table 2 below illustrates the cost share weights that have been utilized for each GPCI update: </P>
          <GPOTABLE CDEF="s125,15,15,15,15,15" COLS="6" OPTS="L2,i1">
            <TTITLE>Table 2.—GPCI (Medicare Economic Index) Cost Share Weights </TTITLE>
            <BOXHD>
              <CHED H="1">Expense category </CHED>
              <CHED H="1">1992-94* </CHED>
              <CHED H="1">1995-97** </CHED>
              <CHED H="1">1998-00** </CHED>
              <CHED H="1">2001-03*** </CHED>
              <CHED H="1">2004-07**** </CHED>
            </BOXHD>
            <ROW>
              <ENT I="01">Physician Earnings </ENT>
              <ENT>54.2 </ENT>
              <ENT>54.2 </ENT>
              <ENT>54.2 </ENT>
              <ENT>54.5 </ENT>
              <ENT>52.466 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Practice Expenses </ENT>
              <ENT>40.2 </ENT>
              <ENT>41.0 </ENT>
              <ENT>41.0 </ENT>
              <ENT>42.3 </ENT>
              <ENT>43.669 </ENT>
            </ROW>
            <ROW>
              <ENT I="03">Employee Wages </ENT>
              <ENT>15.7 </ENT>
              <ENT>16.3 </ENT>
              <ENT>16.3 </ENT>
              <ENT>16.8 </ENT>
              <ENT>18.654 </ENT>
            </ROW>
            <ROW>
              <ENT I="03">Rents </ENT>
              <ENT>11.1 </ENT>
              <ENT>10.3 </ENT>
              <ENT>10.3 </ENT>
              <ENT>11.6 </ENT>
              <ENT>12.209 </ENT>
            </ROW>
            <ROW>
              <ENT I="03">Equip., Supplies, Other </ENT>
              <ENT>13.4 </ENT>
              <ENT>14.4 </ENT>
              <ENT>14.4 </ENT>
              <ENT>13.9 </ENT>
              <ENT>12.807 </ENT>
            </ROW>
            <ROW RUL="n,s">
              <ENT I="01">Malpractice Insurance </ENT>
              <ENT>5.6 </ENT>
              <ENT>4.8 </ENT>
              <ENT>4.8 </ENT>
              <ENT>3.2 </ENT>
              <ENT>3.865 </ENT>
            </ROW>
            <ROW>
              <ENT I="22">  </ENT>
              <ENT>100.0 </ENT>
              <ENT>100.0 </ENT>
              <ENT>100.0 </ENT>
              <ENT>100.0 </ENT>
              <ENT>100.000 </ENT>
            </ROW>
            <TNOTE>*Weights from 1987 AMA survey. <PRTPAGE P="49040"/>
            </TNOTE>
            <TNOTE>**Weights from 1989 AMA survey. </TNOTE>
            <TNOTE>***Weights from 1997 AMA survey </TNOTE>
            <TNOTE>****Weights from Physician Socioeconomic Statistics, 2000-2002 Edition (SMS Survey), Physician Socioeconomic Statistics, 2003 Edition (PCPS Survey), Center for Health Policy Research, American Medical Association; 2003 Employment Cost Index, U.S. Department of Labor, Bureau of Labor Statistics; U.S. Department of Commerce, Bureau Economic Analysis 1997 Benchmark Input Output Tables, and U.S. Department of Commerce, Bureau of the Census, 2002 Current Population Survey. (See section III.A. Rebasing and Revising of the Medicare Economic Index.) </TNOTE>
          </GPOTABLE>
          <P>The Medicare economic index (MEI) is a measure of the average increases in the price of inputs used in operating a private medical practice and is used in the annual update of the MPFS CF. Because the GPCIs and the MEI use the same resource inputs to measure the costs of a private medical practice (the GPCIs measure relative costs among areas while the MEI measures the national average rate of increase in prices), as in the past, the same weights will be used for both the MEI and the GPCIs. </P>
          <P>Once the components and their weights were determined, we had to find data sources that were widely and consistently available to measure costs in all MPFS payment areas. After examining many sources, the following proxies were selected as the best available sources for measuring each component of the original 1992 through 1994 GPCIs: </P>
          <P>• Physician work—The median hourly earnings, based on a 20 percent sample of 1980 census data, of workers in six professional specialty occupation categories (engineers, surveyors, and architects; natural scientists and mathematicians; teachers, counselors, and librarians; social scientists, social workers, and lawyers; registered nurses and pharmacists; writers, artists, and editors) with 5 or more years of college. Adjustments were made to produce a standard occupational mix in each area. The actual reported earnings of physicians were not used to adjust geographical differences in fees because these fees are, in large part, the determinants of the earnings. We believe that the earnings of physicians will vary among areas to the same degree that the earnings of other professionals vary. </P>
          <P>• Employee wages—Median hourly wages of clerical workers, registered nurses, licensed practical nurses, and health technicians were also based on a 20 percent sample of 1980 census data. </P>
          <P>• Office rents—Residential apartment rental data produced annually by the Department of Housing and Urban Development (HUD) were used because there were insufficient data on commercial rents across all physician fee schedule areas. </P>
          <P>• Equipment, supplies, other expenses—The Urban Institute and the Center for Health Economics research assumed that a national market represents this component and that costs do not vary appreciably among areas. This component's index is 1.000 for all areas to indicate no variation from the national average. </P>
          <P>• Malpractice—Premiums in 1985 and 1986 for a mature “claims made” policy (a policy that covers malpractice claims made during the covered period) providing $100,000 to $300,000 of coverage were used. Adjustments were made to incorporate the costs of $1 million to $3 million coverage and mandatory patient compensation fund (PCF) requirements. Some States legally require physicians to join a PCF that provides coverage for catastrophic claims. Premium data were collected for physicians in three risk classes: low-risk (general practitioners who do not perform surgery), moderate risk (general surgeons), and high-risk (orthopedic surgeons). </P>
          <P>The areas selected for measurement purposes were the MSAs. Non-MSA areas within a State were aggregated into one residual area. Using MSAs for measurement satisfied our criteria to have (1) areas in which resource input prices were homogenous, and (2) areas of a large enough size so that market areas are self-contained to minimize border crossing; that is, physicians would probably not move their offices a few miles to secure higher payments and patients who would tend to receive services within their area. </P>
          <P>The Act requires, however, that the GPCIs reflect cost differences among MPFS payment areas. Thus, it was necessary to map Medicare localities to the MSA and non-MSA aggregation of GPCI data. Where localities crossed MSA boundaries, MSA indices were converted to Medicare locality indices by population weights. </P>
          <P>Detailed discussions of the methodology and data sources of the 1992 through 1994 GPCIs can be obtained by requesting studies from the National Technical Information Service by calling 1-800-553-NTIS, or, for residents of Springfield, Virginia, (703) 487-4650. The studies are as follows: </P>
          <P>• The Urban Institute report “The Geographic Medicare Index: Alternative Approaches,” NTIS PB89-216592; </P>

          <P>• The supplement to “The Geographic Medicare Index: Alternative Approaches,” NTIS PB91-113506. This was published in the <E T="04">Federal Register</E> in the September 4, 1990 notice (55 FR 36238) for the model fee schedule; and </P>

          <P>• The Urban Institute report, “Refining the Malpractice Geographic Practice Cost Index,” February 1991, NTIS PB91-155218. The related diskette is NTIS PB91-507491. This is the final version of the 1992 through 1994 GPCIs as published in the <E T="04">Federal Register</E> in the November 25, 1991 final rule (56 FR 59785). </P>
          <HD SOURCE="HD3">5. Revised 1995 Through 1997 Geographic Practice Cost Indices </HD>
          <P>The main criticism of the original GPCIs, that existed from 1992 until 1994, was that they were outdated because they were based on old data; for example, 1980 census data and 1985 and 1986 malpractice premium data, was the most recent data available when the GPCIs were established. The revised 1995 through 1997 GPCIs were based on the most current data available when they were developed in 1993 and 1994. We also made some minor changes from the original GPCI methodology in calculating some of the revised 1995 through 1997 indices. </P>

          <P>One methodological change was made that applied across all indices. As mentioned earlier, under the original GPCIs, where Medicare payment localities crossed MSA boundaries, MSA indices were converted to locality indices by population weights. Medicare expenditure weights were not used because the expenditures under the reasonable charge system contained large differences unrelated to actual resource cost differences among areas. In calculating the revised GPCIs, where payment localities crossed MSA boundaries, locality indices were calculated by weights based on full MPFS RVUs, which reflect resource cost differences among areas. Full MPFS RVUs were used rather than actual 1993 payments because 1993 fee schedule payments still reflected some reasonable charge payment levels. The advantages of RVU weighting are (1) the GPCIs will more closely reflect physician practice costs in the area where the services are provided rather than where the population lives, and (2) budget neutrality is preserved when we combine multiple payment localities into larger areas, such as statewide localities. <PRTPAGE P="49041"/>
          </P>
          <HD SOURCE="HD3">a. Work Geographic Practice Cost Indices</HD>
          <P>Data from the 20 percent sample of census data of median hourly earnings for the same six categories of professional specialty occupations as used in the 1992 through 1994 work GPCIs were used in calculating the 1995 through 1997 work GPCIs. The 1992 through 1994 work GPCIs were calculated using 1980 census data of earnings for professionals with 5 or more years of college. That sample was no longer available with the 1990 census. The 1990 census educational classifications are by highest degree earned, rather than the 1980 census classification by years of schooling. Thus, it was not possible to obtain earnings data exactly comparable to the 1980 data. </P>
          <P>For 1990, data were available for all-education and advanced-degree samples, but not for 5 or more years of college. We elected to use the all-education sample because its larger sample sizes made it more stable and accurate in the less populous areas. Although it could be argued that physicians' earnings might more closely approximate the earnings of professionals with advanced degrees, the differences between the all-education and advanced-degree indices were negligible in all but a few of the smallest localities. We believed that the small sample sizes of advanced-degree occupations in these small localities would produce inaccurate results. </P>
          <P>The 1992 through 1994 work GPCIs used metropolitan-wide median wages for each county within an MSA. That is, all counties within an MSA were assigned the MSA-wide median wage even if there were wage variations within the MSA. We believed that this was appropriate for all but Consolidated Metropolitan Statistical Areas (CMSAs), the largest of the MSAs, such as New York. In these CMSAs, we replaced metropolitan-wide earnings with county-specific earnings. We believed this change was appropriate because costs were, in fact, higher in central city areas (for example, Manhattan and San Francisco) than in the rest of the CMSA. County earnings were a better account of the cost variation within these large metropolitan areas. </P>
          <HD SOURCE="HD3">b. Practice Expense Geographic Practice Cost Indices</HD>
          <P>(1) Employee Wage Indices. </P>
          <P>Data from the 20 percent sample of census data of median hourly earnings for the same categories of medical and clerical occupations used in the 1992 through 1994 practice expense GPCIs were also used in the 1995 through 1997 practice expense GPCIs. The 1995 through 1997 practice expense GPCIs used 1990 rather than 1980 census data. As with the work GPCIs, county level data were used for CMSAs to better reflect the cost variations within these large metropolitan areas. </P>
          <P>(2) Rent Indices. </P>
          <P>As with the original rent indices, the HUD fair market rental (FMR) data for residential rents were again used as the proxy for physician office rents. The 1995 through 1997 practice expense GPCIs reflect 1994 HUD FMRs. Like the work GPCI and the employee wage index of the practice expense GPCIs, county level data were used in CMSAs to recognize the variations within the CMSA. </P>
          <P>The major criticism of the rent indices was that residential rather than commercial rent data were used. As mentioned earlier, for constructing the GPCIs we needed data that were widely and consistently available across all physician fee schedule areas. </P>
          <P>As with the original GPCIs, we again searched for private sources of commercial rent data that were widely and consistently available. The private sources we found were not adequate. None of the sources collected data for non-metropolitan areas, nor did any collect data for all metropolitan areas. The sources did not reflect the average commercial space in the area, but rather the particular type of space most relevant to the needs of a particular source's clients. In addition, the sample sizes were small. A comparison of the average rental for any particular city showed significant variation depending upon the source. Also, the private commercial rent data tended to be for very high priced real estate of the type likely to be used by large institutions such as banks, insurance companies, or financial firms and not for the type of office space most likely used by physicians. </P>
          <P>Among the sources of commercial rent data that were available, the most promising were data from the Building Owners and Managers Association, the General Services Administration, and the U.S. Postal Service. These data were analyzed in depth. We did not use data from the Building Owners and Managers Association and the General Services Administration because of poor geographic coverage, especially outside of large metropolitan areas. That is, data were not widely and consistently available for all physician fee schedule areas. The U.S. Postal Service data had much better geographic coverage, but sample sizes in many areas were unacceptably small and could have led to erroneous results. </P>
          <P>No acceptable national commercial rent data were readily available for physician office rents. Thus, some proxy needed to be used for this portion of the index. In addition, commercial rent data were not available for all areas from published statistical sources. We believed that the HUD FMR data remained the best available data for constructing the office rental index. HUD FMR data were available for all areas, were updated on an annual basis, and were consistent among areas and from year to year. Moreover, we believed that physicians frequently locate in areas and office space that are residential rather than commercial, for example, in apartment complexes and small strip commercial centers adjacent to residential areas. Residential rents may, in fact, be a better measure of the differences among areas in the physician office market than a general commercial rental index. </P>
          <P>(3) Medical Equipment, Supplies, and Miscellaneous Expenses. </P>
          <P>Consistent with the original 1992 through 1994 update for medical equipment, supplies, and miscellaneous, this index assumes a national market in which input prices do not vary among geographic areas. We were unable to find any data sources that demonstrated price differences by geographic area. Anecdotal and interview data with suppliers and manufacturers were inconclusive. While some price differences may exist, we believed they were more likely to be based on volume discounts rather than on geographic areas. Generally, it appears that manufacturers' prices do not vary among areas except for shipping costs. Since manufacturers and suppliers are located all over the country, shipping costs do not vary significantly. </P>
          <HD SOURCE="HD3">c. Malpractice Geographic Practice Cost Indices</HD>

          <P>Again, malpractice premium data for a $1 million to $3 million mature “claims made” policy were collected, with mandatory Patient Compensation Funds (PCFs) considered. Some States have legally required physicians to join PCFs that provide coverage for catastrophic claims. The PCF charges a premium or surcharge just as any other insurer. However, more recent and more comprehensive malpractice insurance data were used in calculating the 1995 through 1997 malpractice GPCIs. The 1995 through 1997 malpractice GPCIs were based on 1990 through 1992 malpractice premium data. Since malpractice premiums may change <PRTPAGE P="49042"/>significantly from year to year, we decided to use the most recent 3-year average available rather than just the most recent single year to smooth out this volatility and present a more accurate indication of malpractice premium trends over time. </P>
          <P>We collected data on more specialties and from more insurers. We collected data on 20 specialties, rather than on only 3 as in the 1992 through 1994 malpractice GPCIs. The 1992 through 1994 malpractice GPCI data were largely drawn from a single nationwide insurer (St. Paul Fire and Marine) and were supplemented by several State-specific carriers in States in which St. Paul did not offer coverage. Subsequent analyses suggest that these data may not be representative of insurers operating in many States. For the revised malpractice GPCI, data were collected from insurers that, on average, represented 82 percent of the market in each State, with the lowest State market share being 60 percent. We believed that the more recent and much more comprehensive data greatly improved the accuracy of the malpractice GPCIs for 1995 through 1997.</P>
          <P>Detailed discussions of the methodology and data sources of the 1995 through 1997 GPCIs can be obtained by requesting the following studies from NTIS by calling 1-800-553-NTIS, or (703) 487-4650 in Springfield, Virginia:</P>
          <P>• “Updating the Geographic Practice Cost Index: Revised Cost Shares.” Debra A. Dayhoff, John E. Schneider, and Gregory C. Pope. NTIS PB94-161072. </P>
          <P>• “Updating the Geographic Practice Cost Index: The Physician Work GPCI.” Gregory C. Pope and Deborah A. Dayhoff. NTIS PB94-161080. </P>
          <P>• “Updating the Geographic Practice Cost Index: The Practice Expense GPCI.” Gregory C. Pope, Deborah A. Dayhoff, Angella R. Merrill, and Killard W. Adamache. NTIS PB94-161098. </P>
          <P>“Updating the Geographic Practice Cost Index: The Malpractice GPCI.” Stephen Zuckerman and Stephen Norton. NTIS PB94-161106. </P>
          <HD SOURCE="HD3">6. Revised 1998 Through 2000 Geographic Practice Cost Indices </HD>
          <P>The same data sources and methodology used for the 1995 through 1997 GPCIs were also used for the revised 1998 through 2000 GPCIs with a few very minor modifications. No acceptable additional data sources were found. The cost shares were the same as in the 1995 through 1997 GPCIs because no changes were made in the MEI weights. Indices for fee schedule areas were based on the indices for the individual counties within the fee schedule area. Fee schedule RVUs were again used to weight the county indices (to reflect volumes of services within counties) when mapping to MPFS payment areas and in constructing the national average indices. However, we used more recent data, 1994 rather than 1992 RVUs, in the county, locality, and national mapping for the proposed GPCIs. The payment effect of using more current RVU weights was negligible in most cases and generally resulted in changes at the third decimal point if at all. </P>
          <HD SOURCE="HD3">a. Work Geographic Practice Cost Indices </HD>
          <P>The work GPCIs were based on the decennial census. The 1992 through 1994 work GPCIs were based on 1980 census data, because 1990 census data were not yet available. The work GPCIs were revised in 1995 with new data from the 1990 census. New census data will not be available again until sometime after the 2000 census is compiled. We searched for other data that would enable us to update the work GPCIs between the decennial censuses. No acceptable data sources were found. The most promising sources of data were the hospital wage data collected by us to calculate the IPPS hospital wage index and the payroll per worker data collected by the U.S. Bureau of Labor Statistics from State unemployment insurance agencies (the ES-202 data). </P>
          <P>The IPPS hospital wage data were examined when we constructed the original GPCIs. They were rejected as a physician fee schedule data source in favor of census data because of their lack of an occupation mix adjustment and their unrepresentative occupational composition (hospital employees rather than professionals or physician office employees). ES-202 data consist of total payroll divided by counts of wage and salary workers. The major disadvantage we identified was that they do not measure hourly earnings, only payroll per employee, and no occupational detail is available. Also, they did not adjust for part-time or full-time and hours worked, and the numbers of workers was too small for certain States, all of which led to unstable estimates of payroll per worker. We compared the changes by State from 1989 to 1993 in the IPPS wage data and the ES-202 data to see if there was any correlation between the two series. The correlation between the two was only moderate, 0.55. The changes indicated by both series were generally small, for example, a few percentage points. The difference between the two series by State was in many cases as large as or greater than the change indicated by either series. The average difference between the two series (2.1 percent) is as large as the change indicated by either series. In addition, changes for particular States were substantially different between the two series. For example, Indiana relative wages rose by 1.9 percent according to the IPPS data, but fell 5.7 percent according to the ES-202 data. </P>
          <P>Since we were unable to find an acceptable data source for updating the work GPCIs, we examined the consequences of not updating the work GPCIs between the decennial censuses. We compared the changes between the 1992 through 1994 work GPCIs, based on the 1980 census, and the 1995 through 1997 GPCIs, based on the 1990 census. On average, the full variation in State work GPCIs changed by about 5 percent. This translates to about a 1.2 percent change in the one-quarter work GPCI calculation prescribed by law. Since work makes up about one-half of the GPCI cost shares, this translated into an average payment change per State of about 0.6 percent from updating the work GPCI based on the 10-year change in relative wages indicated by the census data. Even the maximum change in the full variation in State work GPCIs from the 1992 through 1994 to the 1995 through 1997 GPCIs of 14 percent translates into only about a 1.8 percent change in payments. The largest full work GPCI changes for individual payment areas were from 16 to 20 percent, or about a 4 to 5 percent change in the one-quarter work GPCI, or about a 2.4 percent change in payments. However, 80 percent of payment areas experienced payment changes of less than 1 percent, and 50 percent of payment localities experienced payment changes of less than 0.5 percent as a result of changes in the census data from 1980 to 1990. </P>
          <P>We, therefore, made no changes in the 1998 through 2000 work GPCIs from the 1995 through 1997 work GPCIs, other than the generally negligible changes resulting from using 1994, rather than 1992, RVUs for this GPCI update because we were unable to find acceptable data for use between the decennial censuses. We believed it is preferable that we make no changes rather than make inaccurate changes based on inappropriate data. We felt that this was a reasonable position given the generally small magnitude of the changes in payments resulting from the changes in the work GPCIs from the 1980 to the 1990 census data. </P>
          <HD SOURCE="HD3">b. Practice Expense Geographic Practice Cost Indices </HD>
          <P>(1) Employee Wage Indices. <PRTPAGE P="49043"/>
          </P>
          <P>As with the work GPCIs, the employee wage portion of the practice expense GPCIs were also based on decennial census data. For the same reasons discussed above pertaining to the work GPCIs, we made no changes in the employee wage indices during the 1998 through 2000 GPCI update. The average change from the 1992 through 1994 to 1995 through 1997 employee wage indices across States was about 6 percent. Since the employee wage index has a weight of about 16 percent in the GPCI cost shares, this translates into a 1 percent average change in payments. The maximum payment change in any payment area resulting from changes from the 1992 through 1994 to 1995 through 1997 employee wage indices was about 3.2 percent. Payment changes in over two-thirds of the payment areas were less than 1 percent. </P>
          <P>(2) Rent Indices. </P>
          <P>The office rental indices were again based on HUD residential rent data. The rental indices were based on 1996 HUD data as opposed to 1994 HUD data in the 1995 through 1997 GPCIs. HUD made two small methodological changes in developing the data. First, HUD used the 40th percentile of area rents rather than the 45th percentile. This did not materially affect the GPCIs, which measure relative rents among areas. Second, HUD established a rental floor for rural counties at the statewide rural average. This had the effect of raising the office rental indices slightly in rural areas. </P>
          <P>We made one methodological change in the rent indices. HUD publishes FMRs only for metropolitan areas as a whole. For the 1995 through 1997 GPCIs, HUD used a special tabulation of the 1990 census data to allocate rents by county within CMSAs. In some metropolitan areas, this had the effect of reducing the central city index below the suburban index, probably because of lower unmeasured housing quality in central cities than in suburbs. We did not feel that this was a representative indicator of relative physician rents, since the GPCIs are intended to measure rental costs for offices of similar quality in different areas. The metropolitan-wide rent was most appropriate for measuring the cost of space of an average quality across the metropolitan area, which is why HUD publishes only metropolitan-wide FMRs. Also, the census county adjustments can be updated only once every 10 years. For this reason, we believed that the county-specific adjustment should not be made for all large metropolitan areas but should be retained only for the New York City Primary Metropolitan Statistical Area. Available evidence suggests that rents vary substantially among the boroughs of New York City and that, given the current locality configuration, the county-specific rental adjustment appropriately reflects these patterns in the New York City area, especially the higher rents in Manhattan. </P>
          <P>(3) Medical Equipment, Supplies, and Miscellaneous Expenses. As with the 1992 through 1994 and 1995 through 1997 GPCIs, this component was given a national value of 1.000, indicating no measurable difference among areas in costs. </P>
          <HD SOURCE="HD3">c. Malpractice Geographic Practice Cost Indices. </HD>
          <P>Again, malpractice premium data were collected for a mature “claims made” policy with $1 million to $3 million limits of coverage, with adjustments made for mandatory patient compensation funds. As with the 1995 through 1997 GPCIs, data were collected for the 20 largest Medicare-billing physician specialties. The premium data represent at least 50 percent of the market in each State. Again, we used an average of the 3 most recent premium years to smooth out the considerable year-to-year fluctuations that can occur in malpractice premiums. The revised 1998 through 2000 malpractice indices were based on 1992 through 1994 premium data, the latest years available when this revision was being conducted in 1995 through 1996, compared to the 1990 through 1992 data used in the current 1995 through 1997 indices. Another change from the 1995 through 1997 indices is that the specialty shares of the 20 specialties were weighted by fee schedule RVUs rather than allowed charges. </P>
          <P>Detailed discussions of the methodology and data sources of the 1998 through 2000 GPCIs may be obtained by requesting the following study from NTIS by calling 1-800-533-NTIS, or, for residents of Springfield, Virginia, (703) 487-4650: “Second Update of the Geographic Practice Cost Index.” Gregory C. Pope and Killard W. Adamache. </P>
          <HD SOURCE="HD3">7. Revised 2001-2003 Geographic Practice Cost Indices </HD>
          <P>The same data sources and methodology used for the 1998 through 2000 GPCIs were used for the 2001 through 2003 GPCIs. No acceptable additional data sources were found. The only changes from the 1998 through 2000 GPCI were in the cost shares and RVU weighting. As shown in the cost share table in the discussion of the development of the GPCIs, the cost shares were changed to reflect the revisions in the MEI. This does not affect the work or malpractice GPCIs since they are stand-alone indices (not composed of multiple indices). This cost share revision has a slight effect on the practice expense GPCIs because it changes slightly the weights among the employee wage, rents and miscellaneous components of the practice expense index. We used more recent RVU data, 1998 rather than 1994, in the county, locality, and national mapping in the proposed GPCIs. The payment effect of this was generally negligible. </P>
          <HD SOURCE="HD3">a. Work Geographic Practice Cost Indices. </HD>
          <P>For the same reasons discussed in the section on the 1998 through 2000 work GPCIs, no changes were proposed in the work GPCIs, other than the generally negligible changes resulting from the use of 1998 rather than 1994 RVUs for weighting, because we were unable to find acceptable data for use between the decennial census. </P>
          <HD SOURCE="HD3">b. Practice Expense Geographic Practice Cost Indices</HD>
          <P>(1) Employee Wage Indices. </P>
          <P>As with the work GPCIs, the employee wage indices were based on decennial census data. For the same reasons discussed above pertaining to the work GPCIs, we proposed no changes in the employee wage indices during this GPCI update. </P>
          <P>(2) Rent Indices. </P>
          <P>The office rental indices were again based on HUD residential rent data. No changes were made in the methodology. The proposed rental indices were based on 2000 rather than 1994 HUD data. </P>
          <P>(3) Medical Equipment, Supplies, and Miscellaneous Expenses. As with all previous GPCIs, this component is given a national value of 1.000, indicating no measurable differences among areas in costs. </P>
          <HD SOURCE="HD3">c. Malpractice Geographic Practice Cost Indices </HD>
          <P>The same methodology described in the 1998 through 2000 malpractice GPCI section was used in the revision of malpractice GPCIs section for 2001 through 2003, the only difference being the use of more recent data. The malpractice indices were based on 1996 through 1998 malpractice premium data rather than the 1992 through 1994 malpractice premium data that was used in the previous GPCI update. </P>
          <HD SOURCE="HD3">8. Proposed 2004 through 2007 Geographic Practice Cost Indices </HD>

          <P>The main criticism of the 2001 through 2003 GPCIs was that they were <PRTPAGE P="49044"/>outdated because they were based on old data; for example, 1990 decennial census data and 1996 through 1998 malpractice premiums, the most recent data available when the GPCIs for 2001 through 2003 were established. The calculation of the proposed 2004 through 2007 GPCIs will be based upon the same data sources and methodology, but the 2004 through 2007 GPCIs will utilize more current data: 2000 decennial census data, 2000 HUD fair market rental (FMR) data for residential rents, and 1999 through 2003 malpractice premium data. This should address the criticism of the 2001 through 2003 GPCIs being out of date. </P>
          <HD SOURCE="HD3">a. Proposed Work Geographic Practice Cost Indices </HD>
          <P>We have not yet received the 2000 decennial census data that will be utilized for the revision of the work GPCIs. For this reason, revisions to the work GPCIs will be included in the proposed rule for calendar year 2005. </P>
          <HD SOURCE="HD3">b. Proposed Practice Expense Geographic Practice Cost Indices </HD>
          <P>We have not yet received the 2000 decennial census data that will be utilized for the revision of the majority of the practice expense GPCI. We have obtained 2000 HUD fair market rental (FMR) data for residential rents that is utilized for a portion of the practice expense revision. Since we have not received the primary data upon which practice expense GPCIs are calculated and since the office rent component of the practice expense GPCI has not proven to be a substantially variable component in past GPCI updates and accounts for only approximately 12.0 percent of the total GPCI calculation (phased in over a two year period), we have decided not to revise the practice expense GPCIs now based on our limited data. For these reasons, revisions to the practice expense GPCIs will be included in the proposed rule for calendar year 2005. </P>
          <HD SOURCE="HD3">c. Proposed Malpractice Geographic Practice Cost Indices </HD>
          <P>The malpractice GPCI is the most volatile of the three indexes with relatively large variations existing between localities. Malpractice premium data for a $1 million to $3 million mature “claims made” policy were collected, with mandatory patient compensation funds considered. However, due to the recent concerns regarding the escalating cost of professional liability insurance, especially in 2002 and 2003, we will be collecting more recent malpractice premium data. We propose using actual 1999 through 2002 malpractice premium data and projecting the malpractice premium rates for 2003. The methodology for forecasting 2003 medical malpractice premiums will consist of calculating the geometric mean rate of growth between 1999 through 2002 and applying that rate to the 2002 premium. We will also obtain a national aggregate malpractice premium series with which to benchmark the 2003 forecast. At this point, we are still collecting the 2002 malpractice premium data and are thus unable to project 2003 malpractice premium data in this proposed rule. We are proposing to base the malpractice GPCIs upon actual 2001 and 2002 malpractice premium data and projected 2003 malpractice premium data by January 1, 2004. These revised malpractice GPCIs will be published in this year's final physician fee schedule regulation. They will be considered interim and subject to public comment. </P>
          <HD SOURCE="HD3">9. Payment Localities </HD>
          <P>We are also interested in receiving comments on the composition of the current Medicare physician payment localities (89 separate payment localities) to which the GPCIs are applied. For additional information regarding the composition of the 89 Medicare physician payment localities please refer to both the July 2, 1996 proposed rule (61 FR 34615) and the November 22, 1996 final rule (61 FR 59494) for the Medicare physician fee schedule. </P>
          <HD SOURCE="HD2">C. Coding Issues </HD>
          <HD SOURCE="HD3">1. Payment Policy for CPT Tracking Codes </HD>
          <P>In the November 1, 2001 final rule (66 FR 55269), we stated that carriers have discretion for coverage and payment of services described by CPT tracking codes, also known as CPT Category III codes, unless we have made a national coverage determination (NCD). (These CPT Category III codes are distinct from the HCPCS Level III codes used by local claims processors which are to be discontinued under HIPAA implementation.) We have received several requests to create national payment amounts for some CPT tracking codes even if there has been no NCD with respect to the services. After review of these requests, we are proposing to change our policy regarding payment for CPT tracking codes. </P>
          <P>We propose to create national payment policy and determine national payment amounts for CPT tracking codes when there is a significant programmatic need for us to do so. Such a need could arise, for example, if we receive requests from carrier medical directors that we establish a national payment amount because of carrier inability to do so. This policy change would not change the contractor's discretion over coverage for the CPT tracking codes, but would establish a payment level if the contractor finds that coverage is warranted. Carriers do not need to establish a payment amount for a tracking code until they receive a claim for the code. </P>
          <HD SOURCE="HD3">2. Excision of Benign and Malignant Lesions </HD>

          <P>In the CPT 2003 book, the definitions for excision of benign lesions (CPT codes 11400 through 11446 inclusive) and excision of malignant lesions (CPT codes 11600 through 11646 inclusive) were substantively changed. Starting in 2003, these codes are to be reported based on the excised diameter (actual skin removed) rather than on the size of the lesion. We have reviewed the new code descriptors and are proposing to make the work RVUs the same for removal of all skin lesions with the same excised diameters that are from the same area of the body, whether the lesions are benign or malignant For example, the work RVUs for the removal of benign skin lesions from the trunk, arms or legs with excised diameter 1.1-2.0 cm, CPT code 11402, would be the same as the work RVUs for CPT code 11602, which is the removal of <E T="03">malignant</E> skin lesions from trunk, arms or legs with excised diameter of 1.1-2.0 cm. Therefore, to retain budget neutrality within each code pair, the total work RVUs associated with each code pair will be constant both before and after the work adjustment. We will accomplish this by dividing the total 2003 work RVUs (2003 work RVUs for a given code pair multiplied by 2002 utilization) by the total 2002 utilization for the given code pair. For example: </P>
          <GPOTABLE CDEF="s150,10,2,10,2,10" COLS="6" OPTS="L1,b2,tp0,f8,i1">
            <TTITLE>  </TTITLE>
            <BOXHD>
              <CHED H="1">CPT code </CHED>
              <CHED H="1">2002 <LI>utilization </LI>
              </CHED>
              <CHED H="1">  </CHED>
              <CHED H="1">2003 work <LI>RVU </LI>
              </CHED>
              <CHED H="1">  </CHED>
              <CHED H="1">Total work <LI>RVUs </LI>
              </CHED>
            </BOXHD>
            <ROW>
              <ENT I="01">11400 </ENT>
              <ENT>69,041 </ENT>
              <ENT>× </ENT>
              <ENT>0.85 </ENT>
              <ENT>= </ENT>
              <ENT>58,685 </ENT>
            </ROW>
            <ROW RUL="n,s,n,s,n,s">
              <PRTPAGE P="49045"/>
              <ENT I="01">11600 </ENT>
              <ENT>13,768</ENT>
              <ENT>× </ENT>
              <ENT>1.31 </ENT>
              <ENT>= </ENT>
              <ENT>18,036 </ENT>
            </ROW>
            <ROW>
              <ENT I="02">Total</ENT>
              <ENT>82,809</ENT>
              <ENT> </ENT>
              <ENT/>
              <ENT>  </ENT>
              <ENT>76,721 </ENT>
            </ROW>
            <TNOTE>76,721 divided by 82,809 = 0.93 work RVU </TNOTE>
          </GPOTABLE>
          <P>The proposed work RVUs for these codes follow: </P>
          <GPH DEEP="622" SPAN="3">
            <PRTPAGE P="49046"/>
            <GID>EP15AU03.007</GID>
          </GPH>
          <PRTPAGE P="49047"/>
          <HD SOURCE="HD3">3. Create G Codes for Monitoring Heart Rhythms </HD>
          <P>Technological advances have made cardiac telemetry equipment, typically used in hospitals, available in the home setting. It is now possible to discharge patients with arrhythmias to a home setting and have them monitored at home in a manner similar to hospital monitoring. This monitoring can be used to diagnose arrhythmias or to monitor patients with known arrhythmias to determine, on a real-time basis, whether the patient is having ongoing arrhythmias. The equipment consists of patient leads and a home telemetry station that is connected to a distant monitoring station via the telephone. The monitoring station is attended twenty-four hours a day, seven days a week by a technician. Upon receipt of rhythm strips, the technician records and formats the strips and faxes them to the treating physician. </P>
          <P>This equipment automatically records the patient's heart rhythm and is not triggered by the patient (for example, his response to symptoms). The equipment is pre-set with parameters (for example, heart rate of over 120) that trigger it to transmit the patient's cardiac rhythm to monitoring station. Additionally, the technician at the monitoring station can interrogate the home station and have it transmit rhythm strips upon request even when no arrhythmia has triggered an automatic transmission. These latter transmissions are at the discretion of the technician and may or may not be faxed to the treating physician based on previous orders. </P>
          <P>Depending on the clinical need, patients may be monitored by this equipment for varying lengths of time. Furthermore, the frequency of transmission of cardiac rhythms varies, as does the amount of material that must be reviewed by the physician. For example, a patient may have no cardiac rhythms transmitted for one or more days while on other days the patient may have several minutes of arrhythmias transmitted for physician review. </P>

          <P>To ensure this technology is available to Medicare beneficiaries for covered indications (coverage is currently at the discretion of the local Medicare contractors because there is no national coverage determination for this service) we are creating several HCPCS G codes to describe this service and are establishing national payment amounts for these services. Currently Medicare contractors are requiring both the PC and TC of this service to be billed under CPT code 93799, <E T="03">Unlisted cardiovascular procedure or service.</E> This service is covered under the diagnostic test benefit category at section 1861(s)(3) of the Act. </P>
          <P>Medicare is establishing the following HCPCS codes to describe this service:</P>
          
          <FP SOURCE="FP-1">
            <E T="03">GXXX1—Electrocardiographic monitoring for diagnosis of arrhythmias, utilizing a home computerized telemetry station and trans-telephonic transmission, with automatic activation and real time notification of monitoring station, 24-hour attended monitoring, per 30-day period of time; includes recording, monitoring, receipt of transmissions, analysis, and physician review and interpretation.</E> (global) </FP>
          <FP SOURCE="FP-1">
            <E T="03">GXXX2—Electrocardiographic monitoring for diagnosis of arrhythmias, utilizing a home computerized telemetry station and trans-telephonic transmission, with automatic activation and real time notification of monitoring station, 24-hour attended monitoring, per 30-day period of time; recording (includes hook-up, recording and disconnection)</E>
          </FP>
          <FP SOURCE="FP-1">
            <E T="03">GXXX3—Electrocardiographic monitoring for diagnosis of arrhythmias, utilizing a home computerized telemetry station and trans-telephonic transmission, with automatic activation and real time notification of monitoring station, 24-hour attended monitoring, per 30-day period of time; monitoring, receipt of transmissions, and analysis</E>
          </FP>
          <FP SOURCE="FP-1">
            <E T="03">GXXX4—Electrocardiographic monitoring for diagnosis of arrhythmias, utilizing a home computerized telemetry station and trans-telephonic transmission, with automatic activation and real time notification of monitoring station, 24-hour attended monitoring, per 30-day period of time; physician review and interpretation.</E>
          </FP>
          
          <P>We are establishing the following payment amounts for these codes:</P>
          

          <FP SOURCE="FP-1">GXXX1—We are assigning 0.52 physician work RVUs and 0.24 malpractice RVUs which is equivalent to <E T="03">CPT Code, 93268 Patient demand single or multiple event recording with presymptom memory loop, 24-hour attended monitoring, per 30 day period of time; includes transmission physician review and interpretation.</E> We are also crosswalking the practice expense inputs from CPT Code 93268. </FP>
          <FP SOURCE="FP-1">
            <E T="03">GXXX2</E>—We are assigning 0.07 malpractice RVUs which is equivalent to <E T="03">CPT Code 93270, Patient demand single or multiple event recording with presymptom memory loop, 24-hour attended monitoring, per 30 day period of time; recording (includes hook-up, recording, and disconnection)</E> and crosswalking the practice expense inputs from CPT Code 93270. </FP>
          <FP SOURCE="FP-1">
            <E T="03">GXXX3</E>—We are assigning 0.15 malpractice RVUs which is equivalent to <E T="03">CPT Code 93271, Patient demand single or multiple event recording with presymptom memory loop, 24-hour attended monitoring, per 30 day period of time; monitoring, receipt of transmission, and analysis</E> and also are crosswalking the practice expense inputs from CPT Code 93271. </FP>
          <FP SOURCE="FP-1">
            <E T="03">GXXX4</E>—We are assigning 0.52 physician work RVUs and 0.02 malpractice RVUs which is equivalent to <E T="03">CPT Code 93272 Patient demand single or multiple event recording with presymptom memory loop, 24-hour attended monitoring, per 30 day period of time; physician review and interpretation only.</E> We are also crosswalking the practice expense inputs, from CPT Code 93272. </FP>
          
          <P>We believe these proposed RVUs and crosswalks are appropriate as the services provided in the new codes are very similar in terms of physician work, resource use, and malpractice risk to the existing CPT Codes. </P>
          <HD SOURCE="HD3">4. CPT Code 88180 (Flow Cytometry; Each Cell Surface, Cytoplasmic or Nuclear Marker) </HD>

          <P>Flow cytometry is a technique to analyze single cell suspensions from blood, bone marrow, body fluids, lymph nodes, and other tissues. The technique, currently coded as CPT code 88180, <E T="03">Flow cytometry, each cell surface, cytoplasmic or nuclear marker</E>, quantifies cell surface, cytoplasmic, and nuclear antigens. The results are frequently used to diagnose lymphomas and leukemias. They are also used to monitor lymphocyte subpopulations in patients with HIV infection or solid organ transplantation. For example, in patients with HIV infection, physicians evaluate CD4+ lymphocytes as a measure of the severity of the infection (some physicians also measure other markers although their clinical relevance is not as well established). In patients with solid organ transplantation, physicians measure various lymphocyte subpopulations to help assess early rejection, identify bone marrow toxicity during immunosuppressive therapy, and differentiate infections from transplant rejection. In these cases the treating physician, not the pathologist, makes the diagnosis. It is inappropriate for the pathologist to report the professional component (PC) of this service. In general, flow cytometry results must be utilized along with clinical data to make <PRTPAGE P="49048"/>a diagnosis.  Other clinical situations where flow cytometry tests have some value include stem cell transplantation, paroxysmal nocturnal hemoglobinuria, immune deficiency disorders, etc.</P>
          <P>When flow cytometry is performed to diagnose lymphoma or leukemia, there is a single interpretation based on the quantification of all markers tested. There is not an interpretation of each marker individually. </P>
          <P>Moreover, for a given clinical indication (for example, diagnosis of lymphoma based on lymph node examination) there is variation in the number of markers performed. The number of markers that are necessary depends, in part, on the pathologic information available to the pathologist at the time he/she orders flow cytometry. Therefore, for a given clinical indication (for example, diagnosis of lymphoma from a lymph node) a pathologist who chooses to perform flow cytometry before performing a microscopic examination of the tissue specimen (for example, a lymph node) may order more markers than a pathologist who orders flow cytometry after performing a microscopic examination of the tissue specimen. </P>
          <P>The current coding scheme (payment on a per marker basis) may encourage the performance of more markers than may be medically necessary because the pathologist determines what markers to perform and when to perform them. </P>
          <P>Our review of flow cytometry reports confirms that markers are interpreted (and reported) on a panel basis. From our review, physicians do not typically interpret individual markers. This is consistent with most of the clinical indications for flow cytometry that require performance of several markers to make a diagnosis. There may also be clinical situations where no professional component is performed although it is appropriate to perform the technical component (TC) (for example, monitoring of HIV infected patients, monitoring of solid organ transplantations). </P>
          <P>The fact that markers are generally analyzed on a “panel” basis, not an “individual” basis, means that the current practice and use of flow cytometry is not appropriately reflected by the PC of CPT code 88180. </P>
          <P>However, we do believe that it is appropriate to pay for the TC of each marker separately, although at a lower rate of payment (due to economies of scale) when multiple markers are performed. A coding scheme that pays per marker for the TC and per panel for the PC would more accurately reflect the actual practice of flow cytometry. </P>
          <P>The laboratory community is aware of our concerns about the coding of flow cytometery and will review this issue and consider whether changes should be made to the current coding for the procedure. If no changes in coding are forthcoming, we would consider creating HCPCS codes for flow cytometry. We welcome comments and recommendations on appropriate values for the procedure that we could use in developing any future proposal. </P>
          <HD SOURCE="HD3">5. Create G Codes for Dialysis Patient Seeing the Doctor </HD>
          <P>We have reviewed our current payment policy for the monthly dialysis capitation, CPT codes 90918 through 90921 in response to concerns that have been raised over whether our payment policy is consistent with current medical practice. </P>
          <P>Specifically, we understand that physician involvement in dialysis for end stage renal disease (ESRD) varies based on a patient's condition, response to dialysis, and comorbidities. A physician involvement for a single patient may also vary from month to month. It is our intent to ensure that beneficiaries with ESRD receive the highest quality dialysis care available and that physician involvement in dialysis for ESRD patients is appropriate and consistent with the needs of the patient in any month. </P>
          <P>Observers of the quality of care for dialysis patients have noted that some dialysis patients may benefit from being evaluated by their physician frequently. A recent international comparison study suggested that longer physician-patient contact time in hemodialysis facilities was associated with lower mortality risk. </P>
          <P>To align the payment incentives with the frequency of the physician personally evaluating the dialysis patient, we are proposing to make CPT codes 90918, 90919, 90920, 90921 invalid for Medicare and to create G codes. We are proposing to create 3 new G codes in place of each CPT code with higher payments associated with providing more visits within each month to an ESRD patient. Under our proposal, there will be separate codes when the physician provides 1 visit per month, 2-3 visits per month and 4 or more visits per month. The code for 1 visit per month will have the lowest payment while a higher payment will be provided for 2 to 3 visits per month and the highest payment for 4 or more visits per month. Our methodology for determining payment is described below. These new codes will be reported once per month for services performed in an outpatient setting and related to the patient's ESRD. These physician services will continue to include the establishment of a dialyzing cycle, outpatient evaluation and management of the dialysis visits, telephone calls, and patient management, provided during a full month. These codes would not be used if a hospitalization occurred during the month. </P>
          
          <FP SOURCE="FP-1">GXXX5—End Stage Renal Disease (ESRD) related services per full month, for patients under 2 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents; with 4 or more face-to-face physician visits per month. </FP>
          <FP SOURCE="FP-1">GXXX6—End Stage Renal Disease (ESRD) related services per full month, for patients under 2 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents; with 2 or 3 face-to-face physician visits per month. </FP>
          <FP SOURCE="FP-1">GXXX7—End Stage Renal Disease (ESRD) related services per full month, for patients under 2 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents; with 1 face-to-face physician visit per month. </FP>
          <FP SOURCE="FP-1">GXXX8—End Stage Renal Disease (ESRD) related services per full month, for patients between 2 and 11 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents; with 4 or more face-to-face physician visits per month. </FP>
          <FP SOURCE="FP-1">GXXX9—End Stage Renal Disease (ESRD) related services per full month, for patients between 2 and 11 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents; with 2 or 3 face-to-face physician visits per month. </FP>
          <FP SOURCE="FP-1">GXX10—End Stage Renal Disease (ESRD) related services per full month, for patients between 2 and 11 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents; with 1 face-to-face physician visit per month. </FP>

          <FP SOURCE="FP-1">GXX11—End Stage Renal Disease (ESRD) related services per full month, for patients between 12 and 19 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and <PRTPAGE P="49049"/>counseling of parents; with 4 or more face-to-face physician visits per month. </FP>
          <FP SOURCE="FP-1">GXX12—End Stage Renal Disease (ESRD) related services per full month, for patients between 12 and 19 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents; with 2 or 3 face-to-face physician visits per month. </FP>
          <FP SOURCE="FP-1">GXX13—End Stage Renal Disease (ESRD) related services per full month, for patients between 12 and 19 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents; with 1 face-to-face physician visit per month. </FP>
          <FP SOURCE="FP-1">GXX14—End Stage Renal Disease (ESRD) related services per full month, for patients 20 years of age and over; with 4 or more face-to-face physician visits per month. </FP>
          <FP SOURCE="FP-1">GXX15—End Stage Renal Disease (ESRD) related services per full month, for patients 20 years of age and over; with 2 or 3 face-to-face physician visits per month. </FP>
          <FP SOURCE="FP-1">GXX16—End Stage Renal Disease (ESRD) related services per full month, for patients 20 years of age and over; with 1 face-to-face physician visit per month. </FP>
          
          <P>We are assuming that most physicians will provide 4 or more visits to their ESRD patients and a small proportion will provide 2-3 visits or only 1 visit per month. Using these assumptions and Medicare utilization data from 2002, we developed relative value units for the new G codes that will make the Medicare's aggregate payments for ESRD related services under the physician fee schedule approximately equal to current payments that are occurring using procedure codes 90918 to 90921. Relative to our current payments, we are proposing to lower payment when the physician provides 1 visit per month or 2-3 visits per month. Since we are proposing to lower payment if the physician provides fewer than 4 visits per month, in order to maintain the same aggregate payments for ESRD related services, we are proposing to increase payment if the physician provides 4 or more visits per month. Using these assumptions, the proposed work, practice expense and malpractice RVUs for procedure codes GXXX5 through GXXX16 are shown below: </P>
          <GPOTABLE CDEF="s25,7,7,7" COLS="4" OPTS="L2,i1">
            <TTITLE>Table 4 </TTITLE>
            <BOXHD>
              <CHED H="1">Code </CHED>
              <CHED H="1">Physician <LI>work </LI>
              </CHED>
              <CHED H="1">Practice <LI>expense </LI>
              </CHED>
              <CHED H="1">Malpractice</CHED>
            </BOXHD>
            <ROW>
              <ENT I="01">GXXX5 </ENT>
              <ENT>12.92 </ENT>
              <ENT>8.70 </ENT>
              <ENT>0.60 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">GXXX6 </ENT>
              <ENT>5.19 </ENT>
              <ENT>3.49 </ENT>
              <ENT>0.24 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">GXXX7 </ENT>
              <ENT>3.39 </ENT>
              <ENT>2.29 </ENT>
              <ENT>0.16 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">GXXX8 </ENT>
              <ENT>9.91 </ENT>
              <ENT>4.86 </ENT>
              <ENT>0.43 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">GXXX9 </ENT>
              <ENT>3.55 </ENT>
              <ENT>1.74 </ENT>
              <ENT>0.15 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">GXX10 </ENT>
              <ENT>2.32 </ENT>
              <ENT>1.14 </ENT>
              <ENT>0.10 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">GXX11 </ENT>
              <ENT>8.47 </ENT>
              <ENT>4.54 </ENT>
              <ENT>0.35 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">GXX12 </ENT>
              <ENT>3.14 </ENT>
              <ENT>1.68 </ENT>
              <ENT>0.13 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">GXX13 </ENT>
              <ENT>2.05 </ENT>
              <ENT>1.10 </ENT>
              <ENT>0.08 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">GXX14 </ENT>
              <ENT>5.16 </ENT>
              <ENT>2.94 </ENT>
              <ENT>0.22 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">GXX15 </ENT>
              <ENT>1.94 </ENT>
              <ENT>1.10 </ENT>
              <ENT>0.08 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">GXX16 </ENT>
              <ENT>1.27 </ENT>
              <ENT>0.73 </ENT>
              <ENT>0.06 </ENT>
            </ROW>
          </GPOTABLE>
          <P>We believe that stratifying payment amounts by physician face-to-face involvement would be an improvement over the current method, but still may not be optimal to foster improved outcomes. </P>
          <P>Both the Institute of Medicine and Medicare Payment Advisory Commission (MedPAC) have advocated an increased role for CMS in encouraging improved quality outcomes. In their June 2003 Report to Congress (Variation and Innovation in Medicare), MedPAC recommended “the Secretary should conduct demonstrations to evaluate provider payment differentials and structures that reward and improve quality.” </P>

          <P>We responded to this call by increasing the focus of our Quality Improvement Organizations (formerly called Peer Review Organizations) and ESRD Networks on developing quality measures and also performing or assisting providers with the performance of quality improvement activities. We have also implemented initiatives to address the quality of care provided in various settings. These include: The Home Health Quality Initiative; the Hospital Quality Initiative; the Nursing Home Quality Initiative; the Home Health Quality Initiative and Doctors Office Quality Project (see <E T="03">http://cms.hhs.gov/quality/</E> for more information). </P>

          <P>Additionally, we have developed various demonstration projects that provide incentives to improve quality. For example, as part of an ongoing effort to achieve improved patient outcomes, we announced the ESRD Disease Management Demonstration in the <E T="04">Federal Register</E> on June 4, 2003. The goal of this demonstration is to achieve improved patient outcomes through disease management services and quality incentives. This demonstration does not directly involve renal physicians, but we are considering the use of quality incentives in potential future payment systems for them as well. Renal physicians play a central role in leading the interdisciplinary team charged with managing an ESRD patient's care. </P>
          <P>Thus, we are seeking comment on how to further revise our payment methodology to improve quality of care and outcomes. We are also interested in information that could help us design future demonstrations that would incorporate both dimensions of care (quality and utilization) and help ensure that payment is based on appropriate patient-specific care that has been shown to lead to improved outcomes for this complex patient population. </P>
          <HD SOURCE="HD3">6. Extracorporeal Shock Wave Lithotripsy for Musculoskeletal Conditions </HD>
          <P>We received several comments on the G codes for extracorporeal shock wave lithotripsy created in the December 31, 2002 final rule. We will be responding to those comments as part of this year's final rule, but we would appreciate any additional information on the physician work, practice expenses, and duration of treatment and intensity or energy of the shock waves applied for various conditions at various anatomic sites. </P>
          <HD SOURCE="HD3">7. Late RUC recommendations for 2003 CPT codes. </HD>
          <P>RUC recommendations for RVUs for approximately 20 new CPT codes for 2003 were received too late for incorporation in the December 31, 2002 final rule. We proposed interim RVUs for these codes and, as with all interim values, these were subject to comment. In their comments on the December 2002 final rule, the AMA-RUC requested that we consider their late recommendations for these codes. We will be addressing these, as well as other comments received on the interim RVUs in the upcoming final rule. </P>
          <HD SOURCE="HD1">III. Other Issues </HD>
          <HD SOURCE="HD2">A. Rebasing and Revising of the Medicare Economic Index </HD>
          <HD SOURCE="HD3">1. Background </HD>

          <P>The Medicare Economic Index (MEI) is required by section 1842(b)(3) of the Act, which states that prevailing charge levels beginning after June 30, 1973 may not exceed the level from the previous year except to the extent that the Secretary finds, on the basis of appropriate economic index data, that the higher level is justified by year-to-year economic changes. Beginning July 1, 1975, and continuing through today, the MEI has met this requirement by reflecting the weighted sum of the annual price changes of the inputs used <PRTPAGE P="49050"/>to produce physicians' services. As such, the MEI attempts to be an equitable measure of price changes associated with physician time and operating expenses. </P>

          <P>The current form of the MEI was detailed in the November 25, 1992 <E T="04">Federal Register</E> (57 FR 55896) and was based in part on the recommendations of a Congressionally-mandated meeting of experts held in March 1987. Since that time, the structure of the MEI has remained essentially unchanged, with two exceptions. First, the MEI was rebased in 1998 (63 FR 58845), which moved the cost structure of the index from 1992 data to 1996 data. Second, the methodology for the productivity adjustment was revised in 2002 (67 FR 80019) to reflect the percentage change in the 10-year moving average of economy-wide multifactor productivity. </P>
          <P>We are proposing to rebase and revise the MEI for the 2004 physician fee schedule update. The terms “rebasing” and “revising”, while often used interchangeably, actually denote different activities. Rebasing means moving the base year for the structure of costs of an input price index, while revising means changing data sources, cost categories, or price proxies used in the input price index. As is always the case with a rebasing and revising exercise, we have attempted to use the most recently available, relevant, and appropriate information to develop the MEI cost category weights and price proxies. We detail below the updated cost weights for the MEI expense categories, our rationale for selecting the price proxies in the MEI, and the results of the proposed rebasing and revising of the MEI. </P>
          <HD SOURCE="HD3">2. Use of More Current Data </HD>
          <P>The MEI was last rebased and revised in 1998 for the 1999 physician fee schedule update (63 FR 58845). The current base year for the MEI is 1996, which means that the cost weights in the index reflect physicians' expenses in 1996. However, we believe it is desirable to periodically rebase and revise the index so that the expense shares and proxies reflect more current conditions. For this reason, we propose to rebase the MEI to reflect physicians' expenses in 2000. In addition, we are proposing to revise the cost categories in the MEI and to change three of the proxies we currently use to ensure that the index is appropriately reflecting price changes. We will continue to adjust the MEI for economy-wide multifactor productivity. </P>
          <P>The expense categories in the proposed MEI were primarily derived from the 2003 AMA Physician Socioeconomic Characteristics publication (2003 Patient Care Physician Survey data), which measures physicians' earnings and overall practice expenses for 2000. The AMA data were used to determine expenditure weights for total expenses, physicians' earnings, and malpractice expenses, the only information detailed in this survey. To further disaggregate into subcategories reflecting more detailed expenses, we used data from previous AMA surveys, the 1997 Bureau of Economic Analysis Benchmark Input-Output table (I/O), the 2003 Bureau of Labor Statistics (BLS) Employment Cost Index (ECI), and the 2002 Bureau of the Census Current Population Survey (CPS). </P>
          <HD SOURCE="HD3">3. Rebasing and Revising Expense Categories in the MEI </HD>
          <HD SOURCE="HD3">a. Developing the Weights For Use in the MEI </HD>
          <P>Developing a rebased and revised MEI requires selecting a base year and determining the number and composition of expense categories. We are proposing to rebase the MEI to CY 2000. CY 2000 was chosen as the base year for two main reasons: (1) CY 2000 was the most recent year for which data were available from the AMA, and (2) we believed that the CY 2000 data were representative of the changing distribution of physicians' earnings and practice expenses over time. </P>

          <P>We determined the number and composition of expense categories based on the criteria used to develop the current MEI and other CMS input price index expenditure weights. These criteria are timeliness, reliability, relevance, and public availability. For more information on these criteria, see the May 9, 2002 <E T="04">Federal Register</E> (67 FR 31444) and the detail later in this preamble. Table 5 lists the set of mutually exclusive and exhaustive cost categories that make up the proposed rebased and revised MEI. </P>
          <GPOTABLE CDEF="s200,9.3,9.3,r100" COLS="4" OPTS="L2,i1">
            <TTITLE>Table 5.—Proposed Revised Medicare Economic Index Expenditure Categories, Weights, and Price Proxies </TTITLE>
            <BOXHD>
              <CHED H="1">Expense category </CHED>
              <CHED H="1">Proposed 2000—Expense weights <SU>1</SU>
                <SU>2</SU>
              </CHED>
              <CHED H="1">1996 Expense weights </CHED>
              <CHED H="1">Proposed price proxies </CHED>
            </BOXHD>
            <ROW>
              <ENT I="01">Total </ENT>
              <ENT>100.000 </ENT>
              <ENT>100.000 </ENT>
            </ROW>
            <ROW>
              <ENT I="03">Physician Earnings <SU>3</SU>
              </ENT>
              <ENT>52.466 </ENT>
              <ENT>54.460 </ENT>
            </ROW>
            <ROW>
              <ENT I="05">Wages and Salaries</ENT>
              <ENT>42.730 </ENT>
              <ENT>44.197 </ENT>
              <ENT>AHE—Private. </ENT>
            </ROW>
            <ROW>
              <ENT I="05">Benefits <SU>4</SU>
              </ENT>
              <ENT>9.735 </ENT>
              <ENT>10.263 </ENT>
              <ENT>ECI—Ben: Private. </ENT>
            </ROW>
            <ROW>
              <ENT I="03">Physician Practice Expenses</ENT>
              <ENT>47.534 </ENT>
              <ENT>45.540 </ENT>
            </ROW>
            <ROW>
              <ENT I="05">Nonphysician Employee Compensation </ENT>
              <ENT>18.654 </ENT>
              <ENT>16.812 </ENT>
            </ROW>
            <ROW>
              <ENT I="07">Employee Wages and Salaries</ENT>
              <ENT>13.809 </ENT>
              <ENT>12.424 </ENT>
            </ROW>
            <ROW>
              <ENT I="09">Prof/Tech Wages</ENT>
              <ENT>5.887 </ENT>
              <ENT>5.662 </ENT>
              <ENT>ECI-W/S: Private P&amp;T. </ENT>
            </ROW>
            <ROW>
              <ENT I="09">Managerial Wages</ENT>
              <ENT>3.333 </ENT>
              <ENT>2.410 </ENT>
              <ENT>ECI-W/S: Private Admin. </ENT>
            </ROW>
            <ROW>
              <ENT I="09">Clerical Wages</ENT>
              <ENT>3.892 </ENT>
              <ENT>3.830 </ENT>
              <ENT>ECI-W/S: Private Clerical. </ENT>
            </ROW>
            <ROW>
              <ENT I="09">Services Wages</ENT>
              <ENT>0.696 </ENT>
              <ENT>0.522 </ENT>
              <ENT>ECI-W/S: Private Service. </ENT>
            </ROW>
            <ROW>
              <ENT I="07">Employee Benefits <SU>4</SU>
              </ENT>
              <ENT>4.845 </ENT>
              <ENT>4.388 </ENT>
              <ENT>ECI-Ben: Priv. White Collar. </ENT>
            </ROW>
            <ROW>
              <ENT I="05">Office Expenses</ENT>
              <ENT>12.209 </ENT>
              <ENT>11.581 </ENT>
              <ENT>CPI(U)—Housing </ENT>
            </ROW>
            <ROW>
              <ENT I="05">Professional Liability Insurance</ENT>
              <ENT>3.865 </ENT>
              <ENT>3.152 </ENT>
              <ENT>CMS—Prof. Liab. Phys. Premiums. </ENT>
            </ROW>
            <ROW>
              <ENT I="05">Medical Equipment</ENT>
              <ENT>2.055 </ENT>
              <ENT>1.878 </ENT>
              <ENT>PPI—Medical Instruments &amp; Equip. </ENT>
            </ROW>
            <ROW>
              <ENT I="05">Pharmaceuticals and Medical Materials and Supplies</ENT>
              <ENT>4.320 </ENT>
              <ENT>4.516 </ENT>
            </ROW>
            <ROW>
              <ENT I="07">Medical Materials and Supplies</ENT>
              <ENT>2.011</ENT>
              <ENT/>
              <ENT>PPI Surg. Appliances and Supplies/CPI(U) Med Supplies. </ENT>
            </ROW>
            <ROW>
              <ENT I="07">Pharmaceuticals </ENT>
              <ENT>2.308</ENT>
              <ENT/>
              <ENT>PPI Ethical Prescription Preparations. </ENT>
            </ROW>
            <ROW>
              <ENT I="05">Other Professional Expenses</ENT>
              <ENT>6.433 </ENT>
              <ENT>7.601 </ENT>
              <ENT>CPI-U All Items Less Food and Energy. </ENT>
            </ROW>
            <TNOTE>

              <SU>1</SU> Due to rounding, weights may not sum to 100.000 percent. <PRTPAGE P="49051"/>
            </TNOTE>
            <TNOTE>
              <SU>2</SU> Sources: Physician Socioeconomic Statistics, 2000-2002 Edition (SMS Survey), Physician Socioeconomic Statistics, 2003 Edition (PCPS Survey), Center for Health Policy Research, American Medical Association; 2003 Employment Cost Index, U.S. Department of Labor, Bureau of Labor Statistics; U.S. Department of Commerce, Bureau of Economic Analysis 1997 Benchmark Input Output Tables, and U.S. Department of Commerce, Bureau of the Census, 2002 Current Population Survey. </TNOTE>
            <TNOTE>
              <SU>3</SU> Includes employee physician payroll. </TNOTE>
            <TNOTE>
              <SU>4</SU> Includes paid leave. </TNOTE>
          </GPOTABLE>
          <P>To determine the expenditure weights for the proposed rebased and revised MEI, we used currently available and statistically valid data sources on physician earnings and practice expenses. While we consulted numerous data sources, we used five data sources to determine proposed MEI expenditure weights: (1) The 2003 AMA Physician Socioeconomic Statistics (2000 survey data) for self-employed physicians, (2) the 2000-2002 AMA Physician Socioeconomic Statistics (1998 data) for self-employed physicians, (3) the March 2003 BLS Employment Cost Index, (4) the 2002 Bureau of the Census CPS, and (5) the Bureau of Economic Analysis (BEA) 1997 Benchmark Input-Output tables (I/O). No one data source provided all of the information needed to determine expenditure weights according to our criteria. The development of each of the cost categories using these sources is described in detail below. </P>
          <HD SOURCE="HD3">b. Physician Earnings </HD>
          <P>Like the current MEI, the proposed rebased and revised MEI will use AMA data on mean physician net income (physician earnings) for self-employed physicians to develop a weight for physician earnings. The weight for this expense category was based on AMA data for 2000 and was calculated as a percentage of total mean expenses (physician earnings and practice expenses, including malpractice). The physician earnings expenditure category also includes employee physician compensation. Currently, physician earnings and overhead expenses generated by employee physicians are included in the AMA practice expenses category. However, we believe it is appropriate, for our purposes, to place employee physician compensation in the MEI cost category of physician earnings since employee physician compensation represents actual expenditures made in the delivery of services. In addition, including employee physician payroll in physician earnings in the MEI is consistent with the current payment methodologies in accordance with the physician fee schedule, where the work RVU is computed based on what service is provided and not on who provides the service. Since employee physicians perform the same services as self-employed physicians, employee physician time is reflected in the work RVU. By including the compensation of employee physicians in the physician earnings expense category, these expenses will be adjusted by the appropriate price proxies for a physician's own time. </P>
          <P>To obtain further detail for both wages/salaries and benefits, the ratio between these categories for 1996 (based on current MEI) was updated to 2000 using the growth in the overall employment cost index for private employees for wages/salaries and benefits. Alternative data for determining this split were not readily available from any other source. The main shortcoming of this method is that any changes in quantity and intensity (mix of physicians) are not reflected. However, faced with the lack of alternative data, we deemed this approach to be the most feasible, and the results appear to be consistent with anecdotal evidence on this ratio. Its application resulted in a wage-fringe benefit split of 81.4 and 18.6 percent, respectively, in the proposed revised and rebased MEI compared with a wage-fringe benefit split of 81.2 and 18.8 percent, respectively in the 1996-based MEI. </P>
          <HD SOURCE="HD3">c. Physician Practice Expenses </HD>
          <P>To determine the remaining individual practice expense weights, we updated AMA expense data from 1998 to 2000 using the relative price change in an appropriate price index. After the levels were updated to 2000 values, it was necessary to normalize these levels to equal the 2000 mean total expense data provided by the 2003 AMA survey. The detailed explanations for the derivation of the individual weights are listed below. </P>
          <HD SOURCE="HD3">(i) Nonphysician Employee Compensation </HD>
          <P>The cost share for nonphysician employee compensation was developed by updating the 1998 AMA Socioeconomic Survey data on nonphysician employee compensation costs for self-employed physicians to 2000, using the current proxy for this category, and dividing the resulting amount into total expenses (physician earnings plus practice expenses) for 2000 from the AMA survey. We further divided this cost share into wages/salaries and benefits using BLS Employment Cost Index data. The ECI survey contains data on the proportion of total compensation accounted for by wages/salaries and benefits (including paid leave) by private industry health services occupational category. These proportions can be used to distribute the total non-physician employee compensation weight to wages/salaries and benefits for non-physician employees. We used 2000 data from the March 2003 publication. Although this survey does not contain data specifically for offices of physicians, data are available on wage/fringe shares for private industry health services, which include hospitals, nursing homes, offices of physicians, and offices of dentists. We believe the data for health services from the survey do provide a reasonable estimate of the split between wages and fringe benefits for employees in physicians' offices. Data for 2000 in the ECI survey for total health services indicate that wages and fringe benefits are 74.02 percent and 25.98 percent of compensation, respectively. </P>
          <P>As in the 1996-based MEI, we are proposing to use CPS data on earnings by occupation to develop cost shares for wages for nonphysician occupational groups shown in Table 6. To arrive at a distribution for these separate categories, we multiplied the overall share for nonphysician employee wages/salaries by each of the occupational proportions from the 2000 CPS. The proposed distribution and the distribution in the current MEI are presented in Table 6. </P>
          <GPOTABLE CDEF="s20,10,10" COLS="3" OPTS="L2,i1">
            <TTITLE>Table 6.—Percent Distribution of Nonphysician Payroll Expense by Occupational Group: 2000 and 1996 </TTITLE>
            <BOXHD>
              <CHED H="1">
                <E T="03">BLS Occupational Group</E>
              </CHED>
              <CHED H="1">
                <E T="03">2000</E>
                <LI>
                  <E T="03">Expenditure</E>
                </LI>
                <LI>
                  <E T="03">Shares</E>
                </LI>
              </CHED>
              <CHED H="1">
                <E T="03">1996</E>
                <LI>
                  <E T="03">Expenditure</E>
                </LI>
                <LI>
                  <E T="03">Shares</E>
                </LI>
              </CHED>
            </BOXHD>
            <ROW>
              <ENT I="01">Total</ENT>
              <ENT>100.000</ENT>
              <ENT>100.000 </ENT>
            </ROW>
            <ROW>
              <ENT I="02">Professional &amp; Technical Workers</ENT>
              <ENT>42.635</ENT>
              <ENT>45.573 </ENT>
            </ROW>
            <ROW>
              <ENT I="02">Managers</ENT>
              <ENT>24.138</ENT>
              <ENT>19.398 </ENT>
            </ROW>
            <ROW>
              <ENT I="02">Clerical Workers</ENT>
              <ENT>28.187</ENT>
              <ENT>30.827 </ENT>
            </ROW>
            <ROW>
              <ENT I="02">Service Workers</ENT>
              <ENT>5.040</ENT>
              <ENT>4.202 </ENT>
            </ROW>
            <TNOTE>Note: Values may not sum to 100 due to rounding. </TNOTE>
          </GPOTABLE>
          <PRTPAGE P="49052"/>
          <HD SOURCE="HD3">(ii) Professional Liability Expense </HD>
          <P>The weight for professional liability expense was derived from the 2003 AMA survey (2000 data) and was calculated as the mean professional liability expense expressed as a percentage of total expenses (physician earnings plus practice expenses). This calculation resulted in a 3.865 percent share of total costs in 2000 compared to a 3.152 percent share in the 1996-based index. The increase in weight for professional liability insurance represents the increases in premiums and increases in the amount of coverage purchased by physicians in 2000 compared to 1996. Since the data do not reflect any changes caused by increases in these expenses in 2001 and 2002, they do not take into account the recent acceleration in the growth in premiums that physicians have experienced and, therefore, the weights will not reflect these changes. However, the proxy that we currently use in the 1996-based index—and will continue to use in the proposed rebased and revised index—does reflect the price increases associated with the recent rise in malpractice costs. </P>
          <HD SOURCE="HD3">(iii) Office, Medical Equipment, Pharmaceuticals and Medical Materials and Supplies Expenses, and All Other Expenses </HD>
          <P>The 2003 AMA survey provides less detail for expenses with respect to prior years' publications. Therefore, we calculated the share of each of the above categories by updating the AMA data for 1998 to 2000 using an appropriate price proxy. The primary reason for using the price proxy was that we lacked other data to develop cost weights for each of these categories. As stated previously, the main deficiency of this method is that it does not account for any changes in the quantity or intensity effects associated with these expenses. Our belief, however, was that it was important to continue using these detailed breakouts so that each would be proxied by an appropriate price index and that the quantity/intensity effects over a short period of time are not likely to be large. In fact, we have found that even over longer periods of time, the distribution of costs tends to be relatively similar. </P>
          <P>Office expenses and medical equipment levels were moved to 2000 using the growth from 1998 to 2000 in their respective MEI price proxies. In the case of office expenses, we used the growth in the CPI-U Housing; for medical equipment expenses, we used the growth in the PPI for Medical Instruments and Equipment. </P>
          <P>The share for pharmaceuticals (prescription drugs) and medical materials and supplies was calculated by separating out pharmaceuticals and other medical materials and supplies using 1997 BEA Benchmark Input-Output data. First, the sum of all the pharmaceuticals and medical supplies categories from the Benchmark Input-Output tables for 1997 was calculated. The share of pharmaceuticals and medical supplies was then calculated as a percentage of this total and applied to the 1997 AMA medical supplies data. These calculated levels were then inflated to 2000 using the growth in an appropriate price proxy. We thought it was important and appropriate to account for each of these categories separately so that differences in relative price growth between pharmaceuticals (prescription drugs) and other medical materials and supplies would be more accurately represented. The resulting 2000 data for the two separate categories were then aggregated (summed) together to form the overall total for the share for the pharmaceuticals and medical materials and supplies category in the rebased and revised MEI. The pharmaceuticals category was inflated using the Producer Price Index (PPI) for ethical prescription preparations and the medical materials and supplies category was updated using the PPI for surgical appliances and supplies. </P>
          <P>Finally, the All Other Expense category was calculated as a residual (total expenses less the percentage of all categories currently accounted for). The additional detail for transportation expenses found in the prior MEI was removed because the data were not readily available for measurement of a cost share for 2000. The effect on the MEI of removing the detail is negligible. </P>
          <HD SOURCE="HD3">4. Selection of Price Proxies for Use in the MEI </HD>
          <P>After the 2000 cost weights for the rebased and revised MEI were developed, we reviewed the current set of price proxies to determine whether they were still the most appropriate for each expenditure category. As was the case in the development of the 1996-based MEI (57 FR 55901), most of the indicators we considered are based on BLS data and are grouped into one of the following five categories: </P>
          <HD SOURCE="HD1">Producer Price Indices (PPIs) </HD>
          <P>PPIs measure price changes for goods sold in other than retail markets. They are the preferred proxies for physician purchases at the wholesale level. These fixed-weight indices are a measure of price change at the producer or at the intermediate stage of production, a more likely mode of purchase for physicians. </P>
          <HD SOURCE="HD1">Consumer Price Indices (CPIs) </HD>
          <P>CPIs measure change in the prices of final goods and services purchased by consumers. Like the PPIs, they are fixed-weight. Since they may not represent the price changes faced by producers, CPIs were used if there were no appropriate PPI or if the expenditure category was similar to expenditure of retail consumers in general. </P>
          <HD SOURCE="HD1">Average Hourly Earnings (AHEs) </HD>
          <P>AHEs are available for production and nonsupervisory workers for specific industries as well as for the nonfarm business economy. They are calculated by dividing gross payrolls for wages/salaries by total hours. The series reflects shifts in employment mix and, thus, is representative of actual changes in hourly earnings for industries or for the nonfarm business economy. </P>
          <HD SOURCE="HD1">ECIs for Wages/Salaries </HD>
          <P>These ECIs measure the rate of change in employee wage rates per hour worked. These fixed-weight indices are not affected by shifts in industry or occupation employment levels and measure only the pure rate of change in wages. </P>
          <HD SOURCE="HD1">ECIs for Employee Benefits </HD>
          <P>These ECIs measure the rate of change in employer costs of employee benefits, such as the employer's share of Social Security taxes, pension and other retirement plans, insurance benefits (life, health, disability, and accident), and paid leave. Like ECIs for wages/salaries, the ECIs for employee benefits are not affected by changes in industry output or occupational shifts. </P>
          <P>When choosing wage and price proxies for each expense category, we evaluate the strengths and weaknesses of each proxy variable using four criteria. The first criterion is relevance. The price variable should appropriately represent price changes for specific goods or services within the expense category. Relevance may encompass judgments about relative efficiency of the market generating the price and wage increases. </P>

          <P>The second criterion is reliability or low sampling variability. If the proxy wage-price variable has a high sampling variability or inexplicable erratic patterns over time, its value is greatly diminished, since it is unlikely to accurately reflect price changes in its associated expenditure category. Low sampling variability can conflict with relevance, since the more specifically a price variable is defined in terms of <PRTPAGE P="49053"/>service, commodity, or geographic area, the higher the possibility of sampling variability. The length of time the time-series data have been published is also important. A well-established time series is needed to assess the reasonableness of the series and to provide a solid base from which to forecast future price changes in the series. We need to forecast the MEI to make Federal budget and Trustees Report estimates. </P>
          <P>The third criterion is timeliness of actual published data. For this reason, we prefer monthly and quarterly data to annual data. </P>
          <P>The fourth criterion is public availability. We prefer to use data sources that are publicly available for our indices so that the public may track each of the individual components in the MEI. </P>
          <P>The BLS price proxy categories previously described meet the criteria of relevance, reliability and timeliness, and public availability. Below we discuss the price-wage proxies for the rebased and revised MEI (shown in Table 1). </P>
          <HD SOURCE="HD3">(a) Expense Categories in the MEI </HD>
          <HD SOURCE="HD1">Physician Time </HD>
          <P>In the proposed revised and rebased MEI, we are using the AHE for the private nonfarm economy as the proxy for the physician wages/salaries component; this is the same price measure used in the 1996-based MEI. In our judgment, this proxy still most closely comports with Congressional intent as expressed in the Senate Finance Committee's 1972 report (S. Rept. No. 92-1230 at 191 (1972)). AHEs change in accordance with changes in the type and mix of workers. </P>
          <P>As we discussed extensively in the November 2, 1998 final rule (63 FR 58848) and again in the December 31, 2002 final rule (67 FR 80019), we believe that the current price proxy for physicians' earnings—AHE in the nonfarm business economy—is the most appropriate proxy to use in the MEI. The AHE for the nonfarm business economy reflects the impacts of supply, demand, and economy-wide productivity for the average worker in the economy. Using this measure as the proxy for physicians' earnings captures the parity in the rate of change in wages for the average worker and for physicians. In addition, use of this proxy is consistent with the original legislative intent that the change in the physicians' earnings portion of the MEI parallel the change in general earnings for the economy. Since earnings are expressed per hour, a constant quantity of labor input per unit of time is reflected. The use of the AHE data is also consistent with our using the BLS economy-wide multifactor productivity measures since economy-wide wage increases reflect economy-wide productivity increases. </P>
          <P>Using the ECI for professional and technical workers or other occupational-specific wage proxies has a major shortcoming; in many instances, occupations such as engineering, computer science, and nursing have unique characteristics that are not representative of the overall economy or the physician market. Specifically, wage changes for such occupations can be influenced by excess supply or demand for these types of workers. We believe it would not be appropriate to proxy the physician earnings portion of the MEI with a wage proxy that reflects these other occupation's unique characteristics. </P>
          <P>The current MEI uses the ECI for fringe benefits for total private industry as the price proxy for physician fringe benefits. We are proposing to use the same proxy for the 2000-based MEI. This means that both the wage and fringe benefit proxies for physician earnings are derived from the nonfarm private sector and are computed on a per-hour basis. </P>
          <HD SOURCE="HD1">Nonphysician Employee Compensation </HD>
          <P>As in the 1996-based MEI, we are proposing to use Current Population Survey data on earnings and employment by occupation to develop labor cost shares for the nonphysician occupational groups shown in Table 6. BLS maintains an ECI for each occupational group, and we propose to use these ECIs as price proxies for nonphysician employee wages in the same manner they are used in the current MEI. </P>
          <P>The skill mix shift in employees of physician offices in the last few years has been towards managerial occupations. While these skill mix shifts are captured in the expenditure weights, they are appropriately held constant in a Laspeyres price index such as the MEI. Skill mix shifts, which may reflect the changing intensity of services provided in physicians' offices, are accounted for in the payment system outside of the MEI. </P>
          <P>The current MEI uses the ECI for fringe benefits for white collar employees in the private sector as a proxy for nonphysician benefits. Since most nonphysician employees in physicians' offices are white-collar employees, we are again proposing to use the ECI for benefits for white collar employees in the proposed rebased and revised MEI. </P>
          <HD SOURCE="HD1">Office Expense </HD>
          <P>Office expenses include rent or mortgage for office space, furnishings, insurance, utilities, and telephone. We are proposing the continued use of the CPI-U for housing because it is a comprehensive measure of the cost of housing, including rent, owner's equivalent rent, and the types of goods and services associated with running an office. This proxy covers about 80 percent of the population. </P>
          <HD SOURCE="HD1">Pharmaceuticals and Medical Materials and Supplies </HD>
          <P>This cost category includes drugs, outside laboratory work, x-ray films, and other related services. There is not one price proxy that includes this complete mix of materials and supplies. In the absence of one index, we are proposing to separately account for pharmaceuticals and medical materials and supplies in the 2000-based MEI. </P>
          <P>• Medical Materials and Supplies </P>
          <P>We equally weighted two proxies together (the PPI Surgical Appliances and Supplies and the CPI-U for Medical Equipment and Supplies) since one proxy does not accurately measure the price change associated with these types of products used nor the mode of purchase used in physicians' offices. While both indexes include such items as bandages, dressings, catheters, I.V. equipment, syringes, and other general disposable medical supplies and nonprescription equipment, the indexes reflect significant differences in the mode of purchase. The PPI measures actual transaction prices at the wholesale level, the mode most likely used by physicians, while the CPI measures prices at the retail level or the final stage of production. The price movements in these two indexes can be different and we believe that it is appropriate to combine these indexes into one proxy since physicians likely use both purchasing methods when obtaining medical supplies. </P>
          <P>• Pharmaceuticals </P>

          <P>The PPI for ethical prescription drugs is used to proxy pharmaceutical prices in other CMS market baskets and reflects the price change associated with the average mix of pharmaceuticals purchased economy-wide. We propose to use the PPI for ethical prescription drugs, rather than the CPI for prescription drugs, because physicians generally purchase drugs directly from a wholesaler. The PPIs that we use measure price changes at the final stage of production. <PRTPAGE P="49054"/>
          </P>
          <HD SOURCE="HD1">Professional Liability Insurance </HD>
          <P>It is vital that the MEI accurately reflect the price changes associated with professional liability costs. Accordingly, we continue to incorporate into the MEI a price proxy that accomplishes this goal by making the maximum use of available data on professional liability premiums. </P>
          <P>Each year, we solicit professional liability premium data for physicians from a small sample of commercial carriers. This information is not collected through a survey form, but instead is requested, on a voluntary basis, from a few national commercial carriers via letter. Generally between 5 and 8 carriers volunteer this information. While the sample size certainly does not cover the entire professional liability insurance market, we have attempted to maximize the market share in terms of both national coverage and coverage within States. </P>

          <P>As we require for our other price proxies, the professional liability price proxy should reflect the pure price change associated with this particular cost category. Thus, it should not capture changes in the mix or level of liability coverage. To accomplish this result, we obtain premium information from commercial carriers for a fixed level of coverage, currently $1 million per occurrence and a $3 million annual limit. This information is collected for every State by physician specialty and risk class. Finally, the State-level, physician-specialty data are aggregated by effective premium date to compute a national total, using counts of physicians by State and specialty as provided in the AMA publication, <E T="03">Physician Characteristics and Distribution in the U.S.</E>
          </P>
          <P>The resulting data provide a quarterly time series, indexed to a base year consistent with the MEI and reflect the national trend in the average professional liability premium for a given level of coverage. From this series, quarterly and annual percent changes in professional liability insurance are estimated for inclusion in the MEI. </P>
          <P>The most comprehensive data on professional liability costs are held by the State insurance commissioners but these data are available only with a substantial time lag and, therefore, the data currently incorporated into the MEI are much more timely. We believe that, given the limited data available on professional liability premiums, this methodology adequately reflects the price trends facing physicians. </P>
          <HD SOURCE="HD1">Medical Equipment </HD>
          <P>Medical equipment includes depreciation, leases, and rent on medical equipment. We propose to use the PPI for medical instruments and equipment as the price proxy for this category, consistent with the price proxy used in the 1996-based MEI and other CMS input price indexes. </P>
          <HD SOURCE="HD1">Other Professional Expenses </HD>
          <P>This category includes the residual subcategory of other professional expenses such as accounting services, legal services, office management services, continuing education, professional association memberships, journals, professional car expenses, and other professional expenses. In the absence of one price proxy or even a group of price proxies that might reflect this heterogeneous mix of goods and services, we use the CPI-U for all items, less food and energy, consistent with the price proxy used in the 1996-based MEI. We also propose to condense the structure used in the previous 1996-based MEI because we lack the data to develop a representative weight for transportation, as discussed above. This change would result in only a negligible effect on the overall MEI over the past 8 years; the average increase differs by less than a tenth of a percentage point over that time. </P>
          <HD SOURCE="HD3">(b) Productivity Adjustment to the MEI </HD>
          <P>In the December 2002 final rule, we indicated that we were changing the methodology for adjusting for productivity in the MEI. The MEI used for the 2003 physician payment update reflected changes in the 10-year moving average of private nonfarm business (economy-wide) multifactor productivity applied to the entire index; we had previously used economy-wide private nonfarm business labor productivity applied to the labor portions of the index. We will continue to use the method of adjusting for multifactor productivity applied to the entire index in the proposed rebased and revised MEI. </P>
          <P>As described in the December 31, 2002 final rule, we used multifactor productivity because: (1) it is theoretically more appropriate to explicitly reflect the productivity gains associated with all inputs (both labor and nonlabor); (2) the recent growth rate in economy-wide multifactor productivity appears to be more consistent with the current market conditions facing physicians; and (3) the MEI still uses economy-wide wage changes as a proxy for physician wage changes. We believe that using a 10-year moving average change in economy-wide multifactor productivity produces a stable and predictable adjustment and is consistent with the moving-average methodology used in the current 1996-based MEI. The adjustment will be based on the latest available actual historical economy-wide multifactor productivity data, as measured by BLS. </P>
          <HD SOURCE="HD3">5. Results of Rebasing </HD>
          <P>Updating the MEI from a 1996 base year to a 2000 base year resulted in small changes in expense category weights. Physicians' earnings dropped slightly, from 54.5 percent of the index in 1996 to 52.5 percent in 2000. The expense shares for non-physician employee compensation, office expenses, professional liability insurance, and medical equipment all rose slightly, while expense shares for medical materials and supplies and all other expenses declined. </P>
          <P>The rebased and revised MEI is similar in structure to the current MEI. Except for two-tenths of a percentage point difference in 2000, the annual percent change in the rebased and revised MEI was within one-tenth of a percentage point of the percent change in the 1996-based MEI each year between 1996 and 2003. Therefore, the revision and rebasing proposed in this rule, while making the expense shares more timely, has little impact on the percent changes in the MEI as a whole. Table 7 below shows the average calendar-year percent change from 1996 to 2003 for both the 1996- and 2000-based MEIs. </P>
          <GPOTABLE CDEF="s100,12,12" COLS="3" OPTS="L2,i1">
            <TTITLE>Table 7.—Annual Percent Change in the Current and Proposed Revised and Rebased Medicare Economic Index </TTITLE>
            <BOXHD>
              <CHED H="1">Update year (A) </CHED>
              <CHED H="1">Proposed <LI>2000-based </LI>
                <LI>MEI </LI>
              </CHED>
              <CHED H="1">Current <LI>1996-based </LI>
                <LI>MEI </LI>
              </CHED>
            </BOXHD>
            <ROW>
              <ENT I="01">1996 </ENT>
              <ENT>1.7 </ENT>
              <ENT>1.8 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">1997 </ENT>
              <ENT>1.9 </ENT>
              <ENT>1.9 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49055"/>
              <ENT I="01">1998 </ENT>
              <ENT>2.4 </ENT>
              <ENT>2.4 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">1999 </ENT>
              <ENT>2.7 </ENT>
              <ENT>2.6 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">2000 </ENT>
              <ENT>2.9 </ENT>
              <ENT>2.7 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">2001 </ENT>
              <ENT>2.8 </ENT>
              <ENT>2.8 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">2002 </ENT>
              <ENT>3.3 </ENT>
              <ENT>3.3 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">2003 </ENT>
              <ENT>3.1 </ENT>
              <ENT>3.0 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Avg Change 1996-2003 </ENT>
              <ENT>2.6 </ENT>
              <ENT>2.6 </ENT>
            </ROW>
            <TNOTE>(A) Update year based on historical data through the second quarter of the prior calendar year. For example, the 2003 update is based on historical data through the second quarter 2002. </TNOTE>
          </GPOTABLE>
          <P>The forecast of the proposed rebased and revised MEI for the 2004 Physician Fee Schedule is an increase of 2.5 percent, nearly identical to the forecasted increase using the previous 1996-based MEI. In the final rule we will incorporate historical data through the second quarter of 2003; therefore, the current estimated increase of 2.5 percent for 2004 may differ in the final rule. </P>
          
          <BILCOD>BILLING CODE 4120-01-P</BILCOD>
          
          <GPH DEEP="561" SPAN="3">
            <PRTPAGE P="49056"/>
            <GID>EP15AU03.008</GID>
          </GPH>
          <GPH DEEP="522" SPAN="3">
            <PRTPAGE P="49057"/>
            <GID>EP15AU03.009</GID>
          </GPH>
          
          <BILCOD>BILLING CODE 4120-01-C</BILCOD>
          
          <PRTPAGE P="49058"/>
          <HD SOURCE="HD3">6. Adjustments to RVUs To Match the New MEI Weights </HD>
          <P>As described in the previous section, we are proposing to rebase the MEI and establish new weights for physician work, practice expense and malpractice. Based on 2002 Medicare utilization data, we compared the proportion of total RVUs attributable to physician work, practice expense and malpractice to the new MEI weights. We show the proportion of total RVUs attributable to work, practice expense and malpractice and their respective proposed new MEI weights across all physicians' services in the following table: </P>
          <GPOTABLE CDEF="s100,8,8" COLS="3" OPTS="L2,i1">
            <TTITLE>Table 10 </TTITLE>
            <BOXHD>
              <CHED H="1">  </CHED>
              <CHED H="1">Proposed MEI weight </CHED>
              <CHED H="1">2002 RVUs </CHED>
            </BOXHD>
            <ROW>
              <ENT I="01">Physician Work </ENT>
              <ENT>52.466% </ENT>
              <ENT>52.649% </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Practice Expense </ENT>
              <ENT>43.669% </ENT>
              <ENT>44.175% </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Malpractice </ENT>
              <ENT>3.865% </ENT>
              <ENT>3.176% </ENT>
            </ROW>
          </GPOTABLE>
          <P>The MEI weights for physician work and practice expense are lower than the proportion of 2002 aggregate RVUS attributable to these categories. The malpractice weight within the MEI is higher than its share of total aggregate 2002 RVUs. (The 2002 shares from the Medicare utilization do not match the 1996 MEI weights because deviations occur over time based on changes in the mix of services billed by physicians and other factors). </P>
          <P>We believe there is merit in adjusting the RVUs to match the revised MEI weights. By giving more weight to malpractice and less weight to physician work and practice expenses, Medicare's payments will better reflect each component of physician practice expenses. Section 1848(c)(2)(B)(ii)(II) of the Act requires that increases or decreases in RVUs may not cause the amount of expenditures for the year to differ by more than $20 million from what expenditures would have been in the absence of these changes. If this threshold is exceeded, we make across-the-board adjustments to preserve budget neutrality. Therefore, if we adjust the work, practice expense and malpractice RVUs to match the new MEI weights, we are required by statute to ensure that the adjustments do not increase or decrease Medicare expenditures by more than $20 million. To meet the requirements of the statute and ensure that aggregate pools of RVUs match the proposed new MEI weights, we considered two options. We considered making no adjustments to the physician work RVUs and adjusting only the practice expense and malpractice RVUs or adjusting all 3 categories of RVUs. We considered the first option because the medical community, in the past, has expressed interest in avoiding adjustments to physician work RVUs. However, we could only meet the requirements of section 1848(c)(2)(B)(ii)(II) if we reduced the physician fee schedule conversion factor by an additional 0.3 percentage points in addition to the −4.2 percent reduction we are already forecasting. We believe a small reduction to the physician work RVUs is preferable to a reducing the conversion factor by an additional 0.3 percent. For this reason, we are proposing to reduce the physician work RVUs by 0.35 percent (0.9965) and the practice expense RVUs by 1.15 percent (0.9885) and increase the malpractice RVUs by 21.7 percent (1.217) to match the rebased MEI weights. The effects of these adjustments to the RVUs are included in the RVUs shown in Addendum B of this proposed rule and, as explained previously, would not require a compensating adjustment to the conversion factor. </P>
          <HD SOURCE="HD2">B. Definition of Diabetes for Diabetes Self-Management Training </HD>
          <P>Section 4105(a) of the Balanced Budget Act of 1997 (BBA) (Pub. L. 105-33, enacted on August 5, 1997) provides coverage for outpatient diabetes self-management training in outpatient settings without limiting this coverage to hospital outpatient departments. The BBA provided that the services would be provided “to an individual with diabetes.” In the December 29, 2000, final rule entitled, “Expanded Coverage for Outpatient Diabetes Self-Management Training and Diabetes Outcome Measurements”, (65 FR 83129) we established criteria to define “an individual with diabetes.” At that time, we did not have a definition of diabetes that had been widely accepted. Therefore, we established a set of medical conditions to determine who should receive the service. </P>
          <P>In § 410.141(d), we stated that any beneficiary who has one or more of the following medical conditions occurring within the 12-month period before the physician's order for the training would be eligible for Medicare coverage for training from an approved entity: </P>
          <P>• New onset diabetes. </P>
          <P>• Inadequate glycemic control as evidenced by a glycosylated hemoglobin (HbA1C) level of 8.5 percent or more on two consecutive HbA1C determinations 3 or more months apart in the year before the beneficiary begins receiving training. </P>
          <P>• A change in treatment regimen from no diabetes medications to any diabetes medication, or from oral diabetes medication to insulin. </P>
          <P>• High risk for complications based on inadequate glycemic control (documented acute episodes of severe hyperglycemia or acute severe hyperglycemia occurring in the past year during which the beneficiary needed emergency room visits or hospitalization). </P>
          <P>• High risk based on at least one of the following documented complications:</P>
          
          <FP SOURCE="FP-1">—Lack of feeling in the foot or other foot complications such as foot ulcers, deformities, or amputation; </FP>
          <FP SOURCE="FP-1">—Pre-proliferative or proliferative retinopathy or prior laser treatment of the eye; and </FP>
          <FP SOURCE="FP-1">—Kidney complications related to diabetes, when manifested by albuminuria, without other cause, or elevated creatinine. </FP>
          
          <P>These requirements have been shown to be burdensome to the public and to Medicare contractors. Therefore, we are proposing that the requirements be streamlined to use the definition of diabetes that was established in a later regulation at § 410.130 and is used to determine beneficiary eligibility for Medical Nutrition Therapy when the beneficiary has a diagnosis of diabetes. The definition is: </P>
          <P>
            <E T="03">Diabetes</E> means diabetes mellitus consisting of two types. Type 1 is an autoimmune disease that destroys the beta cells of the pancreas, leading to insulin deficiency. Type 2 is familial hyperglycemia that occurs primarily in adults but can also occur in children <PRTPAGE P="49059"/>and adolescents. It is caused by an insulin resistance whose etiology is multiple and not totally understood. Gestational diabetes is any degree of glucose intolerance with onset or first recognition during pregnancy. The diagnostic criterion for a diagnosis of diabetes for a fasting glucose intolerance test is greater than or equal to 126 mg/dL. </P>
          <HD SOURCE="HD2">C. Outpatient Therapy Services Performed “Incident To” Physicians' Services—Discussion Only </HD>
          <P>In almost all settings, our policy provides that outpatient therapy services can be delivered only by physical therapists, occupational therapists, physical therapy assistants, occupational therapy assistants, and speech and language pathologists as defined by our regulations at § 484.4. While there are currently no national standards for qualifications of individuals providing outpatient therapy services incident to physicians' services, we believe that standards similar to those in § 484.4 are appropriate. Section 1862(a)(20) of the Act requires that any therapy services furnished incident to a physician's professional services must meet the standards and conditions that would apply to such therapy services if they were furnished by a therapist, with the exception of the licensing requirement. </P>

          <P>The OIG conducted a study in March of 1994 (OEI-02-09-00590) which revealed that 78 percent of “incident to” physical therapy services did represent therapy services covered under Medicare (that is, reasonable and necessary as defined in section 1862(a)(1)(A) of the Act). The study also questioned the training of staff providing these services. Also, in 2002 we contracted for a report on the utilization of therapy services. The text of that report is available at <E T="03">www.cms.hhs.gov/medlearn/therapy</E> under Research Tools for Specific Therapy Topics, DynCorp Report—Outpatient Therapy Utilization September 2002. The study found that 25 percent of the beneficiaries in 2000 were treated in the offices of physicians and nonphysician practitioners. There is currently no process to ensure the quality of the services provided in those settings. </P>
          <P>The pending implementation of financial limitations on outpatient therapy services emphasizes the need to define the qualifications of those providing therapy services. The limited therapy services covered by Medicare must be provided by people who meet qualifications needed to render skilled services. </P>
          <P>In order to conform to section 1862(a)(20) of the Act, we are considering adopting the existing qualification and training standards (with the exception of licensure) in § 484.4 for individuals providing therapy services independently and incident to physicians' services. We are not proposing a change at this time, but are interested in receiving comments from the public, particularly physicians and staff who would be affected, on adoption of the existing standards in § 484.4, to services of independent therapists and “incident to” services as well as alternatives that we might use to ensure that qualified staff are providing “incident to” therapy services. These comments would assist us in the development of any future proposal concerning this issue. </P>
          <HD SOURCE="HD2">D. Status of Anesthesia Work and Five-Year Review </HD>
          <P>In the December 2002 final rule, we modestly increased the work of anesthesia services. These changes were based on the analysis submitted by the RUC of its review of the work of 19 high-volume anesthesia codes. The RUC had provided us with its analysis but did not furnish us with a definitive recommendation. The increase in anesthesia work resulted in an increase in the national anesthesia conversion factor. (We increased the physician work component of the anesthesia conversion factor by 2.10 percent to reflect a 9.13 percent increase in anesthesia work applied to 23 percent of anesthesia allowed charges represented by the 19 codes. We applied a 1.6 percent increase to the anesthesia CF.) </P>
          <P>The American Society of Anesthesiologists expressed concerns about the completeness of the review of anesthesia under the five-year review, and, in February 2003, we asked the RUC to continue its review of anesthesia work values; we expected to develop a final recommendation for a change in the anesthesia CF involving all anesthesia codes. We asked that the RUC complete this analysis in 2003. The RUC is considering our request and will respond to us about what action they plan to take on this issue. </P>
          <HD SOURCE="HD2">E. Payment Policies for Anesthesia Services </HD>
          <P>Currently there are different payment policies for teaching anesthesiologists and teaching certified registered nurse anesthetists (CRNAs). We are seeking comments on the appropriateness of applying the CRNA teaching/resident policy to teaching anesthesiologists. </P>
          <HD SOURCE="HD2">F. Technical Correction </HD>
          <P>CPT Code 96155 (Health and behavior intervention, each 15 minutes, face-to-face; family (without the patient present)). </P>
          <P>This code describes a visit with a patient's family without the patient being present and was first included in the November 1, 2001 final rule. It was incorrectly listed as an active code for which payment could be made under the physician fee schedule. Our longstanding payment policy is that we do not pay for visits with family where the patient is not present. Payment for such visits is included in the pre- and post-service work of a visit where the patient is present. Consistent with this policy, this code is non-payable under the physician fee schedule. </P>
          <HD SOURCE="HD1">IV. Collection of Information Requirements </HD>
          <P>This document does not impose information collection and recordkeeping requirements. Consequently, it need not be reviewed by the Office of Management and Budget under the authority of the Paperwork Reduction Act of 1995. </P>
          <HD SOURCE="HD1">V. Response to Comments </HD>

          <P>Because of the large number of items of correspondence we normally receive on <E T="04">Federal Register</E> documents published for comment, we are not able to acknowledge or respond to them individually. We will consider all comments we receive by the date and time specified in the “DATES” section of this preamble, and, if we proceed with a subsequent document, we will respond to the major comments in the preamble to that document. </P>
          <HD SOURCE="HD1">VI. Regulatory Impact Analysis </HD>
          <P>We have examined the impact of this rule as required by Executive Order 12866 (September 1993, Regulatory Planning and Review), the Regulatory Flexibility Act (RFA) (September 16, 1980 Pub. L. 96-354), section 1102(b) of the Social Security Act, the Unfunded Mandates Reform Act of 1995 (Pub. L. 104-4), and Executive Order 13132. </P>

          <P>Executive Order 12866 directs agencies to assess all costs and benefits of available regulatory alternatives and, when regulation is necessary, to select regulatory approaches that maximize net benefits (including potential economic, environmental, public health and safety effects, distributive impacts, and equity). A regulatory impact analysis must be prepared for proposed rules with economically significant effects (that is, a proposed rule that would have an annual effect on the economy of $100 million or more in any <PRTPAGE P="49060"/>1 year, or would adversely affect in a material way the economy, a sector of the economy, productivity, competition, jobs, the environment, public health or safety, or State, local, or tribal governments or communities). We have simulated the effect of the proposed changes to the practice expense RVUs described earlier. The net effect of the changes we are proposing will not materially increase or decrease Medicare expenditures for physicians' services because the statute requires that changes to RVUs cannot increase or decrease expenditures more than $20 million. Since increases in payments resulting from RVU changes must be offset by decreases in payments for other services, the proposed practice expense changes will result in a redistribution of payments among physician specialties. The RVU changes in this proposed rule have an estimated aggregate redistributive effect of approximately $190 million dollars. (Tables 11 and 12 which appear later in this section reflect the estimated specialty impacts.) Therefore, we are considering this proposed rule to be a major rule because it is economically significant, and, thus, we have prepared a regulatory impact analysis. </P>
          <P>The RFA requires that we analyze regulatory options for small businesses and other entities. We prepare a Regulatory Flexibility Analysis unless we certify that a rule would not have a significant economic impact on a substantial number of small entities. The analysis must include a justification concerning the reason action is being taken, the kinds and number of small entities the rule affects, and an explanation of any meaningful options that achieve the objectives and less significant adverse economic impact on the small entities. </P>
          <P>Section 1102(b) of the Act requires us to prepare a regulatory impact analysis for any proposed rule that may have a significant impact on the operations of a substantial number of small rural hospitals. This analysis must conform to the provisions of section 603 of the RFA. For purposes of section 1102(b) of the Act, we define a small rural hospital as a hospital that is located outside a Metropolitan Statistical Area and has fewer than 100 beds. </P>
          <P>For purposes of the RFA, physicians, nonphysicians, and suppliers are considered small businesses if they generate revenues of $6 million or less. Approximately 95 percent of physicians (except mental health specialists) are considered to be small entities. There are about 700,000 physicians, other practitioners and medical suppliers that receive Medicare payment under the physician fee schedule. The analysis and discussion provided in this section as well as elsewhere in this proposed rule is intended to comply with the RFA requirements. </P>
          <P>Section 202 of the Unfunded Mandates Reform Act of 1995 also requires that agencies assess anticipated costs and benefits before issuing any rule that may result in expenditure in any 1 year by State, local, or tribal governments, in the aggregate, or by the private sector, of $110 million. This proposed rule would not impose unfunded mandates on State, local, or tribal governments, or on the private sector of more than $110 million dollars. </P>
          <P>We have examined this proposed rule in accordance with Executive Order 13132 and have determined that this regulation would not have any significant impact on the rights, roles, or responsibilities of State, local, or tribal governments. </P>
          <P>We have prepared the following analysis, which together with the rest of this preamble, meets all assessment requirements. It explains the rationale for, and purposes of, the rule, details the costs and benefits of the rule, analyzes alternatives, and presents the measures we propose to use to minimize the burden on small entities. As indicated elsewhere in this proposed rule, we propose to make changes to the Medicare Economic Index, refine resource-based practice based practice expense RVUs and make a variety of other minor changes to our regulations, payments or payment policy to ensure that our payment systems are updated to reflect changes in medical practice and the relative value of services. We provide information for each of the proposed policy changes in the relevant sections in this proposed rule. As discussed elsewhere in this proposed rule, the provisions of this proposed rule, if adopted, would only change Medicare payment rates for physician fee schedule services. While this rule would revise the definition of diabetes for the purposes of outpatient diabetes self-management training, it does not impose reporting, record-keeping and other compliance requirements. We are unaware of any relevant Federal rules that duplicate, overlap or conflict with this proposed rule. The relevant sections of this proposed rule contain a description of significant alternatives. </P>
          <HD SOURCE="HD2">A. Resource-Based Practice Expense Relative Value Units </HD>
          <P>Under section 1848(c)(2) of the Act, adjustments to RVUs may not cause the amount of expenditures to differ by more than $20 million from the amount of expenditures that would have resulted without such adjustments. We are proposing several changes that would result in a change of expenditures that would exceed $20 million if we made no offsetting adjustments to either the conversion factor or RVUs. </P>
          <P>With respect to practice expense, our policy has been to meet the budget neutrality requirements in the statute by incorporating a rescaling adjustment in the practice expense methodology. That is, we estimate the aggregate number of practice expense relative values that will be paid under current and proposed policy in CY 2004. We apply a uniform adjustment factor to make the aggregate number of proposed practice expense relative values equal the number estimated that would be paid under current policy. </P>
          <P>Table 11 shows the specialty level impact on payment of changes being proposed for CY 2004. The payment impacts reflect averages for each specialty based on Medicare utilization. The payment impact for an individual physician would be different from the average, based on the mix of services the physician provides. The average change in total revenues would be less than the impact displayed here since physicians furnish services to both Medicare and non-Medicare patients and specialties may receive substantial Medicare revenues for services that are not paid under the physician fee schedule. For instance, independent laboratories receive more than 80 percent of their Medicare revenues from clinical laboratory services that are not paid under the physician fee schedules. The table shows only the payment impact on physician fee schedule services. </P>

          <P>We modeled the impact of four changes to the practice expense methodology and illustrated the effect in table 11 below. The column labeled “Utilization Data” shows the effect of updating the practice expense methodology to add 2002 utilization data for codes that did not exist in the 1997-2000 period. In general, updating the methodology with the latest utilization data will have the largest impact on payment for a new service where a code was established in 2002. In some cases, the practice expense RVU will increase (for example, 64561—Implant Neuroelectrodes and 52001, Cystoscopy Removal of Clots). In other cases, they will go down (96567—photodynamic treatment skin and G0249—Providing test materials and equipment for home INR Monitoring, 77418—Radiation Treatment Delivery—Intensity Modulated Radiation). For most specialties, new codes represent a <PRTPAGE P="49061"/>small proportion of the specialties' revenues and updating the practice expense RVUs with utilization will have little impact on payment across all of the services the specialty provides. However, updating the practice expense methodology with the 2002 utilization data will reduce payment to radiation oncologists by approximately 1 percent. The payment reduction occurs because the practice expense RVUs for radiotherapy dose planning and radiation treatment by intensity modulated radiation are going down. Because this service represents 8 percent of Medicare revenues to radiation oncology in 2002, there is a somewhat larger impact on this specialty than will generally occur for most specialties. </P>
          <P>The column labeled “Practice Expense Refinements” shows the impact on payment from proposed refinements to the practice expense RVUs. In general, the largest impact of the refinements is occurring to surgical procedures with 10 and 90-day global periods. Most of the impacts on these procedures will occur because of the standardization of the intra and post period time for clinical staff. There are also modest impacts on some specialties in the non-facility practice expense RVUs from the refinements to clinical staff and medical supplies. Orthopedic surgery and hand surgery will experience an approximate reduction of 2 percent from the practice expense refinements while payments to otolaryngology will increase by nearly 2 percent. There will be more modest payment increases or decreases for all other specialties from the practice expense refinements. </P>
          <P>The column labeled “Maxillofacial Prosthetics” shows the impact on payment from changing the specialty practice expense per hour crosswalk for oral surgery (specialty 19) and maxillofacial surgery (specialty 85) to otolaryngology. Payments to these specialties will increase from this change and there will be virtually no impact on payment to any other specialty. </P>
          <P>As indicated earlier, we are also adding clinical staff time to the professional component of several cardiac catheterization services increasing payments for these services by a small amount. The proposed change will cause minor payment reductions for a few other cardiology services. All other services are unaffected by this proposal. The column labeled “Professional Component of a Diagnostic Test” shows the payment impact of the proposed change. </P>
          <P>The column labeled “Total” in table 11 below shows the payment impact by specialty of all the changes described above. If we change any of these proposals following our consideration of comments, these figures may change. </P>
          
          <BILCOD>BILLING CODE 4120-01-P</BILCOD>
          
          <GPH DEEP="584" SPAN="3">
            <PRTPAGE P="49062"/>
            <GID>EP15AU03.010</GID>
          </GPH>
          <GPH DEEP="586" SPAN="3">
            <PRTPAGE P="49063"/>
            <GID>EP15AU03.011</GID>
          </GPH>
          <GPH DEEP="582" SPAN="3">
            <PRTPAGE P="49064"/>
            <GID>EP15AU03.012</GID>
          </GPH>
          
          <PRTPAGE P="49065"/>
          <P>The statutory methodology for updating physician fee schedule conversion factor is specified in section 1848(d)(4) of the Act. Consistent with the requirements of section 1848(d)(1)(E) of the Act, we made an estimate of the physician fee schedule update for CY 2004 available to the Medicare Payment Advisory Commission (MedPAC) and the public in March of this year. Using our point estimate of −4.2 percent, on table 12, we are showing the estimated change in average payments by specialty based on provisions of this proposed rule and the estimated physician fee schedule update. As indicated above, figures will change if we change any of our proposals following consideration of public comment. Further, we believe it is highly likely that our estimate of the 2004 physician fee schedule update will change before we determine the final figure later this year. </P>
          
          <BILCOD>BILLING CODE 4120-01-P</BILCOD>
          
          <GPH DEEP="628" SPAN="3">
            <PRTPAGE P="49066"/>
            <GID>EP15AU03.013</GID>
          </GPH>
          <GPH DEEP="338" SPAN="3">
            <PRTPAGE P="49067"/>
            <GID>EP15AU03.014</GID>
          </GPH>
          <P>Table 13 shows the impact on payments for selected high volume procedures of all of the changes previously discussed. This table shows the combined impact of the change in the practice expense RVUs and the estimated physician fee schedule update on total payment for the procedure. There are separate columns that show the change in the facility rates and the non-facility rates. For an explanation of facility and non-facility practice expense refer to § 414.22(b)(5)(i). The table shows the estimated change in payment rates based on provisions of this proposed rule and the estimated physician fee schedule update. If we change any of the provisions following the consideration of public comments, these figures may change. Further, the payment amounts shown for 2003 will change once we determine the final figure for the physician fee schedule update.</P>
          
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49068"/>
            <GID>EP15AU03.015</GID>
          </GPH>
          <GPH DEEP="350" SPAN="3">
            <PRTPAGE P="49069"/>
            <GID>EP15AU03.016</GID>
          </GPH>
          
          <BILCOD>BILLING CODE 4120-01-C</BILCOD>
          <HD SOURCE="HD2">B. Geographic Practice Cost Indices </HD>
          <P>As discussed in section II.B., we are proposing to revise the malpractice GPCIs based upon actual 2001 and 2002 malpractice premium data and projected 2003 malpractice premium data. Data collection is not yet complete therefore we were unable to include the proposed malpractice GPCIs in this proposed rule. The revised malpractice GPCIs in the final rule will be subject to public comment. Any changes in the GPCIs will redistribute payments among geographic areas and will not increase or decrease Medicare expenditures. Because the malpractice RVUs only represent 3.9 percent on total payments on average across all physician fee schedule services, we expect any payment impact to be modest. We will illustrate the change in the GPCIs from use of the new malpractice data in the final rule. </P>
          <HD SOURCE="HD2">C. Tracking Codes </HD>
          <P>We are proposing a change in policy that will allow CMS to create national payment policy and determine national payment amounts for CPT tracking codes regardless of whether a national coverage determination for a specific service has been made. This proposal will have no effect on Medicare expenditures but will allow for more flexibility in determining payment rates for new services. </P>
          <HD SOURCE="HD2">D. Excision of Lesions </HD>
          <P>We are proposing to make the work RVUs the same for removal of benign and malignant skin lesions that have the same excised diameters that are from similar locations (for example, torso, arms, and legs). This would result in minor redistribution in payment of these services. Any impact on payment from this proposal is included in the specialty and code level impacts shown above. </P>
          <HD SOURCE="HD2">E. G Codes for Monitoring Heart Rhythms </HD>

          <P>As discussed earlier, we are creating several HCPCS G codes and establishing national payment for new technology services that allow patients with cardiac arrhythmias to be monitored in a home setting. Currently, Medicare is making payment for these services under CPT code 93799, <E T="03">Unlisted cardiovascular procedure or service.</E> Medicare carriers make local payment determinations for unlisted procedure codes. Our proposal will have no impact on Medicare payment for these services since national payment will replace local carrier payment. </P>
          <HD SOURCE="HD2">F. G Codes for Managing Dialysis Patients </HD>

          <P>As we previously discussed in section II.C., we have reviewed our current payment policy for the monthly dialysis capitation payment in response to concerns that have been raised over whether our payment policy is consistent with current medical practice. We are proposing new G codes for these services that would allow us to align the payment incentives to match the frequency of the physician personally evaluating the dialysis patient. We believe that this restructuring of payment will assist in assuring that beneficiaries with ESRD receive the highest quality dialysis care available as the proposed codes provide for reimbursement for physician involvement that is consistent with the needs of the patient in any specific month. Our proposal will not increase or decrease Medicare payments for <PRTPAGE P="49070"/>treatment of dialysis patients. We are decreasing our current payment to the physician for providing fewer than four visits per month. If the physician provides four or more visits per month, we are increasing our current payment. </P>
          <HD SOURCE="HD2">G. Rebasing and Revising the MEI </HD>
          <P>As indicated in section III.A. of this proposed rule, we are proposing to rebase and revise the MEI for the CY 2004 physician fee schedule. Substituting the 2000 MEI weights in place of the 1996 weights currently in use will increase the MEI by approximately 0.1 percent for 2004. Based on our current estimates, we expect no impact from this proposal on any subsequent year MEI. </P>
          <HD SOURCE="HD2">H. Definition of Diabetes for Diabetes Self-Management Training </HD>

          <P>We are proposing to revise the definition of diabetes for purposes of the Outpatient Diabetes Self-Management Training benefit and use the definition established to determine beneficiary eligibility for Medical Nutrition Therapy when the beneficiary has a diagnosis of diabetes. The streamlining of the beneficiary eligibility requirements for Outpatient Diabetes Self-Management Training will reduce administrative burden for the referring physician or qualified non-physician practitioner and for the accredited Outpatient Diabetes Self-Management Training programs by simplifying documentation requirements and eliminating the need for reconsiderations and appeals to clarify that the requirements have been met. As indicated in the February 28, 2003 <E T="04">Federal Register</E> (68 FR 9572), we incorporated an adjustment to the SGR consistent with our original estimates of expenditures associated with this new benefit. Our experience is that expenditures have been less than originally estimated. We expect that simplifying administrative requirements associated with this new benefit will make it more likely that expenditures for diabetes self-management training will be consistent with original estimates and there will be no increase in Medicare expenditures from making these modifications. </P>
          <HD SOURCE="HD2">I. Alternatives Considered </HD>
          <P>This proposed rule contains a range of policies. The preamble identifies those policies when discretion has been exercised and presents rationale for our decisions, including a presentation of nonselected options. </P>
          <HD SOURCE="HD2">J. Impact on Beneficiaries </HD>
          <P>Although changes in physicians' payments were large when the physician fee schedule was implemented in 1992, we detected no problems with beneficiary access to care. We do not believe that there would be any problem with access to care as a result of the proposed changes in this rule. While it has been suggested that the negative update for 2004 may affect beneficiary access to care, we note that the formula to determine this update is set by statute and this regulation cannot, and does not, change it. Furthermore, since beginning our transition to a resource-based practice expense system in CY 1999, we have not found that there are problems with beneficiary access to care. </P>
          <P>In accordance with the provisions of Executive Order 12866, this regulation was reviewed by the Office of Management and Budget. </P>
          <LSTSUB>
            <HD SOURCE="HED">List of Subjects </HD>
            <CFR>42 CFR Part 410 </CFR>
            <P>Health facilities, Health professions, Kidney diseases, Laboratories, Medicare, Rural areas, X-rays. </P>
            <CFR>42 CFR Part 414</CFR>
          </LSTSUB>
          <P>Administrative practice and procedure, Health facilities, Health professions, Kidney diseases, Medicare, Reporting and recordkeeping requirements, Rural areas, X-rays.</P>
          <P>For the reasons set forth in the preamble, the Centers for Medicare &amp; Medicaid Services proposes to amend 42 CFR chapter IV as follows: </P>
          <PART>
            <HD SOURCE="HED">PART 410—SUPPLEMENTARY MEDICAL INSURANCE (SMI) BENEFITS </HD>
            <P>1. The authority citation for part 410 continues to read as follows: </P>
            <AUTH>
              <HD SOURCE="HED">Authority:</HD>
              <P>Secs. 1102 and 1871 of the Social Security Act (42 U.S.C. 1302 and 1395hh).</P>
            </AUTH>
            
            <P>2. Section 410.140 is amended by adding the definition of “Diabetes” to read as follows: </P>
            <SECTION>
              <SECTNO>§ 410.140 </SECTNO>
              <SUBJECT>Definitions. </SUBJECT>
              <STARS/>
              <P>
                <E T="03">Diabetes</E> means diabetes mellitus consisting of two types. Type 1 is an autoimmune disease that destroys the beta cells of the pancreas, leading to insulin deficiency. Type 2 is familial hyperglycemia that occurs primarily in adults but can also occur in children and adolescents. It is caused by an insulin resistance whose etiology is multiple and not totally understood. Gestational diabetes is any degree of glucose intolerance with onset or first recognition during pregnancy. The diagnostic criterion for a diagnosis of diabetes for a fasting glucose intolerance test is greater than or equal to 126 mg/dL. </P>
              <STARS/>
              <P>3. Section 410.141 is amended by adding paragraph (f) to read as follows: </P>
            </SECTION>
            <SECTION>
              <SECTNO>§ 410.141 </SECTNO>
              <SUBJECT>Outpatient diabetes self-management training. </SUBJECT>
              <STARS/>
              <P>(f) Beneficiaries who may be covered. Medicare Part B covers outpatient diabetes self-management training for a beneficiary who has been diagnosed with diabetes. </P>
              <STARS/>
            </SECTION>
          </PART>
          <PART>
            <HD SOURCE="HED">PART 414—PAYMENT FOR PART B MEDICAL AND OTHER HEALTH SERVICES </HD>
            <P>1. The authority citation for part 414 continues to read as follows: </P>
            <AUTH>
              <HD SOURCE="HED">Authority:</HD>
              <P>Secs. 1102, 1871, and 1881(b)(1) of the Social Security Act (42 U.S.C. 1302, 1395hh, and 1395rr(b)(1)). </P>
            </AUTH>
            
            <P>2. Section 414.22(b)(6)(iii) is revised to read as follows: </P>
            <SECTION>
              <SECTNO>§ 414.22 </SECTNO>
              <SUBJECT>Relative value units. </SUBJECT>
              <STARS/>
              <P>(b) * * * </P>
              <P>(6) * * * </P>
              <P>(iii) CMS will consider for use in determining practice expense RVUs for the physician fee schedule survey data and related materials submitted to CMS by March 1, 2004 to determine CY 2005 practice expense RVUs.</P>
              <STARS/>
              <EXTRACT>
                <FP>(Catalog of Federal Domestic Assistance Program No. 93.774, Medicare—Supplementary Medical Insurance Program) </FP>
              </EXTRACT>
            </SECTION>
            <SIG>
              <DATED>Dated: June 20, 2003. </DATED>
              <NAME>Thomas A Scully, </NAME>
              <TITLE>Administrator, Centers for Medicare &amp; Medicaid Services. </TITLE>
            </SIG>
            <SIG>
              <APPR>Approved: July 22, 2003. </APPR>
              <NAME>Tommy G. Thompson, </NAME>
              <TITLE>Secretary. </TITLE>
            </SIG>
            <HD SOURCE="HD1">Addendum A—Explanation and Use of Addenda B </HD>
            <P>The addenda on the following pages provide various data pertaining to the Medicare fee schedule for physicians' services furnished in 2003. Addendum B contains the RVUs for work, non-facility practice expense, facility practice expense, and malpractice expense, and other information for all services included in the physician fee schedule. </P>

            <P>In previous years, we have listed many services in Addendum B that are not paid under the physician fee schedule. To avoid publishing as many pages of codes for these services, we are not including clinical laboratory codes <PRTPAGE P="49071"/>and most alpha-numeric codes (Healthcare Common Procedure Coding System (HCPCS) codes not included in CPT) in Addendum B. </P>
            <HD SOURCE="HD1">Addendum B—2003 Relative Value Units and Related Information Used in Determining Medicare Payments for 2003 </HD>
            <P>This addendum contains the following information for each CPT code and alphanumeric HCPCS code, except for alphanumeric codes beginning with B (enteral and parenteral therapy), E (durable medical equipment), K (temporary codes for nonphysicians' services or items), or L (orthotics), and codes for anesthesiology. </P>
            <P>1. <E T="03">CPT/HCPCS code.</E> This is the CPT or alphanumeric HCPCS number for the service. Alphanumeric HCPCS codes are included at the end of this addendum. </P>
            <P>2. <E T="03">Modifier.</E> A modifier is shown if there is a technical component (modifier TC) and a professional component (PC) (modifier -26) for the service. If there is a PC and a TC for the service, Addendum B contains three entries for the code: One for the global values (both professional and technical); one for modifier -26 (PC); and one for modifier TC. The global service is not designated by a modifier, and physicians must bill using the code without a modifier if the physician furnishes both the PC and the TC of the service. </P>
            <P>Modifier -53 is shown for a discontinued procedure. There will be RVUs for the code (CPT code 45378) with this modifier. </P>
            <P>3. <E T="03">Status indicator.</E> This indicator shows whether the CPT/HCPCS code is in the physician fee schedule and whether it is separately payable if the service is covered. </P>
            <P>A = Active code. These codes are separately payable under the fee schedule if covered. There will be RVUs for codes with this status. The presence of an “A” indicator does not mean that Medicare has made a national decision regarding the coverage of the service. Carriers remain responsible for coverage decisions in the absence of a national Medicare policy. </P>
            <P>B = Bundled code. Payment for covered services is always bundled into payment for other services not specified. If RVUs are shown, they are not used for Medicare payment. If these services are covered, payment for them is subsumed by the payment for the services to which they are incident. (An example is a telephone call from a hospital nurse regarding care of a patient.) </P>
            <P>C = Carrier-priced code. Carriers will establish RVUs and payment amounts for these services, generally on a case-by-case basis following review of documentation, such as an operative report. </P>
            <P>D = Deleted code. These codes are deleted effective with the beginning of the calendar year. </P>
            <P>E = Excluded from physician fee schedule by regulation. These codes are for items or services that we chose to exclude from the physician fee schedule payment by regulation. No RVUs are shown, and no payment may be made under the physician fee schedule for these codes. Payment for them, if they are covered, continues under reasonable charge or other payment procedures. </P>
            <P>F = Deleted/discontinued codes. Code not subject to a 90-day grace period.</P>
            <P>G = Code not valid for Medicare purposes. Medicare does not recognize codes assigned this status. Medicare uses another code for reporting of, and payment for, these services. </P>
            <P>H = Deleted modifier. Either the TC or PC component shown for the code has been deleted, and the deleted component is shown in the data base with the H status indicator. (Code subject to a 90-day grace period.) </P>
            <P>I = Not valid for Medicare purposes. Medicare uses another code for the reporting of, and the payment for these services. (Code NOT subject to a 90-day grace period.) </P>
            <P>N = Noncovered service. These codes are noncovered services. Medicare payment may not be made for these codes. If RVUs are shown, they are not used for Medicare payment. </P>
            <P>P = Bundled or excluded code. There are no RVUs for these services. No separate payment should be made for them under the physician fee schedule. </P>
          </PART>
          <FP SOURCE="FP-1">— If the item or service is covered as incident to a physician's service and is furnished on the same day as a physician's service, payment for it is bundled into the payment for the physician's service to which it is incident (an example is an elastic bandage furnished by a physician incident to a physician's service). </FP>
          <FP SOURCE="FP-1">— If the item or service is covered as other than incident to a physician's service, it is excluded from the physician fee schedule (for example, colostomy supplies) and is paid under the other payment provisions of the Act. </FP>
          <P>R = Restricted coverage. Special coverage instructions apply. If the service is covered and no RVUs are shown, it is carrier-priced. </P>
          <P>T = Injections. There are RVUs for these services, but they are only paid if there are no other services payable under the physician fee schedule billed on the same date by the same provider. If any other services payable under the physician fee schedule are billed on the same date by the same provider, these services are bundled into the service(s) for which payment is made. </P>
          <P>X = Exclusion by law. These codes represent an item or service that is not within the definition of “physicians’ services” for physician fee schedule payment purposes. No RVUs are shown for these codes, and no payment may be made under the physician fee schedule. (Examples are ambulance services and clinical diagnostic laboratory services.) </P>
          <P>4. <E T="03">Description of code.</E> This is an abbreviated version of the narrative description of the code. </P>
          <P>5. <E T="03">Physician work RVUs.</E> These are the RVUs for the physician work for this service in 2003. Codes that are not used for Medicare payment are identified with a “+.” </P>
          <P>6. <E T="03">Facility practice expense RVUs.</E> These are the fully implemented resource-based practice expense RVUs for facility settings. </P>
          <P>7. <E T="03">Non-facility practice expense RVUs.</E> These are the fully implemented resource-based practice expense RVUs for non-facility settings. </P>
          <P>8. <E T="03">Malpractice expense RVUs.</E> These are the RVUs for the malpractice expense for the service for 2003. </P>
          <P>9. <E T="03">Facility total.</E> This is the sum of the work, fully implemented facility practice expense, and malpractice expense RVUs. </P>
          <P>10. <E T="03">Non-facility total.</E> This is the sum of the work, fully implemented non-facility practice expense, and malpractice expense RVUs. </P>
          <P>11. <E T="03">Global period.</E> This indicator shows the number of days in the global period for the code (0, 10, or 90 days). An explanation of the alpha codes follows: </P>
          <P>MMM = The code describes a service furnished in uncomplicated maternity cases including antepartum care, delivery, and postpartum care. The usual global surgical concept does not apply. See the 1999 Physicians' Current Procedural Terminology for specific definitions. </P>
          <P>XXX = The global concept does not apply. </P>
          <P>YYY = The global period is to be set by the carrier (for example, unlisted surgery codes). </P>
          <P>ZZZ = Code related to another service that is always included in the global period of the other service. (Note: Physician work and practice expense are associated with intra service time and in some instances the post service time.) </P>
          <OLPAGES/>
          <OLNOTES>
            <FNRUL>——————————</FNRUL>
            <OLNOTE1>
              <SU>1</SU> CPT codes and descriptions only are copyright American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.</OLNOTE1>
            <OLNOTE1 SOURCE="OLNOTE2">

              <SU>2</SU> Copyright American Dental Association. All rights reserved.<PRTPAGE P="49072"/>
            </OLNOTE1>
          </OLNOTES>
          <GPOTABLE CDEF="xs40,xs24,xls24,r50,8,8,8,8,8,8,8" COLS="11" OPTS="L2,i1">
            <TTITLE>Addendum B.—Relative Value Units (RVUS) and Related Information </TTITLE>
            <BOXHD>
              <CHED H="1">
                <SU>1</SU> CPT/<SU>2</SU> HCPCS </CHED>
              <CHED H="1">MOD </CHED>
              <CHED H="1">Status </CHED>
              <CHED H="1">Description </CHED>
              <CHED H="1">Physician work RVUs </CHED>
              <CHED H="1">Non-<LI>facility PE RVUs </LI>
              </CHED>
              <CHED H="1">Facility PE RVUs </CHED>
              <CHED H="1">Malpractice RVUs </CHED>
              <CHED H="1">Non-<LI> facility total </LI>
              </CHED>
              <CHED H="1">Facility total </CHED>
              <CHED H="1">Global </CHED>
            </BOXHD>
            <ROW>
              <ENT I="01">0001T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Endovas repr abdo ao aneurys</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0002T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Endovas repr abdo ao aneurys</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0003T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Cervicography</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0005T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Perc cath stent/brain cv art</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0006T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Perc cath stent/brain cv art</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0007T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Perc cath stent/brain cv art</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0008T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Upper gi endoscopy w/suture</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0009T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Endometrial cryoablation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0010T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Tb test, gamma interferon</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0012T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Osteochondral knee autograft</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0013T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Osteochondral knee allograft</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0014T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Meniscal transplant, knee</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0016T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Thermotx choroid vasc lesion</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0017T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Photocoagulat macular drusen</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0018T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Transcranial magnetic stimul</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0019T</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Extracorp shock wave tx, ms</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0020T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Extracorp shock wave tx, ft</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0021T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Fetal oximetry, trnsvag/cerv</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0023T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Phenotype drug test, hiv 1</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0024T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Transcath cardiac reduction</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0025T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Ultrasonic pachymetry</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0026T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Measure remnant lipoproteins</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0027T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Endoscopic epidural lysis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0028T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Dexa body composition study</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0029T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Magnetic tx for incontinence</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0030T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Antiprothrombin antibody</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0031T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Speculoscopy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0032T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Speculoscopy w/direct sample</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0033T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Endovasc taa repr incl subcl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0034T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Endovasc taa repr w/o subcl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0035T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Insert endovasc prosth, taa</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0036T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Endovasc prosth, taa, add-on</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0037T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Artery transpose/endovas taa</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0038T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Rad endovasc taa rpr w/cover</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0039T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Rad s/i, endovasc taa repair</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0040T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Rad s/i, endovasc taa prosth</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0041T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Detect ur infect agnt w/cpas</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49073"/>
              <ENT I="01">0042T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Ct perfusion w/contrast, cbf</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0043T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Co expired gas analysis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">0044T</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Whole body photography</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">10021</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fna w/o image</ENT>
              <ENT>1.27</ENT>
              <ENT>2.24</ENT>
              <ENT>0.55</ENT>
              <ENT>0.07</ENT>
              <ENT>3.58</ENT>
              <ENT>1.89</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">10022</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fna w/image</ENT>
              <ENT>1.27</ENT>
              <ENT>2.67</ENT>
              <ENT>0.43</ENT>
              <ENT>0.05</ENT>
              <ENT>3.99</ENT>
              <ENT>1.75</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">10040</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Acne surgery</ENT>
              <ENT>1.18</ENT>
              <ENT>1.03</ENT>
              <ENT>0.69</ENT>
              <ENT>0.05</ENT>
              <ENT>2.26</ENT>
              <ENT>1.92</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">10060</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of skin abscess</ENT>
              <ENT>1.17</ENT>
              <ENT>0.97</ENT>
              <ENT>0.48</ENT>
              <ENT>0.08</ENT>
              <ENT>2.22</ENT>
              <ENT>1.73</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">10061</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of skin abscess</ENT>
              <ENT>2.40</ENT>
              <ENT>1.85</ENT>
              <ENT>1.54</ENT>
              <ENT>0.17</ENT>
              <ENT>4.42</ENT>
              <ENT>4.11</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">10080</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of pilonidal cyst</ENT>
              <ENT>1.17</ENT>
              <ENT>3.11</ENT>
              <ENT>1.17</ENT>
              <ENT>0.09</ENT>
              <ENT>4.37</ENT>
              <ENT>2.43</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">10081</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of pilonidal cyst</ENT>
              <ENT>2.45</ENT>
              <ENT>4.08</ENT>
              <ENT>1.53</ENT>
              <ENT>0.19</ENT>
              <ENT>6.72</ENT>
              <ENT>4.17</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">10120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove foreign body</ENT>
              <ENT>1.22</ENT>
              <ENT>1.50</ENT>
              <ENT>0.42</ENT>
              <ENT>0.10</ENT>
              <ENT>2.82</ENT>
              <ENT>1.74</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">10121</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove foreign body</ENT>
              <ENT>2.69</ENT>
              <ENT>3.39</ENT>
              <ENT>1.91</ENT>
              <ENT>0.25</ENT>
              <ENT>6.33</ENT>
              <ENT>4.85</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">10140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of hematoma/fluid</ENT>
              <ENT>1.53</ENT>
              <ENT>1.54</ENT>
              <ENT>0.92</ENT>
              <ENT>0.15</ENT>
              <ENT>3.22</ENT>
              <ENT>2.60</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">10160</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Puncture drainage of lesion</ENT>
              <ENT>1.20</ENT>
              <ENT>0.74</ENT>
              <ENT>0.47</ENT>
              <ENT>0.11</ENT>
              <ENT>2.05</ENT>
              <ENT>1.78</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">10180</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Complex drainage, wound</ENT>
              <ENT>2.25</ENT>
              <ENT>3.28</ENT>
              <ENT>2.10</ENT>
              <ENT>0.25</ENT>
              <ENT>5.78</ENT>
              <ENT>4.60</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Debride infected skin</ENT>
              <ENT>0.60</ENT>
              <ENT>0.58</ENT>
              <ENT>0.22</ENT>
              <ENT>0.05</ENT>
              <ENT>1.23</ENT>
              <ENT>0.87</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11001</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Debride infected skin add-on</ENT>
              <ENT>0.30</ENT>
              <ENT>0.23</ENT>
              <ENT>0.11</ENT>
              <ENT>0.02</ENT>
              <ENT>0.55</ENT>
              <ENT>0.43</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Debride skin, fx</ENT>
              <ENT>4.20</ENT>
              <ENT>6.85</ENT>
              <ENT>2.37</ENT>
              <ENT>0.45</ENT>
              <ENT>11.50</ENT>
              <ENT>7.02</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11011</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Debride skin/muscle, fx</ENT>
              <ENT>4.95</ENT>
              <ENT>8.17</ENT>
              <ENT>2.41</ENT>
              <ENT>0.53</ENT>
              <ENT>13.65</ENT>
              <ENT>7.89</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11012</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Debride skin/muscle/bone, fx</ENT>
              <ENT>6.88</ENT>
              <ENT>12.07</ENT>
              <ENT>3.93</ENT>
              <ENT>0.89</ENT>
              <ENT>19.84</ENT>
              <ENT>11.70</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11040</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Debride skin, partial</ENT>
              <ENT>0.50</ENT>
              <ENT>0.54</ENT>
              <ENT>0.21</ENT>
              <ENT>0.05</ENT>
              <ENT>1.09</ENT>
              <ENT>0.76</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11041</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Debride skin, full</ENT>
              <ENT>0.82</ENT>
              <ENT>0.68</ENT>
              <ENT>0.33</ENT>
              <ENT>0.06</ENT>
              <ENT>1.56</ENT>
              <ENT>1.21</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11042</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Debride skin/tissue</ENT>
              <ENT>1.12</ENT>
              <ENT>1.01</ENT>
              <ENT>0.47</ENT>
              <ENT>0.09</ENT>
              <ENT>2.22</ENT>
              <ENT>1.68</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11043</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Debride tissue/muscle</ENT>
              <ENT>2.38</ENT>
              <ENT>3.52</ENT>
              <ENT>2.64</ENT>
              <ENT>0.24</ENT>
              <ENT>6.14</ENT>
              <ENT>5.26</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11044</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Debride tissue/muscle/bone</ENT>
              <ENT>3.06</ENT>
              <ENT>4.64</ENT>
              <ENT>3.81</ENT>
              <ENT>0.34</ENT>
              <ENT>8.04</ENT>
              <ENT>7.21</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11055</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Trim skin lesion</ENT>
              <ENT>0.43</ENT>
              <ENT>0.58</ENT>
              <ENT>0.17</ENT>
              <ENT>0.02</ENT>
              <ENT>1.03</ENT>
              <ENT>0.62</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11056</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Trim skin lesions, 2 to 4</ENT>
              <ENT>0.61</ENT>
              <ENT>0.66</ENT>
              <ENT>0.24</ENT>
              <ENT>0.03</ENT>
              <ENT>1.30</ENT>
              <ENT>0.88</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11057</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Trim skin lesions, over 4</ENT>
              <ENT>0.79</ENT>
              <ENT>0.76</ENT>
              <ENT>0.31</ENT>
              <ENT>0.04</ENT>
              <ENT>1.59</ENT>
              <ENT>1.14</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of skin lesion</ENT>
              <ENT>0.81</ENT>
              <ENT>1.29</ENT>
              <ENT>0.37</ENT>
              <ENT>0.04</ENT>
              <ENT>2.14</ENT>
              <ENT>1.22</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11101</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy, skin add-on</ENT>
              <ENT>0.41</ENT>
              <ENT>0.34</ENT>
              <ENT>0.19</ENT>
              <ENT>0.02</ENT>
              <ENT>0.77</ENT>
              <ENT>0.62</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of skin tags</ENT>
              <ENT>0.77</ENT>
              <ENT>1.08</ENT>
              <ENT>0.78</ENT>
              <ENT>0.04</ENT>
              <ENT>1.89</ENT>
              <ENT>1.59</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11201</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove skin tags add-on</ENT>
              <ENT>0.29</ENT>
              <ENT>0.16</ENT>
              <ENT>0.12</ENT>
              <ENT>0.02</ENT>
              <ENT>0.47</ENT>
              <ENT>0.43</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shave skin lesion</ENT>
              <ENT>0.51</ENT>
              <ENT>1.03</ENT>
              <ENT>0.22</ENT>
              <ENT>0.03</ENT>
              <ENT>1.57</ENT>
              <ENT>0.76</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11301</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shave skin lesion</ENT>
              <ENT>0.85</ENT>
              <ENT>1.15</ENT>
              <ENT>0.39</ENT>
              <ENT>0.04</ENT>
              <ENT>2.04</ENT>
              <ENT>1.28</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11302</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shave skin lesion</ENT>
              <ENT>1.05</ENT>
              <ENT>1.34</ENT>
              <ENT>0.47</ENT>
              <ENT>0.05</ENT>
              <ENT>2.44</ENT>
              <ENT>1.57</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11303</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shave skin lesion</ENT>
              <ENT>1.24</ENT>
              <ENT>1.63</ENT>
              <ENT>0.53</ENT>
              <ENT>0.06</ENT>
              <ENT>2.93</ENT>
              <ENT>1.83</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11305</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shave skin lesion</ENT>
              <ENT>0.67</ENT>
              <ENT>0.86</ENT>
              <ENT>0.27</ENT>
              <ENT>0.04</ENT>
              <ENT>1.57</ENT>
              <ENT>0.98</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11306</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shave skin lesion</ENT>
              <ENT>0.99</ENT>
              <ENT>1.13</ENT>
              <ENT>0.43</ENT>
              <ENT>0.05</ENT>
              <ENT>2.17</ENT>
              <ENT>1.47</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11307</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shave skin lesion</ENT>
              <ENT>1.14</ENT>
              <ENT>1.32</ENT>
              <ENT>0.50</ENT>
              <ENT>0.05</ENT>
              <ENT>2.51</ENT>
              <ENT>1.69</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11308</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shave skin lesion</ENT>
              <ENT>1.41</ENT>
              <ENT>1.48</ENT>
              <ENT>0.61</ENT>
              <ENT>0.07</ENT>
              <ENT>2.96</ENT>
              <ENT>2.09</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11310</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shave skin lesion</ENT>
              <ENT>0.73</ENT>
              <ENT>1.16</ENT>
              <ENT>0.33</ENT>
              <ENT>0.04</ENT>
              <ENT>1.93</ENT>
              <ENT>1.10</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11311</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shave skin lesion</ENT>
              <ENT>1.05</ENT>
              <ENT>1.27</ENT>
              <ENT>0.50</ENT>
              <ENT>0.05</ENT>
              <ENT>2.37</ENT>
              <ENT>1.60</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11312</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shave skin lesion</ENT>
              <ENT>1.20</ENT>
              <ENT>1.47</ENT>
              <ENT>0.57</ENT>
              <ENT>0.06</ENT>
              <ENT>2.73</ENT>
              <ENT>1.83</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11313</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shave skin lesion</ENT>
              <ENT>1.62</ENT>
              <ENT>1.86</ENT>
              <ENT>0.73</ENT>
              <ENT>0.09</ENT>
              <ENT>3.57</ENT>
              <ENT>2.44</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc tr-ext b9+marg 0.5 &lt; cm</ENT>
              <ENT>0.93</ENT>
              <ENT>2.10</ENT>
              <ENT>0.94</ENT>
              <ENT>0.06</ENT>
              <ENT>3.09</ENT>
              <ENT>1.93</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11401</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc tr-ext b9+marg 0.6-1 cm</ENT>
              <ENT>1.44</ENT>
              <ENT>2.22</ENT>
              <ENT>1.12</ENT>
              <ENT>0.09</ENT>
              <ENT>3.75</ENT>
              <ENT>2.65</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11402</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc tr-ext b9+marg 1.1-2 cm</ENT>
              <ENT>1.72</ENT>
              <ENT>2.39</ENT>
              <ENT>1.19</ENT>
              <ENT>0.12</ENT>
              <ENT>4.23</ENT>
              <ENT>3.03</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11403</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc tr-ext b9+marg 2.1-3 cm</ENT>
              <ENT>1.97</ENT>
              <ENT>2.55</ENT>
              <ENT>1.42</ENT>
              <ENT>0.16</ENT>
              <ENT>4.68</ENT>
              <ENT>3.55</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11404</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc tr-ext b9+marg 3.1-4 cm</ENT>
              <ENT>2.21</ENT>
              <ENT>2.86</ENT>
              <ENT>1.48</ENT>
              <ENT>0.18</ENT>
              <ENT>5.25</ENT>
              <ENT>3.87</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11406</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc tr-ext b9+marg &gt; 4.0 cm</ENT>
              <ENT>3.03</ENT>
              <ENT>3.27</ENT>
              <ENT>1.79</ENT>
              <ENT>0.25</ENT>
              <ENT>6.55</ENT>
              <ENT>5.07</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc h-f-nk-sp b9+marg 0.5 &lt;</ENT>
              <ENT>1.01</ENT>
              <ENT>1.83</ENT>
              <ENT>0.96</ENT>
              <ENT>0.08</ENT>
              <ENT>2.92</ENT>
              <ENT>2.05</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11421</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc h-f-nk-sp b9+marg 0.6-1</ENT>
              <ENT>1.55</ENT>
              <ENT>2.19</ENT>
              <ENT>1.19</ENT>
              <ENT>0.11</ENT>
              <ENT>3.85</ENT>
              <ENT>2.85</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49074"/>
              <ENT I="01">11422</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc h-f-nk-sp b9+marg 1.1-2</ENT>
              <ENT>1.84</ENT>
              <ENT>2.42</ENT>
              <ENT>1.45</ENT>
              <ENT>0.14</ENT>
              <ENT>4.40</ENT>
              <ENT>3.43</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11423</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc h-f-nk-sp b9+marg 2.1-3</ENT>
              <ENT>2.28</ENT>
              <ENT>2.78</ENT>
              <ENT>1.59</ENT>
              <ENT>0.17</ENT>
              <ENT>5.23</ENT>
              <ENT>4.04</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11424</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc h-f-nk-sp b9+marg 3.1-4</ENT>
              <ENT>2.72</ENT>
              <ENT>3.01</ENT>
              <ENT>1.75</ENT>
              <ENT>0.21</ENT>
              <ENT>5.94</ENT>
              <ENT>4.68</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11426</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc h-f-nk-sp b9+marg &gt; 4 cm</ENT>
              <ENT>4.03</ENT>
              <ENT>3.71</ENT>
              <ENT>2.24</ENT>
              <ENT>0.34</ENT>
              <ENT>8.08</ENT>
              <ENT>6.61</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11440</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc face-mm b9+marg 0.5 &lt; cm</ENT>
              <ENT>1.16</ENT>
              <ENT>2.38</ENT>
              <ENT>1.40</ENT>
              <ENT>0.08</ENT>
              <ENT>3.62</ENT>
              <ENT>2.64</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11441</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc face-mm b9+marg 0.6-1 cm</ENT>
              <ENT>1.89</ENT>
              <ENT>2.64</ENT>
              <ENT>1.72</ENT>
              <ENT>0.11</ENT>
              <ENT>4.64</ENT>
              <ENT>3.72</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11442</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc face-mm b9+marg 1.1-2 cm</ENT>
              <ENT>2.31</ENT>
              <ENT>2.92</ENT>
              <ENT>1.87</ENT>
              <ENT>0.14</ENT>
              <ENT>5.37</ENT>
              <ENT>4.32</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11443</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc face-mm b9+marg 2.1-3 cm</ENT>
              <ENT>2.86</ENT>
              <ENT>3.30</ENT>
              <ENT>2.11</ENT>
              <ENT>0.18</ENT>
              <ENT>6.34</ENT>
              <ENT>5.15</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11444</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc face-mm b9+marg 3.1-4 cm</ENT>
              <ENT>3.78</ENT>
              <ENT>3.93</ENT>
              <ENT>2.52</ENT>
              <ENT>0.25</ENT>
              <ENT>7.96</ENT>
              <ENT>6.55</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11446</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc face-mm b9+marg &gt; 4 cm</ENT>
              <ENT>5.57</ENT>
              <ENT>4.70</ENT>
              <ENT>3.32</ENT>
              <ENT>0.30</ENT>
              <ENT>10.57</ENT>
              <ENT>9.19</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal, sweat gland lesion</ENT>
              <ENT>2.73</ENT>
              <ENT>5.22</ENT>
              <ENT>2.04</ENT>
              <ENT>0.26</ENT>
              <ENT>8.21</ENT>
              <ENT>5.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11451</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal, sweat gland lesion</ENT>
              <ENT>3.95</ENT>
              <ENT>6.87</ENT>
              <ENT>2.57</ENT>
              <ENT>0.39</ENT>
              <ENT>11.21</ENT>
              <ENT>6.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11462</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal, sweat gland lesion</ENT>
              <ENT>2.51</ENT>
              <ENT>5.31</ENT>
              <ENT>2.02</ENT>
              <ENT>0.23</ENT>
              <ENT>8.05</ENT>
              <ENT>4.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11463</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal, sweat gland lesion</ENT>
              <ENT>3.95</ENT>
              <ENT>7.12</ENT>
              <ENT>2.71</ENT>
              <ENT>0.40</ENT>
              <ENT>11.47</ENT>
              <ENT>7.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11470</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal, sweat gland lesion</ENT>
              <ENT>3.25</ENT>
              <ENT>5.25</ENT>
              <ENT>2.28</ENT>
              <ENT>0.30</ENT>
              <ENT>8.80</ENT>
              <ENT>5.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11471</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal, sweat gland lesion</ENT>
              <ENT>4.41</ENT>
              <ENT>7.03</ENT>
              <ENT>2.80</ENT>
              <ENT>0.40</ENT>
              <ENT>11.84</ENT>
              <ENT>7.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc tr-ext mlg+marg 0.5 &lt; cm</ENT>
              <ENT>0.93</ENT>
              <ENT>2.58</ENT>
              <ENT>0.84</ENT>
              <ENT>0.09</ENT>
              <ENT>3.60</ENT>
              <ENT>1.86</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11601</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc tr-ext mlg+marg 0.6-1 cm</ENT>
              <ENT>1.44</ENT>
              <ENT>2.63</ENT>
              <ENT>1.10</ENT>
              <ENT>0.12</ENT>
              <ENT>4.19</ENT>
              <ENT>2.66</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11602</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc tr-ext mlg+marg 1.1-2 cm</ENT>
              <ENT>1.72</ENT>
              <ENT>2.82</ENT>
              <ENT>1.20</ENT>
              <ENT>0.13</ENT>
              <ENT>4.67</ENT>
              <ENT>3.05</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11603</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc tr-ext mlg+marg 2.1-3 cm</ENT>
              <ENT>1.97</ENT>
              <ENT>3.08</ENT>
              <ENT>1.27</ENT>
              <ENT>0.16</ENT>
              <ENT>5.21</ENT>
              <ENT>3.40</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11604</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc tr-ext mlg+marg 3.1-4 cm</ENT>
              <ENT>2.21</ENT>
              <ENT>3.41</ENT>
              <ENT>1.35</ENT>
              <ENT>0.18</ENT>
              <ENT>5.80</ENT>
              <ENT>3.74</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11606</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc tr-ext mlg+marg &gt; 4 cm</ENT>
              <ENT>3.03</ENT>
              <ENT>4.02</ENT>
              <ENT>1.62</ENT>
              <ENT>0.28</ENT>
              <ENT>7.33</ENT>
              <ENT>4.93</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11620</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc h-f-nk-sp mlg+marg 0.5 &lt;</ENT>
              <ENT>1.01</ENT>
              <ENT>2.62</ENT>
              <ENT>0.90</ENT>
              <ENT>0.09</ENT>
              <ENT>3.72</ENT>
              <ENT>2.00</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11621</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc h-f-nk-sp mlg+marg 0.6-1</ENT>
              <ENT>1.55</ENT>
              <ENT>2.70</ENT>
              <ENT>1.18</ENT>
              <ENT>0.12</ENT>
              <ENT>4.37</ENT>
              <ENT>2.85</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11622</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc h-f-nk-sp mlg+marg 1.1-2</ENT>
              <ENT>1.84</ENT>
              <ENT>2.95</ENT>
              <ENT>1.31</ENT>
              <ENT>0.15</ENT>
              <ENT>4.94</ENT>
              <ENT>3.30</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11623</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc h-f-nk-sp mlg+marg 2.1-3</ENT>
              <ENT>2.28</ENT>
              <ENT>3.30</ENT>
              <ENT>1.48</ENT>
              <ENT>0.20</ENT>
              <ENT>5.78</ENT>
              <ENT>3.96</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11624</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc h-f-nk-sp mlg+marg 3.1-4</ENT>
              <ENT>2.72</ENT>
              <ENT>3.72</ENT>
              <ENT>1.67</ENT>
              <ENT>0.25</ENT>
              <ENT>6.69</ENT>
              <ENT>4.64</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11626</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc h-f-nk-sp mlg+mar &gt; 4 cm</ENT>
              <ENT>4.03</ENT>
              <ENT>4.67</ENT>
              <ENT>2.33</ENT>
              <ENT>0.35</ENT>
              <ENT>9.05</ENT>
              <ENT>6.71</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11640</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc face-mm malig+marg 0.5 &lt;</ENT>
              <ENT>1.16</ENT>
              <ENT>2.68</ENT>
              <ENT>1.06</ENT>
              <ENT>0.10</ENT>
              <ENT>3.94</ENT>
              <ENT>2.32</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11641</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc face-mm malig+marg 0.6-1</ENT>
              <ENT>1.89</ENT>
              <ENT>3.01</ENT>
              <ENT>1.44</ENT>
              <ENT>0.15</ENT>
              <ENT>5.05</ENT>
              <ENT>3.48</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11642</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc face-mm malig+marg 1.1-2</ENT>
              <ENT>2.31</ENT>
              <ENT>3.39</ENT>
              <ENT>1.63</ENT>
              <ENT>0.18</ENT>
              <ENT>5.88</ENT>
              <ENT>4.12</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11643</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc face-mm malig+marg 2.1-3</ENT>
              <ENT>2.86</ENT>
              <ENT>3.82</ENT>
              <ENT>1.89</ENT>
              <ENT>0.24</ENT>
              <ENT>6.92</ENT>
              <ENT>4.99</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11644</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc face-mm malig+marg 3.1-4</ENT>
              <ENT>3.78</ENT>
              <ENT>4.72</ENT>
              <ENT>2.40</ENT>
              <ENT>0.33</ENT>
              <ENT>8.83</ENT>
              <ENT>6.51</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49075"/>
              <ENT I="01">11646</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exc face-mm mlg+marg &gt; 4 cm</ENT>
              <ENT>5.57</ENT>
              <ENT>5.76</ENT>
              <ENT>3.38</ENT>
              <ENT>0.46</ENT>
              <ENT>11.79</ENT>
              <ENT>9.41</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11719</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Trim nail(s)</ENT>
              <ENT>0.17</ENT>
              <ENT>0.25</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.43</ENT>
              <ENT>0.25</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11720</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Debride nail, 1-5</ENT>
              <ENT>0.32</ENT>
              <ENT>0.34</ENT>
              <ENT>0.13</ENT>
              <ENT>0.02</ENT>
              <ENT>0.68</ENT>
              <ENT>0.47</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11721</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Debride nail, 6 or more</ENT>
              <ENT>0.54</ENT>
              <ENT>0.44</ENT>
              <ENT>0.21</ENT>
              <ENT>0.04</ENT>
              <ENT>1.02</ENT>
              <ENT>0.79</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11730</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of nail plate</ENT>
              <ENT>1.13</ENT>
              <ENT>1.05</ENT>
              <ENT>0.44</ENT>
              <ENT>0.09</ENT>
              <ENT>2.27</ENT>
              <ENT>1.66</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11732</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove nail plate, add-on</ENT>
              <ENT>0.57</ENT>
              <ENT>0.45</ENT>
              <ENT>0.23</ENT>
              <ENT>0.05</ENT>
              <ENT>1.07</ENT>
              <ENT>0.85</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11740</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain blood from under nail</ENT>
              <ENT>0.37</ENT>
              <ENT>0.87</ENT>
              <ENT>0.15</ENT>
              <ENT>0.03</ENT>
              <ENT>1.27</ENT>
              <ENT>0.55</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11750</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of nail bed</ENT>
              <ENT>1.86</ENT>
              <ENT>2.18</ENT>
              <ENT>1.76</ENT>
              <ENT>0.16</ENT>
              <ENT>4.20</ENT>
              <ENT>3.78</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11752</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove nail bed/finger tip</ENT>
              <ENT>2.67</ENT>
              <ENT>2.50</ENT>
              <ENT>1.92</ENT>
              <ENT>0.33</ENT>
              <ENT>5.50</ENT>
              <ENT>4.92</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11755</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy, nail unit</ENT>
              <ENT>1.31</ENT>
              <ENT>1.12</ENT>
              <ENT>0.56</ENT>
              <ENT>0.06</ENT>
              <ENT>2.49</ENT>
              <ENT>1.93</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11760</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of nail bed</ENT>
              <ENT>1.58</ENT>
              <ENT>1.88</ENT>
              <ENT>1.24</ENT>
              <ENT>0.17</ENT>
              <ENT>3.63</ENT>
              <ENT>2.99</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11762</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of nail bed</ENT>
              <ENT>2.89</ENT>
              <ENT>2.32</ENT>
              <ENT>1.86</ENT>
              <ENT>0.32</ENT>
              <ENT>5.53</ENT>
              <ENT>5.07</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11765</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of nail fold, toe</ENT>
              <ENT>0.69</ENT>
              <ENT>1.18</ENT>
              <ENT>0.53</ENT>
              <ENT>0.05</ENT>
              <ENT>1.92</ENT>
              <ENT>1.27</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11770</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of pilonidal lesion</ENT>
              <ENT>2.61</ENT>
              <ENT>3.50</ENT>
              <ENT>1.53</ENT>
              <ENT>0.24</ENT>
              <ENT>6.35</ENT>
              <ENT>4.38</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11771</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of pilonidal lesion</ENT>
              <ENT>5.74</ENT>
              <ENT>5.80</ENT>
              <ENT>3.35</ENT>
              <ENT>0.56</ENT>
              <ENT>12.10</ENT>
              <ENT>9.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11772</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of pilonidal lesion</ENT>
              <ENT>6.98</ENT>
              <ENT>7.34</ENT>
              <ENT>3.91</ENT>
              <ENT>0.68</ENT>
              <ENT>15.00</ENT>
              <ENT>11.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11900</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection into skin lesions</ENT>
              <ENT>0.52</ENT>
              <ENT>0.67</ENT>
              <ENT>0.22</ENT>
              <ENT>0.02</ENT>
              <ENT>1.21</ENT>
              <ENT>0.76</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11901</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Added skin lesions injection</ENT>
              <ENT>0.80</ENT>
              <ENT>0.68</ENT>
              <ENT>0.36</ENT>
              <ENT>0.03</ENT>
              <ENT>1.51</ENT>
              <ENT>1.19</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11920</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Correct skin color defects</ENT>
              <ENT>1.61</ENT>
              <ENT>2.03</ENT>
              <ENT>0.79</ENT>
              <ENT>0.17</ENT>
              <ENT>3.81</ENT>
              <ENT>2.57</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11921</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Correct skin color defects</ENT>
              <ENT>1.93</ENT>
              <ENT>2.41</ENT>
              <ENT>1.00</ENT>
              <ENT>0.21</ENT>
              <ENT>4.55</ENT>
              <ENT>3.14</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11922</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Correct skin color defects</ENT>
              <ENT>0.49</ENT>
              <ENT>0.38</ENT>
              <ENT>0.25</ENT>
              <ENT>0.05</ENT>
              <ENT>0.92</ENT>
              <ENT>0.79</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11950</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Therapy for contour defects</ENT>
              <ENT>0.84</ENT>
              <ENT>1.18</ENT>
              <ENT>0.42</ENT>
              <ENT>0.06</ENT>
              <ENT>2.08</ENT>
              <ENT>1.32</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11951</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Therapy for contour defects</ENT>
              <ENT>1.19</ENT>
              <ENT>1.53</ENT>
              <ENT>0.52</ENT>
              <ENT>0.10</ENT>
              <ENT>2.82</ENT>
              <ENT>1.81</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11952</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Therapy for contour defects</ENT>
              <ENT>1.69</ENT>
              <ENT>1.90</ENT>
              <ENT>0.70</ENT>
              <ENT>0.17</ENT>
              <ENT>3.76</ENT>
              <ENT>2.56</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11954</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Therapy for contour defects</ENT>
              <ENT>1.85</ENT>
              <ENT>2.48</ENT>
              <ENT>0.92</ENT>
              <ENT>0.19</ENT>
              <ENT>4.52</ENT>
              <ENT>2.96</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11960</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert tissue expander(s)</ENT>
              <ENT>9.08</ENT>
              <ENT>N/A</ENT>
              <ENT>10.74</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>20.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11970</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replace tissue expander</ENT>
              <ENT>7.06</ENT>
              <ENT>N/A</ENT>
              <ENT>6.22</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>14.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11971</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove tissue expander(s)</ENT>
              <ENT>2.13</ENT>
              <ENT>7.24</ENT>
              <ENT>4.84</ENT>
              <ENT>0.21</ENT>
              <ENT>9.58</ENT>
              <ENT>7.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11975</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Insert contraceptive cap</ENT>
              <ENT>1.48</ENT>
              <ENT>1.50</ENT>
              <ENT>0.57</ENT>
              <ENT>0.14</ENT>
              <ENT>3.12</ENT>
              <ENT>2.19</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11976</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Removal of contraceptive cap</ENT>
              <ENT>1.78</ENT>
              <ENT>1.74</ENT>
              <ENT>0.70</ENT>
              <ENT>0.17</ENT>
              <ENT>3.69</ENT>
              <ENT>2.65</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11977</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Removal/reinsert contra cap</ENT>
              <ENT>3.30</ENT>
              <ENT>2.42</ENT>
              <ENT>1.28</ENT>
              <ENT>0.31</ENT>
              <ENT>6.03</ENT>
              <ENT>4.89</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11980</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant hormone pellet(s)</ENT>
              <ENT>1.48</ENT>
              <ENT>1.12</ENT>
              <ENT>0.56</ENT>
              <ENT>0.10</ENT>
              <ENT>2.70</ENT>
              <ENT>2.14</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11981</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert drug implant device</ENT>
              <ENT>1.48</ENT>
              <ENT>1.77</ENT>
              <ENT>0.70</ENT>
              <ENT>0.14</ENT>
              <ENT>3.39</ENT>
              <ENT>2.32</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11982</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove drug implant device</ENT>
              <ENT>1.78</ENT>
              <ENT>2.01</ENT>
              <ENT>0.86</ENT>
              <ENT>0.17</ENT>
              <ENT>3.96</ENT>
              <ENT>2.81</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">11983</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove/insert drug implant</ENT>
              <ENT>3.30</ENT>
              <ENT>2.37</ENT>
              <ENT>1.50</ENT>
              <ENT>0.31</ENT>
              <ENT>5.98</ENT>
              <ENT>5.11</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12001</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair superficial wound(s)</ENT>
              <ENT>1.70</ENT>
              <ENT>2.07</ENT>
              <ENT>0.50</ENT>
              <ENT>0.13</ENT>
              <ENT>3.90</ENT>
              <ENT>2.33</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12002</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair superficial wound(s)</ENT>
              <ENT>1.86</ENT>
              <ENT>2.14</ENT>
              <ENT>0.95</ENT>
              <ENT>0.15</ENT>
              <ENT>4.15</ENT>
              <ENT>2.96</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12004</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair superficial wound(s)</ENT>
              <ENT>2.24</ENT>
              <ENT>2.43</ENT>
              <ENT>1.06</ENT>
              <ENT>0.17</ENT>
              <ENT>4.84</ENT>
              <ENT>3.47</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12005</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair superficial wound(s)</ENT>
              <ENT>2.86</ENT>
              <ENT>2.94</ENT>
              <ENT>1.25</ENT>
              <ENT>0.23</ENT>
              <ENT>6.03</ENT>
              <ENT>4.34</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12006</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair superficial wound(s)</ENT>
              <ENT>3.67</ENT>
              <ENT>3.53</ENT>
              <ENT>1.57</ENT>
              <ENT>0.31</ENT>
              <ENT>7.51</ENT>
              <ENT>5.55</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12007</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair superficial wound(s)</ENT>
              <ENT>4.12</ENT>
              <ENT>3.97</ENT>
              <ENT>1.87</ENT>
              <ENT>0.37</ENT>
              <ENT>8.46</ENT>
              <ENT>6.36</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12011</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair superficial wound(s)</ENT>
              <ENT>1.76</ENT>
              <ENT>2.24</ENT>
              <ENT>0.51</ENT>
              <ENT>0.14</ENT>
              <ENT>4.14</ENT>
              <ENT>2.41</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12013</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair superficial wound(s)</ENT>
              <ENT>1.99</ENT>
              <ENT>2.39</ENT>
              <ENT>0.99</ENT>
              <ENT>0.16</ENT>
              <ENT>4.54</ENT>
              <ENT>3.14</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12014</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair superficial wound(s)</ENT>
              <ENT>2.46</ENT>
              <ENT>2.69</ENT>
              <ENT>1.11</ENT>
              <ENT>0.18</ENT>
              <ENT>5.33</ENT>
              <ENT>3.75</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49076"/>
              <ENT I="01">12015</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair superficial wound(s)</ENT>
              <ENT>3.19</ENT>
              <ENT>3.28</ENT>
              <ENT>1.31</ENT>
              <ENT>0.24</ENT>
              <ENT>6.71</ENT>
              <ENT>4.74</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12016</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair superficial wound(s)</ENT>
              <ENT>3.93</ENT>
              <ENT>3.70</ENT>
              <ENT>1.59</ENT>
              <ENT>0.32</ENT>
              <ENT>7.95</ENT>
              <ENT>5.84</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12017</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair superficial wound(s)</ENT>
              <ENT>4.71</ENT>
              <ENT>N/A</ENT>
              <ENT>1.95</ENT>
              <ENT>0.39</ENT>
              <ENT>N/A</ENT>
              <ENT>7.05</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12018</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair superficial wound(s)</ENT>
              <ENT>5.53</ENT>
              <ENT>N/A</ENT>
              <ENT>2.32</ENT>
              <ENT>0.46</ENT>
              <ENT>N/A</ENT>
              <ENT>8.31</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Closure of split wound</ENT>
              <ENT>2.62</ENT>
              <ENT>2.74</ENT>
              <ENT>1.77</ENT>
              <ENT>0.24</ENT>
              <ENT>5.60</ENT>
              <ENT>4.63</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12021</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Closure of split wound</ENT>
              <ENT>1.84</ENT>
              <ENT>1.81</ENT>
              <ENT>1.43</ENT>
              <ENT>0.19</ENT>
              <ENT>3.84</ENT>
              <ENT>3.46</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12031</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Layer closure of wound(s)</ENT>
              <ENT>2.15</ENT>
              <ENT>2.36</ENT>
              <ENT>0.83</ENT>
              <ENT>0.15</ENT>
              <ENT>4.66</ENT>
              <ENT>3.13</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12032</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Layer closure of wound(s)</ENT>
              <ENT>2.47</ENT>
              <ENT>3.88</ENT>
              <ENT>1.87</ENT>
              <ENT>0.15</ENT>
              <ENT>6.50</ENT>
              <ENT>4.49</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12034</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Layer closure of wound(s)</ENT>
              <ENT>2.92</ENT>
              <ENT>3.24</ENT>
              <ENT>1.44</ENT>
              <ENT>0.21</ENT>
              <ENT>6.37</ENT>
              <ENT>4.57</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12035</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Layer closure of wound(s)</ENT>
              <ENT>3.43</ENT>
              <ENT>5.27</ENT>
              <ENT>2.22</ENT>
              <ENT>0.30</ENT>
              <ENT>9.00</ENT>
              <ENT>5.95</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12036</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Layer closure of wound(s)</ENT>
              <ENT>4.05</ENT>
              <ENT>5.53</ENT>
              <ENT>2.42</ENT>
              <ENT>0.41</ENT>
              <ENT>9.99</ENT>
              <ENT>6.88</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12037</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Layer closure of wound(s)</ENT>
              <ENT>4.67</ENT>
              <ENT>6.62</ENT>
              <ENT>2.83</ENT>
              <ENT>0.49</ENT>
              <ENT>11.78</ENT>
              <ENT>7.99</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12041</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Layer closure of wound(s)</ENT>
              <ENT>2.37</ENT>
              <ENT>2.53</ENT>
              <ENT>0.88</ENT>
              <ENT>0.17</ENT>
              <ENT>5.07</ENT>
              <ENT>3.42</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12042</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Layer closure of wound(s)</ENT>
              <ENT>2.74</ENT>
              <ENT>3.28</ENT>
              <ENT>1.40</ENT>
              <ENT>0.17</ENT>
              <ENT>6.19</ENT>
              <ENT>4.31</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12044</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Layer closure of wound(s)</ENT>
              <ENT>3.14</ENT>
              <ENT>3.28</ENT>
              <ENT>1.59</ENT>
              <ENT>0.24</ENT>
              <ENT>6.66</ENT>
              <ENT>4.97</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12045</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Layer closure of wound(s)</ENT>
              <ENT>3.64</ENT>
              <ENT>3.79</ENT>
              <ENT>2.21</ENT>
              <ENT>0.34</ENT>
              <ENT>7.77</ENT>
              <ENT>6.19</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12046</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Layer closure of wound(s)</ENT>
              <ENT>4.25</ENT>
              <ENT>6.61</ENT>
              <ENT>2.82</ENT>
              <ENT>0.40</ENT>
              <ENT>11.26</ENT>
              <ENT>7.47</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12047</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Layer closure of wound(s)</ENT>
              <ENT>4.65</ENT>
              <ENT>6.50</ENT>
              <ENT>3.15</ENT>
              <ENT>0.41</ENT>
              <ENT>11.56</ENT>
              <ENT>8.21</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12051</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Layer closure of wound(s)</ENT>
              <ENT>2.47</ENT>
              <ENT>3.30</ENT>
              <ENT>1.39</ENT>
              <ENT>0.16</ENT>
              <ENT>5.93</ENT>
              <ENT>4.02</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12052</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Layer closure of wound(s)</ENT>
              <ENT>2.77</ENT>
              <ENT>3.24</ENT>
              <ENT>1.37</ENT>
              <ENT>0.17</ENT>
              <ENT>6.18</ENT>
              <ENT>4.31</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12053</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Layer closure of wound(s)</ENT>
              <ENT>3.12</ENT>
              <ENT>3.29</ENT>
              <ENT>1.53</ENT>
              <ENT>0.20</ENT>
              <ENT>6.61</ENT>
              <ENT>4.85</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12054</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Layer closure of wound(s)</ENT>
              <ENT>3.46</ENT>
              <ENT>3.63</ENT>
              <ENT>1.63</ENT>
              <ENT>0.25</ENT>
              <ENT>7.34</ENT>
              <ENT>5.34</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12055</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Layer closure of wound(s)</ENT>
              <ENT>4.43</ENT>
              <ENT>4.63</ENT>
              <ENT>2.18</ENT>
              <ENT>0.35</ENT>
              <ENT>9.41</ENT>
              <ENT>6.96</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12056</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Layer closure of wound(s)</ENT>
              <ENT>5.24</ENT>
              <ENT>6.92</ENT>
              <ENT>3.13</ENT>
              <ENT>0.43</ENT>
              <ENT>12.59</ENT>
              <ENT>8.80</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">12057</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Layer closure of wound(s)</ENT>
              <ENT>5.96</ENT>
              <ENT>6.27</ENT>
              <ENT>3.84</ENT>
              <ENT>0.50</ENT>
              <ENT>12.73</ENT>
              <ENT>10.30</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">13100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of wound or lesion</ENT>
              <ENT>3.12</ENT>
              <ENT>3.59</ENT>
              <ENT>1.81</ENT>
              <ENT>0.21</ENT>
              <ENT>6.92</ENT>
              <ENT>5.14</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">13101</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of wound or lesion</ENT>
              <ENT>3.92</ENT>
              <ENT>3.83</ENT>
              <ENT>2.26</ENT>
              <ENT>0.22</ENT>
              <ENT>7.97</ENT>
              <ENT>6.40</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">13102</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair wound/lesion add-on</ENT>
              <ENT>1.24</ENT>
              <ENT>0.75</ENT>
              <ENT>0.58</ENT>
              <ENT>0.10</ENT>
              <ENT>2.09</ENT>
              <ENT>1.92</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">13120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of wound or lesion</ENT>
              <ENT>3.30</ENT>
              <ENT>3.69</ENT>
              <ENT>1.85</ENT>
              <ENT>0.23</ENT>
              <ENT>7.22</ENT>
              <ENT>5.38</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">13121</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of wound or lesion</ENT>
              <ENT>4.33</ENT>
              <ENT>4.05</ENT>
              <ENT>2.36</ENT>
              <ENT>0.25</ENT>
              <ENT>8.63</ENT>
              <ENT>6.94</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">13122</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair wound/lesion add-on</ENT>
              <ENT>1.44</ENT>
              <ENT>0.88</ENT>
              <ENT>0.64</ENT>
              <ENT>0.12</ENT>
              <ENT>2.44</ENT>
              <ENT>2.20</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">13131</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of wound or lesion</ENT>
              <ENT>3.79</ENT>
              <ENT>3.96</ENT>
              <ENT>2.18</ENT>
              <ENT>0.25</ENT>
              <ENT>8.00</ENT>
              <ENT>6.22</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">13132</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of wound or lesion</ENT>
              <ENT>5.95</ENT>
              <ENT>4.78</ENT>
              <ENT>3.23</ENT>
              <ENT>0.32</ENT>
              <ENT>11.05</ENT>
              <ENT>9.50</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">13133</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair wound/lesion add-on</ENT>
              <ENT>2.19</ENT>
              <ENT>1.22</ENT>
              <ENT>1.05</ENT>
              <ENT>0.17</ENT>
              <ENT>3.58</ENT>
              <ENT>3.41</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">13150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of wound or lesion</ENT>
              <ENT>3.81</ENT>
              <ENT>5.62</ENT>
              <ENT>2.65</ENT>
              <ENT>0.29</ENT>
              <ENT>9.72</ENT>
              <ENT>6.75</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">13151</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of wound or lesion</ENT>
              <ENT>4.45</ENT>
              <ENT>5.52</ENT>
              <ENT>3.10</ENT>
              <ENT>0.28</ENT>
              <ENT>10.25</ENT>
              <ENT>7.83</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">13152</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of wound or lesion</ENT>
              <ENT>6.33</ENT>
              <ENT>6.21</ENT>
              <ENT>4.01</ENT>
              <ENT>0.38</ENT>
              <ENT>12.92</ENT>
              <ENT>10.72</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">13153</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair wound/lesion add-on</ENT>
              <ENT>2.38</ENT>
              <ENT>1.37</ENT>
              <ENT>1.17</ENT>
              <ENT>0.18</ENT>
              <ENT>3.93</ENT>
              <ENT>3.73</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">13160</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Late closure of wound</ENT>
              <ENT>10.48</ENT>
              <ENT>N/A</ENT>
              <ENT>7.24</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>18.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">14000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin tissue rearrangement</ENT>
              <ENT>5.89</ENT>
              <ENT>8.69</ENT>
              <ENT>5.21</ENT>
              <ENT>0.46</ENT>
              <ENT>15.04</ENT>
              <ENT>11.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">14001</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin tissue rearrangement</ENT>
              <ENT>8.47</ENT>
              <ENT>10.16</ENT>
              <ENT>6.70</ENT>
              <ENT>0.65</ENT>
              <ENT>19.28</ENT>
              <ENT>15.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">14020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin tissue rearrangement</ENT>
              <ENT>6.59</ENT>
              <ENT>9.35</ENT>
              <ENT>6.10</ENT>
              <ENT>0.50</ENT>
              <ENT>16.44</ENT>
              <ENT>13.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">14021</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin tissue rearrangement</ENT>
              <ENT>10.06</ENT>
              <ENT>10.67</ENT>
              <ENT>7.88</ENT>
              <ENT>0.69</ENT>
              <ENT>21.42</ENT>
              <ENT>18.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">14040</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin tissue rearrangement</ENT>
              <ENT>7.87</ENT>
              <ENT>8.44</ENT>
              <ENT>7.01</ENT>
              <ENT>0.55</ENT>
              <ENT>16.86</ENT>
              <ENT>15.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">14041</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin tissue rearrangement</ENT>
              <ENT>11.49</ENT>
              <ENT>10.87</ENT>
              <ENT>8.87</ENT>
              <ENT>0.71</ENT>
              <ENT>23.07</ENT>
              <ENT>21.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">14060</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin tissue rearrangement</ENT>
              <ENT>8.50</ENT>
              <ENT>9.27</ENT>
              <ENT>7.82</ENT>
              <ENT>0.59</ENT>
              <ENT>18.36</ENT>
              <ENT>16.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">14061</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin tissue rearrangement</ENT>
              <ENT>12.29</ENT>
              <ENT>11.90</ENT>
              <ENT>9.69</ENT>
              <ENT>0.75</ENT>
              <ENT>24.94</ENT>
              <ENT>22.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">14300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin tissue rearrangement</ENT>
              <ENT>11.76</ENT>
              <ENT>11.41</ENT>
              <ENT>9.32</ENT>
              <ENT>0.88</ENT>
              <ENT>24.05</ENT>
              <ENT>21.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">14350</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin tissue rearrangement</ENT>
              <ENT>9.61</ENT>
              <ENT>N/A</ENT>
              <ENT>7.26</ENT>
              <ENT>1.09</ENT>
              <ENT>N/A</ENT>
              <ENT>17.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin graft</ENT>
              <ENT>4.00</ENT>
              <ENT>3.89</ENT>
              <ENT>2.24</ENT>
              <ENT>0.37</ENT>
              <ENT>8.26</ENT>
              <ENT>6.61</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15001</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin graft add-on</ENT>
              <ENT>1.00</ENT>
              <ENT>1.39</ENT>
              <ENT>0.42</ENT>
              <ENT>0.11</ENT>
              <ENT>2.50</ENT>
              <ENT>1.53</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15050</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin pinch graft</ENT>
              <ENT>4.30</ENT>
              <ENT>6.08</ENT>
              <ENT>4.81</ENT>
              <ENT>0.46</ENT>
              <ENT>10.84</ENT>
              <ENT>9.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin split graft</ENT>
              <ENT>9.05</ENT>
              <ENT>12.83</ENT>
              <ENT>7.89</ENT>
              <ENT>0.94</ENT>
              <ENT>22.82</ENT>
              <ENT>17.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15101</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin split graft add-on</ENT>
              <ENT>1.72</ENT>
              <ENT>3.89</ENT>
              <ENT>1.69</ENT>
              <ENT>0.18</ENT>
              <ENT>5.79</ENT>
              <ENT>3.59</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin split graft</ENT>
              <ENT>9.83</ENT>
              <ENT>11.04</ENT>
              <ENT>7.95</ENT>
              <ENT>0.90</ENT>
              <ENT>21.77</ENT>
              <ENT>18.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15121</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin split graft add-on</ENT>
              <ENT>2.67</ENT>
              <ENT>4.66</ENT>
              <ENT>1.91</ENT>
              <ENT>0.27</ENT>
              <ENT>7.60</ENT>
              <ENT>4.85</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin full graft</ENT>
              <ENT>8.03</ENT>
              <ENT>10.93</ENT>
              <ENT>6.11</ENT>
              <ENT>0.73</ENT>
              <ENT>19.69</ENT>
              <ENT>14.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15201</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin full graft add-on</ENT>
              <ENT>1.32</ENT>
              <ENT>1.06</ENT>
              <ENT>0.63</ENT>
              <ENT>0.14</ENT>
              <ENT>2.52</ENT>
              <ENT>2.09</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49077"/>
              <ENT I="01">15220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin full graft</ENT>
              <ENT>7.87</ENT>
              <ENT>10.82</ENT>
              <ENT>6.55</ENT>
              <ENT>0.68</ENT>
              <ENT>19.37</ENT>
              <ENT>15.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15221</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin full graft add-on</ENT>
              <ENT>1.19</ENT>
              <ENT>0.92</ENT>
              <ENT>0.58</ENT>
              <ENT>0.12</ENT>
              <ENT>2.23</ENT>
              <ENT>1.89</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15240</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin full graft</ENT>
              <ENT>9.04</ENT>
              <ENT>10.38</ENT>
              <ENT>7.80</ENT>
              <ENT>0.80</ENT>
              <ENT>20.22</ENT>
              <ENT>17.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15241</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin full graft add-on</ENT>
              <ENT>1.86</ENT>
              <ENT>1.48</ENT>
              <ENT>0.93</ENT>
              <ENT>0.17</ENT>
              <ENT>3.51</ENT>
              <ENT>2.96</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15260</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin full graft</ENT>
              <ENT>10.06</ENT>
              <ENT>10.10</ENT>
              <ENT>8.80</ENT>
              <ENT>0.63</ENT>
              <ENT>20.79</ENT>
              <ENT>19.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15261</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin full graft add-on</ENT>
              <ENT>2.23</ENT>
              <ENT>2.78</ENT>
              <ENT>1.45</ENT>
              <ENT>0.17</ENT>
              <ENT>5.18</ENT>
              <ENT>3.85</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15342</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cultured skin graft, 25 cm</ENT>
              <ENT>1.00</ENT>
              <ENT>1.84</ENT>
              <ENT>0.56</ENT>
              <ENT>0.09</ENT>
              <ENT>2.93</ENT>
              <ENT>1.65</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15343</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Culture skn graft addl 25 cm</ENT>
              <ENT>0.25</ENT>
              <ENT>0.27</ENT>
              <ENT>0.10</ENT>
              <ENT>0.02</ENT>
              <ENT>0.54</ENT>
              <ENT>0.37</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15350</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin homograft</ENT>
              <ENT>4.00</ENT>
              <ENT>8.37</ENT>
              <ENT>4.90</ENT>
              <ENT>0.42</ENT>
              <ENT>12.79</ENT>
              <ENT>9.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15351</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin homograft add-on</ENT>
              <ENT>1.00</ENT>
              <ENT>0.95</ENT>
              <ENT>0.40</ENT>
              <ENT>0.11</ENT>
              <ENT>2.06</ENT>
              <ENT>1.51</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin heterograft</ENT>
              <ENT>4.00</ENT>
              <ENT>4.28</ENT>
              <ENT>4.21</ENT>
              <ENT>0.40</ENT>
              <ENT>8.68</ENT>
              <ENT>8.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15401</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin heterograft add-on</ENT>
              <ENT>1.00</ENT>
              <ENT>1.23</ENT>
              <ENT>0.45</ENT>
              <ENT>0.11</ENT>
              <ENT>2.34</ENT>
              <ENT>1.56</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15570</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Form skin pedicle flap</ENT>
              <ENT>9.21</ENT>
              <ENT>9.27</ENT>
              <ENT>6.55</ENT>
              <ENT>0.96</ENT>
              <ENT>19.44</ENT>
              <ENT>16.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15572</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Form skin pedicle flap</ENT>
              <ENT>9.27</ENT>
              <ENT>8.58</ENT>
              <ENT>6.27</ENT>
              <ENT>0.93</ENT>
              <ENT>18.78</ENT>
              <ENT>16.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15574</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Form skin pedicle flap</ENT>
              <ENT>9.88</ENT>
              <ENT>8.98</ENT>
              <ENT>7.08</ENT>
              <ENT>0.92</ENT>
              <ENT>19.78</ENT>
              <ENT>17.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15576</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Form skin pedicle flap</ENT>
              <ENT>8.69</ENT>
              <ENT>9.61</ENT>
              <ENT>6.55</ENT>
              <ENT>0.72</ENT>
              <ENT>19.02</ENT>
              <ENT>15.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin graft</ENT>
              <ENT>1.91</ENT>
              <ENT>7.24</ENT>
              <ENT>2.75</ENT>
              <ENT>0.19</ENT>
              <ENT>9.34</ENT>
              <ENT>4.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15610</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin graft</ENT>
              <ENT>2.42</ENT>
              <ENT>3.83</ENT>
              <ENT>3.09</ENT>
              <ENT>0.25</ENT>
              <ENT>6.50</ENT>
              <ENT>5.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15620</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin graft</ENT>
              <ENT>2.94</ENT>
              <ENT>7.64</ENT>
              <ENT>3.75</ENT>
              <ENT>0.28</ENT>
              <ENT>10.86</ENT>
              <ENT>6.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15630</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin graft</ENT>
              <ENT>3.27</ENT>
              <ENT>7.00</ENT>
              <ENT>4.02</ENT>
              <ENT>0.28</ENT>
              <ENT>10.55</ENT>
              <ENT>7.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15650</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transfer skin pedicle flap</ENT>
              <ENT>3.97</ENT>
              <ENT>6.86</ENT>
              <ENT>4.10</ENT>
              <ENT>0.36</ENT>
              <ENT>11.19</ENT>
              <ENT>8.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15732</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Muscle-skin graft, head/neck</ENT>
              <ENT>17.84</ENT>
              <ENT>18.42</ENT>
              <ENT>12.48</ENT>
              <ENT>1.50</ENT>
              <ENT>37.76</ENT>
              <ENT>31.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15734</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Muscle-skin graft, trunk</ENT>
              <ENT>17.79</ENT>
              <ENT>18.28</ENT>
              <ENT>12.55</ENT>
              <ENT>1.91</ENT>
              <ENT>37.98</ENT>
              <ENT>32.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15736</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Muscle-skin graft, arm</ENT>
              <ENT>16.27</ENT>
              <ENT>18.50</ENT>
              <ENT>11.43</ENT>
              <ENT>1.78</ENT>
              <ENT>36.55</ENT>
              <ENT>29.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15738</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Muscle-skin graft, leg</ENT>
              <ENT>17.92</ENT>
              <ENT>18.28</ENT>
              <ENT>11.95</ENT>
              <ENT>1.95</ENT>
              <ENT>38.15</ENT>
              <ENT>31.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15740</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Island pedicle flap graft</ENT>
              <ENT>10.25</ENT>
              <ENT>9.97</ENT>
              <ENT>7.91</ENT>
              <ENT>0.62</ENT>
              <ENT>20.84</ENT>
              <ENT>18.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15750</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Neurovascular pedicle graft</ENT>
              <ENT>11.41</ENT>
              <ENT>N/A</ENT>
              <ENT>9.16</ENT>
              <ENT>1.16</ENT>
              <ENT>N/A</ENT>
              <ENT>21.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15756</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Free myo/skin flap microvasc</ENT>
              <ENT>35.23</ENT>
              <ENT>N/A</ENT>
              <ENT>21.18</ENT>
              <ENT>3.11</ENT>
              <ENT>N/A</ENT>
              <ENT>59.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15757</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Free skin flap, microvasc</ENT>
              <ENT>35.23</ENT>
              <ENT>N/A</ENT>
              <ENT>22.24</ENT>
              <ENT>3.37</ENT>
              <ENT>N/A</ENT>
              <ENT>60.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15758</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Free fascial flap, microvasc</ENT>
              <ENT>35.10</ENT>
              <ENT>N/A</ENT>
              <ENT>22.23</ENT>
              <ENT>3.52</ENT>
              <ENT>N/A</ENT>
              <ENT>60.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15760</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Composite skin graft</ENT>
              <ENT>8.74</ENT>
              <ENT>9.95</ENT>
              <ENT>7.16</ENT>
              <ENT>0.72</ENT>
              <ENT>19.41</ENT>
              <ENT>16.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15770</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Derma-fat-fascia graft</ENT>
              <ENT>7.52</ENT>
              <ENT>N/A</ENT>
              <ENT>6.84</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>15.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15775</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Hair transplant punch grafts</ENT>
              <ENT>3.96</ENT>
              <ENT>2.83</ENT>
              <ENT>1.35</ENT>
              <ENT>0.43</ENT>
              <ENT>7.22</ENT>
              <ENT>5.74</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15776</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Hair transplant punch grafts</ENT>
              <ENT>5.54</ENT>
              <ENT>5.49</ENT>
              <ENT>2.87</ENT>
              <ENT>0.60</ENT>
              <ENT>11.63</ENT>
              <ENT>9.01</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15780</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Abrasion treatment of skin</ENT>
              <ENT>7.29</ENT>
              <ENT>7.23</ENT>
              <ENT>7.23</ENT>
              <ENT>0.41</ENT>
              <ENT>14.93</ENT>
              <ENT>14.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15781</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Abrasion treatment of skin</ENT>
              <ENT>4.85</ENT>
              <ENT>5.46</ENT>
              <ENT>5.46</ENT>
              <ENT>0.27</ENT>
              <ENT>10.58</ENT>
              <ENT>10.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15782</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Abrasion treatment of skin</ENT>
              <ENT>4.32</ENT>
              <ENT>4.44</ENT>
              <ENT>4.44</ENT>
              <ENT>0.21</ENT>
              <ENT>8.97</ENT>
              <ENT>8.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15783</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Abrasion treatment of skin</ENT>
              <ENT>4.29</ENT>
              <ENT>5.04</ENT>
              <ENT>4.26</ENT>
              <ENT>0.26</ENT>
              <ENT>9.59</ENT>
              <ENT>8.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15786</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Abrasion, lesion, single</ENT>
              <ENT>2.03</ENT>
              <ENT>1.66</ENT>
              <ENT>1.30</ENT>
              <ENT>0.11</ENT>
              <ENT>3.80</ENT>
              <ENT>3.44</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15787</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Abrasion, lesions, add-on</ENT>
              <ENT>0.33</ENT>
              <ENT>0.32</ENT>
              <ENT>0.16</ENT>
              <ENT>0.02</ENT>
              <ENT>0.67</ENT>
              <ENT>0.51</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15788</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Chemical peel, face, epiderm</ENT>
              <ENT>2.09</ENT>
              <ENT>3.39</ENT>
              <ENT>2.24</ENT>
              <ENT>0.11</ENT>
              <ENT>5.59</ENT>
              <ENT>4.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15789</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Chemical peel, face, dermal</ENT>
              <ENT>4.92</ENT>
              <ENT>6.54</ENT>
              <ENT>5.06</ENT>
              <ENT>0.27</ENT>
              <ENT>11.73</ENT>
              <ENT>10.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15792</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Chemical peel, nonfacial</ENT>
              <ENT>1.86</ENT>
              <ENT>3.22</ENT>
              <ENT>2.82</ENT>
              <ENT>0.10</ENT>
              <ENT>5.18</ENT>
              <ENT>4.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15793</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chemical peel, nonfacial</ENT>
              <ENT>3.74</ENT>
              <ENT>N/A</ENT>
              <ENT>4.25</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>8.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15810</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Salabrasion</ENT>
              <ENT>4.74</ENT>
              <ENT>3.99</ENT>
              <ENT>3.99</ENT>
              <ENT>0.42</ENT>
              <ENT>9.15</ENT>
              <ENT>9.15</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15811</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Salabrasion</ENT>
              <ENT>5.39</ENT>
              <ENT>6.43</ENT>
              <ENT>5.62</ENT>
              <ENT>0.52</ENT>
              <ENT>12.34</ENT>
              <ENT>11.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15819</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Plastic surgery, neck</ENT>
              <ENT>9.38</ENT>
              <ENT>N/A</ENT>
              <ENT>7.36</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>17.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of lower eyelid</ENT>
              <ENT>5.15</ENT>
              <ENT>7.01</ENT>
              <ENT>5.48</ENT>
              <ENT>0.30</ENT>
              <ENT>12.46</ENT>
              <ENT>10.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15821</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of lower eyelid</ENT>
              <ENT>5.72</ENT>
              <ENT>7.40</ENT>
              <ENT>5.64</ENT>
              <ENT>0.31</ENT>
              <ENT>13.43</ENT>
              <ENT>11.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15822</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of upper eyelid</ENT>
              <ENT>4.45</ENT>
              <ENT>5.93</ENT>
              <ENT>4.45</ENT>
              <ENT>0.22</ENT>
              <ENT>10.60</ENT>
              <ENT>9.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15823</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of upper eyelid</ENT>
              <ENT>7.05</ENT>
              <ENT>7.93</ENT>
              <ENT>6.35</ENT>
              <ENT>0.32</ENT>
              <ENT>15.30</ENT>
              <ENT>13.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15824</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Removal of forehead wrinkles</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15825</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Removal of neck wrinkles</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15826</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Removal of brow wrinkles</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15828</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Removal of face wrinkles</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15829</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Removal of skin wrinkles</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49078"/>
              <ENT I="01">15831</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise excessive skin tissue</ENT>
              <ENT>12.40</ENT>
              <ENT>N/A</ENT>
              <ENT>8.36</ENT>
              <ENT>1.30</ENT>
              <ENT>N/A</ENT>
              <ENT>22.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15832</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise excessive skin tissue</ENT>
              <ENT>11.59</ENT>
              <ENT>N/A</ENT>
              <ENT>8.52</ENT>
              <ENT>1.21</ENT>
              <ENT>N/A</ENT>
              <ENT>21.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15833</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise excessive skin tissue</ENT>
              <ENT>10.64</ENT>
              <ENT>N/A</ENT>
              <ENT>8.22</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>20.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15834</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise excessive skin tissue</ENT>
              <ENT>10.85</ENT>
              <ENT>N/A</ENT>
              <ENT>7.80</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>19.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15835</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise excessive skin tissue</ENT>
              <ENT>11.67</ENT>
              <ENT>11.70</ENT>
              <ENT>7.76</ENT>
              <ENT>1.13</ENT>
              <ENT>24.50</ENT>
              <ENT>20.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15836</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise excessive skin tissue</ENT>
              <ENT>9.34</ENT>
              <ENT>N/A</ENT>
              <ENT>6.92</ENT>
              <ENT>0.95</ENT>
              <ENT>N/A</ENT>
              <ENT>17.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15837</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise excessive skin tissue</ENT>
              <ENT>8.43</ENT>
              <ENT>8.10</ENT>
              <ENT>7.12</ENT>
              <ENT>0.78</ENT>
              <ENT>17.31</ENT>
              <ENT>16.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15838</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise excessive skin tissue</ENT>
              <ENT>7.13</ENT>
              <ENT>N/A</ENT>
              <ENT>6.23</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>13.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15839</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise excessive skin tissue</ENT>
              <ENT>9.38</ENT>
              <ENT>8.02</ENT>
              <ENT>6.31</ENT>
              <ENT>0.88</ENT>
              <ENT>18.28</ENT>
              <ENT>16.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15840</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Graft for face nerve palsy</ENT>
              <ENT>13.26</ENT>
              <ENT>N/A</ENT>
              <ENT>10.32</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>24.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15841</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Graft for face nerve palsy</ENT>
              <ENT>23.26</ENT>
              <ENT>N/A</ENT>
              <ENT>15.38</ENT>
              <ENT>2.65</ENT>
              <ENT>N/A</ENT>
              <ENT>41.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15842</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Flap for face nerve palsy</ENT>
              <ENT>37.96</ENT>
              <ENT>N/A</ENT>
              <ENT>23.49</ENT>
              <ENT>3.99</ENT>
              <ENT>N/A</ENT>
              <ENT>65.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15845</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin and muscle repair, face</ENT>
              <ENT>12.57</ENT>
              <ENT>N/A</ENT>
              <ENT>9.34</ENT>
              <ENT>0.80</ENT>
              <ENT>N/A</ENT>
              <ENT>22.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15850</ENT>
              <ENT/>
              <ENT>B</ENT>
              <ENT>Removal of sutures</ENT>
              <ENT>0.78</ENT>
              <ENT>1.62</ENT>
              <ENT>0.30</ENT>
              <ENT>0.04</ENT>
              <ENT>2.44</ENT>
              <ENT>1.12</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15851</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of sutures</ENT>
              <ENT>0.86</ENT>
              <ENT>1.78</ENT>
              <ENT>0.34</ENT>
              <ENT>0.05</ENT>
              <ENT>2.69</ENT>
              <ENT>1.25</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15852</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dressing change,not for burn</ENT>
              <ENT>0.86</ENT>
              <ENT>1.90</ENT>
              <ENT>0.36</ENT>
              <ENT>0.07</ENT>
              <ENT>2.83</ENT>
              <ENT>1.29</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15860</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Test for blood flow in graft</ENT>
              <ENT>1.95</ENT>
              <ENT>1.30</ENT>
              <ENT>0.80</ENT>
              <ENT>0.13</ENT>
              <ENT>3.38</ENT>
              <ENT>2.88</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15876</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Suction assisted lipectomy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15877</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Suction assisted lipectomy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15878</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Suction assisted lipectomy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15879</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Suction assisted lipectomy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15920</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of tail bone ulcer</ENT>
              <ENT>7.95</ENT>
              <ENT>N/A</ENT>
              <ENT>5.68</ENT>
              <ENT>0.83</ENT>
              <ENT>N/A</ENT>
              <ENT>14.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15922</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of tail bone ulcer</ENT>
              <ENT>9.90</ENT>
              <ENT>N/A</ENT>
              <ENT>7.50</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>18.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15931</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove sacrum pressure sore</ENT>
              <ENT>9.24</ENT>
              <ENT>N/A</ENT>
              <ENT>5.83</ENT>
              <ENT>0.95</ENT>
              <ENT>N/A</ENT>
              <ENT>16.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15933</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove sacrum pressure sore</ENT>
              <ENT>10.85</ENT>
              <ENT>N/A</ENT>
              <ENT>8.07</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>20.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15934</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove sacrum pressure sore</ENT>
              <ENT>12.69</ENT>
              <ENT>N/A</ENT>
              <ENT>8.35</ENT>
              <ENT>1.35</ENT>
              <ENT>N/A</ENT>
              <ENT>22.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15935</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove sacrum pressure sore</ENT>
              <ENT>14.57</ENT>
              <ENT>N/A</ENT>
              <ENT>10.51</ENT>
              <ENT>1.56</ENT>
              <ENT>N/A</ENT>
              <ENT>26.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15936</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove sacrum pressure sore</ENT>
              <ENT>12.38</ENT>
              <ENT>N/A</ENT>
              <ENT>8.66</ENT>
              <ENT>1.32</ENT>
              <ENT>N/A</ENT>
              <ENT>22.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15937</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove sacrum pressure sore</ENT>
              <ENT>14.21</ENT>
              <ENT>N/A</ENT>
              <ENT>10.23</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>25.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15940</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove hip pressure sore</ENT>
              <ENT>9.34</ENT>
              <ENT>N/A</ENT>
              <ENT>6.33</ENT>
              <ENT>0.98</ENT>
              <ENT>N/A</ENT>
              <ENT>16.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15941</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove hip pressure sore</ENT>
              <ENT>11.43</ENT>
              <ENT>N/A</ENT>
              <ENT>9.75</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>22.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15944</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove hip pressure sore</ENT>
              <ENT>11.46</ENT>
              <ENT>N/A</ENT>
              <ENT>8.87</ENT>
              <ENT>1.21</ENT>
              <ENT>N/A</ENT>
              <ENT>21.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15945</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove hip pressure sore</ENT>
              <ENT>12.69</ENT>
              <ENT>N/A</ENT>
              <ENT>9.92</ENT>
              <ENT>1.38</ENT>
              <ENT>N/A</ENT>
              <ENT>23.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15946</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove hip pressure sore</ENT>
              <ENT>21.57</ENT>
              <ENT>N/A</ENT>
              <ENT>14.86</ENT>
              <ENT>2.32</ENT>
              <ENT>N/A</ENT>
              <ENT>38.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15950</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove thigh pressure sore</ENT>
              <ENT>7.54</ENT>
              <ENT>N/A</ENT>
              <ENT>5.54</ENT>
              <ENT>0.80</ENT>
              <ENT>N/A</ENT>
              <ENT>13.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15951</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove thigh pressure sore</ENT>
              <ENT>10.72</ENT>
              <ENT>N/A</ENT>
              <ENT>8.08</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>19.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15952</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove thigh pressure sore</ENT>
              <ENT>11.39</ENT>
              <ENT>N/A</ENT>
              <ENT>7.81</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>20.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15953</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove thigh pressure sore</ENT>
              <ENT>12.63</ENT>
              <ENT>N/A</ENT>
              <ENT>9.22</ENT>
              <ENT>1.38</ENT>
              <ENT>N/A</ENT>
              <ENT>23.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15956</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove thigh pressure sore</ENT>
              <ENT>15.52</ENT>
              <ENT>N/A</ENT>
              <ENT>10.96</ENT>
              <ENT>1.64</ENT>
              <ENT>N/A</ENT>
              <ENT>28.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15958</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove thigh pressure sore</ENT>
              <ENT>15.48</ENT>
              <ENT>N/A</ENT>
              <ENT>11.24</ENT>
              <ENT>1.66</ENT>
              <ENT>N/A</ENT>
              <ENT>28.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">15999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Removal of pressure sore</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">16000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Initial treatment of burn(s)</ENT>
              <ENT>0.89</ENT>
              <ENT>0.89</ENT>
              <ENT>0.27</ENT>
              <ENT>0.06</ENT>
              <ENT>1.84</ENT>
              <ENT>1.22</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">16010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of burn(s)</ENT>
              <ENT>0.87</ENT>
              <ENT>0.68</ENT>
              <ENT>0.65</ENT>
              <ENT>0.07</ENT>
              <ENT>1.62</ENT>
              <ENT>1.59</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49079"/>
              <ENT I="01">16015</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of burn(s)</ENT>
              <ENT>2.35</ENT>
              <ENT>N/A</ENT>
              <ENT>1.18</ENT>
              <ENT>0.22</ENT>
              <ENT>N/A</ENT>
              <ENT>3.75</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">16020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of burn(s)</ENT>
              <ENT>0.80</ENT>
              <ENT>1.31</ENT>
              <ENT>0.62</ENT>
              <ENT>0.06</ENT>
              <ENT>2.17</ENT>
              <ENT>1.48</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">16025</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of burn(s)</ENT>
              <ENT>1.85</ENT>
              <ENT>1.82</ENT>
              <ENT>0.99</ENT>
              <ENT>0.16</ENT>
              <ENT>3.83</ENT>
              <ENT>3.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">16030</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of burn(s)</ENT>
              <ENT>2.08</ENT>
              <ENT>2.24</ENT>
              <ENT>1.14</ENT>
              <ENT>0.18</ENT>
              <ENT>4.50</ENT>
              <ENT>3.40</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">16035</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of burn scab, initi</ENT>
              <ENT>3.75</ENT>
              <ENT>N/A</ENT>
              <ENT>1.49</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>5.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">16036</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise burn scab, addl incis</ENT>
              <ENT>1.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.61</ENT>
              <ENT>0.11</ENT>
              <ENT>N/A</ENT>
              <ENT>2.22</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destroy benign/premlg lesion</ENT>
              <ENT>0.60</ENT>
              <ENT>1.00</ENT>
              <ENT>0.32</ENT>
              <ENT>0.03</ENT>
              <ENT>1.63</ENT>
              <ENT>0.95</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17003</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destroy lesions, 2-14</ENT>
              <ENT>0.15</ENT>
              <ENT>0.11</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.27</ENT>
              <ENT>0.23</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17004</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destroy lesions, 15 or more</ENT>
              <ENT>2.79</ENT>
              <ENT>2.37</ENT>
              <ENT>1.32</ENT>
              <ENT>0.12</ENT>
              <ENT>5.28</ENT>
              <ENT>4.23</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17106</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction of skin lesions</ENT>
              <ENT>4.59</ENT>
              <ENT>5.01</ENT>
              <ENT>3.29</ENT>
              <ENT>0.28</ENT>
              <ENT>9.88</ENT>
              <ENT>8.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17107</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction of skin lesions</ENT>
              <ENT>9.16</ENT>
              <ENT>7.69</ENT>
              <ENT>5.45</ENT>
              <ENT>0.53</ENT>
              <ENT>17.38</ENT>
              <ENT>15.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17108</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction of skin lesions</ENT>
              <ENT>13.20</ENT>
              <ENT>9.82</ENT>
              <ENT>7.72</ENT>
              <ENT>0.89</ENT>
              <ENT>23.91</ENT>
              <ENT>21.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruct lesion, 1-14</ENT>
              <ENT>0.65</ENT>
              <ENT>1.68</ENT>
              <ENT>0.51</ENT>
              <ENT>0.04</ENT>
              <ENT>2.37</ENT>
              <ENT>1.20</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17111</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruct lesion, 15 or more</ENT>
              <ENT>0.92</ENT>
              <ENT>1.73</ENT>
              <ENT>0.61</ENT>
              <ENT>0.04</ENT>
              <ENT>2.69</ENT>
              <ENT>1.57</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chemical cautery, tissue</ENT>
              <ENT>0.50</ENT>
              <ENT>1.26</ENT>
              <ENT>0.35</ENT>
              <ENT>0.04</ENT>
              <ENT>1.80</ENT>
              <ENT>0.89</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17260</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction of skin lesions</ENT>
              <ENT>0.91</ENT>
              <ENT>1.32</ENT>
              <ENT>0.46</ENT>
              <ENT>0.04</ENT>
              <ENT>2.27</ENT>
              <ENT>1.41</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17261</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction of skin lesions</ENT>
              <ENT>1.17</ENT>
              <ENT>1.66</ENT>
              <ENT>0.60</ENT>
              <ENT>0.05</ENT>
              <ENT>2.88</ENT>
              <ENT>1.82</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17262</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction of skin lesions</ENT>
              <ENT>1.58</ENT>
              <ENT>1.94</ENT>
              <ENT>0.80</ENT>
              <ENT>0.07</ENT>
              <ENT>3.59</ENT>
              <ENT>2.45</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17263</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction of skin lesions</ENT>
              <ENT>1.79</ENT>
              <ENT>2.12</ENT>
              <ENT>0.87</ENT>
              <ENT>0.08</ENT>
              <ENT>3.99</ENT>
              <ENT>2.74</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17264</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction of skin lesions</ENT>
              <ENT>1.94</ENT>
              <ENT>2.28</ENT>
              <ENT>0.90</ENT>
              <ENT>0.08</ENT>
              <ENT>4.30</ENT>
              <ENT>2.92</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17266</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction of skin lesions</ENT>
              <ENT>2.34</ENT>
              <ENT>2.58</ENT>
              <ENT>1.01</ENT>
              <ENT>0.11</ENT>
              <ENT>5.03</ENT>
              <ENT>3.46</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17270</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction of skin lesions</ENT>
              <ENT>1.32</ENT>
              <ENT>1.75</ENT>
              <ENT>0.65</ENT>
              <ENT>0.06</ENT>
              <ENT>3.13</ENT>
              <ENT>2.03</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17271</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction of skin lesions</ENT>
              <ENT>1.49</ENT>
              <ENT>1.83</ENT>
              <ENT>0.76</ENT>
              <ENT>0.06</ENT>
              <ENT>3.38</ENT>
              <ENT>2.31</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17272</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction of skin lesions</ENT>
              <ENT>1.77</ENT>
              <ENT>2.05</ENT>
              <ENT>0.90</ENT>
              <ENT>0.07</ENT>
              <ENT>3.89</ENT>
              <ENT>2.74</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17273</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction of skin lesions</ENT>
              <ENT>2.05</ENT>
              <ENT>2.26</ENT>
              <ENT>1.01</ENT>
              <ENT>0.09</ENT>
              <ENT>4.40</ENT>
              <ENT>3.15</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17274</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction of skin lesions</ENT>
              <ENT>2.59</ENT>
              <ENT>2.63</ENT>
              <ENT>1.23</ENT>
              <ENT>0.11</ENT>
              <ENT>5.33</ENT>
              <ENT>3.93</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17276</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction of skin lesions</ENT>
              <ENT>3.20</ENT>
              <ENT>3.03</ENT>
              <ENT>1.47</ENT>
              <ENT>0.15</ENT>
              <ENT>6.38</ENT>
              <ENT>4.82</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17280</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction of skin lesions</ENT>
              <ENT>1.17</ENT>
              <ENT>1.66</ENT>
              <ENT>0.58</ENT>
              <ENT>0.05</ENT>
              <ENT>2.88</ENT>
              <ENT>1.80</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17281</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction of skin lesions</ENT>
              <ENT>1.72</ENT>
              <ENT>1.96</ENT>
              <ENT>0.87</ENT>
              <ENT>0.07</ENT>
              <ENT>3.75</ENT>
              <ENT>2.66</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17282</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction of skin lesions</ENT>
              <ENT>2.04</ENT>
              <ENT>2.21</ENT>
              <ENT>1.03</ENT>
              <ENT>0.09</ENT>
              <ENT>4.34</ENT>
              <ENT>3.16</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17283</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction of skin lesions</ENT>
              <ENT>2.64</ENT>
              <ENT>2.61</ENT>
              <ENT>1.28</ENT>
              <ENT>0.11</ENT>
              <ENT>5.36</ENT>
              <ENT>4.03</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17284</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction of skin lesions</ENT>
              <ENT>3.21</ENT>
              <ENT>3.01</ENT>
              <ENT>1.55</ENT>
              <ENT>0.14</ENT>
              <ENT>6.36</ENT>
              <ENT>4.90</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17286</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction of skin lesions</ENT>
              <ENT>4.44</ENT>
              <ENT>3.79</ENT>
              <ENT>2.24</ENT>
              <ENT>0.22</ENT>
              <ENT>8.45</ENT>
              <ENT>6.90</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17304</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>1 stage mohs, up to 5 spec</ENT>
              <ENT>7.60</ENT>
              <ENT>8.28</ENT>
              <ENT>3.65</ENT>
              <ENT>0.31</ENT>
              <ENT>16.19</ENT>
              <ENT>11.56</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17305</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>2 stage mohs, up to 5 spec</ENT>
              <ENT>2.85</ENT>
              <ENT>3.90</ENT>
              <ENT>1.37</ENT>
              <ENT>0.12</ENT>
              <ENT>6.87</ENT>
              <ENT>4.34</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17306</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>3 stage mohs, up to 5 spec</ENT>
              <ENT>2.85</ENT>
              <ENT>3.92</ENT>
              <ENT>1.38</ENT>
              <ENT>0.12</ENT>
              <ENT>6.89</ENT>
              <ENT>4.35</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17307</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mohs addl stage up to 5 spec</ENT>
              <ENT>2.85</ENT>
              <ENT>3.87</ENT>
              <ENT>1.40</ENT>
              <ENT>0.12</ENT>
              <ENT>6.84</ENT>
              <ENT>4.37</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17310</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mohs any stage &gt; 5 spec each</ENT>
              <ENT>0.62</ENT>
              <ENT>1.51</ENT>
              <ENT>0.31</ENT>
              <ENT>0.05</ENT>
              <ENT>2.18</ENT>
              <ENT>0.98</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17340</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cryotherapy of skin</ENT>
              <ENT>0.76</ENT>
              <ENT>0.38</ENT>
              <ENT>0.31</ENT>
              <ENT>0.04</ENT>
              <ENT>1.18</ENT>
              <ENT>1.11</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17360</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skin peel therapy</ENT>
              <ENT>1.43</ENT>
              <ENT>1.50</ENT>
              <ENT>0.77</ENT>
              <ENT>0.06</ENT>
              <ENT>2.99</ENT>
              <ENT>2.26</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17380</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Hair removal by electrolysis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">17999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Skin tissue procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of breast lesion</ENT>
              <ENT>0.84</ENT>
              <ENT>2.06</ENT>
              <ENT>0.36</ENT>
              <ENT>0.07</ENT>
              <ENT>2.97</ENT>
              <ENT>1.27</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19001</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain breast lesion add-on</ENT>
              <ENT>0.42</ENT>
              <ENT>0.80</ENT>
              <ENT>0.14</ENT>
              <ENT>0.03</ENT>
              <ENT>1.25</ENT>
              <ENT>0.59</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of breast lesion</ENT>
              <ENT>3.57</ENT>
              <ENT>6.13</ENT>
              <ENT>2.84</ENT>
              <ENT>0.35</ENT>
              <ENT>10.05</ENT>
              <ENT>6.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19030</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection for breast x-ray</ENT>
              <ENT>1.53</ENT>
              <ENT>3.40</ENT>
              <ENT>0.51</ENT>
              <ENT>0.07</ENT>
              <ENT>5.00</ENT>
              <ENT>2.11</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bx breast percut w/o image</ENT>
              <ENT>1.27</ENT>
              <ENT>2.17</ENT>
              <ENT>0.43</ENT>
              <ENT>0.10</ENT>
              <ENT>3.54</ENT>
              <ENT>1.80</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19101</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of breast, open</ENT>
              <ENT>3.18</ENT>
              <ENT>4.74</ENT>
              <ENT>1.71</ENT>
              <ENT>0.20</ENT>
              <ENT>8.12</ENT>
              <ENT>5.09</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19102</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bx breast percut w/image</ENT>
              <ENT>2.00</ENT>
              <ENT>4.02</ENT>
              <ENT>0.67</ENT>
              <ENT>0.13</ENT>
              <ENT>6.15</ENT>
              <ENT>2.80</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19103</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bx breast percut w/device</ENT>
              <ENT>3.70</ENT>
              <ENT>12.24</ENT>
              <ENT>1.26</ENT>
              <ENT>0.16</ENT>
              <ENT>16.10</ENT>
              <ENT>5.12</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nipple exploration</ENT>
              <ENT>4.30</ENT>
              <ENT>7.47</ENT>
              <ENT>3.21</ENT>
              <ENT>0.44</ENT>
              <ENT>12.21</ENT>
              <ENT>7.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19112</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise breast duct fistula</ENT>
              <ENT>3.67</ENT>
              <ENT>7.85</ENT>
              <ENT>2.74</ENT>
              <ENT>0.38</ENT>
              <ENT>11.90</ENT>
              <ENT>6.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of breast lesion</ENT>
              <ENT>5.56</ENT>
              <ENT>4.64</ENT>
              <ENT>3.11</ENT>
              <ENT>0.56</ENT>
              <ENT>10.76</ENT>
              <ENT>9.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19125</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision, breast lesion</ENT>
              <ENT>6.06</ENT>
              <ENT>4.88</ENT>
              <ENT>3.34</ENT>
              <ENT>0.61</ENT>
              <ENT>11.55</ENT>
              <ENT>10.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49080"/>
              <ENT I="01">19126</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision, addl breast lesion</ENT>
              <ENT>2.93</ENT>
              <ENT>N/A</ENT>
              <ENT>1.02</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>4.25</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of breast tissue</ENT>
              <ENT>5.14</ENT>
              <ENT>7.35</ENT>
              <ENT>3.44</ENT>
              <ENT>0.52</ENT>
              <ENT>13.01</ENT>
              <ENT>9.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19160</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of breast tissue</ENT>
              <ENT>5.99</ENT>
              <ENT>N/A</ENT>
              <ENT>3.48</ENT>
              <ENT>0.61</ENT>
              <ENT>N/A</ENT>
              <ENT>10.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19162</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove breast tissue, nodes</ENT>
              <ENT>13.53</ENT>
              <ENT>N/A</ENT>
              <ENT>6.46</ENT>
              <ENT>1.38</ENT>
              <ENT>N/A</ENT>
              <ENT>21.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19180</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of breast</ENT>
              <ENT>8.80</ENT>
              <ENT>N/A</ENT>
              <ENT>5.11</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>14.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19182</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of breast</ENT>
              <ENT>7.73</ENT>
              <ENT>N/A</ENT>
              <ENT>4.84</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>13.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of breast</ENT>
              <ENT>15.49</ENT>
              <ENT>N/A</ENT>
              <ENT>8.12</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>25.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of breast</ENT>
              <ENT>15.72</ENT>
              <ENT>N/A</ENT>
              <ENT>8.39</ENT>
              <ENT>1.56</ENT>
              <ENT>N/A</ENT>
              <ENT>25.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19240</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of breast</ENT>
              <ENT>16.00</ENT>
              <ENT>N/A</ENT>
              <ENT>8.37</ENT>
              <ENT>1.62</ENT>
              <ENT>N/A</ENT>
              <ENT>25.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19260</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of chest wall lesion</ENT>
              <ENT>15.44</ENT>
              <ENT>N/A</ENT>
              <ENT>11.09</ENT>
              <ENT>1.64</ENT>
              <ENT>N/A</ENT>
              <ENT>28.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19271</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of chest wall</ENT>
              <ENT>18.90</ENT>
              <ENT>N/A</ENT>
              <ENT>17.48</ENT>
              <ENT>2.27</ENT>
              <ENT>N/A</ENT>
              <ENT>38.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19272</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive chest wall surgery</ENT>
              <ENT>21.55</ENT>
              <ENT>N/A</ENT>
              <ENT>18.27</ENT>
              <ENT>2.54</ENT>
              <ENT>N/A</ENT>
              <ENT>42.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19290</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Place needle wire, breast</ENT>
              <ENT>1.27</ENT>
              <ENT>3.03</ENT>
              <ENT>0.43</ENT>
              <ENT>0.06</ENT>
              <ENT>4.36</ENT>
              <ENT>1.76</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19291</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Place needle wire, breast</ENT>
              <ENT>0.63</ENT>
              <ENT>1.76</ENT>
              <ENT>0.21</ENT>
              <ENT>0.03</ENT>
              <ENT>2.42</ENT>
              <ENT>0.87</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19295</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Place breast clip, percut</ENT>
              <ENT>0.00</ENT>
              <ENT>2.83</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>2.84</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19316</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Suspension of breast</ENT>
              <ENT>10.69</ENT>
              <ENT>N/A</ENT>
              <ENT>7.83</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>19.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19318</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reduction of large breast</ENT>
              <ENT>15.62</ENT>
              <ENT>N/A</ENT>
              <ENT>11.42</ENT>
              <ENT>1.69</ENT>
              <ENT>N/A</ENT>
              <ENT>28.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19324</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Enlarge breast</ENT>
              <ENT>5.85</ENT>
              <ENT>N/A</ENT>
              <ENT>5.01</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>11.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19325</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Enlarge breast with implant</ENT>
              <ENT>8.45</ENT>
              <ENT>N/A</ENT>
              <ENT>6.71</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>16.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19328</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of breast implant</ENT>
              <ENT>5.68</ENT>
              <ENT>N/A</ENT>
              <ENT>5.17</ENT>
              <ENT>0.61</ENT>
              <ENT>N/A</ENT>
              <ENT>11.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19330</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of implant material</ENT>
              <ENT>7.59</ENT>
              <ENT>N/A</ENT>
              <ENT>6.09</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>14.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19340</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Immediate breast prosthesis</ENT>
              <ENT>6.33</ENT>
              <ENT>N/A</ENT>
              <ENT>3.18</ENT>
              <ENT>0.68</ENT>
              <ENT>N/A</ENT>
              <ENT>10.19</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19342</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Delayed breast prosthesis</ENT>
              <ENT>11.20</ENT>
              <ENT>N/A</ENT>
              <ENT>8.95</ENT>
              <ENT>1.21</ENT>
              <ENT>N/A</ENT>
              <ENT>21.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19350</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Breast reconstruction</ENT>
              <ENT>8.92</ENT>
              <ENT>14.46</ENT>
              <ENT>7.25</ENT>
              <ENT>0.95</ENT>
              <ENT>24.33</ENT>
              <ENT>17.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19355</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Correct inverted nipple(s)</ENT>
              <ENT>7.57</ENT>
              <ENT>13.06</ENT>
              <ENT>5.12</ENT>
              <ENT>0.80</ENT>
              <ENT>21.43</ENT>
              <ENT>13.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19357</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Breast reconstruction</ENT>
              <ENT>18.16</ENT>
              <ENT>N/A</ENT>
              <ENT>14.13</ENT>
              <ENT>1.96</ENT>
              <ENT>N/A</ENT>
              <ENT>34.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19361</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Breast reconstruction</ENT>
              <ENT>19.26</ENT>
              <ENT>N/A</ENT>
              <ENT>12.01</ENT>
              <ENT>2.08</ENT>
              <ENT>N/A</ENT>
              <ENT>33.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19364</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Breast reconstruction</ENT>
              <ENT>41.00</ENT>
              <ENT>N/A</ENT>
              <ENT>24.08</ENT>
              <ENT>3.91</ENT>
              <ENT>N/A</ENT>
              <ENT>68.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19366</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Breast reconstruction</ENT>
              <ENT>21.28</ENT>
              <ENT>N/A</ENT>
              <ENT>11.44</ENT>
              <ENT>2.27</ENT>
              <ENT>N/A</ENT>
              <ENT>34.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19367</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Breast reconstruction</ENT>
              <ENT>25.73</ENT>
              <ENT>N/A</ENT>
              <ENT>16.89</ENT>
              <ENT>2.78</ENT>
              <ENT>N/A</ENT>
              <ENT>45.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19368</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Breast reconstruction</ENT>
              <ENT>32.42</ENT>
              <ENT>N/A</ENT>
              <ENT>20.65</ENT>
              <ENT>3.51</ENT>
              <ENT>N/A</ENT>
              <ENT>56.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19369</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Breast reconstruction</ENT>
              <ENT>29.82</ENT>
              <ENT>N/A</ENT>
              <ENT>20.17</ENT>
              <ENT>3.24</ENT>
              <ENT>N/A</ENT>
              <ENT>53.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19370</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Surgery of breast capsule</ENT>
              <ENT>8.05</ENT>
              <ENT>N/A</ENT>
              <ENT>6.98</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>15.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19371</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of breast capsule</ENT>
              <ENT>9.35</ENT>
              <ENT>N/A</ENT>
              <ENT>8.02</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>18.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19380</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise breast reconstruction</ENT>
              <ENT>9.14</ENT>
              <ENT>N/A</ENT>
              <ENT>7.90</ENT>
              <ENT>0.98</ENT>
              <ENT>N/A</ENT>
              <ENT>18.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19396</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Design custom breast implant</ENT>
              <ENT>2.17</ENT>
              <ENT>5.91</ENT>
              <ENT>1.01</ENT>
              <ENT>0.23</ENT>
              <ENT>8.31</ENT>
              <ENT>3.41</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">19499</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Breast surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of abscess</ENT>
              <ENT>2.12</ENT>
              <ENT>2.44</ENT>
              <ENT>1.63</ENT>
              <ENT>0.17</ENT>
              <ENT>4.73</ENT>
              <ENT>3.92</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20005</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of deep abscess</ENT>
              <ENT>3.42</ENT>
              <ENT>3.44</ENT>
              <ENT>2.15</ENT>
              <ENT>0.34</ENT>
              <ENT>7.20</ENT>
              <ENT>5.91</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore wound, neck</ENT>
              <ENT>10.08</ENT>
              <ENT>5.92</ENT>
              <ENT>4.44</ENT>
              <ENT>0.99</ENT>
              <ENT>16.99</ENT>
              <ENT>15.51</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20101</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore wound, chest</ENT>
              <ENT>3.22</ENT>
              <ENT>3.02</ENT>
              <ENT>1.61</ENT>
              <ENT>0.24</ENT>
              <ENT>6.48</ENT>
              <ENT>5.07</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20102</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore wound, abdomen</ENT>
              <ENT>3.94</ENT>
              <ENT>3.57</ENT>
              <ENT>1.82</ENT>
              <ENT>0.35</ENT>
              <ENT>7.86</ENT>
              <ENT>6.11</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20103</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore wound, extremity</ENT>
              <ENT>5.30</ENT>
              <ENT>4.25</ENT>
              <ENT>3.28</ENT>
              <ENT>0.57</ENT>
              <ENT>10.12</ENT>
              <ENT>9.15</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise epiphyseal bar</ENT>
              <ENT>13.69</ENT>
              <ENT>N/A</ENT>
              <ENT>7.37</ENT>
              <ENT>0.96</ENT>
              <ENT>N/A</ENT>
              <ENT>22.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Muscle biopsy</ENT>
              <ENT>1.46</ENT>
              <ENT>3.20</ENT>
              <ENT>0.79</ENT>
              <ENT>0.17</ENT>
              <ENT>4.83</ENT>
              <ENT>2.42</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20205</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Deep muscle biopsy</ENT>
              <ENT>2.35</ENT>
              <ENT>4.21</ENT>
              <ENT>1.23</ENT>
              <ENT>0.23</ENT>
              <ENT>6.79</ENT>
              <ENT>3.81</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20206</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Needle biopsy, muscle</ENT>
              <ENT>0.99</ENT>
              <ENT>3.23</ENT>
              <ENT>0.35</ENT>
              <ENT>0.06</ENT>
              <ENT>4.28</ENT>
              <ENT>1.40</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bone biopsy, trocar/needle</ENT>
              <ENT>1.27</ENT>
              <ENT>4.83</ENT>
              <ENT>2.80</ENT>
              <ENT>0.06</ENT>
              <ENT>6.16</ENT>
              <ENT>4.13</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20225</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bone biopsy, trocar/needle</ENT>
              <ENT>1.87</ENT>
              <ENT>4.37</ENT>
              <ENT>2.95</ENT>
              <ENT>0.11</ENT>
              <ENT>6.35</ENT>
              <ENT>4.93</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20240</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bone biopsy, excisional</ENT>
              <ENT>3.23</ENT>
              <ENT>N/A</ENT>
              <ENT>2.56</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>6.12</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20245</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bone biopsy, excisional</ENT>
              <ENT>7.78</ENT>
              <ENT>N/A</ENT>
              <ENT>6.39</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>14.61</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Open bone biopsy</ENT>
              <ENT>5.03</ENT>
              <ENT>N/A</ENT>
              <ENT>4.61</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>10.14</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20251</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Open bone biopsy</ENT>
              <ENT>5.56</ENT>
              <ENT>N/A</ENT>
              <ENT>5.26</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>11.61</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection of sinus tract</ENT>
              <ENT>1.23</ENT>
              <ENT>6.00</ENT>
              <ENT>3.86</ENT>
              <ENT>0.10</ENT>
              <ENT>7.33</ENT>
              <ENT>5.19</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20501</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inject sinus tract for x-ray</ENT>
              <ENT>0.76</ENT>
              <ENT>3.04</ENT>
              <ENT>0.25</ENT>
              <ENT>0.03</ENT>
              <ENT>3.83</ENT>
              <ENT>1.04</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of foreign body</ENT>
              <ENT>1.85</ENT>
              <ENT>2.28</ENT>
              <ENT>1.82</ENT>
              <ENT>0.17</ENT>
              <ENT>4.30</ENT>
              <ENT>3.84</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20525</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of foreign body</ENT>
              <ENT>3.50</ENT>
              <ENT>3.44</ENT>
              <ENT>2.68</ENT>
              <ENT>0.40</ENT>
              <ENT>7.34</ENT>
              <ENT>6.58</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49081"/>
              <ENT I="01">20526</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ther injection, carp tunnel</ENT>
              <ENT>0.94</ENT>
              <ENT>0.98</ENT>
              <ENT>0.52</ENT>
              <ENT>0.06</ENT>
              <ENT>1.98</ENT>
              <ENT>1.52</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20550</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inj tendon sheath/ligament</ENT>
              <ENT>0.75</ENT>
              <ENT>0.73</ENT>
              <ENT>0.24</ENT>
              <ENT>0.06</ENT>
              <ENT>1.54</ENT>
              <ENT>1.05</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20551</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inject tendon origin/insert</ENT>
              <ENT>0.75</ENT>
              <ENT>0.70</ENT>
              <ENT>0.34</ENT>
              <ENT>0.06</ENT>
              <ENT>1.51</ENT>
              <ENT>1.15</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20552</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inject trigger point, 1 or 2</ENT>
              <ENT>0.66</ENT>
              <ENT>0.74</ENT>
              <ENT>0.21</ENT>
              <ENT>0.06</ENT>
              <ENT>1.46</ENT>
              <ENT>0.93</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20553</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inject trigger points, =/&gt; 3</ENT>
              <ENT>0.75</ENT>
              <ENT>0.85</ENT>
              <ENT>0.22</ENT>
              <ENT>0.06</ENT>
              <ENT>1.66</ENT>
              <ENT>1.03</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain/inject, joint/bursa</ENT>
              <ENT>0.66</ENT>
              <ENT>0.66</ENT>
              <ENT>0.36</ENT>
              <ENT>0.06</ENT>
              <ENT>1.38</ENT>
              <ENT>1.08</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain/inject, joint/bursa</ENT>
              <ENT>0.68</ENT>
              <ENT>0.77</ENT>
              <ENT>0.37</ENT>
              <ENT>0.06</ENT>
              <ENT>1.51</ENT>
              <ENT>1.11</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20610</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain/inject, joint/bursa</ENT>
              <ENT>0.79</ENT>
              <ENT>0.96</ENT>
              <ENT>0.42</ENT>
              <ENT>0.08</ENT>
              <ENT>1.83</ENT>
              <ENT>1.29</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20612</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Aspirate/inj ganglion cyst</ENT>
              <ENT>0.70</ENT>
              <ENT>0.73</ENT>
              <ENT>0.34</ENT>
              <ENT>0.06</ENT>
              <ENT>1.49</ENT>
              <ENT>1.10</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20615</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of bone cyst</ENT>
              <ENT>2.28</ENT>
              <ENT>2.59</ENT>
              <ENT>1.82</ENT>
              <ENT>0.19</ENT>
              <ENT>5.06</ENT>
              <ENT>4.29</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20650</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert and remove bone pin</ENT>
              <ENT>2.23</ENT>
              <ENT>2.47</ENT>
              <ENT>1.97</ENT>
              <ENT>0.28</ENT>
              <ENT>4.98</ENT>
              <ENT>4.48</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20660</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apply, rem fixation device</ENT>
              <ENT>2.51</ENT>
              <ENT>3.12</ENT>
              <ENT>1.74</ENT>
              <ENT>0.48</ENT>
              <ENT>6.11</ENT>
              <ENT>4.73</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20661</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of head brace</ENT>
              <ENT>4.89</ENT>
              <ENT>N/A</ENT>
              <ENT>5.05</ENT>
              <ENT>0.92</ENT>
              <ENT>N/A</ENT>
              <ENT>10.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20662</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of pelvis brace</ENT>
              <ENT>6.07</ENT>
              <ENT>N/A</ENT>
              <ENT>5.54</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>12.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20663</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of thigh brace</ENT>
              <ENT>5.43</ENT>
              <ENT>N/A</ENT>
              <ENT>4.86</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>11.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20664</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Halo brace application</ENT>
              <ENT>8.06</ENT>
              <ENT>N/A</ENT>
              <ENT>7.16</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>16.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20665</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of fixation device</ENT>
              <ENT>1.31</ENT>
              <ENT>1.98</ENT>
              <ENT>1.32</ENT>
              <ENT>0.17</ENT>
              <ENT>3.46</ENT>
              <ENT>2.80</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20670</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of support implant</ENT>
              <ENT>1.74</ENT>
              <ENT>6.83</ENT>
              <ENT>3.98</ENT>
              <ENT>0.23</ENT>
              <ENT>8.80</ENT>
              <ENT>5.95</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20680</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of support implant</ENT>
              <ENT>3.35</ENT>
              <ENT>3.44</ENT>
              <ENT>3.44</ENT>
              <ENT>0.46</ENT>
              <ENT>7.25</ENT>
              <ENT>7.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20690</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apply bone fixation device</ENT>
              <ENT>3.52</ENT>
              <ENT>N/A</ENT>
              <ENT>2.51</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>6.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20692</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apply bone fixation device</ENT>
              <ENT>6.41</ENT>
              <ENT>N/A</ENT>
              <ENT>3.80</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>10.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20693</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Adjust bone fixation device</ENT>
              <ENT>5.86</ENT>
              <ENT>N/A</ENT>
              <ENT>8.43</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>15.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20694</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove bone fixation device</ENT>
              <ENT>4.16</ENT>
              <ENT>7.10</ENT>
              <ENT>4.64</ENT>
              <ENT>0.57</ENT>
              <ENT>11.83</ENT>
              <ENT>9.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20802</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replantation, arm, complete</ENT>
              <ENT>41.15</ENT>
              <ENT>N/A</ENT>
              <ENT>21.97</ENT>
              <ENT>5.81</ENT>
              <ENT>N/A</ENT>
              <ENT>68.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20805</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replant forearm, complete</ENT>
              <ENT>50.00</ENT>
              <ENT>N/A</ENT>
              <ENT>35.96</ENT>
              <ENT>3.95</ENT>
              <ENT>N/A</ENT>
              <ENT>89.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20808</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replantation hand, complete</ENT>
              <ENT>61.65</ENT>
              <ENT>N/A</ENT>
              <ENT>44.22</ENT>
              <ENT>6.49</ENT>
              <ENT>N/A</ENT>
              <ENT>112.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20816</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replantation digit, complete</ENT>
              <ENT>30.94</ENT>
              <ENT>N/A</ENT>
              <ENT>40.19</ENT>
              <ENT>3.01</ENT>
              <ENT>N/A</ENT>
              <ENT>74.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20822</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replantation digit, complete</ENT>
              <ENT>25.59</ENT>
              <ENT>N/A</ENT>
              <ENT>36.64</ENT>
              <ENT>3.07</ENT>
              <ENT>N/A</ENT>
              <ENT>65.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20824</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replantation thumb, complete</ENT>
              <ENT>30.94</ENT>
              <ENT>N/A</ENT>
              <ENT>38.92</ENT>
              <ENT>3.48</ENT>
              <ENT>N/A</ENT>
              <ENT>73.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20827</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replantation thumb, complete</ENT>
              <ENT>26.41</ENT>
              <ENT>N/A</ENT>
              <ENT>38.68</ENT>
              <ENT>3.21</ENT>
              <ENT>N/A</ENT>
              <ENT>68.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20838</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replantation foot, complete</ENT>
              <ENT>41.41</ENT>
              <ENT>N/A</ENT>
              <ENT>22.96</ENT>
              <ENT>5.85</ENT>
              <ENT>N/A</ENT>
              <ENT>70.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20900</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of bone for graft</ENT>
              <ENT>5.58</ENT>
              <ENT>7.43</ENT>
              <ENT>5.57</ENT>
              <ENT>0.77</ENT>
              <ENT>13.78</ENT>
              <ENT>11.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20902</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of bone for graft</ENT>
              <ENT>7.55</ENT>
              <ENT>N/A</ENT>
              <ENT>7.06</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>15.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20910</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove cartilage for graft</ENT>
              <ENT>5.34</ENT>
              <ENT>7.19</ENT>
              <ENT>5.51</ENT>
              <ENT>0.50</ENT>
              <ENT>13.03</ENT>
              <ENT>11.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20912</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove cartilage for graft</ENT>
              <ENT>6.35</ENT>
              <ENT>N/A</ENT>
              <ENT>6.21</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>13.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20920</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of fascia for graft</ENT>
              <ENT>5.31</ENT>
              <ENT>N/A</ENT>
              <ENT>4.48</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>10.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20922</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of fascia for graft</ENT>
              <ENT>6.61</ENT>
              <ENT>6.90</ENT>
              <ENT>5.18</ENT>
              <ENT>0.88</ENT>
              <ENT>14.39</ENT>
              <ENT>12.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20924</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of tendon for graft</ENT>
              <ENT>6.48</ENT>
              <ENT>N/A</ENT>
              <ENT>6.00</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>13.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20926</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of tissue for graft</ENT>
              <ENT>5.53</ENT>
              <ENT>N/A</ENT>
              <ENT>5.06</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>11.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20931</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Spinal bone allograft</ENT>
              <ENT>1.81</ENT>
              <ENT>N/A</ENT>
              <ENT>0.95</ENT>
              <ENT>0.34</ENT>
              <ENT>N/A</ENT>
              <ENT>3.10</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20937</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Spinal bone autograft</ENT>
              <ENT>2.79</ENT>
              <ENT>N/A</ENT>
              <ENT>1.49</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>4.71</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20938</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Spinal bone autograft</ENT>
              <ENT>3.02</ENT>
              <ENT>N/A</ENT>
              <ENT>1.59</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>5.13</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20950</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fluid pressure, muscle</ENT>
              <ENT>1.26</ENT>
              <ENT>1.39</ENT>
              <ENT>1.02</ENT>
              <ENT>0.16</ENT>
              <ENT>2.81</ENT>
              <ENT>2.44</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20955</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fibula bone graft, microvasc</ENT>
              <ENT>39.21</ENT>
              <ENT>N/A</ENT>
              <ENT>25.69</ENT>
              <ENT>4.35</ENT>
              <ENT>N/A</ENT>
              <ENT>69.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20956</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Iliac bone graft, microvasc</ENT>
              <ENT>39.27</ENT>
              <ENT>N/A</ENT>
              <ENT>25.40</ENT>
              <ENT>5.77</ENT>
              <ENT>N/A</ENT>
              <ENT>70.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20957</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mt bone graft, microvasc</ENT>
              <ENT>40.65</ENT>
              <ENT>N/A</ENT>
              <ENT>19.47</ENT>
              <ENT>5.74</ENT>
              <ENT>N/A</ENT>
              <ENT>65.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20962</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Other bone graft, microvasc</ENT>
              <ENT>39.27</ENT>
              <ENT>N/A</ENT>
              <ENT>26.91</ENT>
              <ENT>5.19</ENT>
              <ENT>N/A</ENT>
              <ENT>71.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20969</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bone/skin graft, microvasc</ENT>
              <ENT>43.92</ENT>
              <ENT>N/A</ENT>
              <ENT>28.25</ENT>
              <ENT>4.34</ENT>
              <ENT>N/A</ENT>
              <ENT>76.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20970</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bone/skin graft, iliac crest</ENT>
              <ENT>43.06</ENT>
              <ENT>N/A</ENT>
              <ENT>26.58</ENT>
              <ENT>4.64</ENT>
              <ENT>N/A</ENT>
              <ENT>74.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20972</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bone/skin graft, metatarsal</ENT>
              <ENT>42.99</ENT>
              <ENT>21.88</ENT>
              <ENT>20.34</ENT>
              <ENT>6.07</ENT>
              <ENT>70.94</ENT>
              <ENT>69.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20973</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bone/skin graft, great toe</ENT>
              <ENT>45.76</ENT>
              <ENT>N/A</ENT>
              <ENT>25.64</ENT>
              <ENT>4.65</ENT>
              <ENT>N/A</ENT>
              <ENT>76.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20974</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Electrical bone stimulation</ENT>
              <ENT>0.62</ENT>
              <ENT>0.63</ENT>
              <ENT>0.56</ENT>
              <ENT>0.09</ENT>
              <ENT>1.34</ENT>
              <ENT>1.27</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49082"/>
              <ENT I="01">20975</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Electrical bone stimulation</ENT>
              <ENT>2.60</ENT>
              <ENT>N/A</ENT>
              <ENT>1.76</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>4.78</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20979</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Us bone stimulation</ENT>
              <ENT>0.62</ENT>
              <ENT>0.78</ENT>
              <ENT>0.34</ENT>
              <ENT>0.04</ENT>
              <ENT>1.44</ENT>
              <ENT>1.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">20999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Musculoskeletal surgery</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of jaw joint</ENT>
              <ENT>10.14</ENT>
              <ENT>N/A</ENT>
              <ENT>7.41</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>18.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21015</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Resection of facial tumor</ENT>
              <ENT>5.29</ENT>
              <ENT>N/A</ENT>
              <ENT>5.73</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>11.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21025</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of bone, lower jaw</ENT>
              <ENT>10.06</ENT>
              <ENT>10.50</ENT>
              <ENT>8.40</ENT>
              <ENT>0.79</ENT>
              <ENT>21.35</ENT>
              <ENT>19.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21026</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of facial bone(s)</ENT>
              <ENT>4.85</ENT>
              <ENT>7.20</ENT>
              <ENT>5.70</ENT>
              <ENT>0.40</ENT>
              <ENT>12.45</ENT>
              <ENT>10.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21029</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contour of face bone lesion</ENT>
              <ENT>7.71</ENT>
              <ENT>8.89</ENT>
              <ENT>6.44</ENT>
              <ENT>0.74</ENT>
              <ENT>17.34</ENT>
              <ENT>14.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21030</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise max/zygoma b9 tumor</ENT>
              <ENT>3.89</ENT>
              <ENT>5.93</ENT>
              <ENT>4.17</ENT>
              <ENT>0.60</ENT>
              <ENT>10.42</ENT>
              <ENT>8.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21031</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove exostosis, mandible</ENT>
              <ENT>3.24</ENT>
              <ENT>4.74</ENT>
              <ENT>3.18</ENT>
              <ENT>0.28</ENT>
              <ENT>8.26</ENT>
              <ENT>6.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21032</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove exostosis, maxilla</ENT>
              <ENT>3.24</ENT>
              <ENT>4.78</ENT>
              <ENT>3.29</ENT>
              <ENT>0.27</ENT>
              <ENT>8.29</ENT>
              <ENT>6.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21034</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise max/zygoma mlg tumor</ENT>
              <ENT>16.17</ENT>
              <ENT>13.91</ENT>
              <ENT>11.51</ENT>
              <ENT>1.37</ENT>
              <ENT>31.45</ENT>
              <ENT>29.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21040</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise mandible lesion</ENT>
              <ENT>3.89</ENT>
              <ENT>5.79</ENT>
              <ENT>3.84</ENT>
              <ENT>0.19</ENT>
              <ENT>9.87</ENT>
              <ENT>7.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21044</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of jaw bone lesion</ENT>
              <ENT>11.86</ENT>
              <ENT>N/A</ENT>
              <ENT>8.95</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>21.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21045</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive jaw surgery</ENT>
              <ENT>16.17</ENT>
              <ENT>N/A</ENT>
              <ENT>11.75</ENT>
              <ENT>1.20</ENT>
              <ENT>N/A</ENT>
              <ENT>29.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21046</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove mandible cyst complex</ENT>
              <ENT>13.00</ENT>
              <ENT>N/A</ENT>
              <ENT>13.21</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>27.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21047</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise lwr jaw cyst w/repair</ENT>
              <ENT>18.75</ENT>
              <ENT>N/A</ENT>
              <ENT>13.84</ENT>
              <ENT>1.53</ENT>
              <ENT>N/A</ENT>
              <ENT>34.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21048</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove maxilla cyst complex</ENT>
              <ENT>13.50</ENT>
              <ENT>N/A</ENT>
              <ENT>13.50</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>28.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21049</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excis uppr jaw cyst w/repair</ENT>
              <ENT>18.00</ENT>
              <ENT>N/A</ENT>
              <ENT>13.41</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>32.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21050</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of jaw joint</ENT>
              <ENT>10.77</ENT>
              <ENT>N/A</ENT>
              <ENT>10.66</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>22.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21060</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove jaw joint cartilage</ENT>
              <ENT>10.23</ENT>
              <ENT>N/A</ENT>
              <ENT>10.18</ENT>
              <ENT>1.16</ENT>
              <ENT>N/A</ENT>
              <ENT>21.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21070</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove coronoid process</ENT>
              <ENT>8.20</ENT>
              <ENT>N/A</ENT>
              <ENT>7.25</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>16.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21076</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prepare face/oral prosthesis</ENT>
              <ENT>13.42</ENT>
              <ENT>13.19</ENT>
              <ENT>10.52</ENT>
              <ENT>1.36</ENT>
              <ENT>27.97</ENT>
              <ENT>25.30</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21077</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prepare face/oral prosthesis</ENT>
              <ENT>33.75</ENT>
              <ENT>33.45</ENT>
              <ENT>27.14</ENT>
              <ENT>3.43</ENT>
              <ENT>70.63</ENT>
              <ENT>64.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21079</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prepare face/oral prosthesis</ENT>
              <ENT>22.34</ENT>
              <ENT>23.11</ENT>
              <ENT>18.12</ENT>
              <ENT>1.59</ENT>
              <ENT>47.04</ENT>
              <ENT>42.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21080</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prepare face/oral prosthesis</ENT>
              <ENT>25.10</ENT>
              <ENT>26.21</ENT>
              <ENT>20.48</ENT>
              <ENT>2.55</ENT>
              <ENT>53.86</ENT>
              <ENT>48.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21081</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prepare face/oral prosthesis</ENT>
              <ENT>22.88</ENT>
              <ENT>23.87</ENT>
              <ENT>18.42</ENT>
              <ENT>1.87</ENT>
              <ENT>48.62</ENT>
              <ENT>43.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21082</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prepare face/oral prosthesis</ENT>
              <ENT>20.87</ENT>
              <ENT>20.66</ENT>
              <ENT>16.57</ENT>
              <ENT>1.46</ENT>
              <ENT>42.99</ENT>
              <ENT>38.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21083</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prepare face/oral prosthesis</ENT>
              <ENT>19.30</ENT>
              <ENT>20.13</ENT>
              <ENT>15.24</ENT>
              <ENT>1.96</ENT>
              <ENT>41.39</ENT>
              <ENT>36.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21084</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prepare face/oral prosthesis</ENT>
              <ENT>22.51</ENT>
              <ENT>23.94</ENT>
              <ENT>18.60</ENT>
              <ENT>1.57</ENT>
              <ENT>48.02</ENT>
              <ENT>42.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21085</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prepare face/oral prosthesis</ENT>
              <ENT>9.00</ENT>
              <ENT>8.84</ENT>
              <ENT>7.11</ENT>
              <ENT>0.65</ENT>
              <ENT>18.49</ENT>
              <ENT>16.76</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21086</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prepare face/oral prosthesis</ENT>
              <ENT>24.92</ENT>
              <ENT>25.25</ENT>
              <ENT>20.19</ENT>
              <ENT>1.86</ENT>
              <ENT>52.03</ENT>
              <ENT>46.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21087</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prepare face/oral prosthesis</ENT>
              <ENT>24.92</ENT>
              <ENT>24.82</ENT>
              <ENT>20.06</ENT>
              <ENT>2.22</ENT>
              <ENT>51.96</ENT>
              <ENT>47.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21088</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Prepare face/oral prosthesis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21089</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Prepare face/oral prosthesis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Maxillofacial fixation</ENT>
              <ENT>4.22</ENT>
              <ENT>5.72</ENT>
              <ENT>4.67</ENT>
              <ENT>0.18</ENT>
              <ENT>10.12</ENT>
              <ENT>9.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Interdental fixation</ENT>
              <ENT>5.21</ENT>
              <ENT>7.23</ENT>
              <ENT>5.78</ENT>
              <ENT>0.28</ENT>
              <ENT>12.72</ENT>
              <ENT>11.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21116</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection, jaw joint x-ray</ENT>
              <ENT>0.81</ENT>
              <ENT>5.67</ENT>
              <ENT>0.34</ENT>
              <ENT>0.05</ENT>
              <ENT>6.53</ENT>
              <ENT>1.20</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of chin</ENT>
              <ENT>4.93</ENT>
              <ENT>9.00</ENT>
              <ENT>5.39</ENT>
              <ENT>0.29</ENT>
              <ENT>14.22</ENT>
              <ENT>10.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21121</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of chin</ENT>
              <ENT>7.64</ENT>
              <ENT>10.71</ENT>
              <ENT>6.82</ENT>
              <ENT>0.56</ENT>
              <ENT>18.91</ENT>
              <ENT>15.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21122</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of chin</ENT>
              <ENT>8.52</ENT>
              <ENT>N/A</ENT>
              <ENT>7.35</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>16.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21123</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of chin</ENT>
              <ENT>11.16</ENT>
              <ENT>N/A</ENT>
              <ENT>8.49</ENT>
              <ENT>1.16</ENT>
              <ENT>N/A</ENT>
              <ENT>20.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49083"/>
              <ENT I="01">21125</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Augmentation, lower jaw bone</ENT>
              <ENT>10.62</ENT>
              <ENT>12.09</ENT>
              <ENT>8.47</ENT>
              <ENT>0.72</ENT>
              <ENT>23.43</ENT>
              <ENT>19.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21127</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Augmentation, lower jaw bone</ENT>
              <ENT>11.12</ENT>
              <ENT>14.95</ENT>
              <ENT>9.29</ENT>
              <ENT>0.76</ENT>
              <ENT>26.83</ENT>
              <ENT>21.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21137</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reduction of forehead</ENT>
              <ENT>9.82</ENT>
              <ENT>N/A</ENT>
              <ENT>7.62</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>17.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21138</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reduction of forehead</ENT>
              <ENT>12.19</ENT>
              <ENT>N/A</ENT>
              <ENT>9.53</ENT>
              <ENT>1.47</ENT>
              <ENT>N/A</ENT>
              <ENT>23.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21139</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reduction of forehead</ENT>
              <ENT>14.61</ENT>
              <ENT>N/A</ENT>
              <ENT>10.04</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>25.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21141</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct midface, lefort</ENT>
              <ENT>18.10</ENT>
              <ENT>N/A</ENT>
              <ENT>14.30</ENT>
              <ENT>1.63</ENT>
              <ENT>N/A</ENT>
              <ENT>34.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21142</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct midface, lefort</ENT>
              <ENT>18.81</ENT>
              <ENT>N/A</ENT>
              <ENT>13.41</ENT>
              <ENT>1.16</ENT>
              <ENT>N/A</ENT>
              <ENT>33.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21143</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct midface, lefort</ENT>
              <ENT>19.58</ENT>
              <ENT>N/A</ENT>
              <ENT>14.55</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>35.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21145</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct midface, lefort</ENT>
              <ENT>19.94</ENT>
              <ENT>N/A</ENT>
              <ENT>14.57</ENT>
              <ENT>2.09</ENT>
              <ENT>N/A</ENT>
              <ENT>36.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21146</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct midface, lefort</ENT>
              <ENT>20.71</ENT>
              <ENT>N/A</ENT>
              <ENT>16.02</ENT>
              <ENT>2.13</ENT>
              <ENT>N/A</ENT>
              <ENT>38.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21147</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct midface, lefort</ENT>
              <ENT>21.77</ENT>
              <ENT>N/A</ENT>
              <ENT>15.70</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>38.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct midface, lefort</ENT>
              <ENT>25.24</ENT>
              <ENT>N/A</ENT>
              <ENT>14.42</ENT>
              <ENT>1.09</ENT>
              <ENT>N/A</ENT>
              <ENT>40.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21151</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct midface, lefort</ENT>
              <ENT>28.30</ENT>
              <ENT>N/A</ENT>
              <ENT>17.70</ENT>
              <ENT>1.98</ENT>
              <ENT>N/A</ENT>
              <ENT>47.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21154</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct midface, lefort</ENT>
              <ENT>30.52</ENT>
              <ENT>N/A</ENT>
              <ENT>20.75</ENT>
              <ENT>4.86</ENT>
              <ENT>N/A</ENT>
              <ENT>56.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21155</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct midface, lefort</ENT>
              <ENT>34.45</ENT>
              <ENT>N/A</ENT>
              <ENT>21.92</ENT>
              <ENT>5.48</ENT>
              <ENT>N/A</ENT>
              <ENT>61.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21159</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct midface, lefort</ENT>
              <ENT>42.38</ENT>
              <ENT>N/A</ENT>
              <ENT>25.08</ENT>
              <ENT>6.74</ENT>
              <ENT>N/A</ENT>
              <ENT>74.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21160</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct midface, lefort</ENT>
              <ENT>46.44</ENT>
              <ENT>N/A</ENT>
              <ENT>24.97</ENT>
              <ENT>4.39</ENT>
              <ENT>N/A</ENT>
              <ENT>75.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21172</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct orbit/forehead</ENT>
              <ENT>27.80</ENT>
              <ENT>N/A</ENT>
              <ENT>14.45</ENT>
              <ENT>1.91</ENT>
              <ENT>N/A</ENT>
              <ENT>44.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21175</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct orbit/forehead</ENT>
              <ENT>33.17</ENT>
              <ENT>N/A</ENT>
              <ENT>18.80</ENT>
              <ENT>5.16</ENT>
              <ENT>N/A</ENT>
              <ENT>57.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21179</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct entire forehead</ENT>
              <ENT>22.25</ENT>
              <ENT>N/A</ENT>
              <ENT>15.41</ENT>
              <ENT>2.48</ENT>
              <ENT>N/A</ENT>
              <ENT>40.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21180</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct entire forehead</ENT>
              <ENT>25.19</ENT>
              <ENT>N/A</ENT>
              <ENT>16.64</ENT>
              <ENT>2.15</ENT>
              <ENT>N/A</ENT>
              <ENT>43.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21181</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contour cranial bone lesion</ENT>
              <ENT>9.90</ENT>
              <ENT>N/A</ENT>
              <ENT>7.69</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>18.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21182</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct cranial bone</ENT>
              <ENT>32.19</ENT>
              <ENT>N/A</ENT>
              <ENT>20.18</ENT>
              <ENT>2.53</ENT>
              <ENT>N/A</ENT>
              <ENT>54.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21183</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct cranial bone</ENT>
              <ENT>35.31</ENT>
              <ENT>N/A</ENT>
              <ENT>21.89</ENT>
              <ENT>2.75</ENT>
              <ENT>N/A</ENT>
              <ENT>59.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21184</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct cranial bone</ENT>
              <ENT>38.24</ENT>
              <ENT>N/A</ENT>
              <ENT>22.40</ENT>
              <ENT>4.12</ENT>
              <ENT>N/A</ENT>
              <ENT>64.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21188</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of midface</ENT>
              <ENT>22.46</ENT>
              <ENT>N/A</ENT>
              <ENT>15.69</ENT>
              <ENT>1.85</ENT>
              <ENT>N/A</ENT>
              <ENT>40.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21193</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconst lwr jaw w/o graft</ENT>
              <ENT>17.15</ENT>
              <ENT>N/A</ENT>
              <ENT>13.39</ENT>
              <ENT>1.53</ENT>
              <ENT>N/A</ENT>
              <ENT>32.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21194</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconst lwr jaw w/graft</ENT>
              <ENT>19.84</ENT>
              <ENT>N/A</ENT>
              <ENT>14.47</ENT>
              <ENT>1.39</ENT>
              <ENT>N/A</ENT>
              <ENT>35.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21195</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconst lwr jaw w/o fixation</ENT>
              <ENT>17.24</ENT>
              <ENT>N/A</ENT>
              <ENT>13.70</ENT>
              <ENT>1.20</ENT>
              <ENT>N/A</ENT>
              <ENT>32.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21196</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconst lwr jaw w/fixation</ENT>
              <ENT>18.91</ENT>
              <ENT>N/A</ENT>
              <ENT>14.31</ENT>
              <ENT>1.62</ENT>
              <ENT>N/A</ENT>
              <ENT>34.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21198</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstr lwr jaw segment</ENT>
              <ENT>14.16</ENT>
              <ENT>N/A</ENT>
              <ENT>11.32</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>26.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21199</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstr lwr jaw w/advance</ENT>
              <ENT>16.00</ENT>
              <ENT>N/A</ENT>
              <ENT>9.40</ENT>
              <ENT>1.26</ENT>
              <ENT>N/A</ENT>
              <ENT>26.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21206</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct upper jaw bone</ENT>
              <ENT>14.10</ENT>
              <ENT>N/A</ENT>
              <ENT>11.14</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>26.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21208</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Augmentation of facial bones</ENT>
              <ENT>10.23</ENT>
              <ENT>14.95</ENT>
              <ENT>9.40</ENT>
              <ENT>0.92</ENT>
              <ENT>26.10</ENT>
              <ENT>20.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21209</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reduction of facial bones</ENT>
              <ENT>6.72</ENT>
              <ENT>12.17</ENT>
              <ENT>7.28</ENT>
              <ENT>0.60</ENT>
              <ENT>19.49</ENT>
              <ENT>14.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21210</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Face bone graft</ENT>
              <ENT>10.23</ENT>
              <ENT>14.17</ENT>
              <ENT>9.66</ENT>
              <ENT>0.88</ENT>
              <ENT>25.28</ENT>
              <ENT>20.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21215</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lower jaw bone graft</ENT>
              <ENT>10.77</ENT>
              <ENT>13.96</ENT>
              <ENT>9.86</ENT>
              <ENT>1.04</ENT>
              <ENT>25.77</ENT>
              <ENT>21.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21230</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rib cartilage graft</ENT>
              <ENT>10.77</ENT>
              <ENT>N/A</ENT>
              <ENT>8.86</ENT>
              <ENT>0.96</ENT>
              <ENT>N/A</ENT>
              <ENT>20.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21235</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ear cartilage graft</ENT>
              <ENT>6.72</ENT>
              <ENT>11.67</ENT>
              <ENT>7.25</ENT>
              <ENT>0.52</ENT>
              <ENT>18.91</ENT>
              <ENT>14.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21240</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of jaw joint</ENT>
              <ENT>14.05</ENT>
              <ENT>N/A</ENT>
              <ENT>13.17</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>28.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21242</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of jaw joint</ENT>
              <ENT>12.95</ENT>
              <ENT>N/A</ENT>
              <ENT>12.63</ENT>
              <ENT>1.40</ENT>
              <ENT>N/A</ENT>
              <ENT>26.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21243</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of jaw joint</ENT>
              <ENT>20.79</ENT>
              <ENT>N/A</ENT>
              <ENT>18.48</ENT>
              <ENT>1.85</ENT>
              <ENT>N/A</ENT>
              <ENT>41.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21244</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of lower jaw</ENT>
              <ENT>11.86</ENT>
              <ENT>N/A</ENT>
              <ENT>10.35</ENT>
              <ENT>0.95</ENT>
              <ENT>N/A</ENT>
              <ENT>23.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21245</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of jaw</ENT>
              <ENT>11.86</ENT>
              <ENT>16.69</ENT>
              <ENT>10.05</ENT>
              <ENT>0.88</ENT>
              <ENT>29.43</ENT>
              <ENT>22.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21246</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of jaw</ENT>
              <ENT>12.47</ENT>
              <ENT>15.05</ENT>
              <ENT>10.13</ENT>
              <ENT>1.21</ENT>
              <ENT>28.73</ENT>
              <ENT>23.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21247</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct lower jaw bone</ENT>
              <ENT>22.63</ENT>
              <ENT>N/A</ENT>
              <ENT>18.53</ENT>
              <ENT>2.21</ENT>
              <ENT>N/A</ENT>
              <ENT>43.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21248</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of jaw</ENT>
              <ENT>11.48</ENT>
              <ENT>13.46</ENT>
              <ENT>9.59</ENT>
              <ENT>1.01</ENT>
              <ENT>25.95</ENT>
              <ENT>22.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21249</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of jaw</ENT>
              <ENT>17.52</ENT>
              <ENT>17.12</ENT>
              <ENT>13.05</ENT>
              <ENT>1.39</ENT>
              <ENT>36.03</ENT>
              <ENT>31.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21255</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct lower jaw bone</ENT>
              <ENT>16.72</ENT>
              <ENT>N/A</ENT>
              <ENT>12.98</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>30.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21256</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of orbit</ENT>
              <ENT>16.19</ENT>
              <ENT>N/A</ENT>
              <ENT>12.47</ENT>
              <ENT>1.04</ENT>
              <ENT>N/A</ENT>
              <ENT>29.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21260</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise eye sockets</ENT>
              <ENT>16.52</ENT>
              <ENT>N/A</ENT>
              <ENT>9.13</ENT>
              <ENT>1.25</ENT>
              <ENT>N/A</ENT>
              <ENT>26.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21261</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise eye sockets</ENT>
              <ENT>31.49</ENT>
              <ENT>N/A</ENT>
              <ENT>19.67</ENT>
              <ENT>2.20</ENT>
              <ENT>N/A</ENT>
              <ENT>53.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21263</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise eye sockets</ENT>
              <ENT>28.42</ENT>
              <ENT>N/A</ENT>
              <ENT>13.14</ENT>
              <ENT>2.16</ENT>
              <ENT>N/A</ENT>
              <ENT>43.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21267</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise eye sockets</ENT>
              <ENT>18.90</ENT>
              <ENT>N/A</ENT>
              <ENT>13.58</ENT>
              <ENT>1.35</ENT>
              <ENT>N/A</ENT>
              <ENT>33.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49084"/>
              <ENT I="01">21268</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise eye sockets</ENT>
              <ENT>24.48</ENT>
              <ENT>N/A</ENT>
              <ENT>15.66</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>40.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21270</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Augmentation, cheek bone</ENT>
              <ENT>10.23</ENT>
              <ENT>12.35</ENT>
              <ENT>8.36</ENT>
              <ENT>0.73</ENT>
              <ENT>23.31</ENT>
              <ENT>19.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21275</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision, orbitofacial bones</ENT>
              <ENT>11.24</ENT>
              <ENT>N/A</ENT>
              <ENT>9.10</ENT>
              <ENT>1.03</ENT>
              <ENT>N/A</ENT>
              <ENT>21.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21280</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of eyelid</ENT>
              <ENT>6.03</ENT>
              <ENT>N/A</ENT>
              <ENT>6.18</ENT>
              <ENT>0.27</ENT>
              <ENT>N/A</ENT>
              <ENT>12.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21282</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of eyelid</ENT>
              <ENT>3.49</ENT>
              <ENT>N/A</ENT>
              <ENT>4.84</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>8.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21295</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of jaw muscle/bone</ENT>
              <ENT>1.53</ENT>
              <ENT>N/A</ENT>
              <ENT>3.02</ENT>
              <ENT>0.13</ENT>
              <ENT>N/A</ENT>
              <ENT>4.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21296</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of jaw muscle/bone</ENT>
              <ENT>4.25</ENT>
              <ENT>N/A</ENT>
              <ENT>4.65</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>9.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21299</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Cranio/maxillofacial surgery</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of skull fracture</ENT>
              <ENT>0.72</ENT>
              <ENT>2.48</ENT>
              <ENT>0.26</ENT>
              <ENT>0.09</ENT>
              <ENT>3.29</ENT>
              <ENT>1.07</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21310</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of nose fracture</ENT>
              <ENT>0.58</ENT>
              <ENT>2.44</ENT>
              <ENT>0.15</ENT>
              <ENT>0.05</ENT>
              <ENT>3.07</ENT>
              <ENT>0.78</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21315</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of nose fracture</ENT>
              <ENT>1.51</ENT>
              <ENT>3.18</ENT>
              <ENT>1.31</ENT>
              <ENT>0.12</ENT>
              <ENT>4.81</ENT>
              <ENT>2.94</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of nose fracture</ENT>
              <ENT>1.85</ENT>
              <ENT>4.44</ENT>
              <ENT>1.89</ENT>
              <ENT>0.15</ENT>
              <ENT>6.44</ENT>
              <ENT>3.89</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21325</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of nose fracture</ENT>
              <ENT>3.77</ENT>
              <ENT>N/A</ENT>
              <ENT>3.84</ENT>
              <ENT>0.31</ENT>
              <ENT>N/A</ENT>
              <ENT>7.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21330</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of nose fracture</ENT>
              <ENT>5.38</ENT>
              <ENT>N/A</ENT>
              <ENT>5.44</ENT>
              <ENT>0.48</ENT>
              <ENT>N/A</ENT>
              <ENT>11.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21335</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of nose fracture</ENT>
              <ENT>8.61</ENT>
              <ENT>N/A</ENT>
              <ENT>7.02</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>16.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21336</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat nasal septal fracture</ENT>
              <ENT>5.72</ENT>
              <ENT>N/A</ENT>
              <ENT>6.18</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>12.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21337</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat nasal septal fracture</ENT>
              <ENT>2.70</ENT>
              <ENT>5.27</ENT>
              <ENT>3.75</ENT>
              <ENT>0.22</ENT>
              <ENT>8.19</ENT>
              <ENT>6.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21338</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat nasoethmoid fracture</ENT>
              <ENT>6.46</ENT>
              <ENT>N/A</ENT>
              <ENT>6.14</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>13.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21339</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat nasoethmoid fracture</ENT>
              <ENT>8.09</ENT>
              <ENT>N/A</ENT>
              <ENT>6.90</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>15.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21340</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of nose fracture</ENT>
              <ENT>10.77</ENT>
              <ENT>N/A</ENT>
              <ENT>8.99</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>20.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21343</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of sinus fracture</ENT>
              <ENT>12.95</ENT>
              <ENT>N/A</ENT>
              <ENT>10.37</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>24.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21344</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of sinus fracture</ENT>
              <ENT>19.72</ENT>
              <ENT>N/A</ENT>
              <ENT>14.00</ENT>
              <ENT>1.72</ENT>
              <ENT>N/A</ENT>
              <ENT>35.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21345</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat nose/jaw fracture</ENT>
              <ENT>8.16</ENT>
              <ENT>12.01</ENT>
              <ENT>8.21</ENT>
              <ENT>0.60</ENT>
              <ENT>20.77</ENT>
              <ENT>16.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21346</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat nose/jaw fracture</ENT>
              <ENT>10.61</ENT>
              <ENT>13.67</ENT>
              <ENT>9.41</ENT>
              <ENT>0.85</ENT>
              <ENT>25.13</ENT>
              <ENT>20.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21347</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat nose/jaw fracture</ENT>
              <ENT>12.69</ENT>
              <ENT>N/A</ENT>
              <ENT>10.02</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>23.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21348</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat nose/jaw fracture</ENT>
              <ENT>16.69</ENT>
              <ENT>N/A</ENT>
              <ENT>11.60</ENT>
              <ENT>1.50</ENT>
              <ENT>N/A</ENT>
              <ENT>29.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21355</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat cheek bone fracture</ENT>
              <ENT>3.77</ENT>
              <ENT>4.86</ENT>
              <ENT>2.43</ENT>
              <ENT>0.29</ENT>
              <ENT>8.92</ENT>
              <ENT>6.49</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21356</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat cheek bone fracture</ENT>
              <ENT>4.15</ENT>
              <ENT>12.21</ENT>
              <ENT>3.31</ENT>
              <ENT>0.36</ENT>
              <ENT>16.72</ENT>
              <ENT>7.82</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21360</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat cheek bone fracture</ENT>
              <ENT>6.46</ENT>
              <ENT>14.59</ENT>
              <ENT>6.32</ENT>
              <ENT>0.52</ENT>
              <ENT>21.57</ENT>
              <ENT>13.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21365</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat cheek bone fracture</ENT>
              <ENT>14.95</ENT>
              <ENT>N/A</ENT>
              <ENT>12.08</ENT>
              <ENT>1.30</ENT>
              <ENT>N/A</ENT>
              <ENT>28.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21366</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat cheek bone fracture</ENT>
              <ENT>17.77</ENT>
              <ENT>N/A</ENT>
              <ENT>11.97</ENT>
              <ENT>1.41</ENT>
              <ENT>N/A</ENT>
              <ENT>31.15</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21385</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat eye socket fracture</ENT>
              <ENT>9.16</ENT>
              <ENT>N/A</ENT>
              <ENT>7.32</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>17.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21386</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat eye socket fracture</ENT>
              <ENT>9.16</ENT>
              <ENT>N/A</ENT>
              <ENT>7.73</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>17.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21387</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat eye socket fracture</ENT>
              <ENT>9.70</ENT>
              <ENT>N/A</ENT>
              <ENT>7.81</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>18.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21390</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat eye socket fracture</ENT>
              <ENT>10.13</ENT>
              <ENT>N/A</ENT>
              <ENT>8.27</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>19.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21395</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat eye socket fracture</ENT>
              <ENT>12.68</ENT>
              <ENT>N/A</ENT>
              <ENT>9.62</ENT>
              <ENT>1.09</ENT>
              <ENT>N/A</ENT>
              <ENT>23.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat eye socket fracture</ENT>
              <ENT>1.40</ENT>
              <ENT>3.80</ENT>
              <ENT>2.10</ENT>
              <ENT>0.12</ENT>
              <ENT>5.32</ENT>
              <ENT>3.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21401</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat eye socket fracture</ENT>
              <ENT>3.26</ENT>
              <ENT>5.11</ENT>
              <ENT>3.84</ENT>
              <ENT>0.34</ENT>
              <ENT>8.71</ENT>
              <ENT>7.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21406</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat eye socket fracture</ENT>
              <ENT>7.01</ENT>
              <ENT>N/A</ENT>
              <ENT>6.58</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>14.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21407</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat eye socket fracture</ENT>
              <ENT>8.61</ENT>
              <ENT>N/A</ENT>
              <ENT>7.38</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>16.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21408</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat eye socket fracture</ENT>
              <ENT>12.38</ENT>
              <ENT>N/A</ENT>
              <ENT>9.49</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>23.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21421</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat mouth roof fracture</ENT>
              <ENT>5.14</ENT>
              <ENT>10.22</ENT>
              <ENT>6.31</ENT>
              <ENT>0.42</ENT>
              <ENT>15.78</ENT>
              <ENT>11.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21422</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat mouth roof fracture</ENT>
              <ENT>8.32</ENT>
              <ENT>11.73</ENT>
              <ENT>7.38</ENT>
              <ENT>0.69</ENT>
              <ENT>20.74</ENT>
              <ENT>16.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21423</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat mouth roof fracture</ENT>
              <ENT>10.40</ENT>
              <ENT>N/A</ENT>
              <ENT>8.72</ENT>
              <ENT>0.95</ENT>
              <ENT>N/A</ENT>
              <ENT>20.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21431</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat craniofacial fracture</ENT>
              <ENT>7.05</ENT>
              <ENT>11.10</ENT>
              <ENT>7.15</ENT>
              <ENT>0.58</ENT>
              <ENT>18.73</ENT>
              <ENT>14.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21432</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat craniofacial fracture</ENT>
              <ENT>8.61</ENT>
              <ENT>N/A</ENT>
              <ENT>6.53</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>15.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21433</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat craniofacial fracture</ENT>
              <ENT>25.35</ENT>
              <ENT>N/A</ENT>
              <ENT>17.38</ENT>
              <ENT>2.46</ENT>
              <ENT>N/A</ENT>
              <ENT>45.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21435</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat craniofacial fracture</ENT>
              <ENT>17.25</ENT>
              <ENT>N/A</ENT>
              <ENT>13.41</ENT>
              <ENT>1.66</ENT>
              <ENT>N/A</ENT>
              <ENT>32.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21436</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat craniofacial fracture</ENT>
              <ENT>28.04</ENT>
              <ENT>N/A</ENT>
              <ENT>18.94</ENT>
              <ENT>2.32</ENT>
              <ENT>N/A</ENT>
              <ENT>49.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21440</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat dental ridge fracture</ENT>
              <ENT>2.70</ENT>
              <ENT>8.32</ENT>
              <ENT>4.22</ENT>
              <ENT>0.22</ENT>
              <ENT>11.24</ENT>
              <ENT>7.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21445</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat dental ridge fracture</ENT>
              <ENT>5.38</ENT>
              <ENT>10.81</ENT>
              <ENT>6.48</ENT>
              <ENT>0.55</ENT>
              <ENT>16.74</ENT>
              <ENT>12.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat lower jaw fracture</ENT>
              <ENT>2.97</ENT>
              <ENT>11.00</ENT>
              <ENT>3.86</ENT>
              <ENT>0.23</ENT>
              <ENT>14.20</ENT>
              <ENT>7.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21451</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat lower jaw fracture</ENT>
              <ENT>4.87</ENT>
              <ENT>9.15</ENT>
              <ENT>6.00</ENT>
              <ENT>0.39</ENT>
              <ENT>14.41</ENT>
              <ENT>11.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21452</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat lower jaw fracture</ENT>
              <ENT>1.98</ENT>
              <ENT>8.19</ENT>
              <ENT>3.81</ENT>
              <ENT>0.14</ENT>
              <ENT>10.31</ENT>
              <ENT>5.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21453</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat lower jaw fracture</ENT>
              <ENT>5.54</ENT>
              <ENT>10.89</ENT>
              <ENT>7.07</ENT>
              <ENT>0.49</ENT>
              <ENT>16.92</ENT>
              <ENT>13.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21454</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat lower jaw fracture</ENT>
              <ENT>6.46</ENT>
              <ENT>N/A</ENT>
              <ENT>6.62</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>13.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21461</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat lower jaw fracture</ENT>
              <ENT>8.09</ENT>
              <ENT>12.99</ENT>
              <ENT>8.58</ENT>
              <ENT>0.73</ENT>
              <ENT>21.81</ENT>
              <ENT>17.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21462</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat lower jaw fracture</ENT>
              <ENT>9.79</ENT>
              <ENT>14.58</ENT>
              <ENT>9.31</ENT>
              <ENT>0.80</ENT>
              <ENT>25.17</ENT>
              <ENT>19.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49085"/>
              <ENT I="01">21465</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat lower jaw fracture</ENT>
              <ENT>11.91</ENT>
              <ENT>N/A</ENT>
              <ENT>10.16</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>22.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21470</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat lower jaw fracture</ENT>
              <ENT>15.34</ENT>
              <ENT>N/A</ENT>
              <ENT>12.41</ENT>
              <ENT>1.36</ENT>
              <ENT>N/A</ENT>
              <ENT>29.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21480</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reset dislocated jaw</ENT>
              <ENT>0.61</ENT>
              <ENT>2.06</ENT>
              <ENT>0.19</ENT>
              <ENT>0.05</ENT>
              <ENT>2.72</ENT>
              <ENT>0.85</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21485</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reset dislocated jaw</ENT>
              <ENT>3.99</ENT>
              <ENT>6.15</ENT>
              <ENT>4.92</ENT>
              <ENT>0.31</ENT>
              <ENT>10.45</ENT>
              <ENT>9.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21490</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair dislocated jaw</ENT>
              <ENT>11.86</ENT>
              <ENT>N/A</ENT>
              <ENT>10.03</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>23.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21493</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat hyoid bone fracture</ENT>
              <ENT>1.27</ENT>
              <ENT>N/A</ENT>
              <ENT>2.96</ENT>
              <ENT>0.10</ENT>
              <ENT>N/A</ENT>
              <ENT>4.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21494</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat hyoid bone fracture</ENT>
              <ENT>6.28</ENT>
              <ENT>N/A</ENT>
              <ENT>5.91</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>12.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21495</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat hyoid bone fracture</ENT>
              <ENT>5.69</ENT>
              <ENT>N/A</ENT>
              <ENT>6.18</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>12.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21497</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Interdental wiring</ENT>
              <ENT>3.86</ENT>
              <ENT>6.77</ENT>
              <ENT>5.16</ENT>
              <ENT>0.31</ENT>
              <ENT>10.94</ENT>
              <ENT>9.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21499</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Head surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21501</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain neck/chest lesion</ENT>
              <ENT>3.81</ENT>
              <ENT>4.79</ENT>
              <ENT>3.95</ENT>
              <ENT>0.36</ENT>
              <ENT>8.96</ENT>
              <ENT>8.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21502</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain chest lesion</ENT>
              <ENT>7.12</ENT>
              <ENT>N/A</ENT>
              <ENT>5.71</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>13.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of bone lesion</ENT>
              <ENT>5.74</ENT>
              <ENT>N/A</ENT>
              <ENT>5.65</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>12.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21550</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of neck/chest</ENT>
              <ENT>2.06</ENT>
              <ENT>3.65</ENT>
              <ENT>1.75</ENT>
              <ENT>0.13</ENT>
              <ENT>5.84</ENT>
              <ENT>3.94</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21555</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove lesion, neck/chest</ENT>
              <ENT>4.35</ENT>
              <ENT>5.15</ENT>
              <ENT>3.21</ENT>
              <ENT>0.41</ENT>
              <ENT>9.91</ENT>
              <ENT>7.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21556</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove lesion, neck/chest</ENT>
              <ENT>5.57</ENT>
              <ENT>N/A</ENT>
              <ENT>4.09</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>10.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21557</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove tumor, neck/chest</ENT>
              <ENT>8.88</ENT>
              <ENT>N/A</ENT>
              <ENT>5.68</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>15.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of rib</ENT>
              <ENT>6.89</ENT>
              <ENT>N/A</ENT>
              <ENT>5.79</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>13.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21610</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of rib</ENT>
              <ENT>14.61</ENT>
              <ENT>N/A</ENT>
              <ENT>9.25</ENT>
              <ENT>1.85</ENT>
              <ENT>N/A</ENT>
              <ENT>25.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21615</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of rib</ENT>
              <ENT>9.87</ENT>
              <ENT>N/A</ENT>
              <ENT>6.63</ENT>
              <ENT>1.20</ENT>
              <ENT>N/A</ENT>
              <ENT>17.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21616</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of rib and nerves</ENT>
              <ENT>12.04</ENT>
              <ENT>N/A</ENT>
              <ENT>8.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>21.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21620</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of sternum</ENT>
              <ENT>6.79</ENT>
              <ENT>N/A</ENT>
              <ENT>6.09</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>13.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21627</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sternal debridement</ENT>
              <ENT>6.81</ENT>
              <ENT>N/A</ENT>
              <ENT>6.82</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>14.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21630</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive sternum surgery</ENT>
              <ENT>17.38</ENT>
              <ENT>N/A</ENT>
              <ENT>11.99</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>31.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21632</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive sternum surgery</ENT>
              <ENT>18.14</ENT>
              <ENT>N/A</ENT>
              <ENT>10.78</ENT>
              <ENT>2.16</ENT>
              <ENT>N/A</ENT>
              <ENT>31.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of neck muscle</ENT>
              <ENT>6.19</ENT>
              <ENT>6.23</ENT>
              <ENT>4.88</ENT>
              <ENT>0.31</ENT>
              <ENT>12.73</ENT>
              <ENT>11.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21705</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of neck muscle/rib</ENT>
              <ENT>9.60</ENT>
              <ENT>N/A</ENT>
              <ENT>5.79</ENT>
              <ENT>0.92</ENT>
              <ENT>N/A</ENT>
              <ENT>16.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21720</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of neck muscle</ENT>
              <ENT>5.68</ENT>
              <ENT>5.68</ENT>
              <ENT>4.78</ENT>
              <ENT>0.80</ENT>
              <ENT>12.16</ENT>
              <ENT>11.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21725</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of neck muscle</ENT>
              <ENT>6.99</ENT>
              <ENT>N/A</ENT>
              <ENT>5.72</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>13.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21740</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of sternum</ENT>
              <ENT>16.50</ENT>
              <ENT>N/A</ENT>
              <ENT>8.67</ENT>
              <ENT>2.03</ENT>
              <ENT>N/A</ENT>
              <ENT>27.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21742</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Repair stern/nuss w/o scope</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21743</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Repair sternum/nuss w/scope</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21750</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of sternum separation</ENT>
              <ENT>10.77</ENT>
              <ENT>N/A</ENT>
              <ENT>6.16</ENT>
              <ENT>1.35</ENT>
              <ENT>N/A</ENT>
              <ENT>18.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of rib fracture</ENT>
              <ENT>0.96</ENT>
              <ENT>2.15</ENT>
              <ENT>1.43</ENT>
              <ENT>0.09</ENT>
              <ENT>3.20</ENT>
              <ENT>2.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21805</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of rib fracture</ENT>
              <ENT>2.75</ENT>
              <ENT>N/A</ENT>
              <ENT>3.31</ENT>
              <ENT>0.29</ENT>
              <ENT>N/A</ENT>
              <ENT>6.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21810</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of rib fracture(s)</ENT>
              <ENT>6.86</ENT>
              <ENT>N/A</ENT>
              <ENT>5.04</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>12.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat sternum fracture</ENT>
              <ENT>1.28</ENT>
              <ENT>2.68</ENT>
              <ENT>1.85</ENT>
              <ENT>0.15</ENT>
              <ENT>4.11</ENT>
              <ENT>3.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21825</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat sternum fracture</ENT>
              <ENT>7.41</ENT>
              <ENT>N/A</ENT>
              <ENT>6.48</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>14.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21899</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Neck/chest surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21920</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy soft tissue of back</ENT>
              <ENT>2.06</ENT>
              <ENT>3.27</ENT>
              <ENT>1.50</ENT>
              <ENT>0.12</ENT>
              <ENT>5.45</ENT>
              <ENT>3.68</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21925</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy soft tissue of back</ENT>
              <ENT>4.49</ENT>
              <ENT>9.16</ENT>
              <ENT>3.44</ENT>
              <ENT>0.44</ENT>
              <ENT>14.09</ENT>
              <ENT>8.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21930</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove lesion, back or flank</ENT>
              <ENT>5.00</ENT>
              <ENT>5.49</ENT>
              <ENT>3.42</ENT>
              <ENT>0.49</ENT>
              <ENT>10.98</ENT>
              <ENT>8.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">21935</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove tumor, back</ENT>
              <ENT>17.96</ENT>
              <ENT>N/A</ENT>
              <ENT>10.50</ENT>
              <ENT>1.87</ENT>
              <ENT>N/A</ENT>
              <ENT>30.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove part of neck vertebra</ENT>
              <ENT>9.73</ENT>
              <ENT>N/A</ENT>
              <ENT>7.82</ENT>
              <ENT>1.55</ENT>
              <ENT>N/A</ENT>
              <ENT>19.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22101</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove part, thorax vertebra</ENT>
              <ENT>9.81</ENT>
              <ENT>N/A</ENT>
              <ENT>8.04</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>19.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22102</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove part, lumbar vertebra</ENT>
              <ENT>9.81</ENT>
              <ENT>N/A</ENT>
              <ENT>8.30</ENT>
              <ENT>1.46</ENT>
              <ENT>N/A</ENT>
              <ENT>19.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22103</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove extra spine segment</ENT>
              <ENT>2.34</ENT>
              <ENT>N/A</ENT>
              <ENT>1.24</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>3.95</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove part of neck vertebra</ENT>
              <ENT>12.74</ENT>
              <ENT>N/A</ENT>
              <ENT>9.54</ENT>
              <ENT>2.20</ENT>
              <ENT>N/A</ENT>
              <ENT>24.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22112</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove part, thorax vertebra</ENT>
              <ENT>12.81</ENT>
              <ENT>N/A</ENT>
              <ENT>9.56</ENT>
              <ENT>1.96</ENT>
              <ENT>N/A</ENT>
              <ENT>24.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22114</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove part, lumbar vertebra</ENT>
              <ENT>12.81</ENT>
              <ENT>N/A</ENT>
              <ENT>9.58</ENT>
              <ENT>1.98</ENT>
              <ENT>N/A</ENT>
              <ENT>24.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22116</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove extra spine segment</ENT>
              <ENT>2.32</ENT>
              <ENT>N/A</ENT>
              <ENT>1.19</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>3.91</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22210</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of neck spine</ENT>
              <ENT>23.82</ENT>
              <ENT>N/A</ENT>
              <ENT>15.88</ENT>
              <ENT>4.23</ENT>
              <ENT>N/A</ENT>
              <ENT>43.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49086"/>
              <ENT I="01">22212</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of thorax spine</ENT>
              <ENT>19.42</ENT>
              <ENT>N/A</ENT>
              <ENT>13.57</ENT>
              <ENT>2.78</ENT>
              <ENT>N/A</ENT>
              <ENT>35.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22214</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of lumbar spine</ENT>
              <ENT>19.45</ENT>
              <ENT>N/A</ENT>
              <ENT>14.04</ENT>
              <ENT>2.78</ENT>
              <ENT>N/A</ENT>
              <ENT>36.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22216</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise, extra spine segment</ENT>
              <ENT>6.04</ENT>
              <ENT>N/A</ENT>
              <ENT>3.20</ENT>
              <ENT>0.98</ENT>
              <ENT>N/A</ENT>
              <ENT>10.22</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of neck spine</ENT>
              <ENT>21.37</ENT>
              <ENT>N/A</ENT>
              <ENT>14.10</ENT>
              <ENT>3.65</ENT>
              <ENT>N/A</ENT>
              <ENT>39.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22222</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of thorax spine</ENT>
              <ENT>21.52</ENT>
              <ENT>N/A</ENT>
              <ENT>11.93</ENT>
              <ENT>3.08</ENT>
              <ENT>N/A</ENT>
              <ENT>36.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22224</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of lumbar spine</ENT>
              <ENT>21.52</ENT>
              <ENT>N/A</ENT>
              <ENT>14.60</ENT>
              <ENT>3.20</ENT>
              <ENT>N/A</ENT>
              <ENT>39.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22226</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise, extra spine segment</ENT>
              <ENT>6.04</ENT>
              <ENT>N/A</ENT>
              <ENT>3.16</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>10.21</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22305</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat spine process fracture</ENT>
              <ENT>2.05</ENT>
              <ENT>3.25</ENT>
              <ENT>2.43</ENT>
              <ENT>0.29</ENT>
              <ENT>5.59</ENT>
              <ENT>4.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22310</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat spine fracture</ENT>
              <ENT>2.61</ENT>
              <ENT>4.98</ENT>
              <ENT>4.20</ENT>
              <ENT>0.37</ENT>
              <ENT>7.96</ENT>
              <ENT>7.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22315</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat spine fracture</ENT>
              <ENT>8.84</ENT>
              <ENT>18.69</ENT>
              <ENT>7.74</ENT>
              <ENT>1.37</ENT>
              <ENT>28.90</ENT>
              <ENT>17.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22318</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat odontoid fx w/o graft</ENT>
              <ENT>21.50</ENT>
              <ENT>N/A</ENT>
              <ENT>13.81</ENT>
              <ENT>4.26</ENT>
              <ENT>N/A</ENT>
              <ENT>39.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22319</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat odontoid fx w/graft</ENT>
              <ENT>24.00</ENT>
              <ENT>N/A</ENT>
              <ENT>15.33</ENT>
              <ENT>4.76</ENT>
              <ENT>N/A</ENT>
              <ENT>44.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22325</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat spine fracture</ENT>
              <ENT>18.30</ENT>
              <ENT>N/A</ENT>
              <ENT>12.41</ENT>
              <ENT>2.61</ENT>
              <ENT>N/A</ENT>
              <ENT>33.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22326</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat neck spine fracture</ENT>
              <ENT>19.59</ENT>
              <ENT>N/A</ENT>
              <ENT>13.20</ENT>
              <ENT>3.54</ENT>
              <ENT>N/A</ENT>
              <ENT>36.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22327</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat thorax spine fracture</ENT>
              <ENT>19.20</ENT>
              <ENT>N/A</ENT>
              <ENT>12.71</ENT>
              <ENT>2.75</ENT>
              <ENT>N/A</ENT>
              <ENT>34.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22328</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat each add spine fx</ENT>
              <ENT>4.61</ENT>
              <ENT>N/A</ENT>
              <ENT>2.32</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>7.59</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22505</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Manipulation of spine</ENT>
              <ENT>1.87</ENT>
              <ENT>N/A</ENT>
              <ENT>0.95</ENT>
              <ENT>0.27</ENT>
              <ENT>N/A</ENT>
              <ENT>3.09</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Percut vertebroplasty thor</ENT>
              <ENT>8.91</ENT>
              <ENT>104.96</ENT>
              <ENT>4.40</ENT>
              <ENT>0.99</ENT>
              <ENT>114.86</ENT>
              <ENT>14.30</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22521</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Percut vertebroplasty lumb</ENT>
              <ENT>8.34</ENT>
              <ENT>93.70</ENT>
              <ENT>4.24</ENT>
              <ENT>0.93</ENT>
              <ENT>102.97</ENT>
              <ENT>13.51</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22522</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Percut vertebroplasty addl</ENT>
              <ENT>4.31</ENT>
              <ENT>N/A</ENT>
              <ENT>1.72</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>6.36</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22548</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Neck spine fusion</ENT>
              <ENT>25.82</ENT>
              <ENT>N/A</ENT>
              <ENT>16.15</ENT>
              <ENT>4.98</ENT>
              <ENT>N/A</ENT>
              <ENT>46.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22554</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Neck spine fusion</ENT>
              <ENT>18.62</ENT>
              <ENT>N/A</ENT>
              <ENT>12.57</ENT>
              <ENT>3.51</ENT>
              <ENT>N/A</ENT>
              <ENT>34.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22556</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thorax spine fusion</ENT>
              <ENT>23.46</ENT>
              <ENT>N/A</ENT>
              <ENT>14.91</ENT>
              <ENT>3.78</ENT>
              <ENT>N/A</ENT>
              <ENT>42.15</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22558</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lumbar spine fusion</ENT>
              <ENT>22.28</ENT>
              <ENT>N/A</ENT>
              <ENT>13.45</ENT>
              <ENT>3.18</ENT>
              <ENT>N/A</ENT>
              <ENT>38.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22585</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Additional spinal fusion</ENT>
              <ENT>5.53</ENT>
              <ENT>N/A</ENT>
              <ENT>2.86</ENT>
              <ENT>0.98</ENT>
              <ENT>N/A</ENT>
              <ENT>9.37</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22590</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Spine &amp; skull spinal fusion</ENT>
              <ENT>20.51</ENT>
              <ENT>N/A</ENT>
              <ENT>13.57</ENT>
              <ENT>3.81</ENT>
              <ENT>N/A</ENT>
              <ENT>37.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22595</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Neck spinal fusion</ENT>
              <ENT>19.39</ENT>
              <ENT>N/A</ENT>
              <ENT>13.06</ENT>
              <ENT>3.62</ENT>
              <ENT>N/A</ENT>
              <ENT>36.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Neck spine fusion</ENT>
              <ENT>16.14</ENT>
              <ENT>N/A</ENT>
              <ENT>11.37</ENT>
              <ENT>2.89</ENT>
              <ENT>N/A</ENT>
              <ENT>30.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22610</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thorax spine fusion</ENT>
              <ENT>16.02</ENT>
              <ENT>N/A</ENT>
              <ENT>11.55</ENT>
              <ENT>2.66</ENT>
              <ENT>N/A</ENT>
              <ENT>30.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22612</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lumbar spine fusion</ENT>
              <ENT>21.00</ENT>
              <ENT>N/A</ENT>
              <ENT>14.36</ENT>
              <ENT>3.28</ENT>
              <ENT>N/A</ENT>
              <ENT>38.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22614</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Spine fusion, extra segment</ENT>
              <ENT>6.44</ENT>
              <ENT>N/A</ENT>
              <ENT>3.43</ENT>
              <ENT>1.04</ENT>
              <ENT>N/A</ENT>
              <ENT>10.91</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22630</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lumbar spine fusion</ENT>
              <ENT>20.84</ENT>
              <ENT>N/A</ENT>
              <ENT>13.82</ENT>
              <ENT>3.79</ENT>
              <ENT>N/A</ENT>
              <ENT>38.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22632</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Spine fusion, extra segment</ENT>
              <ENT>5.23</ENT>
              <ENT>N/A</ENT>
              <ENT>2.73</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>8.86</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of spine</ENT>
              <ENT>18.25</ENT>
              <ENT>N/A</ENT>
              <ENT>12.88</ENT>
              <ENT>2.71</ENT>
              <ENT>N/A</ENT>
              <ENT>33.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22802</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of spine</ENT>
              <ENT>30.88</ENT>
              <ENT>N/A</ENT>
              <ENT>19.84</ENT>
              <ENT>4.42</ENT>
              <ENT>N/A</ENT>
              <ENT>55.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22804</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of spine</ENT>
              <ENT>36.27</ENT>
              <ENT>N/A</ENT>
              <ENT>23.00</ENT>
              <ENT>5.23</ENT>
              <ENT>N/A</ENT>
              <ENT>64.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22808</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of spine</ENT>
              <ENT>26.27</ENT>
              <ENT>N/A</ENT>
              <ENT>16.55</ENT>
              <ENT>4.36</ENT>
              <ENT>N/A</ENT>
              <ENT>47.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22810</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of spine</ENT>
              <ENT>30.27</ENT>
              <ENT>N/A</ENT>
              <ENT>18.61</ENT>
              <ENT>4.49</ENT>
              <ENT>N/A</ENT>
              <ENT>53.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22812</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of spine</ENT>
              <ENT>32.70</ENT>
              <ENT>N/A</ENT>
              <ENT>20.21</ENT>
              <ENT>4.67</ENT>
              <ENT>N/A</ENT>
              <ENT>57.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22818</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Kyphectomy, 1-2 segments</ENT>
              <ENT>31.83</ENT>
              <ENT>N/A</ENT>
              <ENT>19.30</ENT>
              <ENT>5.01</ENT>
              <ENT>N/A</ENT>
              <ENT>56.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22819</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Kyphectomy, 3 or more</ENT>
              <ENT>36.44</ENT>
              <ENT>N/A</ENT>
              <ENT>20.38</ENT>
              <ENT>5.20</ENT>
              <ENT>N/A</ENT>
              <ENT>62.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22830</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of spinal fusion</ENT>
              <ENT>10.85</ENT>
              <ENT>N/A</ENT>
              <ENT>8.13</ENT>
              <ENT>1.73</ENT>
              <ENT>N/A</ENT>
              <ENT>20.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22840</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert spine fixation device</ENT>
              <ENT>12.54</ENT>
              <ENT>N/A</ENT>
              <ENT>6.64</ENT>
              <ENT>2.03</ENT>
              <ENT>N/A</ENT>
              <ENT>21.21</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22842</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert spine fixation device</ENT>
              <ENT>12.58</ENT>
              <ENT>N/A</ENT>
              <ENT>6.66</ENT>
              <ENT>2.04</ENT>
              <ENT>N/A</ENT>
              <ENT>21.28</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22843</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert spine fixation device</ENT>
              <ENT>13.46</ENT>
              <ENT>N/A</ENT>
              <ENT>6.75</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>22.31</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22844</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert spine fixation device</ENT>
              <ENT>16.44</ENT>
              <ENT>N/A</ENT>
              <ENT>8.95</ENT>
              <ENT>2.42</ENT>
              <ENT>N/A</ENT>
              <ENT>27.81</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22845</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert spine fixation device</ENT>
              <ENT>11.96</ENT>
              <ENT>N/A</ENT>
              <ENT>6.22</ENT>
              <ENT>2.22</ENT>
              <ENT>N/A</ENT>
              <ENT>20.40</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22846</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert spine fixation device</ENT>
              <ENT>12.42</ENT>
              <ENT>N/A</ENT>
              <ENT>6.48</ENT>
              <ENT>2.26</ENT>
              <ENT>N/A</ENT>
              <ENT>21.16</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22847</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert spine fixation device</ENT>
              <ENT>13.80</ENT>
              <ENT>N/A</ENT>
              <ENT>7.19</ENT>
              <ENT>2.36</ENT>
              <ENT>N/A</ENT>
              <ENT>23.35</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22848</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert pelv fixation device</ENT>
              <ENT>6.00</ENT>
              <ENT>N/A</ENT>
              <ENT>3.26</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>10.14</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22849</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reinsert spinal fixation</ENT>
              <ENT>18.51</ENT>
              <ENT>N/A</ENT>
              <ENT>12.17</ENT>
              <ENT>2.87</ENT>
              <ENT>N/A</ENT>
              <ENT>33.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22850</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove spine fixation device</ENT>
              <ENT>9.52</ENT>
              <ENT>N/A</ENT>
              <ENT>7.28</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>18.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22851</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apply spine prosth device</ENT>
              <ENT>6.71</ENT>
              <ENT>N/A</ENT>
              <ENT>3.44</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>11.26</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22852</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove spine fixation device</ENT>
              <ENT>9.01</ENT>
              <ENT>N/A</ENT>
              <ENT>7.06</ENT>
              <ENT>1.40</ENT>
              <ENT>N/A</ENT>
              <ENT>17.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22855</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove spine fixation device</ENT>
              <ENT>15.13</ENT>
              <ENT>N/A</ENT>
              <ENT>10.02</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>27.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22899</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Spine surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49087"/>
              <ENT I="01">22900</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove abdominal wall lesion</ENT>
              <ENT>5.80</ENT>
              <ENT>N/A</ENT>
              <ENT>3.32</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>9.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">22999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Abdomen surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of calcium deposits</ENT>
              <ENT>4.36</ENT>
              <ENT>5.59</ENT>
              <ENT>4.74</ENT>
              <ENT>0.50</ENT>
              <ENT>10.45</ENT>
              <ENT>9.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release shoulder joint</ENT>
              <ENT>8.93</ENT>
              <ENT>N/A</ENT>
              <ENT>7.82</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>17.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23030</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain shoulder lesion</ENT>
              <ENT>3.43</ENT>
              <ENT>3.07</ENT>
              <ENT>2.97</ENT>
              <ENT>0.42</ENT>
              <ENT>6.92</ENT>
              <ENT>6.82</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23031</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain shoulder bursa</ENT>
              <ENT>2.74</ENT>
              <ENT>2.73</ENT>
              <ENT>2.73</ENT>
              <ENT>0.33</ENT>
              <ENT>5.80</ENT>
              <ENT>5.80</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23035</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain shoulder bone lesion</ENT>
              <ENT>8.61</ENT>
              <ENT>N/A</ENT>
              <ENT>9.12</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>18.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23040</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploratory shoulder surgery</ENT>
              <ENT>9.20</ENT>
              <ENT>N/A</ENT>
              <ENT>8.20</ENT>
              <ENT>1.28</ENT>
              <ENT>N/A</ENT>
              <ENT>18.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23044</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploratory shoulder surgery</ENT>
              <ENT>7.12</ENT>
              <ENT>N/A</ENT>
              <ENT>6.80</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>14.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23065</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy shoulder tissues</ENT>
              <ENT>2.27</ENT>
              <ENT>2.88</ENT>
              <ENT>1.55</ENT>
              <ENT>0.14</ENT>
              <ENT>5.29</ENT>
              <ENT>3.96</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23066</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy shoulder tissues</ENT>
              <ENT>4.16</ENT>
              <ENT>5.19</ENT>
              <ENT>4.18</ENT>
              <ENT>0.50</ENT>
              <ENT>9.85</ENT>
              <ENT>8.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23075</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of shoulder lesion</ENT>
              <ENT>2.39</ENT>
              <ENT>2.27</ENT>
              <ENT>1.82</ENT>
              <ENT>0.25</ENT>
              <ENT>4.91</ENT>
              <ENT>4.46</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23076</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of shoulder lesion</ENT>
              <ENT>7.63</ENT>
              <ENT>N/A</ENT>
              <ENT>5.88</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>14.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23077</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove tumor of shoulder</ENT>
              <ENT>16.09</ENT>
              <ENT>N/A</ENT>
              <ENT>11.03</ENT>
              <ENT>1.81</ENT>
              <ENT>N/A</ENT>
              <ENT>28.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of shoulder joint</ENT>
              <ENT>6.03</ENT>
              <ENT>N/A</ENT>
              <ENT>5.89</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>12.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23101</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shoulder joint surgery</ENT>
              <ENT>5.58</ENT>
              <ENT>N/A</ENT>
              <ENT>5.68</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>12.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23105</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove shoulder joint lining</ENT>
              <ENT>8.23</ENT>
              <ENT>N/A</ENT>
              <ENT>7.41</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>16.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23106</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of collarbone joint</ENT>
              <ENT>5.96</ENT>
              <ENT>N/A</ENT>
              <ENT>5.93</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>12.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23107</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore treat shoulder joint</ENT>
              <ENT>8.62</ENT>
              <ENT>N/A</ENT>
              <ENT>7.63</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>17.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal, collar bone</ENT>
              <ENT>7.11</ENT>
              <ENT>N/A</ENT>
              <ENT>6.70</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>14.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23125</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of collar bone</ENT>
              <ENT>9.39</ENT>
              <ENT>N/A</ENT>
              <ENT>7.85</ENT>
              <ENT>1.27</ENT>
              <ENT>N/A</ENT>
              <ENT>18.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove shoulder bone, part</ENT>
              <ENT>7.55</ENT>
              <ENT>N/A</ENT>
              <ENT>7.23</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>15.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of bone lesion</ENT>
              <ENT>6.89</ENT>
              <ENT>N/A</ENT>
              <ENT>5.56</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>13.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23145</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of bone lesion</ENT>
              <ENT>9.09</ENT>
              <ENT>N/A</ENT>
              <ENT>7.92</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>18.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23146</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of bone lesion</ENT>
              <ENT>7.83</ENT>
              <ENT>N/A</ENT>
              <ENT>7.39</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>16.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of humerus lesion</ENT>
              <ENT>8.48</ENT>
              <ENT>N/A</ENT>
              <ENT>7.19</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>16.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23155</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of humerus lesion</ENT>
              <ENT>10.35</ENT>
              <ENT>N/A</ENT>
              <ENT>8.64</ENT>
              <ENT>1.20</ENT>
              <ENT>N/A</ENT>
              <ENT>20.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23156</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of humerus lesion</ENT>
              <ENT>8.68</ENT>
              <ENT>N/A</ENT>
              <ENT>7.63</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>17.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23170</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove collar bone lesion</ENT>
              <ENT>6.86</ENT>
              <ENT>N/A</ENT>
              <ENT>6.60</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>14.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23172</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove shoulder blade lesion</ENT>
              <ENT>6.90</ENT>
              <ENT>N/A</ENT>
              <ENT>6.70</ENT>
              <ENT>0.95</ENT>
              <ENT>N/A</ENT>
              <ENT>14.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23174</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove humerus lesion</ENT>
              <ENT>9.51</ENT>
              <ENT>N/A</ENT>
              <ENT>8.63</ENT>
              <ENT>1.30</ENT>
              <ENT>N/A</ENT>
              <ENT>19.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23180</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove collar bone lesion</ENT>
              <ENT>8.53</ENT>
              <ENT>N/A</ENT>
              <ENT>9.76</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>19.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23182</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove shoulder blade lesion</ENT>
              <ENT>8.15</ENT>
              <ENT>N/A</ENT>
              <ENT>9.36</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>18.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23184</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove humerus lesion</ENT>
              <ENT>9.38</ENT>
              <ENT>N/A</ENT>
              <ENT>10.12</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>20.74</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23190</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of scapula</ENT>
              <ENT>7.24</ENT>
              <ENT>N/A</ENT>
              <ENT>6.34</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>14.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23195</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of head of humerus</ENT>
              <ENT>9.81</ENT>
              <ENT>N/A</ENT>
              <ENT>8.00</ENT>
              <ENT>1.38</ENT>
              <ENT>N/A</ENT>
              <ENT>19.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of collar bone</ENT>
              <ENT>12.08</ENT>
              <ENT>N/A</ENT>
              <ENT>9.24</ENT>
              <ENT>1.48</ENT>
              <ENT>N/A</ENT>
              <ENT>22.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23210</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of shoulder blade</ENT>
              <ENT>12.49</ENT>
              <ENT>N/A</ENT>
              <ENT>9.61</ENT>
              <ENT>1.61</ENT>
              <ENT>N/A</ENT>
              <ENT>23.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of humerus</ENT>
              <ENT>14.56</ENT>
              <ENT>N/A</ENT>
              <ENT>11.28</ENT>
              <ENT>2.03</ENT>
              <ENT>N/A</ENT>
              <ENT>27.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23221</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of humerus</ENT>
              <ENT>17.74</ENT>
              <ENT>N/A</ENT>
              <ENT>12.23</ENT>
              <ENT>2.51</ENT>
              <ENT>N/A</ENT>
              <ENT>32.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23222</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of humerus</ENT>
              <ENT>23.92</ENT>
              <ENT>N/A</ENT>
              <ENT>16.44</ENT>
              <ENT>3.37</ENT>
              <ENT>N/A</ENT>
              <ENT>43.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23330</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove shoulder foreign body</ENT>
              <ENT>1.85</ENT>
              <ENT>2.08</ENT>
              <ENT>1.89</ENT>
              <ENT>0.18</ENT>
              <ENT>4.11</ENT>
              <ENT>3.92</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23331</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove shoulder foreign body</ENT>
              <ENT>7.38</ENT>
              <ENT>N/A</ENT>
              <ENT>7.02</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>15.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23332</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove shoulder foreign body</ENT>
              <ENT>11.62</ENT>
              <ENT>N/A</ENT>
              <ENT>9.49</ENT>
              <ENT>1.62</ENT>
              <ENT>N/A</ENT>
              <ENT>22.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49088"/>
              <ENT I="01">23350</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection for shoulder x-ray</ENT>
              <ENT>1.00</ENT>
              <ENT>3.88</ENT>
              <ENT>0.34</ENT>
              <ENT>0.05</ENT>
              <ENT>4.93</ENT>
              <ENT>1.39</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23395</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Muscle transfer,shoulder/arm</ENT>
              <ENT>16.85</ENT>
              <ENT>N/A</ENT>
              <ENT>12.87</ENT>
              <ENT>2.29</ENT>
              <ENT>N/A</ENT>
              <ENT>32.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23397</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Muscle transfers</ENT>
              <ENT>16.13</ENT>
              <ENT>N/A</ENT>
              <ENT>11.59</ENT>
              <ENT>2.24</ENT>
              <ENT>N/A</ENT>
              <ENT>29.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fixation of shoulder blade</ENT>
              <ENT>13.54</ENT>
              <ENT>N/A</ENT>
              <ENT>10.42</ENT>
              <ENT>1.91</ENT>
              <ENT>N/A</ENT>
              <ENT>25.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23405</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of tendon &amp; muscle</ENT>
              <ENT>8.37</ENT>
              <ENT>N/A</ENT>
              <ENT>7.08</ENT>
              <ENT>1.12</ENT>
              <ENT>N/A</ENT>
              <ENT>16.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23406</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise tendon(s) &amp; muscle(s)</ENT>
              <ENT>10.79</ENT>
              <ENT>N/A</ENT>
              <ENT>8.66</ENT>
              <ENT>1.48</ENT>
              <ENT>N/A</ENT>
              <ENT>20.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23410</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair rotator cuff, acute</ENT>
              <ENT>12.45</ENT>
              <ENT>N/A</ENT>
              <ENT>9.69</ENT>
              <ENT>1.72</ENT>
              <ENT>N/A</ENT>
              <ENT>23.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23412</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair rotator cuff, chronic</ENT>
              <ENT>13.31</ENT>
              <ENT>N/A</ENT>
              <ENT>10.19</ENT>
              <ENT>1.86</ENT>
              <ENT>N/A</ENT>
              <ENT>25.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23415</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release of shoulder ligament</ENT>
              <ENT>9.97</ENT>
              <ENT>N/A</ENT>
              <ENT>8.12</ENT>
              <ENT>1.39</ENT>
              <ENT>N/A</ENT>
              <ENT>19.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of shoulder</ENT>
              <ENT>13.30</ENT>
              <ENT>N/A</ENT>
              <ENT>11.08</ENT>
              <ENT>1.86</ENT>
              <ENT>N/A</ENT>
              <ENT>26.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23430</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair biceps tendon</ENT>
              <ENT>9.98</ENT>
              <ENT>N/A</ENT>
              <ENT>8.36</ENT>
              <ENT>1.40</ENT>
              <ENT>N/A</ENT>
              <ENT>19.74</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23440</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove/transplant tendon</ENT>
              <ENT>10.48</ENT>
              <ENT>N/A</ENT>
              <ENT>8.55</ENT>
              <ENT>1.47</ENT>
              <ENT>N/A</ENT>
              <ENT>20.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair shoulder capsule</ENT>
              <ENT>13.40</ENT>
              <ENT>N/A</ENT>
              <ENT>10.16</ENT>
              <ENT>1.86</ENT>
              <ENT>N/A</ENT>
              <ENT>25.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23455</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair shoulder capsule</ENT>
              <ENT>14.37</ENT>
              <ENT>N/A</ENT>
              <ENT>10.75</ENT>
              <ENT>2.01</ENT>
              <ENT>N/A</ENT>
              <ENT>27.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23460</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair shoulder capsule</ENT>
              <ENT>15.37</ENT>
              <ENT>N/A</ENT>
              <ENT>11.58</ENT>
              <ENT>2.17</ENT>
              <ENT>N/A</ENT>
              <ENT>29.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23462</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair shoulder capsule</ENT>
              <ENT>15.30</ENT>
              <ENT>N/A</ENT>
              <ENT>11.08</ENT>
              <ENT>2.16</ENT>
              <ENT>N/A</ENT>
              <ENT>28.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23465</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair shoulder capsule</ENT>
              <ENT>15.85</ENT>
              <ENT>N/A</ENT>
              <ENT>11.52</ENT>
              <ENT>1.61</ENT>
              <ENT>N/A</ENT>
              <ENT>28.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23466</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair shoulder capsule</ENT>
              <ENT>14.22</ENT>
              <ENT>N/A</ENT>
              <ENT>11.48</ENT>
              <ENT>2.00</ENT>
              <ENT>N/A</ENT>
              <ENT>27.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23470</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct shoulder joint</ENT>
              <ENT>17.15</ENT>
              <ENT>N/A</ENT>
              <ENT>12.30</ENT>
              <ENT>2.40</ENT>
              <ENT>N/A</ENT>
              <ENT>31.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23472</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct shoulder joint</ENT>
              <ENT>21.10</ENT>
              <ENT>N/A</ENT>
              <ENT>14.54</ENT>
              <ENT>2.37</ENT>
              <ENT>N/A</ENT>
              <ENT>38.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23480</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of collar bone</ENT>
              <ENT>11.18</ENT>
              <ENT>N/A</ENT>
              <ENT>9.04</ENT>
              <ENT>1.56</ENT>
              <ENT>N/A</ENT>
              <ENT>21.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23485</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of collar bone</ENT>
              <ENT>13.43</ENT>
              <ENT>N/A</ENT>
              <ENT>10.19</ENT>
              <ENT>1.84</ENT>
              <ENT>N/A</ENT>
              <ENT>25.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23490</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reinforce clavicle</ENT>
              <ENT>11.86</ENT>
              <ENT>N/A</ENT>
              <ENT>8.96</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>21.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23491</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reinforce shoulder bones</ENT>
              <ENT>14.21</ENT>
              <ENT>N/A</ENT>
              <ENT>10.90</ENT>
              <ENT>2.00</ENT>
              <ENT>N/A</ENT>
              <ENT>27.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat clavicle fracture</ENT>
              <ENT>2.08</ENT>
              <ENT>3.73</ENT>
              <ENT>2.61</ENT>
              <ENT>0.26</ENT>
              <ENT>6.07</ENT>
              <ENT>4.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23505</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat clavicle fracture</ENT>
              <ENT>3.69</ENT>
              <ENT>5.52</ENT>
              <ENT>3.92</ENT>
              <ENT>0.50</ENT>
              <ENT>9.71</ENT>
              <ENT>8.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23515</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat clavicle fracture</ENT>
              <ENT>7.41</ENT>
              <ENT>N/A</ENT>
              <ENT>6.65</ENT>
              <ENT>1.03</ENT>
              <ENT>N/A</ENT>
              <ENT>15.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat clavicle dislocation</ENT>
              <ENT>2.16</ENT>
              <ENT>3.73</ENT>
              <ENT>2.76</ENT>
              <ENT>0.26</ENT>
              <ENT>6.15</ENT>
              <ENT>5.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23525</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat clavicle dislocation</ENT>
              <ENT>3.60</ENT>
              <ENT>5.35</ENT>
              <ENT>3.95</ENT>
              <ENT>0.44</ENT>
              <ENT>9.39</ENT>
              <ENT>7.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat clavicle dislocation</ENT>
              <ENT>7.31</ENT>
              <ENT>N/A</ENT>
              <ENT>6.08</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>14.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23532</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat clavicle dislocation</ENT>
              <ENT>8.01</ENT>
              <ENT>N/A</ENT>
              <ENT>7.05</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>16.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23540</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat clavicle dislocation</ENT>
              <ENT>2.23</ENT>
              <ENT>4.34</ENT>
              <ENT>2.51</ENT>
              <ENT>0.24</ENT>
              <ENT>6.81</ENT>
              <ENT>4.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23545</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat clavicle dislocation</ENT>
              <ENT>3.25</ENT>
              <ENT>4.59</ENT>
              <ENT>3.45</ENT>
              <ENT>0.39</ENT>
              <ENT>8.23</ENT>
              <ENT>7.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23550</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat clavicle dislocation</ENT>
              <ENT>7.24</ENT>
              <ENT>N/A</ENT>
              <ENT>6.51</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>14.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23552</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat clavicle dislocation</ENT>
              <ENT>8.45</ENT>
              <ENT>N/A</ENT>
              <ENT>7.40</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>17.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23570</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat shoulder blade fx</ENT>
              <ENT>2.23</ENT>
              <ENT>3.74</ENT>
              <ENT>2.92</ENT>
              <ENT>0.29</ENT>
              <ENT>6.26</ENT>
              <ENT>5.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23575</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat shoulder blade fx</ENT>
              <ENT>4.06</ENT>
              <ENT>5.87</ENT>
              <ENT>4.33</ENT>
              <ENT>0.53</ENT>
              <ENT>10.46</ENT>
              <ENT>8.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23585</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat scapula fracture</ENT>
              <ENT>8.96</ENT>
              <ENT>N/A</ENT>
              <ENT>7.74</ENT>
              <ENT>1.25</ENT>
              <ENT>N/A</ENT>
              <ENT>17.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat humerus fracture</ENT>
              <ENT>2.93</ENT>
              <ENT>5.73</ENT>
              <ENT>3.80</ENT>
              <ENT>0.39</ENT>
              <ENT>9.05</ENT>
              <ENT>7.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat humerus fracture</ENT>
              <ENT>4.87</ENT>
              <ENT>7.03</ENT>
              <ENT>5.36</ENT>
              <ENT>0.67</ENT>
              <ENT>12.57</ENT>
              <ENT>10.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23615</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat humerus fracture</ENT>
              <ENT>9.35</ENT>
              <ENT>N/A</ENT>
              <ENT>8.86</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>19.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23616</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat humerus fracture</ENT>
              <ENT>21.27</ENT>
              <ENT>N/A</ENT>
              <ENT>14.39</ENT>
              <ENT>2.98</ENT>
              <ENT>N/A</ENT>
              <ENT>38.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23620</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat humerus fracture</ENT>
              <ENT>2.40</ENT>
              <ENT>5.29</ENT>
              <ENT>3.29</ENT>
              <ENT>0.32</ENT>
              <ENT>8.01</ENT>
              <ENT>6.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23625</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat humerus fracture</ENT>
              <ENT>3.93</ENT>
              <ENT>6.54</ENT>
              <ENT>4.74</ENT>
              <ENT>0.53</ENT>
              <ENT>11.00</ENT>
              <ENT>9.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23630</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat humerus fracture</ENT>
              <ENT>7.35</ENT>
              <ENT>N/A</ENT>
              <ENT>6.71</ENT>
              <ENT>1.03</ENT>
              <ENT>N/A</ENT>
              <ENT>15.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23650</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat shoulder dislocation</ENT>
              <ENT>3.39</ENT>
              <ENT>4.87</ENT>
              <ENT>2.99</ENT>
              <ENT>0.31</ENT>
              <ENT>8.57</ENT>
              <ENT>6.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23655</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat shoulder dislocation</ENT>
              <ENT>4.57</ENT>
              <ENT>N/A</ENT>
              <ENT>4.17</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>9.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23660</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat shoulder dislocation</ENT>
              <ENT>7.49</ENT>
              <ENT>N/A</ENT>
              <ENT>6.48</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>14.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23665</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat dislocation/fracture</ENT>
              <ENT>4.47</ENT>
              <ENT>6.81</ENT>
              <ENT>5.13</ENT>
              <ENT>0.60</ENT>
              <ENT>11.88</ENT>
              <ENT>10.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23670</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat dislocation/fracture</ENT>
              <ENT>7.90</ENT>
              <ENT>N/A</ENT>
              <ENT>6.95</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>15.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23675</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat dislocation/fracture</ENT>
              <ENT>6.05</ENT>
              <ENT>7.70</ENT>
              <ENT>6.17</ENT>
              <ENT>0.83</ENT>
              <ENT>14.58</ENT>
              <ENT>13.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23680</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat dislocation/fracture</ENT>
              <ENT>10.06</ENT>
              <ENT>N/A</ENT>
              <ENT>8.24</ENT>
              <ENT>1.39</ENT>
              <ENT>N/A</ENT>
              <ENT>19.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fixation of shoulder</ENT>
              <ENT>2.52</ENT>
              <ENT>N/A</ENT>
              <ENT>2.39</ENT>
              <ENT>0.35</ENT>
              <ENT>N/A</ENT>
              <ENT>5.26</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of shoulder joint</ENT>
              <ENT>14.16</ENT>
              <ENT>N/A</ENT>
              <ENT>10.76</ENT>
              <ENT>1.97</ENT>
              <ENT>N/A</ENT>
              <ENT>26.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23802</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of shoulder joint</ENT>
              <ENT>16.60</ENT>
              <ENT>N/A</ENT>
              <ENT>10.49</ENT>
              <ENT>2.34</ENT>
              <ENT>N/A</ENT>
              <ENT>29.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23900</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation of arm &amp; girdle</ENT>
              <ENT>19.72</ENT>
              <ENT>N/A</ENT>
              <ENT>12.21</ENT>
              <ENT>2.47</ENT>
              <ENT>N/A</ENT>
              <ENT>34.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23920</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation at shoulder joint</ENT>
              <ENT>14.61</ENT>
              <ENT>N/A</ENT>
              <ENT>10.45</ENT>
              <ENT>1.92</ENT>
              <ENT>N/A</ENT>
              <ENT>26.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23921</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation follow-up surgery</ENT>
              <ENT>5.49</ENT>
              <ENT>5.32</ENT>
              <ENT>5.32</ENT>
              <ENT>0.78</ENT>
              <ENT>11.59</ENT>
              <ENT>11.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23929</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Shoulder surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49089"/>
              <ENT I="01">23930</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of arm lesion</ENT>
              <ENT>2.94</ENT>
              <ENT>3.07</ENT>
              <ENT>2.50</ENT>
              <ENT>0.32</ENT>
              <ENT>6.33</ENT>
              <ENT>5.76</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23931</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of arm bursa</ENT>
              <ENT>1.79</ENT>
              <ENT>2.76</ENT>
              <ENT>2.31</ENT>
              <ENT>0.21</ENT>
              <ENT>4.76</ENT>
              <ENT>4.31</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">23935</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain arm/elbow bone lesion</ENT>
              <ENT>6.09</ENT>
              <ENT>N/A</ENT>
              <ENT>6.74</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>13.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploratory elbow surgery</ENT>
              <ENT>5.82</ENT>
              <ENT>N/A</ENT>
              <ENT>5.56</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>12.15</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24006</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release elbow joint</ENT>
              <ENT>9.31</ENT>
              <ENT>N/A</ENT>
              <ENT>7.93</ENT>
              <ENT>1.27</ENT>
              <ENT>N/A</ENT>
              <ENT>18.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24065</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy arm/elbow soft tissue</ENT>
              <ENT>2.08</ENT>
              <ENT>2.45</ENT>
              <ENT>1.94</ENT>
              <ENT>0.14</ENT>
              <ENT>4.67</ENT>
              <ENT>4.16</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24066</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy arm/elbow soft tissue</ENT>
              <ENT>5.21</ENT>
              <ENT>5.90</ENT>
              <ENT>4.41</ENT>
              <ENT>0.61</ENT>
              <ENT>11.72</ENT>
              <ENT>10.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24075</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove arm/elbow lesion</ENT>
              <ENT>3.92</ENT>
              <ENT>5.18</ENT>
              <ENT>3.79</ENT>
              <ENT>0.43</ENT>
              <ENT>9.53</ENT>
              <ENT>8.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24076</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove arm/elbow lesion</ENT>
              <ENT>6.30</ENT>
              <ENT>N/A</ENT>
              <ENT>5.17</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>12.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24077</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove tumor of arm/elbow</ENT>
              <ENT>11.76</ENT>
              <ENT>N/A</ENT>
              <ENT>8.97</ENT>
              <ENT>1.32</ENT>
              <ENT>N/A</ENT>
              <ENT>22.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy elbow joint lining</ENT>
              <ENT>4.93</ENT>
              <ENT>N/A</ENT>
              <ENT>4.72</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>10.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24101</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore/treat elbow joint</ENT>
              <ENT>6.13</ENT>
              <ENT>N/A</ENT>
              <ENT>6.07</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>13.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24102</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove elbow joint lining</ENT>
              <ENT>8.03</ENT>
              <ENT>N/A</ENT>
              <ENT>7.05</ENT>
              <ENT>1.09</ENT>
              <ENT>N/A</ENT>
              <ENT>16.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24105</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of elbow bursa</ENT>
              <ENT>3.61</ENT>
              <ENT>N/A</ENT>
              <ENT>4.53</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>8.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove humerus lesion</ENT>
              <ENT>7.39</ENT>
              <ENT>N/A</ENT>
              <ENT>6.93</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>15.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24115</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove/graft bone lesion</ENT>
              <ENT>9.63</ENT>
              <ENT>N/A</ENT>
              <ENT>7.58</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>18.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24116</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove/graft bone lesion</ENT>
              <ENT>11.81</ENT>
              <ENT>N/A</ENT>
              <ENT>9.34</ENT>
              <ENT>1.66</ENT>
              <ENT>N/A</ENT>
              <ENT>22.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove elbow lesion</ENT>
              <ENT>6.65</ENT>
              <ENT>N/A</ENT>
              <ENT>6.08</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>13.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24125</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove/graft bone lesion</ENT>
              <ENT>7.89</ENT>
              <ENT>N/A</ENT>
              <ENT>6.38</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>15.15</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24126</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove/graft bone lesion</ENT>
              <ENT>8.31</ENT>
              <ENT>N/A</ENT>
              <ENT>7.19</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>16.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of head of radius</ENT>
              <ENT>6.25</ENT>
              <ENT>N/A</ENT>
              <ENT>6.16</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>13.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24134</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of arm bone lesion</ENT>
              <ENT>9.73</ENT>
              <ENT>N/A</ENT>
              <ENT>9.79</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>20.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24136</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove radius bone lesion</ENT>
              <ENT>7.99</ENT>
              <ENT>N/A</ENT>
              <ENT>7.66</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>16.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24138</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove elbow bone lesion</ENT>
              <ENT>8.05</ENT>
              <ENT>N/A</ENT>
              <ENT>7.71</ENT>
              <ENT>1.12</ENT>
              <ENT>N/A</ENT>
              <ENT>16.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of arm bone</ENT>
              <ENT>9.18</ENT>
              <ENT>N/A</ENT>
              <ENT>10.17</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>20.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24145</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of radius</ENT>
              <ENT>7.58</ENT>
              <ENT>N/A</ENT>
              <ENT>8.80</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>17.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24147</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of elbow</ENT>
              <ENT>7.54</ENT>
              <ENT>N/A</ENT>
              <ENT>9.19</ENT>
              <ENT>1.04</ENT>
              <ENT>N/A</ENT>
              <ENT>17.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24149</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radical resection of elbow</ENT>
              <ENT>14.20</ENT>
              <ENT>N/A</ENT>
              <ENT>11.53</ENT>
              <ENT>1.90</ENT>
              <ENT>N/A</ENT>
              <ENT>27.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive humerus surgery</ENT>
              <ENT>13.27</ENT>
              <ENT>N/A</ENT>
              <ENT>10.47</ENT>
              <ENT>1.81</ENT>
              <ENT>N/A</ENT>
              <ENT>25.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24151</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive humerus surgery</ENT>
              <ENT>15.58</ENT>
              <ENT>N/A</ENT>
              <ENT>12.08</ENT>
              <ENT>2.19</ENT>
              <ENT>N/A</ENT>
              <ENT>29.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24152</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive radius surgery</ENT>
              <ENT>10.06</ENT>
              <ENT>N/A</ENT>
              <ENT>8.27</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>19.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24153</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive radius surgery</ENT>
              <ENT>11.54</ENT>
              <ENT>N/A</ENT>
              <ENT>6.08</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>18.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24155</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of elbow joint</ENT>
              <ENT>11.73</ENT>
              <ENT>N/A</ENT>
              <ENT>8.62</ENT>
              <ENT>1.42</ENT>
              <ENT>N/A</ENT>
              <ENT>21.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24160</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove elbow joint implant</ENT>
              <ENT>7.83</ENT>
              <ENT>N/A</ENT>
              <ENT>6.85</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>15.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24164</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove radius head implant</ENT>
              <ENT>6.23</ENT>
              <ENT>N/A</ENT>
              <ENT>5.77</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>12.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of arm foreign body</ENT>
              <ENT>1.76</ENT>
              <ENT>2.38</ENT>
              <ENT>1.82</ENT>
              <ENT>0.15</ENT>
              <ENT>4.29</ENT>
              <ENT>3.73</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24201</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of arm foreign body</ENT>
              <ENT>4.56</ENT>
              <ENT>5.84</ENT>
              <ENT>4.46</ENT>
              <ENT>0.56</ENT>
              <ENT>10.96</ENT>
              <ENT>9.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection for elbow x-ray</ENT>
              <ENT>1.31</ENT>
              <ENT>7.42</ENT>
              <ENT>0.45</ENT>
              <ENT>0.07</ENT>
              <ENT>8.80</ENT>
              <ENT>1.83</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Manipulate elbow w/anesth</ENT>
              <ENT>3.75</ENT>
              <ENT>N/A</ENT>
              <ENT>5.70</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>9.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24301</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Muscle/tendon transfer</ENT>
              <ENT>10.20</ENT>
              <ENT>N/A</ENT>
              <ENT>8.40</ENT>
              <ENT>1.30</ENT>
              <ENT>N/A</ENT>
              <ENT>19.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24305</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Arm tendon lengthening</ENT>
              <ENT>7.45</ENT>
              <ENT>N/A</ENT>
              <ENT>6.87</ENT>
              <ENT>0.98</ENT>
              <ENT>N/A</ENT>
              <ENT>15.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24310</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of arm tendon</ENT>
              <ENT>5.98</ENT>
              <ENT>N/A</ENT>
              <ENT>5.90</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>12.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of arm tendon</ENT>
              <ENT>10.56</ENT>
              <ENT>N/A</ENT>
              <ENT>7.95</ENT>
              <ENT>1.00</ENT>
              <ENT>N/A</ENT>
              <ENT>19.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24330</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of arm muscles</ENT>
              <ENT>9.60</ENT>
              <ENT>N/A</ENT>
              <ENT>8.09</ENT>
              <ENT>1.21</ENT>
              <ENT>N/A</ENT>
              <ENT>18.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24331</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of arm muscles</ENT>
              <ENT>10.65</ENT>
              <ENT>N/A</ENT>
              <ENT>8.75</ENT>
              <ENT>1.41</ENT>
              <ENT>N/A</ENT>
              <ENT>20.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24332</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tenolysis, triceps</ENT>
              <ENT>7.45</ENT>
              <ENT>N/A</ENT>
              <ENT>6.76</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>14.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24340</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of biceps tendon</ENT>
              <ENT>7.89</ENT>
              <ENT>N/A</ENT>
              <ENT>7.11</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>16.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24341</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair arm tendon/muscle</ENT>
              <ENT>7.90</ENT>
              <ENT>N/A</ENT>
              <ENT>7.86</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>16.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24342</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of ruptured tendon</ENT>
              <ENT>10.62</ENT>
              <ENT>N/A</ENT>
              <ENT>8.68</ENT>
              <ENT>1.48</ENT>
              <ENT>N/A</ENT>
              <ENT>20.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24343</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repr elbow lat ligmnt w/tiss</ENT>
              <ENT>8.65</ENT>
              <ENT>N/A</ENT>
              <ENT>8.21</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>17.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49090"/>
              <ENT I="01">24344</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct elbow lat ligmnt</ENT>
              <ENT>14.00</ENT>
              <ENT>N/A</ENT>
              <ENT>11.53</ENT>
              <ENT>1.83</ENT>
              <ENT>N/A</ENT>
              <ENT>27.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24345</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repr elbw med ligmnt w/tissu</ENT>
              <ENT>8.65</ENT>
              <ENT>N/A</ENT>
              <ENT>8.11</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>17.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24346</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct elbow med ligmnt</ENT>
              <ENT>14.00</ENT>
              <ENT>N/A</ENT>
              <ENT>11.38</ENT>
              <ENT>1.83</ENT>
              <ENT>N/A</ENT>
              <ENT>27.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24350</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of tennis elbow</ENT>
              <ENT>5.25</ENT>
              <ENT>N/A</ENT>
              <ENT>5.68</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>11.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24351</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of tennis elbow</ENT>
              <ENT>5.91</ENT>
              <ENT>N/A</ENT>
              <ENT>6.04</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>12.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24352</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of tennis elbow</ENT>
              <ENT>6.43</ENT>
              <ENT>N/A</ENT>
              <ENT>6.30</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>13.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24354</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of tennis elbow</ENT>
              <ENT>6.48</ENT>
              <ENT>N/A</ENT>
              <ENT>6.26</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>13.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24356</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of tennis elbow</ENT>
              <ENT>6.68</ENT>
              <ENT>N/A</ENT>
              <ENT>6.44</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>14.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24360</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct elbow joint</ENT>
              <ENT>12.34</ENT>
              <ENT>N/A</ENT>
              <ENT>9.48</ENT>
              <ENT>1.69</ENT>
              <ENT>N/A</ENT>
              <ENT>23.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24361</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct elbow joint</ENT>
              <ENT>14.08</ENT>
              <ENT>N/A</ENT>
              <ENT>10.56</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>26.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24362</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct elbow joint</ENT>
              <ENT>14.99</ENT>
              <ENT>N/A</ENT>
              <ENT>10.12</ENT>
              <ENT>1.92</ENT>
              <ENT>N/A</ENT>
              <ENT>27.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24363</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replace elbow joint</ENT>
              <ENT>18.49</ENT>
              <ENT>N/A</ENT>
              <ENT>13.78</ENT>
              <ENT>2.52</ENT>
              <ENT>N/A</ENT>
              <ENT>34.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24365</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct head of radius</ENT>
              <ENT>8.39</ENT>
              <ENT>N/A</ENT>
              <ENT>7.16</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>16.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24366</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct head of radius</ENT>
              <ENT>9.13</ENT>
              <ENT>N/A</ENT>
              <ENT>7.51</ENT>
              <ENT>1.28</ENT>
              <ENT>N/A</ENT>
              <ENT>17.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of humerus</ENT>
              <ENT>11.06</ENT>
              <ENT>N/A</ENT>
              <ENT>9.14</ENT>
              <ENT>1.53</ENT>
              <ENT>N/A</ENT>
              <ENT>21.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24410</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of humerus</ENT>
              <ENT>14.82</ENT>
              <ENT>N/A</ENT>
              <ENT>10.69</ENT>
              <ENT>1.89</ENT>
              <ENT>N/A</ENT>
              <ENT>27.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of humerus</ENT>
              <ENT>13.44</ENT>
              <ENT>N/A</ENT>
              <ENT>11.04</ENT>
              <ENT>1.82</ENT>
              <ENT>N/A</ENT>
              <ENT>26.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24430</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of humerus</ENT>
              <ENT>12.81</ENT>
              <ENT>N/A</ENT>
              <ENT>10.01</ENT>
              <ENT>1.80</ENT>
              <ENT>N/A</ENT>
              <ENT>24.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24435</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair humerus with graft</ENT>
              <ENT>13.17</ENT>
              <ENT>N/A</ENT>
              <ENT>11.10</ENT>
              <ENT>1.84</ENT>
              <ENT>N/A</ENT>
              <ENT>26.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24470</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of elbow joint</ENT>
              <ENT>8.74</ENT>
              <ENT>N/A</ENT>
              <ENT>7.83</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>17.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24495</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompression of forearm</ENT>
              <ENT>8.12</ENT>
              <ENT>N/A</ENT>
              <ENT>9.09</ENT>
              <ENT>0.92</ENT>
              <ENT>N/A</ENT>
              <ENT>18.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24498</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reinforce humerus</ENT>
              <ENT>11.92</ENT>
              <ENT>N/A</ENT>
              <ENT>9.52</ENT>
              <ENT>1.67</ENT>
              <ENT>N/A</ENT>
              <ENT>23.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat humerus fracture</ENT>
              <ENT>3.21</ENT>
              <ENT>5.40</ENT>
              <ENT>3.59</ENT>
              <ENT>0.41</ENT>
              <ENT>9.02</ENT>
              <ENT>7.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24505</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat humerus fracture</ENT>
              <ENT>5.17</ENT>
              <ENT>7.64</ENT>
              <ENT>5.58</ENT>
              <ENT>0.72</ENT>
              <ENT>13.53</ENT>
              <ENT>11.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24515</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat humerus fracture</ENT>
              <ENT>11.65</ENT>
              <ENT>N/A</ENT>
              <ENT>9.48</ENT>
              <ENT>1.63</ENT>
              <ENT>N/A</ENT>
              <ENT>22.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24516</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat humerus fracture</ENT>
              <ENT>11.65</ENT>
              <ENT>N/A</ENT>
              <ENT>9.45</ENT>
              <ENT>1.63</ENT>
              <ENT>N/A</ENT>
              <ENT>22.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat humerus fracture</ENT>
              <ENT>3.50</ENT>
              <ENT>5.59</ENT>
              <ENT>4.11</ENT>
              <ENT>0.47</ENT>
              <ENT>9.56</ENT>
              <ENT>8.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24535</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat humerus fracture</ENT>
              <ENT>6.87</ENT>
              <ENT>8.54</ENT>
              <ENT>6.53</ENT>
              <ENT>0.96</ENT>
              <ENT>16.37</ENT>
              <ENT>14.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24538</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat humerus fracture</ENT>
              <ENT>9.43</ENT>
              <ENT>N/A</ENT>
              <ENT>8.85</ENT>
              <ENT>1.25</ENT>
              <ENT>N/A</ENT>
              <ENT>19.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24545</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat humerus fracture</ENT>
              <ENT>10.46</ENT>
              <ENT>N/A</ENT>
              <ENT>8.55</ENT>
              <ENT>1.47</ENT>
              <ENT>N/A</ENT>
              <ENT>20.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24546</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat humerus fracture</ENT>
              <ENT>15.69</ENT>
              <ENT>N/A</ENT>
              <ENT>11.63</ENT>
              <ENT>2.18</ENT>
              <ENT>N/A</ENT>
              <ENT>29.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24560</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat humerus fracture</ENT>
              <ENT>2.80</ENT>
              <ENT>5.07</ENT>
              <ENT>3.19</ENT>
              <ENT>0.35</ENT>
              <ENT>8.22</ENT>
              <ENT>6.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24565</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat humerus fracture</ENT>
              <ENT>5.56</ENT>
              <ENT>7.42</ENT>
              <ENT>5.50</ENT>
              <ENT>0.74</ENT>
              <ENT>13.72</ENT>
              <ENT>11.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24566</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat humerus fracture</ENT>
              <ENT>7.79</ENT>
              <ENT>N/A</ENT>
              <ENT>8.36</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>17.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24575</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat humerus fracture</ENT>
              <ENT>10.66</ENT>
              <ENT>N/A</ENT>
              <ENT>8.42</ENT>
              <ENT>1.44</ENT>
              <ENT>N/A</ENT>
              <ENT>20.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24576</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat humerus fracture</ENT>
              <ENT>2.86</ENT>
              <ENT>4.94</ENT>
              <ENT>3.57</ENT>
              <ENT>0.38</ENT>
              <ENT>8.18</ENT>
              <ENT>6.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24577</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat humerus fracture</ENT>
              <ENT>5.79</ENT>
              <ENT>7.70</ENT>
              <ENT>5.80</ENT>
              <ENT>0.81</ENT>
              <ENT>14.30</ENT>
              <ENT>12.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24579</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat humerus fracture</ENT>
              <ENT>11.60</ENT>
              <ENT>N/A</ENT>
              <ENT>9.10</ENT>
              <ENT>1.62</ENT>
              <ENT>N/A</ENT>
              <ENT>22.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24582</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat humerus fracture</ENT>
              <ENT>8.55</ENT>
              <ENT>N/A</ENT>
              <ENT>9.17</ENT>
              <ENT>1.20</ENT>
              <ENT>N/A</ENT>
              <ENT>18.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24586</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat elbow fracture</ENT>
              <ENT>15.21</ENT>
              <ENT>N/A</ENT>
              <ENT>11.19</ENT>
              <ENT>2.12</ENT>
              <ENT>N/A</ENT>
              <ENT>28.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24587</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat elbow fracture</ENT>
              <ENT>15.16</ENT>
              <ENT>N/A</ENT>
              <ENT>11.00</ENT>
              <ENT>2.14</ENT>
              <ENT>N/A</ENT>
              <ENT>28.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat elbow dislocation</ENT>
              <ENT>4.23</ENT>
              <ENT>5.86</ENT>
              <ENT>3.74</ENT>
              <ENT>0.49</ENT>
              <ENT>10.58</ENT>
              <ENT>8.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat elbow dislocation</ENT>
              <ENT>5.42</ENT>
              <ENT>N/A</ENT>
              <ENT>5.16</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>11.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24615</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat elbow dislocation</ENT>
              <ENT>9.42</ENT>
              <ENT>N/A</ENT>
              <ENT>7.84</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>18.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24620</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat elbow fracture</ENT>
              <ENT>6.98</ENT>
              <ENT>N/A</ENT>
              <ENT>6.23</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>14.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24635</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat elbow fracture</ENT>
              <ENT>13.19</ENT>
              <ENT>N/A</ENT>
              <ENT>14.76</ENT>
              <ENT>1.84</ENT>
              <ENT>N/A</ENT>
              <ENT>29.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24640</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat elbow dislocation</ENT>
              <ENT>1.20</ENT>
              <ENT>2.06</ENT>
              <ENT>0.91</ENT>
              <ENT>0.11</ENT>
              <ENT>3.37</ENT>
              <ENT>2.22</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24650</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat radius fracture</ENT>
              <ENT>2.16</ENT>
              <ENT>4.64</ENT>
              <ENT>2.79</ENT>
              <ENT>0.28</ENT>
              <ENT>7.08</ENT>
              <ENT>5.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24655</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat radius fracture</ENT>
              <ENT>4.40</ENT>
              <ENT>6.89</ENT>
              <ENT>4.78</ENT>
              <ENT>0.58</ENT>
              <ENT>11.87</ENT>
              <ENT>9.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24665</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat radius fracture</ENT>
              <ENT>8.14</ENT>
              <ENT>N/A</ENT>
              <ENT>7.62</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>16.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24666</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat radius fracture</ENT>
              <ENT>9.49</ENT>
              <ENT>N/A</ENT>
              <ENT>8.30</ENT>
              <ENT>1.32</ENT>
              <ENT>N/A</ENT>
              <ENT>19.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24670</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat ulnar fracture</ENT>
              <ENT>2.54</ENT>
              <ENT>4.52</ENT>
              <ENT>3.07</ENT>
              <ENT>0.33</ENT>
              <ENT>7.39</ENT>
              <ENT>5.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24675</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat ulnar fracture</ENT>
              <ENT>4.72</ENT>
              <ENT>6.94</ENT>
              <ENT>5.01</ENT>
              <ENT>0.65</ENT>
              <ENT>12.31</ENT>
              <ENT>10.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24685</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat ulnar fracture</ENT>
              <ENT>8.80</ENT>
              <ENT>N/A</ENT>
              <ENT>7.77</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>17.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of elbow joint</ENT>
              <ENT>11.20</ENT>
              <ENT>N/A</ENT>
              <ENT>8.95</ENT>
              <ENT>1.41</ENT>
              <ENT>N/A</ENT>
              <ENT>21.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24802</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion/graft of elbow joint</ENT>
              <ENT>13.69</ENT>
              <ENT>N/A</ENT>
              <ENT>10.59</ENT>
              <ENT>1.89</ENT>
              <ENT>N/A</ENT>
              <ENT>26.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24900</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation of upper arm</ENT>
              <ENT>9.60</ENT>
              <ENT>N/A</ENT>
              <ENT>7.53</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>18.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24920</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation of upper arm</ENT>
              <ENT>9.54</ENT>
              <ENT>N/A</ENT>
              <ENT>7.88</ENT>
              <ENT>1.22</ENT>
              <ENT>N/A</ENT>
              <ENT>18.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24925</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation follow-up surgery</ENT>
              <ENT>7.07</ENT>
              <ENT>N/A</ENT>
              <ENT>6.45</ENT>
              <ENT>0.95</ENT>
              <ENT>N/A</ENT>
              <ENT>14.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49091"/>
              <ENT I="01">24930</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation follow-up surgery</ENT>
              <ENT>10.25</ENT>
              <ENT>N/A</ENT>
              <ENT>7.78</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>19.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24931</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputate upper arm &amp; implant</ENT>
              <ENT>12.72</ENT>
              <ENT>N/A</ENT>
              <ENT>6.31</ENT>
              <ENT>1.56</ENT>
              <ENT>N/A</ENT>
              <ENT>20.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24935</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of amputation</ENT>
              <ENT>15.56</ENT>
              <ENT>N/A</ENT>
              <ENT>8.64</ENT>
              <ENT>1.58</ENT>
              <ENT>N/A</ENT>
              <ENT>25.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24940</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Revision of upper arm</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">24999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Upper arm/elbow surgery</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of tendon sheath</ENT>
              <ENT>3.38</ENT>
              <ENT>N/A</ENT>
              <ENT>6.95</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>10.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25001</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise flexor carpi radialis</ENT>
              <ENT>3.38</ENT>
              <ENT>N/A</ENT>
              <ENT>4.29</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>8.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompress forearm 1 space</ENT>
              <ENT>5.92</ENT>
              <ENT>N/A</ENT>
              <ENT>10.24</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>16.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25023</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompress forearm 1 space</ENT>
              <ENT>12.96</ENT>
              <ENT>N/A</ENT>
              <ENT>15.71</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>30.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25024</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompress forearm 2 spaces</ENT>
              <ENT>9.50</ENT>
              <ENT>N/A</ENT>
              <ENT>7.63</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>18.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25025</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompress forarm 2 spaces</ENT>
              <ENT>16.54</ENT>
              <ENT>N/A</ENT>
              <ENT>10.25</ENT>
              <ENT>2.18</ENT>
              <ENT>N/A</ENT>
              <ENT>28.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25028</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of forearm lesion</ENT>
              <ENT>5.25</ENT>
              <ENT>N/A</ENT>
              <ENT>8.79</ENT>
              <ENT>0.61</ENT>
              <ENT>N/A</ENT>
              <ENT>14.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25031</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of forearm bursa</ENT>
              <ENT>4.14</ENT>
              <ENT>N/A</ENT>
              <ENT>8.65</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>13.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25035</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat forearm bone lesion</ENT>
              <ENT>7.36</ENT>
              <ENT>N/A</ENT>
              <ENT>14.64</ENT>
              <ENT>0.98</ENT>
              <ENT>N/A</ENT>
              <ENT>22.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25040</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore/treat wrist joint</ENT>
              <ENT>7.18</ENT>
              <ENT>N/A</ENT>
              <ENT>7.68</ENT>
              <ENT>0.96</ENT>
              <ENT>N/A</ENT>
              <ENT>15.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25065</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy forearm soft tissues</ENT>
              <ENT>1.99</ENT>
              <ENT>2.89</ENT>
              <ENT>2.89</ENT>
              <ENT>0.12</ENT>
              <ENT>5.00</ENT>
              <ENT>5.00</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25066</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy forearm soft tissues</ENT>
              <ENT>4.13</ENT>
              <ENT>N/A</ENT>
              <ENT>7.43</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>12.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25075</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removel forearm lesion subcu</ENT>
              <ENT>3.74</ENT>
              <ENT>N/A</ENT>
              <ENT>6.28</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>10.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25076</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removel forearm lesion deep</ENT>
              <ENT>4.92</ENT>
              <ENT>N/A</ENT>
              <ENT>10.35</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>15.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25077</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove tumor, forearm/wrist</ENT>
              <ENT>9.76</ENT>
              <ENT>N/A</ENT>
              <ENT>12.98</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>23.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25085</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of wrist capsule</ENT>
              <ENT>5.50</ENT>
              <ENT>N/A</ENT>
              <ENT>7.81</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>14.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of wrist joint</ENT>
              <ENT>3.90</ENT>
              <ENT>N/A</ENT>
              <ENT>5.67</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>10.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25101</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore/treat wrist joint</ENT>
              <ENT>4.69</ENT>
              <ENT>N/A</ENT>
              <ENT>6.25</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>11.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25105</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove wrist joint lining</ENT>
              <ENT>5.85</ENT>
              <ENT>N/A</ENT>
              <ENT>7.88</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>14.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25107</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove wrist joint cartilage</ENT>
              <ENT>6.43</ENT>
              <ENT>N/A</ENT>
              <ENT>8.83</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>16.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove wrist tendon lesion</ENT>
              <ENT>3.92</ENT>
              <ENT>N/A</ENT>
              <ENT>7.46</ENT>
              <ENT>0.48</ENT>
              <ENT>N/A</ENT>
              <ENT>11.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25111</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove wrist tendon lesion</ENT>
              <ENT>3.39</ENT>
              <ENT>N/A</ENT>
              <ENT>5.08</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>8.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25112</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reremove wrist tendon lesion</ENT>
              <ENT>4.53</ENT>
              <ENT>N/A</ENT>
              <ENT>5.69</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>10.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25115</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove wrist/forearm lesion</ENT>
              <ENT>8.82</ENT>
              <ENT>N/A</ENT>
              <ENT>14.84</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>24.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25116</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove wrist/forearm lesion</ENT>
              <ENT>7.11</ENT>
              <ENT>N/A</ENT>
              <ENT>13.82</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>21.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25118</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise wrist tendon sheath</ENT>
              <ENT>4.37</ENT>
              <ENT>N/A</ENT>
              <ENT>6.17</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>11.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25119</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of ulna</ENT>
              <ENT>6.04</ENT>
              <ENT>N/A</ENT>
              <ENT>8.17</ENT>
              <ENT>0.80</ENT>
              <ENT>N/A</ENT>
              <ENT>15.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of forearm lesion</ENT>
              <ENT>6.10</ENT>
              <ENT>N/A</ENT>
              <ENT>12.83</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>19.74</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25125</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove/graft forearm lesion</ENT>
              <ENT>7.48</ENT>
              <ENT>N/A</ENT>
              <ENT>13.61</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>22.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25126</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove/graft forearm lesion</ENT>
              <ENT>7.55</ENT>
              <ENT>N/A</ENT>
              <ENT>13.69</ENT>
              <ENT>1.00</ENT>
              <ENT>N/A</ENT>
              <ENT>22.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of wrist lesion</ENT>
              <ENT>5.26</ENT>
              <ENT>N/A</ENT>
              <ENT>6.72</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>12.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25135</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove &amp; graft wrist lesion</ENT>
              <ENT>6.89</ENT>
              <ENT>N/A</ENT>
              <ENT>7.75</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>15.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25136</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove &amp; graft wrist lesion</ENT>
              <ENT>5.97</ENT>
              <ENT>N/A</ENT>
              <ENT>6.87</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>13.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25145</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove forearm bone lesion</ENT>
              <ENT>6.37</ENT>
              <ENT>N/A</ENT>
              <ENT>12.84</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>20.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of ulna</ENT>
              <ENT>7.09</ENT>
              <ENT>N/A</ENT>
              <ENT>8.85</ENT>
              <ENT>0.96</ENT>
              <ENT>N/A</ENT>
              <ENT>16.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25151</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of radius</ENT>
              <ENT>7.39</ENT>
              <ENT>N/A</ENT>
              <ENT>13.46</ENT>
              <ENT>0.93</ENT>
              <ENT>N/A</ENT>
              <ENT>21.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25170</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive forearm surgery</ENT>
              <ENT>11.09</ENT>
              <ENT>N/A</ENT>
              <ENT>15.81</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>28.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25210</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of wrist bone</ENT>
              <ENT>5.95</ENT>
              <ENT>N/A</ENT>
              <ENT>7.10</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>13.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25215</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of wrist bones</ENT>
              <ENT>7.89</ENT>
              <ENT>N/A</ENT>
              <ENT>9.32</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>18.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49092"/>
              <ENT I="01">25230</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of radius</ENT>
              <ENT>5.23</ENT>
              <ENT>N/A</ENT>
              <ENT>6.51</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>12.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25240</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of ulna</ENT>
              <ENT>5.17</ENT>
              <ENT>N/A</ENT>
              <ENT>7.59</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>13.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25246</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection for wrist x-ray</ENT>
              <ENT>1.45</ENT>
              <ENT>7.16</ENT>
              <ENT>0.49</ENT>
              <ENT>0.07</ENT>
              <ENT>8.68</ENT>
              <ENT>2.01</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25248</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove forearm foreign body</ENT>
              <ENT>5.14</ENT>
              <ENT>N/A</ENT>
              <ENT>9.00</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>14.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of wrist prosthesis</ENT>
              <ENT>6.60</ENT>
              <ENT>N/A</ENT>
              <ENT>6.06</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>13.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25251</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of wrist prosthesis</ENT>
              <ENT>9.57</ENT>
              <ENT>N/A</ENT>
              <ENT>7.95</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>18.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25259</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Manipulate wrist w/anesthes</ENT>
              <ENT>3.75</ENT>
              <ENT>N/A</ENT>
              <ENT>5.70</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>9.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25260</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair forearm tendon/muscle</ENT>
              <ENT>7.80</ENT>
              <ENT>N/A</ENT>
              <ENT>14.22</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>22.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25263</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair forearm tendon/muscle</ENT>
              <ENT>7.82</ENT>
              <ENT>N/A</ENT>
              <ENT>14.09</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>22.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25265</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair forearm tendon/muscle</ENT>
              <ENT>9.88</ENT>
              <ENT>N/A</ENT>
              <ENT>14.98</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>26.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25270</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair forearm tendon/muscle</ENT>
              <ENT>6.00</ENT>
              <ENT>N/A</ENT>
              <ENT>12.99</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>19.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25272</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair forearm tendon/muscle</ENT>
              <ENT>7.04</ENT>
              <ENT>N/A</ENT>
              <ENT>13.70</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>21.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25274</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair forearm tendon/muscle</ENT>
              <ENT>8.75</ENT>
              <ENT>N/A</ENT>
              <ENT>14.41</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>24.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25275</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair forearm tendon sheath</ENT>
              <ENT>8.50</ENT>
              <ENT>N/A</ENT>
              <ENT>7.72</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>17.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25280</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise wrist/forearm tendon</ENT>
              <ENT>7.22</ENT>
              <ENT>N/A</ENT>
              <ENT>13.39</ENT>
              <ENT>0.91</ENT>
              <ENT>N/A</ENT>
              <ENT>21.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25290</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise wrist/forearm tendon</ENT>
              <ENT>5.29</ENT>
              <ENT>N/A</ENT>
              <ENT>16.39</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>22.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25295</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release wrist/forearm tendon</ENT>
              <ENT>6.55</ENT>
              <ENT>N/A</ENT>
              <ENT>12.95</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>20.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of tendons at wrist</ENT>
              <ENT>8.80</ENT>
              <ENT>N/A</ENT>
              <ENT>8.66</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>18.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25301</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of tendons at wrist</ENT>
              <ENT>8.40</ENT>
              <ENT>N/A</ENT>
              <ENT>8.38</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>17.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25310</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transplant forearm tendon</ENT>
              <ENT>8.14</ENT>
              <ENT>N/A</ENT>
              <ENT>13.81</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>22.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25312</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transplant forearm tendon</ENT>
              <ENT>9.57</ENT>
              <ENT>N/A</ENT>
              <ENT>14.72</ENT>
              <ENT>1.22</ENT>
              <ENT>N/A</ENT>
              <ENT>25.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25315</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise palsy hand tendon(s)</ENT>
              <ENT>10.20</ENT>
              <ENT>N/A</ENT>
              <ENT>15.32</ENT>
              <ENT>1.26</ENT>
              <ENT>N/A</ENT>
              <ENT>26.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25316</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise palsy hand tendon(s)</ENT>
              <ENT>12.33</ENT>
              <ENT>N/A</ENT>
              <ENT>16.98</ENT>
              <ENT>1.74</ENT>
              <ENT>N/A</ENT>
              <ENT>31.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/revise wrist joint</ENT>
              <ENT>10.77</ENT>
              <ENT>N/A</ENT>
              <ENT>11.40</ENT>
              <ENT>1.32</ENT>
              <ENT>N/A</ENT>
              <ENT>23.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25332</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise wrist joint</ENT>
              <ENT>11.41</ENT>
              <ENT>N/A</ENT>
              <ENT>9.18</ENT>
              <ENT>1.46</ENT>
              <ENT>N/A</ENT>
              <ENT>22.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25335</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Realignment of hand</ENT>
              <ENT>12.88</ENT>
              <ENT>N/A</ENT>
              <ENT>11.90</ENT>
              <ENT>1.66</ENT>
              <ENT>N/A</ENT>
              <ENT>26.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25337</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct ulna/radioulnar</ENT>
              <ENT>10.17</ENT>
              <ENT>N/A</ENT>
              <ENT>11.55</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>23.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25350</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of radius</ENT>
              <ENT>8.78</ENT>
              <ENT>N/A</ENT>
              <ENT>14.68</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>24.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25355</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of radius</ENT>
              <ENT>10.17</ENT>
              <ENT>N/A</ENT>
              <ENT>15.36</ENT>
              <ENT>1.44</ENT>
              <ENT>N/A</ENT>
              <ENT>26.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25360</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of ulna</ENT>
              <ENT>8.43</ENT>
              <ENT>N/A</ENT>
              <ENT>14.59</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>24.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25365</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise radius &amp; ulna</ENT>
              <ENT>12.40</ENT>
              <ENT>N/A</ENT>
              <ENT>16.32</ENT>
              <ENT>1.67</ENT>
              <ENT>N/A</ENT>
              <ENT>30.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25370</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise radius or ulna</ENT>
              <ENT>13.36</ENT>
              <ENT>N/A</ENT>
              <ENT>16.54</ENT>
              <ENT>1.88</ENT>
              <ENT>N/A</ENT>
              <ENT>31.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25375</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise radius &amp; ulna</ENT>
              <ENT>13.04</ENT>
              <ENT>N/A</ENT>
              <ENT>17.15</ENT>
              <ENT>1.84</ENT>
              <ENT>N/A</ENT>
              <ENT>32.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25390</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shorten radius or ulna</ENT>
              <ENT>10.40</ENT>
              <ENT>N/A</ENT>
              <ENT>15.34</ENT>
              <ENT>1.38</ENT>
              <ENT>N/A</ENT>
              <ENT>27.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25391</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lengthen radius or ulna</ENT>
              <ENT>13.65</ENT>
              <ENT>N/A</ENT>
              <ENT>17.22</ENT>
              <ENT>1.73</ENT>
              <ENT>N/A</ENT>
              <ENT>32.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25392</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shorten radius &amp; ulna</ENT>
              <ENT>13.95</ENT>
              <ENT>N/A</ENT>
              <ENT>16.31</ENT>
              <ENT>1.73</ENT>
              <ENT>N/A</ENT>
              <ENT>31.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25393</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lengthen radius &amp; ulna</ENT>
              <ENT>15.87</ENT>
              <ENT>N/A</ENT>
              <ENT>18.23</ENT>
              <ENT>1.87</ENT>
              <ENT>N/A</ENT>
              <ENT>35.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25394</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair carpal bone, shorten</ENT>
              <ENT>10.40</ENT>
              <ENT>N/A</ENT>
              <ENT>8.53</ENT>
              <ENT>1.40</ENT>
              <ENT>N/A</ENT>
              <ENT>20.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair radius or ulna</ENT>
              <ENT>10.92</ENT>
              <ENT>N/A</ENT>
              <ENT>15.93</ENT>
              <ENT>1.50</ENT>
              <ENT>N/A</ENT>
              <ENT>28.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25405</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/graft radius or ulna</ENT>
              <ENT>14.38</ENT>
              <ENT>N/A</ENT>
              <ENT>17.96</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>34.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25415</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair radius &amp; ulna</ENT>
              <ENT>13.35</ENT>
              <ENT>N/A</ENT>
              <ENT>17.20</ENT>
              <ENT>1.87</ENT>
              <ENT>N/A</ENT>
              <ENT>32.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/graft radius &amp; ulna</ENT>
              <ENT>16.33</ENT>
              <ENT>N/A</ENT>
              <ENT>18.97</ENT>
              <ENT>2.20</ENT>
              <ENT>N/A</ENT>
              <ENT>37.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25425</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/graft radius or ulna</ENT>
              <ENT>13.21</ENT>
              <ENT>N/A</ENT>
              <ENT>23.02</ENT>
              <ENT>1.61</ENT>
              <ENT>N/A</ENT>
              <ENT>37.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25426</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/graft radius &amp; ulna</ENT>
              <ENT>15.82</ENT>
              <ENT>N/A</ENT>
              <ENT>17.55</ENT>
              <ENT>2.23</ENT>
              <ENT>N/A</ENT>
              <ENT>35.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25430</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vasc graft into carpal bone</ENT>
              <ENT>9.25</ENT>
              <ENT>N/A</ENT>
              <ENT>7.54</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>17.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25431</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair nonunion carpal bone</ENT>
              <ENT>10.44</ENT>
              <ENT>N/A</ENT>
              <ENT>8.52</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>19.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49093"/>
              <ENT I="01">25440</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/graft wrist bone</ENT>
              <ENT>10.44</ENT>
              <ENT>N/A</ENT>
              <ENT>9.69</ENT>
              <ENT>1.41</ENT>
              <ENT>N/A</ENT>
              <ENT>21.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25441</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct wrist joint</ENT>
              <ENT>12.90</ENT>
              <ENT>N/A</ENT>
              <ENT>10.01</ENT>
              <ENT>1.83</ENT>
              <ENT>N/A</ENT>
              <ENT>24.74</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25442</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct wrist joint</ENT>
              <ENT>10.85</ENT>
              <ENT>N/A</ENT>
              <ENT>8.88</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>20.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25443</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct wrist joint</ENT>
              <ENT>10.39</ENT>
              <ENT>N/A</ENT>
              <ENT>8.76</ENT>
              <ENT>1.30</ENT>
              <ENT>N/A</ENT>
              <ENT>20.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25444</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct wrist joint</ENT>
              <ENT>11.15</ENT>
              <ENT>N/A</ENT>
              <ENT>9.07</ENT>
              <ENT>1.43</ENT>
              <ENT>N/A</ENT>
              <ENT>21.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25445</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct wrist joint</ENT>
              <ENT>9.69</ENT>
              <ENT>N/A</ENT>
              <ENT>8.02</ENT>
              <ENT>1.26</ENT>
              <ENT>N/A</ENT>
              <ENT>18.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25446</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Wrist replacement</ENT>
              <ENT>16.55</ENT>
              <ENT>N/A</ENT>
              <ENT>11.98</ENT>
              <ENT>2.20</ENT>
              <ENT>N/A</ENT>
              <ENT>30.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25447</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair wrist joint(s)</ENT>
              <ENT>10.37</ENT>
              <ENT>N/A</ENT>
              <ENT>8.64</ENT>
              <ENT>1.34</ENT>
              <ENT>N/A</ENT>
              <ENT>20.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25449</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove wrist joint implant</ENT>
              <ENT>14.49</ENT>
              <ENT>N/A</ENT>
              <ENT>10.72</ENT>
              <ENT>1.77</ENT>
              <ENT>N/A</ENT>
              <ENT>26.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of wrist joint</ENT>
              <ENT>7.87</ENT>
              <ENT>N/A</ENT>
              <ENT>10.71</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>19.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25455</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of wrist joint</ENT>
              <ENT>9.49</ENT>
              <ENT>N/A</ENT>
              <ENT>11.66</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>22.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25490</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reinforce radius</ENT>
              <ENT>9.54</ENT>
              <ENT>N/A</ENT>
              <ENT>14.46</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>25.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25491</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reinforce ulna</ENT>
              <ENT>9.96</ENT>
              <ENT>N/A</ENT>
              <ENT>15.21</ENT>
              <ENT>1.41</ENT>
              <ENT>N/A</ENT>
              <ENT>26.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25492</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reinforce radius and ulna</ENT>
              <ENT>12.33</ENT>
              <ENT>N/A</ENT>
              <ENT>15.97</ENT>
              <ENT>1.62</ENT>
              <ENT>N/A</ENT>
              <ENT>29.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat fracture of radius</ENT>
              <ENT>2.45</ENT>
              <ENT>4.06</ENT>
              <ENT>2.77</ENT>
              <ENT>0.28</ENT>
              <ENT>6.79</ENT>
              <ENT>5.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25505</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat fracture of radius</ENT>
              <ENT>5.21</ENT>
              <ENT>7.36</ENT>
              <ENT>5.34</ENT>
              <ENT>0.69</ENT>
              <ENT>13.26</ENT>
              <ENT>11.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25515</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat fracture of radius</ENT>
              <ENT>9.18</ENT>
              <ENT>N/A</ENT>
              <ENT>7.70</ENT>
              <ENT>1.22</ENT>
              <ENT>N/A</ENT>
              <ENT>18.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat fracture of radius</ENT>
              <ENT>6.26</ENT>
              <ENT>7.58</ENT>
              <ENT>5.98</ENT>
              <ENT>0.85</ENT>
              <ENT>14.69</ENT>
              <ENT>13.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25525</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat fracture of radius</ENT>
              <ENT>12.24</ENT>
              <ENT>N/A</ENT>
              <ENT>10.12</ENT>
              <ENT>1.68</ENT>
              <ENT>N/A</ENT>
              <ENT>24.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25526</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat fracture of radius</ENT>
              <ENT>12.98</ENT>
              <ENT>N/A</ENT>
              <ENT>13.93</ENT>
              <ENT>1.80</ENT>
              <ENT>N/A</ENT>
              <ENT>28.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat fracture of ulna</ENT>
              <ENT>2.09</ENT>
              <ENT>4.22</ENT>
              <ENT>2.85</ENT>
              <ENT>0.27</ENT>
              <ENT>6.58</ENT>
              <ENT>5.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25535</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat fracture of ulna</ENT>
              <ENT>5.14</ENT>
              <ENT>6.98</ENT>
              <ENT>5.27</ENT>
              <ENT>0.68</ENT>
              <ENT>12.80</ENT>
              <ENT>11.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25545</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat fracture of ulna</ENT>
              <ENT>8.90</ENT>
              <ENT>N/A</ENT>
              <ENT>7.90</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>18.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25560</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat fracture radius &amp; ulna</ENT>
              <ENT>2.44</ENT>
              <ENT>4.12</ENT>
              <ENT>2.70</ENT>
              <ENT>0.27</ENT>
              <ENT>6.83</ENT>
              <ENT>5.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25565</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat fracture radius &amp; ulna</ENT>
              <ENT>5.63</ENT>
              <ENT>7.49</ENT>
              <ENT>5.41</ENT>
              <ENT>0.76</ENT>
              <ENT>13.88</ENT>
              <ENT>11.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25574</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat fracture radius &amp; ulna</ENT>
              <ENT>7.01</ENT>
              <ENT>N/A</ENT>
              <ENT>7.26</ENT>
              <ENT>0.96</ENT>
              <ENT>N/A</ENT>
              <ENT>15.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25575</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat fracture radius/ulna</ENT>
              <ENT>10.45</ENT>
              <ENT>N/A</ENT>
              <ENT>9.57</ENT>
              <ENT>1.46</ENT>
              <ENT>N/A</ENT>
              <ENT>21.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat fracture radius/ulna</ENT>
              <ENT>2.63</ENT>
              <ENT>4.56</ENT>
              <ENT>3.00</ENT>
              <ENT>0.34</ENT>
              <ENT>7.53</ENT>
              <ENT>5.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat fracture radius/ulna</ENT>
              <ENT>5.81</ENT>
              <ENT>8.18</ENT>
              <ENT>6.13</ENT>
              <ENT>0.81</ENT>
              <ENT>14.80</ENT>
              <ENT>12.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25611</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat fracture radius/ulna</ENT>
              <ENT>7.77</ENT>
              <ENT>N/A</ENT>
              <ENT>8.90</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>17.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25620</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat fracture radius/ulna</ENT>
              <ENT>8.55</ENT>
              <ENT>N/A</ENT>
              <ENT>7.51</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>17.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25622</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat wrist bone fracture</ENT>
              <ENT>2.61</ENT>
              <ENT>4.63</ENT>
              <ENT>3.10</ENT>
              <ENT>0.33</ENT>
              <ENT>7.57</ENT>
              <ENT>6.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25624</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat wrist bone fracture</ENT>
              <ENT>4.53</ENT>
              <ENT>7.10</ENT>
              <ENT>5.00</ENT>
              <ENT>0.61</ENT>
              <ENT>12.24</ENT>
              <ENT>10.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25628</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat wrist bone fracture</ENT>
              <ENT>8.43</ENT>
              <ENT>N/A</ENT>
              <ENT>8.05</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>17.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25630</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat wrist bone fracture</ENT>
              <ENT>2.88</ENT>
              <ENT>4.65</ENT>
              <ENT>3.00</ENT>
              <ENT>0.37</ENT>
              <ENT>7.90</ENT>
              <ENT>6.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25635</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat wrist bone fracture</ENT>
              <ENT>4.39</ENT>
              <ENT>6.87</ENT>
              <ENT>3.96</ENT>
              <ENT>0.39</ENT>
              <ENT>11.65</ENT>
              <ENT>8.74</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25645</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat wrist bone fracture</ENT>
              <ENT>7.25</ENT>
              <ENT>N/A</ENT>
              <ENT>7.01</ENT>
              <ENT>0.93</ENT>
              <ENT>N/A</ENT>
              <ENT>15.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25650</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat wrist bone fracture</ENT>
              <ENT>3.05</ENT>
              <ENT>4.82</ENT>
              <ENT>3.21</ENT>
              <ENT>0.37</ENT>
              <ENT>8.24</ENT>
              <ENT>6.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25651</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pin ulnar styloid fracture</ENT>
              <ENT>5.36</ENT>
              <ENT>N/A</ENT>
              <ENT>5.62</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>11.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25652</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat fracture ulnar styloid</ENT>
              <ENT>7.60</ENT>
              <ENT>N/A</ENT>
              <ENT>7.11</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>15.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25660</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat wrist dislocation</ENT>
              <ENT>4.76</ENT>
              <ENT>N/A</ENT>
              <ENT>4.75</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>10.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25670</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat wrist dislocation</ENT>
              <ENT>7.92</ENT>
              <ENT>N/A</ENT>
              <ENT>7.31</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>16.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25671</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pin radioulnar dislocation</ENT>
              <ENT>6.00</ENT>
              <ENT>N/A</ENT>
              <ENT>6.23</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>13.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25675</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat wrist dislocation</ENT>
              <ENT>4.67</ENT>
              <ENT>6.62</ENT>
              <ENT>4.69</ENT>
              <ENT>0.57</ENT>
              <ENT>11.86</ENT>
              <ENT>9.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25676</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat wrist dislocation</ENT>
              <ENT>8.04</ENT>
              <ENT>N/A</ENT>
              <ENT>7.56</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>16.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25680</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat wrist fracture</ENT>
              <ENT>5.99</ENT>
              <ENT>N/A</ENT>
              <ENT>4.99</ENT>
              <ENT>0.61</ENT>
              <ENT>N/A</ENT>
              <ENT>11.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25685</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat wrist fracture</ENT>
              <ENT>9.78</ENT>
              <ENT>N/A</ENT>
              <ENT>8.12</ENT>
              <ENT>1.25</ENT>
              <ENT>N/A</ENT>
              <ENT>19.15</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25690</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat wrist dislocation</ENT>
              <ENT>5.50</ENT>
              <ENT>N/A</ENT>
              <ENT>5.69</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>11.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25695</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat wrist dislocation</ENT>
              <ENT>8.34</ENT>
              <ENT>N/A</ENT>
              <ENT>7.43</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>16.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of wrist joint</ENT>
              <ENT>9.76</ENT>
              <ENT>N/A</ENT>
              <ENT>9.35</ENT>
              <ENT>1.30</ENT>
              <ENT>N/A</ENT>
              <ENT>20.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25805</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion/graft of wrist joint</ENT>
              <ENT>11.28</ENT>
              <ENT>N/A</ENT>
              <ENT>10.42</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>23.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25810</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion/graft of wrist joint</ENT>
              <ENT>10.57</ENT>
              <ENT>N/A</ENT>
              <ENT>10.15</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>22.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of hand bones</ENT>
              <ENT>7.45</ENT>
              <ENT>N/A</ENT>
              <ENT>8.10</ENT>
              <ENT>0.96</ENT>
              <ENT>N/A</ENT>
              <ENT>16.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25825</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fuse hand bones with graft</ENT>
              <ENT>9.27</ENT>
              <ENT>N/A</ENT>
              <ENT>9.37</ENT>
              <ENT>1.20</ENT>
              <ENT>N/A</ENT>
              <ENT>19.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25830</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion, radioulnar jnt/ulna</ENT>
              <ENT>10.06</ENT>
              <ENT>N/A</ENT>
              <ENT>15.11</ENT>
              <ENT>1.27</ENT>
              <ENT>N/A</ENT>
              <ENT>26.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25900</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation of forearm</ENT>
              <ENT>9.01</ENT>
              <ENT>N/A</ENT>
              <ENT>13.06</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>23.15</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25905</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation of forearm</ENT>
              <ENT>9.12</ENT>
              <ENT>N/A</ENT>
              <ENT>13.13</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>23.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25907</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation follow-up surgery</ENT>
              <ENT>7.80</ENT>
              <ENT>N/A</ENT>
              <ENT>12.59</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>21.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25909</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation follow-up surgery</ENT>
              <ENT>8.96</ENT>
              <ENT>N/A</ENT>
              <ENT>13.10</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>23.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25915</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation of forearm</ENT>
              <ENT>17.08</ENT>
              <ENT>N/A</ENT>
              <ENT>20.05</ENT>
              <ENT>2.41</ENT>
              <ENT>N/A</ENT>
              <ENT>39.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49094"/>
              <ENT I="01">25920</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputate hand at wrist</ENT>
              <ENT>8.68</ENT>
              <ENT>N/A</ENT>
              <ENT>8.22</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>17.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25922</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputate hand at wrist</ENT>
              <ENT>7.42</ENT>
              <ENT>N/A</ENT>
              <ENT>7.25</ENT>
              <ENT>0.93</ENT>
              <ENT>N/A</ENT>
              <ENT>15.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25924</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation follow-up surgery</ENT>
              <ENT>8.46</ENT>
              <ENT>N/A</ENT>
              <ENT>8.46</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>17.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25927</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation of hand</ENT>
              <ENT>8.80</ENT>
              <ENT>N/A</ENT>
              <ENT>12.40</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>22.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25929</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation follow-up surgery</ENT>
              <ENT>7.59</ENT>
              <ENT>N/A</ENT>
              <ENT>6.13</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>14.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25931</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation follow-up surgery</ENT>
              <ENT>7.81</ENT>
              <ENT>N/A</ENT>
              <ENT>12.40</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>21.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">25999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Forearm or wrist surgery</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of finger abscess</ENT>
              <ENT>1.54</ENT>
              <ENT>5.85</ENT>
              <ENT>1.70</ENT>
              <ENT>0.14</ENT>
              <ENT>7.53</ENT>
              <ENT>3.38</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26011</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of finger abscess</ENT>
              <ENT>2.19</ENT>
              <ENT>9.22</ENT>
              <ENT>2.35</ENT>
              <ENT>0.25</ENT>
              <ENT>11.66</ENT>
              <ENT>4.79</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain hand tendon sheath</ENT>
              <ENT>4.67</ENT>
              <ENT>N/A</ENT>
              <ENT>5.61</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>10.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26025</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of palm bursa</ENT>
              <ENT>4.82</ENT>
              <ENT>N/A</ENT>
              <ENT>5.45</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>10.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26030</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of palm bursa(s)</ENT>
              <ENT>5.93</ENT>
              <ENT>N/A</ENT>
              <ENT>6.11</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>12.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26034</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat hand bone lesion</ENT>
              <ENT>6.23</ENT>
              <ENT>N/A</ENT>
              <ENT>6.33</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>13.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26035</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompress fingers/hand</ENT>
              <ENT>9.51</ENT>
              <ENT>N/A</ENT>
              <ENT>8.21</ENT>
              <ENT>1.12</ENT>
              <ENT>N/A</ENT>
              <ENT>18.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26037</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompress fingers/hand</ENT>
              <ENT>7.25</ENT>
              <ENT>N/A</ENT>
              <ENT>6.72</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>14.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26040</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release palm contracture</ENT>
              <ENT>3.33</ENT>
              <ENT>N/A</ENT>
              <ENT>4.00</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>7.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26045</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release palm contracture</ENT>
              <ENT>5.56</ENT>
              <ENT>N/A</ENT>
              <ENT>5.60</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>11.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26055</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise finger tendon sheath</ENT>
              <ENT>2.69</ENT>
              <ENT>14.74</ENT>
              <ENT>3.86</ENT>
              <ENT>0.36</ENT>
              <ENT>17.79</ENT>
              <ENT>6.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26060</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of finger tendon</ENT>
              <ENT>2.81</ENT>
              <ENT>N/A</ENT>
              <ENT>3.52</ENT>
              <ENT>0.35</ENT>
              <ENT>N/A</ENT>
              <ENT>6.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26070</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore/treat hand joint</ENT>
              <ENT>3.69</ENT>
              <ENT>N/A</ENT>
              <ENT>3.39</ENT>
              <ENT>0.35</ENT>
              <ENT>N/A</ENT>
              <ENT>7.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26075</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore/treat finger joint</ENT>
              <ENT>3.79</ENT>
              <ENT>N/A</ENT>
              <ENT>3.80</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>7.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26080</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore/treat finger joint</ENT>
              <ENT>4.24</ENT>
              <ENT>N/A</ENT>
              <ENT>4.82</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>9.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy hand joint lining</ENT>
              <ENT>3.67</ENT>
              <ENT>N/A</ENT>
              <ENT>4.12</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>8.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26105</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy finger joint lining</ENT>
              <ENT>3.71</ENT>
              <ENT>N/A</ENT>
              <ENT>4.20</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>8.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy finger joint lining</ENT>
              <ENT>3.53</ENT>
              <ENT>N/A</ENT>
              <ENT>4.00</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>7.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26115</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removel hand lesion subcut</ENT>
              <ENT>3.86</ENT>
              <ENT>13.55</ENT>
              <ENT>4.71</ENT>
              <ENT>0.48</ENT>
              <ENT>17.89</ENT>
              <ENT>9.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26116</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removel hand lesion, deep</ENT>
              <ENT>5.53</ENT>
              <ENT>N/A</ENT>
              <ENT>5.98</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>12.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26117</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove tumor, hand/finger</ENT>
              <ENT>8.55</ENT>
              <ENT>N/A</ENT>
              <ENT>7.15</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>16.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26121</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release palm contracture</ENT>
              <ENT>7.54</ENT>
              <ENT>N/A</ENT>
              <ENT>7.02</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>15.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26123</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release palm contracture</ENT>
              <ENT>9.29</ENT>
              <ENT>N/A</ENT>
              <ENT>8.90</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>19.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26125</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release palm contracture</ENT>
              <ENT>4.61</ENT>
              <ENT>N/A</ENT>
              <ENT>2.50</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>7.68</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove wrist joint lining</ENT>
              <ENT>5.42</ENT>
              <ENT>N/A</ENT>
              <ENT>5.35</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>11.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26135</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise finger joint, each</ENT>
              <ENT>6.96</ENT>
              <ENT>N/A</ENT>
              <ENT>6.47</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>14.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise finger joint, each</ENT>
              <ENT>6.17</ENT>
              <ENT>N/A</ENT>
              <ENT>6.03</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>12.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26145</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tendon excision, palm/finger</ENT>
              <ENT>6.32</ENT>
              <ENT>N/A</ENT>
              <ENT>6.04</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>13.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26160</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove tendon sheath lesion</ENT>
              <ENT>3.15</ENT>
              <ENT>12.95</ENT>
              <ENT>4.11</ENT>
              <ENT>0.39</ENT>
              <ENT>16.49</ENT>
              <ENT>7.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26170</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of palm tendon, each</ENT>
              <ENT>4.77</ENT>
              <ENT>N/A</ENT>
              <ENT>4.97</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>10.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26180</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of finger tendon</ENT>
              <ENT>5.18</ENT>
              <ENT>N/A</ENT>
              <ENT>5.40</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>11.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26185</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove finger bone</ENT>
              <ENT>5.25</ENT>
              <ENT>N/A</ENT>
              <ENT>6.01</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>11.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove hand bone lesion</ENT>
              <ENT>5.51</ENT>
              <ENT>N/A</ENT>
              <ENT>5.39</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>11.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26205</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove/graft bone lesion</ENT>
              <ENT>7.70</ENT>
              <ENT>N/A</ENT>
              <ENT>6.91</ENT>
              <ENT>0.95</ENT>
              <ENT>N/A</ENT>
              <ENT>15.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26210</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of finger lesion</ENT>
              <ENT>5.15</ENT>
              <ENT>N/A</ENT>
              <ENT>5.41</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>11.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26215</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove/graft finger lesion</ENT>
              <ENT>7.10</ENT>
              <ENT>N/A</ENT>
              <ENT>6.31</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>14.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26230</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of hand bone</ENT>
              <ENT>6.33</ENT>
              <ENT>N/A</ENT>
              <ENT>5.96</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>13.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26235</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal, finger bone</ENT>
              <ENT>6.19</ENT>
              <ENT>N/A</ENT>
              <ENT>5.85</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>12.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26236</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal, finger bone</ENT>
              <ENT>5.32</ENT>
              <ENT>N/A</ENT>
              <ENT>5.37</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>11.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive hand surgery</ENT>
              <ENT>7.55</ENT>
              <ENT>N/A</ENT>
              <ENT>6.46</ENT>
              <ENT>0.92</ENT>
              <ENT>N/A</ENT>
              <ENT>14.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26255</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive hand surgery</ENT>
              <ENT>12.43</ENT>
              <ENT>N/A</ENT>
              <ENT>9.49</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>22.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26260</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive finger surgery</ENT>
              <ENT>7.03</ENT>
              <ENT>N/A</ENT>
              <ENT>6.20</ENT>
              <ENT>0.83</ENT>
              <ENT>N/A</ENT>
              <ENT>14.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26261</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive finger surgery</ENT>
              <ENT>9.09</ENT>
              <ENT>N/A</ENT>
              <ENT>6.35</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>16.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26262</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of finger</ENT>
              <ENT>5.67</ENT>
              <ENT>N/A</ENT>
              <ENT>5.39</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>11.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of implant from hand</ENT>
              <ENT>3.98</ENT>
              <ENT>N/A</ENT>
              <ENT>4.28</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>8.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49095"/>
              <ENT I="01">26340</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Manipulate finger w/anesth</ENT>
              <ENT>2.50</ENT>
              <ENT>N/A</ENT>
              <ENT>4.95</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>7.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26350</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair finger/hand tendon</ENT>
              <ENT>5.99</ENT>
              <ENT>N/A</ENT>
              <ENT>16.02</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>22.74</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26352</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/graft hand tendon</ENT>
              <ENT>7.68</ENT>
              <ENT>N/A</ENT>
              <ENT>16.69</ENT>
              <ENT>0.93</ENT>
              <ENT>N/A</ENT>
              <ENT>25.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26356</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair finger/hand tendon</ENT>
              <ENT>8.07</ENT>
              <ENT>N/A</ENT>
              <ENT>19.20</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>28.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26357</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair finger/hand tendon</ENT>
              <ENT>8.58</ENT>
              <ENT>N/A</ENT>
              <ENT>17.14</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>26.74</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26358</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/graft hand tendon</ENT>
              <ENT>9.14</ENT>
              <ENT>N/A</ENT>
              <ENT>17.96</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>28.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26370</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair finger/hand tendon</ENT>
              <ENT>7.11</ENT>
              <ENT>N/A</ENT>
              <ENT>16.57</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>24.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26372</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/graft hand tendon</ENT>
              <ENT>8.76</ENT>
              <ENT>N/A</ENT>
              <ENT>17.97</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>27.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26373</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair finger/hand tendon</ENT>
              <ENT>8.16</ENT>
              <ENT>N/A</ENT>
              <ENT>17.54</ENT>
              <ENT>0.98</ENT>
              <ENT>N/A</ENT>
              <ENT>26.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26390</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise hand/finger tendon</ENT>
              <ENT>9.19</ENT>
              <ENT>N/A</ENT>
              <ENT>14.34</ENT>
              <ENT>1.09</ENT>
              <ENT>N/A</ENT>
              <ENT>24.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26392</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/graft hand tendon</ENT>
              <ENT>10.26</ENT>
              <ENT>N/A</ENT>
              <ENT>18.34</ENT>
              <ENT>1.26</ENT>
              <ENT>N/A</ENT>
              <ENT>29.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26410</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair hand tendon</ENT>
              <ENT>4.63</ENT>
              <ENT>N/A</ENT>
              <ENT>13.17</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>18.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26412</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/graft hand tendon</ENT>
              <ENT>6.31</ENT>
              <ENT>N/A</ENT>
              <ENT>14.43</ENT>
              <ENT>0.80</ENT>
              <ENT>N/A</ENT>
              <ENT>21.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26415</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision, hand/finger tendon</ENT>
              <ENT>8.34</ENT>
              <ENT>N/A</ENT>
              <ENT>12.79</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>21.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26416</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Graft hand or finger tendon</ENT>
              <ENT>9.37</ENT>
              <ENT>N/A</ENT>
              <ENT>15.71</ENT>
              <ENT>1.20</ENT>
              <ENT>N/A</ENT>
              <ENT>26.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26418</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair finger tendon</ENT>
              <ENT>4.25</ENT>
              <ENT>N/A</ENT>
              <ENT>13.34</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>18.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/graft finger tendon</ENT>
              <ENT>6.77</ENT>
              <ENT>N/A</ENT>
              <ENT>14.78</ENT>
              <ENT>0.83</ENT>
              <ENT>N/A</ENT>
              <ENT>22.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26426</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair finger/hand tendon</ENT>
              <ENT>6.15</ENT>
              <ENT>N/A</ENT>
              <ENT>14.25</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>21.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26428</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/graft finger tendon</ENT>
              <ENT>7.21</ENT>
              <ENT>N/A</ENT>
              <ENT>15.06</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>23.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26432</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair finger tendon</ENT>
              <ENT>4.02</ENT>
              <ENT>N/A</ENT>
              <ENT>11.13</ENT>
              <ENT>0.48</ENT>
              <ENT>N/A</ENT>
              <ENT>15.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26433</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair finger tendon</ENT>
              <ENT>4.56</ENT>
              <ENT>N/A</ENT>
              <ENT>11.83</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>16.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26434</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/graft finger tendon</ENT>
              <ENT>6.09</ENT>
              <ENT>N/A</ENT>
              <ENT>12.43</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>19.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26437</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Realignment of tendons</ENT>
              <ENT>5.82</ENT>
              <ENT>N/A</ENT>
              <ENT>12.34</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>18.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26440</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release palm/finger tendon</ENT>
              <ENT>5.02</ENT>
              <ENT>N/A</ENT>
              <ENT>14.83</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>20.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26442</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release palm &amp; finger tendon</ENT>
              <ENT>8.16</ENT>
              <ENT>N/A</ENT>
              <ENT>17.10</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>26.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26445</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release hand/finger tendon</ENT>
              <ENT>4.31</ENT>
              <ENT>N/A</ENT>
              <ENT>14.59</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>19.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26449</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release forearm/hand tendon</ENT>
              <ENT>7.00</ENT>
              <ENT>N/A</ENT>
              <ENT>16.90</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>24.74</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of palm tendon</ENT>
              <ENT>3.67</ENT>
              <ENT>N/A</ENT>
              <ENT>7.79</ENT>
              <ENT>0.46</ENT>
              <ENT>N/A</ENT>
              <ENT>11.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26455</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of finger tendon</ENT>
              <ENT>3.64</ENT>
              <ENT>N/A</ENT>
              <ENT>7.71</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>11.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26460</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise hand/finger tendon</ENT>
              <ENT>3.46</ENT>
              <ENT>N/A</ENT>
              <ENT>7.52</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>11.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26471</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of finger tendons</ENT>
              <ENT>5.73</ENT>
              <ENT>N/A</ENT>
              <ENT>12.00</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>18.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26474</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of finger tendons</ENT>
              <ENT>5.32</ENT>
              <ENT>N/A</ENT>
              <ENT>12.20</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>18.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26476</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tendon lengthening</ENT>
              <ENT>5.18</ENT>
              <ENT>N/A</ENT>
              <ENT>11.71</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>17.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26477</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tendon shortening</ENT>
              <ENT>5.15</ENT>
              <ENT>N/A</ENT>
              <ENT>11.87</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>17.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26478</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lengthening of hand tendon</ENT>
              <ENT>5.80</ENT>
              <ENT>N/A</ENT>
              <ENT>12.62</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>19.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26479</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shortening of hand tendon</ENT>
              <ENT>5.74</ENT>
              <ENT>N/A</ENT>
              <ENT>12.45</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>18.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26480</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transplant hand tendon</ENT>
              <ENT>6.69</ENT>
              <ENT>N/A</ENT>
              <ENT>16.27</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>23.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26483</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transplant/graft hand tendon</ENT>
              <ENT>8.29</ENT>
              <ENT>N/A</ENT>
              <ENT>16.72</ENT>
              <ENT>1.03</ENT>
              <ENT>N/A</ENT>
              <ENT>26.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26485</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transplant palm tendon</ENT>
              <ENT>7.70</ENT>
              <ENT>N/A</ENT>
              <ENT>16.60</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>25.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26489</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transplant/graft palm tendon</ENT>
              <ENT>9.55</ENT>
              <ENT>N/A</ENT>
              <ENT>13.02</ENT>
              <ENT>0.98</ENT>
              <ENT>N/A</ENT>
              <ENT>23.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26490</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise thumb tendon</ENT>
              <ENT>8.41</ENT>
              <ENT>N/A</ENT>
              <ENT>13.55</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>23.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26492</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tendon transfer with graft</ENT>
              <ENT>9.62</ENT>
              <ENT>N/A</ENT>
              <ENT>14.30</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>25.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26494</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hand tendon/muscle transfer</ENT>
              <ENT>8.47</ENT>
              <ENT>N/A</ENT>
              <ENT>13.78</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>23.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26496</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise thumb tendon</ENT>
              <ENT>9.59</ENT>
              <ENT>N/A</ENT>
              <ENT>13.97</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>24.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26497</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Finger tendon transfer</ENT>
              <ENT>9.57</ENT>
              <ENT>N/A</ENT>
              <ENT>14.36</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>25.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26498</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Finger tendon transfer</ENT>
              <ENT>14.00</ENT>
              <ENT>N/A</ENT>
              <ENT>16.90</ENT>
              <ENT>1.74</ENT>
              <ENT>N/A</ENT>
              <ENT>32.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26499</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of finger</ENT>
              <ENT>8.98</ENT>
              <ENT>N/A</ENT>
              <ENT>13.90</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>23.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hand tendon reconstruction</ENT>
              <ENT>5.96</ENT>
              <ENT>N/A</ENT>
              <ENT>12.48</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>19.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26502</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hand tendon reconstruction</ENT>
              <ENT>7.14</ENT>
              <ENT>N/A</ENT>
              <ENT>12.95</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>20.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26504</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hand tendon reconstruction</ENT>
              <ENT>7.47</ENT>
              <ENT>N/A</ENT>
              <ENT>13.06</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>21.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26508</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release thumb contracture</ENT>
              <ENT>6.01</ENT>
              <ENT>N/A</ENT>
              <ENT>12.48</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>19.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thumb tendon transfer</ENT>
              <ENT>5.43</ENT>
              <ENT>N/A</ENT>
              <ENT>12.16</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>18.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49096"/>
              <ENT I="01">26516</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of knuckle joint</ENT>
              <ENT>7.15</ENT>
              <ENT>N/A</ENT>
              <ENT>13.02</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>21.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26517</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of knuckle joints</ENT>
              <ENT>8.83</ENT>
              <ENT>N/A</ENT>
              <ENT>14.37</ENT>
              <ENT>0.96</ENT>
              <ENT>N/A</ENT>
              <ENT>24.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26518</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of knuckle joints</ENT>
              <ENT>9.02</ENT>
              <ENT>N/A</ENT>
              <ENT>14.19</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>24.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release knuckle contracture</ENT>
              <ENT>5.30</ENT>
              <ENT>N/A</ENT>
              <ENT>15.21</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>21.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26525</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release finger contracture</ENT>
              <ENT>5.33</ENT>
              <ENT>N/A</ENT>
              <ENT>15.33</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>21.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise knuckle joint</ENT>
              <ENT>6.69</ENT>
              <ENT>N/A</ENT>
              <ENT>6.13</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>13.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26531</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise knuckle with implant</ENT>
              <ENT>7.91</ENT>
              <ENT>N/A</ENT>
              <ENT>7.07</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>15.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26535</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise finger joint</ENT>
              <ENT>5.24</ENT>
              <ENT>N/A</ENT>
              <ENT>3.76</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>9.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26536</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise/implant finger joint</ENT>
              <ENT>6.37</ENT>
              <ENT>N/A</ENT>
              <ENT>10.06</ENT>
              <ENT>0.80</ENT>
              <ENT>N/A</ENT>
              <ENT>17.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26540</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair hand joint</ENT>
              <ENT>6.43</ENT>
              <ENT>N/A</ENT>
              <ENT>12.73</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>19.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26541</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair hand joint with graft</ENT>
              <ENT>8.62</ENT>
              <ENT>N/A</ENT>
              <ENT>14.25</ENT>
              <ENT>1.12</ENT>
              <ENT>N/A</ENT>
              <ENT>23.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26542</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair hand joint with graft</ENT>
              <ENT>6.78</ENT>
              <ENT>N/A</ENT>
              <ENT>12.78</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>20.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26545</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct finger joint</ENT>
              <ENT>6.92</ENT>
              <ENT>N/A</ENT>
              <ENT>13.16</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>20.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26546</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair nonunion hand</ENT>
              <ENT>8.92</ENT>
              <ENT>N/A</ENT>
              <ENT>15.44</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>25.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26548</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct finger joint</ENT>
              <ENT>8.03</ENT>
              <ENT>N/A</ENT>
              <ENT>13.81</ENT>
              <ENT>0.98</ENT>
              <ENT>N/A</ENT>
              <ENT>22.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26550</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Construct thumb replacement</ENT>
              <ENT>21.24</ENT>
              <ENT>N/A</ENT>
              <ENT>18.80</ENT>
              <ENT>1.80</ENT>
              <ENT>N/A</ENT>
              <ENT>41.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26551</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Great toe-hand transfer</ENT>
              <ENT>46.58</ENT>
              <ENT>N/A</ENT>
              <ENT>32.79</ENT>
              <ENT>6.57</ENT>
              <ENT>N/A</ENT>
              <ENT>85.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26553</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Single transfer, toe-hand</ENT>
              <ENT>46.27</ENT>
              <ENT>N/A</ENT>
              <ENT>23.66</ENT>
              <ENT>1.99</ENT>
              <ENT>N/A</ENT>
              <ENT>71.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26554</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Double transfer, toe-hand</ENT>
              <ENT>54.95</ENT>
              <ENT>N/A</ENT>
              <ENT>35.88</ENT>
              <ENT>7.76</ENT>
              <ENT>N/A</ENT>
              <ENT>98.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26555</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Positional change of finger</ENT>
              <ENT>16.63</ENT>
              <ENT>N/A</ENT>
              <ENT>19.12</ENT>
              <ENT>2.13</ENT>
              <ENT>N/A</ENT>
              <ENT>37.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26556</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Toe joint transfer</ENT>
              <ENT>47.26</ENT>
              <ENT>N/A</ENT>
              <ENT>30.96</ENT>
              <ENT>6.67</ENT>
              <ENT>N/A</ENT>
              <ENT>84.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26560</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of web finger</ENT>
              <ENT>5.38</ENT>
              <ENT>N/A</ENT>
              <ENT>10.71</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>16.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26561</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of web finger</ENT>
              <ENT>10.92</ENT>
              <ENT>N/A</ENT>
              <ENT>13.30</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>24.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26562</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of web finger</ENT>
              <ENT>15.00</ENT>
              <ENT>N/A</ENT>
              <ENT>17.99</ENT>
              <ENT>0.98</ENT>
              <ENT>N/A</ENT>
              <ENT>33.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26565</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Correct metacarpal flaw</ENT>
              <ENT>6.74</ENT>
              <ENT>N/A</ENT>
              <ENT>12.83</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>20.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26567</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Correct finger deformity</ENT>
              <ENT>6.82</ENT>
              <ENT>N/A</ENT>
              <ENT>12.76</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>20.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26568</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lengthen metacarpal/finger</ENT>
              <ENT>9.08</ENT>
              <ENT>N/A</ENT>
              <ENT>16.65</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>26.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26580</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair hand deformity</ENT>
              <ENT>18.18</ENT>
              <ENT>N/A</ENT>
              <ENT>14.08</ENT>
              <ENT>1.46</ENT>
              <ENT>N/A</ENT>
              <ENT>33.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26587</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct extra finger</ENT>
              <ENT>14.05</ENT>
              <ENT>N/A</ENT>
              <ENT>9.30</ENT>
              <ENT>1.12</ENT>
              <ENT>N/A</ENT>
              <ENT>24.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26590</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair finger deformity</ENT>
              <ENT>17.96</ENT>
              <ENT>N/A</ENT>
              <ENT>14.84</ENT>
              <ENT>1.32</ENT>
              <ENT>N/A</ENT>
              <ENT>34.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26591</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair muscles of hand</ENT>
              <ENT>3.25</ENT>
              <ENT>N/A</ENT>
              <ENT>10.88</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>14.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26593</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release muscles of hand</ENT>
              <ENT>5.31</ENT>
              <ENT>N/A</ENT>
              <ENT>11.84</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>17.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26596</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision constricting tissue</ENT>
              <ENT>8.95</ENT>
              <ENT>N/A</ENT>
              <ENT>9.20</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>19.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat metacarpal fracture</ENT>
              <ENT>1.96</ENT>
              <ENT>4.15</ENT>
              <ENT>2.69</ENT>
              <ENT>0.25</ENT>
              <ENT>6.36</ENT>
              <ENT>4.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat metacarpal fracture</ENT>
              <ENT>2.85</ENT>
              <ENT>5.45</ENT>
              <ENT>3.74</ENT>
              <ENT>0.38</ENT>
              <ENT>8.68</ENT>
              <ENT>6.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26607</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat metacarpal fracture</ENT>
              <ENT>5.36</ENT>
              <ENT>N/A</ENT>
              <ENT>6.65</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>12.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26608</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat metacarpal fracture</ENT>
              <ENT>5.36</ENT>
              <ENT>N/A</ENT>
              <ENT>6.56</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>12.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26615</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat metacarpal fracture</ENT>
              <ENT>5.33</ENT>
              <ENT>N/A</ENT>
              <ENT>5.83</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>11.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26641</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat thumb dislocation</ENT>
              <ENT>3.94</ENT>
              <ENT>5.59</ENT>
              <ENT>3.72</ENT>
              <ENT>0.42</ENT>
              <ENT>9.95</ENT>
              <ENT>8.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26645</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat thumb fracture</ENT>
              <ENT>4.41</ENT>
              <ENT>6.31</ENT>
              <ENT>4.34</ENT>
              <ENT>0.54</ENT>
              <ENT>11.26</ENT>
              <ENT>9.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26650</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat thumb fracture</ENT>
              <ENT>5.72</ENT>
              <ENT>N/A</ENT>
              <ENT>6.88</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>13.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26665</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat thumb fracture</ENT>
              <ENT>7.60</ENT>
              <ENT>N/A</ENT>
              <ENT>7.02</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>15.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26670</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat hand dislocation</ENT>
              <ENT>3.69</ENT>
              <ENT>5.17</ENT>
              <ENT>3.21</ENT>
              <ENT>0.36</ENT>
              <ENT>9.22</ENT>
              <ENT>7.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26675</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat hand dislocation</ENT>
              <ENT>4.64</ENT>
              <ENT>6.26</ENT>
              <ENT>4.41</ENT>
              <ENT>0.56</ENT>
              <ENT>11.46</ENT>
              <ENT>9.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26676</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pin hand dislocation</ENT>
              <ENT>5.52</ENT>
              <ENT>N/A</ENT>
              <ENT>6.92</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>13.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26685</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat hand dislocation</ENT>
              <ENT>6.98</ENT>
              <ENT>N/A</ENT>
              <ENT>6.57</ENT>
              <ENT>0.95</ENT>
              <ENT>N/A</ENT>
              <ENT>14.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26686</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat hand dislocation</ENT>
              <ENT>7.94</ENT>
              <ENT>N/A</ENT>
              <ENT>7.26</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>16.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat knuckle dislocation</ENT>
              <ENT>3.69</ENT>
              <ENT>4.74</ENT>
              <ENT>3.02</ENT>
              <ENT>0.35</ENT>
              <ENT>8.78</ENT>
              <ENT>7.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26705</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat knuckle dislocation</ENT>
              <ENT>4.19</ENT>
              <ENT>6.05</ENT>
              <ENT>4.24</ENT>
              <ENT>0.50</ENT>
              <ENT>10.74</ENT>
              <ENT>8.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26706</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pin knuckle dislocation</ENT>
              <ENT>5.12</ENT>
              <ENT>N/A</ENT>
              <ENT>5.19</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>10.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26715</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat knuckle dislocation</ENT>
              <ENT>5.74</ENT>
              <ENT>N/A</ENT>
              <ENT>6.02</ENT>
              <ENT>0.75</ENT>
              <ENT>N/A</ENT>
              <ENT>12.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26720</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat finger fracture, each</ENT>
              <ENT>1.66</ENT>
              <ENT>3.97</ENT>
              <ENT>2.65</ENT>
              <ENT>0.20</ENT>
              <ENT>5.83</ENT>
              <ENT>4.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26725</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat finger fracture, each</ENT>
              <ENT>3.33</ENT>
              <ENT>6.20</ENT>
              <ENT>4.11</ENT>
              <ENT>0.43</ENT>
              <ENT>9.96</ENT>
              <ENT>7.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26727</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat finger fracture, each</ENT>
              <ENT>5.23</ENT>
              <ENT>N/A</ENT>
              <ENT>6.62</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>12.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26735</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat finger fracture, each</ENT>
              <ENT>5.98</ENT>
              <ENT>N/A</ENT>
              <ENT>6.17</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>12.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26740</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat finger fracture, each</ENT>
              <ENT>1.94</ENT>
              <ENT>3.63</ENT>
              <ENT>2.74</ENT>
              <ENT>0.24</ENT>
              <ENT>5.81</ENT>
              <ENT>4.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26742</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat finger fracture, each</ENT>
              <ENT>3.85</ENT>
              <ENT>6.11</ENT>
              <ENT>4.11</ENT>
              <ENT>0.49</ENT>
              <ENT>10.45</ENT>
              <ENT>8.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26746</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat finger fracture, each</ENT>
              <ENT>5.81</ENT>
              <ENT>N/A</ENT>
              <ENT>6.22</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>12.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26750</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat finger fracture, each</ENT>
              <ENT>1.70</ENT>
              <ENT>3.29</ENT>
              <ENT>2.19</ENT>
              <ENT>0.19</ENT>
              <ENT>5.18</ENT>
              <ENT>4.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26755</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat finger fracture, each</ENT>
              <ENT>3.10</ENT>
              <ENT>4.89</ENT>
              <ENT>3.11</ENT>
              <ENT>0.37</ENT>
              <ENT>8.36</ENT>
              <ENT>6.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49097"/>
              <ENT I="01">26756</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pin finger fracture, each</ENT>
              <ENT>4.39</ENT>
              <ENT>N/A</ENT>
              <ENT>6.24</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>11.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26765</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat finger fracture, each</ENT>
              <ENT>4.17</ENT>
              <ENT>N/A</ENT>
              <ENT>5.05</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>9.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26770</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat finger dislocation</ENT>
              <ENT>3.02</ENT>
              <ENT>4.49</ENT>
              <ENT>2.60</ENT>
              <ENT>0.27</ENT>
              <ENT>7.78</ENT>
              <ENT>5.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26775</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat finger dislocation</ENT>
              <ENT>3.71</ENT>
              <ENT>5.87</ENT>
              <ENT>3.82</ENT>
              <ENT>0.43</ENT>
              <ENT>10.01</ENT>
              <ENT>7.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26776</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pin finger dislocation</ENT>
              <ENT>4.80</ENT>
              <ENT>N/A</ENT>
              <ENT>6.41</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>11.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26785</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat finger dislocation</ENT>
              <ENT>4.21</ENT>
              <ENT>N/A</ENT>
              <ENT>5.09</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>9.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thumb fusion with graft</ENT>
              <ENT>8.26</ENT>
              <ENT>N/A</ENT>
              <ENT>14.03</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>23.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26841</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of thumb</ENT>
              <ENT>7.13</ENT>
              <ENT>N/A</ENT>
              <ENT>13.84</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>21.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26842</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thumb fusion with graft</ENT>
              <ENT>8.24</ENT>
              <ENT>N/A</ENT>
              <ENT>14.11</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>23.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26843</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of hand joint</ENT>
              <ENT>7.61</ENT>
              <ENT>N/A</ENT>
              <ENT>13.01</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>21.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26844</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion/graft of hand joint</ENT>
              <ENT>8.73</ENT>
              <ENT>N/A</ENT>
              <ENT>14.07</ENT>
              <ENT>1.12</ENT>
              <ENT>N/A</ENT>
              <ENT>23.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26850</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of knuckle</ENT>
              <ENT>6.97</ENT>
              <ENT>N/A</ENT>
              <ENT>12.93</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>20.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26852</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of knuckle with graft</ENT>
              <ENT>8.46</ENT>
              <ENT>N/A</ENT>
              <ENT>13.62</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>23.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26860</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of finger joint</ENT>
              <ENT>4.69</ENT>
              <ENT>N/A</ENT>
              <ENT>11.90</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>17.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26861</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of finger jnt, add-on</ENT>
              <ENT>1.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.95</ENT>
              <ENT>0.22</ENT>
              <ENT>N/A</ENT>
              <ENT>2.91</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26862</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion/graft of finger joint</ENT>
              <ENT>7.37</ENT>
              <ENT>N/A</ENT>
              <ENT>13.10</ENT>
              <ENT>0.92</ENT>
              <ENT>N/A</ENT>
              <ENT>21.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26863</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fuse/graft added joint</ENT>
              <ENT>3.90</ENT>
              <ENT>N/A</ENT>
              <ENT>2.16</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>6.57</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26910</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputate metacarpal bone</ENT>
              <ENT>7.60</ENT>
              <ENT>N/A</ENT>
              <ENT>12.03</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>20.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26951</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation of finger/thumb</ENT>
              <ENT>4.59</ENT>
              <ENT>N/A</ENT>
              <ENT>10.94</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>16.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26952</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation of finger/thumb</ENT>
              <ENT>6.31</ENT>
              <ENT>N/A</ENT>
              <ENT>12.51</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>19.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26989</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Hand/finger surgery</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26990</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of pelvis lesion</ENT>
              <ENT>7.48</ENT>
              <ENT>N/A</ENT>
              <ENT>8.16</ENT>
              <ENT>0.92</ENT>
              <ENT>N/A</ENT>
              <ENT>16.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26991</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of pelvis bursa</ENT>
              <ENT>6.68</ENT>
              <ENT>7.77</ENT>
              <ENT>6.24</ENT>
              <ENT>0.85</ENT>
              <ENT>15.30</ENT>
              <ENT>13.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">26992</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of bone lesion</ENT>
              <ENT>13.02</ENT>
              <ENT>N/A</ENT>
              <ENT>11.57</ENT>
              <ENT>1.75</ENT>
              <ENT>N/A</ENT>
              <ENT>26.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of hip tendon</ENT>
              <ENT>5.62</ENT>
              <ENT>N/A</ENT>
              <ENT>5.49</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>11.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27001</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of hip tendon</ENT>
              <ENT>6.94</ENT>
              <ENT>N/A</ENT>
              <ENT>6.36</ENT>
              <ENT>0.95</ENT>
              <ENT>N/A</ENT>
              <ENT>14.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27003</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of hip tendon</ENT>
              <ENT>7.34</ENT>
              <ENT>N/A</ENT>
              <ENT>6.77</ENT>
              <ENT>0.93</ENT>
              <ENT>N/A</ENT>
              <ENT>15.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27005</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of hip tendon</ENT>
              <ENT>9.66</ENT>
              <ENT>N/A</ENT>
              <ENT>8.09</ENT>
              <ENT>1.36</ENT>
              <ENT>N/A</ENT>
              <ENT>19.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27006</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of hip tendons</ENT>
              <ENT>9.68</ENT>
              <ENT>N/A</ENT>
              <ENT>8.25</ENT>
              <ENT>1.33</ENT>
              <ENT>N/A</ENT>
              <ENT>19.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27025</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of hip/thigh fascia</ENT>
              <ENT>11.16</ENT>
              <ENT>N/A</ENT>
              <ENT>8.73</ENT>
              <ENT>1.38</ENT>
              <ENT>N/A</ENT>
              <ENT>21.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27030</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of hip joint</ENT>
              <ENT>13.01</ENT>
              <ENT>N/A</ENT>
              <ENT>9.94</ENT>
              <ENT>1.81</ENT>
              <ENT>N/A</ENT>
              <ENT>24.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27033</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of hip joint</ENT>
              <ENT>13.39</ENT>
              <ENT>N/A</ENT>
              <ENT>10.21</ENT>
              <ENT>1.87</ENT>
              <ENT>N/A</ENT>
              <ENT>25.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27035</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Denervation of hip joint</ENT>
              <ENT>16.69</ENT>
              <ENT>N/A</ENT>
              <ENT>12.66</ENT>
              <ENT>1.70</ENT>
              <ENT>N/A</ENT>
              <ENT>31.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27036</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of hip joint/muscle</ENT>
              <ENT>12.88</ENT>
              <ENT>N/A</ENT>
              <ENT>10.41</ENT>
              <ENT>1.80</ENT>
              <ENT>N/A</ENT>
              <ENT>25.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27040</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of soft tissues</ENT>
              <ENT>2.87</ENT>
              <ENT>2.92</ENT>
              <ENT>2.20</ENT>
              <ENT>0.21</ENT>
              <ENT>6.00</ENT>
              <ENT>5.28</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27041</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of soft tissues</ENT>
              <ENT>9.89</ENT>
              <ENT>N/A</ENT>
              <ENT>6.83</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>17.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27047</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove hip/pelvis lesion</ENT>
              <ENT>7.45</ENT>
              <ENT>6.66</ENT>
              <ENT>5.07</ENT>
              <ENT>0.79</ENT>
              <ENT>14.90</ENT>
              <ENT>13.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27048</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove hip/pelvis lesion</ENT>
              <ENT>6.25</ENT>
              <ENT>N/A</ENT>
              <ENT>5.19</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>12.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27049</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove tumor, hip/pelvis</ENT>
              <ENT>13.66</ENT>
              <ENT>N/A</ENT>
              <ENT>9.20</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>24.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27050</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of sacroiliac joint</ENT>
              <ENT>4.36</ENT>
              <ENT>N/A</ENT>
              <ENT>4.64</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>9.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27052</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of hip joint</ENT>
              <ENT>6.23</ENT>
              <ENT>N/A</ENT>
              <ENT>6.19</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>13.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27054</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of hip joint lining</ENT>
              <ENT>8.54</ENT>
              <ENT>N/A</ENT>
              <ENT>7.71</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>17.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27060</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of ischial bursa</ENT>
              <ENT>5.43</ENT>
              <ENT>N/A</ENT>
              <ENT>4.99</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>11.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27062</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove femur lesion/bursa</ENT>
              <ENT>5.37</ENT>
              <ENT>N/A</ENT>
              <ENT>5.42</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>11.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27065</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of hip bone lesion</ENT>
              <ENT>5.90</ENT>
              <ENT>N/A</ENT>
              <ENT>5.73</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>12.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27066</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of hip bone lesion</ENT>
              <ENT>10.33</ENT>
              <ENT>N/A</ENT>
              <ENT>8.76</ENT>
              <ENT>1.42</ENT>
              <ENT>N/A</ENT>
              <ENT>20.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27067</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove/graft hip bone lesion</ENT>
              <ENT>13.83</ENT>
              <ENT>N/A</ENT>
              <ENT>10.97</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>26.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27070</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of hip bone</ENT>
              <ENT>10.72</ENT>
              <ENT>N/A</ENT>
              <ENT>10.40</ENT>
              <ENT>1.36</ENT>
              <ENT>N/A</ENT>
              <ENT>22.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27071</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of hip bone</ENT>
              <ENT>11.46</ENT>
              <ENT>N/A</ENT>
              <ENT>11.32</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>24.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27075</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive hip surgery</ENT>
              <ENT>35.00</ENT>
              <ENT>N/A</ENT>
              <ENT>20.42</ENT>
              <ENT>2.22</ENT>
              <ENT>N/A</ENT>
              <ENT>57.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27076</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive hip surgery</ENT>
              <ENT>22.12</ENT>
              <ENT>N/A</ENT>
              <ENT>15.35</ENT>
              <ENT>2.86</ENT>
              <ENT>N/A</ENT>
              <ENT>40.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27077</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive hip surgery</ENT>
              <ENT>40.00</ENT>
              <ENT>N/A</ENT>
              <ENT>23.94</ENT>
              <ENT>3.18</ENT>
              <ENT>N/A</ENT>
              <ENT>67.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27078</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive hip surgery</ENT>
              <ENT>13.44</ENT>
              <ENT>N/A</ENT>
              <ENT>10.81</ENT>
              <ENT>1.67</ENT>
              <ENT>N/A</ENT>
              <ENT>25.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27079</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive hip surgery</ENT>
              <ENT>13.75</ENT>
              <ENT>N/A</ENT>
              <ENT>10.45</ENT>
              <ENT>1.86</ENT>
              <ENT>N/A</ENT>
              <ENT>26.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49098"/>
              <ENT I="01">27080</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of tail bone</ENT>
              <ENT>6.39</ENT>
              <ENT>N/A</ENT>
              <ENT>5.24</ENT>
              <ENT>0.80</ENT>
              <ENT>N/A</ENT>
              <ENT>12.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27086</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove hip foreign body</ENT>
              <ENT>1.87</ENT>
              <ENT>2.33</ENT>
              <ENT>2.03</ENT>
              <ENT>0.17</ENT>
              <ENT>4.37</ENT>
              <ENT>4.07</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27087</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove hip foreign body</ENT>
              <ENT>8.54</ENT>
              <ENT>N/A</ENT>
              <ENT>6.84</ENT>
              <ENT>1.09</ENT>
              <ENT>N/A</ENT>
              <ENT>16.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27090</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of hip prosthesis</ENT>
              <ENT>11.15</ENT>
              <ENT>N/A</ENT>
              <ENT>8.81</ENT>
              <ENT>1.55</ENT>
              <ENT>N/A</ENT>
              <ENT>21.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27091</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of hip prosthesis</ENT>
              <ENT>22.14</ENT>
              <ENT>N/A</ENT>
              <ENT>14.12</ENT>
              <ENT>3.11</ENT>
              <ENT>N/A</ENT>
              <ENT>39.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27093</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection for hip x-ray</ENT>
              <ENT>1.30</ENT>
              <ENT>8.65</ENT>
              <ENT>0.49</ENT>
              <ENT>0.09</ENT>
              <ENT>10.04</ENT>
              <ENT>1.88</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27095</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection for hip x-ray</ENT>
              <ENT>1.50</ENT>
              <ENT>7.80</ENT>
              <ENT>0.53</ENT>
              <ENT>0.10</ENT>
              <ENT>9.40</ENT>
              <ENT>2.13</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27096</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inject sacroiliac joint</ENT>
              <ENT>1.40</ENT>
              <ENT>6.89</ENT>
              <ENT>0.33</ENT>
              <ENT>0.08</ENT>
              <ENT>8.37</ENT>
              <ENT>1.81</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27097</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of hip tendon</ENT>
              <ENT>8.80</ENT>
              <ENT>N/A</ENT>
              <ENT>6.65</ENT>
              <ENT>1.22</ENT>
              <ENT>N/A</ENT>
              <ENT>16.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27098</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transfer tendon to pelvis</ENT>
              <ENT>8.83</ENT>
              <ENT>N/A</ENT>
              <ENT>7.28</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>17.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transfer of abdominal muscle</ENT>
              <ENT>11.08</ENT>
              <ENT>N/A</ENT>
              <ENT>8.97</ENT>
              <ENT>1.57</ENT>
              <ENT>N/A</ENT>
              <ENT>21.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27105</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transfer of spinal muscle</ENT>
              <ENT>11.77</ENT>
              <ENT>N/A</ENT>
              <ENT>9.45</ENT>
              <ENT>1.66</ENT>
              <ENT>N/A</ENT>
              <ENT>22.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transfer of iliopsoas muscle</ENT>
              <ENT>13.26</ENT>
              <ENT>N/A</ENT>
              <ENT>9.66</ENT>
              <ENT>1.38</ENT>
              <ENT>N/A</ENT>
              <ENT>24.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27111</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transfer of iliopsoas muscle</ENT>
              <ENT>12.15</ENT>
              <ENT>N/A</ENT>
              <ENT>9.31</ENT>
              <ENT>1.48</ENT>
              <ENT>N/A</ENT>
              <ENT>22.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of hip socket</ENT>
              <ENT>18.01</ENT>
              <ENT>N/A</ENT>
              <ENT>11.96</ENT>
              <ENT>2.45</ENT>
              <ENT>N/A</ENT>
              <ENT>32.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27122</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of hip socket</ENT>
              <ENT>14.98</ENT>
              <ENT>N/A</ENT>
              <ENT>11.06</ENT>
              <ENT>2.08</ENT>
              <ENT>N/A</ENT>
              <ENT>28.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27125</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial hip replacement</ENT>
              <ENT>14.69</ENT>
              <ENT>N/A</ENT>
              <ENT>10.63</ENT>
              <ENT>2.05</ENT>
              <ENT>N/A</ENT>
              <ENT>27.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Total hip arthroplasty</ENT>
              <ENT>20.12</ENT>
              <ENT>N/A</ENT>
              <ENT>13.41</ENT>
              <ENT>2.82</ENT>
              <ENT>N/A</ENT>
              <ENT>36.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27132</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Total hip arthroplasty</ENT>
              <ENT>23.30</ENT>
              <ENT>N/A</ENT>
              <ENT>15.78</ENT>
              <ENT>3.26</ENT>
              <ENT>N/A</ENT>
              <ENT>42.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27134</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise hip joint replacement</ENT>
              <ENT>28.52</ENT>
              <ENT>N/A</ENT>
              <ENT>18.03</ENT>
              <ENT>3.97</ENT>
              <ENT>N/A</ENT>
              <ENT>50.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27137</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise hip joint replacement</ENT>
              <ENT>21.17</ENT>
              <ENT>N/A</ENT>
              <ENT>14.08</ENT>
              <ENT>2.97</ENT>
              <ENT>N/A</ENT>
              <ENT>38.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27138</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise hip joint replacement</ENT>
              <ENT>22.17</ENT>
              <ENT>N/A</ENT>
              <ENT>14.55</ENT>
              <ENT>3.11</ENT>
              <ENT>N/A</ENT>
              <ENT>39.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transplant femur ridge</ENT>
              <ENT>12.24</ENT>
              <ENT>N/A</ENT>
              <ENT>9.66</ENT>
              <ENT>1.67</ENT>
              <ENT>N/A</ENT>
              <ENT>23.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27146</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of hip bone</ENT>
              <ENT>17.43</ENT>
              <ENT>N/A</ENT>
              <ENT>12.65</ENT>
              <ENT>2.27</ENT>
              <ENT>N/A</ENT>
              <ENT>32.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27147</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of hip bone</ENT>
              <ENT>20.58</ENT>
              <ENT>N/A</ENT>
              <ENT>13.76</ENT>
              <ENT>2.61</ENT>
              <ENT>N/A</ENT>
              <ENT>36.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27151</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of hip bones</ENT>
              <ENT>22.51</ENT>
              <ENT>N/A</ENT>
              <ENT>8.40</ENT>
              <ENT>3.12</ENT>
              <ENT>N/A</ENT>
              <ENT>34.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27156</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of hip bones</ENT>
              <ENT>24.63</ENT>
              <ENT>N/A</ENT>
              <ENT>16.52</ENT>
              <ENT>3.48</ENT>
              <ENT>N/A</ENT>
              <ENT>44.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27158</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of pelvis</ENT>
              <ENT>19.74</ENT>
              <ENT>N/A</ENT>
              <ENT>11.58</ENT>
              <ENT>2.60</ENT>
              <ENT>N/A</ENT>
              <ENT>33.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27161</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of neck of femur</ENT>
              <ENT>16.71</ENT>
              <ENT>N/A</ENT>
              <ENT>12.28</ENT>
              <ENT>2.32</ENT>
              <ENT>N/A</ENT>
              <ENT>31.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27165</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision/fixation of femur</ENT>
              <ENT>17.91</ENT>
              <ENT>N/A</ENT>
              <ENT>13.07</ENT>
              <ENT>2.51</ENT>
              <ENT>N/A</ENT>
              <ENT>33.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27170</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/graft femur head/neck</ENT>
              <ENT>16.07</ENT>
              <ENT>N/A</ENT>
              <ENT>11.68</ENT>
              <ENT>2.20</ENT>
              <ENT>N/A</ENT>
              <ENT>29.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27175</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat slipped epiphysis</ENT>
              <ENT>8.46</ENT>
              <ENT>N/A</ENT>
              <ENT>6.70</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>16.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27176</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat slipped epiphysis</ENT>
              <ENT>12.05</ENT>
              <ENT>N/A</ENT>
              <ENT>9.03</ENT>
              <ENT>1.68</ENT>
              <ENT>N/A</ENT>
              <ENT>22.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27177</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat slipped epiphysis</ENT>
              <ENT>15.08</ENT>
              <ENT>N/A</ENT>
              <ENT>10.90</ENT>
              <ENT>2.11</ENT>
              <ENT>N/A</ENT>
              <ENT>28.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27178</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat slipped epiphysis</ENT>
              <ENT>11.99</ENT>
              <ENT>N/A</ENT>
              <ENT>8.45</ENT>
              <ENT>1.68</ENT>
              <ENT>N/A</ENT>
              <ENT>22.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27179</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise head/neck of femur</ENT>
              <ENT>12.98</ENT>
              <ENT>N/A</ENT>
              <ENT>9.84</ENT>
              <ENT>1.84</ENT>
              <ENT>N/A</ENT>
              <ENT>24.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27181</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat slipped epiphysis</ENT>
              <ENT>14.68</ENT>
              <ENT>N/A</ENT>
              <ENT>10.31</ENT>
              <ENT>1.74</ENT>
              <ENT>N/A</ENT>
              <ENT>26.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27185</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of femur epiphysis</ENT>
              <ENT>9.18</ENT>
              <ENT>N/A</ENT>
              <ENT>7.81</ENT>
              <ENT>1.29</ENT>
              <ENT>N/A</ENT>
              <ENT>18.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27187</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reinforce hip bones</ENT>
              <ENT>13.54</ENT>
              <ENT>N/A</ENT>
              <ENT>10.60</ENT>
              <ENT>1.89</ENT>
              <ENT>N/A</ENT>
              <ENT>26.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27193</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat pelvic ring fracture</ENT>
              <ENT>5.56</ENT>
              <ENT>6.99</ENT>
              <ENT>5.41</ENT>
              <ENT>0.77</ENT>
              <ENT>13.32</ENT>
              <ENT>11.74</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27194</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat pelvic ring fracture</ENT>
              <ENT>9.65</ENT>
              <ENT>8.92</ENT>
              <ENT>7.65</ENT>
              <ENT>1.32</ENT>
              <ENT>19.89</ENT>
              <ENT>18.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat tail bone fracture</ENT>
              <ENT>1.84</ENT>
              <ENT>3.09</ENT>
              <ENT>2.22</ENT>
              <ENT>0.22</ENT>
              <ENT>5.15</ENT>
              <ENT>4.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27202</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat tail bone fracture</ENT>
              <ENT>7.04</ENT>
              <ENT>N/A</ENT>
              <ENT>18.09</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>25.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27215</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat pelvic fracture(s)</ENT>
              <ENT>10.05</ENT>
              <ENT>N/A</ENT>
              <ENT>7.46</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>18.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27216</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat pelvic ring fracture</ENT>
              <ENT>15.19</ENT>
              <ENT>N/A</ENT>
              <ENT>10.14</ENT>
              <ENT>2.15</ENT>
              <ENT>N/A</ENT>
              <ENT>27.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27217</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat pelvic ring fracture</ENT>
              <ENT>14.11</ENT>
              <ENT>N/A</ENT>
              <ENT>10.42</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>26.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27218</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat pelvic ring fracture</ENT>
              <ENT>20.15</ENT>
              <ENT>N/A</ENT>
              <ENT>11.78</ENT>
              <ENT>2.85</ENT>
              <ENT>N/A</ENT>
              <ENT>34.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat hip socket fracture</ENT>
              <ENT>6.18</ENT>
              <ENT>7.18</ENT>
              <ENT>5.62</ENT>
              <ENT>0.85</ENT>
              <ENT>14.21</ENT>
              <ENT>12.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27222</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat hip socket fracture</ENT>
              <ENT>12.70</ENT>
              <ENT>N/A</ENT>
              <ENT>9.82</ENT>
              <ENT>1.77</ENT>
              <ENT>N/A</ENT>
              <ENT>24.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27226</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat hip wall fracture</ENT>
              <ENT>14.91</ENT>
              <ENT>N/A</ENT>
              <ENT>8.11</ENT>
              <ENT>2.07</ENT>
              <ENT>N/A</ENT>
              <ENT>25.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27227</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat hip fracture(s)</ENT>
              <ENT>23.45</ENT>
              <ENT>N/A</ENT>
              <ENT>15.72</ENT>
              <ENT>3.24</ENT>
              <ENT>N/A</ENT>
              <ENT>42.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27228</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat hip fracture(s)</ENT>
              <ENT>27.16</ENT>
              <ENT>N/A</ENT>
              <ENT>17.99</ENT>
              <ENT>3.77</ENT>
              <ENT>N/A</ENT>
              <ENT>48.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27230</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat thigh fracture</ENT>
              <ENT>5.50</ENT>
              <ENT>6.64</ENT>
              <ENT>5.14</ENT>
              <ENT>0.73</ENT>
              <ENT>12.87</ENT>
              <ENT>11.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27232</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat thigh fracture</ENT>
              <ENT>10.68</ENT>
              <ENT>N/A</ENT>
              <ENT>7.53</ENT>
              <ENT>1.45</ENT>
              <ENT>N/A</ENT>
              <ENT>19.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27235</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat thigh fracture</ENT>
              <ENT>12.16</ENT>
              <ENT>N/A</ENT>
              <ENT>9.54</ENT>
              <ENT>1.71</ENT>
              <ENT>N/A</ENT>
              <ENT>23.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27236</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat thigh fracture</ENT>
              <ENT>15.60</ENT>
              <ENT>N/A</ENT>
              <ENT>11.14</ENT>
              <ENT>2.18</ENT>
              <ENT>N/A</ENT>
              <ENT>28.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49099"/>
              <ENT I="01">27238</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat thigh fracture</ENT>
              <ENT>5.52</ENT>
              <ENT>N/A</ENT>
              <ENT>5.19</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>11.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27240</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat thigh fracture</ENT>
              <ENT>12.50</ENT>
              <ENT>N/A</ENT>
              <ENT>9.45</ENT>
              <ENT>1.69</ENT>
              <ENT>N/A</ENT>
              <ENT>23.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27244</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat thigh fracture</ENT>
              <ENT>15.94</ENT>
              <ENT>N/A</ENT>
              <ENT>11.44</ENT>
              <ENT>2.23</ENT>
              <ENT>N/A</ENT>
              <ENT>29.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27245</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat thigh fracture</ENT>
              <ENT>20.31</ENT>
              <ENT>N/A</ENT>
              <ENT>13.92</ENT>
              <ENT>2.85</ENT>
              <ENT>N/A</ENT>
              <ENT>37.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27246</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat thigh fracture</ENT>
              <ENT>4.71</ENT>
              <ENT>5.87</ENT>
              <ENT>4.60</ENT>
              <ENT>0.66</ENT>
              <ENT>11.24</ENT>
              <ENT>9.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27248</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat thigh fracture</ENT>
              <ENT>10.45</ENT>
              <ENT>N/A</ENT>
              <ENT>8.31</ENT>
              <ENT>1.45</ENT>
              <ENT>N/A</ENT>
              <ENT>20.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat hip dislocation</ENT>
              <ENT>6.95</ENT>
              <ENT>N/A</ENT>
              <ENT>4.79</ENT>
              <ENT>0.68</ENT>
              <ENT>N/A</ENT>
              <ENT>12.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27252</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat hip dislocation</ENT>
              <ENT>10.39</ENT>
              <ENT>N/A</ENT>
              <ENT>7.53</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>19.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27253</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat hip dislocation</ENT>
              <ENT>12.92</ENT>
              <ENT>N/A</ENT>
              <ENT>9.87</ENT>
              <ENT>1.81</ENT>
              <ENT>N/A</ENT>
              <ENT>24.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27254</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat hip dislocation</ENT>
              <ENT>18.26</ENT>
              <ENT>N/A</ENT>
              <ENT>12.23</ENT>
              <ENT>2.52</ENT>
              <ENT>N/A</ENT>
              <ENT>33.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27256</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat hip dislocation</ENT>
              <ENT>4.12</ENT>
              <ENT>3.50</ENT>
              <ENT>2.13</ENT>
              <ENT>0.49</ENT>
              <ENT>8.11</ENT>
              <ENT>6.74</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27257</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat hip dislocation</ENT>
              <ENT>5.22</ENT>
              <ENT>N/A</ENT>
              <ENT>3.02</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>8.80</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27258</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat hip dislocation</ENT>
              <ENT>15.43</ENT>
              <ENT>N/A</ENT>
              <ENT>11.19</ENT>
              <ENT>2.06</ENT>
              <ENT>N/A</ENT>
              <ENT>28.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27259</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat hip dislocation</ENT>
              <ENT>21.55</ENT>
              <ENT>N/A</ENT>
              <ENT>14.53</ENT>
              <ENT>2.99</ENT>
              <ENT>N/A</ENT>
              <ENT>39.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27265</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat hip dislocation</ENT>
              <ENT>5.05</ENT>
              <ENT>N/A</ENT>
              <ENT>4.85</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>10.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27266</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat hip dislocation</ENT>
              <ENT>7.49</ENT>
              <ENT>N/A</ENT>
              <ENT>6.39</ENT>
              <ENT>1.04</ENT>
              <ENT>N/A</ENT>
              <ENT>14.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27275</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Manipulation of hip joint</ENT>
              <ENT>2.27</ENT>
              <ENT>N/A</ENT>
              <ENT>2.25</ENT>
              <ENT>0.31</ENT>
              <ENT>N/A</ENT>
              <ENT>4.83</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27280</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of sacroiliac joint</ENT>
              <ENT>13.39</ENT>
              <ENT>N/A</ENT>
              <ENT>10.56</ENT>
              <ENT>1.98</ENT>
              <ENT>N/A</ENT>
              <ENT>25.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27282</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of pubic bones</ENT>
              <ENT>11.34</ENT>
              <ENT>N/A</ENT>
              <ENT>8.44</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>20.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27284</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of hip joint</ENT>
              <ENT>23.45</ENT>
              <ENT>N/A</ENT>
              <ENT>15.39</ENT>
              <ENT>2.36</ENT>
              <ENT>N/A</ENT>
              <ENT>41.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27286</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of hip joint</ENT>
              <ENT>23.45</ENT>
              <ENT>N/A</ENT>
              <ENT>16.28</ENT>
              <ENT>2.37</ENT>
              <ENT>N/A</ENT>
              <ENT>42.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27290</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation of leg at hip</ENT>
              <ENT>23.28</ENT>
              <ENT>N/A</ENT>
              <ENT>14.30</ENT>
              <ENT>2.94</ENT>
              <ENT>N/A</ENT>
              <ENT>40.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27295</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation of leg at hip</ENT>
              <ENT>18.65</ENT>
              <ENT>N/A</ENT>
              <ENT>11.79</ENT>
              <ENT>2.35</ENT>
              <ENT>N/A</ENT>
              <ENT>32.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27299</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Pelvis/hip joint surgery</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27301</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain thigh/knee lesion</ENT>
              <ENT>6.49</ENT>
              <ENT>7.81</ENT>
              <ENT>6.33</ENT>
              <ENT>0.80</ENT>
              <ENT>15.10</ENT>
              <ENT>13.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27303</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of bone lesion</ENT>
              <ENT>8.28</ENT>
              <ENT>N/A</ENT>
              <ENT>7.85</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>17.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27305</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise thigh tendon &amp; fascia</ENT>
              <ENT>5.92</ENT>
              <ENT>N/A</ENT>
              <ENT>5.58</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>12.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27306</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of thigh tendon</ENT>
              <ENT>4.62</ENT>
              <ENT>N/A</ENT>
              <ENT>4.96</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>10.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27307</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of thigh tendons</ENT>
              <ENT>5.80</ENT>
              <ENT>N/A</ENT>
              <ENT>5.69</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>12.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27310</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of knee joint</ENT>
              <ENT>9.27</ENT>
              <ENT>N/A</ENT>
              <ENT>8.10</ENT>
              <ENT>1.29</ENT>
              <ENT>N/A</ENT>
              <ENT>18.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27315</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal, thigh nerve</ENT>
              <ENT>6.97</ENT>
              <ENT>N/A</ENT>
              <ENT>4.81</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>12.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal, thigh nerve</ENT>
              <ENT>6.30</ENT>
              <ENT>N/A</ENT>
              <ENT>5.12</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>12.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27323</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy, thigh soft tissues</ENT>
              <ENT>2.28</ENT>
              <ENT>2.54</ENT>
              <ENT>2.07</ENT>
              <ENT>0.17</ENT>
              <ENT>4.99</ENT>
              <ENT>4.52</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27324</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy, thigh soft tissues</ENT>
              <ENT>4.90</ENT>
              <ENT>N/A</ENT>
              <ENT>4.50</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>9.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27327</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of thigh lesion</ENT>
              <ENT>4.47</ENT>
              <ENT>5.47</ENT>
              <ENT>4.03</ENT>
              <ENT>0.50</ENT>
              <ENT>10.44</ENT>
              <ENT>9.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27328</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of thigh lesion</ENT>
              <ENT>5.57</ENT>
              <ENT>N/A</ENT>
              <ENT>4.71</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>10.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27329</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove tumor, thigh/knee</ENT>
              <ENT>14.14</ENT>
              <ENT>N/A</ENT>
              <ENT>9.91</ENT>
              <ENT>1.68</ENT>
              <ENT>N/A</ENT>
              <ENT>25.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27330</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy, knee joint lining</ENT>
              <ENT>4.97</ENT>
              <ENT>N/A</ENT>
              <ENT>4.82</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>10.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27331</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore/treat knee joint</ENT>
              <ENT>5.88</ENT>
              <ENT>N/A</ENT>
              <ENT>5.81</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>12.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27332</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of knee cartilage</ENT>
              <ENT>8.27</ENT>
              <ENT>N/A</ENT>
              <ENT>7.30</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>16.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27333</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of knee cartilage</ENT>
              <ENT>7.30</ENT>
              <ENT>N/A</ENT>
              <ENT>6.83</ENT>
              <ENT>1.03</ENT>
              <ENT>N/A</ENT>
              <ENT>15.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27334</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove knee joint lining</ENT>
              <ENT>8.70</ENT>
              <ENT>N/A</ENT>
              <ENT>7.72</ENT>
              <ENT>1.21</ENT>
              <ENT>N/A</ENT>
              <ENT>17.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27335</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove knee joint lining</ENT>
              <ENT>10.00</ENT>
              <ENT>N/A</ENT>
              <ENT>8.54</ENT>
              <ENT>1.41</ENT>
              <ENT>N/A</ENT>
              <ENT>19.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27340</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of kneecap bursa</ENT>
              <ENT>4.18</ENT>
              <ENT>N/A</ENT>
              <ENT>4.71</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>9.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27345</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of knee cyst</ENT>
              <ENT>5.92</ENT>
              <ENT>N/A</ENT>
              <ENT>5.80</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>12.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27347</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove knee cyst</ENT>
              <ENT>5.78</ENT>
              <ENT>N/A</ENT>
              <ENT>5.70</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>12.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27350</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of kneecap</ENT>
              <ENT>8.17</ENT>
              <ENT>N/A</ENT>
              <ENT>7.43</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>16.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27355</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove femur lesion</ENT>
              <ENT>7.65</ENT>
              <ENT>N/A</ENT>
              <ENT>7.03</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>15.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27356</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove femur lesion/graft</ENT>
              <ENT>9.48</ENT>
              <ENT>N/A</ENT>
              <ENT>8.13</ENT>
              <ENT>1.29</ENT>
              <ENT>N/A</ENT>
              <ENT>18.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27357</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove femur lesion/graft</ENT>
              <ENT>10.53</ENT>
              <ENT>N/A</ENT>
              <ENT>8.87</ENT>
              <ENT>1.48</ENT>
              <ENT>N/A</ENT>
              <ENT>20.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27358</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove femur lesion/fixation</ENT>
              <ENT>4.74</ENT>
              <ENT>N/A</ENT>
              <ENT>2.58</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>7.99</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27360</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal, leg bone(s)</ENT>
              <ENT>10.50</ENT>
              <ENT>N/A</ENT>
              <ENT>10.59</ENT>
              <ENT>1.42</ENT>
              <ENT>N/A</ENT>
              <ENT>22.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27365</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive leg surgery</ENT>
              <ENT>16.27</ENT>
              <ENT>N/A</ENT>
              <ENT>12.20</ENT>
              <ENT>2.26</ENT>
              <ENT>N/A</ENT>
              <ENT>30.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27370</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection for knee x-ray</ENT>
              <ENT>0.96</ENT>
              <ENT>8.43</ENT>
              <ENT>0.33</ENT>
              <ENT>0.06</ENT>
              <ENT>9.45</ENT>
              <ENT>1.35</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27372</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of foreign body</ENT>
              <ENT>5.07</ENT>
              <ENT>6.19</ENT>
              <ENT>4.84</ENT>
              <ENT>0.62</ENT>
              <ENT>11.88</ENT>
              <ENT>10.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27380</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of kneecap tendon</ENT>
              <ENT>7.16</ENT>
              <ENT>N/A</ENT>
              <ENT>7.38</ENT>
              <ENT>1.00</ENT>
              <ENT>N/A</ENT>
              <ENT>15.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27381</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/graft kneecap tendon</ENT>
              <ENT>10.34</ENT>
              <ENT>N/A</ENT>
              <ENT>9.21</ENT>
              <ENT>1.44</ENT>
              <ENT>N/A</ENT>
              <ENT>20.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27385</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of thigh muscle</ENT>
              <ENT>7.76</ENT>
              <ENT>N/A</ENT>
              <ENT>7.73</ENT>
              <ENT>1.09</ENT>
              <ENT>N/A</ENT>
              <ENT>16.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27386</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/graft of thigh muscle</ENT>
              <ENT>10.56</ENT>
              <ENT>N/A</ENT>
              <ENT>9.64</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>21.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49100"/>
              <ENT I="01">27390</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of thigh tendon</ENT>
              <ENT>5.33</ENT>
              <ENT>N/A</ENT>
              <ENT>5.32</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>11.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27391</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of thigh tendons</ENT>
              <ENT>7.20</ENT>
              <ENT>N/A</ENT>
              <ENT>6.62</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>14.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27392</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of thigh tendons</ENT>
              <ENT>9.20</ENT>
              <ENT>N/A</ENT>
              <ENT>7.83</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>18.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27393</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lengthening of thigh tendon</ENT>
              <ENT>6.39</ENT>
              <ENT>N/A</ENT>
              <ENT>5.93</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>13.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27394</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lengthening of thigh tendons</ENT>
              <ENT>8.50</ENT>
              <ENT>N/A</ENT>
              <ENT>7.38</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>17.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27395</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lengthening of thigh tendons</ENT>
              <ENT>11.73</ENT>
              <ENT>N/A</ENT>
              <ENT>9.53</ENT>
              <ENT>1.63</ENT>
              <ENT>N/A</ENT>
              <ENT>22.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27396</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transplant of thigh tendon</ENT>
              <ENT>7.86</ENT>
              <ENT>N/A</ENT>
              <ENT>7.26</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>16.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27397</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transplants of thigh tendons</ENT>
              <ENT>11.28</ENT>
              <ENT>N/A</ENT>
              <ENT>9.27</ENT>
              <ENT>1.58</ENT>
              <ENT>N/A</ENT>
              <ENT>22.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise thigh muscles/tendons</ENT>
              <ENT>9.02</ENT>
              <ENT>N/A</ENT>
              <ENT>7.54</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>17.74</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27403</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of knee cartilage</ENT>
              <ENT>8.33</ENT>
              <ENT>N/A</ENT>
              <ENT>7.32</ENT>
              <ENT>1.16</ENT>
              <ENT>N/A</ENT>
              <ENT>16.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27405</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of knee ligament</ENT>
              <ENT>8.65</ENT>
              <ENT>N/A</ENT>
              <ENT>7.77</ENT>
              <ENT>1.21</ENT>
              <ENT>N/A</ENT>
              <ENT>17.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27407</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of knee ligament</ENT>
              <ENT>10.28</ENT>
              <ENT>N/A</ENT>
              <ENT>8.53</ENT>
              <ENT>1.38</ENT>
              <ENT>N/A</ENT>
              <ENT>20.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27409</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of knee ligaments</ENT>
              <ENT>12.90</ENT>
              <ENT>N/A</ENT>
              <ENT>10.16</ENT>
              <ENT>1.75</ENT>
              <ENT>N/A</ENT>
              <ENT>24.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27418</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair degenerated kneecap</ENT>
              <ENT>10.85</ENT>
              <ENT>N/A</ENT>
              <ENT>9.09</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>21.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of unstable kneecap</ENT>
              <ENT>9.83</ENT>
              <ENT>N/A</ENT>
              <ENT>8.27</ENT>
              <ENT>1.38</ENT>
              <ENT>N/A</ENT>
              <ENT>19.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27422</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of unstable kneecap</ENT>
              <ENT>9.78</ENT>
              <ENT>N/A</ENT>
              <ENT>8.29</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>19.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27424</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision/removal of kneecap</ENT>
              <ENT>9.81</ENT>
              <ENT>N/A</ENT>
              <ENT>8.26</ENT>
              <ENT>1.38</ENT>
              <ENT>N/A</ENT>
              <ENT>19.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27425</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lat retinacular release open</ENT>
              <ENT>5.22</ENT>
              <ENT>N/A</ENT>
              <ENT>5.62</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>11.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27427</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction, knee</ENT>
              <ENT>9.36</ENT>
              <ENT>N/A</ENT>
              <ENT>7.94</ENT>
              <ENT>1.29</ENT>
              <ENT>N/A</ENT>
              <ENT>18.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27428</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction, knee</ENT>
              <ENT>14.00</ENT>
              <ENT>N/A</ENT>
              <ENT>11.36</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>27.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27429</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction, knee</ENT>
              <ENT>15.52</ENT>
              <ENT>N/A</ENT>
              <ENT>12.54</ENT>
              <ENT>2.18</ENT>
              <ENT>N/A</ENT>
              <ENT>30.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27430</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of thigh muscles</ENT>
              <ENT>9.67</ENT>
              <ENT>N/A</ENT>
              <ENT>8.18</ENT>
              <ENT>1.35</ENT>
              <ENT>N/A</ENT>
              <ENT>19.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27435</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of knee joint</ENT>
              <ENT>9.49</ENT>
              <ENT>N/A</ENT>
              <ENT>8.55</ENT>
              <ENT>1.33</ENT>
              <ENT>N/A</ENT>
              <ENT>19.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27437</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise kneecap</ENT>
              <ENT>8.46</ENT>
              <ENT>N/A</ENT>
              <ENT>7.20</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>16.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27438</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise kneecap with implant</ENT>
              <ENT>11.23</ENT>
              <ENT>N/A</ENT>
              <ENT>8.58</ENT>
              <ENT>1.56</ENT>
              <ENT>N/A</ENT>
              <ENT>21.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27440</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of knee joint</ENT>
              <ENT>10.43</ENT>
              <ENT>N/A</ENT>
              <ENT>6.08</ENT>
              <ENT>1.42</ENT>
              <ENT>N/A</ENT>
              <ENT>17.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27441</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of knee joint</ENT>
              <ENT>10.82</ENT>
              <ENT>N/A</ENT>
              <ENT>6.77</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>19.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27442</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of knee joint</ENT>
              <ENT>11.89</ENT>
              <ENT>N/A</ENT>
              <ENT>8.97</ENT>
              <ENT>1.68</ENT>
              <ENT>N/A</ENT>
              <ENT>22.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27443</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of knee joint</ENT>
              <ENT>10.93</ENT>
              <ENT>N/A</ENT>
              <ENT>8.75</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>21.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27445</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of knee joint</ENT>
              <ENT>17.68</ENT>
              <ENT>N/A</ENT>
              <ENT>12.41</ENT>
              <ENT>2.49</ENT>
              <ENT>N/A</ENT>
              <ENT>32.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27446</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of knee joint</ENT>
              <ENT>15.84</ENT>
              <ENT>N/A</ENT>
              <ENT>11.36</ENT>
              <ENT>2.22</ENT>
              <ENT>N/A</ENT>
              <ENT>29.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27447</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Total knee arthroplasty</ENT>
              <ENT>21.48</ENT>
              <ENT>N/A</ENT>
              <ENT>14.72</ENT>
              <ENT>3.00</ENT>
              <ENT>N/A</ENT>
              <ENT>39.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27448</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of thigh</ENT>
              <ENT>11.06</ENT>
              <ENT>N/A</ENT>
              <ENT>8.88</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>21.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of thigh</ENT>
              <ENT>13.98</ENT>
              <ENT>N/A</ENT>
              <ENT>10.76</ENT>
              <ENT>1.96</ENT>
              <ENT>N/A</ENT>
              <ENT>26.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27454</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Realignment of thigh bone</ENT>
              <ENT>17.56</ENT>
              <ENT>N/A</ENT>
              <ENT>12.80</ENT>
              <ENT>2.46</ENT>
              <ENT>N/A</ENT>
              <ENT>32.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27455</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Realignment of knee</ENT>
              <ENT>12.82</ENT>
              <ENT>N/A</ENT>
              <ENT>9.94</ENT>
              <ENT>1.78</ENT>
              <ENT>N/A</ENT>
              <ENT>24.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27457</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Realignment of knee</ENT>
              <ENT>13.45</ENT>
              <ENT>N/A</ENT>
              <ENT>9.91</ENT>
              <ENT>1.88</ENT>
              <ENT>N/A</ENT>
              <ENT>25.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27465</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shortening of thigh bone</ENT>
              <ENT>13.87</ENT>
              <ENT>N/A</ENT>
              <ENT>10.50</ENT>
              <ENT>1.86</ENT>
              <ENT>N/A</ENT>
              <ENT>26.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27466</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lengthening of thigh bone</ENT>
              <ENT>16.33</ENT>
              <ENT>N/A</ENT>
              <ENT>12.17</ENT>
              <ENT>1.92</ENT>
              <ENT>N/A</ENT>
              <ENT>30.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27468</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shorten/lengthen thighs</ENT>
              <ENT>18.97</ENT>
              <ENT>N/A</ENT>
              <ENT>12.59</ENT>
              <ENT>2.68</ENT>
              <ENT>N/A</ENT>
              <ENT>34.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27470</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of thigh</ENT>
              <ENT>16.07</ENT>
              <ENT>N/A</ENT>
              <ENT>12.13</ENT>
              <ENT>2.24</ENT>
              <ENT>N/A</ENT>
              <ENT>30.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27472</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/graft of thigh</ENT>
              <ENT>17.72</ENT>
              <ENT>N/A</ENT>
              <ENT>13.04</ENT>
              <ENT>2.49</ENT>
              <ENT>N/A</ENT>
              <ENT>33.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27475</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Surgery to stop leg growth</ENT>
              <ENT>8.64</ENT>
              <ENT>N/A</ENT>
              <ENT>7.43</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>17.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27477</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Surgery to stop leg growth</ENT>
              <ENT>9.85</ENT>
              <ENT>N/A</ENT>
              <ENT>7.95</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>19.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27479</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Surgery to stop leg growth</ENT>
              <ENT>12.80</ENT>
              <ENT>N/A</ENT>
              <ENT>10.12</ENT>
              <ENT>1.81</ENT>
              <ENT>N/A</ENT>
              <ENT>24.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27485</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Surgery to stop leg growth</ENT>
              <ENT>8.84</ENT>
              <ENT>N/A</ENT>
              <ENT>7.59</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>17.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27486</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise/replace knee joint</ENT>
              <ENT>19.27</ENT>
              <ENT>N/A</ENT>
              <ENT>13.59</ENT>
              <ENT>2.70</ENT>
              <ENT>N/A</ENT>
              <ENT>35.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27487</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise/replace knee joint</ENT>
              <ENT>25.27</ENT>
              <ENT>N/A</ENT>
              <ENT>16.72</ENT>
              <ENT>3.54</ENT>
              <ENT>N/A</ENT>
              <ENT>45.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27488</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of knee prosthesis</ENT>
              <ENT>15.74</ENT>
              <ENT>N/A</ENT>
              <ENT>11.76</ENT>
              <ENT>2.21</ENT>
              <ENT>N/A</ENT>
              <ENT>29.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27495</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reinforce thigh</ENT>
              <ENT>15.55</ENT>
              <ENT>N/A</ENT>
              <ENT>11.75</ENT>
              <ENT>2.18</ENT>
              <ENT>N/A</ENT>
              <ENT>29.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27496</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompression of thigh/knee</ENT>
              <ENT>6.11</ENT>
              <ENT>N/A</ENT>
              <ENT>5.77</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>12.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27497</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompression of thigh/knee</ENT>
              <ENT>7.17</ENT>
              <ENT>N/A</ENT>
              <ENT>5.80</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>13.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49101"/>
              <ENT I="01">27498</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompression of thigh/knee</ENT>
              <ENT>7.99</ENT>
              <ENT>N/A</ENT>
              <ENT>6.15</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>15.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27499</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompression of thigh/knee</ENT>
              <ENT>9.00</ENT>
              <ENT>N/A</ENT>
              <ENT>7.07</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>17.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of thigh fracture</ENT>
              <ENT>5.92</ENT>
              <ENT>7.24</ENT>
              <ENT>5.18</ENT>
              <ENT>0.80</ENT>
              <ENT>13.96</ENT>
              <ENT>11.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27501</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of thigh fracture</ENT>
              <ENT>5.92</ENT>
              <ENT>7.82</ENT>
              <ENT>5.87</ENT>
              <ENT>0.83</ENT>
              <ENT>14.57</ENT>
              <ENT>12.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27502</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of thigh fracture</ENT>
              <ENT>10.58</ENT>
              <ENT>N/A</ENT>
              <ENT>8.36</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>20.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27503</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of thigh fracture</ENT>
              <ENT>10.58</ENT>
              <ENT>N/A</ENT>
              <ENT>8.52</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>20.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27506</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of thigh fracture</ENT>
              <ENT>17.45</ENT>
              <ENT>N/A</ENT>
              <ENT>12.81</ENT>
              <ENT>2.33</ENT>
              <ENT>N/A</ENT>
              <ENT>32.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27507</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of thigh fracture</ENT>
              <ENT>13.99</ENT>
              <ENT>N/A</ENT>
              <ENT>10.13</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>26.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27508</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of thigh fracture</ENT>
              <ENT>5.83</ENT>
              <ENT>7.10</ENT>
              <ENT>5.42</ENT>
              <ENT>0.80</ENT>
              <ENT>13.73</ENT>
              <ENT>12.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27509</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of thigh fracture</ENT>
              <ENT>7.71</ENT>
              <ENT>N/A</ENT>
              <ENT>8.04</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>16.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of thigh fracture</ENT>
              <ENT>9.13</ENT>
              <ENT>N/A</ENT>
              <ENT>7.31</ENT>
              <ENT>1.26</ENT>
              <ENT>N/A</ENT>
              <ENT>17.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27511</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of thigh fracture</ENT>
              <ENT>13.64</ENT>
              <ENT>N/A</ENT>
              <ENT>11.39</ENT>
              <ENT>1.91</ENT>
              <ENT>N/A</ENT>
              <ENT>26.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27513</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of thigh fracture</ENT>
              <ENT>17.92</ENT>
              <ENT>N/A</ENT>
              <ENT>14.08</ENT>
              <ENT>2.51</ENT>
              <ENT>N/A</ENT>
              <ENT>34.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27514</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of thigh fracture</ENT>
              <ENT>17.30</ENT>
              <ENT>N/A</ENT>
              <ENT>13.44</ENT>
              <ENT>2.41</ENT>
              <ENT>N/A</ENT>
              <ENT>33.15</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27516</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat thigh fx growth plate</ENT>
              <ENT>5.37</ENT>
              <ENT>7.41</ENT>
              <ENT>5.48</ENT>
              <ENT>0.74</ENT>
              <ENT>13.52</ENT>
              <ENT>11.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27517</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat thigh fx growth plate</ENT>
              <ENT>8.78</ENT>
              <ENT>9.06</ENT>
              <ENT>7.49</ENT>
              <ENT>1.22</ENT>
              <ENT>19.06</ENT>
              <ENT>17.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27519</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat thigh fx growth plate</ENT>
              <ENT>15.02</ENT>
              <ENT>N/A</ENT>
              <ENT>11.83</ENT>
              <ENT>2.09</ENT>
              <ENT>N/A</ENT>
              <ENT>28.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat kneecap fracture</ENT>
              <ENT>2.86</ENT>
              <ENT>5.32</ENT>
              <ENT>3.48</ENT>
              <ENT>0.38</ENT>
              <ENT>8.56</ENT>
              <ENT>6.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27524</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat kneecap fracture</ENT>
              <ENT>10.00</ENT>
              <ENT>N/A</ENT>
              <ENT>8.29</ENT>
              <ENT>1.40</ENT>
              <ENT>N/A</ENT>
              <ENT>19.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat knee fracture</ENT>
              <ENT>3.78</ENT>
              <ENT>5.99</ENT>
              <ENT>4.35</ENT>
              <ENT>0.51</ENT>
              <ENT>10.28</ENT>
              <ENT>8.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27532</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat knee fracture</ENT>
              <ENT>7.30</ENT>
              <ENT>7.86</ENT>
              <ENT>6.27</ENT>
              <ENT>1.02</ENT>
              <ENT>16.18</ENT>
              <ENT>14.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27535</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat knee fracture</ENT>
              <ENT>11.50</ENT>
              <ENT>N/A</ENT>
              <ENT>10.27</ENT>
              <ENT>1.61</ENT>
              <ENT>N/A</ENT>
              <ENT>23.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27536</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat knee fracture</ENT>
              <ENT>15.65</ENT>
              <ENT>N/A</ENT>
              <ENT>11.70</ENT>
              <ENT>2.19</ENT>
              <ENT>N/A</ENT>
              <ENT>29.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27538</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat knee fracture(s)</ENT>
              <ENT>4.87</ENT>
              <ENT>7.20</ENT>
              <ENT>5.17</ENT>
              <ENT>0.67</ENT>
              <ENT>12.74</ENT>
              <ENT>10.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27540</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat knee fracture</ENT>
              <ENT>13.10</ENT>
              <ENT>N/A</ENT>
              <ENT>9.64</ENT>
              <ENT>1.80</ENT>
              <ENT>N/A</ENT>
              <ENT>24.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27550</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat knee dislocation</ENT>
              <ENT>5.76</ENT>
              <ENT>6.71</ENT>
              <ENT>5.02</ENT>
              <ENT>0.68</ENT>
              <ENT>13.15</ENT>
              <ENT>11.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27552</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat knee dislocation</ENT>
              <ENT>7.90</ENT>
              <ENT>N/A</ENT>
              <ENT>6.99</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>15.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27556</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat knee dislocation</ENT>
              <ENT>14.41</ENT>
              <ENT>N/A</ENT>
              <ENT>12.07</ENT>
              <ENT>2.01</ENT>
              <ENT>N/A</ENT>
              <ENT>28.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27557</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat knee dislocation</ENT>
              <ENT>16.77</ENT>
              <ENT>N/A</ENT>
              <ENT>13.47</ENT>
              <ENT>2.37</ENT>
              <ENT>N/A</ENT>
              <ENT>32.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27558</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat knee dislocation</ENT>
              <ENT>17.72</ENT>
              <ENT>N/A</ENT>
              <ENT>13.52</ENT>
              <ENT>2.51</ENT>
              <ENT>N/A</ENT>
              <ENT>33.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27560</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat kneecap dislocation</ENT>
              <ENT>3.82</ENT>
              <ENT>5.68</ENT>
              <ENT>3.35</ENT>
              <ENT>0.40</ENT>
              <ENT>9.90</ENT>
              <ENT>7.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27562</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat kneecap dislocation</ENT>
              <ENT>5.79</ENT>
              <ENT>N/A</ENT>
              <ENT>4.87</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>11.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27566</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat kneecap dislocation</ENT>
              <ENT>12.23</ENT>
              <ENT>N/A</ENT>
              <ENT>9.43</ENT>
              <ENT>1.73</ENT>
              <ENT>N/A</ENT>
              <ENT>23.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27570</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fixation of knee joint</ENT>
              <ENT>1.74</ENT>
              <ENT>N/A</ENT>
              <ENT>1.91</ENT>
              <ENT>0.24</ENT>
              <ENT>N/A</ENT>
              <ENT>3.89</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27580</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of knee</ENT>
              <ENT>19.37</ENT>
              <ENT>N/A</ENT>
              <ENT>15.13</ENT>
              <ENT>2.70</ENT>
              <ENT>N/A</ENT>
              <ENT>37.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27590</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputate leg at thigh</ENT>
              <ENT>12.03</ENT>
              <ENT>N/A</ENT>
              <ENT>7.33</ENT>
              <ENT>1.35</ENT>
              <ENT>N/A</ENT>
              <ENT>20.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27591</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputate leg at thigh</ENT>
              <ENT>12.68</ENT>
              <ENT>N/A</ENT>
              <ENT>9.27</ENT>
              <ENT>1.63</ENT>
              <ENT>N/A</ENT>
              <ENT>23.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27592</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputate leg at thigh</ENT>
              <ENT>10.02</ENT>
              <ENT>N/A</ENT>
              <ENT>6.84</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>18.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27594</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation follow-up surgery</ENT>
              <ENT>6.92</ENT>
              <ENT>N/A</ENT>
              <ENT>5.56</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>13.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27596</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation follow-up surgery</ENT>
              <ENT>10.60</ENT>
              <ENT>N/A</ENT>
              <ENT>7.44</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>19.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27598</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputate lower leg at knee</ENT>
              <ENT>10.53</ENT>
              <ENT>N/A</ENT>
              <ENT>7.49</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>19.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27599</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Leg surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompression of lower leg</ENT>
              <ENT>5.65</ENT>
              <ENT>N/A</ENT>
              <ENT>4.79</ENT>
              <ENT>0.68</ENT>
              <ENT>N/A</ENT>
              <ENT>11.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27601</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompression of lower leg</ENT>
              <ENT>5.64</ENT>
              <ENT>N/A</ENT>
              <ENT>5.07</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>11.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27602</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompression of lower leg</ENT>
              <ENT>7.35</ENT>
              <ENT>N/A</ENT>
              <ENT>5.36</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>13.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27603</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain lower leg lesion</ENT>
              <ENT>4.94</ENT>
              <ENT>11.05</ENT>
              <ENT>5.10</ENT>
              <ENT>0.56</ENT>
              <ENT>16.55</ENT>
              <ENT>10.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27604</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain lower leg bursa</ENT>
              <ENT>4.47</ENT>
              <ENT>8.90</ENT>
              <ENT>4.78</ENT>
              <ENT>0.54</ENT>
              <ENT>13.91</ENT>
              <ENT>9.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of achilles tendon</ENT>
              <ENT>2.87</ENT>
              <ENT>9.17</ENT>
              <ENT>2.51</ENT>
              <ENT>0.38</ENT>
              <ENT>12.42</ENT>
              <ENT>5.76</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27606</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of achilles tendon</ENT>
              <ENT>4.14</ENT>
              <ENT>10.43</ENT>
              <ENT>3.57</ENT>
              <ENT>0.57</ENT>
              <ENT>15.14</ENT>
              <ENT>8.28</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27607</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat lower leg bone lesion</ENT>
              <ENT>7.97</ENT>
              <ENT>N/A</ENT>
              <ENT>7.19</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>16.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27610</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore/treat ankle joint</ENT>
              <ENT>8.34</ENT>
              <ENT>N/A</ENT>
              <ENT>7.38</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>16.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27612</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of ankle joint</ENT>
              <ENT>7.33</ENT>
              <ENT>N/A</ENT>
              <ENT>6.24</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>14.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27613</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy lower leg soft tissue</ENT>
              <ENT>2.17</ENT>
              <ENT>4.03</ENT>
              <ENT>1.90</ENT>
              <ENT>0.16</ENT>
              <ENT>6.36</ENT>
              <ENT>4.23</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27614</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy lower leg soft tissue</ENT>
              <ENT>5.66</ENT>
              <ENT>8.99</ENT>
              <ENT>4.77</ENT>
              <ENT>0.62</ENT>
              <ENT>15.27</ENT>
              <ENT>11.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27615</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove tumor, lower leg</ENT>
              <ENT>12.56</ENT>
              <ENT>N/A</ENT>
              <ENT>10.91</ENT>
              <ENT>1.39</ENT>
              <ENT>N/A</ENT>
              <ENT>24.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49102"/>
              <ENT I="01">27618</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove lower leg lesion</ENT>
              <ENT>5.09</ENT>
              <ENT>9.29</ENT>
              <ENT>4.35</ENT>
              <ENT>0.54</ENT>
              <ENT>14.92</ENT>
              <ENT>9.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27619</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove lower leg lesion</ENT>
              <ENT>8.40</ENT>
              <ENT>10.82</ENT>
              <ENT>6.34</ENT>
              <ENT>1.01</ENT>
              <ENT>20.23</ENT>
              <ENT>15.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27620</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore/treat ankle joint</ENT>
              <ENT>5.98</ENT>
              <ENT>N/A</ENT>
              <ENT>5.69</ENT>
              <ENT>0.83</ENT>
              <ENT>N/A</ENT>
              <ENT>12.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27625</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove ankle joint lining</ENT>
              <ENT>8.30</ENT>
              <ENT>N/A</ENT>
              <ENT>6.83</ENT>
              <ENT>1.16</ENT>
              <ENT>N/A</ENT>
              <ENT>16.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27626</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove ankle joint lining</ENT>
              <ENT>8.91</ENT>
              <ENT>N/A</ENT>
              <ENT>7.31</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>17.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27630</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of tendon lesion</ENT>
              <ENT>4.80</ENT>
              <ENT>9.26</ENT>
              <ENT>4.62</ENT>
              <ENT>0.60</ENT>
              <ENT>14.66</ENT>
              <ENT>10.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27635</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove lower leg bone lesion</ENT>
              <ENT>7.78</ENT>
              <ENT>N/A</ENT>
              <ENT>7.16</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>16.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27637</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove/graft leg bone lesion</ENT>
              <ENT>9.85</ENT>
              <ENT>N/A</ENT>
              <ENT>8.60</ENT>
              <ENT>1.38</ENT>
              <ENT>N/A</ENT>
              <ENT>19.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27638</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove/graft leg bone lesion</ENT>
              <ENT>10.57</ENT>
              <ENT>N/A</ENT>
              <ENT>8.74</ENT>
              <ENT>1.47</ENT>
              <ENT>N/A</ENT>
              <ENT>20.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27640</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of tibia</ENT>
              <ENT>11.37</ENT>
              <ENT>N/A</ENT>
              <ENT>11.19</ENT>
              <ENT>1.54</ENT>
              <ENT>N/A</ENT>
              <ENT>24.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27641</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of fibula</ENT>
              <ENT>9.24</ENT>
              <ENT>N/A</ENT>
              <ENT>9.22</ENT>
              <ENT>1.22</ENT>
              <ENT>N/A</ENT>
              <ENT>19.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27645</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive lower leg surgery</ENT>
              <ENT>14.17</ENT>
              <ENT>N/A</ENT>
              <ENT>12.76</ENT>
              <ENT>1.98</ENT>
              <ENT>N/A</ENT>
              <ENT>28.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27646</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive lower leg surgery</ENT>
              <ENT>12.66</ENT>
              <ENT>N/A</ENT>
              <ENT>11.72</ENT>
              <ENT>1.55</ENT>
              <ENT>N/A</ENT>
              <ENT>25.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27647</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive ankle/heel surgery</ENT>
              <ENT>12.24</ENT>
              <ENT>N/A</ENT>
              <ENT>8.09</ENT>
              <ENT>1.64</ENT>
              <ENT>N/A</ENT>
              <ENT>21.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27648</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection for ankle x-ray</ENT>
              <ENT>0.96</ENT>
              <ENT>6.70</ENT>
              <ENT>0.34</ENT>
              <ENT>0.05</ENT>
              <ENT>7.71</ENT>
              <ENT>1.35</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27650</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair achilles tendon</ENT>
              <ENT>9.69</ENT>
              <ENT>N/A</ENT>
              <ENT>7.65</ENT>
              <ENT>1.35</ENT>
              <ENT>N/A</ENT>
              <ENT>18.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27652</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/graft achilles tendon</ENT>
              <ENT>10.33</ENT>
              <ENT>N/A</ENT>
              <ENT>8.08</ENT>
              <ENT>1.45</ENT>
              <ENT>N/A</ENT>
              <ENT>19.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27654</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of achilles tendon</ENT>
              <ENT>10.02</ENT>
              <ENT>N/A</ENT>
              <ENT>7.45</ENT>
              <ENT>1.41</ENT>
              <ENT>N/A</ENT>
              <ENT>18.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27656</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair leg fascia defect</ENT>
              <ENT>4.57</ENT>
              <ENT>10.22</ENT>
              <ENT>4.12</ENT>
              <ENT>0.48</ENT>
              <ENT>15.27</ENT>
              <ENT>9.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27658</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of leg tendon, each</ENT>
              <ENT>4.98</ENT>
              <ENT>9.50</ENT>
              <ENT>5.12</ENT>
              <ENT>0.68</ENT>
              <ENT>15.16</ENT>
              <ENT>10.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27659</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of leg tendon, each</ENT>
              <ENT>6.81</ENT>
              <ENT>11.61</ENT>
              <ENT>6.08</ENT>
              <ENT>0.96</ENT>
              <ENT>19.38</ENT>
              <ENT>13.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27664</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of leg tendon, each</ENT>
              <ENT>4.59</ENT>
              <ENT>11.66</ENT>
              <ENT>5.10</ENT>
              <ENT>0.63</ENT>
              <ENT>16.88</ENT>
              <ENT>10.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27665</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of leg tendon, each</ENT>
              <ENT>5.40</ENT>
              <ENT>11.37</ENT>
              <ENT>5.45</ENT>
              <ENT>0.75</ENT>
              <ENT>17.52</ENT>
              <ENT>11.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27675</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair lower leg tendons</ENT>
              <ENT>7.18</ENT>
              <ENT>N/A</ENT>
              <ENT>5.99</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>14.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27676</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair lower leg tendons</ENT>
              <ENT>8.42</ENT>
              <ENT>N/A</ENT>
              <ENT>7.00</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>16.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27680</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release of lower leg tendon</ENT>
              <ENT>5.74</ENT>
              <ENT>N/A</ENT>
              <ENT>5.47</ENT>
              <ENT>0.80</ENT>
              <ENT>N/A</ENT>
              <ENT>12.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27681</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release of lower leg tendons</ENT>
              <ENT>6.82</ENT>
              <ENT>N/A</ENT>
              <ENT>6.17</ENT>
              <ENT>0.92</ENT>
              <ENT>N/A</ENT>
              <ENT>13.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27685</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of lower leg tendon</ENT>
              <ENT>6.50</ENT>
              <ENT>8.31</ENT>
              <ENT>5.69</ENT>
              <ENT>0.91</ENT>
              <ENT>15.72</ENT>
              <ENT>13.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27686</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise lower leg tendons</ENT>
              <ENT>7.46</ENT>
              <ENT>12.79</ENT>
              <ENT>6.81</ENT>
              <ENT>1.05</ENT>
              <ENT>21.30</ENT>
              <ENT>15.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27687</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of calf tendon</ENT>
              <ENT>6.24</ENT>
              <ENT>N/A</ENT>
              <ENT>5.61</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>12.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27690</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise lower leg tendon</ENT>
              <ENT>8.71</ENT>
              <ENT>N/A</ENT>
              <ENT>6.73</ENT>
              <ENT>1.22</ENT>
              <ENT>N/A</ENT>
              <ENT>16.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27691</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise lower leg tendon</ENT>
              <ENT>9.96</ENT>
              <ENT>N/A</ENT>
              <ENT>8.05</ENT>
              <ENT>1.40</ENT>
              <ENT>N/A</ENT>
              <ENT>19.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27692</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise additional leg tendon</ENT>
              <ENT>1.87</ENT>
              <ENT>N/A</ENT>
              <ENT>0.95</ENT>
              <ENT>0.26</ENT>
              <ENT>N/A</ENT>
              <ENT>3.08</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27695</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of ankle ligament</ENT>
              <ENT>6.51</ENT>
              <ENT>N/A</ENT>
              <ENT>6.22</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>13.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27696</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of ankle ligaments</ENT>
              <ENT>8.27</ENT>
              <ENT>N/A</ENT>
              <ENT>6.79</ENT>
              <ENT>1.16</ENT>
              <ENT>N/A</ENT>
              <ENT>16.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27698</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of ankle ligament</ENT>
              <ENT>9.36</ENT>
              <ENT>N/A</ENT>
              <ENT>7.20</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>17.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of ankle joint</ENT>
              <ENT>9.29</ENT>
              <ENT>N/A</ENT>
              <ENT>5.75</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>16.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27702</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct ankle joint</ENT>
              <ENT>13.67</ENT>
              <ENT>N/A</ENT>
              <ENT>10.46</ENT>
              <ENT>1.92</ENT>
              <ENT>N/A</ENT>
              <ENT>26.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27703</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction, ankle joint</ENT>
              <ENT>15.87</ENT>
              <ENT>N/A</ENT>
              <ENT>11.30</ENT>
              <ENT>2.24</ENT>
              <ENT>N/A</ENT>
              <ENT>29.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27704</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of ankle implant</ENT>
              <ENT>7.62</ENT>
              <ENT>N/A</ENT>
              <ENT>5.62</ENT>
              <ENT>0.61</ENT>
              <ENT>N/A</ENT>
              <ENT>13.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27705</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of tibia</ENT>
              <ENT>10.38</ENT>
              <ENT>N/A</ENT>
              <ENT>8.49</ENT>
              <ENT>1.44</ENT>
              <ENT>N/A</ENT>
              <ENT>20.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27707</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of fibula</ENT>
              <ENT>4.37</ENT>
              <ENT>N/A</ENT>
              <ENT>5.21</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>10.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27709</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of tibia &amp; fibula</ENT>
              <ENT>9.95</ENT>
              <ENT>N/A</ENT>
              <ENT>8.41</ENT>
              <ENT>1.39</ENT>
              <ENT>N/A</ENT>
              <ENT>19.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27712</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Realignment of lower leg</ENT>
              <ENT>14.25</ENT>
              <ENT>N/A</ENT>
              <ENT>11.02</ENT>
              <ENT>2.00</ENT>
              <ENT>N/A</ENT>
              <ENT>27.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27715</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of lower leg</ENT>
              <ENT>14.39</ENT>
              <ENT>N/A</ENT>
              <ENT>11.15</ENT>
              <ENT>2.00</ENT>
              <ENT>N/A</ENT>
              <ENT>27.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27720</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of tibia</ENT>
              <ENT>11.79</ENT>
              <ENT>N/A</ENT>
              <ENT>9.73</ENT>
              <ENT>1.66</ENT>
              <ENT>N/A</ENT>
              <ENT>23.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27722</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/graft of tibia</ENT>
              <ENT>11.82</ENT>
              <ENT>N/A</ENT>
              <ENT>9.49</ENT>
              <ENT>1.65</ENT>
              <ENT>N/A</ENT>
              <ENT>22.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27724</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/graft of tibia</ENT>
              <ENT>18.20</ENT>
              <ENT>N/A</ENT>
              <ENT>13.00</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>33.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27725</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of lower leg</ENT>
              <ENT>15.59</ENT>
              <ENT>N/A</ENT>
              <ENT>12.31</ENT>
              <ENT>2.20</ENT>
              <ENT>N/A</ENT>
              <ENT>30.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27727</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of lower leg</ENT>
              <ENT>14.01</ENT>
              <ENT>N/A</ENT>
              <ENT>10.70</ENT>
              <ENT>1.84</ENT>
              <ENT>N/A</ENT>
              <ENT>26.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27730</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of tibia epiphysis</ENT>
              <ENT>7.41</ENT>
              <ENT>18.67</ENT>
              <ENT>6.64</ENT>
              <ENT>0.75</ENT>
              <ENT>26.83</ENT>
              <ENT>14.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27732</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of fibula epiphysis</ENT>
              <ENT>5.32</ENT>
              <ENT>11.91</ENT>
              <ENT>5.28</ENT>
              <ENT>0.63</ENT>
              <ENT>17.86</ENT>
              <ENT>11.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27734</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair lower leg epiphyses</ENT>
              <ENT>8.48</ENT>
              <ENT>N/A</ENT>
              <ENT>6.62</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>15.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27740</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of leg epiphyses</ENT>
              <ENT>9.30</ENT>
              <ENT>21.05</ENT>
              <ENT>8.18</ENT>
              <ENT>1.31</ENT>
              <ENT>31.66</ENT>
              <ENT>18.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49103"/>
              <ENT I="01">27742</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of leg epiphyses</ENT>
              <ENT>10.30</ENT>
              <ENT>12.74</ENT>
              <ENT>7.41</ENT>
              <ENT>1.55</ENT>
              <ENT>24.59</ENT>
              <ENT>19.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27745</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reinforce tibia</ENT>
              <ENT>10.07</ENT>
              <ENT>N/A</ENT>
              <ENT>8.46</ENT>
              <ENT>1.38</ENT>
              <ENT>N/A</ENT>
              <ENT>19.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27750</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of tibia fracture</ENT>
              <ENT>3.19</ENT>
              <ENT>5.47</ENT>
              <ENT>3.84</ENT>
              <ENT>0.43</ENT>
              <ENT>9.09</ENT>
              <ENT>7.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27752</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of tibia fracture</ENT>
              <ENT>5.84</ENT>
              <ENT>7.62</ENT>
              <ENT>5.70</ENT>
              <ENT>0.82</ENT>
              <ENT>14.28</ENT>
              <ENT>12.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27756</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of tibia fracture</ENT>
              <ENT>6.78</ENT>
              <ENT>N/A</ENT>
              <ENT>6.85</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>14.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27758</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of tibia fracture</ENT>
              <ENT>11.67</ENT>
              <ENT>N/A</ENT>
              <ENT>9.36</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>22.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27759</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of tibia fracture</ENT>
              <ENT>13.76</ENT>
              <ENT>N/A</ENT>
              <ENT>10.62</ENT>
              <ENT>1.93</ENT>
              <ENT>N/A</ENT>
              <ENT>26.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27760</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of ankle fracture</ENT>
              <ENT>3.01</ENT>
              <ENT>5.35</ENT>
              <ENT>3.60</ENT>
              <ENT>0.39</ENT>
              <ENT>8.75</ENT>
              <ENT>7.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27762</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of ankle fracture</ENT>
              <ENT>5.25</ENT>
              <ENT>7.26</ENT>
              <ENT>5.26</ENT>
              <ENT>0.71</ENT>
              <ENT>13.22</ENT>
              <ENT>11.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27766</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of ankle fracture</ENT>
              <ENT>8.36</ENT>
              <ENT>N/A</ENT>
              <ENT>7.30</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>16.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27780</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of fibula fracture</ENT>
              <ENT>2.65</ENT>
              <ENT>5.02</ENT>
              <ENT>3.27</ENT>
              <ENT>0.33</ENT>
              <ENT>8.00</ENT>
              <ENT>6.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27781</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of fibula fracture</ENT>
              <ENT>4.40</ENT>
              <ENT>6.47</ENT>
              <ENT>4.58</ENT>
              <ENT>0.57</ENT>
              <ENT>11.44</ENT>
              <ENT>9.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27784</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of fibula fracture</ENT>
              <ENT>7.11</ENT>
              <ENT>N/A</ENT>
              <ENT>6.58</ENT>
              <ENT>0.98</ENT>
              <ENT>N/A</ENT>
              <ENT>14.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27786</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of ankle fracture</ENT>
              <ENT>2.84</ENT>
              <ENT>5.19</ENT>
              <ENT>3.38</ENT>
              <ENT>0.37</ENT>
              <ENT>8.40</ENT>
              <ENT>6.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27788</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of ankle fracture</ENT>
              <ENT>4.45</ENT>
              <ENT>6.59</ENT>
              <ENT>4.58</ENT>
              <ENT>0.61</ENT>
              <ENT>11.65</ENT>
              <ENT>9.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27792</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of ankle fracture</ENT>
              <ENT>7.66</ENT>
              <ENT>N/A</ENT>
              <ENT>7.03</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>15.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27808</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of ankle fracture</ENT>
              <ENT>2.83</ENT>
              <ENT>5.89</ENT>
              <ENT>3.76</ENT>
              <ENT>0.38</ENT>
              <ENT>9.10</ENT>
              <ENT>6.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27810</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of ankle fracture</ENT>
              <ENT>5.13</ENT>
              <ENT>7.18</ENT>
              <ENT>5.19</ENT>
              <ENT>0.71</ENT>
              <ENT>13.02</ENT>
              <ENT>11.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27814</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of ankle fracture</ENT>
              <ENT>10.68</ENT>
              <ENT>N/A</ENT>
              <ENT>8.81</ENT>
              <ENT>1.50</ENT>
              <ENT>N/A</ENT>
              <ENT>20.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27816</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of ankle fracture</ENT>
              <ENT>2.89</ENT>
              <ENT>5.18</ENT>
              <ENT>3.55</ENT>
              <ENT>0.37</ENT>
              <ENT>8.44</ENT>
              <ENT>6.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27818</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of ankle fracture</ENT>
              <ENT>5.50</ENT>
              <ENT>7.29</ENT>
              <ENT>5.23</ENT>
              <ENT>0.74</ENT>
              <ENT>13.53</ENT>
              <ENT>11.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27822</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of ankle fracture</ENT>
              <ENT>11.00</ENT>
              <ENT>N/A</ENT>
              <ENT>10.92</ENT>
              <ENT>1.29</ENT>
              <ENT>N/A</ENT>
              <ENT>23.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27823</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of ankle fracture</ENT>
              <ENT>13.00</ENT>
              <ENT>N/A</ENT>
              <ENT>11.80</ENT>
              <ENT>1.65</ENT>
              <ENT>N/A</ENT>
              <ENT>26.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27824</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat lower leg fracture</ENT>
              <ENT>2.89</ENT>
              <ENT>5.77</ENT>
              <ENT>3.90</ENT>
              <ENT>0.39</ENT>
              <ENT>9.05</ENT>
              <ENT>7.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27825</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat lower leg fracture</ENT>
              <ENT>6.19</ENT>
              <ENT>8.55</ENT>
              <ENT>6.18</ENT>
              <ENT>0.85</ENT>
              <ENT>15.59</ENT>
              <ENT>13.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27826</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat lower leg fracture</ENT>
              <ENT>8.54</ENT>
              <ENT>N/A</ENT>
              <ENT>9.12</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>18.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27827</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat lower leg fracture</ENT>
              <ENT>14.06</ENT>
              <ENT>N/A</ENT>
              <ENT>12.94</ENT>
              <ENT>1.96</ENT>
              <ENT>N/A</ENT>
              <ENT>28.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27828</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat lower leg fracture</ENT>
              <ENT>16.23</ENT>
              <ENT>N/A</ENT>
              <ENT>14.01</ENT>
              <ENT>2.27</ENT>
              <ENT>N/A</ENT>
              <ENT>32.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27829</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat lower leg joint</ENT>
              <ENT>5.49</ENT>
              <ENT>N/A</ENT>
              <ENT>6.89</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>13.15</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27830</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat lower leg dislocation</ENT>
              <ENT>3.79</ENT>
              <ENT>5.23</ENT>
              <ENT>3.90</ENT>
              <ENT>0.44</ENT>
              <ENT>9.46</ENT>
              <ENT>8.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27831</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat lower leg dislocation</ENT>
              <ENT>4.56</ENT>
              <ENT>N/A</ENT>
              <ENT>4.52</ENT>
              <ENT>0.61</ENT>
              <ENT>N/A</ENT>
              <ENT>9.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27832</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat lower leg dislocation</ENT>
              <ENT>6.49</ENT>
              <ENT>N/A</ENT>
              <ENT>6.27</ENT>
              <ENT>0.91</ENT>
              <ENT>N/A</ENT>
              <ENT>13.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27840</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat ankle dislocation</ENT>
              <ENT>4.58</ENT>
              <ENT>N/A</ENT>
              <ENT>3.96</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>9.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27842</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat ankle dislocation</ENT>
              <ENT>6.21</ENT>
              <ENT>N/A</ENT>
              <ENT>5.09</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>12.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27846</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat ankle dislocation</ENT>
              <ENT>9.79</ENT>
              <ENT>N/A</ENT>
              <ENT>8.17</ENT>
              <ENT>1.36</ENT>
              <ENT>N/A</ENT>
              <ENT>19.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27848</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat ankle dislocation</ENT>
              <ENT>11.20</ENT>
              <ENT>N/A</ENT>
              <ENT>9.89</ENT>
              <ENT>1.55</ENT>
              <ENT>N/A</ENT>
              <ENT>22.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27860</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fixation of ankle joint</ENT>
              <ENT>2.34</ENT>
              <ENT>N/A</ENT>
              <ENT>2.20</ENT>
              <ENT>0.31</ENT>
              <ENT>N/A</ENT>
              <ENT>4.85</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27870</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of ankle joint, open</ENT>
              <ENT>13.91</ENT>
              <ENT>N/A</ENT>
              <ENT>10.90</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>26.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27871</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of tibiofibular joint</ENT>
              <ENT>9.17</ENT>
              <ENT>N/A</ENT>
              <ENT>7.86</ENT>
              <ENT>1.29</ENT>
              <ENT>N/A</ENT>
              <ENT>18.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27880</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation of lower leg</ENT>
              <ENT>11.85</ENT>
              <ENT>N/A</ENT>
              <ENT>7.60</ENT>
              <ENT>1.38</ENT>
              <ENT>N/A</ENT>
              <ENT>20.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27881</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation of lower leg</ENT>
              <ENT>12.34</ENT>
              <ENT>N/A</ENT>
              <ENT>9.23</ENT>
              <ENT>1.59</ENT>
              <ENT>N/A</ENT>
              <ENT>23.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27882</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation of lower leg</ENT>
              <ENT>8.94</ENT>
              <ENT>N/A</ENT>
              <ENT>7.17</ENT>
              <ENT>1.03</ENT>
              <ENT>N/A</ENT>
              <ENT>17.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27884</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation follow-up surgery</ENT>
              <ENT>8.21</ENT>
              <ENT>N/A</ENT>
              <ENT>6.28</ENT>
              <ENT>0.95</ENT>
              <ENT>N/A</ENT>
              <ENT>15.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27886</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation follow-up surgery</ENT>
              <ENT>9.32</ENT>
              <ENT>N/A</ENT>
              <ENT>6.98</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>17.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27888</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation of foot at ankle</ENT>
              <ENT>9.67</ENT>
              <ENT>N/A</ENT>
              <ENT>7.81</ENT>
              <ENT>1.26</ENT>
              <ENT>N/A</ENT>
              <ENT>18.74</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27889</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation of foot at ankle</ENT>
              <ENT>9.98</ENT>
              <ENT>N/A</ENT>
              <ENT>6.87</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>18.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49104"/>
              <ENT I="01">27892</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompression of leg</ENT>
              <ENT>7.39</ENT>
              <ENT>N/A</ENT>
              <ENT>5.92</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>14.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27893</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompression of leg</ENT>
              <ENT>7.35</ENT>
              <ENT>N/A</ENT>
              <ENT>5.83</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>14.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27894</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompression of leg</ENT>
              <ENT>10.49</ENT>
              <ENT>N/A</ENT>
              <ENT>7.96</ENT>
              <ENT>1.25</ENT>
              <ENT>N/A</ENT>
              <ENT>19.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">27899</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Leg/ankle surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28001</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of bursa of foot</ENT>
              <ENT>2.73</ENT>
              <ENT>5.98</ENT>
              <ENT>3.58</ENT>
              <ENT>0.31</ENT>
              <ENT>9.02</ENT>
              <ENT>6.62</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28002</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of foot infection</ENT>
              <ENT>4.62</ENT>
              <ENT>7.39</ENT>
              <ENT>4.72</ENT>
              <ENT>0.56</ENT>
              <ENT>12.57</ENT>
              <ENT>9.90</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28003</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of foot infection</ENT>
              <ENT>8.41</ENT>
              <ENT>7.93</ENT>
              <ENT>6.42</ENT>
              <ENT>1.03</ENT>
              <ENT>17.37</ENT>
              <ENT>15.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28005</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat foot bone lesion</ENT>
              <ENT>8.68</ENT>
              <ENT>N/A</ENT>
              <ENT>6.70</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>16.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28008</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of foot fascia</ENT>
              <ENT>4.45</ENT>
              <ENT>5.87</ENT>
              <ENT>3.77</ENT>
              <ENT>0.56</ENT>
              <ENT>10.88</ENT>
              <ENT>8.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of toe tendon</ENT>
              <ENT>2.84</ENT>
              <ENT>5.69</ENT>
              <ENT>3.09</ENT>
              <ENT>0.39</ENT>
              <ENT>8.92</ENT>
              <ENT>6.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28011</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of toe tendons</ENT>
              <ENT>4.14</ENT>
              <ENT>7.63</ENT>
              <ENT>4.50</ENT>
              <ENT>0.58</ENT>
              <ENT>12.35</ENT>
              <ENT>9.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of foot joint</ENT>
              <ENT>5.01</ENT>
              <ENT>7.29</ENT>
              <ENT>4.42</ENT>
              <ENT>0.64</ENT>
              <ENT>12.94</ENT>
              <ENT>10.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28022</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of foot joint</ENT>
              <ENT>4.67</ENT>
              <ENT>6.27</ENT>
              <ENT>4.13</ENT>
              <ENT>0.62</ENT>
              <ENT>11.56</ENT>
              <ENT>9.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28024</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of toe joint</ENT>
              <ENT>4.38</ENT>
              <ENT>6.39</ENT>
              <ENT>4.20</ENT>
              <ENT>0.50</ENT>
              <ENT>11.27</ENT>
              <ENT>9.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28030</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of foot nerve</ENT>
              <ENT>6.15</ENT>
              <ENT>N/A</ENT>
              <ENT>3.75</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>10.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28035</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompression of tibia nerve</ENT>
              <ENT>5.09</ENT>
              <ENT>7.07</ENT>
              <ENT>4.28</ENT>
              <ENT>0.71</ENT>
              <ENT>12.87</ENT>
              <ENT>10.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28043</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of foot lesion</ENT>
              <ENT>3.54</ENT>
              <ENT>5.94</ENT>
              <ENT>3.40</ENT>
              <ENT>0.45</ENT>
              <ENT>9.93</ENT>
              <ENT>7.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28045</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of foot lesion</ENT>
              <ENT>4.72</ENT>
              <ENT>6.30</ENT>
              <ENT>3.89</ENT>
              <ENT>0.62</ENT>
              <ENT>11.64</ENT>
              <ENT>9.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28046</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Resection of tumor, foot</ENT>
              <ENT>10.18</ENT>
              <ENT>9.67</ENT>
              <ENT>7.59</ENT>
              <ENT>1.13</ENT>
              <ENT>20.98</ENT>
              <ENT>18.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28050</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of foot joint lining</ENT>
              <ENT>4.25</ENT>
              <ENT>5.95</ENT>
              <ENT>3.86</ENT>
              <ENT>0.55</ENT>
              <ENT>10.75</ENT>
              <ENT>8.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28052</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of foot joint lining</ENT>
              <ENT>3.94</ENT>
              <ENT>6.16</ENT>
              <ENT>3.76</ENT>
              <ENT>0.51</ENT>
              <ENT>10.61</ENT>
              <ENT>8.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28054</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of toe joint lining</ENT>
              <ENT>3.45</ENT>
              <ENT>6.00</ENT>
              <ENT>3.56</ENT>
              <ENT>0.45</ENT>
              <ENT>9.90</ENT>
              <ENT>7.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28060</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal, foot fascia</ENT>
              <ENT>5.23</ENT>
              <ENT>6.57</ENT>
              <ENT>4.21</ENT>
              <ENT>0.69</ENT>
              <ENT>12.49</ENT>
              <ENT>10.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28062</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of foot fascia</ENT>
              <ENT>6.52</ENT>
              <ENT>7.34</ENT>
              <ENT>4.36</ENT>
              <ENT>0.85</ENT>
              <ENT>14.71</ENT>
              <ENT>11.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28070</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of foot joint lining</ENT>
              <ENT>5.10</ENT>
              <ENT>6.13</ENT>
              <ENT>4.08</ENT>
              <ENT>0.68</ENT>
              <ENT>11.91</ENT>
              <ENT>9.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28072</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of foot joint lining</ENT>
              <ENT>4.58</ENT>
              <ENT>6.62</ENT>
              <ENT>4.56</ENT>
              <ENT>0.64</ENT>
              <ENT>11.84</ENT>
              <ENT>9.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28080</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of foot lesion</ENT>
              <ENT>3.58</ENT>
              <ENT>6.10</ENT>
              <ENT>3.84</ENT>
              <ENT>0.50</ENT>
              <ENT>10.18</ENT>
              <ENT>7.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28086</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise foot tendon sheath</ENT>
              <ENT>4.78</ENT>
              <ENT>9.75</ENT>
              <ENT>4.96</ENT>
              <ENT>0.66</ENT>
              <ENT>15.19</ENT>
              <ENT>10.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28088</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise foot tendon sheath</ENT>
              <ENT>3.86</ENT>
              <ENT>7.26</ENT>
              <ENT>4.24</ENT>
              <ENT>0.52</ENT>
              <ENT>11.64</ENT>
              <ENT>8.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28090</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of foot lesion</ENT>
              <ENT>4.41</ENT>
              <ENT>6.20</ENT>
              <ENT>3.73</ENT>
              <ENT>0.57</ENT>
              <ENT>11.18</ENT>
              <ENT>8.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28092</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of toe lesions</ENT>
              <ENT>3.64</ENT>
              <ENT>6.52</ENT>
              <ENT>3.82</ENT>
              <ENT>0.46</ENT>
              <ENT>10.62</ENT>
              <ENT>7.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of ankle/heel lesion</ENT>
              <ENT>5.66</ENT>
              <ENT>9.50</ENT>
              <ENT>5.04</ENT>
              <ENT>0.76</ENT>
              <ENT>15.92</ENT>
              <ENT>11.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28102</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove/graft foot lesion</ENT>
              <ENT>7.73</ENT>
              <ENT>N/A</ENT>
              <ENT>6.29</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>14.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28103</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove/graft foot lesion</ENT>
              <ENT>6.50</ENT>
              <ENT>8.72</ENT>
              <ENT>4.97</ENT>
              <ENT>0.89</ENT>
              <ENT>16.11</ENT>
              <ENT>12.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28104</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of foot lesion</ENT>
              <ENT>5.12</ENT>
              <ENT>6.54</ENT>
              <ENT>4.29</ENT>
              <ENT>0.69</ENT>
              <ENT>12.35</ENT>
              <ENT>10.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28106</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove/graft foot lesion</ENT>
              <ENT>7.16</ENT>
              <ENT>N/A</ENT>
              <ENT>4.76</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>12.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28107</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove/graft foot lesion</ENT>
              <ENT>5.56</ENT>
              <ENT>7.46</ENT>
              <ENT>4.52</ENT>
              <ENT>0.74</ENT>
              <ENT>13.76</ENT>
              <ENT>10.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28108</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of toe lesions</ENT>
              <ENT>4.16</ENT>
              <ENT>5.60</ENT>
              <ENT>3.52</ENT>
              <ENT>0.52</ENT>
              <ENT>10.28</ENT>
              <ENT>8.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Part removal of metatarsal</ENT>
              <ENT>4.08</ENT>
              <ENT>6.24</ENT>
              <ENT>3.94</ENT>
              <ENT>0.49</ENT>
              <ENT>10.81</ENT>
              <ENT>8.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28111</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Part removal of metatarsal</ENT>
              <ENT>5.01</ENT>
              <ENT>7.45</ENT>
              <ENT>4.45</ENT>
              <ENT>0.63</ENT>
              <ENT>13.09</ENT>
              <ENT>10.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28112</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Part removal of metatarsal</ENT>
              <ENT>4.49</ENT>
              <ENT>6.93</ENT>
              <ENT>4.35</ENT>
              <ENT>0.60</ENT>
              <ENT>12.02</ENT>
              <ENT>9.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28113</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Part removal of metatarsal</ENT>
              <ENT>4.79</ENT>
              <ENT>7.01</ENT>
              <ENT>4.85</ENT>
              <ENT>0.63</ENT>
              <ENT>12.43</ENT>
              <ENT>10.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28114</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of metatarsal heads</ENT>
              <ENT>9.79</ENT>
              <ENT>12.25</ENT>
              <ENT>8.83</ENT>
              <ENT>1.36</ENT>
              <ENT>23.40</ENT>
              <ENT>19.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28116</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of foot</ENT>
              <ENT>7.75</ENT>
              <ENT>7.38</ENT>
              <ENT>5.38</ENT>
              <ENT>1.03</ENT>
              <ENT>16.16</ENT>
              <ENT>14.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28118</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of heel bone</ENT>
              <ENT>5.96</ENT>
              <ENT>7.33</ENT>
              <ENT>4.73</ENT>
              <ENT>0.79</ENT>
              <ENT>14.08</ENT>
              <ENT>11.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28119</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of heel spur</ENT>
              <ENT>5.39</ENT>
              <ENT>6.38</ENT>
              <ENT>4.03</ENT>
              <ENT>0.74</ENT>
              <ENT>12.51</ENT>
              <ENT>10.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Part removal of ankle/heel</ENT>
              <ENT>5.40</ENT>
              <ENT>9.04</ENT>
              <ENT>5.48</ENT>
              <ENT>0.69</ENT>
              <ENT>15.13</ENT>
              <ENT>11.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28122</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of foot bone</ENT>
              <ENT>7.29</ENT>
              <ENT>8.15</ENT>
              <ENT>6.01</ENT>
              <ENT>0.96</ENT>
              <ENT>16.40</ENT>
              <ENT>14.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28124</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of toe</ENT>
              <ENT>4.81</ENT>
              <ENT>6.30</ENT>
              <ENT>4.35</ENT>
              <ENT>0.65</ENT>
              <ENT>11.76</ENT>
              <ENT>9.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28126</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of toe</ENT>
              <ENT>3.52</ENT>
              <ENT>5.52</ENT>
              <ENT>3.79</ENT>
              <ENT>0.49</ENT>
              <ENT>9.53</ENT>
              <ENT>7.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of ankle bone</ENT>
              <ENT>8.11</ENT>
              <ENT>N/A</ENT>
              <ENT>6.92</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>16.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of metatarsal</ENT>
              <ENT>6.91</ENT>
              <ENT>8.47</ENT>
              <ENT>5.19</ENT>
              <ENT>0.84</ENT>
              <ENT>16.22</ENT>
              <ENT>12.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of toe</ENT>
              <ENT>4.09</ENT>
              <ENT>6.19</ENT>
              <ENT>4.05</ENT>
              <ENT>0.52</ENT>
              <ENT>10.80</ENT>
              <ENT>8.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28153</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of toe</ENT>
              <ENT>3.66</ENT>
              <ENT>5.59</ENT>
              <ENT>3.27</ENT>
              <ENT>0.49</ENT>
              <ENT>9.74</ENT>
              <ENT>7.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28160</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of toe</ENT>
              <ENT>3.74</ENT>
              <ENT>5.88</ENT>
              <ENT>4.14</ENT>
              <ENT>0.51</ENT>
              <ENT>10.13</ENT>
              <ENT>8.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28171</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive foot surgery</ENT>
              <ENT>9.60</ENT>
              <ENT>N/A</ENT>
              <ENT>5.90</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>16.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28173</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive foot surgery</ENT>
              <ENT>8.80</ENT>
              <ENT>8.49</ENT>
              <ENT>5.86</ENT>
              <ENT>1.04</ENT>
              <ENT>18.33</ENT>
              <ENT>15.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28175</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive foot surgery</ENT>
              <ENT>6.05</ENT>
              <ENT>6.89</ENT>
              <ENT>4.26</ENT>
              <ENT>0.75</ENT>
              <ENT>13.69</ENT>
              <ENT>11.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28190</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of foot foreign body</ENT>
              <ENT>1.96</ENT>
              <ENT>6.71</ENT>
              <ENT>3.55</ENT>
              <ENT>0.16</ENT>
              <ENT>8.83</ENT>
              <ENT>5.67</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49105"/>
              <ENT I="01">28192</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of foot foreign body</ENT>
              <ENT>4.64</ENT>
              <ENT>6.61</ENT>
              <ENT>3.85</ENT>
              <ENT>0.52</ENT>
              <ENT>11.77</ENT>
              <ENT>9.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28193</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of foot foreign body</ENT>
              <ENT>5.73</ENT>
              <ENT>6.53</ENT>
              <ENT>4.28</ENT>
              <ENT>0.63</ENT>
              <ENT>12.89</ENT>
              <ENT>10.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of foot tendon</ENT>
              <ENT>4.60</ENT>
              <ENT>6.13</ENT>
              <ENT>3.94</ENT>
              <ENT>0.59</ENT>
              <ENT>11.32</ENT>
              <ENT>9.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28202</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/graft of foot tendon</ENT>
              <ENT>6.84</ENT>
              <ENT>8.30</ENT>
              <ENT>4.82</ENT>
              <ENT>0.86</ENT>
              <ENT>16.00</ENT>
              <ENT>12.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28208</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of foot tendon</ENT>
              <ENT>4.37</ENT>
              <ENT>5.91</ENT>
              <ENT>3.67</ENT>
              <ENT>0.59</ENT>
              <ENT>10.87</ENT>
              <ENT>8.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28210</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/graft of foot tendon</ENT>
              <ENT>6.35</ENT>
              <ENT>7.33</ENT>
              <ENT>4.36</ENT>
              <ENT>0.77</ENT>
              <ENT>14.45</ENT>
              <ENT>11.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release of foot tendon</ENT>
              <ENT>4.53</ENT>
              <ENT>5.73</ENT>
              <ENT>3.78</ENT>
              <ENT>0.63</ENT>
              <ENT>10.89</ENT>
              <ENT>8.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28222</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release of foot tendons</ENT>
              <ENT>5.62</ENT>
              <ENT>6.13</ENT>
              <ENT>4.49</ENT>
              <ENT>0.77</ENT>
              <ENT>12.52</ENT>
              <ENT>10.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28225</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release of foot tendon</ENT>
              <ENT>3.66</ENT>
              <ENT>5.43</ENT>
              <ENT>3.28</ENT>
              <ENT>0.50</ENT>
              <ENT>9.59</ENT>
              <ENT>7.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28226</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release of foot tendons</ENT>
              <ENT>4.53</ENT>
              <ENT>5.78</ENT>
              <ENT>4.11</ENT>
              <ENT>0.62</ENT>
              <ENT>10.93</ENT>
              <ENT>9.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28230</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of foot tendon(s)</ENT>
              <ENT>4.24</ENT>
              <ENT>5.81</ENT>
              <ENT>4.08</ENT>
              <ENT>0.59</ENT>
              <ENT>10.64</ENT>
              <ENT>8.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28232</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of toe tendon</ENT>
              <ENT>3.39</ENT>
              <ENT>5.85</ENT>
              <ENT>3.72</ENT>
              <ENT>0.48</ENT>
              <ENT>9.72</ENT>
              <ENT>7.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28234</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of foot tendon</ENT>
              <ENT>3.37</ENT>
              <ENT>6.01</ENT>
              <ENT>3.66</ENT>
              <ENT>0.46</ENT>
              <ENT>9.84</ENT>
              <ENT>7.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28238</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of foot tendon</ENT>
              <ENT>7.73</ENT>
              <ENT>8.19</ENT>
              <ENT>5.27</ENT>
              <ENT>1.08</ENT>
              <ENT>17.00</ENT>
              <ENT>14.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28240</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release of big toe</ENT>
              <ENT>4.36</ENT>
              <ENT>5.77</ENT>
              <ENT>3.88</ENT>
              <ENT>0.61</ENT>
              <ENT>10.74</ENT>
              <ENT>8.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of foot fascia</ENT>
              <ENT>5.92</ENT>
              <ENT>6.73</ENT>
              <ENT>4.50</ENT>
              <ENT>0.81</ENT>
              <ENT>13.46</ENT>
              <ENT>11.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28260</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release of midfoot joint</ENT>
              <ENT>7.96</ENT>
              <ENT>7.27</ENT>
              <ENT>5.34</ENT>
              <ENT>1.08</ENT>
              <ENT>16.31</ENT>
              <ENT>14.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28261</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of foot tendon</ENT>
              <ENT>11.73</ENT>
              <ENT>9.14</ENT>
              <ENT>7.59</ENT>
              <ENT>1.66</ENT>
              <ENT>22.53</ENT>
              <ENT>20.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28262</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of foot and ankle</ENT>
              <ENT>15.83</ENT>
              <ENT>14.73</ENT>
              <ENT>11.92</ENT>
              <ENT>2.22</ENT>
              <ENT>32.78</ENT>
              <ENT>29.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28264</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release of midfoot joint</ENT>
              <ENT>10.35</ENT>
              <ENT>8.74</ENT>
              <ENT>8.19</ENT>
              <ENT>1.46</ENT>
              <ENT>20.55</ENT>
              <ENT>20.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28270</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release of foot contracture</ENT>
              <ENT>4.76</ENT>
              <ENT>6.09</ENT>
              <ENT>4.43</ENT>
              <ENT>0.67</ENT>
              <ENT>11.52</ENT>
              <ENT>9.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28272</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release of toe joint, each</ENT>
              <ENT>3.80</ENT>
              <ENT>5.31</ENT>
              <ENT>3.22</ENT>
              <ENT>0.52</ENT>
              <ENT>9.63</ENT>
              <ENT>7.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28280</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of toes</ENT>
              <ENT>5.19</ENT>
              <ENT>7.46</ENT>
              <ENT>4.76</ENT>
              <ENT>0.72</ENT>
              <ENT>13.37</ENT>
              <ENT>10.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28285</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of hammertoe</ENT>
              <ENT>4.59</ENT>
              <ENT>6.14</ENT>
              <ENT>4.05</ENT>
              <ENT>0.64</ENT>
              <ENT>11.37</ENT>
              <ENT>9.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28286</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of hammertoe</ENT>
              <ENT>4.56</ENT>
              <ENT>5.93</ENT>
              <ENT>3.91</ENT>
              <ENT>0.64</ENT>
              <ENT>11.13</ENT>
              <ENT>9.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28288</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of foot bone</ENT>
              <ENT>4.74</ENT>
              <ENT>6.88</ENT>
              <ENT>5.53</ENT>
              <ENT>0.65</ENT>
              <ENT>12.27</ENT>
              <ENT>10.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28289</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair hallux rigidus</ENT>
              <ENT>7.04</ENT>
              <ENT>9.24</ENT>
              <ENT>6.53</ENT>
              <ENT>0.96</ENT>
              <ENT>17.24</ENT>
              <ENT>14.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28290</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Correction of bunion</ENT>
              <ENT>5.66</ENT>
              <ENT>7.23</ENT>
              <ENT>5.59</ENT>
              <ENT>0.79</ENT>
              <ENT>13.68</ENT>
              <ENT>12.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28292</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Correction of bunion</ENT>
              <ENT>7.04</ENT>
              <ENT>8.00</ENT>
              <ENT>5.93</ENT>
              <ENT>0.98</ENT>
              <ENT>16.02</ENT>
              <ENT>13.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28293</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Correction of bunion</ENT>
              <ENT>9.15</ENT>
              <ENT>10.19</ENT>
              <ENT>6.16</ENT>
              <ENT>1.28</ENT>
              <ENT>20.62</ENT>
              <ENT>16.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28294</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Correction of bunion</ENT>
              <ENT>8.56</ENT>
              <ENT>7.87</ENT>
              <ENT>5.28</ENT>
              <ENT>1.16</ENT>
              <ENT>17.59</ENT>
              <ENT>15.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28296</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Correction of bunion</ENT>
              <ENT>9.18</ENT>
              <ENT>8.38</ENT>
              <ENT>6.04</ENT>
              <ENT>1.28</ENT>
              <ENT>18.84</ENT>
              <ENT>16.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28297</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Correction of bunion</ENT>
              <ENT>9.18</ENT>
              <ENT>9.38</ENT>
              <ENT>7.08</ENT>
              <ENT>1.31</ENT>
              <ENT>19.87</ENT>
              <ENT>17.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28298</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Correction of bunion</ENT>
              <ENT>7.94</ENT>
              <ENT>7.52</ENT>
              <ENT>5.64</ENT>
              <ENT>1.12</ENT>
              <ENT>16.58</ENT>
              <ENT>14.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28299</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Correction of bunion</ENT>
              <ENT>10.58</ENT>
              <ENT>8.95</ENT>
              <ENT>6.66</ENT>
              <ENT>1.24</ENT>
              <ENT>20.77</ENT>
              <ENT>18.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of heel bone</ENT>
              <ENT>9.54</ENT>
              <ENT>13.40</ENT>
              <ENT>7.28</ENT>
              <ENT>1.31</ENT>
              <ENT>24.25</ENT>
              <ENT>18.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28302</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of ankle bone</ENT>
              <ENT>9.55</ENT>
              <ENT>13.39</ENT>
              <ENT>7.16</ENT>
              <ENT>1.15</ENT>
              <ENT>24.09</ENT>
              <ENT>17.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28304</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of midfoot bones</ENT>
              <ENT>9.16</ENT>
              <ENT>8.36</ENT>
              <ENT>5.97</ENT>
              <ENT>1.00</ENT>
              <ENT>18.52</ENT>
              <ENT>16.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28305</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise/graft midfoot bones</ENT>
              <ENT>10.50</ENT>
              <ENT>11.12</ENT>
              <ENT>6.95</ENT>
              <ENT>0.55</ENT>
              <ENT>22.17</ENT>
              <ENT>18.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28306</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of metatarsal</ENT>
              <ENT>5.86</ENT>
              <ENT>7.40</ENT>
              <ENT>4.45</ENT>
              <ENT>0.81</ENT>
              <ENT>14.07</ENT>
              <ENT>11.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28307</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of metatarsal</ENT>
              <ENT>6.33</ENT>
              <ENT>11.84</ENT>
              <ENT>5.50</ENT>
              <ENT>0.71</ENT>
              <ENT>18.88</ENT>
              <ENT>12.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28308</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of metatarsal</ENT>
              <ENT>5.29</ENT>
              <ENT>6.22</ENT>
              <ENT>3.89</ENT>
              <ENT>0.74</ENT>
              <ENT>12.25</ENT>
              <ENT>9.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28309</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of metatarsals</ENT>
              <ENT>12.78</ENT>
              <ENT>N/A</ENT>
              <ENT>8.33</ENT>
              <ENT>1.64</ENT>
              <ENT>N/A</ENT>
              <ENT>22.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28310</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of big toe</ENT>
              <ENT>5.43</ENT>
              <ENT>6.45</ENT>
              <ENT>4.19</ENT>
              <ENT>0.76</ENT>
              <ENT>12.64</ENT>
              <ENT>10.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28312</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of toe</ENT>
              <ENT>4.55</ENT>
              <ENT>6.18</ENT>
              <ENT>4.40</ENT>
              <ENT>0.62</ENT>
              <ENT>11.35</ENT>
              <ENT>9.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28313</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair deformity of toe</ENT>
              <ENT>5.01</ENT>
              <ENT>6.65</ENT>
              <ENT>5.91</ENT>
              <ENT>0.68</ENT>
              <ENT>12.34</ENT>
              <ENT>11.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28315</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of sesamoid bone</ENT>
              <ENT>4.86</ENT>
              <ENT>6.03</ENT>
              <ENT>3.89</ENT>
              <ENT>0.66</ENT>
              <ENT>11.55</ENT>
              <ENT>9.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of foot bones</ENT>
              <ENT>9.18</ENT>
              <ENT>N/A</ENT>
              <ENT>6.97</ENT>
              <ENT>1.27</ENT>
              <ENT>N/A</ENT>
              <ENT>17.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28322</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of metatarsals</ENT>
              <ENT>8.34</ENT>
              <ENT>10.37</ENT>
              <ENT>6.52</ENT>
              <ENT>1.17</ENT>
              <ENT>19.88</ENT>
              <ENT>16.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28340</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Resect enlarged toe tissue</ENT>
              <ENT>6.98</ENT>
              <ENT>7.25</ENT>
              <ENT>4.59</ENT>
              <ENT>0.98</ENT>
              <ENT>15.21</ENT>
              <ENT>12.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28341</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Resect enlarged toe</ENT>
              <ENT>8.41</ENT>
              <ENT>7.43</ENT>
              <ENT>5.13</ENT>
              <ENT>1.18</ENT>
              <ENT>17.02</ENT>
              <ENT>14.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28344</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair extra toe(s)</ENT>
              <ENT>4.26</ENT>
              <ENT>6.93</ENT>
              <ENT>3.89</ENT>
              <ENT>0.60</ENT>
              <ENT>11.79</ENT>
              <ENT>8.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28345</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair webbed toe(s)</ENT>
              <ENT>5.92</ENT>
              <ENT>7.19</ENT>
              <ENT>5.01</ENT>
              <ENT>0.84</ENT>
              <ENT>13.95</ENT>
              <ENT>11.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28360</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct cleft foot</ENT>
              <ENT>13.34</ENT>
              <ENT>N/A</ENT>
              <ENT>10.87</ENT>
              <ENT>1.88</ENT>
              <ENT>N/A</ENT>
              <ENT>26.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of heel fracture</ENT>
              <ENT>2.16</ENT>
              <ENT>4.63</ENT>
              <ENT>3.31</ENT>
              <ENT>0.29</ENT>
              <ENT>7.08</ENT>
              <ENT>5.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28405</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of heel fracture</ENT>
              <ENT>4.57</ENT>
              <ENT>5.77</ENT>
              <ENT>4.82</ENT>
              <ENT>0.63</ENT>
              <ENT>10.97</ENT>
              <ENT>10.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28406</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of heel fracture</ENT>
              <ENT>6.31</ENT>
              <ENT>N/A</ENT>
              <ENT>7.02</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>14.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28415</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat heel fracture</ENT>
              <ENT>15.97</ENT>
              <ENT>N/A</ENT>
              <ENT>13.49</ENT>
              <ENT>2.24</ENT>
              <ENT>N/A</ENT>
              <ENT>31.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat/graft heel fracture</ENT>
              <ENT>16.64</ENT>
              <ENT>N/A</ENT>
              <ENT>13.20</ENT>
              <ENT>2.29</ENT>
              <ENT>N/A</ENT>
              <ENT>32.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28430</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of ankle fracture</ENT>
              <ENT>2.09</ENT>
              <ENT>4.33</ENT>
              <ENT>2.81</ENT>
              <ENT>0.27</ENT>
              <ENT>6.69</ENT>
              <ENT>5.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49106"/>
              <ENT I="01">28435</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of ankle fracture</ENT>
              <ENT>3.40</ENT>
              <ENT>4.74</ENT>
              <ENT>3.90</ENT>
              <ENT>0.47</ENT>
              <ENT>8.61</ENT>
              <ENT>7.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28436</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of ankle fracture</ENT>
              <ENT>4.71</ENT>
              <ENT>N/A</ENT>
              <ENT>6.11</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>11.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28445</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat ankle fracture</ENT>
              <ENT>15.62</ENT>
              <ENT>N/A</ENT>
              <ENT>11.42</ENT>
              <ENT>1.29</ENT>
              <ENT>N/A</ENT>
              <ENT>28.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat midfoot fracture, each</ENT>
              <ENT>1.90</ENT>
              <ENT>4.31</ENT>
              <ENT>2.72</ENT>
              <ENT>0.25</ENT>
              <ENT>6.46</ENT>
              <ENT>4.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28455</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat midfoot fracture, each</ENT>
              <ENT>3.09</ENT>
              <ENT>4.22</ENT>
              <ENT>3.76</ENT>
              <ENT>0.43</ENT>
              <ENT>7.74</ENT>
              <ENT>7.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28456</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat midfoot fracture</ENT>
              <ENT>2.68</ENT>
              <ENT>N/A</ENT>
              <ENT>4.37</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>7.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28465</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat midfoot fracture, each</ENT>
              <ENT>7.01</ENT>
              <ENT>N/A</ENT>
              <ENT>6.49</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>14.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28470</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat metatarsal fracture</ENT>
              <ENT>1.99</ENT>
              <ENT>3.95</ENT>
              <ENT>2.53</ENT>
              <ENT>0.26</ENT>
              <ENT>6.20</ENT>
              <ENT>4.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28475</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat metatarsal fracture</ENT>
              <ENT>2.97</ENT>
              <ENT>4.20</ENT>
              <ENT>3.34</ENT>
              <ENT>0.41</ENT>
              <ENT>7.58</ENT>
              <ENT>6.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28476</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat metatarsal fracture</ENT>
              <ENT>3.38</ENT>
              <ENT>N/A</ENT>
              <ENT>5.09</ENT>
              <ENT>0.46</ENT>
              <ENT>N/A</ENT>
              <ENT>8.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28485</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat metatarsal fracture</ENT>
              <ENT>5.71</ENT>
              <ENT>N/A</ENT>
              <ENT>5.72</ENT>
              <ENT>0.80</ENT>
              <ENT>N/A</ENT>
              <ENT>12.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28490</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat big toe fracture</ENT>
              <ENT>1.09</ENT>
              <ENT>2.33</ENT>
              <ENT>1.83</ENT>
              <ENT>0.13</ENT>
              <ENT>3.55</ENT>
              <ENT>3.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28495</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat big toe fracture</ENT>
              <ENT>1.58</ENT>
              <ENT>2.60</ENT>
              <ENT>2.18</ENT>
              <ENT>0.19</ENT>
              <ENT>4.37</ENT>
              <ENT>3.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28496</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat big toe fracture</ENT>
              <ENT>2.33</ENT>
              <ENT>9.95</ENT>
              <ENT>3.78</ENT>
              <ENT>0.32</ENT>
              <ENT>12.60</ENT>
              <ENT>6.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28505</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat big toe fracture</ENT>
              <ENT>3.81</ENT>
              <ENT>9.95</ENT>
              <ENT>4.86</ENT>
              <ENT>0.50</ENT>
              <ENT>14.26</ENT>
              <ENT>9.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of toe fracture</ENT>
              <ENT>1.09</ENT>
              <ENT>2.08</ENT>
              <ENT>1.78</ENT>
              <ENT>0.13</ENT>
              <ENT>3.30</ENT>
              <ENT>3.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28515</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of toe fracture</ENT>
              <ENT>1.46</ENT>
              <ENT>2.44</ENT>
              <ENT>2.10</ENT>
              <ENT>0.17</ENT>
              <ENT>4.07</ENT>
              <ENT>3.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28525</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat toe fracture</ENT>
              <ENT>3.32</ENT>
              <ENT>9.54</ENT>
              <ENT>4.41</ENT>
              <ENT>0.44</ENT>
              <ENT>13.30</ENT>
              <ENT>8.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat sesamoid bone fracture</ENT>
              <ENT>1.06</ENT>
              <ENT>2.26</ENT>
              <ENT>1.69</ENT>
              <ENT>0.13</ENT>
              <ENT>3.45</ENT>
              <ENT>2.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28531</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat sesamoid bone fracture</ENT>
              <ENT>2.35</ENT>
              <ENT>9.22</ENT>
              <ENT>2.63</ENT>
              <ENT>0.33</ENT>
              <ENT>11.90</ENT>
              <ENT>5.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28540</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat foot dislocation</ENT>
              <ENT>2.04</ENT>
              <ENT>3.03</ENT>
              <ENT>2.88</ENT>
              <ENT>0.24</ENT>
              <ENT>5.31</ENT>
              <ENT>5.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28545</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat foot dislocation</ENT>
              <ENT>2.45</ENT>
              <ENT>2.99</ENT>
              <ENT>2.99</ENT>
              <ENT>0.33</ENT>
              <ENT>5.77</ENT>
              <ENT>5.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28546</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat foot dislocation</ENT>
              <ENT>3.20</ENT>
              <ENT>8.11</ENT>
              <ENT>4.92</ENT>
              <ENT>0.46</ENT>
              <ENT>11.77</ENT>
              <ENT>8.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28555</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair foot dislocation</ENT>
              <ENT>6.30</ENT>
              <ENT>11.76</ENT>
              <ENT>6.66</ENT>
              <ENT>0.88</ENT>
              <ENT>18.94</ENT>
              <ENT>13.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28570</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat foot dislocation</ENT>
              <ENT>1.66</ENT>
              <ENT>3.12</ENT>
              <ENT>2.60</ENT>
              <ENT>0.22</ENT>
              <ENT>5.00</ENT>
              <ENT>4.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28575</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat foot dislocation</ENT>
              <ENT>3.31</ENT>
              <ENT>4.54</ENT>
              <ENT>4.21</ENT>
              <ENT>0.45</ENT>
              <ENT>8.30</ENT>
              <ENT>7.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28576</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat foot dislocation</ENT>
              <ENT>4.17</ENT>
              <ENT>10.43</ENT>
              <ENT>5.60</ENT>
              <ENT>0.56</ENT>
              <ENT>15.16</ENT>
              <ENT>10.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28585</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair foot dislocation</ENT>
              <ENT>7.99</ENT>
              <ENT>8.30</ENT>
              <ENT>6.66</ENT>
              <ENT>1.13</ENT>
              <ENT>17.42</ENT>
              <ENT>15.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat foot dislocation</ENT>
              <ENT>1.89</ENT>
              <ENT>3.49</ENT>
              <ENT>2.90</ENT>
              <ENT>0.24</ENT>
              <ENT>5.62</ENT>
              <ENT>5.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat foot dislocation</ENT>
              <ENT>2.71</ENT>
              <ENT>3.88</ENT>
              <ENT>3.77</ENT>
              <ENT>0.35</ENT>
              <ENT>6.94</ENT>
              <ENT>6.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28606</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat foot dislocation</ENT>
              <ENT>4.90</ENT>
              <ENT>16.30</ENT>
              <ENT>6.12</ENT>
              <ENT>0.68</ENT>
              <ENT>21.88</ENT>
              <ENT>11.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28615</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair foot dislocation</ENT>
              <ENT>7.77</ENT>
              <ENT>N/A</ENT>
              <ENT>8.13</ENT>
              <ENT>1.09</ENT>
              <ENT>N/A</ENT>
              <ENT>16.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28630</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat toe dislocation</ENT>
              <ENT>1.70</ENT>
              <ENT>1.41</ENT>
              <ENT>1.18</ENT>
              <ENT>0.17</ENT>
              <ENT>3.28</ENT>
              <ENT>3.05</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28635</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat toe dislocation</ENT>
              <ENT>1.91</ENT>
              <ENT>1.77</ENT>
              <ENT>1.61</ENT>
              <ENT>0.24</ENT>
              <ENT>3.92</ENT>
              <ENT>3.76</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28636</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat toe dislocation</ENT>
              <ENT>2.77</ENT>
              <ENT>6.41</ENT>
              <ENT>3.16</ENT>
              <ENT>0.39</ENT>
              <ENT>9.57</ENT>
              <ENT>6.32</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28645</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair toe dislocation</ENT>
              <ENT>4.22</ENT>
              <ENT>5.78</ENT>
              <ENT>3.58</ENT>
              <ENT>0.58</ENT>
              <ENT>10.58</ENT>
              <ENT>8.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28660</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat toe dislocation</ENT>
              <ENT>1.23</ENT>
              <ENT>1.79</ENT>
              <ENT>1.23</ENT>
              <ENT>0.11</ENT>
              <ENT>3.13</ENT>
              <ENT>2.57</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28665</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat toe dislocation</ENT>
              <ENT>1.92</ENT>
              <ENT>1.76</ENT>
              <ENT>1.73</ENT>
              <ENT>0.24</ENT>
              <ENT>3.92</ENT>
              <ENT>3.89</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28666</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat toe dislocation</ENT>
              <ENT>2.66</ENT>
              <ENT>6.13</ENT>
              <ENT>2.28</ENT>
              <ENT>0.38</ENT>
              <ENT>9.17</ENT>
              <ENT>5.32</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28675</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of toe dislocation</ENT>
              <ENT>2.92</ENT>
              <ENT>8.97</ENT>
              <ENT>3.84</ENT>
              <ENT>0.41</ENT>
              <ENT>12.30</ENT>
              <ENT>7.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28705</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of foot bones</ENT>
              <ENT>18.80</ENT>
              <ENT>N/A</ENT>
              <ENT>12.85</ENT>
              <ENT>2.13</ENT>
              <ENT>N/A</ENT>
              <ENT>33.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28715</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of foot bones</ENT>
              <ENT>13.10</ENT>
              <ENT>N/A</ENT>
              <ENT>10.11</ENT>
              <ENT>1.84</ENT>
              <ENT>N/A</ENT>
              <ENT>25.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28725</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of foot bones</ENT>
              <ENT>11.61</ENT>
              <ENT>N/A</ENT>
              <ENT>8.63</ENT>
              <ENT>1.63</ENT>
              <ENT>N/A</ENT>
              <ENT>21.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28730</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of foot bones</ENT>
              <ENT>10.76</ENT>
              <ENT>N/A</ENT>
              <ENT>8.72</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>20.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28735</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of foot bones</ENT>
              <ENT>10.85</ENT>
              <ENT>N/A</ENT>
              <ENT>8.18</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>20.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28737</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of foot bones</ENT>
              <ENT>9.64</ENT>
              <ENT>N/A</ENT>
              <ENT>7.13</ENT>
              <ENT>1.36</ENT>
              <ENT>N/A</ENT>
              <ENT>18.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28740</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of foot bones</ENT>
              <ENT>8.02</ENT>
              <ENT>11.91</ENT>
              <ENT>6.72</ENT>
              <ENT>1.13</ENT>
              <ENT>21.06</ENT>
              <ENT>15.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28750</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of big toe joint</ENT>
              <ENT>7.30</ENT>
              <ENT>13.32</ENT>
              <ENT>6.90</ENT>
              <ENT>1.03</ENT>
              <ENT>21.65</ENT>
              <ENT>15.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28755</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of big toe joint</ENT>
              <ENT>4.74</ENT>
              <ENT>7.04</ENT>
              <ENT>4.11</ENT>
              <ENT>0.66</ENT>
              <ENT>12.44</ENT>
              <ENT>9.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28760</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of big toe joint</ENT>
              <ENT>7.75</ENT>
              <ENT>8.25</ENT>
              <ENT>5.78</ENT>
              <ENT>1.07</ENT>
              <ENT>17.07</ENT>
              <ENT>14.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation of midfoot</ENT>
              <ENT>8.21</ENT>
              <ENT>N/A</ENT>
              <ENT>6.17</ENT>
              <ENT>0.98</ENT>
              <ENT>N/A</ENT>
              <ENT>15.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28805</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation thru metatarsal</ENT>
              <ENT>8.39</ENT>
              <ENT>N/A</ENT>
              <ENT>6.01</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>15.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28810</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation toe &amp; metatarsal</ENT>
              <ENT>6.21</ENT>
              <ENT>N/A</ENT>
              <ENT>4.90</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>11.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amputation of toe</ENT>
              <ENT>4.41</ENT>
              <ENT>8.64</ENT>
              <ENT>4.18</ENT>
              <ENT>0.51</ENT>
              <ENT>13.56</ENT>
              <ENT>9.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28825</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial amputation of toe</ENT>
              <ENT>3.59</ENT>
              <ENT>8.09</ENT>
              <ENT>3.88</ENT>
              <ENT>0.43</ENT>
              <ENT>12.11</ENT>
              <ENT>7.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">28899</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Foot/toes surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49107"/>
              <ENT I="01">29000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of body cast</ENT>
              <ENT>2.25</ENT>
              <ENT>3.18</ENT>
              <ENT>1.75</ENT>
              <ENT>0.30</ENT>
              <ENT>5.73</ENT>
              <ENT>4.30</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of body cast</ENT>
              <ENT>2.06</ENT>
              <ENT>3.36</ENT>
              <ENT>1.75</ENT>
              <ENT>0.27</ENT>
              <ENT>5.69</ENT>
              <ENT>4.08</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29015</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of body cast</ENT>
              <ENT>2.41</ENT>
              <ENT>3.06</ENT>
              <ENT>1.61</ENT>
              <ENT>0.21</ENT>
              <ENT>5.68</ENT>
              <ENT>4.23</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of body cast</ENT>
              <ENT>2.11</ENT>
              <ENT>3.33</ENT>
              <ENT>1.43</ENT>
              <ENT>0.16</ENT>
              <ENT>5.60</ENT>
              <ENT>3.70</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29025</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of body cast</ENT>
              <ENT>2.40</ENT>
              <ENT>3.31</ENT>
              <ENT>1.87</ENT>
              <ENT>0.26</ENT>
              <ENT>5.97</ENT>
              <ENT>4.53</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29035</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of body cast</ENT>
              <ENT>1.77</ENT>
              <ENT>3.52</ENT>
              <ENT>1.57</ENT>
              <ENT>0.24</ENT>
              <ENT>5.53</ENT>
              <ENT>3.58</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29040</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of body cast</ENT>
              <ENT>2.22</ENT>
              <ENT>2.63</ENT>
              <ENT>1.53</ENT>
              <ENT>0.35</ENT>
              <ENT>5.20</ENT>
              <ENT>4.10</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29044</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of body cast</ENT>
              <ENT>2.12</ENT>
              <ENT>3.87</ENT>
              <ENT>1.88</ENT>
              <ENT>0.29</ENT>
              <ENT>6.28</ENT>
              <ENT>4.29</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29046</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of body cast</ENT>
              <ENT>2.41</ENT>
              <ENT>3.34</ENT>
              <ENT>2.06</ENT>
              <ENT>0.34</ENT>
              <ENT>6.09</ENT>
              <ENT>4.81</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29049</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of figure eight</ENT>
              <ENT>0.89</ENT>
              <ENT>1.27</ENT>
              <ENT>0.55</ENT>
              <ENT>0.12</ENT>
              <ENT>2.28</ENT>
              <ENT>1.56</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29055</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of shoulder cast</ENT>
              <ENT>1.78</ENT>
              <ENT>2.87</ENT>
              <ENT>1.46</ENT>
              <ENT>0.24</ENT>
              <ENT>4.89</ENT>
              <ENT>3.48</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29058</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of shoulder cast</ENT>
              <ENT>1.31</ENT>
              <ENT>1.53</ENT>
              <ENT>0.74</ENT>
              <ENT>0.14</ENT>
              <ENT>2.98</ENT>
              <ENT>2.19</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29065</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of long arm cast</ENT>
              <ENT>0.87</ENT>
              <ENT>1.29</ENT>
              <ENT>0.75</ENT>
              <ENT>0.12</ENT>
              <ENT>2.28</ENT>
              <ENT>1.74</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29075</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of forearm cast</ENT>
              <ENT>0.77</ENT>
              <ENT>1.23</ENT>
              <ENT>0.68</ENT>
              <ENT>0.11</ENT>
              <ENT>2.11</ENT>
              <ENT>1.56</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29085</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apply hand/wrist cast</ENT>
              <ENT>0.87</ENT>
              <ENT>1.26</ENT>
              <ENT>0.64</ENT>
              <ENT>0.11</ENT>
              <ENT>2.24</ENT>
              <ENT>1.62</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29086</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apply finger cast</ENT>
              <ENT>0.62</ENT>
              <ENT>0.95</ENT>
              <ENT>0.52</ENT>
              <ENT>0.06</ENT>
              <ENT>1.63</ENT>
              <ENT>1.20</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29105</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apply long arm splint</ENT>
              <ENT>0.87</ENT>
              <ENT>1.21</ENT>
              <ENT>0.53</ENT>
              <ENT>0.11</ENT>
              <ENT>2.19</ENT>
              <ENT>1.51</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29125</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apply forearm splint</ENT>
              <ENT>0.59</ENT>
              <ENT>1.01</ENT>
              <ENT>0.41</ENT>
              <ENT>0.06</ENT>
              <ENT>1.66</ENT>
              <ENT>1.06</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29126</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apply forearm splint</ENT>
              <ENT>0.77</ENT>
              <ENT>1.22</ENT>
              <ENT>0.48</ENT>
              <ENT>0.06</ENT>
              <ENT>2.05</ENT>
              <ENT>1.31</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of finger splint</ENT>
              <ENT>0.50</ENT>
              <ENT>0.47</ENT>
              <ENT>0.17</ENT>
              <ENT>0.05</ENT>
              <ENT>1.02</ENT>
              <ENT>0.72</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29131</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of finger splint</ENT>
              <ENT>0.55</ENT>
              <ENT>0.75</ENT>
              <ENT>0.25</ENT>
              <ENT>0.03</ENT>
              <ENT>1.33</ENT>
              <ENT>0.83</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Strapping of chest</ENT>
              <ENT>0.65</ENT>
              <ENT>0.75</ENT>
              <ENT>0.36</ENT>
              <ENT>0.04</ENT>
              <ENT>1.44</ENT>
              <ENT>1.05</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Strapping of low back</ENT>
              <ENT>0.64</ENT>
              <ENT>0.73</ENT>
              <ENT>0.40</ENT>
              <ENT>0.07</ENT>
              <ENT>1.44</ENT>
              <ENT>1.11</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29240</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Strapping of shoulder</ENT>
              <ENT>0.71</ENT>
              <ENT>0.88</ENT>
              <ENT>0.38</ENT>
              <ENT>0.05</ENT>
              <ENT>1.64</ENT>
              <ENT>1.14</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29260</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Strapping of elbow or wrist</ENT>
              <ENT>0.55</ENT>
              <ENT>0.76</ENT>
              <ENT>0.34</ENT>
              <ENT>0.04</ENT>
              <ENT>1.35</ENT>
              <ENT>0.93</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29280</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Strapping of hand or finger</ENT>
              <ENT>0.51</ENT>
              <ENT>0.83</ENT>
              <ENT>0.34</ENT>
              <ENT>0.04</ENT>
              <ENT>1.38</ENT>
              <ENT>0.89</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29305</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of hip cast</ENT>
              <ENT>2.03</ENT>
              <ENT>3.24</ENT>
              <ENT>1.74</ENT>
              <ENT>0.29</ENT>
              <ENT>5.56</ENT>
              <ENT>4.06</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29325</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of hip casts</ENT>
              <ENT>2.32</ENT>
              <ENT>3.43</ENT>
              <ENT>1.93</ENT>
              <ENT>0.31</ENT>
              <ENT>6.06</ENT>
              <ENT>4.56</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29345</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of long leg cast</ENT>
              <ENT>1.40</ENT>
              <ENT>1.72</ENT>
              <ENT>1.06</ENT>
              <ENT>0.19</ENT>
              <ENT>3.31</ENT>
              <ENT>2.65</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29355</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of long leg cast</ENT>
              <ENT>1.53</ENT>
              <ENT>1.68</ENT>
              <ENT>1.12</ENT>
              <ENT>0.20</ENT>
              <ENT>3.41</ENT>
              <ENT>2.85</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29358</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apply long leg cast brace</ENT>
              <ENT>1.43</ENT>
              <ENT>2.00</ENT>
              <ENT>1.09</ENT>
              <ENT>0.19</ENT>
              <ENT>3.62</ENT>
              <ENT>2.71</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29365</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of long leg cast</ENT>
              <ENT>1.18</ENT>
              <ENT>1.61</ENT>
              <ENT>0.94</ENT>
              <ENT>0.17</ENT>
              <ENT>2.96</ENT>
              <ENT>2.29</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29405</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apply short leg cast</ENT>
              <ENT>0.86</ENT>
              <ENT>1.20</ENT>
              <ENT>0.71</ENT>
              <ENT>0.12</ENT>
              <ENT>2.18</ENT>
              <ENT>1.69</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29425</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apply short leg cast</ENT>
              <ENT>1.01</ENT>
              <ENT>1.21</ENT>
              <ENT>0.74</ENT>
              <ENT>0.14</ENT>
              <ENT>2.36</ENT>
              <ENT>1.89</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29435</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apply short leg cast</ENT>
              <ENT>1.18</ENT>
              <ENT>1.52</ENT>
              <ENT>0.92</ENT>
              <ENT>0.17</ENT>
              <ENT>2.87</ENT>
              <ENT>2.27</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29440</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Addition of walker to cast</ENT>
              <ENT>0.57</ENT>
              <ENT>0.68</ENT>
              <ENT>0.28</ENT>
              <ENT>0.07</ENT>
              <ENT>1.32</ENT>
              <ENT>0.92</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29445</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apply rigid leg cast</ENT>
              <ENT>1.78</ENT>
              <ENT>1.78</ENT>
              <ENT>0.98</ENT>
              <ENT>0.24</ENT>
              <ENT>3.80</ENT>
              <ENT>3.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of leg cast</ENT>
              <ENT>2.08</ENT>
              <ENT>1.48</ENT>
              <ENT>1.11</ENT>
              <ENT>0.13</ENT>
              <ENT>3.69</ENT>
              <ENT>3.32</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29505</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application, long leg splint</ENT>
              <ENT>0.69</ENT>
              <ENT>1.18</ENT>
              <ENT>0.48</ENT>
              <ENT>0.06</ENT>
              <ENT>1.93</ENT>
              <ENT>1.23</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29515</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application lower leg splint</ENT>
              <ENT>0.73</ENT>
              <ENT>0.87</ENT>
              <ENT>0.49</ENT>
              <ENT>0.07</ENT>
              <ENT>1.67</ENT>
              <ENT>1.29</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Strapping of hip</ENT>
              <ENT>0.54</ENT>
              <ENT>0.90</ENT>
              <ENT>0.47</ENT>
              <ENT>0.02</ENT>
              <ENT>1.46</ENT>
              <ENT>1.03</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Strapping of knee</ENT>
              <ENT>0.57</ENT>
              <ENT>0.81</ENT>
              <ENT>0.35</ENT>
              <ENT>0.04</ENT>
              <ENT>1.42</ENT>
              <ENT>0.96</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29540</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Strapping of ankle and/or ft</ENT>
              <ENT>0.51</ENT>
              <ENT>0.42</ENT>
              <ENT>0.32</ENT>
              <ENT>0.04</ENT>
              <ENT>0.97</ENT>
              <ENT>0.87</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29550</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Strapping of toes</ENT>
              <ENT>0.47</ENT>
              <ENT>0.42</ENT>
              <ENT>0.28</ENT>
              <ENT>0.05</ENT>
              <ENT>0.94</ENT>
              <ENT>0.80</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29580</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of paste boot</ENT>
              <ENT>0.57</ENT>
              <ENT>0.66</ENT>
              <ENT>0.36</ENT>
              <ENT>0.05</ENT>
              <ENT>1.28</ENT>
              <ENT>0.98</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29590</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Application of foot splint</ENT>
              <ENT>0.76</ENT>
              <ENT>0.52</ENT>
              <ENT>0.30</ENT>
              <ENT>0.06</ENT>
              <ENT>1.34</ENT>
              <ENT>1.12</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal/revision of cast</ENT>
              <ENT>0.57</ENT>
              <ENT>0.88</ENT>
              <ENT>0.29</ENT>
              <ENT>0.07</ENT>
              <ENT>1.52</ENT>
              <ENT>0.93</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29705</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal/revision of cast</ENT>
              <ENT>0.76</ENT>
              <ENT>0.81</ENT>
              <ENT>0.39</ENT>
              <ENT>0.10</ENT>
              <ENT>1.67</ENT>
              <ENT>1.25</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29710</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal/revision of cast</ENT>
              <ENT>1.34</ENT>
              <ENT>1.51</ENT>
              <ENT>0.71</ENT>
              <ENT>0.17</ENT>
              <ENT>3.02</ENT>
              <ENT>2.22</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29715</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal/revision of cast</ENT>
              <ENT>0.94</ENT>
              <ENT>1.15</ENT>
              <ENT>0.41</ENT>
              <ENT>0.08</ENT>
              <ENT>2.17</ENT>
              <ENT>1.43</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29720</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of body cast</ENT>
              <ENT>0.68</ENT>
              <ENT>1.12</ENT>
              <ENT>0.39</ENT>
              <ENT>0.10</ENT>
              <ENT>1.90</ENT>
              <ENT>1.17</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29730</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Windowing of cast</ENT>
              <ENT>0.75</ENT>
              <ENT>0.80</ENT>
              <ENT>0.36</ENT>
              <ENT>0.10</ENT>
              <ENT>1.65</ENT>
              <ENT>1.21</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29740</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Wedging of cast</ENT>
              <ENT>1.12</ENT>
              <ENT>1.13</ENT>
              <ENT>0.50</ENT>
              <ENT>0.15</ENT>
              <ENT>2.40</ENT>
              <ENT>1.77</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29750</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Wedging of clubfoot cast</ENT>
              <ENT>1.26</ENT>
              <ENT>1.06</ENT>
              <ENT>0.59</ENT>
              <ENT>0.16</ENT>
              <ENT>2.48</ENT>
              <ENT>2.01</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29799</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Casting/strapping procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Jaw arthroscopy/surgery</ENT>
              <ENT>6.43</ENT>
              <ENT>N/A</ENT>
              <ENT>7.28</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>14.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29804</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Jaw arthroscopy/surgery</ENT>
              <ENT>8.14</ENT>
              <ENT>N/A</ENT>
              <ENT>8.75</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>17.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29805</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shoulder arthroscopy, dx</ENT>
              <ENT>5.89</ENT>
              <ENT>N/A</ENT>
              <ENT>5.82</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>12.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49108"/>
              <ENT I="01">29806</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shoulder arthroscopy/surgery</ENT>
              <ENT>14.37</ENT>
              <ENT>N/A</ENT>
              <ENT>11.30</ENT>
              <ENT>2.00</ENT>
              <ENT>N/A</ENT>
              <ENT>27.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29807</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shoulder arthroscopy/surgery</ENT>
              <ENT>13.90</ENT>
              <ENT>N/A</ENT>
              <ENT>11.12</ENT>
              <ENT>1.94</ENT>
              <ENT>N/A</ENT>
              <ENT>26.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29819</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shoulder arthroscopy/surgery</ENT>
              <ENT>7.62</ENT>
              <ENT>N/A</ENT>
              <ENT>6.73</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>15.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shoulder arthroscopy/surgery</ENT>
              <ENT>7.07</ENT>
              <ENT>N/A</ENT>
              <ENT>6.23</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>14.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29821</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shoulder arthroscopy/surgery</ENT>
              <ENT>7.72</ENT>
              <ENT>N/A</ENT>
              <ENT>6.75</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>15.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29822</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shoulder arthroscopy/surgery</ENT>
              <ENT>7.43</ENT>
              <ENT>N/A</ENT>
              <ENT>6.63</ENT>
              <ENT>1.04</ENT>
              <ENT>N/A</ENT>
              <ENT>15.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29823</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shoulder arthroscopy/surgery</ENT>
              <ENT>8.17</ENT>
              <ENT>N/A</ENT>
              <ENT>7.22</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>16.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29824</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shoulder arthroscopy/surgery</ENT>
              <ENT>8.25</ENT>
              <ENT>N/A</ENT>
              <ENT>7.47</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>16.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29825</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shoulder arthroscopy/surgery</ENT>
              <ENT>7.62</ENT>
              <ENT>N/A</ENT>
              <ENT>6.71</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>15.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29826</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Shoulder arthroscopy/surgery</ENT>
              <ENT>8.99</ENT>
              <ENT>N/A</ENT>
              <ENT>7.50</ENT>
              <ENT>1.26</ENT>
              <ENT>N/A</ENT>
              <ENT>17.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29827</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Arthroscop rotator cuff repr</ENT>
              <ENT>15.36</ENT>
              <ENT>N/A</ENT>
              <ENT>11.53</ENT>
              <ENT>1.86</ENT>
              <ENT>N/A</ENT>
              <ENT>28.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29830</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Elbow arthroscopy</ENT>
              <ENT>5.76</ENT>
              <ENT>N/A</ENT>
              <ENT>5.30</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>11.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29834</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Elbow arthroscopy/surgery</ENT>
              <ENT>6.28</ENT>
              <ENT>N/A</ENT>
              <ENT>5.83</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>12.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29835</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Elbow arthroscopy/surgery</ENT>
              <ENT>6.48</ENT>
              <ENT>N/A</ENT>
              <ENT>5.88</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>13.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29836</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Elbow arthroscopy/surgery</ENT>
              <ENT>7.55</ENT>
              <ENT>N/A</ENT>
              <ENT>6.73</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>15.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29837</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Elbow arthroscopy/surgery</ENT>
              <ENT>6.87</ENT>
              <ENT>N/A</ENT>
              <ENT>6.13</ENT>
              <ENT>0.96</ENT>
              <ENT>N/A</ENT>
              <ENT>13.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29838</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Elbow arthroscopy/surgery</ENT>
              <ENT>7.71</ENT>
              <ENT>N/A</ENT>
              <ENT>6.84</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>15.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29840</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Wrist arthroscopy</ENT>
              <ENT>5.54</ENT>
              <ENT>N/A</ENT>
              <ENT>5.34</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>11.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29843</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Wrist arthroscopy/surgery</ENT>
              <ENT>6.01</ENT>
              <ENT>N/A</ENT>
              <ENT>5.64</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>12.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29844</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Wrist arthroscopy/surgery</ENT>
              <ENT>6.37</ENT>
              <ENT>N/A</ENT>
              <ENT>5.82</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>13.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29845</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Wrist arthroscopy/surgery</ENT>
              <ENT>7.52</ENT>
              <ENT>N/A</ENT>
              <ENT>6.46</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>14.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29846</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Wrist arthroscopy/surgery</ENT>
              <ENT>6.75</ENT>
              <ENT>N/A</ENT>
              <ENT>6.06</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>13.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29847</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Wrist arthroscopy/surgery</ENT>
              <ENT>7.08</ENT>
              <ENT>N/A</ENT>
              <ENT>6.21</ENT>
              <ENT>0.91</ENT>
              <ENT>N/A</ENT>
              <ENT>14.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29848</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Wrist endoscopy/surgery</ENT>
              <ENT>5.44</ENT>
              <ENT>N/A</ENT>
              <ENT>5.59</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>11.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29850</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Knee arthroscopy/surgery</ENT>
              <ENT>8.19</ENT>
              <ENT>N/A</ENT>
              <ENT>5.13</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>14.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29851</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Knee arthroscopy/surgery</ENT>
              <ENT>13.10</ENT>
              <ENT>N/A</ENT>
              <ENT>9.85</ENT>
              <ENT>1.81</ENT>
              <ENT>N/A</ENT>
              <ENT>24.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29855</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tibial arthroscopy/surgery</ENT>
              <ENT>10.62</ENT>
              <ENT>N/A</ENT>
              <ENT>8.77</ENT>
              <ENT>1.50</ENT>
              <ENT>N/A</ENT>
              <ENT>20.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29856</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tibial arthroscopy/surgery</ENT>
              <ENT>14.14</ENT>
              <ENT>N/A</ENT>
              <ENT>10.71</ENT>
              <ENT>2.00</ENT>
              <ENT>N/A</ENT>
              <ENT>26.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29860</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hip arthroscopy, dx</ENT>
              <ENT>8.05</ENT>
              <ENT>N/A</ENT>
              <ENT>6.95</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>16.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29861</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hip arthroscopy/surgery</ENT>
              <ENT>9.15</ENT>
              <ENT>N/A</ENT>
              <ENT>7.36</ENT>
              <ENT>1.29</ENT>
              <ENT>N/A</ENT>
              <ENT>17.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29862</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hip arthroscopy/surgery</ENT>
              <ENT>9.90</ENT>
              <ENT>N/A</ENT>
              <ENT>8.55</ENT>
              <ENT>1.39</ENT>
              <ENT>N/A</ENT>
              <ENT>19.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29863</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hip arthroscopy/surgery</ENT>
              <ENT>9.90</ENT>
              <ENT>N/A</ENT>
              <ENT>8.49</ENT>
              <ENT>1.40</ENT>
              <ENT>N/A</ENT>
              <ENT>19.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29870</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Knee arthroscopy, dx</ENT>
              <ENT>5.07</ENT>
              <ENT>N/A</ENT>
              <ENT>4.84</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>10.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29871</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Knee arthroscopy/drainage</ENT>
              <ENT>6.55</ENT>
              <ENT>N/A</ENT>
              <ENT>5.87</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>13.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29873</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Knee arthroscopy/surgery</ENT>
              <ENT>6.00</ENT>
              <ENT>N/A</ENT>
              <ENT>6.49</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>13.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29874</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Knee arthroscopy/surgery</ENT>
              <ENT>7.05</ENT>
              <ENT>N/A</ENT>
              <ENT>6.08</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>14.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29875</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Knee arthroscopy/surgery</ENT>
              <ENT>6.31</ENT>
              <ENT>N/A</ENT>
              <ENT>5.84</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>13.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29876</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Knee arthroscopy/surgery</ENT>
              <ENT>7.92</ENT>
              <ENT>N/A</ENT>
              <ENT>7.01</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>16.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29877</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Knee arthroscopy/surgery</ENT>
              <ENT>7.35</ENT>
              <ENT>N/A</ENT>
              <ENT>6.72</ENT>
              <ENT>1.03</ENT>
              <ENT>N/A</ENT>
              <ENT>15.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29879</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Knee arthroscopy/surgery</ENT>
              <ENT>8.04</ENT>
              <ENT>N/A</ENT>
              <ENT>7.10</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>16.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29880</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Knee arthroscopy/surgery</ENT>
              <ENT>8.50</ENT>
              <ENT>N/A</ENT>
              <ENT>7.35</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>17.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29881</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Knee arthroscopy/surgery</ENT>
              <ENT>7.76</ENT>
              <ENT>N/A</ENT>
              <ENT>6.94</ENT>
              <ENT>1.09</ENT>
              <ENT>N/A</ENT>
              <ENT>15.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29882</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Knee arthroscopy/surgery</ENT>
              <ENT>8.65</ENT>
              <ENT>N/A</ENT>
              <ENT>7.24</ENT>
              <ENT>1.09</ENT>
              <ENT>N/A</ENT>
              <ENT>16.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29883</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Knee arthroscopy/surgery</ENT>
              <ENT>11.05</ENT>
              <ENT>N/A</ENT>
              <ENT>9.07</ENT>
              <ENT>1.33</ENT>
              <ENT>N/A</ENT>
              <ENT>21.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29884</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Knee arthroscopy/surgery</ENT>
              <ENT>7.33</ENT>
              <ENT>N/A</ENT>
              <ENT>6.68</ENT>
              <ENT>1.03</ENT>
              <ENT>N/A</ENT>
              <ENT>15.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29885</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Knee arthroscopy/surgery</ENT>
              <ENT>9.09</ENT>
              <ENT>N/A</ENT>
              <ENT>7.90</ENT>
              <ENT>1.27</ENT>
              <ENT>N/A</ENT>
              <ENT>18.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29886</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Knee arthroscopy/surgery</ENT>
              <ENT>7.54</ENT>
              <ENT>N/A</ENT>
              <ENT>6.82</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>15.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29887</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Knee arthroscopy/surgery</ENT>
              <ENT>9.04</ENT>
              <ENT>N/A</ENT>
              <ENT>7.87</ENT>
              <ENT>1.27</ENT>
              <ENT>N/A</ENT>
              <ENT>18.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29888</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Knee arthroscopy/surgery</ENT>
              <ENT>13.90</ENT>
              <ENT>N/A</ENT>
              <ENT>10.27</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>26.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29889</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Knee arthroscopy/surgery</ENT>
              <ENT>16.00</ENT>
              <ENT>N/A</ENT>
              <ENT>12.45</ENT>
              <ENT>2.11</ENT>
              <ENT>N/A</ENT>
              <ENT>30.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29891</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ankle arthroscopy/surgery</ENT>
              <ENT>8.40</ENT>
              <ENT>N/A</ENT>
              <ENT>7.48</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>17.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29892</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ankle arthroscopy/surgery</ENT>
              <ENT>9.00</ENT>
              <ENT>N/A</ENT>
              <ENT>7.73</ENT>
              <ENT>1.26</ENT>
              <ENT>N/A</ENT>
              <ENT>17.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29893</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Scope, plantar fasciotomy</ENT>
              <ENT>5.22</ENT>
              <ENT>6.44</ENT>
              <ENT>4.02</ENT>
              <ENT>0.74</ENT>
              <ENT>12.40</ENT>
              <ENT>9.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29894</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ankle arthroscopy/surgery</ENT>
              <ENT>7.21</ENT>
              <ENT>N/A</ENT>
              <ENT>5.49</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>13.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29895</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ankle arthroscopy/surgery</ENT>
              <ENT>6.99</ENT>
              <ENT>N/A</ENT>
              <ENT>5.49</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>13.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49109"/>
              <ENT I="01">29897</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ankle arthroscopy/surgery</ENT>
              <ENT>7.18</ENT>
              <ENT>N/A</ENT>
              <ENT>5.90</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>14.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29898</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ankle arthroscopy/surgery</ENT>
              <ENT>8.32</ENT>
              <ENT>N/A</ENT>
              <ENT>6.19</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>15.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29899</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ankle arthroscopy/surgery</ENT>
              <ENT>13.91</ENT>
              <ENT>N/A</ENT>
              <ENT>10.02</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>25.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29900</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mcp joint arthroscopy, dx</ENT>
              <ENT>5.42</ENT>
              <ENT>N/A</ENT>
              <ENT>5.95</ENT>
              <ENT>0.75</ENT>
              <ENT>N/A</ENT>
              <ENT>12.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29901</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mcp joint arthroscopy, surg</ENT>
              <ENT>6.13</ENT>
              <ENT>N/A</ENT>
              <ENT>6.34</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>13.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29902</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mcp joint arthroscopy, surg</ENT>
              <ENT>6.70</ENT>
              <ENT>N/A</ENT>
              <ENT>6.63</ENT>
              <ENT>0.93</ENT>
              <ENT>N/A</ENT>
              <ENT>14.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">29999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Arthroscopy of joint</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of nose lesion</ENT>
              <ENT>1.43</ENT>
              <ENT>4.27</ENT>
              <ENT>1.45</ENT>
              <ENT>0.10</ENT>
              <ENT>5.80</ENT>
              <ENT>2.98</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of nose lesion</ENT>
              <ENT>1.43</ENT>
              <ENT>3.43</ENT>
              <ENT>1.53</ENT>
              <ENT>0.08</ENT>
              <ENT>4.94</ENT>
              <ENT>3.04</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intranasal biopsy</ENT>
              <ENT>0.94</ENT>
              <ENT>2.16</ENT>
              <ENT>0.83</ENT>
              <ENT>0.06</ENT>
              <ENT>3.16</ENT>
              <ENT>1.83</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of nose polyp(s)</ENT>
              <ENT>1.63</ENT>
              <ENT>3.48</ENT>
              <ENT>1.63</ENT>
              <ENT>0.12</ENT>
              <ENT>5.23</ENT>
              <ENT>3.38</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30115</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of nose polyp(s)</ENT>
              <ENT>4.35</ENT>
              <ENT>N/A</ENT>
              <ENT>4.19</ENT>
              <ENT>0.31</ENT>
              <ENT>N/A</ENT>
              <ENT>8.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30117</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of intranasal lesion</ENT>
              <ENT>3.16</ENT>
              <ENT>4.79</ENT>
              <ENT>3.40</ENT>
              <ENT>0.22</ENT>
              <ENT>8.17</ENT>
              <ENT>6.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30118</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of intranasal lesion</ENT>
              <ENT>9.69</ENT>
              <ENT>N/A</ENT>
              <ENT>7.53</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>17.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of nose</ENT>
              <ENT>5.27</ENT>
              <ENT>5.71</ENT>
              <ENT>5.63</ENT>
              <ENT>0.41</ENT>
              <ENT>11.39</ENT>
              <ENT>11.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30124</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of nose lesion</ENT>
              <ENT>3.10</ENT>
              <ENT>N/A</ENT>
              <ENT>3.12</ENT>
              <ENT>0.20</ENT>
              <ENT>N/A</ENT>
              <ENT>6.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30125</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of nose lesion</ENT>
              <ENT>7.16</ENT>
              <ENT>N/A</ENT>
              <ENT>6.10</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>13.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of turbinate bones</ENT>
              <ENT>3.38</ENT>
              <ENT>N/A</ENT>
              <ENT>3.67</ENT>
              <ENT>0.22</ENT>
              <ENT>N/A</ENT>
              <ENT>7.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of turbinate bones</ENT>
              <ENT>3.43</ENT>
              <ENT>N/A</ENT>
              <ENT>4.16</ENT>
              <ENT>0.24</ENT>
              <ENT>N/A</ENT>
              <ENT>7.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of nose</ENT>
              <ENT>9.14</ENT>
              <ENT>N/A</ENT>
              <ENT>7.88</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>17.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30160</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of nose</ENT>
              <ENT>9.58</ENT>
              <ENT>N/A</ENT>
              <ENT>7.89</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>18.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection treatment of nose</ENT>
              <ENT>0.78</ENT>
              <ENT>1.79</ENT>
              <ENT>0.79</ENT>
              <ENT>0.06</ENT>
              <ENT>2.63</ENT>
              <ENT>1.63</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30210</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nasal sinus therapy</ENT>
              <ENT>1.08</ENT>
              <ENT>2.22</ENT>
              <ENT>1.36</ENT>
              <ENT>0.08</ENT>
              <ENT>3.38</ENT>
              <ENT>2.52</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert nasal septal button</ENT>
              <ENT>1.54</ENT>
              <ENT>4.67</ENT>
              <ENT>1.59</ENT>
              <ENT>0.11</ENT>
              <ENT>6.32</ENT>
              <ENT>3.24</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove nasal foreign body</ENT>
              <ENT>1.04</ENT>
              <ENT>4.27</ENT>
              <ENT>1.91</ENT>
              <ENT>0.07</ENT>
              <ENT>5.38</ENT>
              <ENT>3.02</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30310</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove nasal foreign body</ENT>
              <ENT>1.96</ENT>
              <ENT>N/A</ENT>
              <ENT>2.93</ENT>
              <ENT>0.14</ENT>
              <ENT>N/A</ENT>
              <ENT>5.03</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove nasal foreign body</ENT>
              <ENT>4.52</ENT>
              <ENT>N/A</ENT>
              <ENT>4.65</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>9.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30400</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Reconstruction of nose</ENT>
              <ENT>9.83</ENT>
              <ENT>N/A</ENT>
              <ENT>9.35</ENT>
              <ENT>0.80</ENT>
              <ENT>N/A</ENT>
              <ENT>19.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30410</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Reconstruction of nose</ENT>
              <ENT>12.98</ENT>
              <ENT>N/A</ENT>
              <ENT>11.13</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>25.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30420</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Reconstruction of nose</ENT>
              <ENT>15.88</ENT>
              <ENT>N/A</ENT>
              <ENT>12.70</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>29.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30430</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Revision of nose</ENT>
              <ENT>7.21</ENT>
              <ENT>N/A</ENT>
              <ENT>8.16</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>15.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30435</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Revision of nose</ENT>
              <ENT>11.71</ENT>
              <ENT>N/A</ENT>
              <ENT>10.78</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>23.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30450</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Revision of nose</ENT>
              <ENT>18.65</ENT>
              <ENT>N/A</ENT>
              <ENT>14.35</ENT>
              <ENT>1.53</ENT>
              <ENT>N/A</ENT>
              <ENT>34.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30460</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of nose</ENT>
              <ENT>9.96</ENT>
              <ENT>N/A</ENT>
              <ENT>8.07</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>18.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30462</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of nose</ENT>
              <ENT>19.57</ENT>
              <ENT>N/A</ENT>
              <ENT>14.00</ENT>
              <ENT>1.92</ENT>
              <ENT>N/A</ENT>
              <ENT>35.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30465</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair nasal stenosis</ENT>
              <ENT>11.64</ENT>
              <ENT>N/A</ENT>
              <ENT>7.88</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>20.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of nasal septum</ENT>
              <ENT>5.70</ENT>
              <ENT>N/A</ENT>
              <ENT>5.37</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>11.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30540</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair nasal defect</ENT>
              <ENT>7.75</ENT>
              <ENT>N/A</ENT>
              <ENT>5.81</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>14.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30545</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair nasal defect</ENT>
              <ENT>11.38</ENT>
              <ENT>N/A</ENT>
              <ENT>8.93</ENT>
              <ENT>0.80</ENT>
              <ENT>N/A</ENT>
              <ENT>21.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30560</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release of nasal adhesions</ENT>
              <ENT>1.26</ENT>
              <ENT>4.38</ENT>
              <ENT>1.99</ENT>
              <ENT>0.09</ENT>
              <ENT>5.73</ENT>
              <ENT>3.34</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30580</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair upper jaw fistula</ENT>
              <ENT>6.69</ENT>
              <ENT>7.43</ENT>
              <ENT>6.34</ENT>
              <ENT>0.50</ENT>
              <ENT>14.62</ENT>
              <ENT>13.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair mouth/nose fistula</ENT>
              <ENT>6.02</ENT>
              <ENT>6.51</ENT>
              <ENT>5.69</ENT>
              <ENT>0.70</ENT>
              <ENT>13.23</ENT>
              <ENT>12.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30620</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intranasal reconstruction</ENT>
              <ENT>5.97</ENT>
              <ENT>N/A</ENT>
              <ENT>6.01</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>12.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30630</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair nasal septum defect</ENT>
              <ENT>7.12</ENT>
              <ENT>N/A</ENT>
              <ENT>6.43</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>14.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30801</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cauterization, inner nose</ENT>
              <ENT>1.09</ENT>
              <ENT>2.29</ENT>
              <ENT>2.17</ENT>
              <ENT>0.08</ENT>
              <ENT>3.46</ENT>
              <ENT>3.34</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30802</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cauterization, inner nose</ENT>
              <ENT>2.03</ENT>
              <ENT>2.85</ENT>
              <ENT>2.70</ENT>
              <ENT>0.15</ENT>
              <ENT>5.03</ENT>
              <ENT>4.88</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30901</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Control of nosebleed</ENT>
              <ENT>1.21</ENT>
              <ENT>1.41</ENT>
              <ENT>0.33</ENT>
              <ENT>0.09</ENT>
              <ENT>2.71</ENT>
              <ENT>1.63</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30903</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Control of nosebleed</ENT>
              <ENT>1.54</ENT>
              <ENT>2.92</ENT>
              <ENT>0.51</ENT>
              <ENT>0.12</ENT>
              <ENT>4.58</ENT>
              <ENT>2.17</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30905</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Control of nosebleed</ENT>
              <ENT>1.97</ENT>
              <ENT>3.73</ENT>
              <ENT>0.78</ENT>
              <ENT>0.15</ENT>
              <ENT>5.85</ENT>
              <ENT>2.90</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30906</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repeat control of nosebleed</ENT>
              <ENT>2.45</ENT>
              <ENT>4.12</ENT>
              <ENT>1.23</ENT>
              <ENT>0.17</ENT>
              <ENT>6.74</ENT>
              <ENT>3.85</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30915</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ligation, nasal sinus artery</ENT>
              <ENT>7.20</ENT>
              <ENT>N/A</ENT>
              <ENT>6.07</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>13.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30920</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ligation, upper jaw artery</ENT>
              <ENT>9.83</ENT>
              <ENT>N/A</ENT>
              <ENT>7.76</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>18.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30930</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Therapy, fracture of nose</ENT>
              <ENT>1.26</ENT>
              <ENT>N/A</ENT>
              <ENT>1.69</ENT>
              <ENT>0.09</ENT>
              <ENT>N/A</ENT>
              <ENT>3.04</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">30999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Nasal surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49110"/>
              <ENT I="01">31000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Irrigation, maxillary sinus</ENT>
              <ENT>1.15</ENT>
              <ENT>2.99</ENT>
              <ENT>1.46</ENT>
              <ENT>0.08</ENT>
              <ENT>4.22</ENT>
              <ENT>2.69</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31002</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Irrigation, sphenoid sinus</ENT>
              <ENT>1.91</ENT>
              <ENT>N/A</ENT>
              <ENT>3.10</ENT>
              <ENT>0.14</ENT>
              <ENT>N/A</ENT>
              <ENT>5.15</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration, maxillary sinus</ENT>
              <ENT>2.94</ENT>
              <ENT>4.31</ENT>
              <ENT>3.66</ENT>
              <ENT>0.20</ENT>
              <ENT>7.45</ENT>
              <ENT>6.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31030</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration, maxillary sinus</ENT>
              <ENT>5.92</ENT>
              <ENT>5.82</ENT>
              <ENT>4.95</ENT>
              <ENT>0.42</ENT>
              <ENT>12.16</ENT>
              <ENT>11.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31032</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore sinus, remove polyps</ENT>
              <ENT>6.57</ENT>
              <ENT>N/A</ENT>
              <ENT>5.82</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>12.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31040</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration behind upper jaw</ENT>
              <ENT>9.42</ENT>
              <ENT>N/A</ENT>
              <ENT>6.44</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>16.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31050</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration, sphenoid sinus</ENT>
              <ENT>5.28</ENT>
              <ENT>N/A</ENT>
              <ENT>4.68</ENT>
              <ENT>0.39</ENT>
              <ENT>N/A</ENT>
              <ENT>10.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31051</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sphenoid sinus surgery</ENT>
              <ENT>7.11</ENT>
              <ENT>N/A</ENT>
              <ENT>6.08</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>13.74</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31070</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of frontal sinus</ENT>
              <ENT>4.28</ENT>
              <ENT>N/A</ENT>
              <ENT>4.40</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>8.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31075</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of frontal sinus</ENT>
              <ENT>9.16</ENT>
              <ENT>N/A</ENT>
              <ENT>7.48</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>17.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31080</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of frontal sinus</ENT>
              <ENT>11.42</ENT>
              <ENT>N/A</ENT>
              <ENT>8.68</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>20.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31081</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of frontal sinus</ENT>
              <ENT>12.75</ENT>
              <ENT>N/A</ENT>
              <ENT>9.70</ENT>
              <ENT>1.84</ENT>
              <ENT>N/A</ENT>
              <ENT>24.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31084</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of frontal sinus</ENT>
              <ENT>13.51</ENT>
              <ENT>N/A</ENT>
              <ENT>10.36</ENT>
              <ENT>0.96</ENT>
              <ENT>N/A</ENT>
              <ENT>24.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31085</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of frontal sinus</ENT>
              <ENT>14.20</ENT>
              <ENT>N/A</ENT>
              <ENT>10.72</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>26.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31086</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of frontal sinus</ENT>
              <ENT>12.86</ENT>
              <ENT>N/A</ENT>
              <ENT>10.18</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>23.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31087</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of frontal sinus</ENT>
              <ENT>13.10</ENT>
              <ENT>N/A</ENT>
              <ENT>10.10</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>24.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31090</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of sinuses</ENT>
              <ENT>9.53</ENT>
              <ENT>N/A</ENT>
              <ENT>8.91</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>19.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of ethmoid sinus</ENT>
              <ENT>4.97</ENT>
              <ENT>N/A</ENT>
              <ENT>5.15</ENT>
              <ENT>0.25</ENT>
              <ENT>N/A</ENT>
              <ENT>10.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31201</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of ethmoid sinus</ENT>
              <ENT>8.37</ENT>
              <ENT>N/A</ENT>
              <ENT>7.09</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>16.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31205</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of ethmoid sinus</ENT>
              <ENT>10.24</ENT>
              <ENT>N/A</ENT>
              <ENT>7.83</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>18.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31225</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of upper jaw</ENT>
              <ENT>19.23</ENT>
              <ENT>N/A</ENT>
              <ENT>14.19</ENT>
              <ENT>1.38</ENT>
              <ENT>N/A</ENT>
              <ENT>34.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31230</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of upper jaw</ENT>
              <ENT>21.94</ENT>
              <ENT>N/A</ENT>
              <ENT>15.60</ENT>
              <ENT>1.57</ENT>
              <ENT>N/A</ENT>
              <ENT>39.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31231</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nasal endoscopy, dx</ENT>
              <ENT>1.10</ENT>
              <ENT>2.92</ENT>
              <ENT>0.93</ENT>
              <ENT>0.08</ENT>
              <ENT>4.10</ENT>
              <ENT>2.11</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31233</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nasal/sinus endoscopy, dx</ENT>
              <ENT>2.18</ENT>
              <ENT>3.67</ENT>
              <ENT>1.54</ENT>
              <ENT>0.16</ENT>
              <ENT>6.01</ENT>
              <ENT>3.88</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31235</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nasal/sinus endoscopy, dx</ENT>
              <ENT>2.64</ENT>
              <ENT>4.13</ENT>
              <ENT>1.79</ENT>
              <ENT>0.18</ENT>
              <ENT>6.95</ENT>
              <ENT>4.61</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31237</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nasal/sinus endoscopy, surg</ENT>
              <ENT>2.98</ENT>
              <ENT>4.41</ENT>
              <ENT>1.95</ENT>
              <ENT>0.21</ENT>
              <ENT>7.60</ENT>
              <ENT>5.14</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31238</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nasal/sinus endoscopy, surg</ENT>
              <ENT>3.26</ENT>
              <ENT>4.42</ENT>
              <ENT>2.16</ENT>
              <ENT>0.23</ENT>
              <ENT>7.91</ENT>
              <ENT>5.65</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31239</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nasal/sinus endoscopy, surg</ENT>
              <ENT>8.70</ENT>
              <ENT>N/A</ENT>
              <ENT>7.86</ENT>
              <ENT>0.46</ENT>
              <ENT>N/A</ENT>
              <ENT>17.02</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31240</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nasal/sinus endoscopy, surg</ENT>
              <ENT>2.61</ENT>
              <ENT>N/A</ENT>
              <ENT>1.79</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>4.58</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31254</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of ethmoid sinus</ENT>
              <ENT>4.65</ENT>
              <ENT>N/A</ENT>
              <ENT>2.94</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>7.91</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31255</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of ethmoid sinus</ENT>
              <ENT>6.96</ENT>
              <ENT>N/A</ENT>
              <ENT>4.24</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>11.69</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31256</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration maxillary sinus</ENT>
              <ENT>3.29</ENT>
              <ENT>N/A</ENT>
              <ENT>2.19</ENT>
              <ENT>0.23</ENT>
              <ENT>N/A</ENT>
              <ENT>5.71</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31267</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endoscopy, maxillary sinus</ENT>
              <ENT>5.46</ENT>
              <ENT>N/A</ENT>
              <ENT>3.40</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>9.24</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31276</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sinus endoscopy, surgical</ENT>
              <ENT>8.85</ENT>
              <ENT>N/A</ENT>
              <ENT>5.27</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>14.74</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31287</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nasal/sinus endoscopy, surg</ENT>
              <ENT>3.92</ENT>
              <ENT>N/A</ENT>
              <ENT>2.54</ENT>
              <ENT>0.27</ENT>
              <ENT>N/A</ENT>
              <ENT>6.73</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31288</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nasal/sinus endoscopy, surg</ENT>
              <ENT>4.58</ENT>
              <ENT>N/A</ENT>
              <ENT>2.91</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>7.81</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31290</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nasal/sinus endoscopy, surg</ENT>
              <ENT>17.24</ENT>
              <ENT>N/A</ENT>
              <ENT>11.74</ENT>
              <ENT>1.20</ENT>
              <ENT>N/A</ENT>
              <ENT>30.18</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31291</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nasal/sinus endoscopy, surg</ENT>
              <ENT>18.19</ENT>
              <ENT>N/A</ENT>
              <ENT>12.23</ENT>
              <ENT>1.73</ENT>
              <ENT>N/A</ENT>
              <ENT>32.15</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31292</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nasal/sinus endoscopy, surg</ENT>
              <ENT>14.76</ENT>
              <ENT>N/A</ENT>
              <ENT>10.33</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>26.08</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31293</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nasal/sinus endoscopy, surg</ENT>
              <ENT>16.21</ENT>
              <ENT>N/A</ENT>
              <ENT>11.16</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>28.34</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31294</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nasal/sinus endoscopy, surg</ENT>
              <ENT>19.06</ENT>
              <ENT>N/A</ENT>
              <ENT>12.69</ENT>
              <ENT>1.04</ENT>
              <ENT>N/A</ENT>
              <ENT>32.79</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31299</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Sinus surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of larynx lesion</ENT>
              <ENT>14.29</ENT>
              <ENT>N/A</ENT>
              <ENT>12.71</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>27.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Diagnostic incision, larynx</ENT>
              <ENT>5.26</ENT>
              <ENT>N/A</ENT>
              <ENT>7.77</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>13.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31360</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of larynx</ENT>
              <ENT>17.08</ENT>
              <ENT>N/A</ENT>
              <ENT>14.71</ENT>
              <ENT>1.20</ENT>
              <ENT>N/A</ENT>
              <ENT>32.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31365</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of larynx</ENT>
              <ENT>24.16</ENT>
              <ENT>N/A</ENT>
              <ENT>18.45</ENT>
              <ENT>1.72</ENT>
              <ENT>N/A</ENT>
              <ENT>44.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31367</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of larynx</ENT>
              <ENT>21.86</ENT>
              <ENT>N/A</ENT>
              <ENT>18.32</ENT>
              <ENT>1.57</ENT>
              <ENT>N/A</ENT>
              <ENT>41.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31368</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of larynx</ENT>
              <ENT>27.09</ENT>
              <ENT>N/A</ENT>
              <ENT>22.10</ENT>
              <ENT>1.90</ENT>
              <ENT>N/A</ENT>
              <ENT>51.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31370</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of larynx</ENT>
              <ENT>21.38</ENT>
              <ENT>N/A</ENT>
              <ENT>17.91</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>40.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49111"/>
              <ENT I="01">31375</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of larynx</ENT>
              <ENT>20.21</ENT>
              <ENT>N/A</ENT>
              <ENT>16.14</ENT>
              <ENT>1.43</ENT>
              <ENT>N/A</ENT>
              <ENT>37.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31380</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of larynx</ENT>
              <ENT>20.21</ENT>
              <ENT>N/A</ENT>
              <ENT>16.08</ENT>
              <ENT>1.40</ENT>
              <ENT>N/A</ENT>
              <ENT>37.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31382</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of larynx</ENT>
              <ENT>20.52</ENT>
              <ENT>N/A</ENT>
              <ENT>17.46</ENT>
              <ENT>1.44</ENT>
              <ENT>N/A</ENT>
              <ENT>39.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31390</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of larynx &amp; pharynx</ENT>
              <ENT>27.53</ENT>
              <ENT>N/A</ENT>
              <ENT>22.31</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>51.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31395</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct larynx &amp; pharynx</ENT>
              <ENT>31.09</ENT>
              <ENT>N/A</ENT>
              <ENT>26.49</ENT>
              <ENT>2.27</ENT>
              <ENT>N/A</ENT>
              <ENT>59.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of larynx</ENT>
              <ENT>10.31</ENT>
              <ENT>N/A</ENT>
              <ENT>10.68</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>21.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of epiglottis</ENT>
              <ENT>10.22</ENT>
              <ENT>N/A</ENT>
              <ENT>10.51</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>21.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert emergency airway</ENT>
              <ENT>2.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.67</ENT>
              <ENT>0.15</ENT>
              <ENT>N/A</ENT>
              <ENT>3.15</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31502</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Change of windpipe airway</ENT>
              <ENT>0.65</ENT>
              <ENT>1.52</ENT>
              <ENT>0.26</ENT>
              <ENT>0.04</ENT>
              <ENT>2.21</ENT>
              <ENT>0.95</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31505</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Diagnostic laryngoscopy</ENT>
              <ENT>0.61</ENT>
              <ENT>1.52</ENT>
              <ENT>0.64</ENT>
              <ENT>0.04</ENT>
              <ENT>2.17</ENT>
              <ENT>1.29</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laryngoscopy with biopsy</ENT>
              <ENT>1.92</ENT>
              <ENT>3.36</ENT>
              <ENT>1.31</ENT>
              <ENT>0.15</ENT>
              <ENT>5.43</ENT>
              <ENT>3.38</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31511</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove foreign body, larynx</ENT>
              <ENT>2.16</ENT>
              <ENT>3.19</ENT>
              <ENT>1.13</ENT>
              <ENT>0.16</ENT>
              <ENT>5.51</ENT>
              <ENT>3.45</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31512</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of larynx lesion</ENT>
              <ENT>2.07</ENT>
              <ENT>3.26</ENT>
              <ENT>1.42</ENT>
              <ENT>0.16</ENT>
              <ENT>5.49</ENT>
              <ENT>3.65</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31513</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection into vocal cord</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>1.52</ENT>
              <ENT>0.15</ENT>
              <ENT>N/A</ENT>
              <ENT>3.77</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31515</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laryngoscopy for aspiration</ENT>
              <ENT>1.80</ENT>
              <ENT>3.41</ENT>
              <ENT>1.11</ENT>
              <ENT>0.12</ENT>
              <ENT>5.33</ENT>
              <ENT>3.03</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Diagnostic laryngoscopy</ENT>
              <ENT>2.56</ENT>
              <ENT>N/A</ENT>
              <ENT>1.63</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>4.36</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31525</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Diagnostic laryngoscopy</ENT>
              <ENT>2.63</ENT>
              <ENT>3.61</ENT>
              <ENT>1.72</ENT>
              <ENT>0.18</ENT>
              <ENT>6.42</ENT>
              <ENT>4.53</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31526</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Diagnostic laryngoscopy</ENT>
              <ENT>2.57</ENT>
              <ENT>N/A</ENT>
              <ENT>1.78</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>4.53</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31527</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laryngoscopy for treatment</ENT>
              <ENT>3.27</ENT>
              <ENT>N/A</ENT>
              <ENT>1.94</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>5.42</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31528</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laryngoscopy and dilation</ENT>
              <ENT>2.37</ENT>
              <ENT>N/A</ENT>
              <ENT>1.47</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>4.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31529</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laryngoscopy and dilation</ENT>
              <ENT>2.68</ENT>
              <ENT>N/A</ENT>
              <ENT>1.75</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>4.61</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Operative laryngoscopy</ENT>
              <ENT>3.39</ENT>
              <ENT>N/A</ENT>
              <ENT>2.01</ENT>
              <ENT>0.24</ENT>
              <ENT>N/A</ENT>
              <ENT>5.64</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31531</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Operative laryngoscopy</ENT>
              <ENT>3.59</ENT>
              <ENT>N/A</ENT>
              <ENT>2.36</ENT>
              <ENT>0.25</ENT>
              <ENT>N/A</ENT>
              <ENT>6.20</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31535</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Operative laryngoscopy</ENT>
              <ENT>3.16</ENT>
              <ENT>N/A</ENT>
              <ENT>2.06</ENT>
              <ENT>0.22</ENT>
              <ENT>N/A</ENT>
              <ENT>5.44</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31536</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Operative laryngoscopy</ENT>
              <ENT>3.56</ENT>
              <ENT>N/A</ENT>
              <ENT>2.33</ENT>
              <ENT>0.25</ENT>
              <ENT>N/A</ENT>
              <ENT>6.14</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31540</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Operative laryngoscopy</ENT>
              <ENT>4.13</ENT>
              <ENT>N/A</ENT>
              <ENT>2.63</ENT>
              <ENT>0.29</ENT>
              <ENT>N/A</ENT>
              <ENT>7.05</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31541</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Operative laryngoscopy</ENT>
              <ENT>4.53</ENT>
              <ENT>N/A</ENT>
              <ENT>2.87</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>7.72</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31560</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Operative laryngoscopy</ENT>
              <ENT>5.46</ENT>
              <ENT>N/A</ENT>
              <ENT>3.22</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>9.06</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31561</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Operative laryngoscopy</ENT>
              <ENT>6.00</ENT>
              <ENT>N/A</ENT>
              <ENT>3.44</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>9.86</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31570</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laryngoscopy with injection</ENT>
              <ENT>3.87</ENT>
              <ENT>5.44</ENT>
              <ENT>2.47</ENT>
              <ENT>0.24</ENT>
              <ENT>9.55</ENT>
              <ENT>6.58</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31571</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laryngoscopy with injection</ENT>
              <ENT>4.27</ENT>
              <ENT>N/A</ENT>
              <ENT>2.69</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>7.26</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31575</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Diagnostic laryngoscopy</ENT>
              <ENT>1.10</ENT>
              <ENT>1.95</ENT>
              <ENT>0.92</ENT>
              <ENT>0.08</ENT>
              <ENT>3.13</ENT>
              <ENT>2.10</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31576</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laryngoscopy with biopsy</ENT>
              <ENT>1.97</ENT>
              <ENT>3.52</ENT>
              <ENT>1.34</ENT>
              <ENT>0.13</ENT>
              <ENT>5.62</ENT>
              <ENT>3.44</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31577</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove foreign body, larynx</ENT>
              <ENT>2.47</ENT>
              <ENT>3.65</ENT>
              <ENT>1.60</ENT>
              <ENT>0.17</ENT>
              <ENT>6.29</ENT>
              <ENT>4.24</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31578</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of larynx lesion</ENT>
              <ENT>2.84</ENT>
              <ENT>4.15</ENT>
              <ENT>1.59</ENT>
              <ENT>0.20</ENT>
              <ENT>7.19</ENT>
              <ENT>4.63</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31579</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Diagnostic laryngoscopy</ENT>
              <ENT>2.26</ENT>
              <ENT>3.30</ENT>
              <ENT>1.55</ENT>
              <ENT>0.16</ENT>
              <ENT>5.72</ENT>
              <ENT>3.97</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31580</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of larynx</ENT>
              <ENT>12.38</ENT>
              <ENT>N/A</ENT>
              <ENT>11.78</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>25.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31582</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of larynx</ENT>
              <ENT>21.62</ENT>
              <ENT>N/A</ENT>
              <ENT>18.17</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>41.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31584</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat larynx fracture</ENT>
              <ENT>19.64</ENT>
              <ENT>N/A</ENT>
              <ENT>15.25</ENT>
              <ENT>1.42</ENT>
              <ENT>N/A</ENT>
              <ENT>36.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31585</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat larynx fracture</ENT>
              <ENT>4.64</ENT>
              <ENT>N/A</ENT>
              <ENT>6.01</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>10.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31586</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat larynx fracture</ENT>
              <ENT>8.03</ENT>
              <ENT>N/A</ENT>
              <ENT>8.90</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>17.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31587</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of larynx</ENT>
              <ENT>11.99</ENT>
              <ENT>N/A</ENT>
              <ENT>10.61</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>23.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31588</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of larynx</ENT>
              <ENT>13.11</ENT>
              <ENT>N/A</ENT>
              <ENT>13.80</ENT>
              <ENT>0.92</ENT>
              <ENT>N/A</ENT>
              <ENT>27.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31590</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reinnervate larynx</ENT>
              <ENT>6.97</ENT>
              <ENT>N/A</ENT>
              <ENT>9.29</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>16.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31595</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Larynx nerve surgery</ENT>
              <ENT>8.34</ENT>
              <ENT>N/A</ENT>
              <ENT>8.09</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>17.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31599</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Larynx surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of windpipe</ENT>
              <ENT>7.18</ENT>
              <ENT>N/A</ENT>
              <ENT>3.24</ENT>
              <ENT>0.34</ENT>
              <ENT>N/A</ENT>
              <ENT>10.76</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31601</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of windpipe</ENT>
              <ENT>4.45</ENT>
              <ENT>N/A</ENT>
              <ENT>2.44</ENT>
              <ENT>0.39</ENT>
              <ENT>N/A</ENT>
              <ENT>7.28</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31603</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of windpipe</ENT>
              <ENT>4.15</ENT>
              <ENT>N/A</ENT>
              <ENT>1.75</ENT>
              <ENT>0.35</ENT>
              <ENT>N/A</ENT>
              <ENT>6.25</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of windpipe</ENT>
              <ENT>3.58</ENT>
              <ENT>N/A</ENT>
              <ENT>1.21</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>5.12</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31610</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of windpipe</ENT>
              <ENT>8.76</ENT>
              <ENT>N/A</ENT>
              <ENT>7.72</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>17.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31611</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Surgery/speech prosthesis</ENT>
              <ENT>5.64</ENT>
              <ENT>N/A</ENT>
              <ENT>6.31</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>12.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31612</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Puncture/clear windpipe</ENT>
              <ENT>0.91</ENT>
              <ENT>1.16</ENT>
              <ENT>0.36</ENT>
              <ENT>0.06</ENT>
              <ENT>2.13</ENT>
              <ENT>1.33</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31613</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair windpipe opening</ENT>
              <ENT>4.59</ENT>
              <ENT>N/A</ENT>
              <ENT>5.60</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>10.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31614</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair windpipe opening</ENT>
              <ENT>7.12</ENT>
              <ENT>N/A</ENT>
              <ENT>8.18</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>15.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31615</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Visualization of windpipe</ENT>
              <ENT>2.09</ENT>
              <ENT>2.68</ENT>
              <ENT>1.22</ENT>
              <ENT>0.14</ENT>
              <ENT>4.91</ENT>
              <ENT>3.45</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31622</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dx bronchoscope/wash</ENT>
              <ENT>2.78</ENT>
              <ENT>4.30</ENT>
              <ENT>0.90</ENT>
              <ENT>0.14</ENT>
              <ENT>7.22</ENT>
              <ENT>3.82</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49112"/>
              <ENT I="01">31623</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dx bronchoscope/brush</ENT>
              <ENT>2.88</ENT>
              <ENT>5.16</ENT>
              <ENT>0.91</ENT>
              <ENT>0.14</ENT>
              <ENT>8.18</ENT>
              <ENT>3.93</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31624</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dx bronchoscope/lavage</ENT>
              <ENT>2.88</ENT>
              <ENT>4.37</ENT>
              <ENT>0.91</ENT>
              <ENT>0.13</ENT>
              <ENT>7.38</ENT>
              <ENT>3.92</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31625</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bronchoscopy w/biopsy(s)</ENT>
              <ENT>3.37</ENT>
              <ENT>9.22</ENT>
              <ENT>1.06</ENT>
              <ENT>0.16</ENT>
              <ENT>12.75</ENT>
              <ENT>4.59</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31628</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bronchoscopy/lung bx, each</ENT>
              <ENT>3.81</ENT>
              <ENT>3.05</ENT>
              <ENT>1.40</ENT>
              <ENT>0.14</ENT>
              <ENT>7.00</ENT>
              <ENT>5.35</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31629</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bronchoscopy/needle bx, each</ENT>
              <ENT>3.37</ENT>
              <ENT>N/A</ENT>
              <ENT>1.28</ENT>
              <ENT>0.13</ENT>
              <ENT>N/A</ENT>
              <ENT>4.78</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31630</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bronchoscopy dilate/fx repr</ENT>
              <ENT>3.82</ENT>
              <ENT>N/A</ENT>
              <ENT>2.00</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>6.12</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31631</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bronchoscopy, dilate w/stent</ENT>
              <ENT>4.37</ENT>
              <ENT>N/A</ENT>
              <ENT>2.03</ENT>
              <ENT>0.31</ENT>
              <ENT>N/A</ENT>
              <ENT>6.71</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31635</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bronchoscopy w/fb removal</ENT>
              <ENT>3.68</ENT>
              <ENT>N/A</ENT>
              <ENT>1.69</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>5.58</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31640</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bronchoscopy w/tumor excise</ENT>
              <ENT>4.94</ENT>
              <ENT>N/A</ENT>
              <ENT>2.35</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>7.66</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31641</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bronchoscopy, treat blockage</ENT>
              <ENT>5.03</ENT>
              <ENT>N/A</ENT>
              <ENT>2.14</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>7.47</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31643</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Diag bronchoscope/catheter</ENT>
              <ENT>3.50</ENT>
              <ENT>N/A</ENT>
              <ENT>1.33</ENT>
              <ENT>0.15</ENT>
              <ENT>N/A</ENT>
              <ENT>4.98</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31645</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bronchoscopy, clear airways</ENT>
              <ENT>3.16</ENT>
              <ENT>N/A</ENT>
              <ENT>1.22</ENT>
              <ENT>0.13</ENT>
              <ENT>N/A</ENT>
              <ENT>4.51</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31646</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bronchoscopy, reclear airway</ENT>
              <ENT>2.72</ENT>
              <ENT>N/A</ENT>
              <ENT>1.09</ENT>
              <ENT>0.12</ENT>
              <ENT>N/A</ENT>
              <ENT>3.93</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31656</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bronchoscopy, inj for x-ray</ENT>
              <ENT>2.17</ENT>
              <ENT>N/A</ENT>
              <ENT>0.93</ENT>
              <ENT>0.10</ENT>
              <ENT>N/A</ENT>
              <ENT>3.20</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of airway catheter</ENT>
              <ENT>1.34</ENT>
              <ENT>2.12</ENT>
              <ENT>0.69</ENT>
              <ENT>0.07</ENT>
              <ENT>3.53</ENT>
              <ENT>2.10</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31708</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Instill airway contrast dye</ENT>
              <ENT>1.41</ENT>
              <ENT>N/A</ENT>
              <ENT>0.59</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>2.06</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31710</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of airway catheter</ENT>
              <ENT>1.30</ENT>
              <ENT>N/A</ENT>
              <ENT>0.71</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>2.07</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31715</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection for bronchus x-ray</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>0.60</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>1.77</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31717</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bronchial brush biopsy</ENT>
              <ENT>2.12</ENT>
              <ENT>2.92</ENT>
              <ENT>0.88</ENT>
              <ENT>0.09</ENT>
              <ENT>5.13</ENT>
              <ENT>3.09</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31720</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Clearance of airways</ENT>
              <ENT>1.06</ENT>
              <ENT>1.51</ENT>
              <ENT>0.33</ENT>
              <ENT>0.06</ENT>
              <ENT>2.63</ENT>
              <ENT>1.45</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31725</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Clearance of airways</ENT>
              <ENT>1.96</ENT>
              <ENT>1.82</ENT>
              <ENT>0.59</ENT>
              <ENT>0.10</ENT>
              <ENT>3.88</ENT>
              <ENT>2.65</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31730</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intro, windpipe wire/tube</ENT>
              <ENT>2.85</ENT>
              <ENT>2.27</ENT>
              <ENT>1.10</ENT>
              <ENT>0.15</ENT>
              <ENT>5.27</ENT>
              <ENT>4.10</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31750</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of windpipe</ENT>
              <ENT>13.02</ENT>
              <ENT>N/A</ENT>
              <ENT>12.06</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>26.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31755</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of windpipe</ENT>
              <ENT>15.93</ENT>
              <ENT>N/A</ENT>
              <ENT>14.74</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>31.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31760</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of windpipe</ENT>
              <ENT>22.35</ENT>
              <ENT>N/A</ENT>
              <ENT>10.51</ENT>
              <ENT>1.48</ENT>
              <ENT>N/A</ENT>
              <ENT>34.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31766</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of windpipe</ENT>
              <ENT>30.43</ENT>
              <ENT>N/A</ENT>
              <ENT>13.60</ENT>
              <ENT>3.16</ENT>
              <ENT>N/A</ENT>
              <ENT>47.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31770</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/graft of bronchus</ENT>
              <ENT>22.51</ENT>
              <ENT>N/A</ENT>
              <ENT>10.16</ENT>
              <ENT>2.27</ENT>
              <ENT>N/A</ENT>
              <ENT>34.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31775</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct bronchus</ENT>
              <ENT>23.54</ENT>
              <ENT>N/A</ENT>
              <ENT>11.78</ENT>
              <ENT>2.91</ENT>
              <ENT>N/A</ENT>
              <ENT>38.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31780</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct windpipe</ENT>
              <ENT>17.72</ENT>
              <ENT>N/A</ENT>
              <ENT>11.12</ENT>
              <ENT>1.55</ENT>
              <ENT>N/A</ENT>
              <ENT>30.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31781</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct windpipe</ENT>
              <ENT>23.53</ENT>
              <ENT>N/A</ENT>
              <ENT>12.15</ENT>
              <ENT>2.04</ENT>
              <ENT>N/A</ENT>
              <ENT>37.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31785</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove windpipe lesion</ENT>
              <ENT>17.23</ENT>
              <ENT>N/A</ENT>
              <ENT>10.46</ENT>
              <ENT>1.36</ENT>
              <ENT>N/A</ENT>
              <ENT>29.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31786</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove windpipe lesion</ENT>
              <ENT>23.98</ENT>
              <ENT>N/A</ENT>
              <ENT>13.24</ENT>
              <ENT>2.20</ENT>
              <ENT>N/A</ENT>
              <ENT>39.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of windpipe injury</ENT>
              <ENT>7.43</ENT>
              <ENT>N/A</ENT>
              <ENT>4.92</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>13.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31805</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of windpipe injury</ENT>
              <ENT>13.13</ENT>
              <ENT>N/A</ENT>
              <ENT>7.17</ENT>
              <ENT>1.45</ENT>
              <ENT>N/A</ENT>
              <ENT>21.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Closure of windpipe lesion</ENT>
              <ENT>4.49</ENT>
              <ENT>5.80</ENT>
              <ENT>5.15</ENT>
              <ENT>0.35</ENT>
              <ENT>10.64</ENT>
              <ENT>9.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31825</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of windpipe defect</ENT>
              <ENT>6.81</ENT>
              <ENT>7.97</ENT>
              <ENT>7.40</ENT>
              <ENT>0.50</ENT>
              <ENT>15.28</ENT>
              <ENT>14.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31830</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise windpipe scar</ENT>
              <ENT>4.50</ENT>
              <ENT>5.92</ENT>
              <ENT>5.47</ENT>
              <ENT>0.36</ENT>
              <ENT>10.78</ENT>
              <ENT>10.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">31899</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Airways surgical procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of chest</ENT>
              <ENT>1.54</ENT>
              <ENT>3.16</ENT>
              <ENT>0.49</ENT>
              <ENT>0.07</ENT>
              <ENT>4.77</ENT>
              <ENT>2.10</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32002</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of collapsed lung</ENT>
              <ENT>2.19</ENT>
              <ENT>3.39</ENT>
              <ENT>0.85</ENT>
              <ENT>0.11</ENT>
              <ENT>5.69</ENT>
              <ENT>3.15</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32005</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat lung lining chemically</ENT>
              <ENT>2.19</ENT>
              <ENT>6.47</ENT>
              <ENT>0.70</ENT>
              <ENT>0.17</ENT>
              <ENT>8.83</ENT>
              <ENT>3.06</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of chest tube</ENT>
              <ENT>3.98</ENT>
              <ENT>N/A</ENT>
              <ENT>1.46</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>5.80</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32035</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of chest</ENT>
              <ENT>8.67</ENT>
              <ENT>N/A</ENT>
              <ENT>5.72</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>15.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32036</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of chest</ENT>
              <ENT>9.68</ENT>
              <ENT>N/A</ENT>
              <ENT>6.24</ENT>
              <ENT>1.20</ENT>
              <ENT>N/A</ENT>
              <ENT>17.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32095</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy through chest wall</ENT>
              <ENT>8.36</ENT>
              <ENT>N/A</ENT>
              <ENT>5.27</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>14.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration/biopsy of chest</ENT>
              <ENT>15.24</ENT>
              <ENT>N/A</ENT>
              <ENT>7.73</ENT>
              <ENT>1.45</ENT>
              <ENT>N/A</ENT>
              <ENT>24.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore/repair chest</ENT>
              <ENT>23.00</ENT>
              <ENT>N/A</ENT>
              <ENT>10.63</ENT>
              <ENT>1.63</ENT>
              <ENT>N/A</ENT>
              <ENT>35.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Re-exploration of chest</ENT>
              <ENT>11.54</ENT>
              <ENT>N/A</ENT>
              <ENT>6.93</ENT>
              <ENT>1.42</ENT>
              <ENT>N/A</ENT>
              <ENT>19.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49113"/>
              <ENT I="01">32124</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore chest free adhesions</ENT>
              <ENT>12.72</ENT>
              <ENT>N/A</ENT>
              <ENT>7.10</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>21.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of lung lesion(s)</ENT>
              <ENT>13.93</ENT>
              <ENT>N/A</ENT>
              <ENT>7.57</ENT>
              <ENT>1.68</ENT>
              <ENT>N/A</ENT>
              <ENT>23.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32141</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove/treat lung lesions</ENT>
              <ENT>14.00</ENT>
              <ENT>N/A</ENT>
              <ENT>7.45</ENT>
              <ENT>1.72</ENT>
              <ENT>N/A</ENT>
              <ENT>23.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of lung lesion(s)</ENT>
              <ENT>14.15</ENT>
              <ENT>N/A</ENT>
              <ENT>7.54</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>23.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32151</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove lung foreign body</ENT>
              <ENT>14.21</ENT>
              <ENT>N/A</ENT>
              <ENT>7.94</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>23.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32160</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Open chest heart massage</ENT>
              <ENT>9.30</ENT>
              <ENT>N/A</ENT>
              <ENT>5.32</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>15.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain, open, lung lesion</ENT>
              <ENT>15.29</ENT>
              <ENT>N/A</ENT>
              <ENT>8.50</ENT>
              <ENT>1.46</ENT>
              <ENT>N/A</ENT>
              <ENT>25.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32201</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain, percut, lung lesion</ENT>
              <ENT>4.00</ENT>
              <ENT>N/A</ENT>
              <ENT>5.60</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>9.78</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32215</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat chest lining</ENT>
              <ENT>11.33</ENT>
              <ENT>N/A</ENT>
              <ENT>6.84</ENT>
              <ENT>1.34</ENT>
              <ENT>N/A</ENT>
              <ENT>19.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release of lung</ENT>
              <ENT>24.00</ENT>
              <ENT>N/A</ENT>
              <ENT>12.61</ENT>
              <ENT>2.39</ENT>
              <ENT>N/A</ENT>
              <ENT>39.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32225</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial release of lung</ENT>
              <ENT>13.96</ENT>
              <ENT>N/A</ENT>
              <ENT>7.64</ENT>
              <ENT>1.70</ENT>
              <ENT>N/A</ENT>
              <ENT>23.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32310</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of chest lining</ENT>
              <ENT>13.44</ENT>
              <ENT>N/A</ENT>
              <ENT>7.38</ENT>
              <ENT>1.65</ENT>
              <ENT>N/A</ENT>
              <ENT>22.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Free/remove chest lining</ENT>
              <ENT>24.00</ENT>
              <ENT>N/A</ENT>
              <ENT>11.97</ENT>
              <ENT>2.50</ENT>
              <ENT>N/A</ENT>
              <ENT>38.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Needle biopsy chest lining</ENT>
              <ENT>1.76</ENT>
              <ENT>1.73</ENT>
              <ENT>0.56</ENT>
              <ENT>0.07</ENT>
              <ENT>3.56</ENT>
              <ENT>2.39</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32402</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Open biopsy chest lining</ENT>
              <ENT>7.56</ENT>
              <ENT>N/A</ENT>
              <ENT>5.11</ENT>
              <ENT>0.91</ENT>
              <ENT>N/A</ENT>
              <ENT>13.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32405</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy, lung or mediastinum</ENT>
              <ENT>1.93</ENT>
              <ENT>2.14</ENT>
              <ENT>0.64</ENT>
              <ENT>0.09</ENT>
              <ENT>4.16</ENT>
              <ENT>2.66</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Puncture/clear lung</ENT>
              <ENT>2.18</ENT>
              <ENT>N/A</ENT>
              <ENT>0.84</ENT>
              <ENT>0.11</ENT>
              <ENT>N/A</ENT>
              <ENT>3.13</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32440</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of lung</ENT>
              <ENT>25.00</ENT>
              <ENT>N/A</ENT>
              <ENT>12.61</ENT>
              <ENT>2.56</ENT>
              <ENT>N/A</ENT>
              <ENT>40.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32442</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sleeve pneumonectomy</ENT>
              <ENT>26.24</ENT>
              <ENT>N/A</ENT>
              <ENT>14.34</ENT>
              <ENT>3.12</ENT>
              <ENT>N/A</ENT>
              <ENT>43.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32445</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of lung</ENT>
              <ENT>25.09</ENT>
              <ENT>N/A</ENT>
              <ENT>13.75</ENT>
              <ENT>3.11</ENT>
              <ENT>N/A</ENT>
              <ENT>41.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32480</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of lung</ENT>
              <ENT>23.75</ENT>
              <ENT>N/A</ENT>
              <ENT>11.81</ENT>
              <ENT>2.24</ENT>
              <ENT>N/A</ENT>
              <ENT>37.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32482</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bilobectomy</ENT>
              <ENT>25.00</ENT>
              <ENT>N/A</ENT>
              <ENT>12.68</ENT>
              <ENT>2.35</ENT>
              <ENT>N/A</ENT>
              <ENT>40.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32484</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Segmentectomy</ENT>
              <ENT>20.69</ENT>
              <ENT>N/A</ENT>
              <ENT>11.12</ENT>
              <ENT>2.54</ENT>
              <ENT>N/A</ENT>
              <ENT>34.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32486</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sleeve lobectomy</ENT>
              <ENT>23.92</ENT>
              <ENT>N/A</ENT>
              <ENT>12.89</ENT>
              <ENT>3.00</ENT>
              <ENT>N/A</ENT>
              <ENT>39.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32488</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Completion pneumonectomy</ENT>
              <ENT>25.71</ENT>
              <ENT>N/A</ENT>
              <ENT>13.44</ENT>
              <ENT>3.18</ENT>
              <ENT>N/A</ENT>
              <ENT>42.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32491</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Lung volume reduction</ENT>
              <ENT>21.25</ENT>
              <ENT>N/A</ENT>
              <ENT>12.23</ENT>
              <ENT>2.66</ENT>
              <ENT>N/A</ENT>
              <ENT>36.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of lung</ENT>
              <ENT>22.00</ENT>
              <ENT>N/A</ENT>
              <ENT>12.02</ENT>
              <ENT>1.77</ENT>
              <ENT>N/A</ENT>
              <ENT>35.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32501</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair bronchus add-on</ENT>
              <ENT>4.69</ENT>
              <ENT>N/A</ENT>
              <ENT>1.54</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>6.79</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove lung &amp; revise chest</ENT>
              <ENT>21.68</ENT>
              <ENT>N/A</ENT>
              <ENT>11.01</ENT>
              <ENT>2.71</ENT>
              <ENT>N/A</ENT>
              <ENT>35.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32522</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove lung &amp; revise chest</ENT>
              <ENT>24.20</ENT>
              <ENT>N/A</ENT>
              <ENT>11.84</ENT>
              <ENT>2.84</ENT>
              <ENT>N/A</ENT>
              <ENT>38.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32525</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove lung &amp; revise chest</ENT>
              <ENT>26.50</ENT>
              <ENT>N/A</ENT>
              <ENT>12.54</ENT>
              <ENT>3.25</ENT>
              <ENT>N/A</ENT>
              <ENT>42.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32540</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of lung lesion</ENT>
              <ENT>14.64</ENT>
              <ENT>N/A</ENT>
              <ENT>9.35</ENT>
              <ENT>1.84</ENT>
              <ENT>N/A</ENT>
              <ENT>25.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32601</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracoscopy, diagnostic</ENT>
              <ENT>5.46</ENT>
              <ENT>N/A</ENT>
              <ENT>2.37</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>8.46</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32602</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracoscopy, diagnostic</ENT>
              <ENT>5.96</ENT>
              <ENT>N/A</ENT>
              <ENT>2.54</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>9.20</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32603</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracoscopy, diagnostic</ENT>
              <ENT>7.81</ENT>
              <ENT>N/A</ENT>
              <ENT>3.07</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>11.64</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32604</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracoscopy, diagnostic</ENT>
              <ENT>8.78</ENT>
              <ENT>N/A</ENT>
              <ENT>3.49</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>13.24</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracoscopy, diagnostic</ENT>
              <ENT>6.93</ENT>
              <ENT>N/A</ENT>
              <ENT>2.91</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>10.70</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32606</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracoscopy, diagnostic</ENT>
              <ENT>8.40</ENT>
              <ENT>N/A</ENT>
              <ENT>3.35</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>12.74</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32650</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracoscopy, surgical</ENT>
              <ENT>10.75</ENT>
              <ENT>N/A</ENT>
              <ENT>6.58</ENT>
              <ENT>1.25</ENT>
              <ENT>N/A</ENT>
              <ENT>18.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32651</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracoscopy, surgical</ENT>
              <ENT>12.91</ENT>
              <ENT>N/A</ENT>
              <ENT>7.10</ENT>
              <ENT>1.50</ENT>
              <ENT>N/A</ENT>
              <ENT>21.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32652</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracoscopy, surgical</ENT>
              <ENT>18.66</ENT>
              <ENT>N/A</ENT>
              <ENT>9.91</ENT>
              <ENT>2.30</ENT>
              <ENT>N/A</ENT>
              <ENT>30.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32653</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracoscopy, surgical</ENT>
              <ENT>12.87</ENT>
              <ENT>N/A</ENT>
              <ENT>6.82</ENT>
              <ENT>1.55</ENT>
              <ENT>N/A</ENT>
              <ENT>21.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32654</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracoscopy, surgical</ENT>
              <ENT>12.44</ENT>
              <ENT>N/A</ENT>
              <ENT>7.31</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>21.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32655</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracoscopy, surgical</ENT>
              <ENT>13.10</ENT>
              <ENT>N/A</ENT>
              <ENT>7.12</ENT>
              <ENT>1.53</ENT>
              <ENT>N/A</ENT>
              <ENT>21.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32656</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracoscopy, surgical</ENT>
              <ENT>12.91</ENT>
              <ENT>N/A</ENT>
              <ENT>7.68</ENT>
              <ENT>1.61</ENT>
              <ENT>N/A</ENT>
              <ENT>22.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32657</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracoscopy, surgical</ENT>
              <ENT>13.65</ENT>
              <ENT>N/A</ENT>
              <ENT>7.51</ENT>
              <ENT>1.64</ENT>
              <ENT>N/A</ENT>
              <ENT>22.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32658</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracoscopy, surgical</ENT>
              <ENT>11.63</ENT>
              <ENT>N/A</ENT>
              <ENT>7.11</ENT>
              <ENT>1.47</ENT>
              <ENT>N/A</ENT>
              <ENT>20.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32659</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracoscopy, surgical</ENT>
              <ENT>11.59</ENT>
              <ENT>N/A</ENT>
              <ENT>7.23</ENT>
              <ENT>1.39</ENT>
              <ENT>N/A</ENT>
              <ENT>20.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32660</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracoscopy, surgical</ENT>
              <ENT>17.43</ENT>
              <ENT>N/A</ENT>
              <ENT>9.20</ENT>
              <ENT>2.09</ENT>
              <ENT>N/A</ENT>
              <ENT>28.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32661</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracoscopy, surgical</ENT>
              <ENT>13.25</ENT>
              <ENT>N/A</ENT>
              <ENT>7.57</ENT>
              <ENT>1.66</ENT>
              <ENT>N/A</ENT>
              <ENT>22.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32662</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracoscopy, surgical</ENT>
              <ENT>16.44</ENT>
              <ENT>N/A</ENT>
              <ENT>8.60</ENT>
              <ENT>2.01</ENT>
              <ENT>N/A</ENT>
              <ENT>27.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32663</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracoscopy, surgical</ENT>
              <ENT>18.47</ENT>
              <ENT>N/A</ENT>
              <ENT>10.45</ENT>
              <ENT>2.28</ENT>
              <ENT>N/A</ENT>
              <ENT>31.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32664</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracoscopy, surgical</ENT>
              <ENT>14.20</ENT>
              <ENT>N/A</ENT>
              <ENT>7.54</ENT>
              <ENT>1.70</ENT>
              <ENT>N/A</ENT>
              <ENT>23.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32665</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracoscopy, surgical</ENT>
              <ENT>15.54</ENT>
              <ENT>N/A</ENT>
              <ENT>8.06</ENT>
              <ENT>1.79</ENT>
              <ENT>N/A</ENT>
              <ENT>25.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair lung hernia</ENT>
              <ENT>13.69</ENT>
              <ENT>N/A</ENT>
              <ENT>7.48</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>22.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32810</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Close chest after drainage</ENT>
              <ENT>13.05</ENT>
              <ENT>N/A</ENT>
              <ENT>7.54</ENT>
              <ENT>1.55</ENT>
              <ENT>N/A</ENT>
              <ENT>22.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32815</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Close bronchial fistula</ENT>
              <ENT>23.15</ENT>
              <ENT>N/A</ENT>
              <ENT>10.90</ENT>
              <ENT>2.84</ENT>
              <ENT>N/A</ENT>
              <ENT>36.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct injured chest</ENT>
              <ENT>21.48</ENT>
              <ENT>N/A</ENT>
              <ENT>12.20</ENT>
              <ENT>2.31</ENT>
              <ENT>N/A</ENT>
              <ENT>35.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32851</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lung transplant, single</ENT>
              <ENT>38.63</ENT>
              <ENT>N/A</ENT>
              <ENT>22.54</ENT>
              <ENT>4.90</ENT>
              <ENT>N/A</ENT>
              <ENT>66.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49114"/>
              <ENT I="01">32852</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lung transplant with bypass</ENT>
              <ENT>41.80</ENT>
              <ENT>N/A</ENT>
              <ENT>26.19</ENT>
              <ENT>5.17</ENT>
              <ENT>N/A</ENT>
              <ENT>73.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32853</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lung transplant, double</ENT>
              <ENT>47.81</ENT>
              <ENT>N/A</ENT>
              <ENT>26.09</ENT>
              <ENT>6.13</ENT>
              <ENT>N/A</ENT>
              <ENT>80.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32854</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lung transplant with bypass</ENT>
              <ENT>50.98</ENT>
              <ENT>N/A</ENT>
              <ENT>28.63</ENT>
              <ENT>6.41</ENT>
              <ENT>N/A</ENT>
              <ENT>86.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32900</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of rib(s)</ENT>
              <ENT>20.27</ENT>
              <ENT>N/A</ENT>
              <ENT>9.96</ENT>
              <ENT>2.42</ENT>
              <ENT>N/A</ENT>
              <ENT>32.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32905</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise &amp; repair chest wall</ENT>
              <ENT>20.75</ENT>
              <ENT>N/A</ENT>
              <ENT>10.15</ENT>
              <ENT>2.54</ENT>
              <ENT>N/A</ENT>
              <ENT>33.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32906</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise &amp; repair chest wall</ENT>
              <ENT>26.77</ENT>
              <ENT>N/A</ENT>
              <ENT>12.07</ENT>
              <ENT>3.30</ENT>
              <ENT>N/A</ENT>
              <ENT>42.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32940</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of lung</ENT>
              <ENT>19.43</ENT>
              <ENT>N/A</ENT>
              <ENT>9.39</ENT>
              <ENT>2.47</ENT>
              <ENT>N/A</ENT>
              <ENT>31.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32960</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Therapeutic pneumothorax</ENT>
              <ENT>1.84</ENT>
              <ENT>1.82</ENT>
              <ENT>0.57</ENT>
              <ENT>0.12</ENT>
              <ENT>3.78</ENT>
              <ENT>2.53</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32997</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Total lung lavage</ENT>
              <ENT>6.00</ENT>
              <ENT>N/A</ENT>
              <ENT>1.93</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>8.48</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">32999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Chest surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of heart sac</ENT>
              <ENT>2.24</ENT>
              <ENT>N/A</ENT>
              <ENT>0.98</ENT>
              <ENT>0.13</ENT>
              <ENT>N/A</ENT>
              <ENT>3.35</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33011</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repeat drainage of heart sac</ENT>
              <ENT>2.24</ENT>
              <ENT>N/A</ENT>
              <ENT>1.01</ENT>
              <ENT>0.13</ENT>
              <ENT>N/A</ENT>
              <ENT>3.38</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33015</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of heart sac</ENT>
              <ENT>6.80</ENT>
              <ENT>N/A</ENT>
              <ENT>4.85</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>12.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of heart sac</ENT>
              <ENT>12.61</ENT>
              <ENT>N/A</ENT>
              <ENT>6.83</ENT>
              <ENT>1.50</ENT>
              <ENT>N/A</ENT>
              <ENT>20.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33025</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of heart sac</ENT>
              <ENT>12.09</ENT>
              <ENT>N/A</ENT>
              <ENT>6.39</ENT>
              <ENT>1.50</ENT>
              <ENT>N/A</ENT>
              <ENT>19.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33030</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of heart sac</ENT>
              <ENT>18.71</ENT>
              <ENT>N/A</ENT>
              <ENT>9.43</ENT>
              <ENT>2.40</ENT>
              <ENT>N/A</ENT>
              <ENT>30.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33031</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of heart sac</ENT>
              <ENT>21.79</ENT>
              <ENT>N/A</ENT>
              <ENT>10.01</ENT>
              <ENT>2.78</ENT>
              <ENT>N/A</ENT>
              <ENT>34.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33050</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of heart sac lesion</ENT>
              <ENT>14.36</ENT>
              <ENT>N/A</ENT>
              <ENT>7.80</ENT>
              <ENT>1.73</ENT>
              <ENT>N/A</ENT>
              <ENT>23.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of heart lesion</ENT>
              <ENT>24.56</ENT>
              <ENT>N/A</ENT>
              <ENT>11.60</ENT>
              <ENT>3.06</ENT>
              <ENT>N/A</ENT>
              <ENT>39.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of heart lesion</ENT>
              <ENT>21.39</ENT>
              <ENT>N/A</ENT>
              <ENT>10.15</ENT>
              <ENT>2.51</ENT>
              <ENT>N/A</ENT>
              <ENT>34.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Heart revascularize (tmr)</ENT>
              <ENT>20.00</ENT>
              <ENT>N/A</ENT>
              <ENT>10.62</ENT>
              <ENT>2.27</ENT>
              <ENT>N/A</ENT>
              <ENT>32.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33141</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Heart tmr w/other procedure</ENT>
              <ENT>4.84</ENT>
              <ENT>N/A</ENT>
              <ENT>1.56</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>6.95</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of heart pacemaker</ENT>
              <ENT>12.48</ENT>
              <ENT>N/A</ENT>
              <ENT>6.96</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>20.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33201</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of heart pacemaker</ENT>
              <ENT>10.18</ENT>
              <ENT>N/A</ENT>
              <ENT>6.59</ENT>
              <ENT>1.21</ENT>
              <ENT>N/A</ENT>
              <ENT>17.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33206</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of heart pacemaker</ENT>
              <ENT>6.67</ENT>
              <ENT>N/A</ENT>
              <ENT>4.60</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>11.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33207</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of heart pacemaker</ENT>
              <ENT>8.04</ENT>
              <ENT>N/A</ENT>
              <ENT>4.89</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>13.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33208</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of heart pacemaker</ENT>
              <ENT>8.13</ENT>
              <ENT>N/A</ENT>
              <ENT>5.03</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>13.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33210</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of heart electrode</ENT>
              <ENT>3.30</ENT>
              <ENT>N/A</ENT>
              <ENT>1.28</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>4.75</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33211</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of heart electrode</ENT>
              <ENT>3.40</ENT>
              <ENT>N/A</ENT>
              <ENT>1.34</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>4.91</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33212</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of pulse generator</ENT>
              <ENT>5.52</ENT>
              <ENT>N/A</ENT>
              <ENT>3.50</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>9.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33213</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of pulse generator</ENT>
              <ENT>6.37</ENT>
              <ENT>N/A</ENT>
              <ENT>3.88</ENT>
              <ENT>0.46</ENT>
              <ENT>N/A</ENT>
              <ENT>10.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33214</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Upgrade of pacemaker system</ENT>
              <ENT>7.75</ENT>
              <ENT>N/A</ENT>
              <ENT>5.07</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>13.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33215</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reposition pacing-defib lead</ENT>
              <ENT>4.76</ENT>
              <ENT>N/A</ENT>
              <ENT>3.21</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>8.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33216</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert lead pace-defib, one</ENT>
              <ENT>5.78</ENT>
              <ENT>N/A</ENT>
              <ENT>4.32</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>10.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33217</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert lead pace-defib, dual</ENT>
              <ENT>5.75</ENT>
              <ENT>N/A</ENT>
              <ENT>4.40</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>10.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33218</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair lead pace-defib, one</ENT>
              <ENT>5.44</ENT>
              <ENT>N/A</ENT>
              <ENT>4.36</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>10.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair lead pace-defib, dual</ENT>
              <ENT>5.52</ENT>
              <ENT>N/A</ENT>
              <ENT>4.35</ENT>
              <ENT>0.39</ENT>
              <ENT>N/A</ENT>
              <ENT>10.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33222</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise pocket, pacemaker</ENT>
              <ENT>4.96</ENT>
              <ENT>N/A</ENT>
              <ENT>4.27</ENT>
              <ENT>0.39</ENT>
              <ENT>N/A</ENT>
              <ENT>9.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33223</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise pocket, pacing-defib</ENT>
              <ENT>6.46</ENT>
              <ENT>N/A</ENT>
              <ENT>4.74</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>11.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33224</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert pacing lead &amp; connect</ENT>
              <ENT>9.05</ENT>
              <ENT>N/A</ENT>
              <ENT>4.08</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>13.49</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33225</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>L ventric pacing lead add-on</ENT>
              <ENT>8.34</ENT>
              <ENT>N/A</ENT>
              <ENT>3.28</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>11.98</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33226</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reposition l ventric lead</ENT>
              <ENT>8.69</ENT>
              <ENT>N/A</ENT>
              <ENT>3.94</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>12.99</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33233</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of pacemaker system</ENT>
              <ENT>3.29</ENT>
              <ENT>N/A</ENT>
              <ENT>3.39</ENT>
              <ENT>0.22</ENT>
              <ENT>N/A</ENT>
              <ENT>6.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49115"/>
              <ENT I="01">33234</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of pacemaker system</ENT>
              <ENT>7.82</ENT>
              <ENT>N/A</ENT>
              <ENT>5.04</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>13.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33235</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal pacemaker electrode</ENT>
              <ENT>9.40</ENT>
              <ENT>N/A</ENT>
              <ENT>6.92</ENT>
              <ENT>0.68</ENT>
              <ENT>N/A</ENT>
              <ENT>17.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33236</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove electrode/thoracotomy</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>7.28</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>21.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33237</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove electrode/thoracotomy</ENT>
              <ENT>13.71</ENT>
              <ENT>N/A</ENT>
              <ENT>7.67</ENT>
              <ENT>1.57</ENT>
              <ENT>N/A</ENT>
              <ENT>22.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33238</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove electrode/thoracotomy</ENT>
              <ENT>15.22</ENT>
              <ENT>N/A</ENT>
              <ENT>8.10</ENT>
              <ENT>1.56</ENT>
              <ENT>N/A</ENT>
              <ENT>24.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33240</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert pulse generator</ENT>
              <ENT>7.60</ENT>
              <ENT>N/A</ENT>
              <ENT>4.74</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>12.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33241</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove pulse generator</ENT>
              <ENT>3.24</ENT>
              <ENT>N/A</ENT>
              <ENT>3.08</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>6.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33243</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove eltrd/thoracotomy</ENT>
              <ENT>22.64</ENT>
              <ENT>N/A</ENT>
              <ENT>11.13</ENT>
              <ENT>2.53</ENT>
              <ENT>N/A</ENT>
              <ENT>36.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33244</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove eltrd, transven</ENT>
              <ENT>13.76</ENT>
              <ENT>N/A</ENT>
              <ENT>8.81</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>23.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33245</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert epic eltrd pace-defib</ENT>
              <ENT>14.30</ENT>
              <ENT>N/A</ENT>
              <ENT>8.00</ENT>
              <ENT>1.28</ENT>
              <ENT>N/A</ENT>
              <ENT>23.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33246</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert epic eltrd/generator</ENT>
              <ENT>20.71</ENT>
              <ENT>N/A</ENT>
              <ENT>10.31</ENT>
              <ENT>2.22</ENT>
              <ENT>N/A</ENT>
              <ENT>33.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33249</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Eltrd/insert pace-defib</ENT>
              <ENT>14.23</ENT>
              <ENT>N/A</ENT>
              <ENT>8.63</ENT>
              <ENT>0.80</ENT>
              <ENT>N/A</ENT>
              <ENT>23.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ablate heart dysrhythm focus</ENT>
              <ENT>21.85</ENT>
              <ENT>N/A</ENT>
              <ENT>11.61</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>34.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33251</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ablate heart dysrhythm focus</ENT>
              <ENT>24.88</ENT>
              <ENT>N/A</ENT>
              <ENT>11.56</ENT>
              <ENT>2.41</ENT>
              <ENT>N/A</ENT>
              <ENT>38.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33253</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct atria</ENT>
              <ENT>31.06</ENT>
              <ENT>N/A</ENT>
              <ENT>13.68</ENT>
              <ENT>3.68</ENT>
              <ENT>N/A</ENT>
              <ENT>48.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33261</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ablate heart dysrhythm focus</ENT>
              <ENT>24.88</ENT>
              <ENT>N/A</ENT>
              <ENT>11.68</ENT>
              <ENT>2.82</ENT>
              <ENT>N/A</ENT>
              <ENT>39.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33282</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant pat-active ht record</ENT>
              <ENT>4.17</ENT>
              <ENT>N/A</ENT>
              <ENT>4.21</ENT>
              <ENT>0.39</ENT>
              <ENT>N/A</ENT>
              <ENT>8.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33284</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove pat-active ht record</ENT>
              <ENT>2.50</ENT>
              <ENT>N/A</ENT>
              <ENT>3.77</ENT>
              <ENT>0.23</ENT>
              <ENT>N/A</ENT>
              <ENT>6.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of heart wound</ENT>
              <ENT>17.92</ENT>
              <ENT>N/A</ENT>
              <ENT>9.28</ENT>
              <ENT>1.91</ENT>
              <ENT>N/A</ENT>
              <ENT>29.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33305</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of heart wound</ENT>
              <ENT>21.44</ENT>
              <ENT>N/A</ENT>
              <ENT>10.50</ENT>
              <ENT>2.68</ENT>
              <ENT>N/A</ENT>
              <ENT>34.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33310</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploratory heart surgery</ENT>
              <ENT>18.51</ENT>
              <ENT>N/A</ENT>
              <ENT>9.47</ENT>
              <ENT>2.26</ENT>
              <ENT>N/A</ENT>
              <ENT>30.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33315</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploratory heart surgery</ENT>
              <ENT>22.37</ENT>
              <ENT>N/A</ENT>
              <ENT>10.74</ENT>
              <ENT>2.90</ENT>
              <ENT>N/A</ENT>
              <ENT>36.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair major blood vessel(s)</ENT>
              <ENT>16.79</ENT>
              <ENT>N/A</ENT>
              <ENT>8.36</ENT>
              <ENT>1.66</ENT>
              <ENT>N/A</ENT>
              <ENT>26.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33321</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair major vessel</ENT>
              <ENT>20.20</ENT>
              <ENT>N/A</ENT>
              <ENT>9.73</ENT>
              <ENT>2.70</ENT>
              <ENT>N/A</ENT>
              <ENT>32.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33322</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair major blood vessel(s)</ENT>
              <ENT>20.62</ENT>
              <ENT>N/A</ENT>
              <ENT>10.29</ENT>
              <ENT>2.51</ENT>
              <ENT>N/A</ENT>
              <ENT>33.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33330</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert major vessel graft</ENT>
              <ENT>21.43</ENT>
              <ENT>N/A</ENT>
              <ENT>10.26</ENT>
              <ENT>2.49</ENT>
              <ENT>N/A</ENT>
              <ENT>34.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33332</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert major vessel graft</ENT>
              <ENT>23.96</ENT>
              <ENT>N/A</ENT>
              <ENT>10.59</ENT>
              <ENT>2.45</ENT>
              <ENT>N/A</ENT>
              <ENT>37.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33335</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert major vessel graft</ENT>
              <ENT>30.01</ENT>
              <ENT>N/A</ENT>
              <ENT>13.22</ENT>
              <ENT>3.79</ENT>
              <ENT>N/A</ENT>
              <ENT>47.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of aortic valve</ENT>
              <ENT>28.50</ENT>
              <ENT>N/A</ENT>
              <ENT>15.23</ENT>
              <ENT>3.09</ENT>
              <ENT>N/A</ENT>
              <ENT>46.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33401</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Valvuloplasty, open</ENT>
              <ENT>23.91</ENT>
              <ENT>N/A</ENT>
              <ENT>13.30</ENT>
              <ENT>2.71</ENT>
              <ENT>N/A</ENT>
              <ENT>39.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33403</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Valvuloplasty, w/cp bypass</ENT>
              <ENT>24.89</ENT>
              <ENT>N/A</ENT>
              <ENT>13.94</ENT>
              <ENT>2.48</ENT>
              <ENT>N/A</ENT>
              <ENT>41.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33404</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prepare heart-aorta conduit</ENT>
              <ENT>28.54</ENT>
              <ENT>N/A</ENT>
              <ENT>14.10</ENT>
              <ENT>3.31</ENT>
              <ENT>N/A</ENT>
              <ENT>45.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33405</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replacement of aortic valve</ENT>
              <ENT>35.00</ENT>
              <ENT>N/A</ENT>
              <ENT>17.75</ENT>
              <ENT>3.86</ENT>
              <ENT>N/A</ENT>
              <ENT>56.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33406</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replacement of aortic valve</ENT>
              <ENT>37.50</ENT>
              <ENT>N/A</ENT>
              <ENT>18.55</ENT>
              <ENT>4.07</ENT>
              <ENT>N/A</ENT>
              <ENT>60.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33410</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replacement of aortic valve</ENT>
              <ENT>32.46</ENT>
              <ENT>N/A</ENT>
              <ENT>16.19</ENT>
              <ENT>4.11</ENT>
              <ENT>N/A</ENT>
              <ENT>52.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33411</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replacement of aortic valve</ENT>
              <ENT>36.25</ENT>
              <ENT>N/A</ENT>
              <ENT>18.20</ENT>
              <ENT>4.16</ENT>
              <ENT>N/A</ENT>
              <ENT>58.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33412</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replacement of aortic valve</ENT>
              <ENT>42.00</ENT>
              <ENT>N/A</ENT>
              <ENT>19.94</ENT>
              <ENT>4.66</ENT>
              <ENT>N/A</ENT>
              <ENT>66.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33413</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replacement of aortic valve</ENT>
              <ENT>43.50</ENT>
              <ENT>N/A</ENT>
              <ENT>20.31</ENT>
              <ENT>4.26</ENT>
              <ENT>N/A</ENT>
              <ENT>68.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33414</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of aortic valve</ENT>
              <ENT>30.35</ENT>
              <ENT>N/A</ENT>
              <ENT>13.85</ENT>
              <ENT>3.79</ENT>
              <ENT>N/A</ENT>
              <ENT>47.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33415</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision, subvalvular tissue</ENT>
              <ENT>27.15</ENT>
              <ENT>N/A</ENT>
              <ENT>11.87</ENT>
              <ENT>3.25</ENT>
              <ENT>N/A</ENT>
              <ENT>42.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33416</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise ventricle muscle</ENT>
              <ENT>30.35</ENT>
              <ENT>N/A</ENT>
              <ENT>13.34</ENT>
              <ENT>3.85</ENT>
              <ENT>N/A</ENT>
              <ENT>47.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33417</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of aortic valve</ENT>
              <ENT>28.53</ENT>
              <ENT>N/A</ENT>
              <ENT>13.33</ENT>
              <ENT>3.58</ENT>
              <ENT>N/A</ENT>
              <ENT>45.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of mitral valve</ENT>
              <ENT>22.70</ENT>
              <ENT>N/A</ENT>
              <ENT>9.76</ENT>
              <ENT>1.48</ENT>
              <ENT>N/A</ENT>
              <ENT>33.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33422</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of mitral valve</ENT>
              <ENT>25.94</ENT>
              <ENT>N/A</ENT>
              <ENT>13.21</ENT>
              <ENT>3.30</ENT>
              <ENT>N/A</ENT>
              <ENT>42.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33425</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of mitral valve</ENT>
              <ENT>27.00</ENT>
              <ENT>N/A</ENT>
              <ENT>12.70</ENT>
              <ENT>3.00</ENT>
              <ENT>N/A</ENT>
              <ENT>42.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33426</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of mitral valve</ENT>
              <ENT>33.00</ENT>
              <ENT>N/A</ENT>
              <ENT>16.66</ENT>
              <ENT>3.87</ENT>
              <ENT>N/A</ENT>
              <ENT>53.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49116"/>
              <ENT I="01">33427</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of mitral valve</ENT>
              <ENT>40.00</ENT>
              <ENT>N/A</ENT>
              <ENT>18.85</ENT>
              <ENT>4.30</ENT>
              <ENT>N/A</ENT>
              <ENT>63.15</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33430</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replacement of mitral valve</ENT>
              <ENT>33.50</ENT>
              <ENT>N/A</ENT>
              <ENT>16.79</ENT>
              <ENT>3.95</ENT>
              <ENT>N/A</ENT>
              <ENT>54.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33460</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of tricuspid valve</ENT>
              <ENT>23.60</ENT>
              <ENT>N/A</ENT>
              <ENT>11.13</ENT>
              <ENT>3.02</ENT>
              <ENT>N/A</ENT>
              <ENT>37.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33463</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Valvuloplasty, tricuspid</ENT>
              <ENT>25.62</ENT>
              <ENT>N/A</ENT>
              <ENT>12.74</ENT>
              <ENT>3.17</ENT>
              <ENT>N/A</ENT>
              <ENT>41.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33464</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Valvuloplasty, tricuspid</ENT>
              <ENT>27.33</ENT>
              <ENT>N/A</ENT>
              <ENT>13.32</ENT>
              <ENT>3.47</ENT>
              <ENT>N/A</ENT>
              <ENT>44.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33465</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replace tricuspid valve</ENT>
              <ENT>28.79</ENT>
              <ENT>N/A</ENT>
              <ENT>12.81</ENT>
              <ENT>3.61</ENT>
              <ENT>N/A</ENT>
              <ENT>45.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33468</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of tricuspid valve</ENT>
              <ENT>30.12</ENT>
              <ENT>N/A</ENT>
              <ENT>13.40</ENT>
              <ENT>4.00</ENT>
              <ENT>N/A</ENT>
              <ENT>47.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33470</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of pulmonary valve</ENT>
              <ENT>20.81</ENT>
              <ENT>N/A</ENT>
              <ENT>10.78</ENT>
              <ENT>2.81</ENT>
              <ENT>N/A</ENT>
              <ENT>34.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33471</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Valvotomy, pulmonary valve</ENT>
              <ENT>22.25</ENT>
              <ENT>N/A</ENT>
              <ENT>9.80</ENT>
              <ENT>3.00</ENT>
              <ENT>N/A</ENT>
              <ENT>35.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33472</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of pulmonary valve</ENT>
              <ENT>22.25</ENT>
              <ENT>N/A</ENT>
              <ENT>11.63</ENT>
              <ENT>2.92</ENT>
              <ENT>N/A</ENT>
              <ENT>36.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33474</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of pulmonary valve</ENT>
              <ENT>23.04</ENT>
              <ENT>N/A</ENT>
              <ENT>10.79</ENT>
              <ENT>2.84</ENT>
              <ENT>N/A</ENT>
              <ENT>36.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33475</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replacement, pulmonary valve</ENT>
              <ENT>33.00</ENT>
              <ENT>N/A</ENT>
              <ENT>15.09</ENT>
              <ENT>2.64</ENT>
              <ENT>N/A</ENT>
              <ENT>50.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33476</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of heart chamber</ENT>
              <ENT>25.77</ENT>
              <ENT>N/A</ENT>
              <ENT>11.97</ENT>
              <ENT>2.40</ENT>
              <ENT>N/A</ENT>
              <ENT>40.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33478</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of heart chamber</ENT>
              <ENT>26.74</ENT>
              <ENT>N/A</ENT>
              <ENT>12.70</ENT>
              <ENT>3.56</ENT>
              <ENT>N/A</ENT>
              <ENT>43.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33496</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair, prosth valve clot</ENT>
              <ENT>27.25</ENT>
              <ENT>N/A</ENT>
              <ENT>12.64</ENT>
              <ENT>3.44</ENT>
              <ENT>N/A</ENT>
              <ENT>43.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair heart vessel fistula</ENT>
              <ENT>25.55</ENT>
              <ENT>N/A</ENT>
              <ENT>11.34</ENT>
              <ENT>2.80</ENT>
              <ENT>N/A</ENT>
              <ENT>39.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33501</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair heart vessel fistula</ENT>
              <ENT>17.78</ENT>
              <ENT>N/A</ENT>
              <ENT>8.28</ENT>
              <ENT>2.05</ENT>
              <ENT>N/A</ENT>
              <ENT>28.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33502</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Coronary artery correction</ENT>
              <ENT>21.04</ENT>
              <ENT>N/A</ENT>
              <ENT>11.04</ENT>
              <ENT>2.51</ENT>
              <ENT>N/A</ENT>
              <ENT>34.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33503</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Coronary artery graft</ENT>
              <ENT>21.78</ENT>
              <ENT>N/A</ENT>
              <ENT>9.91</ENT>
              <ENT>1.42</ENT>
              <ENT>N/A</ENT>
              <ENT>33.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33504</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Coronary artery graft</ENT>
              <ENT>24.66</ENT>
              <ENT>N/A</ENT>
              <ENT>11.76</ENT>
              <ENT>3.04</ENT>
              <ENT>N/A</ENT>
              <ENT>39.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33505</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair artery w/tunnel</ENT>
              <ENT>26.84</ENT>
              <ENT>N/A</ENT>
              <ENT>12.97</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>41.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33506</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair artery, translocation</ENT>
              <ENT>35.50</ENT>
              <ENT>N/A</ENT>
              <ENT>14.56</ENT>
              <ENT>3.19</ENT>
              <ENT>N/A</ENT>
              <ENT>53.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33508</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endoscopic vein harvest</ENT>
              <ENT>0.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>0.03</ENT>
              <ENT>N/A</ENT>
              <ENT>0.44</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>CABG, vein, single</ENT>
              <ENT>29.00</ENT>
              <ENT>N/A</ENT>
              <ENT>15.82</ENT>
              <ENT>3.13</ENT>
              <ENT>N/A</ENT>
              <ENT>47.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33511</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>CABG, vein, two</ENT>
              <ENT>30.00</ENT>
              <ENT>N/A</ENT>
              <ENT>16.54</ENT>
              <ENT>3.34</ENT>
              <ENT>N/A</ENT>
              <ENT>49.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33512</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>CABG, vein, three</ENT>
              <ENT>31.80</ENT>
              <ENT>N/A</ENT>
              <ENT>17.07</ENT>
              <ENT>3.70</ENT>
              <ENT>N/A</ENT>
              <ENT>52.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33513</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>CABG, vein, four</ENT>
              <ENT>32.00</ENT>
              <ENT>N/A</ENT>
              <ENT>17.23</ENT>
              <ENT>3.99</ENT>
              <ENT>N/A</ENT>
              <ENT>53.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33514</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>CABG, vein, five</ENT>
              <ENT>32.75</ENT>
              <ENT>N/A</ENT>
              <ENT>17.49</ENT>
              <ENT>4.37</ENT>
              <ENT>N/A</ENT>
              <ENT>54.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33516</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cabg, vein, six or more</ENT>
              <ENT>35.00</ENT>
              <ENT>N/A</ENT>
              <ENT>18.24</ENT>
              <ENT>4.62</ENT>
              <ENT>N/A</ENT>
              <ENT>57.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33517</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>CABG, artery-vein, single</ENT>
              <ENT>2.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.83</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>3.72</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33518</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>CABG, artery-vein, two</ENT>
              <ENT>4.85</ENT>
              <ENT>N/A</ENT>
              <ENT>1.57</ENT>
              <ENT>0.61</ENT>
              <ENT>N/A</ENT>
              <ENT>7.03</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33519</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>CABG, artery-vein, three</ENT>
              <ENT>7.12</ENT>
              <ENT>N/A</ENT>
              <ENT>2.31</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>10.32</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33521</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>CABG, artery-vein, four</ENT>
              <ENT>9.40</ENT>
              <ENT>N/A</ENT>
              <ENT>3.05</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>13.63</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33522</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>CABG, artery-vein, five</ENT>
              <ENT>11.67</ENT>
              <ENT>N/A</ENT>
              <ENT>3.78</ENT>
              <ENT>1.48</ENT>
              <ENT>N/A</ENT>
              <ENT>16.93</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33523</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cabg, art-vein, six or more</ENT>
              <ENT>13.95</ENT>
              <ENT>N/A</ENT>
              <ENT>4.48</ENT>
              <ENT>1.78</ENT>
              <ENT>N/A</ENT>
              <ENT>20.21</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Coronary artery, bypass/reop</ENT>
              <ENT>5.86</ENT>
              <ENT>N/A</ENT>
              <ENT>1.89</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>8.48</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33533</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>CABG, arterial, single</ENT>
              <ENT>30.00</ENT>
              <ENT>N/A</ENT>
              <ENT>15.96</ENT>
              <ENT>3.24</ENT>
              <ENT>N/A</ENT>
              <ENT>49.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33534</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>CABG, arterial, two</ENT>
              <ENT>32.20</ENT>
              <ENT>N/A</ENT>
              <ENT>17.15</ENT>
              <ENT>3.63</ENT>
              <ENT>N/A</ENT>
              <ENT>52.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33535</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>CABG, arterial, three</ENT>
              <ENT>34.50</ENT>
              <ENT>N/A</ENT>
              <ENT>17.62</ENT>
              <ENT>3.97</ENT>
              <ENT>N/A</ENT>
              <ENT>56.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33536</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cabg, arterial, four or more</ENT>
              <ENT>37.50</ENT>
              <ENT>N/A</ENT>
              <ENT>17.89</ENT>
              <ENT>3.29</ENT>
              <ENT>N/A</ENT>
              <ENT>58.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33542</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of heart lesion</ENT>
              <ENT>28.85</ENT>
              <ENT>N/A</ENT>
              <ENT>12.98</ENT>
              <ENT>3.61</ENT>
              <ENT>N/A</ENT>
              <ENT>45.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33545</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of heart damage</ENT>
              <ENT>36.78</ENT>
              <ENT>N/A</ENT>
              <ENT>15.69</ENT>
              <ENT>4.40</ENT>
              <ENT>N/A</ENT>
              <ENT>56.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33572</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Open coronary endarterectomy</ENT>
              <ENT>4.45</ENT>
              <ENT>N/A</ENT>
              <ENT>1.44</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>6.44</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Closure of valve</ENT>
              <ENT>29.51</ENT>
              <ENT>N/A</ENT>
              <ENT>12.64</ENT>
              <ENT>2.30</ENT>
              <ENT>N/A</ENT>
              <ENT>44.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33602</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Closure of valve</ENT>
              <ENT>28.54</ENT>
              <ENT>N/A</ENT>
              <ENT>12.79</ENT>
              <ENT>2.90</ENT>
              <ENT>N/A</ENT>
              <ENT>44.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33606</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Anastomosis/artery-aorta</ENT>
              <ENT>30.74</ENT>
              <ENT>N/A</ENT>
              <ENT>13.65</ENT>
              <ENT>3.59</ENT>
              <ENT>N/A</ENT>
              <ENT>47.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33608</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair anomaly w/conduit</ENT>
              <ENT>31.09</ENT>
              <ENT>N/A</ENT>
              <ENT>13.82</ENT>
              <ENT>4.17</ENT>
              <ENT>N/A</ENT>
              <ENT>49.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33610</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair by enlargement</ENT>
              <ENT>30.61</ENT>
              <ENT>N/A</ENT>
              <ENT>14.17</ENT>
              <ENT>4.02</ENT>
              <ENT>N/A</ENT>
              <ENT>48.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33611</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair double ventricle</ENT>
              <ENT>34.00</ENT>
              <ENT>N/A</ENT>
              <ENT>13.95</ENT>
              <ENT>3.28</ENT>
              <ENT>N/A</ENT>
              <ENT>51.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33612</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair double ventricle</ENT>
              <ENT>35.00</ENT>
              <ENT>N/A</ENT>
              <ENT>15.01</ENT>
              <ENT>4.44</ENT>
              <ENT>N/A</ENT>
              <ENT>54.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33615</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair, modified fontan</ENT>
              <ENT>34.00</ENT>
              <ENT>N/A</ENT>
              <ENT>15.11</ENT>
              <ENT>3.15</ENT>
              <ENT>N/A</ENT>
              <ENT>52.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33617</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair single ventricle</ENT>
              <ENT>37.00</ENT>
              <ENT>N/A</ENT>
              <ENT>15.82</ENT>
              <ENT>4.09</ENT>
              <ENT>N/A</ENT>
              <ENT>56.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33619</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair single ventricle</ENT>
              <ENT>45.00</ENT>
              <ENT>N/A</ENT>
              <ENT>20.08</ENT>
              <ENT>4.71</ENT>
              <ENT>N/A</ENT>
              <ENT>69.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33641</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair heart septum defect</ENT>
              <ENT>21.39</ENT>
              <ENT>N/A</ENT>
              <ENT>9.47</ENT>
              <ENT>2.67</ENT>
              <ENT>N/A</ENT>
              <ENT>33.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33645</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of heart veins</ENT>
              <ENT>24.82</ENT>
              <ENT>N/A</ENT>
              <ENT>11.50</ENT>
              <ENT>3.27</ENT>
              <ENT>N/A</ENT>
              <ENT>39.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49117"/>
              <ENT I="01">33647</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair heart septum defects</ENT>
              <ENT>28.73</ENT>
              <ENT>N/A</ENT>
              <ENT>13.55</ENT>
              <ENT>3.37</ENT>
              <ENT>N/A</ENT>
              <ENT>45.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33660</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of heart defects</ENT>
              <ENT>30.00</ENT>
              <ENT>N/A</ENT>
              <ENT>13.24</ENT>
              <ENT>2.82</ENT>
              <ENT>N/A</ENT>
              <ENT>46.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33665</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of heart defects</ENT>
              <ENT>28.60</ENT>
              <ENT>N/A</ENT>
              <ENT>13.36</ENT>
              <ENT>3.81</ENT>
              <ENT>N/A</ENT>
              <ENT>45.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33670</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of heart chambers</ENT>
              <ENT>35.00</ENT>
              <ENT>N/A</ENT>
              <ENT>13.57</ENT>
              <ENT>2.18</ENT>
              <ENT>N/A</ENT>
              <ENT>50.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33681</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair heart septum defect</ENT>
              <ENT>30.61</ENT>
              <ENT>N/A</ENT>
              <ENT>14.28</ENT>
              <ENT>3.53</ENT>
              <ENT>N/A</ENT>
              <ENT>48.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33684</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair heart septum defect</ENT>
              <ENT>29.65</ENT>
              <ENT>N/A</ENT>
              <ENT>13.47</ENT>
              <ENT>3.77</ENT>
              <ENT>N/A</ENT>
              <ENT>46.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33688</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair heart septum defect</ENT>
              <ENT>30.62</ENT>
              <ENT>N/A</ENT>
              <ENT>11.91</ENT>
              <ENT>3.89</ENT>
              <ENT>N/A</ENT>
              <ENT>46.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33690</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reinforce pulmonary artery</ENT>
              <ENT>19.55</ENT>
              <ENT>N/A</ENT>
              <ENT>10.07</ENT>
              <ENT>2.56</ENT>
              <ENT>N/A</ENT>
              <ENT>32.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33692</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of heart defects</ENT>
              <ENT>30.75</ENT>
              <ENT>N/A</ENT>
              <ENT>13.89</ENT>
              <ENT>3.77</ENT>
              <ENT>N/A</ENT>
              <ENT>48.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33694</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of heart defects</ENT>
              <ENT>34.00</ENT>
              <ENT>N/A</ENT>
              <ENT>14.42</ENT>
              <ENT>4.27</ENT>
              <ENT>N/A</ENT>
              <ENT>52.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33697</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of heart defects</ENT>
              <ENT>36.00</ENT>
              <ENT>N/A</ENT>
              <ENT>14.66</ENT>
              <ENT>4.54</ENT>
              <ENT>N/A</ENT>
              <ENT>55.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33702</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of heart defects</ENT>
              <ENT>26.54</ENT>
              <ENT>N/A</ENT>
              <ENT>12.29</ENT>
              <ENT>3.45</ENT>
              <ENT>N/A</ENT>
              <ENT>42.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33710</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of heart defects</ENT>
              <ENT>29.71</ENT>
              <ENT>N/A</ENT>
              <ENT>13.90</ENT>
              <ENT>3.85</ENT>
              <ENT>N/A</ENT>
              <ENT>47.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33720</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of heart defect</ENT>
              <ENT>26.56</ENT>
              <ENT>N/A</ENT>
              <ENT>12.15</ENT>
              <ENT>3.21</ENT>
              <ENT>N/A</ENT>
              <ENT>41.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33722</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of heart defect</ENT>
              <ENT>28.41</ENT>
              <ENT>N/A</ENT>
              <ENT>13.38</ENT>
              <ENT>3.80</ENT>
              <ENT>N/A</ENT>
              <ENT>45.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33730</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair heart-vein defect(s)</ENT>
              <ENT>34.25</ENT>
              <ENT>N/A</ENT>
              <ENT>14.28</ENT>
              <ENT>2.85</ENT>
              <ENT>N/A</ENT>
              <ENT>51.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33732</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair heart-vein defect</ENT>
              <ENT>28.16</ENT>
              <ENT>N/A</ENT>
              <ENT>13.45</ENT>
              <ENT>2.78</ENT>
              <ENT>N/A</ENT>
              <ENT>44.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33735</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of heart chamber</ENT>
              <ENT>21.39</ENT>
              <ENT>N/A</ENT>
              <ENT>10.24</ENT>
              <ENT>1.12</ENT>
              <ENT>N/A</ENT>
              <ENT>32.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33736</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of heart chamber</ENT>
              <ENT>23.52</ENT>
              <ENT>N/A</ENT>
              <ENT>11.80</ENT>
              <ENT>2.70</ENT>
              <ENT>N/A</ENT>
              <ENT>38.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33737</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of heart chamber</ENT>
              <ENT>21.76</ENT>
              <ENT>N/A</ENT>
              <ENT>11.01</ENT>
              <ENT>2.93</ENT>
              <ENT>N/A</ENT>
              <ENT>35.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33750</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Major vessel shunt</ENT>
              <ENT>21.41</ENT>
              <ENT>N/A</ENT>
              <ENT>10.46</ENT>
              <ENT>1.74</ENT>
              <ENT>N/A</ENT>
              <ENT>33.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33755</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Major vessel shunt</ENT>
              <ENT>21.79</ENT>
              <ENT>N/A</ENT>
              <ENT>9.31</ENT>
              <ENT>2.93</ENT>
              <ENT>N/A</ENT>
              <ENT>34.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33762</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Major vessel shunt</ENT>
              <ENT>21.79</ENT>
              <ENT>N/A</ENT>
              <ENT>10.49</ENT>
              <ENT>1.59</ENT>
              <ENT>N/A</ENT>
              <ENT>33.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33764</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Major vessel shunt &amp; graft</ENT>
              <ENT>21.79</ENT>
              <ENT>N/A</ENT>
              <ENT>10.31</ENT>
              <ENT>1.93</ENT>
              <ENT>N/A</ENT>
              <ENT>34.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33766</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Major vessel shunt</ENT>
              <ENT>22.76</ENT>
              <ENT>N/A</ENT>
              <ENT>11.29</ENT>
              <ENT>3.04</ENT>
              <ENT>N/A</ENT>
              <ENT>37.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33767</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Major vessel shunt</ENT>
              <ENT>24.50</ENT>
              <ENT>N/A</ENT>
              <ENT>11.72</ENT>
              <ENT>3.14</ENT>
              <ENT>N/A</ENT>
              <ENT>39.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33770</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair great vessels defect</ENT>
              <ENT>37.00</ENT>
              <ENT>N/A</ENT>
              <ENT>14.71</ENT>
              <ENT>4.49</ENT>
              <ENT>N/A</ENT>
              <ENT>56.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33771</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair great vessels defect</ENT>
              <ENT>34.65</ENT>
              <ENT>N/A</ENT>
              <ENT>12.79</ENT>
              <ENT>4.67</ENT>
              <ENT>N/A</ENT>
              <ENT>52.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33774</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair great vessels defect</ENT>
              <ENT>30.98</ENT>
              <ENT>N/A</ENT>
              <ENT>13.75</ENT>
              <ENT>4.18</ENT>
              <ENT>N/A</ENT>
              <ENT>48.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33775</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair great vessels defect</ENT>
              <ENT>32.20</ENT>
              <ENT>N/A</ENT>
              <ENT>14.58</ENT>
              <ENT>4.34</ENT>
              <ENT>N/A</ENT>
              <ENT>51.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33776</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair great vessels defect</ENT>
              <ENT>34.04</ENT>
              <ENT>N/A</ENT>
              <ENT>15.38</ENT>
              <ENT>4.58</ENT>
              <ENT>N/A</ENT>
              <ENT>54.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33777</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair great vessels defect</ENT>
              <ENT>33.46</ENT>
              <ENT>N/A</ENT>
              <ENT>15.26</ENT>
              <ENT>4.51</ENT>
              <ENT>N/A</ENT>
              <ENT>53.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33778</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair great vessels defect</ENT>
              <ENT>40.00</ENT>
              <ENT>N/A</ENT>
              <ENT>16.75</ENT>
              <ENT>4.83</ENT>
              <ENT>N/A</ENT>
              <ENT>61.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33779</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair great vessels defect</ENT>
              <ENT>36.21</ENT>
              <ENT>N/A</ENT>
              <ENT>15.62</ENT>
              <ENT>2.40</ENT>
              <ENT>N/A</ENT>
              <ENT>54.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33780</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair great vessels defect</ENT>
              <ENT>41.75</ENT>
              <ENT>N/A</ENT>
              <ENT>18.87</ENT>
              <ENT>5.21</ENT>
              <ENT>N/A</ENT>
              <ENT>65.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33781</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair great vessels defect</ENT>
              <ENT>36.45</ENT>
              <ENT>N/A</ENT>
              <ENT>13.94</ENT>
              <ENT>4.91</ENT>
              <ENT>N/A</ENT>
              <ENT>55.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33786</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair arterial trunk</ENT>
              <ENT>39.00</ENT>
              <ENT>N/A</ENT>
              <ENT>16.66</ENT>
              <ENT>4.69</ENT>
              <ENT>N/A</ENT>
              <ENT>60.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33788</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of pulmonary artery</ENT>
              <ENT>26.62</ENT>
              <ENT>N/A</ENT>
              <ENT>12.19</ENT>
              <ENT>3.32</ENT>
              <ENT>N/A</ENT>
              <ENT>42.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Aortic suspension</ENT>
              <ENT>16.24</ENT>
              <ENT>N/A</ENT>
              <ENT>7.87</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>25.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33802</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair vessel defect</ENT>
              <ENT>17.66</ENT>
              <ENT>N/A</ENT>
              <ENT>9.04</ENT>
              <ENT>1.56</ENT>
              <ENT>N/A</ENT>
              <ENT>28.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33803</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair vessel defect</ENT>
              <ENT>19.60</ENT>
              <ENT>N/A</ENT>
              <ENT>9.61</ENT>
              <ENT>2.63</ENT>
              <ENT>N/A</ENT>
              <ENT>31.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33813</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair septal defect</ENT>
              <ENT>20.65</ENT>
              <ENT>N/A</ENT>
              <ENT>10.59</ENT>
              <ENT>2.78</ENT>
              <ENT>N/A</ENT>
              <ENT>34.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33814</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair septal defect</ENT>
              <ENT>25.77</ENT>
              <ENT>N/A</ENT>
              <ENT>12.38</ENT>
              <ENT>2.52</ENT>
              <ENT>N/A</ENT>
              <ENT>40.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise major vessel</ENT>
              <ENT>16.29</ENT>
              <ENT>N/A</ENT>
              <ENT>8.13</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>26.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33822</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise major vessel</ENT>
              <ENT>17.32</ENT>
              <ENT>N/A</ENT>
              <ENT>8.71</ENT>
              <ENT>2.33</ENT>
              <ENT>N/A</ENT>
              <ENT>28.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33824</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise major vessel</ENT>
              <ENT>19.52</ENT>
              <ENT>N/A</ENT>
              <ENT>9.87</ENT>
              <ENT>2.61</ENT>
              <ENT>N/A</ENT>
              <ENT>32.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33840</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove aorta constriction</ENT>
              <ENT>20.63</ENT>
              <ENT>N/A</ENT>
              <ENT>10.08</ENT>
              <ENT>2.36</ENT>
              <ENT>N/A</ENT>
              <ENT>33.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33845</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove aorta constriction</ENT>
              <ENT>22.12</ENT>
              <ENT>N/A</ENT>
              <ENT>11.07</ENT>
              <ENT>2.90</ENT>
              <ENT>N/A</ENT>
              <ENT>36.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33851</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove aorta constriction</ENT>
              <ENT>21.27</ENT>
              <ENT>N/A</ENT>
              <ENT>10.45</ENT>
              <ENT>2.86</ENT>
              <ENT>N/A</ENT>
              <ENT>34.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33852</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair septal defect</ENT>
              <ENT>23.71</ENT>
              <ENT>N/A</ENT>
              <ENT>11.32</ENT>
              <ENT>3.19</ENT>
              <ENT>N/A</ENT>
              <ENT>38.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49118"/>
              <ENT I="01">33853</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair septal defect</ENT>
              <ENT>31.72</ENT>
              <ENT>N/A</ENT>
              <ENT>14.46</ENT>
              <ENT>4.23</ENT>
              <ENT>N/A</ENT>
              <ENT>50.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33860</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ascending aortic graft</ENT>
              <ENT>38.00</ENT>
              <ENT>N/A</ENT>
              <ENT>16.22</ENT>
              <ENT>4.30</ENT>
              <ENT>N/A</ENT>
              <ENT>58.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33861</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ascending aortic graft</ENT>
              <ENT>42.00</ENT>
              <ENT>N/A</ENT>
              <ENT>17.49</ENT>
              <ENT>4.24</ENT>
              <ENT>N/A</ENT>
              <ENT>63.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33863</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ascending aortic graft</ENT>
              <ENT>45.00</ENT>
              <ENT>N/A</ENT>
              <ENT>18.45</ENT>
              <ENT>4.60</ENT>
              <ENT>N/A</ENT>
              <ENT>68.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33870</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transverse aortic arch graft</ENT>
              <ENT>44.00</ENT>
              <ENT>N/A</ENT>
              <ENT>18.16</ENT>
              <ENT>5.09</ENT>
              <ENT>N/A</ENT>
              <ENT>67.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33875</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracic aortic graft</ENT>
              <ENT>33.06</ENT>
              <ENT>N/A</ENT>
              <ENT>14.04</ENT>
              <ENT>4.08</ENT>
              <ENT>N/A</ENT>
              <ENT>51.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33877</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracoabdominal graft</ENT>
              <ENT>42.60</ENT>
              <ENT>N/A</ENT>
              <ENT>16.81</ENT>
              <ENT>5.07</ENT>
              <ENT>N/A</ENT>
              <ENT>64.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33910</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove lung artery emboli</ENT>
              <ENT>24.59</ENT>
              <ENT>N/A</ENT>
              <ENT>11.37</ENT>
              <ENT>3.06</ENT>
              <ENT>N/A</ENT>
              <ENT>39.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33915</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove lung artery emboli</ENT>
              <ENT>21.02</ENT>
              <ENT>N/A</ENT>
              <ENT>9.78</ENT>
              <ENT>1.20</ENT>
              <ENT>N/A</ENT>
              <ENT>32.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33916</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Surgery of great vessel</ENT>
              <ENT>25.83</ENT>
              <ENT>N/A</ENT>
              <ENT>11.48</ENT>
              <ENT>3.04</ENT>
              <ENT>N/A</ENT>
              <ENT>40.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33917</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair pulmonary artery</ENT>
              <ENT>24.50</ENT>
              <ENT>N/A</ENT>
              <ENT>11.96</ENT>
              <ENT>3.17</ENT>
              <ENT>N/A</ENT>
              <ENT>39.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33918</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair pulmonary atresia</ENT>
              <ENT>26.45</ENT>
              <ENT>N/A</ENT>
              <ENT>12.37</ENT>
              <ENT>3.42</ENT>
              <ENT>N/A</ENT>
              <ENT>42.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33919</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair pulmonary atresia</ENT>
              <ENT>40.00</ENT>
              <ENT>N/A</ENT>
              <ENT>17.32</ENT>
              <ENT>3.48</ENT>
              <ENT>N/A</ENT>
              <ENT>60.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33920</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair pulmonary atresia</ENT>
              <ENT>31.95</ENT>
              <ENT>N/A</ENT>
              <ENT>13.90</ENT>
              <ENT>3.61</ENT>
              <ENT>N/A</ENT>
              <ENT>49.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33922</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transect pulmonary artery</ENT>
              <ENT>23.52</ENT>
              <ENT>N/A</ENT>
              <ENT>10.91</ENT>
              <ENT>2.30</ENT>
              <ENT>N/A</ENT>
              <ENT>36.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33924</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove pulmonary shunt</ENT>
              <ENT>5.50</ENT>
              <ENT>N/A</ENT>
              <ENT>1.82</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>8.06</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33935</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Transplantation, heart/lung</ENT>
              <ENT>60.96</ENT>
              <ENT>N/A</ENT>
              <ENT>25.80</ENT>
              <ENT>8.15</ENT>
              <ENT>N/A</ENT>
              <ENT>94.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33945</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Transplantation of heart</ENT>
              <ENT>42.10</ENT>
              <ENT>N/A</ENT>
              <ENT>18.74</ENT>
              <ENT>5.42</ENT>
              <ENT>N/A</ENT>
              <ENT>66.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33960</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>External circulation assist</ENT>
              <ENT>19.36</ENT>
              <ENT>N/A</ENT>
              <ENT>4.93</ENT>
              <ENT>2.14</ENT>
              <ENT>N/A</ENT>
              <ENT>26.43</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33961</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>External circulation assist</ENT>
              <ENT>10.93</ENT>
              <ENT>N/A</ENT>
              <ENT>3.63</ENT>
              <ENT>1.47</ENT>
              <ENT>N/A</ENT>
              <ENT>16.03</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33967</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert ia percut device</ENT>
              <ENT>4.85</ENT>
              <ENT>N/A</ENT>
              <ENT>1.87</ENT>
              <ENT>0.28</ENT>
              <ENT>N/A</ENT>
              <ENT>7.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33968</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove aortic assist device</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>0.23</ENT>
              <ENT>0.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.94</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33970</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Aortic circulation assist</ENT>
              <ENT>6.75</ENT>
              <ENT>N/A</ENT>
              <ENT>2.28</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>9.73</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33971</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Aortic circulation assist</ENT>
              <ENT>9.69</ENT>
              <ENT>N/A</ENT>
              <ENT>6.06</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>16.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33973</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert balloon device</ENT>
              <ENT>9.76</ENT>
              <ENT>N/A</ENT>
              <ENT>3.30</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>14.07</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33974</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove intra-aortic balloon</ENT>
              <ENT>14.41</ENT>
              <ENT>N/A</ENT>
              <ENT>8.04</ENT>
              <ENT>1.48</ENT>
              <ENT>N/A</ENT>
              <ENT>23.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33975</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant ventricular device</ENT>
              <ENT>21.00</ENT>
              <ENT>N/A</ENT>
              <ENT>6.25</ENT>
              <ENT>1.72</ENT>
              <ENT>N/A</ENT>
              <ENT>28.97</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33976</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant ventricular device</ENT>
              <ENT>23.00</ENT>
              <ENT>N/A</ENT>
              <ENT>7.50</ENT>
              <ENT>2.82</ENT>
              <ENT>N/A</ENT>
              <ENT>33.32</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33977</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove ventricular device</ENT>
              <ENT>19.29</ENT>
              <ENT>N/A</ENT>
              <ENT>10.79</ENT>
              <ENT>2.44</ENT>
              <ENT>N/A</ENT>
              <ENT>32.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33978</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove ventricular device</ENT>
              <ENT>21.73</ENT>
              <ENT>N/A</ENT>
              <ENT>11.66</ENT>
              <ENT>2.66</ENT>
              <ENT>N/A</ENT>
              <ENT>36.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33979</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert intracorporeal device</ENT>
              <ENT>46.00</ENT>
              <ENT>N/A</ENT>
              <ENT>14.79</ENT>
              <ENT>3.98</ENT>
              <ENT>N/A</ENT>
              <ENT>64.77</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33980</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove intracorporeal device</ENT>
              <ENT>56.25</ENT>
              <ENT>N/A</ENT>
              <ENT>24.81</ENT>
              <ENT>4.60</ENT>
              <ENT>N/A</ENT>
              <ENT>85.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">33999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Cardiac surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34001</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of artery clot</ENT>
              <ENT>12.91</ENT>
              <ENT>N/A</ENT>
              <ENT>6.72</ENT>
              <ENT>1.46</ENT>
              <ENT>N/A</ENT>
              <ENT>21.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34051</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of artery clot</ENT>
              <ENT>15.21</ENT>
              <ENT>N/A</ENT>
              <ENT>7.62</ENT>
              <ENT>1.90</ENT>
              <ENT>N/A</ENT>
              <ENT>24.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34101</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of artery clot</ENT>
              <ENT>10.00</ENT>
              <ENT>N/A</ENT>
              <ENT>5.40</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>16.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34111</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of arm artery clot</ENT>
              <ENT>10.00</ENT>
              <ENT>N/A</ENT>
              <ENT>5.42</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>16.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34151</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of artery clot</ENT>
              <ENT>25.00</ENT>
              <ENT>N/A</ENT>
              <ENT>10.63</ENT>
              <ENT>1.84</ENT>
              <ENT>N/A</ENT>
              <ENT>37.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34201</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of artery clot</ENT>
              <ENT>10.03</ENT>
              <ENT>N/A</ENT>
              <ENT>5.50</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>16.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34203</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of leg artery clot</ENT>
              <ENT>16.50</ENT>
              <ENT>N/A</ENT>
              <ENT>8.15</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>26.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34401</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of vein clot</ENT>
              <ENT>25.00</ENT>
              <ENT>N/A</ENT>
              <ENT>10.82</ENT>
              <ENT>1.20</ENT>
              <ENT>N/A</ENT>
              <ENT>37.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34421</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of vein clot</ENT>
              <ENT>12.00</ENT>
              <ENT>N/A</ENT>
              <ENT>6.38</ENT>
              <ENT>0.95</ENT>
              <ENT>N/A</ENT>
              <ENT>19.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34451</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of vein clot</ENT>
              <ENT>27.00</ENT>
              <ENT>N/A</ENT>
              <ENT>11.53</ENT>
              <ENT>1.59</ENT>
              <ENT>N/A</ENT>
              <ENT>40.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34471</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of vein clot</ENT>
              <ENT>10.18</ENT>
              <ENT>N/A</ENT>
              <ENT>5.44</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>16.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34490</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of vein clot</ENT>
              <ENT>9.86</ENT>
              <ENT>N/A</ENT>
              <ENT>5.51</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>16.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34501</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair valve, femoral vein</ENT>
              <ENT>16.00</ENT>
              <ENT>N/A</ENT>
              <ENT>8.44</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>25.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34502</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct vena cava</ENT>
              <ENT>26.95</ENT>
              <ENT>N/A</ENT>
              <ENT>12.31</ENT>
              <ENT>2.99</ENT>
              <ENT>N/A</ENT>
              <ENT>42.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transposition of vein valve</ENT>
              <ENT>18.95</ENT>
              <ENT>N/A</ENT>
              <ENT>9.42</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>29.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cross-over vein graft</ENT>
              <ENT>17.95</ENT>
              <ENT>N/A</ENT>
              <ENT>8.86</ENT>
              <ENT>1.41</ENT>
              <ENT>N/A</ENT>
              <ENT>28.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Leg vein fusion</ENT>
              <ENT>16.64</ENT>
              <ENT>N/A</ENT>
              <ENT>8.67</ENT>
              <ENT>2.06</ENT>
              <ENT>N/A</ENT>
              <ENT>27.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endovasc abdo repair w/tube</ENT>
              <ENT>20.75</ENT>
              <ENT>N/A</ENT>
              <ENT>9.23</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>31.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34802</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endovasc abdo repr w/device</ENT>
              <ENT>23.00</ENT>
              <ENT>N/A</ENT>
              <ENT>9.93</ENT>
              <ENT>1.65</ENT>
              <ENT>N/A</ENT>
              <ENT>34.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34804</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endovasc abdo repr w/device</ENT>
              <ENT>23.00</ENT>
              <ENT>N/A</ENT>
              <ENT>9.92</ENT>
              <ENT>1.65</ENT>
              <ENT>N/A</ENT>
              <ENT>34.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34808</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endovasc abdo occlud device</ENT>
              <ENT>4.13</ENT>
              <ENT>N/A</ENT>
              <ENT>1.39</ENT>
              <ENT>0.29</ENT>
              <ENT>N/A</ENT>
              <ENT>5.81</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49119"/>
              <ENT I="01">34812</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Xpose for endoprosth, femorl</ENT>
              <ENT>6.75</ENT>
              <ENT>N/A</ENT>
              <ENT>2.27</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>9.51</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34813</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Femoral endovas graft add-on</ENT>
              <ENT>4.80</ENT>
              <ENT>N/A</ENT>
              <ENT>1.59</ENT>
              <ENT>0.34</ENT>
              <ENT>N/A</ENT>
              <ENT>6.73</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Xpose for endoprosth, iliac</ENT>
              <ENT>9.75</ENT>
              <ENT>N/A</ENT>
              <ENT>3.29</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>13.74</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34825</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endovasc extend prosth, init</ENT>
              <ENT>12.00</ENT>
              <ENT>N/A</ENT>
              <ENT>6.21</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>19.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34826</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endovasc exten prosth, addl</ENT>
              <ENT>4.13</ENT>
              <ENT>N/A</ENT>
              <ENT>1.40</ENT>
              <ENT>0.29</ENT>
              <ENT>N/A</ENT>
              <ENT>5.82</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34830</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Open aortic tube prosth repr</ENT>
              <ENT>32.59</ENT>
              <ENT>N/A</ENT>
              <ENT>13.76</ENT>
              <ENT>2.34</ENT>
              <ENT>N/A</ENT>
              <ENT>48.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34831</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Open aortoiliac prosth repr</ENT>
              <ENT>35.34</ENT>
              <ENT>N/A</ENT>
              <ENT>11.91</ENT>
              <ENT>2.53</ENT>
              <ENT>N/A</ENT>
              <ENT>49.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34832</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Open aortofemor prosth repr</ENT>
              <ENT>35.34</ENT>
              <ENT>N/A</ENT>
              <ENT>14.76</ENT>
              <ENT>2.53</ENT>
              <ENT>N/A</ENT>
              <ENT>52.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34833</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Xpose for endoprosth, iliac</ENT>
              <ENT>12.00</ENT>
              <ENT>N/A</ENT>
              <ENT>4.58</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>17.28</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34834</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Xpose, endoprosth, brachial</ENT>
              <ENT>5.35</ENT>
              <ENT>N/A</ENT>
              <ENT>2.26</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>8.10</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">34900</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endovasc iliac repr w/graft</ENT>
              <ENT>16.38</ENT>
              <ENT>N/A</ENT>
              <ENT>7.96</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>25.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35001</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair defect of artery</ENT>
              <ENT>19.64</ENT>
              <ENT>N/A</ENT>
              <ENT>9.52</ENT>
              <ENT>2.44</ENT>
              <ENT>N/A</ENT>
              <ENT>31.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35002</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair artery rupture, neck</ENT>
              <ENT>21.00</ENT>
              <ENT>N/A</ENT>
              <ENT>9.79</ENT>
              <ENT>1.82</ENT>
              <ENT>N/A</ENT>
              <ENT>32.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35005</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair defect of artery</ENT>
              <ENT>18.12</ENT>
              <ENT>N/A</ENT>
              <ENT>8.86</ENT>
              <ENT>1.35</ENT>
              <ENT>N/A</ENT>
              <ENT>28.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35011</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair defect of artery</ENT>
              <ENT>18.00</ENT>
              <ENT>N/A</ENT>
              <ENT>8.07</ENT>
              <ENT>1.30</ENT>
              <ENT>N/A</ENT>
              <ENT>27.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35013</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair artery rupture, arm</ENT>
              <ENT>22.00</ENT>
              <ENT>N/A</ENT>
              <ENT>9.76</ENT>
              <ENT>1.91</ENT>
              <ENT>N/A</ENT>
              <ENT>33.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35021</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair defect of artery</ENT>
              <ENT>19.65</ENT>
              <ENT>N/A</ENT>
              <ENT>9.29</ENT>
              <ENT>1.93</ENT>
              <ENT>N/A</ENT>
              <ENT>30.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35022</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair artery rupture, chest</ENT>
              <ENT>23.18</ENT>
              <ENT>N/A</ENT>
              <ENT>10.08</ENT>
              <ENT>1.99</ENT>
              <ENT>N/A</ENT>
              <ENT>35.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35045</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair defect of arm artery</ENT>
              <ENT>17.57</ENT>
              <ENT>N/A</ENT>
              <ENT>7.73</ENT>
              <ENT>1.25</ENT>
              <ENT>N/A</ENT>
              <ENT>26.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35081</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair defect of artery</ENT>
              <ENT>28.01</ENT>
              <ENT>N/A</ENT>
              <ENT>11.52</ENT>
              <ENT>3.20</ENT>
              <ENT>N/A</ENT>
              <ENT>42.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35082</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair artery rupture, aorta</ENT>
              <ENT>38.50</ENT>
              <ENT>N/A</ENT>
              <ENT>15.52</ENT>
              <ENT>4.07</ENT>
              <ENT>N/A</ENT>
              <ENT>58.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35091</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair defect of artery</ENT>
              <ENT>35.40</ENT>
              <ENT>N/A</ENT>
              <ENT>13.78</ENT>
              <ENT>4.09</ENT>
              <ENT>N/A</ENT>
              <ENT>53.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35092</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair artery rupture, aorta</ENT>
              <ENT>45.00</ENT>
              <ENT>N/A</ENT>
              <ENT>17.92</ENT>
              <ENT>4.31</ENT>
              <ENT>N/A</ENT>
              <ENT>67.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35102</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair defect of artery</ENT>
              <ENT>30.76</ENT>
              <ENT>N/A</ENT>
              <ENT>12.60</ENT>
              <ENT>3.44</ENT>
              <ENT>N/A</ENT>
              <ENT>46.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35103</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair artery rupture, groin</ENT>
              <ENT>40.50</ENT>
              <ENT>N/A</ENT>
              <ENT>16.13</ENT>
              <ENT>3.79</ENT>
              <ENT>N/A</ENT>
              <ENT>60.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35111</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair defect of artery</ENT>
              <ENT>25.00</ENT>
              <ENT>N/A</ENT>
              <ENT>10.58</ENT>
              <ENT>1.81</ENT>
              <ENT>N/A</ENT>
              <ENT>37.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35112</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair artery rupture,spleen</ENT>
              <ENT>30.00</ENT>
              <ENT>N/A</ENT>
              <ENT>12.22</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>44.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35121</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair defect of artery</ENT>
              <ENT>30.00</ENT>
              <ENT>N/A</ENT>
              <ENT>12.57</ENT>
              <ENT>2.93</ENT>
              <ENT>N/A</ENT>
              <ENT>45.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35122</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair artery rupture, belly</ENT>
              <ENT>35.00</ENT>
              <ENT>N/A</ENT>
              <ENT>14.09</ENT>
              <ENT>3.54</ENT>
              <ENT>N/A</ENT>
              <ENT>52.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35131</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair defect of artery</ENT>
              <ENT>25.00</ENT>
              <ENT>N/A</ENT>
              <ENT>10.89</ENT>
              <ENT>2.11</ENT>
              <ENT>N/A</ENT>
              <ENT>38.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35132</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair artery rupture, groin</ENT>
              <ENT>30.00</ENT>
              <ENT>N/A</ENT>
              <ENT>12.58</ENT>
              <ENT>2.48</ENT>
              <ENT>N/A</ENT>
              <ENT>45.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35141</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair defect of artery</ENT>
              <ENT>20.00</ENT>
              <ENT>N/A</ENT>
              <ENT>9.01</ENT>
              <ENT>1.65</ENT>
              <ENT>N/A</ENT>
              <ENT>30.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35142</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair artery rupture, thigh</ENT>
              <ENT>23.30</ENT>
              <ENT>N/A</ENT>
              <ENT>10.48</ENT>
              <ENT>1.75</ENT>
              <ENT>N/A</ENT>
              <ENT>35.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35151</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair defect of artery</ENT>
              <ENT>22.64</ENT>
              <ENT>N/A</ENT>
              <ENT>10.11</ENT>
              <ENT>1.93</ENT>
              <ENT>N/A</ENT>
              <ENT>34.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35152</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair artery rupture, knee</ENT>
              <ENT>25.62</ENT>
              <ENT>N/A</ENT>
              <ENT>11.43</ENT>
              <ENT>1.93</ENT>
              <ENT>N/A</ENT>
              <ENT>38.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35161</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair defect of artery</ENT>
              <ENT>18.76</ENT>
              <ENT>N/A</ENT>
              <ENT>9.16</ENT>
              <ENT>2.21</ENT>
              <ENT>N/A</ENT>
              <ENT>30.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35162</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair artery rupture</ENT>
              <ENT>19.78</ENT>
              <ENT>N/A</ENT>
              <ENT>9.64</ENT>
              <ENT>2.21</ENT>
              <ENT>N/A</ENT>
              <ENT>31.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35180</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>13.62</ENT>
              <ENT>N/A</ENT>
              <ENT>7.02</ENT>
              <ENT>1.44</ENT>
              <ENT>N/A</ENT>
              <ENT>22.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35182</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>30.00</ENT>
              <ENT>N/A</ENT>
              <ENT>12.93</ENT>
              <ENT>1.88</ENT>
              <ENT>N/A</ENT>
              <ENT>44.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35184</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>18.00</ENT>
              <ENT>N/A</ENT>
              <ENT>8.38</ENT>
              <ENT>1.34</ENT>
              <ENT>N/A</ENT>
              <ENT>27.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35188</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>14.28</ENT>
              <ENT>N/A</ENT>
              <ENT>7.60</ENT>
              <ENT>1.53</ENT>
              <ENT>N/A</ENT>
              <ENT>23.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35189</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>28.00</ENT>
              <ENT>N/A</ENT>
              <ENT>12.09</ENT>
              <ENT>2.12</ENT>
              <ENT>N/A</ENT>
              <ENT>42.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35190</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>12.75</ENT>
              <ENT>N/A</ENT>
              <ENT>6.54</ENT>
              <ENT>1.33</ENT>
              <ENT>N/A</ENT>
              <ENT>20.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35201</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>16.14</ENT>
              <ENT>N/A</ENT>
              <ENT>8.01</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>25.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35206</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>13.25</ENT>
              <ENT>N/A</ENT>
              <ENT>6.72</ENT>
              <ENT>1.04</ENT>
              <ENT>N/A</ENT>
              <ENT>21.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35207</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>10.15</ENT>
              <ENT>N/A</ENT>
              <ENT>7.85</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>19.15</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35211</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>22.12</ENT>
              <ENT>N/A</ENT>
              <ENT>10.47</ENT>
              <ENT>2.83</ENT>
              <ENT>N/A</ENT>
              <ENT>35.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35216</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>18.75</ENT>
              <ENT>N/A</ENT>
              <ENT>8.95</ENT>
              <ENT>2.17</ENT>
              <ENT>N/A</ENT>
              <ENT>29.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35221</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>24.39</ENT>
              <ENT>N/A</ENT>
              <ENT>10.20</ENT>
              <ENT>1.79</ENT>
              <ENT>N/A</ENT>
              <ENT>36.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35226</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>14.50</ENT>
              <ENT>N/A</ENT>
              <ENT>7.72</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>23.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49120"/>
              <ENT I="01">35231</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>20.00</ENT>
              <ENT>N/A</ENT>
              <ENT>9.91</ENT>
              <ENT>1.32</ENT>
              <ENT>N/A</ENT>
              <ENT>31.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35236</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>17.11</ENT>
              <ENT>N/A</ENT>
              <ENT>8.08</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>26.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35241</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>23.12</ENT>
              <ENT>N/A</ENT>
              <ENT>10.91</ENT>
              <ENT>2.90</ENT>
              <ENT>N/A</ENT>
              <ENT>36.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35246</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>26.45</ENT>
              <ENT>N/A</ENT>
              <ENT>11.40</ENT>
              <ENT>2.22</ENT>
              <ENT>N/A</ENT>
              <ENT>40.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35251</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>30.20</ENT>
              <ENT>N/A</ENT>
              <ENT>12.11</ENT>
              <ENT>1.87</ENT>
              <ENT>N/A</ENT>
              <ENT>44.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35256</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>18.36</ENT>
              <ENT>N/A</ENT>
              <ENT>8.44</ENT>
              <ENT>1.32</ENT>
              <ENT>N/A</ENT>
              <ENT>28.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35261</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>17.80</ENT>
              <ENT>N/A</ENT>
              <ENT>8.10</ENT>
              <ENT>1.34</ENT>
              <ENT>N/A</ENT>
              <ENT>27.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35266</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>14.91</ENT>
              <ENT>N/A</ENT>
              <ENT>7.16</ENT>
              <ENT>1.16</ENT>
              <ENT>N/A</ENT>
              <ENT>23.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35271</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>22.12</ENT>
              <ENT>N/A</ENT>
              <ENT>10.37</ENT>
              <ENT>2.77</ENT>
              <ENT>N/A</ENT>
              <ENT>35.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35276</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>24.25</ENT>
              <ENT>N/A</ENT>
              <ENT>11.17</ENT>
              <ENT>2.37</ENT>
              <ENT>N/A</ENT>
              <ENT>37.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35281</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>28.00</ENT>
              <ENT>N/A</ENT>
              <ENT>11.93</ENT>
              <ENT>1.82</ENT>
              <ENT>N/A</ENT>
              <ENT>41.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35286</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair blood vessel lesion</ENT>
              <ENT>16.16</ENT>
              <ENT>N/A</ENT>
              <ENT>8.18</ENT>
              <ENT>1.36</ENT>
              <ENT>N/A</ENT>
              <ENT>25.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35301</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rechanneling of artery</ENT>
              <ENT>18.70</ENT>
              <ENT>N/A</ENT>
              <ENT>8.49</ENT>
              <ENT>2.23</ENT>
              <ENT>N/A</ENT>
              <ENT>29.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35311</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rechanneling of artery</ENT>
              <ENT>27.00</ENT>
              <ENT>N/A</ENT>
              <ENT>11.61</ENT>
              <ENT>2.75</ENT>
              <ENT>N/A</ENT>
              <ENT>41.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35321</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rechanneling of artery</ENT>
              <ENT>16.00</ENT>
              <ENT>N/A</ENT>
              <ENT>7.41</ENT>
              <ENT>1.36</ENT>
              <ENT>N/A</ENT>
              <ENT>24.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35331</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rechanneling of artery</ENT>
              <ENT>26.20</ENT>
              <ENT>N/A</ENT>
              <ENT>11.37</ENT>
              <ENT>2.71</ENT>
              <ENT>N/A</ENT>
              <ENT>40.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35341</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rechanneling of artery</ENT>
              <ENT>25.11</ENT>
              <ENT>N/A</ENT>
              <ENT>11.02</ENT>
              <ENT>2.87</ENT>
              <ENT>N/A</ENT>
              <ENT>39.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35351</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rechanneling of artery</ENT>
              <ENT>23.00</ENT>
              <ENT>N/A</ENT>
              <ENT>9.80</ENT>
              <ENT>2.29</ENT>
              <ENT>N/A</ENT>
              <ENT>35.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35355</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rechanneling of artery</ENT>
              <ENT>18.50</ENT>
              <ENT>N/A</ENT>
              <ENT>8.28</ENT>
              <ENT>1.80</ENT>
              <ENT>N/A</ENT>
              <ENT>28.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35361</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rechanneling of artery</ENT>
              <ENT>28.20</ENT>
              <ENT>N/A</ENT>
              <ENT>11.91</ENT>
              <ENT>2.66</ENT>
              <ENT>N/A</ENT>
              <ENT>42.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35363</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rechanneling of artery</ENT>
              <ENT>30.20</ENT>
              <ENT>N/A</ENT>
              <ENT>12.73</ENT>
              <ENT>2.77</ENT>
              <ENT>N/A</ENT>
              <ENT>45.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35371</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rechanneling of artery</ENT>
              <ENT>14.72</ENT>
              <ENT>N/A</ENT>
              <ENT>7.08</ENT>
              <ENT>1.32</ENT>
              <ENT>N/A</ENT>
              <ENT>23.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35372</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rechanneling of artery</ENT>
              <ENT>18.00</ENT>
              <ENT>N/A</ENT>
              <ENT>8.20</ENT>
              <ENT>1.53</ENT>
              <ENT>N/A</ENT>
              <ENT>27.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35381</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rechanneling of artery</ENT>
              <ENT>15.81</ENT>
              <ENT>N/A</ENT>
              <ENT>7.85</ENT>
              <ENT>1.80</ENT>
              <ENT>N/A</ENT>
              <ENT>25.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35390</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reoperation, carotid add-on</ENT>
              <ENT>3.19</ENT>
              <ENT>N/A</ENT>
              <ENT>1.07</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>4.64</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Angioscopy</ENT>
              <ENT>3.00</ENT>
              <ENT>N/A</ENT>
              <ENT>1.05</ENT>
              <ENT>0.34</ENT>
              <ENT>N/A</ENT>
              <ENT>4.39</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair arterial blockage</ENT>
              <ENT>10.07</ENT>
              <ENT>N/A</ENT>
              <ENT>4.07</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>14.98</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35452</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair arterial blockage</ENT>
              <ENT>6.91</ENT>
              <ENT>N/A</ENT>
              <ENT>3.17</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>10.84</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35454</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair arterial blockage</ENT>
              <ENT>6.04</ENT>
              <ENT>N/A</ENT>
              <ENT>2.85</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>9.56</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35456</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair arterial blockage</ENT>
              <ENT>7.35</ENT>
              <ENT>N/A</ENT>
              <ENT>3.29</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>11.46</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35458</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair arterial blockage</ENT>
              <ENT>9.49</ENT>
              <ENT>N/A</ENT>
              <ENT>4.00</ENT>
              <ENT>1.09</ENT>
              <ENT>N/A</ENT>
              <ENT>14.58</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35459</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair arterial blockage</ENT>
              <ENT>8.63</ENT>
              <ENT>N/A</ENT>
              <ENT>3.66</ENT>
              <ENT>0.96</ENT>
              <ENT>N/A</ENT>
              <ENT>13.25</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35460</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair venous blockage</ENT>
              <ENT>6.04</ENT>
              <ENT>N/A</ENT>
              <ENT>2.70</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>9.40</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35470</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair arterial blockage</ENT>
              <ENT>8.63</ENT>
              <ENT>N/A</ENT>
              <ENT>3.89</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>13.02</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35471</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair arterial blockage</ENT>
              <ENT>10.07</ENT>
              <ENT>N/A</ENT>
              <ENT>4.51</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>15.08</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35472</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair arterial blockage</ENT>
              <ENT>6.91</ENT>
              <ENT>N/A</ENT>
              <ENT>3.27</ENT>
              <ENT>0.39</ENT>
              <ENT>N/A</ENT>
              <ENT>10.57</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35473</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair arterial blockage</ENT>
              <ENT>6.04</ENT>
              <ENT>N/A</ENT>
              <ENT>2.94</ENT>
              <ENT>0.34</ENT>
              <ENT>N/A</ENT>
              <ENT>9.32</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35474</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair arterial blockage</ENT>
              <ENT>7.36</ENT>
              <ENT>N/A</ENT>
              <ENT>2.92</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>10.68</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35475</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Repair arterial blockage</ENT>
              <ENT>9.49</ENT>
              <ENT>N/A</ENT>
              <ENT>4.10</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>14.06</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35476</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair venous blockage</ENT>
              <ENT>6.04</ENT>
              <ENT>N/A</ENT>
              <ENT>2.87</ENT>
              <ENT>0.27</ENT>
              <ENT>N/A</ENT>
              <ENT>9.18</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35480</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Atherectomy, open</ENT>
              <ENT>11.08</ENT>
              <ENT>N/A</ENT>
              <ENT>4.55</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>16.76</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35481</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Atherectomy, open</ENT>
              <ENT>7.61</ENT>
              <ENT>N/A</ENT>
              <ENT>3.46</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>11.91</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35482</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Atherectomy, open</ENT>
              <ENT>6.65</ENT>
              <ENT>N/A</ENT>
              <ENT>3.10</ENT>
              <ENT>0.75</ENT>
              <ENT>N/A</ENT>
              <ENT>10.50</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35483</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Atherectomy, open</ENT>
              <ENT>8.10</ENT>
              <ENT>N/A</ENT>
              <ENT>3.55</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>12.46</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35484</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Atherectomy, open</ENT>
              <ENT>10.44</ENT>
              <ENT>N/A</ENT>
              <ENT>4.26</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>15.83</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35485</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Atherectomy, open</ENT>
              <ENT>9.49</ENT>
              <ENT>N/A</ENT>
              <ENT>4.08</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>14.63</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35490</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Atherectomy, percutaneous</ENT>
              <ENT>11.08</ENT>
              <ENT>N/A</ENT>
              <ENT>4.78</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>16.41</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35491</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Atherectomy, percutaneous</ENT>
              <ENT>7.61</ENT>
              <ENT>N/A</ENT>
              <ENT>3.34</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>11.44</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35492</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Atherectomy, percutaneous</ENT>
              <ENT>6.65</ENT>
              <ENT>N/A</ENT>
              <ENT>3.22</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>10.30</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35493</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Atherectomy, percutaneous</ENT>
              <ENT>8.10</ENT>
              <ENT>N/A</ENT>
              <ENT>3.85</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>12.42</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35494</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Atherectomy, percutaneous</ENT>
              <ENT>10.44</ENT>
              <ENT>N/A</ENT>
              <ENT>4.44</ENT>
              <ENT>0.48</ENT>
              <ENT>N/A</ENT>
              <ENT>15.36</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35495</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Atherectomy, percutaneous</ENT>
              <ENT>9.49</ENT>
              <ENT>N/A</ENT>
              <ENT>4.45</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>14.45</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Harvest vein for bypass</ENT>
              <ENT>6.45</ENT>
              <ENT>N/A</ENT>
              <ENT>2.06</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>9.14</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35501</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>19.19</ENT>
              <ENT>N/A</ENT>
              <ENT>8.45</ENT>
              <ENT>2.33</ENT>
              <ENT>N/A</ENT>
              <ENT>29.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35506</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>19.67</ENT>
              <ENT>N/A</ENT>
              <ENT>9.38</ENT>
              <ENT>2.33</ENT>
              <ENT>N/A</ENT>
              <ENT>31.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35507</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>19.67</ENT>
              <ENT>N/A</ENT>
              <ENT>9.36</ENT>
              <ENT>2.27</ENT>
              <ENT>N/A</ENT>
              <ENT>31.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35508</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>18.65</ENT>
              <ENT>N/A</ENT>
              <ENT>9.27</ENT>
              <ENT>2.34</ENT>
              <ENT>N/A</ENT>
              <ENT>30.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35509</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>18.07</ENT>
              <ENT>N/A</ENT>
              <ENT>8.75</ENT>
              <ENT>2.12</ENT>
              <ENT>N/A</ENT>
              <ENT>28.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35511</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>21.20</ENT>
              <ENT>N/A</ENT>
              <ENT>9.43</ENT>
              <ENT>1.74</ENT>
              <ENT>N/A</ENT>
              <ENT>32.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49121"/>
              <ENT I="01">35515</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>18.65</ENT>
              <ENT>N/A</ENT>
              <ENT>9.22</ENT>
              <ENT>2.26</ENT>
              <ENT>N/A</ENT>
              <ENT>30.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35516</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>16.32</ENT>
              <ENT>N/A</ENT>
              <ENT>6.81</ENT>
              <ENT>1.88</ENT>
              <ENT>N/A</ENT>
              <ENT>25.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35518</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>21.20</ENT>
              <ENT>N/A</ENT>
              <ENT>9.12</ENT>
              <ENT>1.78</ENT>
              <ENT>N/A</ENT>
              <ENT>32.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35521</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>22.20</ENT>
              <ENT>N/A</ENT>
              <ENT>9.94</ENT>
              <ENT>1.82</ENT>
              <ENT>N/A</ENT>
              <ENT>33.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35526</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>29.95</ENT>
              <ENT>N/A</ENT>
              <ENT>12.49</ENT>
              <ENT>2.18</ENT>
              <ENT>N/A</ENT>
              <ENT>44.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35531</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>36.20</ENT>
              <ENT>N/A</ENT>
              <ENT>14.73</ENT>
              <ENT>2.91</ENT>
              <ENT>N/A</ENT>
              <ENT>53.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35533</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>28.00</ENT>
              <ENT>N/A</ENT>
              <ENT>11.91</ENT>
              <ENT>2.35</ENT>
              <ENT>N/A</ENT>
              <ENT>42.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35536</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>31.70</ENT>
              <ENT>N/A</ENT>
              <ENT>13.21</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>47.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35541</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>25.80</ENT>
              <ENT>N/A</ENT>
              <ENT>11.28</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>39.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35546</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>25.54</ENT>
              <ENT>N/A</ENT>
              <ENT>10.99</ENT>
              <ENT>2.84</ENT>
              <ENT>N/A</ENT>
              <ENT>39.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35548</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>21.57</ENT>
              <ENT>N/A</ENT>
              <ENT>9.54</ENT>
              <ENT>2.45</ENT>
              <ENT>N/A</ENT>
              <ENT>33.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35549</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>23.35</ENT>
              <ENT>N/A</ENT>
              <ENT>10.39</ENT>
              <ENT>2.77</ENT>
              <ENT>N/A</ENT>
              <ENT>36.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35551</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>26.67</ENT>
              <ENT>N/A</ENT>
              <ENT>11.52</ENT>
              <ENT>3.19</ENT>
              <ENT>N/A</ENT>
              <ENT>41.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35556</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>21.76</ENT>
              <ENT>N/A</ENT>
              <ENT>9.82</ENT>
              <ENT>2.48</ENT>
              <ENT>N/A</ENT>
              <ENT>34.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35558</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>21.20</ENT>
              <ENT>N/A</ENT>
              <ENT>9.64</ENT>
              <ENT>1.58</ENT>
              <ENT>N/A</ENT>
              <ENT>32.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35560</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>32.00</ENT>
              <ENT>N/A</ENT>
              <ENT>13.46</ENT>
              <ENT>2.73</ENT>
              <ENT>N/A</ENT>
              <ENT>48.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35563</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>24.20</ENT>
              <ENT>N/A</ENT>
              <ENT>10.67</ENT>
              <ENT>1.68</ENT>
              <ENT>N/A</ENT>
              <ENT>36.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35565</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>23.20</ENT>
              <ENT>N/A</ENT>
              <ENT>10.31</ENT>
              <ENT>1.71</ENT>
              <ENT>N/A</ENT>
              <ENT>35.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35566</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>26.92</ENT>
              <ENT>N/A</ENT>
              <ENT>11.51</ENT>
              <ENT>3.02</ENT>
              <ENT>N/A</ENT>
              <ENT>41.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35571</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>24.06</ENT>
              <ENT>N/A</ENT>
              <ENT>11.25</ENT>
              <ENT>2.14</ENT>
              <ENT>N/A</ENT>
              <ENT>37.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35572</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Harvest femoropopliteal vein</ENT>
              <ENT>6.82</ENT>
              <ENT>N/A</ENT>
              <ENT>2.37</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>9.82</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35582</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vein bypass graft</ENT>
              <ENT>27.13</ENT>
              <ENT>N/A</ENT>
              <ENT>11.67</ENT>
              <ENT>3.11</ENT>
              <ENT>N/A</ENT>
              <ENT>41.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35583</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vein bypass graft</ENT>
              <ENT>22.37</ENT>
              <ENT>N/A</ENT>
              <ENT>10.37</ENT>
              <ENT>2.53</ENT>
              <ENT>N/A</ENT>
              <ENT>35.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35585</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vein bypass graft</ENT>
              <ENT>28.39</ENT>
              <ENT>N/A</ENT>
              <ENT>12.61</ENT>
              <ENT>3.21</ENT>
              <ENT>N/A</ENT>
              <ENT>44.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35587</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vein bypass graft</ENT>
              <ENT>24.75</ENT>
              <ENT>N/A</ENT>
              <ENT>11.88</ENT>
              <ENT>2.17</ENT>
              <ENT>N/A</ENT>
              <ENT>38.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Harvest artery for cabg</ENT>
              <ENT>4.95</ENT>
              <ENT>N/A</ENT>
              <ENT>1.61</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>7.16</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35601</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>17.50</ENT>
              <ENT>N/A</ENT>
              <ENT>8.58</ENT>
              <ENT>2.08</ENT>
              <ENT>N/A</ENT>
              <ENT>28.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35606</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>18.71</ENT>
              <ENT>N/A</ENT>
              <ENT>8.96</ENT>
              <ENT>2.17</ENT>
              <ENT>N/A</ENT>
              <ENT>29.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35612</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>15.76</ENT>
              <ENT>N/A</ENT>
              <ENT>7.82</ENT>
              <ENT>1.72</ENT>
              <ENT>N/A</ENT>
              <ENT>25.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35616</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>15.70</ENT>
              <ENT>N/A</ENT>
              <ENT>8.00</ENT>
              <ENT>1.84</ENT>
              <ENT>N/A</ENT>
              <ENT>25.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35621</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>20.00</ENT>
              <ENT>N/A</ENT>
              <ENT>8.86</ENT>
              <ENT>1.68</ENT>
              <ENT>N/A</ENT>
              <ENT>30.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35623</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bypass graft, not vein</ENT>
              <ENT>24.00</ENT>
              <ENT>N/A</ENT>
              <ENT>10.64</ENT>
              <ENT>1.91</ENT>
              <ENT>N/A</ENT>
              <ENT>36.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35626</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>27.75</ENT>
              <ENT>N/A</ENT>
              <ENT>11.90</ENT>
              <ENT>2.89</ENT>
              <ENT>N/A</ENT>
              <ENT>42.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35631</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>34.00</ENT>
              <ENT>N/A</ENT>
              <ENT>14.07</ENT>
              <ENT>2.83</ENT>
              <ENT>N/A</ENT>
              <ENT>50.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35636</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>29.50</ENT>
              <ENT>N/A</ENT>
              <ENT>12.60</ENT>
              <ENT>2.37</ENT>
              <ENT>N/A</ENT>
              <ENT>44.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35641</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>24.57</ENT>
              <ENT>N/A</ENT>
              <ENT>11.10</ENT>
              <ENT>2.83</ENT>
              <ENT>N/A</ENT>
              <ENT>38.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35642</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>17.98</ENT>
              <ENT>N/A</ENT>
              <ENT>8.74</ENT>
              <ENT>1.84</ENT>
              <ENT>N/A</ENT>
              <ENT>28.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35645</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>17.47</ENT>
              <ENT>N/A</ENT>
              <ENT>8.39</ENT>
              <ENT>1.91</ENT>
              <ENT>N/A</ENT>
              <ENT>27.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35646</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>31.00</ENT>
              <ENT>N/A</ENT>
              <ENT>13.16</ENT>
              <ENT>3.63</ENT>
              <ENT>N/A</ENT>
              <ENT>47.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35647</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>28.00</ENT>
              <ENT>N/A</ENT>
              <ENT>11.84</ENT>
              <ENT>3.28</ENT>
              <ENT>N/A</ENT>
              <ENT>43.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35650</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>19.00</ENT>
              <ENT>N/A</ENT>
              <ENT>8.46</ENT>
              <ENT>1.64</ENT>
              <ENT>N/A</ENT>
              <ENT>29.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35651</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>25.04</ENT>
              <ENT>N/A</ENT>
              <ENT>10.96</ENT>
              <ENT>2.53</ENT>
              <ENT>N/A</ENT>
              <ENT>38.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35654</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>25.00</ENT>
              <ENT>N/A</ENT>
              <ENT>10.84</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>37.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35656</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>19.53</ENT>
              <ENT>N/A</ENT>
              <ENT>8.73</ENT>
              <ENT>2.21</ENT>
              <ENT>N/A</ENT>
              <ENT>30.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35661</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>19.00</ENT>
              <ENT>N/A</ENT>
              <ENT>9.00</ENT>
              <ENT>1.50</ENT>
              <ENT>N/A</ENT>
              <ENT>29.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35663</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>22.00</ENT>
              <ENT>N/A</ENT>
              <ENT>10.09</ENT>
              <ENT>1.55</ENT>
              <ENT>N/A</ENT>
              <ENT>33.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35665</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>21.00</ENT>
              <ENT>N/A</ENT>
              <ENT>9.61</ENT>
              <ENT>1.76</ENT>
              <ENT>N/A</ENT>
              <ENT>32.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35666</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>22.19</ENT>
              <ENT>N/A</ENT>
              <ENT>11.02</ENT>
              <ENT>2.19</ENT>
              <ENT>N/A</ENT>
              <ENT>35.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35671</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery bypass graft</ENT>
              <ENT>19.33</ENT>
              <ENT>N/A</ENT>
              <ENT>9.72</ENT>
              <ENT>1.68</ENT>
              <ENT>N/A</ENT>
              <ENT>30.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35681</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Composite bypass graft</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>2.32</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35682</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Composite bypass graft</ENT>
              <ENT>7.20</ENT>
              <ENT>N/A</ENT>
              <ENT>2.43</ENT>
              <ENT>0.83</ENT>
              <ENT>N/A</ENT>
              <ENT>10.46</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35683</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Composite bypass graft</ENT>
              <ENT>8.50</ENT>
              <ENT>N/A</ENT>
              <ENT>2.87</ENT>
              <ENT>0.98</ENT>
              <ENT>N/A</ENT>
              <ENT>12.35</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35685</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bypass graft patency/patch</ENT>
              <ENT>4.05</ENT>
              <ENT>N/A</ENT>
              <ENT>1.38</ENT>
              <ENT>0.25</ENT>
              <ENT>N/A</ENT>
              <ENT>5.68</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35686</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bypass graft/av fist patency</ENT>
              <ENT>3.35</ENT>
              <ENT>N/A</ENT>
              <ENT>1.15</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>4.71</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35691</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Arterial transposition</ENT>
              <ENT>18.05</ENT>
              <ENT>N/A</ENT>
              <ENT>8.50</ENT>
              <ENT>2.06</ENT>
              <ENT>N/A</ENT>
              <ENT>28.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35693</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Arterial transposition</ENT>
              <ENT>15.36</ENT>
              <ENT>N/A</ENT>
              <ENT>7.70</ENT>
              <ENT>1.80</ENT>
              <ENT>N/A</ENT>
              <ENT>24.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35694</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Arterial transposition</ENT>
              <ENT>19.16</ENT>
              <ENT>N/A</ENT>
              <ENT>8.73</ENT>
              <ENT>2.13</ENT>
              <ENT>N/A</ENT>
              <ENT>30.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35695</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Arterial transposition</ENT>
              <ENT>19.16</ENT>
              <ENT>N/A</ENT>
              <ENT>8.65</ENT>
              <ENT>2.19</ENT>
              <ENT>N/A</ENT>
              <ENT>30.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reoperation, bypass graft</ENT>
              <ENT>3.08</ENT>
              <ENT>N/A</ENT>
              <ENT>1.03</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>4.47</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35701</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration, carotid artery</ENT>
              <ENT>8.50</ENT>
              <ENT>N/A</ENT>
              <ENT>5.22</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>14.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35721</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration, femoral artery</ENT>
              <ENT>7.18</ENT>
              <ENT>N/A</ENT>
              <ENT>4.52</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>12.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35741</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration popliteal artery</ENT>
              <ENT>8.00</ENT>
              <ENT>N/A</ENT>
              <ENT>4.79</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>13.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35761</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of artery/vein</ENT>
              <ENT>5.37</ENT>
              <ENT>N/A</ENT>
              <ENT>4.10</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>10.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49122"/>
              <ENT I="01">35800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore neck vessels</ENT>
              <ENT>7.02</ENT>
              <ENT>N/A</ENT>
              <ENT>4.64</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>12.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore chest vessels</ENT>
              <ENT>12.88</ENT>
              <ENT>N/A</ENT>
              <ENT>6.96</ENT>
              <ENT>1.61</ENT>
              <ENT>N/A</ENT>
              <ENT>21.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35840</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore abdominal vessels</ENT>
              <ENT>9.77</ENT>
              <ENT>N/A</ENT>
              <ENT>5.41</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>16.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35860</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore limb vessels</ENT>
              <ENT>5.55</ENT>
              <ENT>N/A</ENT>
              <ENT>4.07</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>10.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35870</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair vessel graft defect</ENT>
              <ENT>22.17</ENT>
              <ENT>N/A</ENT>
              <ENT>10.15</ENT>
              <ENT>2.47</ENT>
              <ENT>N/A</ENT>
              <ENT>34.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35875</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of clot in graft</ENT>
              <ENT>10.13</ENT>
              <ENT>N/A</ENT>
              <ENT>5.35</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>16.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35876</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of clot in graft</ENT>
              <ENT>17.00</ENT>
              <ENT>N/A</ENT>
              <ENT>7.75</ENT>
              <ENT>1.88</ENT>
              <ENT>N/A</ENT>
              <ENT>26.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35879</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise graft w/vein</ENT>
              <ENT>16.00</ENT>
              <ENT>N/A</ENT>
              <ENT>7.80</ENT>
              <ENT>1.35</ENT>
              <ENT>N/A</ENT>
              <ENT>25.15</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35881</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise graft w/vein</ENT>
              <ENT>18.00</ENT>
              <ENT>N/A</ENT>
              <ENT>8.75</ENT>
              <ENT>1.44</ENT>
              <ENT>N/A</ENT>
              <ENT>28.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35901</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision, graft, neck</ENT>
              <ENT>8.19</ENT>
              <ENT>N/A</ENT>
              <ENT>5.35</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>14.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35903</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision, graft, extremity</ENT>
              <ENT>9.39</ENT>
              <ENT>N/A</ENT>
              <ENT>6.24</ENT>
              <ENT>1.03</ENT>
              <ENT>N/A</ENT>
              <ENT>16.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35905</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision, graft, thorax</ENT>
              <ENT>31.25</ENT>
              <ENT>N/A</ENT>
              <ENT>13.30</ENT>
              <ENT>2.15</ENT>
              <ENT>N/A</ENT>
              <ENT>46.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">35907</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision, graft, abdomen</ENT>
              <ENT>35.00</ENT>
              <ENT>N/A</ENT>
              <ENT>14.57</ENT>
              <ENT>2.17</ENT>
              <ENT>N/A</ENT>
              <ENT>51.74</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Place needle in vein</ENT>
              <ENT>0.18</ENT>
              <ENT>0.62</ENT>
              <ENT>0.05</ENT>
              <ENT>0.01</ENT>
              <ENT>0.81</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36002</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pseudoaneurysm injection trt</ENT>
              <ENT>1.96</ENT>
              <ENT>2.92</ENT>
              <ENT>1.00</ENT>
              <ENT>0.10</ENT>
              <ENT>4.98</ENT>
              <ENT>3.06</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36005</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection ext venography</ENT>
              <ENT>0.95</ENT>
              <ENT>8.45</ENT>
              <ENT>0.32</ENT>
              <ENT>0.04</ENT>
              <ENT>9.44</ENT>
              <ENT>1.31</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Place catheter in vein</ENT>
              <ENT>2.43</ENT>
              <ENT>N/A</ENT>
              <ENT>0.80</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>3.39</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36011</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Place catheter in vein</ENT>
              <ENT>3.14</ENT>
              <ENT>N/A</ENT>
              <ENT>1.05</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>4.36</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36012</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Place catheter in vein</ENT>
              <ENT>3.52</ENT>
              <ENT>N/A</ENT>
              <ENT>1.18</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>4.87</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36013</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Place catheter in artery</ENT>
              <ENT>2.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.66</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>3.35</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36014</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Place catheter in artery</ENT>
              <ENT>3.02</ENT>
              <ENT>N/A</ENT>
              <ENT>1.01</ENT>
              <ENT>0.14</ENT>
              <ENT>N/A</ENT>
              <ENT>4.17</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36015</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Place catheter in artery</ENT>
              <ENT>3.52</ENT>
              <ENT>N/A</ENT>
              <ENT>1.18</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>4.86</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Establish access to artery</ENT>
              <ENT>3.02</ENT>
              <ENT>N/A</ENT>
              <ENT>1.12</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>4.32</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Establish access to artery</ENT>
              <ENT>2.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.66</ENT>
              <ENT>0.11</ENT>
              <ENT>N/A</ENT>
              <ENT>2.78</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Establish access to artery</ENT>
              <ENT>2.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.65</ENT>
              <ENT>0.12</ENT>
              <ENT>N/A</ENT>
              <ENT>2.78</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36145</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery to vein shunt</ENT>
              <ENT>2.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.67</ENT>
              <ENT>0.10</ENT>
              <ENT>N/A</ENT>
              <ENT>2.78</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36160</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Establish access to aorta</ENT>
              <ENT>2.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.86</ENT>
              <ENT>0.20</ENT>
              <ENT>N/A</ENT>
              <ENT>3.58</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Place catheter in aorta</ENT>
              <ENT>3.02</ENT>
              <ENT>72.76</ENT>
              <ENT>1.04</ENT>
              <ENT>0.15</ENT>
              <ENT>75.93</ENT>
              <ENT>4.21</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36215</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Place catheter in artery</ENT>
              <ENT>4.68</ENT>
              <ENT>N/A</ENT>
              <ENT>1.61</ENT>
              <ENT>0.22</ENT>
              <ENT>N/A</ENT>
              <ENT>6.51</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36216</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Place catheter in artery</ENT>
              <ENT>5.28</ENT>
              <ENT>N/A</ENT>
              <ENT>1.79</ENT>
              <ENT>0.24</ENT>
              <ENT>N/A</ENT>
              <ENT>7.31</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36217</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Place catheter in artery</ENT>
              <ENT>6.30</ENT>
              <ENT>N/A</ENT>
              <ENT>2.18</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>8.80</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36218</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Place catheter in artery</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.35</ENT>
              <ENT>0.05</ENT>
              <ENT>N/A</ENT>
              <ENT>1.41</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36245</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Place catheter in artery</ENT>
              <ENT>4.68</ENT>
              <ENT>N/A</ENT>
              <ENT>1.68</ENT>
              <ENT>0.23</ENT>
              <ENT>N/A</ENT>
              <ENT>6.59</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36246</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Place catheter in artery</ENT>
              <ENT>5.28</ENT>
              <ENT>N/A</ENT>
              <ENT>1.82</ENT>
              <ENT>0.26</ENT>
              <ENT>N/A</ENT>
              <ENT>7.36</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36247</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Place catheter in artery</ENT>
              <ENT>6.30</ENT>
              <ENT>N/A</ENT>
              <ENT>2.15</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>8.77</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36248</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Place catheter in artery</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.35</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>1.42</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36260</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of infusion pump</ENT>
              <ENT>9.71</ENT>
              <ENT>N/A</ENT>
              <ENT>5.04</ENT>
              <ENT>1.00</ENT>
              <ENT>N/A</ENT>
              <ENT>15.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36261</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of infusion pump</ENT>
              <ENT>5.45</ENT>
              <ENT>N/A</ENT>
              <ENT>3.66</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>9.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36262</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of infusion pump</ENT>
              <ENT>4.02</ENT>
              <ENT>N/A</ENT>
              <ENT>2.83</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>7.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36299</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Vessel injection procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bl draw &lt; 3 yrs fem/jugular</ENT>
              <ENT>0.38</ENT>
              <ENT>0.28</ENT>
              <ENT>0.09</ENT>
              <ENT>0.01</ENT>
              <ENT>0.67</ENT>
              <ENT>0.48</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36405</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bl draw &lt; 3 yrs scalp vein</ENT>
              <ENT>0.31</ENT>
              <ENT>0.26</ENT>
              <ENT>0.08</ENT>
              <ENT>0.01</ENT>
              <ENT>0.58</ENT>
              <ENT>0.40</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36406</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bl draw &lt; 3 yrs other vein</ENT>
              <ENT>0.18</ENT>
              <ENT>0.30</ENT>
              <ENT>0.05</ENT>
              <ENT>0.01</ENT>
              <ENT>0.49</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36410</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Non-routine bl draw &gt; 3 yrs</ENT>
              <ENT>0.18</ENT>
              <ENT>0.30</ENT>
              <ENT>0.05</ENT>
              <ENT>0.01</ENT>
              <ENT>0.49</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36415</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Routine venipuncture</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36416</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Capillary blood draw</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vein access cutdown &lt; 1 yr</ENT>
              <ENT>1.01</ENT>
              <ENT>3.18</ENT>
              <ENT>0.28</ENT>
              <ENT>0.09</ENT>
              <ENT>4.28</ENT>
              <ENT>1.38</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36425</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vein access cutdown &gt; 1 yr</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.22</ENT>
              <ENT>0.05</ENT>
              <ENT>N/A</ENT>
              <ENT>1.03</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36430</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Blood transfusion service</ENT>
              <ENT>0.00</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36440</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bl push transfuse, 2 yr or &lt;</ENT>
              <ENT>1.03</ENT>
              <ENT>N/A</ENT>
              <ENT>0.29</ENT>
              <ENT>0.08</ENT>
              <ENT>N/A</ENT>
              <ENT>1.40</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bl exchange/transfuse, nb</ENT>
              <ENT>2.23</ENT>
              <ENT>N/A</ENT>
              <ENT>0.71</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>3.10</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36455</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bl exchange/transfuse non-nb</ENT>
              <ENT>2.43</ENT>
              <ENT>N/A</ENT>
              <ENT>0.84</ENT>
              <ENT>0.10</ENT>
              <ENT>N/A</ENT>
              <ENT>3.37</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36460</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transfusion service, fetal</ENT>
              <ENT>6.59</ENT>
              <ENT>N/A</ENT>
              <ENT>2.26</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>9.41</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36468</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Injection(s), spider veins</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36469</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Injection(s), spider veins</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36470</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection therapy of vein</ENT>
              <ENT>1.09</ENT>
              <ENT>2.75</ENT>
              <ENT>0.45</ENT>
              <ENT>0.10</ENT>
              <ENT>3.94</ENT>
              <ENT>1.64</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36471</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection therapy of veins</ENT>
              <ENT>1.57</ENT>
              <ENT>3.10</ENT>
              <ENT>0.61</ENT>
              <ENT>0.15</ENT>
              <ENT>4.82</ENT>
              <ENT>2.33</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36481</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of catheter, vein</ENT>
              <ENT>6.99</ENT>
              <ENT>7.02</ENT>
              <ENT>2.76</ENT>
              <ENT>0.40</ENT>
              <ENT>14.41</ENT>
              <ENT>10.15</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36488</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of catheter, vein</ENT>
              <ENT>1.35</ENT>
              <ENT>3.45</ENT>
              <ENT>0.75</ENT>
              <ENT>0.09</ENT>
              <ENT>4.89</ENT>
              <ENT>2.19</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49123"/>
              <ENT I="01">36489</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of catheter, vein</ENT>
              <ENT>2.50</ENT>
              <ENT>4.13</ENT>
              <ENT>1.06</ENT>
              <ENT>0.08</ENT>
              <ENT>6.71</ENT>
              <ENT>3.64</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36490</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of catheter, vein</ENT>
              <ENT>1.67</ENT>
              <ENT>4.06</ENT>
              <ENT>0.85</ENT>
              <ENT>0.17</ENT>
              <ENT>5.90</ENT>
              <ENT>2.69</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36491</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of catheter, vein</ENT>
              <ENT>1.43</ENT>
              <ENT>3.41</ENT>
              <ENT>0.78</ENT>
              <ENT>0.13</ENT>
              <ENT>4.97</ENT>
              <ENT>2.34</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36493</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repositioning of cvc</ENT>
              <ENT>1.21</ENT>
              <ENT>4.11</ENT>
              <ENT>0.86</ENT>
              <ENT>0.06</ENT>
              <ENT>5.38</ENT>
              <ENT>2.13</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of catheter, vein</ENT>
              <ENT>3.52</ENT>
              <ENT>N/A</ENT>
              <ENT>1.25</ENT>
              <ENT>0.14</ENT>
              <ENT>N/A</ENT>
              <ENT>4.91</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of catheter, vein</ENT>
              <ENT>1.09</ENT>
              <ENT>3.83</ENT>
              <ENT>0.63</ENT>
              <ENT>0.06</ENT>
              <ENT>4.98</ENT>
              <ENT>1.78</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36511</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apheresis wbc</ENT>
              <ENT>1.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.70</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>2.50</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36512</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apheresis rbc</ENT>
              <ENT>1.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.70</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>2.50</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36513</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apheresis platelets</ENT>
              <ENT>1.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.70</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>2.50</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36514</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apheresis plasma</ENT>
              <ENT>1.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.70</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>2.50</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36515</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apheresis, adsorp/reinfuse</ENT>
              <ENT>1.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.76</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>2.56</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36516</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apheresis, selective</ENT>
              <ENT>1.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.76</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>2.56</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36522</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Photopheresis</ENT>
              <ENT>1.67</ENT>
              <ENT>6.78</ENT>
              <ENT>1.15</ENT>
              <ENT>0.07</ENT>
              <ENT>8.52</ENT>
              <ENT>2.89</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36530</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Insertion of infusion pump</ENT>
              <ENT>6.20</ENT>
              <ENT>N/A</ENT>
              <ENT>3.93</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>10.69</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36531</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Revision of infusion pump</ENT>
              <ENT>4.87</ENT>
              <ENT>N/A</ENT>
              <ENT>3.45</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>8.76</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36532</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Removal of infusion pump</ENT>
              <ENT>3.30</ENT>
              <ENT>N/A</ENT>
              <ENT>1.64</ENT>
              <ENT>0.34</ENT>
              <ENT>N/A</ENT>
              <ENT>5.28</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36533</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of access device</ENT>
              <ENT>5.32</ENT>
              <ENT>14.77</ENT>
              <ENT>3.65</ENT>
              <ENT>0.49</ENT>
              <ENT>20.58</ENT>
              <ENT>9.46</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36534</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of access device</ENT>
              <ENT>2.80</ENT>
              <ENT>N/A</ENT>
              <ENT>1.58</ENT>
              <ENT>0.19</ENT>
              <ENT>N/A</ENT>
              <ENT>4.57</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36535</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of access device</ENT>
              <ENT>2.27</ENT>
              <ENT>2.96</ENT>
              <ENT>1.99</ENT>
              <ENT>0.21</ENT>
              <ENT>5.44</ENT>
              <ENT>4.47</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36536</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove cva device obstruct</ENT>
              <ENT>3.60</ENT>
              <ENT>18.73</ENT>
              <ENT>1.47</ENT>
              <ENT>0.23</ENT>
              <ENT>22.56</ENT>
              <ENT>5.30</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36537</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove cva lumen obstruct</ENT>
              <ENT>0.75</ENT>
              <ENT>4.44</ENT>
              <ENT>0.49</ENT>
              <ENT>0.04</ENT>
              <ENT>5.23</ENT>
              <ENT>1.28</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36550</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Declot vascular device</ENT>
              <ENT>0.00</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Withdrawal of arterial blood</ENT>
              <ENT>0.32</ENT>
              <ENT>0.49</ENT>
              <ENT>0.09</ENT>
              <ENT>0.02</ENT>
              <ENT>0.83</ENT>
              <ENT>0.43</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36620</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion catheter, artery</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.24</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>1.45</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36625</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion catheter, artery</ENT>
              <ENT>2.11</ENT>
              <ENT>N/A</ENT>
              <ENT>0.53</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>2.80</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36640</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion catheter, artery</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>1.04</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>3.32</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36660</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion catheter, artery</ENT>
              <ENT>1.40</ENT>
              <ENT>N/A</ENT>
              <ENT>0.44</ENT>
              <ENT>0.08</ENT>
              <ENT>N/A</ENT>
              <ENT>1.92</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36680</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert needle, bone cavity</ENT>
              <ENT>1.20</ENT>
              <ENT>N/A</ENT>
              <ENT>0.50</ENT>
              <ENT>0.08</ENT>
              <ENT>N/A</ENT>
              <ENT>1.78</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of cannula</ENT>
              <ENT>2.43</ENT>
              <ENT>N/A</ENT>
              <ENT>1.81</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>4.41</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36810</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of cannula</ENT>
              <ENT>3.97</ENT>
              <ENT>N/A</ENT>
              <ENT>1.70</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>6.07</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36815</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of cannula</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>1.18</ENT>
              <ENT>0.26</ENT>
              <ENT>N/A</ENT>
              <ENT>4.06</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36819</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Av fusion/uppr arm vein</ENT>
              <ENT>14.00</ENT>
              <ENT>N/A</ENT>
              <ENT>6.45</ENT>
              <ENT>1.56</ENT>
              <ENT>N/A</ENT>
              <ENT>22.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Av fusion/forearm vein</ENT>
              <ENT>14.00</ENT>
              <ENT>N/A</ENT>
              <ENT>6.45</ENT>
              <ENT>1.56</ENT>
              <ENT>N/A</ENT>
              <ENT>22.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36821</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Av fusion direct any site</ENT>
              <ENT>8.93</ENT>
              <ENT>N/A</ENT>
              <ENT>4.74</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>14.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36822</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of cannula(s)</ENT>
              <ENT>5.42</ENT>
              <ENT>N/A</ENT>
              <ENT>4.31</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>10.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36823</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion of cannula(s)</ENT>
              <ENT>21.00</ENT>
              <ENT>N/A</ENT>
              <ENT>9.51</ENT>
              <ENT>2.18</ENT>
              <ENT>N/A</ENT>
              <ENT>32.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36825</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery-vein autograft</ENT>
              <ENT>9.84</ENT>
              <ENT>N/A</ENT>
              <ENT>5.17</ENT>
              <ENT>1.09</ENT>
              <ENT>N/A</ENT>
              <ENT>16.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36830</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery-vein nonautograft</ENT>
              <ENT>12.00</ENT>
              <ENT>N/A</ENT>
              <ENT>5.39</ENT>
              <ENT>1.32</ENT>
              <ENT>N/A</ENT>
              <ENT>18.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36831</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Open thrombect av fistula</ENT>
              <ENT>8.00</ENT>
              <ENT>N/A</ENT>
              <ENT>4.06</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>12.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36832</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Av fistula revision, open</ENT>
              <ENT>10.50</ENT>
              <ENT>N/A</ENT>
              <ENT>4.89</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>16.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36833</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Av fistula revision</ENT>
              <ENT>11.95</ENT>
              <ENT>N/A</ENT>
              <ENT>5.37</ENT>
              <ENT>1.29</ENT>
              <ENT>N/A</ENT>
              <ENT>18.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36834</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair A-V aneurysm</ENT>
              <ENT>9.93</ENT>
              <ENT>N/A</ENT>
              <ENT>4.79</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>15.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36835</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery to vein shunt</ENT>
              <ENT>7.15</ENT>
              <ENT>N/A</ENT>
              <ENT>4.35</ENT>
              <ENT>0.80</ENT>
              <ENT>N/A</ENT>
              <ENT>12.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36860</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>External cannula declotting</ENT>
              <ENT>2.01</ENT>
              <ENT>2.54</ENT>
              <ENT>1.35</ENT>
              <ENT>0.10</ENT>
              <ENT>4.65</ENT>
              <ENT>3.46</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36861</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cannula declotting</ENT>
              <ENT>2.52</ENT>
              <ENT>N/A</ENT>
              <ENT>1.48</ENT>
              <ENT>0.14</ENT>
              <ENT>N/A</ENT>
              <ENT>4.14</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">36870</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Percut thrombect av fistula</ENT>
              <ENT>5.16</ENT>
              <ENT>47.67</ENT>
              <ENT>3.15</ENT>
              <ENT>0.23</ENT>
              <ENT>53.06</ENT>
              <ENT>8.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of circulation</ENT>
              <ENT>23.60</ENT>
              <ENT>N/A</ENT>
              <ENT>10.65</ENT>
              <ENT>1.21</ENT>
              <ENT>N/A</ENT>
              <ENT>35.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37145</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of circulation</ENT>
              <ENT>24.61</ENT>
              <ENT>N/A</ENT>
              <ENT>11.19</ENT>
              <ENT>2.48</ENT>
              <ENT>N/A</ENT>
              <ENT>38.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37160</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of circulation</ENT>
              <ENT>21.60</ENT>
              <ENT>N/A</ENT>
              <ENT>9.46</ENT>
              <ENT>2.16</ENT>
              <ENT>N/A</ENT>
              <ENT>33.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37180</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of circulation</ENT>
              <ENT>24.61</ENT>
              <ENT>N/A</ENT>
              <ENT>10.56</ENT>
              <ENT>2.63</ENT>
              <ENT>N/A</ENT>
              <ENT>37.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37181</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Splice spleen/kidney veins</ENT>
              <ENT>26.68</ENT>
              <ENT>N/A</ENT>
              <ENT>11.22</ENT>
              <ENT>2.67</ENT>
              <ENT>N/A</ENT>
              <ENT>40.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37182</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert hepatic shunt (tips)</ENT>
              <ENT>17.00</ENT>
              <ENT>N/A</ENT>
              <ENT>6.37</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>24.86</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37183</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove hepatic shunt (tips)</ENT>
              <ENT>8.00</ENT>
              <ENT>N/A</ENT>
              <ENT>3.13</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>11.56</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37195</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thrombolytic therapy, stroke</ENT>
              <ENT>0.00</ENT>
              <ENT>8.06</ENT>
              <ENT>N/A</ENT>
              <ENT>0.38</ENT>
              <ENT>8.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transcatheter biopsy</ENT>
              <ENT>4.56</ENT>
              <ENT>N/A</ENT>
              <ENT>1.53</ENT>
              <ENT>0.19</ENT>
              <ENT>N/A</ENT>
              <ENT>6.28</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37201</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transcatheter therapy infuse</ENT>
              <ENT>5.00</ENT>
              <ENT>N/A</ENT>
              <ENT>2.53</ENT>
              <ENT>0.24</ENT>
              <ENT>N/A</ENT>
              <ENT>7.77</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37202</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transcatheter therapy infuse</ENT>
              <ENT>5.68</ENT>
              <ENT>N/A</ENT>
              <ENT>2.30</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>8.36</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37203</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transcatheter retrieval</ENT>
              <ENT>5.03</ENT>
              <ENT>N/A</ENT>
              <ENT>2.54</ENT>
              <ENT>0.23</ENT>
              <ENT>N/A</ENT>
              <ENT>7.80</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49124"/>
              <ENT I="01">37204</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transcatheter occlusion</ENT>
              <ENT>18.14</ENT>
              <ENT>N/A</ENT>
              <ENT>6.05</ENT>
              <ENT>0.91</ENT>
              <ENT>N/A</ENT>
              <ENT>25.10</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37205</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transcatheter stent</ENT>
              <ENT>8.28</ENT>
              <ENT>N/A</ENT>
              <ENT>3.78</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>12.49</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37206</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transcatheter stent add-on</ENT>
              <ENT>4.13</ENT>
              <ENT>N/A</ENT>
              <ENT>1.47</ENT>
              <ENT>0.22</ENT>
              <ENT>N/A</ENT>
              <ENT>5.82</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37207</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transcatheter stent</ENT>
              <ENT>8.28</ENT>
              <ENT>N/A</ENT>
              <ENT>3.20</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>12.37</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37208</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transcatheter stent add-on</ENT>
              <ENT>4.13</ENT>
              <ENT>N/A</ENT>
              <ENT>1.41</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>5.98</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37209</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exchange arterial catheter</ENT>
              <ENT>2.27</ENT>
              <ENT>N/A</ENT>
              <ENT>0.76</ENT>
              <ENT>0.11</ENT>
              <ENT>N/A</ENT>
              <ENT>3.14</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Iv us first vessel add-on</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.76</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>3.03</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37251</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Iv us each add vessel add-on</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.57</ENT>
              <ENT>0.14</ENT>
              <ENT>N/A</ENT>
              <ENT>2.31</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endoscopy ligate perf veins</ENT>
              <ENT>11.00</ENT>
              <ENT>N/A</ENT>
              <ENT>7.10</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>18.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37501</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Vascular endoscopy procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37565</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ligation of neck vein</ENT>
              <ENT>10.88</ENT>
              <ENT>N/A</ENT>
              <ENT>5.71</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>17.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ligation of neck artery</ENT>
              <ENT>11.25</ENT>
              <ENT>N/A</ENT>
              <ENT>6.79</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>18.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ligation of neck artery</ENT>
              <ENT>13.11</ENT>
              <ENT>N/A</ENT>
              <ENT>7.05</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>20.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37606</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ligation of neck artery</ENT>
              <ENT>6.28</ENT>
              <ENT>N/A</ENT>
              <ENT>4.64</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>11.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37607</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ligation of a-v fistula</ENT>
              <ENT>6.16</ENT>
              <ENT>N/A</ENT>
              <ENT>3.64</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>10.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37609</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Temporal artery procedure</ENT>
              <ENT>3.00</ENT>
              <ENT>4.62</ENT>
              <ENT>2.00</ENT>
              <ENT>0.21</ENT>
              <ENT>7.83</ENT>
              <ENT>5.21</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37615</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ligation of neck artery</ENT>
              <ENT>5.73</ENT>
              <ENT>N/A</ENT>
              <ENT>4.23</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>10.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37616</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ligation of chest artery</ENT>
              <ENT>16.49</ENT>
              <ENT>N/A</ENT>
              <ENT>8.14</ENT>
              <ENT>1.93</ENT>
              <ENT>N/A</ENT>
              <ENT>26.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37617</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ligation of abdomen artery</ENT>
              <ENT>22.06</ENT>
              <ENT>N/A</ENT>
              <ENT>9.48</ENT>
              <ENT>1.69</ENT>
              <ENT>N/A</ENT>
              <ENT>33.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37618</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ligation of extremity artery</ENT>
              <ENT>4.84</ENT>
              <ENT>N/A</ENT>
              <ENT>3.77</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>9.15</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37620</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of major vein</ENT>
              <ENT>10.56</ENT>
              <ENT>N/A</ENT>
              <ENT>5.84</ENT>
              <ENT>0.75</ENT>
              <ENT>N/A</ENT>
              <ENT>17.15</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37650</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of major vein</ENT>
              <ENT>7.80</ENT>
              <ENT>N/A</ENT>
              <ENT>4.76</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>13.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37660</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of major vein</ENT>
              <ENT>21.00</ENT>
              <ENT>N/A</ENT>
              <ENT>9.37</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>31.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise leg vein</ENT>
              <ENT>3.73</ENT>
              <ENT>N/A</ENT>
              <ENT>2.95</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>7.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37720</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of leg vein</ENT>
              <ENT>5.66</ENT>
              <ENT>N/A</ENT>
              <ENT>3.74</ENT>
              <ENT>0.61</ENT>
              <ENT>N/A</ENT>
              <ENT>10.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37730</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of leg veins</ENT>
              <ENT>7.33</ENT>
              <ENT>N/A</ENT>
              <ENT>4.48</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>12.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37735</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of leg veins/lesion</ENT>
              <ENT>10.53</ENT>
              <ENT>N/A</ENT>
              <ENT>5.75</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>17.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37760</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ligation, leg veins, open</ENT>
              <ENT>10.47</ENT>
              <ENT>N/A</ENT>
              <ENT>5.59</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>17.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37780</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of leg vein</ENT>
              <ENT>3.84</ENT>
              <ENT>N/A</ENT>
              <ENT>2.91</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>7.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37785</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise secondary varicosity</ENT>
              <ENT>3.84</ENT>
              <ENT>7.05</ENT>
              <ENT>2.93</ENT>
              <ENT>0.41</ENT>
              <ENT>11.30</ENT>
              <ENT>7.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37788</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revascularization, penis</ENT>
              <ENT>22.01</ENT>
              <ENT>N/A</ENT>
              <ENT>10.07</ENT>
              <ENT>1.35</ENT>
              <ENT>N/A</ENT>
              <ENT>33.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37790</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Penile venous occlusion</ENT>
              <ENT>8.34</ENT>
              <ENT>N/A</ENT>
              <ENT>5.07</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>14.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">37799</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Vascular surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of spleen, total</ENT>
              <ENT>14.50</ENT>
              <ENT>N/A</ENT>
              <ENT>6.30</ENT>
              <ENT>1.30</ENT>
              <ENT>N/A</ENT>
              <ENT>22.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38101</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of spleen, partial</ENT>
              <ENT>15.31</ENT>
              <ENT>N/A</ENT>
              <ENT>6.66</ENT>
              <ENT>1.38</ENT>
              <ENT>N/A</ENT>
              <ENT>23.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38102</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of spleen, total</ENT>
              <ENT>4.80</ENT>
              <ENT>N/A</ENT>
              <ENT>1.67</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>6.96</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38115</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of ruptured spleen</ENT>
              <ENT>15.82</ENT>
              <ENT>N/A</ENT>
              <ENT>6.78</ENT>
              <ENT>1.40</ENT>
              <ENT>N/A</ENT>
              <ENT>24.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy, splenectomy</ENT>
              <ENT>17.00</ENT>
              <ENT>N/A</ENT>
              <ENT>7.49</ENT>
              <ENT>1.73</ENT>
              <ENT>N/A</ENT>
              <ENT>26.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38129</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Laparoscope proc, spleen</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection for spleen x-ray</ENT>
              <ENT>2.64</ENT>
              <ENT>N/A</ENT>
              <ENT>0.91</ENT>
              <ENT>0.12</ENT>
              <ENT>N/A</ENT>
              <ENT>3.67</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38205</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Harvest allogenic stem cells</ENT>
              <ENT>1.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.61</ENT>
              <ENT>0.05</ENT>
              <ENT>N/A</ENT>
              <ENT>2.16</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38206</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Harvest auto stem cells</ENT>
              <ENT>1.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.61</ENT>
              <ENT>0.05</ENT>
              <ENT>N/A</ENT>
              <ENT>2.16</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38207</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Cryopreserve stem cells</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38208</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Thaw preserved stem cells</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38209</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Wash harvest stem cells</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38210</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>T-cell depletion of harvest</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38211</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Tumor cell deplete of harvst</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38212</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Rbc depletion of harvest</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38213</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Platelet deplete of harvest</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38214</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Volume deplete of harvest</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38215</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Harvest stem cell concentrte</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bone marrow aspiration</ENT>
              <ENT>1.08</ENT>
              <ENT>3.99</ENT>
              <ENT>0.43</ENT>
              <ENT>0.03</ENT>
              <ENT>5.10</ENT>
              <ENT>1.54</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38221</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bone marrow biopsy</ENT>
              <ENT>1.37</ENT>
              <ENT>4.17</ENT>
              <ENT>0.54</ENT>
              <ENT>0.04</ENT>
              <ENT>5.58</ENT>
              <ENT>1.95</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38230</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Bone marrow collection</ENT>
              <ENT>4.54</ENT>
              <ENT>N/A</ENT>
              <ENT>2.53</ENT>
              <ENT>0.25</ENT>
              <ENT>N/A</ENT>
              <ENT>7.32</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49125"/>
              <ENT I="01">38240</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Bone marrow/stem transplant</ENT>
              <ENT>2.24</ENT>
              <ENT>N/A</ENT>
              <ENT>0.83</ENT>
              <ENT>0.08</ENT>
              <ENT>N/A</ENT>
              <ENT>3.15</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38241</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Bone marrow/stem transplant</ENT>
              <ENT>2.24</ENT>
              <ENT>N/A</ENT>
              <ENT>0.83</ENT>
              <ENT>0.08</ENT>
              <ENT>N/A</ENT>
              <ENT>3.15</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38242</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lymphocyte infuse transplant</ENT>
              <ENT>1.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.69</ENT>
              <ENT>0.05</ENT>
              <ENT>N/A</ENT>
              <ENT>2.45</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage, lymph node lesion</ENT>
              <ENT>1.99</ENT>
              <ENT>4.39</ENT>
              <ENT>2.10</ENT>
              <ENT>0.15</ENT>
              <ENT>6.53</ENT>
              <ENT>4.24</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38305</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage, lymph node lesion</ENT>
              <ENT>6.00</ENT>
              <ENT>6.12</ENT>
              <ENT>4.44</ENT>
              <ENT>0.36</ENT>
              <ENT>12.48</ENT>
              <ENT>10.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38308</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of lymph channels</ENT>
              <ENT>6.45</ENT>
              <ENT>5.87</ENT>
              <ENT>3.83</ENT>
              <ENT>0.51</ENT>
              <ENT>12.83</ENT>
              <ENT>10.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38380</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracic duct procedure</ENT>
              <ENT>7.46</ENT>
              <ENT>N/A</ENT>
              <ENT>5.73</ENT>
              <ENT>0.68</ENT>
              <ENT>N/A</ENT>
              <ENT>13.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38381</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracic duct procedure</ENT>
              <ENT>12.88</ENT>
              <ENT>N/A</ENT>
              <ENT>6.89</ENT>
              <ENT>1.58</ENT>
              <ENT>N/A</ENT>
              <ENT>21.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38382</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracic duct procedure</ENT>
              <ENT>10.08</ENT>
              <ENT>N/A</ENT>
              <ENT>6.10</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>17.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy/removal, lymph nodes</ENT>
              <ENT>3.75</ENT>
              <ENT>3.84</ENT>
              <ENT>2.13</ENT>
              <ENT>0.28</ENT>
              <ENT>7.87</ENT>
              <ENT>6.16</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38505</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Needle biopsy, lymph nodes</ENT>
              <ENT>1.14</ENT>
              <ENT>2.19</ENT>
              <ENT>0.79</ENT>
              <ENT>0.09</ENT>
              <ENT>3.42</ENT>
              <ENT>2.02</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy/removal, lymph nodes</ENT>
              <ENT>6.43</ENT>
              <ENT>5.77</ENT>
              <ENT>3.57</ENT>
              <ENT>0.38</ENT>
              <ENT>12.58</ENT>
              <ENT>10.38</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy/removal, lymph nodes</ENT>
              <ENT>6.67</ENT>
              <ENT>N/A</ENT>
              <ENT>4.10</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>11.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38525</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy/removal, lymph nodes</ENT>
              <ENT>6.07</ENT>
              <ENT>N/A</ENT>
              <ENT>3.39</ENT>
              <ENT>0.48</ENT>
              <ENT>N/A</ENT>
              <ENT>9.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy/removal, lymph nodes</ENT>
              <ENT>7.98</ENT>
              <ENT>N/A</ENT>
              <ENT>4.44</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>13.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38542</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore deep node(s), neck</ENT>
              <ENT>5.91</ENT>
              <ENT>N/A</ENT>
              <ENT>4.55</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>10.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38550</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal, neck/armpit lesion</ENT>
              <ENT>6.92</ENT>
              <ENT>N/A</ENT>
              <ENT>3.94</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>11.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38555</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal, neck/armpit lesion</ENT>
              <ENT>14.14</ENT>
              <ENT>N/A</ENT>
              <ENT>8.46</ENT>
              <ENT>1.46</ENT>
              <ENT>N/A</ENT>
              <ENT>24.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38562</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal, pelvic lymph nodes</ENT>
              <ENT>10.49</ENT>
              <ENT>N/A</ENT>
              <ENT>5.84</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>17.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38564</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal, abdomen lymph nodes</ENT>
              <ENT>10.83</ENT>
              <ENT>N/A</ENT>
              <ENT>5.35</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>17.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38570</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy, lymph node biop</ENT>
              <ENT>9.25</ENT>
              <ENT>N/A</ENT>
              <ENT>4.02</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>14.16</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38571</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy, lymphadenectomy</ENT>
              <ENT>14.68</ENT>
              <ENT>N/A</ENT>
              <ENT>5.73</ENT>
              <ENT>0.80</ENT>
              <ENT>N/A</ENT>
              <ENT>21.21</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38572</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy, lymphadenectomy</ENT>
              <ENT>16.59</ENT>
              <ENT>N/A</ENT>
              <ENT>7.29</ENT>
              <ENT>1.32</ENT>
              <ENT>N/A</ENT>
              <ENT>25.20</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38589</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Laparoscope proc, lymphatic</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of lymph nodes, neck</ENT>
              <ENT>8.24</ENT>
              <ENT>N/A</ENT>
              <ENT>8.46</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>17.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38720</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of lymph nodes, neck</ENT>
              <ENT>13.61</ENT>
              <ENT>N/A</ENT>
              <ENT>11.49</ENT>
              <ENT>1.03</ENT>
              <ENT>N/A</ENT>
              <ENT>26.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38724</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of lymph nodes, neck</ENT>
              <ENT>14.54</ENT>
              <ENT>N/A</ENT>
              <ENT>12.02</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>27.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38740</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove armpit lymph nodes</ENT>
              <ENT>10.03</ENT>
              <ENT>N/A</ENT>
              <ENT>5.04</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>15.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38745</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove armpit lymph nodes</ENT>
              <ENT>13.10</ENT>
              <ENT>N/A</ENT>
              <ENT>6.36</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>20.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38746</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove thoracic lymph nodes</ENT>
              <ENT>4.89</ENT>
              <ENT>N/A</ENT>
              <ENT>1.60</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>7.04</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38747</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove abdominal lymph nodes</ENT>
              <ENT>4.89</ENT>
              <ENT>N/A</ENT>
              <ENT>1.70</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>7.09</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38760</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove groin lymph nodes</ENT>
              <ENT>12.95</ENT>
              <ENT>N/A</ENT>
              <ENT>6.31</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>20.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38765</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove groin lymph nodes</ENT>
              <ENT>19.98</ENT>
              <ENT>N/A</ENT>
              <ENT>9.27</ENT>
              <ENT>1.50</ENT>
              <ENT>N/A</ENT>
              <ENT>30.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38770</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove pelvis lymph nodes</ENT>
              <ENT>13.23</ENT>
              <ENT>N/A</ENT>
              <ENT>5.97</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>20.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38780</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove abdomen lymph nodes</ENT>
              <ENT>16.59</ENT>
              <ENT>N/A</ENT>
              <ENT>8.47</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>26.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49126"/>
              <ENT I="01">38790</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inject for lymphatic x-ray</ENT>
              <ENT>1.29</ENT>
              <ENT>7.56</ENT>
              <ENT>0.80</ENT>
              <ENT>0.09</ENT>
              <ENT>8.94</ENT>
              <ENT>2.18</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38792</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Identify sentinel node</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.45</ENT>
              <ENT>0.04</ENT>
              <ENT>N/A</ENT>
              <ENT>1.01</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38794</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Access thoracic lymph duct</ENT>
              <ENT>4.45</ENT>
              <ENT>N/A</ENT>
              <ENT>3.41</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>8.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">38999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Blood/lymph system procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">39000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of chest</ENT>
              <ENT>6.10</ENT>
              <ENT>N/A</ENT>
              <ENT>4.65</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>11.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">39010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of chest</ENT>
              <ENT>11.79</ENT>
              <ENT>N/A</ENT>
              <ENT>6.43</ENT>
              <ENT>1.46</ENT>
              <ENT>N/A</ENT>
              <ENT>19.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">39200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal chest lesion</ENT>
              <ENT>13.62</ENT>
              <ENT>N/A</ENT>
              <ENT>6.64</ENT>
              <ENT>1.65</ENT>
              <ENT>N/A</ENT>
              <ENT>21.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">39220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal chest lesion</ENT>
              <ENT>17.42</ENT>
              <ENT>N/A</ENT>
              <ENT>8.32</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>27.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">39400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Visualization of chest</ENT>
              <ENT>5.61</ENT>
              <ENT>N/A</ENT>
              <ENT>4.66</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>10.96</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">39499</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Chest procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">39501</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair diaphragm laceration</ENT>
              <ENT>13.19</ENT>
              <ENT>N/A</ENT>
              <ENT>6.60</ENT>
              <ENT>1.38</ENT>
              <ENT>N/A</ENT>
              <ENT>21.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">39502</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair paraesophageal hernia</ENT>
              <ENT>16.33</ENT>
              <ENT>N/A</ENT>
              <ENT>7.33</ENT>
              <ENT>1.68</ENT>
              <ENT>N/A</ENT>
              <ENT>25.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">39503</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of diaphragm hernia</ENT>
              <ENT>95.00</ENT>
              <ENT>N/A</ENT>
              <ENT>34.01</ENT>
              <ENT>3.52</ENT>
              <ENT>N/A</ENT>
              <ENT>132.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">39520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of diaphragm hernia</ENT>
              <ENT>16.10</ENT>
              <ENT>N/A</ENT>
              <ENT>8.04</ENT>
              <ENT>1.83</ENT>
              <ENT>N/A</ENT>
              <ENT>25.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">39530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of diaphragm hernia</ENT>
              <ENT>15.41</ENT>
              <ENT>N/A</ENT>
              <ENT>7.24</ENT>
              <ENT>1.66</ENT>
              <ENT>N/A</ENT>
              <ENT>24.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">39531</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of diaphragm hernia</ENT>
              <ENT>16.42</ENT>
              <ENT>N/A</ENT>
              <ENT>7.49</ENT>
              <ENT>1.83</ENT>
              <ENT>N/A</ENT>
              <ENT>25.74</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">39540</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of diaphragm hernia</ENT>
              <ENT>13.32</ENT>
              <ENT>N/A</ENT>
              <ENT>6.40</ENT>
              <ENT>1.38</ENT>
              <ENT>N/A</ENT>
              <ENT>21.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">39541</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of diaphragm hernia</ENT>
              <ENT>14.41</ENT>
              <ENT>N/A</ENT>
              <ENT>6.73</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>22.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">39545</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of diaphragm</ENT>
              <ENT>13.37</ENT>
              <ENT>N/A</ENT>
              <ENT>7.48</ENT>
              <ENT>1.55</ENT>
              <ENT>N/A</ENT>
              <ENT>22.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">39560</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Resect diaphragm, simple</ENT>
              <ENT>12.00</ENT>
              <ENT>N/A</ENT>
              <ENT>6.42</ENT>
              <ENT>1.35</ENT>
              <ENT>N/A</ENT>
              <ENT>19.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">39561</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Resect diaphragm, complex</ENT>
              <ENT>17.50</ENT>
              <ENT>N/A</ENT>
              <ENT>9.40</ENT>
              <ENT>1.97</ENT>
              <ENT>N/A</ENT>
              <ENT>28.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">39599</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Diaphragm surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40490</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of lip</ENT>
              <ENT>1.22</ENT>
              <ENT>1.89</ENT>
              <ENT>0.62</ENT>
              <ENT>0.06</ENT>
              <ENT>3.17</ENT>
              <ENT>1.90</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial excision of lip</ENT>
              <ENT>4.28</ENT>
              <ENT>6.22</ENT>
              <ENT>5.00</ENT>
              <ENT>0.31</ENT>
              <ENT>10.81</ENT>
              <ENT>9.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial excision of lip</ENT>
              <ENT>4.70</ENT>
              <ENT>7.10</ENT>
              <ENT>5.01</ENT>
              <ENT>0.38</ENT>
              <ENT>12.18</ENT>
              <ENT>10.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial excision of lip</ENT>
              <ENT>4.67</ENT>
              <ENT>7.60</ENT>
              <ENT>5.26</ENT>
              <ENT>0.42</ENT>
              <ENT>12.69</ENT>
              <ENT>10.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40525</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct lip with flap</ENT>
              <ENT>7.55</ENT>
              <ENT>N/A</ENT>
              <ENT>7.10</ENT>
              <ENT>0.68</ENT>
              <ENT>N/A</ENT>
              <ENT>15.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40527</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct lip with flap</ENT>
              <ENT>9.13</ENT>
              <ENT>N/A</ENT>
              <ENT>8.10</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>18.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of lip</ENT>
              <ENT>5.40</ENT>
              <ENT>6.75</ENT>
              <ENT>5.35</ENT>
              <ENT>0.47</ENT>
              <ENT>12.62</ENT>
              <ENT>11.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40650</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair lip</ENT>
              <ENT>3.64</ENT>
              <ENT>5.71</ENT>
              <ENT>3.89</ENT>
              <ENT>0.31</ENT>
              <ENT>9.66</ENT>
              <ENT>7.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40652</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair lip</ENT>
              <ENT>4.26</ENT>
              <ENT>6.69</ENT>
              <ENT>5.36</ENT>
              <ENT>0.39</ENT>
              <ENT>11.34</ENT>
              <ENT>10.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40654</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair lip</ENT>
              <ENT>5.31</ENT>
              <ENT>7.34</ENT>
              <ENT>6.12</ENT>
              <ENT>0.48</ENT>
              <ENT>13.13</ENT>
              <ENT>11.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair cleft lip/nasal</ENT>
              <ENT>12.79</ENT>
              <ENT>N/A</ENT>
              <ENT>9.77</ENT>
              <ENT>0.93</ENT>
              <ENT>N/A</ENT>
              <ENT>23.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40701</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair cleft lip/nasal</ENT>
              <ENT>15.85</ENT>
              <ENT>N/A</ENT>
              <ENT>12.08</ENT>
              <ENT>1.36</ENT>
              <ENT>N/A</ENT>
              <ENT>29.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40702</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair cleft lip/nasal</ENT>
              <ENT>13.04</ENT>
              <ENT>N/A</ENT>
              <ENT>8.62</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>22.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40720</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair cleft lip/nasal</ENT>
              <ENT>13.55</ENT>
              <ENT>N/A</ENT>
              <ENT>10.75</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>25.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40761</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair cleft lip/nasal</ENT>
              <ENT>14.72</ENT>
              <ENT>N/A</ENT>
              <ENT>11.17</ENT>
              <ENT>1.41</ENT>
              <ENT>N/A</ENT>
              <ENT>27.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40799</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Lip surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of mouth lesion</ENT>
              <ENT>1.17</ENT>
              <ENT>2.32</ENT>
              <ENT>1.18</ENT>
              <ENT>0.09</ENT>
              <ENT>3.58</ENT>
              <ENT>2.44</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40801</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of mouth lesion</ENT>
              <ENT>2.53</ENT>
              <ENT>3.32</ENT>
              <ENT>2.09</ENT>
              <ENT>0.18</ENT>
              <ENT>6.03</ENT>
              <ENT>4.80</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40804</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal, foreign body, mouth</ENT>
              <ENT>1.24</ENT>
              <ENT>2.66</ENT>
              <ENT>1.14</ENT>
              <ENT>0.09</ENT>
              <ENT>3.99</ENT>
              <ENT>2.47</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40805</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal, foreign body, mouth</ENT>
              <ENT>2.69</ENT>
              <ENT>3.57</ENT>
              <ENT>2.03</ENT>
              <ENT>0.17</ENT>
              <ENT>6.43</ENT>
              <ENT>4.89</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40806</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of lip fold</ENT>
              <ENT>0.31</ENT>
              <ENT>1.42</ENT>
              <ENT>0.97</ENT>
              <ENT>0.02</ENT>
              <ENT>1.75</ENT>
              <ENT>1.30</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40808</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of mouth lesion</ENT>
              <ENT>0.96</ENT>
              <ENT>2.42</ENT>
              <ENT>1.11</ENT>
              <ENT>0.07</ENT>
              <ENT>3.45</ENT>
              <ENT>2.14</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40810</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of mouth lesion</ENT>
              <ENT>1.31</ENT>
              <ENT>2.50</ENT>
              <ENT>1.25</ENT>
              <ENT>0.09</ENT>
              <ENT>3.90</ENT>
              <ENT>2.65</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40812</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise/repair mouth lesion</ENT>
              <ENT>2.31</ENT>
              <ENT>3.40</ENT>
              <ENT>1.82</ENT>
              <ENT>0.17</ENT>
              <ENT>5.88</ENT>
              <ENT>4.30</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40814</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise/repair mouth lesion</ENT>
              <ENT>3.42</ENT>
              <ENT>4.95</ENT>
              <ENT>3.38</ENT>
              <ENT>0.26</ENT>
              <ENT>8.63</ENT>
              <ENT>7.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40816</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of mouth lesion</ENT>
              <ENT>3.67</ENT>
              <ENT>5.13</ENT>
              <ENT>3.49</ENT>
              <ENT>0.27</ENT>
              <ENT>9.07</ENT>
              <ENT>7.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40818</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise oral mucosa for graft</ENT>
              <ENT>2.41</ENT>
              <ENT>5.37</ENT>
              <ENT>3.64</ENT>
              <ENT>0.14</ENT>
              <ENT>7.92</ENT>
              <ENT>6.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40819</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise lip or cheek fold</ENT>
              <ENT>2.41</ENT>
              <ENT>4.61</ENT>
              <ENT>3.09</ENT>
              <ENT>0.17</ENT>
              <ENT>7.19</ENT>
              <ENT>5.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of mouth lesion</ENT>
              <ENT>1.28</ENT>
              <ENT>2.80</ENT>
              <ENT>2.45</ENT>
              <ENT>0.08</ENT>
              <ENT>4.16</ENT>
              <ENT>3.81</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49127"/>
              <ENT I="01">40830</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair mouth laceration</ENT>
              <ENT>1.76</ENT>
              <ENT>3.17</ENT>
              <ENT>2.57</ENT>
              <ENT>0.14</ENT>
              <ENT>5.07</ENT>
              <ENT>4.47</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40831</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair mouth laceration</ENT>
              <ENT>2.46</ENT>
              <ENT>3.74</ENT>
              <ENT>3.16</ENT>
              <ENT>0.21</ENT>
              <ENT>6.41</ENT>
              <ENT>5.83</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40840</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Reconstruction of mouth</ENT>
              <ENT>8.73</ENT>
              <ENT>8.83</ENT>
              <ENT>7.54</ENT>
              <ENT>0.79</ENT>
              <ENT>18.35</ENT>
              <ENT>17.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40842</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Reconstruction of mouth</ENT>
              <ENT>8.73</ENT>
              <ENT>8.94</ENT>
              <ENT>7.28</ENT>
              <ENT>0.65</ENT>
              <ENT>18.32</ENT>
              <ENT>16.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40843</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Reconstruction of mouth</ENT>
              <ENT>12.10</ENT>
              <ENT>11.25</ENT>
              <ENT>8.89</ENT>
              <ENT>0.84</ENT>
              <ENT>24.19</ENT>
              <ENT>21.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40844</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Reconstruction of mouth</ENT>
              <ENT>16.01</ENT>
              <ENT>14.16</ENT>
              <ENT>12.01</ENT>
              <ENT>1.63</ENT>
              <ENT>31.80</ENT>
              <ENT>29.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40845</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Reconstruction of mouth</ENT>
              <ENT>18.58</ENT>
              <ENT>16.30</ENT>
              <ENT>13.91</ENT>
              <ENT>1.47</ENT>
              <ENT>36.35</ENT>
              <ENT>33.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">40899</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Mouth surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of mouth lesion</ENT>
              <ENT>1.30</ENT>
              <ENT>2.57</ENT>
              <ENT>1.45</ENT>
              <ENT>0.09</ENT>
              <ENT>3.96</ENT>
              <ENT>2.84</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41005</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of mouth lesion</ENT>
              <ENT>1.26</ENT>
              <ENT>2.79</ENT>
              <ENT>1.67</ENT>
              <ENT>0.09</ENT>
              <ENT>4.14</ENT>
              <ENT>3.02</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41006</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of mouth lesion</ENT>
              <ENT>3.24</ENT>
              <ENT>4.57</ENT>
              <ENT>3.62</ENT>
              <ENT>0.25</ENT>
              <ENT>8.06</ENT>
              <ENT>7.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41007</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of mouth lesion</ENT>
              <ENT>3.10</ENT>
              <ENT>4.40</ENT>
              <ENT>3.46</ENT>
              <ENT>0.22</ENT>
              <ENT>7.72</ENT>
              <ENT>6.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41008</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of mouth lesion</ENT>
              <ENT>3.37</ENT>
              <ENT>4.73</ENT>
              <ENT>3.66</ENT>
              <ENT>0.24</ENT>
              <ENT>8.34</ENT>
              <ENT>7.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41009</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of mouth lesion</ENT>
              <ENT>3.59</ENT>
              <ENT>5.04</ENT>
              <ENT>3.99</ENT>
              <ENT>0.25</ENT>
              <ENT>8.88</ENT>
              <ENT>7.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of tongue fold</ENT>
              <ENT>1.06</ENT>
              <ENT>3.57</ENT>
              <ENT>3.57</ENT>
              <ENT>0.06</ENT>
              <ENT>4.69</ENT>
              <ENT>4.69</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41015</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of mouth lesion</ENT>
              <ENT>3.96</ENT>
              <ENT>5.56</ENT>
              <ENT>4.19</ENT>
              <ENT>0.29</ENT>
              <ENT>9.81</ENT>
              <ENT>8.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41016</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of mouth lesion</ENT>
              <ENT>4.07</ENT>
              <ENT>5.64</ENT>
              <ENT>4.21</ENT>
              <ENT>0.28</ENT>
              <ENT>9.99</ENT>
              <ENT>8.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41017</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of mouth lesion</ENT>
              <ENT>4.07</ENT>
              <ENT>5.55</ENT>
              <ENT>4.28</ENT>
              <ENT>0.32</ENT>
              <ENT>9.94</ENT>
              <ENT>8.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41018</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of mouth lesion</ENT>
              <ENT>5.10</ENT>
              <ENT>6.00</ENT>
              <ENT>4.40</ENT>
              <ENT>0.35</ENT>
              <ENT>11.45</ENT>
              <ENT>9.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of tongue</ENT>
              <ENT>1.63</ENT>
              <ENT>2.67</ENT>
              <ENT>1.46</ENT>
              <ENT>0.12</ENT>
              <ENT>4.42</ENT>
              <ENT>3.21</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41105</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of tongue</ENT>
              <ENT>1.42</ENT>
              <ENT>2.58</ENT>
              <ENT>1.35</ENT>
              <ENT>0.10</ENT>
              <ENT>4.10</ENT>
              <ENT>2.87</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41108</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of floor of mouth</ENT>
              <ENT>1.05</ENT>
              <ENT>2.32</ENT>
              <ENT>1.16</ENT>
              <ENT>0.08</ENT>
              <ENT>3.45</ENT>
              <ENT>2.29</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of tongue lesion</ENT>
              <ENT>1.51</ENT>
              <ENT>2.63</ENT>
              <ENT>1.37</ENT>
              <ENT>0.11</ENT>
              <ENT>4.25</ENT>
              <ENT>2.99</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41112</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of tongue lesion</ENT>
              <ENT>2.73</ENT>
              <ENT>4.44</ENT>
              <ENT>2.79</ENT>
              <ENT>0.20</ENT>
              <ENT>7.37</ENT>
              <ENT>5.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41113</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of tongue lesion</ENT>
              <ENT>3.19</ENT>
              <ENT>4.81</ENT>
              <ENT>3.06</ENT>
              <ENT>0.23</ENT>
              <ENT>8.23</ENT>
              <ENT>6.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41114</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of tongue lesion</ENT>
              <ENT>8.47</ENT>
              <ENT>9.08</ENT>
              <ENT>6.46</ENT>
              <ENT>0.64</ENT>
              <ENT>18.19</ENT>
              <ENT>15.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41115</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of tongue fold</ENT>
              <ENT>1.74</ENT>
              <ENT>3.59</ENT>
              <ENT>2.68</ENT>
              <ENT>0.13</ENT>
              <ENT>5.46</ENT>
              <ENT>4.55</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41116</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of mouth lesion</ENT>
              <ENT>2.44</ENT>
              <ENT>4.41</ENT>
              <ENT>2.93</ENT>
              <ENT>0.17</ENT>
              <ENT>7.02</ENT>
              <ENT>5.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of tongue</ENT>
              <ENT>9.77</ENT>
              <ENT>N/A</ENT>
              <ENT>7.88</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>18.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of tongue</ENT>
              <ENT>11.15</ENT>
              <ENT>N/A</ENT>
              <ENT>8.67</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>20.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41135</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tongue and neck surgery</ENT>
              <ENT>23.09</ENT>
              <ENT>N/A</ENT>
              <ENT>15.27</ENT>
              <ENT>1.66</ENT>
              <ENT>N/A</ENT>
              <ENT>40.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of tongue</ENT>
              <ENT>25.50</ENT>
              <ENT>N/A</ENT>
              <ENT>16.53</ENT>
              <ENT>1.85</ENT>
              <ENT>N/A</ENT>
              <ENT>43.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41145</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tongue removal, neck surgery</ENT>
              <ENT>30.06</ENT>
              <ENT>N/A</ENT>
              <ENT>19.74</ENT>
              <ENT>2.11</ENT>
              <ENT>N/A</ENT>
              <ENT>51.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tongue, mouth, jaw surgery</ENT>
              <ENT>23.04</ENT>
              <ENT>N/A</ENT>
              <ENT>16.02</ENT>
              <ENT>1.67</ENT>
              <ENT>N/A</ENT>
              <ENT>40.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41153</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tongue, mouth, neck surgery</ENT>
              <ENT>23.77</ENT>
              <ENT>N/A</ENT>
              <ENT>16.50</ENT>
              <ENT>1.71</ENT>
              <ENT>N/A</ENT>
              <ENT>41.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41155</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tongue, jaw, &amp; neck surgery</ENT>
              <ENT>27.72</ENT>
              <ENT>N/A</ENT>
              <ENT>18.57</ENT>
              <ENT>2.02</ENT>
              <ENT>N/A</ENT>
              <ENT>48.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair tongue laceration</ENT>
              <ENT>1.91</ENT>
              <ENT>3.19</ENT>
              <ENT>1.66</ENT>
              <ENT>0.15</ENT>
              <ENT>5.25</ENT>
              <ENT>3.72</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41251</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair tongue laceration</ENT>
              <ENT>2.27</ENT>
              <ENT>3.70</ENT>
              <ENT>2.00</ENT>
              <ENT>0.18</ENT>
              <ENT>6.15</ENT>
              <ENT>4.45</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41252</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair tongue laceration</ENT>
              <ENT>2.97</ENT>
              <ENT>4.33</ENT>
              <ENT>2.35</ENT>
              <ENT>0.23</ENT>
              <ENT>7.53</ENT>
              <ENT>5.55</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fixation of tongue</ENT>
              <ENT>3.71</ENT>
              <ENT>N/A</ENT>
              <ENT>3.80</ENT>
              <ENT>0.26</ENT>
              <ENT>N/A</ENT>
              <ENT>7.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tongue to lip surgery</ENT>
              <ENT>3.42</ENT>
              <ENT>N/A</ENT>
              <ENT>3.31</ENT>
              <ENT>0.24</ENT>
              <ENT>N/A</ENT>
              <ENT>6.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction, tongue fold</ENT>
              <ENT>2.73</ENT>
              <ENT>4.22</ENT>
              <ENT>3.35</ENT>
              <ENT>0.19</ENT>
              <ENT>7.14</ENT>
              <ENT>6.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41599</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Tongue and mouth surgery</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of gum lesion</ENT>
              <ENT>1.17</ENT>
              <ENT>2.76</ENT>
              <ENT>1.49</ENT>
              <ENT>0.09</ENT>
              <ENT>4.02</ENT>
              <ENT>2.75</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41805</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal foreign body, gum</ENT>
              <ENT>1.24</ENT>
              <ENT>2.83</ENT>
              <ENT>2.42</ENT>
              <ENT>0.09</ENT>
              <ENT>4.16</ENT>
              <ENT>3.75</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41806</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal foreign body,jawbone</ENT>
              <ENT>2.69</ENT>
              <ENT>3.74</ENT>
              <ENT>3.25</ENT>
              <ENT>0.22</ENT>
              <ENT>6.65</ENT>
              <ENT>6.16</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41820</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Excision, gum, each quadrant</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41821</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Excision of gum flap</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41822</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Excision of gum lesion</ENT>
              <ENT>2.31</ENT>
              <ENT>4.25</ENT>
              <ENT>1.36</ENT>
              <ENT>0.24</ENT>
              <ENT>6.80</ENT>
              <ENT>3.91</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41823</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Excision of gum lesion</ENT>
              <ENT>3.30</ENT>
              <ENT>6.07</ENT>
              <ENT>4.28</ENT>
              <ENT>0.29</ENT>
              <ENT>9.66</ENT>
              <ENT>7.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41825</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of gum lesion</ENT>
              <ENT>1.31</ENT>
              <ENT>3.42</ENT>
              <ENT>2.46</ENT>
              <ENT>0.10</ENT>
              <ENT>4.83</ENT>
              <ENT>3.87</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41826</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of gum lesion</ENT>
              <ENT>2.31</ENT>
              <ENT>4.00</ENT>
              <ENT>3.01</ENT>
              <ENT>0.17</ENT>
              <ENT>6.48</ENT>
              <ENT>5.49</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41827</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of gum lesion</ENT>
              <ENT>3.42</ENT>
              <ENT>5.80</ENT>
              <ENT>3.98</ENT>
              <ENT>0.25</ENT>
              <ENT>9.47</ENT>
              <ENT>7.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41828</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Excision of gum lesion</ENT>
              <ENT>3.09</ENT>
              <ENT>4.57</ENT>
              <ENT>3.46</ENT>
              <ENT>0.22</ENT>
              <ENT>7.88</ENT>
              <ENT>6.77</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41830</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Removal of gum tissue</ENT>
              <ENT>3.35</ENT>
              <ENT>5.10</ENT>
              <ENT>3.71</ENT>
              <ENT>0.23</ENT>
              <ENT>8.68</ENT>
              <ENT>7.29</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41850</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Treatment of gum lesion</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41870</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Gum graft</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49128"/>
              <ENT I="01">41872</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Repair gum</ENT>
              <ENT>2.59</ENT>
              <ENT>4.77</ENT>
              <ENT>3.63</ENT>
              <ENT>0.18</ENT>
              <ENT>7.54</ENT>
              <ENT>6.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41874</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Repair tooth socket</ENT>
              <ENT>3.09</ENT>
              <ENT>4.82</ENT>
              <ENT>3.36</ENT>
              <ENT>0.23</ENT>
              <ENT>8.14</ENT>
              <ENT>6.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">41899</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Dental surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage mouth roof lesion</ENT>
              <ENT>1.23</ENT>
              <ENT>2.83</ENT>
              <ENT>1.29</ENT>
              <ENT>0.10</ENT>
              <ENT>4.16</ENT>
              <ENT>2.62</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy roof of mouth</ENT>
              <ENT>1.31</ENT>
              <ENT>2.40</ENT>
              <ENT>1.40</ENT>
              <ENT>0.10</ENT>
              <ENT>3.81</ENT>
              <ENT>2.81</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42104</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision lesion, mouth roof</ENT>
              <ENT>1.64</ENT>
              <ENT>2.89</ENT>
              <ENT>1.61</ENT>
              <ENT>0.12</ENT>
              <ENT>4.65</ENT>
              <ENT>3.37</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42106</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision lesion, mouth roof</ENT>
              <ENT>2.10</ENT>
              <ENT>3.88</ENT>
              <ENT>2.94</ENT>
              <ENT>0.16</ENT>
              <ENT>6.14</ENT>
              <ENT>5.20</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42107</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision lesion, mouth roof</ENT>
              <ENT>4.44</ENT>
              <ENT>6.29</ENT>
              <ENT>4.33</ENT>
              <ENT>0.32</ENT>
              <ENT>11.05</ENT>
              <ENT>9.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove palate/lesion</ENT>
              <ENT>6.17</ENT>
              <ENT>N/A</ENT>
              <ENT>5.78</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>12.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of uvula</ENT>
              <ENT>1.62</ENT>
              <ENT>2.66</ENT>
              <ENT>2.52</ENT>
              <ENT>0.12</ENT>
              <ENT>4.40</ENT>
              <ENT>4.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42145</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair palate, pharynx/uvula</ENT>
              <ENT>8.05</ENT>
              <ENT>N/A</ENT>
              <ENT>6.88</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>15.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42160</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment mouth roof lesion</ENT>
              <ENT>1.80</ENT>
              <ENT>3.84</ENT>
              <ENT>2.78</ENT>
              <ENT>0.13</ENT>
              <ENT>5.77</ENT>
              <ENT>4.71</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42180</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair palate</ENT>
              <ENT>2.50</ENT>
              <ENT>3.55</ENT>
              <ENT>2.19</ENT>
              <ENT>0.19</ENT>
              <ENT>6.24</ENT>
              <ENT>4.88</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42182</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair palate</ENT>
              <ENT>3.83</ENT>
              <ENT>4.43</ENT>
              <ENT>3.14</ENT>
              <ENT>0.27</ENT>
              <ENT>8.53</ENT>
              <ENT>7.24</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct cleft palate</ENT>
              <ENT>12.00</ENT>
              <ENT>N/A</ENT>
              <ENT>9.28</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>22.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42205</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct cleft palate</ENT>
              <ENT>13.29</ENT>
              <ENT>N/A</ENT>
              <ENT>9.62</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>23.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42210</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct cleft palate</ENT>
              <ENT>14.50</ENT>
              <ENT>N/A</ENT>
              <ENT>10.83</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>26.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42215</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct cleft palate</ENT>
              <ENT>8.82</ENT>
              <ENT>N/A</ENT>
              <ENT>7.78</ENT>
              <ENT>0.96</ENT>
              <ENT>N/A</ENT>
              <ENT>17.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct cleft palate</ENT>
              <ENT>7.02</ENT>
              <ENT>N/A</ENT>
              <ENT>5.83</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>13.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42225</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct cleft palate</ENT>
              <ENT>9.54</ENT>
              <ENT>N/A</ENT>
              <ENT>7.90</ENT>
              <ENT>0.75</ENT>
              <ENT>N/A</ENT>
              <ENT>18.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42226</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lengthening of palate</ENT>
              <ENT>10.01</ENT>
              <ENT>N/A</ENT>
              <ENT>8.16</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>18.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42227</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lengthening of palate</ENT>
              <ENT>9.52</ENT>
              <ENT>N/A</ENT>
              <ENT>7.56</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>17.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42235</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair palate</ENT>
              <ENT>7.87</ENT>
              <ENT>N/A</ENT>
              <ENT>5.48</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>13.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42260</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair nose to lip fistula</ENT>
              <ENT>9.80</ENT>
              <ENT>9.48</ENT>
              <ENT>7.61</ENT>
              <ENT>0.85</ENT>
              <ENT>20.13</ENT>
              <ENT>18.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42280</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Preparation, palate mold</ENT>
              <ENT>1.54</ENT>
              <ENT>2.08</ENT>
              <ENT>0.90</ENT>
              <ENT>0.12</ENT>
              <ENT>3.74</ENT>
              <ENT>2.56</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42281</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insertion, palate prosthesis</ENT>
              <ENT>1.93</ENT>
              <ENT>3.07</ENT>
              <ENT>1.95</ENT>
              <ENT>0.14</ENT>
              <ENT>5.14</ENT>
              <ENT>4.02</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42299</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Palate/uvula surgery</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of salivary gland</ENT>
              <ENT>1.93</ENT>
              <ENT>3.09</ENT>
              <ENT>1.88</ENT>
              <ENT>0.15</ENT>
              <ENT>5.17</ENT>
              <ENT>3.96</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42305</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of salivary gland</ENT>
              <ENT>6.07</ENT>
              <ENT>N/A</ENT>
              <ENT>5.12</ENT>
              <ENT>0.46</ENT>
              <ENT>N/A</ENT>
              <ENT>11.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42310</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of salivary gland</ENT>
              <ENT>1.56</ENT>
              <ENT>2.43</ENT>
              <ENT>1.59</ENT>
              <ENT>0.11</ENT>
              <ENT>4.10</ENT>
              <ENT>3.26</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of salivary gland</ENT>
              <ENT>2.35</ENT>
              <ENT>3.70</ENT>
              <ENT>2.17</ENT>
              <ENT>0.17</ENT>
              <ENT>6.22</ENT>
              <ENT>4.69</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42325</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Create salivary cyst drain</ENT>
              <ENT>2.75</ENT>
              <ENT>3.66</ENT>
              <ENT>2.19</ENT>
              <ENT>0.17</ENT>
              <ENT>6.58</ENT>
              <ENT>5.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42326</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Create salivary cyst drain</ENT>
              <ENT>3.78</ENT>
              <ENT>4.70</ENT>
              <ENT>3.02</ENT>
              <ENT>0.34</ENT>
              <ENT>8.82</ENT>
              <ENT>7.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42330</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of salivary stone</ENT>
              <ENT>2.21</ENT>
              <ENT>3.44</ENT>
              <ENT>1.91</ENT>
              <ENT>0.16</ENT>
              <ENT>5.81</ENT>
              <ENT>4.28</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42335</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of salivary stone</ENT>
              <ENT>3.31</ENT>
              <ENT>4.06</ENT>
              <ENT>3.53</ENT>
              <ENT>0.23</ENT>
              <ENT>7.60</ENT>
              <ENT>7.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42340</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of salivary stone</ENT>
              <ENT>4.60</ENT>
              <ENT>5.35</ENT>
              <ENT>4.47</ENT>
              <ENT>0.34</ENT>
              <ENT>10.29</ENT>
              <ENT>9.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of salivary gland</ENT>
              <ENT>0.78</ENT>
              <ENT>1.82</ENT>
              <ENT>0.73</ENT>
              <ENT>0.06</ENT>
              <ENT>2.66</ENT>
              <ENT>1.57</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42405</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of salivary gland</ENT>
              <ENT>3.29</ENT>
              <ENT>4.33</ENT>
              <ENT>2.54</ENT>
              <ENT>0.24</ENT>
              <ENT>7.86</ENT>
              <ENT>6.07</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42408</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of salivary cyst</ENT>
              <ENT>4.54</ENT>
              <ENT>5.25</ENT>
              <ENT>4.23</ENT>
              <ENT>0.34</ENT>
              <ENT>10.13</ENT>
              <ENT>9.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42409</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of salivary cyst</ENT>
              <ENT>2.81</ENT>
              <ENT>3.70</ENT>
              <ENT>3.25</ENT>
              <ENT>0.20</ENT>
              <ENT>6.71</ENT>
              <ENT>6.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42410</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise parotid gland/lesion</ENT>
              <ENT>9.34</ENT>
              <ENT>N/A</ENT>
              <ENT>6.85</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>16.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42415</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise parotid gland/lesion</ENT>
              <ENT>16.89</ENT>
              <ENT>N/A</ENT>
              <ENT>11.60</ENT>
              <ENT>1.26</ENT>
              <ENT>N/A</ENT>
              <ENT>29.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise parotid gland/lesion</ENT>
              <ENT>19.59</ENT>
              <ENT>N/A</ENT>
              <ENT>13.15</ENT>
              <ENT>1.45</ENT>
              <ENT>N/A</ENT>
              <ENT>34.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42425</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise parotid gland/lesion</ENT>
              <ENT>13.02</ENT>
              <ENT>N/A</ENT>
              <ENT>9.37</ENT>
              <ENT>0.98</ENT>
              <ENT>N/A</ENT>
              <ENT>23.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42426</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise parotid gland/lesion</ENT>
              <ENT>21.26</ENT>
              <ENT>N/A</ENT>
              <ENT>13.82</ENT>
              <ENT>1.57</ENT>
              <ENT>N/A</ENT>
              <ENT>36.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42440</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise submaxillary gland</ENT>
              <ENT>6.97</ENT>
              <ENT>N/A</ENT>
              <ENT>5.25</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>12.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise sublingual gland</ENT>
              <ENT>4.62</ENT>
              <ENT>5.90</ENT>
              <ENT>4.42</ENT>
              <ENT>0.34</ENT>
              <ENT>10.86</ENT>
              <ENT>9.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair salivary duct</ENT>
              <ENT>4.30</ENT>
              <ENT>5.69</ENT>
              <ENT>4.37</ENT>
              <ENT>0.30</ENT>
              <ENT>10.29</ENT>
              <ENT>8.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42505</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair salivary duct</ENT>
              <ENT>6.18</ENT>
              <ENT>7.18</ENT>
              <ENT>5.58</ENT>
              <ENT>0.44</ENT>
              <ENT>13.80</ENT>
              <ENT>12.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42507</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Parotid duct diversion</ENT>
              <ENT>6.11</ENT>
              <ENT>N/A</ENT>
              <ENT>5.40</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>12.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42508</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Parotid duct diversion</ENT>
              <ENT>9.10</ENT>
              <ENT>N/A</ENT>
              <ENT>7.30</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>17.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42509</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Parotid duct diversion</ENT>
              <ENT>11.54</ENT>
              <ENT>N/A</ENT>
              <ENT>8.48</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>21.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Parotid duct diversion</ENT>
              <ENT>8.15</ENT>
              <ENT>N/A</ENT>
              <ENT>6.30</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>15.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42550</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection for salivary x-ray</ENT>
              <ENT>1.25</ENT>
              <ENT>10.77</ENT>
              <ENT>0.42</ENT>
              <ENT>0.06</ENT>
              <ENT>12.08</ENT>
              <ENT>1.73</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Closure of salivary fistula</ENT>
              <ENT>4.82</ENT>
              <ENT>6.09</ENT>
              <ENT>4.70</ENT>
              <ENT>0.34</ENT>
              <ENT>11.25</ENT>
              <ENT>9.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42650</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dilation of salivary duct</ENT>
              <ENT>0.77</ENT>
              <ENT>1.23</ENT>
              <ENT>0.73</ENT>
              <ENT>0.06</ENT>
              <ENT>2.06</ENT>
              <ENT>1.56</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42660</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dilation of salivary duct</ENT>
              <ENT>1.13</ENT>
              <ENT>1.56</ENT>
              <ENT>0.85</ENT>
              <ENT>0.07</ENT>
              <ENT>2.76</ENT>
              <ENT>2.05</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42665</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ligation of salivary duct</ENT>
              <ENT>2.53</ENT>
              <ENT>3.73</ENT>
              <ENT>3.12</ENT>
              <ENT>0.17</ENT>
              <ENT>6.43</ENT>
              <ENT>5.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42699</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Salivary surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of tonsil abscess</ENT>
              <ENT>1.62</ENT>
              <ENT>2.90</ENT>
              <ENT>1.79</ENT>
              <ENT>0.12</ENT>
              <ENT>4.64</ENT>
              <ENT>3.53</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49129"/>
              <ENT I="01">42720</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of throat abscess</ENT>
              <ENT>5.42</ENT>
              <ENT>5.24</ENT>
              <ENT>3.93</ENT>
              <ENT>0.39</ENT>
              <ENT>11.05</ENT>
              <ENT>9.74</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42725</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of throat abscess</ENT>
              <ENT>10.72</ENT>
              <ENT>N/A</ENT>
              <ENT>8.26</ENT>
              <ENT>0.80</ENT>
              <ENT>N/A</ENT>
              <ENT>19.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of throat</ENT>
              <ENT>1.39</ENT>
              <ENT>2.35</ENT>
              <ENT>1.45</ENT>
              <ENT>0.10</ENT>
              <ENT>3.84</ENT>
              <ENT>2.94</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42802</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of throat</ENT>
              <ENT>1.54</ENT>
              <ENT>3.17</ENT>
              <ENT>1.62</ENT>
              <ENT>0.11</ENT>
              <ENT>4.82</ENT>
              <ENT>3.27</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42804</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of upper nose/throat</ENT>
              <ENT>1.24</ENT>
              <ENT>3.16</ENT>
              <ENT>1.54</ENT>
              <ENT>0.09</ENT>
              <ENT>4.49</ENT>
              <ENT>2.87</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42806</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of upper nose/throat</ENT>
              <ENT>1.58</ENT>
              <ENT>3.17</ENT>
              <ENT>1.66</ENT>
              <ENT>0.12</ENT>
              <ENT>4.87</ENT>
              <ENT>3.36</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42808</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise pharynx lesion</ENT>
              <ENT>2.30</ENT>
              <ENT>3.31</ENT>
              <ENT>1.99</ENT>
              <ENT>0.17</ENT>
              <ENT>5.78</ENT>
              <ENT>4.46</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42809</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove pharynx foreign body</ENT>
              <ENT>1.81</ENT>
              <ENT>2.46</ENT>
              <ENT>1.40</ENT>
              <ENT>0.13</ENT>
              <ENT>4.40</ENT>
              <ENT>3.34</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42810</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of neck cyst</ENT>
              <ENT>3.25</ENT>
              <ENT>5.05</ENT>
              <ENT>3.53</ENT>
              <ENT>0.25</ENT>
              <ENT>8.55</ENT>
              <ENT>7.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42815</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of neck cyst</ENT>
              <ENT>7.07</ENT>
              <ENT>N/A</ENT>
              <ENT>5.63</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>13.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove tonsils and adenoids</ENT>
              <ENT>3.91</ENT>
              <ENT>N/A</ENT>
              <ENT>3.63</ENT>
              <ENT>0.28</ENT>
              <ENT>N/A</ENT>
              <ENT>7.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42821</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove tonsils and adenoids</ENT>
              <ENT>4.29</ENT>
              <ENT>N/A</ENT>
              <ENT>3.81</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>8.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42825</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of tonsils</ENT>
              <ENT>3.42</ENT>
              <ENT>N/A</ENT>
              <ENT>3.43</ENT>
              <ENT>0.24</ENT>
              <ENT>N/A</ENT>
              <ENT>7.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42826</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of tonsils</ENT>
              <ENT>3.38</ENT>
              <ENT>N/A</ENT>
              <ENT>3.33</ENT>
              <ENT>0.23</ENT>
              <ENT>N/A</ENT>
              <ENT>6.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42830</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of adenoids</ENT>
              <ENT>2.57</ENT>
              <ENT>N/A</ENT>
              <ENT>2.68</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>5.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42831</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of adenoids</ENT>
              <ENT>2.71</ENT>
              <ENT>N/A</ENT>
              <ENT>2.94</ENT>
              <ENT>0.19</ENT>
              <ENT>N/A</ENT>
              <ENT>5.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42835</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of adenoids</ENT>
              <ENT>2.30</ENT>
              <ENT>N/A</ENT>
              <ENT>2.72</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>5.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42836</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of adenoids</ENT>
              <ENT>3.18</ENT>
              <ENT>N/A</ENT>
              <ENT>3.26</ENT>
              <ENT>0.22</ENT>
              <ENT>N/A</ENT>
              <ENT>6.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42842</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive surgery of throat</ENT>
              <ENT>8.76</ENT>
              <ENT>N/A</ENT>
              <ENT>7.01</ENT>
              <ENT>0.61</ENT>
              <ENT>N/A</ENT>
              <ENT>16.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42844</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive surgery of throat</ENT>
              <ENT>14.31</ENT>
              <ENT>N/A</ENT>
              <ENT>10.36</ENT>
              <ENT>1.04</ENT>
              <ENT>N/A</ENT>
              <ENT>25.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42845</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive surgery of throat</ENT>
              <ENT>24.29</ENT>
              <ENT>N/A</ENT>
              <ENT>16.60</ENT>
              <ENT>1.76</ENT>
              <ENT>N/A</ENT>
              <ENT>42.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42860</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of tonsil tags</ENT>
              <ENT>2.22</ENT>
              <ENT>N/A</ENT>
              <ENT>2.68</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>5.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42870</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of lingual tonsil</ENT>
              <ENT>5.40</ENT>
              <ENT>N/A</ENT>
              <ENT>5.02</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>10.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42890</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of pharynx</ENT>
              <ENT>12.94</ENT>
              <ENT>N/A</ENT>
              <ENT>9.67</ENT>
              <ENT>0.91</ENT>
              <ENT>N/A</ENT>
              <ENT>23.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42892</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of pharyngeal walls</ENT>
              <ENT>15.83</ENT>
              <ENT>N/A</ENT>
              <ENT>11.27</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>28.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42894</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of pharyngeal walls</ENT>
              <ENT>22.88</ENT>
              <ENT>N/A</ENT>
              <ENT>15.55</ENT>
              <ENT>1.64</ENT>
              <ENT>N/A</ENT>
              <ENT>40.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42900</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair throat wound</ENT>
              <ENT>5.25</ENT>
              <ENT>N/A</ENT>
              <ENT>3.79</ENT>
              <ENT>0.39</ENT>
              <ENT>N/A</ENT>
              <ENT>9.43</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42950</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of throat</ENT>
              <ENT>8.10</ENT>
              <ENT>N/A</ENT>
              <ENT>6.82</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>15.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42953</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair throat, esophagus</ENT>
              <ENT>8.96</ENT>
              <ENT>N/A</ENT>
              <ENT>7.77</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>17.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42955</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Surgical opening of throat</ENT>
              <ENT>7.39</ENT>
              <ENT>N/A</ENT>
              <ENT>5.73</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>13.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42960</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Control throat bleeding</ENT>
              <ENT>2.33</ENT>
              <ENT>N/A</ENT>
              <ENT>2.08</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>4.58</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42961</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Control throat bleeding</ENT>
              <ENT>5.59</ENT>
              <ENT>N/A</ENT>
              <ENT>5.02</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>11.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42962</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Control throat bleeding</ENT>
              <ENT>7.14</ENT>
              <ENT>N/A</ENT>
              <ENT>5.91</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>13.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42970</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Control nose/throat bleeding</ENT>
              <ENT>5.43</ENT>
              <ENT>N/A</ENT>
              <ENT>3.72</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>9.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42971</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Control nose/throat bleeding</ENT>
              <ENT>6.21</ENT>
              <ENT>N/A</ENT>
              <ENT>5.17</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>11.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42972</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Control nose/throat bleeding</ENT>
              <ENT>7.20</ENT>
              <ENT>N/A</ENT>
              <ENT>5.64</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>13.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">42999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Throat surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of esophagus</ENT>
              <ENT>8.09</ENT>
              <ENT>N/A</ENT>
              <ENT>5.75</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>14.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43030</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Throat muscle surgery</ENT>
              <ENT>7.69</ENT>
              <ENT>N/A</ENT>
              <ENT>6.00</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>14.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43045</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of esophagus</ENT>
              <ENT>20.12</ENT>
              <ENT>N/A</ENT>
              <ENT>10.51</ENT>
              <ENT>2.15</ENT>
              <ENT>N/A</ENT>
              <ENT>32.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of esophagus lesion</ENT>
              <ENT>9.19</ENT>
              <ENT>N/A</ENT>
              <ENT>6.31</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>16.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43101</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of esophagus lesion</ENT>
              <ENT>16.24</ENT>
              <ENT>N/A</ENT>
              <ENT>7.83</ENT>
              <ENT>1.81</ENT>
              <ENT>N/A</ENT>
              <ENT>25.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43107</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of esophagus</ENT>
              <ENT>40.00</ENT>
              <ENT>N/A</ENT>
              <ENT>17.03</ENT>
              <ENT>3.29</ENT>
              <ENT>N/A</ENT>
              <ENT>60.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43108</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of esophagus</ENT>
              <ENT>34.19</ENT>
              <ENT>N/A</ENT>
              <ENT>14.36</ENT>
              <ENT>3.78</ENT>
              <ENT>N/A</ENT>
              <ENT>52.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43112</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of esophagus</ENT>
              <ENT>43.50</ENT>
              <ENT>N/A</ENT>
              <ENT>18.14</ENT>
              <ENT>3.67</ENT>
              <ENT>N/A</ENT>
              <ENT>65.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43113</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of esophagus</ENT>
              <ENT>35.27</ENT>
              <ENT>N/A</ENT>
              <ENT>15.19</ENT>
              <ENT>4.33</ENT>
              <ENT>N/A</ENT>
              <ENT>54.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43116</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of esophagus</ENT>
              <ENT>31.22</ENT>
              <ENT>N/A</ENT>
              <ENT>17.10</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>50.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43117</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of esophagus</ENT>
              <ENT>40.00</ENT>
              <ENT>N/A</ENT>
              <ENT>16.27</ENT>
              <ENT>3.51</ENT>
              <ENT>N/A</ENT>
              <ENT>59.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43118</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of esophagus</ENT>
              <ENT>33.20</ENT>
              <ENT>N/A</ENT>
              <ENT>13.89</ENT>
              <ENT>3.56</ENT>
              <ENT>N/A</ENT>
              <ENT>50.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49130"/>
              <ENT I="01">43121</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of esophagus</ENT>
              <ENT>29.19</ENT>
              <ENT>N/A</ENT>
              <ENT>12.58</ENT>
              <ENT>3.44</ENT>
              <ENT>N/A</ENT>
              <ENT>45.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43122</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of esophagus</ENT>
              <ENT>40.00</ENT>
              <ENT>N/A</ENT>
              <ENT>16.47</ENT>
              <ENT>3.27</ENT>
              <ENT>N/A</ENT>
              <ENT>59.74</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43123</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of esophagus</ENT>
              <ENT>33.20</ENT>
              <ENT>N/A</ENT>
              <ENT>14.10</ENT>
              <ENT>3.96</ENT>
              <ENT>N/A</ENT>
              <ENT>51.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43124</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of esophagus</ENT>
              <ENT>27.32</ENT>
              <ENT>N/A</ENT>
              <ENT>13.15</ENT>
              <ENT>2.95</ENT>
              <ENT>N/A</ENT>
              <ENT>43.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of esophagus pouch</ENT>
              <ENT>11.75</ENT>
              <ENT>N/A</ENT>
              <ENT>7.69</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>20.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43135</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of esophagus pouch</ENT>
              <ENT>16.10</ENT>
              <ENT>N/A</ENT>
              <ENT>8.04</ENT>
              <ENT>1.85</ENT>
              <ENT>N/A</ENT>
              <ENT>25.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esophagus endoscopy</ENT>
              <ENT>1.59</ENT>
              <ENT>4.49</ENT>
              <ENT>1.11</ENT>
              <ENT>0.11</ENT>
              <ENT>6.19</ENT>
              <ENT>2.81</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43201</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esoph scope w/submucous inj</ENT>
              <ENT>2.09</ENT>
              <ENT>4.92</ENT>
              <ENT>1.29</ENT>
              <ENT>0.12</ENT>
              <ENT>7.13</ENT>
              <ENT>3.50</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43202</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esophagus endoscopy, biopsy</ENT>
              <ENT>1.89</ENT>
              <ENT>5.61</ENT>
              <ENT>0.98</ENT>
              <ENT>0.12</ENT>
              <ENT>7.62</ENT>
              <ENT>2.99</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43204</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esoph scope w/sclerosis inj</ENT>
              <ENT>3.77</ENT>
              <ENT>N/A</ENT>
              <ENT>1.57</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>5.52</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43205</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esophagus endoscopy/ligation</ENT>
              <ENT>3.79</ENT>
              <ENT>N/A</ENT>
              <ENT>1.58</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>5.54</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43215</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esophagus endoscopy</ENT>
              <ENT>2.60</ENT>
              <ENT>N/A</ENT>
              <ENT>1.24</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>4.01</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43216</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esophagus endoscopy/lesion</ENT>
              <ENT>2.40</ENT>
              <ENT>N/A</ENT>
              <ENT>1.21</ENT>
              <ENT>0.15</ENT>
              <ENT>N/A</ENT>
              <ENT>3.76</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43217</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esophagus endoscopy</ENT>
              <ENT>2.90</ENT>
              <ENT>6.99</ENT>
              <ENT>1.24</ENT>
              <ENT>0.17</ENT>
              <ENT>10.06</ENT>
              <ENT>4.31</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43219</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esophagus endoscopy</ENT>
              <ENT>2.80</ENT>
              <ENT>N/A</ENT>
              <ENT>1.39</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>4.35</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esoph endoscopy, dilation</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>1.00</ENT>
              <ENT>0.12</ENT>
              <ENT>N/A</ENT>
              <ENT>3.22</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43226</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esoph endoscopy, dilation</ENT>
              <ENT>2.34</ENT>
              <ENT>N/A</ENT>
              <ENT>1.07</ENT>
              <ENT>0.12</ENT>
              <ENT>N/A</ENT>
              <ENT>3.53</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43227</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esoph endoscopy, repair</ENT>
              <ENT>3.60</ENT>
              <ENT>N/A</ENT>
              <ENT>1.50</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>5.28</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43228</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esoph endoscopy, ablation</ENT>
              <ENT>3.77</ENT>
              <ENT>N/A</ENT>
              <ENT>1.60</ENT>
              <ENT>0.25</ENT>
              <ENT>N/A</ENT>
              <ENT>5.62</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43231</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esoph endoscopy w/us exam</ENT>
              <ENT>3.19</ENT>
              <ENT>N/A</ENT>
              <ENT>1.35</ENT>
              <ENT>0.20</ENT>
              <ENT>N/A</ENT>
              <ENT>4.74</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43232</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esoph endoscopy w/us fn bx</ENT>
              <ENT>4.48</ENT>
              <ENT>N/A</ENT>
              <ENT>1.87</ENT>
              <ENT>0.26</ENT>
              <ENT>N/A</ENT>
              <ENT>6.61</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43234</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Upper GI endoscopy, exam</ENT>
              <ENT>2.01</ENT>
              <ENT>5.37</ENT>
              <ENT>0.91</ENT>
              <ENT>0.13</ENT>
              <ENT>7.51</ENT>
              <ENT>3.05</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43235</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Uppr gi endoscopy, diagnosis</ENT>
              <ENT>2.39</ENT>
              <ENT>5.18</ENT>
              <ENT>1.06</ENT>
              <ENT>0.13</ENT>
              <ENT>7.70</ENT>
              <ENT>3.58</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43236</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Uppr gi scope w/submuc inj</ENT>
              <ENT>2.92</ENT>
              <ENT>6.11</ENT>
              <ENT>1.26</ENT>
              <ENT>0.14</ENT>
              <ENT>9.17</ENT>
              <ENT>4.32</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43239</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Upper GI endoscopy, biopsy</ENT>
              <ENT>2.87</ENT>
              <ENT>5.73</ENT>
              <ENT>1.23</ENT>
              <ENT>0.14</ENT>
              <ENT>8.74</ENT>
              <ENT>4.24</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43240</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esoph endoscope w/drain cyst</ENT>
              <ENT>6.86</ENT>
              <ENT>N/A</ENT>
              <ENT>2.68</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>9.90</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43241</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Upper GI endoscopy with tube</ENT>
              <ENT>2.59</ENT>
              <ENT>N/A</ENT>
              <ENT>1.14</ENT>
              <ENT>0.14</ENT>
              <ENT>N/A</ENT>
              <ENT>3.87</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43242</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Uppr gi endoscopy w/us fn bx</ENT>
              <ENT>7.31</ENT>
              <ENT>N/A</ENT>
              <ENT>2.81</ENT>
              <ENT>0.29</ENT>
              <ENT>N/A</ENT>
              <ENT>10.41</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43243</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Upper gi endoscopy &amp; inject</ENT>
              <ENT>4.57</ENT>
              <ENT>N/A</ENT>
              <ENT>1.85</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>6.63</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43244</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Upper GI endoscopy/ligation</ENT>
              <ENT>5.05</ENT>
              <ENT>N/A</ENT>
              <ENT>2.02</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>7.28</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43245</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Uppr gi scope dilate strictr</ENT>
              <ENT>3.18</ENT>
              <ENT>N/A</ENT>
              <ENT>1.34</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>4.70</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43246</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Place gastrostomy tube</ENT>
              <ENT>4.33</ENT>
              <ENT>N/A</ENT>
              <ENT>1.75</ENT>
              <ENT>0.24</ENT>
              <ENT>N/A</ENT>
              <ENT>6.32</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43247</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Operative upper GI endoscopy</ENT>
              <ENT>3.39</ENT>
              <ENT>N/A</ENT>
              <ENT>1.42</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>4.98</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43248</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Uppr gi endoscopy/guide wire</ENT>
              <ENT>3.15</ENT>
              <ENT>N/A</ENT>
              <ENT>1.35</ENT>
              <ENT>0.15</ENT>
              <ENT>N/A</ENT>
              <ENT>4.65</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43249</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esoph endoscopy, dilation</ENT>
              <ENT>2.90</ENT>
              <ENT>N/A</ENT>
              <ENT>1.25</ENT>
              <ENT>0.15</ENT>
              <ENT>N/A</ENT>
              <ENT>4.30</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Upper GI endoscopy/tumor</ENT>
              <ENT>3.20</ENT>
              <ENT>N/A</ENT>
              <ENT>1.35</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>4.72</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43251</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Operative upper GI endoscopy</ENT>
              <ENT>3.70</ENT>
              <ENT>N/A</ENT>
              <ENT>1.53</ENT>
              <ENT>0.19</ENT>
              <ENT>N/A</ENT>
              <ENT>5.42</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43255</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Operative upper GI endoscopy</ENT>
              <ENT>4.82</ENT>
              <ENT>N/A</ENT>
              <ENT>1.94</ENT>
              <ENT>0.20</ENT>
              <ENT>N/A</ENT>
              <ENT>6.96</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43256</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Uppr gi endoscopy w stent</ENT>
              <ENT>4.35</ENT>
              <ENT>N/A</ENT>
              <ENT>1.77</ENT>
              <ENT>0.23</ENT>
              <ENT>N/A</ENT>
              <ENT>6.35</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49131"/>
              <ENT I="01">43258</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Operative upper GI endoscopy</ENT>
              <ENT>4.55</ENT>
              <ENT>N/A</ENT>
              <ENT>1.84</ENT>
              <ENT>0.22</ENT>
              <ENT>N/A</ENT>
              <ENT>6.61</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43259</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endoscopic ultrasound exam</ENT>
              <ENT>4.89</ENT>
              <ENT>N/A</ENT>
              <ENT>1.95</ENT>
              <ENT>0.22</ENT>
              <ENT>N/A</ENT>
              <ENT>7.06</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43260</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endo cholangiopancreatograph</ENT>
              <ENT>5.96</ENT>
              <ENT>N/A</ENT>
              <ENT>2.35</ENT>
              <ENT>0.27</ENT>
              <ENT>N/A</ENT>
              <ENT>8.58</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43261</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endo cholangiopancreatograph</ENT>
              <ENT>6.27</ENT>
              <ENT>N/A</ENT>
              <ENT>2.46</ENT>
              <ENT>0.29</ENT>
              <ENT>N/A</ENT>
              <ENT>9.02</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43262</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endo cholangiopancreatograph</ENT>
              <ENT>7.39</ENT>
              <ENT>N/A</ENT>
              <ENT>2.86</ENT>
              <ENT>0.34</ENT>
              <ENT>N/A</ENT>
              <ENT>10.59</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43263</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endo cholangiopancreatograph</ENT>
              <ENT>7.29</ENT>
              <ENT>N/A</ENT>
              <ENT>2.84</ENT>
              <ENT>0.28</ENT>
              <ENT>N/A</ENT>
              <ENT>10.41</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43264</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endo cholangiopancreatograph</ENT>
              <ENT>8.90</ENT>
              <ENT>N/A</ENT>
              <ENT>3.40</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>12.71</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43265</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endo cholangiopancreatograph</ENT>
              <ENT>10.02</ENT>
              <ENT>N/A</ENT>
              <ENT>3.80</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>14.24</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43267</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endo cholangiopancreatograph</ENT>
              <ENT>7.39</ENT>
              <ENT>N/A</ENT>
              <ENT>2.86</ENT>
              <ENT>0.34</ENT>
              <ENT>N/A</ENT>
              <ENT>10.59</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43268</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endo cholangiopancreatograph</ENT>
              <ENT>7.39</ENT>
              <ENT>N/A</ENT>
              <ENT>2.96</ENT>
              <ENT>0.34</ENT>
              <ENT>N/A</ENT>
              <ENT>10.69</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43269</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endo cholangiopancreatograph</ENT>
              <ENT>8.21</ENT>
              <ENT>N/A</ENT>
              <ENT>3.16</ENT>
              <ENT>0.28</ENT>
              <ENT>N/A</ENT>
              <ENT>11.65</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43271</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endo cholangiopancreatograph</ENT>
              <ENT>7.39</ENT>
              <ENT>N/A</ENT>
              <ENT>2.86</ENT>
              <ENT>0.34</ENT>
              <ENT>N/A</ENT>
              <ENT>10.59</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43272</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endo cholangiopancreatograph</ENT>
              <ENT>7.39</ENT>
              <ENT>N/A</ENT>
              <ENT>2.87</ENT>
              <ENT>0.34</ENT>
              <ENT>N/A</ENT>
              <ENT>10.60</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43280</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy, fundoplasty</ENT>
              <ENT>17.25</ENT>
              <ENT>N/A</ENT>
              <ENT>7.53</ENT>
              <ENT>1.76</ENT>
              <ENT>N/A</ENT>
              <ENT>26.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43289</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Laparoscope proc, esoph</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of esophagus</ENT>
              <ENT>9.14</ENT>
              <ENT>N/A</ENT>
              <ENT>6.59</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>16.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43305</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair esophagus and fistula</ENT>
              <ENT>17.39</ENT>
              <ENT>N/A</ENT>
              <ENT>10.98</ENT>
              <ENT>1.36</ENT>
              <ENT>N/A</ENT>
              <ENT>29.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43310</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of esophagus</ENT>
              <ENT>25.39</ENT>
              <ENT>N/A</ENT>
              <ENT>11.21</ENT>
              <ENT>3.18</ENT>
              <ENT>N/A</ENT>
              <ENT>39.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43312</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair esophagus and fistula</ENT>
              <ENT>28.42</ENT>
              <ENT>N/A</ENT>
              <ENT>12.16</ENT>
              <ENT>3.38</ENT>
              <ENT>N/A</ENT>
              <ENT>43.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43313</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esophagoplasty congenital</ENT>
              <ENT>45.28</ENT>
              <ENT>N/A</ENT>
              <ENT>20.57</ENT>
              <ENT>5.43</ENT>
              <ENT>N/A</ENT>
              <ENT>71.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43314</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tracheo-esophagoplasty cong</ENT>
              <ENT>50.27</ENT>
              <ENT>N/A</ENT>
              <ENT>22.50</ENT>
              <ENT>5.53</ENT>
              <ENT>N/A</ENT>
              <ENT>78.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fuse esophagus &amp; stomach</ENT>
              <ENT>19.93</ENT>
              <ENT>N/A</ENT>
              <ENT>9.30</ENT>
              <ENT>1.59</ENT>
              <ENT>N/A</ENT>
              <ENT>30.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43324</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise esophagus &amp; stomach</ENT>
              <ENT>20.57</ENT>
              <ENT>N/A</ENT>
              <ENT>8.98</ENT>
              <ENT>1.72</ENT>
              <ENT>N/A</ENT>
              <ENT>31.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43325</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise esophagus &amp; stomach</ENT>
              <ENT>20.06</ENT>
              <ENT>N/A</ENT>
              <ENT>8.96</ENT>
              <ENT>1.65</ENT>
              <ENT>N/A</ENT>
              <ENT>30.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43326</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise esophagus &amp; stomach</ENT>
              <ENT>19.74</ENT>
              <ENT>N/A</ENT>
              <ENT>9.27</ENT>
              <ENT>1.84</ENT>
              <ENT>N/A</ENT>
              <ENT>30.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43330</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of esophagus</ENT>
              <ENT>19.77</ENT>
              <ENT>N/A</ENT>
              <ENT>8.73</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>30.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43331</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of esophagus</ENT>
              <ENT>20.13</ENT>
              <ENT>N/A</ENT>
              <ENT>9.75</ENT>
              <ENT>1.93</ENT>
              <ENT>N/A</ENT>
              <ENT>31.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43340</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fuse esophagus &amp; intestine</ENT>
              <ENT>19.61</ENT>
              <ENT>N/A</ENT>
              <ENT>9.08</ENT>
              <ENT>1.53</ENT>
              <ENT>N/A</ENT>
              <ENT>30.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43341</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fuse esophagus &amp; intestine</ENT>
              <ENT>20.85</ENT>
              <ENT>N/A</ENT>
              <ENT>10.02</ENT>
              <ENT>2.14</ENT>
              <ENT>N/A</ENT>
              <ENT>33.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43350</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Surgical opening, esophagus</ENT>
              <ENT>15.78</ENT>
              <ENT>N/A</ENT>
              <ENT>8.57</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>25.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43351</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Surgical opening, esophagus</ENT>
              <ENT>18.35</ENT>
              <ENT>N/A</ENT>
              <ENT>9.69</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>29.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49132"/>
              <ENT I="01">43352</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Surgical opening, esophagus</ENT>
              <ENT>15.26</ENT>
              <ENT>N/A</ENT>
              <ENT>8.45</ENT>
              <ENT>1.28</ENT>
              <ENT>N/A</ENT>
              <ENT>24.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43360</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Gastrointestinal repair</ENT>
              <ENT>35.70</ENT>
              <ENT>N/A</ENT>
              <ENT>15.16</ENT>
              <ENT>3.00</ENT>
              <ENT>N/A</ENT>
              <ENT>53.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43361</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Gastrointestinal repair</ENT>
              <ENT>40.50</ENT>
              <ENT>N/A</ENT>
              <ENT>16.97</ENT>
              <ENT>3.52</ENT>
              <ENT>N/A</ENT>
              <ENT>60.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ligate esophagus veins</ENT>
              <ENT>21.20</ENT>
              <ENT>N/A</ENT>
              <ENT>9.64</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>31.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43401</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esophagus surgery for veins</ENT>
              <ENT>22.09</ENT>
              <ENT>N/A</ENT>
              <ENT>9.72</ENT>
              <ENT>1.73</ENT>
              <ENT>N/A</ENT>
              <ENT>33.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43405</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ligate/staple esophagus</ENT>
              <ENT>20.01</ENT>
              <ENT>N/A</ENT>
              <ENT>9.56</ENT>
              <ENT>1.63</ENT>
              <ENT>N/A</ENT>
              <ENT>31.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43410</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair esophagus wound</ENT>
              <ENT>13.47</ENT>
              <ENT>N/A</ENT>
              <ENT>7.66</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>22.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43415</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair esophagus wound</ENT>
              <ENT>25.00</ENT>
              <ENT>N/A</ENT>
              <ENT>11.70</ENT>
              <ENT>1.92</ENT>
              <ENT>N/A</ENT>
              <ENT>38.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair esophagus opening</ENT>
              <ENT>14.35</ENT>
              <ENT>N/A</ENT>
              <ENT>7.63</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>22.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43425</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair esophagus opening</ENT>
              <ENT>21.03</ENT>
              <ENT>N/A</ENT>
              <ENT>9.94</ENT>
              <ENT>2.03</ENT>
              <ENT>N/A</ENT>
              <ENT>33.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dilate esophagus</ENT>
              <ENT>1.38</ENT>
              <ENT>2.54</ENT>
              <ENT>0.72</ENT>
              <ENT>0.07</ENT>
              <ENT>3.99</ENT>
              <ENT>2.17</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43453</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dilate esophagus</ENT>
              <ENT>1.51</ENT>
              <ENT>6.12</ENT>
              <ENT>0.79</ENT>
              <ENT>0.08</ENT>
              <ENT>7.71</ENT>
              <ENT>2.38</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43456</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dilate esophagus</ENT>
              <ENT>2.57</ENT>
              <ENT>14.11</ENT>
              <ENT>1.17</ENT>
              <ENT>0.14</ENT>
              <ENT>16.82</ENT>
              <ENT>3.88</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43458</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dilate esophagus</ENT>
              <ENT>3.06</ENT>
              <ENT>6.73</ENT>
              <ENT>1.36</ENT>
              <ENT>0.17</ENT>
              <ENT>9.96</ENT>
              <ENT>4.59</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43460</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pressure treatment esophagus</ENT>
              <ENT>3.80</ENT>
              <ENT>N/A</ENT>
              <ENT>1.51</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>5.52</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43496</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Free jejunum flap, microvasc</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43499</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Esophagus surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Surgical opening of stomach</ENT>
              <ENT>11.05</ENT>
              <ENT>N/A</ENT>
              <ENT>5.23</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>17.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43501</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Surgical repair of stomach</ENT>
              <ENT>20.04</ENT>
              <ENT>N/A</ENT>
              <ENT>8.63</ENT>
              <ENT>1.55</ENT>
              <ENT>N/A</ENT>
              <ENT>30.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43502</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Surgical repair of stomach</ENT>
              <ENT>23.13</ENT>
              <ENT>N/A</ENT>
              <ENT>9.79</ENT>
              <ENT>1.83</ENT>
              <ENT>N/A</ENT>
              <ENT>34.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Surgical opening of stomach</ENT>
              <ENT>13.08</ENT>
              <ENT>N/A</ENT>
              <ENT>6.84</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>20.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of pyloric muscle</ENT>
              <ENT>9.99</ENT>
              <ENT>N/A</ENT>
              <ENT>5.44</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>16.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of stomach</ENT>
              <ENT>1.91</ENT>
              <ENT>N/A</ENT>
              <ENT>1.04</ENT>
              <ENT>0.11</ENT>
              <ENT>N/A</ENT>
              <ENT>3.06</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of stomach</ENT>
              <ENT>11.98</ENT>
              <ENT>N/A</ENT>
              <ENT>5.54</ENT>
              <ENT>0.93</ENT>
              <ENT>N/A</ENT>
              <ENT>18.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43610</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of stomach lesion</ENT>
              <ENT>14.60</ENT>
              <ENT>N/A</ENT>
              <ENT>6.47</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>22.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43611</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of stomach lesion</ENT>
              <ENT>17.84</ENT>
              <ENT>N/A</ENT>
              <ENT>7.88</ENT>
              <ENT>1.38</ENT>
              <ENT>N/A</ENT>
              <ENT>27.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43620</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of stomach</ENT>
              <ENT>30.04</ENT>
              <ENT>N/A</ENT>
              <ENT>12.22</ENT>
              <ENT>2.29</ENT>
              <ENT>N/A</ENT>
              <ENT>44.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43621</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of stomach</ENT>
              <ENT>30.73</ENT>
              <ENT>N/A</ENT>
              <ENT>12.43</ENT>
              <ENT>2.36</ENT>
              <ENT>N/A</ENT>
              <ENT>45.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43622</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of stomach</ENT>
              <ENT>32.53</ENT>
              <ENT>N/A</ENT>
              <ENT>13.03</ENT>
              <ENT>2.48</ENT>
              <ENT>N/A</ENT>
              <ENT>48.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43631</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of stomach, partial</ENT>
              <ENT>22.59</ENT>
              <ENT>N/A</ENT>
              <ENT>9.49</ENT>
              <ENT>1.99</ENT>
              <ENT>N/A</ENT>
              <ENT>34.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43632</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of stomach, partial</ENT>
              <ENT>22.59</ENT>
              <ENT>N/A</ENT>
              <ENT>9.50</ENT>
              <ENT>2.00</ENT>
              <ENT>N/A</ENT>
              <ENT>34.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43633</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of stomach, partial</ENT>
              <ENT>23.10</ENT>
              <ENT>N/A</ENT>
              <ENT>9.67</ENT>
              <ENT>2.05</ENT>
              <ENT>N/A</ENT>
              <ENT>34.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43634</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of stomach, partial</ENT>
              <ENT>25.12</ENT>
              <ENT>N/A</ENT>
              <ENT>10.43</ENT>
              <ENT>2.18</ENT>
              <ENT>N/A</ENT>
              <ENT>37.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43635</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of stomach, partial</ENT>
              <ENT>2.06</ENT>
              <ENT>N/A</ENT>
              <ENT>0.72</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>2.99</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43638</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of stomach, partial</ENT>
              <ENT>29.00</ENT>
              <ENT>N/A</ENT>
              <ENT>12.20</ENT>
              <ENT>2.24</ENT>
              <ENT>N/A</ENT>
              <ENT>43.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43639</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of stomach, partial</ENT>
              <ENT>29.65</ENT>
              <ENT>N/A</ENT>
              <ENT>12.03</ENT>
              <ENT>2.31</ENT>
              <ENT>N/A</ENT>
              <ENT>43.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43640</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vagotomy &amp; pylorus repair</ENT>
              <ENT>17.02</ENT>
              <ENT>N/A</ENT>
              <ENT>7.56</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>26.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43641</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vagotomy &amp; pylorus repair</ENT>
              <ENT>17.27</ENT>
              <ENT>N/A</ENT>
              <ENT>7.66</ENT>
              <ENT>1.53</ENT>
              <ENT>N/A</ENT>
              <ENT>26.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43651</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy, vagus nerve</ENT>
              <ENT>10.15</ENT>
              <ENT>N/A</ENT>
              <ENT>4.82</ENT>
              <ENT>1.03</ENT>
              <ENT>N/A</ENT>
              <ENT>16.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43652</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy, vagus nerve</ENT>
              <ENT>12.15</ENT>
              <ENT>N/A</ENT>
              <ENT>5.53</ENT>
              <ENT>1.25</ENT>
              <ENT>N/A</ENT>
              <ENT>18.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43653</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy, gastrostomy</ENT>
              <ENT>7.73</ENT>
              <ENT>N/A</ENT>
              <ENT>4.43</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>12.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43659</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Laparoscope proc, stom</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43750</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Place gastrostomy tube</ENT>
              <ENT>4.49</ENT>
              <ENT>N/A</ENT>
              <ENT>2.75</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>7.57</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43760</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Change gastrostomy tube</ENT>
              <ENT>1.10</ENT>
              <ENT>1.68</ENT>
              <ENT>0.46</ENT>
              <ENT>0.07</ENT>
              <ENT>2.85</ENT>
              <ENT>1.63</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43761</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reposition gastrostomy tube</ENT>
              <ENT>2.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.80</ENT>
              <ENT>0.10</ENT>
              <ENT>N/A</ENT>
              <ENT>2.91</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of pylorus</ENT>
              <ENT>13.69</ENT>
              <ENT>N/A</ENT>
              <ENT>6.20</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>20.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43810</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of stomach and bowel</ENT>
              <ENT>14.65</ENT>
              <ENT>N/A</ENT>
              <ENT>6.50</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>22.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of stomach and bowel</ENT>
              <ENT>15.37</ENT>
              <ENT>N/A</ENT>
              <ENT>6.74</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>23.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49133"/>
              <ENT I="01">43825</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of stomach and bowel</ENT>
              <ENT>19.22</ENT>
              <ENT>N/A</ENT>
              <ENT>8.33</ENT>
              <ENT>1.50</ENT>
              <ENT>N/A</ENT>
              <ENT>29.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43830</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Place gastrostomy tube</ENT>
              <ENT>9.53</ENT>
              <ENT>N/A</ENT>
              <ENT>5.10</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>15.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43831</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Place gastrostomy tube</ENT>
              <ENT>7.84</ENT>
              <ENT>N/A</ENT>
              <ENT>4.65</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>13.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43832</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Place gastrostomy tube</ENT>
              <ENT>15.60</ENT>
              <ENT>N/A</ENT>
              <ENT>7.19</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>23.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43840</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of stomach lesion</ENT>
              <ENT>15.56</ENT>
              <ENT>N/A</ENT>
              <ENT>7.05</ENT>
              <ENT>1.20</ENT>
              <ENT>N/A</ENT>
              <ENT>23.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43842</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Gastroplasty for obesity</ENT>
              <ENT>18.47</ENT>
              <ENT>N/A</ENT>
              <ENT>8.44</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>28.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43843</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Gastroplasty for obesity</ENT>
              <ENT>18.65</ENT>
              <ENT>N/A</ENT>
              <ENT>8.38</ENT>
              <ENT>1.53</ENT>
              <ENT>N/A</ENT>
              <ENT>28.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43846</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Gastric bypass for obesity</ENT>
              <ENT>24.05</ENT>
              <ENT>N/A</ENT>
              <ENT>10.70</ENT>
              <ENT>1.96</ENT>
              <ENT>N/A</ENT>
              <ENT>36.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43847</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Gastric bypass for obesity</ENT>
              <ENT>26.92</ENT>
              <ENT>N/A</ENT>
              <ENT>11.69</ENT>
              <ENT>2.14</ENT>
              <ENT>N/A</ENT>
              <ENT>40.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43848</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision gastroplasty</ENT>
              <ENT>29.39</ENT>
              <ENT>N/A</ENT>
              <ENT>12.62</ENT>
              <ENT>2.39</ENT>
              <ENT>N/A</ENT>
              <ENT>44.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43850</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise stomach-bowel fusion</ENT>
              <ENT>24.72</ENT>
              <ENT>N/A</ENT>
              <ENT>10.17</ENT>
              <ENT>1.97</ENT>
              <ENT>N/A</ENT>
              <ENT>36.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43855</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise stomach-bowel fusion</ENT>
              <ENT>26.16</ENT>
              <ENT>N/A</ENT>
              <ENT>10.74</ENT>
              <ENT>2.01</ENT>
              <ENT>N/A</ENT>
              <ENT>38.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43860</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise stomach-bowel fusion</ENT>
              <ENT>25.00</ENT>
              <ENT>N/A</ENT>
              <ENT>10.33</ENT>
              <ENT>2.03</ENT>
              <ENT>N/A</ENT>
              <ENT>37.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43865</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise stomach-bowel fusion</ENT>
              <ENT>26.52</ENT>
              <ENT>N/A</ENT>
              <ENT>10.86</ENT>
              <ENT>2.15</ENT>
              <ENT>N/A</ENT>
              <ENT>39.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43870</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair stomach opening</ENT>
              <ENT>9.69</ENT>
              <ENT>N/A</ENT>
              <ENT>4.80</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>15.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43880</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair stomach-bowel fistula</ENT>
              <ENT>24.65</ENT>
              <ENT>N/A</ENT>
              <ENT>10.31</ENT>
              <ENT>1.94</ENT>
              <ENT>N/A</ENT>
              <ENT>36.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">43999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Stomach surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44005</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Freeing of bowel adhesion</ENT>
              <ENT>16.23</ENT>
              <ENT>N/A</ENT>
              <ENT>6.91</ENT>
              <ENT>1.39</ENT>
              <ENT>N/A</ENT>
              <ENT>24.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of small bowel</ENT>
              <ENT>12.52</ENT>
              <ENT>N/A</ENT>
              <ENT>5.65</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>19.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44015</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert needle cath bowel</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.90</ENT>
              <ENT>0.25</ENT>
              <ENT>N/A</ENT>
              <ENT>3.77</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore small intestine</ENT>
              <ENT>13.99</ENT>
              <ENT>N/A</ENT>
              <ENT>6.11</ENT>
              <ENT>1.20</ENT>
              <ENT>N/A</ENT>
              <ENT>21.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44021</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompress small bowel</ENT>
              <ENT>14.08</ENT>
              <ENT>N/A</ENT>
              <ENT>6.18</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>21.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44025</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of large bowel</ENT>
              <ENT>14.28</ENT>
              <ENT>N/A</ENT>
              <ENT>6.20</ENT>
              <ENT>1.21</ENT>
              <ENT>N/A</ENT>
              <ENT>21.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44050</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reduce bowel obstruction</ENT>
              <ENT>14.03</ENT>
              <ENT>N/A</ENT>
              <ENT>6.13</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>21.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44055</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Correct malrotation of bowel</ENT>
              <ENT>22.00</ENT>
              <ENT>N/A</ENT>
              <ENT>8.96</ENT>
              <ENT>1.32</ENT>
              <ENT>N/A</ENT>
              <ENT>32.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of bowel</ENT>
              <ENT>2.01</ENT>
              <ENT>N/A</ENT>
              <ENT>1.11</ENT>
              <ENT>0.12</ENT>
              <ENT>N/A</ENT>
              <ENT>3.24</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise intestine lesion(s)</ENT>
              <ENT>11.81</ENT>
              <ENT>N/A</ENT>
              <ENT>5.40</ENT>
              <ENT>1.00</ENT>
              <ENT>N/A</ENT>
              <ENT>18.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44111</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of bowel lesion(s)</ENT>
              <ENT>14.29</ENT>
              <ENT>N/A</ENT>
              <ENT>6.35</ENT>
              <ENT>1.22</ENT>
              <ENT>N/A</ENT>
              <ENT>21.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of small intestine</ENT>
              <ENT>17.00</ENT>
              <ENT>N/A</ENT>
              <ENT>7.23</ENT>
              <ENT>1.46</ENT>
              <ENT>N/A</ENT>
              <ENT>25.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44121</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of small intestine</ENT>
              <ENT>4.45</ENT>
              <ENT>N/A</ENT>
              <ENT>1.55</ENT>
              <ENT>0.46</ENT>
              <ENT>N/A</ENT>
              <ENT>6.46</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44125</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of small intestine</ENT>
              <ENT>17.54</ENT>
              <ENT>N/A</ENT>
              <ENT>7.41</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>26.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44126</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Enterectomy w/o taper, cong</ENT>
              <ENT>35.50</ENT>
              <ENT>N/A</ENT>
              <ENT>14.38</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>50.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44127</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Enterectomy w/taper, cong</ENT>
              <ENT>41.00</ENT>
              <ENT>N/A</ENT>
              <ENT>18.39</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>59.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44128</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Enterectomy cong, add-on</ENT>
              <ENT>4.45</ENT>
              <ENT>N/A</ENT>
              <ENT>1.58</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>6.48</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bowel to bowel fusion</ENT>
              <ENT>14.49</ENT>
              <ENT>N/A</ENT>
              <ENT>6.35</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>22.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44132</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Enterectomy, cadaver donor</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44133</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Enterectomy, live donor</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44135</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Intestine transplnt, cadaver</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44136</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Intestine transplant, live</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44139</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mobilization of colon</ENT>
              <ENT>2.23</ENT>
              <ENT>N/A</ENT>
              <ENT>0.78</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>3.22</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of colon</ENT>
              <ENT>21.00</ENT>
              <ENT>N/A</ENT>
              <ENT>8.83</ENT>
              <ENT>2.14</ENT>
              <ENT>N/A</ENT>
              <ENT>31.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44141</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of colon</ENT>
              <ENT>19.51</ENT>
              <ENT>N/A</ENT>
              <ENT>10.29</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>31.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44143</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of colon</ENT>
              <ENT>22.99</ENT>
              <ENT>N/A</ENT>
              <ENT>10.91</ENT>
              <ENT>2.02</ENT>
              <ENT>N/A</ENT>
              <ENT>35.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44144</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of colon</ENT>
              <ENT>21.53</ENT>
              <ENT>N/A</ENT>
              <ENT>9.76</ENT>
              <ENT>1.89</ENT>
              <ENT>N/A</ENT>
              <ENT>33.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44145</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of colon</ENT>
              <ENT>26.42</ENT>
              <ENT>N/A</ENT>
              <ENT>11.05</ENT>
              <ENT>2.22</ENT>
              <ENT>N/A</ENT>
              <ENT>39.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44146</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of colon</ENT>
              <ENT>27.54</ENT>
              <ENT>N/A</ENT>
              <ENT>13.15</ENT>
              <ENT>2.20</ENT>
              <ENT>N/A</ENT>
              <ENT>42.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44147</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of colon</ENT>
              <ENT>20.71</ENT>
              <ENT>N/A</ENT>
              <ENT>8.85</ENT>
              <ENT>1.74</ENT>
              <ENT>N/A</ENT>
              <ENT>31.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of colon</ENT>
              <ENT>23.95</ENT>
              <ENT>N/A</ENT>
              <ENT>12.30</ENT>
              <ENT>2.05</ENT>
              <ENT>N/A</ENT>
              <ENT>38.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44151</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of colon/ileostomy</ENT>
              <ENT>26.88</ENT>
              <ENT>N/A</ENT>
              <ENT>13.73</ENT>
              <ENT>1.97</ENT>
              <ENT>N/A</ENT>
              <ENT>42.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44152</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of colon/ileostomy</ENT>
              <ENT>27.83</ENT>
              <ENT>N/A</ENT>
              <ENT>11.88</ENT>
              <ENT>2.36</ENT>
              <ENT>N/A</ENT>
              <ENT>42.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44153</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of colon/ileostomy</ENT>
              <ENT>30.59</ENT>
              <ENT>N/A</ENT>
              <ENT>14.77</ENT>
              <ENT>2.33</ENT>
              <ENT>N/A</ENT>
              <ENT>47.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49134"/>
              <ENT I="01">44155</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of colon/ileostomy</ENT>
              <ENT>27.86</ENT>
              <ENT>N/A</ENT>
              <ENT>13.64</ENT>
              <ENT>2.26</ENT>
              <ENT>N/A</ENT>
              <ENT>43.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44156</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of colon/ileostomy</ENT>
              <ENT>30.79</ENT>
              <ENT>N/A</ENT>
              <ENT>15.33</ENT>
              <ENT>2.19</ENT>
              <ENT>N/A</ENT>
              <ENT>48.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44160</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of colon</ENT>
              <ENT>18.62</ENT>
              <ENT>N/A</ENT>
              <ENT>7.91</ENT>
              <ENT>1.86</ENT>
              <ENT>N/A</ENT>
              <ENT>28.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy, enterolysis</ENT>
              <ENT>14.44</ENT>
              <ENT>N/A</ENT>
              <ENT>6.32</ENT>
              <ENT>1.46</ENT>
              <ENT>N/A</ENT>
              <ENT>22.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44201</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy, jejunostomy</ENT>
              <ENT>9.78</ENT>
              <ENT>N/A</ENT>
              <ENT>4.74</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>15.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44202</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lap resect s/intestine singl</ENT>
              <ENT>22.04</ENT>
              <ENT>N/A</ENT>
              <ENT>9.12</ENT>
              <ENT>2.16</ENT>
              <ENT>N/A</ENT>
              <ENT>33.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44203</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lap resect s/intestine, addl</ENT>
              <ENT>4.45</ENT>
              <ENT>N/A</ENT>
              <ENT>1.53</ENT>
              <ENT>0.46</ENT>
              <ENT>N/A</ENT>
              <ENT>6.44</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44204</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo partial colectomy</ENT>
              <ENT>25.08</ENT>
              <ENT>N/A</ENT>
              <ENT>10.15</ENT>
              <ENT>2.55</ENT>
              <ENT>N/A</ENT>
              <ENT>37.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44205</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lap colectomy part w/ileum</ENT>
              <ENT>22.23</ENT>
              <ENT>N/A</ENT>
              <ENT>9.02</ENT>
              <ENT>2.23</ENT>
              <ENT>N/A</ENT>
              <ENT>33.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44206</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lap part colectomy w/stoma</ENT>
              <ENT>27.00</ENT>
              <ENT>N/A</ENT>
              <ENT>11.54</ENT>
              <ENT>2.02</ENT>
              <ENT>N/A</ENT>
              <ENT>40.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44207</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>L colectomy/coloproctostomy</ENT>
              <ENT>30.00</ENT>
              <ENT>N/A</ENT>
              <ENT>11.78</ENT>
              <ENT>2.22</ENT>
              <ENT>N/A</ENT>
              <ENT>44.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44208</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>L colectomy/coloproctostomy</ENT>
              <ENT>32.00</ENT>
              <ENT>N/A</ENT>
              <ENT>13.48</ENT>
              <ENT>2.20</ENT>
              <ENT>N/A</ENT>
              <ENT>47.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44210</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo total proctocolectomy</ENT>
              <ENT>28.00</ENT>
              <ENT>N/A</ENT>
              <ENT>12.21</ENT>
              <ENT>2.05</ENT>
              <ENT>N/A</ENT>
              <ENT>42.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44211</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo total proctocolectomy</ENT>
              <ENT>35.00</ENT>
              <ENT>N/A</ENT>
              <ENT>14.98</ENT>
              <ENT>2.33</ENT>
              <ENT>N/A</ENT>
              <ENT>52.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44212</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo total proctocolectomy</ENT>
              <ENT>32.50</ENT>
              <ENT>N/A</ENT>
              <ENT>14.09</ENT>
              <ENT>2.26</ENT>
              <ENT>N/A</ENT>
              <ENT>48.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44238</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Laparoscope proc, intestine</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44239</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Laparoscope proc, rectum</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Open bowel to skin</ENT>
              <ENT>12.11</ENT>
              <ENT>N/A</ENT>
              <ENT>5.59</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>18.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44310</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ileostomy/jejunostomy</ENT>
              <ENT>15.95</ENT>
              <ENT>N/A</ENT>
              <ENT>6.84</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>23.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44312</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of ileostomy</ENT>
              <ENT>8.02</ENT>
              <ENT>N/A</ENT>
              <ENT>4.08</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>12.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44314</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of ileostomy</ENT>
              <ENT>15.05</ENT>
              <ENT>N/A</ENT>
              <ENT>6.71</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>22.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44316</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Devise bowel pouch</ENT>
              <ENT>21.09</ENT>
              <ENT>N/A</ENT>
              <ENT>8.73</ENT>
              <ENT>1.41</ENT>
              <ENT>N/A</ENT>
              <ENT>31.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Colostomy</ENT>
              <ENT>17.64</ENT>
              <ENT>N/A</ENT>
              <ENT>7.83</ENT>
              <ENT>1.28</ENT>
              <ENT>N/A</ENT>
              <ENT>26.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44322</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Colostomy with biopsies</ENT>
              <ENT>11.98</ENT>
              <ENT>N/A</ENT>
              <ENT>8.80</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>21.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44340</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of colostomy</ENT>
              <ENT>7.72</ENT>
              <ENT>N/A</ENT>
              <ENT>4.36</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>12.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44345</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of colostomy</ENT>
              <ENT>15.43</ENT>
              <ENT>N/A</ENT>
              <ENT>7.03</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>23.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44346</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of colostomy</ENT>
              <ENT>16.99</ENT>
              <ENT>N/A</ENT>
              <ENT>7.54</ENT>
              <ENT>1.20</ENT>
              <ENT>N/A</ENT>
              <ENT>25.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44360</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Small bowel endoscopy</ENT>
              <ENT>2.59</ENT>
              <ENT>N/A</ENT>
              <ENT>1.14</ENT>
              <ENT>0.14</ENT>
              <ENT>N/A</ENT>
              <ENT>3.87</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44361</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Small bowel endoscopy/biopsy</ENT>
              <ENT>2.87</ENT>
              <ENT>N/A</ENT>
              <ENT>1.24</ENT>
              <ENT>0.15</ENT>
              <ENT>N/A</ENT>
              <ENT>4.26</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44363</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Small bowel endoscopy</ENT>
              <ENT>3.50</ENT>
              <ENT>N/A</ENT>
              <ENT>1.43</ENT>
              <ENT>0.19</ENT>
              <ENT>N/A</ENT>
              <ENT>5.12</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44364</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Small bowel endoscopy</ENT>
              <ENT>3.74</ENT>
              <ENT>N/A</ENT>
              <ENT>1.55</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>5.50</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44365</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Small bowel endoscopy</ENT>
              <ENT>3.31</ENT>
              <ENT>N/A</ENT>
              <ENT>1.41</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>4.90</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44366</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Small bowel endoscopy</ENT>
              <ENT>4.41</ENT>
              <ENT>N/A</ENT>
              <ENT>1.79</ENT>
              <ENT>0.22</ENT>
              <ENT>N/A</ENT>
              <ENT>6.42</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44369</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Small bowel endoscopy</ENT>
              <ENT>4.52</ENT>
              <ENT>N/A</ENT>
              <ENT>1.79</ENT>
              <ENT>0.23</ENT>
              <ENT>N/A</ENT>
              <ENT>6.54</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44370</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Small bowel endoscopy/stent</ENT>
              <ENT>4.80</ENT>
              <ENT>N/A</ENT>
              <ENT>2.03</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>7.04</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44372</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Small bowel endoscopy</ENT>
              <ENT>4.41</ENT>
              <ENT>N/A</ENT>
              <ENT>1.78</ENT>
              <ENT>0.27</ENT>
              <ENT>N/A</ENT>
              <ENT>6.46</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44373</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Small bowel endoscopy</ENT>
              <ENT>3.50</ENT>
              <ENT>N/A</ENT>
              <ENT>1.47</ENT>
              <ENT>0.19</ENT>
              <ENT>N/A</ENT>
              <ENT>5.16</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44376</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Small bowel endoscopy</ENT>
              <ENT>5.26</ENT>
              <ENT>N/A</ENT>
              <ENT>2.08</ENT>
              <ENT>0.29</ENT>
              <ENT>N/A</ENT>
              <ENT>7.63</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44377</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Small bowel endoscopy/biopsy</ENT>
              <ENT>5.53</ENT>
              <ENT>N/A</ENT>
              <ENT>2.20</ENT>
              <ENT>0.28</ENT>
              <ENT>N/A</ENT>
              <ENT>8.01</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44378</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Small bowel endoscopy</ENT>
              <ENT>7.13</ENT>
              <ENT>N/A</ENT>
              <ENT>2.77</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>10.27</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44379</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>S bowel endoscope w/stent</ENT>
              <ENT>7.47</ENT>
              <ENT>N/A</ENT>
              <ENT>2.99</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>10.84</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44380</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Small bowel endoscopy</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.58</ENT>
              <ENT>0.08</ENT>
              <ENT>N/A</ENT>
              <ENT>1.71</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44382</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Small bowel endoscopy</ENT>
              <ENT>1.27</ENT>
              <ENT>N/A</ENT>
              <ENT>0.66</ENT>
              <ENT>0.09</ENT>
              <ENT>N/A</ENT>
              <ENT>2.02</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44383</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ileoscopy w/stent</ENT>
              <ENT>2.94</ENT>
              <ENT>N/A</ENT>
              <ENT>1.31</ENT>
              <ENT>0.13</ENT>
              <ENT>N/A</ENT>
              <ENT>4.38</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44385</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endoscopy of bowel pouch</ENT>
              <ENT>1.82</ENT>
              <ENT>5.20</ENT>
              <ENT>0.98</ENT>
              <ENT>0.12</ENT>
              <ENT>7.14</ENT>
              <ENT>2.92</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44386</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endoscopy, bowel pouch/biop</ENT>
              <ENT>2.12</ENT>
              <ENT>6.70</ENT>
              <ENT>1.13</ENT>
              <ENT>0.15</ENT>
              <ENT>8.97</ENT>
              <ENT>3.40</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44388</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Colon endoscopy</ENT>
              <ENT>2.82</ENT>
              <ENT>5.29</ENT>
              <ENT>1.19</ENT>
              <ENT>0.18</ENT>
              <ENT>8.29</ENT>
              <ENT>4.19</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44389</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Colonoscopy with biopsy</ENT>
              <ENT>3.13</ENT>
              <ENT>6.68</ENT>
              <ENT>1.31</ENT>
              <ENT>0.18</ENT>
              <ENT>9.99</ENT>
              <ENT>4.62</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44390</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Colonoscopy for foreign body</ENT>
              <ENT>3.83</ENT>
              <ENT>6.92</ENT>
              <ENT>1.54</ENT>
              <ENT>0.22</ENT>
              <ENT>10.97</ENT>
              <ENT>5.59</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49135"/>
              <ENT I="01">44391</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Colonoscopy for bleeding</ENT>
              <ENT>4.32</ENT>
              <ENT>8.97</ENT>
              <ENT>1.75</ENT>
              <ENT>0.23</ENT>
              <ENT>13.52</ENT>
              <ENT>6.30</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44392</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Colonoscopy &amp; polypectomy</ENT>
              <ENT>3.82</ENT>
              <ENT>6.74</ENT>
              <ENT>1.54</ENT>
              <ENT>0.23</ENT>
              <ENT>10.79</ENT>
              <ENT>5.59</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44393</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Colonoscopy, lesion removal</ENT>
              <ENT>4.84</ENT>
              <ENT>7.09</ENT>
              <ENT>1.92</ENT>
              <ENT>0.27</ENT>
              <ENT>12.20</ENT>
              <ENT>7.03</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44394</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Colonoscopy w/snare</ENT>
              <ENT>4.43</ENT>
              <ENT>7.95</ENT>
              <ENT>1.78</ENT>
              <ENT>0.26</ENT>
              <ENT>12.64</ENT>
              <ENT>6.47</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44397</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Colonoscopy w/stent</ENT>
              <ENT>4.71</ENT>
              <ENT>N/A</ENT>
              <ENT>2.10</ENT>
              <ENT>0.28</ENT>
              <ENT>N/A</ENT>
              <ENT>7.09</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intro, gastrointestinal tube</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>0.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.87</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44602</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Suture, small intestine</ENT>
              <ENT>16.03</ENT>
              <ENT>N/A</ENT>
              <ENT>6.53</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>23.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44603</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Suture, small intestine</ENT>
              <ENT>18.66</ENT>
              <ENT>N/A</ENT>
              <ENT>7.43</ENT>
              <ENT>1.39</ENT>
              <ENT>N/A</ENT>
              <ENT>27.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44604</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Suture, large intestine</ENT>
              <ENT>16.03</ENT>
              <ENT>N/A</ENT>
              <ENT>6.60</ENT>
              <ENT>1.42</ENT>
              <ENT>N/A</ENT>
              <ENT>24.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of bowel lesion</ENT>
              <ENT>19.53</ENT>
              <ENT>N/A</ENT>
              <ENT>8.59</ENT>
              <ENT>1.54</ENT>
              <ENT>N/A</ENT>
              <ENT>29.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44615</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intestinal stricturoplasty</ENT>
              <ENT>15.93</ENT>
              <ENT>N/A</ENT>
              <ENT>6.82</ENT>
              <ENT>1.39</ENT>
              <ENT>N/A</ENT>
              <ENT>24.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44620</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair bowel opening</ENT>
              <ENT>12.20</ENT>
              <ENT>N/A</ENT>
              <ENT>5.44</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>18.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44625</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair bowel opening</ENT>
              <ENT>15.05</ENT>
              <ENT>N/A</ENT>
              <ENT>6.44</ENT>
              <ENT>1.30</ENT>
              <ENT>N/A</ENT>
              <ENT>22.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44626</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair bowel opening</ENT>
              <ENT>25.36</ENT>
              <ENT>N/A</ENT>
              <ENT>10.02</ENT>
              <ENT>2.53</ENT>
              <ENT>N/A</ENT>
              <ENT>37.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44640</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair bowel-skin fistula</ENT>
              <ENT>21.65</ENT>
              <ENT>N/A</ENT>
              <ENT>8.76</ENT>
              <ENT>1.46</ENT>
              <ENT>N/A</ENT>
              <ENT>31.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44650</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair bowel fistula</ENT>
              <ENT>22.57</ENT>
              <ENT>N/A</ENT>
              <ENT>9.07</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>33.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44660</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair bowel-bladder fistula</ENT>
              <ENT>21.36</ENT>
              <ENT>N/A</ENT>
              <ENT>8.55</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>31.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44661</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair bowel-bladder fistula</ENT>
              <ENT>24.81</ENT>
              <ENT>N/A</ENT>
              <ENT>9.77</ENT>
              <ENT>1.53</ENT>
              <ENT>N/A</ENT>
              <ENT>36.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44680</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Surgical revision, intestine</ENT>
              <ENT>15.40</ENT>
              <ENT>N/A</ENT>
              <ENT>6.59</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>23.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Suspend bowel w/prosthesis</ENT>
              <ENT>16.11</ENT>
              <ENT>N/A</ENT>
              <ENT>6.81</ENT>
              <ENT>1.21</ENT>
              <ENT>N/A</ENT>
              <ENT>24.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44701</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intraop colon lavage add-on</ENT>
              <ENT>3.10</ENT>
              <ENT>N/A</ENT>
              <ENT>1.08</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>4.39</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44799</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Intestine surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of bowel pouch</ENT>
              <ENT>11.23</ENT>
              <ENT>N/A</ENT>
              <ENT>5.49</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>17.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of mesentery lesion</ENT>
              <ENT>12.09</ENT>
              <ENT>N/A</ENT>
              <ENT>5.60</ENT>
              <ENT>1.03</ENT>
              <ENT>N/A</ENT>
              <ENT>18.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44850</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of mesentery</ENT>
              <ENT>10.74</ENT>
              <ENT>N/A</ENT>
              <ENT>5.09</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>16.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44899</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Bowel surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44900</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain app abscess, open</ENT>
              <ENT>10.14</ENT>
              <ENT>N/A</ENT>
              <ENT>4.80</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>15.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44901</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain app abscess, percut</ENT>
              <ENT>3.38</ENT>
              <ENT>N/A</ENT>
              <ENT>4.61</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>8.16</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44950</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Appendectomy</ENT>
              <ENT>10.00</ENT>
              <ENT>N/A</ENT>
              <ENT>4.41</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>15.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44955</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Appendectomy add-on</ENT>
              <ENT>1.53</ENT>
              <ENT>N/A</ENT>
              <ENT>0.55</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>2.24</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44960</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Appendectomy</ENT>
              <ENT>12.34</ENT>
              <ENT>N/A</ENT>
              <ENT>5.46</ENT>
              <ENT>1.09</ENT>
              <ENT>N/A</ENT>
              <ENT>18.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44970</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy, appendectomy</ENT>
              <ENT>8.70</ENT>
              <ENT>N/A</ENT>
              <ENT>4.30</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>13.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">44979</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Laparoscope proc, app</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of pelvic abscess</ENT>
              <ENT>4.52</ENT>
              <ENT>N/A</ENT>
              <ENT>3.01</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>7.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45005</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of rectal abscess</ENT>
              <ENT>1.99</ENT>
              <ENT>4.92</ENT>
              <ENT>1.71</ENT>
              <ENT>0.18</ENT>
              <ENT>7.09</ENT>
              <ENT>3.88</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of rectal abscess</ENT>
              <ENT>4.72</ENT>
              <ENT>N/A</ENT>
              <ENT>3.34</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>8.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of rectum</ENT>
              <ENT>3.68</ENT>
              <ENT>N/A</ENT>
              <ENT>2.42</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>6.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45108</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of anorectal lesion</ENT>
              <ENT>4.76</ENT>
              <ENT>N/A</ENT>
              <ENT>2.95</ENT>
              <ENT>0.46</ENT>
              <ENT>N/A</ENT>
              <ENT>8.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of rectum</ENT>
              <ENT>28.00</ENT>
              <ENT>N/A</ENT>
              <ENT>12.69</ENT>
              <ENT>2.26</ENT>
              <ENT>N/A</ENT>
              <ENT>42.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45111</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of rectum</ENT>
              <ENT>16.48</ENT>
              <ENT>N/A</ENT>
              <ENT>7.33</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>25.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45112</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of rectum</ENT>
              <ENT>30.54</ENT>
              <ENT>N/A</ENT>
              <ENT>12.03</ENT>
              <ENT>2.35</ENT>
              <ENT>N/A</ENT>
              <ENT>44.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45113</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial proctectomy</ENT>
              <ENT>30.58</ENT>
              <ENT>N/A</ENT>
              <ENT>12.92</ENT>
              <ENT>2.13</ENT>
              <ENT>N/A</ENT>
              <ENT>45.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45114</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of rectum</ENT>
              <ENT>27.32</ENT>
              <ENT>N/A</ENT>
              <ENT>11.18</ENT>
              <ENT>2.28</ENT>
              <ENT>N/A</ENT>
              <ENT>40.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45116</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of rectum</ENT>
              <ENT>24.58</ENT>
              <ENT>N/A</ENT>
              <ENT>10.26</ENT>
              <ENT>2.00</ENT>
              <ENT>N/A</ENT>
              <ENT>36.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45119</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove rectum w/reservoir</ENT>
              <ENT>30.84</ENT>
              <ENT>N/A</ENT>
              <ENT>12.77</ENT>
              <ENT>2.13</ENT>
              <ENT>N/A</ENT>
              <ENT>45.74</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of rectum</ENT>
              <ENT>24.60</ENT>
              <ENT>N/A</ENT>
              <ENT>10.36</ENT>
              <ENT>2.28</ENT>
              <ENT>N/A</ENT>
              <ENT>37.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45121</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of rectum and colon</ENT>
              <ENT>27.04</ENT>
              <ENT>N/A</ENT>
              <ENT>11.34</ENT>
              <ENT>2.66</ENT>
              <ENT>N/A</ENT>
              <ENT>41.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45123</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial proctectomy</ENT>
              <ENT>16.71</ENT>
              <ENT>N/A</ENT>
              <ENT>7.01</ENT>
              <ENT>1.04</ENT>
              <ENT>N/A</ENT>
              <ENT>24.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45126</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pelvic exenteration</ENT>
              <ENT>45.16</ENT>
              <ENT>N/A</ENT>
              <ENT>19.84</ENT>
              <ENT>3.23</ENT>
              <ENT>N/A</ENT>
              <ENT>68.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of rectal prolapse</ENT>
              <ENT>16.44</ENT>
              <ENT>N/A</ENT>
              <ENT>6.92</ENT>
              <ENT>1.12</ENT>
              <ENT>N/A</ENT>
              <ENT>24.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45135</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of rectal prolapse</ENT>
              <ENT>19.28</ENT>
              <ENT>N/A</ENT>
              <ENT>8.57</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>29.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45136</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise ileoanal reservior</ENT>
              <ENT>27.30</ENT>
              <ENT>N/A</ENT>
              <ENT>12.70</ENT>
              <ENT>2.72</ENT>
              <ENT>N/A</ENT>
              <ENT>42.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of rectal stricture</ENT>
              <ENT>5.67</ENT>
              <ENT>N/A</ENT>
              <ENT>3.01</ENT>
              <ENT>0.46</ENT>
              <ENT>N/A</ENT>
              <ENT>9.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49136"/>
              <ENT I="01">45160</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of rectal lesion</ENT>
              <ENT>15.32</ENT>
              <ENT>N/A</ENT>
              <ENT>6.79</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>23.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45170</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of rectal lesion</ENT>
              <ENT>11.49</ENT>
              <ENT>N/A</ENT>
              <ENT>5.35</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>17.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45190</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction, rectal tumor</ENT>
              <ENT>9.74</ENT>
              <ENT>N/A</ENT>
              <ENT>4.71</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>15.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Proctosigmoidoscopy dx</ENT>
              <ENT>0.38</ENT>
              <ENT>1.50</ENT>
              <ENT>0.31</ENT>
              <ENT>0.05</ENT>
              <ENT>1.93</ENT>
              <ENT>0.74</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45303</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Proctosigmoidoscopy dilate</ENT>
              <ENT>0.44</ENT>
              <ENT>19.74</ENT>
              <ENT>0.35</ENT>
              <ENT>0.06</ENT>
              <ENT>20.24</ENT>
              <ENT>0.85</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45305</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Proctosigmoidoscopy w/bx</ENT>
              <ENT>1.01</ENT>
              <ENT>2.62</ENT>
              <ENT>0.53</ENT>
              <ENT>0.09</ENT>
              <ENT>3.72</ENT>
              <ENT>1.63</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45307</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Proctosigmoidoscopy fb</ENT>
              <ENT>0.94</ENT>
              <ENT>3.07</ENT>
              <ENT>0.51</ENT>
              <ENT>0.15</ENT>
              <ENT>4.16</ENT>
              <ENT>1.60</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45308</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Proctosigmoidoscopy removal</ENT>
              <ENT>0.83</ENT>
              <ENT>1.97</ENT>
              <ENT>0.47</ENT>
              <ENT>0.13</ENT>
              <ENT>2.93</ENT>
              <ENT>1.43</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45309</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Proctosigmoidoscopy removal</ENT>
              <ENT>2.01</ENT>
              <ENT>2.82</ENT>
              <ENT>0.87</ENT>
              <ENT>0.17</ENT>
              <ENT>5.00</ENT>
              <ENT>3.05</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45315</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Proctosigmoidoscopy removal</ENT>
              <ENT>1.40</ENT>
              <ENT>2.85</ENT>
              <ENT>0.67</ENT>
              <ENT>0.20</ENT>
              <ENT>4.45</ENT>
              <ENT>2.27</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45317</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Proctosigmoidoscopy bleed</ENT>
              <ENT>1.50</ENT>
              <ENT>2.43</ENT>
              <ENT>0.69</ENT>
              <ENT>0.20</ENT>
              <ENT>4.13</ENT>
              <ENT>2.39</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Proctosigmoidoscopy ablate</ENT>
              <ENT>1.58</ENT>
              <ENT>2.89</ENT>
              <ENT>0.74</ENT>
              <ENT>0.20</ENT>
              <ENT>4.67</ENT>
              <ENT>2.52</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45321</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Proctosigmoidoscopy volvul</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>0.59</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>1.93</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45327</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Proctosigmoidoscopy w/stent</ENT>
              <ENT>1.65</ENT>
              <ENT>N/A</ENT>
              <ENT>0.71</ENT>
              <ENT>0.10</ENT>
              <ENT>N/A</ENT>
              <ENT>2.46</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45330</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Diagnostic sigmoidoscopy</ENT>
              <ENT>0.96</ENT>
              <ENT>2.25</ENT>
              <ENT>0.53</ENT>
              <ENT>0.05</ENT>
              <ENT>3.26</ENT>
              <ENT>1.54</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45331</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sigmoidoscopy and biopsy</ENT>
              <ENT>1.15</ENT>
              <ENT>2.90</ENT>
              <ENT>0.64</ENT>
              <ENT>0.07</ENT>
              <ENT>4.12</ENT>
              <ENT>1.86</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45332</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sigmoidoscopy w/fb removal</ENT>
              <ENT>1.79</ENT>
              <ENT>4.86</ENT>
              <ENT>0.86</ENT>
              <ENT>0.11</ENT>
              <ENT>6.76</ENT>
              <ENT>2.76</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45333</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sigmoidoscopy &amp; polypectomy</ENT>
              <ENT>1.79</ENT>
              <ENT>4.81</ENT>
              <ENT>0.86</ENT>
              <ENT>0.12</ENT>
              <ENT>6.72</ENT>
              <ENT>2.77</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45334</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sigmoidoscopy for bleeding</ENT>
              <ENT>2.73</ENT>
              <ENT>N/A</ENT>
              <ENT>1.21</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>4.10</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45335</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sigmoidoscope w/submuc inj</ENT>
              <ENT>1.36</ENT>
              <ENT>3.27</ENT>
              <ENT>0.66</ENT>
              <ENT>0.07</ENT>
              <ENT>4.70</ENT>
              <ENT>2.09</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45337</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sigmoidoscopy &amp; decompress</ENT>
              <ENT>2.36</ENT>
              <ENT>N/A</ENT>
              <ENT>1.06</ENT>
              <ENT>0.15</ENT>
              <ENT>N/A</ENT>
              <ENT>3.57</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45338</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sigmoidoscpy w/tumr remove</ENT>
              <ENT>2.34</ENT>
              <ENT>5.13</ENT>
              <ENT>1.07</ENT>
              <ENT>0.15</ENT>
              <ENT>7.62</ENT>
              <ENT>3.56</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45339</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sigmoidoscopy w/ablate tumr</ENT>
              <ENT>3.14</ENT>
              <ENT>3.36</ENT>
              <ENT>1.35</ENT>
              <ENT>0.17</ENT>
              <ENT>6.67</ENT>
              <ENT>4.66</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45340</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sig w/balloon dilation</ENT>
              <ENT>1.66</ENT>
              <ENT>6.60</ENT>
              <ENT>0.76</ENT>
              <ENT>0.07</ENT>
              <ENT>8.33</ENT>
              <ENT>2.49</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45341</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sigmoidoscopy w/ultrasound</ENT>
              <ENT>2.60</ENT>
              <ENT>N/A</ENT>
              <ENT>1.15</ENT>
              <ENT>0.20</ENT>
              <ENT>N/A</ENT>
              <ENT>3.95</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45342</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sigmoidoscopy w/us guide bx</ENT>
              <ENT>4.06</ENT>
              <ENT>N/A</ENT>
              <ENT>1.62</ENT>
              <ENT>0.23</ENT>
              <ENT>N/A</ENT>
              <ENT>5.91</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45345</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sigmoidoscopy w/stent</ENT>
              <ENT>2.92</ENT>
              <ENT>N/A</ENT>
              <ENT>1.22</ENT>
              <ENT>0.15</ENT>
              <ENT>N/A</ENT>
              <ENT>4.29</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45355</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Surgical colonoscopy</ENT>
              <ENT>3.52</ENT>
              <ENT>N/A</ENT>
              <ENT>1.43</ENT>
              <ENT>0.26</ENT>
              <ENT>N/A</ENT>
              <ENT>5.21</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45378</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Diagnostic colonoscopy</ENT>
              <ENT>3.70</ENT>
              <ENT>6.30</ENT>
              <ENT>1.68</ENT>
              <ENT>0.20</ENT>
              <ENT>10.20</ENT>
              <ENT>5.58</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45378</ENT>
              <ENT>53</ENT>
              <ENT>A</ENT>
              <ENT>Diagnostic colonoscopy</ENT>
              <ENT>0.96</ENT>
              <ENT>2.25</ENT>
              <ENT>0.53</ENT>
              <ENT>0.05</ENT>
              <ENT>3.26</ENT>
              <ENT>1.54</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45379</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Colonoscopy w/fb removal</ENT>
              <ENT>4.69</ENT>
              <ENT>7.83</ENT>
              <ENT>1.94</ENT>
              <ENT>0.25</ENT>
              <ENT>12.77</ENT>
              <ENT>6.88</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45380</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Colonoscopy and biopsy</ENT>
              <ENT>4.44</ENT>
              <ENT>7.26</ENT>
              <ENT>1.81</ENT>
              <ENT>0.21</ENT>
              <ENT>11.91</ENT>
              <ENT>6.46</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45381</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Colonoscope, submucous inj</ENT>
              <ENT>4.20</ENT>
              <ENT>8.00</ENT>
              <ENT>1.72</ENT>
              <ENT>0.21</ENT>
              <ENT>12.41</ENT>
              <ENT>6.13</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45382</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Colonoscopy/control bleeding</ENT>
              <ENT>5.69</ENT>
              <ENT>10.03</ENT>
              <ENT>2.32</ENT>
              <ENT>0.27</ENT>
              <ENT>15.99</ENT>
              <ENT>8.28</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45383</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lesion removal colonoscopy</ENT>
              <ENT>5.87</ENT>
              <ENT>8.05</ENT>
              <ENT>2.31</ENT>
              <ENT>0.32</ENT>
              <ENT>14.24</ENT>
              <ENT>8.50</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45384</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lesion remove colonoscopy</ENT>
              <ENT>4.70</ENT>
              <ENT>6.87</ENT>
              <ENT>1.91</ENT>
              <ENT>0.24</ENT>
              <ENT>11.81</ENT>
              <ENT>6.85</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45385</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lesion removal colonoscopy</ENT>
              <ENT>5.31</ENT>
              <ENT>7.90</ENT>
              <ENT>2.12</ENT>
              <ENT>0.28</ENT>
              <ENT>13.49</ENT>
              <ENT>7.71</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45386</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Colonoscope dilate stricture</ENT>
              <ENT>4.58</ENT>
              <ENT>14.09</ENT>
              <ENT>1.86</ENT>
              <ENT>0.21</ENT>
              <ENT>18.88</ENT>
              <ENT>6.65</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45387</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Colonoscopy w/stent</ENT>
              <ENT>5.91</ENT>
              <ENT>N/A</ENT>
              <ENT>2.40</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>8.64</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of rectum</ENT>
              <ENT>7.29</ENT>
              <ENT>N/A</ENT>
              <ENT>3.63</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>11.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45505</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of rectum</ENT>
              <ENT>7.58</ENT>
              <ENT>N/A</ENT>
              <ENT>3.87</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>11.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of rectal prolapse</ENT>
              <ENT>0.55</ENT>
              <ENT>0.86</ENT>
              <ENT>0.19</ENT>
              <ENT>0.04</ENT>
              <ENT>1.45</ENT>
              <ENT>0.78</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49137"/>
              <ENT I="01">45540</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Correct rectal prolapse</ENT>
              <ENT>16.27</ENT>
              <ENT>N/A</ENT>
              <ENT>6.96</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>24.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45541</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Correct rectal prolapse</ENT>
              <ENT>13.40</ENT>
              <ENT>N/A</ENT>
              <ENT>6.06</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>20.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45550</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair rectum/remove sigmoid</ENT>
              <ENT>23.00</ENT>
              <ENT>N/A</ENT>
              <ENT>9.40</ENT>
              <ENT>1.58</ENT>
              <ENT>N/A</ENT>
              <ENT>33.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45560</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of rectocele</ENT>
              <ENT>10.58</ENT>
              <ENT>N/A</ENT>
              <ENT>5.22</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>16.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45562</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration/repair of rectum</ENT>
              <ENT>15.38</ENT>
              <ENT>N/A</ENT>
              <ENT>7.07</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>23.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45563</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration/repair of rectum</ENT>
              <ENT>23.47</ENT>
              <ENT>N/A</ENT>
              <ENT>10.69</ENT>
              <ENT>1.84</ENT>
              <ENT>N/A</ENT>
              <ENT>36.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair rect/bladder fistula</ENT>
              <ENT>17.77</ENT>
              <ENT>N/A</ENT>
              <ENT>7.57</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>26.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45805</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair fistula w/colostomy</ENT>
              <ENT>20.78</ENT>
              <ENT>N/A</ENT>
              <ENT>9.71</ENT>
              <ENT>1.47</ENT>
              <ENT>N/A</ENT>
              <ENT>31.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair rectourethral fistula</ENT>
              <ENT>18.48</ENT>
              <ENT>N/A</ENT>
              <ENT>7.76</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>27.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45825</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair fistula w/colostomy</ENT>
              <ENT>21.25</ENT>
              <ENT>N/A</ENT>
              <ENT>9.99</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>32.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45900</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reduction of rectal prolapse</ENT>
              <ENT>2.61</ENT>
              <ENT>N/A</ENT>
              <ENT>1.35</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>4.13</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45905</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dilation of anal sphincter</ENT>
              <ENT>2.30</ENT>
              <ENT>10.78</ENT>
              <ENT>1.25</ENT>
              <ENT>0.14</ENT>
              <ENT>13.22</ENT>
              <ENT>3.69</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45910</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dilation of rectal narrowing</ENT>
              <ENT>2.80</ENT>
              <ENT>15.08</ENT>
              <ENT>1.46</ENT>
              <ENT>0.14</ENT>
              <ENT>18.02</ENT>
              <ENT>4.40</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45915</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove rectal obstruction</ENT>
              <ENT>3.14</ENT>
              <ENT>4.88</ENT>
              <ENT>1.19</ENT>
              <ENT>0.17</ENT>
              <ENT>8.19</ENT>
              <ENT>4.50</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">45999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Rectum surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Placement of seton</ENT>
              <ENT>2.90</ENT>
              <ENT>2.30</ENT>
              <ENT>1.88</ENT>
              <ENT>0.22</ENT>
              <ENT>5.42</ENT>
              <ENT>5.00</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46030</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of rectal marker</ENT>
              <ENT>1.23</ENT>
              <ENT>1.37</ENT>
              <ENT>0.72</ENT>
              <ENT>0.11</ENT>
              <ENT>2.71</ENT>
              <ENT>2.06</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46040</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of rectal abscess</ENT>
              <ENT>4.96</ENT>
              <ENT>5.33</ENT>
              <ENT>3.17</ENT>
              <ENT>0.48</ENT>
              <ENT>10.77</ENT>
              <ENT>8.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46045</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of rectal abscess</ENT>
              <ENT>4.32</ENT>
              <ENT>N/A</ENT>
              <ENT>2.88</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>7.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46050</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of anal abscess</ENT>
              <ENT>1.19</ENT>
              <ENT>2.61</ENT>
              <ENT>0.87</ENT>
              <ENT>0.11</ENT>
              <ENT>3.91</ENT>
              <ENT>2.17</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46060</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of rectal abscess</ENT>
              <ENT>5.69</ENT>
              <ENT>N/A</ENT>
              <ENT>3.31</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>9.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46070</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of anal septum</ENT>
              <ENT>2.71</ENT>
              <ENT>N/A</ENT>
              <ENT>2.02</ENT>
              <ENT>0.27</ENT>
              <ENT>N/A</ENT>
              <ENT>5.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46080</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of anal sphincter</ENT>
              <ENT>2.49</ENT>
              <ENT>2.42</ENT>
              <ENT>1.15</ENT>
              <ENT>0.23</ENT>
              <ENT>5.14</ENT>
              <ENT>3.87</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46083</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise external hemorrhoid</ENT>
              <ENT>1.40</ENT>
              <ENT>2.57</ENT>
              <ENT>0.96</ENT>
              <ENT>0.12</ENT>
              <ENT>4.09</ENT>
              <ENT>2.48</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of anal fissure</ENT>
              <ENT>3.42</ENT>
              <ENT>3.66</ENT>
              <ENT>2.40</ENT>
              <ENT>0.30</ENT>
              <ENT>7.38</ENT>
              <ENT>6.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46210</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of anal crypt</ENT>
              <ENT>2.67</ENT>
              <ENT>4.85</ENT>
              <ENT>2.14</ENT>
              <ENT>0.26</ENT>
              <ENT>7.78</ENT>
              <ENT>5.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46211</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of anal crypts</ENT>
              <ENT>4.25</ENT>
              <ENT>5.11</ENT>
              <ENT>2.91</ENT>
              <ENT>0.37</ENT>
              <ENT>9.73</ENT>
              <ENT>7.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of anal tag</ENT>
              <ENT>1.56</ENT>
              <ENT>2.31</ENT>
              <ENT>0.95</ENT>
              <ENT>0.14</ENT>
              <ENT>4.01</ENT>
              <ENT>2.65</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46221</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ligation of hemorrhoid(s)</ENT>
              <ENT>2.04</ENT>
              <ENT>1.64</ENT>
              <ENT>1.14</ENT>
              <ENT>0.12</ENT>
              <ENT>3.80</ENT>
              <ENT>3.30</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46230</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of anal tags</ENT>
              <ENT>2.57</ENT>
              <ENT>3.10</ENT>
              <ENT>1.30</ENT>
              <ENT>0.22</ENT>
              <ENT>5.89</ENT>
              <ENT>4.09</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hemorrhoidectomy</ENT>
              <ENT>3.89</ENT>
              <ENT>4.97</ENT>
              <ENT>2.48</ENT>
              <ENT>0.43</ENT>
              <ENT>9.29</ENT>
              <ENT>6.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46255</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hemorrhoidectomy</ENT>
              <ENT>4.60</ENT>
              <ENT>5.52</ENT>
              <ENT>2.71</ENT>
              <ENT>0.51</ENT>
              <ENT>10.63</ENT>
              <ENT>7.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46257</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove hemorrhoids &amp; fissure</ENT>
              <ENT>5.40</ENT>
              <ENT>N/A</ENT>
              <ENT>2.91</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>8.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46258</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove hemorrhoids &amp; fistula</ENT>
              <ENT>5.73</ENT>
              <ENT>N/A</ENT>
              <ENT>3.27</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>9.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46260</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hemorrhoidectomy</ENT>
              <ENT>6.37</ENT>
              <ENT>N/A</ENT>
              <ENT>3.29</ENT>
              <ENT>0.68</ENT>
              <ENT>N/A</ENT>
              <ENT>10.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46261</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove hemorrhoids &amp; fissure</ENT>
              <ENT>7.08</ENT>
              <ENT>N/A</ENT>
              <ENT>3.67</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>11.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46262</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove hemorrhoids &amp; fistula</ENT>
              <ENT>7.50</ENT>
              <ENT>N/A</ENT>
              <ENT>3.81</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>12.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46270</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of anal fistula</ENT>
              <ENT>3.72</ENT>
              <ENT>4.73</ENT>
              <ENT>2.40</ENT>
              <ENT>0.36</ENT>
              <ENT>8.81</ENT>
              <ENT>6.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46275</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of anal fistula</ENT>
              <ENT>4.56</ENT>
              <ENT>4.43</ENT>
              <ENT>2.61</ENT>
              <ENT>0.40</ENT>
              <ENT>9.39</ENT>
              <ENT>7.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46280</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of anal fistula</ENT>
              <ENT>5.98</ENT>
              <ENT>N/A</ENT>
              <ENT>3.32</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>9.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46285</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of anal fistula</ENT>
              <ENT>4.09</ENT>
              <ENT>3.67</ENT>
              <ENT>2.39</ENT>
              <ENT>0.34</ENT>
              <ENT>8.10</ENT>
              <ENT>6.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46288</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair anal fistula</ENT>
              <ENT>7.13</ENT>
              <ENT>N/A</ENT>
              <ENT>3.75</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>11.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of hemorrhoid clot</ENT>
              <ENT>1.61</ENT>
              <ENT>2.16</ENT>
              <ENT>0.87</ENT>
              <ENT>0.14</ENT>
              <ENT>3.91</ENT>
              <ENT>2.62</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection into hemorrhoid(s)</ENT>
              <ENT>1.61</ENT>
              <ENT>2.83</ENT>
              <ENT>0.63</ENT>
              <ENT>0.12</ENT>
              <ENT>4.56</ENT>
              <ENT>2.36</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Diagnostic anoscopy</ENT>
              <ENT>0.50</ENT>
              <ENT>1.64</ENT>
              <ENT>0.39</ENT>
              <ENT>0.04</ENT>
              <ENT>2.18</ENT>
              <ENT>0.93</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46604</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Anoscopy and dilation</ENT>
              <ENT>1.31</ENT>
              <ENT>9.68</ENT>
              <ENT>0.65</ENT>
              <ENT>0.09</ENT>
              <ENT>11.08</ENT>
              <ENT>2.05</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46606</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Anoscopy and biopsy</ENT>
              <ENT>0.81</ENT>
              <ENT>3.94</ENT>
              <ENT>0.45</ENT>
              <ENT>0.07</ENT>
              <ENT>4.82</ENT>
              <ENT>1.33</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46608</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Anoscopy, remove for body</ENT>
              <ENT>1.51</ENT>
              <ENT>4.58</ENT>
              <ENT>0.70</ENT>
              <ENT>0.13</ENT>
              <ENT>6.22</ENT>
              <ENT>2.34</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46610</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Anoscopy, remove lesion</ENT>
              <ENT>1.32</ENT>
              <ENT>4.17</ENT>
              <ENT>0.65</ENT>
              <ENT>0.12</ENT>
              <ENT>5.61</ENT>
              <ENT>2.09</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46611</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Anoscopy</ENT>
              <ENT>1.81</ENT>
              <ENT>3.45</ENT>
              <ENT>0.81</ENT>
              <ENT>0.15</ENT>
              <ENT>5.41</ENT>
              <ENT>2.77</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46612</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Anoscopy, remove lesions</ENT>
              <ENT>2.34</ENT>
              <ENT>5.30</ENT>
              <ENT>1.02</ENT>
              <ENT>0.18</ENT>
              <ENT>7.82</ENT>
              <ENT>3.54</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46614</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Anoscopy, control bleeding</ENT>
              <ENT>2.01</ENT>
              <ENT>2.33</ENT>
              <ENT>0.88</ENT>
              <ENT>0.14</ENT>
              <ENT>4.48</ENT>
              <ENT>3.03</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46615</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Anoscopy</ENT>
              <ENT>2.68</ENT>
              <ENT>2.57</ENT>
              <ENT>1.11</ENT>
              <ENT>0.23</ENT>
              <ENT>5.48</ENT>
              <ENT>4.02</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of anal stricture</ENT>
              <ENT>9.13</ENT>
              <ENT>N/A</ENT>
              <ENT>4.29</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>13.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49138"/>
              <ENT I="01">46705</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of anal stricture</ENT>
              <ENT>6.90</ENT>
              <ENT>N/A</ENT>
              <ENT>3.71</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>11.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46706</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repr of anal fistula w/glue</ENT>
              <ENT>2.39</ENT>
              <ENT>N/A</ENT>
              <ENT>1.27</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>3.83</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46715</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of anovaginal fistula</ENT>
              <ENT>7.20</ENT>
              <ENT>N/A</ENT>
              <ENT>3.65</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>11.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46716</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of anovaginal fistula</ENT>
              <ENT>15.07</ENT>
              <ENT>N/A</ENT>
              <ENT>8.18</ENT>
              <ENT>1.30</ENT>
              <ENT>N/A</ENT>
              <ENT>24.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46730</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Construction of absent anus</ENT>
              <ENT>26.75</ENT>
              <ENT>N/A</ENT>
              <ENT>12.31</ENT>
              <ENT>2.03</ENT>
              <ENT>N/A</ENT>
              <ENT>41.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46735</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Construction of absent anus</ENT>
              <ENT>32.17</ENT>
              <ENT>N/A</ENT>
              <ENT>14.15</ENT>
              <ENT>2.64</ENT>
              <ENT>N/A</ENT>
              <ENT>48.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46740</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Construction of absent anus</ENT>
              <ENT>30.00</ENT>
              <ENT>N/A</ENT>
              <ENT>13.53</ENT>
              <ENT>1.99</ENT>
              <ENT>N/A</ENT>
              <ENT>45.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46742</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of imperforated anus</ENT>
              <ENT>35.80</ENT>
              <ENT>N/A</ENT>
              <ENT>17.84</ENT>
              <ENT>2.63</ENT>
              <ENT>N/A</ENT>
              <ENT>56.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46744</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of cloacal anomaly</ENT>
              <ENT>52.63</ENT>
              <ENT>N/A</ENT>
              <ENT>21.45</ENT>
              <ENT>2.27</ENT>
              <ENT>N/A</ENT>
              <ENT>76.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46746</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of cloacal anomaly</ENT>
              <ENT>58.22</ENT>
              <ENT>N/A</ENT>
              <ENT>25.92</ENT>
              <ENT>2.51</ENT>
              <ENT>N/A</ENT>
              <ENT>86.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46748</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of cloacal anomaly</ENT>
              <ENT>64.21</ENT>
              <ENT>N/A</ENT>
              <ENT>25.76</ENT>
              <ENT>2.77</ENT>
              <ENT>N/A</ENT>
              <ENT>92.74</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46750</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of anal sphincter</ENT>
              <ENT>10.25</ENT>
              <ENT>N/A</ENT>
              <ENT>5.17</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>16.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46751</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of anal sphincter</ENT>
              <ENT>8.77</ENT>
              <ENT>N/A</ENT>
              <ENT>5.39</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>14.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46753</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of anus</ENT>
              <ENT>8.29</ENT>
              <ENT>N/A</ENT>
              <ENT>3.90</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>12.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46754</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of suture from anus</ENT>
              <ENT>2.20</ENT>
              <ENT>3.73</ENT>
              <ENT>1.72</ENT>
              <ENT>0.12</ENT>
              <ENT>6.05</ENT>
              <ENT>4.04</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46760</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of anal sphincter</ENT>
              <ENT>14.43</ENT>
              <ENT>N/A</ENT>
              <ENT>7.13</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>22.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46761</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of anal sphincter</ENT>
              <ENT>13.84</ENT>
              <ENT>N/A</ENT>
              <ENT>6.16</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>20.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46762</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant artificial sphincter</ENT>
              <ENT>12.71</ENT>
              <ENT>N/A</ENT>
              <ENT>5.59</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>19.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46900</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction, anal lesion(s)</ENT>
              <ENT>1.91</ENT>
              <ENT>3.60</ENT>
              <ENT>0.81</ENT>
              <ENT>0.13</ENT>
              <ENT>5.64</ENT>
              <ENT>2.85</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46910</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction, anal lesion(s)</ENT>
              <ENT>1.86</ENT>
              <ENT>2.75</ENT>
              <ENT>1.12</ENT>
              <ENT>0.14</ENT>
              <ENT>4.75</ENT>
              <ENT>3.12</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46916</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cryosurgery, anal lesion(s)</ENT>
              <ENT>1.86</ENT>
              <ENT>3.14</ENT>
              <ENT>1.44</ENT>
              <ENT>0.09</ENT>
              <ENT>5.09</ENT>
              <ENT>3.39</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46917</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laser surgery, anal lesions</ENT>
              <ENT>1.86</ENT>
              <ENT>14.08</ENT>
              <ENT>1.15</ENT>
              <ENT>0.16</ENT>
              <ENT>16.10</ENT>
              <ENT>3.17</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46922</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of anal lesion(s)</ENT>
              <ENT>1.86</ENT>
              <ENT>3.38</ENT>
              <ENT>1.10</ENT>
              <ENT>0.17</ENT>
              <ENT>5.41</ENT>
              <ENT>3.13</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46924</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction, anal lesion(s)</ENT>
              <ENT>2.76</ENT>
              <ENT>12.56</ENT>
              <ENT>1.39</ENT>
              <ENT>0.20</ENT>
              <ENT>15.52</ENT>
              <ENT>4.35</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46934</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction of hemorrhoids</ENT>
              <ENT>3.51</ENT>
              <ENT>5.18</ENT>
              <ENT>2.81</ENT>
              <ENT>0.26</ENT>
              <ENT>8.95</ENT>
              <ENT>6.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46935</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction of hemorrhoids</ENT>
              <ENT>2.43</ENT>
              <ENT>3.55</ENT>
              <ENT>1.23</ENT>
              <ENT>0.17</ENT>
              <ENT>6.15</ENT>
              <ENT>3.83</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46936</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction of hemorrhoids</ENT>
              <ENT>3.69</ENT>
              <ENT>4.61</ENT>
              <ENT>2.38</ENT>
              <ENT>0.30</ENT>
              <ENT>8.60</ENT>
              <ENT>6.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46937</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cryotherapy of rectal lesion</ENT>
              <ENT>2.69</ENT>
              <ENT>2.79</ENT>
              <ENT>1.25</ENT>
              <ENT>0.12</ENT>
              <ENT>5.60</ENT>
              <ENT>4.06</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46938</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cryotherapy of rectal lesion</ENT>
              <ENT>4.66</ENT>
              <ENT>4.28</ENT>
              <ENT>2.74</ENT>
              <ENT>0.40</ENT>
              <ENT>9.34</ENT>
              <ENT>7.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46940</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of anal fissure</ENT>
              <ENT>2.32</ENT>
              <ENT>2.04</ENT>
              <ENT>1.11</ENT>
              <ENT>0.17</ENT>
              <ENT>4.53</ENT>
              <ENT>3.60</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46942</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of anal fissure</ENT>
              <ENT>2.04</ENT>
              <ENT>1.87</ENT>
              <ENT>1.02</ENT>
              <ENT>0.14</ENT>
              <ENT>4.05</ENT>
              <ENT>3.20</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46945</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ligation of hemorrhoids</ENT>
              <ENT>1.84</ENT>
              <ENT>3.60</ENT>
              <ENT>1.91</ENT>
              <ENT>0.17</ENT>
              <ENT>5.61</ENT>
              <ENT>3.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46946</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ligation of hemorrhoids</ENT>
              <ENT>2.58</ENT>
              <ENT>4.34</ENT>
              <ENT>1.92</ENT>
              <ENT>0.22</ENT>
              <ENT>7.14</ENT>
              <ENT>4.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">46999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Anus surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Needle biopsy of liver</ENT>
              <ENT>1.90</ENT>
              <ENT>3.29</ENT>
              <ENT>0.64</ENT>
              <ENT>0.09</ENT>
              <ENT>5.28</ENT>
              <ENT>2.63</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47001</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Needle biopsy, liver add-on</ENT>
              <ENT>1.90</ENT>
              <ENT>N/A</ENT>
              <ENT>0.66</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>2.74</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Open drainage, liver lesion</ENT>
              <ENT>16.01</ENT>
              <ENT>N/A</ENT>
              <ENT>8.75</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>25.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47011</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Percut drain, liver lesion</ENT>
              <ENT>3.70</ENT>
              <ENT>N/A</ENT>
              <ENT>4.42</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>8.29</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47015</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inject/aspirate liver cyst</ENT>
              <ENT>15.11</ENT>
              <ENT>N/A</ENT>
              <ENT>7.70</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>23.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Wedge biopsy of liver</ENT>
              <ENT>11.67</ENT>
              <ENT>N/A</ENT>
              <ENT>6.22</ENT>
              <ENT>0.75</ENT>
              <ENT>N/A</ENT>
              <ENT>18.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of liver</ENT>
              <ENT>35.50</ENT>
              <ENT>N/A</ENT>
              <ENT>15.57</ENT>
              <ENT>2.29</ENT>
              <ENT>N/A</ENT>
              <ENT>53.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47122</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive removal of liver</ENT>
              <ENT>55.13</ENT>
              <ENT>N/A</ENT>
              <ENT>22.07</ENT>
              <ENT>3.60</ENT>
              <ENT>N/A</ENT>
              <ENT>80.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47125</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of liver</ENT>
              <ENT>49.19</ENT>
              <ENT>N/A</ENT>
              <ENT>20.05</ENT>
              <ENT>3.18</ENT>
              <ENT>N/A</ENT>
              <ENT>72.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of liver</ENT>
              <ENT>53.35</ENT>
              <ENT>N/A</ENT>
              <ENT>21.54</ENT>
              <ENT>3.47</ENT>
              <ENT>N/A</ENT>
              <ENT>78.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47134</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Partial removal, donor liver</ENT>
              <ENT>39.15</ENT>
              <ENT>N/A</ENT>
              <ENT>13.51</ENT>
              <ENT>3.98</ENT>
              <ENT>N/A</ENT>
              <ENT>56.64</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47135</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Transplantation of liver</ENT>
              <ENT>81.52</ENT>
              <ENT>N/A</ENT>
              <ENT>32.18</ENT>
              <ENT>8.13</ENT>
              <ENT>N/A</ENT>
              <ENT>121.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47136</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Transplantation of liver</ENT>
              <ENT>68.60</ENT>
              <ENT>N/A</ENT>
              <ENT>29.48</ENT>
              <ENT>6.93</ENT>
              <ENT>N/A</ENT>
              <ENT>105.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Surgery for liver lesion</ENT>
              <ENT>15.08</ENT>
              <ENT>N/A</ENT>
              <ENT>7.44</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>23.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47350</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair liver wound</ENT>
              <ENT>19.56</ENT>
              <ENT>N/A</ENT>
              <ENT>9.10</ENT>
              <ENT>1.25</ENT>
              <ENT>N/A</ENT>
              <ENT>29.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47360</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair liver wound</ENT>
              <ENT>26.92</ENT>
              <ENT>N/A</ENT>
              <ENT>11.93</ENT>
              <ENT>1.71</ENT>
              <ENT>N/A</ENT>
              <ENT>40.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47361</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair liver wound</ENT>
              <ENT>47.12</ENT>
              <ENT>N/A</ENT>
              <ENT>19.02</ENT>
              <ENT>3.11</ENT>
              <ENT>N/A</ENT>
              <ENT>69.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47362</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair liver wound</ENT>
              <ENT>18.51</ENT>
              <ENT>N/A</ENT>
              <ENT>9.02</ENT>
              <ENT>1.22</ENT>
              <ENT>N/A</ENT>
              <ENT>28.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49139"/>
              <ENT I="01">47370</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo ablate liver tumor rf</ENT>
              <ENT>19.69</ENT>
              <ENT>N/A</ENT>
              <ENT>8.31</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>28.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47371</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo ablate liver cryosurg</ENT>
              <ENT>19.69</ENT>
              <ENT>N/A</ENT>
              <ENT>8.43</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>28.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47379</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Laparoscope procedure, liver</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47380</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Open ablate liver tumor rf</ENT>
              <ENT>23.00</ENT>
              <ENT>N/A</ENT>
              <ENT>9.55</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>33.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47381</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Open ablate liver tumor cryo</ENT>
              <ENT>23.27</ENT>
              <ENT>N/A</ENT>
              <ENT>9.86</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>33.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47382</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Percut ablate liver rf</ENT>
              <ENT>15.19</ENT>
              <ENT>N/A</ENT>
              <ENT>6.00</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>22.33</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47399</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Liver surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of liver duct</ENT>
              <ENT>32.49</ENT>
              <ENT>N/A</ENT>
              <ENT>13.86</ENT>
              <ENT>1.82</ENT>
              <ENT>N/A</ENT>
              <ENT>48.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of bile duct</ENT>
              <ENT>19.88</ENT>
              <ENT>N/A</ENT>
              <ENT>8.99</ENT>
              <ENT>1.70</ENT>
              <ENT>N/A</ENT>
              <ENT>30.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47425</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of bile duct</ENT>
              <ENT>19.83</ENT>
              <ENT>N/A</ENT>
              <ENT>9.04</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>30.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47460</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise bile duct sphincter</ENT>
              <ENT>18.04</ENT>
              <ENT>N/A</ENT>
              <ENT>8.61</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>27.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47480</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of gallbladder</ENT>
              <ENT>10.82</ENT>
              <ENT>N/A</ENT>
              <ENT>6.13</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>17.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47490</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of gallbladder</ENT>
              <ENT>7.23</ENT>
              <ENT>N/A</ENT>
              <ENT>5.97</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>13.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection for liver x-rays</ENT>
              <ENT>1.96</ENT>
              <ENT>N/A</ENT>
              <ENT>0.65</ENT>
              <ENT>0.09</ENT>
              <ENT>N/A</ENT>
              <ENT>2.70</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47505</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection for liver x-rays</ENT>
              <ENT>0.76</ENT>
              <ENT>2.59</ENT>
              <ENT>0.25</ENT>
              <ENT>0.03</ENT>
              <ENT>3.38</ENT>
              <ENT>1.04</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert catheter, bile duct</ENT>
              <ENT>7.83</ENT>
              <ENT>N/A</ENT>
              <ENT>5.02</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>13.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47511</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert bile duct drain</ENT>
              <ENT>10.50</ENT>
              <ENT>N/A</ENT>
              <ENT>5.12</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>16.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47525</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Change bile duct catheter</ENT>
              <ENT>5.55</ENT>
              <ENT>N/A</ENT>
              <ENT>3.26</ENT>
              <ENT>0.24</ENT>
              <ENT>N/A</ENT>
              <ENT>9.05</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise/reinsert bile tube</ENT>
              <ENT>5.85</ENT>
              <ENT>N/A</ENT>
              <ENT>4.30</ENT>
              <ENT>0.29</ENT>
              <ENT>N/A</ENT>
              <ENT>10.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47550</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bile duct endoscopy add-on</ENT>
              <ENT>3.02</ENT>
              <ENT>N/A</ENT>
              <ENT>1.05</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>4.37</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47552</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biliary endoscopy thru skin</ENT>
              <ENT>6.04</ENT>
              <ENT>N/A</ENT>
              <ENT>2.43</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>8.89</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47553</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biliary endoscopy thru skin</ENT>
              <ENT>6.35</ENT>
              <ENT>N/A</ENT>
              <ENT>2.62</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>9.27</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47554</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biliary endoscopy thru skin</ENT>
              <ENT>9.06</ENT>
              <ENT>N/A</ENT>
              <ENT>3.43</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>13.23</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47555</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biliary endoscopy thru skin</ENT>
              <ENT>7.56</ENT>
              <ENT>N/A</ENT>
              <ENT>3.04</ENT>
              <ENT>0.35</ENT>
              <ENT>N/A</ENT>
              <ENT>10.95</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47556</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biliary endoscopy thru skin</ENT>
              <ENT>8.56</ENT>
              <ENT>N/A</ENT>
              <ENT>3.37</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>12.31</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47560</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy w/cholangio</ENT>
              <ENT>4.89</ENT>
              <ENT>N/A</ENT>
              <ENT>1.85</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>7.23</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47561</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo w/cholangio/biopsy</ENT>
              <ENT>5.18</ENT>
              <ENT>N/A</ENT>
              <ENT>2.16</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>7.83</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47562</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopic cholecystectomy</ENT>
              <ENT>11.09</ENT>
              <ENT>N/A</ENT>
              <ENT>5.04</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>17.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47563</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo cholecystectomy/graph</ENT>
              <ENT>11.94</ENT>
              <ENT>N/A</ENT>
              <ENT>5.35</ENT>
              <ENT>1.21</ENT>
              <ENT>N/A</ENT>
              <ENT>18.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47564</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo cholecystectomy/explr</ENT>
              <ENT>14.23</ENT>
              <ENT>N/A</ENT>
              <ENT>6.06</ENT>
              <ENT>1.44</ENT>
              <ENT>N/A</ENT>
              <ENT>21.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47570</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo cholecystoenterostomy</ENT>
              <ENT>12.58</ENT>
              <ENT>N/A</ENT>
              <ENT>5.47</ENT>
              <ENT>1.28</ENT>
              <ENT>N/A</ENT>
              <ENT>19.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47579</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Laparoscope proc, biliary</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of gallbladder</ENT>
              <ENT>13.58</ENT>
              <ENT>N/A</ENT>
              <ENT>6.36</ENT>
              <ENT>1.16</ENT>
              <ENT>N/A</ENT>
              <ENT>21.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of gallbladder</ENT>
              <ENT>14.69</ENT>
              <ENT>N/A</ENT>
              <ENT>6.72</ENT>
              <ENT>1.25</ENT>
              <ENT>N/A</ENT>
              <ENT>22.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47610</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of gallbladder</ENT>
              <ENT>18.82</ENT>
              <ENT>N/A</ENT>
              <ENT>8.20</ENT>
              <ENT>1.61</ENT>
              <ENT>N/A</ENT>
              <ENT>28.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47612</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of gallbladder</ENT>
              <ENT>18.78</ENT>
              <ENT>N/A</ENT>
              <ENT>8.14</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>28.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47620</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of gallbladder</ENT>
              <ENT>20.64</ENT>
              <ENT>N/A</ENT>
              <ENT>8.79</ENT>
              <ENT>1.77</ENT>
              <ENT>N/A</ENT>
              <ENT>31.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47630</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove bile duct stone</ENT>
              <ENT>9.11</ENT>
              <ENT>N/A</ENT>
              <ENT>4.81</ENT>
              <ENT>0.46</ENT>
              <ENT>N/A</ENT>
              <ENT>14.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of bile ducts</ENT>
              <ENT>15.62</ENT>
              <ENT>N/A</ENT>
              <ENT>7.60</ENT>
              <ENT>1.40</ENT>
              <ENT>N/A</ENT>
              <ENT>24.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47701</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bile duct revision</ENT>
              <ENT>27.81</ENT>
              <ENT>N/A</ENT>
              <ENT>11.87</ENT>
              <ENT>3.00</ENT>
              <ENT>N/A</ENT>
              <ENT>42.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47711</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of bile duct tumor</ENT>
              <ENT>23.03</ENT>
              <ENT>N/A</ENT>
              <ENT>10.22</ENT>
              <ENT>1.98</ENT>
              <ENT>N/A</ENT>
              <ENT>35.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47712</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of bile duct tumor</ENT>
              <ENT>30.24</ENT>
              <ENT>N/A</ENT>
              <ENT>12.77</ENT>
              <ENT>2.67</ENT>
              <ENT>N/A</ENT>
              <ENT>45.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47715</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of bile duct cyst</ENT>
              <ENT>18.80</ENT>
              <ENT>N/A</ENT>
              <ENT>8.66</ENT>
              <ENT>1.59</ENT>
              <ENT>N/A</ENT>
              <ENT>29.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47716</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of bile duct cyst</ENT>
              <ENT>16.44</ENT>
              <ENT>N/A</ENT>
              <ENT>8.09</ENT>
              <ENT>1.41</ENT>
              <ENT>N/A</ENT>
              <ENT>25.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47720</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fuse gallbladder &amp; bowel</ENT>
              <ENT>15.91</ENT>
              <ENT>N/A</ENT>
              <ENT>7.69</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>24.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47721</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fuse upper gi structures</ENT>
              <ENT>19.12</ENT>
              <ENT>N/A</ENT>
              <ENT>8.81</ENT>
              <ENT>1.63</ENT>
              <ENT>N/A</ENT>
              <ENT>29.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47740</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fuse gallbladder &amp; bowel</ENT>
              <ENT>18.48</ENT>
              <ENT>N/A</ENT>
              <ENT>8.61</ENT>
              <ENT>1.59</ENT>
              <ENT>N/A</ENT>
              <ENT>28.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47741</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fuse gallbladder &amp; bowel</ENT>
              <ENT>21.34</ENT>
              <ENT>N/A</ENT>
              <ENT>9.54</ENT>
              <ENT>1.82</ENT>
              <ENT>N/A</ENT>
              <ENT>32.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47760</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fuse bile ducts and bowel</ENT>
              <ENT>25.85</ENT>
              <ENT>N/A</ENT>
              <ENT>11.13</ENT>
              <ENT>2.21</ENT>
              <ENT>N/A</ENT>
              <ENT>39.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47765</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fuse liver ducts &amp; bowel</ENT>
              <ENT>24.88</ENT>
              <ENT>N/A</ENT>
              <ENT>11.16</ENT>
              <ENT>2.18</ENT>
              <ENT>N/A</ENT>
              <ENT>38.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47780</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fuse bile ducts and bowel</ENT>
              <ENT>26.50</ENT>
              <ENT>N/A</ENT>
              <ENT>11.50</ENT>
              <ENT>2.27</ENT>
              <ENT>N/A</ENT>
              <ENT>40.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47785</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fuse bile ducts and bowel</ENT>
              <ENT>31.18</ENT>
              <ENT>N/A</ENT>
              <ENT>13.32</ENT>
              <ENT>2.69</ENT>
              <ENT>N/A</ENT>
              <ENT>47.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of bile ducts</ENT>
              <ENT>23.30</ENT>
              <ENT>N/A</ENT>
              <ENT>10.33</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>35.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47801</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Placement, bile duct support</ENT>
              <ENT>15.17</ENT>
              <ENT>N/A</ENT>
              <ENT>8.43</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>24.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47802</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fuse liver duct &amp; intestine</ENT>
              <ENT>21.55</ENT>
              <ENT>N/A</ENT>
              <ENT>9.99</ENT>
              <ENT>1.84</ENT>
              <ENT>N/A</ENT>
              <ENT>33.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49140"/>
              <ENT I="01">47900</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Suture bile duct injury</ENT>
              <ENT>19.90</ENT>
              <ENT>N/A</ENT>
              <ENT>9.11</ENT>
              <ENT>1.65</ENT>
              <ENT>N/A</ENT>
              <ENT>30.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">47999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Bile tract surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of abdomen</ENT>
              <ENT>28.07</ENT>
              <ENT>N/A</ENT>
              <ENT>11.83</ENT>
              <ENT>1.32</ENT>
              <ENT>N/A</ENT>
              <ENT>41.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48001</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Placement of drain, pancreas</ENT>
              <ENT>35.45</ENT>
              <ENT>N/A</ENT>
              <ENT>14.27</ENT>
              <ENT>1.90</ENT>
              <ENT>N/A</ENT>
              <ENT>51.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48005</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Resect/debride pancreas</ENT>
              <ENT>42.17</ENT>
              <ENT>N/A</ENT>
              <ENT>16.95</ENT>
              <ENT>2.26</ENT>
              <ENT>N/A</ENT>
              <ENT>61.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of pancreatic stone</ENT>
              <ENT>15.70</ENT>
              <ENT>N/A</ENT>
              <ENT>7.52</ENT>
              <ENT>1.36</ENT>
              <ENT>N/A</ENT>
              <ENT>24.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of pancreas, open</ENT>
              <ENT>12.23</ENT>
              <ENT>N/A</ENT>
              <ENT>5.82</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>19.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48102</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Needle biopsy, pancreas</ENT>
              <ENT>4.68</ENT>
              <ENT>9.01</ENT>
              <ENT>2.47</ENT>
              <ENT>0.20</ENT>
              <ENT>13.89</ENT>
              <ENT>7.35</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of pancreas lesion</ENT>
              <ENT>15.85</ENT>
              <ENT>N/A</ENT>
              <ENT>7.10</ENT>
              <ENT>1.35</ENT>
              <ENT>N/A</ENT>
              <ENT>24.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of pancreas</ENT>
              <ENT>22.94</ENT>
              <ENT>N/A</ENT>
              <ENT>9.79</ENT>
              <ENT>2.12</ENT>
              <ENT>N/A</ENT>
              <ENT>34.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48145</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of pancreas</ENT>
              <ENT>24.02</ENT>
              <ENT>N/A</ENT>
              <ENT>10.14</ENT>
              <ENT>2.25</ENT>
              <ENT>N/A</ENT>
              <ENT>36.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48146</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pancreatectomy</ENT>
              <ENT>26.40</ENT>
              <ENT>N/A</ENT>
              <ENT>12.29</ENT>
              <ENT>2.43</ENT>
              <ENT>N/A</ENT>
              <ENT>41.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48148</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of pancreatic duct</ENT>
              <ENT>17.34</ENT>
              <ENT>N/A</ENT>
              <ENT>7.88</ENT>
              <ENT>1.61</ENT>
              <ENT>N/A</ENT>
              <ENT>26.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of pancreas</ENT>
              <ENT>48.00</ENT>
              <ENT>N/A</ENT>
              <ENT>20.04</ENT>
              <ENT>4.43</ENT>
              <ENT>N/A</ENT>
              <ENT>72.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48152</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pancreatectomy</ENT>
              <ENT>43.75</ENT>
              <ENT>N/A</ENT>
              <ENT>18.70</ENT>
              <ENT>4.07</ENT>
              <ENT>N/A</ENT>
              <ENT>66.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48153</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pancreatectomy</ENT>
              <ENT>47.89</ENT>
              <ENT>N/A</ENT>
              <ENT>20.15</ENT>
              <ENT>4.40</ENT>
              <ENT>N/A</ENT>
              <ENT>72.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48154</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pancreatectomy</ENT>
              <ENT>44.10</ENT>
              <ENT>N/A</ENT>
              <ENT>18.76</ENT>
              <ENT>4.10</ENT>
              <ENT>N/A</ENT>
              <ENT>66.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48155</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of pancreas</ENT>
              <ENT>24.64</ENT>
              <ENT>N/A</ENT>
              <ENT>12.08</ENT>
              <ENT>2.30</ENT>
              <ENT>N/A</ENT>
              <ENT>39.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48180</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fuse pancreas and bowel</ENT>
              <ENT>24.72</ENT>
              <ENT>N/A</ENT>
              <ENT>10.46</ENT>
              <ENT>2.24</ENT>
              <ENT>N/A</ENT>
              <ENT>37.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection, intraop add-on</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>0.66</ENT>
              <ENT>0.10</ENT>
              <ENT>N/A</ENT>
              <ENT>2.71</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Surgery of pancreatic cyst</ENT>
              <ENT>15.28</ENT>
              <ENT>N/A</ENT>
              <ENT>7.57</ENT>
              <ENT>1.35</ENT>
              <ENT>N/A</ENT>
              <ENT>24.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain pancreatic pseudocyst</ENT>
              <ENT>14.31</ENT>
              <ENT>N/A</ENT>
              <ENT>7.67</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>23.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48511</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain pancreatic pseudocyst</ENT>
              <ENT>4.00</ENT>
              <ENT>N/A</ENT>
              <ENT>3.75</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>7.92</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fuse pancreas cyst and bowel</ENT>
              <ENT>15.59</ENT>
              <ENT>N/A</ENT>
              <ENT>6.94</ENT>
              <ENT>1.41</ENT>
              <ENT>N/A</ENT>
              <ENT>23.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48540</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fuse pancreas cyst and bowel</ENT>
              <ENT>19.72</ENT>
              <ENT>N/A</ENT>
              <ENT>8.37</ENT>
              <ENT>1.82</ENT>
              <ENT>N/A</ENT>
              <ENT>29.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48545</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pancreatorrhaphy</ENT>
              <ENT>18.18</ENT>
              <ENT>N/A</ENT>
              <ENT>8.23</ENT>
              <ENT>1.61</ENT>
              <ENT>N/A</ENT>
              <ENT>28.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48547</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Duodenal exclusion</ENT>
              <ENT>25.83</ENT>
              <ENT>N/A</ENT>
              <ENT>10.76</ENT>
              <ENT>2.30</ENT>
              <ENT>N/A</ENT>
              <ENT>38.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48554</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Transpl allograft pancreas</ENT>
              <ENT>34.17</ENT>
              <ENT>N/A</ENT>
              <ENT>16.00</ENT>
              <ENT>3.30</ENT>
              <ENT>N/A</ENT>
              <ENT>53.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48556</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal, allograft pancreas</ENT>
              <ENT>15.71</ENT>
              <ENT>N/A</ENT>
              <ENT>7.81</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>25.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">48999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Pancreas surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of abdomen</ENT>
              <ENT>11.68</ENT>
              <ENT>N/A</ENT>
              <ENT>5.44</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>18.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49002</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reopening of abdomen</ENT>
              <ENT>10.49</ENT>
              <ENT>N/A</ENT>
              <ENT>5.10</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>16.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration behind abdomen</ENT>
              <ENT>12.28</ENT>
              <ENT>N/A</ENT>
              <ENT>5.96</ENT>
              <ENT>1.22</ENT>
              <ENT>N/A</ENT>
              <ENT>19.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain abdominal abscess</ENT>
              <ENT>22.84</ENT>
              <ENT>N/A</ENT>
              <ENT>10.32</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>34.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49021</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain abdominal abscess</ENT>
              <ENT>3.38</ENT>
              <ENT>N/A</ENT>
              <ENT>5.37</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>8.91</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49040</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain, open, abdom abscess</ENT>
              <ENT>13.52</ENT>
              <ENT>N/A</ENT>
              <ENT>6.54</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>20.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49041</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain, percut, abdom abscess</ENT>
              <ENT>4.00</ENT>
              <ENT>N/A</ENT>
              <ENT>5.69</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>9.87</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49060</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain, open, retrop abscess</ENT>
              <ENT>15.86</ENT>
              <ENT>N/A</ENT>
              <ENT>7.56</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>24.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49061</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain, percut, retroper absc</ENT>
              <ENT>3.70</ENT>
              <ENT>N/A</ENT>
              <ENT>5.68</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>9.55</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49062</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain to peritoneal cavity</ENT>
              <ENT>11.36</ENT>
              <ENT>N/A</ENT>
              <ENT>5.59</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>18.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49080</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Puncture, peritoneal cavity</ENT>
              <ENT>1.35</ENT>
              <ENT>4.18</ENT>
              <ENT>0.46</ENT>
              <ENT>0.07</ENT>
              <ENT>5.60</ENT>
              <ENT>1.88</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49081</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of abdominal fluid</ENT>
              <ENT>1.26</ENT>
              <ENT>2.68</ENT>
              <ENT>0.58</ENT>
              <ENT>0.06</ENT>
              <ENT>4.00</ENT>
              <ENT>1.90</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49085</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove abdomen foreign body</ENT>
              <ENT>12.14</ENT>
              <ENT>N/A</ENT>
              <ENT>5.62</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>18.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49180</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy, abdominal mass</ENT>
              <ENT>1.73</ENT>
              <ENT>3.34</ENT>
              <ENT>0.58</ENT>
              <ENT>0.08</ENT>
              <ENT>5.15</ENT>
              <ENT>2.39</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49141"/>
              <ENT I="01">49200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of abdominal lesion</ENT>
              <ENT>10.25</ENT>
              <ENT>N/A</ENT>
              <ENT>5.12</ENT>
              <ENT>0.92</ENT>
              <ENT>N/A</ENT>
              <ENT>16.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49201</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove abdom lesion, complex</ENT>
              <ENT>14.84</ENT>
              <ENT>N/A</ENT>
              <ENT>7.23</ENT>
              <ENT>1.47</ENT>
              <ENT>N/A</ENT>
              <ENT>23.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49215</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise sacral spine tumor</ENT>
              <ENT>33.50</ENT>
              <ENT>N/A</ENT>
              <ENT>14.50</ENT>
              <ENT>2.48</ENT>
              <ENT>N/A</ENT>
              <ENT>50.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Multiple surgery, abdomen</ENT>
              <ENT>14.88</ENT>
              <ENT>N/A</ENT>
              <ENT>6.74</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>23.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of umbilicus</ENT>
              <ENT>8.35</ENT>
              <ENT>N/A</ENT>
              <ENT>4.35</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>13.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49255</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of omentum</ENT>
              <ENT>11.14</ENT>
              <ENT>N/A</ENT>
              <ENT>5.74</ENT>
              <ENT>1.12</ENT>
              <ENT>N/A</ENT>
              <ENT>18.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Diag laparo separate proc</ENT>
              <ENT>5.10</ENT>
              <ENT>N/A</ENT>
              <ENT>2.60</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>8.20</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49321</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy, biopsy</ENT>
              <ENT>5.40</ENT>
              <ENT>N/A</ENT>
              <ENT>2.61</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>8.54</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49322</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy, aspiration</ENT>
              <ENT>5.70</ENT>
              <ENT>N/A</ENT>
              <ENT>2.94</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>9.21</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49323</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo drain lymphocele</ENT>
              <ENT>9.48</ENT>
              <ENT>N/A</ENT>
              <ENT>4.49</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>14.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49329</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Laparo proc, abdm/per/oment</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Air injection into abdomen</ENT>
              <ENT>1.88</ENT>
              <ENT>N/A</ENT>
              <ENT>0.79</ENT>
              <ENT>0.11</ENT>
              <ENT>N/A</ENT>
              <ENT>2.78</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49419</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insrt abdom cath for chemotx</ENT>
              <ENT>6.65</ENT>
              <ENT>N/A</ENT>
              <ENT>3.60</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>10.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert abdom drain, temp</ENT>
              <ENT>2.22</ENT>
              <ENT>N/A</ENT>
              <ENT>1.13</ENT>
              <ENT>0.13</ENT>
              <ENT>N/A</ENT>
              <ENT>3.48</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49421</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert abdom drain, perm</ENT>
              <ENT>5.54</ENT>
              <ENT>N/A</ENT>
              <ENT>3.18</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>9.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49422</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove perm cannula/catheter</ENT>
              <ENT>6.25</ENT>
              <ENT>N/A</ENT>
              <ENT>2.90</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>9.78</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49423</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exchange drainage catheter</ENT>
              <ENT>1.46</ENT>
              <ENT>N/A</ENT>
              <ENT>0.67</ENT>
              <ENT>0.07</ENT>
              <ENT>N/A</ENT>
              <ENT>2.20</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49424</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Assess cyst, contrast inject</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.44</ENT>
              <ENT>0.03</ENT>
              <ENT>N/A</ENT>
              <ENT>1.23</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49425</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert abdomen-venous drain</ENT>
              <ENT>11.37</ENT>
              <ENT>N/A</ENT>
              <ENT>5.62</ENT>
              <ENT>1.21</ENT>
              <ENT>N/A</ENT>
              <ENT>18.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49426</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise abdomen-venous shunt</ENT>
              <ENT>9.63</ENT>
              <ENT>N/A</ENT>
              <ENT>4.82</ENT>
              <ENT>0.93</ENT>
              <ENT>N/A</ENT>
              <ENT>15.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49427</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection, abdominal shunt</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.48</ENT>
              <ENT>0.05</ENT>
              <ENT>N/A</ENT>
              <ENT>1.42</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49428</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ligation of shunt</ENT>
              <ENT>6.06</ENT>
              <ENT>N/A</ENT>
              <ENT>3.33</ENT>
              <ENT>0.31</ENT>
              <ENT>N/A</ENT>
              <ENT>9.70</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49429</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of shunt</ENT>
              <ENT>7.40</ENT>
              <ENT>N/A</ENT>
              <ENT>3.53</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>11.74</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49491</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rpr hern preemie reduc</ENT>
              <ENT>11.13</ENT>
              <ENT>N/A</ENT>
              <ENT>5.30</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>17.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49492</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rpr ing hern premie, blocked</ENT>
              <ENT>14.03</ENT>
              <ENT>N/A</ENT>
              <ENT>6.29</ENT>
              <ENT>1.47</ENT>
              <ENT>N/A</ENT>
              <ENT>21.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49495</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rpr ing hernia baby, reduc</ENT>
              <ENT>5.89</ENT>
              <ENT>N/A</ENT>
              <ENT>3.07</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>9.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49496</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rpr ing hernia baby, blocked</ENT>
              <ENT>8.79</ENT>
              <ENT>N/A</ENT>
              <ENT>4.42</ENT>
              <ENT>0.92</ENT>
              <ENT>N/A</ENT>
              <ENT>14.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rpr ing hernia, init, reduce</ENT>
              <ENT>5.48</ENT>
              <ENT>N/A</ENT>
              <ENT>3.20</ENT>
              <ENT>0.46</ENT>
              <ENT>N/A</ENT>
              <ENT>9.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49501</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rpr ing hernia, init blocked</ENT>
              <ENT>8.88</ENT>
              <ENT>N/A</ENT>
              <ENT>4.29</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>13.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49505</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prp i/hern init reduc&gt;5 yr</ENT>
              <ENT>7.60</ENT>
              <ENT>4.04</ENT>
              <ENT>3.83</ENT>
              <ENT>0.65</ENT>
              <ENT>12.29</ENT>
              <ENT>12.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49507</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prp i/hern init block&gt;5 yr</ENT>
              <ENT>9.57</ENT>
              <ENT>N/A</ENT>
              <ENT>4.67</ENT>
              <ENT>0.83</ENT>
              <ENT>N/A</ENT>
              <ENT>15.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rerepair ing hernia, reduce</ENT>
              <ENT>9.63</ENT>
              <ENT>N/A</ENT>
              <ENT>4.63</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>15.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49521</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rerepair ing hernia, blocked</ENT>
              <ENT>11.97</ENT>
              <ENT>N/A</ENT>
              <ENT>5.36</ENT>
              <ENT>1.04</ENT>
              <ENT>N/A</ENT>
              <ENT>18.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49525</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair ing hernia, sliding</ENT>
              <ENT>8.57</ENT>
              <ENT>N/A</ENT>
              <ENT>4.23</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>13.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49540</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair lumbar hernia</ENT>
              <ENT>10.39</ENT>
              <ENT>N/A</ENT>
              <ENT>4.91</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>16.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49550</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rpr rem hernia, init, reduce</ENT>
              <ENT>8.63</ENT>
              <ENT>N/A</ENT>
              <ENT>4.22</ENT>
              <ENT>0.75</ENT>
              <ENT>N/A</ENT>
              <ENT>13.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49553</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rpr fem hernia, init blocked</ENT>
              <ENT>9.44</ENT>
              <ENT>N/A</ENT>
              <ENT>4.55</ENT>
              <ENT>0.83</ENT>
              <ENT>N/A</ENT>
              <ENT>14.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49555</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rerepair fem hernia, reduce</ENT>
              <ENT>9.03</ENT>
              <ENT>N/A</ENT>
              <ENT>4.42</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>14.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49557</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rerepair fem hernia, blocked</ENT>
              <ENT>11.15</ENT>
              <ENT>N/A</ENT>
              <ENT>5.14</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>17.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49560</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rpr ventral hern init, reduc</ENT>
              <ENT>11.57</ENT>
              <ENT>N/A</ENT>
              <ENT>5.32</ENT>
              <ENT>1.00</ENT>
              <ENT>N/A</ENT>
              <ENT>17.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49561</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rpr ventral hern init, block</ENT>
              <ENT>14.25</ENT>
              <ENT>N/A</ENT>
              <ENT>6.24</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>21.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49565</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rerepair ventrl hern, reduce</ENT>
              <ENT>11.57</ENT>
              <ENT>N/A</ENT>
              <ENT>5.39</ENT>
              <ENT>1.00</ENT>
              <ENT>N/A</ENT>
              <ENT>17.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49566</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rerepair ventrl hern, block</ENT>
              <ENT>14.40</ENT>
              <ENT>N/A</ENT>
              <ENT>6.31</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>21.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49568</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hernia repair w/mesh</ENT>
              <ENT>4.89</ENT>
              <ENT>N/A</ENT>
              <ENT>1.71</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>7.10</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49570</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rpr epigastric hern, reduce</ENT>
              <ENT>5.69</ENT>
              <ENT>N/A</ENT>
              <ENT>3.23</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>9.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49572</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rpr epigastric hern, blocked</ENT>
              <ENT>6.73</ENT>
              <ENT>N/A</ENT>
              <ENT>3.59</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>10.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49142"/>
              <ENT I="01">49580</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rpr umbil hern, reduc &lt; 5 yr</ENT>
              <ENT>4.11</ENT>
              <ENT>N/A</ENT>
              <ENT>2.68</ENT>
              <ENT>0.34</ENT>
              <ENT>N/A</ENT>
              <ENT>7.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49582</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rpr umbil hern, block &lt; 5 yr</ENT>
              <ENT>6.65</ENT>
              <ENT>N/A</ENT>
              <ENT>3.65</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>10.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49585</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rpr umbil hern, reduc &gt; 5 yr</ENT>
              <ENT>6.23</ENT>
              <ENT>N/A</ENT>
              <ENT>3.43</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>10.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49587</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rpr umbil hern, block &gt; 5 yr</ENT>
              <ENT>7.56</ENT>
              <ENT>N/A</ENT>
              <ENT>3.83</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>12.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49590</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair spigilian hernia</ENT>
              <ENT>8.54</ENT>
              <ENT>N/A</ENT>
              <ENT>4.23</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>13.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair umbilical lesion</ENT>
              <ENT>10.96</ENT>
              <ENT>N/A</ENT>
              <ENT>5.39</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>17.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair umbilical lesion</ENT>
              <ENT>76.00</ENT>
              <ENT>N/A</ENT>
              <ENT>29.13</ENT>
              <ENT>2.57</ENT>
              <ENT>N/A</ENT>
              <ENT>107.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49606</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair umbilical lesion</ENT>
              <ENT>18.60</ENT>
              <ENT>N/A</ENT>
              <ENT>7.89</ENT>
              <ENT>2.22</ENT>
              <ENT>N/A</ENT>
              <ENT>28.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49610</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair umbilical lesion</ENT>
              <ENT>10.50</ENT>
              <ENT>N/A</ENT>
              <ENT>5.42</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>16.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49611</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair umbilical lesion</ENT>
              <ENT>8.92</ENT>
              <ENT>N/A</ENT>
              <ENT>6.51</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>16.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49650</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo hernia repair initial</ENT>
              <ENT>6.27</ENT>
              <ENT>N/A</ENT>
              <ENT>3.22</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>10.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49651</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo hernia repair recur</ENT>
              <ENT>8.24</ENT>
              <ENT>N/A</ENT>
              <ENT>4.14</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>13.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49659</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Laparo proc, hernia repair</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49900</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of abdominal wall</ENT>
              <ENT>12.28</ENT>
              <ENT>N/A</ENT>
              <ENT>6.35</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>19.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49904</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Omental flap, extra-abdom</ENT>
              <ENT>20.00</ENT>
              <ENT>N/A</ENT>
              <ENT>15.88</ENT>
              <ENT>1.91</ENT>
              <ENT>N/A</ENT>
              <ENT>37.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49905</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Omental flap, intra-abdom</ENT>
              <ENT>6.55</ENT>
              <ENT>N/A</ENT>
              <ENT>2.33</ENT>
              <ENT>0.61</ENT>
              <ENT>N/A</ENT>
              <ENT>9.49</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49906</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Free omental flap, microvasc</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">49999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Abdomen surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of kidney</ENT>
              <ENT>10.98</ENT>
              <ENT>N/A</ENT>
              <ENT>5.69</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>17.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Renal abscess, open drain</ENT>
              <ENT>14.66</ENT>
              <ENT>N/A</ENT>
              <ENT>9.32</ENT>
              <ENT>0.80</ENT>
              <ENT>N/A</ENT>
              <ENT>24.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50021</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Renal abscess, percut drain</ENT>
              <ENT>3.38</ENT>
              <ENT>N/A</ENT>
              <ENT>1.45</ENT>
              <ENT>0.15</ENT>
              <ENT>N/A</ENT>
              <ENT>4.98</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50040</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of kidney</ENT>
              <ENT>14.94</ENT>
              <ENT>N/A</ENT>
              <ENT>8.84</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>24.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50045</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of kidney</ENT>
              <ENT>15.46</ENT>
              <ENT>N/A</ENT>
              <ENT>7.12</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>23.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50060</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of kidney stone</ENT>
              <ENT>19.30</ENT>
              <ENT>N/A</ENT>
              <ENT>8.41</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>28.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50065</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of kidney</ENT>
              <ENT>20.79</ENT>
              <ENT>N/A</ENT>
              <ENT>6.40</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>28.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50070</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of kidney</ENT>
              <ENT>20.32</ENT>
              <ENT>N/A</ENT>
              <ENT>8.81</ENT>
              <ENT>1.20</ENT>
              <ENT>N/A</ENT>
              <ENT>30.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50075</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of kidney stone</ENT>
              <ENT>25.34</ENT>
              <ENT>N/A</ENT>
              <ENT>10.62</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>37.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50080</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of kidney stone</ENT>
              <ENT>14.71</ENT>
              <ENT>N/A</ENT>
              <ENT>8.29</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>23.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50081</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of kidney stone</ENT>
              <ENT>21.80</ENT>
              <ENT>N/A</ENT>
              <ENT>10.79</ENT>
              <ENT>1.30</ENT>
              <ENT>N/A</ENT>
              <ENT>33.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise kidney blood vessels</ENT>
              <ENT>16.09</ENT>
              <ENT>N/A</ENT>
              <ENT>8.17</ENT>
              <ENT>1.64</ENT>
              <ENT>N/A</ENT>
              <ENT>25.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of kidney</ENT>
              <ENT>15.91</ENT>
              <ENT>N/A</ENT>
              <ENT>7.33</ENT>
              <ENT>1.04</ENT>
              <ENT>N/A</ENT>
              <ENT>24.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50125</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore and drain kidney</ENT>
              <ENT>16.52</ENT>
              <ENT>N/A</ENT>
              <ENT>7.50</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>25.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of kidney stone</ENT>
              <ENT>17.29</ENT>
              <ENT>N/A</ENT>
              <ENT>7.73</ENT>
              <ENT>1.04</ENT>
              <ENT>N/A</ENT>
              <ENT>26.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50135</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of kidney</ENT>
              <ENT>19.18</ENT>
              <ENT>N/A</ENT>
              <ENT>8.36</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>28.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of kidney</ENT>
              <ENT>2.63</ENT>
              <ENT>N/A</ENT>
              <ENT>0.92</ENT>
              <ENT>0.12</ENT>
              <ENT>N/A</ENT>
              <ENT>3.67</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50205</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of kidney</ENT>
              <ENT>11.31</ENT>
              <ENT>N/A</ENT>
              <ENT>5.47</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>17.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove kidney, open</ENT>
              <ENT>17.15</ENT>
              <ENT>N/A</ENT>
              <ENT>7.77</ENT>
              <ENT>1.16</ENT>
              <ENT>N/A</ENT>
              <ENT>26.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50225</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal kidney open, complex</ENT>
              <ENT>20.23</ENT>
              <ENT>N/A</ENT>
              <ENT>8.73</ENT>
              <ENT>1.26</ENT>
              <ENT>N/A</ENT>
              <ENT>30.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50230</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal kidney open, radical</ENT>
              <ENT>22.07</ENT>
              <ENT>N/A</ENT>
              <ENT>9.22</ENT>
              <ENT>1.35</ENT>
              <ENT>N/A</ENT>
              <ENT>32.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50234</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of kidney &amp; ureter</ENT>
              <ENT>22.40</ENT>
              <ENT>N/A</ENT>
              <ENT>9.43</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>33.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50236</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of kidney &amp; ureter</ENT>
              <ENT>24.86</ENT>
              <ENT>N/A</ENT>
              <ENT>11.85</ENT>
              <ENT>1.50</ENT>
              <ENT>N/A</ENT>
              <ENT>38.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50240</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of kidney</ENT>
              <ENT>22.00</ENT>
              <ENT>N/A</ENT>
              <ENT>10.92</ENT>
              <ENT>1.36</ENT>
              <ENT>N/A</ENT>
              <ENT>34.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50280</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of kidney lesion</ENT>
              <ENT>15.67</ENT>
              <ENT>N/A</ENT>
              <ENT>7.22</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>23.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50290</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of kidney lesion</ENT>
              <ENT>14.73</ENT>
              <ENT>N/A</ENT>
              <ENT>6.92</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>22.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of donor kidney</ENT>
              <ENT>22.21</ENT>
              <ENT>N/A</ENT>
              <ENT>9.47</ENT>
              <ENT>1.78</ENT>
              <ENT>N/A</ENT>
              <ENT>33.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50340</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of kidney</ENT>
              <ENT>12.15</ENT>
              <ENT>N/A</ENT>
              <ENT>7.14</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>20.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50360</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transplantation of kidney</ENT>
              <ENT>31.53</ENT>
              <ENT>N/A</ENT>
              <ENT>14.85</ENT>
              <ENT>2.97</ENT>
              <ENT>N/A</ENT>
              <ENT>49.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50365</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transplantation of kidney</ENT>
              <ENT>36.81</ENT>
              <ENT>N/A</ENT>
              <ENT>17.60</ENT>
              <ENT>3.51</ENT>
              <ENT>N/A</ENT>
              <ENT>57.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50370</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove transplanted kidney</ENT>
              <ENT>13.72</ENT>
              <ENT>N/A</ENT>
              <ENT>7.75</ENT>
              <ENT>1.26</ENT>
              <ENT>N/A</ENT>
              <ENT>22.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50380</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reimplantation of kidney</ENT>
              <ENT>20.76</ENT>
              <ENT>N/A</ENT>
              <ENT>12.31</ENT>
              <ENT>1.80</ENT>
              <ENT>N/A</ENT>
              <ENT>34.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50390</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of kidney lesion</ENT>
              <ENT>1.96</ENT>
              <ENT>N/A</ENT>
              <ENT>0.65</ENT>
              <ENT>0.09</ENT>
              <ENT>N/A</ENT>
              <ENT>2.70</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50392</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert kidney drain</ENT>
              <ENT>3.38</ENT>
              <ENT>N/A</ENT>
              <ENT>1.12</ENT>
              <ENT>0.15</ENT>
              <ENT>N/A</ENT>
              <ENT>4.65</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50393</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert ureteral tube</ENT>
              <ENT>4.16</ENT>
              <ENT>N/A</ENT>
              <ENT>1.38</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>5.72</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49143"/>
              <ENT I="01">50394</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection for kidney x-ray</ENT>
              <ENT>0.76</ENT>
              <ENT>2.52</ENT>
              <ENT>0.25</ENT>
              <ENT>0.04</ENT>
              <ENT>3.32</ENT>
              <ENT>1.05</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50395</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Create passage to kidney</ENT>
              <ENT>3.38</ENT>
              <ENT>N/A</ENT>
              <ENT>1.12</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>4.66</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50396</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Measure kidney pressure</ENT>
              <ENT>2.09</ENT>
              <ENT>N/A</ENT>
              <ENT>0.87</ENT>
              <ENT>0.10</ENT>
              <ENT>N/A</ENT>
              <ENT>3.06</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50398</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Change kidney tube</ENT>
              <ENT>1.46</ENT>
              <ENT>1.21</ENT>
              <ENT>0.49</ENT>
              <ENT>0.07</ENT>
              <ENT>2.74</ENT>
              <ENT>2.02</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of kidney/ureter</ENT>
              <ENT>19.50</ENT>
              <ENT>N/A</ENT>
              <ENT>8.46</ENT>
              <ENT>1.21</ENT>
              <ENT>N/A</ENT>
              <ENT>29.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50405</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of kidney/ureter</ENT>
              <ENT>23.93</ENT>
              <ENT>N/A</ENT>
              <ENT>10.80</ENT>
              <ENT>1.45</ENT>
              <ENT>N/A</ENT>
              <ENT>36.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of kidney wound</ENT>
              <ENT>19.57</ENT>
              <ENT>N/A</ENT>
              <ENT>9.01</ENT>
              <ENT>1.45</ENT>
              <ENT>N/A</ENT>
              <ENT>30.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Close kidney-skin fistula</ENT>
              <ENT>17.23</ENT>
              <ENT>N/A</ENT>
              <ENT>9.11</ENT>
              <ENT>1.26</ENT>
              <ENT>N/A</ENT>
              <ENT>27.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50525</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair renal-abdomen fistula</ENT>
              <ENT>22.27</ENT>
              <ENT>N/A</ENT>
              <ENT>10.50</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>34.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50526</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair renal-abdomen fistula</ENT>
              <ENT>24.02</ENT>
              <ENT>N/A</ENT>
              <ENT>11.18</ENT>
              <ENT>1.62</ENT>
              <ENT>N/A</ENT>
              <ENT>36.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50540</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of horseshoe kidney</ENT>
              <ENT>19.93</ENT>
              <ENT>N/A</ENT>
              <ENT>8.83</ENT>
              <ENT>1.28</ENT>
              <ENT>N/A</ENT>
              <ENT>30.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50541</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo ablate renal cyst</ENT>
              <ENT>16.00</ENT>
              <ENT>N/A</ENT>
              <ENT>6.55</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>23.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50542</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo ablate renal mass</ENT>
              <ENT>20.00</ENT>
              <ENT>N/A</ENT>
              <ENT>8.32</ENT>
              <ENT>1.36</ENT>
              <ENT>N/A</ENT>
              <ENT>29.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50543</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo partial nephrectomy</ENT>
              <ENT>25.50</ENT>
              <ENT>N/A</ENT>
              <ENT>10.50</ENT>
              <ENT>1.36</ENT>
              <ENT>N/A</ENT>
              <ENT>37.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50544</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy, pyeloplasty</ENT>
              <ENT>22.40</ENT>
              <ENT>N/A</ENT>
              <ENT>8.66</ENT>
              <ENT>1.41</ENT>
              <ENT>N/A</ENT>
              <ENT>32.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50545</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo radical nephrectomy</ENT>
              <ENT>24.00</ENT>
              <ENT>N/A</ENT>
              <ENT>9.44</ENT>
              <ENT>1.53</ENT>
              <ENT>N/A</ENT>
              <ENT>34.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50546</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopic nephrectomy</ENT>
              <ENT>20.48</ENT>
              <ENT>N/A</ENT>
              <ENT>8.40</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>30.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50547</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo removal donor kidney</ENT>
              <ENT>25.50</ENT>
              <ENT>N/A</ENT>
              <ENT>10.33</ENT>
              <ENT>2.04</ENT>
              <ENT>N/A</ENT>
              <ENT>37.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50548</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo remove k/ureter</ENT>
              <ENT>24.40</ENT>
              <ENT>N/A</ENT>
              <ENT>9.30</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>35.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50549</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Laparoscope proc, renal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50551</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Kidney endoscopy</ENT>
              <ENT>5.60</ENT>
              <ENT>5.03</ENT>
              <ENT>1.83</ENT>
              <ENT>0.33</ENT>
              <ENT>10.96</ENT>
              <ENT>7.76</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50553</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Kidney endoscopy</ENT>
              <ENT>5.99</ENT>
              <ENT>18.93</ENT>
              <ENT>1.99</ENT>
              <ENT>0.35</ENT>
              <ENT>25.27</ENT>
              <ENT>8.33</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50555</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Kidney endoscopy &amp; biopsy</ENT>
              <ENT>6.53</ENT>
              <ENT>19.59</ENT>
              <ENT>2.16</ENT>
              <ENT>0.38</ENT>
              <ENT>26.50</ENT>
              <ENT>9.07</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50557</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Kidney endoscopy &amp; treatment</ENT>
              <ENT>6.62</ENT>
              <ENT>20.38</ENT>
              <ENT>2.17</ENT>
              <ENT>0.39</ENT>
              <ENT>27.39</ENT>
              <ENT>9.18</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50559</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Renal endoscopy/radiotracer</ENT>
              <ENT>6.78</ENT>
              <ENT>N/A</ENT>
              <ENT>2.24</ENT>
              <ENT>0.27</ENT>
              <ENT>N/A</ENT>
              <ENT>9.29</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50561</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Kidney endoscopy &amp; treatment</ENT>
              <ENT>7.59</ENT>
              <ENT>18.03</ENT>
              <ENT>2.49</ENT>
              <ENT>0.44</ENT>
              <ENT>26.06</ENT>
              <ENT>10.52</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50562</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Renal scope w/tumor resect</ENT>
              <ENT>10.92</ENT>
              <ENT>N/A</ENT>
              <ENT>3.93</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>15.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50570</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Kidney endoscopy</ENT>
              <ENT>9.54</ENT>
              <ENT>N/A</ENT>
              <ENT>3.12</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>13.22</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50572</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Kidney endoscopy</ENT>
              <ENT>10.35</ENT>
              <ENT>N/A</ENT>
              <ENT>3.39</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>14.38</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50574</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Kidney endoscopy &amp; biopsy</ENT>
              <ENT>11.02</ENT>
              <ENT>N/A</ENT>
              <ENT>3.62</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>15.29</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50575</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Kidney endoscopy</ENT>
              <ENT>13.98</ENT>
              <ENT>N/A</ENT>
              <ENT>4.58</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>19.40</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50576</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Kidney endoscopy &amp; treatment</ENT>
              <ENT>10.99</ENT>
              <ENT>N/A</ENT>
              <ENT>3.59</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>15.24</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50578</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Renal endoscopy/radiotracer</ENT>
              <ENT>11.35</ENT>
              <ENT>N/A</ENT>
              <ENT>3.71</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>15.73</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50580</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Kidney endoscopy &amp; treatment</ENT>
              <ENT>11.86</ENT>
              <ENT>N/A</ENT>
              <ENT>3.88</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>16.44</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50590</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fragmenting of kidney stone</ENT>
              <ENT>9.09</ENT>
              <ENT>10.52</ENT>
              <ENT>4.93</ENT>
              <ENT>0.54</ENT>
              <ENT>20.15</ENT>
              <ENT>14.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of ureter</ENT>
              <ENT>15.84</ENT>
              <ENT>N/A</ENT>
              <ENT>7.33</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>24.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert ureteral support</ENT>
              <ENT>15.46</ENT>
              <ENT>N/A</ENT>
              <ENT>7.31</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>23.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50610</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of ureter stone</ENT>
              <ENT>15.92</ENT>
              <ENT>N/A</ENT>
              <ENT>7.60</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>24.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50620</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of ureter stone</ENT>
              <ENT>15.16</ENT>
              <ENT>N/A</ENT>
              <ENT>6.97</ENT>
              <ENT>0.91</ENT>
              <ENT>N/A</ENT>
              <ENT>23.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50630</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of ureter stone</ENT>
              <ENT>14.94</ENT>
              <ENT>N/A</ENT>
              <ENT>6.90</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>22.74</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50650</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of ureter</ENT>
              <ENT>17.41</ENT>
              <ENT>N/A</ENT>
              <ENT>7.87</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>26.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50660</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of ureter</ENT>
              <ENT>19.55</ENT>
              <ENT>N/A</ENT>
              <ENT>8.61</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>29.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50684</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection for ureter x-ray</ENT>
              <ENT>0.76</ENT>
              <ENT>10.78</ENT>
              <ENT>0.25</ENT>
              <ENT>0.04</ENT>
              <ENT>11.58</ENT>
              <ENT>1.05</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50686</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Measure ureter pressure</ENT>
              <ENT>1.51</ENT>
              <ENT>4.66</ENT>
              <ENT>0.66</ENT>
              <ENT>0.09</ENT>
              <ENT>6.26</ENT>
              <ENT>2.26</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50688</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Change of ureter tube</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>1.72</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>2.95</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50690</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection for ureter x-ray</ENT>
              <ENT>1.16</ENT>
              <ENT>10.98</ENT>
              <ENT>0.38</ENT>
              <ENT>0.06</ENT>
              <ENT>12.20</ENT>
              <ENT>1.60</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of ureter</ENT>
              <ENT>15.21</ENT>
              <ENT>N/A</ENT>
              <ENT>7.59</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>23.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50715</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release of ureter</ENT>
              <ENT>18.90</ENT>
              <ENT>N/A</ENT>
              <ENT>9.55</ENT>
              <ENT>1.68</ENT>
              <ENT>N/A</ENT>
              <ENT>30.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50722</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release of ureter</ENT>
              <ENT>16.35</ENT>
              <ENT>N/A</ENT>
              <ENT>8.38</ENT>
              <ENT>1.41</ENT>
              <ENT>N/A</ENT>
              <ENT>26.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50725</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release/revise ureter</ENT>
              <ENT>18.49</ENT>
              <ENT>N/A</ENT>
              <ENT>8.73</ENT>
              <ENT>1.44</ENT>
              <ENT>N/A</ENT>
              <ENT>28.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49144"/>
              <ENT I="01">50727</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise ureter</ENT>
              <ENT>8.18</ENT>
              <ENT>N/A</ENT>
              <ENT>5.44</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>14.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50728</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise ureter</ENT>
              <ENT>12.02</ENT>
              <ENT>N/A</ENT>
              <ENT>6.96</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>19.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50740</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of ureter &amp; kidney</ENT>
              <ENT>18.42</ENT>
              <ENT>N/A</ENT>
              <ENT>8.27</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>28.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50750</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of ureter &amp; kidney</ENT>
              <ENT>19.51</ENT>
              <ENT>N/A</ENT>
              <ENT>8.66</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>29.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50760</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of ureters</ENT>
              <ENT>18.42</ENT>
              <ENT>N/A</ENT>
              <ENT>8.30</ENT>
              <ENT>1.25</ENT>
              <ENT>N/A</ENT>
              <ENT>27.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50770</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Splicing of ureters</ENT>
              <ENT>19.51</ENT>
              <ENT>N/A</ENT>
              <ENT>8.62</ENT>
              <ENT>1.25</ENT>
              <ENT>N/A</ENT>
              <ENT>29.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50780</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reimplant ureter in bladder</ENT>
              <ENT>18.36</ENT>
              <ENT>N/A</ENT>
              <ENT>8.22</ENT>
              <ENT>1.20</ENT>
              <ENT>N/A</ENT>
              <ENT>27.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50782</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reimplant ureter in bladder</ENT>
              <ENT>19.54</ENT>
              <ENT>N/A</ENT>
              <ENT>9.91</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>30.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50783</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reimplant ureter in bladder</ENT>
              <ENT>20.55</ENT>
              <ENT>N/A</ENT>
              <ENT>9.67</ENT>
              <ENT>1.35</ENT>
              <ENT>N/A</ENT>
              <ENT>31.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50785</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reimplant ureter in bladder</ENT>
              <ENT>20.52</ENT>
              <ENT>N/A</ENT>
              <ENT>8.96</ENT>
              <ENT>1.30</ENT>
              <ENT>N/A</ENT>
              <ENT>30.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant ureter in bowel</ENT>
              <ENT>14.52</ENT>
              <ENT>N/A</ENT>
              <ENT>7.34</ENT>
              <ENT>0.92</ENT>
              <ENT>N/A</ENT>
              <ENT>22.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50810</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of ureter &amp; bowel</ENT>
              <ENT>20.05</ENT>
              <ENT>N/A</ENT>
              <ENT>9.89</ENT>
              <ENT>1.78</ENT>
              <ENT>N/A</ENT>
              <ENT>31.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50815</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Urine shunt to intestine</ENT>
              <ENT>19.93</ENT>
              <ENT>N/A</ENT>
              <ENT>9.34</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>30.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Construct bowel bladder</ENT>
              <ENT>21.89</ENT>
              <ENT>N/A</ENT>
              <ENT>9.50</ENT>
              <ENT>1.38</ENT>
              <ENT>N/A</ENT>
              <ENT>32.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50825</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Construct bowel bladder</ENT>
              <ENT>28.18</ENT>
              <ENT>N/A</ENT>
              <ENT>12.20</ENT>
              <ENT>1.81</ENT>
              <ENT>N/A</ENT>
              <ENT>42.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50830</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise urine flow</ENT>
              <ENT>31.28</ENT>
              <ENT>N/A</ENT>
              <ENT>13.12</ENT>
              <ENT>2.20</ENT>
              <ENT>N/A</ENT>
              <ENT>46.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50840</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replace ureter by bowel</ENT>
              <ENT>20.00</ENT>
              <ENT>N/A</ENT>
              <ENT>9.32</ENT>
              <ENT>1.26</ENT>
              <ENT>N/A</ENT>
              <ENT>30.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50845</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Appendico-vesicostomy</ENT>
              <ENT>20.89</ENT>
              <ENT>N/A</ENT>
              <ENT>9.08</ENT>
              <ENT>1.26</ENT>
              <ENT>N/A</ENT>
              <ENT>31.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50860</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transplant ureter to skin</ENT>
              <ENT>15.36</ENT>
              <ENT>N/A</ENT>
              <ENT>7.23</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>23.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50900</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of ureter</ENT>
              <ENT>13.62</ENT>
              <ENT>N/A</ENT>
              <ENT>6.66</ENT>
              <ENT>0.98</ENT>
              <ENT>N/A</ENT>
              <ENT>21.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50920</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Closure ureter/skin fistula</ENT>
              <ENT>14.33</ENT>
              <ENT>N/A</ENT>
              <ENT>7.09</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>22.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50930</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Closure ureter/bowel fistula</ENT>
              <ENT>18.72</ENT>
              <ENT>N/A</ENT>
              <ENT>8.53</ENT>
              <ENT>1.57</ENT>
              <ENT>N/A</ENT>
              <ENT>28.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50940</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release of ureter</ENT>
              <ENT>14.51</ENT>
              <ENT>N/A</ENT>
              <ENT>6.96</ENT>
              <ENT>1.04</ENT>
              <ENT>N/A</ENT>
              <ENT>22.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50945</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy ureterolithotomy</ENT>
              <ENT>17.00</ENT>
              <ENT>N/A</ENT>
              <ENT>7.11</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>25.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50947</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo new ureter/bladder</ENT>
              <ENT>24.50</ENT>
              <ENT>N/A</ENT>
              <ENT>10.14</ENT>
              <ENT>1.99</ENT>
              <ENT>N/A</ENT>
              <ENT>36.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50948</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo new ureter/bladder</ENT>
              <ENT>22.50</ENT>
              <ENT>N/A</ENT>
              <ENT>9.11</ENT>
              <ENT>1.83</ENT>
              <ENT>N/A</ENT>
              <ENT>33.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50949</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Laparoscope proc, ureter</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50951</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endoscopy of ureter</ENT>
              <ENT>5.84</ENT>
              <ENT>5.45</ENT>
              <ENT>1.91</ENT>
              <ENT>0.35</ENT>
              <ENT>11.64</ENT>
              <ENT>8.10</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50953</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endoscopy of ureter</ENT>
              <ENT>6.24</ENT>
              <ENT>18.93</ENT>
              <ENT>2.05</ENT>
              <ENT>0.37</ENT>
              <ENT>25.54</ENT>
              <ENT>8.66</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50955</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ureter endoscopy &amp; biopsy</ENT>
              <ENT>6.75</ENT>
              <ENT>19.81</ENT>
              <ENT>2.25</ENT>
              <ENT>0.38</ENT>
              <ENT>26.94</ENT>
              <ENT>9.38</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50957</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ureter endoscopy &amp; treatment</ENT>
              <ENT>6.79</ENT>
              <ENT>18.54</ENT>
              <ENT>2.23</ENT>
              <ENT>0.40</ENT>
              <ENT>25.73</ENT>
              <ENT>9.42</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50959</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ureter endoscopy &amp; tracer</ENT>
              <ENT>4.40</ENT>
              <ENT>N/A</ENT>
              <ENT>1.40</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>5.98</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50961</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ureter endoscopy &amp; treatment</ENT>
              <ENT>6.05</ENT>
              <ENT>25.86</ENT>
              <ENT>1.98</ENT>
              <ENT>0.35</ENT>
              <ENT>32.26</ENT>
              <ENT>8.38</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50970</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ureter endoscopy</ENT>
              <ENT>7.14</ENT>
              <ENT>N/A</ENT>
              <ENT>2.35</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>9.92</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50972</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ureter endoscopy &amp; catheter</ENT>
              <ENT>6.89</ENT>
              <ENT>N/A</ENT>
              <ENT>2.31</ENT>
              <ENT>0.39</ENT>
              <ENT>N/A</ENT>
              <ENT>9.59</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50974</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ureter endoscopy &amp; biopsy</ENT>
              <ENT>9.17</ENT>
              <ENT>N/A</ENT>
              <ENT>2.99</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>12.69</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50976</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ureter endoscopy &amp; treatment</ENT>
              <ENT>9.04</ENT>
              <ENT>N/A</ENT>
              <ENT>2.97</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>12.54</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50978</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ureter endoscopy &amp; tracer</ENT>
              <ENT>5.10</ENT>
              <ENT>N/A</ENT>
              <ENT>1.73</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>7.13</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">50980</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ureter endoscopy &amp; treatment</ENT>
              <ENT>6.85</ENT>
              <ENT>N/A</ENT>
              <ENT>2.25</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>9.51</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of bladder</ENT>
              <ENT>0.78</ENT>
              <ENT>2.03</ENT>
              <ENT>0.24</ENT>
              <ENT>0.05</ENT>
              <ENT>2.86</ENT>
              <ENT>1.07</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51005</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of bladder</ENT>
              <ENT>1.02</ENT>
              <ENT>3.41</ENT>
              <ENT>0.34</ENT>
              <ENT>0.08</ENT>
              <ENT>4.51</ENT>
              <ENT>1.44</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of bladder</ENT>
              <ENT>3.53</ENT>
              <ENT>5.88</ENT>
              <ENT>1.94</ENT>
              <ENT>0.23</ENT>
              <ENT>9.64</ENT>
              <ENT>5.70</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise &amp; treat bladder</ENT>
              <ENT>6.71</ENT>
              <ENT>N/A</ENT>
              <ENT>4.27</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>11.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51030</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise &amp; treat bladder</ENT>
              <ENT>6.77</ENT>
              <ENT>N/A</ENT>
              <ENT>4.37</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>11.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51040</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise &amp; drain bladder</ENT>
              <ENT>4.40</ENT>
              <ENT>N/A</ENT>
              <ENT>3.12</ENT>
              <ENT>0.27</ENT>
              <ENT>N/A</ENT>
              <ENT>7.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51045</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise bladder/drain ureter</ENT>
              <ENT>6.77</ENT>
              <ENT>N/A</ENT>
              <ENT>4.33</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>11.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51050</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of bladder stone</ENT>
              <ENT>6.92</ENT>
              <ENT>N/A</ENT>
              <ENT>4.01</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>11.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51060</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of ureter stone</ENT>
              <ENT>8.85</ENT>
              <ENT>N/A</ENT>
              <ENT>4.93</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>14.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51065</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove ureter calculus</ENT>
              <ENT>8.85</ENT>
              <ENT>N/A</ENT>
              <ENT>4.77</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>14.15</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51080</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of bladder abscess</ENT>
              <ENT>5.96</ENT>
              <ENT>N/A</ENT>
              <ENT>3.97</ENT>
              <ENT>0.35</ENT>
              <ENT>N/A</ENT>
              <ENT>10.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of bladder cyst</ENT>
              <ENT>10.14</ENT>
              <ENT>N/A</ENT>
              <ENT>5.24</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>16.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of bladder lesion</ENT>
              <ENT>9.29</ENT>
              <ENT>N/A</ENT>
              <ENT>5.10</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>14.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49145"/>
              <ENT I="01">51525</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of bladder lesion</ENT>
              <ENT>13.97</ENT>
              <ENT>N/A</ENT>
              <ENT>6.59</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>21.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of bladder lesion</ENT>
              <ENT>12.38</ENT>
              <ENT>N/A</ENT>
              <ENT>6.18</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>19.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51535</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of ureter lesion</ENT>
              <ENT>12.57</ENT>
              <ENT>N/A</ENT>
              <ENT>6.56</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>20.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51550</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of bladder</ENT>
              <ENT>15.66</ENT>
              <ENT>N/A</ENT>
              <ENT>7.17</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>23.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51555</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of bladder</ENT>
              <ENT>21.23</ENT>
              <ENT>N/A</ENT>
              <ENT>9.18</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>31.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51565</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise bladder &amp; ureter(s)</ENT>
              <ENT>21.62</ENT>
              <ENT>N/A</ENT>
              <ENT>9.51</ENT>
              <ENT>1.40</ENT>
              <ENT>N/A</ENT>
              <ENT>32.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51570</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of bladder</ENT>
              <ENT>24.24</ENT>
              <ENT>N/A</ENT>
              <ENT>10.35</ENT>
              <ENT>1.59</ENT>
              <ENT>N/A</ENT>
              <ENT>36.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51575</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of bladder &amp; nodes</ENT>
              <ENT>30.45</ENT>
              <ENT>N/A</ENT>
              <ENT>12.71</ENT>
              <ENT>1.88</ENT>
              <ENT>N/A</ENT>
              <ENT>45.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51580</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove bladder/revise tract</ENT>
              <ENT>31.08</ENT>
              <ENT>N/A</ENT>
              <ENT>13.17</ENT>
              <ENT>1.94</ENT>
              <ENT>N/A</ENT>
              <ENT>46.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51585</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of bladder &amp; nodes</ENT>
              <ENT>35.23</ENT>
              <ENT>N/A</ENT>
              <ENT>14.42</ENT>
              <ENT>2.18</ENT>
              <ENT>N/A</ENT>
              <ENT>51.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51590</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove bladder/revise tract</ENT>
              <ENT>32.66</ENT>
              <ENT>N/A</ENT>
              <ENT>13.30</ENT>
              <ENT>2.01</ENT>
              <ENT>N/A</ENT>
              <ENT>47.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51595</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove bladder/revise tract</ENT>
              <ENT>37.14</ENT>
              <ENT>N/A</ENT>
              <ENT>14.86</ENT>
              <ENT>2.23</ENT>
              <ENT>N/A</ENT>
              <ENT>54.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51596</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove bladder/create pouch</ENT>
              <ENT>39.52</ENT>
              <ENT>N/A</ENT>
              <ENT>16.01</ENT>
              <ENT>2.39</ENT>
              <ENT>N/A</ENT>
              <ENT>57.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51597</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of pelvic structures</ENT>
              <ENT>38.35</ENT>
              <ENT>N/A</ENT>
              <ENT>15.57</ENT>
              <ENT>2.49</ENT>
              <ENT>N/A</ENT>
              <ENT>56.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection for bladder x-ray</ENT>
              <ENT>0.88</ENT>
              <ENT>5.84</ENT>
              <ENT>0.29</ENT>
              <ENT>0.04</ENT>
              <ENT>6.76</ENT>
              <ENT>1.21</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Preparation for bladder xray</ENT>
              <ENT>0.64</ENT>
              <ENT>6.11</ENT>
              <ENT>0.35</ENT>
              <ENT>0.04</ENT>
              <ENT>6.79</ENT>
              <ENT>1.03</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51610</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection for bladder x-ray</ENT>
              <ENT>1.05</ENT>
              <ENT>1.71</ENT>
              <ENT>0.61</ENT>
              <ENT>0.05</ENT>
              <ENT>2.81</ENT>
              <ENT>1.71</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Irrigation of bladder</ENT>
              <ENT>0.88</ENT>
              <ENT>1.69</ENT>
              <ENT>0.29</ENT>
              <ENT>0.05</ENT>
              <ENT>2.62</ENT>
              <ENT>1.22</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51701</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert bladder catheter</ENT>
              <ENT>0.50</ENT>
              <ENT>1.68</ENT>
              <ENT>0.19</ENT>
              <ENT>0.03</ENT>
              <ENT>2.21</ENT>
              <ENT>0.72</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51702</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert temp bladder cath</ENT>
              <ENT>0.50</ENT>
              <ENT>2.39</ENT>
              <ENT>0.26</ENT>
              <ENT>0.03</ENT>
              <ENT>2.92</ENT>
              <ENT>0.79</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51703</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert bladder cath, complex</ENT>
              <ENT>1.47</ENT>
              <ENT>3.11</ENT>
              <ENT>0.58</ENT>
              <ENT>0.09</ENT>
              <ENT>4.67</ENT>
              <ENT>2.14</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51705</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Change of bladder tube</ENT>
              <ENT>1.02</ENT>
              <ENT>2.39</ENT>
              <ENT>0.63</ENT>
              <ENT>0.06</ENT>
              <ENT>3.47</ENT>
              <ENT>1.71</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51710</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Change of bladder tube</ENT>
              <ENT>1.49</ENT>
              <ENT>3.51</ENT>
              <ENT>0.79</ENT>
              <ENT>0.09</ENT>
              <ENT>5.09</ENT>
              <ENT>2.37</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51715</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endoscopic injection/implant</ENT>
              <ENT>3.74</ENT>
              <ENT>4.09</ENT>
              <ENT>1.39</ENT>
              <ENT>0.24</ENT>
              <ENT>8.07</ENT>
              <ENT>5.37</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51720</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of bladder lesion</ENT>
              <ENT>1.96</ENT>
              <ENT>1.82</ENT>
              <ENT>0.72</ENT>
              <ENT>0.12</ENT>
              <ENT>3.90</ENT>
              <ENT>2.80</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51725</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Simple cystometrogram</ENT>
              <ENT>1.51</ENT>
              <ENT>5.90</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>7.54</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51725</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Simple cystometrogram</ENT>
              <ENT>1.51</ENT>
              <ENT>0.51</ENT>
              <ENT>0.51</ENT>
              <ENT>0.10</ENT>
              <ENT>2.12</ENT>
              <ENT>2.12</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51725</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Simple cystometrogram</ENT>
              <ENT>0.00</ENT>
              <ENT>5.40</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>5.43</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51726</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Complex cystometrogram</ENT>
              <ENT>1.71</ENT>
              <ENT>7.93</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>9.79</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51726</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Complex cystometrogram</ENT>
              <ENT>1.71</ENT>
              <ENT>0.57</ENT>
              <ENT>0.57</ENT>
              <ENT>0.11</ENT>
              <ENT>2.39</ENT>
              <ENT>2.39</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51726</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Complex cystometrogram</ENT>
              <ENT>0.00</ENT>
              <ENT>7.36</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>7.40</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51736</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Urine flow measurement</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.27</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51736</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Urine flow measurement</ENT>
              <ENT>0.61</ENT>
              <ENT>0.20</ENT>
              <ENT>0.20</ENT>
              <ENT>0.04</ENT>
              <ENT>0.85</ENT>
              <ENT>0.85</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51736</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Urine flow measurement</ENT>
              <ENT>0.00</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51741</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Electro-uroflowmetry, first</ENT>
              <ENT>1.14</ENT>
              <ENT>0.83</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.06</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51741</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Electro-uroflowmetry, first</ENT>
              <ENT>1.14</ENT>
              <ENT>0.38</ENT>
              <ENT>0.38</ENT>
              <ENT>0.07</ENT>
              <ENT>1.59</ENT>
              <ENT>1.59</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51741</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Electro-uroflowmetry, first</ENT>
              <ENT>0.00</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51772</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Urethra pressure profile</ENT>
              <ENT>1.61</ENT>
              <ENT>5.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.16</ENT>
              <ENT>7.66</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51772</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Urethra pressure profile</ENT>
              <ENT>1.61</ENT>
              <ENT>0.56</ENT>
              <ENT>0.56</ENT>
              <ENT>0.12</ENT>
              <ENT>2.29</ENT>
              <ENT>2.29</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51772</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Urethra pressure profile</ENT>
              <ENT>0.00</ENT>
              <ENT>5.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>5.37</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51784</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Anal/urinary muscle study</ENT>
              <ENT>1.53</ENT>
              <ENT>4.18</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>5.84</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51784</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Anal/urinary muscle study</ENT>
              <ENT>1.53</ENT>
              <ENT>0.52</ENT>
              <ENT>0.52</ENT>
              <ENT>0.10</ENT>
              <ENT>2.15</ENT>
              <ENT>2.15</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51784</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Anal/urinary muscle study</ENT>
              <ENT>0.00</ENT>
              <ENT>3.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>3.69</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51785</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Anal/urinary muscle study</ENT>
              <ENT>1.53</ENT>
              <ENT>4.69</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>6.34</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51785</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Anal/urinary muscle study</ENT>
              <ENT>1.53</ENT>
              <ENT>0.51</ENT>
              <ENT>0.51</ENT>
              <ENT>0.09</ENT>
              <ENT>2.13</ENT>
              <ENT>2.13</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51785</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Anal/urinary muscle study</ENT>
              <ENT>0.00</ENT>
              <ENT>4.17</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>4.20</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51792</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Urinary reflex study</ENT>
              <ENT>1.10</ENT>
              <ENT>6.13</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>7.43</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51792</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Urinary reflex study</ENT>
              <ENT>1.10</ENT>
              <ENT>0.42</ENT>
              <ENT>0.42</ENT>
              <ENT>0.09</ENT>
              <ENT>1.61</ENT>
              <ENT>1.61</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51792</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Urinary reflex study</ENT>
              <ENT>0.00</ENT>
              <ENT>5.70</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>5.81</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51795</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Urine voiding pressure study</ENT>
              <ENT>1.53</ENT>
              <ENT>7.72</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>9.43</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51795</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Urine voiding pressure study</ENT>
              <ENT>1.53</ENT>
              <ENT>0.51</ENT>
              <ENT>0.51</ENT>
              <ENT>0.10</ENT>
              <ENT>2.14</ENT>
              <ENT>2.14</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51795</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Urine voiding pressure study</ENT>
              <ENT>0.00</ENT>
              <ENT>7.20</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>7.28</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49146"/>
              <ENT I="01">51797</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intraabdominal pressure test</ENT>
              <ENT>1.60</ENT>
              <ENT>6.08</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>7.82</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51797</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Intraabdominal pressure test</ENT>
              <ENT>1.60</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>0.10</ENT>
              <ENT>2.24</ENT>
              <ENT>2.24</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51797</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Intraabdominal pressure test</ENT>
              <ENT>0.00</ENT>
              <ENT>5.54</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>5.58</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51798</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Us urine capacity measure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of bladder/urethra</ENT>
              <ENT>17.42</ENT>
              <ENT>N/A</ENT>
              <ENT>8.05</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>26.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of urinary tract</ENT>
              <ENT>17.89</ENT>
              <ENT>N/A</ENT>
              <ENT>8.71</ENT>
              <ENT>1.45</ENT>
              <ENT>N/A</ENT>
              <ENT>28.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51840</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Attach bladder/urethra</ENT>
              <ENT>10.71</ENT>
              <ENT>N/A</ENT>
              <ENT>5.66</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>17.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51841</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Attach bladder/urethra</ENT>
              <ENT>13.03</ENT>
              <ENT>N/A</ENT>
              <ENT>6.49</ENT>
              <ENT>1.04</ENT>
              <ENT>N/A</ENT>
              <ENT>20.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51845</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair bladder neck</ENT>
              <ENT>9.73</ENT>
              <ENT>N/A</ENT>
              <ENT>5.18</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>15.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51860</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of bladder wound</ENT>
              <ENT>12.02</ENT>
              <ENT>N/A</ENT>
              <ENT>6.18</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>19.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51865</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of bladder wound</ENT>
              <ENT>15.04</ENT>
              <ENT>N/A</ENT>
              <ENT>7.14</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>23.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51880</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of bladder opening</ENT>
              <ENT>7.66</ENT>
              <ENT>N/A</ENT>
              <ENT>4.35</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>12.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51900</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair bladder/vagina lesion</ENT>
              <ENT>12.97</ENT>
              <ENT>N/A</ENT>
              <ENT>6.53</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>20.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51920</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Close bladder-uterus fistula</ENT>
              <ENT>11.81</ENT>
              <ENT>N/A</ENT>
              <ENT>6.05</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>18.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51925</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hysterectomy/bladder repair</ENT>
              <ENT>15.58</ENT>
              <ENT>N/A</ENT>
              <ENT>9.02</ENT>
              <ENT>1.48</ENT>
              <ENT>N/A</ENT>
              <ENT>26.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51940</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Correction of bladder defect</ENT>
              <ENT>28.43</ENT>
              <ENT>N/A</ENT>
              <ENT>12.86</ENT>
              <ENT>1.97</ENT>
              <ENT>N/A</ENT>
              <ENT>43.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51960</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of bladder &amp; bowel</ENT>
              <ENT>23.01</ENT>
              <ENT>N/A</ENT>
              <ENT>10.37</ENT>
              <ENT>1.41</ENT>
              <ENT>N/A</ENT>
              <ENT>34.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51980</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Construct bladder opening</ENT>
              <ENT>11.36</ENT>
              <ENT>N/A</ENT>
              <ENT>5.81</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>17.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51990</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo urethral suspension</ENT>
              <ENT>12.50</ENT>
              <ENT>N/A</ENT>
              <ENT>6.23</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>19.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">51992</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo sling operation</ENT>
              <ENT>14.01</ENT>
              <ENT>N/A</ENT>
              <ENT>6.27</ENT>
              <ENT>0.93</ENT>
              <ENT>N/A</ENT>
              <ENT>21.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy</ENT>
              <ENT>2.01</ENT>
              <ENT>3.45</ENT>
              <ENT>0.78</ENT>
              <ENT>0.12</ENT>
              <ENT>5.58</ENT>
              <ENT>2.91</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52001</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy, removal of clots</ENT>
              <ENT>5.45</ENT>
              <ENT>5.28</ENT>
              <ENT>1.91</ENT>
              <ENT>0.32</ENT>
              <ENT>11.05</ENT>
              <ENT>7.68</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52005</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy &amp; ureter catheter</ENT>
              <ENT>2.37</ENT>
              <ENT>6.17</ENT>
              <ENT>0.92</ENT>
              <ENT>0.15</ENT>
              <ENT>8.69</ENT>
              <ENT>3.44</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52007</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy and biopsy</ENT>
              <ENT>3.02</ENT>
              <ENT>N/A</ENT>
              <ENT>1.18</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>4.38</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy &amp; duct catheter</ENT>
              <ENT>3.02</ENT>
              <ENT>N/A</ENT>
              <ENT>1.16</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>4.36</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52204</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy</ENT>
              <ENT>2.37</ENT>
              <ENT>3.70</ENT>
              <ENT>0.93</ENT>
              <ENT>0.15</ENT>
              <ENT>6.22</ENT>
              <ENT>3.45</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52214</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy and treatment</ENT>
              <ENT>3.71</ENT>
              <ENT>N/A</ENT>
              <ENT>1.36</ENT>
              <ENT>0.22</ENT>
              <ENT>N/A</ENT>
              <ENT>5.29</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52224</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy and treatment</ENT>
              <ENT>3.14</ENT>
              <ENT>N/A</ENT>
              <ENT>1.18</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>4.50</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52234</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy and treatment</ENT>
              <ENT>4.63</ENT>
              <ENT>N/A</ENT>
              <ENT>1.67</ENT>
              <ENT>0.27</ENT>
              <ENT>N/A</ENT>
              <ENT>6.57</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52235</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy and treatment</ENT>
              <ENT>5.45</ENT>
              <ENT>N/A</ENT>
              <ENT>1.95</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>7.72</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52240</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy and treatment</ENT>
              <ENT>9.72</ENT>
              <ENT>N/A</ENT>
              <ENT>3.37</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>13.67</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy and radiotracer</ENT>
              <ENT>4.50</ENT>
              <ENT>N/A</ENT>
              <ENT>1.70</ENT>
              <ENT>0.27</ENT>
              <ENT>N/A</ENT>
              <ENT>6.47</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52260</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy and treatment</ENT>
              <ENT>3.92</ENT>
              <ENT>N/A</ENT>
              <ENT>1.46</ENT>
              <ENT>0.23</ENT>
              <ENT>N/A</ENT>
              <ENT>5.61</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52265</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy and treatment</ENT>
              <ENT>2.94</ENT>
              <ENT>3.83</ENT>
              <ENT>1.14</ENT>
              <ENT>0.18</ENT>
              <ENT>6.95</ENT>
              <ENT>4.26</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52270</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy &amp; revise urethra</ENT>
              <ENT>3.37</ENT>
              <ENT>N/A</ENT>
              <ENT>1.28</ENT>
              <ENT>0.20</ENT>
              <ENT>N/A</ENT>
              <ENT>4.85</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52275</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy &amp; revise urethra</ENT>
              <ENT>4.70</ENT>
              <ENT>N/A</ENT>
              <ENT>1.71</ENT>
              <ENT>0.28</ENT>
              <ENT>N/A</ENT>
              <ENT>6.69</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52276</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy and treatment</ENT>
              <ENT>5.00</ENT>
              <ENT>N/A</ENT>
              <ENT>1.83</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>7.13</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52277</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy and treatment</ENT>
              <ENT>6.17</ENT>
              <ENT>N/A</ENT>
              <ENT>2.31</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>8.86</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52281</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy and treatment</ENT>
              <ENT>2.80</ENT>
              <ENT>7.56</ENT>
              <ENT>1.11</ENT>
              <ENT>0.17</ENT>
              <ENT>10.53</ENT>
              <ENT>4.08</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52282</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy, implant stent</ENT>
              <ENT>6.40</ENT>
              <ENT>N/A</ENT>
              <ENT>2.29</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>9.07</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52283</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy and treatment</ENT>
              <ENT>3.74</ENT>
              <ENT>4.11</ENT>
              <ENT>1.42</ENT>
              <ENT>0.22</ENT>
              <ENT>8.07</ENT>
              <ENT>5.38</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52285</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy and treatment</ENT>
              <ENT>3.61</ENT>
              <ENT>4.18</ENT>
              <ENT>1.37</ENT>
              <ENT>0.22</ENT>
              <ENT>8.01</ENT>
              <ENT>5.20</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52290</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy and treatment</ENT>
              <ENT>4.59</ENT>
              <ENT>N/A</ENT>
              <ENT>1.70</ENT>
              <ENT>0.27</ENT>
              <ENT>N/A</ENT>
              <ENT>6.56</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy and treatment</ENT>
              <ENT>5.31</ENT>
              <ENT>N/A</ENT>
              <ENT>1.96</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>7.59</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52301</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy and treatment</ENT>
              <ENT>5.51</ENT>
              <ENT>N/A</ENT>
              <ENT>2.04</ENT>
              <ENT>0.39</ENT>
              <ENT>N/A</ENT>
              <ENT>7.94</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52305</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy and treatment</ENT>
              <ENT>5.31</ENT>
              <ENT>N/A</ENT>
              <ENT>1.90</ENT>
              <ENT>0.31</ENT>
              <ENT>N/A</ENT>
              <ENT>7.52</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52310</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy and treatment</ENT>
              <ENT>2.81</ENT>
              <ENT>3.60</ENT>
              <ENT>1.06</ENT>
              <ENT>0.17</ENT>
              <ENT>6.58</ENT>
              <ENT>4.04</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52315</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy and treatment</ENT>
              <ENT>5.21</ENT>
              <ENT>N/A</ENT>
              <ENT>1.88</ENT>
              <ENT>0.31</ENT>
              <ENT>N/A</ENT>
              <ENT>7.40</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52317</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove bladder stone</ENT>
              <ENT>6.72</ENT>
              <ENT>N/A</ENT>
              <ENT>2.33</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>9.45</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52318</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove bladder stone</ENT>
              <ENT>9.19</ENT>
              <ENT>N/A</ENT>
              <ENT>3.17</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>12.90</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49147"/>
              <ENT I="01">52320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy and treatment</ENT>
              <ENT>4.70</ENT>
              <ENT>N/A</ENT>
              <ENT>1.68</ENT>
              <ENT>0.28</ENT>
              <ENT>N/A</ENT>
              <ENT>6.66</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52325</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy, stone removal</ENT>
              <ENT>6.16</ENT>
              <ENT>N/A</ENT>
              <ENT>2.16</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>8.69</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52327</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy, inject material</ENT>
              <ENT>5.19</ENT>
              <ENT>N/A</ENT>
              <ENT>1.87</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>7.38</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52330</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy and treatment</ENT>
              <ENT>5.04</ENT>
              <ENT>N/A</ENT>
              <ENT>1.79</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>7.13</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52332</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy and treatment</ENT>
              <ENT>2.83</ENT>
              <ENT>N/A</ENT>
              <ENT>1.08</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>4.08</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52334</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Create passage to kidney</ENT>
              <ENT>4.83</ENT>
              <ENT>N/A</ENT>
              <ENT>1.80</ENT>
              <ENT>0.28</ENT>
              <ENT>N/A</ENT>
              <ENT>6.91</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52341</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cysto w/ureter stricture tx</ENT>
              <ENT>6.00</ENT>
              <ENT>N/A</ENT>
              <ENT>2.27</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>8.64</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52342</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cysto w/up stricture tx</ENT>
              <ENT>6.50</ENT>
              <ENT>N/A</ENT>
              <ENT>2.41</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>9.31</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52343</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cysto w/renal stricture tx</ENT>
              <ENT>7.20</ENT>
              <ENT>N/A</ENT>
              <ENT>2.69</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>10.33</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52344</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cysto/uretero, stone remove</ENT>
              <ENT>7.70</ENT>
              <ENT>N/A</ENT>
              <ENT>2.87</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>11.04</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52345</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cysto/uretero w/up stricture</ENT>
              <ENT>8.20</ENT>
              <ENT>N/A</ENT>
              <ENT>3.03</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>11.73</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52346</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystouretero w/renal strict</ENT>
              <ENT>9.23</ENT>
              <ENT>N/A</ENT>
              <ENT>3.38</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>13.18</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52347</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystoscopy, resect ducts</ENT>
              <ENT>5.28</ENT>
              <ENT>N/A</ENT>
              <ENT>1.76</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>7.37</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52351</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystouretero &amp; or pyeloscope</ENT>
              <ENT>5.86</ENT>
              <ENT>N/A</ENT>
              <ENT>2.20</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>8.42</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52352</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystouretero w/stone remove</ENT>
              <ENT>6.88</ENT>
              <ENT>N/A</ENT>
              <ENT>2.57</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>9.87</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52353</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystouretero w/lithotripsy</ENT>
              <ENT>7.97</ENT>
              <ENT>N/A</ENT>
              <ENT>2.93</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>11.39</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52354</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystouretero w/biopsy</ENT>
              <ENT>7.34</ENT>
              <ENT>N/A</ENT>
              <ENT>2.74</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>10.53</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52355</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystouretero w/excise tumor</ENT>
              <ENT>8.82</ENT>
              <ENT>N/A</ENT>
              <ENT>3.22</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>12.59</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cystouretero w/congen repr</ENT>
              <ENT>9.68</ENT>
              <ENT>N/A</ENT>
              <ENT>4.06</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>14.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of prostate</ENT>
              <ENT>7.64</ENT>
              <ENT>N/A</ENT>
              <ENT>3.80</ENT>
              <ENT>0.46</ENT>
              <ENT>N/A</ENT>
              <ENT>11.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of bladder neck</ENT>
              <ENT>8.47</ENT>
              <ENT>N/A</ENT>
              <ENT>4.06</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>13.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dilation prostatic urethra</ENT>
              <ENT>6.72</ENT>
              <ENT>N/A</ENT>
              <ENT>3.31</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>10.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52601</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prostatectomy (TURP)</ENT>
              <ENT>12.37</ENT>
              <ENT>N/A</ENT>
              <ENT>5.27</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>18.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52606</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Control postop bleeding</ENT>
              <ENT>8.13</ENT>
              <ENT>N/A</ENT>
              <ENT>3.67</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>12.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52612</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prostatectomy, first stage</ENT>
              <ENT>7.98</ENT>
              <ENT>N/A</ENT>
              <ENT>3.87</ENT>
              <ENT>0.48</ENT>
              <ENT>N/A</ENT>
              <ENT>12.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52614</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prostatectomy, second stage</ENT>
              <ENT>6.84</ENT>
              <ENT>N/A</ENT>
              <ENT>3.47</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>10.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52620</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove residual prostate</ENT>
              <ENT>6.61</ENT>
              <ENT>N/A</ENT>
              <ENT>3.18</ENT>
              <ENT>0.39</ENT>
              <ENT>N/A</ENT>
              <ENT>10.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52630</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove prostate regrowth</ENT>
              <ENT>7.26</ENT>
              <ENT>N/A</ENT>
              <ENT>3.38</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>11.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52640</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Relieve bladder contracture</ENT>
              <ENT>6.62</ENT>
              <ENT>N/A</ENT>
              <ENT>3.15</ENT>
              <ENT>0.39</ENT>
              <ENT>N/A</ENT>
              <ENT>10.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52647</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laser surgery of prostate</ENT>
              <ENT>10.36</ENT>
              <ENT>33.53</ENT>
              <ENT>4.68</ENT>
              <ENT>0.61</ENT>
              <ENT>44.50</ENT>
              <ENT>15.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52648</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laser surgery of prostate</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>4.95</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>16.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">52700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of prostate abscess</ENT>
              <ENT>6.80</ENT>
              <ENT>N/A</ENT>
              <ENT>3.37</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>10.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of urethra</ENT>
              <ENT>2.28</ENT>
              <ENT>N/A</ENT>
              <ENT>1.59</ENT>
              <ENT>0.13</ENT>
              <ENT>N/A</ENT>
              <ENT>4.00</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of urethra</ENT>
              <ENT>3.64</ENT>
              <ENT>N/A</ENT>
              <ENT>3.15</ENT>
              <ENT>0.20</ENT>
              <ENT>N/A</ENT>
              <ENT>6.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of urethra</ENT>
              <ENT>1.77</ENT>
              <ENT>3.15</ENT>
              <ENT>0.69</ENT>
              <ENT>0.11</ENT>
              <ENT>5.03</ENT>
              <ENT>2.57</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53025</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of urethra</ENT>
              <ENT>1.13</ENT>
              <ENT>3.93</ENT>
              <ENT>0.52</ENT>
              <ENT>0.07</ENT>
              <ENT>5.13</ENT>
              <ENT>1.72</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53040</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of urethra abscess</ENT>
              <ENT>6.40</ENT>
              <ENT>11.79</ENT>
              <ENT>6.71</ENT>
              <ENT>0.41</ENT>
              <ENT>18.60</ENT>
              <ENT>13.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53060</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of urethra abscess</ENT>
              <ENT>2.63</ENT>
              <ENT>N/A</ENT>
              <ENT>1.49</ENT>
              <ENT>0.23</ENT>
              <ENT>N/A</ENT>
              <ENT>4.35</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53080</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of urinary leakage</ENT>
              <ENT>6.29</ENT>
              <ENT>N/A</ENT>
              <ENT>6.49</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>13.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53085</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of urinary leakage</ENT>
              <ENT>10.27</ENT>
              <ENT>N/A</ENT>
              <ENT>8.00</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>18.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of urethra</ENT>
              <ENT>2.59</ENT>
              <ENT>4.40</ENT>
              <ENT>1.00</ENT>
              <ENT>0.17</ENT>
              <ENT>7.16</ENT>
              <ENT>3.76</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53210</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of urethra</ENT>
              <ENT>12.57</ENT>
              <ENT>N/A</ENT>
              <ENT>6.41</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>19.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53215</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of urethra</ENT>
              <ENT>15.58</ENT>
              <ENT>N/A</ENT>
              <ENT>7.22</ENT>
              <ENT>0.93</ENT>
              <ENT>N/A</ENT>
              <ENT>23.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of urethra lesion</ENT>
              <ENT>7.00</ENT>
              <ENT>N/A</ENT>
              <ENT>4.24</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>11.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53230</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of urethra lesion</ENT>
              <ENT>9.58</ENT>
              <ENT>N/A</ENT>
              <ENT>5.15</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>15.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53235</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of urethra lesion</ENT>
              <ENT>10.14</ENT>
              <ENT>N/A</ENT>
              <ENT>5.34</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>16.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53240</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Surgery for urethra pouch</ENT>
              <ENT>6.45</ENT>
              <ENT>N/A</ENT>
              <ENT>4.01</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>10.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of urethra gland</ENT>
              <ENT>5.89</ENT>
              <ENT>N/A</ENT>
              <ENT>3.65</ENT>
              <ENT>0.35</ENT>
              <ENT>N/A</ENT>
              <ENT>9.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53260</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of urethra lesion</ENT>
              <ENT>2.98</ENT>
              <ENT>3.36</ENT>
              <ENT>1.84</ENT>
              <ENT>0.23</ENT>
              <ENT>6.57</ENT>
              <ENT>5.05</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49148"/>
              <ENT I="01">53265</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of urethra lesion</ENT>
              <ENT>3.12</ENT>
              <ENT>N/A</ENT>
              <ENT>1.88</ENT>
              <ENT>0.20</ENT>
              <ENT>N/A</ENT>
              <ENT>5.20</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53270</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of urethra gland</ENT>
              <ENT>3.09</ENT>
              <ENT>N/A</ENT>
              <ENT>1.92</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>5.22</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53275</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of urethra defect</ENT>
              <ENT>4.53</ENT>
              <ENT>N/A</ENT>
              <ENT>2.33</ENT>
              <ENT>0.28</ENT>
              <ENT>N/A</ENT>
              <ENT>7.14</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise urethra, stage 1</ENT>
              <ENT>12.77</ENT>
              <ENT>N/A</ENT>
              <ENT>6.52</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>20.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53405</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise urethra, stage 2</ENT>
              <ENT>14.48</ENT>
              <ENT>N/A</ENT>
              <ENT>6.90</ENT>
              <ENT>0.91</ENT>
              <ENT>N/A</ENT>
              <ENT>22.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53410</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of urethra</ENT>
              <ENT>16.44</ENT>
              <ENT>N/A</ENT>
              <ENT>7.67</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>25.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53415</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of urethra</ENT>
              <ENT>19.41</ENT>
              <ENT>N/A</ENT>
              <ENT>7.87</ENT>
              <ENT>1.16</ENT>
              <ENT>N/A</ENT>
              <ENT>28.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct urethra, stage 1</ENT>
              <ENT>14.08</ENT>
              <ENT>N/A</ENT>
              <ENT>6.84</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>21.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53425</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct urethra, stage 2</ENT>
              <ENT>15.98</ENT>
              <ENT>N/A</ENT>
              <ENT>7.50</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>24.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53430</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of urethra</ENT>
              <ENT>16.34</ENT>
              <ENT>N/A</ENT>
              <ENT>7.59</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>24.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53431</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct urethra/bladder</ENT>
              <ENT>19.89</ENT>
              <ENT>N/A</ENT>
              <ENT>8.59</ENT>
              <ENT>1.30</ENT>
              <ENT>N/A</ENT>
              <ENT>29.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53440</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Male sling procedure</ENT>
              <ENT>13.62</ENT>
              <ENT>N/A</ENT>
              <ENT>6.27</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>20.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53442</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove/revise male sling</ENT>
              <ENT>11.57</ENT>
              <ENT>N/A</ENT>
              <ENT>5.72</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>17.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53444</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert tandem cuff</ENT>
              <ENT>13.40</ENT>
              <ENT>N/A</ENT>
              <ENT>6.05</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>20.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53445</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert uro/ves nck sphincter</ENT>
              <ENT>14.06</ENT>
              <ENT>N/A</ENT>
              <ENT>7.72</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>22.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53446</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove uro sphincter</ENT>
              <ENT>10.23</ENT>
              <ENT>N/A</ENT>
              <ENT>5.40</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>16.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53447</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove/replace ur sphincter</ENT>
              <ENT>13.49</ENT>
              <ENT>N/A</ENT>
              <ENT>6.63</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>20.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53448</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remov/replc ur sphinctr comp</ENT>
              <ENT>21.15</ENT>
              <ENT>N/A</ENT>
              <ENT>9.32</ENT>
              <ENT>1.39</ENT>
              <ENT>N/A</ENT>
              <ENT>31.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53449</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair uro sphincter</ENT>
              <ENT>9.70</ENT>
              <ENT>N/A</ENT>
              <ENT>5.17</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>15.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of urethra</ENT>
              <ENT>6.14</ENT>
              <ENT>N/A</ENT>
              <ENT>3.79</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>10.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53460</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of urethra</ENT>
              <ENT>7.12</ENT>
              <ENT>N/A</ENT>
              <ENT>4.21</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>11.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53502</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of urethra injury</ENT>
              <ENT>7.63</ENT>
              <ENT>N/A</ENT>
              <ENT>4.50</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>12.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53505</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of urethra injury</ENT>
              <ENT>7.63</ENT>
              <ENT>N/A</ENT>
              <ENT>4.37</ENT>
              <ENT>0.46</ENT>
              <ENT>N/A</ENT>
              <ENT>12.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of urethra injury</ENT>
              <ENT>10.11</ENT>
              <ENT>N/A</ENT>
              <ENT>5.60</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>16.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53515</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of urethra injury</ENT>
              <ENT>13.31</ENT>
              <ENT>N/A</ENT>
              <ENT>6.38</ENT>
              <ENT>0.83</ENT>
              <ENT>N/A</ENT>
              <ENT>20.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of urethra defect</ENT>
              <ENT>8.68</ENT>
              <ENT>N/A</ENT>
              <ENT>4.91</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>14.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dilate urethra stricture</ENT>
              <ENT>1.21</ENT>
              <ENT>1.20</ENT>
              <ENT>0.45</ENT>
              <ENT>0.07</ENT>
              <ENT>2.48</ENT>
              <ENT>1.73</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53601</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dilate urethra stricture</ENT>
              <ENT>0.98</ENT>
              <ENT>1.33</ENT>
              <ENT>0.39</ENT>
              <ENT>0.06</ENT>
              <ENT>2.37</ENT>
              <ENT>1.43</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dilate urethra stricture</ENT>
              <ENT>1.28</ENT>
              <ENT>N/A</ENT>
              <ENT>0.42</ENT>
              <ENT>0.08</ENT>
              <ENT>N/A</ENT>
              <ENT>1.78</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53620</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dilate urethra stricture</ENT>
              <ENT>1.62</ENT>
              <ENT>2.09</ENT>
              <ENT>0.62</ENT>
              <ENT>0.10</ENT>
              <ENT>3.81</ENT>
              <ENT>2.34</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53621</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dilate urethra stricture</ENT>
              <ENT>1.35</ENT>
              <ENT>2.17</ENT>
              <ENT>0.51</ENT>
              <ENT>0.08</ENT>
              <ENT>3.60</ENT>
              <ENT>1.94</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53660</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dilation of urethra</ENT>
              <ENT>0.71</ENT>
              <ENT>1.38</ENT>
              <ENT>0.33</ENT>
              <ENT>0.04</ENT>
              <ENT>2.13</ENT>
              <ENT>1.08</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53661</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dilation of urethra</ENT>
              <ENT>0.72</ENT>
              <ENT>1.37</ENT>
              <ENT>0.31</ENT>
              <ENT>0.04</ENT>
              <ENT>2.13</ENT>
              <ENT>1.07</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53665</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dilation of urethra</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.26</ENT>
              <ENT>0.05</ENT>
              <ENT>N/A</ENT>
              <ENT>1.07</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53850</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prostatic microwave thermotx</ENT>
              <ENT>9.45</ENT>
              <ENT>100.81</ENT>
              <ENT>4.41</ENT>
              <ENT>0.56</ENT>
              <ENT>110.82</ENT>
              <ENT>14.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53852</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prostatic rf thermotx</ENT>
              <ENT>9.88</ENT>
              <ENT>94.95</ENT>
              <ENT>4.80</ENT>
              <ENT>0.58</ENT>
              <ENT>105.41</ENT>
              <ENT>15.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53853</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prostatic water thermother</ENT>
              <ENT>5.24</ENT>
              <ENT>58.79</ENT>
              <ENT>3.25</ENT>
              <ENT>0.27</ENT>
              <ENT>64.30</ENT>
              <ENT>8.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">53899</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Urology surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Slitting of prepuce</ENT>
              <ENT>1.54</ENT>
              <ENT>N/A</ENT>
              <ENT>1.37</ENT>
              <ENT>0.10</ENT>
              <ENT>N/A</ENT>
              <ENT>3.01</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54001</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Slitting of prepuce</ENT>
              <ENT>2.19</ENT>
              <ENT>4.39</ENT>
              <ENT>1.54</ENT>
              <ENT>0.14</ENT>
              <ENT>6.72</ENT>
              <ENT>3.87</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54015</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain penis lesion</ENT>
              <ENT>5.32</ENT>
              <ENT>N/A</ENT>
              <ENT>2.64</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>8.29</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54050</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction, penis lesion(s)</ENT>
              <ENT>1.24</ENT>
              <ENT>1.72</ENT>
              <ENT>1.07</ENT>
              <ENT>0.07</ENT>
              <ENT>3.03</ENT>
              <ENT>2.38</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54055</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction, penis lesion(s)</ENT>
              <ENT>1.22</ENT>
              <ENT>1.64</ENT>
              <ENT>0.82</ENT>
              <ENT>0.07</ENT>
              <ENT>2.93</ENT>
              <ENT>2.11</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54056</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cryosurgery, penis lesion(s)</ENT>
              <ENT>1.24</ENT>
              <ENT>2.53</ENT>
              <ENT>1.40</ENT>
              <ENT>0.06</ENT>
              <ENT>3.83</ENT>
              <ENT>2.70</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54057</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laser surg, penis lesion(s)</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>0.89</ENT>
              <ENT>0.08</ENT>
              <ENT>N/A</ENT>
              <ENT>2.21</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54060</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of penis lesion(s)</ENT>
              <ENT>1.93</ENT>
              <ENT>3.96</ENT>
              <ENT>1.48</ENT>
              <ENT>0.12</ENT>
              <ENT>6.01</ENT>
              <ENT>3.53</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54065</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction, penis lesion(s)</ENT>
              <ENT>2.42</ENT>
              <ENT>N/A</ENT>
              <ENT>1.74</ENT>
              <ENT>0.13</ENT>
              <ENT>N/A</ENT>
              <ENT>4.29</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of penis</ENT>
              <ENT>1.90</ENT>
              <ENT>2.93</ENT>
              <ENT>0.84</ENT>
              <ENT>0.10</ENT>
              <ENT>4.93</ENT>
              <ENT>2.84</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54105</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of penis</ENT>
              <ENT>3.50</ENT>
              <ENT>N/A</ENT>
              <ENT>2.01</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>5.72</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of penis lesion</ENT>
              <ENT>10.13</ENT>
              <ENT>N/A</ENT>
              <ENT>5.97</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>16.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54111</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat penis lesion, graft</ENT>
              <ENT>13.57</ENT>
              <ENT>N/A</ENT>
              <ENT>7.05</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>21.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54112</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat penis lesion, graft</ENT>
              <ENT>15.86</ENT>
              <ENT>N/A</ENT>
              <ENT>8.07</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>24.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54115</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of penis lesion</ENT>
              <ENT>6.15</ENT>
              <ENT>8.78</ENT>
              <ENT>4.66</ENT>
              <ENT>0.39</ENT>
              <ENT>15.32</ENT>
              <ENT>11.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of penis</ENT>
              <ENT>9.97</ENT>
              <ENT>N/A</ENT>
              <ENT>5.93</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>16.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49149"/>
              <ENT I="01">54125</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of penis</ENT>
              <ENT>13.53</ENT>
              <ENT>N/A</ENT>
              <ENT>7.11</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>21.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove penis &amp; nodes</ENT>
              <ENT>20.14</ENT>
              <ENT>N/A</ENT>
              <ENT>9.50</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>30.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54135</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove penis &amp; nodes</ENT>
              <ENT>26.36</ENT>
              <ENT>N/A</ENT>
              <ENT>11.54</ENT>
              <ENT>1.58</ENT>
              <ENT>N/A</ENT>
              <ENT>39.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Circumcision</ENT>
              <ENT>1.81</ENT>
              <ENT>N/A</ENT>
              <ENT>1.00</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>2.98</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54152</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Circumcision</ENT>
              <ENT>2.31</ENT>
              <ENT>N/A</ENT>
              <ENT>1.23</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>3.70</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54160</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Circumcision</ENT>
              <ENT>2.48</ENT>
              <ENT>N/A</ENT>
              <ENT>1.13</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>3.77</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54161</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Circumcision</ENT>
              <ENT>3.27</ENT>
              <ENT>N/A</ENT>
              <ENT>1.61</ENT>
              <ENT>0.20</ENT>
              <ENT>N/A</ENT>
              <ENT>5.08</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54162</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lysis penil circumic lesion</ENT>
              <ENT>3.00</ENT>
              <ENT>N/A</ENT>
              <ENT>2.05</ENT>
              <ENT>0.20</ENT>
              <ENT>N/A</ENT>
              <ENT>5.25</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54163</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of circumcision</ENT>
              <ENT>3.00</ENT>
              <ENT>N/A</ENT>
              <ENT>2.07</ENT>
              <ENT>0.20</ENT>
              <ENT>N/A</ENT>
              <ENT>5.27</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54164</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Frenulotomy of penis</ENT>
              <ENT>2.50</ENT>
              <ENT>N/A</ENT>
              <ENT>1.89</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>4.55</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of penis lesion</ENT>
              <ENT>1.06</ENT>
              <ENT>1.88</ENT>
              <ENT>1.02</ENT>
              <ENT>0.06</ENT>
              <ENT>3.00</ENT>
              <ENT>2.14</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54205</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of penis lesion</ENT>
              <ENT>7.93</ENT>
              <ENT>N/A</ENT>
              <ENT>5.14</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>13.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of penis lesion</ENT>
              <ENT>2.42</ENT>
              <ENT>4.03</ENT>
              <ENT>0.98</ENT>
              <ENT>0.15</ENT>
              <ENT>6.60</ENT>
              <ENT>3.55</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54230</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prepare penis study</ENT>
              <ENT>1.34</ENT>
              <ENT>1.14</ENT>
              <ENT>0.64</ENT>
              <ENT>0.08</ENT>
              <ENT>2.56</ENT>
              <ENT>2.06</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54231</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dynamic cavernosometry</ENT>
              <ENT>2.04</ENT>
              <ENT>1.43</ENT>
              <ENT>0.89</ENT>
              <ENT>0.14</ENT>
              <ENT>3.61</ENT>
              <ENT>3.07</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54235</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Penile injection</ENT>
              <ENT>1.19</ENT>
              <ENT>1.00</ENT>
              <ENT>0.60</ENT>
              <ENT>0.07</ENT>
              <ENT>2.26</ENT>
              <ENT>1.86</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54240</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Penis study</ENT>
              <ENT>1.31</ENT>
              <ENT>1.04</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>2.48</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54240</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Penis study</ENT>
              <ENT>1.31</ENT>
              <ENT>0.44</ENT>
              <ENT>0.44</ENT>
              <ENT>0.08</ENT>
              <ENT>1.83</ENT>
              <ENT>1.83</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54240</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Penis study</ENT>
              <ENT>0.00</ENT>
              <ENT>0.61</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Penis study</ENT>
              <ENT>2.22</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>0.16</ENT>
              <ENT>3.32</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54250</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Penis study</ENT>
              <ENT>2.22</ENT>
              <ENT>0.73</ENT>
              <ENT>0.73</ENT>
              <ENT>0.14</ENT>
              <ENT>3.09</ENT>
              <ENT>3.09</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54250</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Penis study</ENT>
              <ENT>0.00</ENT>
              <ENT>0.22</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.24</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of penis</ENT>
              <ENT>10.41</ENT>
              <ENT>N/A</ENT>
              <ENT>6.17</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>17.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54304</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of penis</ENT>
              <ENT>12.49</ENT>
              <ENT>N/A</ENT>
              <ENT>7.07</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>20.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54308</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of urethra</ENT>
              <ENT>11.83</ENT>
              <ENT>N/A</ENT>
              <ENT>6.67</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>19.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54312</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of urethra</ENT>
              <ENT>13.57</ENT>
              <ENT>N/A</ENT>
              <ENT>7.74</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>22.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54316</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of urethra</ENT>
              <ENT>16.82</ENT>
              <ENT>N/A</ENT>
              <ENT>8.75</ENT>
              <ENT>1.00</ENT>
              <ENT>N/A</ENT>
              <ENT>26.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54318</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of urethra</ENT>
              <ENT>11.25</ENT>
              <ENT>N/A</ENT>
              <ENT>6.61</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>19.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54322</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of urethra</ENT>
              <ENT>13.01</ENT>
              <ENT>N/A</ENT>
              <ENT>6.99</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>20.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54324</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of urethra</ENT>
              <ENT>16.31</ENT>
              <ENT>N/A</ENT>
              <ENT>8.78</ENT>
              <ENT>1.03</ENT>
              <ENT>N/A</ENT>
              <ENT>26.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54326</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of urethra</ENT>
              <ENT>15.72</ENT>
              <ENT>N/A</ENT>
              <ENT>8.48</ENT>
              <ENT>0.93</ENT>
              <ENT>N/A</ENT>
              <ENT>25.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54328</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise penis/urethra</ENT>
              <ENT>15.65</ENT>
              <ENT>N/A</ENT>
              <ENT>7.99</ENT>
              <ENT>0.92</ENT>
              <ENT>N/A</ENT>
              <ENT>24.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54332</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise penis/urethra</ENT>
              <ENT>17.08</ENT>
              <ENT>N/A</ENT>
              <ENT>8.47</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>26.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54336</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise penis/urethra</ENT>
              <ENT>20.04</ENT>
              <ENT>N/A</ENT>
              <ENT>11.27</ENT>
              <ENT>1.90</ENT>
              <ENT>N/A</ENT>
              <ENT>33.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54340</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Secondary urethral surgery</ENT>
              <ENT>8.91</ENT>
              <ENT>N/A</ENT>
              <ENT>5.61</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>15.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54344</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Secondary urethral surgery</ENT>
              <ENT>15.94</ENT>
              <ENT>N/A</ENT>
              <ENT>8.46</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>25.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54348</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Secondary urethral surgery</ENT>
              <ENT>17.15</ENT>
              <ENT>N/A</ENT>
              <ENT>9.20</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>27.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54352</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruct urethra/penis</ENT>
              <ENT>24.74</ENT>
              <ENT>N/A</ENT>
              <ENT>12.15</ENT>
              <ENT>1.62</ENT>
              <ENT>N/A</ENT>
              <ENT>38.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54360</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Penis plastic surgery</ENT>
              <ENT>11.93</ENT>
              <ENT>N/A</ENT>
              <ENT>6.53</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>19.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54380</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair penis</ENT>
              <ENT>13.18</ENT>
              <ENT>N/A</ENT>
              <ENT>7.23</ENT>
              <ENT>1.16</ENT>
              <ENT>N/A</ENT>
              <ENT>21.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54385</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair penis</ENT>
              <ENT>15.39</ENT>
              <ENT>N/A</ENT>
              <ENT>8.84</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>24.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54390</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair penis and bladder</ENT>
              <ENT>21.61</ENT>
              <ENT>N/A</ENT>
              <ENT>10.73</ENT>
              <ENT>1.28</ENT>
              <ENT>N/A</ENT>
              <ENT>33.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert semi-rigid prosthesis</ENT>
              <ENT>8.99</ENT>
              <ENT>N/A</ENT>
              <ENT>4.78</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>14.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54401</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert self-contd prosthesis</ENT>
              <ENT>10.28</ENT>
              <ENT>N/A</ENT>
              <ENT>6.09</ENT>
              <ENT>0.61</ENT>
              <ENT>N/A</ENT>
              <ENT>16.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54405</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert multi-comp penis pros</ENT>
              <ENT>13.43</ENT>
              <ENT>N/A</ENT>
              <ENT>6.49</ENT>
              <ENT>0.80</ENT>
              <ENT>N/A</ENT>
              <ENT>20.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54406</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove muti-comp penis pros</ENT>
              <ENT>12.10</ENT>
              <ENT>N/A</ENT>
              <ENT>5.59</ENT>
              <ENT>0.75</ENT>
              <ENT>N/A</ENT>
              <ENT>18.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54408</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair multi-comp penis pros</ENT>
              <ENT>12.75</ENT>
              <ENT>N/A</ENT>
              <ENT>5.91</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>19.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54410</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove/replace penis prosth</ENT>
              <ENT>15.50</ENT>
              <ENT>N/A</ENT>
              <ENT>6.82</ENT>
              <ENT>0.96</ENT>
              <ENT>N/A</ENT>
              <ENT>23.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54411</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remov/replc penis pros, comp</ENT>
              <ENT>16.00</ENT>
              <ENT>N/A</ENT>
              <ENT>7.25</ENT>
              <ENT>0.80</ENT>
              <ENT>N/A</ENT>
              <ENT>24.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54415</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove self-contd penis pros</ENT>
              <ENT>8.20</ENT>
              <ENT>N/A</ENT>
              <ENT>4.33</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>13.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54416</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remv/repl penis contain pros</ENT>
              <ENT>10.87</ENT>
              <ENT>N/A</ENT>
              <ENT>5.54</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>16.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54417</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remv/replc penis pros, compl</ENT>
              <ENT>14.19</ENT>
              <ENT>N/A</ENT>
              <ENT>6.36</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>21.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of penis</ENT>
              <ENT>11.42</ENT>
              <ENT>N/A</ENT>
              <ENT>6.39</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>18.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54430</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of penis</ENT>
              <ENT>10.15</ENT>
              <ENT>N/A</ENT>
              <ENT>5.97</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>16.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54435</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of penis</ENT>
              <ENT>6.12</ENT>
              <ENT>N/A</ENT>
              <ENT>4.41</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>10.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49150"/>
              <ENT I="01">54440</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Repair of penis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Preputial stretching</ENT>
              <ENT>1.12</ENT>
              <ENT>1.13</ENT>
              <ENT>0.48</ENT>
              <ENT>0.07</ENT>
              <ENT>2.32</ENT>
              <ENT>1.67</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of testis</ENT>
              <ENT>1.31</ENT>
              <ENT>0.62</ENT>
              <ENT>0.58</ENT>
              <ENT>0.08</ENT>
              <ENT>2.01</ENT>
              <ENT>1.97</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54505</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of testis</ENT>
              <ENT>3.46</ENT>
              <ENT>N/A</ENT>
              <ENT>1.98</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>5.65</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54512</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise lesion testis</ENT>
              <ENT>8.58</ENT>
              <ENT>N/A</ENT>
              <ENT>4.37</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>13.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of testis</ENT>
              <ENT>5.23</ENT>
              <ENT>N/A</ENT>
              <ENT>3.01</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>8.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54522</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Orchiectomy, partial</ENT>
              <ENT>9.50</ENT>
              <ENT>N/A</ENT>
              <ENT>5.12</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>15.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of testis</ENT>
              <ENT>8.58</ENT>
              <ENT>N/A</ENT>
              <ENT>4.52</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>13.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54535</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive testis surgery</ENT>
              <ENT>12.16</ENT>
              <ENT>N/A</ENT>
              <ENT>5.96</ENT>
              <ENT>0.83</ENT>
              <ENT>N/A</ENT>
              <ENT>18.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54550</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration for testis</ENT>
              <ENT>7.78</ENT>
              <ENT>N/A</ENT>
              <ENT>4.12</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>12.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54560</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration for testis</ENT>
              <ENT>11.13</ENT>
              <ENT>N/A</ENT>
              <ENT>5.56</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>17.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reduce testis torsion</ENT>
              <ENT>7.01</ENT>
              <ENT>N/A</ENT>
              <ENT>3.79</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>11.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54620</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Suspension of testis</ENT>
              <ENT>4.90</ENT>
              <ENT>N/A</ENT>
              <ENT>2.52</ENT>
              <ENT>0.31</ENT>
              <ENT>N/A</ENT>
              <ENT>7.73</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54640</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Suspension of testis</ENT>
              <ENT>6.90</ENT>
              <ENT>N/A</ENT>
              <ENT>3.97</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>11.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54650</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Orchiopexy (Fowler-Stephens)</ENT>
              <ENT>11.45</ENT>
              <ENT>N/A</ENT>
              <ENT>5.83</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>18.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54660</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of testis</ENT>
              <ENT>5.11</ENT>
              <ENT>N/A</ENT>
              <ENT>3.19</ENT>
              <ENT>0.35</ENT>
              <ENT>N/A</ENT>
              <ENT>8.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54670</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair testis injury</ENT>
              <ENT>6.41</ENT>
              <ENT>N/A</ENT>
              <ENT>3.70</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>10.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54680</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Relocation of testis(es)</ENT>
              <ENT>12.65</ENT>
              <ENT>N/A</ENT>
              <ENT>6.51</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>20.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54690</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy, orchiectomy</ENT>
              <ENT>10.96</ENT>
              <ENT>N/A</ENT>
              <ENT>5.45</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>17.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54692</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy, orchiopexy</ENT>
              <ENT>12.88</ENT>
              <ENT>N/A</ENT>
              <ENT>5.57</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>19.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54699</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Laparoscope proc, testis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of scrotum</ENT>
              <ENT>3.43</ENT>
              <ENT>N/A</ENT>
              <ENT>2.00</ENT>
              <ENT>0.23</ENT>
              <ENT>N/A</ENT>
              <ENT>5.66</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of epididymis</ENT>
              <ENT>2.33</ENT>
              <ENT>0.97</ENT>
              <ENT>0.92</ENT>
              <ENT>0.14</ENT>
              <ENT>3.44</ENT>
              <ENT>3.39</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of epididymis</ENT>
              <ENT>5.14</ENT>
              <ENT>N/A</ENT>
              <ENT>3.16</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>8.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54830</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove epididymis lesion</ENT>
              <ENT>5.38</ENT>
              <ENT>N/A</ENT>
              <ENT>3.25</ENT>
              <ENT>0.34</ENT>
              <ENT>N/A</ENT>
              <ENT>8.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54840</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove epididymis lesion</ENT>
              <ENT>5.20</ENT>
              <ENT>N/A</ENT>
              <ENT>3.01</ENT>
              <ENT>0.31</ENT>
              <ENT>N/A</ENT>
              <ENT>8.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54860</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of epididymis</ENT>
              <ENT>6.32</ENT>
              <ENT>N/A</ENT>
              <ENT>3.61</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>10.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54861</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of epididymis</ENT>
              <ENT>8.90</ENT>
              <ENT>N/A</ENT>
              <ENT>4.55</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>13.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54900</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of spermatic ducts</ENT>
              <ENT>13.20</ENT>
              <ENT>N/A</ENT>
              <ENT>6.13</ENT>
              <ENT>1.34</ENT>
              <ENT>N/A</ENT>
              <ENT>20.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">54901</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of spermatic ducts</ENT>
              <ENT>17.94</ENT>
              <ENT>N/A</ENT>
              <ENT>8.12</ENT>
              <ENT>1.83</ENT>
              <ENT>N/A</ENT>
              <ENT>27.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of hydrocele</ENT>
              <ENT>1.43</ENT>
              <ENT>2.15</ENT>
              <ENT>0.66</ENT>
              <ENT>0.10</ENT>
              <ENT>3.68</ENT>
              <ENT>2.19</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55040</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of hydrocele</ENT>
              <ENT>5.36</ENT>
              <ENT>N/A</ENT>
              <ENT>3.07</ENT>
              <ENT>0.35</ENT>
              <ENT>N/A</ENT>
              <ENT>8.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55041</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of hydroceles</ENT>
              <ENT>7.74</ENT>
              <ENT>N/A</ENT>
              <ENT>4.14</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>12.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55060</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of hydrocele</ENT>
              <ENT>5.52</ENT>
              <ENT>N/A</ENT>
              <ENT>3.25</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>9.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of scrotum abscess</ENT>
              <ENT>2.13</ENT>
              <ENT>3.85</ENT>
              <ENT>1.62</ENT>
              <ENT>0.15</ENT>
              <ENT>6.13</ENT>
              <ENT>3.90</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore scrotum</ENT>
              <ENT>5.70</ENT>
              <ENT>N/A</ENT>
              <ENT>3.31</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>9.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of scrotum lesion</ENT>
              <ENT>5.09</ENT>
              <ENT>8.73</ENT>
              <ENT>3.11</ENT>
              <ENT>0.33</ENT>
              <ENT>14.15</ENT>
              <ENT>8.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of scrotum</ENT>
              <ENT>7.22</ENT>
              <ENT>N/A</ENT>
              <ENT>4.10</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>11.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55175</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of scrotum</ENT>
              <ENT>5.24</ENT>
              <ENT>N/A</ENT>
              <ENT>3.24</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>8.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55180</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of scrotum</ENT>
              <ENT>10.72</ENT>
              <ENT>N/A</ENT>
              <ENT>5.69</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>17.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of sperm duct</ENT>
              <ENT>4.24</ENT>
              <ENT>9.10</ENT>
              <ENT>2.60</ENT>
              <ENT>0.25</ENT>
              <ENT>13.59</ENT>
              <ENT>7.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of sperm duct(s)</ENT>
              <ENT>3.29</ENT>
              <ENT>9.29</ENT>
              <ENT>2.89</ENT>
              <ENT>0.21</ENT>
              <ENT>12.79</ENT>
              <ENT>6.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prepare, sperm duct x-ray</ENT>
              <ENT>3.51</ENT>
              <ENT>N/A</ENT>
              <ENT>1.34</ENT>
              <ENT>0.20</ENT>
              <ENT>N/A</ENT>
              <ENT>5.05</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of sperm duct</ENT>
              <ENT>8.49</ENT>
              <ENT>N/A</ENT>
              <ENT>4.38</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>13.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ligation of sperm duct</ENT>
              <ENT>4.12</ENT>
              <ENT>7.34</ENT>
              <ENT>1.92</ENT>
              <ENT>0.24</ENT>
              <ENT>11.70</ENT>
              <ENT>6.28</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of hydrocele</ENT>
              <ENT>5.59</ENT>
              <ENT>N/A</ENT>
              <ENT>3.28</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>9.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of sperm cord lesion</ENT>
              <ENT>6.03</ENT>
              <ENT>N/A</ENT>
              <ENT>3.41</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>10.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise spermatic cord veins</ENT>
              <ENT>5.66</ENT>
              <ENT>N/A</ENT>
              <ENT>3.24</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>9.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55535</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise spermatic cord veins</ENT>
              <ENT>6.56</ENT>
              <ENT>N/A</ENT>
              <ENT>3.63</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>10.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55540</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise hernia &amp; sperm veins</ENT>
              <ENT>7.67</ENT>
              <ENT>N/A</ENT>
              <ENT>3.96</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>12.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55550</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo ligate spermatic vein</ENT>
              <ENT>6.57</ENT>
              <ENT>N/A</ENT>
              <ENT>3.63</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>10.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55559</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Laparo proc, spermatic cord</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise sperm duct pouch</ENT>
              <ENT>6.38</ENT>
              <ENT>N/A</ENT>
              <ENT>3.63</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>10.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise sperm duct pouch</ENT>
              <ENT>7.96</ENT>
              <ENT>N/A</ENT>
              <ENT>4.55</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>13.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55650</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove sperm duct pouch</ENT>
              <ENT>11.80</ENT>
              <ENT>N/A</ENT>
              <ENT>5.58</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>18.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55680</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove sperm pouch lesion</ENT>
              <ENT>5.19</ENT>
              <ENT>N/A</ENT>
              <ENT>3.19</ENT>
              <ENT>0.31</ENT>
              <ENT>N/A</ENT>
              <ENT>8.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49151"/>
              <ENT I="01">55700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of prostate</ENT>
              <ENT>1.57</ENT>
              <ENT>4.42</ENT>
              <ENT>0.73</ENT>
              <ENT>0.10</ENT>
              <ENT>6.09</ENT>
              <ENT>2.40</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55705</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of prostate</ENT>
              <ENT>4.57</ENT>
              <ENT>N/A</ENT>
              <ENT>2.37</ENT>
              <ENT>0.26</ENT>
              <ENT>N/A</ENT>
              <ENT>7.20</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55720</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of prostate abscess</ENT>
              <ENT>7.64</ENT>
              <ENT>N/A</ENT>
              <ENT>4.32</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>12.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55725</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of prostate abscess</ENT>
              <ENT>8.68</ENT>
              <ENT>N/A</ENT>
              <ENT>4.97</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>14.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55801</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of prostate</ENT>
              <ENT>17.80</ENT>
              <ENT>N/A</ENT>
              <ENT>8.10</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>26.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55810</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive prostate surgery</ENT>
              <ENT>22.58</ENT>
              <ENT>N/A</ENT>
              <ENT>9.58</ENT>
              <ENT>1.35</ENT>
              <ENT>N/A</ENT>
              <ENT>33.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55812</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive prostate surgery</ENT>
              <ENT>27.51</ENT>
              <ENT>N/A</ENT>
              <ENT>11.67</ENT>
              <ENT>1.69</ENT>
              <ENT>N/A</ENT>
              <ENT>40.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55815</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive prostate surgery</ENT>
              <ENT>30.46</ENT>
              <ENT>N/A</ENT>
              <ENT>12.61</ENT>
              <ENT>1.84</ENT>
              <ENT>N/A</ENT>
              <ENT>44.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55821</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of prostate</ENT>
              <ENT>14.25</ENT>
              <ENT>N/A</ENT>
              <ENT>6.66</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>21.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55831</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of prostate</ENT>
              <ENT>15.62</ENT>
              <ENT>N/A</ENT>
              <ENT>7.12</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>23.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55840</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive prostate surgery</ENT>
              <ENT>22.69</ENT>
              <ENT>N/A</ENT>
              <ENT>9.94</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>34.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55842</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive prostate surgery</ENT>
              <ENT>24.38</ENT>
              <ENT>N/A</ENT>
              <ENT>10.50</ENT>
              <ENT>1.48</ENT>
              <ENT>N/A</ENT>
              <ENT>36.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55845</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive prostate surgery</ENT>
              <ENT>28.55</ENT>
              <ENT>N/A</ENT>
              <ENT>11.73</ENT>
              <ENT>1.71</ENT>
              <ENT>N/A</ENT>
              <ENT>41.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55859</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Percut/needle insert, pros</ENT>
              <ENT>12.52</ENT>
              <ENT>N/A</ENT>
              <ENT>6.23</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>19.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55860</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Surgical exposure, prostate</ENT>
              <ENT>14.45</ENT>
              <ENT>N/A</ENT>
              <ENT>6.71</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>21.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55862</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive prostate surgery</ENT>
              <ENT>18.39</ENT>
              <ENT>N/A</ENT>
              <ENT>8.36</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>27.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55865</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive prostate surgery</ENT>
              <ENT>22.87</ENT>
              <ENT>N/A</ENT>
              <ENT>9.79</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>34.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55866</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo radical prostatectomy</ENT>
              <ENT>30.74</ENT>
              <ENT>N/A</ENT>
              <ENT>12.08</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>44.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55870</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Electroejaculation</ENT>
              <ENT>2.58</ENT>
              <ENT>1.59</ENT>
              <ENT>1.11</ENT>
              <ENT>0.14</ENT>
              <ENT>4.31</ENT>
              <ENT>3.83</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55873</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cryoablate prostate</ENT>
              <ENT>19.47</ENT>
              <ENT>N/A</ENT>
              <ENT>9.34</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>29.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">55899</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Genital surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56405</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>I &amp; D of vulva/perineum</ENT>
              <ENT>1.44</ENT>
              <ENT>1.37</ENT>
              <ENT>1.18</ENT>
              <ENT>0.14</ENT>
              <ENT>2.95</ENT>
              <ENT>2.76</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of gland abscess</ENT>
              <ENT>1.39</ENT>
              <ENT>2.37</ENT>
              <ENT>1.11</ENT>
              <ENT>0.13</ENT>
              <ENT>3.89</ENT>
              <ENT>2.63</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56440</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Surgery for vulva lesion</ENT>
              <ENT>2.84</ENT>
              <ENT>N/A</ENT>
              <ENT>1.75</ENT>
              <ENT>0.28</ENT>
              <ENT>N/A</ENT>
              <ENT>4.87</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56441</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lysis of labial lesion(s)</ENT>
              <ENT>1.97</ENT>
              <ENT>1.87</ENT>
              <ENT>1.46</ENT>
              <ENT>0.17</ENT>
              <ENT>4.01</ENT>
              <ENT>3.60</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56501</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destroy, vulva lesions, sim</ENT>
              <ENT>1.53</ENT>
              <ENT>1.84</ENT>
              <ENT>1.30</ENT>
              <ENT>0.15</ENT>
              <ENT>3.52</ENT>
              <ENT>2.98</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56515</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destroy vulva lesion/s compl</ENT>
              <ENT>2.76</ENT>
              <ENT>2.63</ENT>
              <ENT>1.88</ENT>
              <ENT>0.18</ENT>
              <ENT>5.57</ENT>
              <ENT>4.82</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of vulva/perineum</ENT>
              <ENT>1.10</ENT>
              <ENT>1.12</ENT>
              <ENT>0.47</ENT>
              <ENT>0.11</ENT>
              <ENT>2.33</ENT>
              <ENT>1.68</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56606</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of vulva/perineum</ENT>
              <ENT>0.55</ENT>
              <ENT>0.51</ENT>
              <ENT>0.22</ENT>
              <ENT>0.06</ENT>
              <ENT>1.12</ENT>
              <ENT>0.83</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56620</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of vulva</ENT>
              <ENT>7.47</ENT>
              <ENT>N/A</ENT>
              <ENT>5.16</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>13.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56625</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Complete removal of vulva</ENT>
              <ENT>8.40</ENT>
              <ENT>N/A</ENT>
              <ENT>5.81</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>15.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56630</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive vulva surgery</ENT>
              <ENT>12.36</ENT>
              <ENT>N/A</ENT>
              <ENT>7.40</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>20.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56631</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive vulva surgery</ENT>
              <ENT>16.20</ENT>
              <ENT>N/A</ENT>
              <ENT>9.64</ENT>
              <ENT>1.63</ENT>
              <ENT>N/A</ENT>
              <ENT>27.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56632</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive vulva surgery</ENT>
              <ENT>20.29</ENT>
              <ENT>N/A</ENT>
              <ENT>10.11</ENT>
              <ENT>2.03</ENT>
              <ENT>N/A</ENT>
              <ENT>32.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56633</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive vulva surgery</ENT>
              <ENT>16.47</ENT>
              <ENT>N/A</ENT>
              <ENT>9.24</ENT>
              <ENT>1.66</ENT>
              <ENT>N/A</ENT>
              <ENT>27.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56634</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive vulva surgery</ENT>
              <ENT>17.88</ENT>
              <ENT>N/A</ENT>
              <ENT>10.31</ENT>
              <ENT>1.78</ENT>
              <ENT>N/A</ENT>
              <ENT>29.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56637</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive vulva surgery</ENT>
              <ENT>21.97</ENT>
              <ENT>N/A</ENT>
              <ENT>11.98</ENT>
              <ENT>2.18</ENT>
              <ENT>N/A</ENT>
              <ENT>36.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56640</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive vulva surgery</ENT>
              <ENT>22.17</ENT>
              <ENT>N/A</ENT>
              <ENT>11.35</ENT>
              <ENT>2.26</ENT>
              <ENT>N/A</ENT>
              <ENT>35.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of hymen</ENT>
              <ENT>2.52</ENT>
              <ENT>N/A</ENT>
              <ENT>1.78</ENT>
              <ENT>0.24</ENT>
              <ENT>N/A</ENT>
              <ENT>4.54</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56720</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of hymen</ENT>
              <ENT>0.68</ENT>
              <ENT>N/A</ENT>
              <ENT>0.41</ENT>
              <ENT>0.07</ENT>
              <ENT>N/A</ENT>
              <ENT>1.16</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56740</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove vagina gland lesion</ENT>
              <ENT>4.57</ENT>
              <ENT>N/A</ENT>
              <ENT>2.53</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>7.47</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of vagina</ENT>
              <ENT>3.89</ENT>
              <ENT>N/A</ENT>
              <ENT>2.25</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>6.51</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56805</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair clitoris</ENT>
              <ENT>18.86</ENT>
              <ENT>N/A</ENT>
              <ENT>9.80</ENT>
              <ENT>1.82</ENT>
              <ENT>N/A</ENT>
              <ENT>30.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56810</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of perineum</ENT>
              <ENT>4.13</ENT>
              <ENT>N/A</ENT>
              <ENT>2.36</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>6.90</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exam of vulva w/scope</ENT>
              <ENT>1.50</ENT>
              <ENT>1.39</ENT>
              <ENT>0.65</ENT>
              <ENT>0.10</ENT>
              <ENT>2.99</ENT>
              <ENT>2.25</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">56821</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exam/biopsy of vulva w/scope</ENT>
              <ENT>2.05</ENT>
              <ENT>1.82</ENT>
              <ENT>0.92</ENT>
              <ENT>0.13</ENT>
              <ENT>4.00</ENT>
              <ENT>3.10</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of vagina</ENT>
              <ENT>2.97</ENT>
              <ENT>N/A</ENT>
              <ENT>1.78</ENT>
              <ENT>0.28</ENT>
              <ENT>N/A</ENT>
              <ENT>5.03</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of pelvic abscess</ENT>
              <ENT>6.03</ENT>
              <ENT>N/A</ENT>
              <ENT>4.07</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>10.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of pelvic fluid</ENT>
              <ENT>1.50</ENT>
              <ENT>0.98</ENT>
              <ENT>0.61</ENT>
              <ENT>0.15</ENT>
              <ENT>2.63</ENT>
              <ENT>2.26</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57022</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>I &amp; d vaginal hematoma, pp</ENT>
              <ENT>2.56</ENT>
              <ENT>N/A</ENT>
              <ENT>1.55</ENT>
              <ENT>0.24</ENT>
              <ENT>N/A</ENT>
              <ENT>4.35</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57023</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>I &amp; d vag hematoma, non-ob</ENT>
              <ENT>4.75</ENT>
              <ENT>N/A</ENT>
              <ENT>2.66</ENT>
              <ENT>0.24</ENT>
              <ENT>N/A</ENT>
              <ENT>7.65</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57061</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destroy vag lesions, simple</ENT>
              <ENT>1.25</ENT>
              <ENT>1.72</ENT>
              <ENT>1.17</ENT>
              <ENT>0.13</ENT>
              <ENT>3.10</ENT>
              <ENT>2.55</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57065</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destroy vag lesions, complex</ENT>
              <ENT>2.61</ENT>
              <ENT>2.38</ENT>
              <ENT>1.76</ENT>
              <ENT>0.26</ENT>
              <ENT>5.25</ENT>
              <ENT>4.63</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of vagina</ENT>
              <ENT>1.20</ENT>
              <ENT>1.14</ENT>
              <ENT>0.49</ENT>
              <ENT>0.10</ENT>
              <ENT>2.44</ENT>
              <ENT>1.79</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49152"/>
              <ENT I="01">57105</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of vagina</ENT>
              <ENT>1.69</ENT>
              <ENT>2.01</ENT>
              <ENT>1.38</ENT>
              <ENT>0.17</ENT>
              <ENT>3.87</ENT>
              <ENT>3.24</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57106</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove vagina wall, partial</ENT>
              <ENT>6.36</ENT>
              <ENT>N/A</ENT>
              <ENT>4.46</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>11.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57107</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove vagina tissue, part</ENT>
              <ENT>23.00</ENT>
              <ENT>N/A</ENT>
              <ENT>10.90</ENT>
              <ENT>2.17</ENT>
              <ENT>N/A</ENT>
              <ENT>36.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57109</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vaginectomy partial w/nodes</ENT>
              <ENT>27.00</ENT>
              <ENT>N/A</ENT>
              <ENT>11.82</ENT>
              <ENT>1.97</ENT>
              <ENT>N/A</ENT>
              <ENT>40.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove vagina wall, complete</ENT>
              <ENT>14.29</ENT>
              <ENT>N/A</ENT>
              <ENT>7.63</ENT>
              <ENT>1.43</ENT>
              <ENT>N/A</ENT>
              <ENT>23.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57111</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove vagina tissue, compl</ENT>
              <ENT>27.00</ENT>
              <ENT>N/A</ENT>
              <ENT>13.01</ENT>
              <ENT>2.71</ENT>
              <ENT>N/A</ENT>
              <ENT>42.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57112</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vaginectomy w/nodes, compl</ENT>
              <ENT>29.00</ENT>
              <ENT>N/A</ENT>
              <ENT>12.66</ENT>
              <ENT>2.19</ENT>
              <ENT>N/A</ENT>
              <ENT>43.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Closure of vagina</ENT>
              <ENT>7.41</ENT>
              <ENT>N/A</ENT>
              <ENT>4.88</ENT>
              <ENT>0.75</ENT>
              <ENT>N/A</ENT>
              <ENT>13.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove vagina lesion</ENT>
              <ENT>2.43</ENT>
              <ENT>2.24</ENT>
              <ENT>1.60</ENT>
              <ENT>0.23</ENT>
              <ENT>4.90</ENT>
              <ENT>4.26</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57135</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove vagina lesion</ENT>
              <ENT>2.67</ENT>
              <ENT>2.33</ENT>
              <ENT>1.70</ENT>
              <ENT>0.26</ENT>
              <ENT>5.26</ENT>
              <ENT>4.63</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat vagina infection</ENT>
              <ENT>0.55</ENT>
              <ENT>1.14</ENT>
              <ENT>0.22</ENT>
              <ENT>0.06</ENT>
              <ENT>1.75</ENT>
              <ENT>0.83</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57155</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert uteri tandems/ovoids</ENT>
              <ENT>6.27</ENT>
              <ENT>N/A</ENT>
              <ENT>4.04</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>10.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57160</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert pessary/other device</ENT>
              <ENT>0.89</ENT>
              <ENT>1.12</ENT>
              <ENT>0.40</ENT>
              <ENT>0.09</ENT>
              <ENT>2.10</ENT>
              <ENT>1.38</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57170</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fitting of diaphragm/cap</ENT>
              <ENT>0.91</ENT>
              <ENT>1.54</ENT>
              <ENT>0.34</ENT>
              <ENT>0.09</ENT>
              <ENT>2.54</ENT>
              <ENT>1.34</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57180</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat vaginal bleeding</ENT>
              <ENT>1.58</ENT>
              <ENT>2.28</ENT>
              <ENT>1.35</ENT>
              <ENT>0.16</ENT>
              <ENT>4.02</ENT>
              <ENT>3.09</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of vagina</ENT>
              <ENT>3.94</ENT>
              <ENT>N/A</ENT>
              <ENT>2.97</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>7.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57210</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair vagina/perineum</ENT>
              <ENT>5.17</ENT>
              <ENT>N/A</ENT>
              <ENT>3.51</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>9.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of urethra</ENT>
              <ENT>4.31</ENT>
              <ENT>N/A</ENT>
              <ENT>3.18</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>7.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57230</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of urethral lesion</ENT>
              <ENT>5.64</ENT>
              <ENT>N/A</ENT>
              <ENT>3.47</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>9.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57240</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair bladder &amp; vagina</ENT>
              <ENT>6.07</ENT>
              <ENT>N/A</ENT>
              <ENT>3.94</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>10.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair rectum &amp; vagina</ENT>
              <ENT>5.53</ENT>
              <ENT>N/A</ENT>
              <ENT>3.65</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>9.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57260</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of vagina</ENT>
              <ENT>8.27</ENT>
              <ENT>N/A</ENT>
              <ENT>4.98</ENT>
              <ENT>0.83</ENT>
              <ENT>N/A</ENT>
              <ENT>14.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57265</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive repair of vagina</ENT>
              <ENT>11.34</ENT>
              <ENT>N/A</ENT>
              <ENT>6.21</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>18.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57268</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of bowel bulge</ENT>
              <ENT>6.76</ENT>
              <ENT>N/A</ENT>
              <ENT>4.33</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>11.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57270</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of bowel pouch</ENT>
              <ENT>12.11</ENT>
              <ENT>N/A</ENT>
              <ENT>6.44</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>19.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57280</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Suspension of vagina</ENT>
              <ENT>15.04</ENT>
              <ENT>N/A</ENT>
              <ENT>7.58</ENT>
              <ENT>1.44</ENT>
              <ENT>N/A</ENT>
              <ENT>24.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57282</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of vaginal prolapse</ENT>
              <ENT>8.86</ENT>
              <ENT>N/A</ENT>
              <ENT>5.43</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>15.15</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57284</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair paravaginal defect</ENT>
              <ENT>12.70</ENT>
              <ENT>N/A</ENT>
              <ENT>7.30</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>21.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57287</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise/remove sling repair</ENT>
              <ENT>10.71</ENT>
              <ENT>N/A</ENT>
              <ENT>5.65</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>17.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57288</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair bladder defect</ENT>
              <ENT>13.02</ENT>
              <ENT>N/A</ENT>
              <ENT>6.09</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>19.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57289</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair bladder &amp; vagina</ENT>
              <ENT>11.58</ENT>
              <ENT>N/A</ENT>
              <ENT>6.22</ENT>
              <ENT>0.95</ENT>
              <ENT>N/A</ENT>
              <ENT>18.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57291</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Construction of vagina</ENT>
              <ENT>7.95</ENT>
              <ENT>N/A</ENT>
              <ENT>5.08</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>13.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57292</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Construct vagina with graft</ENT>
              <ENT>13.09</ENT>
              <ENT>N/A</ENT>
              <ENT>7.17</ENT>
              <ENT>1.29</ENT>
              <ENT>N/A</ENT>
              <ENT>21.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair rectum-vagina fistula</ENT>
              <ENT>7.61</ENT>
              <ENT>N/A</ENT>
              <ENT>4.37</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>12.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57305</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair rectum-vagina fistula</ENT>
              <ENT>13.77</ENT>
              <ENT>N/A</ENT>
              <ENT>6.40</ENT>
              <ENT>1.33</ENT>
              <ENT>N/A</ENT>
              <ENT>21.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57307</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fistula repair &amp; colostomy</ENT>
              <ENT>15.93</ENT>
              <ENT>N/A</ENT>
              <ENT>7.18</ENT>
              <ENT>1.59</ENT>
              <ENT>N/A</ENT>
              <ENT>24.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57308</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fistula repair, transperine</ENT>
              <ENT>9.94</ENT>
              <ENT>N/A</ENT>
              <ENT>5.28</ENT>
              <ENT>0.91</ENT>
              <ENT>N/A</ENT>
              <ENT>16.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57310</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair urethrovaginal lesion</ENT>
              <ENT>6.78</ENT>
              <ENT>N/A</ENT>
              <ENT>4.22</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>11.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57311</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair urethrovaginal lesion</ENT>
              <ENT>7.98</ENT>
              <ENT>N/A</ENT>
              <ENT>4.70</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>13.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair bladder-vagina lesion</ENT>
              <ENT>8.01</ENT>
              <ENT>N/A</ENT>
              <ENT>4.77</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>13.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57330</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair bladder-vagina lesion</ENT>
              <ENT>12.35</ENT>
              <ENT>N/A</ENT>
              <ENT>6.17</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>19.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57335</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair vagina</ENT>
              <ENT>18.73</ENT>
              <ENT>N/A</ENT>
              <ENT>9.53</ENT>
              <ENT>1.66</ENT>
              <ENT>N/A</ENT>
              <ENT>29.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dilation of vagina</ENT>
              <ENT>2.27</ENT>
              <ENT>N/A</ENT>
              <ENT>1.16</ENT>
              <ENT>0.22</ENT>
              <ENT>N/A</ENT>
              <ENT>3.65</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57410</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pelvic examination</ENT>
              <ENT>1.75</ENT>
              <ENT>2.10</ENT>
              <ENT>0.91</ENT>
              <ENT>0.14</ENT>
              <ENT>3.99</ENT>
              <ENT>2.80</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57415</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove vaginal foreign body</ENT>
              <ENT>2.17</ENT>
              <ENT>N/A</ENT>
              <ENT>1.47</ENT>
              <ENT>0.19</ENT>
              <ENT>N/A</ENT>
              <ENT>3.83</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exam of vagina w/scope</ENT>
              <ENT>1.60</ENT>
              <ENT>1.43</ENT>
              <ENT>0.69</ENT>
              <ENT>0.10</ENT>
              <ENT>3.13</ENT>
              <ENT>2.39</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57421</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exam/biopsy of vag w/scope</ENT>
              <ENT>2.20</ENT>
              <ENT>1.91</ENT>
              <ENT>0.98</ENT>
              <ENT>0.13</ENT>
              <ENT>4.24</ENT>
              <ENT>3.31</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57452</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exam of cervix w/scope</ENT>
              <ENT>1.50</ENT>
              <ENT>1.45</ENT>
              <ENT>0.64</ENT>
              <ENT>0.10</ENT>
              <ENT>3.05</ENT>
              <ENT>2.24</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57454</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bx/curett of cervix w/scope</ENT>
              <ENT>2.33</ENT>
              <ENT>1.80</ENT>
              <ENT>1.02</ENT>
              <ENT>0.13</ENT>
              <ENT>4.26</ENT>
              <ENT>3.48</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57455</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of cervix w/scope</ENT>
              <ENT>1.99</ENT>
              <ENT>1.79</ENT>
              <ENT>0.89</ENT>
              <ENT>0.13</ENT>
              <ENT>3.91</ENT>
              <ENT>3.01</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49153"/>
              <ENT I="01">57456</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endocerv curettage w/scope</ENT>
              <ENT>1.85</ENT>
              <ENT>1.72</ENT>
              <ENT>0.84</ENT>
              <ENT>0.13</ENT>
              <ENT>3.70</ENT>
              <ENT>2.82</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57460</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bx of cervix w/scope, leep</ENT>
              <ENT>2.83</ENT>
              <ENT>6.23</ENT>
              <ENT>1.25</ENT>
              <ENT>0.28</ENT>
              <ENT>9.34</ENT>
              <ENT>4.36</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57461</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Conz of cervix w/scope, leep</ENT>
              <ENT>3.44</ENT>
              <ENT>6.48</ENT>
              <ENT>1.43</ENT>
              <ENT>0.28</ENT>
              <ENT>10.20</ENT>
              <ENT>5.15</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of cervix</ENT>
              <ENT>0.97</ENT>
              <ENT>2.76</ENT>
              <ENT>0.48</ENT>
              <ENT>0.10</ENT>
              <ENT>3.83</ENT>
              <ENT>1.55</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57505</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endocervical curettage</ENT>
              <ENT>1.14</ENT>
              <ENT>1.52</ENT>
              <ENT>1.14</ENT>
              <ENT>0.12</ENT>
              <ENT>2.78</ENT>
              <ENT>2.40</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cauterization of cervix</ENT>
              <ENT>1.90</ENT>
              <ENT>1.61</ENT>
              <ENT>1.07</ENT>
              <ENT>0.18</ENT>
              <ENT>3.69</ENT>
              <ENT>3.15</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57511</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cryocautery of cervix</ENT>
              <ENT>1.90</ENT>
              <ENT>1.88</ENT>
              <ENT>1.42</ENT>
              <ENT>0.18</ENT>
              <ENT>3.96</ENT>
              <ENT>3.50</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57513</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laser surgery of cervix</ENT>
              <ENT>1.90</ENT>
              <ENT>1.93</ENT>
              <ENT>1.45</ENT>
              <ENT>0.19</ENT>
              <ENT>4.02</ENT>
              <ENT>3.54</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Conization of cervix</ENT>
              <ENT>4.04</ENT>
              <ENT>5.05</ENT>
              <ENT>2.86</ENT>
              <ENT>0.41</ENT>
              <ENT>9.50</ENT>
              <ENT>7.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57522</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Conization of cervix</ENT>
              <ENT>3.36</ENT>
              <ENT>4.55</ENT>
              <ENT>2.81</ENT>
              <ENT>0.34</ENT>
              <ENT>8.25</ENT>
              <ENT>6.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of cervix</ENT>
              <ENT>4.79</ENT>
              <ENT>N/A</ENT>
              <ENT>3.67</ENT>
              <ENT>0.48</ENT>
              <ENT>N/A</ENT>
              <ENT>8.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57531</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of cervix, radical</ENT>
              <ENT>28.00</ENT>
              <ENT>N/A</ENT>
              <ENT>13.74</ENT>
              <ENT>2.46</ENT>
              <ENT>N/A</ENT>
              <ENT>44.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57540</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of residual cervix</ENT>
              <ENT>12.22</ENT>
              <ENT>N/A</ENT>
              <ENT>6.55</ENT>
              <ENT>1.21</ENT>
              <ENT>N/A</ENT>
              <ENT>19.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57545</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove cervix/repair pelvis</ENT>
              <ENT>13.03</ENT>
              <ENT>N/A</ENT>
              <ENT>7.00</ENT>
              <ENT>1.30</ENT>
              <ENT>N/A</ENT>
              <ENT>21.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57550</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of residual cervix</ENT>
              <ENT>5.53</ENT>
              <ENT>N/A</ENT>
              <ENT>4.08</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>10.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57555</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove cervix/repair vagina</ENT>
              <ENT>8.95</ENT>
              <ENT>N/A</ENT>
              <ENT>5.39</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>15.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57556</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove cervix, repair bowel</ENT>
              <ENT>8.37</ENT>
              <ENT>N/A</ENT>
              <ENT>5.13</ENT>
              <ENT>0.80</ENT>
              <ENT>N/A</ENT>
              <ENT>14.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of cervix</ENT>
              <ENT>3.55</ENT>
              <ENT>N/A</ENT>
              <ENT>3.28</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>7.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57720</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of cervix</ENT>
              <ENT>4.13</ENT>
              <ENT>N/A</ENT>
              <ENT>3.36</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>7.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dilation of cervical canal</ENT>
              <ENT>0.77</ENT>
              <ENT>0.79</ENT>
              <ENT>0.49</ENT>
              <ENT>0.08</ENT>
              <ENT>1.64</ENT>
              <ENT>1.34</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">57820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>D &amp; c of residual cervix</ENT>
              <ENT>1.67</ENT>
              <ENT>1.52</ENT>
              <ENT>1.17</ENT>
              <ENT>0.17</ENT>
              <ENT>3.36</ENT>
              <ENT>3.01</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of uterus lining</ENT>
              <ENT>1.53</ENT>
              <ENT>1.37</ENT>
              <ENT>0.74</ENT>
              <ENT>0.07</ENT>
              <ENT>2.97</ENT>
              <ENT>2.34</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dilation and curettage</ENT>
              <ENT>3.27</ENT>
              <ENT>2.37</ENT>
              <ENT>1.92</ENT>
              <ENT>0.33</ENT>
              <ENT>5.97</ENT>
              <ENT>5.52</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Myomectomy abdom method</ENT>
              <ENT>14.60</ENT>
              <ENT>N/A</ENT>
              <ENT>7.39</ENT>
              <ENT>1.46</ENT>
              <ENT>N/A</ENT>
              <ENT>23.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58145</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Myomectomy vag method</ENT>
              <ENT>8.04</ENT>
              <ENT>N/A</ENT>
              <ENT>5.08</ENT>
              <ENT>0.80</ENT>
              <ENT>N/A</ENT>
              <ENT>13.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58146</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Myomectomy abdom complex</ENT>
              <ENT>19.00</ENT>
              <ENT>N/A</ENT>
              <ENT>8.97</ENT>
              <ENT>1.46</ENT>
              <ENT>N/A</ENT>
              <ENT>29.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Total hysterectomy</ENT>
              <ENT>15.24</ENT>
              <ENT>N/A</ENT>
              <ENT>7.70</ENT>
              <ENT>1.57</ENT>
              <ENT>N/A</ENT>
              <ENT>24.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58152</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Total hysterectomy</ENT>
              <ENT>20.60</ENT>
              <ENT>N/A</ENT>
              <ENT>10.09</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>32.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58180</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial hysterectomy</ENT>
              <ENT>15.29</ENT>
              <ENT>N/A</ENT>
              <ENT>7.67</ENT>
              <ENT>1.54</ENT>
              <ENT>N/A</ENT>
              <ENT>24.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive hysterectomy</ENT>
              <ENT>21.59</ENT>
              <ENT>N/A</ENT>
              <ENT>10.36</ENT>
              <ENT>2.15</ENT>
              <ENT>N/A</ENT>
              <ENT>34.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58210</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive hysterectomy</ENT>
              <ENT>28.85</ENT>
              <ENT>N/A</ENT>
              <ENT>13.72</ENT>
              <ENT>2.91</ENT>
              <ENT>N/A</ENT>
              <ENT>45.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58240</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of pelvis contents</ENT>
              <ENT>38.39</ENT>
              <ENT>N/A</ENT>
              <ENT>18.32</ENT>
              <ENT>3.76</ENT>
              <ENT>N/A</ENT>
              <ENT>60.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58260</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vaginal hysterectomy</ENT>
              <ENT>12.98</ENT>
              <ENT>N/A</ENT>
              <ENT>6.87</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>21.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58262</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vag hyst including t/o</ENT>
              <ENT>14.77</ENT>
              <ENT>N/A</ENT>
              <ENT>7.63</ENT>
              <ENT>1.42</ENT>
              <ENT>N/A</ENT>
              <ENT>23.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58263</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vag hyst w/t/o &amp; vag repair</ENT>
              <ENT>16.06</ENT>
              <ENT>N/A</ENT>
              <ENT>8.15</ENT>
              <ENT>1.55</ENT>
              <ENT>N/A</ENT>
              <ENT>25.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58267</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vag hyst w/urinary repair</ENT>
              <ENT>17.04</ENT>
              <ENT>N/A</ENT>
              <ENT>8.57</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>27.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58270</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vag hyst w/enterocele repair</ENT>
              <ENT>14.26</ENT>
              <ENT>N/A</ENT>
              <ENT>7.25</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>22.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58275</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hysterectomy/revise vagina</ENT>
              <ENT>15.76</ENT>
              <ENT>N/A</ENT>
              <ENT>7.92</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>25.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58280</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hysterectomy/revise vagina</ENT>
              <ENT>17.01</ENT>
              <ENT>N/A</ENT>
              <ENT>8.42</ENT>
              <ENT>1.54</ENT>
              <ENT>N/A</ENT>
              <ENT>26.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58285</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive hysterectomy</ENT>
              <ENT>22.26</ENT>
              <ENT>N/A</ENT>
              <ENT>10.45</ENT>
              <ENT>1.88</ENT>
              <ENT>N/A</ENT>
              <ENT>34.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58290</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vag hyst complex</ENT>
              <ENT>19.00</ENT>
              <ENT>N/A</ENT>
              <ENT>9.07</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>29.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58291</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vag hyst incl t/o, complex</ENT>
              <ENT>20.79</ENT>
              <ENT>N/A</ENT>
              <ENT>10.10</ENT>
              <ENT>1.42</ENT>
              <ENT>N/A</ENT>
              <ENT>32.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58292</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vag hyst t/o &amp; repair, compl</ENT>
              <ENT>22.08</ENT>
              <ENT>N/A</ENT>
              <ENT>10.64</ENT>
              <ENT>1.55</ENT>
              <ENT>N/A</ENT>
              <ENT>34.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58293</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vag hyst w/uro repair, compl</ENT>
              <ENT>23.06</ENT>
              <ENT>N/A</ENT>
              <ENT>11.15</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>35.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58294</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vag hyst w/enterocele, compl</ENT>
              <ENT>20.28</ENT>
              <ENT>N/A</ENT>
              <ENT>9.89</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>31.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58300</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Insert intrauterine device</ENT>
              <ENT>1.01</ENT>
              <ENT>1.55</ENT>
              <ENT>0.39</ENT>
              <ENT>0.10</ENT>
              <ENT>2.66</ENT>
              <ENT>1.50</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58301</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove intrauterine device</ENT>
              <ENT>1.27</ENT>
              <ENT>1.37</ENT>
              <ENT>0.49</ENT>
              <ENT>0.13</ENT>
              <ENT>2.77</ENT>
              <ENT>1.89</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58321</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artificial insemination</ENT>
              <ENT>0.92</ENT>
              <ENT>1.19</ENT>
              <ENT>0.38</ENT>
              <ENT>0.10</ENT>
              <ENT>2.21</ENT>
              <ENT>1.40</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58322</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artificial insemination</ENT>
              <ENT>1.10</ENT>
              <ENT>1.25</ENT>
              <ENT>0.43</ENT>
              <ENT>0.11</ENT>
              <ENT>2.46</ENT>
              <ENT>1.64</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58323</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sperm washing</ENT>
              <ENT>0.23</ENT>
              <ENT>0.24</ENT>
              <ENT>0.10</ENT>
              <ENT>0.02</ENT>
              <ENT>0.49</ENT>
              <ENT>0.35</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49154"/>
              <ENT I="01">58340</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Catheter for hysterography</ENT>
              <ENT>0.88</ENT>
              <ENT>3.09</ENT>
              <ENT>0.66</ENT>
              <ENT>0.08</ENT>
              <ENT>4.05</ENT>
              <ENT>1.62</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58345</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reopen fallopian tube</ENT>
              <ENT>4.66</ENT>
              <ENT>N/A</ENT>
              <ENT>2.48</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>7.50</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58346</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert heyman uteri capsule</ENT>
              <ENT>6.75</ENT>
              <ENT>N/A</ENT>
              <ENT>4.03</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>11.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58350</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reopen fallopian tube</ENT>
              <ENT>1.01</ENT>
              <ENT>1.54</ENT>
              <ENT>0.95</ENT>
              <ENT>0.10</ENT>
              <ENT>2.65</ENT>
              <ENT>2.06</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58353</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endometr ablate, thermal</ENT>
              <ENT>3.56</ENT>
              <ENT>2.93</ENT>
              <ENT>2.13</ENT>
              <ENT>0.37</ENT>
              <ENT>6.86</ENT>
              <ENT>6.06</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Suspension of uterus</ENT>
              <ENT>6.36</ENT>
              <ENT>N/A</ENT>
              <ENT>4.21</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>11.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58410</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Suspension of uterus</ENT>
              <ENT>12.73</ENT>
              <ENT>N/A</ENT>
              <ENT>6.75</ENT>
              <ENT>1.09</ENT>
              <ENT>N/A</ENT>
              <ENT>20.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of ruptured uterus</ENT>
              <ENT>11.92</ENT>
              <ENT>N/A</ENT>
              <ENT>6.27</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>19.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58540</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of uterus</ENT>
              <ENT>14.64</ENT>
              <ENT>N/A</ENT>
              <ENT>7.23</ENT>
              <ENT>1.28</ENT>
              <ENT>N/A</ENT>
              <ENT>23.15</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58545</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopic myomectomy</ENT>
              <ENT>14.60</ENT>
              <ENT>N/A</ENT>
              <ENT>7.53</ENT>
              <ENT>1.45</ENT>
              <ENT>N/A</ENT>
              <ENT>23.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58546</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo-myomectomy, complex</ENT>
              <ENT>19.00</ENT>
              <ENT>N/A</ENT>
              <ENT>9.38</ENT>
              <ENT>1.45</ENT>
              <ENT>N/A</ENT>
              <ENT>29.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58550</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo-asst vag hysterectomy</ENT>
              <ENT>14.19</ENT>
              <ENT>N/A</ENT>
              <ENT>7.61</ENT>
              <ENT>1.44</ENT>
              <ENT>N/A</ENT>
              <ENT>23.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58552</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo-vag hyst incl t/o</ENT>
              <ENT>14.19</ENT>
              <ENT>N/A</ENT>
              <ENT>7.54</ENT>
              <ENT>1.44</ENT>
              <ENT>N/A</ENT>
              <ENT>23.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58553</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo-vag hyst, complex</ENT>
              <ENT>19.00</ENT>
              <ENT>N/A</ENT>
              <ENT>9.35</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>29.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58554</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparo-vag hyst w/t/o, compl</ENT>
              <ENT>19.00</ENT>
              <ENT>N/A</ENT>
              <ENT>9.58</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>29.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58555</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hysteroscopy, dx, sep proc</ENT>
              <ENT>3.33</ENT>
              <ENT>2.12</ENT>
              <ENT>1.49</ENT>
              <ENT>0.34</ENT>
              <ENT>5.79</ENT>
              <ENT>5.16</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58558</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hysteroscopy, biopsy</ENT>
              <ENT>4.75</ENT>
              <ENT>N/A</ENT>
              <ENT>2.11</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>7.35</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58559</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hysteroscopy, lysis</ENT>
              <ENT>6.17</ENT>
              <ENT>N/A</ENT>
              <ENT>2.68</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>9.47</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58560</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hysteroscopy, resect septum</ENT>
              <ENT>7.00</ENT>
              <ENT>N/A</ENT>
              <ENT>3.03</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>10.74</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58561</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hysteroscopy, remove myoma</ENT>
              <ENT>10.00</ENT>
              <ENT>N/A</ENT>
              <ENT>4.26</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>15.28</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58562</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hysteroscopy, remove fb</ENT>
              <ENT>5.21</ENT>
              <ENT>N/A</ENT>
              <ENT>2.26</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>7.99</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58563</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hysteroscopy, ablation</ENT>
              <ENT>6.17</ENT>
              <ENT>N/A</ENT>
              <ENT>2.69</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>9.48</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58578</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Laparo proc, uterus</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58579</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Hysteroscope procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Division of fallopian tube</ENT>
              <ENT>5.60</ENT>
              <ENT>N/A</ENT>
              <ENT>3.56</ENT>
              <ENT>0.39</ENT>
              <ENT>N/A</ENT>
              <ENT>9.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Division of fallopian tube</ENT>
              <ENT>5.00</ENT>
              <ENT>N/A</ENT>
              <ENT>3.36</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>8.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58611</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ligate oviduct(s) add-on</ENT>
              <ENT>1.45</ENT>
              <ENT>N/A</ENT>
              <ENT>0.58</ENT>
              <ENT>0.07</ENT>
              <ENT>N/A</ENT>
              <ENT>2.10</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58615</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Occlude fallopian tube(s)</ENT>
              <ENT>3.90</ENT>
              <ENT>N/A</ENT>
              <ENT>2.78</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>7.08</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58660</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy, lysis</ENT>
              <ENT>11.29</ENT>
              <ENT>N/A</ENT>
              <ENT>5.50</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>17.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58661</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy, remove adnexa</ENT>
              <ENT>11.05</ENT>
              <ENT>N/A</ENT>
              <ENT>5.26</ENT>
              <ENT>1.12</ENT>
              <ENT>N/A</ENT>
              <ENT>17.43</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58662</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy, excise lesions</ENT>
              <ENT>11.79</ENT>
              <ENT>N/A</ENT>
              <ENT>6.05</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>19.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58670</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy, tubal cautery</ENT>
              <ENT>5.60</ENT>
              <ENT>N/A</ENT>
              <ENT>3.38</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>9.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58671</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy, tubal block</ENT>
              <ENT>5.60</ENT>
              <ENT>N/A</ENT>
              <ENT>3.40</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>9.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58672</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy, fimbrioplasty</ENT>
              <ENT>12.88</ENT>
              <ENT>N/A</ENT>
              <ENT>6.51</ENT>
              <ENT>1.22</ENT>
              <ENT>N/A</ENT>
              <ENT>20.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58673</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy, salpingostomy</ENT>
              <ENT>13.74</ENT>
              <ENT>N/A</ENT>
              <ENT>6.92</ENT>
              <ENT>1.40</ENT>
              <ENT>N/A</ENT>
              <ENT>22.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58679</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Laparo proc, oviduct-ovary</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of fallopian tube</ENT>
              <ENT>12.05</ENT>
              <ENT>N/A</ENT>
              <ENT>6.24</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>18.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58720</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of ovary/tube(s)</ENT>
              <ENT>11.36</ENT>
              <ENT>N/A</ENT>
              <ENT>6.07</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>18.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58740</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise fallopian tube(s)</ENT>
              <ENT>14.00</ENT>
              <ENT>N/A</ENT>
              <ENT>7.46</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>22.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58750</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair oviduct</ENT>
              <ENT>14.84</ENT>
              <ENT>N/A</ENT>
              <ENT>7.69</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>24.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58752</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise ovarian tube(s)</ENT>
              <ENT>14.84</ENT>
              <ENT>N/A</ENT>
              <ENT>7.35</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>23.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58760</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove tubal obstruction</ENT>
              <ENT>13.13</ENT>
              <ENT>N/A</ENT>
              <ENT>7.01</ENT>
              <ENT>1.34</ENT>
              <ENT>N/A</ENT>
              <ENT>21.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58770</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Create new tubal opening</ENT>
              <ENT>13.97</ENT>
              <ENT>N/A</ENT>
              <ENT>7.23</ENT>
              <ENT>1.42</ENT>
              <ENT>N/A</ENT>
              <ENT>22.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of ovarian cyst(s)</ENT>
              <ENT>4.14</ENT>
              <ENT>4.80</ENT>
              <ENT>3.16</ENT>
              <ENT>0.36</ENT>
              <ENT>9.30</ENT>
              <ENT>7.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58805</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of ovarian cyst(s)</ENT>
              <ENT>5.88</ENT>
              <ENT>N/A</ENT>
              <ENT>3.71</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>10.15</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain ovary abscess, open</ENT>
              <ENT>4.22</ENT>
              <ENT>N/A</ENT>
              <ENT>3.49</ENT>
              <ENT>0.29</ENT>
              <ENT>N/A</ENT>
              <ENT>8.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58822</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain ovary abscess, percut</ENT>
              <ENT>10.13</ENT>
              <ENT>N/A</ENT>
              <ENT>5.44</ENT>
              <ENT>0.92</ENT>
              <ENT>N/A</ENT>
              <ENT>16.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58823</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain pelvic abscess, percut</ENT>
              <ENT>3.38</ENT>
              <ENT>N/A</ENT>
              <ENT>1.54</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>5.10</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58825</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transposition, ovary(s)</ENT>
              <ENT>10.98</ENT>
              <ENT>N/A</ENT>
              <ENT>6.08</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>17.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58900</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of ovary(s)</ENT>
              <ENT>5.99</ENT>
              <ENT>N/A</ENT>
              <ENT>3.79</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>10.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49155"/>
              <ENT I="01">58920</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of ovary(s)</ENT>
              <ENT>11.36</ENT>
              <ENT>N/A</ENT>
              <ENT>5.83</ENT>
              <ENT>0.68</ENT>
              <ENT>N/A</ENT>
              <ENT>17.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58925</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of ovarian cyst(s)</ENT>
              <ENT>11.36</ENT>
              <ENT>N/A</ENT>
              <ENT>5.92</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>18.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58940</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of ovary(s)</ENT>
              <ENT>7.29</ENT>
              <ENT>N/A</ENT>
              <ENT>4.32</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>12.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58943</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of ovary(s)</ENT>
              <ENT>18.43</ENT>
              <ENT>N/A</ENT>
              <ENT>9.16</ENT>
              <ENT>1.86</ENT>
              <ENT>N/A</ENT>
              <ENT>29.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58950</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Resect ovarian malignancy</ENT>
              <ENT>16.93</ENT>
              <ENT>N/A</ENT>
              <ENT>8.94</ENT>
              <ENT>1.55</ENT>
              <ENT>N/A</ENT>
              <ENT>27.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58951</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Resect ovarian malignancy</ENT>
              <ENT>22.38</ENT>
              <ENT>N/A</ENT>
              <ENT>11.07</ENT>
              <ENT>2.20</ENT>
              <ENT>N/A</ENT>
              <ENT>35.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58952</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Resect ovarian malignancy</ENT>
              <ENT>25.01</ENT>
              <ENT>N/A</ENT>
              <ENT>12.40</ENT>
              <ENT>2.57</ENT>
              <ENT>N/A</ENT>
              <ENT>39.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58953</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tah, rad dissect for debulk</ENT>
              <ENT>32.00</ENT>
              <ENT>N/A</ENT>
              <ENT>15.03</ENT>
              <ENT>3.30</ENT>
              <ENT>N/A</ENT>
              <ENT>50.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58954</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tah rad debulk/lymph remove</ENT>
              <ENT>35.00</ENT>
              <ENT>N/A</ENT>
              <ENT>16.19</ENT>
              <ENT>3.56</ENT>
              <ENT>N/A</ENT>
              <ENT>54.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58960</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of abdomen</ENT>
              <ENT>14.65</ENT>
              <ENT>N/A</ENT>
              <ENT>7.90</ENT>
              <ENT>1.47</ENT>
              <ENT>N/A</ENT>
              <ENT>24.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58970</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Retrieval of oocyte</ENT>
              <ENT>3.53</ENT>
              <ENT>2.37</ENT>
              <ENT>1.53</ENT>
              <ENT>0.36</ENT>
              <ENT>6.26</ENT>
              <ENT>5.42</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58974</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Transfer of embryo</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58976</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transfer of embryo</ENT>
              <ENT>3.83</ENT>
              <ENT>2.69</ENT>
              <ENT>1.87</ENT>
              <ENT>0.39</ENT>
              <ENT>6.91</ENT>
              <ENT>6.09</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">58999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Genital surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amniocentesis, diagnostic</ENT>
              <ENT>1.30</ENT>
              <ENT>2.17</ENT>
              <ENT>0.70</ENT>
              <ENT>0.23</ENT>
              <ENT>3.70</ENT>
              <ENT>2.23</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59001</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Amniocentesis, therapeutic</ENT>
              <ENT>3.00</ENT>
              <ENT>N/A</ENT>
              <ENT>1.44</ENT>
              <ENT>0.23</ENT>
              <ENT>N/A</ENT>
              <ENT>4.67</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59012</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fetal cord puncture,prenatal</ENT>
              <ENT>3.45</ENT>
              <ENT>N/A</ENT>
              <ENT>1.59</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>5.66</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59015</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chorion biopsy</ENT>
              <ENT>2.20</ENT>
              <ENT>1.61</ENT>
              <ENT>1.08</ENT>
              <ENT>0.40</ENT>
              <ENT>4.21</ENT>
              <ENT>3.68</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fetal contract stress test</ENT>
              <ENT>0.66</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>1.65</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59020</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Fetal contract stress test</ENT>
              <ENT>0.66</ENT>
              <ENT>0.27</ENT>
              <ENT>0.27</ENT>
              <ENT>0.12</ENT>
              <ENT>1.05</ENT>
              <ENT>1.05</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59020</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Fetal contract stress test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59025</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fetal non-stress test</ENT>
              <ENT>0.53</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59025</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Fetal non-stress test</ENT>
              <ENT>0.53</ENT>
              <ENT>0.21</ENT>
              <ENT>0.21</ENT>
              <ENT>0.10</ENT>
              <ENT>0.84</ENT>
              <ENT>0.84</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59025</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Fetal non-stress test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.23</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.25</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59030</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fetal scalp blood sample</ENT>
              <ENT>1.99</ENT>
              <ENT>N/A</ENT>
              <ENT>1.07</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>3.42</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59050</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fetal monitor w/report</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>1.41</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59051</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fetal monitor/interpret only</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.30</ENT>
              <ENT>0.14</ENT>
              <ENT>N/A</ENT>
              <ENT>1.18</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove uterus lesion</ENT>
              <ENT>12.35</ENT>
              <ENT>N/A</ENT>
              <ENT>6.74</ENT>
              <ENT>2.21</ENT>
              <ENT>N/A</ENT>
              <ENT>21.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat ectopic pregnancy</ENT>
              <ENT>11.49</ENT>
              <ENT>N/A</ENT>
              <ENT>6.54</ENT>
              <ENT>2.06</ENT>
              <ENT>N/A</ENT>
              <ENT>20.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59121</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat ectopic pregnancy</ENT>
              <ENT>11.67</ENT>
              <ENT>N/A</ENT>
              <ENT>6.61</ENT>
              <ENT>2.09</ENT>
              <ENT>N/A</ENT>
              <ENT>20.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat ectopic pregnancy</ENT>
              <ENT>14.22</ENT>
              <ENT>N/A</ENT>
              <ENT>6.31</ENT>
              <ENT>2.54</ENT>
              <ENT>N/A</ENT>
              <ENT>23.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59135</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat ectopic pregnancy</ENT>
              <ENT>13.88</ENT>
              <ENT>N/A</ENT>
              <ENT>7.39</ENT>
              <ENT>2.49</ENT>
              <ENT>N/A</ENT>
              <ENT>23.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59136</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat ectopic pregnancy</ENT>
              <ENT>13.18</ENT>
              <ENT>N/A</ENT>
              <ENT>6.92</ENT>
              <ENT>2.36</ENT>
              <ENT>N/A</ENT>
              <ENT>22.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat ectopic pregnancy</ENT>
              <ENT>5.46</ENT>
              <ENT>5.39</ENT>
              <ENT>3.72</ENT>
              <ENT>0.98</ENT>
              <ENT>11.83</ENT>
              <ENT>10.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat ectopic pregnancy</ENT>
              <ENT>11.67</ENT>
              <ENT>N/A</ENT>
              <ENT>6.31</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>19.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59151</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat ectopic pregnancy</ENT>
              <ENT>11.49</ENT>
              <ENT>N/A</ENT>
              <ENT>6.30</ENT>
              <ENT>1.41</ENT>
              <ENT>N/A</ENT>
              <ENT>19.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59160</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>D &amp; c after delivery</ENT>
              <ENT>2.71</ENT>
              <ENT>3.35</ENT>
              <ENT>2.17</ENT>
              <ENT>0.49</ENT>
              <ENT>6.55</ENT>
              <ENT>5.37</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert cervical dilator</ENT>
              <ENT>0.79</ENT>
              <ENT>1.25</ENT>
              <ENT>0.31</ENT>
              <ENT>0.15</ENT>
              <ENT>2.19</ENT>
              <ENT>1.25</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Episiotomy or vaginal repair</ENT>
              <ENT>2.41</ENT>
              <ENT>2.21</ENT>
              <ENT>0.98</ENT>
              <ENT>0.43</ENT>
              <ENT>5.05</ENT>
              <ENT>3.82</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of cervix</ENT>
              <ENT>2.48</ENT>
              <ENT>N/A</ENT>
              <ENT>1.29</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>4.22</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59325</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of cervix</ENT>
              <ENT>4.07</ENT>
              <ENT>N/A</ENT>
              <ENT>1.96</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>6.76</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59350</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of uterus</ENT>
              <ENT>4.95</ENT>
              <ENT>N/A</ENT>
              <ENT>2.00</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>7.83</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Obstetrical care</ENT>
              <ENT>23.06</ENT>
              <ENT>N/A</ENT>
              <ENT>15.87</ENT>
              <ENT>4.14</ENT>
              <ENT>N/A</ENT>
              <ENT>43.07</ENT>
              <ENT>MMM </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59409</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Obstetrical care</ENT>
              <ENT>13.50</ENT>
              <ENT>N/A</ENT>
              <ENT>5.42</ENT>
              <ENT>2.42</ENT>
              <ENT>N/A</ENT>
              <ENT>21.34</ENT>
              <ENT>MMM </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59410</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Obstetrical care</ENT>
              <ENT>14.78</ENT>
              <ENT>N/A</ENT>
              <ENT>6.46</ENT>
              <ENT>2.65</ENT>
              <ENT>N/A</ENT>
              <ENT>23.89</ENT>
              <ENT>MMM </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59412</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Antepartum manipulation</ENT>
              <ENT>1.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.83</ENT>
              <ENT>0.31</ENT>
              <ENT>N/A</ENT>
              <ENT>2.85</ENT>
              <ENT>MMM </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59414</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Deliver placenta</ENT>
              <ENT>1.61</ENT>
              <ENT>N/A</ENT>
              <ENT>0.64</ENT>
              <ENT>0.29</ENT>
              <ENT>N/A</ENT>
              <ENT>2.54</ENT>
              <ENT>MMM </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59425</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Antepartum care only</ENT>
              <ENT>4.81</ENT>
              <ENT>4.38</ENT>
              <ENT>1.90</ENT>
              <ENT>0.86</ENT>
              <ENT>10.05</ENT>
              <ENT>7.57</ENT>
              <ENT>MMM </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59426</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Antepartum care only</ENT>
              <ENT>8.28</ENT>
              <ENT>7.85</ENT>
              <ENT>3.29</ENT>
              <ENT>1.49</ENT>
              <ENT>17.62</ENT>
              <ENT>13.06</ENT>
              <ENT>MMM </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59430</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Care after delivery</ENT>
              <ENT>2.13</ENT>
              <ENT>1.27</ENT>
              <ENT>0.96</ENT>
              <ENT>0.38</ENT>
              <ENT>3.78</ENT>
              <ENT>3.47</ENT>
              <ENT>MMM </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cesarean delivery</ENT>
              <ENT>26.22</ENT>
              <ENT>N/A</ENT>
              <ENT>17.86</ENT>
              <ENT>4.70</ENT>
              <ENT>N/A</ENT>
              <ENT>48.78</ENT>
              <ENT>MMM </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59514</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cesarean delivery only</ENT>
              <ENT>15.97</ENT>
              <ENT>N/A</ENT>
              <ENT>6.35</ENT>
              <ENT>2.86</ENT>
              <ENT>N/A</ENT>
              <ENT>25.18</ENT>
              <ENT>MMM </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59515</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cesarean delivery</ENT>
              <ENT>17.37</ENT>
              <ENT>N/A</ENT>
              <ENT>8.03</ENT>
              <ENT>3.12</ENT>
              <ENT>N/A</ENT>
              <ENT>28.52</ENT>
              <ENT>MMM </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59525</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove uterus after cesarean</ENT>
              <ENT>8.54</ENT>
              <ENT>N/A</ENT>
              <ENT>3.38</ENT>
              <ENT>1.53</ENT>
              <ENT>N/A</ENT>
              <ENT>13.45</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59610</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vbac delivery</ENT>
              <ENT>24.62</ENT>
              <ENT>N/A</ENT>
              <ENT>16.44</ENT>
              <ENT>4.41</ENT>
              <ENT>N/A</ENT>
              <ENT>45.47</ENT>
              <ENT>MMM </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59612</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vbac delivery only</ENT>
              <ENT>15.06</ENT>
              <ENT>N/A</ENT>
              <ENT>6.18</ENT>
              <ENT>2.70</ENT>
              <ENT>N/A</ENT>
              <ENT>23.94</ENT>
              <ENT>MMM </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59614</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vbac care after delivery</ENT>
              <ENT>16.34</ENT>
              <ENT>N/A</ENT>
              <ENT>7.10</ENT>
              <ENT>2.93</ENT>
              <ENT>N/A</ENT>
              <ENT>26.37</ENT>
              <ENT>MMM </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59618</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Attempted vbac delivery</ENT>
              <ENT>27.78</ENT>
              <ENT>N/A</ENT>
              <ENT>18.97</ENT>
              <ENT>4.98</ENT>
              <ENT>N/A</ENT>
              <ENT>51.73</ENT>
              <ENT>MMM </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49156"/>
              <ENT I="01">59620</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Attempted vbac delivery only</ENT>
              <ENT>17.53</ENT>
              <ENT>N/A</ENT>
              <ENT>6.91</ENT>
              <ENT>3.15</ENT>
              <ENT>N/A</ENT>
              <ENT>27.59</ENT>
              <ENT>MMM </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59622</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Attempted vbac after care</ENT>
              <ENT>18.93</ENT>
              <ENT>N/A</ENT>
              <ENT>8.85</ENT>
              <ENT>3.39</ENT>
              <ENT>N/A</ENT>
              <ENT>31.17</ENT>
              <ENT>MMM </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59812</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of miscarriage</ENT>
              <ENT>4.01</ENT>
              <ENT>N/A</ENT>
              <ENT>2.62</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>7.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Care of miscarriage</ENT>
              <ENT>4.01</ENT>
              <ENT>N/A</ENT>
              <ENT>3.62</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>8.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59821</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of miscarriage</ENT>
              <ENT>4.47</ENT>
              <ENT>N/A</ENT>
              <ENT>3.52</ENT>
              <ENT>0.80</ENT>
              <ENT>N/A</ENT>
              <ENT>8.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59830</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat uterus infection</ENT>
              <ENT>6.11</ENT>
              <ENT>N/A</ENT>
              <ENT>4.10</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>11.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59840</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Abortion</ENT>
              <ENT>3.01</ENT>
              <ENT>N/A</ENT>
              <ENT>2.18</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>5.73</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59841</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Abortion</ENT>
              <ENT>5.24</ENT>
              <ENT>3.59</ENT>
              <ENT>3.05</ENT>
              <ENT>0.94</ENT>
              <ENT>9.77</ENT>
              <ENT>9.23</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59850</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Abortion</ENT>
              <ENT>5.91</ENT>
              <ENT>N/A</ENT>
              <ENT>3.33</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>10.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59851</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Abortion</ENT>
              <ENT>5.93</ENT>
              <ENT>N/A</ENT>
              <ENT>3.89</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>10.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59852</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Abortion</ENT>
              <ENT>8.24</ENT>
              <ENT>N/A</ENT>
              <ENT>5.39</ENT>
              <ENT>1.48</ENT>
              <ENT>N/A</ENT>
              <ENT>15.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59855</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Abortion</ENT>
              <ENT>6.12</ENT>
              <ENT>N/A</ENT>
              <ENT>3.72</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>10.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59856</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Abortion</ENT>
              <ENT>7.48</ENT>
              <ENT>N/A</ENT>
              <ENT>4.29</ENT>
              <ENT>1.34</ENT>
              <ENT>N/A</ENT>
              <ENT>13.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59857</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Abortion</ENT>
              <ENT>9.29</ENT>
              <ENT>N/A</ENT>
              <ENT>4.78</ENT>
              <ENT>1.66</ENT>
              <ENT>N/A</ENT>
              <ENT>15.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59866</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Abortion (mpr)</ENT>
              <ENT>4.00</ENT>
              <ENT>N/A</ENT>
              <ENT>1.86</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>6.58</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59870</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Evacuate mole of uterus</ENT>
              <ENT>6.01</ENT>
              <ENT>N/A</ENT>
              <ENT>4.62</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>11.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59871</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove cerclage suture</ENT>
              <ENT>2.13</ENT>
              <ENT>1.81</ENT>
              <ENT>1.16</ENT>
              <ENT>0.38</ENT>
              <ENT>4.32</ENT>
              <ENT>3.67</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59898</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Laparo proc, ob care/deliver</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">59899</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Maternity care procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain thyroid/tongue cyst</ENT>
              <ENT>1.76</ENT>
              <ENT>2.23</ENT>
              <ENT>2.09</ENT>
              <ENT>0.14</ENT>
              <ENT>4.13</ENT>
              <ENT>3.99</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60001</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Aspirate/inject thyriod cyst</ENT>
              <ENT>0.97</ENT>
              <ENT>1.54</ENT>
              <ENT>0.35</ENT>
              <ENT>0.06</ENT>
              <ENT>2.57</ENT>
              <ENT>1.38</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of thyroid</ENT>
              <ENT>1.56</ENT>
              <ENT>1.45</ENT>
              <ENT>0.54</ENT>
              <ENT>0.05</ENT>
              <ENT>3.06</ENT>
              <ENT>2.15</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove thyroid lesion</ENT>
              <ENT>9.55</ENT>
              <ENT>N/A</ENT>
              <ENT>6.24</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>16.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60210</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial thyroid excision</ENT>
              <ENT>10.88</ENT>
              <ENT>N/A</ENT>
              <ENT>5.94</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>17.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60212</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial thyroid excision</ENT>
              <ENT>16.03</ENT>
              <ENT>N/A</ENT>
              <ENT>7.96</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>25.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of thyroid</ENT>
              <ENT>11.90</ENT>
              <ENT>N/A</ENT>
              <ENT>6.47</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>19.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60225</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of thyroid</ENT>
              <ENT>14.19</ENT>
              <ENT>N/A</ENT>
              <ENT>7.67</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>23.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60240</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of thyroid</ENT>
              <ENT>16.06</ENT>
              <ENT>N/A</ENT>
              <ENT>7.95</ENT>
              <ENT>1.50</ENT>
              <ENT>N/A</ENT>
              <ENT>25.51</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60252</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of thyroid</ENT>
              <ENT>20.57</ENT>
              <ENT>N/A</ENT>
              <ENT>10.51</ENT>
              <ENT>1.63</ENT>
              <ENT>N/A</ENT>
              <ENT>32.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60254</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive thyroid surgery</ENT>
              <ENT>26.99</ENT>
              <ENT>N/A</ENT>
              <ENT>14.72</ENT>
              <ENT>1.96</ENT>
              <ENT>N/A</ENT>
              <ENT>43.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60260</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repeat thyroid surgery</ENT>
              <ENT>17.47</ENT>
              <ENT>N/A</ENT>
              <ENT>9.09</ENT>
              <ENT>1.39</ENT>
              <ENT>N/A</ENT>
              <ENT>27.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60270</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of thyroid</ENT>
              <ENT>20.27</ENT>
              <ENT>N/A</ENT>
              <ENT>10.69</ENT>
              <ENT>1.78</ENT>
              <ENT>N/A</ENT>
              <ENT>32.74</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60271</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of thyroid</ENT>
              <ENT>16.83</ENT>
              <ENT>N/A</ENT>
              <ENT>8.98</ENT>
              <ENT>1.35</ENT>
              <ENT>N/A</ENT>
              <ENT>27.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60280</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove thyroid duct lesion</ENT>
              <ENT>5.87</ENT>
              <ENT>N/A</ENT>
              <ENT>4.95</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>11.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60281</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove thyroid duct lesion</ENT>
              <ENT>8.53</ENT>
              <ENT>N/A</ENT>
              <ENT>6.14</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>15.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore parathyroid glands</ENT>
              <ENT>16.23</ENT>
              <ENT>N/A</ENT>
              <ENT>7.66</ENT>
              <ENT>1.61</ENT>
              <ENT>N/A</ENT>
              <ENT>25.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60502</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Re-explore parathyroids</ENT>
              <ENT>20.35</ENT>
              <ENT>N/A</ENT>
              <ENT>9.59</ENT>
              <ENT>2.00</ENT>
              <ENT>N/A</ENT>
              <ENT>31.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60505</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore parathyroid glands</ENT>
              <ENT>21.49</ENT>
              <ENT>N/A</ENT>
              <ENT>11.12</ENT>
              <ENT>2.14</ENT>
              <ENT>N/A</ENT>
              <ENT>34.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60512</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Autotransplant parathyroid</ENT>
              <ENT>4.45</ENT>
              <ENT>N/A</ENT>
              <ENT>1.66</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>6.55</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of thymus gland</ENT>
              <ENT>16.81</ENT>
              <ENT>N/A</ENT>
              <ENT>8.37</ENT>
              <ENT>1.84</ENT>
              <ENT>N/A</ENT>
              <ENT>27.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60521</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of thymus gland</ENT>
              <ENT>18.87</ENT>
              <ENT>N/A</ENT>
              <ENT>9.39</ENT>
              <ENT>2.34</ENT>
              <ENT>N/A</ENT>
              <ENT>30.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60522</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of thymus gland</ENT>
              <ENT>23.09</ENT>
              <ENT>N/A</ENT>
              <ENT>11.11</ENT>
              <ENT>2.83</ENT>
              <ENT>N/A</ENT>
              <ENT>37.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60540</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore adrenal gland</ENT>
              <ENT>17.03</ENT>
              <ENT>N/A</ENT>
              <ENT>7.79</ENT>
              <ENT>1.42</ENT>
              <ENT>N/A</ENT>
              <ENT>26.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60545</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore adrenal gland</ENT>
              <ENT>19.88</ENT>
              <ENT>N/A</ENT>
              <ENT>8.76</ENT>
              <ENT>1.75</ENT>
              <ENT>N/A</ENT>
              <ENT>30.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove carotid body lesion</ENT>
              <ENT>17.93</ENT>
              <ENT>N/A</ENT>
              <ENT>10.94</ENT>
              <ENT>1.87</ENT>
              <ENT>N/A</ENT>
              <ENT>30.74</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove carotid body lesion</ENT>
              <ENT>20.24</ENT>
              <ENT>N/A</ENT>
              <ENT>12.95</ENT>
              <ENT>2.28</ENT>
              <ENT>N/A</ENT>
              <ENT>35.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60650</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laparoscopy adrenalectomy</ENT>
              <ENT>20.00</ENT>
              <ENT>N/A</ENT>
              <ENT>8.13</ENT>
              <ENT>1.98</ENT>
              <ENT>N/A</ENT>
              <ENT>30.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60659</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Laparo proc, endocrine</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">60699</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Endocrine surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove cranial cavity fluid</ENT>
              <ENT>1.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.98</ENT>
              <ENT>0.13</ENT>
              <ENT>N/A</ENT>
              <ENT>2.69</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61001</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove cranial cavity fluid</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>1.09</ENT>
              <ENT>0.15</ENT>
              <ENT>N/A</ENT>
              <ENT>2.73</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove brain cavity fluid</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>1.39</ENT>
              <ENT>0.26</ENT>
              <ENT>N/A</ENT>
              <ENT>3.16</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61026</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection into brain canal</ENT>
              <ENT>1.69</ENT>
              <ENT>N/A</ENT>
              <ENT>1.45</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>3.35</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61050</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove brain canal fluid</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>1.28</ENT>
              <ENT>0.13</ENT>
              <ENT>N/A</ENT>
              <ENT>2.92</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61055</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection into brain canal</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>1.43</ENT>
              <ENT>0.13</ENT>
              <ENT>N/A</ENT>
              <ENT>3.66</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61070</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Brain canal shunt procedure</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>1.05</ENT>
              <ENT>0.09</ENT>
              <ENT>N/A</ENT>
              <ENT>2.03</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61105</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Twist drill hole</ENT>
              <ENT>5.14</ENT>
              <ENT>N/A</ENT>
              <ENT>4.03</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>10.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49157"/>
              <ENT I="01">61107</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drill skull for implantation</ENT>
              <ENT>5.00</ENT>
              <ENT>N/A</ENT>
              <ENT>3.39</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>9.41</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61108</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drill skull for drainage</ENT>
              <ENT>10.19</ENT>
              <ENT>N/A</ENT>
              <ENT>7.29</ENT>
              <ENT>2.04</ENT>
              <ENT>N/A</ENT>
              <ENT>19.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Burr hole for puncture</ENT>
              <ENT>8.76</ENT>
              <ENT>N/A</ENT>
              <ENT>6.11</ENT>
              <ENT>1.81</ENT>
              <ENT>N/A</ENT>
              <ENT>16.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pierce skull for biopsy</ENT>
              <ENT>15.90</ENT>
              <ENT>N/A</ENT>
              <ENT>10.09</ENT>
              <ENT>3.15</ENT>
              <ENT>N/A</ENT>
              <ENT>29.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pierce skull for drainage</ENT>
              <ENT>17.57</ENT>
              <ENT>N/A</ENT>
              <ENT>10.62</ENT>
              <ENT>3.52</ENT>
              <ENT>N/A</ENT>
              <ENT>31.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61151</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pierce skull for drainage</ENT>
              <ENT>12.42</ENT>
              <ENT>N/A</ENT>
              <ENT>7.99</ENT>
              <ENT>2.45</ENT>
              <ENT>N/A</ENT>
              <ENT>22.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61154</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pierce skull &amp; remove clot</ENT>
              <ENT>14.99</ENT>
              <ENT>N/A</ENT>
              <ENT>9.68</ENT>
              <ENT>3.05</ENT>
              <ENT>N/A</ENT>
              <ENT>27.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61156</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pierce skull for drainage</ENT>
              <ENT>16.32</ENT>
              <ENT>N/A</ENT>
              <ENT>10.04</ENT>
              <ENT>3.42</ENT>
              <ENT>N/A</ENT>
              <ENT>29.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61210</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pierce skull, implant device</ENT>
              <ENT>5.84</ENT>
              <ENT>N/A</ENT>
              <ENT>3.79</ENT>
              <ENT>1.16</ENT>
              <ENT>N/A</ENT>
              <ENT>10.79</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61215</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert brain-fluid device</ENT>
              <ENT>4.89</ENT>
              <ENT>N/A</ENT>
              <ENT>4.08</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>9.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pierce skull &amp; explore</ENT>
              <ENT>10.42</ENT>
              <ENT>N/A</ENT>
              <ENT>6.99</ENT>
              <ENT>2.02</ENT>
              <ENT>N/A</ENT>
              <ENT>19.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61253</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pierce skull &amp; explore</ENT>
              <ENT>12.36</ENT>
              <ENT>N/A</ENT>
              <ENT>7.87</ENT>
              <ENT>2.26</ENT>
              <ENT>N/A</ENT>
              <ENT>22.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61304</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Open skull for exploration</ENT>
              <ENT>21.96</ENT>
              <ENT>N/A</ENT>
              <ENT>13.14</ENT>
              <ENT>4.33</ENT>
              <ENT>N/A</ENT>
              <ENT>39.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61305</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Open skull for exploration</ENT>
              <ENT>26.61</ENT>
              <ENT>N/A</ENT>
              <ENT>15.66</ENT>
              <ENT>5.25</ENT>
              <ENT>N/A</ENT>
              <ENT>47.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61312</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Open skull for drainage</ENT>
              <ENT>24.57</ENT>
              <ENT>N/A</ENT>
              <ENT>15.39</ENT>
              <ENT>4.99</ENT>
              <ENT>N/A</ENT>
              <ENT>44.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61313</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Open skull for drainage</ENT>
              <ENT>24.93</ENT>
              <ENT>N/A</ENT>
              <ENT>15.16</ENT>
              <ENT>5.07</ENT>
              <ENT>N/A</ENT>
              <ENT>45.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61314</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Open skull for drainage</ENT>
              <ENT>24.23</ENT>
              <ENT>N/A</ENT>
              <ENT>13.32</ENT>
              <ENT>4.00</ENT>
              <ENT>N/A</ENT>
              <ENT>41.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61315</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Open skull for drainage</ENT>
              <ENT>27.68</ENT>
              <ENT>N/A</ENT>
              <ENT>16.37</ENT>
              <ENT>5.62</ENT>
              <ENT>N/A</ENT>
              <ENT>49.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61316</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implt cran bone flap to abdo</ENT>
              <ENT>1.39</ENT>
              <ENT>N/A</ENT>
              <ENT>0.57</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>2.39</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Open skull for drainage</ENT>
              <ENT>25.62</ENT>
              <ENT>N/A</ENT>
              <ENT>15.11</ENT>
              <ENT>5.20</ENT>
              <ENT>N/A</ENT>
              <ENT>45.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61321</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Open skull for drainage</ENT>
              <ENT>28.50</ENT>
              <ENT>N/A</ENT>
              <ENT>16.49</ENT>
              <ENT>5.35</ENT>
              <ENT>N/A</ENT>
              <ENT>50.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61322</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompressive craniotomy</ENT>
              <ENT>29.50</ENT>
              <ENT>N/A</ENT>
              <ENT>14.57</ENT>
              <ENT>4.99</ENT>
              <ENT>N/A</ENT>
              <ENT>49.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61323</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompressive lobectomy</ENT>
              <ENT>31.00</ENT>
              <ENT>N/A</ENT>
              <ENT>14.76</ENT>
              <ENT>4.99</ENT>
              <ENT>N/A</ENT>
              <ENT>50.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61330</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompress eye socket</ENT>
              <ENT>23.32</ENT>
              <ENT>N/A</ENT>
              <ENT>14.05</ENT>
              <ENT>2.58</ENT>
              <ENT>N/A</ENT>
              <ENT>39.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61332</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore/biopsy eye socket</ENT>
              <ENT>27.28</ENT>
              <ENT>N/A</ENT>
              <ENT>15.97</ENT>
              <ENT>4.15</ENT>
              <ENT>N/A</ENT>
              <ENT>47.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61333</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore orbit/remove lesion</ENT>
              <ENT>27.95</ENT>
              <ENT>N/A</ENT>
              <ENT>15.97</ENT>
              <ENT>2.24</ENT>
              <ENT>N/A</ENT>
              <ENT>46.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61334</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore orbit/remove object</ENT>
              <ENT>18.27</ENT>
              <ENT>N/A</ENT>
              <ENT>10.91</ENT>
              <ENT>3.02</ENT>
              <ENT>N/A</ENT>
              <ENT>32.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61340</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Subtemporal decompression</ENT>
              <ENT>18.66</ENT>
              <ENT>N/A</ENT>
              <ENT>11.39</ENT>
              <ENT>3.66</ENT>
              <ENT>N/A</ENT>
              <ENT>33.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61343</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise skull (press relief)</ENT>
              <ENT>29.77</ENT>
              <ENT>N/A</ENT>
              <ENT>17.43</ENT>
              <ENT>6.04</ENT>
              <ENT>N/A</ENT>
              <ENT>53.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61345</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Relieve cranial pressure</ENT>
              <ENT>27.20</ENT>
              <ENT>N/A</ENT>
              <ENT>15.98</ENT>
              <ENT>5.23</ENT>
              <ENT>N/A</ENT>
              <ENT>48.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61440</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise skull for surgery</ENT>
              <ENT>26.63</ENT>
              <ENT>N/A</ENT>
              <ENT>14.76</ENT>
              <ENT>5.57</ENT>
              <ENT>N/A</ENT>
              <ENT>46.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise skull for surgery</ENT>
              <ENT>25.95</ENT>
              <ENT>N/A</ENT>
              <ENT>14.84</ENT>
              <ENT>5.11</ENT>
              <ENT>N/A</ENT>
              <ENT>45.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61458</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise skull for brain wound</ENT>
              <ENT>27.29</ENT>
              <ENT>N/A</ENT>
              <ENT>16.05</ENT>
              <ENT>5.28</ENT>
              <ENT>N/A</ENT>
              <ENT>48.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61460</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise skull for surgery</ENT>
              <ENT>28.39</ENT>
              <ENT>N/A</ENT>
              <ENT>16.96</ENT>
              <ENT>5.13</ENT>
              <ENT>N/A</ENT>
              <ENT>50.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61470</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise skull for surgery</ENT>
              <ENT>26.06</ENT>
              <ENT>N/A</ENT>
              <ENT>14.40</ENT>
              <ENT>4.65</ENT>
              <ENT>N/A</ENT>
              <ENT>45.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61480</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise skull for surgery</ENT>
              <ENT>26.49</ENT>
              <ENT>N/A</ENT>
              <ENT>15.23</ENT>
              <ENT>5.54</ENT>
              <ENT>N/A</ENT>
              <ENT>47.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61490</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise skull for surgery</ENT>
              <ENT>25.66</ENT>
              <ENT>N/A</ENT>
              <ENT>14.87</ENT>
              <ENT>5.37</ENT>
              <ENT>N/A</ENT>
              <ENT>45.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of skull lesion</ENT>
              <ENT>17.92</ENT>
              <ENT>N/A</ENT>
              <ENT>11.26</ENT>
              <ENT>3.26</ENT>
              <ENT>N/A</ENT>
              <ENT>32.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61501</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove infected skull bone</ENT>
              <ENT>14.84</ENT>
              <ENT>N/A</ENT>
              <ENT>9.62</ENT>
              <ENT>2.63</ENT>
              <ENT>N/A</ENT>
              <ENT>27.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of brain lesion</ENT>
              <ENT>28.45</ENT>
              <ENT>N/A</ENT>
              <ENT>17.22</ENT>
              <ENT>5.77</ENT>
              <ENT>N/A</ENT>
              <ENT>51.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61512</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove brain lining lesion</ENT>
              <ENT>35.09</ENT>
              <ENT>N/A</ENT>
              <ENT>20.36</ENT>
              <ENT>7.14</ENT>
              <ENT>N/A</ENT>
              <ENT>62.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61514</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of brain abscess</ENT>
              <ENT>25.26</ENT>
              <ENT>N/A</ENT>
              <ENT>14.95</ENT>
              <ENT>5.12</ENT>
              <ENT>N/A</ENT>
              <ENT>45.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61516</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of brain lesion</ENT>
              <ENT>24.61</ENT>
              <ENT>N/A</ENT>
              <ENT>14.78</ENT>
              <ENT>4.94</ENT>
              <ENT>N/A</ENT>
              <ENT>44.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61517</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implt brain chemotx add-on</ENT>
              <ENT>1.38</ENT>
              <ENT>N/A</ENT>
              <ENT>0.57</ENT>
              <ENT>0.08</ENT>
              <ENT>N/A</ENT>
              <ENT>2.03</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61518</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of brain lesion</ENT>
              <ENT>37.32</ENT>
              <ENT>N/A</ENT>
              <ENT>21.82</ENT>
              <ENT>7.53</ENT>
              <ENT>N/A</ENT>
              <ENT>66.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61519</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove brain lining lesion</ENT>
              <ENT>41.39</ENT>
              <ENT>N/A</ENT>
              <ENT>23.44</ENT>
              <ENT>8.15</ENT>
              <ENT>N/A</ENT>
              <ENT>72.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of brain lesion</ENT>
              <ENT>54.84</ENT>
              <ENT>N/A</ENT>
              <ENT>31.26</ENT>
              <ENT>10.10</ENT>
              <ENT>N/A</ENT>
              <ENT>96.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61521</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of brain lesion</ENT>
              <ENT>44.48</ENT>
              <ENT>N/A</ENT>
              <ENT>25.05</ENT>
              <ENT>8.85</ENT>
              <ENT>N/A</ENT>
              <ENT>78.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61522</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of brain abscess</ENT>
              <ENT>29.45</ENT>
              <ENT>N/A</ENT>
              <ENT>17.03</ENT>
              <ENT>5.30</ENT>
              <ENT>N/A</ENT>
              <ENT>51.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61524</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of brain lesion</ENT>
              <ENT>27.86</ENT>
              <ENT>N/A</ENT>
              <ENT>16.26</ENT>
              <ENT>5.01</ENT>
              <ENT>N/A</ENT>
              <ENT>49.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61526</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of brain lesion</ENT>
              <ENT>52.17</ENT>
              <ENT>N/A</ENT>
              <ENT>30.38</ENT>
              <ENT>6.72</ENT>
              <ENT>N/A</ENT>
              <ENT>89.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of brain lesion</ENT>
              <ENT>43.86</ENT>
              <ENT>N/A</ENT>
              <ENT>25.88</ENT>
              <ENT>6.17</ENT>
              <ENT>N/A</ENT>
              <ENT>75.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61531</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant brain electrodes</ENT>
              <ENT>14.63</ENT>
              <ENT>N/A</ENT>
              <ENT>9.51</ENT>
              <ENT>2.84</ENT>
              <ENT>N/A</ENT>
              <ENT>26.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61533</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant brain electrodes</ENT>
              <ENT>19.71</ENT>
              <ENT>N/A</ENT>
              <ENT>11.98</ENT>
              <ENT>3.80</ENT>
              <ENT>N/A</ENT>
              <ENT>35.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61534</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of brain lesion</ENT>
              <ENT>20.97</ENT>
              <ENT>N/A</ENT>
              <ENT>12.62</ENT>
              <ENT>4.15</ENT>
              <ENT>N/A</ENT>
              <ENT>37.74</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61535</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove brain electrodes</ENT>
              <ENT>11.63</ENT>
              <ENT>N/A</ENT>
              <ENT>7.82</ENT>
              <ENT>2.29</ENT>
              <ENT>N/A</ENT>
              <ENT>21.74</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61536</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of brain lesion</ENT>
              <ENT>35.52</ENT>
              <ENT>N/A</ENT>
              <ENT>20.47</ENT>
              <ENT>6.68</ENT>
              <ENT>N/A</ENT>
              <ENT>62.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49158"/>
              <ENT I="01">61538</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of brain tissue</ENT>
              <ENT>26.81</ENT>
              <ENT>N/A</ENT>
              <ENT>15.95</ENT>
              <ENT>5.38</ENT>
              <ENT>N/A</ENT>
              <ENT>48.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61539</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of brain tissue</ENT>
              <ENT>32.08</ENT>
              <ENT>N/A</ENT>
              <ENT>18.43</ENT>
              <ENT>6.62</ENT>
              <ENT>N/A</ENT>
              <ENT>57.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61541</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of brain tissue</ENT>
              <ENT>28.85</ENT>
              <ENT>N/A</ENT>
              <ENT>16.77</ENT>
              <ENT>5.50</ENT>
              <ENT>N/A</ENT>
              <ENT>51.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61542</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of brain tissue</ENT>
              <ENT>31.02</ENT>
              <ENT>N/A</ENT>
              <ENT>18.46</ENT>
              <ENT>6.49</ENT>
              <ENT>N/A</ENT>
              <ENT>55.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61543</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of brain tissue</ENT>
              <ENT>29.22</ENT>
              <ENT>N/A</ENT>
              <ENT>16.98</ENT>
              <ENT>6.11</ENT>
              <ENT>N/A</ENT>
              <ENT>52.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61544</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove &amp; treat brain lesion</ENT>
              <ENT>25.50</ENT>
              <ENT>N/A</ENT>
              <ENT>14.21</ENT>
              <ENT>4.91</ENT>
              <ENT>N/A</ENT>
              <ENT>44.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61545</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of brain tumor</ENT>
              <ENT>43.80</ENT>
              <ENT>N/A</ENT>
              <ENT>24.99</ENT>
              <ENT>8.88</ENT>
              <ENT>N/A</ENT>
              <ENT>77.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61546</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of pituitary gland</ENT>
              <ENT>31.30</ENT>
              <ENT>N/A</ENT>
              <ENT>18.13</ENT>
              <ENT>6.06</ENT>
              <ENT>N/A</ENT>
              <ENT>55.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61548</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of pituitary gland</ENT>
              <ENT>21.53</ENT>
              <ENT>N/A</ENT>
              <ENT>13.29</ENT>
              <ENT>3.63</ENT>
              <ENT>N/A</ENT>
              <ENT>38.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61550</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release of skull seams</ENT>
              <ENT>14.65</ENT>
              <ENT>N/A</ENT>
              <ENT>7.34</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>23.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61552</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release of skull seams</ENT>
              <ENT>19.56</ENT>
              <ENT>N/A</ENT>
              <ENT>9.68</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>30.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61556</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise skull/sutures</ENT>
              <ENT>22.26</ENT>
              <ENT>N/A</ENT>
              <ENT>11.81</ENT>
              <ENT>3.57</ENT>
              <ENT>N/A</ENT>
              <ENT>37.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61557</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise skull/sutures</ENT>
              <ENT>22.38</ENT>
              <ENT>N/A</ENT>
              <ENT>13.91</ENT>
              <ENT>4.68</ENT>
              <ENT>N/A</ENT>
              <ENT>40.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61558</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of skull/sutures</ENT>
              <ENT>25.58</ENT>
              <ENT>N/A</ENT>
              <ENT>14.75</ENT>
              <ENT>2.61</ENT>
              <ENT>N/A</ENT>
              <ENT>42.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61559</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of skull/sutures</ENT>
              <ENT>32.79</ENT>
              <ENT>N/A</ENT>
              <ENT>19.61</ENT>
              <ENT>6.86</ENT>
              <ENT>N/A</ENT>
              <ENT>59.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61563</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of skull tumor</ENT>
              <ENT>26.83</ENT>
              <ENT>N/A</ENT>
              <ENT>15.80</ENT>
              <ENT>4.46</ENT>
              <ENT>N/A</ENT>
              <ENT>47.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61564</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excision of skull tumor</ENT>
              <ENT>33.83</ENT>
              <ENT>N/A</ENT>
              <ENT>18.74</ENT>
              <ENT>7.08</ENT>
              <ENT>N/A</ENT>
              <ENT>59.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61570</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove foreign body, brain</ENT>
              <ENT>24.60</ENT>
              <ENT>N/A</ENT>
              <ENT>14.32</ENT>
              <ENT>4.60</ENT>
              <ENT>N/A</ENT>
              <ENT>43.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61571</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise skull for brain wound</ENT>
              <ENT>26.39</ENT>
              <ENT>N/A</ENT>
              <ENT>15.58</ENT>
              <ENT>5.23</ENT>
              <ENT>N/A</ENT>
              <ENT>47.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61575</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skull base/brainstem surgery</ENT>
              <ENT>34.36</ENT>
              <ENT>N/A</ENT>
              <ENT>20.34</ENT>
              <ENT>5.02</ENT>
              <ENT>N/A</ENT>
              <ENT>59.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61576</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Skull base/brainstem surgery</ENT>
              <ENT>52.43</ENT>
              <ENT>N/A</ENT>
              <ENT>30.42</ENT>
              <ENT>4.68</ENT>
              <ENT>N/A</ENT>
              <ENT>87.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61580</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Craniofacial approach, skull</ENT>
              <ENT>30.35</ENT>
              <ENT>N/A</ENT>
              <ENT>24.85</ENT>
              <ENT>2.75</ENT>
              <ENT>N/A</ENT>
              <ENT>57.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61581</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Craniofacial approach, skull</ENT>
              <ENT>34.60</ENT>
              <ENT>N/A</ENT>
              <ENT>22.57</ENT>
              <ENT>3.37</ENT>
              <ENT>N/A</ENT>
              <ENT>60.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61582</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Craniofacial approach, skull</ENT>
              <ENT>31.66</ENT>
              <ENT>N/A</ENT>
              <ENT>26.65</ENT>
              <ENT>6.30</ENT>
              <ENT>N/A</ENT>
              <ENT>64.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61583</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Craniofacial approach, skull</ENT>
              <ENT>36.21</ENT>
              <ENT>N/A</ENT>
              <ENT>25.03</ENT>
              <ENT>6.94</ENT>
              <ENT>N/A</ENT>
              <ENT>68.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61584</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Orbitocranial approach/skull</ENT>
              <ENT>34.65</ENT>
              <ENT>N/A</ENT>
              <ENT>24.40</ENT>
              <ENT>6.53</ENT>
              <ENT>N/A</ENT>
              <ENT>65.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61585</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Orbitocranial approach/skull</ENT>
              <ENT>38.61</ENT>
              <ENT>N/A</ENT>
              <ENT>26.37</ENT>
              <ENT>6.19</ENT>
              <ENT>N/A</ENT>
              <ENT>71.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61586</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Resect nasopharynx, skull</ENT>
              <ENT>25.10</ENT>
              <ENT>N/A</ENT>
              <ENT>21.80</ENT>
              <ENT>3.52</ENT>
              <ENT>N/A</ENT>
              <ENT>50.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61590</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Infratemporal approach/skull</ENT>
              <ENT>41.78</ENT>
              <ENT>N/A</ENT>
              <ENT>29.48</ENT>
              <ENT>4.28</ENT>
              <ENT>N/A</ENT>
              <ENT>75.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61591</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Infratemporal approach/skull</ENT>
              <ENT>43.68</ENT>
              <ENT>N/A</ENT>
              <ENT>30.38</ENT>
              <ENT>5.26</ENT>
              <ENT>N/A</ENT>
              <ENT>79.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61592</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Orbitocranial approach/skull</ENT>
              <ENT>39.64</ENT>
              <ENT>N/A</ENT>
              <ENT>27.03</ENT>
              <ENT>7.55</ENT>
              <ENT>N/A</ENT>
              <ENT>74.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61595</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transtemporal approach/skull</ENT>
              <ENT>29.57</ENT>
              <ENT>N/A</ENT>
              <ENT>23.10</ENT>
              <ENT>3.05</ENT>
              <ENT>N/A</ENT>
              <ENT>55.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61596</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transcochlear approach/skull</ENT>
              <ENT>35.63</ENT>
              <ENT>N/A</ENT>
              <ENT>25.14</ENT>
              <ENT>4.25</ENT>
              <ENT>N/A</ENT>
              <ENT>65.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61597</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transcondylar approach/skull</ENT>
              <ENT>37.96</ENT>
              <ENT>N/A</ENT>
              <ENT>23.44</ENT>
              <ENT>6.65</ENT>
              <ENT>N/A</ENT>
              <ENT>68.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61598</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transpetrosal approach/skull</ENT>
              <ENT>33.41</ENT>
              <ENT>N/A</ENT>
              <ENT>23.82</ENT>
              <ENT>4.60</ENT>
              <ENT>N/A</ENT>
              <ENT>61.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Resect/excise cranial lesion</ENT>
              <ENT>25.85</ENT>
              <ENT>N/A</ENT>
              <ENT>20.35</ENT>
              <ENT>3.12</ENT>
              <ENT>N/A</ENT>
              <ENT>49.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61601</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Resect/excise cranial lesion</ENT>
              <ENT>27.89</ENT>
              <ENT>N/A</ENT>
              <ENT>20.88</ENT>
              <ENT>5.29</ENT>
              <ENT>N/A</ENT>
              <ENT>54.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Resect/excise cranial lesion</ENT>
              <ENT>29.33</ENT>
              <ENT>N/A</ENT>
              <ENT>22.75</ENT>
              <ENT>2.51</ENT>
              <ENT>N/A</ENT>
              <ENT>54.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61606</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Resect/excise cranial lesion</ENT>
              <ENT>38.83</ENT>
              <ENT>N/A</ENT>
              <ENT>25.68</ENT>
              <ENT>6.81</ENT>
              <ENT>N/A</ENT>
              <ENT>71.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61607</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Resect/excise cranial lesion</ENT>
              <ENT>36.27</ENT>
              <ENT>N/A</ENT>
              <ENT>24.32</ENT>
              <ENT>5.69</ENT>
              <ENT>N/A</ENT>
              <ENT>66.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61608</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Resect/excise cranial lesion</ENT>
              <ENT>42.10</ENT>
              <ENT>N/A</ENT>
              <ENT>27.11</ENT>
              <ENT>8.31</ENT>
              <ENT>N/A</ENT>
              <ENT>77.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61609</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transect artery, sinus</ENT>
              <ENT>9.89</ENT>
              <ENT>N/A</ENT>
              <ENT>4.89</ENT>
              <ENT>2.07</ENT>
              <ENT>N/A</ENT>
              <ENT>16.85</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49159"/>
              <ENT I="01">61610</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transect artery, sinus</ENT>
              <ENT>29.67</ENT>
              <ENT>N/A</ENT>
              <ENT>13.44</ENT>
              <ENT>3.52</ENT>
              <ENT>N/A</ENT>
              <ENT>46.63</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61611</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transect artery, sinus</ENT>
              <ENT>7.42</ENT>
              <ENT>N/A</ENT>
              <ENT>3.39</ENT>
              <ENT>1.55</ENT>
              <ENT>N/A</ENT>
              <ENT>12.36</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61612</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transect artery, sinus</ENT>
              <ENT>27.88</ENT>
              <ENT>N/A</ENT>
              <ENT>13.62</ENT>
              <ENT>3.55</ENT>
              <ENT>N/A</ENT>
              <ENT>45.05</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61613</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove aneurysm, sinus</ENT>
              <ENT>40.86</ENT>
              <ENT>N/A</ENT>
              <ENT>26.77</ENT>
              <ENT>8.32</ENT>
              <ENT>N/A</ENT>
              <ENT>75.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61615</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Resect/excise lesion, skull</ENT>
              <ENT>32.07</ENT>
              <ENT>N/A</ENT>
              <ENT>23.28</ENT>
              <ENT>4.64</ENT>
              <ENT>N/A</ENT>
              <ENT>59.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61616</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Resect/excise lesion, skull</ENT>
              <ENT>43.33</ENT>
              <ENT>N/A</ENT>
              <ENT>29.31</ENT>
              <ENT>7.02</ENT>
              <ENT>N/A</ENT>
              <ENT>79.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61618</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair dura</ENT>
              <ENT>16.99</ENT>
              <ENT>N/A</ENT>
              <ENT>10.91</ENT>
              <ENT>2.92</ENT>
              <ENT>N/A</ENT>
              <ENT>30.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61619</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair dura</ENT>
              <ENT>20.71</ENT>
              <ENT>N/A</ENT>
              <ENT>12.75</ENT>
              <ENT>3.42</ENT>
              <ENT>N/A</ENT>
              <ENT>36.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61623</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endovasc tempory vessel occl</ENT>
              <ENT>9.96</ENT>
              <ENT>N/A</ENT>
              <ENT>4.31</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>14.77</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61624</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transcath occlusion, cns</ENT>
              <ENT>20.15</ENT>
              <ENT>N/A</ENT>
              <ENT>7.07</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>28.37</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61626</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transcath occlusion, non-cns</ENT>
              <ENT>16.62</ENT>
              <ENT>N/A</ENT>
              <ENT>5.65</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>23.11</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61680</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intracranial vessel surgery</ENT>
              <ENT>30.71</ENT>
              <ENT>N/A</ENT>
              <ENT>18.07</ENT>
              <ENT>6.04</ENT>
              <ENT>N/A</ENT>
              <ENT>54.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61682</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intracranial vessel surgery</ENT>
              <ENT>61.57</ENT>
              <ENT>N/A</ENT>
              <ENT>33.24</ENT>
              <ENT>12.69</ENT>
              <ENT>N/A</ENT>
              <ENT>107.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61684</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intracranial vessel surgery</ENT>
              <ENT>39.81</ENT>
              <ENT>N/A</ENT>
              <ENT>22.75</ENT>
              <ENT>7.87</ENT>
              <ENT>N/A</ENT>
              <ENT>70.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61686</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intracranial vessel surgery</ENT>
              <ENT>64.49</ENT>
              <ENT>N/A</ENT>
              <ENT>35.77</ENT>
              <ENT>13.20</ENT>
              <ENT>N/A</ENT>
              <ENT>113.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61690</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intracranial vessel surgery</ENT>
              <ENT>29.31</ENT>
              <ENT>N/A</ENT>
              <ENT>17.38</ENT>
              <ENT>5.51</ENT>
              <ENT>N/A</ENT>
              <ENT>52.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61692</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intracranial vessel surgery</ENT>
              <ENT>51.87</ENT>
              <ENT>N/A</ENT>
              <ENT>28.42</ENT>
              <ENT>10.17</ENT>
              <ENT>N/A</ENT>
              <ENT>90.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61697</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Brain aneurysm repr, complx</ENT>
              <ENT>50.52</ENT>
              <ENT>N/A</ENT>
              <ENT>28.82</ENT>
              <ENT>10.31</ENT>
              <ENT>N/A</ENT>
              <ENT>89.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61698</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Brain aneurysm repr, complx</ENT>
              <ENT>48.41</ENT>
              <ENT>N/A</ENT>
              <ENT>27.46</ENT>
              <ENT>9.99</ENT>
              <ENT>N/A</ENT>
              <ENT>85.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Brain aneurysm repr, simple</ENT>
              <ENT>50.52</ENT>
              <ENT>N/A</ENT>
              <ENT>28.64</ENT>
              <ENT>10.18</ENT>
              <ENT>N/A</ENT>
              <ENT>89.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61702</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inner skull vessel surgery</ENT>
              <ENT>48.41</ENT>
              <ENT>N/A</ENT>
              <ENT>26.91</ENT>
              <ENT>9.75</ENT>
              <ENT>N/A</ENT>
              <ENT>85.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61703</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Clamp neck artery</ENT>
              <ENT>17.47</ENT>
              <ENT>N/A</ENT>
              <ENT>10.94</ENT>
              <ENT>3.62</ENT>
              <ENT>N/A</ENT>
              <ENT>32.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61705</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise circulation to head</ENT>
              <ENT>36.20</ENT>
              <ENT>N/A</ENT>
              <ENT>19.88</ENT>
              <ENT>6.67</ENT>
              <ENT>N/A</ENT>
              <ENT>62.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61708</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise circulation to head</ENT>
              <ENT>35.30</ENT>
              <ENT>N/A</ENT>
              <ENT>15.61</ENT>
              <ENT>2.18</ENT>
              <ENT>N/A</ENT>
              <ENT>53.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61710</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise circulation to head</ENT>
              <ENT>29.67</ENT>
              <ENT>N/A</ENT>
              <ENT>14.10</ENT>
              <ENT>2.42</ENT>
              <ENT>N/A</ENT>
              <ENT>46.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61711</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of skull arteries</ENT>
              <ENT>36.33</ENT>
              <ENT>N/A</ENT>
              <ENT>20.47</ENT>
              <ENT>7.39</ENT>
              <ENT>N/A</ENT>
              <ENT>64.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61720</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise skull/brain surgery</ENT>
              <ENT>16.77</ENT>
              <ENT>N/A</ENT>
              <ENT>10.43</ENT>
              <ENT>3.51</ENT>
              <ENT>N/A</ENT>
              <ENT>30.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61735</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise skull/brain surgery</ENT>
              <ENT>20.43</ENT>
              <ENT>N/A</ENT>
              <ENT>12.62</ENT>
              <ENT>4.16</ENT>
              <ENT>N/A</ENT>
              <ENT>37.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61750</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise skull/brain biopsy</ENT>
              <ENT>18.20</ENT>
              <ENT>N/A</ENT>
              <ENT>11.04</ENT>
              <ENT>3.71</ENT>
              <ENT>N/A</ENT>
              <ENT>32.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61751</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Brain biopsy w/ct/mr guide</ENT>
              <ENT>17.62</ENT>
              <ENT>N/A</ENT>
              <ENT>11.21</ENT>
              <ENT>3.57</ENT>
              <ENT>N/A</ENT>
              <ENT>32.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61760</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant brain electrodes</ENT>
              <ENT>22.27</ENT>
              <ENT>N/A</ENT>
              <ENT>8.96</ENT>
              <ENT>4.59</ENT>
              <ENT>N/A</ENT>
              <ENT>35.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61770</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise skull for treatment</ENT>
              <ENT>21.44</ENT>
              <ENT>N/A</ENT>
              <ENT>12.69</ENT>
              <ENT>4.09</ENT>
              <ENT>N/A</ENT>
              <ENT>38.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61790</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat trigeminal nerve</ENT>
              <ENT>10.86</ENT>
              <ENT>N/A</ENT>
              <ENT>6.21</ENT>
              <ENT>1.82</ENT>
              <ENT>N/A</ENT>
              <ENT>18.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61791</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat trigeminal tract</ENT>
              <ENT>14.61</ENT>
              <ENT>N/A</ENT>
              <ENT>9.29</ENT>
              <ENT>3.03</ENT>
              <ENT>N/A</ENT>
              <ENT>26.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61793</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Focus radiation beam</ENT>
              <ENT>17.24</ENT>
              <ENT>N/A</ENT>
              <ENT>10.56</ENT>
              <ENT>3.51</ENT>
              <ENT>N/A</ENT>
              <ENT>31.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61795</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Brain surgery using computer</ENT>
              <ENT>4.04</ENT>
              <ENT>N/A</ENT>
              <ENT>2.08</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>6.93</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61850</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant neuroelectrodes</ENT>
              <ENT>12.39</ENT>
              <ENT>N/A</ENT>
              <ENT>7.96</ENT>
              <ENT>2.23</ENT>
              <ENT>N/A</ENT>
              <ENT>22.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61860</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant neuroelectrodes</ENT>
              <ENT>20.87</ENT>
              <ENT>N/A</ENT>
              <ENT>12.51</ENT>
              <ENT>4.04</ENT>
              <ENT>N/A</ENT>
              <ENT>37.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61862</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant neurostimul, subcort</ENT>
              <ENT>19.34</ENT>
              <ENT>N/A</ENT>
              <ENT>12.47</ENT>
              <ENT>3.97</ENT>
              <ENT>N/A</ENT>
              <ENT>35.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61870</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant neuroelectrodes</ENT>
              <ENT>14.94</ENT>
              <ENT>N/A</ENT>
              <ENT>10.15</ENT>
              <ENT>1.70</ENT>
              <ENT>N/A</ENT>
              <ENT>26.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61875</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant neuroelectrodes</ENT>
              <ENT>15.06</ENT>
              <ENT>N/A</ENT>
              <ENT>8.97</ENT>
              <ENT>2.42</ENT>
              <ENT>N/A</ENT>
              <ENT>26.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61880</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise/remove neuroelectrode</ENT>
              <ENT>6.29</ENT>
              <ENT>N/A</ENT>
              <ENT>4.84</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>12.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61885</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant neurostim one array</ENT>
              <ENT>5.85</ENT>
              <ENT>N/A</ENT>
              <ENT>5.51</ENT>
              <ENT>1.22</ENT>
              <ENT>N/A</ENT>
              <ENT>12.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61886</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant neurostim arrays</ENT>
              <ENT>8.00</ENT>
              <ENT>N/A</ENT>
              <ENT>6.57</ENT>
              <ENT>1.64</ENT>
              <ENT>N/A</ENT>
              <ENT>16.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">61888</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise/remove neuroreceiver</ENT>
              <ENT>5.07</ENT>
              <ENT>N/A</ENT>
              <ENT>3.97</ENT>
              <ENT>1.04</ENT>
              <ENT>N/A</ENT>
              <ENT>10.08</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat skull fracture</ENT>
              <ENT>12.53</ENT>
              <ENT>N/A</ENT>
              <ENT>5.97</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>19.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62005</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat skull fracture</ENT>
              <ENT>16.17</ENT>
              <ENT>N/A</ENT>
              <ENT>9.28</ENT>
              <ENT>2.33</ENT>
              <ENT>N/A</ENT>
              <ENT>27.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of head injury</ENT>
              <ENT>19.81</ENT>
              <ENT>N/A</ENT>
              <ENT>12.15</ENT>
              <ENT>4.05</ENT>
              <ENT>N/A</ENT>
              <ENT>36.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair brain fluid leakage</ENT>
              <ENT>22.03</ENT>
              <ENT>N/A</ENT>
              <ENT>13.31</ENT>
              <ENT>4.07</ENT>
              <ENT>N/A</ENT>
              <ENT>39.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62115</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reduction of skull defect</ENT>
              <ENT>21.66</ENT>
              <ENT>N/A</ENT>
              <ENT>12.02</ENT>
              <ENT>4.53</ENT>
              <ENT>N/A</ENT>
              <ENT>38.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62116</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reduction of skull defect</ENT>
              <ENT>23.59</ENT>
              <ENT>N/A</ENT>
              <ENT>13.80</ENT>
              <ENT>4.85</ENT>
              <ENT>N/A</ENT>
              <ENT>42.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62117</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reduction of skull defect</ENT>
              <ENT>26.60</ENT>
              <ENT>N/A</ENT>
              <ENT>15.64</ENT>
              <ENT>5.56</ENT>
              <ENT>N/A</ENT>
              <ENT>47.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair skull cavity lesion</ENT>
              <ENT>23.35</ENT>
              <ENT>N/A</ENT>
              <ENT>14.71</ENT>
              <ENT>3.07</ENT>
              <ENT>N/A</ENT>
              <ENT>41.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62121</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise skull repair</ENT>
              <ENT>21.58</ENT>
              <ENT>N/A</ENT>
              <ENT>13.17</ENT>
              <ENT>2.47</ENT>
              <ENT>N/A</ENT>
              <ENT>37.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of skull defect</ENT>
              <ENT>13.51</ENT>
              <ENT>N/A</ENT>
              <ENT>8.69</ENT>
              <ENT>2.60</ENT>
              <ENT>N/A</ENT>
              <ENT>24.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62141</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of skull defect</ENT>
              <ENT>14.91</ENT>
              <ENT>N/A</ENT>
              <ENT>9.48</ENT>
              <ENT>2.85</ENT>
              <ENT>N/A</ENT>
              <ENT>27.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49160"/>
              <ENT I="01">62142</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove skull plate/flap</ENT>
              <ENT>10.79</ENT>
              <ENT>N/A</ENT>
              <ENT>7.34</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>20.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62143</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replace skull plate/flap</ENT>
              <ENT>13.05</ENT>
              <ENT>N/A</ENT>
              <ENT>8.44</ENT>
              <ENT>2.55</ENT>
              <ENT>N/A</ENT>
              <ENT>24.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62145</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of skull &amp; brain</ENT>
              <ENT>18.82</ENT>
              <ENT>N/A</ENT>
              <ENT>11.38</ENT>
              <ENT>3.81</ENT>
              <ENT>N/A</ENT>
              <ENT>34.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62146</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of skull with graft</ENT>
              <ENT>16.12</ENT>
              <ENT>N/A</ENT>
              <ENT>10.08</ENT>
              <ENT>2.94</ENT>
              <ENT>N/A</ENT>
              <ENT>29.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62147</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of skull with graft</ENT>
              <ENT>19.34</ENT>
              <ENT>N/A</ENT>
              <ENT>11.84</ENT>
              <ENT>3.64</ENT>
              <ENT>N/A</ENT>
              <ENT>34.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62148</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Retr bone flap to fix skull</ENT>
              <ENT>2.00</ENT>
              <ENT>N/A</ENT>
              <ENT>0.83</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>3.26</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62160</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Neuroendoscopy add-on</ENT>
              <ENT>3.00</ENT>
              <ENT>N/A</ENT>
              <ENT>1.16</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>4.68</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62161</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dissect brain w/scope</ENT>
              <ENT>20.00</ENT>
              <ENT>N/A</ENT>
              <ENT>9.73</ENT>
              <ENT>3.70</ENT>
              <ENT>N/A</ENT>
              <ENT>33.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62162</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove colloid cyst w/scope</ENT>
              <ENT>25.25</ENT>
              <ENT>N/A</ENT>
              <ENT>11.90</ENT>
              <ENT>5.77</ENT>
              <ENT>N/A</ENT>
              <ENT>42.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62163</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Neuroendoscopy w/fb removal</ENT>
              <ENT>15.50</ENT>
              <ENT>N/A</ENT>
              <ENT>7.98</ENT>
              <ENT>3.70</ENT>
              <ENT>N/A</ENT>
              <ENT>27.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62164</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove brain tumor w/scope</ENT>
              <ENT>27.50</ENT>
              <ENT>N/A</ENT>
              <ENT>13.13</ENT>
              <ENT>5.77</ENT>
              <ENT>N/A</ENT>
              <ENT>46.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62165</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove pituit tumor w/scope</ENT>
              <ENT>22.00</ENT>
              <ENT>N/A</ENT>
              <ENT>10.69</ENT>
              <ENT>3.63</ENT>
              <ENT>N/A</ENT>
              <ENT>36.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62180</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Establish brain cavity shunt</ENT>
              <ENT>21.06</ENT>
              <ENT>N/A</ENT>
              <ENT>12.73</ENT>
              <ENT>4.32</ENT>
              <ENT>N/A</ENT>
              <ENT>38.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62190</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Establish brain cavity shunt</ENT>
              <ENT>11.07</ENT>
              <ENT>N/A</ENT>
              <ENT>7.40</ENT>
              <ENT>2.18</ENT>
              <ENT>N/A</ENT>
              <ENT>20.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62192</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Establish brain cavity shunt</ENT>
              <ENT>12.25</ENT>
              <ENT>N/A</ENT>
              <ENT>7.96</ENT>
              <ENT>2.46</ENT>
              <ENT>N/A</ENT>
              <ENT>22.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62194</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replace/irrigate catheter</ENT>
              <ENT>5.03</ENT>
              <ENT>N/A</ENT>
              <ENT>2.84</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>8.37</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Establish brain cavity shunt</ENT>
              <ENT>18.32</ENT>
              <ENT>N/A</ENT>
              <ENT>11.26</ENT>
              <ENT>3.70</ENT>
              <ENT>N/A</ENT>
              <ENT>33.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62201</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Brain cavity shunt w/scope</ENT>
              <ENT>14.86</ENT>
              <ENT>N/A</ENT>
              <ENT>9.79</ENT>
              <ENT>2.52</ENT>
              <ENT>N/A</ENT>
              <ENT>27.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Establish brain cavity shunt</ENT>
              <ENT>13.00</ENT>
              <ENT>N/A</ENT>
              <ENT>8.32</ENT>
              <ENT>2.53</ENT>
              <ENT>N/A</ENT>
              <ENT>23.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62223</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Establish brain cavity shunt</ENT>
              <ENT>12.87</ENT>
              <ENT>N/A</ENT>
              <ENT>8.55</ENT>
              <ENT>2.58</ENT>
              <ENT>N/A</ENT>
              <ENT>24.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62225</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replace/irrigate catheter</ENT>
              <ENT>5.41</ENT>
              <ENT>N/A</ENT>
              <ENT>4.30</ENT>
              <ENT>1.09</ENT>
              <ENT>N/A</ENT>
              <ENT>10.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62230</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replace/revise brain shunt</ENT>
              <ENT>10.54</ENT>
              <ENT>N/A</ENT>
              <ENT>6.75</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>19.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62252</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Csf shunt reprogram</ENT>
              <ENT>0.74</ENT>
              <ENT>1.48</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>2.40</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62252</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Csf shunt reprogram</ENT>
              <ENT>0.74</ENT>
              <ENT>0.38</ENT>
              <ENT>0.38</ENT>
              <ENT>0.16</ENT>
              <ENT>1.28</ENT>
              <ENT>1.28</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62252</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Csf shunt reprogram</ENT>
              <ENT>0.00</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.12</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62256</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove brain cavity shunt</ENT>
              <ENT>6.60</ENT>
              <ENT>N/A</ENT>
              <ENT>4.96</ENT>
              <ENT>1.34</ENT>
              <ENT>N/A</ENT>
              <ENT>12.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62258</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replace brain cavity shunt</ENT>
              <ENT>14.54</ENT>
              <ENT>N/A</ENT>
              <ENT>9.03</ENT>
              <ENT>2.91</ENT>
              <ENT>N/A</ENT>
              <ENT>26.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62263</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Epidural lysis mult sessions</ENT>
              <ENT>6.14</ENT>
              <ENT>12.34</ENT>
              <ENT>2.41</ENT>
              <ENT>0.42</ENT>
              <ENT>18.90</ENT>
              <ENT>8.97</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62264</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Epidural lysis on single day</ENT>
              <ENT>4.43</ENT>
              <ENT>7.85</ENT>
              <ENT>1.42</ENT>
              <ENT>0.30</ENT>
              <ENT>12.58</ENT>
              <ENT>6.15</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62268</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain spinal cord cyst</ENT>
              <ENT>4.74</ENT>
              <ENT>10.78</ENT>
              <ENT>2.21</ENT>
              <ENT>0.29</ENT>
              <ENT>15.81</ENT>
              <ENT>7.24</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62269</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Needle biopsy, spinal cord</ENT>
              <ENT>5.02</ENT>
              <ENT>12.44</ENT>
              <ENT>2.04</ENT>
              <ENT>0.29</ENT>
              <ENT>17.75</ENT>
              <ENT>7.35</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62270</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Spinal fluid tap, diagnostic</ENT>
              <ENT>1.13</ENT>
              <ENT>3.10</ENT>
              <ENT>0.50</ENT>
              <ENT>0.06</ENT>
              <ENT>4.29</ENT>
              <ENT>1.69</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62272</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain cerebro spinal fluid</ENT>
              <ENT>1.35</ENT>
              <ENT>3.72</ENT>
              <ENT>0.65</ENT>
              <ENT>0.13</ENT>
              <ENT>5.20</ENT>
              <ENT>2.13</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62273</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat epidural spine lesion</ENT>
              <ENT>2.15</ENT>
              <ENT>2.83</ENT>
              <ENT>0.58</ENT>
              <ENT>0.14</ENT>
              <ENT>5.12</ENT>
              <ENT>2.87</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62280</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat spinal cord lesion</ENT>
              <ENT>2.63</ENT>
              <ENT>6.81</ENT>
              <ENT>0.89</ENT>
              <ENT>0.17</ENT>
              <ENT>9.61</ENT>
              <ENT>3.69</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62281</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat spinal cord lesion</ENT>
              <ENT>2.66</ENT>
              <ENT>5.96</ENT>
              <ENT>0.78</ENT>
              <ENT>0.16</ENT>
              <ENT>8.78</ENT>
              <ENT>3.60</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62282</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat spinal canal lesion</ENT>
              <ENT>2.33</ENT>
              <ENT>8.37</ENT>
              <ENT>0.80</ENT>
              <ENT>0.14</ENT>
              <ENT>10.84</ENT>
              <ENT>3.27</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62284</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection for myelogram</ENT>
              <ENT>1.54</ENT>
              <ENT>4.98</ENT>
              <ENT>0.61</ENT>
              <ENT>0.10</ENT>
              <ENT>6.62</ENT>
              <ENT>2.25</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62287</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Percutaneous diskectomy</ENT>
              <ENT>8.08</ENT>
              <ENT>N/A</ENT>
              <ENT>5.75</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>14.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62290</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inject for spine disk x-ray</ENT>
              <ENT>3.00</ENT>
              <ENT>6.94</ENT>
              <ENT>1.30</ENT>
              <ENT>0.20</ENT>
              <ENT>10.14</ENT>
              <ENT>4.50</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62291</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inject for spine disk x-ray</ENT>
              <ENT>2.91</ENT>
              <ENT>5.81</ENT>
              <ENT>1.15</ENT>
              <ENT>0.17</ENT>
              <ENT>8.89</ENT>
              <ENT>4.23</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62292</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection into disk lesion</ENT>
              <ENT>7.86</ENT>
              <ENT>N/A</ENT>
              <ENT>4.60</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>13.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62294</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection into spinal artery</ENT>
              <ENT>11.83</ENT>
              <ENT>N/A</ENT>
              <ENT>5.79</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>18.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62310</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inject spine c/t</ENT>
              <ENT>1.91</ENT>
              <ENT>5.02</ENT>
              <ENT>0.51</ENT>
              <ENT>0.11</ENT>
              <ENT>7.04</ENT>
              <ENT>2.53</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62311</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inject spine l/s (cd)</ENT>
              <ENT>1.54</ENT>
              <ENT>5.08</ENT>
              <ENT>0.45</ENT>
              <ENT>0.09</ENT>
              <ENT>6.71</ENT>
              <ENT>2.08</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62318</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inject spine w/cath, c/t</ENT>
              <ENT>2.04</ENT>
              <ENT>5.72</ENT>
              <ENT>0.52</ENT>
              <ENT>0.12</ENT>
              <ENT>7.88</ENT>
              <ENT>2.68</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62319</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inject spine w/cath l/s (cd)</ENT>
              <ENT>1.87</ENT>
              <ENT>5.01</ENT>
              <ENT>0.48</ENT>
              <ENT>0.11</ENT>
              <ENT>6.99</ENT>
              <ENT>2.46</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62350</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant spinal canal cath</ENT>
              <ENT>6.87</ENT>
              <ENT>N/A</ENT>
              <ENT>4.06</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>11.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62351</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant spinal canal cath</ENT>
              <ENT>10.00</ENT>
              <ENT>N/A</ENT>
              <ENT>7.26</ENT>
              <ENT>1.79</ENT>
              <ENT>N/A</ENT>
              <ENT>19.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62355</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove spinal canal catheter</ENT>
              <ENT>5.45</ENT>
              <ENT>N/A</ENT>
              <ENT>3.26</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>9.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62360</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert spine infusion device</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>2.76</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>5.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49161"/>
              <ENT I="01">62361</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant spine infusion pump</ENT>
              <ENT>5.42</ENT>
              <ENT>N/A</ENT>
              <ENT>3.99</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>9.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62362</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant spine infusion pump</ENT>
              <ENT>7.04</ENT>
              <ENT>N/A</ENT>
              <ENT>4.48</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>12.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62365</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove spine infusion device</ENT>
              <ENT>5.42</ENT>
              <ENT>N/A</ENT>
              <ENT>3.66</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>9.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62367</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Analyze spine infusion pump</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62367</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Analyze spine infusion pump</ENT>
              <ENT>0.48</ENT>
              <ENT>0.13</ENT>
              <ENT>0.13</ENT>
              <ENT>0.03</ENT>
              <ENT>0.64</ENT>
              <ENT>0.64</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62367</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Analyze spine infusion pump</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62368</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Analyze spine infusion pump</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62368</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Analyze spine infusion pump</ENT>
              <ENT>0.75</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.05</ENT>
              <ENT>0.99</ENT>
              <ENT>0.99</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">62368</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Analyze spine infusion pump</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63001</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of spinal lamina</ENT>
              <ENT>15.82</ENT>
              <ENT>N/A</ENT>
              <ENT>9.72</ENT>
              <ENT>3.03</ENT>
              <ENT>N/A</ENT>
              <ENT>28.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63003</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of spinal lamina</ENT>
              <ENT>15.95</ENT>
              <ENT>N/A</ENT>
              <ENT>10.06</ENT>
              <ENT>2.98</ENT>
              <ENT>N/A</ENT>
              <ENT>28.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63005</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of spinal lamina</ENT>
              <ENT>14.92</ENT>
              <ENT>N/A</ENT>
              <ENT>10.13</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>27.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63011</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of spinal lamina</ENT>
              <ENT>14.52</ENT>
              <ENT>N/A</ENT>
              <ENT>8.39</ENT>
              <ENT>1.43</ENT>
              <ENT>N/A</ENT>
              <ENT>24.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63012</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of spinal lamina</ENT>
              <ENT>15.40</ENT>
              <ENT>N/A</ENT>
              <ENT>10.25</ENT>
              <ENT>2.71</ENT>
              <ENT>N/A</ENT>
              <ENT>28.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63015</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of spinal lamina</ENT>
              <ENT>19.35</ENT>
              <ENT>N/A</ENT>
              <ENT>12.14</ENT>
              <ENT>3.84</ENT>
              <ENT>N/A</ENT>
              <ENT>35.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63016</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of spinal lamina</ENT>
              <ENT>19.20</ENT>
              <ENT>N/A</ENT>
              <ENT>12.00</ENT>
              <ENT>3.62</ENT>
              <ENT>N/A</ENT>
              <ENT>34.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63017</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of spinal lamina</ENT>
              <ENT>15.94</ENT>
              <ENT>N/A</ENT>
              <ENT>10.57</ENT>
              <ENT>2.91</ENT>
              <ENT>N/A</ENT>
              <ENT>29.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Neck spine disk surgery</ENT>
              <ENT>14.81</ENT>
              <ENT>N/A</ENT>
              <ENT>9.87</ENT>
              <ENT>2.89</ENT>
              <ENT>N/A</ENT>
              <ENT>27.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63030</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Low back disk surgery</ENT>
              <ENT>12.00</ENT>
              <ENT>N/A</ENT>
              <ENT>8.56</ENT>
              <ENT>2.21</ENT>
              <ENT>N/A</ENT>
              <ENT>22.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63035</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Spinal disk surgery add-on</ENT>
              <ENT>3.15</ENT>
              <ENT>N/A</ENT>
              <ENT>1.62</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>5.34</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63040</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laminotomy, single cervical</ENT>
              <ENT>18.81</ENT>
              <ENT>N/A</ENT>
              <ENT>11.70</ENT>
              <ENT>3.36</ENT>
              <ENT>N/A</ENT>
              <ENT>33.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63042</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laminotomy, single lumbar</ENT>
              <ENT>17.47</ENT>
              <ENT>N/A</ENT>
              <ENT>11.53</ENT>
              <ENT>3.11</ENT>
              <ENT>N/A</ENT>
              <ENT>32.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63043</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Laminotomy, addl cervical</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63044</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Laminotomy, addl lumbar</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63045</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of spinal lamina</ENT>
              <ENT>16.50</ENT>
              <ENT>N/A</ENT>
              <ENT>10.54</ENT>
              <ENT>3.19</ENT>
              <ENT>N/A</ENT>
              <ENT>30.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63046</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of spinal lamina</ENT>
              <ENT>15.80</ENT>
              <ENT>N/A</ENT>
              <ENT>10.34</ENT>
              <ENT>2.89</ENT>
              <ENT>N/A</ENT>
              <ENT>29.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63047</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of spinal lamina</ENT>
              <ENT>14.61</ENT>
              <ENT>N/A</ENT>
              <ENT>10.04</ENT>
              <ENT>2.61</ENT>
              <ENT>N/A</ENT>
              <ENT>27.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63048</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove spinal lamina add-on</ENT>
              <ENT>3.26</ENT>
              <ENT>N/A</ENT>
              <ENT>1.70</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>5.54</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63055</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompress spinal cord</ENT>
              <ENT>21.99</ENT>
              <ENT>N/A</ENT>
              <ENT>13.38</ENT>
              <ENT>4.09</ENT>
              <ENT>N/A</ENT>
              <ENT>39.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63056</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompress spinal cord</ENT>
              <ENT>20.36</ENT>
              <ENT>N/A</ENT>
              <ENT>12.76</ENT>
              <ENT>3.34</ENT>
              <ENT>N/A</ENT>
              <ENT>36.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63057</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompress spine cord add-on</ENT>
              <ENT>5.26</ENT>
              <ENT>N/A</ENT>
              <ENT>2.70</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>8.77</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63064</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompress spinal cord</ENT>
              <ENT>24.61</ENT>
              <ENT>N/A</ENT>
              <ENT>14.71</ENT>
              <ENT>4.72</ENT>
              <ENT>N/A</ENT>
              <ENT>44.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63066</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompress spine cord add-on</ENT>
              <ENT>3.26</ENT>
              <ENT>N/A</ENT>
              <ENT>1.70</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>5.59</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63075</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Neck spine disk surgery</ENT>
              <ENT>19.41</ENT>
              <ENT>N/A</ENT>
              <ENT>12.33</ENT>
              <ENT>3.73</ENT>
              <ENT>N/A</ENT>
              <ENT>35.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63076</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Neck spine disk surgery</ENT>
              <ENT>4.05</ENT>
              <ENT>N/A</ENT>
              <ENT>2.10</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>6.93</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63077</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Spine disk surgery, thorax</ENT>
              <ENT>21.44</ENT>
              <ENT>N/A</ENT>
              <ENT>12.92</ENT>
              <ENT>3.44</ENT>
              <ENT>N/A</ENT>
              <ENT>37.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63078</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Spine disk surgery, thorax</ENT>
              <ENT>3.28</ENT>
              <ENT>N/A</ENT>
              <ENT>1.67</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>5.45</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63081</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of vertebral body</ENT>
              <ENT>23.73</ENT>
              <ENT>N/A</ENT>
              <ENT>14.59</ENT>
              <ENT>4.46</ENT>
              <ENT>N/A</ENT>
              <ENT>42.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63082</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove vertebral body add-on</ENT>
              <ENT>4.37</ENT>
              <ENT>N/A</ENT>
              <ENT>2.28</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>7.47</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63085</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of vertebral body</ENT>
              <ENT>26.92</ENT>
              <ENT>N/A</ENT>
              <ENT>15.67</ENT>
              <ENT>4.70</ENT>
              <ENT>N/A</ENT>
              <ENT>47.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63086</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove vertebral body add-on</ENT>
              <ENT>3.19</ENT>
              <ENT>N/A</ENT>
              <ENT>1.62</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>5.36</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63087</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of vertebral body</ENT>
              <ENT>35.57</ENT>
              <ENT>N/A</ENT>
              <ENT>19.78</ENT>
              <ENT>5.87</ENT>
              <ENT>N/A</ENT>
              <ENT>61.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63088</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove vertebral body add-on</ENT>
              <ENT>4.33</ENT>
              <ENT>N/A</ENT>
              <ENT>2.23</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>7.33</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63090</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of vertebral body</ENT>
              <ENT>28.16</ENT>
              <ENT>N/A</ENT>
              <ENT>16.27</ENT>
              <ENT>4.27</ENT>
              <ENT>N/A</ENT>
              <ENT>48.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63091</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove vertebral body add-on</ENT>
              <ENT>3.03</ENT>
              <ENT>N/A</ENT>
              <ENT>1.49</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>4.97</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63170</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise spinal cord tract(s)</ENT>
              <ENT>19.83</ENT>
              <ENT>N/A</ENT>
              <ENT>12.38</ENT>
              <ENT>3.89</ENT>
              <ENT>N/A</ENT>
              <ENT>36.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63172</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of spinal cyst</ENT>
              <ENT>17.66</ENT>
              <ENT>N/A</ENT>
              <ENT>11.22</ENT>
              <ENT>3.46</ENT>
              <ENT>N/A</ENT>
              <ENT>32.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63173</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of spinal cyst</ENT>
              <ENT>21.99</ENT>
              <ENT>N/A</ENT>
              <ENT>13.39</ENT>
              <ENT>4.14</ENT>
              <ENT>N/A</ENT>
              <ENT>39.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49162"/>
              <ENT I="01">63180</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise spinal cord ligaments</ENT>
              <ENT>18.27</ENT>
              <ENT>N/A</ENT>
              <ENT>11.52</ENT>
              <ENT>3.83</ENT>
              <ENT>N/A</ENT>
              <ENT>33.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63182</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise spinal cord ligaments</ENT>
              <ENT>20.50</ENT>
              <ENT>N/A</ENT>
              <ENT>11.44</ENT>
              <ENT>3.48</ENT>
              <ENT>N/A</ENT>
              <ENT>35.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63185</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise spinal column/nerves</ENT>
              <ENT>15.04</ENT>
              <ENT>N/A</ENT>
              <ENT>8.46</ENT>
              <ENT>2.08</ENT>
              <ENT>N/A</ENT>
              <ENT>25.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63190</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise spinal column/nerves</ENT>
              <ENT>17.45</ENT>
              <ENT>N/A</ENT>
              <ENT>10.59</ENT>
              <ENT>2.88</ENT>
              <ENT>N/A</ENT>
              <ENT>30.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63191</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise spinal column/nerves</ENT>
              <ENT>17.54</ENT>
              <ENT>N/A</ENT>
              <ENT>11.04</ENT>
              <ENT>3.50</ENT>
              <ENT>N/A</ENT>
              <ENT>32.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63194</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise spinal column &amp; cord</ENT>
              <ENT>19.19</ENT>
              <ENT>N/A</ENT>
              <ENT>12.05</ENT>
              <ENT>4.01</ENT>
              <ENT>N/A</ENT>
              <ENT>35.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63195</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise spinal column &amp; cord</ENT>
              <ENT>18.84</ENT>
              <ENT>N/A</ENT>
              <ENT>11.56</ENT>
              <ENT>3.44</ENT>
              <ENT>N/A</ENT>
              <ENT>33.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63196</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise spinal column &amp; cord</ENT>
              <ENT>22.30</ENT>
              <ENT>N/A</ENT>
              <ENT>12.34</ENT>
              <ENT>4.66</ENT>
              <ENT>N/A</ENT>
              <ENT>39.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63197</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise spinal column &amp; cord</ENT>
              <ENT>21.11</ENT>
              <ENT>N/A</ENT>
              <ENT>12.55</ENT>
              <ENT>4.42</ENT>
              <ENT>N/A</ENT>
              <ENT>38.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63198</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise spinal column &amp; cord</ENT>
              <ENT>25.38</ENT>
              <ENT>N/A</ENT>
              <ENT>9.91</ENT>
              <ENT>5.31</ENT>
              <ENT>N/A</ENT>
              <ENT>40.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63199</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise spinal column &amp; cord</ENT>
              <ENT>26.89</ENT>
              <ENT>N/A</ENT>
              <ENT>15.19</ENT>
              <ENT>5.62</ENT>
              <ENT>N/A</ENT>
              <ENT>47.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release of spinal cord</ENT>
              <ENT>19.18</ENT>
              <ENT>N/A</ENT>
              <ENT>11.78</ENT>
              <ENT>3.61</ENT>
              <ENT>N/A</ENT>
              <ENT>34.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise spinal cord vessels</ENT>
              <ENT>40.76</ENT>
              <ENT>N/A</ENT>
              <ENT>20.52</ENT>
              <ENT>7.65</ENT>
              <ENT>N/A</ENT>
              <ENT>68.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63251</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise spinal cord vessels</ENT>
              <ENT>41.20</ENT>
              <ENT>N/A</ENT>
              <ENT>23.24</ENT>
              <ENT>7.98</ENT>
              <ENT>N/A</ENT>
              <ENT>72.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63252</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise spinal cord vessels</ENT>
              <ENT>41.19</ENT>
              <ENT>N/A</ENT>
              <ENT>22.89</ENT>
              <ENT>7.75</ENT>
              <ENT>N/A</ENT>
              <ENT>71.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63265</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise intraspinal lesion</ENT>
              <ENT>21.56</ENT>
              <ENT>N/A</ENT>
              <ENT>13.18</ENT>
              <ENT>4.29</ENT>
              <ENT>N/A</ENT>
              <ENT>39.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63266</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise intraspinal lesion</ENT>
              <ENT>22.30</ENT>
              <ENT>N/A</ENT>
              <ENT>13.61</ENT>
              <ENT>4.47</ENT>
              <ENT>N/A</ENT>
              <ENT>40.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63267</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise intraspinal lesion</ENT>
              <ENT>17.95</ENT>
              <ENT>N/A</ENT>
              <ENT>11.45</ENT>
              <ENT>3.50</ENT>
              <ENT>N/A</ENT>
              <ENT>32.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63268</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise intraspinal lesion</ENT>
              <ENT>18.52</ENT>
              <ENT>N/A</ENT>
              <ENT>10.73</ENT>
              <ENT>3.18</ENT>
              <ENT>N/A</ENT>
              <ENT>32.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63270</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise intraspinal lesion</ENT>
              <ENT>26.80</ENT>
              <ENT>N/A</ENT>
              <ENT>15.94</ENT>
              <ENT>5.41</ENT>
              <ENT>N/A</ENT>
              <ENT>48.15</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63271</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise intraspinal lesion</ENT>
              <ENT>26.92</ENT>
              <ENT>N/A</ENT>
              <ENT>16.05</ENT>
              <ENT>5.56</ENT>
              <ENT>N/A</ENT>
              <ENT>48.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63272</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise intraspinal lesion</ENT>
              <ENT>25.32</ENT>
              <ENT>N/A</ENT>
              <ENT>15.15</ENT>
              <ENT>5.07</ENT>
              <ENT>N/A</ENT>
              <ENT>45.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63273</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Excise intraspinal lesion</ENT>
              <ENT>24.29</ENT>
              <ENT>N/A</ENT>
              <ENT>14.75</ENT>
              <ENT>5.08</ENT>
              <ENT>N/A</ENT>
              <ENT>44.12</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63275</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy/excise spinal tumor</ENT>
              <ENT>23.68</ENT>
              <ENT>N/A</ENT>
              <ENT>14.21</ENT>
              <ENT>4.68</ENT>
              <ENT>N/A</ENT>
              <ENT>42.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63276</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy/excise spinal tumor</ENT>
              <ENT>23.45</ENT>
              <ENT>N/A</ENT>
              <ENT>14.11</ENT>
              <ENT>4.63</ENT>
              <ENT>N/A</ENT>
              <ENT>42.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63277</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy/excise spinal tumor</ENT>
              <ENT>20.83</ENT>
              <ENT>N/A</ENT>
              <ENT>12.92</ENT>
              <ENT>4.03</ENT>
              <ENT>N/A</ENT>
              <ENT>37.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63278</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy/excise spinal tumor</ENT>
              <ENT>20.56</ENT>
              <ENT>N/A</ENT>
              <ENT>12.78</ENT>
              <ENT>4.02</ENT>
              <ENT>N/A</ENT>
              <ENT>37.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63280</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy/excise spinal tumor</ENT>
              <ENT>28.35</ENT>
              <ENT>N/A</ENT>
              <ENT>16.81</ENT>
              <ENT>5.80</ENT>
              <ENT>N/A</ENT>
              <ENT>50.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63281</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy/excise spinal tumor</ENT>
              <ENT>28.05</ENT>
              <ENT>N/A</ENT>
              <ENT>16.66</ENT>
              <ENT>5.67</ENT>
              <ENT>N/A</ENT>
              <ENT>50.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63282</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy/excise spinal tumor</ENT>
              <ENT>26.39</ENT>
              <ENT>N/A</ENT>
              <ENT>15.80</ENT>
              <ENT>5.33</ENT>
              <ENT>N/A</ENT>
              <ENT>47.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63283</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy/excise spinal tumor</ENT>
              <ENT>25.00</ENT>
              <ENT>N/A</ENT>
              <ENT>15.12</ENT>
              <ENT>5.12</ENT>
              <ENT>N/A</ENT>
              <ENT>45.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63285</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy/excise spinal tumor</ENT>
              <ENT>36.00</ENT>
              <ENT>N/A</ENT>
              <ENT>20.53</ENT>
              <ENT>7.31</ENT>
              <ENT>N/A</ENT>
              <ENT>63.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63286</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy/excise spinal tumor</ENT>
              <ENT>35.63</ENT>
              <ENT>N/A</ENT>
              <ENT>20.48</ENT>
              <ENT>7.07</ENT>
              <ENT>N/A</ENT>
              <ENT>63.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63287</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy/excise spinal tumor</ENT>
              <ENT>36.70</ENT>
              <ENT>N/A</ENT>
              <ENT>21.04</ENT>
              <ENT>7.48</ENT>
              <ENT>N/A</ENT>
              <ENT>65.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63290</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy/excise spinal tumor</ENT>
              <ENT>37.38</ENT>
              <ENT>N/A</ENT>
              <ENT>21.20</ENT>
              <ENT>7.65</ENT>
              <ENT>N/A</ENT>
              <ENT>66.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of vertebral body</ENT>
              <ENT>24.43</ENT>
              <ENT>N/A</ENT>
              <ENT>14.75</ENT>
              <ENT>4.78</ENT>
              <ENT>N/A</ENT>
              <ENT>43.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63301</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of vertebral body</ENT>
              <ENT>27.60</ENT>
              <ENT>N/A</ENT>
              <ENT>15.96</ENT>
              <ENT>5.03</ENT>
              <ENT>N/A</ENT>
              <ENT>48.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63302</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of vertebral body</ENT>
              <ENT>27.81</ENT>
              <ENT>N/A</ENT>
              <ENT>16.28</ENT>
              <ENT>5.25</ENT>
              <ENT>N/A</ENT>
              <ENT>49.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63303</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of vertebral body</ENT>
              <ENT>30.50</ENT>
              <ENT>N/A</ENT>
              <ENT>17.39</ENT>
              <ENT>5.21</ENT>
              <ENT>N/A</ENT>
              <ENT>53.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63304</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of vertebral body</ENT>
              <ENT>30.33</ENT>
              <ENT>N/A</ENT>
              <ENT>17.80</ENT>
              <ENT>4.72</ENT>
              <ENT>N/A</ENT>
              <ENT>52.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63305</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of vertebral body</ENT>
              <ENT>32.03</ENT>
              <ENT>N/A</ENT>
              <ENT>18.47</ENT>
              <ENT>5.39</ENT>
              <ENT>N/A</ENT>
              <ENT>55.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63306</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of vertebral body</ENT>
              <ENT>32.22</ENT>
              <ENT>N/A</ENT>
              <ENT>18.10</ENT>
              <ENT>2.39</ENT>
              <ENT>N/A</ENT>
              <ENT>52.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63307</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of vertebral body</ENT>
              <ENT>31.63</ENT>
              <ENT>N/A</ENT>
              <ENT>17.31</ENT>
              <ENT>4.23</ENT>
              <ENT>N/A</ENT>
              <ENT>53.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63308</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove vertebral body add-on</ENT>
              <ENT>5.25</ENT>
              <ENT>N/A</ENT>
              <ENT>2.67</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>8.93</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove spinal cord lesion</ENT>
              <ENT>14.02</ENT>
              <ENT>N/A</ENT>
              <ENT>5.59</ENT>
              <ENT>1.22</ENT>
              <ENT>N/A</ENT>
              <ENT>20.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63610</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Stimulation of spinal cord</ENT>
              <ENT>8.73</ENT>
              <ENT>56.96</ENT>
              <ENT>2.32</ENT>
              <ENT>0.43</ENT>
              <ENT>66.12</ENT>
              <ENT>11.48</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63615</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove lesion of spinal cord</ENT>
              <ENT>16.28</ENT>
              <ENT>N/A</ENT>
              <ENT>9.52</ENT>
              <ENT>2.85</ENT>
              <ENT>N/A</ENT>
              <ENT>28.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63650</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant neuroelectrodes</ENT>
              <ENT>6.74</ENT>
              <ENT>N/A</ENT>
              <ENT>3.30</ENT>
              <ENT>0.48</ENT>
              <ENT>N/A</ENT>
              <ENT>10.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63655</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant neuroelectrodes</ENT>
              <ENT>10.29</ENT>
              <ENT>N/A</ENT>
              <ENT>7.17</ENT>
              <ENT>1.85</ENT>
              <ENT>N/A</ENT>
              <ENT>19.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63660</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise/remove neuroelectrode</ENT>
              <ENT>6.16</ENT>
              <ENT>N/A</ENT>
              <ENT>3.80</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>10.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63685</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant neuroreceiver</ENT>
              <ENT>7.04</ENT>
              <ENT>N/A</ENT>
              <ENT>4.34</ENT>
              <ENT>0.96</ENT>
              <ENT>N/A</ENT>
              <ENT>12.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49163"/>
              <ENT I="01">63688</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise/remove neuroreceiver</ENT>
              <ENT>5.39</ENT>
              <ENT>N/A</ENT>
              <ENT>3.75</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>9.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of spinal herniation</ENT>
              <ENT>16.53</ENT>
              <ENT>N/A</ENT>
              <ENT>10.63</ENT>
              <ENT>2.69</ENT>
              <ENT>N/A</ENT>
              <ENT>29.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63702</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of spinal herniation</ENT>
              <ENT>18.48</ENT>
              <ENT>N/A</ENT>
              <ENT>11.00</ENT>
              <ENT>1.36</ENT>
              <ENT>N/A</ENT>
              <ENT>30.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63704</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of spinal herniation</ENT>
              <ENT>21.18</ENT>
              <ENT>N/A</ENT>
              <ENT>13.14</ENT>
              <ENT>3.84</ENT>
              <ENT>N/A</ENT>
              <ENT>38.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63706</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of spinal herniation</ENT>
              <ENT>24.11</ENT>
              <ENT>N/A</ENT>
              <ENT>14.00</ENT>
              <ENT>4.73</ENT>
              <ENT>N/A</ENT>
              <ENT>42.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63707</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair spinal fluid leakage</ENT>
              <ENT>11.26</ENT>
              <ENT>N/A</ENT>
              <ENT>7.99</ENT>
              <ENT>1.96</ENT>
              <ENT>N/A</ENT>
              <ENT>21.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63709</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair spinal fluid leakage</ENT>
              <ENT>14.32</ENT>
              <ENT>N/A</ENT>
              <ENT>9.71</ENT>
              <ENT>2.49</ENT>
              <ENT>N/A</ENT>
              <ENT>26.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63710</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Graft repair of spine defect</ENT>
              <ENT>14.07</ENT>
              <ENT>N/A</ENT>
              <ENT>9.36</ENT>
              <ENT>2.61</ENT>
              <ENT>N/A</ENT>
              <ENT>26.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63740</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Install spinal shunt</ENT>
              <ENT>11.36</ENT>
              <ENT>N/A</ENT>
              <ENT>7.63</ENT>
              <ENT>2.15</ENT>
              <ENT>N/A</ENT>
              <ENT>21.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63741</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Install spinal shunt</ENT>
              <ENT>8.25</ENT>
              <ENT>N/A</ENT>
              <ENT>4.96</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>14.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63744</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of spinal shunt</ENT>
              <ENT>8.10</ENT>
              <ENT>N/A</ENT>
              <ENT>5.49</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>15.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">63746</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of spinal shunt</ENT>
              <ENT>6.43</ENT>
              <ENT>N/A</ENT>
              <ENT>3.96</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>11.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block inj, trigeminal</ENT>
              <ENT>1.11</ENT>
              <ENT>2.06</ENT>
              <ENT>0.37</ENT>
              <ENT>0.06</ENT>
              <ENT>3.23</ENT>
              <ENT>1.54</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64402</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block inj, facial</ENT>
              <ENT>1.25</ENT>
              <ENT>1.79</ENT>
              <ENT>0.54</ENT>
              <ENT>0.07</ENT>
              <ENT>3.11</ENT>
              <ENT>1.86</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64405</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block inj, occipital</ENT>
              <ENT>1.32</ENT>
              <ENT>1.55</ENT>
              <ENT>0.40</ENT>
              <ENT>0.08</ENT>
              <ENT>2.95</ENT>
              <ENT>1.80</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64408</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block inj, vagus</ENT>
              <ENT>1.41</ENT>
              <ENT>1.63</ENT>
              <ENT>0.67</ENT>
              <ENT>0.09</ENT>
              <ENT>3.13</ENT>
              <ENT>2.17</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64410</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block inj, phrenic</ENT>
              <ENT>1.43</ENT>
              <ENT>2.67</ENT>
              <ENT>0.40</ENT>
              <ENT>0.08</ENT>
              <ENT>4.18</ENT>
              <ENT>1.91</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64412</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block inj, spinal accessor</ENT>
              <ENT>1.18</ENT>
              <ENT>2.80</ENT>
              <ENT>0.37</ENT>
              <ENT>0.08</ENT>
              <ENT>4.06</ENT>
              <ENT>1.63</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64413</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block inj, cervical plexus</ENT>
              <ENT>1.40</ENT>
              <ENT>1.95</ENT>
              <ENT>0.44</ENT>
              <ENT>0.09</ENT>
              <ENT>3.44</ENT>
              <ENT>1.93</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64415</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block inj, brachial plexus</ENT>
              <ENT>1.48</ENT>
              <ENT>2.95</ENT>
              <ENT>0.40</ENT>
              <ENT>0.08</ENT>
              <ENT>4.51</ENT>
              <ENT>1.96</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64416</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block cont infuse, b plex</ENT>
              <ENT>3.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.73</ENT>
              <ENT>0.08</ENT>
              <ENT>N/A</ENT>
              <ENT>4.31</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64417</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block inj, axillary</ENT>
              <ENT>1.44</ENT>
              <ENT>3.19</ENT>
              <ENT>0.43</ENT>
              <ENT>0.09</ENT>
              <ENT>4.72</ENT>
              <ENT>1.96</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64418</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block inj, suprascapular</ENT>
              <ENT>1.32</ENT>
              <ENT>2.76</ENT>
              <ENT>0.37</ENT>
              <ENT>0.07</ENT>
              <ENT>4.15</ENT>
              <ENT>1.76</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block inj, intercost, sng</ENT>
              <ENT>1.18</ENT>
              <ENT>3.62</ENT>
              <ENT>0.36</ENT>
              <ENT>0.07</ENT>
              <ENT>4.87</ENT>
              <ENT>1.61</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64421</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block inj, intercost, mlt</ENT>
              <ENT>1.68</ENT>
              <ENT>5.53</ENT>
              <ENT>0.46</ENT>
              <ENT>0.10</ENT>
              <ENT>7.31</ENT>
              <ENT>2.24</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64425</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block inj ilio-ing/hypogi</ENT>
              <ENT>1.75</ENT>
              <ENT>1.74</ENT>
              <ENT>0.48</ENT>
              <ENT>0.11</ENT>
              <ENT>3.60</ENT>
              <ENT>2.34</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64430</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block inj, pudendal</ENT>
              <ENT>1.46</ENT>
              <ENT>2.66</ENT>
              <ENT>0.50</ENT>
              <ENT>0.11</ENT>
              <ENT>4.23</ENT>
              <ENT>2.07</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64435</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block inj, paracervical</ENT>
              <ENT>1.45</ENT>
              <ENT>2.67</ENT>
              <ENT>0.64</ENT>
              <ENT>0.15</ENT>
              <ENT>4.27</ENT>
              <ENT>2.24</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64445</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block inj, sciatic, sng</ENT>
              <ENT>1.48</ENT>
              <ENT>2.78</ENT>
              <ENT>0.38</ENT>
              <ENT>0.08</ENT>
              <ENT>4.34</ENT>
              <ENT>1.94</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64446</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N blk inj, sciatic, cont inf</ENT>
              <ENT>3.25</ENT>
              <ENT>N/A</ENT>
              <ENT>1.21</ENT>
              <ENT>0.08</ENT>
              <ENT>N/A</ENT>
              <ENT>4.54</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64447</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block inj fem, single</ENT>
              <ENT>1.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.52</ENT>
              <ENT>0.08</ENT>
              <ENT>N/A</ENT>
              <ENT>2.10</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64448</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block inj fem, cont inf</ENT>
              <ENT>3.00</ENT>
              <ENT>N/A</ENT>
              <ENT>1.04</ENT>
              <ENT>0.08</ENT>
              <ENT>N/A</ENT>
              <ENT>4.12</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block, other peripheral</ENT>
              <ENT>1.27</ENT>
              <ENT>1.30</ENT>
              <ENT>0.42</ENT>
              <ENT>0.08</ENT>
              <ENT>2.65</ENT>
              <ENT>1.77</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64470</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inj paravertebral c/t</ENT>
              <ENT>1.85</ENT>
              <ENT>4.97</ENT>
              <ENT>0.57</ENT>
              <ENT>0.12</ENT>
              <ENT>6.94</ENT>
              <ENT>2.54</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64472</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inj paravertebral c/t add-on</ENT>
              <ENT>1.29</ENT>
              <ENT>1.99</ENT>
              <ENT>0.31</ENT>
              <ENT>0.09</ENT>
              <ENT>3.37</ENT>
              <ENT>1.69</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64475</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inj paravertebral l/s</ENT>
              <ENT>1.41</ENT>
              <ENT>4.67</ENT>
              <ENT>0.48</ENT>
              <ENT>0.09</ENT>
              <ENT>6.17</ENT>
              <ENT>1.98</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64476</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inj paravertebral l/s add-on</ENT>
              <ENT>0.98</ENT>
              <ENT>1.87</ENT>
              <ENT>0.25</ENT>
              <ENT>0.06</ENT>
              <ENT>2.91</ENT>
              <ENT>1.29</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64479</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inj foramen epidural c/t</ENT>
              <ENT>2.20</ENT>
              <ENT>7.22</ENT>
              <ENT>0.73</ENT>
              <ENT>0.14</ENT>
              <ENT>9.56</ENT>
              <ENT>3.07</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64480</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inj foramen epidural add-on</ENT>
              <ENT>1.54</ENT>
              <ENT>2.46</ENT>
              <ENT>0.48</ENT>
              <ENT>0.09</ENT>
              <ENT>4.09</ENT>
              <ENT>2.11</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64483</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inj foramen epidural l/s</ENT>
              <ENT>1.90</ENT>
              <ENT>7.74</ENT>
              <ENT>0.66</ENT>
              <ENT>0.12</ENT>
              <ENT>9.76</ENT>
              <ENT>2.68</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64484</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inj foramen epidural add-on</ENT>
              <ENT>1.33</ENT>
              <ENT>2.88</ENT>
              <ENT>0.38</ENT>
              <ENT>0.08</ENT>
              <ENT>4.29</ENT>
              <ENT>1.79</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64505</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block, spenopalatine gangl</ENT>
              <ENT>1.36</ENT>
              <ENT>1.26</ENT>
              <ENT>0.48</ENT>
              <ENT>0.08</ENT>
              <ENT>2.70</ENT>
              <ENT>1.92</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64508</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block, carotid sinus s/p</ENT>
              <ENT>1.12</ENT>
              <ENT>3.18</ENT>
              <ENT>0.52</ENT>
              <ENT>0.06</ENT>
              <ENT>4.36</ENT>
              <ENT>1.70</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block, stellate ganglion</ENT>
              <ENT>1.22</ENT>
              <ENT>3.32</ENT>
              <ENT>0.38</ENT>
              <ENT>0.07</ENT>
              <ENT>4.61</ENT>
              <ENT>1.67</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block, lumbar/thoracic</ENT>
              <ENT>1.35</ENT>
              <ENT>4.67</ENT>
              <ENT>0.42</ENT>
              <ENT>0.08</ENT>
              <ENT>6.10</ENT>
              <ENT>1.85</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>N block inj, celiac pelus</ENT>
              <ENT>1.58</ENT>
              <ENT>4.08</ENT>
              <ENT>0.48</ENT>
              <ENT>0.09</ENT>
              <ENT>5.75</ENT>
              <ENT>2.15</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64550</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apply neurostimulator</ENT>
              <ENT>0.18</ENT>
              <ENT>0.28</ENT>
              <ENT>0.05</ENT>
              <ENT>0.01</ENT>
              <ENT>0.47</ENT>
              <ENT>0.24</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64553</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant neuroelectrodes</ENT>
              <ENT>2.31</ENT>
              <ENT>2.95</ENT>
              <ENT>1.90</ENT>
              <ENT>0.17</ENT>
              <ENT>5.43</ENT>
              <ENT>4.38</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64555</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant neuroelectrodes</ENT>
              <ENT>2.27</ENT>
              <ENT>3.22</ENT>
              <ENT>1.23</ENT>
              <ENT>0.11</ENT>
              <ENT>5.60</ENT>
              <ENT>3.61</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64560</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant neuroelectrodes</ENT>
              <ENT>2.36</ENT>
              <ENT>2.73</ENT>
              <ENT>1.34</ENT>
              <ENT>0.17</ENT>
              <ENT>5.26</ENT>
              <ENT>3.87</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64561</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant neuroelectrodes</ENT>
              <ENT>6.74</ENT>
              <ENT>N/A</ENT>
              <ENT>3.23</ENT>
              <ENT>0.11</ENT>
              <ENT>N/A</ENT>
              <ENT>10.08</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64565</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant neuroelectrodes</ENT>
              <ENT>1.76</ENT>
              <ENT>3.38</ENT>
              <ENT>1.29</ENT>
              <ENT>0.08</ENT>
              <ENT>5.22</ENT>
              <ENT>3.13</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64573</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant neuroelectrodes</ENT>
              <ENT>7.50</ENT>
              <ENT>N/A</ENT>
              <ENT>5.43</ENT>
              <ENT>1.48</ENT>
              <ENT>N/A</ENT>
              <ENT>14.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64575</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant neuroelectrodes</ENT>
              <ENT>4.35</ENT>
              <ENT>N/A</ENT>
              <ENT>2.94</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>7.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64577</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant neuroelectrodes</ENT>
              <ENT>4.62</ENT>
              <ENT>N/A</ENT>
              <ENT>3.43</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>8.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64580</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant neuroelectrodes</ENT>
              <ENT>4.12</ENT>
              <ENT>N/A</ENT>
              <ENT>3.78</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>8.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64581</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant neuroelectrodes</ENT>
              <ENT>13.50</ENT>
              <ENT>N/A</ENT>
              <ENT>5.53</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>19.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64585</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise/remove neuroelectrode</ENT>
              <ENT>2.06</ENT>
              <ENT>11.73</ENT>
              <ENT>1.75</ENT>
              <ENT>0.29</ENT>
              <ENT>14.08</ENT>
              <ENT>4.10</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64590</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant neuroreceiver</ENT>
              <ENT>2.40</ENT>
              <ENT>7.41</ENT>
              <ENT>1.94</ENT>
              <ENT>0.40</ENT>
              <ENT>10.21</ENT>
              <ENT>4.74</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49164"/>
              <ENT I="01">64595</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise/remove neuroreceiver</ENT>
              <ENT>1.73</ENT>
              <ENT>10.90</ENT>
              <ENT>1.52</ENT>
              <ENT>0.22</ENT>
              <ENT>12.85</ENT>
              <ENT>3.47</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection treatment of nerve</ENT>
              <ENT>3.45</ENT>
              <ENT>7.83</ENT>
              <ENT>1.60</ENT>
              <ENT>0.28</ENT>
              <ENT>11.56</ENT>
              <ENT>5.33</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection treatment of nerve</ENT>
              <ENT>5.61</ENT>
              <ENT>9.33</ENT>
              <ENT>2.08</ENT>
              <ENT>0.53</ENT>
              <ENT>15.47</ENT>
              <ENT>8.22</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64610</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection treatment of nerve</ENT>
              <ENT>7.16</ENT>
              <ENT>7.94</ENT>
              <ENT>3.65</ENT>
              <ENT>1.12</ENT>
              <ENT>16.22</ENT>
              <ENT>11.93</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64612</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destroy nerve, face muscle</ENT>
              <ENT>1.96</ENT>
              <ENT>2.67</ENT>
              <ENT>1.09</ENT>
              <ENT>0.09</ENT>
              <ENT>4.72</ENT>
              <ENT>3.14</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64613</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destroy nerve, spine muscle</ENT>
              <ENT>1.96</ENT>
              <ENT>3.04</ENT>
              <ENT>1.01</ENT>
              <ENT>0.10</ENT>
              <ENT>5.10</ENT>
              <ENT>3.07</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64614</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destroy nerve, extrem musc</ENT>
              <ENT>2.20</ENT>
              <ENT>3.30</ENT>
              <ENT>1.13</ENT>
              <ENT>0.09</ENT>
              <ENT>5.59</ENT>
              <ENT>3.42</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64620</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection treatment of nerve</ENT>
              <ENT>2.84</ENT>
              <ENT>4.72</ENT>
              <ENT>1.19</ENT>
              <ENT>0.17</ENT>
              <ENT>7.73</ENT>
              <ENT>4.20</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64622</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destr paravertebrl nerve l/s</ENT>
              <ENT>3.00</ENT>
              <ENT>7.63</ENT>
              <ENT>1.25</ENT>
              <ENT>0.17</ENT>
              <ENT>10.80</ENT>
              <ENT>4.42</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64623</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destr paravertebral n add-on</ENT>
              <ENT>0.99</ENT>
              <ENT>2.44</ENT>
              <ENT>0.23</ENT>
              <ENT>0.06</ENT>
              <ENT>3.49</ENT>
              <ENT>1.28</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64626</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destr paravertebrl nerve c/t</ENT>
              <ENT>3.28</ENT>
              <ENT>6.63</ENT>
              <ENT>1.86</ENT>
              <ENT>0.22</ENT>
              <ENT>10.13</ENT>
              <ENT>5.36</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64627</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destr paravertebral n add-on</ENT>
              <ENT>1.16</ENT>
              <ENT>2.63</ENT>
              <ENT>0.27</ENT>
              <ENT>0.08</ENT>
              <ENT>3.87</ENT>
              <ENT>1.51</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64630</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection treatment of nerve</ENT>
              <ENT>3.00</ENT>
              <ENT>2.80</ENT>
              <ENT>1.29</ENT>
              <ENT>0.16</ENT>
              <ENT>5.96</ENT>
              <ENT>4.45</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64640</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection treatment of nerve</ENT>
              <ENT>2.76</ENT>
              <ENT>4.29</ENT>
              <ENT>1.68</ENT>
              <ENT>0.11</ENT>
              <ENT>7.16</ENT>
              <ENT>4.55</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64680</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection treatment of nerve</ENT>
              <ENT>2.62</ENT>
              <ENT>6.18</ENT>
              <ENT>1.28</ENT>
              <ENT>0.15</ENT>
              <ENT>8.95</ENT>
              <ENT>4.05</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64702</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise finger/toe nerve</ENT>
              <ENT>4.23</ENT>
              <ENT>N/A</ENT>
              <ENT>4.22</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>8.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64704</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise hand/foot nerve</ENT>
              <ENT>4.57</ENT>
              <ENT>N/A</ENT>
              <ENT>3.48</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>8.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64708</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise arm/leg nerve</ENT>
              <ENT>6.12</ENT>
              <ENT>N/A</ENT>
              <ENT>5.21</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>12.15</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64712</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of sciatic nerve</ENT>
              <ENT>7.75</ENT>
              <ENT>N/A</ENT>
              <ENT>5.29</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>13.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64713</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of arm nerve(s)</ENT>
              <ENT>11.00</ENT>
              <ENT>N/A</ENT>
              <ENT>6.10</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>18.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64714</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise low back nerve(s)</ENT>
              <ENT>10.33</ENT>
              <ENT>N/A</ENT>
              <ENT>4.40</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>15.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64716</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of cranial nerve</ENT>
              <ENT>6.31</ENT>
              <ENT>N/A</ENT>
              <ENT>5.54</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>12.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64718</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise ulnar nerve at elbow</ENT>
              <ENT>5.99</ENT>
              <ENT>N/A</ENT>
              <ENT>6.22</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>13.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64719</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise ulnar nerve at wrist</ENT>
              <ENT>4.85</ENT>
              <ENT>N/A</ENT>
              <ENT>4.90</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>10.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64721</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Carpal tunnel surgery</ENT>
              <ENT>4.29</ENT>
              <ENT>5.25</ENT>
              <ENT>5.25</ENT>
              <ENT>0.59</ENT>
              <ENT>10.13</ENT>
              <ENT>10.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64722</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Relieve pressure on nerve(s)</ENT>
              <ENT>4.70</ENT>
              <ENT>N/A</ENT>
              <ENT>3.29</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>8.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64726</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release foot/toe nerve</ENT>
              <ENT>4.18</ENT>
              <ENT>N/A</ENT>
              <ENT>3.04</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>7.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64727</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Internal nerve revision</ENT>
              <ENT>3.10</ENT>
              <ENT>N/A</ENT>
              <ENT>1.53</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>5.03</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64732</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of brow nerve</ENT>
              <ENT>4.41</ENT>
              <ENT>N/A</ENT>
              <ENT>3.76</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>8.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64734</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of cheek nerve</ENT>
              <ENT>4.92</ENT>
              <ENT>N/A</ENT>
              <ENT>4.30</ENT>
              <ENT>0.83</ENT>
              <ENT>N/A</ENT>
              <ENT>10.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64736</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of chin nerve</ENT>
              <ENT>4.60</ENT>
              <ENT>N/A</ENT>
              <ENT>4.27</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>9.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64738</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of jaw nerve</ENT>
              <ENT>5.73</ENT>
              <ENT>N/A</ENT>
              <ENT>4.87</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>11.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64740</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of tongue nerve</ENT>
              <ENT>5.59</ENT>
              <ENT>N/A</ENT>
              <ENT>4.63</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>10.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64742</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of facial nerve</ENT>
              <ENT>6.22</ENT>
              <ENT>N/A</ENT>
              <ENT>5.06</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>11.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64744</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise nerve, back of head</ENT>
              <ENT>5.24</ENT>
              <ENT>N/A</ENT>
              <ENT>4.02</ENT>
              <ENT>0.98</ENT>
              <ENT>N/A</ENT>
              <ENT>10.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64746</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise diaphragm nerve</ENT>
              <ENT>5.93</ENT>
              <ENT>N/A</ENT>
              <ENT>4.63</ENT>
              <ENT>0.75</ENT>
              <ENT>N/A</ENT>
              <ENT>11.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64752</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of vagus nerve</ENT>
              <ENT>7.06</ENT>
              <ENT>N/A</ENT>
              <ENT>4.43</ENT>
              <ENT>0.83</ENT>
              <ENT>N/A</ENT>
              <ENT>12.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64755</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of stomach nerves</ENT>
              <ENT>13.52</ENT>
              <ENT>N/A</ENT>
              <ENT>5.91</ENT>
              <ENT>1.16</ENT>
              <ENT>N/A</ENT>
              <ENT>20.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64760</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of vagus nerve</ENT>
              <ENT>6.96</ENT>
              <ENT>N/A</ENT>
              <ENT>3.72</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>11.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64761</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of pelvis nerve</ENT>
              <ENT>6.41</ENT>
              <ENT>N/A</ENT>
              <ENT>3.82</ENT>
              <ENT>0.26</ENT>
              <ENT>N/A</ENT>
              <ENT>10.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64763</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise hip/thigh nerve</ENT>
              <ENT>6.93</ENT>
              <ENT>N/A</ENT>
              <ENT>5.66</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>13.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64766</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise hip/thigh nerve</ENT>
              <ENT>8.67</ENT>
              <ENT>N/A</ENT>
              <ENT>5.53</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>15.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64771</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sever cranial nerve</ENT>
              <ENT>7.35</ENT>
              <ENT>N/A</ENT>
              <ENT>5.83</ENT>
              <ENT>1.32</ENT>
              <ENT>N/A</ENT>
              <ENT>14.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64772</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of spinal nerve</ENT>
              <ENT>7.21</ENT>
              <ENT>N/A</ENT>
              <ENT>5.19</ENT>
              <ENT>1.20</ENT>
              <ENT>N/A</ENT>
              <ENT>13.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64774</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove skin nerve lesion</ENT>
              <ENT>5.17</ENT>
              <ENT>N/A</ENT>
              <ENT>4.11</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>9.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64776</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove digit nerve lesion</ENT>
              <ENT>5.12</ENT>
              <ENT>N/A</ENT>
              <ENT>4.00</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>9.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64778</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Digit nerve surgery add-on</ENT>
              <ENT>3.11</ENT>
              <ENT>N/A</ENT>
              <ENT>1.53</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>5.02</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64782</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove limb nerve lesion</ENT>
              <ENT>6.23</ENT>
              <ENT>N/A</ENT>
              <ENT>3.98</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>11.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49165"/>
              <ENT I="01">64783</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Limb nerve surgery add-on</ENT>
              <ENT>3.72</ENT>
              <ENT>N/A</ENT>
              <ENT>1.88</ENT>
              <ENT>0.48</ENT>
              <ENT>N/A</ENT>
              <ENT>6.08</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64784</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove nerve lesion</ENT>
              <ENT>9.82</ENT>
              <ENT>N/A</ENT>
              <ENT>6.96</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>17.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64786</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove sciatic nerve lesion</ENT>
              <ENT>15.46</ENT>
              <ENT>N/A</ENT>
              <ENT>10.36</ENT>
              <ENT>2.22</ENT>
              <ENT>N/A</ENT>
              <ENT>28.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64787</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant nerve end</ENT>
              <ENT>4.30</ENT>
              <ENT>N/A</ENT>
              <ENT>2.17</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>7.03</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64788</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove skin nerve lesion</ENT>
              <ENT>4.61</ENT>
              <ENT>N/A</ENT>
              <ENT>3.75</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>8.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64790</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of nerve lesion</ENT>
              <ENT>11.31</ENT>
              <ENT>N/A</ENT>
              <ENT>7.57</ENT>
              <ENT>1.68</ENT>
              <ENT>N/A</ENT>
              <ENT>20.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64792</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of nerve lesion</ENT>
              <ENT>14.92</ENT>
              <ENT>N/A</ENT>
              <ENT>9.20</ENT>
              <ENT>1.88</ENT>
              <ENT>N/A</ENT>
              <ENT>26.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64795</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of nerve</ENT>
              <ENT>3.01</ENT>
              <ENT>N/A</ENT>
              <ENT>1.62</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>5.03</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64802</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove sympathetic nerves</ENT>
              <ENT>9.15</ENT>
              <ENT>N/A</ENT>
              <ENT>5.27</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>15.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64804</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove sympathetic nerves</ENT>
              <ENT>14.64</ENT>
              <ENT>N/A</ENT>
              <ENT>7.25</ENT>
              <ENT>1.79</ENT>
              <ENT>N/A</ENT>
              <ENT>23.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64809</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove sympathetic nerves</ENT>
              <ENT>13.67</ENT>
              <ENT>N/A</ENT>
              <ENT>5.94</ENT>
              <ENT>0.96</ENT>
              <ENT>N/A</ENT>
              <ENT>20.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64818</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove sympathetic nerves</ENT>
              <ENT>10.30</ENT>
              <ENT>N/A</ENT>
              <ENT>5.42</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>16.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove sympathetic nerves</ENT>
              <ENT>10.37</ENT>
              <ENT>N/A</ENT>
              <ENT>7.35</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>18.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64821</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove sympathestic nerves</ENT>
              <ENT>8.75</ENT>
              <ENT>N/A</ENT>
              <ENT>7.60</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>17.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64822</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove sympathetic nerves</ENT>
              <ENT>8.75</ENT>
              <ENT>N/A</ENT>
              <ENT>7.53</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>17.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64823</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove sympathetic nerves</ENT>
              <ENT>10.37</ENT>
              <ENT>N/A</ENT>
              <ENT>8.45</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>19.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64831</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of digit nerve</ENT>
              <ENT>9.44</ENT>
              <ENT>N/A</ENT>
              <ENT>7.53</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>18.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64832</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair nerve add-on</ENT>
              <ENT>5.66</ENT>
              <ENT>N/A</ENT>
              <ENT>3.00</ENT>
              <ENT>0.68</ENT>
              <ENT>N/A</ENT>
              <ENT>9.34</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64834</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of hand or foot nerve</ENT>
              <ENT>10.19</ENT>
              <ENT>N/A</ENT>
              <ENT>7.56</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>18.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64835</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of hand or foot nerve</ENT>
              <ENT>10.94</ENT>
              <ENT>N/A</ENT>
              <ENT>8.16</ENT>
              <ENT>1.36</ENT>
              <ENT>N/A</ENT>
              <ENT>20.46</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64836</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of hand or foot nerve</ENT>
              <ENT>10.94</ENT>
              <ENT>N/A</ENT>
              <ENT>8.13</ENT>
              <ENT>1.32</ENT>
              <ENT>N/A</ENT>
              <ENT>20.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64837</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair nerve add-on</ENT>
              <ENT>6.26</ENT>
              <ENT>N/A</ENT>
              <ENT>3.31</ENT>
              <ENT>0.80</ENT>
              <ENT>N/A</ENT>
              <ENT>10.37</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64840</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of leg nerve</ENT>
              <ENT>13.02</ENT>
              <ENT>N/A</ENT>
              <ENT>8.70</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>22.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64856</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/transpose nerve</ENT>
              <ENT>13.80</ENT>
              <ENT>N/A</ENT>
              <ENT>9.68</ENT>
              <ENT>1.71</ENT>
              <ENT>N/A</ENT>
              <ENT>25.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64857</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair arm/leg nerve</ENT>
              <ENT>14.49</ENT>
              <ENT>N/A</ENT>
              <ENT>10.15</ENT>
              <ENT>1.76</ENT>
              <ENT>N/A</ENT>
              <ENT>26.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64858</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair sciatic nerve</ENT>
              <ENT>16.49</ENT>
              <ENT>N/A</ENT>
              <ENT>11.15</ENT>
              <ENT>2.78</ENT>
              <ENT>N/A</ENT>
              <ENT>30.42</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64859</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nerve surgery</ENT>
              <ENT>4.26</ENT>
              <ENT>N/A</ENT>
              <ENT>2.24</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>7.00</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64861</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of arm nerves</ENT>
              <ENT>19.24</ENT>
              <ENT>N/A</ENT>
              <ENT>12.13</ENT>
              <ENT>2.45</ENT>
              <ENT>N/A</ENT>
              <ENT>33.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64862</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of low back nerves</ENT>
              <ENT>19.44</ENT>
              <ENT>N/A</ENT>
              <ENT>12.18</ENT>
              <ENT>2.47</ENT>
              <ENT>N/A</ENT>
              <ENT>34.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64864</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of facial nerve</ENT>
              <ENT>12.55</ENT>
              <ENT>N/A</ENT>
              <ENT>8.52</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>22.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64865</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of facial nerve</ENT>
              <ENT>15.24</ENT>
              <ENT>N/A</ENT>
              <ENT>10.23</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>26.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64866</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of facial/other nerve</ENT>
              <ENT>15.74</ENT>
              <ENT>N/A</ENT>
              <ENT>10.06</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>26.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64868</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of facial/other nerve</ENT>
              <ENT>14.04</ENT>
              <ENT>N/A</ENT>
              <ENT>9.22</ENT>
              <ENT>1.40</ENT>
              <ENT>N/A</ENT>
              <ENT>24.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64870</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fusion of facial/other nerve</ENT>
              <ENT>15.99</ENT>
              <ENT>N/A</ENT>
              <ENT>9.10</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>26.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64872</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Subsequent repair of nerve</ENT>
              <ENT>1.99</ENT>
              <ENT>N/A</ENT>
              <ENT>1.10</ENT>
              <ENT>0.24</ENT>
              <ENT>N/A</ENT>
              <ENT>3.33</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64874</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair &amp; revise nerve add-on</ENT>
              <ENT>2.98</ENT>
              <ENT>N/A</ENT>
              <ENT>1.57</ENT>
              <ENT>0.34</ENT>
              <ENT>N/A</ENT>
              <ENT>4.89</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64876</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair nerve/shorten bone</ENT>
              <ENT>3.38</ENT>
              <ENT>N/A</ENT>
              <ENT>1.31</ENT>
              <ENT>0.39</ENT>
              <ENT>N/A</ENT>
              <ENT>5.08</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64885</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nerve graft, head or neck</ENT>
              <ENT>17.53</ENT>
              <ENT>N/A</ENT>
              <ENT>11.26</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>30.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64886</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nerve graft, head or neck</ENT>
              <ENT>20.75</ENT>
              <ENT>N/A</ENT>
              <ENT>13.13</ENT>
              <ENT>1.73</ENT>
              <ENT>N/A</ENT>
              <ENT>35.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64890</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nerve graft, hand or foot</ENT>
              <ENT>15.15</ENT>
              <ENT>N/A</ENT>
              <ENT>10.52</ENT>
              <ENT>1.74</ENT>
              <ENT>N/A</ENT>
              <ENT>27.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64891</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nerve graft, hand or foot</ENT>
              <ENT>16.14</ENT>
              <ENT>N/A</ENT>
              <ENT>7.97</ENT>
              <ENT>1.38</ENT>
              <ENT>N/A</ENT>
              <ENT>25.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64892</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nerve graft, arm or leg</ENT>
              <ENT>14.65</ENT>
              <ENT>N/A</ENT>
              <ENT>9.31</ENT>
              <ENT>1.65</ENT>
              <ENT>N/A</ENT>
              <ENT>25.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64893</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nerve graft, arm or leg</ENT>
              <ENT>15.60</ENT>
              <ENT>N/A</ENT>
              <ENT>10.30</ENT>
              <ENT>1.77</ENT>
              <ENT>N/A</ENT>
              <ENT>27.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64895</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nerve graft, hand or foot</ENT>
              <ENT>19.25</ENT>
              <ENT>N/A</ENT>
              <ENT>10.06</ENT>
              <ENT>2.04</ENT>
              <ENT>N/A</ENT>
              <ENT>31.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64896</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nerve graft, hand or foot</ENT>
              <ENT>20.49</ENT>
              <ENT>N/A</ENT>
              <ENT>11.53</ENT>
              <ENT>1.85</ENT>
              <ENT>N/A</ENT>
              <ENT>33.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64897</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nerve graft, arm or leg</ENT>
              <ENT>18.24</ENT>
              <ENT>N/A</ENT>
              <ENT>11.19</ENT>
              <ENT>2.64</ENT>
              <ENT>N/A</ENT>
              <ENT>32.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64898</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nerve graft, arm or leg</ENT>
              <ENT>19.50</ENT>
              <ENT>N/A</ENT>
              <ENT>12.29</ENT>
              <ENT>2.71</ENT>
              <ENT>N/A</ENT>
              <ENT>34.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64901</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nerve graft add-on</ENT>
              <ENT>10.22</ENT>
              <ENT>N/A</ENT>
              <ENT>5.39</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>16.60</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49166"/>
              <ENT I="01">64902</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nerve graft add-on</ENT>
              <ENT>11.83</ENT>
              <ENT>N/A</ENT>
              <ENT>6.10</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>19.03</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64905</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nerve pedicle transfer</ENT>
              <ENT>14.02</ENT>
              <ENT>N/A</ENT>
              <ENT>8.98</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>24.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64907</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nerve pedicle transfer</ENT>
              <ENT>18.83</ENT>
              <ENT>N/A</ENT>
              <ENT>12.64</ENT>
              <ENT>1.79</ENT>
              <ENT>N/A</ENT>
              <ENT>33.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">64999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Nervous system surgery</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65091</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise eye</ENT>
              <ENT>6.46</ENT>
              <ENT>N/A</ENT>
              <ENT>9.88</ENT>
              <ENT>0.26</ENT>
              <ENT>N/A</ENT>
              <ENT>16.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65093</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise eye with implant</ENT>
              <ENT>6.87</ENT>
              <ENT>N/A</ENT>
              <ENT>10.25</ENT>
              <ENT>0.28</ENT>
              <ENT>N/A</ENT>
              <ENT>17.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65101</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of eye</ENT>
              <ENT>7.03</ENT>
              <ENT>N/A</ENT>
              <ENT>10.83</ENT>
              <ENT>0.28</ENT>
              <ENT>N/A</ENT>
              <ENT>18.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65103</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove eye/insert implant</ENT>
              <ENT>7.57</ENT>
              <ENT>N/A</ENT>
              <ENT>11.04</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>18.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65105</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove eye/attach implant</ENT>
              <ENT>8.49</ENT>
              <ENT>N/A</ENT>
              <ENT>11.70</ENT>
              <ENT>0.34</ENT>
              <ENT>N/A</ENT>
              <ENT>20.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of eye</ENT>
              <ENT>13.95</ENT>
              <ENT>N/A</ENT>
              <ENT>14.98</ENT>
              <ENT>0.68</ENT>
              <ENT>N/A</ENT>
              <ENT>29.61</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65112</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove eye/revise socket</ENT>
              <ENT>16.38</ENT>
              <ENT>N/A</ENT>
              <ENT>17.38</ENT>
              <ENT>0.96</ENT>
              <ENT>N/A</ENT>
              <ENT>34.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65114</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove eye/revise socket</ENT>
              <ENT>17.53</ENT>
              <ENT>N/A</ENT>
              <ENT>17.50</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>35.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65125</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise ocular implant</ENT>
              <ENT>3.12</ENT>
              <ENT>9.35</ENT>
              <ENT>3.02</ENT>
              <ENT>0.15</ENT>
              <ENT>12.62</ENT>
              <ENT>6.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert ocular implant</ENT>
              <ENT>7.15</ENT>
              <ENT>N/A</ENT>
              <ENT>10.42</ENT>
              <ENT>0.28</ENT>
              <ENT>N/A</ENT>
              <ENT>17.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65135</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert ocular implant</ENT>
              <ENT>7.33</ENT>
              <ENT>N/A</ENT>
              <ENT>10.59</ENT>
              <ENT>0.29</ENT>
              <ENT>N/A</ENT>
              <ENT>18.21</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Attach ocular implant</ENT>
              <ENT>8.02</ENT>
              <ENT>N/A</ENT>
              <ENT>11.06</ENT>
              <ENT>0.31</ENT>
              <ENT>N/A</ENT>
              <ENT>19.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise ocular implant</ENT>
              <ENT>6.26</ENT>
              <ENT>N/A</ENT>
              <ENT>9.43</ENT>
              <ENT>0.25</ENT>
              <ENT>N/A</ENT>
              <ENT>15.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65155</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reinsert ocular implant</ENT>
              <ENT>8.66</ENT>
              <ENT>N/A</ENT>
              <ENT>11.80</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>20.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65175</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of ocular implant</ENT>
              <ENT>6.28</ENT>
              <ENT>N/A</ENT>
              <ENT>9.81</ENT>
              <ENT>0.26</ENT>
              <ENT>N/A</ENT>
              <ENT>16.35</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65205</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove foreign body from eye</ENT>
              <ENT>0.71</ENT>
              <ENT>0.61</ENT>
              <ENT>0.19</ENT>
              <ENT>0.03</ENT>
              <ENT>1.35</ENT>
              <ENT>0.93</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65210</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove foreign body from eye</ENT>
              <ENT>0.84</ENT>
              <ENT>0.75</ENT>
              <ENT>0.30</ENT>
              <ENT>0.03</ENT>
              <ENT>1.62</ENT>
              <ENT>1.17</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove foreign body from eye</ENT>
              <ENT>0.71</ENT>
              <ENT>0.61</ENT>
              <ENT>0.18</ENT>
              <ENT>0.05</ENT>
              <ENT>1.37</ENT>
              <ENT>0.94</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65222</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove foreign body from eye</ENT>
              <ENT>0.93</ENT>
              <ENT>0.77</ENT>
              <ENT>0.27</ENT>
              <ENT>0.04</ENT>
              <ENT>1.74</ENT>
              <ENT>1.24</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65235</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove foreign body from eye</ENT>
              <ENT>7.57</ENT>
              <ENT>N/A</ENT>
              <ENT>7.41</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>15.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65260</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove foreign body from eye</ENT>
              <ENT>10.96</ENT>
              <ENT>N/A</ENT>
              <ENT>11.71</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>23.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65265</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove foreign body from eye</ENT>
              <ENT>12.59</ENT>
              <ENT>N/A</ENT>
              <ENT>12.91</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>26.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65270</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of eye wound</ENT>
              <ENT>1.90</ENT>
              <ENT>3.90</ENT>
              <ENT>2.28</ENT>
              <ENT>0.08</ENT>
              <ENT>5.88</ENT>
              <ENT>4.26</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65272</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of eye wound</ENT>
              <ENT>3.82</ENT>
              <ENT>5.89</ENT>
              <ENT>5.30</ENT>
              <ENT>0.16</ENT>
              <ENT>9.87</ENT>
              <ENT>9.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65273</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of eye wound</ENT>
              <ENT>4.36</ENT>
              <ENT>N/A</ENT>
              <ENT>5.63</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>10.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65275</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of eye wound</ENT>
              <ENT>5.34</ENT>
              <ENT>5.78</ENT>
              <ENT>5.78</ENT>
              <ENT>0.27</ENT>
              <ENT>11.39</ENT>
              <ENT>11.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65280</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of eye wound</ENT>
              <ENT>7.66</ENT>
              <ENT>N/A</ENT>
              <ENT>8.32</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>16.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65285</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of eye wound</ENT>
              <ENT>12.90</ENT>
              <ENT>N/A</ENT>
              <ENT>12.77</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>26.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65286</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of eye wound</ENT>
              <ENT>5.51</ENT>
              <ENT>8.57</ENT>
              <ENT>7.65</ENT>
              <ENT>0.21</ENT>
              <ENT>14.29</ENT>
              <ENT>13.37</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65290</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of eye socket wound</ENT>
              <ENT>5.41</ENT>
              <ENT>N/A</ENT>
              <ENT>6.61</ENT>
              <ENT>0.26</ENT>
              <ENT>N/A</ENT>
              <ENT>12.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of eye lesion</ENT>
              <ENT>6.06</ENT>
              <ENT>8.78</ENT>
              <ENT>7.60</ENT>
              <ENT>0.24</ENT>
              <ENT>15.08</ENT>
              <ENT>13.90</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65410</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of cornea</ENT>
              <ENT>1.47</ENT>
              <ENT>1.74</ENT>
              <ENT>0.66</ENT>
              <ENT>0.06</ENT>
              <ENT>3.27</ENT>
              <ENT>2.19</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of eye lesion</ENT>
              <ENT>4.17</ENT>
              <ENT>7.65</ENT>
              <ENT>6.84</ENT>
              <ENT>0.17</ENT>
              <ENT>11.99</ENT>
              <ENT>11.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65426</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of eye lesion</ENT>
              <ENT>5.25</ENT>
              <ENT>7.62</ENT>
              <ENT>6.66</ENT>
              <ENT>0.20</ENT>
              <ENT>13.07</ENT>
              <ENT>12.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65430</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Corneal smear</ENT>
              <ENT>1.47</ENT>
              <ENT>5.02</ENT>
              <ENT>0.67</ENT>
              <ENT>0.06</ENT>
              <ENT>6.55</ENT>
              <ENT>2.20</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65435</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Curette/treat cornea</ENT>
              <ENT>0.92</ENT>
              <ENT>1.35</ENT>
              <ENT>0.40</ENT>
              <ENT>0.04</ENT>
              <ENT>2.31</ENT>
              <ENT>1.36</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65436</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Curette/treat cornea</ENT>
              <ENT>4.19</ENT>
              <ENT>5.95</ENT>
              <ENT>5.31</ENT>
              <ENT>0.17</ENT>
              <ENT>10.31</ENT>
              <ENT>9.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of corneal lesion</ENT>
              <ENT>3.27</ENT>
              <ENT>7.32</ENT>
              <ENT>6.43</ENT>
              <ENT>0.13</ENT>
              <ENT>10.72</ENT>
              <ENT>9.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of cornea</ENT>
              <ENT>3.40</ENT>
              <ENT>5.73</ENT>
              <ENT>3.17</ENT>
              <ENT>0.14</ENT>
              <ENT>9.27</ENT>
              <ENT>6.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65710</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Corneal transplant</ENT>
              <ENT>12.35</ENT>
              <ENT>N/A</ENT>
              <ENT>12.72</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>25.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65730</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Corneal transplant</ENT>
              <ENT>14.25</ENT>
              <ENT>N/A</ENT>
              <ENT>12.08</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>26.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65750</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Corneal transplant</ENT>
              <ENT>15.00</ENT>
              <ENT>N/A</ENT>
              <ENT>13.75</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>29.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65755</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Corneal transplant</ENT>
              <ENT>14.89</ENT>
              <ENT>N/A</ENT>
              <ENT>13.66</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>29.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65770</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise cornea with implant</ENT>
              <ENT>17.56</ENT>
              <ENT>N/A</ENT>
              <ENT>14.78</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>33.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65772</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Correction of astigmatism</ENT>
              <ENT>4.29</ENT>
              <ENT>7.17</ENT>
              <ENT>6.46</ENT>
              <ENT>0.17</ENT>
              <ENT>11.63</ENT>
              <ENT>10.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65775</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Correction of astigmatism</ENT>
              <ENT>5.79</ENT>
              <ENT>N/A</ENT>
              <ENT>7.65</ENT>
              <ENT>0.22</ENT>
              <ENT>N/A</ENT>
              <ENT>13.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of eye</ENT>
              <ENT>1.91</ENT>
              <ENT>2.31</ENT>
              <ENT>1.14</ENT>
              <ENT>0.08</ENT>
              <ENT>4.30</ENT>
              <ENT>3.13</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65805</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of eye</ENT>
              <ENT>1.91</ENT>
              <ENT>2.31</ENT>
              <ENT>1.15</ENT>
              <ENT>0.08</ENT>
              <ENT>4.30</ENT>
              <ENT>3.14</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65810</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of eye</ENT>
              <ENT>4.87</ENT>
              <ENT>N/A</ENT>
              <ENT>8.08</ENT>
              <ENT>0.19</ENT>
              <ENT>N/A</ENT>
              <ENT>13.14</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65815</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of eye</ENT>
              <ENT>5.05</ENT>
              <ENT>8.41</ENT>
              <ENT>7.51</ENT>
              <ENT>0.20</ENT>
              <ENT>13.66</ENT>
              <ENT>12.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Relieve inner eye pressure</ENT>
              <ENT>8.13</ENT>
              <ENT>N/A</ENT>
              <ENT>10.62</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>19.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49167"/>
              <ENT I="01">65850</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of eye</ENT>
              <ENT>10.52</ENT>
              <ENT>N/A</ENT>
              <ENT>9.71</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>20.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65855</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laser surgery of eye</ENT>
              <ENT>3.85</ENT>
              <ENT>5.29</ENT>
              <ENT>4.12</ENT>
              <ENT>0.17</ENT>
              <ENT>9.31</ENT>
              <ENT>8.14</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65860</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise inner eye adhesions</ENT>
              <ENT>3.55</ENT>
              <ENT>4.02</ENT>
              <ENT>3.36</ENT>
              <ENT>0.14</ENT>
              <ENT>7.71</ENT>
              <ENT>7.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65865</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise inner eye adhesions</ENT>
              <ENT>5.60</ENT>
              <ENT>N/A</ENT>
              <ENT>6.65</ENT>
              <ENT>0.22</ENT>
              <ENT>N/A</ENT>
              <ENT>12.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65870</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise inner eye adhesions</ENT>
              <ENT>6.27</ENT>
              <ENT>N/A</ENT>
              <ENT>7.32</ENT>
              <ENT>0.24</ENT>
              <ENT>N/A</ENT>
              <ENT>13.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65875</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise inner eye adhesions</ENT>
              <ENT>6.54</ENT>
              <ENT>N/A</ENT>
              <ENT>7.62</ENT>
              <ENT>0.25</ENT>
              <ENT>N/A</ENT>
              <ENT>14.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65880</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise inner eye adhesions</ENT>
              <ENT>7.09</ENT>
              <ENT>N/A</ENT>
              <ENT>7.87</ENT>
              <ENT>0.28</ENT>
              <ENT>N/A</ENT>
              <ENT>15.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65900</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove eye lesion</ENT>
              <ENT>10.93</ENT>
              <ENT>N/A</ENT>
              <ENT>11.89</ENT>
              <ENT>0.46</ENT>
              <ENT>N/A</ENT>
              <ENT>23.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65920</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove implant of eye</ENT>
              <ENT>8.40</ENT>
              <ENT>N/A</ENT>
              <ENT>8.87</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>17.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">65930</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove blood clot from eye</ENT>
              <ENT>7.44</ENT>
              <ENT>N/A</ENT>
              <ENT>8.12</ENT>
              <ENT>0.29</ENT>
              <ENT>N/A</ENT>
              <ENT>15.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection treatment of eye</ENT>
              <ENT>1.59</ENT>
              <ENT>2.42</ENT>
              <ENT>1.61</ENT>
              <ENT>0.07</ENT>
              <ENT>4.08</ENT>
              <ENT>3.27</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66030</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection treatment of eye</ENT>
              <ENT>1.25</ENT>
              <ENT>2.25</ENT>
              <ENT>1.45</ENT>
              <ENT>0.05</ENT>
              <ENT>3.55</ENT>
              <ENT>2.75</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove eye lesion</ENT>
              <ENT>7.69</ENT>
              <ENT>7.61</ENT>
              <ENT>7.04</ENT>
              <ENT>0.31</ENT>
              <ENT>15.61</ENT>
              <ENT>15.04</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Glaucoma surgery</ENT>
              <ENT>8.30</ENT>
              <ENT>N/A</ENT>
              <ENT>10.07</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>18.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66155</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Glaucoma surgery</ENT>
              <ENT>8.29</ENT>
              <ENT>N/A</ENT>
              <ENT>10.04</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>18.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66160</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Glaucoma surgery</ENT>
              <ENT>10.17</ENT>
              <ENT>N/A</ENT>
              <ENT>10.90</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>21.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66165</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Glaucoma surgery</ENT>
              <ENT>8.01</ENT>
              <ENT>N/A</ENT>
              <ENT>9.92</ENT>
              <ENT>0.31</ENT>
              <ENT>N/A</ENT>
              <ENT>18.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66170</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Glaucoma surgery</ENT>
              <ENT>12.16</ENT>
              <ENT>N/A</ENT>
              <ENT>12.62</ENT>
              <ENT>0.48</ENT>
              <ENT>N/A</ENT>
              <ENT>25.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66172</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of eye</ENT>
              <ENT>15.04</ENT>
              <ENT>N/A</ENT>
              <ENT>15.19</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>30.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66180</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant eye shunt</ENT>
              <ENT>14.55</ENT>
              <ENT>N/A</ENT>
              <ENT>11.87</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>26.99</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66185</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise eye shunt</ENT>
              <ENT>8.14</ENT>
              <ENT>N/A</ENT>
              <ENT>8.42</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>16.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair eye lesion</ENT>
              <ENT>7.77</ENT>
              <ENT>N/A</ENT>
              <ENT>9.00</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>17.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66225</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair/graft eye lesion</ENT>
              <ENT>11.05</ENT>
              <ENT>N/A</ENT>
              <ENT>9.57</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>21.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Follow-up surgery of eye</ENT>
              <ENT>5.98</ENT>
              <ENT>7.84</ENT>
              <ENT>6.66</ENT>
              <ENT>0.23</ENT>
              <ENT>14.05</ENT>
              <ENT>12.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of iris</ENT>
              <ENT>3.71</ENT>
              <ENT>N/A</ENT>
              <ENT>5.08</ENT>
              <ENT>0.15</ENT>
              <ENT>N/A</ENT>
              <ENT>8.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66505</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of iris</ENT>
              <ENT>4.08</ENT>
              <ENT>N/A</ENT>
              <ENT>5.37</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>9.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove iris and lesion</ENT>
              <ENT>8.68</ENT>
              <ENT>N/A</ENT>
              <ENT>8.96</ENT>
              <ENT>0.34</ENT>
              <ENT>N/A</ENT>
              <ENT>17.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of iris</ENT>
              <ENT>12.79</ENT>
              <ENT>N/A</ENT>
              <ENT>11.57</ENT>
              <ENT>0.61</ENT>
              <ENT>N/A</ENT>
              <ENT>24.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66625</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of iris</ENT>
              <ENT>5.13</ENT>
              <ENT>7.07</ENT>
              <ENT>6.33</ENT>
              <ENT>0.20</ENT>
              <ENT>12.40</ENT>
              <ENT>11.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66630</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of iris</ENT>
              <ENT>6.16</ENT>
              <ENT>N/A</ENT>
              <ENT>7.48</ENT>
              <ENT>0.24</ENT>
              <ENT>N/A</ENT>
              <ENT>13.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66635</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of iris</ENT>
              <ENT>6.25</ENT>
              <ENT>N/A</ENT>
              <ENT>6.79</ENT>
              <ENT>0.24</ENT>
              <ENT>N/A</ENT>
              <ENT>13.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66680</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair iris &amp; ciliary body</ENT>
              <ENT>5.44</ENT>
              <ENT>N/A</ENT>
              <ENT>6.20</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>11.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66682</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair iris &amp; ciliary body</ENT>
              <ENT>6.21</ENT>
              <ENT>N/A</ENT>
              <ENT>7.48</ENT>
              <ENT>0.24</ENT>
              <ENT>N/A</ENT>
              <ENT>13.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction, ciliary body</ENT>
              <ENT>4.78</ENT>
              <ENT>5.44</ENT>
              <ENT>4.13</ENT>
              <ENT>0.19</ENT>
              <ENT>10.41</ENT>
              <ENT>9.10</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66710</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction, ciliary body</ENT>
              <ENT>4.78</ENT>
              <ENT>5.31</ENT>
              <ENT>3.92</ENT>
              <ENT>0.18</ENT>
              <ENT>10.27</ENT>
              <ENT>8.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66720</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction, ciliary body</ENT>
              <ENT>4.78</ENT>
              <ENT>5.76</ENT>
              <ENT>4.69</ENT>
              <ENT>0.19</ENT>
              <ENT>10.73</ENT>
              <ENT>9.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66740</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destruction, ciliary body</ENT>
              <ENT>4.78</ENT>
              <ENT>5.47</ENT>
              <ENT>4.30</ENT>
              <ENT>0.18</ENT>
              <ENT>10.43</ENT>
              <ENT>9.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66761</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of iris</ENT>
              <ENT>4.07</ENT>
              <ENT>5.65</ENT>
              <ENT>4.31</ENT>
              <ENT>0.16</ENT>
              <ENT>9.88</ENT>
              <ENT>8.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66762</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of iris</ENT>
              <ENT>4.58</ENT>
              <ENT>5.73</ENT>
              <ENT>4.30</ENT>
              <ENT>0.18</ENT>
              <ENT>10.49</ENT>
              <ENT>9.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66770</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of inner eye lesion</ENT>
              <ENT>5.18</ENT>
              <ENT>6.16</ENT>
              <ENT>4.81</ENT>
              <ENT>0.20</ENT>
              <ENT>11.54</ENT>
              <ENT>10.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision, secondary cataract</ENT>
              <ENT>3.89</ENT>
              <ENT>N/A</ENT>
              <ENT>7.12</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>11.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66821</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>After cataract laser surgery</ENT>
              <ENT>2.35</ENT>
              <ENT>4.04</ENT>
              <ENT>3.95</ENT>
              <ENT>0.10</ENT>
              <ENT>6.49</ENT>
              <ENT>6.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66825</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reposition intraocular lens</ENT>
              <ENT>8.23</ENT>
              <ENT>N/A</ENT>
              <ENT>10.05</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>18.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66830</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of lens lesion</ENT>
              <ENT>8.20</ENT>
              <ENT>N/A</ENT>
              <ENT>7.26</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>15.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66840</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of lens material</ENT>
              <ENT>7.91</ENT>
              <ENT>N/A</ENT>
              <ENT>7.17</ENT>
              <ENT>0.31</ENT>
              <ENT>N/A</ENT>
              <ENT>15.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66850</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of lens material</ENT>
              <ENT>9.11</ENT>
              <ENT>N/A</ENT>
              <ENT>7.89</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>17.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66852</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of lens material</ENT>
              <ENT>9.97</ENT>
              <ENT>N/A</ENT>
              <ENT>8.35</ENT>
              <ENT>0.39</ENT>
              <ENT>N/A</ENT>
              <ENT>18.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66920</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extraction of lens</ENT>
              <ENT>8.86</ENT>
              <ENT>N/A</ENT>
              <ENT>7.62</ENT>
              <ENT>0.35</ENT>
              <ENT>N/A</ENT>
              <ENT>16.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66930</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extraction of lens</ENT>
              <ENT>10.18</ENT>
              <ENT>N/A</ENT>
              <ENT>8.72</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>19.31</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66940</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extraction of lens</ENT>
              <ENT>8.93</ENT>
              <ENT>N/A</ENT>
              <ENT>8.17</ENT>
              <ENT>0.35</ENT>
              <ENT>N/A</ENT>
              <ENT>17.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66982</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cataract surgery, complex</ENT>
              <ENT>13.50</ENT>
              <ENT>N/A</ENT>
              <ENT>10.10</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>24.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66983</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cataract surg w/iol, 1 stage</ENT>
              <ENT>8.99</ENT>
              <ENT>N/A</ENT>
              <ENT>6.31</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>15.67</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66984</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cataract surg w/iol, 1 stage</ENT>
              <ENT>10.23</ENT>
              <ENT>N/A</ENT>
              <ENT>7.81</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>18.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66985</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert lens prosthesis</ENT>
              <ENT>8.39</ENT>
              <ENT>N/A</ENT>
              <ENT>7.60</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>16.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66986</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exchange lens prosthesis</ENT>
              <ENT>12.28</ENT>
              <ENT>N/A</ENT>
              <ENT>9.38</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>22.15</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66990</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ophthalmic endoscope add-on</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>0.70</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>2.27</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">66999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Eye surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67005</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of eye fluid</ENT>
              <ENT>5.70</ENT>
              <ENT>N/A</ENT>
              <ENT>4.47</ENT>
              <ENT>0.22</ENT>
              <ENT>N/A</ENT>
              <ENT>10.39</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal of eye fluid</ENT>
              <ENT>6.87</ENT>
              <ENT>N/A</ENT>
              <ENT>5.02</ENT>
              <ENT>0.27</ENT>
              <ENT>N/A</ENT>
              <ENT>12.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49168"/>
              <ENT I="01">67015</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release of eye fluid</ENT>
              <ENT>6.92</ENT>
              <ENT>N/A</ENT>
              <ENT>7.66</ENT>
              <ENT>0.27</ENT>
              <ENT>N/A</ENT>
              <ENT>14.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67025</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replace eye fluid</ENT>
              <ENT>6.84</ENT>
              <ENT>14.24</ENT>
              <ENT>7.49</ENT>
              <ENT>0.27</ENT>
              <ENT>21.35</ENT>
              <ENT>14.60</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67027</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant eye drug system</ENT>
              <ENT>10.85</ENT>
              <ENT>12.86</ENT>
              <ENT>8.86</ENT>
              <ENT>0.46</ENT>
              <ENT>24.17</ENT>
              <ENT>20.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67028</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection eye drug</ENT>
              <ENT>2.52</ENT>
              <ENT>6.59</ENT>
              <ENT>1.16</ENT>
              <ENT>0.11</ENT>
              <ENT>9.22</ENT>
              <ENT>3.79</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67030</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise inner eye strands</ENT>
              <ENT>4.84</ENT>
              <ENT>N/A</ENT>
              <ENT>6.78</ENT>
              <ENT>0.19</ENT>
              <ENT>N/A</ENT>
              <ENT>11.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67031</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laser surgery, eye strands</ENT>
              <ENT>3.67</ENT>
              <ENT>4.77</ENT>
              <ENT>4.11</ENT>
              <ENT>0.15</ENT>
              <ENT>8.59</ENT>
              <ENT>7.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67036</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of inner eye fluid</ENT>
              <ENT>11.89</ENT>
              <ENT>N/A</ENT>
              <ENT>9.53</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>21.89</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67038</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Strip retinal membrane</ENT>
              <ENT>21.24</ENT>
              <ENT>N/A</ENT>
              <ENT>16.17</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>38.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67039</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laser treatment of retina</ENT>
              <ENT>14.52</ENT>
              <ENT>N/A</ENT>
              <ENT>12.87</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>27.96</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67040</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laser treatment of retina</ENT>
              <ENT>17.23</ENT>
              <ENT>N/A</ENT>
              <ENT>14.33</ENT>
              <ENT>0.68</ENT>
              <ENT>N/A</ENT>
              <ENT>32.24</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67101</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair detached retina</ENT>
              <ENT>7.53</ENT>
              <ENT>10.08</ENT>
              <ENT>8.31</ENT>
              <ENT>0.29</ENT>
              <ENT>17.90</ENT>
              <ENT>16.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67105</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair detached retina</ENT>
              <ENT>7.41</ENT>
              <ENT>8.14</ENT>
              <ENT>6.35</ENT>
              <ENT>0.29</ENT>
              <ENT>15.84</ENT>
              <ENT>14.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67107</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair detached retina</ENT>
              <ENT>14.84</ENT>
              <ENT>N/A</ENT>
              <ENT>13.11</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>28.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67108</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair detached retina</ENT>
              <ENT>20.82</ENT>
              <ENT>N/A</ENT>
              <ENT>17.42</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>39.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair detached retina</ENT>
              <ENT>8.81</ENT>
              <ENT>15.63</ENT>
              <ENT>9.41</ENT>
              <ENT>0.35</ENT>
              <ENT>24.79</ENT>
              <ENT>18.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67112</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rerepair detached retina</ENT>
              <ENT>16.86</ENT>
              <ENT>N/A</ENT>
              <ENT>14.89</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>32.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67115</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release encircling material</ENT>
              <ENT>4.99</ENT>
              <ENT>N/A</ENT>
              <ENT>7.07</ENT>
              <ENT>0.19</ENT>
              <ENT>N/A</ENT>
              <ENT>12.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove eye implant material</ENT>
              <ENT>5.98</ENT>
              <ENT>12.34</ENT>
              <ENT>6.90</ENT>
              <ENT>0.23</ENT>
              <ENT>18.55</ENT>
              <ENT>13.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67121</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove eye implant material</ENT>
              <ENT>10.67</ENT>
              <ENT>N/A</ENT>
              <ENT>11.45</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>22.54</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67141</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of retina</ENT>
              <ENT>5.20</ENT>
              <ENT>7.28</ENT>
              <ENT>6.51</ENT>
              <ENT>0.20</ENT>
              <ENT>12.68</ENT>
              <ENT>11.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67145</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of retina</ENT>
              <ENT>5.37</ENT>
              <ENT>5.87</ENT>
              <ENT>5.04</ENT>
              <ENT>0.21</ENT>
              <ENT>11.45</ENT>
              <ENT>10.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67208</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of retinal lesion</ENT>
              <ENT>6.70</ENT>
              <ENT>6.06</ENT>
              <ENT>5.48</ENT>
              <ENT>0.26</ENT>
              <ENT>13.02</ENT>
              <ENT>12.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67210</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of retinal lesion</ENT>
              <ENT>8.82</ENT>
              <ENT>6.37</ENT>
              <ENT>5.90</ENT>
              <ENT>0.35</ENT>
              <ENT>15.54</ENT>
              <ENT>15.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67218</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of retinal lesion</ENT>
              <ENT>18.53</ENT>
              <ENT>N/A</ENT>
              <ENT>14.52</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>33.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of choroid lesion</ENT>
              <ENT>13.13</ENT>
              <ENT>10.02</ENT>
              <ENT>9.01</ENT>
              <ENT>0.51</ENT>
              <ENT>23.66</ENT>
              <ENT>22.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67221</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Ocular photodynamic ther</ENT>
              <ENT>4.01</ENT>
              <ENT>4.77</ENT>
              <ENT>1.84</ENT>
              <ENT>0.16</ENT>
              <ENT>8.94</ENT>
              <ENT>6.01</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67225</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Eye photodynamic ther add-on</ENT>
              <ENT>0.47</ENT>
              <ENT>0.26</ENT>
              <ENT>0.22</ENT>
              <ENT>0.01</ENT>
              <ENT>0.74</ENT>
              <ENT>0.70</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67227</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of retinal lesion</ENT>
              <ENT>6.58</ENT>
              <ENT>6.55</ENT>
              <ENT>5.48</ENT>
              <ENT>0.26</ENT>
              <ENT>13.39</ENT>
              <ENT>12.32</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67228</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of retinal lesion</ENT>
              <ENT>12.74</ENT>
              <ENT>11.10</ENT>
              <ENT>8.55</ENT>
              <ENT>0.50</ENT>
              <ENT>24.34</ENT>
              <ENT>21.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reinforce eye wall</ENT>
              <ENT>8.66</ENT>
              <ENT>N/A</ENT>
              <ENT>10.53</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>19.55</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67255</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reinforce/graft eye wall</ENT>
              <ENT>8.90</ENT>
              <ENT>N/A</ENT>
              <ENT>11.13</ENT>
              <ENT>0.35</ENT>
              <ENT>N/A</ENT>
              <ENT>20.38</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67299</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Eye surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67311</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise eye muscle</ENT>
              <ENT>6.65</ENT>
              <ENT>N/A</ENT>
              <ENT>6.52</ENT>
              <ENT>0.27</ENT>
              <ENT>N/A</ENT>
              <ENT>13.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67312</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise two eye muscles</ENT>
              <ENT>8.54</ENT>
              <ENT>N/A</ENT>
              <ENT>7.54</ENT>
              <ENT>0.35</ENT>
              <ENT>N/A</ENT>
              <ENT>16.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67314</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise eye muscle</ENT>
              <ENT>7.52</ENT>
              <ENT>N/A</ENT>
              <ENT>7.25</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>15.07</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67316</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise two eye muscles</ENT>
              <ENT>9.66</ENT>
              <ENT>N/A</ENT>
              <ENT>8.23</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>18.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67318</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise eye muscle(s)</ENT>
              <ENT>7.85</ENT>
              <ENT>N/A</ENT>
              <ENT>7.63</ENT>
              <ENT>0.31</ENT>
              <ENT>N/A</ENT>
              <ENT>15.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise eye muscle(s) add-on</ENT>
              <ENT>4.33</ENT>
              <ENT>N/A</ENT>
              <ENT>2.00</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>6.50</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67331</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Eye surgery follow-up add-on</ENT>
              <ENT>4.06</ENT>
              <ENT>N/A</ENT>
              <ENT>1.95</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>6.18</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67332</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rerevise eye muscles add-on</ENT>
              <ENT>4.49</ENT>
              <ENT>N/A</ENT>
              <ENT>2.07</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>6.74</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67334</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise eye muscle w/suture</ENT>
              <ENT>3.98</ENT>
              <ENT>N/A</ENT>
              <ENT>1.84</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>5.98</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67335</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Eye suture during surgery</ENT>
              <ENT>2.49</ENT>
              <ENT>N/A</ENT>
              <ENT>1.15</ENT>
              <ENT>0.10</ENT>
              <ENT>N/A</ENT>
              <ENT>3.74</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67340</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise eye muscle add-on</ENT>
              <ENT>4.93</ENT>
              <ENT>N/A</ENT>
              <ENT>2.27</ENT>
              <ENT>0.19</ENT>
              <ENT>N/A</ENT>
              <ENT>7.39</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67343</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release eye tissue</ENT>
              <ENT>7.35</ENT>
              <ENT>N/A</ENT>
              <ENT>7.33</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>14.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67345</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Destroy nerve of eye muscle</ENT>
              <ENT>2.96</ENT>
              <ENT>4.46</ENT>
              <ENT>1.40</ENT>
              <ENT>0.13</ENT>
              <ENT>7.55</ENT>
              <ENT>4.49</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67350</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy eye muscle</ENT>
              <ENT>2.87</ENT>
              <ENT>N/A</ENT>
              <ENT>1.91</ENT>
              <ENT>0.13</ENT>
              <ENT>N/A</ENT>
              <ENT>4.91</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67399</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Eye muscle surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore/biopsy eye socket</ENT>
              <ENT>9.76</ENT>
              <ENT>N/A</ENT>
              <ENT>12.74</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>22.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67405</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore/drain eye socket</ENT>
              <ENT>7.93</ENT>
              <ENT>N/A</ENT>
              <ENT>11.44</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>19.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67412</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore/treat eye socket</ENT>
              <ENT>9.50</ENT>
              <ENT>N/A</ENT>
              <ENT>13.20</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>23.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67413</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore/treat eye socket</ENT>
              <ENT>10.00</ENT>
              <ENT>N/A</ENT>
              <ENT>12.38</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>22.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67414</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explr/decompress eye socket</ENT>
              <ENT>11.13</ENT>
              <ENT>N/A</ENT>
              <ENT>14.33</ENT>
              <ENT>0.48</ENT>
              <ENT>N/A</ENT>
              <ENT>25.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67415</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Aspiration, orbital contents</ENT>
              <ENT>1.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.78</ENT>
              <ENT>0.09</ENT>
              <ENT>N/A</ENT>
              <ENT>2.63</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore/treat eye socket</ENT>
              <ENT>20.06</ENT>
              <ENT>N/A</ENT>
              <ENT>19.13</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>40.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49169"/>
              <ENT I="01">67430</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore/treat eye socket</ENT>
              <ENT>13.39</ENT>
              <ENT>N/A</ENT>
              <ENT>15.97</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>30.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67440</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore/drain eye socket</ENT>
              <ENT>13.09</ENT>
              <ENT>N/A</ENT>
              <ENT>15.80</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>29.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67445</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explr/decompress eye socket</ENT>
              <ENT>14.42</ENT>
              <ENT>N/A</ENT>
              <ENT>16.00</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>31.05</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore/biopsy eye socket</ENT>
              <ENT>13.51</ENT>
              <ENT>N/A</ENT>
              <ENT>16.16</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>30.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inject/treat eye socket</ENT>
              <ENT>0.79</ENT>
              <ENT>0.84</ENT>
              <ENT>0.19</ENT>
              <ENT>0.04</ENT>
              <ENT>1.67</ENT>
              <ENT>1.02</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67505</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inject/treat eye socket</ENT>
              <ENT>0.82</ENT>
              <ENT>0.93</ENT>
              <ENT>0.21</ENT>
              <ENT>0.04</ENT>
              <ENT>1.79</ENT>
              <ENT>1.07</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67515</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inject/treat eye socket</ENT>
              <ENT>0.61</ENT>
              <ENT>0.84</ENT>
              <ENT>0.28</ENT>
              <ENT>0.02</ENT>
              <ENT>1.47</ENT>
              <ENT>0.91</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67550</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert eye socket implant</ENT>
              <ENT>10.19</ENT>
              <ENT>N/A</ENT>
              <ENT>12.61</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>23.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67560</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise eye socket implant</ENT>
              <ENT>10.60</ENT>
              <ENT>N/A</ENT>
              <ENT>12.57</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>23.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67570</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decompress optic nerve</ENT>
              <ENT>13.58</ENT>
              <ENT>N/A</ENT>
              <ENT>15.48</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>29.75</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67599</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Orbit surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drainage of eyelid abscess</ENT>
              <ENT>1.35</ENT>
              <ENT>4.90</ENT>
              <ENT>0.64</ENT>
              <ENT>0.06</ENT>
              <ENT>6.31</ENT>
              <ENT>2.05</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67710</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of eyelid</ENT>
              <ENT>1.02</ENT>
              <ENT>5.06</ENT>
              <ENT>0.54</ENT>
              <ENT>0.04</ENT>
              <ENT>6.12</ENT>
              <ENT>1.60</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67715</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of eyelid fold</ENT>
              <ENT>1.22</ENT>
              <ENT>4.64</ENT>
              <ENT>0.63</ENT>
              <ENT>0.05</ENT>
              <ENT>5.91</ENT>
              <ENT>1.90</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove eyelid lesion</ENT>
              <ENT>1.38</ENT>
              <ENT>2.53</ENT>
              <ENT>0.70</ENT>
              <ENT>0.06</ENT>
              <ENT>3.97</ENT>
              <ENT>2.14</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67801</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove eyelid lesions</ENT>
              <ENT>1.88</ENT>
              <ENT>5.41</ENT>
              <ENT>0.94</ENT>
              <ENT>0.08</ENT>
              <ENT>7.37</ENT>
              <ENT>2.90</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67805</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove eyelid lesions</ENT>
              <ENT>2.22</ENT>
              <ENT>5.56</ENT>
              <ENT>1.09</ENT>
              <ENT>0.09</ENT>
              <ENT>7.87</ENT>
              <ENT>3.40</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67808</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove eyelid lesion(s)</ENT>
              <ENT>3.80</ENT>
              <ENT>N/A</ENT>
              <ENT>5.28</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>9.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67810</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of eyelid</ENT>
              <ENT>1.48</ENT>
              <ENT>3.71</ENT>
              <ENT>0.69</ENT>
              <ENT>0.06</ENT>
              <ENT>5.25</ENT>
              <ENT>2.23</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise eyelashes</ENT>
              <ENT>0.89</ENT>
              <ENT>1.13</ENT>
              <ENT>0.38</ENT>
              <ENT>0.04</ENT>
              <ENT>2.06</ENT>
              <ENT>1.31</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67825</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise eyelashes</ENT>
              <ENT>1.38</ENT>
              <ENT>1.61</ENT>
              <ENT>1.09</ENT>
              <ENT>0.06</ENT>
              <ENT>3.05</ENT>
              <ENT>2.53</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67830</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise eyelashes</ENT>
              <ENT>1.70</ENT>
              <ENT>7.58</ENT>
              <ENT>1.99</ENT>
              <ENT>0.07</ENT>
              <ENT>9.35</ENT>
              <ENT>3.76</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67835</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise eyelashes</ENT>
              <ENT>5.56</ENT>
              <ENT>N/A</ENT>
              <ENT>5.10</ENT>
              <ENT>0.22</ENT>
              <ENT>N/A</ENT>
              <ENT>10.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67840</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove eyelid lesion</ENT>
              <ENT>2.04</ENT>
              <ENT>5.39</ENT>
              <ENT>1.01</ENT>
              <ENT>0.08</ENT>
              <ENT>7.51</ENT>
              <ENT>3.13</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67850</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat eyelid lesion</ENT>
              <ENT>1.69</ENT>
              <ENT>6.17</ENT>
              <ENT>1.93</ENT>
              <ENT>0.07</ENT>
              <ENT>7.93</ENT>
              <ENT>3.69</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67875</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Closure of eyelid by suture</ENT>
              <ENT>1.35</ENT>
              <ENT>7.71</ENT>
              <ENT>1.26</ENT>
              <ENT>0.06</ENT>
              <ENT>9.12</ENT>
              <ENT>2.67</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67880</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of eyelid</ENT>
              <ENT>3.80</ENT>
              <ENT>9.81</ENT>
              <ENT>4.38</ENT>
              <ENT>0.16</ENT>
              <ENT>13.77</ENT>
              <ENT>8.34</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67882</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of eyelid</ENT>
              <ENT>5.07</ENT>
              <ENT>11.09</ENT>
              <ENT>5.50</ENT>
              <ENT>0.21</ENT>
              <ENT>16.37</ENT>
              <ENT>10.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67900</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair brow defect</ENT>
              <ENT>6.14</ENT>
              <ENT>10.72</ENT>
              <ENT>6.39</ENT>
              <ENT>0.30</ENT>
              <ENT>17.16</ENT>
              <ENT>12.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67901</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair eyelid defect</ENT>
              <ENT>6.97</ENT>
              <ENT>N/A</ENT>
              <ENT>6.54</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>13.83</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67902</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair eyelid defect</ENT>
              <ENT>7.03</ENT>
              <ENT>N/A</ENT>
              <ENT>6.61</ENT>
              <ENT>0.34</ENT>
              <ENT>N/A</ENT>
              <ENT>13.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67903</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair eyelid defect</ENT>
              <ENT>6.37</ENT>
              <ENT>11.50</ENT>
              <ENT>6.81</ENT>
              <ENT>0.39</ENT>
              <ENT>18.26</ENT>
              <ENT>13.57</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67904</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair eyelid defect</ENT>
              <ENT>6.26</ENT>
              <ENT>12.71</ENT>
              <ENT>7.30</ENT>
              <ENT>0.26</ENT>
              <ENT>19.23</ENT>
              <ENT>13.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67906</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair eyelid defect</ENT>
              <ENT>6.79</ENT>
              <ENT>9.26</ENT>
              <ENT>6.12</ENT>
              <ENT>0.42</ENT>
              <ENT>16.47</ENT>
              <ENT>13.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67908</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair eyelid defect</ENT>
              <ENT>5.13</ENT>
              <ENT>8.99</ENT>
              <ENT>5.78</ENT>
              <ENT>0.20</ENT>
              <ENT>14.32</ENT>
              <ENT>11.11</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67909</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise eyelid defect</ENT>
              <ENT>5.40</ENT>
              <ENT>9.55</ENT>
              <ENT>6.19</ENT>
              <ENT>0.25</ENT>
              <ENT>15.20</ENT>
              <ENT>11.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67911</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise eyelid defect</ENT>
              <ENT>5.27</ENT>
              <ENT>N/A</ENT>
              <ENT>6.16</ENT>
              <ENT>0.23</ENT>
              <ENT>N/A</ENT>
              <ENT>11.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67914</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair eyelid defect</ENT>
              <ENT>3.68</ENT>
              <ENT>9.44</ENT>
              <ENT>4.02</ENT>
              <ENT>0.16</ENT>
              <ENT>13.28</ENT>
              <ENT>7.86</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67915</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair eyelid defect</ENT>
              <ENT>3.18</ENT>
              <ENT>8.02</ENT>
              <ENT>2.63</ENT>
              <ENT>0.13</ENT>
              <ENT>11.33</ENT>
              <ENT>5.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67916</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair eyelid defect</ENT>
              <ENT>5.31</ENT>
              <ENT>11.98</ENT>
              <ENT>5.80</ENT>
              <ENT>0.22</ENT>
              <ENT>17.51</ENT>
              <ENT>11.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67917</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair eyelid defect</ENT>
              <ENT>6.02</ENT>
              <ENT>9.90</ENT>
              <ENT>6.26</ENT>
              <ENT>0.25</ENT>
              <ENT>16.17</ENT>
              <ENT>12.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67921</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair eyelid defect</ENT>
              <ENT>3.40</ENT>
              <ENT>9.24</ENT>
              <ENT>3.82</ENT>
              <ENT>0.14</ENT>
              <ENT>12.78</ENT>
              <ENT>7.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67922</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair eyelid defect</ENT>
              <ENT>3.06</ENT>
              <ENT>7.97</ENT>
              <ENT>3.55</ENT>
              <ENT>0.13</ENT>
              <ENT>11.16</ENT>
              <ENT>6.74</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67923</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair eyelid defect</ENT>
              <ENT>5.88</ENT>
              <ENT>11.44</ENT>
              <ENT>5.91</ENT>
              <ENT>0.24</ENT>
              <ENT>17.56</ENT>
              <ENT>12.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67924</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair eyelid defect</ENT>
              <ENT>5.79</ENT>
              <ENT>9.26</ENT>
              <ENT>5.76</ENT>
              <ENT>0.23</ENT>
              <ENT>15.28</ENT>
              <ENT>11.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67930</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair eyelid wound</ENT>
              <ENT>3.61</ENT>
              <ENT>8.54</ENT>
              <ENT>3.00</ENT>
              <ENT>0.17</ENT>
              <ENT>12.32</ENT>
              <ENT>6.78</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67935</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair eyelid wound</ENT>
              <ENT>6.22</ENT>
              <ENT>11.46</ENT>
              <ENT>5.97</ENT>
              <ENT>0.29</ENT>
              <ENT>17.97</ENT>
              <ENT>12.48</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67938</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove eyelid foreign body</ENT>
              <ENT>1.33</ENT>
              <ENT>5.90</ENT>
              <ENT>0.57</ENT>
              <ENT>0.06</ENT>
              <ENT>7.29</ENT>
              <ENT>1.96</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67950</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of eyelid</ENT>
              <ENT>5.82</ENT>
              <ENT>8.42</ENT>
              <ENT>6.70</ENT>
              <ENT>0.30</ENT>
              <ENT>14.54</ENT>
              <ENT>12.82</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67961</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of eyelid</ENT>
              <ENT>5.69</ENT>
              <ENT>10.32</ENT>
              <ENT>5.79</ENT>
              <ENT>0.26</ENT>
              <ENT>16.27</ENT>
              <ENT>11.74</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67966</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of eyelid</ENT>
              <ENT>6.57</ENT>
              <ENT>8.50</ENT>
              <ENT>5.78</ENT>
              <ENT>0.33</ENT>
              <ENT>15.40</ENT>
              <ENT>12.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67971</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of eyelid</ENT>
              <ENT>9.79</ENT>
              <ENT>N/A</ENT>
              <ENT>7.41</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>17.62</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67973</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of eyelid</ENT>
              <ENT>12.87</ENT>
              <ENT>N/A</ENT>
              <ENT>9.41</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>22.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67974</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of eyelid</ENT>
              <ENT>12.84</ENT>
              <ENT>N/A</ENT>
              <ENT>9.32</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>22.70</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67975</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reconstruction of eyelid</ENT>
              <ENT>9.13</ENT>
              <ENT>N/A</ENT>
              <ENT>7.08</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>16.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">67999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Revision of eyelid</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise/drain eyelid lining</ENT>
              <ENT>1.37</ENT>
              <ENT>5.77</ENT>
              <ENT>0.69</ENT>
              <ENT>0.06</ENT>
              <ENT>7.20</ENT>
              <ENT>2.12</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68040</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treatment of eyelid lesions</ENT>
              <ENT>0.85</ENT>
              <ENT>4.88</ENT>
              <ENT>0.39</ENT>
              <ENT>0.03</ENT>
              <ENT>5.76</ENT>
              <ENT>1.27</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of eyelid lining</ENT>
              <ENT>1.35</ENT>
              <ENT>5.08</ENT>
              <ENT>0.62</ENT>
              <ENT>0.06</ENT>
              <ENT>6.49</ENT>
              <ENT>2.03</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove eyelid lining lesion</ENT>
              <ENT>1.77</ENT>
              <ENT>6.14</ENT>
              <ENT>1.43</ENT>
              <ENT>0.07</ENT>
              <ENT>7.98</ENT>
              <ENT>3.27</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49170"/>
              <ENT I="01">68115</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove eyelid lining lesion</ENT>
              <ENT>2.36</ENT>
              <ENT>5.63</ENT>
              <ENT>1.16</ENT>
              <ENT>0.10</ENT>
              <ENT>8.09</ENT>
              <ENT>3.62</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove eyelid lining lesion</ENT>
              <ENT>4.93</ENT>
              <ENT>8.01</ENT>
              <ENT>4.03</ENT>
              <ENT>0.19</ENT>
              <ENT>13.13</ENT>
              <ENT>9.15</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68135</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove eyelid lining lesion</ENT>
              <ENT>1.84</ENT>
              <ENT>5.39</ENT>
              <ENT>0.92</ENT>
              <ENT>0.07</ENT>
              <ENT>7.30</ENT>
              <ENT>2.83</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Treat eyelid by injection</ENT>
              <ENT>0.49</ENT>
              <ENT>0.74</ENT>
              <ENT>0.23</ENT>
              <ENT>0.02</ENT>
              <ENT>1.25</ENT>
              <ENT>0.74</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise/graft eyelid lining</ENT>
              <ENT>5.37</ENT>
              <ENT>6.68</ENT>
              <ENT>5.51</ENT>
              <ENT>0.21</ENT>
              <ENT>12.26</ENT>
              <ENT>11.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68325</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise/graft eyelid lining</ENT>
              <ENT>7.36</ENT>
              <ENT>N/A</ENT>
              <ENT>6.52</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>14.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68326</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise/graft eyelid lining</ENT>
              <ENT>7.15</ENT>
              <ENT>N/A</ENT>
              <ENT>6.39</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>13.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68328</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise/graft eyelid lining</ENT>
              <ENT>8.18</ENT>
              <ENT>N/A</ENT>
              <ENT>7.13</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>15.71</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68330</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise eyelid lining</ENT>
              <ENT>4.83</ENT>
              <ENT>7.37</ENT>
              <ENT>6.16</ENT>
              <ENT>0.19</ENT>
              <ENT>12.39</ENT>
              <ENT>11.18</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68335</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise/graft eyelid lining</ENT>
              <ENT>7.19</ENT>
              <ENT>N/A</ENT>
              <ENT>6.92</ENT>
              <ENT>0.29</ENT>
              <ENT>N/A</ENT>
              <ENT>14.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68340</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Separate eyelid adhesions</ENT>
              <ENT>4.17</ENT>
              <ENT>10.96</ENT>
              <ENT>4.83</ENT>
              <ENT>0.17</ENT>
              <ENT>15.30</ENT>
              <ENT>9.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68360</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise eyelid lining</ENT>
              <ENT>4.37</ENT>
              <ENT>6.72</ENT>
              <ENT>5.68</ENT>
              <ENT>0.17</ENT>
              <ENT>11.26</ENT>
              <ENT>10.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68362</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise eyelid lining</ENT>
              <ENT>7.34</ENT>
              <ENT>N/A</ENT>
              <ENT>7.86</ENT>
              <ENT>0.29</ENT>
              <ENT>N/A</ENT>
              <ENT>15.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68399</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Eyelid lining surgery</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise/drain tear gland</ENT>
              <ENT>1.69</ENT>
              <ENT>7.73</ENT>
              <ENT>2.09</ENT>
              <ENT>0.07</ENT>
              <ENT>9.49</ENT>
              <ENT>3.85</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise/drain tear sac</ENT>
              <ENT>2.30</ENT>
              <ENT>8.07</ENT>
              <ENT>2.38</ENT>
              <ENT>0.10</ENT>
              <ENT>10.47</ENT>
              <ENT>4.78</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68440</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise tear duct opening</ENT>
              <ENT>0.94</ENT>
              <ENT>5.00</ENT>
              <ENT>0.50</ENT>
              <ENT>0.04</ENT>
              <ENT>5.98</ENT>
              <ENT>1.48</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of tear gland</ENT>
              <ENT>11.02</ENT>
              <ENT>N/A</ENT>
              <ENT>10.36</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>21.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68505</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Partial removal, tear gland</ENT>
              <ENT>10.94</ENT>
              <ENT>N/A</ENT>
              <ENT>11.40</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>22.91</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of tear gland</ENT>
              <ENT>4.61</ENT>
              <ENT>8.57</ENT>
              <ENT>2.14</ENT>
              <ENT>0.19</ENT>
              <ENT>13.37</ENT>
              <ENT>6.94</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of tear sac</ENT>
              <ENT>7.51</ENT>
              <ENT>N/A</ENT>
              <ENT>7.94</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>15.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68525</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of tear sac</ENT>
              <ENT>4.43</ENT>
              <ENT>N/A</ENT>
              <ENT>2.06</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>6.67</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Clearance of tear duct</ENT>
              <ENT>3.66</ENT>
              <ENT>9.59</ENT>
              <ENT>2.90</ENT>
              <ENT>0.16</ENT>
              <ENT>13.41</ENT>
              <ENT>6.72</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68540</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove tear gland lesion</ENT>
              <ENT>10.60</ENT>
              <ENT>N/A</ENT>
              <ENT>10.03</ENT>
              <ENT>0.46</ENT>
              <ENT>N/A</ENT>
              <ENT>21.09</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68550</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove tear gland lesion</ENT>
              <ENT>13.26</ENT>
              <ENT>N/A</ENT>
              <ENT>12.03</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>25.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair tear ducts</ENT>
              <ENT>6.60</ENT>
              <ENT>N/A</ENT>
              <ENT>7.42</ENT>
              <ENT>0.27</ENT>
              <ENT>N/A</ENT>
              <ENT>14.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68705</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise tear duct opening</ENT>
              <ENT>2.06</ENT>
              <ENT>5.52</ENT>
              <ENT>1.02</ENT>
              <ENT>0.08</ENT>
              <ENT>7.66</ENT>
              <ENT>3.16</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68720</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Create tear sac drain</ENT>
              <ENT>8.96</ENT>
              <ENT>N/A</ENT>
              <ENT>8.43</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>17.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68745</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Create tear duct drain</ENT>
              <ENT>8.63</ENT>
              <ENT>N/A</ENT>
              <ENT>8.40</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>17.41</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68750</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Create tear duct drain</ENT>
              <ENT>8.66</ENT>
              <ENT>N/A</ENT>
              <ENT>8.85</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>17.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68760</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Close tear duct opening</ENT>
              <ENT>1.73</ENT>
              <ENT>4.05</ENT>
              <ENT>1.26</ENT>
              <ENT>0.07</ENT>
              <ENT>5.85</ENT>
              <ENT>3.06</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68761</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Close tear duct opening</ENT>
              <ENT>1.36</ENT>
              <ENT>3.48</ENT>
              <ENT>1.00</ENT>
              <ENT>0.06</ENT>
              <ENT>4.90</ENT>
              <ENT>2.42</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68770</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Close tear system fistula</ENT>
              <ENT>7.02</ENT>
              <ENT>12.97</ENT>
              <ENT>6.93</ENT>
              <ENT>0.28</ENT>
              <ENT>20.27</ENT>
              <ENT>14.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68801</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dilate tear duct opening</ENT>
              <ENT>0.94</ENT>
              <ENT>0.95</ENT>
              <ENT>0.61</ENT>
              <ENT>0.04</ENT>
              <ENT>1.93</ENT>
              <ENT>1.59</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68810</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Probe nasolacrimal duct</ENT>
              <ENT>1.90</ENT>
              <ENT>2.36</ENT>
              <ENT>0.94</ENT>
              <ENT>0.08</ENT>
              <ENT>4.34</ENT>
              <ENT>2.92</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68811</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Probe nasolacrimal duct</ENT>
              <ENT>2.35</ENT>
              <ENT>N/A</ENT>
              <ENT>2.40</ENT>
              <ENT>0.10</ENT>
              <ENT>N/A</ENT>
              <ENT>4.85</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68815</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Probe nasolacrimal duct</ENT>
              <ENT>3.20</ENT>
              <ENT>8.29</ENT>
              <ENT>2.73</ENT>
              <ENT>0.14</ENT>
              <ENT>11.63</ENT>
              <ENT>6.07</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68840</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore/irrigate tear ducts</ENT>
              <ENT>1.25</ENT>
              <ENT>1.67</ENT>
              <ENT>0.98</ENT>
              <ENT>0.05</ENT>
              <ENT>2.97</ENT>
              <ENT>2.28</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68850</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection for tear sac x-ray</ENT>
              <ENT>0.80</ENT>
              <ENT>12.84</ENT>
              <ENT>0.30</ENT>
              <ENT>0.03</ENT>
              <ENT>13.67</ENT>
              <ENT>1.13</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">68899</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Tear duct system surgery</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain external ear lesion</ENT>
              <ENT>1.45</ENT>
              <ENT>3.11</ENT>
              <ENT>1.44</ENT>
              <ENT>0.10</ENT>
              <ENT>4.66</ENT>
              <ENT>2.99</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69005</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain external ear lesion</ENT>
              <ENT>2.11</ENT>
              <ENT>3.10</ENT>
              <ENT>1.90</ENT>
              <ENT>0.16</ENT>
              <ENT>5.37</ENT>
              <ENT>4.17</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Drain outer ear canal lesion</ENT>
              <ENT>1.48</ENT>
              <ENT>3.11</ENT>
              <ENT>1.91</ENT>
              <ENT>0.11</ENT>
              <ENT>4.70</ENT>
              <ENT>3.50</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of external ear</ENT>
              <ENT>0.81</ENT>
              <ENT>1.78</ENT>
              <ENT>0.40</ENT>
              <ENT>0.04</ENT>
              <ENT>2.63</ENT>
              <ENT>1.25</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69105</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of external ear canal</ENT>
              <ENT>0.85</ENT>
              <ENT>1.96</ENT>
              <ENT>0.78</ENT>
              <ENT>0.06</ENT>
              <ENT>2.87</ENT>
              <ENT>1.69</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove external ear, partial</ENT>
              <ENT>3.44</ENT>
              <ENT>4.17</ENT>
              <ENT>3.11</ENT>
              <ENT>0.24</ENT>
              <ENT>7.85</ENT>
              <ENT>6.79</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of external ear</ENT>
              <ENT>4.05</ENT>
              <ENT>N/A</ENT>
              <ENT>4.11</ENT>
              <ENT>0.31</ENT>
              <ENT>N/A</ENT>
              <ENT>8.47</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove ear canal lesion(s)</ENT>
              <ENT>7.97</ENT>
              <ENT>N/A</ENT>
              <ENT>6.99</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>15.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69145</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove ear canal lesion(s)</ENT>
              <ENT>2.62</ENT>
              <ENT>3.73</ENT>
              <ENT>2.69</ENT>
              <ENT>0.18</ENT>
              <ENT>6.53</ENT>
              <ENT>5.49</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive ear canal surgery</ENT>
              <ENT>13.43</ENT>
              <ENT>N/A</ENT>
              <ENT>10.23</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>24.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69155</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive ear/neck surgery</ENT>
              <ENT>20.80</ENT>
              <ENT>N/A</ENT>
              <ENT>14.88</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>37.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Clear outer ear canal</ENT>
              <ENT>0.77</ENT>
              <ENT>1.64</ENT>
              <ENT>0.59</ENT>
              <ENT>0.05</ENT>
              <ENT>2.46</ENT>
              <ENT>1.41</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69205</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Clear outer ear canal</ENT>
              <ENT>1.20</ENT>
              <ENT>N/A</ENT>
              <ENT>1.31</ENT>
              <ENT>0.09</ENT>
              <ENT>N/A</ENT>
              <ENT>2.60</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69210</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove impacted ear wax</ENT>
              <ENT>0.61</ENT>
              <ENT>0.66</ENT>
              <ENT>0.24</ENT>
              <ENT>0.04</ENT>
              <ENT>1.31</ENT>
              <ENT>0.89</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Clean out mastoid cavity</ENT>
              <ENT>0.83</ENT>
              <ENT>1.72</ENT>
              <ENT>0.75</ENT>
              <ENT>0.06</ENT>
              <ENT>2.61</ENT>
              <ENT>1.64</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69222</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Clean out mastoid cavity</ENT>
              <ENT>1.40</ENT>
              <ENT>3.23</ENT>
              <ENT>1.86</ENT>
              <ENT>0.10</ENT>
              <ENT>4.73</ENT>
              <ENT>3.36</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49171"/>
              <ENT I="01">69300</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Revise external ear</ENT>
              <ENT>6.36</ENT>
              <ENT>N/A</ENT>
              <ENT>4.35</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>11.14</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69310</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rebuild outer ear canal</ENT>
              <ENT>10.79</ENT>
              <ENT>N/A</ENT>
              <ENT>8.70</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>20.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rebuild outer ear canal</ENT>
              <ENT>16.96</ENT>
              <ENT>N/A</ENT>
              <ENT>12.52</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>30.65</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69399</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Outer ear surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inflate middle ear canal</ENT>
              <ENT>0.83</ENT>
              <ENT>2.14</ENT>
              <ENT>0.69</ENT>
              <ENT>0.06</ENT>
              <ENT>3.03</ENT>
              <ENT>1.58</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69401</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inflate middle ear canal</ENT>
              <ENT>0.63</ENT>
              <ENT>1.04</ENT>
              <ENT>0.66</ENT>
              <ENT>0.04</ENT>
              <ENT>1.71</ENT>
              <ENT>1.33</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69405</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Catheterize middle ear canal</ENT>
              <ENT>2.63</ENT>
              <ENT>3.32</ENT>
              <ENT>2.37</ENT>
              <ENT>0.18</ENT>
              <ENT>6.13</ENT>
              <ENT>5.18</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69410</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inset middle ear (baffle)</ENT>
              <ENT>0.33</ENT>
              <ENT>1.41</ENT>
              <ENT>0.50</ENT>
              <ENT>0.02</ENT>
              <ENT>1.76</ENT>
              <ENT>0.85</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of eardrum</ENT>
              <ENT>1.33</ENT>
              <ENT>2.49</ENT>
              <ENT>1.64</ENT>
              <ENT>0.10</ENT>
              <ENT>3.92</ENT>
              <ENT>3.07</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69421</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incision of eardrum</ENT>
              <ENT>1.73</ENT>
              <ENT>N/A</ENT>
              <ENT>1.89</ENT>
              <ENT>0.13</ENT>
              <ENT>N/A</ENT>
              <ENT>3.75</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69424</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove ventilating tube</ENT>
              <ENT>0.85</ENT>
              <ENT>1.58</ENT>
              <ENT>0.70</ENT>
              <ENT>0.06</ENT>
              <ENT>2.49</ENT>
              <ENT>1.61</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69433</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Create eardrum opening</ENT>
              <ENT>1.52</ENT>
              <ENT>2.48</ENT>
              <ENT>1.71</ENT>
              <ENT>0.11</ENT>
              <ENT>4.11</ENT>
              <ENT>3.34</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69436</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Create eardrum opening</ENT>
              <ENT>1.96</ENT>
              <ENT>N/A</ENT>
              <ENT>2.02</ENT>
              <ENT>0.14</ENT>
              <ENT>N/A</ENT>
              <ENT>4.12</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69440</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exploration of middle ear</ENT>
              <ENT>7.57</ENT>
              <ENT>N/A</ENT>
              <ENT>6.54</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>14.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Eardrum revision</ENT>
              <ENT>5.57</ENT>
              <ENT>N/A</ENT>
              <ENT>5.26</ENT>
              <ENT>0.39</ENT>
              <ENT>N/A</ENT>
              <ENT>11.22</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69501</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mastoidectomy</ENT>
              <ENT>9.07</ENT>
              <ENT>N/A</ENT>
              <ENT>7.34</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>17.06</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69502</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mastoidectomy</ENT>
              <ENT>12.38</ENT>
              <ENT>N/A</ENT>
              <ENT>9.61</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>22.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69505</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove mastoid structures</ENT>
              <ENT>12.99</ENT>
              <ENT>N/A</ENT>
              <ENT>9.87</ENT>
              <ENT>0.92</ENT>
              <ENT>N/A</ENT>
              <ENT>23.78</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69511</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive mastoid surgery</ENT>
              <ENT>13.52</ENT>
              <ENT>N/A</ENT>
              <ENT>10.21</ENT>
              <ENT>0.96</ENT>
              <ENT>N/A</ENT>
              <ENT>24.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extensive mastoid surgery</ENT>
              <ENT>19.19</ENT>
              <ENT>N/A</ENT>
              <ENT>13.44</ENT>
              <ENT>1.32</ENT>
              <ENT>N/A</ENT>
              <ENT>33.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69535</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove part of temporal bone</ENT>
              <ENT>36.14</ENT>
              <ENT>N/A</ENT>
              <ENT>22.99</ENT>
              <ENT>2.59</ENT>
              <ENT>N/A</ENT>
              <ENT>61.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69540</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove ear lesion</ENT>
              <ENT>1.20</ENT>
              <ENT>3.17</ENT>
              <ENT>1.75</ENT>
              <ENT>0.09</ENT>
              <ENT>4.46</ENT>
              <ENT>3.04</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69550</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove ear lesion</ENT>
              <ENT>10.99</ENT>
              <ENT>N/A</ENT>
              <ENT>8.64</ENT>
              <ENT>0.80</ENT>
              <ENT>N/A</ENT>
              <ENT>20.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69552</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove ear lesion</ENT>
              <ENT>19.46</ENT>
              <ENT>N/A</ENT>
              <ENT>13.33</ENT>
              <ENT>1.36</ENT>
              <ENT>N/A</ENT>
              <ENT>34.15</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69554</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove ear lesion</ENT>
              <ENT>33.16</ENT>
              <ENT>N/A</ENT>
              <ENT>21.44</ENT>
              <ENT>2.32</ENT>
              <ENT>N/A</ENT>
              <ENT>56.92</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69601</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mastoid surgery revision</ENT>
              <ENT>13.24</ENT>
              <ENT>N/A</ENT>
              <ENT>10.40</ENT>
              <ENT>0.92</ENT>
              <ENT>N/A</ENT>
              <ENT>24.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69602</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mastoid surgery revision</ENT>
              <ENT>13.58</ENT>
              <ENT>N/A</ENT>
              <ENT>10.32</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>24.84</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69603</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mastoid surgery revision</ENT>
              <ENT>14.02</ENT>
              <ENT>N/A</ENT>
              <ENT>10.54</ENT>
              <ENT>1.00</ENT>
              <ENT>N/A</ENT>
              <ENT>25.56</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69604</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mastoid surgery revision</ENT>
              <ENT>14.02</ENT>
              <ENT>N/A</ENT>
              <ENT>10.52</ENT>
              <ENT>0.98</ENT>
              <ENT>N/A</ENT>
              <ENT>25.52</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mastoid surgery revision</ENT>
              <ENT>18.49</ENT>
              <ENT>N/A</ENT>
              <ENT>13.24</ENT>
              <ENT>1.29</ENT>
              <ENT>N/A</ENT>
              <ENT>33.02</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69610</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of eardrum</ENT>
              <ENT>4.43</ENT>
              <ENT>4.59</ENT>
              <ENT>3.36</ENT>
              <ENT>0.31</ENT>
              <ENT>9.33</ENT>
              <ENT>8.10</ENT>
              <ENT>010 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69620</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair of eardrum</ENT>
              <ENT>5.89</ENT>
              <ENT>6.46</ENT>
              <ENT>4.59</ENT>
              <ENT>0.40</ENT>
              <ENT>12.75</ENT>
              <ENT>10.88</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69631</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair eardrum structures</ENT>
              <ENT>9.86</ENT>
              <ENT>N/A</ENT>
              <ENT>8.18</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>18.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69632</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rebuild eardrum structures</ENT>
              <ENT>12.75</ENT>
              <ENT>N/A</ENT>
              <ENT>10.12</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>23.76</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69633</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rebuild eardrum structures</ENT>
              <ENT>12.10</ENT>
              <ENT>N/A</ENT>
              <ENT>9.78</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>22.72</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69635</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair eardrum structures</ENT>
              <ENT>13.33</ENT>
              <ENT>N/A</ENT>
              <ENT>9.73</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>23.93</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69636</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rebuild eardrum structures</ENT>
              <ENT>15.22</ENT>
              <ENT>N/A</ENT>
              <ENT>11.58</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>27.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69637</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rebuild eardrum structures</ENT>
              <ENT>15.11</ENT>
              <ENT>N/A</ENT>
              <ENT>11.52</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>27.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69641</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise middle ear &amp; mastoid</ENT>
              <ENT>12.71</ENT>
              <ENT>N/A</ENT>
              <ENT>9.84</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>23.44</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69642</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise middle ear &amp; mastoid</ENT>
              <ENT>16.84</ENT>
              <ENT>N/A</ENT>
              <ENT>12.56</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>30.58</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69643</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise middle ear &amp; mastoid</ENT>
              <ENT>15.32</ENT>
              <ENT>N/A</ENT>
              <ENT>11.58</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>27.98</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69644</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise middle ear &amp; mastoid</ENT>
              <ENT>16.97</ENT>
              <ENT>N/A</ENT>
              <ENT>12.50</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>30.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69645</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise middle ear &amp; mastoid</ENT>
              <ENT>16.38</ENT>
              <ENT>N/A</ENT>
              <ENT>12.14</ENT>
              <ENT>1.16</ENT>
              <ENT>N/A</ENT>
              <ENT>29.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69646</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise middle ear &amp; mastoid</ENT>
              <ENT>17.99</ENT>
              <ENT>N/A</ENT>
              <ENT>13.08</ENT>
              <ENT>1.26</ENT>
              <ENT>N/A</ENT>
              <ENT>32.33</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69650</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release middle ear bone</ENT>
              <ENT>9.66</ENT>
              <ENT>N/A</ENT>
              <ENT>7.69</ENT>
              <ENT>0.68</ENT>
              <ENT>N/A</ENT>
              <ENT>18.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69660</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise middle ear bone</ENT>
              <ENT>11.90</ENT>
              <ENT>N/A</ENT>
              <ENT>8.92</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>21.66</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69661</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise middle ear bone</ENT>
              <ENT>15.74</ENT>
              <ENT>N/A</ENT>
              <ENT>11.46</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>28.30</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69662</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise middle ear bone</ENT>
              <ENT>15.44</ENT>
              <ENT>N/A</ENT>
              <ENT>11.17</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>27.69</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69666</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair middle ear structures</ENT>
              <ENT>9.75</ENT>
              <ENT>N/A</ENT>
              <ENT>7.77</ENT>
              <ENT>0.68</ENT>
              <ENT>N/A</ENT>
              <ENT>18.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69667</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair middle ear structures</ENT>
              <ENT>9.76</ENT>
              <ENT>N/A</ENT>
              <ENT>7.75</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>18.23</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49172"/>
              <ENT I="01">69670</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove mastoid air cells</ENT>
              <ENT>11.51</ENT>
              <ENT>N/A</ENT>
              <ENT>8.97</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>21.26</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69676</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove middle ear nerve</ENT>
              <ENT>9.52</ENT>
              <ENT>N/A</ENT>
              <ENT>7.92</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>18.13</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Close mastoid fistula</ENT>
              <ENT>8.23</ENT>
              <ENT>N/A</ENT>
              <ENT>6.03</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>14.81</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69711</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove/repair hearing aid</ENT>
              <ENT>10.44</ENT>
              <ENT>N/A</ENT>
              <ENT>8.37</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>19.43</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69714</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant temple bone w/stimul</ENT>
              <ENT>14.00</ENT>
              <ENT>N/A</ENT>
              <ENT>10.18</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>25.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69715</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Temple bne implnt w/stimulat</ENT>
              <ENT>18.25</ENT>
              <ENT>N/A</ENT>
              <ENT>12.72</ENT>
              <ENT>1.32</ENT>
              <ENT>N/A</ENT>
              <ENT>32.29</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69717</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Temple bone implant revision</ENT>
              <ENT>14.98</ENT>
              <ENT>N/A</ENT>
              <ENT>9.79</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>25.85</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69718</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise temple bone implant</ENT>
              <ENT>18.50</ENT>
              <ENT>N/A</ENT>
              <ENT>12.61</ENT>
              <ENT>1.34</ENT>
              <ENT>N/A</ENT>
              <ENT>32.45</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69720</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release facial nerve</ENT>
              <ENT>14.38</ENT>
              <ENT>N/A</ENT>
              <ENT>11.18</ENT>
              <ENT>1.03</ENT>
              <ENT>N/A</ENT>
              <ENT>26.59</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69725</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release facial nerve</ENT>
              <ENT>25.38</ENT>
              <ENT>N/A</ENT>
              <ENT>17.37</ENT>
              <ENT>1.78</ENT>
              <ENT>N/A</ENT>
              <ENT>44.53</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69740</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair facial nerve</ENT>
              <ENT>15.96</ENT>
              <ENT>N/A</ENT>
              <ENT>10.68</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>27.77</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69745</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair facial nerve</ENT>
              <ENT>16.69</ENT>
              <ENT>N/A</ENT>
              <ENT>11.71</ENT>
              <ENT>1.00</ENT>
              <ENT>N/A</ENT>
              <ENT>29.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69799</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Middle ear surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69801</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise inner ear</ENT>
              <ENT>8.56</ENT>
              <ENT>N/A</ENT>
              <ENT>7.09</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>16.25</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69802</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise inner ear</ENT>
              <ENT>13.10</ENT>
              <ENT>N/A</ENT>
              <ENT>9.96</ENT>
              <ENT>0.91</ENT>
              <ENT>N/A</ENT>
              <ENT>23.97</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69805</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore inner ear</ENT>
              <ENT>13.82</ENT>
              <ENT>N/A</ENT>
              <ENT>10.38</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>25.17</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69806</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Explore inner ear</ENT>
              <ENT>12.35</ENT>
              <ENT>N/A</ENT>
              <ENT>9.52</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>22.73</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Establish inner ear window</ENT>
              <ENT>10.34</ENT>
              <ENT>N/A</ENT>
              <ENT>8.08</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>19.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69840</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revise inner ear window</ENT>
              <ENT>10.26</ENT>
              <ENT>N/A</ENT>
              <ENT>7.05</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>17.95</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69905</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove inner ear</ENT>
              <ENT>11.10</ENT>
              <ENT>N/A</ENT>
              <ENT>8.63</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>20.50</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69910</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove inner ear &amp; mastoid</ENT>
              <ENT>13.63</ENT>
              <ENT>N/A</ENT>
              <ENT>10.06</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>24.63</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69915</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise inner ear nerve</ENT>
              <ENT>21.23</ENT>
              <ENT>N/A</ENT>
              <ENT>14.59</ENT>
              <ENT>1.54</ENT>
              <ENT>N/A</ENT>
              <ENT>37.36</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69930</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Implant cochlear device</ENT>
              <ENT>16.81</ENT>
              <ENT>N/A</ENT>
              <ENT>12.16</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>30.16</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69949</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Inner ear surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69950</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Incise inner ear nerve</ENT>
              <ENT>25.64</ENT>
              <ENT>N/A</ENT>
              <ENT>16.47</ENT>
              <ENT>2.90</ENT>
              <ENT>N/A</ENT>
              <ENT>45.01</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69955</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release facial nerve</ENT>
              <ENT>27.04</ENT>
              <ENT>N/A</ENT>
              <ENT>18.10</ENT>
              <ENT>1.89</ENT>
              <ENT>N/A</ENT>
              <ENT>47.03</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69960</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Release inner ear canal</ENT>
              <ENT>27.04</ENT>
              <ENT>N/A</ENT>
              <ENT>17.53</ENT>
              <ENT>2.43</ENT>
              <ENT>N/A</ENT>
              <ENT>47.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69970</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove inner ear lesion</ENT>
              <ENT>30.04</ENT>
              <ENT>N/A</ENT>
              <ENT>18.82</ENT>
              <ENT>2.34</ENT>
              <ENT>N/A</ENT>
              <ENT>51.20</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69979</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Temporal bone surgery</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">69990</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Microsurgery add-on</ENT>
              <ENT>3.47</ENT>
              <ENT>N/A</ENT>
              <ENT>1.83</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>5.86</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of brain</ENT>
              <ENT>1.19</ENT>
              <ENT>4.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.24</ENT>
              <ENT>6.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70010</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of brain</ENT>
              <ENT>1.19</ENT>
              <ENT>0.40</ENT>
              <ENT>0.40</ENT>
              <ENT>0.06</ENT>
              <ENT>1.65</ENT>
              <ENT>1.65</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70010</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of brain</ENT>
              <ENT>0.00</ENT>
              <ENT>4.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.51</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70015</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of brain</ENT>
              <ENT>1.19</ENT>
              <ENT>1.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>3.07</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70015</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of brain</ENT>
              <ENT>1.19</ENT>
              <ENT>0.40</ENT>
              <ENT>0.40</ENT>
              <ENT>0.05</ENT>
              <ENT>1.64</ENT>
              <ENT>1.64</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70015</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of brain</ENT>
              <ENT>0.00</ENT>
              <ENT>1.35</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.42</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70030</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray eye for foreign body</ENT>
              <ENT>0.17</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70030</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray eye for foreign body</ENT>
              <ENT>0.17</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70030</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray eye for foreign body</ENT>
              <ENT>0.00</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of jaw</ENT>
              <ENT>0.18</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70100</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of jaw</ENT>
              <ENT>0.18</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70100</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of jaw</ENT>
              <ENT>0.00</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of jaw</ENT>
              <ENT>0.25</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70110</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of jaw</ENT>
              <ENT>0.25</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>0.01</ENT>
              <ENT>0.34</ENT>
              <ENT>0.34</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70110</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of jaw</ENT>
              <ENT>0.00</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of mastoids</ENT>
              <ENT>0.18</ENT>
              <ENT>0.68</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70120</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of mastoids</ENT>
              <ENT>0.18</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70120</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of mastoids</ENT>
              <ENT>0.00</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of mastoids</ENT>
              <ENT>0.34</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.29</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70130</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of mastoids</ENT>
              <ENT>0.34</ENT>
              <ENT>0.11</ENT>
              <ENT>0.11</ENT>
              <ENT>0.01</ENT>
              <ENT>0.46</ENT>
              <ENT>0.46</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70130</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of mastoids</ENT>
              <ENT>0.00</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70134</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of middle ear</ENT>
              <ENT>0.34</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70134</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of middle ear</ENT>
              <ENT>0.34</ENT>
              <ENT>0.11</ENT>
              <ENT>0.11</ENT>
              <ENT>0.01</ENT>
              <ENT>0.46</ENT>
              <ENT>0.46</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70134</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of middle ear</ENT>
              <ENT>0.00</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of facial bones</ENT>
              <ENT>0.19</ENT>
              <ENT>0.68</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70140</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of facial bones</ENT>
              <ENT>0.19</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.26</ENT>
              <ENT>0.26</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70140</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of facial bones</ENT>
              <ENT>0.00</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of facial bones</ENT>
              <ENT>0.26</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70150</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of facial bones</ENT>
              <ENT>0.26</ENT>
              <ENT>0.09</ENT>
              <ENT>0.09</ENT>
              <ENT>0.01</ENT>
              <ENT>0.36</ENT>
              <ENT>0.36</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49173"/>
              <ENT I="01">70150</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of facial bones</ENT>
              <ENT>0.00</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70160</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of nasal bones</ENT>
              <ENT>0.17</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70160</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of nasal bones</ENT>
              <ENT>0.17</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70160</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of nasal bones</ENT>
              <ENT>0.00</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70170</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of tear duct</ENT>
              <ENT>0.30</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.41</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70170</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of tear duct</ENT>
              <ENT>0.30</ENT>
              <ENT>0.10</ENT>
              <ENT>0.10</ENT>
              <ENT>0.01</ENT>
              <ENT>0.41</ENT>
              <ENT>0.41</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70170</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of tear duct</ENT>
              <ENT>0.00</ENT>
              <ENT>0.95</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.00</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70190</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of eye sockets</ENT>
              <ENT>0.21</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70190</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of eye sockets</ENT>
              <ENT>0.21</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.29</ENT>
              <ENT>0.29</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70190</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of eye sockets</ENT>
              <ENT>0.00</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of eye sockets</ENT>
              <ENT>0.28</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.21</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70200</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of eye sockets</ENT>
              <ENT>0.28</ENT>
              <ENT>0.09</ENT>
              <ENT>0.09</ENT>
              <ENT>0.01</ENT>
              <ENT>0.38</ENT>
              <ENT>0.38</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70200</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of eye sockets</ENT>
              <ENT>0.00</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70210</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of sinuses</ENT>
              <ENT>0.17</ENT>
              <ENT>0.68</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70210</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of sinuses</ENT>
              <ENT>0.17</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70210</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of sinuses</ENT>
              <ENT>0.00</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of sinuses</ENT>
              <ENT>0.25</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70220</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of sinuses</ENT>
              <ENT>0.25</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>0.01</ENT>
              <ENT>0.34</ENT>
              <ENT>0.34</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70220</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of sinuses</ENT>
              <ENT>0.00</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70240</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam, pituitary saddle</ENT>
              <ENT>0.19</ENT>
              <ENT>0.48</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70240</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam, pituitary saddle</ENT>
              <ENT>0.19</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.26</ENT>
              <ENT>0.26</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70240</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam, pituitary saddle</ENT>
              <ENT>0.00</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of skull</ENT>
              <ENT>0.24</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.98</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70250</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of skull</ENT>
              <ENT>0.24</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>0.01</ENT>
              <ENT>0.33</ENT>
              <ENT>0.33</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70250</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of skull</ENT>
              <ENT>0.00</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70260</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of skull</ENT>
              <ENT>0.34</ENT>
              <ENT>1.00</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.40</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70260</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of skull</ENT>
              <ENT>0.34</ENT>
              <ENT>0.11</ENT>
              <ENT>0.11</ENT>
              <ENT>0.01</ENT>
              <ENT>0.46</ENT>
              <ENT>0.46</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70260</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of skull</ENT>
              <ENT>0.00</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of teeth</ENT>
              <ENT>0.10</ENT>
              <ENT>0.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70300</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of teeth</ENT>
              <ENT>0.10</ENT>
              <ENT>0.05</ENT>
              <ENT>0.05</ENT>
              <ENT>0.01</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70300</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of teeth</ENT>
              <ENT>0.00</ENT>
              <ENT>0.26</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.28</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70310</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of teeth</ENT>
              <ENT>0.16</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70310</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of teeth</ENT>
              <ENT>0.16</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>0.01</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70310</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of teeth</ENT>
              <ENT>0.00</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Full mouth x-ray of teeth</ENT>
              <ENT>0.22</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70320</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Full mouth x-ray of teeth</ENT>
              <ENT>0.22</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>0.01</ENT>
              <ENT>0.31</ENT>
              <ENT>0.31</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70320</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Full mouth x-ray of teeth</ENT>
              <ENT>0.00</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70328</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of jaw joint</ENT>
              <ENT>0.18</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70328</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of jaw joint</ENT>
              <ENT>0.18</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70328</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of jaw joint</ENT>
              <ENT>0.00</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70330</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of jaw joints</ENT>
              <ENT>0.24</ENT>
              <ENT>0.92</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.21</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70330</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of jaw joints</ENT>
              <ENT>0.24</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>0.01</ENT>
              <ENT>0.33</ENT>
              <ENT>0.33</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70330</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of jaw joints</ENT>
              <ENT>0.00</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70332</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of jaw joint</ENT>
              <ENT>0.54</ENT>
              <ENT>2.30</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.96</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70332</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of jaw joint</ENT>
              <ENT>0.54</ENT>
              <ENT>0.20</ENT>
              <ENT>0.20</ENT>
              <ENT>0.02</ENT>
              <ENT>0.76</ENT>
              <ENT>0.76</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70332</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of jaw joint</ENT>
              <ENT>0.00</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.20</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70336</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Magnetic image, jaw joint</ENT>
              <ENT>1.48</ENT>
              <ENT>11.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.56</ENT>
              <ENT>13.75</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70336</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Magnetic image, jaw joint</ENT>
              <ENT>1.48</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>0.07</ENT>
              <ENT>2.05</ENT>
              <ENT>2.05</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70336</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Magnetic image, jaw joint</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>11.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70350</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray head for orthodontia</ENT>
              <ENT>0.17</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70350</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray head for orthodontia</ENT>
              <ENT>0.17</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70350</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray head for orthodontia</ENT>
              <ENT>0.00</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70355</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Panoramic x-ray of jaws</ENT>
              <ENT>0.20</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70355</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Panoramic x-ray of jaws</ENT>
              <ENT>0.20</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>0.01</ENT>
              <ENT>0.29</ENT>
              <ENT>0.29</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70355</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Panoramic x-ray of jaws</ENT>
              <ENT>0.00</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70360</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of neck</ENT>
              <ENT>0.17</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70360</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of neck</ENT>
              <ENT>0.17</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70360</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of neck</ENT>
              <ENT>0.00</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70370</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Throat x-ray &amp; fluoroscopy</ENT>
              <ENT>0.32</ENT>
              <ENT>1.41</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.80</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70370</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Throat x-ray &amp; fluoroscopy</ENT>
              <ENT>0.32</ENT>
              <ENT>0.11</ENT>
              <ENT>0.11</ENT>
              <ENT>0.01</ENT>
              <ENT>0.44</ENT>
              <ENT>0.44</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49174"/>
              <ENT I="01">70370</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Throat x-ray &amp; fluoroscopy</ENT>
              <ENT>0.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70371</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Speech evaluation, complex</ENT>
              <ENT>0.84</ENT>
              <ENT>2.38</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.36</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70371</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Speech evaluation, complex</ENT>
              <ENT>0.84</ENT>
              <ENT>0.28</ENT>
              <ENT>0.28</ENT>
              <ENT>0.04</ENT>
              <ENT>1.16</ENT>
              <ENT>1.16</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70371</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Speech evaluation, complex</ENT>
              <ENT>0.00</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.20</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70373</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of larynx</ENT>
              <ENT>0.44</ENT>
              <ENT>1.93</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.48</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70373</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of larynx</ENT>
              <ENT>0.44</ENT>
              <ENT>0.15</ENT>
              <ENT>0.15</ENT>
              <ENT>0.02</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70373</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of larynx</ENT>
              <ENT>0.00</ENT>
              <ENT>1.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.87</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70380</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of salivary gland</ENT>
              <ENT>0.17</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.93</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70380</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of salivary gland</ENT>
              <ENT>0.17</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70380</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of salivary gland</ENT>
              <ENT>0.00</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70390</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of salivary duct</ENT>
              <ENT>0.38</ENT>
              <ENT>1.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.40</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70390</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of salivary duct</ENT>
              <ENT>0.38</ENT>
              <ENT>0.13</ENT>
              <ENT>0.13</ENT>
              <ENT>0.02</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70390</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of salivary duct</ENT>
              <ENT>0.00</ENT>
              <ENT>1.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.87</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct head/brain w/o dye</ENT>
              <ENT>0.85</ENT>
              <ENT>5.00</ENT>
              <ENT>N/A</ENT>
              <ENT>0.25</ENT>
              <ENT>6.10</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70450</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct head/brain w/o dye</ENT>
              <ENT>0.85</ENT>
              <ENT>0.28</ENT>
              <ENT>0.28</ENT>
              <ENT>0.04</ENT>
              <ENT>1.17</ENT>
              <ENT>1.17</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70450</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct head/brain w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>4.72</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>4.93</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70460</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct head/brain w/dye</ENT>
              <ENT>1.13</ENT>
              <ENT>6.04</ENT>
              <ENT>N/A</ENT>
              <ENT>0.30</ENT>
              <ENT>7.47</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70460</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct head/brain w/dye</ENT>
              <ENT>1.13</ENT>
              <ENT>0.38</ENT>
              <ENT>0.38</ENT>
              <ENT>0.05</ENT>
              <ENT>1.56</ENT>
              <ENT>1.56</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70460</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct head/brain w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>5.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.25</ENT>
              <ENT>5.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70470</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct head/brain w/o&amp;w dye</ENT>
              <ENT>1.27</ENT>
              <ENT>7.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.37</ENT>
              <ENT>9.13</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70470</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct head/brain w/o&amp;w dye</ENT>
              <ENT>1.27</ENT>
              <ENT>0.43</ENT>
              <ENT>0.43</ENT>
              <ENT>0.06</ENT>
              <ENT>1.76</ENT>
              <ENT>1.76</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70470</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct head/brain w/o&amp;w dye</ENT>
              <ENT>0.00</ENT>
              <ENT>7.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70480</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct orbit/ear/fossa w/o dye</ENT>
              <ENT>1.28</ENT>
              <ENT>5.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.27</ENT>
              <ENT>6.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70480</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct orbit/ear/fossa w/o dye</ENT>
              <ENT>1.28</ENT>
              <ENT>0.43</ENT>
              <ENT>0.43</ENT>
              <ENT>0.06</ENT>
              <ENT>1.77</ENT>
              <ENT>1.77</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70480</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct orbit/ear/fossa w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>4.72</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>4.93</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70481</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct orbit/ear/fossa w/dye</ENT>
              <ENT>1.38</ENT>
              <ENT>6.12</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.81</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70481</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct orbit/ear/fossa w/dye</ENT>
              <ENT>1.38</ENT>
              <ENT>0.46</ENT>
              <ENT>0.46</ENT>
              <ENT>0.06</ENT>
              <ENT>1.90</ENT>
              <ENT>1.90</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70481</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct orbit/ear/fossa w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>5.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.25</ENT>
              <ENT>5.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70482</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct orbit/ear/fossa w/o&amp;w dye</ENT>
              <ENT>1.45</ENT>
              <ENT>7.56</ENT>
              <ENT>N/A</ENT>
              <ENT>0.37</ENT>
              <ENT>9.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70482</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct orbit/ear/fossa w/o&amp;w dye</ENT>
              <ENT>1.45</ENT>
              <ENT>0.49</ENT>
              <ENT>0.49</ENT>
              <ENT>0.06</ENT>
              <ENT>2.00</ENT>
              <ENT>2.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70482</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct orbit/ear/fossa w/o&amp;w dye</ENT>
              <ENT>0.00</ENT>
              <ENT>7.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70486</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct maxillofacial w/o dye</ENT>
              <ENT>1.14</ENT>
              <ENT>5.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.26</ENT>
              <ENT>6.50</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70486</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct maxillofacial w/o dye</ENT>
              <ENT>1.14</ENT>
              <ENT>0.38</ENT>
              <ENT>0.38</ENT>
              <ENT>0.05</ENT>
              <ENT>1.57</ENT>
              <ENT>1.57</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70486</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct maxillofacial w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>4.72</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>4.93</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70487</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct maxillofacial w/dye</ENT>
              <ENT>1.30</ENT>
              <ENT>6.09</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70487</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct maxillofacial w/dye</ENT>
              <ENT>1.30</ENT>
              <ENT>0.44</ENT>
              <ENT>0.44</ENT>
              <ENT>0.06</ENT>
              <ENT>1.80</ENT>
              <ENT>1.80</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70487</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct maxillofacial w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>5.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.25</ENT>
              <ENT>5.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70488</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct maxillofacial w/o&amp;w dye</ENT>
              <ENT>1.42</ENT>
              <ENT>7.54</ENT>
              <ENT>N/A</ENT>
              <ENT>0.37</ENT>
              <ENT>9.33</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70488</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct maxillofacial w/o&amp;w dye</ENT>
              <ENT>1.42</ENT>
              <ENT>0.48</ENT>
              <ENT>0.48</ENT>
              <ENT>0.06</ENT>
              <ENT>1.96</ENT>
              <ENT>1.96</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70488</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct maxillofacial w/o&amp;w dye</ENT>
              <ENT>0.00</ENT>
              <ENT>7.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70490</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct soft tissue neck w/o dye</ENT>
              <ENT>1.28</ENT>
              <ENT>5.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.27</ENT>
              <ENT>6.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70490</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct soft tissue neck w/o dye</ENT>
              <ENT>1.28</ENT>
              <ENT>0.43</ENT>
              <ENT>0.43</ENT>
              <ENT>0.06</ENT>
              <ENT>1.77</ENT>
              <ENT>1.77</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70490</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct soft tissue neck w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>4.72</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>4.93</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70491</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct soft tissue neck w/dye</ENT>
              <ENT>1.38</ENT>
              <ENT>6.12</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.81</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70491</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct soft tissue neck w/dye</ENT>
              <ENT>1.38</ENT>
              <ENT>0.46</ENT>
              <ENT>0.46</ENT>
              <ENT>0.06</ENT>
              <ENT>1.90</ENT>
              <ENT>1.90</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70491</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct soft tissue neck w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>5.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.25</ENT>
              <ENT>5.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70492</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct sft tsue nck w/o &amp; w/dye</ENT>
              <ENT>1.45</ENT>
              <ENT>7.55</ENT>
              <ENT>N/A</ENT>
              <ENT>0.37</ENT>
              <ENT>9.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70492</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct sft tsue nck w/o &amp; w/dye</ENT>
              <ENT>1.45</ENT>
              <ENT>0.49</ENT>
              <ENT>0.49</ENT>
              <ENT>0.06</ENT>
              <ENT>2.00</ENT>
              <ENT>2.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49175"/>
              <ENT I="01">70492</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct sft tsue nck w/o &amp; w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>7.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70496</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct angiography, head</ENT>
              <ENT>1.75</ENT>
              <ENT>11.19</ENT>
              <ENT>N/A</ENT>
              <ENT>0.56</ENT>
              <ENT>13.50</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70496</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct angiography, head</ENT>
              <ENT>1.75</ENT>
              <ENT>0.59</ENT>
              <ENT>0.59</ENT>
              <ENT>0.08</ENT>
              <ENT>2.42</ENT>
              <ENT>2.42</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70496</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct angiography, head</ENT>
              <ENT>0.00</ENT>
              <ENT>10.61</ENT>
              <ENT>N/A</ENT>
              <ENT>0.48</ENT>
              <ENT>11.09</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70498</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct angiography, neck</ENT>
              <ENT>1.75</ENT>
              <ENT>11.20</ENT>
              <ENT>N/A</ENT>
              <ENT>0.56</ENT>
              <ENT>13.51</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70498</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct angiography, neck</ENT>
              <ENT>1.75</ENT>
              <ENT>0.59</ENT>
              <ENT>0.59</ENT>
              <ENT>0.08</ENT>
              <ENT>2.42</ENT>
              <ENT>2.42</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70498</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct angiography, neck</ENT>
              <ENT>0.00</ENT>
              <ENT>10.61</ENT>
              <ENT>N/A</ENT>
              <ENT>0.48</ENT>
              <ENT>11.09</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70540</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri orbit/face/neck w/o dye</ENT>
              <ENT>1.35</ENT>
              <ENT>11.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>13.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70540</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri orbit/face/neck w/o dye</ENT>
              <ENT>1.35</ENT>
              <ENT>0.45</ENT>
              <ENT>0.45</ENT>
              <ENT>0.04</ENT>
              <ENT>1.84</ENT>
              <ENT>1.84</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70540</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri orbit/face/neck w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.32</ENT>
              <ENT>11.53</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70542</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri orbit/face/neck w/dye</ENT>
              <ENT>1.62</ENT>
              <ENT>13.99</ENT>
              <ENT>N/A</ENT>
              <ENT>0.44</ENT>
              <ENT>16.05</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70542</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri orbit/face/neck w/dye</ENT>
              <ENT>1.62</ENT>
              <ENT>0.55</ENT>
              <ENT>0.55</ENT>
              <ENT>0.05</ENT>
              <ENT>2.22</ENT>
              <ENT>2.22</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70542</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri orbit/face/neck w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>13.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.39</ENT>
              <ENT>13.83</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70543</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri orbt/fac/nck w/o&amp;w dye</ENT>
              <ENT>2.15</ENT>
              <ENT>25.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.77</ENT>
              <ENT>28.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70543</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri orbt/fac/nck w/o&amp;w dye</ENT>
              <ENT>2.15</ENT>
              <ENT>0.72</ENT>
              <ENT>0.72</ENT>
              <ENT>0.07</ENT>
              <ENT>2.94</ENT>
              <ENT>2.94</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70543</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri orbt/fac/nck w/o&amp;w dye</ENT>
              <ENT>0.00</ENT>
              <ENT>24.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.70</ENT>
              <ENT>25.59</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70544</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mr angiography head w/o dye</ENT>
              <ENT>1.20</ENT>
              <ENT>11.61</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.35</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70544</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mr angiography head w/o dye</ENT>
              <ENT>1.20</ENT>
              <ENT>0.40</ENT>
              <ENT>0.40</ENT>
              <ENT>0.05</ENT>
              <ENT>1.65</ENT>
              <ENT>1.65</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70544</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mr angiography head w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>11.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70545</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mr angiography head w/dye</ENT>
              <ENT>1.20</ENT>
              <ENT>11.61</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.35</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70545</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mr angiography head w/dye</ENT>
              <ENT>1.20</ENT>
              <ENT>0.40</ENT>
              <ENT>0.40</ENT>
              <ENT>0.05</ENT>
              <ENT>1.65</ENT>
              <ENT>1.65</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70545</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mr angiography head w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>11.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70546</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mr angiograph head w/o&amp;w dye</ENT>
              <ENT>1.80</ENT>
              <ENT>23.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.57</ENT>
              <ENT>25.39</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70546</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mr angiograph head w/o&amp;w dye</ENT>
              <ENT>1.80</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>0.08</ENT>
              <ENT>2.49</ENT>
              <ENT>2.49</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70546</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mr angiograph head w/o&amp;w dye</ENT>
              <ENT>0.00</ENT>
              <ENT>22.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>22.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70547</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mr angiography neck w/o dye</ENT>
              <ENT>1.20</ENT>
              <ENT>11.61</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.35</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70547</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mr angiography neck w/o dye</ENT>
              <ENT>1.20</ENT>
              <ENT>0.40</ENT>
              <ENT>0.40</ENT>
              <ENT>0.05</ENT>
              <ENT>1.65</ENT>
              <ENT>1.65</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70547</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mr angiography neck w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>11.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70548</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mr angiography neck w/dye</ENT>
              <ENT>1.20</ENT>
              <ENT>11.61</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.35</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70548</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mr angiography neck w/dye</ENT>
              <ENT>1.20</ENT>
              <ENT>0.40</ENT>
              <ENT>0.40</ENT>
              <ENT>0.05</ENT>
              <ENT>1.65</ENT>
              <ENT>1.65</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70548</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mr angiography neck w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>11.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70549</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mr angiograph neck w/o&amp;w dye</ENT>
              <ENT>1.80</ENT>
              <ENT>23.03</ENT>
              <ENT>N/A</ENT>
              <ENT>0.57</ENT>
              <ENT>25.40</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70549</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mr angiograph neck w/o&amp;w dye</ENT>
              <ENT>1.80</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>0.08</ENT>
              <ENT>2.49</ENT>
              <ENT>2.49</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70549</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mr angiograph neck w/o&amp;w dye</ENT>
              <ENT>0.00</ENT>
              <ENT>22.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>22.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70551</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri brain w/o dye</ENT>
              <ENT>1.48</ENT>
              <ENT>11.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.56</ENT>
              <ENT>13.75</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70551</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri brain w/o dye</ENT>
              <ENT>1.48</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>0.07</ENT>
              <ENT>2.05</ENT>
              <ENT>2.05</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70551</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri brain w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>11.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70552</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri brain w/dye</ENT>
              <ENT>1.78</ENT>
              <ENT>14.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.66</ENT>
              <ENT>16.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70552</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri brain w/dye</ENT>
              <ENT>1.78</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>0.08</ENT>
              <ENT>2.47</ENT>
              <ENT>2.47</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70552</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri brain w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>13.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.58</ENT>
              <ENT>14.02</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70553</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri brain w/o&amp;w dye</ENT>
              <ENT>2.36</ENT>
              <ENT>25.69</ENT>
              <ENT>N/A</ENT>
              <ENT>1.19</ENT>
              <ENT>29.24</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70553</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri brain w/o&amp;w dye</ENT>
              <ENT>2.36</ENT>
              <ENT>0.79</ENT>
              <ENT>0.79</ENT>
              <ENT>0.10</ENT>
              <ENT>3.25</ENT>
              <ENT>3.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">70553</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri brain w/o&amp;w dye</ENT>
              <ENT>0.00</ENT>
              <ENT>24.89</ENT>
              <ENT>N/A</ENT>
              <ENT>1.09</ENT>
              <ENT>25.98</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chest x-ray</ENT>
              <ENT>0.18</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49176"/>
              <ENT I="01">71010</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Chest x-ray</ENT>
              <ENT>0.18</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71010</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Chest x-ray</ENT>
              <ENT>0.00</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71015</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chest x-ray</ENT>
              <ENT>0.21</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.83</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71015</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Chest x-ray</ENT>
              <ENT>0.21</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.29</ENT>
              <ENT>0.29</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71015</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Chest x-ray</ENT>
              <ENT>0.00</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chest x-ray</ENT>
              <ENT>0.22</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.95</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71020</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Chest x-ray</ENT>
              <ENT>0.22</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71020</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Chest x-ray</ENT>
              <ENT>0.00</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71021</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chest x-ray</ENT>
              <ENT>0.27</ENT>
              <ENT>0.83</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71021</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Chest x-ray</ENT>
              <ENT>0.27</ENT>
              <ENT>0.09</ENT>
              <ENT>0.09</ENT>
              <ENT>0.01</ENT>
              <ENT>0.37</ENT>
              <ENT>0.37</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71021</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Chest x-ray</ENT>
              <ENT>0.00</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71022</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chest x-ray</ENT>
              <ENT>0.31</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.21</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71022</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Chest x-ray</ENT>
              <ENT>0.31</ENT>
              <ENT>0.10</ENT>
              <ENT>0.10</ENT>
              <ENT>0.02</ENT>
              <ENT>0.43</ENT>
              <ENT>0.43</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71022</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Chest x-ray</ENT>
              <ENT>0.00</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71023</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chest x-ray and fluoroscopy</ENT>
              <ENT>0.38</ENT>
              <ENT>0.92</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.36</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71023</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Chest x-ray and fluoroscopy</ENT>
              <ENT>0.38</ENT>
              <ENT>0.13</ENT>
              <ENT>0.13</ENT>
              <ENT>0.02</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71023</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Chest x-ray and fluoroscopy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71030</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chest x-ray</ENT>
              <ENT>0.31</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.25</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71030</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Chest x-ray</ENT>
              <ENT>0.31</ENT>
              <ENT>0.10</ENT>
              <ENT>0.10</ENT>
              <ENT>0.01</ENT>
              <ENT>0.42</ENT>
              <ENT>0.42</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71030</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Chest x-ray</ENT>
              <ENT>0.00</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71034</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chest x-ray and fluoroscopy</ENT>
              <ENT>0.46</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.15</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71034</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Chest x-ray and fluoroscopy</ENT>
              <ENT>0.46</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.02</ENT>
              <ENT>0.64</ENT>
              <ENT>0.64</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71034</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Chest x-ray and fluoroscopy</ENT>
              <ENT>0.00</ENT>
              <ENT>1.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71035</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chest x-ray</ENT>
              <ENT>0.18</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71035</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Chest x-ray</ENT>
              <ENT>0.18</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71035</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Chest x-ray</ENT>
              <ENT>0.00</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71040</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of bronchi</ENT>
              <ENT>0.58</ENT>
              <ENT>1.65</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.33</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71040</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of bronchi</ENT>
              <ENT>0.58</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.03</ENT>
              <ENT>0.80</ENT>
              <ENT>0.80</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71040</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of bronchi</ENT>
              <ENT>0.00</ENT>
              <ENT>1.46</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.53</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71060</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of bronchi</ENT>
              <ENT>0.74</ENT>
              <ENT>2.45</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.33</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71060</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of bronchi</ENT>
              <ENT>0.74</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.03</ENT>
              <ENT>1.02</ENT>
              <ENT>1.02</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71060</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of bronchi</ENT>
              <ENT>0.00</ENT>
              <ENT>2.20</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.31</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71090</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray &amp; pacemaker insertion</ENT>
              <ENT>0.54</ENT>
              <ENT>1.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71090</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray &amp; pacemaker insertion</ENT>
              <ENT>0.54</ENT>
              <ENT>0.21</ENT>
              <ENT>0.21</ENT>
              <ENT>0.02</ENT>
              <ENT>0.77</ENT>
              <ENT>0.77</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71090</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray &amp; pacemaker insertion</ENT>
              <ENT>0.00</ENT>
              <ENT>1.68</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of ribs</ENT>
              <ENT>0.22</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71100</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of ribs</ENT>
              <ENT>0.22</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71100</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of ribs</ENT>
              <ENT>0.00</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71101</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of ribs/chest</ENT>
              <ENT>0.27</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71101</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of ribs/chest</ENT>
              <ENT>0.27</ENT>
              <ENT>0.09</ENT>
              <ENT>0.09</ENT>
              <ENT>0.01</ENT>
              <ENT>0.37</ENT>
              <ENT>0.37</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71101</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of ribs/chest</ENT>
              <ENT>0.00</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of ribs</ENT>
              <ENT>0.27</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71110</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of ribs</ENT>
              <ENT>0.27</ENT>
              <ENT>0.09</ENT>
              <ENT>0.09</ENT>
              <ENT>0.01</ENT>
              <ENT>0.37</ENT>
              <ENT>0.37</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71110</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of ribs</ENT>
              <ENT>0.00</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71111</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of ribs/ chest</ENT>
              <ENT>0.32</ENT>
              <ENT>1.00</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71111</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of ribs/ chest</ENT>
              <ENT>0.32</ENT>
              <ENT>0.11</ENT>
              <ENT>0.11</ENT>
              <ENT>0.01</ENT>
              <ENT>0.44</ENT>
              <ENT>0.44</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71111</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of ribs/ chest</ENT>
              <ENT>0.00</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of breastbone</ENT>
              <ENT>0.20</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.95</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71120</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of breastbone</ENT>
              <ENT>0.20</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.28</ENT>
              <ENT>0.28</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71120</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of breastbone</ENT>
              <ENT>0.00</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.68</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of breastbone</ENT>
              <ENT>0.22</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>1.04</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71130</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of breastbone</ENT>
              <ENT>0.22</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71130</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of breastbone</ENT>
              <ENT>0.00</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct thorax w/o dye</ENT>
              <ENT>1.16</ENT>
              <ENT>6.30</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71250</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct thorax w/o dye</ENT>
              <ENT>1.16</ENT>
              <ENT>0.39</ENT>
              <ENT>0.39</ENT>
              <ENT>0.05</ENT>
              <ENT>1.60</ENT>
              <ENT>1.60</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71250</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct thorax w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>5.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.26</ENT>
              <ENT>6.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71260</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct thorax w/dye</ENT>
              <ENT>1.24</ENT>
              <ENT>7.48</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>9.08</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49177"/>
              <ENT I="01">71260</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct thorax w/dye</ENT>
              <ENT>1.24</ENT>
              <ENT>0.41</ENT>
              <ENT>0.41</ENT>
              <ENT>0.05</ENT>
              <ENT>1.70</ENT>
              <ENT>1.70</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71260</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct thorax w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>7.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71270</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct thorax w/o&amp;w dye</ENT>
              <ENT>1.38</ENT>
              <ENT>9.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.44</ENT>
              <ENT>11.13</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71270</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct thorax w/o&amp;w dye</ENT>
              <ENT>1.38</ENT>
              <ENT>0.46</ENT>
              <ENT>0.46</ENT>
              <ENT>0.06</ENT>
              <ENT>1.90</ENT>
              <ENT>1.90</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71270</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct thorax w/o&amp;w dye</ENT>
              <ENT>0.00</ENT>
              <ENT>8.85</ENT>
              <ENT>N/A</ENT>
              <ENT>0.38</ENT>
              <ENT>9.23</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71275</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct angiography, chest</ENT>
              <ENT>1.92</ENT>
              <ENT>13.03</ENT>
              <ENT>N/A</ENT>
              <ENT>0.38</ENT>
              <ENT>15.33</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71275</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct angiography, chest</ENT>
              <ENT>1.92</ENT>
              <ENT>0.64</ENT>
              <ENT>0.64</ENT>
              <ENT>0.06</ENT>
              <ENT>2.62</ENT>
              <ENT>2.62</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71275</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct angiography, chest</ENT>
              <ENT>0.00</ENT>
              <ENT>12.39</ENT>
              <ENT>N/A</ENT>
              <ENT>0.32</ENT>
              <ENT>12.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71550</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri chest w/o dye</ENT>
              <ENT>1.46</ENT>
              <ENT>11.70</ENT>
              <ENT>N/A</ENT>
              <ENT>0.41</ENT>
              <ENT>13.57</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71550</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri chest w/o dye</ENT>
              <ENT>1.46</ENT>
              <ENT>0.49</ENT>
              <ENT>0.49</ENT>
              <ENT>0.04</ENT>
              <ENT>1.99</ENT>
              <ENT>1.99</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71550</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri chest w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.37</ENT>
              <ENT>11.58</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71551</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri chest w/dye</ENT>
              <ENT>1.73</ENT>
              <ENT>14.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>16.24</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71551</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri chest w/dye</ENT>
              <ENT>1.73</ENT>
              <ENT>0.58</ENT>
              <ENT>0.58</ENT>
              <ENT>0.06</ENT>
              <ENT>2.37</ENT>
              <ENT>2.37</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71551</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri chest w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>13.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.43</ENT>
              <ENT>13.87</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71552</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri chest w/o&amp;w/dye</ENT>
              <ENT>2.26</ENT>
              <ENT>25.65</ENT>
              <ENT>N/A</ENT>
              <ENT>0.64</ENT>
              <ENT>28.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71552</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri chest w/o&amp;w/dye</ENT>
              <ENT>2.26</ENT>
              <ENT>0.76</ENT>
              <ENT>0.76</ENT>
              <ENT>0.08</ENT>
              <ENT>3.10</ENT>
              <ENT>3.10</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71552</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri chest w/o&amp;w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>24.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.56</ENT>
              <ENT>25.45</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71555</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Mri angio chest w or w/o dye</ENT>
              <ENT>1.81</ENT>
              <ENT>11.82</ENT>
              <ENT>N/A</ENT>
              <ENT>0.57</ENT>
              <ENT>14.20</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71555</ENT>
              <ENT>26</ENT>
              <ENT>R</ENT>
              <ENT>Mri angio chest w or w/o dye</ENT>
              <ENT>1.81</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>0.08</ENT>
              <ENT>2.50</ENT>
              <ENT>2.50</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">71555</ENT>
              <ENT>TC</ENT>
              <ENT>R</ENT>
              <ENT>Mri angio chest w or w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>11.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of spine</ENT>
              <ENT>0.45</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72010</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of spine</ENT>
              <ENT>0.45</ENT>
              <ENT>0.15</ENT>
              <ENT>0.15</ENT>
              <ENT>0.03</ENT>
              <ENT>0.63</ENT>
              <ENT>0.63</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72010</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of spine</ENT>
              <ENT>0.00</ENT>
              <ENT>1.03</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of spine</ENT>
              <ENT>0.15</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72020</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of spine</ENT>
              <ENT>0.15</ENT>
              <ENT>0.05</ENT>
              <ENT>0.05</ENT>
              <ENT>0.01</ENT>
              <ENT>0.21</ENT>
              <ENT>0.21</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72020</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of spine</ENT>
              <ENT>0.00</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72040</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of neck spine</ENT>
              <ENT>0.22</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.93</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72040</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of neck spine</ENT>
              <ENT>0.22</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72040</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of neck spine</ENT>
              <ENT>0.00</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72050</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of neck spine</ENT>
              <ENT>0.31</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72050</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of neck spine</ENT>
              <ENT>0.31</ENT>
              <ENT>0.10</ENT>
              <ENT>0.10</ENT>
              <ENT>0.02</ENT>
              <ENT>0.43</ENT>
              <ENT>0.43</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72050</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of neck spine</ENT>
              <ENT>0.00</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72052</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of neck spine</ENT>
              <ENT>0.36</ENT>
              <ENT>1.25</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.68</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72052</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of neck spine</ENT>
              <ENT>0.36</ENT>
              <ENT>0.12</ENT>
              <ENT>0.12</ENT>
              <ENT>0.02</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72052</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of neck spine</ENT>
              <ENT>0.00</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72069</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of trunk spine</ENT>
              <ENT>0.22</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.83</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72069</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of trunk spine</ENT>
              <ENT>0.22</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>0.02</ENT>
              <ENT>0.32</ENT>
              <ENT>0.32</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72069</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of trunk spine</ENT>
              <ENT>0.00</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72070</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of thoracic spine</ENT>
              <ENT>0.22</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.98</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72070</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of thoracic spine</ENT>
              <ENT>0.22</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72070</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of thoracic spine</ENT>
              <ENT>0.00</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.68</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72072</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of thoracic spine</ENT>
              <ENT>0.22</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72072</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of thoracic spine</ENT>
              <ENT>0.22</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72072</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of thoracic spine</ENT>
              <ENT>0.00</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72074</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of thoracic spine</ENT>
              <ENT>0.22</ENT>
              <ENT>0.98</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.26</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72074</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of thoracic spine</ENT>
              <ENT>0.22</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72074</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of thoracic spine</ENT>
              <ENT>0.00</ENT>
              <ENT>0.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.96</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72080</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of trunk spine</ENT>
              <ENT>0.22</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72080</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of trunk spine</ENT>
              <ENT>0.22</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.02</ENT>
              <ENT>0.31</ENT>
              <ENT>0.31</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72080</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of trunk spine</ENT>
              <ENT>0.00</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72090</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of trunk spine</ENT>
              <ENT>0.28</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.09</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72090</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of trunk spine</ENT>
              <ENT>0.28</ENT>
              <ENT>0.10</ENT>
              <ENT>0.10</ENT>
              <ENT>0.02</ENT>
              <ENT>0.40</ENT>
              <ENT>0.40</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72090</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of trunk spine</ENT>
              <ENT>0.00</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of lower spine</ENT>
              <ENT>0.22</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49178"/>
              <ENT I="01">72100</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of lower spine</ENT>
              <ENT>0.22</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.02</ENT>
              <ENT>0.31</ENT>
              <ENT>0.31</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72100</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of lower spine</ENT>
              <ENT>0.00</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of lower spine</ENT>
              <ENT>0.31</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.39</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72110</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of lower spine</ENT>
              <ENT>0.31</ENT>
              <ENT>0.10</ENT>
              <ENT>0.10</ENT>
              <ENT>0.02</ENT>
              <ENT>0.43</ENT>
              <ENT>0.43</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72110</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of lower spine</ENT>
              <ENT>0.00</ENT>
              <ENT>0.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.96</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72114</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of lower spine</ENT>
              <ENT>0.36</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.75</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72114</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of lower spine</ENT>
              <ENT>0.36</ENT>
              <ENT>0.12</ENT>
              <ENT>0.12</ENT>
              <ENT>0.03</ENT>
              <ENT>0.51</ENT>
              <ENT>0.51</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72114</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of lower spine</ENT>
              <ENT>0.00</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of lower spine</ENT>
              <ENT>0.22</ENT>
              <ENT>0.96</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.25</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72120</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of lower spine</ENT>
              <ENT>0.22</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.02</ENT>
              <ENT>0.31</ENT>
              <ENT>0.31</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72120</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of lower spine</ENT>
              <ENT>0.00</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72125</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct neck spine w/o dye</ENT>
              <ENT>1.16</ENT>
              <ENT>6.30</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72125</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct neck spine w/o dye</ENT>
              <ENT>1.16</ENT>
              <ENT>0.39</ENT>
              <ENT>0.39</ENT>
              <ENT>0.05</ENT>
              <ENT>1.60</ENT>
              <ENT>1.60</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72125</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct neck spine w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>5.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.26</ENT>
              <ENT>6.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72126</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct neck spine w/dye</ENT>
              <ENT>1.22</ENT>
              <ENT>7.48</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>9.06</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72126</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct neck spine w/dye</ENT>
              <ENT>1.22</ENT>
              <ENT>0.41</ENT>
              <ENT>0.41</ENT>
              <ENT>0.05</ENT>
              <ENT>1.68</ENT>
              <ENT>1.68</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72126</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct neck spine w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>7.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72127</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct neck spine w/o&amp;w/dye</ENT>
              <ENT>1.27</ENT>
              <ENT>9.28</ENT>
              <ENT>N/A</ENT>
              <ENT>0.44</ENT>
              <ENT>10.99</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72127</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct neck spine w/o&amp;w/dye</ENT>
              <ENT>1.27</ENT>
              <ENT>0.43</ENT>
              <ENT>0.43</ENT>
              <ENT>0.06</ENT>
              <ENT>1.76</ENT>
              <ENT>1.76</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72127</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct neck spine w/o&amp;w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>8.85</ENT>
              <ENT>N/A</ENT>
              <ENT>0.38</ENT>
              <ENT>9.23</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72128</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct chest spine w/o dye</ENT>
              <ENT>1.16</ENT>
              <ENT>6.30</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72128</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct chest spine w/o dye</ENT>
              <ENT>1.16</ENT>
              <ENT>0.39</ENT>
              <ENT>0.39</ENT>
              <ENT>0.05</ENT>
              <ENT>1.60</ENT>
              <ENT>1.60</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72128</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct chest spine w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>5.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.26</ENT>
              <ENT>6.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72129</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct chest spine w/dye</ENT>
              <ENT>1.22</ENT>
              <ENT>7.48</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>9.06</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72129</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct chest spine w/dye</ENT>
              <ENT>1.22</ENT>
              <ENT>0.41</ENT>
              <ENT>0.41</ENT>
              <ENT>0.05</ENT>
              <ENT>1.68</ENT>
              <ENT>1.68</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72129</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct chest spine w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>7.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct chest spine w/o&amp;w/dye</ENT>
              <ENT>1.27</ENT>
              <ENT>9.27</ENT>
              <ENT>N/A</ENT>
              <ENT>0.44</ENT>
              <ENT>10.98</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72130</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct chest spine w/o&amp;w/dye</ENT>
              <ENT>1.27</ENT>
              <ENT>0.43</ENT>
              <ENT>0.43</ENT>
              <ENT>0.06</ENT>
              <ENT>1.76</ENT>
              <ENT>1.76</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72130</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct chest spine w/o&amp;w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>8.85</ENT>
              <ENT>N/A</ENT>
              <ENT>0.38</ENT>
              <ENT>9.23</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72131</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct lumbar spine w/o dye</ENT>
              <ENT>1.16</ENT>
              <ENT>6.30</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72131</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct lumbar spine w/o dye</ENT>
              <ENT>1.16</ENT>
              <ENT>0.39</ENT>
              <ENT>0.39</ENT>
              <ENT>0.05</ENT>
              <ENT>1.60</ENT>
              <ENT>1.60</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72131</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct lumbar spine w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>5.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.26</ENT>
              <ENT>6.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72132</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct lumbar spine w/dye</ENT>
              <ENT>1.22</ENT>
              <ENT>7.48</ENT>
              <ENT>N/A</ENT>
              <ENT>0.37</ENT>
              <ENT>9.07</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72132</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct lumbar spine w/dye</ENT>
              <ENT>1.22</ENT>
              <ENT>0.41</ENT>
              <ENT>0.41</ENT>
              <ENT>0.06</ENT>
              <ENT>1.69</ENT>
              <ENT>1.69</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72132</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct lumbar spine w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>7.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72133</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct lumbar spine w/o&amp;w/dye</ENT>
              <ENT>1.27</ENT>
              <ENT>9.28</ENT>
              <ENT>N/A</ENT>
              <ENT>0.44</ENT>
              <ENT>10.99</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72133</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct lumbar spine w/o&amp;w/dye</ENT>
              <ENT>1.27</ENT>
              <ENT>0.43</ENT>
              <ENT>0.43</ENT>
              <ENT>0.06</ENT>
              <ENT>1.76</ENT>
              <ENT>1.76</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72133</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct lumbar spine w/o&amp;w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>8.85</ENT>
              <ENT>N/A</ENT>
              <ENT>0.38</ENT>
              <ENT>9.23</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72141</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri neck spine w/o dye</ENT>
              <ENT>1.60</ENT>
              <ENT>11.75</ENT>
              <ENT>N/A</ENT>
              <ENT>0.56</ENT>
              <ENT>13.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72141</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri neck spine w/o dye</ENT>
              <ENT>1.60</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>0.07</ENT>
              <ENT>2.21</ENT>
              <ENT>2.21</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72141</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri neck spine w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>11.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72142</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri neck spine w/dye</ENT>
              <ENT>1.92</ENT>
              <ENT>14.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.67</ENT>
              <ENT>16.69</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72142</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri neck spine w/dye</ENT>
              <ENT>1.92</ENT>
              <ENT>0.66</ENT>
              <ENT>0.66</ENT>
              <ENT>0.09</ENT>
              <ENT>2.67</ENT>
              <ENT>2.67</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72142</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri neck spine w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>13.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.58</ENT>
              <ENT>14.02</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72146</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri chest spine w/o dye</ENT>
              <ENT>1.60</ENT>
              <ENT>12.98</ENT>
              <ENT>N/A</ENT>
              <ENT>0.60</ENT>
              <ENT>15.18</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72146</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri chest spine w/o dye</ENT>
              <ENT>1.60</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>0.07</ENT>
              <ENT>2.21</ENT>
              <ENT>2.21</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72146</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri chest spine w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>12.45</ENT>
              <ENT>N/A</ENT>
              <ENT>0.53</ENT>
              <ENT>12.98</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72147</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri chest spine w/dye</ENT>
              <ENT>1.92</ENT>
              <ENT>14.09</ENT>
              <ENT>N/A</ENT>
              <ENT>0.67</ENT>
              <ENT>16.68</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72147</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri chest spine w/dye</ENT>
              <ENT>1.92</ENT>
              <ENT>0.65</ENT>
              <ENT>0.65</ENT>
              <ENT>0.09</ENT>
              <ENT>2.66</ENT>
              <ENT>2.66</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72147</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri chest spine w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>13.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.58</ENT>
              <ENT>14.02</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72148</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri lumbar spine w/o dye</ENT>
              <ENT>1.48</ENT>
              <ENT>12.95</ENT>
              <ENT>N/A</ENT>
              <ENT>0.60</ENT>
              <ENT>15.03</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72148</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri lumbar spine w/o dye</ENT>
              <ENT>1.48</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>0.07</ENT>
              <ENT>2.05</ENT>
              <ENT>2.05</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72148</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri lumbar spine w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>12.45</ENT>
              <ENT>N/A</ENT>
              <ENT>0.53</ENT>
              <ENT>12.98</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72149</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri lumbar spine w/dye</ENT>
              <ENT>1.78</ENT>
              <ENT>14.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.67</ENT>
              <ENT>16.50</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72149</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri lumbar spine w/dye</ENT>
              <ENT>1.78</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>0.09</ENT>
              <ENT>2.48</ENT>
              <ENT>2.48</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72149</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri lumbar spine w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>13.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.58</ENT>
              <ENT>14.02</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72156</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri neck spine w/o&amp;w/dye</ENT>
              <ENT>2.57</ENT>
              <ENT>25.76</ENT>
              <ENT>N/A</ENT>
              <ENT>1.20</ENT>
              <ENT>29.53</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72156</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri neck spine w/o&amp;w/dye</ENT>
              <ENT>2.57</ENT>
              <ENT>0.87</ENT>
              <ENT>0.87</ENT>
              <ENT>0.11</ENT>
              <ENT>3.55</ENT>
              <ENT>3.55</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72156</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri neck spine w/o&amp;w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>24.89</ENT>
              <ENT>N/A</ENT>
              <ENT>1.09</ENT>
              <ENT>25.98</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72157</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri chest spine w/o&amp;w/dye</ENT>
              <ENT>2.57</ENT>
              <ENT>25.76</ENT>
              <ENT>N/A</ENT>
              <ENT>1.20</ENT>
              <ENT>29.53</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72157</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri chest spine w/o&amp;w/dye</ENT>
              <ENT>2.57</ENT>
              <ENT>0.86</ENT>
              <ENT>0.86</ENT>
              <ENT>0.11</ENT>
              <ENT>3.54</ENT>
              <ENT>3.54</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72157</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri chest spine w/o&amp;w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>24.89</ENT>
              <ENT>N/A</ENT>
              <ENT>1.09</ENT>
              <ENT>25.98</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49179"/>
              <ENT I="01">72158</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri lumbar spine w/o&amp;w/dye</ENT>
              <ENT>2.36</ENT>
              <ENT>25.69</ENT>
              <ENT>N/A</ENT>
              <ENT>1.20</ENT>
              <ENT>29.25</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72158</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri lumbar spine w/o&amp;w/dye</ENT>
              <ENT>2.36</ENT>
              <ENT>0.79</ENT>
              <ENT>0.79</ENT>
              <ENT>0.11</ENT>
              <ENT>3.26</ENT>
              <ENT>3.26</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72158</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri lumbar spine w/o&amp;w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>24.89</ENT>
              <ENT>N/A</ENT>
              <ENT>1.09</ENT>
              <ENT>25.98</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72159</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Mr angio spine w/o&amp;w/dye</ENT>
              <ENT>1.80</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>0.61</ENT>
              <ENT>15.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72159</ENT>
              <ENT>26</ENT>
              <ENT>N</ENT>
              <ENT>Mr angio spine w/o&amp;w/dye</ENT>
              <ENT>1.80</ENT>
              <ENT>0.70</ENT>
              <ENT>0.70</ENT>
              <ENT>0.08</ENT>
              <ENT>2.58</ENT>
              <ENT>2.58</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72159</ENT>
              <ENT>TC</ENT>
              <ENT>N</ENT>
              <ENT>Mr angio spine w/o&amp;w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>12.45</ENT>
              <ENT>N/A</ENT>
              <ENT>0.53</ENT>
              <ENT>12.98</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72170</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of pelvis</ENT>
              <ENT>0.17</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72170</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of pelvis</ENT>
              <ENT>0.17</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72170</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of pelvis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72190</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of pelvis</ENT>
              <ENT>0.21</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72190</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of pelvis</ENT>
              <ENT>0.21</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.29</ENT>
              <ENT>0.29</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72190</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of pelvis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72191</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct angiograph pelv w/o&amp;w/dye</ENT>
              <ENT>1.81</ENT>
              <ENT>12.64</ENT>
              <ENT>N/A</ENT>
              <ENT>0.38</ENT>
              <ENT>14.83</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72191</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct angiograph pelv w/o&amp;w/dye</ENT>
              <ENT>1.81</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>0.06</ENT>
              <ENT>2.48</ENT>
              <ENT>2.48</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72191</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct angiograph pelv w/o&amp;w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>12.03</ENT>
              <ENT>N/A</ENT>
              <ENT>0.32</ENT>
              <ENT>12.35</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72192</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct pelvis w/o dye</ENT>
              <ENT>1.09</ENT>
              <ENT>6.27</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.67</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72192</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct pelvis w/o dye</ENT>
              <ENT>1.09</ENT>
              <ENT>0.36</ENT>
              <ENT>0.36</ENT>
              <ENT>0.05</ENT>
              <ENT>1.50</ENT>
              <ENT>1.50</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72192</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct pelvis w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>5.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.26</ENT>
              <ENT>6.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72193</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct pelvis w/dye</ENT>
              <ENT>1.16</ENT>
              <ENT>7.23</ENT>
              <ENT>N/A</ENT>
              <ENT>0.35</ENT>
              <ENT>8.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72193</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct pelvis w/dye</ENT>
              <ENT>1.16</ENT>
              <ENT>0.39</ENT>
              <ENT>0.39</ENT>
              <ENT>0.05</ENT>
              <ENT>1.60</ENT>
              <ENT>1.60</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72193</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct pelvis w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>6.85</ENT>
              <ENT>N/A</ENT>
              <ENT>0.30</ENT>
              <ENT>7.15</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72194</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct pelvis w/o&amp;w/dye</ENT>
              <ENT>1.22</ENT>
              <ENT>8.90</ENT>
              <ENT>N/A</ENT>
              <ENT>0.41</ENT>
              <ENT>10.53</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72194</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct pelvis w/o&amp;w/dye</ENT>
              <ENT>1.22</ENT>
              <ENT>0.41</ENT>
              <ENT>0.41</ENT>
              <ENT>0.05</ENT>
              <ENT>1.68</ENT>
              <ENT>1.68</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72194</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct pelvis w/o&amp;w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>8.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>8.85</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72195</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri pelvis w/o dye</ENT>
              <ENT>1.46</ENT>
              <ENT>11.70</ENT>
              <ENT>N/A</ENT>
              <ENT>0.42</ENT>
              <ENT>13.58</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72195</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri pelvis w/o dye</ENT>
              <ENT>1.46</ENT>
              <ENT>0.49</ENT>
              <ENT>0.49</ENT>
              <ENT>0.05</ENT>
              <ENT>2.00</ENT>
              <ENT>2.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72195</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri pelvis w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.37</ENT>
              <ENT>11.58</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72196</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri pelvis w/dye</ENT>
              <ENT>1.73</ENT>
              <ENT>14.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.48</ENT>
              <ENT>16.23</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72196</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri pelvis w/dye</ENT>
              <ENT>1.73</ENT>
              <ENT>0.58</ENT>
              <ENT>0.58</ENT>
              <ENT>0.05</ENT>
              <ENT>2.36</ENT>
              <ENT>2.36</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72196</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri pelvis w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>13.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.43</ENT>
              <ENT>13.87</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72197</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri pelvis w/o &amp; w/dye</ENT>
              <ENT>2.26</ENT>
              <ENT>25.65</ENT>
              <ENT>N/A</ENT>
              <ENT>0.84</ENT>
              <ENT>28.75</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72197</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri pelvis w/o &amp; w/dye</ENT>
              <ENT>2.26</ENT>
              <ENT>0.76</ENT>
              <ENT>0.76</ENT>
              <ENT>0.08</ENT>
              <ENT>3.10</ENT>
              <ENT>3.10</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72197</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri pelvis w/o &amp; w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>24.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.76</ENT>
              <ENT>25.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72198</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mr angio pelvis w/o&amp;w/dye</ENT>
              <ENT>1.80</ENT>
              <ENT>11.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.57</ENT>
              <ENT>14.28</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72198</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mr angio pelvis w/o&amp;w/dye</ENT>
              <ENT>1.80</ENT>
              <ENT>0.70</ENT>
              <ENT>0.70</ENT>
              <ENT>0.08</ENT>
              <ENT>2.58</ENT>
              <ENT>2.58</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72198</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mr angio pelvis w/o&amp;w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>11.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam sacroiliac joints</ENT>
              <ENT>0.17</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72200</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam sacroiliac joints</ENT>
              <ENT>0.17</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72200</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam sacroiliac joints</ENT>
              <ENT>0.00</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72202</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam sacroiliac joints</ENT>
              <ENT>0.19</ENT>
              <ENT>0.68</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72202</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam sacroiliac joints</ENT>
              <ENT>0.19</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.26</ENT>
              <ENT>0.26</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72202</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam sacroiliac joints</ENT>
              <ENT>0.00</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of tailbone</ENT>
              <ENT>0.17</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72220</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of tailbone</ENT>
              <ENT>0.17</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72220</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of tailbone</ENT>
              <ENT>0.00</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72240</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of neck spine</ENT>
              <ENT>0.91</ENT>
              <ENT>5.04</ENT>
              <ENT>N/A</ENT>
              <ENT>0.25</ENT>
              <ENT>6.20</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72240</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of neck spine</ENT>
              <ENT>0.91</ENT>
              <ENT>0.29</ENT>
              <ENT>0.29</ENT>
              <ENT>0.04</ENT>
              <ENT>1.24</ENT>
              <ENT>1.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72240</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of neck spine</ENT>
              <ENT>0.00</ENT>
              <ENT>4.75</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>4.96</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72255</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray, thorax spine</ENT>
              <ENT>0.91</ENT>
              <ENT>4.61</ENT>
              <ENT>N/A</ENT>
              <ENT>0.22</ENT>
              <ENT>5.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49180"/>
              <ENT I="01">72255</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray, thorax spine</ENT>
              <ENT>0.91</ENT>
              <ENT>0.28</ENT>
              <ENT>0.28</ENT>
              <ENT>0.04</ENT>
              <ENT>1.23</ENT>
              <ENT>1.23</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72255</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray, thorax spine</ENT>
              <ENT>0.00</ENT>
              <ENT>4.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.51</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72265</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray, lower spine</ENT>
              <ENT>0.83</ENT>
              <ENT>4.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.22</ENT>
              <ENT>5.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72265</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray, lower spine</ENT>
              <ENT>0.83</ENT>
              <ENT>0.26</ENT>
              <ENT>0.26</ENT>
              <ENT>0.04</ENT>
              <ENT>1.13</ENT>
              <ENT>1.13</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72265</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray, lower spine</ENT>
              <ENT>0.00</ENT>
              <ENT>4.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.25</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72270</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of spine</ENT>
              <ENT>1.33</ENT>
              <ENT>6.53</ENT>
              <ENT>N/A</ENT>
              <ENT>0.34</ENT>
              <ENT>8.20</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72270</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of spine</ENT>
              <ENT>1.33</ENT>
              <ENT>0.43</ENT>
              <ENT>0.43</ENT>
              <ENT>0.07</ENT>
              <ENT>1.83</ENT>
              <ENT>1.83</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72270</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of spine</ENT>
              <ENT>0.00</ENT>
              <ENT>6.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.27</ENT>
              <ENT>6.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72275</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Epidurography</ENT>
              <ENT>0.76</ENT>
              <ENT>2.30</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>3.27</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72275</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Epidurography</ENT>
              <ENT>0.76</ENT>
              <ENT>0.20</ENT>
              <ENT>0.20</ENT>
              <ENT>0.03</ENT>
              <ENT>0.99</ENT>
              <ENT>0.99</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72275</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Epidurography</ENT>
              <ENT>0.00</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>2.28</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72285</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray c/t spine disk</ENT>
              <ENT>1.16</ENT>
              <ENT>8.75</ENT>
              <ENT>N/A</ENT>
              <ENT>0.42</ENT>
              <ENT>10.33</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72285</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray c/t spine disk</ENT>
              <ENT>1.16</ENT>
              <ENT>0.36</ENT>
              <ENT>0.36</ENT>
              <ENT>0.06</ENT>
              <ENT>1.58</ENT>
              <ENT>1.58</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72285</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray c/t spine disk</ENT>
              <ENT>0.00</ENT>
              <ENT>8.38</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>8.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72295</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray of lower spine disk</ENT>
              <ENT>0.83</ENT>
              <ENT>8.14</ENT>
              <ENT>N/A</ENT>
              <ENT>0.37</ENT>
              <ENT>9.34</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72295</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray of lower spine disk</ENT>
              <ENT>0.83</ENT>
              <ENT>0.27</ENT>
              <ENT>0.27</ENT>
              <ENT>0.04</ENT>
              <ENT>1.14</ENT>
              <ENT>1.14</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">72295</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray of lower spine disk</ENT>
              <ENT>0.00</ENT>
              <ENT>7.86</ENT>
              <ENT>N/A</ENT>
              <ENT>0.33</ENT>
              <ENT>8.19</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of collar bone</ENT>
              <ENT>0.16</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73000</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of collar bone</ENT>
              <ENT>0.16</ENT>
              <ENT>0.05</ENT>
              <ENT>0.05</ENT>
              <ENT>0.01</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73000</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of collar bone</ENT>
              <ENT>0.00</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of shoulder blade</ENT>
              <ENT>0.17</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73010</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of shoulder blade</ENT>
              <ENT>0.17</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73010</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of shoulder blade</ENT>
              <ENT>0.00</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of shoulder</ENT>
              <ENT>0.15</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73020</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of shoulder</ENT>
              <ENT>0.15</ENT>
              <ENT>0.05</ENT>
              <ENT>0.05</ENT>
              <ENT>0.01</ENT>
              <ENT>0.21</ENT>
              <ENT>0.21</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73020</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of shoulder</ENT>
              <ENT>0.00</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73030</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of shoulder</ENT>
              <ENT>0.18</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73030</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of shoulder</ENT>
              <ENT>0.18</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73030</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of shoulder</ENT>
              <ENT>0.00</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73040</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of shoulder</ENT>
              <ENT>0.54</ENT>
              <ENT>2.28</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>2.95</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73040</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of shoulder</ENT>
              <ENT>0.54</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.03</ENT>
              <ENT>0.75</ENT>
              <ENT>0.75</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73040</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of shoulder</ENT>
              <ENT>0.00</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.20</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73050</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of shoulders</ENT>
              <ENT>0.20</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73050</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of shoulders</ENT>
              <ENT>0.20</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.02</ENT>
              <ENT>0.29</ENT>
              <ENT>0.29</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73050</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of shoulders</ENT>
              <ENT>0.00</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73060</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of humerus</ENT>
              <ENT>0.17</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73060</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of humerus</ENT>
              <ENT>0.17</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73060</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of humerus</ENT>
              <ENT>0.00</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73070</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of elbow</ENT>
              <ENT>0.15</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.75</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73070</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of elbow</ENT>
              <ENT>0.15</ENT>
              <ENT>0.05</ENT>
              <ENT>0.05</ENT>
              <ENT>0.01</ENT>
              <ENT>0.21</ENT>
              <ENT>0.21</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73070</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of elbow</ENT>
              <ENT>0.00</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73080</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of elbow</ENT>
              <ENT>0.17</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73080</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of elbow</ENT>
              <ENT>0.17</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73080</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of elbow</ENT>
              <ENT>0.00</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73085</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of elbow</ENT>
              <ENT>0.54</ENT>
              <ENT>2.29</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>2.96</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73085</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of elbow</ENT>
              <ENT>0.54</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.03</ENT>
              <ENT>0.76</ENT>
              <ENT>0.76</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73085</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of elbow</ENT>
              <ENT>0.00</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.20</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73090</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of forearm</ENT>
              <ENT>0.16</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73090</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of forearm</ENT>
              <ENT>0.16</ENT>
              <ENT>0.05</ENT>
              <ENT>0.05</ENT>
              <ENT>0.01</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73090</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of forearm</ENT>
              <ENT>0.00</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73092</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of arm, infant</ENT>
              <ENT>0.16</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73092</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of arm, infant</ENT>
              <ENT>0.16</ENT>
              <ENT>0.05</ENT>
              <ENT>0.05</ENT>
              <ENT>0.01</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73092</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of arm, infant</ENT>
              <ENT>0.00</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of wrist</ENT>
              <ENT>0.16</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.75</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73100</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of wrist</ENT>
              <ENT>0.16</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.02</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73100</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of wrist</ENT>
              <ENT>0.00</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of wrist</ENT>
              <ENT>0.17</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73110</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of wrist</ENT>
              <ENT>0.17</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73110</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of wrist</ENT>
              <ENT>0.00</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73115</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of wrist</ENT>
              <ENT>0.54</ENT>
              <ENT>1.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.41</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73115</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of wrist</ENT>
              <ENT>0.54</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.03</ENT>
              <ENT>0.76</ENT>
              <ENT>0.76</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49181"/>
              <ENT I="01">73115</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of wrist</ENT>
              <ENT>0.00</ENT>
              <ENT>1.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.66</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of hand</ENT>
              <ENT>0.16</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73120</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of hand</ENT>
              <ENT>0.16</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73120</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of hand</ENT>
              <ENT>0.00</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of hand</ENT>
              <ENT>0.17</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73130</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of hand</ENT>
              <ENT>0.17</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73130</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of hand</ENT>
              <ENT>0.00</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of finger(s)</ENT>
              <ENT>0.13</ENT>
              <ENT>0.46</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73140</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of finger(s)</ENT>
              <ENT>0.13</ENT>
              <ENT>0.04</ENT>
              <ENT>0.04</ENT>
              <ENT>0.01</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73140</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of finger(s)</ENT>
              <ENT>0.00</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct upper extremity w/o dye</ENT>
              <ENT>1.09</ENT>
              <ENT>5.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.26</ENT>
              <ENT>6.68</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73200</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct upper extremity w/o dye</ENT>
              <ENT>1.09</ENT>
              <ENT>0.37</ENT>
              <ENT>0.37</ENT>
              <ENT>0.05</ENT>
              <ENT>1.51</ENT>
              <ENT>1.51</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73200</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct upper extremity w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>4.96</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>5.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73201</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct upper extremity w/dye</ENT>
              <ENT>1.16</ENT>
              <ENT>6.30</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73201</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct upper extremity w/dye</ENT>
              <ENT>1.16</ENT>
              <ENT>0.39</ENT>
              <ENT>0.39</ENT>
              <ENT>0.05</ENT>
              <ENT>1.60</ENT>
              <ENT>1.60</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73201</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct upper extremity w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>5.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.26</ENT>
              <ENT>6.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73202</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct uppr extremity w/o&amp;w/dye</ENT>
              <ENT>1.22</ENT>
              <ENT>7.84</ENT>
              <ENT>N/A</ENT>
              <ENT>0.38</ENT>
              <ENT>9.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73202</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct uppr extremity w/o&amp;w/dye</ENT>
              <ENT>1.22</ENT>
              <ENT>0.41</ENT>
              <ENT>0.41</ENT>
              <ENT>0.06</ENT>
              <ENT>1.69</ENT>
              <ENT>1.69</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73202</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct uppr extremity w/o&amp;w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>7.43</ENT>
              <ENT>N/A</ENT>
              <ENT>0.32</ENT>
              <ENT>7.75</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73206</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct angio upr extrm w/o&amp;w/dye</ENT>
              <ENT>1.81</ENT>
              <ENT>11.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.38</ENT>
              <ENT>13.76</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73206</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct angio upr extrm w/o&amp;w/dye</ENT>
              <ENT>1.81</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>0.06</ENT>
              <ENT>2.48</ENT>
              <ENT>2.48</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73206</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct angio upr extrm w/o&amp;w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>10.97</ENT>
              <ENT>N/A</ENT>
              <ENT>0.32</ENT>
              <ENT>11.29</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73218</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri upper extremity w/o dye</ENT>
              <ENT>1.35</ENT>
              <ENT>11.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>13.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73218</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri upper extremity w/o dye</ENT>
              <ENT>1.35</ENT>
              <ENT>0.45</ENT>
              <ENT>0.45</ENT>
              <ENT>0.04</ENT>
              <ENT>1.84</ENT>
              <ENT>1.84</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73218</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri upper extremity w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.32</ENT>
              <ENT>11.53</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73219</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri upper extremity w/dye</ENT>
              <ENT>1.62</ENT>
              <ENT>13.99</ENT>
              <ENT>N/A</ENT>
              <ENT>0.44</ENT>
              <ENT>16.05</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73219</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri upper extremity w/dye</ENT>
              <ENT>1.62</ENT>
              <ENT>0.55</ENT>
              <ENT>0.55</ENT>
              <ENT>0.05</ENT>
              <ENT>2.22</ENT>
              <ENT>2.22</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73219</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri upper extremity w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>13.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.39</ENT>
              <ENT>13.83</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri uppr extremity w/o&amp;w/dye</ENT>
              <ENT>2.15</ENT>
              <ENT>25.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.78</ENT>
              <ENT>28.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73220</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri uppr extremity w/o&amp;w/dye</ENT>
              <ENT>2.15</ENT>
              <ENT>0.73</ENT>
              <ENT>0.73</ENT>
              <ENT>0.08</ENT>
              <ENT>2.96</ENT>
              <ENT>2.96</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73220</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri uppr extremity w/o&amp;w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>24.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.70</ENT>
              <ENT>25.59</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73221</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri joint upr extrem w/o dye</ENT>
              <ENT>1.35</ENT>
              <ENT>11.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>13.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73221</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri joint upr extrem w/o dye</ENT>
              <ENT>1.35</ENT>
              <ENT>0.46</ENT>
              <ENT>0.46</ENT>
              <ENT>0.04</ENT>
              <ENT>1.85</ENT>
              <ENT>1.85</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73221</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri joint upr extrem w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.32</ENT>
              <ENT>11.53</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73222</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri joint upr extrem w/dye</ENT>
              <ENT>1.62</ENT>
              <ENT>13.99</ENT>
              <ENT>N/A</ENT>
              <ENT>0.44</ENT>
              <ENT>16.05</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73222</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri joint upr extrem w/dye</ENT>
              <ENT>1.62</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>0.05</ENT>
              <ENT>2.21</ENT>
              <ENT>2.21</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73222</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri joint upr extrem w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>13.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.39</ENT>
              <ENT>13.83</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73223</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri joint upr extr w/o&amp;w/dye</ENT>
              <ENT>2.15</ENT>
              <ENT>25.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.77</ENT>
              <ENT>28.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73223</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri joint upr extr w/o&amp;w/dye</ENT>
              <ENT>2.15</ENT>
              <ENT>0.73</ENT>
              <ENT>0.73</ENT>
              <ENT>0.07</ENT>
              <ENT>2.95</ENT>
              <ENT>2.95</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73223</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri joint upr extr w/o&amp;w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>24.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.70</ENT>
              <ENT>25.59</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73225</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Mr angio upr extr w/o&amp;w/dye</ENT>
              <ENT>1.73</ENT>
              <ENT>11.88</ENT>
              <ENT>N/A</ENT>
              <ENT>0.57</ENT>
              <ENT>14.18</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73225</ENT>
              <ENT>26</ENT>
              <ENT>N</ENT>
              <ENT>Mr angio upr extr w/o&amp;w/dye</ENT>
              <ENT>1.73</ENT>
              <ENT>0.67</ENT>
              <ENT>0.67</ENT>
              <ENT>0.08</ENT>
              <ENT>2.48</ENT>
              <ENT>2.48</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49182"/>
              <ENT I="01">73225</ENT>
              <ENT>TC</ENT>
              <ENT>N</ENT>
              <ENT>Mr angio upr extr w/o&amp;w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>11.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of hip</ENT>
              <ENT>0.17</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73500</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of hip</ENT>
              <ENT>0.17</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73500</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of hip</ENT>
              <ENT>0.00</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of hip</ENT>
              <ENT>0.21</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73510</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of hip</ENT>
              <ENT>0.21</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.02</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73510</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of hip</ENT>
              <ENT>0.00</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of hips</ENT>
              <ENT>0.26</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73520</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of hips</ENT>
              <ENT>0.26</ENT>
              <ENT>0.09</ENT>
              <ENT>0.09</ENT>
              <ENT>0.02</ENT>
              <ENT>0.37</ENT>
              <ENT>0.37</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73520</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of hips</ENT>
              <ENT>0.00</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73525</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of hip</ENT>
              <ENT>0.54</ENT>
              <ENT>2.28</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>2.95</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73525</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of hip</ENT>
              <ENT>0.54</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.03</ENT>
              <ENT>0.75</ENT>
              <ENT>0.75</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73525</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of hip</ENT>
              <ENT>0.00</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.20</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of hip</ENT>
              <ENT>0.29</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73530</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of hip</ENT>
              <ENT>0.29</ENT>
              <ENT>0.10</ENT>
              <ENT>0.10</ENT>
              <ENT>0.01</ENT>
              <ENT>0.40</ENT>
              <ENT>0.40</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73530</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of hip</ENT>
              <ENT>0.00</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73540</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of pelvis &amp; hips</ENT>
              <ENT>0.20</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73540</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of pelvis &amp; hips</ENT>
              <ENT>0.20</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.02</ENT>
              <ENT>0.29</ENT>
              <ENT>0.29</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73540</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of pelvis &amp; hips</ENT>
              <ENT>0.00</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73542</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam, sacroiliac joint</ENT>
              <ENT>0.59</ENT>
              <ENT>2.26</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>2.98</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73542</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam, sacroiliac joint</ENT>
              <ENT>0.59</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.03</ENT>
              <ENT>0.78</ENT>
              <ENT>0.78</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73542</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam, sacroiliac joint</ENT>
              <ENT>0.00</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.20</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73550</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of thigh</ENT>
              <ENT>0.17</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73550</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of thigh</ENT>
              <ENT>0.17</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73550</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of thigh</ENT>
              <ENT>0.00</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73560</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of knee, 1 or 2</ENT>
              <ENT>0.17</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73560</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of knee, 1 or 2</ENT>
              <ENT>0.17</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.02</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73560</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of knee, 1 or 2</ENT>
              <ENT>0.00</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73562</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of knee, 3</ENT>
              <ENT>0.18</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73562</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of knee, 3</ENT>
              <ENT>0.18</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.02</ENT>
              <ENT>0.26</ENT>
              <ENT>0.26</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73562</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of knee, 3</ENT>
              <ENT>0.00</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73564</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam, knee, 4 or more</ENT>
              <ENT>0.22</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73564</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam, knee, 4 or more</ENT>
              <ENT>0.22</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>0.02</ENT>
              <ENT>0.32</ENT>
              <ENT>0.32</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73564</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam, knee, 4 or more</ENT>
              <ENT>0.00</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73565</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of knees</ENT>
              <ENT>0.17</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73565</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of knees</ENT>
              <ENT>0.17</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.02</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73565</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of knees</ENT>
              <ENT>0.00</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73580</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of knee joint</ENT>
              <ENT>0.54</ENT>
              <ENT>2.80</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73580</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of knee joint</ENT>
              <ENT>0.54</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.03</ENT>
              <ENT>0.75</ENT>
              <ENT>0.75</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73580</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of knee joint</ENT>
              <ENT>0.00</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73590</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of lower leg</ENT>
              <ENT>0.17</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73590</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of lower leg</ENT>
              <ENT>0.17</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73590</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of lower leg</ENT>
              <ENT>0.00</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73592</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of leg, infant</ENT>
              <ENT>0.16</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73592</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of leg, infant</ENT>
              <ENT>0.16</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73592</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of leg, infant</ENT>
              <ENT>0.00</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of ankle</ENT>
              <ENT>0.16</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73600</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of ankle</ENT>
              <ENT>0.16</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73600</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of ankle</ENT>
              <ENT>0.00</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73610</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of ankle</ENT>
              <ENT>0.17</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49183"/>
              <ENT I="01">73610</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of ankle</ENT>
              <ENT>0.17</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73610</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of ankle</ENT>
              <ENT>0.00</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73615</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of ankle</ENT>
              <ENT>0.54</ENT>
              <ENT>2.29</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>2.96</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73615</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of ankle</ENT>
              <ENT>0.54</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.03</ENT>
              <ENT>0.76</ENT>
              <ENT>0.76</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73615</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of ankle</ENT>
              <ENT>0.00</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.20</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73620</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of foot</ENT>
              <ENT>0.16</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73620</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of foot</ENT>
              <ENT>0.16</ENT>
              <ENT>0.05</ENT>
              <ENT>0.05</ENT>
              <ENT>0.01</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73620</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of foot</ENT>
              <ENT>0.00</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73630</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of foot</ENT>
              <ENT>0.17</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73630</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of foot</ENT>
              <ENT>0.17</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73630</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of foot</ENT>
              <ENT>0.00</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73650</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of heel</ENT>
              <ENT>0.16</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73650</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of heel</ENT>
              <ENT>0.16</ENT>
              <ENT>0.05</ENT>
              <ENT>0.05</ENT>
              <ENT>0.01</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73650</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of heel</ENT>
              <ENT>0.00</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73660</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of toe(s)</ENT>
              <ENT>0.13</ENT>
              <ENT>0.46</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73660</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of toe(s)</ENT>
              <ENT>0.13</ENT>
              <ENT>0.04</ENT>
              <ENT>0.04</ENT>
              <ENT>0.01</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73660</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of toe(s)</ENT>
              <ENT>0.00</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct lower extremity w/o dye</ENT>
              <ENT>1.09</ENT>
              <ENT>5.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.26</ENT>
              <ENT>6.68</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73700</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct lower extremity w/o dye</ENT>
              <ENT>1.09</ENT>
              <ENT>0.36</ENT>
              <ENT>0.36</ENT>
              <ENT>0.05</ENT>
              <ENT>1.50</ENT>
              <ENT>1.50</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73700</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct lower extremity w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>4.96</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>5.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73701</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct lower extremity w/dye</ENT>
              <ENT>1.16</ENT>
              <ENT>6.30</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73701</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct lower extremity w/dye</ENT>
              <ENT>1.16</ENT>
              <ENT>0.39</ENT>
              <ENT>0.39</ENT>
              <ENT>0.05</ENT>
              <ENT>1.60</ENT>
              <ENT>1.60</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73701</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct lower extremity w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>5.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.26</ENT>
              <ENT>6.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73702</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct lwr extremity w/o&amp;w/dye</ENT>
              <ENT>1.22</ENT>
              <ENT>7.84</ENT>
              <ENT>N/A</ENT>
              <ENT>0.37</ENT>
              <ENT>9.43</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73702</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct lwr extremity w/o&amp;w/dye</ENT>
              <ENT>1.22</ENT>
              <ENT>0.41</ENT>
              <ENT>0.41</ENT>
              <ENT>0.05</ENT>
              <ENT>1.68</ENT>
              <ENT>1.68</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73702</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct lwr extremity w/o&amp;w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>7.43</ENT>
              <ENT>N/A</ENT>
              <ENT>0.32</ENT>
              <ENT>7.75</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73706</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct angio lwr extr w/o&amp;w/dye</ENT>
              <ENT>1.90</ENT>
              <ENT>11.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.38</ENT>
              <ENT>13.88</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73706</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct angio lwr extr w/o&amp;w/dye</ENT>
              <ENT>1.90</ENT>
              <ENT>0.64</ENT>
              <ENT>0.64</ENT>
              <ENT>0.06</ENT>
              <ENT>2.60</ENT>
              <ENT>2.60</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73706</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct angio lwr extr w/o&amp;w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>10.97</ENT>
              <ENT>N/A</ENT>
              <ENT>0.32</ENT>
              <ENT>11.29</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73718</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri lower extremity w/o dye</ENT>
              <ENT>1.35</ENT>
              <ENT>11.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>13.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73718</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri lower extremity w/o dye</ENT>
              <ENT>1.35</ENT>
              <ENT>0.45</ENT>
              <ENT>0.45</ENT>
              <ENT>0.04</ENT>
              <ENT>1.84</ENT>
              <ENT>1.84</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73718</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri lower extremity w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.32</ENT>
              <ENT>11.53</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73719</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri lower extremity w/dye</ENT>
              <ENT>1.62</ENT>
              <ENT>13.99</ENT>
              <ENT>N/A</ENT>
              <ENT>0.44</ENT>
              <ENT>16.05</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73719</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri lower extremity w/dye</ENT>
              <ENT>1.62</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>0.05</ENT>
              <ENT>2.21</ENT>
              <ENT>2.21</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73719</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri lower extremity w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>13.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.39</ENT>
              <ENT>13.83</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73720</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri lwr extremity w/o&amp;w/dye</ENT>
              <ENT>2.15</ENT>
              <ENT>25.61</ENT>
              <ENT>N/A</ENT>
              <ENT>0.78</ENT>
              <ENT>28.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73720</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri lwr extremity w/o&amp;w/dye</ENT>
              <ENT>2.15</ENT>
              <ENT>0.72</ENT>
              <ENT>0.72</ENT>
              <ENT>0.08</ENT>
              <ENT>2.95</ENT>
              <ENT>2.95</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73720</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri lwr extremity w/o&amp;w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>24.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.70</ENT>
              <ENT>25.59</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73721</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri jnt of lwr extre w/o dye</ENT>
              <ENT>1.35</ENT>
              <ENT>11.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>13.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73721</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri jnt of lwr extre w/o dye</ENT>
              <ENT>1.35</ENT>
              <ENT>0.46</ENT>
              <ENT>0.46</ENT>
              <ENT>0.04</ENT>
              <ENT>1.85</ENT>
              <ENT>1.85</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73721</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri jnt of lwr extre w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.32</ENT>
              <ENT>11.53</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73722</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri joint of lwr extr w/dye</ENT>
              <ENT>1.62</ENT>
              <ENT>13.99</ENT>
              <ENT>N/A</ENT>
              <ENT>0.45</ENT>
              <ENT>16.06</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73722</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri joint of lwr extr w/dye</ENT>
              <ENT>1.62</ENT>
              <ENT>0.55</ENT>
              <ENT>0.55</ENT>
              <ENT>0.06</ENT>
              <ENT>2.23</ENT>
              <ENT>2.23</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73722</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri joint of lwr extr w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>13.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.39</ENT>
              <ENT>13.83</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73723</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri joint lwr extr w/o&amp;w/dye</ENT>
              <ENT>2.15</ENT>
              <ENT>25.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.77</ENT>
              <ENT>28.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73723</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri joint lwr extr w/o&amp;w/dye</ENT>
              <ENT>2.15</ENT>
              <ENT>0.73</ENT>
              <ENT>0.73</ENT>
              <ENT>0.07</ENT>
              <ENT>2.95</ENT>
              <ENT>2.95</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73723</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri joint lwr extr w/o&amp;w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>24.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.70</ENT>
              <ENT>25.59</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73725</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Mr ang lwr ext w or w/o dye</ENT>
              <ENT>1.82</ENT>
              <ENT>11.82</ENT>
              <ENT>N/A</ENT>
              <ENT>0.57</ENT>
              <ENT>14.21</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">73725</ENT>
              <ENT>26</ENT>
              <ENT>R</ENT>
              <ENT>Mr ang lwr ext w or w/o dye</ENT>
              <ENT>1.82</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>0.08</ENT>
              <ENT>2.51</ENT>
              <ENT>2.51</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49184"/>
              <ENT I="01">73725</ENT>
              <ENT>TC</ENT>
              <ENT>R</ENT>
              <ENT>Mr ang lwr ext w or w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>11.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of abdomen</ENT>
              <ENT>0.18</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74000</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of abdomen</ENT>
              <ENT>0.18</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74000</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of abdomen</ENT>
              <ENT>0.00</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of abdomen</ENT>
              <ENT>0.23</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.92</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74010</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of abdomen</ENT>
              <ENT>0.23</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>0.01</ENT>
              <ENT>0.32</ENT>
              <ENT>0.32</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74010</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of abdomen</ENT>
              <ENT>0.00</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of abdomen</ENT>
              <ENT>0.27</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74020</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of abdomen</ENT>
              <ENT>0.27</ENT>
              <ENT>0.09</ENT>
              <ENT>0.09</ENT>
              <ENT>0.01</ENT>
              <ENT>0.37</ENT>
              <ENT>0.37</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74020</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of abdomen</ENT>
              <ENT>0.00</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74022</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam series, abdomen</ENT>
              <ENT>0.32</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.21</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74022</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam series, abdomen</ENT>
              <ENT>0.32</ENT>
              <ENT>0.11</ENT>
              <ENT>0.11</ENT>
              <ENT>0.01</ENT>
              <ENT>0.44</ENT>
              <ENT>0.44</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74022</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam series, abdomen</ENT>
              <ENT>0.00</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct abdomen w/o dye</ENT>
              <ENT>1.19</ENT>
              <ENT>6.06</ENT>
              <ENT>N/A</ENT>
              <ENT>0.30</ENT>
              <ENT>7.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74150</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct abdomen w/o dye</ENT>
              <ENT>1.19</ENT>
              <ENT>0.40</ENT>
              <ENT>0.40</ENT>
              <ENT>0.05</ENT>
              <ENT>1.64</ENT>
              <ENT>1.64</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74150</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct abdomen w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>5.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.25</ENT>
              <ENT>5.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74160</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct abdomen w/dye</ENT>
              <ENT>1.27</ENT>
              <ENT>7.27</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>8.90</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74160</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct abdomen w/dye</ENT>
              <ENT>1.27</ENT>
              <ENT>0.42</ENT>
              <ENT>0.42</ENT>
              <ENT>0.06</ENT>
              <ENT>1.75</ENT>
              <ENT>1.75</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74160</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct abdomen w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>6.85</ENT>
              <ENT>N/A</ENT>
              <ENT>0.30</ENT>
              <ENT>7.15</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74170</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct abdomen w/o&amp;w/dye</ENT>
              <ENT>1.40</ENT>
              <ENT>8.96</ENT>
              <ENT>N/A</ENT>
              <ENT>0.42</ENT>
              <ENT>10.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74170</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct abdomen w/o&amp;w/dye</ENT>
              <ENT>1.40</ENT>
              <ENT>0.47</ENT>
              <ENT>0.47</ENT>
              <ENT>0.06</ENT>
              <ENT>1.93</ENT>
              <ENT>1.93</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74170</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct abdomen w/o&amp;w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>8.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>8.85</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74175</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct angio abdom w/o&amp;w/dye</ENT>
              <ENT>1.90</ENT>
              <ENT>12.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.38</ENT>
              <ENT>14.95</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74175</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct angio abdom w/o&amp;w/dye</ENT>
              <ENT>1.90</ENT>
              <ENT>0.64</ENT>
              <ENT>0.64</ENT>
              <ENT>0.06</ENT>
              <ENT>2.60</ENT>
              <ENT>2.60</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74175</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct angio abdom w/o&amp;w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>12.03</ENT>
              <ENT>N/A</ENT>
              <ENT>0.32</ENT>
              <ENT>12.35</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74181</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri abdomen w/o dye</ENT>
              <ENT>1.46</ENT>
              <ENT>11.70</ENT>
              <ENT>N/A</ENT>
              <ENT>0.43</ENT>
              <ENT>13.59</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74181</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri abdomen w/o dye</ENT>
              <ENT>1.46</ENT>
              <ENT>0.49</ENT>
              <ENT>0.49</ENT>
              <ENT>0.06</ENT>
              <ENT>2.01</ENT>
              <ENT>2.01</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74181</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri abdomen w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.37</ENT>
              <ENT>11.58</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74182</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri abdomen w/dye</ENT>
              <ENT>1.73</ENT>
              <ENT>14.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>16.24</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74182</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri abdomen w/dye</ENT>
              <ENT>1.73</ENT>
              <ENT>0.58</ENT>
              <ENT>0.58</ENT>
              <ENT>0.06</ENT>
              <ENT>2.37</ENT>
              <ENT>2.37</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74182</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri abdomen w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>13.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.43</ENT>
              <ENT>13.87</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74183</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri abdomen w/o&amp;w/dye</ENT>
              <ENT>2.26</ENT>
              <ENT>25.65</ENT>
              <ENT>N/A</ENT>
              <ENT>0.84</ENT>
              <ENT>28.75</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74183</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri abdomen w/o&amp;w/dye</ENT>
              <ENT>2.26</ENT>
              <ENT>0.76</ENT>
              <ENT>0.76</ENT>
              <ENT>0.08</ENT>
              <ENT>3.10</ENT>
              <ENT>3.10</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74183</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri abdomen w/o&amp;w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>24.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.76</ENT>
              <ENT>25.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74185</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Mri angio, abdom w or w/o dy</ENT>
              <ENT>1.80</ENT>
              <ENT>11.81</ENT>
              <ENT>N/A</ENT>
              <ENT>0.57</ENT>
              <ENT>14.18</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74185</ENT>
              <ENT>26</ENT>
              <ENT>R</ENT>
              <ENT>Mri angio, abdom w or w/o dy</ENT>
              <ENT>1.80</ENT>
              <ENT>0.60</ENT>
              <ENT>0.60</ENT>
              <ENT>0.08</ENT>
              <ENT>2.48</ENT>
              <ENT>2.48</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74185</ENT>
              <ENT>TC</ENT>
              <ENT>R</ENT>
              <ENT>Mri angio, abdom w or w/o dy</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>11.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74190</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of peritoneum</ENT>
              <ENT>0.48</ENT>
              <ENT>1.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>2.03</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74190</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of peritoneum</ENT>
              <ENT>0.48</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.02</ENT>
              <ENT>0.66</ENT>
              <ENT>0.66</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74190</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of peritoneum</ENT>
              <ENT>0.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74210</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrst x-ray exam of throat</ENT>
              <ENT>0.36</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74210</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrst x-ray exam of throat</ENT>
              <ENT>0.36</ENT>
              <ENT>0.12</ENT>
              <ENT>0.12</ENT>
              <ENT>0.02</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74210</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrst x-ray exam of throat</ENT>
              <ENT>0.00</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray, esophagus</ENT>
              <ENT>0.46</ENT>
              <ENT>1.34</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.87</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74220</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray, esophagus</ENT>
              <ENT>0.46</ENT>
              <ENT>0.15</ENT>
              <ENT>0.15</ENT>
              <ENT>0.02</ENT>
              <ENT>0.63</ENT>
              <ENT>0.63</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74220</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray, esophagus</ENT>
              <ENT>0.00</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74230</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cine/vid x-ray, throat/esoph</ENT>
              <ENT>0.53</ENT>
              <ENT>1.48</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>2.09</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74230</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cine/vid x-ray, throat/esoph</ENT>
              <ENT>0.53</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.02</ENT>
              <ENT>0.73</ENT>
              <ENT>0.73</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74230</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cine/vid x-ray, throat/esoph</ENT>
              <ENT>0.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49185"/>
              <ENT I="01">74235</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove esophagus obstruction</ENT>
              <ENT>1.19</ENT>
              <ENT>3.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>4.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74235</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Remove esophagus obstruction</ENT>
              <ENT>1.19</ENT>
              <ENT>0.40</ENT>
              <ENT>0.40</ENT>
              <ENT>0.05</ENT>
              <ENT>1.64</ENT>
              <ENT>1.64</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74235</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Remove esophagus obstruction</ENT>
              <ENT>0.00</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74240</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam, upper gi tract</ENT>
              <ENT>0.69</ENT>
              <ENT>1.69</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.48</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74240</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam, upper gi tract</ENT>
              <ENT>0.69</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.03</ENT>
              <ENT>0.95</ENT>
              <ENT>0.95</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74240</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam, upper gi tract</ENT>
              <ENT>0.00</ENT>
              <ENT>1.46</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.53</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74241</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam, upper gi tract</ENT>
              <ENT>0.69</ENT>
              <ENT>1.72</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.51</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74241</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam, upper gi tract</ENT>
              <ENT>0.69</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.03</ENT>
              <ENT>0.95</ENT>
              <ENT>0.95</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74241</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam, upper gi tract</ENT>
              <ENT>0.00</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.56</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74245</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam, upper gi tract</ENT>
              <ENT>0.91</ENT>
              <ENT>2.68</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74245</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam, upper gi tract</ENT>
              <ENT>0.91</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>0.04</ENT>
              <ENT>1.25</ENT>
              <ENT>1.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74245</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam, upper gi tract</ENT>
              <ENT>0.00</ENT>
              <ENT>2.38</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74246</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrst x-ray uppr gi tract</ENT>
              <ENT>0.69</ENT>
              <ENT>1.87</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.67</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74246</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrst x-ray uppr gi tract</ENT>
              <ENT>0.69</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.03</ENT>
              <ENT>0.95</ENT>
              <ENT>0.95</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74246</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrst x-ray uppr gi tract</ENT>
              <ENT>0.00</ENT>
              <ENT>1.64</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.72</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74247</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrst x-ray uppr gi tract</ENT>
              <ENT>0.69</ENT>
              <ENT>1.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.72</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74247</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrst x-ray uppr gi tract</ENT>
              <ENT>0.69</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.03</ENT>
              <ENT>0.95</ENT>
              <ENT>0.95</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74247</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrst x-ray uppr gi tract</ENT>
              <ENT>0.00</ENT>
              <ENT>1.68</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74249</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrst x-ray uppr gi tract</ENT>
              <ENT>0.91</ENT>
              <ENT>2.88</ENT>
              <ENT>N/A</ENT>
              <ENT>0.16</ENT>
              <ENT>3.95</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74249</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrst x-ray uppr gi tract</ENT>
              <ENT>0.91</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>0.04</ENT>
              <ENT>1.25</ENT>
              <ENT>1.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74249</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrst x-ray uppr gi tract</ENT>
              <ENT>0.00</ENT>
              <ENT>2.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.69</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of small bowel</ENT>
              <ENT>0.47</ENT>
              <ENT>1.46</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>2.01</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74250</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of small bowel</ENT>
              <ENT>0.47</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.02</ENT>
              <ENT>0.65</ENT>
              <ENT>0.65</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74250</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of small bowel</ENT>
              <ENT>0.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74251</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of small bowel</ENT>
              <ENT>0.69</ENT>
              <ENT>1.54</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.32</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74251</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of small bowel</ENT>
              <ENT>0.69</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.03</ENT>
              <ENT>0.95</ENT>
              <ENT>0.95</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74251</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of small bowel</ENT>
              <ENT>0.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74260</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of small bowel</ENT>
              <ENT>0.50</ENT>
              <ENT>1.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.25</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74260</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of small bowel</ENT>
              <ENT>0.50</ENT>
              <ENT>0.17</ENT>
              <ENT>0.17</ENT>
              <ENT>0.02</ENT>
              <ENT>0.69</ENT>
              <ENT>0.69</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74260</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of small bowel</ENT>
              <ENT>0.00</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.56</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74270</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray exam of colon</ENT>
              <ENT>0.69</ENT>
              <ENT>1.93</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74270</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray exam of colon</ENT>
              <ENT>0.69</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.03</ENT>
              <ENT>0.95</ENT>
              <ENT>0.95</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74270</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray exam of colon</ENT>
              <ENT>0.00</ENT>
              <ENT>1.70</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.79</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74280</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray exam of colon</ENT>
              <ENT>0.99</ENT>
              <ENT>2.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74280</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray exam of colon</ENT>
              <ENT>0.99</ENT>
              <ENT>0.33</ENT>
              <ENT>0.33</ENT>
              <ENT>0.04</ENT>
              <ENT>1.36</ENT>
              <ENT>1.36</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74280</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray exam of colon</ENT>
              <ENT>0.00</ENT>
              <ENT>2.23</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.34</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74283</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray exam of colon</ENT>
              <ENT>2.02</ENT>
              <ENT>3.24</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>5.47</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74283</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray exam of colon</ENT>
              <ENT>2.02</ENT>
              <ENT>0.68</ENT>
              <ENT>0.68</ENT>
              <ENT>0.09</ENT>
              <ENT>2.79</ENT>
              <ENT>2.79</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74283</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray exam of colon</ENT>
              <ENT>0.00</ENT>
              <ENT>2.56</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.68</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74290</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray, gallbladder</ENT>
              <ENT>0.32</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.21</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74290</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray, gallbladder</ENT>
              <ENT>0.32</ENT>
              <ENT>0.11</ENT>
              <ENT>0.11</ENT>
              <ENT>0.01</ENT>
              <ENT>0.44</ENT>
              <ENT>0.44</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74290</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray, gallbladder</ENT>
              <ENT>0.00</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74291</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-rays, gallbladder</ENT>
              <ENT>0.20</ENT>
              <ENT>0.48</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74291</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-rays, gallbladder</ENT>
              <ENT>0.20</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.28</ENT>
              <ENT>0.28</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74291</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-rays, gallbladder</ENT>
              <ENT>0.00</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74300</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>X-ray bile ducts/pancreas</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74300</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray bile ducts/pancreas</ENT>
              <ENT>0.36</ENT>
              <ENT>0.12</ENT>
              <ENT>0.12</ENT>
              <ENT>0.02</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74300</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>X-ray bile ducts/pancreas</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74301</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>X-rays at surgery add-on</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74301</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-rays at surgery add-on</ENT>
              <ENT>0.21</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.29</ENT>
              <ENT>0.29</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74301</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>X-rays at surgery add-on</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49186"/>
              <ENT I="01">74305</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray bile ducts/pancreas</ENT>
              <ENT>0.42</ENT>
              <ENT>0.92</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.40</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74305</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray bile ducts/pancreas</ENT>
              <ENT>0.42</ENT>
              <ENT>0.14</ENT>
              <ENT>0.14</ENT>
              <ENT>0.02</ENT>
              <ENT>0.58</ENT>
              <ENT>0.58</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74305</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray bile ducts/pancreas</ENT>
              <ENT>0.00</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of bile ducts</ENT>
              <ENT>0.54</ENT>
              <ENT>3.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.16</ENT>
              <ENT>4.03</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74320</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of bile ducts</ENT>
              <ENT>0.54</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.02</ENT>
              <ENT>0.74</ENT>
              <ENT>0.74</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74320</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray of bile ducts</ENT>
              <ENT>0.00</ENT>
              <ENT>3.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.29</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74327</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray bile stone removal</ENT>
              <ENT>0.70</ENT>
              <ENT>1.99</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.81</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74327</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray bile stone removal</ENT>
              <ENT>0.70</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.03</ENT>
              <ENT>0.96</ENT>
              <ENT>0.96</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74327</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray bile stone removal</ENT>
              <ENT>0.00</ENT>
              <ENT>1.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.85</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74328</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray bile duct endoscopy</ENT>
              <ENT>0.70</ENT>
              <ENT>3.39</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>4.26</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74328</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray bile duct endoscopy</ENT>
              <ENT>0.70</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>0.03</ENT>
              <ENT>0.97</ENT>
              <ENT>0.97</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74328</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray bile duct endoscopy</ENT>
              <ENT>0.00</ENT>
              <ENT>3.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.29</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74329</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray for pancreas endoscopy</ENT>
              <ENT>0.70</ENT>
              <ENT>3.39</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>4.26</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74329</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray for pancreas endoscopy</ENT>
              <ENT>0.70</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.03</ENT>
              <ENT>0.96</ENT>
              <ENT>0.96</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74329</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray for pancreas endoscopy</ENT>
              <ENT>0.00</ENT>
              <ENT>3.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.29</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74330</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray bile/panc endoscopy</ENT>
              <ENT>0.90</ENT>
              <ENT>3.45</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.53</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74330</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray bile/panc endoscopy</ENT>
              <ENT>0.90</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>0.04</ENT>
              <ENT>1.24</ENT>
              <ENT>1.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74330</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray bile/panc endoscopy</ENT>
              <ENT>0.00</ENT>
              <ENT>3.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.29</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74340</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray guide for GI tube</ENT>
              <ENT>0.54</ENT>
              <ENT>2.80</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.48</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74340</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray guide for GI tube</ENT>
              <ENT>0.54</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.02</ENT>
              <ENT>0.74</ENT>
              <ENT>0.74</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74340</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray guide for GI tube</ENT>
              <ENT>0.00</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74350</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray guide, stomach tube</ENT>
              <ENT>0.76</ENT>
              <ENT>3.41</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>4.34</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74350</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray guide, stomach tube</ENT>
              <ENT>0.76</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.03</ENT>
              <ENT>1.04</ENT>
              <ENT>1.04</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74350</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray guide, stomach tube</ENT>
              <ENT>0.00</ENT>
              <ENT>3.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.29</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74355</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray guide, intestinal tube</ENT>
              <ENT>0.76</ENT>
              <ENT>2.87</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74355</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray guide, intestinal tube</ENT>
              <ENT>0.76</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.03</ENT>
              <ENT>1.04</ENT>
              <ENT>1.04</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74355</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray guide, intestinal tube</ENT>
              <ENT>0.00</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74360</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray guide, GI dilation</ENT>
              <ENT>0.54</ENT>
              <ENT>3.34</ENT>
              <ENT>N/A</ENT>
              <ENT>0.16</ENT>
              <ENT>4.04</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74360</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray guide, GI dilation</ENT>
              <ENT>0.54</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.02</ENT>
              <ENT>0.75</ENT>
              <ENT>0.75</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74360</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray guide, GI dilation</ENT>
              <ENT>0.00</ENT>
              <ENT>3.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.29</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74363</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray, bile duct dilation</ENT>
              <ENT>0.88</ENT>
              <ENT>6.39</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.58</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74363</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray, bile duct dilation</ENT>
              <ENT>0.88</ENT>
              <ENT>0.29</ENT>
              <ENT>0.29</ENT>
              <ENT>0.04</ENT>
              <ENT>1.21</ENT>
              <ENT>1.21</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74363</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray, bile duct dilation</ENT>
              <ENT>0.00</ENT>
              <ENT>6.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.27</ENT>
              <ENT>6.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrst x-ray, urinary tract</ENT>
              <ENT>0.49</ENT>
              <ENT>1.85</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.45</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74400</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrst x-ray, urinary tract</ENT>
              <ENT>0.49</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.02</ENT>
              <ENT>0.67</ENT>
              <ENT>0.67</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74400</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrst x-ray, urinary tract</ENT>
              <ENT>0.00</ENT>
              <ENT>1.68</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74410</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrst x-ray, urinary tract</ENT>
              <ENT>0.49</ENT>
              <ENT>2.12</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.72</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74410</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrst x-ray, urinary tract</ENT>
              <ENT>0.49</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.02</ENT>
              <ENT>0.67</ENT>
              <ENT>0.67</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74410</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrst x-ray, urinary tract</ENT>
              <ENT>0.00</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.04</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74415</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrst x-ray, urinary tract</ENT>
              <ENT>0.49</ENT>
              <ENT>2.28</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.89</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74415</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrst x-ray, urinary tract</ENT>
              <ENT>0.49</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.02</ENT>
              <ENT>0.67</ENT>
              <ENT>0.67</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74415</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrst x-ray, urinary tract</ENT>
              <ENT>0.00</ENT>
              <ENT>2.12</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.22</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrst x-ray, urinary tract</ENT>
              <ENT>0.36</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.24</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74420</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrst x-ray, urinary tract</ENT>
              <ENT>0.36</ENT>
              <ENT>0.12</ENT>
              <ENT>0.12</ENT>
              <ENT>0.02</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74420</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrst x-ray, urinary tract</ENT>
              <ENT>0.00</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74425</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrst x-ray, urinary tract</ENT>
              <ENT>0.36</ENT>
              <ENT>1.43</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.87</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74425</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrst x-ray, urinary tract</ENT>
              <ENT>0.36</ENT>
              <ENT>0.12</ENT>
              <ENT>0.12</ENT>
              <ENT>0.02</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74425</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrst x-ray, urinary tract</ENT>
              <ENT>0.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74430</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray, bladder</ENT>
              <ENT>0.32</ENT>
              <ENT>1.16</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74430</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray, bladder</ENT>
              <ENT>0.32</ENT>
              <ENT>0.11</ENT>
              <ENT>0.11</ENT>
              <ENT>0.02</ENT>
              <ENT>0.45</ENT>
              <ENT>0.45</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74430</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray, bladder</ENT>
              <ENT>0.00</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74440</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray, male genital tract</ENT>
              <ENT>0.38</ENT>
              <ENT>1.26</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74440</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray, male genital tract</ENT>
              <ENT>0.38</ENT>
              <ENT>0.12</ENT>
              <ENT>0.12</ENT>
              <ENT>0.02</ENT>
              <ENT>0.52</ENT>
              <ENT>0.52</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74440</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray, male genital tract</ENT>
              <ENT>0.00</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74445</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of penis</ENT>
              <ENT>1.14</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.75</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74445</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of penis</ENT>
              <ENT>1.14</ENT>
              <ENT>0.38</ENT>
              <ENT>0.38</ENT>
              <ENT>0.05</ENT>
              <ENT>1.57</ENT>
              <ENT>1.57</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74445</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of penis</ENT>
              <ENT>0.00</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray, urethra/bladder</ENT>
              <ENT>0.33</ENT>
              <ENT>1.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.99</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74450</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray, urethra/bladder</ENT>
              <ENT>0.33</ENT>
              <ENT>0.11</ENT>
              <ENT>0.11</ENT>
              <ENT>0.02</ENT>
              <ENT>0.46</ENT>
              <ENT>0.46</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74450</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray, urethra/bladder</ENT>
              <ENT>0.00</ENT>
              <ENT>1.46</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.53</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49187"/>
              <ENT I="01">74455</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray, urethra/bladder</ENT>
              <ENT>0.33</ENT>
              <ENT>1.69</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.12</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74455</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray, urethra/bladder</ENT>
              <ENT>0.33</ENT>
              <ENT>0.11</ENT>
              <ENT>0.11</ENT>
              <ENT>0.02</ENT>
              <ENT>0.46</ENT>
              <ENT>0.46</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74455</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray, urethra/bladder</ENT>
              <ENT>0.00</ENT>
              <ENT>1.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.66</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74470</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of kidney lesion</ENT>
              <ENT>0.54</ENT>
              <ENT>1.43</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>2.05</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74470</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of kidney lesion</ENT>
              <ENT>0.54</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.02</ENT>
              <ENT>0.74</ENT>
              <ENT>0.74</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74470</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of kidney lesion</ENT>
              <ENT>0.00</ENT>
              <ENT>1.25</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74475</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray control, cath insert</ENT>
              <ENT>0.54</ENT>
              <ENT>4.25</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>4.99</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74475</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray control, cath insert</ENT>
              <ENT>0.54</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.02</ENT>
              <ENT>0.74</ENT>
              <ENT>0.74</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74475</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray control, cath insert</ENT>
              <ENT>0.00</ENT>
              <ENT>4.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.25</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74480</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray control, cath insert</ENT>
              <ENT>0.54</ENT>
              <ENT>4.25</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>4.99</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74480</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray control, cath insert</ENT>
              <ENT>0.54</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.02</ENT>
              <ENT>0.74</ENT>
              <ENT>0.74</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74480</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray control, cath insert</ENT>
              <ENT>0.00</ENT>
              <ENT>4.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.25</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74485</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray guide, GU dilation</ENT>
              <ENT>0.54</ENT>
              <ENT>3.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>4.04</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74485</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray guide, GU dilation</ENT>
              <ENT>0.54</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.03</ENT>
              <ENT>0.75</ENT>
              <ENT>0.75</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74485</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray guide, GU dilation</ENT>
              <ENT>0.00</ENT>
              <ENT>3.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.29</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74710</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray measurement of pelvis</ENT>
              <ENT>0.34</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.58</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74710</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray measurement of pelvis</ENT>
              <ENT>0.34</ENT>
              <ENT>0.11</ENT>
              <ENT>0.11</ENT>
              <ENT>0.02</ENT>
              <ENT>0.47</ENT>
              <ENT>0.47</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74710</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray measurement of pelvis</ENT>
              <ENT>0.00</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74740</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray, female genital tract</ENT>
              <ENT>0.38</ENT>
              <ENT>1.43</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.89</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74740</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray, female genital tract</ENT>
              <ENT>0.38</ENT>
              <ENT>0.13</ENT>
              <ENT>0.13</ENT>
              <ENT>0.02</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74740</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray, female genital tract</ENT>
              <ENT>0.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74742</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray, fallopian tube</ENT>
              <ENT>0.61</ENT>
              <ENT>3.36</ENT>
              <ENT>N/A</ENT>
              <ENT>0.16</ENT>
              <ENT>4.13</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74742</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray, fallopian tube</ENT>
              <ENT>0.61</ENT>
              <ENT>0.21</ENT>
              <ENT>0.21</ENT>
              <ENT>0.02</ENT>
              <ENT>0.84</ENT>
              <ENT>0.84</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74742</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray, fallopian tube</ENT>
              <ENT>0.00</ENT>
              <ENT>3.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.29</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74775</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of perineum</ENT>
              <ENT>0.62</ENT>
              <ENT>1.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.39</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74775</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of perineum</ENT>
              <ENT>0.62</ENT>
              <ENT>0.21</ENT>
              <ENT>0.21</ENT>
              <ENT>0.03</ENT>
              <ENT>0.86</ENT>
              <ENT>0.86</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">74775</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of perineum</ENT>
              <ENT>0.00</ENT>
              <ENT>1.46</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.53</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75552</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Heart mri for morph w/o dye</ENT>
              <ENT>1.60</ENT>
              <ENT>11.75</ENT>
              <ENT>N/A</ENT>
              <ENT>0.56</ENT>
              <ENT>13.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75552</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Heart mri for morph w/o dye</ENT>
              <ENT>1.60</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>0.07</ENT>
              <ENT>2.21</ENT>
              <ENT>2.21</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75552</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Heart mri for morph w/o dye</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>11.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75553</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Heart mri for morph w/dye</ENT>
              <ENT>2.00</ENT>
              <ENT>11.88</ENT>
              <ENT>N/A</ENT>
              <ENT>0.58</ENT>
              <ENT>14.46</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75553</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Heart mri for morph w/dye</ENT>
              <ENT>2.00</ENT>
              <ENT>0.67</ENT>
              <ENT>0.67</ENT>
              <ENT>0.09</ENT>
              <ENT>2.76</ENT>
              <ENT>2.76</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75553</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Heart mri for morph w/dye</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>11.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75554</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cardiac MRI/function</ENT>
              <ENT>1.83</ENT>
              <ENT>11.87</ENT>
              <ENT>N/A</ENT>
              <ENT>0.56</ENT>
              <ENT>14.26</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75554</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cardiac MRI/function</ENT>
              <ENT>1.83</ENT>
              <ENT>0.66</ENT>
              <ENT>0.66</ENT>
              <ENT>0.07</ENT>
              <ENT>2.56</ENT>
              <ENT>2.56</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75554</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cardiac MRI/function</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>11.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75555</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cardiac MRI/limited study</ENT>
              <ENT>1.74</ENT>
              <ENT>11.86</ENT>
              <ENT>N/A</ENT>
              <ENT>0.56</ENT>
              <ENT>14.16</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75555</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cardiac MRI/limited study</ENT>
              <ENT>1.74</ENT>
              <ENT>0.65</ENT>
              <ENT>0.65</ENT>
              <ENT>0.07</ENT>
              <ENT>2.46</ENT>
              <ENT>2.46</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75555</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cardiac MRI/limited study</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>11.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray exam of aorta</ENT>
              <ENT>0.49</ENT>
              <ENT>12.79</ENT>
              <ENT>N/A</ENT>
              <ENT>0.56</ENT>
              <ENT>13.84</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75600</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray exam of aorta</ENT>
              <ENT>0.49</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.02</ENT>
              <ENT>0.70</ENT>
              <ENT>0.70</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75600</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray exam of aorta</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray exam of aorta</ENT>
              <ENT>1.14</ENT>
              <ENT>13.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.59</ENT>
              <ENT>14.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75605</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray exam of aorta</ENT>
              <ENT>1.14</ENT>
              <ENT>0.41</ENT>
              <ENT>0.41</ENT>
              <ENT>0.05</ENT>
              <ENT>1.60</ENT>
              <ENT>1.60</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75605</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray exam of aorta</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75625</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast x-ray exam of aorta</ENT>
              <ENT>1.14</ENT>
              <ENT>12.99</ENT>
              <ENT>N/A</ENT>
              <ENT>0.59</ENT>
              <ENT>14.72</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75625</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray exam of aorta</ENT>
              <ENT>1.14</ENT>
              <ENT>0.39</ENT>
              <ENT>0.39</ENT>
              <ENT>0.05</ENT>
              <ENT>1.58</ENT>
              <ENT>1.58</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75625</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast x-ray exam of aorta</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49188"/>
              <ENT I="01">75630</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray aorta, leg arteries</ENT>
              <ENT>1.79</ENT>
              <ENT>13.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.65</ENT>
              <ENT>16.20</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75630</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray aorta, leg arteries</ENT>
              <ENT>1.79</ENT>
              <ENT>0.63</ENT>
              <ENT>0.63</ENT>
              <ENT>0.08</ENT>
              <ENT>2.50</ENT>
              <ENT>2.50</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75630</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray aorta, leg arteries</ENT>
              <ENT>0.00</ENT>
              <ENT>13.13</ENT>
              <ENT>N/A</ENT>
              <ENT>0.57</ENT>
              <ENT>13.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75635</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct angio abdominal arteries</ENT>
              <ENT>2.40</ENT>
              <ENT>16.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.41</ENT>
              <ENT>19.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75635</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct angio abdominal arteries</ENT>
              <ENT>2.40</ENT>
              <ENT>0.81</ENT>
              <ENT>0.81</ENT>
              <ENT>0.09</ENT>
              <ENT>3.30</ENT>
              <ENT>3.30</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75635</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct angio abdominal arteries</ENT>
              <ENT>0.00</ENT>
              <ENT>15.92</ENT>
              <ENT>N/A</ENT>
              <ENT>0.32</ENT>
              <ENT>16.24</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75650</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery x-rays, head &amp; neck</ENT>
              <ENT>1.49</ENT>
              <ENT>13.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.61</ENT>
              <ENT>15.20</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75650</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, head &amp; neck</ENT>
              <ENT>1.49</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>0.07</ENT>
              <ENT>2.06</ENT>
              <ENT>2.06</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75650</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, head &amp; neck</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75658</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery x-rays, arm</ENT>
              <ENT>1.31</ENT>
              <ENT>13.08</ENT>
              <ENT>N/A</ENT>
              <ENT>0.60</ENT>
              <ENT>14.99</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75658</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, arm</ENT>
              <ENT>1.31</ENT>
              <ENT>0.48</ENT>
              <ENT>0.48</ENT>
              <ENT>0.06</ENT>
              <ENT>1.85</ENT>
              <ENT>1.85</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75658</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, arm</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75660</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery x-rays, head &amp; neck</ENT>
              <ENT>1.31</ENT>
              <ENT>13.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.60</ENT>
              <ENT>14.96</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75660</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, head &amp; neck</ENT>
              <ENT>1.31</ENT>
              <ENT>0.45</ENT>
              <ENT>0.45</ENT>
              <ENT>0.06</ENT>
              <ENT>1.82</ENT>
              <ENT>1.82</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75660</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, head &amp; neck</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75662</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery x-rays, head &amp; neck</ENT>
              <ENT>1.66</ENT>
              <ENT>13.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.62</ENT>
              <ENT>15.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75662</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, head &amp; neck</ENT>
              <ENT>1.66</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>0.08</ENT>
              <ENT>2.35</ENT>
              <ENT>2.35</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75662</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, head &amp; neck</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75665</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery x-rays, head &amp; neck</ENT>
              <ENT>1.31</ENT>
              <ENT>13.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.61</ENT>
              <ENT>14.97</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75665</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, head &amp; neck</ENT>
              <ENT>1.31</ENT>
              <ENT>0.45</ENT>
              <ENT>0.45</ENT>
              <ENT>0.07</ENT>
              <ENT>1.83</ENT>
              <ENT>1.83</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75665</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, head &amp; neck</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75671</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery x-rays, head &amp; neck</ENT>
              <ENT>1.66</ENT>
              <ENT>13.16</ENT>
              <ENT>N/A</ENT>
              <ENT>0.62</ENT>
              <ENT>15.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75671</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, head &amp; neck</ENT>
              <ENT>1.66</ENT>
              <ENT>0.56</ENT>
              <ENT>0.56</ENT>
              <ENT>0.08</ENT>
              <ENT>2.30</ENT>
              <ENT>2.30</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75671</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, head &amp; neck</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75676</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery x-rays, neck</ENT>
              <ENT>1.31</ENT>
              <ENT>13.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.61</ENT>
              <ENT>14.97</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75676</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, neck</ENT>
              <ENT>1.31</ENT>
              <ENT>0.45</ENT>
              <ENT>0.45</ENT>
              <ENT>0.07</ENT>
              <ENT>1.83</ENT>
              <ENT>1.83</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75676</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, neck</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75680</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery x-rays, neck</ENT>
              <ENT>1.66</ENT>
              <ENT>13.16</ENT>
              <ENT>N/A</ENT>
              <ENT>0.62</ENT>
              <ENT>15.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75680</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, neck</ENT>
              <ENT>1.66</ENT>
              <ENT>0.56</ENT>
              <ENT>0.56</ENT>
              <ENT>0.08</ENT>
              <ENT>2.30</ENT>
              <ENT>2.30</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75680</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, neck</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75685</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery x-rays, spine</ENT>
              <ENT>1.31</ENT>
              <ENT>13.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.60</ENT>
              <ENT>14.96</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75685</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, spine</ENT>
              <ENT>1.31</ENT>
              <ENT>0.44</ENT>
              <ENT>0.44</ENT>
              <ENT>0.06</ENT>
              <ENT>1.81</ENT>
              <ENT>1.81</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75685</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, spine</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75705</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery x-rays, spine</ENT>
              <ENT>2.18</ENT>
              <ENT>13.35</ENT>
              <ENT>N/A</ENT>
              <ENT>0.65</ENT>
              <ENT>16.18</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75705</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, spine</ENT>
              <ENT>2.18</ENT>
              <ENT>0.75</ENT>
              <ENT>0.75</ENT>
              <ENT>0.11</ENT>
              <ENT>3.04</ENT>
              <ENT>3.04</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75705</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, spine</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75710</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery x-rays, arm/leg</ENT>
              <ENT>1.14</ENT>
              <ENT>13.00</ENT>
              <ENT>N/A</ENT>
              <ENT>0.60</ENT>
              <ENT>14.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75710</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, arm/leg</ENT>
              <ENT>1.14</ENT>
              <ENT>0.39</ENT>
              <ENT>0.39</ENT>
              <ENT>0.06</ENT>
              <ENT>1.59</ENT>
              <ENT>1.59</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75710</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, arm/leg</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75716</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery x-rays, arms/legs</ENT>
              <ENT>1.31</ENT>
              <ENT>13.04</ENT>
              <ENT>N/A</ENT>
              <ENT>0.60</ENT>
              <ENT>14.95</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75716</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, arms/legs</ENT>
              <ENT>1.31</ENT>
              <ENT>0.44</ENT>
              <ENT>0.44</ENT>
              <ENT>0.06</ENT>
              <ENT>1.81</ENT>
              <ENT>1.81</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75716</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, arms/legs</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75722</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery x-rays, kidney</ENT>
              <ENT>1.14</ENT>
              <ENT>13.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.59</ENT>
              <ENT>14.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75722</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, kidney</ENT>
              <ENT>1.14</ENT>
              <ENT>0.41</ENT>
              <ENT>0.41</ENT>
              <ENT>0.05</ENT>
              <ENT>1.60</ENT>
              <ENT>1.60</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75722</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, kidney</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75724</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery x-rays, kidneys</ENT>
              <ENT>1.49</ENT>
              <ENT>13.17</ENT>
              <ENT>N/A</ENT>
              <ENT>0.59</ENT>
              <ENT>15.25</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75724</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, kidneys</ENT>
              <ENT>1.49</ENT>
              <ENT>0.57</ENT>
              <ENT>0.57</ENT>
              <ENT>0.05</ENT>
              <ENT>2.11</ENT>
              <ENT>2.11</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75724</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, kidneys</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75726</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery x-rays, abdomen</ENT>
              <ENT>1.14</ENT>
              <ENT>12.98</ENT>
              <ENT>N/A</ENT>
              <ENT>0.59</ENT>
              <ENT>14.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75726</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, abdomen</ENT>
              <ENT>1.14</ENT>
              <ENT>0.38</ENT>
              <ENT>0.38</ENT>
              <ENT>0.05</ENT>
              <ENT>1.57</ENT>
              <ENT>1.57</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75726</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, abdomen</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75731</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery x-rays, adrenal gland</ENT>
              <ENT>1.14</ENT>
              <ENT>12.98</ENT>
              <ENT>N/A</ENT>
              <ENT>0.59</ENT>
              <ENT>14.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75731</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, adrenal gland</ENT>
              <ENT>1.14</ENT>
              <ENT>0.38</ENT>
              <ENT>0.38</ENT>
              <ENT>0.05</ENT>
              <ENT>1.57</ENT>
              <ENT>1.57</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75731</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, adrenal gland</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75733</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery x-rays, adrenals</ENT>
              <ENT>1.31</ENT>
              <ENT>13.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.60</ENT>
              <ENT>14.96</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75733</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, adrenals</ENT>
              <ENT>1.31</ENT>
              <ENT>0.45</ENT>
              <ENT>0.45</ENT>
              <ENT>0.06</ENT>
              <ENT>1.82</ENT>
              <ENT>1.82</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75733</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, adrenals</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75736</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery x-rays, pelvis</ENT>
              <ENT>1.14</ENT>
              <ENT>12.99</ENT>
              <ENT>N/A</ENT>
              <ENT>0.59</ENT>
              <ENT>14.72</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75736</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, pelvis</ENT>
              <ENT>1.14</ENT>
              <ENT>0.38</ENT>
              <ENT>0.38</ENT>
              <ENT>0.05</ENT>
              <ENT>1.57</ENT>
              <ENT>1.57</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75736</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, pelvis</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49189"/>
              <ENT I="01">75741</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery x-rays, lung</ENT>
              <ENT>1.31</ENT>
              <ENT>13.04</ENT>
              <ENT>N/A</ENT>
              <ENT>0.60</ENT>
              <ENT>14.95</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75741</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, lung</ENT>
              <ENT>1.31</ENT>
              <ENT>0.44</ENT>
              <ENT>0.44</ENT>
              <ENT>0.06</ENT>
              <ENT>1.81</ENT>
              <ENT>1.81</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75741</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, lung</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75743</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery x-rays, lungs</ENT>
              <ENT>1.66</ENT>
              <ENT>13.16</ENT>
              <ENT>N/A</ENT>
              <ENT>0.61</ENT>
              <ENT>15.43</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75743</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, lungs</ENT>
              <ENT>1.66</ENT>
              <ENT>0.56</ENT>
              <ENT>0.56</ENT>
              <ENT>0.07</ENT>
              <ENT>2.29</ENT>
              <ENT>2.29</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75743</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, lungs</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75746</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery x-rays, lung</ENT>
              <ENT>1.14</ENT>
              <ENT>12.99</ENT>
              <ENT>N/A</ENT>
              <ENT>0.59</ENT>
              <ENT>14.72</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75746</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, lung</ENT>
              <ENT>1.14</ENT>
              <ENT>0.39</ENT>
              <ENT>0.39</ENT>
              <ENT>0.05</ENT>
              <ENT>1.58</ENT>
              <ENT>1.58</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75746</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, lung</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75756</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery x-rays, chest</ENT>
              <ENT>1.14</ENT>
              <ENT>13.06</ENT>
              <ENT>N/A</ENT>
              <ENT>0.58</ENT>
              <ENT>14.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75756</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, chest</ENT>
              <ENT>1.14</ENT>
              <ENT>0.46</ENT>
              <ENT>0.46</ENT>
              <ENT>0.04</ENT>
              <ENT>1.64</ENT>
              <ENT>1.64</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75756</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-rays, chest</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75774</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Artery x-ray, each vessel</ENT>
              <ENT>0.36</ENT>
              <ENT>12.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.56</ENT>
              <ENT>13.65</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75774</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-ray, each vessel</ENT>
              <ENT>0.36</ENT>
              <ENT>0.13</ENT>
              <ENT>0.13</ENT>
              <ENT>0.02</ENT>
              <ENT>0.51</ENT>
              <ENT>0.51</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75774</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Artery x-ray, each vessel</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75790</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Visualize A-V shunt</ENT>
              <ENT>1.84</ENT>
              <ENT>1.97</ENT>
              <ENT>N/A</ENT>
              <ENT>0.16</ENT>
              <ENT>3.97</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75790</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Visualize A-V shunt</ENT>
              <ENT>1.84</ENT>
              <ENT>0.62</ENT>
              <ENT>0.62</ENT>
              <ENT>0.09</ENT>
              <ENT>2.55</ENT>
              <ENT>2.55</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75790</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Visualize A-V shunt</ENT>
              <ENT>0.00</ENT>
              <ENT>1.35</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.42</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75801</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lymph vessel x-ray, arm/leg</ENT>
              <ENT>0.81</ENT>
              <ENT>5.69</ENT>
              <ENT>N/A</ENT>
              <ENT>0.29</ENT>
              <ENT>6.79</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75801</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Lymph vessel x-ray, arm/leg</ENT>
              <ENT>0.81</ENT>
              <ENT>0.27</ENT>
              <ENT>0.27</ENT>
              <ENT>0.05</ENT>
              <ENT>1.13</ENT>
              <ENT>1.13</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75801</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Lymph vessel x-ray, arm/leg</ENT>
              <ENT>0.00</ENT>
              <ENT>5.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.24</ENT>
              <ENT>5.66</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75803</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lymph vessel x-ray,arms/legs</ENT>
              <ENT>1.17</ENT>
              <ENT>5.81</ENT>
              <ENT>N/A</ENT>
              <ENT>0.29</ENT>
              <ENT>7.27</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75803</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Lymph vessel x-ray,arms/legs</ENT>
              <ENT>1.17</ENT>
              <ENT>0.39</ENT>
              <ENT>0.39</ENT>
              <ENT>0.05</ENT>
              <ENT>1.61</ENT>
              <ENT>1.61</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75803</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Lymph vessel x-ray,arms/legs</ENT>
              <ENT>0.00</ENT>
              <ENT>5.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.24</ENT>
              <ENT>5.66</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75805</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lymph vessel x-ray, trunk</ENT>
              <ENT>0.81</ENT>
              <ENT>6.38</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.50</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75805</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Lymph vessel x-ray, trunk</ENT>
              <ENT>0.81</ENT>
              <ENT>0.27</ENT>
              <ENT>0.27</ENT>
              <ENT>0.04</ENT>
              <ENT>1.12</ENT>
              <ENT>1.12</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75805</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Lymph vessel x-ray, trunk</ENT>
              <ENT>0.00</ENT>
              <ENT>6.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.27</ENT>
              <ENT>6.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75807</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lymph vessel x-ray, trunk</ENT>
              <ENT>1.17</ENT>
              <ENT>6.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.32</ENT>
              <ENT>7.98</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75807</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Lymph vessel x-ray, trunk</ENT>
              <ENT>1.17</ENT>
              <ENT>0.39</ENT>
              <ENT>0.39</ENT>
              <ENT>0.05</ENT>
              <ENT>1.61</ENT>
              <ENT>1.61</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75807</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Lymph vessel x-ray, trunk</ENT>
              <ENT>0.00</ENT>
              <ENT>6.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.27</ENT>
              <ENT>6.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75809</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nonvascular shunt, x-ray</ENT>
              <ENT>0.47</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.47</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75809</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Nonvascular shunt, x-ray</ENT>
              <ENT>0.47</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.02</ENT>
              <ENT>0.65</ENT>
              <ENT>0.65</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75809</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Nonvascular shunt, x-ray</ENT>
              <ENT>0.00</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75810</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vein x-ray, spleen/liver</ENT>
              <ENT>1.14</ENT>
              <ENT>12.98</ENT>
              <ENT>N/A</ENT>
              <ENT>0.60</ENT>
              <ENT>14.72</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75810</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, spleen/liver</ENT>
              <ENT>1.14</ENT>
              <ENT>0.38</ENT>
              <ENT>0.38</ENT>
              <ENT>0.06</ENT>
              <ENT>1.58</ENT>
              <ENT>1.58</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75810</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, spleen/liver</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75820</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vein x-ray, arm/leg</ENT>
              <ENT>0.70</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.96</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75820</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, arm/leg</ENT>
              <ENT>0.70</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.03</ENT>
              <ENT>0.96</ENT>
              <ENT>0.96</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75820</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, arm/leg</ENT>
              <ENT>0.00</ENT>
              <ENT>0.95</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.00</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75822</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vein x-ray, arms/legs</ENT>
              <ENT>1.06</ENT>
              <ENT>1.83</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>3.01</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75822</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, arms/legs</ENT>
              <ENT>1.06</ENT>
              <ENT>0.35</ENT>
              <ENT>0.35</ENT>
              <ENT>0.05</ENT>
              <ENT>1.46</ENT>
              <ENT>1.46</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75822</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, arms/legs</ENT>
              <ENT>0.00</ENT>
              <ENT>1.48</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75825</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vein x-ray, trunk</ENT>
              <ENT>1.14</ENT>
              <ENT>12.98</ENT>
              <ENT>N/A</ENT>
              <ENT>0.60</ENT>
              <ENT>14.72</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75825</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, trunk</ENT>
              <ENT>1.14</ENT>
              <ENT>0.38</ENT>
              <ENT>0.38</ENT>
              <ENT>0.06</ENT>
              <ENT>1.58</ENT>
              <ENT>1.58</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75825</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, trunk</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75827</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vein x-ray, chest</ENT>
              <ENT>1.14</ENT>
              <ENT>12.98</ENT>
              <ENT>N/A</ENT>
              <ENT>0.59</ENT>
              <ENT>14.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75827</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, chest</ENT>
              <ENT>1.14</ENT>
              <ENT>0.38</ENT>
              <ENT>0.38</ENT>
              <ENT>0.05</ENT>
              <ENT>1.57</ENT>
              <ENT>1.57</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75827</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, chest</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75831</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vein x-ray, kidney</ENT>
              <ENT>1.14</ENT>
              <ENT>12.98</ENT>
              <ENT>N/A</ENT>
              <ENT>0.59</ENT>
              <ENT>14.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75831</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, kidney</ENT>
              <ENT>1.14</ENT>
              <ENT>0.38</ENT>
              <ENT>0.38</ENT>
              <ENT>0.05</ENT>
              <ENT>1.57</ENT>
              <ENT>1.57</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75831</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, kidney</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75833</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vein x-ray, kidneys</ENT>
              <ENT>1.49</ENT>
              <ENT>13.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.61</ENT>
              <ENT>15.20</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75833</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, kidneys</ENT>
              <ENT>1.49</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>0.07</ENT>
              <ENT>2.06</ENT>
              <ENT>2.06</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75833</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, kidneys</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75840</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vein x-ray, adrenal gland</ENT>
              <ENT>1.14</ENT>
              <ENT>12.99</ENT>
              <ENT>N/A</ENT>
              <ENT>0.61</ENT>
              <ENT>14.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75840</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, adrenal gland</ENT>
              <ENT>1.14</ENT>
              <ENT>0.39</ENT>
              <ENT>0.39</ENT>
              <ENT>0.07</ENT>
              <ENT>1.60</ENT>
              <ENT>1.60</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75840</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, adrenal gland</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75842</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vein x-ray, adrenal glands</ENT>
              <ENT>1.49</ENT>
              <ENT>13.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.61</ENT>
              <ENT>15.20</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75842</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, adrenal glands</ENT>
              <ENT>1.49</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>0.07</ENT>
              <ENT>2.06</ENT>
              <ENT>2.06</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75842</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, adrenal glands</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49190"/>
              <ENT I="01">75860</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vein x-ray, neck</ENT>
              <ENT>1.14</ENT>
              <ENT>13.00</ENT>
              <ENT>N/A</ENT>
              <ENT>0.60</ENT>
              <ENT>14.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75860</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, neck</ENT>
              <ENT>1.14</ENT>
              <ENT>0.40</ENT>
              <ENT>0.40</ENT>
              <ENT>0.06</ENT>
              <ENT>1.60</ENT>
              <ENT>1.60</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75860</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, neck</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75870</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vein x-ray, skull</ENT>
              <ENT>1.14</ENT>
              <ENT>13.00</ENT>
              <ENT>N/A</ENT>
              <ENT>0.60</ENT>
              <ENT>14.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75870</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, skull</ENT>
              <ENT>1.14</ENT>
              <ENT>0.40</ENT>
              <ENT>0.40</ENT>
              <ENT>0.06</ENT>
              <ENT>1.60</ENT>
              <ENT>1.60</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75870</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, skull</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75872</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vein x-ray, skull</ENT>
              <ENT>1.14</ENT>
              <ENT>12.98</ENT>
              <ENT>N/A</ENT>
              <ENT>0.59</ENT>
              <ENT>14.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75872</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, skull</ENT>
              <ENT>1.14</ENT>
              <ENT>0.38</ENT>
              <ENT>0.38</ENT>
              <ENT>0.05</ENT>
              <ENT>1.57</ENT>
              <ENT>1.57</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75872</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, skull</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75880</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vein x-ray, eye socket</ENT>
              <ENT>0.70</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.96</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75880</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, eye socket</ENT>
              <ENT>0.70</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>0.03</ENT>
              <ENT>0.97</ENT>
              <ENT>0.97</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75880</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, eye socket</ENT>
              <ENT>0.00</ENT>
              <ENT>0.95</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.00</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75885</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vein x-ray, liver</ENT>
              <ENT>1.44</ENT>
              <ENT>13.08</ENT>
              <ENT>N/A</ENT>
              <ENT>0.60</ENT>
              <ENT>15.12</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75885</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, liver</ENT>
              <ENT>1.44</ENT>
              <ENT>0.48</ENT>
              <ENT>0.48</ENT>
              <ENT>0.06</ENT>
              <ENT>1.98</ENT>
              <ENT>1.98</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75885</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, liver</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75887</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vein x-ray, liver</ENT>
              <ENT>1.44</ENT>
              <ENT>13.08</ENT>
              <ENT>N/A</ENT>
              <ENT>0.60</ENT>
              <ENT>15.12</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75887</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, liver</ENT>
              <ENT>1.44</ENT>
              <ENT>0.48</ENT>
              <ENT>0.48</ENT>
              <ENT>0.06</ENT>
              <ENT>1.98</ENT>
              <ENT>1.98</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75887</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, liver</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75889</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vein x-ray, liver</ENT>
              <ENT>1.14</ENT>
              <ENT>12.98</ENT>
              <ENT>N/A</ENT>
              <ENT>0.59</ENT>
              <ENT>14.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75889</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, liver</ENT>
              <ENT>1.14</ENT>
              <ENT>0.38</ENT>
              <ENT>0.38</ENT>
              <ENT>0.05</ENT>
              <ENT>1.57</ENT>
              <ENT>1.57</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75889</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, liver</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75891</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vein x-ray, liver</ENT>
              <ENT>1.14</ENT>
              <ENT>12.98</ENT>
              <ENT>N/A</ENT>
              <ENT>0.59</ENT>
              <ENT>14.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75891</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, liver</ENT>
              <ENT>1.14</ENT>
              <ENT>0.38</ENT>
              <ENT>0.38</ENT>
              <ENT>0.05</ENT>
              <ENT>1.57</ENT>
              <ENT>1.57</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75891</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vein x-ray, liver</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75893</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Venous sampling by catheter</ENT>
              <ENT>0.54</ENT>
              <ENT>12.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.56</ENT>
              <ENT>13.88</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75893</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Venous sampling by catheter</ENT>
              <ENT>0.54</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.02</ENT>
              <ENT>0.74</ENT>
              <ENT>0.74</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75893</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Venous sampling by catheter</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75894</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-rays, transcath therapy</ENT>
              <ENT>1.31</ENT>
              <ENT>24.58</ENT>
              <ENT>N/A</ENT>
              <ENT>1.12</ENT>
              <ENT>27.01</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75894</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-rays, transcath therapy</ENT>
              <ENT>1.31</ENT>
              <ENT>0.44</ENT>
              <ENT>0.44</ENT>
              <ENT>0.07</ENT>
              <ENT>1.82</ENT>
              <ENT>1.82</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75894</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-rays, transcath therapy</ENT>
              <ENT>0.00</ENT>
              <ENT>24.14</ENT>
              <ENT>N/A</ENT>
              <ENT>1.05</ENT>
              <ENT>25.19</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75896</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-rays, transcath therapy</ENT>
              <ENT>1.31</ENT>
              <ENT>21.45</ENT>
              <ENT>N/A</ENT>
              <ENT>0.97</ENT>
              <ENT>23.73</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75896</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-rays, transcath therapy</ENT>
              <ENT>1.31</ENT>
              <ENT>0.46</ENT>
              <ENT>0.46</ENT>
              <ENT>0.06</ENT>
              <ENT>1.83</ENT>
              <ENT>1.83</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75896</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-rays, transcath therapy</ENT>
              <ENT>0.00</ENT>
              <ENT>20.99</ENT>
              <ENT>N/A</ENT>
              <ENT>0.91</ENT>
              <ENT>21.90</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75898</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Follow-up angiography</ENT>
              <ENT>1.65</ENT>
              <ENT>1.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>3.39</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75898</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Follow-up angiography</ENT>
              <ENT>1.65</ENT>
              <ENT>0.56</ENT>
              <ENT>0.56</ENT>
              <ENT>0.07</ENT>
              <ENT>2.28</ENT>
              <ENT>2.28</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75898</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Follow-up angiography</ENT>
              <ENT>0.00</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75900</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Arterial catheter exchange</ENT>
              <ENT>0.49</ENT>
              <ENT>21.14</ENT>
              <ENT>N/A</ENT>
              <ENT>0.94</ENT>
              <ENT>22.57</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75900</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Arterial catheter exchange</ENT>
              <ENT>0.49</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.02</ENT>
              <ENT>0.67</ENT>
              <ENT>0.67</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75900</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Arterial catheter exchange</ENT>
              <ENT>0.00</ENT>
              <ENT>20.98</ENT>
              <ENT>N/A</ENT>
              <ENT>0.92</ENT>
              <ENT>21.90</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75901</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove cva device obstruct</ENT>
              <ENT>0.49</ENT>
              <ENT>1.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.71</ENT>
              <ENT>2.67</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75901</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Remove cva device obstruct</ENT>
              <ENT>0.49</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.02</ENT>
              <ENT>0.67</ENT>
              <ENT>0.67</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75901</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Remove cva device obstruct</ENT>
              <ENT>0.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.69</ENT>
              <ENT>2.00</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75902</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Remove cva lumen obstruct</ENT>
              <ENT>0.39</ENT>
              <ENT>1.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.71</ENT>
              <ENT>2.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75902</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Remove cva lumen obstruct</ENT>
              <ENT>0.39</ENT>
              <ENT>0.13</ENT>
              <ENT>0.13</ENT>
              <ENT>0.02</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75902</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Remove cva lumen obstruct</ENT>
              <ENT>0.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.69</ENT>
              <ENT>2.00</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75940</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray placement, vein filter</ENT>
              <ENT>0.54</ENT>
              <ENT>12.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.57</ENT>
              <ENT>13.89</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75940</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray placement, vein filter</ENT>
              <ENT>0.54</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.03</ENT>
              <ENT>0.75</ENT>
              <ENT>0.75</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75940</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray placement, vein filter</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75945</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intravascular us</ENT>
              <ENT>0.40</ENT>
              <ENT>4.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.23</ENT>
              <ENT>5.34</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75945</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Intravascular us</ENT>
              <ENT>0.40</ENT>
              <ENT>0.14</ENT>
              <ENT>0.14</ENT>
              <ENT>0.03</ENT>
              <ENT>0.57</ENT>
              <ENT>0.57</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75945</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Intravascular us</ENT>
              <ENT>0.00</ENT>
              <ENT>4.56</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>4.76</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75946</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intravascular us add-on</ENT>
              <ENT>0.40</ENT>
              <ENT>2.43</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>2.97</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75946</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Intravascular us add-on</ENT>
              <ENT>0.40</ENT>
              <ENT>0.14</ENT>
              <ENT>0.14</ENT>
              <ENT>0.03</ENT>
              <ENT>0.57</ENT>
              <ENT>0.57</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75946</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Intravascular us add-on</ENT>
              <ENT>0.00</ENT>
              <ENT>2.29</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.40</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75952</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Endovasc repair abdom aorta</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49191"/>
              <ENT I="01">75952</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Endovasc repair abdom aorta</ENT>
              <ENT>4.50</ENT>
              <ENT>1.52</ENT>
              <ENT>1.52</ENT>
              <ENT>0.68</ENT>
              <ENT>6.70</ENT>
              <ENT>6.70</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75952</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Endovasc repair abdom aorta</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75953</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Abdom aneurysm endovas rpr</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75953</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Abdom aneurysm endovas rpr</ENT>
              <ENT>1.36</ENT>
              <ENT>0.46</ENT>
              <ENT>0.46</ENT>
              <ENT>0.68</ENT>
              <ENT>2.50</ENT>
              <ENT>2.50</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75953</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Abdom aneurysm endovas rpr</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75954</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Iliac aneurysm endovas rpr</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75954</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Iliac aneurysm endovas rpr</ENT>
              <ENT>1.36</ENT>
              <ENT>0.48</ENT>
              <ENT>0.48</ENT>
              <ENT>0.68</ENT>
              <ENT>2.52</ENT>
              <ENT>2.52</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75954</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Iliac aneurysm endovas rpr</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75960</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transcatheter intro, stent</ENT>
              <ENT>0.82</ENT>
              <ENT>15.19</ENT>
              <ENT>N/A</ENT>
              <ENT>0.68</ENT>
              <ENT>16.69</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75960</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Transcatheter intro, stent</ENT>
              <ENT>0.82</ENT>
              <ENT>0.29</ENT>
              <ENT>0.29</ENT>
              <ENT>0.04</ENT>
              <ENT>1.15</ENT>
              <ENT>1.15</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75960</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Transcatheter intro, stent</ENT>
              <ENT>0.00</ENT>
              <ENT>14.90</ENT>
              <ENT>N/A</ENT>
              <ENT>0.64</ENT>
              <ENT>15.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75961</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Retrieval, broken catheter</ENT>
              <ENT>4.25</ENT>
              <ENT>11.93</ENT>
              <ENT>N/A</ENT>
              <ENT>0.64</ENT>
              <ENT>16.82</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75961</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Retrieval, broken catheter</ENT>
              <ENT>4.25</ENT>
              <ENT>1.43</ENT>
              <ENT>1.43</ENT>
              <ENT>0.18</ENT>
              <ENT>5.86</ENT>
              <ENT>5.86</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75961</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Retrieval, broken catheter</ENT>
              <ENT>0.00</ENT>
              <ENT>10.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.46</ENT>
              <ENT>10.96</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75962</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair arterial blockage</ENT>
              <ENT>0.54</ENT>
              <ENT>15.93</ENT>
              <ENT>N/A</ENT>
              <ENT>0.72</ENT>
              <ENT>17.19</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75962</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Repair arterial blockage</ENT>
              <ENT>0.54</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.03</ENT>
              <ENT>0.76</ENT>
              <ENT>0.76</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75962</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Repair arterial blockage</ENT>
              <ENT>0.00</ENT>
              <ENT>15.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.69</ENT>
              <ENT>16.43</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75964</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair artery blockage, each</ENT>
              <ENT>0.36</ENT>
              <ENT>8.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.38</ENT>
              <ENT>9.26</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75964</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Repair artery blockage, each</ENT>
              <ENT>0.36</ENT>
              <ENT>0.12</ENT>
              <ENT>0.12</ENT>
              <ENT>0.02</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75964</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Repair artery blockage, each</ENT>
              <ENT>0.00</ENT>
              <ENT>8.39</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>8.75</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75966</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair arterial blockage</ENT>
              <ENT>1.31</ENT>
              <ENT>16.22</ENT>
              <ENT>N/A</ENT>
              <ENT>0.75</ENT>
              <ENT>18.28</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75966</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Repair arterial blockage</ENT>
              <ENT>1.31</ENT>
              <ENT>0.47</ENT>
              <ENT>0.47</ENT>
              <ENT>0.06</ENT>
              <ENT>1.84</ENT>
              <ENT>1.84</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75966</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Repair arterial blockage</ENT>
              <ENT>0.00</ENT>
              <ENT>15.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.69</ENT>
              <ENT>16.43</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75968</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair artery blockage, each</ENT>
              <ENT>0.36</ENT>
              <ENT>8.53</ENT>
              <ENT>N/A</ENT>
              <ENT>0.37</ENT>
              <ENT>9.26</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75968</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Repair artery blockage, each</ENT>
              <ENT>0.36</ENT>
              <ENT>0.13</ENT>
              <ENT>0.13</ENT>
              <ENT>0.01</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75968</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Repair artery blockage, each</ENT>
              <ENT>0.00</ENT>
              <ENT>8.39</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>8.75</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75970</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vascular biopsy</ENT>
              <ENT>0.83</ENT>
              <ENT>11.83</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.20</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75970</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vascular biopsy</ENT>
              <ENT>0.83</ENT>
              <ENT>0.29</ENT>
              <ENT>0.29</ENT>
              <ENT>0.04</ENT>
              <ENT>1.16</ENT>
              <ENT>1.16</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75970</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vascular biopsy</ENT>
              <ENT>0.00</ENT>
              <ENT>11.55</ENT>
              <ENT>N/A</ENT>
              <ENT>0.50</ENT>
              <ENT>12.05</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75978</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repair venous blockage</ENT>
              <ENT>0.54</ENT>
              <ENT>15.92</ENT>
              <ENT>N/A</ENT>
              <ENT>0.71</ENT>
              <ENT>17.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75978</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Repair venous blockage</ENT>
              <ENT>0.54</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.02</ENT>
              <ENT>0.74</ENT>
              <ENT>0.74</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75978</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Repair venous blockage</ENT>
              <ENT>0.00</ENT>
              <ENT>15.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.69</ENT>
              <ENT>16.43</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75980</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast xray exam bile duct</ENT>
              <ENT>1.44</ENT>
              <ENT>5.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.30</ENT>
              <ENT>7.63</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75980</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast xray exam bile duct</ENT>
              <ENT>1.44</ENT>
              <ENT>0.48</ENT>
              <ENT>0.48</ENT>
              <ENT>0.06</ENT>
              <ENT>1.98</ENT>
              <ENT>1.98</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75980</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast xray exam bile duct</ENT>
              <ENT>0.00</ENT>
              <ENT>5.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.24</ENT>
              <ENT>5.66</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75982</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast xray exam bile duct</ENT>
              <ENT>1.44</ENT>
              <ENT>6.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.33</ENT>
              <ENT>8.35</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75982</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Contrast xray exam bile duct</ENT>
              <ENT>1.44</ENT>
              <ENT>0.48</ENT>
              <ENT>0.48</ENT>
              <ENT>0.06</ENT>
              <ENT>1.98</ENT>
              <ENT>1.98</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75982</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Contrast xray exam bile duct</ENT>
              <ENT>0.00</ENT>
              <ENT>6.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.27</ENT>
              <ENT>6.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75984</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Xray control catheter change</ENT>
              <ENT>0.72</ENT>
              <ENT>2.19</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>3.03</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75984</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Xray control catheter change</ENT>
              <ENT>0.72</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>0.03</ENT>
              <ENT>0.99</ENT>
              <ENT>0.99</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75984</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Xray control catheter change</ENT>
              <ENT>0.00</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.04</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75989</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Abscess drainage under x-ray</ENT>
              <ENT>1.19</ENT>
              <ENT>3.55</ENT>
              <ENT>N/A</ENT>
              <ENT>0.19</ENT>
              <ENT>4.93</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49192"/>
              <ENT I="01">75989</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Abscess drainage under x-ray</ENT>
              <ENT>1.19</ENT>
              <ENT>0.40</ENT>
              <ENT>0.40</ENT>
              <ENT>0.05</ENT>
              <ENT>1.64</ENT>
              <ENT>1.64</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75989</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Abscess drainage under x-ray</ENT>
              <ENT>0.00</ENT>
              <ENT>3.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.29</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75992</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Atherectomy, x-ray exam</ENT>
              <ENT>0.54</ENT>
              <ENT>15.94</ENT>
              <ENT>N/A</ENT>
              <ENT>0.71</ENT>
              <ENT>17.19</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75992</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Atherectomy, x-ray exam</ENT>
              <ENT>0.54</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.02</ENT>
              <ENT>0.75</ENT>
              <ENT>0.75</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75992</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Atherectomy, x-ray exam</ENT>
              <ENT>0.00</ENT>
              <ENT>15.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.69</ENT>
              <ENT>16.43</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75993</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Atherectomy, x-ray exam</ENT>
              <ENT>0.36</ENT>
              <ENT>8.53</ENT>
              <ENT>N/A</ENT>
              <ENT>0.37</ENT>
              <ENT>9.26</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75993</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Atherectomy, x-ray exam</ENT>
              <ENT>0.36</ENT>
              <ENT>0.14</ENT>
              <ENT>0.14</ENT>
              <ENT>0.01</ENT>
              <ENT>0.51</ENT>
              <ENT>0.51</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75993</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Atherectomy, x-ray exam</ENT>
              <ENT>0.00</ENT>
              <ENT>8.39</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>8.75</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75994</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Atherectomy, x-ray exam</ENT>
              <ENT>1.31</ENT>
              <ENT>16.22</ENT>
              <ENT>N/A</ENT>
              <ENT>0.75</ENT>
              <ENT>18.28</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75994</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Atherectomy, x-ray exam</ENT>
              <ENT>1.31</ENT>
              <ENT>0.47</ENT>
              <ENT>0.47</ENT>
              <ENT>0.06</ENT>
              <ENT>1.84</ENT>
              <ENT>1.84</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75994</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Atherectomy, x-ray exam</ENT>
              <ENT>0.00</ENT>
              <ENT>15.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.69</ENT>
              <ENT>16.43</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75995</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Atherectomy, x-ray exam</ENT>
              <ENT>1.31</ENT>
              <ENT>16.23</ENT>
              <ENT>N/A</ENT>
              <ENT>0.75</ENT>
              <ENT>18.29</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75995</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Atherectomy, x-ray exam</ENT>
              <ENT>1.31</ENT>
              <ENT>0.48</ENT>
              <ENT>0.48</ENT>
              <ENT>0.06</ENT>
              <ENT>1.85</ENT>
              <ENT>1.85</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75995</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Atherectomy, x-ray exam</ENT>
              <ENT>0.00</ENT>
              <ENT>15.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.69</ENT>
              <ENT>16.43</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75996</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Atherectomy, x-ray exam</ENT>
              <ENT>0.36</ENT>
              <ENT>8.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.37</ENT>
              <ENT>9.25</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75996</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Atherectomy, x-ray exam</ENT>
              <ENT>0.36</ENT>
              <ENT>0.12</ENT>
              <ENT>0.12</ENT>
              <ENT>0.01</ENT>
              <ENT>0.49</ENT>
              <ENT>0.49</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">75996</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Atherectomy, x-ray exam</ENT>
              <ENT>0.00</ENT>
              <ENT>8.39</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>8.75</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fluoroscope examination</ENT>
              <ENT>0.17</ENT>
              <ENT>1.36</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76000</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Fluoroscope examination</ENT>
              <ENT>0.17</ENT>
              <ENT>0.05</ENT>
              <ENT>0.05</ENT>
              <ENT>0.01</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76000</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Fluoroscope examination</ENT>
              <ENT>0.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76001</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fluoroscope exam, extensive</ENT>
              <ENT>0.67</ENT>
              <ENT>2.85</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.67</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76001</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Fluoroscope exam, extensive</ENT>
              <ENT>0.67</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.03</ENT>
              <ENT>0.93</ENT>
              <ENT>0.93</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76001</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Fluoroscope exam, extensive</ENT>
              <ENT>0.00</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76003</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Needle localization by x-ray</ENT>
              <ENT>0.54</ENT>
              <ENT>1.48</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.11</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76003</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Needle localization by x-ray</ENT>
              <ENT>0.54</ENT>
              <ENT>0.17</ENT>
              <ENT>0.17</ENT>
              <ENT>0.03</ENT>
              <ENT>0.74</ENT>
              <ENT>0.74</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76003</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Needle localization by x-ray</ENT>
              <ENT>0.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76005</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fluoroguide for spine inject</ENT>
              <ENT>0.60</ENT>
              <ENT>1.46</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.15</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76005</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Fluoroguide for spine inject</ENT>
              <ENT>0.60</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.03</ENT>
              <ENT>0.79</ENT>
              <ENT>0.79</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76005</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Fluoroguide for spine inject</ENT>
              <ENT>0.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76006</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray stress view</ENT>
              <ENT>0.41</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.04</ENT>
              <ENT>0.64</ENT>
              <ENT>0.64</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray, nose to rectum</ENT>
              <ENT>0.18</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76010</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray, nose to rectum</ENT>
              <ENT>0.18</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76010</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray, nose to rectum</ENT>
              <ENT>0.00</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76012</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Percut vertebroplasty fluor</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76012</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Percut vertebroplasty fluor</ENT>
              <ENT>1.31</ENT>
              <ENT>0.48</ENT>
              <ENT>0.48</ENT>
              <ENT>0.23</ENT>
              <ENT>2.02</ENT>
              <ENT>2.02</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76012</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Percut vertebroplasty fluor</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76013</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Percut vertebroplasty, ct</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76013</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Percut vertebroplasty, ct</ENT>
              <ENT>1.38</ENT>
              <ENT>0.49</ENT>
              <ENT>0.49</ENT>
              <ENT>0.48</ENT>
              <ENT>2.35</ENT>
              <ENT>2.35</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76013</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Percut vertebroplasty, ct</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-rays for bone age</ENT>
              <ENT>0.19</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76020</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-rays for bone age</ENT>
              <ENT>0.19</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.26</ENT>
              <ENT>0.26</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76020</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-rays for bone age</ENT>
              <ENT>0.00</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76040</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-rays, bone evaluation</ENT>
              <ENT>0.27</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.22</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76040</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-rays, bone evaluation</ENT>
              <ENT>0.27</ENT>
              <ENT>0.09</ENT>
              <ENT>0.09</ENT>
              <ENT>0.03</ENT>
              <ENT>0.39</ENT>
              <ENT>0.39</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76040</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-rays, bone evaluation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76061</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-rays, bone survey</ENT>
              <ENT>0.45</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.67</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76061</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-rays, bone survey</ENT>
              <ENT>0.45</ENT>
              <ENT>0.15</ENT>
              <ENT>0.15</ENT>
              <ENT>0.02</ENT>
              <ENT>0.62</ENT>
              <ENT>0.62</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76061</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-rays, bone survey</ENT>
              <ENT>0.00</ENT>
              <ENT>1.00</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76062</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-rays, bone survey</ENT>
              <ENT>0.54</ENT>
              <ENT>1.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.25</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76062</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-rays, bone survey</ENT>
              <ENT>0.54</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.02</ENT>
              <ENT>0.74</ENT>
              <ENT>0.74</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76062</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-rays, bone survey</ENT>
              <ENT>0.00</ENT>
              <ENT>1.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76065</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-rays, bone evaluation</ENT>
              <ENT>0.70</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.72</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76065</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-rays, bone evaluation</ENT>
              <ENT>0.70</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>0.01</ENT>
              <ENT>0.95</ENT>
              <ENT>0.95</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76065</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-rays, bone evaluation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76066</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Joint survey, single view</ENT>
              <ENT>0.31</ENT>
              <ENT>1.22</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49193"/>
              <ENT I="01">76066</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Joint survey, single view</ENT>
              <ENT>0.31</ENT>
              <ENT>0.11</ENT>
              <ENT>0.11</ENT>
              <ENT>0.02</ENT>
              <ENT>0.44</ENT>
              <ENT>0.44</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76066</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Joint survey, single view</ENT>
              <ENT>0.00</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.16</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76070</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct bone density, axial</ENT>
              <ENT>0.25</ENT>
              <ENT>3.03</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.42</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76070</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct bone density, axial</ENT>
              <ENT>0.25</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>0.01</ENT>
              <ENT>0.34</ENT>
              <ENT>0.34</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76070</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct bone density, axial</ENT>
              <ENT>0.00</ENT>
              <ENT>2.95</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>3.08</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76071</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ct bone density, peripheral</ENT>
              <ENT>0.22</ENT>
              <ENT>3.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>3.29</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76071</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ct bone density, peripheral</ENT>
              <ENT>0.22</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76071</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ct bone density, peripheral</ENT>
              <ENT>0.00</ENT>
              <ENT>2.95</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>2.99</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76075</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dexa, axial skeleton study</ENT>
              <ENT>0.30</ENT>
              <ENT>3.20</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76075</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Dexa, axial skeleton study</ENT>
              <ENT>0.30</ENT>
              <ENT>0.10</ENT>
              <ENT>0.10</ENT>
              <ENT>0.01</ENT>
              <ENT>0.41</ENT>
              <ENT>0.41</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76075</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Dexa, axial skeleton study</ENT>
              <ENT>0.00</ENT>
              <ENT>3.09</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.23</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76076</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dexa, peripheral study</ENT>
              <ENT>0.22</ENT>
              <ENT>0.83</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76076</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Dexa, peripheral study</ENT>
              <ENT>0.22</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>0.01</ENT>
              <ENT>0.31</ENT>
              <ENT>0.31</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76076</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Dexa, peripheral study</ENT>
              <ENT>0.00</ENT>
              <ENT>0.75</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76078</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiographic absorptiometry</ENT>
              <ENT>0.20</ENT>
              <ENT>0.83</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76078</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Radiographic absorptiometry</ENT>
              <ENT>0.20</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.28</ENT>
              <ENT>0.28</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76078</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Radiographic absorptiometry</ENT>
              <ENT>0.00</ENT>
              <ENT>0.75</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76080</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of fistula</ENT>
              <ENT>0.54</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.84</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76080</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of fistula</ENT>
              <ENT>0.54</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.02</ENT>
              <ENT>0.74</ENT>
              <ENT>0.74</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76080</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of fistula</ENT>
              <ENT>0.00</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76085</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Computer mammogram add-on</ENT>
              <ENT>0.06</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76085</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Computer mammogram add-on</ENT>
              <ENT>0.06</ENT>
              <ENT>0.02</ENT>
              <ENT>0.02</ENT>
              <ENT>0.01</ENT>
              <ENT>0.09</ENT>
              <ENT>0.09</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76085</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Computer mammogram add-on</ENT>
              <ENT>0.00</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76086</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray of mammary duct</ENT>
              <ENT>0.36</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.24</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76086</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray of mammary duct</ENT>
              <ENT>0.36</ENT>
              <ENT>0.12</ENT>
              <ENT>0.12</ENT>
              <ENT>0.02</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76086</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray of mammary duct</ENT>
              <ENT>0.00</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76088</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray of mammary ducts</ENT>
              <ENT>0.45</ENT>
              <ENT>3.82</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.45</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76088</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray of mammary ducts</ENT>
              <ENT>0.45</ENT>
              <ENT>0.15</ENT>
              <ENT>0.15</ENT>
              <ENT>0.02</ENT>
              <ENT>0.62</ENT>
              <ENT>0.62</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76088</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray of mammary ducts</ENT>
              <ENT>0.00</ENT>
              <ENT>3.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.16</ENT>
              <ENT>3.83</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76090</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mammogram, one breast</ENT>
              <ENT>0.70</ENT>
              <ENT>1.29</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>2.07</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76090</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mammogram, one breast</ENT>
              <ENT>0.70</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.03</ENT>
              <ENT>0.96</ENT>
              <ENT>0.96</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76090</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mammogram, one breast</ENT>
              <ENT>0.00</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76091</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mammogram, both breasts</ENT>
              <ENT>0.87</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.56</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76091</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mammogram, both breasts</ENT>
              <ENT>0.87</ENT>
              <ENT>0.29</ENT>
              <ENT>0.29</ENT>
              <ENT>0.03</ENT>
              <ENT>1.19</ENT>
              <ENT>1.19</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76091</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mammogram, both breasts</ENT>
              <ENT>0.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76092</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mammogram, screening</ENT>
              <ENT>0.70</ENT>
              <ENT>1.46</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.25</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76092</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mammogram, screening</ENT>
              <ENT>0.70</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.03</ENT>
              <ENT>0.96</ENT>
              <ENT>0.96</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76092</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mammogram, screening</ENT>
              <ENT>0.00</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.29</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76093</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Magnetic image, breast</ENT>
              <ENT>1.63</ENT>
              <ENT>18.18</ENT>
              <ENT>N/A</ENT>
              <ENT>0.83</ENT>
              <ENT>20.64</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76093</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Magnetic image, breast</ENT>
              <ENT>1.63</ENT>
              <ENT>0.55</ENT>
              <ENT>0.55</ENT>
              <ENT>0.07</ENT>
              <ENT>2.25</ENT>
              <ENT>2.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76093</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Magnetic image, breast</ENT>
              <ENT>0.00</ENT>
              <ENT>17.63</ENT>
              <ENT>N/A</ENT>
              <ENT>0.76</ENT>
              <ENT>18.39</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76094</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Magnetic image, both breasts</ENT>
              <ENT>1.63</ENT>
              <ENT>24.46</ENT>
              <ENT>N/A</ENT>
              <ENT>1.10</ENT>
              <ENT>27.19</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76094</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Magnetic image, both breasts</ENT>
              <ENT>1.63</ENT>
              <ENT>0.55</ENT>
              <ENT>0.55</ENT>
              <ENT>0.07</ENT>
              <ENT>2.25</ENT>
              <ENT>2.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76094</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Magnetic image, both breasts</ENT>
              <ENT>0.00</ENT>
              <ENT>23.92</ENT>
              <ENT>N/A</ENT>
              <ENT>1.03</ENT>
              <ENT>24.95</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76095</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Stereotactic breast biopsy</ENT>
              <ENT>1.59</ENT>
              <ENT>7.70</ENT>
              <ENT>N/A</ENT>
              <ENT>0.40</ENT>
              <ENT>9.69</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76095</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Stereotactic breast biopsy</ENT>
              <ENT>1.59</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>0.09</ENT>
              <ENT>2.22</ENT>
              <ENT>2.22</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76095</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Stereotactic breast biopsy</ENT>
              <ENT>0.00</ENT>
              <ENT>7.17</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.48</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76096</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray of needle wire, breast</ENT>
              <ENT>0.56</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76096</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray of needle wire, breast</ENT>
              <ENT>0.56</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.03</ENT>
              <ENT>0.78</ENT>
              <ENT>0.78</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76096</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray of needle wire, breast</ENT>
              <ENT>0.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49194"/>
              <ENT I="01">76098</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam, breast specimen</ENT>
              <ENT>0.16</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76098</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam, breast specimen</ENT>
              <ENT>0.16</ENT>
              <ENT>0.05</ENT>
              <ENT>0.05</ENT>
              <ENT>0.01</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76098</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam, breast specimen</ENT>
              <ENT>0.00</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam of body section</ENT>
              <ENT>0.58</ENT>
              <ENT>1.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.11</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76100</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of body section</ENT>
              <ENT>0.58</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.03</ENT>
              <ENT>0.80</ENT>
              <ENT>0.80</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76100</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>X-ray exam of body section</ENT>
              <ENT>0.00</ENT>
              <ENT>1.25</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76101</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Complex body section x-ray</ENT>
              <ENT>0.58</ENT>
              <ENT>1.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.30</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76101</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Complex body section x-ray</ENT>
              <ENT>0.58</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.03</ENT>
              <ENT>0.80</ENT>
              <ENT>0.80</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76101</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Complex body section x-ray</ENT>
              <ENT>0.00</ENT>
              <ENT>1.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76102</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Complex body section x-rays</ENT>
              <ENT>0.58</ENT>
              <ENT>1.93</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.63</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76102</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Complex body section x-rays</ENT>
              <ENT>0.58</ENT>
              <ENT>0.20</ENT>
              <ENT>0.20</ENT>
              <ENT>0.03</ENT>
              <ENT>0.81</ENT>
              <ENT>0.81</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76102</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Complex body section x-rays</ENT>
              <ENT>0.00</ENT>
              <ENT>1.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.82</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cine/video x-rays</ENT>
              <ENT>0.38</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.64</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76120</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cine/video x-rays</ENT>
              <ENT>0.38</ENT>
              <ENT>0.13</ENT>
              <ENT>0.13</ENT>
              <ENT>0.02</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76120</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cine/video x-rays</ENT>
              <ENT>0.00</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76125</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cine/video x-rays add-on</ENT>
              <ENT>0.27</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.20</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76125</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cine/video x-rays add-on</ENT>
              <ENT>0.27</ENT>
              <ENT>0.09</ENT>
              <ENT>0.09</ENT>
              <ENT>0.01</ENT>
              <ENT>0.37</ENT>
              <ENT>0.37</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76125</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cine/video x-rays add-on</ENT>
              <ENT>0.00</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76140</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>X-ray consultation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>X-ray exam, dry process</ENT>
              <ENT>0.00</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76350</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Special x-ray contrast study</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76355</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>CAT scan for localization</ENT>
              <ENT>1.21</ENT>
              <ENT>8.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.41</ENT>
              <ENT>10.29</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76355</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>CAT scan for localization</ENT>
              <ENT>1.21</ENT>
              <ENT>0.41</ENT>
              <ENT>0.41</ENT>
              <ENT>0.06</ENT>
              <ENT>1.68</ENT>
              <ENT>1.68</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76355</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>CAT scan for localization</ENT>
              <ENT>0.00</ENT>
              <ENT>8.26</ENT>
              <ENT>N/A</ENT>
              <ENT>0.35</ENT>
              <ENT>8.61</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76360</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>CAT scan for needle biopsy</ENT>
              <ENT>1.16</ENT>
              <ENT>8.65</ENT>
              <ENT>N/A</ENT>
              <ENT>0.40</ENT>
              <ENT>10.21</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76360</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>CAT scan for needle biopsy</ENT>
              <ENT>1.16</ENT>
              <ENT>0.39</ENT>
              <ENT>0.39</ENT>
              <ENT>0.05</ENT>
              <ENT>1.60</ENT>
              <ENT>1.60</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76360</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>CAT scan for needle biopsy</ENT>
              <ENT>0.00</ENT>
              <ENT>8.26</ENT>
              <ENT>N/A</ENT>
              <ENT>0.35</ENT>
              <ENT>8.61</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76362</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cat scan for tissue ablation</ENT>
              <ENT>4.00</ENT>
              <ENT>9.59</ENT>
              <ENT>N/A</ENT>
              <ENT>1.39</ENT>
              <ENT>14.98</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76362</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cat scan for tissue ablation</ENT>
              <ENT>4.00</ENT>
              <ENT>1.33</ENT>
              <ENT>1.33</ENT>
              <ENT>0.18</ENT>
              <ENT>5.51</ENT>
              <ENT>5.51</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76362</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cat scan for tissue ablation</ENT>
              <ENT>0.00</ENT>
              <ENT>8.26</ENT>
              <ENT>N/A</ENT>
              <ENT>1.21</ENT>
              <ENT>9.47</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76370</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>CAT scan for therapy guide</ENT>
              <ENT>0.85</ENT>
              <ENT>3.23</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>4.25</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76370</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>CAT scan for therapy guide</ENT>
              <ENT>0.85</ENT>
              <ENT>0.28</ENT>
              <ENT>0.28</ENT>
              <ENT>0.04</ENT>
              <ENT>1.17</ENT>
              <ENT>1.17</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76370</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>CAT scan for therapy guide</ENT>
              <ENT>0.00</ENT>
              <ENT>2.95</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>3.08</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76375</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>3d/holograph reconstr add-on</ENT>
              <ENT>0.16</ENT>
              <ENT>3.59</ENT>
              <ENT>N/A</ENT>
              <ENT>0.16</ENT>
              <ENT>3.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76375</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>3d/holograph reconstr add-on</ENT>
              <ENT>0.16</ENT>
              <ENT>0.05</ENT>
              <ENT>0.05</ENT>
              <ENT>0.01</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76375</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>3d/holograph reconstr add-on</ENT>
              <ENT>0.00</ENT>
              <ENT>3.54</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.69</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76380</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>CAT scan follow-up study</ENT>
              <ENT>0.98</ENT>
              <ENT>3.83</ENT>
              <ENT>N/A</ENT>
              <ENT>0.19</ENT>
              <ENT>5.00</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76380</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>CAT scan follow-up study</ENT>
              <ENT>0.98</ENT>
              <ENT>0.33</ENT>
              <ENT>0.33</ENT>
              <ENT>0.04</ENT>
              <ENT>1.35</ENT>
              <ENT>1.35</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76380</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>CAT scan follow-up study</ENT>
              <ENT>0.00</ENT>
              <ENT>3.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76390</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Mr spectroscopy</ENT>
              <ENT>1.40</ENT>
              <ENT>11.68</ENT>
              <ENT>N/A</ENT>
              <ENT>0.55</ENT>
              <ENT>13.63</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76390</ENT>
              <ENT>26</ENT>
              <ENT>N</ENT>
              <ENT>Mr spectroscopy</ENT>
              <ENT>1.40</ENT>
              <ENT>0.47</ENT>
              <ENT>0.47</ENT>
              <ENT>0.06</ENT>
              <ENT>1.93</ENT>
              <ENT>1.93</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49195"/>
              <ENT I="01">76390</ENT>
              <ENT>TC</ENT>
              <ENT>N</ENT>
              <ENT>Mr spectroscopy</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>11.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76393</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mr guidance for needle place</ENT>
              <ENT>1.50</ENT>
              <ENT>11.72</ENT>
              <ENT>N/A</ENT>
              <ENT>0.53</ENT>
              <ENT>13.75</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76393</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mr guidance for needle place</ENT>
              <ENT>1.50</ENT>
              <ENT>0.51</ENT>
              <ENT>0.51</ENT>
              <ENT>0.07</ENT>
              <ENT>2.08</ENT>
              <ENT>2.08</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76393</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mr guidance for needle place</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.46</ENT>
              <ENT>11.67</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76394</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mri for tissue ablation</ENT>
              <ENT>4.25</ENT>
              <ENT>12.63</ENT>
              <ENT>N/A</ENT>
              <ENT>1.48</ENT>
              <ENT>18.36</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76394</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Mri for tissue ablation</ENT>
              <ENT>4.25</ENT>
              <ENT>1.42</ENT>
              <ENT>1.42</ENT>
              <ENT>0.19</ENT>
              <ENT>5.86</ENT>
              <ENT>5.86</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76394</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Mri for tissue ablation</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>1.29</ENT>
              <ENT>12.50</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Magnetic image, bone marrow</ENT>
              <ENT>1.60</ENT>
              <ENT>11.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.56</ENT>
              <ENT>13.90</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76400</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Magnetic image, bone marrow</ENT>
              <ENT>1.60</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>0.07</ENT>
              <ENT>2.21</ENT>
              <ENT>2.21</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76400</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Magnetic image, bone marrow</ENT>
              <ENT>0.00</ENT>
              <ENT>11.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>11.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76490</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Us for tissue ablation</ENT>
              <ENT>4.00</ENT>
              <ENT>2.85</ENT>
              <ENT>N/A</ENT>
              <ENT>0.35</ENT>
              <ENT>7.20</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76490</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Us for tissue ablation</ENT>
              <ENT>4.00</ENT>
              <ENT>1.33</ENT>
              <ENT>1.33</ENT>
              <ENT>0.11</ENT>
              <ENT>5.44</ENT>
              <ENT>5.44</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76490</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Us for tissue ablation</ENT>
              <ENT>0.00</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.24</ENT>
              <ENT>1.76</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76496</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Fluoroscopic procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76496</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Fluoroscopic procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76496</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Fluoroscopic procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76497</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Ct procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76497</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Ct procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76497</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Ct procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76498</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Mri procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76498</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Mri procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76498</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Mri procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76499</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Radiographic procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76499</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Radiographic procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76499</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Radiographic procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76506</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo exam of head</ENT>
              <ENT>0.63</ENT>
              <ENT>1.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.40</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76506</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of head</ENT>
              <ENT>0.63</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.03</ENT>
              <ENT>0.91</ENT>
              <ENT>0.91</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76506</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of head</ENT>
              <ENT>0.00</ENT>
              <ENT>1.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76511</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo exam of eye</ENT>
              <ENT>0.94</ENT>
              <ENT>1.12</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>2.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76511</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of eye</ENT>
              <ENT>0.94</ENT>
              <ENT>0.41</ENT>
              <ENT>0.41</ENT>
              <ENT>0.02</ENT>
              <ENT>1.37</ENT>
              <ENT>1.37</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76511</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of eye</ENT>
              <ENT>0.00</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76512</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo exam of eye</ENT>
              <ENT>0.66</ENT>
              <ENT>1.04</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.79</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76512</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of eye</ENT>
              <ENT>0.66</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>0.01</ENT>
              <ENT>0.97</ENT>
              <ENT>0.97</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76512</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of eye</ENT>
              <ENT>0.00</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76513</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo exam of eye, water bath</ENT>
              <ENT>0.66</ENT>
              <ENT>1.12</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.87</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76513</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of eye, water bath</ENT>
              <ENT>0.66</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>0.01</ENT>
              <ENT>0.97</ENT>
              <ENT>0.97</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76513</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of eye, water bath</ENT>
              <ENT>0.00</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76516</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo exam of eye</ENT>
              <ENT>0.54</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.35</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76516</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of eye</ENT>
              <ENT>0.54</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.01</ENT>
              <ENT>0.80</ENT>
              <ENT>0.80</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76516</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of eye</ENT>
              <ENT>0.00</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76519</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo exam of eye</ENT>
              <ENT>0.54</ENT>
              <ENT>0.83</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76519</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of eye</ENT>
              <ENT>0.54</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.01</ENT>
              <ENT>0.80</ENT>
              <ENT>0.80</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76519</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of eye</ENT>
              <ENT>0.00</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76529</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo exam of eye</ENT>
              <ENT>0.57</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.43</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76529</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of eye</ENT>
              <ENT>0.57</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.01</ENT>
              <ENT>0.83</ENT>
              <ENT>0.83</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76529</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of eye</ENT>
              <ENT>0.00</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76536</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Us exam of head and neck</ENT>
              <ENT>0.56</ENT>
              <ENT>1.61</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.26</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76536</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Us exam of head and neck</ENT>
              <ENT>0.56</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.02</ENT>
              <ENT>0.77</ENT>
              <ENT>0.77</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76536</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Us exam of head and neck</ENT>
              <ENT>0.00</ENT>
              <ENT>1.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76604</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Us exam, chest, b-scan</ENT>
              <ENT>0.55</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>2.12</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76604</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Us exam, chest, b-scan</ENT>
              <ENT>0.55</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.02</ENT>
              <ENT>0.75</ENT>
              <ENT>0.75</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76604</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Us exam, chest, b-scan</ENT>
              <ENT>0.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76645</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Us exam, breast(s)</ENT>
              <ENT>0.54</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.85</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76645</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Us exam, breast(s)</ENT>
              <ENT>0.54</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.03</ENT>
              <ENT>0.75</ENT>
              <ENT>0.75</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49196"/>
              <ENT I="01">76645</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Us exam, breast(s)</ENT>
              <ENT>0.00</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Us exam, abdom, complete</ENT>
              <ENT>0.81</ENT>
              <ENT>2.24</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>3.18</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76700</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Us exam, abdom, complete</ENT>
              <ENT>0.81</ENT>
              <ENT>0.27</ENT>
              <ENT>0.27</ENT>
              <ENT>0.04</ENT>
              <ENT>1.12</ENT>
              <ENT>1.12</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76700</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Us exam, abdom, complete</ENT>
              <ENT>0.00</ENT>
              <ENT>1.97</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.06</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76705</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo exam of abdomen</ENT>
              <ENT>0.59</ENT>
              <ENT>1.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.31</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76705</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of abdomen</ENT>
              <ENT>0.59</ENT>
              <ENT>0.20</ENT>
              <ENT>0.20</ENT>
              <ENT>0.03</ENT>
              <ENT>0.82</ENT>
              <ENT>0.82</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76705</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of abdomen</ENT>
              <ENT>0.00</ENT>
              <ENT>1.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76770</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Us exam abdo back wall, comp</ENT>
              <ENT>0.74</ENT>
              <ENT>2.22</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>3.08</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76770</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Us exam abdo back wall, comp</ENT>
              <ENT>0.74</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.03</ENT>
              <ENT>1.02</ENT>
              <ENT>1.02</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76770</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Us exam abdo back wall, comp</ENT>
              <ENT>0.00</ENT>
              <ENT>1.97</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.06</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76775</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Us eam abdo back wall, lim</ENT>
              <ENT>0.58</ENT>
              <ENT>1.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.30</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76775</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Us eam abdo back wall, lim</ENT>
              <ENT>0.58</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.03</ENT>
              <ENT>0.80</ENT>
              <ENT>0.80</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76775</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Us eam abdo back wall, lim</ENT>
              <ENT>0.00</ENT>
              <ENT>1.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76778</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Us exam kidney transplant</ENT>
              <ENT>0.74</ENT>
              <ENT>2.22</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>3.08</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76778</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Us exam kidney transplant</ENT>
              <ENT>0.74</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.03</ENT>
              <ENT>1.02</ENT>
              <ENT>1.02</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76778</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Us exam kidney transplant</ENT>
              <ENT>0.00</ENT>
              <ENT>1.97</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.06</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Us exam, spinal canal</ENT>
              <ENT>1.13</ENT>
              <ENT>1.77</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>3.01</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76800</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Us exam, spinal canal</ENT>
              <ENT>1.13</ENT>
              <ENT>0.35</ENT>
              <ENT>0.35</ENT>
              <ENT>0.04</ENT>
              <ENT>1.52</ENT>
              <ENT>1.52</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76800</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Us exam, spinal canal</ENT>
              <ENT>0.00</ENT>
              <ENT>1.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76801</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ob us &lt; 14 wks, single fetus</ENT>
              <ENT>0.99</ENT>
              <ENT>2.45</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.58</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76801</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ob us &lt; 14 wks, single fetus</ENT>
              <ENT>0.99</ENT>
              <ENT>0.35</ENT>
              <ENT>0.35</ENT>
              <ENT>0.04</ENT>
              <ENT>1.38</ENT>
              <ENT>1.38</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76801</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ob us &lt; 14 wks, single fetus</ENT>
              <ENT>0.00</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.20</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76802</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ob us &lt; 14 wks, addl fetus</ENT>
              <ENT>0.83</ENT>
              <ENT>1.35</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>2.32</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76802</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ob us &lt; 14 wks, addl fetus</ENT>
              <ENT>0.83</ENT>
              <ENT>0.29</ENT>
              <ENT>0.29</ENT>
              <ENT>0.04</ENT>
              <ENT>1.16</ENT>
              <ENT>1.16</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76802</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ob us &lt; 14 wks, addl fetus</ENT>
              <ENT>0.00</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76805</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ob us &gt;/= 14 wks, sngl fetus</ENT>
              <ENT>0.99</ENT>
              <ENT>2.45</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.58</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76805</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ob us &gt;/= 14 wks, sngl fetus</ENT>
              <ENT>0.99</ENT>
              <ENT>0.35</ENT>
              <ENT>0.35</ENT>
              <ENT>0.04</ENT>
              <ENT>1.38</ENT>
              <ENT>1.38</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76805</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ob us &gt;/= 14 wks, sngl fetus</ENT>
              <ENT>0.00</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.20</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76810</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ob us &gt;/= 14 wks, addl fetus</ENT>
              <ENT>0.98</ENT>
              <ENT>1.41</ENT>
              <ENT>N/A</ENT>
              <ENT>0.25</ENT>
              <ENT>2.64</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76810</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ob us &gt;/= 14 wks, addl fetus</ENT>
              <ENT>0.98</ENT>
              <ENT>0.35</ENT>
              <ENT>0.35</ENT>
              <ENT>0.07</ENT>
              <ENT>1.40</ENT>
              <ENT>1.40</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76810</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ob us &gt;/= 14 wks, addl fetus</ENT>
              <ENT>0.00</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76811</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ob us, detailed, sngl fetus</ENT>
              <ENT>1.90</ENT>
              <ENT>4.20</ENT>
              <ENT>N/A</ENT>
              <ENT>0.51</ENT>
              <ENT>6.61</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76811</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ob us, detailed, sngl fetus</ENT>
              <ENT>1.90</ENT>
              <ENT>0.67</ENT>
              <ENT>0.67</ENT>
              <ENT>0.15</ENT>
              <ENT>2.72</ENT>
              <ENT>2.72</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76811</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ob us, detailed, sngl fetus</ENT>
              <ENT>0.00</ENT>
              <ENT>3.53</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>3.89</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76812</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ob us, detailed, addl fetus</ENT>
              <ENT>1.78</ENT>
              <ENT>1.70</ENT>
              <ENT>N/A</ENT>
              <ENT>0.46</ENT>
              <ENT>3.94</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76812</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ob us, detailed, addl fetus</ENT>
              <ENT>1.78</ENT>
              <ENT>0.64</ENT>
              <ENT>0.64</ENT>
              <ENT>0.12</ENT>
              <ENT>2.54</ENT>
              <ENT>2.54</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76812</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ob us, detailed, addl fetus</ENT>
              <ENT>0.00</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.34</ENT>
              <ENT>1.39</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76815</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ob us, limited, fetus(s)</ENT>
              <ENT>0.65</ENT>
              <ENT>1.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.40</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76815</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ob us, limited, fetus(s)</ENT>
              <ENT>0.65</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>0.02</ENT>
              <ENT>0.91</ENT>
              <ENT>0.91</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76815</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ob us, limited, fetus(s)</ENT>
              <ENT>0.00</ENT>
              <ENT>1.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76816</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ob us, follow-up, per fetus</ENT>
              <ENT>0.85</ENT>
              <ENT>1.43</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>2.35</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76816</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ob us, follow-up, per fetus</ENT>
              <ENT>0.85</ENT>
              <ENT>0.32</ENT>
              <ENT>0.32</ENT>
              <ENT>0.02</ENT>
              <ENT>1.19</ENT>
              <ENT>1.19</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76816</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ob us, follow-up, per fetus</ENT>
              <ENT>0.00</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.16</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76817</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transvaginal us, obstetric</ENT>
              <ENT>0.75</ENT>
              <ENT>1.80</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76817</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Transvaginal us, obstetric</ENT>
              <ENT>0.75</ENT>
              <ENT>0.28</ENT>
              <ENT>0.28</ENT>
              <ENT>0.02</ENT>
              <ENT>1.05</ENT>
              <ENT>1.05</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49197"/>
              <ENT I="01">76817</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Transvaginal us, obstetric</ENT>
              <ENT>0.00</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.57</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76818</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fetal biophys profile w/nst</ENT>
              <ENT>1.05</ENT>
              <ENT>2.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>3.18</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76818</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Fetal biophys profile w/nst</ENT>
              <ENT>1.05</ENT>
              <ENT>0.40</ENT>
              <ENT>0.40</ENT>
              <ENT>0.04</ENT>
              <ENT>1.49</ENT>
              <ENT>1.49</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76818</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Fetal biophys profile w/nst</ENT>
              <ENT>0.00</ENT>
              <ENT>1.61</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.69</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76819</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fetal biophys profil w/o nst</ENT>
              <ENT>0.77</ENT>
              <ENT>1.90</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76819</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Fetal biophys profil w/o nst</ENT>
              <ENT>0.77</ENT>
              <ENT>0.29</ENT>
              <ENT>0.29</ENT>
              <ENT>0.02</ENT>
              <ENT>1.08</ENT>
              <ENT>1.08</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76819</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Fetal biophys profil w/o nst</ENT>
              <ENT>0.00</ENT>
              <ENT>1.61</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.69</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76825</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo exam of fetal heart</ENT>
              <ENT>1.67</ENT>
              <ENT>2.59</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>4.41</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76825</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of fetal heart</ENT>
              <ENT>1.67</ENT>
              <ENT>0.62</ENT>
              <ENT>0.62</ENT>
              <ENT>0.06</ENT>
              <ENT>2.35</ENT>
              <ENT>2.35</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76825</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of fetal heart</ENT>
              <ENT>0.00</ENT>
              <ENT>1.97</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.06</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76826</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo exam of fetal heart</ENT>
              <ENT>0.83</ENT>
              <ENT>1.00</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.90</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76826</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of fetal heart</ENT>
              <ENT>0.83</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>0.03</ENT>
              <ENT>1.16</ENT>
              <ENT>1.16</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76826</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of fetal heart</ENT>
              <ENT>0.00</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.75</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76827</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo exam of fetal heart</ENT>
              <ENT>0.58</ENT>
              <ENT>1.94</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.64</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76827</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of fetal heart</ENT>
              <ENT>0.58</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>0.02</ENT>
              <ENT>0.82</ENT>
              <ENT>0.82</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76827</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of fetal heart</ENT>
              <ENT>0.00</ENT>
              <ENT>1.72</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>1.82</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76828</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo exam of fetal heart</ENT>
              <ENT>0.56</ENT>
              <ENT>1.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.98</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76828</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of fetal heart</ENT>
              <ENT>0.56</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>0.02</ENT>
              <ENT>0.80</ENT>
              <ENT>0.80</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76828</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of fetal heart</ENT>
              <ENT>0.00</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76830</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transvaginal us, non-ob</ENT>
              <ENT>0.69</ENT>
              <ENT>1.75</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76830</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Transvaginal us, non-ob</ENT>
              <ENT>0.69</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.03</ENT>
              <ENT>0.95</ENT>
              <ENT>0.95</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76830</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Transvaginal us, non-ob</ENT>
              <ENT>0.00</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76831</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo exam, uterus</ENT>
              <ENT>0.72</ENT>
              <ENT>1.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76831</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam, uterus</ENT>
              <ENT>0.72</ENT>
              <ENT>0.26</ENT>
              <ENT>0.26</ENT>
              <ENT>0.02</ENT>
              <ENT>1.00</ENT>
              <ENT>1.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76831</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam, uterus</ENT>
              <ENT>0.00</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76856</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Us exam, pelvic, complete</ENT>
              <ENT>0.69</ENT>
              <ENT>1.75</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76856</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Us exam, pelvic, complete</ENT>
              <ENT>0.69</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.03</ENT>
              <ENT>0.95</ENT>
              <ENT>0.95</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76856</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Us exam, pelvic, complete</ENT>
              <ENT>0.00</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76857</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Us exam, pelvic, limited</ENT>
              <ENT>0.38</ENT>
              <ENT>1.68</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>2.13</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76857</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Us exam, pelvic, limited</ENT>
              <ENT>0.38</ENT>
              <ENT>0.13</ENT>
              <ENT>0.13</ENT>
              <ENT>0.02</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76857</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Us exam, pelvic, limited</ENT>
              <ENT>0.00</ENT>
              <ENT>1.55</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76870</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Us exam, scrotum</ENT>
              <ENT>0.64</ENT>
              <ENT>1.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.48</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76870</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Us exam, scrotum</ENT>
              <ENT>0.64</ENT>
              <ENT>0.21</ENT>
              <ENT>0.21</ENT>
              <ENT>0.03</ENT>
              <ENT>0.88</ENT>
              <ENT>0.88</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76870</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Us exam, scrotum</ENT>
              <ENT>0.00</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76872</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo exam, transrectal</ENT>
              <ENT>0.69</ENT>
              <ENT>1.97</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76872</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam, transrectal</ENT>
              <ENT>0.69</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.04</ENT>
              <ENT>0.96</ENT>
              <ENT>0.96</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76872</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam, transrectal</ENT>
              <ENT>0.00</ENT>
              <ENT>1.75</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.83</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76873</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echograp trans r, pros study</ENT>
              <ENT>1.55</ENT>
              <ENT>2.61</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>4.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76873</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echograp trans r, pros study</ENT>
              <ENT>1.55</ENT>
              <ENT>0.51</ENT>
              <ENT>0.51</ENT>
              <ENT>0.08</ENT>
              <ENT>2.14</ENT>
              <ENT>2.14</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76873</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echograp trans r, pros study</ENT>
              <ENT>0.00</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>2.23</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76880</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Us exam, extremity</ENT>
              <ENT>0.59</ENT>
              <ENT>1.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.31</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76880</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Us exam, extremity</ENT>
              <ENT>0.59</ENT>
              <ENT>0.20</ENT>
              <ENT>0.20</ENT>
              <ENT>0.03</ENT>
              <ENT>0.82</ENT>
              <ENT>0.82</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76880</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Us exam, extremity</ENT>
              <ENT>0.00</ENT>
              <ENT>1.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76885</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Us exam infant hips, dynamic</ENT>
              <ENT>0.74</ENT>
              <ENT>1.77</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76885</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Us exam infant hips, dynamic</ENT>
              <ENT>0.74</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.03</ENT>
              <ENT>1.02</ENT>
              <ENT>1.02</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76885</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Us exam infant hips, dynamic</ENT>
              <ENT>0.00</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76886</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Us exam infant hips, static</ENT>
              <ENT>0.62</ENT>
              <ENT>1.63</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.35</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76886</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Us exam infant hips, static</ENT>
              <ENT>0.62</ENT>
              <ENT>0.21</ENT>
              <ENT>0.21</ENT>
              <ENT>0.03</ENT>
              <ENT>0.86</ENT>
              <ENT>0.86</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76886</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Us exam infant hips, static</ENT>
              <ENT>0.00</ENT>
              <ENT>1.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76930</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo guide, cardiocentesis</ENT>
              <ENT>0.67</ENT>
              <ENT>1.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76930</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo guide, cardiocentesis</ENT>
              <ENT>0.67</ENT>
              <ENT>0.26</ENT>
              <ENT>0.26</ENT>
              <ENT>0.02</ENT>
              <ENT>0.95</ENT>
              <ENT>0.95</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76930</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo guide, cardiocentesis</ENT>
              <ENT>0.00</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76932</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo guide for heart biopsy</ENT>
              <ENT>0.67</ENT>
              <ENT>1.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76932</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo guide for heart biopsy</ENT>
              <ENT>0.67</ENT>
              <ENT>0.26</ENT>
              <ENT>0.26</ENT>
              <ENT>0.02</ENT>
              <ENT>0.95</ENT>
              <ENT>0.95</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76932</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo guide for heart biopsy</ENT>
              <ENT>0.00</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76936</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo guide for artery repair</ENT>
              <ENT>1.99</ENT>
              <ENT>6.97</ENT>
              <ENT>N/A</ENT>
              <ENT>0.39</ENT>
              <ENT>9.35</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49198"/>
              <ENT I="01">76936</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo guide for artery repair</ENT>
              <ENT>1.99</ENT>
              <ENT>0.68</ENT>
              <ENT>0.68</ENT>
              <ENT>0.11</ENT>
              <ENT>2.78</ENT>
              <ENT>2.78</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76936</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo guide for artery repair</ENT>
              <ENT>0.00</ENT>
              <ENT>6.30</ENT>
              <ENT>N/A</ENT>
              <ENT>0.28</ENT>
              <ENT>6.58</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76941</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo guide for transfusion</ENT>
              <ENT>1.34</ENT>
              <ENT>2.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>3.48</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76941</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo guide for transfusion</ENT>
              <ENT>1.34</ENT>
              <ENT>0.49</ENT>
              <ENT>0.49</ENT>
              <ENT>0.06</ENT>
              <ENT>1.89</ENT>
              <ENT>1.89</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76941</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo guide for transfusion</ENT>
              <ENT>0.00</ENT>
              <ENT>1.53</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76942</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo guide for biopsy</ENT>
              <ENT>0.67</ENT>
              <ENT>3.40</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>4.19</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76942</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo guide for biopsy</ENT>
              <ENT>0.67</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>0.04</ENT>
              <ENT>0.93</ENT>
              <ENT>0.93</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76942</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo guide for biopsy</ENT>
              <ENT>0.00</ENT>
              <ENT>3.18</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>3.26</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76945</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo guide, villus sampling</ENT>
              <ENT>0.67</ENT>
              <ENT>1.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.53</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76945</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo guide, villus sampling</ENT>
              <ENT>0.67</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.03</ENT>
              <ENT>0.93</ENT>
              <ENT>0.93</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76945</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo guide, villus sampling</ENT>
              <ENT>0.00</ENT>
              <ENT>1.53</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76946</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo guide for amniocentesis</ENT>
              <ENT>0.38</ENT>
              <ENT>1.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.13</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76946</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo guide for amniocentesis</ENT>
              <ENT>0.38</ENT>
              <ENT>0.14</ENT>
              <ENT>0.14</ENT>
              <ENT>0.01</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76946</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo guide for amniocentesis</ENT>
              <ENT>0.00</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76948</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo guide, ova aspiration</ENT>
              <ENT>0.38</ENT>
              <ENT>1.65</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.13</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76948</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo guide, ova aspiration</ENT>
              <ENT>0.38</ENT>
              <ENT>0.13</ENT>
              <ENT>0.13</ENT>
              <ENT>0.02</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76948</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo guide, ova aspiration</ENT>
              <ENT>0.00</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76950</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo guidance radiotherapy</ENT>
              <ENT>0.58</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.16</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76950</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo guidance radiotherapy</ENT>
              <ENT>0.58</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.03</ENT>
              <ENT>0.80</ENT>
              <ENT>0.80</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76950</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo guidance radiotherapy</ENT>
              <ENT>0.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76965</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo guidance radiotherapy</ENT>
              <ENT>1.34</ENT>
              <ENT>6.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.66</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76965</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo guidance radiotherapy</ENT>
              <ENT>1.34</ENT>
              <ENT>0.44</ENT>
              <ENT>0.44</ENT>
              <ENT>0.07</ENT>
              <ENT>1.85</ENT>
              <ENT>1.85</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76965</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo guidance radiotherapy</ENT>
              <ENT>0.00</ENT>
              <ENT>5.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.24</ENT>
              <ENT>5.81</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76970</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ultrasound exam follow-up</ENT>
              <ENT>0.40</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.66</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76970</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ultrasound exam follow-up</ENT>
              <ENT>0.40</ENT>
              <ENT>0.14</ENT>
              <ENT>0.14</ENT>
              <ENT>0.02</ENT>
              <ENT>0.56</ENT>
              <ENT>0.56</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76970</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ultrasound exam follow-up</ENT>
              <ENT>0.00</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76975</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>GI endoscopic ultrasound</ENT>
              <ENT>0.81</ENT>
              <ENT>1.80</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.72</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76975</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>GI endoscopic ultrasound</ENT>
              <ENT>0.81</ENT>
              <ENT>0.28</ENT>
              <ENT>0.28</ENT>
              <ENT>0.03</ENT>
              <ENT>1.12</ENT>
              <ENT>1.12</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76975</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>GI endoscopic ultrasound</ENT>
              <ENT>0.00</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76977</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Us bone density measure</ENT>
              <ENT>0.05</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76977</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Us bone density measure</ENT>
              <ENT>0.05</ENT>
              <ENT>0.02</ENT>
              <ENT>0.02</ENT>
              <ENT>0.01</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76977</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Us bone density measure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76986</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ultrasound guide intraoper</ENT>
              <ENT>1.20</ENT>
              <ENT>3.03</ENT>
              <ENT>N/A</ENT>
              <ENT>0.19</ENT>
              <ENT>4.42</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76986</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ultrasound guide intraoper</ENT>
              <ENT>1.20</ENT>
              <ENT>0.41</ENT>
              <ENT>0.41</ENT>
              <ENT>0.07</ENT>
              <ENT>1.68</ENT>
              <ENT>1.68</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76986</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ultrasound guide intraoper</ENT>
              <ENT>0.00</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Echo examination procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76999</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Echo examination procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">76999</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Echo examination procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77261</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation therapy planning</ENT>
              <ENT>1.39</ENT>
              <ENT>0.52</ENT>
              <ENT>0.52</ENT>
              <ENT>0.06</ENT>
              <ENT>1.97</ENT>
              <ENT>1.97</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77262</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation therapy planning</ENT>
              <ENT>2.11</ENT>
              <ENT>0.77</ENT>
              <ENT>0.77</ENT>
              <ENT>0.09</ENT>
              <ENT>2.97</ENT>
              <ENT>2.97</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77263</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation therapy planning</ENT>
              <ENT>3.14</ENT>
              <ENT>1.13</ENT>
              <ENT>1.13</ENT>
              <ENT>0.13</ENT>
              <ENT>4.40</ENT>
              <ENT>4.40</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77280</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Set radiation therapy field</ENT>
              <ENT>0.70</ENT>
              <ENT>3.70</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.58</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77280</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Set radiation therapy field</ENT>
              <ENT>0.70</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.03</ENT>
              <ENT>0.96</ENT>
              <ENT>0.96</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77280</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Set radiation therapy field</ENT>
              <ENT>0.00</ENT>
              <ENT>3.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.62</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77285</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Set radiation therapy field</ENT>
              <ENT>1.05</ENT>
              <ENT>5.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.29</ENT>
              <ENT>7.25</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77285</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Set radiation therapy field</ENT>
              <ENT>1.05</ENT>
              <ENT>0.34</ENT>
              <ENT>0.34</ENT>
              <ENT>0.04</ENT>
              <ENT>1.43</ENT>
              <ENT>1.43</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77285</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Set radiation therapy field</ENT>
              <ENT>0.00</ENT>
              <ENT>5.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.25</ENT>
              <ENT>5.82</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77290</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Set radiation therapy field</ENT>
              <ENT>1.56</ENT>
              <ENT>7.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.35</ENT>
              <ENT>8.92</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77290</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Set radiation therapy field</ENT>
              <ENT>1.56</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>0.06</ENT>
              <ENT>2.12</ENT>
              <ENT>2.12</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49199"/>
              <ENT I="01">77290</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Set radiation therapy field</ENT>
              <ENT>0.00</ENT>
              <ENT>6.51</ENT>
              <ENT>N/A</ENT>
              <ENT>0.29</ENT>
              <ENT>6.80</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77295</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Set radiation therapy field</ENT>
              <ENT>4.57</ENT>
              <ENT>29.41</ENT>
              <ENT>N/A</ENT>
              <ENT>1.41</ENT>
              <ENT>35.39</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77295</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Set radiation therapy field</ENT>
              <ENT>4.57</ENT>
              <ENT>1.48</ENT>
              <ENT>1.48</ENT>
              <ENT>0.18</ENT>
              <ENT>6.23</ENT>
              <ENT>6.23</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77295</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Set radiation therapy field</ENT>
              <ENT>0.00</ENT>
              <ENT>27.94</ENT>
              <ENT>N/A</ENT>
              <ENT>1.23</ENT>
              <ENT>29.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77299</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Radiation therapy planning</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77299</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Radiation therapy planning</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77299</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Radiation therapy planning</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation therapy dose plan</ENT>
              <ENT>0.62</ENT>
              <ENT>1.54</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.25</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77300</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Radiation therapy dose plan</ENT>
              <ENT>0.62</ENT>
              <ENT>0.20</ENT>
              <ENT>0.20</ENT>
              <ENT>0.03</ENT>
              <ENT>0.85</ENT>
              <ENT>0.85</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77300</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Radiation therapy dose plan</ENT>
              <ENT>0.00</ENT>
              <ENT>1.34</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.40</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77301</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiotherapy dose plan, imrt</ENT>
              <ENT>8.00</ENT>
              <ENT>30.52</ENT>
              <ENT>N/A</ENT>
              <ENT>1.41</ENT>
              <ENT>39.93</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77301</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Radiotherapy dose plan, imrt</ENT>
              <ENT>8.00</ENT>
              <ENT>2.59</ENT>
              <ENT>2.59</ENT>
              <ENT>0.18</ENT>
              <ENT>10.77</ENT>
              <ENT>10.77</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77301</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Radiotherapy dose plan, imrt</ENT>
              <ENT>0.00</ENT>
              <ENT>27.94</ENT>
              <ENT>N/A</ENT>
              <ENT>1.23</ENT>
              <ENT>29.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77305</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Teletx isodose plan simple</ENT>
              <ENT>0.70</ENT>
              <ENT>2.08</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.90</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77305</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Teletx isodose plan simple</ENT>
              <ENT>0.70</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.03</ENT>
              <ENT>0.96</ENT>
              <ENT>0.96</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77305</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Teletx isodose plan simple</ENT>
              <ENT>0.00</ENT>
              <ENT>1.86</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77310</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Teletx isodose plan intermed</ENT>
              <ENT>1.05</ENT>
              <ENT>2.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.87</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77310</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Teletx isodose plan intermed</ENT>
              <ENT>1.05</ENT>
              <ENT>0.34</ENT>
              <ENT>0.34</ENT>
              <ENT>0.04</ENT>
              <ENT>1.43</ENT>
              <ENT>1.43</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77310</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Teletx isodose plan intermed</ENT>
              <ENT>0.00</ENT>
              <ENT>2.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77315</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Teletx isodose plan complex</ENT>
              <ENT>1.56</ENT>
              <ENT>3.16</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.90</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77315</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Teletx isodose plan complex</ENT>
              <ENT>1.56</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>0.06</ENT>
              <ENT>2.12</ENT>
              <ENT>2.12</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77315</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Teletx isodose plan complex</ENT>
              <ENT>0.00</ENT>
              <ENT>2.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77321</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Special teletx port plan</ENT>
              <ENT>0.95</ENT>
              <ENT>4.35</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>5.51</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77321</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Special teletx port plan</ENT>
              <ENT>0.95</ENT>
              <ENT>0.31</ENT>
              <ENT>0.31</ENT>
              <ENT>0.04</ENT>
              <ENT>1.30</ENT>
              <ENT>1.30</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77321</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Special teletx port plan</ENT>
              <ENT>0.00</ENT>
              <ENT>4.04</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>4.21</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77326</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Brachytx isodose calc simp</ENT>
              <ENT>0.93</ENT>
              <ENT>2.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77326</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Brachytx isodose calc simp</ENT>
              <ENT>0.93</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>0.04</ENT>
              <ENT>1.27</ENT>
              <ENT>1.27</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77326</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Brachytx isodose calc simp</ENT>
              <ENT>0.00</ENT>
              <ENT>2.36</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.47</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77327</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Brachytx isodose calc interm</ENT>
              <ENT>1.39</ENT>
              <ENT>3.92</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>5.52</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77327</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Brachytx isodose calc interm</ENT>
              <ENT>1.39</ENT>
              <ENT>0.45</ENT>
              <ENT>0.45</ENT>
              <ENT>0.06</ENT>
              <ENT>1.90</ENT>
              <ENT>1.90</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77327</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Brachytx isodose calc interm</ENT>
              <ENT>0.00</ENT>
              <ENT>3.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.62</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77328</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Brachytx isodose plan compl</ENT>
              <ENT>2.09</ENT>
              <ENT>5.64</ENT>
              <ENT>N/A</ENT>
              <ENT>0.30</ENT>
              <ENT>8.03</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77328</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Brachytx isodose plan compl</ENT>
              <ENT>2.09</ENT>
              <ENT>0.68</ENT>
              <ENT>0.68</ENT>
              <ENT>0.09</ENT>
              <ENT>2.86</ENT>
              <ENT>2.86</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77328</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Brachytx isodose plan compl</ENT>
              <ENT>0.00</ENT>
              <ENT>4.96</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>5.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77331</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Special radiation dosimetry</ENT>
              <ENT>0.87</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77331</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Special radiation dosimetry</ENT>
              <ENT>0.87</ENT>
              <ENT>0.28</ENT>
              <ENT>0.28</ENT>
              <ENT>0.04</ENT>
              <ENT>1.19</ENT>
              <ENT>1.19</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77331</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Special radiation dosimetry</ENT>
              <ENT>0.00</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77332</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation treatment aid(s)</ENT>
              <ENT>0.54</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>2.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77332</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Radiation treatment aid(s)</ENT>
              <ENT>0.54</ENT>
              <ENT>0.17</ENT>
              <ENT>0.17</ENT>
              <ENT>0.02</ENT>
              <ENT>0.73</ENT>
              <ENT>0.73</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77332</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Radiation treatment aid(s)</ENT>
              <ENT>0.00</ENT>
              <ENT>1.34</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.40</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77333</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation treatment aid(s)</ENT>
              <ENT>0.84</ENT>
              <ENT>2.17</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>3.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77333</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Radiation treatment aid(s)</ENT>
              <ENT>0.84</ENT>
              <ENT>0.27</ENT>
              <ENT>0.27</ENT>
              <ENT>0.04</ENT>
              <ENT>1.15</ENT>
              <ENT>1.15</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49200"/>
              <ENT I="01">77333</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Radiation treatment aid(s)</ENT>
              <ENT>0.00</ENT>
              <ENT>1.90</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.99</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77334</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation treatment aid(s)</ENT>
              <ENT>1.24</ENT>
              <ENT>3.65</ENT>
              <ENT>N/A</ENT>
              <ENT>0.19</ENT>
              <ENT>5.08</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77334</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Radiation treatment aid(s)</ENT>
              <ENT>1.24</ENT>
              <ENT>0.40</ENT>
              <ENT>0.40</ENT>
              <ENT>0.05</ENT>
              <ENT>1.69</ENT>
              <ENT>1.69</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77334</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Radiation treatment aid(s)</ENT>
              <ENT>0.00</ENT>
              <ENT>3.25</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.39</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77336</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation physics consult</ENT>
              <ENT>0.00</ENT>
              <ENT>2.98</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>3.11</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77370</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation physics consult</ENT>
              <ENT>0.00</ENT>
              <ENT>3.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.64</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77399</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>External radiation dosimetry</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77399</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>External radiation dosimetry</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77399</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>External radiation dosimetry</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77401</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation treatment delivery</ENT>
              <ENT>0.00</ENT>
              <ENT>1.77</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.86</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77402</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation treatment delivery</ENT>
              <ENT>0.00</ENT>
              <ENT>1.77</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.86</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77403</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation treatment delivery</ENT>
              <ENT>0.00</ENT>
              <ENT>1.77</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.86</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77404</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation treatment delivery</ENT>
              <ENT>0.00</ENT>
              <ENT>1.77</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.86</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77406</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation treatment delivery</ENT>
              <ENT>0.00</ENT>
              <ENT>1.77</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.86</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77407</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation treatment delivery</ENT>
              <ENT>0.00</ENT>
              <ENT>2.09</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.19</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77408</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation treatment delivery</ENT>
              <ENT>0.00</ENT>
              <ENT>2.09</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.19</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77409</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation treatment delivery</ENT>
              <ENT>0.00</ENT>
              <ENT>2.09</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.19</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77411</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation treatment delivery</ENT>
              <ENT>0.00</ENT>
              <ENT>2.09</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.19</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77412</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation treatment delivery</ENT>
              <ENT>0.00</ENT>
              <ENT>2.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77413</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation treatment delivery</ENT>
              <ENT>0.00</ENT>
              <ENT>2.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77414</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation treatment delivery</ENT>
              <ENT>0.00</ENT>
              <ENT>2.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77416</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation treatment delivery</ENT>
              <ENT>0.00</ENT>
              <ENT>2.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77417</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiology port film(s)</ENT>
              <ENT>0.00</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77418</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation tx delivery, imrt</ENT>
              <ENT>0.00</ENT>
              <ENT>11.61</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>11.72</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77427</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation tx management, x5</ENT>
              <ENT>3.31</ENT>
              <ENT>1.07</ENT>
              <ENT>1.07</ENT>
              <ENT>0.14</ENT>
              <ENT>4.52</ENT>
              <ENT>4.52</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77431</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation therapy management</ENT>
              <ENT>1.81</ENT>
              <ENT>0.69</ENT>
              <ENT>0.69</ENT>
              <ENT>0.07</ENT>
              <ENT>2.57</ENT>
              <ENT>2.57</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77432</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Stereotactic radiation trmt</ENT>
              <ENT>7.93</ENT>
              <ENT>2.95</ENT>
              <ENT>2.95</ENT>
              <ENT>0.33</ENT>
              <ENT>11.21</ENT>
              <ENT>11.21</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77470</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Special radiation treatment</ENT>
              <ENT>2.09</ENT>
              <ENT>11.82</ENT>
              <ENT>N/A</ENT>
              <ENT>0.58</ENT>
              <ENT>14.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77470</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Special radiation treatment</ENT>
              <ENT>2.09</ENT>
              <ENT>0.67</ENT>
              <ENT>0.67</ENT>
              <ENT>0.09</ENT>
              <ENT>2.85</ENT>
              <ENT>2.85</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77470</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Special radiation treatment</ENT>
              <ENT>0.00</ENT>
              <ENT>11.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>11.64</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77499</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Radiation therapy management</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77499</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Radiation therapy management</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77499</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Radiation therapy management</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77520</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Proton trmt, simple w/o comp</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77522</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Proton trmt, simple w/comp</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77523</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Proton trmt, intermediate</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77525</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Proton treatment, complex</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77600</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Hyperthermia treatment</ENT>
              <ENT>1.56</ENT>
              <ENT>3.55</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>5.32</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77600</ENT>
              <ENT>26</ENT>
              <ENT>R</ENT>
              <ENT>Hyperthermia treatment</ENT>
              <ENT>1.56</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>0.08</ENT>
              <ENT>2.14</ENT>
              <ENT>2.14</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77600</ENT>
              <ENT>TC</ENT>
              <ENT>R</ENT>
              <ENT>Hyperthermia treatment</ENT>
              <ENT>0.00</ENT>
              <ENT>3.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>3.18</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77605</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Hyperthermia treatment</ENT>
              <ENT>2.09</ENT>
              <ENT>4.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.13</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77605</ENT>
              <ENT>26</ENT>
              <ENT>R</ENT>
              <ENT>Hyperthermia treatment</ENT>
              <ENT>2.09</ENT>
              <ENT>0.67</ENT>
              <ENT>0.67</ENT>
              <ENT>0.13</ENT>
              <ENT>2.89</ENT>
              <ENT>2.89</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77605</ENT>
              <ENT>TC</ENT>
              <ENT>R</ENT>
              <ENT>Hyperthermia treatment</ENT>
              <ENT>0.00</ENT>
              <ENT>4.06</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.24</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49201"/>
              <ENT I="01">77610</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Hyperthermia treatment</ENT>
              <ENT>1.56</ENT>
              <ENT>3.56</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>5.32</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77610</ENT>
              <ENT>26</ENT>
              <ENT>R</ENT>
              <ENT>Hyperthermia treatment</ENT>
              <ENT>1.56</ENT>
              <ENT>0.52</ENT>
              <ENT>0.52</ENT>
              <ENT>0.07</ENT>
              <ENT>2.15</ENT>
              <ENT>2.15</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77610</ENT>
              <ENT>TC</ENT>
              <ENT>R</ENT>
              <ENT>Hyperthermia treatment</ENT>
              <ENT>0.00</ENT>
              <ENT>3.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>3.18</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77615</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Hyperthermia treatment</ENT>
              <ENT>2.09</ENT>
              <ENT>4.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.27</ENT>
              <ENT>7.09</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77615</ENT>
              <ENT>26</ENT>
              <ENT>R</ENT>
              <ENT>Hyperthermia treatment</ENT>
              <ENT>2.09</ENT>
              <ENT>0.67</ENT>
              <ENT>0.67</ENT>
              <ENT>0.09</ENT>
              <ENT>2.85</ENT>
              <ENT>2.85</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77615</ENT>
              <ENT>TC</ENT>
              <ENT>R</ENT>
              <ENT>Hyperthermia treatment</ENT>
              <ENT>0.00</ENT>
              <ENT>4.06</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.24</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77620</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Hyperthermia treatment</ENT>
              <ENT>1.56</ENT>
              <ENT>3.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.19</ENT>
              <ENT>5.32</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77620</ENT>
              <ENT>26</ENT>
              <ENT>R</ENT>
              <ENT>Hyperthermia treatment</ENT>
              <ENT>1.56</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>0.06</ENT>
              <ENT>2.15</ENT>
              <ENT>2.15</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77620</ENT>
              <ENT>TC</ENT>
              <ENT>R</ENT>
              <ENT>Hyperthermia treatment</ENT>
              <ENT>0.00</ENT>
              <ENT>3.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>3.18</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77750</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Infuse radioactive materials</ENT>
              <ENT>4.91</ENT>
              <ENT>2.93</ENT>
              <ENT>N/A</ENT>
              <ENT>0.23</ENT>
              <ENT>8.07</ENT>
              <ENT>N/A</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77750</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Infuse radioactive materials</ENT>
              <ENT>4.91</ENT>
              <ENT>1.60</ENT>
              <ENT>1.60</ENT>
              <ENT>0.17</ENT>
              <ENT>6.68</ENT>
              <ENT>6.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77750</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Infuse radioactive materials</ENT>
              <ENT>0.00</ENT>
              <ENT>1.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.39</ENT>
              <ENT>N/A</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77761</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apply intrcav radiat simple</ENT>
              <ENT>3.81</ENT>
              <ENT>3.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.28</ENT>
              <ENT>7.71</ENT>
              <ENT>N/A</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77761</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Apply intrcav radiat simple</ENT>
              <ENT>3.81</ENT>
              <ENT>1.11</ENT>
              <ENT>1.11</ENT>
              <ENT>0.16</ENT>
              <ENT>5.08</ENT>
              <ENT>5.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77761</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Apply intrcav radiat simple</ENT>
              <ENT>0.00</ENT>
              <ENT>2.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77762</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apply intrcav radiat interm</ENT>
              <ENT>5.72</ENT>
              <ENT>5.46</ENT>
              <ENT>N/A</ENT>
              <ENT>0.38</ENT>
              <ENT>11.56</ENT>
              <ENT>N/A</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77762</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Apply intrcav radiat interm</ENT>
              <ENT>5.72</ENT>
              <ENT>1.86</ENT>
              <ENT>1.86</ENT>
              <ENT>0.22</ENT>
              <ENT>7.80</ENT>
              <ENT>7.80</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77762</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Apply intrcav radiat interm</ENT>
              <ENT>0.00</ENT>
              <ENT>3.61</ENT>
              <ENT>N/A</ENT>
              <ENT>0.16</ENT>
              <ENT>3.77</ENT>
              <ENT>N/A</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77763</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apply intrcav radiat compl</ENT>
              <ENT>8.57</ENT>
              <ENT>7.26</ENT>
              <ENT>N/A</ENT>
              <ENT>0.53</ENT>
              <ENT>16.36</ENT>
              <ENT>N/A</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77763</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Apply intrcav radiat compl</ENT>
              <ENT>8.57</ENT>
              <ENT>2.77</ENT>
              <ENT>2.77</ENT>
              <ENT>0.34</ENT>
              <ENT>11.68</ENT>
              <ENT>11.68</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77763</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Apply intrcav radiat compl</ENT>
              <ENT>0.00</ENT>
              <ENT>4.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.19</ENT>
              <ENT>4.68</ENT>
              <ENT>N/A</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77776</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apply interstit radiat simpl</ENT>
              <ENT>4.66</ENT>
              <ENT>3.14</ENT>
              <ENT>N/A</ENT>
              <ENT>0.35</ENT>
              <ENT>8.15</ENT>
              <ENT>N/A</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77776</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Apply interstit radiat simpl</ENT>
              <ENT>4.66</ENT>
              <ENT>0.97</ENT>
              <ENT>0.97</ENT>
              <ENT>0.24</ENT>
              <ENT>5.87</ENT>
              <ENT>5.87</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77776</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Apply interstit radiat simpl</ENT>
              <ENT>0.00</ENT>
              <ENT>2.18</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.29</ENT>
              <ENT>N/A</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77777</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apply interstit radiat inter</ENT>
              <ENT>7.48</ENT>
              <ENT>6.63</ENT>
              <ENT>N/A</ENT>
              <ENT>0.50</ENT>
              <ENT>14.61</ENT>
              <ENT>N/A</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77777</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Apply interstit radiat inter</ENT>
              <ENT>7.48</ENT>
              <ENT>2.39</ENT>
              <ENT>2.39</ENT>
              <ENT>0.32</ENT>
              <ENT>10.19</ENT>
              <ENT>10.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77777</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Apply interstit radiat inter</ENT>
              <ENT>0.00</ENT>
              <ENT>4.24</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.42</ENT>
              <ENT>N/A</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77778</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apply interstit radiat compl</ENT>
              <ENT>11.19</ENT>
              <ENT>8.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.69</ENT>
              <ENT>20.62</ENT>
              <ENT>N/A</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77778</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Apply interstit radiat compl</ENT>
              <ENT>11.19</ENT>
              <ENT>3.61</ENT>
              <ENT>3.61</ENT>
              <ENT>0.47</ENT>
              <ENT>15.27</ENT>
              <ENT>15.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77778</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Apply interstit radiat compl</ENT>
              <ENT>0.00</ENT>
              <ENT>5.14</ENT>
              <ENT>N/A</ENT>
              <ENT>0.22</ENT>
              <ENT>5.36</ENT>
              <ENT>N/A</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77781</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>High intensity brachytherapy</ENT>
              <ENT>1.66</ENT>
              <ENT>20.85</ENT>
              <ENT>N/A</ENT>
              <ENT>0.95</ENT>
              <ENT>23.46</ENT>
              <ENT>N/A</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77781</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>High intensity brachytherapy</ENT>
              <ENT>1.66</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>0.07</ENT>
              <ENT>2.27</ENT>
              <ENT>2.27</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77781</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>High intensity brachytherapy</ENT>
              <ENT>0.00</ENT>
              <ENT>20.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.88</ENT>
              <ENT>21.19</ENT>
              <ENT>N/A</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77782</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>High intensity brachytherapy</ENT>
              <ENT>2.49</ENT>
              <ENT>21.11</ENT>
              <ENT>N/A</ENT>
              <ENT>0.98</ENT>
              <ENT>24.58</ENT>
              <ENT>N/A</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77782</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>High intensity brachytherapy</ENT>
              <ENT>2.49</ENT>
              <ENT>0.81</ENT>
              <ENT>0.81</ENT>
              <ENT>0.10</ENT>
              <ENT>3.40</ENT>
              <ENT>3.40</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77782</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>High intensity brachytherapy</ENT>
              <ENT>0.00</ENT>
              <ENT>20.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.88</ENT>
              <ENT>21.19</ENT>
              <ENT>N/A</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77783</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>High intensity brachytherapy</ENT>
              <ENT>3.73</ENT>
              <ENT>21.51</ENT>
              <ENT>N/A</ENT>
              <ENT>1.03</ENT>
              <ENT>26.27</ENT>
              <ENT>N/A</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77783</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>High intensity brachytherapy</ENT>
              <ENT>3.73</ENT>
              <ENT>1.20</ENT>
              <ENT>1.20</ENT>
              <ENT>0.15</ENT>
              <ENT>5.08</ENT>
              <ENT>5.08</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77783</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>High intensity brachytherapy</ENT>
              <ENT>0.00</ENT>
              <ENT>20.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.88</ENT>
              <ENT>21.19</ENT>
              <ENT>N/A</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77784</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>High intensity brachytherapy</ENT>
              <ENT>5.61</ENT>
              <ENT>22.11</ENT>
              <ENT>N/A</ENT>
              <ENT>1.10</ENT>
              <ENT>28.82</ENT>
              <ENT>N/A</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77784</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>High intensity brachytherapy</ENT>
              <ENT>5.61</ENT>
              <ENT>1.81</ENT>
              <ENT>1.81</ENT>
              <ENT>0.22</ENT>
              <ENT>7.64</ENT>
              <ENT>7.64</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77784</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>High intensity brachytherapy</ENT>
              <ENT>0.00</ENT>
              <ENT>20.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.88</ENT>
              <ENT>21.19</ENT>
              <ENT>N/A</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77789</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Apply surface radiation</ENT>
              <ENT>1.12</ENT>
              <ENT>0.83</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>2.00</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77789</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Apply surface radiation</ENT>
              <ENT>1.12</ENT>
              <ENT>0.37</ENT>
              <ENT>0.37</ENT>
              <ENT>0.03</ENT>
              <ENT>1.52</ENT>
              <ENT>1.52</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77789</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Apply surface radiation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77790</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiation handling</ENT>
              <ENT>1.05</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77790</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Radiation handling</ENT>
              <ENT>1.05</ENT>
              <ENT>0.34</ENT>
              <ENT>0.34</ENT>
              <ENT>0.04</ENT>
              <ENT>1.43</ENT>
              <ENT>1.43</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77790</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Radiation handling</ENT>
              <ENT>0.00</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77799</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Radium/radioisotope therapy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49202"/>
              <ENT I="01">77799</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Radium/radioisotope therapy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">77799</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Radium/radioisotope therapy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thyroid, single uptake</ENT>
              <ENT>0.19</ENT>
              <ENT>1.03</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.28</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78000</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid, single uptake</ENT>
              <ENT>0.19</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.27</ENT>
              <ENT>0.27</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78000</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid, single uptake</ENT>
              <ENT>0.00</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78001</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thyroid, multiple uptakes</ENT>
              <ENT>0.26</ENT>
              <ENT>1.40</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.73</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78001</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid, multiple uptakes</ENT>
              <ENT>0.26</ENT>
              <ENT>0.09</ENT>
              <ENT>0.09</ENT>
              <ENT>0.01</ENT>
              <ENT>0.36</ENT>
              <ENT>0.36</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78001</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid, multiple uptakes</ENT>
              <ENT>0.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78003</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thyroid suppress/stimul</ENT>
              <ENT>0.33</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.47</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78003</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid suppress/stimul</ENT>
              <ENT>0.33</ENT>
              <ENT>0.11</ENT>
              <ENT>0.11</ENT>
              <ENT>0.01</ENT>
              <ENT>0.45</ENT>
              <ENT>0.45</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78003</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid suppress/stimul</ENT>
              <ENT>0.00</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78006</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thyroid imaging with uptake</ENT>
              <ENT>0.49</ENT>
              <ENT>2.55</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>3.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78006</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid imaging with uptake</ENT>
              <ENT>0.49</ENT>
              <ENT>0.17</ENT>
              <ENT>0.17</ENT>
              <ENT>0.02</ENT>
              <ENT>0.68</ENT>
              <ENT>0.68</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78006</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid imaging with uptake</ENT>
              <ENT>0.00</ENT>
              <ENT>2.38</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78007</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thyroid image, mult uptakes</ENT>
              <ENT>0.50</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78007</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid image, mult uptakes</ENT>
              <ENT>0.50</ENT>
              <ENT>0.17</ENT>
              <ENT>0.17</ENT>
              <ENT>0.02</ENT>
              <ENT>0.69</ENT>
              <ENT>0.69</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78007</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid image, mult uptakes</ENT>
              <ENT>0.00</ENT>
              <ENT>2.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.69</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thyroid imaging</ENT>
              <ENT>0.39</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.45</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78010</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid imaging</ENT>
              <ENT>0.39</ENT>
              <ENT>0.13</ENT>
              <ENT>0.13</ENT>
              <ENT>0.02</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78010</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid imaging</ENT>
              <ENT>0.00</ENT>
              <ENT>1.82</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78011</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thyroid imaging with flow</ENT>
              <ENT>0.45</ENT>
              <ENT>2.56</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>3.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78011</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid imaging with flow</ENT>
              <ENT>0.45</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.02</ENT>
              <ENT>0.63</ENT>
              <ENT>0.63</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78011</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid imaging with flow</ENT>
              <ENT>0.00</ENT>
              <ENT>2.41</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.52</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78015</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thyroid met imaging</ENT>
              <ENT>0.67</ENT>
              <ENT>2.80</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.62</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78015</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid met imaging</ENT>
              <ENT>0.67</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.03</ENT>
              <ENT>0.93</ENT>
              <ENT>0.93</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78015</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid met imaging</ENT>
              <ENT>0.00</ENT>
              <ENT>2.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.69</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78016</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thyroid met imaging/studies</ENT>
              <ENT>0.82</ENT>
              <ENT>3.77</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78016</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid met imaging/studies</ENT>
              <ENT>0.82</ENT>
              <ENT>0.29</ENT>
              <ENT>0.29</ENT>
              <ENT>0.03</ENT>
              <ENT>1.14</ENT>
              <ENT>1.14</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78016</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid met imaging/studies</ENT>
              <ENT>0.00</ENT>
              <ENT>3.48</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.63</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78018</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thyroid met imaging, body</ENT>
              <ENT>0.86</ENT>
              <ENT>5.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.27</ENT>
              <ENT>6.86</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78018</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid met imaging, body</ENT>
              <ENT>0.86</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>0.03</ENT>
              <ENT>1.19</ENT>
              <ENT>1.19</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78018</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid met imaging, body</ENT>
              <ENT>0.00</ENT>
              <ENT>5.43</ENT>
              <ENT>N/A</ENT>
              <ENT>0.24</ENT>
              <ENT>5.67</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thyroid met uptake</ENT>
              <ENT>0.60</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>2.26</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78020</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid met uptake</ENT>
              <ENT>0.60</ENT>
              <ENT>0.21</ENT>
              <ENT>0.21</ENT>
              <ENT>0.02</ENT>
              <ENT>0.83</ENT>
              <ENT>0.83</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78020</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid met uptake</ENT>
              <ENT>0.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>1.43</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78070</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Parathyroid nuclear imaging</ENT>
              <ENT>0.82</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>3.04</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78070</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Parathyroid nuclear imaging</ENT>
              <ENT>0.82</ENT>
              <ENT>0.28</ENT>
              <ENT>0.28</ENT>
              <ENT>0.03</ENT>
              <ENT>1.13</ENT>
              <ENT>1.13</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78070</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Parathyroid nuclear imaging</ENT>
              <ENT>0.00</ENT>
              <ENT>1.82</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78075</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Adrenal nuclear imaging</ENT>
              <ENT>0.74</ENT>
              <ENT>5.69</ENT>
              <ENT>N/A</ENT>
              <ENT>0.27</ENT>
              <ENT>6.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78075</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Adrenal nuclear imaging</ENT>
              <ENT>0.74</ENT>
              <ENT>0.27</ENT>
              <ENT>0.27</ENT>
              <ENT>0.03</ENT>
              <ENT>1.04</ENT>
              <ENT>1.04</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78075</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Adrenal nuclear imaging</ENT>
              <ENT>0.00</ENT>
              <ENT>5.43</ENT>
              <ENT>N/A</ENT>
              <ENT>0.24</ENT>
              <ENT>5.67</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78099</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Endocrine nuclear procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78099</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Endocrine nuclear procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78099</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Endocrine nuclear procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78102</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bone marrow imaging, ltd</ENT>
              <ENT>0.55</ENT>
              <ENT>2.24</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78102</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Bone marrow imaging, ltd</ENT>
              <ENT>0.55</ENT>
              <ENT>0.20</ENT>
              <ENT>0.20</ENT>
              <ENT>0.02</ENT>
              <ENT>0.77</ENT>
              <ENT>0.77</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78102</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Bone marrow imaging, ltd</ENT>
              <ENT>0.00</ENT>
              <ENT>2.04</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78103</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bone marrow imaging, mult</ENT>
              <ENT>0.75</ENT>
              <ENT>3.43</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>4.35</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49203"/>
              <ENT I="01">78103</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Bone marrow imaging, mult</ENT>
              <ENT>0.75</ENT>
              <ENT>0.26</ENT>
              <ENT>0.26</ENT>
              <ENT>0.03</ENT>
              <ENT>1.04</ENT>
              <ENT>1.04</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78103</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Bone marrow imaging, mult</ENT>
              <ENT>0.00</ENT>
              <ENT>3.17</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.31</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78104</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bone marrow imaging, body</ENT>
              <ENT>0.80</ENT>
              <ENT>4.35</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>5.36</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78104</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Bone marrow imaging, body</ENT>
              <ENT>0.80</ENT>
              <ENT>0.28</ENT>
              <ENT>0.28</ENT>
              <ENT>0.03</ENT>
              <ENT>1.11</ENT>
              <ENT>1.11</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78104</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Bone marrow imaging, body</ENT>
              <ENT>0.00</ENT>
              <ENT>4.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.25</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Plasma volume, single</ENT>
              <ENT>0.19</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.27</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78110</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Plasma volume, single</ENT>
              <ENT>0.19</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.27</ENT>
              <ENT>0.27</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78110</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Plasma volume, single</ENT>
              <ENT>0.00</ENT>
              <ENT>0.95</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.00</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78111</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Plasma volume, multiple</ENT>
              <ENT>0.22</ENT>
              <ENT>2.65</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>3.00</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78111</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Plasma volume, multiple</ENT>
              <ENT>0.22</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>0.01</ENT>
              <ENT>0.31</ENT>
              <ENT>0.31</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78111</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Plasma volume, multiple</ENT>
              <ENT>0.00</ENT>
              <ENT>2.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.69</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Red cell mass, single</ENT>
              <ENT>0.23</ENT>
              <ENT>1.81</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78120</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Red cell mass, single</ENT>
              <ENT>0.23</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>0.01</ENT>
              <ENT>0.32</ENT>
              <ENT>0.32</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78120</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Red cell mass, single</ENT>
              <ENT>0.00</ENT>
              <ENT>1.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.82</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78121</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Red cell mass, multiple</ENT>
              <ENT>0.32</ENT>
              <ENT>3.03</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>3.48</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78121</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Red cell mass, multiple</ENT>
              <ENT>0.32</ENT>
              <ENT>0.12</ENT>
              <ENT>0.12</ENT>
              <ENT>0.01</ENT>
              <ENT>0.45</ENT>
              <ENT>0.45</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78121</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Red cell mass, multiple</ENT>
              <ENT>0.00</ENT>
              <ENT>2.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>3.03</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78122</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Blood volume</ENT>
              <ENT>0.45</ENT>
              <ENT>4.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.22</ENT>
              <ENT>5.43</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78122</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Blood volume</ENT>
              <ENT>0.45</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.02</ENT>
              <ENT>0.63</ENT>
              <ENT>0.63</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78122</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Blood volume</ENT>
              <ENT>0.00</ENT>
              <ENT>4.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>4.80</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Red cell survival study</ENT>
              <ENT>0.61</ENT>
              <ENT>3.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.83</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78130</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Red cell survival study</ENT>
              <ENT>0.61</ENT>
              <ENT>0.21</ENT>
              <ENT>0.21</ENT>
              <ENT>0.03</ENT>
              <ENT>0.85</ENT>
              <ENT>0.85</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78130</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Red cell survival study</ENT>
              <ENT>0.00</ENT>
              <ENT>2.85</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.97</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78135</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Red cell survival kinetics</ENT>
              <ENT>0.64</ENT>
              <ENT>5.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.24</ENT>
              <ENT>5.98</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78135</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Red cell survival kinetics</ENT>
              <ENT>0.64</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>0.03</ENT>
              <ENT>0.89</ENT>
              <ENT>0.89</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78135</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Red cell survival kinetics</ENT>
              <ENT>0.00</ENT>
              <ENT>4.87</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>5.08</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Red cell sequestration</ENT>
              <ENT>0.61</ENT>
              <ENT>4.14</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>4.95</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78140</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Red cell sequestration</ENT>
              <ENT>0.61</ENT>
              <ENT>0.21</ENT>
              <ENT>0.21</ENT>
              <ENT>0.03</ENT>
              <ENT>0.85</ENT>
              <ENT>0.85</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78140</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Red cell sequestration</ENT>
              <ENT>0.00</ENT>
              <ENT>3.94</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>4.11</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78160</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Plasma iron turnover</ENT>
              <ENT>0.33</ENT>
              <ENT>3.79</ENT>
              <ENT>N/A</ENT>
              <ENT>0.19</ENT>
              <ENT>4.31</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78160</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Plasma iron turnover</ENT>
              <ENT>0.33</ENT>
              <ENT>0.12</ENT>
              <ENT>0.12</ENT>
              <ENT>0.03</ENT>
              <ENT>0.48</ENT>
              <ENT>0.48</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78160</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Plasma iron turnover</ENT>
              <ENT>0.00</ENT>
              <ENT>3.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.16</ENT>
              <ENT>3.83</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78162</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radioiron absorption exam</ENT>
              <ENT>0.45</ENT>
              <ENT>3.39</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.99</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78162</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Radioiron absorption exam</ENT>
              <ENT>0.45</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.01</ENT>
              <ENT>0.65</ENT>
              <ENT>0.65</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78162</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Radioiron absorption exam</ENT>
              <ENT>0.00</ENT>
              <ENT>3.20</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.34</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78170</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Red cell iron utilization</ENT>
              <ENT>0.41</ENT>
              <ENT>5.45</ENT>
              <ENT>N/A</ENT>
              <ENT>0.27</ENT>
              <ENT>6.13</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78170</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Red cell iron utilization</ENT>
              <ENT>0.41</ENT>
              <ENT>0.14</ENT>
              <ENT>0.14</ENT>
              <ENT>0.04</ENT>
              <ENT>0.59</ENT>
              <ENT>0.59</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78170</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Red cell iron utilization</ENT>
              <ENT>0.00</ENT>
              <ENT>5.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.23</ENT>
              <ENT>5.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78172</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Total body iron estimation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78172</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Total body iron estimation</ENT>
              <ENT>0.53</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.02</ENT>
              <ENT>0.73</ENT>
              <ENT>0.73</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78172</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Total body iron estimation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78185</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Spleen imaging</ENT>
              <ENT>0.40</ENT>
              <ENT>2.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>3.03</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78185</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Spleen imaging</ENT>
              <ENT>0.40</ENT>
              <ENT>0.14</ENT>
              <ENT>0.14</ENT>
              <ENT>0.02</ENT>
              <ENT>0.56</ENT>
              <ENT>0.56</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78185</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Spleen imaging</ENT>
              <ENT>0.00</ENT>
              <ENT>2.36</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.47</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78190</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Platelet survival, kinetics</ENT>
              <ENT>1.09</ENT>
              <ENT>6.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.50</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78190</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Platelet survival, kinetics</ENT>
              <ENT>1.09</ENT>
              <ENT>0.39</ENT>
              <ENT>0.39</ENT>
              <ENT>0.06</ENT>
              <ENT>1.54</ENT>
              <ENT>1.54</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78190</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Platelet survival, kinetics</ENT>
              <ENT>0.00</ENT>
              <ENT>5.72</ENT>
              <ENT>N/A</ENT>
              <ENT>0.25</ENT>
              <ENT>5.97</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78191</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Platelet survival</ENT>
              <ENT>0.61</ENT>
              <ENT>7.55</ENT>
              <ENT>N/A</ENT>
              <ENT>0.34</ENT>
              <ENT>8.50</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78191</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Platelet survival</ENT>
              <ENT>0.61</ENT>
              <ENT>0.21</ENT>
              <ENT>0.21</ENT>
              <ENT>0.03</ENT>
              <ENT>0.85</ENT>
              <ENT>0.85</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78191</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Platelet survival</ENT>
              <ENT>0.00</ENT>
              <ENT>7.34</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78195</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lymph system imaging</ENT>
              <ENT>1.20</ENT>
              <ENT>4.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.23</ENT>
              <ENT>5.92</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78195</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Lymph system imaging</ENT>
              <ENT>1.20</ENT>
              <ENT>0.42</ENT>
              <ENT>0.42</ENT>
              <ENT>0.05</ENT>
              <ENT>1.67</ENT>
              <ENT>1.67</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78195</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Lymph system imaging</ENT>
              <ENT>0.00</ENT>
              <ENT>4.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.25</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78199</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Blood/lymph nuclear exam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78199</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Blood/lymph nuclear exam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78199</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Blood/lymph nuclear exam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78201</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Liver imaging</ENT>
              <ENT>0.44</ENT>
              <ENT>2.51</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>3.08</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78201</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Liver imaging</ENT>
              <ENT>0.44</ENT>
              <ENT>0.15</ENT>
              <ENT>0.15</ENT>
              <ENT>0.02</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78201</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Liver imaging</ENT>
              <ENT>0.00</ENT>
              <ENT>2.36</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.47</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78202</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Liver imaging with flow</ENT>
              <ENT>0.51</ENT>
              <ENT>3.06</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78202</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Liver imaging with flow</ENT>
              <ENT>0.51</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.02</ENT>
              <ENT>0.71</ENT>
              <ENT>0.71</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49204"/>
              <ENT I="01">78202</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Liver imaging with flow</ENT>
              <ENT>0.00</ENT>
              <ENT>2.88</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>3.00</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78205</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Liver imaging (3D)</ENT>
              <ENT>0.71</ENT>
              <ENT>6.16</ENT>
              <ENT>N/A</ENT>
              <ENT>0.29</ENT>
              <ENT>7.16</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78205</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Liver imaging (3D)</ENT>
              <ENT>0.71</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.03</ENT>
              <ENT>0.99</ENT>
              <ENT>0.99</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78205</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Liver imaging (3D)</ENT>
              <ENT>0.00</ENT>
              <ENT>5.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.26</ENT>
              <ENT>6.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78206</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Liver image (3d) with flow</ENT>
              <ENT>0.96</ENT>
              <ENT>6.25</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>7.34</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78206</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Liver image (3d) with flow</ENT>
              <ENT>0.96</ENT>
              <ENT>0.34</ENT>
              <ENT>0.34</ENT>
              <ENT>0.04</ENT>
              <ENT>1.34</ENT>
              <ENT>1.34</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78206</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Liver image (3d) with flow</ENT>
              <ENT>0.00</ENT>
              <ENT>5.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>6.00</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78215</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Liver and spleen imaging</ENT>
              <ENT>0.49</ENT>
              <ENT>3.11</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78215</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Liver and spleen imaging</ENT>
              <ENT>0.49</ENT>
              <ENT>0.17</ENT>
              <ENT>0.17</ENT>
              <ENT>0.02</ENT>
              <ENT>0.68</ENT>
              <ENT>0.68</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78215</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Liver and spleen imaging</ENT>
              <ENT>0.00</ENT>
              <ENT>2.94</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>3.06</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78216</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Liver &amp; spleen image/flow</ENT>
              <ENT>0.57</ENT>
              <ENT>3.68</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>4.42</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78216</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Liver &amp; spleen image/flow</ENT>
              <ENT>0.57</ENT>
              <ENT>0.20</ENT>
              <ENT>0.20</ENT>
              <ENT>0.02</ENT>
              <ENT>0.79</ENT>
              <ENT>0.79</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78216</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Liver &amp; spleen image/flow</ENT>
              <ENT>0.00</ENT>
              <ENT>3.48</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.63</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Liver function study</ENT>
              <ENT>0.49</ENT>
              <ENT>3.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.56</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78220</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Liver function study</ENT>
              <ENT>0.49</ENT>
              <ENT>0.17</ENT>
              <ENT>0.17</ENT>
              <ENT>0.02</ENT>
              <ENT>0.68</ENT>
              <ENT>0.68</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78220</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Liver function study</ENT>
              <ENT>0.00</ENT>
              <ENT>3.72</ENT>
              <ENT>N/A</ENT>
              <ENT>0.16</ENT>
              <ENT>3.88</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78223</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hepatobiliary imaging</ENT>
              <ENT>0.84</ENT>
              <ENT>3.95</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>4.99</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78223</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Hepatobiliary imaging</ENT>
              <ENT>0.84</ENT>
              <ENT>0.29</ENT>
              <ENT>0.29</ENT>
              <ENT>0.04</ENT>
              <ENT>1.17</ENT>
              <ENT>1.17</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78223</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Hepatobiliary imaging</ENT>
              <ENT>0.00</ENT>
              <ENT>3.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.16</ENT>
              <ENT>3.83</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78230</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Salivary gland imaging</ENT>
              <ENT>0.45</ENT>
              <ENT>2.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>2.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78230</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Salivary gland imaging</ENT>
              <ENT>0.45</ENT>
              <ENT>0.15</ENT>
              <ENT>0.15</ENT>
              <ENT>0.02</ENT>
              <ENT>0.62</ENT>
              <ENT>0.62</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78230</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Salivary gland imaging</ENT>
              <ENT>0.00</ENT>
              <ENT>2.18</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.29</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78231</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Serial salivary imaging</ENT>
              <ENT>0.52</ENT>
              <ENT>3.36</ENT>
              <ENT>N/A</ENT>
              <ENT>0.16</ENT>
              <ENT>4.04</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78231</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Serial salivary imaging</ENT>
              <ENT>0.52</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.02</ENT>
              <ENT>0.73</ENT>
              <ENT>0.73</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78231</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Serial salivary imaging</ENT>
              <ENT>0.00</ENT>
              <ENT>3.17</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.31</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78232</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Salivary gland function exam</ENT>
              <ENT>0.47</ENT>
              <ENT>3.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.16</ENT>
              <ENT>4.34</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78232</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Salivary gland function exam</ENT>
              <ENT>0.47</ENT>
              <ENT>0.17</ENT>
              <ENT>0.17</ENT>
              <ENT>0.01</ENT>
              <ENT>0.65</ENT>
              <ENT>0.65</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78232</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Salivary gland function exam</ENT>
              <ENT>0.00</ENT>
              <ENT>3.54</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.69</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78258</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esophageal motility study</ENT>
              <ENT>0.74</ENT>
              <ENT>3.13</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>4.02</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78258</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Esophageal motility study</ENT>
              <ENT>0.74</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.03</ENT>
              <ENT>1.02</ENT>
              <ENT>1.02</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78258</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Esophageal motility study</ENT>
              <ENT>0.00</ENT>
              <ENT>2.88</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>3.00</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78261</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Gastric mucosa imaging</ENT>
              <ENT>0.69</ENT>
              <ENT>4.35</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>5.25</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78261</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Gastric mucosa imaging</ENT>
              <ENT>0.69</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.03</ENT>
              <ENT>0.97</ENT>
              <ENT>0.97</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78261</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Gastric mucosa imaging</ENT>
              <ENT>0.00</ENT>
              <ENT>4.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.28</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78262</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Gastroesophageal reflux exam</ENT>
              <ENT>0.68</ENT>
              <ENT>4.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>5.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78262</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Gastroesophageal reflux exam</ENT>
              <ENT>0.68</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>0.03</ENT>
              <ENT>0.95</ENT>
              <ENT>0.95</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78262</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Gastroesophageal reflux exam</ENT>
              <ENT>0.00</ENT>
              <ENT>4.26</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78264</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Gastric emptying study</ENT>
              <ENT>0.78</ENT>
              <ENT>4.40</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>5.39</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78264</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Gastric emptying study</ENT>
              <ENT>0.78</ENT>
              <ENT>0.27</ENT>
              <ENT>0.27</ENT>
              <ENT>0.03</ENT>
              <ENT>1.08</ENT>
              <ENT>1.08</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78264</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Gastric emptying study</ENT>
              <ENT>0.00</ENT>
              <ENT>4.13</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.31</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78270</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vit B-12 absorption exam</ENT>
              <ENT>0.20</ENT>
              <ENT>1.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78270</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vit B-12 absorption exam</ENT>
              <ENT>0.20</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.28</ENT>
              <ENT>0.28</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78270</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vit B-12 absorption exam</ENT>
              <ENT>0.00</ENT>
              <ENT>1.55</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.63</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78271</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vit b-12 absrp exam, int fac</ENT>
              <ENT>0.20</ENT>
              <ENT>1.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.00</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78271</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vit b-12 absrp exam, int fac</ENT>
              <ENT>0.20</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.28</ENT>
              <ENT>0.28</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78271</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vit b-12 absrp exam, int fac</ENT>
              <ENT>0.00</ENT>
              <ENT>1.64</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.72</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78272</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vit B-12 absorp, combined</ENT>
              <ENT>0.27</ENT>
              <ENT>2.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.81</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78272</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vit B-12 absorp, combined</ENT>
              <ENT>0.27</ENT>
              <ENT>0.10</ENT>
              <ENT>0.10</ENT>
              <ENT>0.01</ENT>
              <ENT>0.38</ENT>
              <ENT>0.38</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78272</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vit B-12 absorp, combined</ENT>
              <ENT>0.00</ENT>
              <ENT>2.32</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.43</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78278</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Acute GI blood loss imaging</ENT>
              <ENT>0.99</ENT>
              <ENT>5.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.25</ENT>
              <ENT>6.45</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78278</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Acute GI blood loss imaging</ENT>
              <ENT>0.99</ENT>
              <ENT>0.34</ENT>
              <ENT>0.34</ENT>
              <ENT>0.04</ENT>
              <ENT>1.37</ENT>
              <ENT>1.37</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78278</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Acute GI blood loss imaging</ENT>
              <ENT>0.00</ENT>
              <ENT>4.87</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>5.08</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78282</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>GI protein loss exam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78282</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>GI protein loss exam</ENT>
              <ENT>0.38</ENT>
              <ENT>0.13</ENT>
              <ENT>0.13</ENT>
              <ENT>0.02</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49205"/>
              <ENT I="01">78282</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>GI protein loss exam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78290</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Meckel's divert exam</ENT>
              <ENT>0.68</ENT>
              <ENT>3.28</ENT>
              <ENT>N/A</ENT>
              <ENT>0.16</ENT>
              <ENT>4.12</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78290</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Meckel's divert exam</ENT>
              <ENT>0.68</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.03</ENT>
              <ENT>0.94</ENT>
              <ENT>0.94</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78290</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Meckel's divert exam</ENT>
              <ENT>0.00</ENT>
              <ENT>3.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>3.18</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78291</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Leveen/shunt patency exam</ENT>
              <ENT>0.88</ENT>
              <ENT>3.37</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>4.42</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78291</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Leveen/shunt patency exam</ENT>
              <ENT>0.88</ENT>
              <ENT>0.31</ENT>
              <ENT>0.31</ENT>
              <ENT>0.04</ENT>
              <ENT>1.23</ENT>
              <ENT>1.23</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78291</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Leveen/shunt patency exam</ENT>
              <ENT>0.00</ENT>
              <ENT>3.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>3.20</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78299</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>GI nuclear procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78299</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>GI nuclear procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78299</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>GI nuclear procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bone imaging, limited area</ENT>
              <ENT>0.62</ENT>
              <ENT>2.70</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.47</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78300</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Bone imaging, limited area</ENT>
              <ENT>0.62</ENT>
              <ENT>0.21</ENT>
              <ENT>0.21</ENT>
              <ENT>0.03</ENT>
              <ENT>0.86</ENT>
              <ENT>0.86</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78300</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Bone imaging, limited area</ENT>
              <ENT>0.00</ENT>
              <ENT>2.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.61</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78305</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bone imaging, multiple areas</ENT>
              <ENT>0.83</ENT>
              <ENT>3.95</ENT>
              <ENT>N/A</ENT>
              <ENT>0.19</ENT>
              <ENT>4.97</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78305</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Bone imaging, multiple areas</ENT>
              <ENT>0.83</ENT>
              <ENT>0.28</ENT>
              <ENT>0.28</ENT>
              <ENT>0.03</ENT>
              <ENT>1.14</ENT>
              <ENT>1.14</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78305</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Bone imaging, multiple areas</ENT>
              <ENT>0.00</ENT>
              <ENT>3.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.16</ENT>
              <ENT>3.83</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78306</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bone imaging, whole body</ENT>
              <ENT>0.86</ENT>
              <ENT>4.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.22</ENT>
              <ENT>5.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78306</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Bone imaging, whole body</ENT>
              <ENT>0.86</ENT>
              <ENT>0.29</ENT>
              <ENT>0.29</ENT>
              <ENT>0.04</ENT>
              <ENT>1.19</ENT>
              <ENT>1.19</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78306</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Bone imaging, whole body</ENT>
              <ENT>0.00</ENT>
              <ENT>4.27</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.45</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78315</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bone imaging, 3 phase</ENT>
              <ENT>1.02</ENT>
              <ENT>5.13</ENT>
              <ENT>N/A</ENT>
              <ENT>0.25</ENT>
              <ENT>6.40</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78315</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Bone imaging, 3 phase</ENT>
              <ENT>1.02</ENT>
              <ENT>0.35</ENT>
              <ENT>0.35</ENT>
              <ENT>0.04</ENT>
              <ENT>1.41</ENT>
              <ENT>1.41</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78315</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Bone imaging, 3 phase</ENT>
              <ENT>0.00</ENT>
              <ENT>4.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>4.99</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bone imaging (3D)</ENT>
              <ENT>1.04</ENT>
              <ENT>6.28</ENT>
              <ENT>N/A</ENT>
              <ENT>0.30</ENT>
              <ENT>7.62</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78320</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Bone imaging (3D)</ENT>
              <ENT>1.04</ENT>
              <ENT>0.37</ENT>
              <ENT>0.37</ENT>
              <ENT>0.04</ENT>
              <ENT>1.45</ENT>
              <ENT>1.45</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78320</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Bone imaging (3D)</ENT>
              <ENT>0.00</ENT>
              <ENT>5.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.26</ENT>
              <ENT>6.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78350</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bone mineral, single photon</ENT>
              <ENT>0.22</ENT>
              <ENT>0.83</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78350</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Bone mineral, single photon</ENT>
              <ENT>0.22</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>0.01</ENT>
              <ENT>0.31</ENT>
              <ENT>0.31</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78350</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Bone mineral, single photon</ENT>
              <ENT>0.00</ENT>
              <ENT>0.75</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78351</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Bone mineral, dual photon</ENT>
              <ENT>0.30</ENT>
              <ENT>1.76</ENT>
              <ENT>0.12</ENT>
              <ENT>0.01</ENT>
              <ENT>2.07</ENT>
              <ENT>0.43</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78399</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Musculoskeletal nuclear exam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78399</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Musculoskeletal nuclear exam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78399</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Musculoskeletal nuclear exam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78414</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Non-imaging heart function</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78414</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Non-imaging heart function</ENT>
              <ENT>0.45</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.02</ENT>
              <ENT>0.63</ENT>
              <ENT>0.63</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78414</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Non-imaging heart function</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78428</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cardiac shunt imaging</ENT>
              <ENT>0.78</ENT>
              <ENT>2.55</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.47</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78428</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cardiac shunt imaging</ENT>
              <ENT>0.78</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>0.03</ENT>
              <ENT>1.11</ENT>
              <ENT>1.11</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78428</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cardiac shunt imaging</ENT>
              <ENT>0.00</ENT>
              <ENT>2.25</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.36</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78445</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vascular flow imaging</ENT>
              <ENT>0.49</ENT>
              <ENT>2.03</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.63</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78445</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vascular flow imaging</ENT>
              <ENT>0.49</ENT>
              <ENT>0.17</ENT>
              <ENT>0.17</ENT>
              <ENT>0.02</ENT>
              <ENT>0.68</ENT>
              <ENT>0.68</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78445</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vascular flow imaging</ENT>
              <ENT>0.00</ENT>
              <ENT>1.86</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78455</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Venous thrombosis study</ENT>
              <ENT>0.73</ENT>
              <ENT>4.24</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>5.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78455</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Venous thrombosis study</ENT>
              <ENT>0.73</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.03</ENT>
              <ENT>1.01</ENT>
              <ENT>1.01</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78455</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Venous thrombosis study</ENT>
              <ENT>0.00</ENT>
              <ENT>3.98</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>4.15</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78456</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Acute venous thrombus image</ENT>
              <ENT>1.00</ENT>
              <ENT>4.34</ENT>
              <ENT>N/A</ENT>
              <ENT>0.28</ENT>
              <ENT>5.62</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78456</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Acute venous thrombus image</ENT>
              <ENT>1.00</ENT>
              <ENT>0.35</ENT>
              <ENT>0.35</ENT>
              <ENT>0.04</ENT>
              <ENT>1.39</ENT>
              <ENT>1.39</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78456</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Acute venous thrombus image</ENT>
              <ENT>0.00</ENT>
              <ENT>3.98</ENT>
              <ENT>N/A</ENT>
              <ENT>0.24</ENT>
              <ENT>4.22</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49206"/>
              <ENT I="01">78457</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Venous thrombosis imaging</ENT>
              <ENT>0.77</ENT>
              <ENT>2.92</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.84</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78457</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Venous thrombosis imaging</ENT>
              <ENT>0.77</ENT>
              <ENT>0.27</ENT>
              <ENT>0.27</ENT>
              <ENT>0.03</ENT>
              <ENT>1.07</ENT>
              <ENT>1.07</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78457</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Venous thrombosis imaging</ENT>
              <ENT>0.00</ENT>
              <ENT>2.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78458</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ven thrombosis images, bilat</ENT>
              <ENT>0.90</ENT>
              <ENT>4.35</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>5.45</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78458</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ven thrombosis images, bilat</ENT>
              <ENT>0.90</ENT>
              <ENT>0.33</ENT>
              <ENT>0.33</ENT>
              <ENT>0.03</ENT>
              <ENT>1.26</ENT>
              <ENT>1.26</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78458</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ven thrombosis images, bilat</ENT>
              <ENT>0.00</ENT>
              <ENT>4.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>4.19</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78459</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Heart muscle imaging (PET)</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78459</ENT>
              <ENT>26</ENT>
              <ENT>R</ENT>
              <ENT>Heart muscle imaging (PET)</ENT>
              <ENT>1.50</ENT>
              <ENT>0.58</ENT>
              <ENT>0.58</ENT>
              <ENT>0.04</ENT>
              <ENT>2.12</ENT>
              <ENT>2.12</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78459</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Heart muscle imaging (PET)</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78460</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Heart muscle blood, single</ENT>
              <ENT>0.86</ENT>
              <ENT>2.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.66</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78460</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Heart muscle blood, single</ENT>
              <ENT>0.86</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>0.03</ENT>
              <ENT>1.19</ENT>
              <ENT>1.19</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78460</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Heart muscle blood, single</ENT>
              <ENT>0.00</ENT>
              <ENT>2.36</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.47</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78461</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Heart muscle blood, multiple</ENT>
              <ENT>1.23</ENT>
              <ENT>5.16</ENT>
              <ENT>N/A</ENT>
              <ENT>0.26</ENT>
              <ENT>6.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78461</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Heart muscle blood, multiple</ENT>
              <ENT>1.23</ENT>
              <ENT>0.44</ENT>
              <ENT>0.44</ENT>
              <ENT>0.05</ENT>
              <ENT>1.72</ENT>
              <ENT>1.72</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78461</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Heart muscle blood, multiple</ENT>
              <ENT>0.00</ENT>
              <ENT>4.72</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>4.93</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78464</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Heart image (3d), single</ENT>
              <ENT>1.09</ENT>
              <ENT>7.46</ENT>
              <ENT>N/A</ENT>
              <ENT>0.35</ENT>
              <ENT>8.90</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78464</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Heart image (3d), single</ENT>
              <ENT>1.09</ENT>
              <ENT>0.39</ENT>
              <ENT>0.39</ENT>
              <ENT>0.04</ENT>
              <ENT>1.52</ENT>
              <ENT>1.52</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78464</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Heart image (3d), single</ENT>
              <ENT>0.00</ENT>
              <ENT>7.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78465</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Heart image (3d), multiple</ENT>
              <ENT>1.46</ENT>
              <ENT>12.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.56</ENT>
              <ENT>14.35</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78465</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Heart image (3d), multiple</ENT>
              <ENT>1.46</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>0.05</ENT>
              <ENT>2.04</ENT>
              <ENT>2.04</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78465</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Heart image (3d), multiple</ENT>
              <ENT>0.00</ENT>
              <ENT>11.80</ENT>
              <ENT>N/A</ENT>
              <ENT>0.51</ENT>
              <ENT>12.31</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78466</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Heart infarct image</ENT>
              <ENT>0.69</ENT>
              <ENT>2.87</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78466</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Heart infarct image</ENT>
              <ENT>0.69</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.03</ENT>
              <ENT>0.97</ENT>
              <ENT>0.97</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78466</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Heart infarct image</ENT>
              <ENT>0.00</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78468</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Heart infarct image (ef)</ENT>
              <ENT>0.80</ENT>
              <ENT>3.95</ENT>
              <ENT>N/A</ENT>
              <ENT>0.19</ENT>
              <ENT>4.94</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78468</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Heart infarct image (ef)</ENT>
              <ENT>0.80</ENT>
              <ENT>0.28</ENT>
              <ENT>0.28</ENT>
              <ENT>0.03</ENT>
              <ENT>1.11</ENT>
              <ENT>1.11</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78468</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Heart infarct image (ef)</ENT>
              <ENT>0.00</ENT>
              <ENT>3.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.16</ENT>
              <ENT>3.83</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78469</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Heart infarct image (3D)</ENT>
              <ENT>0.92</ENT>
              <ENT>5.54</ENT>
              <ENT>N/A</ENT>
              <ENT>0.26</ENT>
              <ENT>6.72</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78469</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Heart infarct image (3D)</ENT>
              <ENT>0.92</ENT>
              <ENT>0.32</ENT>
              <ENT>0.32</ENT>
              <ENT>0.03</ENT>
              <ENT>1.27</ENT>
              <ENT>1.27</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78469</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Heart infarct image (3D)</ENT>
              <ENT>0.00</ENT>
              <ENT>5.22</ENT>
              <ENT>N/A</ENT>
              <ENT>0.23</ENT>
              <ENT>5.45</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78472</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Gated heart, planar, single</ENT>
              <ENT>0.98</ENT>
              <ENT>5.86</ENT>
              <ENT>N/A</ENT>
              <ENT>0.29</ENT>
              <ENT>7.13</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78472</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Gated heart, planar, single</ENT>
              <ENT>0.98</ENT>
              <ENT>0.35</ENT>
              <ENT>0.35</ENT>
              <ENT>0.04</ENT>
              <ENT>1.37</ENT>
              <ENT>1.37</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78472</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Gated heart, planar, single</ENT>
              <ENT>0.00</ENT>
              <ENT>5.51</ENT>
              <ENT>N/A</ENT>
              <ENT>0.25</ENT>
              <ENT>5.76</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78473</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Gated heart, multiple</ENT>
              <ENT>1.47</ENT>
              <ENT>8.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.40</ENT>
              <ENT>10.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78473</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Gated heart, multiple</ENT>
              <ENT>1.47</ENT>
              <ENT>0.52</ENT>
              <ENT>0.52</ENT>
              <ENT>0.05</ENT>
              <ENT>2.04</ENT>
              <ENT>2.04</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78473</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Gated heart, multiple</ENT>
              <ENT>0.00</ENT>
              <ENT>8.26</ENT>
              <ENT>N/A</ENT>
              <ENT>0.35</ENT>
              <ENT>8.61</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78478</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Heart wall motion add-on</ENT>
              <ENT>0.62</ENT>
              <ENT>1.79</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.51</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78478</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Heart wall motion add-on</ENT>
              <ENT>0.62</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.02</ENT>
              <ENT>0.87</ENT>
              <ENT>0.87</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78478</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Heart wall motion add-on</ENT>
              <ENT>0.00</ENT>
              <ENT>1.56</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.64</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78480</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Heart function add-on</ENT>
              <ENT>0.62</ENT>
              <ENT>1.79</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.51</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78480</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Heart function add-on</ENT>
              <ENT>0.62</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.02</ENT>
              <ENT>0.87</ENT>
              <ENT>0.87</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78480</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Heart function add-on</ENT>
              <ENT>0.00</ENT>
              <ENT>1.56</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.64</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78481</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Heart first pass, single</ENT>
              <ENT>0.98</ENT>
              <ENT>5.59</ENT>
              <ENT>N/A</ENT>
              <ENT>0.26</ENT>
              <ENT>6.83</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78481</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Heart first pass, single</ENT>
              <ENT>0.98</ENT>
              <ENT>0.37</ENT>
              <ENT>0.37</ENT>
              <ENT>0.03</ENT>
              <ENT>1.38</ENT>
              <ENT>1.38</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78481</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Heart first pass, single</ENT>
              <ENT>0.00</ENT>
              <ENT>5.22</ENT>
              <ENT>N/A</ENT>
              <ENT>0.23</ENT>
              <ENT>5.45</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78483</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Heart first pass, multiple</ENT>
              <ENT>1.47</ENT>
              <ENT>8.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.39</ENT>
              <ENT>10.28</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78483</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Heart first pass, multiple</ENT>
              <ENT>1.47</ENT>
              <ENT>0.55</ENT>
              <ENT>0.55</ENT>
              <ENT>0.05</ENT>
              <ENT>2.07</ENT>
              <ENT>2.07</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78483</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Heart first pass, multiple</ENT>
              <ENT>0.00</ENT>
              <ENT>7.87</ENT>
              <ENT>N/A</ENT>
              <ENT>0.34</ENT>
              <ENT>8.21</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78491</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Heart image (pet), single</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78491</ENT>
              <ENT>26</ENT>
              <ENT>I</ENT>
              <ENT>Heart image (pet), single</ENT>
              <ENT>1.50</ENT>
              <ENT>0.60</ENT>
              <ENT>0.60</ENT>
              <ENT>0.05</ENT>
              <ENT>2.15</ENT>
              <ENT>2.15</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78491</ENT>
              <ENT>TC</ENT>
              <ENT>I</ENT>
              <ENT>Heart image (pet), single</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78492</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Heart image (pet), multiple</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78492</ENT>
              <ENT>26</ENT>
              <ENT>I</ENT>
              <ENT>Heart image (pet), multiple</ENT>
              <ENT>1.87</ENT>
              <ENT>0.75</ENT>
              <ENT>0.75</ENT>
              <ENT>0.06</ENT>
              <ENT>2.68</ENT>
              <ENT>2.68</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78492</ENT>
              <ENT>TC</ENT>
              <ENT>I</ENT>
              <ENT>Heart image (pet), multiple</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49207"/>
              <ENT I="01">78494</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Heart image, spect</ENT>
              <ENT>1.19</ENT>
              <ENT>7.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.29</ENT>
              <ENT>8.97</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78494</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Heart image, spect</ENT>
              <ENT>1.19</ENT>
              <ENT>0.43</ENT>
              <ENT>0.43</ENT>
              <ENT>0.04</ENT>
              <ENT>1.66</ENT>
              <ENT>1.66</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78494</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Heart image, spect</ENT>
              <ENT>0.00</ENT>
              <ENT>7.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.25</ENT>
              <ENT>7.32</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78496</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Heart first pass add-on</ENT>
              <ENT>0.50</ENT>
              <ENT>7.25</ENT>
              <ENT>N/A</ENT>
              <ENT>0.27</ENT>
              <ENT>8.02</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78496</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Heart first pass add-on</ENT>
              <ENT>0.50</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.02</ENT>
              <ENT>0.71</ENT>
              <ENT>0.71</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78496</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Heart first pass add-on</ENT>
              <ENT>0.00</ENT>
              <ENT>7.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.25</ENT>
              <ENT>7.32</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78499</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Cardiovascular nuclear exam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78499</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Cardiovascular nuclear exam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78499</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Cardiovascular nuclear exam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78580</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lung perfusion imaging</ENT>
              <ENT>0.74</ENT>
              <ENT>3.69</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.61</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78580</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Lung perfusion imaging</ENT>
              <ENT>0.74</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.03</ENT>
              <ENT>1.02</ENT>
              <ENT>1.02</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78580</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Lung perfusion imaging</ENT>
              <ENT>0.00</ENT>
              <ENT>3.43</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.58</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78584</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lung V/Q image single breath</ENT>
              <ENT>0.99</ENT>
              <ENT>3.53</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78584</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Lung V/Q image single breath</ENT>
              <ENT>0.99</ENT>
              <ENT>0.33</ENT>
              <ENT>0.33</ENT>
              <ENT>0.04</ENT>
              <ENT>1.36</ENT>
              <ENT>1.36</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78584</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Lung V/Q image single breath</ENT>
              <ENT>0.00</ENT>
              <ENT>3.20</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.34</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78585</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lung V/Q imaging</ENT>
              <ENT>1.09</ENT>
              <ENT>6.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.30</ENT>
              <ENT>7.40</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78585</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Lung V/Q imaging</ENT>
              <ENT>1.09</ENT>
              <ENT>0.37</ENT>
              <ENT>0.37</ENT>
              <ENT>0.05</ENT>
              <ENT>1.51</ENT>
              <ENT>1.51</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78585</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Lung V/Q imaging</ENT>
              <ENT>0.00</ENT>
              <ENT>5.64</ENT>
              <ENT>N/A</ENT>
              <ENT>0.25</ENT>
              <ENT>5.89</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78586</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Aerosol lung image, single</ENT>
              <ENT>0.40</ENT>
              <ENT>2.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.27</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78586</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Aerosol lung image, single</ENT>
              <ENT>0.40</ENT>
              <ENT>0.13</ENT>
              <ENT>0.13</ENT>
              <ENT>0.02</ENT>
              <ENT>0.55</ENT>
              <ENT>0.55</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78586</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Aerosol lung image, single</ENT>
              <ENT>0.00</ENT>
              <ENT>2.59</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78587</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Aerosol lung image, multiple</ENT>
              <ENT>0.49</ENT>
              <ENT>2.97</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78587</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Aerosol lung image, multiple</ENT>
              <ENT>0.49</ENT>
              <ENT>0.17</ENT>
              <ENT>0.17</ENT>
              <ENT>0.02</ENT>
              <ENT>0.68</ENT>
              <ENT>0.68</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78587</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Aerosol lung image, multiple</ENT>
              <ENT>0.00</ENT>
              <ENT>2.80</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.92</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78588</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Perfusion lung image</ENT>
              <ENT>1.09</ENT>
              <ENT>3.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>4.86</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78588</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Perfusion lung image</ENT>
              <ENT>1.09</ENT>
              <ENT>0.37</ENT>
              <ENT>0.37</ENT>
              <ENT>0.05</ENT>
              <ENT>1.51</ENT>
              <ENT>1.51</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78588</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Perfusion lung image</ENT>
              <ENT>0.00</ENT>
              <ENT>3.20</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.35</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78591</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vent image, 1 breath, 1 proj</ENT>
              <ENT>0.40</ENT>
              <ENT>2.99</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.53</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78591</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vent image, 1 breath, 1 proj</ENT>
              <ENT>0.40</ENT>
              <ENT>0.14</ENT>
              <ENT>0.14</ENT>
              <ENT>0.02</ENT>
              <ENT>0.56</ENT>
              <ENT>0.56</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78591</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vent image, 1 breath, 1 proj</ENT>
              <ENT>0.00</ENT>
              <ENT>2.85</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.97</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78593</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vent image, 1 proj, gas</ENT>
              <ENT>0.49</ENT>
              <ENT>3.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>4.28</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78593</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vent image, 1 proj, gas</ENT>
              <ENT>0.49</ENT>
              <ENT>0.17</ENT>
              <ENT>0.17</ENT>
              <ENT>0.02</ENT>
              <ENT>0.68</ENT>
              <ENT>0.68</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78593</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vent image, 1 proj, gas</ENT>
              <ENT>0.00</ENT>
              <ENT>3.45</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78594</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vent image, mult proj, gas</ENT>
              <ENT>0.53</ENT>
              <ENT>5.17</ENT>
              <ENT>N/A</ENT>
              <ENT>0.23</ENT>
              <ENT>5.93</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78594</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vent image, mult proj, gas</ENT>
              <ENT>0.53</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.02</ENT>
              <ENT>0.73</ENT>
              <ENT>0.73</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78594</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vent image, mult proj, gas</ENT>
              <ENT>0.00</ENT>
              <ENT>4.98</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>5.19</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78596</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lung differential function</ENT>
              <ENT>1.27</ENT>
              <ENT>7.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>9.13</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78596</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Lung differential function</ENT>
              <ENT>1.27</ENT>
              <ENT>0.43</ENT>
              <ENT>0.43</ENT>
              <ENT>0.05</ENT>
              <ENT>1.75</ENT>
              <ENT>1.75</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78596</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Lung differential function</ENT>
              <ENT>0.00</ENT>
              <ENT>7.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78599</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Respiratory nuclear exam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78599</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Respiratory nuclear exam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78599</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Respiratory nuclear exam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Brain imaging, ltd static</ENT>
              <ENT>0.44</ENT>
              <ENT>3.04</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.62</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78600</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Brain imaging, ltd static</ENT>
              <ENT>0.44</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.02</ENT>
              <ENT>0.62</ENT>
              <ENT>0.62</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78600</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Brain imaging, ltd static</ENT>
              <ENT>0.00</ENT>
              <ENT>2.88</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>3.00</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78601</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Brain imaging, ltd w/ flow</ENT>
              <ENT>0.51</ENT>
              <ENT>3.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>4.26</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78601</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Brain imaging, ltd w/ flow</ENT>
              <ENT>0.51</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.02</ENT>
              <ENT>0.71</ENT>
              <ENT>0.71</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78601</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Brain imaging, ltd w/ flow</ENT>
              <ENT>0.00</ENT>
              <ENT>3.40</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78605</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Brain imaging, complete</ENT>
              <ENT>0.53</ENT>
              <ENT>3.59</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>4.29</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78605</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Brain imaging, complete</ENT>
              <ENT>0.53</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.02</ENT>
              <ENT>0.74</ENT>
              <ENT>0.74</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78605</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Brain imaging, complete</ENT>
              <ENT>0.00</ENT>
              <ENT>3.40</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78606</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Brain imaging, compl w/flow</ENT>
              <ENT>0.64</ENT>
              <ENT>4.09</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>4.93</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49208"/>
              <ENT I="01">78606</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Brain imaging, compl w/flow</ENT>
              <ENT>0.64</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>0.03</ENT>
              <ENT>0.89</ENT>
              <ENT>0.89</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78606</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Brain imaging, compl w/flow</ENT>
              <ENT>0.00</ENT>
              <ENT>3.87</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>4.04</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78607</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Brain imaging (3D)</ENT>
              <ENT>1.23</ENT>
              <ENT>7.00</ENT>
              <ENT>N/A</ENT>
              <ENT>0.34</ENT>
              <ENT>8.57</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78607</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Brain imaging (3D)</ENT>
              <ENT>1.23</ENT>
              <ENT>0.44</ENT>
              <ENT>0.44</ENT>
              <ENT>0.05</ENT>
              <ENT>1.72</ENT>
              <ENT>1.72</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78607</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Brain imaging (3D)</ENT>
              <ENT>0.00</ENT>
              <ENT>6.56</ENT>
              <ENT>N/A</ENT>
              <ENT>0.29</ENT>
              <ENT>6.85</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78608</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Brain imaging (PET)</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78610</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Brain flow imaging only</ENT>
              <ENT>0.30</ENT>
              <ENT>1.69</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.08</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78610</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Brain flow imaging only</ENT>
              <ENT>0.30</ENT>
              <ENT>0.11</ENT>
              <ENT>0.11</ENT>
              <ENT>0.01</ENT>
              <ENT>0.42</ENT>
              <ENT>0.42</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78610</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Brain flow imaging only</ENT>
              <ENT>0.00</ENT>
              <ENT>1.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.66</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78615</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cerebral vascular flow image</ENT>
              <ENT>0.42</ENT>
              <ENT>4.00</ENT>
              <ENT>N/A</ENT>
              <ENT>0.19</ENT>
              <ENT>4.61</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78615</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cerebral vascular flow image</ENT>
              <ENT>0.42</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.02</ENT>
              <ENT>0.60</ENT>
              <ENT>0.60</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78615</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cerebral vascular flow image</ENT>
              <ENT>0.00</ENT>
              <ENT>3.85</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>4.02</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78630</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cerebrospinal fluid scan</ENT>
              <ENT>0.68</ENT>
              <ENT>5.27</ENT>
              <ENT>N/A</ENT>
              <ENT>0.25</ENT>
              <ENT>6.20</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78630</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cerebrospinal fluid scan</ENT>
              <ENT>0.68</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.03</ENT>
              <ENT>0.94</ENT>
              <ENT>0.94</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78630</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cerebrospinal fluid scan</ENT>
              <ENT>0.00</ENT>
              <ENT>5.04</ENT>
              <ENT>N/A</ENT>
              <ENT>0.22</ENT>
              <ENT>5.26</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78635</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>CSF ventriculography</ENT>
              <ENT>0.61</ENT>
              <ENT>2.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.53</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78635</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>CSF ventriculography</ENT>
              <ENT>0.61</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>0.02</ENT>
              <ENT>0.87</ENT>
              <ENT>0.87</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78635</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>CSF ventriculography</ENT>
              <ENT>0.00</ENT>
              <ENT>2.54</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.66</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78645</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>CSF shunt evaluation</ENT>
              <ENT>0.57</ENT>
              <ENT>3.63</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>4.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78645</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>CSF shunt evaluation</ENT>
              <ENT>0.57</ENT>
              <ENT>0.20</ENT>
              <ENT>0.20</ENT>
              <ENT>0.02</ENT>
              <ENT>0.79</ENT>
              <ENT>0.79</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78645</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>CSF shunt evaluation</ENT>
              <ENT>0.00</ENT>
              <ENT>3.43</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.58</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78647</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cerebrospinal fluid scan</ENT>
              <ENT>0.90</ENT>
              <ENT>6.23</ENT>
              <ENT>N/A</ENT>
              <ENT>0.29</ENT>
              <ENT>7.42</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78647</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cerebrospinal fluid scan</ENT>
              <ENT>0.90</ENT>
              <ENT>0.32</ENT>
              <ENT>0.32</ENT>
              <ENT>0.03</ENT>
              <ENT>1.25</ENT>
              <ENT>1.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78647</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cerebrospinal fluid scan</ENT>
              <ENT>0.00</ENT>
              <ENT>5.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.26</ENT>
              <ENT>6.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78650</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>CSF leakage imaging</ENT>
              <ENT>0.61</ENT>
              <ENT>4.86</ENT>
              <ENT>N/A</ENT>
              <ENT>0.22</ENT>
              <ENT>5.69</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78650</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>CSF leakage imaging</ENT>
              <ENT>0.61</ENT>
              <ENT>0.21</ENT>
              <ENT>0.21</ENT>
              <ENT>0.02</ENT>
              <ENT>0.84</ENT>
              <ENT>0.84</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78650</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>CSF leakage imaging</ENT>
              <ENT>0.00</ENT>
              <ENT>4.64</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>4.84</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78660</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nuclear exam of tear flow</ENT>
              <ENT>0.53</ENT>
              <ENT>2.30</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.95</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78660</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Nuclear exam of tear flow</ENT>
              <ENT>0.53</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.02</ENT>
              <ENT>0.73</ENT>
              <ENT>0.73</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78660</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Nuclear exam of tear flow</ENT>
              <ENT>0.00</ENT>
              <ENT>2.12</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.22</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78699</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Nervous system nuclear exam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78699</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Nervous system nuclear exam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78699</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Nervous system nuclear exam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78700</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Kidney imaging, static</ENT>
              <ENT>0.45</ENT>
              <ENT>3.20</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.80</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78700</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Kidney imaging, static</ENT>
              <ENT>0.45</ENT>
              <ENT>0.15</ENT>
              <ENT>0.15</ENT>
              <ENT>0.02</ENT>
              <ENT>0.62</ENT>
              <ENT>0.62</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78700</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Kidney imaging, static</ENT>
              <ENT>0.00</ENT>
              <ENT>3.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>3.18</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78701</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Kidney imaging with flow</ENT>
              <ENT>0.49</ENT>
              <ENT>3.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>4.39</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78701</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Kidney imaging with flow</ENT>
              <ENT>0.49</ENT>
              <ENT>0.17</ENT>
              <ENT>0.17</ENT>
              <ENT>0.02</ENT>
              <ENT>0.68</ENT>
              <ENT>0.68</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78701</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Kidney imaging with flow</ENT>
              <ENT>0.00</ENT>
              <ENT>3.56</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78704</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Imaging renogram</ENT>
              <ENT>0.74</ENT>
              <ENT>4.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>5.15</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78704</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Imaging renogram</ENT>
              <ENT>0.74</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.03</ENT>
              <ENT>1.02</ENT>
              <ENT>1.02</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78704</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Imaging renogram</ENT>
              <ENT>0.00</ENT>
              <ENT>3.96</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>4.13</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78707</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Kidney flow/function image</ENT>
              <ENT>0.96</ENT>
              <ENT>4.80</ENT>
              <ENT>N/A</ENT>
              <ENT>0.23</ENT>
              <ENT>5.99</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78707</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Kidney flow/function image</ENT>
              <ENT>0.96</ENT>
              <ENT>0.33</ENT>
              <ENT>0.33</ENT>
              <ENT>0.04</ENT>
              <ENT>1.33</ENT>
              <ENT>1.33</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78707</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Kidney flow/function image</ENT>
              <ENT>0.00</ENT>
              <ENT>4.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.19</ENT>
              <ENT>4.66</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78708</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Kidney flow/function image</ENT>
              <ENT>1.21</ENT>
              <ENT>4.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.24</ENT>
              <ENT>6.34</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78708</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Kidney flow/function image</ENT>
              <ENT>1.21</ENT>
              <ENT>0.42</ENT>
              <ENT>0.42</ENT>
              <ENT>0.05</ENT>
              <ENT>1.68</ENT>
              <ENT>1.68</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78708</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Kidney flow/function image</ENT>
              <ENT>0.00</ENT>
              <ENT>4.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.19</ENT>
              <ENT>4.66</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78709</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Kidney flow/function image</ENT>
              <ENT>1.41</ENT>
              <ENT>4.95</ENT>
              <ENT>N/A</ENT>
              <ENT>0.25</ENT>
              <ENT>6.61</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78709</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Kidney flow/function image</ENT>
              <ENT>1.41</ENT>
              <ENT>0.48</ENT>
              <ENT>0.48</ENT>
              <ENT>0.06</ENT>
              <ENT>1.95</ENT>
              <ENT>1.95</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78709</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Kidney flow/function image</ENT>
              <ENT>0.00</ENT>
              <ENT>4.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.19</ENT>
              <ENT>4.66</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78710</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Kidney imaging (3D)</ENT>
              <ENT>0.66</ENT>
              <ENT>6.13</ENT>
              <ENT>N/A</ENT>
              <ENT>0.29</ENT>
              <ENT>7.08</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78710</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Kidney imaging (3D)</ENT>
              <ENT>0.66</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.03</ENT>
              <ENT>0.92</ENT>
              <ENT>0.92</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78710</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Kidney imaging (3D)</ENT>
              <ENT>0.00</ENT>
              <ENT>5.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.26</ENT>
              <ENT>6.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78715</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Renal vascular flow exam</ENT>
              <ENT>0.30</ENT>
              <ENT>1.69</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.08</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78715</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Renal vascular flow exam</ENT>
              <ENT>0.30</ENT>
              <ENT>0.11</ENT>
              <ENT>0.11</ENT>
              <ENT>0.01</ENT>
              <ENT>0.42</ENT>
              <ENT>0.42</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78715</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Renal vascular flow exam</ENT>
              <ENT>0.00</ENT>
              <ENT>1.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.66</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78725</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Kidney function study</ENT>
              <ENT>0.38</ENT>
              <ENT>1.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.39</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49209"/>
              <ENT I="01">78725</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Kidney function study</ENT>
              <ENT>0.38</ENT>
              <ENT>0.13</ENT>
              <ENT>0.13</ENT>
              <ENT>0.01</ENT>
              <ENT>0.52</ENT>
              <ENT>0.52</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78725</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Kidney function study</ENT>
              <ENT>0.00</ENT>
              <ENT>1.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.87</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78730</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Urinary bladder retention</ENT>
              <ENT>0.36</ENT>
              <ENT>1.59</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.04</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78730</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Urinary bladder retention</ENT>
              <ENT>0.36</ENT>
              <ENT>0.13</ENT>
              <ENT>0.13</ENT>
              <ENT>0.02</ENT>
              <ENT>0.51</ENT>
              <ENT>0.51</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78730</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Urinary bladder retention</ENT>
              <ENT>0.00</ENT>
              <ENT>1.46</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.53</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78740</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ureteral reflux study</ENT>
              <ENT>0.57</ENT>
              <ENT>2.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>3.00</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78740</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ureteral reflux study</ENT>
              <ENT>0.57</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.02</ENT>
              <ENT>0.78</ENT>
              <ENT>0.78</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78740</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ureteral reflux study</ENT>
              <ENT>0.00</ENT>
              <ENT>2.12</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.22</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78760</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Testicular imaging</ENT>
              <ENT>0.66</ENT>
              <ENT>2.90</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78760</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Testicular imaging</ENT>
              <ENT>0.66</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>0.03</ENT>
              <ENT>0.91</ENT>
              <ENT>0.91</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78760</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Testicular imaging</ENT>
              <ENT>0.00</ENT>
              <ENT>2.68</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.80</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78761</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Testicular imaging/flow</ENT>
              <ENT>0.71</ENT>
              <ENT>3.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>4.32</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78761</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Testicular imaging/flow</ENT>
              <ENT>0.71</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>0.03</ENT>
              <ENT>0.98</ENT>
              <ENT>0.98</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78761</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Testicular imaging/flow</ENT>
              <ENT>0.00</ENT>
              <ENT>3.20</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>3.34</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78799</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Genitourinary nuclear exam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78799</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Genitourinary nuclear exam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78799</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Genitourinary nuclear exam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78800</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tumor imaging, limited area</ENT>
              <ENT>0.66</ENT>
              <ENT>3.63</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.47</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78800</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Tumor imaging, limited area</ENT>
              <ENT>0.66</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>0.03</ENT>
              <ENT>0.91</ENT>
              <ENT>0.91</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78800</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Tumor imaging, limited area</ENT>
              <ENT>0.00</ENT>
              <ENT>3.40</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78801</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tumor imaging, mult areas</ENT>
              <ENT>0.79</ENT>
              <ENT>4.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>5.50</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78801</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Tumor imaging, mult areas</ENT>
              <ENT>0.79</ENT>
              <ENT>0.27</ENT>
              <ENT>0.27</ENT>
              <ENT>0.03</ENT>
              <ENT>1.09</ENT>
              <ENT>1.09</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78801</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Tumor imaging, mult areas</ENT>
              <ENT>0.00</ENT>
              <ENT>4.23</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.41</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78802</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tumor imaging, whole body</ENT>
              <ENT>0.86</ENT>
              <ENT>5.83</ENT>
              <ENT>N/A</ENT>
              <ENT>0.28</ENT>
              <ENT>6.97</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78802</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Tumor imaging, whole body</ENT>
              <ENT>0.86</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>0.03</ENT>
              <ENT>1.19</ENT>
              <ENT>1.19</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78802</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Tumor imaging, whole body</ENT>
              <ENT>0.00</ENT>
              <ENT>5.53</ENT>
              <ENT>N/A</ENT>
              <ENT>0.25</ENT>
              <ENT>5.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78803</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tumor imaging (3D)</ENT>
              <ENT>1.09</ENT>
              <ENT>6.95</ENT>
              <ENT>N/A</ENT>
              <ENT>0.33</ENT>
              <ENT>8.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78803</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Tumor imaging (3D)</ENT>
              <ENT>1.09</ENT>
              <ENT>0.39</ENT>
              <ENT>0.39</ENT>
              <ENT>0.04</ENT>
              <ENT>1.52</ENT>
              <ENT>1.52</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78803</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Tumor imaging (3D)</ENT>
              <ENT>0.00</ENT>
              <ENT>6.56</ENT>
              <ENT>N/A</ENT>
              <ENT>0.29</ENT>
              <ENT>6.85</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78805</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Abscess imaging, ltd area</ENT>
              <ENT>0.73</ENT>
              <ENT>3.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.57</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78805</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Abscess imaging, ltd area</ENT>
              <ENT>0.73</ENT>
              <ENT>0.26</ENT>
              <ENT>0.26</ENT>
              <ENT>0.03</ENT>
              <ENT>1.02</ENT>
              <ENT>1.02</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78805</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Abscess imaging, ltd area</ENT>
              <ENT>0.00</ENT>
              <ENT>3.40</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78806</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Abscess imaging, whole body</ENT>
              <ENT>0.86</ENT>
              <ENT>6.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.32</ENT>
              <ENT>7.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78806</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Abscess imaging, whole body</ENT>
              <ENT>0.86</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>0.03</ENT>
              <ENT>1.19</ENT>
              <ENT>1.19</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78806</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Abscess imaging, whole body</ENT>
              <ENT>0.00</ENT>
              <ENT>6.43</ENT>
              <ENT>N/A</ENT>
              <ENT>0.29</ENT>
              <ENT>6.72</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78807</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nuclear localization/abscess</ENT>
              <ENT>1.09</ENT>
              <ENT>6.96</ENT>
              <ENT>N/A</ENT>
              <ENT>0.33</ENT>
              <ENT>8.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78807</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Nuclear localization/abscess</ENT>
              <ENT>1.09</ENT>
              <ENT>0.40</ENT>
              <ENT>0.40</ENT>
              <ENT>0.04</ENT>
              <ENT>1.53</ENT>
              <ENT>1.53</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78807</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Nuclear localization/abscess</ENT>
              <ENT>0.00</ENT>
              <ENT>6.56</ENT>
              <ENT>N/A</ENT>
              <ENT>0.29</ENT>
              <ENT>6.85</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78810</ENT>
              <ENT>26</ENT>
              <ENT>N</ENT>
              <ENT>Tumor imaging (PET)</ENT>
              <ENT>1.93</ENT>
              <ENT>0.75</ENT>
              <ENT>0.75</ENT>
              <ENT>0.09</ENT>
              <ENT>2.77</ENT>
              <ENT>2.77</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78890</ENT>
              <ENT/>
              <ENT>B</ENT>
              <ENT>Nuclear medicine data proc</ENT>
              <ENT>0.05</ENT>
              <ENT>1.32</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.43</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78890</ENT>
              <ENT>26</ENT>
              <ENT>B</ENT>
              <ENT>Nuclear medicine data proc</ENT>
              <ENT>0.05</ENT>
              <ENT>0.02</ENT>
              <ENT>0.02</ENT>
              <ENT>0.01</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78890</ENT>
              <ENT>TC</ENT>
              <ENT>B</ENT>
              <ENT>Nuclear medicine data proc</ENT>
              <ENT>0.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.36</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78891</ENT>
              <ENT/>
              <ENT>B</ENT>
              <ENT>Nuclear med data proc</ENT>
              <ENT>0.10</ENT>
              <ENT>2.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.88</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78891</ENT>
              <ENT>26</ENT>
              <ENT>B</ENT>
              <ENT>Nuclear med data proc</ENT>
              <ENT>0.10</ENT>
              <ENT>0.04</ENT>
              <ENT>0.04</ENT>
              <ENT>0.01</ENT>
              <ENT>0.15</ENT>
              <ENT>0.15</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78891</ENT>
              <ENT>TC</ENT>
              <ENT>B</ENT>
              <ENT>Nuclear med data proc</ENT>
              <ENT>0.00</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.73</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78990</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Provide diag radionuclide(s)</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Nuclear diagnostic exam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49210"/>
              <ENT I="01">78999</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Nuclear diagnostic exam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">78999</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Nuclear diagnostic exam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Init hyperthyroid therapy</ENT>
              <ENT>1.80</ENT>
              <ENT>3.24</ENT>
              <ENT>N/A</ENT>
              <ENT>0.19</ENT>
              <ENT>5.23</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79000</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Init hyperthyroid therapy</ENT>
              <ENT>1.80</ENT>
              <ENT>0.62</ENT>
              <ENT>0.62</ENT>
              <ENT>0.07</ENT>
              <ENT>2.49</ENT>
              <ENT>2.49</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79000</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Init hyperthyroid therapy</ENT>
              <ENT>0.00</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79001</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Repeat hyperthyroid therapy</ENT>
              <ENT>1.05</ENT>
              <ENT>1.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.82</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79001</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Repeat hyperthyroid therapy</ENT>
              <ENT>1.05</ENT>
              <ENT>0.36</ENT>
              <ENT>0.36</ENT>
              <ENT>0.04</ENT>
              <ENT>1.45</ENT>
              <ENT>1.45</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79001</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Repeat hyperthyroid therapy</ENT>
              <ENT>0.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thyroid ablation</ENT>
              <ENT>1.81</ENT>
              <ENT>3.23</ENT>
              <ENT>N/A</ENT>
              <ENT>0.19</ENT>
              <ENT>5.23</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79020</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid ablation</ENT>
              <ENT>1.81</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>0.07</ENT>
              <ENT>2.49</ENT>
              <ENT>2.49</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79020</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid ablation</ENT>
              <ENT>0.00</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79030</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thyroid ablation, carcinoma</ENT>
              <ENT>2.10</ENT>
              <ENT>3.34</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>5.64</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79030</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid ablation, carcinoma</ENT>
              <ENT>2.10</ENT>
              <ENT>0.72</ENT>
              <ENT>0.72</ENT>
              <ENT>0.08</ENT>
              <ENT>2.90</ENT>
              <ENT>2.90</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79030</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid ablation, carcinoma</ENT>
              <ENT>0.00</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79035</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thyroid metastatic therapy</ENT>
              <ENT>2.52</ENT>
              <ENT>3.51</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>6.24</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79035</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid metastatic therapy</ENT>
              <ENT>2.52</ENT>
              <ENT>0.89</ENT>
              <ENT>0.89</ENT>
              <ENT>0.09</ENT>
              <ENT>3.50</ENT>
              <ENT>3.50</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79035</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Thyroid metastatic therapy</ENT>
              <ENT>0.00</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hematopoetic nuclear therapy</ENT>
              <ENT>1.32</ENT>
              <ENT>3.09</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>4.58</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79100</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Hematopoetic nuclear therapy</ENT>
              <ENT>1.32</ENT>
              <ENT>0.47</ENT>
              <ENT>0.47</ENT>
              <ENT>0.05</ENT>
              <ENT>1.84</ENT>
              <ENT>1.84</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79100</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Hematopoetic nuclear therapy</ENT>
              <ENT>0.00</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intracavitary nuclear trmt</ENT>
              <ENT>1.99</ENT>
              <ENT>3.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.19</ENT>
              <ENT>5.51</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79200</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Intracavitary nuclear trmt</ENT>
              <ENT>1.99</ENT>
              <ENT>0.71</ENT>
              <ENT>0.71</ENT>
              <ENT>0.07</ENT>
              <ENT>2.77</ENT>
              <ENT>2.77</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79200</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Intracavitary nuclear trmt</ENT>
              <ENT>0.00</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79300</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Interstitial nuclear therapy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79300</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Interstitial nuclear therapy</ENT>
              <ENT>1.60</ENT>
              <ENT>0.57</ENT>
              <ENT>0.57</ENT>
              <ENT>0.07</ENT>
              <ENT>2.24</ENT>
              <ENT>2.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79300</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Interstitial nuclear therapy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nonhemato nuclear therapy</ENT>
              <ENT>1.96</ENT>
              <ENT>3.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>5.47</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79400</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Nonhemato nuclear therapy</ENT>
              <ENT>1.96</ENT>
              <ENT>0.68</ENT>
              <ENT>0.68</ENT>
              <ENT>0.08</ENT>
              <ENT>2.72</ENT>
              <ENT>2.72</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79400</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Nonhemato nuclear therapy</ENT>
              <ENT>0.00</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79420</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Intravascular nuclear ther</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79420</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Intravascular nuclear ther</ENT>
              <ENT>1.51</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>0.06</ENT>
              <ENT>2.07</ENT>
              <ENT>2.07</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79420</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Intravascular nuclear ther</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79440</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nuclear joint therapy</ENT>
              <ENT>1.99</ENT>
              <ENT>3.36</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>5.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79440</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Nuclear joint therapy</ENT>
              <ENT>1.99</ENT>
              <ENT>0.74</ENT>
              <ENT>0.74</ENT>
              <ENT>0.08</ENT>
              <ENT>2.81</ENT>
              <ENT>2.81</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79440</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Nuclear joint therapy</ENT>
              <ENT>0.00</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79900</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Provide ther radiopharm(s)</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Nuclear medicine therapy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79999</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Nuclear medicine therapy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">79999</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Nuclear medicine therapy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">80055</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Obstetric panel</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">80500</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lab pathology consultation</ENT>
              <ENT>0.37</ENT>
              <ENT>0.22</ENT>
              <ENT>0.16</ENT>
              <ENT>0.01</ENT>
              <ENT>0.60</ENT>
              <ENT>0.54</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">80502</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lab pathology consultation</ENT>
              <ENT>1.33</ENT>
              <ENT>0.64</ENT>
              <ENT>0.59</ENT>
              <ENT>0.05</ENT>
              <ENT>2.02</ENT>
              <ENT>1.97</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">83020</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Hemoglobin electrophoresis</ENT>
              <ENT>0.37</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.01</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">83912</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Genetic examination</ENT>
              <ENT>0.37</ENT>
              <ENT>0.15</ENT>
              <ENT>0.15</ENT>
              <ENT>0.01</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">84165</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Assay of serum proteins</ENT>
              <ENT>0.37</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.01</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">84181</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Western blot test</ENT>
              <ENT>0.37</ENT>
              <ENT>0.14</ENT>
              <ENT>0.14</ENT>
              <ENT>0.01</ENT>
              <ENT>0.52</ENT>
              <ENT>0.52</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">84182</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Protein, western blot test</ENT>
              <ENT>0.37</ENT>
              <ENT>0.17</ENT>
              <ENT>0.17</ENT>
              <ENT>0.01</ENT>
              <ENT>0.55</ENT>
              <ENT>0.55</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">85060</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Blood smear interpretation</ENT>
              <ENT>0.45</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.02</ENT>
              <ENT>0.66</ENT>
              <ENT>0.66</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">85097</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bone marrow interpretation</ENT>
              <ENT>0.94</ENT>
              <ENT>1.65</ENT>
              <ENT>0.41</ENT>
              <ENT>0.03</ENT>
              <ENT>2.62</ENT>
              <ENT>1.38</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">85390</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Fibrinolysins screen</ENT>
              <ENT>0.37</ENT>
              <ENT>0.12</ENT>
              <ENT>0.12</ENT>
              <ENT>0.01</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">85576</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Blood platelet aggregation</ENT>
              <ENT>0.37</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.01</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49211"/>
              <ENT I="01">86077</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Physician blood bank service</ENT>
              <ENT>0.94</ENT>
              <ENT>0.47</ENT>
              <ENT>0.41</ENT>
              <ENT>0.03</ENT>
              <ENT>1.44</ENT>
              <ENT>1.38</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">86078</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Physician blood bank service</ENT>
              <ENT>0.94</ENT>
              <ENT>0.50</ENT>
              <ENT>0.42</ENT>
              <ENT>0.03</ENT>
              <ENT>1.47</ENT>
              <ENT>1.39</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">86079</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Physician blood bank service</ENT>
              <ENT>0.94</ENT>
              <ENT>0.50</ENT>
              <ENT>0.42</ENT>
              <ENT>0.03</ENT>
              <ENT>1.47</ENT>
              <ENT>1.39</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">86255</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Fluorescent antibody, screen</ENT>
              <ENT>0.37</ENT>
              <ENT>0.17</ENT>
              <ENT>0.16</ENT>
              <ENT>0.01</ENT>
              <ENT>0.55</ENT>
              <ENT>0.54</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">86256</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Fluorescent antibody, titer</ENT>
              <ENT>0.37</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.01</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">86320</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Serum immunoelectrophoresis</ENT>
              <ENT>0.37</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.01</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">86325</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Other immunoelectrophoresis</ENT>
              <ENT>0.37</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.01</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">86327</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Immunoelectrophoresis assay</ENT>
              <ENT>0.42</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.01</ENT>
              <ENT>0.62</ENT>
              <ENT>0.62</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">86334</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Immunofixation procedure</ENT>
              <ENT>0.37</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.01</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">86485</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Skin test, candida</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">86490</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Coccidioidomycosis skin test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.29</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.31</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">86510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Histoplasmosis skin test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.34</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">86580</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>TB intradermal test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.25</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.27</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">86585</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>TB tine test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.20</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">86586</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Skin test, unlisted</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">87164</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Dark field examination</ENT>
              <ENT>0.37</ENT>
              <ENT>0.12</ENT>
              <ENT>0.12</ENT>
              <ENT>0.01</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">87207</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Smear, special stain</ENT>
              <ENT>0.37</ENT>
              <ENT>0.17</ENT>
              <ENT>0.16</ENT>
              <ENT>0.01</ENT>
              <ENT>0.55</ENT>
              <ENT>0.54</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88104</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cytopathology, fluids</ENT>
              <ENT>0.56</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>1.36</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88104</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cytopathology, fluids</ENT>
              <ENT>0.56</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.02</ENT>
              <ENT>0.83</ENT>
              <ENT>0.83</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88104</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cytopathology, fluids</ENT>
              <ENT>0.00</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88106</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cytopathology, fluids</ENT>
              <ENT>0.56</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>1.22</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88106</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cytopathology, fluids</ENT>
              <ENT>0.56</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.02</ENT>
              <ENT>0.83</ENT>
              <ENT>0.83</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88106</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cytopathology, fluids</ENT>
              <ENT>0.00</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.39</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88107</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cytopathology, fluids</ENT>
              <ENT>0.76</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.80</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88107</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cytopathology, fluids</ENT>
              <ENT>0.76</ENT>
              <ENT>0.34</ENT>
              <ENT>0.34</ENT>
              <ENT>0.03</ENT>
              <ENT>1.13</ENT>
              <ENT>1.13</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88107</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cytopathology, fluids</ENT>
              <ENT>0.00</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88108</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cytopath, concentrate tech</ENT>
              <ENT>0.56</ENT>
              <ENT>0.83</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>1.43</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88108</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cytopath, concentrate tech</ENT>
              <ENT>0.56</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.02</ENT>
              <ENT>0.83</ENT>
              <ENT>0.83</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88108</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cytopath, concentrate tech</ENT>
              <ENT>0.00</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88125</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Forensic cytopathology</ENT>
              <ENT>0.26</ENT>
              <ENT>0.26</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88125</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Forensic cytopathology</ENT>
              <ENT>0.26</ENT>
              <ENT>0.12</ENT>
              <ENT>0.12</ENT>
              <ENT>0.01</ENT>
              <ENT>0.39</ENT>
              <ENT>0.39</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88125</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Forensic cytopathology</ENT>
              <ENT>0.00</ENT>
              <ENT>0.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88141</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cytopath, c/v, interpret</ENT>
              <ENT>0.42</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.01</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88160</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cytopath smear, other source</ENT>
              <ENT>0.50</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>1.48</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88160</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cytopath smear, other source</ENT>
              <ENT>0.50</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>0.02</ENT>
              <ENT>0.74</ENT>
              <ENT>0.74</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88160</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cytopath smear, other source</ENT>
              <ENT>0.00</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88161</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cytopath smear, other source</ENT>
              <ENT>0.50</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>1.43</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88161</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cytopath smear, other source</ENT>
              <ENT>0.50</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>0.02</ENT>
              <ENT>0.74</ENT>
              <ENT>0.74</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88161</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cytopath smear, other source</ENT>
              <ENT>0.00</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88162</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cytopath smear, other source</ENT>
              <ENT>0.76</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.50</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88162</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cytopath smear, other source</ENT>
              <ENT>0.76</ENT>
              <ENT>0.34</ENT>
              <ENT>0.34</ENT>
              <ENT>0.03</ENT>
              <ENT>1.13</ENT>
              <ENT>1.13</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88162</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cytopath smear, other source</ENT>
              <ENT>0.00</ENT>
              <ENT>0.35</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88172</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cytopathology eval of fna</ENT>
              <ENT>0.60</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88172</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cytopathology eval of fna</ENT>
              <ENT>0.60</ENT>
              <ENT>0.27</ENT>
              <ENT>0.27</ENT>
              <ENT>0.02</ENT>
              <ENT>0.89</ENT>
              <ENT>0.89</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88172</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cytopathology eval of fna</ENT>
              <ENT>0.00</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88173</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cytopath eval, fna, report</ENT>
              <ENT>1.39</ENT>
              <ENT>1.80</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>3.26</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88173</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cytopath eval, fna, report</ENT>
              <ENT>1.39</ENT>
              <ENT>0.62</ENT>
              <ENT>0.62</ENT>
              <ENT>0.05</ENT>
              <ENT>2.06</ENT>
              <ENT>2.06</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88173</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cytopath eval, fna, report</ENT>
              <ENT>0.00</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.20</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88180</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cell marker study</ENT>
              <ENT>0.36</ENT>
              <ENT>1.46</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>1.85</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49212"/>
              <ENT I="01">88180</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cell marker study</ENT>
              <ENT>0.36</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.01</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88180</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cell marker study</ENT>
              <ENT>0.00</ENT>
              <ENT>1.30</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.32</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88182</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cell marker study</ENT>
              <ENT>0.77</ENT>
              <ENT>1.63</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>2.46</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88182</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cell marker study</ENT>
              <ENT>0.77</ENT>
              <ENT>0.34</ENT>
              <ENT>0.34</ENT>
              <ENT>0.03</ENT>
              <ENT>1.14</ENT>
              <ENT>1.14</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88182</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cell marker study</ENT>
              <ENT>0.00</ENT>
              <ENT>1.28</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88199</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Cytopathology procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88199</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Cytopathology procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88199</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Cytopathology procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88291</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cyto/molecular report</ENT>
              <ENT>0.52</ENT>
              <ENT>0.28</ENT>
              <ENT>0.28</ENT>
              <ENT>0.02</ENT>
              <ENT>0.82</ENT>
              <ENT>0.82</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88299</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Cytogenetic study</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88300</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Surgical path, gross</ENT>
              <ENT>0.08</ENT>
              <ENT>0.28</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88300</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Surgical path, gross</ENT>
              <ENT>0.08</ENT>
              <ENT>0.04</ENT>
              <ENT>0.04</ENT>
              <ENT>0.01</ENT>
              <ENT>0.13</ENT>
              <ENT>0.13</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88300</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Surgical path, gross</ENT>
              <ENT>0.00</ENT>
              <ENT>0.25</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.26</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88302</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tissue exam by pathologist</ENT>
              <ENT>0.13</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88302</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Tissue exam by pathologist</ENT>
              <ENT>0.13</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.20</ENT>
              <ENT>0.20</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88302</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Tissue exam by pathologist</ENT>
              <ENT>0.00</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88304</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tissue exam by pathologist</ENT>
              <ENT>0.22</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88304</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Tissue exam by pathologist</ENT>
              <ENT>0.22</ENT>
              <ENT>0.10</ENT>
              <ENT>0.10</ENT>
              <ENT>0.01</ENT>
              <ENT>0.33</ENT>
              <ENT>0.33</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88304</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Tissue exam by pathologist</ENT>
              <ENT>0.00</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88305</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tissue exam by pathologist</ENT>
              <ENT>0.75</ENT>
              <ENT>1.77</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>2.57</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88305</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Tissue exam by pathologist</ENT>
              <ENT>0.75</ENT>
              <ENT>0.34</ENT>
              <ENT>0.34</ENT>
              <ENT>0.02</ENT>
              <ENT>1.11</ENT>
              <ENT>1.11</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88305</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Tissue exam by pathologist</ENT>
              <ENT>0.00</ENT>
              <ENT>1.43</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>1.46</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88307</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tissue exam by pathologist</ENT>
              <ENT>1.59</ENT>
              <ENT>2.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>4.41</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88307</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Tissue exam by pathologist</ENT>
              <ENT>1.59</ENT>
              <ENT>0.71</ENT>
              <ENT>0.71</ENT>
              <ENT>0.06</ENT>
              <ENT>2.36</ENT>
              <ENT>2.36</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88307</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Tissue exam by pathologist</ENT>
              <ENT>0.00</ENT>
              <ENT>2.00</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>2.05</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88309</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tissue exam by pathologist</ENT>
              <ENT>2.28</ENT>
              <ENT>3.32</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>5.73</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88309</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Tissue exam by pathologist</ENT>
              <ENT>2.28</ENT>
              <ENT>1.01</ENT>
              <ENT>1.01</ENT>
              <ENT>0.08</ENT>
              <ENT>3.37</ENT>
              <ENT>3.37</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88309</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Tissue exam by pathologist</ENT>
              <ENT>0.00</ENT>
              <ENT>2.30</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>2.35</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88311</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Decalcify tissue</ENT>
              <ENT>0.24</ENT>
              <ENT>0.19</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88311</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Decalcify tissue</ENT>
              <ENT>0.24</ENT>
              <ENT>0.11</ENT>
              <ENT>0.11</ENT>
              <ENT>0.01</ENT>
              <ENT>0.36</ENT>
              <ENT>0.36</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88311</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Decalcify tissue</ENT>
              <ENT>0.00</ENT>
              <ENT>0.09</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.10</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88312</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Special stains</ENT>
              <ENT>0.54</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>1.94</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88312</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Special stains</ENT>
              <ENT>0.54</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>0.02</ENT>
              <ENT>0.80</ENT>
              <ENT>0.80</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88312</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Special stains</ENT>
              <ENT>0.00</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88313</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Special stains</ENT>
              <ENT>0.24</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88313</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Special stains</ENT>
              <ENT>0.24</ENT>
              <ENT>0.11</ENT>
              <ENT>0.11</ENT>
              <ENT>0.01</ENT>
              <ENT>0.36</ENT>
              <ENT>0.36</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88313</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Special stains</ENT>
              <ENT>0.00</ENT>
              <ENT>1.00</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88314</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Histochemical stain</ENT>
              <ENT>0.45</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>1.39</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88314</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Histochemical stain</ENT>
              <ENT>0.45</ENT>
              <ENT>0.20</ENT>
              <ENT>0.20</ENT>
              <ENT>0.02</ENT>
              <ENT>0.67</ENT>
              <ENT>0.67</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88314</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Histochemical stain</ENT>
              <ENT>0.00</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88318</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chemical histochemistry</ENT>
              <ENT>0.42</ENT>
              <ENT>0.82</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.26</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88318</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Chemical histochemistry</ENT>
              <ENT>0.42</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.01</ENT>
              <ENT>0.62</ENT>
              <ENT>0.62</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88318</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Chemical histochemistry</ENT>
              <ENT>0.00</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88319</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Enzyme histochemistry</ENT>
              <ENT>0.53</ENT>
              <ENT>1.92</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>2.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88319</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Enzyme histochemistry</ENT>
              <ENT>0.53</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.02</ENT>
              <ENT>0.78</ENT>
              <ENT>0.78</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88319</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Enzyme histochemistry</ENT>
              <ENT>0.00</ENT>
              <ENT>1.69</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88321</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Microslide consultation</ENT>
              <ENT>1.30</ENT>
              <ENT>0.83</ENT>
              <ENT>0.58</ENT>
              <ENT>0.04</ENT>
              <ENT>2.17</ENT>
              <ENT>1.92</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88323</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Microslide consultation</ENT>
              <ENT>1.35</ENT>
              <ENT>1.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>2.89</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88323</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Microslide consultation</ENT>
              <ENT>1.35</ENT>
              <ENT>0.60</ENT>
              <ENT>0.60</ENT>
              <ENT>0.05</ENT>
              <ENT>2.00</ENT>
              <ENT>2.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88323</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Microslide consultation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49213"/>
              <ENT I="01">88325</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Comprehensive review of data</ENT>
              <ENT>2.22</ENT>
              <ENT>3.02</ENT>
              <ENT>0.98</ENT>
              <ENT>0.08</ENT>
              <ENT>5.32</ENT>
              <ENT>3.28</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88329</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Path consult introp</ENT>
              <ENT>0.67</ENT>
              <ENT>0.64</ENT>
              <ENT>0.30</ENT>
              <ENT>0.02</ENT>
              <ENT>1.33</ENT>
              <ENT>0.99</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88331</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Path consult intraop, 1 bloc</ENT>
              <ENT>1.19</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>2.27</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88331</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Path consult intraop, 1 bloc</ENT>
              <ENT>1.19</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>0.04</ENT>
              <ENT>1.76</ENT>
              <ENT>1.76</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88331</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Path consult intraop, 1 bloc</ENT>
              <ENT>0.00</ENT>
              <ENT>0.48</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88332</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Path consult intraop, addl</ENT>
              <ENT>0.59</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88332</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Path consult intraop, addl</ENT>
              <ENT>0.59</ENT>
              <ENT>0.26</ENT>
              <ENT>0.26</ENT>
              <ENT>0.02</ENT>
              <ENT>0.87</ENT>
              <ENT>0.87</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88332</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Path consult intraop, addl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.24</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.26</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88342</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Immunocytochemistry</ENT>
              <ENT>0.85</ENT>
              <ENT>1.38</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>2.28</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88342</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Immunocytochemistry</ENT>
              <ENT>0.85</ENT>
              <ENT>0.38</ENT>
              <ENT>0.38</ENT>
              <ENT>0.03</ENT>
              <ENT>1.26</ENT>
              <ENT>1.26</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88342</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Immunocytochemistry</ENT>
              <ENT>0.00</ENT>
              <ENT>1.00</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88346</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Immunofluorescent study</ENT>
              <ENT>0.86</ENT>
              <ENT>1.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>2.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88346</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Immunofluorescent study</ENT>
              <ENT>0.86</ENT>
              <ENT>0.38</ENT>
              <ENT>0.38</ENT>
              <ENT>0.03</ENT>
              <ENT>1.27</ENT>
              <ENT>1.27</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88346</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Immunofluorescent study</ENT>
              <ENT>0.00</ENT>
              <ENT>1.09</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88347</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Immunofluorescent study</ENT>
              <ENT>0.86</ENT>
              <ENT>1.79</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>2.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88347</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Immunofluorescent study</ENT>
              <ENT>0.86</ENT>
              <ENT>0.36</ENT>
              <ENT>0.36</ENT>
              <ENT>0.03</ENT>
              <ENT>1.25</ENT>
              <ENT>1.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88347</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Immunofluorescent study</ENT>
              <ENT>0.00</ENT>
              <ENT>1.43</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.45</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88348</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Electron microscopy</ENT>
              <ENT>1.51</ENT>
              <ENT>8.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>10.28</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88348</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Electron microscopy</ENT>
              <ENT>1.51</ENT>
              <ENT>0.67</ENT>
              <ENT>0.67</ENT>
              <ENT>0.05</ENT>
              <ENT>2.23</ENT>
              <ENT>2.23</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88348</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Electron microscopy</ENT>
              <ENT>0.00</ENT>
              <ENT>7.99</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>8.05</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88349</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Scanning electron microscopy</ENT>
              <ENT>0.76</ENT>
              <ENT>10.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>10.86</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88349</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Scanning electron microscopy</ENT>
              <ENT>0.76</ENT>
              <ENT>0.34</ENT>
              <ENT>0.34</ENT>
              <ENT>0.03</ENT>
              <ENT>1.13</ENT>
              <ENT>1.13</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88349</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Scanning electron microscopy</ENT>
              <ENT>0.00</ENT>
              <ENT>9.68</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>9.73</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88355</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Analysis, skeletal muscle</ENT>
              <ENT>1.85</ENT>
              <ENT>2.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>4.63</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88355</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Analysis, skeletal muscle</ENT>
              <ENT>1.85</ENT>
              <ENT>0.82</ENT>
              <ENT>0.82</ENT>
              <ENT>0.07</ENT>
              <ENT>2.74</ENT>
              <ENT>2.74</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88355</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Analysis, skeletal muscle</ENT>
              <ENT>0.00</ENT>
              <ENT>1.84</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.89</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88356</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Analysis, nerve</ENT>
              <ENT>3.02</ENT>
              <ENT>2.93</ENT>
              <ENT>N/A</ENT>
              <ENT>0.16</ENT>
              <ENT>6.11</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88356</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Analysis, nerve</ENT>
              <ENT>3.02</ENT>
              <ENT>1.30</ENT>
              <ENT>1.30</ENT>
              <ENT>0.10</ENT>
              <ENT>4.42</ENT>
              <ENT>4.42</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88356</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Analysis, nerve</ENT>
              <ENT>0.00</ENT>
              <ENT>1.63</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.69</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88358</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Analysis, tumor</ENT>
              <ENT>2.82</ENT>
              <ENT>1.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.16</ENT>
              <ENT>4.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88358</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Analysis, tumor</ENT>
              <ENT>2.82</ENT>
              <ENT>1.25</ENT>
              <ENT>1.25</ENT>
              <ENT>0.10</ENT>
              <ENT>4.17</ENT>
              <ENT>4.17</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88358</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Analysis, tumor</ENT>
              <ENT>0.00</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88362</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nerve teasing preparations</ENT>
              <ENT>2.17</ENT>
              <ENT>4.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>6.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88362</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Nerve teasing preparations</ENT>
              <ENT>2.17</ENT>
              <ENT>0.95</ENT>
              <ENT>0.95</ENT>
              <ENT>0.07</ENT>
              <ENT>3.19</ENT>
              <ENT>3.19</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88362</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Nerve teasing preparations</ENT>
              <ENT>0.00</ENT>
              <ENT>3.54</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>3.59</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88365</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tissue hybridization</ENT>
              <ENT>0.93</ENT>
              <ENT>2.25</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>3.23</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88365</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Tissue hybridization</ENT>
              <ENT>0.93</ENT>
              <ENT>0.41</ENT>
              <ENT>0.41</ENT>
              <ENT>0.03</ENT>
              <ENT>1.37</ENT>
              <ENT>1.37</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88365</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Tissue hybridization</ENT>
              <ENT>0.00</ENT>
              <ENT>1.84</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.86</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88371</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Protein, western blot tissue</ENT>
              <ENT>0.37</ENT>
              <ENT>0.13</ENT>
              <ENT>0.13</ENT>
              <ENT>0.01</ENT>
              <ENT>0.51</ENT>
              <ENT>0.51</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88372</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Protein analysis w/probe</ENT>
              <ENT>0.37</ENT>
              <ENT>0.17</ENT>
              <ENT>0.17</ENT>
              <ENT>0.01</ENT>
              <ENT>0.55</ENT>
              <ENT>0.55</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88380</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Microdissection</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88380</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Microdissection</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88380</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Microdissection</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88399</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Surgical pathology procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88399</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Surgical pathology procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">88399</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Surgical pathology procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">89060</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Exam,synovial fluid crystals</ENT>
              <ENT>0.37</ENT>
              <ENT>0.17</ENT>
              <ENT>0.17</ENT>
              <ENT>0.01</ENT>
              <ENT>0.55</ENT>
              <ENT>0.55</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">89100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sample intestinal contents</ENT>
              <ENT>0.60</ENT>
              <ENT>1.64</ENT>
              <ENT>0.22</ENT>
              <ENT>0.02</ENT>
              <ENT>2.26</ENT>
              <ENT>0.84</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">89105</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sample intestinal contents</ENT>
              <ENT>0.50</ENT>
              <ENT>2.28</ENT>
              <ENT>0.17</ENT>
              <ENT>0.02</ENT>
              <ENT>2.80</ENT>
              <ENT>0.69</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">89130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sample stomach contents</ENT>
              <ENT>0.45</ENT>
              <ENT>1.78</ENT>
              <ENT>0.13</ENT>
              <ENT>0.02</ENT>
              <ENT>2.25</ENT>
              <ENT>0.60</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">89132</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sample stomach contents</ENT>
              <ENT>0.19</ENT>
              <ENT>1.53</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>1.73</ENT>
              <ENT>0.26</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49214"/>
              <ENT I="01">89135</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sample stomach contents</ENT>
              <ENT>0.79</ENT>
              <ENT>1.62</ENT>
              <ENT>0.25</ENT>
              <ENT>0.03</ENT>
              <ENT>2.44</ENT>
              <ENT>1.07</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">89136</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sample stomach contents</ENT>
              <ENT>0.21</ENT>
              <ENT>1.68</ENT>
              <ENT>0.09</ENT>
              <ENT>0.01</ENT>
              <ENT>1.90</ENT>
              <ENT>0.31</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">89140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sample stomach contents</ENT>
              <ENT>0.94</ENT>
              <ENT>2.13</ENT>
              <ENT>0.28</ENT>
              <ENT>0.03</ENT>
              <ENT>3.10</ENT>
              <ENT>1.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">89141</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sample stomach contents</ENT>
              <ENT>0.85</ENT>
              <ENT>2.78</ENT>
              <ENT>0.34</ENT>
              <ENT>0.03</ENT>
              <ENT>3.66</ENT>
              <ENT>1.22</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">89350</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sputum specimen collection</ENT>
              <ENT>0.00</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">89360</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Collect sweat for test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">89399</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Pathology lab procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">89399</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Pathology lab procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">89399</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Pathology lab procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90281</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Human ig, im</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90283</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Human ig, iv</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90287</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Botulinum antitoxin</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90288</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Botulism ig, iv</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90291</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Cmv ig, iv</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90379</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Rsv ig, iv</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90384</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Rh ig, full-dose, im</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90386</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Rh ig, iv</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90389</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Tetanus ig, im</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90399</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Immune globulin</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90471</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Immunization admin</ENT>
              <ENT>0.00</ENT>
              <ENT>0.13</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90472</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Immunization admin, each add</ENT>
              <ENT>0.00</ENT>
              <ENT>0.08</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.09</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90723</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Dtap-hep b-ipv vaccine, im</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90748</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Hep b/hib vaccine, im</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90780</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>IV infusion therapy, 1 hour</ENT>
              <ENT>0.00</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90781</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>IV infusion, additional hour</ENT>
              <ENT>0.00</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90782</ENT>
              <ENT/>
              <ENT>T</ENT>
              <ENT>Injection, sc/im</ENT>
              <ENT>0.00</ENT>
              <ENT>0.11</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.12</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90783</ENT>
              <ENT/>
              <ENT>T</ENT>
              <ENT>Injection, ia</ENT>
              <ENT>0.00</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90784</ENT>
              <ENT/>
              <ENT>T</ENT>
              <ENT>Injection, iv</ENT>
              <ENT>0.00</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90788</ENT>
              <ENT/>
              <ENT>T</ENT>
              <ENT>Injection of antibiotic</ENT>
              <ENT>0.00</ENT>
              <ENT>0.12</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.13</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90799</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Ther/prophylactic/dx inject</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90801</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Psy dx interview</ENT>
              <ENT>2.80</ENT>
              <ENT>1.20</ENT>
              <ENT>0.95</ENT>
              <ENT>0.06</ENT>
              <ENT>4.06</ENT>
              <ENT>3.81</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90802</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intac psy dx interview</ENT>
              <ENT>3.01</ENT>
              <ENT>1.23</ENT>
              <ENT>1.00</ENT>
              <ENT>0.07</ENT>
              <ENT>4.31</ENT>
              <ENT>4.08</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90804</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Psytx, office, 20-30 min</ENT>
              <ENT>1.21</ENT>
              <ENT>0.51</ENT>
              <ENT>0.39</ENT>
              <ENT>0.03</ENT>
              <ENT>1.75</ENT>
              <ENT>1.63</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90805</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Psytx, off, 20-30 min w/e&amp;m</ENT>
              <ENT>1.37</ENT>
              <ENT>0.51</ENT>
              <ENT>0.43</ENT>
              <ENT>0.03</ENT>
              <ENT>1.91</ENT>
              <ENT>1.83</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90806</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Psytx, off, 45-50 min</ENT>
              <ENT>1.86</ENT>
              <ENT>0.72</ENT>
              <ENT>0.62</ENT>
              <ENT>0.04</ENT>
              <ENT>2.62</ENT>
              <ENT>2.52</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90807</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Psytx, off, 45-50 min w/e&amp;m</ENT>
              <ENT>2.02</ENT>
              <ENT>0.71</ENT>
              <ENT>0.65</ENT>
              <ENT>0.05</ENT>
              <ENT>2.78</ENT>
              <ENT>2.72</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90808</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Psytx, office, 75-80 min</ENT>
              <ENT>2.79</ENT>
              <ENT>1.05</ENT>
              <ENT>0.92</ENT>
              <ENT>0.07</ENT>
              <ENT>3.91</ENT>
              <ENT>3.78</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90809</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Psytx, off, 75-80, w/e&amp;m</ENT>
              <ENT>2.95</ENT>
              <ENT>1.02</ENT>
              <ENT>0.94</ENT>
              <ENT>0.07</ENT>
              <ENT>4.04</ENT>
              <ENT>3.96</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90810</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intac psytx, off, 20-30 min</ENT>
              <ENT>1.32</ENT>
              <ENT>0.52</ENT>
              <ENT>0.43</ENT>
              <ENT>0.03</ENT>
              <ENT>1.87</ENT>
              <ENT>1.78</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90811</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intac psytx, 20-30, w/e&amp;m</ENT>
              <ENT>1.48</ENT>
              <ENT>0.58</ENT>
              <ENT>0.47</ENT>
              <ENT>0.03</ENT>
              <ENT>2.09</ENT>
              <ENT>1.98</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90812</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intac psytx, off, 45-50 min</ENT>
              <ENT>1.97</ENT>
              <ENT>0.81</ENT>
              <ENT>0.66</ENT>
              <ENT>0.05</ENT>
              <ENT>2.83</ENT>
              <ENT>2.68</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90813</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intac psytx, 45-50 min w/e&amp;m</ENT>
              <ENT>2.13</ENT>
              <ENT>0.79</ENT>
              <ENT>0.68</ENT>
              <ENT>0.05</ENT>
              <ENT>2.97</ENT>
              <ENT>2.86</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90814</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intac psytx, off, 75-80 min</ENT>
              <ENT>2.90</ENT>
              <ENT>1.12</ENT>
              <ENT>1.01</ENT>
              <ENT>0.07</ENT>
              <ENT>4.09</ENT>
              <ENT>3.98</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90815</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intac psytx, 75-80 w/e&amp;m</ENT>
              <ENT>3.06</ENT>
              <ENT>1.07</ENT>
              <ENT>0.97</ENT>
              <ENT>0.07</ENT>
              <ENT>4.20</ENT>
              <ENT>4.10</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90816</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Psytx, hosp, 20-30 min</ENT>
              <ENT>1.25</ENT>
              <ENT>N/A</ENT>
              <ENT>0.47</ENT>
              <ENT>0.03</ENT>
              <ENT>N/A</ENT>
              <ENT>1.75</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90817</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Psytx, hosp, 20-30 min w/e&amp;m</ENT>
              <ENT>1.41</ENT>
              <ENT>N/A</ENT>
              <ENT>0.47</ENT>
              <ENT>0.03</ENT>
              <ENT>N/A</ENT>
              <ENT>1.91</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90818</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Psytx, hosp, 45-50 min</ENT>
              <ENT>1.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.70</ENT>
              <ENT>0.04</ENT>
              <ENT>N/A</ENT>
              <ENT>2.63</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90819</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Psytx, hosp, 45-50 min w/e&amp;m</ENT>
              <ENT>2.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.67</ENT>
              <ENT>0.05</ENT>
              <ENT>N/A</ENT>
              <ENT>2.77</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90821</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Psytx, hosp, 75-80 min</ENT>
              <ENT>2.83</ENT>
              <ENT>N/A</ENT>
              <ENT>1.03</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>3.92</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90822</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Psytx, hosp, 75-80 min w/e&amp;m</ENT>
              <ENT>2.99</ENT>
              <ENT>N/A</ENT>
              <ENT>0.97</ENT>
              <ENT>0.07</ENT>
              <ENT>N/A</ENT>
              <ENT>4.03</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90823</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intac psytx, hosp, 20-30 min</ENT>
              <ENT>1.36</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>0.03</ENT>
              <ENT>N/A</ENT>
              <ENT>1.88</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90824</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intac psytx, hsp 20-30 w/e&amp;m</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.50</ENT>
              <ENT>0.03</ENT>
              <ENT>N/A</ENT>
              <ENT>2.05</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90826</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intac psytx, hosp, 45-50 min</ENT>
              <ENT>2.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.74</ENT>
              <ENT>0.04</ENT>
              <ENT>N/A</ENT>
              <ENT>2.79</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90827</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intac psytx, hsp 45-50 w/e&amp;m</ENT>
              <ENT>2.16</ENT>
              <ENT>N/A</ENT>
              <ENT>0.70</ENT>
              <ENT>0.05</ENT>
              <ENT>N/A</ENT>
              <ENT>2.91</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49215"/>
              <ENT I="01">90828</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intac psytx, hosp, 75-80 min</ENT>
              <ENT>2.94</ENT>
              <ENT>N/A</ENT>
              <ENT>1.09</ENT>
              <ENT>0.07</ENT>
              <ENT>N/A</ENT>
              <ENT>4.10</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90829</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intac psytx, hsp 75-80 w/e&amp;m</ENT>
              <ENT>3.10</ENT>
              <ENT>N/A</ENT>
              <ENT>1.00</ENT>
              <ENT>0.07</ENT>
              <ENT>N/A</ENT>
              <ENT>4.17</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90845</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Psychoanalysis</ENT>
              <ENT>1.79</ENT>
              <ENT>0.59</ENT>
              <ENT>0.57</ENT>
              <ENT>0.04</ENT>
              <ENT>2.42</ENT>
              <ENT>2.40</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90846</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Family psytx w/o patient</ENT>
              <ENT>1.83</ENT>
              <ENT>0.67</ENT>
              <ENT>0.66</ENT>
              <ENT>0.04</ENT>
              <ENT>2.54</ENT>
              <ENT>2.53</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90847</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Family psytx w/patient</ENT>
              <ENT>2.21</ENT>
              <ENT>0.83</ENT>
              <ENT>0.78</ENT>
              <ENT>0.05</ENT>
              <ENT>3.09</ENT>
              <ENT>3.04</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90849</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Multiple family group psytx</ENT>
              <ENT>0.59</ENT>
              <ENT>0.28</ENT>
              <ENT>0.24</ENT>
              <ENT>0.01</ENT>
              <ENT>0.88</ENT>
              <ENT>0.84</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90853</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Group psychotherapy</ENT>
              <ENT>0.59</ENT>
              <ENT>0.25</ENT>
              <ENT>0.24</ENT>
              <ENT>0.01</ENT>
              <ENT>0.85</ENT>
              <ENT>0.84</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90857</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intac group psytx</ENT>
              <ENT>0.63</ENT>
              <ENT>0.30</ENT>
              <ENT>0.26</ENT>
              <ENT>0.02</ENT>
              <ENT>0.95</ENT>
              <ENT>0.91</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90862</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Medication management</ENT>
              <ENT>0.95</ENT>
              <ENT>0.41</ENT>
              <ENT>0.33</ENT>
              <ENT>0.02</ENT>
              <ENT>1.38</ENT>
              <ENT>1.30</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90865</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Narcosynthesis</ENT>
              <ENT>2.84</ENT>
              <ENT>1.64</ENT>
              <ENT>0.91</ENT>
              <ENT>0.07</ENT>
              <ENT>4.55</ENT>
              <ENT>3.82</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90870</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Electroconvulsive therapy</ENT>
              <ENT>1.88</ENT>
              <ENT>0.80</ENT>
              <ENT>0.80</ENT>
              <ENT>0.04</ENT>
              <ENT>2.72</ENT>
              <ENT>2.72</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90871</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Electroconvulsive therapy</ENT>
              <ENT>2.72</ENT>
              <ENT>N/A</ENT>
              <ENT>1.08</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>3.86</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90875</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Psychophysiological therapy</ENT>
              <ENT>1.20</ENT>
              <ENT>0.92</ENT>
              <ENT>0.46</ENT>
              <ENT>0.03</ENT>
              <ENT>2.15</ENT>
              <ENT>1.69</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90876</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Psychophysiological therapy</ENT>
              <ENT>1.90</ENT>
              <ENT>1.20</ENT>
              <ENT>0.74</ENT>
              <ENT>0.04</ENT>
              <ENT>3.14</ENT>
              <ENT>2.68</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90880</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hypnotherapy</ENT>
              <ENT>2.19</ENT>
              <ENT>1.06</ENT>
              <ENT>0.70</ENT>
              <ENT>0.05</ENT>
              <ENT>3.30</ENT>
              <ENT>2.94</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90885</ENT>
              <ENT/>
              <ENT>B</ENT>
              <ENT>Psy evaluation of records</ENT>
              <ENT>0.97</ENT>
              <ENT>0.38</ENT>
              <ENT>0.38</ENT>
              <ENT>0.02</ENT>
              <ENT>1.37</ENT>
              <ENT>1.37</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90887</ENT>
              <ENT/>
              <ENT>B</ENT>
              <ENT>Consultation with family</ENT>
              <ENT>1.48</ENT>
              <ENT>0.84</ENT>
              <ENT>0.57</ENT>
              <ENT>0.03</ENT>
              <ENT>2.35</ENT>
              <ENT>2.08</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90899</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Psychiatric service/therapy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90901</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biofeedback train, any meth</ENT>
              <ENT>0.41</ENT>
              <ENT>0.60</ENT>
              <ENT>0.14</ENT>
              <ENT>0.02</ENT>
              <ENT>1.03</ENT>
              <ENT>0.57</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90911</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biofeedback peri/uro/rectal</ENT>
              <ENT>0.89</ENT>
              <ENT>3.95</ENT>
              <ENT>0.32</ENT>
              <ENT>0.04</ENT>
              <ENT>4.88</ENT>
              <ENT>1.25</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90918</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>ESRD related services, month</ENT>
              <ENT>11.18</ENT>
              <ENT>7.52</ENT>
              <ENT>7.52</ENT>
              <ENT>0.30</ENT>
              <ENT>19.00</ENT>
              <ENT>19.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90919</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>ESRD related services, month</ENT>
              <ENT>8.54</ENT>
              <ENT>4.15</ENT>
              <ENT>4.15</ENT>
              <ENT>0.24</ENT>
              <ENT>12.93</ENT>
              <ENT>12.93</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90920</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>ESRD related services, month</ENT>
              <ENT>7.27</ENT>
              <ENT>3.89</ENT>
              <ENT>3.89</ENT>
              <ENT>0.19</ENT>
              <ENT>11.35</ENT>
              <ENT>11.35</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90921</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>ESRD related services, month</ENT>
              <ENT>4.47</ENT>
              <ENT>2.52</ENT>
              <ENT>2.52</ENT>
              <ENT>0.12</ENT>
              <ENT>7.11</ENT>
              <ENT>7.11</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90922</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ESRD related services, day</ENT>
              <ENT>0.37</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>0.01</ENT>
              <ENT>0.60</ENT>
              <ENT>0.60</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90923</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esrd related services, day</ENT>
              <ENT>0.28</ENT>
              <ENT>0.13</ENT>
              <ENT>0.13</ENT>
              <ENT>0.01</ENT>
              <ENT>0.42</ENT>
              <ENT>0.42</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90924</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esrd related services, day</ENT>
              <ENT>0.24</ENT>
              <ENT>0.12</ENT>
              <ENT>0.12</ENT>
              <ENT>0.01</ENT>
              <ENT>0.37</ENT>
              <ENT>0.37</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90925</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esrd related services, day</ENT>
              <ENT>0.15</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>0.01</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90935</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hemodialysis, one evaluation</ENT>
              <ENT>1.22</ENT>
              <ENT>N/A</ENT>
              <ENT>0.69</ENT>
              <ENT>0.03</ENT>
              <ENT>N/A</ENT>
              <ENT>1.94</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90937</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hemodialysis, repeated eval</ENT>
              <ENT>2.11</ENT>
              <ENT>N/A</ENT>
              <ENT>1.00</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>3.17</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90945</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dialysis, one evaluation</ENT>
              <ENT>1.28</ENT>
              <ENT>N/A</ENT>
              <ENT>0.71</ENT>
              <ENT>0.04</ENT>
              <ENT>N/A</ENT>
              <ENT>2.03</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90947</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dialysis, repeated eval</ENT>
              <ENT>2.16</ENT>
              <ENT>N/A</ENT>
              <ENT>1.02</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>3.24</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90997</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hemoperfusion</ENT>
              <ENT>1.84</ENT>
              <ENT>N/A</ENT>
              <ENT>1.43</ENT>
              <ENT>0.05</ENT>
              <ENT>N/A</ENT>
              <ENT>3.32</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">90999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Dialysis procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esophageal intubation</ENT>
              <ENT>0.73</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91000</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Esophageal intubation</ENT>
              <ENT>0.73</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.03</ENT>
              <ENT>1.01</ENT>
              <ENT>1.01</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91000</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Esophageal intubation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.08</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.09</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esophagus motility study</ENT>
              <ENT>1.25</ENT>
              <ENT>2.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>4.13</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91010</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Esophagus motility study</ENT>
              <ENT>1.25</ENT>
              <ENT>0.45</ENT>
              <ENT>0.45</ENT>
              <ENT>0.05</ENT>
              <ENT>1.75</ENT>
              <ENT>1.75</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91010</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Esophagus motility study</ENT>
              <ENT>0.00</ENT>
              <ENT>2.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>2.38</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91011</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esophagus motility study</ENT>
              <ENT>1.50</ENT>
              <ENT>3.28</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>4.88</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91011</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Esophagus motility study</ENT>
              <ENT>1.50</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>0.05</ENT>
              <ENT>2.09</ENT>
              <ENT>2.09</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91011</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Esophagus motility study</ENT>
              <ENT>0.00</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>2.79</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91012</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esophagus motility study</ENT>
              <ENT>1.46</ENT>
              <ENT>3.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>5.00</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91012</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Esophagus motility study</ENT>
              <ENT>1.46</ENT>
              <ENT>0.52</ENT>
              <ENT>0.52</ENT>
              <ENT>0.06</ENT>
              <ENT>2.04</ENT>
              <ENT>2.04</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91012</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Esophagus motility study</ENT>
              <ENT>0.00</ENT>
              <ENT>2.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>2.95</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Gastric motility</ENT>
              <ENT>1.44</ENT>
              <ENT>3.03</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>4.58</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91020</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Gastric motility</ENT>
              <ENT>1.44</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>0.06</ENT>
              <ENT>2.00</ENT>
              <ENT>2.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91020</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Gastric motility</ENT>
              <ENT>0.00</ENT>
              <ENT>2.53</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>2.58</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91030</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Acid perfusion of esophagus</ENT>
              <ENT>0.91</ENT>
              <ENT>2.45</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>3.41</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91030</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Acid perfusion of esophagus</ENT>
              <ENT>0.91</ENT>
              <ENT>0.33</ENT>
              <ENT>0.33</ENT>
              <ENT>0.03</ENT>
              <ENT>1.27</ENT>
              <ENT>1.27</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49216"/>
              <ENT I="01">91030</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Acid perfusion of esophagus</ENT>
              <ENT>0.00</ENT>
              <ENT>2.12</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>2.14</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91032</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esophagus, acid reflux test</ENT>
              <ENT>1.21</ENT>
              <ENT>4.24</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>5.55</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91032</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Esophagus, acid reflux test</ENT>
              <ENT>1.21</ENT>
              <ENT>0.43</ENT>
              <ENT>0.43</ENT>
              <ENT>0.05</ENT>
              <ENT>1.69</ENT>
              <ENT>1.69</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91032</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Esophagus, acid reflux test</ENT>
              <ENT>0.00</ENT>
              <ENT>3.82</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>3.87</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91033</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prolonged acid reflux test</ENT>
              <ENT>1.30</ENT>
              <ENT>4.27</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>5.71</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91033</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Prolonged acid reflux test</ENT>
              <ENT>1.30</ENT>
              <ENT>0.46</ENT>
              <ENT>0.46</ENT>
              <ENT>0.05</ENT>
              <ENT>1.81</ENT>
              <ENT>1.81</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91033</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Prolonged acid reflux test</ENT>
              <ENT>0.00</ENT>
              <ENT>3.81</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>3.90</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91052</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Gastric analysis test</ENT>
              <ENT>0.79</ENT>
              <ENT>2.24</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>3.08</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91052</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Gastric analysis test</ENT>
              <ENT>0.79</ENT>
              <ENT>0.28</ENT>
              <ENT>0.28</ENT>
              <ENT>0.03</ENT>
              <ENT>1.10</ENT>
              <ENT>1.10</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91052</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Gastric analysis test</ENT>
              <ENT>0.00</ENT>
              <ENT>1.96</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.98</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91055</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Gastric intubation for smear</ENT>
              <ENT>0.94</ENT>
              <ENT>2.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>3.42</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91055</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Gastric intubation for smear</ENT>
              <ENT>0.94</ENT>
              <ENT>0.27</ENT>
              <ENT>0.27</ENT>
              <ENT>0.04</ENT>
              <ENT>1.25</ENT>
              <ENT>1.25</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91055</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Gastric intubation for smear</ENT>
              <ENT>0.00</ENT>
              <ENT>2.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>2.17</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91060</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Gastric saline load test</ENT>
              <ENT>0.45</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91060</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Gastric saline load test</ENT>
              <ENT>0.45</ENT>
              <ENT>0.14</ENT>
              <ENT>0.14</ENT>
              <ENT>0.02</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91060</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Gastric saline load test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91065</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Breath hydrogen test</ENT>
              <ENT>0.20</ENT>
              <ENT>2.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>2.25</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91065</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Breath hydrogen test</ENT>
              <ENT>0.20</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.28</ENT>
              <ENT>0.28</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91065</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Breath hydrogen test</ENT>
              <ENT>0.00</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.97</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pass intestine bleeding tube</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>0.29</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>1.43</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91105</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Gastric intubation treatment</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>0.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.48</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91122</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Anal pressure record</ENT>
              <ENT>1.77</ENT>
              <ENT>6.20</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>8.14</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91122</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Anal pressure record</ENT>
              <ENT>1.77</ENT>
              <ENT>0.62</ENT>
              <ENT>0.62</ENT>
              <ENT>0.10</ENT>
              <ENT>2.49</ENT>
              <ENT>2.49</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91122</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Anal pressure record</ENT>
              <ENT>0.00</ENT>
              <ENT>5.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>5.65</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91132</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Electrogastrography</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91132</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Electrogastrography</ENT>
              <ENT>0.52</ENT>
              <ENT>0.19</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91132</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Electrogastrography</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91133</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Electrogastrography w/test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91133</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Electrogastrography w/test</ENT>
              <ENT>0.66</ENT>
              <ENT>0.24</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.93</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91133</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Electrogastrography w/test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91299</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Gastroenterology procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91299</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Gastroenterology procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">91299</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Gastroenterology procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92002</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Eye exam, new patient</ENT>
              <ENT>0.88</ENT>
              <ENT>0.98</ENT>
              <ENT>0.35</ENT>
              <ENT>0.02</ENT>
              <ENT>1.88</ENT>
              <ENT>1.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92004</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Eye exam, new patient</ENT>
              <ENT>1.67</ENT>
              <ENT>1.71</ENT>
              <ENT>0.69</ENT>
              <ENT>0.03</ENT>
              <ENT>3.41</ENT>
              <ENT>2.39</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92012</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Eye exam established pat</ENT>
              <ENT>0.67</ENT>
              <ENT>1.04</ENT>
              <ENT>0.29</ENT>
              <ENT>0.01</ENT>
              <ENT>1.72</ENT>
              <ENT>0.97</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92014</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Eye exam &amp; treatment</ENT>
              <ENT>1.10</ENT>
              <ENT>1.41</ENT>
              <ENT>0.48</ENT>
              <ENT>0.02</ENT>
              <ENT>2.53</ENT>
              <ENT>1.60</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92015</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Refraction</ENT>
              <ENT>0.38</ENT>
              <ENT>1.19</ENT>
              <ENT>0.15</ENT>
              <ENT>0.01</ENT>
              <ENT>1.58</ENT>
              <ENT>0.54</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92018</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>New eye exam &amp; treatment</ENT>
              <ENT>2.50</ENT>
              <ENT>N/A</ENT>
              <ENT>1.10</ENT>
              <ENT>0.03</ENT>
              <ENT>N/A</ENT>
              <ENT>3.63</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92019</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Eye exam &amp; treatment</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.58</ENT>
              <ENT>0.03</ENT>
              <ENT>N/A</ENT>
              <ENT>1.92</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Special eye evaluation</ENT>
              <ENT>0.37</ENT>
              <ENT>0.33</ENT>
              <ENT>0.16</ENT>
              <ENT>0.01</ENT>
              <ENT>0.71</ENT>
              <ENT>0.54</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92060</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Special eye evaluation</ENT>
              <ENT>0.69</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.45</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92060</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Special eye evaluation</ENT>
              <ENT>0.69</ENT>
              <ENT>0.29</ENT>
              <ENT>0.29</ENT>
              <ENT>0.01</ENT>
              <ENT>0.99</ENT>
              <ENT>0.99</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92060</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Special eye evaluation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92065</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Orthoptic/pleoptic training</ENT>
              <ENT>0.37</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.95</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92065</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Orthoptic/pleoptic training</ENT>
              <ENT>0.37</ENT>
              <ENT>0.15</ENT>
              <ENT>0.15</ENT>
              <ENT>0.01</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92065</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Orthoptic/pleoptic training</ENT>
              <ENT>0.00</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92070</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fitting of contact lens</ENT>
              <ENT>0.70</ENT>
              <ENT>1.09</ENT>
              <ENT>0.32</ENT>
              <ENT>0.01</ENT>
              <ENT>1.80</ENT>
              <ENT>1.03</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92081</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Visual field examination(s)</ENT>
              <ENT>0.36</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.25</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92081</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Visual field examination(s)</ENT>
              <ENT>0.36</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.01</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92081</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Visual field examination(s)</ENT>
              <ENT>0.00</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92082</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Visual field examination(s)</ENT>
              <ENT>0.44</ENT>
              <ENT>1.16</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.62</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92082</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Visual field examination(s)</ENT>
              <ENT>0.44</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.01</ENT>
              <ENT>0.64</ENT>
              <ENT>0.64</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49217"/>
              <ENT I="01">92082</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Visual field examination(s)</ENT>
              <ENT>0.00</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.98</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92083</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Visual field examination(s)</ENT>
              <ENT>0.50</ENT>
              <ENT>1.35</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.87</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92083</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Visual field examination(s)</ENT>
              <ENT>0.50</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>0.01</ENT>
              <ENT>0.73</ENT>
              <ENT>0.73</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92083</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Visual field examination(s)</ENT>
              <ENT>0.00</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Serial tonometry exam(s)</ENT>
              <ENT>0.92</ENT>
              <ENT>1.28</ENT>
              <ENT>0.37</ENT>
              <ENT>0.02</ENT>
              <ENT>2.22</ENT>
              <ENT>1.31</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tonography &amp; eye evaluation</ENT>
              <ENT>0.81</ENT>
              <ENT>1.06</ENT>
              <ENT>0.32</ENT>
              <ENT>0.02</ENT>
              <ENT>1.89</ENT>
              <ENT>1.15</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Water provocation tonography</ENT>
              <ENT>0.81</ENT>
              <ENT>1.26</ENT>
              <ENT>0.38</ENT>
              <ENT>0.02</ENT>
              <ENT>2.09</ENT>
              <ENT>1.21</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92135</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Opthalmic dx imaging</ENT>
              <ENT>0.35</ENT>
              <ENT>0.80</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92135</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Opthalmic dx imaging</ENT>
              <ENT>0.35</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.01</ENT>
              <ENT>0.52</ENT>
              <ENT>0.52</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92135</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Opthalmic dx imaging</ENT>
              <ENT>0.00</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92136</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ophthalmic biometry</ENT>
              <ENT>0.54</ENT>
              <ENT>1.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>2.39</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92136</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ophthalmic biometry</ENT>
              <ENT>0.54</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.01</ENT>
              <ENT>0.80</ENT>
              <ENT>0.80</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92136</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ophthalmic biometry</ENT>
              <ENT>0.00</ENT>
              <ENT>1.53</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.59</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Glaucoma provocative tests</ENT>
              <ENT>0.50</ENT>
              <ENT>0.95</ENT>
              <ENT>0.22</ENT>
              <ENT>0.01</ENT>
              <ENT>1.46</ENT>
              <ENT>0.73</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92225</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Special eye exam, initial</ENT>
              <ENT>0.38</ENT>
              <ENT>0.22</ENT>
              <ENT>0.16</ENT>
              <ENT>0.01</ENT>
              <ENT>0.61</ENT>
              <ENT>0.55</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92226</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Special eye exam, subsequent</ENT>
              <ENT>0.33</ENT>
              <ENT>0.21</ENT>
              <ENT>0.15</ENT>
              <ENT>0.01</ENT>
              <ENT>0.55</ENT>
              <ENT>0.49</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92230</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Eye exam with photos</ENT>
              <ENT>0.60</ENT>
              <ENT>1.70</ENT>
              <ENT>0.20</ENT>
              <ENT>0.02</ENT>
              <ENT>2.32</ENT>
              <ENT>0.82</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92235</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Eye exam with photos</ENT>
              <ENT>0.81</ENT>
              <ENT>2.97</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>3.85</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92235</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Eye exam with photos</ENT>
              <ENT>0.81</ENT>
              <ENT>0.37</ENT>
              <ENT>0.37</ENT>
              <ENT>0.02</ENT>
              <ENT>1.20</ENT>
              <ENT>1.20</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92235</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Eye exam with photos</ENT>
              <ENT>0.00</ENT>
              <ENT>2.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>2.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92240</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Icg angiography</ENT>
              <ENT>1.10</ENT>
              <ENT>7.13</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>8.30</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92240</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Icg angiography</ENT>
              <ENT>1.10</ENT>
              <ENT>0.51</ENT>
              <ENT>0.51</ENT>
              <ENT>0.02</ENT>
              <ENT>1.63</ENT>
              <ENT>1.63</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92240</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Icg angiography</ENT>
              <ENT>0.00</ENT>
              <ENT>6.63</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>6.68</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Eye exam with photos</ENT>
              <ENT>0.44</ENT>
              <ENT>1.75</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>2.21</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92250</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Eye exam with photos</ENT>
              <ENT>0.44</ENT>
              <ENT>0.20</ENT>
              <ENT>0.20</ENT>
              <ENT>0.01</ENT>
              <ENT>0.65</ENT>
              <ENT>0.65</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92250</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Eye exam with photos</ENT>
              <ENT>0.00</ENT>
              <ENT>1.55</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>1.56</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92260</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ophthalmoscopy/dynamometry</ENT>
              <ENT>0.20</ENT>
              <ENT>0.29</ENT>
              <ENT>0.09</ENT>
              <ENT>0.01</ENT>
              <ENT>0.50</ENT>
              <ENT>0.30</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92265</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Eye muscle evaluation</ENT>
              <ENT>0.81</ENT>
              <ENT>1.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92265</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Eye muscle evaluation</ENT>
              <ENT>0.81</ENT>
              <ENT>0.29</ENT>
              <ENT>0.29</ENT>
              <ENT>0.02</ENT>
              <ENT>1.12</ENT>
              <ENT>1.12</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92265</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Eye muscle evaluation</ENT>
              <ENT>0.00</ENT>
              <ENT>1.61</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.63</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92270</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Electro-oculography</ENT>
              <ENT>0.81</ENT>
              <ENT>1.72</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>2.58</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92270</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Electro-oculography</ENT>
              <ENT>0.81</ENT>
              <ENT>0.34</ENT>
              <ENT>0.34</ENT>
              <ENT>0.03</ENT>
              <ENT>1.18</ENT>
              <ENT>1.18</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92270</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Electro-oculography</ENT>
              <ENT>0.00</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.39</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92275</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Electroretinography</ENT>
              <ENT>1.01</ENT>
              <ENT>1.98</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>3.03</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92275</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Electroretinography</ENT>
              <ENT>1.01</ENT>
              <ENT>0.44</ENT>
              <ENT>0.44</ENT>
              <ENT>0.02</ENT>
              <ENT>1.47</ENT>
              <ENT>1.47</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92275</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Electroretinography</ENT>
              <ENT>0.00</ENT>
              <ENT>1.54</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.56</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92283</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Color vision examination</ENT>
              <ENT>0.17</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.04</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92283</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Color vision examination</ENT>
              <ENT>0.17</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92283</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Color vision examination</ENT>
              <ENT>0.00</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92284</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dark adaptation eye exam</ENT>
              <ENT>0.24</ENT>
              <ENT>2.35</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>2.61</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92284</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Dark adaptation eye exam</ENT>
              <ENT>0.24</ENT>
              <ENT>0.09</ENT>
              <ENT>0.09</ENT>
              <ENT>0.01</ENT>
              <ENT>0.34</ENT>
              <ENT>0.34</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92284</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Dark adaptation eye exam</ENT>
              <ENT>0.00</ENT>
              <ENT>2.26</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>2.27</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92285</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Eye photography</ENT>
              <ENT>0.20</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.29</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92285</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Eye photography</ENT>
              <ENT>0.20</ENT>
              <ENT>0.09</ENT>
              <ENT>0.09</ENT>
              <ENT>0.01</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92285</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Eye photography</ENT>
              <ENT>0.00</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>1.00</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92286</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Internal eye photography</ENT>
              <ENT>0.66</ENT>
              <ENT>3.40</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>4.09</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92286</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Internal eye photography</ENT>
              <ENT>0.66</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>0.01</ENT>
              <ENT>0.97</ENT>
              <ENT>0.97</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92286</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Internal eye photography</ENT>
              <ENT>0.00</ENT>
              <ENT>3.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>3.12</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92287</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Internal eye photography</ENT>
              <ENT>0.81</ENT>
              <ENT>2.74</ENT>
              <ENT>0.31</ENT>
              <ENT>0.02</ENT>
              <ENT>3.57</ENT>
              <ENT>1.14</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92310</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Contact lens fitting</ENT>
              <ENT>1.17</ENT>
              <ENT>1.17</ENT>
              <ENT>0.45</ENT>
              <ENT>0.03</ENT>
              <ENT>2.37</ENT>
              <ENT>1.65</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92311</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contact lens fitting</ENT>
              <ENT>1.08</ENT>
              <ENT>1.21</ENT>
              <ENT>0.35</ENT>
              <ENT>0.03</ENT>
              <ENT>2.32</ENT>
              <ENT>1.46</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92312</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contact lens fitting</ENT>
              <ENT>1.26</ENT>
              <ENT>1.18</ENT>
              <ENT>0.50</ENT>
              <ENT>0.03</ENT>
              <ENT>2.47</ENT>
              <ENT>1.79</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92313</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contact lens fitting</ENT>
              <ENT>0.92</ENT>
              <ENT>1.18</ENT>
              <ENT>0.29</ENT>
              <ENT>0.02</ENT>
              <ENT>2.12</ENT>
              <ENT>1.23</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92314</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Prescription of contact lens</ENT>
              <ENT>0.69</ENT>
              <ENT>0.98</ENT>
              <ENT>0.27</ENT>
              <ENT>0.01</ENT>
              <ENT>1.68</ENT>
              <ENT>0.97</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92315</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prescription of contact lens</ENT>
              <ENT>0.45</ENT>
              <ENT>0.96</ENT>
              <ENT>0.16</ENT>
              <ENT>0.01</ENT>
              <ENT>1.42</ENT>
              <ENT>0.62</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92316</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prescription of contact lens</ENT>
              <ENT>0.68</ENT>
              <ENT>1.01</ENT>
              <ENT>0.30</ENT>
              <ENT>0.01</ENT>
              <ENT>1.70</ENT>
              <ENT>0.99</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92317</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prescription of contact lens</ENT>
              <ENT>0.45</ENT>
              <ENT>1.07</ENT>
              <ENT>0.14</ENT>
              <ENT>0.01</ENT>
              <ENT>1.53</ENT>
              <ENT>0.60</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49218"/>
              <ENT I="01">92325</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Modification of contact lens</ENT>
              <ENT>0.00</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92326</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Replacement of contact lens</ENT>
              <ENT>0.00</ENT>
              <ENT>1.63</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.68</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92330</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fitting of artificial eye</ENT>
              <ENT>1.08</ENT>
              <ENT>1.09</ENT>
              <ENT>0.33</ENT>
              <ENT>0.04</ENT>
              <ENT>2.21</ENT>
              <ENT>1.45</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92335</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fitting of artificial eye</ENT>
              <ENT>0.45</ENT>
              <ENT>1.02</ENT>
              <ENT>0.17</ENT>
              <ENT>0.01</ENT>
              <ENT>1.48</ENT>
              <ENT>0.63</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92340</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Fitting of spectacles</ENT>
              <ENT>0.37</ENT>
              <ENT>0.74</ENT>
              <ENT>0.14</ENT>
              <ENT>0.01</ENT>
              <ENT>1.12</ENT>
              <ENT>0.52</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92341</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Fitting of spectacles</ENT>
              <ENT>0.47</ENT>
              <ENT>0.78</ENT>
              <ENT>0.18</ENT>
              <ENT>0.01</ENT>
              <ENT>1.26</ENT>
              <ENT>0.66</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92342</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Fitting of spectacles</ENT>
              <ENT>0.53</ENT>
              <ENT>0.80</ENT>
              <ENT>0.21</ENT>
              <ENT>0.01</ENT>
              <ENT>1.34</ENT>
              <ENT>0.75</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92352</ENT>
              <ENT/>
              <ENT>B</ENT>
              <ENT>Special spectacles fitting</ENT>
              <ENT>0.37</ENT>
              <ENT>0.74</ENT>
              <ENT>0.14</ENT>
              <ENT>0.01</ENT>
              <ENT>1.12</ENT>
              <ENT>0.52</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92353</ENT>
              <ENT/>
              <ENT>B</ENT>
              <ENT>Special spectacles fitting</ENT>
              <ENT>0.50</ENT>
              <ENT>0.79</ENT>
              <ENT>0.19</ENT>
              <ENT>0.02</ENT>
              <ENT>1.31</ENT>
              <ENT>0.71</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92354</ENT>
              <ENT/>
              <ENT>B</ENT>
              <ENT>Special spectacles fitting</ENT>
              <ENT>0.00</ENT>
              <ENT>8.86</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>8.94</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92355</ENT>
              <ENT/>
              <ENT>B</ENT>
              <ENT>Special spectacles fitting</ENT>
              <ENT>0.00</ENT>
              <ENT>4.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>4.34</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92358</ENT>
              <ENT/>
              <ENT>B</ENT>
              <ENT>Eye prosthesis service</ENT>
              <ENT>0.00</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>1.01</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92370</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Repair &amp; adjust spectacles</ENT>
              <ENT>0.32</ENT>
              <ENT>0.60</ENT>
              <ENT>0.12</ENT>
              <ENT>0.02</ENT>
              <ENT>0.94</ENT>
              <ENT>0.46</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92371</ENT>
              <ENT/>
              <ENT>B</ENT>
              <ENT>Repair &amp; adjust spectacles</ENT>
              <ENT>0.00</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92392</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Supply of low vision aids</ENT>
              <ENT>0.00</ENT>
              <ENT>3.84</ENT>
              <ENT>3.84</ENT>
              <ENT>0.02</ENT>
              <ENT>3.86</ENT>
              <ENT>3.86</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92393</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Supply of artificial eye</ENT>
              <ENT>0.00</ENT>
              <ENT>11.92</ENT>
              <ENT>11.92</ENT>
              <ENT>0.47</ENT>
              <ENT>12.39</ENT>
              <ENT>12.39</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92395</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Supply of spectacles</ENT>
              <ENT>0.00</ENT>
              <ENT>1.30</ENT>
              <ENT>1.30</ENT>
              <ENT>0.08</ENT>
              <ENT>1.38</ENT>
              <ENT>1.38</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92396</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Supply of contact lenses</ENT>
              <ENT>0.00</ENT>
              <ENT>2.19</ENT>
              <ENT>2.19</ENT>
              <ENT>0.06</ENT>
              <ENT>2.25</ENT>
              <ENT>2.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92499</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Eye service or procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92499</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Eye service or procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92499</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Eye service or procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92502</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ear and throat examination</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>1.16</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>2.73</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92504</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ear microscopy examination</ENT>
              <ENT>0.18</ENT>
              <ENT>0.53</ENT>
              <ENT>0.09</ENT>
              <ENT>0.01</ENT>
              <ENT>0.72</ENT>
              <ENT>0.28</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92506</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Speech/hearing evaluation</ENT>
              <ENT>0.86</ENT>
              <ENT>2.65</ENT>
              <ENT>0.41</ENT>
              <ENT>0.04</ENT>
              <ENT>3.55</ENT>
              <ENT>1.31</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92507</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Speech/hearing therapy</ENT>
              <ENT>0.52</ENT>
              <ENT>0.97</ENT>
              <ENT>0.24</ENT>
              <ENT>0.02</ENT>
              <ENT>1.51</ENT>
              <ENT>0.78</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92508</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Speech/hearing therapy</ENT>
              <ENT>0.26</ENT>
              <ENT>0.53</ENT>
              <ENT>0.12</ENT>
              <ENT>0.01</ENT>
              <ENT>0.80</ENT>
              <ENT>0.39</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92510</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Rehab for ear implant</ENT>
              <ENT>1.50</ENT>
              <ENT>2.11</ENT>
              <ENT>0.83</ENT>
              <ENT>0.06</ENT>
              <ENT>3.67</ENT>
              <ENT>2.39</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92511</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nasopharyngoscopy</ENT>
              <ENT>0.84</ENT>
              <ENT>2.50</ENT>
              <ENT>0.79</ENT>
              <ENT>0.03</ENT>
              <ENT>3.37</ENT>
              <ENT>1.66</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92512</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nasal function studies</ENT>
              <ENT>0.55</ENT>
              <ENT>1.13</ENT>
              <ENT>0.18</ENT>
              <ENT>0.02</ENT>
              <ENT>1.70</ENT>
              <ENT>0.75</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92516</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Facial nerve function test</ENT>
              <ENT>0.43</ENT>
              <ENT>0.95</ENT>
              <ENT>0.22</ENT>
              <ENT>0.02</ENT>
              <ENT>1.40</ENT>
              <ENT>0.67</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laryngeal function studies</ENT>
              <ENT>0.76</ENT>
              <ENT>0.52</ENT>
              <ENT>0.40</ENT>
              <ENT>0.03</ENT>
              <ENT>1.31</ENT>
              <ENT>1.19</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92526</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Oral function therapy</ENT>
              <ENT>0.55</ENT>
              <ENT>1.67</ENT>
              <ENT>0.20</ENT>
              <ENT>0.02</ENT>
              <ENT>2.24</ENT>
              <ENT>0.77</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92541</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Spontaneous nystagmus test</ENT>
              <ENT>0.40</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>1.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92541</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Spontaneous nystagmus test</ENT>
              <ENT>0.40</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.02</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92541</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Spontaneous nystagmus test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92542</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Positional nystagmus test</ENT>
              <ENT>0.33</ENT>
              <ENT>1.16</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92542</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Positional nystagmus test</ENT>
              <ENT>0.33</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.01</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92542</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Positional nystagmus test</ENT>
              <ENT>0.00</ENT>
              <ENT>1.00</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92543</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Caloric vestibular test</ENT>
              <ENT>0.10</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92543</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Caloric vestibular test</ENT>
              <ENT>0.10</ENT>
              <ENT>0.05</ENT>
              <ENT>0.05</ENT>
              <ENT>0.01</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92543</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Caloric vestibular test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92544</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Optokinetic nystagmus test</ENT>
              <ENT>0.26</ENT>
              <ENT>0.92</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>1.21</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92544</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Optokinetic nystagmus test</ENT>
              <ENT>0.26</ENT>
              <ENT>0.13</ENT>
              <ENT>0.13</ENT>
              <ENT>0.01</ENT>
              <ENT>0.40</ENT>
              <ENT>0.40</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92544</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Optokinetic nystagmus test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92545</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Oscillating tracking test</ENT>
              <ENT>0.23</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>1.12</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92545</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Oscillating tracking test</ENT>
              <ENT>0.23</ENT>
              <ENT>0.11</ENT>
              <ENT>0.11</ENT>
              <ENT>0.01</ENT>
              <ENT>0.35</ENT>
              <ENT>0.35</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92545</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Oscillating tracking test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92546</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sinusoidal rotational test</ENT>
              <ENT>0.29</ENT>
              <ENT>2.14</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>2.46</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92546</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Sinusoidal rotational test</ENT>
              <ENT>0.29</ENT>
              <ENT>0.13</ENT>
              <ENT>0.13</ENT>
              <ENT>0.01</ENT>
              <ENT>0.43</ENT>
              <ENT>0.43</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92546</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Sinusoidal rotational test</ENT>
              <ENT>0.00</ENT>
              <ENT>2.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>2.03</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92547</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Supplemental electrical test</ENT>
              <ENT>0.00</ENT>
              <ENT>1.30</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.35</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92548</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Posturography</ENT>
              <ENT>0.50</ENT>
              <ENT>3.83</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>4.46</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92548</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Posturography</ENT>
              <ENT>0.50</ENT>
              <ENT>0.26</ENT>
              <ENT>0.26</ENT>
              <ENT>0.02</ENT>
              <ENT>0.78</ENT>
              <ENT>0.78</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92548</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Posturography</ENT>
              <ENT>0.00</ENT>
              <ENT>3.56</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>3.67</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92552</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pure tone audiometry, air</ENT>
              <ENT>0.00</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49219"/>
              <ENT I="01">92553</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Audiometry, air &amp; bone</ENT>
              <ENT>0.00</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92555</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Speech threshold audiometry</ENT>
              <ENT>0.00</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92556</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Speech audiometry, complete</ENT>
              <ENT>0.00</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92557</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Comprehensive hearing test</ENT>
              <ENT>0.00</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>1.29</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92561</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bekesy audiometry, diagnosis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92562</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Loudness balance test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92563</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tone decay hearing test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92564</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sisi hearing test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92565</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Stenger test, pure tone</ENT>
              <ENT>0.00</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92567</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tympanometry</ENT>
              <ENT>0.00</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92568</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Acoustic reflex testing</ENT>
              <ENT>0.00</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92569</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Acoustic reflex decay test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92571</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Filtered speech hearing test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.39</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92572</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Staggered spondaic word test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.09</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.10</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92573</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lombard test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.35</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92575</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sensorineural acuity test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92576</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Synthetic sentence test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.48</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92577</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Stenger test, speech</ENT>
              <ENT>0.00</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92579</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Visual audiometry (vra)</ENT>
              <ENT>0.00</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92582</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Conditioning play audiometry</ENT>
              <ENT>0.00</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92583</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Select picture audiometry</ENT>
              <ENT>0.00</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>0.96</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92584</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Electrocochleography</ENT>
              <ENT>0.00</ENT>
              <ENT>2.48</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>2.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92585</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Auditor evoke potent, compre</ENT>
              <ENT>0.50</ENT>
              <ENT>2.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>2.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92585</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Auditor evoke potent, compre</ENT>
              <ENT>0.50</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>0.02</ENT>
              <ENT>0.74</ENT>
              <ENT>0.74</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92585</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Auditor evoke potent, compre</ENT>
              <ENT>0.00</ENT>
              <ENT>1.85</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>1.97</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92586</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Auditor evoke potent, limit</ENT>
              <ENT>0.00</ENT>
              <ENT>1.85</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>1.97</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92587</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Evoked auditory test</ENT>
              <ENT>0.13</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92587</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Evoked auditory test</ENT>
              <ENT>0.13</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.21</ENT>
              <ENT>0.21</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92587</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Evoked auditory test</ENT>
              <ENT>0.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.40</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92588</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Evoked auditory test</ENT>
              <ENT>0.36</ENT>
              <ENT>1.64</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.12</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92588</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Evoked auditory test</ENT>
              <ENT>0.36</ENT>
              <ENT>0.17</ENT>
              <ENT>0.17</ENT>
              <ENT>0.01</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92588</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Evoked auditory test</ENT>
              <ENT>0.00</ENT>
              <ENT>1.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>1.58</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92589</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Auditory function test(s)</ENT>
              <ENT>0.00</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92596</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ear protector evaluation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92597</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Oral speech device eval</ENT>
              <ENT>0.86</ENT>
              <ENT>1.77</ENT>
              <ENT>0.46</ENT>
              <ENT>0.04</ENT>
              <ENT>2.67</ENT>
              <ENT>1.36</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92601</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cochlear implt f/up exam &lt; 7</ENT>
              <ENT>0.00</ENT>
              <ENT>3.64</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>3.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92602</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reprogram cochlear implt &lt; 7</ENT>
              <ENT>0.00</ENT>
              <ENT>2.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>2.58</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92603</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cochlear implt f/up exam 7 &gt;</ENT>
              <ENT>0.00</ENT>
              <ENT>2.38</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>2.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92604</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Reprogram cochlear implt 7 &gt;</ENT>
              <ENT>0.00</ENT>
              <ENT>1.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.63</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92607</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ex for speech device rx, 1hr</ENT>
              <ENT>0.00</ENT>
              <ENT>3.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>3.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92608</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ex for speech device rx addl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92609</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Use of speech device service</ENT>
              <ENT>0.00</ENT>
              <ENT>1.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>1.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92610</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Evaluate swallowing function</ENT>
              <ENT>0.00</ENT>
              <ENT>1.27</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.34</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92611</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Motion fluoroscopy/swallow</ENT>
              <ENT>0.00</ENT>
              <ENT>1.80</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.87</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92612</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Endoscopy swallow tst (fees)</ENT>
              <ENT>1.27</ENT>
              <ENT>3.16</ENT>
              <ENT>0.68</ENT>
              <ENT>0.07</ENT>
              <ENT>4.50</ENT>
              <ENT>2.02</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49220"/>
              <ENT I="01">92614</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laryngoscopic sensory test</ENT>
              <ENT>1.27</ENT>
              <ENT>2.87</ENT>
              <ENT>0.62</ENT>
              <ENT>0.07</ENT>
              <ENT>4.21</ENT>
              <ENT>1.96</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92616</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Fees w/laryngeal sense test</ENT>
              <ENT>1.88</ENT>
              <ENT>3.96</ENT>
              <ENT>0.98</ENT>
              <ENT>0.07</ENT>
              <ENT>5.91</ENT>
              <ENT>2.93</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92700</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Ent procedure/service</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92950</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Heart/lung resuscitation cpr</ENT>
              <ENT>3.80</ENT>
              <ENT>N/A</ENT>
              <ENT>1.00</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>5.01</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92953</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Temporary external pacing</ENT>
              <ENT>0.23</ENT>
              <ENT>N/A</ENT>
              <ENT>0.23</ENT>
              <ENT>0.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.47</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92960</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cardioversion electric, ext</ENT>
              <ENT>2.25</ENT>
              <ENT>6.82</ENT>
              <ENT>1.20</ENT>
              <ENT>0.08</ENT>
              <ENT>9.15</ENT>
              <ENT>3.53</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92961</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cardioversion, electric, int</ENT>
              <ENT>4.60</ENT>
              <ENT>N/A</ENT>
              <ENT>2.12</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>6.89</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92970</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cardioassist, internal</ENT>
              <ENT>3.52</ENT>
              <ENT>N/A</ENT>
              <ENT>1.08</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>4.77</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92971</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cardioassist, external</ENT>
              <ENT>1.77</ENT>
              <ENT>N/A</ENT>
              <ENT>0.87</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>2.70</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92973</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Percut coronary thrombectomy</ENT>
              <ENT>3.28</ENT>
              <ENT>N/A</ENT>
              <ENT>1.32</ENT>
              <ENT>0.12</ENT>
              <ENT>N/A</ENT>
              <ENT>4.72</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92974</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cath place, cardio brachytx</ENT>
              <ENT>3.00</ENT>
              <ENT>N/A</ENT>
              <ENT>1.21</ENT>
              <ENT>0.14</ENT>
              <ENT>N/A</ENT>
              <ENT>4.35</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92975</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dissolve clot, heart vessel</ENT>
              <ENT>7.25</ENT>
              <ENT>N/A</ENT>
              <ENT>2.87</ENT>
              <ENT>0.22</ENT>
              <ENT>N/A</ENT>
              <ENT>10.34</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92977</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dissolve clot, heart vessel</ENT>
              <ENT>0.00</ENT>
              <ENT>8.06</ENT>
              <ENT>N/A</ENT>
              <ENT>0.38</ENT>
              <ENT>8.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92978</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intravasc us, heart add-on</ENT>
              <ENT>1.80</ENT>
              <ENT>5.29</ENT>
              <ENT>N/A</ENT>
              <ENT>0.26</ENT>
              <ENT>7.35</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92978</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Intravasc us, heart add-on</ENT>
              <ENT>1.80</ENT>
              <ENT>0.72</ENT>
              <ENT>0.72</ENT>
              <ENT>0.06</ENT>
              <ENT>2.58</ENT>
              <ENT>2.58</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92978</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Intravasc us, heart add-on</ENT>
              <ENT>0.00</ENT>
              <ENT>4.56</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>4.76</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92979</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intravasc us, heart add-on</ENT>
              <ENT>1.44</ENT>
              <ENT>2.86</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>4.45</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92979</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Intravasc us, heart add-on</ENT>
              <ENT>1.44</ENT>
              <ENT>0.57</ENT>
              <ENT>0.57</ENT>
              <ENT>0.04</ENT>
              <ENT>2.05</ENT>
              <ENT>2.05</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92979</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Intravasc us, heart add-on</ENT>
              <ENT>0.00</ENT>
              <ENT>2.29</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.40</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92980</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert intracoronary stent</ENT>
              <ENT>14.84</ENT>
              <ENT>N/A</ENT>
              <ENT>6.19</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>21.74</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92981</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert intracoronary stent</ENT>
              <ENT>4.17</ENT>
              <ENT>N/A</ENT>
              <ENT>1.67</ENT>
              <ENT>0.20</ENT>
              <ENT>N/A</ENT>
              <ENT>6.04</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92982</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Coronary artery dilation</ENT>
              <ENT>10.98</ENT>
              <ENT>N/A</ENT>
              <ENT>4.64</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>16.14</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92984</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Coronary artery dilation</ENT>
              <ENT>2.97</ENT>
              <ENT>N/A</ENT>
              <ENT>1.19</ENT>
              <ENT>0.14</ENT>
              <ENT>N/A</ENT>
              <ENT>4.30</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92986</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of aortic valve</ENT>
              <ENT>21.80</ENT>
              <ENT>N/A</ENT>
              <ENT>12.00</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>34.94</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92987</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of mitral valve</ENT>
              <ENT>22.70</ENT>
              <ENT>N/A</ENT>
              <ENT>12.40</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>36.28</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92990</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Revision of pulmonary valve</ENT>
              <ENT>17.34</ENT>
              <ENT>N/A</ENT>
              <ENT>9.95</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>28.19</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92992</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Revision of heart chamber</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92993</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Revision of heart chamber</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>090 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92995</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Coronary atherectomy</ENT>
              <ENT>12.09</ENT>
              <ENT>N/A</ENT>
              <ENT>5.08</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>17.75</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92996</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Coronary atherectomy add-on</ENT>
              <ENT>3.26</ENT>
              <ENT>N/A</ENT>
              <ENT>1.30</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>4.72</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92997</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pul art balloon repr, percut</ENT>
              <ENT>12.00</ENT>
              <ENT>N/A</ENT>
              <ENT>4.93</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>17.56</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">92998</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pul art balloon repr, percut</ENT>
              <ENT>6.00</ENT>
              <ENT>N/A</ENT>
              <ENT>2.25</ENT>
              <ENT>0.31</ENT>
              <ENT>N/A</ENT>
              <ENT>8.56</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Electrocardiogram, complete</ENT>
              <ENT>0.17</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93005</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Electrocardiogram, tracing</ENT>
              <ENT>0.00</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Electrocardiogram report</ENT>
              <ENT>0.17</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93012</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transmission of ecg</ENT>
              <ENT>0.00</ENT>
              <ENT>6.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>6.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93014</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Report on transmitted ecg</ENT>
              <ENT>0.52</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.02</ENT>
              <ENT>0.73</ENT>
              <ENT>0.73</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93015</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cardiovascular stress test</ENT>
              <ENT>0.75</ENT>
              <ENT>1.97</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.83</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93016</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cardiovascular stress test</ENT>
              <ENT>0.45</ENT>
              <ENT>0.17</ENT>
              <ENT>0.17</ENT>
              <ENT>0.01</ENT>
              <ENT>0.63</ENT>
              <ENT>0.63</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93017</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cardiovascular stress test</ENT>
              <ENT>0.00</ENT>
              <ENT>1.68</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93018</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cardiovascular stress test</ENT>
              <ENT>0.30</ENT>
              <ENT>0.12</ENT>
              <ENT>0.12</ENT>
              <ENT>0.01</ENT>
              <ENT>0.43</ENT>
              <ENT>0.43</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93024</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cardiac drug stress test</ENT>
              <ENT>1.17</ENT>
              <ENT>1.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.86</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93024</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cardiac drug stress test</ENT>
              <ENT>1.17</ENT>
              <ENT>0.46</ENT>
              <ENT>0.46</ENT>
              <ENT>0.04</ENT>
              <ENT>1.67</ENT>
              <ENT>1.67</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93024</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cardiac drug stress test</ENT>
              <ENT>0.00</ENT>
              <ENT>1.12</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.19</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93025</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Microvolt t-wave assess</ENT>
              <ENT>0.75</ENT>
              <ENT>8.37</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>9.23</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93025</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Microvolt t-wave assess</ENT>
              <ENT>0.75</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>0.02</ENT>
              <ENT>1.07</ENT>
              <ENT>1.07</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93025</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Microvolt t-wave assess</ENT>
              <ENT>0.00</ENT>
              <ENT>8.08</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>8.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93040</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rhythm ECG with report</ENT>
              <ENT>0.16</ENT>
              <ENT>0.20</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93041</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rhythm ECG, tracing</ENT>
              <ENT>0.00</ENT>
              <ENT>0.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93042</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rhythm ECG, report</ENT>
              <ENT>0.16</ENT>
              <ENT>0.05</ENT>
              <ENT>0.05</ENT>
              <ENT>0.01</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93224</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ECG monitor/report, 24 hrs</ENT>
              <ENT>0.52</ENT>
              <ENT>3.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>4.35</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93225</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ECG monitor/record, 24 hrs</ENT>
              <ENT>0.00</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93226</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ECG monitor/report, 24 hrs</ENT>
              <ENT>0.00</ENT>
              <ENT>2.19</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.31</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93227</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ECG monitor/review, 24 hrs</ENT>
              <ENT>0.52</ENT>
              <ENT>0.20</ENT>
              <ENT>0.20</ENT>
              <ENT>0.02</ENT>
              <ENT>0.74</ENT>
              <ENT>0.74</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49221"/>
              <ENT I="01">93230</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ECG monitor/report, 24 hrs</ENT>
              <ENT>0.52</ENT>
              <ENT>3.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.22</ENT>
              <ENT>4.63</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93231</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ecg monitor/record, 24 hrs</ENT>
              <ENT>0.00</ENT>
              <ENT>1.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.61</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93232</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ECG monitor/report, 24 hrs</ENT>
              <ENT>0.00</ENT>
              <ENT>2.18</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.29</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93233</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ECG monitor/review, 24 hrs</ENT>
              <ENT>0.52</ENT>
              <ENT>0.20</ENT>
              <ENT>0.20</ENT>
              <ENT>0.02</ENT>
              <ENT>0.74</ENT>
              <ENT>0.74</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93235</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ECG monitor/report, 24 hrs</ENT>
              <ENT>0.45</ENT>
              <ENT>2.79</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>3.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93236</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ECG monitor/report, 24 hrs</ENT>
              <ENT>0.00</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93237</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ECG monitor/review, 24 hrs</ENT>
              <ENT>0.45</ENT>
              <ENT>0.17</ENT>
              <ENT>0.17</ENT>
              <ENT>0.01</ENT>
              <ENT>0.63</ENT>
              <ENT>0.63</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93268</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ECG record/review</ENT>
              <ENT>0.52</ENT>
              <ENT>7.45</ENT>
              <ENT>N/A</ENT>
              <ENT>0.24</ENT>
              <ENT>8.21</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93270</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ECG recording</ENT>
              <ENT>0.00</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93271</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ecg/monitoring and analysis</ENT>
              <ENT>0.00</ENT>
              <ENT>6.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>6.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93272</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ecg/review, interpret only</ENT>
              <ENT>0.52</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.02</ENT>
              <ENT>0.73</ENT>
              <ENT>0.73</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93278</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ECG/signal-averaged</ENT>
              <ENT>0.25</ENT>
              <ENT>1.25</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>1.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93278</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>ECG/signal-averaged</ENT>
              <ENT>0.25</ENT>
              <ENT>0.10</ENT>
              <ENT>0.10</ENT>
              <ENT>0.01</ENT>
              <ENT>0.36</ENT>
              <ENT>0.36</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93278</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>ECG/signal-averaged</ENT>
              <ENT>0.00</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93303</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo transthoracic</ENT>
              <ENT>1.30</ENT>
              <ENT>4.35</ENT>
              <ENT>N/A</ENT>
              <ENT>0.23</ENT>
              <ENT>5.88</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93303</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo transthoracic</ENT>
              <ENT>1.30</ENT>
              <ENT>0.49</ENT>
              <ENT>0.49</ENT>
              <ENT>0.04</ENT>
              <ENT>1.83</ENT>
              <ENT>1.83</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93303</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo transthoracic</ENT>
              <ENT>0.00</ENT>
              <ENT>3.86</ENT>
              <ENT>N/A</ENT>
              <ENT>0.19</ENT>
              <ENT>4.05</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93304</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo transthoracic</ENT>
              <ENT>0.75</ENT>
              <ENT>2.23</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>3.11</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93304</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo transthoracic</ENT>
              <ENT>0.75</ENT>
              <ENT>0.29</ENT>
              <ENT>0.29</ENT>
              <ENT>0.02</ENT>
              <ENT>1.06</ENT>
              <ENT>1.06</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93304</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo transthoracic</ENT>
              <ENT>0.00</ENT>
              <ENT>1.94</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.05</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93307</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo exam of heart</ENT>
              <ENT>0.92</ENT>
              <ENT>4.22</ENT>
              <ENT>N/A</ENT>
              <ENT>0.22</ENT>
              <ENT>5.36</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93307</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of heart</ENT>
              <ENT>0.92</ENT>
              <ENT>0.36</ENT>
              <ENT>0.36</ENT>
              <ENT>0.03</ENT>
              <ENT>1.31</ENT>
              <ENT>1.31</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93307</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of heart</ENT>
              <ENT>0.00</ENT>
              <ENT>3.86</ENT>
              <ENT>N/A</ENT>
              <ENT>0.19</ENT>
              <ENT>4.05</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93308</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo exam of heart</ENT>
              <ENT>0.53</ENT>
              <ENT>2.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>2.81</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93308</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of heart</ENT>
              <ENT>0.53</ENT>
              <ENT>0.21</ENT>
              <ENT>0.21</ENT>
              <ENT>0.02</ENT>
              <ENT>0.76</ENT>
              <ENT>0.76</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93308</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo exam of heart</ENT>
              <ENT>0.00</ENT>
              <ENT>1.94</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.05</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93312</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo transesophageal</ENT>
              <ENT>2.20</ENT>
              <ENT>4.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.32</ENT>
              <ENT>7.10</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93312</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo transesophageal</ENT>
              <ENT>2.20</ENT>
              <ENT>0.80</ENT>
              <ENT>0.80</ENT>
              <ENT>0.08</ENT>
              <ENT>3.08</ENT>
              <ENT>3.08</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93312</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo transesophageal</ENT>
              <ENT>0.00</ENT>
              <ENT>3.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.24</ENT>
              <ENT>4.02</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93313</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo transesophageal</ENT>
              <ENT>0.95</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>0.05</ENT>
              <ENT>N/A</ENT>
              <ENT>1.21</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93314</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo transesophageal</ENT>
              <ENT>1.25</ENT>
              <ENT>4.26</ENT>
              <ENT>N/A</ENT>
              <ENT>0.28</ENT>
              <ENT>5.79</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93314</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo transesophageal</ENT>
              <ENT>1.25</ENT>
              <ENT>0.48</ENT>
              <ENT>0.48</ENT>
              <ENT>0.04</ENT>
              <ENT>1.77</ENT>
              <ENT>1.77</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93314</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo transesophageal</ENT>
              <ENT>0.00</ENT>
              <ENT>3.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.24</ENT>
              <ENT>4.02</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93315</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Echo transesophageal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93315</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo transesophageal</ENT>
              <ENT>2.78</ENT>
              <ENT>1.03</ENT>
              <ENT>1.03</ENT>
              <ENT>0.10</ENT>
              <ENT>3.91</ENT>
              <ENT>3.91</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93315</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Echo transesophageal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93316</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo transesophageal</ENT>
              <ENT>0.95</ENT>
              <ENT>N/A</ENT>
              <ENT>0.24</ENT>
              <ENT>0.05</ENT>
              <ENT>N/A</ENT>
              <ENT>1.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93317</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Echo transesophageal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93317</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo transesophageal</ENT>
              <ENT>1.83</ENT>
              <ENT>0.68</ENT>
              <ENT>0.68</ENT>
              <ENT>0.06</ENT>
              <ENT>2.57</ENT>
              <ENT>2.57</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93317</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Echo transesophageal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93318</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Echo transesophageal intraop</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93318</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo transesophageal intraop</ENT>
              <ENT>2.20</ENT>
              <ENT>0.48</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93318</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Echo transesophageal intraop</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93320</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Doppler echo exam, heart</ENT>
              <ENT>0.38</ENT>
              <ENT>1.86</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.35</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93320</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Doppler echo exam, heart</ENT>
              <ENT>0.38</ENT>
              <ENT>0.15</ENT>
              <ENT>0.15</ENT>
              <ENT>0.01</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93320</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Doppler echo exam, heart</ENT>
              <ENT>0.00</ENT>
              <ENT>1.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>1.81</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93321</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Doppler echo exam, heart</ENT>
              <ENT>0.15</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.40</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93321</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Doppler echo exam, heart</ENT>
              <ENT>0.15</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93321</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Doppler echo exam, heart</ENT>
              <ENT>0.00</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.18</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93325</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Doppler color flow add-on</ENT>
              <ENT>0.07</ENT>
              <ENT>2.93</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>3.18</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93325</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Doppler color flow add-on</ENT>
              <ENT>0.07</ENT>
              <ENT>0.03</ENT>
              <ENT>0.03</ENT>
              <ENT>0.01</ENT>
              <ENT>0.11</ENT>
              <ENT>0.11</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93325</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Doppler color flow add-on</ENT>
              <ENT>0.00</ENT>
              <ENT>2.90</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>3.07</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93350</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Echo transthoracic</ENT>
              <ENT>1.48</ENT>
              <ENT>2.34</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>3.95</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93350</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Echo transthoracic</ENT>
              <ENT>1.48</ENT>
              <ENT>0.58</ENT>
              <ENT>0.58</ENT>
              <ENT>0.02</ENT>
              <ENT>2.08</ENT>
              <ENT>2.08</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93350</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Echo transthoracic</ENT>
              <ENT>0.00</ENT>
              <ENT>1.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>1.87</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93501</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Right heart catheterization</ENT>
              <ENT>3.02</ENT>
              <ENT>18.08</ENT>
              <ENT>N/A</ENT>
              <ENT>1.03</ENT>
              <ENT>22.13</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49222"/>
              <ENT I="01">93501</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Right heart catheterization</ENT>
              <ENT>3.02</ENT>
              <ENT>1.18</ENT>
              <ENT>1.18</ENT>
              <ENT>0.16</ENT>
              <ENT>4.36</ENT>
              <ENT>4.36</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93501</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Right heart catheterization</ENT>
              <ENT>0.00</ENT>
              <ENT>16.90</ENT>
              <ENT>N/A</ENT>
              <ENT>0.87</ENT>
              <ENT>17.77</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93503</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert/place heart catheter</ENT>
              <ENT>2.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.69</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>3.76</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93505</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Biopsy of heart lining</ENT>
              <ENT>4.38</ENT>
              <ENT>3.70</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>8.44</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93505</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Biopsy of heart lining</ENT>
              <ENT>4.38</ENT>
              <ENT>1.72</ENT>
              <ENT>1.72</ENT>
              <ENT>0.23</ENT>
              <ENT>6.33</ENT>
              <ENT>6.33</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93505</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Biopsy of heart lining</ENT>
              <ENT>0.00</ENT>
              <ENT>1.98</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>2.11</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93508</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cath placement, angiography</ENT>
              <ENT>4.10</ENT>
              <ENT>14.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.75</ENT>
              <ENT>19.58</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93508</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cath placement, angiography</ENT>
              <ENT>4.10</ENT>
              <ENT>2.13</ENT>
              <ENT>2.13</ENT>
              <ENT>0.21</ENT>
              <ENT>6.44</ENT>
              <ENT>6.44</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93508</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cath placement, angiography</ENT>
              <ENT>0.00</ENT>
              <ENT>12.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>13.14</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93510</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Left heart catheterization</ENT>
              <ENT>4.33</ENT>
              <ENT>39.18</ENT>
              <ENT>N/A</ENT>
              <ENT>2.13</ENT>
              <ENT>45.64</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93510</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Left heart catheterization</ENT>
              <ENT>4.33</ENT>
              <ENT>2.22</ENT>
              <ENT>2.22</ENT>
              <ENT>0.22</ENT>
              <ENT>6.77</ENT>
              <ENT>6.77</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93510</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Left heart catheterization</ENT>
              <ENT>0.00</ENT>
              <ENT>36.96</ENT>
              <ENT>N/A</ENT>
              <ENT>1.91</ENT>
              <ENT>38.87</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93511</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Left heart catheterization</ENT>
              <ENT>5.03</ENT>
              <ENT>38.48</ENT>
              <ENT>N/A</ENT>
              <ENT>2.11</ENT>
              <ENT>45.62</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93511</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Left heart catheterization</ENT>
              <ENT>5.03</ENT>
              <ENT>2.50</ENT>
              <ENT>2.50</ENT>
              <ENT>0.26</ENT>
              <ENT>7.79</ENT>
              <ENT>7.79</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93511</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Left heart catheterization</ENT>
              <ENT>0.00</ENT>
              <ENT>35.98</ENT>
              <ENT>N/A</ENT>
              <ENT>1.85</ENT>
              <ENT>37.83</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93514</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Left heart catheterization</ENT>
              <ENT>7.05</ENT>
              <ENT>39.18</ENT>
              <ENT>N/A</ENT>
              <ENT>2.22</ENT>
              <ENT>48.45</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93514</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Left heart catheterization</ENT>
              <ENT>7.05</ENT>
              <ENT>3.20</ENT>
              <ENT>3.20</ENT>
              <ENT>0.37</ENT>
              <ENT>10.62</ENT>
              <ENT>10.62</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93514</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Left heart catheterization</ENT>
              <ENT>0.00</ENT>
              <ENT>35.98</ENT>
              <ENT>N/A</ENT>
              <ENT>1.85</ENT>
              <ENT>37.83</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93524</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Left heart catheterization</ENT>
              <ENT>6.95</ENT>
              <ENT>50.27</ENT>
              <ENT>N/A</ENT>
              <ENT>2.79</ENT>
              <ENT>60.01</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93524</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Left heart catheterization</ENT>
              <ENT>6.95</ENT>
              <ENT>3.25</ENT>
              <ENT>3.25</ENT>
              <ENT>0.36</ENT>
              <ENT>10.56</ENT>
              <ENT>10.56</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93524</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Left heart catheterization</ENT>
              <ENT>0.00</ENT>
              <ENT>47.02</ENT>
              <ENT>N/A</ENT>
              <ENT>2.43</ENT>
              <ENT>49.45</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93526</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rt &amp; Lt heart catheters</ENT>
              <ENT>5.99</ENT>
              <ENT>51.18</ENT>
              <ENT>N/A</ENT>
              <ENT>2.81</ENT>
              <ENT>59.98</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93526</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Rt &amp; Lt heart catheters</ENT>
              <ENT>5.99</ENT>
              <ENT>2.88</ENT>
              <ENT>2.88</ENT>
              <ENT>0.31</ENT>
              <ENT>9.18</ENT>
              <ENT>9.18</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93526</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Rt &amp; Lt heart catheters</ENT>
              <ENT>0.00</ENT>
              <ENT>48.30</ENT>
              <ENT>N/A</ENT>
              <ENT>2.50</ENT>
              <ENT>50.80</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93527</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rt &amp; Lt heart catheters</ENT>
              <ENT>7.28</ENT>
              <ENT>50.41</ENT>
              <ENT>N/A</ENT>
              <ENT>2.81</ENT>
              <ENT>60.50</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93527</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Rt &amp; Lt heart catheters</ENT>
              <ENT>7.28</ENT>
              <ENT>3.39</ENT>
              <ENT>3.39</ENT>
              <ENT>0.38</ENT>
              <ENT>11.05</ENT>
              <ENT>11.05</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93527</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Rt &amp; Lt heart catheters</ENT>
              <ENT>0.00</ENT>
              <ENT>47.02</ENT>
              <ENT>N/A</ENT>
              <ENT>2.43</ENT>
              <ENT>49.45</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93528</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rt &amp; Lt heart catheters</ENT>
              <ENT>9.00</ENT>
              <ENT>51.14</ENT>
              <ENT>N/A</ENT>
              <ENT>2.90</ENT>
              <ENT>63.04</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93528</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Rt &amp; Lt heart catheters</ENT>
              <ENT>9.00</ENT>
              <ENT>4.12</ENT>
              <ENT>4.12</ENT>
              <ENT>0.47</ENT>
              <ENT>13.59</ENT>
              <ENT>13.59</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93528</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Rt &amp; Lt heart catheters</ENT>
              <ENT>0.00</ENT>
              <ENT>47.02</ENT>
              <ENT>N/A</ENT>
              <ENT>2.43</ENT>
              <ENT>49.45</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93529</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rt, lt heart catheterization</ENT>
              <ENT>4.80</ENT>
              <ENT>49.35</ENT>
              <ENT>N/A</ENT>
              <ENT>2.68</ENT>
              <ENT>56.83</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93529</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Rt, lt heart catheterization</ENT>
              <ENT>4.80</ENT>
              <ENT>2.33</ENT>
              <ENT>2.33</ENT>
              <ENT>0.25</ENT>
              <ENT>7.38</ENT>
              <ENT>7.38</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93529</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Rt, lt heart catheterization</ENT>
              <ENT>0.00</ENT>
              <ENT>47.02</ENT>
              <ENT>N/A</ENT>
              <ENT>2.43</ENT>
              <ENT>49.45</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rt heart cath, congenital</ENT>
              <ENT>4.23</ENT>
              <ENT>18.89</ENT>
              <ENT>N/A</ENT>
              <ENT>1.11</ENT>
              <ENT>24.23</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93530</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Rt heart cath, congenital</ENT>
              <ENT>4.23</ENT>
              <ENT>1.98</ENT>
              <ENT>1.98</ENT>
              <ENT>0.24</ENT>
              <ENT>6.45</ENT>
              <ENT>6.45</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93530</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Rt heart cath, congenital</ENT>
              <ENT>0.00</ENT>
              <ENT>16.90</ENT>
              <ENT>N/A</ENT>
              <ENT>0.87</ENT>
              <ENT>17.77</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93531</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>R &amp; l heart cath, congenital</ENT>
              <ENT>8.35</ENT>
              <ENT>51.97</ENT>
              <ENT>N/A</ENT>
              <ENT>2.96</ENT>
              <ENT>63.28</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93531</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>R &amp; l heart cath, congenital</ENT>
              <ENT>8.35</ENT>
              <ENT>3.67</ENT>
              <ENT>3.67</ENT>
              <ENT>0.46</ENT>
              <ENT>12.48</ENT>
              <ENT>12.48</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93531</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>R &amp; l heart cath, congenital</ENT>
              <ENT>0.00</ENT>
              <ENT>48.30</ENT>
              <ENT>N/A</ENT>
              <ENT>2.50</ENT>
              <ENT>50.80</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93532</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>R &amp; l heart cath, congenital</ENT>
              <ENT>10.00</ENT>
              <ENT>51.37</ENT>
              <ENT>N/A</ENT>
              <ENT>2.95</ENT>
              <ENT>64.32</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93532</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>R &amp; l heart cath, congenital</ENT>
              <ENT>10.00</ENT>
              <ENT>4.36</ENT>
              <ENT>4.36</ENT>
              <ENT>0.52</ENT>
              <ENT>14.88</ENT>
              <ENT>14.88</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93532</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>R &amp; l heart cath, congenital</ENT>
              <ENT>0.00</ENT>
              <ENT>47.02</ENT>
              <ENT>N/A</ENT>
              <ENT>2.43</ENT>
              <ENT>49.45</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93533</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>R &amp; l heart cath, congenital</ENT>
              <ENT>6.70</ENT>
              <ENT>49.89</ENT>
              <ENT>N/A</ENT>
              <ENT>2.86</ENT>
              <ENT>59.45</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93533</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>R &amp; l heart cath, congenital</ENT>
              <ENT>6.70</ENT>
              <ENT>2.87</ENT>
              <ENT>2.87</ENT>
              <ENT>0.43</ENT>
              <ENT>10.00</ENT>
              <ENT>10.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93533</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>R &amp; l heart cath, congenital</ENT>
              <ENT>0.00</ENT>
              <ENT>47.02</ENT>
              <ENT>N/A</ENT>
              <ENT>2.43</ENT>
              <ENT>49.45</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93539</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection, cardiac cath</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>0.16</ENT>
              <ENT>0.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.57</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93540</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection, cardiac cath</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>0.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.61</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93541</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection for lung angiogram</ENT>
              <ENT>0.29</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>0.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.42</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93542</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection for heart x-rays</ENT>
              <ENT>0.29</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>0.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.41</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93543</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection for heart x-rays</ENT>
              <ENT>0.29</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>0.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.42</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93544</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Injection for aortography</ENT>
              <ENT>0.25</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>0.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93545</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Inject for coronary x-rays</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>0.16</ENT>
              <ENT>0.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.57</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93555</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Imaging, cardiac cath</ENT>
              <ENT>0.81</ENT>
              <ENT>6.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.72</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49223"/>
              <ENT I="01">93555</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Imaging, cardiac cath</ENT>
              <ENT>0.81</ENT>
              <ENT>0.32</ENT>
              <ENT>0.32</ENT>
              <ENT>0.03</ENT>
              <ENT>1.16</ENT>
              <ENT>1.16</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93555</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Imaging, cardiac cath</ENT>
              <ENT>0.00</ENT>
              <ENT>6.28</ENT>
              <ENT>N/A</ENT>
              <ENT>0.28</ENT>
              <ENT>6.56</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93556</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Imaging, cardiac cath</ENT>
              <ENT>0.83</ENT>
              <ENT>10.22</ENT>
              <ENT>N/A</ENT>
              <ENT>0.45</ENT>
              <ENT>11.50</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93556</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Imaging, cardiac cath</ENT>
              <ENT>0.83</ENT>
              <ENT>0.33</ENT>
              <ENT>0.33</ENT>
              <ENT>0.03</ENT>
              <ENT>1.19</ENT>
              <ENT>1.19</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93556</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Imaging, cardiac cath</ENT>
              <ENT>0.00</ENT>
              <ENT>9.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.42</ENT>
              <ENT>10.31</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93561</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cardiac output measurement</ENT>
              <ENT>0.50</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.26</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93561</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cardiac output measurement</ENT>
              <ENT>0.50</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.02</ENT>
              <ENT>0.68</ENT>
              <ENT>0.68</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93561</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cardiac output measurement</ENT>
              <ENT>0.00</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93562</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cardiac output measurement</ENT>
              <ENT>0.16</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93562</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cardiac output measurement</ENT>
              <ENT>0.16</ENT>
              <ENT>0.05</ENT>
              <ENT>0.05</ENT>
              <ENT>0.01</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93562</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cardiac output measurement</ENT>
              <ENT>0.00</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.35</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93571</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Heart flow reserve measure</ENT>
              <ENT>1.80</ENT>
              <ENT>5.26</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>7.37</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93571</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Heart flow reserve measure</ENT>
              <ENT>1.80</ENT>
              <ENT>0.69</ENT>
              <ENT>0.69</ENT>
              <ENT>0.11</ENT>
              <ENT>2.60</ENT>
              <ENT>2.60</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93571</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Heart flow reserve measure</ENT>
              <ENT>0.00</ENT>
              <ENT>4.56</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>4.76</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93572</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Heart flow reserve measure</ENT>
              <ENT>1.44</ENT>
              <ENT>2.79</ENT>
              <ENT>N/A</ENT>
              <ENT>0.28</ENT>
              <ENT>4.51</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93572</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Heart flow reserve measure</ENT>
              <ENT>1.44</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>0.17</ENT>
              <ENT>2.11</ENT>
              <ENT>2.11</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93572</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Heart flow reserve measure</ENT>
              <ENT>0.00</ENT>
              <ENT>2.29</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.40</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93580</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transcath closure of asd</ENT>
              <ENT>18.00</ENT>
              <ENT>N/A</ENT>
              <ENT>7.33</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>26.47</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93581</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Transcath closure of vsd</ENT>
              <ENT>24.43</ENT>
              <ENT>N/A</ENT>
              <ENT>9.82</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>35.39</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93600</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bundle of His recording</ENT>
              <ENT>2.12</ENT>
              <ENT>2.80</ENT>
              <ENT>N/A</ENT>
              <ENT>0.22</ENT>
              <ENT>5.14</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93600</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Bundle of His recording</ENT>
              <ENT>2.12</ENT>
              <ENT>0.85</ENT>
              <ENT>0.85</ENT>
              <ENT>0.11</ENT>
              <ENT>3.08</ENT>
              <ENT>3.08</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93600</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Bundle of His recording</ENT>
              <ENT>0.00</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.06</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93602</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intra-atrial recording</ENT>
              <ENT>2.12</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>4.25</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93602</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Intra-atrial recording</ENT>
              <ENT>2.12</ENT>
              <ENT>0.84</ENT>
              <ENT>0.84</ENT>
              <ENT>0.12</ENT>
              <ENT>3.08</ENT>
              <ENT>3.08</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93602</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Intra-atrial recording</ENT>
              <ENT>0.00</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93603</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Right ventricular recording</ENT>
              <ENT>2.12</ENT>
              <ENT>2.51</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>4.83</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93603</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Right ventricular recording</ENT>
              <ENT>2.12</ENT>
              <ENT>0.83</ENT>
              <ENT>0.83</ENT>
              <ENT>0.11</ENT>
              <ENT>3.06</ENT>
              <ENT>3.06</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93603</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Right ventricular recording</ENT>
              <ENT>0.00</ENT>
              <ENT>1.68</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.77</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93609</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Map tachycardia, add-on</ENT>
              <ENT>5.00</ENT>
              <ENT>4.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.66</ENT>
              <ENT>10.37</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93609</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Map tachycardia, add-on</ENT>
              <ENT>5.00</ENT>
              <ENT>1.99</ENT>
              <ENT>1.99</ENT>
              <ENT>0.52</ENT>
              <ENT>7.51</ENT>
              <ENT>7.51</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93609</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Map tachycardia, add-on</ENT>
              <ENT>0.00</ENT>
              <ENT>2.72</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>2.86</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93610</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intra-atrial pacing</ENT>
              <ENT>3.02</ENT>
              <ENT>2.54</ENT>
              <ENT>N/A</ENT>
              <ENT>0.25</ENT>
              <ENT>5.81</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93610</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Intra-atrial pacing</ENT>
              <ENT>3.02</ENT>
              <ENT>1.18</ENT>
              <ENT>1.18</ENT>
              <ENT>0.17</ENT>
              <ENT>4.37</ENT>
              <ENT>4.37</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93610</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Intra-atrial pacing</ENT>
              <ENT>0.00</ENT>
              <ENT>1.35</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.43</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93612</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intraventricular pacing</ENT>
              <ENT>3.02</ENT>
              <ENT>2.79</ENT>
              <ENT>N/A</ENT>
              <ENT>0.26</ENT>
              <ENT>6.07</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93612</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Intraventricular pacing</ENT>
              <ENT>3.02</ENT>
              <ENT>1.18</ENT>
              <ENT>1.18</ENT>
              <ENT>0.17</ENT>
              <ENT>4.37</ENT>
              <ENT>4.37</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93612</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Intraventricular pacing</ENT>
              <ENT>0.00</ENT>
              <ENT>1.61</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.70</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93613</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Electrophys map 3d, add-on</ENT>
              <ENT>7.00</ENT>
              <ENT>N/A</ENT>
              <ENT>2.82</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>10.34</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93615</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esophageal recording</ENT>
              <ENT>0.99</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.63</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93615</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Esophageal recording</ENT>
              <ENT>0.99</ENT>
              <ENT>0.27</ENT>
              <ENT>0.27</ENT>
              <ENT>0.03</ENT>
              <ENT>1.29</ENT>
              <ENT>1.29</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93615</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Esophageal recording</ENT>
              <ENT>0.00</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.34</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93616</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Esophageal recording</ENT>
              <ENT>1.49</ENT>
              <ENT>0.75</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>2.32</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93616</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Esophageal recording</ENT>
              <ENT>1.49</ENT>
              <ENT>0.43</ENT>
              <ENT>0.43</ENT>
              <ENT>0.06</ENT>
              <ENT>1.98</ENT>
              <ENT>1.98</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93616</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Esophageal recording</ENT>
              <ENT>0.00</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.34</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93618</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Heart rhythm pacing</ENT>
              <ENT>4.26</ENT>
              <ENT>5.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.42</ENT>
              <ENT>10.35</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93618</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Heart rhythm pacing</ENT>
              <ENT>4.26</ENT>
              <ENT>1.71</ENT>
              <ENT>1.71</ENT>
              <ENT>0.22</ENT>
              <ENT>6.19</ENT>
              <ENT>6.19</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93618</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Heart rhythm pacing</ENT>
              <ENT>0.00</ENT>
              <ENT>3.96</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>4.16</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93619</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Electrophysiology evaluation</ENT>
              <ENT>7.32</ENT>
              <ENT>10.61</ENT>
              <ENT>N/A</ENT>
              <ENT>0.77</ENT>
              <ENT>18.70</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93619</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Electrophysiology evaluation</ENT>
              <ENT>7.32</ENT>
              <ENT>2.91</ENT>
              <ENT>2.91</ENT>
              <ENT>0.38</ENT>
              <ENT>10.61</ENT>
              <ENT>10.61</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93619</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Electrophysiology evaluation</ENT>
              <ENT>0.00</ENT>
              <ENT>7.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.39</ENT>
              <ENT>8.10</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49224"/>
              <ENT I="01">93620</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Electrophysiology evaluation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93620</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Electrophysiology evaluation</ENT>
              <ENT>11.59</ENT>
              <ENT>4.61</ENT>
              <ENT>4.61</ENT>
              <ENT>0.60</ENT>
              <ENT>16.80</ENT>
              <ENT>16.80</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93620</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Electrophysiology evaluation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93621</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Electrophysiology evaluation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93621</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Electrophysiology evaluation</ENT>
              <ENT>2.10</ENT>
              <ENT>0.84</ENT>
              <ENT>0.84</ENT>
              <ENT>0.15</ENT>
              <ENT>3.09</ENT>
              <ENT>3.09</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93621</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Electrophysiology evaluation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93622</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Electrophysiology evaluation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93622</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Electrophysiology evaluation</ENT>
              <ENT>3.10</ENT>
              <ENT>1.23</ENT>
              <ENT>1.23</ENT>
              <ENT>0.67</ENT>
              <ENT>5.00</ENT>
              <ENT>5.00</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93622</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Electrophysiology evaluation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93623</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Stimulation, pacing heart</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93623</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Stimulation, pacing heart</ENT>
              <ENT>2.85</ENT>
              <ENT>1.13</ENT>
              <ENT>1.13</ENT>
              <ENT>0.15</ENT>
              <ENT>4.13</ENT>
              <ENT>4.13</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93623</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Stimulation, pacing heart</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93624</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Electrophysiologic study</ENT>
              <ENT>4.81</ENT>
              <ENT>4.23</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>9.40</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93624</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Electrophysiologic study</ENT>
              <ENT>4.81</ENT>
              <ENT>2.25</ENT>
              <ENT>2.25</ENT>
              <ENT>0.25</ENT>
              <ENT>7.31</ENT>
              <ENT>7.31</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93624</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Electrophysiologic study</ENT>
              <ENT>0.00</ENT>
              <ENT>1.98</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.09</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93631</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Heart pacing, mapping</ENT>
              <ENT>7.60</ENT>
              <ENT>8.95</ENT>
              <ENT>N/A</ENT>
              <ENT>1.17</ENT>
              <ENT>17.72</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93631</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Heart pacing, mapping</ENT>
              <ENT>7.60</ENT>
              <ENT>2.80</ENT>
              <ENT>2.80</ENT>
              <ENT>0.66</ENT>
              <ENT>11.06</ENT>
              <ENT>11.06</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93631</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Heart pacing, mapping</ENT>
              <ENT>0.00</ENT>
              <ENT>6.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.51</ENT>
              <ENT>6.66</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93640</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Evaluation heart device</ENT>
              <ENT>3.52</ENT>
              <ENT>8.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.53</ENT>
              <ENT>12.62</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93640</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Evaluation heart device</ENT>
              <ENT>3.52</ENT>
              <ENT>1.39</ENT>
              <ENT>1.39</ENT>
              <ENT>0.18</ENT>
              <ENT>5.09</ENT>
              <ENT>5.09</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93640</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Evaluation heart device</ENT>
              <ENT>0.00</ENT>
              <ENT>7.18</ENT>
              <ENT>N/A</ENT>
              <ENT>0.35</ENT>
              <ENT>7.53</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93641</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Electrophysiology evaluation</ENT>
              <ENT>5.93</ENT>
              <ENT>9.54</ENT>
              <ENT>N/A</ENT>
              <ENT>0.66</ENT>
              <ENT>16.13</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93641</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Electrophysiology evaluation</ENT>
              <ENT>5.93</ENT>
              <ENT>2.36</ENT>
              <ENT>2.36</ENT>
              <ENT>0.31</ENT>
              <ENT>8.60</ENT>
              <ENT>8.60</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93641</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Electrophysiology evaluation</ENT>
              <ENT>0.00</ENT>
              <ENT>7.18</ENT>
              <ENT>N/A</ENT>
              <ENT>0.35</ENT>
              <ENT>7.53</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93642</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Electrophysiology evaluation</ENT>
              <ENT>4.89</ENT>
              <ENT>9.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.51</ENT>
              <ENT>14.50</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93642</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Electrophysiology evaluation</ENT>
              <ENT>4.89</ENT>
              <ENT>1.92</ENT>
              <ENT>1.92</ENT>
              <ENT>0.16</ENT>
              <ENT>6.97</ENT>
              <ENT>6.97</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93642</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Electrophysiology evaluation</ENT>
              <ENT>0.00</ENT>
              <ENT>7.18</ENT>
              <ENT>N/A</ENT>
              <ENT>0.35</ENT>
              <ENT>7.53</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93650</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ablate heart dysrhythm focus</ENT>
              <ENT>10.51</ENT>
              <ENT>N/A</ENT>
              <ENT>4.53</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>15.59</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93651</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ablate heart dysrhythm focus</ENT>
              <ENT>16.25</ENT>
              <ENT>N/A</ENT>
              <ENT>6.47</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>23.57</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93652</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ablate heart dysrhythm focus</ENT>
              <ENT>17.68</ENT>
              <ENT>N/A</ENT>
              <ENT>7.04</ENT>
              <ENT>0.92</ENT>
              <ENT>N/A</ENT>
              <ENT>25.64</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93660</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tilt table evaluation</ENT>
              <ENT>1.89</ENT>
              <ENT>2.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>4.41</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93660</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Tilt table evaluation</ENT>
              <ENT>1.89</ENT>
              <ENT>0.76</ENT>
              <ENT>0.76</ENT>
              <ENT>0.06</ENT>
              <ENT>2.71</ENT>
              <ENT>2.71</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93660</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Tilt table evaluation</ENT>
              <ENT>0.00</ENT>
              <ENT>1.68</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.70</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93662</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Intracardiac ecg (ice)</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93662</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Intracardiac ecg (ice)</ENT>
              <ENT>2.80</ENT>
              <ENT>1.13</ENT>
              <ENT>1.13</ENT>
              <ENT>0.41</ENT>
              <ENT>4.34</ENT>
              <ENT>4.34</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93662</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Intracardiac ecg (ice)</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93701</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bioimpedance, thoracic</ENT>
              <ENT>0.17</ENT>
              <ENT>1.04</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93701</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Bioimpedance, thoracic</ENT>
              <ENT>0.17</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93701</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Bioimpedance, thoracic</ENT>
              <ENT>0.00</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.98</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93720</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Total body plethysmography</ENT>
              <ENT>0.17</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93721</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Plethysmography tracing</ENT>
              <ENT>0.00</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93722</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Plethysmography report</ENT>
              <ENT>0.17</ENT>
              <ENT>0.05</ENT>
              <ENT>0.05</ENT>
              <ENT>0.01</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93724</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Analyze pacemaker system</ENT>
              <ENT>4.89</ENT>
              <ENT>5.92</ENT>
              <ENT>N/A</ENT>
              <ENT>0.38</ENT>
              <ENT>11.19</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93724</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Analyze pacemaker system</ENT>
              <ENT>4.89</ENT>
              <ENT>1.95</ENT>
              <ENT>1.95</ENT>
              <ENT>0.18</ENT>
              <ENT>7.02</ENT>
              <ENT>7.02</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49225"/>
              <ENT I="01">93724</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Analyze pacemaker system</ENT>
              <ENT>0.00</ENT>
              <ENT>3.96</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>4.16</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93727</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Analyze ilr system</ENT>
              <ENT>0.52</ENT>
              <ENT>0.20</ENT>
              <ENT>0.20</ENT>
              <ENT>0.05</ENT>
              <ENT>0.77</ENT>
              <ENT>0.77</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93731</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Analyze pacemaker system</ENT>
              <ENT>0.45</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93731</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Analyze pacemaker system</ENT>
              <ENT>0.45</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.02</ENT>
              <ENT>0.65</ENT>
              <ENT>0.65</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93731</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Analyze pacemaker system</ENT>
              <ENT>0.00</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93732</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Analyze pacemaker system</ENT>
              <ENT>0.92</ENT>
              <ENT>0.87</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.85</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93732</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Analyze pacemaker system</ENT>
              <ENT>0.92</ENT>
              <ENT>0.36</ENT>
              <ENT>0.36</ENT>
              <ENT>0.03</ENT>
              <ENT>1.31</ENT>
              <ENT>1.31</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93732</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Analyze pacemaker system</ENT>
              <ENT>0.00</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93733</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Telephone analy, pacemaker</ENT>
              <ENT>0.17</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93733</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Telephone analy, pacemaker</ENT>
              <ENT>0.17</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93733</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Telephone analy, pacemaker</ENT>
              <ENT>0.00</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93734</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Analyze pacemaker system</ENT>
              <ENT>0.38</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93734</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Analyze pacemaker system</ENT>
              <ENT>0.38</ENT>
              <ENT>0.15</ENT>
              <ENT>0.15</ENT>
              <ENT>0.01</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93734</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Analyze pacemaker system</ENT>
              <ENT>0.00</ENT>
              <ENT>0.35</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93735</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Analyze pacemaker system</ENT>
              <ENT>0.74</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93735</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Analyze pacemaker system</ENT>
              <ENT>0.74</ENT>
              <ENT>0.29</ENT>
              <ENT>0.29</ENT>
              <ENT>0.03</ENT>
              <ENT>1.06</ENT>
              <ENT>1.06</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93735</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Analyze pacemaker system</ENT>
              <ENT>0.00</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93736</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Telephone analy, pacemaker</ENT>
              <ENT>0.15</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93736</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Telephone analy, pacemaker</ENT>
              <ENT>0.15</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93736</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Telephone analy, pacemaker</ENT>
              <ENT>0.00</ENT>
              <ENT>0.63</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.68</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93740</ENT>
              <ENT/>
              <ENT>B</ENT>
              <ENT>Temperature gradient studies</ENT>
              <ENT>0.16</ENT>
              <ENT>0.20</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93740</ENT>
              <ENT>26</ENT>
              <ENT>B</ENT>
              <ENT>Temperature gradient studies</ENT>
              <ENT>0.16</ENT>
              <ENT>0.04</ENT>
              <ENT>0.04</ENT>
              <ENT>0.01</ENT>
              <ENT>0.21</ENT>
              <ENT>0.21</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93740</ENT>
              <ENT>TC</ENT>
              <ENT>B</ENT>
              <ENT>Temperature gradient studies</ENT>
              <ENT>0.00</ENT>
              <ENT>0.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93741</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Analyze ht pace device sngl</ENT>
              <ENT>0.80</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.84</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93741</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Analyze ht pace device sngl</ENT>
              <ENT>0.80</ENT>
              <ENT>0.32</ENT>
              <ENT>0.32</ENT>
              <ENT>0.02</ENT>
              <ENT>1.14</ENT>
              <ENT>1.14</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93741</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Analyze ht pace device sngl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93742</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Analyze ht pace device sngl</ENT>
              <ENT>0.91</ENT>
              <ENT>1.03</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.99</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93742</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Analyze ht pace device sngl</ENT>
              <ENT>0.91</ENT>
              <ENT>0.36</ENT>
              <ENT>0.36</ENT>
              <ENT>0.02</ENT>
              <ENT>1.29</ENT>
              <ENT>1.29</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93742</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Analyze ht pace device sngl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93743</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Analyze ht pace device dual</ENT>
              <ENT>1.03</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>2.23</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93743</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Analyze ht pace device dual</ENT>
              <ENT>1.03</ENT>
              <ENT>0.41</ENT>
              <ENT>0.41</ENT>
              <ENT>0.03</ENT>
              <ENT>1.47</ENT>
              <ENT>1.47</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93743</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Analyze ht pace device dual</ENT>
              <ENT>0.00</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93744</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Analyze ht pace device dual</ENT>
              <ENT>1.18</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>2.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49226"/>
              <ENT I="01">93744</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Analyze ht pace device dual</ENT>
              <ENT>1.18</ENT>
              <ENT>0.47</ENT>
              <ENT>0.47</ENT>
              <ENT>0.03</ENT>
              <ENT>1.68</ENT>
              <ENT>1.68</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93744</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Analyze ht pace device dual</ENT>
              <ENT>0.00</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93770</ENT>
              <ENT/>
              <ENT>B</ENT>
              <ENT>Measure venous pressure</ENT>
              <ENT>0.16</ENT>
              <ENT>0.08</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.26</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93770</ENT>
              <ENT>26</ENT>
              <ENT>B</ENT>
              <ENT>Measure venous pressure</ENT>
              <ENT>0.16</ENT>
              <ENT>0.05</ENT>
              <ENT>0.05</ENT>
              <ENT>0.01</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93770</ENT>
              <ENT>TC</ENT>
              <ENT>B</ENT>
              <ENT>Measure venous pressure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.03</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.04</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93784</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ambulatory BP monitoring</ENT>
              <ENT>0.17</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.16</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93786</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ambulatory BP recording</ENT>
              <ENT>0.00</ENT>
              <ENT>0.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.92</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93790</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Review/report BP recording</ENT>
              <ENT>0.17</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93797</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cardiac rehab</ENT>
              <ENT>0.18</ENT>
              <ENT>0.39</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.58</ENT>
              <ENT>0.26</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93798</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cardiac rehab/monitor</ENT>
              <ENT>0.28</ENT>
              <ENT>0.51</ENT>
              <ENT>0.11</ENT>
              <ENT>0.01</ENT>
              <ENT>0.80</ENT>
              <ENT>0.40</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93799</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Cardiovascular procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93799</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Cardiovascular procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93799</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Cardiovascular procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93875</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extracranial study</ENT>
              <ENT>0.22</ENT>
              <ENT>1.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>1.99</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93875</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Extracranial study</ENT>
              <ENT>0.22</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>0.01</ENT>
              <ENT>0.31</ENT>
              <ENT>0.31</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93875</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Extracranial study</ENT>
              <ENT>0.00</ENT>
              <ENT>1.59</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>1.68</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93880</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extracranial study</ENT>
              <ENT>0.60</ENT>
              <ENT>4.20</ENT>
              <ENT>N/A</ENT>
              <ENT>0.33</ENT>
              <ENT>5.13</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93880</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Extracranial study</ENT>
              <ENT>0.60</ENT>
              <ENT>0.21</ENT>
              <ENT>0.21</ENT>
              <ENT>0.04</ENT>
              <ENT>0.85</ENT>
              <ENT>0.85</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93880</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Extracranial study</ENT>
              <ENT>0.00</ENT>
              <ENT>3.99</ENT>
              <ENT>N/A</ENT>
              <ENT>0.29</ENT>
              <ENT>4.28</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93882</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extracranial study</ENT>
              <ENT>0.40</ENT>
              <ENT>3.03</ENT>
              <ENT>N/A</ENT>
              <ENT>0.22</ENT>
              <ENT>3.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93882</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Extracranial study</ENT>
              <ENT>0.40</ENT>
              <ENT>0.14</ENT>
              <ENT>0.14</ENT>
              <ENT>0.04</ENT>
              <ENT>0.58</ENT>
              <ENT>0.58</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93882</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Extracranial study</ENT>
              <ENT>0.00</ENT>
              <ENT>2.88</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>3.06</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93886</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intracranial study</ENT>
              <ENT>0.94</ENT>
              <ENT>4.54</ENT>
              <ENT>N/A</ENT>
              <ENT>0.37</ENT>
              <ENT>5.85</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93886</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Intracranial study</ENT>
              <ENT>0.94</ENT>
              <ENT>0.38</ENT>
              <ENT>0.38</ENT>
              <ENT>0.05</ENT>
              <ENT>1.37</ENT>
              <ENT>1.37</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93886</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Intracranial study</ENT>
              <ENT>0.00</ENT>
              <ENT>4.17</ENT>
              <ENT>N/A</ENT>
              <ENT>0.32</ENT>
              <ENT>4.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93888</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intracranial study</ENT>
              <ENT>0.62</ENT>
              <ENT>3.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.26</ENT>
              <ENT>3.95</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93888</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Intracranial study</ENT>
              <ENT>0.62</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.04</ENT>
              <ENT>0.89</ENT>
              <ENT>0.89</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93888</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Intracranial study</ENT>
              <ENT>0.00</ENT>
              <ENT>2.84</ENT>
              <ENT>N/A</ENT>
              <ENT>0.22</ENT>
              <ENT>3.06</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93922</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extremity study</ENT>
              <ENT>0.25</ENT>
              <ENT>1.94</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>2.32</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93922</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Extremity study</ENT>
              <ENT>0.25</ENT>
              <ENT>0.09</ENT>
              <ENT>0.09</ENT>
              <ENT>0.02</ENT>
              <ENT>0.36</ENT>
              <ENT>0.36</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93922</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Extremity study</ENT>
              <ENT>0.00</ENT>
              <ENT>1.85</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>1.96</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93923</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extremity study</ENT>
              <ENT>0.45</ENT>
              <ENT>3.04</ENT>
              <ENT>N/A</ENT>
              <ENT>0.22</ENT>
              <ENT>3.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93923</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Extremity study</ENT>
              <ENT>0.45</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.04</ENT>
              <ENT>0.65</ENT>
              <ENT>0.65</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93923</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Extremity study</ENT>
              <ENT>0.00</ENT>
              <ENT>2.88</ENT>
              <ENT>N/A</ENT>
              <ENT>0.18</ENT>
              <ENT>3.06</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93924</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extremity study</ENT>
              <ENT>0.50</ENT>
              <ENT>3.79</ENT>
              <ENT>N/A</ENT>
              <ENT>0.26</ENT>
              <ENT>4.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93924</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Extremity study</ENT>
              <ENT>0.50</ENT>
              <ENT>0.17</ENT>
              <ENT>0.17</ENT>
              <ENT>0.05</ENT>
              <ENT>0.72</ENT>
              <ENT>0.72</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93924</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Extremity study</ENT>
              <ENT>0.00</ENT>
              <ENT>3.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>3.83</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93925</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lower extremity study</ENT>
              <ENT>0.58</ENT>
              <ENT>4.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.33</ENT>
              <ENT>5.82</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93925</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Lower extremity study</ENT>
              <ENT>0.58</ENT>
              <ENT>0.20</ENT>
              <ENT>0.20</ENT>
              <ENT>0.04</ENT>
              <ENT>0.82</ENT>
              <ENT>0.82</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93925</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Lower extremity study</ENT>
              <ENT>0.00</ENT>
              <ENT>4.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.29</ENT>
              <ENT>5.00</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93926</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lower extremity study</ENT>
              <ENT>0.39</ENT>
              <ENT>3.51</ENT>
              <ENT>N/A</ENT>
              <ENT>0.22</ENT>
              <ENT>4.12</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93926</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Lower extremity study</ENT>
              <ENT>0.39</ENT>
              <ENT>0.13</ENT>
              <ENT>0.13</ENT>
              <ENT>0.03</ENT>
              <ENT>0.55</ENT>
              <ENT>0.55</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93926</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Lower extremity study</ENT>
              <ENT>0.00</ENT>
              <ENT>3.37</ENT>
              <ENT>N/A</ENT>
              <ENT>0.19</ENT>
              <ENT>3.56</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93930</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Upper extremity study</ENT>
              <ENT>0.46</ENT>
              <ENT>3.90</ENT>
              <ENT>N/A</ENT>
              <ENT>0.34</ENT>
              <ENT>4.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93930</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Upper extremity study</ENT>
              <ENT>0.46</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.03</ENT>
              <ENT>0.65</ENT>
              <ENT>0.65</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93930</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Upper extremity study</ENT>
              <ENT>0.00</ENT>
              <ENT>3.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>4.05</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93931</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Upper extremity study</ENT>
              <ENT>0.31</ENT>
              <ENT>2.84</ENT>
              <ENT>N/A</ENT>
              <ENT>0.22</ENT>
              <ENT>3.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93931</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Upper extremity study</ENT>
              <ENT>0.31</ENT>
              <ENT>0.11</ENT>
              <ENT>0.11</ENT>
              <ENT>0.02</ENT>
              <ENT>0.44</ENT>
              <ENT>0.44</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93931</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Upper extremity study</ENT>
              <ENT>0.00</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>2.94</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93965</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extremity study</ENT>
              <ENT>0.35</ENT>
              <ENT>1.88</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.35</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93965</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Extremity study</ENT>
              <ENT>0.35</ENT>
              <ENT>0.12</ENT>
              <ENT>0.12</ENT>
              <ENT>0.02</ENT>
              <ENT>0.49</ENT>
              <ENT>0.49</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93965</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Extremity study</ENT>
              <ENT>0.00</ENT>
              <ENT>1.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>1.86</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93970</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extremity study</ENT>
              <ENT>0.68</ENT>
              <ENT>4.00</ENT>
              <ENT>N/A</ENT>
              <ENT>0.38</ENT>
              <ENT>5.06</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93970</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Extremity study</ENT>
              <ENT>0.68</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.05</ENT>
              <ENT>0.96</ENT>
              <ENT>0.96</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93970</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Extremity study</ENT>
              <ENT>0.00</ENT>
              <ENT>3.77</ENT>
              <ENT>N/A</ENT>
              <ENT>0.33</ENT>
              <ENT>4.10</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93971</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extremity study</ENT>
              <ENT>0.45</ENT>
              <ENT>2.88</ENT>
              <ENT>N/A</ENT>
              <ENT>0.25</ENT>
              <ENT>3.58</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93971</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Extremity study</ENT>
              <ENT>0.45</ENT>
              <ENT>0.15</ENT>
              <ENT>0.15</ENT>
              <ENT>0.03</ENT>
              <ENT>0.63</ENT>
              <ENT>0.63</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93971</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Extremity study</ENT>
              <ENT>0.00</ENT>
              <ENT>2.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.22</ENT>
              <ENT>2.95</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93975</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vascular study</ENT>
              <ENT>1.80</ENT>
              <ENT>5.86</ENT>
              <ENT>N/A</ENT>
              <ENT>0.47</ENT>
              <ENT>8.13</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93975</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vascular study</ENT>
              <ENT>1.80</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>0.11</ENT>
              <ENT>2.52</ENT>
              <ENT>2.52</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93975</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vascular study</ENT>
              <ENT>0.00</ENT>
              <ENT>5.25</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>5.61</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93976</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vascular study</ENT>
              <ENT>1.21</ENT>
              <ENT>3.48</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>5.00</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93976</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vascular study</ENT>
              <ENT>1.21</ENT>
              <ENT>0.41</ENT>
              <ENT>0.41</ENT>
              <ENT>0.06</ENT>
              <ENT>1.68</ENT>
              <ENT>1.68</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49227"/>
              <ENT I="01">93976</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vascular study</ENT>
              <ENT>0.00</ENT>
              <ENT>3.08</ENT>
              <ENT>N/A</ENT>
              <ENT>0.25</ENT>
              <ENT>3.33</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93978</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vascular study</ENT>
              <ENT>0.65</ENT>
              <ENT>3.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>4.63</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93978</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vascular study</ENT>
              <ENT>0.65</ENT>
              <ENT>0.22</ENT>
              <ENT>0.22</ENT>
              <ENT>0.05</ENT>
              <ENT>0.92</ENT>
              <ENT>0.92</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93978</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vascular study</ENT>
              <ENT>0.00</ENT>
              <ENT>3.39</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>3.70</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93979</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vascular study</ENT>
              <ENT>0.44</ENT>
              <ENT>2.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.24</ENT>
              <ENT>3.35</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93979</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Vascular study</ENT>
              <ENT>0.44</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.04</ENT>
              <ENT>0.64</ENT>
              <ENT>0.64</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93979</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Vascular study</ENT>
              <ENT>0.00</ENT>
              <ENT>2.51</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>2.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93980</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Penile vascular study</ENT>
              <ENT>1.25</ENT>
              <ENT>4.77</ENT>
              <ENT>N/A</ENT>
              <ENT>0.35</ENT>
              <ENT>6.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93980</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Penile vascular study</ENT>
              <ENT>1.25</ENT>
              <ENT>0.42</ENT>
              <ENT>0.42</ENT>
              <ENT>0.07</ENT>
              <ENT>1.74</ENT>
              <ENT>1.74</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93980</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Penile vascular study</ENT>
              <ENT>0.00</ENT>
              <ENT>4.35</ENT>
              <ENT>N/A</ENT>
              <ENT>0.28</ENT>
              <ENT>4.63</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93981</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Penile vascular study</ENT>
              <ENT>0.44</ENT>
              <ENT>4.65</ENT>
              <ENT>N/A</ENT>
              <ENT>0.28</ENT>
              <ENT>5.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93981</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Penile vascular study</ENT>
              <ENT>0.44</ENT>
              <ENT>0.15</ENT>
              <ENT>0.15</ENT>
              <ENT>0.02</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93981</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Penile vascular study</ENT>
              <ENT>0.00</ENT>
              <ENT>4.51</ENT>
              <ENT>N/A</ENT>
              <ENT>0.26</ENT>
              <ENT>4.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93990</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Doppler flow testing</ENT>
              <ENT>0.25</ENT>
              <ENT>3.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.21</ENT>
              <ENT>3.90</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93990</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Doppler flow testing</ENT>
              <ENT>0.25</ENT>
              <ENT>0.09</ENT>
              <ENT>0.09</ENT>
              <ENT>0.02</ENT>
              <ENT>0.36</ENT>
              <ENT>0.36</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">93990</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Doppler flow testing</ENT>
              <ENT>0.00</ENT>
              <ENT>3.35</ENT>
              <ENT>N/A</ENT>
              <ENT>0.19</ENT>
              <ENT>3.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Breathing capacity test</ENT>
              <ENT>0.17</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94010</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Breathing capacity test</ENT>
              <ENT>0.17</ENT>
              <ENT>0.05</ENT>
              <ENT>0.05</ENT>
              <ENT>0.01</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94010</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Breathing capacity test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94014</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Patient recorded spirometry</ENT>
              <ENT>0.52</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>1.33</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94015</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Patient recorded spirometry</ENT>
              <ENT>0.00</ENT>
              <ENT>0.61</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94016</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Review patient spirometry</ENT>
              <ENT>0.52</ENT>
              <ENT>0.17</ENT>
              <ENT>0.17</ENT>
              <ENT>0.02</ENT>
              <ENT>0.71</ENT>
              <ENT>0.71</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94060</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Evaluation of wheezing</ENT>
              <ENT>0.31</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94060</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Evaluation of wheezing</ENT>
              <ENT>0.31</ENT>
              <ENT>0.10</ENT>
              <ENT>0.10</ENT>
              <ENT>0.01</ENT>
              <ENT>0.42</ENT>
              <ENT>0.42</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94060</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Evaluation of wheezing</ENT>
              <ENT>0.00</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94070</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Evaluation of wheezing</ENT>
              <ENT>0.60</ENT>
              <ENT>1.25</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94070</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Evaluation of wheezing</ENT>
              <ENT>0.60</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.02</ENT>
              <ENT>0.81</ENT>
              <ENT>0.81</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94070</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Evaluation of wheezing</ENT>
              <ENT>0.00</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94150</ENT>
              <ENT/>
              <ENT>B</ENT>
              <ENT>Vital capacity test</ENT>
              <ENT>0.07</ENT>
              <ENT>0.48</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94150</ENT>
              <ENT>26</ENT>
              <ENT>B</ENT>
              <ENT>Vital capacity test</ENT>
              <ENT>0.07</ENT>
              <ENT>0.03</ENT>
              <ENT>0.03</ENT>
              <ENT>0.01</ENT>
              <ENT>0.11</ENT>
              <ENT>0.11</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94150</ENT>
              <ENT>TC</ENT>
              <ENT>B</ENT>
              <ENT>Vital capacity test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.46</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94200</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lung function test (MBC/MVV)</ENT>
              <ENT>0.11</ENT>
              <ENT>0.46</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94200</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Lung function test (MBC/MVV)</ENT>
              <ENT>0.11</ENT>
              <ENT>0.03</ENT>
              <ENT>0.03</ENT>
              <ENT>0.01</ENT>
              <ENT>0.15</ENT>
              <ENT>0.15</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94200</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Lung function test (MBC/MVV)</ENT>
              <ENT>0.00</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94240</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Residual lung capacity</ENT>
              <ENT>0.26</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94240</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Residual lung capacity</ENT>
              <ENT>0.26</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>0.01</ENT>
              <ENT>0.35</ENT>
              <ENT>0.35</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94240</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Residual lung capacity</ENT>
              <ENT>0.00</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Expired gas collection</ENT>
              <ENT>0.11</ENT>
              <ENT>0.68</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94250</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Expired gas collection</ENT>
              <ENT>0.11</ENT>
              <ENT>0.03</ENT>
              <ENT>0.03</ENT>
              <ENT>0.01</ENT>
              <ENT>0.15</ENT>
              <ENT>0.15</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94250</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Expired gas collection</ENT>
              <ENT>0.00</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94260</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Thoracic gas volume</ENT>
              <ENT>0.13</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.68</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94260</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Thoracic gas volume</ENT>
              <ENT>0.13</ENT>
              <ENT>0.04</ENT>
              <ENT>0.04</ENT>
              <ENT>0.01</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94260</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Thoracic gas volume</ENT>
              <ENT>0.00</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94350</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Lung nitrogen washout curve</ENT>
              <ENT>0.26</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94350</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Lung nitrogen washout curve</ENT>
              <ENT>0.26</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>0.01</ENT>
              <ENT>0.35</ENT>
              <ENT>0.35</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94350</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Lung nitrogen washout curve</ENT>
              <ENT>0.00</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.72</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94360</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Measure airflow resistance</ENT>
              <ENT>0.26</ENT>
              <ENT>0.61</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>0.93</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94360</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Measure airflow resistance</ENT>
              <ENT>0.26</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>0.01</ENT>
              <ENT>0.35</ENT>
              <ENT>0.35</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94360</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Measure airflow resistance</ENT>
              <ENT>0.00</ENT>
              <ENT>0.53</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94370</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Breath airway closing volume</ENT>
              <ENT>0.26</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>1.03</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94370</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Breath airway closing volume</ENT>
              <ENT>0.26</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>0.01</ENT>
              <ENT>0.35</ENT>
              <ENT>0.35</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94370</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Breath airway closing volume</ENT>
              <ENT>0.00</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.68</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94375</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Respiratory flow volume loop</ENT>
              <ENT>0.31</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49228"/>
              <ENT I="01">94375</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Respiratory flow volume loop</ENT>
              <ENT>0.31</ENT>
              <ENT>0.10</ENT>
              <ENT>0.10</ENT>
              <ENT>0.01</ENT>
              <ENT>0.42</ENT>
              <ENT>0.42</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94375</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Respiratory flow volume loop</ENT>
              <ENT>0.00</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>CO2 breathing response curve</ENT>
              <ENT>0.40</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.32</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94400</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>CO2 breathing response curve</ENT>
              <ENT>0.40</ENT>
              <ENT>0.13</ENT>
              <ENT>0.13</ENT>
              <ENT>0.01</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94400</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>CO2 breathing response curve</ENT>
              <ENT>0.00</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hypoxia response curve</ENT>
              <ENT>0.40</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94450</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Hypoxia response curve</ENT>
              <ENT>0.40</ENT>
              <ENT>0.12</ENT>
              <ENT>0.12</ENT>
              <ENT>0.02</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94450</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Hypoxia response curve</ENT>
              <ENT>0.00</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94620</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pulmonary stress test/simple</ENT>
              <ENT>0.64</ENT>
              <ENT>2.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>3.23</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94620</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Pulmonary stress test/simple</ENT>
              <ENT>0.64</ENT>
              <ENT>0.20</ENT>
              <ENT>0.20</ENT>
              <ENT>0.02</ENT>
              <ENT>0.86</ENT>
              <ENT>0.86</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94620</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Pulmonary stress test/simple</ENT>
              <ENT>0.00</ENT>
              <ENT>2.29</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>2.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94621</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pulm stress test/complex</ENT>
              <ENT>1.42</ENT>
              <ENT>2.11</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>3.66</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94621</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Pulm stress test/complex</ENT>
              <ENT>1.42</ENT>
              <ENT>0.44</ENT>
              <ENT>0.44</ENT>
              <ENT>0.05</ENT>
              <ENT>1.91</ENT>
              <ENT>1.91</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94621</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Pulm stress test/complex</ENT>
              <ENT>0.00</ENT>
              <ENT>1.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.75</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94640</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Airway inhalation treatment</ENT>
              <ENT>0.00</ENT>
              <ENT>0.35</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94642</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Aerosol inhalation treatment</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94656</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Initial ventilator mgmt</ENT>
              <ENT>1.22</ENT>
              <ENT>1.23</ENT>
              <ENT>0.32</ENT>
              <ENT>0.06</ENT>
              <ENT>2.51</ENT>
              <ENT>1.60</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94657</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Continued ventilator mgmt</ENT>
              <ENT>0.83</ENT>
              <ENT>1.04</ENT>
              <ENT>0.25</ENT>
              <ENT>0.03</ENT>
              <ENT>1.90</ENT>
              <ENT>1.11</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94660</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pos airway pressure, CPAP</ENT>
              <ENT>0.76</ENT>
              <ENT>0.67</ENT>
              <ENT>0.24</ENT>
              <ENT>0.03</ENT>
              <ENT>1.46</ENT>
              <ENT>1.03</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94662</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Neg press ventilation, cnp</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.24</ENT>
              <ENT>0.02</ENT>
              <ENT>N/A</ENT>
              <ENT>1.02</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94664</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Evaluate pt use of inhaler</ENT>
              <ENT>0.00</ENT>
              <ENT>0.34</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94667</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chest wall manipulation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.56</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94668</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chest wall manipulation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.48</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94680</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exhaled air analysis, o2</ENT>
              <ENT>0.26</ENT>
              <ENT>1.97</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>2.29</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94680</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Exhaled air analysis, o2</ENT>
              <ENT>0.26</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>0.01</ENT>
              <ENT>0.35</ENT>
              <ENT>0.35</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94680</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Exhaled air analysis, o2</ENT>
              <ENT>0.00</ENT>
              <ENT>1.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.94</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94681</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exhaled air analysis, o2/co2</ENT>
              <ENT>0.20</ENT>
              <ENT>2.69</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>3.00</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94681</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Exhaled air analysis, o2/co2</ENT>
              <ENT>0.20</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.28</ENT>
              <ENT>0.28</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94681</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Exhaled air analysis, o2/co2</ENT>
              <ENT>0.00</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>2.72</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94690</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exhaled air analysis</ENT>
              <ENT>0.07</ENT>
              <ENT>2.06</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>2.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94690</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Exhaled air analysis</ENT>
              <ENT>0.07</ENT>
              <ENT>0.02</ENT>
              <ENT>0.02</ENT>
              <ENT>0.01</ENT>
              <ENT>0.10</ENT>
              <ENT>0.10</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94690</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Exhaled air analysis</ENT>
              <ENT>0.00</ENT>
              <ENT>2.04</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>2.07</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94720</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Monoxide diffusing capacity</ENT>
              <ENT>0.26</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.34</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94720</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Monoxide diffusing capacity</ENT>
              <ENT>0.26</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>0.01</ENT>
              <ENT>0.35</ENT>
              <ENT>0.35</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94720</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Monoxide diffusing capacity</ENT>
              <ENT>0.00</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94725</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Membrane diffusion capacity</ENT>
              <ENT>0.26</ENT>
              <ENT>3.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>3.44</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94725</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Membrane diffusion capacity</ENT>
              <ENT>0.26</ENT>
              <ENT>0.08</ENT>
              <ENT>0.08</ENT>
              <ENT>0.01</ENT>
              <ENT>0.35</ENT>
              <ENT>0.35</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94725</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Membrane diffusion capacity</ENT>
              <ENT>0.00</ENT>
              <ENT>2.99</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>3.09</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94750</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pulmonary compliance study</ENT>
              <ENT>0.23</ENT>
              <ENT>1.41</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>1.68</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94750</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Pulmonary compliance study</ENT>
              <ENT>0.23</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.31</ENT>
              <ENT>0.31</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94750</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Pulmonary compliance study</ENT>
              <ENT>0.00</ENT>
              <ENT>1.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>1.36</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94760</ENT>
              <ENT/>
              <ENT>T</ENT>
              <ENT>Measure blood oxygen level</ENT>
              <ENT>0.00</ENT>
              <ENT>0.09</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.11</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49229"/>
              <ENT I="01">94761</ENT>
              <ENT/>
              <ENT>T</ENT>
              <ENT>Measure blood oxygen level</ENT>
              <ENT>0.00</ENT>
              <ENT>0.12</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94762</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Measure blood oxygen level</ENT>
              <ENT>0.00</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94770</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Exhaled carbon dioxide test</ENT>
              <ENT>0.15</ENT>
              <ENT>1.72</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.94</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94770</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Exhaled carbon dioxide test</ENT>
              <ENT>0.15</ENT>
              <ENT>0.04</ENT>
              <ENT>0.04</ENT>
              <ENT>0.01</ENT>
              <ENT>0.20</ENT>
              <ENT>0.20</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94770</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Exhaled carbon dioxide test</ENT>
              <ENT>0.00</ENT>
              <ENT>1.68</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94772</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Breath recording, infant</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94772</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Breath recording, infant</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94772</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Breath recording, infant</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94799</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Pulmonary service/procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94799</ENT>
              <ENT>26</ENT>
              <ENT>C</ENT>
              <ENT>Pulmonary service/procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">94799</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Pulmonary service/procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95004</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Percut allergy skin tests</ENT>
              <ENT>0.00</ENT>
              <ENT>0.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.11</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95010</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Percut allergy titrate test</ENT>
              <ENT>0.15</ENT>
              <ENT>0.33</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.49</ENT>
              <ENT>0.22</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95015</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Id allergy titrate-drug/bug</ENT>
              <ENT>0.15</ENT>
              <ENT>0.15</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.31</ENT>
              <ENT>0.22</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95024</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Id allergy test, drug/bug</ENT>
              <ENT>0.00</ENT>
              <ENT>0.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95027</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Id allergy titrate-airborne</ENT>
              <ENT>0.00</ENT>
              <ENT>0.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95028</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Id allergy test-delayed type</ENT>
              <ENT>0.00</ENT>
              <ENT>0.23</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.24</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95044</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Allergy patch tests</ENT>
              <ENT>0.00</ENT>
              <ENT>0.20</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95052</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Photo patch test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.25</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.26</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95056</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Photosensitivity tests</ENT>
              <ENT>0.00</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95060</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Eye allergy tests</ENT>
              <ENT>0.00</ENT>
              <ENT>0.35</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95065</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nose allergy test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.20</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95070</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bronchial allergy tests</ENT>
              <ENT>0.00</ENT>
              <ENT>2.28</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>2.30</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95071</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Bronchial allergy tests</ENT>
              <ENT>0.00</ENT>
              <ENT>2.92</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>2.94</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95075</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ingestion challenge test</ENT>
              <ENT>0.95</ENT>
              <ENT>0.84</ENT>
              <ENT>0.39</ENT>
              <ENT>0.03</ENT>
              <ENT>1.82</ENT>
              <ENT>1.37</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95078</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Provocative testing</ENT>
              <ENT>0.00</ENT>
              <ENT>0.25</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.27</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95115</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Immunotherapy, one injection</ENT>
              <ENT>0.00</ENT>
              <ENT>0.39</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95117</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Immunotherapy injections</ENT>
              <ENT>0.00</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95120</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Immunotherapy, one injection</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95125</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Immunotherapy, many antigens</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95130</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Immunotherapy, insect venom</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95131</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Immunotherapy, insect venoms</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95132</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Immunotherapy, insect venoms</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95133</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Immunotherapy, insect venoms</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95134</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Immunotherapy, insect venoms</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95144</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Antigen therapy services</ENT>
              <ENT>0.06</ENT>
              <ENT>0.16</ENT>
              <ENT>0.02</ENT>
              <ENT>0.01</ENT>
              <ENT>0.23</ENT>
              <ENT>0.09</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95145</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Antigen therapy services</ENT>
              <ENT>0.06</ENT>
              <ENT>0.20</ENT>
              <ENT>0.02</ENT>
              <ENT>0.01</ENT>
              <ENT>0.27</ENT>
              <ENT>0.09</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95146</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Antigen therapy services</ENT>
              <ENT>0.06</ENT>
              <ENT>0.27</ENT>
              <ENT>0.03</ENT>
              <ENT>0.01</ENT>
              <ENT>0.34</ENT>
              <ENT>0.10</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95147</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Antigen therapy services</ENT>
              <ENT>0.06</ENT>
              <ENT>0.34</ENT>
              <ENT>0.02</ENT>
              <ENT>0.01</ENT>
              <ENT>0.41</ENT>
              <ENT>0.09</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95148</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Antigen therapy services</ENT>
              <ENT>0.06</ENT>
              <ENT>0.42</ENT>
              <ENT>0.03</ENT>
              <ENT>0.01</ENT>
              <ENT>0.49</ENT>
              <ENT>0.10</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95149</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Antigen therapy services</ENT>
              <ENT>0.06</ENT>
              <ENT>0.56</ENT>
              <ENT>0.03</ENT>
              <ENT>0.01</ENT>
              <ENT>0.63</ENT>
              <ENT>0.10</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95165</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Antigen therapy services</ENT>
              <ENT>0.06</ENT>
              <ENT>0.21</ENT>
              <ENT>0.02</ENT>
              <ENT>0.01</ENT>
              <ENT>0.28</ENT>
              <ENT>0.09</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95170</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Antigen therapy services</ENT>
              <ENT>0.06</ENT>
              <ENT>0.14</ENT>
              <ENT>0.02</ENT>
              <ENT>0.01</ENT>
              <ENT>0.21</ENT>
              <ENT>0.09</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95180</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rapid desensitization</ENT>
              <ENT>2.01</ENT>
              <ENT>1.56</ENT>
              <ENT>0.84</ENT>
              <ENT>0.04</ENT>
              <ENT>3.61</ENT>
              <ENT>2.89</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95199</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Allergy immunology services</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95250</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Glucose monitoring, cont</ENT>
              <ENT>0.00</ENT>
              <ENT>3.93</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>3.94</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95805</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Multiple sleep latency test</ENT>
              <ENT>1.88</ENT>
              <ENT>16.80</ENT>
              <ENT>N/A</ENT>
              <ENT>0.34</ENT>
              <ENT>19.02</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95805</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Multiple sleep latency test</ENT>
              <ENT>1.88</ENT>
              <ENT>0.67</ENT>
              <ENT>0.67</ENT>
              <ENT>0.06</ENT>
              <ENT>2.61</ENT>
              <ENT>2.61</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49230"/>
              <ENT I="01">95805</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Multiple sleep latency test</ENT>
              <ENT>0.00</ENT>
              <ENT>16.12</ENT>
              <ENT>N/A</ENT>
              <ENT>0.28</ENT>
              <ENT>16.40</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95806</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sleep study, unattended</ENT>
              <ENT>1.66</ENT>
              <ENT>3.94</ENT>
              <ENT>N/A</ENT>
              <ENT>0.32</ENT>
              <ENT>5.92</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95806</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Sleep study, unattended</ENT>
              <ENT>1.66</ENT>
              <ENT>0.55</ENT>
              <ENT>0.55</ENT>
              <ENT>0.06</ENT>
              <ENT>2.27</ENT>
              <ENT>2.27</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95806</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Sleep study, unattended</ENT>
              <ENT>0.00</ENT>
              <ENT>3.40</ENT>
              <ENT>N/A</ENT>
              <ENT>0.26</ENT>
              <ENT>3.66</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95807</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sleep study, attended</ENT>
              <ENT>1.66</ENT>
              <ENT>12.35</ENT>
              <ENT>N/A</ENT>
              <ENT>0.40</ENT>
              <ENT>14.41</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95807</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Sleep study, attended</ENT>
              <ENT>1.66</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>0.05</ENT>
              <ENT>2.25</ENT>
              <ENT>2.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95807</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Sleep study, attended</ENT>
              <ENT>0.00</ENT>
              <ENT>11.81</ENT>
              <ENT>N/A</ENT>
              <ENT>0.35</ENT>
              <ENT>12.16</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95808</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Polysomnography, 1-3</ENT>
              <ENT>2.65</ENT>
              <ENT>13.34</ENT>
              <ENT>N/A</ENT>
              <ENT>0.44</ENT>
              <ENT>16.43</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95808</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Polysomnography, 1-3</ENT>
              <ENT>2.65</ENT>
              <ENT>0.94</ENT>
              <ENT>0.94</ENT>
              <ENT>0.09</ENT>
              <ENT>3.68</ENT>
              <ENT>3.68</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95808</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Polysomnography, 1-3</ENT>
              <ENT>0.00</ENT>
              <ENT>12.39</ENT>
              <ENT>N/A</ENT>
              <ENT>0.35</ENT>
              <ENT>12.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95810</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Polysomnography, 4 or more</ENT>
              <ENT>3.53</ENT>
              <ENT>17.59</ENT>
              <ENT>N/A</ENT>
              <ENT>0.47</ENT>
              <ENT>21.59</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95810</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Polysomnography, 4 or more</ENT>
              <ENT>3.53</ENT>
              <ENT>1.21</ENT>
              <ENT>1.21</ENT>
              <ENT>0.12</ENT>
              <ENT>4.86</ENT>
              <ENT>4.86</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95810</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Polysomnography, 4 or more</ENT>
              <ENT>0.00</ENT>
              <ENT>16.38</ENT>
              <ENT>N/A</ENT>
              <ENT>0.35</ENT>
              <ENT>16.73</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95811</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Polysomnography w/cpap</ENT>
              <ENT>3.80</ENT>
              <ENT>19.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.49</ENT>
              <ENT>23.30</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95811</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Polysomnography w/cpap</ENT>
              <ENT>3.80</ENT>
              <ENT>1.30</ENT>
              <ENT>1.30</ENT>
              <ENT>0.13</ENT>
              <ENT>5.23</ENT>
              <ENT>5.23</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95811</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Polysomnography w/cpap</ENT>
              <ENT>0.00</ENT>
              <ENT>17.72</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>18.08</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95812</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Eeg, 41-60 minutes</ENT>
              <ENT>1.08</ENT>
              <ENT>3.96</ENT>
              <ENT>N/A</ENT>
              <ENT>0.13</ENT>
              <ENT>5.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95812</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Eeg, 41-60 minutes</ENT>
              <ENT>1.08</ENT>
              <ENT>0.46</ENT>
              <ENT>0.46</ENT>
              <ENT>0.04</ENT>
              <ENT>1.58</ENT>
              <ENT>1.58</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95812</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Eeg, 41-60 minutes</ENT>
              <ENT>0.00</ENT>
              <ENT>3.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>3.59</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95813</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Eeg, over 1 hour</ENT>
              <ENT>1.73</ENT>
              <ENT>5.00</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>6.88</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95813</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Eeg, over 1 hour</ENT>
              <ENT>1.73</ENT>
              <ENT>0.71</ENT>
              <ENT>0.71</ENT>
              <ENT>0.06</ENT>
              <ENT>2.50</ENT>
              <ENT>2.50</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95813</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Eeg, over 1 hour</ENT>
              <ENT>0.00</ENT>
              <ENT>4.28</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>4.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95816</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Eeg, awake and drowsy</ENT>
              <ENT>1.08</ENT>
              <ENT>3.16</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>4.36</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95816</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Eeg, awake and drowsy</ENT>
              <ENT>1.08</ENT>
              <ENT>0.47</ENT>
              <ENT>0.47</ENT>
              <ENT>0.04</ENT>
              <ENT>1.59</ENT>
              <ENT>1.59</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95816</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Eeg, awake and drowsy</ENT>
              <ENT>0.00</ENT>
              <ENT>2.70</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>2.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95819</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Eeg, awake and asleep</ENT>
              <ENT>1.08</ENT>
              <ENT>3.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>4.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95819</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Eeg, awake and asleep</ENT>
              <ENT>1.08</ENT>
              <ENT>0.47</ENT>
              <ENT>0.47</ENT>
              <ENT>0.04</ENT>
              <ENT>1.59</ENT>
              <ENT>1.59</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95819</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Eeg, awake and asleep</ENT>
              <ENT>0.00</ENT>
              <ENT>3.24</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>3.32</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95822</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Eeg, coma or sleep only</ENT>
              <ENT>1.08</ENT>
              <ENT>4.40</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>5.63</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95822</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Eeg, coma or sleep only</ENT>
              <ENT>1.08</ENT>
              <ENT>0.47</ENT>
              <ENT>0.47</ENT>
              <ENT>0.04</ENT>
              <ENT>1.59</ENT>
              <ENT>1.59</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95822</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Eeg, coma or sleep only</ENT>
              <ENT>0.00</ENT>
              <ENT>3.93</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>4.04</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95824</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Eeg, cerebral death only</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95824</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Eeg, cerebral death only</ENT>
              <ENT>0.74</ENT>
              <ENT>0.32</ENT>
              <ENT>0.32</ENT>
              <ENT>0.05</ENT>
              <ENT>1.11</ENT>
              <ENT>1.11</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95824</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Eeg, cerebral death only</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95827</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Eeg, all night recording</ENT>
              <ENT>1.08</ENT>
              <ENT>2.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.94</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95827</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Eeg, all night recording</ENT>
              <ENT>1.08</ENT>
              <ENT>0.42</ENT>
              <ENT>0.42</ENT>
              <ENT>0.03</ENT>
              <ENT>1.53</ENT>
              <ENT>1.53</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95827</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Eeg, all night recording</ENT>
              <ENT>0.00</ENT>
              <ENT>2.29</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.41</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95829</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Surgery electrocorticogram</ENT>
              <ENT>6.21</ENT>
              <ENT>32.94</ENT>
              <ENT>N/A</ENT>
              <ENT>0.33</ENT>
              <ENT>39.48</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95829</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Surgery electrocorticogram</ENT>
              <ENT>6.21</ENT>
              <ENT>2.37</ENT>
              <ENT>2.37</ENT>
              <ENT>0.31</ENT>
              <ENT>8.89</ENT>
              <ENT>8.89</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95829</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Surgery electrocorticogram</ENT>
              <ENT>0.00</ENT>
              <ENT>30.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>30.59</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95830</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Insert electrodes for EEG</ENT>
              <ENT>1.70</ENT>
              <ENT>3.50</ENT>
              <ENT>0.75</ENT>
              <ENT>0.07</ENT>
              <ENT>5.27</ENT>
              <ENT>2.52</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95831</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Limb muscle testing, manual</ENT>
              <ENT>0.28</ENT>
              <ENT>0.33</ENT>
              <ENT>0.13</ENT>
              <ENT>0.01</ENT>
              <ENT>0.62</ENT>
              <ENT>0.42</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95832</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hand muscle testing, manual</ENT>
              <ENT>0.29</ENT>
              <ENT>0.25</ENT>
              <ENT>0.12</ENT>
              <ENT>0.01</ENT>
              <ENT>0.55</ENT>
              <ENT>0.42</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95833</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Body muscle testing, manual</ENT>
              <ENT>0.47</ENT>
              <ENT>0.44</ENT>
              <ENT>0.23</ENT>
              <ENT>0.01</ENT>
              <ENT>0.92</ENT>
              <ENT>0.71</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95834</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Body muscle testing, manual</ENT>
              <ENT>0.60</ENT>
              <ENT>0.50</ENT>
              <ENT>0.28</ENT>
              <ENT>0.02</ENT>
              <ENT>1.12</ENT>
              <ENT>0.90</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95851</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Range of motion measurements</ENT>
              <ENT>0.16</ENT>
              <ENT>0.34</ENT>
              <ENT>0.08</ENT>
              <ENT>0.01</ENT>
              <ENT>0.51</ENT>
              <ENT>0.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95852</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Range of motion measurements</ENT>
              <ENT>0.11</ENT>
              <ENT>0.24</ENT>
              <ENT>0.05</ENT>
              <ENT>0.01</ENT>
              <ENT>0.36</ENT>
              <ENT>0.17</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95857</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tensilon test</ENT>
              <ENT>0.53</ENT>
              <ENT>0.62</ENT>
              <ENT>0.23</ENT>
              <ENT>0.02</ENT>
              <ENT>1.17</ENT>
              <ENT>0.78</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95858</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Tensilon test &amp; myogram</ENT>
              <ENT>1.56</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>2.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95858</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Tensilon test &amp; myogram</ENT>
              <ENT>1.56</ENT>
              <ENT>0.68</ENT>
              <ENT>0.68</ENT>
              <ENT>0.04</ENT>
              <ENT>2.28</ENT>
              <ENT>2.28</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95858</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Tensilon test &amp; myogram</ENT>
              <ENT>0.00</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95860</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Muscle test, one limb</ENT>
              <ENT>0.96</ENT>
              <ENT>1.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>2.48</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95860</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Muscle test, one limb</ENT>
              <ENT>0.96</ENT>
              <ENT>0.43</ENT>
              <ENT>0.43</ENT>
              <ENT>0.03</ENT>
              <ENT>1.42</ENT>
              <ENT>1.42</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95860</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Muscle test, one limb</ENT>
              <ENT>0.00</ENT>
              <ENT>1.04</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95861</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Muscle test, 2 limbs</ENT>
              <ENT>1.54</ENT>
              <ENT>1.43</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>3.07</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95861</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Muscle test, 2 limbs</ENT>
              <ENT>1.54</ENT>
              <ENT>0.69</ENT>
              <ENT>0.69</ENT>
              <ENT>0.05</ENT>
              <ENT>2.28</ENT>
              <ENT>2.28</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95861</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Muscle test, 2 limbs</ENT>
              <ENT>0.00</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49231"/>
              <ENT I="01">95863</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Muscle test, 3 limbs</ENT>
              <ENT>1.87</ENT>
              <ENT>1.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>3.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95863</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Muscle test, 3 limbs</ENT>
              <ENT>1.87</ENT>
              <ENT>0.82</ENT>
              <ENT>0.82</ENT>
              <ENT>0.06</ENT>
              <ENT>2.75</ENT>
              <ENT>2.75</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95863</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Muscle test, 3 limbs</ENT>
              <ENT>0.00</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95864</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Muscle test, 4 limbs</ENT>
              <ENT>1.99</ENT>
              <ENT>2.67</ENT>
              <ENT>N/A</ENT>
              <ENT>0.16</ENT>
              <ENT>4.82</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95864</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Muscle test, 4 limbs</ENT>
              <ENT>1.99</ENT>
              <ENT>0.89</ENT>
              <ENT>0.89</ENT>
              <ENT>0.06</ENT>
              <ENT>2.94</ENT>
              <ENT>2.94</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95864</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Muscle test, 4 limbs</ENT>
              <ENT>0.00</ENT>
              <ENT>1.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>1.88</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95867</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Muscle test cran nerv unilat</ENT>
              <ENT>0.79</ENT>
              <ENT>0.93</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95867</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Muscle test cran nerv unilat</ENT>
              <ENT>0.79</ENT>
              <ENT>0.35</ENT>
              <ENT>0.35</ENT>
              <ENT>0.03</ENT>
              <ENT>1.17</ENT>
              <ENT>1.17</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95867</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Muscle test cran nerv unilat</ENT>
              <ENT>0.00</ENT>
              <ENT>0.58</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.61</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95868</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Muscle test cran nerve bilat</ENT>
              <ENT>1.18</ENT>
              <ENT>1.22</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>2.48</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95868</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Muscle test cran nerve bilat</ENT>
              <ENT>1.18</ENT>
              <ENT>0.52</ENT>
              <ENT>0.52</ENT>
              <ENT>0.04</ENT>
              <ENT>1.74</ENT>
              <ENT>1.74</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95868</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Muscle test cran nerve bilat</ENT>
              <ENT>0.00</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95869</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Muscle test, thor paraspinal</ENT>
              <ENT>0.37</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95869</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Muscle test, thor paraspinal</ENT>
              <ENT>0.37</ENT>
              <ENT>0.17</ENT>
              <ENT>0.17</ENT>
              <ENT>0.01</ENT>
              <ENT>0.55</ENT>
              <ENT>0.55</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95869</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Muscle test, thor paraspinal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.23</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95870</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Muscle test, nonparaspinal</ENT>
              <ENT>0.37</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95870</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Muscle test, nonparaspinal</ENT>
              <ENT>0.37</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.01</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95870</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Muscle test, nonparaspinal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.23</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95872</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Muscle test, one fiber</ENT>
              <ENT>1.50</ENT>
              <ENT>1.25</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>2.83</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95872</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Muscle test, one fiber</ENT>
              <ENT>1.50</ENT>
              <ENT>0.65</ENT>
              <ENT>0.65</ENT>
              <ENT>0.04</ENT>
              <ENT>2.19</ENT>
              <ENT>2.19</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95872</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Muscle test, one fiber</ENT>
              <ENT>0.00</ENT>
              <ENT>0.60</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95875</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Limb exercise test</ENT>
              <ENT>1.10</ENT>
              <ENT>1.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>2.69</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95875</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Limb exercise test</ENT>
              <ENT>1.10</ENT>
              <ENT>0.48</ENT>
              <ENT>0.48</ENT>
              <ENT>0.04</ENT>
              <ENT>1.62</ENT>
              <ENT>1.62</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95875</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Limb exercise test</ENT>
              <ENT>0.00</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.07</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95900</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Motor nerve conduction test</ENT>
              <ENT>0.42</ENT>
              <ENT>1.30</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>1.75</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95900</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Motor nerve conduction test</ENT>
              <ENT>0.42</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.01</ENT>
              <ENT>0.62</ENT>
              <ENT>0.62</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95900</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Motor nerve conduction test</ENT>
              <ENT>0.00</ENT>
              <ENT>1.12</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95903</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Motor nerve conduction test</ENT>
              <ENT>0.60</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>1.87</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95903</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Motor nerve conduction test</ENT>
              <ENT>0.60</ENT>
              <ENT>0.26</ENT>
              <ENT>0.26</ENT>
              <ENT>0.02</ENT>
              <ENT>0.88</ENT>
              <ENT>0.88</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95903</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Motor nerve conduction test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95904</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sense nerve conduction test</ENT>
              <ENT>0.34</ENT>
              <ENT>1.13</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>1.50</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95904</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Sense nerve conduction test</ENT>
              <ENT>0.34</ENT>
              <ENT>0.15</ENT>
              <ENT>0.15</ENT>
              <ENT>0.01</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95904</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Sense nerve conduction test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.98</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.00</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95920</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intraop nerve test add-on</ENT>
              <ENT>2.11</ENT>
              <ENT>2.26</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>4.57</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95920</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Intraop nerve test add-on</ENT>
              <ENT>2.11</ENT>
              <ENT>0.95</ENT>
              <ENT>0.95</ENT>
              <ENT>0.14</ENT>
              <ENT>3.20</ENT>
              <ENT>3.20</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95920</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Intraop nerve test add-on</ENT>
              <ENT>0.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95921</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Autonomic nerv function test</ENT>
              <ENT>0.90</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.66</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95921</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Autonomic nerv function test</ENT>
              <ENT>0.90</ENT>
              <ENT>0.33</ENT>
              <ENT>0.33</ENT>
              <ENT>0.03</ENT>
              <ENT>1.26</ENT>
              <ENT>1.26</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95921</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Autonomic nerv function test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95922</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Autonomic nerv function test</ENT>
              <ENT>0.96</ENT>
              <ENT>0.79</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.80</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95922</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Autonomic nerv function test</ENT>
              <ENT>0.96</ENT>
              <ENT>0.41</ENT>
              <ENT>0.41</ENT>
              <ENT>0.03</ENT>
              <ENT>1.40</ENT>
              <ENT>1.40</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95922</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Autonomic nerv function test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49232"/>
              <ENT I="01">95923</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Autonomic nerv function test</ENT>
              <ENT>0.90</ENT>
              <ENT>2.14</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>3.09</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95923</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Autonomic nerv function test</ENT>
              <ENT>0.90</ENT>
              <ENT>0.39</ENT>
              <ENT>0.39</ENT>
              <ENT>0.03</ENT>
              <ENT>1.32</ENT>
              <ENT>1.32</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95923</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Autonomic nerv function test</ENT>
              <ENT>0.00</ENT>
              <ENT>1.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95925</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Somatosensory testing</ENT>
              <ENT>0.54</ENT>
              <ENT>1.14</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.75</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95925</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Somatosensory testing</ENT>
              <ENT>0.54</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.02</ENT>
              <ENT>0.79</ENT>
              <ENT>0.79</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95925</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Somatosensory testing</ENT>
              <ENT>0.00</ENT>
              <ENT>0.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.96</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95926</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Somatosensory testing</ENT>
              <ENT>0.54</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.76</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95926</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Somatosensory testing</ENT>
              <ENT>0.54</ENT>
              <ENT>0.24</ENT>
              <ENT>0.24</ENT>
              <ENT>0.02</ENT>
              <ENT>0.80</ENT>
              <ENT>0.80</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95926</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Somatosensory testing</ENT>
              <ENT>0.00</ENT>
              <ENT>0.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.96</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95927</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Somatosensory testing</ENT>
              <ENT>0.54</ENT>
              <ENT>1.16</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95927</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Somatosensory testing</ENT>
              <ENT>0.54</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.03</ENT>
              <ENT>0.82</ENT>
              <ENT>0.82</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95927</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Somatosensory testing</ENT>
              <ENT>0.00</ENT>
              <ENT>0.91</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.96</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95930</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Visual evoked potential test</ENT>
              <ENT>0.35</ENT>
              <ENT>1.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.81</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95930</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Visual evoked potential test</ENT>
              <ENT>0.35</ENT>
              <ENT>0.15</ENT>
              <ENT>0.15</ENT>
              <ENT>0.01</ENT>
              <ENT>0.51</ENT>
              <ENT>0.51</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95930</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Visual evoked potential test</ENT>
              <ENT>0.00</ENT>
              <ENT>1.29</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>1.30</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95933</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Blink reflex test</ENT>
              <ENT>0.59</ENT>
              <ENT>1.03</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.69</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95933</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Blink reflex test</ENT>
              <ENT>0.59</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.02</ENT>
              <ENT>0.86</ENT>
              <ENT>0.86</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95933</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Blink reflex test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.83</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95934</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>H-reflex test</ENT>
              <ENT>0.51</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.99</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95934</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>H-reflex test</ENT>
              <ENT>0.51</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.02</ENT>
              <ENT>0.76</ENT>
              <ENT>0.76</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95934</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>H-reflex test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.23</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95936</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>H-reflex test</ENT>
              <ENT>0.55</ENT>
              <ENT>0.46</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>1.05</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95936</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>H-reflex test</ENT>
              <ENT>0.55</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>0.02</ENT>
              <ENT>0.82</ENT>
              <ENT>0.82</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95936</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>H-reflex test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.23</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95937</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Neuromuscular junction test</ENT>
              <ENT>0.65</ENT>
              <ENT>0.61</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>1.30</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95937</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Neuromuscular junction test</ENT>
              <ENT>0.65</ENT>
              <ENT>0.27</ENT>
              <ENT>0.27</ENT>
              <ENT>0.02</ENT>
              <ENT>0.94</ENT>
              <ENT>0.94</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95937</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Neuromuscular junction test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.34</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.36</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95950</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ambulatory eeg monitoring</ENT>
              <ENT>1.51</ENT>
              <ENT>4.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.44</ENT>
              <ENT>6.52</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95950</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Ambulatory eeg monitoring</ENT>
              <ENT>1.51</ENT>
              <ENT>0.65</ENT>
              <ENT>0.65</ENT>
              <ENT>0.08</ENT>
              <ENT>2.24</ENT>
              <ENT>2.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95950</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Ambulatory eeg monitoring</ENT>
              <ENT>0.00</ENT>
              <ENT>3.93</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>4.29</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95951</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>EEG monitoring/videorecord</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95951</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>EEG monitoring/videorecord</ENT>
              <ENT>6.00</ENT>
              <ENT>2.61</ENT>
              <ENT>2.61</ENT>
              <ENT>0.20</ENT>
              <ENT>8.81</ENT>
              <ENT>8.81</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95951</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>EEG monitoring/videorecord</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95953</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>EEG monitoring/computer</ENT>
              <ENT>3.08</ENT>
              <ENT>7.65</ENT>
              <ENT>N/A</ENT>
              <ENT>0.46</ENT>
              <ENT>11.19</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95953</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>EEG monitoring/computer</ENT>
              <ENT>3.08</ENT>
              <ENT>1.32</ENT>
              <ENT>1.32</ENT>
              <ENT>0.10</ENT>
              <ENT>4.50</ENT>
              <ENT>4.50</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95953</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>EEG monitoring/computer</ENT>
              <ENT>0.00</ENT>
              <ENT>6.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>6.69</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95954</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>EEG monitoring/giving drugs</ENT>
              <ENT>2.45</ENT>
              <ENT>4.39</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>6.99</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95954</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>EEG monitoring/giving drugs</ENT>
              <ENT>2.45</ENT>
              <ENT>1.07</ENT>
              <ENT>1.07</ENT>
              <ENT>0.10</ENT>
              <ENT>3.62</ENT>
              <ENT>3.62</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95954</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>EEG monitoring/giving drugs</ENT>
              <ENT>0.00</ENT>
              <ENT>3.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>3.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95955</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>EEG during surgery</ENT>
              <ENT>1.01</ENT>
              <ENT>2.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.19</ENT>
              <ENT>3.53</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95955</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>EEG during surgery</ENT>
              <ENT>1.01</ENT>
              <ENT>0.37</ENT>
              <ENT>0.37</ENT>
              <ENT>0.05</ENT>
              <ENT>1.43</ENT>
              <ENT>1.43</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95955</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>EEG during surgery</ENT>
              <ENT>0.00</ENT>
              <ENT>1.96</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>2.10</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95956</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Eeg monitoring, cable/radio</ENT>
              <ENT>3.08</ENT>
              <ENT>14.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.47</ENT>
              <ENT>17.99</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95956</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Eeg monitoring, cable/radio</ENT>
              <ENT>3.08</ENT>
              <ENT>1.33</ENT>
              <ENT>1.33</ENT>
              <ENT>0.11</ENT>
              <ENT>4.52</ENT>
              <ENT>4.52</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95956</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Eeg monitoring, cable/radio</ENT>
              <ENT>0.00</ENT>
              <ENT>13.11</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>13.47</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95957</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>EEG digital analysis</ENT>
              <ENT>1.98</ENT>
              <ENT>2.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.17</ENT>
              <ENT>4.72</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95957</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>EEG digital analysis</ENT>
              <ENT>1.98</ENT>
              <ENT>0.87</ENT>
              <ENT>0.87</ENT>
              <ENT>0.07</ENT>
              <ENT>2.92</ENT>
              <ENT>2.92</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95957</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>EEG digital analysis</ENT>
              <ENT>0.00</ENT>
              <ENT>1.70</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>1.80</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49233"/>
              <ENT I="01">95958</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>EEG monitoring/function test</ENT>
              <ENT>4.25</ENT>
              <ENT>3.52</ENT>
              <ENT>N/A</ENT>
              <ENT>0.29</ENT>
              <ENT>8.06</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95958</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>EEG monitoring/function test</ENT>
              <ENT>4.25</ENT>
              <ENT>1.78</ENT>
              <ENT>1.78</ENT>
              <ENT>0.18</ENT>
              <ENT>6.21</ENT>
              <ENT>6.21</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95958</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>EEG monitoring/function test</ENT>
              <ENT>0.00</ENT>
              <ENT>1.74</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>1.85</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95961</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Electrode stimulation, brain</ENT>
              <ENT>2.97</ENT>
              <ENT>2.65</ENT>
              <ENT>N/A</ENT>
              <ENT>0.24</ENT>
              <ENT>5.86</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95961</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Electrode stimulation, brain</ENT>
              <ENT>2.97</ENT>
              <ENT>1.35</ENT>
              <ENT>1.35</ENT>
              <ENT>0.18</ENT>
              <ENT>4.50</ENT>
              <ENT>4.50</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95961</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Electrode stimulation, brain</ENT>
              <ENT>0.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95962</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Electrode stim, brain add-on</ENT>
              <ENT>3.21</ENT>
              <ENT>2.72</ENT>
              <ENT>N/A</ENT>
              <ENT>0.23</ENT>
              <ENT>6.16</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95962</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Electrode stim, brain add-on</ENT>
              <ENT>3.21</ENT>
              <ENT>1.42</ENT>
              <ENT>1.42</ENT>
              <ENT>0.17</ENT>
              <ENT>4.80</ENT>
              <ENT>4.80</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95962</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Electrode stim, brain add-on</ENT>
              <ENT>0.00</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.37</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95965</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Meg, spontaneous</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95965</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Meg, spontaneous</ENT>
              <ENT>8.00</ENT>
              <ENT>3.49</ENT>
              <ENT>3.49</ENT>
              <ENT>0.31</ENT>
              <ENT>11.80</ENT>
              <ENT>11.80</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95965</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Meg, spontaneous</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95966</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Meg, evoked, single</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95966</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Meg, evoked, single</ENT>
              <ENT>4.00</ENT>
              <ENT>1.76</ENT>
              <ENT>1.76</ENT>
              <ENT>0.15</ENT>
              <ENT>5.91</ENT>
              <ENT>5.91</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95966</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Meg, evoked, single</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95967</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Meg, evoked, each addl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95967</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Meg, evoked, each addl</ENT>
              <ENT>3.50</ENT>
              <ENT>1.36</ENT>
              <ENT>1.36</ENT>
              <ENT>0.13</ENT>
              <ENT>4.99</ENT>
              <ENT>4.99</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95967</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>Meg, evoked, each addl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95970</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Analyze neurostim, no prog</ENT>
              <ENT>0.45</ENT>
              <ENT>0.17</ENT>
              <ENT>0.15</ENT>
              <ENT>0.03</ENT>
              <ENT>0.65</ENT>
              <ENT>0.63</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95971</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Analyze neurostim, simple</ENT>
              <ENT>0.78</ENT>
              <ENT>0.28</ENT>
              <ENT>0.23</ENT>
              <ENT>0.06</ENT>
              <ENT>1.12</ENT>
              <ENT>1.07</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95972</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Analyze neurostim, complex</ENT>
              <ENT>1.50</ENT>
              <ENT>0.60</ENT>
              <ENT>0.50</ENT>
              <ENT>0.17</ENT>
              <ENT>2.27</ENT>
              <ENT>2.17</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95973</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Analyze neurostim, complex</ENT>
              <ENT>0.92</ENT>
              <ENT>0.40</ENT>
              <ENT>0.35</ENT>
              <ENT>0.07</ENT>
              <ENT>1.39</ENT>
              <ENT>1.34</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95974</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cranial neurostim, complex</ENT>
              <ENT>3.00</ENT>
              <ENT>1.32</ENT>
              <ENT>1.32</ENT>
              <ENT>0.15</ENT>
              <ENT>4.47</ENT>
              <ENT>4.47</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95975</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cranial neurostim, complex</ENT>
              <ENT>1.70</ENT>
              <ENT>0.74</ENT>
              <ENT>0.74</ENT>
              <ENT>0.07</ENT>
              <ENT>2.51</ENT>
              <ENT>2.51</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95990</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Spin/brain pump refil &amp; main</ENT>
              <ENT>0.00</ENT>
              <ENT>1.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">95999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Neurological procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96000</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Motion analysis, video/3d</ENT>
              <ENT>1.80</ENT>
              <ENT>N/A</ENT>
              <ENT>0.57</ENT>
              <ENT>0.02</ENT>
              <ENT>N/A</ENT>
              <ENT>2.39</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96001</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Motion test w/ft press meas</ENT>
              <ENT>2.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.83</ENT>
              <ENT>0.02</ENT>
              <ENT>N/A</ENT>
              <ENT>3.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96002</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dynamic surface emg</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>0.16</ENT>
              <ENT>0.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.59</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96003</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Dynamic fine wire emg</ENT>
              <ENT>0.37</ENT>
              <ENT>N/A</ENT>
              <ENT>0.14</ENT>
              <ENT>0.03</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96004</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Phys review of motion tests</ENT>
              <ENT>2.14</ENT>
              <ENT>0.97</ENT>
              <ENT>0.97</ENT>
              <ENT>0.08</ENT>
              <ENT>3.19</ENT>
              <ENT>3.19</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96100</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Psychological testing</ENT>
              <ENT>0.00</ENT>
              <ENT>1.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>1.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96105</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Assessment of aphasia</ENT>
              <ENT>0.00</ENT>
              <ENT>1.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>1.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96110</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Developmental test, lim</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96111</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Developmental test, extend</ENT>
              <ENT>0.00</ENT>
              <ENT>1.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>1.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96115</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Neurobehavior status exam</ENT>
              <ENT>0.00</ENT>
              <ENT>1.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>1.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96117</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Neuropsych test battery</ENT>
              <ENT>0.00</ENT>
              <ENT>1.76</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>1.91</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Assess lth/behave, init</ENT>
              <ENT>0.50</ENT>
              <ENT>0.19</ENT>
              <ENT>0.18</ENT>
              <ENT>0.02</ENT>
              <ENT>0.71</ENT>
              <ENT>0.70</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96151</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Assess hlth/behave, subseq</ENT>
              <ENT>0.48</ENT>
              <ENT>0.18</ENT>
              <ENT>0.17</ENT>
              <ENT>0.02</ENT>
              <ENT>0.68</ENT>
              <ENT>0.67</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96152</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intervene hlth/behave, indiv</ENT>
              <ENT>0.46</ENT>
              <ENT>0.18</ENT>
              <ENT>0.17</ENT>
              <ENT>0.02</ENT>
              <ENT>0.66</ENT>
              <ENT>0.65</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96153</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intervene hlth/behave, group</ENT>
              <ENT>0.10</ENT>
              <ENT>0.04</ENT>
              <ENT>0.04</ENT>
              <ENT>0.01</ENT>
              <ENT>0.15</ENT>
              <ENT>0.15</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96154</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Interv hlth/behav, fam w/pt</ENT>
              <ENT>0.45</ENT>
              <ENT>0.17</ENT>
              <ENT>0.16</ENT>
              <ENT>0.02</ENT>
              <ENT>0.64</ENT>
              <ENT>0.63</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96155</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Interv hlth/behav fam no pt</ENT>
              <ENT>0.44</ENT>
              <ENT>0.16</ENT>
              <ENT>0.16</ENT>
              <ENT>0.02</ENT>
              <ENT>0.62</ENT>
              <ENT>0.62</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96400</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chemotherapy, sc/im</ENT>
              <ENT>0.00</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.90</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49234"/>
              <ENT I="01">96405</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intralesional chemo admin</ENT>
              <ENT>0.52</ENT>
              <ENT>1.96</ENT>
              <ENT>0.23</ENT>
              <ENT>0.02</ENT>
              <ENT>2.50</ENT>
              <ENT>0.77</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96406</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Intralesional chemo admin</ENT>
              <ENT>0.80</ENT>
              <ENT>2.60</ENT>
              <ENT>0.30</ENT>
              <ENT>0.02</ENT>
              <ENT>3.42</ENT>
              <ENT>1.12</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96408</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chemotherapy, push technique</ENT>
              <ENT>0.00</ENT>
              <ENT>0.97</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.02</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96410</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chemotherapy,infusion method</ENT>
              <ENT>0.00</ENT>
              <ENT>1.55</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.62</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96412</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chemo, infuse method add-on</ENT>
              <ENT>0.00</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>1.21</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96414</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chemo, infuse method add-on</ENT>
              <ENT>0.00</ENT>
              <ENT>1.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.40</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96420</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chemotherapy, push technique</ENT>
              <ENT>0.00</ENT>
              <ENT>1.25</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.32</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96422</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chemotherapy,infusion method</ENT>
              <ENT>0.00</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.30</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96423</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chemo, infuse method add-on</ENT>
              <ENT>0.00</ENT>
              <ENT>0.48</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96425</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chemotherapy,infusion method</ENT>
              <ENT>0.00</ENT>
              <ENT>1.43</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.50</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96440</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chemotherapy, intracavitary</ENT>
              <ENT>2.37</ENT>
              <ENT>7.46</ENT>
              <ENT>1.05</ENT>
              <ENT>0.12</ENT>
              <ENT>9.95</ENT>
              <ENT>3.54</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96445</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chemotherapy, intracavitary</ENT>
              <ENT>2.20</ENT>
              <ENT>7.43</ENT>
              <ENT>1.03</ENT>
              <ENT>0.07</ENT>
              <ENT>9.70</ENT>
              <ENT>3.30</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96450</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chemotherapy, into CNS</ENT>
              <ENT>1.89</ENT>
              <ENT>6.30</ENT>
              <ENT>0.92</ENT>
              <ENT>0.06</ENT>
              <ENT>8.25</ENT>
              <ENT>2.87</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Port pump refill &amp; main</ENT>
              <ENT>0.00</ENT>
              <ENT>0.89</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>0.94</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Syst pump refill &amp; main</ENT>
              <ENT>0.00</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.11</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96542</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chemotherapy injection</ENT>
              <ENT>1.42</ENT>
              <ENT>3.83</ENT>
              <ENT>0.55</ENT>
              <ENT>0.05</ENT>
              <ENT>5.30</ENT>
              <ENT>2.02</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96549</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Chemotherapy, unspecified</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96567</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Photodynamic tx, skin</ENT>
              <ENT>0.00</ENT>
              <ENT>2.79</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>2.82</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96570</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Photodynamic tx, 30 min</ENT>
              <ENT>1.10</ENT>
              <ENT>N/A</ENT>
              <ENT>0.37</ENT>
              <ENT>0.04</ENT>
              <ENT>N/A</ENT>
              <ENT>1.51</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96571</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Photodynamic tx, addl 15 min</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>0.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.77</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96900</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ultraviolet light therapy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.51</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96902</ENT>
              <ENT/>
              <ENT>B</ENT>
              <ENT>Trichogram</ENT>
              <ENT>0.41</ENT>
              <ENT>0.25</ENT>
              <ENT>0.16</ENT>
              <ENT>0.01</ENT>
              <ENT>0.67</ENT>
              <ENT>0.58</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96910</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Photochemotherapy with UV-B</ENT>
              <ENT>0.00</ENT>
              <ENT>1.09</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>1.12</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96912</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Photochemotherapy with UV-A</ENT>
              <ENT>0.00</ENT>
              <ENT>1.38</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>1.42</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96913</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Photochemotherapy, UV-A or B</ENT>
              <ENT>0.00</ENT>
              <ENT>1.82</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.90</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96920</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laser tx, skin &lt; 250 sq cm</ENT>
              <ENT>1.15</ENT>
              <ENT>14.89</ENT>
              <ENT>0.45</ENT>
              <ENT>0.09</ENT>
              <ENT>16.13</ENT>
              <ENT>1.69</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96921</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laser tx, skin 250-500 sq cm</ENT>
              <ENT>1.17</ENT>
              <ENT>14.96</ENT>
              <ENT>0.45</ENT>
              <ENT>0.09</ENT>
              <ENT>16.22</ENT>
              <ENT>1.71</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96922</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Laser tx, skin &gt; 500 sq cm</ENT>
              <ENT>2.10</ENT>
              <ENT>15.58</ENT>
              <ENT>0.81</ENT>
              <ENT>0.16</ENT>
              <ENT>17.84</ENT>
              <ENT>3.07</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">96999</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Dermatological procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97001</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pt evaluation</ENT>
              <ENT>1.20</ENT>
              <ENT>0.75</ENT>
              <ENT>0.46</ENT>
              <ENT>0.05</ENT>
              <ENT>2.00</ENT>
              <ENT>1.71</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97002</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pt re-evaluation</ENT>
              <ENT>0.60</ENT>
              <ENT>0.45</ENT>
              <ENT>0.24</ENT>
              <ENT>0.02</ENT>
              <ENT>1.07</ENT>
              <ENT>0.86</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97003</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ot evaluation</ENT>
              <ENT>1.20</ENT>
              <ENT>0.88</ENT>
              <ENT>0.41</ENT>
              <ENT>0.05</ENT>
              <ENT>2.13</ENT>
              <ENT>1.66</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97004</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ot re-evaluation</ENT>
              <ENT>0.60</ENT>
              <ENT>0.63</ENT>
              <ENT>0.20</ENT>
              <ENT>0.02</ENT>
              <ENT>1.25</ENT>
              <ENT>0.82</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97005</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Athletic train eval</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97006</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Athletic train reeval</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97010</ENT>
              <ENT/>
              <ENT>B</ENT>
              <ENT>Hot or cold packs therapy</ENT>
              <ENT>0.06</ENT>
              <ENT>0.05</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.12</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97012</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Mechanical traction therapy</ENT>
              <ENT>0.25</ENT>
              <ENT>0.14</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97014</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Electric stimulation therapy</ENT>
              <ENT>0.18</ENT>
              <ENT>0.14</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97016</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Vasopneumatic device therapy</ENT>
              <ENT>0.18</ENT>
              <ENT>0.19</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97018</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Paraffin bath therapy</ENT>
              <ENT>0.06</ENT>
              <ENT>0.11</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97020</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Microwave therapy</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.13</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97022</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Whirlpool therapy</ENT>
              <ENT>0.17</ENT>
              <ENT>0.22</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97024</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Diathermy treatment</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.13</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97026</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Infrared therapy</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.13</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97028</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ultraviolet therapy</ENT>
              <ENT>0.08</ENT>
              <ENT>0.07</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97032</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Electrical stimulation</ENT>
              <ENT>0.25</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97033</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Electric current therapy</ENT>
              <ENT>0.26</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97034</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Contrast bath therapy</ENT>
              <ENT>0.21</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49235"/>
              <ENT I="01">97035</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ultrasound therapy</ENT>
              <ENT>0.21</ENT>
              <ENT>0.11</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97036</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hydrotherapy</ENT>
              <ENT>0.28</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97039</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Physical therapy treatment</ENT>
              <ENT>0.20</ENT>
              <ENT>0.11</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97110</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Therapeutic exercises</ENT>
              <ENT>0.45</ENT>
              <ENT>0.28</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.76</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97112</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Neuromuscular reeducation</ENT>
              <ENT>0.45</ENT>
              <ENT>0.31</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97113</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Aquatic therapy/exercises</ENT>
              <ENT>0.44</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97116</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Gait training therapy</ENT>
              <ENT>0.40</ENT>
              <ENT>0.24</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97124</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Massage therapy</ENT>
              <ENT>0.35</ENT>
              <ENT>0.23</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97139</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Physical medicine procedure</ENT>
              <ENT>0.21</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97140</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Manual therapy</ENT>
              <ENT>0.43</ENT>
              <ENT>0.26</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97150</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Group therapeutic procedures</ENT>
              <ENT>0.27</ENT>
              <ENT>0.16</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97504</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Orthotic training</ENT>
              <ENT>0.45</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97520</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prosthetic training</ENT>
              <ENT>0.45</ENT>
              <ENT>0.28</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.75</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97530</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Therapeutic activities</ENT>
              <ENT>0.44</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.78</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97532</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cognitive skills development</ENT>
              <ENT>0.44</ENT>
              <ENT>0.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97533</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sensory integration</ENT>
              <ENT>0.44</ENT>
              <ENT>0.24</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97535</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Self care mngment training</ENT>
              <ENT>0.45</ENT>
              <ENT>0.34</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.81</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97537</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Community/work reintegration</ENT>
              <ENT>0.45</ENT>
              <ENT>0.27</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.73</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97542</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Wheelchair mngment training</ENT>
              <ENT>0.45</ENT>
              <ENT>0.28</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97545</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Work hardening</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97546</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Work hardening add-on</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97601</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Wound(s) care, selective</ENT>
              <ENT>0.50</ENT>
              <ENT>0.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>1.04</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97703</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prosthetic checkout</ENT>
              <ENT>0.25</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97750</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Physical performance test</ENT>
              <ENT>0.45</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97799</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Physical medicine procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97802</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Medical nutrition, indiv, in</ENT>
              <ENT>0.00</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.48</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97803</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Med nutrition, indiv, subseq</ENT>
              <ENT>0.00</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.48</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">97804</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Medical nutrition, group</ENT>
              <ENT>0.00</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.19</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">98925</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Osteopathic manipulation</ENT>
              <ENT>0.45</ENT>
              <ENT>0.33</ENT>
              <ENT>0.14</ENT>
              <ENT>0.01</ENT>
              <ENT>0.79</ENT>
              <ENT>0.60</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">98926</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Osteopathic manipulation</ENT>
              <ENT>0.65</ENT>
              <ENT>0.43</ENT>
              <ENT>0.25</ENT>
              <ENT>0.02</ENT>
              <ENT>1.10</ENT>
              <ENT>0.92</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">98927</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Osteopathic manipulation</ENT>
              <ENT>0.87</ENT>
              <ENT>0.52</ENT>
              <ENT>0.30</ENT>
              <ENT>0.03</ENT>
              <ENT>1.42</ENT>
              <ENT>1.20</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">98928</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Osteopathic manipulation</ENT>
              <ENT>1.03</ENT>
              <ENT>0.61</ENT>
              <ENT>0.35</ENT>
              <ENT>0.03</ENT>
              <ENT>1.67</ENT>
              <ENT>1.41</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">98929</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Osteopathic manipulation</ENT>
              <ENT>1.19</ENT>
              <ENT>0.69</ENT>
              <ENT>0.37</ENT>
              <ENT>0.04</ENT>
              <ENT>1.92</ENT>
              <ENT>1.60</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">98940</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chiropractic manipulation</ENT>
              <ENT>0.45</ENT>
              <ENT>0.24</ENT>
              <ENT>0.12</ENT>
              <ENT>0.01</ENT>
              <ENT>0.70</ENT>
              <ENT>0.58</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">98941</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chiropractic manipulation</ENT>
              <ENT>0.65</ENT>
              <ENT>0.30</ENT>
              <ENT>0.18</ENT>
              <ENT>0.02</ENT>
              <ENT>0.97</ENT>
              <ENT>0.85</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">98942</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Chiropractic manipulation</ENT>
              <ENT>0.87</ENT>
              <ENT>0.37</ENT>
              <ENT>0.24</ENT>
              <ENT>0.03</ENT>
              <ENT>1.27</ENT>
              <ENT>1.14</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">98943</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Chiropractic manipulation</ENT>
              <ENT>0.40</ENT>
              <ENT>0.25</ENT>
              <ENT>0.15</ENT>
              <ENT>0.01</ENT>
              <ENT>0.66</ENT>
              <ENT>0.56</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99082</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Unusual physician travel</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99141</ENT>
              <ENT/>
              <ENT>B</ENT>
              <ENT>Sedation, iv/im or inhalant</ENT>
              <ENT>0.80</ENT>
              <ENT>1.99</ENT>
              <ENT>0.39</ENT>
              <ENT>0.04</ENT>
              <ENT>2.83</ENT>
              <ENT>1.23</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99142</ENT>
              <ENT/>
              <ENT>B</ENT>
              <ENT>Sedation, oral/rectal/nasal</ENT>
              <ENT>0.60</ENT>
              <ENT>1.03</ENT>
              <ENT>0.31</ENT>
              <ENT>0.03</ENT>
              <ENT>1.66</ENT>
              <ENT>0.94</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99170</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Anogenital exam, child</ENT>
              <ENT>1.75</ENT>
              <ENT>1.72</ENT>
              <ENT>0.53</ENT>
              <ENT>0.07</ENT>
              <ENT>3.54</ENT>
              <ENT>2.35</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99175</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Induction of vomiting</ENT>
              <ENT>0.00</ENT>
              <ENT>1.39</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>1.47</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99183</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hyperbaric oxygen therapy</ENT>
              <ENT>2.34</ENT>
              <ENT>4.83</ENT>
              <ENT>0.74</ENT>
              <ENT>0.12</ENT>
              <ENT>7.29</ENT>
              <ENT>3.20</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99185</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Regional hypothermia</ENT>
              <ENT>0.00</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.67</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99186</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Total body hypothermia</ENT>
              <ENT>0.00</ENT>
              <ENT>1.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.37</ENT>
              <ENT>2.15</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99195</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Phlebotomy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.46</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99199</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Special service/proc/report</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99201</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Office/outpatient visit, new</ENT>
              <ENT>0.45</ENT>
              <ENT>0.51</ENT>
              <ENT>0.16</ENT>
              <ENT>0.02</ENT>
              <ENT>0.98</ENT>
              <ENT>0.63</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99202</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Office/outpatient visit, new</ENT>
              <ENT>0.88</ENT>
              <ENT>0.81</ENT>
              <ENT>0.32</ENT>
              <ENT>0.05</ENT>
              <ENT>1.74</ENT>
              <ENT>1.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99203</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Office/outpatient visit, new</ENT>
              <ENT>1.34</ENT>
              <ENT>1.16</ENT>
              <ENT>0.49</ENT>
              <ENT>0.08</ENT>
              <ENT>2.58</ENT>
              <ENT>1.91</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99204</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Office/outpatient visit, new</ENT>
              <ENT>2.00</ENT>
              <ENT>1.54</ENT>
              <ENT>0.72</ENT>
              <ENT>0.10</ENT>
              <ENT>3.64</ENT>
              <ENT>2.82</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99205</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Office/outpatient visit, new</ENT>
              <ENT>2.67</ENT>
              <ENT>1.83</ENT>
              <ENT>0.94</ENT>
              <ENT>0.12</ENT>
              <ENT>4.62</ENT>
              <ENT>3.73</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99211</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Office/outpatient visit, est</ENT>
              <ENT>0.17</ENT>
              <ENT>0.41</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.59</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99212</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Office/outpatient visit, est</ENT>
              <ENT>0.45</ENT>
              <ENT>0.56</ENT>
              <ENT>0.16</ENT>
              <ENT>0.02</ENT>
              <ENT>1.03</ENT>
              <ENT>0.63</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99213</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Office/outpatient visit, est</ENT>
              <ENT>0.67</ENT>
              <ENT>0.72</ENT>
              <ENT>0.23</ENT>
              <ENT>0.03</ENT>
              <ENT>1.42</ENT>
              <ENT>0.93</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99214</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Office/outpatient visit, est</ENT>
              <ENT>1.10</ENT>
              <ENT>1.07</ENT>
              <ENT>0.39</ENT>
              <ENT>0.04</ENT>
              <ENT>2.21</ENT>
              <ENT>1.53</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99215</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Office/outpatient visit, est</ENT>
              <ENT>1.77</ENT>
              <ENT>1.37</ENT>
              <ENT>0.63</ENT>
              <ENT>0.07</ENT>
              <ENT>3.21</ENT>
              <ENT>2.47</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49236"/>
              <ENT I="01">99217</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Observation care discharge</ENT>
              <ENT>1.28</ENT>
              <ENT>N/A</ENT>
              <ENT>0.54</ENT>
              <ENT>0.05</ENT>
              <ENT>N/A</ENT>
              <ENT>1.87</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99218</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Observation care</ENT>
              <ENT>1.28</ENT>
              <ENT>N/A</ENT>
              <ENT>0.44</ENT>
              <ENT>0.05</ENT>
              <ENT>N/A</ENT>
              <ENT>1.77</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99219</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Observation care</ENT>
              <ENT>2.14</ENT>
              <ENT>N/A</ENT>
              <ENT>0.72</ENT>
              <ENT>0.08</ENT>
              <ENT>N/A</ENT>
              <ENT>2.94</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99220</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Observation care</ENT>
              <ENT>2.99</ENT>
              <ENT>N/A</ENT>
              <ENT>1.03</ENT>
              <ENT>0.11</ENT>
              <ENT>N/A</ENT>
              <ENT>4.13</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99221</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Initial hospital care</ENT>
              <ENT>1.28</ENT>
              <ENT>N/A</ENT>
              <ENT>0.45</ENT>
              <ENT>0.05</ENT>
              <ENT>N/A</ENT>
              <ENT>1.78</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99222</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Initial hospital care</ENT>
              <ENT>2.14</ENT>
              <ENT>N/A</ENT>
              <ENT>0.75</ENT>
              <ENT>0.08</ENT>
              <ENT>N/A</ENT>
              <ENT>2.97</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99223</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Initial hospital care</ENT>
              <ENT>2.99</ENT>
              <ENT>N/A</ENT>
              <ENT>1.04</ENT>
              <ENT>0.10</ENT>
              <ENT>N/A</ENT>
              <ENT>4.13</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99231</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Subsequent hospital care</ENT>
              <ENT>0.64</ENT>
              <ENT>N/A</ENT>
              <ENT>0.23</ENT>
              <ENT>0.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.89</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99232</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Subsequent hospital care</ENT>
              <ENT>1.06</ENT>
              <ENT>N/A</ENT>
              <ENT>0.37</ENT>
              <ENT>0.03</ENT>
              <ENT>N/A</ENT>
              <ENT>1.46</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99233</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Subsequent hospital care</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>0.53</ENT>
              <ENT>0.05</ENT>
              <ENT>N/A</ENT>
              <ENT>2.09</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99234</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Observ/hosp same date</ENT>
              <ENT>2.56</ENT>
              <ENT>N/A</ENT>
              <ENT>1.00</ENT>
              <ENT>0.11</ENT>
              <ENT>N/A</ENT>
              <ENT>3.67</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99235</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Observ/hosp same date</ENT>
              <ENT>3.42</ENT>
              <ENT>N/A</ENT>
              <ENT>1.30</ENT>
              <ENT>0.13</ENT>
              <ENT>N/A</ENT>
              <ENT>4.85</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99236</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Observ/hosp same date</ENT>
              <ENT>4.27</ENT>
              <ENT>N/A</ENT>
              <ENT>1.59</ENT>
              <ENT>0.17</ENT>
              <ENT>N/A</ENT>
              <ENT>6.03</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99238</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hospital discharge day</ENT>
              <ENT>1.28</ENT>
              <ENT>N/A</ENT>
              <ENT>0.55</ENT>
              <ENT>0.04</ENT>
              <ENT>N/A</ENT>
              <ENT>1.87</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99239</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hospital discharge day</ENT>
              <ENT>1.75</ENT>
              <ENT>N/A</ENT>
              <ENT>0.74</ENT>
              <ENT>0.05</ENT>
              <ENT>N/A</ENT>
              <ENT>2.54</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99241</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Office consultation</ENT>
              <ENT>0.64</ENT>
              <ENT>0.66</ENT>
              <ENT>0.22</ENT>
              <ENT>0.04</ENT>
              <ENT>1.34</ENT>
              <ENT>0.90</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99242</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Office consultation</ENT>
              <ENT>1.29</ENT>
              <ENT>1.07</ENT>
              <ENT>0.47</ENT>
              <ENT>0.09</ENT>
              <ENT>2.45</ENT>
              <ENT>1.85</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99243</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Office consultation</ENT>
              <ENT>1.72</ENT>
              <ENT>1.42</ENT>
              <ENT>0.63</ENT>
              <ENT>0.10</ENT>
              <ENT>3.24</ENT>
              <ENT>2.45</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99244</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Office consultation</ENT>
              <ENT>2.58</ENT>
              <ENT>1.85</ENT>
              <ENT>0.92</ENT>
              <ENT>0.13</ENT>
              <ENT>4.56</ENT>
              <ENT>3.63</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99245</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Office consultation</ENT>
              <ENT>3.43</ENT>
              <ENT>2.30</ENT>
              <ENT>1.23</ENT>
              <ENT>0.16</ENT>
              <ENT>5.89</ENT>
              <ENT>4.82</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99251</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Initial inpatient consult</ENT>
              <ENT>0.66</ENT>
              <ENT>N/A</ENT>
              <ENT>0.25</ENT>
              <ENT>0.04</ENT>
              <ENT>N/A</ENT>
              <ENT>0.95</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99252</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Initial inpatient consult</ENT>
              <ENT>1.32</ENT>
              <ENT>N/A</ENT>
              <ENT>0.51</ENT>
              <ENT>0.08</ENT>
              <ENT>N/A</ENT>
              <ENT>1.91</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99253</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Initial inpatient consult</ENT>
              <ENT>1.82</ENT>
              <ENT>N/A</ENT>
              <ENT>0.69</ENT>
              <ENT>0.09</ENT>
              <ENT>N/A</ENT>
              <ENT>2.60</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99254</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Initial inpatient consult</ENT>
              <ENT>2.64</ENT>
              <ENT>N/A</ENT>
              <ENT>0.99</ENT>
              <ENT>0.11</ENT>
              <ENT>N/A</ENT>
              <ENT>3.74</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99255</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Initial inpatient consult</ENT>
              <ENT>3.65</ENT>
              <ENT>N/A</ENT>
              <ENT>1.36</ENT>
              <ENT>0.15</ENT>
              <ENT>N/A</ENT>
              <ENT>5.16</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99261</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Follow-up inpatient consult</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>0.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.59</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99262</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Follow-up inpatient consult</ENT>
              <ENT>0.85</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>0.03</ENT>
              <ENT>N/A</ENT>
              <ENT>1.19</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99263</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Follow-up inpatient consult</ENT>
              <ENT>1.27</ENT>
              <ENT>N/A</ENT>
              <ENT>0.46</ENT>
              <ENT>0.04</ENT>
              <ENT>N/A</ENT>
              <ENT>1.77</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99271</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Confirmatory consultation</ENT>
              <ENT>0.45</ENT>
              <ENT>0.56</ENT>
              <ENT>0.16</ENT>
              <ENT>0.03</ENT>
              <ENT>1.04</ENT>
              <ENT>0.64</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99272</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Confirmatory consultation</ENT>
              <ENT>0.84</ENT>
              <ENT>0.83</ENT>
              <ENT>0.31</ENT>
              <ENT>0.06</ENT>
              <ENT>1.73</ENT>
              <ENT>1.21</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99273</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Confirmatory consultation</ENT>
              <ENT>1.19</ENT>
              <ENT>1.12</ENT>
              <ENT>0.45</ENT>
              <ENT>0.07</ENT>
              <ENT>2.38</ENT>
              <ENT>1.71</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99274</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Confirmatory consultation</ENT>
              <ENT>1.73</ENT>
              <ENT>1.38</ENT>
              <ENT>0.65</ENT>
              <ENT>0.09</ENT>
              <ENT>3.20</ENT>
              <ENT>2.47</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99275</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Confirmatory consultation</ENT>
              <ENT>2.31</ENT>
              <ENT>1.65</ENT>
              <ENT>0.83</ENT>
              <ENT>0.10</ENT>
              <ENT>4.06</ENT>
              <ENT>3.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99281</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Emergency dept visit</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>0.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.44</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99282</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Emergency dept visit</ENT>
              <ENT>0.55</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>0.03</ENT>
              <ENT>N/A</ENT>
              <ENT>0.73</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99283</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Emergency dept visit</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>0.31</ENT>
              <ENT>0.08</ENT>
              <ENT>N/A</ENT>
              <ENT>1.63</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99284</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Emergency dept visit</ENT>
              <ENT>1.95</ENT>
              <ENT>N/A</ENT>
              <ENT>0.48</ENT>
              <ENT>0.12</ENT>
              <ENT>N/A</ENT>
              <ENT>2.55</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99285</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Emergency dept visit</ENT>
              <ENT>3.06</ENT>
              <ENT>N/A</ENT>
              <ENT>0.73</ENT>
              <ENT>0.19</ENT>
              <ENT>N/A</ENT>
              <ENT>3.98</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99289</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ped crit care transport</ENT>
              <ENT>4.80</ENT>
              <ENT>N/A</ENT>
              <ENT>1.70</ENT>
              <ENT>0.14</ENT>
              <ENT>N/A</ENT>
              <ENT>6.64</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99290</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ped crit care transport addl</ENT>
              <ENT>2.40</ENT>
              <ENT>N/A</ENT>
              <ENT>0.84</ENT>
              <ENT>0.07</ENT>
              <ENT>N/A</ENT>
              <ENT>3.31</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99291</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Critical care, first hour</ENT>
              <ENT>4.00</ENT>
              <ENT>2.39</ENT>
              <ENT>1.30</ENT>
              <ENT>0.14</ENT>
              <ENT>6.53</ENT>
              <ENT>5.44</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99292</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Critical care, addl 30 min</ENT>
              <ENT>2.00</ENT>
              <ENT>0.82</ENT>
              <ENT>0.65</ENT>
              <ENT>0.07</ENT>
              <ENT>2.89</ENT>
              <ENT>2.72</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99293</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ped critical care, initial</ENT>
              <ENT>16.00</ENT>
              <ENT>N/A</ENT>
              <ENT>5.04</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>21.74</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99294</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ped critical care, subseq</ENT>
              <ENT>8.00</ENT>
              <ENT>N/A</ENT>
              <ENT>2.52</ENT>
              <ENT>0.23</ENT>
              <ENT>N/A</ENT>
              <ENT>10.75</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99295</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Neonate crit care, initial</ENT>
              <ENT>18.49</ENT>
              <ENT>N/A</ENT>
              <ENT>5.47</ENT>
              <ENT>0.70</ENT>
              <ENT>N/A</ENT>
              <ENT>24.66</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99296</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Neonate critical care subseq</ENT>
              <ENT>8.00</ENT>
              <ENT>N/A</ENT>
              <ENT>2.60</ENT>
              <ENT>0.23</ENT>
              <ENT>N/A</ENT>
              <ENT>10.83</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99298</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ic for lbw infant &lt; 1500 gm</ENT>
              <ENT>2.75</ENT>
              <ENT>N/A</ENT>
              <ENT>0.95</ENT>
              <ENT>0.10</ENT>
              <ENT>N/A</ENT>
              <ENT>3.80</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99299</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Ic, lbw infant 1500-2500 gm</ENT>
              <ENT>2.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.97</ENT>
              <ENT>0.10</ENT>
              <ENT>N/A</ENT>
              <ENT>3.57</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99301</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nursing facility care</ENT>
              <ENT>1.20</ENT>
              <ENT>0.43</ENT>
              <ENT>0.43</ENT>
              <ENT>0.04</ENT>
              <ENT>1.67</ENT>
              <ENT>1.67</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99302</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nursing facility care</ENT>
              <ENT>1.61</ENT>
              <ENT>0.59</ENT>
              <ENT>0.59</ENT>
              <ENT>0.05</ENT>
              <ENT>2.25</ENT>
              <ENT>2.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99303</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nursing facility care</ENT>
              <ENT>2.01</ENT>
              <ENT>0.72</ENT>
              <ENT>0.72</ENT>
              <ENT>0.06</ENT>
              <ENT>2.79</ENT>
              <ENT>2.79</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99311</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nursing fac care, subseq</ENT>
              <ENT>0.60</ENT>
              <ENT>0.29</ENT>
              <ENT>0.29</ENT>
              <ENT>0.02</ENT>
              <ENT>0.91</ENT>
              <ENT>0.91</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99312</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nursing fac care, subseq</ENT>
              <ENT>1.00</ENT>
              <ENT>0.47</ENT>
              <ENT>0.47</ENT>
              <ENT>0.03</ENT>
              <ENT>1.50</ENT>
              <ENT>1.50</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99313</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nursing fac care, subseq</ENT>
              <ENT>1.42</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>0.04</ENT>
              <ENT>2.07</ENT>
              <ENT>2.07</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99315</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nursing fac discharge day</ENT>
              <ENT>1.13</ENT>
              <ENT>0.47</ENT>
              <ENT>0.38</ENT>
              <ENT>0.04</ENT>
              <ENT>1.64</ENT>
              <ENT>1.55</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99316</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Nursing fac discharge day</ENT>
              <ENT>1.50</ENT>
              <ENT>0.63</ENT>
              <ENT>0.52</ENT>
              <ENT>0.05</ENT>
              <ENT>2.18</ENT>
              <ENT>2.07</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99321</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rest home visit, new patient</ENT>
              <ENT>0.71</ENT>
              <ENT>0.35</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>1.08</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99322</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rest home visit, new patient</ENT>
              <ENT>1.01</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>1.51</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49237"/>
              <ENT I="01">99323</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rest home visit, new patient</ENT>
              <ENT>1.28</ENT>
              <ENT>0.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>1.89</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99331</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rest home visit, est pat</ENT>
              <ENT>0.60</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.95</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99332</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rest home visit, est pat</ENT>
              <ENT>0.80</ENT>
              <ENT>0.40</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>1.23</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99333</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Rest home visit, est pat</ENT>
              <ENT>1.00</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>1.50</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99341</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Home visit, new patient</ENT>
              <ENT>1.01</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99342</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Home visit, new patient</ENT>
              <ENT>1.52</ENT>
              <ENT>0.69</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>2.26</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99343</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Home visit, new patient</ENT>
              <ENT>2.27</ENT>
              <ENT>0.96</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>3.30</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99344</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Home visit, new patient</ENT>
              <ENT>3.03</ENT>
              <ENT>1.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>4.34</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99345</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Home visit, new patient</ENT>
              <ENT>3.79</ENT>
              <ENT>1.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>5.38</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99347</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Home visit, est patient</ENT>
              <ENT>0.76</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>1.20</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99348</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Home visit, est patient</ENT>
              <ENT>1.26</ENT>
              <ENT>0.59</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>1.89</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99349</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Home visit, est patient</ENT>
              <ENT>2.02</ENT>
              <ENT>0.86</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>2.94</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99350</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Home visit, est patient</ENT>
              <ENT>3.03</ENT>
              <ENT>1.21</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>4.34</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99354</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prolonged service, office</ENT>
              <ENT>1.77</ENT>
              <ENT>0.75</ENT>
              <ENT>0.61</ENT>
              <ENT>0.06</ENT>
              <ENT>2.58</ENT>
              <ENT>2.44</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99355</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prolonged service, office</ENT>
              <ENT>1.77</ENT>
              <ENT>0.73</ENT>
              <ENT>0.58</ENT>
              <ENT>0.06</ENT>
              <ENT>2.56</ENT>
              <ENT>2.41</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99356</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prolonged service, inpatient</ENT>
              <ENT>1.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.62</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>2.39</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99357</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prolonged service, inpatient</ENT>
              <ENT>1.71</ENT>
              <ENT>N/A</ENT>
              <ENT>0.64</ENT>
              <ENT>0.06</ENT>
              <ENT>N/A</ENT>
              <ENT>2.41</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99374</ENT>
              <ENT/>
              <ENT>B</ENT>
              <ENT>Home health care supervision</ENT>
              <ENT>1.10</ENT>
              <ENT>0.71</ENT>
              <ENT>0.43</ENT>
              <ENT>0.04</ENT>
              <ENT>1.85</ENT>
              <ENT>1.57</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99375</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home health care supervision</ENT>
              <ENT>1.73</ENT>
              <ENT>1.57</ENT>
              <ENT>1.57</ENT>
              <ENT>0.06</ENT>
              <ENT>3.36</ENT>
              <ENT>3.36</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99377</ENT>
              <ENT/>
              <ENT>B</ENT>
              <ENT>Hospice care supervision</ENT>
              <ENT>1.10</ENT>
              <ENT>0.71</ENT>
              <ENT>0.43</ENT>
              <ENT>0.04</ENT>
              <ENT>1.85</ENT>
              <ENT>1.57</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99378</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Hospice care supervision</ENT>
              <ENT>1.73</ENT>
              <ENT>1.97</ENT>
              <ENT>1.97</ENT>
              <ENT>0.06</ENT>
              <ENT>3.76</ENT>
              <ENT>3.76</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99379</ENT>
              <ENT/>
              <ENT>B</ENT>
              <ENT>Nursing fac care supervision</ENT>
              <ENT>1.10</ENT>
              <ENT>0.71</ENT>
              <ENT>0.71</ENT>
              <ENT>0.03</ENT>
              <ENT>1.84</ENT>
              <ENT>1.84</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99380</ENT>
              <ENT/>
              <ENT>B</ENT>
              <ENT>Nursing fac care supervision</ENT>
              <ENT>1.73</ENT>
              <ENT>1.01</ENT>
              <ENT>1.01</ENT>
              <ENT>0.05</ENT>
              <ENT>2.79</ENT>
              <ENT>2.79</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99381</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Prev visit, new, infant</ENT>
              <ENT>1.19</ENT>
              <ENT>1.19</ENT>
              <ENT>0.46</ENT>
              <ENT>0.04</ENT>
              <ENT>2.42</ENT>
              <ENT>1.69</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99382</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Prev visit, new, age 1-4</ENT>
              <ENT>1.36</ENT>
              <ENT>1.25</ENT>
              <ENT>0.53</ENT>
              <ENT>0.04</ENT>
              <ENT>2.65</ENT>
              <ENT>1.93</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99383</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Prev visit, new, age 5-11</ENT>
              <ENT>1.36</ENT>
              <ENT>1.25</ENT>
              <ENT>0.53</ENT>
              <ENT>0.04</ENT>
              <ENT>2.65</ENT>
              <ENT>1.93</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99384</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Prev visit, new, age 12-17</ENT>
              <ENT>1.53</ENT>
              <ENT>1.31</ENT>
              <ENT>0.59</ENT>
              <ENT>0.05</ENT>
              <ENT>2.89</ENT>
              <ENT>2.17</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99385</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Prev visit, new, age 18-39</ENT>
              <ENT>1.53</ENT>
              <ENT>1.31</ENT>
              <ENT>0.59</ENT>
              <ENT>0.05</ENT>
              <ENT>2.89</ENT>
              <ENT>2.17</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99386</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Prev visit, new, age 40-64</ENT>
              <ENT>1.88</ENT>
              <ENT>1.45</ENT>
              <ENT>0.73</ENT>
              <ENT>0.06</ENT>
              <ENT>3.39</ENT>
              <ENT>2.67</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99387</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Prev visit, new, 65 &amp; over</ENT>
              <ENT>2.06</ENT>
              <ENT>1.61</ENT>
              <ENT>0.80</ENT>
              <ENT>0.06</ENT>
              <ENT>3.73</ENT>
              <ENT>2.92</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99391</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Prev visit, est, infant</ENT>
              <ENT>1.02</ENT>
              <ENT>1.03</ENT>
              <ENT>0.40</ENT>
              <ENT>0.03</ENT>
              <ENT>2.08</ENT>
              <ENT>1.45</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99392</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Prev visit, est, age 1-4</ENT>
              <ENT>1.19</ENT>
              <ENT>1.10</ENT>
              <ENT>0.46</ENT>
              <ENT>0.04</ENT>
              <ENT>2.33</ENT>
              <ENT>1.69</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99393</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Prev visit, est, age 5-11</ENT>
              <ENT>1.19</ENT>
              <ENT>1.10</ENT>
              <ENT>0.46</ENT>
              <ENT>0.04</ENT>
              <ENT>2.33</ENT>
              <ENT>1.69</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99394</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Prev visit, est, age 12-17</ENT>
              <ENT>1.36</ENT>
              <ENT>1.16</ENT>
              <ENT>0.53</ENT>
              <ENT>0.04</ENT>
              <ENT>2.56</ENT>
              <ENT>1.93</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99395</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Prev visit, est, age 18-39</ENT>
              <ENT>1.36</ENT>
              <ENT>1.16</ENT>
              <ENT>0.53</ENT>
              <ENT>0.04</ENT>
              <ENT>2.56</ENT>
              <ENT>1.93</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99396</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Prev visit, est, age 40-64</ENT>
              <ENT>1.53</ENT>
              <ENT>1.23</ENT>
              <ENT>0.59</ENT>
              <ENT>0.05</ENT>
              <ENT>2.81</ENT>
              <ENT>2.17</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99397</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Prev visit, est, 65 &amp; over</ENT>
              <ENT>1.71</ENT>
              <ENT>1.27</ENT>
              <ENT>0.66</ENT>
              <ENT>0.05</ENT>
              <ENT>3.03</ENT>
              <ENT>2.42</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99401</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Preventive counseling, indiv</ENT>
              <ENT>0.48</ENT>
              <ENT>0.41</ENT>
              <ENT>0.19</ENT>
              <ENT>0.01</ENT>
              <ENT>0.90</ENT>
              <ENT>0.68</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99402</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Preventive counseling, indiv</ENT>
              <ENT>0.98</ENT>
              <ENT>0.60</ENT>
              <ENT>0.38</ENT>
              <ENT>0.02</ENT>
              <ENT>1.60</ENT>
              <ENT>1.38</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99403</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Preventive counseling, indiv</ENT>
              <ENT>1.46</ENT>
              <ENT>0.79</ENT>
              <ENT>0.57</ENT>
              <ENT>0.03</ENT>
              <ENT>2.28</ENT>
              <ENT>2.06</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99404</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Preventive counseling, indiv</ENT>
              <ENT>1.95</ENT>
              <ENT>0.98</ENT>
              <ENT>0.76</ENT>
              <ENT>0.04</ENT>
              <ENT>2.97</ENT>
              <ENT>2.75</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99411</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Preventive counseling, group</ENT>
              <ENT>0.15</ENT>
              <ENT>0.19</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.35</ENT>
              <ENT>0.22</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99412</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Preventive counseling, group</ENT>
              <ENT>0.25</ENT>
              <ENT>0.22</ENT>
              <ENT>0.10</ENT>
              <ENT>0.01</ENT>
              <ENT>0.48</ENT>
              <ENT>0.36</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99431</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Initial care, normal newborn</ENT>
              <ENT>1.17</ENT>
              <ENT>N/A</ENT>
              <ENT>0.39</ENT>
              <ENT>0.04</ENT>
              <ENT>N/A</ENT>
              <ENT>1.60</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99432</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Newborn care, not in hosp</ENT>
              <ENT>1.26</ENT>
              <ENT>0.92</ENT>
              <ENT>0.41</ENT>
              <ENT>0.06</ENT>
              <ENT>2.24</ENT>
              <ENT>1.73</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99433</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Normal newborn care/hospital</ENT>
              <ENT>0.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>0.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.84</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99435</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Newborn discharge day hosp</ENT>
              <ENT>1.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.51</ENT>
              <ENT>0.05</ENT>
              <ENT>N/A</ENT>
              <ENT>2.06</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99436</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Attendance, birth</ENT>
              <ENT>1.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.48</ENT>
              <ENT>0.05</ENT>
              <ENT>N/A</ENT>
              <ENT>2.03</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99440</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Newborn resuscitation</ENT>
              <ENT>2.93</ENT>
              <ENT>N/A</ENT>
              <ENT>0.94</ENT>
              <ENT>0.11</ENT>
              <ENT>N/A</ENT>
              <ENT>3.98</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99455</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Disability examination</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49238"/>
              <ENT I="01">99456</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Disability examination</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99499</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Unlisted e&amp;m service</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99500</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home visit, prenatal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99501</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home visit, postnatal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99502</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home visit, nb care</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99503</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home visit, resp therapy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99504</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home visit mech ventilator</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99505</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home visit, stoma care</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99506</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home visit, im injection</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99507</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home visit, cath maintain</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99509</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home visit day life activity</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99510</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home visit, sing/m/fam couns</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99511</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home visit, fecal/enema mgmt</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99512</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home visit, hemodialysis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99551</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home infus, pain mgmt, iv/sc</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99552</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Hm infus pain mgmt, epid/ith</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99553</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home infuse, tocolytic tx</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99554</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home infus, hormone/platelet</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99555</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home infuse, chemotheraphy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99556</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home infus, antibio/fung/vir</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99557</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home infuse, anticoagulant</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99558</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home infuse, immunotherapy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99559</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home infus, periton dialysis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99560</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home infus, entero nutrition</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99561</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home infuse, hydration tx</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99562</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home infus, parent nutrition</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99563</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home admin, pentamidine</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99564</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Hme infus, antihemophil agnt</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99565</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home infus, proteinase inhib</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99566</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home infuse, iv therapy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99567</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home infuse, sympath agent</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99568</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home infus, misc drug, daily</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99569</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home infuse, each addl tx</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">99600</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Home visit nos</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">A4890</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Repair/maint cont hemo equip</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0120</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Periodic oral evaluation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0140</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Limit oral eval problm focus</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0150</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Comprehensve oral evaluation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0160</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Extensv oral eval prob focus</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0170</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Re-eval,est pt,problem focus</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0180</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Comp periodontal evaluation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0210</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Intraor complete film series</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0220</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Intraoral periapical first f</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49239"/>
              <ENT I="01">D0230</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Intraoral periapical ea add</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0240</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Intraoral occlusal film</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0250</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Extraoral first film</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0260</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Extraoral ea additional film</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0270</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Dental bitewing single film</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0272</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Dental bitewings two films</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0274</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Dental bitewings four films</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0277</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Vert bitewings-sev to eight</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0290</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Dental film skull/facial bon</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0310</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Dental saliography</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0320</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Dental tmj arthrogram incl i</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0321</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Dental other tmj films</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0322</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Dental tomographic survey</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0330</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Dental panoramic film</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0340</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Dental cephalometric film</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0350</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Oral/facial images</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0415</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Bacteriologic study</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0425</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Caries susceptibility test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0460</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Pulp vitality test</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0470</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Diagnostic casts</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0472</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Gross exam, prep &amp; report</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0473</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Micro exam, prep &amp; report</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0474</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Micro w exam of surg margins</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0480</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Cytopath smear prep &amp; report</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0502</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Other oral pathology procedu</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D0999</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Unspecified diagnostic proce</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D1110</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental prophylaxis adult</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D1120</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental prophylaxis child</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D1201</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Topical fluor w prophy child</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D1203</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Topical fluor w/o prophy chi</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D1204</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Topical fluor w/o prophy adu</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D1205</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Topical fluoride w/ prophy a</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D1310</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Nutri counsel-control caries</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D1320</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Tobacco counseling</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D1330</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Oral hygiene instruction</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D1351</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental sealant per tooth</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D1510</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Space maintainer fxd unilat</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D1515</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Fixed bilat space maintainer</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D1520</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Remove unilat space maintain</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D1525</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Remove bilat space maintain</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D1550</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Recement space maintainer</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2140</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Amalgam one surface permanen</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2150</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Amalgam two surfaces permane</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2160</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Amalgam three surfaces perma</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2161</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Amalgam 4 or &gt; surfaces perm</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2330</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Resin one surface-anterior</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49240"/>
              <ENT I="01">D2331</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Resin two surfaces-anterior</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2332</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Resin three surfaces-anterio</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2335</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Resin 4/&gt; surf or w incis an</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2390</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Ant resin-based cmpst crown</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2391</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Post 1 srfc resinbased cmpst</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2392</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Post 2 srfc resinbased cmpst</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2393</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Post 3 srfc resinbased cmpst</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2394</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Post &gt;=4srfc resinbase cmpst</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2410</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental gold foil one surface</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2420</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental gold foil two surface</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2430</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental gold foil three surfa</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2510</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental inlay metalic 1 surf</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2520</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental inlay metallic 2 surf</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2530</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental inlay metl 3/more sur</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2542</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental onlay metallic 2 surf</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2543</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental onlay metallic 3 surf</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2544</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental onlay metl 4/more sur</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2610</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Inlay porcelain/ceramic 1 su</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2620</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Inlay porcelain/ceramic 2 su</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2630</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental onlay porc 3/more sur</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2642</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental onlay porcelin 2 surf</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2643</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental onlay porcelin 3 surf</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2644</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental onlay porc 4/more sur</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2650</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Inlay composite/resin one su</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2651</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Inlay composite/resin two su</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2652</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental inlay resin 3/mre sur</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2662</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental onlay resin 2 surface</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2663</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental onlay resin 3 surface</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2664</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental onlay resin 4/mre sur</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2710</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown resin laboratory</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2720</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown resin w/ high noble me</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2721</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown resin w/ base metal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2722</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown resin w/ noble metal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2740</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown porcelain/ceramic subs</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2750</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown porcelain w/ h noble m</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49241"/>
              <ENT I="01">D2751</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown porcelain fused base m</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2752</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown porcelain w/ noble met</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2780</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown 3/4 cast hi noble met</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2781</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown 3/4 cast base metal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2782</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown 3/4 cast noble metal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2783</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown 3/4 porcelain/ceramic</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2790</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown full cast high noble m</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2791</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown full cast base metal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2792</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown full cast noble metal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2799</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Provisional crown</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2910</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental recement inlay</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2920</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental recement crown</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2930</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Prefab stnlss steel crwn pri</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2931</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Prefab stnlss steel crown pe</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2932</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Prefabricated resin crown</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2933</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Prefab stainless steel crown</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2940</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental sedative filling</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2950</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Core build-up incl any pins</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2951</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Tooth pin retention</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2952</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Post and core cast + crown</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2953</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Each addtnl cast post</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2954</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Prefab post/core + crown</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2955</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Post removal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2957</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Each addtnl prefab post</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2960</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Laminate labial veneer</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2961</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Lab labial veneer resin</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2962</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Lab labial veneer porcelain</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2970</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Temporary- fractured tooth</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2980</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown repair</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D2999</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Dental unspec restorative pr</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3110</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Pulp cap direct</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3120</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Pulp cap indirect</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3220</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Therapeutic pulpotomy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3221</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Gross pulpal debridement</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3230</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Pulpal therapy anterior prim</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3240</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Pulpal therapy posterior pri</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3310</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Anterior</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3320</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Root canal therapy 2 canals</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3330</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Root canal therapy 3 canals</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3331</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Non-surg tx root canal obs</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3332</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Incomplete endodontic tx</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3333</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Internal root repair</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3346</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Retreat root canal anterior</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3347</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Retreat root canal bicuspid</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3348</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Retreat root canal molar</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3351</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Apexification/recalc initial</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3352</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Apexification/recalc interim</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3353</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Apexification/recalc final</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49242"/>
              <ENT I="01">D3410</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Apicoect/perirad surg anter</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3421</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Root surgery bicuspid</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3425</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Root surgery molar</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3426</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Root surgery ea add root</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3430</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Retrograde filling</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3450</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Root amputation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3460</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Endodontic endosseous implan</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3470</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Intentional replantation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3910</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Isolation- tooth w rubb dam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3920</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Tooth splitting</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3950</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Canal prep/fitting of dowel</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D3999</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Endodontic procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4210</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Gingivectomy/plasty per quad</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4211</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Gingivectomy/plasty per toot</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4240</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Gingival flap proc w/ planin</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4241</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Gngvl flap w rootplan 1-3 th</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4245</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Apically positioned flap</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4249</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown lengthen hard tissue</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4260</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Osseous surgery per quadrant</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4261</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Osseous surgl-3teethperquad</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4263</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Bone replce graft first site</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4264</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Bone replce graft each add</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4265</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Bio mtrls to aid soft/os reg</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4266</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Guided tiss regen resorble</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4267</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Guided tiss regen nonresorb</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4268</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Surgical revision procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4270</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Pedicle soft tissue graft pr</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4271</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Free soft tissue graft proc</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4273</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Subepithelial tissue graft</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4274</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Distal/proximal wedge proc</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4275</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Soft tissue allograft</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4276</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Con tissue w dble ped graft</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4320</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Provision splnt intracoronal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4321</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Provisional splint extracoro</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4341</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Periodontal scaling &amp; root</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4342</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Periodontal scaling 1-3teeth</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4355</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Full mouth debridement</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4381</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Localized chemo delivery</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4910</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Periodontal maint procedures</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4920</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Unscheduled dressing change</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D4999</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Unspecified periodontal proc</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5110</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dentures complete maxillary</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5120</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dentures complete mandible</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49243"/>
              <ENT I="01">D5130</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dentures immediat maxillary</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5140</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dentures immediat mandible</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5211</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dentures maxill part resin</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5212</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dentures mand part resin</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5213</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dentures maxill part metal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5214</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dentures mandibl part metal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5281</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Removable partial denture</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5410</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dentures adjust cmplt maxil</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5411</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dentures adjust cmplt mand</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5421</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dentures adjust part maxill</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5422</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dentures adjust part mandbl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5510</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dentur repr broken compl bas</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5520</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Replace denture teeth complt</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5610</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dentures repair resin base</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5620</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Rep part denture cast frame</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5630</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Rep partial denture clasp</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5640</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Replace part denture teeth</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5650</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Add tooth to partial denture</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5660</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Add clasp to partial denture</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5670</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Replc tth&amp;acrlc on mtl frmwk</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5671</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Replc tth&amp;acrlc mandibular</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5710</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dentures rebase cmplt maxil</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5711</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dentures rebase cmplt mand</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5720</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dentures rebase part maxill</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5721</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dentures rebase part mandbl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5730</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Denture reln cmplt maxil ch</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5731</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Denture reln cmplt mand chr</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5740</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Denture reln part maxil chr</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5741</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Denture reln part mand chr</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5750</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Denture reln cmplt max lab</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5751</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Denture reln cmplt mand lab</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5760</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Denture reln part maxil lab</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5761</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Denture reln part mand lab</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5810</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Denture interm cmplt maxill</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5811</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Denture interm cmplt mandbl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5820</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Denture interm part maxill</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5821</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Denture interm part mandbl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5850</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Denture tiss conditn maxill</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5851</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Denture tiss condtin mandbl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5860</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Overdenture complete</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49244"/>
              <ENT I="01">D5861</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Overdenture partial</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5862</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Precision attachment</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5867</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Replacement of precision att</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5875</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Prosthesis modification</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5899</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Removable prosthodontic proc</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5911</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Facial moulage sectional</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5912</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Facial moulage complete</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5913</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Nasal prosthesis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5914</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Auricular prosthesis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5915</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Orbital prosthesis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5916</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Ocular prosthesis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5919</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Facial prosthesis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5922</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Nasal septal prosthesis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5923</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Ocular prosthesis interim</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5924</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Cranial prosthesis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5925</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Facial augmentation implant</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5926</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Replacement nasal prosthesis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5927</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Auricular replacement</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5928</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Orbital replacement</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5929</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Facial replacement</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5931</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Surgical obturator</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5932</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Postsurgical obturator</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5933</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Refitting of obturator</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5934</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Mandibular flange prosthesis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5935</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Mandibular denture prosth</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5936</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Temp obturator prosthesis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5937</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Trismus appliance</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5951</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Feeding aid</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5952</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Pediatric speech aid</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5953</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Adult speech aid</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5954</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Superimposed prosthesis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5955</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Palatal lift prosthesis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5958</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Intraoral con def inter plt</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5959</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Intraoral con def mod palat</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5960</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Modify speech aid prosthesis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5982</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Surgical stent</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5983</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Radiation applicator</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5984</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Radiation shield</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5985</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Radiation cone locator</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5986</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Fluoride applicator</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5987</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Commissure splint</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5988</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Surgical splint</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D5999</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Maxillofacial prosthesis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6010</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Odontics endosteal implant</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6020</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Odontics abutment placement</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6040</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Odontics eposteal implant</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6050</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Odontics transosteal implnt</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6053</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Implnt/abtmnt spprt remv dnt</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6054</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Implnt/abtmnt spprt remvprtl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6055</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Implant connecting bar</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6056</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Prefabricated abutment</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6057</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Custom abutment</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6058</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Abutment supported crown</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49245"/>
              <ENT I="01">D6059</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Abutment supported mtl crown</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6060</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Abutment supported mtl crown</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6061</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Abutment supported mtl crown</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6062</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Abutment supported mtl crown</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6063</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Abutment supported mtl crown</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6064</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Abutment supported mtl crown</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6065</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Implant supported crown</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6066</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Implant supported mtl crown</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6067</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Implant supported mtl crown</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6068</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Abutment supported retainer</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6069</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Abutment supported retainer</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6070</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Abutment supported retainer</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6071</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Abutment supported retainer</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6072</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Abutment supported retainer</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6073</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Abutment supported retainer</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6074</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Abutment supported retainer</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6075</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Implant supported retainer</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6076</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Implant supported retainer</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6077</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Implant supported retainer</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6078</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Implnt/abut suprtd fixd dent</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6079</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Implnt/abut suprtd fixd dent</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6080</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Implant maintenance</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6090</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Repair implant</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6095</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Odontics repr abutment</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6100</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Removal of implant</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6199</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Implant procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6210</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Prosthodont high noble metal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6211</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Bridge base metal cast</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6212</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Bridge noble metal cast</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6240</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Bridge porcelain high noble</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6241</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Bridge porcelain base metal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6242</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Bridge porcelain nobel metal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6245</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Bridge porcelain/ceramic</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6250</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Bridge resin w/high noble</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6251</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Bridge resin base metal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6252</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Bridge resin w/noble metal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6253</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Provisional pontic</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6545</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental retainr cast metl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6548</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Porcelain/ceramic retainer</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6600</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Porcelain/ceramic inlay 2srf</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6601</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Porc/ceram inlay &gt;= 3 surfac</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6602</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Cst hgh nble mtl inlay 2 srf</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49246"/>
              <ENT I="01">D6603</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Cst hgh nble mtl inlay &gt;=3sr</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6604</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Cst bse mtl inlay 2 surfaces</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6605</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Cst bse mtl inlay &gt;= 3 surfa</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6606</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Cast noble metal inlay 2 sur</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6607</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Cst noble mtl inlay &gt;=3 surf</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6608</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Onlay porc/crmc 2 surfaces</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6609</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Onlay porc/crmc &gt;=3 surfaces</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6610</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Onlay cst hgh nbl mtl 2 srfc</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6611</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Onlay cst hgh nbl mtl &gt;=3srf</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6612</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Onlay cst base mtl 2 surface</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6613</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Onlay cst base mtl &gt;=3 surfa</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6614</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Onlay cst nbl mtl 2 surfaces</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6615</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Onlay cst nbl mtl &gt;=3 surfac</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6720</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Retain crown resin w hi nble</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6721</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown resin w/base metal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6722</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown resin w/noble metal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6740</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown porcelain/ceramic</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6750</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown porcelain high noble</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6751</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown porcelain base metal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6752</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown porcelain noble metal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6780</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown 3/4 high noble metal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6781</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown 3/4 cast based metal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6782</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown 3/4 cast noble metal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6783</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown 3/4 porcelain/ceramic</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6790</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown full high noble metal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6791</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown full base metal cast</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6792</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Crown full noble metal cast</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6793</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Provisional retainer crown</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6920</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Dental connector bar</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6930</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dental recement bridge</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6940</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Stress breaker</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6950</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Precision attachment</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6970</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Post &amp; core plus retainer</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6971</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Cast post bridge retainer</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6972</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Prefab post &amp; core plus reta</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6973</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Core build up for retainer</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6975</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Coping metal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6976</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Each addtnl cast post</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6977</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Each addtl prefab post</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6980</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Bridge repair</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6985</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Pediatric partial denture fx</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D6999</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Fixed prosthodontic proc</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49247"/>
              <ENT I="01">D7111</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Coronal remnants deciduous t</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7140</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Extraction erupted tooth/exr</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7210</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Rem imp tooth w mucoper flp</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7220</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Impact tooth remov soft tiss</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7230</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Impact tooth remov part bony</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7240</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Impact tooth remov comp bony</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7241</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Impact tooth rem bony w/comp</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7250</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Tooth root removal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7260</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Oral antral fistula closure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7261</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Primary closure sinus perf</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7270</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Tooth reimplantation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7272</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Tooth transplantation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7280</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Exposure impact tooth orthod</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7281</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Exposure tooth aid eruption</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7282</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Mobilize erupted/malpos toot</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7285</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Biopsy of oral tissue hard</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7286</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Biopsy of oral tissue soft</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7287</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Cytology sample collection</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7290</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Repositioning of teeth</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7291</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Transseptal fiberotomy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7310</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Alveoplasty w/ extraction</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7320</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Alveoplasty w/o extraction</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7340</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Vestibuloplasty ridge extens</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7350</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Vestibuloplasty exten graft</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7410</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Rad exc lesion up to 1.25 cm</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7411</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Excision benign lesion&gt;1.25c</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7412</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Excision benign lesion compl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7413</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Excision malig lesion&lt;=1.25c</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7414</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Excision malig lesion&gt;1.25cm</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7415</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Excision malig les complicat</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7440</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Malig tumor exc to 1.25 cm</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7441</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Malig tumor &gt; 1.25 cm</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7450</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Rem odontogen cyst to 1.25cm</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7451</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Rem odontogen cyst &gt; 1.25 cm</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7460</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Rem nonodonto cyst to 1.25cm</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7461</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Rem nonodonto cyst &gt; 1.25 cm</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7465</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Lesion destruction</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7471</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Rem exostosis any site</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7472</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Removal of torus palatinus</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7473</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Remove torus mandibularis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7485</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Surg reduct osseoustuberosit</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7490</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Mandible resection</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49248"/>
              <ENT I="01">D7510</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>I&amp;d absc intraoral soft tiss</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7520</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>I&amp;d abscess extraoral</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7530</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Removal fb skin/areolar tiss</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7540</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Removal of fb reaction</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7550</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Removal of sloughed off bone</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7560</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Maxillary sinusotomy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7610</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Maxilla open reduct simple</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7620</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Clsd reduct simpl maxilla fx</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7630</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Open red simpl mandible fx</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7640</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Clsd red simpl mandible fx</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7650</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Open red simp malar/zygom fx</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7660</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Clsd red simp malar/zygom fx</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7670</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Closd rductn splint alveolus</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7671</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Alveolus open reduction</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7680</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Reduct simple facial bone fx</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7710</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Maxilla open reduct compound</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7720</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Clsd reduct compd maxilla fx</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7730</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Open reduct compd mandble fx</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7740</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Clsd reduct compd mandble fx</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7750</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Open red comp malar/zygma fx</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7760</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Clsd red comp malar/zygma fx</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7770</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Open reduc compd alveolus fx</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7771</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Alveolus clsd reduc stblz te</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7780</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Reduct compnd facial bone fx</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7810</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Tmj open reduct-dislocation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7820</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Closed tmp manipulation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7830</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Tmj manipulation under anest</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7840</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Removal of tmj condyle</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7850</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Tmj meniscectomy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7852</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Tmj repair of joint disc</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7854</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Tmj excisn of joint membrane</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7856</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Tmj cutting of a muscle</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7858</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Tmj reconstruction</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7860</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Tmj cutting into joint</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7865</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Tmj reshaping components</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7870</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Tmj aspiration joint fluid</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7871</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Lysis + lavage w catheters</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7872</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Tmj diagnostic arthroscopy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7873</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Tmj arthroscopy lysis adhesn</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7874</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Tmj arthroscopy disc reposit</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7875</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Tmj arthroscopy synovectomy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49249"/>
              <ENT I="01">D7876</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Tmj arthroscopy discectomy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7877</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Tmj arthroscopy debridement</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7880</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Occlusal orthotic appliance</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7899</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Tmj unspecified therapy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7910</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Dent sutur recent wnd to 5cm</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7911</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Dental suture wound to 5 cm</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7912</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Suture complicate wnd &gt; 5 cm</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7920</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Dental skin graft</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7940</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Reshaping bone orthognathic</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7941</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Bone cutting ramus closed</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7943</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Cutting ramus open w/graft</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7944</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Bone cutting segmented</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7945</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Bone cutting body mandible</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7946</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Reconstruction maxilla total</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7947</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Reconstruct maxilla segment</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7948</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Reconstruct midface no graft</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7949</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Reconstruct midface w/graft</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7950</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Mandible graft</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7955</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Repair maxillofacial defects</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7960</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Frenulectomy/frenulotomy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7970</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Excision hyperplastic tissue</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7971</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Excision pericoronal gingiva</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7972</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Surg redct fibrous tuberosit</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7980</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Sialolithotomy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7981</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Excision of salivary gland</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7982</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Sialodochoplasty</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7983</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Closure of salivary fistula</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7990</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Emergency tracheotomy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7991</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Dental coronoidectomy</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7995</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Synthetic graft facial bones</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7996</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Implant mandible for augment</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7997</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Appliance removal</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D7999</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Oral surgery procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D8010</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Limited dental tx primary</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D8020</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Limited dental tx transition</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D8030</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Limited dental tx adolescent</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D8040</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Limited dental tx adult</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D8050</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Intercep dental tx primary</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D8060</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Intercep dental tx transitn</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D8070</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Compre dental tx transition</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D8080</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Compre dental tx adolescent</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D8090</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Compre dental tx adult</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D8210</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Orthodontic rem appliance tx</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49250"/>
              <ENT I="01">D8220</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Fixed appliance therapy habt</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D8660</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Preorthodontic tx visit</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D8670</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Periodic orthodontc tx visit</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D8680</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Orthodontic retention</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D8690</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Orthodontic treatment</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D8691</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Repair ortho appliance</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D8692</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Replacement retainer</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D8999</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Orthodontic procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9110</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Tx dental pain minor proc</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9210</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Dent anesthesia w/o surgery</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9211</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Regional block anesthesia</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9212</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Trigeminal block anesthesia</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9215</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Local anesthesia</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9220</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>General anesthesia</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9221</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>General anesthesia ea ad 15m</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9230</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Analgesia</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9241</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Intravenous sedation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9242</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>IV sedation ea ad 30 m</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9248</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Sedation (non-iv)</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9310</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Dental consultation</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9410</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Dental house call</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9420</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Hospital call</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9430</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Office visit during hours</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9440</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Office visit after hours</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9450</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Case presentation tx plan</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9610</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Dent therapeutic drug inject</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9630</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Other drugs/medicaments</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9910</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Dent appl desensitizing med</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9911</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Appl desensitizing resin</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9920</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Behavior management</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9930</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Treatment of complications</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9940</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Dental occlusal guard</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9941</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Fabrication athletic guard</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9950</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Occlusion analysis</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9951</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Limited occlusal adjustment</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9952</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Complete occlusal adjustment</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9970</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Enamel microabrasion</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9971</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Odontoplasty 1-2 teeth</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9972</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Extrnl bleaching per arch</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9973</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Extrnl bleaching per tooth</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9974</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Intrnl bleaching per tooth</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">D9999</ENT>
              <ENT/>
              <ENT>I</ENT>
              <ENT>Adjunctive procedure</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0001</ENT>
              <ENT/>
              <ENT>X</ENT>
              <ENT>Drawing blood for specimen</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0008</ENT>
              <ENT/>
              <ENT>X</ENT>
              <ENT>Admin influenza virus vac</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0009</ENT>
              <ENT/>
              <ENT>X</ENT>
              <ENT>Admin pneumococcal vaccine</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0010</ENT>
              <ENT/>
              <ENT>X</ENT>
              <ENT>Admin hepatitis b vaccine</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0030</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET imaging prev PET single</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0030</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET imaging prev PET single</ENT>
              <ENT>1.50</ENT>
              <ENT>0.60</ENT>
              <ENT>0.60</ENT>
              <ENT>0.04</ENT>
              <ENT>2.14</ENT>
              <ENT>2.14</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0030</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET imaging prev PET single</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0031</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET imaging prev PET multple</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49251"/>
              <ENT I="01">G0031</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET imaging prev PET multple</ENT>
              <ENT>1.87</ENT>
              <ENT>0.74</ENT>
              <ENT>0.74</ENT>
              <ENT>0.06</ENT>
              <ENT>2.67</ENT>
              <ENT>2.67</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0031</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET imaging prev PET multple</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0032</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET follow SPECT 78464 singl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0032</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET follow SPECT 78464 singl</ENT>
              <ENT>1.50</ENT>
              <ENT>0.56</ENT>
              <ENT>0.56</ENT>
              <ENT>0.05</ENT>
              <ENT>2.11</ENT>
              <ENT>2.11</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0032</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET follow SPECT 78464 singl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0033</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET follow SPECT 78464 mult</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0033</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET follow SPECT 78464 mult</ENT>
              <ENT>1.87</ENT>
              <ENT>0.75</ENT>
              <ENT>0.75</ENT>
              <ENT>0.06</ENT>
              <ENT>2.68</ENT>
              <ENT>2.68</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0033</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET follow SPECT 78464 mult</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0034</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET follow SPECT 76865 singl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0034</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET follow SPECT 76865 singl</ENT>
              <ENT>1.50</ENT>
              <ENT>0.58</ENT>
              <ENT>0.58</ENT>
              <ENT>0.05</ENT>
              <ENT>2.13</ENT>
              <ENT>2.13</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0034</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET follow SPECT 76865 singl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0035</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET follow SPECT 78465 mult</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0035</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET follow SPECT 78465 mult</ENT>
              <ENT>1.87</ENT>
              <ENT>0.74</ENT>
              <ENT>0.74</ENT>
              <ENT>0.06</ENT>
              <ENT>2.67</ENT>
              <ENT>2.67</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0035</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET follow SPECT 78465 mult</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0036</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET follow cornry angio sing</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0036</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET follow cornry angio sing</ENT>
              <ENT>1.50</ENT>
              <ENT>0.58</ENT>
              <ENT>0.58</ENT>
              <ENT>0.04</ENT>
              <ENT>2.12</ENT>
              <ENT>2.12</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0036</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET follow cornry angio sing</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0037</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET follow cornry angio mult</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0037</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET follow cornry angio mult</ENT>
              <ENT>1.87</ENT>
              <ENT>0.73</ENT>
              <ENT>0.73</ENT>
              <ENT>0.06</ENT>
              <ENT>2.66</ENT>
              <ENT>2.66</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0037</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET follow cornry angio mult</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0038</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET follow myocard perf sing</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0038</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET follow myocard perf sing</ENT>
              <ENT>1.50</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>0.04</ENT>
              <ENT>2.08</ENT>
              <ENT>2.08</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0038</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET follow myocard perf sing</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0039</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET follow myocard perf mult</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0039</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET follow myocard perf mult</ENT>
              <ENT>1.87</ENT>
              <ENT>0.73</ENT>
              <ENT>0.73</ENT>
              <ENT>0.07</ENT>
              <ENT>2.67</ENT>
              <ENT>2.67</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0039</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET follow myocard perf mult</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0040</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET follow stress echo singl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0040</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET follow stress echo singl</ENT>
              <ENT>1.50</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>0.04</ENT>
              <ENT>2.15</ENT>
              <ENT>2.15</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0040</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET follow stress echo singl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0041</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET follow stress echo mult</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0041</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET follow stress echo mult</ENT>
              <ENT>1.87</ENT>
              <ENT>0.75</ENT>
              <ENT>0.75</ENT>
              <ENT>0.05</ENT>
              <ENT>2.67</ENT>
              <ENT>2.67</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0041</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET follow stress echo mult</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0042</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET follow ventriculogm sing</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49252"/>
              <ENT I="01">G0042</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET follow ventriculogm sing</ENT>
              <ENT>1.50</ENT>
              <ENT>0.62</ENT>
              <ENT>0.62</ENT>
              <ENT>0.04</ENT>
              <ENT>2.16</ENT>
              <ENT>2.16</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0042</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET follow ventriculogm sing</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0043</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET follow ventriculogm mult</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0043</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET follow ventriculogm mult</ENT>
              <ENT>1.87</ENT>
              <ENT>0.76</ENT>
              <ENT>0.76</ENT>
              <ENT>0.06</ENT>
              <ENT>2.69</ENT>
              <ENT>2.69</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0043</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET follow ventriculogm mult</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0044</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET following rest ECG singl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0044</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET following rest ECG singl</ENT>
              <ENT>1.50</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>0.04</ENT>
              <ENT>2.15</ENT>
              <ENT>2.15</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0044</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET following rest ECG singl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0045</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET following rest ECG mult</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0045</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET following rest ECG mult</ENT>
              <ENT>1.87</ENT>
              <ENT>0.74</ENT>
              <ENT>0.74</ENT>
              <ENT>0.06</ENT>
              <ENT>2.67</ENT>
              <ENT>2.67</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0045</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET following rest ECG mult</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0046</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET follow stress ECG singl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0046</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET follow stress ECG singl</ENT>
              <ENT>1.50</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>0.04</ENT>
              <ENT>2.15</ENT>
              <ENT>2.15</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0046</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET follow stress ECG singl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0047</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET follow stress ECG mult</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0047</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET follow stress ECG mult</ENT>
              <ENT>1.87</ENT>
              <ENT>0.75</ENT>
              <ENT>0.75</ENT>
              <ENT>0.06</ENT>
              <ENT>2.68</ENT>
              <ENT>2.68</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0047</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET follow stress ECG mult</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0101</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>CA screen;pelvic/breast exam</ENT>
              <ENT>0.45</ENT>
              <ENT>0.54</ENT>
              <ENT>0.17</ENT>
              <ENT>0.01</ENT>
              <ENT>1.00</ENT>
              <ENT>0.63</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0102</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Prostate ca screening; dre</ENT>
              <ENT>0.17</ENT>
              <ENT>0.41</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.59</ENT>
              <ENT>0.24</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0104</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>CA screen;flexi sigmoidscope</ENT>
              <ENT>0.96</ENT>
              <ENT>2.25</ENT>
              <ENT>0.53</ENT>
              <ENT>0.05</ENT>
              <ENT>3.26</ENT>
              <ENT>1.54</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0105</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Colorectal scrn; hi risk ind</ENT>
              <ENT>3.70</ENT>
              <ENT>6.30</ENT>
              <ENT>1.68</ENT>
              <ENT>0.20</ENT>
              <ENT>10.20</ENT>
              <ENT>5.58</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0106</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Colon CA screen;barium enema</ENT>
              <ENT>0.99</ENT>
              <ENT>2.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0106</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Colon CA screen;barium enema</ENT>
              <ENT>0.99</ENT>
              <ENT>0.33</ENT>
              <ENT>0.33</ENT>
              <ENT>0.04</ENT>
              <ENT>1.36</ENT>
              <ENT>1.36</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0106</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Colon CA screen;barium enema</ENT>
              <ENT>0.00</ENT>
              <ENT>2.23</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.34</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0108</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Diab manage trn  per indiv</ENT>
              <ENT>0.00</ENT>
              <ENT>0.83</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0109</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Diab manage trn ind/group</ENT>
              <ENT>0.00</ENT>
              <ENT>0.48</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0110</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Nett pulm-rehab educ; ind</ENT>
              <ENT>0.90</ENT>
              <ENT>0.72</ENT>
              <ENT>0.29</ENT>
              <ENT>0.03</ENT>
              <ENT>1.65</ENT>
              <ENT>1.22</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0111</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Nett pulm-rehab educ; group</ENT>
              <ENT>0.27</ENT>
              <ENT>0.30</ENT>
              <ENT>0.14</ENT>
              <ENT>0.01</ENT>
              <ENT>0.58</ENT>
              <ENT>0.42</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0112</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Nett;nutrition guid, initial</ENT>
              <ENT>1.72</ENT>
              <ENT>1.25</ENT>
              <ENT>0.67</ENT>
              <ENT>0.05</ENT>
              <ENT>3.02</ENT>
              <ENT>2.44</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0113</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Nett;nutrition guid,subseqnt</ENT>
              <ENT>1.29</ENT>
              <ENT>0.85</ENT>
              <ENT>0.42</ENT>
              <ENT>0.04</ENT>
              <ENT>2.18</ENT>
              <ENT>1.75</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0114</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Nett; psychosocial consult</ENT>
              <ENT>1.20</ENT>
              <ENT>0.49</ENT>
              <ENT>0.38</ENT>
              <ENT>0.03</ENT>
              <ENT>1.72</ENT>
              <ENT>1.61</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0115</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Nett; psychological testing</ENT>
              <ENT>1.20</ENT>
              <ENT>0.64</ENT>
              <ENT>0.38</ENT>
              <ENT>0.04</ENT>
              <ENT>1.88</ENT>
              <ENT>1.62</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0116</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Nett; psychosocial counsel</ENT>
              <ENT>1.11</ENT>
              <ENT>1.02</ENT>
              <ENT>0.34</ENT>
              <ENT>0.04</ENT>
              <ENT>2.17</ENT>
              <ENT>1.49</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0117</ENT>
              <ENT/>
              <ENT>T</ENT>
              <ENT>Glaucoma scrn hgh risk direc</ENT>
              <ENT>0.45</ENT>
              <ENT>0.72</ENT>
              <ENT>0.19</ENT>
              <ENT>0.02</ENT>
              <ENT>1.19</ENT>
              <ENT>0.66</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0118</ENT>
              <ENT/>
              <ENT>T</ENT>
              <ENT>Glaucoma scrn hgh risk direc</ENT>
              <ENT>0.17</ENT>
              <ENT>0.53</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.71</ENT>
              <ENT>0.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0120</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Colon ca scrn; barium enema</ENT>
              <ENT>0.99</ENT>
              <ENT>2.57</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.71</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0120</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Colon ca scrn; barium enema</ENT>
              <ENT>0.99</ENT>
              <ENT>0.33</ENT>
              <ENT>0.33</ENT>
              <ENT>0.04</ENT>
              <ENT>1.36</ENT>
              <ENT>1.36</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49253"/>
              <ENT I="01">G0120</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Colon ca scrn; barium enema</ENT>
              <ENT>0.00</ENT>
              <ENT>2.23</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.34</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0121</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Colon ca scrn not hi rsk ind</ENT>
              <ENT>3.70</ENT>
              <ENT>6.30</ENT>
              <ENT>1.68</ENT>
              <ENT>0.20</ENT>
              <ENT>10.20</ENT>
              <ENT>5.58</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0122</ENT>
              <ENT/>
              <ENT>N</ENT>
              <ENT>Colon ca scrn; barium enema</ENT>
              <ENT>0.99</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>3.76</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0122</ENT>
              <ENT>26</ENT>
              <ENT>N</ENT>
              <ENT>Colon ca scrn; barium enema</ENT>
              <ENT>0.99</ENT>
              <ENT>0.38</ENT>
              <ENT>0.38</ENT>
              <ENT>0.04</ENT>
              <ENT>1.41</ENT>
              <ENT>1.41</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0122</ENT>
              <ENT>TC</ENT>
              <ENT>N</ENT>
              <ENT>Colon ca scrn; barium enema</ENT>
              <ENT>0.00</ENT>
              <ENT>2.23</ENT>
              <ENT>N/A</ENT>
              <ENT>0.11</ENT>
              <ENT>2.34</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0124</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Screen c/v thin layer by MD</ENT>
              <ENT>0.42</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.01</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0125</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET image pulmonary nodule</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0125</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET image pulmonary nodule</ENT>
              <ENT>1.50</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>0.05</ENT>
              <ENT>2.09</ENT>
              <ENT>2.09</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0125</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET image pulmonary nodule</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0127</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Trim nail(s)</ENT>
              <ENT>0.17</ENT>
              <ENT>0.26</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.44</ENT>
              <ENT>0.25</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0128</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>CORF skilled nursing service</ENT>
              <ENT>0.08</ENT>
              <ENT>0.03</ENT>
              <ENT>0.03</ENT>
              <ENT>0.01</ENT>
              <ENT>0.12</ENT>
              <ENT>0.12</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0130</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Single energy x-ray study</ENT>
              <ENT>0.22</ENT>
              <ENT>0.88</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>1.15</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0130</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Single energy x-ray study</ENT>
              <ENT>0.22</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.30</ENT>
              <ENT>0.30</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0130</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Single energy x-ray study</ENT>
              <ENT>0.00</ENT>
              <ENT>0.80</ENT>
              <ENT>N/A</ENT>
              <ENT>0.04</ENT>
              <ENT>0.84</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0141</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Scr c/v cyto,autosys and md</ENT>
              <ENT>0.42</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.01</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0166</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Extrnl counterpulse, per tx</ENT>
              <ENT>0.07</ENT>
              <ENT>2.93</ENT>
              <ENT>0.03</ENT>
              <ENT>0.01</ENT>
              <ENT>3.01</ENT>
              <ENT>0.11</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0167</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Hyperbaric oz tx;no md reqrd</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0168</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Wound closure by adhesive</ENT>
              <ENT>0.45</ENT>
              <ENT>2.03</ENT>
              <ENT>0.16</ENT>
              <ENT>0.01</ENT>
              <ENT>2.49</ENT>
              <ENT>0.62</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0179</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>MD recertification HHA PT</ENT>
              <ENT>0.45</ENT>
              <ENT>1.09</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>1.55</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0180</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>MD certification HHA patient</ENT>
              <ENT>0.67</ENT>
              <ENT>1.32</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>2.01</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0181</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Home health care supervision</ENT>
              <ENT>1.73</ENT>
              <ENT>1.56</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>3.35</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0182</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Hospice care supervision</ENT>
              <ENT>1.73</ENT>
              <ENT>1.75</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>3.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0186</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Dstry eye lesn,fdr vssl tech</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>YYY </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0202</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Screeningmammographydigital</ENT>
              <ENT>0.70</ENT>
              <ENT>2.78</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>3.57</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0202</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Screeningmammographydigital</ENT>
              <ENT>0.70</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.03</ENT>
              <ENT>0.96</ENT>
              <ENT>0.96</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0202</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Screeningmammographydigital</ENT>
              <ENT>0.00</ENT>
              <ENT>2.54</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>2.60</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0204</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Diagnosticmammographydigital</ENT>
              <ENT>0.87</ENT>
              <ENT>2.80</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>3.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0204</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Diagnosticmammographydigital</ENT>
              <ENT>0.87</ENT>
              <ENT>0.29</ENT>
              <ENT>0.29</ENT>
              <ENT>0.04</ENT>
              <ENT>1.20</ENT>
              <ENT>1.20</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0204</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Diagnosticmammographydigital</ENT>
              <ENT>0.00</ENT>
              <ENT>2.50</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>2.56</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0206</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Diagnosticmammographydigital</ENT>
              <ENT>0.70</ENT>
              <ENT>2.26</ENT>
              <ENT>N/A</ENT>
              <ENT>0.09</ENT>
              <ENT>3.05</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0206</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Diagnosticmammographydigital</ENT>
              <ENT>0.70</ENT>
              <ENT>0.23</ENT>
              <ENT>0.23</ENT>
              <ENT>0.04</ENT>
              <ENT>0.97</ENT>
              <ENT>0.97</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0206</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Diagnosticmammographydigital</ENT>
              <ENT>0.00</ENT>
              <ENT>2.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.05</ENT>
              <ENT>2.07</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0210</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET img wholebody dxlung</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0210</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET img wholebody dxlung</ENT>
              <ENT>1.50</ENT>
              <ENT>0.52</ENT>
              <ENT>0.52</ENT>
              <ENT>0.04</ENT>
              <ENT>2.06</ENT>
              <ENT>2.06</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0210</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET img wholebody dxlung</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0211</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET img wholbody init lung</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49254"/>
              <ENT I="01">G0211</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET img wholbody init lung</ENT>
              <ENT>1.50</ENT>
              <ENT>0.52</ENT>
              <ENT>0.52</ENT>
              <ENT>0.04</ENT>
              <ENT>2.06</ENT>
              <ENT>2.06</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0211</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET img wholbody init lung</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0212</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET img wholebod restag lung</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0212</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET img wholebod restag lung</ENT>
              <ENT>1.50</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>0.04</ENT>
              <ENT>2.07</ENT>
              <ENT>2.07</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0212</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET img wholebod restag lung</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0213</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET img wholbody dx</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0213</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET img wholbody dx</ENT>
              <ENT>1.50</ENT>
              <ENT>0.52</ENT>
              <ENT>0.52</ENT>
              <ENT>0.04</ENT>
              <ENT>2.06</ENT>
              <ENT>2.06</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0213</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET img wholbody dx</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0214</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET img wholebod init</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0214</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET img wholebod init</ENT>
              <ENT>1.50</ENT>
              <ENT>0.52</ENT>
              <ENT>0.52</ENT>
              <ENT>0.04</ENT>
              <ENT>2.06</ENT>
              <ENT>2.06</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0214</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET img wholebod init</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0215</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PETimg wholebod restag</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0215</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PETimg wholebod restag</ENT>
              <ENT>1.50</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>0.04</ENT>
              <ENT>2.07</ENT>
              <ENT>2.07</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0215</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PETimg wholebod restag</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0216</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET img wholebod dx melanoma</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0216</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET img wholebod dx melanoma</ENT>
              <ENT>1.50</ENT>
              <ENT>0.52</ENT>
              <ENT>0.52</ENT>
              <ENT>0.04</ENT>
              <ENT>2.06</ENT>
              <ENT>2.06</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0216</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET img wholebod dx melanoma</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0217</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET img wholebod init melan</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0217</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET img wholebod init melan</ENT>
              <ENT>1.50</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>0.04</ENT>
              <ENT>2.07</ENT>
              <ENT>2.07</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0217</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET img wholebod init melan</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0218</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET img wholebod restag mela</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0218</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET img wholebod restag mela</ENT>
              <ENT>1.50</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>0.04</ENT>
              <ENT>2.07</ENT>
              <ENT>2.07</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0218</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET img wholebod restag mela</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0220</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET img wholebod dx lymphoma</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0220</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET img wholebod dx lymphoma</ENT>
              <ENT>1.50</ENT>
              <ENT>0.52</ENT>
              <ENT>0.52</ENT>
              <ENT>0.04</ENT>
              <ENT>2.06</ENT>
              <ENT>2.06</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0220</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET img wholebod dx lymphoma</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0221</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET imag wholbod init lympho</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0221</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET imag wholbod init lympho</ENT>
              <ENT>1.50</ENT>
              <ENT>0.52</ENT>
              <ENT>0.52</ENT>
              <ENT>0.04</ENT>
              <ENT>2.06</ENT>
              <ENT>2.06</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0221</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET imag wholbod init lympho</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0222</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET imag wholbod resta lymph</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0222</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET imag wholbod resta lymph</ENT>
              <ENT>1.50</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>0.04</ENT>
              <ENT>2.07</ENT>
              <ENT>2.07</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0222</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET imag wholbod resta lymph</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0223</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET imag wholbod reg dx head</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0223</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET imag wholbod reg dx head</ENT>
              <ENT>1.50</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>0.04</ENT>
              <ENT>2.07</ENT>
              <ENT>2.07</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0223</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET imag wholbod reg dx head</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0224</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET imag wholbod reg ini hea</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0224</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET imag wholbod reg ini hea</ENT>
              <ENT>1.50</ENT>
              <ENT>0.52</ENT>
              <ENT>0.52</ENT>
              <ENT>0.04</ENT>
              <ENT>2.06</ENT>
              <ENT>2.06</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49255"/>
              <ENT I="01">G0224</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET imag wholbod reg ini hea</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0225</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET whol restag headneckonly</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0225</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET whol restag headneckonly</ENT>
              <ENT>1.50</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>0.04</ENT>
              <ENT>2.07</ENT>
              <ENT>2.07</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0225</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET whol restag headneckonly</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0226</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET img wholbody dx esophagl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0226</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET img wholbody dx esophagl</ENT>
              <ENT>1.50</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>0.04</ENT>
              <ENT>2.08</ENT>
              <ENT>2.08</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0226</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET img wholbody dx esophagl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0227</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET img wholbod ini esophage</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0227</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET img wholbod ini esophage</ENT>
              <ENT>1.50</ENT>
              <ENT>0.54</ENT>
              <ENT>0.54</ENT>
              <ENT>0.04</ENT>
              <ENT>2.08</ENT>
              <ENT>2.08</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0227</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET img wholbod ini esophage</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0228</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET img wholbod restg esopha</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0228</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET img wholbod restg esopha</ENT>
              <ENT>1.50</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>0.04</ENT>
              <ENT>2.07</ENT>
              <ENT>2.07</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0228</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET img wholbod restg esopha</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0229</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET img metaboloc brain pres</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0229</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET img metaboloc brain pres</ENT>
              <ENT>1.50</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>0.04</ENT>
              <ENT>2.07</ENT>
              <ENT>2.07</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0229</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET img metaboloc brain pres</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0230</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET myocard viability post</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0230</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET myocard viability post</ENT>
              <ENT>1.50</ENT>
              <ENT>0.55</ENT>
              <ENT>0.55</ENT>
              <ENT>0.04</ENT>
              <ENT>2.09</ENT>
              <ENT>2.09</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0230</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET myocard viability post</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0231</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET WhBD colorec; gamma cam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0231</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET WhBD colorec; gamma cam</ENT>
              <ENT>1.50</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>0.04</ENT>
              <ENT>2.07</ENT>
              <ENT>2.07</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0231</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET WhBD colorec; gamma cam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0232</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET whbd lymphoma; gamma cam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0232</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET whbd lymphoma; gamma cam</ENT>
              <ENT>1.50</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>0.04</ENT>
              <ENT>2.07</ENT>
              <ENT>2.07</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0232</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET whbd lymphoma; gamma cam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0233</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET whbd melanoma; gamma cam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0233</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET whbd melanoma; gamma cam</ENT>
              <ENT>1.50</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>0.04</ENT>
              <ENT>2.07</ENT>
              <ENT>2.07</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0233</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET whbd melanoma; gamma cam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0234</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET WhBD pulm nod; gamma cam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0234</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET WhBD pulm nod; gamma cam</ENT>
              <ENT>1.50</ENT>
              <ENT>0.53</ENT>
              <ENT>0.53</ENT>
              <ENT>0.04</ENT>
              <ENT>2.07</ENT>
              <ENT>2.07</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0234</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET WhBD pulm nod; gamma cam</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0236</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Digital film convert diag ma</ENT>
              <ENT>0.06</ENT>
              <ENT>0.44</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.52</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0236</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Digital film convert diag ma</ENT>
              <ENT>0.06</ENT>
              <ENT>0.02</ENT>
              <ENT>0.02</ENT>
              <ENT>0.01</ENT>
              <ENT>0.09</ENT>
              <ENT>0.09</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0236</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Digital film convert diag ma</ENT>
              <ENT>0.00</ENT>
              <ENT>0.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.43</ENT>
              <ENT>N/A</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49256"/>
              <ENT I="01">G0237</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Therapeutic procd strg endur</ENT>
              <ENT>0.00</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.49</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0238</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Oth resp proc, indiv</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0239</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Oth resp proc, group</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0245</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Initial foot exam pt lops</ENT>
              <ENT>0.88</ENT>
              <ENT>0.81</ENT>
              <ENT>0.32</ENT>
              <ENT>0.05</ENT>
              <ENT>1.74</ENT>
              <ENT>1.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0246</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Followup eval of foot pt lop</ENT>
              <ENT>0.45</ENT>
              <ENT>0.56</ENT>
              <ENT>0.16</ENT>
              <ENT>0.02</ENT>
              <ENT>1.03</ENT>
              <ENT>0.63</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0247</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Routine footcare pt w lops</ENT>
              <ENT>0.50</ENT>
              <ENT>0.54</ENT>
              <ENT>0.21</ENT>
              <ENT>0.05</ENT>
              <ENT>1.09</ENT>
              <ENT>0.76</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0248</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Demonstrate use home inr mon</ENT>
              <ENT>0.00</ENT>
              <ENT>6.92</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>6.93</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0249</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Provide test material,equipm</ENT>
              <ENT>0.00</ENT>
              <ENT>4.12</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>4.13</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0250</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>MD review interpret of test</ENT>
              <ENT>0.18</ENT>
              <ENT>0.06</ENT>
              <ENT>0.06</ENT>
              <ENT>0.01</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0252</ENT>
              <ENT>26</ENT>
              <ENT>N</ENT>
              <ENT>PET imaging initial dx</ENT>
              <ENT>1.50</ENT>
              <ENT>0.58</ENT>
              <ENT>0.58</ENT>
              <ENT>0.04</ENT>
              <ENT>2.12</ENT>
              <ENT>2.12</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0253</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET image brst dection recur</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0253</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET image brst dection recur</ENT>
              <ENT>1.87</ENT>
              <ENT>0.72</ENT>
              <ENT>0.72</ENT>
              <ENT>0.07</ENT>
              <ENT>2.66</ENT>
              <ENT>2.66</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0253</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET image brst dection recur</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0254</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>PET image brst eval to tx</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0254</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>PET image brst eval to tx</ENT>
              <ENT>1.87</ENT>
              <ENT>0.72</ENT>
              <ENT>0.72</ENT>
              <ENT>0.07</ENT>
              <ENT>2.66</ENT>
              <ENT>2.66</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0254</ENT>
              <ENT>TC</ENT>
              <ENT>C</ENT>
              <ENT>PET image brst eval to tx</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0262</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Sm intestinal image capsule</ENT>
              <ENT>2.12</ENT>
              <ENT>20.88</ENT>
              <ENT>N/A</ENT>
              <ENT>0.08</ENT>
              <ENT>23.08</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0262</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Sm intestinal image capsule</ENT>
              <ENT>2.12</ENT>
              <ENT>0.82</ENT>
              <ENT>0.82</ENT>
              <ENT>0.02</ENT>
              <ENT>2.96</ENT>
              <ENT>2.96</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0262</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Sm intestinal image capsule</ENT>
              <ENT>0.00</ENT>
              <ENT>20.06</ENT>
              <ENT>N/A</ENT>
              <ENT>0.06</ENT>
              <ENT>20.12</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0268</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Removal of impacted wax md</ENT>
              <ENT>0.61</ENT>
              <ENT>0.66</ENT>
              <ENT>0.25</ENT>
              <ENT>0.04</ENT>
              <ENT>1.31</ENT>
              <ENT>0.90</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0270</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>MNT subs tx for change dx</ENT>
              <ENT>0.00</ENT>
              <ENT>0.47</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.48</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0271</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Group MNT 2 or more 30 mins</ENT>
              <ENT>0.00</ENT>
              <ENT>0.18</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.19</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0272</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Naso/oro gastric tube pl MD</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>0.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.46</ENT>
              <ENT>000 </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0273</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Pretx planning, non-Hodgkins</ENT>
              <ENT>0.86</ENT>
              <ENT>11.40</ENT>
              <ENT>N/A</ENT>
              <ENT>0.28</ENT>
              <ENT>12.54</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0273</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Pretx planning, non-Hodgkins</ENT>
              <ENT>0.86</ENT>
              <ENT>0.33</ENT>
              <ENT>0.33</ENT>
              <ENT>0.03</ENT>
              <ENT>1.22</ENT>
              <ENT>1.22</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0273</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Pretx planning, non-Hodgkins</ENT>
              <ENT>0.00</ENT>
              <ENT>11.06</ENT>
              <ENT>N/A</ENT>
              <ENT>0.25</ENT>
              <ENT>11.31</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0274</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Radiopharm tx, non-Hodgkins</ENT>
              <ENT>2.07</ENT>
              <ENT>3.42</ENT>
              <ENT>N/A</ENT>
              <ENT>0.20</ENT>
              <ENT>5.69</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0274</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Radiopharm tx, non-Hodgkins</ENT>
              <ENT>2.07</ENT>
              <ENT>0.80</ENT>
              <ENT>0.80</ENT>
              <ENT>0.08</ENT>
              <ENT>2.95</ENT>
              <ENT>2.95</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0274</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Radiopharm tx, non-Hodgkins</ENT>
              <ENT>0.00</ENT>
              <ENT>2.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.12</ENT>
              <ENT>2.74</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0275</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Renal angio, cardiac cath</ENT>
              <ENT>0.25</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>0.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0278</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Iliac art angio,cardiac cath</ENT>
              <ENT>0.25</ENT>
              <ENT>N/A</ENT>
              <ENT>0.10</ENT>
              <ENT>0.01</ENT>
              <ENT>N/A</ENT>
              <ENT>0.36</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0279</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Excorp shock tx, elbow epi</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0280</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Excorp shock tx other than</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0281</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Elec stim unattend for press</ENT>
              <ENT>0.18</ENT>
              <ENT>0.11</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0283</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Elec stim other than wound</ENT>
              <ENT>0.18</ENT>
              <ENT>0.11</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.30</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0288</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Recon, CTA for surg plan</ENT>
              <ENT>0.00</ENT>
              <ENT>10.62</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>10.77</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">G0289</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Arthro, loose body + chondro</ENT>
              <ENT>1.48</ENT>
              <ENT>N/A</ENT>
              <ENT>0.57</ENT>
              <ENT>0.27</ENT>
              <ENT>N/A</ENT>
              <ENT>2.32</ENT>
              <ENT>ZZZ </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Gxx10</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ESRDrelsvc 1/mo; 2-11yr</ENT>
              <ENT>2.32</ENT>
              <ENT>1.14</ENT>
              <ENT>1.14</ENT>
              <ENT>0.10</ENT>
              <ENT>3.56</ENT>
              <ENT>3.56</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Gxx11</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ESRDrelsvc 4+/mo; 12-19yr</ENT>
              <ENT>8.47</ENT>
              <ENT>4.54</ENT>
              <ENT>4.54</ENT>
              <ENT>0.35</ENT>
              <ENT>13.36</ENT>
              <ENT>13.36</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Gxx12</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ESRDrelsvc 2-3/mo; 12-19yr</ENT>
              <ENT>3.14</ENT>
              <ENT>1.68</ENT>
              <ENT>1.68</ENT>
              <ENT>0.13</ENT>
              <ENT>4.95</ENT>
              <ENT>4.95</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Gxx13</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ESRDrelsvc 1/mo; 12-19yr</ENT>
              <ENT>2.05</ENT>
              <ENT>1.10</ENT>
              <ENT>1.10</ENT>
              <ENT>0.08</ENT>
              <ENT>3.23</ENT>
              <ENT>3.23</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <PRTPAGE P="49257"/>
              <ENT I="01">Gxx14</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ESRDrelsvc 4+/mo; 20+yr</ENT>
              <ENT>5.16</ENT>
              <ENT>2.94</ENT>
              <ENT>2.94</ENT>
              <ENT>0.22</ENT>
              <ENT>8.32</ENT>
              <ENT>8.32</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Gxx15</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ESRDrelsvc 2-3/mo; 20+yr</ENT>
              <ENT>1.94</ENT>
              <ENT>1.10</ENT>
              <ENT>1.10</ENT>
              <ENT>0.08</ENT>
              <ENT>3.12</ENT>
              <ENT>3.12</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Gxx16</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ESRDrelsvc 1/mo; 20+yr</ENT>
              <ENT>1.27</ENT>
              <ENT>0.73</ENT>
              <ENT>0.73</ENT>
              <ENT>0.06</ENT>
              <ENT>2.06</ENT>
              <ENT>2.06</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Gxxx1</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Monitor arrhyth/30day</ENT>
              <ENT>0.52</ENT>
              <ENT>7.45</ENT>
              <ENT>N/A</ENT>
              <ENT>0.24</ENT>
              <ENT>8.21</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Gxxx2</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Monitor arrhyth/30day;rec</ENT>
              <ENT>0.00</ENT>
              <ENT>1.24</ENT>
              <ENT>N/A</ENT>
              <ENT>0.07</ENT>
              <ENT>1.31</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Gxxx3</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Monitor arrhyth/30day;analy</ENT>
              <ENT>0.00</ENT>
              <ENT>6.02</ENT>
              <ENT>N/A</ENT>
              <ENT>0.15</ENT>
              <ENT>6.17</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Gxxx4</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Monitor arrhyth/30day;interp</ENT>
              <ENT>0.52</ENT>
              <ENT>0.19</ENT>
              <ENT>0.19</ENT>
              <ENT>0.02</ENT>
              <ENT>0.73</ENT>
              <ENT>0.73</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Gxxx5</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ESRDrelsvc 4+/mo; undr2</ENT>
              <ENT>12.92</ENT>
              <ENT>8.70</ENT>
              <ENT>8.70</ENT>
              <ENT>0.60</ENT>
              <ENT>22.22</ENT>
              <ENT>22.22</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Gxxx6</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ESRDrelsvc 2-3/mo; undr2</ENT>
              <ENT>5.19</ENT>
              <ENT>3.49</ENT>
              <ENT>3.49</ENT>
              <ENT>0.24</ENT>
              <ENT>8.92</ENT>
              <ENT>8.92</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Gxxx7</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ESRDrelsvc 1/mo; undr2</ENT>
              <ENT>3.39</ENT>
              <ENT>2.29</ENT>
              <ENT>2.29</ENT>
              <ENT>0.16</ENT>
              <ENT>5.84</ENT>
              <ENT>5.84</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Gxxx8</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ESRDrelsvc 4+/mo; 2-11yr</ENT>
              <ENT>9.91</ENT>
              <ENT>4.86</ENT>
              <ENT>4.86</ENT>
              <ENT>0.43</ENT>
              <ENT>15.20</ENT>
              <ENT>15.20</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Gxxx9</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>ESRDrelsvc 2-3/mo; 2-11yr</ENT>
              <ENT>3.55</ENT>
              <ENT>1.74</ENT>
              <ENT>1.74</ENT>
              <ENT>0.15</ENT>
              <ENT>5.44</ENT>
              <ENT>5.44</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">M0064</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Visit for drug monitoring</ENT>
              <ENT>0.37</ENT>
              <ENT>0.34</ENT>
              <ENT>0.12</ENT>
              <ENT>0.01</ENT>
              <ENT>0.72</ENT>
              <ENT>0.50</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">P3001</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Screening pap smear by phys</ENT>
              <ENT>0.42</ENT>
              <ENT>0.18</ENT>
              <ENT>0.18</ENT>
              <ENT>0.01</ENT>
              <ENT>0.61</ENT>
              <ENT>0.61</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Q0035</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Cardiokymography</ENT>
              <ENT>0.17</ENT>
              <ENT>0.45</ENT>
              <ENT>N/A</ENT>
              <ENT>0.03</ENT>
              <ENT>0.65</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Q0035</ENT>
              <ENT>26</ENT>
              <ENT>A</ENT>
              <ENT>Cardiokymography</ENT>
              <ENT>0.17</ENT>
              <ENT>0.07</ENT>
              <ENT>0.07</ENT>
              <ENT>0.01</ENT>
              <ENT>0.25</ENT>
              <ENT>0.25</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Q0035</ENT>
              <ENT>TC</ENT>
              <ENT>A</ENT>
              <ENT>Cardiokymography</ENT>
              <ENT>0.00</ENT>
              <ENT>0.39</ENT>
              <ENT>N/A</ENT>
              <ENT>0.02</ENT>
              <ENT>0.41</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Q0091</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Obtaining screen pap smear</ENT>
              <ENT>0.37</ENT>
              <ENT>0.68</ENT>
              <ENT>0.14</ENT>
              <ENT>0.01</ENT>
              <ENT>1.06</ENT>
              <ENT>0.52</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">Q0092</ENT>
              <ENT/>
              <ENT>A</ENT>
              <ENT>Set up port xray equipment</ENT>
              <ENT>0.00</ENT>
              <ENT>0.32</ENT>
              <ENT>N/A</ENT>
              <ENT>0.01</ENT>
              <ENT>0.33</ENT>
              <ENT>N/A</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">R0070</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Transport portable x-ray</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">R0075</ENT>
              <ENT/>
              <ENT>C</ENT>
              <ENT>Transport port x-ray multipl</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">V5299</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Hearing service</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">V5362</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Speech screening</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">V5363</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Language screening</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <ROW>
              <ENT I="01">V5364</ENT>
              <ENT/>
              <ENT>R</ENT>
              <ENT>Dysphagia screening</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>0.00</ENT>
              <ENT>XXX </ENT>
            </ROW>
            <TNOTE>
              <SU>1</SU> CPT codes and descriptions only are copyright American Medical Association. All Right Reserved. Applicable FARS/DFARS Apply. </TNOTE>
            <TNOTE>
              <SU>2</SU> Copyright American Dental Association. All right reserved. </TNOTE>
          </GPOTABLE>
          <OLNOTES>
            <FNRUL> </FNRUL>
            <OLNOTE1> </OLNOTE1>
            <OLNOTE1 SOURCE="OLNOTE2"> </OLNOTE1>
          </OLNOTES>
          <NOLPAGES/>
          <PRTPAGE P="49257"/>
          <P> </P>
          <BILCOD>BILLING CODE 4120-01-P </BILCOD>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49258"/>
            <GID>EP15AU03.017</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49259"/>
            <GID>EP15AU03.018</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49260"/>
            <GID>EP15AU03.019</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49261"/>
            <GID>EP15AU03.020</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49262"/>
            <GID>EP15AU03.021</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49263"/>
            <GID>EP15AU03.022</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49264"/>
            <GID>EP15AU03.023</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49265"/>
            <GID>EP15AU03.024</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49266"/>
            <GID>EP15AU03.025</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49267"/>
            <GID>EP15AU03.026</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49268"/>
            <GID>EP15AU03.027</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49269"/>
            <GID>EP15AU03.028</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49270"/>
            <GID>EP15AU03.029</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49271"/>
            <GID>EP15AU03.030</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49272"/>
            <GID>EP15AU03.031</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49273"/>
            <GID>EP15AU03.032</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49274"/>
            <GID>EP15AU03.033</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49275"/>
            <GID>EP15AU03.034</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49276"/>
            <GID>EP15AU03.035</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49277"/>
            <GID>EP15AU03.036</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49278"/>
            <GID>EP15AU03.037</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49279"/>
            <GID>EP15AU03.038</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49280"/>
            <GID>EP15AU03.039</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49281"/>
            <GID>EP15AU03.040</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49282"/>
            <GID>EP15AU03.041</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49283"/>
            <GID>EP15AU03.042</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49284"/>
            <GID>EP15AU03.043</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49285"/>
            <GID>EP15AU03.044</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49286"/>
            <GID>EP15AU03.045</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49287"/>
            <GID>EP15AU03.046</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49288"/>
            <GID>EP15AU03.047</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49289"/>
            <GID>EP15AU03.048</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49290"/>
            <GID>EP15AU03.049</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49291"/>
            <GID>EP15AU03.050</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49292"/>
            <GID>EP15AU03.051</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49293"/>
            <GID>EP15AU03.052</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49294"/>
            <GID>EP15AU03.053</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49295"/>
            <GID>EP15AU03.054</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49296"/>
            <GID>EP15AU03.055</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49297"/>
            <GID>EP15AU03.056</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49298"/>
            <GID>EP15AU03.057</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49299"/>
            <GID>EP15AU03.058</GID>
          </GPH>
          <GPH DEEP="640" SPAN="3">
            <PRTPAGE P="49300"/>
            <GID>EP15AU03.059</GID>
          </GPH>
        </SUPLINF>
        <FRDOC>[FR Doc. 03-20662 Filed 8-8-03; 3:56 pm] </FRDOC>
        <BILCOD>BILLING CODE 4120-01-C</BILCOD>
      </PRORULE>
    </PRORULES>
  </NEWPART>
  <VOL>68</VOL>
  <NO>158</NO>
  <DATE>Friday, August 15, 2003</DATE>
  <UNITNAME>Notices</UNITNAME>
  <NEWPART>
    <PTITLE>
      <PRTPAGE P="49301"/>
      <PARTNO>Part IV</PARTNO>
      <AGENCY TYPE="P">Department of Labor</AGENCY>
      <SUBAGY>Employee Benefits Security Administration</SUBAGY>
      <HRULE/>
      <TITLE>Proposed Exemptions; Liberty Media 401(k) Savings Plan (the Plan); Notice</TITLE>
    </PTITLE>
    <NOTICES>
      <NOTICE>
        <PREAMB>
          <PRTPAGE P="49302"/>
          <AGENCY TYPE="S">DEPARTMENT OF LABOR </AGENCY>
          <SUBAGY>Employee Benefits Security Administration </SUBAGY>
          <DEPDOC>[Application No. D-11170, et al.] </DEPDOC>
          <SUBJECT>Proposed Exemptions; Liberty Media 401(k) Savings Plan (the Plan) </SUBJECT>
          <AGY>
            <HD SOURCE="HED">AGENCY:</HD>
            <P>Employee Benefits Security Administration, Labor. </P>
          </AGY>
          <ACT>
            <HD SOURCE="HED">ACTION:</HD>
            <P>Notice of Proposed Exemptions. </P>
          </ACT>
          <SUM>
            <HD SOURCE="HED">SUMMARY:</HD>
            <P>This document contains notices of pendency before the Department of Labor (the Department) of proposed exemptions from certain of the prohibited transaction restrictions of the Employee Retirement Income Security Act of 1974 (the Act) and/or the Internal Revenue Code of 1986 (the Code). </P>
            <HD SOURCE="HD1">Written Comments and Hearing Requests </HD>

            <P>All interested persons are invited to submit written comments or requests for a hearing on the pending exemptions, unless otherwise stated in the Notice of Proposed Exemption, within 45 days from the date of publication of this <E T="04">Federal Register</E> Notice. Comments and requests for a hearing should state: (1) The name, address, and telephone number of the person making the comment or request, and (2) the nature of the person's interest in the exemption and the manner in which the person would be adversely affected by the exemption. A request for a hearing must also state the issues to be addressed and include a general description of the evidence to be presented at the hearing. </P>
          </SUM>
          <ADD>
            <HD SOURCE="HED">ADDRESSES:</HD>

            <P>All written comments and requests for a hearing (at least three copies) should be sent to the Employee Benefits Security Administration (EBSA), Office of Exemption Determinations, Room N-5649, U.S. Department of Labor, 200 Constitution Avenue, NW., Washington, DC 20210. Attention: Application No. ___, stated in each Notice of Proposed Exemption. Interested persons are also invited to submit comments and/or hearing requests to EBSA via e-mail or FAX. Any such comments or requests should be sent either by e-mail to: <E T="03">“moffitt.betty@dol.gov”</E>, or by FAX to (202) 219-0204 by the end of the scheduled comment period. The applications for exemption and the comments received will be available for public inspection in the Public Documents Room of the Employee Benefits Security Administration, U.S. Department of Labor, Room N-1513, 200 Constitution Avenue, NW., Washington, DC 20210. </P>
          </ADD>
          <HD SOURCE="HD1">Notice to Interested Persons </HD>

          <P>Notice of the proposed exemptions will be provided to all interested persons in the manner agreed upon by the applicant and the Department within 15 days of the date of publication in the <E T="04">Federal Register</E>. Such notice shall include a copy of the notice of proposed exemption as published in the <E T="04">Federal Register</E> and shall inform interested persons of their right to comment and to request a hearing (where appropriate). </P>
        </PREAMB>
        <SUPLINF>
          <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD>
          <P>The proposed exemptions were requested in applications filed pursuant to section 408(a) of the Act and/or section 4975(c)(2) of the Code, and in accordance with procedures set forth in 29 CFR part 2570, subpart B (55 FR 32836, 32847, August 10, 1990). Effective December 31, 1978, section 102 of Reorganization Plan No. 4 of 1978, 5 U.S.C. App. 1 (1996), transferred the authority of the Secretary of the Treasury to issue exemptions of the type requested to the Secretary of Labor. Therefore, these notices of proposed exemption are issued solely by the Department. </P>
          <P>The applications contain representations with regard to the proposed exemptions which are summarized below. Interested persons are referred to the applications on file with the Department for a complete statement of the facts and representations.</P>
          <FP SOURCE="FP-1">Liberty Media 401(k) Savings Plan (the Plan) </FP>
          <FP SOURCE="FP-1">Located in Englewood, Colorado </FP>
          <FP SOURCE="FP-1">[Application No. D-11170]. </FP>
          <HD SOURCE="HD1">Proposed Exemption </HD>
          <P>The Department is considering granting an exemption under the authority of section 408(a) of the Act and section 4975(c)(2) of the Code and in accordance with the procedures set forth in 29 CFR part 2570, subpart B (55 FR 32836, August 10, 1990). If the exemption is granted, the restrictions of sections 406(a), 406(b)(1) and (b)(2) and 407(a) of the Act and the sanctions resulting from the application of section 4975 of the Code, by reason of section 4975(c)(1)(A) through (E) of the Code, shall not apply, effective November 25, 2002, to (1) The acquisition of certain stock rights (the Rights) by the Plan in connection with a Rights offering by Liberty Media Corporation (LMC), a party in interest with respect to the Plan; (2) the holding of the Rights by the Plan during the subscription period of the offering; and (3) the exercise of the Rights by the Plan, provided that the following conditions were met: </P>
          <P>(a) The Rights were acquired pursuant to Plan provisions for individually-directed investment of such accounts; </P>
          <P>(b) The Plan's receipt of the Rights occurred in connection with the Rights offering made available to all shareholders of common stock of LMC; </P>
          <P>(c) All decisions regarding the holding and disposition of the Rights by the Plan were made, in accordance with the Plan provisions for individually-directed investment of participant accounts, by the individual Plan participants whose accounts in the Plan received the Rights in connection with the offering; </P>
          <P>(d) The Plan's acquisition of the Rights resulted from an independent act of LMC as a corporate entity, and all holders of the Rights, including the Plan, were treated in the same manner with respect to the acquisition; and </P>
          <P>(e) The Plan received the same proportionate number of the Rights as other owners of Liberty Media Series A and Series B common stock (the Stock). </P>
          <P>This exemption, if granted, will be effective as of November 25, 2002. </P>
          <HD SOURCE="HD2">Summary of Facts and Representations </HD>
          <P>1. The Plan is a defined contribution plan that is intended to satisfy the requirements of Code Sections 401(a) and 401(k). As of December 31, 2001, the Plan had approximately 3,466 participants and total assets of $104,044,000. The shares of LMC common stock held by the Plan were valued at $46,265,000 as of December 31, 2001, and comprised approximately 44.8% percent of the total assets in the Plan. </P>
          <P>The Plan permits participants to contribute a portion of their respective annual compensation to the Plan as a salary reduction contribution under Code Section 401(k). LMC makes a matching contribution to the Plan, which differs for different groups of employees. Participant salary reduction contributions are immediately 100% vested. The matching contributions are vested according to a schedule based on the years of service each participant has completed. The stock received from exercising the Rights will be vested according to the Plan vesting schedule. </P>

          <P>2. The trustee of the Plan is Fidelity Management Trust Company (the Trustee). The Trustee acts as the custodian of Plan assets, holding legal title to the assets, and executing investment directions in accordance with the participants' written instructions. The Plan Administrative Committee is the fiduciary responsible for Plan matters. The Plan allows participants to direct investments of their 401(k) contributions into one of 18 investment categories, including the <PRTPAGE P="49303"/>Liberty Media Common Stock Fund. Matching contributions always are invested in the Liberty Media Common Stock Fund. </P>
          <P>LMC owns interests in a broad range of video programming, broadband distribution, interactive technology services and communications businesses. LMC and its affiliated companies operate in the United States, Europe, South America, and Asia. </P>
          <P>3. LMC announced a special rights offering. Holders of record of the Stock on October 31, 2002 (the Record Date), each received 0.04 of a transferable subscription Right for each share of Series A and Series B common stock held. Each whole Right entitled the holder to purchase one share of Series A common stock at a subscription price determined by a special pricing committee of LMC's board of directors, which was determined to be $6.00 per share. </P>
          <P>LMC stock is traded on the New York Stock Exchange. Series A common stock is traded under the symbol L and Series B common stock is traded under the symbol LMC.B. </P>
          <P>The Plan was a holder of record of the Stock on the Record Date. The Plan established two temporary investment funds under a separate trust called the “Liberty Media Rights Trust” (the Rights Trust). The Rights Holding Fund is a separate fund established under the Rights Trust to hold the Rights when they are issued. Rights were credited to participants' accounts based on their respective balances in the Liberty Media Common Stock Fund on October 31, 2002. The second fund, the “Liberty Media Receivable Fund” (the Receivable Fund), following the exercise of Rights as directed by the Plan participants, reflected the approximate value of the Liberty Media Series A shares due from the subscription agent. </P>
          <P>With respect to Rights allocated to their accounts, Plan participants either may elect to (1) exercise the Rights or (2) sell the Rights. These elections apply to both Stock held in the participant's account attributable to 401(k) contributions and to matching contributions (including vested and unvested matching contributions). Due to securities law restrictions, certain Participants who are reporting persons under Rule 16(b) will not have the right to instruct Fidelity to either Sell or Exercise the Rights credited to their account. Liberty Media provided Fidelity with a list of those Participants. Fidelity established the appropriate restrictions to prevent these participants from exercising or selling the Rights credited to their accounts. As provided by the Plan, Fidelity sold the Rights credited to these Rule 16(b) participant accounts as soon as administratively feasible after the receipt and allocation of the Rights to the participant accounts.<SU>1</SU>
            <FTREF/>
          </P>
          <FTNT>
            <P>
              <SU>1</SU> The Rights issued to the Plan that were sold from the Plan were sold to unrelated third parties on the open market. Those Rights were traded on the New York Stock Exchange under the symbol “LMC.RT”.</P>
          </FTNT>
          <P>4. With the exception of those reporting persons under Rule 16(b) as described above, each participant in the Plan may elect to exercise any percentage of the Rights granted on the participant's Stock allocated to the participant's account in the Plan. Under the offering, a participant of the Plan could elect to exercise a Right by speaking to a Fidelity representative at any time prior to 4 p.m. Eastern Time, November 25, 2002, (the Election Close-Out Date). Participants had the opportunity prior to the Election Close-Out Date to revoke or change instructions to exercise by (1) electing a new percentage; (2) by placing an order to sell; or (3) a combination of both. </P>
          <P>The dollar amount required to exercise the Rights were exchanged from other investments in the participant's account into the Receivable Fund established under the Rights Trust. The required dollar amount equals the percentage of Rights to be exercised (as elected by the participant) multiplied by the number of Rights credited to the participant's account and multiplied by the exercise price for the Rights offering. The dollar amount was exchanged from the other investment categories in which the account is invested on a proportional basis by source. The Liberty Media Stock Fund was not included unless insufficient funds did not exist in the other investment categories under the participant's account. For those individuals with insufficient funds to permit exercise of the entire elected amount, Fidelity exercised as many rights as the account balance permitted. </P>
          <P>On or about November 29, 2002, the Rights to be exercised and necessary funds were submitted to the subscription agent for the purchase of shares. Participant's balances in the Rights Holding Fund were reduced by the number of Rights exercised on a participant's behalf. Fidelity sold all remaining Rights on the open market between November 29, 2002, and December 2, 2002, at which time the Rights expired. Upon receipt of the new shares, the Receivable Fund was closed and the newly received shares were transferred into the Liberty Media Stock Fund and allocated to the participant's accounts. </P>
          <P>For any Rights sold by the Plan, a commission of 3.4 cents per Right was charged to the Plan account from which the Right was sold. The commission was not paid to LMC but to the broker dealer, National Financial Services (NFS) for the sale transaction. NFS is an affiliate of Fidelity Management Trust Company, which serves as a non-discretionary Trustee for the Plan. The discretionary fiduciary for the Plan is the Plan Administrative Committee appointed by the Board of Directors of LMC. The Administrative Committee determined, after reasonable consideration of the alternatives, that the use of NFS was in the best interests of the Plan.<SU>2</SU>
            <FTREF/>
          </P>
          <FTNT>
            <P>
              <SU>2</SU> The Department provides no opinion as to whether the selection of the broker dealer meets the conditions set forth under section 408(b)(2).</P>
          </FTNT>
          <P>Those participants who elected to exercise only a portion of their Rights later could elect to exercise additional Rights if sufficient time existed prior to the Election Close-Out Date. The Election Close-Out Date was established to permit sufficient time for the Trustee to liquidate the other assets in an orderly manner so that the necessary cash would be available to exercise the Rights before the Rights offering expiration date (December 2, 2002). All Rights were exercised or sold prior to the end of the Rights offering period, no Rights held by the Plan expired. A participant may have elected to sell rather than exercise the Rights allocated to his or her account. In order to do so, the participant was required to (1) contact the Fidelity representative; and (2) specify the percentage (in whole amounts) of the Rights he desired to sell. The selling period for participants ran from November 8, 2002, through November 25, 2002. </P>

          <P>Participants in the Plan will be in a like position with other shareholders who are receiving the Rights with the sole exception that the Plan participants were not entitled to participate in the oversubscription privilege described in the prospectus. No expense will be incurred by the Plan from the Rights offering, and full disclosure of the Rights offering was made in the public documents filed with the SEC. The Rights offering and the resulting transactions were in the best interests of and beneficial to the Plan and its participants and beneficiaries. The rights of the participants and beneficiaries of the Plan were protected in the Rights offering and subsequent transactions. All involved participants were notified in advance of the Rights offering of the procedure for instructing the Trustee of the participant's desires <PRTPAGE P="49304"/>for exercise or sale under the Rights offering, and all instructions given by the involved participants to the Trustee were properly executed. </P>
          <P>All actions by the Trustee with respect to the Rights offering were made pursuant to express instructions except when the involved participant failed to act or acted in violation of the published procedures, in which case the Rights were placed on the open market for sale and any unsold rights were allowed to expire unexercised. These instructions as to the disposition of the Rights upon the failure of the involved participant to act or to give valid instructions were fully disclosed in the procedural instructions given to the involved participants. These instructions are consistent with the nature of participant-directed investments under the Plan. </P>
          <P>5. In summary, it is represented that the proposed transaction meets the statutory criteria of section 408(a) of the Act because: </P>
          <P>(a) The Rights were acquired pursuant to Plan provisions for individually-directed investment of such accounts; </P>
          <P>(b) The Plan's receipt of the Rights occurred in connection with the Rights offering made available to all shareholders of common stock of LMC; </P>
          <P>(c) All decisions regarding the holding and disposition of the Rights by the Plan were made, in accordance with the Plan provisions for individually-directed investment of participant accounts, by the individual Plan participants whose accounts in the Plan received the Rights in connection with the offering; </P>
          <P>(d) The Plan's acquisition of the Rights resulted from an independent act of LMC as a corporate entity; and </P>
          <P>(e) The Plan received the same proportionate number of the Rights as other owners of the Stock. </P>
          <P>
            <E T="03">Notice to Interested Persons:</E> Notice of the proposed exemption shall be given to all interested persons in the manner agreed upon by the Employer and Department within 15 days of the date of publication in the <E T="04">Federal Register</E>. Comments and requests for a hearing are due forty-five (45) days after publication of the notice in the <E T="04">Federal Register</E>. </P>
          <FURINF>
            <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
            <P>Khalif Ford of the Department, telephone (202) 219-8883 (this is not a toll-free number). </P>
            
            <FP SOURCE="FP-1">RBC Dain Rauscher, Inc. (RBC-DR) </FP>
            <FP SOURCE="FP-1">Located in Minneapolis, Minnesota </FP>
            <FP SOURCE="FP-1">[Application No. D-11189] </FP>
            <HD SOURCE="HD1">Proposed Exemption </HD>
            <P>The Department is considering granting an exemption under the authority of section 408(a) of the Act, and section 4975 of the Code, in accordance with the procedures set forth in 29 CFR part 2570, subpart B (55 FR 32836, 32847, August 10, 1990). </P>
            <HD SOURCE="HD2">I. Transactions </HD>
            <P>A. Effective for transactions occurring on or after April 18, 2003, the restrictions of section 406(a) and 407(a) of the Employee Retirement Income Security Act of 1974, as amended (the Act), and the taxes imposed by section 4975(a) and (b) of the Internal Revenue Code of 1986, as amended (the Code), by reason of section 4975(c)(1)(A) through (D) of the Code, shall not apply to the following transactions involving Issuers and Securities evidencing interests therein: </P>
            <P>(1) The direct or indirect sale, exchange or transfer of Securities in the initial issuance of Securities between the Sponsor or Underwriter and an employee benefit plan when the Sponsor, Servicer, Trustee or Insurer of an Issuer, the Underwriter of the Securities representing an interest in the Issuer, or an Obligor is a party in interest with respect to such plan; </P>
            <P>(2) The direct or indirect acquisition or disposition of Securities by a plan in the secondary market for such Securities; and </P>
            <P>(3) The continued holding of Securities acquired by a plan pursuant to subsection I.A.(1) or (2). </P>
            <P>Notwithstanding the foregoing, section I.A. does not provide an exemption from the restrictions of sections 406(a)(1)(E), 406(a)(2) and 407 of the Act for the acquisition or holding of a Security on behalf of an Excluded Plan, by any person who has discretionary authority or renders investment advice with respect to the assets of that Excluded Plan.<SU>3</SU>
              <FTREF/>
            </P>
            <FTNT>
              <P>
                <SU>3</SU> Section I.A. provides no relief from sections 406(a)(1)(E), 406(a)(2) and 407 of the Act for any person rendering investment advice to an Excluded Plan within the meaning of section 3(21)(A)(ii) and regulation 29 CFR 2510.3-21(c).</P>
            </FTNT>
            <P>B. Effective for transactions occurring on or after April 18, 2003, the restrictions of sections 406(b)(1) and 406(b)(2) of the Act and the taxes imposed by section 4975(a) and (b) of the Code by reason of section 4975(c)(1)(E) of the Code shall not apply to: </P>
            <P>(1) The direct or indirect sale, exchange or transfer of Securities in the initial issuance of Securities between the Sponsor or Underwriter and a plan when the person who has discretionary authority or renders investment advice with respect to the investment of plan assets in the Securities is (a) an obligor with respect to 5 percent or less of the fair market value of obligations or receivables contained in the Issuer, or (b) an affiliate or a person described in (a); if (i) The plan is not an Excluded Plan; </P>
            <P>(ii) Solely in the case of an acquisition of Securities in connection with the initial issuance of the Securities, at least 50 percent of each class of Securities in which plans have invested is acquired by persons independent of the members of the Restricted Group, and at least 50 percent of the aggregate interest in the Issuer is acquired by persons independent of the Restricted Group; </P>
            <P>(iii) A plan's investment in each class of Securities does not exceed 25 percent of all of the Securities of that class outstanding at the time of the acquisition; and </P>
            <P>(iv) Immediately after the acquisition of the Securities, no more than 25 percent of the assets of a plan with respect to which the person has discretionary authority or renders investment advice are invested in Securities representing an interest in a Issuer containing assets sold or serviced by the same entity.<SU>4</SU>
              <FTREF/> For purposes of this paragraph B.(1)(iv) only, an entity will not be considered to service assets contained in an Issuer if it is merely a Subservicer of that Issuer; </P>
            <FTNT>
              <P>
                <SU>4</SU> For purposes of this exemption, each plan participating in a commingled fund (such as a bank collective trust fund or insurance company pooled separate account) shall be considered to own the same proportionate undivided interest in each asset of the commingled fund as its proportionate interest in the total assets of the commingled fund as calculated on the most recent preceding valuation date of the fund.</P>
            </FTNT>
            <P>(2) The direct or indirect acquisition or disposition of Securities by a plan in the secondary market for such Securities, provided that conditions set forth in paragraphs B.(1)(i), (iii) and (iv) are met; and </P>
            <P>(3) The continued holding of Securities acquired by a plan pursuant to subsection I.B.(1) or (2). </P>
            <P>C. Effective for transactions occurring on or after April 18, 2003, the restrictions of sections 406(a), 406(b) and 407(a) of the Act and the taxes imposed by section 4975(a) and (b) of the Code by reason of section 4975(c) of the Code, shall not apply to transactions in connection with the servicing, management and operation of an Issuer, including the use of any Eligible Swap transaction; or the defeasance of a mortgage obligation held as an asset of the Issuer through the substitution of a new mortgage obligation in a commercial mortgage-backed Designated Transaction, provided: </P>

            <P>(1) Such transactions are carried out in accordance with the terms of a binding Pooling and Servicing Agreement; <PRTPAGE P="49305"/>
            </P>
            <P>(2) The Pooling and Servicing Agreement is provided to, or described in all material respects in the prospectus or private placement memorandum provided to, investing plans before they purchase Securities issued by the Issuer; <SU>5</SU>
              <FTREF/> and </P>
            <FTNT>
              <P>
                <SU>5</SU> In the case of a private placement memorandum, such memorandum must contain substantially the same information that would be disclosed in a prospectus if the offering of the Securities were made in a registered public offering under the Securities Act of 1933. In the Department's view, the private placement memorandum must contain sufficient information to permit plan fiduciaries to make informed investment decisions.</P>
            </FTNT>
            <P>(3) The defeasance of a mortgage obligation and the substitution of a new mortgage obligation in a commercial mortgage-backed Designated Transaction meet the terms and conditions for such defeasance and substitution as are described in the prospectus or private placement memorandum for such Securities, which terms and conditions have been approved by a Rating Agency and does not result in the Securities receiving a lower credit rating from the Rating Agency than the current rating of the Securities. </P>
            <P>Notwithstanding the foregoing, section I.C. does not provide an exemption from the restrictions of section 406(b) of the Act or from the taxes imposed by reason of section 4975(c) of the Code for the receipt of a fee by the Servicer of the Issuer from a person other than the Trustee or Sponsor, unless such fee constitutes a “Qualified Administrative Fee.” </P>
            <P>D. Effective for transactions occurring on or after April 18, 2003, the restrictions of sections 406(a) and 407(a) of the Act, and the taxes imposed by sections 4975(a) and (b) of the Code by reason of sections 4975(c)(1)(A) through (D) of the Code shall not apply to any transactions to which those restrictions or taxes would otherwise apply merely because a person is deemed to be a party in interest or disqualified person (including a fiduciary) with respect to a plan by virtue of providing services to the plan (or by virtue of having a relationship to such service provider described in section 3(14)(F), (G), (H) or (I) of the Act or section 4975(e)(2)(F), (G), (H) or (I) of the Code), solely because of the plan's ownership of Securities. </P>
            <HD SOURCE="HD2">II. General Conditions </HD>
            <P>A. The relief provided under section I is available only if the following conditions are met: </P>
            <P>(1) The acquisition of Securities by a plan is on terms (including the Security price) that are at least as favorable to the plan as such terms would be in an arm's-length transaction with an unrelated party; </P>
            <P>(2) The rights and interests evidenced by the Securities are not subordinated to the rights and interests evidenced by other Securities of the same Issuer, unless the Securities are issued in a Designated Transaction; </P>
            <P>(3) The Securities acquired by the plan have received a rating from Rating Agency at the time of such acquisition that is in one of the three (or in the case of Designated Transactions, four) highest generic rating categories. </P>
            <P>(4) The Trustee is not an Affiliate of any member of the Restricted Group, other than an Underwriter. For purposes of this requirement: </P>
            <P>(a) The Trustee shall not be considered to be an Affiliate of a Servicer solely because the Trustee has succeeded to the rights and responsibilities of the Servicer pursuant to the terms of a Pooling and Servicing Agreement providing for such succession upon the occurrence of one or more events of default by the Servicer; and </P>
            <P>(b) Subsection II.A.(4) will be deemed satisfied notwithstanding a Servicer becoming an Affiliate of the Trustee as a result of a merger or acquisition involving the Trustee, such Servicer and/or their Affiliates which occurs after the initial issuance of the Securities provided that: </P>
            <P>(i) Such Servicer ceases to be an Affiliate of the Trustee no later than six months after the date such Servicer became an Affiliate of the Trustee; and </P>
            <P>(ii) Such Servicer did not breach any of its obligations under the Pooling and Servicing Agreement, unless such breach was immaterial and timely cured in accordance with the terms of such agreement, during the period from the closing date of such merger or acquisition transaction through the date the Servicer ceased to be an Affiliate of the Trustee; </P>
            <P>(5) The sum of all payments made to and retained by the Underwriters in connection with the distribution or placement of Securities represents not more than Reasonable Compensation for underwriting or placing the Securities; the sum of all payments made to and retained by the Sponsor pursuant to the assignment of obligations (or interests therein) to the Issuer represents not more than the fair market value of such obligations (or interests); and the sum of all payments made to and retained by the Servicer represents not more than Reasonable Compensation for the Servicer's services under the Pooling and Servicing Agreement and reimbursement of the Servicer's reasonable expenses in connection therewith; </P>
            <P>(6) The plan investing in such Securities is an “accredited investor” as defined in Rule 501(a)(1) of Regulation D of the Securities and Exchange Commission (SEC) under the Securities Act of 1933; and </P>
            <P>(7) In the event that the obligations used to fund an Issuer have not all been transferred to the Issuer on the Closing Date, additional obligations as specified in subsection III.B.(1) may be transferred to the Issuer during the Pre-Funding Period in exchange for amounts credited to the Pre-Funding Account, provided that: </P>
            <P>(a) The Pre-Funding Limit is not exceeded; </P>
            <P>(b) All such additional obligations meet the same terms and conditions for eligibility as the original obligations used to create the Issuer (as described in the prospectus or private placement memorandum and/or Pooling and Servicing Agreement for such Securities), which terms and conditions have been approved by a Rating Agency. </P>
            <P>Notwithstanding the foregoing, the terms and conditions for determining the eligibility of an obligation may be changed if such changes receive prior approval either by a majority vote of the outstanding securityholders or by a Rating Agency; </P>
            <P>(c) The transfer of such additional obligations to the Issuer during the Pre-Funding Period does not result in the Securities receiving a lower credit rating from a Rating Agency, upon termination of the Pre-Funding Period than the rating that was obtained at the time of the initial issuance of the Securities by the Issuer; </P>
            <P>(d) The weighted average annual percentage interest rate (the average interest rate) for all of the obligations in the Issuer at the end of the Pre-Funding Period will not be more than 100 basis points lower than the average interest rate for the obligations which were transferred to the Issuer on the Closing Date; </P>

            <P>(e) In order to ensure that the characteristics of the receivables actually acquired during the Pre-Funding Period are substantially similar to those which were acquired as of the Closing Date, the characteristics of the additional obligations will either be monitored by a credit support provider or other insurance provider which is independent of the Sponsor or an independent accountant retained by the Sponsor will provide the Sponsor with a letter (with copies provided to the Rating Agency, the Underwriter and the Trustee) stating whether or not the characteristics of the additional <PRTPAGE P="49306"/>obligations conform to the characteristics of such obligations described in the prospectus, private placement memorandum and/or Pooling and Servicing Agreement. In preparing such letter, the independent accountant will use the same type of procedures as were applicable to the obligations which were transferred on the Closing Date; </P>
            <P>(f) The Pre-Funding Period shall be described in the prospectus or private placement memorandum provided to investing plans; and </P>
            <P>(g) The Trustee of the Trust (or any agent with which the Trustee contracts to provide Trust services) will be a substantial financial institution or trust company experienced in trust activities and familiar with its duties, responsibilities, and liabilities as a fiduciary under the Act. The Trustee, as the legal owner of the obligations in the Trust or the holder of a security interest in the obligations held by the Issuer, will enforce all the rights created in favor of securityholders of such Issuer, including employee benefit plans subject to the Act; </P>
            <P>(8) In order to insure that the assets of the Issuer may not be reached by creditors of the Sponsor in the event of bankruptcy or other insolvency of the Sponsor: </P>
            <P>(a) The legal documents establishing the Issuer will contain: </P>
            <P>(i) Restrictions on the Issuer's ability to borrow money or issue debt other than in connection with the securitization; </P>
            <P>(ii) Restrictions on the Issuer merging with another entity, reorganizing, liquidating or selling assets (other than in connection with the securitization); </P>
            <P>(iii) Restrictions limiting the authorized activities of the Issuer to activities relating to the securitization; </P>
            <P>(iv) If the Issuer is not a Trust, provisions for the election of at least one independent director/partner/member whose affirmative consent is required before a voluntary bankruptcy petition can be filed by the Issuer; and </P>
            <P>(v) If the Issuer is not a Trust, requirements that each independent director/partner/member must be an individual that does not have a significant interest in, or other relationships with, the Sponsor or any of its Affiliates; </P>
            <P>(b) The Pooling and Servicing Agreement and/or other agreements establishing the contractual relationships between the parties to the securitization transaction will contain covenants prohibiting all parties thereto from filing an involuntary bankruptcy petition against the Issuer or initiating any other form of insolvency proceeding until after the Securities have been paid; and </P>
            <P>(c) Prior to the issuance by the Issuer of any Securities, a legal opinion is received which states that either: </P>
            <P>(i) A “true sale” of the assets being transferred to the Issuer by the Sponsor has occurred and that such transfer is not being made pursuant to a financing of the assets by the Sponsor; or </P>
            <P>(ii) In the event of insolvency or receivership of the Sponsor, the assets transferred to the Issuer will not be part of the estate of the Sponsor; </P>
            <P>(9) If a particular class of Securities held by any plan involves a Ratings Dependent or Non-Ratings Dependent Swap entered into by the Issuer, then each particular swap transaction relating to such Securities: </P>
            <P>(a) Shall be an Eligible Swap; </P>
            <P>(b) Shall be with an Eligible Swap Counterparty; </P>
            <P>(c) In the case of a Ratings Dependent Swap, shall provide that if the credit rating of the counterparty is withdrawn or reduced by any Rating Agency below a level specified by the Rating Agency, the Servicer (as agent for the Trustee) shall, within the period specified under the Pooling and Servicing Agreement: </P>
            <P>(i) Obtain a replacement swap agreement with an Eligible Swap Counterparty which is acceptable to the Rating Agency and the terms of which are substantially the same as the current swap agreement (at which time the earlier swap agreement shall terminate); or </P>
            <P>(ii) Cause the swap counterparty to establish any collateralization or other arrangement satisfactory to the Rating Agency such that the then current rating by the Rating Agency of the particular class of Securities will not be withdrawn or reduced. </P>
            <P>In the event that the Servicer fails to meet its obligations under this subsection II.A.(9)(c), plan securityholders will be notified in the immediately following Trustee's periodic report which is provided to securityholders, and sixty days after the receipt of such report, the exemptive relief provided under section I.C. will prospectively cease to be applicable to any class of Securities held by a plan which involves such Ratings Dependent Swap; provided that in no event will such plan securityholders be notified any later than the end of the second month that begins after the date on which such failure occurs. </P>
            <P>(d) In the case of a Non-Ratings Dependent Swap, shall provide that, if the credit rating of the counterparty is withdrawn or reduced below the lowest level specified in section III.GG., the Servicer (as agent for the Trustee) shall within a specified period after such rating withdrawal or reduction: </P>
            <P>(i) Obtain a replacement swap agreement with an Eligible Swap Counterparty, the terms of which are substantially the same as the current swap agreement (at which time the earlier swap agreement shall terminate); or </P>
            <P>(ii) Cause the swap counterparty to post collateral with the Trustee in an amount equal to all payments owed by the counterparty if the swap transaction were terminated; or </P>
            <P>(iii) Terminate the swap agreement in accordance with its terms; and </P>
            <P>(e) Shall not require the Issuer to make any termination payments to the counterparty (other than a currently scheduled payment under the swap agreement) except from Excess Spread or other amounts that would otherwise be payable to the Servicer or the Sponsor; </P>
            <P>(10) Any class of Securities, to which one or more swap agreements entered into by the Issuer applies, may be acquired or held in reliance upon this Underwriter Exemption only by Qualified Plan Investors; and </P>
            <P>(11) Prior to the issuance of any debt securities, a legal opinion is received which states that the debt holders have a perfected security interest in the Issuer's assets. </P>
            <P>B. Neither any Underwriter, Sponsor, Trustee, Servicer, Insurer, nor any Obligor, unless it or any of its Affiliates has discretionary authority or renders investment advice with respect to the plan assets used by a plan to acquire Securities, shall be denied the relief provided under Part I, if the provision in subsection II.A.(6) above is not satisfied with respect to acquisition or holding by a plan of such Securities, provided that (1) such condition is disclosed in the prospectus or private placement memorandum; and (2) in the case of a private placement of Securities, the Trustee obtains a representation of each initial purchaser which is a plan that it is in compliance with such condition, and obtains a covenant from each initial purchaser to the effect that, so long as such initial purchaser (or any transferee of such initial purchaser's Securities) is required to obtain from its transferee a representation regarding compliance with the Securities Act of 1933, any such transferees will be required to make a written representation regarding compliance with the condition set forth in section II.A.(6). </P>
            <HD SOURCE="HD2">III. Definitions </HD>
            <P>For purposes of this proposed exemption:<PRTPAGE P="49307"/>
            </P>
            <P>A. “Security” means: </P>
            <P>(1) A pass-through certificate or trust certificate that represents a beneficial ownership interest in the assets of an Issuer which is a Trust and which entitles the holder to pass-through payments of principal, interest, and/or other payments made with respect to the assets of such Trust; or </P>
            <P>(2) A Security which is denominated as a debt instrument that is issued by and is an obligation of an Issuer; with respect to which the Underwriter is either (i) the sole underwriter or the manager or co-manager of the underwriting syndicate, or (ii) a selling or placement agent. </P>
            <P>B. “Issuer” means an investment pool, the corpus or assets of which are held in trust (including a grantor or owner Trust) or whose assets are held by a partnership, special purpose corporation or limited liability company (which Issuer may be a Real Estate Mortgage Investment Conduit (REMIC) or a Financial Asset Securitization Investment Trust (FASIT) within the meaning of section 860D(a) or section 860L, respectively, of the Code); and the corpus or assets of which consist solely of: </P>
            <P>(1)(a) Secured consumer receivables that bear interest or are purchased at a discount (including, but not limited to, home equity loans and obligations secured by shares issued by a cooperative housing association); and/or </P>
            <P>(b) Secured credit instruments that bear interest or are purchased at a discount in transactions by or between business entities (including, but not limited to, Qualified Equipment Notes Secured by Leases); and/or </P>
            <P>(c) Obligations that bear interest or are purchased at a discount and which are secured by single-family residential, multi-family residential and/or commercial real property (including obligations secured by leasehold interests on residential or commercial real property); and/or </P>
            <P>(d) Obligations that bear interest or are purchased at a discount and which are secured by motor vehicles or equipment, or Qualified Motor Vehicle Leases; and/or </P>
            <P>(e) Guaranteed governmental mortgage pool certificates, as defined in 29 CFR § 2510.3-101(1)(2)<SU>6</SU>
              <FTREF/> and/or </P>
            <FTNT>
              <P>
                <SU>6</SU> In Advisory Opinion 99-05A (Feb. 22, 1999), the Department expressed its view that mortgage pool certificates guaranteed and issued by the Federal Agricultural Mortgage Corporation (“Farmer Mac”) meet the definition of a guaranteed governmental mortgage pool certificate as defined in 29 CFR 2510.3-101(i)(2).</P>
            </FTNT>
            <P>(f) Fractional undivided interests in any of the obligations described in clauses (a)-(e) of this subsection B.(1);<SU>7</SU>
              <FTREF/>
            </P>
            <FTNT>
              <P>
                <SU>7</SU> It is the Department's view that the definition of “Issuer” contained in section III.B. includes a two-tier structure under which Securities issued by the first Issuer, which contains a pool of receivables described above, are transferred to a second Issuer which issues Securities that are sold to plans. However, the Department is of the further view that, since the exemption generally provides relief for the direct or indirect acquisition or disposition of Securities that are not subordinated, no relief would be available if the Securities held by the second Issuer were subordinated to the rights and interests evidenced by other Securities issued by the first Issuer, unless such Securities were issued in a Designated Transaction.</P>
            </FTNT>
            <P>Notwithstanding the foregoing, residential and home equity loan receivables issued in Designated Transactions may be less than fully secured, provided that (i) the rights and interests evidenced by the Securities issued in such Designated Transactions are not subordinated to the rights and interests evidenced by Securities of the same Issuer; (ii) such Securities acquired by the plan have received a rating from a Rating Agency at the time of such acquisition that is in one of the two highest generic rating categories; and (iii) any obligation included in the corpus or assets of the Issuer must be secured by collateral whose fair market value on the Closing Date of the Designated Transaction is at least equal to 80% of the sum of: (I) The outstanding principal balance due under the obligation which is held by the Issuer and (II) the outstanding principal balance(s) of any other obligation(s) of higher priority (whether or not held by the Issuer) which are secured by the same collateral. </P>
            <P>(2) Property which had secured any of the obligations described in subsection III.B.(1); </P>
            <P>(3)(a) Undistributed cash or temporary investments made therewith maturing no later than the next date on which distributions are to be made to securityholders; and/or </P>
            <P>(b) Cash or investments made therewith which are credited to an account to provide payments to securityholders pursuant to any Eligible Swap Agreement meeting the conditions of subsection I.A.(9) or pursuant to any Eligible Yield Supplement Agreement, and/or </P>
            <P>(c) Cash transferred to the Issuer on the Closing Date and permitted investments made therewith which: </P>
            <P>(i) Are credited to a Pre-Funding Account established to purchase additional obligations with respect to which the conditions set forth in clauses (a)-(g) of subsection II.A.(7) are met; and/or </P>
            <P>(ii) Are credited to a Capitalized Interest Account; and </P>
            <P>(iii) Are held by the Issuer for a period ending no later than the first distribution date to securityholders occurring after the end of the Pre-Funding Period. </P>
            <P>For purposes of this clause (c) of subsection III.B.(3), the term “permitted investments” means investments which are either (i) Direct obligations of, or obligations fully guaranteed as to timely payment of principal and interest by, the United States or any agency or instrumentality thereof, provided that such obligations are backed by the full faith and credit of the United States, or (ii) have been rated (or the Obligor has been rated) in one of the three highest generic rating categories by a Rating Agency; are described in the Pooling and Servicing Agreement; and are permitted by the Rating Agency. </P>
            <P>(4) Rights of the Trustee under the Pooling and Servicing Agreement, and rights under any insurance policies, third-party guarantees, contracts of suretyship, Eligible Yield Supplement Agreements, Eligible Swap Agreements meeting the conditions of subsection II.A.(9) or other credit support arrangements with respect to any obligations described in section III.B.(1). </P>
            <P>Notwithstanding the foregoing, the term “Issuer” does not include any investment pool unless: (i) The assets of the type described in paragraphs (a)-(f) of subsection III.B.(1) which are contained in the investment pool have been included in other investment pools, (ii) Securities evidencing interests in such other investment pools have been rated in one of the three (or in the case of Designated Transactions, four) highest generic rating categories by a Rating Agency for at least one year prior to the plan's acquisition of Securities pursuant to this exemption, and (iii) Securities evidencing interests in such other investment pools have been purchased by investors other than plans for at least one year prior to the plan's acquisition of Securities pursuant to this exemption. </P>
            <P>C. “Underwriter” means. </P>
            <P>(1) RBC-DR; </P>
            <P>(2) Any person directly or indirectly, through one or more intermediaries, controlling, controlled by or under common control with such investment banking firm; and </P>
            <P>(3) Any member of an underwriting syndicate or selling group of which such firm or person described in subsections III.C.(1) or (2) above is a manager or co-manager with respect to the Securities. </P>

            <P>D. “Sponsor” means the entity that organizes an Issuer by depositing <PRTPAGE P="49308"/>obligations therein in exchange for Securities. </P>
            <P>E. “Master Servicer” means the entity that is a party to the Pooling and Servicing Agreement relating to assets of the Issuer and is fully responsible for servicing, directly or through Subservicers, the assets of the Issuer. </P>
            <P>F. “Subservicer” means an entity which, under the supervision of and on behalf of the Master Servicer, services loans contained in the Issuer, but is not a party to the Pooling and Servicing Agreement. </P>
            <P>G. “Servicer” means any entity which services loans contained in the Issuer, including the Master Servicer and any Subservicer. </P>
            <P>H. “Trust” means an Issuer which is a trust (including an owner trust, grantor trust or a REMIC or FASIT which is organized as a Trust. </P>
            <P>I. “Trustee” means the trustee of any Trust which issues Securities and also includes an Indenture Trustee. “Indenture Trustee” means the Trustee appointed under the indenture pursuant to which the subject Securities are issued, the rights of holders of the Securities are set forth and a security interest in the Trust assets in favor of the holders of the Securities is created. The Trustee or the Indenture Trustee is also a party to or beneficiary of all the documents and instruments transferred to the Trust, and as such, has both the authority to, and the responsibility for, enforcing all the rights created thereby in favor of holders of the Securities, including those rights arising in the event of default by the servicer. </P>
            <P>J. “Insurer” means the insurer or guarantor of, or provider of other credit support for, an Issuer. Notwithstanding the foregoing, a person is not an Insurer solely because it holds securities representing an interest in an Issuer which are of a class subordinated to Securities representing an interest in the same Issuer. </P>
            <P>K. “Obligor” means any person, other than the Insurer, that is obligated to make payments with respect to any obligation or receivable included in the Issuer. Where an Issuer contains Qualified Motor Vehicle Leases or Qualified Equipment Notes secured by Leases, “Obligor” shall also include any owner of property subject to any Lease included in the Issuer, or subject to any Lease securing an obligation included in the Issuer. </P>
            <P>L. “Excluded Plan” means any plan with respect to which any member of the Restricted Group is a “plan sponsor” within the meaning of section 3(16)(B) of the Act. </P>
            <P>M. “Restricted Group” with respect to a class of Securities means:</P>
            <P>(1) Each Underwriter; </P>
            <P>(2) Each Insurer; </P>
            <P>(3) The Sponsor; </P>
            <P>(4) The Trustee; </P>
            <P>(5) Each Servicer; </P>
            <P>(6) Any Obligor with respect to obligations or receivables included in the Issuer constituting more than 5 percent of the aggregate unamortized principal balance of the assets in the Issuer, determined on the date of the initial issuance of Securities by the Issuer; </P>
            <P>(7) Each counterparty in an Eligible Swap Agreement; or </P>
            <P>(8) Any Affiliate of a person described in (1)-(7) above. </P>
            <P>N. “Affiliate” of another person includes:</P>
            <P>(1) Any person, directly or indirectly, through one or more intermediaries, controlling, controlled by or under common control with such other person; </P>
            <P>(2) Any officer, director, partner, employee, relative (as defined in section 3(15) of the Act), a brother, a sister, or a spouse of a brother or sister of such other person; and </P>
            <P>(3) Any corporation or partnership of which such other person is an officer, director or partner. </P>
            <P>O. “Control” means the power to exercise a controlling influence over the management or policies of a person other than an individual. </P>
            <P>P. A person will be “independent” of another person only if: </P>
            <P>(1) Such person is not an Affiliate of that other person; and </P>
            <P>(2) The other person, or an Affiliate thereof, is not a fiduciary who has investment management authority or renders investment advice with respect to assets of such person. </P>
            <P>Q. “Sale” includes the entrance into a Forward Delivery Commitment, provided: </P>
            <P>(1) The terms of the Forward Delivery Commitment (including any fee paid to the investing plan) are no less favorable to the plan than they would be in an arm's-length transaction with an unrelated party; </P>
            <P>(2) The prospectus or private placement memorandum is provided to an investing plan prior to the time the plan enters into the Forward Delivery Commitment; and </P>
            <P>(3) At the time of the delivery, all conditions of this exemption applicable to sales are met. </P>
            <P>R. “Forward Delivery Commitment” means a contact for the purchase or sale of one or more Securities to be delivered at an agreed future settlement date. The term includes both mandatory contracts (which contemplate obligatory delivery and acceptance of the Securities) and optional contracts (which give one party the right but not the obligation to deliver Securities to, or demand delivery of Securities from, the other party). </P>
            <P>S. “Reasonable Compensation” has the same meaning as that term is defined in 29 CFR 2550.408c-2. </P>
            <P>T. “Qualified Administrative Fee” means a fee which meets the following criteria: </P>
            <P>(1) The fee is triggered by an act or failure to act by the Obligor other than the normal timely payment of amounts owing in respect of the obligations; </P>
            <P>(2) The Servicer may not charge the fee absent the act or failure to act referred to in (1); </P>
            <P>(3) The ability to charge the fee, the circumstances in which the fee may be charged, and an explanation of how the fee is calculated are set forth in the Pooling and Servicing Agreement; and </P>
            <P>(4) The amount paid to investors in the Issuer will not be reduced by the amount of any such fee waived by the Servicer. </P>
            <P>U. “Qualified Equipment Note Secured by a Lease” means an equipment note: </P>
            <P>(1) Which is secured by equipment which is leased; </P>
            <P>(2) Which is secured by the obligation of the lessee to pay rent under the equipment lease; and </P>
            <P>(3) With respect to which the Issuer's security interest in the equipment is at least as protective of the rights of the Issuer as would be the case if the equipment note were secured only by the equipment and not the lease. </P>
            <P>V. “Qualified Motor Vehicle Lease” means a lease of a motor vehicle where: </P>
            <P>(1) The Issuer owns or holds a security interest in the lease; </P>
            <P>(2) the Issuer owns or holds a security interest in the leased motor vehicle; and </P>
            <P>(3) the Issuer's security interest in the leased motor vehicle is at least as protective of the Issuer's rights as the Issuer would receive under a motor vehicle installment loan contract. </P>
            <P>W. “Pooling and Servicing Agreement” means the agreement or agreements among a Sponsor, a Servicer and the Trustee establishing a Trust. “Pooling and Servicing Agreement” also includes the indenture entered into by the Issuer and the Indenture Trustee. </P>
            <P>X. “Rating Agency” means Standard &amp; Poor's Ratings Services, a division of The McGraw-Hill Companies, Inc., Moody's Investors Service, Inc., Fitch, Inc. or any successors thereto. </P>

            <P>Y. “Capitalized Interest Account” means an Issuer account (i) which is established to compensate securityholders for shortfalls, if any, between investment earnings on the Pre-<PRTPAGE P="49309"/>Funding Account and the pass-through rate payable under the Securities; and (ii) which meets the requirements of clause (c) of subsection III.B.(3). </P>
            <P>Z. “Closing Date” means the date the Issuer is formed, the Securities are first issued and the Issuer's assets (other than those additional obligations which are to be funded from the Pre-Funding Account pursuant to subsection III.A.(7)) are transferred to the Issuer. </P>
            <P>AA. “Pre-Funding Account” means an Issuer account (i) which is established to purchase additional obligations, which obligations meet the conditions set forth in clauses (a)-(g) of subsection II.A.(7); and (ii) which meets the requirements of clause (c) of subsection III.B.(3). </P>
            <P>BB. “Pre-Funding Limit” means a percentage or ratio of the amount allocated to the Pre-Funding Account, as compared to the total principal amount of the Securities being offered which is less than or equal to 25 percent. </P>
            <P>CC. “Pre-Funding Period” means the period commencing on the Closing Date and ending no later than the earliest to occur of (i) the date the amount on deposit in the Pre-Funding Account is less than the minimum dollar amount specified in the Pooling and Servicing Agreement; (ii) the date on which an event of default occurs under the Pooling and Servicing Agreement; or (iii) the date which is the later of three months or 90 days after the Closing Date. </P>
            <P>DD. “Designated Transaction” means a securitization transaction in which the assets of the Issuer consist of secured consumer receivables, secured credit instruments or secured obligations that bear interest or are purchased at a discount and are: (i) Motor vehicle, home equity and/or manufactured housing consumer receivables; and/or (ii) motor vehicle credit instruments in transactions by or between business entities; and/or (iii) single-family residential, multi-family residential, home equity, manufactured housing and/or commercial mortgage obligations that are secured by single-family residential, multi-family residential, commercial real property or leasehold interests therein. For purposes of this section III.CC., the collateral securing motor vehicle consumer receivables or motor vehicle credit instruments may include motor vehicles and/or Qualified Motor Vehicle Leases. </P>
            <P>EE. “Ratings Dependent Swap” means an interest rate swap, or (if purchased by or on behalf of the Issuer) an interest rate cap contract, that is part of the structure of a class of Securities where the rating assigned by the Rating Agency to any class of Securities held by any plan is dependent on the terms and conditions of the swap and the rating of the counterparty, and if such Security rating is not dependent on the existence of the swap and rating of the counterparty, such swap or cap shall be referred to as a “Non-Ratings Dependent Swap”. With respect to a Non-Ratings Dependent Swap, each Rating Agency rating the Securities must confirm, as of the date of issuance of the Securities by the Issuer, that entering into an Eligible Swap with such counterparty will not affect the rating of the Securities. </P>
            <P>FF. “Eligible Swap” means a Ratings Dependent or Non-Ratings Dependent Swap: </P>
            <P>(1) Which is denominated in U.S. dollars; </P>

            <P>(2) Pursuant to which the Issuer pays or receives, on or immediately prior to the respective payment or distribution date for the class of Securities to which the swap relates, a fixed rate of interest, or a floating rate of interest based on a publicly available index (<E T="03">e.g.</E>, the London Interbank Offered Rate (LIBOR) or the U.S. Federal Reserve's Cost of Funds Index (COFI)), with the Issuer receiving such payments on at least a quarterly basis and obligated to make separate payments no more frequently than the counterparty, with all simultaneous payments being netted; </P>
            <P>(3) Which has a notional amount that does not exceed either: (i) The principal balance of the class of Securities to which the swap relates, or (ii) the portion of the principal balance of such class represented solely by those types of corpus or assets of the Issuer referred to in subsections III.B.(1), (2) and (3); </P>
            <P>(4) Which is not leveraged (<E T="03">i.e.</E>, payments are based on the applicable notional amount, the day count fractions, the fixed or floating rates designated in subsection III.EE.(2), and the difference between the products thereof, calculated on a one to one ratio and not on a multiplier of such difference); </P>
            <P>(5) Which has a final termination date that is either the earlier of the date on which the Issuer terminates or the related class of securities is fully repaid; and </P>
            <P>(6) Which does not incorporate any provision which could cause a unilateral alteration in any provision described in subsections III.EE.(1) through (4) without the consent of the Trustee. </P>
            <P>GG. “Eligible Swap Counterparty” means a bank or other financial institution which has a rating, at the date of issuance of the Securities by the Issuer, which is in one of the three highest long-term credit rating categories, or one of the two highest short-term credit rating categories, utilized by at least one of the Rating Agencies rating the Securities; provided that, if a swap Counterparty is relying on its short-term rating to establish eligibility under the Underwriter Exemption, such swap Counterparty must either have a long-term rating in one of the three highest long-term rating categories or not have a long-term rating from the applicable Rating Agency, and provided further that if the class of Securities with which the swap is associated has a final maturity date of more than one year from the date of issuance of the Securities, and such swap is a Ratings Dependent Swap, the swap Counterparty is required by the terms of the swap agreement to establish any collateralization or other arrangement satisfactory to the Rating Agencies in the event of a ratings downgrade of the swap Counterparty. </P>
            <P>HH. “Qualified Plan Investor” means a plan investor or group of plan investors on whose behalf the decision to purchase Securities is made by an appropriate independent fiduciary that is qualified to analyze and understand the terms and conditions of any swap transaction used by the Issuer and the effect such swap would have upon the credit ratings of the Securities. For purposes of the Underwriter Exemption, such a fiduciary is either: </P>
            <P>(1) A “qualified professional asset manager” (QPAM),<SU>8</SU>
              <FTREF/> as defined under Part V(a) of PTE 84-14, 49 FR 9494, 9506 (March 13, 1984); </P>
            <FTNT>
              <P>

                <SU>8</SU> PTE 84-14 provides a class exemption for transactions between a party in interest with respect to an employee benefit plan and an investment fund (including either a single customer or pooled separate account) in which the plan has an interest, and which is managed by a QPAM, provided certain conditions are met. QPAMs (<E T="03">e.g.</E>, banks, insurance companies, registered investment advisers with total client assets under management in excess of $50 million) are considered to be experienced investment managers for plan investors that are aware of their fiduciary duties under ERISA.</P>
            </FTNT>
            <P>(2) An “in-house asset manager” (INHAM),<SU>9</SU>
              <FTREF/> as defined under part IV(a) of PTE 96-23, 61 FR 15975, 15982 (April 10, 1996); or </P>
            <FTNT>
              <P>
                <SU>9</SU> PTE 96-23 permits various transactions involving employee benefit plans whose assets are managed by an INHAM, an entity which is generally a subsidiary of an employer sponsoring the plan which is a registered investment adviser with management and control of total assets attributable to plans maintained by the employer and its affiliates which are in excess of $50 million.</P>
            </FTNT>
            <P>(3) A plan fiduciary with total assets under management of at least $100 million at the time of the acquisition of such Securities. </P>

            <P>II. “Excess Spread” means, as of any day funds are distributed from the Issuer, the amount by which the interest <PRTPAGE P="49310"/>allocated to Securities exceeds the amount necessary to pay interest to securityholders, servicing fees and expenses. </P>
            <P>JJ. “Eligible Yield Supplement Agreement” means any yield supplement agreement, similar yield maintenance arrangement or, if purchased by or on behalf of the Issuer, an interest rate cap contract to supplement the interest rates otherwise payable on obligations described in subsection III.B.(1). Such an agreement or arrangement may involve a notional principal contract provided that: </P>
            <P>(1) It is denominated in U.S. dollars; </P>

            <P>(2) The Issuer receives on, or immediately prior to the respective payment date for the Securities covered by such agreement or arrangement, a fixed rate of interest or a floating rate of interest based on a publicly available index (<E T="03">e.g.</E>, LIBOR or COFI), with the Issuer receiving such payments on at least a quarterly basis; </P>
            <P>(3) It is not “leveraged” as described in subsection III.EE.(4); </P>
            <P>(4) It does not incorporate any provision which would cause a unilateral alteration in any provision described in subsections III.II.(1)-(3) without the consent of the Trustee; </P>
            <P>(5) It is entered into by the Issuer with an Eligible Swap Counterparty; and </P>
            <P>(6) It has a notional amount that does not exceed either: </P>
            <P>(i) The principal balance of the class of Securities to which such agreement or arrangement relates, or (ii) the portion of the principal balance of such class represented solely by those types of corpus or assets of the Issuer referred to in subsections III.B.(1), (2) and (3).</P>
            <P>The Department notes that this proposed exemption is included within the meaning of the term “Underwriter Exemption” as it is defined in section V(h) of Prohibited Transaction Exemption 95-60 (60 FR 35925, July 12, 1995), the Class Exemption for Certain Transactions Involving Insurance Company General Accounts at (see 60 FR 35932). </P>
            <P>
              <E T="03">Effective Date:</E> This exemption is effective for all transactions described herein which occurred on or after April 18, 2003. </P>
            <HD SOURCE="HD1">Summary of Facts and Representations </HD>
            <P>1. RBC-DR is a Minnesota corporation organized on December 29, 1981 and is a wholly-owned subsidiary of RBC Dain Rauscher Corporation which is a wholly-owned subsidiary of Royal Bank of Canada. RBC-DR is a registered broker-dealer, a registered investment adviser and a member of the New York Stock Exchange, the National Association of Securities Dealers, Inc., and other major securities exchanges, as well as the Securities Investor Protection Corporation. RBC-DR engages in the purchase and sale of securities for the account of its customers, which include individual and institutional accounts. It also purchases and sells securities for its own proprietary trading accounts and for the accounts of its affiliates. RBC-DR engages in trading mortgage-related and other securities, including pass-through certificates issued by the Government National Mortgage Association (GNMA), the Federal National Mortgage Association (FNMA) and the Federal Home Loan Mortgage Corporation (FHLMC), callable agency debt, and collateralized mortgage obligations for the account of its customers and for its own accounts. RBC-DR similarly trades certificates of deposit issued by banks, the deposits of which are insured by the Bank Insurance Fund. Through its division “RBC Capital Markets,” RBC-DR also conducts similar business. </P>
            <P>RBC-DR maintains its principal office at 60 South Sixth Street, Minneapolis, Minnesota 55402-4422. It maintains branch sales offices in 39 states and the District of Columbia. </P>
            <P>2. RBC Mortgage Company (RBC Mortgage) is an Illinois corporation organized on June 22, 1992 and is a wholly-owned subsidiary of Royal Bank of Canada, the ultimate parent corporation to the RBC-DR. RBC Mortgage, formerly known as Prism Mortgage Company, is engaged primarily in the mortgage banking business, and originates, purchases, sells and services prime mortgage loans, sub-prime mortgage loans and home equity loans. It originates mortgage loans through a retail branch system and through mortgage loan brokers and purchases loans originated by correspondents nationwide. It also conducts this business through its affiliated entities Lenders Mortgage Services, LLC (Illinois), Mortgage Market Inc. (Oregon), and Pacific Guaranty Mortgage Corporation (California). It sells substantially all loans that it originates or purchases. In the calendar year ending 2001, RBC Mortgage originated over $17 billion in loans. The principal executive offices of RBC Mortgage are located at 440 North Orleans, Chicago, Illinois 60610. RBC Mortgage may participate as an issuer or servicer in securitizations underwritten by RBC-DR or one of its Affiliates. </P>
            <P>3. RBC Centura Bank (RBC Centura) is a state chartered banking corporation organized under the laws of North Carolina on February 14, 1990. It is a wholly-owned subsidiary of Royal Bank of Canada. RBC Centura offers financial services, including deposit accounts, investments and mutual funds, financial advice, credit and debit cards, business and personal loans, insurance, residential and commercial mortgages. Its deposits are insured by the Federal Deposit Insurance Corporation (FDIC). RBC Centura offers personal and commercial customers banking services through more than 240 banking centers located in five Southeastern states. Through its division, RBC Builder Finance (“RBC-BF”), headquartered in Houston, Texas, RBC Centura engages in lending activity designed to fund single-family construction loans, residential land acquisition and development loans, including finished lot facilities, and participating debt loans. The RBC-BF division targets professional, middle-market, residential homebuilders and developers in major metropolitan markets throughout the United States. Loan production offices are located in the District of Columbia and 16 states, primarily in the South and West. RBC Centura (including its division RBC-BF) may participate as an issuer, servicer or trustee in securitizations underwritten by RBC-DR or one of its Affiliates. </P>
            <P>4. <E T="03">Other Affiliates.</E> For purposes of this application, the term “Affiliate” shall mean any U.S.-domiciled corporation, partnership, or other business entity controlled by Royal Bank of Canada. The term “Applicant” herein shall be used to denote RBC-DR and its Affiliates. </P>
            <P>5. RBC-DR seeks exemptive relief to permit plans to invest in pass-through certificates representing undivided interests in the following categories of trusts: (1) Single and multi-family residential or commercial mortgage investment trusts;<SU>10</SU>
              <FTREF/> (2) motor vehicle receivable investment trusts; (3) consumer or commercial receivables investment trusts; and (4) guaranteed governmental mortgage pool certificate investment trusts.<SU>11</SU>
              <FTREF/> For purposes of the <PRTPAGE P="49311"/>following discussion, the term “trust” includes partnerships, special purpose corporations or limited liability companies. The term “certificate” includes a security which is either a pass-through certificate or a security denominated as a debt security that is issued by one of the above-enumerated entities. </P>
            <FTNT>
              <P>
                <SU>10</SU> PTE 83-1 (48 F.R. 895, January 7, 1983), a class exemption for mortgage pool investment trusts, would generally apply to trusts containing single-family residential mortgages, provided that the applicable conditions of PTE 83-1 are met. RBC-DR requests relief for single-family residential mortgages in this exemption because it would prefer one exemption for all trusts of similar structure, and because the relief in PTE 83-1 is narrower than that in the requested exemption. However, RBC-DR may still avail itself of the exemptive relief provided by PTE 83-1.</P>
            </FTNT>
            <FTNT>
              <P>
                <SU>11</SU> Guaranteed governmental mortgage pool certificates are mortgage-backed securities with respect to which interest and principal payable is guaranteed by GNMA, FHLMC, or FNMA. The Department's regulation relating to the definition of plan assets (29 CFR 2510.3-101(i)) provides that where a plan acquires a guaranteed governmental mortgage pool certificate, the plan's assets include the certificate and all of its rights with respect to such certificate under applicable law, but do not, <PRTPAGE/>solely by reason of the plan's holding of such certificate, include any of the mortgages underlying such certificate. The Applicant is requesting exemptive relief for trusts containing guaranteed governmental mortgage pool certificates because the certificates in such trusts may be plan assets.</P>
            </FTNT>
            <P>Securitization transactions in which the assets of the securitization vehicle reflect the following categories of receivables (all of which are also described in more detail below) are referred to herein as “Designated Transactions”: (1) Automobile and other motor vehicle loans, (2) residential and home equity loans (which may have high loan-to value (HLTV) ratios in excess of 100%), (3) manufactured housing loans and (4) commercial mortgages. </P>
            <HD SOURCE="HD2">Trust Structure </HD>
            <P>6. Each trust is established under a pooling and servicing agreement between a sponsor, a servicer and a trustee. Prior to the closing date under the pooling and servicing agreement, the sponsor or servicer of a trust establishes the trust, designates an entity as trustee, and, except to the extent a pre-funding account, as described below, will be used, selects assets to be included in the trust. The assets are receivables, which may have been originated by a sponsor or servicer of the trust, an affiliate of the sponsor or servicer, or by an unrelated lender and subsequently acquired by the trust sponsor or servicer. </P>
            <P>Typically, on or prior to the closing date, the sponsor acquires legal title to all assets selected for the trust. In some cases, legal title to some or all of such assets continues to be held by the originator of the receivable until the closing date. On the closing date, the sponsor and/or the originator of the receivables conveys to the trust legal title to the assets, and the trustee issues certificates representing fractional undivided interests in the trust assets. RBC-DR, alone or together with other broker-dealers, acts as underwriter or placement agent with respect to the sale of the certificates. RBC-DR currently anticipates that the public offerings of certificates will be underwritten by it on a firm commitment basis. In addition, RBC-DR anticipates that it may privately place certificates on both a firm commitment and an agency basis. RBC-DR may also act as the lead or co-managing underwriter for a syndicate of securities underwriters.</P>
            <P>Certificateholders will be entitled to receive monthly, quarterly or semi-annual installments of principal and/or interest, or lease payments due on the receivables, adjusted, in the case of payments of interest, to a specified rate—the pass-through rate—which may be fixed or variable. </P>

            <P>When installments or payments are made on a semi-annual basis, funds are not permitted to be commingled with the servicer's assets for longer than would be permitted for a monthly-pay security. A segregated account is established in the name of the trustee (on behalf of certificateholders) to hold funds received between distribution dates. The account is under the sole control of the trustee, who invests the account's assets in short-term securities (<E T="03">i.e.</E>, permissible investments), which have received a rating comparable to the rating assigned to the certificates. In some cases, the servicer may be permitted to make a single deposit into the account once a month. When the servicer makes such monthly deposits, payments received from obligors by the servicer may be commingled with the servicer's assets during the month prior to deposit. Usually, the period of time between receipt of funds by the servicer and deposit of these funds in a segregated account does not exceed one month. </P>
            <P>Furthermore, in those cases where distributions are made semiannually, the servicer will furnish a report on the operation of the trust to the trustee on a monthly basis. At or about the time this report is delivered to the trustee, it will be made available to certificateholders and delivered to, or made available to, each rating agency that has rated the certificates. </P>
            <P>The trust may elect to be treated as a real estate mortgage investment conduit (“REMIC”) or a financial asset securitization investment trust (“FASIT”), or may be treated as a grantor trust or a partnership, for federal income tax purposes. </P>
            <P>7. Some of the certificates will be multi-class certificates. RBC-DR requests exemptive relief for two types of multi-class certificates: “strip” certificates and “senior/subordinate” (also sometimes referred to as “fast pay/slow pay”) certificates. Strip certificates are a type of security in which the stream of interest payments on receivables is split from the flow of principal payments and separate classes of certificates are established, each representing rights to disproportionate payments of principal and interest.<SU>12</SU>
              <FTREF/>
            </P>
            <FTNT>
              <P>
                <SU>12</SU> When a plan invests in REMIC “residual” interest certificates to which this exemption applies, some of the income received by the plan as a result of such investment may be considered unrelated business taxable income to the plan, which is subject to federal income tax under the Code. The prudence requirement of section 404(a)(1)(B) of the Act would require plan fiduciaries to carefully consider this and other tax consequences prior to causing plan assets to be invested in certificates pursuant to this exemption.</P>
            </FTNT>
            <P>“Senior/subordinate” certificates involve the issuance of classes of certificates having different stated maturities or the same maturities with different payment schedules. Interest and/or principal payments received on the underlying receivables are distributed first to the class of certificates having the earliest stated maturity of principal, and/or earlier payment schedule, and only when that class of certificates has been paid in full (or has received a specified amount) will distributions be made with respect to the second class of certificates. Distributions on certificates having later stated maturities will proceed in like manner until all the certificateholders have been paid in full. The only difference between this multi-class pass-through arrangement and a single-class pass-through arrangement is the order in which distributions are made to certificateholders. In each case, certificateholders will have a beneficial ownership interest in the underlying assets. Except as permitted in a Designated Transaction, the rights of a plan purchasing a certificate will not be subordinated to the rights of another certificateholder in the event of default on any of the underlying obligations. In particular, unless the certificates are issued in a Designated Transaction, if the amount available for distribution to certificateholders is less than the amount required to be so distributed, all senior certificateholders then entitled to receive distributions will share in the amount distributed on a pro rata basis.<SU>13</SU>
              <FTREF/>
            </P>
            <FTNT>
              <P>
                <SU>13</SU> If a trust issues subordinated certificates, holders of such subordinated certificates may not share in the amount distributed on a pro rata basis with the senior certificateholders. The Department notes that the proposed exemption does not provide relief for plan investments in such subordinated certificates, unless such certificates are issued in a Designated Transaction.</P>
            </FTNT>

            <P>8. For tax reasons, the trust will be maintained as an essentially passive entity. Therefore, both the sponsor's discretion and the servicer's discretion with respect to assets included in a trust are severely limited. Pooling and servicing agreements provide for the substitution of receivables by the sponsor only in the event of defects in documentation discovered within a <PRTPAGE P="49312"/>short time after the issuance of investor certificates (within 120 days, except in the case of obligations having an original term of 30 years, in which case the period will not exceed two years). Any receivable so substituted is required to have characteristics substantially similar to the replaced receivable and will be at least as creditworthy as the replaced receivable. </P>
            <P>In some cases, the affected receivable would be repurchased, with the purchase price applied as a payment on the affected receivable and passed-through to certificateholders. </P>
            <HD SOURCE="HD2">Interest Rate Swaps </HD>
            <P>9. RBC-DR requests relief for both ratings dependent and non-ratings dependent swaps as described in Prohibited Transaction Exemption 2000-58 (65 FR 67765, November 13, 2000) (PTE 2000-58), subject to the same terms and conditions regarding interest rate swaps contained in that exemption. </P>
            <HD SOURCE="HD1">Conditions to Interest Rate Swaps </HD>
            <P>10. Any class of certificates to which one or more swap agreements entered into by the trust applies will be acquired or held only by qualified plan investors. Qualified plan investors will be plan investors represented by an appropriate independent fiduciary that is qualified to analyze and understand the terms and conditions of any swap transaction relating to the class of certificates to be purchased and the effect such swap would have upon the credit rating of the certificates to which the swap relates. </P>
            <HD SOURCE="HD2">Yield Supplement Agreements </HD>
            <P>11. A yield supplement agreement is a contract under which the trust makes a single cash payment to the contract provider in return for the contract provider promising to make certain payments to the trust in the event of market fluctuations in interest rates. For example, if a class of certificates promises an interest rate which is the greater of 7% per annum or LIBOR and LIBOR increases significantly, the yield supplement agreement might obligate the contract provider to pay to the trust the excess of LIBOR over 7% per annum. In some circumstances, the contract provider's obligation may be capped at a certain aggregate maximum dollar liability under the contract. Alternatively, a cap could be placed on the supplemental interest that would be paid to a securityholder from monies paid under the yield supplement agreement. For example, the yield supplement agreement would provide the difference between LIBOR and 7% but only to the extent that the securityholder would be paid a total of 9% per annum. The interest to be paid by the contract provider to the trust under the yield supplement agreement is usually calculated based on a notional principal balance which may mirror the principal balances of those classes of certificates to which the yield supplement agreement relates or some other fixed amount. This notional amount will not exceed either: (i) The principal balance of the class of certificates to which such agreement or arrangement relates, or (ii) the portion of the principal balance of such class represented solely by those types of corpus or assets of the trust referred to in subsections III.B. (1), (2) and (3) of the proposed exemption. In all cases, the trust makes no payments other than the fixed purchase price for the yield supplement agreement and may, therefore, be distinguished from an interest rate swap agreement, notwithstanding that both types of agreements may use an International Swaps and Derivatives Association, Inc. (“ISDA”) form of contract. </P>
            <P>The Applicant notes that no “plan assets” within the meaning of the plan asset regulation (under 29 CFR 2510-3-101) are utilized in the purchase of the yield supplement agreement, as the sponsor or some other third party funds such arrangement with an up-front single-sum payment. The trust's only obligation is to receive payments from the counterparty if interest rate fluctuations require them under the terms of the contract and to pass them through to securityholders. The rating agencies examine the creditworthiness of the counterparty in a ratings dependent yield supplement agreement. The Applicant suggests that the relief for yield supplement agreements should be subject to the same conditions as for interest rate swaps, to the extent relevant. These conditions would include that the yield supplement agreement must be denominated in U.S. dollars, the agreement must not be leveraged, any changes in these conditions must be subject to the consent of the trustee, and the counterparty must be subject to the same eligibility requirements as an interest rate swap counterparty. </P>
            <HD SOURCE="HD2">Pre-Funding Accounts </HD>
            <P>12. Although many transactions occur as described above, it is also common for other transactions to be structured using a pre-funding account and/or a capitalized interest account as described below. </P>
            <P>The pre-funding period for any trust will be defined as the period beginning on the closing date and ending on the earliest to occur of (i) The date on which the amount on deposit in the pre-funding account is less than a specified dollar amount, (ii) the date on which an event of default occurs under the related pooling and servicing agreement <SU>14</SU>
              <FTREF/> or (iii) the date which is the later of three months or ninety days after the closing date. If pre-funding is used, the sponsor or originator will transfer to the trust on the closing date cash sufficient to purchase the receivables to be transferred after the closing date. During the pre-funding period, such cash and temporary investments, if any, made therewith will be held in a pre-funding account and used to purchase the additional receivables, the characteristics of which will be substantially similar to the characteristics of the receivables transferred to the trust on the closing date. Certain specificity and monitoring requirements must be met and will be disclosed in the pooling and servicing agreement and/or the prospectus <SU>15</SU>
              <FTREF/> or private placement memorandum.<SU>16</SU>
              <FTREF/>
            </P>
            <FTNT>
              <P>
                <SU>14</SU> The minimum dollar amount is generally the dollar amount below which it becomes too uneconomical to administer the pre-funding account. An event of default under the pooling and servicing agreement generally occurs when: (i) A breach of a covenant or a breach of a representation and warranty concerning the sponsor, the servicer, or certain other parties occurs which is not cured; (ii) a required payment to certificateholders is not made; or (iii) the servicer becomes insolvent.</P>
            </FTNT>
            <FTNT>
              <P>
                <SU>15</SU> References to the term “prospectus” herein shall include any prospectus supplement related thereto, pursuant to which certificates are offered to investors.</P>
            </FTNT>
            <FTNT>
              <P>
                <SU>16</SU> See the Proposal to PTE 2000-58 (August 23, 2000, 65 FR 51454, at page 51463) for a fuller explanation of pre-funding accounts.</P>
            </FTNT>
            <HD SOURCE="HD2">Capitalized Interest Accounts </HD>
            <P>13. When a pre-funding account is used, the sponsor and/or originator may also transfer to the trust additional cash on the closing date, to be deposited in a capitalized interest account and used during the pre-funding period to compensate the certificateholders for any shortfall between the investment earnings on the pre-funding account and the pass-through interest rate payable under the certificates. </P>

            <P>Because the certificates are supported by the receivables in the trust and the earnings on the pre-funding account, the capitalized interest account is needed when the investment earnings on the pre-funding account and the interest paid on the receivables are less than the interest payable on the certificates. The capitalized interest account funds are paid out periodically to the certificateholders as needed on distribution dates to support the pass-through rate. In addition, a portion of such funds may be returned to the <PRTPAGE P="49313"/>sponsor from time to time as the receivables are transferred into the trust and the need for the capitalized interest account diminishes. Any amounts held in the capitalized interest account generally will be returned to the sponsor and/or originator either at the end of the pre-funding period or periodically as receivables are transferred and the proportionate amount of funds in the capitalized interest account can be reduced. Generally, the capitalized interest account terminates no later than the end of the pre-funding period. However, there may be some cases where the capitalized interest account remains open until the first date distributions are made to certificateholders following the end of the pre-funding period. </P>
            <P>In other transactions, a capitalized interest account is not necessary because the interest paid on the receivables exceeds the interest payable on the certificates at the applicable interest rate and the fees payable by the issuer. Such excess is sufficient to make up any shortfall resulting from the pre-funding account earning less than the interest rate payable on the certificates. In certain of these transactions, this occurs because the aggregate principal amount of receivables exceeds the aggregate principal amount of certificates. </P>
            <HD SOURCE="HD2">Pre-Funding Account and Capitalized Interest Account Payments and Investments </HD>
            <P>14. Pending the acquisition of additional receivables during the pre-funding period, it is expected that amounts in the pre-funding account and the capitalized interest account will be invested in certain permitted investments or will be held uninvested. Pursuant to the pooling and servicing agreement, all permitted investments must mature prior to the date the actual funds are needed. The permitted types of investments in the pre-funding account and capitalized interest account are investments which either: (i) Are direct obligations of, or obligations fully guaranteed as to timely payment of principal and interest by, the United States or any agency or instrumentality thereof, provided that such obligations are backed by the full faith and credit of the United States or (ii) have been rated (or the obligor has been rated) in one of the three highest generic rating categories (or four, in the case of Designated Transactions) by a rating agency, as set forth in the pooling and servicing agreement and as required by the rating agencies. The credit grade quality of the permitted investments is generally no lower than that of the certificates. The types of permitted investments will be described in the pooling and servicing agreement. </P>
            <P>The ordering of interest payments to be made from the pre-funding and capitalized interest accounts is pre-established and set forth in the pooling and servicing agreement. The only principal payments which will be made from the pre-funding account are those made to acquire the receivables during the pre-funding period and those distributed to the certificateholders in the event that the entire amount in the pre-funding account is not used to acquire receivables. The only principal payments which will be made from the capitalized interest account are those made to certificateholders if necessary to support the certificate pass-through rate or those made to the sponsor either periodically as they are no longer needed or at the end of the pre-funding period when the capitalized interest account is no longer necessary. </P>
            <HD SOURCE="HD2">The Characteristics of the Receivables Transferred During the Pre-Funding Period </HD>
            <P>15. In order to ensure that there is sufficient specificity as to the representations and warranties of the sponsor regarding the characteristics of the receivables to be transferred after the closing date: </P>
            <P>(i) The pre-funding limit will not be exceeded; </P>
            <P>(ii) All such receivables will meet the same terms and conditions for eligibility as those of the original receivables used to create the trust corpus (as described in the prospectus or private placement memorandum and/or pooling and servicing agreement for such certificates), which terms and conditions have been approved by a rating agency. However, the terms and conditions for determining the eligibility of a receivable may be changed if such changes receive prior approval either by a majority vote of the outstanding certificateholders or by a rating agency; <SU>17</SU>
              <FTREF/>
            </P>
            <FTNT>
              <P>
                <SU>17</SU> In some transactions, the insurer and/or credit support provider may have the right to veto the inclusion of receivables, even if such receivables otherwise satisfy the underwriting criteria. This right usually takes the form of a requirement that the sponsor obtain the consent of these parties before the receivables can be included in the trust. The insurer and/or credit support provider may, therefore, reject certain receivables or require that the sponsor establish certain trust reserve accounts as a condition of including these receivables. Virtually all trusts which have insurers or other credit support providers are structured to give such veto rights to these parties. The percentage of trusts that have insurers and/or credit support providers, and accordingly feature such veto rights, varies.</P>
            </FTNT>
            <P>(iii) The transfer to the trust of the receivables acquired during the pre-funding period will not result in the certificates receiving a lower credit rating from the rating agency upon termination of the pre-funding period than the rating that was obtained at the time of the initial issuance of the certificates by the trust; </P>
            <P>(iv) The weighted average annual percentage interest rate (the average interest rate) for all of the obligations in the trust at the end of the pre-funding period will not be more than 100 basis points lower than the average interest rate for the obligations which were transferred to the trust on the closing date; and </P>
            <P>(v) The trustee of the trust (or any agent with which the trustee contracts to provide trust services) will be a substantial financial institution or trust company experienced in trust activities and familiar with its duties, responsibilities, and liabilities as a fiduciary under ERISA. The trustee, as the legal owner of the obligations in the trust, will enforce all the rights created in favor of certificateholders of such trust, including employee benefit plans subject to ERISA. </P>
            <P>In order to ensure that the characteristics of the receivables actually acquired during the pre-funding period are substantially similar to receivables that were acquired as of the closing date, the characteristics of the additional obligations subsequently acquired will either be monitored by a credit support provider or other insurance provider which is independent of the sponsor or an independent accountant retained by the sponsor will provide the sponsor with a letter (with copies provided to the rating agency, the underwriter and the trustees) stating whether or not the characteristics of the additional obligations acquired after the closing date conform to the characteristics of such obligations described in the prospectus, private placement memorandum and/or pooling and servicing agreement. In preparing such letter, the independent accountant will use the same type of procedures as were applicable to the obligations which were transferred as of the closing date. </P>

            <P>Each prospectus, private placement memorandum and/or pooling and servicing agreement will set forth the terms and conditions for eligibility of the receivables to be included in the trust as of the related closing date, as well as those to be acquired during the pre-funding period, which terms and conditions will have been agreed to by the rating agencies which are rating the applicable certificates as of the closing date. Also included among these conditions is the requirement that the <PRTPAGE P="49314"/>trustee be given prior notice of the receivables to be transferred, along with such information concerning those receivables as may be requested. Each prospectus or private placement memorandum will describe the amount to be deposited in, and the mechanics of, the pre-funding account and will describe the pre-funding period for the trust. </P>
            <HD SOURCE="HD2">Parties to Transactions </HD>
            <P>16. The originator of a receivable is the entity that initially lends money to a borrower (obligor), such as a homeowner or automobile purchaser, or leases property to a lessee. The originator may either retain a receivable in its portfolio or sell it to a purchaser, such as a trust sponsor. Originators of receivables included in the trusts will be entities that originate receivables in the ordinary course of their business, including finance companies for whom such origination constitutes the bulk of their operations, financial institutions for whom such origination constitutes a substantial part of their operations, and any kind of manufacturer, merchant, or service enterprise for whom such origination is an incidental part of its operations. The originator of the receivables may also function as the trust sponsor or servicer. Each trust may contain assets of one or more originators. </P>
            <P>17. The sponsor will be one of three entities: (i) A special-purpose or other corporation unaffiliated with the servicer, (ii) a special-purpose or other corporation affiliated with the servicer, or (iii) the servicer itself. Where the sponsor is not also the servicer, the sponsor's role will generally be limited to acquiring the receivables to be included in the trust, establishing the trust, designating the trustee, and assigning the receivables to the trust. </P>
            <P>18. The trustee of a trust (or the issuer if it is not a trust) is the legal owner of the obligations in the trust and would hold a security interest in the collateral securing such obligations. The trustee is also a party to or beneficiary of all the documents and instruments deposited in the trust, and as such is responsible for enforcing all the rights created thereby in favor of certificateholders. The trustee generally will be an independent entity, although that the trustee may be related to the Applicant.<SU>18</SU>
              <FTREF/> The Applicant represents that the trustee will be a substantial financial institution or trust company experienced in trust activities. The trustee receives a fee for its services, which will be paid from cash flows in the trust. The method of compensating the trustee, which is specified in the pooling and servicing agreement, will be disclosed in the prospectus or private placement memorandum relating to the offering of the certificates. </P>
            <FTNT>
              <P>
                <SU>18</SU> <E T="03">See</E> Prohibited Transaction Exemption 2002-41 (67 FR 54487, August 22, 2002), an amendment to the prior individual exemptions granted for mortgage-backed and other asset-backed securities (the Underwriter Exemptions), which permits the trustee of the trust to be an affiliate of the underwriter of the certificates.</P>
            </FTNT>
            <P>The rights and obligations of the indenture trustee are no different than those of the trustee of an issuer which is a trust. The indenture trustee is obligated to oversee and administer the activities of all of the ongoing parties to the transaction and possesses the authority to replace those entities, sue them, liquidate the collateral and perform all necessary acts to protect the interests of the debt holders. If debt is issued in a transaction, there may not be a pooling and servicing agreement. Instead, there is a sales agreement and servicing agreement (or these two agreements are sometimes combined into a single agreement). The agreement(s) set(s) forth, among other things, the duties and responsibilities of the parties to the transaction relating to the administration of the Issuer. The indenture trustee is often a party to these agreements. At a minimum, the indenture trustee acknowledges its rights and responsibilities in these agreements or they are contractually set forth in the indenture agreement pursuant to which the indenture trustee is appointed. </P>
            <P>19. The servicer of a trust administers the receivables on behalf of the certificateholders. The servicer's functions typically involve, among other things, notifying borrowers of amounts due on receivables, maintaining records of payments received on receivables and instituting foreclosure or similar proceedings in the event of default. In cases where a pool of receivables has been purchased from a number of different originators and deposited in a trust, the receivables may be “subserviced” by their respective originators and a single entity may “master service” the pool of receivables on behalf of the owners of the related series of certificates. Where this arrangement is adopted, a receivable continues to be serviced from the perspective of the borrower by the local subservicer, while the investor's perspective is that the entire pool of receivables is serviced by a single, central master servicer who collects payments from the local subservicers and passes them through to certificateholders. </P>
            <P>A servicer's default is treated in the same manner whether or not the issuer is a trust. The original servicer can be replaced, and the entity replacing the servicer varies from transaction to transaction. In certain cases, it may be the trustee (or indenture trustee if the issuer is not a trust) or it may be a third party satisfactory to the rating agencies and/or credit support provider. In addition, there are transactions where the trustee or indenture trustee will assume the servicer's responsibilities on a temporary basis until the permanent replacement takes over. In all cases, the replacement entity must be capable of satisfying all of the duties and responsibilities of the original servicer and must be an entity that is satisfactory to the rating agencies. </P>
            <P>If, after the initial issuance of certificates, a servicer of receivables held by a trust which has issued certificates in reliance upon the Underwriter Exemptions (or an affiliate thereof) merges with or is acquired by (or acquires) the trustee of such trust (or an affiliate thereof), and thereby becomes an affiliate of the trustee, the requirement that the trustee not be an affiliate of the restricted group (other than the underwriter) will not be violated, provided that: (i) Such servicer ceases to be an affiliate of the trustee no later than six months after the date such servicer became an affiliate of the trustee; and (ii) such servicer did not breach any of its obligations under the pooling and servicing agreement, unless such breach was immaterial and timely cured in accordance with the terms of such agreement, during the period from the closing date of such merger or acquisition transaction through the date the servicer ceased to be an affiliate of the trustee. </P>
            <P>20. The underwriter will be a registered broker-dealer that acts as underwriter or placement agent with respect to the sale of the certificates. Public offerings of certificates are generally made on a firm commitment basis. Private placements of certificates may be made on a firm commitment or agency basis. It is anticipated that the lead and co-managing underwriters will make a market in certificates offered to the public. </P>

            <P>In most cases, the originator and servicer of receivables to be included in a trust and the sponsor of the trust (although they may themselves be related) will be unrelated to RBC-DR. In other cases, however, affiliates of RBC-DR may originate or service receivables included in a trust or may sponsor a trust. <PRTPAGE P="49315"/>
            </P>
            <HD SOURCE="HD2">Certificate Price, Interest Rate and Fees </HD>
            <P>21. As compensation for the receivables transferred to the trust, the sponsor receives certificates representing the entire beneficial interest in the trust, or the cash proceeds of the sale of such certificates. If the sponsor receives certificates from the trust, the sponsor sells all or a portion of these certificates for cash to investors or securities underwriters. </P>
            <P>22. The price of the certificates, both in the initial offering and in the secondary market, is affected by market forces, including investor demand, the specified interest rate on the certificates in relation to the rate payable on investments of similar types and quality, expectations as to the effect on yield resulting from prepayment of underlying receivables, and expectations as to the likelihood of timely payment. </P>
            <P>The interest rate for certificates is typically equal to the interest rate on receivables included in the trust minus a specified servicing fee.<SU>19</SU>
              <FTREF/> This rate is generally determined by the same market forces that determine the price of a certificate. The price of a certificate and its interest, or coupon, rate together determine the yield to investors. If an investor purchases a certificate at less than par, that discount augments the stated interest rate; conversely, a certificate purchased at a premium yields less than the stated coupon. </P>
            <FTNT>
              <P>
                <SU>19</SU> The interest rate on certificates representing interests in trusts holding leases is determined by breaking down lease payments into “principal” and “interest” components based on an implicit interest rate. Certificates issued by trusts that are classified as REMICs for federal income tax purposes may use different formulas for setting the specified interest rate with respect to certificates.</P>
            </FTNT>
            <P>23. As compensation for performing its servicing duties, the servicer (who may also be the sponsor or an affiliate thereof, and receive fees for acting in that capacity) will retain the difference between payments received on the receivables in the trust and payments payable (at the interest rate) to certificateholders, except that in some cases a portion of the payments on receivables may be paid to a third party, such as a fee paid to a provider of credit support. The servicer may receive additional compensation by having the use of the amounts paid on the receivables between the time they are received by the servicer and the time they are due to the trust (which time is set forth in the pooling and servicing agreement). The servicer typically will be required to pay the administrative expenses of servicing the trust, including in some cases the trustee's fee, out of its servicing compensation. </P>
            <P>The servicer is also compensated to the extent it may provide credit enhancement to the trust or otherwise arrange to obtain credit support from another party. This “credit support fee” may be aggregated with other servicing fees, and is either paid out of the interest income received on the receivables in excess of the pass-through rate or paid in a lump sum at the time the trust is established. </P>
            <P>24. The servicer may be entitled to retain certain administrative fees paid by a third party, usually the obligor. These administrative fees fall into three categories: (a) Prepayment fees; (b) late payment and payment extension fees; and (c) expenses, fees and charges associated with foreclosure or repossession, or other conversion of a secured position into cash proceeds, upon default of an obligation. </P>
            <P>Compensation payable to the servicer will be set forth or referred to in the pooling and servicing agreement and described in reasonable detail in the prospectus or private placement memorandum relating to the certificates. </P>
            <P>25. Payments on receivables may be made by obligors to the servicer at various times during the period preceding any date on which pass-through payments to the trust are due. In some cases, the pooling and servicing agreement may permit the servicer to place these payments in non-interest bearing accounts maintained with itself or to commingle such payments with its own funds prior to the distribution dates. In these cases, the servicer would be entitled to the benefit derived from the use of the funds between the date of payment on a receivable and the pass-through date. Commingled payments may not be protected from the creditors of the servicer in the event of the servicer's bankruptcy or receivership. In those instances when payments on receivables are held in non-interest bearing accounts or are commingled with the servicer's own funds, the servicer is required to deposit these payments by a date specified in the pooling and servicing agreement into an account from which the trustee makes payments to certificateholders. </P>
            <P>26. The underwriter will receive a fee in connection with the securities underwriting or private placement of certificates. In a firm commitment underwriting, this fee would consist of the difference between what the underwriter receives for the certificates that it distributes and what it pays the sponsor for those certificates. In a private placement, the fee normally takes the form of an agency commission paid by the sponsor. In a best efforts underwriting in which the underwriter would sell certificates in a public offering on an agency basis, the underwriter would receive an agency commission rather than a fee based on the difference between the price at which the certificates are sold to the public and what it pays the sponsor. In some private placements, the underwriter may buy certificates as principal, in which case its compensation would be the difference between what it receives for the certificates that it sells and what it pays the sponsor for these certificates. </P>
            <HD SOURCE="HD2">Certificate Ratings </HD>
            <P>27. The certificates for which exemptive relief is requested will have received one of the three highest ratings (four, in the case of Designated Transactions) available from the rating agency. Insurance or other credit support (such as surety bonds, letters of credit, guarantees, or overcollateralization) will be obtained by the trust sponsor to the extent necessary for the certificates to attain the desired rating. The amount of this credit support is set by the rating agencies at a level that is a multiple of the worst historical net credit loss experience for the type of obligations included in the issuing trust. </P>
            <HD SOURCE="HD2">Subordination </HD>
            <P>28. The market has now evolved to the point where asset-backed securities/mortgage-backed securities (“ABS/MBS”) offerings typically include multiple tranches of senior and subordinated investment-grade securities. The Applicant believes that rating agencies can rate subordinated classes of securities with a high level of expertise, thereby ensuring the safety of these investments for plans through the use of other credit support (including increased levels of non-investment-grade securities). The subordination of a security, while factored into the evaluation made by the rating agencies in their assessment of credit risk, is not indicative of whether a security is more or less safe for investors. In fact, there are “AAA” rated subordinated securities.<SU>20</SU>

              <FTREF/> Subordination is simply another form of credit support. The rating agencies, after determining the level of credit support required to achieve a given rating level, are essentially indifferent as to how these credit support requirements are implemented— whether through <PRTPAGE P="49316"/>subordination or other means. If subordination is used, however, the subordinated class will have no greater credit risks or fewer legal protections in comparison with other credit-supported classes that possesses the same rating.</P>
            <FTNT>
              <P>
                <SU>20</SU> For example, a transaction may have two classes of “AAA” rated securities and one is subordinated to the other. The subordinated class would be required to have more credit support to qualify for the “AAA” rating than the more senior “AAA” rated class.</P>
            </FTNT>
            <P>There is much benefit to plan investors in having subordinated securities eligible for exemptive relief. First, credit support provided through third-party credit providers is more expensive than an equal amount of credit support provided through subordination. As a result, the ability to use subordinated tranches to provide credit support for the more senior classes (which may or may not themselves be subordinated) creates economic savings for all the parties to the transaction which, in turn, can allow greater returns to investors. In addition, if the credit rating of a third-party credit support provider is downgraded, the rating of the securities is also downgraded. Second, the yields available on subordinated securities are often higher than those paid on comparably rated non-subordinated securities because investors expect to receive higher returns for subordinated securities. Third, subordinated securities are usually paid after other more senior securities, which results in their having longer terms to maturity. This is appealing to many investors who are looking for medium-term fixed income investments to diversify their portfolios. The combination of these factors benefits investors by making available securities which can provide higher yields for longer periods. It should be noted that as the rating of a security generally addresses the probability of all interest being timely paid and all principal being paid by maturity under various stress scenarios, the rating agencies are particularly concerned with the ability of the pool to generate sufficient cash flow to pay all amounts due on subordinated tranches, and several features of the credit support mechanisms discussed below are designed to protect subordinated classes of securities. </P>
            <HD SOURCE="HD2">Types of Credit Support </HD>
            <P>29. Credit support consists of two general varieties: external credit support and internal credit support. The Applicant notes that the choice of the type of credit support depends on many factors. Internal credit support which is generated by the operation of the Issuer is preferred because it is less expensive than external credit support which must be purchased from outside third parties. In addition, there is a limited number of appropriately rated third-party credit support providers available. Further, certain types of credit support are not relevant to certain asset types. For example, there is generally little or no excess spread available in residential or CMBS transactions because the interest rates on the obligations being securitized are relatively low. Third, the ratings agencies may require certain types of credit support in a particular transaction. In this regard, the selection of the types and amounts of the various kinds of credit support for any given transaction are usually a product of negotiations between the underwriter of the securities and the ratings agencies. For example, the underwriter might propose using excess spread and subordination as the types of credit support for a particular transaction and the rating agency might require cash reserve accounts funded up front by the sponsor, excess spread and a smaller sized subordinated tranche than that proposed by the underwriter. In addition, market forces can affect the types of credit support. For example, there may not be a market for subordinated tranches because the transaction cannot generate sufficient cash flow to pay a high enough interest rate to compensate investors for the subordination feature, or the market may demand an insurance wrap on a class of securities before it will purchase certain classes of securities. All of these considerations interact to dictate which particular combination of credit support will be used in a particular transaction. </P>
            <HD SOURCE="HD2">External Credit Support </HD>
            <P>30. In the case of external credit support, credit enhancement for principal and interest repayments is provided by a third party so that if required collections on the pooled receivables fall short due to greater than anticipated delinquencies or losses, the credit enhancement provider will pay the securityholders the shortfall. Examples of such external credit support features include: insurance policies from “AAA” rated monoline <SU>21</SU>
              <FTREF/> insurance companies (referred to as “wrapped” transactions), corporate guarantees, letters of credit and cash collateral accounts. In the case of wrapped or other credit supported transactions, the Insurer or other credit provider will usually take a lead role in negotiating with the sponsor concerning levels of overcollateralization and selection of receivables for inclusion into the pool as it is the Insurer or credit provider that will bear the ultimate risk of loss. </P>
            <FTNT>
              <P>
                <SU>21</SU> The term “monoline” is used to describe such insurance companies because writing these types of insurance policies is their sole business activity.</P>
            </FTNT>
            <HD SOURCE="HD2">Internal Credit Support </HD>
            <P>31. Internal credit support relies upon some combination of utilization of excess interest generated by the receivables, specified levels of overcollateralization and/or subordination of junior classes of certificates. Transactions that look almost exclusively to the underlying pooled assets for cash payments (or “senior/subordinated” transactions) will contain multiple classes of certificates, some of which bear losses prior to others and, therefore, support more senior certificates. A subordinate certificate will absorb realized losses from the asset pool, and have its principal amount “written down” to zero, before any losses will be allocated to the more senior classes. In this way, the more senior classes will receive higher rating classifications than the more subordinate classes. However, the rating agencies require cash flow modeling of all senior/subordinated structures. These cash flows must be sufficient so that all rated classes, including the subordinated classes, will receive timely payment of interest and ultimate repayment of principal by the maturity date. The cash flow models are tested assuming a variety of stressed prepayment speeds, declining weighted average interest payments and loss assumptions. Other structural mechanisms to assure payment to subordinated classes are to allow collections held in the reserve account for the next payment date to be used if necessary to pay current interest to the subordinated class or to create a separate interest liquidity reserve. The collections held in the reserve account are from principal and interest paid on the underlying mortgages or other receivables held in the trust and are not from the securities issued by the issuer.<SU>22</SU>
              <FTREF/> Also, some structures allow <PRTPAGE P="49317"/>both principal and interest to be applied to all payments to securityholders and, in others, principal can be used to pay interest to the subordinate tranches. </P>
            <FTNT>
              <P>
                <SU>22</SU> A collections reserve account is established for almost all transactions to hold interest and principal payments on the mortgages or receivables as they are collected until the necessary amounts are paid to securityholders on the next periodic distribution date. In some transactions, the rating agencies or other interested parties may require, in order to protect the interests of the securityholders, that excess interest in amount(s) equal to a specified number of future period anticipated collections be retained in the collection account. This protects both senior and subordinated securityholders in situations where there are shortfalls in collections on the underlying obligations because it provides an additional source of funds from which these securityholders can be paid their current distributions before the holders of the residual or more subordinated securities receive their periodic distributions, if any. Accordingly, any reference to “collections” from principal and interest paid on the mortgages is intended to describe such excess <PRTPAGE/>interest or principal not required to cover current payments to the senior and subordinated class eligible to be purchased by plans. Thus, this mechanism is not harmful to the interests of senior securityholders.</P>
            </FTNT>
            <P>Interest which is received but is not required to make monthly payments to securityholders (or to pay servicing or other administrative fees or expenses) can be used as credit support. This excess interest is known as “excess spread” or “excess servicing” and may be paid out to holders of certain securities, returned to the sponsor or used to build up overcollateralization or a loss reserve. The credit given to excess spread is conservatively evaluated to ensure sufficient cash flow at any one point in time to cover losses. The rating agencies reduce the credit given to excess spread as credit support to take into account the risk of higher coupon loans prepaying first, higher than expected total prepayments, timing mismatching of losses with excess spread collections and the amounts allowed to be returned to the sponsor once minimum overcollateralization targets are met (thereby reducing the amounts available for credit support). </P>
            <P>“Overcollateralization” is the difference between the outstanding principal balance of the pool of assets and the outstanding principal balance of the certificates backed by such pool of assets. This results in a larger principal balance of underlying assets than the amount needed to make all required payments of principal to investors. In all senior/subordinated transactions, the requisite level of overcollateralization and the amount of principal that may be paid to holders of the more subordinated certificates before the more senior securities are retired (since once such amounts are paid, they are unavailable to absorb future losses) is determined by the rating agencies and varies from transaction to transaction, depending on the type of assets, quality of the assets, the term of the certificates and other factors. </P>
            <P>The senior/subordinated structure often combines the use of subordinated tranches with overcollateralization that builds over time from the application of excess interest to pay principal on more senior classes. This is often referred to as a “turbo” structure. The credit enhancement for each more senior class is provided by the aggregate dollar amount of the respective subordinated classes, plus overcollateralization that results from the payment of principal to the more senior classes using excess spread prior to payment of any principal to the more subordinated classes. As overcollateralization grows, the pool of loans can withstand a larger dollar amount of losses without resulting in losses on the senior certificates. This also has the effect of increasing the amount of funds available to pay the more subordinated classes as an ever-decreasing portion of the principal cash flow is needed to pay the more senior classes. Excess interest is used to pay down the more senior certificate balances until a specific dollar amount of overcollateralization is achieved. This is referred to as the overcollateralization target amount required by the rating agencies. Typically, the targeted amount is set to ensure that even in a worst-case loss scenario commensurate with the assigned rating level, all securityholders, including holders of subordinated classes, will receive timely payment of interest and ultimate payment of principal by the applicable maturity date. In these transactions, the targeted amount is usually set as a percentage of the original pool balance. It may be reduced after a fixed number of years after the closing date, subject to the satisfaction of certain loss and delinquency triggers. These triggers ensure that overcollateralization continues to be available if pool performance begins to deteriorate. In a senior/subordinated structure, every investment-grade class (whether or not subordinated) is protected by either a lower rated subordinated class or classes or other credit support. </P>
            <HD SOURCE="HD2">Provision of Credit Support Through Servicer Advancing </HD>
            <P>32. In some cases, the master servicer, or an affiliate of the master servicer, may provide credit support to the trust. In these cases, the master servicer, in its capacity as servicer, will first advance funds to the full extent that it determines that such advances will be recoverable (a) Out of late payments by the obligors, (b) from the credit support provider (which may be the master servicer or an affiliate thereof) or (c) in the case of a trust that issues subordinated certificates, from amounts otherwise distributable to holders of subordinated certificates; and the master servicer will advance such funds in a timely manner. When the servicer is the provider of the credit support and provides its own funds to cover defaulted payments, it will do so either on the initiative of the trustee, or on its own initiative on behalf of the trustee, but in either event it will provide such funds to cover payments to the full extent of its obligations under the credit support mechanism. In some cases, however, the master servicer may not be obligated to advance funds but instead would be called upon to provide funds to cover defaulted payments to the full extent of its obligations as insurer. Moreover, a master servicer typically can recover advances either from the provider of credit support or from future payments on the affected assets. </P>
            <P>If the master servicer fails to advance funds, fails to call upon the credit support mechanism to provide funds to cover delinquent payments, or otherwise fails in its duties, the trustee would be required and would be able to enforce the certificateholders' rights, as both a party to the pooling and servicing agreement and the owner of the trust estate, including rights under the credit support mechanism. Therefore, the trustee, who is independent of the servicer, will have the ultimate right to enforce the credit support arrangement. </P>
            <P>When a master servicer advances funds, the amount so advanced is recoverable by the master servicer out of future payments on receivables held by the trust to the extent not covered by credit support. However, where the master servicer provides credit support to the trust, there are protections in place to guard against a delay in calling upon the credit support to take advantage of the fact that the credit support declines proportionally with the decrease in the principal amount of the obligations in the trust as payments on receivables are passed through to investors.<SU>23</SU>
              <FTREF/>
            </P>
            <FTNT>
              <P>
                <SU>23</SU> See the Proposal to PTE 2000-58 (August 23, 2000, 65 FR 51454, at page 51475) for a fuller explanation of these safeguards.</P>
            </FTNT>
            <HD SOURCE="HD2">Description of Designated Transactions</HD>

            <P>33. The Applicant requests relief for senior and/or subordinated investment-grade certificates with respect to a limited number of asset categories: Motor vehicles, residential/home equity, manufactured housing and commercial mortgage backed securities. Accordingly, set forth below are separate profiles of a typical transaction for each asset category. Each profile describes specifically how each type of transaction generally is structured. Information on the due diligence that the rating agencies conduct before assigning a rating to a particular class of such securities, the calculations that are performed to determine projected cash flows, loss frequency and loss severity and the manner in which credit support requirements are determined for each rating class is not included because such information has been provided previously to the Department in connection with PTE 2000-58. The <PRTPAGE P="49318"/>motor vehicle, residential/home equity, manufactured housing and commercial mortgage backed transactions, as described in this section, are collectively referred to herein as “Designated Transactions.” </P>
            <HD SOURCE="HD2">Motor Vehicle Loan Transactions </HD>
            <P>34. In a typical motor vehicle transaction, “AAA” rated senior certificates are issued that might represent approximately 90% or more of the principal balances of the certificates, with “A” rated subordinated certificates issued that might represent the remaining 10% or less of the principal balance of the certificates. The total level of credit enhancement from all sources, including excess spread, typically averages approximately 7% of the initial principal balance of certificates issued by prime issuers and 14% for subprime issuers in order to obtain an “AAA” rated certificate. Credit support equaling 3% for prime issuers is usually required in order to obtain an “A” or better rating on the subordinated certificates. Typical types of credit support used in auto transactions are subordination, reserve accounts, excess spread and financial guarantees from “AAA” rated monoline insurance companies. Transactions with subprime sponsors generally use surety bonds as credit enhancement, so there is no subordinated class. </P>
            <HD SOURCE="HD2">Residential/Home Equity Mortgage Transactions </HD>
            <P>35. In a typical prime residential mortgage transaction, “AAA” rated senior Securities might be issued which represent approximately 95% of the principal balances of the Securities; “AA” rated subordinated Securities might comprise 2%; “A” rated subordinated 1%; “BBB” rated subordinated 1% and junior subordinated Securities might constitute 1%. The total level of credit enhancement from all sources averages about 4% in order to obtain “AAA” rated Securities, 2% for an “AA” rating, 1.5% for an “A” rating and 1% for a “BBB” rating. Subordination is the predominant type of credit support used in traditional prime residential mortgage transactions. </P>
            <P>In a typical “B&amp;C home/equity loan” transaction (loans made primarily to B and C quality borrowers for consolidating credit card and other consumer debt or refinancing mortgage loans), “AAA” rated senior certificates might be issued which represent 80% of the principal balances of the certificates; “AA” rated subordinated certificates might comprise 11%; “A” rated subordinated 6%; “BBB” or lower rated subordinated certificates might constitute 3%. The total level of credit enhancement from all sources averages about 13% in order to obtain “AAA” rated certificates, 10% for an “AA” rating, 7% for an “A” rating and 3% for a “BBB” rating. </P>
            <P>In a typical HLTV ratio (<E T="03">i.e.</E>, above 100%) second-lien loan transaction, “AAA” rated senior certificates might be issued which represent approximately 76% of the principal balances of the certificates; “AA” rated subordinated certificates might comprise 10%; “A” rated subordinated 3%; “BBB” rated subordinated 4% and junior subordinated certificates might constitute 7%. The total level of credit enhancement from all sources averages about 24% in order to obtain “AAA” rated certificates, 14% for an “AA” rating, 10% for an “A” rating and 7% for a “BBB” rating. Typical types of credit support used in home equity transactions are subordination, reserve accounts, excess spread, overcollateralization and in transactions which do not use subordination, financial guarantees from “AAA” rated monoline insurance companies or highly rated sponsors. </P>
            <HD SOURCE="HD2">Manufactured Housing Transactions </HD>
            <P>36. In a typical manufactured housing transaction, “AAA” rated senior certificates might be issued which represent approximately 80% of the principal balances of the certificates; “AA” rated subordinated certificates might comprise 6%; “A” rated subordinated 5%; “BBB” rated subordinated 5% and junior subordinated certificates might constitute 4%. The total level of credit enhancement from all sources including excess spread averages about 15%-16% in order to obtain “AAA” rated certificates, 10%-11% for an “AA” rating, 7.5%-8.5% for an “A” rating and 3.5%-9% for a “BBB” rating. Typical types of credit support used in manufactured housing transactions are subordination, reserve accounts, excess spread, overcollateralization and financial guarantees from “AAA” rated monoline insurance companies or highly rated sponsors. Overcollateralization is also used as credit support for the subordinated certificates once the seniors have been paid. Because the coupon rate on manufactured housing loans is substantially higher than that charged on traditional residential mortgages, there is a large amount of excess spread (typically more than 300 bps) that can be used for credit support of both senior and subordinated tranches. In other structures, the excess spread is trapped into a reserve fund which provides the credit support for the subordinated tranches. In still other cases, credit support is provided to an investment-grade subordinated tranche through a junior subordinated tranche which receives principal only after the more senior subordinated tranches are paid. Sponsor guarantees are also used as credit support. </P>
            <HD SOURCE="HD2">Commercial Mortgage-Backed Securities (CMBS) </HD>
            <P>37. In a typical CMBS transaction, two classes of “AAA” rated certificates might be issued which represent approximately 78% of the principal balances of the certificates (one such “AAA” class will be issued with a shorter, and the other “AAA” class with a longer, expected maturity); “AA” rated subordinated certificates might represent 5%; “A” rated subordinated 5%; “BBB” rated subordinated 5% and junior subordinated certificates 7%. The total level of credit enhancement from all sources averages about 23% in order to obtain “AAA” rated certificates, 18% for an “AA” rating, 13% for an “A” rating and 7% for a “BBB” rating. Subordination is generally the only type of credit support used in CMBS transactions. </P>
            <P>The servicer function in a CMBS transaction is particularly important because not only does the servicer or servicers fulfill the normal functions of collecting and remitting loan payments from borrowers to securityholders and advancing funds for such purposes, but the servicer may also become responsible for activities relating to defaulted or potentially defaulting loans (which are more likely to be restructured than in non-commercial transactions where the loans are usually liquidated). If a servicer advances funds, its credit rating cannot be more than one rating category below the highest rated tranche in the securitization and no less than “BBB” unless it has a qualifying back-up advancer. All entities servicing CMBS transactions must be approved by the rating agencies. </P>

            <P>An additional responsibility of the servicer is ensuring that insurance is maintained by each borrower covering each mortgaged property in accordance with the applicable mortgage documents. Insurance coverage typically includes, at a minimum, fire and casualty, general liability and rental interruption insurance but may include flood and earthquake coverage depending on the location of a particular mortgaged property. If a borrower fails to maintain the required insurance coverage or the mortgaged property defaults and becomes an asset <PRTPAGE P="49319"/>of the trust, the servicer is obligated to obtain insurance which, in pool transactions, may be provided by a blanket policy covering all pool properties. Generally, the blanket policy must be provided by an insurance provider with a rating of at least “BBB.” </P>
            <P>Each servicer, special servicer and subservicer is required to maintain a fidelity bond and a policy of insurance covering loss occasioned by the errors and omissions of its officers and employees in connection with its servicing obligations unless the rating agency allows self-insurance. All fidelity bonds and policies of errors and omissions insurance must be issued in favor of the trustee or other issuer by insurance carriers which are rated by the rating agency with a claims-paying ability rating no lower than two categories below the highest rated certificates in the transaction but no less than “BBB.” Subservicers may not make important servicing decisions (such as modifications of the mortgage loans or the decision to foreclose) without the involvement of the master servicer or special servicer, and the trustee or any successor servicer may be permitted to terminate the subservicing agreement without cause and without cost or further obligation to the issuer or the holders of the rated certificates. </P>
            <P>Loans secured by credit tenant leases require special analysis. Credit enhancement for credit tenant loans is based on an analysis of the probability that the lessee will file bankruptcy, and the likelihood that the lessee will disaffirm the lease and loan structures that may present a risk other than that of the lessee filing bankruptcy. </P>
            <P>Environmental reports for each property are generally required. A reserve is usually required for any reported remediation costs, and any actions covenanted must be completed within a specified period. Risks that cannot be quantified or that have not been mitigated through either remediation or reserves are assumed to pose a risk to the trust and are reflected in the credit enhancement requirements. Properties with certain types of asbestos problems, or those that are assumed to have such problems given their date of construction, are assumed to have higher losses due to the clean-up costs and increased difficulty or cost in leasing or selling the asset. Seasoned or acquired pools that may not have current reports for each property are also assumed to have higher environmental losses. </P>
            <P>In general, although there are other types of credit support available, subordination is the only type of credit support used in CMBS. However, protection is also provided to subordinated classes through the concept of a “directing class” which has evolved to give those holders of rated subordinated certificates in the first loss position some control over the servicing and realization on defaulted mortgage loans. In a typical transaction, the servicer might be required to obtain the consent of the directing class before proceeding with any of the following: any modification, consent or forgiveness of principal or interest with respect to a defaulted mortgage loan; any proposed foreclosure or acquisition of a mortgaged property by deed-in-lieu of foreclosure; any proposed sale of a defaulted mortgage loan and any decision to conduct environmental clean up or remediation. The directing class might also have the right to remove a servicer, with or without cause, subject to the rating agency's confirmation that appointment of the successor servicer would not result in a qualification, withdrawal or downgrade of the then-applicable rating assigned to the rated certificates, compliance with the terms and conditions of the pooling and servicing agreement and payment by the directing class of any and all termination or other fees relating to such removal. Holders of CMBS enjoy additional protection, in that the master servicer or servicer occupies a first-loss position and usually holds an equity stake in the offering, which gives it an incentive to maximize recoveries on defaulted loans. The master servicer and servicer are in a first loss position because they hold the most subordinated equity position interest(s) in the trust. Accordingly, they absorb losses before any other classes of securityholders. </P>
            <P>Additional cash flow stability is created through call protection features on the commercial mortgages held in the trust. Call protection prevents the borrowers from prepaying the mortgage loans during a fixed “lock-out period.” In certain transactions, under the terms of the mortgage agreement, the borrower is only allowed to prepay the loan at the end of the lock-out period if it provides “yield maintenance”<SU>24</SU>
              <FTREF/> whereby it is required to contribute a cash payment derived from a formula which is calculated based on current interest rates and is intended to offset the borrower's refinancing incentive. This amount also effectively compensates the trust for the loss of interest payable on the mortgage loan. </P>
            <FTNT>
              <P>
                <SU>24</SU> The Applicant represents that the yield maintenance provision in the mortgage agreement would meet the definition of a “yield supplement agreement” currently permitted under section III.B.(3)(b) of the Underwriter Exemptions.</P>
            </FTNT>
            <P>Another mechanism, referred to as “defeasance”, assures stability of cash flow and operates as follows. If a borrower wishes to have the mortgage lien released on the property (for example, where it is being sold), the original obligation either remains an asset of the trust and is assumed by a third party, or a new obligation with the same outstanding principal balance, interest rate, periodic payment dates, maturity date and default provisions is entered into with such third party. The new obligation replicates the cash flows over the remaining term of the original obligor's obligation. In either case, the property or assets originally collateralizing the obligation are replaced by collateral consisting of United States Treasury securities or any other security guaranteed as to principal and interest by the United States, or by a person controlled or supervised by and acting as an instrumentality of the Government of the United States (referred to herein as “government securities”).</P>
            <P>Defeasance generally operates so that, pursuant to an assumption and release or similar arrangement valid under applicable state law, the original obligor is replaced with a new obligor. </P>

            <P>The new obligor is generally a bankruptcy-remote special purpose entity (SPE), the assets of which consist of government securities. In the defeasance of a mortgage loan held in a CMBS pool, a new entity must be created (the SPE) which becomes the obligor on the mortgage loan and holds the government securities being substituted for the original collateral securing the mortgage loan. This newly formed entity is required by the rating agencies to be an SPE in order to assure that the owner of the securities to be pledged has no liabilities or creditors other than the CMBS pool trustee, has no assets or business other than the ownership of the government securities and is not susceptible to substantive consolidation with the original mortgage borrower in the event of the original mortgage borrower's bankruptcy. Such an SPE is purely passive and does not engage in any activities other than the ownership of securities. Although there is no prescribed market requirement as to ownership of the SPE, the securitization sponsor (<E T="03">e.g.</E>, the original mortgage lender) is usually its owner, except that in certain circumstances the original mortgage borrower may own the SPE for a variety of reasons; <E T="03">e.g.</E>, to be entitled to any excess value of securities pledged as collateral at maturity of the new defeasance note over the amount <PRTPAGE P="49320"/>due at such time. As a condition to defeasance, all fees and expenses are paid at the substitution of the government securities for the mortgage lien.</P>
            <P>Mechanically, the government securities are transferred to a custodian which holds then as collateral for the securitization trust. The payments on the government securities are actually made directly to the trust so that the SPE does not receive any payments or make any payments. </P>
            <P>Whether the original mortgage obligation is replaced with a new securitized obligation or the original obligation remains an asset of the trust, is usually dictated by how the transaction is treated for mortgage recording tax purposes under state law. Both call protection and defeasance are intended to protect investors from the risk of prepayments of the loans. </P>
            <HD SOURCE="HD1">Disclosure </HD>
            <P>38. In connection with the original issuance of certificates, the prospectus or private placement memorandum will be furnished to investing plans. The prospectus or private placement memorandum will contain information material to a fiduciary's decision to invest in the certificates.<SU>25</SU>
              <FTREF/>
            </P>
            <FTNT>
              <P>
                <SU>25</SU> See the Proposal to PTE 2000-58 (August 23, 2000, 65 FR 51454, at page 51486) for a description of types of disclosure.</P>
            </FTNT>
            <P>Reports indicating the amount of payments of principal and interest are provided to certificateholders at least as frequently as distributions are made to certificateholders. Certificateholders will also be provided with periodic information statements setting forth material information concerning the underlying assets, including, where applicable, information as to the amount and number of delinquent and defaulted loans or receivables. </P>
            <P>In the case of a trust that offers and sells certificates in a registered public offering, the trustee, the servicer or the sponsor will file periodic reports in the form and to the extent required under the Securities Exchange Act of 1934 and current interpretations thereof. </P>
            <P>At or about the time distributions are made to certificateholders, a report will be delivered to the trustee as to the status of the trust and its assets, including underlying obligations. Such report will typically contain information regarding the trust's assets (including those purchased by the trust from any pre-funding account), payments received or collected by the servicer, the amount of prepayments, delinquencies, servicer advances, defaults and foreclosures, the amount of any payments made pursuant to any credit support, and the amount of compensation payable to the servicer. Such report also will be delivered to or made available to the rating agency or agencies that have rated the trust's certificates. </P>
            <P>In addition, promptly after each distribution date, certificateholders will receive a statement prepared by the servicer, paying agent or trustee summarizing information regarding the trust and its assets. Such statement will include information regarding the trust and its assets, including underlying receivables. Such statement will typically contain information regarding payments and prepayments, delinquencies, the remaining amount of the guaranty or other credit support and a breakdown of payments between principal and interest. </P>
            <HD SOURCE="HD2">Forward Delivery Commitments </HD>
            <P>39. To date, no forward delivery commitments have been entered into by RBC-DR in connection with the offering of any certificates, but RBC-DR may contemplate entering into such commitments. The utility of forward delivery commitments has been recognized with respect to offering similar certificates backed by pools of residential mortgages, and RBC-DR may find it desirable in the future to enter into such commitments for the purchase of certificates. </P>
            <HD SOURCE="HD2">Secondary Market Transactions </HD>
            <P>40. It is the Applicant's normal policy to attempt to make a market for certificates for which it is lead or co-managing underwriter, and it is the Applicant's intention to make a market for any certificates for which the Applicant is a lead or co-managing underwriter, although it will have no obligation to do so. At times the Applicant will facilitate sales by investors who purchase certificates if the Applicant has acted as agent or principal in the original private placement of the certificates and if such investors request the Applicant's assistance. </P>
            <HD SOURCE="HD2">Retroactive Relief </HD>
            <P>41. RBC-DR represents that it has not assumed that retroactive relief would be granted prior to the date of its application, and therefore has not engaged in transactions related to mortgage-backed and asset-backed securities based on such an assumption. However, RBC-DR requests the exemptive relief granted to be retroactive to the date of its application, and would like to rely on such retroactive relief for transactions entered into prior to the date exemptive relief may be granted. </P>
            <HD SOURCE="HD2">Summary </HD>
            <P>42. In summary, the Applicant represents that the transactions for which exemptive relief is requested satisfy the statutory criteria of section 408(a) of the Act due to the following: </P>
            <P>(a) The Issuers contain “fixed pools” of assets. There is little discretion on the part of the sponsor to substitute receivables contained in the Issuer once the Issuer has been formed; </P>
            <P>(b) In the case where a pre-funding account is used, the characteristics of the receivables to be transferred to the Issuer during the pre-funding period must be substantially similar to the characteristics of those transferred to the Issuer on the closing date thereby giving the sponsor and/or originator little discretion over the selection process, and compliance with this requirement will be assured by the specificity of the characteristics and monitoring mechanisms contemplated under the exemptive relief proposed. In addition, certain cash accounts will be established to support the certificate interest rate and such cash accounts will be invested in short-term, conservative investments; the pre-funding period will be of a reasonably short duration; a pre-funding limit will be imposed; and any Internal Revenue Service requirements with respect to pre-funding intended to preserve the passive income character of the Issuer will be met. Thus, the fiduciary of the plans making the decision to invest in securities will be fully apprised of the nature of the receivables which will be held in the Issuer and will have sufficient information to make a prudent investment decision; </P>
            <P>(c) Securities for which exemptive relief is requested will have been rated in one of the three highest rating categories (or four in the case of Designated Transactions) by a rating agency. The rating agency, in assigning a rating to such securities, will take into account the fact that Issuers may hold interest rate swaps or yield supplement agreements with notional principal amounts or, in Designated Transactions, securities may be issued by Issuers holding residential and home equity loans with LTV ratios in excess of 100%. Credit support will be obtained to the extent necessary to attain the desired rating; </P>

            <P>(d) Securities will be issued by Issuers whose assets will be protected from the claims of the sponsor's creditors in the event of bankruptcy or other insolvency of the sponsor, and both equity and debt securityholders will have a beneficial or <PRTPAGE P="49321"/>security interest in the receivables held by the Issuer. In addition, an independent trustee will represent the securityholders' interests in dealing with other parties to the transaction; and </P>
            <P>(e) All transactions for which RBC-DR seeks exemptive relief will be governed by the pooling and servicing agreement, which is summarized in the prospectus or private placement memorandum and distributed to plan fiduciaries for their review prior to the plan's investment in securities. </P>
            <P>
              <E T="03">Notice to Interested Persons:</E> RBC-DR represents that any securities offered in reliance upon the proposed exemption prior to the date the final exemption is published in the <E T="04">Federal Register</E> shall disclose in the offering memorandum or prospectus: (a) The availability of the proposed exemption; (b) the right of potentially interested plan fiduciaries to comment on the proposed exemption; and (c) information on how an interested plan fiduciary can obtain a copy of the proposed exemption (once it is available) from RBC-DR. Once this proposed exemption is granted, a copy of the exemption published in the <E T="04">Federal Register</E> shall be distributed to any current or prospective plan investor in a security offered in reliance upon the exemption upon request of such investor. Each offering memorandum or prospectus offering securities in reliance upon the exemption shall describe and disclose the availability of the exemption. </P>

            <P>Comments and requests for a hearing must be received by the Department not later than 45 days from the date of publication of this notice of proposed exemption in the <E T="04">Federal Register</E>. </P>
          </FURINF>
          <FURINF>
            <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD>
            <P>Gary Lefkowitz of the Department, telephone (202) 693-8546. (This is not a toll-free number.) </P>
            <HD SOURCE="HD1">General Information </HD>
            <P>The attention of interested persons is directed to the following: </P>
            <P>(1) The fact that a transaction is the subject of an exemption under section 408(a) of the Act and/or section 4975(c)(2) of the Code does not relieve a fiduciary or other party in interest or disqualified person from certain other provisions of the Act and/or the Code, including any prohibited transaction provisions to which the exemption does not apply and the general fiduciary responsibility provisions of section 404 of the Act, which, among other things, require a fiduciary to discharge his duties respecting the plan solely in the interest of the participants and beneficiaries of the plan and in a prudent fashion in accordance with section 404(a)(1)(b) of the Act; nor does it affect the requirement of section 401(a) of the Code that the plan must operate for the exclusive benefit of the employees of the employer maintaining the plan and their beneficiaries; </P>
            <P>(2) Before an exemption may be granted under section 408(a) of the Act and/or section 4975(c)(2) of the Code, the Department must find that the exemption is administratively feasible, in the interests of the plan and of its participants and beneficiaries, and protective of the rights of participants and beneficiaries of the plan; </P>
            <P>(3) The proposed exemptions, if granted, will be supplemental to, and not in derogation of, any other provisions of the Act and/or the Code, including statutory or administrative exemptions and transitional rules. Furthermore, the fact that a transaction is subject to an administrative or statutory exemption is not dispositive of whether the transaction is in fact a prohibited transaction; and </P>
            <P>(4) The proposed exemptions, if granted, will be subject to the express condition that the material facts and representations contained in each application are true and complete, and that each application accurately describes all material terms of the transaction which is the subject of the exemption. </P>
            <SIG>
              <DATED>Signed at Washington, DC, this 11th day of August, 2003. </DATED>
              <NAME>Ivan Strasfeld, </NAME>
              <TITLE>Director of Exemption Determinations, Employee Benefits Security Administration, Department of Labor. </TITLE>
            </SIG>
          </FURINF>
        </SUPLINF>
        <FRDOC>[FR Doc. 03-20766 Filed 8-14-03; 8:45 am] </FRDOC>
        <BILCOD>BILLING CODE 4510-29-P</BILCOD>
      </NOTICE>
    </NOTICES>
  </NEWPART>
</FEDREG>
